data_5jtq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jtq _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 62.6 m . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 107.286 -1.376 . . . . 60.44 107.286 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -136.98 132.1 33.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.425 0.69 . . . . 61.1 109.27 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -137.77 134.95 35.87 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.746 0.418 . . . . 64.41 110.1 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 pp -81.58 88.2 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 109.201 -0.666 . . . . 75.21 109.201 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -74.91 -41.71 59.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.297 0.639 . . . . 74.12 110.601 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -165.56 133.47 3.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.971 -0.559 . . . . 74.5 110.3 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' HG3' ' C' ' 130' ' ' PRO . 3.8 mp -131.04 120.26 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.386 -1.338 . . . . 73.33 107.386 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -164.06 176.21 9.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.696 0.799 . . . . 70.32 110.411 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.464 HG22 ' SG ' ' A' ' 113' ' ' CYS . 78.7 p -92.69 117.9 30.48 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.201 -0.666 . . . . 73.24 109.201 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 43.9 mtpt -75.69 -30.52 59.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.909 -0.404 . . . . 75.13 109.909 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.59 143.13 19.55 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.543 -0.753 . . . . 73.23 109.63 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 68.4 mt -139.3 144.34 29.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.618 -1.252 . . . . 74.2 107.618 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -150.03 136.19 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.375 -0.602 . . . . 71.42 109.375 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.531 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -140.82 109.75 6.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.714 -1.587 . . . . 73.23 106.714 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.81 119.52 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.48 -0.563 . . . . 74.43 109.48 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.08 83.16 37.89 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.021 -1.103 . . . . 72.21 108.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.29 -18.48 34.49 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.728 2.285 . . . . 75.41 111.937 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -117.35 37.39 3.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.361 1.064 . . . . 71.41 109.749 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.13 93.18 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 114.379 1.252 . . . . 73.44 114.379 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.19 -25.13 8.87 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.698 1.599 . . . . 74.42 111.649 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -78.97 -14.23 59.33 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.935 1.694 . . . . 74.35 111.418 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.43 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 7.1 p -69.76 -22.31 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.692 0.797 . . . . 62.25 111.879 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.82 -25.59 66.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.808 0.843 . . . . 64.32 111.358 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -86.85 -34.06 19.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.239 1.016 . . . . 73.34 111.48 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 68' ' ' LEU . 12.5 ptpt -80.57 171.76 14.63 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.224 0.535 . . . . 75.41 111.36 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.17 144.96 29.46 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.247 -0.888 . . . . 75.2 109.336 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -89.61 63.73 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.703 0.763 . . . . 74.41 110.956 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -149.08 82.37 7.11 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 114.941 -1.027 . . . . 73.24 108.352 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -85.39 170.01 9.46 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.675 2.25 . . . . 73.24 111.265 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.98 114.72 26.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.621 -0.881 . . . . 65.51 108.621 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.419 HG12 HD21 ' A' ' 126' ' ' LEU . 59.5 t -75.61 96.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.829 0.852 . . . . 64.23 109.532 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.6 tttm -102.45 116.44 32.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.538 1.135 . . . . 75.01 109.204 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.04 128.83 53.5 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.203 -1.036 . . . . 74.14 108.203 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.597 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 16.3 m-20 -115.06 131.04 57.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.084 0.954 . . . . 70.32 108.668 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.5 138.65 53.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.919 0.888 . . . . 73.13 109.657 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 26.5 t70 -155.43 146.81 22.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.67 0.788 . . . . 73.04 109.913 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.09 139.02 35.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.42 0.688 . . . . 73.43 110.617 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -139.86 154.34 47.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.236 1.014 . . . . 63.22 110.183 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -129.08 157.77 40.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.667 0.787 . . . . 74.14 108.947 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.3 t -161.45 115.47 1.97 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.256 -0.275 . . . . 61.43 110.256 -172.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -72.06 104.79 3.69 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 71.33 109.817 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 57' ' ' GLU . 65.1 mt -77.79 -41.35 37.67 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.194 0.998 . . . . 65.21 110.891 176.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.28 -175.62 4.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.644 -1.162 . . . . 61.21 108.379 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -58.63 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.865 0.466 . . . . 64.43 110.671 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 59.15 33.55 22.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.859 1.264 . . . . 62.24 112.483 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 61.5 t -112.95 118.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.717 -1.586 . . . . 75.01 106.717 167.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -129.6 131.69 46.56 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.766 -0.828 . . . . 75.33 108.766 -177.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD13 ' A' ' 51' ' ' LEU . 43.6 tt0 -89.25 121.07 31.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.697 0.799 . . . . 73.23 109.054 173.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 99.0 t -100.25 121.85 51.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 123.807 0.843 . . . . 75.32 108.775 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.5 t -108.5 133.66 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.666 -0.494 . . . . 64.14 109.666 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.94 116.0 31.19 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.067 -1.457 . . . . 73.1 107.067 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -91.78 102.3 14.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.635 -1.246 . . . . 65.24 107.635 170.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.453 ' HB ' HD11 ' A' ' 114' ' ' ILE . 2.9 t -101.18 130.33 50.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.036 -1.468 . . . . 73.53 107.036 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -132.04 125.99 32.8 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.221 0.534 . . . . 71.41 109.726 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 47.3 t -111.28 110.05 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.156 0.982 . . . . 73.4 109.167 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 26.3 m -101.12 135.94 41.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.667 -0.864 . . . . 73.43 108.667 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.52 103.85 7.57 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.751 -1.204 . . . . 71.15 107.751 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 m -143.67 128.06 17.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.203 0.601 . . . . 71.11 109.535 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -94.28 84.93 4.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.502 -1.295 . . . . 75.33 107.502 172.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -116.89 4.66 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.539 -1.209 . . . . 74.54 111.277 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.01 -25.44 21.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 70.14 111.059 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.565 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 tp10 -81.25 96.05 7.14 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.556 -0.535 . . . . 73.34 109.556 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -75.31 129.0 36.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.313 0.645 . . . . 73.01 110.811 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.11 4.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.015 0.926 . . . . 75.32 108.917 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -164.94 173.99 11.02 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.586 -1.188 . . . . 72.23 110.62 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.9 tp -140.92 137.75 33.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.575 1.15 . . . . 72.03 108.449 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.0 m -127.54 141.96 51.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.802 1.241 . . . . 74.32 108.751 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.14 134.91 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.207 -0.664 . . . . 74.31 109.207 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.76 111.57 8.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 123.776 0.831 . . . . 73.54 108.991 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -85.52 84.53 7.59 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.437 -0.949 . . . . 64.11 108.437 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.17 96.36 6.53 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.697 -1.223 . . . . 72.23 107.697 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.99 146.33 16.55 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 111.665 -0.574 . . . . 75.33 111.665 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.98 133.9 5.72 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.027 -0.829 . . . . 73.01 111.027 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -85.79 127.49 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.075 -0.713 . . . . 74.21 109.075 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.6 118.95 18.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.155 -1.054 . . . . 74.1 108.155 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 54.0 p -89.52 94.04 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.837 -0.801 . . . . 54.13 108.837 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.71 HG12 HD12 ' A' ' 98' ' ' LEU . 2.8 pp -119.21 144.01 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.747 0.419 . . . . 74.25 111.259 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.31 177.52 3.08 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.273 1.429 . . . . 70.22 108.835 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.34 89.82 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.898 0.719 . . . . 73.34 114.898 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.457 ' O ' ' HE2' ' A' ' 94' ' ' MET . 1.6 pp -136.1 150.15 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.069 -1.085 . . . . 75.42 108.069 173.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -128.55 173.63 10.09 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.484 -0.561 . . . . 74.33 109.484 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.83 -112.33 1.61 Allowed Glycine 0 C--N 1.352 1.434 0 O-C-N 124.832 1.333 . . . . 73.51 116.176 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.0 p -61.89 -50.81 70.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 73.13 111.5 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.43 -33.99 69.89 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.382 0.673 . . . . 70.51 112.118 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.457 ' HE2' ' O ' ' A' ' 89' ' ' ILE . 49.1 tpp -63.85 -51.57 64.05 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.304 0.378 . . . . 63.34 110.381 174.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.56 -35.78 76.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.153 0.581 . . . . 62.21 111.067 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.74 -22.22 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.118 0.967 . . . . 71.43 111.103 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.457 ' HB3' HD22 ' A' ' 98' ' ' LEU . 43.3 t -70.61 -60.55 2.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.638 -0.505 . . . . 75.54 109.638 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.71 HD12 HG12 ' A' ' 86' ' ' ILE . 1.7 mm? -81.92 -23.14 36.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.837 -0.619 . . . . 74.23 111.822 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.32 -28.03 9.48 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 123.534 0.521 . . . . 74.4 113.857 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.97 -63.59 1.42 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.478 0.639 . . . . 72.11 111.004 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.3 -50.23 70.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.778 0.831 . . . . 73.35 112.55 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.0 m -65.12 -49.09 68.36 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.077 -0.963 . . . . 73.42 112.65 -172.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.57 -24.29 56.13 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 121.848 1.698 . . . . 73.25 112.703 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -74.03 -27.74 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.271 0.628 . . . . 54.31 110.44 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.23 -39.67 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.57 0.748 . . . . 73.23 109.718 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 mt -76.72 -24.86 53.07 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.339 -0.846 . . . . 73.13 111.692 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.05 -41.86 47.48 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 114.535 1.309 . . . . 75.23 114.535 -169.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.94 -38.73 76.84 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.034 1.823 . . . . 75.23 113.007 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -77.95 -31.87 51.18 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.684 -0.689 . . . . 74.45 111.245 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.439 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -68.19 -45.69 72.7 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.357 0.663 . . . . 73.42 109.506 174.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HD13 ' C' ' 105' ' ' ILE . 36.0 ttm180 -51.3 -52.85 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.988 1.43 . . . . 73.23 110.382 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.37 -47.81 80.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.724 -1.126 . . . . 72.22 111.86 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.515 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.4 t -59.88 -29.85 68.61 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.949 0.781 . . . . 73.51 111.77 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 118' ' ' VAL . 94.8 mt -73.29 -58.67 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.534 -0.543 . . . . 73.32 109.534 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -51.24 -39.85 57.55 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.093 1.357 . . . . 70.51 112.641 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -70.23 -40.66 74.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.082 -0.963 . . . . 74.22 111.283 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.17 -43.24 99.27 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 120.864 0.364 . . . . 74.15 110.585 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.8 t -57.17 -45.8 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 114.663 -1.153 . . . . 71.24 110.92 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -70.57 -30.9 67.72 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.529 -0.76 . . . . 74.13 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -68.96 -31.28 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.501 0.72 . . . . 73.13 110.86 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 3.52 65.65 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.447 -0.64 . . . . 70.02 113.418 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 67.25 35.17 4.54 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.419 1.104 . . . . 62.11 109.781 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -111.24 149.79 41.06 Favored Pre-proline 0 N--CA 1.478 0.926 0 CA-C-N 114.865 -1.061 . . . . 71.11 110.044 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.35 143.14 94.67 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.872 2.381 . . . . 72.24 112.808 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -53.72 138.62 34.81 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.856 0.862 . . . . 73.22 112.459 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.466 ' HG ' HG12 ' A' ' 64' ' ' VAL . 1.4 tm? -120.93 109.28 14.91 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.579 -1.267 . . . . 72.23 107.579 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -98.97 127.17 44.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.764 0.825 . . . . 74.42 108.859 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 132.59 43.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.412 0.685 . . . . 73.5 109.817 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.58 130.04 86.23 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 118.68 -0.676 . . . . 75.21 109.848 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.61 115.65 2.82 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.341 2.027 . . . . 70.45 111.887 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.86 114.2 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.316 -1.364 . . . . 73.23 107.316 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -76.9 74.68 3.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.4 0.68 . . . . 72.05 109.97 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -55.6 -44.05 76.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 71.12 110.994 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 114.768 -1.105 . . . . 73.13 111.972 -178.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.4 ptm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.194 1.183 . . . . 73.45 114.194 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.577 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 32.8 m -152.79 127.51 9.49 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.188 -1.412 . . . . 70.21 107.188 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -124.3 154.46 40.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.963 -0.755 . . . . 74.21 108.963 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.65 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 50.2 tt0 -153.49 139.42 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.959 0.904 . . . . 72.14 109.829 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.59 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -97.55 113.15 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.092 -1.447 . . . . 74.42 107.092 166.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -77.76 -49.4 14.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.034 -0.416 . . . . 70.14 110.042 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -161.94 133.05 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.478 -0.328 . . . . 75.33 110.194 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.13 137.42 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 107.046 -1.465 . . . . 75.43 107.046 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.89 145.52 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.365 0.602 . . . . 74.14 111.744 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 65.6 m -75.81 115.15 15.21 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.907 -1.042 . . . . 73.43 108.698 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.417 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.1 mtpt -85.75 -31.39 22.43 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.088 0.555 . . . . 74.22 110.568 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.3 t70 -157.78 143.84 17.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.729 -0.668 . . . . 70.21 111.303 -168.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 37.6 mm -139.97 141.03 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 125.304 1.442 . . . . 74.21 108.646 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -141.26 132.39 26.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.601 -1.259 . . . . 75.12 107.601 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 84.5 t80 -144.27 109.71 5.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.244 -1.761 . . . . 75.4 106.244 170.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -119.18 117.3 28.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.013 -0.736 . . . . 74.34 109.013 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.36 86.1 7.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.708 -1.219 . . . . 75.51 107.708 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.57 -28.02 32.1 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.447 2.098 . . . . 73.53 110.811 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -107.0 27.77 8.67 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.745 1.218 . . . . 71.21 109.244 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.62 -57.39 9.98 Favored Pre-proline 0 CA--C 1.57 1.734 0 C-N-CA 124.67 1.188 . . . . 74.32 112.954 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.48 -1.28 10.56 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 121.77 1.647 . . . . 74.14 112.843 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -99.57 -16.43 18.27 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.644 0.778 . . . . 73.04 111.885 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.18 -21.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.534 0.733 . . . . 72.34 112.784 -167.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -73.65 -16.72 61.21 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.517 0.192 . . . . 74.04 111.517 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -81.69 -4.87 57.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.664 0.786 . . . . 72.53 111.082 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.606 ' HD2' ' HB2' ' B' ' 68' ' ' LEU . 72.7 mmtt -106.51 102.17 11.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.573 1.149 . . . . 73.31 109.898 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -115.9 85.99 2.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 72.21 111.954 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.468 ' HB2' HD23 ' B' ' 68' ' ' LEU . 6.2 m0 -159.27 -170.5 3.0 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.678 1.991 . . . . 74.11 106.657 169.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -83.51 125.4 73.94 Favored Pre-proline 0 N--CA 1.478 0.925 0 N-CA-C 107.628 -1.249 . . . . 72.31 107.628 162.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.505 ' HA ' ' HG ' ' B' ' 68' ' ' LEU . 30.3 Cg_endo -62.68 132.64 38.52 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.08 1.853 . . . . 61.35 112.143 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -68.93 103.27 1.77 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.657 -1.156 . . . . 74.11 108.443 171.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.17 128.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.742 0.817 . . . . 74.13 110.079 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -121.75 109.74 15.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.642 1.177 . . . . 74.51 108.048 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.15 153.57 19.24 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.608 0.763 . . . . 63.43 110.64 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.624 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.0 m-20 -136.04 137.17 40.88 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.948 -1.13 . . . . 75.51 107.948 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.475 HD22 HG21 ' B' ' 131' ' ' VAL . 7.1 mp -115.78 132.64 56.58 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.083 -0.71 . . . . 74.44 109.083 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.9 t70 -139.05 155.94 47.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.846 1.258 . . . . 73.11 108.637 -173.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.32 140.11 39.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.759 0.824 . . . . 73.33 109.042 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.61 116.88 17.23 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.485 -1.302 . . . . 75.04 107.485 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -106.38 161.5 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.109 0.564 . . . . 64.14 110.733 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -160.48 136.04 8.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.688 -0.856 . . . . 74.35 108.688 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -88.4 120.27 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.649 -0.871 . . . . 72.35 108.649 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 mt -81.28 -39.33 25.41 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.259 0.552 . . . . 75.53 110.375 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.32 -177.86 6.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.789 -1.096 . . . . 62.54 110.016 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -69.87 130.66 42.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.068 -1.086 . . . . 74.33 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.49 -4.81 1.27 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.604 1.162 . . . . 75.24 112.761 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -123.08 116.96 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.628 0.771 . . . . 74.04 109.61 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.421 ' HD2' HG11 ' B' ' 58' ' ' VAL . 30.0 p90 -126.19 171.58 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.188 0.595 . . . . 75.23 109.418 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -144.71 108.15 4.61 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.625 -1.25 . . . . 74.51 107.625 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' B' ' 56' ' ' TYR . 29.5 m -104.47 137.47 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.148 -0.686 . . . . 72.31 109.148 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.38 119.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.149 -0.686 . . . . 74.23 109.149 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.02 114.32 26.84 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.54 -1.281 . . . . 74.43 107.54 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.5 ttt180 -106.24 122.29 45.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.78 0.832 . . . . 75.31 109.985 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -113.27 118.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.806 -0.813 . . . . 75.05 108.806 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 20.1 m -99.92 145.37 27.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.418 1.087 . . . . 75.54 108.513 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.409 HG23 HD12 ' B' ' 114' ' ' ILE . 52.3 t -136.57 130.17 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.702 0.801 . . . . 74.43 109.268 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -120.96 145.58 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.134 -1.062 . . . . 73.32 108.134 171.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.56 151.33 37.15 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.711 0.291 . . . . 63.15 110.36 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -162.25 143.24 10.41 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.672 1.232 . . . . 63.2 109.657 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.606 ' HB2' ' HD2' ' B' ' 34' ' ' LYS . 5.0 mp -112.38 137.08 51.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.249 -1.019 . . . . 74.22 108.249 168.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.13 -118.33 6.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.112 -0.795 . . . . 75.23 111.112 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.59 29.48 6.57 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.481 0.712 . . . . 74.14 110.506 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -145.4 142.92 29.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.113 0.565 . . . . 73.51 110.355 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 9.1 m -59.52 151.83 23.35 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.338 1.055 . . . . 72.04 112.137 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.505 ' HB3' HD13 ' B' ' 68' ' ' LEU . . . -112.27 -61.78 1.67 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.446 1.098 . . . . 64.3 108.926 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.8 156.88 28.28 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.79 -1.55 . . . . 74.42 108.94 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.37 141.93 49.11 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.335 -1.358 . . . . 73.13 107.335 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.1 t -154.21 152.48 30.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.454 -0.573 . . . . 72.04 109.454 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.15 140.71 5.34 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.264 -0.643 . . . . 72.35 109.264 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' B' ' 110' ' ' ALA . 94.3 t -133.66 146.79 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.079 0.952 . . . . 75.43 108.748 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.7 mt-30 -126.34 101.05 6.54 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.233 0.613 . . . . 74.21 109.443 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -90.8 105.34 17.75 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.531 -0.759 . . . . 74.45 109.801 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.36 156.19 23.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 111.532 -0.627 . . . . 64.44 111.532 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 126.56 1.96 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 111.862 -0.495 . . . . 63.33 111.862 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.0 126.18 40.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.575 -0.898 . . . . 75.12 108.575 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -131.51 155.95 46.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.223 1.009 . . . . 75.03 109.093 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.65 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 44.1 m -131.92 134.32 45.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.293 1.037 . . . . 65.24 109.627 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.734 ' HB ' HD12 ' B' ' 89' ' ' ILE . 2.7 pp -131.59 147.7 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.152 0.981 . . . . 74.55 111.006 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.577 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -154.5 149.7 27.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.436 1.094 . . . . 72.22 108.763 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.04 -47.25 2.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.12 0.39 . . . . 54.21 113.905 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.734 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -83.94 165.0 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.531 0.732 . . . . 74.25 112.073 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -167.9 163.51 13.87 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.729 0.811 . . . . 53.21 110.361 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -113.22 5.0 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.992 0.808 . . . . 74.33 113.143 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.7 m -74.08 -34.28 63.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.871 0.868 . . . . 73.13 111.052 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -32.9 74.15 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.039 0.535 . . . . 73.24 109.913 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.493 ' HE1' HD23 ' B' ' 98' ' ' LEU . 13.2 tpt -76.98 -43.98 32.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.476 0.71 . . . . 62.13 110.811 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.14 75.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.828 0.851 . . . . 73.11 111.321 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -70.81 -30.41 66.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.285 1.034 . . . . 62.31 111.084 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -69.47 -59.45 2.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.092 0.557 . . . . 74.22 110.384 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.493 HD23 ' HE1' ' B' ' 94' ' ' MET . 2.5 pp -72.45 -19.07 61.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.88 0.326 . . . . 74.24 111.88 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -22.07 43.66 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.493 0.557 . . . . 74.42 114.493 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.18 -55.26 0.44 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.189 0.494 . . . . 74.14 111.572 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -62.07 -45.53 93.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.742 0.817 . . . . 73.53 112.082 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 85.8 m -71.13 -47.15 14.33 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.546 -0.74 . . . . 75.34 112.222 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.86 -31.5 52.37 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.249 1.966 . . . . 65.43 114.221 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -36.64 83.02 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 122.941 0.496 . . . . 74.33 111.558 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.03 -45.21 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.592 0.757 . . . . 72.34 110.4 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.08 -25.24 40.13 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.043 -0.981 . . . . 63.3 113.058 -169.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.76 -47.85 94.69 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 117.399 -1.286 . . . . 71.22 113.975 -170.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.18 -41.12 50.73 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.333 2.022 . . . . 74.33 113.655 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -68.1 -51.73 43.04 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.609 -0.723 . . . . 74.23 110.99 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.4 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -60.15 -40.97 91.71 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.564 0.745 . . . . 75.44 111.294 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 23.6 ttp180 -61.88 -58.93 6.05 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.256 1.422 . . . . 71.44 110.992 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -69.79 -26.42 64.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.728 -1.124 . . . . 75.3 111.098 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.3 t -68.63 -37.18 79.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.824 0.45 . . . . 52.32 111.062 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.409 HD12 HG23 ' B' ' 64' ' ' VAL . 76.6 mt -60.61 -49.24 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.126 0.57 . . . . 72.32 109.768 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -69.68 -23.44 63.45 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.606 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.0 t -75.89 -29.1 58.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.697 0.799 . . . . 64.34 110.958 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.464 ' HE1' HG22 ' B' ' 21' ' ' ILE . 21.5 mmt -78.94 -26.68 43.63 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.766 0.426 . . . . 74.34 110.187 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' B' ' 125' ' ' GLN . 49.6 t -58.85 -41.82 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.96 0.904 . . . . 71.44 111.113 170.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.5 t -53.1 -38.72 62.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.401 1.081 . . . . 71.23 111.634 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.0 mtt-85 -76.67 -26.52 54.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.113 -0.949 . . . . 74.42 111.377 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.2 0.54 81.6 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-O 119.472 -0.626 . . . . 72.24 113.743 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p 63.12 18.91 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.112 1.765 . . . . 75.15 114.484 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -110.42 166.76 10.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-O 118.73 -0.652 . . . . 74.21 110.683 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.31 147.19 22.15 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.34 2.694 . . . . 75.14 114.539 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.499 ' HA ' HG13 ' B' ' 118' ' ' VAL . 5.0 pm0 -54.1 145.0 18.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.05 1.34 . . . . 74.33 113.729 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -133.23 85.4 2.21 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.537 -1.283 . . . . 74.12 107.537 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -104.93 133.76 49.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.909 -1.145 . . . . 74.42 107.909 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.562 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.0 mm? -86.7 138.47 31.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.369 0.668 . . . . 75.35 109.544 -169.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.96 148.71 98.39 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.078 0.551 . . . . 73.21 110.603 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.31 112.93 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.804 2.336 . . . . 73.33 111.634 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.475 HG21 HD22 ' B' ' 44' ' ' LEU . 90.9 t -89.77 127.32 42.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.869 0.468 . . . . 64.24 109.829 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -80.41 83.18 6.28 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.739 0.816 . . . . 75.44 109.784 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -63.01 -29.09 70.55 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.615 0.766 . . . . 73.54 111.279 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.9 -53.53 17.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 72.21 110.257 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.63 77.38 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.272 0.629 . . . . 53.44 110.682 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 tt . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 124.249 1.02 . . . . 74.02 110.549 179.481 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.403 ' SD ' HD11 ' C' ' 89' ' ' ILE . 51.9 ttp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.93 0.395 . . . . 74.35 111.838 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 35.6 m -83.83 85.47 7.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 73.35 108.399 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' C' ' 85' ' ' SER . 50.0 t80 -106.44 140.97 38.51 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.413 -1.267 . . . . 74.22 109.443 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 6.0 tp60 -145.68 137.39 25.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.831 0.452 . . . . 73.54 110.477 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.31 110.31 19.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.94 -1.133 . . . . 75.25 107.94 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.428 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 86.8 mm-40 -83.99 -49.22 9.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.867 -0.419 . . . . 73.32 109.867 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -169.1 136.8 1.89 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.693 -0.685 . . . . 75.31 109.627 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -117.06 138.93 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.744 -1.206 . . . . 74.31 107.744 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -176.46 144.02 0.51 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.6 0.36 . . . . 75.03 110.822 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -70.48 124.55 24.47 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.408 0.683 . . . . 60.12 110.124 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -77.07 -49.45 15.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.873 -1.158 . . . . 73.52 107.873 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -135.01 142.14 46.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.185 -1.371 . . . . 75.45 110.309 -174.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.2 mt -136.18 143.01 37.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.055 -1.832 . . . . 74.53 106.055 173.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -156.07 150.31 25.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.311 0.577 . . . . 73.1 109.954 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -148.76 138.79 22.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.627 -1.169 . . . . 71.31 108.034 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.1 132.12 35.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.768 -1.197 . . . . 74.13 107.768 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.12 80.93 16.4 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 64.23 107.254 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.83 -38.19 40.61 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.514 2.143 . . . . 73.34 110.996 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -100.1 32.89 2.79 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.382 1.073 . . . . 73.33 109.914 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.84 96.0 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.131 1.16 . . . . 74.41 114.131 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.88 -23.68 13.83 Favored 'Trans proline' 0 C--N 1.383 2.36 0 CA-C-N 121.435 1.548 . . . . 43.51 112.834 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -65.19 -20.38 66.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.532 0.733 . . . . 73.22 112.852 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' C' ' 34' ' ' LYS . 52.6 t -49.46 -32.07 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.284 1.034 . . . . 64.43 113.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.96 -39.88 96.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.893 0.477 . . . . 72.0 111.695 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.86 15.2 25.74 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.079 0.952 . . . . 75.35 111.261 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.683 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 3.4 ttpm? -108.68 137.02 47.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.873 0.869 . . . . 74.44 109.023 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 131.83 35.24 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.176 -1.046 . . . . 73.1 108.176 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -79.67 72.26 6.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.079 0.552 . . . . 74.32 109.813 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -143.28 48.15 0.92 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 123.79 0.836 . . . . 74.21 110.165 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.11 143.81 18.12 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 121.358 1.372 . . . . 75.23 110.841 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.11 115.21 24.35 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 54.21 108.789 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.99 107.5 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.391 -0.822 . . . . 73.32 110.24 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.463 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 7.3 tmtt? -92.45 104.56 16.87 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 106.375 -1.713 . . . . 74.02 106.375 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.408 HD12 ' HG ' ' C' ' 128' ' ' LEU . 13.5 tp -84.0 146.95 27.7 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.73 -1.211 . . . . 75.42 107.73 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.48 143.3 31.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.257 -1.386 . . . . 73.1 107.257 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 153.97 51.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.233 0.54 . . . . 72.2 111.379 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.8 t70 -151.38 153.26 34.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.784 1.234 . . . . 73.05 108.626 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -139.33 141.53 37.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.077 -0.712 . . . . 71.33 109.077 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -128.66 170.09 13.68 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.101 0.96 . . . . 74.52 109.106 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -147.14 144.66 29.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.457 0.703 . . . . 54.14 109.995 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 66.2 p -144.88 126.29 14.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.265 -1.013 . . . . 73.11 108.265 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.88 115.86 19.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' C' ' 57' ' ' GLU . 51.7 mt -89.36 -35.72 15.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.154 0.582 . . . . 75.3 109.635 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.59 -173.84 4.59 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 73.42 110.016 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.65 117.29 8.6 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.378 -0.828 . . . . 70.02 109.775 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 68.58 0.28 2.55 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.603 1.561 . . . . 74.24 112.364 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.72 108.99 24.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.744 -0.836 . . . . 75.23 108.744 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.26 123.53 41.66 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.529 1.132 . . . . 74.51 108.756 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.666 ' HB2' HD12 ' C' ' 51' ' ' LEU . 32.7 tt0 -83.34 139.05 33.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.253 -1.017 . . . . 75.55 108.253 169.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 95.6 t -118.93 131.86 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.357 -0.979 . . . . 73.11 108.357 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 60.5 t -110.1 102.5 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.745 -0.835 . . . . 73.21 108.745 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -90.56 109.19 20.34 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.109 -1.071 . . . . 75.13 108.109 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.706 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 65.2 mtt85 -95.75 132.7 40.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.814 0.845 . . . . 73.23 109.526 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.0 t -126.62 131.02 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.164 -1.05 . . . . 74.11 108.164 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -125.92 120.45 30.43 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.912 -0.773 . . . . 73.03 108.912 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.442 HG23 HG23 ' C' ' 114' ' ' ILE . 94.4 t -110.27 114.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.145 0.978 . . . . 75.32 108.82 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 16.3 m -98.81 139.16 34.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.868 -1.16 . . . . 75.11 107.868 168.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.98 110.65 7.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.024 -1.843 . . . . 63.24 106.024 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.435 ' HB3' HG23 ' C' ' 72' ' ' THR . 12.5 p -158.16 139.99 13.89 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.641 0.588 . . . . 74.4 110.689 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.0 tp -80.7 -23.85 39.24 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.473 -0.785 . . . . 72.54 109.276 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.04 -97.2 0.11 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 110.056 -1.217 . . . . 71.3 110.056 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -90.46 -31.93 16.6 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.651 -0.87 . . . . 74.1 108.651 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -69.93 84.04 0.49 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.018 -1.105 . . . . 72.13 108.018 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.435 HG23 ' HB3' ' C' ' 67' ' ' SER . 78.7 m -87.89 136.72 32.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.248 -1.342 . . . . 75.12 109.889 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.683 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -72.32 -73.56 0.19 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.92 -1.141 . . . . 64.55 107.92 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.0 167.59 29.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.736 0.779 . . . . 75.4 112.333 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -125.59 138.71 53.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 105.726 -1.953 . . . . 72.35 105.726 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -151.77 113.27 4.36 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 110.011 -0.366 . . . . 74.21 110.011 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -117.06 136.11 53.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.518 0.327 . . . . 74.42 110.129 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' C' ' 110' ' ' ALA . 25.4 t -125.25 114.16 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 55.24 108.673 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.706 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 53.8 mt-30 -90.26 92.7 9.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.472 -0.936 . . . . 74.44 108.472 171.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.16 136.54 37.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.687 -0.688 . . . . 74.24 109.345 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.42 153.04 17.67 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.3 -0.72 . . . . 60.15 111.3 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.436 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -154.94 121.19 1.08 Allowed Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 111.477 -0.649 . . . . 75.22 111.477 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.3 mm -81.71 120.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 107.685 -1.228 . . . . 72.43 107.685 174.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -131.83 138.01 48.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.512 0.725 . . . . 62.11 109.962 -174.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 58.9 m -89.89 113.93 25.62 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.552 -0.906 . . . . 64.43 108.552 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.6 100.55 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.96 -1.126 . . . . 71.42 107.96 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -130.74 152.68 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.914 0.886 . . . . 64.3 110.352 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.16 -39.3 2.8 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.02 -0.536 . . . . 73.44 112.209 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.403 HD11 ' SD ' ' C' ' 9' ' ' MET . 47.6 pt -104.57 160.01 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.256 0.622 . . . . 72.14 109.968 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.432 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 10.7 tp10 -151.03 152.86 34.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.169 0.588 . . . . 75.22 110.551 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.45 -111.91 4.17 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.769 0.668 . . . . 31.1 113.198 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.3 p -73.73 -34.37 64.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.051 0.94 . . . . 74.21 111.693 -175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.26 -36.55 74.52 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.694 -0.484 . . . . 72.21 109.694 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 59.5 ttm -68.23 -36.46 79.53 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.913 -0.585 . . . . 73.01 110.174 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -33.09 74.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.638 0.775 . . . . 71.55 111.024 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -68.34 -35.57 77.96 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.14 0.576 . . . . 73.53 110.845 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 24.9 t -71.87 -62.65 1.34 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.638 0.375 . . . . 72.32 110.633 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.1 pp -75.71 -14.13 60.33 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.309 0.485 . . . . 74.54 112.309 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.31 -18.99 37.04 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.602 -0.555 . . . . 74.12 113.259 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.81 -56.48 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.786 0.793 . . . . 73.53 112.642 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -66.53 -61.15 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.61 0.364 . . . . 75.14 111.862 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 40.6 m -57.05 -45.45 99.95 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 124.08 0.952 . . . . 73.35 113.457 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.79 -25.2 46.12 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.798 1.666 . . . . 73.24 113.493 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -70.55 -29.16 65.55 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.754 0.422 . . . . 72.54 110.175 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.484 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.4 mm -68.4 -40.07 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.569 0.748 . . . . 65.3 109.939 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.436 HD23 ' HA3' ' C' ' 82' ' ' GLY . 91.6 mt -78.31 -26.28 46.88 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.99 -1.005 . . . . 74.22 112.307 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.0 -42.08 79.9 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.507 -1.235 . . . . 75.42 114.062 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.17 -43.63 55.56 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.158 1.905 . . . . 72.43 112.904 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -66.35 -41.31 89.73 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.66 0.784 . . . . 72.52 110.785 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -68.84 -44.8 72.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.665 -0.698 . . . . 73.33 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -50.95 -55.69 16.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.419 1.488 . . . . 72.33 110.995 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.31 -36.82 85.25 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.035 0.834 . . . . 71.22 109.931 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.526 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 12.0 t -66.47 -36.54 83.0 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.444 0.698 . . . . 74.01 111.566 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.451 ' O ' HG23 ' C' ' 118' ' ' VAL . 95.1 mt -70.06 -49.51 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.379 0.672 . . . . 74.32 109.917 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -66.37 -30.23 70.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.109 0.564 . . . . 71.13 111.187 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -65.45 -45.87 82.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.113 -0.699 . . . . 74.52 109.113 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.582 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.73 -34.9 75.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.157 0.983 . . . . 62.14 112.404 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.1 t -62.49 -46.32 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.387 0.675 . . . . 72.35 109.542 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.48 -31.89 72.34 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.149 -0.932 . . . . 71.34 111.669 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.5 mtt-85 -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.376 0.67 . . . . 74.11 109.664 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.35 -4.37 86.86 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.804 0.69 . . . . 73.22 112.811 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.481 HG21 ' HB3' ' D' ' 17' ' ' TYR . 22.9 p 65.57 32.83 9.02 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.716 2.006 . . . . 63.51 113.085 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -89.09 166.49 21.58 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.587 1.155 . . . . 74.1 110.554 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.473 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 31.3 Cg_endo -63.77 112.93 1.95 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.074 1.849 . . . . 74.0 111.89 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -60.99 136.37 58.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.91 0.484 . . . . 74.45 111.023 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -144.6 123.33 12.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.195 -1.039 . . . . 73.33 108.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -103.32 123.73 47.34 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.824 0.45 . . . . 74.34 109.789 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.408 ' HG ' HD12 ' C' ' 42' ' ' LEU . 1.4 tm? -74.24 128.51 35.73 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.16 0.984 . . . . 74.32 109.546 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.5 146.43 98.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.797 0.839 . . . . 70.22 111.374 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.56 ' HG3' HD11 ' A' ' 16' ' ' ILE . 35.5 Cg_endo -61.41 136.09 61.59 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.896 2.397 . . . . 74.33 113.31 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.58 109.83 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.077 -1.082 . . . . 74.44 108.077 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -112.51 93.83 4.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.748 0.819 . . . . 42.2 110.666 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.019 -0.734 . . . . 73.33 109.019 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 124.77 1.228 . . . . 73.13 111.615 174.311 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.488 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.3 ptm . . . . . 0 CA--C 1.563 1.452 0 N-CA-C 114.622 1.341 . . . . 55.51 114.622 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 37.8 m -107.88 143.87 35.89 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.445 0.698 . . . . 70.51 109.318 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.459 ' HB2' ' HE2' ' D' ' 9' ' ' MET . 63.2 t80 -155.55 106.91 2.56 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.39 -0.967 . . . . 75.23 108.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -129.3 146.34 51.21 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.234 0.614 . . . . 75.22 109.614 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.78 109.82 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.568 -1.271 . . . . 63.54 107.568 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -82.69 -47.66 11.77 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.034 0.208 . . . . 74.24 111.46 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -170.11 129.25 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.58 -0.282 . . . . 74.43 111.175 -167.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.442 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.6 mp -103.41 133.2 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.272 -1.381 . . . . 61.51 107.272 173.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.481 ' HB3' HG21 ' C' ' 122' ' ' THR . 27.0 p90 -155.47 144.52 20.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.214 0.531 . . . . 63.14 111.551 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -79.31 115.03 18.71 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.441 -0.8 . . . . 73.41 109.193 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -81.1 -24.5 37.67 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.957 -0.386 . . . . 73.53 109.957 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.9 t70 -153.99 141.59 19.88 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.027 -0.988 . . . . 61.11 109.724 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.582 HG23 ' HE1' ' C' ' 117' ' ' MET . 86.3 mt -139.65 149.55 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.216 1.406 . . . . 74.31 107.689 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -153.04 144.91 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.584 1.154 . . . . 74.43 108.404 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.4 t80 -152.29 115.3 4.65 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 105.928 -1.879 . . . . 72.25 105.928 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.1 mt-10 -127.23 111.41 13.92 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.7 0.4 . . . . 75.42 110.008 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 90.52 4.72 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.809 -1.182 . . . . 71.41 107.809 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.32 -40.56 1.57 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.663 2.242 . . . . 72.0 113.082 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' D' ' 30' ' ' HIS . 5.0 p30 -113.56 43.96 1.68 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.321 1.048 . . . . 74.54 108.927 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.36 -49.23 86.43 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 115.786 1.773 . . . . 75.14 115.786 -169.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 -15.99 13.34 Favored 'Trans proline' 0 C--N 1.388 2.654 0 CA-C-N 122.102 1.786 . . . . 75.33 113.381 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.497 ' HB3' ' HB2' ' D' ' 27' ' ' ASN . 7.1 t-160 -77.08 -46.53 23.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.136 0.974 . . . . 73.01 111.199 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 14.2 p -70.59 -22.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-O 120.968 0.413 . . . . 75.45 110.989 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.17 -33.24 74.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.688 0.795 . . . . 72.45 111.051 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -72.78 -15.37 61.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.703 0.801 . . . . 74.12 111.156 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -93.0 106.82 18.72 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.227 -0.657 . . . . 74.15 109.227 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.41 89.63 7.07 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.285 -0.635 . . . . 71.2 109.285 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.47 ' HB3' HD23 ' D' ' 68' ' ' LEU . 6.3 t-105 -169.99 158.87 7.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 108.487 -0.931 . . . . 74.31 108.487 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.403 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 29.9 mm-40 -86.94 114.48 58.48 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.037 0.535 . . . . 64.22 110.458 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 37.8 Cg_exo -61.79 140.58 86.5 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 123.407 2.738 . . . . 74.15 114.217 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.02 126.16 28.95 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.953 0.901 . . . . 73.55 109.863 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.465 HG11 HG13 ' D' ' 64' ' ' VAL . 47.9 t -99.58 112.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 72.13 110.258 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.413 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 1.4 tmtp? -88.09 122.14 31.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.028 -1.471 . . . . 74.34 107.028 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.08 115.4 27.43 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.773 -1.195 . . . . 74.31 107.773 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.7 m-20 -108.27 136.81 47.3 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.97 -1.122 . . . . 75.52 107.97 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.93 133.33 37.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.083 0.553 . . . . 75.23 109.922 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.8 t70 -142.06 157.25 45.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 74.21 108.198 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -132.29 158.13 42.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.833 0.853 . . . . 74.1 109.5 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -152.68 170.04 21.23 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.957 -0.757 . . . . 64.1 108.957 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 m -150.68 159.56 44.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.973 0.509 . . . . 75.14 109.965 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' D' ' 57' ' ' GLU . 40.3 t -152.06 127.07 9.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.479 -0.934 . . . . 73.14 108.479 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.53 117.8 24.65 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.44 -0.948 . . . . 74.43 108.44 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.2 mt -98.09 -29.73 13.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.171 0.588 . . . . 74.01 110.165 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -161.02 -179.03 7.19 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.033 0.933 . . . . 72.42 109.972 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -68.15 118.66 11.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.006 -0.997 . . . . 75.42 108.819 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 67.53 16.91 9.99 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.131 0.972 . . . . 74.33 112.032 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 76.8 t -127.33 117.12 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.449 -0.945 . . . . 75.13 108.449 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -135.2 129.31 33.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.785 -0.643 . . . . 74.31 109.787 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.3 tt0 -87.15 148.16 25.32 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.604 1.162 . . . . 73.14 108.394 167.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.531 HG12 HD13 ' D' ' 106' ' ' LEU . 4.1 p -134.5 138.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.734 -1.21 . . . . 75.22 107.734 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 94.7 t -108.84 136.85 43.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.072 -0.714 . . . . 75.31 109.072 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.56 116.99 29.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.024 -1.473 . . . . 72.31 107.024 174.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.517 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -97.46 98.21 9.75 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.36 -0.978 . . . . 72.22 108.36 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.1 116.64 39.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.282 -1.007 . . . . 73.43 108.282 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 33.3 m -125.46 132.51 52.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.04 -0.982 . . . . 74.45 109.04 -171.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.638 HG12 HD11 ' D' ' 126' ' ' LEU . 56.6 t -122.59 102.82 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.085 0.954 . . . . 72.23 109.059 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 25.3 m -95.81 91.95 6.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.98 -1.119 . . . . 74.42 107.98 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.51 139.61 31.53 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.598 -0.89 . . . . 75.11 108.598 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.8 p -151.99 135.43 16.05 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.625 0.578 . . . . 73.14 110.34 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' D' ' 36' ' ' TRP . 12.6 tp -112.78 106.09 14.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.714 -0.676 . . . . 74.03 109.318 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.94 -133.12 11.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.755 -0.657 . . . . 75.01 112.201 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 3.78 41.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.584 0.753 . . . . 72.03 111.617 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.46 149.22 45.22 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.729 0.812 . . . . 72.32 109.17 -165.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -56.77 152.85 11.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.405 1.082 . . . . 75.43 111.206 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.26 -62.29 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.463 -0.94 . . . . 73.14 108.463 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.1 149.37 24.52 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.075 -0.966 . . . . 74.43 109.151 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.8 mt -112.03 151.19 29.62 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.982 -1.118 . . . . 73.52 107.982 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.509 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.7 t -158.42 146.77 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.401 0.438 . . . . 73.34 109.987 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.65 132.28 10.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.587 0.755 . . . . 74.01 109.062 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.5 113.2 22.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.425 -0.954 . . . . 73.03 108.425 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.733 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -89.45 81.79 6.53 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.038 -1.097 . . . . 74.33 108.038 171.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.42 ' O ' HD11 ' D' ' 106' ' ' LEU . 6.9 tp-100 -79.7 99.75 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 112.914 -1.948 . . . . 75.51 109.216 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.24 161.66 31.64 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.91 -0.476 . . . . 51.33 111.91 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -164.86 136.23 4.11 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.626 -0.59 . . . . 73.23 111.626 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.96 137.08 22.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.591 0.756 . . . . 74.22 110.074 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.95 132.69 38.71 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.848 0.859 . . . . 71.13 109.533 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 5.7 m -75.52 95.89 3.4 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.352 -0.981 . . . . 74.5 108.352 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 53.4 mt -105.94 99.36 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.451 -0.944 . . . . 64.3 108.451 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -126.88 153.19 46.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.677 1.191 . . . . 74.44 108.778 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.06 -7.9 62.05 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.753 -0.471 . . . . 70.13 113.454 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.508 HD13 ' HG2' ' D' ' 93' ' ' GLN . 5.5 mm -137.97 129.27 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.938 0.895 . . . . 72.45 110.671 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.616 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 3.0 pp20? -148.36 -173.83 4.43 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.655 0.782 . . . . 73.13 110.232 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.42 -140.52 25.46 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.014 -0.326 . . . . 52.42 113.137 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -69.99 -25.11 63.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.202 0.601 . . . . 74.41 110.851 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.508 ' HG2' HD13 ' D' ' 89' ' ' ILE . 6.2 tp-100 -72.74 -32.07 65.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.278 0.631 . . . . 74.32 110.355 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.616 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 21.1 ttt -71.34 -42.41 68.56 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.826 -0.435 . . . . 73.31 109.826 171.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -27.62 69.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.863 0.465 . . . . 74.43 111.036 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.78 -52.76 8.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.676 0.79 . . . . 72.42 110.733 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.29 -51.64 62.51 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.944 0.402 . . . . 72.44 110.963 -172.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 22.5 tp -75.81 -19.3 59.06 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 73.05 110.929 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.41 -5.51 36.93 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.516 -0.602 . . . . 74.42 114.287 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.31 -61.9 0.72 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.941 0.871 . . . . 52.33 111.408 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.83 -47.32 54.0 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.444 0.465 . . . . 74.33 112.027 -171.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 59.8 m -64.75 -44.78 74.38 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 123.491 0.716 . . . . 63.34 111.722 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.9 Cg_exo -57.16 -34.89 98.6 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 122.513 2.142 . . . . 65.55 113.871 166.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.75 -34.43 78.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.082 0.553 . . . . 62.25 110.73 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.37 -33.43 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.796 . . . . 75.32 110.561 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.531 HD13 HG12 ' D' ' 58' ' ' VAL . 91.3 mt -79.38 -20.66 47.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.819 0.848 . . . . 71.24 112.603 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.05 -42.84 64.36 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 113.968 1.099 . . . . 75.45 113.968 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.81 -39.83 87.91 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.054 1.836 . . . . 70.34 113.281 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.67 -36.39 65.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.596 0.758 . . . . 72.34 111.38 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -51.07 70.07 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.297 0.639 . . . . 73.22 110.121 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.0 -48.09 79.28 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.777 1.298 . . . . 75.23 110.589 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.0 -43.16 99.29 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.364 1.04 . . . . 73.44 111.736 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.55 -41.62 97.64 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.553 0.533 . . . . 75.41 110.767 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.509 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.3 mt -67.7 -43.47 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.556 -0.747 . . . . 73.22 110.716 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.4 m -55.63 -46.37 77.41 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.996 0.918 . . . . 70.13 110.66 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.5 t -64.82 -46.93 79.87 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 114.026 -1.443 . . . . 73.15 110.578 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -64.49 -36.5 84.38 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.007 0.523 . . . . 70.12 112.089 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' D' ' 123' ' ' PHE . 45.3 t -67.18 -40.95 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.215 -0.902 . . . . 62.23 110.661 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -75.17 -23.53 57.74 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.416 0.287 . . . . 73.45 111.408 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.526 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 89.2 mtt-85 -74.56 -38.17 62.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.499 0.72 . . . . 73.34 109.723 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.42 1.55 76.11 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.541 -0.754 . . . . 73.21 112.391 173.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 60.13 23.51 12.78 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.852 2.061 . . . . 71.44 113.146 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.467 ' HB2' HG13 ' D' ' 118' ' ' VAL . 78.7 m-85 -80.6 161.16 65.22 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 124.862 1.265 . . . . 70.42 109.114 169.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.21 135.42 43.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.355 2.037 . . . . 73.24 112.234 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -48.45 130.92 17.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.048 1.339 . . . . 75.13 112.562 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.638 HD11 HG12 ' D' ' 64' ' ' VAL . 9.6 tt -108.71 112.49 24.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.618 0.767 . . . . 73.34 109.553 -171.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -124.74 92.71 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.388 0.675 . . . . 75.52 109.683 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 69.4 mt -68.53 132.68 47.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.124 0.569 . . . . 72.55 110.238 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.47 139.89 94.61 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.41 0.684 . . . . 64.55 111.234 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.94 127.66 20.99 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.828 2.352 . . . . 73.31 112.529 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.61 111.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.015 0.926 . . . . 72.44 109.849 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -84.73 101.81 12.51 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.656 -0.498 . . . . 72.33 109.656 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 N--CA 1.479 0.981 0 C-N-CA 123.43 0.692 . . . . 72.23 111.256 -175.861 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.47 -0.567 . . . . 73.44 109.47 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -139.09 114.47 9.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.298 -1.001 . . . . 74.42 108.298 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 96.5 mt-30 -133.66 122.35 23.31 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.216 -0.661 . . . . 74.21 109.216 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -82.27 88.93 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 108.722 -0.844 . . . . 75.34 108.722 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.531 ' NE2' HG21 ' A' ' 83' ' ' ILE . 29.8 tt0 -77.28 -41.22 41.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.119 -0.491 . . . . 74.22 111.882 -165.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -153.94 137.27 15.77 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.209 1.003 . . . . 74.22 108.293 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.63 HD11 ' HG3' ' C' ' 130' ' ' PRO . 4.4 mp -130.6 119.19 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 106.927 -1.509 . . . . 75.25 106.927 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -152.93 174.68 13.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.456 0.702 . . . . 74.31 111.521 -172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -97.73 117.15 31.39 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.757 -0.831 . . . . 71.11 108.757 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -80.73 -22.67 40.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.582 -0.281 . . . . 75.11 110.315 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 16.3 t70 -157.82 147.02 19.67 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.031 0.832 . . . . 74.02 109.637 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 94.7 mt -143.99 138.9 24.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 125.536 1.534 . . . . 74.43 106.944 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.2 t -153.64 108.39 3.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.955 0.502 . . . . 73.45 109.888 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.578 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 57.2 t80 -109.11 131.51 55.0 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 106.343 -1.725 . . . . 74.45 106.343 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -124.97 141.45 52.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -149.71 72.72 9.71 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.834 -1.173 . . . . 70.35 107.834 170.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.05 -25.46 19.37 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.433 2.089 . . . . 63.52 111.063 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.44 ' HA ' ' CD2' ' A' ' 30' ' ' HIS . 92.1 m-20 -104.61 26.15 9.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.895 0.878 . . . . 73.31 110.602 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -59.73 -49.0 93.93 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 123.359 0.664 . . . . 64.34 112.788 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.02 -23.09 30.02 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 121.779 1.653 . . . . 75.15 112.236 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.44 ' CD2' ' HA ' ' A' ' 27' ' ' ASN . 9.4 m-70 -74.33 -21.07 59.88 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.617 -0.719 . . . . 75.31 111.271 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG22 ' HE2' ' A' ' 123' ' ' PHE . 84.2 t -53.62 -25.8 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.625 0.602 . . . . 75.14 112.625 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -67.67 -40.85 84.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.313 0.645 . . . . 65.32 111.487 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.99 -14.01 34.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.415 0.686 . . . . 71.24 111.305 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? -75.27 146.09 41.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.808 0.443 . . . . 75.25 111.484 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -73.25 118.46 16.23 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.296 -1.001 . . . . 74.51 108.296 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -79.18 86.06 5.01 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.918 0.487 . . . . 74.51 111.039 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 35.1 tt0 -139.95 71.12 35.55 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.127 -1.064 . . . . 73.13 108.127 170.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -80.68 117.49 3.35 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.717 2.278 . . . . 72.33 112.073 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.72 110.72 22.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.166 -1.05 . . . . 71.42 108.166 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -82.69 92.7 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 122.498 1.142 . . . . 73.43 109.528 175.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -94.49 130.52 40.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.293 -1.322 . . . . 74.11 108.567 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -124.64 151.3 45.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.798 0.439 . . . . 62.35 111.378 -170.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.43 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -128.97 127.87 42.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.775 1.23 . . . . 71.33 108.483 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.22 133.86 55.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.106 0.562 . . . . 64.41 109.821 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 15.7 t70 -146.64 150.16 34.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.712 0.805 . . . . 75.25 109.666 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.0 m -142.02 127.22 18.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.887 0.875 . . . . 74.5 109.843 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.545 ' HB1' HH22 ' A' ' 61' ' ' ARG . . . -142.78 146.17 33.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.525 0.73 . . . . 73.33 109.767 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -105.7 169.98 8.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.618 0.767 . . . . 75.21 111.239 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -154.94 120.46 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.989 0.916 . . . . 55.54 108.829 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -77.81 114.57 16.8 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.964 -0.384 . . . . 71.04 109.964 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 57' ' ' GLU . 59.6 mt -85.65 -40.71 15.89 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.605 0.762 . . . . 62.42 109.986 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.56 -174.62 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.333 -0.849 . . . . 75.4 110.144 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.3 117.26 6.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.31 -0.626 . . . . 74.11 109.31 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 71.96 2.53 4.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.934 1.293 . . . . 73.12 112.34 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -107.7 112.6 40.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.236 -1.024 . . . . 72.5 108.236 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.94 123.36 28.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.223 -0.658 . . . . 74.24 109.223 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB2' HD13 ' A' ' 51' ' ' LEU . 32.4 tt0 -88.28 140.9 29.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.856 0.862 . . . . 72.13 108.921 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.38 123.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.844 -1.169 . . . . 70.1 107.844 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 33.5 t -103.57 148.8 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.784 0.834 . . . . 74.33 109.82 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.68 117.6 26.14 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.407 -0.961 . . . . 73.3 108.407 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 1.7 mpp_? -88.93 106.87 18.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.38 -0.97 . . . . 72.11 108.38 171.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 110' ' ' ALA . 7.7 t -111.17 114.11 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.144 -1.058 . . . . 65.42 108.144 169.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 27.5 m -110.41 130.55 55.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.095 -1.076 . . . . 71.02 108.095 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.16 108.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.105 -1.072 . . . . 71.51 108.105 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 16.1 m -110.67 133.86 52.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.908 -0.405 . . . . 73.43 109.908 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.47 105.31 15.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.097 -1.075 . . . . 63.42 108.097 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.8 m -118.06 127.16 53.53 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.155 0.582 . . . . 72.0 110.277 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.8 OUTLIER -88.99 85.71 6.77 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.862 0.839 . . . . 74.34 109.05 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.34 -88.97 1.3 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.301 -0.863 . . . . 70.41 111.049 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 -28.75 4.65 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.431 0.692 . . . . 75.52 110.804 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -79.04 134.15 36.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 72.22 109.657 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.3 m -85.88 121.37 28.43 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.099 0.408 . . . . 74.53 110.591 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.65 -58.16 7.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.52 0.728 . . . . 64.33 109.645 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -164.27 162.18 22.34 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.434 -1.257 . . . . 73.42 110.564 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.2 tp -117.54 147.72 42.54 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.452 1.101 . . . . 72.13 109.776 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.452 ' HB3' HG21 ' A' ' 114' ' ' ILE . 61.9 m -140.85 100.15 3.77 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.206 1.002 . . . . 72.34 109.482 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.99 126.56 44.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.132 0.973 . . . . 74.41 109.176 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -136.69 138.78 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.389 0.676 . . . . 63.44 109.764 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -105.52 96.84 6.79 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.655 -0.702 . . . . 75.34 109.577 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -84.56 98.94 10.43 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.109 -0.701 . . . . 72.43 109.109 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -112.39 144.96 17.96 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.606 -0.598 . . . . 71.04 111.606 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.87 146.79 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.374 -0.29 . . . . 64.02 112.374 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.531 HG21 ' NE2' ' A' ' 14' ' ' GLN . 64.3 mt -82.69 128.06 39.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 108.692 -0.855 . . . . 65.41 108.692 174.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -128.92 118.16 22.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.323 -0.621 . . . . 73.05 109.323 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 20.5 m -83.54 87.04 7.01 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.471 -0.937 . . . . 74.21 108.471 176.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.96 138.49 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.849 0.859 . . . . 74.2 110.023 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.07 161.28 12.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.931 0.893 . . . . 64.31 110.881 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 4.24 85.24 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.738 -0.665 . . . . 54.52 114.665 172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.54 ' HB ' ' HE3' ' A' ' 94' ' ' MET . 46.2 mt -119.52 136.48 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.019 -1.104 . . . . 74.13 108.019 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.97 174.69 10.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.175 0.59 . . . . 74.23 109.812 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -144.75 49.24 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.239 -0.891 . . . . 73.43 113.579 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.56 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 41.2 p -71.21 -15.07 62.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.322 1.049 . . . . 73.45 112.318 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -63.56 -50.9 67.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.286 0.634 . . . . 75.11 110.424 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.563 ' SD ' ' HG ' ' A' ' 98' ' ' LEU . 56.1 tpp -83.14 -29.03 28.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.887 0.475 . . . . 74.43 111.054 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 92' ' ' THR . . . -62.21 -28.1 69.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 72.22 110.83 172.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -68.81 -54.68 14.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.862 -1.063 . . . . 75.03 109.78 166.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 4.2 m -64.46 -56.87 11.34 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.593 1.331 . . . . 73.5 114.593 -166.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.563 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 77.9 mt -69.71 -15.86 63.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.635 0.652 . . . . 72.11 112.3 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.55 -0.27 43.15 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.703 -0.498 . . . . 31.5 113.903 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -147.59 -65.91 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.049 0.54 . . . . 74.34 111.358 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.7 t80 -51.65 -52.95 43.86 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.779 1.232 . . . . 70.23 112.818 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -73.24 -48.48 7.41 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.309 -0.853 . . . . 72.12 112.644 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.54 -20.21 69.99 Favored 'Trans proline' 0 C--N 1.383 2.351 0 CA-C-N 121.153 1.448 . . . . 71.22 113.337 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.24 -41.84 80.58 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.452 0.701 . . . . 74.31 110.407 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.91 -37.35 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.432 0.693 . . . . 74.4 110.452 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.69 -26.36 34.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.357 -0.838 . . . . 75.32 112.133 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -62.56 -44.34 86.79 Favored Pre-proline 0 CA--C 1.566 1.568 0 N-CA-C 114.896 1.443 . . . . 74.2 114.896 -169.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 -39.48 43.55 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.884 1.723 . . . . 73.34 112.306 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -73.69 -31.32 63.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.416 0.687 . . . . 75.0 111.369 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.507 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.51 -51.77 61.23 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.327 0.651 . . . . 71.34 109.342 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.49 ' NH1' HD13 ' C' ' 105' ' ' ILE . 39.2 ttm180 -52.43 -51.5 58.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.477 -1.238 . . . . 72.55 110.966 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.19 -46.84 85.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.589 -0.732 . . . . 75.41 111.62 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.8 t -57.95 -38.92 76.86 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.599 0.562 . . . . 73.12 111.335 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.454 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 95.9 mt -67.65 -52.65 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.231 1.012 . . . . 73.0 110.796 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -60.89 -34.0 73.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.495 1.118 . . . . 74.24 111.673 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -69.48 -39.97 77.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.585 -0.734 . . . . 74.12 109.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.578 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.8 mtm -63.51 -38.66 91.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.627 0.371 . . . . 74.24 110.781 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.432 HG21 ' SG ' ' A' ' 76' ' ' CYS . 81.3 t -59.66 -49.65 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.829 0.851 . . . . 64.12 110.622 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.0 p -71.07 -34.09 70.84 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.022 -0.535 . . . . 73.21 111.638 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -68.8 -30.73 69.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.508 0.723 . . . . 64.23 109.873 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.66 -1.12 90.06 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.595 -0.729 . . . . 70.23 112.777 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m 65.33 46.45 2.6 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 122.831 1.3 . . . . 64.3 110.194 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG22 ' A' ' 31' ' ' VAL . 59.6 m-85 -121.16 149.67 52.06 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.29 -1.323 . . . . 74.3 109.095 173.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.99 140.1 91.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.395 2.063 . . . . 74.24 111.41 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.464 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -51.14 134.97 26.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.669 1.188 . . . . 70.13 113.315 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.8 mt -121.11 100.98 7.37 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.081 0.952 . . . . 73.02 108.762 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -117.29 105.02 11.74 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 74.25 109.542 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.26 150.72 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 74.23 109.509 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.82 93.23 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.62 0.768 . . . . 64.43 111.608 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.601 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 18.7 Cg_exo -65.23 115.47 3.34 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.075 1.85 . . . . 74.01 110.74 170.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.64 113.07 32.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.806 -1.183 . . . . 64.31 107.806 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -82.71 72.89 9.78 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.5 1.143 . . . . 72.2 108.221 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -70.59 -20.91 62.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 113.522 -1.672 . . . . 74.22 109.647 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 10.4 t70 . . . . . 0 C--N 1.347 0.464 0 C-N-CA 124.184 0.994 . . . . 71.54 109.922 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.512 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.0 ptm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 113.036 0.754 . . . . 75.44 113.036 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.5 t -165.22 142.84 6.0 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 108.068 -1.086 . . . . 70.03 108.068 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -139.51 134.41 32.2 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.808 -0.812 . . . . 74.32 108.808 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -149.37 143.78 25.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.126 0.57 . . . . 63.52 110.195 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.87 122.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.623 -1.251 . . . . 75.32 107.623 170.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -85.82 -42.84 13.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.514 -0.55 . . . . 74.22 109.514 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -166.25 134.35 2.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.159 -0.473 . . . . 75.23 109.894 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.9 134.53 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 107.149 -1.426 . . . . 74.3 107.149 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -162.4 154.48 18.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.659 0.742 . . . . 73.4 112.093 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -80.51 127.3 32.27 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.421 -1.263 . . . . 73.41 108.676 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -97.31 -32.36 11.93 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.999 0.919 . . . . 74.31 110.884 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -160.07 143.47 13.96 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.176 0.297 . . . . 62.43 110.562 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.494 HG22 ' HE1' ' B' ' 117' ' ' MET . 48.3 mm -136.68 138.0 46.83 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 C-N-CA 125.038 1.335 . . . . 75.45 108.616 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.0 t -134.7 139.5 45.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.103 -1.443 . . . . 74.43 107.103 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.1 t80 -153.33 112.57 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.322 -1.733 . . . . 73.1 106.322 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.41 112.8 17.35 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.146 -0.687 . . . . 61.2 109.146 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.51 83.17 1.88 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.293 -1.003 . . . . 52.32 108.293 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.67 -12.19 15.19 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.698 2.265 . . . . 71.05 112.079 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -125.57 24.19 7.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.973 0.909 . . . . 75.55 109.436 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.33 -52.55 35.09 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.351 1.241 . . . . 73.04 114.351 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.74 -10.77 20.12 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.089 1.86 . . . . 71.54 113.625 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -94.16 -25.56 17.06 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.731 0.813 . . . . 73.15 111.075 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.31 -19.16 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.838 0.855 . . . . 71.02 110.43 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -51.91 -42.25 62.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.632 1.173 . . . . 74.04 112.423 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -81.84 -12.71 58.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.265 0.626 . . . . 74.44 112.016 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.02 100.48 11.81 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.74 0.816 . . . . 73.24 110.843 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.05 78.1 7.5 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.658 0.783 . . . . 74.54 110.621 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.675 ' HB2' HD21 ' B' ' 68' ' ' LEU . 14.8 m-90 -150.41 161.55 42.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.236 1.015 . . . . 75.03 108.635 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.75 112.15 22.7 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.293 -1.002 . . . . 73.44 108.293 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.414 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 31.3 Cg_endo -62.36 117.99 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.637 2.225 . . . . 73.01 111.313 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.0 115.48 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.853 0.721 . . . . 73.43 110.816 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.511 HG21 HD23 ' B' ' 126' ' ' LEU . 27.5 m -97.49 136.75 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.849 0.833 . . . . 74.51 112.236 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -114.09 114.06 25.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.999 1.32 . . . . 73.52 108.036 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.66 140.5 49.13 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.469 -0.567 . . . . 75.43 109.469 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.87 147.14 52.46 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.684 0.794 . . . . 64.43 110.175 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -99.24 131.73 45.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.825 -1.079 . . . . 73.24 108.32 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 16.1 t70 -126.13 140.83 52.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.993 -1.114 . . . . 73.21 107.993 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -121.36 143.74 49.04 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.244 0.545 . . . . 75.01 110.422 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.81 157.9 43.65 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.502 1.121 . . . . 73.44 108.084 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -142.4 168.04 20.67 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.584 0.707 . . . . 75.33 109.676 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' B' ' 57' ' ' GLU . 41.4 t -150.94 157.36 42.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.207 -1.36 . . . . 74.4 107.352 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -121.0 115.86 23.98 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.34 -0.615 . . . . 75.52 109.34 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 68.8 mt -90.02 -35.46 15.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.402 0.681 . . . . 75.11 109.494 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 177.29 11.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 75.42 110.212 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.46 125.19 23.38 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.85 0.03 3.19 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.904 1.282 . . . . 71.33 112.826 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -112.62 96.11 4.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.716 0.806 . . . . 73.23 108.951 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.406 ' CD1' HD13 ' B' ' 86' ' ' ILE . 18.5 m-85 -111.24 139.57 46.53 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.505 0.669 . . . . 73.4 110.359 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' B' ' 49' ' ' SER . 7.1 tm-20 -103.59 97.09 7.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.165 -1.42 . . . . 72.43 107.165 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 121.69 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.604 0.761 . . . . 75.54 109.419 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.9 t -102.44 135.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.438 0.695 . . . . 65.13 109.916 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 117.83 31.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.35 -1.722 . . . . 74.43 106.35 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.6 ttp180 -112.43 113.54 25.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.871 0.367 . . . . 74.24 110.057 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' B' ' 114' ' ' ILE . 57.3 t -104.23 106.32 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.533 -1.284 . . . . 74.3 107.533 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -99.22 123.94 43.9 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.581 HG22 HG21 ' B' ' 114' ' ' ILE . 63.4 t -114.15 129.54 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.945 -1.025 . . . . 73.13 109.222 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -119.28 143.33 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.468 -1.308 . . . . 74.24 107.468 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -133.62 140.02 46.86 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.46 -0.571 . . . . 63.32 109.46 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 44.4 p -135.95 128.82 31.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.857 . . . . 73.41 108.899 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 36' ' ' TRP . 2.4 tt -117.54 120.72 38.94 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.455 -1.313 . . . . 75.21 107.455 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -110.8 3.11 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.896 0.747 . . . . 64.5 111.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.39 3.13 13.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.141 0.976 . . . . 73.15 111.411 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.12 168.54 19.41 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.268 0.627 . . . . 74.2 111.441 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.0 m -67.06 120.87 14.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.062 -0.972 . . . . 74.12 110.481 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.436 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -75.49 -53.38 8.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.307 0.643 . . . . 74.14 109.508 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.98 170.84 16.08 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.369 -1.287 . . . . 73.5 109.735 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.88 154.25 45.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.889 1.275 . . . . 75.53 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -157.59 154.2 28.09 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.5 tt0 -164.56 130.59 2.89 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.573 -0.899 . . . . 74.13 108.573 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.462 HG21 HD12 ' B' ' 21' ' ' ILE . 94.5 t -125.62 142.34 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 109.136 -0.69 . . . . 71.22 109.136 173.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 48.9 mt-30 -117.39 99.67 7.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.609 -1.256 . . . . 75.35 107.609 169.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -91.44 100.2 13.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.169 -1.049 . . . . 74.55 108.169 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -97.38 143.41 16.71 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.86 -0.896 . . . . 75.44 110.86 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.92 127.26 3.35 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 110.969 -0.852 . . . . 71.1 110.969 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.16 131.22 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.96 -1.126 . . . . 75.25 107.96 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -135.19 142.62 46.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.664 0.785 . . . . 72.41 110.703 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -90.68 105.77 18.05 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.349 -0.982 . . . . 73.4 108.349 169.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.406 HD13 ' CD1' ' B' ' 56' ' ' TYR . 1.6 pp -117.58 108.65 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.547 0.739 . . . . 74.21 110.19 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.94 44.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.581 0.752 . . . . 50.32 110.6 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 103.2 -71.3 0.29 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.835 -0.62 . . . . 74.32 112.3 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.417 ' O ' ' HE2' ' B' ' 94' ' ' MET . 2.4 pp -73.6 158.35 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.691 0.396 . . . . 75.15 110.444 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 -176.32 5.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.478 0.711 . . . . 74.35 110.131 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.2 -131.52 50.0 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.584 0.552 . . . . 64.15 113.019 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.8 m -67.55 -24.27 65.51 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.593 0.757 . . . . 71.33 111.456 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.71 -37.15 65.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.312 0.645 . . . . 75.04 110.957 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.417 ' HE2' ' O ' ' B' ' 89' ' ' ILE . 56.3 tpp -73.93 -31.5 63.08 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.77 -0.456 . . . . 74.25 109.77 174.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.22 83.08 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.748 -0.66 . . . . 63.21 111.049 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.46 -36.45 60.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.5 0.72 . . . . 73.32 110.35 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.82 -59.01 5.09 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 72.54 111.021 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.88 -18.72 59.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 73.24 110.949 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.05 1.2 67.46 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-O 119.672 -0.516 . . . . 61.42 114.184 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -153.69 -60.05 0.13 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.775 0.787 . . . . 71.33 112.518 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -65.91 -45.56 81.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.92 0.888 . . . . 73.42 111.335 -171.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 64.4 m -68.45 -49.88 29.47 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 115.442 -0.799 . . . . 60.12 112.187 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.39 -22.41 52.47 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.634 1.556 . . . . 72.42 113.799 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.38 -37.64 86.52 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.259 0.552 . . . . 71.32 110.859 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.93 -40.71 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 73.11 110.871 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 55.6 mt -80.98 -18.65 46.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.289 -0.869 . . . . 75.34 111.915 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.55 -48.03 96.48 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.571 1.323 . . . . 65.52 114.571 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.49 -31.66 80.41 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 121.596 1.531 . . . . 70.43 112.985 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.9 m-85 -68.26 -46.93 69.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.483 0.713 . . . . 70.0 110.817 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -57.64 -43.66 85.02 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.42 -0.809 . . . . 75.0 110.071 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 20.7 mtp-105 -51.26 -64.32 0.85 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.224 1.01 . . . . 74.34 111.434 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.54 -28.99 69.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.625 0.77 . . . . 64.21 110.842 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -71.48 -44.91 63.86 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.829 0.451 . . . . 71.12 110.574 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.618 HD13 HD13 ' B' ' 128' ' ' LEU . 57.0 mt -62.94 -51.26 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.61 0.764 . . . . 64.51 109.979 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.52 -37.7 79.02 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.944 -1.026 . . . . 72.41 111.041 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.7 t -60.65 -52.23 66.03 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.581 -0.736 . . . . 65.1 110.063 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.494 ' HE1' HG22 ' B' ' 21' ' ' ILE . 15.0 mmt -63.75 -38.84 92.61 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.174 0.589 . . . . 71.43 111.151 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 83.2 t -60.6 -45.44 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.537 0.735 . . . . 72.32 110.739 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -69.5 -27.81 65.51 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.265 -0.88 . . . . 74.12 112.019 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 90.7 mtt-85 -68.9 -34.41 75.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.488 0.715 . . . . 70.3 110.222 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.2 7.72 55.28 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.823 0.702 . . . . 72.35 112.842 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p 55.78 32.01 18.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.111 1.764 . . . . 74.43 112.078 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -93.57 157.55 38.24 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.978 0.911 . . . . 72.42 109.985 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -47.73 147.4 7.08 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.82 3.013 . . . . 74.43 114.287 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.576 HE22 ' HB2' ' B' ' 127' ' ' ASN . 21.7 tm0? -62.26 129.75 42.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.583 0.753 . . . . 73.43 109.721 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.511 HD23 HG21 ' B' ' 40' ' ' VAL . 2.2 tm? -126.09 111.18 14.37 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.407 -0.59 . . . . 73.2 109.407 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.576 ' HB2' HE22 ' B' ' 125' ' ' GLN . 41.0 t30 -111.02 134.81 52.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.267 1.027 . . . . 64.22 109.374 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.618 HD13 HD13 ' B' ' 114' ' ' ILE . 36.9 mt -87.46 134.77 33.55 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 109.296 -0.631 . . . . 73.25 109.296 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.41 148.52 85.95 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.17 0.588 . . . . 72.54 110.087 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 99.82 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.914 2.41 . . . . 73.44 112.518 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -90.38 110.46 22.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.883 -1.154 . . . . 75.1 107.883 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -69.6 101.79 1.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.067 -0.716 . . . . 65.53 109.067 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 48.6 m-85 -56.65 -33.93 66.81 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.503 1.121 . . . . 72.4 110.112 176.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.64 -63.76 1.04 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.017 -1.447 . . . . 75.02 111.247 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.42 68.59 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.446 0.699 . . . . 54.33 111.708 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 123.912 0.885 . . . . 74.55 109.759 177.018 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 113.509 0.929 . . . . 74.53 113.509 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -99.0 111.5 23.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.903 0.881 . . . . 73.41 108.832 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.548 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 58.3 t80 -119.03 130.72 55.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.395 -0.965 . . . . 71.41 108.395 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -144.79 133.54 22.31 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.619 0.367 . . . . 73.13 110.218 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.414 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.7 tp -83.96 134.38 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.389 0.676 . . . . 75.25 109.309 171.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.0 mm-40 -101.99 -47.28 4.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.654 0.782 . . . . 75.23 109.556 176.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -168.95 138.85 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.959 0.503 . . . . 72.32 110.899 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 60.9 mt -111.01 148.03 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.55 1.14 . . . . 71.5 108.131 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -177.23 164.23 2.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.289 0.636 . . . . 74.55 110.692 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -84.57 119.08 24.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.649 -0.871 . . . . 62.42 108.649 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.491 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 25.1 mmtp -73.0 -48.2 38.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.446 -0.946 . . . . 75.51 108.446 168.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.0 t70 -136.92 144.08 43.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.22 -1.355 . . . . 73.0 110.093 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.4 mt -139.53 142.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.023 -1.473 . . . . 75.53 107.023 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -156.01 149.52 24.81 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.046 0.45 . . . . 74.2 110.453 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.88 108.51 3.48 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.815 -1.18 . . . . 75.44 107.815 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -117.41 110.82 18.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.234 -0.654 . . . . 74.41 109.234 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.91 93.85 26.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.664 -0.865 . . . . 61.5 108.664 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.67 -35.13 48.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.879 2.386 . . . . 73.15 112.118 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -108.41 36.91 2.65 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.361 -0.836 . . . . 75.45 109.379 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.98 99.57 Favored Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.305 1.224 . . . . 74.13 114.305 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.521 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 24.1 Cg_exo -68.79 -37.3 12.07 Favored 'Trans proline' 0 C--N 1.389 2.699 0 CA-C-N 121.305 1.502 . . . . 75.12 112.678 171.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -66.84 -18.31 65.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.071 0.948 . . . . 72.52 112.771 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.631 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 12.1 p -41.72 -38.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 115.397 1.628 . . . . 70.45 115.397 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.4 -31.0 71.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.226 0.536 . . . . 74.22 111.625 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.31 15.4 22.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.086 0.954 . . . . 75.21 111.953 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 0.1 OUTLIER -89.96 174.96 7.38 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.326 0.512 . . . . 72.15 110.06 178.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.421 ' HB3' HD21 ' C' ' 68' ' ' LEU . 24.6 t0 -87.98 108.93 19.45 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.005 -0.739 . . . . 74.11 109.005 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -84.37 68.2 10.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.242 1.02 . . . . 75.5 112.034 -174.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -161.84 44.2 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 114.898 -1.046 . . . . 70.1 109.656 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.08 170.21 20.12 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 121.434 1.423 . . . . 72.43 112.2 -168.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -84.73 93.0 8.35 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.928 -1.138 . . . . 73.4 107.928 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.446 HG12 HD22 ' C' ' 126' ' ' LEU . 46.3 t -77.4 95.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 107.552 -1.277 . . . . 74.01 107.552 174.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.6 109.43 21.5 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.839 -1.073 . . . . 75.44 108.304 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.67 164.5 16.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.962 -0.563 . . . . 75.11 110.432 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 25.7 t70 -147.49 138.33 23.48 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.074 -1.084 . . . . 74.54 108.074 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.51 141.31 46.68 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.69 141.81 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.124 -0.695 . . . . 73.31 109.124 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.7 t -114.69 136.28 53.23 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.939 -0.763 . . . . 73.11 108.939 173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.58 160.43 21.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.94 0.896 . . . . 72.22 108.633 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -141.91 147.22 36.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.748 0.419 . . . . 72.25 110.272 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -153.95 132.29 11.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.491 0.716 . . . . 75.44 109.682 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.29 117.65 19.75 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.001 -0.74 . . . . 74.32 109.001 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' C' ' 57' ' ' GLU . 74.1 mt -87.24 -45.48 10.59 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.463 0.705 . . . . 74.33 109.259 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.51 -170.99 3.76 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.536 -0.757 . . . . 71.42 110.781 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.39 107.09 0.72 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.248 -0.887 . . . . 60.04 109.987 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 73.46 -0.82 3.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.452 1.501 . . . . 71.52 112.562 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.05 115.5 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.741 -0.837 . . . . 73.23 108.741 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.73 125.52 36.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.875 0.87 . . . . 63.24 109.267 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.63 ' HB2' HD12 ' C' ' 51' ' ' LEU . 39.9 tt0 -83.9 143.13 30.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.768 0.427 . . . . 62.33 110.671 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -117.49 122.95 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.507 -1.294 . . . . 60.13 107.507 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.12 106.38 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.429 -0.952 . . . . 75.11 108.429 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.27 105.92 18.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.415 0.686 . . . . 71.21 109.487 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -81.71 131.67 35.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.472 -0.785 . . . . 72.03 110.283 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.1 t -124.09 122.87 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.089 -1.449 . . . . 74.23 107.089 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.9 m -119.49 145.13 46.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.202 -1.036 . . . . 74.45 108.202 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.05 108.42 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.564 -1.272 . . . . 72.34 107.564 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.5 m -104.12 111.5 24.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.676 -0.861 . . . . 74.2 108.676 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.22 16.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.337 -1.727 . . . . 70.43 106.337 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -151.18 133.06 15.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.692 0.397 . . . . 64.31 109.968 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' C' ' 35' ' ' ASP . 30.9 tp -67.82 -48.15 67.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.176 0.59 . . . . 63.35 110.464 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.16 -73.76 0.04 OUTLIER Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.144 -1.183 . . . . 72.51 110.144 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -101.03 -31.49 11.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.398 0.679 . . . . 75.44 109.28 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -73.4 101.13 3.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.693 0.797 . . . . 74.44 109.741 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -83.39 130.02 35.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.632 -0.507 . . . . 64.44 109.632 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.652 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -73.15 -66.56 0.66 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.11 -1.071 . . . . 74.3 108.11 167.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -161.62 174.75 12.88 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.572 0.701 . . . . 72.05 111.668 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.08 141.88 51.07 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 105.667 -1.975 . . . . 75.14 105.667 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -151.3 112.23 4.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.383 -0.599 . . . . 75.31 109.383 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -122.88 129.29 51.46 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.835 0.454 . . . . 74.54 110.018 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.27 134.85 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.448 -0.945 . . . . 73.44 108.448 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -115.16 90.59 3.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.487 -1.301 . . . . 70.12 107.487 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.11 108.65 12.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.549 -1.205 . . . . 73.14 109.891 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 146.05 20.15 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.958 -0.457 . . . . 62.12 111.958 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.414 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -148.68 120.84 1.24 Allowed Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 111.603 -0.599 . . . . 73.25 111.603 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.51 HD13 HD12 ' C' ' 51' ' ' LEU . 10.4 mm -87.07 110.77 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 109.114 -0.699 . . . . 75.23 109.114 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.414 ' CE2' HD13 ' C' ' 13' ' ' ILE . 77.2 m-85 -121.76 119.9 33.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.555 0.342 . . . . 75.0 110.207 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 m -84.16 114.34 21.71 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.409 -0.589 . . . . 71.41 109.409 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.275 0.63 . . . . 73.12 109.657 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.91 168.78 24.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.851 1.26 . . . . 71.2 108.582 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.35 -27.47 5.66 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 120.916 0.176 . . . . 73.21 112.934 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -122.8 158.87 27.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.725 1.21 . . . . 75.22 109.146 -176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.81 -175.56 5.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.665 0.386 . . . . 73.04 111.323 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.67 -146.33 40.08 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.606 -0.724 . . . . 73.43 113.729 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.7 p -68.32 -19.53 64.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.863 0.865 . . . . 51.33 111.588 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -65.97 -49.21 68.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.803 0.841 . . . . 73.13 110.722 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -25.68 56.86 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 116.476 -0.329 . . . . 70.14 110.746 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.82 74.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.038 0.535 . . . . 74.33 110.979 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -70.9 -28.13 64.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.179 0.592 . . . . 74.14 110.488 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.66 -60.41 2.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.738 0.415 . . . . 72.23 109.985 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.412 HD21 ' SG ' ' C' ' 102' ' ' CYS . 87.8 mt -70.7 -14.86 62.61 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.475 0.71 . . . . 73.33 111.768 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.36 3.92 29.69 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 114.848 0.699 . . . . 75.52 114.848 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -51.53 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 117.936 0.868 . . . . 75.3 111.374 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.601 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 86.9 t80 -70.32 -58.97 3.16 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.561 0.744 . . . . 74.45 111.578 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.548 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 32.7 m -58.02 -48.66 96.69 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.49 1.116 . . . . 64.43 112.986 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.75 -24.27 62.09 Favored 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 121.729 1.62 . . . . 74.13 114.052 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.88 -28.09 61.39 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 118.314 0.506 . . . . 71.31 110.393 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.49 HD13 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -64.33 -31.99 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.145 0.498 . . . . 74.21 109.943 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.414 HD22 ' HA3' ' C' ' 82' ' ' GLY . 84.0 mt -86.86 -24.6 24.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.044 0.938 . . . . 74.42 112.247 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.43 -46.22 99.84 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.249 1.203 . . . . 74.54 114.249 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.91 -38.61 77.99 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.086 1.857 . . . . 75.11 113.247 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -66.56 -45.31 79.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.414 0.686 . . . . 74.12 110.487 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.61 90.76 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.568 -0.742 . . . . 75.33 110.88 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -64.53 -50.94 65.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.904 1.282 . . . . 72.11 110.62 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.36 -31.96 71.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.245 0.618 . . . . 75.5 109.695 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.66 -35.38 75.11 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 122.99 0.516 . . . . 75.33 111.204 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 40.5 mt -70.71 -51.0 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 122.899 0.48 . . . . 71.11 110.137 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m -62.99 -28.88 70.4 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.286 0.634 . . . . 74.14 111.183 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.3 t -64.05 -52.19 60.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.826 -0.805 . . . . 73.33 108.826 171.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.52 -39.33 83.55 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.5 1.12 . . . . 75.3 112.755 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.69 -47.92 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.54 0.736 . . . . 73.11 109.583 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.6 t -68.28 -25.9 65.39 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.94 -1.027 . . . . 75.23 111.616 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -73.38 -40.12 64.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.429 0.692 . . . . 74.12 109.326 177.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.24 -1.08 79.81 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.673 0.608 . . . . 73.51 112.341 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.493 HG21 ' HB3' ' D' ' 17' ' ' TYR . 27.2 p 62.48 35.77 14.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.632 1.973 . . . . 72.31 112.816 173.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.459 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 95.2 m-85 -86.27 165.29 34.47 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 114.738 -1.119 . . . . 72.21 108.852 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 74.3 Cg_endo -69.01 -175.0 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.205 1.936 . . . . 70.11 112.933 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.77 114.19 2.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.361 -0.836 . . . . 74.15 110.618 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.446 HD22 HG12 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -138.65 92.64 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.129 -1.434 . . . . 74.35 107.129 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -123.4 131.8 53.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.334 1.054 . . . . 74.15 108.851 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 140.08 43.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.286 0.635 . . . . 74.33 110.892 -170.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.21 146.56 74.9 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.132 0.973 . . . . 72.32 112.061 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.63 ' HG3' HD11 ' A' ' 16' ' ' ILE . 58.5 Cg_endo -71.26 105.43 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.211 2.607 . . . . 73.11 112.877 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.19 111.15 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.778 -1.193 . . . . 73.33 107.778 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.33 92.14 3.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 72.55 110.853 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -78.71 -25.38 44.68 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.893 0.854 . . . . 73.41 109.341 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 125.471 1.508 . . . . 70.15 111.827 176.396 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.517 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 8.0 ptm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 115.342 1.608 . . . . 74.11 115.342 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -121.11 144.42 48.57 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.163 -0.926 . . . . 64.44 108.878 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' D' ' 85' ' ' SER . 33.4 t80 -154.0 102.55 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.253 -1.017 . . . . 74.32 108.253 175.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -121.06 118.3 29.42 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.882 -0.784 . . . . 74.02 108.882 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.2 102.47 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.914 -1.143 . . . . 74.31 107.914 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -77.63 -44.69 27.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.877 0.471 . . . . 73.31 111.302 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -161.76 132.21 4.97 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 119.838 -0.125 . . . . 74.21 111.137 -170.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.486 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.3 mp -107.61 132.79 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.946 -1.502 . . . . 74.12 106.946 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG21 ' C' ' 122' ' ' THR . 28.1 p90 -169.94 162.85 9.4 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-O 121.839 0.828 . . . . 65.11 111.945 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.7 p -95.37 126.91 40.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.711 -1.131 . . . . 74.24 109.833 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.521 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 47.5 mtpt -95.51 -29.04 14.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.009 0.524 . . . . 73.22 110.048 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -150.74 137.11 18.64 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 124.124 0.89 . . . . 63.51 109.271 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.549 HG23 ' HE1' ' C' ' 117' ' ' MET . 60.1 mt -137.58 147.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.489 1.116 . . . . 74.32 108.056 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -150.86 143.92 24.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.153 0.981 . . . . 72.22 109.494 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.568 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 74.0 t80 -149.53 130.0 13.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.767 -1.938 . . . . 73.24 105.767 169.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.46 136.63 43.34 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.126 0.57 . . . . 64.54 109.829 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -125.03 84.6 58.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 123.594 0.758 . . . . 73.45 109.068 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.53 -46.93 6.32 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.186 2.591 . . . . 63.25 113.082 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -114.18 37.94 3.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.454 0.702 . . . . 74.54 109.617 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.608 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -54.48 -56.53 25.76 Favored Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.332 1.604 . . . . 73.34 115.332 -168.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 21.6 Cg_endo -87.62 -3.59 7.45 Favored 'Trans proline' 0 C--N 1.38 2.195 0 CA-C-N 121.496 1.57 . . . . 74.03 112.49 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -82.76 -41.99 18.52 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.267 1.427 . . . . 64.44 109.173 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.72 -21.84 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.121 -0.945 . . . . 74.41 110.145 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -60.53 -26.4 66.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.271 1.429 . . . . 74.54 112.571 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.07 -33.17 74.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.241 0.617 . . . . 75.21 110.6 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -95.34 98.35 10.52 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.571 -0.9 . . . . 73.2 108.571 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -80.25 95.29 6.27 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.213 0.53 . . . . 64.0 110.223 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.61 ' HB3' HD11 ' D' ' 68' ' ' LEU . 68.4 t-105 -160.88 165.96 29.27 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.677 0.791 . . . . 75.21 109.685 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.15 117.38 67.9 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.413 1.085 . . . . 74.1 110.631 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.27 144.0 94.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.499 2.799 . . . . 74.43 114.278 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.51 128.17 35.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.33 -0.619 . . . . 73.53 109.33 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.61 149.81 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.2 0.6 . . . . 72.45 110.434 -173.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -131.98 114.98 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.592 -1.262 . . . . 75.01 107.592 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.87 145.87 25.47 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.121 0.568 . . . . 73.1 110.045 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 33.2 t70 -145.46 138.94 26.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.587 -1.188 . . . . 55.04 108.442 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.15 134.8 35.02 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.368 -0.975 . . . . 74.44 108.368 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -144.31 146.2 32.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.668 1.187 . . . . 64.41 108.354 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -117.46 154.51 31.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.525 -0.546 . . . . 74.22 109.525 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.59 167.47 27.98 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.049 0.94 . . . . 64.15 109.446 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -158.43 166.12 32.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.121 0.486 . . . . 74.53 111.41 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -159.44 116.82 2.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.779 1.232 . . . . 74.23 107.911 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -79.54 123.34 27.49 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.095 -0.706 . . . . 64.43 109.095 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt -90.59 -41.04 11.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.015 0.526 . . . . 75.44 109.947 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.61 -177.47 6.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.282 -0.872 . . . . 74.22 110.611 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -64.78 120.16 11.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.398 -0.819 . . . . 72.51 109.241 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 65.34 17.31 10.94 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 74.32 111.767 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -120.75 120.45 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.31 -0.996 . . . . 74.12 108.31 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.419 ' HB2' HD12 ' D' ' 86' ' ' ILE . 64.1 m-85 -128.91 126.47 39.77 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.57 -0.9 . . . . 75.44 108.57 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -89.97 132.95 35.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.557 -1.646 . . . . 74.51 106.557 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.403 HG22 HD22 ' D' ' 98' ' ' LEU . 51.1 t -125.43 133.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.177 -1.045 . . . . 75.41 108.177 -172.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 96.4 t -111.75 133.15 58.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.435 0.694 . . . . 75.53 109.395 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.431 HD11 ' HD1' ' D' ' 107' ' ' PHE . 0.9 OUTLIER -110.87 115.42 29.48 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.122 -1.066 . . . . 74.34 108.122 170.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -100.74 107.95 19.67 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.214 -1.032 . . . . 74.34 108.214 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.71 133.35 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.771 -0.826 . . . . 75.11 108.771 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 59.1 m -121.95 135.21 54.85 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.363 0.601 . . . . 73.24 109.646 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 131.53 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.846 1.258 . . . . 74.55 108.455 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 94.0 m -131.14 112.74 13.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.196 0.998 . . . . 71.24 108.86 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.83 48.31 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.744 0.818 . . . . 72.51 109.165 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.437 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.2 m -146.2 127.59 14.95 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.665 0.603 . . . . 72.22 109.67 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' D' ' 36' ' ' TRP . 47.5 tp -111.86 122.8 48.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.686 -0.857 . . . . 62.41 108.686 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 -115.68 5.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.599 0.562 . . . . 72.21 112.836 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -110.86 8.51 22.29 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.274 0.629 . . . . 75.34 111.825 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.08 164.27 30.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.226 0.611 . . . . 75.11 110.97 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -74.55 127.94 34.31 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.055 -0.52 . . . . 74.05 110.523 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.58 -61.29 1.87 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.259 1.023 . . . . 73.01 109.677 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.06 157.9 42.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.257 0.551 . . . . 73.14 111.321 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 79.0 mt -121.97 147.82 45.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.231 1.412 . . . . 72.33 107.586 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.541 ' SG ' HG21 ' D' ' 114' ' ' ILE . 44.8 t -158.57 141.65 14.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.457 0.303 . . . . 64.44 110.216 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.08 135.98 13.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.33 0.652 . . . . 74.42 109.788 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.94 119.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.097 0.559 . . . . 72.35 109.633 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -89.48 86.11 6.69 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.489 -0.93 . . . . 75.52 108.489 167.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.83 101.72 8.69 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.434 -1.257 . . . . 74.12 108.448 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.17 174.41 40.33 Favored Glycine 0 C--O 1.243 0.7 0 O-C-N 123.456 0.472 . . . . 71.03 112.143 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.95 135.5 2.84 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 111.654 -0.578 . . . . 72.24 111.654 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.8 129.96 38.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.513 -0.921 . . . . 74.43 108.513 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -132.28 135.78 46.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.491 0.717 . . . . 73.53 109.586 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.7 m -75.33 116.14 15.74 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.944 -1.132 . . . . 71.43 107.944 168.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.44 HG22 HD13 ' D' ' 89' ' ' ILE . 57.2 mt -121.23 101.72 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.634 -0.506 . . . . 73.34 109.634 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.63 152.6 48.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.406 1.082 . . . . 74.44 109.072 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 75.2 1.33 63.6 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.434 0.459 . . . . 63.31 113.587 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.52 HG22 ' HG2' ' D' ' 93' ' ' GLN . 53.7 mt -117.11 126.77 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 107.814 -1.18 . . . . 72.45 107.814 -174.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -145.84 148.86 33.33 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.973 0.731 . . . . 71.24 112.973 -163.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.09 -127.01 32.27 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.353 0.501 . . . . 65.14 114.197 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.9 p -70.34 -20.61 62.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.356 0.662 . . . . 65.04 111.32 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' D' ' 89' ' ' ILE . 55.9 tt0 -70.47 -41.47 72.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.737 0.815 . . . . 74.32 110.134 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -78.63 -29.42 45.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.288 0.235 . . . . 73.32 110.541 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.77 80.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.067 0.547 . . . . 64.53 110.272 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.01 -35.87 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.335 -0.848 . . . . 74.12 110.537 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -66.29 -43.08 87.36 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.941 0.496 . . . . 62.11 110.584 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.403 HD22 HG22 ' D' ' 58' ' ' VAL . 59.4 mt -80.09 -21.91 42.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.331 0.652 . . . . 75.05 111.082 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 -19.79 38.65 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.932 -0.371 . . . . 75.12 113.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.79 -69.04 0.69 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.39 0.515 . . . . 74.13 112.39 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -65.07 -60.92 2.5 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.283 0.475 . . . . 73.41 112.283 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -58.07 -46.97 99.64 Favored Pre-proline 0 CA--C 1.565 1.537 0 C-N-CA 123.78 0.832 . . . . 74.51 113.122 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 -30.72 51.16 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.921 1.747 . . . . 72.0 113.266 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.82 -35.97 82.18 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.035 0.534 . . . . 63.24 110.646 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.16 -42.71 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.712 0.805 . . . . 75.12 110.35 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -78.67 -19.01 53.5 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.27 -0.877 . . . . 74.24 112.181 -174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.431 ' HD1' HD11 ' D' ' 60' ' ' LEU . 70.8 t80 -62.21 -45.72 90.67 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 113.759 1.022 . . . . 71.34 113.759 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.83 -36.91 75.9 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.113 1.875 . . . . 64.32 113.724 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -79.07 -33.84 44.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.893 0.877 . . . . 75.14 111.693 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.75 -48.47 71.79 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.874 0.47 . . . . 64.32 109.829 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -54.95 -50.82 67.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.368 -1.287 . . . . 75.42 111.013 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.98 -46.76 84.66 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.113 0.883 . . . . 75.33 110.8 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.472 ' SG ' HD11 ' D' ' 21' ' ' ILE . 49.5 t -60.11 -45.13 94.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 123.939 0.774 . . . . 74.1 110.947 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.541 HG21 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.49 -56.5 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.746 0.818 . . . . 74.43 110.897 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -53.03 -46.36 68.42 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.667 1.187 . . . . 74.41 111.796 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.5 t -62.84 -44.09 97.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.032 -0.985 . . . . 71.41 110.2 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.527 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.8 mtm -68.07 -32.93 73.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.103 0.561 . . . . 61.1 111.852 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.62 -39.18 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.269 0.628 . . . . 72.53 110.438 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -74.89 -26.26 59.52 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 122.547 0.339 . . . . 74.14 110.881 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' D' ' 116' ' ' SER . 81.8 mtt-85 -75.47 -32.27 60.55 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.664 0.786 . . . . 72.33 109.635 172.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -1.13 90.19 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 115.534 -0.757 . . . . 71.54 111.922 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p 59.81 22.79 11.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.591 1.957 . . . . 65.35 112.805 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -86.31 159.89 52.5 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.334 1.054 . . . . 75.44 109.514 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.7 118.08 4.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.529 2.153 . . . . 75.24 112.701 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -48.88 133.19 18.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.062 0.945 . . . . 71.44 112.393 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.6 107.86 11.46 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.953 -1.129 . . . . 72.54 107.953 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -102.57 107.76 18.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.481 0.712 . . . . 51.44 109.466 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.95 145.02 54.94 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.73 0.812 . . . . 73.14 111.166 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.62 148.06 36.5 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 122.917 0.487 . . . . 72.45 110.264 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.37 130.82 31.53 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.545 2.163 . . . . 73.0 111.984 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 p -108.13 109.61 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.486 0.714 . . . . 73.1 110.041 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -86.72 106.78 17.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.802 0.841 . . . . 74.34 108.744 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 . . . . . 0 N--CA 1.477 0.889 0 C-N-CA 123.039 0.536 . . . . 75.3 110.624 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.548 -0.908 . . . . 75.04 108.548 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -134.41 134.79 42.04 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.3 0.64 . . . . 74.45 109.351 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 92.4 mt-30 -132.82 123.85 26.89 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.592 -0.892 . . . . 75.52 108.592 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.69 103.95 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.897 -1.149 . . . . 74.53 107.897 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.61 -39.78 15.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 72.24 110.947 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.636 ' HD3' HG22 ' B' ' 122' ' ' THR . 0.1 OUTLIER -158.6 143.99 16.47 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.144 -0.455 . . . . 74.04 109.962 -175.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -145.85 100.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.505 -1.295 . . . . 72.13 107.505 171.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HD1' ' HG3' ' A' ' 15' ' ' ARG . 71.6 m-85 -157.61 169.96 23.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.298 0.639 . . . . 73.32 109.779 -170.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.8 p -81.91 111.66 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.079 -0.51 . . . . 71.33 110.337 -173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 35.4 mtpt -79.5 -32.52 42.44 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.141 -0.481 . . . . 75.11 110.768 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.97 145.1 27.2 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.702 0.627 . . . . 63.22 109.616 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -134.59 144.2 35.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 125.065 1.346 . . . . 75.4 107.567 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.627 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 25.9 t -148.69 130.67 15.29 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.753 0.821 . . . . 74.3 108.857 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.551 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 90.3 t80 -147.6 119.28 8.03 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 106.962 -1.496 . . . . 75.43 106.962 174.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.55 139.63 45.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.831 0.452 . . . . 74.45 109.84 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.23 80.32 72.65 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.221 1.008 . . . . 74.32 108.515 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.51 -43.46 21.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.299 2.666 . . . . 70.15 112.627 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 32.1 m-80 -113.09 37.47 3.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.187 -0.915 . . . . 74.4 109.656 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.03 99.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 C-N-CA 124.121 0.968 . . . . 72.0 113.087 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.06 -22.97 29.96 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.976 1.784 . . . . 72.11 112.631 174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.3 m-70 -78.11 -18.62 55.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.561 0.744 . . . . 73.42 111.656 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.457 HG21 ' HE1' ' A' ' 123' ' ' PHE . 79.1 t -52.53 -28.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.876 0.87 . . . . 74.04 112.447 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -65.53 -42.65 91.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.11 0.781 . . . . 72.32 113.11 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -78.37 -26.05 46.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.577 0.171 . . . . 72.11 110.665 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -76.73 152.08 35.81 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.101 0.56 . . . . 73.4 110.498 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -80.47 147.71 30.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.442 -0.947 . . . . 71.44 108.442 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 -79.05 75.33 5.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.911 0.884 . . . . 74.41 110.634 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.23 82.9 51.84 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.495 1.118 . . . . 71.34 108.639 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.85 123.41 5.21 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.927 2.418 . . . . 73.33 111.964 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -95.07 86.02 4.49 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.143 -1.428 . . . . 63.33 107.143 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 65' ' ' THR . 61.1 t -87.26 103.68 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.333 -1.303 . . . . 70.13 110.505 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -96.5 140.02 31.74 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.726 0.41 . . . . 74.35 110.392 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.1 mt -106.45 139.33 41.1 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.187 -1.042 . . . . 74.01 108.187 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.8 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -129.6 108.23 10.06 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.567 -1.271 . . . . 73.35 107.567 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 44' ' ' LEU . 3.2 mp -103.72 130.59 51.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.367 -0.975 . . . . 75.22 108.367 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.489 ' O ' HD22 ' A' ' 60' ' ' LEU . 19.2 t70 -144.05 151.68 39.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.857 0.863 . . . . 72.24 110.205 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -139.24 138.63 36.99 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.597 0.759 . . . . 64.34 110.094 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 149.05 52.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.631 1.172 . . . . 63.25 109.716 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -96.15 170.35 9.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.293 0.637 . . . . 71.13 111.101 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.0 t -165.7 147.82 7.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.879 1.272 . . . . 73.2 108.526 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -111.98 133.52 54.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.488 -0.931 . . . . 74.11 108.488 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 83' ' ' ILE . 62.6 mt -104.69 -44.62 4.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.579 -0.526 . . . . 63.14 109.579 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.62 -174.35 4.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.583 -0.735 . . . . 73.11 110.38 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.27 117.84 6.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.345 1.058 . . . . 74.3 110.748 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 69.31 -8.2 0.74 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 125.533 1.533 . . . . 74.44 113.08 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.3 109.58 26.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.492 -0.929 . . . . 64.24 108.492 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.15 157.01 35.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.891 0.876 . . . . 72.22 108.763 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -132.46 118.91 19.91 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.53 0.732 . . . . 74.21 109.986 -174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -104.56 112.6 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.717 -1.216 . . . . 61.21 107.717 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -100.0 131.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 72.4 109.924 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.489 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -100.63 114.23 27.74 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.447 . . . . 72.02 107.092 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -99.22 104.1 16.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.722 -0.844 . . . . 73.13 108.722 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -95.49 141.96 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.382 -0.97 . . . . 74.42 108.382 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.8 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 85.6 m -125.78 141.13 52.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 171.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 76.9 t -135.24 110.86 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.616 1.166 . . . . 74.33 108.37 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 m -101.95 142.15 33.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.711 -0.848 . . . . 71.24 108.711 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.46 121.78 20.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.873 -1.158 . . . . 71.25 107.873 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -130.95 130.14 43.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.127 0.571 . . . . 74.12 110.135 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 78.4 mt -87.61 78.71 8.46 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.801 -1.185 . . . . 74.25 107.801 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.59 -106.73 2.17 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 114.392 -1.276 . . . . 70.03 112.219 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -89.12 -26.99 21.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.531 0.732 . . . . 72.31 109.984 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.24 131.3 44.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 73.43 109.627 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.1 m -76.19 128.73 35.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.066 0.46 . . . . 70.02 110.524 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -76.83 -56.4 4.63 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.235 1.014 . . . . 71.11 108.971 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -167.57 174.86 7.47 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.163 -0.926 . . . . 73.22 111.207 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 tp -143.05 150.48 39.61 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.845 1.258 . . . . 73.54 109.133 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.688 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 61.6 m -141.59 141.34 33.49 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.441 0.696 . . . . 74.15 110.681 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 56.4 mp0 -141.47 133.41 27.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.285 1.034 . . . . 74.53 108.321 170.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.42 108.4 5.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.265 -1.013 . . . . 71.3 108.265 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.81 80.39 8.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.207 -1.361 . . . . 71.11 107.645 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.12 92.5 3.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 114.046 -1.434 . . . . 74.32 107.886 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.24 145.62 21.42 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.374 -0.83 . . . . 62.3 111.3 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -135.52 120.25 2.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.772 -0.931 . . . . 71.5 110.772 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 51' ' ' LEU . 45.5 mt -85.2 124.99 40.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.082 -1.081 . . . . 74.24 108.082 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -136.46 138.49 41.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.391 -0.966 . . . . 73.34 108.391 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 12' ' ' GLN . 13.7 p -96.42 105.25 17.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.368 -0.604 . . . . 72.4 109.368 172.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.86 132.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.215 0.606 . . . . 71.11 110.072 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.04 162.88 26.08 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.658 1.183 . . . . 72.43 109.666 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.83 -25.11 12.34 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 114.61 0.604 . . . . 70.42 114.61 171.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.42 152.26 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.303 0.552 . . . . 72.23 110.918 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.499 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 8.5 tt0 -155.89 -172.71 4.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.329 -0.619 . . . . 73.21 109.329 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.499 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.63 -153.25 48.79 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.637 -0.256 . . . . 71.13 113.244 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.6 p -65.35 -26.36 67.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.604 0.762 . . . . 75.52 111.318 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.33 -42.69 99.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.536 0.734 . . . . 74.12 110.641 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 47.0 ttp -64.13 -53.14 54.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.139 0.975 . . . . 74.22 110.926 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.08 -47.69 68.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 61.14 110.958 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -47.71 80.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.617 -1.629 . . . . 72.23 111.192 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.619 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.1 m -71.37 -29.41 64.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.585 0.957 . . . . 72.04 113.585 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.9 mt -83.78 -38.8 20.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.049 0.54 . . . . 73.43 111.1 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.56 5.26 56.93 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.958 -0.565 . . . . 73.45 113.827 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -144.29 -66.67 0.34 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.784 0.792 . . . . 74.31 112.384 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.2 t80 -48.96 -56.58 8.45 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.194 0.998 . . . . 74.32 112.434 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.3 m -71.52 -44.56 12.76 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-O 118.389 -0.815 . . . . 54.34 112.471 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.28 -37.27 80.65 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.152 1.901 . . . . 72.53 113.732 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 61.8 m-20 -60.44 -40.61 91.7 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.108 0.963 . . . . 72.51 110.788 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.3 mm -64.7 -41.46 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.084 -0.962 . . . . 75.15 110.569 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.53 HD22 ' HA3' ' A' ' 82' ' ' GLY . 68.7 mt -75.24 -27.19 59.39 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.634 -0.712 . . . . 73.44 111.751 -173.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -63.15 -42.74 78.08 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.741 1.386 . . . . 74.11 114.741 -168.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -35.57 98.3 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 122.307 2.005 . . . . 75.43 113.603 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.8 -37.92 39.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.333 0.653 . . . . 73.33 111.399 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.46 98.56 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.669 -0.493 . . . . 74.32 109.669 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.503 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.5 ttm180 -57.23 -53.44 58.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.354 1.062 . . . . 75.32 110.908 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.95 -47.88 84.4 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.119 0.887 . . . . 63.22 111.008 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.15 -46.69 82.51 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.08 0.862 . . . . 62.34 111.126 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 64' ' ' VAL . 98.9 mt -62.66 -52.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 123.709 0.63 . . . . 74.03 110.474 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 125' ' ' GLN . 87.7 m -56.13 -39.41 72.21 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.82 0.7 . . . . 74.43 111.596 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -66.47 -48.18 70.71 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.345 -0.843 . . . . 61.1 110.185 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.551 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mtp -54.36 -45.13 72.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.864 0.866 . . . . 74.12 111.486 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.442 HG12 ' HG ' ' A' ' 126' ' ' LEU . 71.0 t -61.86 -47.41 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.943 -1.026 . . . . 75.41 110.852 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -71.38 -24.3 62.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.985 -0.552 . . . . 75.44 111.553 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -71.77 -27.06 62.7 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.302 0.641 . . . . 74.42 110.313 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.75 10.09 63.45 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 123.469 0.481 . . . . 72.12 113.045 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.554 HG22 ' HB3' ' B' ' 17' ' ' TYR . 5.9 t 51.97 24.62 2.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 127.03 2.132 . . . . 75.41 113.279 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.457 ' HE1' HG21 ' A' ' 31' ' ' VAL . 75.6 m-85 -86.55 151.84 53.72 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 115.628 -0.715 . . . . 60.54 109.177 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.24 129.0 32.89 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.717 2.278 . . . . 72.13 110.56 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.499 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.5 pt20 -55.81 142.52 34.56 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.156 0.91 . . . . 75.0 111.345 -169.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 118' ' ' VAL . 51.2 mt -119.46 97.66 5.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.525 0.678 . . . . 73.15 109.231 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.57 123.06 42.52 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.308 -1.315 . . . . 54.14 108.067 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 114' ' ' ILE . 69.3 mt -66.12 122.61 17.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.481 0.712 . . . . 74.43 110.565 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -53.29 136.65 50.23 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 119.012 -0.518 . . . . 73.02 110.293 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.43 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.628 2.218 . . . . 73.22 112.102 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 129' ' ' ALA . 53.9 t -100.25 112.86 34.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.17 -1.048 . . . . 74.34 108.17 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -85.42 92.12 8.4 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.243 -1.021 . . . . 73.05 108.243 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.41 -28.54 69.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.8 -0.636 . . . . 73.53 110.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HB2' ' ND2' ' A' ' 104' ' ' ASN . 3.6 t70 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.082 0.953 . . . . 73.31 110.658 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.7 ptm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 114.695 1.368 . . . . 75.15 114.695 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.8 p -141.46 127.5 19.51 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.616 1.166 . . . . 74.11 108.096 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -122.46 128.09 50.42 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.667 -0.864 . . . . 74.41 108.667 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -142.84 140.82 31.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 64.31 109.176 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.585 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.82 141.52 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.601 -0.888 . . . . 74.53 108.601 172.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.599 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 20.2 mm-40 -106.68 -50.66 3.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.963 0.505 . . . . 75.03 109.884 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -168.49 149.03 4.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.976 0.91 . . . . 75.5 108.567 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.547 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.6 mt -128.3 149.31 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.708 -1.219 . . . . 65.34 107.708 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.554 ' HB3' HG22 ' A' ' 122' ' ' THR . 24.1 p90 -170.87 150.44 3.18 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.255 0.55 . . . . 73.43 112.436 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.7 m -72.98 122.3 21.48 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.012 -0.995 . . . . 65.14 108.535 167.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.436 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.7 mtpt -94.33 -33.74 13.08 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.799 0.839 . . . . 73.41 110.563 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 22.9 t70 -152.14 140.52 20.54 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.47 0.481 . . . . 72.1 111.103 -166.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.456 HD13 ' SG ' ' B' ' 113' ' ' CYS . 45.9 mm -140.96 137.54 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.713 1.205 . . . . 74.42 108.315 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -139.81 108.3 5.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.333 -1.358 . . . . 70.1 107.333 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.496 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.5 t80 -126.11 108.25 11.17 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.451 -1.314 . . . . 71.51 107.451 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.96 111.42 18.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.327 -0.99 . . . . 70.31 108.327 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.59 86.97 3.12 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.53 -1.285 . . . . 65.21 107.53 170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.31 -32.49 41.4 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.493 2.129 . . . . 73.03 110.951 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.466 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 87.0 m-20 -111.87 30.43 7.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.501 -1.227 . . . . 73.45 109.97 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.3 -46.98 46.41 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.298 1.039 . . . . 63.14 111.964 167.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 73.6 Cg_endo -76.83 -16.75 16.12 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.086 1.858 . . . . 74.54 114.549 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 65.3 m80 -95.97 -16.19 21.86 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.872 0.693 . . . . 74.22 112.872 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.91 -11.79 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.742 0.417 . . . . 74.03 110.041 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.74 -43.93 94.01 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.584 0.754 . . . . 65.31 109.886 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' B' ' 30' ' ' HIS . 16.0 mp0 -81.03 -32.02 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.074 -0.512 . . . . 73.13 110.201 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.57 92.73 7.21 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.475 0.71 . . . . 75.15 111.093 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -89.31 105.98 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.579 -0.526 . . . . 74.53 109.579 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -172.98 169.23 4.75 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 74.33 109.453 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.36 114.67 49.18 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.877 0.871 . . . . 71.01 108.741 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 150.67 82.99 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.381 2.054 . . . . 74.22 112.392 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 104.94 1.18 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.773 -0.825 . . . . 73.22 108.773 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -97.57 154.35 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.885 0.85 . . . . 72.02 111.765 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.653 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 70.2 tttt -147.24 115.17 6.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.794 -1.548 . . . . 73.21 107.104 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -86.02 159.39 19.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.19 -1.041 . . . . 73.24 108.19 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.477 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.4 t70 -164.94 110.53 0.94 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.352 -0.61 . . . . 73.42 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.98 144.48 31.2 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.931 0.396 . . . . 72.54 109.985 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.68 141.97 47.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.558 1.143 . . . . 72.21 108.683 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -121.65 139.0 54.1 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.633 -0.506 . . . . 73.43 109.633 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.61 161.02 41.79 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.224 1.01 . . . . 74.2 109.227 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -144.01 170.23 16.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.071 0.548 . . . . 72.42 109.981 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -155.31 136.2 13.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.991 0.916 . . . . 73.14 108.624 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.91 120.58 29.39 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.073 0.549 . . . . 74.42 111.068 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.3 -37.54 17.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.328 -0.619 . . . . 71.12 109.328 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.96 -179.48 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.032 0.933 . . . . 74.3 110.676 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.54 125.27 26.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.925 -1.034 . . . . 71.13 109.537 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 65.42 10.44 6.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.473 1.109 . . . . 71.32 112.385 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -127.33 95.61 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.207 -1.035 . . . . 73.11 108.207 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -117.35 138.11 52.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.875 0.47 . . . . 73.51 109.883 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -102.02 103.47 14.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.761 -1.2 . . . . 73.33 107.761 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' B' ' 98' ' ' LEU . 48.7 t -95.3 129.26 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 73.43 109.48 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.9 t -109.55 129.65 64.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.928 0.891 . . . . 75.14 109.844 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 1.2 tt -106.75 134.04 50.5 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.316 -1.364 . . . . 73.24 107.316 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.505 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 27.6 ttm180 -119.19 130.95 55.77 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.857 -0.794 . . . . 73.04 108.857 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.524 ' HB ' HD11 ' B' ' 114' ' ' ILE . 16.9 t -124.67 123.12 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.38 -0.97 . . . . 72.34 108.38 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 33.3 m -108.75 144.85 36.02 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.305 1.042 . . . . 73.21 109.512 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.517 HG22 HG21 ' B' ' 114' ' ' ILE . 91.0 t -135.94 98.52 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.636 1.174 . . . . 62.25 108.21 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.653 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 27.4 m -83.07 139.3 33.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.939 -0.763 . . . . 65.24 108.939 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.69 140.06 21.37 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.839 0.456 . . . . 75.55 110.06 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.454 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.3 m -142.1 131.91 24.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.401 0.68 . . . . 72.51 109.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.19 108.3 20.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.157 -1.424 . . . . 73.54 107.157 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -118.83 5.75 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.803 -0.919 . . . . 71.02 110.803 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -111.93 4.59 18.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.276 0.63 . . . . 73.32 111.986 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.77 147.28 43.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.487 0.715 . . . . 72.45 110.013 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.3 m -66.05 127.13 30.9 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.021 0.528 . . . . 65.44 111.686 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -86.99 -54.5 4.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.267 -1.012 . . . . 62.23 108.267 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.88 157.52 24.04 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 114.739 -1.119 . . . . 72.4 110.062 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 84.5 mt -130.82 110.82 11.6 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 106.554 -1.647 . . . . 75.12 106.554 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -117.15 136.15 53.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 75.15 108.603 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.6 tt0 -157.61 135.09 10.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.094 -0.706 . . . . 71.44 109.094 -170.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.28 149.97 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.376 -0.829 . . . . 75.33 109.045 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 43.0 mt-30 -123.26 106.04 10.38 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.102 -1.073 . . . . 75.1 108.102 167.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -94.88 101.05 12.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.58 -0.896 . . . . 71.3 108.58 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.17 171.56 32.65 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.546 -0.622 . . . . 53.54 111.546 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.11 141.91 5.99 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.483 -0.647 . . . . 72.13 111.483 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 22.1 mt -92.72 128.05 44.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.811 -0.811 . . . . 72.44 108.811 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.06 134.82 47.64 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.048 0.939 . . . . 73.15 108.545 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 52.7 m -107.24 104.27 13.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.568 0.747 . . . . 71.24 109.002 175.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.458 ' H ' HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.14 121.15 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.691 1.196 . . . . 75.13 109.365 -176.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.5 159.08 40.44 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.908 0.883 . . . . 71.35 109.6 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.52 -43.63 2.77 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.622 0.577 . . . . 73.21 112.805 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 pp -62.49 138.97 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.572 0.749 . . . . 72.33 111.105 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -150.3 172.06 15.98 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.128 0.971 . . . . 75.24 110.416 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.76 -128.98 43.86 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.173 0.921 . . . . 65.33 113.496 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.2 m -67.81 -30.3 69.68 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.78 0.832 . . . . 74.21 110.814 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -74.72 -33.64 62.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.796 -0.638 . . . . 75.43 111.543 -168.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -36.46 68.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.162 0.506 . . . . 75.53 110.299 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.14 -26.96 66.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.793 -1.094 . . . . 65.15 111.247 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -86.56 -34.6 19.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.384 1.074 . . . . 74.3 110.164 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.02 -63.36 1.32 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.258 0.623 . . . . 73.32 111.573 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.454 ' HB2' HG23 ' B' ' 58' ' ' VAL . 1.4 pp -93.75 -3.26 52.49 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.958 0.355 . . . . 72.25 111.958 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.11 -16.34 51.01 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.242 0.339 . . . . 61.41 112.674 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.37 -52.82 0.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.219 0.452 . . . . 71.34 112.219 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -70.94 -43.83 67.38 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 90.7 m -61.86 -49.97 83.43 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.5 -0.762 . . . . 72.12 110.917 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -54.72 -33.63 80.97 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.062 1.841 . . . . 70.35 113.805 168.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.81 -32.49 74.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.881 0.472 . . . . 75.24 111.186 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.86 -42.99 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.288 0.635 . . . . 73.22 110.169 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.85 -26.61 57.3 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.677 -1.147 . . . . 74.24 111.827 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.26 -49.86 82.39 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.726 1.01 . . . . 72.45 113.726 -170.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.435 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 35.3 Cg_endo -61.38 -31.32 88.47 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.704 1.603 . . . . 73.14 112.58 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.547 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.8 m-30 -69.06 -45.57 70.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.821 0.848 . . . . 74.15 110.25 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.98 89.38 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.335 -0.848 . . . . 62.15 110.798 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -59.31 -54.6 44.98 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.652 1.581 . . . . 74.44 111.35 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.57 -33.91 77.02 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.719 0.637 . . . . 72.32 109.854 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.506 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.9 t -68.35 -38.37 81.39 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.163 -0.471 . . . . 74.25 111.075 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.524 HD11 ' HB ' ' B' ' 62' ' ' VAL . 52.6 mt -64.04 -58.74 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.685 -0.487 . . . . 72.24 109.685 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -59.01 -31.3 68.69 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 124.18 0.925 . . . . 65.32 111.368 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -62.01 -54.38 42.4 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.387 0.675 . . . . 75.54 110.48 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -62.31 -36.63 82.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.19 0.596 . . . . 74.55 110.931 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.2 t -63.0 -42.65 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.074 0.949 . . . . 74.34 110.908 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.3 m -68.18 -31.86 71.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.328 0.651 . . . . 75.0 111.035 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 94.6 mtt-85 -68.65 -21.53 64.45 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.552 0.741 . . . . 75.41 110.921 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.11 15.12 61.93 Favored Glycine 0 C--N 1.356 1.685 0 CA-C-O 119.258 -0.746 . . . . 72.31 114.125 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.636 HG22 ' HD3' ' A' ' 15' ' ' ARG . 1.9 p 73.59 12.84 4.53 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 126.377 1.871 . . . . 71.53 113.247 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.24 149.82 43.66 Favored Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 122.183 -0.323 . . . . 73.34 111.163 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.21 163.11 24.11 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.243 2.629 . . . . 51.24 113.667 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 0.6 OUTLIER -63.57 115.35 4.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.232 1.013 . . . . 74.42 111.063 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 tt -130.11 97.47 4.46 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.074 -1.454 . . . . 72.35 107.074 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.75 136.07 33.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.527 -0.916 . . . . 72.44 108.527 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.11 125.13 28.28 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.086 -0.709 . . . . 73.43 109.086 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.85 153.9 92.92 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 123.267 0.627 . . . . 71.42 111.056 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.39 99.06 0.35 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.089 2.526 . . . . 74.34 112.419 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 5.2 p -90.84 113.27 26.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 121.487 0.661 . . . . 71.14 109.336 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -76.55 101.9 5.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.967 -0.753 . . . . 62.11 108.967 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -59.74 -28.68 67.57 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.102 -0.954 . . . . 73.43 109.898 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.51 -52.72 58.68 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.589 1.556 . . . . 72.12 110.684 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.35 79.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.458 1.099 . . . . 70.32 111.173 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.477 0.922 0 O-C-N 123.81 0.694 . . . . 74.34 110.799 -178.335 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.984 0.421 . . . . 72.22 111.235 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -87.92 77.54 8.47 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.65 -0.87 . . . . 74.23 108.65 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -114.66 137.31 52.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.527 -0.76 . . . . 71.5 109.534 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -152.06 134.53 15.3 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.297 0.639 . . . . 75.03 109.483 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 pt -76.27 136.45 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.717 -0.674 . . . . 74.13 109.319 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.1 mm-40 -104.68 -49.04 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.887 0.475 . . . . 64.53 110.005 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -166.11 141.46 4.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.58 -0.736 . . . . 75.3 109.475 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.4 136.02 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.827 -1.175 . . . . 65.5 107.827 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.448 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 7.7 p90 -173.11 154.38 2.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.306 0.574 . . . . 53.54 111.697 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -77.0 116.64 17.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.342 -0.845 . . . . 72.12 109.052 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -70.91 -48.59 52.82 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 107.972 -1.122 . . . . 74.02 107.972 169.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 6.0 t70 -137.02 141.14 42.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.479 -1.692 . . . . 64.14 109.548 -171.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.9 mt -136.57 141.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.321 -1.363 . . . . 75.02 107.321 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -150.23 141.84 23.55 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.395 -0.594 . . . . 63.1 109.395 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.85 141.71 31.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.529 -1.285 . . . . 75.34 107.529 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.79 144.0 31.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.569 -1.271 . . . . 73.31 107.569 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.47 83.18 6.0 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 108.386 -0.968 . . . . 70.23 108.386 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.07 -15.17 39.43 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.026 2.484 . . . . 75.01 112.69 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -126.1 37.89 4.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.171 0.988 . . . . 70.05 109.517 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.74 -51.74 79.69 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 113.809 1.04 . . . . 64.23 113.809 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.69 -24.53 7.27 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 121.64 1.56 . . . . 74.41 112.43 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.75 -22.54 65.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.661 1.184 . . . . 73.15 111.802 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.655 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 11.2 p -50.1 -32.29 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.353 1.061 . . . . 62.24 113.8 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.4 -31.01 70.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.341 0.656 . . . . 74.2 112.001 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -118.01 48.84 1.32 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.699 0.8 . . . . 72.41 110.355 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.655 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 14.6 ptpt -124.41 173.12 8.63 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.881 -0.414 . . . . 71.31 109.881 170.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.59 113.41 20.8 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.026 -1.101 . . . . 74.02 108.026 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -83.76 79.6 9.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.268 1.032 . . . . 73.12 110.81 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.712 ' HB3' HD13 ' C' ' 68' ' ' LEU . 48.4 tt0 -123.53 79.63 54.66 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.342 -1.355 . . . . 74.34 107.342 168.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 91.08 1.2 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.053 2.502 . . . . 72.04 111.973 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.61 91.96 8.42 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.9 -1.889 . . . . 63.51 105.9 169.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.5 141.03 15.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.367 -0.833 . . . . 74.44 109.354 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.594 ' HZ2' ' HB2' ' C' ' 41' ' ' LYS . 4.3 ttmp? -127.13 103.75 7.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.031 -0.729 . . . . 72.25 109.031 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.612 ' H ' HD21 ' C' ' 42' ' ' LEU . 1.6 pt? -89.9 160.71 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.853 . . . . 73.33 109.848 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.93 117.51 8.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.536 0.735 . . . . 65.52 109.216 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.43 120.21 39.64 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.86 -0.793 . . . . 73.23 108.86 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.2 140.93 46.84 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.715 1.206 . . . . 70.32 108.786 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 8.1 t -142.57 138.4 30.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.317 0.58 . . . . 71.43 110.455 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.26 177.32 5.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.143 0.977 . . . . 60.42 108.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -151.83 160.33 43.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 74.02 111.129 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -155.84 140.07 16.58 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.334 1.053 . . . . 75.41 108.614 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.46 115.35 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.497 -0.927 . . . . 64.14 108.497 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' C' ' 57' ' ' GLU . 47.5 mt -85.52 -42.62 14.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.005 -0.739 . . . . 63.22 109.005 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.56 179.78 8.08 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.515 -1.22 . . . . 74.05 109.103 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.06 128.01 34.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.001 -0.741 . . . . 75.43 109.001 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 70.55 -3.66 1.85 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.803 1.241 . . . . 64.31 112.487 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.29 111.22 35.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 108.771 -0.826 . . . . 73.35 108.771 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.34 125.47 42.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.601 0.761 . . . . 74.4 109.124 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.594 ' HB2' HD12 ' C' ' 51' ' ' LEU . 33.9 tt0 -84.5 137.75 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.696 0.798 . . . . 74.51 109.166 171.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.25 140.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 75.24 108.344 165.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' C' ' 46' ' ' THR . 47.5 t -117.51 103.6 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.397 -0.964 . . . . 74.15 108.397 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.64 96.8 10.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.258 -1.016 . . . . 72.21 108.258 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -85.67 126.78 34.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.817 -1.083 . . . . 73.44 109.663 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.9 t -115.18 134.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.276 -1.009 . . . . 62.02 108.276 171.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 4.4 m -118.98 141.71 48.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.531 HG22 HD13 ' C' ' 128' ' ' LEU . 86.3 t -128.64 117.24 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.668 1.187 . . . . 72.33 108.356 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -99.87 144.37 29.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.438 -1.319 . . . . 75.32 107.438 165.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.84 106.7 6.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.354 -1.721 . . . . 51.4 106.354 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -152.45 160.96 43.21 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.557 0.535 . . . . 72.41 110.815 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.712 HD13 ' HB3' ' C' ' 37' ' ' GLN . 20.0 tp -79.27 -50.26 11.19 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.172 -1.047 . . . . 73.21 108.172 162.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.4 -77.31 0.04 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.068 -1.213 . . . . 63.31 110.068 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -89.99 -31.3 17.28 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.229 -0.656 . . . . 75.21 109.229 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -78.05 93.38 4.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.277 1.031 . . . . 70.13 109.933 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -87.91 130.57 34.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.932 0.493 . . . . 74.3 111.65 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.25 -65.07 0.82 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.167 0.987 . . . . 63.4 108.943 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -156.54 164.0 38.72 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 123.797 0.686 . . . . 74.25 111.622 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.443 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -121.66 144.65 48.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.655 -1.609 . . . . 55.43 106.655 168.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.443 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -148.14 150.95 34.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.777 -0.823 . . . . 60.34 108.777 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -159.69 131.59 6.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.724 0.409 . . . . 75.41 110.078 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -129.95 114.64 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.867 0.867 . . . . 74.51 108.757 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.5 mt-30 -90.24 88.6 7.29 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.036 -1.098 . . . . 75.31 108.036 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.62 107.22 12.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.892 -1.049 . . . . 75.33 109.512 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.95 154.95 27.13 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 112.147 -0.381 . . . . 71.01 112.147 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.466 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.05 122.87 1.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.382 -0.687 . . . . 71.34 111.382 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.567 HD13 HD12 ' C' ' 51' ' ' LEU . 10.0 mm -87.9 123.47 40.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.397 -0.964 . . . . 72.54 108.397 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.32 123.33 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.555 0.742 . . . . 73.32 110.053 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -76.93 112.15 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.822 0.449 . . . . 73.34 109.821 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.42 112.12 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.308 -0.997 . . . . 74.15 108.308 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.01 165.66 30.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.741 0.817 . . . . 71.05 110.255 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -24.42 8.71 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.156 -0.474 . . . . 65.13 113.765 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.523 HD13 ' HB3' ' C' ' 93' ' ' GLN . 19.8 tt -123.48 151.66 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.403 1.081 . . . . 71.31 109.558 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.75 161.0 43.09 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.205 0.602 . . . . 63.14 110.606 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.1 -153.61 22.4 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 122.986 0.327 . . . . 73.31 112.856 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -59.53 -26.55 65.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.997 0.919 . . . . 73.41 110.454 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.523 ' HB3' HD13 ' C' ' 89' ' ' ILE . 36.8 mt-30 -61.1 -49.84 75.67 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.904 -1.498 . . . . 73.33 110.799 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -21.33 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 116.273 -0.422 . . . . 75.04 110.694 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.08 83.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.034 0.533 . . . . 75.34 110.57 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -66.09 -31.13 71.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.539 -0.755 . . . . 74.12 110.508 172.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.98 -59.27 2.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.67 0.388 . . . . 75.31 110.737 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.14 -51.05 16.79 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.434 0.694 . . . . 75.34 111.108 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.27 6.53 81.03 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.383 -0.676 . . . . 72.33 114.599 -169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.15 -57.22 0.37 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.906 0.853 . . . . 75.53 111.829 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -68.49 -54.05 19.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.289 0.636 . . . . 74.22 111.233 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.3 -46.96 99.07 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 123.863 0.865 . . . . 74.42 112.597 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.3 -33.55 58.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.954 1.769 . . . . 75.31 113.378 171.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.36 -21.6 63.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.918 0.487 . . . . 55.41 111.78 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.503 HD13 ' NH1' ' A' ' 111' ' ' ARG . 32.4 mm -73.75 -39.35 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.216 0.606 . . . . 74.33 109.492 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.466 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.5 mt -75.44 -26.85 58.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.077 -0.965 . . . . 64.55 111.735 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -54.98 -49.87 89.63 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-O 117.993 -1.003 . . . . 71.53 113.12 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.58 -39.96 73.97 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.227 1.951 . . . . 63.11 113.879 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.98 -45.27 67.71 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.132 0.573 . . . . 75.03 110.882 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.21 81.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.248 0.619 . . . . 70.23 110.09 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -63.73 -50.12 70.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.108 1.363 . . . . 72.43 111.244 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.401 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -69.46 -28.53 66.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.704 0.402 . . . . 72.01 110.109 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.6 t -69.33 -35.98 76.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.778 0.431 . . . . 74.4 110.71 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.486 ' O ' HG23 ' C' ' 118' ' ' VAL . 93.4 mt -71.25 -53.23 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.49 -0.559 . . . . 75.34 109.49 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -61.32 -28.91 69.54 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.794 0.838 . . . . 71.12 111.336 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 38.9 t -65.94 -50.34 64.72 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.084 -0.71 . . . . 74.44 109.084 170.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.85 -31.89 71.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.954 0.901 . . . . 73.13 112.436 179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.486 HG23 ' O ' ' C' ' 114' ' ' ILE . 43.9 t -71.66 -38.9 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -66.47 -29.9 70.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.853 0.861 . . . . 63.13 111.377 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -74.16 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.43 0.692 . . . . 75.21 109.893 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.52 -7.33 68.46 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.418 0.449 . . . . 75.04 112.417 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.485 HG21 ' HB3' ' D' ' 17' ' ' TYR . 32.4 p 63.14 30.25 16.06 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.937 2.095 . . . . 74.22 112.561 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -82.77 162.32 55.68 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.639 -1.164 . . . . 74.43 108.409 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 140.27 92.72 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.41 2.074 . . . . 74.13 111.639 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 13.1 mm100 -57.59 112.55 1.47 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.891 0.877 . . . . 71.34 111.897 -173.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.43 93.21 4.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.45 -0.945 . . . . 74.02 108.45 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.27 127.75 49.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 75.24 108.554 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.531 HD13 HG22 ' C' ' 64' ' ' VAL . 86.8 mt -81.39 144.69 31.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.039 0.535 . . . . 72.32 111.114 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.23 143.26 95.64 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.323 0.649 . . . . 70.51 110.421 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.52 139.49 76.45 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.634 2.223 . . . . 65.41 112.33 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.25 118.2 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 108.888 -0.782 . . . . 74.22 108.888 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -83.87 60.24 5.68 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.864 0.84 . . . . 74.54 109.99 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -78.91 -43.43 24.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.844 -1.071 . . . . 74.2 110.034 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 115.792 -0.64 . . . . 70.4 109.694 177.72 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.5 ttp . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.289 0.848 . . . . 75.22 113.289 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -122.95 142.41 50.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.588 0.755 . . . . 71.42 109.301 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -155.04 98.9 2.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.7 132.62 49.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.269 0.628 . . . . 72.42 109.82 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tp -89.61 128.21 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.15 0.58 . . . . 61.23 109.548 177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -99.62 -40.5 7.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.835 0.854 . . . . 74.24 111.037 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -163.04 123.44 2.31 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.772 -0.649 . . . . 73.21 110.471 -162.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.93 132.1 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.294 -1.373 . . . . 70.43 107.294 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.533 ' HE1' HG13 ' D' ' 83' ' ' ILE . 12.4 p90 -160.04 143.52 14.03 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.957 0.786 . . . . 74.54 111.476 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -76.1 117.48 17.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.943 -1.026 . . . . 74.54 108.917 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -82.59 -26.14 32.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.91 0.386 . . . . 64.21 109.99 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.7 t70 -154.11 141.69 19.85 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.848 -1.069 . . . . 64.34 109.437 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.535 HG23 ' HE1' ' C' ' 117' ' ' MET . 81.1 mt -141.63 145.98 23.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.221 1.408 . . . . 73.21 107.544 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -147.34 141.72 26.35 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.986 0.914 . . . . 75.21 108.69 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.9 t80 -153.77 124.89 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.285 -1.746 . . . . 74.32 106.285 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.43 112.66 7.43 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.596 0.634 . . . . 71.11 110.27 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.9 91.37 12.6 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.38 0.672 . . . . 44.02 109.353 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.5 -43.87 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.759 2.306 . . . . 55.22 112.919 -175.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 44.6 m-80 -99.63 43.42 1.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.754 0.822 . . . . 74.1 109.056 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.78 -52.36 73.04 Favored Pre-proline 0 CA--C 1.57 1.737 0 N-CA-C 114.742 1.386 . . . . 75.42 114.742 -169.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.5 -6.0 8.09 Favored 'Trans proline' 0 C--N 1.388 2.656 0 CA-C-N 121.524 1.58 . . . . 71.5 112.578 172.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.414 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 21.8 t-160 -81.09 -42.15 21.43 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.08 0.952 . . . . 74.35 110.048 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.11 -18.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.27 0.628 . . . . 74.24 110.052 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.98 -29.62 70.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.949 0.9 . . . . 75.41 110.876 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -68.55 -17.71 64.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 74.23 111.841 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.07 109.97 21.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.768 0.827 . . . . 72.02 110.168 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.73 81.99 5.91 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.99 0.916 . . . . 74.13 110.882 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -159.42 161.35 35.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.654 -0.499 . . . . 73.24 109.654 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -82.9 109.07 14.62 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.876 0.87 . . . . 74.54 109.792 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -50.19 140.37 33.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.44 2.76 . . . . 74.54 113.569 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.73 127.29 31.31 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.051 0.845 . . . . 75.44 110.116 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 88.7 t -96.33 105.84 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.734 -0.839 . . . . 74.22 108.734 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -102.78 108.85 20.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.217 -1.401 . . . . 74.12 107.217 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.512 HD13 HD21 ' D' ' 128' ' ' LEU . 1.5 pt? -116.3 149.85 38.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.065 0.46 . . . . 75.03 110.498 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.69 130.27 24.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.395 1.078 . . . . 65.12 108.289 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.21 131.13 54.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.222 0.609 . . . . 71.12 109.503 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -133.55 128.95 36.36 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.853 -1.166 . . . . 74.41 107.853 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -106.23 150.03 26.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.522 0.329 . . . . 74.55 110.211 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.13 169.02 22.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.8 0.84 . . . . 71.21 110.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.4 m -147.87 158.73 44.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.874 0.869 . . . . 71.11 110.019 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -155.35 118.42 4.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.17 -1.048 . . . . 72.23 108.17 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.62 123.14 24.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.147 -0.686 . . . . 75.53 109.147 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' D' ' 57' ' ' GLU . 51.2 mt -96.21 -31.54 12.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.547 . . . . 74.53 110.366 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 179.64 8.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.857 0.863 . . . . 75.31 110.088 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.06 121.34 18.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.906 -1.043 . . . . 73.42 109.274 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 68.24 17.01 9.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.994 1.318 . . . . 71.21 112.069 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.36 116.68 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.61 ' HB2' HD13 ' D' ' 86' ' ' ILE . 82.6 m-85 -129.15 129.83 45.64 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.736 -0.839 . . . . 73.03 108.736 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.458 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.5 tt0 -87.79 135.37 33.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.845 -1.071 . . . . 73.14 108.64 171.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.02 139.2 43.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.853 -1.166 . . . . 71.5 107.853 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.69 131.84 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.39 -0.967 . . . . 71.44 108.39 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -114.58 117.14 30.06 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.267 -1.383 . . . . 73.22 107.267 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 44.6 ttm-85 -95.78 98.72 10.66 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.59 -1.263 . . . . 72.42 107.59 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . 0.619 HG23 ' HB1' ' D' ' 110' ' ' ALA . 47.6 t -99.21 113.81 35.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.031 -1.1 . . . . 71.12 108.031 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.2 m -117.3 132.23 56.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 75.43 109.232 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.28 107.1 10.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.964 0.906 . . . . 73.52 109.286 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.8 m -92.57 119.77 32.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.687 -0.857 . . . . 74.3 108.687 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.73 137.11 46.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.699 -0.852 . . . . 74.42 108.699 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 57.3 p -149.15 140.38 23.12 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.846 0.459 . . . . 73.03 109.951 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.86 130.18 41.36 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.386 -1.338 . . . . 73.44 107.386 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.23 -121.14 12.91 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.706 -0.557 . . . . 74.42 111.706 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.15 6.95 15.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.247 1.019 . . . . 74.1 111.402 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.95 150.19 34.13 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.118 0.567 . . . . 74.23 109.751 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -79.8 116.72 20.13 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.814 -0.439 . . . . 73.02 109.814 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.11 -56.08 10.14 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.824 0.849 . . . . 72.23 110.102 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.54 169.19 23.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.021 -0.991 . . . . 75.33 110.211 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.4 mt -124.41 153.26 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.759 1.224 . . . . 73.14 108.012 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.53 ' SG ' HG22 ' D' ' 114' ' ' ILE . 47.2 t -158.43 139.66 13.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.137 0.575 . . . . 72.11 109.638 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.27 130.66 8.79 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.896 -0.779 . . . . 74.14 108.896 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.5 t -129.74 115.29 33.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.076 -0.713 . . . . 72.33 109.076 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.2 mt-30 -89.36 83.4 6.41 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.302 1.048 . . . . 62.44 108.478 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.79 102.97 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.174 -1.83 . . . . 74.45 109.509 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.2 162.71 23.87 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 116.319 -0.401 . . . . 70.34 112.393 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.0 136.77 5.08 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.951 -0.86 . . . . 72.23 110.951 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.533 HG13 ' HE1' ' D' ' 17' ' ' TYR . 69.2 mt -89.48 120.83 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.814 -0.81 . . . . 73.45 108.814 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -121.4 147.12 46.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.565 -0.531 . . . . 74.51 109.565 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 66.1 m -94.58 106.94 18.94 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.794 -0.817 . . . . 74.01 108.794 170.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' D' ' 94' ' ' MET . 3.5 mp -107.26 107.69 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.33 -0.989 . . . . 63.55 108.33 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.46 148.81 50.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.121 0.568 . . . . 74.15 109.977 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -22.71 11.93 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.073 -0.512 . . . . 64.44 114.273 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' D' ' 94' ' ' MET . 32.5 mm -136.41 139.89 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.247 -1.39 . . . . 73.01 107.247 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.01 179.7 7.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.182 0.593 . . . . 74.03 109.996 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.64 -99.83 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.297 -0.41 . . . . 73.45 113.762 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.7 p -83.45 -56.1 3.93 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.077 0.551 . . . . 74.31 111.977 -168.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.03 -37.63 78.73 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 120.796 0.332 . . . . 70.11 110.85 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.621 ' HG2' HG23 ' D' ' 86' ' ' ILE . 44.5 tpp -77.31 -19.93 55.7 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.956 -0.565 . . . . 74.35 111.751 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.63 -32.49 70.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 120.996 0.427 . . . . 71.32 111.124 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -62.65 -40.57 97.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.244 -0.889 . . . . 74.25 110.988 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.465 ' SG ' ' SG ' ' D' ' 102' ' ' CYS . 38.5 t -72.26 -51.26 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.786 0.434 . . . . 73.04 110.27 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.501 HD13 ' HG3' ' D' ' 94' ' ' MET . 10.7 mp -67.37 -18.86 65.31 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.466 0.706 . . . . 73.3 111.796 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -2.94 56.96 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.372 -0.682 . . . . 61.21 114.056 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.69 -62.79 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.95 0.875 . . . . 73.3 111.999 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -71.06 -50.08 37.8 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.826 0.676 . . . . 72.12 112.826 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.465 ' SG ' ' SG ' ' D' ' 97' ' ' CYS . 18.6 m -62.67 -45.23 88.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.373 0.669 . . . . 63.45 111.877 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.53 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.9 Cg_exo -55.99 -37.63 95.85 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.985 1.79 . . . . 71.23 113.057 168.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.82 -32.47 74.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.537 0.735 . . . . 65.24 111.143 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.14 -41.97 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 123.283 0.633 . . . . 75.33 110.136 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.9 mt -77.42 -17.96 57.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.172 -0.922 . . . . 74.01 111.541 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.98 -44.19 89.09 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 114.181 1.178 . . . . 71.45 114.181 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.23 -41.9 56.28 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.156 1.904 . . . . 64.35 112.808 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.98 -32.62 51.38 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.153 -0.93 . . . . 75.42 111.597 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -62.86 -55.61 24.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.593 0.757 . . . . 63.41 109.441 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.07 -40.45 76.89 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.025 -1.443 . . . . 74.44 110.337 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 3.4 tm-20 -57.42 -53.55 56.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.73 0.812 . . . . 75.23 111.742 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.404 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.6 t -57.74 -42.22 83.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.018 0.824 . . . . 73.24 110.935 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.53 HG22 ' SG ' ' D' ' 76' ' ' CYS . 60.6 mt -63.35 -54.15 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.348 -0.842 . . . . 72.51 110.642 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 48.0 m -54.02 -38.03 64.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 75.24 111.389 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -73.02 -44.49 60.83 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.062 -0.972 . . . . 73.2 110.462 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 73.4 mtm -65.2 -31.02 71.98 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.785 0.434 . . . . 71.24 111.803 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.36 -47.55 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 124.008 0.817 . . . . 74.02 109.771 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -70.49 -27.91 64.57 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 123.356 0.41 . . . . 75.32 111.06 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -73.5 -34.79 65.45 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.794 0.838 . . . . 73.13 110.044 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.45 -1.56 88.73 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.663 -0.698 . . . . 71.31 112.008 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 58.94 34.69 23.76 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.753 2.021 . . . . 73.34 112.784 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -96.45 163.58 20.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.489 -1.232 . . . . 71.31 108.287 170.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.28 139.62 72.77 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.02 1.814 . . . . 75.1 111.025 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.21 135.23 49.78 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.716 0.807 . . . . 73.31 112.189 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.493 HD23 HG21 ' D' ' 114' ' ' ILE . 58.7 tp -103.02 104.84 15.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.491 -0.929 . . . . 73.12 108.491 -175.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -98.42 84.5 3.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.205 -1.406 . . . . 75.42 107.205 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.512 HD21 HD13 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -63.78 115.41 4.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.07 -1.085 . . . . 74.43 108.07 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 135.35 90.67 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 124.153 0.908 . . . . 72.44 111.554 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 107.25 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.663 2.242 . . . . 73.02 111.567 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 m -107.33 144.38 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.69 0.796 . . . . 74.23 109.455 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -82.15 101.45 10.44 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.138 -0.69 . . . . 74.3 109.138 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.733 0.813 . . . . 74.5 111.374 178.429 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.064 -0.717 . . . . 75.22 109.064 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.58 130.44 53.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.621 -1.251 . . . . 75.54 107.621 167.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.609 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 30.9 tt0 -133.57 106.65 7.53 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.205 -0.665 . . . . 70.14 109.205 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -75.87 102.92 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.402 -1.333 . . . . 75.35 107.402 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 7.2 tp-100 -74.75 -43.16 56.38 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.796 -0.638 . . . . 72.35 110.8 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 178.36 156.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.281 1.032 . . . . 73.22 110.243 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.56 106.42 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.228 1.011 . . . . 72.43 108.555 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CD1' HG22 ' B' ' 122' ' ' THR . 77.0 m-85 -148.39 157.66 43.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.388 0.675 . . . . 75.15 110.604 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -73.72 120.69 19.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.033 0.933 . . . . 73.44 110.526 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -88.81 -22.58 23.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.983 -0.553 . . . . 72.54 110.743 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -154.86 141.86 19.24 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.937 0.773 . . . . 62.35 110.278 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.8 mt -143.19 141.62 26.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.539 1.536 . . . . 62.51 107.534 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -149.97 135.17 18.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.285 -1.006 . . . . 75.43 108.285 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 74.0 t80 -138.08 111.59 8.11 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 106.099 -1.815 . . . . 74.51 106.099 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.87 118.81 32.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.801 0.44 . . . . 65.1 110.183 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.69 75.07 32.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.694 0.797 . . . . 70.4 109.726 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.12 -27.56 29.37 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.47 2.113 . . . . 72.44 110.656 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.435 ' O ' HG21 ' A' ' 31' ' ' VAL . 57.7 m-20 -96.69 24.96 5.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.08 -1.418 . . . . 75.24 109.777 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.14 99.86 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.985 0.914 . . . . 72.4 112.829 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HG2' ' HD1' ' A' ' 30' ' ' HIS . 43.3 Cg_endo -69.07 -16.35 40.38 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 121.714 1.609 . . . . 74.12 112.638 172.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.469 ' HD1' ' HG2' ' A' ' 29' ' ' PRO . 2.1 m80 -85.81 -20.5 29.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.662 0.785 . . . . 75.03 110.461 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 27' ' ' ASN . 46.3 t -68.97 -23.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.201 0.524 . . . . 73.53 110.459 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -67.98 -30.25 69.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.592 -0.731 . . . . 75.25 110.517 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -72.6 -30.39 64.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.964 0.906 . . . . 72.53 110.177 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -75.42 161.28 29.37 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.676 -0.693 . . . . 74.34 111.243 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.41 159.72 29.25 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.818 -1.083 . . . . 74.43 108.755 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.0 m-90 -82.82 57.25 3.74 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.322 0.582 . . . . 65.5 110.283 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -154.9 79.67 4.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.554 0.741 . . . . 72.54 109.406 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.98 155.89 23.29 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.202 1.935 . . . . 73.34 110.83 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.17 115.97 28.31 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.007 -1.109 . . . . 72.41 108.007 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 65' ' ' THR . 21.9 m -98.96 98.8 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.703 0.764 . . . . 74.33 110.921 -173.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.73 115.44 19.33 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.364 -0.976 . . . . 73.31 108.364 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 pt? -98.71 145.05 27.3 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.379 -0.6 . . . . 73.51 109.379 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.1 t70 -137.67 122.52 18.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.03 -1.1 . . . . 72.22 108.03 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.482 HD23 HG12 ' A' ' 131' ' ' VAL . 4.1 mp -102.62 118.12 36.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.837 -0.801 . . . . 72.24 108.837 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -132.12 137.27 47.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.484 0.714 . . . . 72.33 109.734 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.7 m -131.1 139.11 49.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.868 0.867 . . . . 75.22 109.631 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.76 115.32 5.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.668 0.787 . . . . 73.04 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.2 m -90.17 155.37 19.07 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.569 0.748 . . . . 74.54 110.51 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -149.57 161.15 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.534 1.134 . . . . 71.2 108.786 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -114.85 115.93 27.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.275 0.63 . . . . 71.51 109.719 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -90.04 -31.22 17.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.402 0.681 . . . . 72.54 111.471 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 -172.48 3.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.744 0.652 . . . . 74.43 110.365 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.74 105.65 1.03 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.209 1.003 . . . . 73.13 111.055 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 67.93 12.44 8.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.083 1.353 . . . . 74.44 112.733 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.33 106.86 19.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.48 -1.304 . . . . 75.45 107.48 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -113.16 123.96 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.967 -1.015 . . . . 74.35 109.146 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.7 119.86 38.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.147 -1.388 . . . . 75.0 108.548 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.24 123.61 53.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.676 -1.601 . . . . 75.12 106.676 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.422 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 99.4 t -104.19 130.0 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.635 -0.876 . . . . 75.22 108.635 173.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 113.14 26.49 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.574 -1.639 . . . . 75.21 106.574 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -100.22 101.99 13.15 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.969 -1.123 . . . . 74.02 107.969 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.3 t -95.11 126.79 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.278 -1.008 . . . . 74.53 108.278 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 23.2 m -110.55 133.95 52.84 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.24 105.85 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.166 -1.42 . . . . 64.33 107.166 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.0 m -103.78 130.35 51.3 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.732 -0.84 . . . . 72.31 108.732 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.36 109.69 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.147 -1.057 . . . . 73.22 108.147 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.3 m -136.61 128.5 29.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.035 -0.728 . . . . 63.51 109.035 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 tt -94.65 87.66 5.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.611 -1.625 . . . . 73.21 106.611 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.76 -121.3 5.4 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.528 -0.629 . . . . 64.32 111.528 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -90.8 -25.84 19.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.195 0.598 . . . . 75.35 111.602 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 125.79 34.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.774 -0.454 . . . . 74.53 109.774 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 m -74.36 134.37 42.48 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 115.776 -0.647 . . . . 64.35 109.658 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.63 -55.62 4.34 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -167.3 168.99 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.039 -0.982 . . . . 75.53 110.476 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.5 tp -132.52 143.68 49.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.644 1.178 . . . . 72.25 108.673 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.444 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 13.8 m -138.02 124.93 21.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.635 0.774 . . . . 64.14 109.432 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.41 125.77 23.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.106 -0.701 . . . . 73.23 109.106 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -131.89 114.69 25.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.979 0.912 . . . . 74.23 109.512 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 74.1 mt-30 -85.53 86.6 7.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.154 -0.93 . . . . 72.31 108.876 172.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.67 99.1 5.68 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.078 -0.965 . . . . 73.53 109.071 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.66 152.41 21.08 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.593 -0.603 . . . . 73.14 111.593 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.07 134.24 5.67 Favored Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.273 -1.131 . . . . 71.21 110.273 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 43.4 mt -87.85 125.71 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.255 -1.017 . . . . 72.24 108.255 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -131.82 120.23 22.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 48.3 t -92.2 100.83 13.37 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.177 -1.045 . . . . 73.33 108.177 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.425 HD11 HD23 ' A' ' 98' ' ' LEU . 50.5 pt -116.16 141.01 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.246 0.618 . . . . 74.13 110.515 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.39 174.32 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.115 0.966 . . . . 52.24 110.119 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.61 -32.1 5.47 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.129 -0.487 . . . . 71.32 112.791 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.47 156.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.872 0.869 . . . . 73.21 109.883 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.9 175.04 12.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.042 -0.725 . . . . 54.32 109.042 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.46 -144.52 37.41 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.871 -0.492 . . . . 54.33 111.871 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -65.41 -16.3 63.48 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.147 0.579 . . . . 75.2 112.151 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.19 -54.55 31.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.832 0.853 . . . . 74.34 110.204 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 56.3 ttm -72.22 -34.62 68.48 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.451 -0.795 . . . . 74.41 110.761 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.12 -41.29 95.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.537 0.735 . . . . 74.32 111.63 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -59.76 -40.28 87.62 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.678 -0.692 . . . . 55.33 110.159 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.724 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 8.6 m -76.08 -37.34 58.31 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.598 0.962 . . . . 74.52 113.598 -172.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD23 HD11 ' A' ' 86' ' ' ILE . 89.1 mt -85.41 -15.45 43.04 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.93 0.332 . . . . 71.33 110.578 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.59 -28.65 9.4 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.399 -0.667 . . . . 73.34 113.56 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.06 -55.71 0.71 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.255 1.027 . . . . 73.24 113.153 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.724 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.4 t80 -50.64 -65.04 0.63 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.722 0.809 . . . . 74.33 111.699 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.4 m -64.46 -45.67 77.42 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 118.209 -0.9 . . . . 63.32 112.848 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.68 -41.34 54.28 Favored 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.181 1.921 . . . . 73.31 113.69 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.417 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 21.4 t-20 -71.78 -32.24 67.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.371 0.669 . . . . 75.21 110.52 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 101' ' ' TYR . 24.3 mm -65.37 -35.27 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.781 0.832 . . . . 75.24 110.487 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -80.69 -20.42 42.97 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.168 0.987 . . . . 74.43 111.471 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 25.8 t80 -67.63 -43.39 40.18 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 114.263 1.209 . . . . 75.1 114.263 -168.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 36.3 Cg_exo -62.13 -34.89 78.12 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.78 1.653 . . . . 75.22 112.425 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -74.25 -40.99 62.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.445 0.698 . . . . 75.34 111.593 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.75 82.62 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.789 0.436 . . . . 72.13 109.923 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.501 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.5 ttm180 -53.88 -51.68 62.89 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.509 1.131 . . . . 75.44 110.164 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.72 -46.15 90.91 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.181 0.925 . . . . 72.11 110.881 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -57.75 -48.75 78.75 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.898 0.749 . . . . 64.12 110.773 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -61.93 -50.62 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.063 0.945 . . . . 73.15 110.499 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.542 HG21 ' HG3' ' A' ' 125' ' ' GLN . 87.2 m -57.24 -41.42 79.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.722 0.809 . . . . 61.35 111.33 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.14 -40.71 82.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.284 -0.871 . . . . 72.41 109.691 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.422 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 16.4 mtp -59.14 -42.06 89.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 73.15 110.951 174.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -63.65 -45.83 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.006 0.922 . . . . 73.2 110.952 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.4 p -73.88 -28.86 61.77 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.923 0.489 . . . . 73.11 111.429 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -72.38 -28.42 62.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.504 0.721 . . . . 74.42 109.264 172.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.17 89.05 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.456 -0.793 . . . . 75.33 112.831 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.5 m 68.67 17.14 8.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.651 1.181 . . . . 52.31 111.515 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -92.03 161.01 34.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 74.22 110.739 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.62 123.88 14.77 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.469 2.113 . . . . 55.1 111.176 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.542 ' HG3' HG21 ' A' ' 115' ' ' THR . 30.2 tt0 -54.45 141.3 31.27 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.869 1.268 . . . . 61.3 112.96 -175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.3 mt -125.63 96.11 4.67 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.593 0.757 . . . . 71.45 109.563 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.2 105.45 17.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.713 -0.847 . . . . 73.45 108.713 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -62.73 130.14 43.63 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.651 0.594 . . . . 71.41 110.0 -174.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.67 144.92 94.42 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 122.908 0.483 . . . . 63.43 111.2 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.574 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 73.7 Cg_exo -54.62 144.52 63.66 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 124.152 3.235 . . . . 74.4 115.153 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 44' ' ' LEU . 31.5 m -115.98 115.06 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.81 0.844 . . . . 71.3 109.873 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -89.41 65.72 7.21 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.625 0.77 . . . . 74.13 109.0 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.61 -33.11 41.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.384 -0.826 . . . . 75.32 109.857 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 75.54 110.037 171.683 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 115.036 1.495 . . . . 74.15 115.036 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -134.68 127.03 30.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.363 -1.347 . . . . 74.13 107.363 169.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -121.98 146.86 46.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.635 -0.876 . . . . 73.4 108.635 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -166.81 142.54 4.39 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.932 0.77 . . . . 75.42 110.145 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.07 120.41 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.393 -0.966 . . . . 75.01 108.393 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -79.88 -47.31 15.3 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.948 -0.39 . . . . 75.31 109.948 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -164.47 145.34 8.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.92 -0.582 . . . . 72.35 109.83 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -118.05 150.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 106.851 -1.537 . . . . 75.34 106.851 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -168.75 145.61 3.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.832 0.453 . . . . 74.43 111.172 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.3 m -73.04 117.24 14.53 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.037 -1.097 . . . . 74.52 108.037 167.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -83.94 -42.98 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.829 -0.623 . . . . 74.02 110.2 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 25.9 t70 -144.81 142.03 29.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.028 -0.533 . . . . 63.21 111.578 -168.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.516 HG22 ' HE1' ' B' ' 117' ' ' MET . 43.3 mm -137.15 142.96 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.091 1.357 . . . . 73.54 108.053 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -141.35 137.97 32.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.924 -1.51 . . . . 73.33 106.924 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.2 t80 -152.01 110.04 3.69 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.778 -1.193 . . . . 73.52 107.778 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -118.72 111.89 19.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.869 -0.789 . . . . 74.04 108.869 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.558 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -108.8 85.92 3.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 109.116 -0.698 . . . . 75.12 109.116 170.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.8 -22.85 36.19 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.024 2.483 . . . . 72.3 110.8 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -125.03 29.89 6.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.88 1.272 . . . . 75.35 109.617 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -46.27 -48.11 45.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 125.191 1.397 . . . . 61.13 113.365 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.5 Cg_endo -84.65 -15.06 6.24 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.364 2.043 . . . . 74.12 112.771 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.92 -0.32 47.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.232 0.613 . . . . 63.43 111.6 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.444 HG22 HD11 ' B' ' 68' ' ' LEU . 11.2 p -69.46 -31.13 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.225 0.61 . . . . 75.5 110.919 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -71.66 -40.6 69.54 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.551 0.74 . . . . 73.43 110.96 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -81.1 -8.32 59.74 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.372 -0.831 . . . . 71.11 111.264 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.437 ' HD2' HD23 ' B' ' 68' ' ' LEU . 5.8 mmtp -100.13 109.1 21.38 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.057 0.943 . . . . 75.03 109.98 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -96.0 75.89 3.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.59 0.756 . . . . 75.13 111.903 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.465 ' HB2' HD22 ' B' ' 68' ' ' LEU . 4.8 m-90 -153.76 172.28 17.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.47 1.508 . . . . 74.01 107.159 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -90.24 119.49 69.22 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.655 -0.869 . . . . 64.42 108.655 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.19 102.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.117 2.544 . . . . 75.01 112.214 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.83 102.55 1.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.042 -0.526 . . . . 72.41 109.826 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.57 121.38 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 73.34 110.121 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -118.86 123.68 45.31 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.856 1.262 . . . . 75.34 108.52 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.447 HD22 HD22 ' B' ' 128' ' ' LEU . 6.4 mp -92.72 158.88 15.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.3 0.64 . . . . 74.31 110.279 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.59 110.76 3.68 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.948 -1.13 . . . . 72.11 107.948 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -104.99 150.19 25.13 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.37 0.605 . . . . 71.24 110.063 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -138.16 128.12 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.447 -1.252 . . . . 74.32 108.643 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -110.35 108.15 18.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.505 0.722 . . . . 74.43 109.335 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.54 153.94 33.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.242 1.017 . . . . 71.41 109.492 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -143.57 162.98 34.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.32 0.648 . . . . 64.02 109.508 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.7 p -150.6 150.4 31.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.161 0.584 . . . . 73.13 109.658 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -84.56 112.6 20.57 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.847 -0.797 . . . . 75.14 108.847 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -88.93 -54.2 4.24 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.724 -0.473 . . . . 71.01 109.724 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -170.24 3.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.784 0.834 . . . . 75.01 110.004 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.84 117.38 7.46 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.19 -0.914 . . . . 74.41 110.19 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 71.41 -2.27 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.456 1.503 . . . . 63.44 112.092 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -106.51 103.15 14.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.784 0.833 . . . . 74.03 109.448 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -108.65 141.39 40.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.85 0.86 . . . . 73.22 109.641 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -99.64 102.52 14.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.393 -0.965 . . . . 74.23 108.393 172.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.05 118.56 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.565 -0.902 . . . . 73.01 108.565 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.5 t -104.82 119.57 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.721 0.808 . . . . 74.15 109.164 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.24 129.45 39.29 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.674 -1.602 . . . . 74.41 106.674 171.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 24.7 ttp180 -121.31 108.25 13.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.723 -0.843 . . . . 74.01 108.723 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' B' ' 114' ' ' ILE . 19.9 t -105.17 120.04 55.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.865 -1.161 . . . . 62.44 107.865 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -113.54 126.96 55.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 73.54 108.962 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.586 HG22 HG21 ' B' ' 114' ' ' ILE . 42.0 t -113.65 119.26 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.432 1.093 . . . . 72.22 109.153 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -118.31 140.33 49.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.327 -0.99 . . . . 72.41 108.327 170.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.87 143.41 50.14 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.053 -1.091 . . . . 64.35 108.053 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.4 p -130.71 130.35 43.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.771 -0.455 . . . . 73.51 109.771 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' B' ' 36' ' ' TRP . 0.8 OUTLIER -110.31 112.66 24.76 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.146 -1.057 . . . . 73.34 108.146 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.69 -113.3 3.77 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.331 -1.107 . . . . 75.33 110.331 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.62 5.5 10.57 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.811 0.844 . . . . 74.43 111.164 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -114.43 166.84 11.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.523 0.729 . . . . 74.31 109.245 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 33.5 m -69.59 135.63 50.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.035 0.534 . . . . 72.42 110.707 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' B' ' 68' ' ' LEU . . . -87.31 -58.66 2.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.5 -1.296 . . . . 73.22 107.5 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -156.95 163.69 38.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.617 -1.174 . . . . 65.14 109.956 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 73.6 mt -124.74 143.27 50.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.822 -1.547 . . . . 74.53 106.822 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.3 151.89 29.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.507 -0.923 . . . . 60.32 108.507 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.1 tt0 -165.16 130.99 2.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.049 -0.723 . . . . 73.44 109.049 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.2 t -125.17 144.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 74.22 109.369 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.477 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 25.7 mt-30 -121.14 94.62 4.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.62 -1.252 . . . . 72.25 107.62 169.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -85.39 100.44 11.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.57 -0.9 . . . . 64.23 108.57 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.86 162.92 31.71 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.149 -0.78 . . . . 64.12 111.149 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.37 127.5 1.75 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.619 -0.592 . . . . 71.41 111.619 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.6 mt -85.08 126.0 40.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.691 0.796 . . . . 74.05 109.162 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.29 134.04 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.026 0.931 . . . . 71.41 108.748 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -100.98 100.56 11.19 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.029 0.932 . . . . 63.52 108.727 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.516 HG13 HD12 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -121.61 143.04 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.092 0.957 . . . . 71.52 110.813 -177.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.57 159.17 43.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 72.54 109.709 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.54 -44.42 2.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.359 0.412 . . . . 75.01 112.692 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.467 HG22 ' HB3' ' B' ' 93' ' ' GLN . 13.1 pt -65.64 140.27 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 74.04 111.828 177.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -151.65 152.01 32.24 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.351 1.06 . . . . 52.44 108.36 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.92 -113.87 5.49 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 124.027 0.829 . . . . 65.11 113.284 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 68.4 m -65.79 -40.55 92.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.49 1.116 . . . . 73.11 111.609 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' B' ' 89' ' ' ILE . 90.0 mt-30 -65.81 -43.69 87.89 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.835 0.454 . . . . 72.11 111.172 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.456 ' HE1' HD21 ' B' ' 98' ' ' LEU . 14.2 tpt -69.37 -35.5 75.9 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.562 -0.745 . . . . 74.25 110.676 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 -24.96 59.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.289 -0.869 . . . . 71.23 110.99 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 25.8 t-80 -81.97 -29.54 32.1 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.274 0.63 . . . . 74.23 110.59 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -78.91 -68.09 0.69 Allowed 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 109.458 -0.571 . . . . 75.13 109.458 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.516 HD12 HG13 ' B' ' 86' ' ' ILE . 8.4 mp -73.5 -25.99 60.69 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.924 0.489 . . . . 70.23 112.289 -173.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.2 -30.13 23.39 Favored Glycine 0 C--N 1.334 0.457 0 O-C-N 123.368 0.417 . . . . 71.04 113.018 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -123.44 -56.58 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.734 0.642 . . . . 71.1 112.734 -170.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -72.94 -49.18 30.91 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.295 0.48 . . . . 75.11 112.295 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.3 m -60.39 -47.81 95.47 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.263 1.025 . . . . 71.03 111.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.555 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 72.7 Cg_exo -56.5 -37.77 96.66 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.985 1.79 . . . . 74.12 113.102 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.4 -29.94 70.21 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 75.31 110.892 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.39 -49.23 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.654 0.781 . . . . 74.25 109.774 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.83 -12.61 59.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 73.25 111.942 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.05 -48.0 61.37 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 118.141 -0.933 . . . . 74.22 112.944 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.46 -33.43 97.29 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.023 1.816 . . . . 74.52 113.488 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.407 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 53.8 m-85 -71.08 -44.47 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.426 0.69 . . . . 75.33 110.556 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.77 92.5 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.883 0.873 . . . . 74.21 110.193 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 57.4 ttt-85 -60.3 -57.02 14.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.487 1.515 . . . . 73.42 111.087 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -58.38 -33.49 69.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.923 0.889 . . . . 74.03 110.89 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.472 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.3 m -63.31 -54.94 29.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.312 0.645 . . . . 65.14 111.38 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.586 HG21 HG22 ' B' ' 64' ' ' VAL . 57.6 mt -58.86 -54.53 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.233 0.613 . . . . 74.12 110.05 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.3 m -55.9 -39.26 71.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.762 1.225 . . . . 71.25 111.663 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.4 t -62.04 -50.67 71.06 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 115.788 -0.642 . . . . 74.32 110.094 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.516 ' HE1' HG22 ' B' ' 21' ' ' ILE . 17.0 mmt -65.74 -33.71 76.49 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.441 0.696 . . . . 75.13 111.522 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.404 HG23 ' O ' ' B' ' 114' ' ' ILE . 76.9 t -63.26 -46.57 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.886 0.874 . . . . 73.52 110.192 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' B' ' 123' ' ' PHE . 23.3 m -68.35 -28.92 67.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.653 -0.703 . . . . 74.14 111.481 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 96.1 mtt-85 -72.3 -16.08 61.9 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 115.621 -0.718 . . . . 64.2 110.708 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.15 15.89 59.9 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.657 -1.079 . . . . 70.13 115.476 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.448 HG22 ' CD1' ' A' ' 17' ' ' TYR . 15.5 p 79.56 13.17 1.1 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 126.576 1.95 . . . . 74.31 112.507 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' B' ' 119' ' ' SER . 96.6 m-85 -103.63 153.7 38.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 122.811 0.444 . . . . 72.32 110.597 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.08 153.26 59.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.856 2.371 . . . . 75.12 112.296 172.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.589 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 1.1 mp0 -64.86 115.11 5.0 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.445 0.465 . . . . 73.42 110.227 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -108.12 85.65 2.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.983 -1.117 . . . . 65.22 107.983 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -92.37 132.63 36.59 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.045 -0.979 . . . . 74.11 109.07 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.455 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 30.5 mt -81.0 147.85 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.42 -0.809 . . . . 71.24 111.439 -169.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.58 147.94 50.67 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.519 0.728 . . . . 72.1 109.639 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.85 97.9 0.41 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.912 2.408 . . . . 64.1 111.474 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.87 111.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 107.92 -1.141 . . . . 74.4 107.92 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.18 100.62 1.31 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.4 -0.818 . . . . 74.02 110.159 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -59.45 -33.2 70.99 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.115 -0.948 . . . . 75.44 109.649 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -65.13 -39.01 92.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.611 1.564 . . . . 75.21 112.175 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.12 73.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.791 0.436 . . . . 72.42 110.434 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 115.061 -0.972 . . . . 74.32 109.615 178.532 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.474 ' HG3' HG12 ' C' ' 89' ' ' ILE . 28.0 ttt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 121.537 0.684 . . . . 75.34 112.784 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 44.0 m -115.62 88.42 2.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.638 -0.71 . . . . 74.01 109.217 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.574 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 73.5 t80 -97.63 129.96 44.69 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.62 -0.882 . . . . 74.21 108.62 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -139.89 125.73 19.53 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.277 0.631 . . . . 74.15 109.367 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.3 mt -77.67 119.99 27.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.702 -0.851 . . . . 74.44 108.702 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 32.5 mm-40 -83.95 -49.32 9.09 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.641 0.377 . . . . 74.42 110.038 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -170.09 145.36 2.83 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.682 0.614 . . . . 73.32 109.741 -171.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -133.11 133.95 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -167.47 162.68 14.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.901 0.858 . . . . 75.3 111.676 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -83.38 120.52 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.064 -0.971 . . . . 71.45 109.462 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -73.35 -49.33 27.86 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.527 -0.916 . . . . 74.32 108.527 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.1 t70 -134.3 139.26 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.681 -1.145 . . . . 71.31 109.412 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -137.2 138.24 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.097 -1.446 . . . . 74.43 107.097 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 38.9 t -152.11 149.87 29.28 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.479 0.712 . . . . 73.21 109.118 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -155.67 138.47 15.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.08 -1.081 . . . . 75.45 108.08 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 56.4 mt-10 -135.1 148.25 49.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.284 1.034 . . . . 75.54 108.452 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.98 85.5 3.55 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 106.963 -1.495 . . . . 74.15 106.963 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 -50.12 4.15 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.328 2.018 . . . . 75.02 111.144 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.48 35.68 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.025 0.93 . . . . 64.42 110.517 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.37 88.46 Favored Pre-proline 0 CA--C 1.565 1.519 0 C-N-CA 124.441 1.096 . . . . 75.15 113.81 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.81 -25.08 20.6 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 121.642 1.561 . . . . 72.04 112.126 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -67.93 -19.57 64.99 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.96 1.304 . . . . 74.33 112.809 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.17 -25.44 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 113.621 0.971 . . . . 75.21 113.621 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -65.79 -40.42 91.93 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.212 0.529 . . . . 75.2 110.667 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -98.75 13.59 31.73 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.258 1.023 . . . . 74.4 110.413 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -77.95 136.7 38.03 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.325 -0.62 . . . . 75.13 109.325 -176.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -85.05 92.58 8.39 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.327 -1.731 . . . . 65.11 106.327 168.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -75.34 89.28 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.763 0.792 . . . . 74.52 112.028 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -150.27 67.74 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.018 -1.104 . . . . 44.31 108.018 163.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -91.85 154.46 3.38 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.651 2.234 . . . . 72.44 111.747 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -86.82 118.35 26.16 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.85 -0.796 . . . . 74.04 108.85 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.78 97.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.177 -1.046 . . . . 74.42 108.177 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.509 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 53.0 mtpt -95.2 101.28 13.01 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.342 -0.984 . . . . 73.34 108.342 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.546 HD23 HG21 ' C' ' 64' ' ' VAL . 2.9 tm? -102.13 129.77 48.57 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.116 -1.068 . . . . 74.14 108.116 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.31 131.92 45.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.048 0.939 . . . . 55.23 108.83 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 99.3 mt -123.78 148.47 46.63 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.825 0.85 . . . . 75.11 109.384 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.21 125.43 8.02 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.74 -0.837 . . . . 74.13 108.74 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -113.4 147.72 37.2 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.569 -0.53 . . . . 70.43 109.569 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.06 42.74 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.209 1.004 . . . . 75.44 108.435 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -137.8 145.96 42.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.722 0.409 . . . . 74.21 110.259 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.1 p -145.0 129.81 18.21 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.625 0.77 . . . . 72.33 109.691 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -74.36 118.18 17.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.026 0.53 . . . . 70.23 109.881 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.454 HD13 HD13 ' C' ' 83' ' ' ILE . 74.2 mt -84.67 -40.61 17.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.145 0.578 . . . . 73.55 109.774 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.09 -178.94 7.67 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.092 . . . . 73.3 109.399 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -62.75 124.87 22.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.967 -0.56 . . . . 53.01 109.993 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.03 -5.98 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.288 1.435 . . . . 73.44 111.944 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.28 114.78 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.061 0.944 . . . . 74.32 109.697 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.93 125.5 35.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.18 0.992 . . . . 70.14 108.869 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -95.39 121.19 36.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.997 0.919 . . . . 71.33 109.935 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.73 132.41 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.596 -0.89 . . . . 73.24 108.596 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -126.28 112.53 30.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 124.164 0.985 . . . . 64.3 108.777 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.95 111.72 23.64 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.319 -0.993 . . . . 73.42 108.319 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.82 107.33 12.51 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.114 -0.699 . . . . 75.34 109.114 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -100.76 127.2 54.12 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 CA-C-N 114.956 -1.02 . . . . 72.15 108.408 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 48.4 m -131.43 130.23 42.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.405 -0.591 . . . . 74.24 109.405 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.546 HG21 HD23 ' C' ' 42' ' ' LEU . 86.0 t -120.11 120.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.11 109.302 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.509 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -114.45 130.0 56.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.544 -0.909 . . . . 75.5 108.544 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.33 93.62 4.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.904 -1.517 . . . . 75.12 106.904 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 78.7 p -158.56 140.42 13.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.282 0.633 . . . . 72.23 109.565 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.1 tp -77.99 -32.97 51.5 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.291 -0.633 . . . . 74.11 109.291 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.82 -82.67 0.06 OUTLIER Glycine 0 C--N 1.345 1.059 0 N-CA-C 110.4 -1.08 . . . . 74.12 110.4 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.88 -31.79 16.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.185 0.594 . . . . 71.11 109.841 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.46 96.08 7.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.22 0.608 . . . . 73.44 109.789 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -90.69 133.63 35.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.274 -0.876 . . . . 74.43 110.929 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.2 -56.91 3.76 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.406 -0.961 . . . . 75.2 108.406 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -160.74 175.34 12.72 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.745 -1.116 . . . . 75.23 111.952 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.5 tm? -141.29 146.65 37.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.387 1.875 . . . . 72.22 105.95 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.5 t -152.78 153.55 33.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.274 0.629 . . . . 50.12 109.315 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -159.64 136.47 9.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.707 0.403 . . . . 65.14 111.128 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' C' ' 110' ' ' ALA . 45.8 t -140.78 113.49 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.518 1.127 . . . . 72.41 108.881 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 66.1 mt-30 -91.97 97.76 11.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.252 -1.018 . . . . 73.43 108.252 173.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.501 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 6.8 tp-100 -86.56 114.16 23.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.514 0.726 . . . . 74.04 109.755 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.27 145.07 15.86 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.201 -0.359 . . . . 74.32 112.201 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.527 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -146.72 132.81 4.55 Favored Glycine 0 CA--C 1.504 -0.601 0 N-CA-C 111.839 -0.504 . . . . 75.13 111.839 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.454 HD13 HD13 ' C' ' 51' ' ' LEU . 7.8 mm -87.29 121.59 38.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.226 -1.027 . . . . 74.31 108.226 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.34 123.8 26.06 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.607 0.763 . . . . 73.12 109.569 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 36.5 p -97.75 125.46 42.58 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.84 0.456 . . . . 74.43 110.167 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.77 132.74 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.381 -0.97 . . . . 75.14 108.381 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.448 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -137.01 147.79 46.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.581 0.752 . . . . 63.33 109.755 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.1 -53.02 3.89 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.936 -0.574 . . . . 60.11 111.726 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' C' ' 9' ' ' MET . 2.9 pp -96.78 164.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.858 0.863 . . . . 71.42 111.487 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -168.41 -170.62 1.29 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.891 1.276 . . . . 74.44 109.264 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.09 -121.98 26.13 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 119.77 -0.461 . . . . 74.51 113.427 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 18.2 p -65.22 -33.21 75.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.943 0.897 . . . . 73.24 112.281 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.57 -42.49 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.908 0.483 . . . . 74.52 110.908 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptm -76.1 -24.93 55.03 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.005 0.19 . . . . 74.31 110.644 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.88 -43.7 78.74 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.165 0.507 . . . . 75.12 110.269 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -67.79 -34.36 76.63 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.268 -0.878 . . . . 71.55 110.805 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.88 -54.8 11.83 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.767 0.427 . . . . 75.01 110.478 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.488 HD21 ' SG ' ' C' ' 102' ' ' CYS . 63.8 mt -76.45 -14.53 60.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.648 0.779 . . . . 71.35 111.569 -177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.48 -29.88 8.52 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.388 0.43 . . . . 75.12 113.483 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.3 -59.39 1.98 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.094 0.558 . . . . 74.01 110.93 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.402 ' O ' HG12 ' C' ' 105' ' ' ILE . 62.0 t80 -72.66 -55.43 6.83 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.206 0.941 . . . . 73.32 111.721 -164.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.488 ' SG ' HD21 ' C' ' 98' ' ' LEU . 61.0 m -58.45 -48.06 97.64 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 124.073 0.949 . . . . 72.25 112.804 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.5 Cg_exo -59.38 -34.25 97.55 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.296 1.998 . . . . 71.32 113.082 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.539 HD22 ' HB ' ' C' ' 131' ' ' VAL . 38.5 t-20 -70.79 -33.85 71.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.64 0.776 . . . . 73.15 110.308 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.501 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -66.85 -42.17 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 122.851 0.46 . . . . 72.21 109.842 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.527 HD23 ' HA3' ' C' ' 82' ' ' GLY . 95.9 mt -68.88 -32.19 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.053 -0.976 . . . . 74.55 111.408 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.66 -53.52 59.39 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.315 1.228 . . . . 73.1 114.315 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.58 -34.41 95.3 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.325 2.016 . . . . 73.45 113.541 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -67.96 -45.72 73.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.541 0.737 . . . . 72.31 110.469 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -66.59 -35.71 80.87 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.421 -0.809 . . . . 74.24 110.946 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -65.32 -46.77 78.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.96 1.304 . . . . 72.34 110.363 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.406 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -68.39 -35.59 77.91 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 70.44 109.779 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.6 t -68.65 -31.39 70.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.884 0.473 . . . . 75.3 111.351 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.536 HG23 HG22 ' C' ' 64' ' ' VAL . 63.3 mt -74.32 -47.92 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 74.41 110.162 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.4 m -63.48 -28.92 70.29 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.063 0.545 . . . . 75.15 110.746 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.3 t -69.2 -46.75 66.68 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 123.861 0.865 . . . . 64.51 109.559 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.646 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.58 -39.9 89.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.214 1.005 . . . . 75.54 112.256 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 79.6 t -67.71 -38.78 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.95 0.9 . . . . 72.11 110.254 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.589 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 40.4 t -65.22 -37.66 87.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.564 -0.744 . . . . 74.43 111.069 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.5 mtt-85 -68.64 -35.89 77.87 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.247 -0.888 . . . . 71.14 109.469 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.55 1.91 80.46 Favored Glycine 0 C--N 1.354 1.54 0 O-C-N 123.801 0.688 . . . . 74.44 113.339 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 55.53 60.99 3.04 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.746 1.618 . . . . 33.51 111.853 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.434 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 86.7 m-85 -124.04 163.76 33.64 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 124.89 1.276 . . . . 75.1 108.822 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 97.2 Cg_endo -74.33 -169.26 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.948 2.432 . . . . 72.22 113.484 -174.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.409 ' HB3' ' OD1' ' C' ' 127' ' ' ASN . 21.0 mm-40 -54.41 112.02 0.91 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.059 -0.973 . . . . 73.23 111.591 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.454 HD13 HG12 ' C' ' 64' ' ' VAL . 3.1 tm? -108.07 87.01 2.4 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.426 -2.064 . . . . 74.3 105.426 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' C' ' 125' ' ' GLN . 12.1 m120 -95.31 97.53 9.92 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.311 -0.996 . . . . 64.05 108.311 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.488 HD22 ' H ' ' C' ' 129' ' ' ALA . 1.2 tt -63.6 149.21 46.93 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.205 -0.907 . . . . 73.42 108.99 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . 0.488 ' H ' HD22 ' C' ' 128' ' ' LEU . . . -49.54 153.09 2.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.68 1.192 . . . . 74.53 112.76 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.11 -158.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.417 2.745 . . . . 70.01 114.959 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . 0.539 ' HB ' HD22 ' C' ' 104' ' ' ASN . 20.5 m -93.94 155.19 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.838 0.828 . . . . 75.44 112.493 -168.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -69.83 110.62 5.07 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 113.776 -1.556 . . . . 64.43 110.936 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -44.54 -34.49 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.371 1.468 . . . . 70.41 114.305 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 CA--C 1.552 1.039 0 N-CA-C 112.197 0.443 . . . . 73.52 112.197 -176.027 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.445 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 7.1 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 113.602 0.964 . . . . 71.1 113.602 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 60.0 m -131.02 130.53 43.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 72.52 108.827 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.1 t80 -149.11 104.31 3.41 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.278 -1.008 . . . . 74.24 108.278 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -119.23 127.5 53.33 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.456 0.702 . . . . 65.2 109.732 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.25 117.52 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 108.529 -0.915 . . . . 73.1 108.529 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -95.4 -46.99 6.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.137 0.575 . . . . 75.24 112.429 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -164.6 134.29 3.81 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.741 0.246 . . . . 74.22 111.165 -168.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.422 ' N ' HD13 ' D' ' 16' ' ' ILE . 2.8 mp -118.64 130.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.673 -1.232 . . . . 73.33 107.673 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -168.34 150.24 5.16 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.883 0.849 . . . . 64.44 112.115 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -81.9 123.07 28.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.837 -1.074 . . . . 72.44 109.388 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -92.47 -20.34 21.08 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 110.199 -0.297 . . . . 74.34 110.199 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.693 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.7 t70 -155.41 134.62 12.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.412 -0.813 . . . . 65.02 108.841 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.646 HG21 ' HE1' ' C' ' 117' ' ' MET . 79.8 mt -139.79 148.56 22.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 124.807 1.243 . . . . 75.02 107.865 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.26 141.5 23.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.934 0.893 . . . . 72.24 109.284 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.552 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -153.29 132.76 12.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.811 -1.922 . . . . 74.41 105.811 171.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -135.23 145.25 47.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.69 0.796 . . . . 64.53 109.136 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -146.81 71.45 12.48 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.252 -1.018 . . . . 72.14 108.252 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.8 -26.08 19.49 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.683 2.255 . . . . 74.43 112.609 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.486 ' O ' HG23 ' D' ' 31' ' ' VAL . 28.8 m-20 -115.11 23.11 12.77 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.927 0.891 . . . . 63.51 109.629 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.608 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -48.04 -54.93 20.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 115.783 1.772 . . . . 71.45 115.783 -168.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.49 ' HA ' ' CD1' ' D' ' 32' ' ' PHE . 51.9 Cg_endo -76.1 -16.97 17.57 Favored 'Trans proline' 0 C--N 1.384 2.417 0 CA-C-N 121.162 1.451 . . . . 70.3 112.469 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.7 t-160 -77.18 -30.49 54.88 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.514 1.525 . . . . 71.53 109.782 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.486 HG23 ' O ' ' D' ' 27' ' ' ASN . 57.7 t -77.26 -27.81 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.2 0.6 . . . . 64.52 110.384 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' D' ' 29' ' ' PRO . 18.4 m-30 -66.05 -21.08 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.74 0.416 . . . . 74.43 111.381 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -64.71 -33.46 76.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.495 0.718 . . . . 72.44 110.439 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.18 100.35 12.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.144 -1.058 . . . . 75.42 108.144 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.4 63.26 3.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.985 0.914 . . . . 72.53 111.532 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.401 ' O ' ' HD3' ' D' ' 38' ' ' PRO . 61.4 t-105 -143.62 160.11 41.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.444 -0.576 . . . . 71.41 109.444 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -81.52 107.08 7.09 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.784 1.234 . . . . 74.11 108.736 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.43 ' HA ' HD12 ' D' ' 68' ' ' LEU . 35.8 Cg_exo -44.28 151.41 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 124.204 3.269 . . . . 72.1 116.392 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' D' ' 67' ' ' SER . 7.6 tm-20 -61.44 138.32 58.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.222 -1.354 . . . . 73.3 110.226 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 106.24 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 122.603 0.361 . . . . 74.12 110.329 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -98.99 142.5 30.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.322 -0.992 . . . . 74.31 108.322 167.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.722 HD13 HD23 ' D' ' 128' ' ' LEU . 2.7 mm? -120.08 122.17 40.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.157 0.583 . . . . 75.54 109.438 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.787 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.0 m-20 -107.23 130.9 54.67 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.219 -1.4 . . . . 75.21 107.219 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.38 147.97 39.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.152 0.581 . . . . 72.43 110.638 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 28.5 t70 -164.98 154.32 12.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.265 1.026 . . . . 73.31 108.773 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -142.11 162.4 35.58 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.456 0.702 . . . . 71.51 109.432 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.43 163.34 40.12 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.776 0.83 . . . . 44.45 109.114 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -154.17 153.7 32.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.859 0.463 . . . . 73.34 109.918 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.4 p -150.28 146.67 26.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.987 0.915 . . . . 72.15 109.248 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -90.67 119.05 30.59 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.669 -0.863 . . . . 74.53 108.669 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -92.0 -31.47 15.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.073 0.549 . . . . 75.15 109.772 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.21 -170.21 1.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.063 0.945 . . . . 74.22 110.63 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.45 116.27 7.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.449 0.7 . . . . 64.4 110.374 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.91 17.21 9.82 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.475 1.11 . . . . 53.33 112.237 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.7 t -116.0 118.64 59.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 172.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.683 ' HB2' HD13 ' D' ' 86' ' ' ILE . 87.5 m-85 -136.45 130.1 32.12 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.55 -0.907 . . . . 65.44 108.55 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.567 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.0 tt0 -91.15 125.86 36.06 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.586 1.154 . . . . 63.12 109.629 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.74 125.59 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.085 -0.709 . . . . 72.43 109.085 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 60.9 t -104.96 133.85 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 74.15 109.428 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.78 125.43 53.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.584 -1.265 . . . . 74.11 107.584 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.0 ttm180 -104.95 102.49 12.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.009 -0.737 . . . . 73.32 109.009 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.19 118.01 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.821 -1.177 . . . . 74.44 107.821 168.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -116.96 136.32 53.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.992 0.517 . . . . 65.34 109.634 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 54.8 t -115.64 115.96 50.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.193 0.997 . . . . 74.33 109.141 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.0 m -103.19 115.95 31.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.846 -1.168 . . . . 73.34 107.846 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.62 54.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 70.33 110.065 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 74.1 p -139.27 146.34 40.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.654 0.782 . . . . 75.42 109.006 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' D' ' 38' ' ' PRO . 16.7 tp -134.76 106.05 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.535 -0.913 . . . . 72.33 108.535 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.16 -114.99 4.59 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.577 -0.738 . . . . 43.02 111.691 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 4.56 14.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.654 0.781 . . . . 73.42 110.2 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -123.53 162.55 22.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.492 0.717 . . . . 65.14 110.583 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.07 129.03 37.54 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.67 0.606 . . . . 75.43 109.888 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -84.3 -58.9 2.56 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.436 0.694 . . . . 64.14 109.452 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -161.33 166.14 27.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.64 -1.164 . . . . 75.12 109.21 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 95.4 mt -126.8 153.09 46.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.402 1.081 . . . . 71.35 108.271 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.493 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.41 144.99 17.39 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.063 0.545 . . . . 62.41 109.719 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.21 135.61 11.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.888 0.875 . . . . 73.43 109.151 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.72 114.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.515 -0.55 . . . . 73.32 109.515 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.693 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.5 mt-30 -90.48 87.02 6.6 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.041 0.924 . . . . 73.54 109.397 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.77 96.71 6.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.558 -1.655 . . . . 75.42 109.146 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.83 144.1 20.96 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.37 -0.692 . . . . 72.24 111.37 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.24 4.57 Favored Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 110.603 -0.999 . . . . 71.45 110.603 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -87.69 123.83 40.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.214 -1.402 . . . . 74.14 107.214 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -127.12 164.26 22.0 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.062 0.945 . . . . 75.12 108.475 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.1 t -113.18 106.43 14.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.904 -1.147 . . . . 73.34 107.904 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' D' ' 56' ' ' TYR . 3.6 mp -108.86 107.48 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.512 -0.922 . . . . 74.32 108.512 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.617 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -134.08 146.4 50.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.237 1.015 . . . . 71.33 109.583 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.13 -21.56 8.04 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 114.526 0.57 . . . . 53.43 114.526 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.48 HD11 ' HG3' ' D' ' 93' ' ' GLN . 12.1 tt -109.2 130.44 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.614 0.765 . . . . 74.22 108.99 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.64 -177.45 5.3 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.431 0.692 . . . . 75.1 111.673 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.53 -140.33 36.82 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.978 0.799 . . . . 72.25 113.408 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -81.43 -20.85 39.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.453 0.701 . . . . 74.31 111.437 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.48 ' HG3' HD11 ' D' ' 89' ' ' ILE . 7.2 tp60 -69.65 -40.24 76.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.189 0.596 . . . . 75.44 111.051 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.415 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 5.2 ppp? -69.34 -33.78 73.62 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.796 -0.446 . . . . 73.12 109.796 174.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.97 99.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.361 0.664 . . . . 75.25 110.812 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -72.32 -34.32 68.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.5 -0.773 . . . . 72.25 110.183 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.94 -36.73 85.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.342 0.657 . . . . 72.45 111.124 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.616 HD23 HG12 ' D' ' 86' ' ' ILE . 31.5 mt -80.17 -23.2 41.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.976 0.51 . . . . 72.12 111.013 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.75 -2.35 55.23 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.697 -0.502 . . . . 63.13 113.736 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.13 -60.43 0.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.617 0.709 . . . . 74.35 111.412 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.61 -40.99 66.05 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.942 0.497 . . . . 71.55 111.797 -171.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.433 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 68.8 m -69.26 -49.04 25.14 Favored Pre-proline 0 CA--C 1.559 1.313 0 CA-C-O 118.956 -0.545 . . . . 73.22 110.975 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.4 Cg_exo -52.13 -31.13 43.93 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.542 2.161 . . . . 74.2 114.566 168.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.66 -35.64 81.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.993 0.517 . . . . 74.11 110.755 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.19 -44.11 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.242 0.617 . . . . 74.14 110.251 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.8 -20.24 58.35 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.341 -0.845 . . . . 70.11 112.027 -172.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -65.48 -48.03 67.26 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.459 0.911 . . . . 74.33 113.459 -171.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.48 -34.01 88.06 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.884 1.722 . . . . 64.12 112.821 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.27 -35.68 47.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.863 0.865 . . . . 74.34 111.816 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.69 76.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.286 0.634 . . . . 73.13 109.963 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.4 HH12 ' HG3' ' D' ' 130' ' ' PRO . 14.4 ptt180 -75.11 -31.63 61.19 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.958 -1.019 . . . . 75.12 110.784 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.98 -49.71 75.01 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.007 0.817 . . . . 63.32 110.305 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.509 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.3 t -58.81 -40.47 84.22 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.853 0.72 . . . . 75.13 110.517 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.493 HG12 ' SG ' ' D' ' 76' ' ' CYS . 64.9 mt -57.58 -53.18 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 123.794 0.684 . . . . 72.14 110.236 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.432 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.0 m -57.62 -45.79 84.95 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 124.26 1.024 . . . . 74.14 111.17 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.5 t -64.31 -41.04 97.02 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.636 -1.166 . . . . 65.21 110.138 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -69.02 -33.53 73.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.111 0.565 . . . . 74.11 111.587 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.11 -46.76 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 O-C-N 123.823 0.702 . . . . 64.14 110.203 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.7 p -71.16 -29.46 65.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.617 0.367 . . . . 63.05 110.858 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' D' ' 116' ' ' SER . 80.7 mtt-85 -70.55 -30.29 66.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.653 0.781 . . . . 71.35 110.1 172.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.63 7.16 81.98 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 123.724 0.64 . . . . 74.11 112.834 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 43.5 p 56.76 28.69 14.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.395 1.878 . . . . 75.14 113.262 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.74 158.59 34.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.883 0.873 . . . . 73.53 110.137 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.76 127.33 25.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.008 2.472 . . . . 65.21 112.932 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.432 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.0 tt0 -51.26 130.61 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.611 1.195 . . . . 73.21 112.201 -175.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.1 tp -115.19 100.89 8.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.63 0.372 . . . . 64.33 110.292 -176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -99.61 112.51 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.351 -1.352 . . . . 74.24 107.351 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.722 HD23 HD13 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -74.37 135.85 42.45 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 123.42 0.45 . . . . 75.35 110.592 -171.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.17 123.05 58.26 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 124.467 1.104 . . . . 62.2 110.933 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.4 ' HG3' HH12 ' D' ' 111' ' ' ARG . 43.0 Cg_exo -57.4 129.87 36.22 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.321 2.014 . . . . 74.24 111.238 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -123.73 110.55 26.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 109.194 -0.669 . . . . 65.13 109.194 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -77.28 95.57 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.794 -1.188 . . . . 73.03 107.794 167.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.476 0.83 0 CA-C-N 115.641 -0.709 . . . . 73.12 111.159 -176.117 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.675 0.274 . . . . 73.32 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.93 137.26 34.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.478 1.111 . . . . 74.12 108.394 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -160.69 136.76 8.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.269 0.227 . . . . 73.12 110.838 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.8 mp -69.18 114.48 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.077 -1.083 . . . . 73.24 108.077 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -95.29 -30.07 14.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.138 0.575 . . . . 72.41 111.176 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -166.03 148.41 7.17 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.682 -0.488 . . . . 73.43 109.682 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.443 HG12 ' HG3' ' C' ' 130' ' ' PRO . 2.5 pp -141.03 139.05 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.726 -1.213 . . . . 74.45 107.726 171.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 42.1 p90 -176.97 176.16 1.47 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.566 0.698 . . . . 75.34 110.949 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -99.73 111.07 23.43 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.042 0.937 . . . . 75.45 109.241 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -76.01 -28.92 57.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.957 -0.386 . . . . 73.03 109.957 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.0 t70 -150.61 147.77 27.82 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.955 -0.566 . . . . 73.43 110.126 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.4 mt -138.72 145.39 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.477 1.511 . . . . 73.54 107.398 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -154.22 117.58 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.662 0.385 . . . . 65.3 110.457 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.673 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.1 t80 -124.44 116.32 22.34 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.353 -1.351 . . . . 74.41 107.353 172.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -119.67 128.17 53.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.433 -0.58 . . . . 74.34 109.433 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.56 76.61 48.15 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 108.546 -0.909 . . . . 71.34 108.546 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 -18.23 22.4 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.68 2.253 . . . . 74.54 112.024 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 64.6 m-20 -115.76 30.72 7.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.934 0.893 . . . . 75.35 108.962 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -58.12 -46.33 99.68 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.864 0.866 . . . . 73.35 112.584 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 31.6 Cg_exo -62.92 -28.16 75.13 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.025 1.817 . . . . 74.01 113.21 169.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.456 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 1.1 m80 -73.13 -24.39 60.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.77 0.428 . . . . 75.04 111.327 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.41 -27.41 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 120.967 0.413 . . . . 74.24 110.819 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.591 ' HD2' HH11 ' B' ' 15' ' ' ARG . 81.9 t80 -74.86 -41.69 59.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.381 0.672 . . . . 74.21 110.239 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' A' ' 30' ' ' HIS . 13.1 pt20 -80.3 -30.47 38.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.584 0.354 . . . . 74.32 111.556 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.541 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 3.8 mmmp? -82.36 156.85 24.0 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.883 0.873 . . . . 75.42 112.107 -176.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.59 140.4 54.41 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.473 -1.24 . . . . 74.13 110.757 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -88.24 63.92 7.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.634 0.731 . . . . 72.43 109.378 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -124.63 78.34 63.36 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.376 1.07 . . . . 73.42 108.819 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.87 167.2 24.14 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.985 2.457 . . . . 73.21 113.606 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -123.77 95.37 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.829 -1.545 . . . . 65.2 106.829 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.25 125.62 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.311 0.577 . . . . 75.54 110.391 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 35.5 mttp -120.85 114.77 22.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.391 1.077 . . . . 53.52 108.612 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.6 mt -111.1 107.26 16.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.734 -1.121 . . . . 74.53 108.778 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -114.46 145.23 42.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.606 1.162 . . . . 61.42 110.128 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.48 153.23 48.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 72.13 110.605 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.434 ' O ' HD22 ' A' ' 60' ' ' LEU . 20.7 t70 -157.86 143.47 17.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.383 1.073 . . . . 73.04 109.014 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.1 m -126.62 135.08 50.74 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.672 0.789 . . . . 72.12 109.584 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.55 132.48 40.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.075 0.95 . . . . 72.32 109.842 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -91.35 153.26 20.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.104 0.478 . . . . 64.23 110.445 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 t -150.82 138.28 19.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.079 1.352 . . . . 71.24 108.262 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -113.75 124.34 52.03 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.44 -0.578 . . . . 64.22 109.44 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.15 -44.07 7.11 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.566 0.746 . . . . 75.34 110.393 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 -173.45 4.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.461 -0.791 . . . . 75.14 109.982 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -63.02 112.66 2.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.302 0.641 . . . . 55.4 109.773 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 65.02 8.9 5.03 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.858 1.263 . . . . 62.51 113.038 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.01 109.93 25.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.004 -1.109 . . . . 71.14 108.004 172.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -119.94 123.82 44.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.491 0.716 . . . . 75.15 109.579 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -97.5 131.54 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.609 -1.178 . . . . 70.0 108.641 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.53 129.63 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.938 -1.134 . . . . 71.33 107.938 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.8 t -104.49 132.57 50.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.534 -0.913 . . . . 73.05 108.534 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -108.85 110.18 21.48 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.715 -1.587 . . . . 73.35 106.715 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -103.29 102.67 12.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.808 0.843 . . . . 73.33 108.792 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 HD23 ' A' ' 60' ' ' LEU . 58.5 t -106.41 134.48 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 114.686 -1.143 . . . . 74.54 109.295 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.7 m -120.39 141.37 50.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.092 -0.707 . . . . 73.31 109.092 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -138.54 107.83 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.926 1.29 . . . . 72.41 108.321 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 19.2 m -102.22 146.05 28.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.316 -0.624 . . . . 74.41 109.316 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.17 120.28 15.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.492 0.717 . . . . 70.2 109.146 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 49.1 m -128.56 125.15 37.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.998 0.519 . . . . 75.44 110.008 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 85.16 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.75 0.786 . . . . 73.33 109.054 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.3 -118.65 5.14 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.283 -1.326 . . . . 74.11 111.359 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -87.89 -31.98 19.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 72.4 109.347 174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.15 133.77 35.52 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.67 0.788 . . . . 74.45 109.469 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.6 m -78.94 136.68 37.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.094 -0.335 . . . . 73.45 110.094 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.57 -60.55 2.15 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.496 0.718 . . . . 61.01 109.112 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -165.83 176.13 8.15 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.628 -1.169 . . . . 75.31 111.098 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -138.62 145.82 40.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.34 1.456 . . . . 73.43 108.139 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.474 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.1 m -135.89 140.37 44.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.928 0.891 . . . . 74.04 109.838 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -150.33 130.7 13.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.179 0.592 . . . . 72.45 109.652 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.82 119.86 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.171 0.589 . . . . 73.3 110.362 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -89.26 83.12 6.45 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.445 1.098 . . . . 74.54 108.523 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.49 94.39 3.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.279 -0.873 . . . . 74.15 109.443 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.93 144.16 17.93 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.772 -0.531 . . . . 73.42 111.772 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.525 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.86 124.18 2.77 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.811 -0.916 . . . . 62.23 110.811 -176.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.61 128.49 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.671 -0.863 . . . . 75.51 108.671 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -135.18 140.0 45.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.666 -0.864 . . . . 75.23 108.666 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.1 p -101.92 106.88 17.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 72.23 109.015 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.2 pt -125.19 131.55 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.335 0.654 . . . . 74.41 110.769 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.85 157.42 26.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.114 0.965 . . . . 74.01 110.207 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.16 64.86 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.067 -0.515 . . . . 65.42 114.383 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.462 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.63 145.48 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.643 0.721 . . . . 74.54 109.368 -177.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.603 ' HA ' ' HE2' ' A' ' 94' ' ' MET . 9.9 tt0 -142.68 179.32 7.06 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.021 0.528 . . . . 74.53 109.956 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.73 -123.81 31.73 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 124.239 0.924 . . . . 72.01 114.738 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -74.86 -26.56 59.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 74.24 111.365 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -65.72 -48.66 71.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.744 0.817 . . . . 64.5 110.063 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.603 ' HE2' ' HA ' ' A' ' 90' ' ' GLU . 39.8 ttp -79.71 -33.29 41.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.202 -1.363 . . . . 51.53 110.6 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.58 92.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.27 0.557 . . . . 74.35 109.956 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -55.13 -47.54 74.92 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.547 -1.206 . . . . 75.31 111.092 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.644 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 35.3 m -71.33 -33.22 69.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.741 1.015 . . . . 74.32 113.741 -172.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.09 -30.09 39.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.809 0.443 . . . . 75.25 111.342 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.98 -17.61 31.92 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.633 -0.537 . . . . 65.24 114.292 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.52 -63.91 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.708 0.754 . . . . 75.22 112.614 -171.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.644 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.83 -56.39 12.42 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.085 0.954 . . . . 62.34 112.758 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.56 -48.62 12.05 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.315 -0.85 . . . . 72.42 113.113 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.3 -20.27 62.04 Favored 'Trans proline' 0 C--N 1.388 2.636 0 CA-C-N 121.111 1.432 . . . . 75.42 113.718 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.29 -42.8 92.72 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.017 0.527 . . . . 71.32 110.711 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -59.65 -41.85 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.97 0.89 . . . . 72.02 110.201 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.525 HD22 ' HA3' ' A' ' 82' ' ' GLY . 94.9 mt -74.99 -29.1 60.8 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 113.874 -1.512 . . . . 63.44 112.579 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.476 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 20.6 t80 -64.26 -45.17 78.46 Favored Pre-proline 0 CA--C 1.558 1.28 0 N-CA-C 114.866 1.432 . . . . 74.34 114.866 -167.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.88 -32.51 95.23 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 121.616 1.544 . . . . 70.34 113.046 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -79.73 -37.72 34.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.453 0.701 . . . . 74.11 112.349 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.19 71.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 110.01 -0.367 . . . . 65.44 110.01 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -53.51 -48.8 68.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.371 1.068 . . . . 74.22 110.102 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.26 -47.25 86.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.982 0.913 . . . . 64.43 111.613 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.541 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.3 t -60.37 -44.19 95.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 73.34 111.002 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.462 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 15.3 mt -63.08 -51.79 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.31 1.044 . . . . 73.32 110.905 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.8 m -59.1 -36.4 75.08 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.258 1.023 . . . . 71.35 112.023 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.65 -39.72 80.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 75.43 110.115 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.673 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 46.5 mtm -63.08 -39.63 95.28 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.637 0.375 . . . . 74.51 110.533 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.88 -47.05 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.146 0.978 . . . . 74.02 111.207 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -72.61 -33.37 66.63 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.096 -0.502 . . . . 43.22 111.184 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.433 HH12 ' HG3' ' B' ' 112' ' ' GLU . 82.7 mtt-85 -69.39 -26.61 64.73 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.333 0.653 . . . . 72.23 110.138 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.61 1.07 88.7 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.683 -0.69 . . . . 75.52 112.861 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.4 m 69.56 18.14 7.78 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.392 1.077 . . . . 73.24 111.277 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.44 152.38 40.02 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 73.12 110.892 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.76 125.35 18.8 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.74 2.293 . . . . 73.13 112.0 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.515 ' HG3' HG23 ' A' ' 115' ' ' THR . 25.3 tt0 -50.34 136.66 19.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.859 1.264 . . . . 74.34 112.957 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.2 mt -125.61 104.62 8.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.837 0.855 . . . . 64.3 108.81 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -101.9 123.18 45.39 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.678 0.791 . . . . 74.24 109.103 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.476 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -73.4 120.44 19.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.909 -1.145 . . . . 75.51 107.909 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.09 129.07 85.92 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.864 0.727 . . . . 70.42 110.631 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.63 107.4 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.045 1.83 . . . . 75.25 111.741 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -98.96 110.84 27.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.51 -1.292 . . . . 74.05 107.51 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.12 82.04 8.54 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.437 -0.801 . . . . 71.05 109.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.22 -32.78 71.44 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.246 -1.343 . . . . 74.03 109.803 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 124.359 1.064 . . . . 73.45 111.606 173.881 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 112.494 0.553 . . . . 75.02 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 15.2 t -155.61 143.54 19.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.082 -0.71 . . . . 65.12 109.082 170.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -139.45 113.28 8.61 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.158 -1.052 . . . . 74.2 108.158 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 22.8 tt0 -133.11 139.76 47.29 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.487 0.715 . . . . 73.4 109.469 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.53 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -89.83 116.04 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.183 -1.043 . . . . 74.22 108.183 170.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.403 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 72.5 mt-30 -77.63 -40.83 40.58 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.753 -0.462 . . . . 65.2 109.753 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.591 HH11 ' HD2' ' A' ' 32' ' ' PHE . 18.6 ttt180 -166.42 137.89 3.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 71.15 108.846 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 57.8 mt -114.39 139.23 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 106.986 -1.487 . . . . 74.04 106.986 170.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -168.19 146.57 4.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.762 0.71 . . . . 71.42 112.298 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -73.35 120.83 19.51 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.655 -1.157 . . . . 74.34 108.711 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -96.44 -26.59 15.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.443 0.697 . . . . 75.31 111.242 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -161.26 141.74 11.04 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.055 0.222 . . . . 62.42 110.924 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -138.3 141.69 37.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 125.024 1.33 . . . . 73.3 109.035 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 35.0 t -140.12 124.22 17.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.166 -1.42 . . . . 63.44 107.166 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -138.61 111.41 7.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.396 -1.335 . . . . 75.32 107.396 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.98 117.51 29.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.671 -0.863 . . . . 74.04 108.671 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 84.68 6.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.492 -1.299 . . . . 73.34 107.492 168.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.63 -26.92 11.25 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.829 2.353 . . . . 71.23 112.649 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 1.8 m-20 -110.96 20.24 17.69 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 74.52 109.438 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.496 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.01 -60.52 1.65 Allowed Pre-proline 0 CA--C 1.574 1.89 0 C-N-CA 126.368 1.867 . . . . 74.31 114.931 -169.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.0 -1.86 9.49 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.26 1.973 . . . . 72.13 113.57 -174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -96.74 -38.21 9.99 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 73.14 110.505 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 73' ' ' ALA . 10.5 p -79.33 -14.16 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.478 -0.783 . . . . 74.51 110.114 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.06 -34.56 44.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.676 1.19 . . . . 73.2 111.798 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -73.15 -15.94 61.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.068 0.947 . . . . 75.13 112.028 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.55 ' HD3' HD13 ' B' ' 68' ' ' LEU . 89.6 mttt -105.52 109.37 21.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.148 0.979 . . . . 74.42 110.481 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.27 83.63 5.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.367 0.667 . . . . 62.25 110.407 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.581 ' HE3' HD11 ' B' ' 68' ' ' LEU . 3.6 m-90 -153.43 161.75 41.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.492 1.117 . . . . 74.41 109.378 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.31 119.94 73.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.207 -1.034 . . . . 75.52 108.207 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.14 167.72 26.04 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.787 2.325 . . . . 64.04 113.684 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.66 103.39 4.23 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.955 -1.128 . . . . 61.55 107.955 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.403 HG21 HD23 ' B' ' 126' ' ' LEU . 27.4 m -100.88 127.78 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.206 0.602 . . . . 74.2 110.261 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -106.63 124.6 49.85 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.608 -0.886 . . . . 73.4 108.608 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 mt -92.25 124.79 36.58 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.037 -1.098 . . . . 72.4 108.037 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.0 t70 -136.23 151.89 50.16 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 107.996 -1.113 . . . . 75.31 107.996 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.57 169.41 17.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.184 0.516 . . . . 71.12 111.674 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.9 t70 -159.39 142.72 14.49 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.755 1.222 . . . . 73.23 108.432 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -109.29 118.7 37.38 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.765 -0.828 . . . . 61.24 108.765 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -117.73 151.3 37.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 71.03 108.553 172.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -145.43 163.75 33.67 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 122.927 0.491 . . . . 74.32 110.511 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -157.83 136.54 11.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.679 1.191 . . . . 72.25 108.148 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -93.79 127.02 39.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.926 0.49 . . . . 74.42 110.032 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 -40.32 14.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.215 -0.661 . . . . 71.0 109.215 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.49 -178.83 5.13 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.779 1.232 . . . . 74.33 108.851 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -72.45 134.51 45.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.876 -0.787 . . . . 74.13 108.876 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.3 m-20 73.64 -3.87 2.38 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.404 1.481 . . . . 74.34 111.808 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.38 84.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.993 -1.114 . . . . 63.34 107.993 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.39 138.95 46.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.949 -0.759 . . . . 71.3 108.949 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -115.04 110.0 18.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.829 -1.174 . . . . 71.22 107.829 -172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' B' ' 98' ' ' LEU . 67.0 t -104.55 128.83 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.988 0.515 . . . . 74.51 110.187 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 39.6 t -102.37 119.91 51.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.538 1.135 . . . . 75.43 109.466 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -92.89 111.67 23.37 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.166 -1.42 . . . . 73.53 107.166 172.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.6 ttt180 -100.18 125.38 46.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.009 -0.737 . . . . 73.33 109.009 175.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.538 HG13 HD11 ' B' ' 128' ' ' LEU . 15.4 t -119.58 127.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.856 -0.794 . . . . 72.01 108.856 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 86.1 m -104.04 141.05 36.87 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.57 0.544 . . . . 71.41 110.11 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.619 HG22 HG21 ' B' ' 114' ' ' ILE . 53.0 t -133.3 122.18 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.491 1.116 . . . . 74.14 108.549 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -117.36 146.17 43.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.744 . . . . 75.23 108.993 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.0 133.41 21.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.755 -0.832 . . . . 71.52 108.755 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 63.6 p -138.52 136.34 36.0 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 122.877 0.471 . . . . 70.42 110.207 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.581 HD11 ' HE3' ' B' ' 36' ' ' TRP . 0.3 OUTLIER -110.44 107.86 17.67 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.891 -1.152 . . . . 75.12 107.891 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.33 -111.37 3.24 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 123.662 0.601 . . . . 63.31 112.755 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.87 2.46 23.47 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.216 0.606 . . . . 73.44 111.042 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.525 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 11.9 pt-20 -135.71 170.46 15.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.989 0.516 . . . . 73.44 110.441 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.1 m -71.84 143.57 49.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 73.25 110.334 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' B' ' 31' ' ' VAL . . . -98.4 -58.77 1.89 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.919 0.888 . . . . 74.21 109.07 173.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -161.04 164.34 30.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.313 -0.858 . . . . 74.34 110.353 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.26 141.59 45.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.911 1.284 . . . . 75.14 107.646 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.74 154.59 38.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.076 0.55 . . . . 71.4 109.87 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.2 tt0 -164.96 133.88 3.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.7 -0.852 . . . . 75.34 108.7 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -127.25 145.41 34.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.68 -0.859 . . . . 75.14 108.68 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -122.98 93.09 3.85 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.744 -0.835 . . . . 74.24 108.744 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -84.69 100.43 11.47 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.601 -0.889 . . . . 71.13 108.601 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 173.5 40.1 Favored Glycine 0 C--O 1.245 0.788 0 N-CA-C 111.775 -0.53 . . . . 72.32 111.775 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.5 133.2 2.71 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.697 -0.561 . . . . 44.43 111.697 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 36.7 mt -85.85 131.12 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.373 -0.973 . . . . 74.15 108.373 172.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.54 152.85 48.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.068 0.947 . . . . 75.43 109.626 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 14.8 m -123.59 105.05 9.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.052 0.941 . . . . 73.21 108.894 -172.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.598 HG22 HD13 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -134.46 141.89 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.101 0.56 . . . . 73.05 112.053 -169.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.05 167.69 25.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.399 1.08 . . . . 74.42 109.734 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.75 -62.45 4.38 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.609 0.568 . . . . 65.24 112.328 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.533 HD12 ' HB ' ' B' ' 86' ' ' ILE . 2.5 pp -68.62 145.58 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.922 0.889 . . . . 75.12 111.992 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.33 175.52 13.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 71.55 110.45 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -122.26 29.23 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.883 0.74 . . . . 70.52 113.536 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -70.8 -33.59 70.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.889 0.875 . . . . 74.43 110.878 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.23 -29.86 61.91 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.274 -0.876 . . . . 73.33 110.779 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.439 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 0.3 OUTLIER -71.07 -43.9 66.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.552 0.741 . . . . 75.12 109.199 173.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.52 66.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.041 -0.981 . . . . 61.25 111.769 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.43 -38.56 65.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.979 0.512 . . . . 73.43 110.212 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.57 -59.14 2.87 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.368 -0.833 . . . . 75.53 110.83 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.646 ' HB3' HG22 ' B' ' 58' ' ' VAL . 6.1 mp -87.37 -14.05 41.76 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.756 0.651 . . . . 74.13 112.756 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.09 -37.15 8.5 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 120.151 -0.25 . . . . 72.31 112.668 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.15 -48.09 3.14 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.495 0.648 . . . . 70.41 111.841 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -79.38 -42.36 25.72 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.119 0.415 . . . . 75.33 112.119 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.646 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 96.6 m -61.19 -47.74 93.73 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.43 -0.795 . . . . 74.4 111.746 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -53.44 -35.2 74.87 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.03 1.82 . . . . 72.24 114.601 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.76 -33.2 75.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 118.173 0.442 . . . . 72.21 110.95 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.03 -47.11 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.071 0.948 . . . . 73.33 110.554 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 78.4 mt -78.82 -19.31 52.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.135 -0.938 . . . . 63.51 112.196 -172.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.509 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 66.6 t80 -62.92 -45.73 87.22 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.886 1.069 . . . . 71.12 113.886 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.25 -38.78 93.47 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 121.96 1.773 . . . . 75.43 113.352 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.438 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 77.2 m-85 -68.05 -45.55 73.58 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.091 0.556 . . . . 75.4 110.671 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -43.74 97.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.376 -0.829 . . . . 73.1 110.545 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -56.71 -54.79 42.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.31 1.444 . . . . 75.23 110.929 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.433 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.9 tp10 -59.26 -41.02 87.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.492 1.117 . . . . 71.31 111.018 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.493 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.8 t -68.78 -39.36 80.22 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.655 -0.248 . . . . 75.53 111.262 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.619 HG21 HG22 ' B' ' 64' ' ' VAL . 89.4 mt -62.58 -54.69 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.054 0.542 . . . . 75.41 109.79 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 39.2 m -61.78 -30.1 70.58 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 124.108 0.88 . . . . 65.51 111.526 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.6 t -67.06 -45.76 76.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.401 0.681 . . . . 74.35 110.483 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.4 mmt -67.98 -37.01 81.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.492 0.317 . . . . 74.04 110.739 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.18 -41.09 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.941 0.896 . . . . 75.53 110.195 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.9 t -65.16 -34.99 79.7 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.807 -1.088 . . . . 60.3 111.248 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.541 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 85.5 mtt-85 -68.59 -28.43 66.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.207 0.603 . . . . 73.35 111.11 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.43 9.58 61.23 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.703 0.627 . . . . 75.54 112.623 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 77.0 p 52.53 55.07 9.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.99 1.716 . . . . 73.33 112.531 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -107.52 161.22 23.85 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-N 115.63 -0.714 . . . . 73.3 110.257 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.26 -167.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 123.312 2.675 . . . . 55.35 114.046 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.773 ' HB3' ' HA ' ' C' ' 124' ' ' PRO . 29.0 pt20 -62.76 122.65 16.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.217 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.403 HD23 HG21 ' B' ' 40' ' ' VAL . 1.1 tm? -151.28 81.77 1.31 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.758 -0.83 . . . . 75.23 108.758 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.13 135.96 36.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.742 0.817 . . . . 73.14 108.887 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.582 HD13 HD13 ' B' ' 114' ' ' ILE . 0.9 OUTLIER -64.55 131.33 46.73 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 123.969 0.793 . . . . 73.35 109.005 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 146.09 87.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.506 0.722 . . . . 75.21 110.858 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.22 108.74 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.016 2.477 . . . . 75.42 113.218 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.72 123.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.621 0.768 . . . . 74.21 110.171 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -87.22 92.54 9.1 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.384 0.674 . . . . 73.02 110.005 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -62.47 -41.48 98.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.306 -0.861 . . . . 74.31 109.754 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.6 -35.16 73.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.415 -1.72 . . . . 72.41 112.015 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.37 -49.78 45.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.433 0.693 . . . . 70.13 111.867 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 tt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.173 -0.677 . . . . 73.53 109.173 179.416 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.584 ' HE1' ' SG ' ' C' ' 97' ' ' CYS . 25.8 ttt . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 121.407 0.622 . . . . 73.53 112.588 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 55.0 m -85.1 98.06 10.22 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.151 -1.055 . . . . 75.0 108.151 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -108.67 129.0 55.34 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.345 -0.983 . . . . 72.23 108.345 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.32 125.3 16.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.846 -0.428 . . . . 75.34 109.846 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.639 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -75.92 133.64 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 108.533 -0.914 . . . . 70.21 108.533 175.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -107.74 -48.73 3.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.231 0.612 . . . . 74.2 110.689 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -162.06 136.15 6.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.673 0.389 . . . . 74.43 110.16 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.639 HG13 HD11 ' C' ' 13' ' ' ILE . 88.3 mt -119.87 140.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.037 -1.097 . . . . 74.23 108.037 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -173.77 161.33 3.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.229 0.538 . . . . 74.3 110.968 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -82.66 112.92 19.97 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.161 -0.927 . . . . 71.34 109.387 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -74.28 -33.27 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.195 -0.669 . . . . 75.34 109.195 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.2 t70 -146.52 147.17 30.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.367 -0.833 . . . . 74.13 110.233 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.8 mt -146.3 145.87 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.993 1.717 . . . . 65.22 106.842 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -162.96 151.97 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 122.87 0.468 . . . . 75.22 110.117 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.14 108.35 3.41 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.492 -0.929 . . . . 72.45 108.492 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.18 118.73 33.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.794 0.837 . . . . 71.41 109.218 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.58 83.81 48.12 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.55 1.14 . . . . 71.22 108.411 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.88 -19.06 31.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.732 2.288 . . . . 74.22 111.775 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' C' ' 72' ' ' THR . 77.9 m-20 -117.69 38.61 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.169 0.987 . . . . 73.52 109.51 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HB2' ' HE3' ' D' ' 19' ' ' LYS . . . -59.07 -47.24 98.93 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 123.586 0.754 . . . . 73.22 112.705 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.97 -14.64 38.98 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.788 1.659 . . . . 74.44 113.852 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -67.61 -23.91 65.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 119.186 -0.435 . . . . 74.41 111.984 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.59 -29.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.727 0.811 . . . . 72.2 112.523 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.458 ' HE1' HH11 ' D' ' 15' ' ' ARG . 38.2 m-85 -68.75 -41.44 78.89 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.229 0.612 . . . . 70.21 111.315 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.26 5.78 49.45 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.047 -0.979 . . . . 73.42 110.527 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.439 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 4.6 ttmp? -93.47 145.85 24.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.66 0.784 . . . . 74.24 110.403 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.44 132.07 34.62 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.861 -1.162 . . . . 64.31 107.861 172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -74.99 78.48 2.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 122.312 1.053 . . . . 74.01 111.575 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.422 ' O ' HD13 ' C' ' 68' ' ' LEU . 38.0 tt0 -157.56 65.13 3.33 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 113.924 -1.489 . . . . 74.11 108.327 168.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.08 150.81 4.75 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.653 1.569 . . . . 73.25 111.254 169.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -86.32 96.06 9.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.522 -1.288 . . . . 72.33 107.522 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.53 98.35 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.474 1.131 . . . . 74.51 108.86 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -91.18 116.84 29.14 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.805 -1.543 . . . . 74.24 108.331 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.557 HD12 HD12 ' C' ' 128' ' ' LEU . 30.1 tp -84.24 144.12 29.13 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.374 -0.973 . . . . 75.11 108.374 172.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.9 t70 -137.47 128.56 27.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.496 -1.298 . . . . 73.43 107.496 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.83 132.07 38.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.049 -0.723 . . . . 75.1 109.049 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -137.65 155.84 48.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.805 0.842 . . . . 72.54 109.009 174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -138.32 149.52 45.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.923 0.489 . . . . 64.23 109.921 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 167.59 21.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.768 0.827 . . . . 64.03 109.179 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.3 p -148.3 144.64 27.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.649 0.379 . . . . 72.23 111.062 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 75.9 p -147.66 145.77 29.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.062 0.945 . . . . 74.1 110.242 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -87.14 130.56 34.47 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.007 -0.738 . . . . 74.31 109.007 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.695 HD12 ' HB2' ' C' ' 57' ' ' GLU . 59.5 mt -106.37 -41.84 5.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.627 0.771 . . . . 74.31 109.944 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.18 -169.32 3.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.507 0.723 . . . . 53.52 110.736 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.83 108.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.132 -0.94 . . . . 73.15 109.396 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 52.1 m-20 69.97 -0.84 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.639 1.175 . . . . 64.13 113.269 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -96.68 113.95 32.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.533 0.733 . . . . 75.42 109.166 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.97 130.16 52.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.361 1.064 . . . . 74.32 108.71 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.695 ' HB2' HD12 ' C' ' 51' ' ' LEU . 44.6 tt0 -87.98 143.9 26.84 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.362 -0.835 . . . . 72.34 108.817 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.478 HG12 HD11 ' C' ' 106' ' ' LEU . 2.6 p -125.46 124.6 67.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.557 -0.905 . . . . 74.54 108.557 169.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.85 104.69 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.578 -1.267 . . . . 74.55 107.578 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.49 100.85 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.974 0.91 . . . . 75.33 108.759 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -81.65 124.15 29.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.573 0.749 . . . . 73.4 110.237 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.26 126.56 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.531 -1.285 . . . . 72.41 107.531 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.5 m -128.59 128.79 44.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.899 -0.778 . . . . 74.33 108.899 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.541 HG21 HD12 ' C' ' 114' ' ' ILE . 88.5 t -110.71 110.16 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.664 -0.865 . . . . 73.11 108.664 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.8 m -99.34 110.29 22.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.85 -0.796 . . . . 73.14 108.85 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.22 99.97 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.488 -1.301 . . . . 73.44 107.488 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -146.65 156.45 43.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.647 0.592 . . . . 50.53 109.865 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.422 HD13 ' O ' ' C' ' 37' ' ' GLN . 53.7 tp -111.8 80.18 1.29 Allowed 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.767 -1.568 . . . . 74.12 106.767 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.91 -96.2 0.18 Allowed Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.903 -1.044 . . . . 72.11 112.339 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -91.13 -31.94 16.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.847 0.859 . . . . 74.32 111.221 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.404 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 13.2 tp10 -87.22 93.13 9.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.652 0.781 . . . . 71.23 110.281 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 60.8 m -84.72 130.44 34.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.826 -0.624 . . . . 75.34 111.038 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.36 -55.76 4.67 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.028 0.931 . . . . 63.4 109.863 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -157.37 170.73 21.8 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.408 0.623 . . . . 74.12 111.721 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.51 111.5 6.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.723 -1.584 . . . . 70.23 106.723 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.8 t -111.02 143.98 40.86 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.981 -0.748 . . . . 74.32 108.981 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -147.55 117.8 7.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.203 0.601 . . . . 75.33 109.621 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.87 114.99 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.787 1.235 . . . . 74.32 109.234 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 24.5 mt-30 -94.16 102.62 14.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.141 -0.689 . . . . 72.31 109.141 172.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.546 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.1 tp-100 -87.56 109.4 19.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.471 0.708 . . . . 70.2 109.34 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.62 146.88 20.26 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.617 -0.593 . . . . 73.41 111.617 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.46 117.36 1.27 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.569 -0.613 . . . . 71.54 111.569 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 12.8 mm -83.01 126.09 40.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.614 -0.884 . . . . 71.34 108.614 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -140.62 138.33 34.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.649 0.38 . . . . 71.42 110.114 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -94.54 117.75 30.61 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.8 pp -116.12 142.06 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 122.72 0.408 . . . . 74.33 110.113 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -155.86 155.82 33.59 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.219 0.608 . . . . 75.41 110.443 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -45.81 3.32 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.195 -0.457 . . . . 70.4 112.556 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -88.7 151.03 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.8 0.84 . . . . 64.14 109.09 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.9 -179.45 7.66 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.858 0.463 . . . . 72.33 109.811 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.23 -137.33 50.1 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 115.268 0.867 . . . . 73.24 115.268 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -72.2 -20.09 61.63 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 73.45 112.39 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -80.12 -38.77 30.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.23 0.212 . . . . 65.44 110.863 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -70.21 -31.81 69.41 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.443 -0.577 . . . . 72.24 109.443 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.07 71.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.474 -0.785 . . . . 73.14 110.433 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -61.67 -49.17 77.59 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.459 0.474 . . . . 75.13 110.173 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.584 ' SG ' ' HE1' ' C' ' 9' ' ' MET . 46.8 t -61.96 -48.86 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.51 0.506 . . . . 73.45 110.478 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.69 -16.35 63.33 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.613 0.765 . . . . 74.43 111.38 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.0 10.8 20.62 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-O 119.622 -0.544 . . . . 73.31 114.279 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.15 -61.11 0.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.703 0.751 . . . . 64.35 111.02 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.4 -56.68 6.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.707 0.403 . . . . 73.23 111.673 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.44 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 60.7 m -56.81 -46.95 99.8 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.59 0.756 . . . . 74.23 111.951 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 92.1 Cg_exo -53.32 -38.35 82.06 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 122.512 2.141 . . . . 64.43 114.923 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -63.4 -36.44 83.75 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 123.81 0.844 . . . . 65.31 110.506 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.68 -40.21 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.586 0.755 . . . . 73.51 110.414 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.478 HD11 HG12 ' C' ' 58' ' ' VAL . 64.2 mt -85.72 -26.12 26.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.565 -1.198 . . . . 74.04 112.096 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -55.52 -47.58 98.32 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 113.809 1.04 . . . . 73.24 113.809 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.32 -40.43 82.02 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.277 1.984 . . . . 74.22 113.612 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -65.7 -43.37 89.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.165 0.586 . . . . 73.44 110.374 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -69.5 -33.74 73.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.414 -0.812 . . . . 73.51 111.241 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -64.98 -47.36 77.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 74.14 110.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -71.92 -33.0 67.92 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.695 -0.684 . . . . 73.02 109.552 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.409 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 47.9 t -69.12 -31.15 69.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.234 0.614 . . . . 73.13 111.089 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.541 HD12 HG21 ' C' ' 64' ' ' VAL . 63.3 mt -72.62 -51.52 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.04 0.536 . . . . 71.22 109.762 171.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 39.9 m -61.73 -31.08 71.22 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.815 0.446 . . . . 73.33 111.143 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -60.18 -54.31 47.41 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.181 0.992 . . . . 64.01 108.995 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.648 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.82 -42.32 79.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.031 1.333 . . . . 73.43 112.475 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.413 HG21 ' O ' ' C' ' 114' ' ' ILE . 85.5 t -66.02 -40.85 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 72.43 109.924 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -73.75 -24.04 59.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.935 -1.03 . . . . 73.14 111.645 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.3 mtt-85 -74.1 -40.06 62.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.254 -0.647 . . . . 75.2 109.254 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -1.24 65.31 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.824 0.703 . . . . 64.14 112.229 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.455 HG21 ' HB3' ' D' ' 17' ' ' TYR . 37.5 p 63.73 25.8 14.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.869 2.067 . . . . 64.34 112.83 173.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.12 158.77 63.8 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.049 0.94 . . . . 73.32 108.538 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.773 ' HA ' ' HB3' ' B' ' 125' ' ' GLN . 36.3 Cg_endo -61.25 151.32 79.89 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.799 2.333 . . . . 74.31 114.206 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -56.55 112.05 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.084 1.354 . . . . 72.11 111.761 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.06 90.15 3.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.524 -1.287 . . . . 75.55 107.524 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -91.31 110.38 21.68 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.527 -0.916 . . . . 73.31 108.527 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.557 HD12 HD12 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -77.19 134.17 38.72 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.095 0.958 . . . . 74.34 110.316 -171.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.79 144.96 83.61 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.252 1.021 . . . . 75.23 111.846 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.443 ' HG3' HG12 ' A' ' 16' ' ' ILE . 93.1 Cg_endo -78.54 104.13 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.816 2.344 . . . . 70.15 112.895 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.62 107.73 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.111 -1.441 . . . . 63.21 107.111 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -105.64 98.02 7.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.081 0.552 . . . . 70.35 109.803 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -67.1 -36.95 83.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.432 0.693 . . . . 64.04 110.1 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 114.449 -1.25 . . . . 74.52 111.702 -179.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 113.518 0.932 . . . . 75.32 113.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 90.3 m -142.55 139.96 31.59 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.409 1.084 . . . . 72.34 108.326 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.455 ' CE2' ' SG ' ' D' ' 102' ' ' CYS . 79.5 t80 -155.01 101.09 2.24 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.529 -1.285 . . . . 72.01 107.529 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.23 122.7 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.88 0.472 . . . . 73.23 109.825 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.13 119.75 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 109.138 -0.69 . . . . 74.14 109.138 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.455 HE22 HG22 ' D' ' 55' ' ' VAL . 40.9 mt-30 -98.67 -46.46 5.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.574 0.35 . . . . 74.42 110.586 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.458 HH11 ' HE1' ' C' ' 32' ' ' PHE . 34.5 ttt180 -165.07 120.08 1.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.505 -0.183 . . . . 72.21 110.505 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -103.06 136.91 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.77 -1.196 . . . . 55.45 107.77 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.455 ' HB3' HG21 ' C' ' 122' ' ' THR . 31.2 p90 -164.37 177.59 8.12 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.826 0.85 . . . . 74.32 110.763 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -107.5 127.56 53.72 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.738 -0.665 . . . . 71.35 110.013 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 27.4 mtpt -95.54 -30.99 13.54 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.529 -0.545 . . . . 72.44 109.529 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.771 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -144.61 134.9 24.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.834 -0.802 . . . . 74.22 108.834 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.648 HG21 ' HE1' ' C' ' 117' ' ' MET . 27.1 mt -139.04 147.7 24.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.144 -1.428 . . . . 75.21 107.144 174.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -155.13 147.47 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.986 0.422 . . . . 74.41 110.351 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 67.8 t80 -150.06 127.89 11.76 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.16 1.384 . . . . 71.31 107.351 173.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -126.61 148.06 49.83 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.039 0.936 . . . . 74.32 108.974 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.25 84.03 61.14 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.816 -0.809 . . . . 72.42 108.816 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.24 -48.06 5.3 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.789 2.993 . . . . 65.42 114.195 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -111.87 45.57 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.885 -0.783 . . . . 74.22 108.885 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.79 -59.34 9.06 Favored Pre-proline 0 CA--C 1.575 1.928 0 N-CA-C 115.703 1.742 . . . . 74.52 115.703 -166.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.66 -4.45 10.73 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 122.545 1.945 . . . . 72.21 112.99 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -84.15 -35.62 23.47 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.332 1.053 . . . . 72.12 110.476 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 p -84.31 -13.29 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.394 0.616 . . . . 72.31 110.411 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -30.7 69.71 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.862 -0.608 . . . . 74.4 109.939 166.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -72.38 -6.28 42.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.444 1.098 . . . . 74.43 111.943 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -125.41 87.13 2.65 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.379 1.072 . . . . 75.22 109.225 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.23 93.86 5.95 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.172 0.987 . . . . 73.45 110.425 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.38 170.98 20.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.314 1.046 . . . . 75.01 109.815 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.59 107.37 7.12 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.191 -1.04 . . . . 64.2 108.191 166.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.63 153.92 76.25 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.945 2.43 . . . . 71.51 113.001 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.01 123.81 23.59 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.444 -0.947 . . . . 73.33 108.444 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.513 HG11 HD12 ' D' ' 126' ' ' LEU . 7.7 p -117.71 142.35 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.079 0.552 . . . . 74.52 110.283 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' D' ' 41' ' ' LYS . 11.4 mmpt? -109.77 123.83 50.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.344 1.058 . . . . 64.23 108.711 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.62 126.87 55.84 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.464 0.706 . . . . 75.23 110.566 -171.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -130.67 120.2 23.56 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.945 0.898 . . . . 75.35 109.168 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.55 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.8 pt? -108.48 132.56 53.69 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.219 -0.66 . . . . 73.31 109.219 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.446 ' O ' HD21 ' D' ' 60' ' ' LEU . 26.7 t70 -135.48 145.26 46.96 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.862 0.865 . . . . 64.11 108.967 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -123.59 155.58 37.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.852 0.834 . . . . 74.4 111.62 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.19 166.86 27.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 113.801 -1.545 . . . . 62.32 108.073 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.4 p -151.91 156.38 39.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.133 0.573 . . . . 70.23 109.568 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -158.51 119.03 3.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.774 0.83 . . . . 73.31 109.022 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.71 117.79 11.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.987 -0.746 . . . . 74.53 108.987 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.55 -36.38 17.61 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.306 -0.627 . . . . 74.32 109.306 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.84 -171.38 2.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 71.11 111.322 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -54.8 104.68 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.607 1.563 . . . . 73.32 111.371 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 58.33 20.65 7.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.19 0.996 . . . . 74.2 112.432 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.455 HG22 HE22 ' D' ' 14' ' ' GLN . 75.3 t -109.46 122.22 63.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 107.523 -1.288 . . . . 74.14 107.523 170.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -130.89 128.41 40.5 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.836 -0.801 . . . . 73.22 108.836 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -88.66 135.88 33.28 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.528 1.131 . . . . 72.4 108.464 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 81.3 t -117.87 139.83 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.34 -0.985 . . . . 71.23 108.34 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.6 t -115.78 141.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.237 -1.023 . . . . 73.21 108.237 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.36 118.61 24.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.287 -1.375 . . . . 73.04 107.287 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -107.28 97.86 7.57 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.963 -0.754 . . . . 72.42 108.963 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.02 125.74 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.876 -0.787 . . . . 74.54 108.876 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -113.1 144.43 42.65 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.691 0.796 . . . . 73.33 109.798 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.56 HG22 HG21 ' D' ' 114' ' ' ILE . 25.6 t -135.8 104.82 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.243 1.417 . . . . 73.41 108.367 -173.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 10.0 m -112.14 90.99 3.49 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.563 -1.273 . . . . 72.32 107.563 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.53 125.32 42.17 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.9 p -158.69 124.92 4.58 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.167 0.987 . . . . 71.55 109.539 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.85 130.07 43.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.556 -1.276 . . . . 74.32 107.556 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 -146.41 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.012 -0.54 . . . . 64.31 113.323 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.03 11.11 16.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.207 1.003 . . . . 65.12 112.239 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.76 161.9 40.31 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.819 0.342 . . . . 63.43 111.428 -167.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -83.33 124.79 30.96 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.644 -0.707 . . . . 71.34 110.063 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.416 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -73.4 -63.84 1.11 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.125 0.97 . . . . 71.42 110.161 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -157.87 157.56 33.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.142 0.496 . . . . 74.12 111.065 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.96 146.62 47.45 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.408 1.083 . . . . 73.13 109.075 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.554 ' SG ' ' HE3' ' D' ' 117' ' ' MET . 53.7 t -160.0 141.42 12.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.191 0.596 . . . . 65.14 110.334 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.41 122.34 5.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.374 -0.602 . . . . 71.52 109.374 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . 0.479 HG23 HG22 ' D' ' 21' ' ' ILE . 47.8 t -124.48 123.95 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.446 0.698 . . . . 74.33 110.581 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.771 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.5 93.61 9.57 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.386 0.612 . . . . 74.33 109.396 164.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.69 109.88 14.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.979 -1.009 . . . . 74.44 108.371 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.69 149.37 19.1 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 111.735 -0.546 . . . . 64.4 111.735 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -144.22 130.52 4.02 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 110.885 -0.886 . . . . 74.42 110.885 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.77 126.34 41.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.022 -1.103 . . . . 74.24 108.022 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.98 162.75 27.97 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.297 -0.631 . . . . 73.41 109.297 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -116.35 101.62 8.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.556 0.742 . . . . 71.24 109.354 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.77 110.63 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.083 0.953 . . . . 72.14 110.097 -174.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.53 38.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.012 0.925 . . . . 74.53 109.829 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.76 -20.0 6.84 Favored Glycine 0 N--CA 1.477 1.432 0 N-CA-C 114.646 0.619 . . . . 63.01 114.646 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.471 HD12 ' HG3' ' D' ' 93' ' ' GLN . 4.4 tt -121.16 137.26 55.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 C-N-CA 124.237 1.015 . . . . 75.21 109.478 -174.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.69 -170.99 3.81 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.72 0.808 . . . . 72.3 110.822 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.5 -140.81 26.76 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.32 0.387 . . . . 73.05 113.606 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -80.0 -24.44 40.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.52 0.728 . . . . 74.15 110.833 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.471 ' HG3' HD12 ' D' ' 89' ' ' ILE . 6.5 tp-100 -70.26 -36.95 74.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.135 0.574 . . . . 62.12 110.632 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -33.6 62.76 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.668 -0.493 . . . . 65.43 109.668 174.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.76 81.2 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.361 0.601 . . . . 74.42 110.425 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -67.71 -44.81 76.79 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.972 -1.013 . . . . 73.14 111.231 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.96 -50.5 73.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.051 0.54 . . . . 73.42 110.699 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.34 -22.85 54.39 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.869 0.868 . . . . 73.53 111.316 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.2 -7.56 46.24 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 115.215 0.846 . . . . 75.14 115.215 -172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.28 -51.86 0.35 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.793 0.796 . . . . 71.34 110.965 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -71.8 -39.44 69.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.764 0.426 . . . . 74.24 112.057 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.455 ' SG ' ' CE2' ' D' ' 11' ' ' PHE . 57.7 m -73.37 -44.59 7.59 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.693 -0.67 . . . . 74.24 111.347 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.53 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 64.6 Cg_exo -56.64 -32.75 91.58 Favored 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 121.983 1.789 . . . . 71.33 113.244 168.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -63.82 -35.75 81.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.205 0.602 . . . . 64.33 110.669 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -65.75 -42.11 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.437 0.695 . . . . 71.53 110.111 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.45 HD22 ' HA3' ' D' ' 82' ' ' GLY . 94.0 mt -75.9 -19.26 58.97 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.075 -0.966 . . . . 75.31 112.318 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.23 -43.84 56.41 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 113.851 1.056 . . . . 74.14 113.851 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.99 -41.4 79.2 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.937 1.758 . . . . 75.03 113.512 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.43 -38.36 68.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.516 0.726 . . . . 74.22 111.525 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.65 79.35 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.486 0.714 . . . . 71.23 110.398 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -55.35 -52.37 63.72 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.507 1.129 . . . . 73.34 110.6 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.18 -43.95 93.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.894 0.746 . . . . 74.53 111.779 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.504 ' SG ' HD11 ' D' ' 21' ' ' ILE . 51.6 t -55.35 -40.3 71.07 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.764 0.665 . . . . 74.5 110.833 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.56 HG21 HG22 ' D' ' 64' ' ' VAL . 97.3 mt -65.83 -53.38 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.071 -0.968 . . . . 73.21 110.483 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.421 HG22 ' HG3' ' D' ' 125' ' ' GLN . 22.5 m -57.31 -35.99 70.53 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.252 1.021 . . . . 71.42 111.818 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.99 -45.69 76.86 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.204 -0.907 . . . . 74.45 110.139 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.554 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.1 mtm -65.6 -31.45 72.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.24 0.616 . . . . 72.02 111.7 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' D' ' 114' ' ' ILE . 71.2 t -66.25 -46.21 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.388 -0.824 . . . . 73.43 110.038 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.03 -25.44 60.95 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.333 -0.394 . . . . 74.32 111.428 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.409 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -74.39 -35.42 63.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.588 0.755 . . . . 65.24 109.676 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.67 -1.37 83.11 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 115.692 -0.685 . . . . 72.32 112.111 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p 57.19 36.29 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.2 1.8 . . . . 73.54 111.825 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.62 158.31 32.38 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 113.908 -1.496 . . . . 72.03 109.815 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.13 128.24 29.07 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.526 2.151 . . . . 74.2 113.07 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.421 ' HG3' HG22 ' D' ' 115' ' ' THR . 27.1 tt0 -52.39 140.97 20.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.052 1.341 . . . . 73.41 112.702 -175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.513 HD12 HG11 ' D' ' 40' ' ' VAL . 28.2 tp -112.99 126.77 55.86 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.11 -0.7 . . . . 73.54 109.11 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.451 ' HB3' HG13 ' B' ' 13' ' ' ILE . 94.3 m-20 -121.28 103.78 9.23 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.074 0.95 . . . . 70.0 109.025 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.76 119.75 12.36 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.641 0.776 . . . . 73.12 110.12 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.18 88.32 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.089 0.556 . . . . 75.12 110.602 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 110.7 1.36 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.464 2.109 . . . . 75.25 111.827 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.65 110.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.08 -1.082 . . . . 75.34 108.08 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -82.31 75.29 9.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.157 0.979 . . . . 73.53 109.375 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 28.4 t80 . . . . . 0 CA--C 1.549 0.916 0 CA-C-N 114.304 -1.316 . . . . 75.3 109.767 -179.751 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.6 m . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.498 -0.556 . . . . 73.13 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -133.17 112.38 11.68 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.744 -1.206 . . . . 74.33 107.744 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -140.06 110.5 6.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.27 -0.641 . . . . 75.3 109.27 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.416 HG13 ' CD2' ' A' ' 84' ' ' PHE . 1.5 mp -81.11 119.41 30.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 107.559 -1.274 . . . . 75.04 107.559 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.17 -41.49 16.97 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.014 -0.736 . . . . 75.32 109.014 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -168.07 137.47 2.51 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.328 -0.367 . . . . 74.33 110.561 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.614 HG23 HD23 ' A' ' 106' ' ' LEU . 92.0 mt -139.88 98.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.988 -1.115 . . . . 72.15 107.988 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.3 m-85 -163.45 166.02 23.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.102 0.961 . . . . 75.32 109.409 -167.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -74.18 126.33 30.34 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.075 -0.342 . . . . 75.2 110.075 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 41.2 mtpt -85.05 -44.41 13.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.392 0.615 . . . . 75.42 109.456 171.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.5 t70 -135.36 142.1 45.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.71 -1.132 . . . . 73.44 109.885 -176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.5 mt -138.19 140.01 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.453 1.501 . . . . 73.11 107.684 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.74 128.65 10.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.618 . . . . 73.42 109.333 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 89.0 t80 -134.1 125.07 27.23 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.389 -1.338 . . . . 71.1 107.389 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.75 148.07 49.19 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.039 -0.726 . . . . 72.31 109.039 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.0 77.78 25.48 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 106.628 -1.619 . . . . 74.24 106.628 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.93 -31.86 36.98 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.749 2.299 . . . . 72.13 111.873 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -109.28 32.14 5.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.704 0.802 . . . . 73.41 109.524 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -59.31 -46.8 99.07 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.262 1.025 . . . . 75.32 113.282 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 13.7 Cg_exo -71.61 -12.99 29.73 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.688 1.592 . . . . 72.04 113.167 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -90.14 -11.82 40.06 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.762 0.825 . . . . 74.33 111.698 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 29.9 m -60.24 -15.09 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 113.617 0.969 . . . . 64.34 113.617 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.64 -41.19 65.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 72.35 110.844 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -89.84 -15.61 31.88 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.375 -0.83 . . . . 74.33 110.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 3.7 mmpt? -73.21 129.21 37.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.231 0.612 . . . . 73.32 111.096 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.64 116.73 12.34 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.153 -1.055 . . . . 75.23 108.153 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -71.52 83.49 0.83 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.816 0.817 . . . . 75.45 111.283 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -141.0 80.19 17.39 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.203 -1.777 . . . . 74.23 106.203 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.74 135.36 6.76 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.904 2.403 . . . . 70.31 111.597 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -94.2 100.77 12.78 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 105.862 -1.903 . . . . 65.54 105.862 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.01 90.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.751 0.786 . . . . 72.3 109.068 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 56.7 tttp -86.39 127.67 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.36 -1.291 . . . . 71.44 108.837 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 tp -123.16 144.31 49.43 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.707 -0.849 . . . . 74.54 108.707 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.32 144.74 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.752 -0.833 . . . . 75.14 108.752 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.96 124.06 17.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.15 0.58 . . . . 75.11 110.272 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 20.7 t70 -123.5 148.04 46.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.994 1.317 . . . . 64.14 109.513 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.6 m -139.54 136.77 34.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.039 0.536 . . . . 73.12 110.579 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -146.29 127.64 14.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.28 0.632 . . . . 54.14 110.527 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -89.07 161.13 16.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.579 0.752 . . . . 74.31 109.87 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 47.2 t -167.33 116.67 0.83 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.991 -0.374 . . . . 74.34 109.991 -174.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.513 HE21 ' H ' ' A' ' 54' ' ' ASP . 62.8 tt0 -71.25 104.17 3.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.452 0.701 . . . . 75.43 110.011 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 83' ' ' ILE . 86.6 mt -77.95 -38.8 44.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.861 0.865 . . . . 74.33 111.044 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.92 -172.35 4.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.889 0.875 . . . . 71.33 109.776 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -57.21 97.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.188 0.595 . . . . 73.53 111.183 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.513 ' H ' HE21 ' A' ' 50' ' ' GLN . 10.4 m-20 58.39 32.95 22.68 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.201 1.4 . . . . 70.44 112.299 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 59.9 t -107.72 120.57 59.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.651 -1.611 . . . . 75.43 106.651 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.0 m-85 -130.89 128.5 40.69 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.952 -0.759 . . . . 75.32 108.952 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.81 123.16 34.99 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.901 -0.777 . . . . 72.3 108.901 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 33.2 m -99.75 122.09 51.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 107.543 -1.28 . . . . 71.14 107.543 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.9 t -100.49 130.13 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.14 -0.689 . . . . 75.55 109.14 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.7 112.97 26.26 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.425 -1.324 . . . . 73.31 107.425 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttm-85 -93.14 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.715 -1.217 . . . . 75.05 107.715 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.65 124.36 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.517 -0.92 . . . . 75.02 108.517 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -123.64 129.75 51.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.781 0.432 . . . . 75.21 109.952 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 53.0 t -123.63 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.541 1.136 . . . . 73.34 109.883 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 m -103.46 141.16 36.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.963 -0.384 . . . . 72.43 109.963 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.66 103.0 8.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.39 -1.337 . . . . 72.3 107.39 168.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 34.3 m -112.0 125.3 53.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.476 0.655 . . . . 73.41 109.401 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' A' ' 73' ' ' ALA . 5.9 mp -102.32 86.67 2.87 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.753 -1.943 . . . . 74.24 105.753 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -122.91 5.96 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.931 -0.868 . . . . 71.45 110.931 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.64 -23.78 24.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.235 0.614 . . . . 73.23 110.104 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.91 108.93 19.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.336 0.654 . . . . 73.11 111.17 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -74.39 117.35 16.11 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.373 0.669 . . . . 74.02 109.517 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -59.57 -54.86 41.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.553 0.741 . . . . 73.45 109.529 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -156.56 153.67 29.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.36 -1.291 . . . . 74.54 111.526 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -125.49 135.85 52.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.906 1.282 . . . . 73.22 108.732 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.499 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.0 m -120.35 140.61 51.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 71.01 109.247 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -147.43 125.59 12.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.784 -0.821 . . . . 71.44 108.784 166.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.34 109.64 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.211 1.005 . . . . 61.41 108.511 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 79.2 mt-30 -86.8 84.86 7.28 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.332 -0.849 . . . . 64.25 109.098 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.36 96.6 4.04 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.088 -1.414 . . . . 71.41 109.548 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.74 145.68 18.04 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.81 -0.516 . . . . 74.11 111.81 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.97 122.65 2.38 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.719 -0.952 . . . . 72.13 110.719 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 51' ' ' LEU . 48.0 mt -82.3 125.02 39.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 109.268 -0.642 . . . . 75.12 109.268 174.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CD2' HG13 ' A' ' 13' ' ' ILE . 55.4 m-85 -130.93 120.35 23.44 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.698 -0.853 . . . . 74.21 108.698 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 36.1 t -96.35 107.02 19.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 72.03 109.111 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.581 ' HB ' HD13 ' A' ' 89' ' ' ILE . 42.9 pt -130.45 127.79 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.148 0.579 . . . . 73.2 110.767 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.85 134.18 27.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.627 0.771 . . . . 60.34 109.926 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.15 7.8 62.02 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 123.549 0.531 . . . . 60.34 113.237 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.581 HD13 ' HB ' ' A' ' 86' ' ' ILE . 4.5 mp -109.32 136.03 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.238 -1.023 . . . . 73.41 108.238 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 13.4 tt0 -159.62 -178.14 6.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.13 0.572 . . . . 74.13 109.52 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.39 -143.23 36.94 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.659 -0.246 . . . . 65.05 112.821 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -68.93 -17.79 64.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.063 0.945 . . . . 75.54 112.116 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.92 -57.7 5.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.599 0.76 . . . . 74.21 109.312 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.447 ' HE2' ' HB3' ' A' ' 94' ' ' MET . 12.7 ttp -65.27 -40.42 93.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.93 1.292 . . . . 73.42 111.236 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.12 70.3 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.002 0.814 . . . . 75.31 110.044 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -64.27 -48.49 75.53 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 114.401 -1.272 . . . . 75.3 111.309 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 36.3 m -71.01 -45.23 64.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.969 1.1 . . . . 75.4 113.969 -165.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -83.26 -15.19 51.25 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.044 0.387 . . . . 75.01 112.044 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.56 -3.94 18.04 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 114.727 0.651 . . . . 73.34 114.727 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.97 -60.58 0.46 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.591 0.696 . . . . 70.1 110.941 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.474 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.2 t80 -57.55 -62.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.163 0.985 . . . . 74.52 112.394 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.01 -39.0 2.09 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.182 -1.372 . . . . 73.43 112.924 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 106' ' ' LEU . 10.4 Cg_endo -57.29 -37.86 96.53 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.703 1.602 . . . . 71.33 113.399 165.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.96 -37.71 86.7 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.079 0.4 . . . . 71.41 110.531 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 mm -58.26 -40.57 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.999 0.92 . . . . 64.02 110.946 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 16' ' ' ILE . 94.6 mt -70.74 -31.54 68.41 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.672 -0.695 . . . . 64.23 111.84 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.08 -43.73 98.68 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 124.845 1.258 . . . . 70.45 114.251 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.32 -35.48 83.99 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.415 2.077 . . . . 74.24 114.219 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.02 -22.37 45.56 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.606 0.362 . . . . 75.22 111.485 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.4 65.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.531 -0.544 . . . . 71.11 109.531 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.419 HH22 ' HB3' ' A' ' 130' ' ' PRO . 42.1 ttm180 -56.75 -42.31 79.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.648 1.179 . . . . 75.01 110.975 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -48.71 -56.55 8.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.211 1.404 . . . . 63.42 111.372 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.72 -48.69 68.44 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.82 -1.537 . . . . 74.53 111.363 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.443 ' O ' HG21 ' A' ' 118' ' ' VAL . 93.8 mt -57.35 -54.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 124.14 0.9 . . . . 71.1 110.565 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -61.54 -34.48 75.63 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.83 0.706 . . . . 71.54 111.801 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -67.84 -44.92 76.06 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.248 -0.433 . . . . 73.04 110.347 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.465 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 10.8 mtp -55.62 -45.16 77.57 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.802 0.841 . . . . 64.21 110.978 175.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -61.89 -46.96 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.603 1.161 . . . . 75.31 111.135 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 88.3 p -73.06 -24.68 60.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.077 -0.511 . . . . 63.21 111.84 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.8 mtt-85 -74.96 -24.07 58.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.244 0.618 . . . . 75.24 110.627 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.31 16.23 24.67 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.537 0.523 . . . . 74.11 112.421 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 t 52.38 28.89 6.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.224 2.21 . . . . 73.13 112.848 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -94.06 140.11 22.79 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.133 -1.062 . . . . 74.12 108.133 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 144.25 99.53 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.53 2.154 . . . . 73.2 111.07 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -54.79 132.62 46.45 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.724 0.64 . . . . 73.31 112.338 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.08 98.85 4.54 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.607 -1.627 . . . . 73.34 106.607 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' C' ' 15' ' ' ARG . 8.0 p30 -98.21 126.15 43.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.481 0.658 . . . . 63.41 109.927 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.91 141.47 55.02 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.598 -1.183 . . . . 73.04 111.382 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.18 142.54 84.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.402 0.681 . . . . 73.52 110.113 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.419 ' HB3' HH22 ' A' ' 111' ' ' ARG . 60.6 Cg_endo -74.57 136.68 21.7 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.408 2.072 . . . . 75.31 111.349 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.05 111.41 29.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.234 -1.395 . . . . 74.21 107.234 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -85.82 75.86 9.98 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.694 0.759 . . . . 75.23 110.621 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.16 -40.58 90.42 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.291 -1.322 . . . . 75.12 110.559 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.473 0.705 0 CA-C-N 115.258 -0.883 . . . . 75.0 111.67 175.672 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.9 ptm . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 114.243 1.201 . . . . 72.2 114.243 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.9 p -145.75 133.22 20.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.832 0.853 . . . . 72.41 108.805 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.446 ' HD1' HG22 ' B' ' 86' ' ' ILE . 91.4 t80 -129.71 139.17 51.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.648 0.779 . . . . 72.33 109.857 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -160.37 143.04 13.24 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.278 0.361 . . . . 71.54 111.494 173.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.609 HG21 HG13 ' B' ' 16' ' ' ILE . 3.7 mp -86.02 123.11 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.493 -0.928 . . . . 75.41 108.493 173.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -40.03 24.4 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.739 0.416 . . . . 74.35 110.395 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -161.36 136.62 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.274 -0.421 . . . . 75.54 110.43 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.609 HG13 HG21 ' B' ' 13' ' ' ILE . 67.0 mt -115.91 139.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 107.101 -1.444 . . . . 74.1 107.101 168.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.52 164.78 14.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.982 0.896 . . . . 74.33 112.461 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.5 m -96.87 125.61 41.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.066 -1.425 . . . . 74.44 108.821 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.42 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -97.64 -32.85 11.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.654 0.782 . . . . 74.12 110.372 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.18 138.58 18.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.966 -0.561 . . . . 73.2 110.641 -168.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.566 HD13 ' SG ' ' B' ' 113' ' ' CYS . 45.7 mm -141.01 142.17 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.381 1.473 . . . . 74.22 108.86 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 87.1 p -138.84 145.61 40.22 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.562 -0.903 . . . . 64.24 108.562 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.0 t80 -152.19 109.79 3.61 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.006 -1.479 . . . . 71.01 107.006 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -118.21 114.39 22.95 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.494 0.718 . . . . 72.22 109.213 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.568 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -109.54 87.27 5.13 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.904 0.882 . . . . 72.53 109.214 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.12 -24.98 16.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.781 2.321 . . . . 71.52 112.59 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.42 18.5 14.33 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.784 0.834 . . . . 74.13 110.447 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.568 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -47.37 -49.11 55.11 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 125.446 1.499 . . . . 50.41 114.249 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -65.49 -29.19 53.35 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.103 1.868 . . . . 72.22 112.118 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -99.55 -8.97 23.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.011 0.925 . . . . 71.41 112.836 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.55 -14.07 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.597 0.592 . . . . 74.3 112.597 -167.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.82 -21.69 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.955 0.502 . . . . 73.54 111.583 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -76.57 -13.41 60.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.948 0.899 . . . . 63.24 111.37 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.609 ' HB3' HD23 ' B' ' 68' ' ' LEU . 35.5 mmtp -102.43 101.7 11.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.703 0.801 . . . . 74.02 110.85 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -96.13 84.47 3.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.36 -0.978 . . . . 72.53 108.36 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -164.69 166.38 20.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.43 1.092 . . . . 71.13 108.207 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.46 127.36 55.08 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-O 119.203 -0.427 . . . . 73.44 110.127 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.74 133.57 25.93 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.015 1.81 . . . . 74.31 112.086 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.92 107.34 5.25 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 108.441 -0.948 . . . . 75.33 108.441 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.08 133.99 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.965 0.412 . . . . 73.44 109.962 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -114.78 104.06 11.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.625 -0.88 . . . . 75.12 108.625 166.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.92 141.52 28.55 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.876 -1.056 . . . . 72.42 108.823 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -162.9 147.16 11.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.913 -0.773 . . . . 71.14 108.913 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.96 152.5 24.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 74.11 109.933 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -141.33 150.47 42.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.047 1.339 . . . . 64.15 108.109 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -119.56 137.43 53.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 74.23 111.148 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -130.83 150.1 52.16 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.651 1.181 . . . . 65.34 108.133 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -142.67 162.21 36.06 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.689 0.395 . . . . 70.04 110.234 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -165.84 148.21 7.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.102 0.961 . . . . 70.51 109.206 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -119.29 125.33 48.83 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.075 -0.713 . . . . 62.31 109.075 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.428 HD13 HG22 ' B' ' 83' ' ' ILE . 40.5 mt -89.71 -46.65 8.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.528 0.731 . . . . 75.43 110.053 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.7 178.1 8.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.076 -0.966 . . . . 55.14 110.133 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.42 114.06 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.04 0.936 . . . . 75.41 110.201 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 69.98 3.16 4.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.685 1.194 . . . . 64.04 112.913 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.66 95.76 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.673 -1.232 . . . . 75.1 107.673 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -112.83 135.98 52.98 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.52 -0.919 . . . . 73.0 108.52 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.59 107.3 16.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.882 0.873 . . . . 74.3 108.686 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.54 133.68 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.498 0.719 . . . . 74.45 109.828 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 35.4 t -112.33 120.8 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 72.22 109.686 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.95 121.37 35.35 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.497 -1.297 . . . . 73.23 107.497 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -111.05 119.48 39.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.378 -0.601 . . . . 75.15 109.378 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.83 111.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.544 -0.91 . . . . 74.34 108.544 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 49.6 m -97.35 135.99 38.45 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.236 -0.653 . . . . 75.31 109.236 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.585 HG11 HD13 ' B' ' 126' ' ' LEU . 79.5 t -132.69 134.1 58.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 123.485 0.714 . . . . 74.31 109.247 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.8 m -124.71 148.24 48.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.368 1.067 . . . . 74.23 108.167 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 148.49 32.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 122.803 0.441 . . . . 70.2 109.967 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 m -138.23 124.01 19.9 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.837 0.711 . . . . 74.42 109.934 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.609 HD23 ' HB3' ' B' ' 34' ' ' LYS . 0.7 OUTLIER -104.45 119.36 38.79 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.127 -1.064 . . . . 73.44 108.127 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -112.08 3.41 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.024 -0.83 . . . . 72.02 111.024 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -119.64 13.8 12.54 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.875 0.87 . . . . 64.45 110.949 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.36 167.41 22.98 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.667 0.787 . . . . 71.44 110.271 -170.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -62.09 134.46 56.62 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.663 0.602 . . . . 74.13 110.846 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' B' ' 68' ' ' LEU . . . -90.18 -57.68 2.76 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.911 -1.144 . . . . 74.23 107.911 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.43 ' CE1' HD12 ' B' ' 126' ' ' LEU . 52.5 p90 -160.92 169.08 23.33 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 113.697 -1.592 . . . . 73.23 109.779 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.2 mt -135.32 140.95 45.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.616 -1.624 . . . . 75.23 106.616 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -155.19 142.53 19.5 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.545 -0.539 . . . . 62.32 109.545 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -158.81 133.24 7.95 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.158 -0.682 . . . . 75.22 109.158 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.489 HG21 HD12 ' B' ' 21' ' ' ILE . 93.2 t -124.41 148.1 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.674 0.79 . . . . 71.04 109.342 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -123.16 100.52 6.91 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.439 -0.949 . . . . 75.04 108.439 169.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.91 99.05 11.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.269 -1.011 . . . . 73.24 108.269 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.65 157.92 26.92 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.147 -0.781 . . . . 74.21 111.147 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.75 134.03 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.958 -0.457 . . . . 73.43 111.958 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.428 HG22 HD13 ' B' ' 51' ' ' LEU . 43.6 mt -89.9 121.22 39.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.739 -0.837 . . . . 72.42 108.739 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -123.82 136.45 54.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 74.3 110.091 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -99.26 108.37 20.91 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.606 1.162 . . . . 74.04 108.021 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.515 ' H ' HD12 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.7 137.94 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.847 0.859 . . . . 71.23 108.825 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 132.26 10.17 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.16 -1.052 . . . . 60.22 108.16 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.6 11.36 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.385 -0.675 . . . . 71.33 113.744 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 27.2 pt -50.16 146.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 123.779 0.832 . . . . 73.01 111.989 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.408 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 14.9 mm-40 -150.71 156.27 40.98 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.043 0.757 . . . . 74.31 113.043 -167.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.66 -126.28 41.55 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.763 -1.562 . . . . 53.13 113.481 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.43 -38.09 42.19 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.57 0.748 . . . . 73.02 109.981 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.41 -21.95 65.55 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.634 -1.166 . . . . 73.35 110.839 -171.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.612 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 49.3 ttm -54.37 -49.23 70.32 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.275 1.03 . . . . 72.23 110.762 169.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.39 69.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.445 -1.252 . . . . 74.33 111.761 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 69.2 m-70 -74.76 -18.85 60.42 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.522 0.329 . . . . 65.02 111.875 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.59 -56.15 8.1 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.404 0.621 . . . . 65.44 110.324 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.97 -22.34 25.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.215 -0.902 . . . . 74.45 112.026 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.74 -15.7 41.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 113.897 0.319 . . . . 61.45 113.897 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -129.51 -55.83 1.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 117.101 0.45 . . . . 72.33 111.955 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -70.22 -49.29 51.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.006 0.522 . . . . 75.35 111.547 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.469 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.18 -50.79 84.43 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.568 -0.729 . . . . 75.21 112.505 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 51.5 Cg_exo -58.53 -31.55 94.64 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.25 1.967 . . . . 72.12 113.577 173.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.43 -27.41 63.27 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.621 0.369 . . . . 75.31 111.231 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 97.5 mt -70.25 -43.36 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.591 0.756 . . . . 74.14 109.714 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.62 -17.71 61.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.047 -0.979 . . . . 71.44 111.529 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.35 -51.3 81.12 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.791 1.236 . . . . 71.05 113.886 -170.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.509 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 28.6 Cg_endo -60.29 -33.06 94.87 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.957 1.772 . . . . 75.45 113.047 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.13 -43.97 73.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.095 0.558 . . . . 75.22 111.038 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.69 98.38 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.268 0.627 . . . . 44.32 110.501 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.509 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 29.7 mtp-105 -54.21 -57.73 10.07 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.503 1.121 . . . . 74.23 111.427 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.59 -26.56 64.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.414 -0.812 . . . . 75.44 110.287 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.566 ' SG ' HD13 ' B' ' 21' ' ' ILE . 6.1 t -68.76 -46.32 69.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.446 0.299 . . . . 65.13 110.44 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' B' ' 126' ' ' LEU . 69.3 mt -60.97 -48.03 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.058 0.543 . . . . 73.41 109.585 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -55.15 -43.65 74.41 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.438 -1.256 . . . . 75.04 111.429 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -65.68 -45.02 84.45 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.648 -0.706 . . . . 61.5 110.838 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -71.91 -35.96 69.86 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.038 0.535 . . . . 74.42 111.392 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.579 HG21 ' HB2' ' B' ' 123' ' ' PHE . 9.1 p -75.35 -28.55 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.073 -0.512 . . . . 75.24 110.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.419 ' HA ' HE22 ' C' ' 125' ' ' GLN . 69.9 m -63.14 -35.64 80.95 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.437 0.695 . . . . 61.32 110.855 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.1 mtt-85 -69.57 -19.14 63.68 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 114.721 -1.127 . . . . 74.53 111.385 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 13.63 61.13 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.179 -0.789 . . . . 74.42 114.74 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.5 p 70.06 13.44 7.82 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.034 1.733 . . . . 72.05 113.038 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.579 ' HB2' HG21 ' B' ' 118' ' ' VAL . 73.2 m-85 -104.18 145.56 30.89 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 119.246 -0.407 . . . . 74.24 110.259 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.31 165.28 5.78 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.619 2.879 . . . . 53.12 113.825 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -61.06 155.66 19.8 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.297 -0.865 . . . . 74.32 111.915 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.585 HD13 HG11 ' B' ' 64' ' ' VAL . 87.6 mt -131.44 84.0 2.14 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.915 -0.772 . . . . 64.21 108.915 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.42 ' HB3' HH21 ' B' ' 111' ' ' ARG . 35.6 m-80 -106.65 100.36 9.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.788 -1.096 . . . . 74.11 108.376 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.58 133.88 53.21 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.169 -0.923 . . . . 65.34 109.312 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.54 150.13 94.19 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.074 0.55 . . . . 64.41 110.808 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.48 96.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.043 2.496 . . . . 73.0 112.565 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.43 117.56 33.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.567 -0.901 . . . . 75.24 108.567 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.15 97.63 5.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.024 -1.472 . . . . 73.12 107.024 170.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.483 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 19.2 m-85 -55.82 -30.2 61.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.135 0.974 . . . . 71.34 110.664 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.11 -36.45 81.79 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.614 -1.175 . . . . 74.12 111.076 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.14 -51.87 64.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.579 0.752 . . . . 71.44 111.127 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.484 1.264 0 O-C-N 123.731 0.644 . . . . 65.35 110.118 178.814 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.3 ttm . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.043 0.449 . . . . 74.24 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -85.56 87.34 7.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.146 -1.057 . . . . 75.52 108.146 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -105.58 136.41 45.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.874 -1.057 . . . . 72.53 109.19 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -152.92 132.83 13.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.246 0.618 . . . . 74.23 109.705 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.55 105.72 11.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.157 -1.053 . . . . 73.25 108.157 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.42 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.7 mm-40 -78.92 -41.58 29.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.893 -0.594 . . . . 74.31 110.11 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.401 ' HA ' HD22 ' A' ' 127' ' ' ASN . 23.2 ttt85 -170.79 157.17 5.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.668 0.605 . . . . 74.23 110.996 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.51 145.92 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 107.194 -1.41 . . . . 72.45 107.194 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -173.86 162.25 3.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.648 0.737 . . . . 73.14 109.866 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -80.14 111.76 16.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.868 -1.06 . . . . 70.34 108.249 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.86 -45.75 81.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.098 -1.075 . . . . 74.33 108.098 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.2 t70 -140.37 140.99 35.65 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 113.57 -1.65 . . . . 72.15 109.697 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.58 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.3 mt -131.46 145.58 34.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 106.907 -1.516 . . . . 72.54 106.907 170.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -153.82 146.63 24.34 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.338 0.59 . . . . 72.1 109.602 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -146.25 144.02 29.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.555 -1.276 . . . . 71.12 107.555 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -138.48 144.95 40.27 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.674 1.189 . . . . 73.23 107.835 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' C' ' 28' ' ' ALA . . . -150.6 80.04 7.02 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 106.683 -1.599 . . . . 63.34 106.683 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.73 -37.11 16.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.578 2.185 . . . . 63.11 111.349 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.524 ' ND2' ' HG3' ' C' ' 71' ' ' GLU . 1.7 m-20 -107.93 27.65 9.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.472 1.109 . . . . 73.44 109.439 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.477 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . . . -50.17 -51.88 58.7 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.888 1.275 . . . . 74.3 113.889 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 66.3 Cg_endo -86.57 -19.21 2.91 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 121.67 1.58 . . . . 70.34 113.321 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -68.18 -21.64 64.88 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.983 0.913 . . . . 74.34 112.553 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.61 -5.49 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 123.343 0.657 . . . . 74.25 112.506 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.563 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 19.8 m-85 -67.42 -27.7 67.28 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.349 0.66 . . . . 73.24 112.451 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 29.0 7.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.485 0.714 . . . . 72.13 109.368 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.8 155.33 41.25 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.299 0.64 . . . . 74.22 111.253 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.71 129.99 39.48 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.385 -1.279 . . . . 73.33 110.572 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -84.53 65.65 9.09 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 122.19 0.995 . . . . 74.22 111.933 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -151.54 60.42 3.75 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 115.564 -0.744 . . . . 73.44 110.673 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.38 153.92 75.43 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.21 1.94 . . . . 72.23 110.498 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.72 109.15 17.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.828 -1.545 . . . . 71.01 106.828 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.406 HG11 HD11 ' C' ' 126' ' ' LEU . 77.8 t -75.25 106.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.891 -1.05 . . . . 71.34 110.646 -174.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.733 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 6.4 mtpm? -103.35 143.88 32.09 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.272 1.029 . . . . 73.53 108.323 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -128.87 164.05 23.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.79 0.436 . . . . 74.32 110.896 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.0 t70 -154.29 125.91 7.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.428 -0.805 . . . . 72.15 108.991 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -115.4 112.07 21.77 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.646 -1.242 . . . . 75.33 107.646 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -126.68 119.98 28.33 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.609 -1.256 . . . . 72.31 107.609 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -118.42 150.42 39.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.389 -0.597 . . . . 71.11 109.389 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.09 171.96 13.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 73.4 109.13 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -146.83 143.39 28.56 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.843 -0.799 . . . . 74.33 108.843 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.7 t -145.0 126.39 14.9 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.307 -0.997 . . . . 70.02 108.307 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -80.1 117.33 20.81 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.525 -0.546 . . . . 73.52 109.525 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.671 HD12 ' HB2' ' C' ' 57' ' ' GLU . 69.9 mt -86.73 -45.5 10.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.684 0.793 . . . . 74.54 110.087 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.79 -165.15 2.19 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.66 -0.7 . . . . 72.2 111.132 -173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.13 102.03 0.19 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.1 0.875 . . . . 62.25 110.966 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 63.72 18.5 11.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.154 0.982 . . . . 73.54 111.884 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -106.96 114.22 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.27 -1.011 . . . . 73.24 108.27 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -122.0 124.82 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.151 0.98 . . . . 74.01 108.891 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.671 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.8 tt0 -89.59 114.99 26.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.177 0.991 . . . . 75.32 109.245 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -95.86 129.47 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.089 -1.078 . . . . 73.52 108.089 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 t -120.64 106.53 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.667 -0.864 . . . . 71.35 108.667 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.9 102.41 14.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.473 -0.936 . . . . 74.33 108.473 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 33.3 ttm105 -79.51 107.3 12.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.587 -0.894 . . . . 75.34 108.587 168.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -99.96 124.28 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.137 -1.431 . . . . 74.52 107.137 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.9 m -123.74 119.59 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.785 -0.821 . . . . 73.33 108.785 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 77.7 t -111.01 129.41 66.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.739 -1.119 . . . . 65.14 108.626 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.733 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.5 m -122.69 138.17 54.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.722 0.809 . . . . 74.14 109.164 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.62 100.88 6.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.281 -1.377 . . . . 74.11 107.281 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -140.63 118.21 11.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.827 -0.805 . . . . 75.24 108.827 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.26 -40.18 85.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 75.44 110.238 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.12 -79.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.482 -1.047 . . . . 75.52 110.482 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.0 -32.01 16.95 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.727 0.811 . . . . 61.32 109.434 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.524 ' HG3' ' ND2' ' C' ' 27' ' ' ASN . 40.8 tt0 -88.69 121.32 30.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.194 0.997 . . . . 73.1 111.096 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.6 m -84.23 126.71 33.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.999 0.52 . . . . 72.15 110.107 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.93 -55.21 5.83 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.817 0.847 . . . . 74.23 109.105 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.57 165.44 34.49 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.581 -1.19 . . . . 74.13 110.84 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.466 HD23 HG21 ' C' ' 65' ' ' THR . 3.0 tm? -135.05 144.92 47.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.271 -1.381 . . . . 73.44 107.271 174.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 43.6 t -144.8 143.96 30.91 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.158 -0.682 . . . . 72.1 109.158 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -153.17 134.18 14.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.143 0.577 . . . . 73.24 109.507 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' C' ' 110' ' ' ALA . 39.8 t -133.09 113.55 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.236 1.014 . . . . 73.12 108.444 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -92.73 90.6 7.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.914 0.885 . . . . 74.05 108.73 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.421 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.3 tp-100 -82.97 105.97 14.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.081 -0.963 . . . . 72.52 109.897 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.11 147.54 18.63 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.79 -0.524 . . . . 73.01 111.79 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.49 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.63 123.46 2.16 Favored Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.759 -0.937 . . . . 70.42 110.759 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.2 mm -80.65 118.51 28.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.931 -1.137 . . . . 72.24 107.931 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -132.75 130.8 40.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.468 0.707 . . . . 73.4 109.534 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 m -81.49 115.55 20.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.053 -0.721 . . . . 61.42 109.053 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.635 HG13 HD22 ' C' ' 98' ' ' LEU . 27.3 mm -116.73 100.89 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.404 -0.961 . . . . 71.25 108.404 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.92 168.45 19.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.323 0.649 . . . . 60.23 110.179 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.29 -56.27 4.25 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.028 -0.533 . . . . 70.43 112.354 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -104.01 163.08 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.826 0.85 . . . . 62.41 109.472 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.8 -177.12 5.55 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.729 0.412 . . . . 71.01 111.543 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.42 -144.76 48.9 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.485 -0.78 . . . . 55.42 114.818 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' C' ' 95' ' ' ALA . 43.7 p -68.67 -19.89 64.42 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.65 0.78 . . . . 73.31 111.863 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -67.02 -41.66 86.25 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.231 1.012 . . . . 74.3 110.305 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -83.14 -23.21 33.08 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.366 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' C' ' 92' ' ' THR . . . -71.45 -25.8 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.096 0.559 . . . . 63.54 111.256 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -63.58 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.796 0.438 . . . . 74.1 110.221 170.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 17.6 t -76.61 -60.36 2.38 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.202 -0.666 . . . . 72.32 109.202 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.635 HD22 HG13 ' C' ' 86' ' ' ILE . 98.6 mt -60.72 -26.83 67.45 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.062 0.945 . . . . 73.2 113.065 -174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.19 10.86 33.85 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.545 -0.586 . . . . 70.43 113.902 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.05 -60.64 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.584 0.692 . . . . 73.44 111.698 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' C' ' 104' ' ' ASN . 65.1 t80 -75.13 -42.47 56.21 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.877 0.695 . . . . 74.33 112.877 -170.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 63.3 m -66.44 -49.39 52.83 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.207 0.603 . . . . 61.02 111.708 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.46 -18.25 43.68 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 121.594 1.529 . . . . 73.24 113.265 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 27.1 t-20 -57.13 -41.75 79.65 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.549 0.69 . . . . 73.4 109.92 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.45 -38.58 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.141 -1.391 . . . . 64.14 110.875 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.49 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.5 mt -81.29 -34.25 32.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.193 -0.912 . . . . 73.32 112.369 -170.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -54.66 -45.73 99.48 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 124.299 1.04 . . . . 74.0 113.527 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.71 -52.03 7.4 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.795 2.33 . . . . 72.24 113.686 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -63.91 -48.71 75.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.357 -0.838 . . . . 75.11 111.732 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -64.52 -41.23 96.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.085 0.554 . . . . 72.51 111.735 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -64.16 -44.53 91.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.2 0.937 . . . . 73.45 110.592 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -70.65 -31.87 68.95 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.522 -0.763 . . . . 65.01 110.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.8 -34.2 77.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.093 0.557 . . . . 65.3 110.436 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.09 -42.21 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.369 0.668 . . . . 73.52 110.379 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 81.6 m -62.2 -30.93 71.42 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.004 0.522 . . . . 64.03 110.284 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -70.86 -54.18 12.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.634 0.773 . . . . 73.22 109.912 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.619 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.48 -45.93 66.35 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.482 1.113 . . . . 73.02 112.385 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.01 -42.33 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.907 0.883 . . . . 73.43 110.834 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -64.21 -32.53 74.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.933 -0.576 . . . . 74.2 111.02 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.512 ' HD2' ' HE3' ' C' ' 117' ' ' MET . 79.3 mtt-85 -70.49 -35.46 73.25 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.387 -0.824 . . . . 63.52 109.696 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.98 2.76 67.83 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.683 0.614 . . . . 72.53 113.188 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 54.38 48.12 21.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.088 1.755 . . . . 75.44 112.184 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.418 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 90.9 m-85 -115.02 149.29 42.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 114.083 -1.417 . . . . 72.24 108.091 169.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.5 154.98 22.52 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.654 2.902 . . . . 60.51 113.844 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.419 HE22 ' HA ' ' B' ' 119' ' ' SER . 87.8 mt-30 -58.11 150.44 21.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.893 0.877 . . . . 74.11 112.753 -173.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.406 HD11 HG11 ' C' ' 40' ' ' VAL . 1.9 tt -145.47 85.97 1.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.298 -1.371 . . . . 65.12 107.298 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.05 108.29 19.77 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.834 -1.076 . . . . 62.05 108.349 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 130.41 46.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.294 1.038 . . . . 74.22 109.964 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.32 137.17 97.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.677 0.791 . . . . 72.52 111.685 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.68 122.64 10.32 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.747 2.298 . . . . 75.53 112.04 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 109.86 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.137 -1.06 . . . . 72.24 108.137 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -87.2 63.62 7.92 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.978 0.911 . . . . 75.25 109.579 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -77.13 -43.95 32.21 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.021 -0.536 . . . . 72.23 110.582 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.829 0.851 . . . . 75.04 110.457 174.222 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.54 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 113.33 0.863 . . . . 75.11 113.33 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.451 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 27.4 m -132.88 139.56 47.47 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.152 -1.055 . . . . 75.43 108.152 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' D' ' 85' ' ' SER . 45.3 t80 -159.07 98.06 1.43 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.01 0.819 . . . . 72.31 108.792 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.21 115.39 24.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.61 0.764 . . . . 73.41 109.618 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' D' ' 84' ' ' PHE . 3.9 tp -77.61 104.38 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 108.408 -0.96 . . . . 75.32 108.408 171.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -84.62 -39.13 19.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.11 -0.95 . . . . 74.53 111.833 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.563 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 65.2 ttt180 -165.41 127.5 2.07 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.587 -0.279 . . . . 74.51 110.354 -166.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.441 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.4 mp -112.65 129.1 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.323 -1.362 . . . . 73.32 107.323 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -165.49 176.91 7.81 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 122.176 0.989 . . . . 74.14 113.117 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -108.32 119.36 39.26 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.02 -1.446 . . . . 65.13 108.36 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -86.94 -17.94 31.94 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.32 -0.622 . . . . 74.14 109.32 173.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.757 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.5 t70 -155.7 140.24 16.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.924 . . . . 75.24 109.817 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.619 HG23 ' HE1' ' C' ' 117' ' ' MET . 58.5 mt -139.92 140.02 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.548 1.539 . . . . 75.33 107.786 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -143.84 136.84 27.49 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.457 0.703 . . . . 72.1 109.473 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.58 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.8 t80 -142.8 116.9 9.46 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.98 -1.859 . . . . 72.34 105.98 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.43 ' O ' ' HD3' ' D' ' 26' ' ' PRO . 44.7 mt-10 -127.32 116.27 20.27 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.108 -0.701 . . . . 72.23 109.108 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.52 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -107.47 88.79 4.37 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 123.313 0.645 . . . . 75.34 109.559 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' D' ' 24' ' ' GLU . 16.6 Cg_exo -71.01 -38.7 4.78 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.222 2.615 . . . . 74.51 112.49 -173.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 85.3 m-20 -118.24 40.86 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.221 1.008 . . . . 75.13 110.035 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -54.84 -57.8 17.56 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 114.976 1.473 . . . . 73.4 114.976 -169.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.53 -3.83 10.76 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 121.619 1.614 . . . . 65.44 112.266 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.98 -45.03 13.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.06 1.344 . . . . 74.31 109.804 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.97 -19.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.734 0.814 . . . . 74.42 110.312 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.5 -23.86 64.85 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.309 1.043 . . . . 75.34 111.791 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -79.61 -3.24 46.2 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.503 0.721 . . . . 74.35 111.769 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -121.59 110.02 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.635 0.774 . . . . 75.04 110.082 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.61 93.52 4.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.851 0.861 . . . . 74.44 109.744 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -169.05 158.37 8.48 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.45 1.1 . . . . 75.23 108.49 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -76.49 111.93 18.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.825 0.85 . . . . 73.44 110.033 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.64 128.1 26.93 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.048 2.498 . . . . 73.22 112.599 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -67.43 118.74 11.17 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.165 -0.679 . . . . 75.14 109.165 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.491 HG11 HD11 ' D' ' 126' ' ' LEU . 98.8 t -99.36 133.46 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.223 -0.899 . . . . 72.53 110.819 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -101.8 142.79 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 166.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.31 126.03 54.55 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.721 -0.844 . . . . 75.43 108.721 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 22.7 t70 -121.94 149.22 43.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.1 . . . . 74.14 108.142 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.16 151.39 49.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.863 0.465 . . . . 64.52 110.855 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.1 t70 -155.83 155.6 33.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.178 0.991 . . . . 73.3 108.82 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -133.45 160.03 38.62 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.278 0.631 . . . . 72.23 109.67 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 164.51 37.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.682 -0.858 . . . . 62.32 108.682 174.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -148.36 159.84 43.61 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.964 0.411 . . . . 71.3 111.136 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -160.86 126.71 3.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.33 1.052 . . . . 74.21 109.785 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.51 120.34 28.71 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.859 -0.793 . . . . 73.2 108.859 171.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -91.95 -40.96 10.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.766 -0.652 . . . . 72.54 110.182 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.59 -168.74 1.9 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.508 -0.769 . . . . 73.4 110.433 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.44 115.81 3.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.97 -1.013 . . . . 72.13 110.275 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.74 5.24 3.25 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.622 1.169 . . . . 74.34 112.318 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.93 120.23 59.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 107.531 -1.285 . . . . 74.02 107.531 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -131.47 161.79 31.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 73.42 108.96 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' D' ' 51' ' ' LEU . 6.6 tm-20 -132.43 136.92 47.08 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.085 -1.45 . . . . 63.54 107.085 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 134.8 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.748 -0.834 . . . . 73.52 108.748 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.5 t -107.48 128.18 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.752 0.821 . . . . 73.15 109.575 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -102.08 121.99 43.25 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.394 -1.336 . . . . 75.42 107.394 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.9 ttm180 -104.36 108.42 19.82 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.33 -0.989 . . . . 74.42 108.33 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.9 t -95.2 127.73 46.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 107.715 -1.217 . . . . 70.12 107.715 166.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.5 m -118.27 127.13 53.43 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.773 0.797 . . . . 54.32 109.846 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 53.7 t -115.01 114.29 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 125.879 1.671 . . . . 63.11 108.245 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -112.19 97.8 6.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.525 -0.917 . . . . 61.15 108.525 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.19 129.91 43.38 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.046 -0.724 . . . . 70.01 109.046 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 34.9 p -145.49 128.79 16.8 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.125 -0.695 . . . . 72.33 109.125 -175.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -123.23 123.91 41.83 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.476 -0.935 . . . . 72.24 108.476 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -116.0 4.57 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.516 0.51 . . . . 72.13 112.494 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -123.44 26.5 7.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.023 0.529 . . . . 64.33 110.464 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.0 pt-20 -137.69 155.19 49.39 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 123.64 0.776 . . . . 74.25 110.053 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -78.7 117.12 19.54 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 109.696 -0.483 . . . . 72.55 109.696 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.431 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.39 -61.55 1.79 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.589 0.755 . . . . 61.42 110.025 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.1 170.01 19.93 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.658 -1.156 . . . . 72.44 109.819 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 80.0 mt -126.74 145.54 50.56 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.385 1.074 . . . . 74.4 108.721 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.8 m -143.07 136.06 27.95 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.689 -1.226 . . . . 70.03 107.689 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -156.74 121.01 4.4 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.531 -0.914 . . . . 75.22 108.531 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -130.76 117.82 39.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 122.988 0.515 . . . . 75.45 109.635 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.757 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -89.74 87.46 7.0 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.057 0.848 . . . . 73.13 109.079 170.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.5 98.57 6.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.393 -1.276 . . . . 70.43 109.171 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.25 144.3 17.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 116.437 -0.347 . . . . 65.11 112.292 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.489 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -146.91 135.76 5.86 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.999 -0.441 . . . . 64.42 111.999 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.18 128.48 43.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 123.717 0.807 . . . . 73.44 109.877 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.469 ' CE2' HD11 ' D' ' 13' ' ' ILE . 63.4 m-85 -130.23 137.05 49.84 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 74.0 109.811 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 18.6 m -77.73 103.68 7.81 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.144 -1.058 . . . . 72.23 108.144 168.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.43 106.65 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.72 -0.844 . . . . 74.04 108.72 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.451 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -148.65 167.83 24.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.289 1.036 . . . . 72.5 109.628 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.14 6.08 67.72 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.49 -0.323 . . . . 71.32 113.799 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 tp -141.08 143.73 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 73.35 109.444 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 -172.05 4.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.107 0.563 . . . . 73.23 110.818 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.67 -138.82 22.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.52 0.513 . . . . 64.21 113.382 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -83.86 -24.2 30.99 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.509 0.724 . . . . 70.41 111.001 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -70.69 -32.97 70.39 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.11 0.564 . . . . 75.25 111.846 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -30.35 67.31 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 110.161 -0.311 . . . . 75.14 110.161 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.88 68.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.535 0.734 . . . . 74.34 110.405 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -65.2 -36.74 85.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.353 -0.84 . . . . 72.53 110.613 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.1 -47.29 65.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.995 -0.548 . . . . 63.34 110.022 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -73.15 -27.48 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.621 0.768 . . . . 74.45 111.452 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.34 5.06 33.38 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.361 -0.688 . . . . 73.21 114.526 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.46 -58.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 117.88 0.84 . . . . 62.15 111.534 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -70.92 -54.41 11.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.141 0.576 . . . . 71.33 112.17 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.416 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 66.2 m -62.11 -46.13 91.26 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 123.852 0.861 . . . . 73.14 112.072 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.506 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.6 Cg_exo -57.24 -36.05 98.97 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.409 2.073 . . . . 64.34 113.436 169.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -62.66 -34.74 77.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.95 0.5 . . . . 75.41 111.187 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -66.75 -40.22 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.007 0.923 . . . . 75.22 110.616 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.489 HD22 ' HA3' ' D' ' 82' ' ' GLY . 87.3 mt -74.51 -21.49 59.52 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.702 -0.681 . . . . 73.55 111.548 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -62.68 -46.0 88.5 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 114.143 1.164 . . . . 73.21 114.143 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -51.95 -38.22 68.61 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.056 1.837 . . . . 70.24 113.227 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -79.31 -34.71 42.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.099 0.96 . . . . 74.04 111.618 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -48.63 73.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.359 0.664 . . . . 71.11 109.862 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -57.54 -45.44 85.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.365 -1.289 . . . . 74.23 110.749 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.45 -46.5 89.8 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.097 0.873 . . . . 72.42 111.109 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.33 -41.7 85.19 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.719 0.637 . . . . 75.1 111.353 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.42 HG22 HG23 ' D' ' 64' ' ' VAL . 90.4 mt -63.14 -56.12 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.214 -0.903 . . . . 74.23 110.372 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.4 m -53.43 -39.03 64.06 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.582 1.153 . . . . 74.45 112.046 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -71.78 -41.05 68.81 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.422 -0.808 . . . . 73.23 110.813 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.461 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 74.5 mtm -65.29 -31.59 72.8 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.71 0.404 . . . . 74.33 111.408 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.23 -42.35 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 72.52 110.252 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 72.8 p -74.18 -26.4 60.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.36 0.264 . . . . 71.42 111.25 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.63 -29.69 59.25 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.548 0.739 . . . . 74.52 110.049 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 2.96 87.5 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.645 -0.707 . . . . 74.53 112.051 171.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 14.7 p 63.84 18.01 10.89 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.094 2.158 . . . . 63.11 114.267 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 59.6 m-85 -87.65 166.2 26.21 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.847 1.259 . . . . 73.13 109.948 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 56.5 Cg_endo -68.13 134.17 30.88 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.142 1.895 . . . . 75.24 111.143 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.37 143.47 34.31 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.201 0.6 . . . . 72.32 110.534 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.491 HD11 HG11 ' D' ' 40' ' ' VAL . 4.4 tt -110.5 111.62 22.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.282 -1.007 . . . . 74.31 108.282 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -98.96 87.11 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.16 117.1 7.98 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.109 -0.95 . . . . 75.44 108.647 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.84 136.57 55.62 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.89 0.876 . . . . 61.43 111.568 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.91 122.59 9.5 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.222 1.948 . . . . 75.41 110.446 176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.82 144.82 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.171 0.588 . . . . 73.3 109.415 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -74.3 94.68 2.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.467 -0.938 . . . . 62.44 108.467 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.481 1.08 0 CA-C-N 115.343 -0.844 . . . . 73.34 111.649 179.084 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 108.694 -0.854 . . . . 73.33 108.694 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -137.9 113.51 9.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.709 -0.848 . . . . 73.52 108.709 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -142.0 137.88 31.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 75.5 109.769 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.37 133.44 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 71.42 109.929 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.92 -42.31 11.28 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.65 -0.5 . . . . 73.14 109.65 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.518 ' HD2' HD13 ' A' ' 83' ' ' ILE . 11.9 ptp180 -175.56 146.07 0.76 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.067 -0.969 . . . . 75.02 109.39 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.499 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 77.2 mt -137.03 125.98 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.123 -1.065 . . . . 72.4 108.123 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' HE2' ' HB2' ' B' ' 28' ' ' ALA . 22.2 p90 -164.75 161.65 20.69 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.805 0.842 . . . . 75.35 110.635 -170.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -75.83 123.25 25.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.092 -0.504 . . . . 74.54 109.825 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.1 mtpt -86.99 -32.05 20.27 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.695 0.398 . . . . 71.21 109.999 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -147.28 144.94 29.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.524 -0.762 . . . . 75.33 109.907 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.2 mt -134.99 146.4 30.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 125.451 1.5 . . . . 63.32 107.674 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 t -149.33 138.78 21.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.306 0.642 . . . . 72.41 109.812 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -147.19 126.95 13.43 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.12 -1.437 . . . . 74.55 107.12 175.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.86 127.54 29.03 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.564 -0.902 . . . . 64.4 108.564 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.18 86.61 32.91 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 109.007 -0.738 . . . . 63.31 109.007 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -34.47 27.03 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.165 2.577 . . . . 73.11 113.081 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.63 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 2.4 m-80 -109.84 33.94 4.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.549 0.74 . . . . 70.3 109.926 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -52.88 -48.51 91.17 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 113.727 1.01 . . . . 73.21 113.727 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 16.5 Cg_exo -68.62 -30.94 27.53 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 121.674 1.582 . . . . 74.4 112.214 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -75.8 -21.89 56.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.697 0.799 . . . . 74.14 111.825 -170.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 27' ' ' ASN . 57.9 t -53.61 -27.24 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 123.773 0.829 . . . . 75.5 111.848 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -78.82 -39.03 36.67 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.746 0.818 . . . . 74.51 111.047 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -88.29 -26.64 22.17 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.302 0.641 . . . . 70.45 112.383 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' HD12 ' A' ' 68' ' ' LEU . 55.8 mtpt -80.5 163.49 23.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.15 0.58 . . . . 75.31 111.234 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.06 115.84 15.13 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.457 0.703 . . . . 71.05 109.331 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -73.24 86.01 1.42 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.987 0.915 . . . . 75.4 111.445 -172.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.53 80.63 65.69 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 124.031 0.932 . . . . 74.55 108.899 171.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.45 121.71 8.47 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.876 2.384 . . . . 74.45 111.872 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.86 105.96 18.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.378 -0.971 . . . . 75.13 108.378 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.09 92.47 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.705 -0.85 . . . . 74.43 108.705 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.2 tttm -100.33 115.29 29.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.92 0.888 . . . . 74.43 109.139 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -100.84 141.91 33.05 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.028 0.531 . . . . 74.13 109.808 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.5 m-20 -128.19 111.68 13.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.265 -1.383 . . . . 74.52 107.265 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.414 HD11 HG23 ' A' ' 131' ' ' VAL . 75.2 mt -109.74 119.89 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.753 -0.462 . . . . 72.51 109.753 -174.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -130.31 137.46 49.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.051 0.94 . . . . 74.11 109.463 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.6 m -117.07 132.97 56.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.572 0.749 . . . . 75.33 109.902 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.03 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.641 1.176 . . . . 74.4 109.036 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -132.54 158.94 40.86 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.594 0.758 . . . . 75.41 110.43 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -157.17 157.34 34.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.458 1.103 . . . . 75.05 110.009 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -113.95 136.97 52.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.776 0.83 . . . . 55.12 109.572 174.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.03 -33.91 3.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.134 0.573 . . . . 73.55 111.209 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.46 -174.04 4.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.232 0.613 . . . . 63.03 110.199 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.1 117.01 9.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.457 0.703 . . . . 72.42 109.487 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 67.62 14.65 9.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.481 1.112 . . . . 72.14 111.816 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -118.93 104.93 16.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.478 -0.934 . . . . 75.31 108.478 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -125.53 126.65 45.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.67 0.788 . . . . 75.24 109.116 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -92.48 130.04 38.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.747 1.219 . . . . 74.4 109.432 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.405 HG11 ' HD3' ' A' ' 103' ' ' PRO . 65.4 t -114.28 123.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.956 -1.127 . . . . 73.1 107.956 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.5 t -106.52 134.96 46.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.617 0.767 . . . . 62.05 109.277 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.9 113.93 27.83 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.296 -1.372 . . . . 72.51 107.296 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -96.6 100.72 12.27 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.988 -1.115 . . . . 75.35 107.988 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.84 131.61 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.525 -0.917 . . . . 73.43 108.525 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.1 m -116.6 137.15 52.4 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.784 -1.191 . . . . 63.32 107.784 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.418 HG22 HG21 ' A' ' 114' ' ' ILE . 86.3 t -128.72 128.05 67.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.567 -2.012 . . . . 74.34 105.567 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 27.6 m -124.67 139.24 54.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.934 -1.506 . . . . 72.12 106.934 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.95 119.75 20.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.403 -0.962 . . . . 62.44 108.403 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 68.5 m -107.07 131.37 54.17 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.369 -0.604 . . . . 74.22 109.369 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -88.94 76.22 7.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.559 -1.275 . . . . 73.42 107.559 -175.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.36 -102.2 2.26 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.324 -1.51 . . . . 71.41 109.324 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.56 -27.82 4.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.373 0.669 . . . . 75.23 110.096 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.44 131.44 34.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.936 0.894 . . . . 74.01 108.59 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 24.5 m -62.01 130.17 44.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.052 . . . . 64.32 113.205 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -76.89 -59.3 2.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.433 1.093 . . . . 72.34 109.307 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -161.83 174.48 13.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.631 -1.168 . . . . 72.21 111.112 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.0 tp -137.69 145.26 42.38 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 75.1 108.329 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HB3' HG22 ' A' ' 114' ' ' ILE . 70.2 m -146.99 104.44 3.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.914 0.885 . . . . 71.4 110.165 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.21 126.35 38.95 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.895 0.478 . . . . 72.11 109.774 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 113' ' ' CYS . 42.1 t -134.89 112.49 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.871 0.868 . . . . 74.31 109.663 -174.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -85.09 83.39 8.05 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.402 -0.962 . . . . 63.03 108.402 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.14 98.53 5.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.222 -0.899 . . . . 64.21 109.448 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.01 144.49 19.41 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.83 -0.508 . . . . 64.34 111.83 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.21 122.46 2.43 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.114 -1.194 . . . . 72.02 110.114 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.518 HD13 ' HD2' ' A' ' 15' ' ' ARG . 49.5 mt -88.5 129.13 40.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.275 -1.009 . . . . 73.24 108.275 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -129.1 126.02 38.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.652 0.381 . . . . 74.54 110.313 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 p -83.24 100.13 10.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.887 -0.782 . . . . 73.22 108.887 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.5 pt -112.8 137.1 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.798 0.839 . . . . 75.51 111.437 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.18 155.77 11.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.882 1.273 . . . . 60.03 108.964 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.89 86.54 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 120.154 -0.248 . . . . 70.01 113.63 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.47 140.9 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.994 0.918 . . . . 75.4 109.259 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 22.5 tt0 -155.47 177.74 11.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.864 0.466 . . . . 70.44 110.292 -174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.486 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.1 -157.18 43.57 Favored Glycine 0 C--N 1.345 1.07 0 C-N-CA 123.936 0.779 . . . . 72.51 114.127 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 p -71.83 -13.84 61.79 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.797 0.839 . . . . 71.03 111.026 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.12 -46.66 88.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.317 1.047 . . . . 61.35 111.022 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.4 61.96 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.094 -0.335 . . . . 75.23 110.094 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.29 75.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.338 0.655 . . . . 63.42 110.704 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -65.04 -48.12 74.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.764 1.226 . . . . 73.25 110.07 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.64 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 13.4 m -73.84 -26.02 60.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.955 1.094 . . . . 65.02 113.955 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.2 mt -97.31 -30.61 12.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.854 0.462 . . . . 74.52 111.332 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -20.34 49.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.098 -0.501 . . . . 73.14 113.217 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -132.77 -70.7 0.54 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.23 0.455 . . . . 71.3 112.23 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.64 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.1 t80 -45.0 -58.6 3.07 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 124.899 1.279 . . . . 73.01 113.9 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.5 m -72.08 -41.61 8.8 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.323 -0.846 . . . . 74.12 113.166 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.405 ' HD3' HG11 ' A' ' 58' ' ' VAL . 9.3 Cg_endo -60.72 -23.91 77.44 Favored 'Trans proline' 0 C--N 1.388 2.63 0 CA-C-N 121.281 1.493 . . . . 72.22 113.851 165.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.56 HD22 ' HB2' ' A' ' 133' ' ' PHE . 32.9 m-80 -73.19 -35.52 66.4 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 118.71 0.686 . . . . 73.14 110.484 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.29 -41.87 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.236 0.615 . . . . 73.32 109.576 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.528 HD22 ' HA3' ' A' ' 82' ' ' GLY . 96.2 mt -71.47 -24.89 62.08 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.219 -0.901 . . . . 73.13 112.354 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.97 -44.05 70.23 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.825 -1.084 . . . . 74.51 113.859 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.89 -32.64 92.82 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.247 1.965 . . . . 71.4 113.577 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -75.94 -38.58 57.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.247 0.619 . . . . 74.22 110.959 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.53 -46.24 76.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.106 0.562 . . . . 71.21 109.629 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -50.67 -54.28 24.34 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.865 1.353 . . . . 75.52 110.478 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -58.1 -49.47 76.85 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.437 1.085 . . . . 74.15 111.748 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.445 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.1 t -58.99 -43.57 91.47 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.062 0.851 . . . . 64.42 110.934 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 76' ' ' CYS . 84.7 mt -60.55 -55.1 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 123.997 0.811 . . . . 71.22 110.265 174.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -59.71 -34.57 73.08 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.768 1.227 . . . . 73.12 111.837 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.1 t -73.46 -42.13 62.33 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.648 -0.705 . . . . 74.32 110.137 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.437 ' SD ' HG22 ' A' ' 21' ' ' ILE . 7.5 mtp -57.47 -42.2 82.14 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.552 0.741 . . . . 75.0 111.128 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 114' ' ' ILE . 81.0 t -61.14 -46.76 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.619 1.167 . . . . 72.54 111.016 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.2 p -75.76 -26.54 57.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.864 0.466 . . . . 74.43 111.506 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.96 -29.22 64.04 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.566 0.747 . . . . 75.43 109.762 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 1.51 79.52 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.652 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.3 m 68.59 11.69 8.43 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.865 1.266 . . . . 71.12 111.558 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -87.09 150.25 49.32 Favored Pre-proline 0 C--O 1.243 0.75 0 CA-C-N 115.608 -0.724 . . . . 74.32 109.093 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -45.84 112.63 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.144 2.563 . . . . 75.13 112.698 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.05 122.8 10.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.854 1.262 . . . . 64.43 111.656 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.28 96.08 6.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.186 -1.042 . . . . 64.44 108.186 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -99.83 83.57 2.76 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.379 -0.971 . . . . 72.33 108.379 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.589 HD21 ' H ' ' A' ' 128' ' ' LEU . 1.2 pt? -59.63 136.88 58.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.003 -0.998 . . . . 74.52 111.941 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.91 148.82 82.74 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.413 1.085 . . . . 72.2 112.018 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 129.74 36.21 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.477 . . . . 75.43 113.72 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.414 HG23 HD11 ' A' ' 44' ' ' LEU . 87.9 t -103.08 122.03 55.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.632 -0.877 . . . . 70.43 108.632 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -88.57 71.25 8.89 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.919 0.888 . . . . 54.41 111.006 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.56 ' HB2' HD22 ' A' ' 104' ' ' ASN . 39.6 m-85 -61.43 -38.76 88.32 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.726 0.774 . . . . 64.22 109.263 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.649 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 10.9 t70 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.427 -1.26 . . . . 74.11 111.318 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.707 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.8 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 115.279 1.585 . . . . 74.42 115.279 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -137.05 136.92 38.82 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.335 -1.302 . . . . 72.1 107.785 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.04 124.46 40.71 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.32 -0.993 . . . . 74.24 108.32 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.43 110.34 7.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.151 0.58 . . . . 73.04 109.596 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.418 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -70.19 115.86 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 109.313 -0.625 . . . . 74.34 109.313 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.84 -51.62 6.28 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.263 0.554 . . . . 75.33 109.653 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -169.71 133.89 1.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.098 -0.956 . . . . 73.24 108.535 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.549 HG21 ' CD1' ' B' ' 109' ' ' TYR . 73.3 mt -114.75 146.13 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.539 -1.282 . . . . 73.03 107.539 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -168.02 149.67 5.32 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.598 0.592 . . . . 73.25 112.598 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -73.59 124.92 26.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.199 -0.91 . . . . 74.32 108.7 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 38.9 mtpt -98.31 -37.37 9.67 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.347 0.659 . . . . 73.13 110.858 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 26.8 m-20 -148.09 133.51 18.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.064 -0.517 . . . . 60.44 109.91 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.439 HG22 ' HE1' ' B' ' 117' ' ' MET . 46.1 mm -130.01 142.58 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 74.13 109.74 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -133.68 135.34 44.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.311 1.444 . . . . 75.12 108.867 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.5 t80 -149.63 127.0 11.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.808 -1.182 . . . . 74.23 107.808 166.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.16 126.68 25.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.72 0.808 . . . . 74.55 109.297 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -124.19 88.0 53.15 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.136 -0.69 . . . . 72.42 109.136 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.37 -27.47 28.31 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.028 2.485 . . . . 54.33 112.034 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -117.61 28.98 8.11 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.146 0.979 . . . . 74.44 109.019 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -44.49 -54.19 12.91 Favored Pre-proline 0 C--N 1.366 1.312 0 C-N-CA 124.684 1.194 . . . . 74.44 112.331 167.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.0 Cg_exo -69.32 -19.79 37.77 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.339 2.026 . . . . 72.42 112.498 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 11.5 m-70 -96.67 2.98 52.69 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.238 1.015 . . . . 75.12 111.936 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.47 -32.69 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 112.861 0.689 . . . . 72.12 112.861 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -74.21 -26.69 60.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.17 0.509 . . . . 74.44 110.563 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.87 -16.66 61.12 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.807 1.243 . . . . 73.53 110.523 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 mmmt -101.91 95.46 6.39 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.979 0.912 . . . . 70.21 111.707 -170.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.75 87.14 3.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 75.33 111.062 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -176.96 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.698 1.599 . . . . 75.41 108.136 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -87.98 133.83 36.49 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.254 0.622 . . . . 74.34 109.727 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 13.8 Cg_exo -65.5 134.78 39.75 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.005 1.803 . . . . 73.14 111.874 170.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.455 ' HG3' ' HE2' ' B' ' 41' ' ' LYS . 16.0 tp10 -63.95 103.93 0.65 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.253 0.621 . . . . 70.13 109.39 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.27 147.94 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 72.05 111.42 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.455 ' HE2' ' HG3' ' B' ' 39' ' ' GLU . 73.4 mmtt -136.48 143.92 44.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.74 1.216 . . . . 74.41 109.423 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -127.48 132.72 49.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.684 0.794 . . . . 75.03 109.269 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.668 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 11.6 m-20 -132.14 115.42 15.71 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.281 -1.007 . . . . 75.41 108.281 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.29 135.27 40.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.862 -0.792 . . . . 73.4 108.862 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 31.9 t70 -146.07 149.12 33.47 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.935 0.894 . . . . 75.22 108.953 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -128.97 123.81 33.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.48 0.712 . . . . 72.13 109.602 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.575 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -114.48 159.43 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.495 -1.298 . . . . 61.41 107.495 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -145.26 164.23 32.03 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.25 0.548 . . . . 75.53 111.028 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -153.58 143.03 21.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.591 -1.186 . . . . 74.45 107.983 169.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.06 104.9 14.71 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.927 -0.768 . . . . 74.04 108.927 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.531 HD12 HG22 ' B' ' 83' ' ' ILE . 86.1 mt -73.51 -45.21 55.19 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.032 0.444 . . . . 73.32 109.808 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -178.07 6.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.012 -0.994 . . . . 72.22 110.005 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.35 128.67 35.9 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.957 -1.02 . . . . 61.23 109.186 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 67.42 10.73 7.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.635 1.174 . . . . 70.31 112.061 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.4 t -129.23 99.17 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.31 1.044 . . . . 73.51 108.781 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.925 0.869 . . . . 73.41 111.266 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.98 95.02 2.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.473 -2.418 . . . . 70.54 104.473 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.18 130.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.241 0.543 . . . . 75.12 109.612 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 32.9 t -102.03 143.46 14.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 114.953 -1.022 . . . . 61.43 109.172 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.7 OUTLIER -119.59 111.08 17.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.588 -1.264 . . . . 74.45 107.588 176.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.0 ttt180 -96.69 108.84 21.54 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.072 0.549 . . . . 64.34 110.23 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.5 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.1 t -105.88 118.83 54.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.445 -0.946 . . . . 74.14 108.445 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.668 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 38.0 m -103.92 141.34 36.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.565 0.746 . . . . 71.43 109.028 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.571 HG22 HG21 ' B' ' 114' ' ' ILE . 47.5 t -129.25 130.82 67.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.367 1.067 . . . . 73.41 108.901 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.3 m -125.42 140.07 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.896 -0.779 . . . . 73.12 108.896 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -140.17 131.37 26.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.608 -0.886 . . . . 72.42 108.608 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.447 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.0 p -133.29 126.26 31.06 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.808 -0.441 . . . . 74.03 109.808 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' B' ' 73' ' ' ALA . 0.9 OUTLIER -110.86 130.07 55.69 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.67 -1.604 . . . . 71.32 106.67 -176.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -119.09 5.7 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.585 -1.006 . . . . 75.22 110.585 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -120.35 3.81 10.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.654 0.782 . . . . 64.45 110.711 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -115.48 165.5 12.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.818 0.847 . . . . 63.23 110.145 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 42.6 m -70.23 131.6 44.46 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.711 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . . . -86.16 -57.99 2.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.024 -1.102 . . . . 74.35 108.024 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -160.27 166.44 29.54 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.327 -1.306 . . . . 73.54 110.679 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 94.7 mt -133.91 136.16 44.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.496 1.518 . . . . 72.34 107.033 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 50.0 t -143.23 147.49 34.92 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.443 -0.947 . . . . 72.32 108.443 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.3 tt0 -162.94 139.1 7.19 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.167 -0.679 . . . . 71.53 109.167 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' B' ' 110' ' ' ALA . 98.7 t -130.95 144.31 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.644 0.778 . . . . 71.14 109.021 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.553 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 26.4 mt-30 -122.82 92.91 3.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.624 -0.88 . . . . 75.53 108.624 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -85.43 102.73 13.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.823 -1.08 . . . . 71.1 109.296 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.31 168.71 29.87 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.617 -0.593 . . . . 75.33 111.617 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.25 128.56 1.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 112.084 -0.407 . . . . 74.03 112.084 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.531 HG22 HD12 ' B' ' 51' ' ' LEU . 19.7 mt -83.58 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.075 -1.083 . . . . 74.02 108.075 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -130.13 132.9 46.29 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.022 -0.733 . . . . 63.43 109.022 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -95.82 115.07 26.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.788 -0.819 . . . . 74.13 108.788 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.485 ' H ' HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -129.11 137.37 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.754 1.222 . . . . 71.31 109.212 -175.299 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.8 173.05 16.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.296 0.638 . . . . 75.2 109.896 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.59 -66.7 1.4 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.922 -0.471 . . . . 64.13 111.922 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.707 HG23 ' HB3' ' B' ' 9' ' ' MET . 8.3 pt -60.74 145.11 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.708 0.803 . . . . 74.11 111.887 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.54 146.26 24.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.061 -0.972 . . . . 63.31 109.411 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.08 7.64 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.416 0.448 . . . . 75.45 112.76 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.8 m -70.04 -50.14 44.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.656 0.783 . . . . 74.53 111.124 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -61.46 -24.94 66.91 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.925 0.89 . . . . 73.4 111.696 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.449 ' HA ' HD12 ' B' ' 89' ' ' ILE . 52.6 ttp -67.24 -40.21 86.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.503 1.121 . . . . 75.1 110.823 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.14 69.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.856 0.862 . . . . 64.41 111.991 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -65.45 -29.65 70.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.231 0.612 . . . . 75.41 111.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.2 -68.53 0.65 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.227 0.211 . . . . 73.44 111.437 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.487 HD21 ' SG ' ' B' ' 102' ' ' CYS . 94.1 mt -75.65 -22.89 56.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.256 0.465 . . . . 74.42 112.256 -172.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.75 -39.52 24.64 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.575 0.547 . . . . 70.22 112.327 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.15 -53.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.783 0.66 . . . . 73.53 112.783 -164.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -66.31 -45.38 80.53 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.311 0.644 . . . . 62.54 112.015 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.487 ' SG ' HD21 ' B' ' 98' ' ' LEU . 71.4 m -63.99 -50.06 71.51 Favored Pre-proline 0 CA--C 1.556 1.191 0 CA-C-O 118.373 -0.823 . . . . 75.32 110.61 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.2 Cg_exo -51.18 -33.03 42.61 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.624 2.216 . . . . 75.11 114.865 165.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.75 -25.27 64.65 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 118.355 0.525 . . . . 73.22 112.067 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -42.18 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.377 0.671 . . . . 75.31 109.77 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.435 ' HB2' HD12 ' B' ' 60' ' ' LEU . 95.8 mt -72.99 -24.73 60.8 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.025 -0.989 . . . . 75.41 110.926 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.17 -50.69 74.34 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.756 -1.116 . . . . 75.04 113.169 -169.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.434 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 37.6 Cg_endo -63.17 -32.42 74.29 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 121.638 1.558 . . . . 73.35 112.094 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.7 m-30 -66.42 -43.3 86.09 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.018 0.927 . . . . 71.53 110.454 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.419 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -66.42 -42.31 87.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.962 0.905 . . . . 65.43 110.204 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -61.68 -52.99 62.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.649 1.58 . . . . 75.31 111.476 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.84 -33.61 75.59 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.079 0.862 . . . . 74.23 109.756 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.7 t -71.94 -34.99 69.47 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.854 -0.612 . . . . 70.15 111.059 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.571 HG21 HG22 ' B' ' 64' ' ' VAL . 53.1 mt -65.22 -54.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.122 -0.696 . . . . 74.34 109.122 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -58.97 -31.33 68.64 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.799 -1.092 . . . . 71.23 110.846 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.5 t -64.61 -55.5 19.92 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.652 0.781 . . . . 70.31 110.159 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.529 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 14.3 mmt -63.23 -36.75 84.69 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.702 0.401 . . . . 72.11 111.619 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.16 -51.63 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.056 0.942 . . . . 74.41 110.687 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.35 -20.24 60.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.067 0.547 . . . . 74.13 111.991 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.445 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.4 mtt-85 -68.89 -31.36 70.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.308 0.643 . . . . 75.55 110.28 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.5 14.59 57.64 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 123.854 0.721 . . . . 73.31 112.666 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.7 p 55.45 30.7 15.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.83 1.652 . . . . 73.22 112.492 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.46 155.45 39.65 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.928 0.891 . . . . 72.24 109.999 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.07 143.09 99.58 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.029 2.486 . . . . 72.34 113.034 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -59.08 123.11 15.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.76 1.224 . . . . 73.34 111.566 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.15 89.73 3.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.476 0.71 . . . . 71.05 109.849 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.37 100.14 12.52 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.224 -0.898 . . . . 73.23 110.377 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.49 151.02 42.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.203 1.001 . . . . 74.34 112.6 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.35 150.43 84.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.641 -0.709 . . . . 73.23 110.682 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.26 110.84 2.55 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.434 2.089 . . . . 75.03 110.044 176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.49 110.81 21.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 74.11 106.981 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -76.26 91.55 3.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.875 -1.528 . . . . 74.33 106.875 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -53.48 -40.24 65.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.89 -1.05 . . . . 65.4 110.399 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.74 -53.99 27.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.512 1.125 . . . . 72.3 111.688 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -22.38 64.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.613 0.765 . . . . 75.05 111.674 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 123.785 0.834 . . . . 71.11 109.793 178.689 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.418 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 52.7 ttp . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.145 0.497 . . . . 73.42 110.545 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.507 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 40.2 m -84.04 78.79 9.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.128 -1.064 . . . . 73.03 108.128 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.518 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 42.2 t80 -100.18 127.94 46.35 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.809 -1.541 . . . . 75.43 108.571 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -138.03 142.73 40.35 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.336 -0.616 . . . . 74.12 109.336 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.33 110.21 11.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.319 -0.855 . . . . 73.11 108.738 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.5 mm-40 -77.67 -39.93 43.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.93 -0.577 . . . . 74.12 109.938 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.459 HH11 ' HD1' ' D' ' 32' ' ' PHE . 24.2 ttt180 179.27 124.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.393 0.677 . . . . 75.33 109.953 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 87.9 mt -110.08 138.62 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.818 -1.178 . . . . 64.23 107.818 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' D' ' 122' ' ' THR . 23.9 p90 -174.17 154.1 2.16 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.752 0.657 . . . . 73.53 110.729 -175.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.3 p -75.58 122.93 24.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.28 -0.873 . . . . 72.55 109.733 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -78.34 -50.58 11.51 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.218 -1.03 . . . . 64.53 108.218 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.5 t70 -133.53 139.19 46.47 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.551 -1.204 . . . . 74.3 109.939 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.37 140.06 38.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.794 -1.558 . . . . 73.54 106.794 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -160.7 150.75 17.74 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.119 0.485 . . . . 63.15 109.708 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 78.4 t80 -152.16 115.79 4.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.854 -1.165 . . . . 75.43 107.854 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.98 110.57 17.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.156 0.582 . . . . 72.15 110.432 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.6 86.24 34.29 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.405 1.082 . . . . 71.4 108.573 167.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.81 -32.31 29.87 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.414 2.076 . . . . 70.34 110.56 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -89.23 22.69 2.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.132 -1.394 . . . . 74.35 111.415 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB2' ' HE3' ' D' ' 19' ' ' LYS . . . -55.49 -43.59 99.22 Favored Pre-proline 0 CA--C 1.574 1.866 0 C-N-CA 124.226 1.011 . . . . 75.52 113.52 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -89.41 -17.96 1.75 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.958 1.772 . . . . 74.43 113.17 169.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.59 -31.69 68.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.535 1.134 . . . . 70.33 110.593 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.87 -2.45 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 124.473 1.109 . . . . 74.02 112.344 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -49.99 -41.72 47.61 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.389 1.476 . . . . 74.23 113.11 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -125.12 49.63 1.86 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.245 1.018 . . . . 73.44 108.499 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.79 149.29 47.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.82 -0.55 . . . . 71.3 111.22 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.2 132.91 50.33 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.285 -0.871 . . . . 75.43 110.406 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -83.52 65.86 8.63 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.026 0.917 . . . . 74.21 110.509 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -152.61 58.18 2.39 Favored Pre-proline 0 CA--C 1.558 1.281 0 CA-C-N 115.12 -0.946 . . . . 71.14 110.553 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.0 149.54 9.52 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.1 1.866 . . . . 70.42 110.8 165.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.24 113.63 24.04 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.284 0.634 . . . . 75.23 109.902 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -77.51 111.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.141 0.576 . . . . 72.1 109.747 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.653 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 26.6 mmmt -92.79 104.57 16.82 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.853 -1.165 . . . . 75.02 107.853 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.482 ' H ' HD21 ' C' ' 42' ' ' LEU . 2.4 pt? -87.25 145.65 26.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.33 . . . . 71.23 110.194 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.548 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 30.2 t70 -140.88 109.02 5.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.11 -0.7 . . . . 73.22 109.11 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -117.22 125.68 51.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.951 -0.759 . . . . 72.31 108.951 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -143.92 160.53 40.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.446 1.098 . . . . 71.24 109.869 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -129.76 153.72 47.92 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.282 0.633 . . . . 75.5 109.651 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 164.58 26.32 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.067 0.947 . . . . 54.21 109.079 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.469 ' HB3' HD23 ' C' ' 98' ' ' LEU . 33.1 p -142.31 145.36 33.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.037 0.535 . . . . 74.51 110.5 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -145.99 126.38 14.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.379 1.072 . . . . 64.04 108.431 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.68 116.05 23.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.462 -0.94 . . . . 74.45 108.462 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.521 HD13 HD13 ' C' ' 83' ' ' ILE . 67.0 mt -85.41 -43.02 13.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.47 0.708 . . . . 75.42 110.17 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 -171.98 3.61 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.847 -1.069 . . . . 71.51 109.964 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.25 108.91 0.99 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.129 -0.941 . . . . 75.24 110.025 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 71.04 -3.08 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.972 1.309 . . . . 74.3 112.955 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -95.53 97.28 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.842 -1.169 . . . . 72.23 107.842 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -106.97 159.07 16.55 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.541 0.736 . . . . 75.23 110.119 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.99 120.26 31.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.426 1.09 . . . . 74.52 108.265 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.41 133.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.854 -1.165 . . . . 72.3 107.854 172.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.21 105.65 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.184 -0.673 . . . . 64.45 109.184 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.05 99.44 12.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.905 -1.146 . . . . 73.12 107.905 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.53 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.6 tmm_? -92.28 120.94 33.3 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.288 0.635 . . . . 74.54 110.151 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.504 ' HB ' HD11 ' C' ' 114' ' ' ILE . 37.2 t -112.09 125.33 69.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.569 -0.9 . . . . 65.32 108.569 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -118.53 123.66 45.64 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.486 -0.931 . . . . 71.33 108.486 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 76.3 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.989 -1.005 . . . . 73.14 108.725 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 5.7 m -98.46 136.54 38.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.579 -1.637 . . . . 75.31 106.579 169.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.22 106.65 6.83 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.985 -1.857 . . . . 74.23 105.985 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 12.5 p -164.46 158.12 18.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 123.622 0.576 . . . . 63.22 110.688 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -113.71 20.24 16.06 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.645 0.735 . . . . 71.4 110.181 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.86 -83.47 0.35 Allowed Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.437 -0.801 . . . . 75.14 111.166 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.12 -32.03 11.12 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.29 0.636 . . . . 72.23 110.423 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -82.35 91.36 6.79 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 108.896 -0.779 . . . . 74.03 108.896 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -81.87 128.22 33.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.543 . . . . 73.32 109.563 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -64.11 1.01 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.614 -1.254 . . . . 72.14 107.614 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -159.76 172.37 17.83 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 121.971 0.891 . . . . 75.35 111.524 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -129.25 140.67 51.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.627 -1.99 . . . . 72.51 105.627 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.39 144.32 29.66 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.402 -0.962 . . . . 61.3 108.402 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.97 128.71 7.88 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.602 -0.518 . . . . 54.45 109.602 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.13 123.22 58.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.01 -0.995 . . . . 62.32 108.567 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.53 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 74.1 mt-30 -98.25 91.28 5.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.224 -1.398 . . . . 72.1 107.224 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -78.34 102.53 7.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.868 -0.606 . . . . 72.51 109.572 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.19 145.44 23.22 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.417 -0.811 . . . . 64.45 111.186 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.6 116.06 0.76 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.343 -1.103 . . . . 62.43 110.343 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.521 HD13 HD13 ' C' ' 51' ' ' LEU . 12.7 mm -81.44 127.82 39.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 107.932 -1.136 . . . . 74.44 107.932 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.88 123.5 23.56 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.358 0.663 . . . . 73.43 109.553 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.5 p -77.04 106.54 8.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.729 -1.211 . . . . 73.31 107.729 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 48.3 mt -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.127 -1.064 . . . . 73.32 108.127 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.507 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -127.84 158.63 37.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.767 0.827 . . . . 75.54 110.25 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -51.76 3.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.828 -0.623 . . . . 71.51 113.029 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.7 tt -81.28 145.47 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.539 0.735 . . . . 74.25 109.978 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.12 -179.36 8.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.99 0.516 . . . . 64.12 110.759 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.26 -148.64 47.72 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.61 -0.723 . . . . 60.41 112.789 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 77.0 p -69.67 -18.05 63.53 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.22 1.008 . . . . 75.4 111.453 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -64.9 -46.19 82.76 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 75.43 110.108 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 57.5 ttp -68.07 -32.2 72.37 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.451 -0.795 . . . . 74.55 110.181 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.74 85.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.333 0.653 . . . . 72.43 110.981 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -65.78 -32.75 74.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.719 0.808 . . . . 75.23 111.308 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.49 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 43.8 t -76.33 -55.34 5.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 74.41 110.294 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' C' ' 48' ' ' SER . 9.6 tt -65.64 -31.82 73.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.298 1.039 . . . . 74.44 111.225 -172.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.85 10.06 55.54 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.44 -0.644 . . . . 63.3 114.024 -175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.75 -59.03 0.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.776 0.788 . . . . 73.11 111.657 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -69.88 -55.54 9.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.449 0.7 . . . . 74.33 111.967 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.518 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 9.8 m -61.56 -45.82 93.85 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.635 0.774 . . . . 64.1 112.039 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.472 ' HB3' HD22 ' C' ' 60' ' ' LEU . 39.1 Cg_exo -61.05 -32.18 91.67 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.349 2.032 . . . . 74.3 113.501 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.95 -35.63 79.03 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.457 0.703 . . . . 72.32 110.882 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.42 -44.69 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.586 0.755 . . . . 73.15 110.254 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.7 mt -82.28 -23.96 34.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.869 -1.06 . . . . 74.31 112.506 -171.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.412 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 39.8 t80 -54.8 -48.22 96.15 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 124.84 1.256 . . . . 75.45 113.59 -172.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.531 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 23.3 Cg_exo -63.7 -34.44 62.48 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.932 1.755 . . . . 73.2 113.019 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -64.75 -44.75 89.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.105 0.562 . . . . 74.12 110.46 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.62 99.24 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.445 -0.798 . . . . 41.43 110.667 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' C' ' 108' ' ' PRO . 39.4 mtp180 -56.38 -53.39 57.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.966 0.906 . . . . 74.52 111.402 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.46 -32.76 71.89 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.711 0.632 . . . . 74.34 110.794 -173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.6 t -70.6 -29.96 66.5 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.565 0.346 . . . . 65.32 110.811 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' C' ' 62' ' ' VAL . 65.3 mt -73.65 -49.09 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.996 0.518 . . . . 74.34 109.724 171.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 92.3 m -59.47 -35.42 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.026 0.93 . . . . 74.22 111.454 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.1 t -63.31 -51.27 66.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.241 -0.891 . . . . 73.43 109.114 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.609 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -60.87 -32.72 72.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.754 0.822 . . . . 73.3 112.704 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' C' ' 123' ' ' PHE . 97.5 t -73.72 -37.6 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 53.44 110.141 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 63.6 p -75.54 -25.36 57.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.923 0.489 . . . . 71.23 110.745 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.609 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -70.49 -44.0 68.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.703 0.801 . . . . 71.21 109.567 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.33 -5.5 85.58 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.528 0.517 . . . . 73.24 112.618 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.495 HG21 ' HB3' ' D' ' 17' ' ' TYR . 18.8 p 67.31 25.97 8.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.534 1.933 . . . . 64.11 113.336 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.453 ' HB2' HG13 ' C' ' 118' ' ' VAL . 98.6 m-85 -85.45 163.77 43.32 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.682 0.793 . . . . 74.21 109.794 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.38 151.36 30.11 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.128 2.552 . . . . 71.13 113.984 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.441 HE22 HD21 ' C' ' 127' ' ' ASN . 0.6 OUTLIER -58.92 112.33 1.62 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.861 1.264 . . . . 62.35 110.069 -173.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.4 107.75 10.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.846 -0.798 . . . . 73.32 108.846 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.441 HD21 HE22 ' C' ' 125' ' ' GLN . 6.0 p30 -126.62 133.6 50.97 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.196 -1.409 . . . . 73.2 107.196 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.8 113.89 4.66 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.75 -1.204 . . . . 72.24 107.75 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.67 134.1 82.61 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.883 0.74 . . . . 74.42 110.846 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.499 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 52.7 Cg_exo -56.13 90.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.485 2.79 . . . . 75.42 113.248 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.67 110.37 30.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.537 -0.912 . . . . 75.02 108.537 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -85.7 89.32 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.62 -0.718 . . . . 74.44 110.509 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -40.81 93.36 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.568 -1.196 . . . . 71.14 109.13 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 CA--C 1.544 0.712 0 CA-C-N 113.68 -1.6 . . . . 72.33 112.969 175.64 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 114.363 1.246 . . . . 73.23 114.363 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.6 m -138.69 139.93 38.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.979 -1.489 . . . . 74.31 106.979 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.79 114.44 7.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.268 -1.012 . . . . 75.24 108.268 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -129.87 142.54 50.65 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.98 -0.748 . . . . 72.45 108.98 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.1 101.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.041 -1.466 . . . . 72.51 107.041 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -46.67 38.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.491 0.717 . . . . 72.1 111.221 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -166.9 133.77 2.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.957 -0.565 . . . . 74.14 110.072 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.496 ' N ' HD13 ' D' ' 16' ' ' ILE . 2.7 mp -108.91 135.87 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.366 -1.346 . . . . 73.11 107.366 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HB3' HG21 ' C' ' 122' ' ' THR . 17.1 p90 -161.96 170.95 18.43 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 122.13 0.967 . . . . 73.3 112.423 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 46.6 p -104.55 119.17 38.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.679 -1.146 . . . . 75.22 109.088 172.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 36.7 mtpt -86.45 -30.79 21.78 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.056 -0.35 . . . . 65.54 110.056 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -145.9 137.59 25.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.61 . . . . 65.24 109.984 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.553 HG23 ' HE1' ' C' ' 117' ' ' MET . 81.3 mt -134.41 148.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 73.43 108.242 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -148.26 140.97 24.57 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.294 1.037 . . . . 74.52 109.07 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.508 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.4 t80 -148.36 111.39 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.708 -1.96 . . . . 71.25 105.708 169.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -123.03 110.48 15.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.457 0.703 . . . . 71.21 109.348 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.2 88.14 2.97 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.063 -1.088 . . . . 63.24 108.063 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.12 -45.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.455 2.103 . . . . 74.34 112.405 -171.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 36.3 m-80 -102.9 42.33 1.16 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.048 0.939 . . . . 74.01 108.475 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.433 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -57.33 -51.96 77.8 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.225 1.194 . . . . 63.03 114.225 -169.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.59 -0.6 8.82 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 121.591 1.604 . . . . 72.42 112.968 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.482 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 13.6 t-160 -83.05 -26.7 30.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.67 1.188 . . . . 74.53 109.011 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 27' ' ' ASN . 93.2 t -82.31 -24.29 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.211 0.604 . . . . 71.34 110.114 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.459 ' HD1' HH11 ' C' ' 15' ' ' ARG . 60.5 t80 -53.98 -39.84 66.36 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.105 0.962 . . . . 74.5 112.542 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -79.37 -13.73 59.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.246 0.461 . . . . 73.42 112.246 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -111.5 100.68 9.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.069 -0.715 . . . . 75.52 109.069 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.39 89.24 4.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.011 0.524 . . . . 74.54 109.8 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.556 ' HB3' HD12 ' D' ' 68' ' ' LEU . 17.0 t-105 -159.21 158.24 32.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.027 -1.101 . . . . 74.33 108.027 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -81.66 112.52 35.05 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.474 0.709 . . . . 71.53 110.508 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -48.88 139.15 25.71 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.771 2.981 . . . . 74.2 114.058 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.12 121.69 16.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.529 -0.545 . . . . 73.53 109.529 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.13 115.69 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.085 0.469 . . . . 74.45 110.572 -174.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -87.26 146.28 26.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.491 1.116 . . . . 74.54 108.901 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -110.18 131.03 55.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.179 -0.675 . . . . 73.22 109.179 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.487 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.5 m-20 -133.37 142.72 48.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.652 1.181 . . . . 55.5 108.195 171.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -138.49 164.75 28.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.788 0.435 . . . . 72.3 110.707 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 29.3 t70 -168.43 155.36 7.55 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.498 1.119 . . . . 72.44 108.721 174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -132.48 158.06 43.05 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.987 -0.745 . . . . 73.12 108.987 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.7 167.7 29.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.511 0.725 . . . . 63.34 109.632 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' D' ' 58' ' ' VAL . 56.5 p -159.6 153.6 23.3 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.791 0.836 . . . . 74.33 110.196 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.5 p -151.52 142.59 23.13 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.933 0.893 . . . . 73.22 108.627 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -90.69 117.51 29.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.058 0.543 . . . . 75.43 109.591 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.7 mt -89.62 -31.66 17.45 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.511 -0.552 . . . . 72.34 109.511 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.75 -177.84 4.97 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.121 -0.945 . . . . 60.43 109.852 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.58 119.67 10.27 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.565 -1.198 . . . . 73.51 108.946 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 71.58 2.78 4.41 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.263 1.425 . . . . 71.15 112.741 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -113.77 123.91 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.539 0.736 . . . . 71.42 109.391 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.26 130.42 35.13 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.775 0.43 . . . . 73.13 110.516 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.3 tt0 -92.86 112.05 23.88 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.35 -0.982 . . . . 71.14 108.35 167.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' D' ' 48' ' ' SER . 12.7 m -102.3 137.87 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 170.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.39 140.27 30.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.182 -0.673 . . . . 75.12 109.182 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -112.56 123.81 51.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.175 -1.046 . . . . 74.01 108.175 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.3 ttm-85 -105.44 101.94 11.44 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.207 -0.664 . . . . 72.13 109.207 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.42 119.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.868 -1.16 . . . . 75.33 107.868 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 18.0 m -125.35 142.71 51.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.622 0.725 . . . . 64.25 109.675 -172.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -137.35 123.62 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.881 1.273 . . . . 74.14 108.875 -170.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -115.72 108.48 16.41 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.788 -0.819 . . . . 73.35 108.788 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.1 53.88 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.322 -0.622 . . . . 75.44 109.322 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.7 p -142.0 125.79 17.04 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.174 0.59 . . . . 74.42 109.661 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' D' ' 36' ' ' TRP . 28.0 tp -99.72 116.64 32.29 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.575 -0.898 . . . . 73.42 108.575 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.2 -133.16 23.98 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.72 0.637 . . . . 73.11 112.432 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -92.1 21.6 4.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.43 0.692 . . . . 74.02 110.847 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -141.14 146.41 36.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.249 0.619 . . . . 63.5 111.157 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -68.67 130.8 43.88 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.249 0.619 . . . . 71.25 109.968 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.12 -64.12 1.15 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.574 0.75 . . . . 65.53 109.323 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.47 161.64 40.03 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.31 -0.859 . . . . 74.12 110.321 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -121.38 151.23 40.4 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.282 1.433 . . . . 72.14 107.163 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.424 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 49.7 t -156.98 141.53 16.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 110.153 -0.314 . . . . 71.15 110.153 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.92 137.67 14.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.654 0.782 . . . . 65.25 109.139 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.15 114.24 16.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.44 -0.578 . . . . 75.04 109.44 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.639 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.5 mt-30 -91.93 85.16 5.48 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.221 -0.9 . . . . 74.25 108.89 171.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -80.15 101.89 9.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.913 -1.494 . . . . 75.25 109.705 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.27 142.36 15.99 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.759 -0.537 . . . . 74.12 111.759 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.3 133.65 5.55 Favored Glycine 0 C--O 1.236 0.279 0 N-CA-C 111.77 -0.532 . . . . 74.32 111.77 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.87 128.85 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.602 -1.258 . . . . 72.54 107.602 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.59 144.6 51.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.788 0.835 . . . . 74.53 108.817 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -97.52 102.43 14.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.983 -0.747 . . . . 64.25 108.983 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.504 HG23 ' HG3' ' D' ' 94' ' ' MET . 3.4 mp -107.62 99.7 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 107.564 -1.273 . . . . 75.03 107.564 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.41 123.21 35.58 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.49 -0.559 . . . . 74.54 109.49 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.8 22.5 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-O 118.571 -1.127 . . . . 64.55 114.872 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 mt -140.41 140.31 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.57 1.185 . . . . 72.41 110.424 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.94 175.84 9.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.875 1.27 . . . . 74.43 109.856 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.36 -140.97 26.17 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 114.537 0.575 . . . . 71.35 114.537 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 43.1 p -66.31 -32.45 73.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 70.4 111.618 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -70.53 -40.96 73.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.436 0.694 . . . . 73.02 110.155 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.504 ' HG3' HG23 ' D' ' 86' ' ' ILE . 49.7 ttp -70.89 -32.68 69.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.533 -0.758 . . . . 72.43 110.564 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.24 83.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.226 0.61 . . . . 73.31 110.29 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -62.0 -34.0 75.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.698 0.799 . . . . 70.41 110.53 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -68.55 -51.43 42.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.919 -0.582 . . . . 73.24 110.387 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.4 -28.4 61.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.81 0.844 . . . . 73.54 112.597 -173.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.28 -4.44 25.45 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.216 -0.769 . . . . 70.34 114.393 -169.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -54.6 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.984 0.892 . . . . 73.34 110.629 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -73.15 -43.49 61.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.718 0.407 . . . . 74.04 111.931 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 63.4 m -70.35 -45.56 19.91 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 118.694 -0.67 . . . . 72.55 111.381 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.527 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.2 Cg_exo -53.89 -36.37 83.04 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.438 2.092 . . . . 75.52 113.229 165.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.97 -33.05 75.11 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.493 0.717 . . . . 72.22 110.928 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.4 -43.33 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.044 0.538 . . . . 70.05 110.059 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.88 -19.63 58.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.318 -0.855 . . . . 73.44 111.738 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.441 ' HZ ' HD11 ' D' ' 128' ' ' LEU . 60.6 t80 -66.71 -42.26 43.65 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.946 -1.026 . . . . 74.24 113.413 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.43 -38.34 73.85 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.902 1.735 . . . . 75.34 112.993 168.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -78.57 -35.32 46.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.106 0.962 . . . . 72.35 112.115 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.74 -42.07 74.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.253 0.621 . . . . 75.51 109.553 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -62.42 -46.84 86.76 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.331 -1.304 . . . . 72.4 109.922 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 2.6 tm-20 -56.35 -48.97 75.7 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.292 0.995 . . . . 70.44 111.553 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -61.24 -41.22 96.53 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.04 0.837 . . . . 65.42 110.903 -177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.414 HG12 ' SG ' ' D' ' 76' ' ' CYS . 64.6 mt -63.29 -50.72 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.146 0.578 . . . . 75.33 110.105 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.8 m -54.03 -43.26 69.99 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.969 1.308 . . . . 75.14 111.134 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -69.16 -44.96 71.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.756 -1.111 . . . . 51.03 110.605 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.424 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.9 mtm -67.81 -33.2 74.33 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.671 0.388 . . . . 75.3 111.827 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.53 -42.52 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.944 0.897 . . . . 74.11 110.248 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -72.72 -29.45 63.37 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.668 0.387 . . . . 75.54 110.897 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -74.62 -26.98 60.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.859 0.864 . . . . 74.33 110.303 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.42 67.42 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.531 -0.758 . . . . 72.04 112.731 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.474 HG22 ' HB3' ' C' ' 17' ' ' TYR . 60.6 p 56.57 21.94 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 125.874 1.67 . . . . 65.21 113.243 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -95.41 154.85 39.26 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.751 0.82 . . . . 73.53 109.955 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.88 137.94 83.77 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.418 2.745 . . . . 74.22 112.671 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -57.8 124.91 20.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.774 0.672 . . . . 74.2 112.233 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.1 tt -108.51 99.05 8.48 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.727 -0.842 . . . . 75.35 108.727 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.61 103.07 14.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.553 -0.906 . . . . 73.51 108.553 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 0.2 OUTLIER -64.06 116.47 5.94 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.375 0.67 . . . . 61.32 109.636 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 145.33 99.12 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.305 0.642 . . . . 74.53 111.927 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.73 106.0 0.26 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.569 2.179 . . . . 72.23 111.508 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.04 147.82 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.205 0.602 . . . . 74.23 110.351 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -79.33 91.1 5.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.051 -0.522 . . . . 74.31 109.77 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.476 0.857 0 CA-C-N 115.849 -0.614 . . . . 72.2 110.624 178.283 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 110.233 -0.284 . . . . 73.11 110.233 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -139.3 115.73 10.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.089 -1.449 . . . . 75.42 107.089 168.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -149.79 134.47 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.545 0.338 . . . . 73.42 111.068 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.576 ' HB ' HD12 ' A' ' 16' ' ' ILE . 2.7 pp -80.93 132.1 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.312 -0.996 . . . . 75.12 108.312 169.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -113.8 -38.37 4.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.962 0.505 . . . . 75.34 110.792 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -165.15 123.18 1.62 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.911 -0.403 . . . . 73.41 109.911 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 13' ' ' ILE . 4.5 mp -121.71 123.39 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.083 -1.08 . . . . 74.42 108.083 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.566 ' HE2' ' HB3' ' B' ' 28' ' ' ALA . 9.5 p90 -172.23 176.58 3.37 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.511 0.724 . . . . 75.12 110.929 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -102.01 120.84 41.07 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 71.34 108.832 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -98.44 -27.62 13.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.196 0.198 . . . . 74.31 111.155 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.745 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 13.7 m-20 -137.77 129.52 28.46 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.759 -0.83 . . . . 64.53 108.759 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.504 HG23 HG23 ' A' ' 78' ' ' VAL . 54.6 mt -132.34 137.46 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.144 -1.058 . . . . 74.34 108.144 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -145.19 127.23 15.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.8 0.84 . . . . 75.13 109.405 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.664 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.6 t80 -131.12 133.01 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.692 -1.595 . . . . 74.02 106.692 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -141.0 119.34 12.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.394 0.677 . . . . 75.42 109.522 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -125.12 82.1 62.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 107.831 -1.174 . . . . 73.44 107.831 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.31 -35.89 29.96 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.753 2.302 . . . . 72.43 111.369 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 72' ' ' THR . 78.5 m-20 -111.49 35.63 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.66 -1.155 . . . . 52.35 109.458 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -57.68 -47.14 99.46 Favored Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 123.988 0.915 . . . . 61.23 111.803 171.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 -13.86 25.3 Favored 'Trans proline' 0 C--N 1.403 3.42 0 C-N-CA 122.419 2.079 . . . . 54.24 113.428 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -69.82 -32.59 71.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.423 0.289 . . . . 75.11 110.46 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.564 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 17.5 t -64.98 -19.21 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.84 0.456 . . . . 74.51 110.793 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.64 -41.09 80.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.564 0.746 . . . . 75.13 111.3 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -99.89 -23.53 14.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.143 0.577 . . . . 72.01 111.55 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.2 mmtp -77.27 144.97 37.77 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.283 0.563 . . . . 74.41 111.767 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -79.82 158.1 26.87 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.91 -1.041 . . . . 74.41 110.067 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -90.22 80.17 6.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.054 0.931 . . . . 73.45 110.649 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -135.73 74.56 58.29 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.157 -1.383 . . . . 71.54 107.434 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -91.99 144.39 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.764 2.309 . . . . 75.51 112.567 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.1 115.6 27.8 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.848 -1.167 . . . . 74.43 107.848 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 65' ' ' THR . 85.0 t -95.26 135.94 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.545 0.738 . . . . 73.24 110.133 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 53.3 mtpt -120.62 143.4 48.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.439 0.695 . . . . 72.42 109.492 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -133.22 108.2 8.63 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.66 -1.154 . . . . 75.41 109.21 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -123.48 117.66 25.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.604 1.162 . . . . 64.2 108.662 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -118.4 159.91 22.61 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.075 0.95 . . . . 74.5 110.847 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.455 ' O ' HD22 ' A' ' 60' ' ' LEU . 24.1 t70 -157.83 148.66 21.02 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.38 0.672 . . . . 71.42 110.369 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.4 m -131.72 134.49 45.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.509 0.724 . . . . 61.53 110.092 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.78 135.69 29.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.748 0.819 . . . . 72.14 109.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -113.96 157.88 21.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.131 0.572 . . . . 71.22 109.507 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -160.79 116.07 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.392 -0.595 . . . . 74.13 109.392 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.535 HE21 ' H ' ' A' ' 54' ' ' ASP . 62.6 tt0 -70.98 108.66 4.67 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.355 0.662 . . . . 61.43 110.18 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 57' ' ' GLU . 71.6 mt -79.04 -40.24 31.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.859 0.864 . . . . 72.35 110.89 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.28 -176.12 5.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.198 0.999 . . . . 71.54 109.004 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.79 102.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.347 0.659 . . . . 74.43 111.518 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' H ' HE21 ' A' ' 50' ' ' GLN . 3.6 m-20 58.41 29.67 18.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.201 1.4 . . . . 75.32 112.631 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.3 t -112.13 122.22 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 106.5 -1.667 . . . . 71.54 106.5 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.64 133.43 38.2 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.492 -0.929 . . . . 73.34 108.492 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 35.0 tt0 -85.8 121.72 28.85 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.644 -0.873 . . . . 72.44 108.644 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.57 115.12 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.999 0.919 . . . . 73.13 108.715 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -97.29 135.09 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.228 -0.896 . . . . 74.23 109.257 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -110.73 115.09 28.95 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.098 -1.445 . . . . 74.41 107.098 170.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -102.64 106.02 16.61 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.014 -0.735 . . . . 73.51 109.014 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.442 HG23 HD23 ' A' ' 60' ' ' LEU . 47.6 t -103.32 133.02 48.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.47 -0.937 . . . . 75.41 108.47 175.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -123.54 125.23 44.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.849 -0.797 . . . . 63.43 108.849 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 114' ' ' ILE . 61.4 t -118.42 130.83 72.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.624 -1.25 . . . . 74.33 107.624 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.2 m -127.7 149.45 50.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.497 -0.927 . . . . 71.51 108.497 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.24 121.26 13.69 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.256 -1.387 . . . . 72.54 107.256 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.6 m -144.47 129.24 18.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.102 0.561 . . . . 74.05 110.481 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 34' ' ' LYS . 2.4 tt -88.04 80.92 7.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.452 -1.685 . . . . 72.34 106.452 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.77 -110.17 2.98 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.67 -1.15 . . . . 75.13 111.649 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.74 -26.31 18.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.081 0.952 . . . . 73.05 111.291 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -83.34 116.44 22.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.84 -0.8 . . . . 74.54 108.84 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 32.9 m -77.43 126.56 31.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 110.056 -0.35 . . . . 74.2 110.056 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.55 -52.39 9.12 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.382 -0.97 . . . . 61.32 108.382 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -161.95 170.33 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.06 -0.973 . . . . 74.22 111.204 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.5 tp -141.12 148.77 40.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.34 1.456 . . . . 73.45 107.936 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 62.4 m -142.82 139.74 31.04 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.488 1.115 . . . . 74.41 108.488 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -149.41 118.96 6.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.965 -0.754 . . . . 71.22 108.965 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.584 HG22 HG13 ' A' ' 114' ' ' ILE . 54.8 t -122.82 118.89 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 121.124 0.488 . . . . 74.54 109.715 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.745 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 48.5 mt-30 -89.92 91.46 8.6 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.971 -1.013 . . . . 75.55 108.97 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.73 97.65 4.54 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.593 -1.185 . . . . 75.44 108.6 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.8 140.38 17.09 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.789 -0.924 . . . . 62.44 110.789 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.72 120.64 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.858 -1.297 . . . . 75.34 109.858 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 38.6 mt -81.75 129.26 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.703 -0.851 . . . . 74.14 108.703 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -135.73 122.15 20.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.857 -1.164 . . . . 73.54 107.857 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -90.96 105.97 18.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.044 -0.724 . . . . 53.34 109.044 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -122.01 135.03 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.349 0.66 . . . . 72.34 110.537 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.73 157.81 42.54 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.613 1.165 . . . . 75.41 109.476 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.21 -18.68 9.56 Favored Glycine 0 N--CA 1.471 1.004 0 N-CA-C 114.601 0.601 . . . . 62.04 114.601 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.98 133.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.319 -0.993 . . . . 72.45 108.319 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -147.39 174.32 11.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.875 0.87 . . . . 73.14 109.664 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.6 -115.42 7.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.623 -0.543 . . . . 74.13 113.182 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -71.26 -22.57 61.95 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.297 0.639 . . . . 72.0 111.418 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.42 -50.53 44.9 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.243 1.017 . . . . 73.42 110.789 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -27.65 52.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.012 -0.54 . . . . 74.3 110.14 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.94 94.68 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.334 0.654 . . . . 54.52 110.348 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -65.58 -54.28 30.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.532 -1.213 . . . . 70.23 110.219 170.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.66 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 62.7 m -68.2 -59.34 3.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.047 0.758 . . . . 72.03 113.047 -168.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.6 mt -67.71 -25.72 65.8 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.234 0.457 . . . . 73.31 112.234 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.24 -13.77 56.91 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.448 -0.64 . . . . 51.15 114.084 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.625 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -140.76 -67.27 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.775 0.788 . . . . 75.23 112.638 -173.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.66 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.34 -57.71 7.31 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 124.611 1.164 . . . . 71.24 113.423 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.6 m -71.69 -45.37 12.56 Favored Pre-proline 0 CA--C 1.559 1.312 0 CA-C-O 118.562 -0.732 . . . . 72.34 112.93 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.92 -25.25 74.19 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.548 1.499 . . . . 74.32 113.516 168.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -69.25 -37.47 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.45 -0.574 . . . . 72.32 109.45 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.03 -44.78 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.758 0.823 . . . . 64.11 110.489 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.85 -24.02 58.52 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.568 -0.742 . . . . 73.33 112.249 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -67.08 -44.57 50.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.109 1.151 . . . . 74.44 114.109 -169.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -34.65 96.12 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 122.12 1.88 . . . . 75.1 112.862 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.92 -43.13 36.69 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.659 0.784 . . . . 75.43 111.631 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -45.01 79.88 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.588 0.355 . . . . 73.41 110.439 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.433 HH12 HD13 ' C' ' 105' ' ' ILE . 29.3 ttm180 -48.53 -58.26 4.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.726 1.266 . . . . 74.41 109.545 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.98 -42.92 95.23 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.403 1.064 . . . . 73.45 111.909 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.91 -34.55 78.22 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.631 0.582 . . . . 75.34 111.572 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.584 HG13 HG22 ' A' ' 78' ' ' VAL . 4.4 mt -70.12 -53.11 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.097 0.559 . . . . 72.42 109.669 171.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.2 m -58.8 -30.64 67.77 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.965 1.306 . . . . 72.52 111.759 -172.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -71.74 -43.16 66.31 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.045 -0.979 . . . . 72.22 109.86 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.664 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.0 mtm -61.4 -36.85 81.42 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.747 0.419 . . . . 54.51 110.96 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.93 -46.5 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 123.854 0.721 . . . . 75.15 110.595 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.41 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 84.9 p -71.68 -34.85 70.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.997 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -67.16 -32.09 72.96 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.703 0.801 . . . . 74.51 109.586 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.47 -1.42 65.35 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.196 -0.911 . . . . 74.23 112.837 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m 73.26 10.5 5.11 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.071 1.348 . . . . 73.22 111.627 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -88.04 157.62 50.99 Favored Pre-proline 0 C--O 1.245 0.864 0 N-CA-C 108.961 -0.755 . . . . 73.32 108.961 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.74 113.62 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.418 2.078 . . . . 72.42 111.058 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HG3' ' HB3' ' A' ' 119' ' ' SER . 17.6 tt0 -57.06 119.67 6.72 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.515 1.126 . . . . 75.23 110.717 -172.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.8 mt -104.93 101.44 11.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.321 0.648 . . . . 72.15 109.598 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.404 ' OD1' ' HB ' ' C' ' 16' ' ' ILE . 10.1 m-80 -100.07 105.76 17.44 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.523 -1.288 . . . . 75.41 107.523 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.62 157.79 34.79 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.988 0.915 . . . . 73.33 112.513 -167.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.35 142.81 87.23 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.86 0.864 . . . . 70.12 111.794 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HB3' HH22 ' A' ' 111' ' ' ARG . 72.8 Cg_endo -86.37 116.31 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.498 2.132 . . . . 73.21 112.827 170.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.29 114.03 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.254 -1.017 . . . . 65.52 108.254 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.89 99.35 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.684 -0.858 . . . . 73.21 108.684 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.625 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 61.8 t80 -69.63 -26.76 64.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.308 0.243 . . . . 64.14 110.516 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 72.41 110.369 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 114.124 1.157 . . . . 75.43 114.124 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -150.57 123.2 8.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.261 1.024 . . . . 72.02 108.412 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -119.74 126.08 50.21 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.547 -0.908 . . . . 72.44 108.547 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.66 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.3 tt0 -139.48 132.32 29.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.828 0.851 . . . . 71.31 109.145 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.97 114.82 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.369 -0.975 . . . . 75.42 108.369 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -82.83 -46.24 13.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.783 0.433 . . . . 75.14 110.257 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -164.55 142.24 6.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.573 -0.285 . . . . 75.11 111.176 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.54 141.46 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.231 -1.396 . . . . 74.01 107.231 168.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.475 ' HE1' HG13 ' B' ' 83' ' ' ILE . 14.5 p90 -170.53 151.09 3.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.816 0.673 . . . . 75.21 112.816 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -80.2 123.15 27.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.983 0.913 . . . . 73.3 108.93 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -97.02 -28.84 13.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.329 0.652 . . . . 74.41 110.974 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.2 t70 -154.09 140.03 18.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.207 -0.452 . . . . 75.02 109.984 -170.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.479 HD13 ' SG ' ' B' ' 113' ' ' CYS . 31.5 mm -133.95 143.57 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.412 1.085 . . . . 75.31 109.098 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -139.64 135.24 33.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.257 1.023 . . . . 73.1 108.81 168.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.61 107.9 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.172 -1.788 . . . . 74.23 106.172 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 22.1 mt-10 -119.07 112.98 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.495 -0.928 . . . . 74.51 108.495 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.21 86.48 21.18 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.974 -1.121 . . . . 73.14 107.974 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.97 -22.81 41.45 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.843 2.362 . . . . 72.42 112.99 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -115.94 22.53 12.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.83 0.852 . . . . 73.34 110.267 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 17' ' ' TYR . . . -49.8 -53.08 45.85 Favored Pre-proline 0 CA--C 1.561 1.367 0 N-CA-C 114.54 1.311 . . . . 75.53 114.54 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.29 -21.39 41.53 Favored 'Trans proline' 0 C--N 1.392 2.82 0 CA-C-N 121.075 1.42 . . . . 75.32 112.646 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.99 1.96 43.03 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.346 1.058 . . . . 73.32 112.623 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' B' ' 123' ' ' PHE . 11.5 p -62.1 -25.83 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.785 1.031 . . . . 71.32 113.785 -167.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -75.84 -0.61 21.81 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.399 0.518 . . . . 72.23 112.399 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -80.77 -32.93 35.34 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.875 0.87 . . . . 73.11 110.027 165.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.638 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 75.7 mmtt -85.44 84.89 7.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.377 1.071 . . . . 72.54 110.454 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -116.4 83.0 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.546 0.738 . . . . 65.22 111.114 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -166.86 -171.76 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.276 1.43 . . . . 75.54 108.934 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.93 115.67 63.34 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.318 0.647 . . . . 72.23 109.593 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.07 153.37 28.55 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.525 2.15 . . . . 70.02 112.74 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.52 103.78 2.15 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.547 -0.909 . . . . 70.41 108.547 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.53 126.07 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.43 0.692 . . . . 73.14 110.472 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -110.5 127.89 55.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.952 1.301 . . . . 73.12 108.866 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.89 123.61 43.27 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 105.427 -2.064 . . . . 73.11 105.427 161.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.563 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.6 t70 -124.07 129.51 51.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.266 -1.383 . . . . 74.11 107.266 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.464 HD22 HG13 ' B' ' 131' ' ' VAL . 3.9 mp -106.19 136.65 45.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.753 -1.202 . . . . 70.32 107.753 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -154.71 156.37 36.26 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 71.3 108.691 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -146.27 137.04 24.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.488 0.661 . . . . 72.02 110.167 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.01 158.21 31.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.491 -1.67 . . . . 72.25 106.491 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -145.03 171.31 14.64 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.501 0.592 . . . . 51.34 111.425 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -151.61 135.82 16.71 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.382 -1.34 . . . . 75.12 107.382 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -100.83 110.17 22.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.88 0.764 . . . . 74.21 109.487 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.574 HD12 HG22 ' B' ' 83' ' ' ILE . 79.3 mt -72.34 -30.24 64.56 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.69 0.796 . . . . 73.41 112.002 -172.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 179.18 8.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.861 0.864 . . . . 43.34 109.456 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.49 121.09 12.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.222 -0.899 . . . . 74.43 108.603 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.494 ' HB3' ' HB1' ' B' ' 87' ' ' ALA . 19.5 m-20 76.24 -5.72 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.992 1.717 . . . . 74.35 112.726 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -107.31 88.79 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.006 -1.109 . . . . 74.54 108.006 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.94 138.33 38.14 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.522 -0.918 . . . . 74.23 108.522 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -110.75 100.98 9.64 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.023 -1.473 . . . . 72.14 107.023 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.45 124.21 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.398 0.679 . . . . 73.31 109.762 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.589 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -106.03 116.34 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.778 0.831 . . . . 52.33 110.043 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.28 113.92 26.3 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.076 -1.083 . . . . 74.54 108.076 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -99.62 109.62 22.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.986 0.915 . . . . 74.42 109.829 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.8 t -106.24 119.24 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.912 -0.773 . . . . 71.22 108.912 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.1 m -106.08 146.94 29.52 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.292 1.037 . . . . 75.54 109.616 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.566 HG23 HD12 ' B' ' 114' ' ' ILE . 55.8 t -132.68 131.77 59.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.405 1.082 . . . . 75.42 108.572 173.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.0 m -124.44 136.5 54.09 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.521 -0.918 . . . . 60.35 108.521 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.8 131.06 30.61 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.745 -1.206 . . . . 61.23 107.745 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 66.4 p -137.57 134.24 35.39 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.071 0.548 . . . . 72.04 109.884 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.638 ' HB3' ' HD2' ' B' ' 34' ' ' LYS . 0.9 OUTLIER -113.6 117.78 32.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.336 -1.357 . . . . 75.24 107.336 -179.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.64 -130.25 10.14 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.793 -0.523 . . . . 55.23 111.793 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.27 31.67 5.21 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.893 0.877 . . . . 74.21 109.655 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.83 145.28 28.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.477 0.711 . . . . 64.32 110.082 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -68.12 132.14 46.68 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 122.863 0.465 . . . . 72.04 110.392 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.87 -55.39 3.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.079 . . . . 73.03 108.721 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -163.58 164.7 24.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 74.41 110.842 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 52.3 mt -133.42 145.34 50.19 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.203 1.401 . . . . 74.03 107.739 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.7 t -153.63 143.14 21.69 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.409 -0.96 . . . . 72.24 108.409 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -158.99 133.14 7.7 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.809 -0.812 . . . . 75.05 108.809 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 90.1 t -125.22 145.45 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.858 . . . . 75.03 108.916 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.7 mt-30 -119.97 93.59 4.11 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.332 -0.988 . . . . 75.42 108.332 171.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -84.01 100.23 10.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.52 -0.763 . . . . 74.33 109.263 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.41 166.47 36.42 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.71 -0.556 . . . . 73.11 111.71 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.47 126.66 1.51 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.462 -0.655 . . . . 62.3 111.462 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.574 HG22 HD12 ' B' ' 51' ' ' LEU . 33.5 mt -85.97 116.1 28.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.51 163.79 17.41 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.687 -0.857 . . . . 72.31 108.687 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.66 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.9 m -129.68 93.22 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.783 -1.191 . . . . 73.21 107.783 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.411 HG22 ' SG ' ' B' ' 97' ' ' CYS . 0.1 OUTLIER -112.31 111.68 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 107.969 -1.123 . . . . 73.15 107.969 -175.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' B' ' 54' ' ' ASP . . . -130.55 159.37 37.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.914 0.885 . . . . 61.34 110.499 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.48 -42.97 2.04 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.605 0.566 . . . . 64.02 114.096 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' B' ' 94' ' ' MET . 0.2 OUTLIER -74.58 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.942 0.897 . . . . 74.42 112.527 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.549 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.4 pt-20 -161.41 -178.2 6.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.917 -1.038 . . . . 74.32 110.547 166.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.62 -118.9 15.96 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.348 -0.842 . . . . 74.01 114.488 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -71.72 -35.64 70.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.685 0.794 . . . . 75.34 111.143 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -73.54 -35.41 65.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.801 0.441 . . . . 73.55 110.878 -171.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.549 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 24.2 ptt? -74.72 -25.65 59.27 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.45 0.3 . . . . 73.44 110.964 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.16 82.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.249 0.62 . . . . 75.3 111.266 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 16.8 m-70 -85.34 -21.34 28.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.202 0.601 . . . . 74.42 111.453 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' B' ' 86' ' ' ILE . 35.8 t -84.37 -62.74 1.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.926 0.394 . . . . 73.33 110.403 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.0 -27.0 61.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.819 0.448 . . . . 73.54 111.456 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.58 -1.31 60.45 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.422 -0.655 . . . . 63.42 114.381 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -150.16 -50.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.995 0.897 . . . . 72.23 112.674 -174.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -65.23 -49.34 70.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.455 0.702 . . . . 64.5 110.744 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.9 m -64.0 -51.73 61.36 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-O 118.538 -0.744 . . . . 74.4 111.575 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.4 Cg_exo -53.37 -34.56 71.53 Favored 'Trans proline' 0 C--N 1.403 3.405 0 C-N-CA 122.627 2.218 . . . . 73.32 114.726 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.73 -37.9 89.18 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.069 0.548 . . . . 62.12 111.163 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.59 -43.33 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.709 0.804 . . . . 72.43 110.038 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.28 -20.91 50.6 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.147 -0.933 . . . . 75.24 112.504 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -59.69 -51.59 79.87 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 117.844 -1.074 . . . . 73.22 113.769 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.06 -34.43 92.57 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 122.088 1.859 . . . . 55.01 113.285 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.443 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 89.1 m-85 -68.63 -49.74 56.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.695 0.798 . . . . 75.41 110.824 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.98 84.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.544 0.738 . . . . 73.24 110.808 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.444 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.8 ttt180 -62.67 -52.56 62.84 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 63.54 110.956 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.97 -38.33 90.69 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.135 -0.938 . . . . 71.01 110.167 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.479 ' SG ' HD13 ' B' ' 21' ' ' ILE . 8.5 t -69.31 -34.31 74.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.93 -0.577 . . . . 74.2 111.929 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.566 HD12 HG23 ' B' ' 64' ' ' VAL . 66.0 mt -64.66 -57.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.023 0.529 . . . . 71.24 109.584 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.3 m -60.4 -31.16 70.1 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.942 0.776 . . . . 74.44 111.5 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.2 t -62.84 -48.29 79.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.85 0.86 . . . . 63.21 110.917 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.425 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 23.2 mmt -67.83 -34.41 76.68 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.91 0.484 . . . . 62.43 110.867 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.506 HG11 HD13 ' B' ' 126' ' ' LEU . 74.1 t -63.21 -37.66 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 124.17 0.988 . . . . 72.23 110.86 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -63.83 -40.64 97.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.533 0.733 . . . . 53.45 110.866 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -64.39 -32.05 73.5 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.735 -1.12 . . . . 74.43 111.947 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.76 17.5 56.27 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.672 0.608 . . . . 60.21 113.697 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 60.53 26.74 16.39 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.616 1.566 . . . . 72.04 112.912 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.421 ' CE1' HG23 ' B' ' 31' ' ' VAL . 81.3 m-85 -91.84 156.79 42.31 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.395 0.678 . . . . 75.24 110.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.41 177.42 3.27 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 123.238 2.625 . . . . 75.3 114.241 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -67.26 124.32 22.78 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.825 -1.079 . . . . 73.21 111.62 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.506 HD13 HG11 ' B' ' 118' ' ' VAL . 11.0 mp -117.27 96.41 5.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.96 0.904 . . . . 75.2 109.36 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 92.63 8.5 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.08 0.467 . . . . 74.43 110.29 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.444 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 73.1 mt -67.27 141.9 57.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.175 0.59 . . . . 64.13 110.606 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 143.27 39.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.224 0.61 . . . . 55.34 110.558 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.539 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 28.8 Cg_endo -61.7 123.34 12.48 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.129 2.552 . . . . 74.35 111.598 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.464 HG13 HD22 ' B' ' 44' ' ' LEU . 12.8 t -100.0 127.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.753 -0.462 . . . . 72.31 109.753 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.61 96.43 10.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.957 -1.127 . . . . 74.52 107.957 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.424 ' CE1' HD23 ' B' ' 44' ' ' LEU . 58.8 m-85 -59.17 -34.52 72.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 71.24 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.72 -39.09 93.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.384 -1.28 . . . . 73.31 111.198 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.19 78.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.322 0.649 . . . . 74.02 111.585 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.548 0.884 0 O-C-N 123.849 0.718 . . . . 64.22 110.274 178.293 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 44.6 ttp . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 121.243 0.544 . . . . 74.1 110.401 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.662 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 12.4 m -86.79 76.29 9.49 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.604 -1.258 . . . . 73.53 107.604 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -92.0 129.19 38.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.211 -0.904 . . . . 73.02 108.591 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.88 139.53 21.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.686 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -82.56 133.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 107.542 -1.281 . . . . 75.2 107.542 174.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.9 mm-40 -107.62 -46.91 3.72 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.355 0.662 . . . . 65.21 110.006 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.41 ' NH1' ' HA ' ' D' ' 29' ' ' PRO . 56.1 ttt180 -166.79 141.15 4.02 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.59 -0.732 . . . . 73.34 109.654 -172.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.686 HG13 HD11 ' C' ' 13' ' ' ILE . 86.3 mt -129.39 142.01 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 106.926 -1.509 . . . . 70.24 106.926 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -174.03 160.46 3.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.624 0.77 . . . . 70.1 110.248 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.5 p -85.47 107.37 17.39 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.706 -0.679 . . . . 74.03 109.544 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -65.97 -41.84 90.64 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.281 -0.637 . . . . 73.01 109.281 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.6 t70 -147.8 147.12 29.5 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.768 -0.651 . . . . 75.15 109.815 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.2 mt -143.79 145.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.484 1.513 . . . . 71.51 106.965 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -157.96 150.07 22.09 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.081 0.553 . . . . 72.33 109.55 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -146.15 123.27 11.47 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.655 -1.239 . . . . 73.45 107.655 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 36.0 mt-10 -123.59 112.43 17.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.46 0.704 . . . . 75.35 109.558 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.22 85.92 25.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.69 -0.856 . . . . 71.35 108.69 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -36.33 10.79 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.586 2.19 . . . . 75.55 111.429 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.527 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 66.8 m-80 -106.45 36.05 2.75 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.151 -0.931 . . . . 73.11 110.156 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.408 ' HA ' ' HZ ' ' C' ' 123' ' ' PHE . . . -56.11 -47.18 99.34 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.504 1.122 . . . . 75.43 112.536 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -94.39 -10.04 1.48 Allowed 'Trans proline' 0 C--N 1.397 3.111 0 C-N-CA 122.257 1.971 . . . . 63.11 113.641 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.527 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-160 -71.96 -30.95 65.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.332 0.653 . . . . 73.25 111.282 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.574 HG11 ' HE1' ' C' ' 123' ' ' PHE . 7.6 p -76.76 -13.73 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.839 0.855 . . . . 75.44 111.832 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -51.51 -37.34 48.76 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.407 1.483 . . . . 73.43 113.259 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -126.54 26.49 6.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.399 0.68 . . . . 75.14 110.134 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -125.4 153.0 44.08 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.252 -0.905 . . . . 73.41 111.922 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.85 133.14 47.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.536 1.534 . . . . 61.15 112.586 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -86.1 104.76 15.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.691 0.796 . . . . 74.55 110.598 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -161.47 68.5 2.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.441 -0.948 . . . . 73.22 108.441 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -86.92 138.47 5.04 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.063 1.842 . . . . 74.1 110.959 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.46 97.62 9.08 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.771 -1.937 . . . . 71.13 105.771 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -79.37 99.45 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.812 -1.085 . . . . 74.34 110.837 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -93.51 117.1 29.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.278 -0.874 . . . . 72.13 110.185 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -92.02 148.29 22.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.686 -0.857 . . . . 73.1 108.686 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.9 t70 -146.77 112.45 5.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.16 -1.052 . . . . 73.24 108.16 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.37 111.56 24.04 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.043 -1.095 . . . . 75.25 108.043 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -123.61 158.55 31.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.686 1.195 . . . . 72.05 108.657 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -145.64 151.36 37.93 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.281 0.562 . . . . 72.02 109.742 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 173.8 11.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.541 1.136 . . . . 74.35 108.338 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.7 p -152.3 148.09 27.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 122.866 0.467 . . . . 74.53 110.016 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -145.38 125.47 13.68 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.675 -1.231 . . . . 75.15 107.675 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.44 115.16 22.4 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.369 -0.974 . . . . 74.12 108.369 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' C' ' 57' ' ' GLU . 58.9 mt -84.92 -39.33 18.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.458 0.703 . . . . 75.3 110.272 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.71 -173.33 4.06 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.021 -0.99 . . . . 72.54 110.384 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.28 111.73 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.34 -1.3 . . . . 74.1 110.322 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 64.8 17.52 11.03 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.611 1.164 . . . . 75.44 112.443 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.4 103.82 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.343 -0.984 . . . . 75.54 108.343 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -118.12 125.84 51.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.82 0.848 . . . . 71.43 109.933 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.583 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.5 tt0 -84.03 112.09 19.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.05 0.94 . . . . 74.11 109.306 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.72 129.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.745 -1.206 . . . . 74.32 107.745 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.42 105.23 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.68 100.38 12.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.192 -1.04 . . . . 63.33 108.192 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -93.43 111.33 22.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.097 1.359 . . . . 75.3 109.486 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.556 ' HB ' HD11 ' C' ' 114' ' ' ILE . 2.9 t -103.11 137.23 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.02 -0.733 . . . . 75.53 109.02 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 54.1 m -119.17 133.76 55.59 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.541 -0.911 . . . . 70.32 108.541 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.59 HG23 HG21 ' C' ' 114' ' ' ILE . 93.9 t -124.76 117.31 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.979 1.312 . . . . 71.4 107.49 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -117.02 134.4 54.79 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.937 -0.764 . . . . 72.42 108.937 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.0 95.52 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.889 -1.523 . . . . 63.52 106.889 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -149.07 123.16 9.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.367 0.267 . . . . 65.12 111.317 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -85.86 77.29 9.75 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.045 -1.095 . . . . 72.21 108.045 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.44 -93.23 0.24 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.169 -0.923 . . . . 74.23 112.643 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.4 -15.48 21.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.998 0.919 . . . . 65.31 111.522 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -98.1 95.42 7.43 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.088 0.555 . . . . 63.42 110.231 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.8 m -89.46 118.39 29.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.012 0.434 . . . . 65.12 111.242 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.83 -53.44 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.127 0.971 . . . . 63.43 108.846 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.15 168.48 27.3 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.454 -1.248 . . . . 75.33 111.844 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.4 tm? -140.65 146.31 37.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.39 -2.078 . . . . 72.5 105.39 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.404 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.8 t -153.33 130.81 11.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.179 -0.675 . . . . 64.33 109.179 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -136.36 129.55 31.48 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.757 -0.46 . . . . 74.34 109.757 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.71 114.67 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.857 . . . . 73.14 109.062 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.99 95.44 10.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.146 0.978 . . . . 64.43 108.701 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.554 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.9 tp-100 -83.67 105.76 14.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.851 -0.613 . . . . 74.33 109.685 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.24 144.37 21.63 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.565 -0.614 . . . . 71.2 111.565 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.43 117.16 0.93 Allowed Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 110.155 -1.178 . . . . 71.32 110.155 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.57 HD13 HD12 ' C' ' 51' ' ' LEU . 11.2 mm -81.52 122.33 36.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.093 -1.077 . . . . 73.2 108.093 176.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -131.2 128.75 40.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.731 0.812 . . . . 74.3 109.028 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.3 m -71.36 114.19 9.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.128 -0.693 . . . . 75.23 109.128 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 mm -116.85 101.24 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.957 0.903 . . . . 74.31 108.64 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -133.94 150.58 51.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.698 . . . . 73.35 109.76 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -47.12 3.58 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 121.247 0.36 . . . . 31.52 113.074 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.75 149.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.84 1.256 . . . . 65.44 110.527 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -160.6 155.93 24.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.935 0.494 . . . . 74.14 111.032 -174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.09 -142.76 28.89 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.166 0.412 . . . . 51.02 113.687 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -61.42 -24.72 66.72 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.161 0.984 . . . . 74.53 111.821 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -58.95 -57.39 13.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.82 0.848 . . . . 75.23 110.097 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.418 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 26.6 ptm -74.41 -23.35 58.94 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.775 -0.648 . . . . 72.14 111.056 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.63 84.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.296 0.638 . . . . 72.02 111.064 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.51 -29.99 68.71 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.255 0.622 . . . . 75.51 110.955 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.37 -62.34 1.51 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.536 0.334 . . . . 74.52 110.296 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.8 pp -76.08 -12.92 60.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.172 0.589 . . . . 74.53 112.521 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.38 33.16 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.587 -0.563 . . . . 65.33 113.962 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.28 -56.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 117.626 0.713 . . . . 75.13 111.588 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -70.78 -61.46 1.76 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.684 0.394 . . . . 75.14 111.798 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 69.3 m -54.86 -45.5 99.7 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.97 0.908 . . . . 72.14 112.291 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -47.97 -48.57 15.94 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.757 2.304 . . . . 72.14 113.72 167.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.495 HD22 ' HA ' ' C' ' 132' ' ' ASN . 4.8 m-20 -74.63 -15.42 60.82 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.687 0.795 . . . . 73.31 113.114 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.433 HD13 HH12 ' A' ' 111' ' ' ARG . 36.3 mm -75.5 -40.89 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.279 -0.637 . . . . 75.42 109.279 169.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 67.8 mt -86.31 -17.92 33.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.178 0.991 . . . . 74.21 111.915 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.428 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 50.2 t80 -65.12 -46.63 73.17 Favored Pre-proline 0 CA--C 1.55 0.981 0 CA-C-O 117.535 -1.221 . . . . 73.14 113.031 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.89 -37.75 97.49 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.942 1.761 . . . . 71.3 112.634 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -65.28 -52.68 52.7 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 74.42 110.873 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -66.16 -35.17 79.77 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.151 0.58 . . . . 74.1 111.351 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.24 -53.11 61.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.573 1.149 . . . . 73.13 110.217 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.1 tm-20 -67.35 -34.94 78.36 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.837 0.711 . . . . 74.41 110.107 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 27.6 t -67.39 -32.92 74.16 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.071 0.548 . . . . 73.34 111.393 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.59 HG21 HG23 ' C' ' 64' ' ' VAL . 88.7 mt -73.11 -51.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.362 0.665 . . . . 75.34 110.223 172.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 34.8 m -63.03 -29.0 70.48 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.281 0.632 . . . . 62.44 110.929 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.4 t -65.44 -52.4 53.46 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.306 -0.861 . . . . 74.11 109.033 170.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.6 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.53 -40.44 75.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.889 1.276 . . . . 73.44 113.016 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -65.89 -45.2 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.667 0.787 . . . . 75.21 109.761 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.9 t -70.64 -24.01 62.63 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.153 -0.931 . . . . 72.31 111.26 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.4 mtt-85 -69.94 -36.41 75.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.472 0.709 . . . . 72.5 109.272 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.34 10.06 62.43 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 124.002 0.814 . . . . 61.42 112.79 172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 81.9 p 57.61 37.21 27.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.046 1.738 . . . . 62.32 113.425 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.574 ' HE1' HG11 ' C' ' 31' ' ' VAL . 61.1 m-85 -105.73 162.23 20.36 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.363 1.065 . . . . 73.24 110.216 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.99 146.0 97.02 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.107 2.538 . . . . 74.11 113.384 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -58.49 108.92 0.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.003 0.921 . . . . 74.2 109.632 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.2 tp -110.21 91.64 3.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.839 -1.171 . . . . 72.23 107.839 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -91.17 115.47 28.05 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.564 -0.902 . . . . 72.33 108.564 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.428 ' HB3' ' HZ ' ' C' ' 107' ' ' PHE . 2.3 tt -64.97 132.86 50.42 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.325 -0.991 . . . . 74.14 108.325 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.94 139.42 70.72 Favored Pre-proline 0 CA--C 1.549 0.921 0 O-C-N 124.11 0.882 . . . . 72.11 110.968 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.48 104.61 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.303 2.002 . . . . 72.54 111.296 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.0 107.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 108.402 -0.962 . . . . 74.42 108.402 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.495 ' HA ' HD22 ' C' ' 104' ' ' ASN . 15.3 m120 -113.23 89.52 3.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.498 0.719 . . . . 73.43 110.149 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -70.78 -30.32 66.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.049 -0.978 . . . . 73.41 109.428 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.245 1.018 . . . . 73.52 111.364 173.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.6 ttp . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 113.13 0.789 . . . . 75.14 113.13 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.596 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 42.0 m -115.26 135.15 54.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.173 -1.047 . . . . 73.13 108.173 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' D' ' 85' ' ' SER . 72.0 t80 -154.22 119.31 5.03 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.443 -0.947 . . . . 72.54 108.443 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -132.37 147.21 52.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.565 0.746 . . . . 65.33 110.371 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 122.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.916 -1.142 . . . . 74.34 107.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -100.3 -46.36 5.29 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.1 -0.375 . . . . 75.22 110.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -169.92 121.99 0.69 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.484 0.49 . . . . 75.51 110.606 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' B' ' 130' ' ' PRO . 2.6 mp -109.63 131.76 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 107.469 -1.308 . . . . 74.43 107.469 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.451 ' HE2' ' HG2' ' D' ' 19' ' ' LYS . 44.3 p90 -162.52 178.47 8.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.52 0.676 . . . . 71.42 111.794 -173.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.2 p -104.91 123.75 48.29 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.671 0.788 . . . . 53.25 109.654 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.451 ' HG2' ' HE2' ' D' ' 17' ' ' TYR . 32.3 mtpt -91.27 -22.96 20.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.965 -0.383 . . . . 64.12 109.965 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.9 t70 -155.11 141.73 18.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.521 0.728 . . . . 73.05 109.76 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.6 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.2 mt -140.84 147.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.01 1.324 . . . . 73.12 108.085 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.74 145.99 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.843 0.857 . . . . 72.02 109.34 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.3 t80 -148.97 124.93 10.63 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.649 -1.611 . . . . 71.03 106.649 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.6 mt-10 -124.31 142.16 51.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.581 0.753 . . . . 73.24 109.487 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' D' ' 28' ' ' ALA . . . -147.68 76.31 10.8 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.763 0.825 . . . . 72.35 109.081 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.54 -47.71 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.43 2.087 . . . . 72.01 111.622 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' D' ' 72' ' ' THR . 26.1 m-20 -97.12 36.13 1.48 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.953 0.901 . . . . 74.44 108.955 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' D' ' 25' ' ' ALA . . . -60.47 -54.66 52.68 Favored Pre-proline 0 CA--C 1.559 1.289 0 N-CA-C 114.294 1.22 . . . . 61.12 114.294 -172.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.41 ' HA ' ' NH1' ' C' ' 15' ' ' ARG . 49.3 Cg_endo -80.04 -7.3 14.23 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 121.237 1.477 . . . . 71.33 112.605 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.521 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 19.4 t-160 -83.83 -38.81 20.74 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.214 1.406 . . . . 73.53 110.099 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -82.96 -20.83 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 74.24 110.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.23 -28.91 69.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.856 0.862 . . . . 73.23 110.688 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 63.3 mt-30 -67.04 -20.39 65.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.749 1.219 . . . . 75.31 111.557 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -100.86 111.59 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.271 1.029 . . . . 75.51 110.059 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -85.86 63.26 7.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.354 1.061 . . . . 73.13 111.108 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.524 ' HB3' HD13 ' D' ' 68' ' ' LEU . 48.2 t-105 -144.69 167.98 21.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.71 116.64 66.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.586 0.754 . . . . 73.34 110.031 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -50.61 133.93 39.17 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.642 2.894 . . . . 73.32 113.764 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.39 130.6 43.89 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.782 -0.451 . . . . 75.24 109.782 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.43 134.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.382 0.673 . . . . 72.45 110.786 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.533 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.1 tmtt? -130.6 121.38 25.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.428 -1.693 . . . . 72.32 106.428 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 146.9 26.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.102 0.561 . . . . 74.13 110.978 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.718 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.8 m-20 -137.14 122.95 20.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.215 1.406 . . . . 75.34 107.609 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -117.2 144.24 44.99 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.986 0.514 . . . . 75.03 110.943 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 2.6 t70 -146.82 154.02 40.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.511 1.124 . . . . 74.11 109.3 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -142.76 148.42 37.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.469 0.708 . . . . 71.13 109.775 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 168.0 25.01 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.651 1.18 . . . . 70.5 108.14 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -160.5 153.83 21.96 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.054 0.454 . . . . 74.41 111.244 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -154.36 119.6 5.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.717 1.207 . . . . 63.44 108.98 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.58 126.28 29.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.167 0.587 . . . . 74.24 109.543 175.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.66 -40.69 13.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.942 0.497 . . . . 75.33 109.701 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.14 -174.97 4.99 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.078 -0.964 . . . . 74.23 110.243 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -63.08 123.35 18.36 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.631 -0.713 . . . . 73.33 110.301 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.44 -2.24 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.873 1.269 . . . . 73.43 112.909 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.68 118.68 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.842 0.857 . . . . 63.44 108.868 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -128.97 128.53 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.877 -1.157 . . . . 75.51 107.877 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -97.13 141.33 30.4 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.824 -1.547 . . . . 64.15 106.824 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.26 130.55 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.052 -0.722 . . . . 73.42 109.052 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.82 138.84 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 123.916 0.887 . . . . 74.3 109.684 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.17 120.77 27.95 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.528 -1.286 . . . . 72.43 107.528 171.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -107.25 121.62 44.91 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.231 1.012 . . . . 75.54 109.32 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.59 122.49 67.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.613 -1.255 . . . . 73.14 107.613 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.6 m -121.2 131.81 54.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.743 0.817 . . . . 75.2 109.462 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.436 HG21 HD12 ' D' ' 114' ' ' ILE . 80.7 t -119.55 109.13 25.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.082 1.353 . . . . 74.31 109.261 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 23.6 m -94.89 117.68 30.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.144 -1.058 . . . . 74.55 108.144 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.92 133.07 51.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.464 -0.569 . . . . 64.25 109.464 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.432 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 51.2 p -145.83 134.82 22.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.069 0.548 . . . . 70.51 109.797 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' D' ' 36' ' ' TRP . 19.0 tp -117.87 118.94 33.37 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.105 -0.702 . . . . 72.22 109.105 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.09 -115.18 4.01 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.15 -0.78 . . . . 64.41 111.15 -170.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.19 9.06 10.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.032 0.933 . . . . 70.43 110.268 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.88 156.56 39.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.014 0.926 . . . . 65.13 110.298 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 99.1 m -68.83 123.99 22.47 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.654 0.782 . . . . 70.23 110.576 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.432 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.52 -57.28 3.21 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.707 0.803 . . . . 73.11 109.322 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.94 149.75 16.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.801 -1.091 . . . . 74.04 109.683 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -113.65 153.64 28.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.418 1.087 . . . . 75.22 108.209 172.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.583 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.8 t -156.09 142.41 18.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.106 0.562 . . . . 75.21 109.592 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.22 121.4 4.3 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.838 0.455 . . . . 64.41 110.075 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.31 115.26 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.316 0.647 . . . . 74.33 109.973 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.2 mt-30 -89.16 87.76 7.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.737 -0.838 . . . . 70.33 108.737 169.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.89 104.04 10.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.516 -1.22 . . . . 74.34 108.664 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.59 143.68 15.7 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.901 -0.479 . . . . 61.22 111.901 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.411 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.99 131.41 4.57 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.789 -0.524 . . . . 73.52 111.789 -171.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.8 123.03 40.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 C-N-CA 123.926 0.89 . . . . 64.44 108.761 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -128.64 163.05 25.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.925 0.89 . . . . 73.5 109.98 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.8 m -107.3 112.88 25.94 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.529 -0.915 . . . . 71.21 108.529 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.77 115.63 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 107.877 -1.157 . . . . 75.3 107.877 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -145.91 157.6 43.89 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.318 1.047 . . . . 63.24 109.785 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.44 -14.28 12.96 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.086 -0.506 . . . . 44.44 113.567 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.9 138.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.956 1.303 . . . . 74.11 109.312 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -152.4 -177.35 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.2 0.6 . . . . 73.34 110.718 174.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.64 -120.15 6.81 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.037 -0.529 . . . . 73.21 112.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -64.33 -39.3 93.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.805 0.842 . . . . 75.44 111.301 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.91 -37.63 72.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.738 0.415 . . . . 74.1 111.094 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.653 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 58.3 ttp -72.58 -36.1 68.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.596 0.359 . . . . 74.32 110.567 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.71 86.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.169 0.588 . . . . 62.21 110.392 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -68.3 -37.72 80.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.814 0.846 . . . . 73.44 110.809 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' D' ' 102' ' ' CYS . 33.3 t -68.68 -51.25 43.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.673 0.389 . . . . 61.43 110.158 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.41 -18.78 59.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.347 0.659 . . . . 72.2 111.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.61 -8.98 44.87 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.409 -0.662 . . . . 74.12 114.14 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.94 -63.19 0.35 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.878 0.839 . . . . 70.52 112.25 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.13 -56.52 11.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.397 0.888 . . . . 72.53 113.397 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' D' ' 97' ' ' CYS . 65.4 m -61.91 -43.27 86.51 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-O 118.594 -0.717 . . . . 75.32 111.606 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -51.6 -39.6 65.38 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.463 2.109 . . . . 74.12 114.121 164.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -69.98 -25.29 63.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.599 0.76 . . . . 74.5 111.063 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 48.2 mm -70.27 -40.61 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.349 0.66 . . . . 72.12 110.112 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.411 HD22 ' HA3' ' D' ' 82' ' ' GLY . 61.7 mt -77.06 -26.51 53.62 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.194 -0.912 . . . . 73.11 111.667 -174.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.497 ' HZ ' HD11 ' D' ' 128' ' ' LEU . 85.4 t80 -53.97 -47.91 95.52 Favored Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 125.039 1.336 . . . . 74.12 114.469 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 80.7 Cg_exo -51.0 -41.07 57.97 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.431 2.087 . . . . 72.43 113.712 172.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.539 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 70.9 m-85 -75.87 -34.98 60.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.892 0.877 . . . . 75.44 111.888 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.84 73.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.141 0.577 . . . . 72.01 109.894 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -56.45 -48.34 77.25 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.581 1.176 . . . . 73.33 110.234 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.45 -44.69 95.81 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.081 0.863 . . . . 74.51 111.121 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.6 t -61.38 -43.71 98.41 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.594 0.559 . . . . 73.21 110.856 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.583 HG12 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -57.11 -57.91 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.877 0.871 . . . . 74.13 110.23 173.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.54 HG21 ' HG3' ' D' ' 125' ' ' GLN . 87.9 m -53.79 -46.69 71.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.362 1.465 . . . . 75.51 112.02 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -62.55 -41.11 98.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.91 -1.041 . . . . 71.14 110.036 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.414 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.4 mtm -70.05 -33.8 72.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.144 0.578 . . . . 73.15 111.667 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -64.39 -43.3 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.594 0.758 . . . . 75.05 110.406 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.79 -33.51 66.32 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 116.105 -0.498 . . . . 73.54 110.704 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -68.06 -32.68 73.2 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.997 0.919 . . . . 75.41 110.42 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.04 81.86 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.719 -0.673 . . . . 65.31 112.849 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 56.18 45.15 23.85 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.446 1.498 . . . . 72.23 112.258 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -117.85 155.37 50.98 Favored Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.799 -1.092 . . . . 75.11 110.23 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.48 112.07 0.61 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.25 2.633 . . . . 74.13 112.321 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.54 ' HG3' HG21 ' D' ' 115' ' ' THR . 34.9 tt0 -61.28 128.74 37.83 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.148 0.905 . . . . 75.2 112.025 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.25 120.29 41.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.878 -1.156 . . . . 73.12 107.878 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -112.72 95.13 5.25 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.864 -1.162 . . . . 72.03 107.864 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.497 HD11 ' HZ ' ' D' ' 107' ' ' PHE . 0.2 OUTLIER -70.34 125.93 28.19 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.062 0.545 . . . . 72.12 109.642 -174.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 142.14 96.66 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.896 0.878 . . . . 74.32 111.508 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.4 124.9 6.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.948 2.432 . . . . 74.44 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -127.27 123.72 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.947 0.899 . . . . 64.52 109.481 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -76.82 94.83 3.93 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.894 -0.78 . . . . 75.33 108.894 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 118.815 -0.612 . . . . 74.24 111.256 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.232 0.183 0 N-CA-C 108.051 -1.092 . . . . 70.54 108.051 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -131.56 152.91 50.39 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.282 0.633 . . . . 74.4 110.316 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -155.84 123.24 5.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.565 0.746 . . . . 75.12 109.522 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -81.04 125.91 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.641 -1.615 . . . . 74.14 106.641 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.462 ' HB3' HH11 ' A' ' 15' ' ' ARG . 88.3 mt-30 -109.83 -42.05 4.35 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 122.092 -0.38 . . . . 74.12 111.134 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.462 HH11 ' HB3' ' A' ' 14' ' ' GLN . 2.3 mpt_? -152.34 141.46 21.32 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.219 -1.03 . . . . 70.41 108.219 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.682 HG22 HD23 ' A' ' 106' ' ' LEU . 55.5 mt -141.13 101.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.025 -1.842 . . . . 74.12 106.025 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 73.0 m-85 -155.36 177.97 10.75 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.634 0.774 . . . . 75.0 110.287 -162.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.3 p -98.24 113.56 25.53 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.679 -0.691 . . . . 73.22 109.846 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -78.17 -32.61 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.802 -0.444 . . . . 74.45 109.802 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.0 t70 -149.02 147.63 28.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.999 -0.546 . . . . 73.42 109.735 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.8 mt -140.72 144.13 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.198 1.399 . . . . 73.41 107.803 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -157.4 120.9 4.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.77 0.319 . . . . 73.04 110.915 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.8 t80 -118.41 134.3 55.17 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.126 -1.435 . . . . 73.31 107.126 171.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -129.55 140.8 51.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.216 -1.031 . . . . 72.23 108.216 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.16 84.29 16.91 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.55 -0.907 . . . . 70.4 108.55 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.23 -49.64 1.85 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.986 2.457 . . . . 73.42 112.199 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 44.4 m-80 -103.28 43.92 1.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.605 0.762 . . . . 70.42 109.445 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.48 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -59.42 -51.95 77.71 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.125 0.97 . . . . 73.44 113.205 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -22.66 14.73 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.867 1.711 . . . . 73.43 111.939 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 7.5 t60 -83.04 -25.35 32.21 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.948 1.299 . . . . 74.21 111.992 -168.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.99 -26.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.915 0.886 . . . . 73.32 112.553 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.407 ' HD2' ' HZ2' ' A' ' 36' ' ' TRP . 70.2 m-85 -70.3 -34.73 73.09 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.621 0.768 . . . . 75.14 112.169 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -63.36 -36.32 83.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.199 0.999 . . . . 70.11 110.177 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.84 154.79 23.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.549 -1.205 . . . . 74.32 110.756 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.0 118.49 16.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.008 -0.738 . . . . 74.24 109.008 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.407 ' HZ2' ' HD2' ' A' ' 32' ' ' PHE . 5.5 m0 -60.47 86.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 74.22 112.298 -174.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -128.26 75.04 79.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.074 0.95 . . . . 75.01 108.579 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.16 139.88 7.36 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.589 2.193 . . . . 71.35 112.279 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.571 ' HB2' ' HZ1' ' A' ' 41' ' ' LYS . 31.4 mt-10 -95.82 106.77 18.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.708 -1.59 . . . . 74.42 106.708 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -85.15 92.07 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 123.651 0.594 . . . . 74.01 109.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' A' ' 39' ' ' GLU . 10.7 mptt -75.82 133.03 40.74 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.944 -0.761 . . . . 74.32 108.944 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -121.56 115.79 23.45 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.466 -1.309 . . . . 74.22 107.466 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.66 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.5 m-20 -122.14 135.76 54.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.02 0.928 . . . . 73.41 108.707 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.0 mt -121.72 134.06 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.692 0.797 . . . . 72.22 109.11 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 33.8 t70 -142.17 144.66 33.53 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.896 0.478 . . . . 53.23 110.039 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -139.11 130.59 27.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.77 0.828 . . . . 74.14 110.73 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.45 149.27 42.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.958 0.903 . . . . 71.51 109.754 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.6 p -106.28 164.17 12.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.577 0.751 . . . . 74.54 109.628 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -153.97 131.16 11.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.056 0.942 . . . . 75.33 108.476 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -88.73 122.35 32.05 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.023 0.529 . . . . 74.13 110.563 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.2 mt -91.5 -44.71 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.164 -0.925 . . . . 53.52 109.106 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.18 176.82 10.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.626 -1.17 . . . . 73.12 109.532 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.84 114.62 10.12 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.919 -1.141 . . . . 71.22 107.919 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 75.23 3.52 4.06 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.314 1.446 . . . . 75.35 112.908 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.1 t -112.79 111.97 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 108.649 -0.871 . . . . 65.31 108.649 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -125.21 156.01 39.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.433 0.693 . . . . 75.34 110.054 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -131.5 117.78 19.26 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.155 0.982 . . . . 74.42 108.743 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.98 128.63 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.167 -1.049 . . . . 72.23 108.167 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -109.03 134.23 51.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.636 0.775 . . . . 73.44 109.197 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.15 118.75 37.57 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.447 -1.316 . . . . 74.54 107.447 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.26 101.75 13.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.166 -1.05 . . . . 75.22 108.166 171.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.3 t -95.32 132.77 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.78 -1.193 . . . . 72.1 107.78 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.66 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.0 m -118.24 133.12 56.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.844 -0.799 . . . . 73.2 108.844 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -132.52 105.07 8.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.798 -1.556 . . . . 74.15 106.798 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.8 m -113.21 129.45 56.51 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.929 -0.767 . . . . 74.23 108.929 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.89 105.42 11.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.742 -1.207 . . . . 73.2 107.742 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 23.9 m -121.66 127.82 51.22 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.674 -0.491 . . . . 72.11 109.674 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt -89.17 81.98 6.65 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.917 -1.512 . . . . 72.31 106.917 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -119.17 5.14 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.419 -0.81 . . . . 42.2 112.245 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.81 -14.66 41.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.776 0.83 . . . . 73.25 111.3 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.3 132.56 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.661 1.184 . . . . 72.13 109.336 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -83.83 131.37 34.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.856 0.36 . . . . 75.5 110.717 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.91 -54.11 5.34 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.883 0.873 . . . . 74.45 109.008 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -159.79 174.13 14.95 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.539 -0.755 . . . . 72.34 111.533 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 tp -141.18 148.4 39.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.571 1.548 . . . . 73.44 108.058 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.547 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 60.2 m -136.86 133.44 35.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.432 -0.951 . . . . 73.13 108.432 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.96 124.8 11.91 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.14 -0.689 . . . . 74.32 109.14 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.93 117.12 25.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 123.581 0.753 . . . . 74.44 109.45 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -84.79 85.1 7.49 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.309 -0.997 . . . . 73.21 108.309 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.21 92.44 6.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.774 -1.195 . . . . 71.41 107.774 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -103.66 143.67 15.78 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.762 -0.935 . . . . 72.31 110.762 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.51 141.82 11.44 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.308 -0.717 . . . . 74.12 111.308 -174.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.4 mt -88.37 120.76 37.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.981 -0.748 . . . . 74.41 108.981 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.88 118.1 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.45 1.1 . . . . 73.31 108.086 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -83.74 115.32 22.15 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.262 -1.014 . . . . 74.32 108.262 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.448 HG22 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -133.71 135.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.22 0.608 . . . . 62.23 109.38 -173.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 172.33 15.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.796 1.239 . . . . 71.52 109.669 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.34 -36.84 3.8 Favored Glycine 0 N--CA 1.465 0.613 0 CA-C-N 115.575 -0.738 . . . . 64.24 112.673 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.8 147.42 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.367 0.667 . . . . 71.1 110.374 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.513 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.7 tt0 -135.98 -176.33 4.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.133 0.973 . . . . 74.44 108.951 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.513 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.49 -137.15 28.74 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.94 -0.367 . . . . 74.12 112.88 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -65.6 -20.79 66.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.917 0.887 . . . . 71.1 111.723 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.69 -53.33 22.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.012 0.925 . . . . 62.14 110.626 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -29.19 62.23 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 116.347 -0.388 . . . . 74.3 110.343 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.72 96.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.359 0.664 . . . . 64.15 109.862 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.474 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 8.3 t-80 -62.48 -39.01 92.08 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.328 -1.305 . . . . 74.11 110.741 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 7.1 m -78.35 -61.96 1.84 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.047 0.758 . . . . 62.35 113.047 -175.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.448 HD21 HG22 ' A' ' 86' ' ' ILE . 95.0 mt -67.74 -22.7 65.22 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 75.03 112.471 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.06 -10.84 44.59 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.407 -0.663 . . . . 64.43 114.364 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 96' ' ' HIS . . . -149.01 -52.6 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.979 1.474 . . . . 75.23 114.979 -169.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.626 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.4 t80 -55.24 -59.74 4.36 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.077 0.951 . . . . 73.31 110.25 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -67.88 -45.65 43.14 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 114.334 -1.303 . . . . 72.01 112.747 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.44 -42.2 41.97 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.661 2.241 . . . . 74.04 114.54 168.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -71.73 -30.75 65.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.794 0.438 . . . . 73.43 110.493 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.8 mm -70.54 -34.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 72.4 110.278 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 16' ' ' ILE . 84.0 mt -73.29 -28.77 62.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.907 0.883 . . . . 74.15 111.305 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.81 -44.87 87.14 Favored Pre-proline 0 CA--C 1.568 1.647 0 N-CA-C 115.144 1.535 . . . . 74.14 115.144 -167.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.51 -31.31 80.36 Favored 'Trans proline' 0 C--N 1.387 2.589 0 CA-C-N 122.028 1.76 . . . . 72.21 113.257 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.82 -34.29 39.63 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.245 0.618 . . . . 73.4 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.82 77.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.55 -0.537 . . . . 71.11 109.55 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.51 HH12 HD13 ' C' ' 105' ' ' ILE . 38.4 ttm180 -52.6 -49.84 64.23 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.922 1.389 . . . . 75.34 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.36 -48.02 81.61 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.046 0.841 . . . . 75.3 111.196 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -60.39 -36.02 77.1 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.797 0.686 . . . . 73.24 111.491 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.481 HG21 HG22 ' A' ' 64' ' ' VAL . 87.4 mt -67.08 -58.68 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.678 0.791 . . . . 74.11 109.945 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 125' ' ' GLN . 69.0 m -56.09 -31.76 63.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.736 1.214 . . . . 71.03 111.438 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.2 -47.42 67.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.111 -0.95 . . . . 54.43 110.163 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -62.36 -38.24 88.79 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 122.696 0.399 . . . . 73.42 111.221 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.0 t -60.2 -49.56 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 O-C-N 123.968 0.792 . . . . 71.54 109.787 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -26.93 62.36 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.733 -0.667 . . . . 73.33 111.478 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.21 -31.09 65.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.385 0.674 . . . . 75.15 109.559 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 5.52 80.37 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.852 -0.613 . . . . 71.32 112.888 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.415 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 4.3 t 58.26 21.82 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.253 2.221 . . . . 73.22 113.902 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.2 148.11 44.11 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.982 -0.748 . . . . 75.24 108.982 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.45 128.17 26.81 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.026 2.484 . . . . 63.3 112.084 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -58.16 146.05 34.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.475 0.71 . . . . 71.34 111.532 -168.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.19 97.97 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.226 0.61 . . . . 73.44 109.376 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.19 108.05 20.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 55.12 108.532 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.4 148.58 41.07 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.745 0.818 . . . . 72.5 110.954 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.68 129.91 90.87 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.141 0.576 . . . . 54.11 110.427 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.441 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 11.9 Cg_exo -67.89 108.72 1.75 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.027 . . . . 75.43 111.549 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.7 t -99.7 111.11 28.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.092 . . . . 72.43 108.053 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -82.17 86.25 6.66 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.995 0.902 . . . . 52.32 109.379 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -59.95 -32.36 70.74 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.511 -1.222 . . . . 71.43 110.656 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.446 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.4 p-10 . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 124.189 0.996 . . . . 72.13 111.577 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.499 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 6.7 ptt? . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 113.299 0.851 . . . . 64.31 113.299 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.2 t -156.11 131.78 9.65 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 107.849 -1.167 . . . . 71.12 107.849 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' B' ' 85' ' ' SER . 69.3 t80 -131.71 146.36 52.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.926 0.891 . . . . 73.44 109.494 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -159.37 142.85 14.63 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.638 0.375 . . . . 73.44 110.756 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.422 HD12 HD13 ' B' ' 105' ' ' ILE . 54.3 mt -89.53 123.3 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.284 -1.006 . . . . 73.51 108.284 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.1 -35.7 16.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.748 0.419 . . . . 73.11 109.935 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.415 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 62.1 ttt180 -163.77 146.65 9.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.49 0.316 . . . . 74.32 110.589 -171.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.47 139.77 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.807 -1.553 . . . . 71.33 106.807 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.442 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 15.0 p90 -173.03 168.34 4.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.038 0.923 . . . . 74.21 112.642 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 66.9 m -90.38 129.27 36.6 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.32 -1.309 . . . . 73.43 108.89 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.442 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 48.6 mtpt -98.17 -40.1 8.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.399 0.68 . . . . 73.22 110.573 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.2 t70 -146.8 135.11 21.78 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.589 -0.732 . . . . 72.24 109.896 -163.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.482 HG22 ' HE2' ' B' ' 117' ' ' MET . 45.7 mm -136.3 140.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.713 1.205 . . . . 74.35 109.382 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -140.29 131.41 26.38 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.138 -1.43 . . . . 74.33 107.138 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.423 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -147.03 119.03 8.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.172 -1.418 . . . . 74.12 107.172 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.99 129.94 55.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.495 -0.928 . . . . 74.44 108.495 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.84 81.2 66.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.93 -27.73 20.51 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.649 2.233 . . . . 72.41 111.764 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.91 29.47 7.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.136 0.974 . . . . 74.41 109.839 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.57 -50.61 65.16 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.595 1.158 . . . . 74.21 113.179 174.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.69 -12.67 6.25 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 122.055 1.837 . . . . 71.33 113.277 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.411 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.7 m-70 -93.7 3.82 54.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.883 0.873 . . . . 73.52 110.116 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.21 -14.37 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 123.751 0.82 . . . . 72.32 111.442 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -64.65 -30.9 71.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.494 0.718 . . . . 73.42 112.503 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.574 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.5 pt20 -85.19 -33.29 22.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.597 0.359 . . . . 74.32 110.104 171.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.587 ' HD3' ' HB3' ' B' ' 68' ' ' LEU . 95.8 mttt -109.48 66.49 0.63 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 74.43 111.984 -175.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.52 85.57 4.96 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 108.62 -0.881 . . . . 72.14 108.62 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -156.47 169.91 23.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.04 -0.726 . . . . 75.02 109.04 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.1 113.98 23.59 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.644 0.778 . . . . 75.35 110.609 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.62 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 2.8 Cg_exo -73.46 144.19 35.9 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.339 2.026 . . . . 74.33 111.9 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.01 103.2 1.78 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.466 -0.788 . . . . 74.53 109.204 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.41 135.75 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.241 -0.891 . . . . 71.22 110.782 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.622 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 97.1 mttt -132.12 101.21 5.31 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.357 1.063 . . . . 74.53 108.376 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.62 144.96 28.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.279 0.632 . . . . 75.13 109.828 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -148.25 139.21 23.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.757 -0.831 . . . . 75.44 108.757 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.403 HD11 HD22 ' B' ' 60' ' ' LEU . 3.7 mm? -111.31 133.17 53.83 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.965 0.906 . . . . 73.23 108.697 -173.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.7 t70 -127.91 135.74 50.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 55.21 108.952 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -109.97 114.08 27.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.683 0.793 . . . . 75.14 110.324 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.539 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -117.2 151.68 36.39 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.118 0.967 . . . . 75.33 109.336 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -145.08 168.82 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.797 0.439 . . . . 74.41 111.157 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.0 p -153.75 154.49 34.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 74.44 108.92 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.96 103.27 13.37 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.179 -0.674 . . . . 73.12 109.179 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' B' ' 57' ' ' GLU . 67.4 mt -77.88 -34.16 51.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.19 -0.913 . . . . 75.33 110.631 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.94 -170.64 2.01 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.805 0.842 . . . . 65.14 110.256 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.58 108.79 2.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.746 -1.116 . . . . 63.14 109.39 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 72.31 2.58 4.38 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.376 1.47 . . . . 71.2 112.863 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.87 93.4 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.651 -1.24 . . . . 61.44 107.651 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -107.26 138.38 43.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.993 -1.003 . . . . 75.11 109.392 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.445 ' HB2' HD13 ' B' ' 51' ' ' LEU . 23.2 tt0 -98.87 127.43 44.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.537 -1.282 . . . . 71.42 107.537 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.27 122.05 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 108.06 -1.089 . . . . 75.21 108.06 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.539 ' HB ' ' HB1' ' B' ' 47' ' ' ALA . 45.5 t -102.91 114.07 41.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.256 -1.016 . . . . 73.52 108.256 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.403 HD22 HD11 ' B' ' 44' ' ' LEU . 1.8 tt -91.24 127.12 36.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.75 -1.574 . . . . 72.22 106.75 175.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.3 ttt180 -119.0 120.77 38.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.613 -0.884 . . . . 73.12 108.613 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.545 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.2 t -112.85 112.94 42.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.966 -1.124 . . . . 64.01 107.966 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 43.0 m -93.96 135.88 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.273 -1.01 . . . . 74.03 108.273 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.442 HG22 HG21 ' B' ' 114' ' ' ILE . 82.6 t -130.31 130.95 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.027 0.931 . . . . 73.11 109.15 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.8 m -125.1 148.23 48.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.006 -1.109 . . . . 74.01 108.006 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -148.09 132.74 17.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.053 -1.091 . . . . 72.23 108.053 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.421 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 14.0 m -139.87 137.11 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.372 0.269 . . . . 71.03 110.579 -172.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.587 ' HB3' ' HD3' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -117.39 113.16 21.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.871 -1.159 . . . . 74.53 107.871 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.14 -129.59 18.04 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.624 0.578 . . . . 71.42 112.89 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -92.86 19.46 7.64 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 74.13 111.267 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.416 ' HB3' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 tp10 -147.96 159.3 44.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.588 0.355 . . . . 72.45 111.12 -171.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.7 m -71.23 137.48 48.69 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.477 0.711 . . . . 75.41 109.752 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.42 -56.63 3.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.078 -1.082 . . . . 64.1 108.078 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.49 171.32 17.25 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.731 -1.122 . . . . 74.14 110.674 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -141.1 146.17 36.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.609 1.564 . . . . 73.32 107.308 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.41 154.73 35.02 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.395 -0.595 . . . . 71.41 109.395 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.09 133.53 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.231 -0.655 . . . . 71.42 109.231 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.425 HG21 HD12 ' B' ' 21' ' ' ILE . 92.1 t -126.77 144.98 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.624 0.769 . . . . 72.2 109.138 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.62 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.0 mt-30 -123.15 94.8 4.37 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.816 -0.809 . . . . 74.32 108.816 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.81 98.82 9.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.926 -1.034 . . . . 72.05 109.106 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 143.85 17.6 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.83 -0.908 . . . . 70.14 110.83 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.64 130.66 3.86 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.259 -0.736 . . . . 74.04 111.259 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.57 126.24 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.88 -0.785 . . . . 74.52 108.88 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.65 162.08 33.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.471 1.109 . . . . 71.11 109.125 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.8 m -131.51 112.97 13.12 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.493 0.717 . . . . 64.24 109.735 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.427 HD12 ' N ' ' B' ' 86' ' ' ILE . 1.1 mp -125.29 114.9 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.119 -1.067 . . . . 73.33 108.119 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.22 147.15 45.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.281 0.632 . . . . 52.03 110.793 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.23 -40.15 2.53 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.818 0.699 . . . . 65.11 113.133 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.672 HD13 ' HB2' ' B' ' 93' ' ' GLN . 5.7 tp -91.01 148.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.049 0.54 . . . . 74.22 111.037 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.466 ' H ' HD12 ' B' ' 89' ' ' ILE . 10.2 pt-20 -156.47 164.14 38.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.616 0.766 . . . . 71.41 111.319 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.97 -137.57 18.79 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 114.908 -1.042 . . . . 52.14 113.435 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 43.4 m -65.63 -40.35 92.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.089 0.956 . . . . 65.14 111.921 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.672 ' HB2' HD13 ' B' ' 89' ' ' ILE . 2.3 mp0 -66.0 -36.85 84.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 74.31 111.054 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.417 ' HB2' HG13 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -75.34 -25.21 57.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.206 0.602 . . . . 65.31 110.66 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.93 64.54 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.47 0.708 . . . . 63.34 111.907 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -86.47 -20.31 28.29 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.232 0.613 . . . . 74.14 111.231 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.401 ' HG ' HG12 ' B' ' 86' ' ' ILE . 41.9 t -70.84 -62.6 1.33 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.431 0.292 . . . . 73.11 110.4 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.68 -16.43 41.86 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.093 -0.379 . . . . 70.42 111.532 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.32 -37.4 17.99 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 123.471 0.482 . . . . 61.21 112.669 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.42 -50.54 1.76 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.704 0.631 . . . . 74.32 112.704 -170.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -69.44 -54.57 13.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.259 0.624 . . . . 65.43 111.602 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 81.4 m -63.33 -46.83 85.13 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.54 -0.743 . . . . 73.04 112.015 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -54.95 -38.25 93.12 Favored 'Trans proline' 0 C--N 1.391 2.782 0 C-N-CA 121.94 1.76 . . . . 64.44 113.901 170.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.73 -32.87 74.5 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.015 0.435 . . . . 75.32 111.083 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.422 HD13 HD12 ' B' ' 13' ' ' ILE . 94.8 mt -67.84 -44.25 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.262 1.025 . . . . 75.12 110.684 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.34 -26.1 46.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.022 0.929 . . . . 74.14 112.199 -172.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.407 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 49.3 t80 -59.43 -45.13 98.93 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.707 1.203 . . . . 74.53 113.986 -169.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.54 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 18.7 Cg_endo -58.23 -37.24 96.2 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.328 2.018 . . . . 73.31 113.984 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -70.36 -45.3 66.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.91 0.484 . . . . 74.43 110.368 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.84 -42.51 89.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.33 -0.85 . . . . 62.34 110.367 175.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.54 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 21.6 mtp-105 -52.21 -63.42 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.302 1.041 . . . . 74.31 111.391 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.44 -29.69 67.96 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.197 0.936 . . . . 64.31 110.639 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.8 t -70.81 -48.6 53.22 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.104 0.561 . . . . 71.53 111.086 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.545 HD11 ' HB ' ' B' ' 62' ' ' VAL . 48.2 mt -62.07 -51.86 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 123.417 0.687 . . . . 74.21 110.059 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -34.52 72.48 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.585 -1.189 . . . . 74.13 110.875 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.1 t -67.39 -50.2 60.65 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.534 -0.757 . . . . 65.13 110.392 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -63.48 -38.04 89.63 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.884 0.473 . . . . 75.2 111.421 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.99 -43.16 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.014 0.925 . . . . 72.52 110.767 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -62.68 -36.77 83.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.925 0.89 . . . . 63.42 111.055 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 93.6 mtt-85 -68.74 -20.62 64.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.138 -0.937 . . . . 75.4 111.472 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.07 16.63 59.87 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 119.482 -0.621 . . . . 75.35 114.209 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p 72.65 13.0 5.34 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 126.528 1.931 . . . . 74.31 112.836 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -97.94 152.83 38.27 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 122.641 0.376 . . . . 71.34 110.922 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.34 144.14 98.29 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.227 2.618 . . . . 71.33 112.001 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.721 ' HB3' HE21 ' C' ' 125' ' ' GLN . 4.9 pp0? -61.41 129.24 40.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.527 0.731 . . . . 74.51 111.715 -172.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.19 86.86 2.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.694 -0.854 . . . . 75.1 108.694 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -90.64 118.4 30.06 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.672 -1.233 . . . . 70.31 107.672 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.526 ' HB2' ' HG2' ' B' ' 111' ' ' ARG . 2.4 mm? -77.47 128.34 34.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.277 -0.638 . . . . 75.53 109.277 -173.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.37 136.51 93.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.37 0.668 . . . . 60.12 110.626 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.614 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 19.0 Cg_endo -60.5 89.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.135 2.557 . . . . 73.31 112.796 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.55 118.95 39.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.721 -0.844 . . . . 74.33 108.721 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.67 114.59 7.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.564 0.745 . . . . 73.43 110.419 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.556 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 53.3 m-85 -64.75 -29.18 70.15 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.826 0.85 . . . . 73.52 110.268 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -66.64 -40.92 88.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.946 0.898 . . . . 72.41 110.807 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.07 68.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.453 0.701 . . . . 74.22 110.948 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 124.032 0.933 . . . . 75.34 109.314 173.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.678 ' HG2' ' HB ' ' C' ' 89' ' ' ILE . 69.0 mtp . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.131 0.491 . . . . 63.01 111.518 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.699 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 49.4 m -84.43 85.91 7.34 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.447 -1.316 . . . . 73.45 107.447 173.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.441 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 80.9 t80 -106.16 126.25 51.98 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.435 -1.257 . . . . 72.32 109.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -145.8 139.78 26.65 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.018 -0.734 . . . . 62.31 109.018 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.39 106.45 3.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.209 -1.034 . . . . 73.4 108.209 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.554 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.8 mm-40 -77.29 -48.83 16.42 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 123.254 0.346 . . . . 74.51 110.343 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -166.87 149.29 6.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.526 -0.761 . . . . 74.45 109.438 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.2 mt -133.89 132.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 107.633 -1.247 . . . . 73.53 107.633 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -171.11 165.28 7.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.033 0.921 . . . . 75.11 112.849 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -88.04 104.01 16.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.296 -1.32 . . . . 75.14 109.072 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 7.0 mtmt -71.1 -23.71 62.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.884 0.374 . . . . 74.53 110.201 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.602 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.5 t70 -158.25 140.7 14.38 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.603 -0.726 . . . . 73.13 109.319 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.1 mt -134.69 144.16 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.212 -1.403 . . . . 74.1 107.212 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -149.57 150.12 31.74 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.345 0.658 . . . . 71.01 109.276 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -155.69 118.75 4.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.256 -1.016 . . . . 75.32 108.256 175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.95 121.39 40.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.398 -0.964 . . . . 65.05 108.398 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.89 85.76 29.27 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.043 -1.095 . . . . 75.43 108.043 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.94 -37.81 10.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.59 2.193 . . . . 74.32 111.857 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.64 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 1.9 m-20 -107.69 39.8 1.85 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.91 -0.774 . . . . 72.22 108.91 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -51.65 -49.54 82.41 Favored Pre-proline 0 CA--C 1.563 1.448 0 N-CA-C 114.271 1.212 . . . . 72.42 114.271 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.474 ' HA ' HH12 ' D' ' 15' ' ' ARG . 37.2 Cg_endo -86.99 -22.2 1.87 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 121.523 1.482 . . . . 62.45 112.831 173.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.64 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 25.1 t-80 -69.51 -23.49 63.62 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.119 0.968 . . . . 75.45 111.547 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.435 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 7.1 p -60.55 -23.4 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.85 0.86 . . . . 74.52 112.25 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.435 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 82.2 t80 -59.14 -41.18 87.68 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.147 0.979 . . . . 72.32 111.847 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -86.96 6.0 34.34 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.62 0.6 . . . . 73.51 112.62 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.435 ' HZ2' ' HA ' ' C' ' 31' ' ' VAL . 16.1 pttm -123.42 178.28 5.23 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.255 0.55 . . . . 74.11 110.736 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.62 133.97 33.72 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.484 -1.235 . . . . 73.25 110.003 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.477 ' HB3' ' HG3' ' C' ' 124' ' ' PRO . 20.4 m-90 -85.38 64.72 8.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.752 0.821 . . . . 74.12 111.041 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -144.37 62.98 10.59 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.466 1.107 . . . . 74.34 108.737 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.53 174.99 9.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.226 1.951 . . . . 74.03 110.847 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -85.36 115.83 23.33 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.901 -0.778 . . . . 74.12 108.901 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.13 101.18 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.564 -0.902 . . . . 74.21 108.564 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.81 98.47 11.62 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.552 -1.647 . . . . 73.41 106.552 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -89.38 162.36 15.83 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.42 0.288 . . . . 74.51 110.506 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -159.62 108.47 1.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.272 0.629 . . . . 65.43 109.575 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -107.57 141.15 39.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.104 0.961 . . . . 63.24 108.804 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.28 153.73 35.4 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.921 0.888 . . . . 73.54 108.69 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -131.76 133.84 45.21 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.405 -0.591 . . . . 73.23 109.405 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -113.24 172.25 7.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.536 1.135 . . . . 61.22 109.261 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.1 p -151.24 146.62 26.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.323 0.649 . . . . 75.22 109.971 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.54 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 10.1 m -144.14 149.07 35.91 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.577 -1.268 . . . . 73.2 107.577 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.13 114.55 28.75 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.649 -1.241 . . . . 74.34 107.649 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' C' ' 57' ' ' GLU . 24.9 mt -93.03 -36.89 12.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.394 0.678 . . . . 75.4 109.846 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.484 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -157.09 -175.64 5.53 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.922 -1.035 . . . . 74.21 110.039 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.24 108.5 1.09 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.399 -1.273 . . . . 72.54 110.016 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 70.6 -2.38 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.694 1.597 . . . . 75.41 113.106 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 97.0 t -98.61 102.81 13.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.412 -0.959 . . . . 74.12 108.412 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -110.19 160.21 16.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.539 0.736 . . . . 70.22 109.352 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.649 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.3 tt0 -120.51 127.27 52.04 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.142 0.977 . . . . 74.53 108.72 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.87 127.39 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.491 -1.3 . . . . 75.32 107.491 170.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 27.0 t -112.79 101.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.287 -1.005 . . . . 61.43 108.287 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.64 95.07 9.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.829 -1.174 . . . . 75.32 107.829 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -88.29 112.5 22.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.509 -1.223 . . . . 74.14 108.827 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.462 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.7 t -107.44 139.89 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.586 -0.894 . . . . 71.44 108.586 174.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -131.44 133.94 45.7 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.626 -0.879 . . . . 74.32 108.626 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.34 111.5 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.692 1.197 . . . . 74.11 108.6 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.53 HG21 HD23 ' C' ' 75' ' ' LEU . 2.4 m -99.06 146.57 25.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.835 -1.172 . . . . 72.11 107.835 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.86 107.99 7.22 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.945 -1.502 . . . . 63.24 106.945 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.426 ' HB3' HG23 ' C' ' 72' ' ' THR . 11.8 p -162.43 144.13 10.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.475 0.484 . . . . 65.1 110.577 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.9 tp -118.72 85.82 2.43 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.809 -1.182 . . . . 75.15 107.809 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -107.88 2.35 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 114.698 -1.137 . . . . 42.1 111.525 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.55 -32.89 17.94 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.708 -0.478 . . . . 71.22 109.708 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -75.12 84.17 2.34 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.605 0.762 . . . . 73.23 110.089 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.426 HG23 ' HB3' ' C' ' 67' ' ' SER . 61.4 m -81.89 126.29 31.72 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.053 -0.976 . . . . 73.13 110.145 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.94 -61.04 2.11 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.649 -0.871 . . . . 75.31 108.649 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -158.33 178.02 10.62 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.876 0.846 . . . . 71.01 112.259 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.53 HD23 HG21 ' C' ' 65' ' ' THR . 3.0 tm? -141.62 146.2 35.93 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.575 -2.009 . . . . 74.12 105.575 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.4 t -150.55 148.2 28.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.258 -1.016 . . . . 71.52 108.258 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.16 134.54 10.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.781 -0.452 . . . . 72.53 109.781 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -133.17 116.63 26.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 123.815 0.846 . . . . 72.44 108.921 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.602 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.6 mt-30 -87.8 86.17 7.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.342 -1.355 . . . . 74.41 107.342 169.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -79.48 96.1 5.99 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.936 -1.029 . . . . 73.51 108.832 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -88.48 144.35 18.35 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.244 -0.742 . . . . 72.32 111.244 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.492 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.18 119.93 1.3 Allowed Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 110.259 -1.136 . . . . 71.14 110.259 -175.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 7.4 mm -82.58 123.76 38.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.206 -1.035 . . . . 75.22 108.206 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.49 120.94 24.91 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.887 0.875 . . . . 73.1 108.829 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 22.0 p -77.93 109.81 12.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.987 -1.116 . . . . 75.14 107.987 170.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.422 HG23 ' HD1' ' C' ' 11' ' ' PHE . 27.2 pt -118.51 113.22 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.4 0.619 . . . . 74.23 109.352 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.699 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -123.83 156.23 36.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.823 0.849 . . . . 72.33 109.762 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.34 -35.8 3.52 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.572 0.545 . . . . 74.52 113.382 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.678 ' HB ' ' HG2' ' C' ' 9' ' ' MET . 19.3 tt -88.4 145.97 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.075 0.55 . . . . 74.03 110.667 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.78 -177.56 5.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.003 0.921 . . . . 73.52 110.403 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 60.67 -147.07 46.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.649 -0.705 . . . . 73.43 114.626 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -69.86 -19.18 63.45 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 74.13 111.863 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.12 -42.36 69.35 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.746 0.819 . . . . 75.2 110.566 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 25.9 ptt? -69.87 -28.57 65.76 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 110.223 -0.288 . . . . 74.11 110.223 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.29 90.26 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.75 0.656 . . . . 75.45 110.365 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -60.54 -39.38 87.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 75.31 110.783 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -63.21 -58.29 7.69 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.839 0.455 . . . . 74.13 110.952 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -77.12 -12.47 59.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.586 0.587 . . . . 74.3 112.586 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.9 9.79 21.13 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.341 -0.699 . . . . 63.24 114.739 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -53.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 117.764 0.782 . . . . 72.34 111.284 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.61 -59.84 2.55 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.368 0.667 . . . . 74.43 111.584 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 70.2 m -60.78 -44.89 96.47 Favored Pre-proline 0 CA--C 1.566 1.565 0 C-N-CA 124.465 1.106 . . . . 71.2 113.461 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.35 -20.86 48.16 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.005 1.803 . . . . 73.33 113.476 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -71.53 -30.63 66.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.994 0.517 . . . . 63.2 110.467 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.51 HD13 HH12 ' A' ' 111' ' ' ARG . 44.2 mm -68.2 -28.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 73.14 110.261 173.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.492 HD21 ' HA3' ' C' ' 82' ' ' GLY . 85.7 mt -86.47 -22.85 26.23 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.819 0.848 . . . . 74.41 112.182 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -53.77 -50.6 82.74 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.996 -1.002 . . . . 73.14 113.374 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.01 -36.5 96.57 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 122.022 1.815 . . . . 72.31 113.482 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.36 -44.44 62.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.139 0.576 . . . . 73.45 111.089 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -41.92 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.465 0.478 . . . . 64.52 109.887 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -60.28 -51.29 70.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.14 1.376 . . . . 73.42 111.142 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.409 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.2 tm-20 -70.81 -30.36 66.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.498 0.499 . . . . 64.42 110.291 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.0 t -69.86 -30.82 68.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.832 0.453 . . . . 74.34 111.178 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.462 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -77.3 -50.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.528 0.731 . . . . 70.3 109.949 175.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -62.98 -29.08 70.54 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.625 0.77 . . . . 74.14 111.228 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.8 t -64.91 -52.31 57.15 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.837 -0.801 . . . . 74.02 108.837 172.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.47 -38.71 78.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.435 1.094 . . . . 74.21 112.754 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.86 -50.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.274 0.629 . . . . 71.14 109.864 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.1 t -71.14 -22.23 62.09 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.179 -0.919 . . . . 63.23 111.392 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 116' ' ' SER . 84.2 mtt-85 -71.9 -37.11 70.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.067 -0.716 . . . . 74.33 109.067 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.28 3.76 79.95 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.905 0.753 . . . . 72.32 113.131 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.4 p 57.5 40.74 26.86 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.8 1.64 . . . . 62.13 112.153 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -99.29 165.04 15.55 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.758 1.223 . . . . 75.45 110.838 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.477 ' HG3' ' HB3' ' C' ' 36' ' ' TRP . 22.5 Cg_endo -57.48 147.36 78.85 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.572 2.848 . . . . 70.44 113.927 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.721 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.6 mm-40 -58.51 111.94 1.42 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.555 1.142 . . . . 75.11 111.522 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.6 tp -122.15 97.28 5.4 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.408 0.683 . . . . 73.53 109.319 -174.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -101.35 115.9 31.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 74.22 108.709 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.13 134.56 50.74 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.956 -0.757 . . . . 74.54 108.956 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.35 132.35 95.32 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.077 0.551 . . . . 75.31 111.171 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -71.37 90.19 0.69 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.974 2.449 . . . . 75.14 112.783 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -100.12 112.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.737 0.815 . . . . 74.32 109.792 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -97.75 95.38 7.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.352 0.661 . . . . 72.42 109.384 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -65.86 -30.43 71.04 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.516 0.726 . . . . 72.44 111.348 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.279 0.562 . . . . 72.01 110.208 177.816 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.524 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.6 tpt . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 113.595 0.961 . . . . 74.34 113.595 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.1 m -143.36 140.54 30.55 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.747 0.819 . . . . 63.11 110.166 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.456 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 44.5 t80 -143.01 115.61 8.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.937 -1.505 . . . . 72.44 106.937 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 44.2 mt-30 -128.13 147.36 50.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.276 -0.639 . . . . 72.32 109.276 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.501 HG22 ' HG2' ' B' ' 130' ' ' PRO . 3.8 mp -103.6 121.0 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.992 -1.114 . . . . 74.23 107.992 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.45 -42.22 6.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.893 0.477 . . . . 73.54 111.891 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.483 ' HD3' HD12 ' D' ' 83' ' ' ILE . 47.4 ttt180 -163.7 123.83 2.16 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.701 -0.19 . . . . 74.01 110.616 -168.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.6 136.62 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.156 -1.424 . . . . 74.03 107.156 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 39.7 p90 -166.0 177.72 6.88 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.947 0.779 . . . . 70.12 111.32 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -101.89 117.47 34.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.206 -0.907 . . . . 70.31 109.073 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 26.9 mtpp -80.53 -27.91 37.5 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.569 -0.287 . . . . 74.51 110.356 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.69 148.88 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.529 0.731 . . . . 72.01 109.13 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.574 HG21 ' HE1' ' C' ' 117' ' ' MET . 83.3 mt -143.44 147.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.97 1.308 . . . . 74.13 108.506 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -148.03 144.44 27.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.491 1.116 . . . . 72.33 109.275 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.434 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.61 126.29 8.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.154 -1.795 . . . . 64.03 106.154 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -128.65 141.13 51.44 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.206 0.602 . . . . 72.51 109.46 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.75 77.13 9.54 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.211 1.004 . . . . 61.3 108.349 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.54 -38.71 13.8 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.611 2.207 . . . . 71.4 111.421 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 13.2 p30 -102.24 31.06 4.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.814 1.646 . . . . 74.42 109.746 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.419 ' HA ' ' HZ ' ' D' ' 123' ' ' PHE . . . -60.07 -48.48 94.39 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 114.53 1.307 . . . . 74.32 114.53 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.489 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.6 Cg_endo -83.29 -4.71 11.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 CA-C-N 121.299 1.5 . . . . 73.21 112.685 175.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.6 t-160 -81.39 -54.74 5.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 74.22 109.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' D' ' 73' ' ' ALA . 52.8 t -67.9 -16.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.918 0.887 . . . . 75.03 111.186 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -63.56 -18.28 63.7 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.323 1.049 . . . . 74.12 112.415 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.89 -16.09 57.49 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.163 0.585 . . . . 74.3 111.1 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -113.81 104.41 12.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.965 0.906 . . . . 71.24 110.187 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.47 95.34 8.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.006 0.522 . . . . 73.11 109.981 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.492 ' HB3' HD12 ' D' ' 68' ' ' LEU . 56.3 t-105 -161.69 158.53 26.11 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.73 110.11 8.98 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.121 0.969 . . . . 72.41 109.614 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.18 131.13 31.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.771 2.98 . . . . 72.5 113.312 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.06 119.55 13.53 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.56 -0.533 . . . . 72.32 109.56 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' D' ' 66' ' ' ALA . 9.3 m -98.83 120.77 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.42 0.688 . . . . 74.04 111.436 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -87.66 115.85 25.38 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.018 -1.104 . . . . 74.1 108.018 166.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -96.51 142.11 28.99 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.833 -0.803 . . . . 74.44 108.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.648 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -127.8 112.33 14.64 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.89 -1.152 . . . . 73.11 107.89 173.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -96.57 134.48 39.74 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.952 -0.759 . . . . 61.02 108.952 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.1 t70 -152.22 147.95 27.01 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.943 -1.132 . . . . 65.44 107.943 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -139.59 163.92 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.078 0.466 . . . . 75.34 110.28 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.06 163.05 39.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.148 0.979 . . . . 75.31 109.761 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -142.41 153.33 43.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.658 -0.867 . . . . 73.21 108.658 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -155.76 152.46 28.52 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.359 1.064 . . . . 72.34 108.352 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -99.42 134.09 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.502 -0.555 . . . . 73.52 109.502 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' D' ' 57' ' ' GLU . 46.4 mt -103.14 -41.37 6.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.709 0.804 . . . . 74.53 109.265 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.18 -171.83 3.52 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.205 -0.907 . . . . 74.5 109.95 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.28 122.84 18.04 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.559 -0.746 . . . . 73.44 109.233 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 63.78 9.17 4.23 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.527 1.131 . . . . 63.54 112.831 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -119.26 120.56 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.058 0.943 . . . . 72.34 108.486 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 73.0 m-85 -136.34 135.98 39.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.852 0.461 . . . . 74.14 110.246 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD23 ' D' ' 51' ' ' LEU . 6.2 tp10 -91.08 113.75 26.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.094 0.958 . . . . 73.11 109.378 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.44 127.82 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.659 -1.237 . . . . 75.42 107.659 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.36 146.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.433 0.693 . . . . 73.41 109.341 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -127.47 108.76 11.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.006 -1.109 . . . . 73.23 108.006 176.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.7 ttm-85 -85.13 107.05 17.02 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.201 -0.666 . . . . 72.54 109.201 170.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.0 t -105.29 103.95 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.013 -1.106 . . . . 75.5 108.013 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.648 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 45.3 m -96.61 135.84 37.96 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.888 -0.782 . . . . 73.03 108.888 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.442 HG21 HD12 ' D' ' 114' ' ' ILE . 64.1 t -122.35 127.41 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.194 -1.039 . . . . 72.23 108.194 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -129.03 93.55 3.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.706 -1.22 . . . . 72.43 107.706 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' D' ' 40' ' ' VAL . . . -95.95 148.97 22.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.181 0.592 . . . . 72.3 110.039 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -151.05 136.91 18.12 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.988 0.805 . . . . 71.41 109.525 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' D' ' 36' ' ' TRP . 24.9 tp -120.53 128.34 53.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.813 -0.81 . . . . 74.41 108.813 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.88 -119.39 8.12 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.193 0.308 . . . . 72.11 112.349 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.36 7.01 17.52 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.073 0.949 . . . . 73.2 109.783 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -116.46 145.88 42.96 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.497 1.119 . . . . 55.35 109.304 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' THR . . . . . 0.4 ' HB ' HD22 ' D' ' 27' ' ' ASN . 54.2 m -59.23 145.67 42.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.556 0.743 . . . . 72.31 109.038 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.53 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -106.57 -57.36 2.07 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.955 -0.387 . . . . 63.53 109.955 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.44 147.22 18.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.765 -0.652 . . . . 73.44 110.148 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 48.3 mt -110.69 149.15 30.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.538 1.135 . . . . 70.42 108.701 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' D' ' 114' ' ' ILE . 44.3 t -160.06 149.66 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.195 0.598 . . . . 64.32 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -156.61 141.0 16.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.506 -0.924 . . . . 70.35 108.506 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -136.37 118.66 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.301 -0.629 . . . . 75.01 109.301 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.5 85.75 6.59 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.534 -0.913 . . . . 74.33 108.534 170.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.58 102.15 8.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.517 -1.219 . . . . 73.42 108.7 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.8 142.96 15.86 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.315 -0.714 . . . . 65.23 111.315 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.88 132.19 5.63 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.415 -1.074 . . . . 52.2 110.415 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.483 HD12 ' HD3' ' D' ' 15' ' ' ARG . 89.7 mt -88.09 114.26 26.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.441 -0.948 . . . . 73.44 108.441 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.63 136.44 54.39 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.053 0.941 . . . . 74.34 109.461 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 6.5 m -79.31 105.98 11.01 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.923 -0.769 . . . . 73.13 108.923 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 37.3 mm -106.18 102.57 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.253 -1.018 . . . . 64.55 108.253 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.21 152.99 51.35 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.954 0.901 . . . . 63.23 109.535 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.89 -1.93 66.44 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 114.632 0.613 . . . . 62.14 114.632 174.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.86 125.76 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.011 -0.737 . . . . 75.24 109.011 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.94 -173.92 3.94 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.467 0.707 . . . . 70.12 111.075 -171.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 -134.58 25.14 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.782 -0.644 . . . . 55.55 113.05 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.803 0.841 . . . . 75.43 111.215 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -68.18 -38.47 82.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.645 0.778 . . . . 62.23 110.871 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.29 66.78 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.534 -0.303 . . . . 70.32 110.399 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.2 71.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.347 0.659 . . . . 63.22 111.113 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -67.66 -40.28 84.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 73.34 110.847 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -68.64 -52.3 32.75 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.061 -0.518 . . . . 60.11 110.624 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.56 -16.96 61.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.597 0.759 . . . . 75.03 111.637 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.04 -24.68 24.25 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.769 -0.462 . . . . 75.03 114.052 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.1 -57.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.679 0.74 . . . . 72.34 111.805 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -67.07 -50.75 60.71 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.798 0.839 . . . . 75.34 112.633 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.456 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 19.3 m -69.67 -44.79 24.65 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.307 0.643 . . . . 72.21 111.679 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.8 Cg_exo -58.72 -31.84 95.74 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.147 1.898 . . . . 70.31 113.416 169.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.95 -37.49 87.59 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.073 0.549 . . . . 72.33 110.721 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.57 -41.81 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.539 0.736 . . . . 74.13 109.976 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.8 -17.69 60.58 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.17 -0.923 . . . . 74.5 112.143 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -68.36 -42.7 29.85 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 113.607 0.966 . . . . 73.4 113.607 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.8 -37.14 84.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 122.072 1.848 . . . . 74.44 113.618 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.614 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 94.7 m-85 -81.37 -33.58 32.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.995 0.918 . . . . 74.54 111.431 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.63 66.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.383 0.673 . . . . 74.33 109.382 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.0 ttp180 -53.25 -53.42 51.08 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.964 -1.471 . . . . 73.31 110.458 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.9 -46.65 84.63 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.281 0.988 . . . . 73.22 111.838 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.43 -42.0 90.84 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.986 0.804 . . . . 70.4 111.175 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.442 HD12 HG21 ' D' ' 64' ' ' VAL . 75.9 mt -65.22 -53.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.666 0.604 . . . . 71.3 110.277 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.427 HG22 ' HG3' ' D' ' 125' ' ' GLN . 48.4 m -55.19 -40.54 70.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.701 1.2 . . . . 73.51 111.513 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.8 t -66.75 -43.21 84.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.59 -1.186 . . . . 74.32 110.436 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.4 mtm -67.77 -32.83 73.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.007 0.523 . . . . 73.32 112.163 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.427 HG22 ' O ' ' D' ' 114' ' ' ILE . 83.4 t -67.41 -42.01 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.372 0.669 . . . . 71.21 109.764 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -76.08 -28.39 57.57 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.097 -0.502 . . . . 74.51 111.131 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -71.61 -32.48 68.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.644 0.778 . . . . 75.14 109.567 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 6.13 73.52 Favored Glycine 0 C--N 1.355 1.623 0 O-C-N 123.754 0.659 . . . . 62.31 112.544 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 63.3 p 57.58 21.46 7.16 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.83 2.052 . . . . 75.31 114.291 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 65.7 m-85 -85.39 157.6 58.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.928 0.891 . . . . 74.5 109.301 170.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.51 121.82 10.71 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.718 2.278 . . . . 72.11 111.477 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.427 ' HG3' HG22 ' D' ' 115' ' ' THR . 24.1 tt0 -48.29 132.23 16.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.009 1.324 . . . . 63.32 112.47 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -107.14 106.1 16.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -97.61 89.71 4.76 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.702 -1.222 . . . . 61.01 107.702 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.468 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 5.6 mp -62.9 112.51 2.6 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.786 0.679 . . . . 74.04 109.594 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.79 139.57 73.86 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.255 -0.646 . . . . 64.24 109.255 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.51 165.28 27.79 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.245 1.963 . . . . 62.33 112.727 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.81 138.7 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.368 -0.605 . . . . 73.53 109.368 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -74.81 95.26 2.88 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 108.955 -0.757 . . . . 74.51 108.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.474 0.757 0 CA-C-N 115.039 -0.982 . . . . 75.41 111.045 -179.83 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.0 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.62 -0.511 . . . . 70.41 109.62 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -139.85 115.33 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.326 -0.99 . . . . 74.42 108.326 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 55.2 mt-30 -134.25 122.65 23.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.154 0.582 . . . . 74.23 110.104 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.43 107.99 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.539 -0.911 . . . . 75.1 108.539 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -86.33 -40.33 15.57 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.443 0.297 . . . . 75.21 110.434 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.668 ' HD2' HG22 ' B' ' 122' ' ' THR . 10.1 tpp180 -167.68 134.4 2.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.471 -0.566 . . . . 71.22 109.471 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.444 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 91.6 mt -138.4 100.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.962 -0.755 . . . . 74.33 108.962 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.9 m-85 -164.09 176.16 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 75.13 109.693 -165.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -85.33 114.05 22.11 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.146 -0.479 . . . . 72.33 110.093 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -88.92 -34.47 16.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.727 0.298 . . . . 74.32 110.371 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 9.1 m-20 -137.38 147.0 45.14 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.482 0.658 . . . . 65.25 109.736 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 66.9 mt -144.99 143.88 22.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 126.381 1.872 . . . . 75.02 106.508 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -158.79 121.36 3.64 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.607 -0.516 . . . . 72.21 109.607 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.612 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.9 t80 -119.8 136.62 54.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.428 -1.323 . . . . 73.25 107.428 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.38 148.8 51.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.578 0.751 . . . . 74.14 109.017 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.12 80.72 7.79 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.869 -1.16 . . . . 75.15 107.869 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -31.2 24.86 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.528 2.152 . . . . 74.12 111.667 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -112.53 34.29 4.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.544 1.138 . . . . 74.44 109.334 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.45 -47.1 99.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.444 1.097 . . . . 72.14 113.581 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.1 -20.9 32.64 Favored 'Trans proline' 0 C--N 1.392 2.828 0 CA-C-N 121.124 1.437 . . . . 75.51 112.421 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -79.87 -24.97 40.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.58 0.752 . . . . 71.55 111.656 -172.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.16 -22.32 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 112.461 0.541 . . . . 75.01 112.461 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -80.04 -35.02 37.78 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.297 1.039 . . . . 72.13 110.699 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -88.36 -18.04 29.28 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.178 0.591 . . . . 74.32 111.108 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HZ2' ' HG3' ' A' ' 71' ' ' GLU . 96.4 mttt -75.59 167.15 22.43 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.864 0.69 . . . . 73.54 112.864 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.27 118.28 23.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.69 -1.141 . . . . 62.14 108.05 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.412 ' HA ' HD12 ' A' ' 68' ' ' LEU . 20.5 m-90 -73.33 85.72 1.46 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.759 0.79 . . . . 72.12 110.939 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -130.78 76.98 76.35 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.063 1.345 . . . . 74.23 108.195 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.46 111.86 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.717 2.278 . . . . 75.34 111.843 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -96.14 85.09 3.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.94 -1.504 . . . . 75.54 106.94 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.1 m -88.25 122.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.453 -1.248 . . . . 65.52 111.889 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -108.17 116.61 32.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.652 1.181 . . . . 72.04 109.111 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.04 108.24 19.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.181 0.593 . . . . 74.54 109.691 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.562 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.4 t70 -103.41 130.38 50.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.728 0.811 . . . . 72.03 109.601 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.43 119.75 40.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.509 -0.922 . . . . 70.01 108.509 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' HD22 ' A' ' 60' ' ' LEU . 25.3 t70 -122.68 138.08 54.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.493 0.717 . . . . 73.12 109.532 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.7 m -133.35 143.69 49.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.938 0.495 . . . . 75.44 110.146 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.71 152.69 40.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.406 1.082 . . . . 74.01 109.395 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -130.96 155.97 45.89 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.515 -0.92 . . . . 64.25 108.515 172.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -163.26 116.43 1.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 117.882 0.31 . . . . 74.45 110.314 -173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.465 HE21 ' H ' ' A' ' 54' ' ' ASP . 51.8 tt0 -70.22 105.62 3.02 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.992 0.917 . . . . 73.22 110.353 -177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 57' ' ' GLU . 44.9 mt -77.94 -39.9 41.25 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.309 1.044 . . . . 74.53 111.008 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.08 -171.81 3.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.822 -1.081 . . . . 63.44 109.447 -172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.76 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.114 0.566 . . . . 74.23 110.5 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 9.4 m-20 54.6 31.4 15.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.117 1.367 . . . . 73.23 112.932 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 54.6 t -107.55 122.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.9 -1.519 . . . . 71.43 106.9 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 138.02 49.65 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.953 -0.758 . . . . 73.43 108.953 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.511 ' HB2' HD13 ' A' ' 51' ' ' LEU . 37.0 tt0 -86.92 121.87 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.987 -1.116 . . . . 73.3 107.987 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -99.29 118.58 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.446 -1.316 . . . . 72.4 107.446 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 90.9 t -98.18 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 123.28 0.632 . . . . 74.32 109.545 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -120.93 110.47 16.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.291 -1.744 . . . . 74.52 106.291 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 23.4 ttp180 -104.84 103.61 13.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.661 -0.866 . . . . 74.5 108.661 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 60' ' ' LEU . 60.9 t -95.39 129.08 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.535 -1.211 . . . . 73.02 108.662 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 41.5 m -109.17 131.76 54.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.739 -0.837 . . . . 74.31 108.739 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 t -123.93 107.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.21 -1.404 . . . . 74.1 107.21 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -107.45 135.66 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.117 -1.068 . . . . 62.21 108.117 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.32 136.78 49.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.501 -1.296 . . . . 72.54 107.501 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.2 m -147.22 135.65 21.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.81 0.844 . . . . 75.24 109.651 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.522 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 2.3 mm? -87.23 86.52 7.28 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.868 -1.16 . . . . 75.4 107.868 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.57 -85.15 1.25 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.017 -0.992 . . . . 75.11 111.483 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -26.0 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.322 0.649 . . . . 64.24 111.312 -175.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.56 ' HG3' ' HZ2' ' A' ' 34' ' ' LYS . 10.5 tp10 -101.06 133.04 46.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.064 0.546 . . . . 70.24 109.965 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 m -65.44 146.35 54.99 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.154 0.982 . . . . 73.14 112.729 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB2' HD23 ' A' ' 68' ' ' LEU . . . -90.12 -65.56 1.0 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.833 1.253 . . . . 63.43 108.436 168.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -150.33 159.8 44.19 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.242 -1.345 . . . . 73.24 110.375 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.6 tp -134.72 116.84 15.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.231 1.012 . . . . 72.43 109.565 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.2 m -106.47 142.51 36.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 75.23 110.311 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -148.07 118.78 7.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.371 1.068 . . . . 72.53 108.838 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.32 116.73 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.136 0.425 . . . . 70.31 109.917 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.797 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 15.6 mp0 -85.57 86.51 7.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.434 -1.321 . . . . 72.13 107.434 169.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -77.01 96.01 4.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.085 -0.962 . . . . 73.23 108.607 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.84 146.0 18.1 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.274 -0.73 . . . . 75.42 111.274 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.18 123.89 2.53 Favored Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.265 -1.134 . . . . 71.4 110.265 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 29' ' ' PRO . 56.4 mt -81.02 125.22 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.351 -0.611 . . . . 64.4 109.351 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -134.4 119.85 19.09 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.722 -0.844 . . . . 75.45 108.722 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 33.3 t -81.43 92.7 6.49 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.654 -0.869 . . . . 74.55 108.654 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 10' ' ' THR . 11.0 pt -125.89 127.21 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.558 0.743 . . . . 72.33 110.801 -170.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . . . -160.89 171.11 19.32 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.981 0.913 . . . . 75.53 110.759 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.56 -24.07 32.35 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.391 -0.822 . . . . 72.22 113.135 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -109.5 146.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.94 0.496 . . . . 73.2 109.791 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -147.46 175.81 10.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.243 -0.889 . . . . 74.42 111.282 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.97 -132.46 33.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 114.683 -1.144 . . . . 73.04 112.642 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -69.48 -20.68 63.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.575 0.75 . . . . 75.24 111.882 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.08 -44.64 46.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.505 0.722 . . . . 74.15 110.736 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.7 tpt -80.73 -25.07 38.32 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.239 -0.437 . . . . 73.43 110.195 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.49 88.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.218 0.607 . . . . 73.23 109.837 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.87 -43.35 83.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.742 -1.117 . . . . 74.15 110.491 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.675 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.4 m -73.05 -34.34 66.22 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.595 0.961 . . . . 70.23 113.595 -171.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -91.42 -9.24 45.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.486 0.314 . . . . 75.51 111.556 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.65 5.88 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 113.665 0.226 . . . . 50.44 113.665 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.6 -65.7 0.71 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.806 0.842 . . . . 72.12 111.034 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.4 t80 -43.62 -61.51 1.37 Allowed 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 125.125 1.37 . . . . 72.43 113.193 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 83.6 m -72.63 -50.82 7.44 Favored Pre-proline 0 CA--C 1.556 1.194 0 CA-C-O 118.255 -0.878 . . . . 71.41 112.822 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.05 -17.94 61.7 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.718 1.612 . . . . 70.41 113.815 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.29 -48.25 68.23 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 72.4 108.592 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.0 mm -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.58 -1.191 . . . . 74.44 110.782 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.424 HD23 HG23 ' A' ' 16' ' ' ILE . 95.3 mt -71.47 -28.64 64.08 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.738 -0.665 . . . . 75.41 111.953 -173.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -65.23 -43.54 65.67 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.373 1.249 . . . . 74.22 114.373 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -34.92 96.53 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.194 1.93 . . . . 71.22 113.381 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.452 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 89.0 m-85 -80.96 -33.92 33.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 73.3 111.494 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.13 63.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 110.046 -0.353 . . . . 74.33 110.046 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.496 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.1 ttm180 -51.75 -45.06 63.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.678 1.191 . . . . 75.01 110.348 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.61 -50.32 71.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.026 0.93 . . . . 74.05 111.487 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.47 -39.96 95.12 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.178 0.924 . . . . 72.55 111.098 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.594 HG21 HG22 ' A' ' 64' ' ' VAL . 12.8 mt -64.33 -58.11 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.561 0.745 . . . . 75.43 110.374 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.467 HG22 ' HG3' ' A' ' 125' ' ' GLN . 96.7 m -53.02 -38.95 62.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.159 0.912 . . . . 73.3 111.289 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -66.34 -42.43 88.13 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.384 -0.826 . . . . 75.32 110.472 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.6 mtm -63.49 -37.73 88.42 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.982 0.513 . . . . 64.33 111.168 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 114' ' ' ILE . 74.9 t -63.12 -45.41 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.281 1.032 . . . . 71.33 110.545 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.0 p -75.17 -29.63 60.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.02 -0.537 . . . . 74.44 111.327 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -72.05 -28.07 63.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 75.23 109.81 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.13 1.25 89.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.552 -0.749 . . . . 64.53 113.014 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 m 68.68 18.33 8.77 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.762 1.225 . . . . 60.44 111.578 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -90.37 154.37 46.56 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.702 0.801 . . . . 64.21 110.805 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -59.79 134.11 55.2 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.94 2.426 . . . . 74.31 112.253 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HG3' HG22 ' A' ' 115' ' ' THR . 31.6 tt0 -62.7 132.34 51.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.605 0.762 . . . . 73.22 111.883 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.3 mt -113.0 114.4 26.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.018 -1.104 . . . . 75.32 108.018 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -97.4 100.86 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.993 -1.114 . . . . 73.22 107.993 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.63 135.78 57.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.235 0.614 . . . . 74.34 110.619 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.06 145.86 88.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.995 0.518 . . . . 74.4 110.99 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.5 119.92 7.03 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.941 1.761 . . . . 73.23 109.174 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.5 t -95.64 111.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.251 -1.388 . . . . 74.4 107.251 -176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -82.12 66.17 7.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.937 -1.029 . . . . 74.45 109.318 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -68.8 -34.83 76.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.624 -0.716 . . . . 70.53 109.85 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 CA--C 1.544 0.74 0 O-C-N 123.958 0.786 . . . . 73.33 109.743 172.749 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.579 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.7 ptm . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 114.941 1.46 . . . . 75.33 114.941 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -143.39 122.36 12.8 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.184 -1.043 . . . . 71.25 108.184 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -110.51 134.86 51.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.027 0.931 . . . . 74.1 108.677 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -145.61 141.37 28.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.774 -0.824 . . . . 73.32 108.774 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.533 ' H ' HD11 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -91.66 134.49 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.79 -0.818 . . . . 75.25 108.79 173.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -92.4 -50.3 5.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.129 0.572 . . . . 73.45 109.585 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -164.54 139.26 5.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.436 -0.802 . . . . 74.22 109.409 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -114.84 144.7 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 106.218 -1.771 . . . . 73.55 106.218 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG13 ' B' ' 83' ' ' ILE . 30.0 p90 -172.3 149.44 2.24 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.133 0.424 . . . . 72.22 110.908 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.726 HG23 HD12 ' B' ' 21' ' ' ILE . 26.8 m -80.14 121.66 25.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.353 -0.61 . . . . 73.11 109.353 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -87.7 -33.8 18.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.014 0.526 . . . . 72.34 110.203 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.4 t70 -146.99 127.97 14.54 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.75 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.726 HD12 HG23 ' B' ' 18' ' ' THR . 34.3 mm -113.47 147.08 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.395 -1.335 . . . . 71.2 107.395 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -150.72 140.51 21.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.294 -0.632 . . . . 73.14 109.294 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.532 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 93.3 t80 -155.22 114.91 3.7 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 107.663 -1.236 . . . . 73.33 107.663 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.65 113.88 17.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.731 -1.211 . . . . 72.34 107.731 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.0 89.32 3.61 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.544 -0.91 . . . . 62.21 108.544 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.17 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.837 2.358 . . . . 65.21 112.602 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -127.26 29.58 5.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.013 0.925 . . . . 74.1 110.773 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.1 -55.8 16.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 C-N-CA 123.983 0.913 . . . . 64.41 112.419 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.474 ' HA ' HD11 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -70.5 -16.66 34.45 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.845 1.697 . . . . 73.22 112.622 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -101.5 4.81 41.51 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.5 0.926 . . . . 71.44 113.5 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.68 -31.36 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 118.22 0.464 . . . . 71.3 111.775 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -73.35 -17.82 61.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.464 0.705 . . . . 74.22 110.958 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -79.43 -35.79 39.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.251 1.02 . . . . 73.0 110.813 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -108.02 110.28 21.95 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.39 0.676 . . . . 72.43 110.607 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -98.45 78.03 2.38 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.227 0.611 . . . . 75.31 110.374 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -151.35 161.6 42.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.374 -1.343 . . . . 72.2 107.374 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -85.3 133.5 42.43 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 122.722 0.409 . . . . 73.11 110.221 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' B' ' 68' ' ' LEU . 78.7 Cg_endo -72.52 136.51 26.18 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.421 2.081 . . . . 73.42 112.799 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -66.63 104.16 1.23 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.8 0.84 . . . . 73.54 109.067 168.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.469 HG13 HD21 ' B' ' 126' ' ' LEU . 11.0 m -98.43 150.44 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.979 0.511 . . . . 72.55 110.423 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.438 ' HE3' ' HB ' ' B' ' 65' ' ' THR . 1.1 tmmt? -150.69 121.63 7.64 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.566 -0.901 . . . . 74.43 108.566 -175.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.458 HD12 HD13 ' B' ' 126' ' ' LEU . 2.2 mm? -96.49 134.69 39.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.795 0.838 . . . . 74.14 109.602 -173.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.6 m-20 -123.62 113.45 18.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.342 -0.984 . . . . 74.34 108.342 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -101.67 148.0 25.78 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.384 -0.599 . . . . 72.14 109.384 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -161.31 152.33 18.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.62 -1.252 . . . . 62.5 107.62 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -153.43 143.87 22.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.988 0.423 . . . . 73.14 110.73 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.66 161.16 35.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.991 1.316 . . . . 74.2 108.331 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.3 m -130.44 165.18 23.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.335 0.588 . . . . 72.04 110.729 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -151.54 146.29 25.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.067 1.347 . . . . 71.31 107.554 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.65 112.13 24.92 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.292 -0.632 . . . . 63.2 109.292 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.39 -34.49 25.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.015 0.436 . . . . 75.02 110.086 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -159.94 178.6 9.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.8 0.84 . . . . 75.22 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.46 117.29 5.51 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.649 -1.159 . . . . 75.32 109.524 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 71.53 -4.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.438 1.495 . . . . 75.32 112.542 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 78.7 t -104.93 95.23 3.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.399 -0.963 . . . . 71.34 108.399 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -107.58 136.4 47.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.629 -0.714 . . . . 74.41 110.435 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -101.48 100.75 11.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.539 -1.282 . . . . 73.14 107.539 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.18 127.32 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.243 1.017 . . . . 72.31 109.669 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.2 t -103.63 123.63 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.825 0.85 . . . . 64.2 110.036 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.94 134.38 35.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.926 -1.509 . . . . 75.23 106.926 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -120.51 121.74 39.09 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.08 0.952 . . . . 75.21 108.701 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -115.53 104.29 16.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.093 -1.447 . . . . 74.5 107.093 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 21.7 m -96.92 130.22 44.26 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.542 -0.91 . . . . 74.12 108.542 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.533 HG23 HD12 ' B' ' 114' ' ' ILE . 69.8 t -112.85 130.7 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.394 0.678 . . . . 72.13 109.401 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.438 ' HB ' ' HE3' ' B' ' 41' ' ' LYS . 22.0 m -119.67 123.64 44.31 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.514 -0.921 . . . . 70.44 108.514 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 140.18 49.05 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 122.734 0.413 . . . . 73.41 109.984 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.519 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 22.5 p -138.2 126.71 23.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 73.1 110.152 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' B' ' 38' ' ' PRO . 2.6 tt -93.46 100.55 12.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.914 -1.513 . . . . 72.43 106.914 -176.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.39 -137.47 19.75 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 111.767 -0.533 . . . . 70.31 111.767 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.53 33.93 1.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.676 0.79 . . . . 60.11 110.387 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.28 146.7 24.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.058 0.943 . . . . 74.31 108.794 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -74.99 138.3 42.14 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.074 0.464 . . . . 72.34 111.388 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.519 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.07 -61.92 1.58 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.292 -1.003 . . . . 63.21 108.292 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.37 157.62 32.7 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.782 -1.099 . . . . 75.31 110.078 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.79 111.82 12.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.394 -1.335 . . . . 75.41 107.394 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.32 152.8 35.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.412 0.685 . . . . 55.13 109.538 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -155.61 134.64 12.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.514 -0.921 . . . . 75.51 108.514 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.574 HG23 HD13 ' B' ' 21' ' ' ILE . 84.0 t -129.07 141.36 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.366 -0.605 . . . . 70.13 109.366 171.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 51.4 mt-30 -118.88 100.88 7.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.378 1.071 . . . . 75.45 109.007 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -87.41 101.17 13.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.715 -0.675 . . . . 74.33 109.362 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 150.64 21.57 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.316 -0.714 . . . . 74.13 111.316 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.26 125.86 2.04 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 111.65 -0.58 . . . . 75.01 111.65 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.41 HG13 ' HE1' ' B' ' 17' ' ' TYR . 21.0 mt -85.66 126.53 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.061 -1.088 . . . . 75.21 108.061 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -130.85 160.38 34.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.651 1.18 . . . . 72.24 108.855 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -130.79 108.06 9.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.934 0.893 . . . . 52.41 108.777 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.688 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -123.69 115.38 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.823 1.249 . . . . 72.23 109.428 -174.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 51.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.702 0.801 . . . . 65.32 110.275 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.01 -46.01 1.23 Allowed Glycine 0 C--N 1.345 1.031 0 O-C-N 123.548 0.53 . . . . 63.01 112.112 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.688 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -90.75 154.23 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.1 0.96 . . . . 73.23 111.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -159.46 156.81 28.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.694 0.398 . . . . 72.22 110.522 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.27 -116.45 7.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.245 -0.434 . . . . 53.21 112.749 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -67.75 -33.48 74.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.769 0.828 . . . . 73.13 111.044 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.14 -50.31 66.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.735 -0.666 . . . . 72.44 110.529 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 28.2 ttt -71.73 -28.19 63.5 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.287 -0.87 . . . . 74.43 110.944 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -38.14 85.81 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.805 -0.634 . . . . 75.43 110.688 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -70.47 -34.79 72.79 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.505 -0.771 . . . . 74.42 110.299 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.31 -48.39 56.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.171 0.588 . . . . 74.23 111.034 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.25 -16.85 44.76 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.524 0.73 . . . . 73.42 111.812 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.75 2.84 58.73 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.88 -0.4 . . . . 71.0 113.307 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.84 -55.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.276 0.538 . . . . 75.33 112.132 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -81.52 -50.98 8.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.942 0.497 . . . . 74.15 111.768 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.7 m -56.89 -49.6 92.94 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.712 -0.661 . . . . 74.42 112.518 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.45 -26.86 47.3 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.989 1.793 . . . . 73.45 112.842 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.99 -33.56 76.34 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.942 0.401 . . . . 72.12 110.995 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.21 -47.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.672 0.789 . . . . 75.21 110.189 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.22 -22.36 61.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.226 -0.897 . . . . 74.11 112.268 -172.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -63.66 -47.87 81.39 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 114.211 1.189 . . . . 75.3 114.211 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.42 -36.14 93.39 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.09 1.86 . . . . 72.15 113.352 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -70.93 -46.84 61.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.194 0.597 . . . . 75.42 110.797 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.09 94.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.467 0.707 . . . . 73.45 110.651 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -59.38 -56.0 27.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.885 0.874 . . . . 75.45 110.624 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -37.8 84.35 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.791 0.682 . . . . 75.35 110.057 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.5 m -57.08 -53.44 58.03 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 74.05 111.917 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.533 HD12 HG23 ' B' ' 64' ' ' VAL . 80.9 mt -60.73 -58.12 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.595 0.758 . . . . 75.45 111.065 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.3 m -63.56 -30.3 71.43 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.252 0.97 . . . . 70.44 111.206 -168.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 43.7 t -59.79 -56.59 19.91 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.684 -0.689 . . . . 65.21 109.397 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.638 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 19.1 mmt -61.57 -32.96 73.07 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.748 0.819 . . . . 73.53 112.158 -175.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.12 -50.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.027 0.931 . . . . 72.13 110.66 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 84.8 p -74.54 -20.1 60.09 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.292 0.637 . . . . 74.3 111.339 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.638 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.43 -33.48 75.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.786 0.834 . . . . 74.43 110.06 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.73 8.66 78.25 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.39 0.431 . . . . 73.31 112.622 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.668 HG22 ' HD2' ' A' ' 15' ' ' ARG . 4.8 p 69.09 15.05 8.77 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.64 1.976 . . . . 73.53 113.148 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.05 155.3 67.42 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.776 0.83 . . . . 74.43 111.104 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.56 128.79 30.85 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.518 2.812 . . . . 74.33 113.396 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.427 ' HG3' ' OE1' ' C' ' 125' ' ' GLN . 72.7 mt-30 -55.66 133.33 50.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.171 1.388 . . . . 74.34 112.516 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.469 HD21 HG13 ' B' ' 40' ' ' VAL . 3.7 mm? -109.51 82.36 1.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.929 -0.767 . . . . 74.31 108.929 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -91.84 96.23 10.29 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.933 -1.136 . . . . 71.14 107.933 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.42 ' HG ' ' HG ' ' B' ' 42' ' ' LEU . 0.8 OUTLIER -75.19 128.63 35.92 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.179 -0.674 . . . . 75.32 109.179 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.95 148.5 94.57 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.033 0.933 . . . . 73.12 111.376 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.29 93.62 0.57 Allowed 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.177 1.918 . . . . 74.03 111.401 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.6 140.75 15.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.083 -0.962 . . . . 71.52 108.648 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -68.23 99.89 0.97 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.568 0.747 . . . . 72.01 110.339 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -56.34 -30.76 63.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.074 -0.966 . . . . 74.31 110.096 170.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.4 -56.91 13.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.063 1.345 . . . . 72.13 111.46 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.9 94.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.886 0.741 . . . . 62.54 111.74 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 123.69 0.796 . . . . 74.53 109.567 178.308 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 13.0 tmm? . . . . . 0 CA--C 1.559 1.297 0 N-CA-C 113.288 0.847 . . . . 72.31 113.288 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -94.22 105.79 17.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 71.31 110.023 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.633 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 80.3 t80 -122.61 143.18 49.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 72.55 109.232 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.76 140.47 17.04 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.177 0.591 . . . . 72.43 109.687 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.0 mt -79.11 117.88 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.251 -1.018 . . . . 74.24 108.251 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -88.9 -45.4 9.73 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.772 0.67 . . . . 74.44 110.064 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.8 144.45 6.02 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.887 0.475 . . . . 72.31 110.277 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.84 139.85 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.173 -1.047 . . . . 74.34 108.173 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -173.78 158.18 3.21 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.312 0.577 . . . . 75.32 111.136 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -82.47 116.92 22.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.502 -0.772 . . . . 63.3 109.513 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -78.09 -41.0 36.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.696 0.76 . . . . 75.21 109.074 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -140.41 140.02 35.39 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.55 -1.205 . . . . 74.1 109.741 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.9 mt -136.36 141.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.482 1.513 . . . . 72.24 107.093 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -158.61 148.8 19.78 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.189 0.519 . . . . 74.34 110.222 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -148.27 149.41 31.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -143.45 146.42 33.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.046 1.338 . . . . 72.34 107.714 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' D' ' 19' ' ' LYS . . . -149.77 82.79 6.53 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.83 -1.174 . . . . 74.23 107.83 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.25 -31.9 43.17 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.497 2.131 . . . . 62.1 111.996 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 79.0 m-20 -112.15 38.82 2.58 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 74.45 109.599 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.79 96.53 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.512 1.125 . . . . 75.14 113.348 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.89 -21.14 8.47 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.729 1.619 . . . . 71.13 112.613 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.454 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.8 t-160 -67.56 -20.31 65.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.893 0.877 . . . . 75.33 111.686 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.543 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 11.7 p -46.03 -28.99 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 124.792 1.237 . . . . 61.11 114.212 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -66.92 -43.07 84.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.906 0.482 . . . . 72.32 111.824 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -127.66 39.15 3.92 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.536 0.684 . . . . 72.22 110.806 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.543 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -94.03 169.56 10.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 167.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.99 120.89 25.83 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.51 -0.922 . . . . 62.52 108.51 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t90 -78.44 81.61 4.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.481 0.657 . . . . 73.14 109.674 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -153.86 74.95 6.28 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.478 -1.237 . . . . 72.2 107.745 168.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.26 106.64 1.76 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.745 2.296 . . . . 74.53 110.611 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.67 94.89 8.74 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.323 -1.732 . . . . 73.42 106.323 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 96.4 t -86.07 102.33 11.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.549 -1.205 . . . . 64.32 110.198 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -90.29 101.83 14.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.255 -1.338 . . . . 74.11 108.007 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.486 HD22 ' H ' ' C' ' 42' ' ' LEU . 0.7 OUTLIER -89.11 147.49 24.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.978 -0.749 . . . . 72.21 108.978 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.3 t70 -142.69 136.19 28.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.631 0.772 . . . . 71.11 109.156 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 135.44 41.87 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.89 0.876 . . . . 73.34 109.085 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.34 152.06 30.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.445 1.098 . . . . 72.31 108.204 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -131.02 135.78 47.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.421 0.629 . . . . 62.12 110.896 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.52 170.64 8.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.975 -1.011 . . . . 73.33 108.747 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 59.5 p -150.86 151.22 31.93 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.654 0.382 . . . . 75.21 110.534 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.7 p -147.3 128.07 14.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.201 1.001 . . . . 75.53 109.189 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -72.2 118.15 14.72 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.629 -0.508 . . . . 72.35 109.629 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' C' ' 57' ' ' GLU . 54.9 mt -87.28 -43.83 11.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.214 -0.661 . . . . 71.44 109.214 176.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.97 -178.35 6.43 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.705 -1.134 . . . . 55.23 109.895 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.74 120.32 11.0 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.573 -0.74 . . . . 75.33 110.157 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 66.92 3.45 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.755 1.222 . . . . 74.42 112.872 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.99 113.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.907 0.883 . . . . 71.1 108.985 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.13 125.46 43.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.355 1.062 . . . . 63.12 108.717 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.61 ' HB2' HD12 ' C' ' 51' ' ' LEU . 43.7 tt0 -83.74 110.99 18.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.094 -0.706 . . . . 65.21 109.094 172.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -95.55 124.01 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.573 -1.269 . . . . 74.01 107.573 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.83 107.57 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.351 0.66 . . . . 74.45 109.245 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.52 104.89 16.9 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.556 -0.905 . . . . 73.22 108.556 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -90.78 121.29 32.52 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.066 1.346 . . . . 75.23 110.219 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.22 121.65 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.82 0.848 . . . . 73.42 109.302 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.0 m -103.34 141.58 35.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.901 -0.778 . . . . 72.13 108.901 166.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.619 HG23 HG21 ' C' ' 114' ' ' ILE . 87.3 t -129.45 112.32 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.094 -1.076 . . . . 75.51 108.094 173.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -108.16 106.95 17.38 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.684 -0.858 . . . . 73.34 108.684 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.94 100.61 10.1 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.851 -0.796 . . . . 73.34 108.851 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -156.81 146.5 20.73 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.111 -0.7 . . . . 54.45 109.111 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 tp -71.2 -44.97 64.36 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.501 -0.926 . . . . 75.52 108.501 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.75 -76.92 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.359 -1.096 . . . . 70.03 110.359 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.31 -33.29 16.16 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 74.14 109.376 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.4 93.72 0.9 Allowed 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.196 -1.038 . . . . 73.41 108.196 171.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -89.53 118.18 28.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.877 -0.601 . . . . 75.32 109.624 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.93 -57.73 4.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.308 -1.368 . . . . 75.23 107.308 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.42 158.69 27.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.123 -0.944 . . . . 65.02 110.725 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -126.21 143.97 50.94 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.254 -1.758 . . . . 62.31 106.254 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 34.9 t -150.89 147.52 27.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.634 -0.506 . . . . 72.44 109.634 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -156.53 129.76 8.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.831 -0.433 . . . . 72.11 109.831 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 36.9 t -127.49 114.73 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.177 0.991 . . . . 75.15 108.827 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.5 mt-30 -91.27 95.26 9.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.515 -0.921 . . . . 65.13 108.515 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.507 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.0 tp-100 -83.22 108.62 16.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.594 -0.73 . . . . 74.12 109.817 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.53 150.47 25.67 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 111.809 -0.516 . . . . 70.24 111.809 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.97 118.06 0.88 Allowed Glycine 0 CA--C 1.501 -0.828 0 N-CA-C 110.556 -1.018 . . . . 50.43 110.556 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.499 HD13 HD12 ' C' ' 51' ' ' LEU . 15.4 mm -79.61 127.91 38.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.48 -1.304 . . . . 73.54 107.48 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -135.21 150.63 50.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 75.12 110.172 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -108.42 113.93 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.238 -0.892 . . . . 73.34 108.991 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 51.5 mt -116.01 110.19 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.984 0.914 . . . . 73.12 108.834 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.41 159.16 42.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 74.25 109.817 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -26.24 8.16 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.361 -0.381 . . . . 73.2 113.374 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' C' ' 93' ' ' GLN . 10.4 tt -123.43 159.19 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.643 0.777 . . . . 75.52 110.33 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -157.93 -177.35 6.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.437 0.695 . . . . 74.23 110.34 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -153.25 40.19 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.189 -0.459 . . . . 71.01 113.563 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 76.0 p -66.0 -21.16 66.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.55 0.74 . . . . 73.34 111.259 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.444 ' HB3' HD13 ' C' ' 89' ' ' ILE . 23.2 mt-30 -59.32 -51.68 68.92 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.012 0.925 . . . . 75.34 110.88 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.422 ' HB3' HG23 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -76.26 -23.76 54.47 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.329 -0.396 . . . . 75.24 110.916 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.78 97.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.235 0.614 . . . . 71.42 111.536 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.82 -26.87 64.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.615 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -69.95 -60.78 2.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 110.357 -0.238 . . . . 75.55 110.357 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 pp -72.89 -13.98 61.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.088 0.403 . . . . 75.13 112.088 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.99 -21.14 28.82 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.779 -0.456 . . . . 61.14 113.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.8 -59.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.392 0.596 . . . . 70.3 111.432 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -51.71 66.85 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.54 0.736 . . . . 75.54 112.365 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 m -68.13 -46.68 40.74 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.731 0.812 . . . . 64.32 112.506 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.57 -24.05 49.04 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.013 1.809 . . . . 72.4 113.793 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -69.88 -20.18 63.4 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 122.751 0.42 . . . . 71.43 112.006 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.496 HD13 ' NH1' ' A' ' 111' ' ' ARG . 36.4 mm -70.34 -41.4 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.365 0.602 . . . . 74.32 109.722 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' C' ' 82' ' ' GLY . 78.9 mt -81.67 -27.81 33.86 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.849 -1.069 . . . . 72.34 111.931 -171.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.523 ' HZ ' HD23 ' C' ' 128' ' ' LEU . 49.1 t80 -56.26 -47.44 98.86 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 117.692 -1.147 . . . . 74.53 113.607 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.12 -42.1 67.23 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.345 2.03 . . . . 74.33 113.036 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.4 -47.52 76.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.976 0.91 . . . . 74.12 111.388 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -65.7 -37.47 86.53 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.796 -0.638 . . . . 65.13 110.894 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -62.16 -46.1 90.48 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.387 1.055 . . . . 74.43 110.134 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.11 -37.11 75.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.713 0.633 . . . . 74.14 110.705 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.5 t -64.7 -31.81 73.2 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.522 0.513 . . . . 65.41 110.793 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.619 HG21 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -73.99 -49.16 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.911 -0.586 . . . . 74.22 110.756 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.0 m -57.8 -33.63 68.77 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.44 0.638 . . . . 73.11 110.703 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -65.84 -51.57 57.76 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.702 -1.135 . . . . 73.24 109.574 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.594 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.25 -37.09 74.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.769 1.228 . . . . 74.23 112.79 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.436 HG21 ' O ' ' C' ' 114' ' ' ILE . 94.0 t -69.28 -43.51 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.809 0.844 . . . . 75.31 109.821 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.6 t -69.63 -25.39 63.91 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.12 -0.945 . . . . 73.34 110.988 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -71.54 -38.76 71.02 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 108.793 -0.818 . . . . 74.01 108.793 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.31 84.63 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 123.789 0.681 . . . . 72.53 113.043 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.6 p 62.88 29.81 16.56 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.437 1.895 . . . . 73.31 112.852 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -92.4 163.97 24.6 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 124.43 1.092 . . . . 75.54 111.246 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.62 177.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.065 3.177 . . . . 74.13 115.935 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.427 ' OE1' ' HG3' ' B' ' 125' ' ' GLN . 19.5 mm100 -60.42 112.12 1.84 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.708 1.203 . . . . 74.44 112.026 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -111.33 90.49 3.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.785 -1.561 . . . . 75.23 106.785 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -122.81 105.02 9.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.761 -1.2 . . . . 65.32 107.761 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.523 HD23 ' HZ ' ' C' ' 107' ' ' PHE . 2.8 tt -80.87 116.47 20.87 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.629 -0.878 . . . . 73.24 108.629 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 142.77 98.72 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.087 0.955 . . . . 62.34 111.739 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.452 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 18.3 Cg_endo -58.03 109.66 0.52 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.974 2.449 . . . . 70.41 112.847 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 p -97.89 110.39 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.943 -1.132 . . . . 75.45 107.943 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -102.44 78.39 1.72 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.684 -0.689 . . . . 75.2 111.1 -164.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -69.44 -29.16 66.81 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.18 -0.918 . . . . 75.13 110.508 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 CA--C 1.545 0.758 0 CA-C-N 115.724 -0.671 . . . . 74.32 109.923 178.337 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 CA--C 1.561 1.368 0 N-CA-C 114.716 1.376 . . . . 74.21 114.716 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.7 m -144.86 142.73 30.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 72.45 108.936 166.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.534 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 29.4 t80 -152.79 121.45 6.43 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.051 -1.092 . . . . 75.11 108.051 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -137.67 144.39 41.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.989 0.516 . . . . 75.32 109.765 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.3 mm -84.13 116.91 28.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.95 0.9 . . . . 72.23 108.657 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -101.46 -48.68 4.27 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.929 0.331 . . . . 70.42 111.753 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.423 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 35.3 ttt180 -173.96 128.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 111.923 0.342 . . . . 74.11 111.923 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.13 132.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 124.177 0.991 . . . . 75.54 108.373 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.423 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 18.2 p90 -163.13 176.02 10.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.692 0.797 . . . . 75.53 112.043 -172.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -111.05 126.59 54.97 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 64.01 109.636 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 35.3 mtpt -97.39 -14.41 21.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.78 0.432 . . . . 75.25 110.302 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.74 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -161.33 138.29 8.68 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.385 1.074 . . . . 73.51 109.136 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.594 HG23 ' HE1' ' C' ' 117' ' ' MET . 51.8 mt -140.68 144.49 27.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.787 -1.56 . . . . 73.1 106.787 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 20.3 t -150.23 143.5 25.01 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.024 -0.732 . . . . 71.33 109.024 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.541 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -152.39 125.7 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.67 -1.604 . . . . 75.52 106.67 173.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.0 mt-10 -126.59 142.02 51.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.995 0.918 . . . . 73.34 108.528 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 85.4 60.4 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.021 -1.103 . . . . 73.32 108.021 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.04 -45.08 8.45 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.448 2.765 . . . . 74.43 113.803 -167.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -114.53 44.56 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.154 0.982 . . . . 72.33 108.432 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.91 -57.86 12.23 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 115.808 1.781 . . . . 73.02 115.808 -167.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' C' ' 83' ' ' ILE . 51.6 Cg_endo -85.25 -5.76 9.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 122.345 1.873 . . . . 74.1 112.636 176.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -84.07 -39.79 19.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.27 1.428 . . . . 72.22 109.947 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.03 -16.59 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.517 0.727 . . . . 64.13 109.828 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -55.46 -32.44 62.78 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.438 1.095 . . . . 74.13 111.789 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.72 -8.21 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.457 0.703 . . . . 74.41 112.531 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -125.47 106.19 9.61 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.295 1.038 . . . . 72.2 109.485 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -89.23 81.93 6.63 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.28 1.038 . . . . 74.51 110.478 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.569 ' HB3' HD12 ' D' ' 68' ' ' LEU . 33.5 t-105 -146.04 157.25 43.86 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.925 -1.139 . . . . 70.22 107.925 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -61.41 105.21 0.55 Allowed Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 125.161 1.384 . . . . 75.14 110.912 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.35 111.38 1.11 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.272 2.648 . . . . 74.1 111.883 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 113.27 2.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.378 0.671 . . . . 74.41 110.542 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 27.7 m -100.76 150.27 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 70.34 110.579 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -121.63 118.92 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.621 -1.992 . . . . 75.12 105.621 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.611 ' HG ' HD22 ' D' ' 128' ' ' LEU . 0.0 OUTLIER -96.38 151.45 19.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.726 -0.842 . . . . 73.11 108.726 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -149.79 144.15 25.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.421 0.688 . . . . 64.43 109.754 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -119.73 131.82 55.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.706 0.802 . . . . 75.12 110.01 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.7 t70 -134.04 117.71 16.96 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.539 -1.282 . . . . 75.02 107.539 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -103.5 156.91 17.41 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.218 0.533 . . . . 63.42 110.359 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 171.38 18.09 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.16 0.984 . . . . 75.52 109.076 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 48.5 p -150.45 163.32 38.69 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.458 0.703 . . . . 73.43 109.582 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -158.14 118.13 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.769 -1.197 . . . . 64.32 107.769 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -85.43 122.63 29.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.454 -0.572 . . . . 74.11 109.454 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.9 -40.55 12.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.51 0.724 . . . . 75.53 109.44 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.59 5.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.698 -1.137 . . . . 75.2 109.491 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.55 130.65 43.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.41 -0.589 . . . . 73.44 109.41 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.57 5.49 5.41 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.769 1.227 . . . . 72.13 111.635 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 99.9 t -126.95 115.29 40.85 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 124.658 1.183 . . . . 74.32 108.906 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.478 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 24.7 m-85 -134.27 127.26 31.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.076 -0.713 . . . . 75.32 109.076 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.67 114.43 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.84 1.256 . . . . 71.52 108.678 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.53 137.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.446 -0.946 . . . . 73.02 108.446 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 67.9 t -115.7 138.56 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.981 0.913 . . . . 72.34 108.921 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -126.48 119.6 27.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.386 -1.338 . . . . 72.41 107.386 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -102.85 98.69 8.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.518 -0.919 . . . . 73.52 108.518 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.15 130.92 40.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.962 -0.755 . . . . 71.32 108.962 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -123.4 143.32 50.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.894 -0.594 . . . . 61.41 110.062 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.414 HG21 HG23 ' D' ' 114' ' ' ILE . 70.8 t -130.1 125.41 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.486 1.114 . . . . 74.31 108.859 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 84.3 m -115.55 110.62 19.5 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.095 -1.076 . . . . 75.45 108.095 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -98.53 157.49 16.2 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.84 0.456 . . . . 74.24 109.8 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.5 p -158.34 137.28 11.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.656 -0.498 . . . . 63.44 109.656 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.569 HD12 ' HB3' ' D' ' 36' ' ' TRP . 18.1 tp -136.03 110.34 8.43 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.054 -1.091 . . . . 72.41 108.054 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.95 -127.35 7.97 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.596 0.56 . . . . 54.24 113.382 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -94.4 9.44 38.32 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.182 0.593 . . . . 74.52 111.838 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.45 163.93 31.51 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.249 0.547 . . . . 75.31 111.349 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -74.18 134.51 42.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.823 -1.08 . . . . 74.4 109.516 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.29 -53.03 5.26 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.49 0.716 . . . . 75.41 109.865 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.92 172.47 18.4 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.76 -1.109 . . . . 73.41 109.7 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 98.5 mt -138.68 149.57 45.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.241 1.417 . . . . 73.4 108.087 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.765 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -159.76 142.37 13.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.676 0.39 . . . . 62.22 110.671 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -155.94 126.85 6.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.941 0.496 . . . . 72.14 109.883 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.33 119.07 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.667 0.787 . . . . 71.32 110.074 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.74 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 25.3 mt-30 -89.22 88.09 7.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.715 0.769 . . . . 72.34 109.037 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.86 107.99 13.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.197 -1.365 . . . . 75.41 108.676 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.47 164.04 18.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 112.347 -0.301 . . . . 64.33 112.347 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.53 3.74 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.903 -0.479 . . . . 65.32 111.903 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -88.85 126.94 41.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.639 -0.875 . . . . 74.41 108.639 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -130.54 143.48 50.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.352 1.061 . . . . 73.52 109.101 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 12.9 m -80.66 101.18 9.08 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.816 -0.809 . . . . 70.25 108.816 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.478 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 43.1 mm -107.01 106.04 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.093 -1.076 . . . . 63.24 108.093 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.11 162.13 39.46 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.387 0.675 . . . . 74.31 110.849 -173.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 -0.2 55.33 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.926 0.73 . . . . 74.4 114.926 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.402 HD13 HG21 ' D' ' 86' ' ' ILE . 17.1 pt -134.03 141.21 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.879 0.872 . . . . 74.12 109.806 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.41 166.03 25.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.578 0.751 . . . . 74.54 110.873 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.75 -112.6 3.23 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.794 0.684 . . . . 74.13 114.018 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -72.57 -30.51 64.46 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.311 1.044 . . . . 74.21 111.353 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -67.05 -52.47 41.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 72.3 110.577 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.406 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 27.5 ptm -70.26 -29.91 66.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.818 -0.628 . . . . 73.45 110.545 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.48 77.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.895 0.478 . . . . 74.31 111.09 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -64.41 -43.01 95.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.329 0.652 . . . . 73.14 110.031 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.96 -49.36 77.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.884 0.473 . . . . 73.54 111.033 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' D' ' 94' ' ' MET . 88.2 mt -70.76 -22.32 62.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.637 0.775 . . . . 75.45 111.78 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.44 9.1 24.34 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.247 -0.752 . . . . 72.32 114.607 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.11 -75.77 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.021 0.91 . . . . 74.13 111.279 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -68.69 -50.91 47.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.276 0.843 . . . . 74.53 113.276 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.534 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 25.5 m -62.9 -46.32 87.5 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.743 -0.646 . . . . 64.22 111.849 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.544 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.2 Cg_exo -57.95 -33.93 97.74 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.47 2.113 . . . . 74.33 113.347 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.53 -29.68 69.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.462 0.705 . . . . 73.52 111.147 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.73 -38.6 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.492 0.663 . . . . 71.51 110.228 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 52.2 mt -81.55 -13.65 57.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.991 -1.004 . . . . 73.35 111.624 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.597 ' HZ ' HD21 ' D' ' 128' ' ' LEU . 56.9 t80 -69.04 -46.28 30.38 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.217 -0.897 . . . . 72.14 113.371 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 -32.42 90.88 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.085 1.857 . . . . 64.23 112.912 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.89 -35.39 38.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.767 0.827 . . . . 74.33 111.948 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.64 -51.91 63.12 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.111 0.564 . . . . 72.3 109.817 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -67.69 -34.24 76.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.15 -0.932 . . . . 73.54 111.552 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.94 -43.93 81.93 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.18 0.925 . . . . 75.0 110.159 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.541 ' SG ' HD11 ' D' ' 21' ' ' ILE . 45.7 t -57.53 -43.13 84.09 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 123.626 0.579 . . . . 63.52 109.929 176.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.765 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.2 mt -63.74 -46.1 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.188 -0.914 . . . . 73.32 110.749 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 94.0 m -55.76 -49.73 72.35 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.291 1.037 . . . . 64.23 110.527 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -65.3 -44.12 88.93 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 113.581 -1.645 . . . . 73.24 110.387 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.3 mtm -64.63 -35.92 82.57 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.894 0.478 . . . . 74.55 112.217 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.56 -44.77 86.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.441 0.696 . . . . 71.34 110.492 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.83 -25.73 62.1 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 122.478 0.311 . . . . 61.42 111.192 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -74.69 -34.81 62.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.641 0.777 . . . . 74.24 109.162 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 0.4 76.37 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 115.393 -0.821 . . . . 72.42 112.362 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.26 27.86 16.67 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 126.85 2.06 . . . . 73.13 112.907 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -94.92 160.63 30.64 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.45 -1.25 . . . . 75.54 108.706 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -53.44 136.07 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 124.066 3.177 . . . . 71.13 113.571 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.0 128.06 31.84 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 124.303 1.002 . . . . 74.34 111.804 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 47.7 tp -117.15 95.63 5.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 75.41 110.805 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -99.91 113.34 25.83 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.801 -1.185 . . . . 73.03 107.801 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.611 HD22 ' HG ' ' D' ' 42' ' ' LEU . 1.1 tt -74.57 124.66 27.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.768 -0.456 . . . . 71.12 109.768 -174.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.79 131.32 92.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.663 0.785 . . . . 74.25 110.99 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -77.78 127.4 8.68 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.65 2.233 . . . . 71.34 112.53 -170.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.37 112.5 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.451 0.643 . . . . 75.21 109.389 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -89.03 72.97 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.919 0.866 . . . . 55.14 109.413 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 CA--C 1.546 0.818 0 CA-C-N 114.789 -1.096 . . . . 73.22 110.866 178.233 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 108.103 -1.073 . . . . 70.12 108.103 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -139.79 119.44 13.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.359 0.663 . . . . 73.22 109.45 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -138.54 115.64 10.97 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.044 0.538 . . . . 75.02 110.103 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.478 HG13 ' HD2' ' A' ' 84' ' ' PHE . 2.9 mp -78.28 115.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.35 -1.352 . . . . 60.23 107.35 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -94.13 -44.41 8.02 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.601 0.36 . . . . 72.43 111.061 -171.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.643 ' HD3' HG22 ' B' ' 122' ' ' THR . 86.0 mtt180 -159.02 157.05 30.47 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.141 0.976 . . . . 75.44 110.228 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -144.63 101.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' HD1' ' HB3' ' A' ' 15' ' ' ARG . 89.4 m-85 -159.87 177.66 10.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.943 1.297 . . . . 65.42 109.476 -165.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -90.84 135.58 33.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 122.241 -0.287 . . . . 70.51 110.735 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 42.4 mtpt -96.47 -48.64 5.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.178 -0.675 . . . . 75.21 109.178 168.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 27.8 t70 -133.26 137.23 45.96 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.271 -1.331 . . . . 74.12 109.28 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 79.4 mt -139.19 139.48 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 106.876 -1.527 . . . . 74.1 106.876 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -147.53 129.38 15.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.582 0.753 . . . . 74.33 109.458 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.7 t80 -142.1 125.06 16.16 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.076 -1.453 . . . . 74.21 107.076 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.78 116.45 14.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.029 -0.73 . . . . 70.42 109.029 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.64 82.99 48.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 108.878 -0.786 . . . . 74.34 108.878 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 -32.76 13.98 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.574 2.183 . . . . 74.13 111.294 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.72 31.39 4.77 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.05 0.94 . . . . 74.25 109.859 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.93 98.26 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.991 0.916 . . . . 75.42 112.22 171.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -70.18 -14.97 35.36 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.962 1.775 . . . . 71.11 113.609 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -68.96 -46.59 67.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.758 -0.46 . . . . 71.33 109.758 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.8 -20.19 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.415 1.086 . . . . 73.43 112.153 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.22 -42.05 94.34 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.171 0.988 . . . . 65.04 111.107 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.95 -20.28 14.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.749 0.82 . . . . 72.12 111.652 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HD3' ' H ' ' A' ' 35' ' ' ASP . 3.9 tmtp? -83.79 163.37 20.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.261 1.024 . . . . 74.34 110.582 -171.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.612 ' H ' ' HD3' ' A' ' 34' ' ' LYS . 10.6 m-20 -63.69 143.53 57.76 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.207 1.003 . . . . 73.5 111.431 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -96.34 65.08 2.31 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.1 . . . . 74.33 110.609 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.44 77.38 9.72 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 109.558 -0.534 . . . . 75.33 109.558 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -82.14 148.48 15.06 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.032 1.821 . . . . 73.13 111.037 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.23 99.87 12.04 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.768 -1.197 . . . . 64.04 107.768 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 126' ' ' LEU . 26.8 t -76.69 95.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.138 -0.937 . . . . 73.33 109.946 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -79.87 131.9 35.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.148 0.979 . . . . 64.55 109.796 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 64' ' ' VAL . 2.1 mm? -115.3 149.47 37.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.115 0.483 . . . . 74.24 110.789 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.6 m-20 -136.34 125.92 25.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.076 1.35 . . . . 73.33 107.611 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.4 mt -116.64 119.1 34.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.622 -0.881 . . . . 75.02 108.622 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -132.51 147.74 52.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.98 0.912 . . . . 71.31 109.979 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.4 m -142.84 128.67 19.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.428 0.691 . . . . 72.32 110.161 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.78 152.3 49.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.648 0.779 . . . . 50.1 109.395 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.5 m -127.2 167.34 16.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 54.12 109.597 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -168.25 122.06 0.9 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 122.978 0.174 . . . . 72.32 110.548 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -69.78 114.45 7.99 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.793 0.837 . . . . 64.21 110.905 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 57' ' ' GLU . 58.7 mt -83.54 -41.93 17.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.324 1.05 . . . . 71.54 110.955 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.12 178.78 7.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.549 1.14 . . . . 70.12 108.309 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.14 99.01 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.922 0.392 . . . . 72.32 110.151 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 1.4 m-20 69.53 29.89 4.19 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 113.803 -1.544 . . . . 74.4 111.696 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -114.8 121.73 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.132 -1.803 . . . . 71.52 106.132 164.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.474 ' CE2' ' HA ' ' A' ' 54' ' ' ASP . 4.0 m-85 -132.49 137.33 47.16 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.309 0.576 . . . . 73.3 109.616 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD13 ' A' ' 51' ' ' LEU . 10.3 tt0 -87.09 114.14 23.44 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.283 -1.326 . . . . 75.2 108.645 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.39 110.16 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.05 -1.093 . . . . 73.41 108.05 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 97.4 t -98.45 137.79 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.523 0.729 . . . . 75.11 110.572 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.66 110.78 21.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.257 -1.386 . . . . 75.04 107.257 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -108.83 111.33 23.01 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.927 0.891 . . . . 75.21 109.386 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.1 t -110.71 128.79 66.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 123.578 0.751 . . . . 72.44 109.304 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.7 m -108.83 143.78 37.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.235 -0.654 . . . . 73.22 109.235 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.7 t -137.21 109.28 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.655 1.582 . . . . 75.22 107.759 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.4 m -114.81 119.49 36.81 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.651 -0.5 . . . . 75.24 109.651 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.28 107.33 18.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.738 -1.208 . . . . 60.44 107.738 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.0 m -129.79 128.63 42.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.917 0.487 . . . . 74.43 109.769 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.533 HD21 ' HE2' ' A' ' 34' ' ' LYS . 4.7 tt -101.44 85.49 2.79 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.162 -1.421 . . . . 75.23 107.162 172.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.86 2.19 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.204 -0.907 . . . . 73.41 111.756 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -88.16 -28.05 21.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.55 0.74 . . . . 64.42 110.779 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.46 125.5 35.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 71.55 110.212 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -88.02 114.92 25.11 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.95 -0.759 . . . . 73.14 108.95 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.89 -51.47 58.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.645 0.778 . . . . 73.44 109.347 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.474 ' HZ ' HD13 ' A' ' 126' ' ' LEU . 52.5 p90 -164.36 173.59 12.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.385 -1.28 . . . . 70.32 111.931 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.27 146.65 52.14 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.729 1.611 . . . . 73.53 107.921 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.5 m -141.92 138.99 32.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.165 0.986 . . . . 73.33 108.751 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -150.92 133.0 15.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.962 -0.755 . . . . 74.24 108.962 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' A' ' 113' ' ' CYS . 47.0 t -131.53 115.62 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.458 0.703 . . . . 74.3 109.121 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 62.5 mt-30 -84.6 84.83 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.057 -1.09 . . . . 71.31 108.057 170.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.91 95.82 4.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.742 -1.117 . . . . 74.44 108.555 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.84 142.96 19.55 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.819 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -137.83 122.47 2.47 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.211 -1.556 . . . . 74.22 109.211 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -89.3 122.38 40.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.478 ' HD2' HG13 ' A' ' 13' ' ' ILE . 29.3 m-85 -125.45 118.46 25.88 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.435 -2.061 . . . . 75.13 105.435 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -93.79 94.61 8.63 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.907 -1.146 . . . . 73.52 107.907 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -117.85 148.48 20.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 123.666 0.786 . . . . 73.25 110.136 -174.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -170.93 148.22 2.79 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.949 1.3 . . . . 75.34 109.351 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.44 6.64 62.53 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.167 0.292 . . . . 75.03 113.305 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.571 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.6 mp -127.33 136.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.116 -1.438 . . . . 72.24 107.116 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 175.58 11.19 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.312 0.505 . . . . 72.44 110.596 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 -152.14 48.15 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.262 -0.881 . . . . 70.53 112.767 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -65.48 -24.99 67.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.077 0.951 . . . . 54.31 112.429 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -59.65 -49.74 76.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.287 0.635 . . . . 73.14 109.969 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.571 ' SD ' ' HB ' ' A' ' 89' ' ' ILE . 2.5 tpt -80.86 -30.81 35.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.133 -0.939 . . . . 74.25 110.94 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -29.56 69.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.212 0.605 . . . . 75.32 110.842 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -73.55 -36.96 65.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.988 -0.551 . . . . 75.25 110.522 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.3 t -76.78 -65.11 0.98 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.912 -0.131 . . . . 74.13 111.11 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.92 -29.27 70.46 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.954 0.502 . . . . 73.41 112.327 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.44 -22.77 36.17 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 114.333 0.493 . . . . 73.23 114.333 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -133.09 -49.85 0.87 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.534 0.667 . . . . 65.05 112.424 -170.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -71.84 -47.55 52.33 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.856 0.862 . . . . 74.21 111.742 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 73.9 m -67.32 -47.62 48.71 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.425 1.09 . . . . 74.11 112.675 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.26 -26.88 56.28 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.891 1.727 . . . . 72.12 112.825 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.72 -29.29 62.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.622 0.369 . . . . 74.42 110.436 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 49.7 mt -61.44 -47.04 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.752 0.821 . . . . 74.31 109.429 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.511 HD22 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -73.71 -20.4 60.54 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.698 -1.137 . . . . 73.21 112.053 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -64.65 -46.11 76.41 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 114.627 1.343 . . . . 64.11 114.627 -166.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.63 -35.13 98.91 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.932 1.754 . . . . 74.42 112.706 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -73.72 -36.46 65.22 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.369 -0.832 . . . . 73.33 111.609 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.17 -42.81 68.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.262 0.225 . . . . 74.1 110.453 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.468 HH22 ' HA ' ' A' ' 130' ' ' PRO . 38.2 ttm105 -52.13 -48.6 64.76 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.114 0.884 . . . . 65.22 110.289 175.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.36 -52.53 61.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.851 -1.068 . . . . 73.53 111.429 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.425 ' HB3' HG12 ' A' ' 78' ' ' VAL . 46.8 t -61.42 -29.21 69.8 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.908 0.755 . . . . 71.41 112.013 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.594 HG21 HG22 ' A' ' 64' ' ' VAL . 79.1 mt -71.68 -60.37 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.69 -0.686 . . . . 73.53 109.694 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -55.03 -30.31 59.29 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.548 1.139 . . . . 71.14 112.333 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 -44.49 72.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.69 -0.686 . . . . 74.54 109.992 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.512 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.9 mtm -61.11 -41.11 96.09 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.881 0.473 . . . . 62.54 110.58 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -58.23 -47.76 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.532 -1.213 . . . . 75.33 110.667 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -75.21 -26.95 59.35 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.894 -0.594 . . . . 75.23 111.411 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -71.71 -27.88 63.31 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.708 0.803 . . . . 74.12 109.852 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.65 3.78 77.2 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.494 -0.775 . . . . 50.51 112.642 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.3 m 68.06 14.6 9.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.943 1.297 . . . . 74.25 111.216 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -85.81 149.91 51.98 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.853 -0.795 . . . . 73.21 108.853 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.82 143.3 91.34 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.574 2.182 . . . . 71.11 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -61.48 132.69 54.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.685 0.394 . . . . 74.32 110.734 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.474 HD13 ' HZ ' ' A' ' 74' ' ' PHE . 63.8 mt -133.42 96.36 3.7 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.306 -0.998 . . . . 74.25 108.306 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -98.85 123.23 42.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.101 -0.5 . . . . 74.45 109.759 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.407 HD22 ' H ' ' A' ' 128' ' ' LEU . 2.4 pt? -73.13 152.72 41.05 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.919 0.762 . . . . 74.03 110.576 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.62 147.85 68.82 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.37 1.068 . . . . 64.34 112.074 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.468 ' HA ' HH22 ' A' ' 111' ' ' ARG . 15.7 Cg_exo -68.59 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.404 2.07 . . . . 64.44 110.964 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.91 111.79 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.305 -0.998 . . . . 74.45 108.305 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.61 96.65 6.86 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.494 -0.928 . . . . 73.42 108.494 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -59.55 -23.41 62.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.472 -0.786 . . . . 75.01 110.258 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 19.0 t70 . . . . . 0 C--N 1.348 0.53 0 C-N-CA 123.997 0.919 . . . . 73.31 111.16 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 114.419 1.266 . . . . 72.54 114.419 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -140.34 122.22 15.51 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.248 -1.019 . . . . 75.13 108.248 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -123.95 141.0 52.43 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.321 -0.622 . . . . 75.44 109.321 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 59.8 tt0 -153.97 141.69 19.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.827 0.851 . . . . 71.45 109.161 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.59 ' H ' HD11 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -94.41 117.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.39 -0.967 . . . . 73.34 108.39 175.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -87.04 -48.87 7.74 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.285 -0.416 . . . . 75.01 110.119 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -164.34 140.84 6.33 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.683 -0.488 . . . . 75.34 109.683 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -114.64 141.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.937 -1.505 . . . . 73.32 106.937 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.531 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 37.8 p90 -168.25 148.35 4.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.202 0.455 . . . . 73.14 111.825 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.2 m -74.24 126.82 31.46 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.071 -0.714 . . . . 75.01 109.071 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.531 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 19.2 mtpp -94.51 -41.0 9.58 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.385 -0.598 . . . . 74.1 109.385 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -139.62 141.46 37.09 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.771 -0.65 . . . . 74.14 110.533 -171.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.572 HD11 HG12 ' B' ' 78' ' ' VAL . 41.0 mm -135.81 143.09 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.161 1.384 . . . . 71.2 107.512 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 57.4 p -148.0 138.7 23.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.697 -0.853 . . . . 71.44 108.697 168.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 83.5 t80 -141.21 116.44 10.0 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 106.244 -1.761 . . . . 75.13 106.244 168.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.81 110.86 14.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.688 -1.597 . . . . 73.13 106.688 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.91 88.18 9.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.707 -0.849 . . . . 63.31 108.707 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.95 -26.59 51.28 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.007 2.472 . . . . 75.12 112.447 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -120.81 28.31 8.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.774 0.829 . . . . 74.43 110.054 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.94 -46.34 81.23 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 124.786 1.234 . . . . 73.22 113.669 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 84.1 Cg_endo -79.06 -15.15 13.14 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.717 1.611 . . . . 75.35 113.088 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.406 ' HB3' HE21 ' B' ' 33' ' ' GLN . 58.7 m80 -100.43 1.55 41.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.894 0.878 . . . . 72.13 112.899 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.46 -20.91 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.452 0.701 . . . . 62.42 111.786 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.06 -28.15 69.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 72.33 111.851 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' B' ' 30' ' ' HIS . 42.9 mt-30 -67.37 -46.64 72.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.663 -0.698 . . . . 74.45 109.587 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.61 ' HZ2' ' HB3' ' B' ' 71' ' ' GLU . 79.2 mttt -111.86 74.83 0.88 Allowed 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.828 -1.078 . . . . 74.41 111.355 -171.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.94 82.75 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.162 -1.051 . . . . 61.24 108.162 167.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -153.78 165.61 35.49 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.37 -0.832 . . . . 73.15 109.041 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -77.99 120.67 82.15 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.804 -0.813 . . . . 72.3 108.804 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.36 154.59 32.03 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.324 2.016 . . . . 64.32 112.068 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 22.1 mm-40 -64.75 115.4 5.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.02 -0.733 . . . . 74.33 109.02 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 p -83.8 122.32 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.607 -0.886 . . . . 73.25 108.607 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 93.4 mttt -126.44 100.38 6.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.604 -1.258 . . . . 75.34 107.604 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 pp -88.91 140.04 29.84 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.078 -0.965 . . . . 74.32 110.78 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.794 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.0 m-20 -136.8 145.47 44.56 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.473 -1.677 . . . . 65.21 106.473 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.39 161.54 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.903 -1.147 . . . . 74.41 107.903 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.738 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.8 t70 -159.16 143.22 15.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.192 -0.67 . . . . 73.14 109.192 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -107.34 109.67 21.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.931 -1.137 . . . . 73.43 107.931 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.522 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -113.91 154.52 27.4 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.121 -1.066 . . . . 50.14 108.121 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -143.78 162.7 35.36 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.356 0.598 . . . . 74.24 112.108 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -162.87 151.49 14.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.368 1.467 . . . . 63.3 108.4 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -123.14 127.3 48.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.543 -0.54 . . . . 75.14 109.543 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.13 -37.65 12.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.946 0.498 . . . . 74.15 110.047 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.93 -175.53 3.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.903 0.881 . . . . 71.45 110.758 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -72.98 124.47 25.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.963 -1.017 . . . . 74.54 108.631 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 68.69 11.95 8.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.072 1.349 . . . . 75.22 111.932 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.65 88.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.45 1.1 . . . . 73.23 108.171 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.481 ' HB2' HD13 ' B' ' 86' ' ' ILE . 3.5 t80 -97.85 166.21 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.101 -0.703 . . . . 70.11 109.101 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -140.3 100.1 3.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.097 -1.446 . . . . 72.51 107.097 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -95.8 137.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.985 0.514 . . . . 72.24 109.657 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 21.9 t -117.17 152.45 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.414 1.086 . . . . 71.35 109.131 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -127.89 119.65 26.05 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.158 -1.423 . . . . 75.54 107.158 176.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.738 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.5 ttt180 -105.45 106.37 16.84 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.042 -0.725 . . . . 73.14 109.042 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.2 t -106.33 111.91 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.329 -0.989 . . . . 73.03 108.329 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.794 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.0 m -106.05 125.94 51.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.357 -0.608 . . . . 74.21 109.357 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 82.7 t -120.32 99.46 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.209 1.003 . . . . 74.3 109.345 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 86.4 m -86.84 147.84 25.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.991 -1.004 . . . . 74.23 109.312 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.64 152.49 37.96 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.986 0.514 . . . . 64.41 110.287 175.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.1 p -147.01 128.83 15.31 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.301 0.376 . . . . 75.12 111.726 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.459 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 60.9 mt -91.42 100.65 13.39 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.222 -1.029 . . . . 72.34 108.222 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.51 -120.62 8.37 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.211 -0.904 . . . . 54.33 111.885 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.61 22.73 13.1 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.668 0.747 . . . . 73.22 110.145 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.61 ' HB3' ' HZ2' ' B' ' 34' ' ' LYS . 13.0 tp10 -137.1 144.49 43.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 74.45 109.298 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -68.87 136.86 53.3 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.751 0.31 . . . . 73.12 110.917 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.459 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -86.13 -65.29 1.03 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.411 -0.959 . . . . 53.15 108.411 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.27 166.78 29.86 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 114.658 -1.155 . . . . 72.53 110.018 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.2 mt -135.92 109.73 8.13 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.79 -1.559 . . . . 75.22 106.79 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -118.89 141.46 48.63 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.509 -0.923 . . . . 73.13 108.509 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -149.45 129.05 13.13 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.534 -0.913 . . . . 71.43 108.534 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.572 HG12 HD11 ' B' ' 21' ' ' ILE . 79.1 t -125.03 148.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 73.34 109.211 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -127.63 99.58 5.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 174.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -89.09 109.22 20.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.136 -0.938 . . . . 75.21 109.325 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.15 169.65 26.74 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 111.987 -0.445 . . . . 54.43 111.987 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.03 130.92 2.12 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.271 -0.731 . . . . 74.42 111.271 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.77 127.67 40.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -134.78 135.59 41.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.234 1.014 . . . . 63.32 109.282 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 6.6 m -88.57 121.51 31.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.115 0.966 . . . . 74.41 108.702 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pp -134.55 130.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.09 0.556 . . . . 75.41 110.545 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.99 153.09 33.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.672 0.789 . . . . 72.23 109.939 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.03 -53.84 4.51 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.641 0.588 . . . . 62.52 113.27 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.53 133.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.048 1.339 . . . . 72.3 111.526 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -150.58 176.0 11.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.58 0.752 . . . . 72.24 111.411 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.13 -136.76 35.21 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.066 -1.425 . . . . 64.44 113.199 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.5 m -65.59 -37.54 86.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.885 0.874 . . . . 71.1 111.079 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -65.26 -27.79 68.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.115 -1.402 . . . . 72.31 111.006 -172.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 -33.39 69.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.215 0.606 . . . . 62.54 110.604 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.35 70.49 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.189 0.596 . . . . 63.22 111.379 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -76.74 -23.02 53.01 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.332 0.653 . . . . 75.34 111.344 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.72 -64.97 1.0 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.736 0.414 . . . . 72.14 110.545 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 mt -80.05 -28.56 39.23 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.889 0.476 . . . . 74.03 111.766 -172.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.5 66.74 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-O 119.559 -0.578 . . . . 64.42 113.846 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 -57.05 0.34 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.87 0.835 . . . . 72.01 112.351 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.33 -47.56 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.268 0.627 . . . . 75.44 112.126 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -65.88 -46.38 65.15 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.641 -0.695 . . . . 71.22 111.377 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 94.6 Cg_exo -50.84 -38.67 57.92 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.491 2.127 . . . . 73.24 113.791 166.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.525 HD22 ' HA ' ' B' ' 132' ' ' ASN . 1.7 m120 -64.4 -29.73 70.79 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.243 0.46 . . . . 64.23 112.243 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.73 -42.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.724 -0.473 . . . . 64.22 109.724 172.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.19 -17.41 54.95 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.124 -0.944 . . . . 75.33 111.756 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.97 -49.78 83.87 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.88 -1.057 . . . . 72.12 113.592 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.04 -39.38 70.06 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.44 2.093 . . . . 60.5 113.873 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.19 -46.57 49.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.642 -0.708 . . . . 75.55 111.114 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.44 78.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.616 0.766 . . . . 64.25 110.387 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -64.66 -50.8 65.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 75.3 110.549 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -34.68 78.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.162 0.585 . . . . 73.24 109.931 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.1 m -59.74 -52.83 63.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.751 0.82 . . . . 54.41 111.405 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.435 HD11 ' HB ' ' B' ' 62' ' ' VAL . 69.2 mt -58.25 -56.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.661 0.785 . . . . 74.32 110.805 178.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -64.77 -31.94 73.39 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 124.154 0.909 . . . . 74.1 111.582 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.6 t -61.79 -50.4 72.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.01 0.524 . . . . 74.4 110.039 174.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.531 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 19.9 mmt -68.85 -34.09 74.89 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.4 0.68 . . . . 73.41 111.232 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.08 -43.16 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.843 0.857 . . . . 70.23 110.309 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 73.1 m -67.93 -30.34 69.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.367 -0.833 . . . . 71.13 111.995 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -68.38 -28.09 66.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.409 0.684 . . . . 74.51 110.927 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.78 17.09 59.88 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 114.334 0.494 . . . . 64.12 114.334 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.643 HG22 ' HD3' ' A' ' 15' ' ' ARG . 4.1 p 69.67 12.31 8.06 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.049 1.74 . . . . 73.03 113.233 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.84 144.56 30.42 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 109.162 -0.681 . . . . 72.25 109.162 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.58 146.29 54.34 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.944 2.43 . . . . 60.11 111.676 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 18.7 mp0 -64.48 114.43 4.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.514 0.509 . . . . 74.21 110.978 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.26 85.06 2.07 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.575 -1.269 . . . . 74.05 107.575 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -101.47 121.59 42.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.14 -1.391 . . . . 71.44 108.148 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.96 139.66 40.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.281 0.632 . . . . 73.42 109.548 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 154.12 84.05 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 124.02 0.928 . . . . 51.33 111.047 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.437 ' HG3' ' HH ' ' D' ' 109' ' ' TYR . 48.7 Cg_exo -55.13 92.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.252 2.635 . . . . 74.24 112.567 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.51 111.92 25.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.492 -0.776 . . . . 74.14 109.499 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . 0.525 ' HA ' HD22 ' B' ' 104' ' ' ASN . 2.1 m-20 -82.06 107.23 14.6 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.421 -0.955 . . . . 60.12 108.421 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -58.83 -37.19 75.88 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.363 1.04 . . . . 72.1 110.581 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.61 -52.74 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.872 -1.058 . . . . 73.43 110.724 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.02 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.87 0.731 . . . . 75.21 112.013 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 N--CA 1.471 0.624 0 O-C-N 124.193 0.933 . . . . 73.42 110.446 176.448 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.2 ttp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.038 0.447 . . . . 71.11 111.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.5 m -118.6 102.06 8.59 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.098 -1.445 . . . . 72.41 107.098 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -118.6 122.79 43.45 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.687 0.795 . . . . 72.01 109.242 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -137.28 136.19 37.81 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.513 -0.551 . . . . 72.1 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.6 HD13 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -68.55 123.45 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.04 -0.726 . . . . 73.03 109.04 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -103.25 -47.96 4.16 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.723 -0.671 . . . . 72.21 109.76 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -173.24 151.98 2.16 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.651 0.595 . . . . 73.14 110.407 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.6 HG13 HD13 ' C' ' 13' ' ' ILE . 89.6 mt -138.26 140.42 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.539 1.136 . . . . 73.21 108.354 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -172.02 158.53 4.72 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.762 0.791 . . . . 74.51 111.364 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -78.76 106.13 10.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.444 -1.253 . . . . 70.21 109.05 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . 5.3 mmmm -66.85 -42.76 85.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.751 0.786 . . . . 74.13 109.638 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -144.53 141.47 29.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.502 -1.227 . . . . 72.31 109.341 -175.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.2 mt -135.82 146.2 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.182 -1.414 . . . . 75.3 107.182 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -154.82 149.27 26.25 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.229 0.538 . . . . 65.11 109.886 171.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -146.61 144.29 29.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.805 -1.089 . . . . 71.41 108.064 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -137.79 139.56 40.09 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.623 1.169 . . . . 74.31 107.89 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 79.29 66.25 Favored Pre-proline 0 C--O 1.241 0.652 0 N-CA-C 107.811 -1.181 . . . . 73.53 107.811 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.64 -22.04 64.89 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.641 2.227 . . . . 71.43 111.844 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.632 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 93.5 m-20 -125.91 47.24 2.27 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.448 1.099 . . . . 62.14 109.972 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.15 -54.96 50.29 Favored Pre-proline 0 CA--C 1.571 1.754 0 C-N-CA 124.279 1.031 . . . . 65.33 112.157 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.85 -26.44 44.66 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 121.976 1.784 . . . . 64.3 112.74 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.632 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 21.2 m170 -66.39 -16.35 64.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.26 1.024 . . . . 72.1 113.304 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.62 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 7.9 p -48.59 -33.66 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 112.757 0.651 . . . . 73.54 112.757 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.412 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 92.6 m-85 -76.13 -30.53 58.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.473 0.709 . . . . 74.52 111.939 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -112.88 3.51 16.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.995 0.918 . . . . 74.35 112.866 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -89.97 172.73 8.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.425 0.557 . . . . 75.3 111.061 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.407 ' HB3' HD23 ' C' ' 68' ' ' LEU . 20.6 t70 -83.9 133.36 34.72 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.197 0.999 . . . . 75.1 110.451 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -75.31 78.26 2.4 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.705 0.802 . . . . 74.53 109.995 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.441 ' HB3' HD12 ' C' ' 68' ' ' LEU . 49.6 tt0 -164.48 78.49 1.44 Allowed Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.28 -1.378 . . . . 73.34 107.28 169.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.22 106.62 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.285 1.99 . . . . 70.25 111.885 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -84.29 92.14 7.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.372 -1.344 . . . . 70.4 107.372 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 89.3 t -84.71 110.54 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.904 -1.498 . . . . 74.31 109.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.419 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 48.1 mtpt -93.05 115.68 28.34 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.323 -0.621 . . . . 74.33 109.323 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' C' ' 128' ' ' LEU . 5.8 tt -86.39 126.7 34.56 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.06 -1.459 . . . . 75.43 107.06 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -120.32 132.93 55.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.414 -0.958 . . . . 73.23 108.414 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tt -134.35 117.83 16.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.392 -1.336 . . . . 71.32 107.392 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.61 149.9 52.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.962 1.305 . . . . 74.14 108.381 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -142.08 153.42 44.16 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.058 0.456 . . . . 75.32 110.032 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.96 178.35 10.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.654 1.182 . . . . 75.12 108.635 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -145.73 159.63 42.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.036 0.535 . . . . 74.44 110.333 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -145.65 126.91 14.82 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.912 0.885 . . . . 70.01 108.662 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.38 117.64 24.43 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.124 -0.695 . . . . 74.25 109.124 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.755 HD12 ' HB2' ' C' ' 57' ' ' GLU . 25.7 mt -100.93 -26.89 13.58 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.967 0.907 . . . . 73.45 110.48 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.03 -170.54 1.96 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.14 0.976 . . . . 60.35 109.918 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -69.7 101.7 1.73 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.564 -0.743 . . . . 75.22 109.606 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 74.82 6.92 4.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.538 1.535 . . . . 75.23 112.532 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.62 113.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.442 -0.947 . . . . 72.23 108.442 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.36 125.31 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.108 0.963 . . . . 74.0 109.307 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.755 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.2 tt0 -86.08 116.67 24.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.565 -0.902 . . . . 75.41 108.565 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.22 125.51 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.636 -1.246 . . . . 64.31 107.636 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.37 106.31 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.946 -1.131 . . . . 72.25 107.946 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.66 98.33 8.04 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.425 -0.954 . . . . 75.44 108.425 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -83.14 124.19 30.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.076 -0.966 . . . . 71.11 109.627 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.76 124.83 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.768 -1.197 . . . . 64.15 107.768 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -127.64 125.0 39.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 72.55 109.655 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.592 HG21 HD12 ' C' ' 114' ' ' ILE . 90.1 t -107.28 119.96 57.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.743 -0.836 . . . . 75.31 108.743 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.5 m -99.7 139.52 35.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.229 -1.397 . . . . 64.45 107.229 167.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.46 107.22 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.046 -1.464 . . . . 72.54 107.046 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 58.3 p -159.85 150.96 19.43 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.425 0.453 . . . . 73.44 111.29 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' C' ' 37' ' ' GLN . 66.0 tp -83.76 -48.17 10.39 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.701 -0.851 . . . . 63.53 108.701 165.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.56 -82.05 0.05 OUTLIER Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.553 -1.019 . . . . 70.34 110.553 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.95 -31.94 17.91 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.954 -0.758 . . . . 74.42 108.954 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.93 87.49 4.11 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.415 -0.957 . . . . 73.44 108.415 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.6 m -88.75 121.1 30.77 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.836 -0.62 . . . . 62.45 109.813 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.87 -61.73 1.9 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.923 -0.769 . . . . 74.42 108.923 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . 0.461 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 41.7 p90 -158.89 171.87 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.72 0.772 . . . . 74.52 112.112 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.403 HD23 HG21 ' C' ' 65' ' ' THR . 2.5 tm? -137.28 135.45 37.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.235 -1.765 . . . . 75.43 106.235 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.9 t -137.98 136.76 37.26 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.279 -1.008 . . . . 71.22 108.279 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.2 120.96 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.868 0.467 . . . . 70.23 110.053 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.26 125.73 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.312 1.045 . . . . 74.24 109.585 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 1.7 mp0 -100.15 91.83 4.94 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.569 -1.271 . . . . 72.23 107.569 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -82.12 100.13 9.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.015 -0.539 . . . . 73.41 109.59 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 145.54 22.99 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.918 -0.873 . . . . 73.44 110.918 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.493 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.63 121.49 1.39 Allowed Glycine 0 CA--C 1.5 -0.902 0 N-CA-C 111.281 -0.727 . . . . 62.14 111.281 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 18.3 mm -80.31 128.09 38.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 108.067 -1.086 . . . . 73.53 108.067 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.65 139.43 38.49 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.272 0.629 . . . . 73.02 109.483 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.7 p -91.73 104.7 17.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.188 -1.041 . . . . 73.15 108.188 170.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.45 100.18 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.15 -1.056 . . . . 73.01 108.15 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.22 161.47 31.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.999 0.92 . . . . 74.45 110.364 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.47 -18.39 33.79 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.365 0.506 . . . . 54.1 114.365 168.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.78 144.82 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.282 1.033 . . . . 74.11 110.218 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -146.12 149.74 34.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.929 0.491 . . . . 64.4 111.689 -167.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.03 24.72 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.383 -0.826 . . . . 62.31 113.486 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -64.22 -23.94 67.49 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.165 0.986 . . . . 71.55 111.46 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -58.26 -57.38 13.14 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.648 0.779 . . . . 70.0 110.23 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.434 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.8 ptt? -73.12 -25.91 61.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.451 -0.795 . . . . 70.14 110.956 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.43 78.59 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.595 0.56 . . . . 70.53 110.485 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -67.36 -30.94 70.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.528 -0.76 . . . . 75.53 111.064 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.07 -64.43 1.01 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.307 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.5 pp -73.79 -16.32 61.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.558 0.577 . . . . 74.24 112.558 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.44 -9.92 37.27 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 119.449 -0.64 . . . . 62.13 114.018 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.01 -52.56 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.967 0.884 . . . . 74.13 112.571 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -73.18 -51.55 17.41 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.906 0.482 . . . . 73.31 112.2 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.6 m -61.89 -47.12 92.24 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 123.413 0.685 . . . . 72.05 110.842 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.0 Cg_exo -53.1 -36.62 77.38 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.603 2.202 . . . . 74.11 114.513 168.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.403 HD22 ' ND2' ' C' ' 132' ' ' ASN . 27.5 t-20 -63.3 -38.54 91.57 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.523 0.729 . . . . 73.44 110.974 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -39.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.443 0.697 . . . . 74.41 110.417 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.493 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.1 mt -80.67 -28.94 36.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.491 -0.777 . . . . 71.34 112.415 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -54.14 -47.12 98.23 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-O 118.012 -0.994 . . . . 71.53 113.603 -173.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.58 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.546 2.164 . . . . 73.15 114.155 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.56 -45.52 79.08 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.36 0.664 . . . . 74.03 110.504 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.04 82.67 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.224 -0.898 . . . . 75.31 110.826 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.55 -46.99 80.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.455 1.502 . . . . 75.55 110.355 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.78 -34.4 64.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.96 0.504 . . . . 64.03 110.118 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.8 t -66.42 -27.01 67.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.84 0.456 . . . . 73.3 111.017 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.592 HD12 HG21 ' C' ' 64' ' ' VAL . 77.0 mt -75.27 -54.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.922 -0.581 . . . . 73.01 109.916 171.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.8 m -62.35 -29.49 70.5 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.256 0.622 . . . . 74.41 111.696 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -67.01 -49.41 65.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.101 -0.703 . . . . 54.42 109.101 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.567 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.58 -35.18 77.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.13 0.972 . . . . 62.04 112.308 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.52 -47.5 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.42 0.688 . . . . 65.32 109.683 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 37.9 t -69.13 -27.04 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.155 -0.93 . . . . 74.34 111.211 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -71.34 -34.23 70.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 73.02 109.602 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.14 1.99 88.45 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.537 0.523 . . . . 72.21 112.494 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.8 p 60.15 35.79 21.11 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.591 1.956 . . . . 75.51 113.354 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.16 154.91 43.19 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.595 0.758 . . . . 72.5 109.817 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.91 169.75 8.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.345 2.696 . . . . 74.34 114.376 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' C' ' 127' ' ' ASN . 47.5 tp60 -60.22 113.81 2.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.476 -1.238 . . . . 73.04 111.389 -173.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.461 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 33.3 tp -134.88 115.12 13.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.791 0.836 . . . . 74.45 108.925 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.552 HD22 ' NE2' ' C' ' 125' ' ' GLN . 5.0 m120 -129.95 130.43 45.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.255 1.022 . . . . 73.25 108.404 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.411 HD12 ' HG ' ' C' ' 42' ' ' LEU . 88.9 mt -77.2 140.45 40.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.731 0.412 . . . . 73.21 110.801 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.19 137.8 78.76 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.658 0.783 . . . . 63.45 110.675 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.67 107.86 1.54 Allowed 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.847 2.364 . . . . 71.23 112.211 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.43 110.93 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.326 -0.99 . . . . 65.1 108.326 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.403 ' ND2' HD22 ' C' ' 104' ' ' ASN . 15.5 m120 -103.24 89.2 3.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.524 0.73 . . . . 52.23 110.823 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -72.76 -31.85 65.21 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.771 0.796 . . . . 75.41 109.095 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 CA--C 1.541 0.612 0 CA-C-N 113.997 -1.456 . . . . 62.45 111.132 172.635 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.4 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 113.996 1.109 . . . . 71.41 113.996 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.3 m -138.46 122.08 17.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.06 0.944 . . . . 70.1 108.622 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -141.98 101.18 3.89 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.181 -1.044 . . . . 71.44 108.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -122.04 127.38 50.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.067 0.547 . . . . 73.11 110.086 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.37 112.21 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.983 -1.117 . . . . 75.03 107.983 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.97 -47.81 7.36 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 119.528 -0.273 . . . . 75.42 111.716 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.412 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 42.6 ttt85 -173.12 132.92 0.51 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.563 0.209 . . . . 75.11 111.563 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.41 ' N ' HD13 ' D' ' 16' ' ' ILE . 1.9 mp -115.3 134.45 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.513 -1.292 . . . . 74.5 107.513 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -162.83 177.83 8.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.893 0.854 . . . . 73.44 111.641 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.1 p -109.72 118.96 37.92 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.617 -1.174 . . . . 74.1 108.351 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -85.46 -21.51 28.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.651 -0.5 . . . . 75.54 109.651 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.1 t70 -155.65 140.57 17.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.284 1.034 . . . . 74.25 108.657 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.567 HD12 ' HG3' ' C' ' 117' ' ' MET . 48.8 mt -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.521 -1.289 . . . . 75.41 107.521 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -153.24 140.38 19.4 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 123.748 0.655 . . . . 63.21 110.329 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.5 t80 -142.85 135.98 28.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.714 -1.587 . . . . 75.1 106.714 170.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.666 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -134.33 150.75 50.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.151 0.98 . . . . 72.24 108.538 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.63 77.69 10.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.82 -32.91 17.4 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.777 2.318 . . . . 75.32 113.545 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -114.75 41.7 2.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.935 0.894 . . . . 65.44 108.61 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.406 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -57.12 -56.28 35.32 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.64 1.348 . . . . 74.51 114.64 -169.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.45 -3.75 12.1 Favored 'Trans proline' 0 C--N 1.39 2.725 0 CA-C-N 122.11 1.789 . . . . 73.43 112.708 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.432 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 23.1 t-160 -84.65 -42.73 15.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.382 1.073 . . . . 64.51 110.393 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.04 -10.17 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-O 121.18 0.514 . . . . 64.54 110.546 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.65 -36.88 77.29 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.918 -0.583 . . . . 74.13 110.262 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 56.4 mt-30 -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.51 110.594 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -98.93 70.59 1.84 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.011 -1.107 . . . . 72.53 108.011 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.71 88.8 0.99 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.33 1.062 . . . . 75.32 109.666 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.51 ' HB3' HD23 ' D' ' 68' ' ' LEU . 67.8 t-105 -160.46 170.63 20.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.398 -1.273 . . . . 74.02 108.468 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -71.75 110.09 6.96 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.937 1.295 . . . . 74.52 109.613 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.51 ' HA ' HD13 ' D' ' 68' ' ' LEU . 27.4 Cg_exo -65.66 141.9 68.35 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.227 2.618 . . . . 74.42 112.72 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.72 113.64 3.91 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.102 -0.703 . . . . 71.25 109.102 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.77 115.11 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.205 1.002 . . . . 74.0 110.593 -171.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -87.61 111.07 20.87 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 165.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.606 HD21 ' H ' ' D' ' 42' ' ' LEU . 2.0 pt? -96.76 148.2 23.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.451 -0.944 . . . . 75.34 108.451 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.4 t70 -151.38 151.94 32.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.775 0.43 . . . . 75.23 110.729 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.08 154.18 49.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.891 0.876 . . . . 73.51 109.97 170.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.3 t70 -152.36 137.58 17.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.426 1.091 . . . . 74.22 108.433 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -104.46 144.82 31.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 109.02 -0.733 . . . . 75.22 109.02 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.67 162.86 40.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.102 -1.073 . . . . 71.54 108.102 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.4 p -168.82 158.95 9.29 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.072 0.463 . . . . 74.33 111.916 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.7 p -152.11 119.58 6.01 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.685 1.194 . . . . 72.14 108.616 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.64 124.33 23.33 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.998 -0.742 . . . . 74.3 108.998 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 69.2 mt -87.96 -36.91 16.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.455 0.472 . . . . 72.21 109.925 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.99 -175.24 4.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.625 0.77 . . . . 61.22 111.061 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.97 124.51 20.98 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.938 -1.028 . . . . 70.12 109.141 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.494 ' HB3' ' HB1' ' D' ' 87' ' ' ALA . 19.0 m-20 66.54 -0.09 1.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.411 1.084 . . . . 74.14 113.112 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -116.05 118.06 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.051 0.94 . . . . 63.43 108.62 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.98 129.69 40.49 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.508 -0.923 . . . . 70.32 108.508 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.76 136.04 33.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.022 -1.103 . . . . 71.22 108.022 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' D' ' 102' ' ' CYS . 7.4 p -123.8 132.22 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.465 -0.939 . . . . 72.31 108.465 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 62.0 t -108.62 128.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 123.383 0.673 . . . . 70.31 109.199 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.58 114.89 27.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.945 -1.131 . . . . 74.41 107.945 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -97.14 133.09 42.25 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.645 -1.161 . . . . 74.43 108.623 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.73 120.2 44.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.523 -1.288 . . . . 62.21 107.523 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.6 m -116.95 137.41 52.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.563 0.745 . . . . 75.15 110.245 -172.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 75.3 t -125.41 117.73 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.621 1.168 . . . . 73.1 109.33 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 63.9 m -110.44 92.51 4.07 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.792 -1.188 . . . . 75.04 107.792 170.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.02 132.5 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.347 -0.612 . . . . 62.0 109.347 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -148.48 135.02 19.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.155 -1.054 . . . . 73.23 108.155 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' D' ' 38' ' ' PRO . 20.0 tp -113.83 124.9 53.35 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 117.789 0.268 . . . . 75.03 110.489 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.13 -110.66 3.17 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.722 -0.551 . . . . 62.14 111.722 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 4.31 9.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.589 0.756 . . . . 73.33 110.149 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.36 154.91 27.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.663 0.785 . . . . 73.43 109.435 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.0 m -74.62 141.28 44.68 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 110.045 -0.354 . . . . 73.35 110.045 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.7 -62.5 1.24 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.049 0.94 . . . . 74.33 109.421 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -158.17 138.23 12.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.373 -0.83 . . . . 75.44 109.235 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 92.3 mt -102.76 153.91 19.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.607 -0.886 . . . . 71.41 108.607 172.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 53.8 t -159.11 145.78 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.522 -0.547 . . . . 63.31 109.522 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -156.56 131.24 8.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.288 -1.005 . . . . 72.32 108.288 168.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -124.34 140.32 48.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.469 -0.937 . . . . 74.15 108.469 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -118.89 86.21 2.5 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.989 -1.115 . . . . 72.52 107.989 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.417 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.5 tp-100 -80.26 97.5 7.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.673 -1.603 . . . . 74.3 108.925 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.79 141.65 15.73 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.856 -0.498 . . . . 62.24 111.856 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 138.01 7.24 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.726 -0.55 . . . . 71.32 111.726 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.47 130.12 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.564 0.746 . . . . 65.02 109.064 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -132.67 142.48 49.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.564 0.746 . . . . 74.44 109.585 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -78.58 108.26 11.84 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.167 -1.049 . . . . 62.24 108.167 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 35.8 mm -106.7 100.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.093 -1.447 . . . . 73.33 107.093 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -144.88 158.24 43.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.136 -0.938 . . . . 74.32 109.709 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.52 -0.04 51.47 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.48 0.487 . . . . 63.3 113.75 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.22 128.67 68.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.918 1.287 . . . . 74.35 107.806 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 179.83 6.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.668 0.787 . . . . 61.32 111.245 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.1 -141.96 29.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.474 -0.785 . . . . 75.31 113.218 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 35.3 m -78.33 -18.94 54.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.599 0.76 . . . . 72.42 110.429 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -46.4 85.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.347 0.659 . . . . 72.52 110.745 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -69.59 -26.7 64.59 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.405 0.441 . . . . 74.04 110.758 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.92 71.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.376 0.671 . . . . 74.33 110.947 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.79 -38.15 64.72 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.975 0.51 . . . . 72.32 110.737 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.91 -42.35 97.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.029 0.532 . . . . 53.11 110.953 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tt -78.49 -33.31 48.3 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.294 0.638 . . . . 73.15 109.613 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.43 58.97 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.138 -0.483 . . . . 74.22 114.281 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -52.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.493 0.647 . . . . 71.54 112.024 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -68.7 -43.7 75.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.658 0.614 . . . . 72.23 112.658 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.443 ' HB3' HG13 ' D' ' 58' ' ' VAL . 69.5 m -69.17 -43.05 23.7 Favored Pre-proline 0 CA--C 1.567 1.599 0 C-N-CA 122.943 0.497 . . . . 71.02 111.524 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.41 -34.48 89.28 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.765 2.31 . . . . 73.02 113.878 165.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -66.44 -26.52 67.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.708 0.803 . . . . 73.03 111.01 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.4 -41.23 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.62 0.724 . . . . 75.43 109.739 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.417 HD11 ' O ' ' D' ' 80' ' ' GLN . 94.4 mt -78.92 -14.41 59.24 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.688 -1.142 . . . . 71.4 111.836 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.418 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 55.7 t80 -61.98 -47.99 89.74 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.769 1.228 . . . . 73.54 113.745 -173.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 37.6 Cg_exo -59.98 -33.7 95.42 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 121.852 1.701 . . . . 73.14 112.682 175.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.437 ' HH ' ' HG3' ' B' ' 130' ' ' PRO . 82.1 m-85 -76.18 -31.64 58.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 74.31 111.73 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.39 -56.26 19.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.076 0.55 . . . . 72.44 110.098 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -67.81 -32.42 72.95 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.508 -1.224 . . . . 74.22 110.787 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.29 -50.99 71.86 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.219 0.949 . . . . 75.01 110.155 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.5 t -58.61 -42.59 88.49 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.862 0.726 . . . . 74.25 110.867 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.41 HG12 ' SG ' ' D' ' 76' ' ' CYS . 73.8 mt -61.44 -52.53 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.342 0.657 . . . . 74.35 110.34 175.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.521 HG21 ' HG3' ' D' ' 125' ' ' GLN . 99.1 m -53.6 -47.33 70.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.553 1.141 . . . . 75.0 110.999 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.2 t -63.82 -42.05 97.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.5 -1.227 . . . . 73.32 110.322 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.8 mtm -69.61 -30.64 68.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.089 0.556 . . . . 74.41 111.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 72.3 t -74.02 -37.86 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.304 0.641 . . . . 74.22 110.514 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -74.05 -30.26 62.31 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 120.843 0.354 . . . . 73.33 110.497 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -72.25 -30.41 64.84 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.742 0.817 . . . . 74.4 109.606 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.93 4.21 81.04 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.481 -0.781 . . . . 53.44 112.599 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 81.4 p 60.6 34.19 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.238 1.815 . . . . 72.42 113.72 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.34 163.88 27.61 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 123.815 0.846 . . . . 75.1 112.13 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.47 125.3 5.92 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 124.375 3.383 . . . . 62.02 114.273 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.521 ' HG3' HG21 ' D' ' 115' ' ' THR . 31.1 tt0 -55.04 130.36 41.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.656 1.182 . . . . 75.42 111.51 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.57 92.76 3.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.271 0.628 . . . . 74.45 109.596 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -100.86 113.49 26.48 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 14.7 tp -76.07 127.74 33.57 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.409 0.443 . . . . 74.45 109.831 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.77 138.96 82.46 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.555 0.742 . . . . 74.53 111.805 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -75.43 96.29 1.03 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.298 1.999 . . . . 64.32 110.555 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.69 134.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.512 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -88.71 104.84 17.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.12 -1.067 . . . . 72.53 108.12 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 N--CA 1.478 0.974 0 C-N-CA 123.203 0.601 . . . . 72.21 110.984 -178.155 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 109.625 -0.509 . . . . 70.33 109.625 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -139.68 112.92 8.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.78 -1.193 . . . . 72.51 107.78 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -133.84 116.97 16.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.177 0.591 . . . . 72.12 109.77 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.66 115.32 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.264 -1.013 . . . . 74.55 108.264 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.06 -44.86 10.05 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.81 -0.441 . . . . 75.02 109.81 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -174.52 144.69 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.795 0.438 . . . . 72.21 110.616 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.87 123.7 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 75.15 107.725 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -152.51 148.22 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.597 0.713 . . . . 74.44 111.126 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -79.96 112.58 17.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.638 -1.165 . . . . 74.25 109.904 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -82.1 -21.65 36.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.589 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -153.04 141.44 20.68 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.312 -0.858 . . . . 73.34 109.947 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 71.4 mt -144.78 143.11 22.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.812 1.645 . . . . 74.31 106.779 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.6 t -158.4 124.58 4.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.423 0.452 . . . . 71.23 110.208 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.444 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 91.8 t80 -116.49 147.54 41.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.027 -1.471 . . . . 74.41 107.027 169.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -142.5 140.49 31.86 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.871 0.868 . . . . 62.33 109.543 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -152.14 68.14 7.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 106.685 -1.598 . . . . 73.22 106.685 170.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.02 -20.46 21.86 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.234 1.956 . . . . 75.01 110.948 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -105.86 16.12 25.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.37 1.068 . . . . 74.11 109.729 -179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.644 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -54.19 -45.49 99.14 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.166 1.173 . . . . 75.13 114.166 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -64.68 -26.93 60.71 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.93 1.753 . . . . 71.21 113.006 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -75.33 -33.5 61.14 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.781 0.832 . . . . 74.33 111.747 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 73' ' ' ALA . 3.9 m -72.07 -23.62 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 122.923 0.489 . . . . 75.33 111.285 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -70.88 -31.37 68.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.794 -1.094 . . . . 53.44 110.232 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -76.53 -47.41 22.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.897 0.879 . . . . 73.24 110.381 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -82.65 167.1 18.58 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.5 -0.773 . . . . 72.25 111.928 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 116.21 6.34 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.778 -0.823 . . . . 63.34 108.778 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -84.88 63.98 8.37 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 122.583 1.182 . . . . 75.33 110.53 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -120.51 86.42 39.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 107.252 -1.388 . . . . 63.34 107.252 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.56 173.17 7.6 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.522 2.148 . . . . 73.43 113.154 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -96.6 124.36 40.56 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.5 90.17 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.499 -0.926 . . . . 74.22 108.499 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -96.39 127.91 42.83 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.016 -1.105 . . . . 74.02 108.016 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -134.21 145.97 49.69 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.064 -0.717 . . . . 75.31 109.064 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.74 148.5 39.1 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.023 -1.103 . . . . 75.5 108.023 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.8 147.58 40.98 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.197 -0.668 . . . . 72.14 109.197 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 11.6 t70 -154.11 137.28 15.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.966 0.906 . . . . 72.12 109.083 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -107.53 130.44 54.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.559 0.744 . . . . 74.42 109.634 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.74 150.6 52.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.184 0.994 . . . . 73.15 109.118 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -134.37 161.35 35.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.283 0.633 . . . . 73.45 110.816 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -152.29 152.75 32.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 73.21 108.753 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.38 123.43 48.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.146 -0.687 . . . . 63.33 109.146 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 57' ' ' GLU . 51.5 mt -101.81 -33.27 9.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.863 0.865 . . . . 73.01 110.725 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.57 -167.67 1.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.664 0.786 . . . . 74.44 110.64 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.16 99.37 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.215 1.006 . . . . 73.33 110.803 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 66.49 13.03 9.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.008 1.323 . . . . 72.44 112.303 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.5 t -99.54 111.04 28.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.541 -1.652 . . . . 72.12 106.541 167.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -119.79 168.84 10.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.526 -0.761 . . . . 73.41 109.167 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HB2' HD13 ' A' ' 51' ' ' LEU . 37.6 tt0 -132.51 134.53 45.12 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 125.065 1.346 . . . . 72.44 107.389 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.4 HG13 ' HD3' ' A' ' 103' ' ' PRO . 97.9 t -121.18 124.17 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 171.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.503 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.8 t -109.78 135.42 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.126 0.97 . . . . 64.3 109.338 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 121.28 44.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.681 -0.859 . . . . 75.22 108.681 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.23 105.09 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.472 0.709 . . . . 74.11 109.565 172.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.45 128.23 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.283 -1.006 . . . . 75.43 108.283 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -119.26 120.58 37.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.158 0.504 . . . . 74.42 109.832 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.436 HG22 HG21 ' A' ' 114' ' ' ILE . 71.0 t -112.25 105.84 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.346 1.058 . . . . 73.43 108.549 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.9 m -110.83 138.23 47.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.063 -0.717 . . . . 70.21 109.063 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.13 127.75 40.4 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.024 -1.102 . . . . 72.24 108.024 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -141.36 125.62 17.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.891 0.477 . . . . 70.14 110.632 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.673 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.1 pt? -93.39 84.27 4.71 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.159 0.984 . . . . 72.44 108.369 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.41 -102.44 1.49 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.339 -1.301 . . . . 54.32 112.093 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -95.96 -24.26 16.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.56 0.744 . . . . 71.13 109.664 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -92.06 135.55 33.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.895 1.278 . . . . 63.13 109.482 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 80.9 m -77.93 133.01 38.14 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.72 -0.474 . . . . 65.14 109.72 170.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -76.8 -59.92 2.57 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -165.88 166.79 17.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.125 -1.398 . . . . 75.31 110.189 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.22 127.57 32.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.226 1.01 . . . . 73.22 108.697 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 57.1 m -119.27 137.72 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.993 0.917 . . . . 64.2 108.657 172.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.16 122.48 9.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.407 -0.96 . . . . 73.12 108.407 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.28 132.21 69.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.302 0.641 . . . . 73.04 109.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.726 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.1 mt-30 -96.98 90.57 5.24 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.427 -0.806 . . . . 74.14 109.428 166.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.8 95.49 6.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.725 -1.125 . . . . 71.11 108.34 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.37 161.33 26.29 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.188 -0.46 . . . . 74.12 112.092 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.44 140.67 7.37 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.835 -0.906 . . . . 64.41 110.835 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.7 mt -86.26 127.19 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 N-CA-C 108.635 -0.876 . . . . 62.15 108.635 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -133.19 118.13 18.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.374 -0.973 . . . . 72.53 108.374 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -88.0 100.56 13.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.777 -0.823 . . . . 75.53 108.777 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.5 pt -119.52 147.75 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.262 0.553 . . . . 75.12 111.428 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.53 164.69 6.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.978 1.711 . . . . 62.33 108.852 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.45 9.01 87.37 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.752 -0.471 . . . . 54.33 114.11 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.26 146.67 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.452 0.701 . . . . 73.34 109.94 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.16 170.78 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.318 0.647 . . . . 71.53 109.469 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.76 -125.55 37.25 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.776 0.672 . . . . 71.15 114.758 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -72.4 -37.94 68.56 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.884 0.874 . . . . 75.51 111.705 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.51 -35.06 78.2 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.114 0.566 . . . . 75.41 111.003 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 55.8 ttp -68.93 -45.73 70.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.952 0.901 . . . . 71.12 111.054 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.04 73.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.627 0.771 . . . . 74.44 111.478 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -66.05 -48.43 71.05 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.915 -1.039 . . . . 75.53 110.551 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.649 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 0.8 OUTLIER -68.81 -55.68 10.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.304 0.853 . . . . 74.32 113.304 -168.11 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.3 -25.67 55.06 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 122.113 -0.367 . . . . 73.54 111.382 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.07 -18.67 45.76 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 114.292 0.477 . . . . 70.04 114.292 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -135.98 -58.01 0.76 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.169 0.588 . . . . 71.41 111.638 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 1.4 t80 -54.88 -53.6 53.31 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.179 0.992 . . . . 74.32 113.065 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m -68.56 -49.58 29.53 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.616 -0.707 . . . . 72.03 112.684 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' HG13 ' A' ' 58' ' ' VAL . 38.3 Cg_endo -65.56 -15.41 49.4 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 121.637 1.558 . . . . 75.22 113.56 172.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -72.79 -35.74 67.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.469 -0.567 . . . . 73.54 109.469 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mm -65.75 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.471 0.709 . . . . 73.03 110.135 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.8 -24.26 60.89 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.102 -0.954 . . . . 64.33 111.557 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.14 -45.02 39.93 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 114.451 1.278 . . . . 73.42 114.451 -168.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.611 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 29.4 Cg_endo -62.83 -29.86 77.01 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 121.553 1.59 . . . . 73.53 112.511 174.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' C' ' 108' ' ' PRO . 11.6 m-85 -81.94 -26.23 34.19 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.882 0.473 . . . . 71.52 111.861 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.29 49.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.684 -0.858 . . . . 41.23 108.684 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.423 HH22 ' HB3' ' A' ' 130' ' ' PRO . 39.2 ttm180 -51.6 -48.15 63.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.026 -1.443 . . . . 73.23 110.913 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.48 -47.93 77.13 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.428 -0.806 . . . . 74.22 111.149 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.23 -32.95 73.68 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.401 0.681 . . . . 70.41 111.402 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.436 HG21 HG22 ' A' ' 64' ' ' VAL . 74.9 mt -71.71 -58.51 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.706 0.802 . . . . 71.23 110.139 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.0 m -56.23 -33.74 65.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.69 1.196 . . . . 74.04 111.955 -173.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -67.34 -44.0 80.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.341 -0.845 . . . . 71.15 110.583 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.444 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.0 mtm -65.17 -35.0 79.71 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.593 0.357 . . . . 74.43 111.253 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.65 -46.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.8 0.84 . . . . 71.51 110.286 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.4 p -74.25 -28.95 61.46 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.783 -0.644 . . . . 72.51 111.458 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -71.79 -29.79 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.453 0.701 . . . . 73.34 109.828 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.27 -0.18 85.78 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.627 -0.715 . . . . 71.5 112.685 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m 68.04 29.75 6.23 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.89 1.276 . . . . 64.03 110.8 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.608 ' HE1' HG23 ' A' ' 31' ' ' VAL . 83.2 m-85 -99.11 152.1 37.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 115.287 -0.87 . . . . 73.23 110.329 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.05 141.7 77.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.386 2.057 . . . . 72.5 111.353 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -62.28 144.73 55.26 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.562 0.745 . . . . 73.45 112.312 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -146.48 103.01 3.64 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.336 -1.357 . . . . 55.34 107.336 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.17 119.11 37.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.419 0.688 . . . . 71.2 109.212 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.49 136.51 44.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.325 0.65 . . . . 75.04 110.404 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.21 138.36 86.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 45.32 111.36 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.423 ' HB3' HH22 ' A' ' 111' ' ' ARG . 46.9 Cg_endo -77.84 112.24 3.25 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.981 1.788 . . . . 73.31 111.035 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.58 136.05 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.65 -0.87 . . . . 72.31 108.65 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.96 78.48 1.17 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.277 0.631 . . . . 74.33 110.771 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -77.02 -26.6 53.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.862 -1.063 . . . . 72.42 108.758 173.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 16.3 t70 . . . . . 0 CA--C 1.546 0.806 0 CA-C-N 113.891 -1.504 . . . . 72.23 110.504 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 113.672 0.989 . . . . 61.31 113.672 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -160.49 143.08 13.07 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.499 -0.773 . . . . 74.43 109.877 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -132.43 113.36 13.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.832 -0.803 . . . . 75.02 108.832 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.78 140.11 52.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.256 1.022 . . . . 72.45 108.539 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.512 ' H ' HD11 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.67 137.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.819 -0.808 . . . . 74.03 108.819 167.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -101.47 -51.58 3.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.726 0.41 . . . . 73.22 110.431 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -161.13 139.4 9.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.035 -0.357 . . . . 73.13 110.035 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.34 140.58 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 107.271 -1.381 . . . . 75.1 107.271 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -167.84 147.96 5.03 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.279 0.561 . . . . 75.34 112.151 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -74.34 119.36 18.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.923 -1.035 . . . . 65.4 108.724 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -93.92 -29.47 15.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.565 0.746 . . . . 73.01 111.807 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 29.4 t70 -160.2 142.72 13.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.625 0.25 . . . . 73.23 110.803 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 31.6 mm -143.83 145.57 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.837 1.255 . . . . 74.11 109.055 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -146.38 141.95 27.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.302 -1.369 . . . . 72.03 107.302 163.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.493 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -150.03 111.83 4.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.244 -1.761 . . . . 64.32 106.244 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -115.98 156.9 25.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.597 -0.89 . . . . 73.32 108.597 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.67 76.39 14.19 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 105.817 -1.92 . . . . 64.51 105.817 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.02 -28.79 80.82 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.229 2.62 . . . . 74.54 113.212 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -124.48 29.31 6.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.855 . . . . 74.2 109.589 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.44 -53.39 24.19 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 115.162 1.541 . . . . 63.45 115.162 -172.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.83 -8.85 18.13 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.151 1.9 . . . . 74.31 113.433 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -97.75 -42.48 7.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.608 0.763 . . . . 71.25 110.65 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.69 -13.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.224 1.01 . . . . 71.34 110.181 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.73 -36.63 57.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.419 1.088 . . . . 73.51 111.342 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -70.6 -23.28 62.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.698 0.799 . . . . 72.4 112.488 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.98 111.24 20.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.688 0.795 . . . . 74.42 111.543 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.68 87.85 3.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.914 0.486 . . . . 64.01 109.904 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.61 ' HB3' HD21 ' B' ' 68' ' ' LEU . 29.9 t90 -154.36 157.31 38.39 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.016 -1.105 . . . . 75.04 108.016 174.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -67.1 116.87 40.47 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.368 0.667 . . . . 73.45 110.4 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 53.8 Cg_endo -67.87 127.53 16.31 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.057 1.838 . . . . 74.03 111.463 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.03 104.61 0.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.576 1.15 . . . . 73.24 109.848 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -91.65 136.01 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.314 0.578 . . . . 70.51 111.363 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 61.9 tttp -136.75 104.95 5.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.297 1.039 . . . . 75.54 108.572 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.422 ' H ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -86.49 167.85 14.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.193 0.597 . . . . 63.23 110.828 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 29.4 t70 -153.01 115.17 4.38 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.287 -0.869 . . . . 62.43 108.763 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.65 134.64 43.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.611 -0.885 . . . . 73.43 108.611 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.5 t70 -142.92 142.17 31.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.768 0.827 . . . . 64.4 109.612 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 42.7 p -118.55 116.19 26.14 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.411 -0.813 . . . . 71.23 109.76 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.81 152.31 32.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.135 -1.432 . . . . 71.3 107.135 168.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 62.3 m -143.53 169.96 16.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.019 0.438 . . . . 73.33 110.78 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -155.13 169.07 24.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.406 1.082 . . . . 52.05 108.679 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -125.1 128.03 47.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.713 0.805 . . . . 74.54 108.929 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -100.16 -22.65 15.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.429 0.691 . . . . 72.4 110.911 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.99 176.54 4.67 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.792 0.837 . . . . 74.35 110.207 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.69 122.26 13.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.702 -0.481 . . . . 74.01 109.702 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 72.37 -5.85 1.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.821 1.648 . . . . 74.33 112.705 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.4 t -103.78 100.84 11.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 N-CA-C 108.462 -0.94 . . . . 73.05 108.462 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.55 137.82 50.23 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.282 0.633 . . . . 73.33 109.699 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -110.29 97.39 6.87 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.349 -1.352 . . . . 74.42 107.349 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 57.8 t -95.97 123.55 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.363 0.665 . . . . 74.24 110.079 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 45.8 t -100.61 119.04 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.033 0.933 . . . . 74.31 110.108 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.16 114.19 26.27 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.219 -1.03 . . . . 75.14 108.219 177.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.403 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 29.3 ttm180 -99.51 117.62 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.932 0.396 . . . . 70.23 110.249 171.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -112.94 102.64 14.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.967 -1.123 . . . . 70.13 107.967 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 7.0 m -98.1 134.94 40.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.32 137.27 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.54 0.736 . . . . 70.11 109.941 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 85.3 m -121.33 146.44 46.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.213 1.005 . . . . 75.24 108.844 175.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -144.17 129.16 18.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.633 -0.877 . . . . 72.0 108.633 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -130.22 139.57 50.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.994 -0.743 . . . . 73.4 108.994 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' B' ' 36' ' ' TRP . 1.8 tt -124.99 105.98 9.61 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.964 -1.124 . . . . 72.32 107.964 -177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.28 -115.06 4.15 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.651 -0.704 . . . . 74.44 112.016 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -108.75 4.52 23.78 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.822 0.811 . . . . 73.24 111.509 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.86 169.5 17.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.934 0.494 . . . . 73.21 111.158 -173.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -73.62 133.11 43.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.51 -0.768 . . . . 71.02 110.26 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' B' ' 68' ' ' LEU . . . -85.44 -58.22 2.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.146 0.978 . . . . 74.22 108.378 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . 0.512 ' HZ ' HD12 ' B' ' 126' ' ' LEU . 45.4 p90 -164.3 161.51 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.548 -1.205 . . . . 73.13 110.246 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.73 152.12 47.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.08 1.352 . . . . 74.35 108.941 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.9 t -151.51 157.92 42.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.427 0.691 . . . . 62.45 109.408 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -165.77 128.48 2.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.76 -0.83 . . . . 73.44 108.76 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' B' ' 110' ' ' ALA . 65.7 t -126.17 143.6 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.044 -0.724 . . . . 71.3 109.044 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -124.75 102.36 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.531 -0.915 . . . . 73.03 108.531 172.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -94.04 100.66 12.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.132 -1.062 . . . . 71.0 108.132 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.66 144.18 16.93 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.452 -0.659 . . . . 73.43 111.452 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.48 127.47 3.64 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.694 -0.562 . . . . 74.54 111.694 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.16 125.99 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.33 -0.989 . . . . 73.31 108.33 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -131.43 161.44 32.46 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.363 1.065 . . . . 74.14 109.319 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -131.29 93.54 3.39 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.874 0.87 . . . . 73.43 108.725 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.451 ' H ' HD12 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -117.33 139.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.999 0.92 . . . . 73.34 110.098 -176.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.91 168.82 26.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 72.41 109.792 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.55 -28.77 5.16 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 123.539 0.525 . . . . 60.24 113.513 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 pt -90.84 137.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.709 1.204 . . . . 65.32 110.552 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -149.31 149.8 31.48 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.022 0.929 . . . . 74.43 109.243 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.23 -118.78 9.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.704 -0.68 . . . . 74.3 113.367 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.3 m -65.22 -40.43 94.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.794 0.838 . . . . 70.25 110.339 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -63.06 -34.19 77.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.672 -1.149 . . . . 63.15 110.853 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.514 ' SD ' HD12 ' B' ' 98' ' ' LEU . 13.2 tmm? -79.94 -43.07 22.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.909 -1.041 . . . . 74.14 111.089 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.13 91.96 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.564 -0.744 . . . . 74.23 112.46 -168.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 3.0 p80 -82.82 -12.46 57.45 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.602 -0.272 . . . . 75.54 110.996 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -85.35 -68.68 0.71 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.614 -0.266 . . . . 73.35 110.355 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.514 HD12 ' SD ' ' B' ' 94' ' ' MET . 2.4 pp -85.07 -14.8 46.11 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.198 0.444 . . . . 52.13 112.198 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.2 -2.98 59.0 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.75 -0.472 . . . . 72.13 113.303 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -147.29 -60.86 0.28 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.274 0.537 . . . . 73.4 112.036 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.67 -43.52 89.06 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.914 0.485 . . . . 74.23 112.136 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 67.1 m -69.35 -44.72 26.95 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.198 0.599 . . . . 71.03 111.403 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.503 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 80.2 Cg_exo -53.3 -37.34 80.87 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.152 1.901 . . . . 73.53 113.731 164.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.35 -27.32 66.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.48 0.312 . . . . 74.01 111.798 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.53 -42.69 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.663 0.785 . . . . 73.21 110.009 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.406 ' HB2' HD13 ' B' ' 60' ' ' LEU . 42.4 mt -81.54 -15.63 54.25 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.791 -1.095 . . . . 72.24 111.243 -174.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -60.17 -49.6 90.03 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 117.533 -1.223 . . . . 73.35 113.9 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.52 -32.21 96.01 Favored 'Trans proline' 0 C--N 1.38 2.202 0 CA-C-N 121.748 1.66 . . . . 62.44 112.913 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.38 -47.51 48.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.22 0.608 . . . . 75.24 110.413 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.408 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -58.02 -43.46 86.72 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.635 -0.711 . . . . 73.1 110.294 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -58.97 -52.01 67.59 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.633 1.573 . . . . 63.25 111.313 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.32 -37.09 86.05 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.928 0.767 . . . . 74.31 110.313 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.8 t -65.79 -41.43 91.98 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 123.612 0.57 . . . . 74.13 111.49 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.95 -53.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.449 0.7 . . . . 74.01 110.343 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -69.14 -24.1 64.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.762 -0.654 . . . . 73.11 111.403 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.8 t -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.09 0.556 . . . . 73.44 110.054 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -70.44 -32.04 69.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.485 0.314 . . . . 75.34 110.452 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.07 -35.76 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.836 0.854 . . . . 74.41 110.695 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 m -61.39 -46.51 89.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.267 0.627 . . . . 62.4 110.082 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -63.81 -36.5 84.09 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.738 -1.119 . . . . 74.02 111.189 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.9 -1.25 87.11 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.389 -0.673 . . . . 63.42 113.434 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 60.4 p 55.81 30.76 16.35 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.098 1.759 . . . . 74.04 112.598 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.38 162.87 38.51 Favored Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 124.565 1.146 . . . . 74.44 110.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.11 164.02 15.46 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 123.229 2.619 . . . . 74.34 113.649 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 0.6 OUTLIER -65.14 111.11 2.78 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.295 -0.866 . . . . 74.4 110.585 -172.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.512 HD12 ' HZ ' ' B' ' 74' ' ' PHE . 96.1 mt -135.05 83.58 2.03 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.779 -1.193 . . . . 74.44 107.779 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -101.07 122.61 43.87 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.362 -1.348 . . . . 73.45 107.362 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 33.6 tp -66.4 133.53 50.66 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.652 0.595 . . . . 74.02 111.034 -170.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.07 143.74 94.7 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.245 1.018 . . . . 74.51 111.67 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 87.24 0.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.911 2.407 . . . . 72.11 112.423 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 63.1 t -94.89 133.89 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.45 0.7 . . . . 74.33 110.526 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.96 113.74 26.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.33 1.052 . . . . 75.34 109.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.79 -29.4 67.76 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 71.43 111.916 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.6 -34.23 67.24 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.608 0.763 . . . . 63.35 110.763 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.78 -38.23 88.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.89 -0.595 . . . . 74.2 109.717 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 124.015 0.926 . . . . 74.41 109.69 176.269 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.0 ttp . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.255 0.55 . . . . 74.44 112.105 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -86.8 86.41 7.32 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.837 -0.801 . . . . 74.22 108.837 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 67.5 t80 -89.6 128.12 35.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.396 -0.594 . . . . 70.12 109.396 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.14 132.84 22.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.302 -0.629 . . . . 75.55 109.302 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.1 134.57 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.9 -0.778 . . . . 74.41 108.9 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -105.42 -51.44 3.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.523 0.329 . . . . 63.41 110.346 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -171.09 145.85 2.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.695 0.398 . . . . 73.42 109.934 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -124.05 138.45 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.116 -1.068 . . . . 72.35 108.116 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.468 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -170.94 146.18 2.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.547 0.339 . . . . 75.32 110.103 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -69.17 128.98 38.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.87 0.468 . . . . 73.44 110.448 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -84.48 -46.26 11.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.054 0.931 . . . . 72.21 108.869 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 8.0 t70 -134.79 136.95 42.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.175 -1.375 . . . . 74.31 109.325 -173.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -134.56 139.65 47.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.289 -1.374 . . . . 73.24 107.289 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.61 143.67 25.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.56 -0.745 . . . . 75.11 109.43 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -153.37 109.25 3.29 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.074 -1.084 . . . . 75.54 108.074 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.4 136.07 53.43 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.939 0.896 . . . . 74.33 109.106 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.78 91.7 10.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.46 -0.941 . . . . 71.53 108.46 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.95 -41.83 12.77 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 75.41 112.367 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 33.0 m-20 -99.09 35.53 1.88 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.171 0.588 . . . . 74.13 109.687 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.486 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -59.55 -51.54 80.41 Favored Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 118.254 -0.879 . . . . 60.24 112.941 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 37.9 Cg_exo -64.79 -33.52 53.26 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 121.783 1.656 . . . . 75.51 112.351 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.515 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -66.58 -19.5 65.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.52 1.128 . . . . 75.22 112.41 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.576 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 3.2 p -58.5 -14.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 113.043 0.757 . . . . 64.34 113.043 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -55.41 -40.66 71.72 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.06 0.944 . . . . 75.11 111.341 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -114.74 40.25 2.64 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.432 1.093 . . . . 74.11 109.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 0.0 OUTLIER -83.61 144.13 29.65 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.975 0.91 . . . . 72.41 110.721 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -88.1 113.57 23.87 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.625 -1.25 . . . . 74.15 107.625 163.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -83.47 64.02 7.64 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.839 0.828 . . . . 74.22 110.161 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -142.44 52.58 2.47 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.977 1.311 . . . . 75.23 108.573 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.41 144.81 9.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.023 1.816 . . . . 64.25 111.697 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.25 95.92 8.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.54 -0.911 . . . . 72.44 108.54 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' C' ' 65' ' ' THR . 16.7 m -71.76 102.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.293 -0.867 . . . . 73.13 110.565 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.415 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.1 mttt -91.97 100.2 12.9 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.159 -1.052 . . . . 70.11 108.159 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.3 163.53 16.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.347 -0.612 . . . . 74.41 109.347 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.6 t70 -156.33 146.29 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.53 -0.915 . . . . 75.13 108.53 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -133.8 117.35 16.78 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 75.42 107.757 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.78 137.57 46.85 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.02 1.328 . . . . 75.43 107.861 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.8 t -113.11 149.82 32.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.428 0.633 . . . . 64.43 110.28 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.53 162.17 28.8 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.568 -1.196 . . . . 73.13 107.995 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -135.63 151.15 49.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.282 0.633 . . . . 53.54 109.7 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.4 t -149.91 125.99 10.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.098 -1.075 . . . . 71.34 108.098 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -83.63 120.52 26.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.184 -0.673 . . . . 74.21 109.184 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -92.79 -40.81 10.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.42 0.688 . . . . 64.24 109.842 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 175.3 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.832 -1.076 . . . . 64.32 109.339 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.67 123.74 18.34 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.542 0.526 . . . . 74.53 109.76 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 68.16 2.14 3.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.055 1.342 . . . . 73.12 113.554 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.76 112.35 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.46 -0.941 . . . . 71.15 108.46 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -125.05 122.51 37.44 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.513 0.673 . . . . 74.1 109.295 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD12 ' C' ' 51' ' ' LEU . 33.4 tt0 -85.46 138.36 32.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.161 -1.382 . . . . 75.13 108.303 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.518 HG23 HD13 ' C' ' 106' ' ' LEU . 17.5 m -130.25 143.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.975 -0.75 . . . . 75.32 108.975 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.67 105.12 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.312 -0.995 . . . . 73.55 108.312 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.545 HD22 ' HB3' ' C' ' 103' ' ' PRO . 2.8 tm? -92.54 104.39 16.7 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.168 -1.049 . . . . 74.22 108.168 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -79.07 124.07 27.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.386 1.074 . . . . 75.41 109.385 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.471 ' HB ' HD11 ' C' ' 114' ' ' ILE . 22.0 t -112.84 110.22 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.596 -1.261 . . . . 75.51 107.596 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.8 m -99.21 136.57 38.97 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.904 -1.147 . . . . 71.24 107.904 176.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.556 HG21 HG23 ' C' ' 114' ' ' ILE . 64.9 t -135.94 113.16 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.135 0.974 . . . . 73.13 108.74 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 21.3 m -104.06 144.35 31.67 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.28 104.24 5.14 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.204 -1.036 . . . . 60.34 108.204 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.443 ' HB3' HG22 ' C' ' 72' ' ' THR . 56.5 p -159.91 169.16 24.1 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.113 0.565 . . . . 74.54 109.923 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -120.73 -40.82 2.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.954 -0.758 . . . . 74.21 108.954 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.36 -97.8 0.12 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 110.799 -0.92 . . . . 64.44 110.799 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -88.08 -27.86 21.69 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.645 -0.872 . . . . 72.14 108.645 170.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.33 87.92 1.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.356 -0.838 . . . . 75.13 109.334 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.443 HG22 ' HB3' ' C' ' 67' ' ' SER . 64.6 m -88.03 136.68 32.86 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.44 -0.8 . . . . 74.21 109.476 171.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.39 -63.95 1.28 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.633 -0.877 . . . . 71.34 108.633 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.42 177.36 9.59 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.299 1.047 . . . . 75.12 111.96 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.31 143.75 46.35 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 105.009 -2.219 . . . . 72.51 105.009 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -149.49 144.15 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.106 -1.072 . . . . 62.42 108.106 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -158.85 131.24 6.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.557 -0.535 . . . . 74.52 109.557 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -126.98 120.75 56.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.975 -1.011 . . . . 74.42 108.725 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -99.15 90.39 4.57 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.807 -1.183 . . . . 75.21 107.807 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.405 ' O ' HD11 ' C' ' 106' ' ' LEU . 8.3 tp-100 -79.96 108.86 13.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.261 -1.336 . . . . 70.21 109.511 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 158.69 29.71 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.977 -0.556 . . . . 63.31 112.266 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.22 126.23 1.56 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.365 -0.294 . . . . 73.33 112.365 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.518 HD13 HD12 ' C' ' 51' ' ' LEU . 12.2 mm -88.4 124.62 41.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.553 -0.906 . . . . 75.14 108.553 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.76 122.5 18.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.549 0.74 . . . . 75.42 109.674 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -90.36 110.44 21.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.965 0.506 . . . . 73.15 110.093 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.76 118.68 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 108.491 -0.929 . . . . 72.22 108.491 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.75 160.44 30.81 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.472 0.709 . . . . 73.32 111.531 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.87 -61.15 3.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.48 -0.782 . . . . 73.55 112.389 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.9 mm -91.02 145.71 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.007 0.923 . . . . 72.1 110.204 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -147.02 -171.31 3.74 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.3 1.04 . . . . 75.12 110.258 -173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 73.21 -143.34 32.95 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.171 -0.468 . . . . 74.33 113.316 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.9 p -66.84 -23.18 66.0 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.93 0.892 . . . . 74.32 111.914 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.06 -44.09 66.48 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.605 0.762 . . . . 63.35 110.994 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.484 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 21.6 ptt? -71.91 -32.96 67.89 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.447 -0.575 . . . . 70.15 109.447 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.15 -27.21 67.85 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.26 0.624 . . . . 65.42 110.989 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -73.42 -38.66 65.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.529 0.732 . . . . 75.0 110.411 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -67.97 -61.51 1.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.405 0.282 . . . . 73.51 111.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -76.3 -16.55 59.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.125 0.57 . . . . 74.22 112.142 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.96 -24.02 23.81 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.768 -0.462 . . . . 70.41 113.352 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.43 -59.05 1.1 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.393 0.596 . . . . 64.45 111.819 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.401 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 42.5 t80 -60.42 -57.27 13.46 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.74 0.816 . . . . 74.34 111.967 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.47 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 47.4 m -62.05 -47.7 90.14 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 115.312 -0.858 . . . . 74.44 112.17 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.545 ' HB3' HD22 ' C' ' 60' ' ' LEU . 89.8 Cg_exo -54.03 -35.67 81.91 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.85 2.366 . . . . 75.55 114.594 169.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -21.16 60.1 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.09 0.556 . . . . 75.22 111.368 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.422 HD13 HH12 ' A' ' 111' ' ' ARG . 21.8 mm -77.48 -35.05 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.464 0.706 . . . . 75.23 109.945 171.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.518 HD13 HG23 ' C' ' 58' ' ' VAL . 98.8 mt -76.45 -38.77 54.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.222 0.609 . . . . 74.55 111.992 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.14 -41.35 74.15 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 124.359 1.063 . . . . 72.55 113.333 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 39.7 Cg_exo -43.9 -55.21 3.21 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.643 2.229 . . . . 75.44 115.883 168.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.19 -30.63 71.13 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.328 0.585 . . . . 73.12 110.343 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.6 73.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.093 -0.958 . . . . 71.13 111.274 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.503 ' HD3' ' CZ ' ' A' ' 109' ' ' TYR . 22.3 ttt180 -56.43 -51.76 67.18 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.492 0.717 . . . . 75.25 110.982 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.75 -31.32 69.23 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.451 0.47 . . . . 74.41 110.667 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.42 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 7.1 t -69.25 -28.11 66.03 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.664 0.386 . . . . 74.41 111.245 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.556 HG23 HG21 ' C' ' 64' ' ' VAL . 89.2 mt -79.17 -50.1 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.402 0.681 . . . . 75.4 110.141 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -65.55 -29.33 69.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.866 0.467 . . . . 72.32 111.353 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -63.98 -52.25 60.51 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.287 -0.634 . . . . 71.55 109.287 172.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.474 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.66 -40.69 75.93 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.629 1.172 . . . . 75.3 112.468 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG21 ' O ' ' C' ' 114' ' ' ILE . 78.6 t -65.75 -43.4 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.555 0.742 . . . . 74.14 110.383 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 37.9 t -69.6 -25.0 63.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.786 -0.643 . . . . 74.23 111.451 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.2 mtt-85 -72.03 -34.37 68.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.3 0.64 . . . . 74.24 109.994 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.67 6.34 74.15 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.618 0.574 . . . . 74.2 113.146 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.525 HG22 ' HB3' ' D' ' 17' ' ' TYR . 44.4 p 65.28 22.23 12.08 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.722 2.009 . . . . 73.45 113.268 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.402 ' HB2' HG13 ' C' ' 118' ' ' VAL . 99.0 m-85 -84.52 162.12 51.77 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.84 0.856 . . . . 74.12 110.415 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.06 151.05 86.98 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.657 2.238 . . . . 73.35 113.074 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 24.4 mm-40 -60.26 112.36 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.965 0.906 . . . . 71.45 112.036 -172.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.61 90.35 3.28 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.346 0.658 . . . . 75.02 110.089 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.47 118.49 31.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.491 0.716 . . . . 74.34 109.937 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.459 ' O ' ' HD2' ' C' ' 111' ' ' ARG . 3.0 mm? -87.19 135.07 33.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.985 0.914 . . . . 74.1 109.233 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 141.86 87.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.451 0.7 . . . . 75.11 111.153 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.52 ' HB3' ' HE2' ' A' ' 109' ' ' TYR . 38.5 Cg_endo -65.65 125.72 14.84 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.4 2.067 . . . . 73.12 111.302 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.43 114.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.526 -0.916 . . . . 72.22 108.526 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.61 75.22 4.16 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.005 0.922 . . . . 72.22 109.958 -177.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.55 -43.61 18.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.733 0.413 . . . . 72.21 110.188 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 115.958 -0.565 . . . . 74.03 110.015 177.327 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.484 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 112.664 0.616 . . . . 73.41 112.664 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 32.7 m -115.36 143.08 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.782 0.433 . . . . 74.44 109.868 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.8 t80 -157.14 94.67 1.43 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.636 -1.246 . . . . 70.45 107.636 171.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -112.95 121.47 44.75 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.641 -0.709 . . . . 72.1 109.351 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.88 99.65 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 106.974 -1.491 . . . . 52.45 106.974 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -79.17 -46.92 16.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.682 -0.236 . . . . 73.1 110.915 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -169.04 131.66 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.213 -0.449 . . . . 61.04 111.964 -161.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.469 ' N ' HD13 ' D' ' 16' ' ' ILE . 2.6 mp -115.7 138.5 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.772 -1.195 . . . . 63.3 107.772 169.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.525 ' HB3' HG22 ' C' ' 122' ' ' THR . 10.1 p90 -164.76 177.3 8.07 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 121.872 0.844 . . . . 72.44 111.212 -176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -109.69 118.46 36.6 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.869 -1.06 . . . . 74.45 109.351 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.412 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.7 mtpt -88.57 -23.96 22.99 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.624 -0.51 . . . . 73.43 109.624 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.586 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.8 t70 -156.84 130.43 8.14 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.95 -1.023 . . . . 73.03 109.228 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.474 HG23 ' HE1' ' C' ' 117' ' ' MET . 68.6 mt -128.09 135.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.261 1.024 . . . . 75.12 108.292 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -134.83 137.48 43.35 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.082 0.953 . . . . 70.13 108.473 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -149.5 120.55 7.72 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.318 -1.364 . . . . 72.43 107.318 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 1.8 mp0 -120.41 137.65 54.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.993 -0.743 . . . . 75.02 108.993 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.41 81.07 37.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.32 -0.993 . . . . 62.13 108.32 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.3 -44.1 0.33 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.753 2.302 . . . . 75.21 112.764 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' D' ' 72' ' ' THR . 81.4 m-20 -100.87 44.36 1.02 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.217 1.007 . . . . 73.34 108.637 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.468 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.74 -53.57 63.05 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 114.118 -1.401 . . . . 75.33 114.471 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.72 6.65 5.46 Favored 'Trans proline' 0 C--N 1.392 2.868 0 CA-C-N 121.972 1.74 . . . . 65.4 112.662 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.423 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 4.9 t-160 -85.06 -46.23 11.35 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.32 1.048 . . . . 65.3 109.323 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.405 HG22 ' HB1' ' D' ' 73' ' ' ALA . 11.5 p -72.88 -16.98 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.169 0.509 . . . . 74.05 110.699 177.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -56.54 -30.23 62.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.734 1.214 . . . . 75.14 111.854 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' D' ' 30' ' ' HIS . 35.9 mt-30 -82.7 -16.4 48.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.71 0.804 . . . . 73.44 111.056 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.576 ' HB3' HD23 ' D' ' 68' ' ' LEU . 85.7 mttt -109.53 112.41 24.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.005 0.922 . . . . 73.45 111.537 -173.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.91 71.65 1.67 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.812 0.845 . . . . 73.04 110.873 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -164.57 158.85 18.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.083 -0.71 . . . . 74.51 109.083 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -62.02 114.09 10.46 Favored Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.075 0.55 . . . . 64.43 111.436 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.591 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 43.6 Cg_exo -60.06 114.82 2.26 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 121.972 1.781 . . . . 64.42 109.647 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.31 121.66 10.69 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.207 0.942 . . . . 71.51 109.897 -174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -96.67 112.32 28.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.375 -0.829 . . . . 55.3 110.292 -168.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.581 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 63.0 tttt -87.07 142.02 28.23 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.922 -1.14 . . . . 73.04 107.922 167.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.39 139.88 49.12 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 9.2 t70 -141.9 149.1 39.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.725 -1.213 . . . . 74.42 107.725 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.29 166.32 24.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.053 0.541 . . . . 73.5 110.971 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.5 t70 -170.18 156.11 5.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.766 1.227 . . . . 70.33 108.033 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.1 t -135.08 161.18 36.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.061 0.545 . . . . 70.1 109.828 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.93 163.47 38.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.831 0.852 . . . . 72.23 109.076 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -148.93 153.48 38.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.138 0.575 . . . . 75.53 110.092 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -159.77 121.64 3.3 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.464 0.706 . . . . 70.54 109.366 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.5 124.88 26.11 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.134 -0.691 . . . . 71.43 109.134 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' D' ' 57' ' ' GLU . 23.6 mt -94.08 -33.69 13.28 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.799 0.44 . . . . 73.32 110.423 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.46 -172.02 2.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.002 -0.999 . . . . 73.12 110.595 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.1 116.42 6.48 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.804 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 10.1 m-20 63.32 19.29 11.6 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 73.24 112.068 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -119.53 120.5 63.71 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -130.4 129.38 42.99 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.881 -0.785 . . . . 72.23 108.881 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD13 ' D' ' 51' ' ' LEU . 10.3 tm-20 -100.8 137.45 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.801 -1.185 . . . . 74.35 107.801 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' D' ' 102' ' ' CYS . 4.2 p -127.17 134.17 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.673 -0.862 . . . . 75.53 108.673 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 80.3 t -106.08 131.08 56.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.153 0.581 . . . . 72.32 109.756 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.585 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -107.38 120.97 43.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.808 -1.553 . . . . 65.21 106.808 174.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.6 ttm-85 -105.39 107.36 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.711 -0.848 . . . . 73.22 108.711 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.4 t -107.44 124.29 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.052 0.941 . . . . 75.43 108.662 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 8.8 m -125.04 130.66 52.76 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.235 0.614 . . . . 75.24 110.124 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.64 107.45 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.382 1.073 . . . . 74.03 109.104 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.0 m -103.19 96.92 7.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.262 0.625 . . . . 73.44 109.583 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.18 124.73 41.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.972 -0.751 . . . . 74.43 108.972 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 69.5 m -147.31 130.48 16.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.673 0.789 . . . . 73.31 109.419 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' D' ' 34' ' ' LYS . 35.7 tp -116.81 121.8 42.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.355 -0.609 . . . . 74.44 109.355 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 -113.66 4.24 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.576 -0.609 . . . . 64.34 111.576 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.29 2.42 8.48 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.318 0.647 . . . . 63.45 110.944 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -115.46 150.96 35.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.045 0.538 . . . . 71.1 110.618 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 94.3 m -69.45 120.68 15.61 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 114.586 -1.188 . . . . 71.44 110.205 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.405 ' HB1' HG22 ' D' ' 31' ' ' VAL . . . -83.4 -59.64 2.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 122.941 0.496 . . . . 74.34 109.664 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.31 152.61 26.22 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.394 -0.821 . . . . 74.34 110.454 172.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -124.29 153.34 41.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.562 1.145 . . . . 75.31 109.823 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -158.31 146.17 18.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.64 -0.709 . . . . 74.24 110.356 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.88 132.11 11.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.8 -0.815 . . . . 72.41 108.8 172.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.59 124.24 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 122.744 0.418 . . . . 74.05 109.994 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.586 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 40.5 mt-30 -88.97 85.09 6.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.767 -0.827 . . . . 73.33 108.767 166.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.83 96.79 6.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.203 -1.362 . . . . 75.32 108.593 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.06 155.95 24.0 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.302 -0.408 . . . . 74.4 112.179 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -153.21 133.77 4.15 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.645 0.223 . . . . 71.21 112.683 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.454 HG13 ' HE1' ' D' ' 17' ' ' TYR . 68.5 mt -89.24 126.0 42.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 C-N-CA 124.067 0.947 . . . . 71.23 109.502 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.96 138.44 46.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.411 0.685 . . . . 75.02 109.835 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.9 m -91.66 100.15 12.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.472 0.709 . . . . 75.13 109.502 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.1 116.69 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.638 0.775 . . . . 74.24 110.384 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -147.67 162.5 39.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.228 1.011 . . . . 54.4 110.801 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.49 -20.19 6.36 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 114.879 0.712 . . . . 71.33 114.879 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -114.51 157.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.054 0.942 . . . . 73.22 110.493 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.24 -174.55 4.99 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.692 0.797 . . . . 73.33 110.84 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.67 -133.85 51.48 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.717 0.636 . . . . 74.03 113.711 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -73.9 -22.54 59.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.307 0.643 . . . . 73.53 110.722 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.34 -41.06 73.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.806 0.842 . . . . 72.4 111.041 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -75.12 -30.43 60.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.995 -0.372 . . . . 74.4 109.995 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.4 63.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.241 0.616 . . . . 64.53 110.949 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -79.45 -44.13 21.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.898 0.879 . . . . 73.22 110.693 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.8 t -66.5 -48.91 68.29 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.173 -0.467 . . . . 62.51 110.92 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.01 -39.5 25.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.693 0.797 . . . . 73.12 109.812 -176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -27.58 35.66 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.69 -0.505 . . . . 74.42 114.251 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.88 -53.2 2.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.852 0.826 . . . . 64.1 111.391 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -74.09 -44.97 52.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.546 0.573 . . . . 71.35 112.546 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.51 ' HB3' HG13 ' D' ' 58' ' ' VAL . 72.4 m -63.48 -46.48 84.02 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.417 -0.801 . . . . 74.12 112.499 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.585 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 31.9 Cg_exo -64.23 -30.07 64.36 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 122.12 1.88 . . . . 72.31 112.862 171.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.84 -31.36 71.92 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.334 0.654 . . . . 74.0 110.363 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -69.95 -42.83 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.501 0.721 . . . . 75.21 109.974 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.531 HD22 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -74.42 -18.47 60.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.87 -0.605 . . . . 75.34 111.72 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -68.26 -42.76 31.14 Favored Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 114.314 1.227 . . . . 73.23 114.314 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.66 -32.1 96.12 Favored 'Trans proline' 0 C--N 1.383 2.358 0 CA-C-N 121.627 1.617 . . . . 71.44 112.871 171.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -81.45 -30.06 33.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.386 0.674 . . . . 73.43 110.995 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.49 -53.98 43.62 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.641 -0.874 . . . . 72.3 108.641 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.12 -50.09 65.19 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 113.91 -1.495 . . . . 75.33 110.981 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.92 -44.17 93.72 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.924 0.765 . . . . 74.0 111.661 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 -41.47 86.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.567 0.542 . . . . 64.2 110.761 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.529 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.0 mt -66.26 -53.81 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.093 -0.958 . . . . 65.33 110.21 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.515 HG22 ' HG3' ' D' ' 125' ' ' GLN . 37.5 m -54.46 -38.35 66.29 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.771 1.228 . . . . 71.43 111.765 -176.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -70.19 -46.23 65.03 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.356 -0.838 . . . . 53.42 110.805 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.4 mtm -63.42 -33.07 74.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.782 0.433 . . . . 75.42 111.74 176.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' D' ' 123' ' ' PHE . 39.6 t -68.2 -40.66 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.922 -1.035 . . . . 70.23 110.225 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -76.08 -22.91 55.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.263 0.225 . . . . 71.33 111.335 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 85.1 mtt-85 -76.85 -33.08 57.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.503 0.721 . . . . 74.33 109.487 173.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 0.84 88.49 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 115.43 -0.804 . . . . 65.14 112.079 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 61.54 17.86 8.91 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.921 2.088 . . . . 71.5 113.417 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.516 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 30.1 m-85 -82.94 168.97 19.37 Favored Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.615 1.566 . . . . 75.4 110.634 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 52.5 Cg_endo -64.17 135.7 48.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.007 2.471 . . . . 71.14 113.135 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.515 ' HG3' HG22 ' D' ' 115' ' ' THR . 33.2 tt0 -55.21 131.5 45.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.895 0.878 . . . . 74.11 111.778 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.88 97.62 7.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.92 0.888 . . . . 74.15 108.722 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -97.44 86.9 3.98 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.336 -0.987 . . . . 74.51 108.336 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.58 123.3 18.45 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.806 -1.088 . . . . 74.21 109.489 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.73 131.66 86.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 O-C-N 123.727 0.642 . . . . 75.23 110.768 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.37 115.36 3.3 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 121.966 1.777 . . . . 74.03 111.329 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.45 108.93 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.31 -0.626 . . . . 70.24 109.31 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -84.99 103.74 14.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.297 -0.865 . . . . 65.21 109.046 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.477 0.909 0 CA-C-N 115.393 -0.821 . . . . 75.02 111.173 -179.43 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 109.24 -0.652 . . . . 72.42 109.24 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.466 ' HA ' HG23 ' A' ' 86' ' ' ILE . 49.0 m-85 -136.35 112.14 9.48 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.291 -1.374 . . . . 75.04 107.291 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -132.77 134.44 44.72 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.042 0.537 . . . . 65.22 110.702 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.25 97.09 5.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 106.448 -1.686 . . . . 73.34 106.448 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -72.83 -40.2 65.97 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.216 0.606 . . . . 73.43 109.912 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -165.31 140.93 5.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.745 -0.835 . . . . 74.4 108.745 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.13 137.96 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.646 -0.872 . . . . 72.44 108.646 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -171.69 170.97 5.44 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.808 0.693 . . . . 73.54 111.195 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -91.06 117.95 30.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.446 -0.797 . . . . 71.35 109.213 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 34.4 mtpt -80.54 -28.84 37.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 110.04 -0.356 . . . . 70.51 110.04 172.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.3 t70 -149.13 142.16 24.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.582 -0.735 . . . . 62.42 110.301 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 117' ' ' MET . 59.0 mt -134.66 136.18 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.29 -1.374 . . . . 74.52 107.29 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -142.98 129.7 20.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.461 -0.94 . . . . 72.35 108.461 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 89.3 t80 -144.36 122.53 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.375 -1.343 . . . . 74.25 107.375 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.63 143.69 51.14 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.148 -0.686 . . . . 73.22 109.148 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.22 73.98 63.05 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.503 -1.295 . . . . 64.2 107.503 171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.42 -32.03 20.84 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.588 2.192 . . . . 74.15 111.204 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 31' ' ' VAL . 86.5 m-20 -103.92 30.6 5.03 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.699 -1.137 . . . . 75.13 109.768 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -55.71 -46.53 99.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.578 -0.725 . . . . 62.25 112.7 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 38.4 Cg_exo -61.46 -28.28 83.43 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 121.828 1.686 . . . . 73.32 112.98 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -74.21 -32.92 63.22 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 116.038 -0.528 . . . . 71.21 110.448 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 27' ' ' ASN . 55.1 t -63.51 -27.54 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.511 0.596 . . . . 73.41 111.659 -176.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -71.09 -39.66 72.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.417 0.687 . . . . 75.31 111.591 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.77 -38.29 14.79 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.383 0.673 . . . . 73.51 111.125 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HB3' HD11 ' A' ' 68' ' ' LEU . 13.6 mmmm -82.03 157.81 24.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 63.1 109.243 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 68' ' ' LEU . 22.6 m-20 -71.77 118.03 14.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.762 0.425 . . . . 75.5 110.572 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -75.66 76.96 2.65 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.484 1.135 . . . . 75.02 110.374 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -136.99 82.67 30.15 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.182 -1.414 . . . . 75.42 107.182 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -87.11 155.8 8.35 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.53 2.153 . . . . 74.41 113.049 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.3 124.04 41.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.716 -1.216 . . . . 72.21 107.716 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 92.52 2.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 109.129 -0.693 . . . . 73.44 109.129 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.3 tttt -87.29 139.43 30.57 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.66 -1.237 . . . . 74.11 107.66 169.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 pt? -139.1 151.23 46.54 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.056 0.542 . . . . 74.13 109.959 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -131.15 136.08 48.01 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.421 0.688 . . . . 70.34 109.767 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.0 tp -103.91 128.78 51.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.057 0.943 . . . . 74.41 109.495 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 14.7 t70 -146.23 139.32 25.74 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.878 -0.786 . . . . 75.31 108.878 170.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.1 m -144.89 134.18 22.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.301 1.041 . . . . 74.52 109.124 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.475 ' HB1' HH22 ' A' ' 61' ' ' ARG . . . -159.66 133.09 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.635 0.374 . . . . 64.54 110.238 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.575 ' HB3' HG23 ' A' ' 58' ' ' VAL . 59.9 p -91.38 177.06 6.34 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.29 0.636 . . . . 73.54 110.828 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 t -166.61 116.76 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.195 -0.669 . . . . 63.14 109.195 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -69.62 104.91 2.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.407 0.442 . . . . 75.42 109.968 -173.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 57' ' ' GLU . 49.7 mt -78.69 -37.27 42.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.659 0.784 . . . . 70.41 111.086 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.86 -173.5 4.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.648 0.779 . . . . 72.53 109.532 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.71 97.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.325 0.65 . . . . 75.14 111.166 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 6.0 m-20 60.1 31.01 20.41 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.47 1.108 . . . . 61.05 112.173 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.26 120.63 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.009 -1.478 . . . . 74.43 107.009 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.83 130.49 41.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.503 -0.925 . . . . 73.01 108.503 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.559 ' HB2' HD13 ' A' ' 51' ' ' LEU . 33.3 tt0 -86.13 117.98 25.3 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.86 -0.793 . . . . 72.43 108.86 171.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 48' ' ' SER . 47.2 t -98.73 118.64 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 107.406 -1.331 . . . . 73.13 107.406 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.503 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 36.2 t -102.45 131.47 50.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.4 -0.593 . . . . 64.42 109.4 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.59 115.1 29.76 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.197 -1.408 . . . . 75.32 107.197 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.646 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -89.89 100.88 13.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.002 -1.481 . . . . 74.41 107.002 172.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.53 124.36 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 13.5 m -112.22 138.9 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.413 -0.958 . . . . 70.14 108.413 172.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.1 t -133.63 107.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.893 1.277 . . . . 75.13 107.673 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 43.4 m -103.66 136.89 42.51 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.961 -0.755 . . . . 73.34 108.961 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.79 23.67 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.406 0.682 . . . . 73.51 109.364 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.3 m -143.22 142.73 31.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.421 0.688 . . . . 71.02 110.36 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.07 78.73 2.11 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 169.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.43 -99.31 1.08 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.647 -0.706 . . . . 73.54 112.287 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.41 -28.24 21.04 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.644 0.778 . . . . 75.11 110.834 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.576 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 5.4 tp10 -94.73 132.18 39.76 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.273 -0.64 . . . . 74.44 109.273 -174.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -82.4 130.82 35.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.203 -0.665 . . . . 73.4 109.203 170.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.92 -59.93 2.54 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.447 -0.945 . . . . 72.44 108.447 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -168.51 174.92 6.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.675 -1.148 . . . . 72.25 110.779 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 tp -132.12 144.87 51.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.551 1.141 . . . . 71.41 109.277 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.2 m -137.99 140.14 40.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.385 1.074 . . . . 64.24 109.477 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -149.32 130.32 14.38 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.46 -0.57 . . . . 73.3 109.46 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.18 110.79 18.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.689 0.796 . . . . 72.33 108.922 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -86.75 85.17 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.085 -0.962 . . . . 72.32 108.887 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD21 ' A' ' 106' ' ' LEU . 7.8 tp-100 -79.08 96.52 5.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.478 -1.237 . . . . 74.13 108.728 -177.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.14 142.86 16.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.333 -0.707 . . . . 75.43 111.333 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.14 126.4 3.35 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 110.411 -1.076 . . . . 72.54 110.411 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 51' ' ' LEU . 55.1 mt -81.79 129.8 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 173.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -134.41 121.09 20.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.517 0.727 . . . . 74.11 109.928 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -91.06 95.99 10.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.481 -0.933 . . . . 75.24 108.481 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' A' ' 11' ' ' PHE . 26.1 pt -130.04 131.88 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.793 0.837 . . . . 75.51 110.354 -171.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . . . -168.99 176.9 5.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.39 0.676 . . . . 73.4 111.44 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.57 31.07 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.088 -0.96 . . . . 71.54 112.399 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.448 HD12 ' HE3' ' A' ' 94' ' ' MET . 2.3 pp -138.09 172.33 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 124.216 1.007 . . . . 74.13 110.159 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.562 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.3 tt0 -154.73 -169.14 3.12 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.69 -0.855 . . . . 74.43 108.69 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.562 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.2 -130.68 24.39 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 120.129 -0.262 . . . . 64.21 112.971 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -66.96 -32.85 74.37 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.857 0.863 . . . . 73.34 111.395 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.63 -39.66 80.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.776 0.83 . . . . 73.33 110.823 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.472 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.0 tpp -72.7 -41.78 64.91 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.354 0.409 . . . . 74.23 110.441 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.54 66.46 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 72.22 111.279 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -79.88 -37.71 34.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.51 0.724 . . . . 63.44 111.054 172.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -63.03 -57.44 10.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.651 0.38 . . . . 74.32 111.955 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.542 HD22 ' HG ' ' A' ' 48' ' ' SER . 0.5 OUTLIER -95.18 -10.3 30.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.398 0.518 . . . . 75.14 112.398 -177.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.5 -21.26 15.12 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.156 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.43 -64.59 1.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.591 0.756 . . . . 73.32 110.257 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -60.21 -53.12 61.53 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.166 0.986 . . . . 73.43 112.725 -172.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 98' ' ' LEU . 84.4 m -60.21 -52.26 74.45 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.165 -0.921 . . . . 61.23 112.735 -176.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.86 -24.09 40.58 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.816 1.677 . . . . 75.23 113.233 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -73.61 -28.76 61.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.944 0.498 . . . . 74.33 110.605 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -68.84 -42.41 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.389 0.676 . . . . 74.33 109.418 168.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD22 ' HA3' ' A' ' 82' ' ' GLY . 88.7 mt -71.61 -25.96 62.38 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.962 -1.017 . . . . 71.32 111.768 -176.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -67.24 -44.61 48.66 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.81 -1.091 . . . . 72.51 113.823 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 20.6 Cg_endo -62.66 -33.27 77.82 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 121.875 1.717 . . . . 74.12 112.647 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -75.14 -34.36 61.62 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.181 0.592 . . . . 73.55 111.875 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.87 65.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.355 -0.609 . . . . 74.23 109.355 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.469 HH12 HD13 ' C' ' 105' ' ' ILE . 34.7 ttm180 -51.96 -51.68 55.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.121 1.368 . . . . 75.25 110.684 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.17 -48.48 81.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.253 0.971 . . . . 75.21 111.211 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.9 t -56.84 -45.76 82.17 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.297 0.998 . . . . 71.42 110.92 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 118' ' ' VAL . 95.3 mt -63.59 -52.4 58.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 124.084 0.865 . . . . 72.54 110.551 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.5 m -53.82 -43.77 69.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.816 0.847 . . . . 64.34 111.112 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.38 -42.99 82.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.652 -1.158 . . . . 65.01 110.365 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.462 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mtp -56.5 -46.19 80.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.736 0.814 . . . . 75.22 111.25 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 114' ' ' ILE . 91.1 t -60.99 -47.47 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.699 -1.137 . . . . 74.44 110.989 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -71.82 -26.57 62.45 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.995 -0.548 . . . . 71.41 111.246 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.412 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 40.0 mtt180 -72.88 -30.38 63.92 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.489 0.716 . . . . 73.11 110.017 172.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.04 0.48 78.87 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.564 -0.743 . . . . 54.35 112.543 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 66.89 37.85 3.87 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.804 1.242 . . . . 75.32 110.109 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -113.69 153.7 45.86 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.893 -1.048 . . . . 64.24 109.299 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.98 132.97 52.75 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.009 2.472 . . . . 74.42 112.189 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -61.99 147.4 47.17 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.867 0.73 . . . . 64.2 111.262 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -117.8 95.44 4.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.05 0.54 . . . . 75.55 109.555 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -100.76 97.24 7.9 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.699 -0.852 . . . . 71.4 108.699 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -73.39 136.99 44.4 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.659 -0.867 . . . . 75.33 108.659 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.68 148.48 91.07 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.039 0.535 . . . . 73.33 111.753 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -77.9 119.48 4.75 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.906 1.737 . . . . 74.41 111.458 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.81 111.52 31.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.519 -1.289 . . . . 75.3 107.519 170.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.99 93.0 9.23 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.253 0.621 . . . . 64.51 109.593 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -61.96 -27.92 69.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.42 -0.809 . . . . 63.1 108.859 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--N 1.352 0.686 0 CA-C-N 115.076 -0.965 . . . . 75.25 111.592 173.225 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.421 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 21.8 ptm . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 114.528 1.307 . . . . 72.21 114.528 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -152.78 125.64 8.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.763 1.225 . . . . 74.11 107.742 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -135.72 135.52 40.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 74.33 108.542 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.685 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 55.3 tt0 -150.42 142.33 23.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.809 0.844 . . . . 74.41 109.192 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.5 115.05 32.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.485 -1.302 . . . . 71.41 107.485 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.418 HE22 HG12 ' B' ' 55' ' ' VAL . 71.6 mt-30 -79.79 -48.31 13.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.933 -0.395 . . . . 73.3 109.933 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -167.74 136.32 2.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.743 -0.662 . . . . 73.34 109.747 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.1 mt -114.67 140.99 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.051 -1.463 . . . . 74.11 107.051 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -165.96 146.73 6.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.528 0.68 . . . . 74.2 111.077 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 40.6 m -77.44 117.07 18.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.108 -0.951 . . . . 71.44 109.078 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -86.92 -27.64 23.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.318 0.647 . . . . 75.24 110.82 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 21.1 t70 -150.9 139.68 20.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.272 -0.422 . . . . 73.51 111.097 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.679 HD13 ' SG ' ' B' ' 113' ' ' CYS . 33.7 mm -128.66 143.5 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.126 1.37 . . . . 74.45 108.142 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.3 t -141.03 142.93 34.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.099 -1.075 . . . . 71.15 108.099 169.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -157.8 120.04 3.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.656 -1.609 . . . . 74.1 106.656 171.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.05 146.69 49.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.304 -0.628 . . . . 74.24 109.304 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.69 79.84 10.07 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.046 -1.094 . . . . 70.51 108.046 175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.6 -25.46 20.87 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.067 2.511 . . . . 72.14 112.793 -172.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -116.66 19.39 14.57 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.872 0.869 . . . . 72.0 109.793 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -47.49 -52.69 35.14 Favored Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 115.313 1.597 . . . . 61.42 115.313 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.28 -11.42 19.21 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 121.839 1.693 . . . . 74.15 112.725 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -97.89 -26.24 14.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.657 0.783 . . . . 74.21 111.728 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' B' ' 68' ' ' LEU . 34.7 m -82.24 0.49 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.459 0.304 . . . . 75.14 111.176 175.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.99 -42.61 99.33 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.339 1.056 . . . . 72.32 110.892 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.25 -13.89 48.42 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.114 0.566 . . . . 74.53 111.479 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -83.95 78.69 9.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.386 0.674 . . . . 74.24 110.06 -170.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.91 102.59 5.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.791 -0.818 . . . . 72.12 108.791 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -159.56 162.6 35.42 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 73.45 108.059 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.49 109.19 29.88 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.546 -0.74 . . . . 73.34 109.032 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.15 131.03 43.42 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.648 2.232 . . . . 74.31 113.408 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.25 102.51 2.13 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 107.741 -1.207 . . . . 71.21 107.741 167.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' B' ' 65' ' ' THR . 23.7 m -97.6 146.35 7.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.2 -0.909 . . . . 74.41 110.765 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.84 118.87 19.49 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.514 -1.291 . . . . 73.32 107.514 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.465 ' HG ' HD13 ' B' ' 128' ' ' LEU . 2.4 tt -96.28 123.55 39.95 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.024 -1.843 . . . . 64.44 106.024 171.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.5 t70 -124.8 129.95 51.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.875 -0.787 . . . . 74.01 108.875 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.17 125.82 53.87 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.193 -1.04 . . . . 75.22 108.193 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.82 133.07 35.51 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -118.78 121.77 40.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.23 0.612 . . . . 74.45 111.21 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.38 160.93 19.83 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.799 1.24 . . . . 75.43 108.582 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 61.3 p -143.35 163.92 31.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 122.892 0.477 . . . . 71.13 110.3 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 159.32 43.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.485 1.114 . . . . 74.32 108.86 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -125.54 119.76 29.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.442 0.697 . . . . 73.05 109.133 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.2 -36.75 26.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.178 0.591 . . . . 75.51 110.566 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.33 -177.6 5.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.107 0.963 . . . . 61.33 109.915 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -66.1 118.58 10.05 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.597 -0.729 . . . . 74.02 110.105 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 71.67 3.17 4.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.524 1.53 . . . . 71.5 112.151 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.418 HG12 HE22 ' B' ' 14' ' ' GLN . 59.0 t -109.93 87.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.758 1.223 . . . . 74.23 108.329 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.411 ' CD1' HD13 ' B' ' 86' ' ' ILE . 12.2 m-85 -98.84 147.0 25.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.1 0.56 . . . . 75.54 109.587 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -131.79 100.31 5.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.016 -1.105 . . . . 72.35 108.016 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 29.8 m -94.22 138.1 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.858 -0.423 . . . . 72.03 109.858 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.08 114.11 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.631 0.773 . . . . 72.51 109.756 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.51 129.55 39.68 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.409 -1.33 . . . . 73.41 107.409 176.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -122.04 112.32 18.1 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.808 0.843 . . . . 75.15 109.157 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.05 125.77 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.619 -0.882 . . . . 73.45 108.619 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.2 m -117.91 146.85 43.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.215 0.531 . . . . 74.24 109.577 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.603 HG22 HG21 ' B' ' 114' ' ' ILE . 42.9 t -132.6 132.69 59.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.443 1.497 . . . . 74.21 108.723 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 100.0 m -126.13 143.74 51.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.924 -0.769 . . . . 70.41 108.924 169.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.54 140.25 44.57 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.743 -1.206 . . . . 73.11 107.743 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.1 m -129.51 128.83 43.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.795 0.438 . . . . 64.44 110.048 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.449 HD11 ' HB ' ' B' ' 31' ' ' VAL . 31.3 mt -114.69 102.25 9.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.499 -0.926 . . . . 73.34 108.499 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.99 -131.61 10.52 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.586 -0.734 . . . . 74.33 111.896 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -95.33 8.3 43.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.206 0.602 . . . . 73.3 110.632 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -135.81 166.52 23.09 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.645 0.778 . . . . 74.4 111.288 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -71.33 125.68 27.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.283 -0.871 . . . . 72.31 110.911 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' B' ' 31' ' ' VAL . . . -73.55 -62.86 1.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.527 0.731 . . . . 63.01 109.095 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -160.84 165.56 30.01 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 74.24 110.726 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.21 154.92 46.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.732 1.613 . . . . 75.22 108.366 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' B' ' 114' ' ' ILE . 35.0 t -160.76 132.09 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.199 -0.667 . . . . 73.11 109.199 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.4 tt0 -141.82 123.65 15.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.351 -0.981 . . . . 75.52 108.351 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.502 HG12 HD11 ' B' ' 21' ' ' ILE . 99.3 t -122.57 143.76 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.508 -0.553 . . . . 75.02 109.508 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.7 mt-30 -121.97 103.18 8.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.306 -0.861 . . . . 75.42 109.175 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.06 103.53 16.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.562 -0.745 . . . . 52.45 109.129 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.9 143.56 16.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.141 -0.784 . . . . 64.23 111.141 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.23 126.53 3.23 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 112.002 -0.439 . . . . 61.12 112.002 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 12.8 mt -85.85 131.83 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.557 -0.905 . . . . 74.44 108.557 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -138.06 137.16 37.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.977 0.911 . . . . 72.23 109.574 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.685 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 23.4 m -88.89 113.28 24.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.567 -0.901 . . . . 75.31 108.567 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.541 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -121.66 138.33 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.127 0.571 . . . . 74.32 110.411 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.02 163.36 37.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.011 0.924 . . . . 61.24 109.277 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.48 -48.25 3.93 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 122.663 0.173 . . . . 62.23 112.905 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -61.06 153.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.256 1.023 . . . . 74.3 111.857 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.1 165.29 15.69 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.882 0.873 . . . . 72.15 110.149 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -119.68 19.3 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.44 0.462 . . . . 72.21 113.491 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.6 m -69.38 -31.67 70.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.93 0.892 . . . . 70.14 111.124 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.471 ' HB3' HG21 ' B' ' 89' ' ' ILE . 93.7 mt-30 -62.89 -52.57 62.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.446 0.699 . . . . 70.22 110.382 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.513 ' HE2' HD23 ' B' ' 98' ' ' LEU . 3.4 tpt -62.99 -45.14 93.8 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.456 -0.793 . . . . 73.53 110.628 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.47 78.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.372 0.669 . . . . 65.21 111.693 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -76.77 -33.13 58.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.324 0.649 . . . . 72.03 110.387 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -65.23 -52.4 54.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.136 0.575 . . . . 73.44 110.881 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.513 HD23 ' HE2' ' B' ' 94' ' ' MET . 4.5 pp -84.84 -20.36 31.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.877 0.471 . . . . 75.24 111.804 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -31.77 16.48 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.347 0.404 . . . . 55.23 113.258 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.05 1.82 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.916 0.487 . . . . 64.24 111.484 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -76.28 -41.93 47.19 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.187 0.81 . . . . 72.12 113.187 -168.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.76 -45.94 82.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 118.688 -0.672 . . . . 73.33 110.913 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -56.57 -37.14 98.07 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.974 1.782 . . . . 73.21 113.514 166.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.36 -35.43 79.11 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.971 0.508 . . . . 74.44 111.416 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -66.13 -49.51 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.757 0.823 . . . . 64.33 110.162 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.34 -16.33 52.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.112 -0.949 . . . . 74.23 112.409 -168.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.56 -46.96 68.8 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 117.48 -1.248 . . . . 75.33 113.075 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.401 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.7 Cg_endo -58.6 -36.78 96.83 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.153 1.902 . . . . 71.44 112.688 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -65.68 -49.42 68.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.399 0.68 . . . . 73.44 110.732 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -35.37 80.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.672 0.789 . . . . 75.23 110.96 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.728 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.0 ttp180 -59.78 -65.13 0.73 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.348 1.059 . . . . 74.22 110.479 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.15 -20.93 64.93 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.96 -1.018 . . . . 75.32 110.619 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.679 ' SG ' HD13 ' B' ' 21' ' ' ILE . 1.9 t -67.12 -49.62 64.26 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.709 -0.478 . . . . 72.43 109.709 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.603 HG21 HG22 ' B' ' 64' ' ' VAL . 91.4 mt -58.96 -54.44 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 123.731 0.645 . . . . 73.12 110.267 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.463 HG21 ' NE2' ' B' ' 125' ' ' GLN . 8.5 m -61.31 -29.17 69.71 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.105 0.962 . . . . 75.02 111.523 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -77.01 -35.36 57.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.447 0.699 . . . . 43.2 111.118 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.1 mmt -68.01 -30.86 70.21 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.893 0.378 . . . . 72.43 110.26 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.77 -39.23 83.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.97 0.908 . . . . 71.33 109.952 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.2 m -64.26 -32.46 74.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.523 0.729 . . . . 75.0 111.617 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.472 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.3 mtt-85 -71.32 -35.21 71.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.415 -0.811 . . . . 75.33 110.112 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.0 3.05 82.05 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.903 0.752 . . . . 61.51 112.951 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p 56.84 24.03 8.76 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.082 1.753 . . . . 71.35 112.649 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.05 156.09 42.5 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 65.42 110.137 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.2 140.58 93.22 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.052 2.501 . . . . 71.15 111.807 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.463 ' NE2' HG21 ' B' ' 115' ' ' THR . 14.7 mm100 -63.95 122.65 17.0 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.778 0.831 . . . . 75.44 112.493 -170.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -110.16 97.22 6.75 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.065 -1.457 . . . . 74.2 107.065 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -91.36 135.67 33.65 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.479 -0.782 . . . . 74.23 108.975 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -82.31 115.18 21.25 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.746 -0.835 . . . . 75.05 108.746 -173.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 137.92 88.47 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 124.404 1.065 . . . . 73.54 110.9 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.555 ' HG3' HD13 ' D' ' 16' ' ' ILE . 60.1 Cg_endo -66.6 99.05 0.42 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.739 2.293 . . . . 74.32 111.026 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.0 120.45 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.077 -1.083 . . . . 73.01 108.077 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.31 88.63 0.46 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.901 0.88 . . . . 74.44 110.515 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -52.92 -36.71 59.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.285 1.034 . . . . 75.23 112.221 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.22 -42.61 99.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.587 1.155 . . . . 73.03 111.892 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.92 -35.24 59.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.295 0.638 . . . . 71.14 110.597 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 123.614 0.766 . . . . 75.53 110.412 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.7 ttm . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.286 0.565 . . . . 74.25 112.246 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 21.7 m -84.84 92.78 8.35 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.321 -0.992 . . . . 73.22 108.321 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -116.41 125.85 52.61 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -151.76 134.24 15.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.207 0.603 . . . . 73.21 109.41 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.409 HG12 ' HE2' ' C' ' 84' ' ' PHE . 41.1 mt -74.81 109.0 7.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.555 -0.906 . . . . 70.22 108.555 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -85.88 -41.24 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.266 0.626 . . . . 72.13 111.175 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -170.77 142.95 2.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.957 -0.757 . . . . 70.2 108.957 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.0 mt -131.76 133.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.829 -0.804 . . . . 70.43 108.829 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.476 ' HH ' HD11 ' C' ' 83' ' ' ILE . 19.4 p90 -173.06 153.03 2.44 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.41 0.624 . . . . 64.31 111.509 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -74.76 125.09 28.0 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.954 -1.021 . . . . 73.43 109.782 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -77.64 -47.68 18.66 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.565 -1.272 . . . . 74.02 107.565 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -132.34 143.48 49.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.125 -1.398 . . . . 55.13 110.231 -171.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.2 mt -142.35 142.68 27.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.659 1.583 . . . . 73.45 106.767 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.48 148.71 21.66 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.163 0.506 . . . . 64.25 109.904 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -150.28 115.08 5.29 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.245 -1.391 . . . . 75.32 107.245 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -116.42 111.1 19.54 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.605 -0.517 . . . . 72.23 109.605 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.53 78.86 54.94 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 73.12 108.641 167.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.28 -28.61 39.76 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.045 1.83 . . . . 72.24 109.341 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -92.99 27.25 2.48 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.115 -1.402 . . . . 72.51 110.443 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.73 -50.17 89.44 Favored Pre-proline 0 CA--C 1.574 1.881 0 C-N-CA 123.746 0.818 . . . . 73.32 111.584 171.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 22.1 Cg_exo -66.1 -21.14 56.3 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.473 2.115 . . . . 75.41 113.247 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -60.59 -34.16 73.8 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 118.14 -0.933 . . . . 73.13 111.047 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.431 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.3 p -51.05 -31.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.196 0.813 . . . . 73.44 113.196 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -73.58 -29.18 62.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.811 0.844 . . . . 72.53 111.664 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.48 11.78 12.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.778 0.831 . . . . 73.53 112.217 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 18.5 ttpp -110.37 159.38 17.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 71.1 110.206 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.96 118.24 20.78 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.475 -0.784 . . . . 71.44 109.192 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -86.22 63.63 8.12 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.969 0.89 . . . . 74.4 110.862 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -145.2 72.95 14.56 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.177 -1.416 . . . . 75.54 107.177 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.56 151.61 4.3 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.787 2.325 . . . . 73.21 112.027 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.84 112.79 21.44 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.208 -1.034 . . . . 73.23 108.208 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.72 99.08 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 108.672 -0.862 . . . . 64.5 108.672 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.461 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 24.7 tptt -92.94 100.98 13.33 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.429 -1.322 . . . . 75.54 107.429 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -92.27 135.28 34.14 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.338 -0.986 . . . . 75.12 108.338 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.84 103.73 4.89 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.258 -1.016 . . . . 61.04 108.258 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -95.42 148.75 22.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.446 -0.576 . . . . 74.02 109.446 176.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -148.85 162.51 39.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.74 1.216 . . . . 71.53 107.976 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' C' ' 60' ' ' LEU . 10.2 t -145.65 137.14 25.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.344 0.657 . . . . 73.14 109.563 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.85 162.02 22.97 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.095 0.958 . . . . 72.12 108.985 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -139.31 143.78 38.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.894 0.477 . . . . 74.51 110.581 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -148.86 126.51 11.73 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.745 0.818 . . . . 74.43 109.518 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -88.29 120.22 29.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.539 -0.911 . . . . 72.22 108.539 173.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.596 HD12 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -91.2 -39.1 12.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.514 0.726 . . . . 74.31 110.699 -174.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.3 -175.54 5.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.477 -0.783 . . . . 61.21 110.305 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.6 105.39 1.51 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.028 0.931 . . . . 74.04 110.937 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 68.85 10.91 8.16 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.26 1.424 . . . . 73.41 112.979 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 76.2 t -105.34 113.71 42.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 73.42 108.341 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -117.5 160.47 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.056 0.942 . . . . 71.31 109.129 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.596 ' HB2' HD12 ' C' ' 51' ' ' LEU . 34.6 tt0 -127.58 146.69 50.45 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.055 1.342 . . . . 73.15 107.741 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.403 HG22 ' HG3' ' C' ' 103' ' ' PRO . 3.2 p -137.21 124.77 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.642 -0.873 . . . . 73.44 108.642 171.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.92 104.97 15.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.607 -0.886 . . . . 74.41 108.607 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' C' ' 46' ' ' THR . 0.8 OUTLIER -91.38 118.22 30.35 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.938 -0.393 . . . . 75.52 109.938 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -83.88 105.17 14.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.635 -0.876 . . . . 75.32 108.635 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.452 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.4 t -100.2 125.88 53.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.899 -1.149 . . . . 64.44 107.899 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 31.2 m -118.77 133.47 55.82 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.553 -0.906 . . . . 73.45 108.553 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.523 HG22 HG23 ' C' ' 114' ' ' ILE . 94.7 t -128.23 109.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 8.9 m -99.22 144.07 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.387 -0.968 . . . . 74.11 108.387 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.92 95.44 3.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.307 -1.738 . . . . 75.32 106.307 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -153.01 138.69 17.85 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.675 -0.491 . . . . 74.12 109.675 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.64 92.25 6.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.61 -79.31 1.26 Allowed Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.401 -0.818 . . . . 65.32 112.281 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -30.66 2.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.952 0.901 . . . . 74.14 110.617 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.62 102.59 0.93 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.754 0.821 . . . . 72.33 109.852 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -81.37 136.27 35.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.447 -0.797 . . . . 75.33 110.789 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.0 -55.45 3.68 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 63.21 107.485 163.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.67 175.07 9.15 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.844 0.831 . . . . 72.42 112.072 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.55 146.1 47.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.642 -1.984 . . . . 72.21 105.642 170.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' C' ' 114' ' ' ILE . 48.0 t -152.53 113.4 4.16 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.401 -0.592 . . . . 74.1 109.401 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -126.55 118.9 25.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.034 0.534 . . . . 71.11 109.852 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.84 134.05 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.825 0.85 . . . . 74.35 109.66 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.679 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -110.45 97.5 6.94 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.888 -1.153 . . . . 73.13 107.888 174.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -83.48 115.62 22.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.877 -0.602 . . . . 75.31 109.869 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.04 153.34 21.82 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.606 0.566 . . . . 73.45 111.775 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.443 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 119.99 0.97 Allowed Glycine 0 C--O 1.238 0.374 0 N-CA-C 111.195 -0.762 . . . . 74.3 111.195 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.476 HD11 ' HH ' ' C' ' 17' ' ' TYR . 11.7 mm -84.28 125.81 40.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.435 -0.95 . . . . 74.22 108.435 176.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.409 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.5 m-85 -137.62 135.08 36.26 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.967 0.907 . . . . 72.31 109.298 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -75.85 118.4 18.61 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.236 -1.024 . . . . 72.45 108.236 166.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.5 HG22 ' HE2' ' C' ' 94' ' ' MET . 16.2 mm -122.29 110.0 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.802 -0.814 . . . . 75.23 108.802 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.576 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -147.77 165.18 31.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.658 0.783 . . . . 73.34 109.206 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.9 -50.54 3.96 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.404 -0.362 . . . . 72.33 112.22 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.73 141.89 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.705 0.802 . . . . 72.43 109.203 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -148.74 155.53 41.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.897 0.479 . . . . 74.31 110.862 -170.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.14 -145.41 28.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.865 0.728 . . . . 63.42 113.059 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.8 p -62.62 -28.33 69.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.996 . . . . 71.44 111.559 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -59.24 -49.0 79.53 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.535 0.734 . . . . 73.24 110.676 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.5 ' HE2' HG22 ' C' ' 86' ' ' ILE . 0.4 OUTLIER -71.37 -40.17 70.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 74.11 110.358 -177.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.39 78.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.611 0.764 . . . . 73.41 110.904 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -70.97 -41.27 71.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.306 -0.861 . . . . 61.3 110.777 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.11 -51.71 65.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.664 0.386 . . . . 71.31 110.818 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.454 HD23 ' HE3' ' C' ' 94' ' ' MET . 24.0 tp -75.87 -16.14 60.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.671 0.788 . . . . 74.32 111.087 -177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.89 3.32 31.89 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 119.511 -0.605 . . . . 53.44 114.113 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.37 -60.77 0.41 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.731 0.766 . . . . 75.44 110.851 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -68.44 -57.28 6.1 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.706 0.629 . . . . 73.0 111.835 -171.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 56.9 m -58.46 -45.95 99.65 Favored Pre-proline 0 CA--C 1.564 1.513 0 CA-C-O 118.415 -0.802 . . . . 74.52 111.901 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 44.3 Cg_exo -57.57 -37.12 98.1 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.278 1.985 . . . . 74.15 113.737 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -73.02 -26.55 61.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.767 0.427 . . . . 72.31 111.311 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.469 HD13 HH12 ' A' ' 111' ' ' ARG . 26.2 mm -65.56 -42.19 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.26 0.552 . . . . 75.45 109.587 169.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.492 ' HB2' HD23 ' C' ' 60' ' ' LEU . 92.3 mt -79.77 -19.26 49.06 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.651 -1.159 . . . . 74.2 111.882 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.5 -45.35 99.68 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.645 -1.169 . . . . 75.12 113.124 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 75.0 Cg_exo -52.91 -39.69 77.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.465 2.11 . . . . 74.21 113.262 172.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -68.98 -44.76 72.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.627 0.771 . . . . 74.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.02 99.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.216 0.606 . . . . 74.05 110.248 175.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -61.66 -49.41 76.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.84 1.256 . . . . 72.43 110.768 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.96 -33.83 74.34 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.684 0.615 . . . . 73.11 110.295 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -67.54 -37.33 82.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 75.43 110.975 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.523 HG23 HG22 ' C' ' 64' ' ' VAL . 96.3 mt -71.54 -47.47 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.707 0.803 . . . . 74.52 110.631 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 41.6 m -67.07 -28.85 68.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.77 0.828 . . . . 72.01 111.076 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.1 t -68.61 -45.09 72.83 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.373 0.669 . . . . 74.44 109.442 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.573 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.91 -39.8 93.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.027 0.931 . . . . 71.32 111.941 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.31 -45.32 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.634 0.774 . . . . 73.23 109.917 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.1 t -64.92 -33.09 75.19 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.061 -0.972 . . . . 65.01 111.369 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -73.69 -33.59 64.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.596 0.758 . . . . 73.45 110.291 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.57 -3.98 90.14 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.55 0.531 . . . . 74.23 112.46 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.528 HG21 ' HB3' ' D' ' 17' ' ' TYR . 19.1 p 65.29 45.43 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.581 1.952 . . . . 71.22 112.182 174.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.4 m-85 -106.89 164.22 15.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-N 114.077 -1.42 . . . . 73.11 109.1 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 95.3 Cg_endo -72.33 179.65 4.84 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.752 2.301 . . . . 75.33 112.977 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -60.11 111.99 1.73 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.7 -0.682 . . . . 73.42 111.592 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.27 96.58 5.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 106.362 -1.718 . . . . 74.14 106.362 169.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.12 122.47 47.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.647 0.779 . . . . 74.43 109.511 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 57.0 mt -83.0 133.57 35.09 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.227 0.611 . . . . 73.3 109.402 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.74 143.19 78.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 123.509 0.506 . . . . 74.04 110.607 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.97 133.37 41.07 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.395 2.064 . . . . 64.14 111.726 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 p -102.0 111.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.458 -0.941 . . . . 62.14 108.458 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -83.75 57.68 4.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.446 0.698 . . . . 73.41 110.389 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -76.88 -21.53 54.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.817 0.818 . . . . 74.41 109.232 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 . . . . . 0 C--O 1.242 0.707 0 C-N-CA 124.534 1.134 . . . . 72.32 110.951 172.424 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.514 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.9 tpt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 113.848 1.055 . . . . 74.34 113.848 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.402 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 96.9 m -148.18 142.3 26.03 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.449 1.1 . . . . 75.23 109.12 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -164.2 103.5 0.86 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.67 -1.233 . . . . 73.34 107.67 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.53 ' HG3' ' HB2' ' D' ' 85' ' ' SER . 5.2 pt20 -149.51 127.08 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.528 0.731 . . . . 75.25 109.569 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.489 HD12 ' O ' ' D' ' 83' ' ' ILE . 3.3 tp -84.26 110.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 75.45 109.353 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -73.36 -40.99 63.95 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.332 1.053 . . . . 72.43 112.036 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.416 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 43.6 ttt180 -159.77 124.51 3.94 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.404 -0.221 . . . . 73.41 110.404 -166.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.555 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.2 mp -103.26 132.61 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 107.069 -1.456 . . . . 72.35 107.069 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.528 ' HB3' HG21 ' C' ' 122' ' ' THR . 28.9 p90 -158.83 167.62 28.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.084 0.945 . . . . 71.4 111.724 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -102.52 120.21 40.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.038 -1.437 . . . . 75.42 109.426 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -87.63 -24.37 23.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 71.25 110.754 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.8 t70 -158.11 139.65 13.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.336 -0.847 . . . . 73.0 109.354 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.573 HG23 ' HE1' ' C' ' 117' ' ' MET . 63.4 mt -139.82 144.88 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.828 -1.175 . . . . 54.32 107.828 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -149.77 144.82 26.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.141 0.976 . . . . 63.24 109.031 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.7 t80 -151.92 111.55 3.98 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.047 -1.834 . . . . 74.21 106.047 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.6 mt-10 -122.44 113.78 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.745 0.418 . . . . 73.44 110.527 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.61 81.22 54.48 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.983 0.913 . . . . 73.01 109.227 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . 0.447 ' HG2' ' ND2' ' D' ' 27' ' ' ASN . 58.8 Cg_endo -71.5 -37.56 5.41 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.619 2.213 . . . . 73.01 111.945 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' D' ' 26' ' ' PRO . 2.0 m-80 -103.72 38.53 1.79 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.983 0.913 . . . . 75.13 108.699 -175.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -50.66 84.26 Favored Pre-proline 0 CA--C 1.575 1.904 0 N-CA-C 114.561 1.319 . . . . 71.11 114.561 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.96 -12.72 4.89 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 121.757 1.638 . . . . 74.42 112.853 171.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -69.74 -40.07 76.41 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.625 1.17 . . . . 75.24 109.837 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.36 -18.13 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.139 0.576 . . . . 74.11 110.429 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -57.45 -35.53 70.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.362 0.665 . . . . 74.33 111.362 171.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -59.66 -25.28 64.6 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.91 0.756 . . . . 74.43 111.343 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -110.84 91.42 3.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.323 -1.362 . . . . 75.55 107.323 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.49 67.14 5.16 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 122.465 1.126 . . . . 62.2 110.929 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -128.3 158.23 38.75 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.791 -1.188 . . . . 74.11 107.791 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 20.9 mm-40 -84.73 118.23 70.54 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 122.849 0.459 . . . . 73.43 110.049 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.496 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 34.1 Cg_exo -64.59 158.76 48.19 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.845 3.03 . . . . 74.13 113.844 -172.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.2 tt0 -71.82 124.63 25.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.987 -0.745 . . . . 74.45 108.987 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.491 HG21 HG13 ' D' ' 64' ' ' VAL . 3.2 p -96.8 114.25 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.68 0.752 . . . . 73.05 110.088 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.56 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 8.9 tppt? -95.57 107.62 19.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.787 -1.19 . . . . 75.13 107.787 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -101.04 116.9 33.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.906 -0.405 . . . . 73.03 109.906 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.468 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.7 m-20 -116.66 124.85 50.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.739 0.816 . . . . 62.34 109.52 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.18 137.61 48.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.488 0.715 . . . . 75.31 110.108 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.587 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -146.33 146.71 30.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.899 1.28 . . . . 62.31 108.061 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -123.55 165.51 17.01 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.907 -0.405 . . . . 62.22 109.907 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -157.38 164.52 37.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.4 0.68 . . . . 71.53 109.789 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.0 p -156.22 153.4 29.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.01 0.524 . . . . 74.1 110.897 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 98.0 p -154.47 155.0 34.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 60.2 108.655 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -97.26 116.96 30.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.208 -0.664 . . . . 75.55 109.208 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' D' ' 57' ' ' GLU . 25.3 mt -92.5 -28.89 16.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.028 0.531 . . . . 74.11 110.123 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.19 -178.98 5.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.23 1.014 . . . . 70.34 110.623 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.36 117.12 8.16 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.548 -1.66 . . . . 61.43 110.513 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 63.18 21.25 12.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.26 1.424 . . . . 74.11 111.442 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.5 115.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 124.141 0.976 . . . . 74.01 109.137 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -132.74 130.27 39.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.511 -0.922 . . . . 73.14 108.511 -172.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.506 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.7 tt0 -86.54 138.08 32.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.62 0.768 . . . . 74.32 109.146 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.494 HG11 ' HD3' ' D' ' 103' ' ' PRO . 97.6 t -122.07 128.89 75.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.434 -1.321 . . . . 74.24 107.434 170.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 29.3 t -110.42 132.74 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.293 -0.632 . . . . 74.41 109.293 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.61 119.0 38.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.063 -1.088 . . . . 74.44 108.063 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.47 103.52 13.9 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.411 -0.959 . . . . 74.14 108.411 175.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.76 133.02 46.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.195 -1.039 . . . . 75.42 108.195 170.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 7.9 m -126.95 128.15 45.97 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.491 HG13 HG21 ' D' ' 40' ' ' VAL . 61.1 t -119.38 102.12 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.12 0.968 . . . . 70.0 108.658 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 96.0 m -106.19 100.89 10.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.613 0.765 . . . . 71.01 109.354 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -98.66 134.96 40.85 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.75 0.42 . . . . 71.12 110.11 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 40.8 p -146.32 140.15 26.22 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.613 -0.884 . . . . 73.24 108.613 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.62 119.13 25.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.529 -0.545 . . . . 75.12 109.529 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.1 -117.9 5.78 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.821 0.701 . . . . 73.01 113.238 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 5.33 46.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.88 . . . . 74.15 110.993 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.41 155.06 43.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.006 0.431 . . . . 73.53 111.434 -161.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -66.77 136.91 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.432 1.093 . . . . 74.24 110.726 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.35 -66.72 0.89 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.579 0.752 . . . . 64.25 109.526 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 151.22 26.23 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.629 0.772 . . . . 71.33 109.396 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.9 mt -118.95 154.25 33.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.889 0.876 . . . . 63.22 109.173 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.449 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 54.1 t -158.66 146.22 17.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.02 0.528 . . . . 73.14 110.894 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -156.52 137.77 13.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.65 -0.871 . . . . 54.45 108.65 167.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -135.31 116.21 19.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.41 0.684 . . . . 74.24 109.27 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 53.0 mt-30 -92.29 85.28 5.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.504 0.722 . . . . 74.31 109.059 171.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.84 100.83 8.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.805 1.242 . . . . 73.44 109.721 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 143.28 16.51 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.144 -0.382 . . . . 73.42 112.144 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.15 134.21 6.6 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.945 -0.462 . . . . 72.34 111.945 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.489 ' O ' HD12 ' D' ' 13' ' ' ILE . 60.1 mt -90.51 125.82 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.708 0.803 . . . . 71.25 109.142 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.23 129.26 49.7 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.446 0.699 . . . . 70.32 110.218 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.53 ' HB2' ' HG3' ' D' ' 12' ' ' GLN . 33.0 m -79.12 104.97 10.11 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 167.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.6 117.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.586 0.754 . . . . 70.44 110.09 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -149.8 159.97 43.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.612 0.765 . . . . 71.02 109.948 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 86.72 -20.79 22.03 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.086 -0.506 . . . . 41.45 114.292 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.26 144.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.738 0.815 . . . . 74.34 109.89 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -176.51 5.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.816 0.846 . . . . 73.11 110.256 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.59 -140.16 44.22 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.641 0.588 . . . . 72.42 114.188 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -63.03 -34.02 76.67 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.106 0.963 . . . . 73.13 111.397 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.48 -51.35 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.13 0.572 . . . . 73.32 109.743 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.82 -42.98 97.55 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.822 0.701 . . . . 75.11 111.256 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.63 97.07 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.827 0.704 . . . . 75.12 110.88 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -71.41 -34.27 70.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.811 . . . . 72.13 111.055 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.57 -48.05 76.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.746 0.418 . . . . 62.31 109.982 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -71.92 -18.19 62.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 122.797 0.439 . . . . 71.24 111.824 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.57 10.5 32.87 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.222 -0.765 . . . . 74.23 114.25 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.1 -64.22 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.948 0.874 . . . . 61.0 111.842 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -69.2 -40.1 78.23 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.409 0.683 . . . . 71.11 112.592 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.26 -44.84 7.88 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.478 0.711 . . . . 74.34 110.976 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HD3' HG11 ' D' ' 58' ' ' VAL . 72.2 Cg_exo -54.85 -33.16 80.58 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.514 2.142 . . . . 65.03 113.694 166.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.16 -39.02 93.46 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.826 0.85 . . . . 73.12 109.948 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.15 -41.75 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.029 0.932 . . . . 74.53 110.868 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.08 -20.16 57.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.406 -0.815 . . . . 74.22 112.27 -173.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -65.1 -41.96 57.46 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.789 1.033 . . . . 72.42 113.789 -170.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.29 -41.25 67.33 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.22 1.947 . . . . 65.03 113.317 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.9 m-85 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.766 0.826 . . . . 75.34 111.842 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -51.02 64.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 73.01 109.855 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -57.29 -44.52 84.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.557 -1.201 . . . . 71.14 111.332 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.48 -47.46 85.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.696 0.798 . . . . 71.33 111.528 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.15 -39.52 79.02 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.914 0.759 . . . . 74.44 110.972 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.7 -49.7 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.76 0.824 . . . . 73.5 110.842 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.425 HG22 ' HG3' ' D' ' 125' ' ' GLN . 30.2 m -57.06 -39.14 74.32 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.109 0.964 . . . . 73.23 111.578 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 36.4 t -65.89 -43.01 89.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.38 -0.827 . . . . 72.14 111.067 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.88 -35.16 74.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.813 0.445 . . . . 75.21 111.717 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.21 -40.92 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.27 -0.877 . . . . 71.11 110.315 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -71.19 -29.96 65.8 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.334 0.253 . . . . 65.53 110.886 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' D' ' 116' ' ' SER . 93.8 mtt-85 -69.26 -32.82 72.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.044 0.538 . . . . 73.45 110.322 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.22 7.52 80.35 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.694 0.621 . . . . 74.22 113.0 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 53.71 36.08 22.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.787 1.635 . . . . 75.42 112.466 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -104.69 155.07 38.01 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.464 1.105 . . . . 75.34 109.815 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.55 141.15 97.13 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.416 2.744 . . . . 74.1 113.125 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' D' ' 115' ' ' THR . 33.4 tt0 -54.46 133.71 45.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.398 1.079 . . . . 70.41 112.231 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.18 97.37 6.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.029 -1.1 . . . . 75.31 108.029 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -108.58 108.94 20.04 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.578 0.751 . . . . 62.3 109.435 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.24 139.88 44.63 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.729 0.812 . . . . 75.35 111.3 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.95 145.59 96.78 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.937 0.895 . . . . 62.14 111.957 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -69.07 104.38 1.2 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.23 2.62 . . . . 74.42 112.137 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.02 110.35 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.219 -0.66 . . . . 43.14 109.219 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -88.04 92.67 9.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.532 -0.914 . . . . 75.25 108.532 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 122.828 0.451 . . . . 75.25 110.561 178.515 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.465 -0.568 . . . . 73.51 109.465 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -137.21 125.06 22.57 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.32 -0.993 . . . . 74.42 108.32 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -135.69 112.56 10.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.347 0.659 . . . . 75.12 109.721 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.12 119.68 28.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.813 -1.18 . . . . 74.32 107.813 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 82.0 mm-40 -81.55 -41.51 21.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.651 0.594 . . . . 74.01 109.92 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.723 HH11 HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -173.47 163.96 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.319 1.048 . . . . 72.21 110.281 173.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.557 HD13 ' HG3' ' C' ' 130' ' ' PRO . 1.6 pp -144.03 101.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 108.279 -1.008 . . . . 72.43 108.279 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 64.7 m-85 -155.64 173.45 16.69 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.018 0.927 . . . . 72.35 109.886 -166.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.96 115.47 26.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.264 -0.425 . . . . 62.4 111.076 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -73.79 -44.74 55.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.967 -0.753 . . . . 72.32 108.967 171.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.8 t70 -135.78 148.35 48.73 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.757 -1.11 . . . . 75.11 110.368 -174.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.471 HG22 ' SD ' ' A' ' 117' ' ' MET . 92.4 mt -145.13 142.75 22.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 126.021 1.728 . . . . 75.1 106.94 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -155.47 133.02 11.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.761 0.424 . . . . 73.53 110.403 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 77.1 t80 -127.28 131.11 50.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.241 -1.392 . . . . 75.43 107.241 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -129.24 126.51 39.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.235 0.614 . . . . 73.24 109.708 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 79.33 32.07 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.402 -0.962 . . . . 73.43 108.402 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.72 -11.87 20.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.771 2.314 . . . . 73.3 112.328 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -119.16 30.99 6.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.311 1.044 . . . . 73.14 109.112 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.27 99.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 N-CA-C 113.688 0.996 . . . . 62.42 113.688 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.17 -18.12 35.27 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 121.572 1.515 . . . . 74.11 113.277 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -80.12 -12.75 59.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.705 0.802 . . . . 75.14 112.765 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.12 -33.62 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 124.093 0.957 . . . . 74.44 112.806 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.27 -32.79 74.64 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.31 0.644 . . . . 74.34 111.637 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -90.72 -36.44 14.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 74.53 111.078 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.17 155.52 23.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.116 0.966 . . . . 75.34 111.517 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.416 ' HB2' HD13 ' A' ' 68' ' ' LEU . 7.6 m-20 -70.43 137.11 50.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.758 0.823 . . . . 61.1 110.007 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -88.36 61.66 6.28 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.87 -0.789 . . . . 65.3 108.87 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -142.45 58.56 7.6 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.972 0.909 . . . . 72.42 109.94 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.55 152.43 7.67 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.875 1.717 . . . . 74.23 112.208 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -93.28 117.51 30.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.583 -1.265 . . . . 73.5 107.583 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.68 136.25 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.971 0.508 . . . . 75.03 110.826 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -119.04 131.45 55.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.316 1.447 . . . . 65.13 108.913 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -97.53 152.2 19.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.986 -1.116 . . . . 72.12 107.986 170.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' VAL . 26.3 t70 -144.2 143.35 31.02 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.087 -1.079 . . . . 75.5 108.087 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -140.61 125.31 18.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.494 0.717 . . . . 75.32 109.837 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 12.8 t70 -132.54 142.91 49.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.047 0.939 . . . . 74.35 109.517 -177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.9 m -124.46 124.4 42.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.527 0.731 . . . . 75.45 110.404 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.56 8.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.362 0.665 . . . . 74.03 110.41 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.8 m -90.8 158.09 17.02 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.584 0.753 . . . . 71.11 109.585 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.5 t -162.13 118.35 2.01 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.085 0.402 . . . . 63.5 111.048 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.53 103.39 2.47 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.492 0.717 . . . . 74.2 110.74 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 57' ' ' GLU . 48.2 mt -83.36 -34.54 25.59 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 71.41 110.862 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.36 -174.6 4.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.44 1.096 . . . . 73.3 108.908 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.84 96.32 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.433 0.458 . . . . 74.24 110.979 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.47 27.71 15.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.915 1.286 . . . . 73.32 112.278 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.484 HG12 ' HG ' ' A' ' 85' ' ' SER . 46.9 t -104.18 113.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.784 -1.561 . . . . 74.31 106.784 168.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 49' ' ' SER . 22.7 m-85 -119.1 129.06 54.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.868 -0.79 . . . . 74.2 108.868 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.798 ' HB2' HD12 ' A' ' 51' ' ' LEU . 39.5 tt0 -83.32 114.99 21.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.906 -1.146 . . . . 65.14 107.906 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.85 111.26 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.314 -1.365 . . . . 73.05 107.314 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.556 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 80.7 t -97.16 136.11 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.353 1.061 . . . . 74.22 109.352 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.52 HD23 HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -108.16 116.14 31.42 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 175.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.572 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -92.9 106.49 18.45 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.777 -0.823 . . . . 72.31 108.777 173.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.52 HG23 HD23 ' A' ' 60' ' ' LEU . 49.5 t -107.74 133.17 53.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.323 0.649 . . . . 74.22 109.666 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.1 m -121.95 138.96 54.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.574 -0.528 . . . . 72.25 109.574 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG23 HG21 ' A' ' 114' ' ' ILE . 53.6 t -126.12 105.63 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.877 -1.527 . . . . 72.43 106.877 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.0 m -108.13 144.0 36.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.417 -0.957 . . . . 75.32 108.417 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.37 124.87 27.96 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.991 -1.115 . . . . 61.25 107.991 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -126.05 125.95 43.46 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.654 0.596 . . . . 73.13 109.829 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 35' ' ' ASP . 49.0 tp -91.86 73.3 5.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.035 0.934 . . . . 74.41 108.922 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.61 -92.12 0.78 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.715 -0.675 . . . . 74.52 112.847 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -98.84 -26.81 14.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.822 0.849 . . . . 72.32 111.23 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.37 138.01 44.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.575 0.75 . . . . 73.2 111.001 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -60.65 129.72 42.96 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.446 0.466 . . . . 71.41 110.202 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.86 -56.05 4.22 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.585 -0.524 . . . . 74.25 109.585 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.477 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -164.75 166.89 19.51 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.326 0.65 . . . . 72.32 109.77 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -143.79 146.4 33.07 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.201 0.6 . . . . 75.12 111.283 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.477 ' SG ' ' HE1' ' A' ' 74' ' ' PHE . 51.7 m -143.54 142.29 31.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.2 1.4 . . . . 73.14 109.88 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -148.45 123.53 10.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 70.11 109.602 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.18 130.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.609 0.764 . . . . 74.42 110.183 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.572 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 72.3 mt-30 -95.67 96.95 9.36 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.472 0.709 . . . . 75.4 109.57 168.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -83.21 93.94 7.78 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.026 -0.731 . . . . 74.22 109.026 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.2 144.4 19.24 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.823 -0.511 . . . . 71.41 111.823 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.37 122.25 2.03 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.445 -1.062 . . . . 65.41 110.445 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.723 HD12 HH11 ' A' ' 15' ' ' ARG . 33.8 mt -82.79 123.87 38.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.572 -0.899 . . . . 75.31 108.572 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -129.28 138.31 51.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.158 -0.682 . . . . 71.24 109.158 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.484 ' HG ' HG12 ' A' ' 55' ' ' VAL . 18.6 m -108.63 119.09 38.51 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.918 -1.141 . . . . 65.31 107.918 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.36 131.16 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 120.975 0.417 . . . . 65.22 110.829 -172.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.7 165.53 28.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.202 1.001 . . . . 70.5 110.88 -173.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.4 -33.19 6.38 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 116.063 -0.517 . . . . 72.01 112.86 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.85 178.26 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.085 0.954 . . . . 65.31 108.827 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 14.6 tt0 -161.64 -179.44 7.28 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 110.238 -0.282 . . . . 61.44 110.238 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.443 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.97 -147.96 40.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.561 0.585 . . . . 64.1 114.561 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -63.37 -26.76 68.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.371 1.068 . . . . 72.44 113.013 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.12 -41.05 82.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.194 0.598 . . . . 72.31 111.915 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.465 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 3.4 ptp -84.02 -33.86 24.42 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.717 -0.219 . . . . 62.3 111.39 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -24.15 67.77 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.227 0.537 . . . . 71.45 110.718 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -64.86 -54.49 30.17 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 70.41 109.984 164.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.6 m -65.73 -63.37 1.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.268 0.84 . . . . 71.21 113.268 -170.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.08 -8.07 34.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.862 0.756 . . . . 75.52 112.206 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.49 -4.0 40.47 Favored Glycine 0 C--N 1.36 1.911 0 N-CA-C 115.263 0.865 . . . . 64.42 115.263 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.02 -59.23 0.25 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.767 0.784 . . . . 64.54 111.025 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.0 t80 -53.46 -54.74 32.65 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 124.571 1.148 . . . . 71.44 112.949 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.7 m -71.69 -42.02 10.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.384 0.674 . . . . 72.22 111.739 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.78 -39.02 78.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.463 2.109 . . . . 74.53 113.973 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -72.62 -24.45 61.07 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.367 0.667 . . . . 72.14 111.442 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.7 mm -69.13 -45.59 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.411 0.684 . . . . 71.34 109.407 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.31 -33.56 71.68 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.283 -0.871 . . . . 73.44 112.01 -173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.64 -44.7 92.34 Favored Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 114.56 1.318 . . . . 74.25 114.56 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.48 -32.25 96.02 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.111 1.874 . . . . 74.03 113.617 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.72 -32.46 31.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.423 0.689 . . . . 73.33 111.358 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.22 75.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.711 -0.477 . . . . 71.13 109.711 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -54.54 -49.05 71.21 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.67 1.231 . . . . 72.02 110.19 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.67 -51.46 69.68 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.162 0.914 . . . . 74.41 110.912 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.15 -45.56 79.59 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.192 0.933 . . . . 74.53 111.155 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 118' ' ' VAL . 5.7 mt -60.43 -58.49 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 74.43 110.189 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.434 HG22 ' HB2' ' A' ' 125' ' ' GLN . 65.7 m -52.67 -40.5 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.988 0.915 . . . . 75.15 112.087 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.6 t -66.9 -43.24 83.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.212 -0.904 . . . . 74.23 109.981 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 21' ' ' ILE . 10.9 mtp -58.36 -44.03 88.64 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.509 0.724 . . . . 63.05 110.954 174.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 114' ' ' ILE . 39.3 t -61.2 -46.0 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.626 0.77 . . . . 74.21 110.6 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.3 p -73.36 -30.66 63.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.34 -0.846 . . . . 74.23 111.111 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -69.75 -25.21 63.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.568 0.747 . . . . 74.44 109.782 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.95 0.02 84.08 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.649 -0.705 . . . . 72.5 112.682 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.0 m 69.98 12.19 7.79 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.823 1.249 . . . . 73.13 111.137 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -94.47 152.99 40.44 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 123.268 0.627 . . . . 74.55 110.37 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -54.11 120.45 7.97 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.776 2.317 . . . . 74.53 111.4 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.434 ' HB2' HG22 ' A' ' 115' ' ' THR . 3.4 pt20 -60.08 160.22 8.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.961 0.904 . . . . 72.41 112.63 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.4 115.27 17.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.614 -0.884 . . . . 75.21 108.614 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.54 120.98 43.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.71 0.804 . . . . 74.21 109.194 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.432 HD23 HG22 ' A' ' 64' ' ' VAL . 57.3 mt -73.36 135.38 44.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.753 0.821 . . . . 75.13 110.437 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.91 136.61 96.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.372 0.42 . . . . 71.1 110.569 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.655 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 29.7 Cg_endo -91.1 103.09 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.999 2.466 . . . . 72.51 112.311 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.1 116.04 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -69.83 106.48 3.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.474 -0.565 . . . . 73.41 109.474 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.59 -17.27 62.3 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.286 -0.87 . . . . 70.33 111.71 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.042 0.537 . . . . 71.03 111.479 174.857 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.616 ' HE3' HD13 ' B' ' 89' ' ' ILE . 11.7 ptm . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 114.758 1.392 . . . . 75.12 114.758 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -155.85 136.2 13.12 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.813 1.245 . . . . 75.42 108.003 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.563 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 8.5 t80 -134.84 112.16 10.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.509 -0.552 . . . . 74.41 109.509 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -127.03 115.94 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.786 -0.82 . . . . 74.14 108.786 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.5 135.76 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 116.455 -0.339 . . . . 73.31 110.218 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -98.47 -50.14 4.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.61 -0.885 . . . . 75.14 108.61 169.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -163.1 142.31 8.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.068 -0.515 . . . . 71.22 110.696 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.2 mt -116.89 142.26 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 106.403 -1.703 . . . . 71.41 106.403 165.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -167.74 142.12 3.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.136 0.425 . . . . 73.23 111.374 -173.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -72.19 121.48 19.41 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.189 -0.914 . . . . 73.32 108.808 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.423 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.8 mtpt -97.07 -24.87 15.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.472 0.709 . . . . 73.21 110.729 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -156.66 138.13 13.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.863 -0.608 . . . . 72.31 110.28 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.532 HD13 ' SG ' ' B' ' 113' ' ' CYS . 43.5 mm -132.63 148.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.752 1.221 . . . . 72.15 107.963 173.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -150.22 142.33 24.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.294 -0.867 . . . . 75.12 109.162 165.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.438 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.1 t80 -146.57 114.2 6.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.076 -1.824 . . . . 72.23 106.076 168.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.92 114.35 20.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.806 -0.813 . . . . 73.31 108.806 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -106.45 85.59 1.81 Allowed Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.418 -0.956 . . . . 72.42 108.418 171.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.76 -20.81 29.64 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.827 2.351 . . . . 74.12 111.289 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.478 ' O ' HG23 ' B' ' 31' ' ' VAL . 80.7 m-20 -125.98 20.2 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.532 1.133 . . . . 73.11 110.577 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.499 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -37.81 -55.0 2.24 Favored Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 125.671 1.589 . . . . 73.14 114.415 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 8.5 Cg_exo -69.56 -20.11 36.21 Favored 'Trans proline' 0 C--N 1.392 2.847 0 C-N-CA 123.057 2.505 . . . . 73.45 112.903 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -96.59 -27.45 14.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.026 0.93 . . . . 75.51 112.442 -171.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.478 HG23 ' O ' ' B' ' 27' ' ' ASN . 64.2 t -67.22 -22.78 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.119 0.568 . . . . 74.51 110.916 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -57.33 -38.3 73.86 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.214 0.606 . . . . 75.44 111.499 171.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -73.6 -15.59 61.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.915 0.886 . . . . 74.22 111.731 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.641 ' HZ2' ' HB3' ' B' ' 71' ' ' GLU . 88.0 mttt -104.17 108.86 20.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.529 0.732 . . . . 74.04 111.16 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -100.03 86.02 3.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.489 0.716 . . . . 73.24 109.949 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.597 ' HB3' HD21 ' B' ' 68' ' ' LEU . 22.3 t90 -165.75 157.98 14.81 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.893 0.877 . . . . 74.23 109.107 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.7 121.35 84.92 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.4 109.536 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 146.69 52.37 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.48 2.12 . . . . 74.15 112.811 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.39 103.52 2.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.2 0.6 . . . . 73.54 109.503 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.776 HG11 HD23 ' B' ' 126' ' ' LEU . 23.0 t -106.46 144.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.316 0.646 . . . . 72.34 109.838 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -145.17 131.07 19.15 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.159 -1.052 . . . . 74.42 108.159 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.465 HD23 ' HG ' ' B' ' 128' ' ' LEU . 7.1 mp -88.49 165.98 14.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.455 -0.572 . . . . 74.44 109.455 173.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -160.76 142.85 12.5 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.348 -1.352 . . . . 64.42 107.348 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.63 170.01 10.46 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.243 0.544 . . . . 75.13 110.72 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.668 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.4 t70 -142.14 126.37 17.52 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.683 -1.144 . . . . 61.4 108.281 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 p -107.93 103.94 13.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.602 0.761 . . . . 73.43 109.202 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.56 133.2 34.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.646 0.778 . . . . 72.3 109.699 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.6 m -140.13 164.97 28.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.548 0.739 . . . . 72.53 109.113 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -151.63 139.73 20.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.838 0.455 . . . . 73.51 110.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -81.84 112.53 19.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.938 -0.764 . . . . 74.51 108.938 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.19 -51.93 12.19 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.424 0.631 . . . . 75.42 110.016 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.9 -172.35 3.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.47 1.108 . . . . 60.35 109.527 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 124.33 23.99 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.992 -0.744 . . . . 73.14 108.992 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 63.38 22.08 13.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.318 1.047 . . . . 72.25 112.152 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -138.75 123.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.097 -1.075 . . . . 71.34 108.097 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.487 ' HE1' ' HB2' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -130.88 -179.51 5.36 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.662 -0.496 . . . . 73.41 109.662 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -142.39 109.65 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.04 -1.096 . . . . 75.35 108.04 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.58 124.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.755 0.822 . . . . 73.31 109.397 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.1 t -106.69 122.31 60.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 N-CA-C 109.487 -0.561 . . . . 75.04 109.487 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.5 OUTLIER -94.36 112.17 23.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.131 -1.433 . . . . 74.32 107.131 171.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.668 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 52.6 ttt180 -102.02 126.19 48.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.743 -0.465 . . . . 64.42 109.743 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.81 111.1 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.309 1.044 . . . . 62.44 108.882 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -94.79 138.59 32.4 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.761 -0.829 . . . . 65.54 108.761 170.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.5 t -131.52 130.03 62.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.107 0.963 . . . . 71.01 108.414 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.9 m -125.54 138.41 53.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.325 -0.621 . . . . 74.43 109.325 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 137.45 32.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.556 0.743 . . . . 74.31 109.289 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.3 p -144.03 124.82 14.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.284 0.634 . . . . 61.32 109.957 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' B' ' 36' ' ' TRP . 3.0 tt -95.63 112.8 24.44 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.78 -1.192 . . . . 73.13 107.78 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.13 -111.51 3.28 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.914 -0.874 . . . . 74.54 110.914 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.98 15.69 9.99 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.067 0.947 . . . . 73.41 110.612 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.641 ' HB3' ' HZ2' ' B' ' 34' ' ' LYS . 7.1 tp10 -118.63 141.12 48.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.5 1.12 . . . . 74.12 108.665 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 71.5 m -61.4 134.49 56.97 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.325 0.511 . . . . 73.02 110.517 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.86 -58.11 2.59 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.376 -0.972 . . . . 70.53 108.376 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.44 159.1 30.53 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.778 -1.101 . . . . 75.12 109.765 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.02 145.78 51.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.364 -1.347 . . . . 72.31 107.364 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.2 146.1 22.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.307 -0.627 . . . . 65.14 109.307 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -158.7 125.25 4.68 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.714 -0.476 . . . . 73.55 109.714 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.465 HG12 HD11 ' B' ' 21' ' ' ILE . 77.0 t -122.57 150.22 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 72.41 109.36 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -127.05 102.47 6.99 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.03 -0.73 . . . . 72.42 109.03 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.489 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -89.82 104.02 16.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.889 -0.596 . . . . 74.33 109.586 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.423 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.0 170.38 37.72 Favored Glycine 0 C--O 1.245 0.809 0 O-C-N 123.551 0.532 . . . . 71.52 112.133 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.56 125.84 1.36 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.913 -0.475 . . . . 71.41 111.913 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.7 mt -86.36 119.36 34.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.639 -0.874 . . . . 73.03 108.639 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.487 ' HB2' ' HE1' ' B' ' 56' ' ' TYR . 47.0 m-85 -121.83 135.05 54.9 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -100.61 120.87 40.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.203 1.001 . . . . 75.1 108.669 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.09 109.55 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.629 0.771 . . . . 74.55 111.528 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.74 140.12 50.11 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.704 0.801 . . . . 71.05 110.382 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.01 -26.91 14.51 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 111.993 -0.443 . . . . 71.23 111.993 -170.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.616 HD13 ' HE3' ' B' ' 9' ' ' MET . 2.1 mp -63.95 131.97 29.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 125.339 1.455 . . . . 73.42 110.897 -176.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -159.79 143.58 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.214 0.946 . . . . 73.14 109.716 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.35 -117.86 11.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.831 0.707 . . . . 65.44 113.997 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' THR . . . . . 0.51 ' HA ' ' HB2' ' B' ' 95' ' ' ALA . 39.3 m -65.88 -29.8 70.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.363 1.065 . . . . 73.4 111.898 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -49.9 -46.66 52.02 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 124.111 0.882 . . . . 73.52 111.064 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.506 ' HA ' ' HB3' ' B' ' 97' ' ' CYS . 9.1 ptm -94.18 -29.07 15.31 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.423 0.897 . . . . 74.21 113.423 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' B' ' 92' ' ' THR . . . -57.54 -28.86 63.89 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.912 0.778 . . . . 74.32 111.362 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.07 -32.72 17.41 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.257 1.023 . . . . 74.13 110.952 172.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.563 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 42.6 t -70.17 -66.82 0.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.923 0.489 . . . . 74.22 111.556 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.46 HD23 ' HE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -63.77 -18.71 64.34 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 118.07 0.396 . . . . 72.43 111.773 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.44 -20.25 58.92 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 116.126 -0.488 . . . . 32.42 113.858 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.61 -58.7 0.16 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.398 0.599 . . . . 72.24 112.543 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.37 -51.7 61.97 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.943 0.72 . . . . 74.14 112.943 -167.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 75.2 m -60.71 -48.52 92.9 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.545 -0.74 . . . . 74.24 111.263 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -50.14 -35.52 42.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.373 2.049 . . . . 74.12 114.797 167.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -35.67 78.99 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.355 0.525 . . . . 75.4 111.433 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.881 0.872 . . . . 74.55 110.1 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 74.6 mt -84.26 -20.49 32.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.793 -1.094 . . . . 74.14 112.401 -170.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -58.39 -48.94 96.05 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.047 -0.978 . . . . 73.25 113.311 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 76.9 Cg_exo -55.22 -39.76 89.29 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.571 2.181 . . . . 71.23 114.15 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.489 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.5 m-85 -65.89 -49.6 67.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.698 . . . . 74.41 111.257 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.86 96.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.678 0.791 . . . . 50.03 110.863 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.567 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.0 ttt-85 -63.11 -56.23 18.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.134 1.374 . . . . 72.34 111.457 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.89 -40.87 73.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.377 1.071 . . . . 72.23 110.83 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -65.93 -44.4 85.21 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.577 -0.283 . . . . 74.43 111.082 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.462 HD13 HD22 ' B' ' 128' ' ' LEU . 72.7 mt -60.52 -54.8 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 123.524 0.729 . . . . 74.21 110.992 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -58.36 -29.79 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.448 0.699 . . . . 74.24 111.501 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -70.16 -54.37 13.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.436 0.694 . . . . 73.31 110.131 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.3 mmt -63.2 -34.86 78.55 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.248 0.619 . . . . 74.42 111.866 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.8 -46.66 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.901 0.881 . . . . 74.13 110.902 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.447 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 80.4 p -73.58 -24.79 60.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.773 0.429 . . . . 73.11 111.714 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -63.42 -28.58 70.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.708 0.803 . . . . 74.41 110.637 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.99 17.28 59.55 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.249 -0.75 . . . . 70.14 113.631 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.2 p 70.19 13.35 7.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 126.231 1.813 . . . . 64.32 113.418 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -90.61 150.5 42.62 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 122.618 0.367 . . . . 72.51 110.373 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.8 159.13 18.31 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.363 2.709 . . . . 71.4 113.368 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.31 135.6 57.7 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.882 0.739 . . . . 71.41 110.112 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.776 HD23 HG11 ' B' ' 40' ' ' VAL . 1.3 tm? -108.61 110.91 22.48 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.796 -1.557 . . . . 74.23 106.796 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -91.62 94.25 9.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.798 -0.816 . . . . 73.41 108.798 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.567 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 5.4 mp -69.93 108.14 3.88 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.589 -1.263 . . . . 71.01 107.589 171.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.31 139.26 87.0 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.563 0.539 . . . . 72.45 110.081 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.516 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 54.8 Cg_endo -69.49 82.72 0.68 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 122.194 1.929 . . . . 72.51 111.14 175.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -91.32 132.59 35.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 114.722 -1.126 . . . . 75.1 108.424 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -70.73 113.2 7.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.526 0.73 . . . . 73.55 110.299 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.12 -40.17 92.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.329 1.051 . . . . 72.43 110.788 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -61.42 -34.17 74.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.154 -0.93 . . . . 75.11 111.046 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.52 90.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.938 0.495 . . . . 64.53 111.163 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 109.208 -0.664 . . . . 75.13 109.208 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.473 ' H ' HG21 ' C' ' 89' ' ' ILE . 54.2 ttp . . . . . 0 CA--C 1.55 0.968 0 CA-C-O 121.885 0.85 . . . . 74.23 112.093 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -128.27 101.58 6.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.434 -1.321 . . . . 62.24 107.434 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.484 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -114.78 143.47 45.02 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.376 0.67 . . . . 73.21 110.181 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -147.84 144.62 28.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.274 0.629 . . . . 75.23 110.02 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -92.2 120.24 41.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.815 -0.809 . . . . 74.14 108.815 171.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -91.39 -38.32 12.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.53 0.332 . . . . 72.41 110.42 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.56 148.54 3.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.073 -0.343 . . . . 72.4 110.073 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -136.04 132.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.137 -1.06 . . . . 73.42 108.137 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HB2' ' HA2' ' D' ' 121' ' ' GLY . 35.0 p90 -170.72 162.56 7.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.643 0.735 . . . . 72.32 112.09 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -87.39 117.35 26.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.826 -1.079 . . . . 73.23 110.203 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 6.8 mtmt -92.83 -7.52 46.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.411 0.284 . . . . 74.22 110.697 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.8 t70 -160.27 135.19 7.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.391 -0.966 . . . . 70.04 108.391 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.9 mt -149.05 139.11 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.014 -1.847 . . . . 74.22 106.014 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -158.92 151.04 21.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.063 0.459 . . . . 74.52 109.869 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.9 128.98 15.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.519 -1.289 . . . . 71.23 107.519 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.4 mt-10 -124.7 142.43 51.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.72 -0.844 . . . . 71.21 108.72 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' C' ' 28' ' ' ALA . . . -154.43 77.94 5.26 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.753 -0.832 . . . . 73.11 108.753 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 -30.5 22.87 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.48 2.12 . . . . 71.23 111.574 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' C' ' 72' ' ' THR . 37.4 m-20 -112.14 33.51 4.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.007 0.923 . . . . 75.43 109.371 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.423 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . . . -54.29 -45.89 99.1 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.496 1.118 . . . . 71.01 113.583 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -75.57 -25.55 10.89 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.401 2.067 . . . . 74.2 113.4 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.13 -51.28 70.28 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.741 0.651 . . . . 73.01 111.256 -172.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 14.5 p -55.39 -25.53 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.423 1.089 . . . . 72.34 113.342 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -66.88 -42.82 84.93 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.84 0.456 . . . . 72.35 111.515 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -103.4 13.85 32.73 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.26 0.624 . . . . 73.52 110.29 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 24.3 ttpp -124.46 174.2 7.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.368 1.067 . . . . 74.41 109.434 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' C' ' 34' ' ' LYS . 21.5 t70 -54.57 113.8 1.43 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.337 1.055 . . . . 74.55 110.958 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -86.85 64.97 8.77 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.879 0.847 . . . . 72.33 111.24 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -158.95 78.79 2.98 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.617 -0.883 . . . . 74.32 108.617 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -88.35 174.22 4.39 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.697 2.265 . . . . 74.51 111.574 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' C' ' 67' ' ' SER . 11.0 tp10 -85.8 107.63 17.73 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.052 -0.722 . . . . 65.33 109.052 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.96 99.98 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.274 -0.875 . . . . 71.44 108.988 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.426 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.8 tmtt? -107.41 103.22 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.292 -1.003 . . . . 70.24 108.292 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.546 HD11 ' H ' ' C' ' 42' ' ' LEU . 0.0 OUTLIER -87.25 155.37 20.1 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.141 -0.689 . . . . 73.22 109.141 173.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.554 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.1 t70 -150.95 143.82 24.55 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.998 -0.741 . . . . 63.15 108.998 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.98 145.72 48.39 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.467 -0.568 . . . . 73.15 109.467 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -156.99 149.98 23.78 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.78 0.832 . . . . 73.24 108.794 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -130.8 154.3 48.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.187 0.518 . . . . 74.2 110.214 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.481 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -140.8 171.13 14.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.022 . . . . 75.41 108.607 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 25.8 p -159.02 143.55 15.63 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.9 0.48 . . . . 65.05 110.35 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -149.84 128.02 12.03 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.859 0.863 . . . . 74.12 109.021 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.74 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.54 0.336 . . . . 71.43 110.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' C' ' 57' ' ' GLU . 31.7 mt -103.49 -30.12 10.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.835 0.854 . . . . 70.53 110.204 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.58 -178.43 6.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.88 0.872 . . . . 63.32 110.489 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -62.16 117.31 5.86 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.299 -0.864 . . . . 73.51 109.925 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.91 0.27 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.528 1.131 . . . . 75.04 113.171 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.2 t -103.8 114.81 44.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.215 0.531 . . . . 75.54 109.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -124.22 123.56 40.53 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.732 -1.21 . . . . 74.02 107.732 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.697 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.6 111.08 18.25 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.74 -0.837 . . . . 74.33 108.74 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.28 126.66 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.287 -1.005 . . . . 73.43 108.287 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 42.0 t -110.96 102.3 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.112 -1.07 . . . . 75.21 108.112 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' C' ' 103' ' ' PRO . 2.2 tm? -91.95 102.83 15.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.781 -0.822 . . . . 75.51 108.781 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -85.08 125.47 32.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.904 1.281 . . . . 70.14 110.866 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.2 t -119.27 141.73 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.313 1.045 . . . . 75.44 108.954 170.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.0 m -131.94 133.46 44.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.888 0.875 . . . . 74.31 109.256 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.624 HG21 HD12 ' C' ' 114' ' ' ILE . 93.2 t -116.74 117.18 54.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.345 -0.983 . . . . 74.0 108.345 167.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 13.9 m -105.15 141.92 35.84 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.597 -0.89 . . . . 75.45 108.597 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.02 93.04 2.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.176 -1.416 . . . . 75.42 107.176 176.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' C' ' 39' ' ' GLU . 59.6 p -161.85 131.84 4.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.874 0.47 . . . . 75.03 109.896 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.78 39.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.793 0.806 . . . . 74.35 109.911 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.89 -84.33 0.72 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.093 -0.803 . . . . 72.12 111.093 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.12 -31.34 17.14 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.712 0.805 . . . . 73.42 111.232 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -101.23 98.73 9.09 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.087 0.955 . . . . 74.21 110.252 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 32.2 m -88.88 118.31 28.5 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.96 0.504 . . . . 74.42 111.997 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -51.74 29.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.681 0.792 . . . . 73.02 109.071 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -162.52 174.72 12.29 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.98 -1.464 . . . . 73.24 110.621 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.418 HD22 HG21 ' C' ' 65' ' ' THR . 3.4 tm? -145.56 146.39 31.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 73.22 105.773 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -151.4 132.64 14.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.715 -0.846 . . . . 71.43 108.715 175.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -141.38 134.47 29.22 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.431 -0.581 . . . . 73.24 109.431 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.19 140.4 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.032 . . . . 72.21 108.603 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.0 mt-30 -115.04 102.19 9.71 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.594 -0.891 . . . . 75.13 108.594 170.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.454 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.1 tp-100 -82.45 99.6 9.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.919 0.888 . . . . 73.31 109.552 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.65 144.85 22.43 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.317 -0.713 . . . . 64.3 111.317 174.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.27 118.94 1.35 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.211 -0.755 . . . . 73.1 111.211 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.416 HD13 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -80.97 122.17 35.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.984 -1.117 . . . . 73.13 107.984 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -135.54 154.57 51.33 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.014 0.525 . . . . 74.32 110.608 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -105.19 118.83 37.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.34 -0.985 . . . . 71.13 108.34 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.432 HG23 ' HG3' ' C' ' 94' ' ' MET . 3.8 mp -113.86 107.01 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.158 -1.423 . . . . 73.42 107.158 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.61 16.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.997 0.919 . . . . 64.23 110.341 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.92 -55.23 4.06 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.945 -0.57 . . . . 62.32 112.686 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.473 HG21 ' H ' ' C' ' 9' ' ' MET . 2.6 pp -110.02 175.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.731 0.812 . . . . 64.5 111.139 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.2 pt-20 -163.78 -176.21 4.5 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.795 -0.638 . . . . 73.3 110.78 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.23 -124.8 28.49 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.333 -0.394 . . . . 61.22 113.768 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -60.58 -36.76 79.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.122 0.969 . . . . 73.11 111.175 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -66.93 -42.18 85.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.621 -1.172 . . . . 74.43 110.991 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 58.8 ttm -71.84 -36.53 70.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.951 0.501 . . . . 75.33 110.385 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.27 94.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.282 0.633 . . . . 74.42 111.075 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.73 -27.62 66.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.603 0.761 . . . . 74.25 111.134 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 36.6 t -72.81 -62.46 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 110.047 -0.353 . . . . 74.51 110.047 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.23 -17.83 62.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.829 0.452 . . . . 70.4 112.126 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.61 -10.83 46.09 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.433 -0.649 . . . . 71.25 114.181 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.83 -56.18 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 117.874 0.837 . . . . 65.54 112.343 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.655 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 76.5 t80 -70.68 -49.43 47.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.14 0.576 . . . . 74.22 112.128 -172.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.503 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.9 m -63.4 -46.36 84.51 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.358 0.663 . . . . 65.51 111.247 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.1 Cg_exo -55.54 -36.67 94.87 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.686 2.257 . . . . 74.53 114.73 169.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.464 HD22 ' ND2' ' C' ' 132' ' ' ASN . 28.2 t-20 -58.4 -38.7 77.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.356 0.662 . . . . 71.2 111.265 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.01 -41.94 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.116 -0.947 . . . . 75.21 110.403 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.65 -20.0 28.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.589 -1.187 . . . . 74.33 112.428 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.46 -50.55 87.43 Favored Pre-proline 0 CA--C 1.554 1.103 0 CA-C-O 117.772 -1.108 . . . . 74.05 113.147 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 -37.9 94.43 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.238 1.959 . . . . 65.4 113.365 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -67.92 -51.32 49.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.788 0.835 . . . . 75.42 111.605 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -59.64 -35.83 75.16 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.038 0.935 . . . . 74.5 110.891 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -65.39 -47.92 74.67 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.707 -1.588 . . . . 74.03 110.527 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.518 0.511 . . . . 74.05 110.234 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.3 t -69.0 -29.23 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.82 0.448 . . . . 73.13 110.817 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.624 HD12 HG21 ' C' ' 64' ' ' VAL . 80.1 mt -75.89 -49.02 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.701 -0.681 . . . . 72.44 109.945 169.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 54.1 m -52.83 -41.92 64.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 73.32 111.491 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.5 t -63.0 -49.02 76.3 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.303 -1.317 . . . . 74.34 109.377 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.635 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.76 -42.11 88.13 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.564 1.145 . . . . 73.4 112.959 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.34 -43.69 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 109.519 -0.549 . . . . 73.34 109.519 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.7 t -71.79 -25.88 62.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.001 0.92 . . . . 61.23 111.7 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.4 mtt-85 -71.44 -33.86 69.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.393 0.677 . . . . 73.01 109.577 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.4 11.2 56.64 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 124.041 0.838 . . . . 71.21 112.703 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.411 HG22 ' HB3' ' D' ' 17' ' ' TYR . 68.1 p 57.02 26.4 11.88 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.256 1.822 . . . . 71.4 112.918 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HE1' HG13 ' C' ' 31' ' ' VAL . 69.0 m-85 -94.83 146.78 31.99 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.68 -0.859 . . . . 65.3 108.68 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -60.91 146.55 97.47 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.94 2.427 . . . . 72.02 112.647 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.447 ' HG2' ' HB2' ' B' ' 119' ' ' SER . 19.8 mp0 -59.1 125.37 23.31 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.837 0.855 . . . . 64.55 112.467 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -109.7 90.46 3.31 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.048 -1.834 . . . . 75.14 106.048 168.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -91.07 109.34 20.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.57 132.22 48.18 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.074 0.859 . . . . 74.1 109.713 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.89 132.58 89.43 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 123.558 0.536 . . . . 74.31 111.056 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.557 ' HG3' HD13 ' A' ' 16' ' ' ILE . 61.3 Cg_endo -69.75 102.81 1.07 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.905 2.403 . . . . 75.41 112.491 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 6.8 p -105.33 122.63 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.072 0.549 . . . . 74.5 109.853 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.464 ' ND2' HD22 ' C' ' 104' ' ' ASN . 15.6 m120 -109.12 81.54 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.567 0.747 . . . . 71.21 110.386 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -72.89 -31.8 64.94 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.806 -0.813 . . . . 75.02 108.806 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.539 0.549 0 CA-C-N 114.401 -1.272 . . . . 74.53 111.269 170.232 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.46 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 12.1 tpt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 112.797 0.666 . . . . 73.23 112.797 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 92.5 m -143.05 141.59 31.33 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.096 0.958 . . . . 74.43 110.282 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -160.91 90.21 0.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.263 -1.755 . . . . 73.14 106.263 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -114.03 150.23 34.24 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.854 -0.612 . . . . 75.24 110.377 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.4 120.86 43.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.767 0.827 . . . . 73.42 109.057 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -100.27 -49.54 4.23 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.014 0.196 . . . . 74.24 110.575 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -167.81 118.72 0.83 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.559 -0.163 . . . . 74.23 110.559 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.04 134.26 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.065 -1.458 . . . . 74.12 107.065 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HB3' HG22 ' C' ' 122' ' ' THR . 37.2 p90 -164.96 177.35 7.89 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.528 0.68 . . . . 74.14 111.705 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -97.43 124.16 41.52 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.181 -0.918 . . . . 63.04 109.053 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -88.61 -27.54 21.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.61 -0.515 . . . . 65.35 109.61 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.3 t70 -150.06 145.09 26.17 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.426 -0.806 . . . . 72.43 109.784 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.635 HG21 ' HE1' ' C' ' 117' ' ' MET . 64.0 mt -144.99 149.08 17.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.411 1.484 . . . . 72.42 107.667 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -151.87 144.88 24.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.553 0.741 . . . . 64.45 109.528 171.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.532 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.4 t80 -154.1 123.81 6.69 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.089 -1.448 . . . . 74.44 107.089 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 49.1 mt-10 -131.36 142.5 50.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.252 0.548 . . . . 75.41 110.089 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 74.49 10.36 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.404 1.082 . . . . 74.21 108.144 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.4 -43.39 4.32 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 121.906 1.738 . . . . 73.23 110.937 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.425 ' O ' HG23 ' D' ' 31' ' ' VAL . 18.7 m-20 -92.17 25.49 2.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.601 1.16 . . . . 72.52 109.769 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.427 ' HB2' ' HD2' ' C' ' 19' ' ' LYS . . . -54.64 -56.73 23.99 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.326 1.232 . . . . 71.23 114.326 -168.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.89 -19.09 18.47 Favored 'Trans proline' 0 C--N 1.386 2.553 0 CA-C-N 121.437 1.549 . . . . 72.23 112.089 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -70.87 -36.76 72.95 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.018 1.327 . . . . 71.15 110.342 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 27' ' ' ASN . 84.5 t -79.0 -33.98 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.38 0.672 . . . . 74.13 110.68 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -60.82 -20.83 62.39 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.737 0.643 . . . . 64.21 112.737 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.8 -32.96 74.89 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 72.32 110.621 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.431 ' HZ3' ' HB3' ' D' ' 71' ' ' GLU . 49.5 mtmt -91.52 105.91 18.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.25 1.02 . . . . 71.43 108.813 172.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.08 89.81 5.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.287 0.635 . . . . 74.0 109.595 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.586 ' HB3' HD12 ' D' ' 68' ' ' LEU . 41.5 t-105 -163.75 158.45 20.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.479 0.712 . . . . 73.41 109.854 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.66 115.13 61.93 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.917 0.887 . . . . 75.23 110.148 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -51.64 166.71 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 125.029 3.819 . . . . 75.43 116.667 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -98.22 113.24 25.1 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.439 -1.255 . . . . 72.44 108.316 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.57 HG11 HG13 ' D' ' 64' ' ' VAL . 45.0 t -98.43 111.37 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.661 0.784 . . . . 72.23 110.767 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -86.85 117.36 25.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.796 -1.557 . . . . 71.45 106.796 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 tp -96.33 141.74 29.3 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.251 -0.648 . . . . 74.24 109.251 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.6 t70 -129.87 146.77 51.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.826 -1.175 . . . . 75.42 107.826 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . 0.411 ' H ' HD22 ' D' ' 44' ' ' LEU . 1.9 pt? -125.94 141.69 51.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.347 0.659 . . . . 74.44 110.049 -171.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.3 t70 -157.74 150.84 23.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.835 0.854 . . . . 74.23 109.212 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -130.77 158.07 41.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 64.21 108.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.586 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.14 173.7 14.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.99 -0.55 . . . . 74.53 109.929 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.554 ' HB3' HD23 ' D' ' 98' ' ' LEU . 66.0 p -157.65 158.82 36.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.056 0.543 . . . . 73.04 110.745 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.31 118.27 2.25 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.215 1.006 . . . . 75.35 108.434 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -77.9 117.19 19.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.796 -0.816 . . . . 73.22 108.796 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.61 -35.07 14.45 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.861 -0.609 . . . . 71.01 110.406 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.17 -179.09 7.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.562 -0.745 . . . . 62.44 110.433 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.23 116.26 9.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.133 -0.939 . . . . 75.3 109.65 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.7 9.29 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.784 1.234 . . . . 64.41 112.502 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.26 114.29 46.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.629 -0.878 . . . . 71.34 108.629 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -125.04 129.42 50.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.15 0.98 . . . . 73.41 108.741 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.1 117.47 34.42 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 124.222 1.009 . . . . 73.51 108.664 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.5 HG11 ' HD3' ' D' ' 103' ' ' PRO . 43.6 t -100.52 135.82 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.243 -1.021 . . . . 71.23 108.243 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 84.5 t -113.72 146.56 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.74 0.816 . . . . 65.1 109.072 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.47 124.92 42.44 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.079 -1.452 . . . . 74.42 107.079 176.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.576 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.9 ttm-85 -104.68 105.13 15.09 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.71 -0.848 . . . . 74.02 108.71 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.17 103.08 14.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.844 -1.169 . . . . 73.14 107.844 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 37.8 m -102.08 129.14 48.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.249 0.619 . . . . 73.23 109.805 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.57 HG13 HG11 ' D' ' 40' ' ' VAL . 74.2 t -129.1 102.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.435 1.094 . . . . 71.42 109.15 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 61.8 m -102.07 108.09 19.41 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.433 -0.951 . . . . 63.53 108.433 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' D' ' 74' ' ' PHE . . . -109.37 141.85 41.14 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.081 -0.711 . . . . 74.25 109.081 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.418 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.1 p -147.56 126.4 12.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.394 -0.821 . . . . 74.14 109.58 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.586 HD12 ' HB3' ' D' ' 36' ' ' TRP . 30.8 tp -99.87 110.44 22.8 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.521 -0.918 . . . . 74.44 108.521 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.46 -124.09 6.39 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.402 -0.679 . . . . 73.33 111.402 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 5.67 46.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.287 0.635 . . . . 74.41 110.966 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.431 ' HB3' ' HZ3' ' D' ' 34' ' ' LYS . 9.5 tp10 -120.18 144.85 47.48 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.382 0.673 . . . . 71.33 111.319 -170.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -63.64 125.23 23.6 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.57 0.748 . . . . 72.34 110.551 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -89.41 -73.83 0.5 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.286 1.034 . . . . 65.22 109.648 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' D' ' 66' ' ' ALA . 55.1 p90 -144.17 138.02 27.84 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-O 121.246 0.546 . . . . 63.14 110.127 174.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.6 mt -103.08 148.14 26.09 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.257 1.023 . . . . 70.23 108.413 175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.542 ' SG ' HG22 ' D' ' 114' ' ' ILE . 52.0 t -160.22 146.41 15.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.082 0.553 . . . . 72.12 110.381 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -157.18 127.6 6.47 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.063 -0.717 . . . . 65.44 109.063 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . 0.412 HG21 HG22 ' D' ' 21' ' ' ILE . 67.7 t -126.73 115.89 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.857 0.463 . . . . 71.34 109.9 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.3 mt-30 -91.79 87.16 6.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.5 0.72 . . . . 71.21 109.181 170.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.43 108.44 12.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.566 -1.197 . . . . 75.34 108.81 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.43 141.69 15.4 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.693 -0.563 . . . . 64.4 111.693 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.41 130.49 5.13 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.045 -0.822 . . . . 53.21 111.045 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.1 mt -88.97 116.45 30.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.701 1.2 . . . . 71.42 108.995 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -120.7 143.87 48.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.747 0.819 . . . . 74.34 109.237 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -98.29 96.84 8.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.905 -0.776 . . . . 75.51 108.905 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.65 109.16 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.401 -0.963 . . . . 72.31 108.401 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -140.66 168.65 19.29 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.14 0.976 . . . . 45.45 109.527 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.18 -15.09 30.01 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 114.189 0.435 . . . . 75.41 114.189 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -139.4 153.54 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.579 0.752 . . . . 64.31 110.144 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . 0.485 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -149.81 -170.24 3.59 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.778 0.831 . . . . 75.21 110.662 177.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.36 -142.33 26.98 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.002 -0.544 . . . . 61.24 113.843 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -73.94 -21.0 60.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.483 0.713 . . . . 72.3 111.762 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.35 -47.98 66.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.191 0.597 . . . . 72.34 110.273 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 23.5 ptt? -71.94 -27.27 62.68 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.349 0.406 . . . . 74.45 110.608 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.41 67.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.45 0.7 . . . . 65.11 111.25 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' D' ' 100' ' ' ALA . 14.6 t-80 -71.93 -29.32 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.593 0.757 . . . . 71.33 110.663 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.14 -43.45 78.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 110.327 -0.249 . . . . 72.3 110.327 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.554 HD23 ' HB3' ' D' ' 48' ' ' SER . 9.2 tt -75.36 -45.23 40.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.524 0.73 . . . . 72.44 110.712 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.73 6.97 79.87 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.769 -0.462 . . . . 52.04 114.063 -172.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' D' ' 96' ' ' HIS . . . -147.09 -63.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.489 0.645 . . . . 63.11 111.8 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.6 -40.26 84.77 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.632 0.604 . . . . 72.44 112.632 -169.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.12 -44.66 14.09 Favored Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.413 0.685 . . . . 73.4 111.575 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.567 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.7 Cg_exo -54.66 -32.62 76.21 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 122.815 2.343 . . . . 72.53 113.448 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' D' ' 133' ' ' PHE . 4.1 t-20 -64.8 -36.62 84.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.178 0.591 . . . . 64.15 110.915 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.9 -42.82 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.577 0.751 . . . . 74.43 110.07 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.8 -20.63 56.18 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.943 -1.026 . . . . 75.02 112.053 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -64.09 -45.73 79.81 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 114.55 1.315 . . . . 75.23 114.55 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . 0.532 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 22.1 Cg_endo -59.16 -35.2 98.21 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.656 1.571 . . . . 73.53 112.683 174.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.516 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 96.5 m-85 -73.9 -36.21 64.73 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.822 0.849 . . . . 73.33 111.601 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.35 -50.59 69.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.835 0.854 . . . . 73.41 109.947 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -55.76 -48.68 74.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.996 -1.456 . . . . 70.22 111.225 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -62.99 -45.88 90.33 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.637 0.775 . . . . 74.23 111.278 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.9 t -55.45 -39.28 70.11 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.942 0.776 . . . . 73.11 111.002 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.681 HG21 HD11 ' D' ' 126' ' ' LEU . 52.8 mt -66.62 -50.92 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.373 -0.83 . . . . 74.4 110.779 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.6 m -58.79 -38.5 78.7 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.898 0.749 . . . . 72.42 111.54 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 38.5 t -63.69 -44.87 92.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.268 -0.878 . . . . 75.53 110.538 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -67.47 -35.15 78.62 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.95 0.5 . . . . 71.1 111.538 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.22 -40.37 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.972 0.909 . . . . 74.44 110.672 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.52 -32.83 66.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 120.959 0.409 . . . . 74.02 110.718 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 94.5 mtt-85 -67.39 -31.83 72.32 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.698 0.799 . . . . 74.15 110.204 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -87.93 6.07 84.0 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.896 0.747 . . . . 75.4 112.983 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 48.8 p 54.74 27.61 9.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 126.199 1.8 . . . . 74.25 113.408 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -92.25 159.9 36.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.43 1.092 . . . . 63.22 110.686 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.17 138.29 85.6 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.405 2.736 . . . . 73.1 112.259 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -50.99 129.97 24.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.726 1.266 . . . . 73.41 112.758 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.681 HD11 HG21 ' D' ' 114' ' ' ILE . 2.7 tm? -115.9 95.74 5.26 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.32 107.714 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -133.83 114.58 13.5 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.872 -1.158 . . . . 64.31 107.872 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.6 148.96 40.3 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.652 -0.704 . . . . 71.21 110.417 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.79 162.93 64.58 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.997 -1.001 . . . . 71.21 109.966 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.34 154.94 49.43 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.255 1.97 . . . . 70.52 112.868 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.63 139.43 23.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 115.683 -0.69 . . . . 74.04 109.378 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -68.44 117.54 10.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.949 -0.759 . . . . 73.5 108.949 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.537 ' HB3' ' HB2' ' D' ' 104' ' ' ASN . 33.3 p90 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 123.982 0.913 . . . . 74.5 113.388 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 108.553 -0.906 . . . . 73.54 108.553 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 102' ' ' CYS . 1.2 t80 -139.76 114.84 9.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.625 -0.88 . . . . 75.05 108.625 167.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -155.63 137.29 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.24 0.616 . . . . 71.43 109.668 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.551 HD13 ' H ' ' A' ' 13' ' ' ILE . 2.5 mp -75.96 131.72 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.474 -0.935 . . . . 75.34 108.474 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 -35.79 12.52 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.808 0.276 . . . . 73.14 111.052 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 137.58 12.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 121.999 0.12 . . . . 75.41 110.821 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.441 HG13 HG21 ' A' ' 13' ' ' ILE . 2.3 mp -122.88 118.84 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.058 -1.46 . . . . 74.1 107.058 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 43.7 p90 -166.55 177.57 6.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.218 1.008 . . . . 74.32 113.031 -171.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -102.68 124.02 47.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.253 -1.34 . . . . 73.33 108.875 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.9 mtpt -91.58 -24.05 19.7 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.03 0.443 . . . . 75.13 110.071 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -153.21 138.26 17.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.937 -1.029 . . . . 74.34 109.308 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 74.5 mt -141.93 143.64 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.088 1.355 . . . . 75.23 107.593 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -155.8 139.16 15.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.343 0.592 . . . . 71.33 110.136 170.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.417 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -131.14 134.88 46.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.32 -1.733 . . . . 74.35 106.32 171.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.08 118.74 12.34 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.132 -0.692 . . . . 70.13 109.132 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -124.51 82.11 59.14 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 107.205 -1.405 . . . . 73.34 107.205 173.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.39 -29.8 20.31 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.171 1.914 . . . . 74.54 110.344 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.4 m-20 -110.14 31.69 5.7 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.904 -1.044 . . . . 72.11 109.598 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -58.58 -44.58 99.23 Favored Pre-proline 0 CA--C 1.565 1.525 0 C-N-CA 123.736 0.815 . . . . 75.53 112.276 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.64 -20.07 20.72 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 121.735 1.623 . . . . 75.13 112.786 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.4 m-70 -85.25 -20.01 30.74 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.851 0.461 . . . . 75.12 111.945 -171.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.474 HG13 ' HE2' ' A' ' 123' ' ' PHE . 9.8 p -71.61 -19.19 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 120.968 0.414 . . . . 71.13 111.297 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -78.73 -41.68 30.18 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.572 0.749 . . . . 75.03 110.745 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -75.95 -29.0 58.14 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.904 0.482 . . . . 64.03 110.63 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 33.8 mmtp -83.2 169.45 15.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.273 0.629 . . . . 75.32 110.543 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.14 128.96 37.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.557 -0.905 . . . . 75.23 108.557 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.476 ' HH2' ' NH2' ' B' ' 15' ' ' ARG . 2.8 t90 -84.78 68.31 10.4 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.148 0.975 . . . . 71.22 108.6 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.36 76.38 10.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 114.226 -1.352 . . . . 75.34 107.638 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -85.52 166.83 10.43 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.298 1.999 . . . . 73.41 111.389 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.19 128.53 42.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.35 -1.352 . . . . 70.15 107.35 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.519 0.676 . . . . 73.15 110.358 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 1.7 ttpp -116.65 115.62 26.02 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.916 -1.142 . . . . 72.21 107.916 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.15 106.48 15.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.342 -0.984 . . . . 72.42 108.342 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.576 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -109.02 111.67 23.44 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.816 -0.809 . . . . 74.31 108.816 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.43 122.6 46.94 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.564 -0.532 . . . . 74.25 109.564 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -139.03 135.25 34.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.171 0.989 . . . . 62.2 109.399 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.8 m -107.52 138.57 43.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.278 0.631 . . . . 64.31 109.607 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.29 150.22 52.24 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.659 1.183 . . . . 63.53 108.012 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.2 m -124.38 161.18 26.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.144 0.497 . . . . 74.44 111.208 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 t -150.21 147.41 27.66 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.995 1.318 . . . . 64.34 108.768 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -112.85 124.52 52.78 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.947 -0.76 . . . . 73.32 108.947 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.434 HD12 HG22 ' A' ' 83' ' ' ILE . 77.9 mt -98.72 -36.38 9.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.983 0.513 . . . . 74.4 110.471 177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.69 -174.23 4.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.584 0.754 . . . . 75.24 110.2 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.39 117.57 8.81 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 24.8 m-20 67.89 5.26 4.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.531 1.133 . . . . 64.23 112.583 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.78 104.52 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.52 -1.289 . . . . 74.3 107.52 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -122.58 146.47 47.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.499 0.666 . . . . 74.4 110.714 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 112.58 15.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.185 -1.413 . . . . 74.21 107.185 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 98' ' ' LEU . 30.8 m -102.91 126.62 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.077 -1.082 . . . . 71.54 108.077 174.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.54 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.4 t -102.97 129.39 54.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.721 0.808 . . . . 72.33 109.342 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.84 112.13 24.32 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.59 -1.263 . . . . 73.2 107.59 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -103.17 106.89 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.638 0.775 . . . . 74.13 109.883 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.32 133.3 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.836 -1.074 . . . . 73.4 109.15 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.4 m -116.34 143.13 45.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.604 -0.888 . . . . 74.04 108.604 171.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 37.1 t -133.94 130.73 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.138 -1.43 . . . . 63.25 107.138 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -132.46 139.08 47.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.007 -0.368 . . . . 74.42 110.007 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.84 105.32 12.57 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.131 -1.063 . . . . 61.42 108.131 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 49.6 m -133.24 126.21 31.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.906 0.483 . . . . 71.12 110.525 -177.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.12 86.33 4.56 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.14 -1.429 . . . . 74.32 107.14 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.99 -85.06 1.0 Allowed Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.448 -0.661 . . . . 73.15 111.448 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -118.1 -27.32 6.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 73.53 110.015 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -77.8 91.77 4.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.042 0.537 . . . . 75.41 109.853 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 85.1 m -73.79 105.97 5.31 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 122.894 0.477 . . . . 64.22 110.205 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.53 72.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.493 1.117 . . . . 53.11 110.061 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -161.35 173.07 15.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.078 -1.419 . . . . 70.41 111.548 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.429 HD11 ' H ' ' A' ' 76' ' ' CYS . 25.4 tp -142.06 147.97 37.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.67 1.588 . . . . 74.23 107.904 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.429 ' H ' HD11 ' A' ' 75' ' ' LEU . 75.2 m -144.91 140.27 28.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.449 1.1 . . . . 72.21 109.266 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -149.55 120.32 7.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.32 -0.622 . . . . 71.33 109.32 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 113' ' ' CYS . 58.7 t -128.75 113.29 28.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.622 0.769 . . . . 74.43 109.684 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.652 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.8 mt-30 -89.88 90.89 8.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.552 0.741 . . . . 74.5 109.581 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.97 98.97 8.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.224 1.01 . . . . 75.23 109.007 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -98.55 144.58 17.31 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 112.152 -0.379 . . . . 55.11 112.152 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.86 132.44 6.03 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 110.994 -0.842 . . . . 70.23 110.994 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 51' ' ' LEU . 59.0 mt -83.86 129.77 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.695 -0.854 . . . . 75.1 108.695 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -129.79 120.11 24.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.122 0.569 . . . . 72.51 109.703 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -82.8 110.85 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.88 -0.785 . . . . 75.11 108.88 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 22.3 pt -120.9 157.3 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.369 0.668 . . . . 75.23 109.973 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.93 146.64 1.56 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.471 0.708 . . . . 74.11 110.47 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.74 -25.39 23.6 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 114.963 0.745 . . . . 72.31 114.963 169.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.2 pt -109.9 134.85 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.674 0.737 . . . . 75.04 109.857 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.29 172.11 12.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.587 . . . . 70.02 109.965 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -132.95 44.51 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.213 0.321 . . . . 62.2 113.578 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 27.1 p -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.987 0.915 . . . . 75.13 112.228 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -63.98 -54.53 33.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.405 0.682 . . . . 73.23 110.38 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -24.82 39.98 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.542 -0.754 . . . . 75.34 110.785 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -70.9 -28.1 64.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.744 0.418 . . . . 72.42 111.011 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.31 -51.06 26.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.357 0.663 . . . . 74.32 109.784 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 6.1 m -73.84 -35.63 64.83 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.706 1.002 . . . . 75.35 113.706 -167.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.408 ' HB3' HG13 ' A' ' 58' ' ' VAL . 88.8 mt -87.4 -23.61 24.48 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.011 0.369 . . . . 75.25 111.003 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.15 -20.53 35.59 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 114.434 0.534 . . . . 61.42 114.434 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -138.05 -60.16 0.63 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.202 0.601 . . . . 61.12 111.59 -170.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 9.7 t80 -52.68 -56.28 16.59 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.411 1.084 . . . . 75.44 112.26 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 11' ' ' PHE . 82.2 m -74.49 -44.3 5.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.454 -1.26 . . . . 62.2 114.314 -171.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.38 -27.51 85.18 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.914 1.719 . . . . 61.34 112.439 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -73.86 -32.19 63.53 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 122.811 0.444 . . . . 72.13 110.663 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.6 mm -65.89 -42.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.706 0.802 . . . . 64.32 109.935 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.03 -18.39 60.34 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.128 -0.942 . . . . 75.41 111.292 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -70.92 -43.38 13.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.543 -1.218 . . . . 74.2 114.158 -170.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.513 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 32.1 Cg_endo -63.12 -27.51 73.35 Favored 'Trans proline' 0 C--N 1.383 2.38 0 CA-C-N 122.087 1.781 . . . . 71.13 112.363 172.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.44 -41.01 48.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.442 0.697 . . . . 74.51 111.7 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.88 75.7 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.994 -0.373 . . . . 54.12 109.994 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HD13 ' C' ' 105' ' ' ILE . 39.0 ttm180 -55.29 -49.73 71.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.547 1.155 . . . . 73.55 109.873 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.03 -47.82 84.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.188 0.93 . . . . 64.11 111.176 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.487 ' HB3' HG12 ' A' ' 78' ' ' VAL . 34.4 t -65.1 -37.01 86.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.95 0.781 . . . . 73.21 111.637 -174.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.563 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 92.3 mt -67.21 -60.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.179 -0.674 . . . . 62.35 109.179 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.479 HG21 ' HG3' ' A' ' 125' ' ' GLN . 66.4 m -50.73 -37.35 41.21 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.84 1.338 . . . . 75.53 112.309 -176.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.9 t -69.38 -43.83 72.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.71 -0.677 . . . . 72.41 110.065 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.563 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 44.0 mtm -62.9 -38.64 91.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.798 0.439 . . . . 75.24 111.063 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 114' ' ' ILE . 87.0 t -57.66 -50.24 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.34 1.025 . . . . 72.02 110.005 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -73.7 -28.53 61.78 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.644 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -70.47 -27.73 64.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.495 0.718 . . . . 74.02 109.96 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 5.99 69.82 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.748 0.655 . . . . 61.22 113.331 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m 64.87 27.98 12.78 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.833 1.253 . . . . 70.33 110.753 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.474 ' HE2' HG13 ' A' ' 31' ' ' VAL . 90.1 m-85 -97.45 153.85 38.21 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.455 1.102 . . . . 75.24 109.337 172.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -65.96 143.31 72.17 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.104 1.87 . . . . 65.31 111.37 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.479 ' HG3' HG21 ' A' ' 115' ' ' THR . 27.5 tt0 -59.07 137.67 57.85 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 124.191 0.932 . . . . 74.24 112.565 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.15 102.0 5.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.399 -0.963 . . . . 73.11 108.399 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.984 -0.747 . . . . 63.23 108.984 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.53 139.33 56.96 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 72.31 109.837 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.12 128.54 92.45 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 122.983 0.513 . . . . 73.33 111.226 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 2.7 Cg_exo -76.43 89.36 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.964 2.443 . . . . 74.23 112.456 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.61 115.02 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.808 0.843 . . . . 75.42 109.434 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.95 106.03 5.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.446 0.698 . . . . 75.32 110.314 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.97 -6.26 58.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.732 0.813 . . . . 73.31 111.978 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 2.0 m-20 . . . . . 0 N--CA 1.481 1.089 0 O-C-N 123.438 0.461 . . . . 75.32 110.519 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.507 ' HB3' HG23 ' B' ' 89' ' ' ILE . 22.5 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 116.216 1.932 . . . . 74.1 116.216 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.8 m -143.25 118.96 10.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.494 -1.685 . . . . 71.1 107.763 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.433 ' HB2' ' HE3' ' B' ' 9' ' ' MET . 59.0 t80 -120.22 134.93 55.15 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.092 -0.707 . . . . 74.52 109.092 173.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -151.19 127.79 10.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.051 -0.722 . . . . 73.44 109.051 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.407 ' H ' HD11 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -86.05 143.39 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.234 -0.654 . . . . 74.1 109.234 173.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -109.3 -48.46 3.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.032 0.533 . . . . 64.55 109.58 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.476 ' NH2' ' HH2' ' A' ' 36' ' ' TRP . 16.0 ttt180 -158.17 149.91 21.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.463 -0.335 . . . . 73.44 110.948 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -127.96 144.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.594 -1.632 . . . . 73.33 106.594 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.403 ' HE1' HG13 ' B' ' 83' ' ' ILE . 21.7 p90 -171.66 147.12 2.25 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.493 0.317 . . . . 73.13 111.342 -176.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -73.79 119.36 17.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.605 -0.887 . . . . 74.4 108.605 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -92.26 -33.69 14.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.966 0.506 . . . . 74.4 110.362 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.658 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.2 t70 -151.78 143.2 23.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.836 -168.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.1 mm -140.96 147.12 22.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.715 1.606 . . . . 75.3 107.59 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -150.33 140.27 21.93 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.888 -0.782 . . . . 52.22 108.888 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.542 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -145.65 125.2 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.506 -1.294 . . . . 74.32 107.506 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -128.54 122.46 31.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.685 0.794 . . . . 64.05 109.338 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.14 84.8 9.48 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.121 -1.437 . . . . 71.41 107.121 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.22 -31.53 35.58 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.646 2.231 . . . . 72.21 111.951 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -124.31 27.41 7.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.07 0.948 . . . . 50.34 110.138 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.504 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.14 -53.13 17.81 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 125.395 1.478 . . . . 74.32 114.741 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.21 -9.24 14.0 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.904 1.736 . . . . 74.03 112.891 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -95.68 -33.39 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.687 0.795 . . . . 72.33 110.54 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.423 HG23 ' HD2' ' B' ' 34' ' ' LYS . 8.7 p -81.36 -8.38 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.854 0.862 . . . . 74.01 110.379 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -59.29 -37.43 77.68 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.784 0.833 . . . . 74.33 110.232 171.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -69.83 -26.94 64.47 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.513 0.725 . . . . 74.54 111.168 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.423 ' HD2' HG23 ' B' ' 31' ' ' VAL . 84.7 mttt -87.02 97.45 10.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.205 0.602 . . . . 74.34 110.391 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.09 77.88 9.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.091 0.472 . . . . 61.41 110.352 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.445 ' HB2' HD13 ' B' ' 68' ' ' LEU . 17.1 m-90 -151.84 168.88 23.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.414 1.086 . . . . 75.45 108.283 176.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -86.41 115.73 63.24 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.795 -1.187 . . . . 74.45 107.795 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.44 139.67 77.89 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.248 1.966 . . . . 74.02 111.195 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.1 104.06 0.68 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.036 -0.728 . . . . 74.44 109.036 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.05 158.52 2.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.109 -0.951 . . . . 74.54 111.56 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -149.04 118.84 7.05 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.286 -1.325 . . . . 74.14 108.551 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.95 148.87 25.15 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.027 -0.731 . . . . 74.12 109.027 163.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.87 110.27 2.86 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.57 -1.271 . . . . 64.14 107.57 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.445 HD21 HG12 ' B' ' 131' ' ' VAL . 5.6 mp -101.71 152.09 21.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.932 0.893 . . . . 73.25 109.85 -174.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 13.7 t70 -145.82 144.66 30.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.198 1.399 . . . . 63.31 108.42 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -114.05 141.14 47.83 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.342 -0.614 . . . . 75.52 109.342 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.69 154.92 49.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.014 0.926 . . . . 75.41 109.026 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -145.05 163.22 34.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.328 0.651 . . . . 74.54 110.781 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -152.47 139.26 18.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.476 1.11 . . . . 70.13 108.17 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -96.27 118.02 31.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.427 -0.583 . . . . 65.4 109.427 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.453 HD12 HG22 ' B' ' 83' ' ' ILE . 33.7 mt -90.41 -39.81 12.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.691 -0.485 . . . . 74.34 109.691 176.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.92 -171.64 3.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.309 -0.86 . . . . 72.23 110.332 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.84 119.76 8.84 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 114.946 -1.024 . . . . 73.14 109.927 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.7 -1.73 1.56 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.575 1.15 . . . . 71.12 112.777 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.6 t -104.33 106.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.617 -0.882 . . . . 54.34 108.617 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.08 134.82 54.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.196 0.522 . . . . 74.53 110.224 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -100.32 97.43 8.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.482 -1.673 . . . . 65.11 106.482 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.29 124.5 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.853 0.861 . . . . 74.13 109.121 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 38.4 t -100.68 142.97 14.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.122 -0.696 . . . . 73.45 109.122 177.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -116.29 121.01 40.75 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.576 -1.268 . . . . 73.24 107.576 173.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.433 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 58.0 ttt180 -106.76 116.77 32.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.249 1.02 . . . . 74.23 109.545 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -114.79 120.23 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.963 -1.125 . . . . 75.21 107.963 171.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -116.03 133.36 56.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.227 0.611 . . . . 73.25 109.403 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.545 HG22 HG21 ' B' ' 114' ' ' ILE . 38.7 t -114.28 136.35 51.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.406 1.083 . . . . 74.3 110.586 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -125.1 145.18 50.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.672 1.189 . . . . 75.54 108.303 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.08 141.61 25.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.006 -0.738 . . . . 71.32 109.006 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 37.3 p -146.37 134.96 22.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.716 0.635 . . . . 74.11 109.829 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' B' ' 36' ' ' TRP . 14.4 tp -132.24 122.23 24.87 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.805 -0.813 . . . . 74.4 108.805 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.93 -128.21 8.32 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.868 0.73 . . . . 71.12 112.215 -174.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.67 19.62 20.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.519 0.728 . . . . 75.22 110.927 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -156.54 167.05 31.63 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.808 0.443 . . . . 74.15 111.83 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -70.56 136.39 49.24 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.406 -0.815 . . . . 74.23 110.275 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.71 -54.81 3.89 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.117 0.967 . . . . 61.11 109.22 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.73 167.58 29.12 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.267 -0.879 . . . . 75.25 110.971 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.57 145.12 34.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.868 1.667 . . . . 74.13 107.553 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -151.14 159.43 44.46 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.175 -0.676 . . . . 72.32 109.175 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.78 136.62 3.7 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.989 -0.745 . . . . 73.53 108.989 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.8 t -130.0 144.87 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.967 -0.753 . . . . 71.42 108.967 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.658 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.8 mt-30 -128.18 97.66 4.84 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.237 -0.653 . . . . 74.1 109.237 173.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.42 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -88.15 103.13 15.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.028 -0.987 . . . . 72.33 108.881 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.01 147.46 19.28 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.602 -0.599 . . . . 72.13 111.602 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.15 126.54 2.74 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.535 -0.626 . . . . 62.23 111.535 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.453 HG22 HD12 ' B' ' 51' ' ' LEU . 56.5 mt -85.57 117.95 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.412 -0.958 . . . . 72.31 108.412 174.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -124.49 167.07 14.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 74.44 109.816 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -132.47 114.59 14.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.13 0.972 . . . . 75.04 109.157 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.646 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.2 pp -118.96 135.84 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.15 0.98 . . . . 62.32 110.429 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 166.66 32.4 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.732 0.813 . . . . 70.04 109.42 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.84 -61.79 4.71 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.267 0.355 . . . . 60.11 112.398 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.665 HD12 ' SD ' ' B' ' 94' ' ' MET . 1.1 pp -56.97 150.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.877 0.871 . . . . 63.22 112.802 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.53 164.01 36.52 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.69 0.796 . . . . 75.22 110.659 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -120.72 23.69 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.803 0.689 . . . . 72.34 113.312 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.2 m -67.95 -35.23 78.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.282 0.633 . . . . 74.32 111.588 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -68.91 -43.33 75.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.103 0.561 . . . . 71.44 110.726 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.665 ' SD ' HD12 ' B' ' 89' ' ' ILE . 5.3 tpt -67.85 -43.45 79.45 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.952 -0.567 . . . . 74.53 110.327 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.57 75.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.206 0.603 . . . . 63.31 111.899 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.44 -32.0 58.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.665 0.786 . . . . 74.5 110.776 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.431 ' HB3' ' HE1' ' B' ' 94' ' ' MET . 53.7 t -70.81 -52.87 17.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.889 0.476 . . . . 64.43 111.225 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.71 -26.36 64.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.058 0.543 . . . . 75.12 110.786 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 3.15 63.24 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-O 119.246 -0.752 . . . . 53.03 114.839 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -154.11 -53.52 0.1 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.853 0.826 . . . . 70.03 112.138 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.6 -56.03 16.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.556 0.742 . . . . 60.14 111.206 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.417 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.9 m -61.51 -50.22 83.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.253 -0.879 . . . . 64.5 112.191 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.6 Cg_exo -55.06 -36.43 92.8 Favored 'Trans proline' 0 C--N 1.399 3.194 0 C-N-CA 122.287 1.991 . . . . 71.21 113.975 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.22 -33.82 76.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.65 0.38 . . . . 72.44 111.323 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.18 -44.61 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 74.22 110.446 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.458 ' HB2' HD12 ' B' ' 60' ' ' LEU . 77.3 mt -83.29 -19.4 36.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.913 -1.04 . . . . 71.34 112.637 -169.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.41 -45.84 94.58 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 117.677 -1.154 . . . . 73.33 113.689 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.61 -43.25 46.51 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.656 2.238 . . . . 74.42 113.977 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.42 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 73.7 m-85 -65.94 -44.92 83.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.873 0.733 . . . . 71.13 110.506 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.55 87.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.656 -0.702 . . . . 74.14 111.06 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.69 -53.57 54.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.044 1.338 . . . . 74.11 110.953 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -40.68 95.21 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.722 0.639 . . . . 75.45 110.223 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -66.66 -33.26 75.26 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 123.814 0.696 . . . . 73.13 111.853 -174.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.545 HG21 HG22 ' B' ' 64' ' ' VAL . 71.3 mt -68.24 -52.63 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.398 -0.593 . . . . 74.51 109.398 172.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.5 m -59.12 -28.65 66.74 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 124.176 0.922 . . . . 74.23 111.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -66.99 -53.17 34.03 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 115.297 -0.865 . . . . 70.04 109.658 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.486 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 20.6 mmt -64.3 -34.72 78.78 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 123.455 0.472 . . . . 72.44 111.95 -176.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.78 -48.39 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.906 0.882 . . . . 74.42 110.665 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -72.41 -24.22 61.2 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.872 -0.604 . . . . 64.31 111.448 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.486 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -67.5 -32.68 73.67 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.359 0.664 . . . . 72.54 109.907 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.23 8.69 75.81 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.96 0.788 . . . . 71.42 113.282 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.407 HG21 ' HB3' ' A' ' 17' ' ' TYR . 69.9 p 57.7 34.07 24.01 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.976 1.71 . . . . 73.03 113.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.22 156.27 39.07 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.808 0.843 . . . . 73.44 110.18 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 179.57 0.55 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.124 2.549 . . . . 75.15 113.542 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -56.68 113.88 1.82 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.501 -0.772 . . . . 75.42 111.254 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.22 100.91 5.78 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.486 -1.672 . . . . 73.04 106.486 172.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -131.44 134.11 45.87 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.691 -0.855 . . . . 74.1 108.691 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.3 132.93 35.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.553 0.741 . . . . 73.04 110.419 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.69 154.0 81.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.047 0.939 . . . . 73.53 110.151 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -59.98 114.18 1.97 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.931 2.421 . . . . 60.35 111.845 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.445 HG12 HD21 ' B' ' 44' ' ' LEU . 90.7 t -90.0 118.15 34.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.644 -0.707 . . . . 64.34 109.998 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.91 93.47 3.78 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.292 -0.632 . . . . 74.42 109.292 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 91.6 m-85 -62.65 -35.76 80.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.673 -1.149 . . . . 73.2 110.858 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -63.69 -39.53 94.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.516 -1.22 . . . . 75.35 110.961 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.61 -27.48 58.49 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.705 0.628 . . . . 62.12 111.807 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.121 -0.696 . . . . 71.32 109.121 178.555 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.747 0.308 . . . . 74.21 111.305 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -85.92 93.43 8.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.218 -0.66 . . . . 74.21 109.218 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.461 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.9 t80 -118.97 123.56 44.87 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.983 -1.008 . . . . 73.41 108.392 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -137.84 140.96 40.76 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.707 0.403 . . . . 72.44 110.068 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.566 HD13 HG13 ' C' ' 16' ' ' ILE . 5.6 tp -85.27 136.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.128 0.571 . . . . 75.33 109.854 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.7 mm-40 -109.55 -50.64 2.96 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.615 -0.721 . . . . 74.14 109.74 174.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -169.02 138.65 2.18 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.655 -0.702 . . . . 73.51 109.41 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.566 HG13 HD13 ' C' ' 13' ' ' ILE . 88.4 mt -122.39 144.57 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.6 -1.259 . . . . 73.44 107.6 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -174.24 165.26 4.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.364 0.602 . . . . 75.21 110.612 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.04 107.35 17.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.997 -1.001 . . . . 73.34 109.802 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.585 ' HZ1' ' HB2' ' D' ' 28' ' ' ALA . 23.6 mmmt -65.86 -35.03 79.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.761 -0.654 . . . . 74.44 109.877 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -150.53 144.4 25.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.98 -1.009 . . . . 74.24 109.549 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.3 mt -139.28 140.45 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.64 -1.615 . . . . 74.25 106.64 172.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.43 147.6 17.56 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.799 -0.445 . . . . 74.31 109.799 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -147.32 116.67 6.98 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.192 -1.04 . . . . 72.54 108.192 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.94 120.44 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.77 0.828 . . . . 74.53 108.99 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.2 85.58 54.96 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 74.2 108.583 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.12 -32.58 33.82 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.725 2.284 . . . . 75.32 111.595 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 73.6 m-20 -114.56 38.4 3.11 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.023 0.929 . . . . 70.25 109.422 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.464 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -58.83 -50.98 85.09 Favored Pre-proline 0 CA--C 1.569 1.682 0 N-CA-C 114.333 1.234 . . . . 64.21 114.333 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 7.2 Cg_exo -73.6 -28.59 11.7 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 121.871 1.714 . . . . 74.44 111.554 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.404 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 80.5 t60 -68.0 -20.67 65.04 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.33 1.052 . . . . 72.24 112.583 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -62.07 -16.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 118.117 0.417 . . . . 75.43 111.827 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.43 -43.53 76.93 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.492 -0.558 . . . . 71.33 109.492 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -92.07 51.24 1.77 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.62 1.168 . . . . 75.12 109.379 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.01 148.11 47.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.099 0.56 . . . . 74.45 110.997 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.47 129.28 37.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.19 -1.041 . . . . 72.45 108.19 164.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -83.93 69.5 10.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.799 0.809 . . . . 74.44 110.738 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.63 73.19 13.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.103 1.361 . . . . 72.43 107.46 165.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.59 118.87 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.215 1.943 . . . . 64.24 111.419 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.52 116.11 22.95 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.388 -0.968 . . . . 71.15 108.388 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.44 101.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 114.743 -1.117 . . . . 72.05 108.827 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.45 103.9 16.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 74.31 108.258 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.26 133.15 33.71 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.187 -0.671 . . . . 72.22 109.187 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.5 t70 -119.63 143.64 47.57 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.763 1.225 . . . . 73.51 108.148 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.22 148.94 49.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.668 0.787 . . . . 74.21 109.173 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -156.18 150.79 25.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.657 0.783 . . . . 62.33 109.034 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -133.88 146.59 50.71 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.849 0.46 . . . . 70.04 110.236 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.99 144.8 30.34 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.5 -0.926 . . . . 74.13 108.5 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.3 p -126.99 147.04 50.13 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.156 0.583 . . . . 70.21 110.172 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -147.14 127.81 14.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.068 0.947 . . . . 74.43 108.941 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -81.41 117.62 22.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.232 -0.655 . . . . 75.23 109.232 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.633 HD12 ' HB2' ' C' ' 57' ' ' GLU . 23.8 mt -87.94 -40.63 13.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.566 0.747 . . . . 74.15 109.974 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.37 -177.42 5.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.806 -1.088 . . . . 74.24 110.282 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.83 109.43 1.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.512 -1.222 . . . . 71.24 110.11 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 70.22 7.67 6.32 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.165 1.386 . . . . 70.24 112.895 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 70.4 t -110.32 105.74 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.352 0.661 . . . . 73.35 109.593 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.99 129.06 56.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.195 0.998 . . . . 74.33 109.989 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.633 ' HB2' HD12 ' C' ' 51' ' ' LEU . 44.9 tt0 -85.61 143.78 28.25 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.157 -0.683 . . . . 72.45 109.157 165.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 p -132.07 134.95 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.094 -1.076 . . . . 74.41 108.094 169.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.74 105.92 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.352 -0.981 . . . . 75.15 108.352 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.97 108.01 19.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.756 -1.201 . . . . 72.33 107.756 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -79.05 123.48 27.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.21 1.004 . . . . 64.14 109.136 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.88 122.33 68.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.843 -1.169 . . . . 70.02 107.843 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 19.7 m -125.62 123.87 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.601 HG23 HG21 ' C' ' 114' ' ' ILE . 97.4 t -105.0 123.6 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.516 0.726 . . . . 71.12 109.107 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -113.96 115.0 26.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.701 -0.852 . . . . 73.33 108.701 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.785 -1.561 . . . . 70.32 106.785 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -154.71 -178.11 6.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.498 0.555 . . . . 74.23 112.498 -166.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -134.3 29.99 3.6 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.198 1.399 . . . . 73.4 107.784 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.35 -108.14 1.31 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.02 -0.991 . . . . 61.32 110.972 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.34 -31.39 18.94 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.598 -0.89 . . . . 72.41 108.598 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.95 91.79 0.21 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.743 1.217 . . . . 71.3 109.839 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.3 m -89.71 128.19 36.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.417 -0.811 . . . . 73.52 111.063 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 -58.45 3.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.058 -1.09 . . . . 71.31 108.058 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.33 144.59 22.07 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.051 -0.977 . . . . 73.54 110.747 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.43 HD12 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -105.04 145.75 30.03 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.662 -1.607 . . . . 72.15 106.662 163.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.43 ' N ' HD12 ' C' ' 75' ' ' LEU . 42.2 t -150.42 143.23 24.66 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.182 -0.673 . . . . 72.11 109.182 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.09 131.9 17.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 71.45 109.95 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.86 123.52 62.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.684 -0.858 . . . . 75.44 108.684 168.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -97.84 104.33 16.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.037 -1.097 . . . . 75.42 108.037 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.462 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.9 tp-100 -91.98 114.47 27.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.17 0.588 . . . . 73.24 109.64 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.72 146.69 17.23 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.918 -0.473 . . . . 62.53 111.918 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.45 123.36 2.15 Favored Glycine 0 CA--C 1.505 -0.554 0 N-CA-C 111.302 -0.719 . . . . 72.04 111.302 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 7.1 mm -83.49 122.92 38.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.424 -0.954 . . . . 73.23 108.424 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -134.75 125.22 26.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.799 0.839 . . . . 73.22 109.633 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -80.48 109.47 15.02 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.35 -0.611 . . . . 61.33 109.35 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 60.3 mt -114.99 120.63 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.838 0.855 . . . . 71.44 109.567 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.66 163.17 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.367 1.067 . . . . 75.14 109.847 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.27 -36.41 3.42 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.283 -0.417 . . . . 73.13 112.385 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -112.75 141.23 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.647 1.179 . . . . 72.24 109.631 -173.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.95 156.39 42.2 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.615 0.766 . . . . 64.34 110.33 -175.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 -141.63 20.43 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.167 -0.47 . . . . 62.3 113.379 172.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -64.77 -28.66 69.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.805 0.842 . . . . 74.31 111.503 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.93 -46.39 89.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.871 0.868 . . . . 73.21 109.997 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.53 -35.24 75.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.985 -1.007 . . . . 73.0 110.259 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.16 -27.33 67.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.536 0.734 . . . . 72.3 111.654 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.29 -57.58 8.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.198 0.599 . . . . 74.54 110.439 171.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.0 -41.57 98.21 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.822 0.701 . . . . 75.01 111.195 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp -76.79 -27.18 55.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.413 1.085 . . . . 72.33 110.997 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.19 -5.32 46.7 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-O 119.378 -0.679 . . . . 71.14 114.325 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -135.32 -56.68 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.706 0.753 . . . . 64.34 111.59 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -68.98 -54.13 16.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.973 0.36 . . . . 72.54 111.973 -173.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.461 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 21.7 m -59.83 -46.29 98.33 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.673 -0.68 . . . . 73.23 111.317 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 56.6 Cg_exo -50.21 -39.53 52.12 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.106 2.538 . . . . 74.51 114.714 167.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.49 -23.9 61.89 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.296 0.638 . . . . 74.41 112.183 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.455 HD13 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -75.4 -33.17 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 109.596 -0.52 . . . . 75.03 109.596 172.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.509 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.7 mt -82.61 -28.36 30.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.152 0.981 . . . . 74.54 112.56 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.04 -46.16 99.89 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.535 -1.222 . . . . 73.24 113.586 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 73.9 Cg_exo -54.36 -41.63 74.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.236 1.957 . . . . 74.35 113.609 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.98 -46.31 68.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.523 0.729 . . . . 74.21 110.571 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -61.13 -40.64 94.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.512 -0.767 . . . . 72.12 111.17 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -62.26 -51.97 65.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.2 -1.364 . . . . 75.24 110.728 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.62 -31.29 70.35 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 123.607 0.567 . . . . 74.12 110.175 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.418 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.5 t -71.29 -29.88 65.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.886 0.474 . . . . 73.41 110.963 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.601 HG21 HG23 ' C' ' 64' ' ' VAL . 88.0 mt -74.32 -50.54 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.464 -0.569 . . . . 72.31 109.464 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -56.69 -33.69 66.69 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.17 0.988 . . . . 72.3 111.112 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -51.43 55.58 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.648 -1.16 . . . . 74.31 109.674 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.22 -33.87 71.51 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.631 0.772 . . . . 72.12 112.493 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.22 -48.26 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 74.11 109.717 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 70.0 p -70.61 -26.83 63.68 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.343 -0.844 . . . . 73.14 110.654 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -70.78 -34.57 71.92 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.048 -0.978 . . . . 74.23 109.766 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.01 86.89 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.216 -0.769 . . . . 43.43 113.083 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.412 HG22 ' HB3' ' D' ' 17' ' ' TYR . 73.2 p 58.04 35.13 24.94 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.88 1.672 . . . . 75.33 111.91 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 30.2 m-85 -97.73 164.46 17.45 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.096 1.358 . . . . 74.1 110.451 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -53.7 142.02 62.83 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 123.528 2.818 . . . . 72.14 113.568 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.7 115.58 3.75 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.427 1.091 . . . . 73.44 110.325 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 63.0 tp -111.57 124.03 51.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.494 1.118 . . . . 74.21 110.446 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -133.88 120.86 20.93 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.835 0.854 . . . . 71.41 109.924 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.65 140.69 29.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.328 0.651 . . . . 71.44 110.845 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 148.88 50.0 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 123.86 0.864 . . . . 63.23 110.092 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.52 145.57 37.89 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.305 2.003 . . . . 74.33 112.194 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.77 110.62 25.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.835 -1.172 . . . . 71.42 107.835 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -90.85 58.23 3.77 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.724 0.773 . . . . 74.24 109.861 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -80.97 -46.36 15.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.827 -1.079 . . . . 75.44 108.609 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.505 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 17.2 t70 . . . . . 0 C--N 1.354 0.765 0 CA-C-N 115.393 -0.821 . . . . 72.51 109.796 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 114.513 1.301 . . . . 70.12 114.513 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.435 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 30.4 m -119.97 142.05 49.11 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.794 0.837 . . . . 72.24 108.919 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' D' ' 85' ' ' SER . 83.2 t80 -150.35 108.8 3.79 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.558 -0.904 . . . . 73.21 108.558 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.41 131.52 51.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.781 0.833 . . . . 75.14 109.995 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.74 104.79 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.843 -1.169 . . . . 72.4 107.843 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -79.39 -47.65 15.38 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.98 0.733 . . . . 71.21 112.98 -170.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -159.2 121.16 3.43 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.369 -0.234 . . . . 72.22 110.369 -165.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.9 mp -105.47 129.34 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.459 -1.312 . . . . 71.42 107.459 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG22 ' C' ' 122' ' ' THR . 38.7 p90 -165.87 178.09 6.73 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-O 121.876 0.846 . . . . 70.44 112.153 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -107.82 125.58 51.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.536 -1.211 . . . . 75.53 109.488 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 28.5 mtpt -97.87 -22.3 16.43 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.608 -0.516 . . . . 65.51 109.608 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -152.03 131.63 13.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.78 -1.1 . . . . 75.24 108.835 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG23 ' HE1' ' C' ' 117' ' ' MET . 84.2 mt -134.89 142.69 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.53 -1.285 . . . . 75.32 107.53 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 24.2 t -146.77 139.27 24.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.102 0.961 . . . . 72.31 108.45 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.43 116.89 5.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.187 -1.783 . . . . 62.51 106.187 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.3 mt-10 -121.26 140.28 52.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.065 0.546 . . . . 75.22 109.602 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.97 78.89 10.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.377 -0.972 . . . . 73.24 108.377 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.67 -32.31 6.04 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.37 2.047 . . . . 64.54 111.546 175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 17.6 m-20 -100.71 31.15 3.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.525 1.13 . . . . 73.54 108.839 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.585 ' HB2' ' HZ1' ' C' ' 19' ' ' LYS . . . -59.6 -47.63 97.27 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 115.023 1.49 . . . . 64.05 115.023 -169.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.482 ' HB3' HD11 ' C' ' 83' ' ' ILE . 33.8 Cg_endo -88.87 -3.99 6.24 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.637 1.558 . . . . 75.12 112.591 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.424 ' HA ' HE21 ' D' ' 33' ' ' GLN . 21.0 t-160 -77.2 -40.95 43.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.326 1.05 . . . . 73.13 109.491 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' D' ' 73' ' ' ALA . 61.7 t -79.29 -15.89 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.677 0.791 . . . . 74.24 110.201 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -65.68 -25.99 67.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.596 0.758 . . . . 74.42 110.888 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' D' ' 30' ' ' HIS . 45.5 mt-30 -73.62 -17.96 61.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.396 0.678 . . . . 74.45 111.334 174.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -105.73 106.41 16.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.704 0.802 . . . . 72.41 109.452 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.96 51.37 2.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.792 0.837 . . . . 72.24 110.317 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -131.64 162.55 30.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.444 0.697 . . . . 75.14 109.622 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.33 110.51 29.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.302 1.041 . . . . 74.1 109.33 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.457 ' HA ' HD12 ' D' ' 68' ' ' LEU . 90.5 Cg_exo -49.21 150.98 6.78 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 124.132 3.221 . . . . 73.25 115.117 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -75.55 132.75 40.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.977 -0.749 . . . . 74.32 108.977 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.4 124.99 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.275 0.559 . . . . 75.12 110.633 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -110.49 110.71 21.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.019 -1.845 . . . . 73.35 106.019 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.9 tp -96.14 137.4 35.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.112 0.482 . . . . 74.55 110.448 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.581 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.4 m-20 -129.63 141.25 50.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.746 1.218 . . . . 75.31 108.1 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.67 147.55 44.97 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.095 -0.705 . . . . 75.51 109.095 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -154.1 145.97 23.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.351 -0.981 . . . . 72.45 108.351 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.9 t -114.28 164.87 13.32 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.092 0.557 . . . . 73.21 109.56 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.37 147.98 22.72 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.509 0.724 . . . . 63.32 109.424 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.7 p -135.12 151.98 51.21 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.056 -0.72 . . . . 71.23 109.056 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -157.1 117.1 3.48 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.18 -1.044 . . . . 71.42 108.18 -175.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -72.61 124.96 26.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.364 -0.606 . . . . 72.23 109.364 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.83 -40.69 12.28 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.69 -0.485 . . . . 72.21 109.69 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.64 4.32 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.183 -0.917 . . . . 62.42 110.327 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.34 116.97 4.66 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.21 -0.905 . . . . 72.14 110.177 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.0 2.96 4.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.391 1.476 . . . . 73.04 113.089 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.67 116.84 52.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.42 -0.956 . . . . 75.51 108.42 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.483 ' HB2' HD12 ' D' ' 86' ' ' ILE . 50.5 m-85 -129.08 127.47 41.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.628 -1.249 . . . . 75.21 107.628 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -96.13 137.23 35.5 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.035 0.934 . . . . 74.51 108.655 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.62 126.23 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.687 -1.227 . . . . 73.21 107.687 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.1 t -102.48 135.42 39.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.007 -0.738 . . . . 72.33 109.007 173.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -112.47 121.45 44.87 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.786 -0.82 . . . . 74.44 108.786 175.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -97.72 115.8 28.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.901 -0.777 . . . . 75.41 108.901 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.87 123.06 70.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.013 -1.106 . . . . 74.21 108.013 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -126.65 133.37 50.99 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.384 0.611 . . . . 62.42 110.088 -172.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 76.7 t -126.44 103.7 11.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.973 1.309 . . . . 73.33 109.118 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -97.53 93.17 6.29 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.069 -1.085 . . . . 55.43 108.069 172.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.86 133.99 41.61 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.198 -0.667 . . . . 55.34 109.198 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 59.2 p -140.78 131.7 26.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.802 0.841 . . . . 61.33 109.254 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' D' ' 38' ' ' PRO . 9.5 tp -107.12 107.63 18.7 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 75.11 108.474 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.72 -121.99 5.67 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.479 -0.782 . . . . 60.34 112.805 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.59 4.99 50.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.041 0.936 . . . . 73.34 110.981 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.36 147.21 35.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.697 0.399 . . . . 73.13 110.347 -163.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' THR . . . . . 0.456 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 99.7 m -58.48 141.53 51.47 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.785 0.834 . . . . 70.22 111.56 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.643 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -100.47 -68.14 0.82 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.602 1.161 . . . . 73.32 109.519 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.84 139.0 19.22 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.843 -0.617 . . . . 75.11 109.491 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.1 mt -101.06 152.81 20.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.95 -0.759 . . . . 75.13 108.95 173.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.649 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.5 t -159.26 143.4 15.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.826 0.45 . . . . 71.04 110.279 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -155.94 121.88 5.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.007 0.523 . . . . 74.03 109.667 171.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.03 114.86 43.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.326 0.651 . . . . 74.22 109.898 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -90.24 89.63 7.72 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.026 -0.731 . . . . 75.01 109.026 167.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.17 95.83 5.71 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.531 -1.213 . . . . 75.15 108.46 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 140.95 18.02 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.684 -0.566 . . . . 74.55 111.684 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -137.03 129.45 4.77 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.241 -1.144 . . . . 72.11 110.241 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.92 128.42 41.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.438 -0.949 . . . . 74.35 108.438 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.19 161.57 28.99 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.074 0.55 . . . . 74.44 110.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 32.8 m -116.42 108.89 16.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.984 0.914 . . . . 75.31 109.35 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.523 HG12 HD13 ' D' ' 98' ' ' LEU . 3.3 mp -109.57 119.4 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.399 0.68 . . . . 70.42 109.415 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.435 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -142.97 155.64 44.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.409 1.083 . . . . 54.33 109.226 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 -13.07 5.73 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 114.323 0.489 . . . . 70.33 114.323 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.484 HG23 HG21 ' D' ' 86' ' ' ILE . 5.5 tt -134.9 137.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.313 1.445 . . . . 72.12 107.822 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -161.56 175.15 12.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.794 0.837 . . . . 62.45 110.012 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.6 -133.38 13.04 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.255 0.347 . . . . 64.2 113.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -71.41 -38.07 71.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.149 0.979 . . . . 74.02 112.137 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.45 -32.74 70.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.149 0.579 . . . . 72.41 110.029 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.485 ' HG3' HG23 ' D' ' 86' ' ' ILE . 59.2 ttp -69.21 -37.72 78.22 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.689 -0.687 . . . . 73.24 110.363 174.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.79 70.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.095 0.558 . . . . 71.4 111.25 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -71.56 -37.67 71.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.338 0.655 . . . . 63.01 110.744 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.56 -50.19 47.18 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.927 0.491 . . . . 74.14 111.203 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.523 HD13 HG12 ' D' ' 86' ' ' ILE . 9.9 mp -75.8 -25.11 56.07 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.802 0.841 . . . . 71.15 111.573 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.38 66.43 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 119.592 -0.56 . . . . 71.13 113.511 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.14 -66.43 0.52 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.474 0.546 . . . . 63.42 112.474 -174.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -62.19 -46.08 90.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.335 0.654 . . . . 75.21 112.425 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -67.11 -44.27 48.84 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-O 118.672 -0.68 . . . . 73.23 112.316 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.528 ' HB2' ' HZ ' ' D' ' 133' ' ' PHE . 77.0 Cg_exo -54.4 -32.29 71.99 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.418 2.079 . . . . 71.31 114.482 166.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -64.51 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.28 0.491 . . . . 74.02 111.741 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -67.8 -42.91 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 121.436 0.636 . . . . 75.33 110.019 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.467 HD22 ' HA3' ' D' ' 82' ' ' GLY . 97.2 mt -77.01 -27.64 54.72 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.834 -1.076 . . . . 73.11 112.725 -171.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.74 -45.89 88.14 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.891 1.071 . . . . 65.12 113.891 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -34.76 98.3 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.714 1.609 . . . . 73.41 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.88 -34.47 51.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 75.21 111.485 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.25 -46.82 69.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.279 0.632 . . . . 71.14 110.841 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -69.86 -33.47 72.3 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.215 -0.902 . . . . 73.24 110.669 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -66.32 -42.4 88.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.305 1.003 . . . . 75.24 111.005 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -59.69 -40.04 86.56 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.739 0.65 . . . . 71.33 110.139 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.649 HG12 ' SG ' ' D' ' 76' ' ' CYS . 53.7 mt -63.29 -50.39 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.051 0.845 . . . . 72.54 110.548 173.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 50.0 m -56.43 -44.62 80.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.129 0.972 . . . . 74.43 111.464 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.8 t -65.16 -44.95 86.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 114.68 -1.145 . . . . 74.25 110.429 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.17 -31.2 72.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.737 0.415 . . . . 75.3 112.074 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.49 -41.91 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.818 0.698 . . . . 73.34 110.483 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -73.38 -24.45 60.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.669 0.271 . . . . 72.33 110.97 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.418 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 92.2 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.602 0.761 . . . . 74.31 109.582 172.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.3 -3.66 88.65 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.766 0.666 . . . . 75.24 112.399 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.4 p 58.32 30.92 20.24 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.426 1.89 . . . . 71.02 112.208 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -95.03 169.38 9.51 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.714 1.606 . . . . 73.1 110.099 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.75 130.99 43.36 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.115 2.543 . . . . 71.24 112.625 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.27 147.49 16.65 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.251 1.02 . . . . 75.2 112.255 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -135.4 95.81 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.083 0.468 . . . . 73.23 110.499 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -100.97 114.41 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.914 -1.143 . . . . 72.15 107.914 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 98.7 mt -75.94 134.71 40.14 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.773 0.321 . . . . 71.52 110.514 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.59 142.03 91.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 65.14 111.078 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.3 131.24 27.66 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.41 2.073 . . . . 74.43 111.077 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.15 127.02 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.803 0.841 . . . . 72.32 110.219 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.55 77.97 9.75 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.919 . . . . 74.23 109.18 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.528 ' HZ ' ' HB2' ' D' ' 103' ' ' PRO . 45.2 p90 . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 114.81 -1.086 . . . . 75.34 111.05 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.8 m . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 108.875 -0.787 . . . . 70.24 108.875 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -135.83 120.43 18.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.877 -1.157 . . . . 75.14 107.877 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 78.8 mt-30 -132.16 108.6 9.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.415 0.686 . . . . 72.4 109.347 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 pt -83.73 86.96 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.322 -0.992 . . . . 73.42 108.322 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -72.88 -39.53 66.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.946 -0.57 . . . . 62.34 111.496 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -172.07 146.78 2.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.317 -0.623 . . . . 73.44 109.317 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.433 HD13 ' HG2' ' C' ' 130' ' ' PRO . 94.7 mt -137.1 100.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.174 0.59 . . . . 74.42 109.433 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 26.6 m-85 -159.67 160.66 34.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.483 1.113 . . . . 74.23 110.701 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.472 HG22 ' SG ' ' A' ' 113' ' ' CYS . 30.5 p -71.64 129.18 38.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.445 -1.252 . . . . 74.14 111.117 -167.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -84.43 -38.67 19.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.416 0.627 . . . . 74.25 109.583 169.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.6 t70 -139.9 137.66 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.968 -1.014 . . . . 72.11 109.442 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.438 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 70.1 mt -132.65 146.1 33.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.077 1.351 . . . . 74.33 107.515 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.65 140.24 17.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.961 -0.755 . . . . 70.24 108.961 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 88.9 t80 -142.71 123.47 14.23 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 106.01 -1.848 . . . . 75.2 106.01 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -118.29 152.05 36.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.407 -0.96 . . . . 72.12 108.407 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.3 74.33 14.11 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.881 -1.526 . . . . 64.22 106.881 168.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.98 -20.71 25.22 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.556 2.171 . . . . 73.23 111.842 -172.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 31' ' ' VAL . 89.1 m-20 -118.46 29.93 7.49 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.425 1.09 . . . . 51.11 109.661 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -55.17 -49.47 92.09 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 113.182 0.808 . . . . 64.31 113.182 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 31.9 Cg_exo -61.99 -27.05 79.16 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.007 1.805 . . . . 72.43 113.373 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -73.41 -38.32 65.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.943 0.497 . . . . 74.01 110.502 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 27' ' ' ASN . 60.1 t -66.78 -34.44 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.524 0.73 . . . . 74.42 110.416 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -56.47 -31.09 63.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.39 1.076 . . . . 75.24 111.361 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -91.22 -45.56 8.57 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.456 1.102 . . . . 74.45 110.714 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.58 165.61 20.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.354 0.662 . . . . 74.23 112.193 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.15 126.19 28.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.845 -1.071 . . . . 54.44 110.894 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.17 82.28 7.13 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.576 -0.738 . . . . 65.34 110.21 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -142.88 79.12 14.99 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.039 -1.097 . . . . 72.53 108.039 171.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -86.65 144.07 7.49 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.616 2.211 . . . . 73.41 112.736 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -98.03 126.0 43.26 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.384 1.074 . . . . 75.14 108.151 175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.58 130.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.226 0.536 . . . . 64.1 110.749 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 63.1 tttm -119.62 112.32 19.16 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.079 -1.452 . . . . 73.4 107.079 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 mt -115.48 107.74 15.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.638 -0.875 . . . . 73.32 108.638 -167.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.8 m-20 -106.13 109.18 21.03 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 65.44 109.331 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.25 132.58 49.4 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.358 -0.608 . . . . 74.11 109.358 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.46 ' O ' HD22 ' A' ' 60' ' ' LEU . 16.3 t70 -142.55 141.65 32.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.13 0.972 . . . . 73.43 109.04 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.9 m -137.73 140.51 40.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.292 0.637 . . . . 75.25 110.428 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.93 134.73 14.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.599 0.76 . . . . 74.22 110.391 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.565 ' HB3' HG23 ' A' ' 58' ' ' VAL . 68.0 p -111.31 167.72 10.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.117 0.567 . . . . 73.34 110.297 173.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -168.58 119.13 0.76 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.583 -0.525 . . . . 65.44 109.583 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -69.09 108.07 3.43 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.252 0.621 . . . . 73.32 109.936 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -77.83 -41.59 36.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.584 0.754 . . . . 75.34 110.488 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -172.87 4.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.915 . . . . 73.12 109.779 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.28 105.18 0.31 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.976 0.51 . . . . 63.12 110.124 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 58.15 22.04 8.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.105 1.362 . . . . 74.04 112.984 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.2 t -108.33 120.82 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.089 -1.449 . . . . 71.35 107.089 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 136.09 41.2 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.813 -1.18 . . . . 75.35 107.813 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.622 ' HB2' HD13 ' A' ' 51' ' ' LEU . 30.4 tt0 -89.13 115.74 26.87 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.94 0.896 . . . . 72.33 108.789 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 48' ' ' SER . 26.9 t -99.25 110.98 27.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 107.017 -1.475 . . . . 74.12 107.017 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.566 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -99.41 119.66 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.061 0.544 . . . . 73.31 109.671 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.66 112.47 24.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.038 -1.097 . . . . 72.43 108.038 175.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -101.29 106.67 17.88 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.901 0.881 . . . . 73.44 109.443 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.99 114.37 46.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.524 1.13 . . . . 71.04 109.137 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.1 m -102.83 146.51 28.17 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 50.1 t -142.01 107.16 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.716 1.206 . . . . 70.04 108.073 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.6 m -103.14 135.83 44.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.312 -0.625 . . . . 72.24 109.312 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.59 118.37 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.552 -1.277 . . . . 73.25 107.552 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -124.32 126.2 45.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.281 -0.637 . . . . 73.23 109.281 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.61 62.91 6.05 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.82 0.819 . . . . 75.34 109.134 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.77 -106.85 1.42 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.877 -1.289 . . . . 74.14 109.877 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -115.82 -26.22 7.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.799 0.84 . . . . 74.21 110.336 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.26 132.05 37.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.911 0.484 . . . . 75.22 109.832 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -71.81 110.89 6.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.931 0.892 . . . . 62.54 110.212 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.1 -57.23 13.97 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.064 0.945 . . . . 65.25 109.598 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -161.72 173.23 14.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.013 -1.449 . . . . 72.0 109.631 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.425 HD11 ' H ' ' A' ' 76' ' ' CYS . 47.3 tp -137.62 149.36 46.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.228 1.011 . . . . 70.11 109.752 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.5 m -136.82 139.95 42.11 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 124.652 1.181 . . . . 72.2 108.694 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -150.18 129.3 12.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.483 -0.562 . . . . 72.05 109.483 172.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.86 112.51 13.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.774 0.829 . . . . 74.2 109.393 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.3 mt-30 -85.75 82.5 8.17 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.741 -0.837 . . . . 70.2 108.741 171.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.65 93.58 3.65 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.235 -1.348 . . . . 72.35 109.545 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.17 146.1 20.92 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.195 -0.457 . . . . 61.14 112.056 -177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.537 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.47 122.97 2.51 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.156 -1.178 . . . . 73.31 110.156 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.9 mt -86.08 121.74 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.731 -0.84 . . . . 74.11 108.731 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -128.68 118.97 23.79 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.967 -1.123 . . . . 72.34 107.967 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.624 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 26.7 t -94.92 86.34 4.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.067 -1.086 . . . . 75.51 108.067 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -114.72 143.39 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.232 0.613 . . . . 72.13 110.756 -175.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.65 167.47 23.11 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.172 0.989 . . . . 61.23 110.885 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -6.18 79.0 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.256 -0.884 . . . . 72.21 113.66 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.26 146.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.566 0.746 . . . . 71.04 109.779 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 172.2 14.82 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.949 0.499 . . . . 72.43 110.375 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.18 -127.55 40.48 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.264 0.353 . . . . 74.41 113.391 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -74.4 -20.44 60.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.341 0.656 . . . . 75.43 112.015 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.27 -49.69 68.62 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.459 0.704 . . . . 75.35 109.962 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 94' ' ' MET . 9.9 tmm? -75.67 -37.25 59.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.478 -1.237 . . . . 75.44 110.755 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.99 85.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.378 0.609 . . . . 70.5 110.758 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -65.7 -41.8 91.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.075 -0.966 . . . . 74.32 110.419 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.645 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.5 m -74.71 -26.91 60.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.467 0.914 . . . . 71.02 113.467 -173.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.68 -23.36 24.23 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.64 0.376 . . . . 73.14 111.149 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.47 -16.08 21.27 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.526 0.57 . . . . 71.3 114.526 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.9 -64.22 0.58 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.597 0.698 . . . . 63.1 111.636 -172.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 12.5 t80 -48.89 -65.92 0.49 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.577 1.151 . . . . 75.42 113.084 -174.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.31 -44.78 13.61 Favored Pre-proline 0 CA--C 1.559 1.317 0 CA-C-O 118.207 -0.902 . . . . 63.51 113.067 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.56 -31.82 87.43 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.839 1.693 . . . . 72.21 113.849 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -67.92 -34.13 76.03 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.131 0.423 . . . . 63.41 110.45 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.39 -41.23 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.691 0.796 . . . . 63.13 110.238 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.537 HD22 ' HA3' ' A' ' 82' ' ' GLY . 96.9 mt -70.53 -25.51 63.15 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.49 -0.777 . . . . 74.02 112.003 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -67.0 -43.23 46.19 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.675 1.361 . . . . 65.54 114.675 -167.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.4 -36.79 88.58 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.284 1.989 . . . . 72.21 113.596 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -76.07 -39.0 56.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.19 0.596 . . . . 74.34 111.523 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.38 92.4 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.58 0.352 . . . . 62.24 110.25 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.468 ' NH1' HD13 ' C' ' 105' ' ' ILE . 40.6 ttm180 -53.85 -51.81 62.41 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.813 1.32 . . . . 73.31 110.358 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.61 -42.67 99.21 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.086 -0.961 . . . . 75.33 112.022 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.472 ' SG ' HG22 ' A' ' 18' ' ' THR . 45.0 t -68.23 -39.02 82.43 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.654 0.596 . . . . 61.42 111.523 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.548 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 85.0 mt -64.51 -55.2 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.48 0.712 . . . . 72.24 109.626 176.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.503 HG23 ' HG3' ' A' ' 125' ' ' GLN . 64.8 m -58.43 -34.16 70.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.351 1.061 . . . . 73.42 111.792 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -65.28 -44.27 88.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.806 -0.634 . . . . 73.32 110.578 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.548 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 52.2 mtm -63.41 -40.75 98.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.712 0.405 . . . . 74.22 110.869 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 114' ' ' ILE . 97.1 t -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 O-C-N 124.191 0.932 . . . . 70.53 110.622 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -74.47 -31.35 62.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.943 -0.571 . . . . 72.31 111.16 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -69.44 -29.95 67.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.657 0.783 . . . . 65.31 110.042 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -3.66 82.98 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.569 -0.741 . . . . 71.44 112.985 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m 67.47 17.7 10.06 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.507 1.123 . . . . 72.1 110.783 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.54 157.12 37.7 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.911 0.884 . . . . 72.23 110.884 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.64 122.77 11.48 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.999 2.466 . . . . 74.53 112.478 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -53.17 136.52 36.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.951 1.3 . . . . 72.4 112.563 -176.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.7 mt -120.67 99.25 6.43 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.728 -0.841 . . . . 73.01 108.728 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -98.89 125.22 44.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.543 0.737 . . . . 74.11 109.391 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.21 138.26 45.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.806 0.843 . . . . 63.42 110.202 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.82 126.1 92.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.659 -0.497 . . . . 73.51 109.659 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -65.95 103.63 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.406 2.071 . . . . 73.24 112.388 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.1 143.16 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.744 0.818 . . . . 74.21 110.008 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -89.27 85.45 6.61 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.235 1.014 . . . . 74.24 110.606 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -36.5 72.5 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.65 1.18 . . . . 72.43 113.042 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 123.536 0.734 . . . . 74.1 111.334 -175.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.574 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.3 ptm . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 115.003 1.482 . . . . 62.35 115.003 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 95.9 m -154.65 136.61 14.6 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.131 1.373 . . . . 74.33 107.616 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -143.06 138.2 29.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.564 -0.532 . . . . 74.11 109.564 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.598 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 58.2 tt0 -155.16 140.82 17.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.822 0.849 . . . . 73.33 109.664 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.31 117.41 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 108.978 -0.749 . . . . 74.14 108.978 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.86 -50.3 9.35 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.803 0.274 . . . . 72.41 110.499 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -166.31 142.32 4.8 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.85 0.46 . . . . 75.21 109.822 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.5 mt -115.01 148.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.313 -1.366 . . . . 62.33 107.313 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.402 ' HE1' HG13 ' B' ' 83' ' ' ILE . 27.0 p90 -170.63 143.89 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.198 0.454 . . . . 73.23 110.973 -177.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.0 m -73.61 118.31 16.42 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.414 -0.812 . . . . 64.11 108.848 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -91.31 -29.24 17.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.567 0.747 . . . . 74.34 111.182 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.9 t70 -160.58 146.38 14.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.336 0.397 . . . . 72.15 111.19 -172.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.488 HG22 ' HE2' ' B' ' 117' ' ' MET . 46.7 mm -143.03 143.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 C-N-CA 125.975 1.71 . . . . 74.14 108.172 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.551 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.9 t -143.07 140.35 30.89 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.163 1.385 . . . . 70.44 107.285 171.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.434 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.3 t80 -151.64 126.78 9.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.316 -1.365 . . . . 73.35 107.316 171.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 138.46 53.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.901 0.88 . . . . 70.31 108.995 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.37 81.41 70.19 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 107.044 -1.465 . . . . 72.51 107.044 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.49 -26.0 55.16 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.805 2.337 . . . . 74.2 111.979 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -126.48 32.92 5.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.361 1.064 . . . . 75.24 109.514 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.424 ' O ' HG12 ' B' ' 31' ' ' VAL . . . -47.54 -50.09 51.93 Favored Pre-proline 0 CA--C 1.565 1.538 0 C-N-CA 124.504 1.122 . . . . 72.13 113.347 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.484 ' HG2' ' HD1' ' B' ' 30' ' ' HIS . 58.4 Cg_endo -72.61 -12.06 26.6 Favored 'Trans proline' 0 C--N 1.391 2.763 0 C-N-CA 121.769 1.646 . . . . 74.02 113.774 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.484 ' HD1' ' HG2' ' B' ' 29' ' ' PRO . 29.3 m80 -97.07 -22.27 16.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.622 0.769 . . . . 73.42 112.515 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.424 HG12 ' O ' ' B' ' 28' ' ' ALA . 8.3 p -68.63 -23.88 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.808 0.443 . . . . 74.22 112.1 -174.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.91 -29.91 71.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.396 0.678 . . . . 75.23 111.53 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.47 -30.77 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.285 0.634 . . . . 72.5 110.419 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.39 94.55 7.12 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 74.24 111.548 -172.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -94.19 81.1 4.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.361 0.665 . . . . 64.52 109.269 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -151.12 162.03 41.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.688 1.195 . . . . 75.4 108.517 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -75.05 113.84 28.97 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.222 1.009 . . . . 75.52 109.354 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.676 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 69.7 Cg_endo -71.92 147.47 49.65 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.348 2.032 . . . . 74.41 111.017 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 37.6 tt0 -51.7 106.43 0.14 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.588 0.755 . . . . 73.12 110.449 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.52 122.34 37.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.517 -1.29 . . . . 75.15 107.517 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -149.09 104.23 3.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.897 -0.592 . . . . 73.5 109.497 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.8 147.25 23.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.366 -0.833 . . . . 75.11 109.225 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -136.71 145.8 45.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.404 1.082 . . . . 61.11 108.096 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.61 163.04 22.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.146 -0.687 . . . . 71.51 109.146 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.0 t70 -164.04 139.21 6.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.832 -1.076 . . . . 71.31 108.946 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -122.43 115.63 22.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.546 0.738 . . . . 72.0 110.211 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -120.51 160.01 24.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 73.3 109.466 174.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 169.04 18.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.279 1.032 . . . . 75.2 109.354 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 1.5 m -149.42 135.11 18.64 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.395 -0.965 . . . . 72.34 108.395 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.85 100.44 12.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.285 -1.006 . . . . 75.15 108.285 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.9 mt -78.85 -31.28 45.62 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.603 -0.726 . . . . 73.31 110.315 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.72 -171.49 1.63 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.072 0.949 . . . . 73.41 110.648 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.96 124.86 24.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.798 -1.092 . . . . 64.12 109.533 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.37 -4.91 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.89 1.276 . . . . 64.32 112.31 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.73 97.16 5.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.602 0.761 . . . . 64.14 109.118 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -102.51 170.82 7.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.542 0.737 . . . . 73.02 110.131 172.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 8.8 tm-20 -145.76 103.01 3.74 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.018 -1.105 . . . . 75.44 108.018 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.07 125.9 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.178 0.591 . . . . 75.11 110.389 -175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.61 ' HB ' ' HB1' ' B' ' 47' ' ' ALA . 32.3 t -103.98 111.82 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.933 0.893 . . . . 75.45 109.147 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.72 110.23 22.1 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.041 -1.096 . . . . 72.42 108.041 176.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 66.8 ttt180 -97.23 116.23 29.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.344 0.658 . . . . 73.13 109.921 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -114.03 120.92 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.217 -1.031 . . . . 75.32 108.217 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.0 m -114.61 136.97 52.46 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.703 0.801 . . . . 72.25 109.191 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.578 HG22 HG21 ' B' ' 114' ' ' ILE . 52.8 t -115.99 132.9 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.588 1.155 . . . . 74.31 109.646 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -127.21 144.38 51.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.465 0.706 . . . . 65.4 109.667 170.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -143.76 150.85 39.2 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.362 -0.835 . . . . 73.14 110.333 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 m -134.78 136.8 42.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.21 0.604 . . . . 75.35 110.951 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 31.4 mt -129.95 99.59 5.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.282 1.033 . . . . 74.33 108.924 172.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -132.79 16.46 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.38 -0.827 . . . . 71.12 113.091 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -93.18 21.46 5.9 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.824 0.85 . . . . 72.41 111.364 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.74 161.07 41.38 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 123.834 0.853 . . . . 73.45 109.179 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -76.98 134.81 38.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.971 -0.559 . . . . 71.2 110.005 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.27 -65.59 0.94 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.488 -0.93 . . . . 75.13 108.488 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -155.38 160.37 40.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.757 . . . . 75.42 111.053 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -133.07 135.21 45.19 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.47 1.508 . . . . 74.32 107.093 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.3 t -139.15 158.06 44.85 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.362 -0.977 . . . . 53.04 108.362 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -165.28 128.04 2.18 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.146 -0.687 . . . . 75.11 109.146 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.1 t -126.01 146.55 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.832 0.853 . . . . 72.21 108.961 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -123.85 96.41 4.94 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.231 -1.026 . . . . 74.12 108.231 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.501 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -85.55 100.4 11.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.377 -0.971 . . . . 74.14 108.377 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.55 169.41 35.72 Favored Glycine 0 C--O 1.244 0.775 0 N-CA-C 111.163 -0.775 . . . . 64.02 111.163 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.8 128.63 1.65 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.44 -0.664 . . . . 63.11 111.44 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' B' ' 17' ' ' TYR . 38.3 mt -84.73 126.81 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.677 -0.861 . . . . 71.31 108.677 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -132.1 133.17 44.02 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.318 1.047 . . . . 75.2 108.658 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.598 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 26.6 m -93.3 97.59 10.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.802 -0.814 . . . . 72.44 108.802 173.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.617 HG12 HD12 ' B' ' 98' ' ' LEU . 2.6 pp -115.6 140.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.282 1.033 . . . . 74.43 110.463 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.37 172.35 18.5 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.901 0.88 . . . . 62.24 109.495 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.62 -58.65 5.02 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.249 -0.195 . . . . 44.44 112.642 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.484 HD12 ' HE2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -55.01 127.49 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.519 0.728 . . . . 71.32 110.97 174.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.67 161.74 39.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 72.42 109.698 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.68 -131.32 10.96 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.908 -0.587 . . . . 65.45 112.225 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -76.39 -35.69 58.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.69 0.796 . . . . 73.3 110.944 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -64.71 -28.63 69.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.166 -0.925 . . . . 71.45 112.043 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.563 ' HE3' HD21 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.453 0.701 . . . . 74.43 110.106 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.6 78.63 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.384 -0.825 . . . . 64.23 111.461 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -79.07 -23.7 44.01 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.607 0.763 . . . . 74.13 111.246 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.27 -66.32 0.91 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.582 0.353 . . . . 70.3 110.501 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.617 HD12 HG12 ' B' ' 86' ' ' ILE . 14.0 tp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.845 0.458 . . . . 75.24 111.451 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.28 -21.64 58.31 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.806 -0.634 . . . . 75.51 113.728 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.14 -56.0 2.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.306 0.553 . . . . 72.11 111.768 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -68.52 -43.69 76.23 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.564 0.54 . . . . 74.52 112.359 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.532 ' SG ' HD13 ' B' ' 98' ' ' LEU . 75.3 m -63.73 -49.36 76.86 Favored Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 118.298 -0.858 . . . . 65.41 111.533 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.521 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 88.0 Cg_exo -56.73 -33.02 93.02 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.115 1.876 . . . . 75.1 114.143 168.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.38 -31.8 72.27 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.088 0.555 . . . . 73.35 110.859 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.91 -48.43 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.831 0.853 . . . . 73.35 109.615 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.4 mt -82.27 -12.64 57.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.326 -0.852 . . . . 75.31 111.919 -169.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.59 -47.91 55.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 117.78 -1.105 . . . . 75.53 113.049 -174.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.43 -36.09 98.81 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 121.909 1.739 . . . . 73.43 113.313 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.501 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 43.3 m-85 -70.51 -45.58 65.31 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.649 0.78 . . . . 75.35 110.474 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.05 99.49 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.7 0.8 . . . . 74.13 110.264 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -56.86 -54.96 40.47 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.83 1.652 . . . . 75.41 111.589 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.3 -31.94 73.34 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.733 0.646 . . . . 71.25 110.032 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.529 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.5 t -68.09 -41.97 81.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.536 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.578 HG21 HG22 ' B' ' 64' ' ' VAL . 62.8 mt -63.79 -51.88 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.133 0.573 . . . . 73.41 110.085 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.6 m -58.27 -34.24 70.28 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.139 0.976 . . . . 75.35 111.072 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.9 t -64.41 -54.65 29.4 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.129 -0.941 . . . . 72.21 109.414 173.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.9 mmt -61.88 -33.86 74.97 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.133 0.573 . . . . 63.31 112.13 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.9 -46.82 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.709 0.804 . . . . 75.41 110.934 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 74.7 p -70.01 -25.29 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.584 0.353 . . . . 71.14 110.999 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 85.1 mtt-85 -69.85 -20.23 63.42 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 118.783 -0.627 . . . . 73.44 111.172 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.2 12.18 61.95 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.12 -0.822 . . . . 70.35 114.365 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 17' ' ' TYR . 2.7 p 72.54 14.54 5.2 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.936 1.694 . . . . 72.12 112.169 -177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -91.14 154.18 44.86 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 122.725 0.41 . . . . 73.1 111.125 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -55.16 149.5 44.14 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 123.321 2.681 . . . . 65.33 113.06 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -59.02 123.25 15.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.39 1.076 . . . . 71.31 111.592 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.07 100.99 7.69 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.121 -1.066 . . . . 70.44 108.121 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -99.8 117.67 34.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 74.42 109.189 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.79 134.93 37.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.171 0.588 . . . . 74.23 110.16 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.05 139.81 36.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.801 0.84 . . . . 74.12 110.398 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.6 99.53 0.45 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.907 2.405 . . . . 74.54 111.972 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -90.81 126.07 43.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.753 -0.832 . . . . 75.13 108.753 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.23 113.23 11.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.531 -0.914 . . . . 70.0 108.531 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -63.88 -20.89 66.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.662 0.785 . . . . 74.03 110.859 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.079 1.352 . . . . 73.1 109.735 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.64 -31.31 63.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.481 -1.236 . . . . 73.35 110.682 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 N--CA 1.486 1.331 0 C-N-CA 123.141 0.576 . . . . 75.14 110.075 176.823 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.467 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 54.0 ttp . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 121.291 0.567 . . . . 73.11 111.812 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.8 m -99.79 87.39 3.52 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.501 -1.296 . . . . 74.15 107.501 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -89.09 133.12 34.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.367 -0.833 . . . . 75.32 109.233 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 7.9 tt0 -151.81 144.95 24.6 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.937 -0.764 . . . . 73.14 108.937 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.429 HD13 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -92.52 136.88 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.386 -0.598 . . . . 74.35 109.386 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -105.24 -50.06 3.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.642 0.777 . . . . 74.04 110.281 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -163.18 142.64 8.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.049 0.54 . . . . 74.41 109.549 -173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.429 HG13 HD13 ' C' ' 13' ' ' ILE . 79.8 mt -128.24 134.84 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.417 -1.327 . . . . 74.31 107.417 174.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -171.16 153.79 3.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 73.25 111.336 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -79.11 120.74 24.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.168 -0.923 . . . . 74.12 109.471 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -74.26 -49.01 25.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.321 -0.992 . . . . 75.14 108.321 170.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -134.39 138.33 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.747 -1.569 . . . . 60.24 109.135 -167.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -142.73 139.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.711 -1.588 . . . . 75.22 106.711 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.88 149.52 18.15 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.83 -0.433 . . . . 53.23 109.83 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -154.34 108.8 3.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.124 -1.065 . . . . 74.25 108.124 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.79 122.13 42.61 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.076 -0.713 . . . . 65.14 109.076 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.81 93.42 20.51 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 108.423 -0.955 . . . . 75.22 108.423 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.68 -49.45 8.65 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.108 2.538 . . . . 63.24 111.697 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' C' ' 72' ' ' THR . 68.4 m-20 -103.79 53.19 0.75 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.429 -0.805 . . . . 74.11 109.036 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' HE3' ' D' ' 19' ' ' LYS . . . -59.11 -52.99 70.78 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.982 1.104 . . . . 73.15 113.982 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 39.4 Cg_exo -63.81 -21.72 69.28 Favored 'Trans proline' 0 C--N 1.398 3.139 0 C-N-CA 122.185 1.924 . . . . 73.31 112.909 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.431 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 13.6 m-70 -64.64 -18.95 65.41 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.291 1.036 . . . . 74.23 113.133 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.46 -37.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.087 0.955 . . . . 73.02 113.494 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -81.14 -36.4 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.054 0.941 . . . . 60.44 111.091 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -85.17 4.64 33.53 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 125.293 1.437 . . . . 71.12 111.08 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.617 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.2 ttmp? -107.81 153.18 23.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.376 1.07 . . . . 74.04 111.024 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.25 114.23 19.0 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.06 -1.459 . . . . 73.34 107.06 166.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -85.32 61.47 6.88 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.141 0.972 . . . . 74.41 112.504 -168.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -150.23 58.74 3.26 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.011 1.325 . . . . 73.14 107.598 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.47 160.8 31.85 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.011 1.807 . . . . 71.33 111.364 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.45 103.94 13.2 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.896 -1.15 . . . . 71.34 107.896 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.82 97.41 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 114.963 -1.017 . . . . 65.11 108.642 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.483 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 50.7 mtpt -95.77 105.64 17.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.996 -0.742 . . . . 74.25 108.996 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -87.04 149.1 24.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.901 0.881 . . . . 73.31 109.609 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.3 t70 -149.17 127.41 12.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.314 -0.995 . . . . 72.35 108.314 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.78 149.68 50.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.228 0.467 . . . . 73.23 110.769 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 17.5 m-20 -140.81 161.1 38.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 64.35 109.826 176.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -130.48 136.06 48.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.054 0.941 . . . . 72.11 108.473 171.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -131.51 172.51 12.13 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.124 0.97 . . . . 74.13 108.507 176.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.7 p -164.61 160.14 19.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.927 0.491 . . . . 75.34 111.112 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -167.34 138.21 3.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.061 0.944 . . . . 74.04 109.452 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -77.87 117.5 19.29 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.88 -0.785 . . . . 75.23 108.88 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' C' ' 57' ' ' GLU . 40.5 mt -87.27 -37.97 16.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.734 0.413 . . . . 74.22 110.608 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.459 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -159.23 -172.05 3.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.262 -0.881 . . . . 71.33 110.682 -174.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.67 111.56 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.01 -0.995 . . . . 73.24 109.681 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 64.09 15.9 9.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.831 1.252 . . . . 71.43 112.314 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 89.1 t -118.0 103.79 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.298 -1.001 . . . . 74.33 108.298 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' C' ' 86' ' ' ILE . 14.9 m-85 -117.95 139.17 51.54 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.907 0.883 . . . . 72.42 108.959 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.684 ' HB2' HD12 ' C' ' 51' ' ' LEU . 35.2 tt0 -100.3 146.14 27.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.843 0.857 . . . . 74.23 109.355 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.38 144.33 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.747 -0.835 . . . . 75.44 108.747 165.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 58.2 t -119.63 107.14 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.886 0.875 . . . . 71.51 109.127 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -90.25 99.91 12.84 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.074 -1.084 . . . . 73.35 108.074 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 75.6 ttt-85 -84.53 134.82 34.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.858 0.863 . . . . 74.24 109.385 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -129.05 148.13 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.794 -1.187 . . . . 73.04 107.794 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 57.5 m -138.9 135.35 34.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 75.31 107.5 171.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.635 HG23 HG21 ' C' ' 114' ' ' ILE . 47.1 t -118.36 113.33 41.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 107.659 -1.237 . . . . 75.31 107.659 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.1 m -98.33 134.35 41.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.749 -1.204 . . . . 74.5 107.749 171.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 94.82 3.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.231 -1.396 . . . . 74.12 107.231 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 14.1 m -144.76 143.48 30.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.279 0.632 . . . . 62.24 109.692 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.03 10.17 39.8 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.493 0.717 . . . . 70.55 109.578 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.27 -95.63 0.4 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.395 -1.082 . . . . 63.53 110.395 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.48 -32.98 16.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 74.11 109.261 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 8.7 tp10 -83.67 91.28 7.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.874 0.87 . . . . 61.32 109.484 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 28.3 m -86.75 135.88 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.284 -0.871 . . . . 73.32 110.232 -178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.59 -65.03 1.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.669 -0.863 . . . . 74.55 108.669 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.36 175.5 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.907 0.86 . . . . 74.13 112.332 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.455 HD23 HG21 ' C' ' 65' ' ' THR . 2.5 tm? -137.34 135.6 37.2 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 105.219 -2.141 . . . . 53.52 105.219 169.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.2 t -144.73 117.84 8.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.841 0.456 . . . . 70.21 109.983 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -121.06 131.35 54.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.03 135.41 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.194 0.998 . . . . 75.51 108.488 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.6 mt-30 -115.04 103.2 10.66 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.567 -0.901 . . . . 75.35 108.567 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.34 110.02 18.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.587 0.755 . . . . 74.32 109.618 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.02 146.65 22.14 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.178 -0.769 . . . . 70.12 111.178 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.51 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.52 118.66 0.99 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.913 -0.475 . . . . 74.12 111.913 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.482 HD13 HD12 ' C' ' 51' ' ' LEU . 8.7 mm -87.72 119.36 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.917 -0.771 . . . . 72.15 108.917 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -129.36 128.7 43.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.9 0.88 . . . . 74.34 109.237 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 24.5 m -70.82 108.74 4.62 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.305 -0.628 . . . . 73.4 109.305 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' C' ' 56' ' ' TYR . 43.5 mm -114.36 101.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.21 -1.034 . . . . 75.35 108.21 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.53 150.05 51.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.97 0.908 . . . . 72.32 109.754 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.37 28.76 Favored Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.349 0.5 . . . . 70.14 114.349 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' C' ' 9' ' ' MET . 17.8 tt -108.57 151.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.331 1.052 . . . . 74.53 110.134 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -164.13 154.68 15.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.185 0.594 . . . . 75.32 110.756 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.83 -148.61 19.31 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.369 0.509 . . . . 74.32 112.243 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.9 p -65.89 -21.18 66.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.946 0.898 . . . . 75.51 111.115 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -61.53 -51.1 70.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.173 0.989 . . . . 74.41 109.95 170.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 53.3 ttm -66.47 -35.82 81.22 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.901 -0.59 . . . . 75.13 110.376 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.2 95.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.497 0.719 . . . . 73.41 111.487 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' C' ' 134' ' ' ASP . 56.5 t-80 -68.5 -23.74 64.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.251 -0.886 . . . . 74.12 111.415 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 99.6 m -82.7 -51.33 7.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.221 0.608 . . . . 74.54 110.896 173.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.74 -42.67 66.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.735 1.214 . . . . 74.44 111.314 -163.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.61 11.53 46.45 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.02 -0.537 . . . . 73.24 113.438 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -146.12 -73.44 0.23 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.505 0.652 . . . . 73.22 111.963 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.557 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 92.0 t80 -65.22 -53.55 42.81 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.308 0.855 . . . . 74.11 113.308 -168.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.421 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 31.9 m -61.04 -44.55 94.75 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 123.126 0.57 . . . . 70.03 111.835 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 87.9 Cg_exo -55.23 -33.59 85.12 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.654 2.236 . . . . 75.12 114.536 166.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.19 -25.15 65.09 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 123.048 0.539 . . . . 74.24 111.762 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.468 HD13 ' NH1' ' A' ' 111' ' ' ARG . 38.4 mm -69.0 -39.67 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.476 -0.564 . . . . 74.31 109.476 171.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.51 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.5 mt -76.93 -26.89 54.58 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.843 -1.071 . . . . 73.21 111.811 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -56.03 -47.09 99.52 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.405 1.082 . . . . 72.44 113.807 -173.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.78 -40.16 86.22 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.031 1.821 . . . . 70.13 113.542 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.38 -45.76 71.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.224 0.61 . . . . 74.34 110.712 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.4 82.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.713 0.805 . . . . 74.24 110.665 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -65.83 -49.45 68.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.411 -1.268 . . . . 75.01 110.658 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.09 -29.74 66.79 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.416 0.686 . . . . 72.04 110.673 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.8 t -65.61 -40.43 92.61 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.408 0.683 . . . . 72.15 110.12 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.635 HG21 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -67.9 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.867 -0.606 . . . . 75.21 110.133 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 62.3 m -58.24 -29.56 65.85 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.823 0.849 . . . . 74.11 111.011 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.9 -51.51 18.31 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.37 -0.832 . . . . 75.44 109.715 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.563 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.17 -39.51 60.16 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.806 0.842 . . . . 72.3 112.369 177.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.463 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.6 t -68.85 -44.92 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.389 0.676 . . . . 73.1 110.259 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.07 -28.61 66.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.281 0.562 . . . . 74.41 110.926 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -67.21 -37.19 83.21 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 114.71 -1.132 . . . . 73.12 110.05 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.62 83.74 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 119.352 -0.693 . . . . 73.32 112.952 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.488 HG22 ' HB3' ' D' ' 17' ' ' TYR . 64.0 p 58.96 25.36 13.69 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.237 1.815 . . . . 73.21 112.833 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.433 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 84.3 m-85 -93.21 160.43 33.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.298 1.039 . . . . 74.31 108.923 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.06 117.46 4.47 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.716 2.277 . . . . 70.24 112.418 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.12 134.72 44.17 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.467 1.107 . . . . 64.31 112.414 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.59 107.35 18.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.948 -1.13 . . . . 73.0 107.948 -174.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.67 100.64 13.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.266 -1.013 . . . . 73.02 108.266 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 134.36 48.63 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.339 0.655 . . . . 73.22 110.079 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.66 99.06 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.773 0.829 . . . . 75.31 110.974 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.433 ' HG2' HD13 ' A' ' 16' ' ' ILE . 24.0 Cg_exo -64.18 87.19 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.84 2.36 . . . . 72.01 112.702 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.33 111.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.682 -0.859 . . . . 75.52 108.682 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -109.44 103.12 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.962 -0.755 . . . . 63.13 108.962 -177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.19 -29.24 69.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.21 1.004 . . . . 75.33 111.561 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.407 ' HB2' ' CE1' ' C' ' 96' ' ' HIS . 4.8 p-10 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 123.584 0.753 . . . . 75.21 110.584 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.426 ' HG3' HG13 ' D' ' 89' ' ' ILE . 6.0 ttp . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 114.004 1.112 . . . . 72.21 114.004 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -139.32 136.8 35.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.778 0.831 . . . . 75.22 109.037 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -152.97 93.78 1.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 74.33 107.518 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.3 mt-30 -114.51 153.61 29.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.562 -0.744 . . . . 73.21 109.587 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.57 131.07 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.95 0.9 . . . . 74.21 109.16 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -109.42 -49.57 3.1 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.363 0.528 . . . . 63.3 111.909 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.31 121.08 0.73 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.509 0.559 . . . . 75.32 112.509 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.493 ' N ' HD13 ' D' ' 16' ' ' ILE . 1.7 mp -108.6 133.52 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.653 -1.239 . . . . 73.25 107.653 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.488 ' HB3' HG22 ' C' ' 122' ' ' THR . 36.1 p90 -161.89 176.05 11.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.911 0.862 . . . . 73.01 112.021 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -107.07 117.87 35.21 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.778 -1.101 . . . . 74.12 109.265 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 33.6 mtpt -85.47 -25.24 27.02 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.287 -0.634 . . . . 74.5 109.287 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.1 t70 -148.32 141.03 24.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.328 1.051 . . . . 63.03 109.869 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.563 HG23 ' HE1' ' C' ' 117' ' ' MET . 46.1 mt -138.41 142.96 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.445 1.498 . . . . 73.55 107.713 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -148.01 137.09 22.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.233 1.013 . . . . 73.33 108.852 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.561 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.4 t80 -153.86 119.54 5.25 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.117 -1.438 . . . . 75.25 107.117 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.0 118.54 19.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.394 0.677 . . . . 73.23 109.57 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.75 90.2 12.49 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.703 -0.851 . . . . 73.21 108.703 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.61 -46.44 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.964 2.443 . . . . 74.52 112.829 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 77.4 m-20 -103.31 43.51 1.08 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.279 1.032 . . . . 54.54 108.26 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.46 64.95 Favored Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 114.795 1.406 . . . . 74.32 114.795 -168.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.67 -3.86 12.0 Favored 'Trans proline' 0 C--N 1.393 2.88 0 CA-C-N 121.806 1.681 . . . . 74.32 113.865 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -84.6 -40.17 17.84 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.896 0.878 . . . . 65.14 110.454 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -82.26 -14.05 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.755 0.822 . . . . 74.23 109.923 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.21 -28.76 70.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.377 1.071 . . . . 74.15 110.96 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 61.0 mt-30 -72.64 -7.66 51.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.39 1.076 . . . . 75.3 111.293 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -111.78 111.81 23.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.423 1.089 . . . . 75.52 109.877 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.63 63.4 7.54 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.705 0.802 . . . . 71.34 110.052 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.468 ' HB3' HD21 ' D' ' 68' ' ' LEU . 65.7 t-105 -150.58 166.87 28.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.826 -0.805 . . . . 75.14 108.826 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.74 108.69 27.1 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.118 0.967 . . . . 75.41 110.471 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -43.24 144.94 1.55 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 124.506 3.471 . . . . 74.21 115.612 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.73 118.37 15.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.569 -0.741 . . . . 72.31 110.379 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.451 HG11 HG13 ' D' ' 64' ' ' VAL . 99.1 t -109.23 125.33 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.877 0.871 . . . . 73.52 111.02 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -111.54 120.95 43.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.68 -1.23 . . . . 74.31 107.68 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 155.66 16.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.403 -0.962 . . . . 74.1 108.403 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.6 t70 -143.59 140.89 30.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.887 0.875 . . . . 74.13 108.963 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.9 153.44 31.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.275 0.63 . . . . 75.42 110.544 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.9 t0 -165.75 152.7 10.04 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.579 1.152 . . . . 71.41 108.781 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -125.08 164.52 20.03 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.31 0.576 . . . . 74.11 110.279 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -156.86 167.53 30.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.529 1.131 . . . . 70.0 108.465 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.4 p -161.6 154.34 20.42 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.971 0.508 . . . . 61.03 110.97 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -154.95 149.62 26.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.513 1.125 . . . . 74.4 108.832 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -91.34 118.53 30.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.548 -0.908 . . . . 74.33 108.548 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.54 -38.49 12.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.099 0.56 . . . . 71.23 109.995 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.72 -177.11 6.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.662 0.744 . . . . 64.22 111.013 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.66 125.64 29.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.74 -1.118 . . . . 73.1 110.083 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 63.8 10.58 5.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.304 1.442 . . . . 72.4 112.308 -172.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.1 t -123.76 120.07 58.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.787 0.835 . . . . 74.55 109.025 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.497 ' HD1' ' HB ' ' D' ' 86' ' ' ILE . 64.3 m-85 -132.88 130.03 39.18 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.778 -0.823 . . . . 74.35 108.778 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.9 138.82 31.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.199 1.0 . . . . 65.22 108.888 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.66 123.92 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.228 -1.397 . . . . 73.34 107.228 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 48.1 t -102.25 130.73 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 75.4 108.808 175.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.5 117.93 35.28 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.575 -1.268 . . . . 72.51 107.575 176.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -96.58 107.2 19.58 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.727 -1.212 . . . . 74.54 107.727 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.15 129.91 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.448 -0.945 . . . . 75.12 108.448 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -116.71 147.55 41.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.919 0.888 . . . . 73.34 109.65 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 23.7 t -134.11 128.72 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 73.54 108.442 174.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -124.83 119.64 29.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.08 139.3 53.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.311 0.644 . . . . 74.53 109.634 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 41.7 p -155.49 129.13 8.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.62 0.768 . . . . 70.04 109.415 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' D' ' 36' ' ' TRP . 15.5 tp -113.54 111.61 22.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.504 -0.925 . . . . 71.33 108.504 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.97 -144.98 26.73 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.876 0.735 . . . . 63.34 111.88 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.37 2.88 34.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.611 0.764 . . . . 64.25 112.021 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.1 pt-20 -123.81 152.16 42.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.777 0.831 . . . . 74.31 110.423 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 80.9 m -74.07 136.04 43.03 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.61 0.569 . . . . 73.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.58 -54.8 3.74 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.918 0.887 . . . . 73.24 109.436 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -161.52 164.04 29.85 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.78 -1.1 . . . . 73.2 109.312 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.79 152.53 50.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.102 1.361 . . . . 74.22 107.803 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.623 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.4 t -159.63 142.94 14.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.732 0.413 . . . . 62.32 110.784 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.45 127.54 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.169 0.588 . . . . 75.44 109.562 168.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.2 115.82 42.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 123.617 0.767 . . . . 75.4 109.549 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.702 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.3 mt-30 -89.86 87.13 6.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.867 0.841 . . . . 72.14 108.874 170.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.35 95.75 6.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 113.612 -1.631 . . . . 73.15 109.429 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 142.76 18.35 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.173 -0.371 . . . . 74.54 112.173 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.05 131.95 4.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.545 -0.622 . . . . 51.21 111.545 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.45 123.28 44.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 124.488 1.115 . . . . 65.52 108.78 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -126.16 131.77 51.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.935 0.894 . . . . 75.54 109.635 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 9.8 m -80.59 94.51 6.31 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.641 -0.874 . . . . 61.13 108.641 173.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.497 ' HB ' ' HD1' ' D' ' 56' ' ' TYR . 69.9 mt -108.5 111.02 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 71.55 109.205 -175.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.64 128.81 15.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.634 0.774 . . . . 64.2 109.822 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.76 50.13 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-O 119.756 -0.469 . . . . 62.33 113.705 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.436 HD11 HG23 ' D' ' 86' ' ' ILE . 2.9 mp -95.8 126.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.706 -1.591 . . . . 75.33 106.706 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.26 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.751 0.82 . . . . 75.21 111.35 -169.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.31 -141.84 39.89 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.039 -0.982 . . . . 72.12 112.719 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -90.38 -16.33 29.32 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.649 0.78 . . . . 74.42 110.02 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.46 -33.37 72.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.583 1.153 . . . . 73.32 111.123 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -64.1 -33.16 75.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.996 0.519 . . . . 74.32 111.694 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.58 80.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.201 0.6 . . . . 75.1 110.427 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -72.78 -36.19 67.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.907 -0.588 . . . . 71.51 110.925 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -64.33 -43.29 95.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.794 0.437 . . . . 55.11 110.053 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.6 tp -72.73 -35.98 67.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.175 0.99 . . . . 73.03 111.336 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.14 53.98 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.446 -0.641 . . . . 51.54 114.434 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.92 -60.27 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.741 0.77 . . . . 61.43 111.873 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.22 -46.13 85.19 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.364 0.666 . . . . 73.51 112.145 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 33.4 m -71.62 -45.3 12.78 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-O 118.558 -0.734 . . . . 72.03 112.03 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.8 Cg_exo -57.82 -29.06 84.75 Favored 'Trans proline' 0 C--N 1.399 3.226 0 C-N-CA 122.446 2.097 . . . . 75.45 113.915 169.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.86 -32.29 73.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.262 0.625 . . . . 74.31 110.702 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.23 -34.56 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 123.661 0.785 . . . . 74.42 110.186 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.448 HD22 ' HA3' ' D' ' 82' ' ' GLY . 74.6 mt -82.5 -17.76 43.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.23 1.012 . . . . 74.0 112.39 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -65.78 -44.66 64.14 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.656 0.984 . . . . 72.31 113.656 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.86 -32.07 90.96 Favored 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 121.952 1.768 . . . . 71.3 112.873 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -80.16 -33.97 37.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 71.34 112.398 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.17 58.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.263 -0.643 . . . . 52.45 109.263 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -68.35 -31.7 71.27 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 114.883 -1.053 . . . . 75.13 111.213 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.13 -50.38 72.1 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 124.223 0.952 . . . . 75.21 110.692 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.3 t -59.02 -42.04 89.18 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.689 0.618 . . . . 65.32 110.52 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.623 HG12 ' SG ' ' D' ' 76' ' ' CYS . 99.5 mt -59.3 -52.84 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.314 1.045 . . . . 74.22 110.708 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.508 HG22 ' HG3' ' D' ' 125' ' ' GLN . 74.1 m -58.64 -41.82 86.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.882 0.873 . . . . 74.45 110.808 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.56 -43.97 88.19 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 114.65 -1.159 . . . . 70.12 110.448 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.41 -30.58 69.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.711 0.404 . . . . 74.55 111.459 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.92 -45.42 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.451 0.701 . . . . 75.12 110.029 173.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -74.26 -25.63 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.748 0.419 . . . . 74.03 110.967 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -75.63 -35.23 60.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.593 0.757 . . . . 74.42 109.255 172.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.38 -3.89 88.84 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.854 0.721 . . . . 62.11 112.039 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.5 p 58.05 34.69 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.71 2.004 . . . . 72.33 112.894 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -93.28 166.74 15.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.738 1.215 . . . . 73.23 108.989 171.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.56 132.26 44.89 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.097 1.864 . . . . 73.5 111.514 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.508 ' HG3' HG22 ' D' ' 115' ' ' THR . 31.6 tt0 -52.49 139.6 24.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.544 1.137 . . . . 74.21 112.406 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.7 tp -126.04 99.89 6.11 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.947 0.403 . . . . 74.35 110.862 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -100.15 117.81 35.18 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.179 -1.415 . . . . 75.14 107.179 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -73.17 123.16 23.1 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.624 -0.509 . . . . 65.1 109.624 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.66 147.07 84.73 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 124.635 1.209 . . . . 70.41 112.311 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.93 123.06 12.21 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.262 2.641 . . . . 73.12 113.555 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.75 145.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.828 0.851 . . . . 72.2 109.92 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -68.25 118.48 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.328 -0.99 . . . . 63.02 108.328 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.2 p90 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 124.772 1.229 . . . . 75.24 113.969 -179.509 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 108.809 -0.811 . . . . 75.13 108.809 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.01 114.0 9.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.401 -1.703 . . . . 75.04 106.401 159.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -138.78 121.07 15.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.335 -0.617 . . . . 74.31 109.335 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' C' ' 130' ' ' PRO . 25.0 pt -73.98 111.77 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 71.45 109.036 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -96.39 -43.32 7.71 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.764 -0.458 . . . . 71.31 109.764 -174.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -155.95 140.43 16.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.139 0.976 . . . . 74.44 108.865 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.558 HG21 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -128.72 112.53 26.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 106.122 -1.807 . . . . 74.15 106.122 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' HE2' ' HB2' ' B' ' 28' ' ' ALA . 28.8 p90 -157.64 169.14 25.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.252 0.548 . . . . 73.21 111.817 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -89.4 121.77 31.97 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.797 -0.816 . . . . 75.21 108.797 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.7 mtpt -87.51 -36.0 17.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.217 0.532 . . . . 72.02 109.751 175.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -146.83 140.44 25.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.108 -0.951 . . . . 73.5 108.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 22' ' ' SER . 70.5 mt -132.62 146.58 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.314 1.046 . . . . 73.43 108.671 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 21' ' ' ILE . 72.2 m -146.1 124.96 12.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.182 0.993 . . . . 73.11 109.229 175.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 83.3 t80 -123.91 126.89 47.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.192 -1.781 . . . . 75.01 106.192 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -134.73 108.36 7.95 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.994 -0.743 . . . . 72.04 108.994 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.72 82.42 59.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.975 0.91 . . . . 72.11 108.796 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.2 -22.22 22.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.591 2.194 . . . . 72.14 111.576 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 89.3 m-20 -114.34 33.72 5.13 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.112 0.965 . . . . 75.43 109.953 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.57 98.99 Favored Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 123.827 0.851 . . . . 74.45 112.491 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD2' ' HD2' ' A' ' 30' ' ' HIS . 7.7 Cg_exo -74.81 -28.91 9.12 Favored 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 121.937 1.758 . . . . 74.44 112.747 172.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.2 m-70 -68.93 -28.22 66.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.543 0.737 . . . . 70.54 111.34 -172.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.549 HG12 ' HE1' ' A' ' 123' ' ' PHE . 9.4 p -63.96 -27.0 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.478 0.711 . . . . 70.54 111.587 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -68.12 -30.67 69.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.746 0.818 . . . . 72.33 110.583 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -75.89 -46.08 32.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.519 -0.764 . . . . 74.22 109.965 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HE2' HD12 ' A' ' 68' ' ' LEU . 41.3 mtpt -81.73 157.37 24.58 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.676 -1.147 . . . . 64.44 110.66 -173.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -64.44 135.36 56.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.552 0.341 . . . . 60.12 111.008 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -84.29 64.88 8.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.111 0.958 . . . . 73.21 109.529 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -132.0 66.59 77.94 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.065 1.346 . . . . 71.51 108.01 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -87.54 156.04 7.78 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.053 1.835 . . . . 71.23 112.389 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.34 124.22 40.26 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.509 -0.923 . . . . 74.03 108.509 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.1 t -90.59 99.59 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.825 0.85 . . . . 61.52 109.656 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 90.2 mttt -95.55 142.28 28.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.544 0.737 . . . . 74.33 110.424 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.06 112.28 12.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.458 -0.792 . . . . 72.42 109.795 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -115.32 113.55 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.231 1.012 . . . . 75.4 108.698 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.07 155.8 25.3 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.446 0.641 . . . . 74.41 111.449 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 15.8 t70 -149.16 154.95 39.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 65.3 109.059 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -133.41 132.82 41.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.809 0.844 . . . . 72.11 109.201 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.06 130.31 41.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.676 0.79 . . . . 71.54 109.681 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -88.65 155.27 19.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.299 0.64 . . . . 74.35 110.464 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.3 t -149.53 119.06 6.92 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 -176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.87 107.88 19.53 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.785 -0.82 . . . . 64.45 108.785 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.32 -27.98 20.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.863 -0.608 . . . . 74.01 110.659 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.94 -174.03 1.96 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.868 -1.06 . . . . 64.33 110.205 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.5 128.43 35.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.339 -0.846 . . . . 71.31 109.68 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 62.04 18.18 9.72 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.582 1.176 . . . . 72.11 111.813 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.0 107.31 17.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 124.482 1.113 . . . . 75.23 108.057 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -125.97 124.48 40.84 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.786 0.834 . . . . 75.24 108.996 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.95 124.43 49.5 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.4 1.48 . . . . 72.14 108.666 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.38 134.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.187 -1.042 . . . . 73.13 108.187 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.568 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.6 t -106.6 125.33 62.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.048 -0.978 . . . . 71.4 108.387 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.39 107.53 19.92 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.45 -1.685 . . . . 75.41 106.45 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 5.3 ttp180 -94.46 97.08 9.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.11 -1.441 . . . . 73.13 107.11 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.8 132.57 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -126.29 126.7 44.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.381 -0.97 . . . . 73.34 108.381 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG23 HD12 ' A' ' 114' ' ' ILE . 89.8 t -120.78 129.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.3 -1.371 . . . . 71.34 107.3 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 34.5 m -125.51 137.61 53.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.036 -0.727 . . . . 71.14 109.036 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.18 105.8 10.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.948 -1.501 . . . . 74.31 106.948 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -130.71 125.9 35.09 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.621 -0.881 . . . . 63.24 108.621 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.577 HD12 ' HE2' ' A' ' 34' ' ' LYS . 1.3 pt? -91.07 84.25 5.69 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.992 -1.114 . . . . 74.21 107.992 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.85 -124.25 7.04 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.724 -1.125 . . . . 64.03 110.639 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.86 -26.9 21.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.801 0.841 . . . . 73.13 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -96.25 133.16 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 74.02 110.63 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -80.33 126.92 31.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.976 0.91 . . . . 73.35 110.844 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.75 -51.46 12.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.001 0.92 . . . . 70.25 109.189 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -161.95 168.3 23.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.148 0.979 . . . . 71.25 110.061 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.453 HD11 ' H ' ' A' ' 76' ' ' CYS . 40.6 tp -138.11 149.11 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.66 1.184 . . . . 73.53 109.221 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.453 ' H ' HD11 ' A' ' 75' ' ' LEU . 63.7 m -139.66 140.34 36.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.068 1.347 . . . . 74.3 108.947 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.37 132.63 18.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.71 0.804 . . . . 74.01 108.839 170.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.76 112.86 13.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.805 -0.813 . . . . 72.13 108.805 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.23 80.58 9.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.765 -1.107 . . . . 75.33 108.399 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.76 92.71 3.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.808 -1.087 . . . . 65.21 109.129 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -93.33 144.74 17.24 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.664 -0.574 . . . . 72.2 111.664 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.55 127.55 3.81 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.752 -0.539 . . . . 74.45 111.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.39 126.18 39.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.975 -1.12 . . . . 72.32 107.975 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.15 121.48 20.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.221 -0.659 . . . . 75.54 109.221 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -81.09 110.77 16.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.932 -0.766 . . . . 74.01 108.932 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.36 144.21 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.142 0.577 . . . . 73.21 110.684 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.4 162.75 22.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.998 . . . . 71.21 109.779 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.17 -6.83 48.47 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 115.99 -0.55 . . . . 74.24 114.47 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.93 155.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.461 1.104 . . . . 73.45 109.288 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -164.28 174.61 10.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.355 -0.609 . . . . 72.53 109.355 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.14 -125.17 29.37 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 116.112 -0.494 . . . . 70.3 112.75 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -73.16 -18.78 61.23 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.804 0.842 . . . . 74.43 111.945 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -70.71 -50.75 32.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.607 0.763 . . . . 75.41 109.59 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -75.23 -29.85 60.38 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.423 -0.808 . . . . 74.14 110.441 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.97 -44.08 97.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.143 0.577 . . . . 71.53 110.042 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.08 -49.52 77.34 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 115.518 -0.765 . . . . 75.35 110.688 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.3 m -69.17 -59.78 2.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 74.54 112.973 -171.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.75 -14.95 60.78 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.142 0.423 . . . . 74.45 112.142 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.42 -18.42 30.84 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.862 -0.41 . . . . 71.32 113.817 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.59 -69.17 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.492 0.646 . . . . 75.53 111.998 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 8.6 t80 -44.12 -57.89 3.15 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.1 1.36 . . . . 72.41 112.788 -174.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.7 -47.99 5.1 Favored Pre-proline 0 CA--C 1.559 1.325 0 CA-C-O 117.856 -1.069 . . . . 75.11 113.077 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HA ' HD13 ' A' ' 106' ' ' LEU . 22.0 Cg_endo -62.63 -21.45 72.93 Favored 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.739 1.657 . . . . 62.43 113.398 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.06 -26.89 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.085 0.554 . . . . 73.01 110.213 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.4 mm -67.74 -41.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.356 0.598 . . . . 74.54 109.526 167.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.558 HD23 HG21 ' A' ' 16' ' ' ILE . 68.8 mt -71.46 -25.68 62.4 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.015 -0.993 . . . . 74.32 111.315 -175.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.05 -43.4 67.11 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 117.709 -1.139 . . . . 72.53 114.005 -170.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.47 -39.89 88.56 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.336 2.024 . . . . 71.43 113.633 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -77.08 -32.7 56.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.477 0.711 . . . . 73.2 111.871 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -46.68 70.03 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.343 -0.614 . . . . 75.12 109.343 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.504 ' NH1' HD13 ' C' ' 105' ' ' ILE . 35.4 ttm180 -53.5 -49.72 66.93 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.881 1.363 . . . . 75.0 110.443 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.61 -49.65 75.74 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.434 1.084 . . . . 75.1 110.849 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.2 -40.42 93.89 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 124.139 0.899 . . . . 71.54 111.584 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.541 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 80.1 mt -65.31 -59.22 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 123.832 0.707 . . . . 74.33 110.061 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.0 m -55.54 -33.29 63.69 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.516 1.135 . . . . 74.43 111.533 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -71.67 -43.63 65.68 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.42 -0.809 . . . . 73.2 110.545 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 49.9 mtm -59.29 -41.71 89.61 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.146 0.43 . . . . 75.12 110.756 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -57.16 -50.31 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.526 -1.216 . . . . 72.4 110.422 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.48 -23.31 58.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.971 0.508 . . . . 70.23 111.692 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.46 -28.36 61.0 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.438 0.695 . . . . 74.45 109.609 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 8.07 71.85 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 115.537 -0.756 . . . . 71.42 112.497 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.573 HG22 ' HB3' ' B' ' 17' ' ' TYR . 7.1 t 48.13 43.74 18.69 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.693 1.997 . . . . 75.12 112.771 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.549 ' HE1' HG12 ' A' ' 31' ' ' VAL . 83.0 m-85 -99.1 158.54 32.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.749 -1.114 . . . . 75.21 108.657 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.62 149.86 64.81 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.602 2.201 . . . . 74.14 111.884 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -69.67 134.46 48.72 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.361 0.664 . . . . 74.3 111.704 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.11 112.19 23.4 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.544 -0.91 . . . . 71.23 108.544 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' C' ' 15' ' ' ARG . 80.5 m-20 -98.47 100.55 11.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.421 0.688 . . . . 74.34 109.531 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.06 120.98 8.35 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.144 0.978 . . . . 75.05 110.05 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.58 85.88 Favored Pre-proline 0 C--O 1.242 0.695 0 O-C-N 123.56 0.537 . . . . 70.31 109.662 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.47 104.78 1.63 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.866 1.711 . . . . 75.35 111.692 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -99.93 110.76 27.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.618 -1.253 . . . . 72.51 107.618 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.411 HD22 ' HB2' ' A' ' 134' ' ' ASP . 11.4 t30 -79.86 90.93 5.31 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.613 -1.255 . . . . 71.52 107.613 176.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.938 -1.028 . . . . 75.31 111.166 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.411 ' HB2' HD22 ' A' ' 132' ' ' ASN . 4.7 m-20 . . . . . 0 C--O 1.217 -0.616 0 C-N-CA 125.121 1.368 . . . . 73.44 112.232 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.421 ' SD ' HD12 ' B' ' 89' ' ' ILE . 17.1 ptm . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 114.262 1.208 . . . . 74.12 114.262 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.2 m -138.75 103.62 4.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.633 -1.247 . . . . 61.24 107.633 174.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -110.72 146.58 36.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.441 0.696 . . . . 74.44 109.462 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.557 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 49.4 tt0 -164.54 141.4 6.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.285 0.634 . . . . 74.5 110.333 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.27 131.28 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 108.759 -0.83 . . . . 74.23 108.759 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -101.15 -50.83 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.15 -0.315 . . . . 63.42 110.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -157.43 140.93 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.514 -0.312 . . . . 74.32 110.183 -171.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.6 mt -123.16 134.68 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.867 -1.531 . . . . 75.43 106.867 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.573 ' HB3' HG22 ' A' ' 122' ' ' THR . 9.2 p90 -166.97 147.12 5.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.428 0.899 . . . . 72.41 113.428 -172.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.2 m -73.68 122.04 21.69 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.059 -1.428 . . . . 65.02 108.837 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -97.46 -29.05 13.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.669 0.788 . . . . 75.34 110.674 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 24.4 t70 -157.13 141.6 16.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.389 -0.369 . . . . 71.23 110.787 -169.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.437 HD12 HG21 ' B' ' 78' ' ' VAL . 47.0 mm -138.48 144.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.719 1.208 . . . . 74.51 109.366 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.55 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -136.98 138.44 40.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.948 1.299 . . . . 75.1 108.422 167.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -142.85 131.46 22.5 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.064 -1.828 . . . . 72.41 106.064 164.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.5 mt-10 -131.48 136.42 47.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.739 -0.837 . . . . 74.31 108.739 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.536 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -131.4 80.37 67.71 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 107.223 -1.399 . . . . 61.32 107.223 170.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.21 -33.48 60.1 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.527 2.151 . . . . 71.42 110.779 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -118.77 24.29 10.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.581 1.152 . . . . 74.1 110.0 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.626 ' HA ' ' HZ ' ' B' ' 123' ' ' PHE . . . -38.14 -56.18 2.11 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 115.053 1.501 . . . . 74.14 115.053 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.8 Cg_endo -82.21 -6.63 12.04 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.338 2.026 . . . . 73.25 113.332 -176.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.4 ' HA ' HE22 ' B' ' 33' ' ' GLN . 72.2 m80 -96.82 -24.22 16.0 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.696 0.798 . . . . 72.43 111.572 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.588 HG23 ' HA ' ' B' ' 73' ' ' ALA . 59.8 t -82.3 -6.66 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.584 0.754 . . . . 70.15 110.085 173.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.66 -43.27 72.26 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.277 1.031 . . . . 73.41 111.155 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' B' ' 30' ' ' HIS . 0.8 OUTLIER -72.81 -32.83 65.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.543 0.737 . . . . 74.14 110.151 -178.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.18 85.16 4.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.1 -0.955 . . . . 74.45 110.426 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.54 77.41 9.31 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.746 0.784 . . . . 72.23 108.967 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.442 ' HB2' HD23 ' B' ' 68' ' ' LEU . 5.9 m-90 -151.88 158.0 42.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.387 1.475 . . . . 74.24 108.294 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.94 113.74 45.33 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.151 -1.055 . . . . 71.01 108.151 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 56.7 Cg_endo -68.43 160.74 47.86 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.402 2.068 . . . . 75.14 112.572 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.0 tt0 -60.27 103.73 0.26 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.072 0.858 . . . . 71.35 110.046 175.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.13 135.41 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.064 -0.717 . . . . 65.31 109.064 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -142.41 134.99 28.08 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.871 -0.788 . . . . 73.12 108.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.23 123.49 48.37 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.751 -1.203 . . . . 74.11 107.751 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.636 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 8.8 m-20 -122.9 111.49 16.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.671 -1.233 . . . . 73.11 107.671 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.578 HD22 HG13 ' B' ' 131' ' ' VAL . 7.5 mp -100.31 143.3 30.66 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.365 0.666 . . . . 73.53 110.178 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.9 t70 -147.59 147.12 29.73 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.524 1.13 . . . . 65.43 108.129 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -132.53 124.56 28.72 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.311 0.644 . . . . 74.11 109.815 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.64 154.87 30.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.175 0.99 . . . . 71.32 108.49 173.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.1 p -145.46 161.18 40.33 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.236 0.614 . . . . 72.23 110.085 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.4 p -169.08 159.96 9.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.03 0.932 . . . . 74.2 109.482 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -118.08 134.98 54.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.06 0.544 . . . . 74.23 109.806 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.31 -49.18 5.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.86 0.864 . . . . 74.21 110.695 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 -172.8 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.331 -0.85 . . . . 74.03 110.376 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.55 107.62 1.77 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.36 1.037 . . . . 73.11 110.789 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' B' ' 85' ' ' SER . 21.3 m-20 77.82 1.07 2.85 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 126.516 1.926 . . . . 62.2 111.3 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.57 88.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.341 -1.355 . . . . 75.21 107.341 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -95.75 165.69 12.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.604 -0.888 . . . . 71.33 108.604 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.81 113.74 7.98 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.754 -1.202 . . . . 73.33 107.754 -174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.09 127.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.39 0.676 . . . . 64.24 109.745 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 27.9 t -103.27 131.99 50.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.926 0.89 . . . . 71.34 109.308 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -116.21 112.04 21.05 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.401 -1.333 . . . . 73.52 107.401 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 28.7 ttm180 -100.02 121.95 42.16 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.853 -0.425 . . . . 75.4 109.853 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' B' ' 114' ' ' ILE . 17.4 t -117.22 133.64 63.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.477 -1.305 . . . . 71.43 107.477 168.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.636 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.4 m -119.09 134.35 55.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.063 -0.717 . . . . 64.02 109.063 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.567 HG23 HD12 ' B' ' 114' ' ' ILE . 63.7 t -117.15 104.8 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.91 0.884 . . . . 74.23 108.839 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.0 m -97.48 140.85 31.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.121 -1.399 . . . . 75.0 108.871 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -141.5 134.22 28.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.327 0.392 . . . . 74.31 110.359 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -140.36 135.83 32.54 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.31 0.644 . . . . 75.34 109.312 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 17.1 tp -136.55 124.0 22.11 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.227 0.611 . . . . 74.23 109.486 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.1 -116.85 4.47 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.656 -0.702 . . . . 72.1 111.505 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.81 19.75 13.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.352 1.061 . . . . 73.32 109.693 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -156.23 176.63 12.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.895 0.478 . . . . 74.12 111.038 -170.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -72.58 141.93 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.618 0.767 . . . . 74.21 110.563 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.588 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -94.32 -59.24 2.0 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.038 -0.727 . . . . 61.43 109.038 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -157.89 168.76 26.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.871 -1.059 . . . . 73.52 109.886 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 78.8 mt -141.04 140.69 34.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.37 1.468 . . . . 73.54 107.251 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.412 ' SG ' HG22 ' B' ' 114' ' ' ILE . 45.8 t -148.99 155.47 40.85 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.877 -0.786 . . . . 75.31 108.877 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.6 tt0 -164.49 138.47 5.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.899 -0.778 . . . . 74.44 108.899 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.437 HG21 HD12 ' B' ' 21' ' ' ILE . 92.4 t -134.54 145.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.93 0.892 . . . . 70.52 109.098 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.5 mt-30 -122.08 94.15 4.21 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.289 -1.004 . . . . 73.33 108.289 170.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -84.54 101.15 11.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.731 -0.84 . . . . 73.33 108.731 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.53 165.83 31.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.27 -0.732 . . . . 74.53 111.27 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.66 133.73 3.54 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 112.325 -0.31 . . . . 71.33 112.325 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 63.6 mt -86.32 123.39 39.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.875 -0.787 . . . . 75.03 108.875 171.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.28 135.24 46.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.627 1.171 . . . . 75.12 109.077 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 53.5 m -101.81 106.35 17.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.81 0.844 . . . . 71.22 109.009 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.48 ' H ' HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -126.03 131.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.881 0.873 . . . . 74.35 109.417 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 160.6 40.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.136 0.974 . . . . 73.31 109.022 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 -29.09 3.98 Favored Glycine 0 N--CA 1.473 1.118 0 N-CA-C 114.281 0.472 . . . . 65.4 114.281 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.421 HD12 ' SD ' ' B' ' 9' ' ' MET . 16.0 tt -83.03 152.35 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.975 0.91 . . . . 73.23 110.352 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 166.07 32.7 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.172 0.511 . . . . 72.3 112.008 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.82 30.53 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 114.761 -1.109 . . . . 73.42 113.848 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 47.4 m -65.04 -33.81 76.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.97 0.908 . . . . 74.45 110.611 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.54 -51.98 66.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.109 -0.951 . . . . 74.15 110.381 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -62.6 -41.06 98.74 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.805 0.842 . . . . 73.43 111.388 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.8 81.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.007 0.817 . . . . 73.45 112.09 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -95.99 -12.32 25.17 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.539 0.336 . . . . 73.42 111.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -80.38 -65.02 1.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.659 -0.497 . . . . 74.21 109.659 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.403 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 20.6 tp -75.89 -28.31 58.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.085 -0.507 . . . . 73.31 110.468 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.2 -34.06 18.6 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.754 -0.657 . . . . 63.31 114.294 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.86 -41.3 2.12 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.05 0.925 . . . . 74.12 113.075 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -76.94 -39.93 48.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.803 0.441 . . . . 74.42 111.29 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 74.0 m -66.34 -45.51 59.9 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.698 -0.668 . . . . 74.21 110.782 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.445 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 85.6 Cg_exo -55.73 -35.74 93.85 Favored 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 122.49 2.127 . . . . 71.43 113.896 163.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.673 0.389 . . . . 71.2 111.425 -178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.96 -44.51 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.078 0.951 . . . . 73.51 110.001 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.7 mt -75.43 -23.52 56.98 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.853 -1.067 . . . . 75.4 112.37 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.87 -48.07 95.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 113.936 1.087 . . . . 75.35 113.936 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.33 -34.47 94.13 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.153 1.902 . . . . 72.32 113.383 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.63 -43.82 62.75 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.228 0.611 . . . . 72.24 110.316 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.51 -39.57 80.45 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 123.49 0.716 . . . . 72.25 110.135 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -56.46 -63.98 1.02 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.749 1.22 . . . . 74.24 111.128 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.01 -28.69 69.67 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.112 0.882 . . . . 73.31 110.785 -171.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.505 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -69.27 -42.77 75.11 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.846 0.458 . . . . 72.24 110.843 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.567 HD12 HG23 ' B' ' 64' ' ' VAL . 93.5 mt -62.97 -53.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.204 0.602 . . . . 73.24 110.045 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -59.26 -33.11 70.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.508 -1.223 . . . . 70.54 110.796 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.3 t -62.87 -53.66 50.68 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.123 -0.944 . . . . 71.52 109.942 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.532 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 14.4 mmt -60.29 -34.99 74.54 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.195 0.598 . . . . 73.41 111.965 -175.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.77 -48.64 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.833 0.853 . . . . 65.13 111.005 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 61.0 p -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.915 0.486 . . . . 74.01 111.615 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.532 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 86.5 mtt-85 -68.18 -37.63 81.16 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.392 0.677 . . . . 73.14 109.324 171.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 11.88 54.29 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.133 0.895 . . . . 72.24 113.41 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.8 p 53.14 39.68 30.01 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.662 1.585 . . . . 71.21 112.341 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.626 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 65.5 m-85 -108.44 159.74 29.67 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 124.759 1.224 . . . . 73.4 110.336 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 106.66 0.2 Allowed 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 123.037 2.491 . . . . 53.12 112.483 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.487 ' HG2' ' HG2' ' C' ' 125' ' ' GLN . 12.9 pt20 -50.03 125.26 11.72 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.284 1.434 . . . . 70.44 111.598 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.29 112.97 25.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.276 -1.009 . . . . 73.3 108.276 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -90.38 129.73 36.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.688 0.795 . . . . 63.41 109.091 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.5 107.38 9.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.015 0.926 . . . . 73.14 109.214 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.26 152.55 96.45 Favored Pre-proline 0 CA--C 1.554 1.107 0 CA-C-N 115.704 -0.68 . . . . 74.43 109.695 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.4 111.21 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.427 2.752 . . . . 73.24 113.034 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . 0.578 HG13 HD22 ' B' ' 44' ' ' LEU . 48.5 t -88.65 110.09 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.743 -1.577 . . . . 74.34 106.743 168.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.64 91.61 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -56.09 -42.76 77.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.091 0.956 . . . . 74.34 111.25 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.07 -54.59 45.31 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.49 -1.232 . . . . 72.53 110.908 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.1 63.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.449 -0.796 . . . . 72.11 112.164 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 124.196 0.998 . . . . 71.4 109.595 -176.723 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.472 ' HE2' HG12 ' C' ' 89' ' ' ILE . 38.2 ttm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.397 0.618 . . . . 71.42 111.798 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -85.78 85.93 7.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.879 -0.786 . . . . 72.41 108.879 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.409 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -105.17 121.49 43.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.389 -1.278 . . . . 74.23 108.093 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.23 137.2 38.83 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.367 -0.605 . . . . 74.31 109.367 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 49.5 mt -81.29 121.51 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.105 -0.952 . . . . 74.0 109.241 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.0 mm-40 -89.47 -49.6 6.59 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.194 0.598 . . . . 72.43 109.965 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.431 ' HA ' HD22 ' A' ' 127' ' ' ASN . 53.2 ttt180 -164.01 122.69 1.91 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.61 0.364 . . . . 72.24 110.538 -176.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.62 136.33 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.436 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 36.0 p90 -169.07 165.65 11.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.108 0.956 . . . . 75.15 112.855 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -87.01 111.73 21.15 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.732 -1.576 . . . . 73.13 108.838 173.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 57.9 mmtt -65.29 -48.46 73.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.389 1.09 . . . . 74.13 108.49 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -134.62 140.4 46.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.133 -1.848 . . . . 70.34 109.207 -170.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.6 mt -137.13 143.45 34.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.074 -1.454 . . . . 71.51 107.074 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -160.63 151.04 18.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.389 0.614 . . . . 75.41 109.86 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -152.72 115.22 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.282 -1.377 . . . . 72.21 107.282 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -116.08 109.14 17.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.304 -0.628 . . . . 74.44 109.304 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.15 85.28 15.12 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.382 1.073 . . . . 71.41 108.113 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -35.23 20.29 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 121.927 1.751 . . . . 63.1 110.382 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 77.7 m-20 -98.55 30.58 3.19 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.712 1.205 . . . . 75.43 110.29 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.15 99.96 Favored Pre-proline 0 CA--C 1.57 1.727 0 C-N-CA 124.558 1.143 . . . . 62.52 112.591 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.35 -18.37 4.07 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.169 1.913 . . . . 75.44 113.189 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -69.75 -41.33 75.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.447 0.699 . . . . 74.41 110.529 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.714 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.1 p -66.63 -16.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.553 1.141 . . . . 75.31 112.311 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -62.36 -37.19 84.74 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.087 1.355 . . . . 74.45 112.059 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -118.77 24.93 10.57 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.826 0.822 . . . . 72.54 109.398 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.714 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 20.1 ttpp -123.53 176.12 6.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.05 0.54 . . . . 73.21 110.675 -170.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' C' ' 37' ' ' GLN . 5.0 p-10 -55.24 120.74 7.5 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.379 1.072 . . . . 71.33 111.203 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -90.02 63.31 5.88 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.899 -0.592 . . . . 74.43 109.525 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' C' ' 35' ' ' ASP . 15.4 pt20 -146.16 64.57 9.99 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-O 121.19 0.519 . . . . 71.32 111.147 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.04 134.12 8.05 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 121.724 1.616 . . . . 64.21 110.648 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -84.52 93.67 8.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.37 -1.344 . . . . 75.23 107.37 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 65.8 t -67.39 133.19 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.445 -1.252 . . . . 70.54 110.413 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -130.04 130.22 44.66 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.554 -1.276 . . . . 64.3 107.554 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.521 HD22 ' H ' ' C' ' 42' ' ' LEU . 2.4 pt? -95.49 133.3 39.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.367 -0.975 . . . . 71.03 108.367 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -118.88 141.03 49.02 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.955 -1.498 . . . . 74.2 106.955 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -134.06 143.03 47.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.047 0.451 . . . . 73.54 110.205 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -147.5 149.7 33.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.261 1.024 . . . . 64.01 108.655 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 14.5 t -130.99 144.1 51.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.809 0.444 . . . . 74.02 110.437 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.01 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.282 1.033 . . . . 75.4 108.433 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -130.83 142.37 50.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.834 0.453 . . . . 52.31 110.344 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -160.6 133.41 6.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.815 0.846 . . . . 72.54 109.814 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.21 133.44 40.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.11 0.564 . . . . 53.31 110.168 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.671 HD12 ' HB2' ' C' ' 57' ' ' GLU . 49.0 mt -102.7 -38.56 7.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.226 0.61 . . . . 72.42 110.253 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -152.19 178.77 9.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.835 0.854 . . . . 74.33 110.097 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.93 116.87 5.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.184 -0.916 . . . . 71.14 109.112 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.98 0.11 2.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.332 1.453 . . . . 75.43 113.11 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 53.4 t -109.69 108.43 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.301 -0.629 . . . . 75.43 109.301 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -113.59 161.65 17.17 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.923 0.889 . . . . 74.22 109.036 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.671 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.0 tt0 -124.25 141.45 52.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.985 0.914 . . . . 72.24 108.808 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.37 134.53 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 122.916 0.486 . . . . 74.14 109.933 168.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' C' ' 46' ' ' THR . 58.0 t -103.41 128.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.681 -1.229 . . . . 73.24 107.681 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.5 96.43 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.133 -1.062 . . . . 73.35 108.133 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -86.47 114.81 23.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.175 -1.375 . . . . 73.32 110.49 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' C' ' 114' ' ' ILE . 46.1 t -109.35 109.94 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.736 -0.838 . . . . 74.4 108.736 172.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -103.55 113.48 27.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.194 0.521 . . . . 73.41 109.603 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.553 HG22 HD12 ' C' ' 114' ' ' ILE . 71.1 t -100.8 109.75 26.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 123.571 0.748 . . . . 74.41 109.206 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 15.2 m -102.0 127.31 48.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.155 -0.683 . . . . 75.31 109.155 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.72 100.2 6.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.651 -1.24 . . . . 55.2 107.651 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -151.15 147.08 26.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.702 -0.681 . . . . 74.42 109.961 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.77 -14.56 56.27 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.254 -0.43 . . . . 75.23 109.919 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.47 -102.18 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 110.977 -0.849 . . . . 71.41 110.977 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.39 -23.38 26.14 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.685 -0.857 . . . . 73.32 108.685 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -79.67 100.87 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.269 1.028 . . . . 71.1 109.02 174.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.0 m -88.97 128.56 35.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.549 -0.75 . . . . 75.03 110.429 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.29 -56.71 4.45 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 62.22 107.914 170.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -154.87 155.92 35.22 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.002 -0.999 . . . . 63.41 110.816 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -121.7 143.63 49.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.358 -2.09 . . . . 75.42 105.358 170.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -147.08 145.66 29.71 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.258 -1.015 . . . . 73.11 108.258 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.0 128.33 6.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.86 0.362 . . . . 72.41 110.42 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -131.13 139.15 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.69 1.196 . . . . 72.33 108.495 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -113.66 94.69 4.96 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.515 -0.921 . . . . 75.31 108.515 171.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.428 ' O ' HD11 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.77 98.13 7.63 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.319 -0.855 . . . . 74.4 109.114 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.89 144.6 17.24 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.286 -0.726 . . . . 75.55 111.286 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -140.77 128.36 3.74 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 112.369 -0.292 . . . . 73.33 112.369 -172.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.458 HD13 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -91.43 122.96 43.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.898 -1.149 . . . . 75.11 107.898 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -137.84 121.77 17.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.613 0.765 . . . . 74.33 109.61 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 p -84.22 113.4 21.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 71.21 109.127 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 44.2 pt -115.18 127.47 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.577 0.703 . . . . 72.44 109.687 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.62 154.25 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.475 1.11 . . . . 74.53 108.485 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -18.82 38.97 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 120.426 -0.097 . . . . 75.25 112.866 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.472 HG12 ' HE2' ' C' ' 9' ' ' MET . 10.7 tp -123.3 151.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.89 0.876 . . . . 74.22 109.488 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.494 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 14.3 pt-20 -159.82 -179.58 7.96 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.041 0.537 . . . . 63.04 111.183 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.35 -149.35 50.85 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.456 -0.793 . . . . 74.23 114.3 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.7 p -60.79 -24.33 65.72 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.506 1.122 . . . . 74.21 112.002 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -67.72 -51.1 53.31 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.7 1.2 . . . . 71.11 111.189 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.494 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 21.2 ptt? -70.88 -24.4 62.48 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.917 -0.401 . . . . 64.42 109.917 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.09 84.53 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.715 0.634 . . . . 73.41 110.7 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -63.87 -37.7 88.35 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.504 0.502 . . . . 75.24 110.667 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -65.54 -55.47 17.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.751 -0.463 . . . . 72.52 109.751 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.25 -16.26 63.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.792 0.837 . . . . 73.5 112.238 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.11 3.77 26.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.478 -0.624 . . . . 65.23 114.114 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.13 -64.73 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.558 0.679 . . . . 73.11 110.483 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.63 -55.36 31.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.958 0.503 . . . . 71.43 112.211 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.423 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 18.2 m -60.97 -47.09 96.52 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.574 -0.726 . . . . 74.32 111.883 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 70.6 Cg_exo -50.23 -38.9 52.39 Favored 'Trans proline' 0 C--N 1.396 3.045 0 C-N-CA 122.767 2.311 . . . . 75.02 114.478 165.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.46 -25.52 63.22 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.516 0.726 . . . . 75.13 111.765 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.504 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.54 -41.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.169 0.588 . . . . 74.14 109.665 171.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.428 HD11 ' O ' ' C' ' 80' ' ' GLN . 95.9 mt -75.3 -26.36 58.63 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.074 -0.966 . . . . 73.34 111.848 -175.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.4 -44.01 94.67 Favored Pre-proline 0 CA--C 1.565 1.534 0 CA-C-O 117.637 -1.173 . . . . 75.21 113.764 -172.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.76 -46.22 33.36 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.604 2.203 . . . . 74.21 113.752 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.28 -43.39 77.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.75 0.82 . . . . 72.51 110.908 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.47 98.81 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.637 -0.71 . . . . 72.33 110.317 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -57.48 -50.0 74.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.579 1.152 . . . . 73.33 111.053 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.63 -31.78 71.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.244 0.618 . . . . 73.33 110.212 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.7 t -71.37 -29.7 65.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.217 0.607 . . . . 74.33 111.221 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.553 HD12 HG22 ' C' ' 64' ' ' VAL . 80.8 mt -80.03 -48.65 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 75.03 110.248 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 43.4 m -60.57 -32.11 71.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.664 0.786 . . . . 72.54 110.818 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.8 t -61.63 -51.64 67.66 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.248 -0.887 . . . . 72.24 109.34 171.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.544 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.53 -38.96 92.03 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.71 1.204 . . . . 72.14 113.078 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.2 -45.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.199 1.0 . . . . 72.12 109.253 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -70.41 -31.11 68.17 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.159 -1.382 . . . . 73.43 111.544 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' C' ' 116' ' ' SER . 83.0 mtt-85 -70.63 -35.67 73.04 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.63 0.772 . . . . 73.43 109.891 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.2 -0.91 90.43 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.32 -0.711 . . . . 44.55 113.173 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p 59.14 62.6 1.8 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.704 1.602 . . . . 73.13 111.693 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 63.1 m-85 -123.57 161.98 42.92 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 114.39 -1.277 . . . . 73.12 110.096 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 30.7 Cg_endo -61.57 158.3 37.45 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.236 2.624 . . . . 74.14 114.317 -173.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.487 ' HG2' ' HG2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -59.61 119.69 8.05 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.022 0.929 . . . . 71.42 110.403 -175.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 54.3 tp -131.01 114.44 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.298 -0.865 . . . . 72.42 108.905 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -123.79 129.71 51.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.425 -0.954 . . . . 74.04 108.425 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 90.9 mt -86.79 121.76 29.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.174 0.59 . . . . 73.45 110.41 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.39 88.33 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 123.414 0.686 . . . . 74.04 110.19 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 13' ' ' ILE . 42.4 Cg_endo -68.19 143.06 57.71 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.076 1.851 . . . . 74.12 112.136 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.6 108.78 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.773 -1.195 . . . . 74.42 107.773 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -98.48 90.7 4.86 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.463 0.649 . . . . 72.03 111.348 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -75.23 -29.61 60.31 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.925 -1.034 . . . . 75.34 109.425 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 CA--C 1.544 0.744 0 CA-C-N 114.476 -1.238 . . . . 72.42 111.312 177.021 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' D' ' 87' ' ' ALA . 7.9 ttp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 113.189 0.811 . . . . 74.35 113.189 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.8 m -122.57 142.74 50.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.631 -0.877 . . . . 72.21 108.631 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' D' ' 85' ' ' SER . 57.3 t80 -154.09 101.36 2.4 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.125 -1.065 . . . . 71.23 108.125 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -132.08 147.0 52.42 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.837 0.855 . . . . 74.32 109.336 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -102.49 105.8 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.672 -0.862 . . . . 75.45 108.672 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -74.84 -45.23 44.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.4 1.08 . . . . 74.12 112.098 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.425 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 54.7 ttt180 -155.3 129.55 8.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.181 0.193 . . . . 72.45 110.512 -170.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.475 HD11 ' N ' ' D' ' 16' ' ' ILE . 2.5 mp -114.43 126.71 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.606 1.162 . . . . 75.05 107.877 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 38.0 p90 -162.87 177.32 9.37 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.946 0.879 . . . . 75.12 112.884 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -112.95 129.61 56.42 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.472 -1.24 . . . . 74.43 109.059 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -98.46 -25.05 14.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.758 0.423 . . . . 74.12 110.782 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.6 t70 -149.81 132.59 15.98 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.733 -0.839 . . . . 73.02 108.733 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.544 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.1 mt -131.83 146.62 33.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.805 -1.183 . . . . 72.54 107.805 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -148.35 142.46 26.0 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.315 1.046 . . . . 70.24 108.913 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.511 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.8 t80 -151.62 124.3 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.219 -1.771 . . . . 72.14 106.219 170.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -131.28 122.65 26.82 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.881 0.872 . . . . 75.33 109.18 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.65 85.0 13.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.573 -0.899 . . . . 73.15 108.573 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.83 -31.58 10.09 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.44 2.094 . . . . 71.33 113.056 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.9 m-20 -114.37 41.65 2.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.429 1.092 . . . . 71.52 108.639 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.41 ' HA ' ' HZ ' ' D' ' 123' ' ' PHE . . . -55.05 -52.75 68.45 Favored Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 115.306 1.595 . . . . 74.12 115.306 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.425 ' HB3' HD11 ' C' ' 83' ' ' ILE . 19.3 Cg_endo -91.06 2.69 4.6 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.8 1.667 . . . . 73.34 112.474 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.416 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 17.3 t-160 -84.39 -42.09 16.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.648 1.179 . . . . 62.54 108.954 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.2 t -78.16 -11.62 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 C-N-CA 123.595 0.758 . . . . 75.43 110.402 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -55.32 -36.41 66.21 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.954 0.902 . . . . 74.33 111.853 167.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -83.18 -1.72 53.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.653 0.781 . . . . 74.34 112.606 -172.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.407 ' HD3' ' HG ' ' D' ' 68' ' ' LEU . 14.3 ptpt -127.56 107.81 10.25 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.387 0.675 . . . . 73.45 111.155 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.19 92.6 8.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.165 0.986 . . . . 60.03 109.72 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.584 ' HB3' HD12 ' D' ' 68' ' ' LEU . 25.1 t-105 -161.6 166.85 26.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.593 -0.892 . . . . 72.21 108.593 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.8 111.64 39.14 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.284 1.034 . . . . 75.33 109.109 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.61 142.6 49.25 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.968 2.445 . . . . 71.33 113.263 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -75.8 122.55 24.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.144 -0.687 . . . . 65.55 109.144 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.415 HG13 HG13 ' D' ' 64' ' ' VAL . 61.6 t -99.24 135.34 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.836 0.854 . . . . 74.53 110.988 -173.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.627 ' HZ2' ' HB2' ' D' ' 43' ' ' ASP . 35.4 tttm -110.56 138.01 47.5 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.221 -1.029 . . . . 72.53 108.221 164.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.676 HD21 HD12 ' D' ' 128' ' ' LEU . 48.5 tp -101.76 142.41 33.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.024 -1.102 . . . . 71.23 108.024 171.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HZ2' ' D' ' 41' ' ' LYS . 19.4 t70 -140.73 128.2 21.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.283 -1.006 . . . . 74.4 108.283 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.6 mt -118.48 150.4 39.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.032 0.533 . . . . 73.3 110.786 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.6 t70 -152.62 132.34 13.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.095 1.358 . . . . 74.52 107.699 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -109.21 153.21 24.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.195 0.522 . . . . 62.14 109.987 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.71 165.65 35.32 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.279 1.032 . . . . 71.43 108.692 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -166.56 161.52 16.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.273 0.629 . . . . 73.14 111.334 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -151.27 152.8 33.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.483 1.113 . . . . 71.42 108.843 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -92.04 119.06 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.031 -0.359 . . . . 73.44 110.031 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' D' ' 57' ' ' GLU . 30.9 mt -92.58 -35.79 13.37 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.071 0.548 . . . . 75.32 110.312 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.07 -176.41 5.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.808 0.843 . . . . 74.25 110.24 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.72 107.64 0.63 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.709 0.804 . . . . 72.02 110.525 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 5.9 m-20 62.21 15.91 7.93 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.191 0.996 . . . . 71.32 112.473 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 20.4 t -107.51 125.38 63.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.028 -1.101 . . . . 74.42 108.028 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.23 133.52 45.55 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.759 -0.655 . . . . 74.31 110.849 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.549 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.6 tt0 -87.29 111.8 21.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.557 -1.275 . . . . 74.55 107.557 168.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.71 120.04 47.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 N-CA-C 107.458 -1.312 . . . . 63.11 107.458 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 92.1 t -99.69 140.27 19.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 123.603 0.761 . . . . 74.31 109.488 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.72 122.58 38.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.487 -0.931 . . . . 71.23 108.487 179.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 43.3 ttm-85 -102.42 105.94 16.6 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.12 0.968 . . . . 71.33 108.496 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.3 t -105.97 120.65 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.208 -1.034 . . . . 65.43 108.208 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.8 m -123.96 130.71 53.04 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.413 0.685 . . . . 63.05 109.876 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.47 HG21 HD12 ' D' ' 114' ' ' ILE . 90.7 t -116.21 117.86 56.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.878 1.271 . . . . 64.41 109.35 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -111.88 93.73 4.6 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.886 -1.153 . . . . 72.51 107.886 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.57 137.18 42.79 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.304 0.641 . . . . 71.31 109.764 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 61.7 p -142.39 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.357 0.663 . . . . 75.11 109.52 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' D' ' 36' ' ' TRP . 15.2 tp -120.26 115.98 24.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.195 0.598 . . . . 71.33 109.422 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 -123.68 6.28 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.067 -0.813 . . . . 62.32 111.067 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.25 4.36 20.83 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.45 0.7 . . . . 73.11 110.663 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.03 162.98 16.26 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.711 0.805 . . . . 52.03 109.74 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.2 m -76.23 136.79 39.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.548 -0.538 . . . . 73.02 109.548 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -93.07 -55.28 3.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.25 -0.886 . . . . 71.31 109.434 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -163.14 154.61 17.39 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.137 -0.938 . . . . 74.34 109.745 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.84 148.42 48.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.723 1.209 . . . . 71.14 108.184 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 46.4 t -157.53 147.36 20.4 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.818 0.447 . . . . 64.22 110.244 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -156.45 133.23 10.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 75.13 109.482 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -133.22 117.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.163 0.585 . . . . 64.41 109.846 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -91.31 88.49 6.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.661 0.785 . . . . 70.41 110.053 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.57 102.61 9.89 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.881 1.272 . . . . 72.33 109.355 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.74 141.43 15.63 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.626 -0.589 . . . . 73.21 111.626 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.66 132.04 5.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.138 -0.785 . . . . 70.21 111.138 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -89.06 108.22 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.34 -0.615 . . . . 74.33 109.34 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.03 126.16 51.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.761 0.824 . . . . 73.43 110.09 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 42.7 m -78.2 114.36 17.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.823 0.849 . . . . 71.13 108.945 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 73.3 mt -108.14 144.11 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.131 -1.433 . . . . 72.11 107.131 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' D' ' 9' ' ' MET . . . -162.05 151.44 15.97 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.262 -0.644 . . . . 75.05 109.262 173.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 1.76 53.83 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 123.815 0.697 . . . . 74.54 114.782 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.52 139.36 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.443 0.697 . . . . 74.54 110.574 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 -171.0 3.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.046 0.939 . . . . 75.22 110.386 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.8 -133.79 14.12 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.52 0.512 . . . . 72.23 113.221 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -63.81 -37.54 87.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.688 0.795 . . . . 74.42 111.386 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -71.24 -36.45 71.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.96 0.504 . . . . 72.1 112.147 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -70.13 -34.7 73.39 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.443 0.565 . . . . 73.42 109.926 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.9 -31.38 69.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.643 0.777 . . . . 64.11 110.677 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -75.32 -30.41 60.32 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.65 1.18 . . . . 74.34 110.527 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' D' ' 102' ' ' CYS . 73.5 m -68.36 -51.32 45.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.557 -0.534 . . . . 75.21 109.557 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.22 -24.32 64.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.024 0.53 . . . . 75.0 111.441 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.46 -0.4 37.47 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.799 -1.0 . . . . 71.42 114.719 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.87 -62.58 0.11 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.47 1.135 . . . . 72.44 112.408 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.97 -49.34 29.74 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.775 0.657 . . . . 74.52 112.775 -164.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' D' ' 97' ' ' CYS . 58.7 m -63.9 -45.89 81.14 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.541 -0.742 . . . . 60.41 111.691 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.475 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 89.3 Cg_exo -54.06 -35.31 81.07 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.723 2.282 . . . . 74.45 113.83 166.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.244 0.618 . . . . 75.5 111.258 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -67.46 -43.33 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.561 0.744 . . . . 64.3 110.314 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.52 -23.42 56.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.982 -1.008 . . . . 74.44 112.35 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -64.98 -42.42 61.97 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 117.917 -1.039 . . . . 62.32 113.694 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.05 -42.87 63.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.113 1.876 . . . . 72.14 113.4 170.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -72.83 -36.69 67.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.817 0.847 . . . . 73.23 111.619 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.57 -43.12 77.25 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.451 0.7 . . . . 75.12 110.462 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -59.58 -48.18 82.66 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.2 1.0 . . . . 73.24 110.291 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.53 -46.17 91.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.26 0.975 . . . . 73.31 111.372 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -57.84 -41.15 81.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.186 0.929 . . . . 72.51 110.575 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.484 HG22 ' SG ' ' D' ' 76' ' ' CYS . 84.3 mt -60.0 -58.64 6.32 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 O-C-N 123.924 0.765 . . . . 70.13 110.145 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 5.6 m -54.02 -41.74 68.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.645 1.178 . . . . 74.32 111.492 -170.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 39.9 t -65.06 -44.87 87.57 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.575 -1.193 . . . . 71.1 110.552 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.501 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.2 mtm -68.91 -31.25 70.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.041 0.537 . . . . 74.24 112.232 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.417 HG22 ' O ' ' D' ' 114' ' ' ILE . 89.7 t -70.56 -38.94 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.442 0.697 . . . . 74.44 110.058 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.95 -28.6 57.98 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.626 0.37 . . . . 63.35 110.803 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' D' ' 116' ' ' SER . 81.0 mtt-85 -70.37 -31.41 68.65 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.553 0.741 . . . . 75.35 109.34 171.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.55 8.52 64.89 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.324 -0.853 . . . . 64.33 112.58 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 36.8 p 55.71 26.25 9.18 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.401 1.881 . . . . 75.34 113.809 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.41 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 43.8 m-85 -96.9 164.88 17.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 73.45 108.858 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.69 143.58 94.83 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.254 1.969 . . . . 75.3 110.027 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -65.0 150.95 47.17 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.368 0.531 . . . . 71.23 110.839 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.48 100.21 9.79 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.59 92.38 5.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.276 -1.009 . . . . 70.43 108.276 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.676 HD12 HD21 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -70.8 115.07 9.52 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.104 -1.073 . . . . 75.42 108.104 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -71.65 132.75 85.09 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.489 0.716 . . . . 65.01 111.445 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.5 Cg_exo -65.15 127.34 18.16 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.242 2.628 . . . . 64.52 112.458 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.61 152.07 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.864 0.866 . . . . 75.31 110.49 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -74.69 109.46 8.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.354 0.661 . . . . 75.14 110.607 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 124.118 0.967 . . . . 73.01 111.702 -178.975 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 108.342 -0.985 . . . . 74.3 108.342 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -139.91 114.27 9.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.362 -0.977 . . . . 72.22 108.362 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -150.46 136.73 18.69 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.733 0.301 . . . . 74.3 111.262 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.415 1.086 . . . . 74.21 110.67 169.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.14 -44.56 5.41 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 74.23 109.247 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.46 ' HD2' ' HZ ' ' B' ' 32' ' ' PHE . 78.3 mtt180 -158.79 153.32 24.36 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.328 1.051 . . . . 73.42 110.86 172.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.641 HG21 HD22 ' A' ' 106' ' ' LEU . 4.0 mp -123.2 119.62 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.116 -1.809 . . . . 74.54 106.116 173.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -160.03 167.77 27.13 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 120.947 0.403 . . . . 74.54 111.674 -170.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -91.31 118.29 30.37 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.861 -0.422 . . . . 73.34 109.861 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.04 -26.39 29.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.733 0.413 . . . . 75.2 111.052 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.43 148.3 21.39 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.221 -0.659 . . . . 73.44 109.221 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.6 mt -145.38 142.6 22.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.233 1.413 . . . . 75.13 107.522 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -148.0 136.73 21.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.401 0.681 . . . . 74.3 109.325 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 79.1 t80 -136.21 143.04 44.15 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.209 -1.404 . . . . 74.3 107.209 171.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.38 147.58 39.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.884 0.873 . . . . 75.03 109.159 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 72.09 11.72 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.613 -1.625 . . . . 64.21 106.613 167.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 -24.44 36.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.228 1.952 . . . . 65.34 111.188 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 58.9 m-20 -113.61 33.51 5.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.519 1.128 . . . . 62.54 109.09 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.98 99.34 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 123.834 0.854 . . . . 72.54 113.04 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.73 -29.31 35.95 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 121.637 1.558 . . . . 74.14 113.006 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.2 m-70 -74.46 -35.77 63.31 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.702 0.401 . . . . 75.43 111.653 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.29 -21.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 121.09 0.471 . . . . 73.03 110.712 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -74.77 -39.66 61.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.498 0.719 . . . . 63.43 110.399 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.22 -26.78 32.97 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.516 0.726 . . . . 75.32 110.771 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.45 173.38 10.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.43 0.692 . . . . 65.33 111.373 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -72.94 138.06 45.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.875 0.87 . . . . 70.24 110.722 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -84.88 69.62 10.78 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.801 0.81 . . . . 74.22 109.57 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -129.23 73.47 81.66 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.039 -0.982 . . . . 74.52 108.711 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.43 158.76 10.96 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.549 2.166 . . . . 62.33 112.173 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.43 127.89 44.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.769 -0.826 . . . . 71.33 108.769 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.03 94.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 123.75 0.656 . . . . 71.32 109.28 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -102.86 115.03 29.8 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.702 -1.221 . . . . 74.04 107.702 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.91 148.57 43.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.378 0.671 . . . . 75.34 109.702 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.595 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 27.7 m-20 -141.35 149.07 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.979 1.311 . . . . 74.52 108.847 170.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.92 160.93 22.46 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.064 -0.717 . . . . 75.22 109.064 169.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -159.28 144.64 15.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.492 0.717 . . . . 75.1 109.368 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 m -127.33 135.52 50.65 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.086 0.954 . . . . 74.44 108.829 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.83 133.02 45.57 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.157 0.983 . . . . 72.21 109.308 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -92.95 153.28 18.85 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.599 0.759 . . . . 73.25 110.59 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.7 t -160.45 138.91 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 72.54 108.622 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.9 122.17 42.6 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.92 -34.04 13.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.69 0.796 . . . . 74.0 111.976 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.87 -177.56 6.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 65.44 109.618 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.64 117.09 7.59 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.722 -0.844 . . . . 75.04 108.722 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 74.2 m-20 68.05 8.98 6.88 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.433 1.093 . . . . 71.51 112.776 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.09 106.38 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.777 -1.194 . . . . 74.51 107.777 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -107.78 162.51 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.594 0.711 . . . . 75.41 109.518 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -133.16 125.23 29.02 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.699 1.2 . . . . 74.42 108.35 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -107.49 121.01 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.212 -1.403 . . . . 75.53 107.212 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.501 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.4 t -99.53 136.73 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.538 -0.912 . . . . 73.14 108.538 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.08 114.1 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -104.7 128.6 52.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.871 0.868 . . . . 75.42 108.841 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -116.09 129.93 71.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.558 -0.904 . . . . 75.2 108.558 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 14.4 m -110.52 134.7 52.13 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.801 -0.815 . . . . 72.3 108.801 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 114' ' ' ILE . 53.0 t -135.18 106.57 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.437 1.095 . . . . 73.05 108.48 -174.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 45.6 m -104.25 138.31 40.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.413 -0.588 . . . . 75.23 109.413 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.31 112.17 17.8 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.167 -1.42 . . . . 54.22 107.167 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.7 m -130.95 129.37 42.08 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.195 0.598 . . . . 73.53 109.576 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.449 HD21 ' H ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -87.76 85.16 7.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.459 1.123 . . . . 73.2 108.479 177.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -86.65 1.28 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 114.23 -1.35 . . . . 64.32 111.237 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -121.74 -26.1 4.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.485 0.714 . . . . 74.41 110.878 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.78 127.51 32.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.956 0.502 . . . . 62.31 109.791 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.2 m -75.0 122.64 23.81 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.715 -0.476 . . . . 74.2 109.715 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.97 -51.66 11.92 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.59 -0.893 . . . . 73.23 108.59 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -166.73 169.58 13.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.479 -1.237 . . . . 74.34 110.239 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.417 HD11 ' H ' ' A' ' 76' ' ' CYS . 31.7 tp -137.13 143.34 42.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.252 1.021 . . . . 74.42 109.079 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.417 ' H ' HD11 ' A' ' 75' ' ' LEU . 21.2 m -135.5 136.69 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.334 1.054 . . . . 74.34 108.605 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.88 125.13 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.303 -0.628 . . . . 64.35 109.303 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.54 130.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 123.825 0.85 . . . . 71.51 109.653 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -103.41 90.92 3.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.375 1.07 . . . . 74.42 108.815 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.46 92.34 5.24 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.052 -1.092 . . . . 71.42 108.052 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.87 144.96 17.99 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.305 -0.718 . . . . 72.31 111.305 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.88 132.73 5.7 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.253 -0.739 . . . . 61.54 111.253 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.1 mt -85.12 128.71 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.435 -0.95 . . . . 75.41 108.435 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -134.98 118.26 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.636 -0.876 . . . . 74.14 108.636 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.4 t -85.29 99.09 10.9 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.621 -0.881 . . . . 75.24 108.621 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.87 141.8 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.818 0.847 . . . . 75.22 109.553 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . . . -177.03 152.51 0.91 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.877 0.871 . . . . 72.11 110.965 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.33 64.69 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.463 0.477 . . . . 73.41 113.934 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.454 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.2 mp -110.98 147.59 14.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.512 -1.292 . . . . 70.02 107.512 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -142.19 176.07 9.26 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.906 0.882 . . . . 74.44 108.63 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.97 -152.72 52.51 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.238 -0.437 . . . . 70.44 113.172 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.481 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 26.0 p -70.74 -15.33 62.68 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.197 0.999 . . . . 74.42 112.617 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -73.55 -42.23 61.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.045 0.538 . . . . 74.3 110.448 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.454 ' SD ' ' HB ' ' A' ' 89' ' ' ILE . 1.3 tpt -76.69 -31.38 57.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.724 -0.473 . . . . 71.1 109.724 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' ' HA ' ' A' ' 92' ' ' THR . . . -64.79 -32.59 74.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.697 0.799 . . . . 71.42 111.167 174.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.465 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.6 t-80 -61.9 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.64 -0.709 . . . . 75.53 110.019 170.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.3 m -73.44 -47.55 40.76 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.592 0.59 . . . . 64.32 112.592 -173.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -86.62 -23.69 25.61 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 111.75 0.278 . . . . 74.41 111.75 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.85 5.22 34.48 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.25 -0.75 . . . . 63.51 113.949 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.768 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.52 -60.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.169 0.985 . . . . 74.35 112.21 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.606 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -53.03 -60.17 3.62 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.544 1.138 . . . . 73.43 111.052 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 69.7 m -61.4 -51.8 74.96 Favored Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 114.167 1.173 . . . . 71.31 114.167 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.62 -26.64 75.79 Favored 'Trans proline' 0 C--N 1.394 2.954 0 CA-C-N 121.914 1.719 . . . . 71.53 113.609 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.72 -26.2 44.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.957 0.503 . . . . 72.54 110.833 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.6 mm -67.02 -42.35 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 121.661 0.743 . . . . 71.4 109.681 171.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.641 HD22 HG21 ' A' ' 16' ' ' ILE . 50.3 mt -79.86 -29.36 40.03 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.562 -1.199 . . . . 75.3 112.484 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.3 -42.63 81.72 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.514 1.302 . . . . 60.51 114.514 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.21 -35.48 95.48 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.296 1.997 . . . . 65.34 113.429 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -85.23 -29.57 24.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.607 0.763 . . . . 74.24 111.222 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.87 76.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.999 0.52 . . . . 73.45 109.779 173.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -58.41 -48.51 80.44 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.546 1.154 . . . . 74.43 109.968 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 2.9 tm-20 -61.73 -44.85 96.11 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.014 0.821 . . . . 74.1 111.062 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.482 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 42.0 t -62.87 -41.21 99.3 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.909 0.756 . . . . 74.42 111.491 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 64' ' ' VAL . 79.2 mt -66.28 -57.24 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.453 0.701 . . . . 74.45 110.534 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.413 HG21 ' HG3' ' A' ' 125' ' ' GLN . 94.4 m -53.45 -39.57 64.54 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.904 1.282 . . . . 72.24 111.778 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.24 -42.38 79.79 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.181 -0.918 . . . . 63.04 110.444 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.431 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 63.8 mtm -61.06 -37.73 83.68 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.731 0.412 . . . . 71.14 111.307 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 114' ' ' ILE . 80.9 t -59.66 -49.21 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.05 0.94 . . . . 72.03 110.458 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 83.5 p -71.59 -29.48 64.75 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.597 -0.728 . . . . 74.14 111.482 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.408 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -71.81 -29.89 64.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.588 0.755 . . . . 75.13 110.061 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.68 55.69 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.53 -0.759 . . . . 70.12 112.855 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.4 m 69.24 35.5 2.65 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-O 123.058 1.409 . . . . 62.31 109.63 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -115.33 149.94 43.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 114.818 -1.083 . . . . 73.42 109.34 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.85 151.96 73.61 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.561 2.174 . . . . 74.1 111.055 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.413 ' HG3' HG21 ' A' ' 115' ' ' THR . 2.3 tt0 -58.78 133.73 56.22 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.639 0.607 . . . . 73.41 112.639 -175.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.05 95.2 4.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.101 -1.074 . . . . 74.33 108.101 168.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -98.94 126.66 44.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.339 -0.985 . . . . 73.4 108.339 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.0 150.26 40.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.625 -0.716 . . . . 74.41 110.736 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.57 143.62 98.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.308 0.643 . . . . 63.24 110.881 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.96 109.58 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.475 2.117 . . . . 72.25 111.371 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.53 111.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.308 -1.738 . . . . 71.1 106.308 174.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.03 70.55 10.5 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.317 -1.364 . . . . 72.33 107.317 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -69.05 -28.76 66.83 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.699 -1.591 . . . . 74.1 111.374 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.768 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 6.4 p-10 . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 114.858 -1.065 . . . . 72.31 111.264 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.509 ' SD ' HD13 ' B' ' 89' ' ' ILE . 18.8 ptm . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 113.29 0.848 . . . . 74.1 113.29 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 98.0 m -140.13 127.72 21.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.706 0.802 . . . . 75.12 109.576 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.03 130.28 37.31 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -150.97 138.94 19.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.334 0.654 . . . . 72.11 109.237 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.53 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -90.17 128.68 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.451 -0.944 . . . . 74.32 108.451 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.471 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 10.4 mm100 -94.09 -49.87 5.56 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.314 -0.624 . . . . 74.24 109.314 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -164.05 146.07 9.04 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.678 -0.692 . . . . 75.02 109.17 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.15 145.78 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.047 -1.464 . . . . 74.22 107.047 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -169.71 146.28 3.23 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.452 0.569 . . . . 72.42 112.362 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -73.54 116.12 13.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.036 -0.984 . . . . 73.32 108.374 168.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -86.81 -34.16 19.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.672 -0.695 . . . . 75.55 110.691 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.48 142.09 18.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.645 -0.252 . . . . 61.33 110.56 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.472 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -132.49 144.35 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.752 1.221 . . . . 71.43 109.081 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.0 t -141.88 131.91 24.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 75.21 107.591 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -144.64 122.31 11.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.158 -1.423 . . . . 71.41 107.158 169.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 48.2 mt-10 -124.64 134.72 52.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.556 0.743 . . . . 73.44 109.174 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.512 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -132.2 80.75 63.15 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.497 -0.927 . . . . 73.12 108.497 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.69 -31.88 19.97 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.983 2.455 . . . . 75.34 111.71 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 40.8 m-80 -117.99 28.53 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.133 0.973 . . . . 74.32 109.887 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -49.46 -50.41 65.73 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.013 1.325 . . . . 75.03 113.82 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.05 -12.31 14.56 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.123 1.882 . . . . 75.11 112.83 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.457 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 68.2 m-70 -98.49 -6.83 29.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.075 0.95 . . . . 74.23 111.681 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.428 HG13 ' HE1' ' B' ' 123' ' ' PHE . 6.9 p -68.59 -15.7 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.191 0.596 . . . . 74.42 111.26 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . 0.46 ' HZ ' ' HD2' ' A' ' 15' ' ' ARG . 75.8 m-85 -76.18 -7.78 55.58 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.724 0.81 . . . . 74.22 111.781 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -82.33 -32.3 29.45 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.689 0.757 . . . . 54.31 109.095 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.491 ' HZ1' ' HA3' ' B' ' 69' ' ' GLY . 12.4 mmmm -106.73 90.83 3.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.527 -1.215 . . . . 75.53 110.556 -162.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.56 84.97 2.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.943 0.402 . . . . 73.23 110.427 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -153.45 -179.45 7.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.477 1.511 . . . . 75.3 108.052 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -78.82 118.63 73.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.142 -1.058 . . . . 73.33 108.142 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.72 149.92 67.78 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.477 2.118 . . . . 73.51 110.994 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.42 104.21 3.71 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.587 -0.894 . . . . 71.04 108.587 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.465 HG11 HD21 ' B' ' 126' ' ' LEU . 39.4 t -95.72 137.06 24.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.485 -0.78 . . . . 73.0 110.189 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -130.04 119.29 22.89 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.266 1.026 . . . . 74.43 108.405 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.691 HD13 HG21 ' B' ' 64' ' ' VAL . 1.6 mm? -104.44 134.96 46.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.942 -0.762 . . . . 75.02 108.942 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -137.45 153.32 50.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.074 0.95 . . . . 65.34 109.573 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.15 150.07 42.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.987 0.915 . . . . 74.32 109.727 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.1 t70 -136.7 141.75 43.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.103 0.961 . . . . 71.14 108.624 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.2 p -113.41 104.34 12.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.44 0.696 . . . . 72.44 109.445 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.66 156.63 33.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.038 0.935 . . . . 71.24 109.014 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -145.11 173.78 11.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 75.05 110.462 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -156.61 133.96 10.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.985 0.914 . . . . 73.3 109.016 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -81.38 120.75 25.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.964 0.506 . . . . 71.42 110.835 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -88.08 -37.87 15.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.425 0.69 . . . . 74.13 110.114 174.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.5 -176.11 5.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.873 0.869 . . . . 74.12 110.618 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.73 116.19 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.696 -1.138 . . . . 71.45 109.527 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' B' ' 85' ' ' SER . 20.3 m-20 72.18 -5.1 1.83 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.493 1.517 . . . . 64.23 112.872 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -105.19 96.41 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.523 -0.917 . . . . 75.02 108.523 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -112.34 138.44 49.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.815 -0.629 . . . . 74.51 109.313 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -101.95 97.57 7.9 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 125.192 1.397 . . . . 72.03 107.518 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -90.9 121.02 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.91 0.884 . . . . 74.23 110.198 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.566 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -102.97 120.82 53.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.544 0.738 . . . . 74.23 110.315 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.2 121.54 34.68 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.908 -1.516 . . . . 63.4 106.908 170.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 61.6 ttt180 -110.5 108.93 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.275 -0.639 . . . . 74.42 109.275 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.63 121.14 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.304 -0.999 . . . . 71.24 108.304 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.1 m -116.29 130.64 56.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.097 0.475 . . . . 75.35 109.896 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.691 HG21 HD13 ' B' ' 42' ' ' LEU . 51.8 t -111.37 135.46 50.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.912 1.285 . . . . 74.44 110.132 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 30.9 m -124.76 144.58 50.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.604 -0.887 . . . . 73.43 108.604 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 125.31 11.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.387 -0.968 . . . . 71.45 108.387 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.4 m -138.62 134.5 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.084 -0.71 . . . . 72.44 109.084 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 22.4 tp -133.57 122.94 24.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.779 -0.823 . . . . 71.23 108.779 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . 0.491 ' HA3' ' HZ1' ' B' ' 34' ' ' LYS . . . 73.99 -131.39 13.82 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.594 0.559 . . . . 71.32 112.573 -176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -93.78 1.41 56.49 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 75.15 111.147 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.73 155.83 48.15 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.101 0.56 . . . . 75.42 110.984 -167.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 130.53 39.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.685 -0.689 . . . . 73.24 109.665 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.02 -56.19 4.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.576 0.751 . . . . 65.3 109.208 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.68 161.47 23.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.772 -1.104 . . . . 72.43 109.739 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 95.4 mt -132.53 146.96 52.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.886 1.275 . . . . 62.23 108.22 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -150.15 157.15 42.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.195 -0.668 . . . . 75.33 109.195 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.4 tt0 -165.43 131.48 2.67 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.408 -0.96 . . . . 74.05 108.408 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.437 HG21 HD12 ' B' ' 21' ' ' ILE . 98.1 t -125.02 144.0 36.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.897 0.879 . . . . 73.34 108.693 175.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 19.7 mt-30 -122.84 89.87 3.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.711 -0.848 . . . . 73.14 108.711 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -81.68 100.01 9.23 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.14 -0.937 . . . . 61.13 108.502 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.61 169.97 37.93 Favored Glycine 0 C--O 1.244 0.78 0 N-CA-C 111.062 -0.815 . . . . 74.14 111.062 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.11 127.36 1.43 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.086 -0.806 . . . . 64.23 111.086 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 21.3 mt -84.98 129.52 37.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.623 -1.251 . . . . 75.22 107.623 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -132.25 162.51 30.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.474 1.11 . . . . 64.53 108.572 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 73.7 m -129.11 108.17 10.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.616 0.767 . . . . 62.02 109.042 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.427 ' H ' HD12 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -119.02 127.28 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.175 1.39 . . . . 75.43 108.782 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.625 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -140.6 145.53 36.81 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.628 0.771 . . . . 54.34 110.118 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -29.81 3.86 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.66 0.6 . . . . 54.13 114.237 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.509 HD13 ' SD ' ' B' ' 9' ' ' MET . 19.4 tt -78.4 139.51 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.683 0.793 . . . . 75.23 110.718 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.31 165.87 35.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.753 0.821 . . . . 74.33 111.608 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.29 -131.61 24.88 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.285 -0.871 . . . . 75.22 114.104 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -66.08 -36.66 83.78 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.385 1.074 . . . . 73.21 110.731 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.46 -34.64 72.65 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.45 -1.25 . . . . 73.11 110.096 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.424 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 56.9 ttp -52.95 -53.05 55.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.646 1.178 . . . . 75.21 110.732 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.34 72.51 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.279 -0.873 . . . . 73.31 111.924 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 20.4 t60 -71.03 -25.15 62.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.963 0.905 . . . . 73.12 110.969 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.13 -69.08 0.71 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.467 0.307 . . . . 73.03 111.464 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.8 pp -73.45 -22.86 60.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.542 0.571 . . . . 75.25 112.542 -170.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.87 -25.58 24.52 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.462 0.476 . . . . 64.23 112.508 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -122.91 -54.95 1.81 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.383 0.512 . . . . 63.21 112.383 -170.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -72.61 -48.66 37.82 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.554 0.576 . . . . 74.32 112.554 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.451 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.9 m -59.69 -48.09 96.07 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 118.608 -0.71 . . . . 74.3 111.482 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 75.2 Cg_exo -57.11 -34.87 98.55 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.426 2.084 . . . . 71.4 114.117 169.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -63.14 -34.17 77.05 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 122.95 0.5 . . . . 74.23 111.054 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.37 -47.44 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.889 0.876 . . . . 73.12 110.401 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -80.75 -19.6 44.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.954 -1.021 . . . . 74.52 112.742 -169.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -63.23 -46.85 85.75 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.41 -1.281 . . . . 62.54 113.63 -171.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.31 -37.0 97.63 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.055 1.837 . . . . 73.15 113.688 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -67.78 -48.92 64.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.101 0.56 . . . . 74.31 110.38 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.88 86.75 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.25 -0.886 . . . . 74.34 111.04 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.628 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.8 ttt180 -57.75 -57.83 11.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.679 1.591 . . . . 75.45 110.679 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.15 -31.09 71.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.07 -0.968 . . . . 72.1 110.538 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' B' ' 21' ' ' ILE . 5.2 t -70.9 -38.6 73.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.989 0.516 . . . . 71.51 111.361 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.658 HG21 HG22 ' B' ' 64' ' ' VAL . 77.3 mt -64.4 -50.13 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.267 0.627 . . . . 73.3 109.907 175.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.426 HG22 ' OG ' ' C' ' 119' ' ' SER . 20.6 m -58.16 -36.44 73.01 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.489 -1.232 . . . . 74.44 110.956 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.2 t -64.84 -45.37 86.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.357 -1.292 . . . . 64.44 110.719 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 38.0 mmt -59.44 -45.22 92.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.106 0.562 . . . . 74.5 111.711 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.642 0.777 . . . . 73.42 111.54 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.3 p -70.34 -28.4 65.11 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.725 -0.67 . . . . 73.32 112.086 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 113' ' ' CYS . 86.6 mtt-85 -67.07 -30.44 70.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.352 0.661 . . . . 75.32 111.232 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 13.26 39.64 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-O 119.613 -0.549 . . . . 73.52 112.94 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.6 p 54.81 23.65 5.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.441 1.896 . . . . 63.13 113.009 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG13 ' B' ' 31' ' ' VAL . 37.9 m-85 -89.97 156.92 46.53 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.76 0.824 . . . . 75.11 109.337 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.8 121.47 10.08 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 74.03 110.712 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.486 ' H ' ' HB2' ' C' ' 125' ' ' GLN . 4.9 pp0? -58.94 152.38 19.71 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.912 0.757 . . . . 65.21 112.284 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.465 HD21 HG11 ' B' ' 40' ' ' VAL . 1.4 tm? -111.32 105.5 14.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.766 -1.198 . . . . 75.24 107.766 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -90.85 112.59 24.49 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.963 -1.125 . . . . 73.33 107.963 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.628 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.13 117.98 10.68 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.676 -0.861 . . . . 74.25 108.676 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.65 87.64 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.636 0.585 . . . . 72.01 110.654 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.29 86.36 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.682 2.255 . . . . 74.3 112.571 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 80.7 t -91.13 110.79 22.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.585 -0.895 . . . . 74.13 108.585 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -88.61 109.79 20.39 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.165 -0.68 . . . . 73.24 109.165 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.86 -33.46 75.75 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.505 1.122 . . . . 73.42 109.826 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -59.93 -44.5 94.29 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.031 -1.441 . . . . 75.34 110.918 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.16 67.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.587 0.755 . . . . 74.34 111.557 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 122.807 0.443 . . . . 75.3 110.393 177.121 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 113.58 0.956 . . . . 74.44 113.58 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -87.43 103.9 15.95 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 169.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -124.88 141.09 52.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.944 0.897 . . . . 65.23 109.162 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -160.76 123.34 3.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.179 0.592 . . . . 74.23 109.729 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -76.14 140.62 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.755 -0.832 . . . . 74.23 108.755 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.671 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -111.45 -49.71 2.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.679 0.792 . . . . 75.32 110.219 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -164.01 123.35 1.99 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.791 0.436 . . . . 75.33 110.04 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.9 mt -106.46 148.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.056 -1.09 . . . . 72.31 108.056 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.587 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 38.0 p90 -173.98 168.64 4.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.365 0.666 . . . . 73.35 110.325 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.0 p -86.62 117.7 25.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.156 0.582 . . . . 75.31 109.635 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.587 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 24.4 mmmt -66.86 -46.79 73.94 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.819 -0.808 . . . . 73.53 108.819 172.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.23 150.99 34.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.275 -1.329 . . . . 71.42 109.388 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.6 mt -142.46 142.47 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.791 1.636 . . . . 72.53 106.892 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -154.19 149.55 27.16 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.798 0.839 . . . . 74.33 109.183 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -152.16 128.38 10.51 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.467 -1.309 . . . . 75.21 107.467 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.59 130.75 36.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 63.24 108.45 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 82.67 15.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.841 -0.8 . . . . 73.31 108.841 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -67.37 -30.95 35.9 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.134 2.556 . . . . 71.55 112.366 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.79 34.01 3.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.831 0.852 . . . . 74.02 110.172 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.542 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -59.65 -56.81 31.98 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.058 -0.972 . . . . 75.25 112.534 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 14.9 Cg_exo -68.45 -27.5 33.49 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.838 1.692 . . . . 73.0 111.827 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.93 -23.33 65.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.755 1.222 . . . . 74.44 112.539 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.712 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 5.5 p -59.07 -20.99 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.481 0.712 . . . . 64.44 112.39 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.26 -41.44 99.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.349 1.06 . . . . 73.22 111.341 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -109.82 44.97 1.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.069 0.937 . . . . 71.55 109.511 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.712 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 22.3 ttpt -125.17 140.98 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.655 0.782 . . . . 75.34 110.794 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.44 132.85 39.89 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.105 0.962 . . . . 74.42 109.592 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -84.78 71.5 10.84 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.946 0.899 . . . . 73.51 111.317 -172.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -143.32 69.67 17.77 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.961 -1.018 . . . . 74.45 108.411 168.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.98 140.08 2.72 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.402 2.068 . . . . 64.23 111.121 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.92 111.39 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 107.495 -1.298 . . . . 74.43 107.495 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -75.85 98.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.272 -1.011 . . . . 74.42 108.272 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 59.9 tttm -98.22 105.26 17.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.47 1.108 . . . . 74.33 108.959 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -87.73 156.8 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.989 0.515 . . . . 72.23 110.021 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -144.8 105.82 4.18 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.476 0.711 . . . . 62.34 109.728 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.31 126.47 50.48 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.857 -0.794 . . . . 73.41 108.857 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.1 t70 -135.09 151.65 50.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.869 0.867 . . . . 73.45 109.019 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 3.1 m -133.48 127.48 33.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.127 0.571 . . . . 65.45 111.112 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.14 164.2 19.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.893 1.277 . . . . 62.44 108.483 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -154.43 145.44 22.68 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.959 0.345 . . . . 74.33 110.982 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -145.76 129.54 17.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.642 1.177 . . . . 73.31 109.378 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.66 119.95 21.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.253 -0.647 . . . . 75.54 109.253 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.426 HD13 HD13 ' C' ' 83' ' ' ILE . 84.2 mt -87.69 -38.38 15.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.348 0.659 . . . . 74.33 111.097 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -159.06 -172.93 3.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.437 -0.802 . . . . 72.12 110.518 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.2 105.13 0.84 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.796 1.239 . . . . 73.3 110.08 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 69.0 6.73 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.352 1.461 . . . . 75.42 113.019 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 91.9 t -103.07 118.16 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.947 -0.76 . . . . 71.11 108.947 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.1 158.42 32.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.871 0.868 . . . . 73.34 109.353 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -126.16 137.79 53.61 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.622 -1.621 . . . . 75.22 106.622 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.31 133.08 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 109.908 -0.405 . . . . 74.23 109.908 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 46' ' ' THR . 46.3 t -110.93 107.23 22.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.498 1.119 . . . . 73.04 108.918 -174.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.23 101.35 13.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.546 -1.279 . . . . 72.24 107.546 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.6 ttt180 -79.38 129.57 34.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.489 1.116 . . . . 73.43 109.121 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.39 105.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.857 -1.164 . . . . 74.41 107.857 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.5 m -103.08 113.85 27.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.534 -0.913 . . . . 73.14 108.534 170.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 79.6 t -101.34 108.42 23.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.175 -1.046 . . . . 75.34 108.175 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.499 HG21 HD23 ' C' ' 75' ' ' LEU . 4.0 m -99.06 140.35 33.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.323 -0.991 . . . . 72.15 108.323 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.41 95.34 4.23 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.712 -1.588 . . . . 62.3 106.712 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -147.02 132.46 18.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.533 0.333 . . . . 74.1 111.145 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 65.8 tp -67.79 -30.61 70.08 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.629 0.772 . . . . 73.35 109.952 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.67 -87.55 0.09 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.266 -1.134 . . . . 53.12 110.266 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -89.11 -25.01 22.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.636 0.774 . . . . 73.33 109.091 171.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -90.5 96.02 10.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.253 1.021 . . . . 73.44 109.266 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -89.31 133.36 34.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 70.01 110.784 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.453 ' HA ' ' NZ ' ' C' ' 34' ' ' LYS . . . -75.03 -59.51 2.7 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.145 0.978 . . . . 64.24 109.845 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.03 170.75 21.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.774 -1.103 . . . . 73.54 111.01 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.499 HD23 HG21 ' C' ' 65' ' ' THR . 2.9 tm? -136.03 140.88 44.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.127 -1.805 . . . . 75.51 106.127 173.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.22 150.85 34.47 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.522 -0.918 . . . . 71.24 108.522 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.58 131.2 9.76 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.687 -0.486 . . . . 71.42 109.687 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.76 115.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.27 -1.011 . . . . 52.3 108.27 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 75.7 mt-30 -88.15 91.27 8.71 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.506 -1.294 . . . . 72.24 107.506 174.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -82.39 115.14 21.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.672 -0.694 . . . . 73.32 109.41 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.66 179.57 23.51 Favored Glycine 0 C--O 1.244 0.723 0 O-C-N 123.452 0.47 . . . . 51.33 112.836 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.91 154.65 16.54 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.245 -0.477 . . . . 51.22 112.022 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.8 mm -102.4 123.5 55.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.684 -1.228 . . . . 74.32 107.684 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -136.37 120.23 17.45 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.979 -0.748 . . . . 64.41 108.979 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.4 p -78.32 118.3 20.39 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.819 -0.808 . . . . 74.42 108.819 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.24 107.04 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 107.284 -1.376 . . . . 75.03 107.284 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.64 169.75 17.4 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.165 0.507 . . . . 70.35 111.735 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.21 -58.42 2.75 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 115.145 -0.934 . . . . 75.51 112.576 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.18 -177.55 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.685 0.794 . . . . 75.52 112.211 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.12 -173.89 4.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.708 0.803 . . . . 75.13 110.884 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.11 -141.51 39.66 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 116.086 -0.506 . . . . 74.32 113.748 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -68.08 -18.47 64.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.013 0.925 . . . . 71.34 111.637 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -68.9 -40.63 79.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.484 0.714 . . . . 74.23 110.522 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.74 -34.0 24.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.329 0.251 . . . . 50.31 110.755 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.45 -25.74 63.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.871 0.868 . . . . 73.41 111.764 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -57.54 -51.62 68.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.785 0.834 . . . . 75.02 110.324 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.48 -52.75 12.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.995 -0.548 . . . . 72.15 110.533 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.78 -25.91 67.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.438 0.695 . . . . 72.33 112.064 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.46 -29.06 8.55 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.055 -0.52 . . . . 72.25 113.847 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.07 -60.03 1.89 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.682 0.741 . . . . 64.34 111.202 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.01 -56.06 15.31 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.09 0.556 . . . . 65.32 112.235 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.483 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 59.5 m -56.9 -50.68 86.7 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.188 -0.911 . . . . 74.5 112.727 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 45.4 Cg_exo -61.16 -31.09 89.85 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.194 1.929 . . . . 73.54 113.286 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -28.93 62.85 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.772 0.829 . . . . 73.34 110.374 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.85 -39.97 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.399 1.08 . . . . 75.4 109.85 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' C' ' 102' ' ' CYS . 68.9 mt -82.59 -16.31 48.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.336 -0.847 . . . . 73.12 111.397 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.64 -55.29 44.6 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.059 -0.972 . . . . 74.11 113.141 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.414 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 37.5 Cg_endo -63.43 -37.85 46.41 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.085 1.857 . . . . 74.14 113.207 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -63.33 -45.86 89.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.322 0.649 . . . . 71.43 111.25 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.45 96.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.62 -0.718 . . . . 72.24 110.831 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 6.2 ttp-105 -60.51 -43.13 97.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 75.53 110.583 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.77 -34.89 67.27 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.922 0.764 . . . . 63.44 110.387 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.451 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 34.0 t -68.53 -30.33 69.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.787 0.435 . . . . 75.53 111.339 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.43 ' O ' HG23 ' C' ' 118' ' ' VAL . 92.5 mt -77.81 -43.97 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.833 -0.622 . . . . 54.44 110.094 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 54.3 m -55.93 -36.83 68.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.603 0.761 . . . . 72.13 110.427 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.7 t -61.06 -53.75 53.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.228 -1.351 . . . . 72.14 109.535 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.478 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.76 -38.02 80.65 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.847 1.259 . . . . 72.23 113.28 -178.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.4 t -63.98 -49.27 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.705 0.802 . . . . 72.33 109.349 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.426 ' OG ' HG22 ' B' ' 115' ' ' THR . 33.7 t -68.74 -26.49 65.27 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.167 -0.924 . . . . 74.41 111.747 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.6 mtt-85 -68.83 -39.25 80.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.279 0.632 . . . . 73.32 109.482 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 10.35 60.51 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.626 0.579 . . . . 73.11 112.747 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p 56.38 40.68 29.65 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.055 1.742 . . . . 74.41 112.503 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.16 156.82 34.84 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.583 -1.189 . . . . 74.15 108.281 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 171.47 9.11 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.084 2.523 . . . . 75.5 113.858 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.486 ' HB2' ' H ' ' B' ' 125' ' ' GLN . 51.3 tp60 -60.23 132.07 52.76 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.318 -0.856 . . . . 74.52 113.083 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.92 85.9 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.477 -1.305 . . . . 74.2 107.477 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -95.71 105.89 17.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.851 -1.166 . . . . 71.43 107.851 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -74.2 137.0 42.8 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 106.775 -1.565 . . . . 74.21 106.775 170.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.65 131.87 55.56 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 124.342 1.026 . . . . 72.13 111.506 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 16' ' ' ILE . 17.4 Cg_exo -68.09 89.22 0.38 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.512 2.141 . . . . 72.32 111.168 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 94.0 t -97.92 109.67 24.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.464 -0.789 . . . . 65.5 109.31 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -104.77 83.0 1.95 Allowed 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.261 -1.015 . . . . 74.34 108.261 176.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.78 -44.58 69.84 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.107 -0.951 . . . . 75.41 111.267 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.482 1.127 0 C-N-CA 123.268 0.627 . . . . 73.14 110.946 177.296 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.465 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.5 ptm . . . . . 0 CA--C 1.562 1.414 0 N-CA-C 114.648 1.351 . . . . 75.21 114.648 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.2 m -144.0 140.25 29.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.279 1.032 . . . . 74.23 108.265 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' D' ' 85' ' ' SER . 78.5 t80 -155.57 113.64 3.4 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.346 -0.983 . . . . 75.31 108.346 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -134.81 131.05 37.0 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.421 0.688 . . . . 75.45 109.643 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.94 141.18 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.481 -0.933 . . . . 73.44 108.481 172.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -111.5 -46.03 3.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.682 0.393 . . . . 65.54 110.673 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.22 122.84 1.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.148 -0.315 . . . . 72.4 110.148 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.6 126.69 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 106.523 -1.658 . . . . 74.12 106.523 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -168.1 178.03 5.26 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.811 0.695 . . . . 73.01 111.538 -165.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.6 p -108.21 133.48 52.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.005 -0.998 . . . . 65.03 109.59 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.43 -32.92 9.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.428 -0.582 . . . . 75.34 109.428 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -144.21 138.61 28.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.867 -1.061 . . . . 64.34 108.898 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.478 HG21 ' HE1' ' C' ' 117' ' ' MET . 60.6 mt -141.15 149.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 72.13 108.199 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -152.74 145.39 24.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.249 0.62 . . . . 74.21 110.35 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.3 t80 -147.58 124.8 11.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.689 -1.597 . . . . 74.44 106.689 168.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.0 mp0 -120.16 142.04 49.32 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.692 -0.855 . . . . 75.52 108.692 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.467 ' HB3' ' HB1' ' D' ' 28' ' ' ALA . . . -148.28 73.75 10.88 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.355 -0.979 . . . . 71.01 108.355 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.38 -18.57 17.82 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.446 2.097 . . . . 73.2 111.553 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.463 ' O ' HG23 ' D' ' 31' ' ' VAL . 57.5 m-20 -114.23 23.88 12.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.136 0.974 . . . . 73.14 109.617 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.492 ' HA ' ' HZ ' ' D' ' 123' ' ' PHE . . . -48.0 -53.8 29.61 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.885 1.439 . . . . 74.32 114.885 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.524 ' HB3' HD11 ' C' ' 83' ' ' ILE . 28.6 Cg_endo -84.48 -4.32 10.09 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.482 1.454 . . . . 55.15 112.892 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.437 ' CE1' ' HG2' ' D' ' 71' ' ' GLU . 21.5 t-160 -80.62 -36.95 31.95 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.848 1.259 . . . . 73.54 109.522 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.463 HG23 ' O ' ' D' ' 27' ' ' ASN . 59.3 t -72.77 -25.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.332 0.653 . . . . 74.11 110.663 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.29 -28.99 57.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.07 0.948 . . . . 73.13 112.083 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -76.41 -15.32 59.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.324 0.65 . . . . 73.44 112.408 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -125.61 111.92 15.56 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.439 0.696 . . . . 74.44 110.641 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.25 87.33 7.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.975 0.91 . . . . 72.53 109.855 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.673 ' HB3' HD13 ' D' ' 68' ' ' LEU . 42.6 t-105 -160.01 158.08 29.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.724 -0.843 . . . . 75.22 108.724 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.44 116.82 56.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.077 0.551 . . . . 73.54 109.918 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.07 141.87 86.5 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.134 2.556 . . . . 73.45 113.593 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.61 113.38 4.18 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.55 -0.907 . . . . 72.52 108.55 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.418 HG12 HG11 ' D' ' 64' ' ' VAL . 61.8 t -99.09 106.57 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.65 -0.5 . . . . 74.42 109.65 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -87.41 109.39 19.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.194 -1.41 . . . . 75.54 107.194 167.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.77 156.29 16.39 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.52 -0.918 . . . . 74.14 108.52 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.498 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.7 t70 -151.2 155.74 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.157 0.583 . . . . 74.01 109.966 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -133.35 152.12 51.9 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.348 0.659 . . . . 74.43 110.824 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.5 t70 -153.36 151.51 30.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.006 1.322 . . . . 64.32 108.175 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -128.9 152.37 48.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.299 -0.63 . . . . 71.21 109.299 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.79 169.6 20.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.557 -0.905 . . . . 72.51 108.557 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -149.04 159.45 44.21 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.84 0.456 . . . . 75.41 110.737 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -155.7 119.26 4.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.115 0.966 . . . . 74.0 109.184 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.23 121.62 23.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.83 -0.433 . . . . 72.12 109.83 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.475 HD11 HG22 ' D' ' 83' ' ' ILE . 90.5 mt -99.63 -26.5 14.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.416 0.686 . . . . 73.33 110.889 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.17 -177.01 3.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.026 0.93 . . . . 71.53 110.036 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.46 120.57 22.64 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.23 -1.026 . . . . 72.23 108.23 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 72.15 3.87 4.82 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.067 1.347 . . . . 72.33 112.742 -172.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.15 117.51 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.423 -0.584 . . . . 61.41 109.423 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -133.04 130.5 39.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.362 0.665 . . . . 73.21 109.468 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -87.16 140.1 29.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 64.1 108.372 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.34 132.87 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.76 -1.2 . . . . 75.31 107.76 169.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.72 130.94 57.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.564 1.145 . . . . 74.35 108.783 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 121.8 45.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.675 -0.861 . . . . 73.21 108.675 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.5 ttm-85 -106.88 99.17 8.76 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.891 -0.781 . . . . 74.34 108.891 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.59 104.13 15.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.199 -1.037 . . . . 71.41 108.199 172.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.2 m -99.3 148.12 24.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.152 -0.931 . . . . 74.52 110.022 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.515 HG21 HD12 ' D' ' 114' ' ' ILE . 25.3 t -138.43 132.98 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.629 1.572 . . . . 75.31 107.927 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -133.94 93.44 3.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.721 -1.215 . . . . 74.41 107.721 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.36 141.76 29.3 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.719 -0.673 . . . . 65.31 109.288 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -149.51 126.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.123 0.969 . . . . 71.31 108.975 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.673 HD13 ' HB3' ' D' ' 36' ' ' TRP . 19.7 tp -99.13 114.06 26.61 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.58 -0.896 . . . . 74.54 108.58 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.95 -113.33 4.13 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.7 0.625 . . . . 72.52 113.051 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 5.88 41.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.728 0.811 . . . . 72.33 111.205 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' CE1' ' D' ' 30' ' ' HIS . 9.7 tp10 -149.22 151.52 34.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.471 0.308 . . . . 71.43 111.336 -165.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' THR . . . . . 0.436 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 71.8 m -55.21 141.46 35.11 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.983 1.313 . . . . 75.02 111.711 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.402 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -106.99 -71.85 0.74 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.037 0.935 . . . . 73.05 109.522 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -147.54 137.63 22.99 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.367 0.603 . . . . 71.33 109.778 173.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 51.3 mt -105.03 154.02 20.69 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.397 1.079 . . . . 75.52 108.491 175.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.669 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.5 t -160.64 146.28 14.78 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.935 0.494 . . . . 75.12 110.043 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.05 126.48 6.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.379 -0.6 . . . . 65.03 109.379 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.71 116.88 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.787 0.435 . . . . 62.22 110.638 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.7 mt-30 -92.45 88.03 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.29 1.036 . . . . 73.35 110.084 170.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.2 98.73 7.48 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.679 -1.146 . . . . 73.14 108.857 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.38 141.89 17.01 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.627 -0.589 . . . . 72.45 111.627 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -139.72 132.16 5.47 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.291 -0.723 . . . . 62.15 111.291 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.475 HG22 HD11 ' D' ' 51' ' ' LEU . 58.0 mt -90.52 123.6 42.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 C-N-CA 123.93 0.892 . . . . 75.43 109.007 177.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -133.04 141.32 48.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.124 0.57 . . . . 71.44 109.684 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 33.2 m -100.17 105.23 16.81 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.726 0.81 . . . . 73.12 108.972 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mt -108.04 102.03 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.596 -0.89 . . . . 75.21 108.596 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.18 169.1 16.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.004 1.321 . . . . 74.53 109.879 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.42 -4.66 33.06 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 114.49 0.556 . . . . 75.13 114.49 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.44 151.41 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.96 0.904 . . . . 72.55 109.863 -170.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.15 177.02 8.07 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.014 0.926 . . . . 73.01 111.974 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -132.64 48.25 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 116.287 1.275 . . . . 74.45 116.287 165.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 8.5 t -62.94 -35.89 81.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 73.23 112.45 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -73.79 -39.42 64.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.774 0.43 . . . . 71.24 111.626 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.9 ptm -73.63 -31.95 63.78 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 110.022 -0.362 . . . . 75.2 110.022 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.75 70.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.438 0.695 . . . . 74.31 110.628 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -71.86 -33.36 68.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.159 0.984 . . . . 74.4 110.321 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.9 -52.1 53.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.157 -0.474 . . . . 72.21 110.548 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.59 -18.02 46.26 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.82 0.448 . . . . 73.4 112.114 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.65 -26.63 16.82 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-O 119.795 -0.447 . . . . 75.11 113.72 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.88 -59.36 1.27 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.932 0.493 . . . . 63.1 111.641 -174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -67.29 -47.23 71.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.377 0.423 . . . . 74.34 111.972 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.4 m -67.61 -45.46 46.15 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 118.328 -0.844 . . . . 71.11 111.936 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.92 -35.23 98.47 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.359 2.039 . . . . 74.41 113.498 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.17 -32.96 74.71 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.415 0.686 . . . . 72.01 110.784 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.54 -45.06 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.416 0.687 . . . . 71.53 109.815 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' D' ' 82' ' ' GLY . 90.1 mt -73.68 -21.4 60.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.162 -0.926 . . . . 74.1 112.1 -174.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.416 ' HZ ' HD13 ' D' ' 128' ' ' LEU . 42.8 t80 -66.12 -46.81 62.89 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 113.934 1.087 . . . . 64.4 113.934 -168.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.67 -34.16 97.74 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.072 1.848 . . . . 74.43 112.768 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -76.03 -37.68 58.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.023 0.929 . . . . 72.53 111.026 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -49.94 67.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.565 0.746 . . . . 72.34 110.792 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -71.54 -31.88 67.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.862 -1.063 . . . . 75.1 111.186 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.02 -42.94 89.0 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.029 0.831 . . . . 74.2 110.707 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.437 ' SG ' HD11 ' D' ' 21' ' ' ILE . 43.0 t -58.5 -39.5 80.24 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.821 0.7 . . . . 75.24 110.259 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.669 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.0 mt -61.56 -54.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.69 0.796 . . . . 74.44 110.35 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.458 HG22 ' HG3' ' D' ' 125' ' ' GLN . 28.8 m -57.71 -39.06 76.35 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.463 1.105 . . . . 72.31 111.593 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -67.06 -43.61 82.23 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 114.855 -1.066 . . . . 75.4 110.141 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.65 -27.18 63.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.775 0.43 . . . . 74.23 111.738 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.1 t -67.96 -43.09 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.564 0.746 . . . . 72.44 109.651 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 94.1 p -74.27 -25.98 59.93 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.895 0.478 . . . . 71.12 111.225 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.451 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.6 mtt-85 -75.38 -32.17 60.72 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.456 0.703 . . . . 75.12 109.758 173.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.56 -0.37 89.92 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.62 -0.718 . . . . 64.44 111.991 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.7 p 63.39 27.27 15.23 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.68 1.992 . . . . 74.04 113.257 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 56.5 m-85 -94.07 162.3 27.11 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 124.707 1.203 . . . . 74.41 110.535 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.1 140.91 97.22 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 123.483 2.789 . . . . 63.2 112.402 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.458 ' HG3' HG22 ' D' ' 115' ' ' THR . 34.1 tt0 -54.68 135.01 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.119 0.968 . . . . 75.34 112.722 -174.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -126.02 102.5 7.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.892 0.877 . . . . 73.34 109.913 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -102.58 121.44 42.39 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.71 -0.848 . . . . 74.41 108.71 175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.416 HD13 ' HZ ' ' D' ' 107' ' ' PHE . 0.1 OUTLIER -74.76 114.54 13.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.345 -0.983 . . . . 64.55 108.345 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.12 143.36 97.7 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 122.63 0.372 . . . . 73.14 110.898 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.81 132.22 22.81 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 72.4 112.887 -169.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.18 128.97 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.136 0.574 . . . . 73.35 109.771 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.73 93.3 7.9 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.88 -0.785 . . . . 72.34 108.88 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 123.242 0.617 . . . . 72.34 111.101 -178.976 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 90.1 m . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 107.554 -1.276 . . . . 64.42 107.554 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -138.82 121.85 16.75 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.026 -0.731 . . . . 74.44 109.026 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 29.6 tt0 -134.12 111.7 10.54 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.585 0.754 . . . . 71.22 109.159 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.62 109.21 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 108.174 -1.047 . . . . 72.13 108.174 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -91.99 -40.53 11.06 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.407 -0.59 . . . . 74.53 109.407 -174.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -170.73 140.96 1.75 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.321 0.648 . . . . 74.5 110.083 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.554 HG21 HD23 ' A' ' 106' ' ' LEU . 3.9 mp -128.59 100.54 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.033 -1.469 . . . . 74.5 107.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -160.82 175.8 12.17 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.234 1.014 . . . . 75.2 110.157 -166.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -81.44 127.01 32.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.649 0.261 . . . . 71.1 110.692 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -83.27 -47.45 11.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.755 0.788 . . . . 74.44 109.045 165.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 12.0 t70 -136.86 139.36 41.61 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.529 -1.214 . . . . 74.24 109.595 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.555 HG22 ' SD ' ' A' ' 117' ' ' MET . 78.5 mt -128.21 136.06 61.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.876 -1.527 . . . . 74.41 106.876 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -146.16 108.24 4.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.162 -0.681 . . . . 73.55 109.162 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 89.8 t80 -112.56 119.26 37.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.959 -1.497 . . . . 73.14 106.959 173.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -127.99 111.93 14.09 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.038 -0.727 . . . . 73.21 109.038 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.19 84.68 4.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.613 -1.255 . . . . 74.31 107.613 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.38 -31.29 18.03 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.285 1.99 . . . . 74.32 111.428 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.7 m-20 -109.29 34.38 3.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.501 1.12 . . . . 73.43 108.767 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.24 -47.33 98.5 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.658 0.783 . . . . 62.35 113.059 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.64 -24.59 41.31 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.229 1.953 . . . . 73.21 113.275 171.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 25.4 m80 -64.89 -38.11 89.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.613 0.365 . . . . 74.44 110.611 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.81 -25.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.79 0.436 . . . . 74.54 111.626 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.26 -38.44 90.33 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.108 0.563 . . . . 74.41 111.283 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -90.32 -21.19 22.16 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.902 0.481 . . . . 71.23 111.12 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HZ1' HD21 ' A' ' 68' ' ' LEU . 6.1 tmtt? -82.0 148.79 28.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.036 0.934 . . . . 62.41 111.479 -172.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.42 139.34 57.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.638 0.775 . . . . 74.43 110.736 170.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -84.61 74.04 10.48 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.927 0.87 . . . . 74.41 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -139.38 74.12 35.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.779 -0.823 . . . . 62.22 108.779 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.46 141.51 4.01 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.433 2.088 . . . . 64.14 112.665 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.94 121.97 40.5 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.874 -1.158 . . . . 74.21 107.874 171.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.67 115.49 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.184 0.594 . . . . 73.31 110.542 -167.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -93.77 121.09 34.85 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.298 1.039 . . . . 71.52 109.15 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.0 129.36 55.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.463 0.705 . . . . 72.1 110.328 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -114.39 113.46 24.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.806 0.843 . . . . 74.5 108.8 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.24 118.27 36.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.487 -1.301 . . . . 74.21 107.487 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' O ' HD22 ' A' ' 60' ' ' LEU . 21.6 t70 -129.23 144.93 51.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.77 0.828 . . . . 73.33 109.782 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.4 m -142.13 135.72 29.33 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.273 0.629 . . . . 73.45 110.342 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.48 119.65 9.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.439 0.695 . . . . 72.02 110.928 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 t -91.73 154.21 19.12 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.374 -0.602 . . . . 74.33 109.374 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.3 t -161.86 115.94 1.9 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 117.932 0.333 . . . . 73.14 110.308 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.44 105.87 5.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.784 0.834 . . . . 74.32 111.651 -172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 57' ' ' GLU . 70.1 mt -77.93 -40.48 39.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.85 0.86 . . . . 75.25 111.253 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.99 -172.0 3.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.122 0.969 . . . . 74.41 109.542 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.07 100.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.323 0.649 . . . . 62.41 111.159 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.86 32.79 13.02 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.797 1.239 . . . . 71.54 113.083 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 49.1 t -108.51 121.64 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 106.715 -1.587 . . . . 71.44 106.715 167.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -132.48 131.04 41.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.254 -0.647 . . . . 65.32 109.254 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HB2' HD13 ' A' ' 51' ' ' LEU . 41.1 tt0 -86.37 120.22 27.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.629 -0.878 . . . . 63.42 108.629 168.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.33 116.25 42.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.715 -1.217 . . . . 74.52 107.715 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.2 t -98.07 134.88 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.129 -0.693 . . . . 74.35 109.129 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -109.39 109.86 20.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.141 -1.429 . . . . 75.21 107.141 171.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -96.99 102.0 13.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.913 -1.143 . . . . 74.0 107.913 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.86 140.6 16.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.511 -1.292 . . . . 73.24 107.511 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -129.48 124.4 33.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.338 -0.616 . . . . 74.22 109.338 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 114' ' ' ILE . 70.8 t -115.76 105.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.935 -1.135 . . . . 75.21 107.935 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.3 m -112.33 122.86 48.93 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.561 -0.903 . . . . 71.23 108.561 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.25 110.81 21.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.613 -1.625 . . . . 72.35 106.613 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -148.38 147.47 29.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 70.23 109.827 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.597 HD21 ' HZ1' ' A' ' 34' ' ' LYS . 28.1 tp -113.32 86.85 2.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.032 -1.099 . . . . 65.53 108.032 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.11 -93.12 1.5 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.15 -0.932 . . . . 74.31 111.472 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -116.04 -26.9 7.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.72 0.808 . . . . 74.41 111.014 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.0 tp10 -77.67 107.08 9.9 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.184 -1.043 . . . . 72.25 108.184 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -76.01 142.53 41.85 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.479 -0.563 . . . . 75.15 109.479 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.46 -58.68 2.47 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.377 -0.971 . . . . 74.44 108.377 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -168.89 176.76 5.3 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.558 0.743 . . . . 75.15 110.727 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.3 tp -139.42 141.82 37.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.186 1.395 . . . . 74.41 108.342 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.453 ' HB3' ' HE1' ' A' ' 117' ' ' MET . 35.3 m -147.69 97.79 2.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.943 0.497 . . . . 75.03 110.144 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.43 122.32 46.04 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.575 0.75 . . . . 74.34 109.622 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.11 115.0 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.535 0.734 . . . . 71.14 109.864 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -85.91 82.19 8.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.401 1.081 . . . . 74.22 108.207 172.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.49 93.57 3.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.899 -1.046 . . . . 72.33 108.97 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.47 145.91 18.66 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.138 -0.483 . . . . 61.55 111.9 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.515 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -140.56 122.76 2.22 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 110.205 -1.158 . . . . 75.31 110.205 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' B' ' 29' ' ' PRO . 54.9 mt -82.21 126.83 40.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.8 -0.815 . . . . 74.03 108.8 175.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -132.71 117.05 17.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.426 -0.953 . . . . 71.32 108.426 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 40.7 t -84.56 97.64 9.7 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.397 -0.964 . . . . 73.34 108.397 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 10' ' ' THR . 34.1 pt -120.21 125.67 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.696 0.76 . . . . 64.41 111.59 -172.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.73 158.82 43.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.0 1.32 . . . . 63.35 108.932 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.17 8.74 86.07 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.796 -0.447 . . . . 55.11 114.213 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.463 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -117.69 134.1 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.823 -0.806 . . . . 74.23 108.823 173.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.33 169.1 17.72 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.99 0.516 . . . . 71.34 111.198 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.95 -111.76 0.79 Allowed Glycine 0 C--N 1.358 1.773 0 O-C-N 124.774 1.296 . . . . 44.13 115.209 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.0 p -70.12 -35.84 74.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.176 0.99 . . . . 70.32 111.772 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.89 -47.56 82.77 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.268 0.627 . . . . 72.31 111.197 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -72.13 -35.75 69.21 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.019 0.528 . . . . 74.02 111.333 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.09 81.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.546 0.738 . . . . 64.11 110.595 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -46.88 86.73 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.625 -1.171 . . . . 73.01 109.985 172.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.0 m -70.84 -37.66 73.16 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.048 0.758 . . . . 74.23 113.048 -172.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.433 HD22 HD13 ' A' ' 86' ' ' ILE . 77.8 mt -84.84 -18.86 33.56 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.926 0.343 . . . . 74.22 111.926 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.71 -10.85 54.97 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 119.831 -0.427 . . . . 61.24 113.268 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -73.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.734 -0.651 . . . . 61.25 112.642 -172.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.5 t80 -41.41 -54.92 2.94 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 124.882 1.273 . . . . 73.11 113.158 -175.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -78.6 -52.54 1.34 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-O 118.256 -0.878 . . . . 72.1 112.975 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HA ' HD12 ' A' ' 106' ' ' LEU . 38.6 Cg_endo -64.67 -25.27 61.69 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.791 1.661 . . . . 72.1 114.448 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -71.62 -33.98 69.43 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.933 0.493 . . . . 75.15 110.454 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.0 mm -62.16 -42.37 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.273 0.629 . . . . 74.12 109.879 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.554 HD23 HG21 ' A' ' 16' ' ' ILE . 60.2 mt -72.89 -25.42 61.06 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.586 -0.734 . . . . 74.33 111.678 -174.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.58 -43.32 70.35 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 115.088 1.514 . . . . 71.43 115.088 -168.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.23 -34.52 98.66 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.114 1.876 . . . . 74.11 113.232 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.418 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 84.3 m-85 -80.0 -35.55 37.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.733 0.813 . . . . 73.44 111.158 -176.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.1 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.135 0.574 . . . . 75.32 109.574 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.407 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.1 ttm180 -53.79 -45.64 70.77 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.764 1.29 . . . . 75.41 110.466 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.08 -50.23 64.82 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.633 0.773 . . . . 71.42 111.352 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.2 t -56.09 -46.6 78.99 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.214 0.946 . . . . 73.13 110.659 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.555 HG21 HG22 ' A' ' 64' ' ' VAL . 11.6 mt -57.77 -54.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.104 0.878 . . . . 75.21 110.657 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 125' ' ' GLN . 65.8 m -56.44 -39.54 73.3 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.73 0.644 . . . . 73.41 111.594 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.35 -39.27 81.93 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.474 -0.785 . . . . 74.41 109.814 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.591 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 17.6 mtp -61.17 -40.85 95.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.524 0.73 . . . . 64.21 110.92 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 114' ' ' ILE . 92.1 t -62.89 -46.5 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.268 1.027 . . . . 75.15 110.698 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.7 p -75.25 -37.05 61.18 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.575 -0.739 . . . . 74.34 111.211 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -66.31 -28.33 68.6 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.308 0.643 . . . . 73.44 109.909 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.01 -3.07 89.36 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.558 -0.747 . . . . 75.51 113.43 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 65.83 38.32 5.18 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.028 1.394 . . . . 70.31 110.541 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.05 150.53 43.72 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 115.025 -0.989 . . . . 75.32 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.7 130.53 40.43 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.935 2.423 . . . . 75.05 112.271 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HG3' HG22 ' A' ' 115' ' ' THR . 32.7 tt0 -58.46 127.31 31.49 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.064 0.853 . . . . 74.35 112.128 -175.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.9 mt -117.32 95.58 5.04 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.994 -1.113 . . . . 72.32 107.994 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -98.4 126.74 44.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.746 -0.835 . . . . 75.13 108.746 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.28 149.0 40.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.772 -0.649 . . . . 74.13 111.958 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.03 142.02 87.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.326 0.651 . . . . 65.52 110.142 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 5.4 Cg_endo -78.24 96.94 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.171 1.914 . . . . 74.31 110.785 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.66 114.04 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.752 0.787 . . . . 73.34 109.04 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -93.23 93.28 8.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.964 -1.016 . . . . 73.43 109.663 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -64.55 -26.59 68.48 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.306 -0.861 . . . . 70.32 111.316 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 123.625 0.77 . . . . 72.24 110.214 -175.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 114.205 1.187 . . . . 74.01 114.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.3 m -148.2 131.34 16.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.73 0.812 . . . . 74.44 109.059 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' B' ' 85' ' ' SER . 66.9 t80 -136.58 142.74 43.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.756 0.422 . . . . 74.31 110.397 172.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -155.92 140.49 16.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.317 1.047 . . . . 74.1 109.306 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.07 106.35 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.478 -1.304 . . . . 74.0 107.478 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -78.24 -46.42 20.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.68 0.392 . . . . 74.23 110.19 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -163.58 140.87 7.3 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.063 -0.517 . . . . 74.25 110.166 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.1 mt -117.96 144.84 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.342 -1.355 . . . . 75.13 107.342 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.429 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.7 p90 -170.12 147.0 3.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.592 0.633 . . . . 73.41 111.913 -177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -72.92 119.22 16.87 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.666 -1.152 . . . . 73.52 108.069 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -90.95 -30.25 16.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.326 0.65 . . . . 75.35 110.851 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -158.02 138.94 13.15 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.583 0.552 . . . . 72.03 111.112 -171.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.457 HD12 HG21 ' B' ' 78' ' ' VAL . 47.8 mm -132.33 138.22 52.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 C-N-CA 124.635 1.174 . . . . 74.3 109.007 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -131.25 136.08 47.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.332 -1.359 . . . . 75.11 107.332 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.488 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.6 t80 -151.84 122.1 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.363 -1.347 . . . . 74.31 107.363 171.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.62 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 42.1 mt-10 -124.1 133.68 53.55 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.29 -1.004 . . . . 75.13 108.29 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.78 87.47 54.67 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.162 -0.681 . . . . 62.4 109.162 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.7 -22.99 36.62 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.158 1.905 . . . . 70.31 111.004 172.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -115.04 24.96 11.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.135 0.974 . . . . 74.14 111.148 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.81 -53.64 40.21 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 123.704 0.801 . . . . 75.51 111.133 164.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.582 ' HA ' HD13 ' A' ' 83' ' ' ILE . 69.2 Cg_endo -77.0 -22.78 11.16 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.907 1.738 . . . . 71.32 113.374 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -94.46 2.94 55.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.54 0.736 . . . . 74.01 111.662 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.83 -31.73 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.222 1.009 . . . . 74.43 112.813 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -74.12 -34.83 64.05 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.354 . . . . 74.42 110.772 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -68.93 -23.78 64.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.648 1.179 . . . . 64.03 110.962 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' B' ' 34' ' ' LYS . 10.6 mmpt? -75.9 100.27 4.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.253 0.621 . . . . 64.53 111.422 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -113.42 78.84 1.17 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.339 1.056 . . . . 75.25 111.149 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -176.89 178.22 1.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.626 1.97 . . . . 75.44 107.143 171.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.56 131.93 36.63 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.501 -0.926 . . . . 71.24 108.501 164.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.466 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 47.6 Cg_endo -67.7 133.6 30.12 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.165 1.91 . . . . 72.43 112.961 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 25.5 tt0 -51.21 117.18 2.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.811 1.244 . . . . 70.5 109.631 164.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 134.2 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.736 0.414 . . . . 60.32 110.604 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -142.85 101.83 3.92 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.343 1.057 . . . . 73.11 108.611 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -94.8 153.07 17.92 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.177 -0.675 . . . . 70.45 109.177 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -138.35 130.27 28.26 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.403 -0.962 . . . . 73.44 108.403 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.96 128.47 53.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.606 -1.257 . . . . 75.35 107.606 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.3 t70 -142.85 155.66 44.81 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.428 1.091 . . . . 61.12 108.777 -174.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.1 p -141.89 119.59 11.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.369 0.668 . . . . 64.33 110.358 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.99 119.07 25.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.372 -0.973 . . . . 72.2 108.372 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -117.0 164.54 14.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.637 0.375 . . . . 72.5 110.979 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -152.41 136.89 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.2 1.0 . . . . 73.31 109.03 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -80.8 121.62 26.16 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.227 -0.657 . . . . 75.3 109.227 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 45.6 mt -80.53 -39.87 27.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.564 -0.532 . . . . 70.54 109.564 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.25 -179.1 4.88 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.758 -1.11 . . . . 51.53 109.966 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.78 129.59 41.15 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.409 -0.814 . . . . 74.44 108.95 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' B' ' 85' ' ' SER . 2.5 m-20 71.07 1.49 3.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.479 1.112 . . . . 74.44 112.283 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 t -125.75 88.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.475 -0.935 . . . . 74.32 108.475 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -108.86 137.85 46.13 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.823 -0.806 . . . . 74.43 108.823 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -119.76 108.3 14.25 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.405 -0.961 . . . . 74.24 108.405 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -99.94 124.11 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.857 0.863 . . . . 51.23 109.188 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.535 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 24.9 t -103.33 124.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 109.575 -0.528 . . . . 62.2 109.575 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.3 116.48 29.04 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.001 -1.481 . . . . 73.21 107.001 171.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.502 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 43.1 ttt180 -105.17 107.82 19.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.144 0.577 . . . . 63.41 109.887 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.9 t -107.9 121.39 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.963 -0.754 . . . . 74.32 108.963 172.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -109.46 141.96 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.365 0.666 . . . . 72.33 109.532 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.575 HG23 HD12 ' B' ' 114' ' ' ILE . 43.0 t -124.88 127.0 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.997 0.919 . . . . 74.2 108.658 171.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -125.62 147.24 49.38 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.776 -0.824 . . . . 74.43 108.776 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.11 148.72 30.93 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.605 0.565 . . . . 64.44 111.418 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.1 m -133.99 126.71 30.84 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 115.327 -0.852 . . . . 72.51 108.743 174.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' B' ' 34' ' ' LYS . 1.7 tt -118.92 115.82 25.19 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.948 -1.501 . . . . 75.52 106.948 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -143.95 29.94 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.343 -0.703 . . . . 72.51 111.343 -170.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -92.3 19.74 6.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 71.25 112.197 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.44 178.93 8.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.321 0.648 . . . . 64.32 110.45 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.5 m -69.2 139.49 54.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.241 0.616 . . . . 75.03 110.551 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . . . -87.41 -65.2 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.108 0.956 . . . . 74.54 108.762 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -156.02 161.44 40.45 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 113.311 -1.768 . . . . 71.14 108.848 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.62 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 81.6 mt -132.17 143.17 49.78 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.079 -1.452 . . . . 75.34 107.079 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -155.87 152.22 28.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.882 -0.784 . . . . 70.12 108.882 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.1 tt0 -165.85 135.9 3.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.696 -0.853 . . . . 74.41 108.696 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.457 HG21 HD12 ' B' ' 21' ' ' ILE . 93.1 t -125.1 143.6 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.56 0.744 . . . . 53.1 109.022 174.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 23.3 mt-30 -123.69 91.05 3.39 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.549 -0.908 . . . . 74.22 108.549 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -83.8 101.06 11.34 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.366 -0.834 . . . . 55.44 109.622 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.1 164.9 32.58 Favored Glycine 0 C--O 1.243 0.661 0 O-C-N 123.419 0.449 . . . . 73.4 112.074 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.88 125.34 1.46 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.676 -0.57 . . . . 51.34 111.676 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.429 HG13 ' HE1' ' B' ' 17' ' ' TYR . 45.7 mt -85.23 119.64 34.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 108.17 -1.048 . . . . 74.22 108.17 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.94 151.3 43.74 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.851 0.86 . . . . 73.34 109.864 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 13.4 m -96.3 100.57 12.18 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.051 -1.092 . . . . 75.53 108.051 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.552 HG21 ' SD ' ' B' ' 94' ' ' MET . 12.3 mm -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.496 -0.557 . . . . 72.3 109.496 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -142.42 153.01 43.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.988 0.515 . . . . 71.31 111.077 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.01 -67.15 3.8 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.914 0.759 . . . . 72.24 112.212 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 tt -49.24 135.29 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.281 1.832 . . . . 75.31 112.325 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -151.74 177.14 10.69 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.658 0.383 . . . . 74.14 111.241 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.08 -133.57 34.0 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.39 -0.823 . . . . 74.31 113.636 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.1 m -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.279 1.032 . . . . 71.4 110.858 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -66.67 -47.62 71.9 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.869 -1.514 . . . . 74.15 109.719 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.552 ' SD ' HG21 ' B' ' 86' ' ' ILE . 11.4 tpt -70.57 -33.97 71.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.611 0.764 . . . . 73.45 111.301 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.813 0.445 . . . . 74.14 111.072 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -67.49 -37.49 82.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.81 0.844 . . . . 74.11 111.189 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -69.93 -45.25 67.9 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.5 0.667 . . . . 71.23 110.961 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.27 -38.17 66.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.526 1.13 . . . . 71.44 111.228 -172.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.24 4.81 60.67 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.508 -0.769 . . . . 74.41 114.38 -173.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.48 -61.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.865 0.833 . . . . 72.04 112.758 -175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -64.63 -52.97 54.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.636 0.774 . . . . 73.54 112.148 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.447 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 77.8 m -62.06 -51.15 76.88 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.274 -0.87 . . . . 72.31 112.33 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.458 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 32.3 Cg_exo -61.38 -29.51 85.71 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 121.935 1.757 . . . . 74.03 113.764 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.46 -35.99 81.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.941 0.497 . . . . 71.25 111.221 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.75 -40.26 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 124.043 0.937 . . . . 72.22 110.166 172.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.85 -18.84 31.72 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.871 -1.059 . . . . 74.31 112.763 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -59.4 -45.95 98.96 Favored Pre-proline 0 N--CA 1.485 1.282 0 N-CA-C 114.301 1.223 . . . . 74.24 114.301 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.89 -43.27 48.06 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.347 2.032 . . . . 74.4 113.734 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -70.0 -44.02 70.22 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.247 -0.888 . . . . 73.23 110.561 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.31 96.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.451 0.7 . . . . 71.44 110.917 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.7 ttt180 -56.88 -58.55 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.491 1.517 . . . . 75.32 110.92 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.09 -38.83 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.729 1.212 . . . . 73.35 111.085 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.05 -46.95 75.97 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.286 -0.415 . . . . 75.04 110.935 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.575 HD12 HG23 ' B' ' 64' ' ' VAL . 50.7 mt -60.37 -53.4 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.743 0.417 . . . . 74.34 110.589 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -26.76 68.76 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.271 -0.877 . . . . 75.11 111.406 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.1 t -72.26 -50.07 30.13 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.138 0.575 . . . . 73.3 110.526 172.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.1 mmt -65.65 -35.06 79.68 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.441 0.696 . . . . 74.44 112.273 -173.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.65 -34.19 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.773 0.429 . . . . 75.21 110.751 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 33.2 t -67.63 -30.4 69.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.762 0.825 . . . . 73.1 110.565 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.428 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 92.6 mtt-85 -65.79 -26.77 67.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.702 0.801 . . . . 74.45 111.552 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 10.4 65.7 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-O 119.681 -0.51 . . . . 74.02 114.261 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 5.1 p 67.85 12.09 8.67 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.18 1.792 . . . . 62.52 113.129 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -85.88 159.1 55.36 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.877 -0.582 . . . . 74.25 110.311 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -41.81 124.94 2.85 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.512 2.808 . . . . 71.3 113.271 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.47 111.78 3.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.552 -0.749 . . . . 75.11 109.517 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.9 94.79 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.154 -1.054 . . . . 73.22 108.154 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -91.66 121.73 33.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.847 -1.168 . . . . 75.44 107.847 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -73.8 144.83 45.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 74.14 110.92 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.37 144.88 54.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.274 -0.876 . . . . 64.25 109.686 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.657 ' HG3' HD13 ' D' ' 16' ' ' ILE . 37.0 Cg_endo -63.07 99.41 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.626 2.217 . . . . 65.14 112.327 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.38 132.03 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.307 0.575 . . . . 70.54 110.249 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.46 113.12 24.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.84 0.856 . . . . 75.2 108.983 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -72.81 -18.71 61.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.698 0.799 . . . . 72.24 111.841 -174.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.86 -41.6 95.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.199 0.6 . . . . 72.21 109.742 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.02 88.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.284 -0.871 . . . . 73.2 110.057 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 CA--C 1.548 0.894 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.442 178.149 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.625 ' HE2' HD13 ' C' ' 89' ' ' ILE . 29.3 ttm . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.305 0.574 . . . . 73.52 111.435 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -101.36 75.16 1.6 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.535 -1.283 . . . . 73.33 107.535 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' C' ' 85' ' ' SER . 56.6 t80 -84.8 118.06 24.24 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 108.221 -1.029 . . . . 64.35 108.221 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -147.49 131.97 17.68 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.725 -0.842 . . . . 63.4 108.725 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -75.95 125.65 35.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.75 -0.834 . . . . 74.44 108.75 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.3 mm-40 -95.11 -45.49 7.19 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 74.23 110.115 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -166.76 126.31 1.5 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.958 0.503 . . . . 75.12 109.888 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.01 144.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.974 -1.121 . . . . 73.22 107.974 174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -177.97 161.22 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.454 0.645 . . . . 73.02 111.017 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -86.28 110.69 19.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.38 -0.827 . . . . 75.23 108.977 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.428 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 7.3 mmmt -72.23 -44.71 62.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.397 -0.964 . . . . 72.32 108.397 172.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.9 t70 -134.51 143.86 47.69 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.661 -1.154 . . . . 70.34 110.234 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.93 147.77 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.267 1.827 . . . . 74.13 106.444 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -157.55 151.64 24.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.066 0.546 . . . . 71.13 110.153 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -148.74 146.28 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.871 -1.159 . . . . 75.02 107.871 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 47.6 mt-10 -141.79 150.11 41.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.259 -1.385 . . . . 72.2 107.259 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.85 88.97 3.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.47 -45.58 17.65 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.832 2.355 . . . . 75.05 111.759 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.428 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 67.1 m-80 -98.79 40.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.733 -0.667 . . . . 71.42 110.594 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -42.19 91.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.335 1.054 . . . . 62.12 113.32 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.95 -34.7 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 121.611 1.541 . . . . 72.12 112.833 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.428 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 38.1 t-80 -68.11 -19.49 64.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.064 1.346 . . . . 74.34 111.874 -172.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.544 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.1 p -48.58 -35.27 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 124.618 1.167 . . . . 73.15 113.55 175.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -59.18 -40.4 85.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.797 0.839 . . . . 71.24 111.35 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -115.6 18.31 15.9 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.364 -0.835 . . . . 75.32 111.331 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.544 ' HE2' HG23 ' C' ' 31' ' ' VAL . 0.0 OUTLIER -82.63 165.51 19.97 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.236 -0.653 . . . . 75.12 109.236 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.39 130.75 35.09 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.721 -0.844 . . . . 71.24 108.721 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -75.34 85.85 2.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.632 0.73 . . . . 74.11 110.075 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -154.27 68.8 6.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.562 -1.199 . . . . 72.01 107.773 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -91.95 112.34 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.334 2.023 . . . . 60.02 111.287 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.56 95.04 9.61 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 108.104 -1.073 . . . . 53.01 108.104 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.95 107.58 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.126 -0.943 . . . . 62.22 110.134 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.5 mttp -91.05 102.83 15.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 74.42 107.669 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.07 145.23 26.54 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.131 -1.063 . . . . 74.25 108.131 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -139.91 137.82 35.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.874 0.87 . . . . 71.04 108.691 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.34 146.49 51.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.894 0.878 . . . . 74.33 109.149 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.04 154.71 28.06 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.045 0.938 . . . . 64.23 109.218 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -155.87 148.54 24.01 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.929 0.395 . . . . 64.21 110.384 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.78 163.35 33.59 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.04 0.936 . . . . 73.12 109.036 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.1 p -130.72 147.16 52.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.994 0.517 . . . . 73.33 110.048 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.0 p -143.97 129.06 18.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.73 0.812 . . . . 72.31 109.305 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -78.46 116.49 18.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.915 0.486 . . . . 73.03 110.295 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' C' ' 57' ' ' GLU . 47.2 mt -87.96 -45.77 9.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.799 0.84 . . . . 73.52 109.317 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.71 -179.49 6.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.39 -1.277 . . . . 64.33 109.343 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.38 109.57 0.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.929 0.768 . . . . 65.41 110.216 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.67 22.44 7.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.603 1.161 . . . . 74.42 112.018 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.1 105.61 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.511 1.124 . . . . 75.21 108.027 173.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -114.64 128.81 56.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.675 0.79 . . . . 74.53 110.07 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.614 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.98 115.29 22.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.595 0.758 . . . . 74.51 109.195 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.9 t -96.81 121.17 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.14 -1.059 . . . . 72.34 108.14 173.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.7 105.31 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.5 -0.926 . . . . 71.22 108.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -91.29 105.0 17.47 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.277 -1.008 . . . . 70.01 108.277 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -95.9 121.93 38.16 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.951 0.9 . . . . 75.43 110.194 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.8 t -107.35 146.67 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 107.909 -1.145 . . . . 74.54 107.909 169.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 23.4 m -139.46 120.69 14.82 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.495 0.664 . . . . 73.11 109.501 170.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.544 HG22 HG21 ' C' ' 114' ' ' ILE . 85.7 t -101.85 108.86 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.73 -1.123 . . . . 75.32 108.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.8 m -97.92 135.55 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.178 -1.415 . . . . 73.34 107.178 169.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.28 102.97 5.15 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.028 -1.471 . . . . 63.35 107.028 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 26.2 p -168.51 154.48 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.695 0.622 . . . . 52.23 110.838 -172.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -95.5 -42.81 8.27 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.187 -0.672 . . . . 74.13 109.187 171.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.42 -80.85 0.05 OUTLIER Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.781 -0.928 . . . . 55.41 110.781 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -89.4 -31.65 17.65 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.779 -0.823 . . . . 74.11 108.779 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.91 85.25 2.23 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.626 -0.715 . . . . 74.55 109.48 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -89.31 116.86 27.84 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.233 -0.44 . . . . 75.45 110.197 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.51 -64.78 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.511 -1.292 . . . . 63.25 107.511 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.81 171.61 16.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.545 0.688 . . . . 70.43 111.645 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.7 tm? -132.08 145.35 51.35 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.563 -2.014 . . . . 74.21 105.563 171.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -151.72 142.99 23.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.382 -0.97 . . . . 63.14 108.382 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -150.1 134.25 17.11 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.404 -0.591 . . . . 73.43 109.404 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' C' ' 110' ' ' ALA . 50.3 t -134.27 113.69 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.89 0.876 . . . . 74.25 108.661 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.745 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 54.3 mt-30 -91.05 90.13 7.71 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.525 -0.917 . . . . 73.25 108.525 171.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -78.81 103.77 8.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.84 -1.073 . . . . 74.1 109.48 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.74 144.74 22.28 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.458 -0.657 . . . . 72.13 111.458 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.05 117.1 0.9 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.557 -1.017 . . . . 74.5 110.557 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.506 HD13 HD12 ' C' ' 51' ' ' LEU . 12.0 mm -80.0 126.73 39.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.854 -1.165 . . . . 72.21 107.854 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.6 143.33 47.27 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.892 0.477 . . . . 75.21 109.812 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 15.6 m -82.1 107.14 14.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.656 -1.238 . . . . 75.15 107.656 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.4 99.72 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.095 -1.076 . . . . 75.0 108.095 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -128.75 159.31 36.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.362 1.065 . . . . 64.54 110.152 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -53.45 4.37 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.53 0.519 . . . . 72.13 113.435 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.625 HD13 ' HE2' ' C' ' 9' ' ' MET . 30.0 pt -80.92 150.82 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.872 0.869 . . . . 72.42 112.117 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -147.23 153.75 40.18 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.77 1.228 . . . . 72.44 108.85 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.64 -111.32 2.07 Favored Glycine 0 C--N 1.355 1.612 0 O-C-N 123.548 0.53 . . . . 74.04 114.136 170.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 24.9 p -50.6 -55.42 16.37 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.293 1.437 . . . . 74.24 112.868 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.38 -46.32 80.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.054 0.542 . . . . 74.4 111.502 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -68.83 -31.48 70.5 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.356 0.41 . . . . 75.42 111.484 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.61 75.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.166 0.587 . . . . 73.11 111.528 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -69.58 -29.46 67.01 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.837 -0.62 . . . . 71.43 110.846 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.34 -58.93 3.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.908 0.483 . . . . 62.13 110.486 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -73.36 -15.62 61.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.94 0.496 . . . . 74.21 111.652 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.32 7.73 58.46 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 119.588 -0.562 . . . . 64.13 113.822 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.426 ' HB3' ' HD2' ' C' ' 133' ' ' PHE . . . -159.43 -60.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.689 0.745 . . . . 71.14 112.152 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.41 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 65.1 t80 -73.41 -44.8 57.65 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.453 0.701 . . . . 74.21 112.788 -167.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.479 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 38.0 m -68.65 -47.2 34.44 Favored Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.14 0.576 . . . . 65.23 111.415 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 38.2 Cg_exo -64.48 -26.15 62.66 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.177 1.918 . . . . 74.45 114.192 173.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.484 ' ND2' HD21 ' C' ' 132' ' ' ASN . 29.2 t-20 -55.06 -49.05 72.6 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.894 0.877 . . . . 70.14 110.277 176.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.407 HD13 ' NH1' ' A' ' 111' ' ' ARG . 43.6 mm -56.96 -41.98 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 124.163 0.915 . . . . 71.11 110.897 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.1 mt -83.41 -23.0 32.55 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.126 -0.943 . . . . 72.13 112.566 -171.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.74 -50.34 87.25 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.57 -1.205 . . . . 71.24 113.494 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.41 -34.17 93.82 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.071 1.847 . . . . 72.34 112.918 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -68.0 -50.72 53.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.787 0.835 . . . . 73.23 111.448 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -65.31 -35.03 79.74 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 116.018 -0.537 . . . . 60.21 111.117 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.465 HH12 ' HG3' ' C' ' 130' ' ' PRO . 59.6 ttt180 -60.66 -48.51 81.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.797 1.639 . . . . 72.11 110.647 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 3.1 tm-20 -72.82 -33.62 66.31 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.873 0.469 . . . . 75.31 109.993 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.419 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 8.6 t -65.55 -28.73 69.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.979 0.512 . . . . 74.04 111.135 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.544 HG21 HG22 ' C' ' 64' ' ' VAL . 87.9 mt -78.77 -51.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.659 -0.7 . . . . 73.44 110.033 173.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 33.6 m -58.97 -28.56 66.44 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.251 0.548 . . . . 71.45 111.173 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 44.6 t -63.38 -55.27 25.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.266 1.026 . . . . 74.33 109.053 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -34.69 71.19 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.739 1.216 . . . . 73.22 112.774 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.9 t -66.2 -48.09 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.855 -0.794 . . . . 73.45 108.855 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -31.97 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.022 -0.99 . . . . 73.2 111.214 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.5 mtt-85 -66.94 -40.85 87.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.524 0.73 . . . . 72.11 109.437 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.73 3.93 62.52 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.826 0.704 . . . . 73.11 112.988 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 59.69 31.33 20.81 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.436 1.894 . . . . 75.53 112.994 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.98 153.47 43.42 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.078 0.951 . . . . 72.13 108.929 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 -169.89 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.91 2.406 . . . . 73.55 113.536 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -52.28 117.96 3.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.367 1.067 . . . . 74.12 113.138 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.55 104.39 4.93 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.033 -1.469 . . . . 74.12 107.033 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.12 131.1 38.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.672 1.189 . . . . 75.31 108.227 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -86.11 142.54 28.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.925 -0.398 . . . . 74.31 109.925 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 139.03 97.55 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.32 1.048 . . . . 54.32 111.922 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.465 ' HG3' HH12 ' C' ' 111' ' ' ARG . 27.0 Cg_exo -63.44 98.28 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.758 2.305 . . . . 74.33 112.837 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.86 109.17 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.05 -0.722 . . . . 71.51 109.05 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.484 HD21 ' ND2' ' C' ' 104' ' ' ASN . 19.2 m120 -115.36 102.99 10.35 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.79 0.836 . . . . 64.11 109.95 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.426 ' HD2' ' HB3' ' C' ' 100' ' ' ALA . 67.2 t80 -80.37 -24.18 39.97 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.58 0.705 . . . . 75.15 110.212 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.406 1.083 . . . . 71.24 111.123 176.087 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 114.851 1.426 . . . . 70.14 114.851 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 45.5 m -145.69 143.65 29.91 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.452 1.101 . . . . 74.25 109.202 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' D' ' 85' ' ' SER . 44.8 t80 -154.08 109.92 3.23 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.053 -1.091 . . . . 71.53 108.053 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.8 116.42 27.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.313 0.645 . . . . 64.01 110.259 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 30.9 pt -78.39 99.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.483 -0.932 . . . . 75.21 108.483 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -83.44 -45.31 13.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.944 -0.472 . . . . 74.23 111.669 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.422 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 20.5 ttt180 -164.71 126.6 2.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.597 -0.149 . . . . 75.3 110.597 -167.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.657 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -113.15 133.68 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.639 -1.245 . . . . 74.43 107.639 174.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.9 p90 -159.03 178.42 10.08 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.429 0.692 . . . . 71.42 111.782 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 58.2 p -107.36 132.19 53.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.619 -0.882 . . . . 73.34 108.619 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -96.21 -31.48 12.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.195 -0.298 . . . . 65.22 110.195 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.0 t70 -150.24 141.27 22.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.929 0.892 . . . . 74.11 108.916 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.535 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.1 mt -143.75 148.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.7 1.2 . . . . 64.0 107.921 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.6 t -151.64 145.46 25.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.331 1.053 . . . . 74.33 109.176 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -150.59 125.27 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.725 -1.954 . . . . 73.44 105.725 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -131.79 131.94 43.35 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.139 0.427 . . . . 71.54 110.104 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -145.55 79.69 11.22 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.779 -0.823 . . . . 75.13 108.779 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.77 -39.72 14.42 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.584 2.189 . . . . 73.32 111.303 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -98.79 24.73 7.27 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.811 . . . . 73.22 109.97 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' D' ' 25' ' ' ALA . . . -51.97 -49.13 85.77 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 115.132 1.53 . . . . 74.21 115.132 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.462 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.9 Cg_endo -84.83 -7.37 9.47 Favored 'Trans proline' 0 C--N 1.39 2.745 0 CA-C-N 121.791 1.675 . . . . 73.34 112.996 175.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -83.82 -40.15 19.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 74.11 109.813 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.42 -12.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.549 0.739 . . . . 72.21 110.712 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -56.82 -29.77 63.08 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.667 1.187 . . . . 75.02 111.815 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.89 -14.24 62.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.228 1.011 . . . . 64.32 112.124 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.632 ' HZ1' ' HB2' ' D' ' 71' ' ' GLU . 56.7 mtmt -123.42 108.76 13.06 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.805 0.842 . . . . 72.33 109.771 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.69 82.16 3.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.654 0.74 . . . . 64.14 110.383 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -148.63 165.46 31.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.193 0.997 . . . . 74.05 108.666 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.5 mp0 -69.52 110.67 6.8 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.281 1.433 . . . . 74.44 111.222 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 16.6 Cg_exo -71.12 124.07 10.2 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.058 2.505 . . . . 72.12 112.392 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -60.99 118.91 7.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.378 0.424 . . . . 74.54 110.807 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.464 HG21 HG13 ' D' ' 64' ' ' VAL . 2.3 p -98.91 128.0 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.797 0.839 . . . . 75.53 109.498 -176.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 9.3 tmtt? -99.29 117.0 32.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.046 -1.835 . . . . 74.41 106.046 170.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.448 HD22 HD22 ' D' ' 128' ' ' LEU . 53.2 tp -95.1 134.79 37.42 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.984 -1.117 . . . . 73.51 107.984 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.442 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.5 t70 -135.43 149.92 49.72 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.263 -1.384 . . . . 75.14 107.263 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -135.43 164.69 27.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.482 0.313 . . . . 72.24 111.195 -174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.9 t70 -171.23 156.18 4.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.514 1.125 . . . . 64.22 109.351 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -134.63 160.54 37.79 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.476 0.711 . . . . 74.31 110.003 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.1 162.83 39.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.056 0.942 . . . . 43.21 109.344 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -140.63 157.94 44.72 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.163 0.585 . . . . 71.23 110.803 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -161.15 130.2 4.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.571 1.148 . . . . 45.2 108.567 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -89.89 123.55 33.93 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 172.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' D' ' 57' ' ' GLU . 56.6 mt -97.94 -35.62 10.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.791 0.836 . . . . 63.55 110.056 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -160.32 -175.62 5.14 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.954 -1.021 . . . . 44.35 110.564 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.97 109.39 1.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.787 -1.097 . . . . 73.54 109.674 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.81 10.01 6.5 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.985 1.314 . . . . 75.12 112.925 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 89.1 t -109.02 118.33 56.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.233 -1.025 . . . . 71.12 108.233 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.63 129.83 44.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.066 -0.97 . . . . 73.43 109.74 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.601 ' HB2' HD11 ' D' ' 51' ' ' LEU . 35.3 tt0 -87.24 130.75 34.45 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.316 1.046 . . . . 73.13 108.683 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.0 145.0 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.142 -1.059 . . . . 72.05 108.142 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 85.6 t -117.46 142.46 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.017 0.927 . . . . 74.43 108.73 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 116.56 24.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.435 -1.321 . . . . 75.14 107.435 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -101.44 103.92 14.84 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.126 -1.064 . . . . 74.32 108.126 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.73 117.77 49.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.244 -1.021 . . . . 73.43 108.244 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 10.4 m -118.02 127.92 54.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.245 0.618 . . . . 74.5 110.385 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 73.4 t -114.63 123.78 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.322 1.449 . . . . 72.32 108.962 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 32.3 m -123.6 91.61 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.908 -1.145 . . . . 73.13 107.908 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 138.74 34.3 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.254 -0.647 . . . . 52.34 109.254 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -154.62 125.86 7.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.437 -0.801 . . . . 72.54 109.692 -173.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' D' ' 71' ' ' GLU . 46.4 tp -113.38 99.19 7.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.067 -0.716 . . . . 74.03 109.067 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.83 -128.74 9.08 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 112.157 -0.377 . . . . 63.03 112.157 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -90.33 14.54 12.52 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.307 1.043 . . . . 71.43 110.839 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.632 ' HB2' ' HZ1' ' D' ' 34' ' ' LYS . 3.3 tp10 -115.31 134.31 55.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.179 0.992 . . . . 73.2 111.431 -158.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.3 m -69.59 110.47 4.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.594 -0.891 . . . . 75.24 108.594 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 -66.83 0.84 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.66 -0.496 . . . . 74.41 109.66 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -154.35 136.6 14.85 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.399 0.619 . . . . 71.13 110.265 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.3 mt -105.12 152.49 22.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.649 1.18 . . . . 72.11 108.0 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.561 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 41.0 t -160.37 148.77 16.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.119 0.568 . . . . 62.41 109.963 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.7 125.75 6.59 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.818 -0.808 . . . . 75.21 108.818 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.413 0.685 . . . . 74.34 109.607 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -93.89 87.11 5.27 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.719 -0.845 . . . . 74.33 108.719 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.04 110.01 13.87 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.434 -1.257 . . . . 74.52 108.45 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.45 143.93 15.75 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.239 -0.344 . . . . 72.55 112.239 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.48 139.84 9.45 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.833 0.317 . . . . 71.33 112.347 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.35 123.17 40.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.806 0.842 . . . . 75.44 108.984 173.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.08 141.51 48.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.106 0.963 . . . . 74.05 108.729 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 17.4 m -102.37 112.69 25.5 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.315 -0.624 . . . . 72.02 109.315 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.99 103.56 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.245 -1.02 . . . . 75.53 108.245 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -131.55 153.48 49.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.442 1.097 . . . . 74.42 109.711 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 2.78 61.29 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.102 0.252 . . . . 71.21 113.367 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 44.9 mm -131.41 129.83 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.861 1.264 . . . . 74.04 108.317 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.65 179.1 7.02 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.191 0.997 . . . . 74.04 110.814 -174.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.0 -135.46 24.39 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.886 -0.597 . . . . 64.14 114.083 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -80.1 -21.85 42.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.936 0.894 . . . . 75.51 111.927 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.57 -40.4 73.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.959 0.504 . . . . 75.34 111.164 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -28.64 64.75 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 110.311 -0.255 . . . . 72.24 110.311 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.55 -32.76 66.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.475 0.71 . . . . 64.25 110.555 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -65.93 -43.43 88.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.257 0.623 . . . . 75.55 110.198 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.516 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 89.8 m -61.67 -42.33 98.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.437 0.295 . . . . 65.41 110.884 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.01 -40.02 65.54 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.065 0.546 . . . . 74.45 111.629 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.97 3.68 38.59 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-O 119.414 -0.659 . . . . 71.55 114.662 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.43 -63.24 0.37 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.979 0.889 . . . . 74.21 112.203 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.516 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 82.7 t80 -64.95 -58.19 6.79 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.372 0.508 . . . . 72.51 112.372 -170.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 66.1 m -59.94 -44.23 96.36 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 118.513 -0.756 . . . . 72.02 112.737 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.43 -37.5 94.76 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.419 2.079 . . . . 72.42 113.919 167.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.96 -28.54 66.73 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.446 0.698 . . . . 62.54 110.858 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.5 -40.63 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.398 0.618 . . . . 75.54 109.773 170.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.53 -18.97 58.42 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.23 -0.896 . . . . 61.24 112.008 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -64.11 -43.4 74.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.293 1.22 . . . . 74.2 114.293 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.45 -39.94 63.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.051 1.834 . . . . 61.52 113.292 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . 0.433 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 98.8 m-85 -78.93 -30.18 44.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.746 0.818 . . . . 75.32 111.621 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.67 65.62 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.212 0.605 . . . . 71.03 109.641 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.44 -49.42 74.62 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.2 -1.364 . . . . 75.32 110.607 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.73 -45.9 92.48 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.041 0.838 . . . . 75.45 111.697 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.484 ' SG ' HD11 ' D' ' 21' ' ' ILE . 48.6 t -59.13 -40.97 87.1 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.715 0.635 . . . . 71.42 110.745 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.506 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.6 mt -61.79 -56.89 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 123.791 0.682 . . . . 70.42 109.873 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.537 HG22 ' HG3' ' D' ' 125' ' ' GLN . 41.0 m -54.11 -38.69 65.68 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.649 1.18 . . . . 75.14 111.787 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 38.0 t -66.8 -44.01 82.36 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.791 -1.095 . . . . 74.55 110.399 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.5 -29.77 65.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.116 0.566 . . . . 73.24 111.907 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.407 HG22 ' O ' ' D' ' 114' ' ' ILE . 75.9 t -68.16 -42.26 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 123.785 0.678 . . . . 74.11 109.336 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -75.63 -28.0 58.65 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.257 -0.429 . . . . 74.34 111.174 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.419 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 94.2 mtt-85 -69.97 -35.74 74.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.509 0.724 . . . . 74.01 109.614 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.53 0.16 77.03 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.794 0.683 . . . . 70.25 112.33 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.62 28.13 16.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.51 1.924 . . . . 75.44 112.677 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 37.4 m-85 -91.03 162.25 33.18 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.19 1.396 . . . . 74.23 110.683 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.9 133.22 52.25 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.766 2.31 . . . . 75.02 111.853 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.537 ' HG3' HG22 ' D' ' 115' ' ' THR . 31.7 tt0 -56.62 137.84 53.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.874 0.869 . . . . 75.33 112.446 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.39 108.95 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.894 -1.151 . . . . 74.32 107.894 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -113.27 110.96 21.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.805 -0.813 . . . . 72.34 108.805 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.448 HD22 HD22 ' D' ' 42' ' ' LEU . 90.5 mt -69.2 135.58 50.8 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.133 0.573 . . . . 71.12 110.279 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.51 146.95 98.81 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.024 0.929 . . . . 64.42 111.42 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -66.7 121.37 8.59 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.638 2.226 . . . . 74.43 111.269 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.74 118.8 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.338 0.655 . . . . 75.52 110.323 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -86.55 78.35 9.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.153 -1.054 . . . . 73.21 108.153 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 74.11 111.333 178.214 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 108.267 -1.012 . . . . 71.53 108.267 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.416 ' HB3' HG12 ' A' ' 86' ' ' ILE . 19.0 p90 -134.87 117.38 15.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.924 0.89 . . . . 72.0 108.868 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -155.32 138.42 15.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.963 0.505 . . . . 63.24 110.386 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 13' ' ' ILE . 4.1 mp -68.15 116.38 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 72.1 109.319 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.97 -41.67 17.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.013 -0.736 . . . . 75.13 109.013 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.529 HH11 ' HD2' ' B' ' 32' ' ' PHE . 72.0 ttt180 -168.56 140.63 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.502 0.721 . . . . 74.23 109.072 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.24 137.78 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.592 -0.892 . . . . 72.11 108.592 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -173.68 167.71 4.47 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.399 0.619 . . . . 64.34 112.251 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -86.15 123.97 32.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.835 -0.802 . . . . 64.43 108.835 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -86.36 -32.14 21.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.438 0.637 . . . . 75.23 109.523 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.9 t70 -141.63 140.91 33.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.955 -1.021 . . . . 63.13 110.45 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.4 mt -141.59 145.38 24.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.949 1.7 . . . . 73.25 106.795 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -159.24 130.32 6.09 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 84.4 t80 -132.11 119.51 21.05 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.353 -1.351 . . . . 72.1 107.353 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -118.59 140.87 49.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.822 -0.807 . . . . 74.32 108.822 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.68 78.66 15.77 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 107.444 -1.317 . . . . 74.4 107.444 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 -29.98 61.88 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.519 2.146 . . . . 73.33 111.726 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 31.6 m-80 -117.01 40.71 2.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.879 0.872 . . . . 71.11 109.23 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.16 99.47 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.089 0.956 . . . . 64.13 113.2 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.25 -25.8 18.34 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.573 1.515 . . . . 72.1 112.462 171.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.6 m-70 -77.79 -33.37 52.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.793 -0.639 . . . . 63.1 112.223 -173.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG11 ' HE1' ' A' ' 123' ' ' PHE . 11.1 p -64.45 -22.17 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 120.958 0.409 . . . . 74.32 111.501 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -72.94 -29.54 63.18 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 63.42 110.681 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -82.7 -51.43 7.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.33 1.052 . . . . 75.15 110.574 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -82.22 133.89 35.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.829 0.852 . . . . 74.33 109.8 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.64 134.57 54.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.048 1.339 . . . . 73.45 113.221 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -71.1 83.06 0.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.546 0.738 . . . . 74.44 112.419 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -137.01 78.87 39.78 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.272 1.029 . . . . 74.24 109.011 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -84.03 133.3 5.68 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.955 2.436 . . . . 74.04 112.389 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.4 116.25 29.26 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.905 -1.146 . . . . 75.23 107.905 171.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.53 119.73 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.309 0.643 . . . . 74.24 110.761 -173.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -110.18 138.44 46.55 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.958 -1.127 . . . . 75.35 107.958 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.06 146.16 52.27 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.31 0.644 . . . . 74.34 111.388 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.85 144.62 50.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.418 1.087 . . . . 74.13 109.382 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -138.27 136.69 36.75 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 62.25 109.182 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.712 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 17.4 t70 -158.13 149.29 21.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.786 0.434 . . . . 74.41 110.84 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.418 HG22 ' HG3' ' A' ' 103' ' ' PRO . 19.8 m -135.19 126.58 28.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.199 1.0 . . . . 74.14 110.176 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.49 110.26 10.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.073 0.549 . . . . 75.22 110.11 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -88.39 153.25 21.33 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.78 -0.822 . . . . 73.25 108.78 175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -164.88 117.04 1.21 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.213 0.46 . . . . 70.43 110.197 -171.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.84 105.39 3.78 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.828 0.851 . . . . 75.21 110.629 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.447 HD12 HG22 ' A' ' 83' ' ' ILE . 97.6 mt -77.45 -37.72 50.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.804 0.842 . . . . 72.31 111.635 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.63 -174.11 4.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.255 1.022 . . . . 72.42 108.592 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.42 97.42 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.108 0.563 . . . . 71.45 110.519 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 58.71 27.72 16.29 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.722 1.209 . . . . 74.1 112.661 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -103.91 121.09 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.884 -1.524 . . . . 74.45 106.884 165.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.84 130.04 50.59 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.277 -0.638 . . . . 75.22 109.277 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.86 118.81 25.58 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.008 0.923 . . . . 71.52 108.63 168.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.42 111.8 29.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.396 -1.335 . . . . 65.11 107.396 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.4 t -99.26 130.96 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.501 -0.555 . . . . 64.53 109.501 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -106.79 113.56 27.12 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.579 -0.897 . . . . 75.31 108.579 -174.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -87.45 102.69 14.79 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.973 -0.751 . . . . 73.31 108.973 174.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.04 130.34 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.341 -0.985 . . . . 72.43 108.341 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 m -121.18 133.21 55.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.352 -0.981 . . . . 72.35 108.352 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 HG21 ' A' ' 114' ' ' ILE . 75.8 t -131.15 104.61 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.976 -1.12 . . . . 73.1 107.976 -176.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -105.77 146.26 30.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.818 -0.808 . . . . 74.21 108.818 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.53 115.72 13.38 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.645 -1.243 . . . . 73.51 107.645 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -109.26 126.0 52.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.52 -0.548 . . . . 53.13 109.52 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.09 82.7 6.06 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 105.777 -1.935 . . . . 74.3 105.777 176.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.7 -127.18 7.83 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.435 -0.802 . . . . 64.12 111.665 -170.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.25 -14.72 30.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.972 0.509 . . . . 74.02 111.093 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -95.03 135.02 37.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.879 0.871 . . . . 75.32 109.511 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -65.34 129.25 39.06 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.01 0.524 . . . . 73.31 111.227 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.593 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -77.81 -58.05 3.47 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.093 -1.077 . . . . 64.44 108.093 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -166.91 165.74 15.87 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.641 -1.163 . . . . 73.54 110.437 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -134.73 145.14 48.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.535 1.134 . . . . 74.41 108.792 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.439 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 20.0 m -141.58 98.92 3.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.611 0.764 . . . . 73.23 109.44 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -109.28 129.21 55.52 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.625 -0.509 . . . . 72.54 109.625 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -130.51 132.82 64.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 123.753 0.821 . . . . 72.34 109.325 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.733 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.2 mt-30 -105.74 102.91 12.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.592 -0.731 . . . . 71.01 109.52 169.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.77 98.89 12.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.842 -1.072 . . . . 73.23 109.366 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.4 142.14 15.97 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.374 -0.69 . . . . 65.31 111.374 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.52 122.58 2.42 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.929 -0.868 . . . . 72.41 110.929 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 51' ' ' LEU . 51.7 mt -80.91 125.37 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.636 -0.876 . . . . 73.24 108.636 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.8 121.58 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.203 0.601 . . . . 75.04 109.508 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -84.13 103.37 13.29 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.278 -1.008 . . . . 71.34 108.278 171.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.539 HD12 HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.47 124.69 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.48 0.657 . . . . 73.44 109.811 -171.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.29 175.77 13.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.126 0.97 . . . . 63.4 111.045 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.23 -24.97 29.02 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.758 -0.656 . . . . 73.25 113.043 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 86' ' ' ILE . 13.6 pt -110.46 168.88 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.23 110.615 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.547 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 24.3 tt0 -150.85 -172.37 4.18 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.576 -1.193 . . . . 73.35 108.507 -171.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.46 -142.62 46.84 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.03 0.772 . . . . 74.44 115.03 171.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -77.29 -14.39 59.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.086 0.954 . . . . 72.45 111.561 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -47.96 69.9 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.763 0.825 . . . . 73.31 110.015 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ttt -80.64 -35.83 33.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 74.14 111.074 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.44 67.7 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.403 0.621 . . . . 71.51 111.447 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.28 -49.67 70.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.633 -1.167 . . . . 70.32 110.272 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 5.3 m -68.24 -63.22 1.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.701 1.0 . . . . 51.42 113.701 -170.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -12.35 60.04 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 118.88 0.764 . . . . 75.13 112.415 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.69 -6.07 44.16 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.178 -0.79 . . . . 74.34 114.5 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.19 -57.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 117.873 0.836 . . . . 64.01 111.786 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.563 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -55.69 -58.35 8.17 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.576 1.15 . . . . 71.23 112.045 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.96 -41.8 6.97 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 113.314 0.857 . . . . 64.24 113.314 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.511 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.9 Cg_endo -66.28 -24.86 50.2 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 121.624 1.55 . . . . 73.42 113.873 169.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -76.47 -22.35 54.66 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.941 0.791 . . . . 53.1 110.21 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mm -67.45 -43.02 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.267 0.627 . . . . 75.24 109.493 166.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 103' ' ' PRO . 90.3 mt -71.25 -31.44 67.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.042 -0.981 . . . . 74.51 111.99 -175.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.51 -43.33 84.01 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.819 1.044 . . . . 73.43 113.819 -168.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.82 -31.79 82.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.276 1.984 . . . . 73.44 113.835 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -83.38 -28.78 28.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.186 0.594 . . . . 65.02 111.863 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.99 77.49 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.296 -0.631 . . . . 53.35 109.296 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.495 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.2 ttm180 -65.84 -38.35 88.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.524 -1.216 . . . . 73.44 110.327 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -53.51 -54.21 40.47 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.215 1.006 . . . . 75.22 110.247 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -61.85 -50.96 70.15 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.936 -1.484 . . . . 71.22 111.24 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 118' ' ' VAL . 17.7 mt -62.41 -58.9 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.703 0.801 . . . . 75.35 111.371 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -54.49 -38.58 66.61 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.871 0.732 . . . . 65.25 111.088 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.5 t -65.88 -45.89 80.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.496 -0.775 . . . . 54.24 110.285 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.592 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 14.5 mtp -57.15 -41.83 79.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.595 0.758 . . . . 61.15 111.31 176.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.2 t -60.45 -47.67 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.901 0.881 . . . . 74.11 110.233 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.663 -0.699 . . . . 71.44 111.585 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -74.62 -30.53 61.69 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.738 0.815 . . . . 74.0 109.747 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.48 2.37 67.48 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.519 -0.764 . . . . 72.13 112.569 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 68.27 22.31 8.14 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.874 1.27 . . . . 74.11 110.552 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.422 ' HE1' HG11 ' A' ' 31' ' ' VAL . 24.6 m-85 -96.5 153.27 38.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.823 0.849 . . . . 74.42 110.288 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 123.73 14.54 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.652 2.235 . . . . 72.14 111.075 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.75 147.44 27.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 124.036 0.835 . . . . 62.12 111.747 -171.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.0 mt -111.95 105.77 14.28 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.717 -0.846 . . . . 65.53 108.717 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.13 93.05 6.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.535 -0.913 . . . . 74.33 108.535 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.07 127.7 33.57 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.443 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 137.56 94.75 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.544 0.738 . . . . 75.03 111.58 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HB3' HH22 ' A' ' 111' ' ' ARG . 34.1 Cg_endo -83.83 145.92 11.56 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.594 2.196 . . . . 61.21 113.02 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 114.21 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.636 -0.876 . . . . 63.52 108.636 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -85.4 75.21 10.25 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.691 0.758 . . . . 64.41 110.008 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -68.89 -28.31 66.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.591 -1.186 . . . . 74.23 109.895 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 115.205 -0.907 . . . . 75.44 110.402 175.584 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' MET . . . . . 0.419 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.3 ptm . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 114.17 1.174 . . . . 74.4 114.17 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.0 m -152.42 125.58 8.62 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.136 0.974 . . . . 74.22 108.604 171.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -136.24 127.87 28.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.37 -0.604 . . . . 74.51 109.37 163.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -158.02 141.53 15.38 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.998 -1.112 . . . . 74.11 107.998 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.28 123.14 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.555 -0.906 . . . . 74.24 108.555 170.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -83.29 -50.6 8.22 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.083 -0.34 . . . . 74.43 110.083 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.31 130.48 1.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.113 -0.494 . . . . 72.42 109.817 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' B' ' 109' ' ' TYR . 92.3 mt -114.22 146.04 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.651 -0.87 . . . . 70.01 108.651 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -163.49 155.41 17.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.413 0.625 . . . . 74.44 111.494 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.6 m -78.26 126.17 30.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.007 -0.997 . . . . 75.12 108.625 170.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.478 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.3 mtpt -98.18 -32.6 11.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.57 0.748 . . . . 75.45 111.175 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.3 t70 -155.8 139.9 16.46 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.07 -0.514 . . . . 73.34 111.523 -167.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.8 mm -147.14 145.69 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.658 1.583 . . . . 73.23 108.355 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.92 151.98 32.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.718 -0.845 . . . . 73.31 108.718 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -147.58 115.48 6.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.853 -1.536 . . . . 74.22 106.853 173.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.6 121.97 42.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.7 -0.852 . . . . 70.23 108.7 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -125.47 80.61 65.49 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.853 -1.166 . . . . 63.35 107.853 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.09 -45.63 0.64 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.55 2.167 . . . . 75.44 111.693 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -98.8 18.65 16.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.699 0.8 . . . . 74.32 110.743 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -48.11 -50.53 54.65 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 125.213 1.405 . . . . 61.22 114.239 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -20.77 25.9 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.879 1.72 . . . . 74.33 112.593 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -91.0 -28.37 18.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.769 0.828 . . . . 72.15 110.868 -173.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.01 -8.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.424 0.689 . . . . 73.23 110.256 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . 0.529 ' HD2' HH11 ' A' ' 15' ' ' ARG . 75.9 t80 -56.72 -33.94 66.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.929 1.292 . . . . 74.41 110.81 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -71.8 -29.52 64.54 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.037 -0.983 . . . . 72.51 111.27 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.505 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 95.6 mttt -94.89 110.21 22.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.448 0.699 . . . . 75.24 111.086 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.22 81.72 1.86 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.455 -0.942 . . . . 71.51 108.455 171.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.767 ' HB2' HD21 ' B' ' 68' ' ' LEU . 51.0 m95 -149.94 178.07 9.27 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.461 1.104 . . . . 75.05 108.457 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -78.04 127.36 81.84 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.43 0.692 . . . . 74.23 110.026 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' B' ' 68' ' ' LEU . 72.6 Cg_endo -77.86 146.83 23.77 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.946 1.764 . . . . 72.34 112.212 168.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.75 103.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.061 0.945 . . . . 75.44 108.932 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -86.62 129.98 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.541 0.736 . . . . 73.42 109.493 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.1 tttm -136.14 128.48 30.17 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.419 -0.956 . . . . 74.42 108.419 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.02 153.87 26.2 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.646 -0.872 . . . . 75.12 108.646 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.607 -0.886 . . . . 75.35 108.607 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.72 138.2 40.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.891 0.876 . . . . 74.34 109.014 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.2 t70 -144.79 152.7 40.74 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.02 1.328 . . . . 73.51 108.308 -174.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.9 t -151.33 140.46 21.2 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.312 0.645 . . . . 72.31 109.381 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.68 124.47 17.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.8 -1.185 . . . . 65.14 107.8 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -97.29 160.99 14.01 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.686 -0.487 . . . . 75.31 109.686 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -149.41 155.37 40.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.006 -1.109 . . . . 75.11 108.006 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -124.78 129.17 49.94 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.364 0.665 . . . . 75.14 109.692 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.87 -45.06 10.02 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.324 0.649 . . . . 72.54 109.641 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.12 -176.09 5.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.295 -0.866 . . . . 71.41 110.093 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -61.9 125.96 25.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.0 -1.0 . . . . 62.01 109.055 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.36 2.85 3.47 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.134 1.374 . . . . 75.45 112.762 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 t -120.32 96.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.607 -0.886 . . . . 73.33 108.607 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.22 165.16 11.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.995 0.518 . . . . 74.21 110.159 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -142.97 95.44 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.288 -1.745 . . . . 74.22 106.288 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.9 131.23 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.303 -0.628 . . . . 72.54 109.303 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.545 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.7 t -106.13 151.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.942 0.897 . . . . 75.32 109.952 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' B' ' 106' ' ' LEU . 1.0 OUTLIER -134.18 119.49 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.087 -1.449 . . . . 72.21 107.087 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.605 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 38.3 ttp180 -105.96 120.98 43.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.872 0.368 . . . . 74.23 110.846 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.06 128.15 63.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.927 -1.138 . . . . 74.31 107.927 168.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -120.78 130.28 53.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.378 -0.601 . . . . 73.55 109.378 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.426 HG22 HG23 ' B' ' 114' ' ' ILE . 98.7 t -118.22 134.14 62.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.276 -0.875 . . . . 74.41 109.055 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 98.6 m -125.58 137.65 53.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.901 -1.045 . . . . 70.45 108.489 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.73 125.36 19.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.508 -1.293 . . . . 74.21 107.508 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 p -136.46 123.44 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.286 -1.005 . . . . 74.11 108.286 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' B' ' 36' ' ' TRP . 3.2 tt -95.61 116.18 28.48 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.48 -0.933 . . . . 73.32 108.48 -172.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -114.06 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 124.11 0.881 . . . . 70.43 111.517 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.48 4.73 15.34 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.182 0.993 . . . . 71.51 111.637 -175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.2 pt-20 -129.62 163.89 25.07 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.317 0.647 . . . . 74.31 110.023 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 12.6 m -67.21 148.59 51.57 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.446 0.466 . . . . 65.42 110.66 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.93 -56.83 2.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.578 0.751 . . . . 64.12 109.024 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -165.36 153.67 11.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.139 -0.937 . . . . 74.12 110.235 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -131.43 144.56 51.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 75.14 108.13 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 40.2 t -151.57 152.27 32.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.559 -0.534 . . . . 73.44 109.559 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -158.36 129.6 6.48 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.21 0.604 . . . . 74.32 109.416 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' B' ' 21' ' ' ILE . 82.7 t -124.56 148.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.812 0.845 . . . . 72.41 109.985 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.605 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 41.7 mt-30 -125.69 98.45 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.23 -1.026 . . . . 75.44 108.23 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.9 tp-100 -85.89 104.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.839 -0.619 . . . . 74.23 109.429 174.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.74 168.47 25.01 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 111.544 -0.622 . . . . 74.44 111.544 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.47 130.76 2.2 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.466 -0.397 . . . . 73.53 112.97 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -84.14 128.92 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.147 0.979 . . . . 74.51 109.018 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.61 140.85 44.91 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.34 1.056 . . . . 63.3 109.759 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -87.49 107.6 18.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.211 1.004 . . . . 73.42 109.032 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.406 HG13 HD22 ' B' ' 98' ' ' LEU . 17.6 mm -122.77 121.8 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.673 0.789 . . . . 71.44 110.478 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.36 167.68 29.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.074 0.55 . . . . 54.24 110.987 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 85.62 -45.19 3.45 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.97 -0.559 . . . . 65.21 113.398 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 41.2 mm -74.36 138.49 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.663 0.785 . . . . 62.3 109.763 178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.03 -172.43 4.03 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.809 0.843 . . . . 75.04 111.149 -176.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.28 -113.52 5.98 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.742 0.651 . . . . 61.32 113.981 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -88.29 -35.6 17.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.723 0.809 . . . . 71.24 110.59 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -71.2 -18.98 62.45 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.096 -0.956 . . . . 74.41 111.599 -168.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ptp -56.12 -28.78 59.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.992 0.917 . . . . 73.32 112.097 173.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.25 87.61 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.101 0.96 . . . . 72.22 112.358 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -88.99 -27.53 20.82 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.367 -0.833 . . . . 71.21 111.218 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.624 0.369 . . . . 74.53 111.821 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.406 HD22 HG13 ' B' ' 86' ' ' ILE . 77.4 mt -102.49 -35.08 8.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.749 0.42 . . . . 74.13 111.976 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.8 -23.25 53.53 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 120.029 -0.317 . . . . 73.31 113.842 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.35 -46.75 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.145 0.473 . . . . 51.04 112.047 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -77.1 -48.57 17.4 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.372 0.669 . . . . 75.15 110.796 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.463 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.2 m -60.72 -49.98 87.25 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.682 -0.675 . . . . 64.33 111.6 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.9 Cg_exo -56.77 -30.77 85.96 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.6 2.2 . . . . 71.04 114.496 171.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -63.36 -32.64 74.12 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.08 0.467 . . . . 64.43 110.965 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.2 mt -74.17 -44.54 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.864 0.866 . . . . 64.4 110.582 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.402 ' HB2' HD12 ' B' ' 60' ' ' LEU . 96.3 mt -72.36 -29.99 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.726 -1.125 . . . . 73.43 112.397 -172.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 80.5 t80 -59.93 -46.1 98.18 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 113.901 1.074 . . . . 71.2 113.901 -168.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.62 -41.75 72.51 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.233 1.955 . . . . 73.42 113.113 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.533 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.0 m-30 -64.26 -39.42 93.9 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.907 -1.042 . . . . 75.05 109.991 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.53 82.93 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.881 0.872 . . . . 74.4 110.961 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -57.23 -58.96 5.95 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.411 1.084 . . . . 74.25 111.752 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 -25.39 63.66 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.199 0.312 . . . . 70.14 110.267 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.426 ' O ' ' HG2' ' B' ' 117' ' ' MET . 13.4 t -70.2 -30.32 67.39 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.929 0.492 . . . . 74.32 111.626 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.426 HG23 HG22 ' B' ' 64' ' ' VAL . 88.6 mt -72.26 -55.92 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.082 0.553 . . . . 74.11 109.662 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.5 m -60.84 -27.98 68.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.54 -1.209 . . . . 74.54 111.411 -172.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.43 -46.02 84.99 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.915 0.886 . . . . 73.21 110.375 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.0 mmt -68.32 -31.3 70.63 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.095 0.558 . . . . 75.11 110.702 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.05 -38.96 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.956 0.902 . . . . 75.34 110.279 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.0 m -66.31 -37.74 86.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.726 0.81 . . . . 71.32 110.99 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -65.02 -38.8 92.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.275 -0.875 . . . . 75.44 109.351 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.35 -0.51 72.12 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 124.057 0.848 . . . . 64.25 113.877 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 55.39 36.26 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.596 1.558 . . . . 74.24 112.309 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -104.86 157.12 34.89 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.609 1.163 . . . . 65.44 110.282 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 129.39 33.87 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.119 2.546 . . . . 72.44 112.508 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -60.4 130.58 47.31 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.913 0.885 . . . . 74.53 112.514 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 90.2 mt -118.97 99.89 7.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.396 -0.965 . . . . 75.34 108.396 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.409 HD21 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -95.19 131.07 41.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.398 0.679 . . . . 74.51 109.469 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.452 ' HB3' ' CZ ' ' B' ' 107' ' ' PHE . 2.1 mm? -76.16 139.06 41.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.351 0.661 . . . . 71.01 110.922 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.38 141.44 45.8 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.027 0.931 . . . . 72.13 111.41 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.71 100.12 0.41 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.896 2.397 . . . . 74.15 112.46 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.87 133.36 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.759 0.824 . . . . 74.4 109.366 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.52 108.55 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.565 0.746 . . . . 75.12 111.219 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -59.95 -35.86 75.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.298 1.039 . . . . 72.04 110.167 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -56.69 14.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.228 -1.351 . . . . 75.04 111.954 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.74 68.84 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.625 0.77 . . . . 74.51 111.51 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 CA--C 1.55 0.96 0 C-N-CA 124.268 1.027 . . . . 73.44 110.613 176.347 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.336 0.589 . . . . 73.53 112.229 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.579 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 25.9 m -85.76 95.45 9.41 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.441 -0.948 . . . . 74.45 108.441 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -119.66 131.86 55.54 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.393 -1.276 . . . . 75.42 108.702 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -151.68 141.72 22.15 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.245 -0.65 . . . . 71.44 109.245 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.9 mt -76.49 116.34 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.525 -0.917 . . . . 73.05 108.525 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -88.33 -49.64 6.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.987 0.515 . . . . 73.0 110.217 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -159.13 138.8 11.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.96 -0.564 . . . . 63.14 109.48 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.84 135.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.1 -1.074 . . . . 73.14 108.1 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -171.57 158.22 5.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.514 0.674 . . . . 72.31 112.152 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -83.99 111.2 19.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.894 -1.048 . . . . 72.03 108.934 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -79.26 -46.68 17.3 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.717 0.77 . . . . 71.22 109.255 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.8 t70 -133.66 137.38 45.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.687 -1.142 . . . . 74.33 108.728 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -142.27 141.64 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.245 1.418 . . . . 65.45 107.379 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -155.24 143.14 19.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.811 -0.44 . . . . 72.52 109.811 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -142.64 141.95 31.99 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 107.54 -1.281 . . . . 72.43 107.54 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -140.08 142.6 36.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.563 -1.273 . . . . 71.02 107.563 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . 0.55 ' HB1' ' HB1' ' C' ' 28' ' ' ALA . . . -142.15 84.28 11.72 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 108.86 -0.793 . . . . 73.53 108.86 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.59 -39.46 15.96 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.909 2.406 . . . . 70.01 112.212 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 88.4 m-20 -111.87 44.75 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.77 0.828 . . . . 71.44 109.658 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.55 ' HB1' ' HB1' ' C' ' 25' ' ' ALA . . . -56.41 -57.9 20.22 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.435 1.094 . . . . 63.0 113.709 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.3 Cg_exo -72.52 -26.54 16.63 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 122.013 1.809 . . . . 63.43 112.009 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.569 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.5 t60 -67.11 -21.73 65.84 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.298 1.439 . . . . 64.54 111.463 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.445 HG22 ' HE2' ' C' ' 34' ' ' LYS . 7.6 p -54.53 -24.1 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.15 0.58 . . . . 72.53 112.538 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -63.5 -40.75 97.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.296 1.038 . . . . 74.02 111.527 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -90.14 5.29 47.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.646 0.379 . . . . 74.15 111.043 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.51 ' HE3' ' HB3' ' C' ' 73' ' ' ALA . 4.7 ttpm? -100.74 146.76 26.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.097 0.959 . . . . 75.22 109.918 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -85.54 134.55 34.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.661 0.784 . . . . 74.33 109.185 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -69.22 71.29 0.26 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.406 1.083 . . . . 65.25 112.382 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -137.65 74.84 45.12 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 108.04 -1.096 . . . . 73.32 108.04 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.42 113.59 3.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.154 1.903 . . . . 72.32 109.591 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.56 83.79 7.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 105.021 -2.214 . . . . 63.34 105.021 174.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.602 HG13 HD11 ' C' ' 126' ' ' LEU . 31.9 m -71.7 128.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-N 115.215 -0.902 . . . . 75.34 111.824 -166.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -92.98 103.65 15.95 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.586 -1.635 . . . . 74.42 106.586 172.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -93.12 151.68 19.71 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.515 -0.766 . . . . 75.23 109.602 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.563 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 45.2 t0 -158.15 147.38 19.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.276 -0.875 . . . . 72.21 108.979 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 148.87 49.35 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 73.22 109.381 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.418 ' O ' HD22 ' C' ' 60' ' ' LEU . 12.0 m-20 -150.34 161.37 42.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.484 1.114 . . . . 74.41 108.904 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -138.71 154.23 48.56 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.125 -0.695 . . . . 75.32 109.125 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.65 151.43 43.06 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.576 -0.527 . . . . 72.42 109.576 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -123.58 143.52 50.16 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.365 0.666 . . . . 73.21 110.171 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -153.13 126.41 8.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.878 0.871 . . . . 73.4 108.701 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -82.61 127.0 32.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.239 -0.652 . . . . 74.45 109.239 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.562 HD13 HD13 ' C' ' 83' ' ' ILE . 59.9 mt -89.59 -42.05 11.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.209 0.604 . . . . 75.4 110.123 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.8 -174.37 4.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.471 0.708 . . . . 71.24 110.621 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.26 114.32 2.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.884 -1.053 . . . . 75.05 109.761 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 69.43 -4.59 1.31 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.196 1.399 . . . . 74.42 112.956 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.46 114.11 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.846 -0.798 . . . . 73.34 108.846 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -126.52 158.83 35.1 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.529 0.732 . . . . 74.43 109.962 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.78 138.36 53.84 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.308 1.043 . . . . 73.43 108.818 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.35 137.81 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.071 -1.085 . . . . 75.41 108.071 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.35 109.35 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.902 -0.777 . . . . 72.34 108.902 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.433 HD23 HG21 ' C' ' 62' ' ' VAL . 0.7 OUTLIER -87.47 102.92 15.03 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.182 -1.044 . . . . 73.54 108.182 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.594 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 18.7 ttp85 -82.79 106.58 14.74 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.936 -0.764 . . . . 70.22 108.936 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.5 t -99.68 132.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.682 -0.858 . . . . 75.25 108.682 173.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 55.2 m -115.18 130.51 56.94 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.827 0.851 . . . . 72.4 109.156 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.546 HG22 HG21 ' C' ' 114' ' ' ILE . 78.1 t -122.13 134.24 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.186 -1.37 . . . . 72.34 107.918 172.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -123.86 143.15 50.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.342 -1.355 . . . . 72.53 107.342 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.0 106.86 8.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.689 -1.226 . . . . 65.52 107.689 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -154.75 158.26 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.69 . . . . 74.21 110.079 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 tp -123.84 78.87 1.66 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.726 -1.953 . . . . 71.41 105.726 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.42 -119.78 4.96 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 115.71 -0.677 . . . . 64.24 112.231 -173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.28 -20.84 26.28 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.625 0.77 . . . . 74.34 109.669 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.459 ' HG3' ' HD3' ' C' ' 34' ' ' LYS . 16.0 tp10 -71.42 86.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.512 1.125 . . . . 74.34 109.446 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 36.0 m -84.75 121.77 28.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.253 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.51 ' HB3' ' HE3' ' C' ' 34' ' ' LYS . . . -71.86 -55.51 7.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.165 -1.05 . . . . 61.31 108.165 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -162.86 173.27 13.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.808 -1.087 . . . . 72.3 111.423 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.92 143.52 45.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.759 -1.571 . . . . 74.22 106.759 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.8 t -149.45 130.43 14.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.693 0.397 . . . . 75.44 110.338 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -131.71 133.28 44.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.671 -0.863 . . . . 72.22 108.671 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -129.52 138.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.687 0.795 . . . . 72.44 108.914 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.594 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.1 mt-30 -113.23 98.59 7.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.585 -0.894 . . . . 75.1 108.585 173.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -84.87 103.84 14.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.361 -0.836 . . . . 75.4 109.688 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.13 148.78 21.65 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.887 -0.485 . . . . 74.15 111.887 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.34 121.32 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.688 -0.565 . . . . 75.13 111.688 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.562 HD13 HD13 ' C' ' 51' ' ' LEU . 8.5 mm -85.66 126.89 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.647 -0.872 . . . . 70.32 108.647 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -135.35 134.72 40.1 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.814 0.846 . . . . 73.43 109.473 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.6 p -81.18 116.57 21.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.414 -0.588 . . . . 74.03 109.414 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.44 111.4 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 72.11 108.511 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.579 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -147.51 169.61 19.2 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 71.55 110.339 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.07 -58.36 3.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.447 -0.661 . . . . 71.32 111.447 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.14 166.33 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 63.14 108.668 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.99 156.18 44.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.543 0.737 . . . . 73.22 110.537 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.39 -148.0 44.88 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.47 0.481 . . . . 70.14 114.155 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' THR . . . . . 0.52 ' HA ' ' HB1' ' C' ' 95' ' ' ALA . 32.4 p -69.38 -18.26 63.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.679 0.792 . . . . 73.35 112.098 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -63.7 -42.47 97.98 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.205 0.602 . . . . 73.01 110.285 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -82.92 -26.33 31.56 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.569 0.348 . . . . 74.24 110.884 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' C' ' 92' ' ' THR . . . -68.16 -22.05 64.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.666 0.786 . . . . 75.15 111.577 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -53.41 -48.75 68.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.934 0.494 . . . . 73.34 110.763 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -65.17 -47.63 76.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.714 -0.676 . . . . 73.53 110.162 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.32 -32.84 74.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.599 0.76 . . . . 75.01 110.925 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.8 -5.32 61.31 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-O 119.572 -0.571 . . . . 63.04 114.251 -171.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.53 -63.17 0.51 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.658 0.729 . . . . 72.22 111.243 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -62.93 -47.64 82.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.035 0.534 . . . . 75.11 112.419 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.69 -42.76 36.88 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.642 -0.695 . . . . 73.4 112.281 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.43 -38.91 89.59 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.266 1.977 . . . . 75.3 113.248 166.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.29 -29.16 70.53 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.973 0.509 . . . . 74.24 111.62 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.495 HD13 ' NH1' ' A' ' 111' ' ' ARG . 38.0 mm -69.9 -41.47 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.139 0.575 . . . . 73.42 110.052 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.478 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -75.8 -25.3 56.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.208 -0.905 . . . . 74.41 111.924 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -56.88 -46.25 99.88 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.596 1.158 . . . . 73.54 113.852 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.63 -40.24 85.09 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.359 2.04 . . . . 74.23 114.074 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.437 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 57.1 m-85 -71.24 -39.99 71.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.811 0.445 . . . . 74.41 110.34 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.2 94.66 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.489 -0.778 . . . . 74.31 110.546 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -59.27 -54.33 48.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.248 1.019 . . . . 75.21 109.91 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -62.33 -35.01 77.74 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.043 0.839 . . . . 60.12 111.1 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 26.1 t -71.24 -36.84 71.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.307 0.643 . . . . 71.42 110.973 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.546 HG21 HG22 ' C' ' 64' ' ' VAL . 77.8 mt -72.19 -50.1 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.4 -0.593 . . . . 74.51 109.4 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 78.6 m -57.19 -33.59 67.63 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.338 1.055 . . . . 73.21 110.793 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -64.52 -54.41 32.77 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 115.352 -0.84 . . . . 75.23 108.74 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.552 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.32 -40.16 70.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.808 1.243 . . . . 73.33 112.76 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.1 t -64.62 -48.44 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.803 0.841 . . . . 75.01 109.411 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.43 ' HB2' HE21 ' C' ' 125' ' ' GLN . 36.4 t -66.98 -28.06 67.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.606 -1.179 . . . . 71.41 111.335 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -70.67 -37.38 73.66 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 123.738 0.815 . . . . 75.42 109.271 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.34 3.28 73.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.912 0.757 . . . . 74.21 113.363 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 66.0 p 60.28 28.45 18.06 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.036 1.734 . . . . 73.04 112.731 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.404 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 62.4 m-85 -97.46 161.76 24.86 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.545 1.138 . . . . 74.25 111.07 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.37 119.3 6.47 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.342 2.695 . . . . 70.41 112.384 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' C' ' 119' ' ' SER . 90.1 mt-30 -62.13 146.88 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.556 1.142 . . . . 72.51 113.416 -172.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.602 HD11 HG13 ' C' ' 40' ' ' VAL . 4.4 mm? -106.85 95.12 5.5 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.069 0.948 . . . . 71.11 108.958 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -90.35 90.83 8.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.325 -0.991 . . . . 73.33 108.325 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.73 126.18 29.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.909 -1.041 . . . . 75.11 110.807 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.67 156.12 86.86 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.091 0.956 . . . . 73.24 111.292 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.86 124.74 11.77 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.177 1.918 . . . . 72.32 111.851 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.96 138.01 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.041 0.537 . . . . 72.52 109.556 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -88.1 61.5 6.33 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.904 0.859 . . . . 71.32 110.234 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.98 -32.22 70.31 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.851 -1.068 . . . . 74.32 111.149 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 122.71 0.404 . . . . 72.3 110.054 175.292 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 9' ' ' MET . . . . . 0.545 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.6 ptm . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.28 0.844 . . . . 73.42 113.28 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 40.0 m -128.64 146.63 50.81 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.926 -0.768 . . . . 74.25 108.926 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' D' ' 85' ' ' SER . 49.9 t80 -155.93 102.44 2.17 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.483 -1.303 . . . . 73.23 107.483 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.23 139.99 53.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.062 0.545 . . . . 74.03 110.027 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.58 110.2 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.194 0.998 . . . . 72.34 108.97 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -89.26 -47.43 8.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.04 0.136 . . . . 74.24 111.357 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.23 119.74 0.7 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 119.423 -0.323 . . . . 71.13 110.341 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.22 136.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.215 -1.031 . . . . 73.2 108.215 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -165.99 174.32 9.57 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.637 0.732 . . . . 65.11 111.769 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -101.73 128.12 48.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.388 -0.823 . . . . 74.41 109.088 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 33.3 mtpt -98.46 -16.49 19.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.873 0.469 . . . . 70.04 110.244 176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.727 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -161.2 141.88 11.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.277 1.031 . . . . 74.15 109.496 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.556 HD11 ' SG ' ' D' ' 113' ' ' CYS . 61.9 mt -144.49 145.22 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.426 . . . . 71.34 107.676 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -148.25 144.05 27.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.872 0.869 . . . . 74.0 109.631 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.448 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -152.7 127.1 9.28 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.774 -1.565 . . . . 74.54 106.774 172.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.4 mt-10 -133.61 120.81 21.18 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.434 0.693 . . . . 64.11 109.481 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.14 83.88 61.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.368 -0.975 . . . . 73.23 108.368 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.62 -50.47 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.083 2.522 . . . . 62.11 111.725 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.491 ' O ' HG21 ' D' ' 31' ' ' VAL . 56.2 m-20 -89.34 31.8 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.183 0.993 . . . . 71.14 109.765 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -48.73 96.43 Favored Pre-proline 0 CA--C 1.561 1.4 0 N-CA-C 114.736 1.384 . . . . 75.51 114.736 -170.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.19 -7.09 12.06 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.595 1.53 . . . . 75.14 112.558 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -83.78 -36.31 23.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.878 1.271 . . . . 74.05 110.123 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' D' ' 73' ' ' ALA . 92.0 t -69.43 -25.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.544 0.738 . . . . 75.23 110.207 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.23 -24.53 64.93 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.21 1.004 . . . . 72.15 111.974 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -81.54 -14.16 57.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.753 0.821 . . . . 75.52 112.209 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -121.33 110.72 16.45 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.999 0.919 . . . . 75.04 109.818 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 91.85 8.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.879 0.871 . . . . 72.4 110.621 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.636 ' HB3' HD13 ' D' ' 68' ' ' LEU . 38.6 t-105 -168.23 163.98 13.17 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.531 HE21 ' HG3' ' D' ' 124' ' ' PRO . 1.2 mp0 -90.87 116.15 65.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.302 0.641 . . . . 61.1 110.455 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.431 ' HG3' ' HB2' ' D' ' 68' ' ' LEU . 85.7 Cg_exo -47.35 149.03 4.46 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 124.855 3.703 . . . . 62.41 116.078 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 60.8 mm-40 -64.89 112.09 3.13 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.734 -0.839 . . . . 60.14 108.734 169.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 76.6 t -109.37 117.15 53.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.457 0.646 . . . . 65.3 110.801 -177.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.74 147.65 23.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.497 -1.229 . . . . 61.25 108.074 164.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.42 154.96 45.49 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.079 -1.082 . . . . 74.32 108.079 176.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.2 t70 -150.43 155.84 40.31 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.38 0.672 . . . . 74.13 109.395 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -134.9 139.69 45.19 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.053 -0.721 . . . . 75.5 109.053 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 29.1 t70 -141.49 132.12 25.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 75.42 106.968 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -104.25 163.46 12.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.455 0.57 . . . . 75.2 110.754 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.571 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -160.92 172.42 16.97 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.068 0.947 . . . . 65.4 109.422 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.6 p -166.97 178.29 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.027 0.531 . . . . 65.44 111.138 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -169.89 118.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.979 1.312 . . . . 55.41 108.114 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -79.53 122.22 26.2 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.785 -0.45 . . . . 71.13 109.785 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.8 mt -90.11 -36.62 14.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.215 0.606 . . . . 73.42 109.88 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.45 -176.54 4.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.968 0.907 . . . . 73.31 110.721 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.39 122.49 16.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.956 -1.02 . . . . 75.22 109.165 175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 65.89 1.24 1.78 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.027 1.331 . . . . 71.53 113.044 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.13 116.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.88 -0.785 . . . . 74.34 108.88 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.93 162.58 24.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.218 -1.03 . . . . 74.45 108.218 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' D' ' 51' ' ' LEU . 6.4 tm-20 -131.18 131.93 44.38 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 105.736 -1.95 . . . . 74.45 105.736 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.408 HG11 ' HD3' ' D' ' 103' ' ' PRO . 92.1 t -125.61 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.625 -0.88 . . . . 75.44 108.625 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 58.5 t -116.95 138.58 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.521 0.728 . . . . 73.1 109.688 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -118.35 118.12 30.91 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.638 -1.245 . . . . 73.45 107.638 177.184 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.403 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.0 ttm-85 -99.24 103.22 15.06 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.287 1.035 . . . . 73.33 108.323 176.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.09 124.95 50.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.511 -0.922 . . . . 72.32 108.511 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.9 m -108.96 145.39 35.55 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.65 0.594 . . . . 72.54 110.066 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.27 133.39 52.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.843 1.257 . . . . 75.24 108.544 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 46.3 m -127.69 115.63 19.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.152 -1.055 . . . . 74.43 108.152 172.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -124.81 130.57 52.65 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.032 0.533 . . . . 74.33 109.935 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 70.2 m -142.08 130.08 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.756 0.822 . . . . 72.24 108.95 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' D' ' 36' ' ' TRP . 23.6 tp -105.35 108.21 19.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.879 -0.786 . . . . 73.32 108.879 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.44 -110.41 3.35 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.879 -0.888 . . . . 73.13 110.879 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.89 7.49 9.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 63.11 110.191 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.68 147.86 42.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.191 0.596 . . . . 73.34 111.162 -175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 100.0 m -65.54 115.12 5.42 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.78 0.675 . . . . 75.45 109.978 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -82.89 -63.98 1.26 Allowed 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.604 0.565 . . . . 74.23 110.35 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -156.13 139.03 15.31 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.567 -0.742 . . . . 72.05 109.794 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 66.9 mt -109.0 149.7 28.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.448 -1.316 . . . . 74.31 107.448 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.612 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.6 t -158.39 139.33 13.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.654 -0.212 . . . . 75.12 110.578 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -154.84 123.21 5.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.733 0.413 . . . . 65.44 109.954 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -123.8 117.6 51.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.443 0.697 . . . . 72.44 109.833 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.727 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.3 mt-30 -93.94 88.17 5.63 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.581 0.705 . . . . 71.32 109.266 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.446 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.69 108.26 13.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.245 -1.343 . . . . 72.43 109.209 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.23 172.83 32.32 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.154 0.308 . . . . 71.23 112.394 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.25 138.32 4.57 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 111.822 -0.511 . . . . 64.23 111.822 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.7 mt -90.56 120.74 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.066 -0.716 . . . . 75.22 109.066 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -125.47 125.65 43.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.608 1.163 . . . . 71.14 109.226 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 14.9 m -82.42 95.38 7.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.99 -0.744 . . . . 71.41 108.99 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.56 115.74 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.921 -0.77 . . . . 75.41 108.921 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.49 168.35 19.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.823 0.849 . . . . 75.14 110.698 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.5 -2.13 48.2 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.845 0.716 . . . . 70.43 114.676 173.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -135.51 157.31 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.327 1.051 . . . . 73.34 109.141 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.42 173.11 12.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.628 0.771 . . . . 64.03 111.098 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.49 -121.78 21.76 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.984 0.754 . . . . 65.21 114.984 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -68.85 -18.78 64.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.717 0.807 . . . . 75.21 112.654 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -75.27 -48.53 22.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.22 0.608 . . . . 74.32 110.287 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -75.04 -25.78 58.96 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 116.678 -0.237 . . . . 70.13 110.379 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.42 75.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.38 0.672 . . . . 71.24 110.495 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.63 -36.35 82.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.881 0.872 . . . . 74.51 110.552 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . 0.535 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 91.0 m -67.56 -54.08 22.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.254 0.346 . . . . 74.4 111.04 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.62 -19.69 60.79 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 122.327 -0.233 . . . . 74.43 111.597 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.48 -27.2 10.06 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.298 -0.723 . . . . 74.11 114.175 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 -51.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.959 0.88 . . . . 72.52 112.891 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 49.2 t80 -73.33 -55.19 6.73 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.752 0.649 . . . . 72.35 112.752 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.3 m -60.46 -44.64 96.3 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 118.517 -0.754 . . . . 75.11 111.676 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.551 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.0 Cg_exo -53.02 -35.69 72.95 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.492 2.128 . . . . 73.43 114.046 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -66.15 -39.67 89.98 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.572 0.749 . . . . 71.52 109.721 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -63.7 -41.03 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.497 0.719 . . . . 73.3 110.079 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.446 HD11 ' O ' ' D' ' 80' ' ' GLN . 91.8 mt -75.43 -24.43 57.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.076 -0.965 . . . . 64.31 112.14 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -62.84 -42.49 78.34 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 117.881 -1.056 . . . . 72.11 113.697 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.29 -38.82 73.17 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 121.923 1.748 . . . . 75.2 113.59 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.55 -32.14 28.75 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.637 0.775 . . . . 73.42 111.831 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.75 74.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.236 0.614 . . . . 64.31 109.807 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 35.0 ttp180 -61.07 -45.9 92.87 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 124.338 1.024 . . . . 72.24 110.282 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.26 -50.25 69.99 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.539 1.149 . . . . 75.24 111.694 -174.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.0 t -60.97 -40.98 95.45 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.249 0.968 . . . . 71.12 111.217 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.612 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -60.19 -55.9 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.369 0.668 . . . . 74.55 110.204 173.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.2 m -53.51 -40.66 65.61 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.117 1.367 . . . . 73.11 110.65 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.3 t -69.51 -47.87 62.42 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.412 -1.267 . . . . 62.21 110.954 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.0 mtm -67.08 -30.95 71.13 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.078 0.399 . . . . 75.45 112.078 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -67.39 -46.06 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 123.557 0.535 . . . . 75.0 109.868 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -71.18 -25.28 62.46 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.477 -0.329 . . . . 63.14 110.757 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -75.69 -33.71 60.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.966 0.906 . . . . 74.52 109.511 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.56 1.05 67.88 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.552 -0.749 . . . . 61.15 112.537 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.5 p 56.04 40.44 30.31 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.265 1.826 . . . . 73.22 112.106 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.443 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 58.4 m-85 -103.68 169.68 7.06 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 125.075 1.35 . . . . 73.11 108.172 171.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.531 ' HG3' HE21 ' D' ' 37' ' ' GLN . 34.6 Cg_endo -62.92 138.92 71.08 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.899 1.732 . . . . 75.54 109.864 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -63.36 156.01 27.13 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.425 0.557 . . . . 75.2 111.176 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.85 115.11 24.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.128 -1.064 . . . . 73.23 108.128 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -107.78 92.96 4.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.474 0.71 . . . . 74.42 109.642 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.442 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 68.9 mt -67.17 117.24 8.93 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.848 -0.614 . . . . 74.22 109.543 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 133.13 94.31 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 122.359 0.263 . . . . 74.23 110.494 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.18 109.29 2.79 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.222 1.948 . . . . 71.41 110.465 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 93.7 t -107.46 111.08 34.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.906 0.882 . . . . 72.01 109.046 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -83.1 73.2 10.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.024 0.916 . . . . 71.42 109.626 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.477 0.909 0 CA-C-N 114.904 -1.043 . . . . 74.33 109.764 176.326 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.385 -0.598 . . . . 63.41 109.385 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 p -176.94 -62.92 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.351 1.06 . . . . 64.3 109.716 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.79 81.14 5.11 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.663 0.785 . . . . 73.25 109.865 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -143.48 33.99 1.3 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.742 1.258 . . . . 65.33 107.618 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -72.88 84.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.86 -1.518 . . . . 72.34 108.646 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -101.65 157.67 16.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.75 -1.204 . . . . 64.13 107.75 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -80.01 62.16 4.12 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.465 1.126 . . . . 73.21 110.637 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -92.53 -48.53 6.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 74.25 109.426 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.457 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -65.06 149.43 49.89 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.48 0.657 . . . . 73.34 112.49 -173.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 62.6 m -147.85 116.52 6.69 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.286 -1.376 . . . . 60.44 107.286 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -136.98 132.1 33.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.425 0.69 . . . . 61.1 109.27 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -137.77 134.95 35.87 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.746 0.418 . . . . 64.41 110.1 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 pp -81.58 88.2 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 109.201 -0.666 . . . . 75.21 109.201 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -74.91 -41.71 59.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.297 0.639 . . . . 74.12 110.601 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.9 tpp85 -165.56 133.47 3.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.971 -0.559 . . . . 74.5 110.3 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.56 HD11 ' HG3' ' C' ' 130' ' ' PRO . 3.8 mp -131.04 120.26 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.386 -1.338 . . . . 73.33 107.386 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -164.06 176.21 9.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.696 0.799 . . . . 70.32 110.411 -169.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.464 HG22 ' SG ' ' A' ' 113' ' ' CYS . 78.7 p -92.69 117.9 30.48 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.201 -0.666 . . . . 73.24 109.201 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 43.9 mtpt -75.69 -30.52 59.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.909 -0.404 . . . . 75.13 109.909 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.59 143.13 19.55 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.543 -0.753 . . . . 73.23 109.63 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 68.4 mt -139.3 144.34 29.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.618 -1.252 . . . . 74.2 107.618 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -150.03 136.19 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.375 -0.602 . . . . 71.42 109.375 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.531 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -140.82 109.75 6.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.714 -1.587 . . . . 73.23 106.714 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.81 119.52 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.48 -0.563 . . . . 74.43 109.48 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.08 83.16 37.89 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.021 -1.103 . . . . 72.21 108.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.29 -18.48 34.49 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.728 2.285 . . . . 75.41 111.937 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -117.35 37.39 3.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.361 1.064 . . . . 71.41 109.749 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.13 93.18 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 114.379 1.252 . . . . 73.44 114.379 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.19 -25.13 8.87 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.698 1.599 . . . . 74.42 111.649 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -78.97 -14.23 59.33 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.935 1.694 . . . . 74.35 111.418 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.43 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 7.1 p -69.76 -22.31 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.692 0.797 . . . . 62.25 111.879 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.82 -25.59 66.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.808 0.843 . . . . 64.32 111.358 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -86.85 -34.06 19.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.239 1.016 . . . . 73.34 111.48 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.64 ' HD3' HD21 ' A' ' 68' ' ' LEU . 12.5 ptpt -80.57 171.76 14.63 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.224 0.535 . . . . 75.41 111.36 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.17 144.96 29.46 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.247 -0.888 . . . . 75.2 109.336 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -89.61 63.73 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.703 0.763 . . . . 74.41 110.956 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -149.08 82.37 7.11 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 114.941 -1.027 . . . . 73.24 108.352 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -85.39 170.01 9.46 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.675 2.25 . . . . 73.24 111.265 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.98 114.72 26.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.621 -0.881 . . . . 65.51 108.621 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.704 ' HB ' ' HG3' ' F' ' 128' ' ' LYS . 59.5 t -75.61 96.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.829 0.852 . . . . 64.23 109.532 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.6 tttm -102.45 116.44 32.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.538 1.135 . . . . 75.01 109.204 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.04 128.83 53.5 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.203 -1.036 . . . . 74.14 108.203 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.597 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 16.3 m-20 -115.06 131.04 57.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.084 0.954 . . . . 70.32 108.668 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.5 138.65 53.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.919 0.888 . . . . 73.13 109.657 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 26.5 t70 -155.43 146.81 22.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.67 0.788 . . . . 73.04 109.913 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.09 139.02 35.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.42 0.688 . . . . 73.43 110.617 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -139.86 154.34 47.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.236 1.014 . . . . 63.22 110.183 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -129.08 157.77 40.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.667 0.787 . . . . 74.14 108.947 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.3 t -161.45 115.47 1.97 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.256 -0.275 . . . . 61.43 110.256 -172.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -72.06 104.79 3.69 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 71.33 109.817 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 57' ' ' GLU . 65.1 mt -77.79 -41.35 37.67 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.194 0.998 . . . . 65.21 110.891 176.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.28 -175.62 4.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.644 -1.162 . . . . 61.21 108.379 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -58.63 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.865 0.466 . . . . 64.43 110.671 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 59.15 33.55 22.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.859 1.264 . . . . 62.24 112.483 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 61.5 t -112.95 118.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.717 -1.586 . . . . 75.01 106.717 167.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -129.6 131.69 46.56 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.766 -0.828 . . . . 75.33 108.766 -177.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD13 ' A' ' 51' ' ' LEU . 43.6 tt0 -89.25 121.07 31.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.697 0.799 . . . . 73.23 109.054 173.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 99.0 t -100.25 121.85 51.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 123.807 0.843 . . . . 75.32 108.775 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.5 t -108.5 133.66 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.666 -0.494 . . . . 64.14 109.666 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.94 116.0 31.19 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.067 -1.457 . . . . 73.1 107.067 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -91.78 102.3 14.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.635 -1.246 . . . . 65.24 107.635 170.318 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.453 ' HB ' HD11 ' A' ' 114' ' ' ILE . 2.9 t -101.18 130.33 50.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.036 -1.468 . . . . 73.53 107.036 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.597 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -132.04 125.99 32.8 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.221 0.534 . . . . 71.41 109.726 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 47.3 t -111.28 110.05 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.156 0.982 . . . . 73.4 109.167 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 26.3 m -101.12 135.94 41.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.667 -0.864 . . . . 73.43 108.667 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.52 103.85 7.57 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.751 -1.204 . . . . 71.15 107.751 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 m -143.67 128.06 17.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.203 0.601 . . . . 71.11 109.535 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.64 HD21 ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -94.28 84.93 4.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.502 -1.295 . . . . 75.33 107.502 172.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -116.89 4.66 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.539 -1.209 . . . . 74.54 111.277 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.01 -25.44 21.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 70.14 111.059 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.565 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 tp10 -81.25 96.05 7.14 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.556 -0.535 . . . . 73.34 109.556 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -75.31 129.0 36.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.313 0.645 . . . . 73.01 110.811 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.11 4.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.015 0.926 . . . . 75.32 108.917 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -164.94 173.99 11.02 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.586 -1.188 . . . . 72.23 110.62 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.9 tp -140.92 137.75 33.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.575 1.15 . . . . 72.03 108.449 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.0 m -127.54 141.96 51.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.802 1.241 . . . . 74.32 108.751 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.14 134.91 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.207 -0.664 . . . . 74.31 109.207 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.76 111.57 8.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 123.776 0.831 . . . . 73.54 108.991 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -85.52 84.53 7.59 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.437 -0.949 . . . . 64.11 108.437 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.17 96.36 6.53 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.697 -1.223 . . . . 72.23 107.697 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.99 146.33 16.55 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 111.665 -0.574 . . . . 75.33 111.665 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.98 133.9 5.72 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.027 -0.829 . . . . 73.01 111.027 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -85.79 127.49 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.075 -0.713 . . . . 74.21 109.075 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.6 118.95 18.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.155 -1.054 . . . . 74.1 108.155 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 54.0 p -89.52 94.04 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.837 -0.801 . . . . 54.13 108.837 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.71 HG12 HD12 ' A' ' 98' ' ' LEU . 2.8 pp -119.21 144.01 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.747 0.419 . . . . 74.25 111.259 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.31 177.52 3.08 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.273 1.429 . . . . 70.22 108.835 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 83.53 3.34 89.82 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.898 0.719 . . . . 73.34 114.898 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.457 ' O ' ' HE2' ' A' ' 94' ' ' MET . 1.6 pp -136.1 150.15 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.069 -1.085 . . . . 75.42 108.069 173.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -128.55 173.63 10.09 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.484 -0.561 . . . . 74.33 109.484 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.83 -112.33 1.61 Allowed Glycine 0 C--N 1.352 1.434 0 O-C-N 124.832 1.333 . . . . 73.51 116.176 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.0 p -61.89 -50.81 70.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 73.13 111.5 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.43 -33.99 69.89 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.382 0.673 . . . . 70.51 112.118 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.457 ' HE2' ' O ' ' A' ' 89' ' ' ILE . 49.1 tpp -63.85 -51.57 64.05 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.304 0.378 . . . . 63.34 110.381 174.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.56 -35.78 76.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.153 0.581 . . . . 62.21 111.067 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -75.74 -22.22 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.118 0.967 . . . . 71.43 111.103 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.457 ' HB3' HD22 ' A' ' 98' ' ' LEU . 43.3 t -70.61 -60.55 2.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.638 -0.505 . . . . 75.54 109.638 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.71 HD12 HG12 ' A' ' 86' ' ' ILE . 1.7 mm? -81.92 -23.14 36.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.837 -0.619 . . . . 74.23 111.822 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.32 -28.03 9.48 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 123.534 0.521 . . . . 74.4 113.857 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.97 -63.59 1.42 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.478 0.639 . . . . 72.11 111.004 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.3 -50.23 70.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.778 0.831 . . . . 73.35 112.55 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.0 m -65.12 -49.09 68.36 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.077 -0.963 . . . . 73.42 112.65 -172.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.57 -24.29 56.13 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 121.848 1.698 . . . . 73.25 112.703 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -74.03 -27.74 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.271 0.628 . . . . 54.31 110.44 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.23 -39.67 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.57 0.748 . . . . 73.23 109.718 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 mt -76.72 -24.86 53.07 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.339 -0.846 . . . . 73.13 111.692 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.05 -41.86 47.48 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 114.535 1.309 . . . . 75.23 114.535 -169.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.94 -38.73 76.84 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.034 1.823 . . . . 75.23 113.007 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -77.95 -31.87 51.18 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.684 -0.689 . . . . 74.45 111.245 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.439 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -68.19 -45.69 72.7 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.357 0.663 . . . . 73.42 109.506 174.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HD13 ' C' ' 105' ' ' ILE . 36.0 ttm180 -51.3 -52.85 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.988 1.43 . . . . 73.23 110.382 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.37 -47.81 80.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.724 -1.126 . . . . 72.22 111.86 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.515 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.4 t -59.88 -29.85 68.61 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.949 0.781 . . . . 73.51 111.77 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 118' ' ' VAL . 94.8 mt -73.29 -58.67 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.534 -0.543 . . . . 73.32 109.534 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -51.24 -39.85 57.55 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.093 1.357 . . . . 70.51 112.641 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -70.23 -40.66 74.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.082 -0.963 . . . . 74.22 111.283 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.17 -43.24 99.27 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 120.864 0.364 . . . . 74.15 110.585 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.8 t -57.17 -45.8 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 114.663 -1.153 . . . . 71.24 110.92 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -70.57 -30.9 67.72 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.529 -0.76 . . . . 74.13 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -68.96 -31.28 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.501 0.72 . . . . 73.13 110.86 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 3.52 65.65 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.447 -0.64 . . . . 70.02 113.418 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 67.25 35.17 4.54 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.419 1.104 . . . . 62.11 109.781 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -111.24 149.79 41.06 Favored Pre-proline 0 N--CA 1.478 0.926 0 CA-C-N 114.865 -1.061 . . . . 71.11 110.044 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.35 143.14 94.67 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.872 2.381 . . . . 72.24 112.808 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -53.72 138.62 34.81 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.856 0.862 . . . . 73.22 112.459 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.466 ' HG ' HG12 ' A' ' 64' ' ' VAL . 1.4 tm? -120.93 109.28 14.91 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.579 -1.267 . . . . 72.23 107.579 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -98.97 127.17 44.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.764 0.825 . . . . 74.42 108.859 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 132.59 43.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.412 0.685 . . . . 73.5 109.817 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.58 130.04 86.23 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 118.68 -0.676 . . . . 75.21 109.848 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.61 115.65 2.82 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.341 2.027 . . . . 70.45 111.887 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.86 114.2 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.316 -1.364 . . . . 73.23 107.316 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.419 HD21 ' HB2' ' A' ' 135' ' ' ALA . 21.6 p-10 -76.9 74.68 3.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.4 0.68 . . . . 72.05 109.97 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -55.6 -44.05 76.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 71.12 110.994 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.46 -52.48 38.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.768 -1.105 . . . . 73.13 111.972 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.419 ' HB2' HD21 ' A' ' 132' ' ' ASN . . . -71.16 -43.44 67.5 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.739 0.649 . . . . 53.41 111.611 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.36 -35.09 78.66 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.729 0.812 . . . . 71.13 111.569 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.34 -46.83 81.79 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 110.072 -0.344 . . . . 74.43 110.072 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.657 ' HE3' ' HG2' ' C' ' 143' ' ' GLN . 77.1 mmm -73.57 -29.21 62.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.88 -0.6 . . . . 75.4 111.367 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -58.59 -60.32 3.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.858 1.263 . . . . 74.13 109.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -64.13 -31.62 72.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.809 -1.087 . . . . 75.22 111.98 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.7 tt -55.86 -48.31 75.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.83 0.852 . . . . 73.42 110.737 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -172.9 -13.8 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.845 0.716 . . . . 74.33 111.886 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.487 ' NE2' ' HB3' ' A' ' 138' ' ' MET . 43.0 mt-30 -88.83 46.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.423 0.63 . . . . 73.5 111.161 -172.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' C' ' 1' ' ' MET . 48.7 mt-30 -72.81 -12.22 60.9 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.256 -0.884 . . . . 75.22 111.977 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.71 22.21 3.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.229 1.012 . . . . 73.2 109.687 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.2 158.04 15.69 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.768 -0.651 . . . . 53.02 113.177 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.716 ' HG3' ' HB ' ' C' ' 7' ' ' THR . 29.6 tt0 -143.32 124.93 14.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.345 0.658 . . . . 72.45 109.872 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.01 92.61 0.35 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.826 -0.509 . . . . 75.21 111.826 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -77.76 161.99 27.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.231 0.612 . . . . 74.31 110.113 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 133.82 54.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.639 0.776 . . . . 73.04 110.383 -176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.59 123.46 21.39 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 109.15 -0.685 . . . . 70.02 109.15 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.585 ' HA ' ' HE2' ' C' ' 137' ' ' PHE . 44.9 m80 -80.45 88.51 5.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.595 -0.73 . . . . 65.32 109.436 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -93.13 139.81 30.18 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.678 -1.147 . . . . 74.35 110.181 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.77 -69.47 0.29 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.006 0.923 . . . . 73.22 110.585 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 124.382 1.073 . . . . 75.41 108.345 179.765 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 109.222 -0.659 . . . . 73.34 109.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -147.42 -70.32 0.23 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.014 -1.106 . . . . 75.24 108.014 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 56.79 23.61 8.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.499 1.119 . . . . 71.43 112.514 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -87.84 93.21 9.39 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.687 -0.857 . . . . 75.42 108.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -63.45 108.6 1.38 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.764 0.826 . . . . 75.41 110.617 -175.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.53 132.65 45.83 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.297 0.998 . . . . 74.05 110.152 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.401 HG22 ' HB3' ' B' ' 9' ' ' MET . 7.8 t -138.85 161.6 36.88 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.398 1.079 . . . . 70.2 108.912 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.2 -38.79 91.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.254 0.622 . . . . 72.1 110.147 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.401 ' HB3' HG22 ' B' ' 7' ' ' THR . 19.4 ptm 47.49 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.17 1.788 . . . . 73.45 114.194 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.577 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 32.8 m -152.79 127.51 9.49 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.188 -1.412 . . . . 70.21 107.188 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -124.3 154.46 40.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.963 -0.755 . . . . 74.21 108.963 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.65 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 50.2 tt0 -153.49 139.42 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.959 0.904 . . . . 72.14 109.829 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.59 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -97.55 113.15 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.092 -1.447 . . . . 74.42 107.092 166.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -77.76 -49.4 14.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.034 -0.416 . . . . 70.14 110.042 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -161.94 133.05 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.478 -0.328 . . . . 75.33 110.194 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.13 137.42 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 107.046 -1.465 . . . . 75.43 107.046 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.89 145.52 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.365 0.602 . . . . 74.14 111.744 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 65.6 m -75.81 115.15 15.21 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.907 -1.042 . . . . 73.43 108.698 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.417 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.1 mtpt -85.75 -31.39 22.43 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.088 0.555 . . . . 74.22 110.568 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.3 t70 -157.78 143.84 17.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.729 -0.668 . . . . 70.21 111.303 -168.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 37.6 mm -139.97 141.03 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 125.304 1.442 . . . . 74.21 108.646 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -141.26 132.39 26.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.601 -1.259 . . . . 75.12 107.601 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 84.5 t80 -144.27 109.71 5.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.244 -1.761 . . . . 75.4 106.244 170.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -119.18 117.3 28.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.013 -0.736 . . . . 74.34 109.013 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.36 86.1 7.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.708 -1.219 . . . . 75.51 107.708 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.57 -28.02 32.1 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.447 2.098 . . . . 73.53 110.811 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -107.0 27.77 8.67 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.745 1.218 . . . . 71.21 109.244 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.62 -57.39 9.98 Favored Pre-proline 0 CA--C 1.57 1.734 0 C-N-CA 124.67 1.188 . . . . 74.32 112.954 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -82.48 -1.28 10.56 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 121.77 1.647 . . . . 74.14 112.843 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -99.57 -16.43 18.27 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.644 0.778 . . . . 73.04 111.885 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.18 -21.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.534 0.733 . . . . 72.34 112.784 -167.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -73.65 -16.72 61.21 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.517 0.192 . . . . 74.04 111.517 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -81.69 -4.87 57.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.664 0.786 . . . . 72.53 111.082 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.606 ' HD2' ' HB2' ' B' ' 68' ' ' LEU . 72.7 mmtt -106.51 102.17 11.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.573 1.149 . . . . 73.31 109.898 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -115.9 85.99 2.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 72.21 111.954 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.468 ' HB2' HD23 ' B' ' 68' ' ' LEU . 6.2 m0 -159.27 -170.5 3.0 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.678 1.991 . . . . 74.11 106.657 169.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -83.51 125.4 73.94 Favored Pre-proline 0 N--CA 1.478 0.925 0 N-CA-C 107.628 -1.249 . . . . 72.31 107.628 162.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.505 ' HA ' ' HG ' ' B' ' 68' ' ' LEU . 30.3 Cg_endo -62.68 132.64 38.52 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.08 1.853 . . . . 61.35 112.143 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -68.93 103.27 1.77 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.657 -1.156 . . . . 74.11 108.443 171.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.17 128.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.742 0.817 . . . . 74.13 110.079 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -121.75 109.74 15.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.642 1.177 . . . . 74.51 108.048 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.487 HD23 HD13 ' E' ' 129' ' ' LEU . 1.6 pp -92.15 153.57 19.24 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.608 0.763 . . . . 63.43 110.64 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.624 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.0 m-20 -136.04 137.17 40.88 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.948 -1.13 . . . . 75.51 107.948 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.475 HD22 HG21 ' B' ' 131' ' ' VAL . 7.1 mp -115.78 132.64 56.58 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.083 -0.71 . . . . 74.44 109.083 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.9 t70 -139.05 155.94 47.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.846 1.258 . . . . 73.11 108.637 -173.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.467 ' HG1' HG23 ' E' ' 123' ' ' VAL . 1.0 OUTLIER -138.32 140.11 39.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.759 0.824 . . . . 73.33 109.042 171.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.61 116.88 17.23 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.485 -1.302 . . . . 75.04 107.485 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -106.38 161.5 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.109 0.564 . . . . 64.14 110.733 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -160.48 136.04 8.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.688 -0.856 . . . . 74.35 108.688 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -88.4 120.27 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.649 -0.871 . . . . 72.35 108.649 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 mt -81.28 -39.33 25.41 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.259 0.552 . . . . 75.53 110.375 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.32 -177.86 6.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.789 -1.096 . . . . 62.54 110.016 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -69.87 130.66 42.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.068 -1.086 . . . . 74.33 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.49 -4.81 1.27 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.604 1.162 . . . . 75.24 112.761 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -123.08 116.96 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.628 0.771 . . . . 74.04 109.61 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.421 ' HD2' HG11 ' B' ' 58' ' ' VAL . 30.0 p90 -126.19 171.58 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.188 0.595 . . . . 75.23 109.418 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -144.71 108.15 4.61 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.625 -1.25 . . . . 74.51 107.625 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.421 HG11 ' HD2' ' B' ' 56' ' ' TYR . 29.5 m -104.47 137.47 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.148 -0.686 . . . . 72.31 109.148 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.38 119.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.149 -0.686 . . . . 74.23 109.149 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.02 114.32 26.84 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.54 -1.281 . . . . 74.43 107.54 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.5 ttt180 -106.24 122.29 45.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.78 0.832 . . . . 75.31 109.985 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -113.27 118.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.806 -0.813 . . . . 75.05 108.806 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.624 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 20.1 m -99.92 145.37 27.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.418 1.087 . . . . 75.54 108.513 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.409 HG23 HD12 ' B' ' 114' ' ' ILE . 52.3 t -136.57 130.17 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.702 0.801 . . . . 74.43 109.268 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -120.96 145.58 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.134 -1.062 . . . . 73.32 108.134 171.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.56 151.33 37.15 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.711 0.291 . . . . 63.15 110.36 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -162.25 143.24 10.41 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.672 1.232 . . . . 63.2 109.657 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.606 ' HB2' ' HD2' ' B' ' 34' ' ' LYS . 5.0 mp -112.38 137.08 51.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.249 -1.019 . . . . 74.22 108.249 168.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.13 -118.33 6.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.112 -0.795 . . . . 75.23 111.112 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.59 29.48 6.57 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.481 0.712 . . . . 74.14 110.506 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -145.4 142.92 29.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.113 0.565 . . . . 73.51 110.355 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 9.1 m -59.52 151.83 23.35 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.338 1.055 . . . . 72.04 112.137 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.505 ' HB3' HD13 ' B' ' 68' ' ' LEU . . . -112.27 -61.78 1.67 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.446 1.098 . . . . 64.3 108.926 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.8 156.88 28.28 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.79 -1.55 . . . . 74.42 108.94 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.37 141.93 49.11 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.335 -1.358 . . . . 73.13 107.335 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.1 t -154.21 152.48 30.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.454 -0.573 . . . . 72.04 109.454 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.15 140.71 5.34 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.264 -0.643 . . . . 72.35 109.264 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.4 HG11 ' HA ' ' B' ' 110' ' ' ALA . 94.3 t -133.66 146.79 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.079 0.952 . . . . 75.43 108.748 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.487 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.7 mt-30 -126.34 101.05 6.54 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.233 0.613 . . . . 74.21 109.443 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -90.8 105.34 17.75 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.531 -0.759 . . . . 74.45 109.801 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.417 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.36 156.19 23.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 111.532 -0.627 . . . . 64.44 111.532 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 126.56 1.96 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 111.862 -0.495 . . . . 63.33 111.862 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.0 126.18 40.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.575 -0.898 . . . . 75.12 108.575 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -131.51 155.95 46.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.223 1.009 . . . . 75.03 109.093 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.65 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 44.1 m -131.92 134.32 45.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.293 1.037 . . . . 65.24 109.627 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.734 ' HB ' HD12 ' B' ' 89' ' ' ILE . 2.7 pp -131.59 147.7 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.152 0.981 . . . . 74.55 111.006 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.577 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -154.5 149.7 27.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.436 1.094 . . . . 72.22 108.763 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.04 -47.25 2.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.12 0.39 . . . . 54.21 113.905 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.734 HD12 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -83.94 165.0 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.531 0.732 . . . . 74.25 112.073 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -167.9 163.51 13.87 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.729 0.811 . . . . 53.21 110.361 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -113.22 5.0 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.992 0.808 . . . . 74.33 113.143 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.7 m -74.08 -34.28 63.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.871 0.868 . . . . 73.13 111.052 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -32.9 74.15 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.039 0.535 . . . . 73.24 109.913 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.493 ' HE1' HD23 ' B' ' 98' ' ' LEU . 13.2 tpt -76.98 -43.98 32.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.476 0.71 . . . . 62.13 110.811 175.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.14 75.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.828 0.851 . . . . 73.11 111.321 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -70.81 -30.41 66.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.285 1.034 . . . . 62.31 111.084 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -69.47 -59.45 2.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.092 0.557 . . . . 74.22 110.384 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.493 HD23 ' HE1' ' B' ' 94' ' ' MET . 2.5 pp -72.45 -19.07 61.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.88 0.326 . . . . 74.24 111.88 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -22.07 43.66 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.493 0.557 . . . . 74.42 114.493 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.18 -55.26 0.44 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.189 0.494 . . . . 74.14 111.572 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -62.07 -45.53 93.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.742 0.817 . . . . 73.53 112.082 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 85.8 m -71.13 -47.15 14.33 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.546 -0.74 . . . . 75.34 112.222 -178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -52.86 -31.5 52.37 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.249 1.966 . . . . 65.43 114.221 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -36.64 83.02 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 122.941 0.496 . . . . 74.33 111.558 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.03 -45.21 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.592 0.757 . . . . 72.34 110.4 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.08 -25.24 40.13 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.043 -0.981 . . . . 63.3 113.058 -169.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.76 -47.85 94.69 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 117.399 -1.286 . . . . 71.22 113.975 -170.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.18 -41.12 50.73 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.333 2.022 . . . . 74.33 113.655 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -68.1 -51.73 43.04 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.609 -0.723 . . . . 74.23 110.99 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.4 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -60.15 -40.97 91.71 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.564 0.745 . . . . 75.44 111.294 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.562 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 23.6 ttp180 -61.88 -58.93 6.05 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.256 1.422 . . . . 71.44 110.992 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -69.79 -26.42 64.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.728 -1.124 . . . . 75.3 111.098 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.444 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.3 t -68.63 -37.18 79.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.824 0.45 . . . . 52.32 111.062 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.409 HD12 HG23 ' B' ' 64' ' ' VAL . 76.6 mt -60.61 -49.24 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.126 0.57 . . . . 72.32 109.768 173.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -69.68 -23.44 63.45 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.606 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.0 t -75.89 -29.1 58.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.697 0.799 . . . . 64.34 110.958 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.464 ' HE1' HG22 ' B' ' 21' ' ' ILE . 21.5 mmt -78.94 -26.68 43.63 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.766 0.426 . . . . 74.34 110.187 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.499 HG13 ' HA ' ' B' ' 125' ' ' GLN . 49.6 t -58.85 -41.82 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.96 0.904 . . . . 71.44 111.113 170.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.5 t -53.1 -38.72 62.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.401 1.081 . . . . 71.23 111.634 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.0 mtt-85 -76.67 -26.52 54.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.113 -0.949 . . . . 74.42 111.377 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.2 0.54 81.6 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-O 119.472 -0.626 . . . . 72.24 113.743 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p 63.12 18.91 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.112 1.765 . . . . 75.15 114.484 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -110.42 166.76 10.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-O 118.73 -0.652 . . . . 74.21 110.683 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.31 147.19 22.15 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.34 2.694 . . . . 75.14 114.539 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.499 ' HA ' HG13 ' B' ' 118' ' ' VAL . 5.0 pm0 -54.1 145.0 18.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.05 1.34 . . . . 74.33 113.729 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -133.23 85.4 2.21 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.537 -1.283 . . . . 74.12 107.537 171.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -104.93 133.76 49.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.909 -1.145 . . . . 74.42 107.909 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.562 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.0 mm? -86.7 138.47 31.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.369 0.668 . . . . 75.35 109.544 -169.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' E' ' 131' ' ' ALA . . . -67.96 148.71 98.39 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.078 0.551 . . . . 73.21 110.603 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.31 112.93 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.804 2.336 . . . . 73.33 111.634 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.475 HG21 HD22 ' B' ' 44' ' ' LEU . 90.9 t -89.77 127.32 42.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.869 0.468 . . . . 64.24 109.829 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -80.41 83.18 6.28 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.739 0.816 . . . . 75.44 109.784 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -63.01 -29.09 70.55 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.615 0.766 . . . . 73.54 111.279 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.9 -53.53 17.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 72.21 110.257 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.63 77.38 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.272 0.629 . . . . 53.44 110.682 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.455 HD23 ' N ' ' E' ' 124' ' ' ARG . 7.3 tt -67.75 -38.34 83.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.249 1.02 . . . . 74.02 110.549 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -63.0 -37.75 88.46 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.442 0.697 . . . . 74.13 109.959 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.9 mtt -68.39 -38.86 81.74 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.895 -0.593 . . . . 75.13 109.993 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.55 -15.12 60.86 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.282 0.633 . . . . 75.3 111.611 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -72.66 -40.2 66.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.171 0.588 . . . . 75.22 110.105 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.466 HD13 ' NE2' ' B' ' 144' ' ' GLN . 1.5 pp -121.51 26.96 8.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.419 0.687 . . . . 71.21 111.73 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 64.39 -78.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.481 1.512 . . . . 74.45 112.944 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -129.21 144.98 51.41 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.256 0.622 . . . . 75.33 109.998 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . 0.466 ' NE2' HD13 ' B' ' 141' ' ' LEU . 32.5 mm-40 -65.2 117.69 8.15 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.83 0.707 . . . . 73.53 109.438 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.75 91.78 1.41 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.782 -1.192 . . . . 71.12 107.782 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.91 -71.99 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 116.122 -0.49 . . . . 64.22 113.929 -168.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 69.15 148.76 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.762 1.225 . . . . 72.45 111.506 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.83 -154.92 24.4 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 119.456 -0.636 . . . . 50.11 111.737 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 68.7 m 56.81 73.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.892 0.877 . . . . 74.25 110.291 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -92.98 142.78 26.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.803 -1.089 . . . . 70.04 110.749 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.41 94.69 6.85 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.367 -0.605 . . . . 72.34 109.367 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -89.68 49.64 1.77 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.126 0.571 . . . . 75.42 109.862 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -66.49 91.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.527 0.731 . . . . 71.41 110.9 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 160.77 16.19 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.118 0.967 . . . . 64.41 108.872 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 74.41 108.819 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.522 ' HA ' ' HB3' ' A' ' 144' ' ' GLN . 83.0 mtp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.908 -0.404 . . . . 75.21 109.908 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -93.43 90.7 6.83 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.229 -1.026 . . . . 64.34 108.229 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -80.41 67.82 6.38 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.925 0.869 . . . . 71.43 110.346 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -105.95 -0.85 24.69 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.615 1.166 . . . . 71.1 110.548 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.576 HD21 HG21 ' C' ' 7' ' ' THR . 1.0 OUTLIER -122.63 141.22 51.96 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.736 1.214 . . . . 73.41 110.206 -172.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.7 10.27 18.77 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.457 0.91 . . . . 72.21 113.457 -169.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.716 ' HB ' ' HG3' ' A' ' 147' ' ' GLU . 14.4 t -61.7 -26.27 67.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.097 0.559 . . . . 73.32 112.037 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -72.32 -37.97 68.79 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.102 0.561 . . . . 73.3 111.052 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.403 ' SD ' HD11 ' C' ' 89' ' ' ILE . 51.9 ttp 63.97 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.93 1.292 . . . . 74.35 111.838 -176.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 35.6 m -83.83 85.47 7.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 73.35 108.399 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' C' ' 85' ' ' SER . 50.0 t80 -106.44 140.97 38.51 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.413 -1.267 . . . . 74.22 109.443 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 6.0 tp60 -145.68 137.39 25.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.831 0.452 . . . . 73.54 110.477 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.449 ' HB ' HD22 ' F' ' 129' ' ' LEU . 25.5 mm -86.31 110.31 19.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.94 -1.133 . . . . 75.25 107.94 172.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.428 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 86.8 mm-40 -83.99 -49.22 9.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.867 -0.419 . . . . 73.32 109.867 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -169.1 136.8 1.89 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.693 -0.685 . . . . 75.31 109.627 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -117.06 138.93 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.744 -1.206 . . . . 74.31 107.744 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -176.46 144.02 0.51 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.6 0.36 . . . . 75.03 110.822 -175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -70.48 124.55 24.47 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.408 0.683 . . . . 60.12 110.124 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -77.07 -49.45 15.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.873 -1.158 . . . . 73.52 107.873 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.703 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -135.01 142.14 46.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.185 -1.371 . . . . 75.45 110.309 -174.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.2 mt -136.18 143.01 37.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.055 -1.832 . . . . 74.53 106.055 173.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -156.07 150.31 25.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.311 0.577 . . . . 73.1 109.954 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -148.76 138.79 22.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.627 -1.169 . . . . 71.31 108.034 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.1 132.12 35.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.768 -1.197 . . . . 74.13 107.768 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.12 80.93 16.4 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 64.23 107.254 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.83 -38.19 40.61 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.514 2.143 . . . . 73.34 110.996 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -100.1 32.89 2.79 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.382 1.073 . . . . 73.33 109.914 -177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.75 -43.84 96.0 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.131 1.16 . . . . 74.41 114.131 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.88 -23.68 13.83 Favored 'Trans proline' 0 C--N 1.383 2.36 0 CA-C-N 121.435 1.548 . . . . 43.51 112.834 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -65.19 -20.38 66.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.532 0.733 . . . . 73.22 112.852 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' C' ' 34' ' ' LYS . 52.6 t -49.46 -32.07 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.284 1.034 . . . . 64.43 113.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.96 -39.88 96.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.893 0.477 . . . . 72.0 111.695 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.86 15.2 25.74 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.079 0.952 . . . . 75.35 111.261 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.683 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 3.4 ttpm? -108.68 137.02 47.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.873 0.869 . . . . 74.44 109.023 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 131.83 35.24 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.176 -1.046 . . . . 73.1 108.176 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -79.67 72.26 6.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.079 0.552 . . . . 74.32 109.813 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -143.28 48.15 0.92 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 123.79 0.836 . . . . 74.21 110.165 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.11 143.81 18.12 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 121.358 1.372 . . . . 75.23 110.841 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.11 115.21 24.35 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 54.21 108.789 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.99 107.5 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.391 -0.822 . . . . 73.32 110.24 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.463 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 7.3 tmtt? -92.45 104.56 16.87 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 106.375 -1.713 . . . . 74.02 106.375 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.408 HD12 ' HG ' ' C' ' 128' ' ' LEU . 13.5 tp -84.0 146.95 27.7 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.73 -1.211 . . . . 75.42 107.73 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.48 143.3 31.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.257 -1.386 . . . . 73.1 107.257 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 153.97 51.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.233 0.54 . . . . 72.2 111.379 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.8 t70 -151.38 153.26 34.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.784 1.234 . . . . 73.05 108.626 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -139.33 141.53 37.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.077 -0.712 . . . . 71.33 109.077 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -128.66 170.09 13.68 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.101 0.96 . . . . 74.52 109.106 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -147.14 144.66 29.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.457 0.703 . . . . 54.14 109.995 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 66.2 p -144.88 126.29 14.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.265 -1.013 . . . . 73.11 108.265 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.88 115.86 19.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.666 HD12 ' HB2' ' C' ' 57' ' ' GLU . 51.7 mt -89.36 -35.72 15.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.154 0.582 . . . . 75.3 109.635 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.59 -173.84 4.59 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 73.42 110.016 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.65 117.29 8.6 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.378 -0.828 . . . . 70.02 109.775 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 68.58 0.28 2.55 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.603 1.561 . . . . 74.24 112.364 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.72 108.99 24.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.744 -0.836 . . . . 75.23 108.744 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.26 123.53 41.66 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.529 1.132 . . . . 74.51 108.756 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.666 ' HB2' HD12 ' C' ' 51' ' ' LEU . 32.7 tt0 -83.34 139.05 33.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.253 -1.017 . . . . 75.55 108.253 169.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 95.6 t -118.93 131.86 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.357 -0.979 . . . . 73.11 108.357 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 60.5 t -110.1 102.5 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.745 -0.835 . . . . 73.21 108.745 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -90.56 109.19 20.34 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.109 -1.071 . . . . 75.13 108.109 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.706 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 65.2 mtt85 -95.75 132.7 40.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.814 0.845 . . . . 73.23 109.526 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.419 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.0 t -126.62 131.02 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.164 -1.05 . . . . 74.11 108.164 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -125.92 120.45 30.43 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.912 -0.773 . . . . 73.03 108.912 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.442 HG23 HG23 ' C' ' 114' ' ' ILE . 94.4 t -110.27 114.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.145 0.978 . . . . 75.32 108.82 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 16.3 m -98.81 139.16 34.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.868 -1.16 . . . . 75.11 107.868 168.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.98 110.65 7.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.024 -1.843 . . . . 63.24 106.024 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.435 ' HB3' HG23 ' C' ' 72' ' ' THR . 12.5 p -158.16 139.99 13.89 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.641 0.588 . . . . 74.4 110.689 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.0 tp -80.7 -23.85 39.24 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.473 -0.785 . . . . 72.54 109.276 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.04 -97.2 0.11 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 110.056 -1.217 . . . . 71.3 110.056 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -90.46 -31.93 16.6 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.651 -0.87 . . . . 74.1 108.651 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -69.93 84.04 0.49 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.018 -1.105 . . . . 72.13 108.018 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.435 HG23 ' HB3' ' C' ' 67' ' ' SER . 78.7 m -87.89 136.72 32.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.248 -1.342 . . . . 75.12 109.889 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.683 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -72.32 -73.56 0.19 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.92 -1.141 . . . . 64.55 107.92 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.0 167.59 29.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.736 0.779 . . . . 75.4 112.333 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -125.59 138.71 53.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 105.726 -1.953 . . . . 72.35 105.726 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -151.77 113.27 4.36 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 110.011 -0.366 . . . . 74.21 110.011 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -117.06 136.11 53.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.518 0.327 . . . . 74.42 110.129 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.404 HG12 ' HA ' ' C' ' 110' ' ' ALA . 25.4 t -125.25 114.16 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 55.24 108.673 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.706 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 53.8 mt-30 -90.26 92.7 9.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.472 -0.936 . . . . 74.44 108.472 171.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.16 136.54 37.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.687 -0.688 . . . . 74.24 109.345 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.42 153.04 17.67 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.3 -0.72 . . . . 60.15 111.3 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.436 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -154.94 121.19 1.08 Allowed Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 111.477 -0.649 . . . . 75.22 111.477 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.3 mm -81.71 120.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 107.685 -1.228 . . . . 72.43 107.685 174.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -131.83 138.01 48.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.512 0.725 . . . . 62.11 109.962 -174.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 58.9 m -89.89 113.93 25.62 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.552 -0.906 . . . . 64.43 108.552 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.6 100.55 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.96 -1.126 . . . . 71.42 107.96 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -130.74 152.68 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.914 0.886 . . . . 64.3 110.352 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.16 -39.3 2.8 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.02 -0.536 . . . . 73.44 112.209 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.403 HD11 ' SD ' ' C' ' 9' ' ' MET . 47.6 pt -104.57 160.01 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.256 0.622 . . . . 72.14 109.968 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.432 ' HA ' ' HE1' ' C' ' 94' ' ' MET . 10.7 tp10 -151.03 152.86 34.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.169 0.588 . . . . 75.22 110.551 -177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.45 -111.91 4.17 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.769 0.668 . . . . 31.1 113.198 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.3 p -73.73 -34.37 64.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.051 0.94 . . . . 74.21 111.693 -175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.26 -36.55 74.52 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.694 -0.484 . . . . 72.21 109.694 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.458 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 59.5 ttm -68.23 -36.46 79.53 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.913 -0.585 . . . . 73.01 110.174 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -33.09 74.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.638 0.775 . . . . 71.55 111.024 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -68.34 -35.57 77.96 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.14 0.576 . . . . 73.53 110.845 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 24.9 t -71.87 -62.65 1.34 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.638 0.375 . . . . 72.32 110.633 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.1 pp -75.71 -14.13 60.33 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.309 0.485 . . . . 74.54 112.309 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.31 -18.99 37.04 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.602 -0.555 . . . . 74.12 113.259 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.81 -56.48 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.786 0.793 . . . . 73.53 112.642 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -66.53 -61.15 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.61 0.364 . . . . 75.14 111.862 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 40.6 m -57.05 -45.45 99.95 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 124.08 0.952 . . . . 73.35 113.457 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.79 -25.2 46.12 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.798 1.666 . . . . 73.24 113.493 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -70.55 -29.16 65.55 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.754 0.422 . . . . 72.54 110.175 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.484 HD13 ' NH1' ' A' ' 111' ' ' ARG . 47.4 mm -68.4 -40.07 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.569 0.748 . . . . 65.3 109.939 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.436 HD23 ' HA3' ' C' ' 82' ' ' GLY . 91.6 mt -78.31 -26.28 46.88 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.99 -1.005 . . . . 74.22 112.307 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.0 -42.08 79.9 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.507 -1.235 . . . . 75.42 114.062 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.17 -43.63 55.56 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.158 1.905 . . . . 72.43 112.904 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -66.35 -41.31 89.73 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.66 0.784 . . . . 72.52 110.785 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.404 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -68.84 -44.8 72.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.665 -0.698 . . . . 73.33 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -50.95 -55.69 16.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.419 1.488 . . . . 72.33 110.995 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.31 -36.82 85.25 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.035 0.834 . . . . 71.22 109.931 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.526 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 12.0 t -66.47 -36.54 83.0 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.444 0.698 . . . . 74.01 111.566 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.451 ' O ' HG23 ' C' ' 118' ' ' VAL . 95.1 mt -70.06 -49.51 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.379 0.672 . . . . 74.32 109.917 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -66.37 -30.23 70.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.109 0.564 . . . . 71.13 111.187 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -65.45 -45.87 82.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.113 -0.699 . . . . 74.52 109.113 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.582 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.73 -34.9 75.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.157 0.983 . . . . 62.14 112.404 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.1 t -62.49 -46.32 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.387 0.675 . . . . 72.35 109.542 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.48 -31.89 72.34 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.149 -0.932 . . . . 71.34 111.669 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.5 mtt-85 -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.376 0.67 . . . . 74.11 109.664 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.35 -4.37 86.86 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.804 0.69 . . . . 73.22 112.811 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.481 HG21 ' HB3' ' D' ' 17' ' ' TYR . 22.9 p 65.57 32.83 9.02 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.716 2.006 . . . . 63.51 113.085 172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -89.09 166.49 21.58 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.587 1.155 . . . . 74.1 110.554 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.473 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 31.3 Cg_endo -63.77 112.93 1.95 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.074 1.849 . . . . 74.0 111.89 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -60.99 136.37 58.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.91 0.484 . . . . 74.45 111.023 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.719 HD22 ' HB ' ' E' ' 142' ' ' ILE . 38.9 tp -144.6 123.33 12.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.195 -1.039 . . . . 73.33 108.195 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -103.32 123.73 47.34 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.824 0.45 . . . . 74.34 109.789 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.408 ' HG ' HD12 ' C' ' 42' ' ' LEU . 1.4 tm? -74.24 128.51 35.73 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.16 0.984 . . . . 74.32 109.546 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.5 146.43 98.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.797 0.839 . . . . 70.22 111.374 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.56 ' HG3' HD11 ' A' ' 16' ' ' ILE . 35.5 Cg_endo -61.41 136.09 61.59 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.896 2.397 . . . . 74.33 113.31 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.58 109.83 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.077 -1.082 . . . . 74.44 108.077 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -112.51 93.83 4.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.748 0.819 . . . . 42.2 110.666 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.019 -0.734 . . . . 73.33 109.019 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.39 -55.05 39.77 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.77 1.228 . . . . 73.13 111.615 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.71 -19.68 58.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.567 0.747 . . . . 73.31 111.837 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.0 tp -55.62 -29.81 59.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.675 0.79 . . . . 73.4 112.117 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.585 ' HE2' ' HA ' ' A' ' 152' ' ' HIS . 92.7 m-85 -73.48 -32.39 64.28 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.334 0.654 . . . . 74.54 111.501 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.1 mtp -74.85 -33.65 62.17 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.85 0.86 . . . . 75.33 110.127 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -67.72 -39.92 84.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.565 1.146 . . . . 71.21 110.097 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.48 -80.08 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.699 1.199 . . . . 74.52 110.051 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.1 tp -52.63 101.9 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.501 1.12 . . . . 75.31 111.763 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.416 ' HA ' HE21 ' C' ' 142' ' ' GLN . 0.0 OUTLIER -81.79 144.96 30.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.778 -1.101 . . . . 71.54 108.157 171.129 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.657 ' HG2' ' HE3' ' A' ' 138' ' ' MET . 53.7 tp60 -73.67 -83.94 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.194 0.309 . . . . 64.11 111.27 -170.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 179.38 -59.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.715 0.806 . . . . 75.54 108.862 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.57 159.88 28.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.416 1.086 . . . . 73.41 111.972 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.16 -44.05 0.02 OUTLIER Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.802 -0.519 . . . . 60.13 111.802 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.49 114.94 14.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.41 0.684 . . . . 73.41 110.68 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.36 -101.68 2.44 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.751 -0.94 . . . . 74.24 110.751 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.1 m 66.62 165.21 0.2 Allowed 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.573 1.149 . . . . 71.24 110.62 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 75.11 104.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.993 1.317 . . . . 72.11 111.582 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.97 -90.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.655 1.182 . . . . 74.3 109.328 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 60.66 -89.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.533 1.533 . . . . 74.21 113.402 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -171.23 151.13 3.08 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.193 0.597 . . . . 64.02 110.068 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -97.68 -37.4 9.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 71.21 110.604 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 74.03 110.589 -176.63 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.962 -0.385 . . . . 74.33 109.962 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.7 p -155.4 145.05 21.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.5 1.12 . . . . 75.35 108.939 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.76 -55.09 14.4 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.827 0.704 . . . . 64.21 110.067 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 60.56 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.139 1.376 . . . . 74.42 112.85 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -127.67 90.39 3.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.107 -1.072 . . . . 64.23 108.107 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.08 138.13 11.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.091 -0.707 . . . . 74.13 109.091 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -99.48 -4.33 31.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.862 0.865 . . . . 74.13 111.593 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -69.4 -19.49 63.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.178 0.591 . . . . 74.44 112.035 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.488 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.3 ptm -33.62 151.82 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.115 1.366 . . . . 55.51 114.622 165.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 37.8 m -107.88 143.87 35.89 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.445 0.698 . . . . 70.51 109.318 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.459 ' HB2' ' HE2' ' D' ' 9' ' ' MET . 63.2 t80 -155.55 106.91 2.56 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.39 -0.967 . . . . 75.23 108.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -129.3 146.34 51.21 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.234 0.614 . . . . 75.22 109.614 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.78 109.82 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.568 -1.271 . . . . 63.54 107.568 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -82.69 -47.66 11.77 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.034 0.208 . . . . 74.24 111.46 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -170.11 129.25 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.58 -0.282 . . . . 74.43 111.175 -167.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.442 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.6 mp -103.41 133.2 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.272 -1.381 . . . . 61.51 107.272 173.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.481 ' HB3' HG21 ' C' ' 122' ' ' THR . 27.0 p90 -155.47 144.52 20.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.214 0.531 . . . . 63.14 111.551 176.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -79.31 115.03 18.71 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.441 -0.8 . . . . 73.41 109.193 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -81.1 -24.5 37.67 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.957 -0.386 . . . . 73.53 109.957 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.9 t70 -153.99 141.59 19.88 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.027 -0.988 . . . . 61.11 109.724 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.582 HG23 ' HE1' ' C' ' 117' ' ' MET . 86.3 mt -139.65 149.55 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.216 1.406 . . . . 74.31 107.689 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -153.04 144.91 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.584 1.154 . . . . 74.43 108.404 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.4 t80 -152.29 115.3 4.65 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 105.928 -1.879 . . . . 72.25 105.928 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.1 mt-10 -127.23 111.41 13.92 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.7 0.4 . . . . 75.42 110.008 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 90.52 4.72 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.809 -1.182 . . . . 71.41 107.809 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.32 -40.56 1.57 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.663 2.242 . . . . 72.0 113.082 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.497 ' HB2' ' HB3' ' D' ' 30' ' ' HIS . 5.0 p30 -113.56 43.96 1.68 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.321 1.048 . . . . 74.54 108.927 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.36 -49.23 86.43 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 115.786 1.773 . . . . 75.14 115.786 -169.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 -15.99 13.34 Favored 'Trans proline' 0 C--N 1.388 2.654 0 CA-C-N 122.102 1.786 . . . . 75.33 113.381 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.497 ' HB3' ' HB2' ' D' ' 27' ' ' ASN . 7.1 t-160 -77.08 -46.53 23.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.136 0.974 . . . . 73.01 111.199 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 14.2 p -70.59 -22.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-O 120.968 0.413 . . . . 75.45 110.989 176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.17 -33.24 74.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.688 0.795 . . . . 72.45 111.051 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -72.78 -15.37 61.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.703 0.801 . . . . 74.12 111.156 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -93.0 106.82 18.72 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.227 -0.657 . . . . 74.15 109.227 175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.41 89.63 7.07 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.285 -0.635 . . . . 71.2 109.285 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.47 ' HB3' HD23 ' D' ' 68' ' ' LEU . 6.3 t-105 -169.99 158.87 7.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 108.487 -0.931 . . . . 74.31 108.487 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' F' ' 140' ' ' SER . 29.9 mm-40 -86.94 114.48 58.48 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.037 0.535 . . . . 64.22 110.458 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 37.8 Cg_exo -61.79 140.58 86.5 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 123.407 2.738 . . . . 74.15 114.217 -178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.02 126.16 28.95 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.953 0.901 . . . . 73.55 109.863 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.465 HG11 HG13 ' D' ' 64' ' ' VAL . 47.9 t -99.58 112.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 72.13 110.258 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.413 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 1.4 tmtp? -88.09 122.14 31.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.028 -1.471 . . . . 74.34 107.028 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.08 115.4 27.43 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.773 -1.195 . . . . 74.31 107.773 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.612 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.7 m-20 -108.27 136.81 47.3 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.97 -1.122 . . . . 75.52 107.97 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.93 133.33 37.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.083 0.553 . . . . 75.23 109.922 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.8 t70 -142.06 157.25 45.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 74.21 108.198 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -132.29 158.13 42.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.833 0.853 . . . . 74.1 109.5 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -152.68 170.04 21.23 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.957 -0.757 . . . . 64.1 108.957 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' D' ' 152' ' ' HIS . 39.6 m -150.68 159.56 44.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.973 0.509 . . . . 75.14 109.965 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . 0.431 ' HB3' ' HB3' ' D' ' 57' ' ' GLU . 40.3 t -152.06 127.07 9.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.479 -0.934 . . . . 73.14 108.479 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.53 117.8 24.65 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.44 -0.948 . . . . 74.43 108.44 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.505 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.2 mt -98.09 -29.73 13.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.171 0.588 . . . . 74.01 110.165 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.49 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -161.02 -179.03 7.19 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.033 0.933 . . . . 72.42 109.972 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -68.15 118.66 11.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.006 -0.997 . . . . 75.42 108.819 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 67.53 16.91 9.99 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.131 0.972 . . . . 74.33 112.032 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 76.8 t -127.33 117.12 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.449 -0.945 . . . . 75.13 108.449 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -135.2 129.31 33.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.785 -0.643 . . . . 74.31 109.787 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.505 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.3 tt0 -87.15 148.16 25.32 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.604 1.162 . . . . 73.14 108.394 167.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.531 HG12 HD13 ' D' ' 106' ' ' LEU . 4.1 p -134.5 138.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.734 -1.21 . . . . 75.22 107.734 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 94.7 t -108.84 136.85 43.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.072 -0.714 . . . . 75.31 109.072 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.56 116.99 29.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.024 -1.473 . . . . 72.31 107.024 174.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.517 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -97.46 98.21 9.75 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.36 -0.978 . . . . 72.22 108.36 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.1 116.64 39.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.282 -1.007 . . . . 73.43 108.282 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 33.3 m -125.46 132.51 52.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.04 -0.982 . . . . 74.45 109.04 -171.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.638 HG12 HD11 ' D' ' 126' ' ' LEU . 56.6 t -122.59 102.82 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.085 0.954 . . . . 72.23 109.059 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 25.3 m -95.81 91.95 6.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.98 -1.119 . . . . 74.42 107.98 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.51 139.61 31.53 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.598 -0.89 . . . . 75.11 108.598 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.8 p -151.99 135.43 16.05 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.625 0.578 . . . . 73.14 110.34 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' D' ' 36' ' ' TRP . 12.6 tp -112.78 106.09 14.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.714 -0.676 . . . . 74.03 109.318 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.94 -133.12 11.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.755 -0.657 . . . . 75.01 112.201 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 3.78 41.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.584 0.753 . . . . 72.03 111.617 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -138.46 149.22 45.22 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.729 0.812 . . . . 72.32 109.17 -165.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -56.77 152.85 11.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.405 1.082 . . . . 75.43 111.206 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.26 -62.29 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.463 -0.94 . . . . 73.14 108.463 171.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.1 149.37 24.52 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.075 -0.966 . . . . 74.43 109.151 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.452 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.8 mt -112.03 151.19 29.62 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.982 -1.118 . . . . 73.52 107.982 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.509 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.7 t -158.42 146.77 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.401 0.438 . . . . 73.34 109.987 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.65 132.28 10.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.587 0.755 . . . . 74.01 109.062 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.5 113.2 22.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.425 -0.954 . . . . 73.03 108.425 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.733 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -89.45 81.79 6.53 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.038 -1.097 . . . . 74.33 108.038 171.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.42 ' O ' HD11 ' D' ' 106' ' ' LEU . 6.9 tp-100 -79.7 99.75 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 112.914 -1.948 . . . . 75.51 109.216 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.24 161.66 31.64 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.91 -0.476 . . . . 51.33 111.91 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.451 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -164.86 136.23 4.11 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.626 -0.59 . . . . 73.23 111.626 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.96 137.08 22.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.591 0.756 . . . . 74.22 110.074 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.95 132.69 38.71 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.848 0.859 . . . . 71.13 109.533 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 5.7 m -75.52 95.89 3.4 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.352 -0.981 . . . . 74.5 108.352 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 53.4 mt -105.94 99.36 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.451 -0.944 . . . . 64.3 108.451 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.471 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -126.88 153.19 46.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.677 1.191 . . . . 74.44 108.778 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.06 -7.9 62.05 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.753 -0.471 . . . . 70.13 113.454 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.508 HD13 ' HG2' ' D' ' 93' ' ' GLN . 5.5 mm -137.97 129.27 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.938 0.895 . . . . 72.45 110.671 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.616 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 3.0 pp20? -148.36 -173.83 4.43 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.655 0.782 . . . . 73.13 110.232 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.42 -140.52 25.46 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.014 -0.326 . . . . 52.42 113.137 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -69.99 -25.11 63.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.202 0.601 . . . . 74.41 110.851 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.508 ' HG2' HD13 ' D' ' 89' ' ' ILE . 6.2 tp-100 -72.74 -32.07 65.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.278 0.631 . . . . 74.32 110.355 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.616 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 21.1 ttt -71.34 -42.41 68.56 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.826 -0.435 . . . . 73.31 109.826 171.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -27.62 69.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.863 0.465 . . . . 74.43 111.036 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.78 -52.76 8.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.676 0.79 . . . . 72.42 110.733 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.29 -51.64 62.51 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.944 0.402 . . . . 72.44 110.963 -172.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 22.5 tp -75.81 -19.3 59.06 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 73.05 110.929 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.41 -5.51 36.93 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.516 -0.602 . . . . 74.42 114.287 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.31 -61.9 0.72 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.941 0.871 . . . . 52.33 111.408 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.83 -47.32 54.0 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.444 0.465 . . . . 74.33 112.027 -171.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 59.8 m -64.75 -44.78 74.38 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 123.491 0.716 . . . . 63.34 111.722 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.9 Cg_exo -57.16 -34.89 98.6 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 122.513 2.142 . . . . 65.55 113.871 166.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.75 -34.43 78.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.082 0.553 . . . . 62.25 110.73 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.37 -33.43 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.796 . . . . 75.32 110.561 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.531 HD13 HG12 ' D' ' 58' ' ' VAL . 91.3 mt -79.38 -20.66 47.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.819 0.848 . . . . 71.24 112.603 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.05 -42.84 64.36 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 113.968 1.099 . . . . 75.45 113.968 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.81 -39.83 87.91 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.054 1.836 . . . . 70.34 113.281 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.67 -36.39 65.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.596 0.758 . . . . 72.34 111.38 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -51.07 70.07 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.297 0.639 . . . . 73.22 110.121 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.0 -48.09 79.28 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.777 1.298 . . . . 75.23 110.589 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.0 -43.16 99.29 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.364 1.04 . . . . 73.44 111.736 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.55 -41.62 97.64 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.553 0.533 . . . . 75.41 110.767 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.509 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.3 mt -67.7 -43.47 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.556 -0.747 . . . . 73.22 110.716 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.4 m -55.63 -46.37 77.41 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.996 0.918 . . . . 70.13 110.66 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.5 t -64.82 -46.93 79.87 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 114.026 -1.443 . . . . 73.15 110.578 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -64.49 -36.5 84.38 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.007 0.523 . . . . 70.12 112.089 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.467 HG13 ' HB2' ' D' ' 123' ' ' PHE . 45.3 t -67.18 -40.95 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.215 -0.902 . . . . 62.23 110.661 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -75.17 -23.53 57.74 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.416 0.287 . . . . 73.45 111.408 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.526 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 89.2 mtt-85 -74.56 -38.17 62.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.499 0.72 . . . . 73.34 109.723 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.42 1.55 76.11 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.541 -0.754 . . . . 73.21 112.391 173.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 60.13 23.51 12.78 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.852 2.061 . . . . 71.44 113.146 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.467 ' HB2' HG13 ' D' ' 118' ' ' VAL . 78.7 m-85 -80.6 161.16 65.22 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 124.862 1.265 . . . . 70.42 109.114 169.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.21 135.42 43.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.355 2.037 . . . . 73.24 112.234 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -48.45 130.92 17.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.048 1.339 . . . . 75.13 112.562 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.638 HD11 HG12 ' D' ' 64' ' ' VAL . 9.6 tt -108.71 112.49 24.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.618 0.767 . . . . 73.34 109.553 -171.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -124.74 92.71 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.388 0.675 . . . . 75.52 109.683 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 69.4 mt -68.53 132.68 47.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.124 0.569 . . . . 72.55 110.238 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.47 139.89 94.61 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.41 0.684 . . . . 64.55 111.234 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.94 127.66 20.99 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.828 2.352 . . . . 73.31 112.529 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.561 HG22 ' HH ' ' F' ' 143' ' ' TYR . 39.6 t -114.61 111.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.015 0.926 . . . . 72.44 109.849 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -84.73 101.81 12.51 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.656 -0.498 . . . . 72.33 109.656 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.95 -22.26 62.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.43 0.692 . . . . 72.23 111.256 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.81 -50.46 70.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.552 1.141 . . . . 73.34 111.716 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.35 80.13 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.616 0.573 . . . . 73.34 111.708 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.06 -39.99 90.56 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.247 -0.888 . . . . 72.1 109.875 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -66.48 -32.16 73.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.794 0.838 . . . . 74.44 111.079 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 16.4 mmt -59.48 -46.51 88.59 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.314 0.578 . . . . 64.04 110.075 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -71.18 -31.39 67.59 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.677 -1.147 . . . . 64.53 111.365 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -57.12 -36.84 71.14 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.715 0.806 . . . . 74.42 112.436 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.13 -44.13 87.62 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 74.32 111.752 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -87.67 3.36 48.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.823 0.449 . . . . 72.33 111.55 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -120.67 71.18 0.92 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.738 0.78 . . . . 75.0 109.627 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -143.8 102.04 3.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.234 -1.348 . . . . 71.11 107.995 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.29 -27.87 60.92 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.531 0.681 . . . . 72.12 109.939 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.2 -166.37 39.6 Favored Glycine 0 C--O 1.242 0.595 0 CA-C-N 114.472 -1.24 . . . . 75.35 110.194 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 61.41 -172.56 0.14 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.972 0.909 . . . . 73.11 112.341 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.32 92.91 0.14 Allowed Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.738 -0.545 . . . . 71.14 111.738 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -134.36 146.74 50.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.218 0.607 . . . . 73.03 110.248 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.13 175.92 10.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.632 1.173 . . . . 74.32 109.788 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -149.55 122.66 8.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.009 0.524 . . . . 72.45 109.881 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' D' ' 48' ' ' SER . 72.4 m80 -140.62 100.2 3.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.906 0.882 . . . . 73.45 108.854 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -161.38 116.03 2.03 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.308 0.643 . . . . 70.41 109.481 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -142.57 153.87 43.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.302 -0.999 . . . . 74.22 108.302 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.751 -0.642 . . . . 74.45 109.968 -176.925 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 110.158 -0.312 . . . . 70.3 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.76 91.96 1.17 Allowed 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.632 0.582 . . . . 75.01 110.019 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.09 84.72 7.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.298 -1.001 . . . . 72.32 108.298 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -74.64 79.77 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.625 0.726 . . . . 71.14 109.445 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -168.87 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.146 1.378 . . . . 74.45 108.999 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.76 -54.48 34.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.539 0.736 . . . . 74.34 110.62 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.583 ' HG2' ' H ' ' E' ' 115' ' ' LEU . 30.0 ttpt 67.46 -163.18 0.22 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.269 1.028 . . . . 74.34 110.316 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.583 ' H ' ' HG2' ' E' ' 114' ' ' LYS . 78.7 mt -92.57 36.44 1.01 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.559 0.744 . . . . 72.23 111.456 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.67 71.32 15.43 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.178 -0.675 . . . . 70.04 109.178 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -93.64 4.15 3.06 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 123.084 2.523 . . . . 65.14 113.043 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -157.35 142.3 16.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.637 -0.875 . . . . 73.33 108.637 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -100.32 -48.59 4.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.831 0.853 . . . . 65.14 110.846 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 65.42 88.89 0.1 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.805 1.242 . . . . 75.22 109.883 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -134.12 76.37 1.65 Allowed 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.571 -1.27 . . . . 74.12 107.571 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -167.38 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.696 -0.684 . . . . 70.2 111.267 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . 0.467 HG23 ' HG1' ' B' ' 46' ' ' THR . 31.2 t 55.55 80.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.021 0.928 . . . . 74.13 108.925 -159.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . 0.455 ' N ' HD23 ' B' ' 136' ' ' LEU . 48.1 ttt85 -74.22 75.24 1.81 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.88 0.872 . . . . 75.43 110.164 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -97.0 95.47 7.83 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 108.355 -0.98 . . . . 72.44 108.355 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -94.77 6.73 48.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.572 0.749 . . . . 72.44 111.476 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -114.84 59.21 0.42 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.211 -0.355 . . . . 73.42 112.211 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -58.24 130.26 45.84 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.636 0.774 . . . . 71.41 111.334 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . 0.487 HD13 HD23 ' B' ' 42' ' ' LEU . 1.2 pp -139.51 -166.24 2.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.383 1.073 . . . . 74.42 109.596 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 tt -123.27 -45.66 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.353 0.661 . . . . 73.13 109.371 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . 0.478 ' HA ' ' HB3' ' B' ' 129' ' ' ALA . . . -167.69 -169.06 1.1 Allowed 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.408 1.083 . . . . 74.22 109.103 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -65.75 134.88 95.36 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.928 -1.034 . . . . 73.14 108.837 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.68 87.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.389 2.726 . . . . 74.41 113.445 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 19.2 tt -174.89 124.19 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.263 1.425 . . . . 72.35 107.991 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.84 103.61 14.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.087 0.555 . . . . 64.13 110.544 -174.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.8 -9.4 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.004 0.921 . . . . 71.15 109.877 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -78.08 76.09 4.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.936 1.294 . . . . 74.42 110.466 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.55 109.41 0.73 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.9 0.88 . . . . 74.42 109.632 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' C' ' 126' ' ' LEU . 24.0 tp -165.89 133.71 2.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.522 0.729 . . . . 75.12 109.955 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -139.73 -151.81 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 76.6 mt 67.6 17.24 9.93 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.273 1.029 . . . . 73.53 112.154 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . 0.719 ' HB ' HD22 ' C' ' 126' ' ' LEU . 6.7 tt -84.43 126.94 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.321 1.048 . . . . 75.22 109.129 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 54.9 89.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.895 0.878 . . . . 63.15 111.356 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -65.97 -22.8 66.49 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.456 -0.793 . . . . 74.34 110.052 173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -97.66 -176.55 3.51 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.386 1.074 . . . . 74.42 111.094 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -83.37 -166.37 1.35 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.555 1.142 . . . . 73.34 110.871 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.49 169.64 17.89 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.215 1.006 . . . . 74.4 110.448 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 9.9 tt -85.01 112.45 43.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 109.15 -0.685 . . . . 74.12 109.15 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 C--N 1.38 2.235 0 C-N-CA 123.568 2.845 . . . . 63.25 112.247 174.566 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.725 -0.472 . . . . 74.21 109.725 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -133.29 8.12 3.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.006 0.922 . . . . 74.42 110.927 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.01 101.95 0.76 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.244 0.617 . . . . 74.21 111.037 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 47.2 t80 66.19 121.73 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.248 1.819 . . . . 72.53 113.579 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -162.84 -79.41 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.7 -1.592 . . . . 74.51 106.7 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 54.24 90.37 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.254 1.422 . . . . 73.13 112.205 169.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.1 154.43 41.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.652 -0.704 . . . . 75.44 111.351 -174.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.83 -37.64 85.22 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.11 -0.7 . . . . 74.32 109.11 169.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -117.73 87.31 26.38 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.591 0.757 . . . . 74.52 109.633 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.04 -70.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.85 2.367 . . . . 73.53 110.499 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 24.2 t80 58.75 92.04 0.04 OUTLIER 'General case' 0 C--N 1.363 1.184 0 C-N-CA 125.32 1.448 . . . . 71.44 111.779 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 2.0 m -64.25 -55.57 20.56 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.592 -0.731 . . . . 75.22 110.662 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 50.91 43.53 28.6 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.909 1.284 . . . . 74.35 111.484 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -87.47 37.69 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.071 -1.422 . . . . 73.04 110.082 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.02 29.86 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.549 1.14 . . . . 61.31 110.214 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -60.58 118.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.418 0.687 . . . . 72.31 111.28 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -155.96 126.28 6.67 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.184 -0.462 . . . . 75.14 110.274 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -155.27 154.55 32.31 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.368 1.467 . . . . 74.35 108.042 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -64.92 -69.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.77 0.428 . . . . 73.45 111.268 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.65 -98.81 0.41 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 110.948 -0.861 . . . . 74.2 110.948 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . 0.704 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 2.9 mppt? -81.89 157.45 24.35 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.924 -0.398 . . . . 74.15 109.924 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.449 HD22 ' HB ' ' C' ' 13' ' ' ILE . 1.0 OUTLIER -140.06 -8.62 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.873 0.869 . . . . 70.21 111.42 175.382 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 pt -68.91 137.13 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.101 0.56 . . . . 73.43 110.326 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.76 -55.37 0.73 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.088 0.555 . . . . 64.41 110.841 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -85.15 108.12 14.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.176 -0.676 . . . . 73.35 109.176 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.33 73.55 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.392 2.728 . . . . 73.12 111.758 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.434 HG12 HG11 ' F' ' 136' ' ' VAL . 16.0 tt -62.89 125.84 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 116.141 -0.481 . . . . 75.22 110.403 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.19 96.2 2.73 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.302 0.641 . . . . 75.41 109.498 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.628 HG21 ' H ' ' F' ' 137' ' ' GLU . 2.8 m -127.56 -85.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.813 0.845 . . . . 72.42 110.544 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . 0.628 ' H ' HG21 ' F' ' 136' ' ' VAL . 44.8 tt0 55.07 -80.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.5 1.52 . . . . 74.33 112.391 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -128.08 126.17 40.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.091 . . . . 71.45 108.972 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.58 119.17 9.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.244 1.018 . . . . 73.13 111.589 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 140' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' D' ' 37' ' ' GLN . 18.8 m -93.25 170.23 9.79 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.991 0.916 . . . . 73.14 108.866 172.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt 67.56 11.26 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.6 1.16 . . . . 75.13 111.775 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.05 125.22 40.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.498 0.719 . . . . 74.43 109.22 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . 0.561 ' HH ' HG22 ' D' ' 131' ' ' VAL . 13.6 t80 63.63 -176.05 0.16 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.205 1.002 . . . . 75.32 110.381 177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -103.02 -171.0 1.87 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.808 0.843 . . . . 75.11 109.53 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -98.76 32.88 2.45 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.683 -1.229 . . . . 71.05 107.683 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -76.55 -79.34 0.11 Allowed 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.954 -0.758 . . . . 75.53 108.954 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 4.8 tt 50.54 75.52 0.18 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.792 1.237 . . . . 74.2 109.825 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 131.98 85.55 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 116.159 -0.473 . . . . 64.44 110.66 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--N 1.377 2.04 0 C-N-CA 122.756 2.304 . . . . 70.5 112.074 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.63 -0.507 . . . . 75.33 109.63 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -162.66 -70.71 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 75.41 108.933 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -121.07 122.84 40.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 73.31 108.838 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 66.7 84.11 0.16 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.481 1.112 . . . . 71.2 110.925 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -107.25 92.22 3.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.226 -1.027 . . . . 75.32 108.226 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -136.72 -10.72 1.82 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.029 0.932 . . . . 71.32 110.671 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -95.56 -57.81 2.29 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.826 0.45 . . . . 73.21 110.534 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.24 -46.24 51.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.721 0.808 . . . . 74.31 111.783 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.8 mtt -139.26 144.46 38.41 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.686 0.794 . . . . 74.22 109.255 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.5 m -146.94 129.84 16.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.007 0.923 . . . . 73.44 109.47 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -139.09 114.47 9.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.298 -1.001 . . . . 74.42 108.298 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 96.5 mt-30 -133.66 122.35 23.31 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.216 -0.661 . . . . 74.21 109.216 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -82.27 88.93 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 108.722 -0.844 . . . . 75.34 108.722 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.531 ' NE2' HG21 ' A' ' 83' ' ' ILE . 29.8 tt0 -77.28 -41.22 41.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.119 -0.491 . . . . 74.22 111.882 -165.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -153.94 137.27 15.77 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.209 1.003 . . . . 74.22 108.293 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.63 HD11 ' HG3' ' C' ' 130' ' ' PRO . 4.4 mp -130.6 119.19 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 106.927 -1.509 . . . . 75.25 106.927 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -152.93 174.68 13.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.456 0.702 . . . . 74.31 111.521 -172.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -97.73 117.15 31.39 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.757 -0.831 . . . . 71.11 108.757 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -80.73 -22.67 40.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.582 -0.281 . . . . 75.11 110.315 174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 16.3 t70 -157.82 147.02 19.67 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.031 0.832 . . . . 74.02 109.637 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 94.7 mt -143.99 138.9 24.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 125.536 1.534 . . . . 74.43 106.944 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.2 t -153.64 108.39 3.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.955 0.502 . . . . 73.45 109.888 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.578 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 57.2 t80 -109.11 131.51 55.0 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 106.343 -1.725 . . . . 74.45 106.343 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -124.97 141.45 52.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -149.71 72.72 9.71 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.834 -1.173 . . . . 70.35 107.834 170.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.05 -25.46 19.37 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.433 2.089 . . . . 63.52 111.063 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.44 ' HA ' ' CD2' ' A' ' 30' ' ' HIS . 92.1 m-20 -104.61 26.15 9.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.895 0.878 . . . . 73.31 110.602 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -59.73 -49.0 93.93 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 123.359 0.664 . . . . 64.34 112.788 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -70.02 -23.09 30.02 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 121.779 1.653 . . . . 75.15 112.236 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.44 ' CD2' ' HA ' ' A' ' 27' ' ' ASN . 9.4 m-70 -74.33 -21.07 59.88 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.617 -0.719 . . . . 75.31 111.271 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG22 ' HE2' ' A' ' 123' ' ' PHE . 84.2 t -53.62 -25.8 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.625 0.602 . . . . 75.14 112.625 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -67.67 -40.85 84.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.313 0.645 . . . . 65.32 111.487 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.99 -14.01 34.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.415 0.686 . . . . 71.24 111.305 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.527 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? -75.27 146.09 41.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.808 0.443 . . . . 75.25 111.484 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -73.25 118.46 16.23 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.296 -1.001 . . . . 74.51 108.296 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -79.18 86.06 5.01 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.918 0.487 . . . . 74.51 111.039 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.424 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 35.1 tt0 -139.95 71.12 35.55 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.127 -1.064 . . . . 73.13 108.127 170.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -80.68 117.49 3.35 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.717 2.278 . . . . 72.33 112.073 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.72 110.72 22.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.166 -1.05 . . . . 71.42 108.166 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -82.69 92.7 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 122.498 1.142 . . . . 73.43 109.528 175.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -94.49 130.52 40.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.293 -1.322 . . . . 74.11 108.567 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' F' ' 125' ' ' TYR . 2.7 pt? -124.64 151.3 45.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.798 0.439 . . . . 62.35 111.378 -170.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.43 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -128.97 127.87 42.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.775 1.23 . . . . 71.33 108.483 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' F' ' 123' ' ' VAL . 79.9 mt -118.22 133.86 55.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.106 0.562 . . . . 64.41 109.821 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 15.7 t70 -146.64 150.16 34.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.712 0.805 . . . . 75.25 109.666 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.0 m -142.02 127.22 18.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.887 0.875 . . . . 74.5 109.843 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.545 ' HB1' HH22 ' A' ' 61' ' ' ARG . . . -142.78 146.17 33.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.525 0.73 . . . . 73.33 109.767 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -105.7 169.98 8.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.618 0.767 . . . . 75.21 111.239 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -154.94 120.46 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.989 0.916 . . . . 55.54 108.829 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -77.81 114.57 16.8 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.964 -0.384 . . . . 71.04 109.964 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.446 HD13 ' HB2' ' A' ' 57' ' ' GLU . 59.6 mt -85.65 -40.71 15.89 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.605 0.762 . . . . 62.42 109.986 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.56 -174.62 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.333 -0.849 . . . . 75.4 110.144 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.3 117.26 6.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.31 -0.626 . . . . 74.11 109.31 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 71.96 2.53 4.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.934 1.293 . . . . 73.12 112.34 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -107.7 112.6 40.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.236 -1.024 . . . . 72.5 108.236 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.94 123.36 28.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.223 -0.658 . . . . 74.24 109.223 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB2' HD13 ' A' ' 51' ' ' LEU . 32.4 tt0 -88.28 140.9 29.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.856 0.862 . . . . 72.13 108.921 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.38 123.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.844 -1.169 . . . . 70.1 107.844 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 33.5 t -103.57 148.8 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.784 0.834 . . . . 74.33 109.82 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.68 117.6 26.14 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.407 -0.961 . . . . 73.3 108.407 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 1.7 mpp_? -88.93 106.87 18.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.38 -0.97 . . . . 72.11 108.38 171.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.507 HG21 ' HB1' ' A' ' 110' ' ' ALA . 7.7 t -111.17 114.11 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.144 -1.058 . . . . 65.42 108.144 169.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.43 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 27.5 m -110.41 130.55 55.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.095 -1.076 . . . . 71.02 108.095 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.16 108.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.105 -1.072 . . . . 71.51 108.105 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.46 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 16.1 m -110.67 133.86 52.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.908 -0.405 . . . . 73.43 109.908 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.47 105.31 15.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.097 -1.075 . . . . 63.42 108.097 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.8 m -118.06 127.16 53.53 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.155 0.582 . . . . 72.0 110.277 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.8 OUTLIER -88.99 85.71 6.77 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.862 0.839 . . . . 74.34 109.05 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.34 -88.97 1.3 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.301 -0.863 . . . . 70.41 111.049 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 -28.75 4.65 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.431 0.692 . . . . 75.52 110.804 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -79.04 134.15 36.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 72.22 109.657 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.3 m -85.88 121.37 28.43 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.099 0.408 . . . . 74.53 110.591 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.65 -58.16 7.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.52 0.728 . . . . 64.33 109.645 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -164.27 162.18 22.34 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.434 -1.257 . . . . 73.42 110.564 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.2 tp -117.54 147.72 42.54 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.452 1.101 . . . . 72.13 109.776 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.452 ' HB3' HG21 ' A' ' 114' ' ' ILE . 61.9 m -140.85 100.15 3.77 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.206 1.002 . . . . 72.34 109.482 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.99 126.56 44.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.132 0.973 . . . . 74.41 109.176 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -136.69 138.78 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.389 0.676 . . . . 63.44 109.764 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -105.52 96.84 6.79 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.655 -0.702 . . . . 75.34 109.577 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -84.56 98.94 10.43 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.109 -0.701 . . . . 72.43 109.109 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -112.39 144.96 17.96 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.606 -0.598 . . . . 71.04 111.606 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.87 146.79 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.374 -0.29 . . . . 64.02 112.374 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.531 HG21 ' NE2' ' A' ' 14' ' ' GLN . 64.3 mt -82.69 128.06 39.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 108.692 -0.855 . . . . 65.41 108.692 174.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -128.92 118.16 22.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.323 -0.621 . . . . 73.05 109.323 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 20.5 m -83.54 87.04 7.01 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.471 -0.937 . . . . 74.21 108.471 176.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.96 138.49 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.849 0.859 . . . . 74.2 110.023 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.07 161.28 12.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.931 0.893 . . . . 64.31 110.881 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 4.24 85.24 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.738 -0.665 . . . . 54.52 114.665 172.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.54 ' HB ' ' HE3' ' A' ' 94' ' ' MET . 46.2 mt -119.52 136.48 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.019 -1.104 . . . . 74.13 108.019 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.97 174.69 10.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.175 0.59 . . . . 74.23 109.812 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -144.75 49.24 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.239 -0.891 . . . . 73.43 113.579 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.56 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 41.2 p -71.21 -15.07 62.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.322 1.049 . . . . 73.45 112.318 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -63.56 -50.9 67.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.286 0.634 . . . . 75.11 110.424 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.563 ' SD ' ' HG ' ' A' ' 98' ' ' LEU . 56.1 tpp -83.14 -29.03 28.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.887 0.475 . . . . 74.43 111.054 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.56 ' HB1' ' HA ' ' A' ' 92' ' ' THR . . . -62.21 -28.1 69.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 72.22 110.83 172.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -68.81 -54.68 14.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.862 -1.063 . . . . 75.03 109.78 166.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.568 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 4.2 m -64.46 -56.87 11.34 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.593 1.331 . . . . 73.5 114.593 -166.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.563 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 77.9 mt -69.71 -15.86 63.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.635 0.652 . . . . 72.11 112.3 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.55 -0.27 43.15 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.703 -0.498 . . . . 31.5 113.903 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -147.59 -65.91 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.049 0.54 . . . . 74.34 111.358 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.568 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.7 t80 -51.65 -52.95 43.86 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.779 1.232 . . . . 70.23 112.818 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -73.24 -48.48 7.41 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.309 -0.853 . . . . 72.12 112.644 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.54 -20.21 69.99 Favored 'Trans proline' 0 C--N 1.383 2.351 0 CA-C-N 121.153 1.448 . . . . 71.22 113.337 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.24 -41.84 80.58 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.452 0.701 . . . . 74.31 110.407 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.91 -37.35 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.432 0.693 . . . . 74.4 110.452 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.69 -26.36 34.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.357 -0.838 . . . . 75.32 112.133 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -62.56 -44.34 86.79 Favored Pre-proline 0 CA--C 1.566 1.568 0 N-CA-C 114.896 1.443 . . . . 74.2 114.896 -169.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 -39.48 43.55 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.884 1.723 . . . . 73.34 112.306 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -73.69 -31.32 63.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.416 0.687 . . . . 75.0 111.369 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.507 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.51 -51.77 61.23 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.327 0.651 . . . . 71.34 109.342 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.49 ' NH1' HD13 ' C' ' 105' ' ' ILE . 39.2 ttm180 -52.43 -51.5 58.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.477 -1.238 . . . . 72.55 110.966 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.19 -46.84 85.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.589 -0.732 . . . . 75.41 111.62 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.8 t -57.95 -38.92 76.86 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.599 0.562 . . . . 73.12 111.335 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.454 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 95.9 mt -67.65 -52.65 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.231 1.012 . . . . 73.0 110.796 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.464 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -60.89 -34.0 73.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.495 1.118 . . . . 74.24 111.673 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -69.48 -39.97 77.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.585 -0.734 . . . . 74.12 109.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.578 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.8 mtm -63.51 -38.66 91.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.627 0.371 . . . . 74.24 110.781 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.432 HG21 ' SG ' ' A' ' 76' ' ' CYS . 81.3 t -59.66 -49.65 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.829 0.851 . . . . 64.12 110.622 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.0 p -71.07 -34.09 70.84 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.022 -0.535 . . . . 73.21 111.638 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -68.8 -30.73 69.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.508 0.723 . . . . 64.23 109.873 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.66 -1.12 90.06 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.595 -0.729 . . . . 70.23 112.777 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m 65.33 46.45 2.6 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 122.831 1.3 . . . . 64.3 110.194 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG22 ' A' ' 31' ' ' VAL . 59.6 m-85 -121.16 149.67 52.06 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.29 -1.323 . . . . 74.3 109.095 173.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.99 140.1 91.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.395 2.063 . . . . 74.24 111.41 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.464 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -51.14 134.97 26.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.669 1.188 . . . . 70.13 113.315 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 86.8 mt -121.11 100.98 7.37 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.081 0.952 . . . . 73.02 108.762 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -117.29 105.02 11.74 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 74.25 109.542 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.26 150.72 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 74.23 109.509 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.82 93.23 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.62 0.768 . . . . 64.43 111.608 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.601 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 18.7 Cg_exo -65.23 115.47 3.34 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.075 1.85 . . . . 74.01 110.74 170.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.64 113.07 32.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.806 -1.183 . . . . 64.31 107.806 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -82.71 72.89 9.78 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.5 1.143 . . . . 72.2 108.221 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -70.59 -20.91 62.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 113.522 -1.672 . . . . 74.22 109.647 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 10.4 t70 -59.01 -47.3 85.68 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.184 0.994 . . . . 71.54 109.922 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.33 -30.83 69.77 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.275 0.985 . . . . 75.31 112.347 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.6 tp -58.5 -49.27 77.99 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.722 0.409 . . . . 63.35 111.206 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -85.79 -28.33 24.6 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.169 -0.469 . . . . 72.33 110.678 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.564 ' SD ' HD22 ' A' ' 141' ' ' LEU . 13.0 tpt -66.9 -30.08 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.638 0.375 . . . . 72.44 111.23 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 91.4 m-20 -61.5 -35.31 77.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.174 0.589 . . . . 70.2 110.915 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -79.04 -36.83 40.41 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.913 -0.585 . . . . 75.31 110.393 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.564 HD22 ' SD ' ' A' ' 138' ' ' MET . 47.6 tp -67.97 -49.86 59.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.162 0.985 . . . . 65.43 112.124 -172.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -159.9 15.35 0.14 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.113 0.565 . . . . 74.0 110.256 -173.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER 57.98 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.367 1.067 . . . . 74.11 111.363 -173.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -156.04 113.21 3.21 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.737 -0.838 . . . . 73.0 108.737 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.07 165.0 2.86 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.612 1.165 . . . . 70.41 110.005 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' C' ' 140' ' ' TYR . . . 91.99 121.64 2.8 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.783 -0.454 . . . . 63.22 112.196 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -105.05 100.54 10.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.665 0.733 . . . . 73.21 109.621 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.65 76.94 1.81 Allowed Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.462 -1.055 . . . . 61.14 110.462 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -118.36 107.54 13.98 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.678 0.791 . . . . 72.32 110.471 -173.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.27 84.77 0.72 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.057 -1.09 . . . . 62.14 108.057 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.433 ' HG2' ' HE1' ' C' ' 133' ' ' PHE . 36.2 mt-10 -76.93 91.94 3.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.31 -0.859 . . . . 74.1 109.226 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -89.28 145.03 25.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.361 1.064 . . . . 74.4 109.973 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -78.02 91.22 4.23 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.983 -0.747 . . . . 74.3 108.983 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.26 132.51 46.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.21 1.004 . . . . 74.14 110.031 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.538 ' H ' ' HD3' ' E' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 124.113 0.965 . . . . 73.24 110.327 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.938 -0.393 . . . . 73.55 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -146.12 132.55 19.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.616 -0.883 . . . . 63.55 108.616 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.55 159.49 15.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.322 0.649 . . . . 74.43 111.226 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -123.16 87.25 2.72 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.108 -1.071 . . . . 75.45 108.108 172.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -110.41 167.29 10.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.729 . . . . 61.32 110.316 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -76.31 135.8 39.58 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.114 -1.069 . . . . 61.4 108.114 166.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -67.0 -28.86 68.59 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.706 0.403 . . . . 75.02 111.024 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 67.73 -70.86 0.11 Allowed 'General case' 0 C--N 1.362 1.136 0 C-N-CA 125.535 1.534 . . . . 71.21 110.496 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.512 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.0 ptm 58.58 -178.22 0.08 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.158 1.783 . . . . 75.44 113.036 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.5 t -165.22 142.84 6.0 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 108.068 -1.086 . . . . 70.03 108.068 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -139.51 134.41 32.2 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.808 -0.812 . . . . 74.32 108.808 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -149.37 143.78 25.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.126 0.57 . . . . 63.52 110.195 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.87 122.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.623 -1.251 . . . . 75.32 107.623 170.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -85.82 -42.84 13.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.514 -0.55 . . . . 74.22 109.514 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -166.25 134.35 2.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.159 -0.473 . . . . 75.23 109.894 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.9 134.53 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 107.149 -1.426 . . . . 74.3 107.149 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -162.4 154.48 18.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.659 0.742 . . . . 73.4 112.093 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -80.51 127.3 32.27 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.421 -1.263 . . . . 73.41 108.676 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -97.31 -32.36 11.93 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.999 0.919 . . . . 74.31 110.884 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -160.07 143.47 13.96 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.176 0.297 . . . . 62.43 110.562 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.494 HG22 ' HE1' ' B' ' 117' ' ' MET . 48.3 mm -136.68 138.0 46.83 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 C-N-CA 125.038 1.335 . . . . 75.45 108.616 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.0 t -134.7 139.5 45.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.103 -1.443 . . . . 74.43 107.103 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.1 t80 -153.33 112.57 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.322 -1.733 . . . . 73.1 106.322 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.41 112.8 17.35 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.146 -0.687 . . . . 61.2 109.146 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.51 83.17 1.88 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.293 -1.003 . . . . 52.32 108.293 174.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.67 -12.19 15.19 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.698 2.265 . . . . 71.05 112.079 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -125.57 24.19 7.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.973 0.909 . . . . 75.55 109.436 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.33 -52.55 35.09 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.351 1.241 . . . . 73.04 114.351 -174.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.74 -10.77 20.12 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.089 1.86 . . . . 71.54 113.625 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -94.16 -25.56 17.06 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.731 0.813 . . . . 73.15 111.075 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 88.7 t -75.31 -19.16 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.838 0.855 . . . . 71.02 110.43 174.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -51.91 -42.25 62.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.632 1.173 . . . . 74.04 112.423 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -81.84 -12.71 58.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.265 0.626 . . . . 74.44 112.016 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.02 100.48 11.81 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.74 0.816 . . . . 73.24 110.843 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.05 78.1 7.5 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.658 0.783 . . . . 74.54 110.621 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.675 ' HB2' HD21 ' B' ' 68' ' ' LEU . 14.8 m-90 -150.41 161.55 42.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.236 1.015 . . . . 75.03 108.635 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.75 112.15 22.7 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.293 -1.002 . . . . 73.44 108.293 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.414 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 31.3 Cg_endo -62.36 117.99 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.637 2.225 . . . . 73.01 111.313 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.0 115.48 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.853 0.721 . . . . 73.43 110.816 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.511 HG21 HD23 ' B' ' 126' ' ' LEU . 27.5 m -97.49 136.75 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.849 0.833 . . . . 74.51 112.236 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -114.09 114.06 25.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.999 1.32 . . . . 73.52 108.036 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.66 140.5 49.13 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.469 -0.567 . . . . 75.43 109.469 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.87 147.14 52.46 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.684 0.794 . . . . 64.43 110.175 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -99.24 131.73 45.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.825 -1.079 . . . . 73.24 108.32 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.513 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 16.1 t70 -126.13 140.83 52.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.993 -1.114 . . . . 73.21 107.993 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -121.36 143.74 49.04 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.244 0.545 . . . . 75.01 110.422 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.81 157.9 43.65 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.502 1.121 . . . . 73.44 108.084 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -142.4 168.04 20.67 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.584 0.707 . . . . 75.33 109.676 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' B' ' 57' ' ' GLU . 41.4 t -150.94 157.36 42.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.207 -1.36 . . . . 74.4 107.352 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -121.0 115.86 23.98 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.34 -0.615 . . . . 75.52 109.34 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 68.8 mt -90.02 -35.46 15.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.402 0.681 . . . . 75.11 109.494 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 177.29 11.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 75.42 110.212 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.46 125.19 23.38 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.85 0.03 3.19 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.904 1.282 . . . . 71.33 112.826 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -112.62 96.11 4.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.716 0.806 . . . . 73.23 108.951 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.406 ' CD1' HD13 ' B' ' 86' ' ' ILE . 18.5 m-85 -111.24 139.57 46.53 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.505 0.669 . . . . 73.4 110.359 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' B' ' 49' ' ' SER . 7.1 tm-20 -103.59 97.09 7.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.165 -1.42 . . . . 72.43 107.165 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 121.69 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.604 0.761 . . . . 75.54 109.419 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.9 t -102.44 135.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.438 0.695 . . . . 65.13 109.916 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 117.83 31.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.35 -1.722 . . . . 74.43 106.35 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.513 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.6 ttp180 -112.43 113.54 25.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.871 0.367 . . . . 74.24 110.057 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.407 ' HB ' HD11 ' B' ' 114' ' ' ILE . 57.3 t -104.23 106.32 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.533 -1.284 . . . . 74.3 107.533 172.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -99.22 123.94 43.9 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.581 HG22 HG21 ' B' ' 114' ' ' ILE . 63.4 t -114.15 129.54 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.945 -1.025 . . . . 73.13 109.222 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -119.28 143.33 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.468 -1.308 . . . . 74.24 107.468 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -133.62 140.02 46.86 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.46 -0.571 . . . . 63.32 109.46 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 44.4 p -135.95 128.82 31.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.857 . . . . 73.41 108.899 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' B' ' 36' ' ' TRP . 2.4 tt -117.54 120.72 38.94 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.455 -1.313 . . . . 75.21 107.455 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -110.8 3.11 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.896 0.747 . . . . 64.5 111.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.39 3.13 13.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.141 0.976 . . . . 73.15 111.411 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.12 168.54 19.41 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.268 0.627 . . . . 74.2 111.441 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.0 m -67.06 120.87 14.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.062 -0.972 . . . . 74.12 110.481 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.436 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -75.49 -53.38 8.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.307 0.643 . . . . 74.14 109.508 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.98 170.84 16.08 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.369 -1.287 . . . . 73.5 109.735 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.88 154.25 45.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.889 1.275 . . . . 75.53 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -157.59 154.2 28.09 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.5 tt0 -164.56 130.59 2.89 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.573 -0.899 . . . . 74.13 108.573 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.462 HG21 HD12 ' B' ' 21' ' ' ILE . 94.5 t -125.62 142.34 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 109.136 -0.69 . . . . 71.22 109.136 173.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 48.9 mt-30 -117.39 99.67 7.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.609 -1.256 . . . . 75.35 107.609 169.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -91.44 100.2 13.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.169 -1.049 . . . . 74.55 108.169 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -97.38 143.41 16.71 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.86 -0.896 . . . . 75.44 110.86 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.92 127.26 3.35 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 110.969 -0.852 . . . . 71.1 110.969 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.16 131.22 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.96 -1.126 . . . . 75.25 107.96 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -135.19 142.62 46.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.664 0.785 . . . . 72.41 110.703 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -90.68 105.77 18.05 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.349 -0.982 . . . . 73.4 108.349 169.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.406 HD13 ' CD1' ' B' ' 56' ' ' TYR . 1.6 pp -117.58 108.65 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.547 0.739 . . . . 74.21 110.19 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.94 44.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.581 0.752 . . . . 50.32 110.6 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 103.2 -71.3 0.29 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.835 -0.62 . . . . 74.32 112.3 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.417 ' O ' ' HE2' ' B' ' 94' ' ' MET . 2.4 pp -73.6 158.35 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.691 0.396 . . . . 75.15 110.444 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 -176.32 5.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.478 0.711 . . . . 74.35 110.131 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.2 -131.52 50.0 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.584 0.552 . . . . 64.15 113.019 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.8 m -67.55 -24.27 65.51 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.593 0.757 . . . . 71.33 111.456 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.71 -37.15 65.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.312 0.645 . . . . 75.04 110.957 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.417 ' HE2' ' O ' ' B' ' 89' ' ' ILE . 56.3 tpp -73.93 -31.5 63.08 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.77 -0.456 . . . . 74.25 109.77 174.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.538 ' HA ' ' HD1' ' E' ' 116' ' ' TYR . . . -65.63 -36.22 83.08 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.748 -0.66 . . . . 63.21 111.049 174.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.46 -36.45 60.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.5 0.72 . . . . 73.32 110.35 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.82 -59.01 5.09 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 72.54 111.021 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' E' ' 116' ' ' TYR . 7.0 mp -75.88 -18.72 59.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 73.24 110.949 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.05 1.2 67.46 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-O 119.672 -0.516 . . . . 61.42 114.184 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.416 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -153.69 -60.05 0.13 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.775 0.787 . . . . 71.33 112.518 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -65.91 -45.56 81.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.92 0.888 . . . . 73.42 111.335 -171.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 64.4 m -68.45 -49.88 29.47 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 115.442 -0.799 . . . . 60.12 112.187 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.39 -22.41 52.47 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.634 1.556 . . . . 72.42 113.799 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.38 -37.64 86.52 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.259 0.552 . . . . 71.32 110.859 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.93 -40.71 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 73.11 110.871 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 55.6 mt -80.98 -18.65 46.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.289 -0.869 . . . . 75.34 111.915 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.55 -48.03 96.48 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.571 1.323 . . . . 65.52 114.571 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.49 -31.66 80.41 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 121.596 1.531 . . . . 70.43 112.985 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.45 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.9 m-85 -68.26 -46.93 69.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.483 0.713 . . . . 70.0 110.817 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -57.64 -43.66 85.02 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.42 -0.809 . . . . 75.0 110.071 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 20.7 mtp-105 -51.26 -64.32 0.85 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.224 1.01 . . . . 74.34 111.434 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.54 -28.99 69.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.625 0.77 . . . . 64.21 110.842 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -71.48 -44.91 63.86 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.829 0.451 . . . . 71.12 110.574 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.618 HD13 HD13 ' B' ' 128' ' ' LEU . 57.0 mt -62.94 -51.26 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.61 0.764 . . . . 64.51 109.979 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.52 -37.7 79.02 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.944 -1.026 . . . . 72.41 111.041 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.7 t -60.65 -52.23 66.03 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.581 -0.736 . . . . 65.1 110.063 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.494 ' HE1' HG22 ' B' ' 21' ' ' ILE . 15.0 mmt -63.75 -38.84 92.61 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.174 0.589 . . . . 71.43 111.151 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 83.2 t -60.6 -45.44 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.537 0.735 . . . . 72.32 110.739 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -69.5 -27.81 65.51 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.265 -0.88 . . . . 74.12 112.019 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 90.7 mtt-85 -68.9 -34.41 75.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.488 0.715 . . . . 70.3 110.222 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.2 7.72 55.28 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.823 0.702 . . . . 72.35 112.842 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p 55.78 32.01 18.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.111 1.764 . . . . 74.43 112.078 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -93.57 157.55 38.24 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.978 0.911 . . . . 72.42 109.985 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -47.73 147.4 7.08 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.82 3.013 . . . . 74.43 114.287 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.576 HE22 ' HB2' ' B' ' 127' ' ' ASN . 21.7 tm0? -62.26 129.75 42.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.583 0.753 . . . . 73.43 109.721 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.511 HD23 HG21 ' B' ' 40' ' ' VAL . 2.2 tm? -126.09 111.18 14.37 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.407 -0.59 . . . . 73.2 109.407 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.576 ' HB2' HE22 ' B' ' 125' ' ' GLN . 41.0 t30 -111.02 134.81 52.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.267 1.027 . . . . 64.22 109.374 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.618 HD13 HD13 ' B' ' 114' ' ' ILE . 36.9 mt -87.46 134.77 33.55 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 109.296 -0.631 . . . . 73.25 109.296 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.41 148.52 85.95 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.17 0.588 . . . . 72.54 110.087 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 99.82 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.914 2.41 . . . . 73.44 112.518 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -90.38 110.46 22.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.883 -1.154 . . . . 75.1 107.883 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -69.6 101.79 1.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.067 -0.716 . . . . 65.53 109.067 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 48.6 m-85 -56.65 -33.93 66.81 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.503 1.121 . . . . 72.4 110.112 176.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.64 -63.76 1.04 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.017 -1.447 . . . . 75.02 111.247 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.42 68.59 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.446 0.699 . . . . 54.33 111.708 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.86 -52.36 65.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.912 0.885 . . . . 74.55 109.759 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.415 ' HE1' ' HB1' ' E' ' 122' ' ' ALA . 27.9 t80 -91.35 -29.87 16.86 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.35 -0.841 . . . . 73.51 112.199 -170.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 33.4 mmt -75.49 -29.65 59.62 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.798 0.439 . . . . 72.3 111.176 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -76.35 -28.57 56.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.909 -0.404 . . . . 73.34 109.909 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -70.01 -25.57 63.65 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.041 -0.527 . . . . 73.23 110.217 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.4 mt -117.96 35.46 4.71 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.22 1.008 . . . . 71.3 110.236 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.08 109.79 0.71 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 120.856 0.36 . . . . 74.02 110.379 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -158.84 -0.03 0.09 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.84 0.856 . . . . 70.12 109.764 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.77 112.58 6.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 108.069 -1.086 . . . . 73.3 108.069 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.01 150.21 34.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.975 0.91 . . . . 72.35 109.174 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.04 91.8 0.28 Allowed Glycine 0 C--N 1.342 0.908 0 O-C-N 123.137 0.273 . . . . 54.31 112.456 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.64 128.54 33.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.224 0.609 . . . . 64.3 110.119 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.45 -144.11 16.31 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.919 -0.378 . . . . 73.01 112.299 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 35.4 m 63.49 90.93 0.08 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.8 1.24 . . . . 73.3 111.475 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.54 48.13 2.28 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.759 0.824 . . . . 73.25 109.754 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.51 ' HG3' ' HA ' ' D' ' 2' ' ' SER . 37.4 tt0 -47.31 120.29 3.11 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.928 1.291 . . . . 73.33 112.528 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -142.11 78.74 1.64 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.463 -0.94 . . . . 75.11 108.463 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.67 112.73 23.32 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.108 0.963 . . . . 73.33 108.918 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -141.34 139.48 33.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.811 0.845 . . . . 73.22 109.718 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 C-N-CA 123.348 0.659 . . . . 74.45 109.512 -176.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.982 -0.377 . . . . 72.14 109.982 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m -78.47 80.1 4.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.952 -0.759 . . . . 73.42 108.952 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.07 96.35 1.74 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.195 -0.911 . . . . 70.21 110.358 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 67.07 100.56 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.78 1.232 . . . . 71.14 111.546 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.97 162.21 33.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.493 0.717 . . . . 75.5 109.241 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -126.41 118.24 24.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.639 0.776 . . . . 62.23 109.095 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.446 ' OG1' ' HA ' ' C' ' 143' ' ' GLN . 23.2 p -117.88 106.21 12.74 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.901 0.88 . . . . 52.32 109.742 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.472 ' HG3' ' H ' ' C' ' 9' ' ' MET . 7.4 pt-20 -60.69 -68.01 0.34 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 122.976 0.51 . . . . 64.31 111.365 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.472 ' H ' ' HG3' ' C' ' 8' ' ' GLU . 27.9 ttt 52.65 111.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.75 1.62 . . . . 74.53 113.509 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -99.0 111.5 23.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.903 0.881 . . . . 73.41 108.832 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.548 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 58.3 t80 -119.03 130.72 55.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.395 -0.965 . . . . 71.41 108.395 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -144.79 133.54 22.31 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.619 0.367 . . . . 73.13 110.218 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.414 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.7 tp -83.96 134.38 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.389 0.676 . . . . 75.25 109.309 171.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.0 mm-40 -101.99 -47.28 4.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.654 0.782 . . . . 75.23 109.556 176.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -168.95 138.85 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.959 0.503 . . . . 72.32 110.899 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 60.9 mt -111.01 148.03 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.55 1.14 . . . . 71.5 108.131 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -177.23 164.23 2.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.289 0.636 . . . . 74.55 110.692 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -84.57 119.08 24.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.649 -0.871 . . . . 62.42 108.649 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.491 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 25.1 mmtp -73.0 -48.2 38.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.446 -0.946 . . . . 75.51 108.446 168.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.0 t70 -136.92 144.08 43.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.22 -1.355 . . . . 73.0 110.093 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.568 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.4 mt -139.53 142.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.023 -1.473 . . . . 75.53 107.023 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -156.01 149.52 24.81 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.046 0.45 . . . . 74.2 110.453 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.88 108.51 3.48 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.815 -1.18 . . . . 75.44 107.815 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -117.41 110.82 18.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.234 -0.654 . . . . 74.41 109.234 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.91 93.85 26.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.664 -0.865 . . . . 61.5 108.664 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.67 -35.13 48.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.879 2.386 . . . . 73.15 112.118 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -108.41 36.91 2.65 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.361 -0.836 . . . . 75.45 109.379 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.85 -45.98 99.57 Favored Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.305 1.224 . . . . 74.13 114.305 -178.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.521 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 24.1 Cg_exo -68.79 -37.3 12.07 Favored 'Trans proline' 0 C--N 1.389 2.699 0 CA-C-N 121.305 1.502 . . . . 75.12 112.678 171.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -66.84 -18.31 65.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.071 0.948 . . . . 72.52 112.771 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.631 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 12.1 p -41.72 -38.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 115.397 1.628 . . . . 70.45 115.397 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.4 -31.0 71.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.226 0.536 . . . . 74.22 111.625 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.31 15.4 22.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.086 0.954 . . . . 75.21 111.953 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 0.1 OUTLIER -89.96 174.96 7.38 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.326 0.512 . . . . 72.15 110.06 178.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.421 ' HB3' HD21 ' C' ' 68' ' ' LEU . 24.6 t0 -87.98 108.93 19.45 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.005 -0.739 . . . . 74.11 109.005 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -84.37 68.2 10.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.242 1.02 . . . . 75.5 112.034 -174.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -161.84 44.2 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 114.898 -1.046 . . . . 70.1 109.656 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.08 170.21 20.12 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 121.434 1.423 . . . . 72.43 112.2 -168.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -84.73 93.0 8.35 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.928 -1.138 . . . . 73.4 107.928 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.448 ' HB ' HG12 ' E' ' 142' ' ' ILE . 46.3 t -77.4 95.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 107.552 -1.277 . . . . 74.01 107.552 174.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.6 109.43 21.5 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.839 -1.073 . . . . 75.44 108.304 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.67 164.5 16.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.962 -0.563 . . . . 75.11 110.432 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.472 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 25.7 t70 -147.49 138.33 23.48 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.074 -1.084 . . . . 74.54 108.074 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.51 141.31 46.68 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.69 141.81 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.124 -0.695 . . . . 73.31 109.124 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.7 t -114.69 136.28 53.23 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.939 -0.763 . . . . 73.11 108.939 173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.58 160.43 21.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.94 0.896 . . . . 72.22 108.633 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -141.91 147.22 36.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.748 0.419 . . . . 72.25 110.272 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -153.95 132.29 11.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.491 0.716 . . . . 75.44 109.682 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.29 117.65 19.75 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.001 -0.74 . . . . 74.32 109.001 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' C' ' 57' ' ' GLU . 74.1 mt -87.24 -45.48 10.59 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.463 0.705 . . . . 74.33 109.259 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.51 -170.99 3.76 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.536 -0.757 . . . . 71.42 110.781 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.39 107.09 0.72 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.248 -0.887 . . . . 60.04 109.987 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 73.46 -0.82 3.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.452 1.501 . . . . 71.52 112.562 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.05 115.5 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.741 -0.837 . . . . 73.23 108.741 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.73 125.52 36.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.875 0.87 . . . . 63.24 109.267 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.63 ' HB2' HD12 ' C' ' 51' ' ' LEU . 39.9 tt0 -83.9 143.13 30.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.768 0.427 . . . . 62.33 110.671 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -117.49 122.95 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.507 -1.294 . . . . 60.13 107.507 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.12 106.38 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.429 -0.952 . . . . 75.11 108.429 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.27 105.92 18.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.415 0.686 . . . . 71.21 109.487 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -81.71 131.67 35.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.472 -0.785 . . . . 72.03 110.283 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.1 t -124.09 122.87 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.089 -1.449 . . . . 74.23 107.089 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.9 m -119.49 145.13 46.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.202 -1.036 . . . . 74.45 108.202 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.05 108.42 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.564 -1.272 . . . . 72.34 107.564 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.5 m -104.12 111.5 24.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.676 -0.861 . . . . 74.2 108.676 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.22 16.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.337 -1.727 . . . . 70.43 106.337 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -151.18 133.06 15.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.692 0.397 . . . . 64.31 109.968 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' C' ' 35' ' ' ASP . 30.9 tp -67.82 -48.15 67.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.176 0.59 . . . . 63.35 110.464 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.16 -73.76 0.04 OUTLIER Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.144 -1.183 . . . . 72.51 110.144 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -101.03 -31.49 11.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.398 0.679 . . . . 75.44 109.28 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -73.4 101.13 3.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.693 0.797 . . . . 74.44 109.741 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -83.39 130.02 35.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.632 -0.507 . . . . 64.44 109.632 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.652 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -73.15 -66.56 0.66 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.11 -1.071 . . . . 74.3 108.11 167.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -161.62 174.75 12.88 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.572 0.701 . . . . 72.05 111.668 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.08 141.88 51.07 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 105.667 -1.975 . . . . 75.14 105.667 169.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -151.3 112.23 4.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.383 -0.599 . . . . 75.31 109.383 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -122.88 129.29 51.46 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.835 0.454 . . . . 74.54 110.018 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.27 134.85 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.448 -0.945 . . . . 73.44 108.448 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -115.16 90.59 3.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.487 -1.301 . . . . 70.12 107.487 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.11 108.65 12.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.549 -1.205 . . . . 73.14 109.891 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 146.05 20.15 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.958 -0.457 . . . . 62.12 111.958 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.414 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -148.68 120.84 1.24 Allowed Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 111.603 -0.599 . . . . 73.25 111.603 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.51 HD13 HD12 ' C' ' 51' ' ' LEU . 10.4 mm -87.07 110.77 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 109.114 -0.699 . . . . 75.23 109.114 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.414 ' CE2' HD13 ' C' ' 13' ' ' ILE . 77.2 m-85 -121.76 119.9 33.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.555 0.342 . . . . 75.0 110.207 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 m -84.16 114.34 21.71 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.409 -0.589 . . . . 71.41 109.409 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.275 0.63 . . . . 73.12 109.657 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.91 168.78 24.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.851 1.26 . . . . 71.2 108.582 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.35 -27.47 5.66 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 120.916 0.176 . . . . 73.21 112.934 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -122.8 158.87 27.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.725 1.21 . . . . 75.22 109.146 -176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.81 -175.56 5.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.665 0.386 . . . . 73.04 111.323 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.67 -146.33 40.08 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.606 -0.724 . . . . 73.43 113.729 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.7 p -68.32 -19.53 64.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.863 0.865 . . . . 51.33 111.588 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -65.97 -49.21 68.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.803 0.841 . . . . 73.13 110.722 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -25.68 56.86 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 116.476 -0.329 . . . . 70.14 110.746 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.82 74.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.038 0.535 . . . . 74.33 110.979 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -70.9 -28.13 64.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.179 0.592 . . . . 74.14 110.488 174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.66 -60.41 2.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.738 0.415 . . . . 72.23 109.985 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.412 HD21 ' SG ' ' C' ' 102' ' ' CYS . 87.8 mt -70.7 -14.86 62.61 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.475 0.71 . . . . 73.33 111.768 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -110.36 3.92 29.69 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 114.848 0.699 . . . . 75.52 114.848 -175.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -51.53 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 117.936 0.868 . . . . 75.3 111.374 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.601 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 86.9 t80 -70.32 -58.97 3.16 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.561 0.744 . . . . 74.45 111.578 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.548 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 32.7 m -58.02 -48.66 96.69 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.49 1.116 . . . . 64.43 112.986 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.75 -24.27 62.09 Favored 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 121.729 1.62 . . . . 74.13 114.052 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.88 -28.09 61.39 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 118.314 0.506 . . . . 71.31 110.393 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.49 HD13 ' NH1' ' A' ' 111' ' ' ARG . 45.0 mm -64.33 -31.99 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.145 0.498 . . . . 74.21 109.943 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.414 HD22 ' HA3' ' C' ' 82' ' ' GLY . 84.0 mt -86.86 -24.6 24.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.044 0.938 . . . . 74.42 112.247 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.43 -46.22 99.84 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.249 1.203 . . . . 74.54 114.249 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.91 -38.61 77.99 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.086 1.857 . . . . 75.11 113.247 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -66.56 -45.31 79.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.414 0.686 . . . . 74.12 110.487 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.61 90.76 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.568 -0.742 . . . . 75.33 110.88 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -64.53 -50.94 65.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.904 1.282 . . . . 72.11 110.62 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.36 -31.96 71.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.245 0.618 . . . . 75.5 109.695 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.66 -35.38 75.11 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 122.99 0.516 . . . . 75.33 111.204 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 40.5 mt -70.71 -51.0 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 122.899 0.48 . . . . 71.11 110.137 173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m -62.99 -28.88 70.4 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.286 0.634 . . . . 74.14 111.183 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.3 t -64.05 -52.19 60.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.826 -0.805 . . . . 73.33 108.826 171.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.52 -39.33 83.55 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.5 1.12 . . . . 75.3 112.755 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.8 t -61.69 -47.92 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.54 0.736 . . . . 73.11 109.583 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.6 t -68.28 -25.9 65.39 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.94 -1.027 . . . . 75.23 111.616 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -73.38 -40.12 64.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.429 0.692 . . . . 74.12 109.326 177.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.24 -1.08 79.81 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.673 0.608 . . . . 73.51 112.341 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.493 HG21 ' HB3' ' D' ' 17' ' ' TYR . 27.2 p 62.48 35.77 14.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.632 1.973 . . . . 72.31 112.816 173.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.459 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 95.2 m-85 -86.27 165.29 34.47 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 114.738 -1.119 . . . . 72.21 108.852 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 74.3 Cg_endo -69.01 -175.0 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.205 1.936 . . . . 70.11 112.933 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.77 114.19 2.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.361 -0.836 . . . . 74.15 110.618 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.446 HD22 HG12 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -138.65 92.64 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.129 -1.434 . . . . 74.35 107.129 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -123.4 131.8 53.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.334 1.054 . . . . 74.15 108.851 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 140.08 43.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.286 0.635 . . . . 74.33 110.892 -170.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.21 146.56 74.9 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.132 0.973 . . . . 72.32 112.061 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.63 ' HG3' HD11 ' A' ' 16' ' ' ILE . 58.5 Cg_endo -71.26 105.43 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.211 2.607 . . . . 73.11 112.877 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.19 111.15 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.778 -1.193 . . . . 73.33 107.778 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.33 92.14 3.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 72.55 110.853 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.433 ' HE1' ' HG2' ' A' ' 151' ' ' GLU . 57.9 t80 -78.71 -25.38 44.68 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.893 0.854 . . . . 73.41 109.341 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -70.73 -60.71 2.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.471 1.508 . . . . 70.15 111.827 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.71 -31.19 68.03 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.311 1.044 . . . . 62.45 112.568 -170.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.406 ' O ' ' HD1' ' C' ' 140' ' ' TYR . 55.8 tp -57.89 -56.62 19.66 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.195 0.934 . . . . 72.34 110.195 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -76.99 -22.01 53.83 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.814 0.446 . . . . 72.11 111.662 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -63.05 -51.15 67.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.387 0.675 . . . . 71.45 111.858 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.14 -37.25 72.28 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 123.623 0.577 . . . . 74.01 110.967 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 146' ' ' GLY . 49.0 m-85 -71.5 -84.07 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.115 0.966 . . . . 73.32 112.257 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 tp -137.06 106.91 6.23 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.669 0.787 . . . . 75.22 109.6 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -160.02 -75.66 0.07 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.907 -0.405 . . . . 74.12 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.446 ' HA ' ' OG1' ' C' ' 7' ' ' THR . 22.0 tm0? -141.32 106.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.574 -1.269 . . . . 72.34 107.574 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -132.1 91.21 2.92 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.952 -0.759 . . . . 73.45 108.952 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.62 126.13 4.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.725 -1.125 . . . . 74.21 108.953 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 179.28 38.61 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.375 0.422 . . . . 71.12 112.349 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -164.62 170.68 15.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.049 0.94 . . . . 61.25 109.487 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.18 146.5 50.39 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.796 0.236 . . . . 61.32 112.964 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 42.8 p -97.92 -175.77 3.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.948 0.899 . . . . 75.5 111.017 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 135.35 43.45 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.784 -1.562 . . . . 75.33 106.784 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -130.75 22.85 5.01 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.836 0.454 . . . . 72.4 111.598 -170.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m80 65.79 36.61 6.09 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.484 1.114 . . . . 54.05 110.079 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.74 144.22 39.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.748 -0.66 . . . . 74.22 111.69 -173.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.9 t70 51.37 68.18 0.83 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.975 1.31 . . . . 75.11 111.97 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.334 0 CA-C-N 114.952 -1.022 . . . . 63.53 108.838 178.19 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.762 . . . . 71.33 108.944 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' SER . . . . . 0.51 ' HA ' ' HG3' ' B' ' 151' ' ' GLU . 37.6 t -130.16 128.47 41.83 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 65.23 109.326 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.69 173.49 10.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.157 0.983 . . . . 72.14 110.142 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -154.97 144.75 21.54 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.62 -0.882 . . . . 75.55 108.62 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -69.4 82.47 0.38 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.468 0.652 . . . . 72.12 110.194 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -98.85 35.27 1.9 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.221 1.008 . . . . 74.32 109.383 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -69.25 -12.04 61.33 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.123 0.969 . . . . 74.04 111.669 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.78 -16.78 62.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.074 0.949 . . . . 75.14 111.589 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.517 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 8.0 ptm -33.05 149.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.342 1.608 . . . . 74.11 115.342 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -121.11 144.42 48.57 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.163 -0.926 . . . . 64.44 108.878 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.556 ' HA ' ' O ' ' D' ' 85' ' ' SER . 33.4 t80 -154.0 102.55 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.253 -1.017 . . . . 74.32 108.253 175.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -121.06 118.3 29.42 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.882 -0.784 . . . . 74.02 108.882 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.2 102.47 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.914 -1.143 . . . . 74.31 107.914 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -77.63 -44.69 27.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.877 0.471 . . . . 73.31 111.302 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -161.76 132.21 4.97 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 119.838 -0.125 . . . . 74.21 111.137 -170.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.486 ' N ' HD13 ' D' ' 16' ' ' ILE . 3.3 mp -107.61 132.79 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.946 -1.502 . . . . 74.12 106.946 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG21 ' C' ' 122' ' ' THR . 28.1 p90 -169.94 162.85 9.4 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-O 121.839 0.828 . . . . 65.11 111.945 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.7 p -95.37 126.91 40.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.711 -1.131 . . . . 74.24 109.833 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.521 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 47.5 mtpt -95.51 -29.04 14.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.009 0.524 . . . . 73.22 110.048 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.625 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -150.74 137.11 18.64 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 124.124 0.89 . . . . 63.51 109.271 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.549 HG23 ' HE1' ' C' ' 117' ' ' MET . 60.1 mt -137.58 147.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.489 1.116 . . . . 74.32 108.056 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -150.86 143.92 24.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.153 0.981 . . . . 72.22 109.494 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.568 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 74.0 t80 -149.53 130.0 13.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.767 -1.938 . . . . 73.24 105.767 169.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.46 136.63 43.34 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.126 0.57 . . . . 64.54 109.829 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -125.03 84.6 58.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 123.594 0.758 . . . . 73.45 109.068 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.53 -46.93 6.32 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.186 2.591 . . . . 63.25 113.082 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -114.18 37.94 3.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.454 0.702 . . . . 74.54 109.617 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.608 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -54.48 -56.53 25.76 Favored Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.332 1.604 . . . . 73.34 115.332 -168.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 21.6 Cg_endo -87.62 -3.59 7.45 Favored 'Trans proline' 0 C--N 1.38 2.195 0 CA-C-N 121.496 1.57 . . . . 74.03 112.49 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -82.76 -41.99 18.52 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.267 1.427 . . . . 64.44 109.173 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.72 -21.84 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.121 -0.945 . . . . 74.41 110.145 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -60.53 -26.4 66.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.271 1.429 . . . . 74.54 112.571 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.07 -33.17 74.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.241 0.617 . . . . 75.21 110.6 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -95.34 98.35 10.52 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.571 -0.9 . . . . 73.2 108.571 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' F' ' 135' ' ' ALA . 17.3 p-10 -80.25 95.29 6.27 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.213 0.53 . . . . 64.0 110.223 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.61 ' HB3' HD11 ' D' ' 68' ' ' LEU . 68.4 t-105 -160.88 165.96 29.27 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.677 0.791 . . . . 75.21 109.685 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.15 117.38 67.9 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.413 1.085 . . . . 74.1 110.631 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.27 144.0 94.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.499 2.799 . . . . 74.43 114.278 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.51 128.17 35.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.33 -0.619 . . . . 73.53 109.33 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.47 HG13 HG22 ' F' ' 142' ' ' ILE . 15.0 p -98.61 149.81 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.2 0.6 . . . . 72.45 110.434 -173.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -131.98 114.98 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.592 -1.262 . . . . 75.01 107.592 171.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.87 145.87 25.47 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.121 0.568 . . . . 73.1 110.045 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.518 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 33.2 t70 -145.46 138.94 26.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.587 -1.188 . . . . 55.04 108.442 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.15 134.8 35.02 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.368 -0.975 . . . . 74.44 108.368 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -144.31 146.2 32.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.668 1.187 . . . . 64.41 108.354 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -117.46 154.51 31.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.525 -0.546 . . . . 74.22 109.525 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.434 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.59 167.47 27.98 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.049 0.94 . . . . 64.15 109.446 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -158.43 166.12 32.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.121 0.486 . . . . 74.53 111.41 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -159.44 116.82 2.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.779 1.232 . . . . 74.23 107.911 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -79.54 123.34 27.49 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.095 -0.706 . . . . 64.43 109.095 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt -90.59 -41.04 11.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.015 0.526 . . . . 75.44 109.947 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.61 -177.47 6.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.282 -0.872 . . . . 74.22 110.611 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -64.78 120.16 11.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.398 -0.819 . . . . 72.51 109.241 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 65.34 17.31 10.94 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 74.32 111.767 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -120.75 120.45 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.31 -0.996 . . . . 74.12 108.31 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.419 ' HB2' HD12 ' D' ' 86' ' ' ILE . 64.1 m-85 -128.91 126.47 39.77 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.57 -0.9 . . . . 75.44 108.57 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -89.97 132.95 35.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.557 -1.646 . . . . 74.51 106.557 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.403 HG22 HD22 ' D' ' 98' ' ' LEU . 51.1 t -125.43 133.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.177 -1.045 . . . . 75.41 108.177 -172.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 96.4 t -111.75 133.15 58.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.435 0.694 . . . . 75.53 109.395 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.431 HD11 ' HD1' ' D' ' 107' ' ' PHE . 0.9 OUTLIER -110.87 115.42 29.48 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.122 -1.066 . . . . 74.34 108.122 170.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -100.74 107.95 19.67 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.214 -1.032 . . . . 74.34 108.214 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.71 133.35 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.771 -0.826 . . . . 75.11 108.771 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.518 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 59.1 m -121.95 135.21 54.85 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.363 0.601 . . . . 73.24 109.646 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 131.53 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.846 1.258 . . . . 74.55 108.455 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 94.0 m -131.14 112.74 13.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.196 0.998 . . . . 71.24 108.86 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.83 48.31 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.744 0.818 . . . . 72.51 109.165 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.437 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.2 m -146.2 127.59 14.95 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.665 0.603 . . . . 72.22 109.67 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.61 HD11 ' HB3' ' D' ' 36' ' ' TRP . 47.5 tp -111.86 122.8 48.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.686 -0.857 . . . . 62.41 108.686 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 -115.68 5.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.599 0.562 . . . . 72.21 112.836 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -110.86 8.51 22.29 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.274 0.629 . . . . 75.34 111.825 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.08 164.27 30.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.226 0.611 . . . . 75.11 110.97 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -74.55 127.94 34.31 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.055 -0.52 . . . . 74.05 110.523 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.58 -61.29 1.87 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.259 1.023 . . . . 73.01 109.677 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.06 157.9 42.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.257 0.551 . . . . 73.14 111.321 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 79.0 mt -121.97 147.82 45.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.231 1.412 . . . . 72.33 107.586 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.541 ' SG ' HG21 ' D' ' 114' ' ' ILE . 44.8 t -158.57 141.65 14.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.457 0.303 . . . . 64.44 110.216 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.08 135.98 13.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.33 0.652 . . . . 74.42 109.788 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.94 119.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.097 0.559 . . . . 72.35 109.633 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.625 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -89.48 86.11 6.69 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.489 -0.93 . . . . 75.52 108.489 167.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.83 101.72 8.69 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.434 -1.257 . . . . 74.12 108.448 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.17 174.41 40.33 Favored Glycine 0 C--O 1.243 0.7 0 O-C-N 123.456 0.472 . . . . 71.03 112.143 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.95 135.5 2.84 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 111.654 -0.578 . . . . 72.24 111.654 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.8 129.96 38.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.513 -0.921 . . . . 74.43 108.513 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -132.28 135.78 46.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.491 0.717 . . . . 73.53 109.586 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.556 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.7 m -75.33 116.14 15.74 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.944 -1.132 . . . . 71.43 107.944 168.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.44 HG22 HD13 ' D' ' 89' ' ' ILE . 57.2 mt -121.23 101.72 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.634 -0.506 . . . . 73.34 109.634 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.63 152.6 48.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.406 1.082 . . . . 74.44 109.072 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.517 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 75.2 1.33 63.6 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.434 0.459 . . . . 63.31 113.587 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.52 HG22 ' HG2' ' D' ' 93' ' ' GLN . 53.7 mt -117.11 126.77 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 107.814 -1.18 . . . . 72.45 107.814 -174.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -145.84 148.86 33.33 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.973 0.731 . . . . 71.24 112.973 -163.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.09 -127.01 32.27 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.353 0.501 . . . . 65.14 114.197 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.9 p -70.34 -20.61 62.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.356 0.662 . . . . 65.04 111.32 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.52 ' HG2' HG22 ' D' ' 89' ' ' ILE . 55.9 tt0 -70.47 -41.47 72.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.737 0.815 . . . . 74.32 110.134 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -78.63 -29.42 45.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.288 0.235 . . . . 73.32 110.541 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.77 80.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.067 0.547 . . . . 64.53 110.272 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.01 -35.87 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.335 -0.848 . . . . 74.12 110.537 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -66.29 -43.08 87.36 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.941 0.496 . . . . 62.11 110.584 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.403 HD22 HG22 ' D' ' 58' ' ' VAL . 59.4 mt -80.09 -21.91 42.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.331 0.652 . . . . 75.05 111.082 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 -19.79 38.65 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.932 -0.371 . . . . 75.12 113.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.79 -69.04 0.69 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.39 0.515 . . . . 74.13 112.39 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -65.07 -60.92 2.5 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.283 0.475 . . . . 73.41 112.283 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -58.07 -46.97 99.64 Favored Pre-proline 0 CA--C 1.565 1.537 0 C-N-CA 123.78 0.832 . . . . 74.51 113.122 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 -30.72 51.16 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.921 1.747 . . . . 72.0 113.266 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.82 -35.97 82.18 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.035 0.534 . . . . 63.24 110.646 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.16 -42.71 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.712 0.805 . . . . 75.12 110.35 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -78.67 -19.01 53.5 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.27 -0.877 . . . . 74.24 112.181 -174.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.431 ' HD1' HD11 ' D' ' 60' ' ' LEU . 70.8 t80 -62.21 -45.72 90.67 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 113.759 1.022 . . . . 71.34 113.759 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.83 -36.91 75.9 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.113 1.875 . . . . 64.32 113.724 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -79.07 -33.84 44.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.893 0.877 . . . . 75.14 111.693 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.75 -48.47 71.79 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.874 0.47 . . . . 64.32 109.829 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -54.95 -50.82 67.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.368 -1.287 . . . . 75.42 111.013 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.98 -46.76 84.66 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.113 0.883 . . . . 75.33 110.8 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.472 ' SG ' HD11 ' D' ' 21' ' ' ILE . 49.5 t -60.11 -45.13 94.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 123.939 0.774 . . . . 74.1 110.947 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.541 HG21 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.49 -56.5 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.746 0.818 . . . . 74.43 110.897 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -53.03 -46.36 68.42 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.667 1.187 . . . . 74.41 111.796 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.5 t -62.84 -44.09 97.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.032 -0.985 . . . . 71.41 110.2 -177.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.527 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.8 mtm -68.07 -32.93 73.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.103 0.561 . . . . 61.1 111.852 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.62 -39.18 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.269 0.628 . . . . 72.53 110.438 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -74.89 -26.26 59.52 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 122.547 0.339 . . . . 74.14 110.881 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' D' ' 116' ' ' SER . 81.8 mtt-85 -75.47 -32.27 60.55 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.664 0.786 . . . . 72.33 109.635 172.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -1.13 90.19 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 115.534 -0.757 . . . . 71.54 111.922 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p 59.81 22.79 11.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.591 1.957 . . . . 65.35 112.805 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -86.31 159.89 52.5 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.334 1.054 . . . . 75.44 109.514 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.586 ' HA ' ' H ' ' F' ' 137' ' ' GLU . 52.8 Cg_exo -53.7 118.08 4.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.529 2.153 . . . . 75.24 112.701 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -48.88 133.19 18.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.062 0.945 . . . . 71.44 112.393 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.6 107.86 11.46 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.953 -1.129 . . . . 72.54 107.953 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -102.57 107.76 18.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.481 0.712 . . . . 51.44 109.466 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.95 145.02 54.94 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.73 0.812 . . . . 73.14 111.166 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.62 148.06 36.5 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 122.917 0.487 . . . . 72.45 110.264 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.37 130.82 31.53 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.545 2.163 . . . . 73.0 111.984 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 p -108.13 109.61 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.486 0.714 . . . . 73.1 110.041 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -86.72 106.78 17.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.802 0.841 . . . . 74.34 108.744 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -78.09 -33.71 50.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.039 0.536 . . . . 75.3 110.624 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.04 -45.08 91.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.777 1.231 . . . . 70.22 111.583 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.96 79.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.41 0.684 . . . . 71.33 112.15 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.65 -25.75 45.04 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.469 0.707 . . . . 74.32 110.648 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -69.72 -32.51 71.12 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.778 0.831 . . . . 75.44 110.28 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.5 mmt -61.18 -36.55 80.15 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.31 0.576 . . . . 74.2 109.52 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.7 -34.42 77.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.857 -1.065 . . . . 65.15 111.122 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.85 -30.91 68.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.63 0.372 . . . . 74.43 111.68 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 mp -71.23 -36.13 71.72 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.978 -0.451 . . . . 73.52 111.344 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -91.06 -0.76 57.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.059 0.544 . . . . 75.11 111.687 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -142.66 89.2 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.202 -1.407 . . . . 72.35 107.202 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -140.12 122.88 16.42 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.751 -0.463 . . . . 52.13 109.751 -169.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.43 166.79 22.66 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.371 1.068 . . . . 74.34 109.184 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.28 115.05 7.41 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.515 0.51 . . . . 62.41 111.832 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -104.64 134.63 47.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.345 0.658 . . . . 75.41 110.257 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.36 0.36 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.353 -0.699 . . . . 74.21 111.353 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 56.1 p -67.97 83.2 0.21 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.236 1.014 . . . . 62.21 111.345 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -110.38 -153.93 0.53 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.483 1.113 . . . . 55.11 109.878 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.54 54.95 1.82 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.533 1.133 . . . . 64.2 109.694 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -141.78 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.018 -1.446 . . . . 73.35 108.859 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 62.88 79.74 0.25 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.067 0.947 . . . . 74.44 109.277 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 66.89 172.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.966 1.306 . . . . 74.44 111.524 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.482 0 C-N-CA 123.375 0.67 . . . . 64.53 109.598 -177.81 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 108.953 -0.758 . . . . 75.31 108.953 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -123.18 103.18 8.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.31 0.644 . . . . 75.44 110.4 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.32 129.25 35.08 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.805 0.842 . . . . 73.14 109.345 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.76 94.78 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.484 -0.561 . . . . 75.13 109.484 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . 0.621 ' HB2' ' HB2' ' E' ' 117' ' ' PRO . 11.5 pt20 -150.62 126.76 10.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.912 0.885 . . . . 75.33 109.085 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -142.58 -43.46 0.32 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.719 0.408 . . . . 55.13 111.428 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.85 161.91 29.13 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.059 0.544 . . . . 74.32 110.852 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 mt -50.05 140.25 12.79 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.78 1.232 . . . . 70.52 113.124 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . 0.538 ' HD1' ' HA ' ' B' ' 95' ' ' ALA . 10.6 t80 59.78 58.49 4.73 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 124.79 1.306 . . . . 71.4 109.618 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.621 ' HB2' ' HB2' ' E' ' 112' ' ' GLN . 90.4 Cg_endo -77.92 -1.83 11.98 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.881 2.388 . . . . 72.25 113.308 -169.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -145.48 116.72 7.92 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.765 -0.828 . . . . 54.42 108.765 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 60.5 p -85.13 133.12 34.22 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.05 0.94 . . . . 70.53 108.82 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -76.78 89.84 3.43 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.113 0.959 . . . . 74.54 109.818 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.7 -45.25 65.32 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.235 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . 0.415 ' HB1' ' HE1' ' B' ' 137' ' ' PHE . . . -71.28 85.67 0.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.451 0.643 . . . . 74.33 111.194 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.51 131.54 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.551 1.14 . . . . 73.43 108.774 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -165.48 132.47 2.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.776 0.431 . . . . 73.34 110.828 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -140.56 92.62 2.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.295 0.569 . . . . 74.31 109.972 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.12 67.52 0.79 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.959 0.903 . . . . 75.13 108.968 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -134.02 87.31 0.26 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.17 -0.923 . . . . 61.42 111.205 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -63.9 141.03 58.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.021 0.528 . . . . 72.43 110.745 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -153.12 161.19 42.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.246 0.618 . . . . 73.12 110.303 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 10.0 tp -156.42 168.7 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.625 -0.88 . . . . 73.52 108.625 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.39 147.82 47.28 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.394 0.678 . . . . 61.52 110.669 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -61.67 153.37 71.32 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.866 0.867 . . . . 72.4 112.573 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.98 94.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.996 2.464 . . . . 74.12 112.154 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 7.2 tt -161.05 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.683 1.193 . . . . 71.11 108.662 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.46 65.13 1.6 Allowed 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.546 1.139 . . . . 72.04 109.822 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 14.2 p -65.9 -13.89 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.935 -1.029 . . . . 75.2 111.214 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.27 82.65 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.543 1.137 . . . . 73.44 112.029 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -164.3 25.95 0.07 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.476 -1.238 . . . . 74.41 109.899 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.96 27.17 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.247 1.019 . . . . 75.24 110.543 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.6 p -73.58 -13.53 61.04 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.338 1.055 . . . . 64.21 111.419 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.39 83.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.848 0.859 . . . . 74.55 108.925 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . 0.448 HG12 ' HB ' ' C' ' 40' ' ' VAL . 23.9 mt -123.94 -57.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.66 1.184 . . . . 74.01 108.13 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.89 164.44 29.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.09 1.356 . . . . 75.35 108.672 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -130.39 -17.3 3.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.333 0.494 . . . . 73.21 112.333 -176.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . 0.538 ' HD3' ' H ' ' A' ' 155' ' ' ALA . 27.1 mtpp -76.45 -177.55 4.2 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.88 0.472 . . . . 65.34 110.343 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.43 -87.58 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.072 0.549 . . . . 74.55 110.278 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 68.9 mt -156.49 -66.17 0.11 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.183 -1.043 . . . . 71.12 108.183 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.24 -51.96 0.18 Allowed Pre-proline 0 CA--C 1.565 1.544 0 CA-C-N 115.272 -0.876 . . . . 74.03 109.806 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 C--N 1.394 2.947 0 C-N-CA 121.832 1.688 . . . . 73.34 113.59 175.625 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.593 -0.892 . . . . 74.53 108.593 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 68.53 85.05 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.022 0.929 . . . . 75.11 109.604 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 71.83 -70.03 0.17 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.283 1.433 . . . . 75.3 111.212 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -70.45 97.32 1.27 Allowed 'General case' 0 C--O 1.246 0.897 0 C-N-CA 123.86 0.864 . . . . 72.43 110.124 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 127.94 34.63 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.49 -0.929 . . . . 63.24 108.49 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -72.91 84.83 1.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.351 0.596 . . . . 74.21 110.476 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -99.28 59.46 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.731 -0.84 . . . . 74.35 108.731 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.478 HD21 ' H ' ' F' ' 115' ' ' LEU . 2.2 pt? -65.96 83.84 0.08 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.744 -1.116 . . . . 74.34 109.394 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -148.16 157.35 42.89 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.188 0.995 . . . . 72.33 110.759 -170.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' A' ' 98' ' ' LEU . 65.3 Cg_endo -84.07 154.07 12.84 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.263 2.642 . . . . 74.32 113.097 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -70.19 137.24 50.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 60.32 109.888 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 48.7 p -80.73 80.55 7.17 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.653 0.781 . . . . 73.23 110.508 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -100.89 157.57 16.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.13 0.972 . . . . 75.33 111.183 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.41 11.38 35.05 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.828 0.851 . . . . 74.41 109.95 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.45 -22.02 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.414 0.685 . . . . 74.31 111.641 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 22.9 m -68.23 -24.76 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.87 0.868 . . . . 75.21 112.193 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -50.63 -55.9 14.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.357 1.063 . . . . 75.42 112.033 -171.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . 0.486 ' HD2' HD11 ' A' ' 42' ' ' LEU . 63.9 t80 66.88 167.38 0.23 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.621 1.168 . . . . 73.41 112.729 170.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -158.28 144.28 17.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 73.22 109.198 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.15 105.86 0.19 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.154 -0.778 . . . . 73.13 111.154 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . 0.62 ' HZ1' ' HB2' ' F' ' 128' ' ' LYS . 9.7 mtmp? -87.09 105.61 17.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.953 0.501 . . . . 73.02 110.041 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.51 106.49 17.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.828 -0.434 . . . . 75.11 109.828 174.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 10.8 tp -84.9 -19.12 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 124.122 0.969 . . . . 63.45 110.501 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 69.23 -76.81 0.06 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.516 1.526 . . . . 74.23 110.966 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -171.84 132.67 0.78 Allowed Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 124.255 1.022 . . . . 74.4 108.454 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.09 78.2 1.48 Allowed 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.821 2.347 . . . . 73.33 111.92 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.407 HG13 HG11 ' F' ' 136' ' ' VAL . 6.8 tp -86.09 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.744 -1.116 . . . . 65.32 108.538 175.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.425 ' H ' ' HB2' ' D' ' 35' ' ' ASP . . . -75.67 86.05 2.71 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.167 0.508 . . . . 74.52 109.899 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.407 HG11 HG13 ' F' ' 134' ' ' ILE . 10.6 m -122.79 170.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.579 1.152 . . . . 75.35 110.632 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . 0.586 ' H ' ' HA ' ' D' ' 124' ' ' PRO . 0.5 OUTLIER 53.26 33.23 15.01 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.927 1.291 . . . . 74.3 112.875 177.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 18.7 2.2 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.185 0.994 . . . . 74.33 110.507 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.63 ' HG ' HD11 ' F' ' 142' ' ' ILE . 16.1 tp -76.39 82.65 3.13 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.907 0.861 . . . . 73.44 110.532 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 61.3 p -111.39 13.01 21.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.276 -1.329 . . . . 61.25 111.067 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.07 15.26 1.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.245 0.618 . . . . 74.51 111.343 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.63 HD11 ' HG ' ' F' ' 139' ' ' LEU . 2.8 mm -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.143 -1.058 . . . . 63.23 108.143 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 67.07 -74.7 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.463 1.505 . . . . 75.42 110.815 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 68.69 -80.74 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.363 1.465 . . . . 72.54 110.632 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -90.16 123.32 33.88 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.119 0.568 . . . . 75.04 109.649 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 44.66 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.529 1.532 . . . . 63.3 113.61 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.79 -72.7 0.15 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.549 -0.908 . . . . 72.34 108.549 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 tt -168.78 73.04 0.78 Allowed Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 106.316 -1.735 . . . . 75.24 106.316 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 C--N 1.377 2.044 0 C-N-CA 123.354 2.702 . . . . 71.15 111.421 178.566 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.333 -0.247 . . . . 74.3 110.333 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -91.83 93.99 9.11 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.926 -0.768 . . . . 73.31 108.926 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.02 -70.76 0.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.342 -0.984 . . . . 72.42 108.342 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -88.27 91.32 8.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.765 . . . . 73.2 108.933 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -66.2 -40.56 90.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 70.43 109.419 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -93.34 98.13 11.04 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.311 -0.859 . . . . 74.05 109.437 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -99.99 101.41 12.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.425 0.69 . . . . 74.43 110.121 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -130.96 86.91 2.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.109 0.964 . . . . 75.22 109.653 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.9 OUTLIER -93.58 149.33 21.31 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.922 . . . . 74.42 109.752 177.267 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m -144.93 100.95 3.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.548 -0.908 . . . . 75.04 108.548 169.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -134.41 134.79 42.04 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.3 0.64 . . . . 74.45 109.351 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.436 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 92.4 mt-30 -132.82 123.85 26.89 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.592 -0.892 . . . . 75.52 108.592 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.69 103.95 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.897 -1.149 . . . . 74.53 107.897 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.61 -39.78 15.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 72.24 110.947 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.636 ' HD3' HG22 ' B' ' 122' ' ' THR . 0.1 OUTLIER -158.6 143.99 16.47 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.144 -0.455 . . . . 74.04 109.962 -175.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -145.85 100.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.505 -1.295 . . . . 72.13 107.505 171.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' HD1' ' HG3' ' A' ' 15' ' ' ARG . 71.6 m-85 -157.61 169.96 23.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.298 0.639 . . . . 73.32 109.779 -170.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.8 p -81.91 111.66 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.079 -0.51 . . . . 71.33 110.337 -173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 35.4 mtpt -79.5 -32.52 42.44 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.141 -0.481 . . . . 75.11 110.768 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.97 145.1 27.2 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.702 0.627 . . . . 63.22 109.616 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -134.59 144.2 35.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 125.065 1.346 . . . . 75.4 107.567 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.627 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 25.9 t -148.69 130.67 15.29 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.753 0.821 . . . . 74.3 108.857 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 90.3 t80 -147.6 119.28 8.03 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 106.962 -1.496 . . . . 75.43 106.962 174.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.55 139.63 45.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.831 0.452 . . . . 74.45 109.84 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.23 80.32 72.65 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.221 1.008 . . . . 74.32 108.515 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.51 -43.46 21.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.299 2.666 . . . . 70.15 112.627 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.528 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 32.1 m-80 -113.09 37.47 3.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.187 -0.915 . . . . 74.4 109.656 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.37 -46.03 99.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 C-N-CA 124.121 0.968 . . . . 72.0 113.087 177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.06 -22.97 29.96 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.976 1.784 . . . . 72.11 112.631 174.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.3 m-70 -78.11 -18.62 55.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.561 0.744 . . . . 73.42 111.656 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.457 HG21 ' HE1' ' A' ' 123' ' ' PHE . 79.1 t -52.53 -28.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.876 0.87 . . . . 74.04 112.447 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -65.53 -42.65 91.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.11 0.781 . . . . 72.32 113.11 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -78.37 -26.05 46.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.577 0.171 . . . . 72.11 110.665 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -76.73 152.08 35.81 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.101 0.56 . . . . 73.4 110.498 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -80.47 147.71 30.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.442 -0.947 . . . . 71.44 108.442 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 -79.05 75.33 5.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.911 0.884 . . . . 74.41 110.634 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.23 82.9 51.84 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.495 1.118 . . . . 71.34 108.639 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.85 123.41 5.21 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.927 2.418 . . . . 73.33 111.964 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -95.07 86.02 4.49 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.143 -1.428 . . . . 63.33 107.143 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 65' ' ' THR . 61.1 t -87.26 103.68 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.333 -1.303 . . . . 70.13 110.505 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.496 ' HA ' ' HA3' ' F' ' 127' ' ' GLY . 56.2 tttm -96.5 140.02 31.74 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.726 0.41 . . . . 74.35 110.392 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.1 mt -106.45 139.33 41.1 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.187 -1.042 . . . . 74.01 108.187 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.8 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -129.6 108.23 10.06 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.567 -1.271 . . . . 73.35 107.567 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.405 HD11 ' N ' ' A' ' 44' ' ' LEU . 3.2 mp -103.72 130.59 51.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.367 -0.975 . . . . 75.22 108.367 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.489 ' O ' HD22 ' A' ' 60' ' ' LEU . 19.2 t70 -144.05 151.68 39.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.857 0.863 . . . . 72.24 110.205 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -139.24 138.63 36.99 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.597 0.759 . . . . 64.34 110.094 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 149.05 52.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.631 1.172 . . . . 63.25 109.716 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -96.15 170.35 9.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.293 0.637 . . . . 71.13 111.101 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.0 t -165.7 147.82 7.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.879 1.272 . . . . 73.2 108.526 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -111.98 133.52 54.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.488 -0.931 . . . . 74.11 108.488 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.411 HD12 HG22 ' A' ' 83' ' ' ILE . 62.6 mt -104.69 -44.62 4.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.579 -0.526 . . . . 63.14 109.579 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.62 -174.35 4.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.583 -0.735 . . . . 73.11 110.38 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.27 117.84 6.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.345 1.058 . . . . 74.3 110.748 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 69.31 -8.2 0.74 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 125.533 1.533 . . . . 74.44 113.08 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.3 109.58 26.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.492 -0.929 . . . . 64.24 108.492 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.15 157.01 35.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.891 0.876 . . . . 72.22 108.763 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -132.46 118.91 19.91 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.53 0.732 . . . . 74.21 109.986 -174.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -104.56 112.6 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.717 -1.216 . . . . 61.21 107.717 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -100.0 131.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 72.4 109.924 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.489 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -100.63 114.23 27.74 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.447 . . . . 72.02 107.092 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -99.22 104.1 16.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.722 -0.844 . . . . 73.13 108.722 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -95.49 141.96 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.382 -0.97 . . . . 74.42 108.382 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.8 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 85.6 m -125.78 141.13 52.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 171.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.688 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 76.9 t -135.24 110.86 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.616 1.166 . . . . 74.33 108.37 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.473 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 m -101.95 142.15 33.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.711 -0.848 . . . . 71.24 108.711 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.46 121.78 20.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.873 -1.158 . . . . 71.25 107.873 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -130.95 130.14 43.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.127 0.571 . . . . 74.12 110.135 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' A' ' 73' ' ' ALA . 78.4 mt -87.61 78.71 8.46 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.801 -1.185 . . . . 74.25 107.801 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.59 -106.73 2.17 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 114.392 -1.276 . . . . 70.03 112.219 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -89.12 -26.99 21.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.531 0.732 . . . . 72.31 109.984 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.24 131.3 44.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 73.43 109.627 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.1 m -76.19 128.73 35.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.066 0.46 . . . . 70.02 110.524 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . . . -76.83 -56.4 4.63 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.235 1.014 . . . . 71.11 108.971 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -167.57 174.86 7.47 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.163 -0.926 . . . . 73.22 111.207 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 tp -143.05 150.48 39.61 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.845 1.258 . . . . 73.54 109.133 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.688 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 61.6 m -141.59 141.34 33.49 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.441 0.696 . . . . 74.15 110.681 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.627 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 56.4 mp0 -141.47 133.41 27.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.285 1.034 . . . . 74.53 108.321 170.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.42 108.4 5.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.265 -1.013 . . . . 71.3 108.265 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.81 80.39 8.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.207 -1.361 . . . . 71.11 107.645 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.12 92.5 3.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 114.046 -1.434 . . . . 74.32 107.886 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.24 145.62 21.42 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.374 -0.83 . . . . 62.3 111.3 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.53 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -135.52 120.25 2.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.772 -0.931 . . . . 71.5 110.772 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.411 HG22 HD12 ' A' ' 51' ' ' LEU . 45.5 mt -85.2 124.99 40.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.082 -1.081 . . . . 74.24 108.082 173.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -136.46 138.49 41.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.391 -0.966 . . . . 73.34 108.391 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.436 ' OG ' ' HB2' ' A' ' 12' ' ' GLN . 13.7 p -96.42 105.25 17.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.368 -0.604 . . . . 72.4 109.368 172.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.86 132.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.215 0.606 . . . . 71.11 110.072 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.04 162.88 26.08 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.658 1.183 . . . . 72.43 109.666 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.83 -25.11 12.34 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 114.61 0.604 . . . . 70.42 114.61 171.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.42 152.26 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.303 0.552 . . . . 72.23 110.918 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 8.5 tt0 -155.89 -172.71 4.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.329 -0.619 . . . . 73.21 109.329 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.499 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.63 -153.25 48.79 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.637 -0.256 . . . . 71.13 113.244 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.431 ' HB ' HD23 ' A' ' 141' ' ' LEU . 32.6 p -65.35 -26.36 67.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.604 0.762 . . . . 75.52 111.318 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.33 -42.69 99.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.536 0.734 . . . . 74.12 110.641 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.499 ' HE2' ' HG3' ' F' ' 117' ' ' PRO . 47.0 ttp -64.13 -53.14 54.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.139 0.975 . . . . 74.22 110.926 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.08 -47.69 68.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 61.14 110.958 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -47.71 80.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.617 -1.629 . . . . 72.23 111.192 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.619 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.1 m -71.37 -29.41 64.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.585 0.957 . . . . 72.04 113.585 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.9 mt -83.78 -38.8 20.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.049 0.54 . . . . 73.43 111.1 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.56 5.26 56.93 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.958 -0.565 . . . . 73.45 113.827 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -144.29 -66.67 0.34 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.784 0.792 . . . . 74.31 112.384 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.619 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.2 t80 -48.96 -56.58 8.45 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.194 0.998 . . . . 74.32 112.434 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.3 m -71.52 -44.56 12.76 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-O 118.389 -0.815 . . . . 54.34 112.471 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.28 -37.27 80.65 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.152 1.901 . . . . 72.53 113.732 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.481 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 61.8 m-20 -60.44 -40.61 91.7 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.108 0.963 . . . . 72.51 110.788 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.3 mm -64.7 -41.46 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.084 -0.962 . . . . 75.15 110.569 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.53 HD22 ' HA3' ' A' ' 82' ' ' GLY . 68.7 mt -75.24 -27.19 59.39 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.634 -0.712 . . . . 73.44 111.751 -173.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -63.15 -42.74 78.08 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.741 1.386 . . . . 74.11 114.741 -168.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -35.57 98.3 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 122.307 2.005 . . . . 75.43 113.603 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.8 -37.92 39.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.333 0.653 . . . . 73.33 111.399 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.46 98.56 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.669 -0.493 . . . . 74.32 109.669 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.503 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.5 ttm180 -57.23 -53.44 58.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.354 1.062 . . . . 75.32 110.908 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.95 -47.88 84.4 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.119 0.887 . . . . 63.22 111.008 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.15 -46.69 82.51 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.08 0.862 . . . . 62.34 111.126 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.551 HG21 HG22 ' A' ' 64' ' ' VAL . 98.9 mt -62.66 -52.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 123.709 0.63 . . . . 74.03 110.474 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 125' ' ' GLN . 87.7 m -56.13 -39.41 72.21 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.82 0.7 . . . . 74.43 111.596 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -66.47 -48.18 70.71 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.345 -0.843 . . . . 61.1 110.185 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.551 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mtp -54.36 -45.13 72.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.864 0.866 . . . . 74.12 111.486 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.442 HG12 ' HG ' ' A' ' 126' ' ' LEU . 71.0 t -61.86 -47.41 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.943 -1.026 . . . . 75.41 110.852 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -71.38 -24.3 62.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.985 -0.552 . . . . 75.44 111.553 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -71.77 -27.06 62.7 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.302 0.641 . . . . 74.42 110.313 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.75 10.09 63.45 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 123.469 0.481 . . . . 72.12 113.045 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.554 HG22 ' HB3' ' B' ' 17' ' ' TYR . 5.9 t 51.97 24.62 2.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 127.03 2.132 . . . . 75.41 113.279 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.457 ' HE1' HG21 ' A' ' 31' ' ' VAL . 75.6 m-85 -86.55 151.84 53.72 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 115.628 -0.715 . . . . 60.54 109.177 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.24 129.0 32.89 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.717 2.278 . . . . 72.13 110.56 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.499 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.5 pt20 -55.81 142.52 34.56 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.156 0.91 . . . . 75.0 111.345 -169.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.442 ' HG ' HG12 ' A' ' 118' ' ' VAL . 51.2 mt -119.46 97.66 5.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.525 0.678 . . . . 73.15 109.231 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.57 123.06 42.52 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.308 -1.315 . . . . 54.14 108.067 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 114' ' ' ILE . 69.3 mt -66.12 122.61 17.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.481 0.712 . . . . 74.43 110.565 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.41 ' O ' HG22 ' A' ' 131' ' ' VAL . . . -53.29 136.65 50.23 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 119.012 -0.518 . . . . 73.02 110.293 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.43 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.628 2.218 . . . . 73.22 112.102 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.548 HG13 ' HH ' ' F' ' 125' ' ' TYR . 53.9 t -100.25 112.86 34.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.17 -1.048 . . . . 74.34 108.17 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -85.42 92.12 8.4 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.243 -1.021 . . . . 73.05 108.243 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.41 -28.54 69.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.8 -0.636 . . . . 73.53 110.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.481 ' HB2' ' ND2' ' A' ' 104' ' ' ASN . 3.6 t70 -68.53 -52.09 35.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.082 0.953 . . . . 73.31 110.658 -171.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.18 88.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.024 -0.989 . . . . 65.25 110.688 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.2 tt -60.05 -46.2 90.34 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 124.188 0.93 . . . . 71.04 109.887 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.93 -40.15 91.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.057 -0.974 . . . . 74.11 109.973 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.582 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 13.0 mmt -63.54 -56.32 16.89 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.783 0.677 . . . . 74.24 111.507 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -65.14 -31.99 73.46 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.172 0.295 . . . . 74.14 111.483 -174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -66.79 -52.31 45.46 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.379 0.424 . . . . 72.33 110.068 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.431 HD23 ' HB ' ' A' ' 92' ' ' THR . 55.4 tp -56.18 -51.26 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.782 -1.099 . . . . 73.44 111.49 -171.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 170.78 -17.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 125.002 1.439 . . . . 75.14 110.811 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.24 91.23 6.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.624 0.726 . . . . 75.23 110.408 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -58.3 -30.41 66.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.263 1.425 . . . . 74.03 112.57 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.57 -75.53 0.54 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.273 0.629 . . . . 75.15 110.846 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.24 96.08 0.8 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.648 -0.581 . . . . 54.23 111.648 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.538 ' HB3' ' HB1' ' C' ' 145' ' ' ALA . 7.5 pt-20 -115.32 125.03 52.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.443 0.697 . . . . 63.31 110.185 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.86 87.79 0.08 OUTLIER Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.362 -1.095 . . . . 52.05 110.362 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -157.82 38.85 0.27 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.969 0.89 . . . . 71.04 109.537 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 77.27 1.09 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 122.187 0.994 . . . . 75.12 109.622 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -105.96 133.38 50.76 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.443 -1.318 . . . . 72.53 107.443 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -123.93 -70.0 0.78 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.67 0.388 . . . . 74.52 110.428 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -169.93 111.4 0.44 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.784 0.434 . . . . 71.35 110.394 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.04 108.79 18.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.768 0.827 . . . . 74.5 110.306 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.808 -1.182 . . . . 73.41 107.808 177.229 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.574 ' H2 ' ' HG3' ' B' ' 8' ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.321 -0.251 . . . . 74.05 110.321 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -169.67 154.25 5.38 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.406 0.682 . . . . 73.31 110.931 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 57.7 83.06 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.791 1.236 . . . . 72.42 111.665 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -174.46 -169.95 0.48 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.856 0.862 . . . . 75.3 110.253 -173.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.63 -171.85 2.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.897 0.879 . . . . 74.52 109.913 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.88 87.3 0.36 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.745 0.783 . . . . 74.41 109.994 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -142.96 170.93 14.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.45 -1.25 . . . . 74.51 108.937 -173.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.574 ' HG3' ' H2 ' ' B' ' 1' ' ' MET . 7.7 mm-40 71.7 111.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.653 1.581 . . . . 73.31 112.104 172.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.7 ptm 53.49 175.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.652 1.981 . . . . 75.15 114.695 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.8 p -141.46 127.5 19.51 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.616 1.166 . . . . 74.11 108.096 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -122.46 128.09 50.42 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.667 -0.864 . . . . 74.41 108.667 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -142.84 140.82 31.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 64.31 109.176 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.585 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.82 141.52 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.601 -0.888 . . . . 74.53 108.601 172.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.599 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 20.2 mm-40 -106.68 -50.66 3.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.963 0.505 . . . . 75.03 109.884 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -168.49 149.03 4.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.976 0.91 . . . . 75.5 108.567 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.547 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.6 mt -128.3 149.31 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.708 -1.219 . . . . 65.34 107.708 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.554 ' HB3' HG22 ' A' ' 122' ' ' THR . 24.1 p90 -170.87 150.44 3.18 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.255 0.55 . . . . 73.43 112.436 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.7 m -72.98 122.3 21.48 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.012 -0.995 . . . . 65.14 108.535 167.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.436 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.7 mtpt -94.33 -33.74 13.08 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.799 0.839 . . . . 73.41 110.563 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 22.9 t70 -152.14 140.52 20.54 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.47 0.481 . . . . 72.1 111.103 -166.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.456 HD13 ' SG ' ' B' ' 113' ' ' CYS . 45.9 mm -140.96 137.54 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.713 1.205 . . . . 74.42 108.315 177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.41 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -139.81 108.3 5.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.333 -1.358 . . . . 70.1 107.333 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.496 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.5 t80 -126.11 108.25 11.17 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.451 -1.314 . . . . 71.51 107.451 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.96 111.42 18.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.327 -0.99 . . . . 70.31 108.327 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.59 86.97 3.12 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.53 -1.285 . . . . 65.21 107.53 170.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.31 -32.49 41.4 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.493 2.129 . . . . 73.03 110.951 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.466 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 87.0 m-20 -111.87 30.43 7.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.501 -1.227 . . . . 73.45 109.97 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.3 -46.98 46.41 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.298 1.039 . . . . 63.14 111.964 167.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 73.6 Cg_endo -76.83 -16.75 16.12 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.086 1.858 . . . . 74.54 114.549 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.466 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 65.3 m80 -95.97 -16.19 21.86 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.872 0.693 . . . . 74.22 112.872 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.91 -11.79 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.742 0.417 . . . . 74.03 110.041 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.74 -43.93 94.01 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.584 0.754 . . . . 65.31 109.886 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' B' ' 30' ' ' HIS . 16.0 mp0 -81.03 -32.02 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.074 -0.512 . . . . 73.13 110.201 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.57 92.73 7.21 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.475 0.71 . . . . 75.15 111.093 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -89.31 105.98 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.579 -0.526 . . . . 74.53 109.579 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -172.98 169.23 4.75 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 74.33 109.453 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.36 114.67 49.18 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.877 0.871 . . . . 71.01 108.741 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 150.67 82.99 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.381 2.054 . . . . 74.22 112.392 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 104.94 1.18 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.773 -0.825 . . . . 73.22 108.773 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -97.57 154.35 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.885 0.85 . . . . 72.02 111.765 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.653 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 70.2 tttt -147.24 115.17 6.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.794 -1.548 . . . . 73.21 107.104 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -86.02 159.39 19.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.19 -1.041 . . . . 73.24 108.19 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.477 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.4 t70 -164.94 110.53 0.94 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.352 -0.61 . . . . 73.42 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.635 ' HB2' HG11 ' E' ' 123' ' ' VAL . 6.3 mp -102.98 144.48 31.2 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.931 0.396 . . . . 72.54 109.985 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.68 141.97 47.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.558 1.143 . . . . 72.21 108.683 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -121.65 139.0 54.1 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.633 -0.506 . . . . 73.43 109.633 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.61 161.02 41.79 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.224 1.01 . . . . 74.2 109.227 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -144.01 170.23 16.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.071 0.548 . . . . 72.42 109.981 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -155.31 136.2 13.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.991 0.916 . . . . 73.14 108.624 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.91 120.58 29.39 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.073 0.549 . . . . 74.42 111.068 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.3 -37.54 17.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.328 -0.619 . . . . 71.12 109.328 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.96 -179.48 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.032 0.933 . . . . 74.3 110.676 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.54 125.27 26.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.925 -1.034 . . . . 71.13 109.537 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 65.42 10.44 6.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.473 1.109 . . . . 71.32 112.385 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -127.33 95.61 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.207 -1.035 . . . . 73.11 108.207 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.427 ' HE1' HD12 ' E' ' 115' ' ' LEU . 75.8 m-85 -117.35 138.11 52.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.875 0.47 . . . . 73.51 109.883 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -102.02 103.47 14.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.761 -1.2 . . . . 73.33 107.761 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' B' ' 98' ' ' LEU . 48.7 t -95.3 129.26 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 73.43 109.48 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.9 t -109.55 129.65 64.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.928 0.891 . . . . 75.14 109.844 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' B' ' 79' ' ' GLN . 1.2 tt -106.75 134.04 50.5 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.316 -1.364 . . . . 73.24 107.316 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.505 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 27.6 ttm180 -119.19 130.95 55.77 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.857 -0.794 . . . . 73.04 108.857 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.524 ' HB ' HD11 ' B' ' 114' ' ' ILE . 16.9 t -124.67 123.12 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.38 -0.97 . . . . 72.34 108.38 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 33.3 m -108.75 144.85 36.02 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.305 1.042 . . . . 73.21 109.512 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.517 HG22 HG21 ' B' ' 114' ' ' ILE . 91.0 t -135.94 98.52 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.636 1.174 . . . . 62.25 108.21 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.653 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 27.4 m -83.07 139.3 33.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.939 -0.763 . . . . 65.24 108.939 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.69 140.06 21.37 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.839 0.456 . . . . 75.55 110.06 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.454 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.3 m -142.1 131.91 24.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.401 0.68 . . . . 72.51 109.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.19 108.3 20.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.157 -1.424 . . . . 73.54 107.157 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -118.83 5.75 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.803 -0.919 . . . . 71.02 110.803 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -111.93 4.59 18.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.276 0.63 . . . . 73.32 111.986 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.77 147.28 43.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.487 0.715 . . . . 72.45 110.013 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.3 m -66.05 127.13 30.9 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.021 0.528 . . . . 65.44 111.686 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -86.99 -54.5 4.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.267 -1.012 . . . . 62.23 108.267 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.88 157.52 24.04 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 114.739 -1.119 . . . . 72.4 110.062 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 84.5 mt -130.82 110.82 11.6 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 106.554 -1.647 . . . . 75.12 106.554 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -117.15 136.15 53.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 75.15 108.603 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.41 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.6 tt0 -157.61 135.09 10.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.094 -0.706 . . . . 71.44 109.094 -170.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.28 149.97 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.376 -0.829 . . . . 75.33 109.045 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 43.0 mt-30 -123.26 106.04 10.38 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.102 -1.073 . . . . 75.1 108.102 167.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -94.88 101.05 12.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.58 -0.896 . . . . 71.3 108.58 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.17 171.56 32.65 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.546 -0.622 . . . . 53.54 111.546 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.11 141.91 5.99 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.483 -0.647 . . . . 72.13 111.483 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 22.1 mt -92.72 128.05 44.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.811 -0.811 . . . . 72.44 108.811 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.06 134.82 47.64 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.048 0.939 . . . . 73.15 108.545 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 52.7 m -107.24 104.27 13.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.568 0.747 . . . . 71.24 109.002 175.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.458 ' H ' HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.14 121.15 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.691 1.196 . . . . 75.13 109.365 -176.003 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.5 159.08 40.44 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.908 0.883 . . . . 71.35 109.6 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.52 -43.63 2.77 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.622 0.577 . . . . 73.21 112.805 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 1.7 pp -62.49 138.97 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.572 0.749 . . . . 72.33 111.105 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -150.3 172.06 15.98 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.128 0.971 . . . . 75.24 110.416 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.76 -128.98 43.86 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.173 0.921 . . . . 65.33 113.496 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.2 m -67.81 -30.3 69.68 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.78 0.832 . . . . 74.21 110.814 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -74.72 -33.64 62.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.796 -0.638 . . . . 75.43 111.543 -168.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.418 ' SD ' ' HA ' ' E' ' 115' ' ' LEU . 0.0 OUTLIER -72.39 -36.46 68.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.162 0.506 . . . . 75.53 110.299 174.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.14 -26.96 66.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.793 -1.094 . . . . 65.15 111.247 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -86.56 -34.6 19.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.384 1.074 . . . . 74.3 110.164 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.02 -63.36 1.32 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.258 0.623 . . . . 73.32 111.573 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.454 ' HB2' HG23 ' B' ' 58' ' ' VAL . 1.4 pp -93.75 -3.26 52.49 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.958 0.355 . . . . 72.25 111.958 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.11 -16.34 51.01 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.242 0.339 . . . . 61.41 112.674 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.37 -52.82 0.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.219 0.452 . . . . 71.34 112.219 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -70.94 -43.83 67.38 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 111.998 0.37 . . . . 73.32 111.998 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 90.7 m -61.86 -49.97 83.43 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.5 -0.762 . . . . 72.12 110.917 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -54.72 -33.63 80.97 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.062 1.841 . . . . 70.35 113.805 168.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.81 -32.49 74.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.881 0.472 . . . . 75.24 111.186 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.86 -42.99 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.288 0.635 . . . . 73.22 110.169 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.85 -26.61 57.3 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.677 -1.147 . . . . 74.24 111.827 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.26 -49.86 82.39 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.726 1.01 . . . . 72.45 113.726 -170.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.435 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 35.3 Cg_endo -61.38 -31.32 88.47 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.704 1.603 . . . . 73.14 112.58 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.547 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.8 m-30 -69.06 -45.57 70.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.821 0.848 . . . . 74.15 110.25 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.98 89.38 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.335 -0.848 . . . . 62.15 110.798 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttt180 -59.31 -54.6 44.98 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.652 1.581 . . . . 74.44 111.35 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.57 -33.91 77.02 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.719 0.637 . . . . 72.32 109.854 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.506 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.9 t -68.35 -38.37 81.39 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.163 -0.471 . . . . 74.25 111.075 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.524 HD11 ' HB ' ' B' ' 62' ' ' VAL . 52.6 mt -64.04 -58.74 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.685 -0.487 . . . . 72.24 109.685 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -59.01 -31.3 68.69 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 124.18 0.925 . . . . 65.32 111.368 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.412 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -62.01 -54.38 42.4 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.387 0.675 . . . . 75.54 110.48 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -62.31 -36.63 82.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.19 0.596 . . . . 74.55 110.931 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.2 t -63.0 -42.65 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.074 0.949 . . . . 74.34 110.908 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.3 m -68.18 -31.86 71.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.328 0.651 . . . . 75.0 111.035 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 94.6 mtt-85 -68.65 -21.53 64.45 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.552 0.741 . . . . 75.41 110.921 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.11 15.12 61.93 Favored Glycine 0 C--N 1.356 1.685 0 CA-C-O 119.258 -0.746 . . . . 72.31 114.125 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.636 HG22 ' HD3' ' A' ' 15' ' ' ARG . 1.9 p 73.59 12.84 4.53 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 126.377 1.871 . . . . 71.53 113.247 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.24 149.82 43.66 Favored Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 122.183 -0.323 . . . . 73.34 111.163 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.21 163.11 24.11 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.243 2.629 . . . . 51.24 113.667 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.465 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 0.6 OUTLIER -63.57 115.35 4.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.232 1.013 . . . . 74.42 111.063 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 tt -130.11 97.47 4.46 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.074 -1.454 . . . . 72.35 107.074 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.75 136.07 33.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.527 -0.916 . . . . 72.44 108.527 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -75.11 125.13 28.28 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.086 -0.709 . . . . 73.43 109.086 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.85 153.9 92.92 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 123.267 0.627 . . . . 71.42 111.056 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.39 99.06 0.35 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.089 2.526 . . . . 74.34 112.419 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 5.2 p -90.84 113.27 26.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 121.487 0.661 . . . . 71.14 109.336 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -76.55 101.9 5.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.967 -0.753 . . . . 62.11 108.967 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -59.74 -28.68 67.57 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.102 -0.954 . . . . 73.43 109.898 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.51 -52.72 58.68 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.589 1.556 . . . . 72.12 110.684 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.35 79.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.458 1.099 . . . . 70.32 111.173 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.648 ' HG ' ' HA ' ' E' ' 123' ' ' VAL . 2.9 tm? -58.84 -54.59 45.42 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.81 0.694 . . . . 74.34 110.799 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.89 -38.71 92.08 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.749 0.656 . . . . 65.22 111.065 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.0 mmm -71.32 -36.24 71.51 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.901 0.48 . . . . 73.12 111.004 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.44 -25.96 54.97 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.197 0.599 . . . . 74.2 111.21 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -61.16 -37.19 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.591 0.756 . . . . 73.12 111.247 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 pp -120.25 23.04 11.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.21 1.004 . . . . 72.15 111.196 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -79.69 96.5 6.24 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.014 0.525 . . . . 74.21 109.665 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -163.18 -35.76 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.569 0.748 . . . . 74.42 110.583 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.57 88.94 0.08 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.804 1.242 . . . . 70.01 108.821 -171.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.15 91.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.822 0.849 . . . . 64.22 111.713 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.68 -163.14 54.36 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.897 -0.592 . . . . 71.54 113.895 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.56 -175.76 5.57 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.728 0.811 . . . . 62.24 110.167 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.35 125.86 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.696 -0.562 . . . . 73.42 111.696 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.4 p -105.55 135.42 46.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.468 0.707 . . . . 74.14 110.134 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -136.97 100.95 4.43 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.714 0.805 . . . . 73.43 109.098 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.99 143.8 26.19 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.87 0.868 . . . . 72.51 110.53 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -129.75 163.63 25.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.915 0.886 . . . . 71.13 109.556 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -158.28 128.85 6.21 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.682 -0.858 . . . . 73.05 108.682 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -136.13 95.03 3.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.057 0.543 . . . . 71.33 109.813 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 123.372 0.669 . . . . 71.42 110.253 178.208 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.989 -0.745 . . . . 73.51 108.989 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -99.44 39.6 1.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.697 0.799 . . . . 75.21 111.655 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.66 82.7 4.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.934 1.35 . . . . 65.32 109.224 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -86.11 84.29 7.54 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.876 -1.056 . . . . 73.12 108.647 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -73.7 91.04 1.86 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.655 -1.157 . . . . 72.41 110.703 -172.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -153.13 100.04 2.44 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.089 -1.078 . . . . 64.23 108.089 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 34.9 p -113.75 -4.69 13.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.393 0.677 . . . . 75.53 111.807 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.43 140.36 30.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.986 -0.375 . . . . 74.52 109.986 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.5 ttm 63.97 115.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.469 1.508 . . . . 72.22 111.235 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -87.92 77.54 8.47 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.65 -0.87 . . . . 74.23 108.65 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -114.66 137.31 52.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.527 -0.76 . . . . 71.5 109.534 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -152.06 134.53 15.3 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.297 0.639 . . . . 75.03 109.483 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 pt -76.27 136.45 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.717 -0.674 . . . . 74.13 109.319 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.1 mm-40 -104.68 -49.04 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.887 0.475 . . . . 64.53 110.005 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -166.11 141.46 4.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.58 -0.736 . . . . 75.3 109.475 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.4 136.02 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.827 -1.175 . . . . 65.5 107.827 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.448 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 7.7 p90 -173.11 154.38 2.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.306 0.574 . . . . 53.54 111.697 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -77.0 116.64 17.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.342 -0.845 . . . . 72.12 109.052 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -70.91 -48.59 52.82 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 107.972 -1.122 . . . . 74.02 107.972 169.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 6.0 t70 -137.02 141.14 42.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.479 -1.692 . . . . 64.14 109.548 -171.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.9 mt -136.57 141.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.321 -1.363 . . . . 75.02 107.321 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -150.23 141.84 23.55 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.395 -0.594 . . . . 63.1 109.395 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.85 141.71 31.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.529 -1.285 . . . . 75.34 107.529 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.79 144.0 31.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.569 -1.271 . . . . 73.31 107.569 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -150.47 83.18 6.0 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 108.386 -0.968 . . . . 70.23 108.386 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.07 -15.17 39.43 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.026 2.484 . . . . 75.01 112.69 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -126.1 37.89 4.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.171 0.988 . . . . 70.05 109.517 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.74 -51.74 79.69 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 113.809 1.04 . . . . 64.23 113.809 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.69 -24.53 7.27 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 121.64 1.56 . . . . 74.41 112.43 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.75 -22.54 65.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.661 1.184 . . . . 73.15 111.802 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.655 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 11.2 p -50.1 -32.29 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.353 1.061 . . . . 62.24 113.8 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.4 -31.01 70.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.341 0.656 . . . . 74.2 112.001 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -118.01 48.84 1.32 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.699 0.8 . . . . 72.41 110.355 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.655 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 14.6 ptpt -124.41 173.12 8.63 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.881 -0.414 . . . . 71.31 109.881 170.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.59 113.41 20.8 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.026 -1.101 . . . . 74.02 108.026 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -83.76 79.6 9.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.268 1.032 . . . . 73.12 110.81 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.712 ' HB3' HD13 ' C' ' 68' ' ' LEU . 48.4 tt0 -123.53 79.63 54.66 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.342 -1.355 . . . . 74.34 107.342 168.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.468 ' HG2' ' HG ' ' E' ' 139' ' ' LEU . 2.8 Cg_exo -77.13 91.08 1.2 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.053 2.502 . . . . 72.04 111.973 -173.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.61 91.96 8.42 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.9 -1.889 . . . . 63.51 105.9 169.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.5 141.03 15.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.367 -0.833 . . . . 74.44 109.354 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.594 ' HZ2' ' HB2' ' C' ' 41' ' ' LYS . 4.3 ttmp? -127.13 103.75 7.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.031 -0.729 . . . . 72.25 109.031 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.612 ' H ' HD21 ' C' ' 42' ' ' LEU . 1.6 pt? -89.9 160.71 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.853 . . . . 73.33 109.848 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.93 117.51 8.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.536 0.735 . . . . 65.52 109.216 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.43 120.21 39.64 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.86 -0.793 . . . . 73.23 108.86 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.2 140.93 46.84 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.715 1.206 . . . . 70.32 108.786 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 8.1 t -142.57 138.4 30.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.317 0.58 . . . . 71.43 110.455 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.26 177.32 5.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.143 0.977 . . . . 60.42 108.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -151.83 160.33 43.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 74.02 111.129 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -155.84 140.07 16.58 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.334 1.053 . . . . 75.41 108.614 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.46 115.35 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.497 -0.927 . . . . 64.14 108.497 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.594 HD12 ' HB2' ' C' ' 57' ' ' GLU . 47.5 mt -85.52 -42.62 14.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.005 -0.739 . . . . 63.22 109.005 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.56 179.78 8.08 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.515 -1.22 . . . . 74.05 109.103 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.06 128.01 34.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.001 -0.741 . . . . 75.43 109.001 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 70.55 -3.66 1.85 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.803 1.241 . . . . 64.31 112.487 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.29 111.22 35.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 108.771 -0.826 . . . . 73.35 108.771 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.34 125.47 42.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.601 0.761 . . . . 74.4 109.124 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.594 ' HB2' HD12 ' C' ' 51' ' ' LEU . 33.9 tt0 -84.5 137.75 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.696 0.798 . . . . 74.51 109.166 171.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 29.3 m -124.25 140.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 75.24 108.344 165.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' C' ' 46' ' ' THR . 47.5 t -117.51 103.6 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.397 -0.964 . . . . 74.15 108.397 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.64 96.8 10.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.258 -1.016 . . . . 72.21 108.258 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -85.67 126.78 34.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.817 -1.083 . . . . 73.44 109.663 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.463 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.9 t -115.18 134.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.276 -1.009 . . . . 62.02 108.276 171.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 4.4 m -118.98 141.71 48.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.531 HG22 HD13 ' C' ' 128' ' ' LEU . 86.3 t -128.64 117.24 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.668 1.187 . . . . 72.33 108.356 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -99.87 144.37 29.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.438 -1.319 . . . . 75.32 107.438 165.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.84 106.7 6.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.354 -1.721 . . . . 51.4 106.354 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -152.45 160.96 43.21 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.557 0.535 . . . . 72.41 110.815 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.712 HD13 ' HB3' ' C' ' 37' ' ' GLN . 20.0 tp -79.27 -50.26 11.19 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.172 -1.047 . . . . 73.21 108.172 162.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.4 -77.31 0.04 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.068 -1.213 . . . . 63.31 110.068 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -89.99 -31.3 17.28 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.229 -0.656 . . . . 75.21 109.229 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -78.05 93.38 4.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.277 1.031 . . . . 70.13 109.933 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -87.91 130.57 34.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.932 0.493 . . . . 74.3 111.65 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.25 -65.07 0.82 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.167 0.987 . . . . 63.4 108.943 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -156.54 164.0 38.72 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 123.797 0.686 . . . . 74.25 111.622 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.443 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -121.66 144.65 48.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.655 -1.609 . . . . 55.43 106.655 168.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.443 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -148.14 150.95 34.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.777 -0.823 . . . . 60.34 108.777 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -159.69 131.59 6.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.724 0.409 . . . . 75.41 110.078 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -129.95 114.64 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.867 0.867 . . . . 74.51 108.757 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.71 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.5 mt-30 -90.24 88.6 7.29 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.036 -1.098 . . . . 75.31 108.036 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.62 107.22 12.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.892 -1.049 . . . . 75.33 109.512 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.95 154.95 27.13 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 112.147 -0.381 . . . . 71.01 112.147 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.466 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.05 122.87 1.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.382 -0.687 . . . . 71.34 111.382 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.567 HD13 HD12 ' C' ' 51' ' ' LEU . 10.0 mm -87.9 123.47 40.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.397 -0.964 . . . . 72.54 108.397 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.32 123.33 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.555 0.742 . . . . 73.32 110.053 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -76.93 112.15 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.822 0.449 . . . . 73.34 109.821 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.42 112.12 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.308 -0.997 . . . . 74.15 108.308 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.01 165.66 30.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.741 0.817 . . . . 71.05 110.255 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -24.42 8.71 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.156 -0.474 . . . . 65.13 113.765 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.523 HD13 ' HB3' ' C' ' 93' ' ' GLN . 19.8 tt -123.48 151.66 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.403 1.081 . . . . 71.31 109.558 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.75 161.0 43.09 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.205 0.602 . . . . 63.14 110.606 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.1 -153.61 22.4 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 122.986 0.327 . . . . 73.31 112.856 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -59.53 -26.55 65.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.997 0.919 . . . . 73.41 110.454 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.523 ' HB3' HD13 ' C' ' 89' ' ' ILE . 36.8 mt-30 -61.1 -49.84 75.67 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.904 -1.498 . . . . 73.33 110.799 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -21.33 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 116.273 -0.422 . . . . 75.04 110.694 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.08 83.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.034 0.533 . . . . 75.34 110.57 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -66.09 -31.13 71.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.539 -0.755 . . . . 74.12 110.508 172.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.98 -59.27 2.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.67 0.388 . . . . 75.31 110.737 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.14 -51.05 16.79 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.434 0.694 . . . . 75.34 111.108 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.27 6.53 81.03 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.383 -0.676 . . . . 72.33 114.599 -169.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.15 -57.22 0.37 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.906 0.853 . . . . 75.53 111.829 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -68.49 -54.05 19.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.289 0.636 . . . . 74.22 111.233 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.3 -46.96 99.07 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 123.863 0.865 . . . . 74.42 112.597 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.3 -33.55 58.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.954 1.769 . . . . 75.31 113.378 171.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.36 -21.6 63.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.918 0.487 . . . . 55.41 111.78 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.503 HD13 ' NH1' ' A' ' 111' ' ' ARG . 32.4 mm -73.75 -39.35 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.216 0.606 . . . . 74.33 109.492 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.466 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.5 mt -75.44 -26.85 58.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.077 -0.965 . . . . 64.55 111.735 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -54.98 -49.87 89.63 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-O 117.993 -1.003 . . . . 71.53 113.12 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.58 -39.96 73.97 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.227 1.951 . . . . 63.11 113.879 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.98 -45.27 67.71 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.132 0.573 . . . . 75.03 110.882 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.21 81.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.248 0.619 . . . . 70.23 110.09 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -63.73 -50.12 70.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.108 1.363 . . . . 72.43 111.244 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.401 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.3 tm-20 -69.46 -28.53 66.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.704 0.402 . . . . 72.01 110.109 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.6 t -69.33 -35.98 76.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.778 0.431 . . . . 74.4 110.71 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.486 ' O ' HG23 ' C' ' 118' ' ' VAL . 93.4 mt -71.25 -53.23 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.49 -0.559 . . . . 75.34 109.49 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -61.32 -28.91 69.54 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.794 0.838 . . . . 71.12 111.336 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 38.9 t -65.94 -50.34 64.72 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.084 -0.71 . . . . 74.44 109.084 170.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.85 -31.89 71.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.954 0.901 . . . . 73.13 112.436 179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.486 HG23 ' O ' ' C' ' 114' ' ' ILE . 43.9 t -71.66 -38.9 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -66.47 -29.9 70.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.853 0.861 . . . . 63.13 111.377 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.501 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -74.16 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.43 0.692 . . . . 75.21 109.893 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.52 -7.33 68.46 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.418 0.449 . . . . 75.04 112.417 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.485 HG21 ' HB3' ' D' ' 17' ' ' TYR . 32.4 p 63.14 30.25 16.06 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.937 2.095 . . . . 74.22 112.561 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -82.77 162.32 55.68 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.639 -1.164 . . . . 74.43 108.409 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 140.27 92.72 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.41 2.074 . . . . 74.13 111.639 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.465 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 13.1 mm100 -57.59 112.55 1.47 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.891 0.877 . . . . 71.34 111.897 -173.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.43 93.21 4.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.45 -0.945 . . . . 74.02 108.45 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.27 127.75 49.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 75.24 108.554 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.531 HD13 HG22 ' C' ' 64' ' ' VAL . 86.8 mt -81.39 144.69 31.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.039 0.535 . . . . 72.32 111.114 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.23 143.26 95.64 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.323 0.649 . . . . 70.51 110.421 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.52 139.49 76.45 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.634 2.223 . . . . 65.41 112.33 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.25 118.2 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 108.888 -0.782 . . . . 74.22 108.888 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 4.2 m-20 -83.87 60.24 5.68 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.864 0.84 . . . . 74.54 109.99 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -78.91 -43.43 24.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.844 -1.071 . . . . 74.2 110.034 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -70.99 -37.09 72.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.792 -0.64 . . . . 70.4 109.694 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -62.27 -29.82 70.69 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 124.267 1.027 . . . . 75.2 111.757 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.602 HD13 HD22 ' E' ' 148' ' ' LEU . 9.5 tt -52.93 -51.11 62.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.85 0.86 . . . . 73.44 110.246 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -74.47 -27.14 60.44 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.624 -0.716 . . . . 74.15 111.279 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 95.8 mmm -69.41 -31.05 69.16 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.288 0.635 . . . . 74.22 111.462 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.81 -39.35 94.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.779 0.675 . . . . 53.32 110.171 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.52 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.524 -0.762 . . . . 73.45 110.779 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 58.42 167.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.246 1.018 . . . . 73.23 112.545 -168.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.56 92.82 0.9 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.524 -0.762 . . . . 73.22 109.14 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -160.69 135.42 7.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.189 -0.914 . . . . 73.12 109.077 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -86.59 149.1 25.17 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.548 0.739 . . . . 74.33 110.086 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 147' ' ' GLU . . . -144.68 -168.35 2.89 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.113 0.965 . . . . 73.05 109.061 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.18 99.64 0.14 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.773 -0.931 . . . . 72.54 110.773 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.36 171.74 0.74 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.749 0.82 . . . . 73.41 112.034 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.42 -47.28 1.27 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.699 -0.682 . . . . 72.11 111.903 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -69.78 123.5 21.58 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.705 -0.85 . . . . 63.21 108.705 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.03 -8.18 55.79 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.363 0.665 . . . . 71.32 112.634 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -150.76 174.87 12.55 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.386 0.674 . . . . 71.32 110.768 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -82.46 90.59 6.75 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.788 0.804 . . . . 75.45 109.976 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -145.91 173.47 12.11 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.687 0.795 . . . . 71.54 109.589 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.03 160.42 31.32 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.198 -0.456 . . . . 63.32 109.918 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 108.743 -0.836 . . . . 54.05 108.743 -179.217 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.422 ' SD ' ' N ' ' D' ' 1' ' ' MET . 3.2 mpp? . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.287 -0.634 . . . . 73.11 109.287 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -124.86 13.55 8.54 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.421 1.089 . . . . 75.1 110.599 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 60.97 91.33 0.06 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 73.44 109.249 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.95 93.25 0.11 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.971 -1.013 . . . . 64.21 110.247 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.64 102.21 14.84 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.921 0.888 . . . . 72.42 109.26 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.409 ' HA ' HD13 ' D' ' 89' ' ' ILE . 46.7 t30 -61.78 -30.09 70.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.477 1.111 . . . . 75.43 111.836 -177.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 m -67.38 -45.74 75.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.315 0.646 . . . . 75.42 111.433 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -87.67 -14.28 40.34 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 118.886 -0.578 . . . . 74.23 111.65 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.5 ttp -30.24 125.31 0.16 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.906 1.283 . . . . 75.22 113.289 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -122.95 142.41 50.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.588 0.755 . . . . 71.42 109.301 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -155.04 98.9 2.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.7 132.62 49.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.269 0.628 . . . . 72.42 109.82 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tp -89.61 128.21 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.15 0.58 . . . . 61.23 109.548 177.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -99.62 -40.5 7.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.835 0.854 . . . . 74.24 111.037 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -163.04 123.44 2.31 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.772 -0.649 . . . . 73.21 110.471 -162.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.93 132.1 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.294 -1.373 . . . . 70.43 107.294 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.533 ' HE1' HG13 ' D' ' 83' ' ' ILE . 12.4 p90 -160.04 143.52 14.03 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.957 0.786 . . . . 74.54 111.476 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -76.1 117.48 17.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.943 -1.026 . . . . 74.54 108.917 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -82.59 -26.14 32.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.91 0.386 . . . . 64.21 109.99 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.7 t70 -154.11 141.69 19.85 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.848 -1.069 . . . . 64.34 109.437 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.535 HG23 ' HE1' ' C' ' 117' ' ' MET . 81.1 mt -141.63 145.98 23.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.221 1.408 . . . . 73.21 107.544 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -147.34 141.72 26.35 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.986 0.914 . . . . 75.21 108.69 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.467 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.9 t80 -153.77 124.89 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.285 -1.746 . . . . 74.32 106.285 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.43 112.66 7.43 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.596 0.634 . . . . 71.11 110.27 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.9 91.37 12.6 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.38 0.672 . . . . 44.02 109.353 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.5 -43.87 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.759 2.306 . . . . 55.22 112.919 -175.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 44.6 m-80 -99.63 43.42 1.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.754 0.822 . . . . 74.1 109.056 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.448 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.78 -52.36 73.04 Favored Pre-proline 0 CA--C 1.57 1.737 0 N-CA-C 114.742 1.386 . . . . 75.42 114.742 -169.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.5 -6.0 8.09 Favored 'Trans proline' 0 C--N 1.388 2.656 0 CA-C-N 121.524 1.58 . . . . 71.5 112.578 172.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.414 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 21.8 t-160 -81.09 -42.15 21.43 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.08 0.952 . . . . 74.35 110.048 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.11 -18.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.27 0.628 . . . . 74.24 110.052 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.98 -29.62 70.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.949 0.9 . . . . 75.41 110.876 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -68.55 -17.71 64.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 74.23 111.841 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.07 109.97 21.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.768 0.827 . . . . 72.02 110.168 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.73 81.99 5.91 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.99 0.916 . . . . 74.13 110.882 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -159.42 161.35 35.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.654 -0.499 . . . . 73.24 109.654 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.422 ' HG3' ' HA ' ' F' ' 139' ' ' LEU . 1.5 mp0 -82.9 109.07 14.62 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.876 0.87 . . . . 74.54 109.792 173.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -50.19 140.37 33.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.44 2.76 . . . . 74.54 113.569 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.443 ' HG3' HD21 ' F' ' 141' ' ' LEU . 36.2 tt0 -57.73 127.29 31.31 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.051 0.845 . . . . 75.44 110.116 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.57 ' HB ' ' HA ' ' F' ' 142' ' ' ILE . 88.7 t -96.33 105.84 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.734 -0.839 . . . . 74.22 108.734 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -102.78 108.85 20.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.217 -1.401 . . . . 74.12 107.217 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.512 HD13 HD21 ' D' ' 128' ' ' LEU . 1.5 pt? -116.3 149.85 38.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.065 0.46 . . . . 75.03 110.498 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.69 130.27 24.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.395 1.078 . . . . 65.12 108.289 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.21 131.13 54.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.222 0.609 . . . . 71.12 109.503 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -133.55 128.95 36.36 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.853 -1.166 . . . . 74.41 107.853 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -106.23 150.03 26.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.522 0.329 . . . . 74.55 110.211 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.13 169.02 22.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.8 0.84 . . . . 71.21 110.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.4 m -147.87 158.73 44.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.874 0.869 . . . . 71.11 110.019 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -155.35 118.42 4.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.17 -1.048 . . . . 72.23 108.17 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.62 123.14 24.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.147 -0.686 . . . . 75.53 109.147 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' D' ' 57' ' ' GLU . 51.2 mt -96.21 -31.54 12.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.547 . . . . 74.53 110.366 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 179.64 8.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.857 0.863 . . . . 75.31 110.088 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.06 121.34 18.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.906 -1.043 . . . . 73.42 109.274 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 68.24 17.01 9.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.994 1.318 . . . . 71.21 112.069 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.36 116.68 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.61 ' HB2' HD13 ' D' ' 86' ' ' ILE . 82.6 m-85 -129.15 129.83 45.64 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.736 -0.839 . . . . 73.03 108.736 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.458 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.5 tt0 -87.79 135.37 33.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.845 -1.071 . . . . 73.14 108.64 171.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.02 139.2 43.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.853 -1.166 . . . . 71.5 107.853 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.69 131.84 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.39 -0.967 . . . . 71.44 108.39 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -114.58 117.14 30.06 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.267 -1.383 . . . . 73.22 107.267 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 44.6 ttm-85 -95.78 98.72 10.66 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.59 -1.263 . . . . 72.42 107.59 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . 0.619 HG23 ' HB1' ' D' ' 110' ' ' ALA . 47.6 t -99.21 113.81 35.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.031 -1.1 . . . . 71.12 108.031 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.2 m -117.3 132.23 56.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 75.43 109.232 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.28 107.1 10.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.964 0.906 . . . . 73.52 109.286 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.8 m -92.57 119.77 32.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.687 -0.857 . . . . 74.3 108.687 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.73 137.11 46.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.699 -0.852 . . . . 74.42 108.699 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 57.3 p -149.15 140.38 23.12 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.846 0.459 . . . . 73.03 109.951 -176.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.86 130.18 41.36 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.386 -1.338 . . . . 73.44 107.386 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.23 -121.14 12.91 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.706 -0.557 . . . . 74.42 111.706 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.15 6.95 15.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.247 1.019 . . . . 74.1 111.402 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.95 150.19 34.13 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.118 0.567 . . . . 74.23 109.751 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -79.8 116.72 20.13 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.814 -0.439 . . . . 73.02 109.814 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.11 -56.08 10.14 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.824 0.849 . . . . 72.23 110.102 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.54 169.19 23.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.021 -0.991 . . . . 75.33 110.211 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.4 mt -124.41 153.26 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.759 1.224 . . . . 73.14 108.012 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.53 ' SG ' HG22 ' D' ' 114' ' ' ILE . 47.2 t -158.43 139.66 13.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.137 0.575 . . . . 72.11 109.638 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.27 130.66 8.79 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.896 -0.779 . . . . 74.14 108.896 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.5 t -129.74 115.29 33.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.076 -0.713 . . . . 72.33 109.076 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.575 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.2 mt-30 -89.36 83.4 6.41 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.302 1.048 . . . . 62.44 108.478 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.79 102.97 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.174 -1.83 . . . . 74.45 109.509 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.2 162.71 23.87 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 116.319 -0.401 . . . . 70.34 112.393 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.0 136.77 5.08 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.951 -0.86 . . . . 72.23 110.951 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.533 HG13 ' HE1' ' D' ' 17' ' ' TYR . 69.2 mt -89.48 120.83 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.814 -0.81 . . . . 73.45 108.814 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -121.4 147.12 46.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.565 -0.531 . . . . 74.51 109.565 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 66.1 m -94.58 106.94 18.94 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.794 -0.817 . . . . 74.01 108.794 170.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' D' ' 94' ' ' MET . 3.5 mp -107.26 107.69 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.33 -0.989 . . . . 63.55 108.33 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.46 148.81 50.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.121 0.568 . . . . 74.15 109.977 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -22.71 11.93 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.073 -0.512 . . . . 64.44 114.273 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' D' ' 94' ' ' MET . 32.5 mm -136.41 139.89 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.247 -1.39 . . . . 73.01 107.247 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.01 179.7 7.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.182 0.593 . . . . 74.03 109.996 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.64 -99.83 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.297 -0.41 . . . . 73.45 113.762 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.7 p -83.45 -56.1 3.93 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.077 0.551 . . . . 74.31 111.977 -168.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.03 -37.63 78.73 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 120.796 0.332 . . . . 70.11 110.85 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.621 ' HG2' HG23 ' D' ' 86' ' ' ILE . 44.5 tpp -77.31 -19.93 55.7 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.956 -0.565 . . . . 74.35 111.751 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.63 -32.49 70.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 120.996 0.427 . . . . 71.32 111.124 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -62.65 -40.57 97.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.244 -0.889 . . . . 74.25 110.988 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.465 ' SG ' ' SG ' ' D' ' 102' ' ' CYS . 38.5 t -72.26 -51.26 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.786 0.434 . . . . 73.04 110.27 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.501 HD13 ' HG3' ' D' ' 94' ' ' MET . 10.7 mp -67.37 -18.86 65.31 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.466 0.706 . . . . 73.3 111.796 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -2.94 56.96 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.372 -0.682 . . . . 61.21 114.056 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.69 -62.79 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.95 0.875 . . . . 73.3 111.999 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -71.06 -50.08 37.8 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.826 0.676 . . . . 72.12 112.826 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.465 ' SG ' ' SG ' ' D' ' 97' ' ' CYS . 18.6 m -62.67 -45.23 88.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.373 0.669 . . . . 63.45 111.877 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.53 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.9 Cg_exo -55.99 -37.63 95.85 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.985 1.79 . . . . 71.23 113.057 168.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.82 -32.47 74.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.537 0.735 . . . . 65.24 111.143 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.14 -41.97 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 123.283 0.633 . . . . 75.33 110.136 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.9 mt -77.42 -17.96 57.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.172 -0.922 . . . . 74.01 111.541 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.98 -44.19 89.09 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 114.181 1.178 . . . . 71.45 114.181 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.23 -41.9 56.28 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.156 1.904 . . . . 64.35 112.808 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.98 -32.62 51.38 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.153 -0.93 . . . . 75.42 111.597 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' D' ' 62' ' ' VAL . . . -62.86 -55.61 24.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.593 0.757 . . . . 63.41 109.441 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.07 -40.45 76.89 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.025 -1.443 . . . . 74.44 110.337 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.435 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 3.4 tm-20 -57.42 -53.55 56.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.73 0.812 . . . . 75.23 111.742 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.404 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.6 t -57.74 -42.22 83.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.018 0.824 . . . . 73.24 110.935 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.53 HG22 ' SG ' ' D' ' 76' ' ' CYS . 60.6 mt -63.35 -54.15 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.348 -0.842 . . . . 72.51 110.642 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 48.0 m -54.02 -38.03 64.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 75.24 111.389 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -73.02 -44.49 60.83 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.062 -0.972 . . . . 73.2 110.462 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 73.4 mtm -65.2 -31.02 71.98 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.785 0.434 . . . . 71.24 111.803 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 79.4 t -66.36 -47.55 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 124.008 0.817 . . . . 74.02 109.771 176.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -70.49 -27.91 64.57 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 123.356 0.41 . . . . 75.32 111.06 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -73.5 -34.79 65.45 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.794 0.838 . . . . 73.13 110.044 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.45 -1.56 88.73 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.663 -0.698 . . . . 71.31 112.008 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 58.94 34.69 23.76 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.753 2.021 . . . . 73.34 112.784 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -96.45 163.58 20.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.489 -1.232 . . . . 71.31 108.287 170.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.28 139.62 72.77 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.02 1.814 . . . . 75.1 111.025 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -55.21 135.23 49.78 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.716 0.807 . . . . 73.31 112.189 -173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.493 HD23 HG21 ' D' ' 114' ' ' ILE . 58.7 tp -103.02 104.84 15.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.491 -0.929 . . . . 73.12 108.491 -175.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -98.42 84.5 3.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.205 -1.406 . . . . 75.42 107.205 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.512 HD21 HD13 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -63.78 115.41 4.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.07 -1.085 . . . . 74.43 108.07 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 135.35 90.67 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 124.153 0.908 . . . . 72.44 111.554 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 107.25 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.663 2.242 . . . . 73.02 111.567 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 m -107.33 144.38 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.69 0.796 . . . . 74.23 109.455 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -82.15 101.45 10.44 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.138 -0.69 . . . . 74.3 109.138 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -62.17 -31.9 72.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.733 0.813 . . . . 74.5 111.374 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -40.23 80.08 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.93 0.769 . . . . 72.31 110.33 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -34.17 77.13 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.111 0.564 . . . . 64.22 111.276 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.71 -32.51 57.88 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.622 -0.717 . . . . 74.12 109.566 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.28 -31.99 73.41 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.875 0.87 . . . . 73.31 110.412 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 14.2 mmt -57.52 -46.9 83.28 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.553 0.692 . . . . 73.41 109.187 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 20.3 m120 -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.467 -1.242 . . . . 75.31 111.2 -178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -59.23 -41.93 89.86 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.625 0.77 . . . . 75.22 111.237 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.44 -30.67 71.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.324 0.649 . . . . 74.13 111.066 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.66 3.35 29.33 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.63 0.772 . . . . 74.21 111.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 73.2 mt-30 -120.91 92.46 3.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.148 0.979 . . . . 74.1 109.331 -177.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -143.7 133.71 24.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.495 0.718 . . . . 71.23 109.687 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.5 168.81 17.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.924 0.89 . . . . 65.12 110.209 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.08 142.25 13.74 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.076 -0.81 . . . . 73.41 111.076 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -137.52 123.24 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.121 -1.066 . . . . 62.44 108.121 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.63 142.58 9.3 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 111.339 -0.705 . . . . 64.34 111.339 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.3 m -132.46 124.69 29.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.147 0.579 . . . . 74.34 110.065 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.84 159.86 32.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.338 0.655 . . . . 72.34 110.013 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -80.45 149.62 30.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.066 0.546 . . . . 72.02 110.245 -176.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -73.57 -34.95 65.38 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.447 -0.575 . . . . 72.02 109.447 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.6 104.61 0.94 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.065 -1.457 . . . . 72.02 107.065 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.84 103.62 10.8 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.103 -0.703 . . . . 45.05 109.103 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 C-N-CA 123.21 0.604 . . . . 73.44 110.185 179.327 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 119.848 -0.12 . . . . 71.21 110.75 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 66.58 28.87 9.18 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.55 1.14 . . . . 75.2 112.671 173.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.06 -16.93 1.64 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.01 0.524 . . . . 73.52 111.944 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.76 142.72 33.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.495 0.718 . . . . 75.23 109.46 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -65.68 127.5 32.16 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.928 0.768 . . . . 74.15 110.887 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -77.67 -77.21 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.068 -1.086 . . . . 73.04 108.068 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt 174.58 -46.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.103 1.361 . . . . 73.42 107.569 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.427 HD12 ' HE1' ' B' ' 56' ' ' TYR . 27.1 mt 50.38 75.14 0.19 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.96 1.413 . . . . 74.13 110.698 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . 0.432 ' HA ' HD12 ' B' ' 98' ' ' LEU . 72.6 t80 -166.65 136.33 2.47 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 115.493 -0.776 . . . . 75.15 109.211 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -54.05 133.85 57.12 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.919 2.413 . . . . 74.13 112.988 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.41 -40.29 25.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.054 1.342 . . . . 74.14 112.369 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 22.6 p -143.46 -55.16 0.39 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.331 1.052 . . . . 74.1 108.627 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 5.7 t90 80.43 -19.86 0.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 126.315 1.846 . . . . 71.1 110.48 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.87 -87.96 0.03 OUTLIER 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.774 1.63 . . . . 60.32 111.183 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.86 143.05 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.959 0.904 . . . . 74.4 109.13 -173.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . 0.648 ' HA ' ' HG ' ' B' ' 136' ' ' LEU . 8.1 p -74.47 94.19 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-O 122.292 1.044 . . . . 74.41 110.525 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -89.02 91.49 8.85 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.636 -0.875 . . . . 73.35 108.636 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -105.28 -171.2 1.87 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.919 -1.037 . . . . 64.53 108.951 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -74.43 4.15 6.4 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.106 0.78 . . . . 74.21 113.106 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.75 0.89 Allowed Glycine 0 C--N 1.351 1.406 0 N-CA-C 111.915 -0.474 . . . . 72.21 111.915 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.85 107.74 12.87 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.449 -0.574 . . . . 74.33 109.449 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . 0.448 HD12 HG13 ' E' ' 130' ' ' ILE . 0.0 OUTLIER -62.36 -20.67 64.64 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.192 0.997 . . . . 73.34 112.343 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.448 HG13 HD12 ' E' ' 129' ' ' LEU . 52.2 mt -66.24 95.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.347 1.059 . . . . 73.42 109.967 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.55 -43.84 46.51 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.991 0.516 . . . . 74.21 110.293 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.22 116.79 4.07 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.846 0.858 . . . . 75.42 109.153 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.52 164.78 10.8 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.481 2.121 . . . . 74.3 112.359 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.98 -45.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.152 0.581 . . . . 73.13 110.026 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.97 -34.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.712 1.605 . . . . 74.22 112.86 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t 68.56 12.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 125.366 1.466 . . . . 73.13 110.282 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 62.38 171.17 0.13 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 125.584 1.554 . . . . 75.41 113.064 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.54 115.52 5.84 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.885 -0.598 . . . . 72.5 109.665 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . 0.468 ' HG ' ' HG2' ' C' ' 38' ' ' PRO . 9.8 mp -65.55 89.33 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.875 0.734 . . . . 72.32 109.428 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 18.6 m -88.88 176.36 7.07 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.336 -1.302 . . . . 55.12 109.826 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 56.5 mt 68.39 5.04 4.53 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.624 1.17 . . . . 73.55 112.126 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 30.6 pt -78.1 -41.74 27.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 123.305 0.642 . . . . 75.33 109.554 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -160.41 119.09 2.64 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.141 1.776 . . . . 72.44 107.27 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.01 -73.4 0.23 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.943 -0.762 . . . . 72.43 108.943 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -144.96 -165.25 2.12 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.327 1.051 . . . . 71.11 109.112 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.28 -172.36 0.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.75 1.22 . . . . 73.31 111.303 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -152.73 -76.69 0.12 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.436 -1.32 . . . . 74.01 107.436 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.602 HD22 HD13 ' C' ' 136' ' ' LEU . 9.6 tt -161.68 96.28 1.28 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.523 -1.288 . . . . 71.34 107.523 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.561 1.866 0 C-N-CA 123.235 2.623 . . . . 74.13 111.258 174.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.704 -0.48 . . . . 74.32 109.704 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.48 103.89 5.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.584 0.753 . . . . 74.21 109.054 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.82 161.06 22.09 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.722 -0.473 . . . . 62.25 109.722 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.1 -170.09 2.15 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.246 1.018 . . . . 73.01 109.214 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 73.99 165.95 0.29 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.557 1.143 . . . . 74.42 111.798 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.89 149.04 21.58 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.135 -0.939 . . . . 72.13 110.22 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' F' ' 114' ' ' LYS . 0.4 OUTLIER -92.08 83.51 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.064 -1.087 . . . . 74.31 108.064 175.159 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.7 103.37 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.48 -0.782 . . . . 75.32 110.175 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -170.21 79.33 0.61 Allowed Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.113 0.883 . . . . 74.34 109.507 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.499 ' HG3' ' HE2' ' A' ' 94' ' ' MET . 73.2 Cg_endo -77.6 -52.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.429 2.086 . . . . 75.32 112.174 176.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -89.3 -171.76 3.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 75.31 109.108 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 76.1 m -134.63 -74.51 0.47 Allowed 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.086 0.554 . . . . 74.22 110.327 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -171.96 132.21 0.68 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.643 -1.243 . . . . 73.42 107.643 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.47 -161.11 0.57 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.974 0.51 . . . . 73.12 110.582 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.05 44.6 0.95 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.234 1.014 . . . . 51.54 112.189 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 16.1 t -84.54 71.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 N-CA-C 108.24 -1.022 . . . . 72.54 108.24 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -92.77 -52.61 4.54 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.539 -1.21 . . . . 75.01 109.156 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . 0.548 ' HH ' HG13 ' A' ' 131' ' ' VAL . 18.8 m-85 68.48 136.07 0.03 OUTLIER 'General case' 0 C--N 1.356 0.873 0 O-C-N 125.192 1.558 . . . . 73.53 112.817 -176.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -83.1 -172.01 3.89 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.172 -0.922 . . . . 73.12 109.111 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 41' ' ' LYS . . . -158.33 83.93 0.13 Allowed Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.533 -0.841 . . . . 64.52 115.117 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -131.83 20.61 4.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.249 1.02 . . . . 74.25 108.562 167.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 pp -85.85 138.27 32.16 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.844 -0.616 . . . . 75.24 111.229 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 tp -161.56 134.58 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.817 1.247 . . . . 75.24 107.782 174.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.13 -62.49 1.41 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.618 -0.512 . . . . 73.34 109.618 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -167.07 119.71 0.77 Allowed Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.307 -0.861 . . . . 74.42 109.07 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.35 79.03 3.2 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.836 2.357 . . . . 63.54 111.072 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.41 HG21 HG21 ' F' ' 136' ' ' VAL . 7.8 tt -62.33 141.75 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 115.729 -0.669 . . . . 75.33 110.146 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.17 79.91 0.34 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.375 0.67 . . . . 63.14 111.046 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.41 HG21 HG21 ' F' ' 134' ' ' ILE . 34.7 m -139.8 147.6 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.865 1.266 . . . . 74.25 108.781 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.37 -74.96 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.499 -1.297 . . . . 73.51 107.499 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.28 113.69 20.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.995 0.918 . . . . 70.05 109.003 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.422 ' HA ' ' HG3' ' D' ' 37' ' ' GLN . 28.5 tp -64.46 100.56 0.37 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.236 1.014 . . . . 74.51 110.755 177.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 25.6 m -94.72 -160.83 0.81 Allowed 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.362 -1.29 . . . . 75.14 109.353 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . 0.443 HD21 ' HG3' ' D' ' 39' ' ' GLU . 0.5 OUTLIER 70.77 34.43 2.01 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.29 1.036 . . . . 72.24 109.164 -177.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.57 ' HA ' ' HB ' ' D' ' 40' ' ' VAL . 14.8 mm -69.48 122.3 20.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-N 114.964 -1.016 . . . . 75.22 108.636 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 70.2 121.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.47 1.108 . . . . 75.05 110.571 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -68.99 -45.29 70.96 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.317 -0.623 . . . . 64.25 109.317 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . 0.628 ' HB3' ' HZ2' ' F' ' 145' ' ' LYS . 8.7 mtpm? -74.86 -82.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.22 -0.9 . . . . 72.43 110.472 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -169.98 148.59 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.366 0.666 . . . . 64.51 110.241 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . 0.408 HD23 HD11 ' F' ' 148' ' ' LEU . 6.4 tt -88.76 93.46 9.58 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.154 -1.054 . . . . 75.13 108.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . 0.408 HD11 HD23 ' F' ' 147' ' ' LEU . 9.9 mp 68.42 147.82 0.12 Allowed Pre-proline 0 N--CA 1.488 1.465 0 C-N-CA 124.516 1.127 . . . . 52.21 111.373 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--N 1.376 1.989 0 C-N-CA 122.339 2.026 . . . . 75.53 111.234 -178.584 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.131 -0.322 . . . . 72.31 110.131 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -84.06 107.38 16.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.624 0.77 . . . . 75.24 109.109 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.15 38.57 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 74.5 110.311 -170.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.22 133.6 54.71 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.515 0.726 . . . . 74.14 109.547 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -156.08 144.72 20.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.519 0.728 . . . . 73.41 109.27 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.07 134.65 30.06 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.103 -0.703 . . . . 72.03 109.103 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -145.47 -43.0 0.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.547 0.739 . . . . 62.23 109.417 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 63.3 98.26 0.04 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 125.366 1.466 . . . . 71.5 109.8 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.634 ' HB3' HG22 ' A' ' 89' ' ' ILE . 1.9 ppp? -160.36 162.3 33.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.589 0.756 . . . . 70.13 110.962 -174.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.407 HG23 ' H ' ' A' ' 154' ' ' ASP . 20.4 m -153.37 123.99 7.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.837 1.255 . . . . 75.22 109.064 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.58 130.44 53.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.621 -1.251 . . . . 75.54 107.621 167.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.609 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 30.9 tt0 -133.57 106.65 7.53 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.205 -0.665 . . . . 70.14 109.205 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -75.87 102.92 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.402 -1.333 . . . . 75.35 107.402 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.469 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 7.2 tp-100 -74.75 -43.16 56.38 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.796 -0.638 . . . . 72.35 110.8 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 178.36 156.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.281 1.032 . . . . 73.22 110.243 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.56 106.42 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.228 1.011 . . . . 72.43 108.555 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CD1' HG22 ' B' ' 122' ' ' THR . 77.0 m-85 -148.39 157.66 43.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.388 0.675 . . . . 75.15 110.604 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -73.72 120.69 19.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.033 0.933 . . . . 73.44 110.526 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -88.81 -22.58 23.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.983 -0.553 . . . . 72.54 110.743 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.556 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -154.86 141.86 19.24 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.937 0.773 . . . . 62.35 110.278 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 79.8 mt -143.19 141.62 26.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.539 1.536 . . . . 62.51 107.534 178.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -149.97 135.17 18.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.285 -1.006 . . . . 75.43 108.285 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 74.0 t80 -138.08 111.59 8.11 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 106.099 -1.815 . . . . 74.51 106.099 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.87 118.81 32.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.801 0.44 . . . . 65.1 110.183 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.69 75.07 32.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.694 0.797 . . . . 70.4 109.726 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.12 -27.56 29.37 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.47 2.113 . . . . 72.44 110.656 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.435 ' O ' HG21 ' A' ' 31' ' ' VAL . 57.7 m-20 -96.69 24.96 5.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.08 -1.418 . . . . 75.24 109.777 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.14 99.86 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.985 0.914 . . . . 72.4 112.829 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.469 ' HG2' ' HD1' ' A' ' 30' ' ' HIS . 43.3 Cg_endo -69.07 -16.35 40.38 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 121.714 1.609 . . . . 74.12 112.638 172.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.469 ' HD1' ' HG2' ' A' ' 29' ' ' PRO . 2.1 m80 -85.81 -20.5 29.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.662 0.785 . . . . 75.03 110.461 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 27' ' ' ASN . 46.3 t -68.97 -23.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.201 0.524 . . . . 73.53 110.459 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -67.98 -30.25 69.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.592 -0.731 . . . . 75.25 110.517 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -72.6 -30.39 64.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.964 0.906 . . . . 72.53 110.177 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -75.42 161.28 29.37 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.676 -0.693 . . . . 74.34 111.243 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.41 159.72 29.25 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.818 -1.083 . . . . 74.43 108.755 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.0 m-90 -82.82 57.25 3.74 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.322 0.582 . . . . 65.5 110.283 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -154.9 79.67 4.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.554 0.741 . . . . 72.54 109.406 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.98 155.89 23.29 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.202 1.935 . . . . 73.34 110.83 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.17 115.97 28.31 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.007 -1.109 . . . . 72.41 108.007 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 65' ' ' THR . 21.9 m -98.96 98.8 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.703 0.764 . . . . 74.33 110.921 -173.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.73 115.44 19.33 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.364 -0.976 . . . . 73.31 108.364 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 pt? -98.71 145.05 27.3 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.379 -0.6 . . . . 73.51 109.379 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.568 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.1 t70 -137.67 122.52 18.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.03 -1.1 . . . . 72.22 108.03 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.482 HD23 HG12 ' A' ' 131' ' ' VAL . 4.1 mp -102.62 118.12 36.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.837 -0.801 . . . . 72.24 108.837 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -132.12 137.27 47.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.484 0.714 . . . . 72.33 109.734 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.7 m -131.1 139.11 49.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.868 0.867 . . . . 75.22 109.631 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.76 115.32 5.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.668 0.787 . . . . 73.04 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.2 m -90.17 155.37 19.07 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.569 0.748 . . . . 74.54 110.51 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -149.57 161.15 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.534 1.134 . . . . 71.2 108.786 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -114.85 115.93 27.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.275 0.63 . . . . 71.51 109.719 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -90.04 -31.22 17.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.402 0.681 . . . . 72.54 111.471 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 -172.48 3.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.744 0.652 . . . . 74.43 110.365 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.74 105.65 1.03 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.209 1.003 . . . . 73.13 111.055 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 67.93 12.44 8.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.083 1.353 . . . . 74.44 112.733 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.33 106.86 19.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.48 -1.304 . . . . 75.45 107.48 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -113.16 123.96 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.967 -1.015 . . . . 74.35 109.146 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.7 119.86 38.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.147 -1.388 . . . . 75.0 108.548 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.24 123.61 53.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.676 -1.601 . . . . 75.12 106.676 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.422 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 99.4 t -104.19 130.0 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.635 -0.876 . . . . 75.22 108.635 173.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 113.14 26.49 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.574 -1.639 . . . . 75.21 106.574 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -100.22 101.99 13.15 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.969 -1.123 . . . . 74.02 107.969 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.3 t -95.11 126.79 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.278 -1.008 . . . . 74.53 108.278 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 23.2 m -110.55 133.95 52.84 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.24 105.85 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.166 -1.42 . . . . 64.33 107.166 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.0 m -103.78 130.35 51.3 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.732 -0.84 . . . . 72.31 108.732 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.36 109.69 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.147 -1.057 . . . . 73.22 108.147 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.3 m -136.61 128.5 29.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.035 -0.728 . . . . 63.51 109.035 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 tt -94.65 87.66 5.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.611 -1.625 . . . . 73.21 106.611 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.76 -121.3 5.4 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.528 -0.629 . . . . 64.32 111.528 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -90.8 -25.84 19.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.195 0.598 . . . . 75.35 111.602 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 125.79 34.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.774 -0.454 . . . . 74.53 109.774 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 m -74.36 134.37 42.48 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 115.776 -0.647 . . . . 64.35 109.658 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.63 -55.62 4.34 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -167.3 168.99 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.039 -0.982 . . . . 75.53 110.476 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.5 tp -132.52 143.68 49.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.644 1.178 . . . . 72.25 108.673 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.444 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 13.8 m -138.02 124.93 21.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.635 0.774 . . . . 64.14 109.432 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.41 125.77 23.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.106 -0.701 . . . . 73.23 109.106 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -131.89 114.69 25.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.979 0.912 . . . . 74.23 109.512 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.556 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 74.1 mt-30 -85.53 86.6 7.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.154 -0.93 . . . . 72.31 108.876 172.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.67 99.1 5.68 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.078 -0.965 . . . . 73.53 109.071 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.66 152.41 21.08 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.593 -0.603 . . . . 73.14 111.593 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.07 134.24 5.67 Favored Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.273 -1.131 . . . . 71.21 110.273 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 43.4 mt -87.85 125.71 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.255 -1.017 . . . . 72.24 108.255 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -131.82 120.23 22.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.609 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 48.3 t -92.2 100.83 13.37 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.177 -1.045 . . . . 73.33 108.177 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.425 HD11 HD23 ' A' ' 98' ' ' LEU . 50.5 pt -116.16 141.01 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.246 0.618 . . . . 74.13 110.515 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.39 174.32 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.115 0.966 . . . . 52.24 110.119 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 91.61 -32.1 5.47 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.129 -0.487 . . . . 71.32 112.791 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.634 HG22 ' HB3' ' A' ' 9' ' ' MET . 2.1 pp -112.47 156.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.872 0.869 . . . . 73.21 109.883 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.9 175.04 12.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.042 -0.725 . . . . 54.32 109.042 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.46 -144.52 37.41 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.871 -0.492 . . . . 54.33 111.871 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -65.41 -16.3 63.48 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.147 0.579 . . . . 75.2 112.151 -178.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.19 -54.55 31.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.832 0.853 . . . . 74.34 110.204 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.572 ' SD ' ' HB3' ' F' ' 115' ' ' LEU . 56.3 ttm -72.22 -34.62 68.48 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.451 -0.795 . . . . 74.41 110.761 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -65.12 -41.29 95.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.537 0.735 . . . . 74.32 111.63 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -59.76 -40.28 87.62 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.678 -0.692 . . . . 55.33 110.159 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.724 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 8.6 m -76.08 -37.34 58.31 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.598 0.962 . . . . 74.52 113.598 -172.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD23 HD11 ' A' ' 86' ' ' ILE . 89.1 mt -85.41 -15.45 43.04 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.93 0.332 . . . . 71.33 110.578 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.59 -28.65 9.4 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.399 -0.667 . . . . 73.34 113.56 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.06 -55.71 0.71 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.255 1.027 . . . . 73.24 113.153 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.724 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.4 t80 -50.64 -65.04 0.63 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.722 0.809 . . . . 74.33 111.699 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.4 m -64.46 -45.67 77.42 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 118.209 -0.9 . . . . 63.32 112.848 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.68 -41.34 54.28 Favored 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.181 1.921 . . . . 73.31 113.69 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.417 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 21.4 t-20 -71.78 -32.24 67.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.371 0.669 . . . . 75.21 110.52 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 101' ' ' TYR . 24.3 mm -65.37 -35.27 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.781 0.832 . . . . 75.24 110.487 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -80.69 -20.42 42.97 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.168 0.987 . . . . 74.43 111.471 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.459 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 25.8 t80 -67.63 -43.39 40.18 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 114.263 1.209 . . . . 75.1 114.263 -168.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 36.3 Cg_exo -62.13 -34.89 78.12 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.78 1.653 . . . . 75.22 112.425 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -74.25 -40.99 62.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.445 0.698 . . . . 75.34 111.593 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.75 82.62 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.789 0.436 . . . . 72.13 109.923 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.501 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.5 ttm180 -53.88 -51.68 62.89 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.509 1.131 . . . . 75.44 110.164 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.72 -46.15 90.91 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.181 0.925 . . . . 72.11 110.881 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -57.75 -48.75 78.75 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.898 0.749 . . . . 64.12 110.773 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.438 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -61.93 -50.62 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.063 0.945 . . . . 73.15 110.499 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.542 HG21 ' HG3' ' A' ' 125' ' ' GLN . 87.2 m -57.24 -41.42 79.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.722 0.809 . . . . 61.35 111.33 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.14 -40.71 82.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.284 -0.871 . . . . 72.41 109.691 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.422 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 16.4 mtp -59.14 -42.06 89.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 73.15 110.951 174.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -63.65 -45.83 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.006 0.922 . . . . 73.2 110.952 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.4 p -73.88 -28.86 61.77 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.923 0.489 . . . . 73.11 111.429 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -72.38 -28.42 62.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.504 0.721 . . . . 74.42 109.264 172.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.17 89.05 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.456 -0.793 . . . . 75.33 112.831 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.5 m 68.67 17.14 8.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.651 1.181 . . . . 52.31 111.515 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -92.03 161.01 34.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 74.22 110.739 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.62 123.88 14.77 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.469 2.113 . . . . 55.1 111.176 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.542 ' HG3' HG21 ' A' ' 115' ' ' THR . 30.2 tt0 -54.45 141.3 31.27 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.869 1.268 . . . . 61.3 112.96 -175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 82.3 mt -125.63 96.11 4.67 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.593 0.757 . . . . 71.45 109.563 -177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.2 105.45 17.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.713 -0.847 . . . . 73.45 108.713 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.459 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -62.73 130.14 43.63 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.651 0.594 . . . . 71.41 110.0 -174.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.411 ' HB1' ' HE1' ' F' ' 125' ' ' TYR . . . -69.67 144.92 94.42 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 122.908 0.483 . . . . 63.43 111.2 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.574 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 73.7 Cg_exo -54.62 144.52 63.66 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 124.152 3.235 . . . . 74.4 115.153 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.482 HG12 HD23 ' A' ' 44' ' ' LEU . 31.5 m -115.98 115.06 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.81 0.844 . . . . 71.3 109.873 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 9.5 m120 -89.41 65.72 7.21 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.625 0.77 . . . . 74.13 109.0 174.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.61 -33.11 41.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.384 -0.826 . . . . 75.32 109.857 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 138' ' ' MET . 5.6 m-20 -58.62 -46.51 86.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 75.54 110.037 171.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.413 ' HB2' ' HB3' ' A' ' 132' ' ' ASN . . . -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.407 0.683 . . . . 72.3 111.649 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.59 -36.42 76.21 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.948 0.78 . . . . 75.12 110.83 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -68.32 -49.47 60.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.792 -0.64 . . . . 63.35 110.421 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 33.8 mmt -57.09 -44.95 83.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.573 0.749 . . . . 71.12 112.92 -170.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.724 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 10.8 p30 -68.04 -34.89 77.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.763 0.316 . . . . 75.13 111.702 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.01 -45.13 59.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.583 -0.735 . . . . 74.14 109.807 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.16 -47.87 66.87 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 73.43 112.108 -172.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -149.78 -13.03 0.28 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.255 0.465 . . . . 73.13 112.255 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.724 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 59.5 tt0 63.47 -78.27 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.174 1.39 . . . . 64.12 110.629 -168.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.57 80.32 8.06 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.431 -0.951 . . . . 75.02 108.431 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.85 109.16 5.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.738 -0.665 . . . . 75.13 110.308 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.63 140.49 42.71 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.738 0.649 . . . . 72.13 113.023 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.9 141.19 58.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.39 0.676 . . . . 74.24 111.26 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.11 122.01 2.01 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.044 -0.526 . . . . 54.13 111.896 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.7 p -98.12 164.08 12.48 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.541 0.736 . . . . 73.23 110.239 173.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.81 172.78 9.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.777 0.831 . . . . 70.23 111.154 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.13 -56.26 2.6 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.721 -1.214 . . . . 64.32 107.721 168.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -158.86 -175.5 5.33 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 75.53 110.207 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -134.32 175.22 9.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.309 1.443 . . . . 63.3 108.608 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.407 ' H ' HG23 ' A' ' 10' ' ' THR . 5.5 m-20 58.55 20.79 7.93 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.142 0.977 . . . . 61.21 111.192 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.395 1.078 . . . . 74.41 108.882 -174.15 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.42 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.264 -0.643 . . . . 73.14 109.264 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 55.4 p -108.78 113.88 27.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.373 0.669 . . . . 73.34 109.625 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.67 97.08 1.29 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.902 -0.777 . . . . 72.42 108.902 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -131.53 11.63 4.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.043 0.937 . . . . 75.32 109.491 173.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -133.26 -86.43 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.723 0.809 . . . . 75.33 109.131 -164.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -176.54 80.3 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.099 1.36 . . . . 73.22 108.651 168.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -150.47 -172.2 4.12 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.926 -0.579 . . . . 73.13 109.895 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 68.82 137.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.903 1.281 . . . . 72.23 111.217 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm 51.67 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.16 1.784 . . . . 74.15 115.036 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -134.68 127.03 30.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.363 -1.347 . . . . 74.13 107.363 169.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -121.98 146.86 46.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.635 -0.876 . . . . 73.4 108.635 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.536 ' HA ' ' HG ' ' F' ' 147' ' ' LEU . 23.9 tt0 -166.81 142.54 4.39 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.932 0.77 . . . . 75.42 110.145 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.07 120.41 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.393 -0.966 . . . . 75.01 108.393 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -79.88 -47.31 15.3 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.948 -0.39 . . . . 75.31 109.948 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -164.47 145.34 8.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.92 -0.582 . . . . 72.35 109.83 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -118.05 150.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 106.851 -1.537 . . . . 75.34 106.851 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -168.75 145.61 3.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.832 0.453 . . . . 74.43 111.172 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.3 m -73.04 117.24 14.53 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.037 -1.097 . . . . 74.52 108.037 167.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -83.94 -42.98 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.829 -0.623 . . . . 74.02 110.2 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 25.9 t70 -144.81 142.03 29.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.028 -0.533 . . . . 63.21 111.578 -168.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.516 HG22 ' HE1' ' B' ' 117' ' ' MET . 43.3 mm -137.15 142.96 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.091 1.357 . . . . 73.54 108.053 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -141.35 137.97 32.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.924 -1.51 . . . . 73.33 106.924 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.404 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.2 t80 -152.01 110.04 3.69 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.778 -1.193 . . . . 73.52 107.778 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -118.72 111.89 19.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.869 -0.789 . . . . 74.04 108.869 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.558 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -108.8 85.92 3.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 109.116 -0.698 . . . . 75.12 109.116 170.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.8 -22.85 36.19 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.024 2.483 . . . . 72.3 110.8 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -125.03 29.89 6.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.88 1.272 . . . . 75.35 109.617 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.558 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -46.27 -48.11 45.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 125.191 1.397 . . . . 61.13 113.365 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.5 Cg_endo -84.65 -15.06 6.24 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.364 2.043 . . . . 74.12 112.771 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.92 -0.32 47.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.232 0.613 . . . . 63.43 111.6 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.444 HG22 HD11 ' B' ' 68' ' ' LEU . 11.2 p -69.46 -31.13 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.225 0.61 . . . . 75.5 110.919 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -71.66 -40.6 69.54 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.551 0.74 . . . . 73.43 110.96 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -81.1 -8.32 59.74 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.372 -0.831 . . . . 71.11 111.264 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.437 ' HD2' HD23 ' B' ' 68' ' ' LEU . 5.8 mmtp -100.13 109.1 21.38 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.057 0.943 . . . . 75.03 109.98 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -96.0 75.89 3.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.59 0.756 . . . . 75.13 111.903 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.465 ' HB2' HD22 ' B' ' 68' ' ' LEU . 4.8 m-90 -153.76 172.28 17.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.47 1.508 . . . . 74.01 107.159 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -90.24 119.49 69.22 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.655 -0.869 . . . . 64.42 108.655 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.19 102.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.117 2.544 . . . . 75.01 112.214 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.83 102.55 1.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.042 -0.526 . . . . 72.41 109.826 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.57 121.38 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 73.34 110.121 -175.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -118.86 123.68 45.31 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.856 1.262 . . . . 75.34 108.52 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.447 HD22 HD22 ' B' ' 128' ' ' LEU . 6.4 mp -92.72 158.88 15.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.3 0.64 . . . . 74.31 110.279 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.59 110.76 3.68 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.948 -1.13 . . . . 72.11 107.948 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -104.99 150.19 25.13 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.37 0.605 . . . . 71.24 110.063 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -138.16 128.12 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.447 -1.252 . . . . 74.32 108.643 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -110.35 108.15 18.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.505 0.722 . . . . 74.43 109.335 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.54 153.94 33.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.242 1.017 . . . . 71.41 109.492 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -143.57 162.98 34.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.32 0.648 . . . . 64.02 109.508 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.7 p -150.6 150.4 31.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.161 0.584 . . . . 73.13 109.658 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -84.56 112.6 20.57 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.847 -0.797 . . . . 75.14 108.847 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -88.93 -54.2 4.24 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.724 -0.473 . . . . 71.01 109.724 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -170.24 3.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.784 0.834 . . . . 75.01 110.004 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.84 117.38 7.46 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.19 -0.914 . . . . 74.41 110.19 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 71.41 -2.27 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.456 1.503 . . . . 63.44 112.092 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -106.51 103.15 14.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.784 0.833 . . . . 74.03 109.448 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -108.65 141.39 40.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.85 0.86 . . . . 73.22 109.641 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -99.64 102.52 14.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.393 -0.965 . . . . 74.23 108.393 172.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.05 118.56 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.565 -0.902 . . . . 73.01 108.565 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.5 t -104.82 119.57 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.721 0.808 . . . . 74.15 109.164 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.24 129.45 39.29 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.674 -1.602 . . . . 74.41 106.674 171.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 24.7 ttp180 -121.31 108.25 13.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.723 -0.843 . . . . 74.01 108.723 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.509 ' HB ' HD11 ' B' ' 114' ' ' ILE . 19.9 t -105.17 120.04 55.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.865 -1.161 . . . . 62.44 107.865 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -113.54 126.96 55.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 73.54 108.962 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.586 HG22 HG21 ' B' ' 114' ' ' ILE . 42.0 t -113.65 119.26 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.432 1.093 . . . . 72.22 109.153 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -118.31 140.33 49.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.327 -0.99 . . . . 72.41 108.327 170.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.87 143.41 50.14 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.053 -1.091 . . . . 64.35 108.053 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.4 p -130.71 130.35 43.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.771 -0.455 . . . . 73.51 109.771 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.465 HD22 ' HB2' ' B' ' 36' ' ' TRP . 0.8 OUTLIER -110.31 112.66 24.76 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.146 -1.057 . . . . 73.34 108.146 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.69 -113.3 3.77 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.331 -1.107 . . . . 75.33 110.331 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.62 5.5 10.57 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.811 0.844 . . . . 74.43 111.164 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -114.43 166.84 11.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.523 0.729 . . . . 74.31 109.245 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 33.5 m -69.59 135.63 50.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.035 0.534 . . . . 72.42 110.707 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' B' ' 68' ' ' LEU . . . -87.31 -58.66 2.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.5 -1.296 . . . . 73.22 107.5 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -156.95 163.69 38.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.617 -1.174 . . . . 65.14 109.956 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 73.6 mt -124.74 143.27 50.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.822 -1.547 . . . . 74.53 106.822 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.3 151.89 29.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.507 -0.923 . . . . 60.32 108.507 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.1 tt0 -165.16 130.99 2.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.049 -0.723 . . . . 73.44 109.049 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.419 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.2 t -125.17 144.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 74.22 109.369 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.477 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 25.7 mt-30 -121.14 94.62 4.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.62 -1.252 . . . . 72.25 107.62 169.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -85.39 100.44 11.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.57 -0.9 . . . . 64.23 108.57 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.86 162.92 31.71 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.149 -0.78 . . . . 64.12 111.149 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.37 127.5 1.75 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.619 -0.592 . . . . 71.41 111.619 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.6 mt -85.08 126.0 40.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.691 0.796 . . . . 74.05 109.162 174.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.29 134.04 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.026 0.931 . . . . 71.41 108.748 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -100.98 100.56 11.19 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.029 0.932 . . . . 63.52 108.727 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.516 HG13 HD12 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -121.61 143.04 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.092 0.957 . . . . 71.52 110.813 -177.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.57 159.17 43.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 72.54 109.709 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.54 -44.42 2.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.359 0.412 . . . . 75.01 112.692 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.467 HG22 ' HB3' ' B' ' 93' ' ' GLN . 13.1 pt -65.64 140.27 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 74.04 111.828 177.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -151.65 152.01 32.24 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.351 1.06 . . . . 52.44 108.36 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.619 ' HA2' ' HD2' ' E' ' 117' ' ' PRO . . . 58.92 -113.87 5.49 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 124.027 0.829 . . . . 65.11 113.284 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 68.4 m -65.79 -40.55 92.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.49 1.116 . . . . 73.11 111.609 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.467 ' HB3' HG22 ' B' ' 89' ' ' ILE . 90.0 mt-30 -65.81 -43.69 87.89 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.835 0.454 . . . . 72.11 111.172 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.584 ' HE2' ' HB2' ' E' ' 115' ' ' LEU . 14.2 tpt -69.37 -35.5 75.9 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.562 -0.745 . . . . 74.25 110.676 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 -24.96 59.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.289 -0.869 . . . . 71.23 110.99 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.425 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 25.8 t-80 -81.97 -29.54 32.1 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.274 0.63 . . . . 74.23 110.59 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -78.91 -68.09 0.69 Allowed 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 109.458 -0.571 . . . . 75.13 109.458 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.516 HD12 HG13 ' B' ' 86' ' ' ILE . 8.4 mp -73.5 -25.99 60.69 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.924 0.489 . . . . 70.23 112.289 -173.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.2 -30.13 23.39 Favored Glycine 0 C--N 1.334 0.457 0 O-C-N 123.368 0.417 . . . . 71.04 113.018 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -123.44 -56.58 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.734 0.642 . . . . 71.1 112.734 -170.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -72.94 -49.18 30.91 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.295 0.48 . . . . 75.11 112.295 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.3 m -60.39 -47.81 95.47 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.263 1.025 . . . . 71.03 111.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.555 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 72.7 Cg_exo -56.5 -37.77 96.66 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.985 1.79 . . . . 74.12 113.102 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.4 -29.94 70.21 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 75.31 110.892 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.39 -49.23 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.654 0.781 . . . . 74.25 109.774 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.83 -12.61 59.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 73.25 111.942 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.05 -48.0 61.37 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 118.141 -0.933 . . . . 74.22 112.944 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.46 -33.43 97.29 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.023 1.816 . . . . 74.52 113.488 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.407 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 53.8 m-85 -71.08 -44.47 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.426 0.69 . . . . 75.33 110.556 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.2 -38.77 92.5 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.883 0.873 . . . . 74.21 110.193 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.455 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 57.4 ttt-85 -60.3 -57.02 14.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.487 1.515 . . . . 73.42 111.087 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -58.38 -33.49 69.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.923 0.889 . . . . 74.03 110.89 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.472 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.3 m -63.31 -54.94 29.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.312 0.645 . . . . 65.14 111.38 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.586 HG21 HG22 ' B' ' 64' ' ' VAL . 57.6 mt -58.86 -54.53 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.233 0.613 . . . . 74.12 110.05 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.3 m -55.9 -39.26 71.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.762 1.225 . . . . 71.25 111.663 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.4 t -62.04 -50.67 71.06 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 115.788 -0.642 . . . . 74.32 110.094 176.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.516 ' HE1' HG22 ' B' ' 21' ' ' ILE . 17.0 mmt -65.74 -33.71 76.49 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.441 0.696 . . . . 75.13 111.522 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.404 HG23 ' O ' ' B' ' 114' ' ' ILE . 76.9 t -63.26 -46.57 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.886 0.874 . . . . 73.52 110.192 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' B' ' 123' ' ' PHE . 23.3 m -68.35 -28.92 67.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.653 -0.703 . . . . 74.14 111.481 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 96.1 mtt-85 -72.3 -16.08 61.9 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 115.621 -0.718 . . . . 64.2 110.708 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.15 15.89 59.9 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.657 -1.079 . . . . 70.13 115.476 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.448 HG22 ' CD1' ' A' ' 17' ' ' TYR . 15.5 p 79.56 13.17 1.1 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 126.576 1.95 . . . . 74.31 112.507 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.426 ' O ' ' HA ' ' B' ' 119' ' ' SER . 96.6 m-85 -103.63 153.7 38.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 122.811 0.444 . . . . 72.32 110.597 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.08 153.26 59.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.856 2.371 . . . . 75.12 112.296 172.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.589 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 1.1 mp0 -64.86 115.11 5.0 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.445 0.465 . . . . 73.42 110.227 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -108.12 85.65 2.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.983 -1.117 . . . . 65.22 107.983 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -92.37 132.63 36.59 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.045 -0.979 . . . . 74.11 109.07 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.46 ' HA ' HD11 ' E' ' 129' ' ' LEU . 30.5 mt -81.0 147.85 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.42 -0.809 . . . . 71.24 111.439 -169.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.58 147.94 50.67 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.519 0.728 . . . . 72.1 109.639 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.85 97.9 0.41 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.912 2.408 . . . . 64.1 111.474 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.87 111.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 107.92 -1.141 . . . . 74.4 107.92 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.18 100.62 1.31 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.4 -0.818 . . . . 74.02 110.159 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -59.45 -33.2 70.99 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.115 -0.948 . . . . 75.44 109.649 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -65.13 -39.01 92.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.611 1.564 . . . . 75.21 112.175 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.12 73.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.791 0.436 . . . . 72.42 110.434 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.91 -36.95 67.37 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.061 -0.972 . . . . 74.32 109.615 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.93 -43.46 87.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.253 1.021 . . . . 73.23 109.758 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.01 -36.79 77.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.257 1.023 . . . . 72.24 110.343 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -74.46 -21.52 59.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.339 -1.3 . . . . 74.12 111.086 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -65.06 -47.27 77.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.488 0.715 . . . . 63.23 110.34 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.97 20.19 6.96 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.494 0.718 . . . . 71.15 110.555 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 64.5 -166.96 0.22 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 124.799 1.24 . . . . 74.3 112.106 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -108.85 165.54 11.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 65.5 110.125 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -121.71 -78.91 0.6 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.325 0.65 . . . . 74.41 110.422 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.35 170.89 0.16 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.44 1.096 . . . . 74.32 112.132 -171.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.63 -150.91 5.86 Favored Glycine 0 C--O 1.238 0.396 0 CA-C-N 115.316 -0.857 . . . . 75.13 111.67 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.13 -177.94 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 73.23 110.59 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.65 165.26 29.16 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.417 -0.673 . . . . 72.22 111.417 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.5 p -113.91 158.62 20.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.701 . . . . 72.31 111.099 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.49 143.04 44.31 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 106.901 -1.518 . . . . 73.24 106.901 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.11 152.49 30.77 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.904 0.482 . . . . 63.13 111.76 -171.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -151.95 81.51 1.27 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.415 1.086 . . . . 74.04 108.724 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 134.59 51.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.332 -0.988 . . . . 65.44 108.332 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -72.56 135.98 45.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.576 0.351 . . . . 74.35 110.656 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.761 0.824 . . . . 72.25 109.985 177.66 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.833 -0.062 . . . . 53.44 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t -152.44 -49.3 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.512 -0.28 . . . . 72.1 111.558 -172.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 58.03 81.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.967 0.907 . . . . 73.34 109.554 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.606 ' HB2' ' H ' ' C' ' 149' ' ' THR . 22.4 mp0 -70.26 126.47 29.76 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.845 -0.616 . . . . 64.34 109.986 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -64.71 111.64 2.85 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.169 0.918 . . . . 75.04 111.242 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -68.45 145.06 54.43 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.711 1.204 . . . . 63.05 111.114 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -155.91 154.98 32.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.479 0.712 . . . . 63.32 109.685 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' C' ' 141' ' ' LEU . 35.9 tt0 57.58 88.06 0.06 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.925 1.29 . . . . 71.21 111.823 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.474 ' HG3' HG12 ' C' ' 89' ' ' ILE . 28.0 ttt 64.71 116.46 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.09 1.356 . . . . 75.34 112.784 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 44.0 m -115.62 88.42 2.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.638 -0.71 . . . . 74.01 109.217 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.574 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 73.5 t80 -97.63 129.96 44.69 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.62 -0.882 . . . . 74.21 108.62 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -139.89 125.73 19.53 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.277 0.631 . . . . 74.15 109.367 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.3 mt -77.67 119.99 27.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.702 -0.851 . . . . 74.44 108.702 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 32.5 mm-40 -83.95 -49.32 9.09 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.641 0.377 . . . . 74.42 110.038 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.608 HH22 HG23 ' F' ' 134' ' ' ILE . 50.7 ttt180 -170.09 145.36 2.83 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.682 0.614 . . . . 73.32 109.741 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -133.11 133.95 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 34.2 p90 -167.47 162.68 14.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.901 0.858 . . . . 75.3 111.676 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -83.38 120.52 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.064 -0.971 . . . . 71.45 109.462 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -73.35 -49.33 27.86 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.527 -0.916 . . . . 74.32 108.527 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.1 t70 -134.3 139.26 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.681 -1.145 . . . . 71.31 109.412 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -137.2 138.24 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.097 -1.446 . . . . 74.43 107.097 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 38.9 t -152.11 149.87 29.28 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.479 0.712 . . . . 73.21 109.118 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -155.67 138.47 15.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.08 -1.081 . . . . 75.45 108.08 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 56.4 mt-10 -135.1 148.25 49.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.284 1.034 . . . . 75.54 108.452 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.98 85.5 3.55 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 106.963 -1.495 . . . . 74.15 106.963 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 -50.12 4.15 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.328 2.018 . . . . 75.02 111.144 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.48 35.68 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.025 0.93 . . . . 64.42 110.517 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.3 -50.37 88.46 Favored Pre-proline 0 CA--C 1.565 1.519 0 C-N-CA 124.441 1.096 . . . . 75.15 113.81 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.81 -25.08 20.6 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 121.642 1.561 . . . . 72.04 112.126 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -67.93 -19.57 64.99 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.96 1.304 . . . . 74.33 112.809 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.17 -25.44 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 113.621 0.971 . . . . 75.21 113.621 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -65.79 -40.42 91.93 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.212 0.529 . . . . 75.2 110.667 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -98.75 13.59 31.73 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.258 1.023 . . . . 74.4 110.413 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.477 ' HZ1' ' HB2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -77.95 136.7 38.03 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.325 -0.62 . . . . 75.13 109.325 -176.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -85.05 92.58 8.39 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.327 -1.731 . . . . 65.11 106.327 168.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -75.34 89.28 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.763 0.792 . . . . 74.52 112.028 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -150.27 67.74 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.018 -1.104 . . . . 44.31 108.018 163.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -91.85 154.46 3.38 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.651 2.234 . . . . 72.44 111.747 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -86.82 118.35 26.16 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.85 -0.796 . . . . 74.04 108.85 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.78 97.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.177 -1.046 . . . . 74.42 108.177 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.509 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 53.0 mtpt -95.2 101.28 13.01 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.342 -0.984 . . . . 73.34 108.342 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.546 HD23 HG21 ' C' ' 64' ' ' VAL . 2.9 tm? -102.13 129.77 48.57 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.116 -1.068 . . . . 74.14 108.116 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.31 131.92 45.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.048 0.939 . . . . 55.23 108.83 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 99.3 mt -123.78 148.47 46.63 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.825 0.85 . . . . 75.11 109.384 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.21 125.43 8.02 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.74 -0.837 . . . . 74.13 108.74 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -113.4 147.72 37.2 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.569 -0.53 . . . . 70.43 109.569 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.06 42.74 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.209 1.004 . . . . 75.44 108.435 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -137.8 145.96 42.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.722 0.409 . . . . 74.21 110.259 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.1 p -145.0 129.81 18.21 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.625 0.77 . . . . 72.33 109.691 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -74.36 118.18 17.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.026 0.53 . . . . 70.23 109.881 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.454 HD13 HD13 ' C' ' 83' ' ' ILE . 74.2 mt -84.67 -40.61 17.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.145 0.578 . . . . 73.55 109.774 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.09 -178.94 7.67 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.092 . . . . 73.3 109.399 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -62.75 124.87 22.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.967 -0.56 . . . . 53.01 109.993 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.03 -5.98 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.288 1.435 . . . . 73.44 111.944 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.28 114.78 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.061 0.944 . . . . 74.32 109.697 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.93 125.5 35.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.18 0.992 . . . . 70.14 108.869 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -95.39 121.19 36.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.997 0.919 . . . . 71.33 109.935 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.73 132.41 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.596 -0.89 . . . . 73.24 108.596 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -126.28 112.53 30.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 124.164 0.985 . . . . 64.3 108.777 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.95 111.72 23.64 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.319 -0.993 . . . . 73.42 108.319 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.82 107.33 12.51 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.114 -0.699 . . . . 75.34 109.114 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -100.76 127.2 54.12 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 CA-C-N 114.956 -1.02 . . . . 72.15 108.408 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 48.4 m -131.43 130.23 42.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.405 -0.591 . . . . 74.24 109.405 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.546 HG21 HD23 ' C' ' 42' ' ' LEU . 86.0 t -120.11 120.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.11 109.302 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.509 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -114.45 130.0 56.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.544 -0.909 . . . . 75.5 108.544 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.33 93.62 4.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.904 -1.517 . . . . 75.12 106.904 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 78.7 p -158.56 140.42 13.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.282 0.633 . . . . 72.23 109.565 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.1 tp -77.99 -32.97 51.5 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.291 -0.633 . . . . 74.11 109.291 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.82 -82.67 0.06 OUTLIER Glycine 0 C--N 1.345 1.059 0 N-CA-C 110.4 -1.08 . . . . 74.12 110.4 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.88 -31.79 16.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.185 0.594 . . . . 71.11 109.841 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.46 96.08 7.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.22 0.608 . . . . 73.44 109.789 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -90.69 133.63 35.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.274 -0.876 . . . . 74.43 110.929 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.2 -56.91 3.76 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.406 -0.961 . . . . 75.2 108.406 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -160.74 175.34 12.72 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.745 -1.116 . . . . 75.23 111.952 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.605 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.5 tm? -141.29 146.65 37.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.387 1.875 . . . . 72.22 105.95 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' C' ' 114' ' ' ILE . 49.5 t -152.78 153.55 33.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.274 0.629 . . . . 50.12 109.315 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -159.64 136.47 9.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.707 0.403 . . . . 65.14 111.128 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' C' ' 110' ' ' ALA . 45.8 t -140.78 113.49 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.518 1.127 . . . . 72.41 108.881 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 66.1 mt-30 -91.97 97.76 11.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.252 -1.018 . . . . 73.43 108.252 173.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.501 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 6.8 tp-100 -86.56 114.16 23.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.514 0.726 . . . . 74.04 109.755 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.27 145.07 15.86 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.201 -0.359 . . . . 74.32 112.201 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.527 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -146.72 132.81 4.55 Favored Glycine 0 CA--C 1.504 -0.601 0 N-CA-C 111.839 -0.504 . . . . 75.13 111.839 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.454 HD13 HD13 ' C' ' 51' ' ' LEU . 7.8 mm -87.29 121.59 38.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.226 -1.027 . . . . 74.31 108.226 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.34 123.8 26.06 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.607 0.763 . . . . 73.12 109.569 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 36.5 p -97.75 125.46 42.58 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.84 0.456 . . . . 74.43 110.167 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.77 132.74 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.381 -0.97 . . . . 75.14 108.381 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.448 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -137.01 147.79 46.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.581 0.752 . . . . 63.33 109.755 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.1 -53.02 3.89 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.936 -0.574 . . . . 60.11 111.726 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' C' ' 9' ' ' MET . 2.9 pp -96.78 164.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.858 0.863 . . . . 71.42 111.487 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -168.41 -170.62 1.29 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.891 1.276 . . . . 74.44 109.264 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.09 -121.98 26.13 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 119.77 -0.461 . . . . 74.51 113.427 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 18.2 p -65.22 -33.21 75.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.943 0.897 . . . . 73.24 112.281 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.57 -42.49 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.908 0.483 . . . . 74.52 110.908 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptm -76.1 -24.93 55.03 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.005 0.19 . . . . 74.31 110.644 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.88 -43.7 78.74 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.165 0.507 . . . . 75.12 110.269 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -67.79 -34.36 76.63 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.268 -0.878 . . . . 71.55 110.805 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.88 -54.8 11.83 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.767 0.427 . . . . 75.01 110.478 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.488 HD21 ' SG ' ' C' ' 102' ' ' CYS . 63.8 mt -76.45 -14.53 60.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.648 0.779 . . . . 71.35 111.569 -177.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.48 -29.88 8.52 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.388 0.43 . . . . 75.12 113.483 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.3 -59.39 1.98 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.094 0.558 . . . . 74.01 110.93 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.402 ' O ' HG12 ' C' ' 105' ' ' ILE . 62.0 t80 -72.66 -55.43 6.83 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.206 0.941 . . . . 73.32 111.721 -164.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.488 ' SG ' HD21 ' C' ' 98' ' ' LEU . 61.0 m -58.45 -48.06 97.64 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 124.073 0.949 . . . . 72.25 112.804 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.5 Cg_exo -59.38 -34.25 97.55 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.296 1.998 . . . . 71.32 113.082 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.539 HD22 ' HB ' ' C' ' 131' ' ' VAL . 38.5 t-20 -70.79 -33.85 71.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.64 0.776 . . . . 73.15 110.308 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.501 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -66.85 -42.17 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 122.851 0.46 . . . . 72.21 109.842 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.527 HD23 ' HA3' ' C' ' 82' ' ' GLY . 95.9 mt -68.88 -32.19 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.053 -0.976 . . . . 74.55 111.408 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.66 -53.52 59.39 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.315 1.228 . . . . 73.1 114.315 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.58 -34.41 95.3 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.325 2.016 . . . . 73.45 113.541 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -67.96 -45.72 73.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.541 0.737 . . . . 72.31 110.469 179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -66.59 -35.71 80.87 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.421 -0.809 . . . . 74.24 110.946 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -65.32 -46.77 78.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.96 1.304 . . . . 72.34 110.363 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.406 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -68.39 -35.59 77.91 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 70.44 109.779 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.6 t -68.65 -31.39 70.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.884 0.473 . . . . 75.3 111.351 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.536 HG23 HG22 ' C' ' 64' ' ' VAL . 63.3 mt -74.32 -47.92 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 74.41 110.162 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.4 m -63.48 -28.92 70.29 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.063 0.545 . . . . 75.15 110.746 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.3 t -69.2 -46.75 66.68 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 123.861 0.865 . . . . 64.51 109.559 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.646 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.58 -39.9 89.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.214 1.005 . . . . 75.54 112.256 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 79.6 t -67.71 -38.78 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.95 0.9 . . . . 72.11 110.254 176.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.589 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 40.4 t -65.22 -37.66 87.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.564 -0.744 . . . . 74.43 111.069 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.5 mtt-85 -68.64 -35.89 77.87 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.247 -0.888 . . . . 71.14 109.469 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.55 1.91 80.46 Favored Glycine 0 C--N 1.354 1.54 0 O-C-N 123.801 0.688 . . . . 74.44 113.339 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 55.53 60.99 3.04 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.746 1.618 . . . . 33.51 111.853 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.434 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 86.7 m-85 -124.04 163.76 33.64 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 124.89 1.276 . . . . 75.1 108.822 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.676 ' HG3' ' HB ' ' E' ' 136' ' ' VAL . 97.2 Cg_endo -74.33 -169.26 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.948 2.432 . . . . 72.22 113.484 -174.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.409 ' HB3' ' OD1' ' C' ' 127' ' ' ASN . 21.0 mm-40 -54.41 112.02 0.91 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.059 -0.973 . . . . 73.23 111.591 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.454 HD13 HG12 ' C' ' 64' ' ' VAL . 3.1 tm? -108.07 87.01 2.4 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.426 -2.064 . . . . 74.3 105.426 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.409 ' OD1' ' HB3' ' C' ' 125' ' ' GLN . 12.1 m120 -95.31 97.53 9.92 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.311 -0.996 . . . . 64.05 108.311 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.488 HD22 ' H ' ' C' ' 129' ' ' ALA . 1.2 tt -63.6 149.21 46.93 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.205 -0.907 . . . . 73.42 108.99 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.488 ' H ' HD22 ' C' ' 128' ' ' LEU . . . -49.54 153.09 2.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.68 1.192 . . . . 74.53 112.76 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.11 -158.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.417 2.745 . . . . 70.01 114.959 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.539 ' HB ' HD22 ' C' ' 104' ' ' ASN . 20.5 m -93.94 155.19 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.838 0.828 . . . . 75.44 112.493 -168.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -69.83 110.62 5.07 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 113.776 -1.556 . . . . 64.43 110.936 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -44.54 -34.49 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.371 1.468 . . . . 70.41 114.305 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.417 ' HA ' ' HD2' ' C' ' 137' ' ' PHE . 17.6 t0 -65.38 -19.23 65.86 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 112.197 0.443 . . . . 73.52 112.197 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -29.21 59.32 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.783 0.833 . . . . 63.13 112.141 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.604 HD13 HD21 ' C' ' 139' ' ' ASN . 26.8 tp -64.8 -29.56 70.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.236 0.614 . . . . 75.23 110.617 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.417 ' HD2' ' HA ' ' C' ' 134' ' ' ASP . 97.2 m-85 -66.94 -20.29 65.87 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.691 -0.686 . . . . 74.51 112.622 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -69.25 -41.67 76.62 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.324 -0.621 . . . . 75.53 109.324 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.604 HD21 HD13 ' C' ' 136' ' ' LEU . 47.8 m-20 -60.79 -36.97 80.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.674 -1.148 . . . . 71.23 110.742 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.459 ' HD1' ' HG3' ' A' ' 138' ' ' MET . 16.9 t80 -59.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 O-C-N 124.416 1.073 . . . . 73.21 109.553 164.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' C' ' 8' ' ' GLU . 49.3 tp 70.64 -88.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.63 1.172 . . . . 74.44 108.741 -173.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -149.69 -75.48 0.16 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.45 0.7 . . . . 75.12 109.781 171.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -144.71 21.92 1.63 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.326 0.651 . . . . 74.24 111.529 -171.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -55.94 123.52 14.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.96 0.904 . . . . 70.0 111.445 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.499 ' HB3' ' ND2' ' A' ' 139' ' ' ASN . . . -148.58 77.69 1.39 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.033 0.933 . . . . 71.32 108.705 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.3 69.12 0.54 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.573 -0.74 . . . . 61.42 112.459 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 111.62 15.0 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.657 -1.238 . . . . 73.54 107.657 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.3 -124.37 1.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.47 -0.628 . . . . 61.34 112.644 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.606 ' H ' ' HB2' ' C' ' 4' ' ' GLN . 8.1 m 63.46 26.61 14.92 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.574 1.15 . . . . 75.02 109.932 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -87.46 121.73 30.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.932 -1.031 . . . . 74.21 111.287 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -152.69 125.82 8.57 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.896 1.278 . . . . 74.02 110.107 173.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -98.61 114.65 27.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.435 0.694 . . . . 75.03 109.469 170.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.92 107.78 11.91 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.03 -0.73 . . . . 74.13 109.03 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.24 125.89 30.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.032 -0.729 . . . . 71.12 109.032 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 C-N-CA 123.777 0.831 . . . . 64.55 109.758 -178.382 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 107.986 -1.116 . . . . 73.2 107.986 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 24.5 t 69.64 57.38 0.33 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.848 1.343 . . . . 75.43 110.558 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.69 80.38 1.54 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.764 -1.107 . . . . 70.25 109.705 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -131.19 -62.68 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.525 -0.762 . . . . 72.45 109.925 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 59.54 32.6 21.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.994 0.918 . . . . 70.44 110.933 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -59.18 140.53 55.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.533 -1.212 . . . . 71.12 109.986 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -71.93 73.16 0.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.783 0.833 . . . . 65.05 110.179 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 174.3 111.73 0.02 OUTLIER 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.222 1.809 . . . . 72.35 106.306 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.445 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 7.1 ttp -33.17 128.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.79 1.236 . . . . 71.1 113.602 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 60.0 m -131.02 130.53 43.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 72.52 108.827 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.422 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.1 t80 -149.11 104.31 3.41 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.278 -1.008 . . . . 74.24 108.278 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -119.23 127.5 53.33 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.456 0.702 . . . . 65.2 109.732 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.25 117.52 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 108.529 -0.915 . . . . 73.1 108.529 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -95.4 -46.99 6.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.137 0.575 . . . . 75.24 112.429 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -164.6 134.29 3.81 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.741 0.246 . . . . 74.22 111.165 -168.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.422 ' N ' HD13 ' D' ' 16' ' ' ILE . 2.8 mp -118.64 130.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.673 -1.232 . . . . 73.33 107.673 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -168.34 150.24 5.16 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.883 0.849 . . . . 64.44 112.115 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -81.9 123.07 28.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.837 -1.074 . . . . 72.44 109.388 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -92.47 -20.34 21.08 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 110.199 -0.297 . . . . 74.34 110.199 174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.693 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.7 t70 -155.41 134.62 12.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.412 -0.813 . . . . 65.02 108.841 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.646 HG21 ' HE1' ' C' ' 117' ' ' MET . 79.8 mt -139.79 148.56 22.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 124.807 1.243 . . . . 75.02 107.865 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.26 141.5 23.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.934 0.893 . . . . 72.24 109.284 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.552 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -153.29 132.76 12.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.811 -1.922 . . . . 74.41 105.811 171.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -135.23 145.25 47.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.69 0.796 . . . . 64.53 109.136 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.608 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -146.81 71.45 12.48 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.252 -1.018 . . . . 72.14 108.252 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.8 -26.08 19.49 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.683 2.255 . . . . 74.43 112.609 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.486 ' O ' HG23 ' D' ' 31' ' ' VAL . 28.8 m-20 -115.11 23.11 12.77 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.927 0.891 . . . . 63.51 109.629 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.608 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -48.04 -54.93 20.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 115.783 1.772 . . . . 71.45 115.783 -168.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.49 ' HA ' ' CD1' ' D' ' 32' ' ' PHE . 51.9 Cg_endo -76.1 -16.97 17.57 Favored 'Trans proline' 0 C--N 1.384 2.417 0 CA-C-N 121.162 1.451 . . . . 70.3 112.469 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.7 t-160 -77.18 -30.49 54.88 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.514 1.525 . . . . 71.53 109.782 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.486 HG23 ' O ' ' D' ' 27' ' ' ASN . 57.7 t -77.26 -27.81 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.2 0.6 . . . . 64.52 110.384 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.49 ' CD1' ' HA ' ' D' ' 29' ' ' PRO . 18.4 m-30 -66.05 -21.08 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.74 0.416 . . . . 74.43 111.381 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -64.71 -33.46 76.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.495 0.718 . . . . 72.44 110.439 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.18 100.35 12.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.144 -1.058 . . . . 75.42 108.144 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.4 63.26 3.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.985 0.914 . . . . 72.53 111.532 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.401 ' O ' ' HD3' ' D' ' 38' ' ' PRO . 61.4 t-105 -143.62 160.11 41.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.444 -0.576 . . . . 71.41 109.444 176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.476 ' HB3' ' H ' ' F' ' 140' ' ' SER . 1.5 mp0 -81.52 107.08 7.09 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.784 1.234 . . . . 74.11 108.736 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.43 ' HA ' HD12 ' D' ' 68' ' ' LEU . 35.8 Cg_exo -44.28 151.41 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 124.204 3.269 . . . . 72.1 116.392 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.568 ' HG2' HD22 ' F' ' 141' ' ' LEU . 7.6 tm-20 -61.44 138.32 58.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.222 -1.354 . . . . 73.3 110.226 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 106.24 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 122.603 0.361 . . . . 74.12 110.329 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -98.99 142.5 30.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.322 -0.992 . . . . 74.31 108.322 167.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.722 HD13 HD23 ' D' ' 128' ' ' LEU . 2.7 mm? -120.08 122.17 40.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.157 0.583 . . . . 75.54 109.438 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.787 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.0 m-20 -107.23 130.9 54.67 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.219 -1.4 . . . . 75.21 107.219 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.38 147.97 39.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.152 0.581 . . . . 72.43 110.638 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 28.5 t70 -164.98 154.32 12.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.265 1.026 . . . . 73.31 108.773 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -142.11 162.4 35.58 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.456 0.702 . . . . 71.51 109.432 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.43 163.34 40.12 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.776 0.83 . . . . 44.45 109.114 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -154.17 153.7 32.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.859 0.463 . . . . 73.34 109.918 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.4 p -150.28 146.67 26.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.987 0.915 . . . . 72.15 109.248 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -90.67 119.05 30.59 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.669 -0.863 . . . . 74.53 108.669 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -92.0 -31.47 15.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.073 0.549 . . . . 75.15 109.772 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.21 -170.21 1.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.063 0.945 . . . . 74.22 110.63 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.45 116.27 7.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.449 0.7 . . . . 64.4 110.374 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.91 17.21 9.82 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.475 1.11 . . . . 53.33 112.237 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.7 t -116.0 118.64 59.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 172.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.683 ' HB2' HD13 ' D' ' 86' ' ' ILE . 87.5 m-85 -136.45 130.1 32.12 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.55 -0.907 . . . . 65.44 108.55 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.567 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.0 tt0 -91.15 125.86 36.06 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.586 1.154 . . . . 63.12 109.629 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.74 125.59 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.085 -0.709 . . . . 72.43 109.085 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 60.9 t -104.96 133.85 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 74.15 109.428 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.525 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.78 125.43 53.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.584 -1.265 . . . . 74.11 107.584 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.0 ttm180 -104.95 102.49 12.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.009 -0.737 . . . . 73.32 109.009 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.19 118.01 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.821 -1.177 . . . . 74.44 107.821 168.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.787 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -116.96 136.32 53.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.992 0.517 . . . . 65.34 109.634 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 54.8 t -115.64 115.96 50.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.193 0.997 . . . . 74.33 109.141 172.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.0 m -103.19 115.95 31.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.846 -1.168 . . . . 73.34 107.846 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.62 54.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 70.33 110.065 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 74.1 p -139.27 146.34 40.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.654 0.782 . . . . 75.42 109.006 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' D' ' 38' ' ' PRO . 16.7 tp -134.76 106.05 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.535 -0.913 . . . . 72.33 108.535 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.16 -114.99 4.59 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.577 -0.738 . . . . 43.02 111.691 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 4.56 14.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.654 0.781 . . . . 73.42 110.2 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -123.53 162.55 22.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.492 0.717 . . . . 65.14 110.583 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.07 129.03 37.54 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.67 0.606 . . . . 75.43 109.888 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -84.3 -58.9 2.56 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.436 0.694 . . . . 64.14 109.452 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -161.33 166.14 27.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.64 -1.164 . . . . 75.12 109.21 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.554 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 95.4 mt -126.8 153.09 46.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.402 1.081 . . . . 71.35 108.271 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.493 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.41 144.99 17.39 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.063 0.545 . . . . 62.41 109.719 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.21 135.61 11.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.888 0.875 . . . . 73.43 109.151 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.72 114.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.515 -0.55 . . . . 73.32 109.515 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.693 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.5 mt-30 -90.48 87.02 6.6 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.041 0.924 . . . . 73.54 109.397 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.77 96.71 6.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.558 -1.655 . . . . 75.42 109.146 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.83 144.1 20.96 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.37 -0.692 . . . . 72.24 111.37 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.24 4.57 Favored Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 110.603 -0.999 . . . . 71.45 110.603 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -87.69 123.83 40.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.214 -1.402 . . . . 74.14 107.214 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -127.12 164.26 22.0 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.062 0.945 . . . . 75.12 108.475 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.1 t -113.18 106.43 14.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.904 -1.147 . . . . 73.34 107.904 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.683 HD13 ' HB2' ' D' ' 56' ' ' TYR . 3.6 mp -108.86 107.48 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.512 -0.922 . . . . 74.32 108.512 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.617 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -134.08 146.4 50.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.237 1.015 . . . . 71.33 109.583 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.13 -21.56 8.04 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 114.526 0.57 . . . . 53.43 114.526 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.48 HD11 ' HG3' ' D' ' 93' ' ' GLN . 12.1 tt -109.2 130.44 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.614 0.765 . . . . 74.22 108.99 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.64 -177.45 5.3 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.431 0.692 . . . . 75.1 111.673 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.53 -140.33 36.82 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.978 0.799 . . . . 72.25 113.408 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -81.43 -20.85 39.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.453 0.701 . . . . 74.31 111.437 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.48 ' HG3' HD11 ' D' ' 89' ' ' ILE . 7.2 tp60 -69.65 -40.24 76.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.189 0.596 . . . . 75.44 111.051 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.415 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 5.2 ppp? -69.34 -33.78 73.62 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.796 -0.446 . . . . 73.12 109.796 174.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.97 99.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.361 0.664 . . . . 75.25 110.812 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -72.32 -34.32 68.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.5 -0.773 . . . . 72.25 110.183 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.94 -36.73 85.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.342 0.657 . . . . 72.45 111.124 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.616 HD23 HG12 ' D' ' 86' ' ' ILE . 31.5 mt -80.17 -23.2 41.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.976 0.51 . . . . 72.12 111.013 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.75 -2.35 55.23 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.697 -0.502 . . . . 63.13 113.736 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.13 -60.43 0.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.617 0.709 . . . . 74.35 111.412 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.61 -40.99 66.05 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.942 0.497 . . . . 71.55 111.797 -171.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.433 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 68.8 m -69.26 -49.04 25.14 Favored Pre-proline 0 CA--C 1.559 1.313 0 CA-C-O 118.956 -0.545 . . . . 73.22 110.975 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.525 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.4 Cg_exo -52.13 -31.13 43.93 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.542 2.161 . . . . 74.2 114.566 168.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.66 -35.64 81.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.993 0.517 . . . . 74.11 110.755 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.19 -44.11 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.242 0.617 . . . . 74.14 110.251 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.8 -20.24 58.35 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.341 -0.845 . . . . 70.11 112.027 -172.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -65.48 -48.03 67.26 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.459 0.911 . . . . 74.33 113.459 -171.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.48 -34.01 88.06 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.884 1.722 . . . . 64.12 112.821 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.27 -35.68 47.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.863 0.865 . . . . 74.34 111.816 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.69 76.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.286 0.634 . . . . 73.13 109.963 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.4 HH12 ' HG3' ' D' ' 130' ' ' PRO . 14.4 ptt180 -75.11 -31.63 61.19 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.958 -1.019 . . . . 75.12 110.784 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.98 -49.71 75.01 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.007 0.817 . . . . 63.32 110.305 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.509 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.3 t -58.81 -40.47 84.22 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.853 0.72 . . . . 75.13 110.517 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.493 HG12 ' SG ' ' D' ' 76' ' ' CYS . 64.9 mt -57.58 -53.18 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 123.794 0.684 . . . . 72.14 110.236 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.432 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.0 m -57.62 -45.79 84.95 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 124.26 1.024 . . . . 74.14 111.17 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 32.5 t -64.31 -41.04 97.02 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.636 -1.166 . . . . 65.21 110.138 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -69.02 -33.53 73.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.111 0.565 . . . . 74.11 111.587 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.11 -46.76 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 O-C-N 123.823 0.702 . . . . 64.14 110.203 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.7 p -71.16 -29.46 65.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.617 0.367 . . . . 63.05 110.858 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' D' ' 116' ' ' SER . 80.7 mtt-85 -70.55 -30.29 66.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.653 0.781 . . . . 71.35 110.1 172.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.63 7.16 81.98 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 123.724 0.64 . . . . 74.11 112.834 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 43.5 p 56.76 28.69 14.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.395 1.878 . . . . 75.14 113.262 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.74 158.59 34.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.883 0.873 . . . . 73.53 110.137 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.76 127.33 25.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.008 2.472 . . . . 65.21 112.932 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.432 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.0 tt0 -51.26 130.61 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.611 1.195 . . . . 73.21 112.201 -175.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.1 tp -115.19 100.89 8.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.63 0.372 . . . . 64.33 110.292 -176.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -99.61 112.51 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.351 -1.352 . . . . 74.24 107.351 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.722 HD23 HD13 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -74.37 135.85 42.45 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 123.42 0.45 . . . . 75.35 110.592 -171.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.17 123.05 58.26 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 124.467 1.104 . . . . 62.2 110.933 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.565 ' HD2' HD12 ' F' ' 147' ' ' LEU . 43.0 Cg_exo -57.4 129.87 36.22 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.321 2.014 . . . . 74.24 111.238 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.443 ' HA ' ' HB2' ' F' ' 148' ' ' LEU . 51.6 t -123.73 110.55 26.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 109.194 -0.669 . . . . 65.13 109.194 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -77.28 95.57 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.794 -1.188 . . . . 73.03 107.794 167.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.21 -30.92 71.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.641 -0.709 . . . . 73.12 111.159 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.45 -51.6 59.02 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.354 0.662 . . . . 74.5 109.549 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.581 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -63.55 -38.5 91.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 65.24 111.519 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.56 -47.3 84.72 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.243 0.964 . . . . 70.22 109.992 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -77.23 -30.94 54.78 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.995 0.518 . . . . 75.44 111.292 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.581 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 61.2 mtm -62.49 -23.03 66.71 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 119.251 -0.404 . . . . 73.33 111.944 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -51.12 -44.05 61.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.497 0.719 . . . . 75.14 111.342 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.99 -40.58 91.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.807 0.843 . . . . 74.33 111.648 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.31 -30.47 71.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.233 0.613 . . . . 73.24 111.003 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -79.7 2.58 22.17 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.123 0.969 . . . . 71.15 111.976 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -130.16 89.83 2.86 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.266 1.026 . . . . 51.22 109.363 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -166.39 173.09 10.3 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.315 1.046 . . . . 73.55 109.91 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.65 -32.32 28.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.14 0.576 . . . . 72.03 110.751 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.61 -95.83 1.32 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.195 -0.457 . . . . 52.2 112.705 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -94.47 109.79 21.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.707 0.803 . . . . 74.44 111.19 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.08 -134.9 2.88 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.251 -0.431 . . . . 72.44 112.81 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 21.0 m -68.2 -16.95 64.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 74.41 112.019 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -60.91 -27.78 68.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.524 1.13 . . . . 73.12 112.358 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -40.72 73.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.78 0.832 . . . . 74.03 110.174 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -84.34 104.59 14.49 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.15 -0.932 . . . . 71.33 108.955 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -75.52 82.24 2.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.318 0.647 . . . . 72.34 109.367 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.08 142.96 30.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.066 -0.97 . . . . 75.42 109.995 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.764 -0.636 . . . . 43.24 110.627 -178.06 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.356 -0.609 . . . . 64.15 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -76.36 -23.87 54.16 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.059 0.544 . . . . 73.4 110.886 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.51 81.44 8.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.653 0.781 . . . . 73.34 109.473 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.88 -37.69 26.51 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.651 -0.704 . . . . 65.3 110.562 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -105.69 161.53 14.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.141 0.976 . . . . 73.52 111.076 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -161.4 145.63 13.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.57 0.748 . . . . 71.42 110.294 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.461 ' H ' ' HD3' ' E' ' 114' ' ' LYS . 0.0 OUTLIER -134.52 142.27 46.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.696 1.198 . . . . 72.22 108.254 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.584 ' HB2' ' HE2' ' B' ' 94' ' ' MET . 82.7 mt -89.38 -32.95 17.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.522 0.329 . . . . 73.31 110.709 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -103.76 100.26 19.13 Favored Pre-proline 0 C--N 1.357 0.93 0 N-CA-C 109.689 -0.486 . . . . 74.11 109.689 171.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.619 ' HD2' ' HA2' ' B' ' 91' ' ' GLY . 26.4 Cg_endo -92.72 5.35 3.3 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.947 2.431 . . . . 75.2 111.303 163.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -76.09 141.84 41.88 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.686 0.794 . . . . 65.4 109.771 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 55.7 m -77.07 87.51 3.57 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.469 0.708 . . . . 65.24 110.408 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.74 85.58 3.59 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.979 -1.119 . . . . 72.42 107.979 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -129.26 22.6 5.62 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.784 -1.098 . . . . 73.23 109.839 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.15 -89.29 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 118.951 -0.547 . . . . 72.3 110.518 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t 37.83 67.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 125.014 1.326 . . . . 74.53 111.164 -173.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -51.66 9.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.999 -0.546 . . . . 74.34 110.12 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 64.36 -174.87 0.17 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.591 1.156 . . . . 75.25 111.396 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -157.33 153.87 28.07 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.455 0.702 . . . . 75.11 110.019 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -96.62 25.92 24.18 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.896 -0.593 . . . . 73.02 113.133 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 2.8 tmtp? -112.34 114.92 27.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.357 -1.349 . . . . 64.22 107.357 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . 0.461 ' HB3' HD12 ' E' ' 130' ' ' ILE . 6.2 tt -145.26 -54.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.161 -1.052 . . . . 75.54 108.161 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' E' ' 129' ' ' LEU . 3.4 mp -79.44 84.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.682 -0.858 . . . . 74.42 108.682 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.27 -36.0 21.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.965 -1.016 . . . . 73.52 109.522 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.69 103.03 53.78 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.132 -1.062 . . . . 73.1 108.132 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.76 46.94 2.16 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.898 2.398 . . . . 75.4 111.593 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 7.3 tp -71.56 84.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 122.472 1.129 . . . . 72.41 109.579 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.51 -21.82 57.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.36 -1.291 . . . . 72.4 111.183 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.676 ' HB ' ' HG3' ' C' ' 124' ' ' PRO . 73.7 t 62.05 -86.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.599 1.16 . . . . 70.04 109.958 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 59.48 -165.27 0.2 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.211 1.004 . . . . 73.32 111.897 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 66.01 14.53 9.65 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.198 0.999 . . . . 71.54 111.753 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 31.27 6.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.714 1.206 . . . . 75.34 109.821 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 48.2 m -93.88 9.25 38.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.713 -0.676 . . . . 72.32 111.005 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . 0.554 HD21 ' H ' ' E' ' 141' ' ' LEU . 1.4 pt? -78.23 83.31 4.49 Favored 'General case' 0 C--N 1.361 1.066 0 CA-C-O 122.325 1.06 . . . . 75.14 109.19 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . 0.526 HG12 ' H ' ' E' ' 143' ' ' TYR . 13.3 tt -128.74 -177.62 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-N 114.414 -1.266 . . . . 74.04 107.97 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . 0.526 ' H ' HG12 ' E' ' 142' ' ' ILE . 83.6 m-85 -54.49 103.12 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.028 0.931 . . . . 74.43 112.293 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -120.72 96.04 4.96 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.311 -0.996 . . . . 75.31 108.311 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . 0.42 ' HG2' ' H ' ' E' ' 146' ' ' ASP . 58.8 tttm -171.15 178.32 3.37 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.381 1.072 . . . . 74.51 108.468 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . 0.42 ' H ' ' HG2' ' E' ' 145' ' ' LYS . 5.9 p-10 -69.48 79.96 0.4 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.127 0.965 . . . . 64.34 111.221 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.93 -10.02 49.36 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.476 -0.784 . . . . 70.32 110.609 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.538 HD13 HD21 ' C' ' 136' ' ' LEU . 3.9 tp -177.83 87.5 0.24 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.154 1.381 . . . . 73.31 108.944 175.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 CA--C 1.561 1.849 0 C-N-CA 123.215 2.61 . . . . 74.0 111.839 172.674 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.027 -0.36 . . . . 75.33 110.027 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -74.5 130.33 39.4 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.698 0.799 . . . . 71.53 110.4 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.86 114.69 8.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.912 0.885 . . . . 71.03 110.58 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.16 -63.04 1.07 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.965 0.906 . . . . 74.44 109.152 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 39.95 73.0 0.13 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.126 1.771 . . . . 74.31 114.004 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -107.38 92.69 4.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.114 -1.069 . . . . 71.55 108.114 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -119.93 141.55 49.53 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.544 0.737 . . . . 73.42 109.894 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.572 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 89.6 mt -70.7 100.06 1.8 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.9 0.88 . . . . 72.03 110.662 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -159.71 84.11 2.23 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.44 -0.948 . . . . 75.25 108.44 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -95.03 -173.27 0.28 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.352 2.701 . . . . 71.24 113.998 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . 0.483 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 47.0 t80 62.11 84.46 0.14 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.75 1.62 . . . . 73.2 110.81 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 3.3 t -69.44 86.63 0.44 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.075 -0.966 . . . . 63.42 110.845 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -158.22 144.37 17.23 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.744 -1.117 . . . . 75.34 109.067 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -165.62 97.89 0.67 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.914 0.886 . . . . 72.22 109.003 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.92 94.08 2.43 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.965 -0.754 . . . . 73.24 108.965 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.5 121.35 8.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.559 0.744 . . . . 75.22 109.988 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 mtt180 -125.61 176.17 7.06 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 106.744 -1.576 . . . . 74.41 106.744 167.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . 0.411 ' HE1' ' HB1' ' A' ' 129' ' ' ALA . 49.4 t80 -159.37 117.64 2.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.988 -1.486 . . . . 74.01 106.988 167.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . 0.465 ' N ' HD21 ' F' ' 126' ' ' ASN . 0.8 OUTLIER -96.42 -55.94 2.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.454 -0.943 . . . . 75.22 108.454 177.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.43 -144.3 47.55 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.988 0.805 . . . . 61.11 113.37 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -165.34 119.17 1.23 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.019 -1.104 . . . . 73.55 108.019 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.433 HD22 HG23 ' A' ' 40' ' ' VAL . 22.6 tp -128.14 167.18 17.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 74.31 110.365 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 59.5 mt 69.62 86.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.494 1.518 . . . . 73.33 109.068 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.98 -52.88 5.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.22 -0.9 . . . . 71.13 110.682 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.98 106.9 6.84 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.309 0.644 . . . . 75.42 109.657 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.32 179.25 6.34 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.989 2.459 . . . . 75.11 112.39 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.608 HG23 HH22 ' C' ' 15' ' ' ARG . 13.5 tt -166.76 146.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.547 0.739 . . . . 74.22 109.357 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.72 119.57 16.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.165 0.586 . . . . 75.32 109.888 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.69 30.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.025 0.93 . . . . 75.13 111.293 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.92 -63.56 1.13 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.143 0.977 . . . . 74.25 109.988 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.6 151.28 28.65 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.216 -1.356 . . . . 64.13 108.187 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' D' ' 37' ' ' GLN . 15.5 tp -82.02 139.88 34.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.074 0.55 . . . . 71.25 109.653 -175.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 140' ' ' SER . . . . . 0.476 ' H ' ' HB3' ' D' ' 37' ' ' GLN . 22.0 t -78.48 179.16 7.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.561 0.744 . . . . 74.0 110.875 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . 0.568 HD22 ' HG2' ' D' ' 39' ' ' GLU . 6.4 mp 61.21 21.79 12.2 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.308 1.043 . . . . 74.22 112.188 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 9.3 tp -72.2 144.02 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.851 -0.796 . . . . 75.44 108.851 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . 0.702 ' HB3' ' HB2' ' F' ' 146' ' ' ASP . 90.2 m-85 -69.21 95.88 0.79 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.265 0.626 . . . . 72.25 110.777 -174.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -66.84 114.91 6.06 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.332 -0.849 . . . . 73.22 109.662 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . 0.531 ' HZ3' ' HB2' ' F' ' 145' ' ' LYS . 3.3 ttmp? 74.52 -5.47 2.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.307 1.443 . . . . 72.41 112.564 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . 0.702 ' HB2' ' HB3' ' F' ' 143' ' ' TYR . 32.3 m-20 -93.89 47.09 1.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.584 0.707 . . . . 74.44 109.589 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . 0.565 HD12 ' HD2' ' D' ' 130' ' ' PRO . 2.1 mm? -99.36 105.24 17.19 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.361 -1.348 . . . . 73.03 107.361 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' D' ' 131' ' ' VAL . 5.4 mp -92.8 101.19 4.83 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 123.639 0.776 . . . . 74.11 108.99 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo . . . . . 0 C--N 1.377 2.045 0 C-N-CA 122.682 2.255 . . . . 64.22 111.966 -178.564 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.823 -0.436 . . . . 72.23 109.823 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.7 p -170.04 -42.12 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.034 0.934 . . . . 74.03 108.784 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 62.28 23.48 13.9 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.491 1.116 . . . . 74.42 112.107 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -137.45 -5.39 1.8 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.503 0.721 . . . . 73.41 111.527 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.55 155.58 37.35 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.663 0.785 . . . . 75.32 111.371 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -95.91 23.62 6.19 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.104 0.962 . . . . 71.32 110.27 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 m -83.03 2.39 35.21 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.741 0.817 . . . . 70.33 111.07 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.78 155.14 21.96 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.975 0.91 . . . . 75.45 109.472 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -65.86 131.22 45.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.927 -0.768 . . . . 63.43 108.927 171.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.3 m -151.91 131.1 12.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.154 0.582 . . . . 73.32 110.387 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.93 137.26 34.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.478 1.111 . . . . 74.12 108.394 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -160.69 136.76 8.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.269 0.227 . . . . 73.12 110.838 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.405 HD12 ' H ' ' A' ' 13' ' ' ILE . 3.8 mp -69.18 114.48 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.077 -1.083 . . . . 73.24 108.077 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -95.29 -30.07 14.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.138 0.575 . . . . 72.41 111.176 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -166.03 148.41 7.17 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.682 -0.488 . . . . 73.43 109.682 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.443 HG12 ' HG3' ' C' ' 130' ' ' PRO . 2.5 pp -141.03 139.05 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.726 -1.213 . . . . 74.45 107.726 171.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 42.1 p90 -176.97 176.16 1.47 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.566 0.698 . . . . 75.34 110.949 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -99.73 111.07 23.43 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.042 0.937 . . . . 75.45 109.241 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -76.01 -28.92 57.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.957 -0.386 . . . . 73.03 109.957 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.0 t70 -150.61 147.77 27.82 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.955 -0.566 . . . . 73.43 110.126 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.4 mt -138.72 145.39 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.477 1.511 . . . . 73.54 107.398 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -154.22 117.58 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.662 0.385 . . . . 65.3 110.457 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.673 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.1 t80 -124.44 116.32 22.34 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.353 -1.351 . . . . 74.41 107.353 172.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -119.67 128.17 53.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.433 -0.58 . . . . 74.34 109.433 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.56 76.61 48.15 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 108.546 -0.909 . . . . 71.34 108.546 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 -18.23 22.4 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.68 2.253 . . . . 74.54 112.024 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 64.6 m-20 -115.76 30.72 7.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.934 0.893 . . . . 75.35 108.962 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.445 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -58.12 -46.33 99.68 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.864 0.866 . . . . 73.35 112.584 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 31.6 Cg_exo -62.92 -28.16 75.13 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.025 1.817 . . . . 74.01 113.21 169.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.456 ' HA ' ' HG2' ' A' ' 33' ' ' GLN . 1.1 m80 -73.13 -24.39 60.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.77 0.428 . . . . 75.04 111.327 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.41 -27.41 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 120.967 0.413 . . . . 74.24 110.819 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.591 ' HD2' HH11 ' B' ' 15' ' ' ARG . 81.9 t80 -74.86 -41.69 59.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.381 0.672 . . . . 74.21 110.239 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.456 ' HG2' ' HA ' ' A' ' 30' ' ' HIS . 13.1 pt20 -80.3 -30.47 38.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.584 0.354 . . . . 74.32 111.556 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.541 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 3.8 mmmp? -82.36 156.85 24.0 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.883 0.873 . . . . 75.42 112.107 -176.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.59 140.4 54.41 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.473 -1.24 . . . . 74.13 110.757 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -88.24 63.92 7.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.634 0.731 . . . . 72.43 109.378 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -124.63 78.34 63.36 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.376 1.07 . . . . 73.42 108.819 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.87 167.2 24.14 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.985 2.457 . . . . 73.21 113.606 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -123.77 95.37 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.829 -1.545 . . . . 65.2 106.829 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.25 125.62 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.311 0.577 . . . . 75.54 110.391 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 35.5 mttp -120.85 114.77 22.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.391 1.077 . . . . 53.52 108.612 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.467 HD13 ' HA3' ' F' ' 127' ' ' GLY . 72.6 mt -111.1 107.26 16.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.734 -1.121 . . . . 74.53 108.778 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -114.46 145.23 42.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.606 1.162 . . . . 61.42 110.128 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.48 153.23 48.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 72.13 110.605 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.434 ' O ' HD22 ' A' ' 60' ' ' LEU . 20.7 t70 -157.86 143.47 17.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.383 1.073 . . . . 73.04 109.014 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.1 m -126.62 135.08 50.74 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.672 0.789 . . . . 72.12 109.584 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.55 132.48 40.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.075 0.95 . . . . 72.32 109.842 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -91.35 153.26 20.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.104 0.478 . . . . 64.23 110.445 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 t -150.82 138.28 19.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.079 1.352 . . . . 71.24 108.262 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -113.75 124.34 52.03 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.44 -0.578 . . . . 64.22 109.44 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.15 -44.07 7.11 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.566 0.746 . . . . 75.34 110.393 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 -173.45 4.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.461 -0.791 . . . . 75.14 109.982 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -63.02 112.66 2.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.302 0.641 . . . . 55.4 109.773 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 65.02 8.9 5.03 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.858 1.263 . . . . 62.51 113.038 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.01 109.93 25.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.004 -1.109 . . . . 71.14 108.004 172.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -119.94 123.82 44.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.491 0.716 . . . . 75.15 109.579 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -97.5 131.54 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.609 -1.178 . . . . 70.0 108.641 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.53 129.63 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.938 -1.134 . . . . 71.33 107.938 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.44 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.8 t -104.49 132.57 50.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.534 -0.913 . . . . 73.05 108.534 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.434 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -108.85 110.18 21.48 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.715 -1.587 . . . . 73.35 106.715 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -103.29 102.67 12.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.808 0.843 . . . . 73.33 108.792 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG23 HD23 ' A' ' 60' ' ' LEU . 58.5 t -106.41 134.48 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 114.686 -1.143 . . . . 74.54 109.295 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.465 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.7 m -120.39 141.37 50.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.092 -0.707 . . . . 73.31 109.092 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -138.54 107.83 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.926 1.29 . . . . 72.41 108.321 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 19.2 m -102.22 146.05 28.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.316 -0.624 . . . . 74.41 109.316 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.17 120.28 15.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.492 0.717 . . . . 70.2 109.146 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 49.1 m -128.56 125.15 37.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.998 0.519 . . . . 75.44 110.008 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.71 85.16 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.75 0.786 . . . . 73.33 109.054 178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.3 -118.65 5.14 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.283 -1.326 . . . . 74.11 111.359 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -87.89 -31.98 19.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 72.4 109.347 174.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.15 133.77 35.52 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.67 0.788 . . . . 74.45 109.469 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.6 m -78.94 136.68 37.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.094 -0.335 . . . . 73.45 110.094 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.57 -60.55 2.15 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.496 0.718 . . . . 61.01 109.112 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -165.83 176.13 8.15 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.628 -1.169 . . . . 75.31 111.098 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -138.62 145.82 40.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.34 1.456 . . . . 73.43 108.139 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.474 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.1 m -135.89 140.37 44.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.928 0.891 . . . . 74.04 109.838 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -150.33 130.7 13.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.179 0.592 . . . . 72.45 109.652 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.82 119.86 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.171 0.589 . . . . 73.3 110.362 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -89.26 83.12 6.45 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.445 1.098 . . . . 74.54 108.523 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -76.49 94.39 3.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.279 -0.873 . . . . 74.15 109.443 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.93 144.16 17.93 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.772 -0.531 . . . . 73.42 111.772 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.525 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.86 124.18 2.77 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.811 -0.916 . . . . 62.23 110.811 -176.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.61 128.49 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.671 -0.863 . . . . 75.51 108.671 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -135.18 140.0 45.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.666 -0.864 . . . . 75.23 108.666 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.1 p -101.92 106.88 17.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 72.23 109.015 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.2 pt -125.19 131.55 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.335 0.654 . . . . 74.41 110.769 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.85 157.42 26.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.114 0.965 . . . . 74.01 110.207 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.16 64.86 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.067 -0.515 . . . . 65.42 114.383 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.462 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.63 145.48 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.643 0.721 . . . . 74.54 109.368 -177.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.603 ' HA ' ' HE2' ' A' ' 94' ' ' MET . 9.9 tt0 -142.68 179.32 7.06 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.021 0.528 . . . . 74.53 109.956 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.73 -123.81 31.73 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 124.239 0.924 . . . . 72.01 114.738 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.719 ' HB ' HD13 ' A' ' 141' ' ' LEU . 66.6 p -74.86 -26.56 59.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 74.24 111.365 -172.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -65.72 -48.66 71.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.744 0.817 . . . . 64.5 110.063 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.603 ' HE2' ' HA ' ' A' ' 90' ' ' GLU . 39.8 ttp -79.71 -33.29 41.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.202 -1.363 . . . . 51.53 110.6 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.58 92.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.27 0.557 . . . . 74.35 109.956 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -55.13 -47.54 74.92 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.547 -1.206 . . . . 75.31 111.092 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.644 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 35.3 m -71.33 -33.22 69.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.741 1.015 . . . . 74.32 113.741 -172.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.408 HD12 ' HD2' ' F' ' 117' ' ' PRO . 86.3 mt -80.09 -30.09 39.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.809 0.443 . . . . 75.25 111.342 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.98 -17.61 31.92 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.633 -0.537 . . . . 65.24 114.292 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.52 -63.91 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.708 0.754 . . . . 75.22 112.614 -171.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.644 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.83 -56.39 12.42 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.085 0.954 . . . . 62.34 112.758 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.56 -48.62 12.05 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.315 -0.85 . . . . 72.42 113.113 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.3 -20.27 62.04 Favored 'Trans proline' 0 C--N 1.388 2.636 0 CA-C-N 121.111 1.432 . . . . 75.42 113.718 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.29 -42.8 92.72 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.017 0.527 . . . . 71.32 110.711 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -59.65 -41.85 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.97 0.89 . . . . 72.02 110.201 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.525 HD22 ' HA3' ' A' ' 82' ' ' GLY . 94.9 mt -74.99 -29.1 60.8 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 113.874 -1.512 . . . . 63.44 112.579 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.476 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 20.6 t80 -64.26 -45.17 78.46 Favored Pre-proline 0 CA--C 1.558 1.28 0 N-CA-C 114.866 1.432 . . . . 74.34 114.866 -167.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.88 -32.51 95.23 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 121.616 1.544 . . . . 70.34 113.046 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -79.73 -37.72 34.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.453 0.701 . . . . 74.11 112.349 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.19 71.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 110.01 -0.367 . . . . 65.44 110.01 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -53.51 -48.8 68.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.371 1.068 . . . . 74.22 110.102 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.26 -47.25 86.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.982 0.913 . . . . 64.43 111.613 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.541 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.3 t -60.37 -44.19 95.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 73.34 111.002 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.462 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 15.3 mt -63.08 -51.79 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.31 1.044 . . . . 73.32 110.905 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.515 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.8 m -59.1 -36.4 75.08 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.258 1.023 . . . . 71.35 112.023 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.65 -39.72 80.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 75.43 110.115 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.673 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 46.5 mtm -63.08 -39.63 95.28 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.637 0.375 . . . . 74.51 110.533 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.88 -47.05 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.146 0.978 . . . . 74.02 111.207 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -72.61 -33.37 66.63 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.096 -0.502 . . . . 43.22 111.184 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.433 HH12 ' HG3' ' B' ' 112' ' ' GLU . 82.7 mtt-85 -69.39 -26.61 64.73 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.333 0.653 . . . . 72.23 110.138 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.61 1.07 88.7 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.683 -0.69 . . . . 75.52 112.861 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.4 m 69.56 18.14 7.78 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.392 1.077 . . . . 73.24 111.277 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.44 152.38 40.02 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 73.12 110.892 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.76 125.35 18.8 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.74 2.293 . . . . 73.13 112.0 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.515 ' HG3' HG23 ' A' ' 115' ' ' THR . 25.3 tt0 -50.34 136.66 19.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.859 1.264 . . . . 74.34 112.957 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.2 mt -125.61 104.62 8.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.837 0.855 . . . . 64.3 108.81 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -101.9 123.18 45.39 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.678 0.791 . . . . 74.24 109.103 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.476 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -73.4 120.44 19.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.909 -1.145 . . . . 75.51 107.909 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.09 129.07 85.92 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.864 0.727 . . . . 70.42 110.631 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.63 107.4 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.045 1.83 . . . . 75.25 111.741 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -98.96 110.84 27.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.51 -1.292 . . . . 74.05 107.51 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.12 82.04 8.54 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.437 -0.801 . . . . 71.05 109.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.22 -32.78 71.44 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.246 -1.343 . . . . 74.03 109.803 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.5 -49.67 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.359 1.064 . . . . 73.45 111.606 173.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.88 99.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.944 0.498 . . . . 71.5 111.72 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.38 -44.11 84.04 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.418 0.687 . . . . 72.2 110.497 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.59 -35.94 81.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.644 -0.707 . . . . 75.41 109.795 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.568 ' HB3' ' HA ' ' A' ' 144' ' ' GLN . 92.0 mmm -71.05 -41.77 70.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.783 0.433 . . . . 74.11 110.804 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -56.45 -38.65 71.93 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.232 0.613 . . . . 74.11 110.746 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -73.27 -40.58 64.48 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.95 -1.023 . . . . 74.53 110.993 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.719 HD13 ' HB ' ' A' ' 92' ' ' THR . 18.7 tp -66.66 -50.39 63.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.295 1.038 . . . . 74.5 111.368 -170.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -168.94 28.76 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.125 -0.943 . . . . 70.02 110.092 -170.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.468 ' HB3' ' HG3' ' C' ' 144' ' ' GLN . 79.5 mt-30 62.27 34.21 16.07 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.883 0.873 . . . . 73.33 111.484 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 138' ' ' MET . 79.7 mt-30 69.3 141.1 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.067 1.747 . . . . 75.44 110.776 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.85 155.98 24.39 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.54 0.736 . . . . 73.42 109.431 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.09 162.49 24.77 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.366 0.416 . . . . 74.24 113.433 -174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -152.14 117.46 5.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.323 0.649 . . . . 75.54 109.978 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.48 102.62 1.63 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.591 -1.004 . . . . 72.43 110.591 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.0 m -59.16 -51.46 69.9 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.495 0.664 . . . . 71.24 109.852 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -174.88 171.57 3.09 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.97 -1.468 . . . . 73.45 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.15 68.8 1.47 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.277 -1.008 . . . . 75.04 108.277 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -132.24 167.78 19.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.878 0.871 . . . . 74.21 110.802 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -159.97 88.82 0.84 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.906 -1.146 . . . . 75.33 107.906 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.99 83.43 7.79 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.286 -1.005 . . . . 74.33 108.286 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 124.761 1.224 . . . . 71.44 110.883 -173.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.491 -0.559 . . . . 73.35 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.0 m -144.57 98.28 3.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.23 1.012 . . . . 73.44 108.884 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.64 134.51 35.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.569 0.748 . . . . 74.31 110.308 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -63.4 147.88 50.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.475 1.11 . . . . 73.55 112.016 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.63 170.72 14.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.992 0.517 . . . . 74.52 110.863 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -93.77 -29.3 15.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.57 0.348 . . . . 54.23 111.764 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.586 HG23 ' HA ' ' B' ' 150' ' ' GLU . 28.1 m -92.27 99.76 12.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.023 0.44 . . . . 65.24 111.839 -174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -172.59 -59.13 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.466 1.106 . . . . 72.34 108.319 165.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.8 ptm 48.02 -172.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.0 1.72 . . . . 75.02 112.494 -169.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 15.2 t -155.61 143.54 19.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.082 -0.71 . . . . 65.12 109.082 170.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -139.45 113.28 8.61 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.158 -1.052 . . . . 74.2 108.158 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.488 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 22.8 tt0 -133.11 139.76 47.29 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.487 0.715 . . . . 73.4 109.469 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.53 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -89.83 116.04 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.183 -1.043 . . . . 74.22 108.183 170.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.403 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 72.5 mt-30 -77.63 -40.83 40.58 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.753 -0.462 . . . . 65.2 109.753 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.591 HH11 ' HD2' ' A' ' 32' ' ' PHE . 18.6 ttt180 -166.42 137.89 3.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 71.15 108.846 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 57.8 mt -114.39 139.23 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 106.986 -1.487 . . . . 74.04 106.986 170.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -168.19 146.57 4.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.762 0.71 . . . . 71.42 112.298 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -73.35 120.83 19.51 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.655 -1.157 . . . . 74.34 108.711 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -96.44 -26.59 15.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.443 0.697 . . . . 75.31 111.242 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -161.26 141.74 11.04 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.055 0.222 . . . . 62.42 110.924 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -138.3 141.69 37.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 125.024 1.33 . . . . 73.3 109.035 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.425 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 35.0 t -140.12 124.22 17.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.166 -1.42 . . . . 63.44 107.166 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -138.61 111.41 7.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.396 -1.335 . . . . 75.32 107.396 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.98 117.51 29.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.671 -0.863 . . . . 74.04 108.671 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 84.68 6.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.492 -1.299 . . . . 73.34 107.492 168.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.63 -26.92 11.25 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.829 2.353 . . . . 71.23 112.649 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 1.8 m-20 -110.96 20.24 17.69 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 74.52 109.438 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.496 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.01 -60.52 1.65 Allowed Pre-proline 0 CA--C 1.574 1.89 0 C-N-CA 126.368 1.867 . . . . 74.31 114.931 -169.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.0 -1.86 9.49 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.26 1.973 . . . . 72.13 113.57 -174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -96.74 -38.21 9.99 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 73.14 110.505 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' B' ' 73' ' ' ALA . 10.5 p -79.33 -14.16 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.478 -0.783 . . . . 74.51 110.114 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.06 -34.56 44.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.676 1.19 . . . . 73.2 111.798 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -73.15 -15.94 61.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.068 0.947 . . . . 75.13 112.028 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.55 ' HD3' HD13 ' B' ' 68' ' ' LEU . 89.6 mttt -105.52 109.37 21.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.148 0.979 . . . . 74.42 110.481 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.27 83.63 5.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.367 0.667 . . . . 62.25 110.407 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.581 ' HE3' HD11 ' B' ' 68' ' ' LEU . 3.6 m-90 -153.43 161.75 41.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.492 1.117 . . . . 74.41 109.378 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.31 119.94 73.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.207 -1.034 . . . . 75.52 108.207 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.14 167.72 26.04 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.787 2.325 . . . . 64.04 113.684 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.66 103.39 4.23 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.955 -1.128 . . . . 61.55 107.955 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.403 HG21 HD23 ' B' ' 126' ' ' LEU . 27.4 m -100.88 127.78 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.206 0.602 . . . . 74.2 110.261 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -106.63 124.6 49.85 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.608 -0.886 . . . . 73.4 108.608 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 mt -92.25 124.79 36.58 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.037 -1.098 . . . . 72.4 108.037 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.0 t70 -136.23 151.89 50.16 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 107.996 -1.113 . . . . 75.31 107.996 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.57 169.41 17.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.184 0.516 . . . . 71.12 111.674 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.9 t70 -159.39 142.72 14.49 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.755 1.222 . . . . 73.23 108.432 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.441 HG22 ' CD1' ' E' ' 120' ' ' TRP . 6.5 t -109.29 118.7 37.38 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.765 -0.828 . . . . 61.24 108.765 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -117.73 151.3 37.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 71.03 108.553 172.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -145.43 163.75 33.67 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 122.927 0.491 . . . . 74.32 110.511 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -157.83 136.54 11.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.679 1.191 . . . . 72.25 108.148 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -93.79 127.02 39.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.926 0.49 . . . . 74.42 110.032 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 -40.32 14.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.215 -0.661 . . . . 71.0 109.215 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.49 -178.83 5.13 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.779 1.232 . . . . 74.33 108.851 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -72.45 134.51 45.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.876 -0.787 . . . . 74.13 108.876 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.3 m-20 73.64 -3.87 2.38 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.404 1.481 . . . . 74.34 111.808 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.38 84.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.993 -1.114 . . . . 63.34 107.993 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.582 ' HH ' HD11 ' E' ' 115' ' ' LEU . 21.7 m-85 -110.39 138.95 46.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.949 -0.759 . . . . 71.3 108.949 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -115.04 110.0 18.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.829 -1.174 . . . . 71.22 107.829 -172.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.646 HG22 ' HB3' ' B' ' 98' ' ' LEU . 67.0 t -104.55 128.83 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.988 0.515 . . . . 74.51 110.187 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 39.6 t -102.37 119.91 51.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.538 1.135 . . . . 75.43 109.466 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -92.89 111.67 23.37 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.166 -1.42 . . . . 73.53 107.166 172.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.6 ttt180 -100.18 125.38 46.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.009 -0.737 . . . . 73.33 109.009 175.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.538 HG13 HD11 ' B' ' 128' ' ' LEU . 15.4 t -119.58 127.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.856 -0.794 . . . . 72.01 108.856 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 86.1 m -104.04 141.05 36.87 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.57 0.544 . . . . 71.41 110.11 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.619 HG22 HG21 ' B' ' 114' ' ' ILE . 53.0 t -133.3 122.18 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.491 1.116 . . . . 74.14 108.549 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -117.36 146.17 43.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.744 . . . . 75.23 108.993 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.0 133.41 21.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.755 -0.832 . . . . 71.52 108.755 177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 63.6 p -138.52 136.34 36.0 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 122.877 0.471 . . . . 70.42 110.207 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.581 HD11 ' HE3' ' B' ' 36' ' ' TRP . 0.3 OUTLIER -110.44 107.86 17.67 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.891 -1.152 . . . . 75.12 107.891 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.33 -111.37 3.24 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 123.662 0.601 . . . . 63.31 112.755 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.87 2.46 23.47 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.216 0.606 . . . . 73.44 111.042 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.525 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 11.9 pt-20 -135.71 170.46 15.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.989 0.516 . . . . 73.44 110.441 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.1 m -71.84 143.57 49.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 73.25 110.334 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.46 ' HA ' HG22 ' B' ' 31' ' ' VAL . . . -98.4 -58.77 1.89 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.919 0.888 . . . . 74.21 109.07 173.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -161.04 164.34 30.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.313 -0.858 . . . . 74.34 110.353 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.26 141.59 45.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.911 1.284 . . . . 75.14 107.646 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.74 154.59 38.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.076 0.55 . . . . 71.4 109.87 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.2 tt0 -164.96 133.88 3.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.7 -0.852 . . . . 75.34 108.7 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.8 t -127.25 145.41 34.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.68 -0.859 . . . . 75.14 108.68 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -122.98 93.09 3.85 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.744 -0.835 . . . . 74.24 108.744 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.438 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -84.69 100.43 11.47 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.601 -0.889 . . . . 71.13 108.601 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 173.5 40.1 Favored Glycine 0 C--O 1.245 0.788 0 N-CA-C 111.775 -0.53 . . . . 72.32 111.775 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.5 133.2 2.71 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.697 -0.561 . . . . 44.43 111.697 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 36.7 mt -85.85 131.12 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.373 -0.973 . . . . 74.15 108.373 172.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.54 152.85 48.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.068 0.947 . . . . 75.43 109.626 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.488 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 14.8 m -123.59 105.05 9.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.052 0.941 . . . . 73.21 108.894 -172.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.598 HG22 HD13 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -134.46 141.89 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.101 0.56 . . . . 73.05 112.053 -169.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.05 167.69 25.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.399 1.08 . . . . 74.42 109.734 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.75 -62.45 4.38 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.609 0.568 . . . . 65.24 112.328 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.533 HD12 ' HB ' ' B' ' 86' ' ' ILE . 2.5 pp -68.62 145.58 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.922 0.889 . . . . 75.12 111.992 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.439 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.33 175.52 13.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 71.55 110.45 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -122.26 29.23 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.883 0.74 . . . . 70.52 113.536 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -70.8 -33.59 70.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.889 0.875 . . . . 74.43 110.878 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.23 -29.86 61.91 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.274 -0.876 . . . . 73.33 110.779 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.66 ' HG3' ' HB3' ' E' ' 115' ' ' LEU . 0.3 OUTLIER -71.07 -43.9 66.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.552 0.741 . . . . 75.12 109.199 173.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.52 66.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.041 -0.981 . . . . 61.25 111.769 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.43 -38.56 65.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.979 0.512 . . . . 73.43 110.212 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.57 -59.14 2.87 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.368 -0.833 . . . . 75.53 110.83 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.646 ' HB3' HG22 ' B' ' 58' ' ' VAL . 6.1 mp -87.37 -14.05 41.76 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.756 0.651 . . . . 74.13 112.756 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.09 -37.15 8.5 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 120.151 -0.25 . . . . 72.31 112.668 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.15 -48.09 3.14 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.495 0.648 . . . . 70.41 111.841 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -79.38 -42.36 25.72 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.119 0.415 . . . . 75.33 112.119 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.646 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 96.6 m -61.19 -47.74 93.73 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.43 -0.795 . . . . 74.4 111.746 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -53.44 -35.2 74.87 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.03 1.82 . . . . 72.24 114.601 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.76 -33.2 75.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 118.173 0.442 . . . . 72.21 110.95 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.03 -47.11 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.071 0.948 . . . . 73.33 110.554 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 78.4 mt -78.82 -19.31 52.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.135 -0.938 . . . . 63.51 112.196 -172.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.509 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 66.6 t80 -62.92 -45.73 87.22 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.886 1.069 . . . . 71.12 113.886 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.25 -38.78 93.47 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 121.96 1.773 . . . . 75.43 113.352 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.438 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 77.2 m-85 -68.05 -45.55 73.58 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.091 0.556 . . . . 75.4 110.671 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -43.74 97.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.376 -0.829 . . . . 73.1 110.545 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -56.71 -54.79 42.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.31 1.444 . . . . 75.23 110.929 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.433 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.9 tp10 -59.26 -41.02 87.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.492 1.117 . . . . 71.31 111.018 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.493 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.8 t -68.78 -39.36 80.22 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.655 -0.248 . . . . 75.53 111.262 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.619 HG21 HG22 ' B' ' 64' ' ' VAL . 89.4 mt -62.58 -54.69 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.054 0.542 . . . . 75.41 109.79 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 39.2 m -61.78 -30.1 70.58 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 124.108 0.88 . . . . 65.51 111.526 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.6 t -67.06 -45.76 76.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.401 0.681 . . . . 74.35 110.483 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.4 mmt -67.98 -37.01 81.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.492 0.317 . . . . 74.04 110.739 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.18 -41.09 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.941 0.896 . . . . 75.53 110.195 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.9 t -65.16 -34.99 79.7 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.807 -1.088 . . . . 60.3 111.248 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.541 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 85.5 mtt-85 -68.59 -28.43 66.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.207 0.603 . . . . 73.35 111.11 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.43 9.58 61.23 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.703 0.627 . . . . 75.54 112.623 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 77.0 p 52.53 55.07 9.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.99 1.716 . . . . 73.33 112.531 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -107.52 161.22 23.85 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-N 115.63 -0.714 . . . . 73.3 110.257 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.26 -167.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 123.312 2.675 . . . . 55.35 114.046 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.773 ' HB3' ' HA ' ' C' ' 124' ' ' PRO . 29.0 pt20 -62.76 122.65 16.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.217 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.403 HD23 HG21 ' B' ' 40' ' ' VAL . 1.1 tm? -151.28 81.77 1.31 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.758 -0.83 . . . . 75.23 108.758 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.13 135.96 36.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.742 0.817 . . . . 73.14 108.887 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.582 HD13 HD13 ' B' ' 114' ' ' ILE . 0.9 OUTLIER -64.55 131.33 46.73 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 123.969 0.793 . . . . 73.35 109.005 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 146.09 87.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.506 0.722 . . . . 75.21 110.858 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.22 108.74 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.016 2.477 . . . . 75.42 113.218 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.72 123.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.621 0.768 . . . . 74.21 110.171 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -87.22 92.54 9.1 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.384 0.674 . . . . 73.02 110.005 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -62.47 -41.48 98.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.306 -0.861 . . . . 74.31 109.754 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.6 -35.16 73.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.415 -1.72 . . . . 72.41 112.015 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.37 -49.78 45.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.433 0.693 . . . . 70.13 111.867 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.79 -43.8 97.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.173 -0.677 . . . . 73.53 109.173 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -68.31 -33.62 74.66 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.009 -0.996 . . . . 74.33 110.857 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -71.35 -34.2 70.29 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.619 0.768 . . . . 65.53 109.97 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.34 -13.93 60.45 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.08 0.552 . . . . 73.31 110.92 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.93 -34.1 24.55 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.838 -0.801 . . . . 72.51 108.838 168.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 55.2 mt -102.14 29.25 5.21 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.574 0.75 . . . . 64.52 111.167 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -65.35 -23.14 66.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.693 0.797 . . . . 74.01 112.941 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.6 81.96 2.61 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.74 0.816 . . . . 74.24 109.762 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 59.6 124.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.856 1.663 . . . . 74.3 113.516 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.95 83.33 2.12 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.474 0.71 . . . . 63.53 109.674 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.47 -161.45 29.59 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.468 -0.787 . . . . 74.33 113.224 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.42 -167.69 1.93 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.482 1.113 . . . . 72.34 109.218 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.41 -87.16 0.39 Allowed Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.787 -0.525 . . . . 64.54 111.787 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -159.39 159.51 33.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.84 0.856 . . . . 71.12 109.935 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.586 ' HA ' HG23 ' B' ' 7' ' ' THR . 47.9 mt-10 -133.7 119.59 19.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.643 0.777 . . . . 63.43 109.425 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.549 ' H ' HG23 ' B' ' 7' ' ' THR . 9.2 pt-20 -149.13 173.3 13.57 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.282 1.033 . . . . 73.23 110.362 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -136.97 121.87 18.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.874 0.87 . . . . 75.45 108.988 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -87.48 146.42 25.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.884 . . . . 72.44 110.285 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.48 110.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.759 0.823 . . . . 71.23 110.276 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.074 0.95 . . . . 64.23 110.477 -177.373 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 109.872 -0.418 . . . . 63.2 109.872 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -162.92 173.95 13.0 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.197 1.399 . . . . 74.54 109.385 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.41 89.36 2.64 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.156 -1.053 . . . . 74.45 108.156 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 55.03 61.85 2.77 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.322 1.049 . . . . 74.43 110.45 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -127.03 -62.23 1.12 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 107.37 -1.344 . . . . 74.31 107.37 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.6 17.23 10.26 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.672 1.189 . . . . 73.02 112.519 171.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -99.1 146.72 25.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.329 1.052 . . . . 75.43 110.259 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 151.92 44.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.666 0.786 . . . . 75.33 111.395 174.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.584 ' HE1' ' SG ' ' C' ' 97' ' ' CYS . 25.8 ttt 64.74 116.0 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.074 1.349 . . . . 73.53 112.588 177.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 55.0 m -85.1 98.06 10.22 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.151 -1.055 . . . . 75.0 108.151 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -108.67 129.0 55.34 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.345 -0.983 . . . . 72.23 108.345 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.32 125.3 16.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.846 -0.428 . . . . 75.34 109.846 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.639 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -75.92 133.64 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 108.533 -0.914 . . . . 70.21 108.533 175.166 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -107.74 -48.73 3.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.231 0.612 . . . . 74.2 110.689 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -162.06 136.15 6.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.673 0.389 . . . . 74.43 110.16 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.639 HG13 HD11 ' C' ' 13' ' ' ILE . 88.3 mt -119.87 140.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.037 -1.097 . . . . 74.23 108.037 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -173.77 161.33 3.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.229 0.538 . . . . 74.3 110.968 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -82.66 112.92 19.97 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.161 -0.927 . . . . 71.34 109.387 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -74.28 -33.27 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.195 -0.669 . . . . 75.34 109.195 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.402 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 21.2 t70 -146.52 147.17 30.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.367 -0.833 . . . . 74.13 110.233 -177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.8 mt -146.3 145.87 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.993 1.717 . . . . 65.22 106.842 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -162.96 151.97 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 122.87 0.468 . . . . 75.22 110.117 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.14 108.35 3.41 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.492 -0.929 . . . . 72.45 108.492 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.18 118.73 33.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.794 0.837 . . . . 71.41 109.218 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.58 83.81 48.12 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.55 1.14 . . . . 71.22 108.411 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.88 -19.06 31.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.732 2.288 . . . . 74.22 111.775 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' C' ' 72' ' ' THR . 77.9 m-20 -117.69 38.61 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.169 0.987 . . . . 73.52 109.51 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.467 ' HB2' ' HE3' ' D' ' 19' ' ' LYS . . . -59.07 -47.24 98.93 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 123.586 0.754 . . . . 73.22 112.705 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.97 -14.64 38.98 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.788 1.659 . . . . 74.44 113.852 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -67.61 -23.91 65.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 119.186 -0.435 . . . . 74.41 111.984 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.59 -29.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.727 0.811 . . . . 72.2 112.523 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.458 ' HE1' HH11 ' D' ' 15' ' ' ARG . 38.2 m-85 -68.75 -41.44 78.89 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.229 0.612 . . . . 70.21 111.315 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.26 5.78 49.45 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.047 -0.979 . . . . 73.42 110.527 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.439 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 4.6 ttmp? -93.47 145.85 24.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.66 0.784 . . . . 74.24 110.403 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.44 132.07 34.62 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.861 -1.162 . . . . 64.31 107.861 172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -74.99 78.48 2.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 122.312 1.053 . . . . 74.01 111.575 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.422 ' O ' HD13 ' C' ' 68' ' ' LEU . 38.0 tt0 -157.56 65.13 3.33 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 113.924 -1.489 . . . . 74.11 108.327 168.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.08 150.81 4.75 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.653 1.569 . . . . 73.25 111.254 169.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -86.32 96.06 9.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.522 -1.288 . . . . 72.33 107.522 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.53 98.35 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.474 1.131 . . . . 74.51 108.86 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -91.18 116.84 29.14 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.805 -1.543 . . . . 74.24 108.331 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.557 HD12 HD12 ' C' ' 128' ' ' LEU . 30.1 tp -84.24 144.12 29.13 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.374 -0.973 . . . . 75.11 108.374 172.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.493 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.9 t70 -137.47 128.56 27.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.496 -1.298 . . . . 73.43 107.496 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.83 132.07 38.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.049 -0.723 . . . . 75.1 109.049 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -137.65 155.84 48.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.805 0.842 . . . . 72.54 109.009 174.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -138.32 149.52 45.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.923 0.489 . . . . 64.23 109.921 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 167.59 21.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.768 0.827 . . . . 64.03 109.179 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.3 p -148.3 144.64 27.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.649 0.379 . . . . 72.23 111.062 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 75.9 p -147.66 145.77 29.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.062 0.945 . . . . 74.1 110.242 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -87.14 130.56 34.47 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.007 -0.738 . . . . 74.31 109.007 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.695 HD12 ' HB2' ' C' ' 57' ' ' GLU . 59.5 mt -106.37 -41.84 5.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.627 0.771 . . . . 74.31 109.944 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.18 -169.32 3.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.507 0.723 . . . . 53.52 110.736 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.83 108.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.132 -0.94 . . . . 73.15 109.396 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.417 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 52.1 m-20 69.97 -0.84 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.639 1.175 . . . . 64.13 113.269 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -96.68 113.95 32.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.533 0.733 . . . . 75.42 109.166 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.97 130.16 52.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.361 1.064 . . . . 74.32 108.71 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.695 ' HB2' HD12 ' C' ' 51' ' ' LEU . 44.6 tt0 -87.98 143.9 26.84 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.362 -0.835 . . . . 72.34 108.817 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.478 HG12 HD11 ' C' ' 106' ' ' LEU . 2.6 p -125.46 124.6 67.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.557 -0.905 . . . . 74.54 108.557 169.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.85 104.69 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.578 -1.267 . . . . 74.55 107.578 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.49 100.85 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.974 0.91 . . . . 75.33 108.759 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -81.65 124.15 29.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.573 0.749 . . . . 73.4 110.237 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.26 126.56 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.531 -1.285 . . . . 72.41 107.531 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.5 m -128.59 128.79 44.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.899 -0.778 . . . . 74.33 108.899 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.541 HG21 HD12 ' C' ' 114' ' ' ILE . 88.5 t -110.71 110.16 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.664 -0.865 . . . . 73.11 108.664 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.8 m -99.34 110.29 22.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.85 -0.796 . . . . 73.14 108.85 173.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.22 99.97 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.488 -1.301 . . . . 73.44 107.488 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -146.65 156.45 43.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.647 0.592 . . . . 50.53 109.865 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.422 HD13 ' O ' ' C' ' 37' ' ' GLN . 53.7 tp -111.8 80.18 1.29 Allowed 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.767 -1.568 . . . . 74.12 106.767 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.91 -96.2 0.18 Allowed Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.903 -1.044 . . . . 72.11 112.339 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -91.13 -31.94 16.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.847 0.859 . . . . 74.32 111.221 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.404 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 13.2 tp10 -87.22 93.13 9.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.652 0.781 . . . . 71.23 110.281 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 60.8 m -84.72 130.44 34.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.826 -0.624 . . . . 75.34 111.038 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.36 -55.76 4.67 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.028 0.931 . . . . 63.4 109.863 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -157.37 170.73 21.8 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.408 0.623 . . . . 74.12 111.721 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -143.51 111.5 6.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.723 -1.584 . . . . 70.23 106.723 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.8 t -111.02 143.98 40.86 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.981 -0.748 . . . . 74.32 108.981 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -147.55 117.8 7.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.203 0.601 . . . . 75.33 109.621 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.87 114.99 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.787 1.235 . . . . 74.32 109.234 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 24.5 mt-30 -94.16 102.62 14.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.141 -0.689 . . . . 72.31 109.141 172.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.546 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.1 tp-100 -87.56 109.4 19.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.471 0.708 . . . . 70.2 109.34 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.62 146.88 20.26 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.617 -0.593 . . . . 73.41 111.617 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.46 117.36 1.27 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.569 -0.613 . . . . 71.54 111.569 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 12.8 mm -83.01 126.09 40.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.614 -0.884 . . . . 71.34 108.614 174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -140.62 138.33 34.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.649 0.38 . . . . 71.42 110.114 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -94.54 117.75 30.61 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.417 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.8 pp -116.12 142.06 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 122.72 0.408 . . . . 74.33 110.113 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.55 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -155.86 155.82 33.59 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.219 0.608 . . . . 75.41 110.443 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -45.81 3.32 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.195 -0.457 . . . . 70.4 112.556 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -88.7 151.03 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.8 0.84 . . . . 64.14 109.09 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.9 -179.45 7.66 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.858 0.463 . . . . 72.33 109.811 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.23 -137.33 50.1 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 115.268 0.867 . . . . 73.24 115.268 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -72.2 -20.09 61.63 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 73.45 112.39 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.403 HE21 ' HB2' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -80.12 -38.77 30.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.23 0.212 . . . . 65.44 110.863 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 16.9 ptt? -70.21 -31.81 69.41 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.443 -0.577 . . . . 72.24 109.443 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.07 71.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.474 -0.785 . . . . 73.14 110.433 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -61.67 -49.17 77.59 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.459 0.474 . . . . 75.13 110.173 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.584 ' SG ' ' HE1' ' C' ' 9' ' ' MET . 46.8 t -61.96 -48.86 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.51 0.506 . . . . 73.45 110.478 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.69 -16.35 63.33 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.613 0.765 . . . . 74.43 111.38 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.0 10.8 20.62 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-O 119.622 -0.544 . . . . 73.31 114.279 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.15 -61.11 0.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.703 0.751 . . . . 64.35 111.02 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.4 -56.68 6.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.707 0.403 . . . . 73.23 111.673 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.44 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 60.7 m -56.81 -46.95 99.8 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.59 0.756 . . . . 74.23 111.951 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 92.1 Cg_exo -53.32 -38.35 82.06 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 122.512 2.141 . . . . 64.43 114.923 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -63.4 -36.44 83.75 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 123.81 0.844 . . . . 65.31 110.506 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.68 -40.21 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.586 0.755 . . . . 73.51 110.414 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.478 HD11 HG12 ' C' ' 58' ' ' VAL . 64.2 mt -85.72 -26.12 26.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.565 -1.198 . . . . 74.04 112.096 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -55.52 -47.58 98.32 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 113.809 1.04 . . . . 73.24 113.809 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.32 -40.43 82.02 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.277 1.984 . . . . 74.22 113.612 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -65.7 -43.37 89.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.165 0.586 . . . . 73.44 110.374 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -69.5 -33.74 73.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.414 -0.812 . . . . 73.51 111.241 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -64.98 -47.36 77.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 74.14 110.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -71.92 -33.0 67.92 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.695 -0.684 . . . . 73.02 109.552 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.409 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 47.9 t -69.12 -31.15 69.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.234 0.614 . . . . 73.13 111.089 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.541 HD12 HG21 ' C' ' 64' ' ' VAL . 63.3 mt -72.62 -51.52 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.04 0.536 . . . . 71.22 109.762 171.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 39.9 m -61.73 -31.08 71.22 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.815 0.446 . . . . 73.33 111.143 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -60.18 -54.31 47.41 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.181 0.992 . . . . 64.01 108.995 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.648 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.82 -42.32 79.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.031 1.333 . . . . 73.43 112.475 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.413 HG21 ' O ' ' C' ' 114' ' ' ILE . 85.5 t -66.02 -40.85 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 72.43 109.924 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -73.75 -24.04 59.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.935 -1.03 . . . . 73.14 111.645 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.3 mtt-85 -74.1 -40.06 62.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.254 -0.647 . . . . 75.2 109.254 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -1.24 65.31 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.824 0.703 . . . . 64.14 112.229 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.455 HG21 ' HB3' ' D' ' 17' ' ' TYR . 37.5 p 63.73 25.8 14.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.869 2.067 . . . . 64.34 112.83 173.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.12 158.77 63.8 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.049 0.94 . . . . 73.32 108.538 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.773 ' HA ' ' HB3' ' B' ' 125' ' ' GLN . 36.3 Cg_endo -61.25 151.32 79.89 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.799 2.333 . . . . 74.31 114.206 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -56.55 112.05 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.084 1.354 . . . . 72.11 111.761 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.06 90.15 3.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.524 -1.287 . . . . 75.55 107.524 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -91.31 110.38 21.68 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.527 -0.916 . . . . 73.31 108.527 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.557 HD12 HD12 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -77.19 134.17 38.72 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.095 0.958 . . . . 74.34 110.316 -171.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.79 144.96 83.61 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.252 1.021 . . . . 75.23 111.846 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.443 ' HG3' HG12 ' A' ' 16' ' ' ILE . 93.1 Cg_endo -78.54 104.13 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.816 2.344 . . . . 70.15 112.895 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.62 107.73 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.111 -1.441 . . . . 63.21 107.111 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -105.64 98.02 7.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.081 0.552 . . . . 70.35 109.803 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -67.1 -36.95 83.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.432 0.693 . . . . 64.04 110.1 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -56.94 -48.96 77.08 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.449 -1.25 . . . . 74.52 111.702 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.27 63.24 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.04 0.936 . . . . 54.52 112.844 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.695 HD11 HD23 ' E' ' 148' ' ' LEU . 8.3 mp -69.79 -47.61 62.23 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.267 0.627 . . . . 73.54 110.507 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.97 -27.05 61.59 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.391 0.676 . . . . 73.41 111.617 -174.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 94.3 mmm -71.47 -39.7 70.75 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.145 0.578 . . . . 73.22 111.417 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -71.59 -38.79 70.84 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 110.123 -0.325 . . . . 72.14 110.123 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -55.19 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.695 0.798 . . . . 74.22 110.916 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.3 87.39 3.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.447 0.642 . . . . 73.24 109.381 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -69.96 158.32 35.83 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.436 -1.256 . . . . 75.04 110.946 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -114.56 -71.06 0.76 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.527 0.331 . . . . 75.54 110.33 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.468 ' HG3' ' HB3' ' A' ' 143' ' ' GLN . 0.5 OUTLIER 57.03 86.91 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.684 1.194 . . . . 74.21 110.323 -171.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.33 -172.11 3.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.039 -0.982 . . . . 70.44 108.595 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.17 83.67 0.04 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 112.005 -0.438 . . . . 75.21 112.005 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.71 89.47 0.55 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.32 -1.363 . . . . 73.04 107.32 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -123.25 60.39 0.59 Allowed Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.19 -0.913 . . . . 72.41 112.456 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 p -64.14 178.13 0.72 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.002 0.521 . . . . 64.42 111.371 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -64.73 139.82 58.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.051 0.54 . . . . 71.32 111.538 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.18 101.47 0.41 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.015 0.926 . . . . 72.11 108.836 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -78.79 102.98 8.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.566 0.747 . . . . 73.45 110.818 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -147.85 102.77 3.44 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 75.31 108.536 168.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.05 169.13 9.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.555 1.142 . . . . 65.33 110.086 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.359 0 C-N-CA 123.637 0.775 . . . . 73.11 110.544 -175.586 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 111.14 0.052 . . . . 73.24 111.14 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -140.38 150.99 44.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.989 0.516 . . . . 72.34 110.326 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -171.55 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.195 0.998 . . . . 74.45 109.346 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 66.45 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.794 1.238 . . . . 75.44 108.654 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.526 ' HB3' ' HG2' ' D' ' 8' ' ' GLU . 17.5 t-20 177.21 145.4 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.067 1.347 . . . . 73.34 108.084 167.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -63.81 -32.98 74.67 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.288 0.635 . . . . 74.33 112.239 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.458 HG22 ' OD1' ' D' ' 5' ' ' ASN . 4.3 t -82.78 -19.47 37.7 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 117.659 0.209 . . . . 74.04 111.196 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.526 ' HG2' ' HB3' ' D' ' 5' ' ' ASN . 27.1 mm-40 -70.11 -16.02 63.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 119.114 -0.47 . . . . 65.51 111.773 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 19.3 ttt -32.16 133.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.528 1.131 . . . . 75.32 113.518 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 90.3 m -142.55 139.96 31.59 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.409 1.084 . . . . 72.34 108.326 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.455 ' CE2' ' SG ' ' D' ' 102' ' ' CYS . 79.5 t80 -155.01 101.09 2.24 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.529 -1.285 . . . . 72.01 107.529 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.23 122.7 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.88 0.472 . . . . 73.23 109.825 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.13 119.75 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 109.138 -0.69 . . . . 74.14 109.138 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.455 HE22 HG22 ' D' ' 55' ' ' VAL . 40.9 mt-30 -98.67 -46.46 5.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.574 0.35 . . . . 74.42 110.586 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.608 HH12 HG23 ' E' ' 134' ' ' ILE . 34.5 ttt180 -165.07 120.08 1.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.505 -0.183 . . . . 72.21 110.505 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -103.06 136.91 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.77 -1.196 . . . . 55.45 107.77 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.455 ' HB3' HG21 ' C' ' 122' ' ' THR . 31.2 p90 -164.37 177.59 8.12 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.826 0.85 . . . . 74.32 110.763 -177.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -107.5 127.56 53.72 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.738 -0.665 . . . . 71.35 110.013 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 27.4 mtpt -95.54 -30.99 13.54 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.529 -0.545 . . . . 72.44 109.529 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.771 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -144.61 134.9 24.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.834 -0.802 . . . . 74.22 108.834 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.648 HG21 ' HE1' ' C' ' 117' ' ' MET . 27.1 mt -139.04 147.7 24.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.144 -1.428 . . . . 75.21 107.144 174.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -155.13 147.47 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.986 0.422 . . . . 74.41 110.351 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 67.8 t80 -150.06 127.89 11.76 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.16 1.384 . . . . 71.31 107.351 173.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -126.61 148.06 49.83 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.039 0.936 . . . . 74.32 108.974 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.25 84.03 61.14 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.816 -0.809 . . . . 72.42 108.816 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.24 -48.06 5.3 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.789 2.993 . . . . 65.42 114.195 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -111.87 45.57 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.885 -0.783 . . . . 74.22 108.885 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.79 -59.34 9.06 Favored Pre-proline 0 CA--C 1.575 1.928 0 N-CA-C 115.703 1.742 . . . . 74.52 115.703 -166.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.66 -4.45 10.73 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 122.545 1.945 . . . . 72.21 112.99 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -84.15 -35.62 23.47 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.332 1.053 . . . . 72.12 110.476 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 p -84.31 -13.29 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.394 0.616 . . . . 72.31 110.411 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -30.7 69.71 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.862 -0.608 . . . . 74.4 109.939 166.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -72.38 -6.28 42.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.444 1.098 . . . . 74.43 111.943 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -125.41 87.13 2.65 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.379 1.072 . . . . 75.22 109.225 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.489 ' HB2' ' HA ' ' F' ' 134' ' ' ILE . 7.2 p-10 -80.23 93.86 5.95 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.172 0.987 . . . . 73.45 110.425 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.38 170.98 20.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.314 1.046 . . . . 75.01 109.815 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.59 107.37 7.12 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.191 -1.04 . . . . 64.2 108.191 166.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.63 153.92 76.25 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.945 2.43 . . . . 71.51 113.001 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.01 123.81 23.59 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.444 -0.947 . . . . 73.33 108.444 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.513 HG11 HD12 ' D' ' 126' ' ' LEU . 7.7 p -117.71 142.35 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.079 0.552 . . . . 74.52 110.283 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' D' ' 41' ' ' LYS . 11.4 mmpt? -109.77 123.83 50.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.344 1.058 . . . . 64.23 108.711 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.62 126.87 55.84 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.464 0.706 . . . . 75.23 110.566 -171.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -130.67 120.2 23.56 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.945 0.898 . . . . 75.35 109.168 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.55 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.8 pt? -108.48 132.56 53.69 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.219 -0.66 . . . . 73.31 109.219 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.446 ' O ' HD21 ' D' ' 60' ' ' LEU . 26.7 t70 -135.48 145.26 46.96 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.862 0.865 . . . . 64.11 108.967 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -123.59 155.58 37.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.852 0.834 . . . . 74.4 111.62 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.509 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.19 166.86 27.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 113.801 -1.545 . . . . 62.32 108.073 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.4 p -151.91 156.38 39.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.133 0.573 . . . . 70.23 109.568 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -158.51 119.03 3.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.774 0.83 . . . . 73.31 109.022 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.71 117.79 11.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.987 -0.746 . . . . 74.53 108.987 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.55 -36.38 17.61 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.306 -0.627 . . . . 74.32 109.306 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.84 -171.38 2.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 71.11 111.322 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -54.8 104.68 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.607 1.563 . . . . 73.32 111.371 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 58.33 20.65 7.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.19 0.996 . . . . 74.2 112.432 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.455 HG22 HE22 ' D' ' 14' ' ' GLN . 75.3 t -109.46 122.22 63.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 107.523 -1.288 . . . . 74.14 107.523 170.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -130.89 128.41 40.5 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.836 -0.801 . . . . 73.22 108.836 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -88.66 135.88 33.28 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.528 1.131 . . . . 72.4 108.464 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 81.3 t -117.87 139.83 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.34 -0.985 . . . . 71.23 108.34 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.6 t -115.78 141.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.237 -1.023 . . . . 73.21 108.237 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.53 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.36 118.61 24.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.287 -1.375 . . . . 73.04 107.287 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -107.28 97.86 7.57 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.963 -0.754 . . . . 72.42 108.963 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.02 125.74 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.876 -0.787 . . . . 74.54 108.876 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -113.1 144.43 42.65 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.691 0.796 . . . . 73.33 109.798 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.56 HG22 HG21 ' D' ' 114' ' ' ILE . 25.6 t -135.8 104.82 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.243 1.417 . . . . 73.41 108.367 -173.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 10.0 m -112.14 90.99 3.49 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.563 -1.273 . . . . 72.32 107.563 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.53 125.32 42.17 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.44 -0.578 . . . . 74.04 109.44 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.9 p -158.69 124.92 4.58 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.167 0.987 . . . . 71.55 109.539 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.85 130.07 43.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.556 -1.276 . . . . 74.32 107.556 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 -146.41 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.012 -0.54 . . . . 64.31 113.323 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -88.03 11.11 16.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.207 1.003 . . . . 65.12 112.239 -177.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.76 161.9 40.31 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.819 0.342 . . . . 63.43 111.428 -167.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -83.33 124.79 30.96 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.644 -0.707 . . . . 71.34 110.063 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.416 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -73.4 -63.84 1.11 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.125 0.97 . . . . 71.42 110.161 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -157.87 157.56 33.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.142 0.496 . . . . 74.12 111.065 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.96 146.62 47.45 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.408 1.083 . . . . 73.13 109.075 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.554 ' SG ' ' HE3' ' D' ' 117' ' ' MET . 53.7 t -160.0 141.42 12.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.191 0.596 . . . . 65.14 110.334 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.41 122.34 5.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.374 -0.602 . . . . 71.52 109.374 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . 0.479 HG23 HG22 ' D' ' 21' ' ' ILE . 47.8 t -124.48 123.95 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.446 0.698 . . . . 74.33 110.581 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.771 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.5 93.61 9.57 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.386 0.612 . . . . 74.33 109.396 164.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.69 109.88 14.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.979 -1.009 . . . . 74.44 108.371 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.69 149.37 19.1 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 111.735 -0.546 . . . . 64.4 111.735 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -144.22 130.52 4.02 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 110.885 -0.886 . . . . 74.42 110.885 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.77 126.34 41.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.022 -1.103 . . . . 74.24 108.022 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -129.98 162.75 27.97 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.297 -0.631 . . . . 73.41 109.297 177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -116.35 101.62 8.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.556 0.742 . . . . 71.24 109.354 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.77 110.63 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.083 0.953 . . . . 72.14 110.097 -174.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.53 38.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.012 0.925 . . . . 74.53 109.829 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.76 -20.0 6.84 Favored Glycine 0 N--CA 1.477 1.432 0 N-CA-C 114.646 0.619 . . . . 63.01 114.646 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.471 HD12 ' HG3' ' D' ' 93' ' ' GLN . 4.4 tt -121.16 137.26 55.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 C-N-CA 124.237 1.015 . . . . 75.21 109.478 -174.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.69 -170.99 3.81 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.72 0.808 . . . . 72.3 110.822 -177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.5 -140.81 26.76 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.32 0.387 . . . . 73.05 113.606 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -80.0 -24.44 40.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.52 0.728 . . . . 74.15 110.833 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.471 ' HG3' HD12 ' D' ' 89' ' ' ILE . 6.5 tp-100 -70.26 -36.95 74.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.135 0.574 . . . . 62.12 110.632 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -33.6 62.76 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.668 -0.493 . . . . 65.43 109.668 174.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.76 81.2 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.361 0.601 . . . . 74.42 110.425 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.425 ' HB2' HD13 ' D' ' 141' ' ' LEU . 8.2 t-80 -67.71 -44.81 76.79 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.972 -1.013 . . . . 73.14 111.231 172.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.96 -50.5 73.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.051 0.54 . . . . 73.42 110.699 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.34 -22.85 54.39 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.869 0.868 . . . . 73.53 111.316 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.2 -7.56 46.24 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 115.215 0.846 . . . . 75.14 115.215 -172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.28 -51.86 0.35 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.793 0.796 . . . . 71.34 110.965 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -71.8 -39.44 69.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.764 0.426 . . . . 74.24 112.057 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.455 ' SG ' ' CE2' ' D' ' 11' ' ' PHE . 57.7 m -73.37 -44.59 7.59 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.693 -0.67 . . . . 74.24 111.347 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.53 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 64.6 Cg_exo -56.64 -32.75 91.58 Favored 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 121.983 1.789 . . . . 71.33 113.244 168.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -63.82 -35.75 81.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.205 0.602 . . . . 64.33 110.669 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -65.75 -42.11 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.437 0.695 . . . . 71.53 110.111 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.45 HD22 ' HA3' ' D' ' 82' ' ' GLY . 94.0 mt -75.9 -19.26 58.97 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.075 -0.966 . . . . 75.31 112.318 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.23 -43.84 56.41 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 113.851 1.056 . . . . 74.14 113.851 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.99 -41.4 79.2 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.937 1.758 . . . . 75.03 113.512 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.43 -38.36 68.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.516 0.726 . . . . 74.22 111.525 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.65 79.35 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.486 0.714 . . . . 71.23 110.398 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -55.35 -52.37 63.72 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.507 1.129 . . . . 73.34 110.6 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.18 -43.95 93.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.894 0.746 . . . . 74.53 111.779 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.504 ' SG ' HD11 ' D' ' 21' ' ' ILE . 51.6 t -55.35 -40.3 71.07 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.764 0.665 . . . . 74.5 110.833 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.56 HG21 HG22 ' D' ' 64' ' ' VAL . 97.3 mt -65.83 -53.38 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.071 -0.968 . . . . 73.21 110.483 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.421 HG22 ' HG3' ' D' ' 125' ' ' GLN . 22.5 m -57.31 -35.99 70.53 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.252 1.021 . . . . 71.42 111.818 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.99 -45.69 76.86 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.204 -0.907 . . . . 74.45 110.139 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.554 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 79.1 mtm -65.6 -31.45 72.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.24 0.616 . . . . 72.02 111.7 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.4 HG23 ' O ' ' D' ' 114' ' ' ILE . 71.2 t -66.25 -46.21 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.388 -0.824 . . . . 73.43 110.038 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.03 -25.44 60.95 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.333 -0.394 . . . . 74.32 111.428 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.409 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -74.39 -35.42 63.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.588 0.755 . . . . 65.24 109.676 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.67 -1.37 83.11 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 115.692 -0.685 . . . . 72.32 112.111 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p 57.19 36.29 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.2 1.8 . . . . 73.54 111.825 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.62 158.31 32.38 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 113.908 -1.496 . . . . 72.03 109.815 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.5 ' HB2' HD11 ' F' ' 139' ' ' LEU . 73.1 Cg_exo -54.13 128.24 29.07 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.526 2.151 . . . . 74.2 113.07 174.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.421 ' HG3' HG22 ' D' ' 115' ' ' THR . 27.1 tt0 -52.39 140.97 20.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.052 1.341 . . . . 73.41 112.702 -175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.513 HD12 HG11 ' D' ' 40' ' ' VAL . 28.2 tp -112.99 126.77 55.86 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.11 -0.7 . . . . 73.54 109.11 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.451 ' HB3' HG13 ' B' ' 13' ' ' ILE . 94.3 m-20 -121.28 103.78 9.23 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.074 0.95 . . . . 70.0 109.025 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.76 119.75 12.36 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.641 0.776 . . . . 73.12 110.12 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.18 88.32 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.089 0.556 . . . . 75.12 110.602 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 110.7 1.36 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.464 2.109 . . . . 75.25 111.827 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.65 110.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.08 -1.082 . . . . 75.34 108.08 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' D' ' 135' ' ' ALA . 59.3 t30 -82.31 75.29 9.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.157 0.979 . . . . 73.53 109.375 -176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.523 ' HA ' HD21 ' F' ' 148' ' ' LEU . 28.4 t80 -78.51 -24.05 46.0 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.304 -1.316 . . . . 75.3 109.767 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -52.66 -34.96 54.02 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.585 1.554 . . . . 71.45 111.287 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.468 ' HB3' ' ND2' ' D' ' 132' ' ' ASN . . . -63.32 -31.96 73.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.04 0.936 . . . . 71.52 112.992 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 46.8 tp -66.22 -37.34 85.33 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.254 0.549 . . . . 74.25 110.379 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -66.15 -28.54 68.86 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.168 -0.924 . . . . 72.33 112.872 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.3 mmt -52.35 -50.07 63.08 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.041 0.448 . . . . 72.42 110.041 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -66.32 -49.19 67.86 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.946 -1.025 . . . . 72.52 110.389 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.58 1.552 . . . . 75.34 112.285 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' D' ' 96' ' ' HIS . 8.0 mp -67.16 -51.14 57.48 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.304 1.042 . . . . 74.22 110.958 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -77.2 -4.04 42.66 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 116.069 -0.514 . . . . 71.44 112.144 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -122.41 41.85 3.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.459 -0.941 . . . . 74.41 108.459 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -162.96 -71.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.808 1.643 . . . . 75.52 107.637 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.23 89.55 0.03 OUTLIER 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.225 1.41 . . . . 72.42 111.022 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.92 -168.66 12.7 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 116.234 -0.439 . . . . 52.3 112.389 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.47 121.78 21.54 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.828 -0.804 . . . . 74.43 108.828 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.41 65.0 0.6 Allowed Glycine 0 C--N 1.341 0.835 0 N-CA-C 111.455 -0.658 . . . . 75.3 111.455 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.9 t -156.92 175.52 13.97 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.878 -0.786 . . . . 70.25 108.878 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 -53.63 0.71 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.012 0.525 . . . . 74.52 110.131 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 175.61 132.98 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.211 1.004 . . . . 74.42 108.318 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -119.97 118.02 29.58 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.619 -1.252 . . . . 74.45 107.619 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -65.23 101.34 0.54 Allowed 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.366 0.603 . . . . 73.01 110.666 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.75 122.89 26.59 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.087 -1.415 . . . . 65.2 108.424 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.135 0.974 . . . . 65.44 108.726 -178.369 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 108.851 -0.796 . . . . 72.13 108.851 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.58 36.01 26.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.421 1.088 . . . . 71.02 112.204 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.8 63.89 6.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.438 0.695 . . . . 74.53 109.507 175.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -78.17 143.87 36.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.526 -0.761 . . . . 74.43 109.88 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -77.76 84.05 4.1 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.985 -0.552 . . . . 72.24 110.352 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.23 166.65 23.15 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.019 -0.991 . . . . 75.31 109.271 171.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.45 -73.85 0.09 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.165 0.586 . . . . 72.44 109.683 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.66 ' HB3' ' HG3' ' B' ' 94' ' ' MET . 6.7 mp -141.01 -33.14 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.478 0.711 . . . . 74.13 111.699 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -125.85 83.64 62.34 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 123.11 0.564 . . . . 75.3 111.065 -166.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.54 -17.44 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.014 2.476 . . . . 70.33 113.394 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -109.31 118.8 37.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.472 0.709 . . . . 73.43 109.873 -164.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 44.6 p -116.86 60.53 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.958 0.903 . . . . 75.33 110.222 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.441 ' CD1' HG22 ' B' ' 46' ' ' THR . 15.1 m95 64.14 -82.19 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.978 1.311 . . . . 75.4 113.165 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 27.7 t70 67.79 153.06 0.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.959 1.304 . . . . 64.0 110.952 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 59.34 34.9 23.04 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.159 0.984 . . . . 71.43 111.716 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.6 87.99 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.099 -0.955 . . . . 72.02 109.72 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -142.61 92.22 2.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.763 -1.199 . . . . 75.12 107.763 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -84.91 67.97 10.35 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.158 -1.053 . . . . 74.32 108.158 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -82.8 80.57 8.84 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.447 -0.946 . . . . 74.1 108.447 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.2 110.09 1.23 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.286 -1.324 . . . . 53.33 109.997 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.89 102.64 0.8 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.723 -0.473 . . . . 75.11 109.723 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 pp -161.14 148.41 15.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.086 0.954 . . . . 73.22 110.023 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 7.3 tp -157.94 89.2 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.61 0.764 . . . . 73.43 109.354 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 56.85 -150.65 0.43 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.262 1.025 . . . . 60.12 111.081 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -98.48 124.3 47.08 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.658 -1.238 . . . . 73.33 107.658 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.09 106.99 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.9 2.4 . . . . 74.21 113.696 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . 0.608 HG23 HH12 ' D' ' 15' ' ' ARG . 7.7 tt -167.84 120.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.167 0.987 . . . . 73.45 109.532 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.98 89.66 7.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.398 0.679 . . . . 74.1 110.324 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 t -86.22 -22.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.878 0.471 . . . . 74.41 109.91 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 66.25 -170.97 0.19 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.594 1.158 . . . . 72.33 113.139 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.59 119.88 24.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.28 0.632 . . . . 73.12 110.311 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.39 126.45 37.48 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.234 1.014 . . . . 74.3 109.864 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -150.58 110.89 4.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.48 0.712 . . . . 74.21 109.869 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 3.6 tt -159.82 78.82 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.359 -1.349 . . . . 74.53 107.359 177.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 15.7 pt -137.79 -50.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.56 0.744 . . . . 73.5 110.505 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -143.76 -59.89 0.4 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.054 -1.461 . . . . 73.13 107.054 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 73.89 -4.25 2.31 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.365 1.466 . . . . 64.25 113.297 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . 0.594 ' HZ2' ' HB3' ' E' ' 145' ' ' LYS . 9.3 mtpm? -133.93 -76.67 0.47 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.579 0.752 . . . . 71.3 109.852 172.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.82 96.66 10.55 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.169 0.987 . . . . 71.54 110.041 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.52 -56.89 4.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.761 -1.2 . . . . 73.24 107.761 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.695 HD23 HD11 ' C' ' 136' ' ' LEU . 5.9 tt -170.55 96.39 0.45 Allowed Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 107.392 -1.336 . . . . 74.32 107.392 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.57 2.281 0 C-N-CA 123.316 2.678 . . . . 74.23 111.928 174.498 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.002 -0.37 . . . . 73.35 110.002 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -133.57 158.03 44.21 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.255 1.022 . . . . 75.44 109.468 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 119.1 6.42 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.961 0.905 . . . . 73.22 108.765 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -117.44 95.13 4.82 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 74.42 108.546 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.35 22.62 10.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.763 0.825 . . . . 74.34 110.695 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.19 113.1 1.97 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.348 1.059 . . . . 75.15 110.148 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -166.44 152.18 8.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.023 -0.732 . . . . 73.51 109.023 -171.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.422 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 11.6 tp -78.51 72.59 5.04 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.09 -0.707 . . . . 73.24 109.09 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . 0.421 ' HH ' ' HD2' ' F' ' 118' ' ' PHE . 55.9 t80 -154.86 87.72 3.32 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.147 0.979 . . . . 74.11 108.675 -178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.408 ' HD2' HD12 ' A' ' 98' ' ' LEU . 44.3 Cg_endo -91.89 9.04 2.87 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 123.185 2.59 . . . . 71.24 113.834 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . 0.421 ' HD2' ' HH ' ' F' ' 116' ' ' TYR . 68.7 t80 -78.63 94.58 5.06 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.339 -0.615 . . . . 72.24 109.339 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 32.6 m -133.71 87.72 2.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.161 -1.051 . . . . 74.21 108.161 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . 0.429 ' CZ2' ' HB3' ' F' ' 122' ' ' ALA . 59.3 t90 -159.13 148.06 18.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.911 0.885 . . . . 75.13 109.349 -176.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -146.68 98.16 3.02 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 74.34 110.372 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . 0.429 ' HB3' ' CZ2' ' F' ' 120' ' ' TRP . . . -167.9 83.76 0.2 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.798 0.839 . . . . 64.24 109.677 169.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.09 136.05 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.363 0.665 . . . . 60.03 110.512 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.8 146.56 50.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.991 0.916 . . . . 74.14 108.836 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . 0.425 ' HE2' ' HA ' ' A' ' 43' ' ' ASP . 32.5 p90 -151.6 147.51 26.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.859 0.864 . . . . 72.33 109.32 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -145.7 -173.89 4.26 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.407 0.683 . . . . 75.42 110.201 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . 0.467 ' HA3' HD13 ' A' ' 42' ' ' LEU . . . -157.9 87.76 0.12 Allowed Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.251 -0.431 . . . . 73.12 112.231 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -76.47 -75.37 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.147 -1.057 . . . . 75.34 108.147 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.43 ' HB3' ' H ' ' F' ' 130' ' ' ILE . 9.2 mp 47.58 -146.94 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.734 1.213 . . . . 73.14 111.751 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . 0.43 ' H ' ' HB3' ' F' ' 129' ' ' LEU . 37.4 mm 58.21 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.708 1.203 . . . . 62.03 110.91 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.07 111.17 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.1 -0.955 . . . . 74.14 109.135 177.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 40.6 t80 69.14 112.87 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.94 1.296 . . . . 75.55 110.785 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.42 150.02 19.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.712 2.275 . . . . 74.14 112.264 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.489 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 14.8 tt -142.03 118.02 6.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 109.23 -0.656 . . . . 74.11 109.23 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.23 95.66 5.04 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.033 -0.729 . . . . 71.21 109.033 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 13.6 m -82.49 79.07 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 122.238 1.018 . . . . 75.24 110.354 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -115.13 -176.68 2.96 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.108 -0.951 . . . . 75.42 110.79 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.26 134.22 44.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.485 0.714 . . . . 52.23 112.834 -169.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.5 HD11 ' HB2' ' D' ' 124' ' ' PRO . 10.3 mp -83.47 43.17 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.612 1.165 . . . . 73.21 110.465 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 31.9 m -75.4 -13.74 60.42 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.345 0.658 . . . . 74.42 111.333 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.41 -27.34 65.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.151 0.98 . . . . 74.52 112.965 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.49 HG21 ' H ' ' D' ' 40' ' ' VAL . 2.9 pp -78.22 2.27 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.524 0.73 . . . . 75.33 112.81 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -103.01 156.82 17.41 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.686 0.794 . . . . 72.31 111.153 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -145.65 45.84 1.29 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.991 0.916 . . . . 71.43 108.532 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt 73.08 -18.35 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.466 1.506 . . . . 71.25 112.886 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.83 92.32 2.51 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.049 0.94 . . . . 74.32 110.493 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 87.2 mt -119.16 35.13 4.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.3 1.04 . . . . 73.42 108.388 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' D' ' 133' ' ' PHE . 8.5 mp 59.43 67.2 1.94 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 114.059 -1.428 . . . . 71.1 109.589 -163.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.389 2.689 0 C-N-CA 123.762 2.975 . . . . 71.14 111.6 -178.656 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.765 0.317 . . . . 64.35 110.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -74.94 92.69 2.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.134 0.574 . . . . 73.34 109.477 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -94.93 33.61 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.654 -0.703 . . . . 72.23 111.094 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -78.79 91.62 4.74 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.139 -1.06 . . . . 75.33 108.139 170.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.404 ' N ' HD21 ' A' ' 5' ' ' ASN . 0.8 OUTLIER -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.439 0.696 . . . . 71.31 110.475 -173.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -149.66 128.7 12.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.188 -0.671 . . . . 73.32 109.188 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -78.91 83.93 4.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.144 -0.687 . . . . 73.44 109.144 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.64 -165.66 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.053 -0.976 . . . . 72.41 110.295 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.544 ' HE3' HE22 ' A' ' 93' ' ' GLN . 58.3 mtt 74.93 177.52 0.22 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.385 1.074 . . . . 74.13 111.96 170.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.6 m -140.93 130.67 24.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.624 0.769 . . . . 73.13 109.498 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -133.17 112.38 11.68 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.744 -1.206 . . . . 74.33 107.744 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -140.06 110.5 6.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.27 -0.641 . . . . 75.3 109.27 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' E' ' 147' ' ' LEU . 1.5 mp -81.11 119.41 30.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 107.559 -1.274 . . . . 75.04 107.559 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.428 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.17 -41.49 16.97 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.014 -0.736 . . . . 75.32 109.014 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -168.07 137.47 2.51 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.328 -0.367 . . . . 74.33 110.561 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.614 HG23 HD23 ' A' ' 106' ' ' LEU . 92.0 mt -139.88 98.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.988 -1.115 . . . . 72.15 107.988 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.3 m-85 -163.45 166.02 23.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.102 0.961 . . . . 75.32 109.409 -167.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -74.18 126.33 30.34 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.075 -0.342 . . . . 75.2 110.075 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 41.2 mtpt -85.05 -44.41 13.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.392 0.615 . . . . 75.42 109.456 171.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.579 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.5 t70 -135.36 142.1 45.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.71 -1.132 . . . . 73.44 109.885 -176.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.5 mt -138.19 140.01 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.453 1.501 . . . . 73.11 107.684 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.74 128.65 10.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.618 . . . . 73.42 109.333 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 89.0 t80 -134.1 125.07 27.23 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.389 -1.338 . . . . 71.1 107.389 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.75 148.07 49.19 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.039 -0.726 . . . . 72.31 109.039 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.0 77.78 25.48 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 106.628 -1.619 . . . . 74.24 106.628 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.93 -31.86 36.98 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.749 2.299 . . . . 72.13 111.873 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -109.28 32.14 5.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.704 0.802 . . . . 73.41 109.524 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.408 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -59.31 -46.8 99.07 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.262 1.025 . . . . 75.32 113.282 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 13.7 Cg_exo -71.61 -12.99 29.73 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.688 1.592 . . . . 72.04 113.167 174.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -90.14 -11.82 40.06 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.762 0.825 . . . . 74.33 111.698 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.48 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 29.9 m -60.24 -15.09 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 113.617 0.969 . . . . 64.34 113.617 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.64 -41.19 65.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 72.35 110.844 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -89.84 -15.61 31.88 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.375 -0.83 . . . . 74.33 110.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 3.7 mmpt? -73.21 129.21 37.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.231 0.612 . . . . 73.32 111.096 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.64 116.73 12.34 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.153 -1.055 . . . . 75.23 108.153 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -71.52 83.49 0.83 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.816 0.817 . . . . 75.45 111.283 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -141.0 80.19 17.39 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.203 -1.777 . . . . 74.23 106.203 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.74 135.36 6.76 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.904 2.403 . . . . 70.31 111.597 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -94.2 100.77 12.78 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 105.862 -1.903 . . . . 65.54 105.862 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.01 90.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.751 0.786 . . . . 72.3 109.068 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 56.7 tttp -86.39 127.67 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.36 -1.291 . . . . 71.44 108.837 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 tp -123.16 144.31 49.43 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.707 -0.849 . . . . 74.54 108.707 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.32 144.74 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.752 -0.833 . . . . 75.14 108.752 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.96 124.06 17.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.15 0.58 . . . . 75.11 110.272 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 20.7 t70 -123.5 148.04 46.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.994 1.317 . . . . 64.14 109.513 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.6 m -139.54 136.77 34.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.039 0.536 . . . . 73.12 110.579 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -146.29 127.64 14.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.28 0.632 . . . . 54.14 110.527 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -89.07 161.13 16.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.579 0.752 . . . . 74.31 109.87 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 47.2 t -167.33 116.67 0.83 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.991 -0.374 . . . . 74.34 109.991 -174.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.513 HE21 ' H ' ' A' ' 54' ' ' ASP . 62.8 tt0 -71.25 104.17 3.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.452 0.701 . . . . 75.43 110.011 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 83' ' ' ILE . 86.6 mt -77.95 -38.8 44.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.861 0.865 . . . . 74.33 111.044 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.92 -172.35 4.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.889 0.875 . . . . 71.33 109.776 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -57.21 97.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.188 0.595 . . . . 73.53 111.183 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.513 ' H ' HE21 ' A' ' 50' ' ' GLN . 10.4 m-20 58.39 32.95 22.68 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.201 1.4 . . . . 70.44 112.299 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 59.9 t -107.72 120.57 59.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.651 -1.611 . . . . 75.43 106.651 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.0 m-85 -130.89 128.5 40.69 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.952 -0.759 . . . . 75.32 108.952 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.81 123.16 34.99 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.901 -0.777 . . . . 72.3 108.901 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 33.2 m -99.75 122.09 51.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 107.543 -1.28 . . . . 71.14 107.543 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.9 t -100.49 130.13 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.14 -0.689 . . . . 75.55 109.14 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.7 112.97 26.26 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.425 -1.324 . . . . 73.31 107.425 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttm-85 -93.14 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.715 -1.217 . . . . 75.05 107.715 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.65 124.36 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.517 -0.92 . . . . 75.02 108.517 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -123.64 129.75 51.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.781 0.432 . . . . 75.21 109.952 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 53.0 t -123.63 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.541 1.136 . . . . 73.34 109.883 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 m -103.46 141.16 36.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.963 -0.384 . . . . 72.43 109.963 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.66 103.0 8.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.39 -1.337 . . . . 72.3 107.39 168.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 34.3 m -112.0 125.3 53.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.476 0.655 . . . . 73.41 109.401 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' A' ' 73' ' ' ALA . 5.9 mp -102.32 86.67 2.87 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.753 -1.943 . . . . 74.24 105.753 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -122.91 5.96 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.931 -0.868 . . . . 71.45 110.931 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.64 -23.78 24.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.235 0.614 . . . . 73.23 110.104 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.91 108.93 19.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.336 0.654 . . . . 73.11 111.17 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -74.39 117.35 16.11 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.373 0.669 . . . . 74.02 109.517 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 68' ' ' LEU . . . -59.57 -54.86 41.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.553 0.741 . . . . 73.45 109.529 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -156.56 153.67 29.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.36 -1.291 . . . . 74.54 111.526 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -125.49 135.85 52.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.906 1.282 . . . . 73.22 108.732 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.499 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.0 m -120.35 140.61 51.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 71.01 109.247 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -147.43 125.59 12.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.784 -0.821 . . . . 71.44 108.784 166.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.34 109.64 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.211 1.005 . . . . 61.41 108.511 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 79.2 mt-30 -86.8 84.86 7.28 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.332 -0.849 . . . . 64.25 109.098 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.36 96.6 4.04 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.088 -1.414 . . . . 71.41 109.548 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.74 145.68 18.04 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.81 -0.516 . . . . 74.11 111.81 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.97 122.65 2.38 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.719 -0.952 . . . . 72.13 110.719 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 51' ' ' LEU . 48.0 mt -82.3 125.02 39.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 109.268 -0.642 . . . . 75.12 109.268 174.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.416 ' CD2' HG13 ' A' ' 13' ' ' ILE . 55.4 m-85 -130.93 120.35 23.44 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.698 -0.853 . . . . 74.21 108.698 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 36.1 t -96.35 107.02 19.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 72.03 109.111 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.581 ' HB ' HD13 ' A' ' 89' ' ' ILE . 42.9 pt -130.45 127.79 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.148 0.579 . . . . 73.2 110.767 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.85 134.18 27.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.627 0.771 . . . . 60.34 109.926 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.15 7.8 62.02 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 123.549 0.531 . . . . 60.34 113.237 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.581 HD13 ' HB ' ' A' ' 86' ' ' ILE . 4.5 mp -109.32 136.03 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.238 -1.023 . . . . 73.41 108.238 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.519 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 13.4 tt0 -159.62 -178.14 6.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.13 0.572 . . . . 74.13 109.52 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.519 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.39 -143.23 36.94 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.659 -0.246 . . . . 65.05 112.821 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -68.93 -17.79 64.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.063 0.945 . . . . 75.54 112.116 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.544 HE22 ' HE3' ' A' ' 9' ' ' MET . 34.6 mt-30 -67.92 -57.7 5.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.599 0.76 . . . . 74.21 109.312 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.447 ' HE2' ' HB3' ' A' ' 94' ' ' MET . 12.7 ttp -65.27 -40.42 93.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.93 1.292 . . . . 73.42 111.236 177.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.12 70.3 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.002 0.814 . . . . 75.31 110.044 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -64.27 -48.49 75.53 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 114.401 -1.272 . . . . 75.3 111.309 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 36.3 m -71.01 -45.23 64.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.969 1.1 . . . . 75.4 113.969 -165.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -83.26 -15.19 51.25 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.044 0.387 . . . . 75.01 112.044 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.56 -3.94 18.04 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 114.727 0.651 . . . . 73.34 114.727 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.97 -60.58 0.46 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.591 0.696 . . . . 70.1 110.941 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.474 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.2 t80 -57.55 -62.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.163 0.985 . . . . 74.52 112.394 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.01 -39.0 2.09 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.182 -1.372 . . . . 73.43 112.924 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.426 ' HA ' HD12 ' A' ' 106' ' ' LEU . 10.4 Cg_endo -57.29 -37.86 96.53 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.703 1.602 . . . . 71.33 113.399 165.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.96 -37.71 86.7 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.079 0.4 . . . . 71.41 110.531 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 mm -58.26 -40.57 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.999 0.92 . . . . 64.02 110.946 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.614 HD23 HG23 ' A' ' 16' ' ' ILE . 94.6 mt -70.74 -31.54 68.41 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.672 -0.695 . . . . 64.23 111.84 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.08 -43.73 98.68 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 124.845 1.258 . . . . 70.45 114.251 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.32 -35.48 83.99 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.415 2.077 . . . . 74.24 114.219 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.02 -22.37 45.56 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.606 0.362 . . . . 75.22 111.485 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.4 65.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.531 -0.544 . . . . 71.11 109.531 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.419 HH22 ' HB3' ' A' ' 130' ' ' PRO . 42.1 ttm180 -56.75 -42.31 79.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.648 1.179 . . . . 75.01 110.975 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -48.71 -56.55 8.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.211 1.404 . . . . 63.42 111.372 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.72 -48.69 68.44 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.82 -1.537 . . . . 74.53 111.363 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.443 ' O ' HG21 ' A' ' 118' ' ' VAL . 93.8 mt -57.35 -54.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 124.14 0.9 . . . . 71.1 110.565 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -61.54 -34.48 75.63 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.83 0.706 . . . . 71.54 111.801 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -67.84 -44.92 76.06 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.248 -0.433 . . . . 73.04 110.347 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.465 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 10.8 mtp -55.62 -45.16 77.57 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.802 0.841 . . . . 64.21 110.978 175.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -61.89 -46.96 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.603 1.161 . . . . 75.31 111.135 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 88.3 p -73.06 -24.68 60.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.077 -0.511 . . . . 63.21 111.84 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.8 mtt-85 -74.96 -24.07 58.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.244 0.618 . . . . 75.24 110.627 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.31 16.23 24.67 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.537 0.523 . . . . 74.11 112.421 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 t 52.38 28.89 6.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.224 2.21 . . . . 73.13 112.848 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -94.06 140.11 22.79 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.133 -1.062 . . . . 74.12 108.133 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 144.25 99.53 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.53 2.154 . . . . 73.2 111.07 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -54.79 132.62 46.45 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.724 0.64 . . . . 73.31 112.338 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.08 98.85 4.54 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.607 -1.627 . . . . 73.34 106.607 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.401 HD22 ' HA ' ' C' ' 15' ' ' ARG . 8.0 p30 -98.21 126.15 43.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.481 0.658 . . . . 63.41 109.927 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 pp -68.91 141.47 55.02 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.598 -1.183 . . . . 73.04 111.382 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.18 142.54 84.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.402 0.681 . . . . 73.52 110.113 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.419 ' HB3' HH22 ' A' ' 111' ' ' ARG . 60.6 Cg_endo -74.57 136.68 21.7 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.408 2.072 . . . . 75.31 111.349 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.05 111.41 29.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.234 -1.395 . . . . 74.21 107.234 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -85.82 75.86 9.98 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.694 0.759 . . . . 75.23 110.621 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.16 -40.58 90.42 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.291 -1.322 . . . . 75.12 110.559 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -50.69 73.0 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.258 -0.883 . . . . 75.0 111.67 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.12 90.73 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.691 0.619 . . . . 64.24 110.805 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.01 -46.94 84.46 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.115 0.566 . . . . 74.21 110.802 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.25 -49.83 25.61 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.826 -0.625 . . . . 73.52 110.408 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.55 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 59.0 mtp -80.41 -23.29 40.47 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.228 0.825 . . . . 75.03 113.228 -166.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -61.28 -39.25 89.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.345 0.593 . . . . 74.55 109.419 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -80.3 -34.64 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.835 -1.075 . . . . 74.44 110.819 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 64.6 tp -67.32 -53.74 26.99 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.072 0.549 . . . . 73.43 111.504 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -158.49 -0.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.559 0.744 . . . . 72.42 112.422 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 66.12 163.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.778 1.231 . . . . 73.34 112.005 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -69.5 100.11 1.36 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.892 -0.505 . . . . 75.13 109.852 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.48 16.28 5.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.1 0.96 . . . . 71.42 109.995 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.33 145.04 17.45 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.729 -0.669 . . . . 75.13 113.121 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -113.01 135.71 53.48 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.153 0.981 . . . . 72.31 109.197 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.27 77.98 2.03 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.569 -0.613 . . . . 73.24 111.569 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 m -71.46 117.29 12.82 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.355 0.662 . . . . 75.13 110.764 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -69.06 93.16 0.56 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.321 0.648 . . . . 64.21 110.979 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -79.8 -42.15 25.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.076 -1.453 . . . . 74.03 107.076 163.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 62.58 100.66 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.679 . . . . 74.42 112.936 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -74.07 110.62 8.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.07 -1.085 . . . . 73.34 108.07 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -84.11 -68.98 0.67 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.318 0.647 . . . . 74.15 110.729 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.632 ' HA ' ' HB2' ' E' ' 143' ' ' TYR . . . . . . . . 0 C--O 1.245 0.856 0 CA-C-N 115.262 -0.881 . . . . 72.01 110.144 -169.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.674 -0.861 . . . . 74.03 108.674 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.6 m -69.93 94.73 0.87 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.597 -0.52 . . . . 64.32 109.597 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.64 99.42 0.32 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.391 -0.822 . . . . 52.32 109.286 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -170.06 174.94 5.25 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.504 1.122 . . . . 73.31 108.558 -176.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 76.28 164.62 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.011 1.324 . . . . 72.51 111.786 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -142.55 -54.51 0.42 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.139 0.975 . . . . 75.14 108.676 -172.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.498 HG21 ' H ' ' B' ' 9' ' ' MET . 21.5 m 71.17 150.1 0.09 Allowed 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.096 1.358 . . . . 71.42 111.807 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -39.16 72.69 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.838 -0.43 . . . . 74.12 109.838 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.498 ' H ' HG21 ' B' ' 7' ' ' THR . 15.9 ptm 50.65 -177.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.788 2.035 . . . . 72.2 114.243 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.9 p -145.75 133.22 20.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.832 0.853 . . . . 72.41 108.805 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.446 ' HD1' HG22 ' B' ' 86' ' ' ILE . 91.4 t80 -129.71 139.17 51.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.648 0.779 . . . . 72.33 109.857 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.563 ' HB2' ' HA ' ' F' ' 145' ' ' LYS . 8.2 tp-100 -160.37 143.04 13.24 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.278 0.361 . . . . 71.54 111.494 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.609 HG21 HG13 ' B' ' 16' ' ' ILE . 3.7 mp -86.02 123.11 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.493 -0.928 . . . . 75.41 108.493 173.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -40.03 24.4 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.739 0.416 . . . . 74.35 110.395 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -161.36 136.62 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.274 -0.421 . . . . 75.54 110.43 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.609 HG13 HG21 ' B' ' 13' ' ' ILE . 67.0 mt -115.91 139.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 107.101 -1.444 . . . . 74.1 107.101 168.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.52 164.78 14.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.982 0.896 . . . . 74.33 112.461 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.5 m -96.87 125.61 41.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.066 -1.425 . . . . 74.44 108.821 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.42 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -97.64 -32.85 11.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.654 0.782 . . . . 74.12 110.372 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.18 138.58 18.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.966 -0.561 . . . . 73.2 110.641 -168.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.566 HD13 ' SG ' ' B' ' 113' ' ' CYS . 45.7 mm -141.01 142.17 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.381 1.473 . . . . 74.22 108.86 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 87.1 p -138.84 145.61 40.22 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.562 -0.903 . . . . 64.24 108.562 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.0 t80 -152.19 109.79 3.61 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.006 -1.479 . . . . 71.01 107.006 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -118.21 114.39 22.95 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.494 0.718 . . . . 72.22 109.213 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.568 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -109.54 87.27 5.13 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.904 0.882 . . . . 72.53 109.214 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.12 -24.98 16.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.781 2.321 . . . . 71.52 112.59 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.42 18.5 14.33 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.784 0.834 . . . . 74.13 110.447 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.568 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -47.37 -49.11 55.11 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 125.446 1.499 . . . . 50.41 114.249 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -65.49 -29.19 53.35 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.103 1.868 . . . . 72.22 112.118 -177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -99.55 -8.97 23.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.011 0.925 . . . . 71.41 112.836 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.55 -14.07 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.597 0.592 . . . . 74.3 112.597 -167.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.82 -21.69 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.955 0.502 . . . . 73.54 111.583 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -76.57 -13.41 60.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.948 0.899 . . . . 63.24 111.37 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.609 ' HB3' HD23 ' B' ' 68' ' ' LEU . 35.5 mmtp -102.43 101.7 11.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.703 0.801 . . . . 74.02 110.85 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -96.13 84.47 3.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.36 -0.978 . . . . 72.53 108.36 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -164.69 166.38 20.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.43 1.092 . . . . 71.13 108.207 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.46 127.36 55.08 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-O 119.203 -0.427 . . . . 73.44 110.127 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.74 133.57 25.93 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.015 1.81 . . . . 74.31 112.086 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.92 107.34 5.25 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 108.441 -0.948 . . . . 75.33 108.441 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.08 133.99 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.965 0.412 . . . . 73.44 109.962 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -114.78 104.06 11.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.625 -0.88 . . . . 75.12 108.625 166.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pp -94.92 141.52 28.55 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.876 -1.056 . . . . 72.42 108.823 175.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -162.9 147.16 11.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.913 -0.773 . . . . 71.14 108.913 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.96 152.5 24.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 74.11 109.933 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -141.33 150.47 42.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.047 1.339 . . . . 64.15 108.109 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.478 HG23 ' NE1' ' E' ' 120' ' ' TRP . 39.4 p -119.56 137.43 53.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 74.23 111.148 -175.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -130.83 150.1 52.16 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.651 1.181 . . . . 65.34 108.133 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -142.67 162.21 36.06 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.689 0.395 . . . . 70.04 110.234 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -165.84 148.21 7.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.102 0.961 . . . . 70.51 109.206 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -119.29 125.33 48.83 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.075 -0.713 . . . . 62.31 109.075 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.428 HD13 HG22 ' B' ' 83' ' ' ILE . 40.5 mt -89.71 -46.65 8.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.528 0.731 . . . . 75.43 110.053 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.7 178.1 8.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.076 -0.966 . . . . 55.14 110.133 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.42 114.06 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.04 0.936 . . . . 75.41 110.201 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 69.98 3.16 4.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.685 1.194 . . . . 64.04 112.913 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.66 95.76 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.673 -1.232 . . . . 75.1 107.673 176.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -112.83 135.98 52.98 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.52 -0.919 . . . . 73.0 108.52 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.59 107.3 16.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.882 0.873 . . . . 74.3 108.686 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.54 133.68 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.498 0.719 . . . . 74.45 109.828 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 35.4 t -112.33 120.8 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 72.22 109.686 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.471 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.95 121.37 35.35 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.497 -1.297 . . . . 73.23 107.497 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -111.05 119.48 39.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.378 -0.601 . . . . 75.15 109.378 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.83 111.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.544 -0.91 . . . . 74.34 108.544 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 49.6 m -97.35 135.99 38.45 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.236 -0.653 . . . . 75.31 109.236 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.585 HG11 HD13 ' B' ' 126' ' ' LEU . 79.5 t -132.69 134.1 58.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 123.485 0.714 . . . . 74.31 109.247 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.8 m -124.71 148.24 48.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.368 1.067 . . . . 74.23 108.167 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 148.49 32.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 122.803 0.441 . . . . 70.2 109.967 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 m -138.23 124.01 19.9 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.837 0.711 . . . . 74.42 109.934 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.609 HD23 ' HB3' ' B' ' 34' ' ' LYS . 0.7 OUTLIER -104.45 119.36 38.79 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.127 -1.064 . . . . 73.44 108.127 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -112.08 3.41 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.024 -0.83 . . . . 72.02 111.024 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -119.64 13.8 12.54 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.875 0.87 . . . . 64.45 110.949 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.36 167.41 22.98 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.667 0.787 . . . . 71.44 110.271 -170.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -62.09 134.46 56.62 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.663 0.602 . . . . 74.13 110.846 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' B' ' 68' ' ' LEU . . . -90.18 -57.68 2.76 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.911 -1.144 . . . . 74.23 107.911 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.43 ' CE1' HD12 ' B' ' 126' ' ' LEU . 52.5 p90 -160.92 169.08 23.33 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 113.697 -1.592 . . . . 73.23 109.779 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.2 mt -135.32 140.95 45.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.616 -1.624 . . . . 75.23 106.616 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -155.19 142.53 19.5 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.545 -0.539 . . . . 62.32 109.545 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -158.81 133.24 7.95 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.158 -0.682 . . . . 75.22 109.158 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.489 HG21 HD12 ' B' ' 21' ' ' ILE . 93.2 t -124.41 148.1 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.674 0.79 . . . . 71.04 109.342 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -123.16 100.52 6.91 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.439 -0.949 . . . . 75.04 108.439 169.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.91 99.05 11.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.269 -1.011 . . . . 73.24 108.269 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.65 157.92 26.92 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.147 -0.781 . . . . 74.21 111.147 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.75 134.03 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.958 -0.457 . . . . 73.43 111.958 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.428 HG22 HD13 ' B' ' 51' ' ' LEU . 43.6 mt -89.9 121.22 39.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.739 -0.837 . . . . 72.42 108.739 175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -123.82 136.45 54.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 74.3 110.091 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -99.26 108.37 20.91 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.606 1.162 . . . . 74.04 108.021 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.515 ' H ' HD12 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.7 137.94 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.847 0.859 . . . . 71.23 108.825 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 132.26 10.17 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.16 -1.052 . . . . 60.22 108.16 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.6 11.36 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.385 -0.675 . . . . 71.33 113.744 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.612 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 27.2 pt -50.16 146.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 123.779 0.832 . . . . 73.01 111.989 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.408 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 14.9 mm-40 -150.71 156.27 40.98 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.043 0.757 . . . . 74.31 113.043 -167.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.66 -126.28 41.55 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.763 -1.562 . . . . 53.13 113.481 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.43 -38.09 42.19 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.57 0.748 . . . . 73.02 109.981 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.41 -21.95 65.55 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.634 -1.166 . . . . 73.35 110.839 -171.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.612 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 49.3 ttm -54.37 -49.23 70.32 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.275 1.03 . . . . 72.23 110.762 169.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.39 69.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.445 -1.252 . . . . 74.33 111.761 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 69.2 m-70 -74.76 -18.85 60.42 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.522 0.329 . . . . 65.02 111.875 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.59 -56.15 8.1 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.404 0.621 . . . . 65.44 110.324 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.97 -22.34 25.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.215 -0.902 . . . . 74.45 112.026 -175.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.74 -15.7 41.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 113.897 0.319 . . . . 61.45 113.897 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.483 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -129.51 -55.83 1.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 117.101 0.45 . . . . 72.33 111.955 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -70.22 -49.29 51.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.006 0.522 . . . . 75.35 111.547 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.469 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.18 -50.79 84.43 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.568 -0.729 . . . . 75.21 112.505 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.471 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 51.5 Cg_exo -58.53 -31.55 94.64 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.25 1.967 . . . . 72.12 113.577 173.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.43 -27.41 63.27 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.621 0.369 . . . . 75.31 111.231 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 97.5 mt -70.25 -43.36 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.591 0.756 . . . . 74.14 109.714 170.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.62 -17.71 61.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.047 -0.979 . . . . 71.44 111.529 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.35 -51.3 81.12 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.791 1.236 . . . . 71.05 113.886 -170.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.509 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 28.6 Cg_endo -60.29 -33.06 94.87 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.957 1.772 . . . . 75.45 113.047 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.13 -43.97 73.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.095 0.558 . . . . 75.22 111.038 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.69 98.38 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.268 0.627 . . . . 44.32 110.501 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.509 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 29.7 mtp-105 -54.21 -57.73 10.07 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.503 1.121 . . . . 74.23 111.427 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.59 -26.56 64.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.414 -0.812 . . . . 75.44 110.287 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.566 ' SG ' HD13 ' B' ' 21' ' ' ILE . 6.1 t -68.76 -46.32 69.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.446 0.299 . . . . 65.13 110.44 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.532 HG22 ' HB2' ' B' ' 126' ' ' LEU . 69.3 mt -60.97 -48.03 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.058 0.543 . . . . 73.41 109.585 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -55.15 -43.65 74.41 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.438 -1.256 . . . . 75.04 111.429 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -65.68 -45.02 84.45 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.648 -0.706 . . . . 61.5 110.838 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -71.91 -35.96 69.86 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.038 0.535 . . . . 74.42 111.392 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.579 HG21 ' HB2' ' B' ' 123' ' ' PHE . 9.1 p -75.35 -28.55 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.073 -0.512 . . . . 75.24 110.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.419 ' HA ' HE22 ' C' ' 125' ' ' GLN . 69.9 m -63.14 -35.64 80.95 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.437 0.695 . . . . 61.32 110.855 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.1 mtt-85 -69.57 -19.14 63.68 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 114.721 -1.127 . . . . 74.53 111.385 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 13.63 61.13 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.179 -0.789 . . . . 74.42 114.74 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.5 p 70.06 13.44 7.82 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.034 1.733 . . . . 72.05 113.038 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.579 ' HB2' HG21 ' B' ' 118' ' ' VAL . 73.2 m-85 -104.18 145.56 30.89 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 119.246 -0.407 . . . . 74.24 110.259 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.31 165.28 5.78 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.619 2.879 . . . . 53.12 113.825 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -61.06 155.66 19.8 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.297 -0.865 . . . . 74.32 111.915 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.585 HD13 HG11 ' B' ' 64' ' ' VAL . 87.6 mt -131.44 84.0 2.14 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.915 -0.772 . . . . 64.21 108.915 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.42 ' HB3' HH21 ' B' ' 111' ' ' ARG . 35.6 m-80 -106.65 100.36 9.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.788 -1.096 . . . . 74.11 108.376 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.58 133.88 53.21 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.169 -0.923 . . . . 65.34 109.312 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.54 150.13 94.19 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.074 0.55 . . . . 64.41 110.808 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.48 96.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.043 2.496 . . . . 73.0 112.565 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.43 117.56 33.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.567 -0.901 . . . . 75.24 108.567 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.15 97.63 5.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.024 -1.472 . . . . 73.12 107.024 170.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.483 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 19.2 m-85 -55.82 -30.2 61.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.135 0.974 . . . . 71.34 110.664 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.11 -36.45 81.79 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.614 -1.175 . . . . 74.12 111.076 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.14 -51.87 64.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.579 0.752 . . . . 71.44 111.127 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.91 -32.74 74.59 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.731 0.644 . . . . 65.35 110.118 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.469 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 0.2 OUTLIER -62.91 -45.02 94.48 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.532 0.733 . . . . 74.32 109.18 175.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.0 mmt -66.91 -28.59 68.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.759 0.823 . . . . 73.24 111.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -72.54 -38.58 67.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.194 0.598 . . . . 72.34 110.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.65 -25.43 66.57 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.351 -0.84 . . . . 74.24 110.655 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 49.2 mt -105.77 18.61 21.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 74.01 111.54 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.13 74.74 0.68 Allowed 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.982 0.896 . . . . 74.05 110.265 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -151.63 145.22 24.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.295 1.438 . . . . 75.32 108.291 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.73 140.24 15.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.55 0.74 . . . . 73.51 109.335 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.31 -48.52 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.43 0.692 . . . . 53.34 110.264 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.54 -167.49 54.33 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.421 -0.809 . . . . 75.43 112.668 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.37 162.09 24.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.743 0.817 . . . . 75.33 109.415 174.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.93 14.09 8.81 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.005 -0.543 . . . . 63.44 111.785 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.1 m -65.07 116.49 6.53 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.844 0.858 . . . . 75.03 110.191 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -151.58 133.28 14.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.965 0.906 . . . . 73.0 109.273 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -156.58 167.75 29.48 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.718 -0.845 . . . . 74.01 108.718 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 72.2 t60 75.68 136.26 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.954 1.302 . . . . 75.1 111.967 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -121.28 140.16 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.249 1.019 . . . . 74.4 109.182 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.72 174.34 8.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.89 0.476 . . . . 72.12 109.867 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 N-CA-C 109.103 -0.703 . . . . 65.52 109.103 178.394 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.106 -0.701 . . . . 75.42 109.106 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.428 ' HB3' ' HB2' ' F' ' 122' ' ' ALA . 21.6 p -105.23 104.03 13.68 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.819 0.847 . . . . 65.15 110.451 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -101.31 13.92 33.57 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.516 0.726 . . . . 70.22 111.193 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -79.19 73.55 5.77 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 75.24 108.842 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -100.43 103.16 14.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.909 0.883 . . . . 75.32 109.356 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.13 -30.28 0.63 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.764 0.826 . . . . 75.34 110.316 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m 71.04 -74.27 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.364 1.466 . . . . 72.01 110.999 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 64.79 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.263 1.425 . . . . 74.25 111.154 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.3 ttm 66.01 123.93 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.793 1.237 . . . . 74.24 111.441 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -85.56 87.34 7.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.146 -1.057 . . . . 75.52 108.146 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -105.58 136.41 45.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.874 -1.057 . . . . 72.53 109.19 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -152.92 132.83 13.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.246 0.618 . . . . 74.23 109.705 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.55 105.72 11.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.157 -1.053 . . . . 73.25 108.157 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.42 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.7 mm-40 -78.92 -41.58 29.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.893 -0.594 . . . . 74.31 110.11 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.401 ' HA ' HD22 ' A' ' 127' ' ' ASN . 23.2 ttt85 -170.79 157.17 5.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.668 0.605 . . . . 74.23 110.996 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.51 145.92 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 107.194 -1.41 . . . . 72.45 107.194 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -173.86 162.25 3.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.648 0.737 . . . . 73.14 109.866 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -80.14 111.76 16.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.868 -1.06 . . . . 70.34 108.249 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.86 -45.75 81.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.098 -1.075 . . . . 74.33 108.098 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.2 t70 -140.37 140.99 35.65 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 113.57 -1.65 . . . . 72.15 109.697 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.58 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.3 mt -131.46 145.58 34.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 106.907 -1.516 . . . . 72.54 106.907 170.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -153.82 146.63 24.34 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.338 0.59 . . . . 72.1 109.602 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -146.25 144.02 29.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.555 -1.276 . . . . 71.12 107.555 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -138.48 144.95 40.27 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.674 1.189 . . . . 73.23 107.835 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' C' ' 28' ' ' ALA . . . -150.6 80.04 7.02 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 106.683 -1.599 . . . . 63.34 106.683 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.73 -37.11 16.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.578 2.185 . . . . 63.11 111.349 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.524 ' ND2' ' HG3' ' C' ' 71' ' ' GLU . 1.7 m-20 -107.93 27.65 9.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.472 1.109 . . . . 73.44 109.439 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.477 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . . . -50.17 -51.88 58.7 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.888 1.275 . . . . 74.3 113.889 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 66.3 Cg_endo -86.57 -19.21 2.91 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 121.67 1.58 . . . . 70.34 113.321 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -68.18 -21.64 64.88 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.983 0.913 . . . . 74.34 112.553 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.61 -5.49 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 123.343 0.657 . . . . 74.25 112.506 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.563 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 19.8 m-85 -67.42 -27.7 67.28 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.349 0.66 . . . . 73.24 112.451 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 29.0 7.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.485 0.714 . . . . 72.13 109.368 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.8 155.33 41.25 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.299 0.64 . . . . 74.22 111.253 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.71 129.99 39.48 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.385 -1.279 . . . . 73.33 110.572 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.449 ' CD1' ' HB3' ' E' ' 137' ' ' GLU . 32.0 p90 -84.53 65.65 9.09 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 122.19 0.995 . . . . 74.22 111.933 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -151.54 60.42 3.75 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 115.564 -0.744 . . . . 73.44 110.673 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' HG ' ' E' ' 139' ' ' LEU . 14.8 Cg_exo -67.38 153.92 75.43 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.21 1.94 . . . . 72.23 110.498 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.72 109.15 17.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.828 -1.545 . . . . 71.01 106.828 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.406 HG11 HD11 ' C' ' 126' ' ' LEU . 77.8 t -75.25 106.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.891 -1.05 . . . . 71.34 110.646 -174.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.733 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 6.4 mtpm? -103.35 143.88 32.09 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.272 1.029 . . . . 73.53 108.323 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -128.87 164.05 23.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.79 0.436 . . . . 74.32 110.896 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.0 t70 -154.29 125.91 7.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.428 -0.805 . . . . 72.15 108.991 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -115.4 112.07 21.77 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.646 -1.242 . . . . 75.33 107.646 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -126.68 119.98 28.33 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.609 -1.256 . . . . 72.31 107.609 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -118.42 150.42 39.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.389 -0.597 . . . . 71.11 109.389 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.09 171.96 13.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 73.4 109.13 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -146.83 143.39 28.56 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.843 -0.799 . . . . 74.33 108.843 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.7 t -145.0 126.39 14.9 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.307 -0.997 . . . . 70.02 108.307 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -80.1 117.33 20.81 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.525 -0.546 . . . . 73.52 109.525 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.671 HD12 ' HB2' ' C' ' 57' ' ' GLU . 69.9 mt -86.73 -45.5 10.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.684 0.793 . . . . 74.54 110.087 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.79 -165.15 2.19 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.66 -0.7 . . . . 72.2 111.132 -173.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.13 102.03 0.19 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.1 0.875 . . . . 62.25 110.966 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 63.72 18.5 11.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.154 0.982 . . . . 73.54 111.884 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -106.96 114.22 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.27 -1.011 . . . . 73.24 108.27 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -122.0 124.82 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.151 0.98 . . . . 74.01 108.891 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.671 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.8 tt0 -89.59 114.99 26.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.177 0.991 . . . . 75.32 109.245 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -95.86 129.47 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.089 -1.078 . . . . 73.52 108.089 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 t -120.64 106.53 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.667 -0.864 . . . . 71.35 108.667 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.9 102.41 14.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.473 -0.936 . . . . 74.33 108.473 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.405 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 33.3 ttm105 -79.51 107.3 12.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.587 -0.894 . . . . 75.34 108.587 168.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -99.96 124.28 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.137 -1.431 . . . . 74.52 107.137 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.9 m -123.74 119.59 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.785 -0.821 . . . . 73.33 108.785 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 77.7 t -111.01 129.41 66.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.739 -1.119 . . . . 65.14 108.626 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.733 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.5 m -122.69 138.17 54.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.722 0.809 . . . . 74.14 109.164 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.62 100.88 6.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.281 -1.377 . . . . 74.11 107.281 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -140.63 118.21 11.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.827 -0.805 . . . . 75.24 108.827 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.26 -40.18 85.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 75.44 110.238 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.12 -79.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.482 -1.047 . . . . 75.52 110.482 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.0 -32.01 16.95 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.727 0.811 . . . . 61.32 109.434 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.524 ' HG3' ' ND2' ' C' ' 27' ' ' ASN . 40.8 tt0 -88.69 121.32 30.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.194 0.997 . . . . 73.1 111.096 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.6 m -84.23 126.71 33.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.999 0.52 . . . . 72.15 110.107 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.93 -55.21 5.83 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.817 0.847 . . . . 74.23 109.105 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.57 165.44 34.49 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.581 -1.19 . . . . 74.13 110.84 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.466 HD23 HG21 ' C' ' 65' ' ' THR . 3.0 tm? -135.05 144.92 47.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.271 -1.381 . . . . 73.44 107.271 174.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 43.6 t -144.8 143.96 30.91 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.158 -0.682 . . . . 72.1 109.158 177.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -153.17 134.18 14.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.143 0.577 . . . . 73.24 109.507 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' C' ' 110' ' ' ALA . 39.8 t -133.09 113.55 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.236 1.014 . . . . 73.12 108.444 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -92.73 90.6 7.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.914 0.885 . . . . 74.05 108.73 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.421 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.3 tp-100 -82.97 105.97 14.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.081 -0.963 . . . . 72.52 109.897 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.11 147.54 18.63 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.79 -0.524 . . . . 73.01 111.79 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.49 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.63 123.46 2.16 Favored Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.759 -0.937 . . . . 70.42 110.759 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 11.2 mm -80.65 118.51 28.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.931 -1.137 . . . . 72.24 107.931 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -132.75 130.8 40.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.468 0.707 . . . . 73.4 109.534 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 m -81.49 115.55 20.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.053 -0.721 . . . . 61.42 109.053 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.635 HG13 HD22 ' C' ' 98' ' ' LEU . 27.3 mm -116.73 100.89 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.404 -0.961 . . . . 71.25 108.404 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.92 168.45 19.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.323 0.649 . . . . 60.23 110.179 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.29 -56.27 4.25 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.028 -0.533 . . . . 70.43 112.354 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -104.01 163.08 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.826 0.85 . . . . 62.41 109.472 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.8 -177.12 5.55 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.729 0.412 . . . . 71.01 111.543 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.42 -144.76 48.9 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.485 -0.78 . . . . 55.42 114.818 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.4 ' HA ' ' HB2' ' C' ' 95' ' ' ALA . 43.7 p -68.67 -19.89 64.42 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.65 0.78 . . . . 73.31 111.863 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -67.02 -41.66 86.25 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.231 1.012 . . . . 74.3 110.305 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -83.14 -23.21 33.08 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.366 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' C' ' 92' ' ' THR . . . -71.45 -25.8 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.096 0.559 . . . . 63.54 111.256 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -63.58 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.796 0.438 . . . . 74.1 110.221 170.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 17.6 t -76.61 -60.36 2.38 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.202 -0.666 . . . . 72.32 109.202 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.635 HD22 HG13 ' C' ' 86' ' ' ILE . 98.6 mt -60.72 -26.83 67.45 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.062 0.945 . . . . 73.2 113.065 -174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.19 10.86 33.85 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.545 -0.586 . . . . 70.43 113.902 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.05 -60.64 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.584 0.692 . . . . 73.44 111.698 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' C' ' 104' ' ' ASN . 65.1 t80 -75.13 -42.47 56.21 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.877 0.695 . . . . 74.33 112.877 -170.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.533 ' SG ' ' SG ' ' C' ' 97' ' ' CYS . 63.3 m -66.44 -49.39 52.83 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.207 0.603 . . . . 61.02 111.708 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.46 -18.25 43.68 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 121.594 1.529 . . . . 73.24 113.265 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 27.1 t-20 -57.13 -41.75 79.65 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.549 0.69 . . . . 73.4 109.92 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.45 -38.58 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.141 -1.391 . . . . 64.14 110.875 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.49 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.5 mt -81.29 -34.25 32.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.193 -0.912 . . . . 73.32 112.369 -170.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -54.66 -45.73 99.48 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 124.299 1.04 . . . . 74.0 113.527 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.71 -52.03 7.4 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.795 2.33 . . . . 72.24 113.686 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -63.91 -48.71 75.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.357 -0.838 . . . . 75.11 111.732 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -64.52 -41.23 96.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.085 0.554 . . . . 72.51 111.735 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -64.16 -44.53 91.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.2 0.937 . . . . 73.45 110.592 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -70.65 -31.87 68.95 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.522 -0.763 . . . . 65.01 110.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.8 -34.2 77.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.093 0.557 . . . . 65.3 110.436 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.09 -42.21 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.369 0.668 . . . . 73.52 110.379 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 81.6 m -62.2 -30.93 71.42 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.004 0.522 . . . . 64.03 110.284 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -70.86 -54.18 12.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.634 0.773 . . . . 73.22 109.912 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.619 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.48 -45.93 66.35 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.482 1.113 . . . . 73.02 112.385 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.01 -42.33 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.907 0.883 . . . . 73.43 110.834 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -64.21 -32.53 74.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.933 -0.576 . . . . 74.2 111.02 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.512 ' HD2' ' HE3' ' C' ' 117' ' ' MET . 79.3 mtt-85 -70.49 -35.46 73.25 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.387 -0.824 . . . . 63.52 109.696 178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.98 2.76 67.83 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.683 0.614 . . . . 72.53 113.188 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 54.38 48.12 21.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.088 1.755 . . . . 75.44 112.184 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.418 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 90.9 m-85 -115.02 149.29 42.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 114.083 -1.417 . . . . 72.24 108.091 169.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.5 154.98 22.52 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.654 2.902 . . . . 60.51 113.844 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.419 HE22 ' HA ' ' B' ' 119' ' ' SER . 87.8 mt-30 -58.11 150.44 21.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.893 0.877 . . . . 74.11 112.753 -173.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.406 HD11 HG11 ' C' ' 40' ' ' VAL . 1.9 tt -145.47 85.97 1.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.298 -1.371 . . . . 65.12 107.298 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.05 108.29 19.77 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.834 -1.076 . . . . 62.05 108.349 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 130.41 46.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.294 1.038 . . . . 74.22 109.964 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.32 137.17 97.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.677 0.791 . . . . 72.52 111.685 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.425 ' HG2' HD21 ' E' ' 147' ' ' LEU . 35.9 Cg_endo -65.68 122.64 10.32 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.747 2.298 . . . . 75.53 112.04 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 109.86 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.137 -1.06 . . . . 72.24 108.137 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.663 ' HB3' ' HB1' ' C' ' 135' ' ' ALA . 4.0 m-20 -87.2 63.62 7.92 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.978 0.911 . . . . 75.25 109.579 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -77.13 -43.95 32.21 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.021 -0.536 . . . . 72.23 110.582 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.41 -39.32 90.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.829 0.851 . . . . 75.04 110.457 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.663 ' HB1' ' HB3' ' C' ' 132' ' ' ASN . . . -69.62 -31.22 69.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.533 -1.212 . . . . 72.3 111.455 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 47.7 tp -59.67 -31.04 69.19 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.541 1.136 . . . . 72.04 112.282 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.44 -43.16 77.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.845 0.458 . . . . 74.33 110.464 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 68.5 mtm -77.73 -41.71 36.79 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.622 0.769 . . . . 72.1 112.014 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.83 -36.13 70.1 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.571 0.748 . . . . 75.45 111.657 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -68.35 -88.91 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.154 -0.927 . . . . 75.43 109.217 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tt 25.34 -97.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.941 2.096 . . . . 74.3 111.973 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 164.82 124.37 0.01 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.126 2.57 . . . . 75.31 105.9 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -132.19 126.16 32.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.338 -1.356 . . . . 71.21 107.338 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -167.74 106.29 0.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.303 0.641 . . . . 75.12 109.583 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -166.35 160.95 16.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.961 0.904 . . . . 72.43 109.364 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.75 174.64 20.97 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.711 -0.556 . . . . 75.15 111.711 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -151.48 -39.86 0.12 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.566 0.746 . . . . 75.2 109.423 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.99 -150.13 17.65 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 114.915 -1.039 . . . . 73.21 110.892 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 96.2 m -149.03 129.78 14.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.816 0.846 . . . . 74.44 109.134 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.03 104.01 2.0 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.888 -1.153 . . . . 71.32 107.888 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.86 126.15 26.69 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.157 0.983 . . . . 74.44 111.703 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -132.61 60.56 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.217 1.007 . . . . 71.54 108.594 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -120.6 101.53 7.81 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.992 -1.004 . . . . 71.33 109.752 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -77.4 135.91 38.36 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.34 -0.615 . . . . 71.43 109.34 173.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 123.688 0.795 . . . . 74.43 109.217 179.494 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.764 -0.458 . . . . 73.14 109.764 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 74.0 m -76.54 81.82 3.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.783 0.802 . . . . 71.32 109.75 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 51.27 1.17 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.369 -1.287 . . . . 73.32 108.533 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -60.03 105.64 0.42 Allowed 'General case' 0 C--N 1.348 0.535 0 CA-C-N 114.269 -1.332 . . . . 72.32 110.462 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -62.21 145.86 52.39 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.393 -0.821 . . . . 75.15 109.246 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -60.42 -63.33 1.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.519 -0.919 . . . . 75.33 108.519 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.406 HG23 ' H ' ' D' ' 8' ' ' GLU . 2.5 m 64.99 178.4 0.19 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.121 0.968 . . . . 71.42 110.372 177.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.406 ' H ' HG23 ' D' ' 7' ' ' THR . 35.0 mt-10 -75.13 143.85 43.11 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.108 -0.995 . . . . 75.23 109.725 170.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.54 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm -31.88 128.26 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.497 1.519 . . . . 75.11 113.33 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.451 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 27.4 m -132.88 139.56 47.47 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.152 -1.055 . . . . 75.43 108.152 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.439 ' HA ' ' O ' ' D' ' 85' ' ' SER . 45.3 t80 -159.07 98.06 1.43 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.01 0.819 . . . . 72.31 108.792 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.21 115.39 24.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.61 0.764 . . . . 73.41 109.618 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.469 HD11 ' CE2' ' D' ' 84' ' ' PHE . 3.9 tp -77.61 104.38 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 108.408 -0.96 . . . . 75.32 108.408 171.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -84.62 -39.13 19.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.11 -0.95 . . . . 74.53 111.833 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.563 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 65.2 ttt180 -165.41 127.5 2.07 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.587 -0.279 . . . . 74.51 110.354 -166.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.441 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.4 mp -112.65 129.1 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.323 -1.362 . . . . 73.32 107.323 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -165.49 176.91 7.81 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 122.176 0.989 . . . . 74.14 113.117 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -108.32 119.36 39.26 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.02 -1.446 . . . . 65.13 108.36 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -86.94 -17.94 31.94 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.32 -0.622 . . . . 74.14 109.32 173.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.757 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.5 t70 -155.7 140.24 16.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.924 . . . . 75.24 109.817 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.619 HG23 ' HE1' ' C' ' 117' ' ' MET . 58.5 mt -139.92 140.02 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.548 1.539 . . . . 75.33 107.786 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -143.84 136.84 27.49 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.457 0.703 . . . . 72.1 109.473 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.58 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.8 t80 -142.8 116.9 9.46 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.98 -1.859 . . . . 72.34 105.98 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.43 ' O ' ' HD3' ' D' ' 26' ' ' PRO . 44.7 mt-10 -127.32 116.27 20.27 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.108 -0.701 . . . . 72.23 109.108 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.52 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -107.47 88.79 4.37 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 123.313 0.645 . . . . 75.34 109.559 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' D' ' 24' ' ' GLU . 16.6 Cg_exo -71.01 -38.7 4.78 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.222 2.615 . . . . 74.51 112.49 -173.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 85.3 m-20 -118.24 40.86 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.221 1.008 . . . . 75.13 110.035 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -54.84 -57.8 17.56 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 114.976 1.473 . . . . 73.4 114.976 -169.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.53 -3.83 10.76 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 121.619 1.614 . . . . 65.44 112.266 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.98 -45.03 13.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.06 1.344 . . . . 74.31 109.804 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.97 -19.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.734 0.814 . . . . 74.42 110.312 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.5 -23.86 64.85 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.309 1.043 . . . . 75.34 111.791 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -79.61 -3.24 46.2 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.503 0.721 . . . . 74.35 111.769 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -121.59 110.02 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.635 0.774 . . . . 75.04 110.082 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.61 93.52 4.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.851 0.861 . . . . 74.44 109.744 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -169.05 158.37 8.48 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.45 1.1 . . . . 75.23 108.49 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.403 ' HG3' ' HA ' ' F' ' 139' ' ' LEU . 1.8 mp0 -76.49 111.93 18.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.825 0.85 . . . . 73.44 110.033 174.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.427 ' HD2' HD12 ' F' ' 139' ' ' LEU . 84.5 Cg_exo -52.64 128.1 26.93 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.048 2.498 . . . . 73.22 112.599 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -67.43 118.74 11.17 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.165 -0.679 . . . . 75.14 109.165 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.491 HG11 HD11 ' D' ' 126' ' ' LEU . 98.8 t -99.36 133.46 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.223 -0.899 . . . . 72.53 110.819 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -101.8 142.79 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.422 -0.955 . . . . 74.23 108.422 166.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.31 126.03 54.55 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.721 -0.844 . . . . 75.43 108.721 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 22.7 t70 -121.94 149.22 43.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.1 . . . . 74.14 108.142 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.16 151.39 49.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.863 0.465 . . . . 64.52 110.855 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.616 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.1 t70 -155.83 155.6 33.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.178 0.991 . . . . 73.3 108.82 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -133.45 160.03 38.62 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.278 0.631 . . . . 72.23 109.67 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 164.51 37.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.682 -0.858 . . . . 62.32 108.682 174.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -148.36 159.84 43.61 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.964 0.411 . . . . 71.3 111.136 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -160.86 126.71 3.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.33 1.052 . . . . 74.21 109.785 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.51 120.34 28.71 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.859 -0.793 . . . . 73.2 108.859 171.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -91.95 -40.96 10.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.766 -0.652 . . . . 72.54 110.182 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.59 -168.74 1.9 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.508 -0.769 . . . . 73.4 110.433 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.44 115.81 3.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.97 -1.013 . . . . 72.13 110.275 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.74 5.24 3.25 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.622 1.169 . . . . 74.34 112.318 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.93 120.23 59.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 107.531 -1.285 . . . . 74.02 107.531 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -131.47 161.79 31.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 73.42 108.96 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' D' ' 51' ' ' LEU . 6.6 tm-20 -132.43 136.92 47.08 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.085 -1.45 . . . . 63.54 107.085 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 134.8 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.748 -0.834 . . . . 73.52 108.748 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.587 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.5 t -107.48 128.18 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.752 0.821 . . . . 73.15 109.575 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -102.08 121.99 43.25 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.394 -1.336 . . . . 75.42 107.394 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.616 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.9 ttm180 -104.36 108.42 19.82 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.33 -0.989 . . . . 74.42 108.33 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.9 t -95.2 127.73 46.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 107.715 -1.217 . . . . 70.12 107.715 166.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.5 m -118.27 127.13 53.43 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.773 0.797 . . . . 54.32 109.846 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 53.7 t -115.01 114.29 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 125.879 1.671 . . . . 63.11 108.245 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -112.19 97.8 6.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.525 -0.917 . . . . 61.15 108.525 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.19 129.91 43.38 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.046 -0.724 . . . . 70.01 109.046 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 34.9 p -145.49 128.79 16.8 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.125 -0.695 . . . . 72.33 109.125 -175.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -123.23 123.91 41.83 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.476 -0.935 . . . . 72.24 108.476 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -116.0 4.57 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.516 0.51 . . . . 72.13 112.494 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -123.44 26.5 7.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.023 0.529 . . . . 64.33 110.464 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.0 pt-20 -137.69 155.19 49.39 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 123.64 0.776 . . . . 74.25 110.053 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -78.7 117.12 19.54 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 109.696 -0.483 . . . . 72.55 109.696 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.431 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.39 -61.55 1.79 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.589 0.755 . . . . 61.42 110.025 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.1 170.01 19.93 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.658 -1.156 . . . . 72.44 109.819 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 80.0 mt -126.74 145.54 50.56 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.385 1.074 . . . . 74.4 108.721 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.472 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.8 m -143.07 136.06 27.95 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.689 -1.226 . . . . 70.03 107.689 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -156.74 121.01 4.4 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.531 -0.914 . . . . 75.22 108.531 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -130.76 117.82 39.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 122.988 0.515 . . . . 75.45 109.635 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.757 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -89.74 87.46 7.0 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.057 0.848 . . . . 73.13 109.079 170.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.5 98.57 6.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.393 -1.276 . . . . 70.43 109.171 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.25 144.3 17.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 116.437 -0.347 . . . . 65.11 112.292 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.489 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -146.91 135.76 5.86 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.999 -0.441 . . . . 64.42 111.999 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.18 128.48 43.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 123.717 0.807 . . . . 73.44 109.877 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.469 ' CE2' HD11 ' D' ' 13' ' ' ILE . 63.4 m-85 -130.23 137.05 49.84 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 74.0 109.811 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 18.6 m -77.73 103.68 7.81 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.144 -1.058 . . . . 72.23 108.144 168.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.43 106.65 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.72 -0.844 . . . . 74.04 108.72 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.451 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -148.65 167.83 24.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.289 1.036 . . . . 72.5 109.628 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.14 6.08 67.72 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.49 -0.323 . . . . 71.32 113.799 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 tp -141.08 143.73 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 73.35 109.444 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 -172.05 4.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.107 0.563 . . . . 73.23 110.818 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.67 -138.82 22.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.52 0.513 . . . . 64.21 113.382 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -83.86 -24.2 30.99 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.509 0.724 . . . . 70.41 111.001 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -70.69 -32.97 70.39 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.11 0.564 . . . . 75.25 111.846 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -30.35 67.31 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 110.161 -0.311 . . . . 75.14 110.161 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.88 68.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.535 0.734 . . . . 74.34 110.405 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -65.2 -36.74 85.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.353 -0.84 . . . . 72.53 110.613 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.1 -47.29 65.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.995 -0.548 . . . . 63.34 110.022 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -73.15 -27.48 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.621 0.768 . . . . 74.45 111.452 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.34 5.06 33.38 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.361 -0.688 . . . . 73.21 114.526 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.46 -58.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 117.88 0.84 . . . . 62.15 111.534 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -70.92 -54.41 11.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.141 0.576 . . . . 71.33 112.17 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.416 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 66.2 m -62.11 -46.13 91.26 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 123.852 0.861 . . . . 73.14 112.072 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.506 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.6 Cg_exo -57.24 -36.05 98.97 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.409 2.073 . . . . 64.34 113.436 169.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -62.66 -34.74 77.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.95 0.5 . . . . 75.41 111.187 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -66.75 -40.22 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.007 0.923 . . . . 75.22 110.616 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.489 HD22 ' HA3' ' D' ' 82' ' ' GLY . 87.3 mt -74.51 -21.49 59.52 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.702 -0.681 . . . . 73.55 111.548 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -62.68 -46.0 88.5 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 114.143 1.164 . . . . 73.21 114.143 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -51.95 -38.22 68.61 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.056 1.837 . . . . 70.24 113.227 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -79.31 -34.71 42.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.099 0.96 . . . . 74.04 111.618 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -48.63 73.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.359 0.664 . . . . 71.11 109.862 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -57.54 -45.44 85.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.365 -1.289 . . . . 74.23 110.749 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.45 -46.5 89.8 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.097 0.873 . . . . 72.42 111.109 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.33 -41.7 85.19 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.719 0.637 . . . . 75.1 111.353 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.42 HG22 HG23 ' D' ' 64' ' ' VAL . 90.4 mt -63.14 -56.12 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.214 -0.903 . . . . 74.23 110.372 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.4 m -53.43 -39.03 64.06 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.582 1.153 . . . . 74.45 112.046 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -71.78 -41.05 68.81 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.422 -0.808 . . . . 73.23 110.813 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.461 ' HE2' ' HG ' ' D' ' 76' ' ' CYS . 74.5 mtm -65.29 -31.59 72.8 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.71 0.404 . . . . 74.33 111.408 176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 78.2 t -68.23 -42.35 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 72.52 110.252 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 72.8 p -74.18 -26.4 60.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.36 0.264 . . . . 71.42 111.25 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.63 -29.69 59.25 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.548 0.739 . . . . 74.52 110.049 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 2.96 87.5 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.645 -0.707 . . . . 74.53 112.051 171.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 14.7 p 63.84 18.01 10.89 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.094 2.158 . . . . 63.11 114.267 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 59.6 m-85 -87.65 166.2 26.21 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.847 1.259 . . . . 73.13 109.948 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 56.5 Cg_endo -68.13 134.17 30.88 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.142 1.895 . . . . 75.24 111.143 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.37 143.47 34.31 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.201 0.6 . . . . 72.32 110.534 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.491 HD11 HG11 ' D' ' 40' ' ' VAL . 4.4 tt -110.5 111.62 22.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.282 -1.007 . . . . 74.31 108.282 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -98.96 87.11 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.16 117.1 7.98 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.109 -0.95 . . . . 75.44 108.647 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.84 136.57 55.62 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.89 0.876 . . . . 61.43 111.568 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.91 122.59 9.5 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.222 1.948 . . . . 75.41 110.446 176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.82 144.82 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.171 0.588 . . . . 73.3 109.415 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -74.3 94.68 2.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.467 -0.938 . . . . 62.44 108.467 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -61.84 -30.23 70.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.343 -0.844 . . . . 73.34 111.649 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.77 -50.52 66.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.777 0.831 . . . . 74.23 110.417 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.23 76.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.402 0.681 . . . . 73.23 111.93 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.42 -37.12 63.43 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.393 -0.822 . . . . 72.41 109.588 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -69.26 -30.44 68.57 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.756 0.822 . . . . 71.42 110.967 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 43.0 mtt -63.42 -32.73 74.25 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.501 0.72 . . . . 71.54 110.776 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -67.88 -38.32 82.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.158 0.583 . . . . 74.41 110.329 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.94 -39.61 90.15 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.152 0.981 . . . . 75.42 111.558 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.98 -29.64 70.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.393 0.677 . . . . 73.31 111.617 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -83.2 6.92 17.74 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.804 0.842 . . . . 74.42 111.87 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -120.6 90.9 3.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.964 0.905 . . . . 73.32 109.268 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -142.53 153.89 43.99 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.959 1.304 . . . . 65.51 108.587 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.57 146.49 25.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.702 0.401 . . . . 72.03 110.859 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.22 113.15 4.17 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.221 -0.752 . . . . 74.34 111.221 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.73 108.21 13.25 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.448 0.699 . . . . 75.11 110.685 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.92 139.46 25.22 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.013 -0.835 . . . . 70.14 111.013 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 43.2 p -99.85 -58.46 1.91 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 117.65 0.725 . . . . 73.2 109.967 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 58.63 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.761 1.224 . . . . 75.1 110.373 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.32 161.79 27.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.509 0.724 . . . . 75.14 110.784 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -92.47 157.3 16.64 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.487 1.115 . . . . 72.33 109.397 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -101.54 -101.12 0.26 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 109.284 -0.636 . . . . 72.11 109.284 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -158.07 13.84 0.21 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.915 0.886 . . . . 73.13 111.319 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 C-N-CA 124.553 1.141 . . . . 73.33 110.845 -172.174 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 109.444 -0.576 . . . . 74.24 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -154.79 -144.94 0.15 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.0 1.32 . . . . 72.2 107.598 -171.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.39 91.46 0.08 Allowed 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.627 -0.509 . . . . 75.24 109.627 170.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -82.89 161.03 22.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.11 0.964 . . . . 74.35 110.911 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -71.51 178.86 3.26 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.154 0.982 . . . . 72.23 111.891 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.84 158.86 33.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.923 0.489 . . . . 73.12 110.507 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 68.68 129.81 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.993 1.317 . . . . 75.14 111.457 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.492 HD21 HG12 ' B' ' 86' ' ' ILE . 5.6 mp -86.96 48.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 74.21 109.964 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -168.85 90.9 0.6 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.977 -0.749 . . . . 75.02 108.977 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.579 ' HD3' ' SD ' ' B' ' 94' ' ' MET . 93.6 Cg_endo -86.23 -2.12 8.61 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.874 2.382 . . . . 74.0 113.78 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.21 163.61 12.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.625 0.77 . . . . 75.33 110.206 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 25.4 p -90.23 -48.74 6.96 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.639 0.776 . . . . 71.4 109.752 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.478 ' NE1' HG23 ' B' ' 46' ' ' THR . 3.8 t-105 60.09 35.08 21.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 72.22 110.777 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -77.45 -28.83 52.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.798 0.839 . . . . 75.55 110.746 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.05 81.88 5.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.728 0.811 . . . . 73.43 110.539 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -126.96 113.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.003 0.921 . . . . 71.24 109.064 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -137.03 142.42 42.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.996 0.918 . . . . 74.44 109.991 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -146.81 56.92 1.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.261 1.029 . . . . 74.45 109.47 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -77.09 80.81 3.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.664 -1.153 . . . . 72.35 109.408 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.69 -48.68 0.3 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.942 -0.572 . . . . 64.35 112.197 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt 65.77 85.8 0.14 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.654 1.181 . . . . 75.12 109.944 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.02 140.95 14.9 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.945 -0.761 . . . . 73.34 108.945 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 tt -162.62 -53.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.157 0.583 . . . . 72.43 110.676 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 131.69 52.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.323 0.649 . . . . 73.23 110.483 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . 0.703 ' HB3' ' HB2' ' E' ' 135' ' ' ALA . 61.6 t80 -70.04 140.59 88.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 107.955 -1.128 . . . . 74.43 107.955 168.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.74 -40.32 31.33 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.549 2.833 . . . . 74.15 114.656 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . 0.423 HG22 ' HD1' ' C' ' 32' ' ' PHE . 0.3 OUTLIER -118.97 38.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.695 1.236 . . . . 74.31 109.409 -176.495 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.703 ' HB2' ' HB3' ' E' ' 132' ' ' TYR . . . -87.0 34.26 0.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.018 . . . . 75.42 111.087 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 24.7 t 65.29 112.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 C-N-CA 125.458 1.503 . . . . 74.54 110.421 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . 0.449 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 37.5 tt0 -79.75 162.84 24.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.428 -0.952 . . . . 73.32 108.428 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -46.16 128.39 9.47 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.813 1.245 . . . . 41.23 112.473 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . 0.466 ' HG ' ' HD2' ' C' ' 38' ' ' PRO . 10.1 mp -61.13 93.24 0.03 OUTLIER 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.289 0.993 . . . . 75.01 110.01 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.1 m -78.08 -7.91 57.56 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.149 . . . . 75.32 111.397 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 tt -91.22 105.41 17.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.07 -1.085 . . . . 72.45 108.07 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 14.9 tt -168.38 153.57 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.677 0.791 . . . . 74.11 109.209 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . 0.632 ' HB2' ' HA ' ' A' ' 155' ' ' ALA . 26.5 p90 -67.89 159.54 30.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.44 0.696 . . . . 70.5 110.582 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.22 90.05 1.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.389 -0.597 . . . . 74.22 109.389 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . 0.509 ' HA ' ' HE3' ' E' ' 145' ' ' LYS . 0.7 OUTLIER -132.8 82.86 2.02 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.488 -0.56 . . . . 73.34 109.488 178.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.43 -156.01 0.23 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.399 1.08 . . . . 74.5 111.77 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 13' ' ' ILE . 3.7 tt -151.83 142.74 23.02 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.002 -1.481 . . . . 64.12 107.002 172.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.406 ' N ' HD22 ' E' ' 147' ' ' LEU . 7.1 mp -56.55 137.25 76.94 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 123.544 0.738 . . . . 75.21 110.746 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--N 1.377 2.065 0 C-N-CA 122.754 2.303 . . . . 65.21 111.869 173.823 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.013 -0.366 . . . . 62.11 110.013 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 63.97 39.48 7.98 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.954 1.301 . . . . 74.14 111.98 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.35 -76.04 0.45 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.071 0.548 . . . . 75.2 110.433 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 66.6 t80 71.85 -22.82 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.38 1.472 . . . . 75.5 113.655 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -60.87 -30.83 70.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.202 1.001 . . . . 75.23 111.56 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 31.2 t70 55.89 -94.38 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.98 1.312 . . . . 72.31 111.409 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -161.91 122.65 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.408 0.683 . . . . 75.13 109.296 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 89' ' ' ILE . 16.1 tp -94.57 59.28 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.161 0.584 . . . . 64.21 109.875 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -168.61 63.16 0.54 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.626 0.771 . . . . 74.52 109.734 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.27 10.82 2.65 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.109 2.539 . . . . 74.34 113.562 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -110.45 132.29 54.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.177 0.591 . . . . 75.15 109.862 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 66.9 p -106.28 124.29 49.36 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.03 0.932 . . . . 72.02 109.276 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.64 77.96 6.22 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.45 0.7 . . . . 75.22 110.482 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.91 98.23 9.66 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.785 -1.561 . . . . 65.5 106.785 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . 0.428 ' HB2' ' HB3' ' C' ' 2' ' ' SER . . . -151.9 -87.53 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.376 0.67 . . . . 64.52 109.819 -174.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -176.41 150.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.398 1.079 . . . . 73.12 108.942 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -76.49 -59.92 2.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.246 -1.02 . . . . 75.22 108.246 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -167.4 -178.19 3.92 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.283 -0.872 . . . . 73.15 109.932 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.68 124.63 6.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.214 -0.661 . . . . 54.0 109.214 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.51 162.25 10.29 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.348 0.405 . . . . 73.33 113.176 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' F' ' 128' ' ' LYS . 0.0 OUTLIER -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.949 1.3 . . . . 70.31 108.717 175.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -151.25 146.89 26.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.12 0.568 . . . . 73.03 109.769 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 10.8 tp -132.21 1.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 124.562 1.145 . . . . 75.13 108.637 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 63.61 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.328 1.451 . . . . 75.12 110.37 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -163.78 118.32 1.08 Allowed Pre-proline 0 C--O 1.245 0.828 0 N-CA-C 107.482 -1.303 . . . . 64.03 107.482 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.05 84.66 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.293 1.995 . . . . 73.41 111.037 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 9.4 tt -68.1 -31.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 115.423 -0.808 . . . . 72.14 110.206 174.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 73.67 -9.74 1.17 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.767 1.227 . . . . 61.33 114.209 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 20.0 m -53.97 134.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.216 0.606 . . . . 73.31 111.137 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -156.39 142.54 18.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.19 0.596 . . . . 75.51 110.231 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.14 79.74 0.14 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 124.575 1.172 . . . . 74.43 111.866 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.431 ' HB2' ' HG2' ' D' ' 124' ' ' PRO . 20.3 tp -65.7 100.62 0.55 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.601 -0.727 . . . . 72.11 109.954 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 37.5 m -116.45 -125.19 0.28 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 114.526 -1.216 . . . . 63.55 109.33 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 79.6 mt 64.84 19.63 11.9 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.684 1.194 . . . . 75.42 112.072 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.65 172.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.157 0.983 . . . . 64.34 109.824 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -59.0 137.52 57.9 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.223 0.609 . . . . 64.43 110.163 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 28.7 p30 -152.52 161.26 42.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.498 0.319 . . . . 75.03 111.59 -172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . 0.563 ' HA ' ' HB2' ' B' ' 12' ' ' GLN . 49.3 tttm 78.36 -42.27 0.33 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.991 2.116 . . . . 74.43 111.866 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.48 146.23 42.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.641 0.776 . . . . 73.31 110.397 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 19.0 tp -129.41 5.87 5.23 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.038 0.935 . . . . 75.12 109.788 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp 54.88 73.03 0.95 Allowed Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.342 1.457 . . . . 74.43 111.006 -172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 122.599 2.2 . . . . 75.35 112.67 -178.757 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 111.556 0.206 . . . . 72.52 111.556 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 p -84.37 124.7 31.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.944 0.498 . . . . 72.13 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -153.76 139.81 18.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.372 1.069 . . . . 75.34 109.402 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -121.79 -170.01 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 55.24 109.945 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -60.83 112.13 1.92 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.954 -1.128 . . . . 70.44 107.954 172.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -72.45 -77.4 0.1 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.975 0.91 . . . . 74.42 110.849 -168.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -143.48 107.08 4.61 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.923 0.889 . . . . 75.42 108.946 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.02 89.44 1.12 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.93 -1.137 . . . . 73.42 107.93 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.531 ' SD ' HG22 ' A' ' 89' ' ' ILE . 65.4 mtt -143.8 175.89 9.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.273 1.029 . . . . 75.13 109.902 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -141.9 99.42 3.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 73.33 108.694 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -137.9 113.51 9.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.709 -0.848 . . . . 73.52 108.709 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -142.0 137.88 31.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 75.5 109.769 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.37 133.44 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 71.42 109.929 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.92 -42.31 11.28 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.65 -0.5 . . . . 73.14 109.65 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.518 ' HD2' HD13 ' A' ' 83' ' ' ILE . 11.9 ptp180 -175.56 146.07 0.76 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.067 -0.969 . . . . 75.02 109.39 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.499 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 77.2 mt -137.03 125.98 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.123 -1.065 . . . . 72.4 108.123 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' HE2' ' HB2' ' B' ' 28' ' ' ALA . 22.2 p90 -164.75 161.65 20.69 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.805 0.842 . . . . 75.35 110.635 -170.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -75.83 123.25 25.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.092 -0.504 . . . . 74.54 109.825 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.1 mtpt -86.99 -32.05 20.27 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.695 0.398 . . . . 71.21 109.999 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -147.28 144.94 29.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.524 -0.762 . . . . 75.33 109.907 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.494 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.2 mt -134.99 146.4 30.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 125.451 1.5 . . . . 63.32 107.674 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 t -149.33 138.78 21.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.306 0.642 . . . . 72.41 109.812 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -147.19 126.95 13.43 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.12 -1.437 . . . . 74.55 107.12 175.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.86 127.54 29.03 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.564 -0.902 . . . . 64.4 108.564 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.18 86.61 32.91 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 109.007 -0.738 . . . . 63.31 109.007 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -34.47 27.03 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.165 2.577 . . . . 73.11 113.081 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.63 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 2.4 m-80 -109.84 33.94 4.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.549 0.74 . . . . 70.3 109.926 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' B' ' 19' ' ' LYS . . . -52.88 -48.51 91.17 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 113.727 1.01 . . . . 73.21 113.727 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 16.5 Cg_exo -68.62 -30.94 27.53 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 121.674 1.582 . . . . 74.4 112.214 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -75.8 -21.89 56.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.697 0.799 . . . . 74.14 111.825 -170.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 27' ' ' ASN . 57.9 t -53.61 -27.24 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 123.773 0.829 . . . . 75.5 111.848 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -78.82 -39.03 36.67 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.746 0.818 . . . . 74.51 111.047 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -88.29 -26.64 22.17 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.302 0.641 . . . . 70.45 112.383 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HB2' HD12 ' A' ' 68' ' ' LEU . 55.8 mtpt -80.5 163.49 23.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.15 0.58 . . . . 75.31 111.234 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.06 115.84 15.13 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.457 0.703 . . . . 71.05 109.331 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.592 ' HZ3' ' HB2' ' F' ' 133' ' ' PRO . 23.1 p-90 -73.24 86.01 1.42 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.987 0.915 . . . . 75.4 111.445 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.53 80.63 65.69 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 124.031 0.932 . . . . 74.55 108.899 171.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.45 121.71 8.47 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.876 2.384 . . . . 74.45 111.872 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.86 105.96 18.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.378 -0.971 . . . . 75.13 108.378 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.09 92.47 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.705 -0.85 . . . . 74.43 108.705 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.2 tttm -100.33 115.29 29.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.92 0.888 . . . . 74.43 109.139 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD13 ' HG ' ' F' ' 129' ' ' LEU . 4.2 mp -100.84 141.91 33.05 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.028 0.531 . . . . 74.13 109.808 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.5 m-20 -128.19 111.68 13.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.265 -1.383 . . . . 74.52 107.265 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.414 HD11 HG23 ' A' ' 131' ' ' VAL . 75.2 mt -109.74 119.89 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.753 -0.462 . . . . 72.51 109.753 -174.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -130.31 137.46 49.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.051 0.94 . . . . 74.11 109.463 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.6 m -117.07 132.97 56.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.572 0.749 . . . . 75.33 109.902 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.03 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.641 1.176 . . . . 74.4 109.036 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -132.54 158.94 40.86 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.594 0.758 . . . . 75.41 110.43 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -157.17 157.34 34.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.458 1.103 . . . . 75.05 110.009 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -113.95 136.97 52.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.776 0.83 . . . . 55.12 109.572 174.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.03 -33.91 3.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.134 0.573 . . . . 73.55 111.209 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.46 -174.04 4.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.232 0.613 . . . . 63.03 110.199 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.1 117.01 9.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.457 0.703 . . . . 72.42 109.487 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 67.62 14.65 9.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.481 1.112 . . . . 72.14 111.816 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -118.93 104.93 16.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.478 -0.934 . . . . 75.31 108.478 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -125.53 126.65 45.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.67 0.788 . . . . 75.24 109.116 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -92.48 130.04 38.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.747 1.219 . . . . 74.4 109.432 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.405 HG11 ' HD3' ' A' ' 103' ' ' PRO . 65.4 t -114.28 123.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.956 -1.127 . . . . 73.1 107.956 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.5 t -106.52 134.96 46.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.617 0.767 . . . . 62.05 109.277 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.9 113.93 27.83 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.296 -1.372 . . . . 72.51 107.296 177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -96.6 100.72 12.27 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.988 -1.115 . . . . 75.35 107.988 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 t -101.84 131.61 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.525 -0.917 . . . . 73.43 108.525 177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.1 m -116.6 137.15 52.4 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.784 -1.191 . . . . 63.32 107.784 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.418 HG22 HG21 ' A' ' 114' ' ' ILE . 86.3 t -128.72 128.05 67.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.567 -2.012 . . . . 74.34 105.567 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 27.6 m -124.67 139.24 54.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.934 -1.506 . . . . 72.12 106.934 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.95 119.75 20.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.403 -0.962 . . . . 62.44 108.403 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 68.5 m -107.07 131.37 54.17 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.369 -0.604 . . . . 74.22 109.369 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -88.94 76.22 7.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.559 -1.275 . . . . 73.42 107.559 -175.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.36 -102.2 2.26 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.324 -1.51 . . . . 71.41 109.324 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.56 -27.82 4.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.373 0.669 . . . . 75.23 110.096 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.44 131.44 34.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.936 0.894 . . . . 74.01 108.59 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 24.5 m -62.01 130.17 44.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.052 . . . . 64.32 113.205 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.516 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -76.89 -59.3 2.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.433 1.093 . . . . 72.34 109.307 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -161.83 174.48 13.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.631 -1.168 . . . . 72.21 111.112 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.0 tp -137.69 145.26 42.38 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 75.1 108.329 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.493 ' HB3' HG22 ' A' ' 114' ' ' ILE . 70.2 m -146.99 104.44 3.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.914 0.885 . . . . 71.4 110.165 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.21 126.35 38.95 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.895 0.478 . . . . 72.11 109.774 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 113' ' ' CYS . 42.1 t -134.89 112.49 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.871 0.868 . . . . 74.31 109.663 -174.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -85.09 83.39 8.05 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.402 -0.962 . . . . 63.03 108.402 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.14 98.53 5.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.222 -0.899 . . . . 64.21 109.448 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.01 144.49 19.41 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.83 -0.508 . . . . 64.34 111.83 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.21 122.46 2.43 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.114 -1.194 . . . . 72.02 110.114 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.518 HD13 ' HD2' ' A' ' 15' ' ' ARG . 49.5 mt -88.5 129.13 40.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.275 -1.009 . . . . 73.24 108.275 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -129.1 126.02 38.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.652 0.381 . . . . 74.54 110.313 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 p -83.24 100.13 10.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.887 -0.782 . . . . 73.22 108.887 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.5 pt -112.8 137.1 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.798 0.839 . . . . 75.51 111.437 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.18 155.77 11.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.882 1.273 . . . . 60.03 108.964 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.89 86.54 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 120.154 -0.248 . . . . 70.01 113.63 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.531 HG22 ' SD ' ' A' ' 9' ' ' MET . 44.7 pt -110.47 140.9 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.994 0.918 . . . . 75.4 109.259 -173.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.486 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 22.5 tt0 -155.47 177.74 11.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.864 0.466 . . . . 70.44 110.292 -174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.486 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.1 -157.18 43.57 Favored Glycine 0 C--N 1.345 1.07 0 C-N-CA 123.936 0.779 . . . . 72.51 114.127 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 p -71.83 -13.84 61.79 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.797 0.839 . . . . 71.03 111.026 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.12 -46.66 88.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.317 1.047 . . . . 61.35 111.022 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.4 61.96 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.094 -0.335 . . . . 75.23 110.094 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.29 75.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.338 0.655 . . . . 63.42 110.704 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -65.04 -48.12 74.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.764 1.226 . . . . 73.25 110.07 172.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.64 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 13.4 m -73.84 -26.02 60.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.955 1.094 . . . . 65.02 113.955 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.2 mt -97.31 -30.61 12.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.854 0.462 . . . . 74.52 111.332 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -20.34 49.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.098 -0.501 . . . . 73.14 113.217 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.649 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -132.77 -70.7 0.54 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.23 0.455 . . . . 71.3 112.23 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.64 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.1 t80 -45.0 -58.6 3.07 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 124.899 1.279 . . . . 73.01 113.9 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.5 m -72.08 -41.61 8.8 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.323 -0.846 . . . . 74.12 113.166 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.405 ' HD3' HG11 ' A' ' 58' ' ' VAL . 9.3 Cg_endo -60.72 -23.91 77.44 Favored 'Trans proline' 0 C--N 1.388 2.63 0 CA-C-N 121.281 1.493 . . . . 72.22 113.851 165.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.56 HD22 ' HB2' ' A' ' 133' ' ' PHE . 32.9 m-80 -73.19 -35.52 66.4 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 118.71 0.686 . . . . 73.14 110.484 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.29 -41.87 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.236 0.615 . . . . 73.32 109.576 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.528 HD22 ' HA3' ' A' ' 82' ' ' GLY . 96.2 mt -71.47 -24.89 62.08 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.219 -0.901 . . . . 73.13 112.354 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.97 -44.05 70.23 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.825 -1.084 . . . . 74.51 113.859 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.89 -32.64 92.82 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.247 1.965 . . . . 71.4 113.577 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -75.94 -38.58 57.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.247 0.619 . . . . 74.22 110.959 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.53 -46.24 76.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.106 0.562 . . . . 71.21 109.629 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -50.67 -54.28 24.34 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.865 1.353 . . . . 75.52 110.478 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -58.1 -49.47 76.85 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.437 1.085 . . . . 74.15 111.748 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.445 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.1 t -58.99 -43.57 91.47 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.062 0.851 . . . . 64.42 110.934 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.493 HG22 ' HB3' ' A' ' 76' ' ' CYS . 84.7 mt -60.55 -55.1 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 123.997 0.811 . . . . 71.22 110.265 174.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -59.71 -34.57 73.08 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.768 1.227 . . . . 73.12 111.837 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.1 t -73.46 -42.13 62.33 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.648 -0.705 . . . . 74.32 110.137 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.437 ' SD ' HG22 ' A' ' 21' ' ' ILE . 7.5 mtp -57.47 -42.2 82.14 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.552 0.741 . . . . 75.0 111.128 174.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 114' ' ' ILE . 81.0 t -61.14 -46.76 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.619 1.167 . . . . 72.54 111.016 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.2 p -75.76 -26.54 57.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.864 0.466 . . . . 74.43 111.506 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.96 -29.22 64.04 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.566 0.747 . . . . 75.43 109.762 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 1.51 79.52 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.652 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.3 m 68.59 11.69 8.43 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.865 1.266 . . . . 71.12 111.558 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -87.09 150.25 49.32 Favored Pre-proline 0 C--O 1.243 0.75 0 CA-C-N 115.608 -0.724 . . . . 74.32 109.093 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -45.84 112.63 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.144 2.563 . . . . 75.13 112.698 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.05 122.8 10.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.854 1.262 . . . . 64.43 111.656 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.28 96.08 6.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.186 -1.042 . . . . 64.44 108.186 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -99.83 83.57 2.76 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.379 -0.971 . . . . 72.33 108.379 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.589 HD21 ' H ' ' A' ' 128' ' ' LEU . 1.2 pt? -59.63 136.88 58.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.003 -0.998 . . . . 74.52 111.941 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.91 148.82 82.74 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.413 1.085 . . . . 72.2 112.018 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 129.74 36.21 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.477 . . . . 75.43 113.72 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.414 HG23 HD11 ' A' ' 44' ' ' LEU . 87.9 t -103.08 122.03 55.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.632 -0.877 . . . . 70.43 108.632 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.612 ' HB2' ' HB1' ' A' ' 135' ' ' ALA . 25.0 p-10 -88.57 71.25 8.89 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.919 0.888 . . . . 54.41 111.006 -173.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.56 ' HB2' HD22 ' A' ' 104' ' ' ASN . 39.6 m-85 -61.43 -38.76 88.32 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.726 0.774 . . . . 64.22 109.263 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.649 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 10.9 t70 -71.38 -40.78 70.36 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.427 -1.26 . . . . 74.11 111.318 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.612 ' HB1' ' HB2' ' A' ' 132' ' ' ASN . . . -78.75 -29.54 45.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 114.558 -1.201 . . . . 73.43 112.08 -171.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.94 -47.33 86.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.996 -0.742 . . . . 65.54 108.996 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -69.46 -37.44 77.32 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.593 -0.73 . . . . 75.33 110.415 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -35.77 80.75 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.885 0.874 . . . . 73.34 111.209 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -57.39 -55.77 30.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.342 0.657 . . . . 74.11 109.832 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -69.16 -33.01 72.73 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.997 -1.001 . . . . 74.32 112.105 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.91 -53.34 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.707 0.629 . . . . 74.41 111.277 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -160.13 -13.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.093 0.957 . . . . 74.24 111.058 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.465 ' HB2' HE22 ' C' ' 4' ' ' GLN . 51.3 tt0 56.47 81.95 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.256 1.022 . . . . 72.22 109.72 -164.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.8 129.25 40.25 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.961 -0.563 . . . . 75.53 110.169 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.01 -49.3 3.66 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 72.25 109.183 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.98 174.43 24.5 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.974 -0.557 . . . . 75.15 112.608 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.9 149.22 17.85 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.056 -0.72 . . . . 74.04 109.056 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.51 -163.32 36.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.181 -0.463 . . . . 73.12 112.654 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.0 m -129.16 -38.98 1.57 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.609 1.164 . . . . 73.42 109.769 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 75.47 149.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.788 1.305 . . . . 73.0 111.649 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 66.7 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.681 1.192 . . . . 64.54 111.146 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -128.72 -21.5 3.4 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.276 0.63 . . . . 75.32 111.473 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -162.93 150.16 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.553 0.341 . . . . 73.41 110.923 -171.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.4 t70 68.47 93.81 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.423 1.489 . . . . 71.15 111.655 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.431 1.093 . . . . 72.32 108.193 176.006 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.04 -0.726 . . . . 74.34 109.04 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.7 m -87.04 167.94 13.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.864 0.865 . . . . 70.55 111.456 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.15 126.06 30.3 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.46 -0.791 . . . . 71.1 109.912 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -81.94 72.57 8.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.484 0.714 . . . . 73.2 110.112 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 m120 59.87 -84.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.073 1.349 . . . . 74.53 111.254 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -167.31 12.44 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.483 1.113 . . . . 61.41 110.765 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.5 t -76.85 162.72 27.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.892 0.477 . . . . 75.23 110.69 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 66.88 -173.85 0.19 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.87 1.268 . . . . 71.23 111.513 -171.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.707 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.8 ptm 56.4 173.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 126.457 1.903 . . . . 74.42 115.279 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -137.05 136.92 38.82 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.335 -1.302 . . . . 72.1 107.785 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.04 124.46 40.71 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.32 -0.993 . . . . 74.24 108.32 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.401 ' NE2' HD11 ' F' ' 147' ' ' LEU . 0.1 OUTLIER -137.43 110.34 7.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.151 0.58 . . . . 73.04 109.596 -177.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.418 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -70.19 115.86 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 109.313 -0.625 . . . . 74.34 109.313 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.84 -51.62 6.28 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.263 0.554 . . . . 75.33 109.653 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -169.71 133.89 1.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.098 -0.956 . . . . 73.24 108.535 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.549 HG21 ' CD1' ' B' ' 109' ' ' TYR . 73.3 mt -114.75 146.13 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.539 -1.282 . . . . 73.03 107.539 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -168.02 149.67 5.32 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.598 0.592 . . . . 73.25 112.598 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -73.59 124.92 26.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.199 -0.91 . . . . 74.32 108.7 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 28' ' ' ALA . 38.9 mtpt -98.31 -37.37 9.67 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.347 0.659 . . . . 73.13 110.858 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 26.8 m-20 -148.09 133.51 18.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.064 -0.517 . . . . 60.44 109.91 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.439 HG22 ' HE1' ' B' ' 117' ' ' MET . 46.1 mm -130.01 142.58 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 74.13 109.74 174.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.616 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -133.68 135.34 44.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.311 1.444 . . . . 75.12 108.867 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.494 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.5 t80 -149.63 127.0 11.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.808 -1.182 . . . . 74.23 107.808 166.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.16 126.68 25.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.72 0.808 . . . . 74.55 109.297 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.579 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -124.19 88.0 53.15 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.136 -0.69 . . . . 72.42 109.136 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.37 -27.47 28.31 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.028 2.485 . . . . 54.33 112.034 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -117.61 28.98 8.11 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.146 0.979 . . . . 74.44 109.019 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.579 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -44.49 -54.19 12.91 Favored Pre-proline 0 C--N 1.366 1.312 0 C-N-CA 124.684 1.194 . . . . 74.44 112.331 167.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.0 Cg_exo -69.32 -19.79 37.77 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.339 2.026 . . . . 72.42 112.498 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 11.5 m-70 -96.67 2.98 52.69 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.238 1.015 . . . . 75.12 111.936 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.47 -32.69 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 112.861 0.689 . . . . 72.12 112.861 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -74.21 -26.69 60.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.17 0.509 . . . . 74.44 110.563 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.87 -16.66 61.12 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.807 1.243 . . . . 73.53 110.523 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 mmmt -101.91 95.46 6.39 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.979 0.912 . . . . 70.21 111.707 -170.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.75 87.14 3.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 75.33 111.062 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -176.96 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.698 1.599 . . . . 75.41 108.136 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -87.98 133.83 36.49 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.254 0.622 . . . . 74.34 109.727 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 13.8 Cg_exo -65.5 134.78 39.75 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.005 1.803 . . . . 73.14 111.874 170.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.455 ' HG3' ' HE2' ' B' ' 41' ' ' LYS . 16.0 tp10 -63.95 103.93 0.65 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.253 0.621 . . . . 70.13 109.39 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.27 147.94 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 72.05 111.42 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.455 ' HE2' ' HG3' ' B' ' 39' ' ' GLU . 73.4 mmtt -136.48 143.92 44.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.74 1.216 . . . . 74.41 109.423 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -127.48 132.72 49.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.684 0.794 . . . . 75.03 109.269 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.668 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 11.6 m-20 -132.14 115.42 15.71 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.281 -1.007 . . . . 75.41 108.281 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.29 135.27 40.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.862 -0.792 . . . . 73.4 108.862 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 31.9 t70 -146.07 149.12 33.47 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.935 0.894 . . . . 75.22 108.953 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -128.97 123.81 33.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.48 0.712 . . . . 72.13 109.602 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.575 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -114.48 159.43 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.495 -1.298 . . . . 61.41 107.495 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -145.26 164.23 32.03 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.25 0.548 . . . . 75.53 111.028 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -153.58 143.03 21.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.591 -1.186 . . . . 74.45 107.983 169.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.06 104.9 14.71 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.927 -0.768 . . . . 74.04 108.927 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.531 HD12 HG22 ' B' ' 83' ' ' ILE . 86.1 mt -73.51 -45.21 55.19 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.032 0.444 . . . . 73.32 109.808 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -178.07 6.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.012 -0.994 . . . . 72.22 110.005 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.35 128.67 35.9 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.957 -1.02 . . . . 61.23 109.186 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 67.42 10.73 7.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.635 1.174 . . . . 70.31 112.061 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.4 t -129.23 99.17 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.31 1.044 . . . . 73.51 108.781 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.925 0.869 . . . . 73.41 111.266 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.98 95.02 2.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.473 -2.418 . . . . 70.54 104.473 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.18 130.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.241 0.543 . . . . 75.12 109.612 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.575 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 32.9 t -102.03 143.46 14.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 114.953 -1.022 . . . . 61.43 109.172 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.7 OUTLIER -119.59 111.08 17.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.588 -1.264 . . . . 74.45 107.588 176.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.511 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.0 ttt180 -96.69 108.84 21.54 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.072 0.549 . . . . 64.34 110.23 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.5 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.1 t -105.88 118.83 54.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.445 -0.946 . . . . 74.14 108.445 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.668 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 38.0 m -103.92 141.34 36.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.565 0.746 . . . . 71.43 109.028 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.571 HG22 HG21 ' B' ' 114' ' ' ILE . 47.5 t -129.25 130.82 67.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.367 1.067 . . . . 73.41 108.901 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.3 m -125.42 140.07 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.896 -0.779 . . . . 73.12 108.896 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -140.17 131.37 26.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.608 -0.886 . . . . 72.42 108.608 175.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.447 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.0 p -133.29 126.26 31.06 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.808 -0.441 . . . . 74.03 109.808 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.506 ' HB2' ' HB3' ' B' ' 73' ' ' ALA . 0.9 OUTLIER -110.86 130.07 55.69 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.67 -1.604 . . . . 71.32 106.67 -176.232 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -119.09 5.7 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.585 -1.006 . . . . 75.22 110.585 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -120.35 3.81 10.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.654 0.782 . . . . 64.45 110.711 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -115.48 165.5 12.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.818 0.847 . . . . 63.23 110.145 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 42.6 m -70.23 131.6 44.46 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.711 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . . . -86.16 -57.99 2.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.024 -1.102 . . . . 74.35 108.024 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -160.27 166.44 29.54 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.327 -1.306 . . . . 73.54 110.679 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 94.7 mt -133.91 136.16 44.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.496 1.518 . . . . 72.34 107.033 178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 50.0 t -143.23 147.49 34.92 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.443 -0.947 . . . . 72.32 108.443 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.616 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.3 tt0 -162.94 139.1 7.19 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.167 -0.679 . . . . 71.53 109.167 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' B' ' 110' ' ' ALA . 98.7 t -130.95 144.31 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.644 0.778 . . . . 71.14 109.021 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.553 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 26.4 mt-30 -122.82 92.91 3.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.624 -0.88 . . . . 75.53 108.624 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -85.43 102.73 13.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.823 -1.08 . . . . 71.1 109.296 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.31 168.71 29.87 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.617 -0.593 . . . . 75.33 111.617 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.25 128.56 1.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 112.084 -0.407 . . . . 74.03 112.084 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.531 HG22 HD12 ' B' ' 51' ' ' LEU . 19.7 mt -83.58 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.075 -1.083 . . . . 74.02 108.075 172.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -130.13 132.9 46.29 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.022 -0.733 . . . . 63.43 109.022 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -95.82 115.07 26.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.788 -0.819 . . . . 74.13 108.788 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.485 ' H ' HD11 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -129.11 137.37 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.754 1.222 . . . . 71.31 109.212 -175.299 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.8 173.05 16.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.296 0.638 . . . . 75.2 109.896 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.59 -66.7 1.4 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.922 -0.471 . . . . 64.13 111.922 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.707 HG23 ' HB3' ' B' ' 9' ' ' MET . 8.3 pt -60.74 145.11 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.708 0.803 . . . . 74.11 111.887 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.54 146.26 24.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.061 -0.972 . . . . 63.31 109.411 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.08 7.64 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.416 0.448 . . . . 75.45 112.76 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.8 m -70.04 -50.14 44.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.656 0.783 . . . . 74.53 111.124 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -61.46 -24.94 66.91 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.925 0.89 . . . . 73.4 111.696 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' E' ' 115' ' ' LEU . 52.6 ttp -67.24 -40.21 86.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.503 1.121 . . . . 75.1 110.823 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.14 69.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.856 0.862 . . . . 64.41 111.991 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -65.45 -29.65 70.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.231 0.612 . . . . 75.41 111.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.2 -68.53 0.65 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.227 0.211 . . . . 73.44 111.437 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.487 HD21 ' SG ' ' B' ' 102' ' ' CYS . 94.1 mt -75.65 -22.89 56.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.256 0.465 . . . . 74.42 112.256 -172.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.75 -39.52 24.64 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.575 0.547 . . . . 70.22 112.327 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.15 -53.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.783 0.66 . . . . 73.53 112.783 -164.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -66.31 -45.38 80.53 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.311 0.644 . . . . 62.54 112.015 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.487 ' SG ' HD21 ' B' ' 98' ' ' LEU . 71.4 m -63.99 -50.06 71.51 Favored Pre-proline 0 CA--C 1.556 1.191 0 CA-C-O 118.373 -0.823 . . . . 75.32 110.61 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.2 Cg_exo -51.18 -33.03 42.61 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.624 2.216 . . . . 75.11 114.865 165.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.75 -25.27 64.65 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 118.355 0.525 . . . . 73.22 112.067 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -42.18 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.377 0.671 . . . . 75.31 109.77 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.435 ' HB2' HD12 ' B' ' 60' ' ' LEU . 95.8 mt -72.99 -24.73 60.8 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.025 -0.989 . . . . 75.41 110.926 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.17 -50.69 74.34 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.756 -1.116 . . . . 75.04 113.169 -169.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.434 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 37.6 Cg_endo -63.17 -32.42 74.29 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 121.638 1.558 . . . . 73.35 112.094 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.549 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.7 m-30 -66.42 -43.3 86.09 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.018 0.927 . . . . 71.53 110.454 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.419 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -66.42 -42.31 87.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.962 0.905 . . . . 65.43 110.204 175.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -61.68 -52.99 62.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.649 1.58 . . . . 75.31 111.476 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.84 -33.61 75.59 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.079 0.862 . . . . 74.23 109.756 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.495 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.7 t -71.94 -34.99 69.47 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.854 -0.612 . . . . 70.15 111.059 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.571 HG21 HG22 ' B' ' 64' ' ' VAL . 53.1 mt -65.22 -54.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.122 -0.696 . . . . 74.34 109.122 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -58.97 -31.33 68.64 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.799 -1.092 . . . . 71.23 110.846 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.5 t -64.61 -55.5 19.92 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.652 0.781 . . . . 70.31 110.159 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.529 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 14.3 mmt -63.23 -36.75 84.69 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.702 0.401 . . . . 72.11 111.619 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.16 -51.63 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.056 0.942 . . . . 74.41 110.687 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.35 -20.24 60.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.067 0.547 . . . . 74.13 111.991 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.445 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.4 mtt-85 -68.89 -31.36 70.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.308 0.643 . . . . 75.55 110.28 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.5 14.59 57.64 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 123.854 0.721 . . . . 73.31 112.666 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.7 p 55.45 30.7 15.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.83 1.652 . . . . 73.22 112.492 -178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.46 155.45 39.65 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.928 0.891 . . . . 72.24 109.999 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.07 143.09 99.58 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.029 2.486 . . . . 72.34 113.034 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -59.08 123.11 15.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.76 1.224 . . . . 73.34 111.566 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.15 89.73 3.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.476 0.71 . . . . 71.05 109.849 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.37 100.14 12.52 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.224 -0.898 . . . . 73.23 110.377 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.49 151.02 42.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.203 1.001 . . . . 74.34 112.6 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' E' ' 130' ' ' ILE . . . -75.35 150.43 84.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.641 -0.709 . . . . 73.23 110.682 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.26 110.84 2.55 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.434 2.089 . . . . 75.03 110.044 176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.49 110.81 21.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 74.11 106.981 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -76.26 91.55 3.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.875 -1.528 . . . . 74.33 106.875 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -53.48 -40.24 65.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.89 -1.05 . . . . 65.4 110.399 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.74 -53.99 27.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.512 1.125 . . . . 72.3 111.688 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -22.38 64.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.613 0.765 . . . . 75.05 111.674 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.33 -51.71 68.38 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.785 0.834 . . . . 71.11 109.793 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.484 ' HB2' ' HZ3' ' E' ' 120' ' ' TRP . 26.8 t80 -76.88 -28.74 55.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.835 -0.621 . . . . 74.44 110.541 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 59.6 ttp -65.39 -31.14 72.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.027 0.531 . . . . 75.11 110.71 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.61 -30.85 59.69 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 74.11 110.376 175.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -65.09 -35.59 81.62 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.98 0.419 . . . . 75.12 109.981 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 39.8 mt -93.96 36.02 1.13 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.035 0.934 . . . . 61.45 109.906 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -57.6 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.07 0.948 . . . . 73.25 111.562 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -136.56 -170.56 2.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.722 1.209 . . . . 71.23 108.672 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.38 136.91 53.47 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.661 0.784 . . . . 71.24 110.074 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.51 137.54 4.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.118 1.367 . . . . 72.31 108.361 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.98 156.44 19.54 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.801 -0.238 . . . . 72.11 113.139 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -112.92 71.19 0.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.596 0.712 . . . . 74.12 111.127 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.06 87.66 1.57 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 114.852 -1.067 . . . . 41.52 110.675 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.0 p -123.68 -91.2 0.55 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.067 -0.716 . . . . 71.53 109.067 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 62.05 134.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.656 1.582 . . . . 75.25 113.744 171.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -151.42 119.74 6.38 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.685 -0.857 . . . . 75.44 108.685 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -123.95 111.8 16.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.886 0.874 . . . . 71.51 108.916 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -73.83 119.74 18.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.144 0.978 . . . . 72.54 110.452 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -113.99 65.31 0.66 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.173 0.989 . . . . 73.2 108.713 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.494 -0.928 . . . . 64.22 108.494 179.687 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 37.2 tpp . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.463 -0.569 . . . . 74.45 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 65.0 p -80.82 152.17 28.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.823 -0.626 . . . . 74.21 109.901 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.57 115.5 7.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.701 -0.851 . . . . 73.34 108.701 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.465 HE22 ' HB2' ' A' ' 143' ' ' GLN . 26.9 mt-30 -91.18 56.44 3.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.713 0.805 . . . . 74.31 110.871 -170.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -75.66 118.21 18.25 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.129 -0.941 . . . . 74.51 110.362 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -152.41 -87.31 0.06 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.466 -0.938 . . . . 64.11 108.466 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 175.73 144.37 0.07 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.896 2.078 . . . . 73.43 107.253 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.7 67.81 1.31 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.035 0.934 . . . . 75.1 108.671 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.418 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 52.7 ttp 65.1 116.34 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.495 -1.229 . . . . 73.42 110.545 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.507 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 40.2 m -84.04 78.79 9.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.128 -1.064 . . . . 73.03 108.128 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.518 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 42.2 t80 -100.18 127.94 46.35 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.809 -1.541 . . . . 75.43 108.571 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -138.03 142.73 40.35 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.336 -0.616 . . . . 74.12 109.336 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.33 110.21 11.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.319 -0.855 . . . . 73.11 108.738 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.5 mm-40 -77.67 -39.93 43.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.93 -0.577 . . . . 74.12 109.938 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.459 HH11 ' HD1' ' D' ' 32' ' ' PHE . 24.2 ttt180 179.27 124.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.393 0.677 . . . . 75.33 109.953 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 87.9 mt -110.08 138.62 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.818 -1.178 . . . . 64.23 107.818 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.474 ' HB3' HG22 ' D' ' 122' ' ' THR . 23.9 p90 -174.17 154.1 2.16 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.752 0.657 . . . . 73.53 110.729 -175.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.3 p -75.58 122.93 24.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.28 -0.873 . . . . 72.55 109.733 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -78.34 -50.58 11.51 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.218 -1.03 . . . . 64.53 108.218 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.5 t70 -133.53 139.19 46.47 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.551 -1.204 . . . . 74.3 109.939 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.37 140.06 38.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.794 -1.558 . . . . 73.54 106.794 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -160.7 150.75 17.74 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.119 0.485 . . . . 63.15 109.708 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 78.4 t80 -152.16 115.79 4.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.854 -1.165 . . . . 75.43 107.854 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.98 110.57 17.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.156 0.582 . . . . 72.15 110.432 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.6 86.24 34.29 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.405 1.082 . . . . 71.4 108.573 167.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.81 -32.31 29.87 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.414 2.076 . . . . 70.34 110.56 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -89.23 22.69 2.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.132 -1.394 . . . . 74.35 111.415 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB2' ' HE3' ' D' ' 19' ' ' LYS . . . -55.49 -43.59 99.22 Favored Pre-proline 0 CA--C 1.574 1.866 0 C-N-CA 124.226 1.011 . . . . 75.52 113.52 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -89.41 -17.96 1.75 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.958 1.772 . . . . 74.43 113.17 169.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.59 -31.69 68.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.535 1.134 . . . . 70.33 110.593 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.87 -2.45 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 124.473 1.109 . . . . 74.02 112.344 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.646 ' HA ' HD12 ' E' ' 134' ' ' ILE . 74.4 t80 -49.99 -41.72 47.61 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.389 1.476 . . . . 74.23 113.11 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -125.12 49.63 1.86 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.245 1.018 . . . . 73.44 108.499 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.79 149.29 47.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.82 -0.55 . . . . 71.3 111.22 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.2 132.91 50.33 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.285 -0.871 . . . . 75.43 110.406 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.771 ' HB3' ' HA ' ' E' ' 136' ' ' VAL . 29.1 p90 -83.52 65.86 8.63 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.026 0.917 . . . . 74.21 110.509 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -152.61 58.18 2.39 Favored Pre-proline 0 CA--C 1.558 1.281 0 CA-C-N 115.12 -0.946 . . . . 71.14 110.553 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.0 149.54 9.52 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.1 1.866 . . . . 70.42 110.8 165.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.24 113.63 24.04 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.284 0.634 . . . . 75.23 109.902 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -77.51 111.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.141 0.576 . . . . 72.1 109.747 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.653 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 26.6 mmmt -92.79 104.57 16.82 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.853 -1.165 . . . . 75.02 107.853 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.517 ' HB3' HD12 ' E' ' 142' ' ' ILE . 2.4 pt? -87.25 145.65 26.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.33 . . . . 71.23 110.194 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.548 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 30.2 t70 -140.88 109.02 5.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.11 -0.7 . . . . 73.22 109.11 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -117.22 125.68 51.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.951 -0.759 . . . . 72.31 108.951 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -143.92 160.53 40.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.446 1.098 . . . . 71.24 109.869 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -129.76 153.72 47.92 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.282 0.633 . . . . 75.5 109.651 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 164.58 26.32 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.067 0.947 . . . . 54.21 109.079 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.469 ' HB3' HD23 ' C' ' 98' ' ' LEU . 33.1 p -142.31 145.36 33.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.037 0.535 . . . . 74.51 110.5 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -145.99 126.38 14.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.379 1.072 . . . . 64.04 108.431 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.68 116.05 23.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.462 -0.94 . . . . 74.45 108.462 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.521 HD13 HD13 ' C' ' 83' ' ' ILE . 67.0 mt -85.41 -43.02 13.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.47 0.708 . . . . 75.42 110.17 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 -171.98 3.61 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.847 -1.069 . . . . 71.51 109.964 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.25 108.91 0.99 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.129 -0.941 . . . . 75.24 110.025 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 71.04 -3.08 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.972 1.309 . . . . 74.3 112.955 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -95.53 97.28 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.842 -1.169 . . . . 72.23 107.842 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -106.97 159.07 16.55 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.541 0.736 . . . . 75.23 110.119 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.99 120.26 31.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.426 1.09 . . . . 74.52 108.265 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.41 133.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.854 -1.165 . . . . 72.3 107.854 172.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.21 105.65 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.184 -0.673 . . . . 64.45 109.184 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.05 99.44 12.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.905 -1.146 . . . . 73.12 107.905 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.53 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.6 tmm_? -92.28 120.94 33.3 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.288 0.635 . . . . 74.54 110.151 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.504 ' HB ' HD11 ' C' ' 114' ' ' ILE . 37.2 t -112.09 125.33 69.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.569 -0.9 . . . . 65.32 108.569 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.548 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -118.53 123.66 45.64 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.486 -0.931 . . . . 71.33 108.486 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 76.3 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.989 -1.005 . . . . 73.14 108.725 174.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 5.7 m -98.46 136.54 38.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.579 -1.637 . . . . 75.31 106.579 169.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.22 106.65 6.83 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.985 -1.857 . . . . 74.23 105.985 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 12.5 p -164.46 158.12 18.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 123.622 0.576 . . . . 63.22 110.688 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -113.71 20.24 16.06 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.645 0.735 . . . . 71.4 110.181 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.86 -83.47 0.35 Allowed Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.437 -0.801 . . . . 75.14 111.166 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.12 -32.03 11.12 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.29 0.636 . . . . 72.23 110.423 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -82.35 91.36 6.79 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 108.896 -0.779 . . . . 74.03 108.896 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -81.87 128.22 33.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.543 . . . . 73.32 109.563 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -64.11 1.01 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.614 -1.254 . . . . 72.14 107.614 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -159.76 172.37 17.83 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 121.971 0.891 . . . . 75.35 111.524 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -129.25 140.67 51.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.627 -1.99 . . . . 72.51 105.627 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.39 144.32 29.66 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.402 -0.962 . . . . 61.3 108.402 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.97 128.71 7.88 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.602 -0.518 . . . . 54.45 109.602 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.13 123.22 58.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.01 -0.995 . . . . 62.32 108.567 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.53 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 74.1 mt-30 -98.25 91.28 5.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.224 -1.398 . . . . 72.1 107.224 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -78.34 102.53 7.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.868 -0.606 . . . . 72.51 109.572 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.19 145.44 23.22 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.417 -0.811 . . . . 64.45 111.186 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.6 116.06 0.76 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.343 -1.103 . . . . 62.43 110.343 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.521 HD13 HD13 ' C' ' 51' ' ' LEU . 12.7 mm -81.44 127.82 39.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 107.932 -1.136 . . . . 74.44 107.932 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.88 123.5 23.56 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.358 0.663 . . . . 73.43 109.553 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.5 p -77.04 106.54 8.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.729 -1.211 . . . . 73.31 107.729 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 48.3 mt -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.127 -1.064 . . . . 73.32 108.127 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.507 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -127.84 158.63 37.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.767 0.827 . . . . 75.54 110.25 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -51.76 3.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.828 -0.623 . . . . 71.51 113.029 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.7 tt -81.28 145.47 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.539 0.735 . . . . 74.25 109.978 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.12 -179.36 8.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.99 0.516 . . . . 64.12 110.759 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.26 -148.64 47.72 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.61 -0.723 . . . . 60.41 112.789 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 77.0 p -69.67 -18.05 63.53 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.22 1.008 . . . . 75.4 111.453 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -64.9 -46.19 82.76 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 75.43 110.108 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 57.5 ttp -68.07 -32.2 72.37 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.451 -0.795 . . . . 74.55 110.181 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.74 85.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.333 0.653 . . . . 72.43 110.981 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 46.7 t-80 -65.78 -32.75 74.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.719 0.808 . . . . 75.23 111.308 176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.49 ' SG ' ' SG ' ' C' ' 102' ' ' CYS . 43.8 t -76.33 -55.34 5.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 74.41 110.294 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' C' ' 48' ' ' SER . 9.6 tt -65.64 -31.82 73.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.298 1.039 . . . . 74.44 111.225 -172.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.85 10.06 55.54 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.44 -0.644 . . . . 63.3 114.024 -175.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.75 -59.03 0.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.776 0.788 . . . . 73.11 111.657 -178.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -69.88 -55.54 9.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.449 0.7 . . . . 74.33 111.967 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.518 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 9.8 m -61.56 -45.82 93.85 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.635 0.774 . . . . 64.1 112.039 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.472 ' HB3' HD22 ' C' ' 60' ' ' LEU . 39.1 Cg_exo -61.05 -32.18 91.67 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.349 2.032 . . . . 74.3 113.501 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.95 -35.63 79.03 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.457 0.703 . . . . 72.32 110.882 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.42 -44.69 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.586 0.755 . . . . 73.15 110.254 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.7 mt -82.28 -23.96 34.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.869 -1.06 . . . . 74.31 112.506 -171.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.412 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 39.8 t80 -54.8 -48.22 96.15 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 124.84 1.256 . . . . 75.45 113.59 -172.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.531 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 23.3 Cg_exo -63.7 -34.44 62.48 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.932 1.755 . . . . 73.2 113.019 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -64.75 -44.75 89.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.105 0.562 . . . . 74.12 110.46 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.62 99.24 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.445 -0.798 . . . . 41.43 110.667 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.531 ' HD3' ' HA ' ' C' ' 108' ' ' PRO . 39.4 mtp180 -56.38 -53.39 57.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.966 0.906 . . . . 74.52 111.402 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.46 -32.76 71.89 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.711 0.632 . . . . 74.34 110.794 -173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.6 t -70.6 -29.96 66.5 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.565 0.346 . . . . 65.32 110.811 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.504 HD11 ' HB ' ' C' ' 62' ' ' VAL . 65.3 mt -73.65 -49.09 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.996 0.518 . . . . 74.34 109.724 171.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 92.3 m -59.47 -35.42 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.026 0.93 . . . . 74.22 111.454 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.1 t -63.31 -51.27 66.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.241 -0.891 . . . . 73.43 109.114 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.609 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -60.87 -32.72 72.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.754 0.822 . . . . 73.3 112.704 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.453 HG13 ' HB2' ' C' ' 123' ' ' PHE . 97.5 t -73.72 -37.6 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 53.44 110.141 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 63.6 p -75.54 -25.36 57.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.923 0.489 . . . . 71.23 110.745 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.609 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -70.49 -44.0 68.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.703 0.801 . . . . 71.21 109.567 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.33 -5.5 85.58 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.528 0.517 . . . . 73.24 112.618 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.495 HG21 ' HB3' ' D' ' 17' ' ' TYR . 18.8 p 67.31 25.97 8.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.534 1.933 . . . . 64.11 113.336 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.453 ' HB2' HG13 ' C' ' 118' ' ' VAL . 98.6 m-85 -85.45 163.77 43.32 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.682 0.793 . . . . 74.21 109.794 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.38 151.36 30.11 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.128 2.552 . . . . 71.13 113.984 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.441 HE22 HD21 ' C' ' 127' ' ' ASN . 0.6 OUTLIER -58.92 112.33 1.62 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.861 1.264 . . . . 62.35 110.069 -173.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.4 107.75 10.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.846 -0.798 . . . . 73.32 108.846 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.441 HD21 HE22 ' C' ' 125' ' ' GLN . 6.0 p30 -126.62 133.6 50.97 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.196 -1.409 . . . . 73.2 107.196 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.8 113.89 4.66 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.75 -1.204 . . . . 72.24 107.75 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.67 134.1 82.61 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.883 0.74 . . . . 74.42 110.846 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.499 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 52.7 Cg_exo -56.13 90.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.485 2.79 . . . . 75.42 113.248 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.67 110.37 30.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.537 -0.912 . . . . 75.02 108.537 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -85.7 89.32 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.62 -0.718 . . . . 74.44 110.509 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -40.81 93.36 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.568 -1.196 . . . . 71.14 109.13 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -53.47 -38.47 63.65 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.68 -1.6 . . . . 72.33 112.969 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.49 77.95 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.611 0.765 . . . . 51.4 112.846 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.0 -47.77 79.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.689 -0.486 . . . . 72.15 109.689 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.471 ' HA ' ' HD1' ' C' ' 140' ' ' TYR . 80.3 m-85 -82.41 -14.44 55.16 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.767 0.827 . . . . 74.32 112.63 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.24 -44.51 75.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.488 0.715 . . . . 64.31 109.844 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -64.18 -35.16 79.9 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.768 0.668 . . . . 74.21 111.431 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.471 ' HD1' ' HA ' ' C' ' 137' ' ' PHE . 65.6 m-85 -53.95 -83.9 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.13 0.972 . . . . 75.5 110.759 170.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.525 HD21 ' H ' ' C' ' 141' ' ' LEU . 1.3 pt? -102.66 100.65 10.72 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.645 0.736 . . . . 73.42 109.135 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -89.12 47.55 1.51 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.184 0.994 . . . . 74.12 109.554 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.33 75.84 8.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.613 0.72 . . . . 75.54 111.513 -170.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.429 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 15.0 mm100 -141.79 88.98 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.871 -1.529 . . . . 75.15 106.871 172.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.62 96.48 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.514 . . . . 75.04 110.382 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.3 83.0 0.05 OUTLIER Glycine 0 C--N 1.335 0.484 0 N-CA-C 109.522 -1.431 . . . . 65.21 109.522 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -49.52 144.3 5.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.444 1.098 . . . . 74.34 113.06 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.34 47.43 1.04 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 111.024 -0.83 . . . . 52.22 111.024 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 53.1 p -62.67 97.39 0.1 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.08 0.552 . . . . 73.31 109.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -83.28 -173.07 4.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.081 -0.963 . . . . 64.23 110.748 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.01 106.76 5.91 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.987 -1.486 . . . . 63.44 106.987 165.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -53.06 103.64 0.08 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.46 1.1 . . . . 74.24 111.055 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.1 158.11 23.63 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.835 -1.075 . . . . 74.53 111.405 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -147.0 113.45 5.95 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.131 -0.692 . . . . 73.43 109.131 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 108.962 -0.755 . . . . 51.14 108.962 -176.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.419 ' SD ' ' N ' ' D' ' 1' ' ' MET . 2.9 mpp? . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.195 0.521 . . . . 60.2 110.267 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -146.21 156.77 43.63 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.952 -1.129 . . . . 73.24 107.952 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -166.98 108.99 0.67 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.596 0.358 . . . . 73.23 110.368 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.563 ' HB2' ' H ' ' D' ' 90' ' ' GLU . 83.9 mm-40 -120.9 122.9 41.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.644 -0.873 . . . . 73.33 108.644 173.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -133.16 70.82 1.46 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.011 -1.477 . . . . 72.2 107.011 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -111.46 155.88 22.52 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.191 -1.368 . . . . 75.42 109.892 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -79.35 11.52 2.9 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.051 0.941 . . . . 75.42 111.883 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -77.07 -24.91 51.89 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.708 -0.62 . . . . 74.11 111.388 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp -31.89 128.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.855 1.347 . . . . 73.23 114.363 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.6 m -138.69 139.93 38.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.979 -1.489 . . . . 74.31 106.979 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.79 114.44 7.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.268 -1.012 . . . . 75.24 108.268 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -129.87 142.54 50.65 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.98 -0.748 . . . . 72.45 108.98 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.1 101.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.041 -1.466 . . . . 72.51 107.041 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -46.67 38.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.491 0.717 . . . . 72.1 111.221 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -166.9 133.77 2.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.957 -0.565 . . . . 74.14 110.072 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.496 ' N ' HD13 ' D' ' 16' ' ' ILE . 2.7 mp -108.91 135.87 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.366 -1.346 . . . . 73.11 107.366 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HB3' HG21 ' C' ' 122' ' ' THR . 17.1 p90 -161.96 170.95 18.43 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 122.13 0.967 . . . . 73.3 112.423 176.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 46.6 p -104.55 119.17 38.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.679 -1.146 . . . . 75.22 109.088 172.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.446 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 36.7 mtpt -86.45 -30.79 21.78 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.056 -0.35 . . . . 65.54 110.056 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -145.9 137.59 25.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.61 . . . . 65.24 109.984 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.553 HG23 ' HE1' ' C' ' 117' ' ' MET . 81.3 mt -134.41 148.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 73.43 108.242 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -148.26 140.97 24.57 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.294 1.037 . . . . 74.52 109.07 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.508 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.4 t80 -148.36 111.39 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.708 -1.96 . . . . 71.25 105.708 169.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -123.03 110.48 15.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.457 0.703 . . . . 71.21 109.348 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.2 88.14 2.97 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.063 -1.088 . . . . 63.24 108.063 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.12 -45.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.455 2.103 . . . . 74.34 112.405 -171.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 36.3 m-80 -102.9 42.33 1.16 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.048 0.939 . . . . 74.01 108.475 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.433 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -57.33 -51.96 77.8 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.225 1.194 . . . . 63.03 114.225 -169.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.59 -0.6 8.82 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 121.591 1.604 . . . . 72.42 112.968 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.482 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 13.6 t-160 -83.05 -26.7 30.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.67 1.188 . . . . 74.53 109.011 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.443 HG23 ' O ' ' D' ' 27' ' ' ASN . 93.2 t -82.31 -24.29 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.211 0.604 . . . . 71.34 110.114 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.459 ' HD1' HH11 ' C' ' 15' ' ' ARG . 60.5 t80 -53.98 -39.84 66.36 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.105 0.962 . . . . 74.5 112.542 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -79.37 -13.73 59.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.246 0.461 . . . . 73.42 112.246 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -111.5 100.68 9.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.069 -0.715 . . . . 75.52 109.069 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.39 89.24 4.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.011 0.524 . . . . 74.54 109.8 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.556 ' HB3' HD12 ' D' ' 68' ' ' LEU . 17.0 t-105 -159.21 158.24 32.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.027 -1.101 . . . . 74.33 108.027 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -81.66 112.52 35.05 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.474 0.709 . . . . 71.53 110.508 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -48.88 139.15 25.71 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.771 2.981 . . . . 74.2 114.058 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.12 121.69 16.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.529 -0.545 . . . . 73.53 109.529 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.591 ' HB ' ' HB ' ' F' ' 142' ' ' ILE . 17.8 t -100.13 115.69 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.085 0.469 . . . . 74.45 110.572 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -87.26 146.28 26.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.491 1.116 . . . . 74.54 108.901 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -110.18 131.03 55.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.179 -0.675 . . . . 73.22 109.179 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.487 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.5 m-20 -133.37 142.72 48.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.652 1.181 . . . . 55.5 108.195 171.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -138.49 164.75 28.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.788 0.435 . . . . 72.3 110.707 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 29.3 t70 -168.43 155.36 7.55 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.498 1.119 . . . . 72.44 108.721 174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -132.48 158.06 43.05 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.987 -0.745 . . . . 73.12 108.987 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.7 167.7 29.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.511 0.725 . . . . 63.34 109.632 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' D' ' 58' ' ' VAL . 56.5 p -159.6 153.6 23.3 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.791 0.836 . . . . 74.33 110.196 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.5 p -151.52 142.59 23.13 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.933 0.893 . . . . 73.22 108.627 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -90.69 117.51 29.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.058 0.543 . . . . 75.43 109.591 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.7 mt -89.62 -31.66 17.45 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.511 -0.552 . . . . 72.34 109.511 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.75 -177.84 4.97 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.121 -0.945 . . . . 60.43 109.852 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.58 119.67 10.27 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.565 -1.198 . . . . 73.51 108.946 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 71.58 2.78 4.41 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.263 1.425 . . . . 71.15 112.741 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -113.77 123.91 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.539 0.736 . . . . 71.42 109.391 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.26 130.42 35.13 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.775 0.43 . . . . 73.13 110.516 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.3 tt0 -92.86 112.05 23.88 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.35 -0.982 . . . . 71.14 108.35 167.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' D' ' 48' ' ' SER . 12.7 m -102.3 137.87 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 170.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.39 140.27 30.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.182 -0.673 . . . . 75.12 109.182 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -112.56 123.81 51.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.175 -1.046 . . . . 74.01 108.175 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.3 ttm-85 -105.44 101.94 11.44 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.207 -0.664 . . . . 72.13 109.207 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.42 119.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.868 -1.16 . . . . 75.33 107.868 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 18.0 m -125.35 142.71 51.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.622 0.725 . . . . 64.25 109.675 -172.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -137.35 123.62 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.881 1.273 . . . . 74.14 108.875 -170.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -115.72 108.48 16.41 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.788 -0.819 . . . . 73.35 108.788 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.1 53.88 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.322 -0.622 . . . . 75.44 109.322 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.429 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.7 p -142.0 125.79 17.04 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.174 0.59 . . . . 74.42 109.661 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.556 HD12 ' HB3' ' D' ' 36' ' ' TRP . 28.0 tp -99.72 116.64 32.29 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.575 -0.898 . . . . 73.42 108.575 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.2 -133.16 23.98 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.72 0.637 . . . . 73.11 112.432 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -92.1 21.6 4.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.43 0.692 . . . . 74.02 110.847 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -141.14 146.41 36.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.249 0.619 . . . . 63.5 111.157 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -68.67 130.8 43.88 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.249 0.619 . . . . 71.25 109.968 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.429 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -92.12 -64.12 1.15 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.574 0.75 . . . . 65.53 109.323 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.47 161.64 40.03 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.31 -0.859 . . . . 74.12 110.321 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -121.38 151.23 40.4 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.282 1.433 . . . . 72.14 107.163 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.424 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 49.7 t -156.98 141.53 16.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 110.153 -0.314 . . . . 71.15 110.153 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.92 137.67 14.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.654 0.782 . . . . 65.25 109.139 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.7 t -135.15 114.24 16.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.44 -0.578 . . . . 75.04 109.44 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.639 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.5 mt-30 -91.93 85.16 5.48 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.221 -0.9 . . . . 74.25 108.89 171.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -80.15 101.89 9.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.913 -1.494 . . . . 75.25 109.705 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.27 142.36 15.99 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.759 -0.537 . . . . 74.12 111.759 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.3 133.65 5.55 Favored Glycine 0 C--O 1.236 0.279 0 N-CA-C 111.77 -0.532 . . . . 74.32 111.77 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.87 128.85 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.602 -1.258 . . . . 72.54 107.602 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.59 144.6 51.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.788 0.835 . . . . 74.53 108.817 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -97.52 102.43 14.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.983 -0.747 . . . . 64.25 108.983 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.504 HG23 ' HG3' ' D' ' 94' ' ' MET . 3.4 mp -107.62 99.7 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 107.564 -1.273 . . . . 75.03 107.564 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.41 123.21 35.58 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.49 -0.559 . . . . 74.54 109.49 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.8 22.5 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-O 118.571 -1.127 . . . . 64.55 114.872 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 mt -140.41 140.31 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.57 1.185 . . . . 72.41 110.424 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.563 ' H ' ' HB2' ' D' ' 4' ' ' GLN . 42.7 mt-10 -136.94 175.84 9.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.875 1.27 . . . . 74.43 109.856 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.36 -140.97 26.17 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 114.537 0.575 . . . . 71.35 114.537 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 43.1 p -66.31 -32.45 73.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 70.4 111.618 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -70.53 -40.96 73.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.436 0.694 . . . . 73.02 110.155 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.504 ' HG3' HG23 ' D' ' 86' ' ' ILE . 49.7 ttp -70.89 -32.68 69.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.533 -0.758 . . . . 72.43 110.564 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.24 83.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.226 0.61 . . . . 73.31 110.29 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -62.0 -34.0 75.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.698 0.799 . . . . 70.41 110.53 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -68.55 -51.43 42.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.919 -0.582 . . . . 73.24 110.387 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.4 -28.4 61.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.81 0.844 . . . . 73.54 112.597 -173.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.28 -4.44 25.45 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.216 -0.769 . . . . 70.34 114.393 -169.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -54.6 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.984 0.892 . . . . 73.34 110.629 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -73.15 -43.49 61.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.718 0.407 . . . . 74.04 111.931 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 63.4 m -70.35 -45.56 19.91 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 118.694 -0.67 . . . . 72.55 111.381 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.527 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.2 Cg_exo -53.89 -36.37 83.04 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.438 2.092 . . . . 75.52 113.229 165.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.97 -33.05 75.11 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.493 0.717 . . . . 72.22 110.928 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.4 -43.33 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.044 0.538 . . . . 70.05 110.059 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.88 -19.63 58.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.318 -0.855 . . . . 73.44 111.738 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.441 ' HZ ' HD11 ' D' ' 128' ' ' LEU . 60.6 t80 -66.71 -42.26 43.65 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.946 -1.026 . . . . 74.24 113.413 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.43 -38.34 73.85 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.902 1.735 . . . . 75.34 112.993 168.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -78.57 -35.32 46.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.106 0.962 . . . . 72.35 112.115 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.74 -42.07 74.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.253 0.621 . . . . 75.51 109.553 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.49 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -62.42 -46.84 86.76 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.331 -1.304 . . . . 72.4 109.922 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 2.6 tm-20 -56.35 -48.97 75.7 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.292 0.995 . . . . 70.44 111.553 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -61.24 -41.22 96.53 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.04 0.837 . . . . 65.42 110.903 -177.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.414 HG12 ' SG ' ' D' ' 76' ' ' CYS . 64.6 mt -63.29 -50.72 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.146 0.578 . . . . 75.33 110.105 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.8 m -54.03 -43.26 69.99 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.969 1.308 . . . . 75.14 111.134 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -69.16 -44.96 71.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.756 -1.111 . . . . 51.03 110.605 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.424 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 73.9 mtm -67.81 -33.2 74.33 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.671 0.388 . . . . 75.3 111.827 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.53 -42.52 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.944 0.897 . . . . 74.11 110.248 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -72.72 -29.45 63.37 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.668 0.387 . . . . 75.54 110.897 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -74.62 -26.98 60.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.859 0.864 . . . . 74.33 110.303 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.42 67.42 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.531 -0.758 . . . . 72.04 112.731 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.474 HG22 ' HB3' ' C' ' 17' ' ' TYR . 60.6 p 56.57 21.94 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 125.874 1.67 . . . . 65.21 113.243 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -95.41 154.85 39.26 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.751 0.82 . . . . 73.53 109.955 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.88 137.94 83.77 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.418 2.745 . . . . 74.22 112.671 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -57.8 124.91 20.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.774 0.672 . . . . 74.2 112.233 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.453 HD11 HD22 ' F' ' 139' ' ' LEU . 5.1 tt -108.51 99.05 8.48 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.727 -0.842 . . . . 75.35 108.727 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.61 103.07 14.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.553 -0.906 . . . . 73.51 108.553 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.49 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 0.2 OUTLIER -64.06 116.47 5.94 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.375 0.67 . . . . 61.32 109.636 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 145.33 99.12 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.305 0.642 . . . . 74.53 111.927 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.73 106.0 0.26 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.569 2.179 . . . . 72.23 111.508 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.04 147.82 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.205 0.602 . . . . 74.23 110.351 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.513 HD22 ' HB2' ' D' ' 134' ' ' ASP . 5.3 t-20 -79.33 91.1 5.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.051 -0.522 . . . . 74.31 109.77 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.14 -22.24 55.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.849 -0.614 . . . . 72.2 110.624 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.513 ' HB2' HD22 ' D' ' 132' ' ' ASN . 4.9 m-20 -53.53 -41.09 66.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.318 1.047 . . . . 74.22 112.062 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -54.22 43.2 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 123.959 0.787 . . . . 70.01 110.797 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.67 -42.11 96.42 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.543 0.737 . . . . 52.51 111.584 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -65.18 -42.32 93.73 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.166 0.986 . . . . 73.32 110.627 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 7.4 ttp -62.07 -46.31 89.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.033 . . . . 65.33 110.824 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -60.64 -41.71 95.46 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.081 0.553 . . . . 72.32 110.676 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.8 -41.98 99.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.283 1.033 . . . . 74.14 111.913 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.52 -30.14 71.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.333 0.653 . . . . 73.4 111.737 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -82.24 1.24 37.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.295 0.638 . . . . 75.41 111.326 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -127.11 44.5 2.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.524 0.73 . . . . 73.32 109.611 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -164.24 143.25 7.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.044 0.538 . . . . 73.13 111.431 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.04 99.71 0.21 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.326 1.45 . . . . 74.04 107.272 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.59 81.65 0.07 OUTLIER Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.615 -0.594 . . . . 65.24 111.615 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -89.28 113.34 24.59 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.701 0.8 . . . . 71.1 109.524 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.61 -118.9 0.88 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.112 -0.795 . . . . 74.31 111.112 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 25.8 m 67.29 111.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.836 1.254 . . . . 74.32 111.863 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.15 90.44 2.37 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.173 -1.047 . . . . 75.53 108.173 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.86 74.04 3.48 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.727 -0.669 . . . . 73.03 109.22 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -89.32 70.71 8.19 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.584 -0.895 . . . . 63.45 108.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -78.76 92.2 4.78 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.047 -1.094 . . . . 73.05 108.047 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.76 -21.94 16.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.773 -0.648 . . . . 74.24 110.263 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.09 0 N-CA-C 108.934 -0.765 . . . . 64.24 108.934 170.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 109.282 -0.636 . . . . 73.1 109.282 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 60.69 49.6 6.21 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.794 0.838 . . . . 73.12 109.505 -168.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -86.19 106.28 17.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.233 -0.894 . . . . 74.34 110.246 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.04 129.76 55.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.757 0.823 . . . . 75.43 109.141 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.09 79.85 2.92 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 71.23 109.353 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.41 167.77 20.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.727 -1.124 . . . . 72.24 109.327 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 160.38 4.55 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.697 0.399 . . . . 72.52 111.472 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.566 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.6 mp -62.75 -15.23 52.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.605 0.965 . . . . 75.22 113.605 -165.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -114.73 90.81 23.31 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.564 -0.902 . . . . 73.3 108.564 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -88.98 -171.5 0.57 Allowed 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.28 2.653 . . . . 72.33 112.392 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 62.71 -176.42 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.669 1.187 . . . . 75.21 111.957 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.35 27.36 4.11 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.24 -1.022 . . . . 74.2 108.24 172.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.484 ' HZ3' ' HB2' ' B' ' 137' ' ' PHE . 8.9 m95 62.61 -88.02 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.516 -1.22 . . . . 70.12 110.36 -166.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 35.5 t70 67.64 143.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.025 1.33 . . . . 62.41 112.598 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.5 11.32 8.31 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.912 1.285 . . . . 65.44 112.261 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 86.4 t -89.22 100.76 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.565 1.146 . . . . 74.44 109.797 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.97 98.42 3.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.057 -1.09 . . . . 74.42 108.057 175.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -73.39 89.61 1.63 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.621 -0.718 . . . . 72.51 109.478 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -130.0 94.14 3.65 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.281 -1.377 . . . . 74.35 107.281 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 156.37 130.07 1.23 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.443 -1.063 . . . . 73.13 110.443 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 74.02 -59.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.512 1.525 . . . . 73.43 112.298 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.88 -142.16 0.77 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.525 0.73 . . . . 73.23 109.537 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.43 ' HA ' ' HB1' ' B' ' 129' ' ' ALA . 24.2 pt -65.75 -10.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 118.994 0.816 . . . . 73.35 112.679 -177.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.4 -74.04 0.09 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.373 1.469 . . . . 73.43 112.677 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.21 94.57 48.46 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.986 0.914 . . . . 63.24 110.174 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.9 -20.65 25.54 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.587 2.191 . . . . 74.23 112.337 166.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . 0.646 HD12 ' HA ' ' C' ' 32' ' ' PHE . 7.3 pt 55.6 -171.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 126.653 1.981 . . . . 72.13 113.093 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.468 ' O ' HG13 ' E' ' 134' ' ' ILE . . . -76.26 165.78 24.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.263 0.625 . . . . 75.32 110.45 172.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.771 ' HA ' ' HB3' ' C' ' 36' ' ' TRP . 19.1 t 67.71 68.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 122.657 1.218 . . . . 74.54 110.171 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.12 -28.86 13.55 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.911 -1.495 . . . . 74.24 110.047 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -130.0 140.29 50.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.526 1.131 . . . . 64.4 109.233 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 25.8 tp -134.46 118.91 17.89 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.683 0.793 . . . . 75.2 109.649 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.0 p -152.29 80.49 1.24 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.799 0.84 . . . . 72.41 109.206 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -151.96 89.85 1.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 106.841 -1.54 . . . . 73.43 106.841 175.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . 0.517 HD12 ' HB3' ' C' ' 42' ' ' LEU . 11.3 tt -163.83 -143.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 106.538 -1.653 . . . . 74.43 106.538 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . 0.493 ' H ' HG12 ' E' ' 142' ' ' ILE . 21.6 p90 -75.56 67.55 2.08 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 119.784 1.174 . . . . 75.01 110.339 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -70.03 113.12 6.92 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.445 -0.798 . . . . 71.42 110.399 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt 63.49 26.56 14.85 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.702 1.201 . . . . 75.21 112.261 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.53 -70.73 0.23 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.514 0.725 . . . . 74.25 111.574 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 63.47 -168.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.294 1.038 . . . . 75.22 112.596 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.46 156.21 62.46 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.917 0.887 . . . . 73.02 109.55 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.564 2.021 0 C-N-CA 122.203 1.935 . . . . 74.52 111.227 170.345 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.872 -0.418 . . . . 73.13 109.872 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.94 151.22 46.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.066 0.546 . . . . 75.41 110.478 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.17 8.81 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.515 -0.766 . . . . 74.4 110.51 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 60.51 89.73 0.07 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.808 1.243 . . . . 72.41 110.305 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 69.64 -179.7 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.504 1.522 . . . . 64.0 111.611 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -157.41 147.43 20.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.794 -1.187 . . . . 70.25 107.794 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -80.83 78.47 7.61 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.289 -0.634 . . . . 74.22 109.289 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 80.1 mt -64.57 104.4 0.8 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.999 -1.0 . . . . 74.24 110.107 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -144.55 149.7 44.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.269 1.028 . . . . 74.23 109.614 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.76 137.21 34.94 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.893 2.395 . . . . 73.14 112.121 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -58.76 -47.59 84.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.767 0.827 . . . . 75.23 111.528 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 95.6 m -157.61 126.25 5.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.018 0.927 . . . . 75.23 109.717 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -151.9 88.54 1.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.69 -1.226 . . . . 73.35 107.69 169.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -130.51 -3.21 4.28 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.943 0.897 . . . . 61.02 111.276 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.35 97.62 6.9 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.653 0.781 . . . . 71.55 109.637 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.85 99.38 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.568 0.747 . . . . 71.33 109.195 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -82.89 77.88 9.56 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.801 . . . . 74.34 109.536 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -80.82 125.82 30.56 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.938 -0.764 . . . . 72.03 108.938 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.8 -171.03 3.72 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.057 0.943 . . . . 62.35 109.444 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.92 176.09 45.33 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.001 -0.545 . . . . 75.53 111.748 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -91.0 106.23 18.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.232 0.613 . . . . 74.13 109.678 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.407 ' HG ' HD13 ' A' ' 42' ' ' LEU . 2.7 mm? -62.99 -44.23 96.59 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.178 0.591 . . . . 73.43 111.025 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.52 168.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.578 1.151 . . . . 74.24 108.96 172.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.03 19.0 0.37 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.212 0.605 . . . . 73.41 110.722 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.64 103.49 5.89 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 74.13 109.591 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . 0.592 ' HB2' ' HZ3' ' A' ' 36' ' ' TRP . 41.1 Cg_endo -89.05 45.84 0.9 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.014 2.476 . . . . 65.0 112.753 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.67 116.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 CA-C-O 121.198 0.523 . . . . 70.03 111.002 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.7 86.61 4.65 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.407 -0.815 . . . . 73.15 109.208 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.59 HG23 ' H ' ' F' ' 137' ' ' GLU . 2.5 m -80.98 -69.82 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.074 -0.966 . . . . 71.53 109.923 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . 0.59 ' H ' HG23 ' F' ' 136' ' ' VAL . 3.8 mm-40 52.7 -82.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 125.65 1.58 . . . . 73.43 113.287 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.65 148.12 35.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.367 0.667 . . . . 72.35 109.68 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.453 HD22 HD11 ' D' ' 126' ' ' LEU . 10.4 tp -94.34 112.26 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.288 0.635 . . . . 73.24 110.863 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 52.0 p -100.75 -160.34 0.79 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.358 1.063 . . . . 72.23 110.394 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mp 64.25 26.5 13.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.953 1.301 . . . . 74.44 110.856 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.591 ' HB ' ' HB ' ' D' ' 40' ' ' VAL . 10.3 tt -144.39 155.55 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.491 1.516 . . . . 74.44 107.961 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 65.02 25.86 12.63 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.805 1.242 . . . . 74.23 109.98 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.72 115.44 3.65 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.357 -1.292 . . . . 63.31 109.071 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . 0.629 ' HZ2' ' HB2' ' F' ' 145' ' ' LYS . 4.9 ttmp? 79.59 -48.69 0.38 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.728 1.611 . . . . 74.15 111.934 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -146.1 155.22 42.61 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.002 0.521 . . . . 73.21 110.753 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . 0.401 HD11 ' NE2' ' B' ' 12' ' ' GLN . 3.8 mm? -64.76 -42.1 95.38 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.741 1.216 . . . . 75.02 111.62 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 62.0 tp -123.92 85.88 53.84 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.704 -1.221 . . . . 74.31 107.704 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.376 2.005 0 C-N-CA 123.319 2.679 . . . . 72.32 112.718 -178.727 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.362 -0.236 . . . . 74.33 110.362 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -81.22 159.08 24.65 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.476 0.71 . . . . 51.54 109.094 167.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.39 110.87 3.26 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.494 0.496 . . . . 75.23 110.465 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -66.18 -42.02 89.45 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.209 -1.404 . . . . 74.32 107.209 169.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 64.49 -69.91 0.08 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.946 2.098 . . . . 75.11 113.57 163.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -60.12 92.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.451 1.1 . . . . 64.42 111.325 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 t -117.1 106.11 13.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.024 -1.473 . . . . 74.12 107.024 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.26 -70.55 0.19 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.637 0.775 . . . . 74.14 111.265 -172.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.8 mtt -142.11 138.06 31.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.127 0.971 . . . . 75.43 108.833 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -142.92 134.73 26.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.618 0.767 . . . . 73.11 110.233 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -139.3 115.73 10.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.089 -1.449 . . . . 75.42 107.089 168.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -149.79 134.47 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.545 0.338 . . . . 73.42 111.068 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.576 ' HB ' HD12 ' A' ' 16' ' ' ILE . 2.7 pp -80.93 132.1 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.312 -0.996 . . . . 75.12 108.312 169.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -113.8 -38.37 4.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.962 0.505 . . . . 75.34 110.792 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -165.15 123.18 1.62 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.911 -0.403 . . . . 73.41 109.911 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 13' ' ' ILE . 4.5 mp -121.71 123.39 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.083 -1.08 . . . . 74.42 108.083 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.566 ' HE2' ' HB3' ' B' ' 28' ' ' ALA . 9.5 p90 -172.23 176.58 3.37 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.511 0.724 . . . . 75.12 110.929 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -102.01 120.84 41.07 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 71.34 108.832 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -98.44 -27.62 13.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.196 0.198 . . . . 74.31 111.155 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.745 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 13.7 m-20 -137.77 129.52 28.46 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.759 -0.83 . . . . 64.53 108.759 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.504 HG23 HG23 ' A' ' 78' ' ' VAL . 54.6 mt -132.34 137.46 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.144 -1.058 . . . . 74.34 108.144 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -145.19 127.23 15.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.8 0.84 . . . . 75.13 109.405 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.664 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.6 t80 -131.12 133.01 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.692 -1.595 . . . . 74.02 106.692 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -141.0 119.34 12.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.394 0.677 . . . . 75.42 109.522 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -125.12 82.1 62.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 107.831 -1.174 . . . . 73.44 107.831 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.31 -35.89 29.96 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.753 2.302 . . . . 72.43 111.369 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 72' ' ' THR . 78.5 m-20 -111.49 35.63 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.66 -1.155 . . . . 52.35 109.458 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -57.68 -47.14 99.46 Favored Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 123.988 0.915 . . . . 61.23 111.803 171.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 -13.86 25.3 Favored 'Trans proline' 0 C--N 1.403 3.42 0 C-N-CA 122.419 2.079 . . . . 54.24 113.428 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -69.82 -32.59 71.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.423 0.289 . . . . 75.11 110.46 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.564 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 17.5 t -64.98 -19.21 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.84 0.456 . . . . 74.51 110.793 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.64 -41.09 80.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.564 0.746 . . . . 75.13 111.3 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -99.89 -23.53 14.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.143 0.577 . . . . 72.01 111.55 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.2 mmtp -77.27 144.97 37.77 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.283 0.563 . . . . 74.41 111.767 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -79.82 158.1 26.87 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.91 -1.041 . . . . 74.41 110.067 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -90.22 80.17 6.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.054 0.931 . . . . 73.45 110.649 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -135.73 74.56 58.29 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.157 -1.383 . . . . 71.54 107.434 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -91.99 144.39 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.764 2.309 . . . . 75.51 112.567 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.1 115.6 27.8 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.848 -1.167 . . . . 74.43 107.848 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 65' ' ' THR . 85.0 t -95.26 135.94 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.545 0.738 . . . . 73.24 110.133 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.563 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 53.3 mtpt -120.62 143.4 48.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.439 0.695 . . . . 72.42 109.492 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -133.22 108.2 8.63 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.66 -1.154 . . . . 75.41 109.21 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -123.48 117.66 25.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.604 1.162 . . . . 64.2 108.662 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.441 HD11 ' N ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -118.4 159.91 22.61 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.075 0.95 . . . . 74.5 110.847 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.455 ' O ' HD22 ' A' ' 60' ' ' LEU . 24.1 t70 -157.83 148.66 21.02 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.38 0.672 . . . . 71.42 110.369 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 78.4 m -131.72 134.49 45.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.509 0.724 . . . . 61.53 110.092 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.78 135.69 29.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.748 0.819 . . . . 72.14 109.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -113.96 157.88 21.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.131 0.572 . . . . 71.22 109.507 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -160.79 116.07 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.392 -0.595 . . . . 74.13 109.392 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.535 HE21 ' H ' ' A' ' 54' ' ' ASP . 62.6 tt0 -70.98 108.66 4.67 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.355 0.662 . . . . 61.43 110.18 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' A' ' 57' ' ' GLU . 71.6 mt -79.04 -40.24 31.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.859 0.864 . . . . 72.35 110.89 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.28 -176.12 5.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.198 0.999 . . . . 71.54 109.004 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.79 102.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.347 0.659 . . . . 74.43 111.518 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' H ' HE21 ' A' ' 50' ' ' GLN . 3.6 m-20 58.41 29.67 18.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.201 1.4 . . . . 75.32 112.631 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.3 t -112.13 122.22 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 106.5 -1.667 . . . . 71.54 106.5 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.64 133.43 38.2 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.492 -0.929 . . . . 73.34 108.492 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 35.0 tt0 -85.8 121.72 28.85 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.644 -0.873 . . . . 72.44 108.644 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.57 115.12 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.999 0.919 . . . . 73.13 108.715 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 97.6 t -97.29 135.09 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.228 -0.896 . . . . 74.23 109.257 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -110.73 115.09 28.95 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.098 -1.445 . . . . 74.41 107.098 170.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -102.64 106.02 16.61 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.014 -0.735 . . . . 73.51 109.014 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.442 HG23 HD23 ' A' ' 60' ' ' LEU . 47.6 t -103.32 133.02 48.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.47 -0.937 . . . . 75.41 108.47 175.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -123.54 125.23 44.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.849 -0.797 . . . . 63.43 108.849 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.514 HG22 HG21 ' A' ' 114' ' ' ILE . 61.4 t -118.42 130.83 72.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.624 -1.25 . . . . 74.33 107.624 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.563 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.2 m -127.7 149.45 50.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.497 -0.927 . . . . 71.51 108.497 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.24 121.26 13.69 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.256 -1.387 . . . . 72.54 107.256 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.6 m -144.47 129.24 18.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.102 0.561 . . . . 74.05 110.481 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.421 HD11 ' HD2' ' A' ' 34' ' ' LYS . 2.4 tt -88.04 80.92 7.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.452 -1.685 . . . . 72.34 106.452 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.77 -110.17 2.98 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.67 -1.15 . . . . 75.13 111.649 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.74 -26.31 18.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.081 0.952 . . . . 73.05 111.291 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -83.34 116.44 22.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.84 -0.8 . . . . 74.54 108.84 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 32.9 m -77.43 126.56 31.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 110.056 -0.35 . . . . 74.2 110.056 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.55 -52.39 9.12 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.382 -0.97 . . . . 61.32 108.382 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -161.95 170.33 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.06 -0.973 . . . . 74.22 111.204 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.5 tp -141.12 148.77 40.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.34 1.456 . . . . 73.45 107.936 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 62.4 m -142.82 139.74 31.04 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.488 1.115 . . . . 74.41 108.488 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -149.41 118.96 6.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.965 -0.754 . . . . 71.22 108.965 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.584 HG22 HG13 ' A' ' 114' ' ' ILE . 54.8 t -122.82 118.89 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 121.124 0.488 . . . . 74.54 109.715 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.745 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 48.5 mt-30 -89.92 91.46 8.6 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.971 -1.013 . . . . 75.55 108.97 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.73 97.65 4.54 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.593 -1.185 . . . . 75.44 108.6 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.8 140.38 17.09 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.789 -0.924 . . . . 62.44 110.789 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.72 120.64 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.858 -1.297 . . . . 75.34 109.858 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 38.6 mt -81.75 129.26 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.703 -0.851 . . . . 74.14 108.703 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -135.73 122.15 20.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.857 -1.164 . . . . 73.54 107.857 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -90.96 105.97 18.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.044 -0.724 . . . . 53.34 109.044 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -122.01 135.03 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.349 0.66 . . . . 72.34 110.537 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.73 157.81 42.54 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.613 1.165 . . . . 75.41 109.476 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.21 -18.68 9.56 Favored Glycine 0 N--CA 1.471 1.004 0 N-CA-C 114.601 0.601 . . . . 62.04 114.601 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.98 133.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.319 -0.993 . . . . 72.45 108.319 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -147.39 174.32 11.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.875 0.87 . . . . 73.14 109.664 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.6 -115.42 7.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.623 -0.543 . . . . 74.13 113.182 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -71.26 -22.57 61.95 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.297 0.639 . . . . 72.0 111.418 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.42 -50.53 44.9 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.243 1.017 . . . . 73.42 110.789 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.522 ' HE2' ' HB3' ' F' ' 114' ' ' LYS . 0.0 OUTLIER -77.34 -27.65 52.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.012 -0.54 . . . . 74.3 110.14 179.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.94 94.68 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.334 0.654 . . . . 54.52 110.348 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.7 t-80 -65.58 -54.28 30.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.532 -1.213 . . . . 70.23 110.219 170.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.66 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 62.7 m -68.2 -59.34 3.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.047 0.758 . . . . 72.03 113.047 -168.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.6 mt -67.71 -25.72 65.8 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.234 0.457 . . . . 73.31 112.234 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.24 -13.77 56.91 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.448 -0.64 . . . . 51.15 114.084 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.625 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -140.76 -67.27 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.775 0.788 . . . . 75.23 112.638 -173.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.66 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.34 -57.71 7.31 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 124.611 1.164 . . . . 71.24 113.423 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.6 m -71.69 -45.37 12.56 Favored Pre-proline 0 CA--C 1.559 1.312 0 CA-C-O 118.562 -0.732 . . . . 72.34 112.93 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.92 -25.25 74.19 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.548 1.499 . . . . 74.32 113.516 168.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -69.25 -37.47 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.45 -0.574 . . . . 72.32 109.45 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.03 -44.78 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.758 0.823 . . . . 64.11 110.489 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.85 -24.02 58.52 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.568 -0.742 . . . . 73.33 112.249 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -67.08 -44.57 50.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.109 1.151 . . . . 74.44 114.109 -169.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -34.65 96.12 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 122.12 1.88 . . . . 75.1 112.862 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.92 -43.13 36.69 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.659 0.784 . . . . 75.43 111.631 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -45.01 79.88 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.588 0.355 . . . . 73.41 110.439 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.433 HH12 HD13 ' C' ' 105' ' ' ILE . 29.3 ttm180 -48.53 -58.26 4.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.726 1.266 . . . . 74.41 109.545 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.98 -42.92 95.23 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.403 1.064 . . . . 73.45 111.909 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.91 -34.55 78.22 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.631 0.582 . . . . 75.34 111.572 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.584 HG13 HG22 ' A' ' 78' ' ' VAL . 4.4 mt -70.12 -53.11 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.097 0.559 . . . . 72.42 109.669 171.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 62.2 m -58.8 -30.64 67.77 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.965 1.306 . . . . 72.52 111.759 -172.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -71.74 -43.16 66.31 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.045 -0.979 . . . . 72.22 109.86 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.664 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.0 mtm -61.4 -36.85 81.42 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.747 0.419 . . . . 54.51 110.96 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.93 -46.5 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 123.854 0.721 . . . . 75.15 110.595 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.41 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 84.9 p -71.68 -34.85 70.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.17 -0.468 . . . . 74.12 110.997 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -67.16 -32.09 72.96 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.703 0.801 . . . . 74.51 109.586 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.47 -1.42 65.35 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.196 -0.911 . . . . 74.23 112.837 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m 73.26 10.5 5.11 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.071 1.348 . . . . 73.22 111.627 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -88.04 157.62 50.99 Favored Pre-proline 0 C--O 1.245 0.864 0 N-CA-C 108.961 -0.755 . . . . 73.32 108.961 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.74 113.62 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.418 2.078 . . . . 72.42 111.058 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HG3' ' HB3' ' A' ' 119' ' ' SER . 17.6 tt0 -57.06 119.67 6.72 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.515 1.126 . . . . 75.23 110.717 -172.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.8 mt -104.93 101.44 11.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.321 0.648 . . . . 72.15 109.598 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.404 ' OD1' ' HB ' ' C' ' 16' ' ' ILE . 10.1 m-80 -100.07 105.76 17.44 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.523 -1.288 . . . . 75.41 107.523 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.62 157.79 34.79 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.988 0.915 . . . . 73.33 112.513 -167.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.449 ' HB2' HD22 ' F' ' 129' ' ' LEU . . . -71.35 142.81 87.23 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.86 0.864 . . . . 70.12 111.794 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.427 ' HB3' HH22 ' A' ' 111' ' ' ARG . 72.8 Cg_endo -86.37 116.31 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.498 2.132 . . . . 73.21 112.827 170.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.29 114.03 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.254 -1.017 . . . . 65.52 108.254 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.89 99.35 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.684 -0.858 . . . . 73.21 108.684 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.625 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 61.8 t80 -69.63 -26.76 64.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.308 0.243 . . . . 64.14 110.516 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.22 -38.62 68.68 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 72.41 110.369 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.03 -48.56 81.15 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.452 0.701 . . . . 71.43 110.81 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -71.56 -37.16 71.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.223 1.009 . . . . 63.25 112.047 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.47 -50.8 42.0 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.732 -0.47 . . . . 72.34 109.732 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.407 ' HB3' ' HB1' ' A' ' 145' ' ' ALA . 97.1 mmm -66.37 -25.39 66.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.221 0.609 . . . . 75.41 110.875 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.68 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 43.3 t30 -64.16 -42.67 96.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.28 1.032 . . . . 74.13 111.053 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -77.35 -33.07 55.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.362 -0.836 . . . . 74.02 110.572 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.48 -49.86 61.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.431 0.692 . . . . 74.41 110.987 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -155.7 -3.17 0.13 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 116.106 -0.497 . . . . 75.03 111.281 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.68 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.6 tt0 70.79 -73.1 0.1 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.305 1.442 . . . . 72.23 111.205 -174.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -74.74 99.64 3.78 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.853 0.861 . . . . 73.53 109.075 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.407 ' HB1' ' HB3' ' A' ' 138' ' ' MET . . . -91.09 96.14 10.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.578 -0.527 . . . . 74.25 109.578 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.16 -74.15 2.37 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.607 -0.724 . . . . 72.21 113.382 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 65.23 119.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.542 1.537 . . . . 75.13 110.549 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.58 174.88 50.14 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.426 -0.67 . . . . 62.15 111.426 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.6 t -165.74 175.24 8.95 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.258 0.623 . . . . 74.42 110.732 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.75 29.28 1.72 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 107.79 -1.189 . . . . 63.31 107.79 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 58.35 -90.57 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.453 1.501 . . . . 64.35 109.962 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 173.7 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.902 1.281 . . . . 72.04 109.746 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.54 86.69 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.21 1.404 . . . . 61.23 109.51 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.26 112.95 24.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.409 0.684 . . . . 60.15 110.256 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 123.407 0.683 . . . . 73.45 109.678 177.697 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.943 -0.391 . . . . 64.0 109.943 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.9 t -95.39 176.9 6.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.375 0.67 . . . . 63.24 109.595 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' B' ' 93' ' ' GLN . 0.3 OUTLIER -151.99 -74.28 0.14 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.012 -1.477 . . . . 45.14 107.012 175.346 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.92 -23.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.446 1.099 . . . . 74.45 109.144 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 67.3 35.75 4.25 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.595 1.158 . . . . 74.01 111.381 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 61.34 -165.2 0.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.561 1.144 . . . . 73.31 111.036 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.525 HG22 ' HB3' ' B' ' 151' ' ' GLU . 25.0 m 64.4 14.36 8.75 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.886 1.327 . . . . 72.24 110.351 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.49 -144.01 0.17 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 105.751 -1.944 . . . . 74.33 105.751 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptm 50.85 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.092 1.357 . . . . 75.43 114.124 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 1.1 p -150.57 123.2 8.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.261 1.024 . . . . 72.02 108.412 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -119.74 126.08 50.21 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.547 -0.908 . . . . 72.44 108.547 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.66 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.3 tt0 -139.48 132.32 29.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.828 0.851 . . . . 71.31 109.145 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.97 114.82 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.369 -0.975 . . . . 75.42 108.369 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -82.83 -46.24 13.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.783 0.433 . . . . 75.14 110.257 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -164.55 142.24 6.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.573 -0.285 . . . . 75.11 111.176 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.54 141.46 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.231 -1.396 . . . . 74.01 107.231 168.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.475 ' HE1' HG13 ' B' ' 83' ' ' ILE . 14.5 p90 -170.53 151.09 3.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.816 0.673 . . . . 75.21 112.816 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -80.2 123.15 27.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.983 0.913 . . . . 73.3 108.93 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -97.02 -28.84 13.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.329 0.652 . . . . 74.41 110.974 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.674 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.2 t70 -154.09 140.03 18.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.207 -0.452 . . . . 75.02 109.984 -170.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.479 HD13 ' SG ' ' B' ' 113' ' ' CYS . 31.5 mm -133.95 143.57 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.412 1.085 . . . . 75.31 109.098 174.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -139.64 135.24 33.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.257 1.023 . . . . 73.1 108.81 168.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.61 107.9 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.172 -1.788 . . . . 74.23 106.172 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.515 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 22.1 mt-10 -119.07 112.98 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.495 -0.928 . . . . 74.51 108.495 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.21 86.48 21.18 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.974 -1.121 . . . . 73.14 107.974 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.97 -22.81 41.45 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.843 2.362 . . . . 72.42 112.99 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -115.94 22.53 12.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.83 0.852 . . . . 73.34 110.267 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.566 ' HB3' ' HE2' ' A' ' 17' ' ' TYR . . . -49.8 -53.08 45.85 Favored Pre-proline 0 CA--C 1.561 1.367 0 N-CA-C 114.54 1.311 . . . . 75.53 114.54 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.29 -21.39 41.53 Favored 'Trans proline' 0 C--N 1.392 2.82 0 CA-C-N 121.075 1.42 . . . . 75.32 112.646 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.99 1.96 43.03 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.346 1.058 . . . . 73.32 112.623 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.421 HG23 ' CE1' ' B' ' 123' ' ' PHE . 11.5 p -62.1 -25.83 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.785 1.031 . . . . 71.32 113.785 -167.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -75.84 -0.61 21.81 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.399 0.518 . . . . 72.23 112.399 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -80.77 -32.93 35.34 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.875 0.87 . . . . 73.11 110.027 165.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.638 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 75.7 mmtt -85.44 84.89 7.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.377 1.071 . . . . 72.54 110.454 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -116.4 83.0 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.546 0.738 . . . . 65.22 111.114 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -166.86 -171.76 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.276 1.43 . . . . 75.54 108.934 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.93 115.67 63.34 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.318 0.647 . . . . 72.23 109.593 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.07 153.37 28.55 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.525 2.15 . . . . 70.02 112.74 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.52 103.78 2.15 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.547 -0.909 . . . . 70.41 108.547 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.53 126.07 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.43 0.692 . . . . 73.14 110.472 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -110.5 127.89 55.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.952 1.301 . . . . 73.12 108.866 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.89 123.61 43.27 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 105.427 -2.064 . . . . 73.11 105.427 161.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.563 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.6 t70 -124.07 129.51 51.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.266 -1.383 . . . . 74.11 107.266 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.464 HD22 HG13 ' B' ' 131' ' ' VAL . 3.9 mp -106.19 136.65 45.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.753 -1.202 . . . . 70.32 107.753 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.46 ' HA ' ' NE1' ' E' ' 120' ' ' TRP . 37.9 t70 -154.71 156.37 36.26 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 71.3 108.691 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -146.27 137.04 24.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.488 0.661 . . . . 72.02 110.167 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.01 158.21 31.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.491 -1.67 . . . . 72.25 106.491 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -145.03 171.31 14.64 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.501 0.592 . . . . 51.34 111.425 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -151.61 135.82 16.71 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.382 -1.34 . . . . 75.12 107.382 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -100.83 110.17 22.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.88 0.764 . . . . 74.21 109.487 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.574 HD12 HG22 ' B' ' 83' ' ' ILE . 79.3 mt -72.34 -30.24 64.56 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.69 0.796 . . . . 73.41 112.002 -172.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 179.18 8.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.861 0.864 . . . . 43.34 109.456 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.49 121.09 12.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.222 -0.899 . . . . 74.43 108.603 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.494 ' HB3' ' HB1' ' B' ' 87' ' ' ALA . 19.5 m-20 76.24 -5.72 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.992 1.717 . . . . 74.35 112.726 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -107.31 88.79 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.006 -1.109 . . . . 74.54 108.006 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.416 ' HH ' ' HB3' ' E' ' 116' ' ' TYR . 0.2 OUTLIER -100.94 138.33 38.14 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.522 -0.918 . . . . 74.23 108.522 -178.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -110.75 100.98 9.64 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.023 -1.473 . . . . 72.14 107.023 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.45 124.21 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.398 0.679 . . . . 73.31 109.762 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.589 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -106.03 116.34 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.778 0.831 . . . . 52.33 110.043 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.28 113.92 26.3 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.076 -1.083 . . . . 74.54 108.076 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -99.62 109.62 22.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.986 0.915 . . . . 74.42 109.829 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.8 t -106.24 119.24 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.912 -0.773 . . . . 71.22 108.912 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.1 m -106.08 146.94 29.52 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.292 1.037 . . . . 75.54 109.616 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.566 HG23 HD12 ' B' ' 114' ' ' ILE . 55.8 t -132.68 131.77 59.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.405 1.082 . . . . 75.42 108.572 173.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.0 m -124.44 136.5 54.09 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.521 -0.918 . . . . 60.35 108.521 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.8 131.06 30.61 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.745 -1.206 . . . . 61.23 107.745 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 66.4 p -137.57 134.24 35.39 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.071 0.548 . . . . 72.04 109.884 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.638 ' HB3' ' HD2' ' B' ' 34' ' ' LYS . 0.9 OUTLIER -113.6 117.78 32.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.336 -1.357 . . . . 75.24 107.336 -179.349 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.64 -130.25 10.14 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.793 -0.523 . . . . 55.23 111.793 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.27 31.67 5.21 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.893 0.877 . . . . 74.21 109.655 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.83 145.28 28.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.477 0.711 . . . . 64.32 110.082 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -68.12 132.14 46.68 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 122.863 0.465 . . . . 72.04 110.392 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.87 -55.39 3.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.079 . . . . 73.03 108.721 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -163.58 164.7 24.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 74.41 110.842 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 52.3 mt -133.42 145.34 50.19 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.203 1.401 . . . . 74.03 107.739 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.7 t -153.63 143.14 21.69 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.409 -0.96 . . . . 72.24 108.409 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -158.99 133.14 7.7 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.809 -0.812 . . . . 75.05 108.809 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 90.1 t -125.22 145.45 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.858 . . . . 75.03 108.916 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.674 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.7 mt-30 -119.97 93.59 4.11 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.332 -0.988 . . . . 75.42 108.332 171.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -84.01 100.23 10.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.52 -0.763 . . . . 74.33 109.263 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.41 166.47 36.42 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.71 -0.556 . . . . 73.11 111.71 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.47 126.66 1.51 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.462 -0.655 . . . . 62.3 111.462 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.574 HG22 HD12 ' B' ' 51' ' ' LEU . 33.5 mt -85.97 116.1 28.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 75.04 108.581 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.51 163.79 17.41 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.687 -0.857 . . . . 72.31 108.687 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.66 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.9 m -129.68 93.22 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.783 -1.191 . . . . 73.21 107.783 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.411 HG22 ' SG ' ' B' ' 97' ' ' CYS . 0.1 OUTLIER -112.31 111.68 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 107.969 -1.123 . . . . 73.15 107.969 -175.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.494 ' HB1' ' HB3' ' B' ' 54' ' ' ASP . . . -130.55 159.37 37.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.914 0.885 . . . . 61.34 110.499 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.48 -42.97 2.04 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.605 0.566 . . . . 64.02 114.096 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' B' ' 94' ' ' MET . 0.2 OUTLIER -74.58 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.942 0.897 . . . . 74.42 112.527 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.549 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.4 pt-20 -161.41 -178.2 6.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.917 -1.038 . . . . 74.32 110.547 166.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.62 -118.9 15.96 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.348 -0.842 . . . . 74.01 114.488 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -71.72 -35.64 70.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.685 0.794 . . . . 75.34 111.143 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.474 ' HB2' ' HG3' ' B' ' 3' ' ' GLU . 1.6 tt0 -73.54 -35.41 65.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.801 0.441 . . . . 73.55 110.878 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.549 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 24.2 ptt? -74.72 -25.65 59.27 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.45 0.3 . . . . 73.44 110.964 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.16 82.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.249 0.62 . . . . 75.3 111.266 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 16.8 m-70 -85.34 -21.34 28.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.202 0.601 . . . . 74.42 111.453 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' B' ' 86' ' ' ILE . 35.8 t -84.37 -62.74 1.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.926 0.394 . . . . 73.33 110.403 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.0 -27.0 61.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.819 0.448 . . . . 73.54 111.456 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.58 -1.31 60.45 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.422 -0.655 . . . . 63.42 114.381 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -150.16 -50.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.995 0.897 . . . . 72.23 112.674 -174.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -65.23 -49.34 70.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.455 0.702 . . . . 64.5 110.744 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.459 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.9 m -64.0 -51.73 61.36 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-O 118.538 -0.744 . . . . 74.4 111.575 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.4 Cg_exo -53.37 -34.56 71.53 Favored 'Trans proline' 0 C--N 1.403 3.405 0 C-N-CA 122.627 2.218 . . . . 73.32 114.726 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.73 -37.9 89.18 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.069 0.548 . . . . 62.12 111.163 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.59 -43.33 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.709 0.804 . . . . 72.43 110.038 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.28 -20.91 50.6 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.147 -0.933 . . . . 75.24 112.504 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -59.69 -51.59 79.87 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 117.844 -1.074 . . . . 73.22 113.769 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.06 -34.43 92.57 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 122.088 1.859 . . . . 55.01 113.285 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.443 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 89.1 m-85 -68.63 -49.74 56.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.695 0.798 . . . . 75.41 110.824 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.98 84.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.544 0.738 . . . . 73.24 110.808 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.444 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.8 ttt180 -62.67 -52.56 62.84 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 63.54 110.956 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.97 -38.33 90.69 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.135 -0.938 . . . . 71.01 110.167 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.479 ' SG ' HD13 ' B' ' 21' ' ' ILE . 8.5 t -69.31 -34.31 74.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.93 -0.577 . . . . 74.2 111.929 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.566 HD12 HG23 ' B' ' 64' ' ' VAL . 66.0 mt -64.66 -57.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.023 0.529 . . . . 71.24 109.584 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.3 m -60.4 -31.16 70.1 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.942 0.776 . . . . 74.44 111.5 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.2 t -62.84 -48.29 79.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.85 0.86 . . . . 63.21 110.917 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.425 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 23.2 mmt -67.83 -34.41 76.68 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.91 0.484 . . . . 62.43 110.867 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.506 HG11 HD13 ' B' ' 126' ' ' LEU . 74.1 t -63.21 -37.66 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 124.17 0.988 . . . . 72.23 110.86 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -63.83 -40.64 97.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.533 0.733 . . . . 53.45 110.866 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -64.39 -32.05 73.5 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.735 -1.12 . . . . 74.43 111.947 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.76 17.5 56.27 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.672 0.608 . . . . 60.21 113.697 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 73.0 p 60.53 26.74 16.39 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.616 1.566 . . . . 72.04 112.912 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.421 ' CE1' HG23 ' B' ' 31' ' ' VAL . 81.3 m-85 -91.84 156.79 42.31 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.395 0.678 . . . . 75.24 110.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.41 177.42 3.27 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 123.238 2.625 . . . . 75.3 114.241 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -67.26 124.32 22.78 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.825 -1.079 . . . . 73.21 111.62 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.506 HD13 HG11 ' B' ' 118' ' ' VAL . 11.0 mp -117.27 96.41 5.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.96 0.904 . . . . 75.2 109.36 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.626 HD22 HG23 ' E' ' 130' ' ' ILE . 0.2 OUTLIER -91.75 92.63 8.5 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.08 0.467 . . . . 74.43 110.29 173.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.444 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 73.1 mt -67.27 141.9 57.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.175 0.59 . . . . 64.13 110.606 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 143.27 39.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.224 0.61 . . . . 55.34 110.558 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.539 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 28.8 Cg_endo -61.7 123.34 12.48 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.129 2.552 . . . . 74.35 111.598 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.464 HG13 HD22 ' B' ' 44' ' ' LEU . 12.8 t -100.0 127.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.753 -0.462 . . . . 72.31 109.753 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.61 96.43 10.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.957 -1.127 . . . . 74.52 107.957 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.466 ' HD1' ' HH2' ' E' ' 120' ' ' TRP . 58.8 m-85 -59.17 -34.52 72.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 71.24 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.72 -39.09 93.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.384 -1.28 . . . . 73.31 111.198 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.19 78.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.322 0.649 . . . . 74.02 111.585 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.63 -49.63 74.41 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.849 0.718 . . . . 64.22 110.274 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -75.07 -20.42 59.52 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.687 -0.688 . . . . 74.12 112.588 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.691 ' SD ' ' HB3' ' B' ' 145' ' ' ALA . 71.8 mtm -74.8 -38.28 62.15 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.938 -0.393 . . . . 73.12 109.938 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -74.53 -19.55 60.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.994 0.518 . . . . 74.43 110.96 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.167 0.508 . . . . 63.21 110.389 170.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.6 mt -100.76 13.46 34.86 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.87 0.868 . . . . 74.41 111.497 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 63.37 51.81 2.54 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.221 1.008 . . . . 73.2 110.082 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 56.32 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.456 1.503 . . . . 74.25 110.839 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -132.61 109.06 9.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.367 0.667 . . . . 65.03 109.797 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.691 ' HB3' ' SD ' ' B' ' 138' ' ' MET . . . -145.4 154.03 41.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.098 0.959 . . . . 64.34 110.27 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.22 121.71 1.12 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.483 -0.647 . . . . 73.52 111.483 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -78.97 111.94 15.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.971 -0.751 . . . . 74.32 108.971 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.07 61.05 0.23 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 112.27 -0.332 . . . . 73.44 112.27 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 83.3 m -122.78 83.46 2.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.953 0.901 . . . . 72.15 108.724 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.61 ' HA ' HD22 ' F' ' 148' ' ' LEU . 43.3 mt-10 -135.54 152.43 51.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 74.42 109.23 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.525 ' HB3' HG22 ' B' ' 7' ' ' THR . 9.7 tp10 69.74 143.64 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.462 1.505 . . . . 74.43 111.408 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -84.82 143.72 28.9 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.893 -0.78 . . . . 62.2 108.893 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.83 84.69 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.738 -1.578 . . . . 74.4 106.738 166.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -93.25 108.99 20.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.134 -0.939 . . . . 75.23 109.173 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.315 0.646 . . . . 74.33 109.356 178.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.53 ' SD ' ' HB1' ' F' ' 122' ' ' ALA . 64.9 mtt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -149.44 145.59 27.0 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.787 0.835 . . . . 63.3 109.378 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.63 178.9 7.01 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.958 0.903 . . . . 64.14 109.648 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 66.38 141.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.296 1.438 . . . . 74.33 111.73 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.421 ' ND2' ' HB2' ' C' ' 150' ' ' GLU . 6.0 p30 -161.16 136.15 7.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.229 0.612 . . . . 75.3 110.726 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -128.61 93.63 3.67 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.422 -1.325 . . . . 74.11 107.422 170.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -67.4 99.0 0.69 Allowed 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.348 -0.842 . . . . 72.13 110.981 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.34 131.31 46.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.79 -0.818 . . . . 72.11 108.79 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 44.6 ttp 63.88 112.68 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.706 1.254 . . . . 74.1 110.401 -166.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.662 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 12.4 m -86.79 76.29 9.49 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.604 -1.258 . . . . 73.53 107.604 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -92.0 129.19 38.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.211 -0.904 . . . . 73.02 108.591 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.88 139.53 21.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.686 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -82.56 133.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 107.542 -1.281 . . . . 75.2 107.542 174.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.9 mm-40 -107.62 -46.91 3.72 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.355 0.662 . . . . 65.21 110.006 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.41 ' NH1' ' HA ' ' D' ' 29' ' ' PRO . 56.1 ttt180 -166.79 141.15 4.02 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.59 -0.732 . . . . 73.34 109.654 -172.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.686 HG13 HD11 ' C' ' 13' ' ' ILE . 86.3 mt -129.39 142.01 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 106.926 -1.509 . . . . 70.24 106.926 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -174.03 160.46 3.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.624 0.77 . . . . 70.1 110.248 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.5 p -85.47 107.37 17.39 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.706 -0.679 . . . . 74.03 109.544 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -65.97 -41.84 90.64 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.281 -0.637 . . . . 73.01 109.281 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.6 t70 -147.8 147.12 29.5 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.768 -0.651 . . . . 75.15 109.815 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.521 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.2 mt -143.79 145.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.484 1.513 . . . . 71.51 106.965 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -157.96 150.07 22.09 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.081 0.553 . . . . 72.33 109.55 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -146.15 123.27 11.47 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.655 -1.239 . . . . 73.45 107.655 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 36.0 mt-10 -123.59 112.43 17.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.46 0.704 . . . . 75.35 109.558 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.22 85.92 25.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.69 -0.856 . . . . 71.35 108.69 172.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -36.33 10.79 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.586 2.19 . . . . 75.55 111.429 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.527 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 66.8 m-80 -106.45 36.05 2.75 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.151 -0.931 . . . . 73.11 110.156 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.408 ' HA ' ' HZ ' ' C' ' 123' ' ' PHE . . . -56.11 -47.18 99.34 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.504 1.122 . . . . 75.43 112.536 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -94.39 -10.04 1.48 Allowed 'Trans proline' 0 C--N 1.397 3.111 0 C-N-CA 122.257 1.971 . . . . 63.11 113.641 173.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.527 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-160 -71.96 -30.95 65.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.332 0.653 . . . . 73.25 111.282 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.574 HG11 ' HE1' ' C' ' 123' ' ' PHE . 7.6 p -76.76 -13.73 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.839 0.855 . . . . 75.44 111.832 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -51.51 -37.34 48.76 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.407 1.483 . . . . 73.43 113.259 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -126.54 26.49 6.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.399 0.68 . . . . 75.14 110.134 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -125.4 153.0 44.08 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.252 -0.905 . . . . 73.41 111.922 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.85 133.14 47.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.536 1.534 . . . . 61.15 112.586 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' E' ' 135' ' ' ALA . 24.2 p90 -86.1 104.76 15.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.691 0.796 . . . . 74.55 110.598 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -161.47 68.5 2.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.441 -0.948 . . . . 73.22 108.441 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -86.92 138.47 5.04 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.063 1.842 . . . . 74.1 110.959 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.46 97.62 9.08 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.771 -1.937 . . . . 71.13 105.771 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -79.37 99.45 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.812 -1.085 . . . . 74.34 110.837 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -93.51 117.1 29.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.278 -0.874 . . . . 72.13 110.185 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -92.02 148.29 22.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.686 -0.857 . . . . 73.1 108.686 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.9 t70 -146.77 112.45 5.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.16 -1.052 . . . . 73.24 108.16 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.37 111.56 24.04 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.043 -1.095 . . . . 75.25 108.043 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -123.61 158.55 31.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.686 1.195 . . . . 72.05 108.657 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -145.64 151.36 37.93 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.281 0.562 . . . . 72.02 109.742 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 173.8 11.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.541 1.136 . . . . 74.35 108.338 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.7 p -152.3 148.09 27.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 122.866 0.467 . . . . 74.53 110.016 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -145.38 125.47 13.68 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.675 -1.231 . . . . 75.15 107.675 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.44 115.16 22.4 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.369 -0.974 . . . . 74.12 108.369 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.583 HD12 ' HB2' ' C' ' 57' ' ' GLU . 58.9 mt -84.92 -39.33 18.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.458 0.703 . . . . 75.3 110.272 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.71 -173.33 4.06 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.021 -0.99 . . . . 72.54 110.384 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.28 111.73 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.34 -1.3 . . . . 74.1 110.322 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 64.8 17.52 11.03 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.611 1.164 . . . . 75.44 112.443 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.4 103.82 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.343 -0.984 . . . . 75.54 108.343 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -118.12 125.84 51.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.82 0.848 . . . . 71.43 109.933 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.583 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.5 tt0 -84.03 112.09 19.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.05 0.94 . . . . 74.11 109.306 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.72 129.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.745 -1.206 . . . . 74.32 107.745 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.42 105.23 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.68 100.38 12.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.192 -1.04 . . . . 63.33 108.192 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -93.43 111.33 22.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.097 1.359 . . . . 75.3 109.486 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.556 ' HB ' HD11 ' C' ' 114' ' ' ILE . 2.9 t -103.11 137.23 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.02 -0.733 . . . . 75.53 109.02 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 54.1 m -119.17 133.76 55.59 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.541 -0.911 . . . . 70.32 108.541 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.59 HG23 HG21 ' C' ' 114' ' ' ILE . 93.9 t -124.76 117.31 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.979 1.312 . . . . 71.4 107.49 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -117.02 134.4 54.79 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.937 -0.764 . . . . 72.42 108.937 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.0 95.52 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.889 -1.523 . . . . 63.52 106.889 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -149.07 123.16 9.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.367 0.267 . . . . 65.12 111.317 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -85.86 77.29 9.75 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.045 -1.095 . . . . 72.21 108.045 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.44 -93.23 0.24 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.169 -0.923 . . . . 74.23 112.643 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.4 -15.48 21.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.998 0.919 . . . . 65.31 111.522 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -98.1 95.42 7.43 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.088 0.555 . . . . 63.42 110.231 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.8 m -89.46 118.39 29.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.012 0.434 . . . . 65.12 111.242 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.83 -53.44 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.127 0.971 . . . . 63.43 108.846 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.15 168.48 27.3 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.454 -1.248 . . . . 75.33 111.844 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.536 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.4 tm? -140.65 146.31 37.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.39 -2.078 . . . . 72.5 105.39 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.404 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.8 t -153.33 130.81 11.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.179 -0.675 . . . . 64.33 109.179 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -136.36 129.55 31.48 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.757 -0.46 . . . . 74.34 109.757 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.71 114.67 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.857 . . . . 73.14 109.062 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.99 95.44 10.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.146 0.978 . . . . 64.43 108.701 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.554 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.9 tp-100 -83.67 105.76 14.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.851 -0.613 . . . . 74.33 109.685 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.24 144.37 21.63 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.565 -0.614 . . . . 71.2 111.565 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.43 117.16 0.93 Allowed Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 110.155 -1.178 . . . . 71.32 110.155 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.57 HD13 HD12 ' C' ' 51' ' ' LEU . 11.2 mm -81.52 122.33 36.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.093 -1.077 . . . . 73.2 108.093 176.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -131.2 128.75 40.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.731 0.812 . . . . 74.3 109.028 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.3 m -71.36 114.19 9.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.128 -0.693 . . . . 75.23 109.128 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 mm -116.85 101.24 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.957 0.903 . . . . 74.31 108.64 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.662 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -133.94 150.58 51.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.698 . . . . 73.35 109.76 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -47.12 3.58 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 121.247 0.36 . . . . 31.52 113.074 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.75 149.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.84 1.256 . . . . 65.44 110.527 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -160.6 155.93 24.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.935 0.494 . . . . 74.14 111.032 -174.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.09 -142.76 28.89 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.166 0.412 . . . . 51.02 113.687 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -61.42 -24.72 66.72 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.161 0.984 . . . . 74.53 111.821 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -58.95 -57.39 13.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.82 0.848 . . . . 75.23 110.097 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.418 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 26.6 ptm -74.41 -23.35 58.94 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.775 -0.648 . . . . 72.14 111.056 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.63 84.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.296 0.638 . . . . 72.02 111.064 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.51 -29.99 68.71 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.255 0.622 . . . . 75.51 110.955 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.37 -62.34 1.51 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.536 0.334 . . . . 74.52 110.296 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.8 pp -76.08 -12.92 60.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.172 0.589 . . . . 74.53 112.521 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.38 33.16 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.587 -0.563 . . . . 65.33 113.962 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.28 -56.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 117.626 0.713 . . . . 75.13 111.588 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -70.78 -61.46 1.76 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.684 0.394 . . . . 75.14 111.798 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 69.3 m -54.86 -45.5 99.7 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.97 0.908 . . . . 72.14 112.291 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -47.97 -48.57 15.94 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.757 2.304 . . . . 72.14 113.72 167.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.495 HD22 ' HA ' ' C' ' 132' ' ' ASN . 4.8 m-20 -74.63 -15.42 60.82 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.687 0.795 . . . . 73.31 113.114 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.433 HD13 HH12 ' A' ' 111' ' ' ARG . 36.3 mm -75.5 -40.89 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.279 -0.637 . . . . 75.42 109.279 169.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 67.8 mt -86.31 -17.92 33.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.178 0.991 . . . . 74.21 111.915 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.428 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 50.2 t80 -65.12 -46.63 73.17 Favored Pre-proline 0 CA--C 1.55 0.981 0 CA-C-O 117.535 -1.221 . . . . 73.14 113.031 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.89 -37.75 97.49 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.942 1.761 . . . . 71.3 112.634 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -65.28 -52.68 52.7 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 74.42 110.873 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -66.16 -35.17 79.77 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.151 0.58 . . . . 74.1 111.351 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.24 -53.11 61.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.573 1.149 . . . . 73.13 110.217 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.41 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.1 tm-20 -67.35 -34.94 78.36 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.837 0.711 . . . . 74.41 110.107 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 27.6 t -67.39 -32.92 74.16 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.071 0.548 . . . . 73.34 111.393 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.59 HG21 HG23 ' C' ' 64' ' ' VAL . 88.7 mt -73.11 -51.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.362 0.665 . . . . 75.34 110.223 172.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 34.8 m -63.03 -29.0 70.48 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.281 0.632 . . . . 62.44 110.929 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.411 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.4 t -65.44 -52.4 53.46 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.306 -0.861 . . . . 74.11 109.033 170.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.6 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.53 -40.44 75.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.889 1.276 . . . . 73.44 113.016 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -65.89 -45.2 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.667 0.787 . . . . 75.21 109.761 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.9 t -70.64 -24.01 62.63 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.153 -0.931 . . . . 72.31 111.26 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.499 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.4 mtt-85 -69.94 -36.41 75.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.472 0.709 . . . . 72.5 109.272 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.34 10.06 62.43 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 124.002 0.814 . . . . 61.42 112.79 172.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 81.9 p 57.61 37.21 27.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.046 1.738 . . . . 62.32 113.425 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.574 ' HE1' HG11 ' C' ' 31' ' ' VAL . 61.1 m-85 -105.73 162.23 20.36 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.363 1.065 . . . . 73.24 110.216 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' E' ' 136' ' ' VAL . 25.5 Cg_endo -59.99 146.0 97.02 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.107 2.538 . . . . 74.11 113.384 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -58.49 108.92 0.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.003 0.921 . . . . 74.2 109.632 173.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.2 tp -110.21 91.64 3.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.839 -1.171 . . . . 72.23 107.839 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -91.17 115.47 28.05 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.564 -0.902 . . . . 72.33 108.564 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.428 ' HB3' ' HZ ' ' C' ' 107' ' ' PHE . 2.3 tt -64.97 132.86 50.42 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.325 -0.991 . . . . 74.14 108.325 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.94 139.42 70.72 Favored Pre-proline 0 CA--C 1.549 0.921 0 O-C-N 124.11 0.882 . . . . 72.11 110.968 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.48 104.61 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.303 2.002 . . . . 72.54 111.296 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.0 107.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 108.402 -0.962 . . . . 74.42 108.402 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.495 ' HA ' HD22 ' C' ' 104' ' ' ASN . 15.3 m120 -113.23 89.52 3.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.498 0.719 . . . . 73.43 110.149 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -70.78 -30.32 66.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.049 -0.978 . . . . 73.41 109.428 172.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.08 -39.5 82.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.245 1.018 . . . . 73.52 111.364 173.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.13 70.28 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.719 0.808 . . . . 74.1 111.885 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.9 -39.38 94.04 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.637 0.775 . . . . 74.35 110.776 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -74.04 -41.05 62.38 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.656 -1.156 . . . . 62.33 110.509 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.635 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 25.8 ttt -65.67 -45.23 83.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.165 0.986 . . . . 74.13 112.37 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -65.28 -38.19 89.52 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.339 0.399 . . . . 72.55 110.174 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.88 -88.04 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 O-C-N 124.321 1.013 . . . . 74.52 111.479 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.21 82.92 1.81 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.954 0.902 . . . . 74.33 108.604 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.635 ' HB2' ' HA ' ' C' ' 138' ' ' MET . 27.8 tt0 -94.5 99.08 11.3 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.054 -0.721 . . . . 75.32 109.054 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -65.06 125.54 25.24 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.018 -0.992 . . . . 73.54 110.231 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.08 170.17 19.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.48 0.657 . . . . 71.41 111.674 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.7 -177.2 6.1 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 125.138 1.375 . . . . 65.41 108.22 173.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.03 -37.21 0.32 Allowed Glycine 0 N--CA 1.471 1.018 0 N-CA-C 111.529 -0.628 . . . . 75.24 111.529 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 61.42 84.86 0.13 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.887 1.275 . . . . 73.42 111.59 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.58 -127.31 44.65 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 124.036 0.835 . . . . 74.51 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -176.27 178.17 1.41 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.484 1.113 . . . . 73.42 109.072 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.421 ' HB2' ' ND2' ' C' ' 5' ' ' ASN . 41.1 tt0 -134.27 139.82 45.99 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.552 0.741 . . . . 72.0 109.361 176.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -147.6 150.08 33.76 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.232 -1.025 . . . . 64.11 108.232 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 63.95 83.69 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.51 1.124 . . . . 73.51 110.677 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.73 -35.38 67.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.237 -0.892 . . . . 74.45 111.514 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.85 163.29 38.43 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.293 0.637 . . . . 72.54 111.266 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.039 0 C-N-CA 123.867 0.867 . . . . 72.34 111.045 -177.647 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.152 -0.684 . . . . 74.21 109.152 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -59.81 95.12 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.767 0.827 . . . . 71.45 110.323 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -74.59 114.06 12.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.899 0.88 . . . . 73.23 109.479 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -155.37 -170.29 3.41 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 122.834 0.454 . . . . 73.1 110.186 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -68.42 79.94 0.26 Allowed 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 122.299 1.047 . . . . 73.31 110.128 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.405 1.082 . . . . 75.44 108.618 -172.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.5 m 64.18 31.86 12.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.772 1.229 . . . . 73.45 109.143 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.25 76.68 4.76 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.255 -1.339 . . . . 72.42 107.898 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.6 ttp -34.27 125.99 0.47 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.469 1.508 . . . . 75.14 113.13 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.596 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 42.0 m -115.26 135.15 54.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.173 -1.047 . . . . 73.13 108.173 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' D' ' 85' ' ' SER . 72.0 t80 -154.22 119.31 5.03 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.443 -0.947 . . . . 72.54 108.443 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -132.37 147.21 52.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.565 0.746 . . . . 65.33 110.371 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 122.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.916 -1.142 . . . . 74.34 107.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -100.3 -46.36 5.29 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.1 -0.375 . . . . 75.22 110.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -169.92 121.99 0.69 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.484 0.49 . . . . 75.51 110.606 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.478 HD12 ' HG3' ' B' ' 130' ' ' PRO . 2.6 mp -109.63 131.76 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 107.469 -1.308 . . . . 74.43 107.469 178.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.451 ' HE2' ' HG2' ' D' ' 19' ' ' LYS . 44.3 p90 -162.52 178.47 8.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.52 0.676 . . . . 71.42 111.794 -173.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.2 p -104.91 123.75 48.29 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.671 0.788 . . . . 53.25 109.654 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.451 ' HG2' ' HE2' ' D' ' 17' ' ' TYR . 32.3 mtpt -91.27 -22.96 20.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.965 -0.383 . . . . 64.12 109.965 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.9 t70 -155.11 141.73 18.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.521 0.728 . . . . 73.05 109.76 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.6 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.2 mt -140.84 147.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.01 1.324 . . . . 73.12 108.085 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.74 145.99 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.843 0.857 . . . . 72.02 109.34 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.3 t80 -148.97 124.93 10.63 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.649 -1.611 . . . . 71.03 106.649 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.628 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.6 mt-10 -124.31 142.16 51.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.581 0.753 . . . . 73.24 109.487 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' D' ' 28' ' ' ALA . . . -147.68 76.31 10.8 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.763 0.825 . . . . 72.35 109.081 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.54 -47.71 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.43 2.087 . . . . 72.01 111.622 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' D' ' 72' ' ' THR . 26.1 m-20 -97.12 36.13 1.48 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.953 0.901 . . . . 74.44 108.955 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' D' ' 25' ' ' ALA . . . -60.47 -54.66 52.68 Favored Pre-proline 0 CA--C 1.559 1.289 0 N-CA-C 114.294 1.22 . . . . 61.12 114.294 -172.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.41 ' HA ' ' NH1' ' C' ' 15' ' ' ARG . 49.3 Cg_endo -80.04 -7.3 14.23 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 121.237 1.477 . . . . 71.33 112.605 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.521 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 19.4 t-160 -83.83 -38.81 20.74 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.214 1.406 . . . . 73.53 110.099 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -82.96 -20.83 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 74.24 110.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.23 -28.91 69.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.856 0.862 . . . . 73.23 110.688 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 63.3 mt-30 -67.04 -20.39 65.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.749 1.219 . . . . 75.31 111.557 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -100.86 111.59 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.271 1.029 . . . . 75.51 110.059 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -85.86 63.26 7.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.354 1.061 . . . . 73.13 111.108 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.524 ' HB3' HD13 ' D' ' 68' ' ' LEU . 48.2 t-105 -144.69 167.98 21.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.71 116.64 66.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.586 0.754 . . . . 73.34 110.031 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.415 ' O ' HD11 ' F' ' 139' ' ' LEU . 95.2 Cg_exo -50.61 133.93 39.17 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.642 2.894 . . . . 73.32 113.764 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.39 130.6 43.89 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.782 -0.451 . . . . 75.24 109.782 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.43 134.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.382 0.673 . . . . 72.45 110.786 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.533 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.1 tmtt? -130.6 121.38 25.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.428 -1.693 . . . . 72.32 106.428 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 146.9 26.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.102 0.561 . . . . 74.13 110.978 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.718 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.8 m-20 -137.14 122.95 20.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.215 1.406 . . . . 75.34 107.609 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -117.2 144.24 44.99 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.986 0.514 . . . . 75.03 110.943 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 2.6 t70 -146.82 154.02 40.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.511 1.124 . . . . 74.11 109.3 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -142.76 148.42 37.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.469 0.708 . . . . 71.13 109.775 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 168.0 25.01 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.651 1.18 . . . . 70.5 108.14 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -160.5 153.83 21.96 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.054 0.454 . . . . 74.41 111.244 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -154.36 119.6 5.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.717 1.207 . . . . 63.44 108.98 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.58 126.28 29.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.167 0.587 . . . . 74.24 109.543 175.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.66 -40.69 13.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.942 0.497 . . . . 75.33 109.701 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.14 -174.97 4.99 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.078 -0.964 . . . . 74.23 110.243 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -63.08 123.35 18.36 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.631 -0.713 . . . . 73.33 110.301 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.44 -2.24 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.873 1.269 . . . . 73.43 112.909 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.68 118.68 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.842 0.857 . . . . 63.44 108.868 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -128.97 128.53 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.877 -1.157 . . . . 75.51 107.877 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -97.13 141.33 30.4 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.824 -1.547 . . . . 64.15 106.824 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.26 130.55 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.052 -0.722 . . . . 73.42 109.052 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.82 138.84 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 123.916 0.887 . . . . 74.3 109.684 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.17 120.77 27.95 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.528 -1.286 . . . . 72.43 107.528 171.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -107.25 121.62 44.91 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.231 1.012 . . . . 75.54 109.32 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.59 122.49 67.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.613 -1.255 . . . . 73.14 107.613 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.6 m -121.2 131.81 54.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.743 0.817 . . . . 75.2 109.462 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.436 HG21 HD12 ' D' ' 114' ' ' ILE . 80.7 t -119.55 109.13 25.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.082 1.353 . . . . 74.31 109.261 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 23.6 m -94.89 117.68 30.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.144 -1.058 . . . . 74.55 108.144 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.92 133.07 51.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.464 -0.569 . . . . 64.25 109.464 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.432 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 51.2 p -145.83 134.82 22.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.069 0.548 . . . . 70.51 109.797 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' D' ' 36' ' ' TRP . 19.0 tp -117.87 118.94 33.37 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.105 -0.702 . . . . 72.22 109.105 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.09 -115.18 4.01 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.15 -0.78 . . . . 64.41 111.15 -170.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.19 9.06 10.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.032 0.933 . . . . 70.43 110.268 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.88 156.56 39.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.014 0.926 . . . . 65.13 110.298 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' THR . . . . . 0.414 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 99.1 m -68.83 123.99 22.47 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.654 0.782 . . . . 70.23 110.576 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.432 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.52 -57.28 3.21 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.707 0.803 . . . . 73.11 109.322 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.94 149.75 16.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.801 -1.091 . . . . 74.04 109.683 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.628 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -113.65 153.64 28.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.418 1.087 . . . . 75.22 108.209 172.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.583 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.8 t -156.09 142.41 18.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.106 0.562 . . . . 75.21 109.592 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.22 121.4 4.3 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.838 0.455 . . . . 64.41 110.075 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.31 115.26 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.316 0.647 . . . . 74.33 109.973 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.2 mt-30 -89.16 87.76 7.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.737 -0.838 . . . . 70.33 108.737 169.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.89 104.04 10.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.516 -1.22 . . . . 74.34 108.664 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.59 143.68 15.7 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.901 -0.479 . . . . 61.22 111.901 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.411 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.99 131.41 4.57 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.789 -0.524 . . . . 73.52 111.789 -171.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.8 123.03 40.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 C-N-CA 123.926 0.89 . . . . 64.44 108.761 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -128.64 163.05 25.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.925 0.89 . . . . 73.5 109.98 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.8 m -107.3 112.88 25.94 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.529 -0.915 . . . . 71.21 108.529 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.77 115.63 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 107.877 -1.157 . . . . 75.3 107.877 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.596 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -145.91 157.6 43.89 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.318 1.047 . . . . 63.24 109.785 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.44 -14.28 12.96 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.086 -0.506 . . . . 44.44 113.567 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.9 138.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.956 1.303 . . . . 74.11 109.312 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -152.4 -177.35 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.2 0.6 . . . . 73.34 110.718 174.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.64 -120.15 6.81 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.037 -0.529 . . . . 73.21 112.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' THR . . . . . 0.49 ' HB ' HD23 ' D' ' 141' ' ' LEU . 23.9 p -64.33 -39.3 93.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.805 0.842 . . . . 75.44 111.301 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.91 -37.63 72.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.738 0.415 . . . . 74.1 111.094 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.653 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 58.3 ttp -72.58 -36.1 68.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.596 0.359 . . . . 74.32 110.567 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.71 86.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.169 0.588 . . . . 62.21 110.392 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -68.3 -37.72 80.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.814 0.846 . . . . 73.44 110.809 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' D' ' 102' ' ' CYS . 33.3 t -68.68 -51.25 43.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.673 0.389 . . . . 61.43 110.158 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.41 -18.78 59.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.347 0.659 . . . . 72.2 111.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.61 -8.98 44.87 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.409 -0.662 . . . . 74.12 114.14 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.94 -63.19 0.35 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.878 0.839 . . . . 70.52 112.25 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.13 -56.52 11.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.397 0.888 . . . . 72.53 113.397 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.531 ' SG ' ' SG ' ' D' ' 97' ' ' CYS . 65.4 m -61.91 -43.27 86.51 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-O 118.594 -0.717 . . . . 75.32 111.606 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -51.6 -39.6 65.38 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.463 2.109 . . . . 74.12 114.121 164.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -69.98 -25.29 63.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.599 0.76 . . . . 74.5 111.063 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 48.2 mm -70.27 -40.61 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.349 0.66 . . . . 72.12 110.112 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.411 HD22 ' HA3' ' D' ' 82' ' ' GLY . 61.7 mt -77.06 -26.51 53.62 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.194 -0.912 . . . . 73.11 111.667 -174.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.497 ' HZ ' HD11 ' D' ' 128' ' ' LEU . 85.4 t80 -53.97 -47.91 95.52 Favored Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 125.039 1.336 . . . . 74.12 114.469 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 80.7 Cg_exo -51.0 -41.07 57.97 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.431 2.087 . . . . 72.43 113.712 172.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.539 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 70.9 m-85 -75.87 -34.98 60.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.892 0.877 . . . . 75.44 111.888 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.84 73.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.141 0.577 . . . . 72.01 109.894 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -56.45 -48.34 77.25 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.581 1.176 . . . . 73.33 110.234 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.45 -44.69 95.81 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.081 0.863 . . . . 74.51 111.121 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.6 t -61.38 -43.71 98.41 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.594 0.559 . . . . 73.21 110.856 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.583 HG12 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -57.11 -57.91 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.877 0.871 . . . . 74.13 110.23 173.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.54 HG21 ' HG3' ' D' ' 125' ' ' GLN . 87.9 m -53.79 -46.69 71.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.362 1.465 . . . . 75.51 112.02 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -62.55 -41.11 98.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.91 -1.041 . . . . 71.14 110.036 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.414 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.4 mtm -70.05 -33.8 72.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.144 0.578 . . . . 73.15 111.667 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 72.7 t -64.39 -43.3 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.594 0.758 . . . . 75.05 110.406 176.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.79 -33.51 66.32 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 116.105 -0.498 . . . . 73.54 110.704 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -68.06 -32.68 73.2 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.997 0.919 . . . . 75.41 110.42 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.04 81.86 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.719 -0.673 . . . . 65.31 112.849 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 56.18 45.15 23.85 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.446 1.498 . . . . 72.23 112.258 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -117.85 155.37 50.98 Favored Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.799 -1.092 . . . . 75.11 110.23 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.48 112.07 0.61 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.25 2.633 . . . . 74.13 112.321 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.54 ' HG3' HG21 ' D' ' 115' ' ' THR . 34.9 tt0 -61.28 128.74 37.83 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.148 0.905 . . . . 75.2 112.025 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.25 120.29 41.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.878 -1.156 . . . . 73.12 107.878 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -112.72 95.13 5.25 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.864 -1.162 . . . . 72.03 107.864 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.497 HD11 ' HZ ' ' D' ' 107' ' ' PHE . 0.2 OUTLIER -70.34 125.93 28.19 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.062 0.545 . . . . 72.12 109.642 -174.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 142.14 96.66 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.896 0.878 . . . . 74.32 111.508 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.4 124.9 6.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.948 2.432 . . . . 74.44 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -127.27 123.72 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.947 0.899 . . . . 64.52 109.481 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -76.82 94.83 3.93 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.894 -0.78 . . . . 75.33 108.894 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.48 ' HA ' HD21 ' D' ' 136' ' ' LEU . 19.7 p90 -85.31 -16.83 38.72 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.815 -0.612 . . . . 74.24 111.256 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' D' ' 138' ' ' MET . 2.2 m-20 -48.61 -50.75 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.077 0.951 . . . . 71.2 111.482 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.506 ' HB3' ' HG2' ' B' ' 150' ' ' GLU . . . -51.14 -38.08 49.94 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 124.298 0.999 . . . . 75.41 113.112 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.48 HD21 ' HA ' ' D' ' 133' ' ' PHE . 2.9 mm? -78.67 -35.6 44.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.231 0.613 . . . . 65.43 110.777 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -63.67 -28.96 70.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.316 0.646 . . . . 71.33 111.948 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 59.4 mtt -56.1 -31.18 63.01 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.522 0.729 . . . . 72.32 111.877 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -74.41 -38.85 62.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.321 0.649 . . . . 75.24 110.523 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -56.0 -36.2 67.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.646 0.778 . . . . 70.32 111.836 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.49 HD23 ' HB ' ' D' ' 92' ' ' THR . 10.7 mp -62.19 -34.61 76.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.22 0.608 . . . . 73.4 111.011 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -89.01 0.01 57.04 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.779 0.831 . . . . 74.44 111.088 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -126.47 48.07 2.2 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.577 1.151 . . . . 73.22 108.735 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -146.12 107.87 4.31 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.299 -0.864 . . . . 74.5 109.462 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.36 169.07 18.4 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.169 0.988 . . . . 62.12 110.122 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.86 148.96 13.6 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.987 -0.551 . . . . 75.12 112.528 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.98 173.44 9.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.629 0.771 . . . . 75.24 110.542 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.82 141.19 3.06 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.614 -0.548 . . . . 75.24 112.492 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 29.1 m -75.2 96.04 3.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.466 0.706 . . . . 64.4 109.855 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.34 164.88 26.04 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.364 0.666 . . . . 73.32 111.793 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 58.1 -87.21 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.961 1.304 . . . . 71.24 110.397 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.5 t60 43.88 35.53 1.13 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.623 1.569 . . . . 73.12 112.596 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -69.21 126.26 29.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.1 0.56 . . . . 71.13 111.024 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.22 167.14 21.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.606 0.762 . . . . 74.15 110.756 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 123.683 0.793 . . . . 73.21 109.527 -178.644 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.117 -0.327 . . . . 72.35 110.117 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp 70.25 89.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.097 1.359 . . . . 73.11 110.208 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.69 142.98 57.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.345 1.058 . . . . 74.2 112.888 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.5 155.56 37.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.036 0.934 . . . . 74.04 110.796 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -120.43 158.83 26.36 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.203 1.001 . . . . 74.31 109.901 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.27 -44.16 92.46 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.191 0.997 . . . . 55.53 111.097 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -76.8 148.98 36.28 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.233 -0.894 . . . . 75.12 110.217 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.507 ' H ' HD23 ' E' ' 115' ' ' LEU . 2.2 pt? -76.48 18.29 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.514 1.302 . . . . 74.23 114.514 -164.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . 0.416 ' HB3' ' HH ' ' B' ' 56' ' ' TYR . 45.2 t80 -124.99 87.19 55.74 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.899 -1.149 . . . . 75.34 107.899 164.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.21 -30.16 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.943 2.429 . . . . 73.25 113.799 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -70.2 132.6 46.01 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.284 0.634 . . . . 73.24 110.135 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -86.06 30.27 0.69 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.976 0.91 . . . . 61.23 110.558 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.466 ' HH2' ' HD1' ' B' ' 133' ' ' PHE . 73.8 t-105 59.05 88.98 0.06 Allowed 'General case' 0 C--N 1.359 1.022 0 C-N-CA 124.508 1.123 . . . . 75.43 110.21 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -94.39 -68.75 0.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.283 -0.871 . . . . 74.42 111.073 -168.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.39 113.18 16.16 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.281 0.633 . . . . 74.1 111.846 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 1.1 m -128.2 -111.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 C-N-CA 124.879 1.272 . . . . 74.31 109.835 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.23 22.57 11.95 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.494 1.117 . . . . 74.31 112.349 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -79.2 126.65 31.03 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.788 -0.449 . . . . 73.22 109.788 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -168.91 -166.86 0.68 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 107.246 -1.39 . . . . 62.43 107.246 170.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.51 -43.92 3.03 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 118.017 0.371 . . . . 71.4 113.554 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -73.06 -81.24 0.06 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.631 -0.507 . . . . 74.44 109.631 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 54.97 -90.65 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.386 1.074 . . . . 73.23 111.17 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.626 HG23 HD22 ' B' ' 127' ' ' ASN . 72.2 mt -129.01 80.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 106.833 -1.543 . . . . 74.2 106.833 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.21 -40.57 71.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.49 -0.777 . . . . 74.31 110.141 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -118.83 96.08 49.75 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 74.11 110.596 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.37 78.46 3.4 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.105 1.87 . . . . 74.04 110.353 164.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 40.4 mm -68.49 90.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.383 0.673 . . . . 74.41 110.339 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' C' ' 36' ' ' TRP . . . 61.88 24.76 14.79 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.955 -1.02 . . . . 72.55 112.728 170.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' C' ' 124' ' ' PRO . 33.8 m -83.51 72.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 123.049 1.404 . . . . 70.33 111.211 -174.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.75 -179.81 4.07 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 114.463 -1.244 . . . . 61.13 109.279 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.5 -31.37 64.0 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.595 1.158 . . . . 74.14 112.077 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp 61.88 31.95 18.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.557 1.143 . . . . 75.3 110.836 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 19.8 m -91.02 55.5 2.92 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.687 -1.142 . . . . 74.33 111.16 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.78 -32.12 40.9 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.439 -0.8 . . . . 74.41 110.48 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 25.6 pt -85.91 159.14 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.47 -0.786 . . . . 73.04 110.715 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 71.07 154.01 0.13 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.465 1.506 . . . . 75.1 112.124 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -148.55 -73.72 0.19 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.967 -0.56 . . . . 71.24 109.934 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.17 -43.41 9.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.549 0.74 . . . . 75.2 110.365 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.59 159.13 18.44 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.123 0.569 . . . . 63.35 110.314 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 pp -104.81 -10.19 17.55 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.034 0.934 . . . . 75.44 110.874 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 49.2 tp -103.32 114.98 64.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.978 0.911 . . . . 74.24 109.031 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--N 1.382 2.304 0 C-N-CA 122.893 2.395 . . . . 63.2 112.219 179.514 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.995 0.426 . . . . 75.03 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -132.57 -42.08 0.94 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.594 1.158 . . . . 74.31 108.232 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.17 82.41 1.83 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.29 -1.323 . . . . 74.11 107.878 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.91 87.04 7.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.437 0.695 . . . . 73.44 110.329 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 57.82 86.98 0.07 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.469 1.107 . . . . 65.3 111.994 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -131.0 -174.29 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.726 -0.842 . . . . 71.31 108.726 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.522 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 63.0 mttp -72.06 95.64 1.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.945 0.898 . . . . 72.05 110.755 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.44 20.65 18.33 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.583 1.153 . . . . 65.24 110.879 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -176.66 -54.52 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.835 1.254 . . . . 74.11 111.391 178.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.38 106.98 1.87 Allowed 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.818 1.678 . . . . 74.33 113.025 -170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -120.71 147.55 45.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 71.23 109.733 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 11.3 t -90.82 113.43 25.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.373 0.669 . . . . 62.33 110.113 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -162.62 160.34 25.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 65.33 109.67 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -150.34 -47.26 0.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.51 0.724 . . . . 71.25 110.592 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . 0.53 ' HB1' ' SD ' ' C' ' 1' ' ' MET . . . -68.42 83.13 0.26 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.014 0.526 . . . . 74.5 111.72 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 85.0 t -98.65 -66.46 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.782 0.833 . . . . 63.21 108.843 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.99 143.37 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.391 1.476 . . . . 74.35 111.82 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -149.4 138.16 21.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.691 -0.855 . . . . 75.33 108.691 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -148.26 161.69 41.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.064 0.945 . . . . 62.42 109.367 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.2 104.32 2.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.696 -0.562 . . . . 75.35 111.696 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.69 -12.15 24.19 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.518 0.727 . . . . 74.32 110.62 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 129' ' ' ALA . 3.4 mm? 62.96 21.32 12.81 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.698 1.199 . . . . 74.43 112.651 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 38.1 mm -79.94 85.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.659 -0.867 . . . . 74.13 108.659 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.73 -54.37 3.91 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.995 -1.002 . . . . 74.23 110.357 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -150.25 115.98 3.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 115.952 -0.567 . . . . 71.35 110.174 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.22 75.52 5.01 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.073 2.515 . . . . 74.0 112.725 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 9.6 tt -72.96 148.95 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.086 -1.079 . . . . 72.12 108.086 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.47 -77.23 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.684 0.794 . . . . 53.23 112.176 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 31.1 t 64.96 -3.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 C-N-CA 125.001 1.32 . . . . 62.54 113.069 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.01 -70.34 0.26 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.951 0.9 . . . . 73.2 110.678 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.62 47.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.092 0.472 . . . . 73.23 110.393 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.415 HD11 ' O ' ' D' ' 38' ' ' PRO . 9.8 tp -100.5 84.41 2.77 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.149 -1.426 . . . . 71.44 107.149 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -68.28 -16.63 64.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.131 -1.395 . . . . 74.35 112.98 -169.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.73 92.71 2.5 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.015 0.436 . . . . 75.14 109.993 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 13.0 tt -157.06 146.31 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.787 0.835 . . . . 74.52 109.308 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -66.17 139.06 58.1 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.299 0.639 . . . . 74.31 111.229 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -122.39 -10.12 8.48 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 74.52 109.859 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.97 -34.22 77.27 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.751 1.22 . . . . 75.24 110.429 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.15 97.56 7.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.979 -1.01 . . . . 75.03 109.89 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt -158.48 115.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.178 -1.416 . . . . 71.13 107.178 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' B' ' 150' ' ' GLU . 5.9 mp -86.94 116.12 64.95 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 109.121 -0.696 . . . . 73.12 109.121 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.853 3.036 . . . . 73.41 112.422 176.418 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.821 -0.437 . . . . 63.31 109.821 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 p -133.81 88.42 2.47 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.807 0.843 . . . . 73.32 109.853 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -89.21 114.07 25.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.055 0.942 . . . . 65.25 109.407 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.24 -66.26 0.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.201 -1.037 . . . . 74.23 108.201 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -170.71 138.69 1.44 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.568 1.147 . . . . 74.03 108.431 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -74.61 -93.38 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.328 0.651 . . . . 74.42 109.341 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -163.58 -60.31 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.35 1.06 . . . . 75.43 108.379 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 60.75 87.75 0.09 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.468 -1.242 . . . . 73.31 110.93 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -60.36 134.16 56.8 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.914 -0.585 . . . . 74.04 110.374 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 m -141.01 101.98 4.16 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.051 -1.092 . . . . 70.54 108.051 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -131.56 152.91 50.39 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.282 0.633 . . . . 74.4 110.316 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -155.84 123.24 5.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.565 0.746 . . . . 75.12 109.522 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -81.04 125.91 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.641 -1.615 . . . . 74.14 106.641 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.462 ' HB3' HH11 ' A' ' 15' ' ' ARG . 88.3 mt-30 -109.83 -42.05 4.35 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 122.092 -0.38 . . . . 74.12 111.134 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.462 HH11 ' HB3' ' A' ' 14' ' ' GLN . 2.3 mpt_? -152.34 141.46 21.32 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.219 -1.03 . . . . 70.41 108.219 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.682 HG22 HD23 ' A' ' 106' ' ' LEU . 55.5 mt -141.13 101.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.025 -1.842 . . . . 74.12 106.025 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 73.0 m-85 -155.36 177.97 10.75 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.634 0.774 . . . . 75.0 110.287 -162.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.3 p -98.24 113.56 25.53 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.679 -0.691 . . . . 73.22 109.846 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -78.17 -32.61 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.802 -0.444 . . . . 74.45 109.802 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.0 t70 -149.02 147.63 28.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.999 -0.546 . . . . 73.42 109.735 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.423 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.8 mt -140.72 144.13 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.198 1.399 . . . . 73.41 107.803 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -157.4 120.9 4.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.77 0.319 . . . . 73.04 110.915 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.8 t80 -118.41 134.3 55.17 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.126 -1.435 . . . . 73.31 107.126 171.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -129.55 140.8 51.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.216 -1.031 . . . . 72.23 108.216 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.16 84.29 16.91 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.55 -0.907 . . . . 70.4 108.55 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.23 -49.64 1.85 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.986 2.457 . . . . 73.42 112.199 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 44.4 m-80 -103.28 43.92 1.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.605 0.762 . . . . 70.42 109.445 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.48 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -59.42 -51.95 77.71 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.125 0.97 . . . . 73.44 113.205 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -22.66 14.73 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.867 1.711 . . . . 73.43 111.939 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 7.5 t60 -83.04 -25.35 32.21 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.948 1.299 . . . . 74.21 111.992 -168.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.99 -26.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.915 0.886 . . . . 73.32 112.553 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.407 ' HD2' ' HZ2' ' A' ' 36' ' ' TRP . 70.2 m-85 -70.3 -34.73 73.09 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.621 0.768 . . . . 75.14 112.169 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -63.36 -36.32 83.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.199 0.999 . . . . 70.11 110.177 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.84 154.79 23.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.549 -1.205 . . . . 74.32 110.756 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.0 118.49 16.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.008 -0.738 . . . . 74.24 109.008 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.407 ' HZ2' ' HD2' ' A' ' 32' ' ' PHE . 5.5 m0 -60.47 86.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 74.22 112.298 -174.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -128.26 75.04 79.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.074 0.95 . . . . 75.01 108.579 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.16 139.88 7.36 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.589 2.193 . . . . 71.35 112.279 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.571 ' HB2' ' HZ1' ' A' ' 41' ' ' LYS . 31.4 mt-10 -95.82 106.77 18.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.708 -1.59 . . . . 74.42 106.708 175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' F' ' 128' ' ' LYS . 47.4 t -85.15 92.07 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 123.651 0.594 . . . . 74.01 109.537 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' A' ' 39' ' ' GLU . 10.7 mptt -75.82 133.03 40.74 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.944 -0.761 . . . . 74.32 108.944 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.431 HD13 ' HD2' ' F' ' 125' ' ' TYR . 2.2 tm? -121.56 115.79 23.45 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.466 -1.309 . . . . 74.22 107.466 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.66 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.5 m-20 -122.14 135.76 54.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.02 0.928 . . . . 73.41 108.707 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.0 mt -121.72 134.06 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.692 0.797 . . . . 72.22 109.11 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 33.8 t70 -142.17 144.66 33.53 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.896 0.478 . . . . 53.23 110.039 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -139.11 130.59 27.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.77 0.828 . . . . 74.14 110.73 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.45 149.27 42.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.958 0.903 . . . . 71.51 109.754 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.6 p -106.28 164.17 12.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.577 0.751 . . . . 74.54 109.628 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -153.97 131.16 11.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.056 0.942 . . . . 75.33 108.476 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -88.73 122.35 32.05 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.023 0.529 . . . . 74.13 110.563 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.2 mt -91.5 -44.71 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.164 -0.925 . . . . 53.52 109.106 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.18 176.82 10.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.626 -1.17 . . . . 73.12 109.532 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.617 ' H ' ' HB1' ' F' ' 110' ' ' ALA . 9.6 t70 -71.84 114.62 10.12 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.919 -1.141 . . . . 71.22 107.919 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 75.23 3.52 4.06 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.314 1.446 . . . . 75.35 112.908 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.1 t -112.79 111.97 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 108.649 -0.871 . . . . 65.31 108.649 173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -125.21 156.01 39.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.433 0.693 . . . . 75.34 110.054 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -131.5 117.78 19.26 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.155 0.982 . . . . 74.42 108.743 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.98 128.63 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.167 -1.049 . . . . 72.23 108.167 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -109.03 134.23 51.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.636 0.775 . . . . 73.44 109.197 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.15 118.75 37.57 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.447 -1.316 . . . . 74.54 107.447 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.537 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.26 101.75 13.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.166 -1.05 . . . . 75.22 108.166 171.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.409 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.3 t -95.32 132.77 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.78 -1.193 . . . . 72.1 107.78 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.66 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.0 m -118.24 133.12 56.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.844 -0.799 . . . . 73.2 108.844 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -132.52 105.07 8.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.798 -1.556 . . . . 74.15 106.798 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.8 m -113.21 129.45 56.51 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.929 -0.767 . . . . 74.23 108.929 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.89 105.42 11.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.742 -1.207 . . . . 73.2 107.742 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 23.9 m -121.66 127.82 51.22 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.674 -0.491 . . . . 72.11 109.674 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt -89.17 81.98 6.65 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.917 -1.512 . . . . 72.31 106.917 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -119.17 5.14 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.419 -0.81 . . . . 42.2 112.245 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.81 -14.66 41.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.776 0.83 . . . . 73.25 111.3 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.3 132.56 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.661 1.184 . . . . 72.13 109.336 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -83.83 131.37 34.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.856 0.36 . . . . 75.5 110.717 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.91 -54.11 5.34 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.883 0.873 . . . . 74.45 109.008 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -159.79 174.13 14.95 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.539 -0.755 . . . . 72.34 111.533 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 tp -141.18 148.4 39.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.571 1.548 . . . . 73.44 108.058 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.547 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 60.2 m -136.86 133.44 35.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.432 -0.951 . . . . 73.13 108.432 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.96 124.8 11.91 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.14 -0.689 . . . . 74.32 109.14 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.93 117.12 25.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 123.581 0.753 . . . . 74.44 109.45 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.543 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -84.79 85.1 7.49 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.309 -0.997 . . . . 73.21 108.309 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.21 92.44 6.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.774 -1.195 . . . . 71.41 107.774 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -103.66 143.67 15.78 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.762 -0.935 . . . . 72.31 110.762 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.51 141.82 11.44 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.308 -0.717 . . . . 74.12 111.308 -174.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.4 mt -88.37 120.76 37.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.981 -0.748 . . . . 74.41 108.981 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.88 118.1 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.45 1.1 . . . . 73.31 108.086 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -83.74 115.32 22.15 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.262 -1.014 . . . . 74.32 108.262 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.448 HG22 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -133.71 135.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.22 0.608 . . . . 62.23 109.38 -173.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 172.33 15.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.796 1.239 . . . . 71.52 109.669 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.34 -36.84 3.8 Favored Glycine 0 N--CA 1.465 0.613 0 CA-C-N 115.575 -0.738 . . . . 64.24 112.673 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.8 147.42 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.367 0.667 . . . . 71.1 110.374 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.534 ' HG3' HD13 ' F' ' 115' ' ' LEU . 21.7 tt0 -135.98 -176.33 4.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.133 0.973 . . . . 74.44 108.951 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.513 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.49 -137.15 28.74 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.94 -0.367 . . . . 74.12 112.88 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -65.6 -20.79 66.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.917 0.887 . . . . 71.1 111.723 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.69 -53.33 22.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.012 0.925 . . . . 62.14 110.626 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -29.19 62.23 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 116.347 -0.388 . . . . 74.3 110.343 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.72 96.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.359 0.664 . . . . 64.15 109.862 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.474 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 8.3 t-80 -62.48 -39.01 92.08 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.328 -1.305 . . . . 74.11 110.741 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.626 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 7.1 m -78.35 -61.96 1.84 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.047 0.758 . . . . 62.35 113.047 -175.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.448 HD21 HG22 ' A' ' 86' ' ' ILE . 95.0 mt -67.74 -22.7 65.22 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 75.03 112.471 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.06 -10.84 44.59 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.407 -0.663 . . . . 64.43 114.364 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.479 ' HB2' ' CE2' ' A' ' 137' ' ' PHE . . . -149.01 -52.6 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.979 1.474 . . . . 75.23 114.979 -169.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.626 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.4 t80 -55.24 -59.74 4.36 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.077 0.951 . . . . 73.31 110.25 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -67.88 -45.65 43.14 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 114.334 -1.303 . . . . 72.01 112.747 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.44 -42.2 41.97 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.661 2.241 . . . . 74.04 114.54 168.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -71.73 -30.75 65.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.794 0.438 . . . . 73.43 110.493 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.8 mm -70.54 -34.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 72.4 110.278 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.682 HD23 HG22 ' A' ' 16' ' ' ILE . 84.0 mt -73.29 -28.77 62.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.907 0.883 . . . . 74.15 111.305 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.81 -44.87 87.14 Favored Pre-proline 0 CA--C 1.568 1.647 0 N-CA-C 115.144 1.535 . . . . 74.14 115.144 -167.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.51 -31.31 80.36 Favored 'Trans proline' 0 C--N 1.387 2.589 0 CA-C-N 122.028 1.76 . . . . 72.21 113.257 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.82 -34.29 39.63 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.245 0.618 . . . . 73.4 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.82 77.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.55 -0.537 . . . . 71.11 109.55 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.51 HH12 HD13 ' C' ' 105' ' ' ILE . 38.4 ttm180 -52.6 -49.84 64.23 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.922 1.389 . . . . 75.34 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.36 -48.02 81.61 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.046 0.841 . . . . 75.3 111.196 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -60.39 -36.02 77.1 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.797 0.686 . . . . 73.24 111.491 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.481 HG21 HG22 ' A' ' 64' ' ' VAL . 87.4 mt -67.08 -58.68 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.678 0.791 . . . . 74.11 109.945 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 125' ' ' GLN . 69.0 m -56.09 -31.76 63.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.736 1.214 . . . . 71.03 111.438 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.2 -47.42 67.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.111 -0.95 . . . . 54.43 110.163 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -62.36 -38.24 88.79 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 122.696 0.399 . . . . 73.42 111.221 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.0 t -60.2 -49.56 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 O-C-N 123.968 0.792 . . . . 71.54 109.787 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -26.93 62.36 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.733 -0.667 . . . . 73.33 111.478 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.21 -31.09 65.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.385 0.674 . . . . 75.15 109.559 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 5.52 80.37 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.852 -0.613 . . . . 71.32 112.888 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.415 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 4.3 t 58.26 21.82 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.253 2.221 . . . . 73.22 113.902 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.2 148.11 44.11 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.982 -0.748 . . . . 75.24 108.982 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.45 128.17 26.81 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.026 2.484 . . . . 63.3 112.084 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -58.16 146.05 34.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.475 0.71 . . . . 71.34 111.532 -168.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.19 97.97 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.226 0.61 . . . . 73.44 109.376 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.19 108.05 20.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 55.12 108.532 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -74.4 148.58 41.07 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.745 0.818 . . . . 72.5 110.954 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.68 129.91 90.87 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.141 0.576 . . . . 54.11 110.427 -177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.441 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 11.9 Cg_exo -67.89 108.72 1.75 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.027 . . . . 75.43 111.549 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.7 t -99.7 111.11 28.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.092 . . . . 72.43 108.053 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -82.17 86.25 6.66 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.995 0.902 . . . . 52.32 109.379 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -59.95 -32.36 70.74 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.511 -1.222 . . . . 71.43 110.656 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.446 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.4 p-10 -65.7 -30.69 71.41 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.189 0.996 . . . . 72.13 111.577 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.8 73.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.933 -0.576 . . . . 64.35 110.647 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.92 -42.16 93.32 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.028 0.931 . . . . 74.35 112.391 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 25.7 m-85 -59.87 -47.16 86.87 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.663 0.385 . . . . 74.31 110.834 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.5 ' HB3' ' HG3' ' A' ' 144' ' ' GLN . 85.0 mmm -73.58 -28.46 61.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.324 0.65 . . . . 71.34 111.165 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -69.61 -35.29 75.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.213 1.405 . . . . 75.31 110.459 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -85.32 -31.31 23.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.649 -0.705 . . . . 74.21 110.441 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 tp -67.34 -48.69 66.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.663 0.785 . . . . 73.11 111.495 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -159.01 17.56 0.18 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 116.497 -0.32 . . . . 65.44 110.793 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 55.12 70.17 0.66 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.98 0.912 . . . . 72.13 111.22 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.5 ' HG3' ' HB3' ' A' ' 138' ' ' MET . 4.5 pt20 -154.35 178.85 9.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.484 -0.78 . . . . 74.15 110.491 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.66 163.84 31.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.799 0.84 . . . . 75.4 109.529 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.4 51.38 4.55 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 112.618 -0.193 . . . . 75.44 112.618 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.73 127.7 53.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.005 -1.109 . . . . 63.13 108.005 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.76 155.17 7.07 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.439 -0.645 . . . . 75.54 111.586 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m 59.88 109.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.105 1.362 . . . . 73.32 113.292 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.75 169.09 11.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.184 0.594 . . . . 73.35 109.76 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.404 ' H ' ' HD1' ' C' ' 137' ' ' PHE . 42.5 mt-10 65.03 -172.3 0.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.925 1.29 . . . . 55.24 112.575 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -158.02 119.14 3.5 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.746 -0.835 . . . . 74.24 108.746 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 133.02 54.33 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.983 -0.747 . . . . 73.11 108.983 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.87 107.7 0.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.092 0.957 . . . . 72.12 111.36 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.251 0 C-N-CA 124.278 1.031 . . . . 72.34 108.804 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.64 0.257 . . . . 74.05 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m -139.02 155.33 48.05 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.432 0.693 . . . . 73.52 109.637 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.31 16.04 2.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.866 0.866 . . . . 72.03 111.252 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -72.68 -18.14 61.58 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.589 1.156 . . . . 75.14 110.506 170.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.3 m120 71.54 -76.95 0.06 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.374 1.47 . . . . 74.1 111.629 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -68.07 137.41 54.98 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.91 0.884 . . . . 74.35 110.808 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.665 ' HB ' HD11 ' B' ' 89' ' ' ILE . 89.3 m -146.41 129.74 16.72 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.922 -1.14 . . . . 73.45 107.922 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -68.88 -35.51 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.3 1.04 . . . . 72.55 110.764 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.499 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 6.7 ptt? 51.91 -163.21 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.591 1.556 . . . . 64.31 113.299 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.2 t -156.11 131.78 9.65 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 107.849 -1.167 . . . . 71.12 107.849 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' B' ' 85' ' ' SER . 69.3 t80 -131.71 146.36 52.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.926 0.891 . . . . 73.44 109.494 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.706 ' HB2' ' HA ' ' F' ' 146' ' ' ASP . 20.1 tt0 -159.37 142.85 14.63 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.638 0.375 . . . . 73.44 110.756 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.422 HD12 HD13 ' B' ' 105' ' ' ILE . 54.3 mt -89.53 123.3 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.284 -1.006 . . . . 73.51 108.284 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.1 -35.7 16.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.748 0.419 . . . . 73.11 109.935 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.415 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 62.1 ttt180 -163.77 146.65 9.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.49 0.316 . . . . 74.32 110.589 -171.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.47 139.77 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.807 -1.553 . . . . 71.33 106.807 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.442 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 15.0 p90 -173.03 168.34 4.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.038 0.923 . . . . 74.21 112.642 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 66.9 m -90.38 129.27 36.6 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.32 -1.309 . . . . 73.43 108.89 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.442 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 48.6 mtpt -98.17 -40.1 8.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.399 0.68 . . . . 73.22 110.573 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.62 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.2 t70 -146.8 135.11 21.78 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.589 -0.732 . . . . 72.24 109.896 -163.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.482 HG22 ' HE2' ' B' ' 117' ' ' MET . 45.7 mm -136.3 140.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.713 1.205 . . . . 74.35 109.382 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -140.29 131.41 26.38 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.138 -1.43 . . . . 74.33 107.138 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.423 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -147.03 119.03 8.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.172 -1.418 . . . . 74.12 107.172 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.99 129.94 55.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.495 -0.928 . . . . 74.44 108.495 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.84 81.2 66.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.93 -27.73 20.51 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.649 2.233 . . . . 72.41 111.764 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.91 29.47 7.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.136 0.974 . . . . 74.41 109.839 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.57 -50.61 65.16 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.595 1.158 . . . . 74.21 113.179 174.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.69 -12.67 6.25 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 122.055 1.837 . . . . 71.33 113.277 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.411 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.7 m-70 -93.7 3.82 54.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.883 0.873 . . . . 73.52 110.116 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.21 -14.37 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 123.751 0.82 . . . . 72.32 111.442 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -64.65 -30.9 71.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.494 0.718 . . . . 73.42 112.503 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.574 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.5 pt20 -85.19 -33.29 22.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.597 0.359 . . . . 74.32 110.104 171.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.587 ' HD3' ' HB3' ' B' ' 68' ' ' LEU . 95.8 mttt -109.48 66.49 0.63 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 74.43 111.984 -175.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.52 85.57 4.96 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 108.62 -0.881 . . . . 72.14 108.62 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -156.47 169.91 23.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.04 -0.726 . . . . 75.02 109.04 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.1 113.98 23.59 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.644 0.778 . . . . 75.35 110.609 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.62 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 2.8 Cg_exo -73.46 144.19 35.9 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.339 2.026 . . . . 74.33 111.9 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.01 103.2 1.78 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.466 -0.788 . . . . 74.53 109.204 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.41 135.75 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.241 -0.891 . . . . 71.22 110.782 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.622 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 97.1 mttt -132.12 101.21 5.31 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.357 1.063 . . . . 74.53 108.376 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.62 144.96 28.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.279 0.632 . . . . 75.13 109.828 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -148.25 139.21 23.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.757 -0.831 . . . . 75.44 108.757 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.403 HD11 HD22 ' B' ' 60' ' ' LEU . 3.7 mm? -111.31 133.17 53.83 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.965 0.906 . . . . 73.23 108.697 -173.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.7 t70 -127.91 135.74 50.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 55.21 108.952 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -109.97 114.08 27.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.683 0.793 . . . . 75.14 110.324 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.539 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -117.2 151.68 36.39 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.118 0.967 . . . . 75.33 109.336 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -145.08 168.82 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.797 0.439 . . . . 74.41 111.157 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.0 p -153.75 154.49 34.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 74.44 108.92 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.96 103.27 13.37 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.179 -0.674 . . . . 73.12 109.179 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' B' ' 57' ' ' GLU . 67.4 mt -77.88 -34.16 51.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.19 -0.913 . . . . 75.33 110.631 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.94 -170.64 2.01 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.805 0.842 . . . . 65.14 110.256 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.58 108.79 2.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.746 -1.116 . . . . 63.14 109.39 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 72.31 2.58 4.38 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.376 1.47 . . . . 71.2 112.863 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.87 93.4 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.651 -1.24 . . . . 61.44 107.651 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -107.26 138.38 43.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.993 -1.003 . . . . 75.11 109.392 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.445 ' HB2' HD13 ' B' ' 51' ' ' LEU . 23.2 tt0 -98.87 127.43 44.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.537 -1.282 . . . . 71.42 107.537 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.27 122.05 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 108.06 -1.089 . . . . 75.21 108.06 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.539 ' HB ' ' HB1' ' B' ' 47' ' ' ALA . 45.5 t -102.91 114.07 41.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.256 -1.016 . . . . 73.52 108.256 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.403 HD22 HD11 ' B' ' 44' ' ' LEU . 1.8 tt -91.24 127.12 36.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.75 -1.574 . . . . 72.22 106.75 175.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.3 ttt180 -119.0 120.77 38.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.613 -0.884 . . . . 73.12 108.613 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.545 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.2 t -112.85 112.94 42.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.966 -1.124 . . . . 64.01 107.966 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 43.0 m -93.96 135.88 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.273 -1.01 . . . . 74.03 108.273 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.442 HG22 HG21 ' B' ' 114' ' ' ILE . 82.6 t -130.31 130.95 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.027 0.931 . . . . 73.11 109.15 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.8 m -125.1 148.23 48.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.006 -1.109 . . . . 74.01 108.006 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.62 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -148.09 132.74 17.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.053 -1.091 . . . . 72.23 108.053 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.421 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 14.0 m -139.87 137.11 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.372 0.269 . . . . 71.03 110.579 -172.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.587 ' HB3' ' HD3' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -117.39 113.16 21.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.871 -1.159 . . . . 74.53 107.871 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.14 -129.59 18.04 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.624 0.578 . . . . 71.42 112.89 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -92.86 19.46 7.64 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 74.13 111.267 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.416 ' HB3' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 tp10 -147.96 159.3 44.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.588 0.355 . . . . 72.45 111.12 -171.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.7 m -71.23 137.48 48.69 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.477 0.711 . . . . 75.41 109.752 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.42 -56.63 3.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.078 -1.082 . . . . 64.1 108.078 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.49 171.32 17.25 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.731 -1.122 . . . . 74.14 110.674 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -141.1 146.17 36.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.609 1.564 . . . . 73.32 107.308 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.41 154.73 35.02 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.395 -0.595 . . . . 71.41 109.395 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.09 133.53 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.231 -0.655 . . . . 71.42 109.231 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.425 HG21 HD12 ' B' ' 21' ' ' ILE . 92.1 t -126.77 144.98 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.624 0.769 . . . . 72.2 109.138 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.62 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.0 mt-30 -123.15 94.8 4.37 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.816 -0.809 . . . . 74.32 108.816 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.81 98.82 9.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.926 -1.034 . . . . 72.05 109.106 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.422 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 143.85 17.6 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.83 -0.908 . . . . 70.14 110.83 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.64 130.66 3.86 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.259 -0.736 . . . . 74.04 111.259 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.57 126.24 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.88 -0.785 . . . . 74.52 108.88 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.65 162.08 33.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.471 1.109 . . . . 71.11 109.125 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.8 m -131.51 112.97 13.12 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.493 0.717 . . . . 64.24 109.735 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.427 HD12 ' N ' ' B' ' 86' ' ' ILE . 1.1 mp -125.29 114.9 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.119 -1.067 . . . . 73.33 108.119 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.22 147.15 45.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.281 0.632 . . . . 52.03 110.793 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.23 -40.15 2.53 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.818 0.699 . . . . 65.11 113.133 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.672 HD13 ' HB2' ' B' ' 93' ' ' GLN . 5.7 tp -91.01 148.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.049 0.54 . . . . 74.22 111.037 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.466 ' H ' HD12 ' B' ' 89' ' ' ILE . 10.2 pt-20 -156.47 164.14 38.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.616 0.766 . . . . 71.41 111.319 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.97 -137.57 18.79 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 114.908 -1.042 . . . . 52.14 113.435 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 43.4 m -65.63 -40.35 92.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.089 0.956 . . . . 65.14 111.921 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.672 ' HB2' HD13 ' B' ' 89' ' ' ILE . 2.3 mp0 -66.0 -36.85 84.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 74.31 111.054 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.417 ' HB2' HG13 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -75.34 -25.21 57.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.206 0.602 . . . . 65.31 110.66 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' E' ' 117' ' ' PRO . . . -61.41 -21.93 64.54 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.47 0.708 . . . . 63.34 111.907 173.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -86.47 -20.31 28.29 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.232 0.613 . . . . 74.14 111.231 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.401 ' HG ' HG12 ' B' ' 86' ' ' ILE . 41.9 t -70.84 -62.6 1.33 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.431 0.292 . . . . 73.11 110.4 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.68 -16.43 41.86 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.093 -0.379 . . . . 70.42 111.532 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.32 -37.4 17.99 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 123.471 0.482 . . . . 61.21 112.669 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.42 -50.54 1.76 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.704 0.631 . . . . 74.32 112.704 -170.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -69.44 -54.57 13.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.259 0.624 . . . . 65.43 111.602 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 81.4 m -63.33 -46.83 85.13 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.54 -0.743 . . . . 73.04 112.015 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -54.95 -38.25 93.12 Favored 'Trans proline' 0 C--N 1.391 2.782 0 C-N-CA 121.94 1.76 . . . . 64.44 113.901 170.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.73 -32.87 74.5 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.015 0.435 . . . . 75.32 111.083 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.422 HD13 HD12 ' B' ' 13' ' ' ILE . 94.8 mt -67.84 -44.25 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.262 1.025 . . . . 75.12 110.684 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.34 -26.1 46.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.022 0.929 . . . . 74.14 112.199 -172.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.407 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 49.3 t80 -59.43 -45.13 98.93 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.707 1.203 . . . . 74.53 113.986 -169.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.54 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 18.7 Cg_endo -58.23 -37.24 96.2 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.328 2.018 . . . . 73.31 113.984 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -70.36 -45.3 66.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.91 0.484 . . . . 74.43 110.368 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.84 -42.51 89.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.33 -0.85 . . . . 62.34 110.367 175.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.54 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 21.6 mtp-105 -52.21 -63.42 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.302 1.041 . . . . 74.31 111.391 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.44 -29.69 67.96 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.197 0.936 . . . . 64.31 110.639 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.496 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.8 t -70.81 -48.6 53.22 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.104 0.561 . . . . 71.53 111.086 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.545 HD11 ' HB ' ' B' ' 62' ' ' VAL . 48.2 mt -62.07 -51.86 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 123.417 0.687 . . . . 74.21 110.059 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -34.52 72.48 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.585 -1.189 . . . . 74.13 110.875 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.1 t -67.39 -50.2 60.65 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.534 -0.757 . . . . 65.13 110.392 175.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -63.48 -38.04 89.63 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.884 0.473 . . . . 75.2 111.421 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.99 -43.16 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.014 0.925 . . . . 72.52 110.767 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -62.68 -36.77 83.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.925 0.89 . . . . 63.42 111.055 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.421 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 93.6 mtt-85 -68.74 -20.62 64.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.138 -0.937 . . . . 75.4 111.472 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.07 16.63 59.87 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 119.482 -0.621 . . . . 75.35 114.209 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p 72.65 13.0 5.34 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 126.528 1.931 . . . . 74.31 112.836 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -97.94 152.83 38.27 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 122.641 0.376 . . . . 71.34 110.922 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.34 144.14 98.29 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.227 2.618 . . . . 71.33 112.001 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.721 ' HB3' HE21 ' C' ' 125' ' ' GLN . 4.9 pp0? -61.41 129.24 40.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.527 0.731 . . . . 74.51 111.715 -172.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.19 86.86 2.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.694 -0.854 . . . . 75.1 108.694 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -90.64 118.4 30.06 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.672 -1.233 . . . . 70.31 107.672 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.526 ' HB2' ' HG2' ' B' ' 111' ' ' ARG . 2.4 mm? -77.47 128.34 34.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.277 -0.638 . . . . 75.53 109.277 -173.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.37 136.51 93.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.37 0.668 . . . . 60.12 110.626 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.614 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 19.0 Cg_endo -60.5 89.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.135 2.557 . . . . 73.31 112.796 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.55 118.95 39.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.721 -0.844 . . . . 74.33 108.721 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.67 114.59 7.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.564 0.745 . . . . 73.43 110.419 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.556 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 53.3 m-85 -64.75 -29.18 70.15 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.826 0.85 . . . . 73.52 110.268 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -66.64 -40.92 88.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.946 0.898 . . . . 72.41 110.807 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.07 68.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.453 0.701 . . . . 74.22 110.948 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' E' ' 123' ' ' VAL . 4.0 tt -60.05 -43.82 95.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.032 0.933 . . . . 75.34 109.314 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -63.84 -39.03 93.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.535 0.734 . . . . 74.34 111.233 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 24.5 mmt -65.91 -35.9 81.89 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.75 0.42 . . . . 73.12 110.181 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.67 -23.93 49.51 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.253 1.021 . . . . 73.51 110.805 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -71.65 -30.32 65.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.194 0.998 . . . . 74.14 109.618 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.53 21.32 5.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.148 0.979 . . . . 73.24 110.423 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 68.65 -74.25 0.08 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.215 1.406 . . . . 74.41 109.815 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -166.18 147.06 6.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.084 0.953 . . . . 74.31 108.786 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -146.8 136.78 23.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.186 0.594 . . . . 73.23 109.92 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.07 126.24 34.63 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.372 -0.974 . . . . 73.24 108.372 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.86 86.69 1.51 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.768 -0.533 . . . . 63.45 111.768 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.44 132.65 48.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.041 0.536 . . . . 74.13 110.901 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.52 -179.44 32.31 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.414 -0.357 . . . . 64.33 112.694 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.7 t -139.3 -171.45 3.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.497 1.119 . . . . 75.41 108.258 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.31 142.61 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.533 0.606 . . . . 74.41 111.326 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.34 -50.11 6.15 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.885 -1.154 . . . . 73.33 107.885 164.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 3.4 t60 61.71 35.69 16.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.94 1.296 . . . . 75.01 110.577 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.83 115.37 4.3 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.762 0.825 . . . . 72.23 109.878 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -75.86 164.24 26.41 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.218 0.607 . . . . 61.21 111.451 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 CA-C-N 115.476 -0.783 . . . . 74.32 110.259 178.63 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 119.594 -0.241 . . . . 75.33 111.005 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 60.14 46.72 10.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.624 0.726 . . . . 75.21 110.2 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.5 130.33 35.01 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.774 -1.103 . . . . 64.12 110.047 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 65.22 94.46 0.06 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.67 1.588 . . . . 71.2 111.837 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -157.57 74.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.644 -1.613 . . . . 75.51 106.644 164.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.431 ' N ' HD21 ' C' ' 6' ' ' ASN . 0.0 OUTLIER -167.64 18.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.631 -1.168 . . . . 73.42 111.052 -173.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -92.02 100.44 13.09 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.876 -0.416 . . . . 65.13 109.876 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -73.31 173.33 9.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.476 0.711 . . . . 72.21 109.632 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.678 ' HG2' ' HB ' ' C' ' 89' ' ' ILE . 69.0 mtp 65.38 119.77 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.553 1.141 . . . . 63.01 111.518 -174.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.699 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 49.4 m -84.43 85.91 7.34 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.447 -1.316 . . . . 73.45 107.447 173.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.441 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 80.9 t80 -106.16 126.25 51.98 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.435 -1.257 . . . . 72.32 109.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -145.8 139.78 26.65 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.018 -0.734 . . . . 62.31 109.018 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.39 106.45 3.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.209 -1.034 . . . . 73.4 108.209 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.554 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.8 mm-40 -77.29 -48.83 16.42 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 123.254 0.346 . . . . 74.51 110.343 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -166.87 149.29 6.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.526 -0.761 . . . . 74.45 109.438 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.2 mt -133.89 132.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 107.633 -1.247 . . . . 73.53 107.633 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -171.11 165.28 7.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.033 0.921 . . . . 75.11 112.849 -173.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -88.04 104.01 16.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.296 -1.32 . . . . 75.14 109.072 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 7.0 mtmt -71.1 -23.71 62.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.884 0.374 . . . . 74.53 110.201 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.602 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.5 t70 -158.25 140.7 14.38 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.603 -0.726 . . . . 73.13 109.319 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.434 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.1 mt -134.69 144.16 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.212 -1.403 . . . . 74.1 107.212 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -149.57 150.12 31.74 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.345 0.658 . . . . 71.01 109.276 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -155.69 118.75 4.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.256 -1.016 . . . . 75.32 108.256 175.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.95 121.39 40.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.398 -0.964 . . . . 65.05 108.398 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.89 85.76 29.27 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.043 -1.095 . . . . 75.43 108.043 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.94 -37.81 10.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.59 2.193 . . . . 74.32 111.857 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.64 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 1.9 m-20 -107.69 39.8 1.85 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.91 -0.774 . . . . 72.22 108.91 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -51.65 -49.54 82.41 Favored Pre-proline 0 CA--C 1.563 1.448 0 N-CA-C 114.271 1.212 . . . . 72.42 114.271 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.474 ' HA ' HH12 ' D' ' 15' ' ' ARG . 37.2 Cg_endo -86.99 -22.2 1.87 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 121.523 1.482 . . . . 62.45 112.831 173.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.64 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 25.1 t-80 -69.51 -23.49 63.62 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.119 0.968 . . . . 75.45 111.547 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.435 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 7.1 p -60.55 -23.4 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.85 0.86 . . . . 74.52 112.25 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.435 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 82.2 t80 -59.14 -41.18 87.68 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.147 0.979 . . . . 72.32 111.847 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -86.96 6.0 34.34 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.62 0.6 . . . . 73.51 112.62 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.435 ' HZ2' ' HA ' ' C' ' 31' ' ' VAL . 16.1 pttm -123.42 178.28 5.23 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.255 0.55 . . . . 74.11 110.736 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.62 133.97 33.72 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.484 -1.235 . . . . 73.25 110.003 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.477 ' HB3' ' HG3' ' C' ' 124' ' ' PRO . 20.4 m-90 -85.38 64.72 8.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.752 0.821 . . . . 74.12 111.041 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -144.37 62.98 10.59 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.466 1.107 . . . . 74.34 108.737 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.53 174.99 9.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.226 1.951 . . . . 74.03 110.847 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' E' ' 141' ' ' LEU . 43.1 tt0 -85.36 115.83 23.33 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.901 -0.778 . . . . 74.12 108.901 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.4 ' H ' HD21 ' E' ' 141' ' ' LEU . 88.6 t -75.13 101.18 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.564 -0.902 . . . . 74.21 108.564 173.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.81 98.47 11.62 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.552 -1.647 . . . . 73.41 106.552 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -89.38 162.36 15.83 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.42 0.288 . . . . 74.51 110.506 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -159.62 108.47 1.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.272 0.629 . . . . 65.43 109.575 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -107.57 141.15 39.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.104 0.961 . . . . 63.24 108.804 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.28 153.73 35.4 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.921 0.888 . . . . 73.54 108.69 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -131.76 133.84 45.21 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.405 -0.591 . . . . 73.23 109.405 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.524 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -113.24 172.25 7.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.536 1.135 . . . . 61.22 109.261 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.1 p -151.24 146.62 26.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.323 0.649 . . . . 75.22 109.971 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.54 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 10.1 m -144.14 149.07 35.91 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.577 -1.268 . . . . 73.2 107.577 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.13 114.55 28.75 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.649 -1.241 . . . . 74.34 107.649 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' C' ' 57' ' ' GLU . 24.9 mt -93.03 -36.89 12.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.394 0.678 . . . . 75.4 109.846 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.484 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -157.09 -175.64 5.53 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.922 -1.035 . . . . 74.21 110.039 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.24 108.5 1.09 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.399 -1.273 . . . . 72.54 110.016 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 70.6 -2.38 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.694 1.597 . . . . 75.41 113.106 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.484 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 97.0 t -98.61 102.81 13.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.412 -0.959 . . . . 74.12 108.412 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -110.19 160.21 16.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.539 0.736 . . . . 70.22 109.352 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.649 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.3 tt0 -120.51 127.27 52.04 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.142 0.977 . . . . 74.53 108.72 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.87 127.39 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.491 -1.3 . . . . 75.32 107.491 170.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 27.0 t -112.79 101.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.287 -1.005 . . . . 61.43 108.287 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.64 95.07 9.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.829 -1.174 . . . . 75.32 107.829 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -88.29 112.5 22.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.509 -1.223 . . . . 74.14 108.827 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.462 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.7 t -107.44 139.89 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.586 -0.894 . . . . 71.44 108.586 174.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -131.44 133.94 45.7 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.626 -0.879 . . . . 74.32 108.626 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.34 111.5 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.692 1.197 . . . . 74.11 108.6 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.53 HG21 HD23 ' C' ' 75' ' ' LEU . 2.4 m -99.06 146.57 25.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.835 -1.172 . . . . 72.11 107.835 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.86 107.99 7.22 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.945 -1.502 . . . . 63.24 106.945 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.426 ' HB3' HG23 ' C' ' 72' ' ' THR . 11.8 p -162.43 144.13 10.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.475 0.484 . . . . 65.1 110.577 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.9 tp -118.72 85.82 2.43 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.809 -1.182 . . . . 75.15 107.809 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -107.88 2.35 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 114.698 -1.137 . . . . 42.1 111.525 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.55 -32.89 17.94 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.708 -0.478 . . . . 71.22 109.708 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -75.12 84.17 2.34 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.605 0.762 . . . . 73.23 110.089 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.426 HG23 ' HB3' ' C' ' 67' ' ' SER . 61.4 m -81.89 126.29 31.72 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.053 -0.976 . . . . 73.13 110.145 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.94 -61.04 2.11 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.649 -0.871 . . . . 75.31 108.649 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -158.33 178.02 10.62 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.876 0.846 . . . . 71.01 112.259 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.53 HD23 HG21 ' C' ' 65' ' ' THR . 3.0 tm? -141.62 146.2 35.93 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.575 -2.009 . . . . 74.12 105.575 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.4 t -150.55 148.2 28.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.258 -1.016 . . . . 71.52 108.258 176.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.16 134.54 10.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.781 -0.452 . . . . 72.53 109.781 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -133.17 116.63 26.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 123.815 0.846 . . . . 72.44 108.921 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.602 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.6 mt-30 -87.8 86.17 7.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.342 -1.355 . . . . 74.41 107.342 169.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -79.48 96.1 5.99 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.936 -1.029 . . . . 73.51 108.832 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -88.48 144.35 18.35 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.244 -0.742 . . . . 72.32 111.244 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.492 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.18 119.93 1.3 Allowed Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 110.259 -1.136 . . . . 71.14 110.259 -175.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 7.4 mm -82.58 123.76 38.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.206 -1.035 . . . . 75.22 108.206 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.49 120.94 24.91 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.887 0.875 . . . . 73.1 108.829 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 22.0 p -77.93 109.81 12.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.987 -1.116 . . . . 75.14 107.987 170.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.422 HG23 ' HD1' ' C' ' 11' ' ' PHE . 27.2 pt -118.51 113.22 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.4 0.619 . . . . 74.23 109.352 173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.699 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -123.83 156.23 36.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.823 0.849 . . . . 72.33 109.762 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.34 -35.8 3.52 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.572 0.545 . . . . 74.52 113.382 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.678 ' HB ' ' HG2' ' C' ' 9' ' ' MET . 19.3 tt -88.4 145.97 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.075 0.55 . . . . 74.03 110.667 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.78 -177.56 5.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.003 0.921 . . . . 73.52 110.403 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 60.67 -147.07 46.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.649 -0.705 . . . . 73.43 114.626 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -69.86 -19.18 63.45 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 74.13 111.863 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.12 -42.36 69.35 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.746 0.819 . . . . 75.2 110.566 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.448 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 25.9 ptt? -69.87 -28.57 65.76 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 110.223 -0.288 . . . . 74.11 110.223 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.29 90.26 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.75 0.656 . . . . 75.45 110.365 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -60.54 -39.38 87.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 75.31 110.783 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -63.21 -58.29 7.69 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.839 0.455 . . . . 74.13 110.952 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -77.12 -12.47 59.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.586 0.587 . . . . 74.3 112.586 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.9 9.79 21.13 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.341 -0.699 . . . . 63.24 114.739 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -53.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 117.764 0.782 . . . . 72.34 111.284 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.61 -59.84 2.55 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.368 0.667 . . . . 74.43 111.584 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 70.2 m -60.78 -44.89 96.47 Favored Pre-proline 0 CA--C 1.566 1.565 0 C-N-CA 124.465 1.106 . . . . 71.2 113.461 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.35 -20.86 48.16 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.005 1.803 . . . . 73.33 113.476 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -71.53 -30.63 66.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.994 0.517 . . . . 63.2 110.467 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.51 HD13 HH12 ' A' ' 111' ' ' ARG . 44.2 mm -68.2 -28.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 73.14 110.261 173.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.492 HD21 ' HA3' ' C' ' 82' ' ' GLY . 85.7 mt -86.47 -22.85 26.23 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.819 0.848 . . . . 74.41 112.182 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -53.77 -50.6 82.74 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.996 -1.002 . . . . 73.14 113.374 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.01 -36.5 96.57 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 122.022 1.815 . . . . 72.31 113.482 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.36 -44.44 62.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.139 0.576 . . . . 73.45 111.089 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -41.92 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.465 0.478 . . . . 64.52 109.887 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -60.28 -51.29 70.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.14 1.376 . . . . 73.42 111.142 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.409 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.2 tm-20 -70.81 -30.36 66.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.498 0.499 . . . . 64.42 110.291 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.0 t -69.86 -30.82 68.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.832 0.453 . . . . 74.34 111.178 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.462 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -77.3 -50.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.528 0.731 . . . . 70.3 109.949 175.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -62.98 -29.08 70.54 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.625 0.77 . . . . 74.14 111.228 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.8 t -64.91 -52.31 57.15 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.837 -0.801 . . . . 74.02 108.837 172.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.47 -38.71 78.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.435 1.094 . . . . 74.21 112.754 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.86 -50.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.274 0.629 . . . . 71.14 109.864 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.1 t -71.14 -22.23 62.09 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.179 -0.919 . . . . 63.23 111.392 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' C' ' 116' ' ' SER . 84.2 mtt-85 -71.9 -37.11 70.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.067 -0.716 . . . . 74.33 109.067 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.28 3.76 79.95 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.905 0.753 . . . . 72.32 113.131 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 71.4 p 57.5 40.74 26.86 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.8 1.64 . . . . 62.13 112.153 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -99.29 165.04 15.55 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.758 1.223 . . . . 75.45 110.838 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.477 ' HG3' ' HB3' ' C' ' 36' ' ' TRP . 22.5 Cg_endo -57.48 147.36 78.85 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.572 2.848 . . . . 70.44 113.927 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.721 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.6 mm-40 -58.51 111.94 1.42 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.555 1.142 . . . . 75.11 111.522 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.6 tp -122.15 97.28 5.4 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.408 0.683 . . . . 73.53 109.319 -174.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -101.35 115.9 31.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 74.22 108.709 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.13 134.56 50.74 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.956 -0.757 . . . . 74.54 108.956 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.35 132.35 95.32 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.077 0.551 . . . . 75.31 111.171 -177.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -71.37 90.19 0.69 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.974 2.449 . . . . 75.14 112.783 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' E' ' 147' ' ' LEU . 67.0 t -100.12 112.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.737 0.815 . . . . 74.32 109.792 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -97.75 95.38 7.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.352 0.661 . . . . 72.42 109.384 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -65.86 -30.43 71.04 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.516 0.726 . . . . 72.44 111.348 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.86 -47.24 69.5 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.279 0.562 . . . . 72.01 110.208 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.89 63.14 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 114.763 -1.108 . . . . 75.03 111.911 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.566 HD12 ' HD2' ' E' ' 149' ' ' PRO . 10.4 tt -50.04 -39.51 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 125.243 1.417 . . . . 71.34 112.67 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.404 ' HD1' ' H ' ' A' ' 151' ' ' GLU . 81.9 m-85 -72.19 -46.88 54.43 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.963 0.905 . . . . 74.24 111.226 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.84 -26.33 62.33 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.427 1.091 . . . . 70.41 112.284 -176.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.511 HD21 HD21 ' E' ' 148' ' ' LEU . 93.5 m-20 -67.63 -34.59 77.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 71.24 110.535 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -68.84 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 O-C-N 123.637 0.585 . . . . 74.51 110.949 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp 55.42 177.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.179 0.992 . . . . 75.04 112.702 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 59.72 121.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.863 1.665 . . . . 74.44 113.377 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -70.2 93.13 0.8 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.321 0.648 . . . . 75.24 109.484 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 64.16 108.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.025 1.33 . . . . 71.43 112.476 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.77 169.37 14.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.842 0.857 . . . . 63.32 111.794 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.58 -130.35 6.33 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.869 -0.605 . . . . 74.51 111.631 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -159.93 141.14 12.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.565 0.746 . . . . 74.32 110.43 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.56 62.13 0.65 Allowed Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.033 -0.827 . . . . 51.03 111.033 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 71.2 p -68.07 97.24 0.68 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.247 1.019 . . . . 74.23 111.068 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -89.06 112.46 23.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 74.32 109.944 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.91 138.8 41.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.723 0.809 . . . . 74.11 110.58 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -98.97 143.43 29.26 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.702 -0.851 . . . . 75.32 108.702 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -71.3 127.22 31.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.192 -1.04 . . . . 61.24 108.192 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.81 -21.63 47.43 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.475 0.31 . . . . 65.22 110.837 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.771 1.228 . . . . 71.3 110.402 -173.96 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.134 -0.321 . . . . 73.42 110.134 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -164.44 179.27 6.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.14 0.976 . . . . 75.44 108.843 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.55 135.74 35.02 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 108.615 -0.883 . . . . 74.22 108.615 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -82.54 -61.78 1.79 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 64.2 110.289 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.97 106.69 1.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.12 -0.946 . . . . 73.05 110.226 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -76.04 84.96 2.92 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.52 -0.918 . . . . 75.01 108.52 173.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -71.44 168.93 16.44 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.092 -1.413 . . . . 71.24 108.695 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.74 106.26 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.524 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.6 tpt -28.87 124.95 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.107 1.763 . . . . 74.34 113.595 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.1 m -143.36 140.54 30.55 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.747 0.819 . . . . 63.11 110.166 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.456 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 44.5 t80 -143.01 115.61 8.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.937 -1.505 . . . . 72.44 106.937 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 44.2 mt-30 -128.13 147.36 50.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.276 -0.639 . . . . 72.32 109.276 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.501 HG22 ' HG2' ' B' ' 130' ' ' PRO . 3.8 mp -103.6 121.0 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.992 -1.114 . . . . 74.23 107.992 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.45 -42.22 6.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.893 0.477 . . . . 73.54 111.891 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.483 ' HD3' HD12 ' D' ' 83' ' ' ILE . 47.4 ttt180 -163.7 123.83 2.16 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.701 -0.19 . . . . 74.01 110.616 -168.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.6 136.62 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.156 -1.424 . . . . 74.03 107.156 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.431 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 39.7 p90 -166.0 177.72 6.88 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.947 0.779 . . . . 70.12 111.32 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -101.89 117.47 34.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.206 -0.907 . . . . 70.31 109.073 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 26.9 mtpp -80.53 -27.91 37.5 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.569 -0.287 . . . . 74.51 110.356 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.69 148.88 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.529 0.731 . . . . 72.01 109.13 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.574 HG21 ' HE1' ' C' ' 117' ' ' MET . 83.3 mt -143.44 147.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.97 1.308 . . . . 74.13 108.506 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -148.03 144.44 27.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.491 1.116 . . . . 72.33 109.275 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.434 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.61 126.29 8.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.154 -1.795 . . . . 64.03 106.154 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -128.65 141.13 51.44 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.206 0.602 . . . . 72.51 109.46 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.75 77.13 9.54 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.211 1.004 . . . . 61.3 108.349 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.54 -38.71 13.8 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.611 2.207 . . . . 71.4 111.421 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 13.2 p30 -102.24 31.06 4.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.814 1.646 . . . . 74.42 109.746 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.419 ' HA ' ' HZ ' ' D' ' 123' ' ' PHE . . . -60.07 -48.48 94.39 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 114.53 1.307 . . . . 74.32 114.53 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.489 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.6 Cg_endo -83.29 -4.71 11.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 CA-C-N 121.299 1.5 . . . . 73.21 112.685 175.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.6 t-160 -81.39 -54.74 5.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 74.22 109.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.53 HG23 ' HA ' ' D' ' 73' ' ' ALA . 52.8 t -67.9 -16.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.918 0.887 . . . . 75.03 111.186 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -63.56 -18.28 63.7 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.323 1.049 . . . . 74.12 112.415 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.89 -16.09 57.49 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.163 0.585 . . . . 74.3 111.1 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -113.81 104.41 12.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.965 0.906 . . . . 71.24 110.187 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.47 95.34 8.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.006 0.522 . . . . 73.11 109.981 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.492 ' HB3' HD12 ' D' ' 68' ' ' LEU . 56.3 t-105 -161.69 158.53 26.11 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.73 110.11 8.98 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.121 0.969 . . . . 72.41 109.614 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.508 ' HD2' HD22 ' F' ' 139' ' ' LEU . 31.3 Cg_exo -63.18 131.13 31.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.771 2.98 . . . . 72.5 113.312 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.06 119.55 13.53 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.56 -0.533 . . . . 72.32 109.56 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' D' ' 66' ' ' ALA . 9.3 m -98.83 120.77 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.42 0.688 . . . . 74.04 111.436 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -87.66 115.85 25.38 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.018 -1.104 . . . . 74.1 108.018 166.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -96.51 142.11 28.99 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.833 -0.803 . . . . 74.44 108.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.648 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -127.8 112.33 14.64 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.89 -1.152 . . . . 73.11 107.89 173.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -96.57 134.48 39.74 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.952 -0.759 . . . . 61.02 108.952 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.1 t70 -152.22 147.95 27.01 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.943 -1.132 . . . . 65.44 107.943 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -139.59 163.92 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.078 0.466 . . . . 75.34 110.28 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.06 163.05 39.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.148 0.979 . . . . 75.31 109.761 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -142.41 153.33 43.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.658 -0.867 . . . . 73.21 108.658 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -155.76 152.46 28.52 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.359 1.064 . . . . 72.34 108.352 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -99.42 134.09 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.502 -0.555 . . . . 73.52 109.502 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.456 HD23 ' HB2' ' D' ' 57' ' ' GLU . 46.4 mt -103.14 -41.37 6.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.709 0.804 . . . . 74.53 109.265 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.18 -171.83 3.52 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.205 -0.907 . . . . 74.5 109.95 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.28 122.84 18.04 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.559 -0.746 . . . . 73.44 109.233 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 63.78 9.17 4.23 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.527 1.131 . . . . 63.54 112.831 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -119.26 120.56 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.058 0.943 . . . . 72.34 108.486 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.416 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 73.0 m-85 -136.34 135.98 39.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.852 0.461 . . . . 74.14 110.246 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD23 ' D' ' 51' ' ' LEU . 6.2 tp10 -91.08 113.75 26.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.094 0.958 . . . . 73.11 109.378 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.44 127.82 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.659 -1.237 . . . . 75.42 107.659 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.36 146.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.433 0.693 . . . . 73.41 109.341 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -127.47 108.76 11.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.006 -1.109 . . . . 73.23 108.006 176.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.7 ttm-85 -85.13 107.05 17.02 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.201 -0.666 . . . . 72.54 109.201 170.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.0 t -105.29 103.95 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.013 -1.106 . . . . 75.5 108.013 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.648 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 45.3 m -96.61 135.84 37.96 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.888 -0.782 . . . . 73.03 108.888 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.442 HG21 HD12 ' D' ' 114' ' ' ILE . 64.1 t -122.35 127.41 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.194 -1.039 . . . . 72.23 108.194 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -129.03 93.55 3.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.706 -1.22 . . . . 72.43 107.706 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.521 ' HB3' HG13 ' D' ' 40' ' ' VAL . . . -95.95 148.97 22.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.181 0.592 . . . . 72.3 110.039 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -151.05 136.91 18.12 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.988 0.805 . . . . 71.41 109.525 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.492 HD12 ' HB3' ' D' ' 36' ' ' TRP . 24.9 tp -120.53 128.34 53.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.813 -0.81 . . . . 74.41 108.813 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.88 -119.39 8.12 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.193 0.308 . . . . 72.11 112.349 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.36 7.01 17.52 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.073 0.949 . . . . 73.2 109.783 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -116.46 145.88 42.96 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.497 1.119 . . . . 55.35 109.304 -175.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' THR . . . . . 0.4 ' HB ' HD22 ' D' ' 27' ' ' ASN . 54.2 m -59.23 145.67 42.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.556 0.743 . . . . 72.31 109.038 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.53 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -106.57 -57.36 2.07 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.955 -0.387 . . . . 63.53 109.955 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.44 147.22 18.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.765 -0.652 . . . . 73.44 110.148 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 48.3 mt -110.69 149.15 30.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.538 1.135 . . . . 70.42 108.701 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' D' ' 114' ' ' ILE . 44.3 t -160.06 149.66 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.195 0.598 . . . . 64.32 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -156.61 141.0 16.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.506 -0.924 . . . . 70.35 108.506 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -136.37 118.66 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.301 -0.629 . . . . 75.01 109.301 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.5 85.75 6.59 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.534 -0.913 . . . . 74.33 108.534 170.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.58 102.15 8.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.517 -1.219 . . . . 73.42 108.7 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.8 142.96 15.86 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.315 -0.714 . . . . 65.23 111.315 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.88 132.19 5.63 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.415 -1.074 . . . . 52.2 110.415 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.483 HD12 ' HD3' ' D' ' 15' ' ' ARG . 89.7 mt -88.09 114.26 26.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.441 -0.948 . . . . 73.44 108.441 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.63 136.44 54.39 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.053 0.941 . . . . 74.34 109.461 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 6.5 m -79.31 105.98 11.01 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.923 -0.769 . . . . 73.13 108.923 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.416 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 37.3 mm -106.18 102.57 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.253 -1.018 . . . . 64.55 108.253 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.21 152.99 51.35 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.954 0.901 . . . . 63.23 109.535 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.89 -1.93 66.44 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 114.632 0.613 . . . . 62.14 114.632 174.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.86 125.76 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.011 -0.737 . . . . 75.24 109.011 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.94 -173.92 3.94 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.467 0.707 . . . . 70.12 111.075 -171.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 -134.58 25.14 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.782 -0.644 . . . . 55.55 113.05 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.803 0.841 . . . . 75.43 111.215 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -68.18 -38.47 82.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.645 0.778 . . . . 62.23 110.871 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.29 66.78 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.534 -0.303 . . . . 70.32 110.399 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.2 71.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.347 0.659 . . . . 63.22 111.113 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -67.66 -40.28 84.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 73.34 110.847 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -68.64 -52.3 32.75 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.061 -0.518 . . . . 60.11 110.624 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.56 -16.96 61.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.597 0.759 . . . . 75.03 111.637 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.04 -24.68 24.25 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.769 -0.462 . . . . 75.03 114.052 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.1 -57.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.679 0.74 . . . . 72.34 111.805 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -67.07 -50.75 60.71 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.798 0.839 . . . . 75.34 112.633 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.456 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 19.3 m -69.67 -44.79 24.65 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.307 0.643 . . . . 72.21 111.679 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.8 Cg_exo -58.72 -31.84 95.74 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.147 1.898 . . . . 70.31 113.416 169.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.95 -37.49 87.59 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.073 0.549 . . . . 72.33 110.721 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.57 -41.81 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.539 0.736 . . . . 74.13 109.976 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.8 -17.69 60.58 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.17 -0.923 . . . . 74.5 112.143 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -68.36 -42.7 29.85 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 113.607 0.966 . . . . 73.4 113.607 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.8 -37.14 84.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 122.072 1.848 . . . . 74.44 113.618 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.614 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 94.7 m-85 -81.37 -33.58 32.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.995 0.918 . . . . 74.54 111.431 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.63 66.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.383 0.673 . . . . 74.33 109.382 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.0 ttp180 -53.25 -53.42 51.08 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.964 -1.471 . . . . 73.31 110.458 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.9 -46.65 84.63 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.281 0.988 . . . . 73.22 111.838 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.43 -42.0 90.84 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.986 0.804 . . . . 70.4 111.175 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.442 HD12 HG21 ' D' ' 64' ' ' VAL . 75.9 mt -65.22 -53.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.666 0.604 . . . . 71.3 110.277 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.427 HG22 ' HG3' ' D' ' 125' ' ' GLN . 48.4 m -55.19 -40.54 70.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.701 1.2 . . . . 73.51 111.513 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.8 t -66.75 -43.21 84.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.59 -1.186 . . . . 74.32 110.436 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.4 mtm -67.77 -32.83 73.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.007 0.523 . . . . 73.32 112.163 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.427 HG22 ' O ' ' D' ' 114' ' ' ILE . 83.4 t -67.41 -42.01 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.372 0.669 . . . . 71.21 109.764 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -76.08 -28.39 57.57 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.097 -0.502 . . . . 74.51 111.131 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -71.61 -32.48 68.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.644 0.778 . . . . 75.14 109.567 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 6.13 73.52 Favored Glycine 0 C--N 1.355 1.623 0 O-C-N 123.754 0.659 . . . . 62.31 112.544 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 63.3 p 57.58 21.46 7.16 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.83 2.052 . . . . 75.31 114.291 176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 65.7 m-85 -85.39 157.6 58.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.928 0.891 . . . . 74.5 109.301 170.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.51 121.82 10.71 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.718 2.278 . . . . 72.11 111.477 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.427 ' HG3' HG22 ' D' ' 115' ' ' THR . 24.1 tt0 -48.29 132.23 16.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.009 1.324 . . . . 63.32 112.47 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' F' ' 142' ' ' ILE . 61.4 tp -107.14 106.1 16.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -97.61 89.71 4.76 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.702 -1.222 . . . . 61.01 107.702 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.493 ' HA ' HG12 ' F' ' 142' ' ' ILE . 5.6 mp -62.9 112.51 2.6 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.786 0.679 . . . . 74.04 109.594 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.52 ' HB1' HD13 ' F' ' 147' ' ' LEU . . . -74.79 139.57 73.86 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.255 -0.646 . . . . 64.24 109.255 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.51 165.28 27.79 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.245 1.963 . . . . 62.33 112.727 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.81 138.7 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.368 -0.605 . . . . 73.53 109.368 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -74.81 95.26 2.88 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 108.955 -0.757 . . . . 74.51 108.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -59.68 -39.61 85.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.039 -0.982 . . . . 75.41 111.045 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.32 -54.87 34.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.458 1.103 . . . . 73.11 111.846 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.84 74.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.074 0.549 . . . . 73.35 112.332 -173.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.86 -41.24 75.12 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.314 0.646 . . . . 75.44 109.524 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.409 ' O ' HD11 ' D' ' 141' ' ' LEU . 58.8 t80 -64.13 -31.61 72.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.373 1.069 . . . . 73.31 111.185 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.7 mmt -53.72 -51.55 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.361 0.664 . . . . 72.11 111.097 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.69 -30.61 64.38 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.766 -1.107 . . . . 71.1 111.145 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -58.01 -35.91 71.92 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.708 0.803 . . . . 71.13 111.62 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.409 HD11 ' O ' ' D' ' 137' ' ' PHE . 8.4 mp -61.17 -45.53 94.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.229 0.612 . . . . 74.52 111.687 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -82.35 3.93 25.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.071 0.397 . . . . 73.4 112.071 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -121.26 87.68 2.8 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.65 0.78 . . . . 64.02 109.766 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.1 84.93 1.78 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.856 -1.165 . . . . 71.33 107.856 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.73 -3.93 1.44 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.655 0.782 . . . . 70.42 110.985 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.39 127.48 12.31 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.634 -0.586 . . . . 72.34 111.634 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.35 -26.38 68.0 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.313 0.645 . . . . 74.52 111.668 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.78 -149.09 51.56 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.569 0.543 . . . . 55.54 112.519 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 72.5 p -125.79 137.44 53.79 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 72.23 108.816 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -70.79 91.84 0.85 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.132 -0.692 . . . . 73.02 109.132 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -94.04 113.53 25.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.301 -0.863 . . . . 73.13 110.038 -174.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -154.28 169.83 22.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.286 1.034 . . . . 73.21 109.33 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.09 151.35 44.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.928 0.491 . . . . 74.12 110.712 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -94.84 -42.04 8.9 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.401 0.68 . . . . 70.34 109.532 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.84 0 CA-C-N 115.655 -0.702 . . . . 64.41 109.629 175.76 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.865 -0.42 . . . . 73.53 109.865 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -139.16 55.5 1.7 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.062 -1.459 . . . . 72.32 107.062 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 73.16 178.74 0.23 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.645 1.578 . . . . 74.4 111.439 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -143.62 -173.11 3.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.391 0.677 . . . . 65.53 110.576 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.91 171.29 15.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.116 0.966 . . . . 73.25 110.907 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -80.06 177.95 8.58 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.419 0.687 . . . . 75.1 111.466 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm 64.75 85.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.649 1.179 . . . . 73.25 109.507 -167.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.44 HD11 ' HA ' ' B' ' 90' ' ' GLU . 26.3 tp -80.59 80.75 6.99 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.868 -1.06 . . . . 63.45 109.336 -176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -164.95 77.97 1.36 Allowed Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 124.395 1.078 . . . . 75.35 109.368 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.419 ' HG2' ' HB3' ' B' ' 95' ' ' ALA . 96.5 Cg_endo -90.12 -178.98 1.66 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.567 2.178 . . . . 73.11 113.542 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 62.45 -93.52 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.432 1.493 . . . . 75.32 111.931 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 24.2 m 57.23 89.35 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.742 0.817 . . . . 64.33 110.792 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -66.39 114.61 5.55 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.264 0.554 . . . . 74.43 109.802 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.29 34.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.484 1.135 . . . . 51.31 110.229 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.73 85.29 0.7 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.197 -1.038 . . . . 71.24 108.197 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . 0.401 ' HA ' HD23 ' B' ' 136' ' ' LEU . 34.1 m -74.05 -35.0 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 116.161 -0.472 . . . . 74.41 110.234 176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? 65.56 -72.27 0.07 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.731 1.613 . . . . 75.14 111.603 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 64.33 -137.4 0.28 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.195 0.998 . . . . 75.22 110.658 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -147.77 151.48 36.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.84 -0.8 . . . . 72.51 108.84 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.66 70.18 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 124.222 0.951 . . . . 51.15 114.182 -171.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -96.2 -40.97 8.92 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.712 -0.477 . . . . 73.2 109.712 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 42.5 tp 69.4 -63.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.857 1.663 . . . . 74.51 112.434 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 24.7 pt -62.48 89.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 CA-C-O 122.383 1.087 . . . . 74.42 112.654 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.56 85.52 3.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.921 -1.036 . . . . 72.42 109.613 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -133.31 132.72 22.22 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 107.763 -1.199 . . . . 74.53 107.763 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.93 -30.0 46.27 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.348 2.699 . . . . 75.42 115.145 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 pp -127.28 165.99 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.956 0.502 . . . . 73.43 111.112 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -140.45 113.07 8.05 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.937 -1.134 . . . . 73.02 107.937 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.83 138.12 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 123.559 0.744 . . . . 73.54 111.437 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -163.54 0.87 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.827 0.851 . . . . 72.33 111.606 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -96.83 104.47 16.48 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.472 0.709 . . . . 74.52 109.585 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 41.6 tp -76.74 124.64 27.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.297 0.639 . . . . 71.32 111.002 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -173.0 129.89 0.48 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.68 1.192 . . . . 64.14 108.479 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' C' ' 39' ' ' GLU . 2.3 pt? -155.83 19.15 0.38 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.866 0.866 . . . . 72.41 110.039 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 31.7 pt -93.35 158.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.262 1.025 . . . . 75.22 111.288 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 60.17 76.57 0.36 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.658 1.183 . . . . 73.42 112.211 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -91.41 70.44 5.99 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 108.916 -0.772 . . . . 74.32 108.916 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 47.4 tttm 178.78 -71.51 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.292 1.437 . . . . 72.04 108.529 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -178.58 169.32 1.73 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.969 1.308 . . . . 63.43 108.613 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . 0.401 ' HB3' HG23 ' C' ' 131' ' ' VAL . 71.6 mt -75.72 -27.87 58.33 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.093 0.557 . . . . 74.42 111.094 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.511 HD21 HD21 ' C' ' 139' ' ' ASN . 6.1 mp -104.43 125.85 33.05 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.28 1.032 . . . . 74.15 109.118 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . 0.566 ' HD2' HD12 ' C' ' 136' ' ' LEU . 43.2 Cg_endo . . . . . 0 CA--C 1.566 2.082 0 C-N-CA 122.46 2.106 . . . . 65.11 111.569 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.926 -0.398 . . . . 73.32 109.926 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.28 112.57 18.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.918 0.887 . . . . 73.2 109.459 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . 0.617 ' HB1' ' H ' ' A' ' 53' ' ' ASP . . . 69.05 3.39 4.03 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.055 1.131 . . . . 75.22 114.055 165.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -90.15 -35.53 15.34 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.414 0.552 . . . . 75.32 111.043 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -61.81 140.46 58.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.762 0.825 . . . . 61.21 110.955 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.36 123.1 13.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.438 1.095 . . . . 75.14 112.522 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.422 ' HG2' ' N ' ' F' ' 115' ' ' LEU . 67.0 tttt -138.39 155.59 48.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.042 1.737 . . . . 74.41 106.897 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.534 HD13 ' HG3' ' A' ' 90' ' ' GLU . 26.4 tp 77.33 -29.24 0.17 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.073 1.349 . . . . 75.12 112.735 167.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.12 76.48 59.64 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 124.292 1.037 . . . . 71.2 110.12 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -90.59 -2.28 5.13 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.406 2.07 . . . . 73.14 112.376 165.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -80.22 113.44 18.39 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.941 0.896 . . . . 72.04 109.361 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 70.6 p -79.19 87.45 4.92 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.535 0.734 . . . . 73.13 110.261 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -73.09 114.24 11.04 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.211 0.605 . . . . 74.42 110.376 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.52 87.83 1.33 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.287 0.635 . . . . 52.11 109.944 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.59 24.91 0.46 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 75.31 109.175 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.34 97.49 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.141 -0.936 . . . . 75.12 110.657 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -160.33 140.05 11.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.301 1.04 . . . . 75.2 108.754 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . 0.431 ' HD2' HD13 ' A' ' 42' ' ' LEU . 43.1 t80 -154.34 66.71 0.71 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.277 -1.009 . . . . 75.24 108.277 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -77.61 -178.22 5.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.047 -0.979 . . . . 72.15 112.442 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 106.54 -130.09 10.03 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.616 -0.993 . . . . 70.14 110.616 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 23.7 pttm -161.5 163.17 30.45 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.25 0.62 . . . . 74.5 110.885 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.35 136.81 35.17 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.179 0.591 . . . . 70.41 109.641 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 tp -157.98 138.98 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.023 0.929 . . . . 74.24 108.745 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.29 -72.4 0.62 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.232 -0.655 . . . . 74.24 109.232 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -137.08 105.56 8.74 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 108.483 -0.932 . . . . 75.33 108.483 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.21 78.78 3.12 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.749 2.299 . . . . 74.22 111.335 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 14.8 tt -63.91 -40.27 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.775 -0.648 . . . . 74.42 109.421 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.19 46.49 10.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 51.34 111.867 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 5.4 m -60.26 119.81 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.226 -0.897 . . . . 75.33 111.373 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.82 146.47 33.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.082 0.953 . . . . 73.2 109.527 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.5 117.36 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.45 1.1 . . . . 74.44 111.583 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.508 HD22 ' HD2' ' D' ' 38' ' ' PRO . 28.4 tp -66.06 99.46 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.684 1.194 . . . . 63.55 110.714 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.6 m -110.49 14.52 22.49 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.04 -0.982 . . . . 74.41 111.245 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.15 7.02 5.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.388 0.675 . . . . 73.11 112.535 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.521 ' HB ' HD11 ' D' ' 126' ' ' LEU . 9.8 tp -62.54 -39.79 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.018 0.927 . . . . 74.12 111.372 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -146.3 168.16 21.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.738 1.215 . . . . 75.11 109.088 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.22 156.87 39.32 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 120.757 0.313 . . . . 72.21 111.463 -173.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' F' ' 145' ' ' LYS . 0.6 OUTLIER 64.65 49.96 2.2 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.896 1.678 . . . . 75.11 111.822 175.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . 0.706 ' HA ' ' HB2' ' B' ' 12' ' ' GLN . 13.5 m-20 53.29 30.39 10.02 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.87 1.268 . . . . 74.25 113.469 171.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . 0.52 HD13 ' HB1' ' D' ' 129' ' ' ALA . 86.2 mt 60.78 -172.48 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.217 1.007 . . . . 74.24 113.418 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.96 161.89 23.35 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 114.575 -1.193 . . . . 74.42 108.643 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 CA--C 1.57 2.288 0 C-N-CA 122.08 1.853 . . . . 74.45 112.42 169.457 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 110.415 -0.217 . . . . 75.22 110.415 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -130.14 107.53 9.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.917 0.887 . . . . 73.42 110.014 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.96 63.63 0.41 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.985 0.898 . . . . 74.42 110.492 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -127.46 109.91 12.22 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.509 -1.293 . . . . 72.54 107.509 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -69.93 146.26 51.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.705 0.802 . . . . 71.52 111.11 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.81 163.96 23.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.498 0.719 . . . . 64.41 110.989 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -69.72 157.1 37.93 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.103 -0.953 . . . . 73.14 110.069 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.98 161.54 21.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.75 0.42 . . . . 73.23 110.059 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 73.17 160.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.777 1.231 . . . . 73.32 111.214 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.0 m -145.96 134.16 21.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.657 0.783 . . . . 70.41 109.62 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -139.85 115.33 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.326 -0.99 . . . . 74.42 108.326 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.508 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 55.2 mt-30 -134.25 122.65 23.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.154 0.582 . . . . 74.23 110.104 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.43 107.99 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.539 -0.911 . . . . 75.1 108.539 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -86.33 -40.33 15.57 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.443 0.297 . . . . 75.21 110.434 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.668 ' HD2' HG22 ' B' ' 122' ' ' THR . 10.1 tpp180 -167.68 134.4 2.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.471 -0.566 . . . . 71.22 109.471 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.444 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 91.6 mt -138.4 100.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.962 -0.755 . . . . 74.33 108.962 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.9 m-85 -164.09 176.16 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 75.13 109.693 -165.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -85.33 114.05 22.11 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.146 -0.479 . . . . 72.33 110.093 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -88.92 -34.47 16.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.727 0.298 . . . . 74.32 110.371 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.797 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 9.1 m-20 -137.38 147.0 45.14 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.482 0.658 . . . . 65.25 109.736 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 66.9 mt -144.99 143.88 22.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 126.381 1.872 . . . . 75.02 106.508 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -158.79 121.36 3.64 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.607 -0.516 . . . . 72.21 109.607 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.612 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.9 t80 -119.8 136.62 54.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.428 -1.323 . . . . 73.25 107.428 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.38 148.8 51.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.578 0.751 . . . . 74.14 109.017 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.12 80.72 7.79 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.869 -1.16 . . . . 75.15 107.869 172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -31.2 24.86 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.528 2.152 . . . . 74.12 111.667 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -112.53 34.29 4.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.544 1.138 . . . . 74.44 109.334 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.45 -47.1 99.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.444 1.097 . . . . 72.14 113.581 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.1 -20.9 32.64 Favored 'Trans proline' 0 C--N 1.392 2.828 0 CA-C-N 121.124 1.437 . . . . 75.51 112.421 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -79.87 -24.97 40.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.58 0.752 . . . . 71.55 111.656 -172.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.16 -22.32 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 112.461 0.541 . . . . 75.01 112.461 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -80.04 -35.02 37.78 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.297 1.039 . . . . 72.13 110.699 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -88.36 -18.04 29.28 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.178 0.591 . . . . 74.32 111.108 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.56 ' HZ2' ' HG3' ' A' ' 71' ' ' GLU . 96.4 mttt -75.59 167.15 22.43 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.864 0.69 . . . . 73.54 112.864 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.27 118.28 23.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.69 -1.141 . . . . 62.14 108.05 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.412 ' HA ' HD12 ' A' ' 68' ' ' LEU . 20.5 m-90 -73.33 85.72 1.46 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.759 0.79 . . . . 72.12 110.939 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -130.78 76.98 76.35 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.063 1.345 . . . . 74.23 108.195 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.46 111.86 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.717 2.278 . . . . 75.34 111.843 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -96.14 85.09 3.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.94 -1.504 . . . . 75.54 106.94 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.1 m -88.25 122.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.453 -1.248 . . . . 65.52 111.889 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -108.17 116.61 32.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.652 1.181 . . . . 72.04 109.111 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.04 108.24 19.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.181 0.593 . . . . 74.54 109.691 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.562 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.4 t70 -103.41 130.38 50.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.728 0.811 . . . . 72.03 109.601 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -110.43 119.75 40.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.509 -0.922 . . . . 70.01 108.509 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.45 ' O ' HD22 ' A' ' 60' ' ' LEU . 25.3 t70 -122.68 138.08 54.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.493 0.717 . . . . 73.12 109.532 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.7 m -133.35 143.69 49.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.938 0.495 . . . . 75.44 110.146 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.71 152.69 40.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.406 1.082 . . . . 74.01 109.395 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -130.96 155.97 45.89 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.515 -0.92 . . . . 64.25 108.515 172.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -163.26 116.43 1.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 117.882 0.31 . . . . 74.45 110.314 -173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.465 HE21 ' H ' ' A' ' 54' ' ' ASP . 51.8 tt0 -70.22 105.62 3.02 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.992 0.917 . . . . 73.22 110.353 -177.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 57' ' ' GLU . 44.9 mt -77.94 -39.9 41.25 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.309 1.044 . . . . 74.53 111.008 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.08 -171.81 3.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.822 -1.081 . . . . 63.44 109.447 -172.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.76 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.114 0.566 . . . . 74.23 110.5 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 9.4 m-20 54.6 31.4 15.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.117 1.367 . . . . 73.23 112.932 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 54.6 t -107.55 122.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.9 -1.519 . . . . 71.43 106.9 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 138.02 49.65 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.953 -0.758 . . . . 73.43 108.953 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.511 ' HB2' HD13 ' A' ' 51' ' ' LEU . 37.0 tt0 -86.92 121.87 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.987 -1.116 . . . . 73.3 107.987 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -99.29 118.58 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.446 -1.316 . . . . 72.4 107.446 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.442 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 90.9 t -98.18 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 123.28 0.632 . . . . 74.32 109.545 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -120.93 110.47 16.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.291 -1.744 . . . . 74.52 106.291 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.577 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 23.4 ttp180 -104.84 103.61 13.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.661 -0.866 . . . . 74.5 108.661 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 60' ' ' LEU . 60.9 t -95.39 129.08 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.535 -1.211 . . . . 73.02 108.662 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 41.5 m -109.17 131.76 54.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.739 -0.837 . . . . 74.31 108.739 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.614 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 t -123.93 107.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.21 -1.404 . . . . 74.1 107.21 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.508 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -107.45 135.66 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.117 -1.068 . . . . 62.21 108.117 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.32 136.78 49.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.501 -1.296 . . . . 72.54 107.501 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.2 m -147.22 135.65 21.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.81 0.844 . . . . 75.24 109.651 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.522 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 2.3 mm? -87.23 86.52 7.28 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.868 -1.16 . . . . 75.4 107.868 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.57 -85.15 1.25 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.017 -0.992 . . . . 75.11 111.483 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -26.0 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.322 0.649 . . . . 64.24 111.312 -175.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.56 ' HG3' ' HZ2' ' A' ' 34' ' ' LYS . 10.5 tp10 -101.06 133.04 46.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.064 0.546 . . . . 70.24 109.965 -177.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 m -65.44 146.35 54.99 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.154 0.982 . . . . 73.14 112.729 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' HB2' HD23 ' A' ' 68' ' ' LEU . . . -90.12 -65.56 1.0 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.833 1.253 . . . . 63.43 108.436 168.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -150.33 159.8 44.19 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.242 -1.345 . . . . 73.24 110.375 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.6 tp -134.72 116.84 15.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.231 1.012 . . . . 72.43 109.565 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.614 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.2 m -106.47 142.51 36.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 75.23 110.311 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -148.07 118.78 7.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.371 1.068 . . . . 72.53 108.838 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.32 116.73 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.136 0.425 . . . . 70.31 109.917 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.797 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 15.6 mp0 -85.57 86.51 7.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.434 -1.321 . . . . 72.13 107.434 169.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -77.01 96.01 4.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.085 -0.962 . . . . 73.23 108.607 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.84 146.0 18.1 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.274 -0.73 . . . . 75.42 111.274 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.18 123.89 2.53 Favored Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.265 -1.134 . . . . 71.4 110.265 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' B' ' 29' ' ' PRO . 56.4 mt -81.02 125.22 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.351 -0.611 . . . . 64.4 109.351 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -134.4 119.85 19.09 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.722 -0.844 . . . . 75.45 108.722 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 33.3 t -81.43 92.7 6.49 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.654 -0.869 . . . . 74.55 108.654 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 10' ' ' THR . 11.0 pt -125.89 127.21 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.558 0.743 . . . . 72.33 110.801 -170.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . . . -160.89 171.11 19.32 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.981 0.913 . . . . 75.53 110.759 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.56 -24.07 32.35 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.391 -0.822 . . . . 72.22 113.135 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.492 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -109.5 146.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.94 0.496 . . . . 73.2 109.791 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -147.46 175.81 10.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.243 -0.889 . . . . 74.42 111.282 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.97 -132.46 33.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 114.683 -1.144 . . . . 73.04 112.642 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -69.48 -20.68 63.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.575 0.75 . . . . 75.24 111.882 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.08 -44.64 46.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.505 0.722 . . . . 74.15 110.736 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.519 ' HG2' HD21 ' F' ' 115' ' ' LEU . 9.7 tpt -80.73 -25.07 38.32 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.239 -0.437 . . . . 73.43 110.195 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' F' ' 117' ' ' PRO . . . -66.22 -38.49 88.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.218 0.607 . . . . 73.23 109.837 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.87 -43.35 83.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.742 -1.117 . . . . 74.15 110.491 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.675 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.4 m -73.05 -34.34 66.22 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.595 0.961 . . . . 70.23 113.595 -171.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -91.42 -9.24 45.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.486 0.314 . . . . 75.51 111.556 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.65 5.88 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 113.665 0.226 . . . . 50.44 113.665 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.6 -65.7 0.71 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.806 0.842 . . . . 72.12 111.034 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.4 t80 -43.62 -61.51 1.37 Allowed 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 125.125 1.37 . . . . 72.43 113.193 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 83.6 m -72.63 -50.82 7.44 Favored Pre-proline 0 CA--C 1.556 1.194 0 CA-C-O 118.255 -0.878 . . . . 71.41 112.822 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.05 -17.94 61.7 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.718 1.612 . . . . 70.41 113.815 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.29 -48.25 68.23 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 72.4 108.592 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.0 mm -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.58 -1.191 . . . . 74.44 110.782 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.424 HD23 HG23 ' A' ' 16' ' ' ILE . 95.3 mt -71.47 -28.64 64.08 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.738 -0.665 . . . . 75.41 111.953 -173.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -65.23 -43.54 65.67 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.373 1.249 . . . . 74.22 114.373 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -34.92 96.53 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.194 1.93 . . . . 71.22 113.381 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.452 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 89.0 m-85 -80.96 -33.92 33.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 73.3 111.494 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.13 63.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 110.046 -0.353 . . . . 74.33 110.046 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.496 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.1 ttm180 -51.75 -45.06 63.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.678 1.191 . . . . 75.01 110.348 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.61 -50.32 71.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.026 0.93 . . . . 74.05 111.487 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.47 -39.96 95.12 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.178 0.924 . . . . 72.55 111.098 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.594 HG21 HG22 ' A' ' 64' ' ' VAL . 12.8 mt -64.33 -58.11 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.561 0.745 . . . . 75.43 110.374 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.467 HG22 ' HG3' ' A' ' 125' ' ' GLN . 96.7 m -53.02 -38.95 62.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.159 0.912 . . . . 73.3 111.289 -176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -66.34 -42.43 88.13 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.384 -0.826 . . . . 75.32 110.472 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.6 mtm -63.49 -37.73 88.42 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.982 0.513 . . . . 64.33 111.168 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 114' ' ' ILE . 74.9 t -63.12 -45.41 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.281 1.032 . . . . 71.33 110.545 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.0 p -75.17 -29.63 60.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.02 -0.537 . . . . 74.44 111.327 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -72.05 -28.07 63.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 75.23 109.81 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.13 1.25 89.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.552 -0.749 . . . . 64.53 113.014 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 m 68.68 18.33 8.77 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.762 1.225 . . . . 60.44 111.578 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -90.37 154.37 46.56 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.702 0.801 . . . . 64.21 110.805 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -59.79 134.11 55.2 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.94 2.426 . . . . 74.31 112.253 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.467 ' HG3' HG22 ' A' ' 115' ' ' THR . 31.6 tt0 -62.7 132.34 51.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.605 0.762 . . . . 73.22 111.883 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.3 mt -113.0 114.4 26.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.018 -1.104 . . . . 75.32 108.018 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -97.4 100.86 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.993 -1.114 . . . . 73.22 107.993 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.63 135.78 57.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.235 0.614 . . . . 74.34 110.619 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.616 ' HB1' ' HG ' ' F' ' 129' ' ' LEU . . . -61.06 145.86 88.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.995 0.518 . . . . 74.4 110.99 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.5 119.92 7.03 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.941 1.761 . . . . 73.23 109.174 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.5 t -95.64 111.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.251 -1.388 . . . . 74.4 107.251 -176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.414 HD21 ' HB2' ' A' ' 135' ' ' ALA . 3.8 p-10 -82.12 66.17 7.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.937 -1.029 . . . . 74.45 109.318 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -68.8 -34.83 76.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.624 -0.716 . . . . 70.53 109.85 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.469 ' O ' ' HG2' ' A' ' 138' ' ' MET . 2.1 m-20 -56.58 -53.01 62.58 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.958 0.786 . . . . 73.33 109.743 172.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.414 ' HB2' HD21 ' A' ' 132' ' ' ASN . . . -70.65 -28.64 64.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.577 0.751 . . . . 74.32 111.434 -177.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.504 HD22 ' HA ' ' F' ' 123' ' ' VAL . 56.4 tp -65.25 -48.23 74.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.449 1.099 . . . . 73.44 110.201 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.04 -28.18 65.26 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.976 -1.011 . . . . 74.31 110.236 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.612 ' HE3' ' HG2' ' A' ' 147' ' ' GLU . 14.3 mmt -65.54 -34.01 77.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.077 -0.487 . . . . 75.23 112.079 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -56.71 -32.15 65.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.259 0.552 . . . . 64.24 110.699 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.73 -39.7 23.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.932 -1.031 . . . . 74.12 110.865 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.4 tp -71.66 -52.41 18.04 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.411 0.893 . . . . 75.12 113.411 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -169.35 20.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.048 0.539 . . . . 73.53 110.438 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 65.79 -159.64 0.27 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.983 -1.118 . . . . 73.44 107.983 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.601 ' HG2' ' HB3' ' C' ' 6' ' ' ASN . 0.2 OUTLIER -73.82 74.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.026 1.284 . . . . 62.24 111.92 -173.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' C' ' 145' ' ' ALA . . . -179.68 128.38 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.73 1.612 . . . . 74.42 107.973 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.52 -39.84 0.24 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 117.845 0.293 . . . . 72.42 112.898 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.612 ' HG2' ' HE3' ' A' ' 138' ' ' MET . 61.4 mm-40 -83.95 171.36 13.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.585 0.707 . . . . 73.04 112.359 177.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 67.4 -137.7 33.26 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 113.811 -1.54 . . . . 74.32 112.883 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.8 m 61.79 80.05 0.23 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.082 0.953 . . . . 70.11 111.123 171.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -145.03 166.35 25.59 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.084 0.469 . . . . 75.31 111.89 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.55 -47.95 0.08 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.807 -1.088 . . . . 74.32 110.581 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -71.9 90.56 1.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.547 0.689 . . . . 74.42 111.975 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -84.89 -17.48 37.75 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.757 -1.111 . . . . 73.42 109.267 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.06 143.45 49.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.661 0.784 . . . . 74.52 110.528 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.364 0 N-CA-C 109.0 -0.741 . . . . 61.04 109.0 177.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.502 ' HA ' ' HB3' ' B' ' 141' ' ' LEU . 61.1 mtt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 110.003 -0.369 . . . . 73.12 110.003 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.3 m 63.61 80.84 0.22 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.6 1.188 . . . . 71.1 110.857 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -118.28 145.76 44.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.966 -1.015 . . . . 74.24 109.604 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -165.41 11.34 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.601 0.593 . . . . 75.23 112.601 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.497 HD22 ' HG2' ' B' ' 93' ' ' GLN . 0.8 OUTLIER -74.17 161.37 30.04 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.284 0.493 . . . . 75.24 111.63 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -134.86 -177.89 4.83 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.887 0.875 . . . . 73.0 108.954 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -70.53 78.33 0.57 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.117 0.96 . . . . 71.35 108.912 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.94 -156.72 0.74 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.992 1.317 . . . . 73.33 109.217 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.579 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.7 ptm 56.18 -177.35 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 126.049 1.74 . . . . 75.33 114.941 170.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -143.39 122.36 12.8 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.184 -1.043 . . . . 71.25 108.184 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -110.51 134.86 51.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.027 0.931 . . . . 74.1 108.677 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -145.61 141.37 28.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.774 -0.824 . . . . 73.32 108.774 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.533 ' H ' HD11 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -91.66 134.49 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.79 -0.818 . . . . 75.25 108.79 173.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -92.4 -50.3 5.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.129 0.572 . . . . 73.45 109.585 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -164.54 139.26 5.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.436 -0.802 . . . . 74.22 109.409 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -114.84 144.7 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 106.218 -1.771 . . . . 73.55 106.218 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG13 ' B' ' 83' ' ' ILE . 30.0 p90 -172.3 149.44 2.24 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.133 0.424 . . . . 72.22 110.908 -178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.726 HG23 HD12 ' B' ' 21' ' ' ILE . 26.8 m -80.14 121.66 25.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.353 -0.61 . . . . 73.11 109.353 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -87.7 -33.8 18.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.014 0.526 . . . . 72.34 110.203 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.4 t70 -146.99 127.97 14.54 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.75 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.726 HD12 HG23 ' B' ' 18' ' ' THR . 34.3 mm -113.47 147.08 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.395 -1.335 . . . . 71.2 107.395 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -150.72 140.51 21.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.294 -0.632 . . . . 73.14 109.294 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.532 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 93.3 t80 -155.22 114.91 3.7 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 107.663 -1.236 . . . . 73.33 107.663 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.65 113.88 17.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.731 -1.211 . . . . 72.34 107.731 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.0 89.32 3.61 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.544 -0.91 . . . . 62.21 108.544 179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.17 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.837 2.358 . . . . 65.21 112.602 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -127.26 29.58 5.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.013 0.925 . . . . 74.1 110.773 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.1 -55.8 16.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 C-N-CA 123.983 0.913 . . . . 64.41 112.419 172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.474 ' HA ' HD11 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -70.5 -16.66 34.45 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.845 1.697 . . . . 73.22 112.622 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -101.5 4.81 41.51 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.5 0.926 . . . . 71.44 113.5 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.68 -31.36 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 118.22 0.464 . . . . 71.3 111.775 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -73.35 -17.82 61.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.464 0.705 . . . . 74.22 110.958 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -79.43 -35.79 39.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.251 1.02 . . . . 73.0 110.813 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -108.02 110.28 21.95 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.39 0.676 . . . . 72.43 110.607 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -98.45 78.03 2.38 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.227 0.611 . . . . 75.31 110.374 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -151.35 161.6 42.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.374 -1.343 . . . . 72.2 107.374 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -85.3 133.5 42.43 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 122.722 0.409 . . . . 73.11 110.221 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' B' ' 68' ' ' LEU . 78.7 Cg_endo -72.52 136.51 26.18 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.421 2.081 . . . . 73.42 112.799 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -66.63 104.16 1.23 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.8 0.84 . . . . 73.54 109.067 168.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.469 HG13 HD21 ' B' ' 126' ' ' LEU . 11.0 m -98.43 150.44 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.979 0.511 . . . . 72.55 110.423 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.438 ' HE3' ' HB ' ' B' ' 65' ' ' THR . 1.1 tmmt? -150.69 121.63 7.64 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.566 -0.901 . . . . 74.43 108.566 -175.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.458 HD12 HD13 ' B' ' 126' ' ' LEU . 2.2 mm? -96.49 134.69 39.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.795 0.838 . . . . 74.14 109.602 -173.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.6 m-20 -123.62 113.45 18.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.342 -0.984 . . . . 74.34 108.342 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -101.67 148.0 25.78 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.384 -0.599 . . . . 72.14 109.384 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -161.31 152.33 18.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.62 -1.252 . . . . 62.5 107.62 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -153.43 143.87 22.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.988 0.423 . . . . 73.14 110.73 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.66 161.16 35.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.991 1.316 . . . . 74.2 108.331 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.3 m -130.44 165.18 23.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.335 0.588 . . . . 72.04 110.729 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -151.54 146.29 25.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.067 1.347 . . . . 71.31 107.554 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.65 112.13 24.92 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.292 -0.632 . . . . 63.2 109.292 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.39 -34.49 25.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.015 0.436 . . . . 75.02 110.086 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.407 ' HB1' ' HB ' ' B' ' 55' ' ' VAL . . . -159.94 178.6 9.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.8 0.84 . . . . 75.22 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.46 117.29 5.51 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.649 -1.159 . . . . 75.32 109.524 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 71.53 -4.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.438 1.495 . . . . 75.32 112.542 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.407 ' HB ' ' HB1' ' B' ' 52' ' ' ALA . 78.7 t -104.93 95.23 3.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.399 -0.963 . . . . 71.34 108.399 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -107.58 136.4 47.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.629 -0.714 . . . . 74.41 110.435 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -101.48 100.75 11.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.539 -1.282 . . . . 73.14 107.539 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.18 127.32 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.243 1.017 . . . . 72.31 109.669 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.2 t -103.63 123.63 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.825 0.85 . . . . 64.2 110.036 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.94 134.38 35.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.926 -1.509 . . . . 75.23 106.926 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -120.51 121.74 39.09 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.08 0.952 . . . . 75.21 108.701 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -115.53 104.29 16.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.093 -1.447 . . . . 74.5 107.093 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 21.7 m -96.92 130.22 44.26 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.542 -0.91 . . . . 74.12 108.542 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.533 HG23 HD12 ' B' ' 114' ' ' ILE . 69.8 t -112.85 130.7 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.394 0.678 . . . . 72.13 109.401 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.438 ' HB ' ' HE3' ' B' ' 41' ' ' LYS . 22.0 m -119.67 123.64 44.31 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.514 -0.921 . . . . 70.44 108.514 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 140.18 49.05 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 122.734 0.413 . . . . 73.41 109.984 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.519 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 22.5 p -138.2 126.71 23.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 73.1 110.152 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' B' ' 38' ' ' PRO . 2.6 tt -93.46 100.55 12.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.914 -1.513 . . . . 72.43 106.914 -176.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.39 -137.47 19.75 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 111.767 -0.533 . . . . 70.31 111.767 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.53 33.93 1.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.676 0.79 . . . . 60.11 110.387 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.28 146.7 24.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.058 0.943 . . . . 74.31 108.794 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -74.99 138.3 42.14 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.074 0.464 . . . . 72.34 111.388 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.519 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.07 -61.92 1.58 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.292 -1.003 . . . . 63.21 108.292 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.37 157.62 32.7 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.782 -1.099 . . . . 75.31 110.078 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.79 111.82 12.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.394 -1.335 . . . . 75.41 107.394 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.32 152.8 35.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.412 0.685 . . . . 55.13 109.538 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -155.61 134.64 12.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.514 -0.921 . . . . 75.51 108.514 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.574 HG23 HD13 ' B' ' 21' ' ' ILE . 84.0 t -129.07 141.36 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.366 -0.605 . . . . 70.13 109.366 171.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 51.4 mt-30 -118.88 100.88 7.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.378 1.071 . . . . 75.45 109.007 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -87.41 101.17 13.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.715 -0.675 . . . . 74.33 109.362 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 150.64 21.57 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.316 -0.714 . . . . 74.13 111.316 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.26 125.86 2.04 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 111.65 -0.58 . . . . 75.01 111.65 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.41 HG13 ' HE1' ' B' ' 17' ' ' TYR . 21.0 mt -85.66 126.53 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.061 -1.088 . . . . 75.21 108.061 172.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -130.85 160.38 34.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.651 1.18 . . . . 72.24 108.855 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -130.79 108.06 9.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.934 0.893 . . . . 52.41 108.777 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.688 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -123.69 115.38 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.823 1.249 . . . . 72.23 109.428 -174.13 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 51.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.702 0.801 . . . . 65.32 110.275 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.01 -46.01 1.23 Allowed Glycine 0 C--N 1.345 1.031 0 O-C-N 123.548 0.53 . . . . 63.01 112.112 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.688 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -90.75 154.23 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.1 0.96 . . . . 73.23 111.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -159.46 156.81 28.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.694 0.398 . . . . 72.22 110.522 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.27 -116.45 7.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.245 -0.434 . . . . 53.21 112.749 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -67.75 -33.48 74.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.769 0.828 . . . . 73.13 111.044 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.497 ' HG2' HD22 ' B' ' 5' ' ' ASN . 44.1 mt-30 -65.14 -50.31 66.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.735 -0.666 . . . . 72.44 110.529 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.584 ' SD ' ' HB3' ' E' ' 115' ' ' LEU . 28.2 ttt -71.73 -28.19 63.5 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.287 -0.87 . . . . 74.43 110.944 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -38.14 85.81 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.805 -0.634 . . . . 75.43 110.688 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -70.47 -34.79 72.79 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.505 -0.771 . . . . 74.42 110.299 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.31 -48.39 56.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.171 0.588 . . . . 74.23 111.034 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.25 -16.85 44.76 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.524 0.73 . . . . 73.42 111.812 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.75 2.84 58.73 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.88 -0.4 . . . . 71.0 113.307 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.84 -55.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.276 0.538 . . . . 75.33 112.132 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -81.52 -50.98 8.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.942 0.497 . . . . 74.15 111.768 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.7 m -56.89 -49.6 92.94 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.712 -0.661 . . . . 74.42 112.518 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.45 -26.86 47.3 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.989 1.793 . . . . 73.45 112.842 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.99 -33.56 76.34 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.942 0.401 . . . . 72.12 110.995 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.21 -47.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.672 0.789 . . . . 75.21 110.189 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.22 -22.36 61.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.226 -0.897 . . . . 74.11 112.268 -172.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -63.66 -47.87 81.39 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 114.211 1.189 . . . . 75.3 114.211 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.42 -36.14 93.39 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.09 1.86 . . . . 72.15 113.352 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -70.93 -46.84 61.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.194 0.597 . . . . 75.42 110.797 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.09 94.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.467 0.707 . . . . 73.45 110.651 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -59.38 -56.0 27.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.885 0.874 . . . . 75.45 110.624 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -37.8 84.35 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.791 0.682 . . . . 75.35 110.057 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.5 m -57.08 -53.44 58.03 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 74.05 111.917 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.533 HD12 HG23 ' B' ' 64' ' ' VAL . 80.9 mt -60.73 -58.12 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.595 0.758 . . . . 75.45 111.065 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.3 m -63.56 -30.3 71.43 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.252 0.97 . . . . 70.44 111.206 -168.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 43.7 t -59.79 -56.59 19.91 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.684 -0.689 . . . . 65.21 109.397 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.638 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 19.1 mmt -61.57 -32.96 73.07 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.748 0.819 . . . . 73.53 112.158 -175.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.12 -50.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.027 0.931 . . . . 72.13 110.66 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 84.8 p -74.54 -20.1 60.09 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.292 0.637 . . . . 74.3 111.339 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.638 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.43 -33.48 75.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.786 0.834 . . . . 74.43 110.06 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.73 8.66 78.25 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.39 0.431 . . . . 73.31 112.622 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.668 HG22 ' HD2' ' A' ' 15' ' ' ARG . 4.8 p 69.09 15.05 8.77 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.64 1.976 . . . . 73.53 113.148 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.05 155.3 67.42 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.776 0.83 . . . . 74.43 111.104 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.56 128.79 30.85 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.518 2.812 . . . . 74.33 113.396 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.427 ' HG3' ' OE1' ' C' ' 125' ' ' GLN . 72.7 mt-30 -55.66 133.33 50.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.171 1.388 . . . . 74.34 112.516 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.469 HD21 HG13 ' B' ' 40' ' ' VAL . 3.7 mm? -109.51 82.36 1.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.929 -0.767 . . . . 74.31 108.929 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -91.84 96.23 10.29 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.933 -1.136 . . . . 71.14 107.933 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.433 HD21 ' HE2' ' E' ' 125' ' ' TYR . 0.8 OUTLIER -75.19 128.63 35.92 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.179 -0.674 . . . . 75.32 109.179 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.95 148.5 94.57 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.033 0.933 . . . . 73.12 111.376 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.29 93.62 0.57 Allowed 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.177 1.918 . . . . 74.03 111.401 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.6 140.75 15.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.083 -0.962 . . . . 71.52 108.648 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -68.23 99.89 0.97 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.568 0.747 . . . . 72.01 110.339 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -56.34 -30.76 63.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.074 -0.966 . . . . 74.31 110.096 170.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.4 -56.91 13.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.063 1.345 . . . . 72.13 111.46 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.9 94.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.886 0.741 . . . . 62.54 111.74 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.488 HD22 ' HA ' ' E' ' 123' ' ' VAL . 4.0 tt -59.87 -45.93 90.89 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.69 0.796 . . . . 74.53 109.567 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -64.85 -40.88 95.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.874 -1.057 . . . . 73.43 111.456 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 98.2 mmm -68.1 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.799 0.44 . . . . 74.24 111.201 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -76.35 -17.83 59.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.226 0.611 . . . . 75.33 111.287 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -76.43 -30.8 57.56 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.932 -0.396 . . . . 75.42 109.932 171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' B' ' 1' ' ' MET . 72.0 mt -81.1 39.13 0.49 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.2 1.0 . . . . 65.24 112.745 -173.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -81.73 79.55 8.26 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.976 -1.078 . . . . 73.34 110.634 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -139.25 161.71 36.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.248 1.019 . . . . 74.51 108.45 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.8 -60.67 2.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.801 0.44 . . . . 73.24 110.11 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.23 108.85 4.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.635 . . . . 73.21 110.405 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.68 60.87 0.64 Allowed Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.491 -1.044 . . . . 71.43 110.491 172.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -69.94 101.49 1.78 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.831 0.852 . . . . 75.41 110.653 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.89 78.84 1.18 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.68 -0.968 . . . . 31.33 110.68 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 66.1 p -79.12 162.93 25.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.768 0.827 . . . . 75.25 112.447 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.8 153.1 23.2 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.817 0.847 . . . . 72.1 111.383 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -143.74 80.94 1.68 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.117 0.961 . . . . 74.22 110.207 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -99.15 133.6 43.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.559 -0.746 . . . . 74.01 110.182 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -107.7 140.36 40.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.918 0.887 . . . . 64.52 110.533 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.96 -60.73 2.26 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.603 0.761 . . . . 74.3 109.333 172.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.999 0.92 . . . . 71.45 108.972 -179.695 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -72.98 -70.34 0.36 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.182 0.593 . . . . 75.3 110.31 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' C' ' 145' ' ' ALA . 39.4 tt0 -121.7 144.88 48.53 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.38 0.61 . . . . 70.02 110.46 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.47 169.54 17.61 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.636 1.574 . . . . 74.24 107.502 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 17.2 m120 74.03 115.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.353 1.061 . . . . 74.43 112.403 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.601 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 41.8 t30 -161.68 161.66 29.54 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 73.35 108.822 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -58.81 118.39 5.67 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.023 0.929 . . . . 74.42 111.028 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.53 -40.86 66.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.099 0.96 . . . . 72.31 110.534 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 13.0 tmm? 65.73 125.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.077 1.351 . . . . 72.31 113.288 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -94.22 105.79 17.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 71.31 110.023 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.633 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 80.3 t80 -122.61 143.18 49.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 72.55 109.232 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.76 140.47 17.04 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.177 0.591 . . . . 72.43 109.687 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.0 mt -79.11 117.88 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.251 -1.018 . . . . 74.24 108.251 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -88.9 -45.4 9.73 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.772 0.67 . . . . 74.44 110.064 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.596 HH11 ' HB3' ' F' ' 132' ' ' TYR . 51.3 ttt85 -165.8 144.45 6.02 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.887 0.475 . . . . 72.31 110.277 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.84 139.85 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.173 -1.047 . . . . 74.34 108.173 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -173.78 158.18 3.21 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.312 0.577 . . . . 75.32 111.136 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -82.47 116.92 22.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.502 -0.772 . . . . 63.3 109.513 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -78.09 -41.0 36.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.696 0.76 . . . . 75.21 109.074 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -140.41 140.02 35.39 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.55 -1.205 . . . . 74.1 109.741 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.9 mt -136.36 141.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.482 1.513 . . . . 72.24 107.093 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -158.61 148.8 19.78 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.189 0.519 . . . . 74.34 110.222 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -148.27 149.41 31.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -143.45 146.42 33.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.046 1.338 . . . . 72.34 107.714 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.542 ' HB2' ' HA ' ' D' ' 19' ' ' LYS . . . -149.77 82.79 6.53 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.83 -1.174 . . . . 74.23 107.83 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.25 -31.9 43.17 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.497 2.131 . . . . 62.1 111.996 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 79.0 m-20 -112.15 38.82 2.58 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 74.45 109.599 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.86 -48.79 96.53 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.512 1.125 . . . . 75.14 113.348 177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.89 -21.14 8.47 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.729 1.619 . . . . 71.13 112.613 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.454 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.8 t-160 -67.56 -20.31 65.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.893 0.877 . . . . 75.33 111.686 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.543 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 11.7 p -46.03 -28.99 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 124.792 1.237 . . . . 61.11 114.212 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -66.92 -43.07 84.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.906 0.482 . . . . 72.32 111.824 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -127.66 39.15 3.92 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.536 0.684 . . . . 72.22 110.806 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.543 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -94.03 169.56 10.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 167.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.99 120.89 25.83 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.51 -0.922 . . . . 62.52 108.51 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t90 -78.44 81.61 4.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.481 0.657 . . . . 73.14 109.674 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -153.86 74.95 6.28 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.478 -1.237 . . . . 72.2 107.745 168.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.26 106.64 1.76 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.745 2.296 . . . . 74.53 110.611 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.67 94.89 8.74 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.323 -1.732 . . . . 73.42 106.323 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.544 HG22 HD23 ' E' ' 139' ' ' LEU . 96.4 t -86.07 102.33 11.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.549 -1.205 . . . . 64.32 110.198 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -90.29 101.83 14.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.255 -1.338 . . . . 74.11 108.007 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.486 HD22 ' H ' ' C' ' 42' ' ' LEU . 0.7 OUTLIER -89.11 147.49 24.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.978 -0.749 . . . . 72.21 108.978 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.598 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.3 t70 -142.69 136.19 28.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.631 0.772 . . . . 71.11 109.156 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 135.44 41.87 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.89 0.876 . . . . 73.34 109.085 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.34 152.06 30.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.445 1.098 . . . . 72.31 108.204 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -131.02 135.78 47.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.421 0.629 . . . . 62.12 110.896 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.52 170.64 8.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.975 -1.011 . . . . 73.33 108.747 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 59.5 p -150.86 151.22 31.93 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.654 0.382 . . . . 75.21 110.534 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.7 p -147.3 128.07 14.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.201 1.001 . . . . 75.53 109.189 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -72.2 118.15 14.72 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.629 -0.508 . . . . 72.35 109.629 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.61 HD12 ' HB2' ' C' ' 57' ' ' GLU . 54.9 mt -87.28 -43.83 11.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.214 -0.661 . . . . 71.44 109.214 176.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.97 -178.35 6.43 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.705 -1.134 . . . . 55.23 109.895 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.74 120.32 11.0 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.573 -0.74 . . . . 75.33 110.157 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 66.92 3.45 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.755 1.222 . . . . 74.42 112.872 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.99 113.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.907 0.883 . . . . 71.1 108.985 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.13 125.46 43.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.355 1.062 . . . . 63.12 108.717 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.61 ' HB2' HD12 ' C' ' 51' ' ' LEU . 43.7 tt0 -83.74 110.99 18.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.094 -0.706 . . . . 65.21 109.094 172.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -95.55 124.01 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.573 -1.269 . . . . 74.01 107.573 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.83 107.57 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.351 0.66 . . . . 74.45 109.245 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.52 104.89 16.9 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.556 -0.905 . . . . 73.22 108.556 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -90.78 121.29 32.52 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.066 1.346 . . . . 75.23 110.219 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.22 121.65 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.82 0.848 . . . . 73.42 109.302 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.598 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.0 m -103.34 141.58 35.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.901 -0.778 . . . . 72.13 108.901 166.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.619 HG23 HG21 ' C' ' 114' ' ' ILE . 87.3 t -129.45 112.32 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.094 -1.076 . . . . 75.51 108.094 173.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -108.16 106.95 17.38 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.684 -0.858 . . . . 73.34 108.684 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.94 100.61 10.1 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.851 -0.796 . . . . 73.34 108.851 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -156.81 146.5 20.73 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.111 -0.7 . . . . 54.45 109.111 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 tp -71.2 -44.97 64.36 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.501 -0.926 . . . . 75.52 108.501 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.75 -76.92 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.359 -1.096 . . . . 70.03 110.359 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.31 -33.29 16.16 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 74.14 109.376 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.4 93.72 0.9 Allowed 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.196 -1.038 . . . . 73.41 108.196 171.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -89.53 118.18 28.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.877 -0.601 . . . . 75.32 109.624 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.93 -57.73 4.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.308 -1.368 . . . . 75.23 107.308 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.42 158.69 27.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.123 -0.944 . . . . 65.02 110.725 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -126.21 143.97 50.94 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.254 -1.758 . . . . 62.31 106.254 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 34.9 t -150.89 147.52 27.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.634 -0.506 . . . . 72.44 109.634 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -156.53 129.76 8.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.831 -0.433 . . . . 72.11 109.831 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 36.9 t -127.49 114.73 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.177 0.991 . . . . 75.15 108.827 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.5 mt-30 -91.27 95.26 9.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.515 -0.921 . . . . 65.13 108.515 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.507 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.0 tp-100 -83.22 108.62 16.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.594 -0.73 . . . . 74.12 109.817 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.53 150.47 25.67 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 111.809 -0.516 . . . . 70.24 111.809 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.463 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.97 118.06 0.88 Allowed Glycine 0 CA--C 1.501 -0.828 0 N-CA-C 110.556 -1.018 . . . . 50.43 110.556 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.499 HD13 HD12 ' C' ' 51' ' ' LEU . 15.4 mm -79.61 127.91 38.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.48 -1.304 . . . . 73.54 107.48 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -135.21 150.63 50.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 75.12 110.172 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -108.42 113.93 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.238 -0.892 . . . . 73.34 108.991 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 51.5 mt -116.01 110.19 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.984 0.914 . . . . 73.12 108.834 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.41 159.16 42.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 74.25 109.817 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -26.24 8.16 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.361 -0.381 . . . . 73.2 113.374 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' C' ' 93' ' ' GLN . 10.4 tt -123.43 159.19 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.643 0.777 . . . . 75.52 110.33 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -157.93 -177.35 6.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.437 0.695 . . . . 74.23 110.34 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -153.25 40.19 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.189 -0.459 . . . . 71.01 113.563 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 76.0 p -66.0 -21.16 66.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.55 0.74 . . . . 73.34 111.259 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.444 ' HB3' HD13 ' C' ' 89' ' ' ILE . 23.2 mt-30 -59.32 -51.68 68.92 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.012 0.925 . . . . 75.34 110.88 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.422 ' HB3' HG23 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -76.26 -23.76 54.47 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.329 -0.396 . . . . 75.24 110.916 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.78 97.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.235 0.614 . . . . 71.42 111.536 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.82 -26.87 64.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.615 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -69.95 -60.78 2.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 110.357 -0.238 . . . . 75.55 110.357 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 pp -72.89 -13.98 61.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.088 0.403 . . . . 75.13 112.088 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.99 -21.14 28.82 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.779 -0.456 . . . . 61.14 113.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.8 -59.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.392 0.596 . . . . 70.3 111.432 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -51.71 66.85 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.54 0.736 . . . . 75.54 112.365 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 m -68.13 -46.68 40.74 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.731 0.812 . . . . 64.32 112.506 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.57 -24.05 49.04 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.013 1.809 . . . . 72.4 113.793 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -69.88 -20.18 63.4 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 122.751 0.42 . . . . 71.43 112.006 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.496 HD13 ' NH1' ' A' ' 111' ' ' ARG . 36.4 mm -70.34 -41.4 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.365 0.602 . . . . 74.32 109.722 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.463 HD21 ' HA3' ' C' ' 82' ' ' GLY . 78.9 mt -81.67 -27.81 33.86 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.849 -1.069 . . . . 72.34 111.931 -171.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.523 ' HZ ' HD23 ' C' ' 128' ' ' LEU . 49.1 t80 -56.26 -47.44 98.86 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 117.692 -1.147 . . . . 74.53 113.607 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.12 -42.1 67.23 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.345 2.03 . . . . 74.33 113.036 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.4 -47.52 76.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.976 0.91 . . . . 74.12 111.388 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -65.7 -37.47 86.53 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.796 -0.638 . . . . 65.13 110.894 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -62.16 -46.1 90.48 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.387 1.055 . . . . 74.43 110.134 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.11 -37.11 75.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.713 0.633 . . . . 74.14 110.705 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.5 t -64.7 -31.81 73.2 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.522 0.513 . . . . 65.41 110.793 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.619 HG21 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -73.99 -49.16 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.911 -0.586 . . . . 74.22 110.756 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.0 m -57.8 -33.63 68.77 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.44 0.638 . . . . 73.11 110.703 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -65.84 -51.57 57.76 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.702 -1.135 . . . . 73.24 109.574 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.594 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.25 -37.09 74.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.769 1.228 . . . . 74.23 112.79 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.436 HG21 ' O ' ' C' ' 114' ' ' ILE . 94.0 t -69.28 -43.51 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.809 0.844 . . . . 75.31 109.821 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.6 t -69.63 -25.39 63.91 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.12 -0.945 . . . . 73.34 110.988 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.498 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -71.54 -38.76 71.02 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 108.793 -0.818 . . . . 74.01 108.793 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.31 84.63 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 123.789 0.681 . . . . 72.53 113.043 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.6 p 62.88 29.81 16.56 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.437 1.895 . . . . 73.31 112.852 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -92.4 163.97 24.6 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 124.43 1.092 . . . . 75.54 111.246 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.405 ' HB3' ' O ' ' E' ' 136' ' ' VAL . 19.5 Cg_endo -55.62 177.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.065 3.177 . . . . 74.13 115.935 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.427 ' OE1' ' HG3' ' B' ' 125' ' ' GLN . 19.5 mm100 -60.42 112.12 1.84 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.708 1.203 . . . . 74.44 112.026 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -111.33 90.49 3.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.785 -1.561 . . . . 75.23 106.785 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -122.81 105.02 9.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.761 -1.2 . . . . 65.32 107.761 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.523 HD23 ' HZ ' ' C' ' 107' ' ' PHE . 2.8 tt -80.87 116.47 20.87 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.629 -0.878 . . . . 73.24 108.629 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 142.77 98.72 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.087 0.955 . . . . 62.34 111.739 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.452 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 18.3 Cg_endo -58.03 109.66 0.52 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.974 2.449 . . . . 70.41 112.847 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 p -97.89 110.39 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.943 -1.132 . . . . 75.45 107.943 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -102.44 78.39 1.72 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.684 -0.689 . . . . 75.2 111.1 -164.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -69.44 -29.16 66.81 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.18 -0.918 . . . . 75.13 110.508 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -69.92 -50.12 45.31 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.724 -0.671 . . . . 74.32 109.923 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' C' ' 138' ' ' MET . . . -68.55 -23.21 64.48 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.453 1.101 . . . . 74.45 111.903 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 tt -54.56 -52.1 63.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.66 0.784 . . . . 74.14 109.007 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.71 -32.79 53.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.447 -0.797 . . . . 74.11 111.661 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.413 ' HB2' ' HA ' ' C' ' 135' ' ' ALA . 96.3 mmm -68.68 -30.73 69.47 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 111.913 0.338 . . . . 64.51 111.913 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -71.21 -41.13 70.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.869 0.468 . . . . 73.44 110.266 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -70.76 -83.75 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.583 0.753 . . . . 74.42 111.847 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.94 1.61 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.085 1.354 . . . . 74.43 112.149 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.511 ' HG2' ' HG2' ' C' ' 143' ' ' GLN . 52.6 tt0 54.31 -82.39 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.697 1.599 . . . . 74.55 111.278 -170.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.511 ' HG2' ' HG2' ' C' ' 142' ' ' GLN . 12.9 mm-40 -132.71 138.14 47.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.776 0.831 . . . . 74.42 109.674 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -153.14 -85.59 0.07 Allowed 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 107.295 -1.372 . . . . 74.5 107.295 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.619 ' HB2' ' HB1' ' A' ' 145' ' ' ALA . . . -174.88 177.24 2.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.875 . . . . 75.3 110.981 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.47 146.19 12.19 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.665 -0.974 . . . . 43.34 110.665 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.54 161.37 29.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.115 0.566 . . . . 74.13 110.501 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.68 162.04 37.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.696 -0.684 . . . . 74.5 113.561 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 70.4 m -140.36 -54.84 0.52 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.914 -1.143 . . . . 73.32 107.914 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -172.81 -40.59 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.006 0.922 . . . . 72.42 110.714 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 62.46 -89.46 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.588 1.155 . . . . 74.45 109.07 -162.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 50.21 41.36 23.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.047 1.339 . . . . 73.42 112.8 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.89 153.49 20.86 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.406 1.082 . . . . 74.21 112.987 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 65.37 -86.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.45 1.5 . . . . 72.2 110.864 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.44 -0.948 . . . . 75.44 108.44 177.575 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 111.537 0.199 . . . . 60.53 111.537 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -98.47 121.97 41.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.605 -0.517 . . . . 74.32 109.605 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.71 82.7 2.09 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.674 0.79 . . . . 74.24 109.683 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -147.37 161.31 41.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.495 -0.775 . . . . 73.43 110.439 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -154.11 47.46 0.61 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.7 -1.593 . . . . 73.03 106.7 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -84.17 5.76 25.1 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.993 -1.003 . . . . 75.31 111.842 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -67.23 98.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.156 0.982 . . . . 75.3 109.763 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -81.62 66.0 6.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.36 1.064 . . . . 70.04 110.778 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.8 ttt -34.09 141.27 0.05 Allowed 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.716 1.376 . . . . 74.21 114.716 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.7 m -144.86 142.73 30.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 72.45 108.936 166.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.534 ' HE2' ' SG ' ' D' ' 102' ' ' CYS . 29.4 t80 -152.79 121.45 6.43 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.051 -1.092 . . . . 75.11 108.051 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -137.67 144.39 41.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.989 0.516 . . . . 75.32 109.765 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.3 mm -84.13 116.91 28.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.95 0.9 . . . . 72.23 108.657 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -101.46 -48.68 4.27 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.929 0.331 . . . . 70.42 111.753 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.423 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 35.3 ttt180 -173.96 128.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 111.923 0.342 . . . . 74.11 111.923 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.13 132.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 124.177 0.991 . . . . 75.54 108.373 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.423 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 18.2 p90 -163.13 176.02 10.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.692 0.797 . . . . 75.53 112.043 -172.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -111.05 126.59 54.97 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 64.01 109.636 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.542 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 35.3 mtpt -97.39 -14.41 21.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.78 0.432 . . . . 75.25 110.302 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.74 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -161.33 138.29 8.68 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.385 1.074 . . . . 73.51 109.136 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.594 HG23 ' HE1' ' C' ' 117' ' ' MET . 51.8 mt -140.68 144.49 27.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.787 -1.56 . . . . 73.1 106.787 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 20.3 t -150.23 143.5 25.01 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.024 -0.732 . . . . 71.33 109.024 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.541 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -152.39 125.7 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.67 -1.604 . . . . 75.52 106.67 173.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.0 mt-10 -126.59 142.02 51.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.995 0.918 . . . . 73.34 108.528 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 85.4 60.4 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.021 -1.103 . . . . 73.32 108.021 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.04 -45.08 8.45 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.448 2.765 . . . . 74.43 113.803 -167.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -114.53 44.56 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.154 0.982 . . . . 72.33 108.432 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.91 -57.86 12.23 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 115.808 1.781 . . . . 73.02 115.808 -167.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.437 ' HB3' HD11 ' C' ' 83' ' ' ILE . 51.6 Cg_endo -85.25 -5.76 9.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 122.345 1.873 . . . . 74.1 112.636 176.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -84.07 -39.79 19.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.27 1.428 . . . . 72.22 109.947 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.03 -16.59 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.517 0.727 . . . . 64.13 109.828 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -55.46 -32.44 62.78 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.438 1.095 . . . . 74.13 111.789 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -67.72 -8.21 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.457 0.703 . . . . 74.41 112.531 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -125.47 106.19 9.61 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.295 1.038 . . . . 72.2 109.485 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -89.23 81.93 6.63 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.28 1.038 . . . . 74.51 110.478 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.569 ' HB3' HD12 ' D' ' 68' ' ' LEU . 33.5 t-105 -146.04 157.25 43.86 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.925 -1.139 . . . . 70.22 107.925 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.579 ' NE2' HG21 ' F' ' 136' ' ' VAL . 1.7 mp0 -61.41 105.21 0.55 Allowed Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 125.161 1.384 . . . . 75.14 110.912 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' F' ' 139' ' ' LEU . 45.1 Cg_exo -61.35 111.38 1.11 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.272 2.648 . . . . 74.1 111.883 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 113.27 2.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.378 0.671 . . . . 74.41 110.542 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' D' ' 66' ' ' ALA . 27.7 m -100.76 150.27 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 70.34 110.579 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -121.63 118.92 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.621 -1.992 . . . . 75.12 105.621 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.611 ' HG ' HD22 ' D' ' 128' ' ' LEU . 0.0 OUTLIER -96.38 151.45 19.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.726 -0.842 . . . . 73.11 108.726 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -149.79 144.15 25.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.421 0.688 . . . . 64.43 109.754 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -119.73 131.82 55.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.706 0.802 . . . . 75.12 110.01 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.7 t70 -134.04 117.71 16.96 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.539 -1.282 . . . . 75.02 107.539 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -103.5 156.91 17.41 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.218 0.533 . . . . 63.42 110.359 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 171.38 18.09 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.16 0.984 . . . . 75.52 109.076 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 48.5 p -150.45 163.32 38.69 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.458 0.703 . . . . 73.43 109.582 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -158.14 118.13 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.769 -1.197 . . . . 64.32 107.769 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -85.43 122.63 29.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.454 -0.572 . . . . 74.11 109.454 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.9 -40.55 12.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.51 0.724 . . . . 75.53 109.44 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.59 5.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.698 -1.137 . . . . 75.2 109.491 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.55 130.65 43.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.41 -0.589 . . . . 73.44 109.41 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.57 5.49 5.41 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.769 1.227 . . . . 72.13 111.635 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 99.9 t -126.95 115.29 40.85 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 124.658 1.183 . . . . 74.32 108.906 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.478 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 24.7 m-85 -134.27 127.26 31.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.076 -0.713 . . . . 75.32 109.076 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.67 114.43 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.84 1.256 . . . . 71.52 108.678 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.53 137.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.446 -0.946 . . . . 73.02 108.446 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' D' ' 47' ' ' ALA . 67.9 t -115.7 138.56 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.981 0.913 . . . . 72.34 108.921 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.544 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -126.48 119.6 27.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.386 -1.338 . . . . 72.41 107.386 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -102.85 98.69 8.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.518 -0.919 . . . . 73.52 108.518 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.15 130.92 40.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.962 -0.755 . . . . 71.32 108.962 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -123.4 143.32 50.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.894 -0.594 . . . . 61.41 110.062 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.414 HG21 HG23 ' D' ' 114' ' ' ILE . 70.8 t -130.1 125.41 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.486 1.114 . . . . 74.31 108.859 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 84.3 m -115.55 110.62 19.5 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.095 -1.076 . . . . 75.45 108.095 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -98.53 157.49 16.2 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.84 0.456 . . . . 74.24 109.8 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.5 p -158.34 137.28 11.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.656 -0.498 . . . . 63.44 109.656 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.569 HD12 ' HB3' ' D' ' 36' ' ' TRP . 18.1 tp -136.03 110.34 8.43 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.054 -1.091 . . . . 72.41 108.054 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.95 -127.35 7.97 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.596 0.56 . . . . 54.24 113.382 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -94.4 9.44 38.32 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.182 0.593 . . . . 74.52 111.838 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.45 163.93 31.51 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.249 0.547 . . . . 75.31 111.349 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -74.18 134.51 42.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.823 -1.08 . . . . 74.4 109.516 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.29 -53.03 5.26 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.49 0.716 . . . . 75.41 109.865 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.92 172.47 18.4 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.76 -1.109 . . . . 73.41 109.7 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 98.5 mt -138.68 149.57 45.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.241 1.417 . . . . 73.4 108.087 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.765 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -159.76 142.37 13.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.676 0.39 . . . . 62.22 110.671 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -155.94 126.85 6.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.941 0.496 . . . . 72.14 109.883 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.33 119.07 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.667 0.787 . . . . 71.32 110.074 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.74 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 25.3 mt-30 -89.22 88.09 7.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.715 0.769 . . . . 72.34 109.037 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.86 107.99 13.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.197 -1.365 . . . . 75.41 108.676 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.47 164.04 18.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 112.347 -0.301 . . . . 64.33 112.347 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.53 3.74 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.903 -0.479 . . . . 65.32 111.903 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -88.85 126.94 41.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.639 -0.875 . . . . 74.41 108.639 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -130.54 143.48 50.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.352 1.061 . . . . 73.52 109.101 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 12.9 m -80.66 101.18 9.08 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.816 -0.809 . . . . 70.25 108.816 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.478 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 43.1 mm -107.01 106.04 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.093 -1.076 . . . . 63.24 108.093 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.11 162.13 39.46 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.387 0.675 . . . . 74.31 110.849 -173.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 -0.2 55.33 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.926 0.73 . . . . 74.4 114.926 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.402 HD13 HG21 ' D' ' 86' ' ' ILE . 17.1 pt -134.03 141.21 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.879 0.872 . . . . 74.12 109.806 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.41 166.03 25.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.578 0.751 . . . . 74.54 110.873 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.75 -112.6 3.23 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.794 0.684 . . . . 74.13 114.018 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -72.57 -30.51 64.46 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.311 1.044 . . . . 74.21 111.353 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -67.05 -52.47 41.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 72.3 110.577 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.406 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 27.5 ptm -70.26 -29.91 66.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.818 -0.628 . . . . 73.45 110.545 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.48 77.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.895 0.478 . . . . 74.31 111.09 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -64.41 -43.01 95.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.329 0.652 . . . . 73.14 110.031 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.96 -49.36 77.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.884 0.473 . . . . 73.54 111.033 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' D' ' 94' ' ' MET . 88.2 mt -70.76 -22.32 62.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.637 0.775 . . . . 75.45 111.78 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.44 9.1 24.34 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.247 -0.752 . . . . 72.32 114.607 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.11 -75.77 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.021 0.91 . . . . 74.13 111.279 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -68.69 -50.91 47.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.276 0.843 . . . . 74.53 113.276 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.534 ' SG ' ' HE2' ' D' ' 11' ' ' PHE . 25.5 m -62.9 -46.32 87.5 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.743 -0.646 . . . . 64.22 111.849 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.544 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.2 Cg_exo -57.95 -33.93 97.74 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.47 2.113 . . . . 74.33 113.347 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.53 -29.68 69.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.462 0.705 . . . . 73.52 111.147 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.73 -38.6 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.492 0.663 . . . . 71.51 110.228 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 52.2 mt -81.55 -13.65 57.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.991 -1.004 . . . . 73.35 111.624 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.597 ' HZ ' HD21 ' D' ' 128' ' ' LEU . 56.9 t80 -69.04 -46.28 30.38 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.217 -0.897 . . . . 72.14 113.371 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 -32.42 90.88 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.085 1.857 . . . . 64.23 112.912 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.89 -35.39 38.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.767 0.827 . . . . 74.33 111.948 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.64 -51.91 63.12 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.111 0.564 . . . . 72.3 109.817 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -67.69 -34.24 76.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.15 -0.932 . . . . 73.54 111.552 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.94 -43.93 81.93 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.18 0.925 . . . . 75.0 110.159 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.541 ' SG ' HD11 ' D' ' 21' ' ' ILE . 45.7 t -57.53 -43.13 84.09 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 123.626 0.579 . . . . 63.52 109.929 176.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.765 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.2 mt -63.74 -46.1 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.188 -0.914 . . . . 73.32 110.749 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 94.0 m -55.76 -49.73 72.35 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.291 1.037 . . . . 64.23 110.527 -176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -65.3 -44.12 88.93 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 113.581 -1.645 . . . . 73.24 110.387 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.3 mtm -64.63 -35.92 82.57 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.894 0.478 . . . . 74.55 112.217 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 54.1 t -67.56 -44.77 86.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.441 0.696 . . . . 71.34 110.492 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.83 -25.73 62.1 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 122.478 0.311 . . . . 61.42 111.192 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -74.69 -34.81 62.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.641 0.777 . . . . 74.24 109.162 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 0.4 76.37 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 115.393 -0.821 . . . . 72.42 112.362 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.26 27.86 16.67 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 126.85 2.06 . . . . 73.13 112.907 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -94.92 160.63 30.64 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.45 -1.25 . . . . 75.54 108.706 172.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.437 ' HD3' HG12 ' F' ' 136' ' ' VAL . 16.3 Cg_endo -53.44 136.07 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 124.066 3.177 . . . . 71.13 113.571 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.0 128.06 31.84 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 124.303 1.002 . . . . 74.34 111.804 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.667 HD12 ' HG ' ' F' ' 139' ' ' LEU . 47.7 tp -117.15 95.63 5.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 75.41 110.805 -175.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -99.91 113.34 25.83 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.801 -1.185 . . . . 73.03 107.801 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.611 HD22 ' HG ' ' D' ' 42' ' ' LEU . 1.1 tt -74.57 124.66 27.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.768 -0.456 . . . . 71.12 109.768 -174.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.79 131.32 92.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.663 0.785 . . . . 74.25 110.99 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -77.78 127.4 8.68 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.65 2.233 . . . . 71.34 112.53 -170.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.37 112.5 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.451 0.643 . . . . 75.21 109.389 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -89.03 72.97 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.919 0.866 . . . . 55.14 109.413 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.71 -24.23 61.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.789 -1.096 . . . . 73.22 110.866 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.64 -42.53 97.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.926 0.89 . . . . 72.33 110.846 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' D' ' 138' ' ' MET . . . -68.62 -22.93 64.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.728 -0.669 . . . . 73.35 112.796 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.96 -49.2 75.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.423 0.689 . . . . 75.34 110.813 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.401 ' O ' ' HB3' ' D' ' 140' ' ' TYR . 64.2 t80 -81.19 -30.08 34.43 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 72.51 110.533 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.434 ' HB3' ' HA ' ' D' ' 135' ' ' ALA . 30.2 ttm -57.51 -37.58 73.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 73.12 111.109 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.434 ' HA ' HE21 ' D' ' 142' ' ' GLN . 62.6 t30 -68.08 -30.15 69.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.468 -0.787 . . . . 72.03 110.818 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' D' ' 137' ' ' PHE . 87.0 t80 -58.27 -35.35 71.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.549 0.739 . . . . 75.12 111.399 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.28 -32.44 73.44 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.172 0.589 . . . . 75.44 110.676 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.434 HE21 ' HA ' ' D' ' 139' ' ' ASN . 35.9 mt-30 -87.42 -0.37 56.69 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.485 0.714 . . . . 74.4 111.014 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -121.65 47.23 1.91 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.748 -1.204 . . . . 75.13 107.748 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -171.52 -61.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.556 -1.202 . . . . 73.25 108.135 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 57.67 29.75 17.78 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.569 1.147 . . . . 74.13 111.774 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.51 -122.11 0.59 Allowed Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.758 -0.655 . . . . 72.31 113.486 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -97.51 -178.99 4.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.877 0.871 . . . . 72.43 110.549 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.78 -54.53 3.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.781 -0.928 . . . . 65.12 110.781 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -173.92 159.49 3.38 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.879 0.872 . . . . 73.01 110.679 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -106.96 99.13 8.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.565 -1.272 . . . . 75.31 107.565 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.33 95.53 6.39 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.727 0.411 . . . . 74.12 111.367 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -84.94 73.24 10.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.613 -1.625 . . . . 65.43 106.613 163.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -147.63 152.71 38.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.538 -1.21 . . . . 74.24 109.113 -167.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -76.7 72.59 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.908 0.861 . . . . 74.1 109.82 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.746 -1.115 . . . . 72.25 108.373 -174.557 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.16 -0.311 . . . . 75.52 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 156.49 21.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.568 0.747 . . . . 74.13 109.14 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.53 -15.83 60.34 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.441 0.696 . . . . 75.43 111.225 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 78.5 t80 70.71 154.59 0.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.323 1.449 . . . . 71.54 111.028 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.38 70.83 4.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.342 0.591 . . . . 73.03 109.554 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.38 -59.01 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.6 -0.889 . . . . 52.01 108.6 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -133.75 178.62 6.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.198 0.999 . . . . 75.22 110.061 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.584 ' HB3' ' SD ' ' B' ' 94' ' ' MET . 6.9 mp -66.42 -32.81 74.42 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 109.136 -0.691 . . . . 74.21 109.136 169.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . 0.517 ' HB2' ' HE2' ' B' ' 94' ' ' MET . 68.9 t80 -117.93 86.11 24.58 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.104 0.962 . . . . 75.54 109.06 172.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -98.72 24.57 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.508 2.805 . . . . 74.35 112.166 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -96.52 149.69 21.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.51 0.724 . . . . 54.4 109.998 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 9.5 t -103.3 138.19 40.41 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.698 0.799 . . . . 74.42 111.762 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -121.24 108.73 14.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.095 -1.076 . . . . 73.41 108.095 174.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.43 -7.31 0.89 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.662 0.785 . . . . 75.44 111.382 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.7 122.21 38.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.294 0.638 . . . . 73.11 109.957 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . 0.488 ' HA ' HD22 ' B' ' 136' ' ' LEU . 65.1 t -127.46 131.79 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.585 1.154 . . . . 74.13 108.773 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -127.87 138.58 52.73 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.054 0.942 . . . . 74.43 109.497 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . 0.433 ' HE2' HD21 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -135.49 -75.54 0.45 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 74.21 109.658 178.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.86 32.69 22.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.109 0.964 . . . . 73.04 110.673 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.24 139.75 23.7 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.046 -0.979 . . . . 72.04 113.496 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -105.88 88.49 2.83 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.127 0.971 . . . . 74.41 110.451 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.73 -63.91 1.2 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.386 -0.825 . . . . 74.03 110.499 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 19.2 mt -79.2 -2.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.64 0.776 . . . . 72.42 110.783 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.75 -24.4 67.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.36 0.664 . . . . 74.53 112.002 174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -80.41 128.88 71.22 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 108.665 -0.865 . . . . 62.42 108.665 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 9.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.201 2.601 . . . . 74.41 114.972 -168.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.7 137.31 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 122.895 0.478 . . . . 72.53 109.883 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -109.11 -81.3 0.57 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.311 -0.626 . . . . 61.41 109.311 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' C' ' 124' ' ' PRO . 23.8 t 53.03 30.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.313 1.054 . . . . 74.31 109.986 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.05 161.38 24.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.423 -0.808 . . . . 73.44 111.17 -171.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 68.12 -96.88 0.04 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 125.309 1.444 . . . . 64.13 109.651 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . 0.544 HD23 HG22 ' C' ' 40' ' ' VAL . 18.3 tp 169.36 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.151 0.98 . . . . 74.1 109.451 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 15.1 t 77.49 -71.58 0.11 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.49 1.516 . . . . 60.21 110.957 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 tt -108.47 112.98 25.66 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.466 -0.568 . . . . 75.33 109.466 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 10.3 tt -160.38 142.55 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.159 0.984 . . . . 73.41 109.416 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 9.2 t80 67.57 177.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.568 1.147 . . . . 75.12 111.101 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -100.55 169.19 9.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.486 0.714 . . . . 70.34 111.034 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.9 -48.92 76.87 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.512 -0.767 . . . . 74.23 109.904 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -92.01 159.66 15.61 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.62 -0.718 . . . . 72.3 110.563 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.48 -50.56 44.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.953 0.901 . . . . 75.22 111.298 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.9 95.68 34.85 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 73.52 109.018 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.379 2.159 0 C-N-CA 123.037 2.492 . . . . 72.12 112.157 178.469 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.116 -0.327 . . . . 74.12 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -155.51 140.38 17.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.341 0.656 . . . . 73.25 110.315 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.66 161.97 38.63 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.728 1.211 . . . . 63.41 109.217 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -75.37 81.09 2.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.144 -1.058 . . . . 73.31 108.144 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -68.57 -30.53 69.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.837 -1.074 . . . . 74.24 111.452 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.18 132.65 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.121 0.568 . . . . 73.23 110.051 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -77.15 -69.26 0.54 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.567 -0.531 . . . . 73.32 109.567 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.519 HD21 ' HG2' ' A' ' 94' ' ' MET . 19.3 mt 58.67 -179.86 0.07 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 125.177 1.391 . . . . 74.12 112.088 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 12.6 t80 71.98 150.61 0.13 Allowed Pre-proline 0 N--CA 1.496 1.86 0 C-N-CA 124.599 1.16 . . . . 75.24 112.211 166.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.473 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 10.2 Cg_endo -54.1 141.99 67.41 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.911 2.407 . . . . 74.11 114.467 171.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -94.42 -168.58 1.87 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.851 1.26 . . . . 75.35 110.126 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 97.7 m -85.16 122.9 30.02 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.845 0.858 . . . . 71.23 111.781 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -152.57 -39.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.205 -1.035 . . . . 74.33 108.205 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 64.0 14.22 8.29 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.311 1.445 . . . . 74.23 114.748 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.27 84.43 5.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.562 -0.903 . . . . 55.01 108.562 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . 0.504 ' HA ' HD22 ' A' ' 136' ' ' LEU . 69.7 t -107.35 123.08 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.241 1.016 . . . . 74.15 109.609 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.42 137.24 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.183 0.993 . . . . 75.13 108.572 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -147.34 -47.55 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.363 0.665 . . . . 71.21 110.46 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -169.8 -74.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.603 0.761 . . . . 72.14 110.116 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.81 -102.22 0.23 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.75 -0.94 . . . . 73.12 110.75 -174.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -85.2 -61.6 1.73 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.199 0.6 . . . . 75.14 109.625 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.616 ' HG ' ' HB1' ' A' ' 129' ' ' ALA . 1.6 tm? 65.46 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.749 1.62 . . . . 72.34 110.64 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -153.23 124.29 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.965 0.906 . . . . 73.54 108.556 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.23 157.15 42.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.472 0.709 . . . . 71.44 110.245 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . 0.596 ' HB3' HH11 ' C' ' 15' ' ' ARG . 2.2 m-85 59.01 54.09 4.85 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.934 1.293 . . . . 71.03 111.966 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' F' ' 132' ' ' TYR . 49.3 Cg_endo -95.47 52.88 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.396 2.73 . . . . 70.24 111.626 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.407 HG12 HG13 ' F' ' 136' ' ' VAL . 8.1 tt -55.8 115.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-N 115.039 -0.982 . . . . 74.12 110.847 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.04 83.03 2.26 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.465 -0.789 . . . . 70.45 110.849 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.579 HG21 ' NE2' ' D' ' 37' ' ' GLN . 13.9 p -165.11 81.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 122.597 1.189 . . . . 70.2 108.266 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -97.6 -22.97 16.2 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.907 -1.042 . . . . 73.11 111.477 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.37 133.99 55.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.943 0.897 . . . . 74.22 109.488 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.667 ' HG ' HD12 ' D' ' 126' ' ' LEU . 0.9 OUTLIER -70.15 -50.55 39.28 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.901 -0.777 . . . . 71.21 108.901 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m 72.57 -49.74 0.7 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 125.169 1.388 . . . . 65.5 113.913 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.62 56.93 3.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.528 1.131 . . . . 65.02 110.828 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.603 HD13 ' HG ' ' D' ' 128' ' ' LEU . 4.8 tp -117.28 126.05 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.529 0.732 . . . . 65.11 110.154 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' F' ' 145' ' ' LYS . 44.9 t80 66.85 -74.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.6 . . . . 75.32 110.694 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 59.8 t30 56.44 76.83 0.28 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.157 . . . . 73.11 111.501 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . 0.498 ' HB3' ' CE1' ' F' ' 143' ' ' TYR . 0.1 OUTLIER -171.01 171.28 5.91 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.527 -1.215 . . . . 72.33 108.225 -176.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.11 -2.57 4.3 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.938 1.088 . . . . 74.5 113.938 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 76.3 mt 70.39 10.89 7.35 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.332 1.053 . . . . 75.42 111.696 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 66.8 tp -154.9 106.57 2.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.936 -1.135 . . . . 73.43 107.936 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.564 2.014 0 C-N-CA 122.432 2.088 . . . . 71.42 112.527 -178.773 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.978 -0.379 . . . . 74.03 109.978 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -156.36 108.5 2.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.595 1.158 . . . . 71.24 108.811 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.59 87.46 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.637 -0.875 . . . . 70.15 108.637 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -123.43 -59.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.67 0.388 . . . . 74.35 111.348 -171.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 76.22 -28.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.449 1.499 . . . . 73.32 112.438 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 77.32 -70.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.643 1.577 . . . . 75.45 111.855 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.4 p -108.91 -80.57 0.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.432 0.693 . . . . 74.3 110.141 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -169.19 -54.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.592 1.157 . . . . 74.24 108.046 -175.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.58 136.64 33.7 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.103 -0.953 . . . . 75.24 110.446 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -141.56 127.26 19.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.463 1.105 . . . . 70.12 108.103 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -139.79 119.44 13.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.359 0.663 . . . . 73.22 109.45 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -138.54 115.64 10.97 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.044 0.538 . . . . 75.02 110.103 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.478 HG13 ' HD2' ' A' ' 84' ' ' PHE . 2.9 mp -78.28 115.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.35 -1.352 . . . . 60.23 107.35 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -94.13 -44.41 8.02 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.601 0.36 . . . . 72.43 111.061 -171.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.643 ' HD3' HG22 ' B' ' 122' ' ' THR . 86.0 mtt180 -159.02 157.05 30.47 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.141 0.976 . . . . 75.44 110.228 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -144.63 101.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' HD1' ' HB3' ' A' ' 15' ' ' ARG . 89.4 m-85 -159.87 177.66 10.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.943 1.297 . . . . 65.42 109.476 -165.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -90.84 135.58 33.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 122.241 -0.287 . . . . 70.51 110.735 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 42.4 mtpt -96.47 -48.64 5.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.178 -0.675 . . . . 75.21 109.178 168.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.514 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 27.8 t70 -133.26 137.23 45.96 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.271 -1.331 . . . . 74.12 109.28 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 79.4 mt -139.19 139.48 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 106.876 -1.527 . . . . 74.1 106.876 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -147.53 129.38 15.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.582 0.753 . . . . 74.33 109.458 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 81.7 t80 -142.1 125.06 16.16 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.076 -1.453 . . . . 74.21 107.076 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.78 116.45 14.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.029 -0.73 . . . . 70.42 109.029 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.64 82.99 48.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 108.878 -0.786 . . . . 74.34 108.878 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 -32.76 13.98 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.574 2.183 . . . . 74.13 111.294 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -104.72 31.39 4.77 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.05 0.94 . . . . 74.25 109.859 179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.93 98.26 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.991 0.916 . . . . 75.42 112.22 171.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -70.18 -14.97 35.36 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.962 1.775 . . . . 71.11 113.609 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -68.96 -46.59 67.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.758 -0.46 . . . . 71.33 109.758 178.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.8 -20.19 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.415 1.086 . . . . 73.43 112.153 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.22 -42.05 94.34 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.171 0.988 . . . . 65.04 111.107 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.95 -20.28 14.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.749 0.82 . . . . 72.12 111.652 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HD3' ' H ' ' A' ' 35' ' ' ASP . 3.9 tmtp? -83.79 163.37 20.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.261 1.024 . . . . 74.34 110.582 -171.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.612 ' H ' ' HD3' ' A' ' 34' ' ' LYS . 10.6 m-20 -63.69 143.53 57.76 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.207 1.003 . . . . 73.5 111.431 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -96.34 65.08 2.31 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.1 . . . . 74.33 110.609 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.44 77.38 9.72 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 109.558 -0.534 . . . . 75.33 109.558 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -82.14 148.48 15.06 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.032 1.821 . . . . 73.13 111.037 177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.23 99.87 12.04 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.768 -1.197 . . . . 64.04 107.768 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 126' ' ' LEU . 26.8 t -76.69 95.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.138 -0.937 . . . . 73.33 109.946 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HA ' ' HG2' ' F' ' 128' ' ' LYS . 35.2 tttm -79.87 131.9 35.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.148 0.979 . . . . 64.55 109.796 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.447 HD12 HG21 ' A' ' 64' ' ' VAL . 2.1 mm? -115.3 149.47 37.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.115 0.483 . . . . 74.24 110.789 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.6 m-20 -136.34 125.92 25.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.076 1.35 . . . . 73.33 107.611 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.4 mt -116.64 119.1 34.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.622 -0.881 . . . . 75.02 108.622 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -132.51 147.74 52.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.98 0.912 . . . . 71.31 109.979 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.4 m -142.84 128.67 19.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.428 0.691 . . . . 72.32 110.161 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.78 152.3 49.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.648 0.779 . . . . 50.1 109.395 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.5 m -127.2 167.34 16.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 54.12 109.597 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -168.25 122.06 0.9 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 122.978 0.174 . . . . 72.32 110.548 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' NE2' ' HE3' ' F' ' 114' ' ' LYS . 47.8 tt0 -69.78 114.45 7.99 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.793 0.837 . . . . 64.21 110.905 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 57' ' ' GLU . 58.7 mt -83.54 -41.93 17.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.324 1.05 . . . . 71.54 110.955 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.12 178.78 7.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.549 1.14 . . . . 70.12 108.309 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.14 99.01 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.922 0.392 . . . . 72.32 110.151 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.489 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 1.4 m-20 69.53 29.89 4.19 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 113.803 -1.544 . . . . 74.4 111.696 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -114.8 121.73 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.132 -1.803 . . . . 71.52 106.132 164.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.474 ' CE2' ' HA ' ' A' ' 54' ' ' ASP . 4.0 m-85 -132.49 137.33 47.16 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.309 0.576 . . . . 73.3 109.616 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD13 ' A' ' 51' ' ' LEU . 10.3 tt0 -87.09 114.14 23.44 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.283 -1.326 . . . . 75.2 108.645 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.39 110.16 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.05 -1.093 . . . . 73.41 108.05 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.43 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 97.4 t -98.45 137.79 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.523 0.729 . . . . 75.11 110.572 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.66 110.78 21.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.257 -1.386 . . . . 75.04 107.257 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -108.83 111.33 23.01 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.927 0.891 . . . . 75.21 109.386 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.1 t -110.71 128.79 66.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 123.578 0.751 . . . . 72.44 109.304 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.7 m -108.83 143.78 37.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.235 -0.654 . . . . 73.22 109.235 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.66 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.7 t -137.21 109.28 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.655 1.582 . . . . 75.22 107.759 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.4 m -114.81 119.49 36.81 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.651 -0.5 . . . . 75.24 109.651 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.28 107.33 18.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.738 -1.208 . . . . 60.44 107.738 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.0 m -129.79 128.63 42.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.917 0.487 . . . . 74.43 109.769 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.533 HD21 ' HE2' ' A' ' 34' ' ' LYS . 4.7 tt -101.44 85.49 2.79 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.162 -1.421 . . . . 75.23 107.162 172.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.86 2.19 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.204 -0.907 . . . . 73.41 111.756 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -88.16 -28.05 21.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.55 0.74 . . . . 64.42 110.779 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.46 125.5 35.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 71.55 110.212 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -88.02 114.92 25.11 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.95 -0.759 . . . . 73.14 108.95 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.89 -51.47 58.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.645 0.778 . . . . 73.44 109.347 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.474 ' HZ ' HD13 ' A' ' 126' ' ' LEU . 52.5 p90 -164.36 173.59 12.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.385 -1.28 . . . . 70.32 111.931 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.27 146.65 52.14 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.729 1.611 . . . . 73.53 107.921 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.66 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.5 m -141.92 138.99 32.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.165 0.986 . . . . 73.33 108.751 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -150.92 133.0 15.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.962 -0.755 . . . . 74.24 108.962 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.425 HG12 ' HB3' ' A' ' 113' ' ' CYS . 47.0 t -131.53 115.62 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.458 0.703 . . . . 74.3 109.121 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 62.5 mt-30 -84.6 84.83 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.057 -1.09 . . . . 71.31 108.057 170.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.91 95.82 4.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.742 -1.117 . . . . 74.44 108.555 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.84 142.96 19.55 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.819 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -137.83 122.47 2.47 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.211 -1.556 . . . . 74.22 109.211 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -89.3 122.38 40.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.478 ' HD2' HG13 ' A' ' 13' ' ' ILE . 29.3 m-85 -125.45 118.46 25.88 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.435 -2.061 . . . . 75.13 105.435 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -93.79 94.61 8.63 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.907 -1.146 . . . . 73.52 107.907 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.439 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -117.85 148.48 20.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 123.666 0.786 . . . . 73.25 110.136 -174.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.489 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -170.93 148.22 2.79 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.949 1.3 . . . . 75.34 109.351 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.44 6.64 62.53 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.167 0.292 . . . . 75.03 113.305 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.571 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.6 mp -127.33 136.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.116 -1.438 . . . . 72.24 107.116 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 175.58 11.19 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.312 0.505 . . . . 72.44 110.596 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 -152.14 48.15 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.262 -0.881 . . . . 70.53 112.767 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -65.48 -24.99 67.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.077 0.951 . . . . 54.31 112.429 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -59.65 -49.74 76.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.287 0.635 . . . . 73.14 109.969 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.717 ' SD ' HD11 ' F' ' 115' ' ' LEU . 2.5 tpt -80.86 -30.81 35.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.133 -0.939 . . . . 74.25 110.94 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -29.56 69.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.212 0.605 . . . . 75.32 110.842 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -73.55 -36.96 65.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.988 -0.551 . . . . 75.25 110.522 173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.3 t -76.78 -65.11 0.98 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.912 -0.131 . . . . 74.13 111.11 -176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.92 -29.27 70.46 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.954 0.502 . . . . 73.41 112.327 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.44 -22.77 36.17 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 114.333 0.493 . . . . 73.23 114.333 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -133.09 -49.85 0.87 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.534 0.667 . . . . 65.05 112.424 -170.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -71.84 -47.55 52.33 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.856 0.862 . . . . 74.21 111.742 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 73.9 m -67.32 -47.62 48.71 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.425 1.09 . . . . 74.11 112.675 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.26 -26.88 56.28 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.891 1.727 . . . . 72.12 112.825 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.72 -29.29 62.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.622 0.369 . . . . 74.42 110.436 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 49.7 mt -61.44 -47.04 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.752 0.821 . . . . 74.31 109.429 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.511 HD22 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -73.71 -20.4 60.54 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.698 -1.137 . . . . 73.21 112.053 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -64.65 -46.11 76.41 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 114.627 1.343 . . . . 64.11 114.627 -166.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.63 -35.13 98.91 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.932 1.754 . . . . 74.42 112.706 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -73.72 -36.46 65.22 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.369 -0.832 . . . . 73.33 111.609 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.17 -42.81 68.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.262 0.225 . . . . 74.1 110.453 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.468 HH22 ' HA ' ' A' ' 130' ' ' PRO . 38.2 ttm105 -52.13 -48.6 64.76 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.114 0.884 . . . . 65.22 110.289 175.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.36 -52.53 61.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.851 -1.068 . . . . 73.53 111.429 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.425 ' HB3' HG12 ' A' ' 78' ' ' VAL . 46.8 t -61.42 -29.21 69.8 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.908 0.755 . . . . 71.41 112.013 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.594 HG21 HG22 ' A' ' 64' ' ' VAL . 79.1 mt -71.68 -60.37 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.69 -0.686 . . . . 73.53 109.694 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -55.03 -30.31 59.29 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.548 1.139 . . . . 71.14 112.333 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 -44.49 72.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.69 -0.686 . . . . 74.54 109.992 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.512 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.9 mtm -61.11 -41.11 96.09 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.881 0.473 . . . . 62.54 110.58 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -58.23 -47.76 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.532 -1.213 . . . . 75.33 110.667 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -75.21 -26.95 59.35 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.894 -0.594 . . . . 75.23 111.411 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -71.71 -27.88 63.31 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.708 0.803 . . . . 74.12 109.852 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.65 3.78 77.2 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.494 -0.775 . . . . 50.51 112.642 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.3 m 68.06 14.6 9.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.943 1.297 . . . . 74.25 111.216 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -85.81 149.91 51.98 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.853 -0.795 . . . . 73.21 108.853 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.82 143.3 91.34 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.574 2.182 . . . . 71.11 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -61.48 132.69 54.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.685 0.394 . . . . 74.32 110.734 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.474 HD13 ' HZ ' ' A' ' 74' ' ' PHE . 63.8 mt -133.42 96.36 3.7 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.306 -0.998 . . . . 74.25 108.306 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -98.85 123.23 42.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.101 -0.5 . . . . 74.45 109.759 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.407 HD22 ' H ' ' A' ' 128' ' ' LEU . 2.4 pt? -73.13 152.72 41.05 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.919 0.762 . . . . 74.03 110.576 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.62 147.85 68.82 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.37 1.068 . . . . 64.34 112.074 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.468 ' HA ' HH22 ' A' ' 111' ' ' ARG . 15.7 Cg_exo -68.59 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.404 2.07 . . . . 64.44 110.964 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.91 111.79 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.305 -0.998 . . . . 74.45 108.305 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.61 96.65 6.86 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.494 -0.928 . . . . 73.42 108.494 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.4 ' HB3' ' HZ2' ' F' ' 120' ' ' TRP . 72.8 m-85 -59.55 -23.41 62.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.472 -0.786 . . . . 75.01 110.258 168.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 19.0 t70 -62.23 -51.31 68.26 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 123.997 0.919 . . . . 73.31 111.16 175.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.24 -30.67 69.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.622 0.576 . . . . 71.1 111.83 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.212 0.605 . . . . 72.23 110.894 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 140' ' ' TYR . 41.8 t80 -87.49 -23.05 24.55 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.749 0.42 . . . . 71.13 111.487 -177.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.8 tpt -77.47 -33.88 54.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.707 -0.849 . . . . 73.3 108.707 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.06 -54.01 47.4 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.301 -1.318 . . . . 74.11 109.722 166.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.47 ' HB3' ' HA ' ' A' ' 137' ' ' PHE . 90.8 t80 -63.5 -29.1 70.43 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.102 0.961 . . . . 75.42 111.91 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.5 tp -50.26 -47.29 55.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.577 1.151 . . . . 73.32 111.477 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -168.54 -16.13 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.65 0.594 . . . . 70.2 111.971 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.55 -53.9 12.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.591 0.356 . . . . 74.13 111.947 -167.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 70.77 -64.51 0.37 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.86 1.264 . . . . 74.01 111.551 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.91 131.67 21.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.777 0.831 . . . . 71.21 109.357 172.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.76 173.9 43.36 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.53 -0.628 . . . . 62.53 111.53 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -108.45 149.25 29.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.254 0.622 . . . . 74.21 109.8 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.51 97.72 0.63 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.202 -0.759 . . . . 62.24 111.202 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -67.43 98.94 0.69 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.439 0.696 . . . . 74.02 110.931 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.75 93.99 5.67 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.777 -0.823 . . . . 73.44 108.777 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -108.38 134.13 51.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.236 -1.024 . . . . 75.11 108.236 170.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -73.97 93.34 2.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.952 0.901 . . . . 70.02 109.253 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -70.04 101.0 1.71 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.308 -0.86 . . . . 74.3 110.199 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.01 140.49 57.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.099 -0.955 . . . . 64.43 110.598 -177.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 O-C-N 124.271 0.982 . . . . 72.43 110.728 -177.581 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' E' ' 112' ' ' GLN . 10.6 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 108.998 -0.742 . . . . 74.51 108.998 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.8 m -149.04 95.41 2.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.929 0.891 . . . . 73.55 109.412 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.77 84.39 2.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.191 0.996 . . . . 74.23 108.348 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -82.82 100.34 10.26 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 114.722 -1.126 . . . . 73.52 110.404 -172.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -168.32 163.02 12.88 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.354 1.062 . . . . 74.23 109.194 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -72.71 87.12 1.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.141 -1.059 . . . . 64.22 108.141 168.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 24.6 p -87.02 133.45 33.58 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.046 -0.979 . . . . 75.13 108.37 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.01 -21.15 43.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.343 1.057 . . . . 71.54 112.33 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.9 ptm 58.96 -179.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.571 1.949 . . . . 72.54 114.419 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -140.34 122.22 15.51 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.248 -1.019 . . . . 75.13 108.248 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -123.95 141.0 52.43 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.321 -0.622 . . . . 75.44 109.321 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 59.8 tt0 -153.97 141.69 19.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.827 0.851 . . . . 71.45 109.161 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.59 ' H ' HD11 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -94.41 117.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.39 -0.967 . . . . 73.34 108.39 175.562 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -87.04 -48.87 7.74 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.285 -0.416 . . . . 75.01 110.119 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -164.34 140.84 6.33 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.683 -0.488 . . . . 75.34 109.683 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -114.64 141.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.937 -1.505 . . . . 73.32 106.937 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.531 ' HE2' ' HZ3' ' B' ' 19' ' ' LYS . 37.8 p90 -168.25 148.35 4.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.202 0.455 . . . . 73.14 111.825 -177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.2 m -74.24 126.82 31.46 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.071 -0.714 . . . . 75.01 109.071 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.531 ' HZ3' ' HE2' ' B' ' 17' ' ' TYR . 19.2 mtpp -94.51 -41.0 9.58 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.385 -0.598 . . . . 74.1 109.385 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -139.62 141.46 37.09 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.771 -0.65 . . . . 74.14 110.533 -171.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.572 HD11 HG12 ' B' ' 78' ' ' VAL . 41.0 mm -135.81 143.09 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.161 1.384 . . . . 71.2 107.512 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 57.4 p -148.0 138.7 23.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.697 -0.853 . . . . 71.44 108.697 168.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 83.5 t80 -141.21 116.44 10.0 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 106.244 -1.761 . . . . 75.13 106.244 168.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.81 110.86 14.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.688 -1.597 . . . . 73.13 106.688 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.91 88.18 9.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.707 -0.849 . . . . 63.31 108.707 -178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.95 -26.59 51.28 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.007 2.472 . . . . 75.12 112.447 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -120.81 28.31 8.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.774 0.829 . . . . 74.43 110.054 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.94 -46.34 81.23 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 124.786 1.234 . . . . 73.22 113.669 171.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 84.1 Cg_endo -79.06 -15.15 13.14 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.717 1.611 . . . . 75.35 113.088 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.406 ' HB3' HE21 ' B' ' 33' ' ' GLN . 58.7 m80 -100.43 1.55 41.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.894 0.878 . . . . 72.13 112.899 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.46 -20.91 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.452 0.701 . . . . 62.42 111.786 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.06 -28.15 69.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 72.33 111.851 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' B' ' 30' ' ' HIS . 42.9 mt-30 -67.37 -46.64 72.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.663 -0.698 . . . . 74.45 109.587 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.61 ' HZ2' ' HB3' ' B' ' 71' ' ' GLU . 79.2 mttt -111.86 74.83 0.88 Allowed 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.828 -1.078 . . . . 74.41 111.355 -171.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.94 82.75 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.162 -1.051 . . . . 61.24 108.162 167.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -153.78 165.61 35.49 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.37 -0.832 . . . . 73.15 109.041 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -77.99 120.67 82.15 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.804 -0.813 . . . . 72.3 108.804 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -77.36 154.59 32.03 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.324 2.016 . . . . 64.32 112.068 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 22.1 mm-40 -64.75 115.4 5.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.02 -0.733 . . . . 74.33 109.02 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 p -83.8 122.32 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.607 -0.886 . . . . 73.25 108.607 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 93.4 mttt -126.44 100.38 6.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.604 -1.258 . . . . 75.34 107.604 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.464 HD21 ' HE1' ' E' ' 125' ' ' TYR . 1.5 pp -88.91 140.04 29.84 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.078 -0.965 . . . . 74.32 110.78 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.794 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.0 m-20 -136.8 145.47 44.56 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.473 -1.677 . . . . 65.21 106.473 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.667 ' HG ' HG12 ' E' ' 123' ' ' VAL . 1.3 pt? -140.39 161.54 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.903 -1.147 . . . . 74.41 107.903 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.738 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.8 t70 -159.16 143.22 15.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.192 -0.67 . . . . 73.14 109.192 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -107.34 109.67 21.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.931 -1.137 . . . . 73.43 107.931 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.522 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -113.91 154.52 27.4 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.121 -1.066 . . . . 50.14 108.121 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -143.78 162.7 35.36 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.356 0.598 . . . . 74.24 112.108 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -162.87 151.49 14.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.368 1.467 . . . . 63.3 108.4 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -123.14 127.3 48.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.543 -0.54 . . . . 75.14 109.543 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.13 -37.65 12.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.946 0.498 . . . . 74.15 110.047 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.93 -175.53 3.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.903 0.881 . . . . 71.45 110.758 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -72.98 124.47 25.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.963 -1.017 . . . . 74.54 108.631 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 68.69 11.95 8.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.072 1.349 . . . . 75.22 111.932 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.65 88.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.45 1.1 . . . . 73.23 108.171 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.481 ' HB2' HD13 ' B' ' 86' ' ' ILE . 3.5 t80 -97.85 166.21 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.101 -0.703 . . . . 70.11 109.101 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -140.3 100.1 3.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.097 -1.446 . . . . 72.51 107.097 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -95.8 137.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.985 0.514 . . . . 72.24 109.657 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.522 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 21.9 t -117.17 152.45 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.414 1.086 . . . . 71.35 109.131 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -127.89 119.65 26.05 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.158 -1.423 . . . . 75.54 107.158 176.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.738 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.5 ttt180 -105.45 106.37 16.84 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.042 -0.725 . . . . 73.14 109.042 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.2 t -106.33 111.91 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.329 -0.989 . . . . 73.03 108.329 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.794 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.0 m -106.05 125.94 51.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.357 -0.608 . . . . 74.21 109.357 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 82.7 t -120.32 99.46 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.209 1.003 . . . . 74.3 109.345 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 86.4 m -86.84 147.84 25.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.991 -1.004 . . . . 74.23 109.312 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.64 152.49 37.96 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.986 0.514 . . . . 64.41 110.287 175.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.1 p -147.01 128.83 15.31 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.301 0.376 . . . . 75.12 111.726 -178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.459 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 60.9 mt -91.42 100.65 13.39 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.222 -1.029 . . . . 72.34 108.222 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.51 -120.62 8.37 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.211 -0.904 . . . . 54.33 111.885 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.61 22.73 13.1 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.668 0.747 . . . . 73.22 110.145 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.61 ' HB3' ' HZ2' ' B' ' 34' ' ' LYS . 13.0 tp10 -137.1 144.49 43.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 74.45 109.298 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -68.87 136.86 53.3 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.751 0.31 . . . . 73.12 110.917 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.459 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -86.13 -65.29 1.03 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.411 -0.959 . . . . 53.15 108.411 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.27 166.78 29.86 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 114.658 -1.155 . . . . 72.53 110.018 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.2 mt -135.92 109.73 8.13 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.79 -1.559 . . . . 75.22 106.79 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -118.89 141.46 48.63 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.509 -0.923 . . . . 73.13 108.509 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -149.45 129.05 13.13 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.534 -0.913 . . . . 71.43 108.534 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.572 HG12 HD11 ' B' ' 21' ' ' ILE . 79.1 t -125.03 148.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 73.34 109.211 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -127.63 99.58 5.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 174.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -89.09 109.22 20.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.136 -0.938 . . . . 75.21 109.325 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.15 169.65 26.74 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 111.987 -0.445 . . . . 54.43 111.987 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.03 130.92 2.12 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.271 -0.731 . . . . 74.42 111.271 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.77 127.67 40.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -134.78 135.59 41.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.234 1.014 . . . . 63.32 109.282 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.481 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 6.6 m -88.57 121.51 31.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.115 0.966 . . . . 74.41 108.702 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.481 HD13 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pp -134.55 130.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.09 0.556 . . . . 75.41 110.545 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.99 153.09 33.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.672 0.789 . . . . 72.23 109.939 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.03 -53.84 4.51 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.641 0.588 . . . . 62.52 113.27 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.53 133.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.048 1.339 . . . . 72.3 111.526 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -150.58 176.0 11.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.58 0.752 . . . . 72.24 111.411 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.13 -136.76 35.21 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.066 -1.425 . . . . 64.44 113.199 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.5 m -65.59 -37.54 86.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.885 0.874 . . . . 71.1 111.079 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -65.26 -27.79 68.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.115 -1.402 . . . . 72.31 111.006 -172.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.485 ' HE2' ' HB3' ' E' ' 115' ' ' LEU . 0.0 OUTLIER -71.4 -33.39 69.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.215 0.606 . . . . 62.54 110.604 -178.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.35 70.49 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.189 0.596 . . . . 63.22 111.379 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -76.74 -23.02 53.01 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.332 0.653 . . . . 75.34 111.344 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.72 -64.97 1.0 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.736 0.414 . . . . 72.14 110.545 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 mt -80.05 -28.56 39.23 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.889 0.476 . . . . 74.03 111.766 -172.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.5 66.74 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-O 119.559 -0.578 . . . . 64.42 113.846 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 -57.05 0.34 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.87 0.835 . . . . 72.01 112.351 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.33 -47.56 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.268 0.627 . . . . 75.44 112.126 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -65.88 -46.38 65.15 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.641 -0.695 . . . . 71.22 111.377 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.485 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 94.6 Cg_exo -50.84 -38.67 57.92 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.491 2.127 . . . . 73.24 113.791 166.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.525 HD22 ' HA ' ' B' ' 132' ' ' ASN . 1.7 m120 -64.4 -29.73 70.79 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.243 0.46 . . . . 64.23 112.243 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.73 -42.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.724 -0.473 . . . . 64.22 109.724 172.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.19 -17.41 54.95 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.124 -0.944 . . . . 75.33 111.756 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.97 -49.78 83.87 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.88 -1.057 . . . . 72.12 113.592 -172.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.04 -39.38 70.06 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.44 2.093 . . . . 60.5 113.873 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.19 -46.57 49.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.642 -0.708 . . . . 75.55 111.114 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.44 78.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.616 0.766 . . . . 64.25 110.387 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -64.66 -50.8 65.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 75.3 110.549 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -34.68 78.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.162 0.585 . . . . 73.24 109.931 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.1 m -59.74 -52.83 63.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.751 0.82 . . . . 54.41 111.405 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.435 HD11 ' HB ' ' B' ' 62' ' ' VAL . 69.2 mt -58.25 -56.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.661 0.785 . . . . 74.32 110.805 178.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -64.77 -31.94 73.39 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 124.154 0.909 . . . . 74.1 111.582 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.6 t -61.79 -50.4 72.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.01 0.524 . . . . 74.4 110.039 174.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.531 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 19.9 mmt -68.85 -34.09 74.89 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.4 0.68 . . . . 73.41 111.232 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.08 -43.16 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.843 0.857 . . . . 70.23 110.309 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 73.1 m -67.93 -30.34 69.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.367 -0.833 . . . . 71.13 111.995 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -68.38 -28.09 66.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.409 0.684 . . . . 74.51 110.927 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.78 17.09 59.88 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 114.334 0.494 . . . . 64.12 114.334 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.643 HG22 ' HD3' ' A' ' 15' ' ' ARG . 4.1 p 69.67 12.31 8.06 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.049 1.74 . . . . 73.03 113.233 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.84 144.56 30.42 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 109.162 -0.681 . . . . 72.25 109.162 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.58 146.29 54.34 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.944 2.43 . . . . 60.11 111.676 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 18.7 mp0 -64.48 114.43 4.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.514 0.509 . . . . 74.21 110.978 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.26 85.06 2.07 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.575 -1.269 . . . . 74.05 107.575 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -101.47 121.59 42.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.14 -1.391 . . . . 71.44 108.148 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.96 139.66 40.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.281 0.632 . . . . 73.42 109.548 -172.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 154.12 84.05 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 124.02 0.928 . . . . 51.33 111.047 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.437 ' HG3' ' HH ' ' D' ' 109' ' ' TYR . 48.7 Cg_exo -55.13 92.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.252 2.635 . . . . 74.24 112.567 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.51 111.92 25.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.492 -0.776 . . . . 74.14 109.499 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.525 ' HA ' HD22 ' B' ' 104' ' ' ASN . 2.1 m-20 -82.06 107.23 14.6 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.421 -0.955 . . . . 60.12 108.421 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -58.83 -37.19 75.88 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.363 1.04 . . . . 72.1 110.581 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.61 -52.74 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.872 -1.058 . . . . 73.43 110.724 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.456 ' HA ' ' HE2' ' B' ' 138' ' ' MET . . . -61.39 -37.88 85.02 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.87 0.731 . . . . 75.21 112.013 -174.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.594 HD23 ' HD2' ' E' ' 125' ' ' TYR . 56.3 tp -59.31 -49.01 79.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.193 0.933 . . . . 73.42 110.446 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -77.5 -16.71 58.56 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.721 -0.672 . . . . 74.25 111.378 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.456 ' HE2' ' HA ' ' B' ' 135' ' ' ALA . 57.2 mtm -66.85 -15.44 63.62 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.749 0.42 . . . . 73.04 111.993 174.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -77.85 -28.28 50.05 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.676 0.79 . . . . 73.3 110.436 173.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -70.08 -30.67 67.96 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.175 0.59 . . . . 74.4 109.598 169.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -90.35 20.28 4.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.271 1.029 . . . . 74.44 111.276 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.26 97.69 1.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.666 -1.235 . . . . 75.53 107.666 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -133.36 114.27 13.53 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.221 1.008 . . . . 73.11 109.044 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 56.26 82.34 0.11 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.646 1.179 . . . . 72.52 110.123 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.38 93.0 8.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.227 -0.657 . . . . 74.34 109.227 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.08 86.92 0.13 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.147 -0.781 . . . . 70.42 111.147 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.72 128.61 14.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.991 -1.115 . . . . 72.52 107.991 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.78 162.65 32.23 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 123.006 0.191 . . . . 61.32 113.103 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -157.95 147.29 19.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.647 1.179 . . . . 62.53 108.987 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -137.57 134.16 35.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.47 0.708 . . . . 74.21 109.477 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -163.69 166.06 22.61 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 72.23 109.041 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 m80 72.44 75.36 0.15 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.881 1.272 . . . . 75.23 109.932 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.46 151.54 46.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.793 -1.094 . . . . 74.25 111.469 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -162.21 95.34 0.94 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.582 -0.896 . . . . 74.32 108.582 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 108.523 -0.917 . . . . 74.31 108.523 179.692 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.679 0.752 . . . . 74.34 109.283 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.8 t -103.75 -29.17 11.21 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.015 -0.993 . . . . 73.14 108.848 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.08 157.24 33.13 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.705 0.802 . . . . 73.32 109.482 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -150.35 153.62 36.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.445 0.698 . . . . 65.45 109.793 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.482 ' HA ' ' OE1' ' C' ' 144' ' ' GLN . 19.0 m120 -122.57 28.04 7.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.396 0.678 . . . . 70.31 111.496 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -76.12 86.18 2.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.624 0.77 . . . . 74.41 109.571 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.533 ' HB ' ' HA ' ' C' ' 145' ' ' ALA . 4.1 m -144.99 174.53 10.94 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.83 -0.804 . . . . 72.42 108.83 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.496 ' H ' HG23 ' C' ' 7' ' ' THR . 7.7 mp0 -61.39 175.36 0.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.431 1.092 . . . . 72.33 112.31 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.2 ttp 65.4 119.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.905 1.282 . . . . 71.11 111.462 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.5 m -118.6 102.06 8.59 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.098 -1.445 . . . . 72.41 107.098 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -118.6 122.79 43.45 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.687 0.795 . . . . 72.01 109.242 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -137.28 136.19 37.81 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.513 -0.551 . . . . 72.1 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.6 HD13 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -68.55 123.45 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.04 -0.726 . . . . 73.03 109.04 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -103.25 -47.96 4.16 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.723 -0.671 . . . . 72.21 109.76 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.475 HH22 ' CG1' ' F' ' 134' ' ' ILE . 20.4 ttt180 -173.24 151.98 2.16 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.651 0.595 . . . . 73.14 110.407 -176.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.6 HG13 HD13 ' C' ' 13' ' ' ILE . 89.6 mt -138.26 140.42 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.539 1.136 . . . . 73.21 108.354 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -172.02 158.53 4.72 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.762 0.791 . . . . 74.51 111.364 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.1 p -78.76 106.13 10.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.444 -1.253 . . . . 70.21 109.05 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' C' ' 19' ' ' LYS . 5.3 mmmm -66.85 -42.76 85.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.751 0.786 . . . . 74.13 109.638 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -144.53 141.47 29.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.502 -1.227 . . . . 72.31 109.341 -175.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.2 mt -135.82 146.2 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.182 -1.414 . . . . 75.3 107.182 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -154.82 149.27 26.25 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.229 0.538 . . . . 65.11 109.886 171.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -146.61 144.29 29.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.805 -1.089 . . . . 71.41 108.064 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -137.79 139.56 40.09 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.623 1.169 . . . . 74.31 107.89 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 79.29 66.25 Favored Pre-proline 0 C--O 1.241 0.652 0 N-CA-C 107.811 -1.181 . . . . 73.53 107.811 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.64 -22.04 64.89 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.641 2.227 . . . . 71.43 111.844 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.632 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 93.5 m-20 -125.91 47.24 2.27 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.448 1.099 . . . . 62.14 109.972 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.15 -54.96 50.29 Favored Pre-proline 0 CA--C 1.571 1.754 0 C-N-CA 124.279 1.031 . . . . 65.33 112.157 176.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -66.85 -26.44 44.66 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 121.976 1.784 . . . . 64.3 112.74 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.632 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 21.2 m170 -66.39 -16.35 64.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.26 1.024 . . . . 72.1 113.304 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.62 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 7.9 p -48.59 -33.66 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 112.757 0.651 . . . . 73.54 112.757 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.65 ' HE2' ' HB3' ' E' ' 132' ' ' TYR . 92.6 m-85 -76.13 -30.53 58.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.473 0.709 . . . . 74.52 111.939 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -112.88 3.51 16.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.995 0.918 . . . . 74.35 112.866 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.62 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -89.97 172.73 8.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.425 0.557 . . . . 75.3 111.061 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.407 ' HB3' HD23 ' C' ' 68' ' ' LEU . 20.6 t70 -83.9 133.36 34.72 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.197 0.999 . . . . 75.1 110.451 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -75.31 78.26 2.4 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.705 0.802 . . . . 74.53 109.995 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.441 ' HB3' HD12 ' C' ' 68' ' ' LEU . 49.6 tt0 -164.48 78.49 1.44 Allowed Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.28 -1.378 . . . . 73.34 107.28 169.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.22 106.62 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.285 1.99 . . . . 70.25 111.885 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -84.29 92.14 7.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.372 -1.344 . . . . 70.4 107.372 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.41 ' O ' HG12 ' E' ' 142' ' ' ILE . 89.3 t -84.71 110.54 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.904 -1.498 . . . . 74.31 109.385 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.419 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 48.1 mtpt -93.05 115.68 28.34 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.323 -0.621 . . . . 74.33 109.323 176.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.411 ' HG ' HD12 ' C' ' 128' ' ' LEU . 5.8 tt -86.39 126.7 34.56 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.06 -1.459 . . . . 75.43 107.06 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -120.32 132.93 55.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.414 -0.958 . . . . 73.23 108.414 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tt -134.35 117.83 16.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.392 -1.336 . . . . 71.32 107.392 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.61 149.9 52.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.962 1.305 . . . . 74.14 108.381 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -142.08 153.42 44.16 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.058 0.456 . . . . 75.32 110.032 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.96 178.35 10.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.654 1.182 . . . . 75.12 108.635 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -145.73 159.63 42.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.036 0.535 . . . . 74.44 110.333 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -145.65 126.91 14.82 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.912 0.885 . . . . 70.01 108.662 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.38 117.64 24.43 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.124 -0.695 . . . . 74.25 109.124 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.755 HD12 ' HB2' ' C' ' 57' ' ' GLU . 25.7 mt -100.93 -26.89 13.58 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.967 0.907 . . . . 73.45 110.48 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.03 -170.54 1.96 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.14 0.976 . . . . 60.35 109.918 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -69.7 101.7 1.73 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.564 -0.743 . . . . 75.22 109.606 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 74.82 6.92 4.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.538 1.535 . . . . 75.23 112.532 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.62 113.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.442 -0.947 . . . . 72.23 108.442 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.36 125.31 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.108 0.963 . . . . 74.0 109.307 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.755 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.2 tt0 -86.08 116.67 24.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.565 -0.902 . . . . 75.41 108.565 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.22 125.51 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.636 -1.246 . . . . 64.31 107.636 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.37 106.31 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.946 -1.131 . . . . 72.25 107.946 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.66 98.33 8.04 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.425 -0.954 . . . . 75.44 108.425 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -83.14 124.19 30.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.076 -0.966 . . . . 71.11 109.627 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.76 124.83 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.768 -1.197 . . . . 64.15 107.768 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -127.64 125.0 39.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 72.55 109.655 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.592 HG21 HD12 ' C' ' 114' ' ' ILE . 90.1 t -107.28 119.96 57.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.743 -0.836 . . . . 75.31 108.743 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 3.5 m -99.7 139.52 35.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.229 -1.397 . . . . 64.45 107.229 167.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.46 107.22 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.046 -1.464 . . . . 72.54 107.046 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 58.3 p -159.85 150.96 19.43 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.425 0.453 . . . . 73.44 111.29 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.441 HD12 ' HB3' ' C' ' 37' ' ' GLN . 66.0 tp -83.76 -48.17 10.39 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.701 -0.851 . . . . 63.53 108.701 165.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.56 -82.05 0.05 OUTLIER Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.553 -1.019 . . . . 70.34 110.553 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.95 -31.94 17.91 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.954 -0.758 . . . . 74.42 108.954 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.93 87.49 4.11 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.415 -0.957 . . . . 73.44 108.415 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.6 m -88.75 121.1 30.77 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.836 -0.62 . . . . 62.45 109.813 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.87 -61.73 1.9 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.923 -0.769 . . . . 74.42 108.923 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.461 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 41.7 p90 -158.89 171.87 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.72 0.772 . . . . 74.52 112.112 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.403 HD23 HG21 ' C' ' 65' ' ' THR . 2.5 tm? -137.28 135.45 37.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.235 -1.765 . . . . 75.43 106.235 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.9 t -137.98 136.76 37.26 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.279 -1.008 . . . . 71.22 108.279 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.2 120.96 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.868 0.467 . . . . 70.23 110.053 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.26 125.73 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.312 1.045 . . . . 74.24 109.585 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 1.7 mp0 -100.15 91.83 4.94 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.569 -1.271 . . . . 72.23 107.569 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -82.12 100.13 9.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.015 -0.539 . . . . 73.41 109.59 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 145.54 22.99 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.918 -0.873 . . . . 73.44 110.918 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.493 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.63 121.49 1.39 Allowed Glycine 0 CA--C 1.5 -0.902 0 N-CA-C 111.281 -0.727 . . . . 62.14 111.281 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 18.3 mm -80.31 128.09 38.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 108.067 -1.086 . . . . 73.53 108.067 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.65 139.43 38.49 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.272 0.629 . . . . 73.02 109.483 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.7 p -91.73 104.7 17.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.188 -1.041 . . . . 73.15 108.188 170.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.45 100.18 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.15 -1.056 . . . . 73.01 108.15 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.22 161.47 31.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.999 0.92 . . . . 74.45 110.364 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.47 -18.39 33.79 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.365 0.506 . . . . 54.1 114.365 168.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.78 144.82 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.282 1.033 . . . . 74.11 110.218 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -146.12 149.74 34.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.929 0.491 . . . . 64.4 111.689 -167.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.03 24.72 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.383 -0.826 . . . . 62.31 113.486 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -64.22 -23.94 67.49 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.165 0.986 . . . . 71.55 111.46 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -58.26 -57.38 13.14 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.648 0.779 . . . . 70.0 110.23 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.434 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.8 ptt? -73.12 -25.91 61.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.451 -0.795 . . . . 70.14 110.956 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.43 78.59 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.595 0.56 . . . . 70.53 110.485 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -67.36 -30.94 70.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.528 -0.76 . . . . 75.53 111.064 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.07 -64.43 1.01 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.307 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.5 pp -73.79 -16.32 61.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.558 0.577 . . . . 74.24 112.558 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.44 -9.92 37.27 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 119.449 -0.64 . . . . 62.13 114.018 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.01 -52.56 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.967 0.884 . . . . 74.13 112.571 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -73.18 -51.55 17.41 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.906 0.482 . . . . 73.31 112.2 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.6 m -61.89 -47.12 92.24 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 123.413 0.685 . . . . 72.05 110.842 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.0 Cg_exo -53.1 -36.62 77.38 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.603 2.202 . . . . 74.11 114.513 168.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.403 HD22 ' ND2' ' C' ' 132' ' ' ASN . 27.5 t-20 -63.3 -38.54 91.57 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.523 0.729 . . . . 73.44 110.974 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -39.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.443 0.697 . . . . 74.41 110.417 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.493 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.1 mt -80.67 -28.94 36.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.491 -0.777 . . . . 71.34 112.415 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -54.14 -47.12 98.23 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-O 118.012 -0.994 . . . . 71.53 113.603 -173.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.58 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.546 2.164 . . . . 73.15 114.155 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.56 -45.52 79.08 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.36 0.664 . . . . 74.03 110.504 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.04 82.67 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.224 -0.898 . . . . 75.31 110.826 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.55 -46.99 80.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.455 1.502 . . . . 75.55 110.355 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.78 -34.4 64.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.96 0.504 . . . . 64.03 110.118 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.8 t -66.42 -27.01 67.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.84 0.456 . . . . 73.3 111.017 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.592 HD12 HG21 ' C' ' 64' ' ' VAL . 77.0 mt -75.27 -54.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.922 -0.581 . . . . 73.01 109.916 171.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.8 m -62.35 -29.49 70.5 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.256 0.622 . . . . 74.41 111.696 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -67.01 -49.41 65.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.101 -0.703 . . . . 54.42 109.101 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.567 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.58 -35.18 77.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.13 0.972 . . . . 62.04 112.308 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.52 -47.5 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.42 0.688 . . . . 65.32 109.683 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 37.9 t -69.13 -27.04 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.155 -0.93 . . . . 74.34 111.211 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -71.34 -34.23 70.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 73.02 109.602 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.14 1.99 88.45 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.537 0.523 . . . . 72.21 112.494 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.8 p 60.15 35.79 21.11 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.591 1.956 . . . . 75.51 113.354 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.16 154.91 43.19 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.595 0.758 . . . . 72.5 109.817 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.91 169.75 8.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.345 2.696 . . . . 74.34 114.376 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' C' ' 127' ' ' ASN . 47.5 tp60 -60.22 113.81 2.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.476 -1.238 . . . . 73.04 111.389 -173.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.461 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 33.3 tp -134.88 115.12 13.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.791 0.836 . . . . 74.45 108.925 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.552 HD22 ' NE2' ' C' ' 125' ' ' GLN . 5.0 m120 -129.95 130.43 45.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.255 1.022 . . . . 73.25 108.404 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.411 HD12 ' HG ' ' C' ' 42' ' ' LEU . 88.9 mt -77.2 140.45 40.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.731 0.412 . . . . 73.21 110.801 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.19 137.8 78.76 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.658 0.783 . . . . 63.45 110.675 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.67 107.86 1.54 Allowed 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.847 2.364 . . . . 71.23 112.211 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.43 110.93 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.326 -0.99 . . . . 65.1 108.326 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.403 ' ND2' HD22 ' C' ' 104' ' ' ASN . 15.5 m120 -103.24 89.2 3.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.524 0.73 . . . . 52.23 110.823 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -72.76 -31.85 65.21 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.771 0.796 . . . . 75.41 109.095 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.84 -53.0 62.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.997 -1.456 . . . . 62.45 111.132 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.492 ' HA ' ' HB3' ' C' ' 138' ' ' MET . . . -64.26 -28.27 69.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.521 0.728 . . . . 64.2 112.354 -174.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.569 ' HB2' HD21 ' E' ' 148' ' ' LEU . 45.6 tp -56.09 -58.39 8.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.876 0.871 . . . . 72.22 110.691 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.8 -14.59 57.94 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.204 -0.907 . . . . 74.04 111.616 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.492 ' HB3' ' HA ' ' C' ' 135' ' ' ALA . 24.4 ttt -71.71 -31.21 66.49 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.792 0.437 . . . . 73.22 110.607 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -57.71 -38.7 75.7 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.236 -0.283 . . . . 74.12 110.236 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -72.59 -85.88 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.657 0.783 . . . . 74.45 111.232 171.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 11.7 tp -102.35 -177.33 3.37 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.287 1.035 . . . . 74.04 110.596 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 95.21 -15.61 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 126.483 1.913 . . . . 72.41 111.895 174.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.09 159.01 22.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.891 0.477 . . . . 71.25 110.17 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' C' ' 5' ' ' ASN . 6.1 tp-100 58.36 75.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.597 1.186 . . . . 75.23 110.215 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.533 ' HA ' ' HB ' ' C' ' 7' ' ' THR . . . -175.55 -176.55 0.9 Allowed 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.51 -1.223 . . . . 74.24 108.968 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.63 -143.6 16.12 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 123.152 0.282 . . . . 72.3 112.931 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -144.23 172.68 12.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.96 0.904 . . . . 73.34 110.634 -174.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.55 108.86 0.22 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 116.197 -0.456 . . . . 74.33 112.133 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -147.77 152.51 37.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.782 0.833 . . . . 74.5 109.463 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.46 133.26 45.14 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.331 0.652 . . . . 73.13 109.716 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.57 135.92 35.49 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 106.855 -1.535 . . . . 73.11 106.855 172.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -128.77 136.46 50.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.877 0.471 . . . . 73.0 110.101 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.13 127.74 54.08 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.904 0.882 . . . . 74.41 109.143 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 10.7 40.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.714 0.806 . . . . 72.33 110.177 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 124.087 0.955 . . . . 75.15 110.771 178.535 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.236 -0.653 . . . . 73.41 109.236 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t 72.4 154.86 0.15 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.975 1.31 . . . . 72.2 112.423 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -78.81 91.51 4.74 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.951 -1.022 . . . . 74.12 109.726 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -71.95 93.47 1.36 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.555 0.742 . . . . 71.22 110.662 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -76.49 124.1 27.05 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.15 -0.932 . . . . 73.33 108.921 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.473 HD21 ' HB2' ' D' ' 87' ' ' ALA . 52.1 t30 -151.7 144.12 24.13 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.914 -0.772 . . . . 74.41 108.914 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -107.42 173.66 6.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.909 . . . . 64.01 109.881 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.91 86.32 0.13 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.659 1.184 . . . . 73.1 109.144 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.4 ttp -32.24 127.24 0.25 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.109 1.364 . . . . 71.41 113.996 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.688 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.3 m -138.46 122.08 17.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.06 0.944 . . . . 70.1 108.622 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -141.98 101.18 3.89 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.181 -1.044 . . . . 71.44 108.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -122.04 127.38 50.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.067 0.547 . . . . 73.11 110.086 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.37 112.21 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.983 -1.117 . . . . 75.03 107.983 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.97 -47.81 7.36 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 119.528 -0.273 . . . . 75.42 111.716 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.412 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 42.6 ttt85 -173.12 132.92 0.51 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.563 0.209 . . . . 75.11 111.563 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.41 ' N ' HD13 ' D' ' 16' ' ' ILE . 1.9 mp -115.3 134.45 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.513 -1.292 . . . . 74.5 107.513 178.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -162.83 177.83 8.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.893 0.854 . . . . 73.44 111.641 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.1 p -109.72 118.96 37.92 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.617 -1.174 . . . . 74.1 108.351 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -85.46 -21.51 28.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.651 -0.5 . . . . 75.54 109.651 175.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.528 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.1 t70 -155.65 140.57 17.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.284 1.034 . . . . 74.25 108.657 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.567 HD12 ' HG3' ' C' ' 117' ' ' MET . 48.8 mt -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.521 -1.289 . . . . 75.41 107.521 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -153.24 140.38 19.4 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 123.748 0.655 . . . . 63.21 110.329 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.49 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.5 t80 -142.85 135.98 28.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.714 -1.587 . . . . 75.1 106.714 170.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.666 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -134.33 150.75 50.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.151 0.98 . . . . 72.24 108.538 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.63 77.69 10.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.82 -32.91 17.4 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.777 2.318 . . . . 75.32 113.545 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -114.75 41.7 2.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.935 0.894 . . . . 65.44 108.61 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.406 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -57.12 -56.28 35.32 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.64 1.348 . . . . 74.51 114.64 -169.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.45 -3.75 12.1 Favored 'Trans proline' 0 C--N 1.39 2.725 0 CA-C-N 122.11 1.789 . . . . 73.43 112.708 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.432 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 23.1 t-160 -84.65 -42.73 15.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.382 1.073 . . . . 64.51 110.393 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.04 -10.17 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-O 121.18 0.514 . . . . 64.54 110.546 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.43 ' HZ ' ' HB2' ' F' ' 132' ' ' TYR . 31.0 t80 -59.65 -36.88 77.29 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.918 -0.583 . . . . 74.13 110.262 166.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 56.4 mt-30 -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.51 110.594 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -98.93 70.59 1.84 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.011 -1.107 . . . . 72.53 108.011 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.71 88.8 0.99 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.33 1.062 . . . . 75.32 109.666 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.51 ' HB3' HD23 ' D' ' 68' ' ' LEU . 67.8 t-105 -160.46 170.63 20.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.398 -1.273 . . . . 74.02 108.468 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -71.75 110.09 6.96 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.937 1.295 . . . . 74.52 109.613 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.51 ' HA ' HD13 ' D' ' 68' ' ' LEU . 27.4 Cg_exo -65.66 141.9 68.35 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.227 2.618 . . . . 74.42 112.72 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.72 113.64 3.91 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.102 -0.703 . . . . 71.25 109.102 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.77 115.11 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.205 1.002 . . . . 74.0 110.593 -171.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -87.61 111.07 20.87 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 165.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.606 HD21 ' H ' ' D' ' 42' ' ' LEU . 2.0 pt? -96.76 148.2 23.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.451 -0.944 . . . . 75.34 108.451 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.524 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.4 t70 -151.38 151.94 32.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.775 0.43 . . . . 75.23 110.729 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.08 154.18 49.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.891 0.876 . . . . 73.51 109.97 170.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.3 t70 -152.36 137.58 17.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.426 1.091 . . . . 74.22 108.433 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -104.46 144.82 31.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 109.02 -0.733 . . . . 75.22 109.02 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.67 162.86 40.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.102 -1.073 . . . . 71.54 108.102 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.4 p -168.82 158.95 9.29 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.072 0.463 . . . . 74.33 111.916 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.7 p -152.11 119.58 6.01 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.685 1.194 . . . . 72.14 108.616 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.64 124.33 23.33 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.998 -0.742 . . . . 74.3 108.998 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 69.2 mt -87.96 -36.91 16.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.455 0.472 . . . . 72.21 109.925 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.99 -175.24 4.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.625 0.77 . . . . 61.22 111.061 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.97 124.51 20.98 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.938 -1.028 . . . . 70.12 109.141 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.494 ' HB3' ' HB1' ' D' ' 87' ' ' ALA . 19.0 m-20 66.54 -0.09 1.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.411 1.084 . . . . 74.14 113.112 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -116.05 118.06 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.051 0.94 . . . . 63.43 108.62 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.98 129.69 40.49 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.508 -0.923 . . . . 70.32 108.508 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.76 136.04 33.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.022 -1.103 . . . . 71.22 108.022 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' D' ' 102' ' ' CYS . 7.4 p -123.8 132.22 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.465 -0.939 . . . . 72.31 108.465 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 62.0 t -108.62 128.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 123.383 0.673 . . . . 70.31 109.199 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.58 114.89 27.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.945 -1.131 . . . . 74.41 107.945 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -97.14 133.09 42.25 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.645 -1.161 . . . . 74.43 108.623 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.73 120.2 44.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.523 -1.288 . . . . 62.21 107.523 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.6 m -116.95 137.41 52.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.563 0.745 . . . . 75.15 110.245 -172.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 75.3 t -125.41 117.73 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.621 1.168 . . . . 73.1 109.33 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 63.9 m -110.44 92.51 4.07 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.792 -1.188 . . . . 75.04 107.792 170.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.02 132.5 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.347 -0.612 . . . . 62.0 109.347 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -148.48 135.02 19.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.155 -1.054 . . . . 73.23 108.155 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.51 HD13 ' HA ' ' D' ' 38' ' ' PRO . 20.0 tp -113.83 124.9 53.35 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 117.789 0.268 . . . . 75.03 110.489 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.13 -110.66 3.17 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.722 -0.551 . . . . 62.14 111.722 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 4.31 9.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.589 0.756 . . . . 73.33 110.149 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.36 154.91 27.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.663 0.785 . . . . 73.43 109.435 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.0 m -74.62 141.28 44.68 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 110.045 -0.354 . . . . 73.35 110.045 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.7 -62.5 1.24 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.049 0.94 . . . . 74.33 109.421 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -158.17 138.23 12.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.373 -0.83 . . . . 75.44 109.235 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.666 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 92.3 mt -102.76 153.91 19.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.607 -0.886 . . . . 71.41 108.607 172.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 53.8 t -159.11 145.78 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.522 -0.547 . . . . 63.31 109.522 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -156.56 131.24 8.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.288 -1.005 . . . . 72.32 108.288 168.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -124.34 140.32 48.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.469 -0.937 . . . . 74.15 108.469 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.528 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -118.89 86.21 2.5 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.989 -1.115 . . . . 72.52 107.989 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.417 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.5 tp-100 -80.26 97.5 7.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.673 -1.603 . . . . 74.3 108.925 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.79 141.65 15.73 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.856 -0.498 . . . . 62.24 111.856 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 138.01 7.24 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.726 -0.55 . . . . 71.32 111.726 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.47 130.12 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.564 0.746 . . . . 65.02 109.064 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -132.67 142.48 49.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.564 0.746 . . . . 74.44 109.585 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -78.58 108.26 11.84 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.167 -1.049 . . . . 62.24 108.167 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 35.8 mm -106.7 100.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.093 -1.447 . . . . 73.33 107.093 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.688 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -144.88 158.24 43.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.136 -0.938 . . . . 74.32 109.709 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.52 -0.04 51.47 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.48 0.487 . . . . 63.3 113.75 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.22 128.67 68.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.918 1.287 . . . . 74.35 107.806 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 179.83 6.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.668 0.787 . . . . 61.32 111.245 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.1 -141.96 29.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.474 -0.785 . . . . 75.31 113.218 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 35.3 m -78.33 -18.94 54.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.599 0.76 . . . . 72.42 110.429 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -46.4 85.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.347 0.659 . . . . 72.52 110.745 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -69.59 -26.7 64.59 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.405 0.441 . . . . 74.04 110.758 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.92 71.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.376 0.671 . . . . 74.33 110.947 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.79 -38.15 64.72 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.975 0.51 . . . . 72.32 110.737 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.91 -42.35 97.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.029 0.532 . . . . 53.11 110.953 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tt -78.49 -33.31 48.3 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.294 0.638 . . . . 73.15 109.613 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.43 58.97 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.138 -0.483 . . . . 74.22 114.281 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -52.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.493 0.647 . . . . 71.54 112.024 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -68.7 -43.7 75.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.658 0.614 . . . . 72.23 112.658 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.443 ' HB3' HG13 ' D' ' 58' ' ' VAL . 69.5 m -69.17 -43.05 23.7 Favored Pre-proline 0 CA--C 1.567 1.599 0 C-N-CA 122.943 0.497 . . . . 71.02 111.524 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.41 -34.48 89.28 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.765 2.31 . . . . 73.02 113.878 165.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -66.44 -26.52 67.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.708 0.803 . . . . 73.03 111.01 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.4 -41.23 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.62 0.724 . . . . 75.43 109.739 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.417 HD11 ' O ' ' D' ' 80' ' ' GLN . 94.4 mt -78.92 -14.41 59.24 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.688 -1.142 . . . . 71.4 111.836 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.418 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 55.7 t80 -61.98 -47.99 89.74 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.769 1.228 . . . . 73.54 113.745 -173.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.418 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 37.6 Cg_exo -59.98 -33.7 95.42 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 121.852 1.701 . . . . 73.14 112.682 175.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.437 ' HH ' ' HG3' ' B' ' 130' ' ' PRO . 82.1 m-85 -76.18 -31.64 58.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 74.31 111.73 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.39 -56.26 19.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.076 0.55 . . . . 72.44 110.098 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -67.81 -32.42 72.95 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.508 -1.224 . . . . 74.22 110.787 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.29 -50.99 71.86 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.219 0.949 . . . . 75.01 110.155 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.5 t -58.61 -42.59 88.49 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.862 0.726 . . . . 74.25 110.867 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.41 HG12 ' SG ' ' D' ' 76' ' ' CYS . 73.8 mt -61.44 -52.53 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.342 0.657 . . . . 74.35 110.34 175.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.521 HG21 ' HG3' ' D' ' 125' ' ' GLN . 99.1 m -53.6 -47.33 70.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.553 1.141 . . . . 75.0 110.999 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.2 t -63.82 -42.05 97.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.5 -1.227 . . . . 73.32 110.322 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.8 mtm -69.61 -30.64 68.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.089 0.556 . . . . 74.41 111.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 72.3 t -74.02 -37.86 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.304 0.641 . . . . 74.22 110.514 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -74.05 -30.26 62.31 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 120.843 0.354 . . . . 73.33 110.497 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -72.25 -30.41 64.84 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.742 0.817 . . . . 74.4 109.606 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.93 4.21 81.04 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.481 -0.781 . . . . 53.44 112.599 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 81.4 p 60.6 34.19 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.238 1.815 . . . . 72.42 113.72 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.34 163.88 27.61 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 123.815 0.846 . . . . 75.1 112.13 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.47 125.3 5.92 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 124.375 3.383 . . . . 62.02 114.273 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.521 ' HG3' HG21 ' D' ' 115' ' ' THR . 31.1 tt0 -55.04 130.36 41.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.656 1.182 . . . . 75.42 111.51 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.57 92.76 3.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.271 0.628 . . . . 74.45 109.596 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -100.86 113.49 26.48 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 14.7 tp -76.07 127.74 33.57 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.409 0.443 . . . . 74.45 109.831 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.77 138.96 82.46 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.555 0.742 . . . . 74.53 111.805 -173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -75.43 96.29 1.03 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.298 1.999 . . . . 64.32 110.555 -176.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.69 134.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.512 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -88.71 104.84 17.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.12 -1.067 . . . . 72.53 108.12 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.56 -33.43 75.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.203 0.601 . . . . 72.21 110.984 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 -42.43 96.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.629 0.771 . . . . 73.54 110.313 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.48 93.63 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.281 0.632 . . . . 74.24 110.922 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.44 HD12 HD21 ' F' ' 148' ' ' LEU . 55.8 tp -66.78 -33.64 76.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.325 0.65 . . . . 73.11 111.03 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.05 -47.52 77.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.674 0.79 . . . . 75.44 109.77 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -73.65 -19.19 60.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.481 0.712 . . . . 73.1 111.273 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -35.03 78.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.928 -0.767 . . . . 75.51 108.928 173.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -69.37 -26.89 64.89 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 120.691 0.282 . . . . 75.42 110.965 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.21 -32.34 68.71 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.54 -0.725 . . . . 73.55 111.152 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -91.78 -1.21 57.47 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.693 0.397 . . . . 73.02 111.575 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -147.02 91.25 1.98 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.562 1.145 . . . . 73.44 109.116 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -139.59 18.47 2.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.839 0.856 . . . . 72.43 110.595 -174.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.51 -50.75 10.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.531 0.732 . . . . 74.54 110.459 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.38 50.54 0.02 OUTLIER Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.881 -0.488 . . . . 72.4 111.881 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.5 126.5 45.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.728 1.211 . . . . 75.3 109.074 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.55 2.01 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.647 -0.581 . . . . 44.41 111.647 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 45.0 p -89.23 141.31 28.64 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.567 0.747 . . . . 75.33 110.104 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -106.53 -93.13 0.39 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.505 -1.294 . . . . 72.1 107.505 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 57.67 164.33 0.03 OUTLIER 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.447 1.499 . . . . 71.24 112.989 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -162.87 177.74 9.0 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.555 -0.748 . . . . 74.52 110.137 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.96 117.47 7.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.487 -1.233 . . . . 74.42 108.603 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.6 -60.9 2.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.141 0.576 . . . . 64.14 110.346 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.092 0.957 . . . . 70.31 108.552 177.009 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.573 -0.158 . . . . 73.43 110.573 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -126.45 27.6 6.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.445 1.098 . . . . 74.31 109.83 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.73 83.49 4.09 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 110.017 -0.364 . . . . 72.43 110.017 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -65.85 -52.98 45.75 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.717 0.807 . . . . 74.22 110.414 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' B' ' 1' ' ' MET . 49.8 tp60 63.02 12.66 6.09 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.497 1.119 . . . . 71.04 111.842 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -61.97 -35.72 79.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.178 0.991 . . . . 73.23 110.087 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.56 163.31 16.28 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.17 -1.377 . . . . 74.54 108.251 168.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.485 ' HB3' ' HE2' ' B' ' 94' ' ' MET . 9.0 mp -77.97 77.77 4.47 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.06 -0.718 . . . . 74.22 109.06 173.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -177.31 71.44 0.23 Allowed Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.772 1.629 . . . . 75.25 107.767 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -93.22 162.23 2.52 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.169 2.579 . . . . 72.0 112.874 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 62.81 -175.54 0.15 Allowed 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.085 0.954 . . . . 74.52 110.845 172.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -160.03 173.69 15.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.97 0.508 . . . . 75.11 110.132 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.79 132.89 40.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.852 0.861 . . . . 71.23 110.808 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.66 -19.57 23.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.599 0.76 . . . . 74.44 111.186 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.43 99.8 2.22 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.288 0.635 . . . . 73.15 110.19 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . 0.667 HG12 ' HG ' ' B' ' 44' ' ' LEU . 5.4 t -87.51 69.08 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.797 -0.816 . . . . 74.32 108.797 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -161.01 147.15 14.7 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.137 0.575 . . . . 74.21 110.916 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . 0.594 ' HD2' HD23 ' B' ' 136' ' ' LEU . 1.3 p90 -134.75 133.43 39.9 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.146 0.978 . . . . 74.43 109.036 169.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -128.98 173.79 10.11 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.253 1.021 . . . . 75.52 109.843 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.18 -145.74 16.51 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.915 -0.584 . . . . 74.15 111.663 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.01 85.01 2.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.665 0.786 . . . . 73.12 109.812 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.75 149.75 20.92 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.842 -0.617 . . . . 74.41 110.745 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt 61.31 78.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.084 1.354 . . . . 73.31 110.57 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -120.05 21.83 11.68 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.379 -0.828 . . . . 73.42 109.682 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . 0.65 ' HB3' ' HE2' ' C' ' 32' ' ' PHE . 98.4 m-85 -116.54 91.38 33.77 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 75.32 110.239 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.22 127.58 6.81 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.913 2.408 . . . . 71.5 112.516 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . 0.538 HG21 HG23 ' C' ' 31' ' ' VAL . 48.3 mm -94.74 128.73 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.656 0.783 . . . . 74.23 109.043 176.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.57 15.5 3.73 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.255 0.622 . . . . 73.41 112.319 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.446 ' H ' HG22 ' E' ' 134' ' ' ILE . 12.5 p -146.78 140.04 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.767 0.827 . . . . 73.11 109.491 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.85 -177.86 4.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.564 1.146 . . . . 72.13 109.283 170.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.37 56.81 6.88 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.166 0.916 . . . . 74.3 110.387 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.5 92.36 0.44 Allowed 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.067 -0.969 . . . . 65.32 109.8 -176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 30.9 p -151.29 110.32 3.9 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.086 -0.961 . . . . 74.24 108.725 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 tt -160.02 44.98 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.803 -1.554 . . . . 72.31 106.803 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . 0.41 HG12 ' O ' ' C' ' 40' ' ' VAL . 5.4 mt -118.74 -70.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.551 -0.749 . . . . 73.34 109.851 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -115.9 138.38 51.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.557 0.743 . . . . 73.42 109.672 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -81.6 -36.06 29.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.21 0.604 . . . . 74.13 110.149 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -166.72 -68.38 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.279 -1.378 . . . . 74.42 107.279 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . 0.577 ' HB3' ' HG3' ' E' ' 149' ' ' PRO . 6.0 m-20 61.36 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.105 1.362 . . . . 75.44 113.057 167.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . 0.429 HD12 ' H ' ' A' ' 13' ' ' ILE . 2.4 tt 59.69 75.62 0.39 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.646 1.178 . . . . 65.32 109.114 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' C' ' 136' ' ' LEU . 57.1 tp 61.68 80.39 0.25 Allowed Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.268 1.027 . . . . 72.43 110.668 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . 0.577 ' HG3' ' HB3' ' E' ' 146' ' ' ASP . 8.1 Cg_endo . . . . . 0 CA--C 1.56 1.811 0 C-N-CA 123.024 2.483 . . . . 74.42 111.599 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 27.8 t70 . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.136 -0.691 . . . . 75.02 109.136 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -90.22 -59.31 2.22 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.91 88.92 2.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.267 1.027 . . . . 73.34 108.353 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -135.12 -53.06 0.79 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.122 0.969 . . . . 74.22 108.544 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 60.15 114.22 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 63.23 110.221 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -69.88 86.95 0.52 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.435 0.694 . . . . 73.45 110.327 -173.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.506 ' HE3' ' NE2' ' A' ' 50' ' ' GLN . 53.0 mttp -84.56 130.77 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.905 0.882 . . . . 75.3 110.707 -176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.717 HD11 ' SD ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -149.51 143.14 25.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.766 -1.106 . . . . 64.12 110.61 -156.702 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -149.27 163.12 26.56 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.397 1.079 . . . . 74.5 110.962 -172.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.86 -169.47 0.76 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.875 2.383 . . . . 75.04 111.897 165.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -153.22 158.4 41.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.739 0.816 . . . . 74.12 108.999 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -81.31 139.22 35.52 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.14 -0.689 . . . . 75.44 109.14 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . 0.4 ' HZ2' ' HB3' ' A' ' 133' ' ' PHE . 28.0 p-90 -145.67 -73.84 0.23 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 119.196 -0.43 . . . . 74.01 111.138 177.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 59.04 153.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.955 1.302 . . . . 74.4 112.403 -170.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.85 13.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.907 -0.495 . . . . 74.4 111.639 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.19 -27.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.936 0.495 . . . . 75.25 111.75 -172.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? 63.63 60.53 1.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.644 1.178 . . . . 74.21 108.372 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -66.18 103.15 0.93 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.927 -1.033 . . . . 74.11 111.706 -168.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -140.92 24.05 2.2 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.764 1.226 . . . . 71.33 107.835 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.36 126.69 10.24 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-N 115.042 -0.981 . . . . 51.05 112.214 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 41' ' ' LYS . 52.2 mtmt -106.37 140.52 39.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.559 0.743 . . . . 75.2 110.983 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -142.13 -172.15 3.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.832 0.853 . . . . 74.11 109.869 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 11.0 tt -156.04 -30.63 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.824 0.85 . . . . 74.14 110.508 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 64.38 -154.14 0.3 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.745 1.218 . . . . 71.02 110.093 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . 0.43 ' HB2' ' HZ ' ' D' ' 32' ' ' PHE . 13.7 p90 -119.28 88.21 37.17 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 121.385 0.612 . . . . 74.21 111.102 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -93.72 -176.21 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.376 2.717 . . . . 74.31 112.98 175.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.475 ' CG1' HH22 ' C' ' 15' ' ' ARG . 10.6 mm -94.85 122.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.355 -0.98 . . . . 75.51 108.355 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.62 -75.44 0.2 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.457 0.703 . . . . 75.15 110.393 -175.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m 42.86 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 126.577 1.951 . . . . 74.12 114.856 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -136.39 -68.3 0.5 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.841 1.256 . . . . 73.32 108.164 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.27 -169.62 3.42 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.528 -1.669 . . . . 74.43 107.497 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.44 HD13 ' O ' ' D' ' 38' ' ' PRO . 0.0 OUTLIER -83.57 -57.2 3.33 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.279 -0.637 . . . . 74.12 109.279 178.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m 69.1 -12.54 0.4 Allowed 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.063 1.505 . . . . 73.32 115.063 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.93 -24.5 55.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.58 0.627 . . . . 74.22 111.523 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.408 HG23 HD22 ' D' ' 42' ' ' LEU . 18.7 pt -67.25 121.6 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.198 -0.668 . . . . 75.12 109.198 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 74.06 -60.66 0.52 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.429 1.492 . . . . 74.55 111.61 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 40.0 t30 63.89 95.13 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.942 1.297 . . . . 74.24 110.809 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 65.67 -72.33 0.08 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 74.54 111.516 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.24 94.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.365 1.066 . . . . 72.51 110.684 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.86 102.08 1.19 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.347 -1.353 . . . . 72.12 107.347 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . 0.44 HD21 HD12 ' D' ' 136' ' ' LEU . 55.0 tp 65.5 85.45 0.16 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 124.569 1.148 . . . . 75.41 109.321 -170.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.028 0 C-N-CA 123.13 2.553 . . . . 72.03 111.349 176.601 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.413 0.149 . . . . 75.51 111.023 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 p -163.4 142.91 8.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.807 0.843 . . . . 64.02 109.733 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.47 146.85 36.22 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.562 -0.533 . . . . 75.42 109.562 170.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.14 140.9 29.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.333 0.587 . . . . 73.15 110.441 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -126.99 -177.11 3.92 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.29 1.036 . . . . 62.15 109.456 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.6 79.16 5.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.981 0.896 . . . . 55.5 110.858 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 t -164.57 135.32 4.15 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.675 -1.148 . . . . 75.42 108.788 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 55.32 -159.36 0.2 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.987 0.915 . . . . 73.4 111.989 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 75.0 mtm 66.57 135.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.743 1.217 . . . . 72.45 110.701 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.0 m -139.75 112.08 7.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.121 0.568 . . . . 70.33 109.625 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -139.68 112.92 8.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.78 -1.193 . . . . 72.51 107.78 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -133.84 116.97 16.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.177 0.591 . . . . 72.12 109.77 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.66 115.32 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.264 -1.013 . . . . 74.55 108.264 174.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.06 -44.86 10.05 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.81 -0.441 . . . . 75.02 109.81 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -174.52 144.69 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.795 0.438 . . . . 72.21 110.616 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.87 123.7 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 75.15 107.725 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -152.51 148.22 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.597 0.713 . . . . 74.44 111.126 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -79.96 112.58 17.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.638 -1.165 . . . . 74.25 109.904 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -82.1 -21.65 36.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.589 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.726 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -153.04 141.44 20.68 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.312 -0.858 . . . . 73.34 109.947 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 71.4 mt -144.78 143.11 22.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.812 1.645 . . . . 74.31 106.779 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.6 t -158.4 124.58 4.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.423 0.452 . . . . 71.23 110.208 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.444 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 91.8 t80 -116.49 147.54 41.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.027 -1.471 . . . . 74.41 107.027 169.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -142.5 140.49 31.86 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.871 0.868 . . . . 62.33 109.543 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.644 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -152.14 68.14 7.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 106.685 -1.598 . . . . 73.22 106.685 170.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.02 -20.46 21.86 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.234 1.956 . . . . 75.01 110.948 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -105.86 16.12 25.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.37 1.068 . . . . 74.11 109.729 -179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.644 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -54.19 -45.49 99.14 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.166 1.173 . . . . 75.13 114.166 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -64.68 -26.93 60.71 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.93 1.753 . . . . 71.21 113.006 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -75.33 -33.5 61.14 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.781 0.832 . . . . 74.33 111.747 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 73' ' ' ALA . 3.9 m -72.07 -23.62 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 122.923 0.489 . . . . 75.33 111.285 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -70.88 -31.37 68.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.794 -1.094 . . . . 53.44 110.232 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -76.53 -47.41 22.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.897 0.879 . . . . 73.24 110.381 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -82.65 167.1 18.58 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.5 -0.773 . . . . 72.25 111.928 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 116.21 6.34 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.778 -0.823 . . . . 63.34 108.778 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.658 ' HE1' ' HB3' ' F' ' 135' ' ' ALA . 38.0 p90 -84.88 63.98 8.37 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 122.583 1.182 . . . . 75.33 110.53 -171.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -120.51 86.42 39.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 107.252 -1.388 . . . . 63.34 107.252 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.56 173.17 7.6 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.522 2.148 . . . . 73.43 113.154 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -96.6 124.36 40.56 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.5 90.17 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.499 -0.926 . . . . 74.22 108.499 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -96.39 127.91 42.83 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.016 -1.105 . . . . 74.02 108.016 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.44 HD22 ' HA3' ' F' ' 127' ' ' GLY . 4.0 pp -134.21 145.97 49.69 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.064 -0.717 . . . . 75.31 109.064 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.74 148.5 39.1 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.023 -1.103 . . . . 75.5 108.023 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.8 147.58 40.98 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.197 -0.668 . . . . 72.14 109.197 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 11.6 t70 -154.11 137.28 15.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.966 0.906 . . . . 72.12 109.083 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -107.53 130.44 54.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.559 0.744 . . . . 74.42 109.634 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.74 150.6 52.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.184 0.994 . . . . 73.15 109.118 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -134.37 161.35 35.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.283 0.633 . . . . 73.45 110.816 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -152.29 152.75 32.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 73.21 108.753 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.38 123.43 48.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.146 -0.687 . . . . 63.33 109.146 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 57' ' ' GLU . 51.5 mt -101.81 -33.27 9.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.863 0.865 . . . . 73.01 110.725 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.57 -167.67 1.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.664 0.786 . . . . 74.44 110.64 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.16 99.37 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.215 1.006 . . . . 73.33 110.803 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 66.49 13.03 9.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.008 1.323 . . . . 72.44 112.303 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 56.5 t -99.54 111.04 28.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.541 -1.652 . . . . 72.12 106.541 167.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.403 ' HH ' ' HB2' ' F' ' 115' ' ' LEU . 93.0 m-85 -119.79 168.84 10.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.526 -0.761 . . . . 73.41 109.167 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.462 ' HB2' HD13 ' A' ' 51' ' ' LEU . 37.6 tt0 -132.51 134.53 45.12 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 125.065 1.346 . . . . 72.44 107.389 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.4 HG13 ' HD3' ' A' ' 103' ' ' PRO . 97.9 t -121.18 124.17 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 171.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.503 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.8 t -109.78 135.42 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.126 0.97 . . . . 64.3 109.338 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 121.28 44.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.681 -0.859 . . . . 75.22 108.681 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.23 105.09 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.472 0.709 . . . . 74.11 109.565 172.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.45 128.23 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.283 -1.006 . . . . 75.43 108.283 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -119.26 120.58 37.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.158 0.504 . . . . 74.42 109.832 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.436 HG22 HG21 ' A' ' 114' ' ' ILE . 71.0 t -112.25 105.84 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.346 1.058 . . . . 73.43 108.549 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.9 m -110.83 138.23 47.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.063 -0.717 . . . . 70.21 109.063 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.13 127.75 40.4 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.024 -1.102 . . . . 72.24 108.024 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -141.36 125.62 17.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.891 0.477 . . . . 70.14 110.632 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.673 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.1 pt? -93.39 84.27 4.71 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.159 0.984 . . . . 72.44 108.369 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.41 -102.44 1.49 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.339 -1.301 . . . . 54.32 112.093 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -95.96 -24.26 16.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.56 0.744 . . . . 71.13 109.664 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -92.06 135.55 33.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.895 1.278 . . . . 63.13 109.482 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 80.9 m -77.93 133.01 38.14 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.72 -0.474 . . . . 65.14 109.72 170.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.608 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -76.8 -59.92 2.57 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.003 -0.74 . . . . 73.43 109.003 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -165.88 166.79 17.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.125 -1.398 . . . . 75.31 110.189 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.22 127.57 32.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.226 1.01 . . . . 73.22 108.697 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.4 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 57.1 m -119.27 137.72 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.993 0.917 . . . . 64.2 108.657 172.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.16 122.48 9.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.407 -0.96 . . . . 73.12 108.407 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.28 132.21 69.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.302 0.641 . . . . 73.04 109.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.726 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.1 mt-30 -96.98 90.57 5.24 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.427 -0.806 . . . . 74.14 109.428 166.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.8 95.49 6.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.725 -1.125 . . . . 71.11 108.34 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.37 161.33 26.29 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.188 -0.46 . . . . 74.12 112.092 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.44 140.67 7.37 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.835 -0.906 . . . . 64.41 110.835 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.7 mt -86.26 127.19 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 N-CA-C 108.635 -0.876 . . . . 62.15 108.635 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -133.19 118.13 18.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.374 -0.973 . . . . 72.53 108.374 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -88.0 100.56 13.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.777 -0.823 . . . . 75.53 108.777 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.5 pt -119.52 147.75 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.262 0.553 . . . . 75.12 111.428 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HA ' HD21 ' F' ' 115' ' ' LEU . . . -171.53 164.69 6.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.978 1.711 . . . . 62.33 108.852 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.45 9.01 87.37 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.752 -0.471 . . . . 54.33 114.11 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -120.26 146.67 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.452 0.701 . . . . 73.34 109.94 176.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.16 170.78 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.318 0.647 . . . . 71.53 109.469 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.76 -125.55 37.25 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.776 0.672 . . . . 71.15 114.758 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -72.4 -37.94 68.56 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.884 0.874 . . . . 75.51 111.705 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.51 -35.06 78.2 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.114 0.566 . . . . 75.41 111.003 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.809 ' SD ' ' HA ' ' F' ' 115' ' ' LEU . 55.8 ttp -68.93 -45.73 70.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.952 0.901 . . . . 71.12 111.054 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' F' ' 117' ' ' PRO . . . -60.84 -34.04 73.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.627 0.771 . . . . 74.44 111.478 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -66.05 -48.43 71.05 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.915 -1.039 . . . . 75.53 110.551 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.649 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 0.8 OUTLIER -68.81 -55.68 10.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.304 0.853 . . . . 74.32 113.304 -168.11 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.463 HD21 ' HD3' ' F' ' 117' ' ' PRO . 4.1 pp -76.3 -25.67 55.06 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 122.113 -0.367 . . . . 73.54 111.382 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.07 -18.67 45.76 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 114.292 0.477 . . . . 70.04 114.292 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -135.98 -58.01 0.76 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.169 0.588 . . . . 71.41 111.638 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.649 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 1.4 t80 -54.88 -53.6 53.31 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.179 0.992 . . . . 74.32 113.065 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m -68.56 -49.58 29.53 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.616 -0.707 . . . . 72.03 112.684 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD3' HG13 ' A' ' 58' ' ' VAL . 38.3 Cg_endo -65.56 -15.41 49.4 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 121.637 1.558 . . . . 75.22 113.56 172.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -72.79 -35.74 67.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.469 -0.567 . . . . 73.54 109.469 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mm -65.75 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.471 0.709 . . . . 73.03 110.135 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.8 -24.26 60.89 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.102 -0.954 . . . . 64.33 111.557 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.14 -45.02 39.93 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 114.451 1.278 . . . . 73.42 114.451 -168.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.611 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 29.4 Cg_endo -62.83 -29.86 77.01 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 121.553 1.59 . . . . 73.53 112.511 174.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.535 ' CE1' ' HA ' ' C' ' 108' ' ' PRO . 11.6 m-85 -81.94 -26.23 34.19 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.882 0.473 . . . . 71.52 111.861 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.29 49.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.684 -0.858 . . . . 41.23 108.684 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.423 HH22 ' HB3' ' A' ' 130' ' ' PRO . 39.2 ttm180 -51.6 -48.15 63.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.026 -1.443 . . . . 73.23 110.913 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.48 -47.93 77.13 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.428 -0.806 . . . . 74.22 111.149 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.23 -32.95 73.68 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.401 0.681 . . . . 70.41 111.402 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.436 HG21 HG22 ' A' ' 64' ' ' VAL . 74.9 mt -71.71 -58.51 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.706 0.802 . . . . 71.23 110.139 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.0 m -56.23 -33.74 65.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.69 1.196 . . . . 74.04 111.955 -173.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -67.34 -44.0 80.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.341 -0.845 . . . . 71.15 110.583 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.444 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.0 mtm -65.17 -35.0 79.71 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.593 0.357 . . . . 74.43 111.253 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.65 -46.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.8 0.84 . . . . 71.51 110.286 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.4 p -74.25 -28.95 61.46 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.783 -0.644 . . . . 72.51 111.458 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -71.79 -29.79 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.453 0.701 . . . . 73.34 109.828 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.27 -0.18 85.78 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.627 -0.715 . . . . 71.5 112.685 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m 68.04 29.75 6.23 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.89 1.276 . . . . 64.03 110.8 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.608 ' HE1' HG23 ' A' ' 31' ' ' VAL . 83.2 m-85 -99.11 152.1 37.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 115.287 -0.87 . . . . 73.23 110.329 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.05 141.7 77.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.386 2.057 . . . . 72.5 111.353 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -62.28 144.73 55.26 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.562 0.745 . . . . 73.45 112.312 -175.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -146.48 103.01 3.64 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.336 -1.357 . . . . 55.34 107.336 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.17 119.11 37.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.419 0.688 . . . . 71.2 109.212 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.49 136.51 44.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.325 0.65 . . . . 75.04 110.404 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.21 138.36 86.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 45.32 111.36 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.423 ' HB3' HH22 ' A' ' 111' ' ' ARG . 46.9 Cg_endo -77.84 112.24 3.25 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.981 1.788 . . . . 73.31 111.035 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.58 136.05 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.65 -0.87 . . . . 72.31 108.65 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 4.1 m-20 -72.96 78.48 1.17 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.277 0.631 . . . . 74.33 110.771 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -77.02 -26.6 53.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.862 -1.063 . . . . 72.42 108.758 173.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 16.3 t70 -64.54 -48.42 75.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.891 -1.504 . . . . 72.23 110.504 175.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' A' ' 132' ' ' ASN . . . -79.57 -19.31 49.71 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.597 -0.729 . . . . 71.44 111.806 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 139' ' ' ASN . 49.8 tp -66.7 -33.19 75.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.942 0.497 . . . . 72.45 110.374 174.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -67.41 -27.6 67.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.063 -0.517 . . . . 75.15 110.892 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.427 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 66.0 mtp -68.12 -22.17 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.525 0.33 . . . . 75.13 111.506 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.504 HD21 HD11 ' A' ' 136' ' ' LEU . 81.7 m-20 -66.78 -27.55 67.68 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.367 0.667 . . . . 74.53 111.144 172.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -85.98 -35.6 20.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.783 0.833 . . . . 74.42 110.475 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 63.4 tp -63.17 -50.0 72.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.955 0.902 . . . . 75.34 111.971 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.36 25.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.355 -0.609 . . . . 72.05 109.355 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.5 tt0 62.35 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.341 1.457 . . . . 73.04 111.333 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -153.94 110.76 3.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.82 -0.808 . . . . 73.44 108.82 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.12 151.6 33.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.648 0.779 . . . . 53.55 110.038 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.51 -169.04 12.04 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 111.57 -0.612 . . . . 75.23 111.57 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.44 156.73 37.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.803 0.441 . . . . 71.44 110.747 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.29 41.57 2.05 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.465 -0.788 . . . . 54.34 112.486 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.5 p -69.98 84.92 0.51 Allowed 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.603 0.716 . . . . 71.4 109.715 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 149.83 32.34 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.235 -0.893 . . . . 63.24 110.774 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 49.36 50.35 18.24 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.069 1.348 . . . . 74.55 112.999 166.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -74.04 90.54 2.0 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.353 0.597 . . . . 73.33 109.57 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.12 120.45 40.46 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.981 -1.008 . . . . 75.42 110.713 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.04 82.34 1.93 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.209 1.004 . . . . 73.23 108.376 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 109.088 -0.708 . . . . 42.54 109.088 -179.583 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.917 -0.772 . . . . 72.54 108.917 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 t 65.43 26.11 11.91 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 124.343 1.057 . . . . 65.14 109.606 -163.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -164.31 160.57 21.09 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 125.063 1.345 . . . . 75.34 108.179 -170.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -166.7 132.79 2.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.842 0.457 . . . . 74.05 110.184 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.608 ' HB3' ' HB2' ' B' ' 90' ' ' GLU . 42.5 t30 -148.72 136.93 21.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.581 -0.896 . . . . 61.23 108.581 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -135.12 135.91 41.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.646 0.779 . . . . 70.14 109.281 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.626 HG21 ' H ' ' B' ' 8' ' ' GLU . 5.2 m -118.75 -159.94 0.78 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 107.386 -1.339 . . . . 73.44 107.386 174.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.626 ' H ' HG21 ' B' ' 7' ' ' THR . 19.6 mm-40 -62.56 -27.38 69.14 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.076 1.307 . . . . 73.14 110.767 175.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ptm 57.91 -179.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.779 2.032 . . . . 61.31 113.672 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -160.49 143.08 13.07 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.499 -0.773 . . . . 74.43 109.877 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -132.43 113.36 13.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.832 -0.803 . . . . 75.02 108.832 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.78 140.11 52.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.256 1.022 . . . . 72.45 108.539 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.512 ' H ' HD11 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.67 137.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.819 -0.808 . . . . 74.03 108.819 167.258 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -101.47 -51.58 3.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.726 0.41 . . . . 73.22 110.431 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -161.13 139.4 9.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.035 -0.357 . . . . 73.13 110.035 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.34 140.58 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 107.271 -1.381 . . . . 75.1 107.271 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -167.84 147.96 5.03 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.279 0.561 . . . . 75.34 112.151 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -74.34 119.36 18.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.923 -1.035 . . . . 65.4 108.724 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -93.92 -29.47 15.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.565 0.746 . . . . 73.01 111.807 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.415 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 29.4 t70 -160.2 142.72 13.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.625 0.25 . . . . 73.23 110.803 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 31.6 mm -143.83 145.57 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.837 1.255 . . . . 74.11 109.055 -175.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -146.38 141.95 27.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.302 -1.369 . . . . 72.03 107.302 163.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.493 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -150.03 111.83 4.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.244 -1.761 . . . . 64.32 106.244 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -115.98 156.9 25.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.597 -0.89 . . . . 73.32 108.597 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.67 76.39 14.19 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 105.817 -1.92 . . . . 64.51 105.817 174.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.02 -28.79 80.82 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.229 2.62 . . . . 74.54 113.212 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -124.48 29.31 6.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.855 . . . . 74.2 109.589 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.44 -53.39 24.19 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 115.162 1.541 . . . . 63.45 115.162 -172.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.83 -8.85 18.13 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.151 1.9 . . . . 74.31 113.433 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -97.75 -42.48 7.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.608 0.763 . . . . 71.25 110.65 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.69 -13.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.224 1.01 . . . . 71.34 110.181 173.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.73 -36.63 57.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.419 1.088 . . . . 73.51 111.342 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -70.6 -23.28 62.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.698 0.799 . . . . 72.4 112.488 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.98 111.24 20.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.688 0.795 . . . . 74.42 111.543 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.68 87.85 3.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.914 0.486 . . . . 64.01 109.904 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.61 ' HB3' HD21 ' B' ' 68' ' ' LEU . 29.9 t90 -154.36 157.31 38.39 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.016 -1.105 . . . . 75.04 108.016 174.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -67.1 116.87 40.47 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.368 0.667 . . . . 73.45 110.4 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 53.8 Cg_endo -67.87 127.53 16.31 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.057 1.838 . . . . 74.03 111.463 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.03 104.61 0.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.576 1.15 . . . . 73.24 109.848 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -91.65 136.01 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.314 0.578 . . . . 70.51 111.363 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 61.9 tttp -136.75 104.95 5.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.297 1.039 . . . . 75.54 108.572 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.422 ' H ' HD11 ' B' ' 42' ' ' LEU . 0.0 OUTLIER -86.49 167.85 14.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.193 0.597 . . . . 63.23 110.828 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 29.4 t70 -153.01 115.17 4.38 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.287 -0.869 . . . . 62.43 108.763 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.463 HD21 ' HH ' ' E' ' 125' ' ' TYR . 8.1 mp -100.65 134.64 43.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.611 -0.885 . . . . 73.43 108.611 176.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.5 t70 -142.92 142.17 31.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.768 0.827 . . . . 64.4 109.612 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 42.7 p -118.55 116.19 26.14 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.411 -0.813 . . . . 71.23 109.76 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -114.81 152.31 32.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.135 -1.432 . . . . 71.3 107.135 168.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 62.3 m -143.53 169.96 16.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.019 0.438 . . . . 73.33 110.78 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -155.13 169.07 24.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.406 1.082 . . . . 52.05 108.679 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -125.1 128.03 47.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.713 0.805 . . . . 74.54 108.929 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -100.16 -22.65 15.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.429 0.691 . . . . 72.4 110.911 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.99 176.54 4.67 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.792 0.837 . . . . 74.35 110.207 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.69 122.26 13.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.702 -0.481 . . . . 74.01 109.702 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 72.37 -5.85 1.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.821 1.648 . . . . 74.33 112.705 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.4 t -103.78 100.84 11.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 N-CA-C 108.462 -0.94 . . . . 73.05 108.462 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.55 137.82 50.23 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.282 0.633 . . . . 73.33 109.699 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -110.29 97.39 6.87 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.349 -1.352 . . . . 74.42 107.349 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 57.8 t -95.97 123.55 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.363 0.665 . . . . 74.24 110.079 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 45.8 t -100.61 119.04 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.033 0.933 . . . . 74.31 110.108 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.16 114.19 26.27 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.219 -1.03 . . . . 75.14 108.219 177.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.403 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 29.3 ttm180 -99.51 117.62 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.932 0.396 . . . . 70.23 110.249 171.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -112.94 102.64 14.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.967 -1.123 . . . . 70.13 107.967 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 7.0 m -98.1 134.94 40.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.32 137.27 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.54 0.736 . . . . 70.11 109.941 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 85.3 m -121.33 146.44 46.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.213 1.005 . . . . 75.24 108.844 175.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -144.17 129.16 18.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.633 -0.877 . . . . 72.0 108.633 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -130.22 139.57 50.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.994 -0.743 . . . . 73.4 108.994 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.61 HD21 ' HB3' ' B' ' 36' ' ' TRP . 1.8 tt -124.99 105.98 9.61 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.964 -1.124 . . . . 72.32 107.964 -177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.28 -115.06 4.15 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.651 -0.704 . . . . 74.44 112.016 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -108.75 4.52 23.78 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.822 0.811 . . . . 73.24 111.509 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.86 169.5 17.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.934 0.494 . . . . 73.21 111.158 -173.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -73.62 133.11 43.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.51 -0.768 . . . . 71.02 110.26 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.486 ' HB1' ' HB2' ' B' ' 68' ' ' LEU . . . -85.44 -58.22 2.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.146 0.978 . . . . 74.22 108.378 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.512 ' HZ ' HD12 ' B' ' 126' ' ' LEU . 45.4 p90 -164.3 161.51 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.548 -1.205 . . . . 73.13 110.246 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.73 152.12 47.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.08 1.352 . . . . 74.35 108.941 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.9 t -151.51 157.92 42.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.427 0.691 . . . . 62.45 109.408 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -165.77 128.48 2.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.76 -0.83 . . . . 73.44 108.76 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' B' ' 110' ' ' ALA . 65.7 t -126.17 143.6 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.044 -0.724 . . . . 71.3 109.044 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.415 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -124.75 102.36 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.531 -0.915 . . . . 73.03 108.531 172.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -94.04 100.66 12.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.132 -1.062 . . . . 71.0 108.132 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.66 144.18 16.93 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.452 -0.659 . . . . 73.43 111.452 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.48 127.47 3.64 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.694 -0.562 . . . . 74.54 111.694 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.16 125.99 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.33 -0.989 . . . . 73.31 108.33 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -131.43 161.44 32.46 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.363 1.065 . . . . 74.14 109.319 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -131.29 93.54 3.39 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.874 0.87 . . . . 73.43 108.725 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.451 ' H ' HD12 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -117.33 139.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.999 0.92 . . . . 73.34 110.098 -176.79 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.91 168.82 26.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 72.41 109.792 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.55 -28.77 5.16 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 123.539 0.525 . . . . 60.24 113.513 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 pt -90.84 137.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.709 1.204 . . . . 65.32 110.552 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' B' ' 5' ' ' ASN . 42.4 mt-10 -149.31 149.8 31.48 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.022 0.929 . . . . 74.43 109.243 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.23 -118.78 9.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.704 -0.68 . . . . 74.3 113.367 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.3 m -65.22 -40.43 94.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.794 0.838 . . . . 70.25 110.339 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -63.06 -34.19 77.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.672 -1.149 . . . . 63.15 110.853 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.514 ' SD ' HD12 ' B' ' 98' ' ' LEU . 13.2 tmm? -79.94 -43.07 22.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.909 -1.041 . . . . 74.14 111.089 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.13 91.96 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.564 -0.744 . . . . 74.23 112.46 -168.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 3.0 p80 -82.82 -12.46 57.45 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.602 -0.272 . . . . 75.54 110.996 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -85.35 -68.68 0.71 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.614 -0.266 . . . . 73.35 110.355 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.514 HD12 ' SD ' ' B' ' 94' ' ' MET . 2.4 pp -85.07 -14.8 46.11 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.198 0.444 . . . . 52.13 112.198 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.2 -2.98 59.0 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.75 -0.472 . . . . 72.13 113.303 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -147.29 -60.86 0.28 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.274 0.537 . . . . 73.4 112.036 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.67 -43.52 89.06 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.914 0.485 . . . . 74.23 112.136 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 67.1 m -69.35 -44.72 26.95 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.198 0.599 . . . . 71.03 111.403 -177.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.503 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 80.2 Cg_exo -53.3 -37.34 80.87 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.152 1.901 . . . . 73.53 113.731 164.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.35 -27.32 66.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.48 0.312 . . . . 74.01 111.798 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.53 -42.69 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.663 0.785 . . . . 73.21 110.009 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.406 ' HB2' HD13 ' B' ' 60' ' ' LEU . 42.4 mt -81.54 -15.63 54.25 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.791 -1.095 . . . . 72.24 111.243 -174.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -60.17 -49.6 90.03 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 117.533 -1.223 . . . . 73.35 113.9 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.52 -32.21 96.01 Favored 'Trans proline' 0 C--N 1.38 2.202 0 CA-C-N 121.748 1.66 . . . . 62.44 112.913 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.38 -47.51 48.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.22 0.608 . . . . 75.24 110.413 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.408 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -58.02 -43.46 86.72 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.635 -0.711 . . . . 73.1 110.294 175.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -58.97 -52.01 67.59 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.633 1.573 . . . . 63.25 111.313 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.32 -37.09 86.05 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.928 0.767 . . . . 74.31 110.313 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.514 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.8 t -65.79 -41.43 91.98 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 123.612 0.57 . . . . 74.13 111.49 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.95 -53.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.449 0.7 . . . . 74.01 110.343 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -69.14 -24.1 64.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.762 -0.654 . . . . 73.11 111.403 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.8 t -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.09 0.556 . . . . 73.44 110.054 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -70.44 -32.04 69.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.485 0.314 . . . . 75.34 110.452 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.07 -35.76 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.836 0.854 . . . . 74.41 110.695 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 m -61.39 -46.51 89.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.267 0.627 . . . . 62.4 110.082 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -63.81 -36.5 84.09 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.738 -1.119 . . . . 74.02 111.189 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.9 -1.25 87.11 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.389 -0.673 . . . . 63.42 113.434 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 60.4 p 55.81 30.76 16.35 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.098 1.759 . . . . 74.04 112.598 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.38 162.87 38.51 Favored Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 124.565 1.146 . . . . 74.44 110.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.11 164.02 15.46 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 123.229 2.619 . . . . 74.34 113.649 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.411 ' HA ' ' HG2' ' C' ' 125' ' ' GLN . 0.6 OUTLIER -65.14 111.11 2.78 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.295 -0.866 . . . . 74.4 110.585 -172.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.512 HD12 ' HZ ' ' B' ' 74' ' ' PHE . 96.1 mt -135.05 83.58 2.03 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.779 -1.193 . . . . 74.44 107.779 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -101.07 122.61 43.87 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.362 -1.348 . . . . 73.45 107.362 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 33.6 tp -66.4 133.53 50.66 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.652 0.595 . . . . 74.02 111.034 -170.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.07 143.74 94.7 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.245 1.018 . . . . 74.51 111.67 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 87.24 0.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.911 2.407 . . . . 72.11 112.423 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 63.1 t -94.89 133.89 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.45 0.7 . . . . 74.33 110.526 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.96 113.74 26.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.33 1.052 . . . . 75.34 109.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.79 -29.4 67.76 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 71.43 111.916 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.6 -34.23 67.24 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.608 0.763 . . . . 63.35 110.763 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.78 -38.23 88.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.89 -0.595 . . . . 74.2 109.717 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.5 HD12 HG11 ' E' ' 123' ' ' VAL . 2.4 tm? -64.8 -40.38 95.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.015 0.926 . . . . 74.41 109.69 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.12 -47.52 80.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.69 0.796 . . . . 72.41 110.759 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 64.4 mtt -70.45 -38.35 74.49 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.578 -0.737 . . . . 73.11 110.432 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -18.56 59.27 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.331 0.652 . . . . 75.42 111.594 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -53.85 -46.37 71.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.602 1.161 . . . . 72.42 110.15 177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 pp -118.96 22.23 12.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.179 -1.373 . . . . 73.04 110.596 -174.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 61.57 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.966 1.307 . . . . 72.21 111.426 -170.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -69.31 81.69 0.37 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.946 0.879 . . . . 75.13 111.239 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.31 95.06 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.53 -1.656 . . . . 73.03 106.53 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.09 157.58 36.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.101 0.96 . . . . 74.53 108.801 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.87 63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.06 -0.816 . . . . 52.21 111.06 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.0 48.75 1.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.319 1.047 . . . . 73.41 110.984 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.64 78.52 0.73 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.296 -0.722 . . . . 63.14 111.296 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.0 t -149.31 162.13 40.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.531 0.732 . . . . 71.52 109.911 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -143.07 -174.6 4.24 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.272 1.029 . . . . 72.43 108.805 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 143.41 18.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.433 -0.58 . . . . 75.1 109.433 173.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -91.84 102.23 14.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.577 -0.897 . . . . 75.31 108.577 172.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -141.32 109.37 5.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.025 0.93 . . . . 73.34 109.023 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -155.33 142.97 19.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.998 0.519 . . . . 74.14 109.712 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.39 0 O-C-N 124.606 1.191 . . . . 74.03 111.216 -178.359 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.927 -0.397 . . . . 72.22 109.927 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -155.32 26.55 0.41 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.597 1.559 . . . . 71.4 108.253 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -91.28 -25.35 19.5 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.543 1.137 . . . . 64.32 112.796 -164.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.577 ' HB3' ' HG2' ' C' ' 150' ' ' GLU . 0.5 OUTLIER -69.83 166.34 19.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 120.867 0.365 . . . . 71.34 111.194 174.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -128.93 -64.85 0.9 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.844 0.458 . . . . 63.31 109.954 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.99 79.87 0.21 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.17 0.988 . . . . 74.41 111.088 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.1 p -134.65 18.9 3.57 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.559 0.743 . . . . 73.22 110.529 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -104.64 78.87 1.49 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.909 0.883 . . . . 74.12 109.842 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.0 ttp 65.61 112.31 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.005 1.722 . . . . 74.44 112.105 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -86.8 86.41 7.32 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.837 -0.801 . . . . 74.22 108.837 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.44 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 67.5 t80 -89.6 128.12 35.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.396 -0.594 . . . . 70.12 109.396 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.14 132.84 22.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.302 -0.629 . . . . 75.55 109.302 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.1 134.57 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.9 -0.778 . . . . 74.41 108.9 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -105.42 -51.44 3.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.523 0.329 . . . . 63.41 110.346 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -171.09 145.85 2.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.695 0.398 . . . . 73.42 109.934 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -124.05 138.45 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.116 -1.068 . . . . 72.35 108.116 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.468 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -170.94 146.18 2.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.547 0.339 . . . . 75.32 110.103 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -69.17 128.98 38.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.87 0.468 . . . . 73.44 110.448 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -84.48 -46.26 11.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.054 0.931 . . . . 72.21 108.869 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 8.0 t70 -134.79 136.95 42.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.175 -1.375 . . . . 74.31 109.325 -173.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -134.56 139.65 47.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.289 -1.374 . . . . 73.24 107.289 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.61 143.67 25.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.56 -0.745 . . . . 75.11 109.43 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -153.37 109.25 3.29 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.074 -1.084 . . . . 75.54 108.074 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.4 136.07 53.43 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.939 0.896 . . . . 74.33 109.106 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.78 91.7 10.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.46 -0.941 . . . . 71.53 108.46 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.95 -41.83 12.77 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 75.41 112.367 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 33.0 m-20 -99.09 35.53 1.88 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.171 0.588 . . . . 74.13 109.687 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.486 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -59.55 -51.54 80.41 Favored Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 118.254 -0.879 . . . . 60.24 112.941 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 37.9 Cg_exo -64.79 -33.52 53.26 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 121.783 1.656 . . . . 75.51 112.351 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.515 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -66.58 -19.5 65.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.52 1.128 . . . . 75.22 112.41 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.576 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 3.2 p -58.5 -14.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 113.043 0.757 . . . . 64.34 113.043 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -55.41 -40.66 71.72 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.06 0.944 . . . . 75.11 111.341 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -114.74 40.25 2.64 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.432 1.093 . . . . 74.11 109.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.576 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 0.0 OUTLIER -83.61 144.13 29.65 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.975 0.91 . . . . 72.41 110.721 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -88.1 113.57 23.87 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.625 -1.25 . . . . 74.15 107.625 163.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -83.47 64.02 7.64 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.839 0.828 . . . . 74.22 110.161 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.484 ' HG2' ' HB3' ' E' ' 140' ' ' SER . 74.1 mt-30 -142.44 52.58 2.47 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.977 1.311 . . . . 75.23 108.573 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.41 144.81 9.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.023 1.816 . . . . 64.25 111.697 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.581 ' HA ' HD23 ' E' ' 141' ' ' LEU . 38.5 tt0 -84.25 95.92 8.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.54 -0.911 . . . . 72.44 108.54 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' C' ' 65' ' ' THR . 16.7 m -71.76 102.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.293 -0.867 . . . . 73.13 110.565 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.415 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.1 mttt -91.97 100.2 12.9 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.159 -1.052 . . . . 70.11 108.159 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.3 163.53 16.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.347 -0.612 . . . . 74.41 109.347 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.6 t70 -156.33 146.29 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.53 -0.915 . . . . 75.13 108.53 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -133.8 117.35 16.78 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 75.42 107.757 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.78 137.57 46.85 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.02 1.328 . . . . 75.43 107.861 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.8 t -113.11 149.82 32.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.428 0.633 . . . . 64.43 110.28 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.53 162.17 28.8 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.568 -1.196 . . . . 73.13 107.995 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -135.63 151.15 49.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.282 0.633 . . . . 53.54 109.7 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.4 t -149.91 125.99 10.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.098 -1.075 . . . . 71.34 108.098 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -83.63 120.52 26.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.184 -0.673 . . . . 74.21 109.184 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -92.79 -40.81 10.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.42 0.688 . . . . 64.24 109.842 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 175.3 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.832 -1.076 . . . . 64.32 109.339 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.67 123.74 18.34 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.542 0.526 . . . . 74.53 109.76 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 68.16 2.14 3.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.055 1.342 . . . . 73.12 113.554 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.76 112.35 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.46 -0.941 . . . . 71.15 108.46 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -125.05 122.51 37.44 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.513 0.673 . . . . 74.1 109.295 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD12 ' C' ' 51' ' ' LEU . 33.4 tt0 -85.46 138.36 32.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.161 -1.382 . . . . 75.13 108.303 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.518 HG23 HD13 ' C' ' 106' ' ' LEU . 17.5 m -130.25 143.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.975 -0.75 . . . . 75.32 108.975 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.67 105.12 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.312 -0.995 . . . . 73.55 108.312 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.545 HD22 ' HB3' ' C' ' 103' ' ' PRO . 2.8 tm? -92.54 104.39 16.7 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.168 -1.049 . . . . 74.22 108.168 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -79.07 124.07 27.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.386 1.074 . . . . 75.41 109.385 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.471 ' HB ' HD11 ' C' ' 114' ' ' ILE . 22.0 t -112.84 110.22 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.596 -1.261 . . . . 75.51 107.596 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.8 m -99.21 136.57 38.97 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.904 -1.147 . . . . 71.24 107.904 176.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.556 HG21 HG23 ' C' ' 114' ' ' ILE . 64.9 t -135.94 113.16 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.135 0.974 . . . . 73.13 108.74 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 21.3 m -104.06 144.35 31.67 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.658 -0.867 . . . . 73.42 108.658 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.28 104.24 5.14 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.204 -1.036 . . . . 60.34 108.204 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.443 ' HB3' HG22 ' C' ' 72' ' ' THR . 56.5 p -159.91 169.16 24.1 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.113 0.565 . . . . 74.54 109.923 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -120.73 -40.82 2.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.954 -0.758 . . . . 74.21 108.954 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.36 -97.8 0.12 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 110.799 -0.92 . . . . 64.44 110.799 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -88.08 -27.86 21.69 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.645 -0.872 . . . . 72.14 108.645 170.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.33 87.92 1.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.356 -0.838 . . . . 75.13 109.334 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.443 HG22 ' HB3' ' C' ' 67' ' ' SER . 64.6 m -88.03 136.68 32.86 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.44 -0.8 . . . . 74.21 109.476 171.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.39 -63.95 1.28 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.633 -0.877 . . . . 71.34 108.633 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.42 177.36 9.59 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.299 1.047 . . . . 75.12 111.96 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.31 143.75 46.35 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 105.009 -2.219 . . . . 72.51 105.009 168.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.9 t -149.49 144.15 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.106 -1.072 . . . . 62.42 108.106 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -158.85 131.24 6.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.557 -0.535 . . . . 74.52 109.557 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -126.98 120.75 56.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.975 -1.011 . . . . 74.42 108.725 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -99.15 90.39 4.57 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.807 -1.183 . . . . 75.21 107.807 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.405 ' O ' HD11 ' C' ' 106' ' ' LEU . 8.3 tp-100 -79.96 108.86 13.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.261 -1.336 . . . . 70.21 109.511 -174.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 158.69 29.71 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.977 -0.556 . . . . 63.31 112.266 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.22 126.23 1.56 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.365 -0.294 . . . . 73.33 112.365 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.518 HD13 HD12 ' C' ' 51' ' ' LEU . 12.2 mm -88.4 124.62 41.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.553 -0.906 . . . . 75.14 108.553 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.76 122.5 18.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.549 0.74 . . . . 75.42 109.674 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -90.36 110.44 21.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.965 0.506 . . . . 73.15 110.093 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.76 118.68 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 108.491 -0.929 . . . . 72.22 108.491 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.75 160.44 30.81 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.472 0.709 . . . . 73.32 111.531 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.87 -61.15 3.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.48 -0.782 . . . . 73.55 112.389 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.9 mm -91.02 145.71 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.007 0.923 . . . . 72.1 110.204 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -147.02 -171.31 3.74 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.3 1.04 . . . . 75.12 110.258 -173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 73.21 -143.34 32.95 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.171 -0.468 . . . . 74.33 113.316 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.9 p -66.84 -23.18 66.0 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.93 0.892 . . . . 74.32 111.914 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.06 -44.09 66.48 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.605 0.762 . . . . 63.35 110.994 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.484 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 21.6 ptt? -71.91 -32.96 67.89 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.447 -0.575 . . . . 70.15 109.447 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.15 -27.21 67.85 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.26 0.624 . . . . 65.42 110.989 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -73.42 -38.66 65.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.529 0.732 . . . . 75.0 110.411 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -67.97 -61.51 1.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.405 0.282 . . . . 73.51 111.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -76.3 -16.55 59.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.125 0.57 . . . . 74.22 112.142 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.96 -24.02 23.81 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.768 -0.462 . . . . 70.41 113.352 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.43 -59.05 1.1 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.393 0.596 . . . . 64.45 111.819 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.401 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 42.5 t80 -60.42 -57.27 13.46 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.74 0.816 . . . . 74.34 111.967 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.47 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 47.4 m -62.05 -47.7 90.14 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 115.312 -0.858 . . . . 74.44 112.17 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.545 ' HB3' HD22 ' C' ' 60' ' ' LEU . 89.8 Cg_exo -54.03 -35.67 81.91 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.85 2.366 . . . . 75.55 114.594 169.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -21.16 60.1 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.09 0.556 . . . . 75.22 111.368 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.422 HD13 HH12 ' A' ' 111' ' ' ARG . 21.8 mm -77.48 -35.05 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.464 0.706 . . . . 75.23 109.945 171.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.518 HD13 HG23 ' C' ' 58' ' ' VAL . 98.8 mt -76.45 -38.77 54.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.222 0.609 . . . . 74.55 111.992 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.14 -41.35 74.15 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 124.359 1.063 . . . . 72.55 113.333 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.611 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 39.7 Cg_exo -43.9 -55.21 3.21 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.643 2.229 . . . . 75.44 115.883 168.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.19 -30.63 71.13 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.328 0.585 . . . . 73.12 110.343 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.6 73.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.093 -0.958 . . . . 71.13 111.274 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.503 ' HD3' ' CZ ' ' A' ' 109' ' ' TYR . 22.3 ttt180 -56.43 -51.76 67.18 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.492 0.717 . . . . 75.25 110.982 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.75 -31.32 69.23 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.451 0.47 . . . . 74.41 110.667 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.42 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 7.1 t -69.25 -28.11 66.03 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.664 0.386 . . . . 74.41 111.245 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.556 HG23 HG21 ' C' ' 64' ' ' VAL . 89.2 mt -79.17 -50.1 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.402 0.681 . . . . 75.4 110.141 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -65.55 -29.33 69.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.866 0.467 . . . . 72.32 111.353 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -63.98 -52.25 60.51 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.287 -0.634 . . . . 71.55 109.287 172.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.474 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.66 -40.69 75.93 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.629 1.172 . . . . 75.3 112.468 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG21 ' O ' ' C' ' 114' ' ' ILE . 78.6 t -65.75 -43.4 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.555 0.742 . . . . 74.14 110.383 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 37.9 t -69.6 -25.0 63.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.786 -0.643 . . . . 74.23 111.451 176.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.2 mtt-85 -72.03 -34.37 68.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.3 0.64 . . . . 74.24 109.994 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.67 6.34 74.15 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.618 0.574 . . . . 74.2 113.146 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.525 HG22 ' HB3' ' D' ' 17' ' ' TYR . 44.4 p 65.28 22.23 12.08 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.722 2.009 . . . . 73.45 113.268 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.402 ' HB2' HG13 ' C' ' 118' ' ' VAL . 99.0 m-85 -84.52 162.12 51.77 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.84 0.856 . . . . 74.12 110.415 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.467 ' HD3' HG11 ' E' ' 136' ' ' VAL . 36.7 Cg_endo -64.06 151.05 86.98 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.657 2.238 . . . . 73.35 113.074 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' B' ' 125' ' ' GLN . 24.4 mm-40 -60.26 112.36 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.965 0.906 . . . . 71.45 112.036 -172.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.61 90.35 3.28 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.346 0.658 . . . . 75.02 110.089 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.47 118.49 31.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.491 0.716 . . . . 74.34 109.937 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.459 ' O ' ' HD2' ' C' ' 111' ' ' ARG . 3.0 mm? -87.19 135.07 33.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.985 0.914 . . . . 74.1 109.233 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 141.86 87.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.451 0.7 . . . . 75.11 111.153 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.52 ' HB3' ' HE2' ' A' ' 109' ' ' TYR . 38.5 Cg_endo -65.65 125.72 14.84 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.4 2.067 . . . . 73.12 111.302 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.43 114.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.526 -0.916 . . . . 72.22 108.526 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.635 ' HB3' ' HB1' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -77.61 75.22 4.16 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.005 0.922 . . . . 72.22 109.958 -177.39 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.55 -43.61 18.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.733 0.413 . . . . 72.21 110.188 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.95 -45.66 60.26 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.958 -0.565 . . . . 74.03 110.015 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.635 ' HB1' ' HB3' ' C' ' 132' ' ' ASN . . . -63.74 -20.7 65.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.83 -1.077 . . . . 75.24 111.984 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 28.8 tp -64.22 -37.51 87.73 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.62 0.768 . . . . 75.13 110.765 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -79.92 -31.3 40.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.059 0.544 . . . . 71.22 110.728 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.521 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 85.4 mtp -64.21 -44.03 93.2 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.083 0.553 . . . . 75.52 111.739 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -68.39 -34.65 76.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.085 0.241 . . . . 73.3 110.436 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -63.99 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.903 0.881 . . . . 73.01 110.954 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 57.3 tp -142.17 95.19 2.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.017 0.527 . . . . 73.33 109.677 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.521 ' HB3' ' HA ' ' C' ' 138' ' ' MET . 53.9 tt0 -170.32 112.55 0.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.956 0.903 . . . . 62.32 109.129 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.92 7.3 3.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.754 0.821 . . . . 74.12 111.005 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -83.05 175.81 9.72 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.893 0.877 . . . . 73.53 111.127 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.74 82.98 0.17 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.375 1.07 . . . . 74.13 110.423 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.7 -34.7 0.02 OUTLIER Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.366 -0.834 . . . . 73.32 111.749 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -83.43 112.72 20.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.16 -1.052 . . . . 70.1 108.16 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.37 -162.53 10.37 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.585 -0.734 . . . . 44.01 111.758 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.5 t -72.81 82.84 1.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.697 0.76 . . . . 71.23 109.896 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' C' ' 4' ' ' GLN . 11.7 pt-20 -70.46 -31.56 68.77 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.12 -0.946 . . . . 74.02 110.93 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.437 ' HG3' ' HG3' ' C' ' 150' ' ' GLU . 1.8 pp20? -135.69 144.28 45.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.854 0.862 . . . . 75.11 109.72 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 177.5 116.29 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 72.35 108.048 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -78.31 145.39 35.36 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.918 -0.771 . . . . 72.03 108.918 168.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.96 95.81 0.06 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.312 1.045 . . . . 75.23 111.482 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.885 0 C-N-CA 124.054 0.941 . . . . 72.03 109.779 -175.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.324 -0.621 . . . . 74.34 109.324 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m -149.88 90.97 1.74 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.066 0.947 . . . . 63.32 108.907 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.9 118.42 36.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.24 -1.393 . . . . 71.24 107.24 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -68.17 119.23 12.42 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 74.24 110.717 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -76.43 104.88 7.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.075 -1.454 . . . . 71.42 107.075 164.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.32 87.76 0.12 Allowed 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.617 0.722 . . . . 74.42 109.493 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -128.71 170.11 13.68 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 125.21 1.404 . . . . 71.14 108.124 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.48 83.37 0.82 Allowed 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.342 -0.614 . . . . 63.32 109.342 172.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.484 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm -32.18 129.99 0.17 Allowed 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.316 1.446 . . . . 73.41 112.664 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 32.7 m -115.36 143.08 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.782 0.433 . . . . 74.44 109.868 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.512 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.8 t80 -157.14 94.67 1.43 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.636 -1.246 . . . . 70.45 107.636 171.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -112.95 121.47 44.75 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.641 -0.709 . . . . 72.1 109.351 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.88 99.65 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 106.974 -1.491 . . . . 52.45 106.974 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -79.17 -46.92 16.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.682 -0.236 . . . . 73.1 110.915 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 43.4 ttt180 -169.04 131.66 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.213 -0.449 . . . . 61.04 111.964 -161.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.469 ' N ' HD13 ' D' ' 16' ' ' ILE . 2.6 mp -115.7 138.5 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.772 -1.195 . . . . 63.3 107.772 169.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.525 ' HB3' HG22 ' C' ' 122' ' ' THR . 10.1 p90 -164.76 177.3 8.07 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 121.872 0.844 . . . . 72.44 111.212 -176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -109.69 118.46 36.6 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.869 -1.06 . . . . 74.45 109.351 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.412 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.7 mtpt -88.57 -23.96 22.99 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.624 -0.51 . . . . 73.43 109.624 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.586 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.8 t70 -156.84 130.43 8.14 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.95 -1.023 . . . . 73.03 109.228 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.474 HG23 ' HE1' ' C' ' 117' ' ' MET . 68.6 mt -128.09 135.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.261 1.024 . . . . 75.12 108.292 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -134.83 137.48 43.35 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.082 0.953 . . . . 70.13 108.473 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -149.5 120.55 7.72 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.318 -1.364 . . . . 72.43 107.318 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 1.8 mp0 -120.41 137.65 54.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.993 -0.743 . . . . 75.02 108.993 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.41 81.07 37.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.32 -0.993 . . . . 62.13 108.32 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.3 -44.1 0.33 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.753 2.302 . . . . 75.21 112.764 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' D' ' 72' ' ' THR . 81.4 m-20 -100.87 44.36 1.02 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.217 1.007 . . . . 73.34 108.637 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.468 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.74 -53.57 63.05 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 114.118 -1.401 . . . . 75.33 114.471 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.72 6.65 5.46 Favored 'Trans proline' 0 C--N 1.392 2.868 0 CA-C-N 121.972 1.74 . . . . 65.4 112.662 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.423 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 4.9 t-160 -85.06 -46.23 11.35 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.32 1.048 . . . . 65.3 109.323 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.405 HG22 ' HB1' ' D' ' 73' ' ' ALA . 11.5 p -72.88 -16.98 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.169 0.509 . . . . 74.05 110.699 177.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -56.54 -30.23 62.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.734 1.214 . . . . 75.14 111.854 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.414 HE21 ' HA ' ' D' ' 30' ' ' HIS . 35.9 mt-30 -82.7 -16.4 48.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.71 0.804 . . . . 73.44 111.056 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.576 ' HB3' HD23 ' D' ' 68' ' ' LEU . 85.7 mttt -109.53 112.41 24.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.005 0.922 . . . . 73.45 111.537 -173.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.412 ' HA ' HD12 ' F' ' 139' ' ' LEU . 3.8 m-20 -99.91 71.65 1.67 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.812 0.845 . . . . 73.04 110.873 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -164.57 158.85 18.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.083 -0.71 . . . . 74.51 109.083 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.493 ' HB3' HD13 ' F' ' 141' ' ' LEU . 26.9 tp60 -62.02 114.09 10.46 Favored Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.075 0.55 . . . . 64.43 111.436 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.591 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 43.6 Cg_exo -60.06 114.82 2.26 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 121.972 1.781 . . . . 64.42 109.647 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.31 121.66 10.69 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.207 0.942 . . . . 71.51 109.897 -174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -96.67 112.32 28.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.375 -0.829 . . . . 55.3 110.292 -168.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.581 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 63.0 tttt -87.07 142.02 28.23 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.922 -1.14 . . . . 73.04 107.922 167.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.39 139.88 49.12 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 9.2 t70 -141.9 149.1 39.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.725 -1.213 . . . . 74.42 107.725 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.29 166.32 24.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.053 0.541 . . . . 73.5 110.971 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.5 t70 -170.18 156.11 5.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.766 1.227 . . . . 70.33 108.033 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.1 t -135.08 161.18 36.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.061 0.545 . . . . 70.1 109.828 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.93 163.47 38.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.831 0.852 . . . . 72.23 109.076 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -148.93 153.48 38.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.138 0.575 . . . . 75.53 110.092 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -159.77 121.64 3.3 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.464 0.706 . . . . 70.54 109.366 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.5 124.88 26.11 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.134 -0.691 . . . . 71.43 109.134 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.472 HD13 ' HB2' ' D' ' 57' ' ' GLU . 23.6 mt -94.08 -33.69 13.28 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.799 0.44 . . . . 73.32 110.423 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.46 -172.02 2.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.002 -0.999 . . . . 73.12 110.595 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.1 116.42 6.48 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.804 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 10.1 m-20 63.32 19.29 11.6 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 73.24 112.068 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -119.53 120.5 63.71 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -130.4 129.38 42.99 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.881 -0.785 . . . . 72.23 108.881 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD13 ' D' ' 51' ' ' LEU . 10.3 tm-20 -100.8 137.45 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.801 -1.185 . . . . 74.35 107.801 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.51 HG13 ' HB3' ' D' ' 102' ' ' CYS . 4.2 p -127.17 134.17 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.673 -0.862 . . . . 75.53 108.673 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 80.3 t -106.08 131.08 56.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.153 0.581 . . . . 72.32 109.756 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.585 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -107.38 120.97 43.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.808 -1.553 . . . . 65.21 106.808 174.224 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.6 ttm-85 -105.39 107.36 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.711 -0.848 . . . . 73.22 108.711 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.4 t -107.44 124.29 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.052 0.941 . . . . 75.43 108.662 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 8.8 m -125.04 130.66 52.76 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.235 0.614 . . . . 75.24 110.124 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.64 107.45 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.382 1.073 . . . . 74.03 109.104 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.0 m -103.19 96.92 7.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.262 0.625 . . . . 73.44 109.583 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.18 124.73 41.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.972 -0.751 . . . . 74.43 108.972 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 69.5 m -147.31 130.48 16.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.673 0.789 . . . . 73.31 109.419 -177.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.576 HD23 ' HB3' ' D' ' 34' ' ' LYS . 35.7 tp -116.81 121.8 42.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.355 -0.609 . . . . 74.44 109.355 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 -113.66 4.24 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.576 -0.609 . . . . 64.34 111.576 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.29 2.42 8.48 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.318 0.647 . . . . 63.45 110.944 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -115.46 150.96 35.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.045 0.538 . . . . 71.1 110.618 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 94.3 m -69.45 120.68 15.61 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 114.586 -1.188 . . . . 71.44 110.205 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.405 ' HB1' HG22 ' D' ' 31' ' ' VAL . . . -83.4 -59.64 2.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 122.941 0.496 . . . . 74.34 109.664 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.31 152.61 26.22 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.394 -0.821 . . . . 74.34 110.454 172.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.474 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -124.29 153.34 41.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.562 1.145 . . . . 75.31 109.823 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.529 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -158.31 146.17 18.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.64 -0.709 . . . . 74.24 110.356 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.88 132.11 11.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.8 -0.815 . . . . 72.41 108.8 172.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.59 124.24 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 122.744 0.418 . . . . 74.05 109.994 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.586 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 40.5 mt-30 -88.97 85.09 6.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.767 -0.827 . . . . 73.33 108.767 166.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.83 96.79 6.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.203 -1.362 . . . . 75.32 108.593 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.06 155.95 24.0 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.302 -0.408 . . . . 74.4 112.179 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -153.21 133.77 4.15 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.645 0.223 . . . . 71.21 112.683 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.454 HG13 ' HE1' ' D' ' 17' ' ' TYR . 68.5 mt -89.24 126.0 42.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 C-N-CA 124.067 0.947 . . . . 71.23 109.502 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.96 138.44 46.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.411 0.685 . . . . 75.02 109.835 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.512 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.9 m -91.66 100.15 12.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.472 0.709 . . . . 75.13 109.502 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.1 116.69 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.638 0.775 . . . . 74.24 110.384 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -147.67 162.5 39.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.228 1.011 . . . . 54.4 110.801 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.49 -20.19 6.36 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 114.879 0.712 . . . . 71.33 114.879 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -114.51 157.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.054 0.942 . . . . 73.22 110.493 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.24 -174.55 4.99 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.692 0.797 . . . . 73.33 110.84 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.67 -133.85 51.48 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.717 0.636 . . . . 74.03 113.711 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -73.9 -22.54 59.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.307 0.643 . . . . 73.53 110.722 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.34 -41.06 73.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.806 0.842 . . . . 72.4 111.041 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -75.12 -30.43 60.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.995 -0.372 . . . . 74.4 109.995 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.4 63.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.241 0.616 . . . . 64.53 110.949 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -79.45 -44.13 21.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.898 0.879 . . . . 73.22 110.693 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.8 t -66.5 -48.91 68.29 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.173 -0.467 . . . . 62.51 110.92 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.01 -39.5 25.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.693 0.797 . . . . 73.12 109.812 -176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -27.58 35.66 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.69 -0.505 . . . . 74.42 114.251 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.88 -53.2 2.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.852 0.826 . . . . 64.1 111.391 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -74.09 -44.97 52.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.546 0.573 . . . . 71.35 112.546 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.51 ' HB3' HG13 ' D' ' 58' ' ' VAL . 72.4 m -63.48 -46.48 84.02 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.417 -0.801 . . . . 74.12 112.499 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.585 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 31.9 Cg_exo -64.23 -30.07 64.36 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 122.12 1.88 . . . . 72.31 112.862 171.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.84 -31.36 71.92 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.334 0.654 . . . . 74.0 110.363 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -69.95 -42.83 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.501 0.721 . . . . 75.21 109.974 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.531 HD22 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -74.42 -18.47 60.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.87 -0.605 . . . . 75.34 111.72 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -68.26 -42.76 31.14 Favored Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 114.314 1.227 . . . . 73.23 114.314 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.66 -32.1 96.12 Favored 'Trans proline' 0 C--N 1.383 2.358 0 CA-C-N 121.627 1.617 . . . . 71.44 112.871 171.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -81.45 -30.06 33.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.386 0.674 . . . . 73.43 110.995 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.49 -53.98 43.62 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.641 -0.874 . . . . 72.3 108.641 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.12 -50.09 65.19 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 113.91 -1.495 . . . . 75.33 110.981 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.92 -44.17 93.72 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.924 0.765 . . . . 74.0 111.661 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 -41.47 86.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.567 0.542 . . . . 64.2 110.761 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.529 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.0 mt -66.26 -53.81 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.093 -0.958 . . . . 65.33 110.21 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.515 HG22 ' HG3' ' D' ' 125' ' ' GLN . 37.5 m -54.46 -38.35 66.29 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.771 1.228 . . . . 71.43 111.765 -176.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -70.19 -46.23 65.03 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.356 -0.838 . . . . 53.42 110.805 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.4 mtm -63.42 -33.07 74.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.782 0.433 . . . . 75.42 111.74 176.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' D' ' 123' ' ' PHE . 39.6 t -68.2 -40.66 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.922 -1.035 . . . . 70.23 110.225 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -76.08 -22.91 55.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.263 0.225 . . . . 71.33 111.335 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 85.1 mtt-85 -76.85 -33.08 57.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.503 0.721 . . . . 74.33 109.487 173.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 0.84 88.49 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 115.43 -0.804 . . . . 65.14 112.079 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 61.54 17.86 8.91 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.921 2.088 . . . . 71.5 113.417 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.516 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 30.1 m-85 -82.94 168.97 19.37 Favored Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.615 1.566 . . . . 75.4 110.634 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 52.5 Cg_endo -64.17 135.7 48.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.007 2.471 . . . . 71.14 113.135 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.515 ' HG3' HG22 ' D' ' 115' ' ' THR . 33.2 tt0 -55.21 131.5 45.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.895 0.878 . . . . 74.11 111.778 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.88 97.62 7.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.92 0.888 . . . . 74.15 108.722 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -97.44 86.9 3.98 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.336 -0.987 . . . . 74.51 108.336 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.58 123.3 18.45 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.806 -1.088 . . . . 74.21 109.489 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.73 131.66 86.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 O-C-N 123.727 0.642 . . . . 75.23 110.768 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.37 115.36 3.3 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 121.966 1.777 . . . . 74.03 111.329 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.45 108.93 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.31 -0.626 . . . . 70.24 109.31 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' D' ' 134' ' ' ASP . 18.6 t-20 -84.99 103.74 14.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.297 -0.865 . . . . 65.21 109.046 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -73.24 -22.36 60.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.393 -0.821 . . . . 75.02 111.173 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.471 ' HB2' HD22 ' D' ' 132' ' ' ASN . 20.9 m-20 -58.01 -54.48 46.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.69 1.196 . . . . 63.35 112.477 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.79 84.73 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.967 0.792 . . . . 75.11 111.865 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 40.5 tp -73.57 -43.52 59.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.791 0.837 . . . . 73.11 110.976 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.52 -29.38 64.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.488 0.715 . . . . 74.35 110.715 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' D' ' 138' ' ' MET . 34.7 ttm -60.18 -27.15 66.89 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.567 1.147 . . . . 64.13 111.89 -177.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.471 ' HA ' HE21 ' D' ' 142' ' ' GLN . 8.3 t30 -72.63 -30.49 64.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.727 0.811 . . . . 74.41 111.535 178.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.39 -31.63 72.33 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.004 0.922 . . . . 71.15 111.383 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.36 -27.36 68.46 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.647 0.779 . . . . 73.33 111.195 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.471 HE21 ' HA ' ' D' ' 139' ' ' ASN . 31.9 mt-30 -89.39 0.62 56.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.432 0.693 . . . . 73.35 111.625 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.02 51.08 2.15 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 74.2 110.0 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -141.99 124.53 15.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.358 0.599 . . . . 71.32 109.967 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.96 148.8 10.4 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.556 1.142 . . . . 71.25 108.547 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.75 120.63 3.07 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.025 -0.43 . . . . 52.32 112.025 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.56 74.94 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.987 -1.116 . . . . 73.34 107.987 172.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.43 140.36 21.89 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.34 -0.845 . . . . 40.24 112.307 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -134.3 174.33 10.63 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.505 0.722 . . . . 55.45 110.288 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.1 153.89 37.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.691 0.796 . . . . 65.51 109.832 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.04 134.25 34.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.582 0.753 . . . . 74.15 109.471 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -115.41 114.22 24.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.276 -1.009 . . . . 62.35 108.276 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -81.11 64.64 5.93 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.659 0.743 . . . . 71.21 110.183 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.57 116.32 22.53 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.387 -0.824 . . . . 72.12 110.023 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.077 0.951 . . . . 75.01 109.203 -175.309 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.614 0.245 . . . . 74.22 110.415 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.05 123.0 28.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.062 -0.517 . . . . 74.34 110.571 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.27 104.9 3.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.236 1.014 . . . . 62.12 108.601 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -126.76 128.67 46.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 75.34 110.566 -172.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -71.27 133.79 46.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.958 -0.756 . . . . 75.21 108.958 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -158.57 -83.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.137 -0.32 . . . . 74.32 110.137 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -149.31 -177.13 5.67 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.132 0.973 . . . . 72.15 110.334 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.446 ' HG ' ' HG3' ' B' ' 94' ' ' MET . 6.7 mp -83.69 71.81 10.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.776 0.83 . . . . 75.35 109.916 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -146.97 156.35 47.37 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.414 1.085 . . . . 71.45 109.705 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.29 133.34 40.02 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 121.995 1.796 . . . . 75.12 111.102 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -68.38 -150.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.393 1.077 . . . . 74.42 111.308 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 39.8 m -45.38 -56.9 4.47 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.513 1.125 . . . . 75.11 113.092 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 73.55 -27.59 0.19 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.934 1.294 . . . . 65.03 112.97 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.1 81.6 1.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.087 0.955 . . . . 75.43 110.072 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -168.4 17.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.113 1.365 . . . . 75.34 109.814 174.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . 0.5 HG11 HD12 ' B' ' 136' ' ' LEU . 11.7 m -70.87 76.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.908 0.883 . . . . 71.21 110.715 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -63.15 -38.17 90.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.159 -0.928 . . . . 73.44 111.461 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . 0.463 ' HH ' HD21 ' B' ' 44' ' ' LEU . 0.2 OUTLIER 57.67 -148.63 0.48 Allowed 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.408 1.068 . . . . 72.45 110.467 -178.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 67.48 170.09 0.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.886 0.874 . . . . 75.1 111.452 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.05 -114.78 3.5 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.439 -0.664 . . . . 43.14 111.439 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -103.28 66.7 0.9 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.822 0.82 . . . . 73.34 109.961 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.16 -54.55 3.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.09 0.956 . . . . 73.25 109.277 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.87 73.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.59 -1.263 . . . . 72.14 107.59 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.93 82.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.427 -1.26 . . . . 55.2 111.743 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -133.17 142.43 44.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.853 . . . . 70.15 109.993 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -89.07 25.67 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.241 2.627 . . . . 65.54 113.104 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 19.2 pt -64.18 127.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.798 0.839 . . . . 73.24 110.636 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.28 59.03 4.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.055 0.942 . . . . 75.52 111.681 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.467 HG11 ' HD3' ' C' ' 124' ' ' PRO . 14.3 t -91.51 58.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 108.043 -1.095 . . . . 72.15 108.043 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.74 -44.59 2.93 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.225 -0.898 . . . . 74.44 111.324 -170.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.06 36.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.476 0.711 . . . . 75.21 110.463 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 mp -86.41 117.23 25.07 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.297 -1.001 . . . . 74.22 108.297 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 140' ' ' SER . . . . . 0.484 ' HB3' ' HG2' ' C' ' 37' ' ' GLN . 45.4 t -63.82 -36.69 84.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.929 0.492 . . . . 71.11 111.094 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' C' ' 39' ' ' GLU . 3.7 tt -104.18 110.59 22.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.079 -1.082 . . . . 75.14 108.079 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 7.5 tt -167.46 117.89 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.891 0.876 . . . . 74.03 110.155 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 61.41 160.36 0.06 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.736 1.215 . . . . 74.2 114.075 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -159.26 64.79 0.39 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.617 -1.174 . . . . 75.25 108.364 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt 69.55 -2.31 1.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.045 1.338 . . . . 74.12 112.705 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.78 25.65 1.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.562 0.745 . . . . 63.23 111.83 -173.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . 0.439 HD12 ' N ' ' E' ' 148' ' ' LEU . 3.4 pp -62.19 -31.62 72.16 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.986 0.514 . . . . 75.33 110.877 169.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.439 ' N ' HD12 ' E' ' 147' ' ' LEU . 39.8 tp -169.69 87.82 0.57 Allowed Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.093 1.357 . . . . 75.41 107.523 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 CA--C 1.563 1.954 0 C-N-CA 122.681 2.254 . . . . 61.12 112.34 178.318 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.118 -0.697 . . . . 74.51 109.118 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -69.22 -54.6 13.92 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.551 0.532 . . . . 75.53 111.095 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 53.82 57.29 6.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 122.014 0.911 . . . . 73.43 111.24 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -91.61 12.11 22.11 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.966 -1.015 . . . . 74.3 112.939 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.94 -59.59 5.02 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.369 0.667 . . . . 75.15 110.976 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -169.1 112.46 0.53 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.914 0.886 . . . . 73.14 109.311 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -160.81 176.3 11.63 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.706 0.802 . . . . 74.4 109.728 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.809 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 8.8 mp 61.0 45.55 9.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.425 1.09 . . . . 75.45 112.116 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . 0.401 ' HA ' ' HD3' ' F' ' 117' ' ' PRO . 66.6 m-85 -140.19 114.7 7.64 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 107.946 -1.131 . . . . 74.42 107.946 167.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.557 ' HB3' ' HE3' ' A' ' 94' ' ' MET . 16.8 Cg_endo -99.91 -162.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.769 2.979 . . . . 74.5 114.369 -169.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -62.61 155.89 24.85 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.6 -1.182 . . . . 73.41 110.589 167.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 10.0 t -77.48 -19.97 55.11 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.574 0.35 . . . . 73.14 111.308 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 25.9 t90 69.43 -68.75 0.18 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.132 1.373 . . . . 75.33 111.388 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 t70 69.48 87.48 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.131 . . . . 72.24 110.894 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.61 103.36 0.1 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 71.41 109.178 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.6 107.77 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.442 0.697 . . . . 72.24 110.099 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 4.0 tpm_? -106.03 85.72 2.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.762 -1.199 . . . . 73.35 107.762 172.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -115.75 143.3 45.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.763 0.825 . . . . 75.11 109.452 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -128.78 144.61 51.21 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.56 0.744 . . . . 71.44 109.635 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . 0.44 ' HA3' HD22 ' A' ' 42' ' ' LEU . . . -148.12 21.39 1.41 Allowed Glycine 0 C--N 1.347 1.156 0 O-C-N 123.235 0.334 . . . . 71.44 113.222 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.28 65.96 8.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.976 0.894 . . . . 75.31 108.776 176.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 3.7 pp -102.18 -14.96 16.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.304 -1.316 . . . . 73.43 110.782 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 13.9 tt -66.03 88.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-O 122.863 1.316 . . . . 74.21 109.693 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -137.08 -41.34 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.931 -1.486 . . . . 73.35 109.425 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -62.79 108.93 1.94 Allowed Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 123.65 0.78 . . . . 74.12 111.087 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.04 111.75 2.74 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.697 2.264 . . . . 74.15 111.109 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 6.0 tp -167.63 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 122.364 1.078 . . . . 72.51 108.853 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.658 ' HB3' ' HE1' ' A' ' 36' ' ' TRP . . . -78.99 112.38 16.13 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.059 -1.089 . . . . 73.32 108.059 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.501 ' HA ' HD13 ' F' ' 139' ' ' LEU . 16.2 t -72.83 -8.15 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 124.355 1.062 . . . . 71.21 110.641 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -69.61 -32.92 71.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.444 1.497 . . . . 74.03 111.074 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.86 -27.38 66.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.265 0.626 . . . . 73.52 110.274 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' F' ' 136' ' ' VAL . 7.0 mp -80.16 2.08 25.63 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.483 -0.78 . . . . 73.3 111.836 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.4 m -110.3 105.68 14.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.206 0.603 . . . . 71.42 110.365 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' D' ' 37' ' ' GLN . 80.0 mt -130.78 -49.7 1.04 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.248 1.019 . . . . 64.24 108.894 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm 67.48 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 125.396 1.478 . . . . 71.22 112.526 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -55.05 145.06 21.63 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.746 1.218 . . . . 75.33 112.074 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -157.06 127.18 6.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.96 0.504 . . . . 75.45 110.36 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' F' ' 145' ' ' LYS . 6.0 mmpt? -144.19 -46.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.197 0.999 . . . . 73.03 109.715 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -138.05 -59.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.189 -1.041 . . . . 74.33 108.189 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 62.4 mt 65.05 22.6 12.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.997 1.319 . . . . 74.23 111.434 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 8.1 mp 55.17 74.68 0.69 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.864 1.266 . . . . 74.01 111.114 -174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.379 2.155 0 C-N-CA 122.771 2.314 . . . . 62.13 112.858 -178.686 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.461 -0.57 . . . . 73.42 109.461 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.422 ' HB3' HE22 ' A' ' 4' ' ' GLN . 38.7 m -150.02 91.25 1.76 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.128 0.571 . . . . 61.4 110.104 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.52 92.24 3.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.725 0.81 . . . . 75.33 109.101 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.422 HE22 ' HB3' ' A' ' 2' ' ' SER . 0.1 OUTLIER -136.83 144.03 43.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.055 0.942 . . . . 74.53 109.017 177.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.13 72.08 10.14 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.675 0.75 . . . . 75.3 110.199 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -93.88 -166.69 1.55 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.014 -0.994 . . . . 73.21 110.059 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 HG21 ' SD ' ' A' ' 9' ' ' MET . 8.8 t -62.64 154.95 27.59 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.364 0.666 . . . . 74.54 111.495 176.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -91.46 130.19 37.33 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.541 -0.754 . . . . 72.1 108.998 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.426 ' SD ' HG21 ' A' ' 7' ' ' THR . 3.6 mpp? -98.62 137.86 36.65 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.072 -0.714 . . . . 72.45 109.072 175.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.9 m -140.24 130.06 24.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 72.42 109.24 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.466 ' HA ' HG23 ' A' ' 86' ' ' ILE . 49.0 m-85 -136.35 112.14 9.48 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.291 -1.374 . . . . 75.04 107.291 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -132.77 134.44 44.72 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.042 0.537 . . . . 65.22 110.702 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.679 ' HB ' HD11 ' E' ' 147' ' ' LEU . 3.3 mp -86.25 97.09 5.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 106.448 -1.686 . . . . 73.34 106.448 167.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -72.83 -40.2 65.97 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.216 0.606 . . . . 73.43 109.912 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -165.31 140.93 5.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.745 -0.835 . . . . 74.4 108.745 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.13 137.96 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.646 -0.872 . . . . 72.44 108.646 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -171.69 170.97 5.44 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.808 0.693 . . . . 73.54 111.195 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -91.06 117.95 30.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.446 -0.797 . . . . 71.35 109.213 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HE3' ' HB1' ' B' ' 28' ' ' ALA . 34.4 mtpt -80.54 -28.84 37.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 110.04 -0.356 . . . . 70.51 110.04 172.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.3 t70 -149.13 142.16 24.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.582 -0.735 . . . . 62.42 110.301 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.416 HG23 ' SD ' ' A' ' 117' ' ' MET . 59.0 mt -134.66 136.18 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.29 -1.374 . . . . 74.52 107.29 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -142.98 129.7 20.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.461 -0.94 . . . . 72.35 108.461 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 89.3 t80 -144.36 122.53 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.375 -1.343 . . . . 74.25 107.375 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.63 143.69 51.14 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.148 -0.686 . . . . 73.22 109.148 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.22 73.98 63.05 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.503 -1.295 . . . . 64.2 107.503 171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.42 -32.03 20.84 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.588 2.192 . . . . 74.15 111.204 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 31' ' ' VAL . 86.5 m-20 -103.92 30.6 5.03 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.699 -1.137 . . . . 75.13 109.768 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -55.71 -46.53 99.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.578 -0.725 . . . . 62.25 112.7 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 38.4 Cg_exo -61.46 -28.28 83.43 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 121.828 1.686 . . . . 73.32 112.98 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -74.21 -32.92 63.22 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 116.038 -0.528 . . . . 71.21 110.448 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 27' ' ' ASN . 55.1 t -63.51 -27.54 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.511 0.596 . . . . 73.41 111.659 -176.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -71.09 -39.66 72.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.417 0.687 . . . . 75.31 111.591 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.77 -38.29 14.79 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.383 0.673 . . . . 73.51 111.125 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HB3' HD11 ' A' ' 68' ' ' LEU . 13.6 mmmm -82.03 157.81 24.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 63.1 109.243 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.416 ' O ' HD12 ' A' ' 68' ' ' LEU . 22.6 m-20 -71.77 118.03 14.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.762 0.425 . . . . 75.5 110.572 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -75.66 76.96 2.65 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.484 1.135 . . . . 75.02 110.374 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -136.99 82.67 30.15 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.182 -1.414 . . . . 75.42 107.182 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -87.11 155.8 8.35 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.53 2.153 . . . . 74.41 113.049 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.3 124.04 41.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.716 -1.216 . . . . 72.21 107.716 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 92.52 2.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 109.129 -0.693 . . . . 73.44 109.129 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.502 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.3 tttt -87.29 139.43 30.57 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.66 -1.237 . . . . 74.11 107.66 169.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 pt? -139.1 151.23 46.54 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.056 0.542 . . . . 74.13 109.959 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -131.15 136.08 48.01 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.421 0.688 . . . . 70.34 109.767 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.0 tp -103.91 128.78 51.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.057 0.943 . . . . 74.41 109.495 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 14.7 t70 -146.23 139.32 25.74 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.878 -0.786 . . . . 75.31 108.878 170.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.1 m -144.89 134.18 22.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.301 1.041 . . . . 74.52 109.124 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.475 ' HB1' HH22 ' A' ' 61' ' ' ARG . . . -159.66 133.09 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.635 0.374 . . . . 64.54 110.238 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.575 ' HB3' HG23 ' A' ' 58' ' ' VAL . 59.9 p -91.38 177.06 6.34 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.29 0.636 . . . . 73.54 110.828 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.565 ' HA ' ' HD2' ' F' ' 114' ' ' LYS . 34.4 t -166.61 116.76 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.195 -0.669 . . . . 63.14 109.195 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -69.62 104.91 2.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.407 0.442 . . . . 75.42 109.968 -173.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.559 HD13 ' HB2' ' A' ' 57' ' ' GLU . 49.7 mt -78.69 -37.27 42.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.659 0.784 . . . . 70.41 111.086 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.86 -173.5 4.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.648 0.779 . . . . 72.53 109.532 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.71 97.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.325 0.65 . . . . 75.14 111.166 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.5 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 6.0 m-20 60.1 31.01 20.41 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.47 1.108 . . . . 61.05 112.173 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.26 120.63 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.009 -1.478 . . . . 74.43 107.009 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.83 130.49 41.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.503 -0.925 . . . . 73.01 108.503 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.559 ' HB2' HD13 ' A' ' 51' ' ' LEU . 33.3 tt0 -86.13 117.98 25.3 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.86 -0.793 . . . . 72.43 108.86 171.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 48' ' ' SER . 47.2 t -98.73 118.64 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 107.406 -1.331 . . . . 73.13 107.406 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.503 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 36.2 t -102.45 131.47 50.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.4 -0.593 . . . . 64.42 109.4 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.59 115.1 29.76 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.197 -1.408 . . . . 75.32 107.197 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.646 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -89.89 100.88 13.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.002 -1.481 . . . . 74.41 107.002 172.295 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.53 124.36 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.14 -1.059 . . . . 75.32 108.14 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 13.5 m -112.22 138.9 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.413 -0.958 . . . . 70.14 108.413 172.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.1 t -133.63 107.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.893 1.277 . . . . 75.13 107.673 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 43.4 m -103.66 136.89 42.51 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.961 -0.755 . . . . 73.34 108.961 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.79 23.67 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.406 0.682 . . . . 73.51 109.364 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.3 m -143.22 142.73 31.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.421 0.688 . . . . 71.02 110.36 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.576 ' HG ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.07 78.73 2.11 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 169.076 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.43 -99.31 1.08 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.647 -0.706 . . . . 73.54 112.287 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.41 -28.24 21.04 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.644 0.778 . . . . 75.11 110.834 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.576 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 5.4 tp10 -94.73 132.18 39.76 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.273 -0.64 . . . . 74.44 109.273 -174.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -82.4 130.82 35.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.203 -0.665 . . . . 73.4 109.203 170.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.92 -59.93 2.54 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.447 -0.945 . . . . 72.44 108.447 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -168.51 174.92 6.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.675 -1.148 . . . . 72.25 110.779 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 tp -132.12 144.87 51.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.551 1.141 . . . . 71.41 109.277 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.2 m -137.99 140.14 40.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.385 1.074 . . . . 64.24 109.477 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -149.32 130.32 14.38 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.46 -0.57 . . . . 73.3 109.46 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.18 110.79 18.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.689 0.796 . . . . 72.33 108.922 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -86.75 85.17 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.085 -0.962 . . . . 72.32 108.887 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HG3' HD21 ' A' ' 106' ' ' LEU . 7.8 tp-100 -79.08 96.52 5.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.478 -1.237 . . . . 74.13 108.728 -177.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.14 142.86 16.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.333 -0.707 . . . . 75.43 111.333 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -139.14 126.4 3.35 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 110.411 -1.076 . . . . 72.54 110.411 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 51' ' ' LEU . 55.1 mt -81.79 129.8 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 173.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -134.41 121.09 20.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.517 0.727 . . . . 74.11 109.928 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -91.06 95.99 10.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.481 -0.933 . . . . 75.24 108.481 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.466 HG23 ' HA ' ' A' ' 11' ' ' PHE . 26.1 pt -130.04 131.88 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.793 0.837 . . . . 75.51 110.354 -171.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . . . -168.99 176.9 5.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.39 0.676 . . . . 73.4 111.44 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.57 31.07 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.088 -0.96 . . . . 71.54 112.399 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.448 HD12 ' HE3' ' A' ' 94' ' ' MET . 2.3 pp -138.09 172.33 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 124.216 1.007 . . . . 74.13 110.159 -178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.562 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.3 tt0 -154.73 -169.14 3.12 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.69 -0.855 . . . . 74.43 108.69 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.562 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.2 -130.68 24.39 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 120.129 -0.262 . . . . 64.21 112.971 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -66.96 -32.85 74.37 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.857 0.863 . . . . 73.34 111.395 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.63 -39.66 80.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.776 0.83 . . . . 73.33 110.823 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.472 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.0 tpp -72.7 -41.78 64.91 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.354 0.409 . . . . 74.23 110.441 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.54 66.46 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 72.22 111.279 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -79.88 -37.71 34.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.51 0.724 . . . . 63.44 111.054 172.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.9 t -63.03 -57.44 10.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.651 0.38 . . . . 74.32 111.955 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' F' ' 116' ' ' TYR . 0.5 OUTLIER -95.18 -10.3 30.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.398 0.518 . . . . 75.14 112.398 -177.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.5 -21.26 15.12 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.156 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.43 -64.59 1.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.591 0.756 . . . . 73.32 110.257 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -60.21 -53.12 61.53 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.166 0.986 . . . . 73.43 112.725 -172.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 98' ' ' LEU . 84.4 m -60.21 -52.26 74.45 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.165 -0.921 . . . . 61.23 112.735 -176.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.86 -24.09 40.58 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.816 1.677 . . . . 75.23 113.233 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -73.61 -28.76 61.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.944 0.498 . . . . 74.33 110.605 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -68.84 -42.41 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.389 0.676 . . . . 74.33 109.418 168.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD22 ' HA3' ' A' ' 82' ' ' GLY . 88.7 mt -71.61 -25.96 62.38 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.962 -1.017 . . . . 71.32 111.768 -176.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -67.24 -44.61 48.66 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.81 -1.091 . . . . 72.51 113.823 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.439 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 20.6 Cg_endo -62.66 -33.27 77.82 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 121.875 1.717 . . . . 74.12 112.647 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -75.14 -34.36 61.62 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.181 0.592 . . . . 73.55 111.875 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.87 65.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.355 -0.609 . . . . 74.23 109.355 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.469 HH12 HD13 ' C' ' 105' ' ' ILE . 34.7 ttm180 -51.96 -51.68 55.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.121 1.368 . . . . 75.25 110.684 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.17 -48.48 81.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.253 0.971 . . . . 75.21 111.211 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.9 t -56.84 -45.76 82.17 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.297 0.998 . . . . 71.42 110.92 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 118' ' ' VAL . 95.3 mt -63.59 -52.4 58.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 124.084 0.865 . . . . 72.54 110.551 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.5 m -53.82 -43.77 69.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.816 0.847 . . . . 64.34 111.112 -176.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.38 -42.99 82.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.652 -1.158 . . . . 65.01 110.365 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.462 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mtp -56.5 -46.19 80.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.736 0.814 . . . . 75.22 111.25 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 114' ' ' ILE . 91.1 t -60.99 -47.47 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.699 -1.137 . . . . 74.44 110.989 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -71.82 -26.57 62.45 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.995 -0.548 . . . . 71.41 111.246 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.412 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 40.0 mtt180 -72.88 -30.38 63.92 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.489 0.716 . . . . 73.11 110.017 172.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.04 0.48 78.87 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.564 -0.743 . . . . 54.35 112.543 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 66.89 37.85 3.87 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.804 1.242 . . . . 75.32 110.109 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -113.69 153.7 45.86 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.893 -1.048 . . . . 64.24 109.299 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.98 132.97 52.75 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.009 2.472 . . . . 74.42 112.189 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -61.99 147.4 47.17 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.867 0.73 . . . . 64.2 111.262 -172.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -117.8 95.44 4.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.05 0.54 . . . . 75.55 109.555 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -100.76 97.24 7.9 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.699 -0.852 . . . . 71.4 108.699 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -73.39 136.99 44.4 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.659 -0.867 . . . . 75.33 108.659 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.68 148.48 91.07 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.039 0.535 . . . . 73.33 111.753 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -77.9 119.48 4.75 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.906 1.737 . . . . 74.41 111.458 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.81 111.52 31.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.519 -1.289 . . . . 75.3 107.519 170.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.99 93.0 9.23 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.253 0.621 . . . . 64.51 109.593 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -61.96 -27.92 69.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.42 -0.809 . . . . 63.1 108.859 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.25 -55.46 28.19 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 115.076 -0.965 . . . . 75.25 111.592 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.59 82.08 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.168 0.918 . . . . 74.41 112.081 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.58 -34.25 75.47 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.931 0.769 . . . . 74.42 112.094 -175.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -88.87 -23.22 22.82 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.511 0.724 . . . . 74.54 111.301 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.618 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 14.7 mmt -75.98 -53.6 8.14 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.857 -0.592 . . . . 75.11 109.599 179.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.417 ' OD1' ' HB3' ' C' ' 145' ' ' ALA . 3.8 p30 -60.85 -33.63 73.35 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.62 0.575 . . . . 71.31 109.552 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.471 ' HA ' ' HB2' ' C' ' 145' ' ' ALA . 2.7 t80 -53.0 -59.62 4.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.889 1.276 . . . . 74.34 111.256 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.89 -53.64 43.45 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.827 0.704 . . . . 74.31 111.045 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.486 ' HG2' ' HG2' ' C' ' 144' ' ' GLN . 0.0 OUTLIER 174.32 -21.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.989 1.316 . . . . 74.21 110.597 174.14 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 57.21 101.08 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.406 1.483 . . . . 62.25 112.636 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -172.19 135.37 0.77 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.625 1.17 . . . . 75.05 109.061 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.612 0.765 . . . . 72.34 109.419 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.8 76.1 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 111.503 -0.639 . . . . 65.21 111.503 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.72 137.09 34.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.76 -0.83 . . . . 74.44 108.76 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.89 164.45 20.67 Favored Glycine 0 C--N 1.344 0.988 0 O-C-N 123.666 0.604 . . . . 63.43 112.589 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.3 m -98.9 120.04 38.67 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.621 0.768 . . . . 74.4 109.672 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -77.69 91.77 4.08 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 108.636 -0.875 . . . . 74.41 108.636 171.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.658 ' HG3' ' HB2' ' E' ' 146' ' ' ASP . 1.9 tm-20 -67.72 96.54 0.56 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.366 1.067 . . . . 72.41 110.753 -171.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 176.01 149.86 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.661 1.584 . . . . 74.11 107.523 171.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -167.67 -76.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.748 0.419 . . . . 73.54 110.454 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -154.56 -15.1 0.12 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.268 1.027 . . . . 52.04 110.118 -171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.842 0 C-N-CA 124.292 1.037 . . . . 73.53 110.494 -177.468 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 108.966 -0.753 . . . . 74.05 108.966 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -141.34 156.85 45.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.696 0.798 . . . . 74.02 110.258 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -138.09 153.45 49.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.389 0.676 . . . . 73.43 109.566 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -84.37 33.89 0.51 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.552 1.141 . . . . 74.2 111.933 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -132.13 152.3 51.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.534 1.134 . . . . 74.04 108.872 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -64.73 89.34 0.07 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.487 0.715 . . . . 63.15 109.272 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -141.17 -2.27 1.29 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.816 1.247 . . . . 62.11 109.238 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.63 126.24 39.8 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 107.726 -1.213 . . . . 71.34 107.726 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.421 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 21.8 ptm 50.76 177.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 126.497 1.919 . . . . 72.21 114.528 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -152.78 125.64 8.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.763 1.225 . . . . 74.11 107.742 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -135.72 135.52 40.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 74.33 108.542 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.685 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 55.3 tt0 -150.42 142.33 23.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.809 0.844 . . . . 74.41 109.192 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.5 115.05 32.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.485 -1.302 . . . . 71.41 107.485 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.418 HE22 HG12 ' B' ' 55' ' ' VAL . 71.6 mt-30 -79.79 -48.31 13.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.933 -0.395 . . . . 73.3 109.933 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -167.74 136.32 2.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.743 -0.662 . . . . 73.34 109.747 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.1 mt -114.67 140.99 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.051 -1.463 . . . . 74.11 107.051 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -165.96 146.73 6.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.528 0.68 . . . . 74.2 111.077 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 40.6 m -77.44 117.07 18.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.108 -0.951 . . . . 71.44 109.078 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -86.92 -27.64 23.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.318 0.647 . . . . 75.24 110.82 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 21.1 t70 -150.9 139.68 20.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.272 -0.422 . . . . 73.51 111.097 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.679 HD13 ' SG ' ' B' ' 113' ' ' CYS . 33.7 mm -128.66 143.5 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.126 1.37 . . . . 74.45 108.142 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.3 t -141.03 142.93 34.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.099 -1.075 . . . . 71.15 108.099 169.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -157.8 120.04 3.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.656 -1.609 . . . . 74.1 106.656 171.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.05 146.69 49.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.304 -0.628 . . . . 74.24 109.304 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.69 79.84 10.07 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.046 -1.094 . . . . 70.51 108.046 175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.6 -25.46 20.87 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.067 2.511 . . . . 72.14 112.793 -172.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -116.66 19.39 14.57 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.872 0.869 . . . . 72.0 109.793 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -47.49 -52.69 35.14 Favored Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 115.313 1.597 . . . . 61.42 115.313 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.28 -11.42 19.21 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 121.839 1.693 . . . . 74.15 112.725 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -97.89 -26.24 14.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.657 0.783 . . . . 74.21 111.728 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' B' ' 68' ' ' LEU . 34.7 m -82.24 0.49 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.459 0.304 . . . . 75.14 111.176 175.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.99 -42.61 99.33 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.339 1.056 . . . . 72.32 110.892 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.25 -13.89 48.42 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.114 0.566 . . . . 74.53 111.479 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -83.95 78.69 9.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.386 0.674 . . . . 74.24 110.06 -170.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.91 102.59 5.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.791 -0.818 . . . . 72.12 108.791 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -159.56 162.6 35.42 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 73.45 108.059 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.49 109.19 29.88 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.546 -0.74 . . . . 73.34 109.032 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.15 131.03 43.42 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.648 2.232 . . . . 74.31 113.408 -175.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.25 102.51 2.13 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 107.741 -1.207 . . . . 71.21 107.741 167.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' B' ' 65' ' ' THR . 23.7 m -97.6 146.35 7.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.2 -0.909 . . . . 74.41 110.765 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.84 118.87 19.49 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.514 -1.291 . . . . 73.32 107.514 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.625 ' H ' HD21 ' E' ' 129' ' ' LEU . 2.4 tt -96.28 123.55 39.95 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.024 -1.843 . . . . 64.44 106.024 171.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.5 t70 -124.8 129.95 51.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.875 -0.787 . . . . 74.01 108.875 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.17 125.82 53.87 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.193 -1.04 . . . . 75.22 108.193 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.82 133.07 35.51 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.4 HG23 ' HE1' ' E' ' 120' ' ' TRP . 36.9 p -118.78 121.77 40.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.23 0.612 . . . . 74.45 111.21 -174.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.38 160.93 19.83 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.799 1.24 . . . . 75.43 108.582 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 61.3 p -143.35 163.92 31.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 122.892 0.477 . . . . 71.13 110.3 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 159.32 43.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.485 1.114 . . . . 74.32 108.86 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -125.54 119.76 29.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.442 0.697 . . . . 73.05 109.133 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.2 -36.75 26.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.178 0.591 . . . . 75.51 110.566 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.33 -177.6 5.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.107 0.963 . . . . 61.33 109.915 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -66.1 118.58 10.05 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.597 -0.729 . . . . 74.02 110.105 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 71.67 3.17 4.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.524 1.53 . . . . 71.5 112.151 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.418 HG12 HE22 ' B' ' 14' ' ' GLN . 59.0 t -109.93 87.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.758 1.223 . . . . 74.23 108.329 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.411 ' CD1' HD13 ' B' ' 86' ' ' ILE . 12.2 m-85 -98.84 147.0 25.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.1 0.56 . . . . 75.54 109.587 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -131.79 100.31 5.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.016 -1.105 . . . . 72.35 108.016 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 29.8 m -94.22 138.1 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.858 -0.423 . . . . 72.03 109.858 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.08 114.11 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.631 0.773 . . . . 72.51 109.756 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.51 129.55 39.68 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.409 -1.33 . . . . 73.41 107.409 176.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -122.04 112.32 18.1 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.808 0.843 . . . . 75.15 109.157 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.05 125.77 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.619 -0.882 . . . . 73.45 108.619 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.2 m -117.91 146.85 43.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.215 0.531 . . . . 74.24 109.577 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.603 HG22 HG21 ' B' ' 114' ' ' ILE . 42.9 t -132.6 132.69 59.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.443 1.497 . . . . 74.21 108.723 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 100.0 m -126.13 143.74 51.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.924 -0.769 . . . . 70.41 108.924 169.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.54 140.25 44.57 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.743 -1.206 . . . . 73.11 107.743 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 17.1 m -129.51 128.83 43.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.795 0.438 . . . . 64.44 110.048 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.449 HD11 ' HB ' ' B' ' 31' ' ' VAL . 31.3 mt -114.69 102.25 9.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.499 -0.926 . . . . 73.34 108.499 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.99 -131.61 10.52 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.586 -0.734 . . . . 74.33 111.896 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -95.33 8.3 43.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.206 0.602 . . . . 73.3 110.632 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -135.81 166.52 23.09 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.645 0.778 . . . . 74.4 111.288 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -71.33 125.68 27.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.283 -0.871 . . . . 72.31 110.911 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' B' ' 31' ' ' VAL . . . -73.55 -62.86 1.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.527 0.731 . . . . 63.01 109.095 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -160.84 165.56 30.01 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 74.24 110.726 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.21 154.92 46.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.732 1.613 . . . . 75.22 108.366 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.452 ' SG ' HG22 ' B' ' 114' ' ' ILE . 35.0 t -160.76 132.09 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.199 -0.667 . . . . 73.11 109.199 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.4 tt0 -141.82 123.65 15.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.351 -0.981 . . . . 75.52 108.351 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.502 HG12 HD11 ' B' ' 21' ' ' ILE . 99.3 t -122.57 143.76 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.508 -0.553 . . . . 75.02 109.508 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.7 mt-30 -121.97 103.18 8.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.306 -0.861 . . . . 75.42 109.175 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.06 103.53 16.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.562 -0.745 . . . . 52.45 109.129 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.9 143.56 16.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.141 -0.784 . . . . 64.23 111.141 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.23 126.53 3.23 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 112.002 -0.439 . . . . 61.12 112.002 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 12.8 mt -85.85 131.83 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.557 -0.905 . . . . 74.44 108.557 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -138.06 137.16 37.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.977 0.911 . . . . 72.23 109.574 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.685 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 23.4 m -88.89 113.28 24.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.567 -0.901 . . . . 75.31 108.567 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.541 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -121.66 138.33 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.127 0.571 . . . . 74.32 110.411 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.02 163.36 37.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.011 0.924 . . . . 61.24 109.277 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.48 -48.25 3.93 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 122.663 0.173 . . . . 62.23 112.905 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.541 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -61.06 153.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.256 1.023 . . . . 74.3 111.857 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -167.1 165.29 15.69 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.882 0.873 . . . . 72.15 110.149 176.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -119.68 19.3 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.44 0.462 . . . . 72.21 113.491 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.6 m -69.38 -31.67 70.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.93 0.892 . . . . 70.14 111.124 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.471 ' HB3' HG21 ' B' ' 89' ' ' ILE . 93.7 mt-30 -62.89 -52.57 62.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.446 0.699 . . . . 70.22 110.382 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.513 ' HE2' HD23 ' B' ' 98' ' ' LEU . 3.4 tpt -62.99 -45.14 93.8 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.456 -0.793 . . . . 73.53 110.628 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.47 78.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.372 0.669 . . . . 65.21 111.693 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -76.77 -33.13 58.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.324 0.649 . . . . 72.03 110.387 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -65.23 -52.4 54.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.136 0.575 . . . . 73.44 110.881 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.513 HD23 ' HE2' ' B' ' 94' ' ' MET . 4.5 pp -84.84 -20.36 31.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.877 0.471 . . . . 75.24 111.804 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -31.77 16.48 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.347 0.404 . . . . 55.23 113.258 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.05 1.82 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.916 0.487 . . . . 64.24 111.484 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -76.28 -41.93 47.19 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.187 0.81 . . . . 72.12 113.187 -168.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.3 m -63.76 -45.94 82.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 118.688 -0.672 . . . . 73.33 110.913 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -56.57 -37.14 98.07 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.974 1.782 . . . . 73.21 113.514 166.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.36 -35.43 79.11 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.971 0.508 . . . . 74.44 111.416 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -66.13 -49.51 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.757 0.823 . . . . 64.33 110.162 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.34 -16.33 52.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.112 -0.949 . . . . 74.23 112.409 -168.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.56 -46.96 68.8 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 117.48 -1.248 . . . . 75.33 113.075 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.401 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.7 Cg_endo -58.6 -36.78 96.83 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.153 1.902 . . . . 71.44 112.688 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -65.68 -49.42 68.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.399 0.68 . . . . 73.44 110.732 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -35.37 80.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.672 0.789 . . . . 75.23 110.96 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.728 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.0 ttp180 -59.78 -65.13 0.73 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.348 1.059 . . . . 74.22 110.479 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.15 -20.93 64.93 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.96 -1.018 . . . . 75.32 110.619 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.679 ' SG ' HD13 ' B' ' 21' ' ' ILE . 1.9 t -67.12 -49.62 64.26 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.709 -0.478 . . . . 72.43 109.709 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.603 HG21 HG22 ' B' ' 64' ' ' VAL . 91.4 mt -58.96 -54.44 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 123.731 0.645 . . . . 73.12 110.267 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.463 HG21 ' NE2' ' B' ' 125' ' ' GLN . 8.5 m -61.31 -29.17 69.71 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.105 0.962 . . . . 75.02 111.523 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -77.01 -35.36 57.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.447 0.699 . . . . 43.2 111.118 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.513 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.1 mmt -68.01 -30.86 70.21 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.893 0.378 . . . . 72.43 110.26 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.77 -39.23 83.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.97 0.908 . . . . 71.33 109.952 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.2 m -64.26 -32.46 74.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.523 0.729 . . . . 75.0 111.617 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.472 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.3 mtt-85 -71.32 -35.21 71.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.415 -0.811 . . . . 75.33 110.112 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.0 3.05 82.05 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.903 0.752 . . . . 61.51 112.951 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p 56.84 24.03 8.76 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.082 1.753 . . . . 71.35 112.649 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.05 156.09 42.5 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 65.42 110.137 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.2 140.58 93.22 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.052 2.501 . . . . 71.15 111.807 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.463 ' NE2' HG21 ' B' ' 115' ' ' THR . 14.7 mm100 -63.95 122.65 17.0 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.778 0.831 . . . . 75.44 112.493 -170.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -110.16 97.22 6.75 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.065 -1.457 . . . . 74.2 107.065 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -91.36 135.67 33.65 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.479 -0.782 . . . . 74.23 108.975 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.728 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -82.31 115.18 21.25 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.746 -0.835 . . . . 75.05 108.746 -173.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 137.92 88.47 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 124.404 1.065 . . . . 73.54 110.9 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.555 ' HG3' HD13 ' D' ' 16' ' ' ILE . 60.1 Cg_endo -66.6 99.05 0.42 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.739 2.293 . . . . 74.32 111.026 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.0 120.45 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.077 -1.083 . . . . 73.01 108.077 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.31 88.63 0.46 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.901 0.88 . . . . 74.44 110.515 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -52.92 -36.71 59.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.285 1.034 . . . . 75.23 112.221 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.22 -42.61 99.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.587 1.155 . . . . 73.03 111.892 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.92 -35.24 59.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.295 0.638 . . . . 71.14 110.597 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.22 -43.5 95.95 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.614 0.766 . . . . 75.53 110.412 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -67.33 -40.26 85.92 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.635 -1.166 . . . . 72.51 110.41 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.9 ttt -66.87 -37.17 83.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 74.24 111.352 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.447 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 42.4 m-80 -86.15 -18.74 31.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.884 0.474 . . . . 73.33 110.927 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.83 -27.18 63.67 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.429 -0.582 . . . . 74.44 109.429 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -114.79 30.98 6.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.382 1.073 . . . . 71.4 110.188 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.447 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 23.8 tp60 -65.75 102.74 0.79 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.849 0.46 . . . . 71.31 111.831 -170.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -166.36 145.0 5.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.396 1.078 . . . . 63.51 108.684 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -65.62 -65.15 0.71 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.424 0.69 . . . . 73.41 112.476 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.88 -167.41 0.21 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.415 1.072 . . . . 64.41 110.257 -167.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 72.77 0.03 OUTLIER Glycine 0 C--N 1.348 1.239 0 C-N-CA 120.662 -0.78 . . . . 71.34 114.102 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.77 142.42 24.54 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.789 -0.819 . . . . 62.45 108.789 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.22 -19.21 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.991 -0.55 . . . . 73.01 112.962 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 74.2 p -77.59 161.29 27.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.886 0.474 . . . . 75.15 109.936 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -76.5 -33.06 58.65 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.197 -0.456 . . . . 65.41 111.422 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 73.85 -56.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.446 1.498 . . . . 74.51 107.928 -160.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 85.07 132.0 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.59 1.556 . . . . 71.03 111.862 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -81.73 168.12 18.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.57 0.748 . . . . 74.51 110.462 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.41 -60.92 0.41 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.317 -0.623 . . . . 70.21 109.317 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.236 0 C-N-CA 125.076 1.351 . . . . 73.11 111.965 175.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 109.724 -0.473 . . . . 75.31 109.724 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -116.97 90.96 3.45 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.083 -1.451 . . . . 72.5 107.083 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -84.21 136.53 33.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.752 -0.658 . . . . 74.51 111.886 -166.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.83 162.98 31.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.86 1.264 . . . . 71.14 109.375 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -165.94 132.14 2.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.519 -0.548 . . . . 74.32 109.519 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.91 90.89 1.49 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.918 -0.771 . . . . 73.12 108.918 173.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.2 p -79.76 118.58 21.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.288 -0.869 . . . . 72.41 109.764 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.01 179.23 5.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.366 0.666 . . . . 74.34 109.762 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.7 ttm 65.49 115.97 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.536 1.135 . . . . 74.25 112.246 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 21.7 m -84.84 92.78 8.35 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.321 -0.992 . . . . 73.22 108.321 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -116.41 125.85 52.61 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -151.76 134.24 15.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.207 0.603 . . . . 73.21 109.41 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.409 HG12 ' HE2' ' C' ' 84' ' ' PHE . 41.1 mt -74.81 109.0 7.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.555 -0.906 . . . . 70.22 108.555 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -85.88 -41.24 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.266 0.626 . . . . 72.13 111.175 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -170.77 142.95 2.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.957 -0.757 . . . . 70.2 108.957 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.0 mt -131.76 133.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.829 -0.804 . . . . 70.43 108.829 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.476 ' HH ' HD11 ' C' ' 83' ' ' ILE . 19.4 p90 -173.06 153.03 2.44 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.41 0.624 . . . . 64.31 111.509 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -74.76 125.09 28.0 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.954 -1.021 . . . . 73.43 109.782 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -77.64 -47.68 18.66 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.565 -1.272 . . . . 74.02 107.565 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -132.34 143.48 49.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.125 -1.398 . . . . 55.13 110.231 -171.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.2 mt -142.35 142.68 27.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.659 1.583 . . . . 73.45 106.767 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.48 148.71 21.66 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.163 0.506 . . . . 64.25 109.904 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -150.28 115.08 5.29 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.245 -1.391 . . . . 75.32 107.245 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -116.42 111.1 19.54 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.605 -0.517 . . . . 72.23 109.605 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.53 78.86 54.94 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 73.12 108.641 167.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.28 -28.61 39.76 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.045 1.83 . . . . 72.24 109.341 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -92.99 27.25 2.48 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.115 -1.402 . . . . 72.51 110.443 177.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.73 -50.17 89.44 Favored Pre-proline 0 CA--C 1.574 1.881 0 C-N-CA 123.746 0.818 . . . . 73.32 111.584 171.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.483 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 22.1 Cg_exo -66.1 -21.14 56.3 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.473 2.115 . . . . 75.41 113.247 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -60.59 -34.16 73.8 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 118.14 -0.933 . . . . 73.13 111.047 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.431 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.3 p -51.05 -31.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.196 0.813 . . . . 73.44 113.196 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -73.58 -29.18 62.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.811 0.844 . . . . 72.53 111.664 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.48 11.78 12.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.778 0.831 . . . . 73.53 112.217 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.431 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 18.5 ttpp -110.37 159.38 17.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 71.1 110.206 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.96 118.24 20.78 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.475 -0.784 . . . . 71.44 109.192 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -86.22 63.63 8.12 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.969 0.89 . . . . 74.4 110.862 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -145.2 72.95 14.56 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.177 -1.416 . . . . 75.54 107.177 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.56 151.61 4.3 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.787 2.325 . . . . 73.21 112.027 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.84 112.79 21.44 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.208 -1.034 . . . . 73.23 108.208 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.72 99.08 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 108.672 -0.862 . . . . 64.5 108.672 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.461 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 24.7 tptt -92.94 100.98 13.33 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.429 -1.322 . . . . 75.54 107.429 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -92.27 135.28 34.14 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.338 -0.986 . . . . 75.12 108.338 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.84 103.73 4.89 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.258 -1.016 . . . . 61.04 108.258 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -95.42 148.75 22.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.446 -0.576 . . . . 74.02 109.446 176.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -148.85 162.51 39.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.74 1.216 . . . . 71.53 107.976 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' C' ' 60' ' ' LEU . 10.2 t -145.65 137.14 25.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.344 0.657 . . . . 73.14 109.563 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.85 162.02 22.97 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.095 0.958 . . . . 72.12 108.985 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -139.31 143.78 38.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.894 0.477 . . . . 74.51 110.581 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -148.86 126.51 11.73 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.745 0.818 . . . . 74.43 109.518 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -88.29 120.22 29.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.539 -0.911 . . . . 72.22 108.539 173.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.596 HD12 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -91.2 -39.1 12.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.514 0.726 . . . . 74.31 110.699 -174.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.3 -175.54 5.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.477 -0.783 . . . . 61.21 110.305 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.6 105.39 1.51 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.028 0.931 . . . . 74.04 110.937 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 68.85 10.91 8.16 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.26 1.424 . . . . 73.41 112.979 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 76.2 t -105.34 113.71 42.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 73.42 108.341 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -117.5 160.47 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.056 0.942 . . . . 71.31 109.129 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.596 ' HB2' HD12 ' C' ' 51' ' ' LEU . 34.6 tt0 -127.58 146.69 50.45 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.055 1.342 . . . . 73.15 107.741 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.403 HG22 ' HG3' ' C' ' 103' ' ' PRO . 3.2 p -137.21 124.77 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.642 -0.873 . . . . 73.44 108.642 171.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.92 104.97 15.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.607 -0.886 . . . . 74.41 108.607 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' C' ' 46' ' ' THR . 0.8 OUTLIER -91.38 118.22 30.35 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.938 -0.393 . . . . 75.52 109.938 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -83.88 105.17 14.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.635 -0.876 . . . . 75.32 108.635 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.452 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.4 t -100.2 125.88 53.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.899 -1.149 . . . . 64.44 107.899 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 31.2 m -118.77 133.47 55.82 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.553 -0.906 . . . . 73.45 108.553 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.523 HG22 HG23 ' C' ' 114' ' ' ILE . 94.7 t -128.23 109.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.443 -0.947 . . . . 74.44 108.443 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.461 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 8.9 m -99.22 144.07 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.387 -0.968 . . . . 74.11 108.387 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.92 95.44 3.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.307 -1.738 . . . . 75.32 106.307 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -153.01 138.69 17.85 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.675 -0.491 . . . . 74.12 109.675 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.64 92.25 6.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.61 -79.31 1.26 Allowed Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.401 -0.818 . . . . 65.32 112.281 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -30.66 2.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.952 0.901 . . . . 74.14 110.617 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.62 102.59 0.93 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.754 0.821 . . . . 72.33 109.852 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -81.37 136.27 35.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.447 -0.797 . . . . 75.33 110.789 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.0 -55.45 3.68 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 63.21 107.485 163.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.67 175.07 9.15 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.844 0.831 . . . . 72.42 112.072 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.55 146.1 47.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.642 -1.984 . . . . 72.21 105.642 170.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.425 ' SG ' HG21 ' C' ' 114' ' ' ILE . 48.0 t -152.53 113.4 4.16 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.401 -0.592 . . . . 74.1 109.401 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -126.55 118.9 25.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.034 0.534 . . . . 71.11 109.852 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.84 134.05 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.825 0.85 . . . . 74.35 109.66 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.679 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -110.45 97.5 6.94 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.888 -1.153 . . . . 73.13 107.888 174.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -83.48 115.62 22.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.877 -0.602 . . . . 75.31 109.869 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.04 153.34 21.82 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.606 0.566 . . . . 73.45 111.775 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.443 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 119.99 0.97 Allowed Glycine 0 C--O 1.238 0.374 0 N-CA-C 111.195 -0.762 . . . . 74.3 111.195 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.476 HD11 ' HH ' ' C' ' 17' ' ' TYR . 11.7 mm -84.28 125.81 40.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.435 -0.95 . . . . 74.22 108.435 176.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.409 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.5 m-85 -137.62 135.08 36.26 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.967 0.907 . . . . 72.31 109.298 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -75.85 118.4 18.61 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.236 -1.024 . . . . 72.45 108.236 166.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.5 HG22 ' HE2' ' C' ' 94' ' ' MET . 16.2 mm -122.29 110.0 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.802 -0.814 . . . . 75.23 108.802 178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.576 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -147.77 165.18 31.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.658 0.783 . . . . 73.34 109.206 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.9 -50.54 3.96 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.404 -0.362 . . . . 72.33 112.22 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.73 141.89 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.705 0.802 . . . . 72.43 109.203 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -148.74 155.53 41.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.897 0.479 . . . . 74.31 110.862 -170.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.14 -145.41 28.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.865 0.728 . . . . 63.42 113.059 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.8 p -62.62 -28.33 69.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.996 . . . . 71.44 111.559 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -59.24 -49.0 79.53 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.535 0.734 . . . . 73.24 110.676 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.5 ' HE2' HG22 ' C' ' 86' ' ' ILE . 0.4 OUTLIER -71.37 -40.17 70.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 74.11 110.358 -177.247 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.39 78.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.611 0.764 . . . . 73.41 110.904 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -70.97 -41.27 71.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.306 -0.861 . . . . 61.3 110.777 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.11 -51.71 65.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.664 0.386 . . . . 71.31 110.818 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.454 HD23 ' HE3' ' C' ' 94' ' ' MET . 24.0 tp -75.87 -16.14 60.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.671 0.788 . . . . 74.32 111.087 -177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.89 3.32 31.89 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 119.511 -0.605 . . . . 53.44 114.113 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.37 -60.77 0.41 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.731 0.766 . . . . 75.44 110.851 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -68.44 -57.28 6.1 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.706 0.629 . . . . 73.0 111.835 -171.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 56.9 m -58.46 -45.95 99.65 Favored Pre-proline 0 CA--C 1.564 1.513 0 CA-C-O 118.415 -0.802 . . . . 74.52 111.901 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 44.3 Cg_exo -57.57 -37.12 98.1 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.278 1.985 . . . . 74.15 113.737 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -73.02 -26.55 61.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.767 0.427 . . . . 72.31 111.311 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.469 HD13 HH12 ' A' ' 111' ' ' ARG . 26.2 mm -65.56 -42.19 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.26 0.552 . . . . 75.45 109.587 169.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.492 ' HB2' HD23 ' C' ' 60' ' ' LEU . 92.3 mt -79.77 -19.26 49.06 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.651 -1.159 . . . . 74.2 111.882 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.5 -45.35 99.68 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.645 -1.169 . . . . 75.12 113.124 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 75.0 Cg_exo -52.91 -39.69 77.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.465 2.11 . . . . 74.21 113.262 172.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -68.98 -44.76 72.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.627 0.771 . . . . 74.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.02 99.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.216 0.606 . . . . 74.05 110.248 175.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -61.66 -49.41 76.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.84 1.256 . . . . 72.43 110.768 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.96 -33.83 74.34 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.684 0.615 . . . . 73.11 110.295 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -67.54 -37.33 82.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 75.43 110.975 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.523 HG23 HG22 ' C' ' 64' ' ' VAL . 96.3 mt -71.54 -47.47 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.707 0.803 . . . . 74.52 110.631 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 41.6 m -67.07 -28.85 68.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.77 0.828 . . . . 72.01 111.076 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.1 t -68.61 -45.09 72.83 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.373 0.669 . . . . 74.44 109.442 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.573 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.91 -39.8 93.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.027 0.931 . . . . 71.32 111.941 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.31 -45.32 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.634 0.774 . . . . 73.23 109.917 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.1 t -64.92 -33.09 75.19 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.061 -0.972 . . . . 65.01 111.369 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -73.69 -33.59 64.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.596 0.758 . . . . 73.45 110.291 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.57 -3.98 90.14 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.55 0.531 . . . . 74.23 112.46 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.528 HG21 ' HB3' ' D' ' 17' ' ' TYR . 19.1 p 65.29 45.43 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.581 1.952 . . . . 71.22 112.182 174.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.439 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.4 m-85 -106.89 164.22 15.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-N 114.077 -1.42 . . . . 73.11 109.1 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' E' ' 136' ' ' VAL . 95.3 Cg_endo -72.33 179.65 4.84 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.752 2.301 . . . . 75.33 112.977 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -60.11 111.99 1.73 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.7 -0.682 . . . . 73.42 111.592 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.27 96.58 5.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 106.362 -1.718 . . . . 74.14 106.362 169.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.12 122.47 47.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.647 0.779 . . . . 74.43 109.511 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 57.0 mt -83.0 133.57 35.09 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.227 0.611 . . . . 73.3 109.402 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.74 143.19 78.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 123.509 0.506 . . . . 74.04 110.607 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.495 ' HG2' HD13 ' E' ' 147' ' ' LEU . 28.0 Cg_endo -62.97 133.37 41.07 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.395 2.064 . . . . 64.14 111.726 175.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 p -102.0 111.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.458 -0.941 . . . . 62.14 108.458 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.761 ' HB3' ' HB2' ' C' ' 135' ' ' ALA . 7.2 m-20 -83.75 57.68 4.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.446 0.698 . . . . 73.41 110.389 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -76.88 -21.53 54.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.817 0.818 . . . . 74.41 109.232 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -79.78 -47.41 15.27 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.534 1.134 . . . . 72.32 110.951 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.761 ' HB2' ' HB3' ' C' ' 132' ' ' ASN . . . -64.88 -47.66 77.03 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 124.417 1.073 . . . . 63.2 112.186 -170.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.467 HD12 ' HD2' ' E' ' 149' ' ' PRO . 56.7 tp -54.02 -43.88 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.859 0.724 . . . . 73.12 112.405 -175.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.83 -32.73 40.64 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.416 0.524 . . . . 75.43 112.416 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.0 ptm -78.19 -30.04 48.78 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.741 0.246 . . . . 75.45 111.194 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.13 -37.94 69.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.882 0.873 . . . . 74.11 109.956 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -70.7 -151.32 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 123.748 0.819 . . . . 72.22 109.285 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 14.3 tp 65.12 -172.01 0.18 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.271 1.028 . . . . 73.21 109.627 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.498 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 0.0 OUTLIER -147.52 91.86 2.02 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 122.091 0.948 . . . . 74.31 110.087 175.44 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -116.2 114.0 23.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.744 -1.206 . . . . 72.12 107.744 174.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.486 ' HG2' ' HG2' ' A' ' 142' ' ' GLN . 77.5 mt-30 -108.64 138.54 44.79 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.338 0.655 . . . . 75.02 110.569 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 140' ' ' TYR . . . -96.72 159.52 14.88 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.101 0.96 . . . . 40.34 109.218 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.63 166.19 29.69 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.738 -0.665 . . . . 73.45 111.691 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.08 141.9 8.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 106.848 -1.538 . . . . 71.24 106.848 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.51 124.42 1.38 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.081 -0.807 . . . . 75.55 111.081 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -119.48 151.03 39.25 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 122.883 0.473 . . . . 73.13 110.727 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -164.56 113.75 1.14 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.609 1.164 . . . . 74.13 108.517 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.07 172.67 17.74 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.198 1.399 . . . . 73.23 108.783 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -167.31 122.04 1.03 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.673 0.789 . . . . 72.33 109.199 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.96 -38.11 84.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.77 0.828 . . . . 73.13 111.295 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.79 105.13 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.561 1.145 . . . . 64.25 110.328 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 123.52 0.728 . . . . 74.34 110.68 -178.525 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.618 -0.512 . . . . 65.43 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -144.54 -170.91 3.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.632 0.773 . . . . 62.4 109.076 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -144.44 88.84 1.96 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.287 0.635 . . . . 75.51 109.52 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -90.12 154.62 19.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.13 -0.693 . . . . 74.0 109.13 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.79 128.1 34.76 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.189 -1.041 . . . . 75.25 108.189 170.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.61 127.64 32.42 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.855 0.722 . . . . 73.13 110.276 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.2 p -85.39 175.3 8.95 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.387 0.675 . . . . 73.11 109.504 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.23 -178.58 1.35 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.849 0.459 . . . . 73.31 109.964 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.514 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.9 tpt -30.81 123.07 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 74.34 113.848 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.402 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 96.9 m -148.18 142.3 26.03 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.449 1.1 . . . . 75.23 109.12 -176.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -164.2 103.5 0.86 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.67 -1.233 . . . . 73.34 107.67 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.53 ' HG3' ' HB2' ' D' ' 85' ' ' SER . 5.2 pt20 -149.51 127.08 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.528 0.731 . . . . 75.25 109.569 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.489 HD12 ' O ' ' D' ' 83' ' ' ILE . 3.3 tp -84.26 110.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 75.45 109.353 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.432 ' O ' ' HB3' ' E' ' 131' ' ' ALA . 74.9 mt-30 -73.36 -40.99 63.95 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.332 1.053 . . . . 72.43 112.036 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.435 HH12 HG12 ' E' ' 134' ' ' ILE . 43.6 ttt180 -159.77 124.51 3.94 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.404 -0.221 . . . . 73.41 110.404 -166.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.555 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.2 mp -103.26 132.61 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 107.069 -1.456 . . . . 72.35 107.069 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.528 ' HB3' HG21 ' C' ' 122' ' ' THR . 28.9 p90 -158.83 167.62 28.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.084 0.945 . . . . 71.4 111.724 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p -102.52 120.21 40.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.038 -1.437 . . . . 75.42 109.426 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -87.63 -24.37 23.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 71.25 110.754 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.8 t70 -158.11 139.65 13.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.336 -0.847 . . . . 73.0 109.354 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.573 HG23 ' HE1' ' C' ' 117' ' ' MET . 63.4 mt -139.82 144.88 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.828 -1.175 . . . . 54.32 107.828 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -149.77 144.82 26.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.141 0.976 . . . . 63.24 109.031 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.529 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 88.7 t80 -151.92 111.55 3.98 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.047 -1.834 . . . . 74.21 106.047 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.6 mt-10 -122.44 113.78 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.745 0.418 . . . . 73.44 110.527 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.61 81.22 54.48 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.983 0.913 . . . . 73.01 109.227 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . 0.447 ' HG2' ' ND2' ' D' ' 27' ' ' ASN . 58.8 Cg_endo -71.5 -37.56 5.41 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.619 2.213 . . . . 73.01 111.945 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' D' ' 26' ' ' PRO . 2.0 m-80 -103.72 38.53 1.79 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.983 0.913 . . . . 75.13 108.699 -175.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.7 -50.66 84.26 Favored Pre-proline 0 CA--C 1.575 1.904 0 N-CA-C 114.561 1.319 . . . . 71.11 114.561 -168.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.96 -12.72 4.89 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 121.757 1.638 . . . . 74.42 112.853 171.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -69.74 -40.07 76.41 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.625 1.17 . . . . 75.24 109.837 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.36 -18.13 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.139 0.576 . . . . 74.11 110.429 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -57.45 -35.53 70.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.362 0.665 . . . . 74.33 111.362 171.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -59.66 -25.28 64.6 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.91 0.756 . . . . 74.43 111.343 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -110.84 91.42 3.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.323 -1.362 . . . . 75.55 107.323 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.49 67.14 5.16 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 122.465 1.126 . . . . 62.2 110.929 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -128.3 158.23 38.75 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.791 -1.188 . . . . 74.11 107.791 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.443 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 20.9 mm-40 -84.73 118.23 70.54 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 122.849 0.459 . . . . 73.43 110.049 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.496 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 34.1 Cg_exo -64.59 158.76 48.19 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.845 3.03 . . . . 74.13 113.844 -172.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.2 tt0 -71.82 124.63 25.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.987 -0.745 . . . . 74.45 108.987 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.491 HG21 HG13 ' D' ' 64' ' ' VAL . 3.2 p -96.8 114.25 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.68 0.752 . . . . 73.05 110.088 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.56 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 8.9 tppt? -95.57 107.62 19.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.787 -1.19 . . . . 75.13 107.787 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -101.04 116.9 33.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.906 -0.405 . . . . 73.03 109.906 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.468 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.7 m-20 -116.66 124.85 50.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.739 0.816 . . . . 62.34 109.52 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.18 137.61 48.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.488 0.715 . . . . 75.31 110.108 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.587 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -146.33 146.71 30.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.899 1.28 . . . . 62.31 108.061 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -123.55 165.51 17.01 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.907 -0.405 . . . . 62.22 109.907 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -157.38 164.52 37.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.4 0.68 . . . . 71.53 109.789 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.0 p -156.22 153.4 29.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.01 0.524 . . . . 74.1 110.897 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 98.0 p -154.47 155.0 34.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 60.2 108.655 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -97.26 116.96 30.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.208 -0.664 . . . . 75.55 109.208 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' D' ' 57' ' ' GLU . 25.3 mt -92.5 -28.89 16.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.028 0.531 . . . . 74.11 110.123 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.19 -178.98 5.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.23 1.014 . . . . 70.34 110.623 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.36 117.12 8.16 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.548 -1.66 . . . . 61.43 110.513 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 63.18 21.25 12.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.26 1.424 . . . . 74.11 111.442 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.8 t -131.5 115.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 124.141 0.976 . . . . 74.01 109.137 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -132.74 130.27 39.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.511 -0.922 . . . . 73.14 108.511 -172.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.506 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.7 tt0 -86.54 138.08 32.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.62 0.768 . . . . 74.32 109.146 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.494 HG11 ' HD3' ' D' ' 103' ' ' PRO . 97.6 t -122.07 128.89 75.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.434 -1.321 . . . . 74.24 107.434 170.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 29.3 t -110.42 132.74 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.293 -0.632 . . . . 74.41 109.293 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.472 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.61 119.0 38.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.063 -1.088 . . . . 74.44 108.063 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.587 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.47 103.52 13.9 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.411 -0.959 . . . . 74.14 108.411 175.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.76 133.02 46.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.195 -1.039 . . . . 75.42 108.195 170.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 7.9 m -126.95 128.15 45.97 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.491 HG13 HG21 ' D' ' 40' ' ' VAL . 61.1 t -119.38 102.12 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.12 0.968 . . . . 70.0 108.658 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 96.0 m -106.19 100.89 10.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.613 0.765 . . . . 71.01 109.354 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.496 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -98.66 134.96 40.85 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.75 0.42 . . . . 71.12 110.11 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 40.8 p -146.32 140.15 26.22 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.613 -0.884 . . . . 73.24 108.613 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.62 119.13 25.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.529 -0.545 . . . . 75.12 109.529 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.1 -117.9 5.78 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.821 0.701 . . . . 73.01 113.238 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 5.33 46.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.88 . . . . 74.15 110.993 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.41 155.06 43.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.006 0.431 . . . . 73.53 111.434 -161.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -66.77 136.91 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.432 1.093 . . . . 74.24 110.726 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.35 -66.72 0.89 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.579 0.752 . . . . 64.25 109.526 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 151.22 26.23 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.629 0.772 . . . . 71.33 109.396 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.9 mt -118.95 154.25 33.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.889 0.876 . . . . 63.22 109.173 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.449 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 54.1 t -158.66 146.22 17.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.02 0.528 . . . . 73.14 110.894 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -156.52 137.77 13.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.65 -0.871 . . . . 54.45 108.65 167.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -135.31 116.21 19.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.41 0.684 . . . . 74.24 109.27 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 53.0 mt-30 -92.29 85.28 5.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.504 0.722 . . . . 74.31 109.059 171.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.84 100.83 8.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.805 1.242 . . . . 73.44 109.721 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 143.28 16.51 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.144 -0.382 . . . . 73.42 112.144 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.15 134.21 6.6 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.945 -0.462 . . . . 72.34 111.945 -177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.489 ' O ' HD12 ' D' ' 13' ' ' ILE . 60.1 mt -90.51 125.82 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.708 0.803 . . . . 71.25 109.142 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.23 129.26 49.7 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.446 0.699 . . . . 70.32 110.218 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.53 ' HB2' ' HG3' ' D' ' 12' ' ' GLN . 33.0 m -79.12 104.97 10.11 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 167.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.6 117.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.586 0.754 . . . . 70.44 110.09 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -149.8 159.97 43.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.612 0.765 . . . . 71.02 109.948 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 86.72 -20.79 22.03 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.086 -0.506 . . . . 41.45 114.292 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.26 144.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.738 0.815 . . . . 74.34 109.89 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -176.51 5.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.816 0.846 . . . . 73.11 110.256 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.59 -140.16 44.22 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.641 0.588 . . . . 72.42 114.188 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -63.03 -34.02 76.67 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.106 0.963 . . . . 73.13 111.397 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.48 -51.35 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.13 0.572 . . . . 73.32 109.743 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.82 -42.98 97.55 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.822 0.701 . . . . 75.11 111.256 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.63 97.07 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.827 0.704 . . . . 75.12 110.88 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.442 ' HE2' ' HA ' ' D' ' 134' ' ' ASP . 14.3 t-80 -71.41 -34.27 70.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.811 . . . . 72.13 111.055 176.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.57 -48.05 76.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.746 0.418 . . . . 62.31 109.982 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -71.92 -18.19 62.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 122.797 0.439 . . . . 71.24 111.824 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.57 10.5 32.87 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.222 -0.765 . . . . 74.23 114.25 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.1 -64.22 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.948 0.874 . . . . 61.0 111.842 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -69.2 -40.1 78.23 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.409 0.683 . . . . 71.11 112.592 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 60.9 m -73.26 -44.84 7.88 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.478 0.711 . . . . 74.34 110.976 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HD3' HG11 ' D' ' 58' ' ' VAL . 72.2 Cg_exo -54.85 -33.16 80.58 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.514 2.142 . . . . 65.03 113.694 166.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.16 -39.02 93.46 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.826 0.85 . . . . 73.12 109.948 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.15 -41.75 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.029 0.932 . . . . 74.53 110.868 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 93.5 mt -76.08 -20.16 57.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.406 -0.815 . . . . 74.22 112.27 -173.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -65.1 -41.96 57.46 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.789 1.033 . . . . 72.42 113.789 -170.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.29 -41.25 67.33 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.22 1.947 . . . . 65.03 113.317 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.401 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.9 m-85 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.766 0.826 . . . . 75.34 111.842 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -51.02 64.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 73.01 109.855 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -57.29 -44.52 84.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.557 -1.201 . . . . 71.14 111.332 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.48 -47.46 85.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.696 0.798 . . . . 71.33 111.528 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.15 -39.52 79.02 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.914 0.759 . . . . 74.44 110.972 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.7 -49.7 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.76 0.824 . . . . 73.5 110.842 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.425 HG22 ' HG3' ' D' ' 125' ' ' GLN . 30.2 m -57.06 -39.14 74.32 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.109 0.964 . . . . 73.23 111.578 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 36.4 t -65.89 -43.01 89.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.38 -0.827 . . . . 72.14 111.067 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.88 -35.16 74.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.813 0.445 . . . . 75.21 111.717 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.21 -40.92 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.27 -0.877 . . . . 71.11 110.315 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -71.19 -29.96 65.8 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.334 0.253 . . . . 65.53 110.886 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' D' ' 116' ' ' SER . 93.8 mtt-85 -69.26 -32.82 72.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.044 0.538 . . . . 73.45 110.322 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.22 7.52 80.35 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.694 0.621 . . . . 74.22 113.0 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 53.71 36.08 22.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.787 1.635 . . . . 75.42 112.466 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -104.69 155.07 38.01 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.464 1.105 . . . . 75.34 109.815 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.55 141.15 97.13 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.416 2.744 . . . . 74.1 113.125 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' D' ' 115' ' ' THR . 33.4 tt0 -54.46 133.71 45.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.398 1.079 . . . . 70.41 112.231 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.43 HD21 ' HG ' ' F' ' 139' ' ' LEU . 3.2 tm? -112.18 97.37 6.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.029 -1.1 . . . . 75.31 108.029 -173.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -108.58 108.94 20.04 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.578 0.751 . . . . 62.3 109.435 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.24 139.88 44.63 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.729 0.812 . . . . 75.35 111.3 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.95 145.59 96.78 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.937 0.895 . . . . 62.14 111.957 -178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -69.07 104.38 1.2 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.23 2.62 . . . . 74.42 112.137 175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.02 110.35 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.219 -0.66 . . . . 43.14 109.219 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -88.04 92.67 9.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.532 -0.914 . . . . 75.25 108.532 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -65.66 -33.49 76.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.828 0.451 . . . . 75.25 110.561 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.442 ' HA ' ' HE2' ' D' ' 96' ' ' HIS . 6.7 m-20 -56.0 -42.86 77.05 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.89 0.876 . . . . 73.41 110.813 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.39 -60.04 4.1 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 124.26 0.975 . . . . 73.23 111.007 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.618 HD21 ' HD2' ' F' ' 149' ' ' PRO . 8.6 mp -61.16 -34.62 75.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.202 0.601 . . . . 73.45 112.103 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -62.34 -62.33 1.84 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 74.33 110.002 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.6 ptp -65.32 -28.35 69.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.524 -0.762 . . . . 75.15 111.223 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.42 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 95.1 m-20 -70.35 -42.95 71.16 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 123.818 0.699 . . . . 71.4 110.829 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.25 0.344 . . . . 74.24 110.455 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.74 -46.13 80.05 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.281 0.632 . . . . 74.24 111.472 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.42 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.5 pt20 -76.27 2.21 13.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.731 0.412 . . . . 74.22 111.986 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -121.2 44.61 2.48 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.811 0.844 . . . . 63.34 109.319 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -145.73 123.7 12.05 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.743 1.217 . . . . 61.22 107.817 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.44 143.2 44.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 44.21 110.582 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.83 -154.02 19.9 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.772 0.67 . . . . 44.01 111.459 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.6 148.12 50.77 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.624 0.77 . . . . 64.25 110.534 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.52 -176.25 18.36 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.773 -0.649 . . . . 74.53 111.652 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.9 p -74.97 88.45 2.36 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.373 0.669 . . . . 73.13 112.154 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.8 73.73 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.591 1.186 . . . . 65.23 109.462 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -72.75 121.23 19.53 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.502 -1.226 . . . . 72.22 110.984 -172.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -122.27 123.74 42.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.681 0.792 . . . . 75.41 109.322 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -118.26 -179.5 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.908 0.883 . . . . 74.55 110.372 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.74 115.5 21.01 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.834 -0.802 . . . . 71.21 108.834 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 123.206 0.602 . . . . 63.43 110.925 -179.262 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.861 -0.422 . . . . 71.13 109.861 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -115.39 54.23 0.81 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.364 0.602 . . . . 73.23 111.138 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.22 -42.59 15.76 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.808 -0.812 . . . . 71.12 108.808 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 21.0 t80 76.84 -57.05 0.54 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.284 1.834 . . . . 72.52 112.274 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 61.24 75.74 0.4 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.507 1.123 . . . . 75.42 110.847 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -177.57 -59.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.787 -1.097 . . . . 74.05 109.13 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -58.58 -32.2 68.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.329 1.052 . . . . 72.44 112.491 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.468 ' O ' ' HD3' ' E' ' 117' ' ' PRO . 37.1 tp 78.34 -52.48 0.49 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.526 1.53 . . . . 73.23 111.663 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -86.68 94.26 0.36 Allowed Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.648 1.179 . . . . 74.32 108.669 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' E' ' 115' ' ' LEU . 50.0 Cg_endo -102.17 5.89 0.49 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.158 2.572 . . . . 64.14 113.509 -172.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -152.97 120.73 6.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.107 0.563 . . . . 64.35 109.754 -168.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 70.7 p -82.6 107.35 15.18 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.977 0.798 . . . . 75.01 109.238 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.4 ' HE1' HG23 ' B' ' 46' ' ' THR . 18.1 t-105 -75.26 105.76 6.45 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.794 0.807 . . . . 74.23 111.158 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.93 115.47 28.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.484 -1.234 . . . . 74.33 108.805 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.53 33.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.385 0.674 . . . . 54.22 111.44 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 18.3 m -83.69 2.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.258 0.836 . . . . 73.1 113.258 -168.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 74.25 -69.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 72.15 110.374 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 65.0 t80 74.68 133.8 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.484 1.514 . . . . 70.21 112.841 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -170.91 144.51 2.2 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.628 1.171 . . . . 70.15 109.232 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 145.11 -137.82 7.35 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 111.172 -0.771 . . . . 61.34 111.172 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.64 87.82 2.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.865 0.841 . . . . 75.52 109.804 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . 0.625 HD21 ' H ' ' B' ' 42' ' ' LEU . 2.2 pp -97.69 2.99 50.33 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.366 -1.288 . . . . 74.03 110.785 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -85.51 145.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.98 -0.748 . . . . 73.43 108.98 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' D' ' 14' ' ' GLN . . . -61.03 -71.56 0.14 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.746 0.818 . . . . 72.41 110.592 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -162.82 147.68 9.45 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.009 0.924 . . . . 75.01 108.6 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.19 101.4 0.34 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.947 2.431 . . . . 75.43 112.964 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . 0.435 HG12 HH12 ' D' ' 15' ' ' ARG . 6.1 tp -129.93 120.92 50.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 107.965 -1.124 . . . . 73.22 107.965 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.89 139.06 39.21 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.104 -0.702 . . . . 71.43 109.104 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.549 ' HB ' ' HD3' ' C' ' 124' ' ' PRO . 16.5 m -126.64 -19.85 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.73 0.812 . . . . 74.3 111.069 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 67.46 127.69 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.56 1.544 . . . . 75.01 110.586 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.38 74.82 1.38 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.349 0.659 . . . . 64.51 110.129 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.33 138.04 57.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.6 0.76 . . . . 75.34 111.869 -172.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 22.8 p -150.16 27.26 0.77 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.0 0.92 . . . . 72.51 110.438 -171.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . 0.607 HD21 ' H ' ' E' ' 141' ' ' LEU . 2.0 pt? -89.51 42.46 1.09 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.177 0.989 . . . . 73.14 109.703 177.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.78 -67.1 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.407 1.083 . . . . 73.22 108.631 -175.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.94 100.86 3.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.52 1.128 . . . . 71.23 109.322 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -90.73 94.98 9.91 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.328 -0.99 . . . . 72.41 108.328 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . 0.667 ' HB2' ' HZ2' ' E' ' 145' ' ' LYS . 2.3 ttmp? 68.59 -163.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.268 1.027 . . . . 74.33 110.19 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . 0.658 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . 34.3 t70 65.01 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.006 1.323 . . . . 73.23 110.993 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . 0.679 HD11 ' HB ' ' A' ' 13' ' ' ILE . 1.2 tt -145.88 143.5 29.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.698 -0.853 . . . . 71.22 108.698 -177.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' C' ' 132' ' ' ASN . 4.8 mp -70.69 135.16 85.92 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.579 0.752 . . . . 75.54 109.671 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . 0.467 ' HD2' HD12 ' C' ' 136' ' ' LEU . 8.1 Cg_exo . . . . . 0 CA--C 1.562 1.884 0 C-N-CA 122.365 2.044 . . . . 72.34 110.657 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.398 0.618 . . . . 65.21 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.2 90.11 7.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.088 0.955 . . . . 75.33 109.457 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.45 88.93 2.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.932 0.893 . . . . 74.53 109.405 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.79 86.88 3.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.08 -0.711 . . . . 71.24 109.08 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -77.13 146.67 37.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.662 -1.154 . . . . 74.12 110.396 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -61.91 120.21 10.32 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.047 -1.094 . . . . 75.25 108.047 167.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.565 ' HD2' ' HA ' ' A' ' 49' ' ' SER . 11.0 tppt? -57.45 -48.75 78.33 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.257 0.973 . . . . 75.21 110.233 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 35.7 tp -170.66 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.364 -1.289 . . . . 75.25 107.855 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . 0.599 ' HB3' HD11 ' A' ' 98' ' ' LEU . 35.1 p90 -75.22 123.23 88.66 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.802 -1.09 . . . . 73.01 111.495 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.77 -166.13 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 123.161 2.574 . . . . 74.21 110.369 158.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 52.4 t80 57.26 87.28 0.06 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.294 1.037 . . . . 74.35 112.17 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 57.3 m -110.39 105.17 14.08 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.61 0.764 . . . . 75.34 109.175 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -109.56 156.7 19.84 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.831 0.852 . . . . 71.3 110.817 -175.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -125.35 131.97 52.9 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.648 0.779 . . . . 74.41 110.155 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -168.63 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.907 0.883 . . . . 74.4 111.104 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.37 155.12 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.053 0.541 . . . . 73.25 111.727 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -144.56 121.94 11.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.572 -0.74 . . . . 74.21 109.447 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -105.16 150.17 25.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.996 0.918 . . . . 71.12 109.569 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -161.2 151.06 17.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.257 -1.016 . . . . 73.41 108.257 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -72.47 -93.23 0.09 OUTLIER Glycine 0 C--N 1.347 1.156 0 O-C-N 123.606 0.566 . . . . 51.44 111.824 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 60.65 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.109 1.364 . . . . 75.31 111.892 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 1.2 pp -68.61 132.5 47.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.751 0.82 . . . . 64.45 111.924 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 56.5 mt -134.51 148.63 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.697 1.199 . . . . 74.31 108.316 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.22 123.81 23.07 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.656 -0.498 . . . . 62.23 109.656 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -71.0 125.42 92.01 Favored Pre-proline 0 CA--C 1.555 1.15 0 O-C-N 123.301 0.375 . . . . 74.13 110.332 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -94.9 164.2 1.71 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.857 2.372 . . . . 70.4 112.753 171.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.467 HG12 ' H ' ' F' ' 135' ' ' ALA . 14.4 tt -89.86 -177.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 107.33 -1.359 . . . . 73.11 107.33 166.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.467 ' H ' HG12 ' F' ' 134' ' ' ILE . . . -62.07 88.31 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.577 0.626 . . . . 71.45 110.331 174.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.52 96.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 74.54 110.461 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -145.14 -70.87 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.006 0.922 . . . . 73.43 109.116 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.34 128.77 10.64 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.736 0.814 . . . . 63.54 109.085 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.43 ' HG ' HD21 ' D' ' 126' ' ' LEU . 0.6 OUTLIER -66.01 96.74 0.33 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.071 0.948 . . . . 73.42 109.366 -176.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -80.06 172.58 13.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.865 0.866 . . . . 65.33 110.163 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 57.5 mt 65.03 30.45 11.71 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.433 1.093 . . . . 73.34 109.482 -163.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.454 HD11 HG12 ' D' ' 40' ' ' VAL . 10.2 tp -70.9 148.15 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.299 -1.319 . . . . 73.5 109.41 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -58.09 139.2 55.18 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.69 0.796 . . . . 74.21 111.373 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -106.4 -41.37 5.32 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.969 0.508 . . . . 75.13 110.302 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -82.26 70.84 9.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.307 0.575 . . . . 74.21 109.967 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . 0.622 ' HA ' ' HG3' ' F' ' 149' ' ' PRO . 28.8 t0 -164.66 173.65 11.66 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.838 -1.074 . . . . 73.43 108.305 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 tt 64.18 71.42 0.48 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.757 -1.571 . . . . 73.32 106.757 -168.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mp 60.08 73.77 0.62 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 114.593 -1.185 . . . . 72.04 110.34 -171.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . 0.622 ' HG3' ' HA ' ' F' ' 146' ' ' ASP . 27.5 Cg_exo . . . . . 0 C--N 1.384 2.399 0 C-N-CA 122.701 2.267 . . . . 71.11 111.537 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 110.126 -0.324 . . . . 62.05 110.126 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -65.21 105.26 1.06 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.729 0.812 . . . . 75.2 110.703 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -79.66 86.23 5.3 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.337 0.655 . . . . 74.35 109.891 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -153.12 154.7 35.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.96 0.904 . . . . 73.3 110.235 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -118.12 -45.41 2.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.537 0.735 . . . . 73.43 109.788 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 60.65 63.05 1.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.691 1.196 . . . . 72.23 111.129 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -131.32 154.76 48.21 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.402 0.681 . . . . 75.43 110.839 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 61.48 71.88 0.53 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.573 1.149 . . . . 73.32 111.583 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -99.14 152.8 19.47 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.774 -1.103 . . . . 73.13 109.782 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.0 m -143.11 113.69 7.46 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.496 0.718 . . . . 73.51 109.465 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -137.21 125.06 22.57 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.32 -0.993 . . . . 74.42 108.32 175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -135.69 112.56 10.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.347 0.659 . . . . 75.12 109.721 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mp -79.12 119.68 28.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.813 -1.18 . . . . 74.32 107.813 175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 82.0 mm-40 -81.55 -41.51 21.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.651 0.594 . . . . 74.01 109.92 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.723 HH11 HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -173.47 163.96 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.319 1.048 . . . . 72.21 110.281 173.473 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.557 HD13 ' HG3' ' C' ' 130' ' ' PRO . 1.6 pp -144.03 101.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 108.279 -1.008 . . . . 72.43 108.279 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 64.7 m-85 -155.64 173.45 16.69 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.018 0.927 . . . . 72.35 109.886 -166.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.96 115.47 26.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.264 -0.425 . . . . 62.4 111.076 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -73.79 -44.74 55.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.967 -0.753 . . . . 72.32 108.967 171.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.8 t70 -135.78 148.35 48.73 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.757 -1.11 . . . . 75.11 110.368 -174.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.471 HG22 ' SD ' ' A' ' 117' ' ' MET . 92.4 mt -145.13 142.75 22.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 126.021 1.728 . . . . 75.1 106.94 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -155.47 133.02 11.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.761 0.424 . . . . 73.53 110.403 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 77.1 t80 -127.28 131.11 50.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.241 -1.392 . . . . 75.43 107.241 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -129.24 126.51 39.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.235 0.614 . . . . 73.24 109.708 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 79.33 32.07 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.402 -0.962 . . . . 73.43 108.402 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.72 -11.87 20.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.771 2.314 . . . . 73.3 112.328 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -119.16 30.99 6.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.311 1.044 . . . . 73.14 109.112 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.27 99.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 N-CA-C 113.688 0.996 . . . . 62.42 113.688 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.17 -18.12 35.27 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 121.572 1.515 . . . . 74.11 113.277 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -80.12 -12.75 59.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.705 0.802 . . . . 75.14 112.765 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.12 -33.62 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 124.093 0.957 . . . . 74.44 112.806 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.27 -32.79 74.64 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.31 0.644 . . . . 74.34 111.637 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -90.72 -36.44 14.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 74.53 111.078 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.17 155.52 23.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.116 0.966 . . . . 75.34 111.517 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.416 ' HB2' HD13 ' A' ' 68' ' ' LEU . 7.6 m-20 -70.43 137.11 50.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.758 0.823 . . . . 61.1 110.007 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -88.36 61.66 6.28 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.87 -0.789 . . . . 65.3 108.87 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -142.45 58.56 7.6 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.972 0.909 . . . . 72.42 109.94 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.55 152.43 7.67 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.875 1.717 . . . . 74.23 112.208 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -93.28 117.51 30.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.583 -1.265 . . . . 73.5 107.583 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.68 136.25 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.971 0.508 . . . . 75.03 110.826 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -119.04 131.45 55.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.316 1.447 . . . . 65.13 108.913 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.413 HD23 HD21 ' F' ' 129' ' ' LEU . 4.6 pp -97.53 152.2 19.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.986 -1.116 . . . . 72.12 107.986 170.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' VAL . 26.3 t70 -144.2 143.35 31.02 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.087 -1.079 . . . . 75.5 108.087 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -140.61 125.31 18.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.494 0.717 . . . . 75.32 109.837 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.526 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 12.8 t70 -132.54 142.91 49.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.047 0.939 . . . . 74.35 109.517 -177.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.9 m -124.46 124.4 42.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.527 0.731 . . . . 75.45 110.404 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.56 8.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.362 0.665 . . . . 74.03 110.41 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.8 m -90.8 158.09 17.02 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.584 0.753 . . . . 71.11 109.585 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.5 t -162.13 118.35 2.01 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.085 0.402 . . . . 63.5 111.048 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.53 103.39 2.47 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.492 0.717 . . . . 74.2 110.74 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.798 HD12 ' HB2' ' A' ' 57' ' ' GLU . 48.2 mt -83.36 -34.54 25.59 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 71.41 110.862 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.36 -174.6 4.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.44 1.096 . . . . 73.3 108.908 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.84 96.32 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.433 0.458 . . . . 74.24 110.979 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.47 27.71 15.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.915 1.286 . . . . 73.32 112.278 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.484 HG12 ' HG ' ' A' ' 85' ' ' SER . 46.9 t -104.18 113.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.784 -1.561 . . . . 74.31 106.784 168.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 49' ' ' SER . 22.7 m-85 -119.1 129.06 54.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.868 -0.79 . . . . 74.2 108.868 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.798 ' HB2' HD12 ' A' ' 51' ' ' LEU . 39.5 tt0 -83.32 114.99 21.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.906 -1.146 . . . . 65.14 107.906 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.85 111.26 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.314 -1.365 . . . . 73.05 107.314 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.556 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 80.7 t -97.16 136.11 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.353 1.061 . . . . 74.22 109.352 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.52 HD23 HG23 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -108.16 116.14 31.42 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.062 -0.718 . . . . 74.45 109.062 175.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.572 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -92.9 106.49 18.45 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.777 -0.823 . . . . 72.31 108.777 173.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.52 HG23 HD23 ' A' ' 60' ' ' LEU . 49.5 t -107.74 133.17 53.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.323 0.649 . . . . 74.22 109.666 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.1 m -121.95 138.96 54.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.574 -0.528 . . . . 72.25 109.574 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG23 HG21 ' A' ' 114' ' ' ILE . 53.6 t -126.12 105.63 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.877 -1.527 . . . . 72.43 106.877 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.0 m -108.13 144.0 36.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.417 -0.957 . . . . 75.32 108.417 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.37 124.87 27.96 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.991 -1.115 . . . . 61.25 107.991 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -126.05 125.95 43.46 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.654 0.596 . . . . 73.13 109.829 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 35' ' ' ASP . 49.0 tp -91.86 73.3 5.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.035 0.934 . . . . 74.41 108.922 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.61 -92.12 0.78 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.715 -0.675 . . . . 74.52 112.847 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -98.84 -26.81 14.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.822 0.849 . . . . 72.32 111.23 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.37 138.01 44.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.575 0.75 . . . . 73.2 111.001 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -60.65 129.72 42.96 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.446 0.466 . . . . 71.41 110.202 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.86 -56.05 4.22 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.585 -0.524 . . . . 74.25 109.585 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.477 ' HE1' ' SG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -164.75 166.89 19.51 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.326 0.65 . . . . 72.32 109.77 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 27.8 tp -143.79 146.4 33.07 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.201 0.6 . . . . 75.12 111.283 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.477 ' SG ' ' HE1' ' A' ' 74' ' ' PHE . 51.7 m -143.54 142.29 31.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.2 1.4 . . . . 73.14 109.88 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -148.45 123.53 10.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 70.11 109.602 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.18 130.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.609 0.764 . . . . 74.42 110.183 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.572 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 72.3 mt-30 -95.67 96.95 9.36 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.472 0.709 . . . . 75.4 109.57 168.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -83.21 93.94 7.78 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.026 -0.731 . . . . 74.22 109.026 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.2 144.4 19.24 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.823 -0.511 . . . . 71.41 111.823 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.37 122.25 2.03 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.445 -1.062 . . . . 65.41 110.445 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.723 HD12 HH11 ' A' ' 15' ' ' ARG . 33.8 mt -82.79 123.87 38.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.572 -0.899 . . . . 75.31 108.572 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -129.28 138.31 51.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.158 -0.682 . . . . 71.24 109.158 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.484 ' HG ' HG12 ' A' ' 55' ' ' VAL . 18.6 m -108.63 119.09 38.51 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.918 -1.141 . . . . 65.31 107.918 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.36 131.16 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 120.975 0.417 . . . . 65.22 110.829 -172.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.7 165.53 28.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.202 1.001 . . . . 70.5 110.88 -173.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.4 -33.19 6.38 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 116.063 -0.517 . . . . 72.01 112.86 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.46 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.85 178.26 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.085 0.954 . . . . 65.31 108.827 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 14.6 tt0 -161.64 -179.44 7.28 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 110.238 -0.282 . . . . 61.44 110.238 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.443 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.97 -147.96 40.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.561 0.585 . . . . 64.1 114.561 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -63.37 -26.76 68.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.371 1.068 . . . . 72.44 113.013 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.12 -41.05 82.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.194 0.598 . . . . 72.31 111.915 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.698 ' SD ' ' HG ' ' F' ' 115' ' ' LEU . 3.4 ptp -84.02 -33.86 24.42 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.717 -0.219 . . . . 62.3 111.39 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -24.15 67.77 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.227 0.537 . . . . 71.45 110.718 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -64.86 -54.49 30.17 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 70.41 109.984 164.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.6 m -65.73 -63.37 1.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.268 0.84 . . . . 71.21 113.268 -170.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.08 -8.07 34.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.862 0.756 . . . . 75.52 112.206 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.49 -4.0 40.47 Favored Glycine 0 C--N 1.36 1.911 0 N-CA-C 115.263 0.865 . . . . 64.42 115.263 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.02 -59.23 0.25 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.767 0.784 . . . . 64.54 111.025 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.0 t80 -53.46 -54.74 32.65 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 124.571 1.148 . . . . 71.44 112.949 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 19.7 m -71.69 -42.02 10.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.384 0.674 . . . . 72.22 111.739 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.78 -39.02 78.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.463 2.109 . . . . 74.53 113.973 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -72.62 -24.45 61.07 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.367 0.667 . . . . 72.14 111.442 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.7 mm -69.13 -45.59 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.411 0.684 . . . . 71.34 109.407 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.31 -33.56 71.68 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.283 -0.871 . . . . 73.44 112.01 -173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.64 -44.7 92.34 Favored Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 114.56 1.318 . . . . 74.25 114.56 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.48 -32.25 96.02 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.111 1.874 . . . . 74.03 113.617 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.72 -32.46 31.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.423 0.689 . . . . 73.33 111.358 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.22 75.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.711 -0.477 . . . . 71.13 109.711 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -54.54 -49.05 71.21 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.67 1.231 . . . . 72.02 110.19 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.67 -51.46 69.68 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.162 0.914 . . . . 74.41 110.912 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.15 -45.56 79.59 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.192 0.933 . . . . 74.53 111.155 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.492 ' O ' HG23 ' A' ' 118' ' ' VAL . 5.7 mt -60.43 -58.49 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 74.43 110.189 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.434 HG22 ' HB2' ' A' ' 125' ' ' GLN . 65.7 m -52.67 -40.5 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.988 0.915 . . . . 75.15 112.087 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.6 t -66.9 -43.24 83.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.212 -0.904 . . . . 74.23 109.981 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.471 ' SD ' HG22 ' A' ' 21' ' ' ILE . 10.9 mtp -58.36 -44.03 88.64 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.509 0.724 . . . . 63.05 110.954 174.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 114' ' ' ILE . 39.3 t -61.2 -46.0 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.626 0.77 . . . . 74.21 110.6 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.3 p -73.36 -30.66 63.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.34 -0.846 . . . . 74.23 111.111 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -69.75 -25.21 63.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.568 0.747 . . . . 74.44 109.782 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.95 0.02 84.08 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.649 -0.705 . . . . 72.5 112.682 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.0 m 69.98 12.19 7.79 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.823 1.249 . . . . 73.13 111.137 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -94.47 152.99 40.44 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 123.268 0.627 . . . . 74.55 110.37 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -54.11 120.45 7.97 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.776 2.317 . . . . 74.53 111.4 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.434 ' HB2' HG22 ' A' ' 115' ' ' THR . 3.4 pt20 -60.08 160.22 8.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.961 0.904 . . . . 72.41 112.63 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.4 115.27 17.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.614 -0.884 . . . . 75.21 108.614 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.54 120.98 43.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.71 0.804 . . . . 74.21 109.194 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.432 HD23 HG22 ' A' ' 64' ' ' VAL . 57.3 mt -73.36 135.38 44.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.753 0.821 . . . . 75.13 110.437 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.91 136.61 96.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.372 0.42 . . . . 71.1 110.569 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.655 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 29.7 Cg_endo -91.1 103.09 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.999 2.466 . . . . 72.51 112.311 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.1 116.04 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.028 -1.101 . . . . 73.25 108.028 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -69.83 106.48 3.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.474 -0.565 . . . . 73.41 109.474 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.59 -17.27 62.3 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.286 -0.87 . . . . 70.33 111.71 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -60.09 -39.22 85.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.042 0.537 . . . . 71.03 111.479 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.83 70.23 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.157 0.91 . . . . 73.45 111.534 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.77 -39.84 80.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.742 0.817 . . . . 71.01 110.955 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -89.24 -20.91 23.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.407 -0.36 . . . . 73.42 111.951 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.23 -43.36 99.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.395 0.678 . . . . 65.12 110.837 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 8.8 p30 -65.49 -21.11 66.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.045 -0.98 . . . . 71.43 111.701 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -92.15 -34.83 14.18 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.507 0.723 . . . . 75.5 110.692 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 tp -68.14 -51.75 42.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.771 0.828 . . . . 75.43 112.438 -170.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -147.83 -15.11 0.37 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.144 0.978 . . . . 74.14 109.378 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 24.2 tm0? 62.92 -77.03 0.03 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.374 1.469 . . . . 74.24 111.228 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -65.01 -53.04 52.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.934 0.894 . . . . 74.22 110.659 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.75 -171.06 0.16 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.317 1.047 . . . . 75.03 110.979 -174.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.13 92.67 0.09 OUTLIER Glycine 0 C--N 1.344 1.011 0 N-CA-C 112.09 -0.404 . . . . 70.02 112.09 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.21 136.43 35.84 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.958 0.503 . . . . 75.1 110.128 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.43 -8.37 85.12 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.776 0.672 . . . . 71.15 112.687 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 155' ' ' ALA . 75.0 p -70.23 128.73 37.26 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.045 0.938 . . . . 73.54 110.348 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -153.55 -40.25 0.1 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.919 0.487 . . . . 75.41 111.846 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.41 ' HB3' ' OD2' ' A' ' 154' ' ' ASP . 2.9 tt0 -93.72 -88.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 118.806 -0.616 . . . . 72.0 110.41 -173.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -174.01 -43.76 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.696 0.628 . . . . 74.34 112.696 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -66.56 -17.04 64.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.248 0.547 . . . . 74.43 111.227 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.41 ' OD2' ' HB3' ' A' ' 151' ' ' GLU . 14.0 p-10 -102.56 100.5 10.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.248 1.419 . . . . 72.51 109.674 177.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.422 ' HA ' HG22 ' A' ' 149' ' ' THR . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 117.86 -1.067 . . . . 74.4 109.533 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 109.949 -0.389 . . . . 71.14 109.949 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -149.52 152.14 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.88 0.872 . . . . 75.04 109.418 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.35 78.93 1.35 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.97 -1.122 . . . . 75.42 107.97 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -135.77 134.34 38.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.914 0.486 . . . . 75.22 109.995 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.01 107.33 12.71 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.812 -0.81 . . . . 72.52 108.812 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -166.71 -164.59 0.66 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.447 -0.945 . . . . 70.22 108.447 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 43.7 p -79.63 68.28 5.64 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.99 0.9 . . . . 72.53 110.063 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' B' ' 9' ' ' MET . 21.9 tt0 -121.7 -162.89 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 106.889 -1.523 . . . . 72.44 106.889 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.616 ' HE3' HD13 ' B' ' 89' ' ' ILE . 11.7 ptm 59.32 169.78 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.096 1.758 . . . . 75.12 114.758 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -155.85 136.2 13.12 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.813 1.245 . . . . 75.42 108.003 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.563 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 8.5 t80 -134.84 112.16 10.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.509 -0.552 . . . . 74.41 109.509 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -127.03 115.94 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.786 -0.82 . . . . 74.14 108.786 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.5 135.76 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 116.455 -0.339 . . . . 73.31 110.218 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -98.47 -50.14 4.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.61 -0.885 . . . . 75.14 108.61 169.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -163.1 142.31 8.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.068 -0.515 . . . . 71.22 110.696 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.2 mt -116.89 142.26 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 106.403 -1.703 . . . . 71.41 106.403 165.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -167.74 142.12 3.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.136 0.425 . . . . 73.23 111.374 -173.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -72.19 121.48 19.41 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.189 -0.914 . . . . 73.32 108.808 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.423 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.8 mtpt -97.07 -24.87 15.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.472 0.709 . . . . 73.21 110.729 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -156.66 138.13 13.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.863 -0.608 . . . . 72.31 110.28 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.532 HD13 ' SG ' ' B' ' 113' ' ' CYS . 43.5 mm -132.63 148.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.752 1.221 . . . . 72.15 107.963 173.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -150.22 142.33 24.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.294 -0.867 . . . . 75.12 109.162 165.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.438 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.1 t80 -146.57 114.2 6.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.076 -1.824 . . . . 72.23 106.076 168.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.92 114.35 20.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.806 -0.813 . . . . 73.31 108.806 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -106.45 85.59 1.81 Allowed Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.418 -0.956 . . . . 72.42 108.418 171.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.76 -20.81 29.64 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.827 2.351 . . . . 74.12 111.289 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.478 ' O ' HG23 ' B' ' 31' ' ' VAL . 80.7 m-20 -125.98 20.2 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.532 1.133 . . . . 73.11 110.577 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.499 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -37.81 -55.0 2.24 Favored Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 125.671 1.589 . . . . 73.14 114.415 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 8.5 Cg_exo -69.56 -20.11 36.21 Favored 'Trans proline' 0 C--N 1.392 2.847 0 C-N-CA 123.057 2.505 . . . . 73.45 112.903 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -96.59 -27.45 14.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.026 0.93 . . . . 75.51 112.442 -171.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.478 HG23 ' O ' ' B' ' 27' ' ' ASN . 64.2 t -67.22 -22.78 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.119 0.568 . . . . 74.51 110.916 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -57.33 -38.3 73.86 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.214 0.606 . . . . 75.44 111.499 171.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -73.6 -15.59 61.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.915 0.886 . . . . 74.22 111.731 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.641 ' HZ2' ' HB3' ' B' ' 71' ' ' GLU . 88.0 mttt -104.17 108.86 20.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.529 0.732 . . . . 74.04 111.16 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -100.03 86.02 3.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.489 0.716 . . . . 73.24 109.949 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.597 ' HB3' HD21 ' B' ' 68' ' ' LEU . 22.3 t90 -165.75 157.98 14.81 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.893 0.877 . . . . 74.23 109.107 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.7 121.35 84.92 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.4 109.536 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 146.69 52.37 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.48 2.12 . . . . 74.15 112.811 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.39 103.52 2.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.2 0.6 . . . . 73.54 109.503 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.776 HG11 HD23 ' B' ' 126' ' ' LEU . 23.0 t -106.46 144.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.316 0.646 . . . . 72.34 109.838 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -145.17 131.07 19.15 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.159 -1.052 . . . . 74.42 108.159 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.465 HD23 ' HG ' ' B' ' 128' ' ' LEU . 7.1 mp -88.49 165.98 14.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.455 -0.572 . . . . 74.44 109.455 173.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -160.76 142.85 12.5 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.348 -1.352 . . . . 64.42 107.348 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.404 ' HB2' HG23 ' E' ' 123' ' ' VAL . 37.7 mt -122.63 170.01 10.46 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.243 0.544 . . . . 75.13 110.72 -178.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.668 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.4 t70 -142.14 126.37 17.52 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.683 -1.144 . . . . 61.4 108.281 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 p -107.93 103.94 13.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.602 0.761 . . . . 73.43 109.202 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.56 133.2 34.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.646 0.778 . . . . 72.3 109.699 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.439 ' HB2' ' HE1' ' E' ' 116' ' ' TYR . 8.6 m -140.13 164.97 28.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.548 0.739 . . . . 72.53 109.113 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -151.63 139.73 20.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.838 0.455 . . . . 73.51 110.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -81.84 112.53 19.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.938 -0.764 . . . . 74.51 108.938 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.19 -51.93 12.19 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.424 0.631 . . . . 75.42 110.016 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.9 -172.35 3.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.47 1.108 . . . . 60.35 109.527 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 124.33 23.99 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.992 -0.744 . . . . 73.14 108.992 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 63.38 22.08 13.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.318 1.047 . . . . 72.25 112.152 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -138.75 123.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.097 -1.075 . . . . 71.34 108.097 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.487 ' HE1' ' HB2' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -130.88 -179.51 5.36 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.662 -0.496 . . . . 73.41 109.662 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -142.39 109.65 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.04 -1.096 . . . . 75.35 108.04 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.58 124.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.755 0.822 . . . . 73.31 109.397 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.1 t -106.69 122.31 60.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 N-CA-C 109.487 -0.561 . . . . 75.04 109.487 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.5 OUTLIER -94.36 112.17 23.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.131 -1.433 . . . . 74.32 107.131 171.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.668 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 52.6 ttt180 -102.02 126.19 48.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.743 -0.465 . . . . 64.42 109.743 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.81 111.1 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.309 1.044 . . . . 62.44 108.882 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -94.79 138.59 32.4 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.761 -0.829 . . . . 65.54 108.761 170.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.5 t -131.52 130.03 62.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.107 0.963 . . . . 71.01 108.414 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.9 m -125.54 138.41 53.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.325 -0.621 . . . . 74.43 109.325 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 137.45 32.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.556 0.743 . . . . 74.31 109.289 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.3 p -144.03 124.82 14.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.284 0.634 . . . . 61.32 109.957 179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' B' ' 36' ' ' TRP . 3.0 tt -95.63 112.8 24.44 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.78 -1.192 . . . . 73.13 107.78 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.13 -111.51 3.28 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.914 -0.874 . . . . 74.54 110.914 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.98 15.69 9.99 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.067 0.947 . . . . 73.41 110.612 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.641 ' HB3' ' HZ2' ' B' ' 34' ' ' LYS . 7.1 tp10 -118.63 141.12 48.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.5 1.12 . . . . 74.12 108.665 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 71.5 m -61.4 134.49 56.97 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.325 0.511 . . . . 73.02 110.517 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -90.86 -58.11 2.59 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.376 -0.972 . . . . 70.53 108.376 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.44 159.1 30.53 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.778 -1.101 . . . . 75.12 109.765 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.02 145.78 51.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.364 -1.347 . . . . 72.31 107.364 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.2 146.1 22.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.307 -0.627 . . . . 65.14 109.307 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -158.7 125.25 4.68 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.714 -0.476 . . . . 73.55 109.714 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.465 HG12 HD11 ' B' ' 21' ' ' ILE . 77.0 t -122.57 150.22 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 72.41 109.36 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -127.05 102.47 6.99 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.03 -0.73 . . . . 72.42 109.03 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.489 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -89.82 104.02 16.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.889 -0.596 . . . . 74.33 109.586 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.423 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.0 170.38 37.72 Favored Glycine 0 C--O 1.245 0.809 0 O-C-N 123.551 0.532 . . . . 71.52 112.133 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.56 125.84 1.36 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.913 -0.475 . . . . 71.41 111.913 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.7 mt -86.36 119.36 34.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.639 -0.874 . . . . 73.03 108.639 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.487 ' HB2' ' HE1' ' B' ' 56' ' ' TYR . 47.0 m-85 -121.83 135.05 54.9 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -100.61 120.87 40.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.203 1.001 . . . . 75.1 108.669 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.09 109.55 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.629 0.771 . . . . 74.55 111.528 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.74 140.12 50.11 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.704 0.801 . . . . 71.05 110.382 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.01 -26.91 14.51 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 111.993 -0.443 . . . . 71.23 111.993 -170.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.616 HD13 ' HE3' ' B' ' 9' ' ' MET . 2.1 mp -63.95 131.97 29.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 125.339 1.455 . . . . 73.42 110.897 -176.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -159.79 143.58 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.214 0.946 . . . . 73.14 109.716 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.35 -117.86 11.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.831 0.707 . . . . 65.44 113.997 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.51 ' HA ' ' HB2' ' B' ' 95' ' ' ALA . 39.3 m -65.88 -29.8 70.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.363 1.065 . . . . 73.4 111.898 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -49.9 -46.66 52.02 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 124.111 0.882 . . . . 73.52 111.064 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.506 ' HA ' ' HB3' ' B' ' 97' ' ' CYS . 9.1 ptm -94.18 -29.07 15.31 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.423 0.897 . . . . 74.21 113.423 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.51 ' HB2' ' HA ' ' B' ' 92' ' ' THR . . . -57.54 -28.86 63.89 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.912 0.778 . . . . 74.32 111.362 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.07 -32.72 17.41 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.257 1.023 . . . . 74.13 110.952 172.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.563 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 42.6 t -70.17 -66.82 0.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.923 0.489 . . . . 74.22 111.556 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' E' ' 117' ' ' PRO . 0.8 OUTLIER -63.77 -18.71 64.34 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 118.07 0.396 . . . . 72.43 111.773 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.44 -20.25 58.92 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 116.126 -0.488 . . . . 32.42 113.858 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.61 -58.7 0.16 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.398 0.599 . . . . 72.24 112.543 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.37 -51.7 61.97 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.943 0.72 . . . . 74.14 112.943 -167.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 75.2 m -60.71 -48.52 92.9 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.545 -0.74 . . . . 74.24 111.263 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_exo -50.14 -35.52 42.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.373 2.049 . . . . 74.12 114.797 167.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -35.67 78.99 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.355 0.525 . . . . 75.4 111.433 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.881 0.872 . . . . 74.55 110.1 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 74.6 mt -84.26 -20.49 32.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.793 -1.094 . . . . 74.14 112.401 -170.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -58.39 -48.94 96.05 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.047 -0.978 . . . . 73.25 113.311 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.532 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 76.9 Cg_exo -55.22 -39.76 89.29 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.571 2.181 . . . . 71.23 114.15 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.489 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.5 m-85 -65.89 -49.6 67.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.698 . . . . 74.41 111.257 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.86 96.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.678 0.791 . . . . 50.03 110.863 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.567 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.0 ttt-85 -63.11 -56.23 18.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.134 1.374 . . . . 72.34 111.457 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.89 -40.87 73.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.377 1.071 . . . . 72.23 110.83 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -65.93 -44.4 85.21 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.577 -0.283 . . . . 74.43 111.082 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.462 HD13 HD22 ' B' ' 128' ' ' LEU . 72.7 mt -60.52 -54.8 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 123.524 0.729 . . . . 74.21 110.992 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -58.36 -29.79 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.448 0.699 . . . . 74.24 111.501 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -70.16 -54.37 13.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.436 0.694 . . . . 73.31 110.131 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.3 mmt -63.2 -34.86 78.55 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.248 0.619 . . . . 74.42 111.866 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.8 -46.66 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.901 0.881 . . . . 74.13 110.902 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.447 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 80.4 p -73.58 -24.79 60.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.773 0.429 . . . . 73.11 111.714 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -63.42 -28.58 70.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.708 0.803 . . . . 74.41 110.637 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.99 17.28 59.55 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.249 -0.75 . . . . 70.14 113.631 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.2 p 70.19 13.35 7.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 126.231 1.813 . . . . 64.32 113.418 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -90.61 150.5 42.62 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 122.618 0.367 . . . . 72.51 110.373 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.8 159.13 18.31 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.363 2.709 . . . . 71.4 113.368 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.31 135.6 57.7 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.882 0.739 . . . . 71.41 110.112 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.776 HD23 HG11 ' B' ' 40' ' ' VAL . 1.3 tm? -108.61 110.91 22.48 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.796 -1.557 . . . . 74.23 106.796 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -91.62 94.25 9.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.798 -0.816 . . . . 73.41 108.798 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.567 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 5.4 mp -69.93 108.14 3.88 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.589 -1.263 . . . . 71.01 107.589 171.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.31 139.26 87.0 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.563 0.539 . . . . 72.45 110.081 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.516 ' HB3' ' HH ' ' D' ' 109' ' ' TYR . 54.8 Cg_endo -69.49 82.72 0.68 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 122.194 1.929 . . . . 72.51 111.14 175.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.447 ' HB ' ' CE1' ' E' ' 125' ' ' TYR . 66.1 t -91.32 132.59 35.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 114.722 -1.126 . . . . 75.1 108.424 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -70.73 113.2 7.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.526 0.73 . . . . 73.55 110.299 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.12 -40.17 92.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.329 1.051 . . . . 72.43 110.788 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' B' ' 138' ' ' MET . 4.2 p30 -61.42 -34.17 74.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.154 -0.93 . . . . 75.11 111.046 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.52 90.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.938 0.495 . . . . 64.53 111.163 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.419 HD11 ' HZ3' ' E' ' 120' ' ' TRP . 0.2 OUTLIER -67.2 -34.43 77.5 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.208 -0.664 . . . . 75.13 109.208 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.55 -41.32 97.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.064 0.945 . . . . 72.41 111.127 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 19.6 mmt -63.34 -37.81 88.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 120.974 0.416 . . . . 74.04 110.218 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.445 ' HA ' ' HG3' ' B' ' 142' ' ' GLN . 36.0 m-80 -76.43 -22.04 55.17 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.544 -0.753 . . . . 75.22 112.322 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -68.24 -32.98 73.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.667 0.387 . . . . 73.13 110.741 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.86 4.62 52.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.734 0.414 . . . . 73.23 111.818 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.445 ' HG3' ' HA ' ' B' ' 139' ' ' ASN . 5.4 pp0? -132.82 174.91 9.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.484 0.713 . . . . 73.13 109.708 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -150.64 157.42 42.96 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.079 -0.711 . . . . 75.21 109.079 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.41 86.31 0.43 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.028 -1.101 . . . . 71.22 108.028 168.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.75 120.51 26.11 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.888 -1.051 . . . . 75.31 111.087 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.39 58.84 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.401 -0.68 . . . . 72.33 111.401 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 61.94 25.93 15.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.815 1.246 . . . . 74.32 112.067 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.92 -9.89 11.74 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.927 -0.579 . . . . 53.11 112.598 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.483 HG22 ' HB3' ' B' ' 154' ' ' ASP . 21.0 m -70.57 131.26 43.7 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.241 0.616 . . . . 73.02 111.874 -174.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -63.98 -36.97 85.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.379 0.671 . . . . 72.45 110.822 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.22 119.18 16.06 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.683 -0.69 . . . . 74.41 109.153 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -79.62 -8.38 59.15 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.597 0.759 . . . . 75.04 111.937 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -68.73 -30.71 69.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.798 0.839 . . . . 74.05 109.89 170.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.483 ' HB3' HG22 ' B' ' 149' ' ' THR . 25.2 t70 -111.17 144.67 39.96 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.674 0.79 . . . . 71.24 109.786 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 122.984 0.514 . . . . 62.22 110.285 -178.944 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.795 -0.446 . . . . 73.32 109.795 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -148.15 89.63 1.75 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.045 0.938 . . . . 75.02 108.776 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.56 79.47 4.06 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.067 0.937 . . . . 72.23 110.275 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -77.81 78.82 4.31 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.314 1.054 . . . . 73.02 108.916 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -74.61 112.5 10.87 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.76 -1.563 . . . . 73.4 111.081 -174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -154.53 132.05 11.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.524 -0.547 . . . . 73.24 109.524 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -119.81 -17.0 8.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.291 1.037 . . . . 72.24 109.773 174.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -89.5 106.73 18.65 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.721 0.809 . . . . 74.24 109.61 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.473 ' H ' HG21 ' C' ' 89' ' ' ILE . 54.2 ttp 65.68 115.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.421 1.488 . . . . 74.23 112.093 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -128.27 101.58 6.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.434 -1.321 . . . . 62.24 107.434 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.484 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -114.78 143.47 45.02 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.376 0.67 . . . . 73.21 110.181 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -147.84 144.62 28.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.274 0.629 . . . . 75.23 110.02 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -92.2 120.24 41.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.815 -0.809 . . . . 74.14 108.815 171.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -91.39 -38.32 12.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.53 0.332 . . . . 72.41 110.42 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.56 148.54 3.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.073 -0.343 . . . . 72.4 110.073 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -136.04 132.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.137 -1.06 . . . . 73.42 108.137 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HB2' ' HA2' ' D' ' 121' ' ' GLY . 35.0 p90 -170.72 162.56 7.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.643 0.735 . . . . 72.32 112.09 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -87.39 117.35 26.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.826 -1.079 . . . . 73.23 110.203 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 6.8 mtmt -92.83 -7.52 46.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.411 0.284 . . . . 74.22 110.697 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.8 t70 -160.27 135.19 7.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.391 -0.966 . . . . 70.04 108.391 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.532 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.9 mt -149.05 139.11 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.014 -1.847 . . . . 74.22 106.014 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -158.92 151.04 21.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.063 0.459 . . . . 74.52 109.869 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.9 128.98 15.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.519 -1.289 . . . . 71.23 107.519 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.402 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.4 mt-10 -124.7 142.43 51.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.72 -0.844 . . . . 71.21 108.72 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' C' ' 28' ' ' ALA . . . -154.43 77.94 5.26 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.753 -0.832 . . . . 73.11 108.753 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 -30.5 22.87 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.48 2.12 . . . . 71.23 111.574 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.539 ' HB2' ' O ' ' C' ' 72' ' ' THR . 37.4 m-20 -112.14 33.51 4.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.007 0.923 . . . . 75.43 109.371 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.423 ' HB3' ' HB1' ' C' ' 25' ' ' ALA . . . -54.29 -45.89 99.1 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.496 1.118 . . . . 71.01 113.583 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -75.57 -25.55 10.89 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.401 2.067 . . . . 74.2 113.4 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.13 -51.28 70.28 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.741 0.651 . . . . 73.01 111.256 -172.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 14.5 p -55.39 -25.53 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.423 1.089 . . . . 72.34 113.342 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -66.88 -42.82 84.93 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.84 0.456 . . . . 72.35 111.515 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -103.4 13.85 32.73 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.26 0.624 . . . . 73.52 110.29 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.532 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 24.3 ttpp -124.46 174.2 7.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.368 1.067 . . . . 74.41 109.434 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' C' ' 34' ' ' LYS . 21.5 t70 -54.57 113.8 1.43 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.337 1.055 . . . . 74.55 110.958 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -86.85 64.97 8.77 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.879 0.847 . . . . 72.33 111.24 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -158.95 78.79 2.98 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.617 -0.883 . . . . 74.32 108.617 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -88.35 174.22 4.39 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.697 2.265 . . . . 74.51 111.574 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' C' ' 67' ' ' SER . 11.0 tp10 -85.8 107.63 17.73 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.052 -0.722 . . . . 65.33 109.052 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.6 ' H ' HD11 ' E' ' 141' ' ' LEU . 57.4 t -74.96 99.98 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.274 -0.875 . . . . 71.44 108.988 176.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.426 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.8 tmtt? -107.41 103.22 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.292 -1.003 . . . . 70.24 108.292 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.546 HD11 ' H ' ' C' ' 42' ' ' LEU . 0.0 OUTLIER -87.25 155.37 20.1 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.141 -0.689 . . . . 73.22 109.141 173.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.554 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.1 t70 -150.95 143.82 24.55 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.998 -0.741 . . . . 63.15 108.998 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.98 145.72 48.39 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.467 -0.568 . . . . 73.15 109.467 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -156.99 149.98 23.78 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.78 0.832 . . . . 73.24 108.794 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -130.8 154.3 48.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.187 0.518 . . . . 74.2 110.214 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.481 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -140.8 171.13 14.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.022 . . . . 75.41 108.607 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 25.8 p -159.02 143.55 15.63 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.9 0.48 . . . . 65.05 110.35 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -149.84 128.02 12.03 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.859 0.863 . . . . 74.12 109.021 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.74 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.54 0.336 . . . . 71.43 110.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.697 HD12 ' HB2' ' C' ' 57' ' ' GLU . 31.7 mt -103.49 -30.12 10.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.835 0.854 . . . . 70.53 110.204 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.58 -178.43 6.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.88 0.872 . . . . 63.32 110.489 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -62.16 117.31 5.86 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.299 -0.864 . . . . 73.51 109.925 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.91 0.27 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.528 1.131 . . . . 75.04 113.171 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.2 t -103.8 114.81 44.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.215 0.531 . . . . 75.54 109.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -124.22 123.56 40.53 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.732 -1.21 . . . . 74.02 107.732 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.697 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.6 111.08 18.25 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.74 -0.837 . . . . 74.33 108.74 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.28 126.66 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.287 -1.005 . . . . 73.43 108.287 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.481 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 42.0 t -110.96 102.3 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.112 -1.07 . . . . 75.21 108.112 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' C' ' 103' ' ' PRO . 2.2 tm? -91.95 102.83 15.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.781 -0.822 . . . . 75.51 108.781 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -85.08 125.47 32.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.904 1.281 . . . . 70.14 110.866 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.2 t -119.27 141.73 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.313 1.045 . . . . 75.44 108.954 170.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.554 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.0 m -131.94 133.46 44.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.888 0.875 . . . . 74.31 109.256 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.624 HG21 HD12 ' C' ' 114' ' ' ILE . 93.2 t -116.74 117.18 54.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.345 -0.983 . . . . 74.0 108.345 167.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 13.9 m -105.15 141.92 35.84 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.597 -0.89 . . . . 75.45 108.597 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.02 93.04 2.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.176 -1.416 . . . . 75.42 107.176 176.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' C' ' 39' ' ' GLU . 59.6 p -161.85 131.84 4.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.874 0.47 . . . . 75.03 109.896 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.78 39.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.793 0.806 . . . . 74.35 109.911 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.89 -84.33 0.72 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.093 -0.803 . . . . 72.12 111.093 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.12 -31.34 17.14 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.712 0.805 . . . . 73.42 111.232 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -101.23 98.73 9.09 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.087 0.955 . . . . 74.21 110.252 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 32.2 m -88.88 118.31 28.5 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.96 0.504 . . . . 74.42 111.997 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -51.74 29.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.681 0.792 . . . . 73.02 109.071 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -162.52 174.72 12.29 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.98 -1.464 . . . . 73.24 110.621 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.418 HD22 HG21 ' C' ' 65' ' ' THR . 3.4 tm? -145.56 146.39 31.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 73.22 105.773 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -151.4 132.64 14.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.715 -0.846 . . . . 71.43 108.715 175.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -141.38 134.47 29.22 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.431 -0.581 . . . . 73.24 109.431 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.19 140.4 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.032 . . . . 72.21 108.603 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.638 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.0 mt-30 -115.04 102.19 9.71 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.594 -0.891 . . . . 75.13 108.594 170.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.454 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.1 tp-100 -82.45 99.6 9.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.919 0.888 . . . . 73.31 109.552 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.65 144.85 22.43 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.317 -0.713 . . . . 64.3 111.317 174.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.27 118.94 1.35 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.211 -0.755 . . . . 73.1 111.211 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.416 HD13 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -80.97 122.17 35.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.984 -1.117 . . . . 73.13 107.984 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -135.54 154.57 51.33 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.014 0.525 . . . . 74.32 110.608 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -105.19 118.83 37.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.34 -0.985 . . . . 71.13 108.34 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.432 HG23 ' HG3' ' C' ' 94' ' ' MET . 3.8 mp -113.86 107.01 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.158 -1.423 . . . . 73.42 107.158 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.61 16.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.997 0.919 . . . . 64.23 110.341 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.92 -55.23 4.06 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.945 -0.57 . . . . 62.32 112.686 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.473 HG21 ' H ' ' C' ' 9' ' ' MET . 2.6 pp -110.02 175.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.731 0.812 . . . . 64.5 111.139 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.493 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.2 pt-20 -163.78 -176.21 4.5 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.795 -0.638 . . . . 73.3 110.78 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.23 -124.8 28.49 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.333 -0.394 . . . . 61.22 113.768 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -60.58 -36.76 79.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.122 0.969 . . . . 73.11 111.175 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -66.93 -42.18 85.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.621 -1.172 . . . . 74.43 110.991 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.493 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 58.8 ttm -71.84 -36.53 70.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.951 0.501 . . . . 75.33 110.385 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.27 94.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.282 0.633 . . . . 74.42 111.075 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.73 -27.62 66.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.603 0.761 . . . . 74.25 111.134 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 36.6 t -72.81 -62.46 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 110.047 -0.353 . . . . 74.51 110.047 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.23 -17.83 62.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.829 0.452 . . . . 70.4 112.126 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.61 -10.83 46.09 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.433 -0.649 . . . . 71.25 114.181 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.83 -56.18 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 117.874 0.837 . . . . 65.54 112.343 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.655 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 76.5 t80 -70.68 -49.43 47.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.14 0.576 . . . . 74.22 112.128 -172.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.503 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.9 m -63.4 -46.36 84.51 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.358 0.663 . . . . 65.51 111.247 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.1 Cg_exo -55.54 -36.67 94.87 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.686 2.257 . . . . 74.53 114.73 169.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.464 HD22 ' ND2' ' C' ' 132' ' ' ASN . 28.2 t-20 -58.4 -38.7 77.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.356 0.662 . . . . 71.2 111.265 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.01 -41.94 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.116 -0.947 . . . . 75.21 110.403 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.65 -20.0 28.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.589 -1.187 . . . . 74.33 112.428 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.46 -50.55 87.43 Favored Pre-proline 0 CA--C 1.554 1.103 0 CA-C-O 117.772 -1.108 . . . . 74.05 113.147 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 -37.9 94.43 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.238 1.959 . . . . 65.4 113.365 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -67.92 -51.32 49.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.788 0.835 . . . . 75.42 111.605 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -59.64 -35.83 75.16 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.038 0.935 . . . . 74.5 110.891 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -65.39 -47.92 74.67 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.707 -1.588 . . . . 74.03 110.527 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.518 0.511 . . . . 74.05 110.234 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.3 t -69.0 -29.23 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.82 0.448 . . . . 73.13 110.817 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.624 HD12 HG21 ' C' ' 64' ' ' VAL . 80.1 mt -75.89 -49.02 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.701 -0.681 . . . . 72.44 109.945 169.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 54.1 m -52.83 -41.92 64.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 73.32 111.491 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.5 t -63.0 -49.02 76.3 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.303 -1.317 . . . . 74.34 109.377 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.635 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.76 -42.11 88.13 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.564 1.145 . . . . 73.4 112.959 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.34 -43.69 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 109.519 -0.549 . . . . 73.34 109.519 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.7 t -71.79 -25.88 62.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.001 0.92 . . . . 61.23 111.7 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.4 mtt-85 -71.44 -33.86 69.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.393 0.677 . . . . 73.01 109.577 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.4 11.2 56.64 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 124.041 0.838 . . . . 71.21 112.703 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.411 HG22 ' HB3' ' D' ' 17' ' ' TYR . 68.1 p 57.02 26.4 11.88 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.256 1.822 . . . . 71.4 112.918 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.427 ' HE1' HG13 ' C' ' 31' ' ' VAL . 69.0 m-85 -94.83 146.78 31.99 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.68 -0.859 . . . . 65.3 108.68 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -60.91 146.55 97.47 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.94 2.427 . . . . 72.02 112.647 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.447 ' HG2' ' HB2' ' B' ' 119' ' ' SER . 19.8 mp0 -59.1 125.37 23.31 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.837 0.855 . . . . 64.55 112.467 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -109.7 90.46 3.31 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.048 -1.834 . . . . 75.14 106.048 168.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -91.07 109.34 20.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.57 132.22 48.18 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.074 0.859 . . . . 74.1 109.713 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.89 132.58 89.43 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 123.558 0.536 . . . . 74.31 111.056 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.557 ' HG3' HD13 ' A' ' 16' ' ' ILE . 61.3 Cg_endo -69.75 102.81 1.07 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.905 2.403 . . . . 75.41 112.491 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 6.8 p -105.33 122.63 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.072 0.549 . . . . 74.5 109.853 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.464 ' ND2' HD22 ' C' ' 104' ' ' ASN . 15.6 m120 -109.12 81.54 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.567 0.747 . . . . 71.21 110.386 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -72.89 -31.8 64.94 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.806 -0.813 . . . . 75.02 108.806 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.75 -57.59 8.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.401 -1.272 . . . . 74.53 111.269 170.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' C' ' 138' ' ' MET . . . -71.6 -24.21 61.85 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.845 0.858 . . . . 55.25 111.457 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.469 HD21 HD11 ' E' ' 148' ' ' LEU . 63.2 tp -60.55 -53.74 53.81 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.984 0.803 . . . . 74.23 110.42 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -77.19 -23.05 51.52 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.138 -0.483 . . . . 74.34 110.61 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.54 ' HA ' HD22 ' C' ' 141' ' ' LEU . 27.6 ttt -71.03 -38.62 72.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.338 0.655 . . . . 75.41 111.696 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -67.99 -33.43 74.61 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 110.205 -0.294 . . . . 72.34 110.205 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -66.27 -88.69 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 118.977 -0.535 . . . . 74.31 110.541 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' C' ' 138' ' ' MET . 1.3 mm? 48.51 84.68 0.03 OUTLIER 'General case' 0 C--N 1.368 1.371 0 C-N-CA 124.003 0.921 . . . . 75.24 110.574 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -69.29 86.81 0.41 Allowed 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.287 0.565 . . . . 73.12 110.172 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -158.75 179.5 9.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.415 1.086 . . . . 72.21 109.402 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -133.69 137.53 45.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.269 0.627 . . . . 75.13 110.07 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.45 133.96 55.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 72.15 110.204 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.481 ' HA2' HE22 ' A' ' 143' ' ' GLN . . . -153.18 159.2 28.4 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.783 0.677 . . . . 75.45 111.437 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.42 138.15 35.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.2 0.6 . . . . 75.51 110.218 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.62 -131.75 5.63 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.067 -0.813 . . . . 73.13 111.067 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -130.83 83.36 2.11 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.144 0.973 . . . . 75.25 109.156 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -120.01 123.66 44.01 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.437 -0.801 . . . . 74.41 109.514 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -77.82 109.79 12.13 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.651 0.739 . . . . 73.25 111.037 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -80.87 84.3 6.41 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.475 -0.784 . . . . 75.13 109.629 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -130.75 129.41 42.44 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.778 1.231 . . . . 72.13 107.733 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.11 136.71 39.84 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.063 0.545 . . . . 70.21 110.676 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 C-N-CA 123.891 0.876 . . . . 73.21 111.137 -174.676 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 110.11 -0.329 . . . . 75.33 110.11 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.5 m 65.95 -79.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.601 1.16 . . . . 74.01 111.527 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -78.68 110.48 13.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.776 0.83 . . . . 73.25 110.054 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -75.02 81.17 2.21 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.198 -0.668 . . . . 75.12 109.198 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -117.6 -29.55 5.73 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.975 0.91 . . . . 72.11 110.533 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 61.86 84.33 0.14 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.676 1.191 . . . . 72.05 110.446 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 m -147.48 -34.98 0.24 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.936 1.294 . . . . 74.53 107.859 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.57 115.39 4.65 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.359 -1.291 . . . . 64.35 110.233 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.46 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 12.1 tpt -33.03 128.56 0.26 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.805 1.242 . . . . 73.23 112.797 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 92.5 m -143.05 141.59 31.33 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.096 0.958 . . . . 74.43 110.282 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -160.91 90.21 0.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.263 -1.755 . . . . 73.14 106.263 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -114.03 150.23 34.24 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.854 -0.612 . . . . 75.24 110.377 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.4 120.86 43.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.767 0.827 . . . . 73.42 109.057 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -100.27 -49.54 4.23 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.014 0.196 . . . . 74.24 110.575 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -167.81 118.72 0.83 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.559 -0.163 . . . . 74.23 110.559 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.04 134.26 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.065 -1.458 . . . . 74.12 107.065 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HB3' HG22 ' C' ' 122' ' ' THR . 37.2 p90 -164.96 177.35 7.89 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.528 0.68 . . . . 74.14 111.705 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -97.43 124.16 41.52 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.181 -0.918 . . . . 63.04 109.053 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -88.61 -27.54 21.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.61 -0.515 . . . . 65.35 109.61 172.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.637 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.3 t70 -150.06 145.09 26.17 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.426 -0.806 . . . . 72.43 109.784 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.635 HG21 ' HE1' ' C' ' 117' ' ' MET . 64.0 mt -144.99 149.08 17.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.411 1.484 . . . . 72.42 107.667 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -151.87 144.88 24.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.553 0.741 . . . . 64.45 109.528 171.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.532 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.4 t80 -154.1 123.81 6.69 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.089 -1.448 . . . . 74.44 107.089 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 49.1 mt-10 -131.36 142.5 50.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.252 0.548 . . . . 75.41 110.089 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.68 74.49 10.36 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.404 1.082 . . . . 74.21 108.144 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.4 -43.39 4.32 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 121.906 1.738 . . . . 73.23 110.937 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.425 ' O ' HG23 ' D' ' 31' ' ' VAL . 18.7 m-20 -92.17 25.49 2.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.601 1.16 . . . . 72.52 109.769 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.427 ' HB2' ' HD2' ' C' ' 19' ' ' LYS . . . -54.64 -56.73 23.99 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.326 1.232 . . . . 71.23 114.326 -168.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.89 -19.09 18.47 Favored 'Trans proline' 0 C--N 1.386 2.553 0 CA-C-N 121.437 1.549 . . . . 72.23 112.089 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -70.87 -36.76 72.95 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.018 1.327 . . . . 71.15 110.342 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 27' ' ' ASN . 84.5 t -79.0 -33.98 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.38 0.672 . . . . 74.13 110.68 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -60.82 -20.83 62.39 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.737 0.643 . . . . 64.21 112.737 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.8 -32.96 74.89 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 72.32 110.621 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.431 ' HZ3' ' HB3' ' D' ' 71' ' ' GLU . 49.5 mtmt -91.52 105.91 18.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.25 1.02 . . . . 71.43 108.813 172.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.08 89.81 5.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.287 0.635 . . . . 74.0 109.595 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.586 ' HB3' HD12 ' D' ' 68' ' ' LEU . 41.5 t-105 -163.75 158.45 20.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.479 0.712 . . . . 73.41 109.854 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.418 ' NE2' ' HA ' ' F' ' 136' ' ' VAL . 1.7 mp0 -87.66 115.13 61.93 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.917 0.887 . . . . 75.23 110.148 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -51.64 166.71 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 125.029 3.819 . . . . 75.43 116.667 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' F' ' 141' ' ' LEU . 20.8 mt-10 -98.22 113.24 25.1 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.439 -1.255 . . . . 72.44 108.316 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.57 HG11 HG13 ' D' ' 64' ' ' VAL . 45.0 t -98.43 111.37 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.661 0.784 . . . . 72.23 110.767 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -86.85 117.36 25.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.796 -1.557 . . . . 71.45 106.796 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 tp -96.33 141.74 29.3 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.251 -0.648 . . . . 74.24 109.251 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.533 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.6 t70 -129.87 146.77 51.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.826 -1.175 . . . . 75.42 107.826 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.411 ' H ' HD22 ' D' ' 44' ' ' LEU . 1.9 pt? -125.94 141.69 51.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.347 0.659 . . . . 74.44 110.049 -171.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.3 t70 -157.74 150.84 23.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.835 0.854 . . . . 74.23 109.212 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -130.77 158.07 41.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 64.21 108.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.586 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.14 173.7 14.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.99 -0.55 . . . . 74.53 109.929 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.554 ' HB3' HD23 ' D' ' 98' ' ' LEU . 66.0 p -157.65 158.82 36.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.056 0.543 . . . . 73.04 110.745 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.31 118.27 2.25 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.215 1.006 . . . . 75.35 108.434 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -77.9 117.19 19.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.796 -0.816 . . . . 73.22 108.796 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.61 -35.07 14.45 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.861 -0.609 . . . . 71.01 110.406 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.17 -179.09 7.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.562 -0.745 . . . . 62.44 110.433 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.23 116.26 9.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.133 -0.939 . . . . 75.3 109.65 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.7 9.29 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.784 1.234 . . . . 64.41 112.502 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.26 114.29 46.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.629 -0.878 . . . . 71.34 108.629 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -125.04 129.42 50.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.15 0.98 . . . . 73.41 108.741 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.1 117.47 34.42 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 124.222 1.009 . . . . 73.51 108.664 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.5 HG11 ' HD3' ' D' ' 103' ' ' PRO . 43.6 t -100.52 135.82 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.243 -1.021 . . . . 71.23 108.243 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.586 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 84.5 t -113.72 146.56 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.74 0.816 . . . . 65.1 109.072 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.47 124.92 42.44 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.079 -1.452 . . . . 74.42 107.079 176.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.576 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.9 ttm-85 -104.68 105.13 15.09 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.71 -0.848 . . . . 74.02 108.71 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.17 103.08 14.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.844 -1.169 . . . . 73.14 107.844 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.533 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 37.8 m -102.08 129.14 48.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.249 0.619 . . . . 73.23 109.805 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.57 HG13 HG11 ' D' ' 40' ' ' VAL . 74.2 t -129.1 102.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.435 1.094 . . . . 71.42 109.15 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 61.8 m -102.07 108.09 19.41 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.433 -0.951 . . . . 63.53 108.433 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' D' ' 74' ' ' PHE . . . -109.37 141.85 41.14 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.081 -0.711 . . . . 74.25 109.081 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.418 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.1 p -147.56 126.4 12.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.394 -0.821 . . . . 74.14 109.58 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.586 HD12 ' HB3' ' D' ' 36' ' ' TRP . 30.8 tp -99.87 110.44 22.8 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.521 -0.918 . . . . 74.44 108.521 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.46 -124.09 6.39 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.402 -0.679 . . . . 73.33 111.402 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 5.67 46.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.287 0.635 . . . . 74.41 110.966 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.431 ' HB3' ' HZ3' ' D' ' 34' ' ' LYS . 9.5 tp10 -120.18 144.85 47.48 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.382 0.673 . . . . 71.33 111.319 -170.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -63.64 125.23 23.6 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.57 0.748 . . . . 72.34 110.551 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -89.41 -73.83 0.5 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.286 1.034 . . . . 65.22 109.648 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' D' ' 66' ' ' ALA . 55.1 p90 -144.17 138.02 27.84 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-O 121.246 0.546 . . . . 63.14 110.127 174.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.462 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.6 mt -103.08 148.14 26.09 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.257 1.023 . . . . 70.23 108.413 175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.542 ' SG ' HG22 ' D' ' 114' ' ' ILE . 52.0 t -160.22 146.41 15.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.082 0.553 . . . . 72.12 110.381 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -157.18 127.6 6.47 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.063 -0.717 . . . . 65.44 109.063 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . 0.412 HG21 HG22 ' D' ' 21' ' ' ILE . 67.7 t -126.73 115.89 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.857 0.463 . . . . 71.34 109.9 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.637 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.3 mt-30 -91.79 87.16 6.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.5 0.72 . . . . 71.21 109.181 170.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.43 108.44 12.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.566 -1.197 . . . . 75.34 108.81 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.43 141.69 15.4 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.693 -0.563 . . . . 64.4 111.693 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.41 130.49 5.13 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.045 -0.822 . . . . 53.21 111.045 -175.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.1 mt -88.97 116.45 30.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.701 1.2 . . . . 71.42 108.995 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -120.7 143.87 48.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.747 0.819 . . . . 74.34 109.237 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -98.29 96.84 8.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.905 -0.776 . . . . 75.51 108.905 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.65 109.16 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.401 -0.963 . . . . 72.31 108.401 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -140.66 168.65 19.29 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.14 0.976 . . . . 45.45 109.527 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.18 -15.09 30.01 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 114.189 0.435 . . . . 75.41 114.189 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -139.4 153.54 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.579 0.752 . . . . 64.31 110.144 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.485 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -149.81 -170.24 3.59 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.778 0.831 . . . . 75.21 110.662 177.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.36 -142.33 26.98 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.002 -0.544 . . . . 61.24 113.843 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -73.94 -21.0 60.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.483 0.713 . . . . 72.3 111.762 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.35 -47.98 66.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.191 0.597 . . . . 72.34 110.273 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.485 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 23.5 ptt? -71.94 -27.27 62.68 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.349 0.406 . . . . 74.45 110.608 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.41 67.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.45 0.7 . . . . 65.11 111.25 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' D' ' 100' ' ' ALA . 14.6 t-80 -71.93 -29.32 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.593 0.757 . . . . 71.33 110.663 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.14 -43.45 78.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 110.327 -0.249 . . . . 72.3 110.327 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.554 HD23 ' HB3' ' D' ' 48' ' ' SER . 9.2 tt -75.36 -45.23 40.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.524 0.73 . . . . 72.44 110.712 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.73 6.97 79.87 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.769 -0.462 . . . . 52.04 114.063 -172.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' D' ' 137' ' ' PHE . . . -147.09 -63.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.489 0.645 . . . . 63.11 111.8 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.6 -40.26 84.77 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.632 0.604 . . . . 72.44 112.632 -169.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.12 -44.66 14.09 Favored Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.413 0.685 . . . . 73.4 111.575 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.567 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.7 Cg_exo -54.66 -32.62 76.21 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 122.815 2.343 . . . . 72.53 113.448 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' D' ' 133' ' ' PHE . 4.1 t-20 -64.8 -36.62 84.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.178 0.591 . . . . 64.15 110.915 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.9 -42.82 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.577 0.751 . . . . 74.43 110.07 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 84.1 mt -76.8 -20.63 56.18 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.943 -1.026 . . . . 75.02 112.053 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -64.09 -45.73 79.81 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 114.55 1.315 . . . . 75.23 114.55 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . 0.532 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 22.1 Cg_endo -59.16 -35.2 98.21 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.656 1.571 . . . . 73.53 112.683 174.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.516 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 96.5 m-85 -73.9 -36.21 64.73 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.822 0.849 . . . . 73.33 111.601 177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.35 -50.59 69.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.835 0.854 . . . . 73.41 109.947 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -55.76 -48.68 74.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.996 -1.456 . . . . 70.22 111.225 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -62.99 -45.88 90.33 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.637 0.775 . . . . 74.23 111.278 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.9 t -55.45 -39.28 70.11 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.942 0.776 . . . . 73.11 111.002 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.681 HG21 HD11 ' D' ' 126' ' ' LEU . 52.8 mt -66.62 -50.92 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.373 -0.83 . . . . 74.4 110.779 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.6 m -58.79 -38.5 78.7 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.898 0.749 . . . . 72.42 111.54 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 38.5 t -63.69 -44.87 92.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.268 -0.878 . . . . 75.53 110.538 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -67.47 -35.15 78.62 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.95 0.5 . . . . 71.1 111.538 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.22 -40.37 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.972 0.909 . . . . 74.44 110.672 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.52 -32.83 66.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 120.959 0.409 . . . . 74.02 110.718 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 94.5 mtt-85 -67.39 -31.83 72.32 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.698 0.799 . . . . 74.15 110.204 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -87.93 6.07 84.0 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.896 0.747 . . . . 75.4 112.983 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 48.8 p 54.74 27.61 9.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 126.199 1.8 . . . . 74.25 113.408 178.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -92.25 159.9 36.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.43 1.092 . . . . 63.22 110.686 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.413 ' HB3' ' HB ' ' F' ' 136' ' ' VAL . 14.1 Cg_endo -57.17 138.29 85.6 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.405 2.736 . . . . 73.1 112.259 173.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -50.99 129.97 24.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.726 1.266 . . . . 73.41 112.758 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.681 HD11 HG21 ' D' ' 114' ' ' ILE . 2.7 tm? -115.9 95.74 5.26 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.32 107.714 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -133.83 114.58 13.5 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.872 -1.158 . . . . 64.31 107.872 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.6 148.96 40.3 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.652 -0.704 . . . . 71.21 110.417 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.79 162.93 64.58 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.997 -1.001 . . . . 71.21 109.966 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.34 154.94 49.43 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.255 1.97 . . . . 70.52 112.868 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.63 139.43 23.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 115.683 -0.69 . . . . 74.04 109.378 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -68.44 117.54 10.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.949 -0.759 . . . . 73.5 108.949 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.537 ' HB3' ' HB2' ' D' ' 104' ' ' ASN . 33.3 p90 -53.94 -28.47 37.33 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.982 0.913 . . . . 74.5 113.388 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.29 -39.51 69.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.175 0.99 . . . . 71.52 111.753 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.72 88.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.324 0.649 . . . . 74.05 111.424 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.76 -44.3 93.88 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.359 0.664 . . . . 71.21 109.385 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.747 ' HB2' ' HB3' ' D' ' 100' ' ' ALA . 75.8 t80 -64.58 -49.36 71.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.984 -1.007 . . . . 74.45 111.617 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.3 ptp -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.748 0.419 . . . . 75.13 111.071 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.552 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 4.9 m-20 -68.31 -37.67 80.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 119.208 -0.425 . . . . 63.1 110.855 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -47.43 -38.41 13.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.249 1.019 . . . . 74.22 112.504 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.54 -46.6 75.58 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.551 -0.749 . . . . 61.02 110.871 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -91.22 38.75 0.97 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.015 0.926 . . . . 75.15 112.582 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 18.7 mm100 -117.4 79.02 1.28 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.092 0.949 . . . . 74.15 110.3 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -144.39 73.25 1.37 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.612 -1.625 . . . . 71.33 106.612 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.19 120.01 3.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.223 -1.353 . . . . 72.1 109.185 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.99 40.2 0.67 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 110.033 -1.227 . . . . 75.33 110.033 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.55 81.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.064 0.946 . . . . 75.02 111.617 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.85 103.48 0.01 OUTLIER Glycine 0 C--N 1.346 1.102 0 O-C-N 123.451 0.469 . . . . 71.4 112.899 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 55.6 p -61.43 -32.89 72.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.216 0.606 . . . . 73.44 110.49 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 61.53 33.54 18.38 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.889 1.276 . . . . 63.02 110.789 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -73.6 139.93 45.86 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.434 -0.803 . . . . 73.33 111.675 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -148.63 81.0 1.45 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.789 0.836 . . . . 74.4 109.006 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.36 106.93 18.83 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.807 -0.812 . . . . 74.24 108.807 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.43 58.22 1.25 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.542 1.137 . . . . 65.55 108.828 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 CA-C-N 114.357 -1.292 . . . . 70.21 109.005 -175.326 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.337 -0.246 . . . . 74.32 110.337 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -136.05 64.07 1.57 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.572 -1.27 . . . . 75.24 107.572 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.19 -155.87 0.34 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.364 1.066 . . . . 74.44 110.479 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -150.19 -82.02 0.11 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.501 -0.555 . . . . 73.11 109.501 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -110.49 -37.24 5.54 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.967 -0.753 . . . . 73.45 108.967 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . 0.456 ' CB ' ' HB3' ' E' ' 116' ' ' TYR . 5.2 m-20 -63.04 148.88 46.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.901 -1.045 . . . . 74.24 109.968 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -73.1 -63.79 1.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.717 0.635 . . . . 65.34 111.699 -170.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.43 ' HB3' ' SD ' ' B' ' 94' ' ' MET . 7.1 mp -93.89 -38.81 11.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.242 0.217 . . . . 71.22 111.009 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . 0.456 ' HB3' ' CB ' ' E' ' 113' ' ' ASP . 63.9 t80 -48.19 109.8 1.24 Allowed Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 124.84 1.256 . . . . 74.25 111.867 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.499 ' HD2' HD22 ' B' ' 98' ' ' LEU . 95.4 Cg_endo -78.4 -51.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.04 2.493 . . . . 70.13 113.224 -170.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -166.17 -50.14 0.03 OUTLIER 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.5 0.72 . . . . 75.13 110.361 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 59.5 m 63.09 112.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.84 1.256 . . . . 73.35 110.351 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.419 ' HZ3' HD11 ' B' ' 136' ' ' LEU . 5.1 p-90 -55.2 124.48 17.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.354 1.062 . . . . 70.05 112.332 -175.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.93 84.22 2.11 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.036 -0.727 . . . . 72.44 109.036 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.5 34.64 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.367 1.067 . . . . 74.54 110.02 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' B' ' 44' ' ' LEU . 8.1 p -84.99 66.75 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 122.85 1.31 . . . . 73.24 110.875 -175.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -66.29 -35.24 79.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.68 -1.146 . . . . 73.34 110.285 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . 0.447 ' CE1' ' HB ' ' B' ' 131' ' ' VAL . 21.2 t80 64.04 28.68 14.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.176 0.99 . . . . 65.14 111.045 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -72.14 143.71 48.86 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.789 -1.096 . . . . 70.32 110.751 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.35 -172.96 39.43 Favored Glycine 0 C--O 1.242 0.654 0 CA-C-N 115.519 -0.764 . . . . 53.05 111.685 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.57 82.07 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.007 0.523 . . . . 75.21 109.856 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.69 111.47 23.97 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.105 -0.702 . . . . 75.15 109.105 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 8.7 tp -166.23 -42.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.174 0.99 . . . . 72.45 109.08 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 64.1 -170.2 0.19 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.75 1.22 . . . . 62.14 110.902 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -108.1 102.85 47.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.335 -0.617 . . . . 72.04 109.335 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.55 119.64 5.83 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.07 1.847 . . . . 54.24 111.206 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 tp -67.03 105.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.462 0.649 . . . . 63.34 109.737 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.17 84.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.159 -0.928 . . . . 65.14 109.558 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.78 -26.58 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.961 -1.018 . . . . 75.42 112.148 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.82 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.659 1.583 . . . . 71.24 113.346 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.68 -2.49 36.32 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.499 1.12 . . . . 75.55 113.311 -173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 60.6 tp -74.44 83.28 1.96 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.527 0.68 . . . . 73.21 109.995 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 63.0 m -153.94 -71.17 0.14 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.278 -1.008 . . . . 72.0 108.278 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . 0.6 HD11 ' H ' ' C' ' 40' ' ' VAL . 89.6 mt 61.57 14.37 5.91 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.726 1.211 . . . . 74.31 112.854 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.94 143.52 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.514 0.726 . . . . 63.24 110.211 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.9 103.07 1.71 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 121.56 0.695 . . . . 74.53 109.984 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -96.28 32.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.15 0.98 . . . . 73.34 111.281 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -153.68 -69.83 0.14 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 74.31 110.2 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.19 75.82 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.556 0.742 . . . . 71.34 110.096 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 10.5 tt -62.89 -45.02 94.5 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.175 -0.92 . . . . 73.33 110.001 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.469 HD11 HD21 ' C' ' 136' ' ' LEU . 56.8 tp -160.42 91.18 1.68 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.979 -1.119 . . . . 74.44 107.979 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 C--N 1.375 1.928 0 C-N-CA 123.121 2.547 . . . . 75.04 111.729 179.094 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.573 0.225 . . . . 73.44 110.704 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.83 125.26 29.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.355 0.662 . . . . 74.21 110.317 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.91 140.57 9.38 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.568 0.747 . . . . 65.24 110.095 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -107.55 113.77 27.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.605 0.762 . . . . 72.14 110.043 175.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.74 158.52 18.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.41 0.684 . . . . 74.31 109.642 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . 0.418 ' HA ' ' CD2' ' F' ' 116' ' ' TYR . 21.0 t70 82.21 87.66 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.421 1.488 . . . . 73.13 111.699 167.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -136.49 132.14 34.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.924 0.89 . . . . 75.02 109.015 167.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.698 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 8.5 mp 67.99 0.71 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.916 1.286 . . . . 74.23 113.525 167.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . 0.418 ' CD2' ' HA ' ' F' ' 113' ' ' ASP . 18.5 m-85 -69.47 153.63 95.6 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 123.475 0.71 . . . . 72.32 112.465 -169.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.17 -168.78 0.63 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.779 2.319 . . . . 60.12 113.966 -171.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -84.55 160.32 20.5 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.139 -0.937 . . . . 73.45 109.797 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -65.97 -28.55 68.98 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.619 0.575 . . . . 75.4 110.785 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 m95 67.77 174.9 0.27 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.083 1.353 . . . . 73.41 110.892 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -160.25 -77.66 0.06 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.721 -0.474 . . . . 60.35 109.721 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.63 81.06 6.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.295 0.638 . . . . 75.14 110.414 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.91 83.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 106.958 -1.497 . . . . 72.14 106.958 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -87.05 62.36 7.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.159 -0.928 . . . . 74.42 108.981 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.88 124.44 33.1 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.12 -1.4 . . . . 75.22 107.727 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -66.67 92.01 0.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.413 0.685 . . . . 75.43 109.916 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.52 135.13 11.98 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.798 -0.637 . . . . 73.45 111.778 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -147.94 -58.62 0.25 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.155 -1.054 . . . . 74.05 108.155 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.413 HD21 HD23 ' A' ' 42' ' ' LEU . 80.2 mt 76.83 -25.01 0.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.297 1.439 . . . . 73.22 114.459 163.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 tp -71.14 88.52 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 122.358 1.075 . . . . 64.3 109.328 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.32 164.4 25.58 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.194 -1.366 . . . . 73.11 109.355 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -70.09 108.17 3.13 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.285 0.634 . . . . 75.53 109.895 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -96.98 -157.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.347 2.698 . . . . 73.05 111.736 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 13.5 tt -162.97 130.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.976 -1.12 . . . . 71.4 107.976 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.87 93.42 2.65 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.614 0.765 . . . . 60.14 109.209 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.418 ' HA ' ' NE2' ' D' ' 37' ' ' GLN . 15.3 m -111.73 117.5 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.541 -0.754 . . . . 73.11 111.189 -174.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.64 -65.26 0.7 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.912 0.885 . . . . 73.21 109.919 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.26 -74.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.207 -1.405 . . . . 74.42 107.207 172.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.491 ' HG ' HD23 ' D' ' 126' ' ' LEU . 0.3 OUTLIER -171.79 120.83 0.47 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.761 -1.57 . . . . 71.02 106.761 172.309 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 28.7 t -78.14 -73.86 0.29 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.168 0.587 . . . . 73.12 110.887 -172.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' D' ' 39' ' ' GLU . 4.3 mp -87.89 109.86 20.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.698 -0.853 . . . . 72.21 108.698 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.519 ' HA ' ' HB ' ' D' ' 40' ' ' VAL . 14.2 tt -132.32 150.55 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 73.11 109.215 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 76.95 138.82 0.07 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.366 1.467 . . . . 74.4 110.872 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -84.54 71.67 10.73 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.776 -0.824 . . . . 72.44 108.776 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -175.79 -73.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.889 -1.523 . . . . 74.31 106.889 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -161.78 -79.29 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.307 1.043 . . . . 75.03 108.527 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tt 174.32 145.51 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.868 1.667 . . . . 73.2 106.599 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 tp -111.78 92.96 18.7 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.924 -0.769 . . . . 75.11 108.924 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.562 1.882 0 C-N-CA 123.508 2.805 . . . . 71.32 112.275 177.537 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.367 -0.605 . . . . 74.41 109.367 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.7 m -152.32 123.0 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.398 1.079 . . . . 70.22 108.71 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.052 -0.722 . . . . 74.32 109.052 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 65.25 144.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.252 1.821 . . . . 73.22 113.122 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -74.63 -27.72 60.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 71.42 111.183 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.41 86.87 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 124.192 0.997 . . . . 73.11 111.884 -172.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -65.42 -49.69 68.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.023 -0.99 . . . . 75.44 108.707 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -174.72 93.62 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 113.554 -1.657 . . . . 75.41 107.925 167.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 87.9 mtp -140.49 132.93 28.49 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.975 -0.75 . . . . 73.52 108.975 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -149.21 118.7 6.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.553 -0.906 . . . . 73.54 108.553 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.421 ' HZ ' ' SG ' ' A' ' 102' ' ' CYS . 1.2 t80 -139.76 114.84 9.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.625 -0.88 . . . . 75.05 108.625 167.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -155.63 137.29 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.24 0.616 . . . . 71.43 109.668 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.551 HD13 ' H ' ' A' ' 13' ' ' ILE . 2.5 mp -75.96 131.72 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.474 -0.935 . . . . 75.34 108.474 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 -35.79 12.52 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.808 0.276 . . . . 73.14 111.052 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 137.58 12.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 121.999 0.12 . . . . 75.41 110.821 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.441 HG13 HG21 ' A' ' 13' ' ' ILE . 2.3 mp -122.88 118.84 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.058 -1.46 . . . . 74.1 107.058 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 43.7 p90 -166.55 177.57 6.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.218 1.008 . . . . 74.32 113.031 -171.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -102.68 124.02 47.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.253 -1.34 . . . . 73.33 108.875 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.402 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.9 mtpt -91.58 -24.05 19.7 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.03 0.443 . . . . 75.13 110.071 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.652 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -153.21 138.26 17.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.937 -1.029 . . . . 74.34 109.308 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 74.5 mt -141.93 143.64 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.088 1.355 . . . . 75.23 107.593 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -155.8 139.16 15.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.343 0.592 . . . . 71.33 110.136 170.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.417 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -131.14 134.88 46.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.32 -1.733 . . . . 74.35 106.32 171.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.08 118.74 12.34 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.132 -0.692 . . . . 70.13 109.132 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.446 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -124.51 82.11 59.14 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 107.205 -1.405 . . . . 73.34 107.205 173.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.39 -29.8 20.31 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.171 1.914 . . . . 74.54 110.344 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.4 m-20 -110.14 31.69 5.7 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.904 -1.044 . . . . 72.11 109.598 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.446 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -58.58 -44.58 99.23 Favored Pre-proline 0 CA--C 1.565 1.525 0 C-N-CA 123.736 0.815 . . . . 75.53 112.276 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.64 -20.07 20.72 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 121.735 1.623 . . . . 75.13 112.786 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.4 m-70 -85.25 -20.01 30.74 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.851 0.461 . . . . 75.12 111.945 -171.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.474 HG13 ' HE2' ' A' ' 123' ' ' PHE . 9.8 p -71.61 -19.19 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 120.968 0.414 . . . . 71.13 111.297 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -78.73 -41.68 30.18 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.572 0.749 . . . . 75.03 110.745 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -75.95 -29.0 58.14 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.904 0.482 . . . . 64.03 110.63 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.5 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 33.8 mmtp -83.2 169.45 15.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.273 0.629 . . . . 75.32 110.543 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.14 128.96 37.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.557 -0.905 . . . . 75.23 108.557 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.476 ' HH2' ' NH2' ' B' ' 15' ' ' ARG . 2.8 t90 -84.78 68.31 10.4 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.148 0.975 . . . . 71.22 108.6 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.36 76.38 10.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 114.226 -1.352 . . . . 75.34 107.638 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -85.52 166.83 10.43 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.298 1.999 . . . . 73.41 111.389 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.19 128.53 42.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.35 -1.352 . . . . 70.15 107.35 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.519 0.676 . . . . 73.15 110.358 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 1.7 ttpp -116.65 115.62 26.02 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.916 -1.142 . . . . 72.21 107.916 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.15 106.48 15.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.342 -0.984 . . . . 72.42 108.342 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.576 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -109.02 111.67 23.44 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.816 -0.809 . . . . 74.31 108.816 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.43 122.6 46.94 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.564 -0.532 . . . . 74.25 109.564 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -139.03 135.25 34.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.171 0.989 . . . . 62.2 109.399 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.8 m -107.52 138.57 43.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.278 0.631 . . . . 64.31 109.607 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.29 150.22 52.24 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.659 1.183 . . . . 63.53 108.012 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.2 m -124.38 161.18 26.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.144 0.497 . . . . 74.44 111.208 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 t -150.21 147.41 27.66 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.995 1.318 . . . . 64.34 108.768 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -112.85 124.52 52.78 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.947 -0.76 . . . . 73.32 108.947 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.434 HD12 HG22 ' A' ' 83' ' ' ILE . 77.9 mt -98.72 -36.38 9.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.983 0.513 . . . . 74.4 110.471 177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.69 -174.23 4.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.584 0.754 . . . . 75.24 110.2 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.39 117.57 8.81 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 24.8 m-20 67.89 5.26 4.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.531 1.133 . . . . 64.23 112.583 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.1 t -108.78 104.52 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.52 -1.289 . . . . 74.3 107.52 173.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -122.58 146.47 47.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.499 0.666 . . . . 74.4 110.714 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 112.58 15.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.185 -1.413 . . . . 74.21 107.185 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG13 ' HB3' ' A' ' 98' ' ' LEU . 30.8 m -102.91 126.62 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.077 -1.082 . . . . 71.54 108.077 174.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.54 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.4 t -102.97 129.39 54.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.721 0.808 . . . . 72.33 109.342 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.84 112.13 24.32 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.59 -1.263 . . . . 73.2 107.59 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -103.17 106.89 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.638 0.775 . . . . 74.13 109.883 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.32 133.3 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.836 -1.074 . . . . 73.4 109.15 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.4 m -116.34 143.13 45.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.604 -0.888 . . . . 74.04 108.604 171.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 37.1 t -133.94 130.73 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.138 -1.43 . . . . 63.25 107.138 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -132.46 139.08 47.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.007 -0.368 . . . . 74.42 110.007 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.84 105.32 12.57 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.131 -1.063 . . . . 61.42 108.131 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 49.6 m -133.24 126.21 31.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.906 0.483 . . . . 71.12 110.525 -177.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.12 86.33 4.56 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.14 -1.429 . . . . 74.32 107.14 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.99 -85.06 1.0 Allowed Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.448 -0.661 . . . . 73.15 111.448 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -118.1 -27.32 6.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 73.53 110.015 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.5 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -77.8 91.77 4.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.042 0.537 . . . . 75.41 109.853 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 85.1 m -73.79 105.97 5.31 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 122.894 0.477 . . . . 64.22 110.205 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.53 72.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.493 1.117 . . . . 53.11 110.061 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -161.35 173.07 15.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.078 -1.419 . . . . 70.41 111.548 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.429 HD11 ' H ' ' A' ' 76' ' ' CYS . 25.4 tp -142.06 147.97 37.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.67 1.588 . . . . 74.23 107.904 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.429 ' H ' HD11 ' A' ' 75' ' ' LEU . 75.2 m -144.91 140.27 28.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.449 1.1 . . . . 72.21 109.266 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -149.55 120.32 7.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.32 -0.622 . . . . 71.33 109.32 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.487 HG12 ' HB3' ' A' ' 113' ' ' CYS . 58.7 t -128.75 113.29 28.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.622 0.769 . . . . 74.43 109.684 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.652 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.8 mt-30 -89.88 90.89 8.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.552 0.741 . . . . 74.5 109.581 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.97 98.97 8.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.224 1.01 . . . . 75.23 109.007 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -98.55 144.58 17.31 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 112.152 -0.379 . . . . 55.11 112.152 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.86 132.44 6.03 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 110.994 -0.842 . . . . 70.23 110.994 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 51' ' ' LEU . 59.0 mt -83.86 129.77 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.695 -0.854 . . . . 75.1 108.695 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -129.79 120.11 24.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.122 0.569 . . . . 72.51 109.703 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -82.8 110.85 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.88 -0.785 . . . . 75.11 108.88 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.429 HG13 HD11 ' F' ' 115' ' ' LEU . 22.3 pt -120.9 157.3 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.369 0.668 . . . . 75.23 109.973 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.93 146.64 1.56 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.471 0.708 . . . . 74.11 110.47 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.74 -25.39 23.6 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 114.963 0.745 . . . . 72.31 114.963 169.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.2 pt -109.9 134.85 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.674 0.737 . . . . 75.04 109.857 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.29 172.11 12.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.587 . . . . 70.02 109.965 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -132.95 44.51 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.213 0.321 . . . . 62.2 113.578 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 27.1 p -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.987 0.915 . . . . 75.13 112.228 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -63.98 -54.53 33.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.405 0.682 . . . . 73.23 110.38 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -24.82 39.98 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.542 -0.754 . . . . 75.34 110.785 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -70.9 -28.1 64.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.744 0.418 . . . . 72.42 111.011 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.31 -51.06 26.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.357 0.663 . . . . 74.32 109.784 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.624 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 6.1 m -73.84 -35.63 64.83 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.706 1.002 . . . . 75.35 113.706 -167.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.408 ' HB3' HG13 ' A' ' 58' ' ' VAL . 88.8 mt -87.4 -23.61 24.48 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.011 0.369 . . . . 75.25 111.003 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.15 -20.53 35.59 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 114.434 0.534 . . . . 61.42 114.434 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.461 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -138.05 -60.16 0.63 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.202 0.601 . . . . 61.12 111.59 -170.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 9.7 t80 -52.68 -56.28 16.59 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.411 1.084 . . . . 75.44 112.26 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.421 ' SG ' ' HZ ' ' A' ' 11' ' ' PHE . 82.2 m -74.49 -44.3 5.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.454 -1.26 . . . . 62.2 114.314 -171.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.38 -27.51 85.18 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.914 1.719 . . . . 61.34 112.439 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -73.86 -32.19 63.53 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 122.811 0.444 . . . . 72.13 110.663 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.6 mm -65.89 -42.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.706 0.802 . . . . 64.32 109.935 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.03 -18.39 60.34 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.128 -0.942 . . . . 75.41 111.292 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -70.92 -43.38 13.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.543 -1.218 . . . . 74.2 114.158 -170.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.513 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 32.1 Cg_endo -63.12 -27.51 73.35 Favored 'Trans proline' 0 C--N 1.383 2.38 0 CA-C-N 122.087 1.781 . . . . 71.13 112.363 172.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.44 -41.01 48.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.442 0.697 . . . . 74.51 111.7 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.88 75.7 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.994 -0.373 . . . . 54.12 109.994 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.455 ' NH1' HD13 ' C' ' 105' ' ' ILE . 39.0 ttm180 -55.29 -49.73 71.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.547 1.155 . . . . 73.55 109.873 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.03 -47.82 84.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.188 0.93 . . . . 64.11 111.176 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.487 ' HB3' HG12 ' A' ' 78' ' ' VAL . 34.4 t -65.1 -37.01 86.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.95 0.781 . . . . 73.21 111.637 -174.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.563 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 92.3 mt -67.21 -60.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.179 -0.674 . . . . 62.35 109.179 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.479 HG21 ' HG3' ' A' ' 125' ' ' GLN . 66.4 m -50.73 -37.35 41.21 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.84 1.338 . . . . 75.53 112.309 -176.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.9 t -69.38 -43.83 72.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.71 -0.677 . . . . 72.41 110.065 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.563 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 44.0 mtm -62.9 -38.64 91.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.798 0.439 . . . . 75.24 111.063 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 114' ' ' ILE . 87.0 t -57.66 -50.24 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.34 1.025 . . . . 72.02 110.005 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -73.7 -28.53 61.78 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.644 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -70.47 -27.73 64.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.495 0.718 . . . . 74.02 109.96 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 5.99 69.82 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.748 0.655 . . . . 61.22 113.331 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.5 m 64.87 27.98 12.78 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.833 1.253 . . . . 70.33 110.753 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.474 ' HE2' HG13 ' A' ' 31' ' ' VAL . 90.1 m-85 -97.45 153.85 38.21 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.455 1.102 . . . . 75.24 109.337 172.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -65.96 143.31 72.17 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.104 1.87 . . . . 65.31 111.37 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.479 ' HG3' HG21 ' A' ' 115' ' ' THR . 27.5 tt0 -59.07 137.67 57.85 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 124.191 0.932 . . . . 74.24 112.565 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.15 102.0 5.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.399 -0.963 . . . . 73.11 108.399 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.984 -0.747 . . . . 63.23 108.984 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.53 139.33 56.96 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 72.31 109.837 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.12 128.54 92.45 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 122.983 0.513 . . . . 73.33 111.226 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 2.7 Cg_exo -76.43 89.36 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.964 2.443 . . . . 74.23 112.456 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.61 115.02 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.808 0.843 . . . . 75.42 109.434 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.95 106.03 5.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.446 0.698 . . . . 75.32 110.314 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.97 -6.26 58.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.732 0.813 . . . . 73.31 111.978 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.461 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 2.0 m-20 -52.9 -51.91 59.49 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.438 0.461 . . . . 75.32 110.519 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.06 66.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.207 0.942 . . . . 75.03 112.249 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.14 -52.13 60.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.713 0.805 . . . . 72.21 109.503 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -68.68 -31.36 70.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.945 -0.571 . . . . 71.14 110.901 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 93.1 mmm -66.5 -38.55 87.48 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 119.191 -0.433 . . . . 75.44 111.103 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -56.3 -30.38 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 123.549 0.531 . . . . 72.04 111.074 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -80.42 -39.0 29.11 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.696 0.799 . . . . 60.41 111.114 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 tt -66.72 -57.76 6.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.042 0.537 . . . . 72.44 110.829 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -173.34 -16.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 125.606 1.562 . . . . 73.33 109.896 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 79.81 -48.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.264 1.825 . . . . 75.1 110.272 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -83.56 137.3 33.9 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.291 1.037 . . . . 74.55 109.922 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.41 152.66 44.5 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.884 0.874 . . . . 63.41 109.175 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.02 112.62 0.53 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.24 -0.436 . . . . 73.14 112.643 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 174.99 9.51 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.347 0.659 . . . . 75.52 109.905 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 68.76 0.12 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.479 -1.048 . . . . 75.52 110.479 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.0 m -70.51 90.13 0.73 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.459 0.704 . . . . 75.11 110.866 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -88.87 172.2 9.36 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 64.41 110.424 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -156.04 157.92 36.93 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.29 -0.868 . . . . 63.1 109.361 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -151.51 66.34 0.88 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.634 0.774 . . . . 72.43 109.377 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -80.36 134.05 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.912 -0.585 . . . . 74.32 110.573 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.28 107.73 19.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.279 0.632 . . . . 73.31 109.373 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.155 0 C-N-CA 123.533 0.733 . . . . 73.43 110.001 179.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.512 0.196 . . . . 72.3 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -81.37 -0.26 40.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.703 0.801 . . . . 62.34 112.138 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 65.19 -175.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.527 1.131 . . . . 54.31 113.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -93.91 150.73 20.11 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.327 1.051 . . . . 72.42 110.8 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.44 166.01 0.27 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 124.542 1.151 . . . . 75.13 112.22 172.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.482 ' HB2' ' HA3' ' B' ' 148' ' ' GLY . 1.8 m-20 -70.45 82.8 0.57 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.353 0.661 . . . . 74.45 110.388 174.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -77.91 99.29 5.94 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.549 -0.908 . . . . 73.33 108.549 170.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' B' ' 9' ' ' MET . 5.8 tt0 -154.99 -153.71 0.46 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.426 -1.324 . . . . 74.55 107.426 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.516 ' H ' ' HG2' ' B' ' 8' ' ' GLU . 22.5 ptm 52.85 176.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.216 1.932 . . . . 74.1 116.216 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.8 m -143.25 118.96 10.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.494 -1.685 . . . . 71.1 107.763 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.433 ' HB2' ' HE3' ' B' ' 9' ' ' MET . 59.0 t80 -120.22 134.93 55.15 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.092 -0.707 . . . . 74.52 109.092 173.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -151.19 127.79 10.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.051 -0.722 . . . . 73.44 109.051 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.407 ' H ' HD11 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -86.05 143.39 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.234 -0.654 . . . . 74.1 109.234 173.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -109.3 -48.46 3.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.032 0.533 . . . . 64.55 109.58 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.476 ' NH2' ' HH2' ' A' ' 36' ' ' TRP . 16.0 ttt180 -158.17 149.91 21.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.463 -0.335 . . . . 73.44 110.948 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -127.96 144.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.594 -1.632 . . . . 73.33 106.594 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.403 ' HE1' HG13 ' B' ' 83' ' ' ILE . 21.7 p90 -171.66 147.12 2.25 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.493 0.317 . . . . 73.13 111.342 -176.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -73.79 119.36 17.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.605 -0.887 . . . . 74.4 108.605 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -92.26 -33.69 14.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.966 0.506 . . . . 74.4 110.362 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.658 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.2 t70 -151.78 143.2 23.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.836 -168.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.1 mm -140.96 147.12 22.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.715 1.606 . . . . 75.3 107.59 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -150.33 140.27 21.93 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.888 -0.782 . . . . 52.22 108.888 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.542 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -145.65 125.2 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.506 -1.294 . . . . 74.32 107.506 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -128.54 122.46 31.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.685 0.794 . . . . 64.05 109.338 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.504 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.14 84.8 9.48 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.121 -1.437 . . . . 71.41 107.121 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.22 -31.53 35.58 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.646 2.231 . . . . 72.21 111.951 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -124.31 27.41 7.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.07 0.948 . . . . 50.34 110.138 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.504 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.14 -53.13 17.81 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 125.395 1.478 . . . . 74.32 114.741 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.21 -9.24 14.0 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.904 1.736 . . . . 74.03 112.891 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -95.68 -33.39 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.687 0.795 . . . . 72.33 110.54 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.423 HG23 ' HD2' ' B' ' 34' ' ' LYS . 8.7 p -81.36 -8.38 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.854 0.862 . . . . 74.01 110.379 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -59.29 -37.43 77.68 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.784 0.833 . . . . 74.33 110.232 171.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -69.83 -26.94 64.47 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.513 0.725 . . . . 74.54 111.168 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.423 ' HD2' HG23 ' B' ' 31' ' ' VAL . 84.7 mttt -87.02 97.45 10.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.205 0.602 . . . . 74.34 110.391 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.09 77.88 9.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.091 0.472 . . . . 61.41 110.352 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.445 ' HB2' HD13 ' B' ' 68' ' ' LEU . 17.1 m-90 -151.84 168.88 23.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.414 1.086 . . . . 75.45 108.283 176.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -86.41 115.73 63.24 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.795 -1.187 . . . . 74.45 107.795 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.44 139.67 77.89 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.248 1.966 . . . . 74.02 111.195 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.1 104.06 0.68 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.036 -0.728 . . . . 74.44 109.036 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -92.05 158.52 2.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.109 -0.951 . . . . 74.54 111.56 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -149.04 118.84 7.05 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.286 -1.325 . . . . 74.14 108.551 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.95 148.87 25.15 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.027 -0.731 . . . . 74.12 109.027 163.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.87 110.27 2.86 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.57 -1.271 . . . . 64.14 107.57 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.521 HD13 ' HB3' ' E' ' 125' ' ' TYR . 5.6 mp -101.71 152.09 21.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.932 0.893 . . . . 73.25 109.85 -174.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.433 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 13.7 t70 -145.82 144.66 30.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.198 1.399 . . . . 63.31 108.42 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.466 ' H ' HG12 ' E' ' 123' ' ' VAL . 11.9 t -114.05 141.14 47.83 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.342 -0.614 . . . . 75.52 109.342 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.69 154.92 49.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.014 0.926 . . . . 75.41 109.026 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -145.05 163.22 34.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.328 0.651 . . . . 74.54 110.781 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -152.47 139.26 18.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.476 1.11 . . . . 70.13 108.17 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -96.27 118.02 31.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.427 -0.583 . . . . 65.4 109.427 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.453 HD12 HG22 ' B' ' 83' ' ' ILE . 33.7 mt -90.41 -39.81 12.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.691 -0.485 . . . . 74.34 109.691 176.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.92 -171.64 3.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.309 -0.86 . . . . 72.23 110.332 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.84 119.76 8.84 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 114.946 -1.024 . . . . 73.14 109.927 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.7 -1.73 1.56 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.575 1.15 . . . . 71.12 112.777 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.6 t -104.33 106.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.617 -0.882 . . . . 54.34 108.617 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.08 134.82 54.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.196 0.522 . . . . 74.53 110.224 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -100.32 97.43 8.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.482 -1.673 . . . . 65.11 106.482 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.29 124.5 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.853 0.861 . . . . 74.13 109.121 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 38.4 t -100.68 142.97 14.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.122 -0.696 . . . . 73.45 109.122 177.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -116.29 121.01 40.75 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.576 -1.268 . . . . 73.24 107.576 173.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.433 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 58.0 ttt180 -106.76 116.77 32.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.249 1.02 . . . . 74.23 109.545 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -114.79 120.23 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.963 -1.125 . . . . 75.21 107.963 171.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -116.03 133.36 56.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.227 0.611 . . . . 73.25 109.403 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.545 HG22 HG21 ' B' ' 114' ' ' ILE . 38.7 t -114.28 136.35 51.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.406 1.083 . . . . 74.3 110.586 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -125.1 145.18 50.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.672 1.189 . . . . 75.54 108.303 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.08 141.61 25.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.006 -0.738 . . . . 71.32 109.006 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 37.3 p -146.37 134.96 22.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.716 0.635 . . . . 74.11 109.829 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.445 HD13 ' HB2' ' B' ' 36' ' ' TRP . 14.4 tp -132.24 122.23 24.87 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.805 -0.813 . . . . 74.4 108.805 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.93 -128.21 8.32 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.868 0.73 . . . . 71.12 112.215 -174.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.67 19.62 20.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.519 0.728 . . . . 75.22 110.927 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -156.54 167.05 31.63 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.808 0.443 . . . . 74.15 111.83 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -70.56 136.39 49.24 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.406 -0.815 . . . . 74.23 110.275 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.71 -54.81 3.89 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.117 0.967 . . . . 61.11 109.22 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.73 167.58 29.12 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.267 -0.879 . . . . 75.25 110.971 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.57 145.12 34.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.868 1.667 . . . . 74.13 107.553 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -151.14 159.43 44.46 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.175 -0.676 . . . . 72.32 109.175 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.78 136.62 3.7 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.989 -0.745 . . . . 73.53 108.989 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.8 t -130.0 144.87 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.967 -0.753 . . . . 71.42 108.967 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.658 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.8 mt-30 -128.18 97.66 4.84 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.237 -0.653 . . . . 74.1 109.237 173.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.42 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -88.15 103.13 15.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.028 -0.987 . . . . 72.33 108.881 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.01 147.46 19.28 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.602 -0.599 . . . . 72.13 111.602 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.15 126.54 2.74 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.535 -0.626 . . . . 62.23 111.535 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.453 HG22 HD12 ' B' ' 51' ' ' LEU . 56.5 mt -85.57 117.95 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.412 -0.958 . . . . 72.31 108.412 174.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -124.49 167.07 14.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 74.44 109.816 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -132.47 114.59 14.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.13 0.972 . . . . 75.04 109.157 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.646 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.2 pp -118.96 135.84 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.15 0.98 . . . . 62.32 110.429 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 166.66 32.4 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.732 0.813 . . . . 70.04 109.42 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.84 -61.79 4.71 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.267 0.355 . . . . 60.11 112.398 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.665 HD12 ' SD ' ' B' ' 94' ' ' MET . 1.1 pp -56.97 150.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.877 0.871 . . . . 63.22 112.802 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.53 164.01 36.52 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.69 0.796 . . . . 75.22 110.659 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -120.72 23.69 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.803 0.689 . . . . 72.34 113.312 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.2 m -67.95 -35.23 78.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.282 0.633 . . . . 74.32 111.588 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -68.91 -43.33 75.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.103 0.561 . . . . 71.44 110.726 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.665 ' SD ' HD12 ' B' ' 89' ' ' ILE . 5.3 tpt -67.85 -43.45 79.45 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.952 -0.567 . . . . 74.53 110.327 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.57 75.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.206 0.603 . . . . 63.31 111.899 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.44 -32.0 58.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.665 0.786 . . . . 74.5 110.776 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.431 ' HB3' ' HE1' ' B' ' 94' ' ' MET . 53.7 t -70.81 -52.87 17.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.889 0.476 . . . . 64.43 111.225 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.71 -26.36 64.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.058 0.543 . . . . 75.12 110.786 177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 3.15 63.24 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-O 119.246 -0.752 . . . . 53.03 114.839 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -154.11 -53.52 0.1 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.853 0.826 . . . . 70.03 112.138 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.6 -56.03 16.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.556 0.742 . . . . 60.14 111.206 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.417 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.9 m -61.51 -50.22 83.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.253 -0.879 . . . . 64.5 112.191 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.6 Cg_exo -55.06 -36.43 92.8 Favored 'Trans proline' 0 C--N 1.399 3.194 0 C-N-CA 122.287 1.991 . . . . 71.21 113.975 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.22 -33.82 76.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.65 0.38 . . . . 72.44 111.323 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.18 -44.61 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 74.22 110.446 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.458 ' HB2' HD12 ' B' ' 60' ' ' LEU . 77.3 mt -83.29 -19.4 36.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.913 -1.04 . . . . 71.34 112.637 -169.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.41 -45.84 94.58 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 117.677 -1.154 . . . . 73.33 113.689 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.61 -43.25 46.51 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.656 2.238 . . . . 74.42 113.977 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.42 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 73.7 m-85 -65.94 -44.92 83.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.873 0.733 . . . . 71.13 110.506 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.55 87.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.656 -0.702 . . . . 74.14 111.06 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.69 -53.57 54.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.044 1.338 . . . . 74.11 110.953 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -40.68 95.21 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.722 0.639 . . . . 75.45 110.223 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -66.66 -33.26 75.26 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 123.814 0.696 . . . . 73.13 111.853 -174.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.545 HG21 HG22 ' B' ' 64' ' ' VAL . 71.3 mt -68.24 -52.63 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.398 -0.593 . . . . 74.51 109.398 172.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.5 m -59.12 -28.65 66.74 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 124.176 0.922 . . . . 74.23 111.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -66.99 -53.17 34.03 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 115.297 -0.865 . . . . 70.04 109.658 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.486 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 20.6 mmt -64.3 -34.72 78.78 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 123.455 0.472 . . . . 72.44 111.95 -176.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.78 -48.39 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.906 0.882 . . . . 74.42 110.665 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -72.41 -24.22 61.2 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.872 -0.604 . . . . 64.31 111.448 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.486 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -67.5 -32.68 73.67 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.359 0.664 . . . . 72.54 109.907 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.23 8.69 75.81 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.96 0.788 . . . . 71.42 113.282 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.407 HG21 ' HB3' ' A' ' 17' ' ' TYR . 69.9 p 57.7 34.07 24.01 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.976 1.71 . . . . 73.03 113.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.22 156.27 39.07 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.808 0.843 . . . . 73.44 110.18 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 179.57 0.55 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.124 2.549 . . . . 75.15 113.542 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -56.68 113.88 1.82 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.501 -0.772 . . . . 75.42 111.254 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -129.22 100.91 5.78 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.486 -1.672 . . . . 73.04 106.486 172.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -131.44 134.11 45.87 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.691 -0.855 . . . . 74.1 108.691 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.3 132.93 35.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.553 0.741 . . . . 73.04 110.419 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.69 154.0 81.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.047 0.939 . . . . 73.53 110.151 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -59.98 114.18 1.97 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.931 2.421 . . . . 60.35 111.845 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.445 HG12 HD21 ' B' ' 44' ' ' LEU . 90.7 t -90.0 118.15 34.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.644 -0.707 . . . . 64.34 109.998 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.91 93.47 3.78 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.292 -0.632 . . . . 74.42 109.292 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 91.6 m-85 -62.65 -35.76 80.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.673 -1.149 . . . . 73.2 110.858 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -63.69 -39.53 94.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.516 -1.22 . . . . 75.35 110.961 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.61 -27.48 58.49 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.705 0.628 . . . . 62.12 111.807 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.411 HD11 ' HZ3' ' E' ' 120' ' ' TRP . 1.6 tm? -77.5 -42.63 34.97 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.121 -0.696 . . . . 71.32 109.121 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -66.46 -29.19 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.572 0.749 . . . . 74.4 110.321 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 57.6 ttp -57.64 -33.29 68.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.054 0.942 . . . . 73.44 112.13 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -74.25 -25.76 59.82 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.886 0.475 . . . . 74.24 111.478 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.38 -48.88 77.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.636 0.775 . . . . 73.3 111.237 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.03 8.24 32.26 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.735 -0.666 . . . . 62.41 111.584 -176.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.57 91.94 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.718 1.207 . . . . 75.02 111.025 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 70.61 143.05 0.05 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.254 1.422 . . . . 74.43 111.462 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -152.81 170.8 19.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.308 0.643 . . . . 75.2 110.708 172.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.86 139.32 43.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.105 -0.952 . . . . 75.25 109.085 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.87 32.85 0.34 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.166 0.291 . . . . 75.43 112.787 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -80.2 89.85 5.48 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.579 0.752 . . . . 73.04 109.172 176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' B' ' 6' ' ' ASN . . . 161.51 95.44 0.11 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.513 -0.767 . . . . 53.21 111.582 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.1 t -142.45 3.21 1.49 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.368 0.667 . . . . 74.41 110.528 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.93 143.78 56.62 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 122.736 0.414 . . . . 74.24 110.629 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 151.27 45.87 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.45 1.1 . . . . 73.01 112.514 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -164.01 1.95 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.689 -1.141 . . . . 75.42 109.86 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -133.98 165.8 24.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.015 0.926 . . . . 74.51 109.617 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.03 8.41 8.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.718 0.807 . . . . 64.51 109.364 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.021 1.328 . . . . 71.43 108.05 173.919 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.48 ' SD ' ' NE2' ' C' ' 153' ' ' GLN . 17.5 tpt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 109.759 -0.46 . . . . 71.21 109.759 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t 67.14 166.68 0.23 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.153 1.381 . . . . 64.04 110.867 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 63.51 77.12 0.34 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.155 0.982 . . . . 72.15 108.503 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -101.26 174.93 5.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.618 0.767 . . . . 73.14 111.083 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.69 -9.04 52.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.46 1.104 . . . . 73.42 112.545 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -49.09 146.4 3.52 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.088 1.355 . . . . 72.14 110.789 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.7 p -47.39 120.55 3.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.765 1.226 . . . . 74.4 112.98 -171.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.52 -71.78 0.32 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.723 -1.126 . . . . 75.32 111.196 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 57.1 ttp 62.75 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.717 1.207 . . . . 74.21 111.305 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -85.92 93.43 8.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.218 -0.66 . . . . 74.21 109.218 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.461 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.9 t80 -118.97 123.56 44.87 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.983 -1.008 . . . . 73.41 108.392 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -137.84 140.96 40.76 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.707 0.403 . . . . 72.44 110.068 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.566 HD13 HG13 ' C' ' 16' ' ' ILE . 5.6 tp -85.27 136.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.128 0.571 . . . . 75.33 109.854 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.525 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.7 mm-40 -109.55 -50.64 2.96 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.615 -0.721 . . . . 74.14 109.74 174.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -169.02 138.65 2.18 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.655 -0.702 . . . . 73.51 109.41 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.566 HG13 HD13 ' C' ' 13' ' ' ILE . 88.4 mt -122.39 144.57 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.6 -1.259 . . . . 73.44 107.6 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -174.24 165.26 4.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.364 0.602 . . . . 75.21 110.612 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.04 107.35 17.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.997 -1.001 . . . . 73.34 109.802 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.585 ' HZ1' ' HB2' ' D' ' 28' ' ' ALA . 23.6 mmmt -65.86 -35.03 79.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.761 -0.654 . . . . 74.44 109.877 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -150.53 144.4 25.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.98 -1.009 . . . . 74.24 109.549 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.3 mt -139.28 140.45 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.64 -1.615 . . . . 74.25 106.64 172.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.43 147.6 17.56 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.799 -0.445 . . . . 74.31 109.799 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -147.32 116.67 6.98 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.192 -1.04 . . . . 72.54 108.192 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.94 120.44 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.77 0.828 . . . . 74.53 108.99 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.2 85.58 54.96 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 74.2 108.583 176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.12 -32.58 33.82 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.725 2.284 . . . . 75.32 111.595 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 73.6 m-20 -114.56 38.4 3.11 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.023 0.929 . . . . 70.25 109.422 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.464 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -58.83 -50.98 85.09 Favored Pre-proline 0 CA--C 1.569 1.682 0 N-CA-C 114.333 1.234 . . . . 64.21 114.333 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 7.2 Cg_exo -73.6 -28.59 11.7 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 121.871 1.714 . . . . 74.44 111.554 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.404 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 80.5 t60 -68.0 -20.67 65.04 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.33 1.052 . . . . 72.24 112.583 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -62.07 -16.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 118.117 0.417 . . . . 75.43 111.827 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.43 -43.53 76.93 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.492 -0.558 . . . . 71.33 109.492 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -92.07 51.24 1.77 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.62 1.168 . . . . 75.12 109.379 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.01 148.11 47.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.099 0.56 . . . . 74.45 110.997 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.47 129.28 37.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.19 -1.041 . . . . 72.45 108.19 164.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -83.93 69.5 10.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.799 0.809 . . . . 74.44 110.738 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.63 73.19 13.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.103 1.361 . . . . 72.43 107.46 165.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.59 118.87 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.215 1.943 . . . . 64.24 111.419 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.52 116.11 22.95 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.388 -0.968 . . . . 71.15 108.388 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.44 101.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 114.743 -1.117 . . . . 72.05 108.827 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.45 103.9 16.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 74.31 108.258 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.26 133.15 33.71 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.187 -0.671 . . . . 72.22 109.187 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.5 t70 -119.63 143.64 47.57 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.763 1.225 . . . . 73.51 108.148 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.22 148.94 49.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.668 0.787 . . . . 74.21 109.173 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -156.18 150.79 25.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.657 0.783 . . . . 62.33 109.034 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -133.88 146.59 50.71 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.849 0.46 . . . . 70.04 110.236 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.99 144.8 30.34 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.5 -0.926 . . . . 74.13 108.5 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.3 p -126.99 147.04 50.13 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.156 0.583 . . . . 70.21 110.172 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -147.14 127.81 14.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.068 0.947 . . . . 74.43 108.941 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -81.41 117.62 22.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.232 -0.655 . . . . 75.23 109.232 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.633 HD12 ' HB2' ' C' ' 57' ' ' GLU . 23.8 mt -87.94 -40.63 13.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.566 0.747 . . . . 74.15 109.974 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.37 -177.42 5.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.806 -1.088 . . . . 74.24 110.282 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.83 109.43 1.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.512 -1.222 . . . . 71.24 110.11 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 70.22 7.67 6.32 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.165 1.386 . . . . 70.24 112.895 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 70.4 t -110.32 105.74 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.352 0.661 . . . . 73.35 109.593 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.99 129.06 56.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.195 0.998 . . . . 74.33 109.989 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.633 ' HB2' HD12 ' C' ' 51' ' ' LEU . 44.9 tt0 -85.61 143.78 28.25 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.157 -0.683 . . . . 72.45 109.157 165.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 5.0 p -132.07 134.95 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.094 -1.076 . . . . 74.41 108.094 169.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.74 105.92 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.352 -0.981 . . . . 75.15 108.352 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.97 108.01 19.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.756 -1.201 . . . . 72.33 107.756 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -79.05 123.48 27.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.21 1.004 . . . . 64.14 109.136 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.88 122.33 68.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.843 -1.169 . . . . 70.02 107.843 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 19.7 m -125.62 123.87 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.601 HG23 HG21 ' C' ' 114' ' ' ILE . 97.4 t -105.0 123.6 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.516 0.726 . . . . 71.12 109.107 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -113.96 115.0 26.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.701 -0.852 . . . . 73.33 108.701 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.785 -1.561 . . . . 70.32 106.785 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -154.71 -178.11 6.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.498 0.555 . . . . 74.23 112.498 -166.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -134.3 29.99 3.6 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.198 1.399 . . . . 73.4 107.784 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.35 -108.14 1.31 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.02 -0.991 . . . . 61.32 110.972 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.34 -31.39 18.94 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.598 -0.89 . . . . 72.41 108.598 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.95 91.79 0.21 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.743 1.217 . . . . 71.3 109.839 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.3 m -89.71 128.19 36.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.417 -0.811 . . . . 73.52 111.063 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 -58.45 3.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.058 -1.09 . . . . 71.31 108.058 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.33 144.59 22.07 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.051 -0.977 . . . . 73.54 110.747 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.43 HD12 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -105.04 145.75 30.03 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.662 -1.607 . . . . 72.15 106.662 163.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.43 ' N ' HD12 ' C' ' 75' ' ' LEU . 42.2 t -150.42 143.23 24.66 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.182 -0.673 . . . . 72.11 109.182 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.09 131.9 17.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 71.45 109.95 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.86 123.52 62.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.684 -0.858 . . . . 75.44 108.684 168.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -97.84 104.33 16.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.037 -1.097 . . . . 75.42 108.037 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.462 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 7.9 tp-100 -91.98 114.47 27.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.17 0.588 . . . . 73.24 109.64 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.72 146.69 17.23 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.918 -0.473 . . . . 62.53 111.918 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.45 123.36 2.15 Favored Glycine 0 CA--C 1.505 -0.554 0 N-CA-C 111.302 -0.719 . . . . 72.04 111.302 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 7.1 mm -83.49 122.92 38.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.424 -0.954 . . . . 73.23 108.424 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -134.75 125.22 26.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.799 0.839 . . . . 73.22 109.633 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -80.48 109.47 15.02 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.35 -0.611 . . . . 61.33 109.35 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 60.3 mt -114.99 120.63 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.838 0.855 . . . . 71.44 109.567 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.66 163.17 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.367 1.067 . . . . 75.14 109.847 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.27 -36.41 3.42 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.283 -0.417 . . . . 73.13 112.385 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -112.75 141.23 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.647 1.179 . . . . 72.24 109.631 -173.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.95 156.39 42.2 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.615 0.766 . . . . 64.34 110.33 -175.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 -141.63 20.43 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.167 -0.47 . . . . 62.3 113.379 172.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -64.77 -28.66 69.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.805 0.842 . . . . 74.31 111.503 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.93 -46.39 89.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.871 0.868 . . . . 73.21 109.997 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.53 -35.24 75.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.985 -1.007 . . . . 73.0 110.259 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.16 -27.33 67.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.536 0.734 . . . . 72.3 111.654 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.29 -57.58 8.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.198 0.599 . . . . 74.54 110.439 171.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.0 -41.57 98.21 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.822 0.701 . . . . 75.01 111.195 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp -76.79 -27.18 55.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.413 1.085 . . . . 72.33 110.997 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.19 -5.32 46.7 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-O 119.378 -0.679 . . . . 71.14 114.325 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.505 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -135.32 -56.68 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.706 0.753 . . . . 64.34 111.59 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -68.98 -54.13 16.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.973 0.36 . . . . 72.54 111.973 -173.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.461 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 21.7 m -59.83 -46.29 98.33 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.673 -0.68 . . . . 73.23 111.317 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 56.6 Cg_exo -50.21 -39.53 52.12 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.106 2.538 . . . . 74.51 114.714 167.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.49 -23.9 61.89 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.296 0.638 . . . . 74.41 112.183 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.455 HD13 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -75.4 -33.17 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 109.596 -0.52 . . . . 75.03 109.596 172.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.509 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.7 mt -82.61 -28.36 30.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.152 0.981 . . . . 74.54 112.56 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.04 -46.16 99.89 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.535 -1.222 . . . . 73.24 113.586 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.513 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 73.9 Cg_exo -54.36 -41.63 74.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.236 1.957 . . . . 74.35 113.609 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.98 -46.31 68.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.523 0.729 . . . . 74.21 110.571 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -61.13 -40.64 94.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.512 -0.767 . . . . 72.12 111.17 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -62.26 -51.97 65.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.2 -1.364 . . . . 75.24 110.728 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.62 -31.29 70.35 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 123.607 0.567 . . . . 74.12 110.175 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.418 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.5 t -71.29 -29.88 65.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.886 0.474 . . . . 73.41 110.963 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.601 HG21 HG23 ' C' ' 64' ' ' VAL . 88.0 mt -74.32 -50.54 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.464 -0.569 . . . . 72.31 109.464 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -56.69 -33.69 66.69 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.17 0.988 . . . . 72.3 111.112 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -51.43 55.58 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.648 -1.16 . . . . 74.31 109.674 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.22 -33.87 71.51 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.631 0.772 . . . . 72.12 112.493 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 84.7 t -67.22 -48.26 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 74.11 109.717 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 70.0 p -70.61 -26.83 63.68 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.343 -0.844 . . . . 73.14 110.654 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -70.78 -34.57 71.92 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.048 -0.978 . . . . 74.23 109.766 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.01 86.89 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.216 -0.769 . . . . 43.43 113.083 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.412 HG22 ' HB3' ' D' ' 17' ' ' TYR . 73.2 p 58.04 35.13 24.94 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.88 1.672 . . . . 75.33 111.91 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 30.2 m-85 -97.73 164.46 17.45 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.096 1.358 . . . . 74.1 110.451 -178.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -53.7 142.02 62.83 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 123.528 2.818 . . . . 72.14 113.568 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.7 115.58 3.75 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.427 1.091 . . . . 73.44 110.325 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 63.0 tp -111.57 124.03 51.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.494 1.118 . . . . 74.21 110.446 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -133.88 120.86 20.93 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.835 0.854 . . . . 71.41 109.924 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.65 140.69 29.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.328 0.651 . . . . 71.44 110.845 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 148.88 50.0 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 123.86 0.864 . . . . 63.23 110.092 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.52 145.57 37.89 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.305 2.003 . . . . 74.33 112.194 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.77 110.62 25.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.835 -1.172 . . . . 71.42 107.835 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.522 ' HB3' ' HB1' ' C' ' 135' ' ' ALA . 66.5 m-20 -90.85 58.23 3.77 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.724 0.773 . . . . 74.24 109.861 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -80.97 -46.36 15.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.827 -1.079 . . . . 75.44 108.609 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.505 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 17.2 t70 -71.23 -42.63 68.64 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.393 -0.821 . . . . 72.51 109.796 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' C' ' 132' ' ' ASN . . . -63.88 -24.68 67.83 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.01 -0.996 . . . . 71.0 111.99 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 -33.13 66.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.185 0.594 . . . . 75.21 110.346 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.35 -34.39 67.97 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.869 0.468 . . . . 75.22 111.252 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.9 mtt -79.29 -30.08 42.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.875 0.47 . . . . 75.12 111.661 175.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.28 -44.32 92.06 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.04 0.936 . . . . 65.44 109.835 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.65 -80.61 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 113.952 -1.476 . . . . 72.31 109.221 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 32.2 tp 73.74 -71.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.506 1.523 . . . . 75.15 110.499 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 57.03 89.13 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 62.04 111.28 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -162.38 142.5 9.8 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.788 . . . . 73.12 109.174 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.79 95.27 3.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 106.901 -1.518 . . . . 75.23 106.901 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.61 -42.81 11.8 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.396 0.678 . . . . 72.15 110.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.03 179.07 29.93 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.451 -0.795 . . . . 62.55 112.458 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.52 -62.95 1.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.48 1.112 . . . . 70.34 111.355 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.69 67.58 1.91 Allowed Glycine 0 C--N 1.351 1.382 0 O-C-N 123.433 0.458 . . . . 71.45 113.75 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.5 t -146.06 155.94 43.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.932 0.493 . . . . 74.41 110.834 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -106.67 108.17 19.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.949 0.9 . . . . 61.12 109.342 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.45 -38.52 91.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.338 1.055 . . . . 74.42 111.114 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -59.37 -30.89 68.74 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.375 -0.83 . . . . 74.03 111.172 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.48 ' NE2' ' SD ' ' C' ' 1' ' ' MET . 7.6 tt0 -73.66 102.78 4.03 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.997 -0.547 . . . . 74.25 109.707 173.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.49 -13.83 56.03 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.084 0.954 . . . . 62.41 110.725 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 123.775 0.83 . . . . 74.42 110.829 -178.78 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 108.992 -0.744 . . . . 74.4 108.992 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t 55.67 78.28 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.106 0.963 . . . . 73.4 110.221 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.76 -25.24 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.753 -0.658 . . . . 71.41 111.005 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -63.44 88.41 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.706 0.802 . . . . 74.24 110.291 -176.172 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -160.38 3.9 0.07 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.375 1.07 . . . . 71.2 109.448 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -125.96 161.04 28.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.974 0.91 . . . . 75.01 111.123 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -96.77 8.77 43.54 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.547 0.739 . . . . 73.12 110.333 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.59 -6.97 49.94 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.978 0.911 . . . . 65.22 111.211 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp -28.25 125.3 0.1 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.221 1.808 . . . . 70.12 114.513 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.435 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 30.4 m -119.97 142.05 49.11 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.794 0.837 . . . . 72.24 108.919 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' D' ' 85' ' ' SER . 83.2 t80 -150.35 108.8 3.79 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.558 -0.904 . . . . 73.21 108.558 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.41 131.52 51.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.781 0.833 . . . . 75.14 109.995 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.74 104.79 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.843 -1.169 . . . . 72.4 107.843 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -79.39 -47.65 15.38 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.98 0.733 . . . . 71.21 112.98 -170.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -159.2 121.16 3.43 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.369 -0.234 . . . . 72.22 110.369 -165.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.9 mp -105.47 129.34 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.459 -1.312 . . . . 71.42 107.459 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG22 ' C' ' 122' ' ' THR . 38.7 p90 -165.87 178.09 6.73 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-O 121.876 0.846 . . . . 70.44 112.153 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.8 p -107.82 125.58 51.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.536 -1.211 . . . . 75.53 109.488 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.445 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 28.5 mtpt -97.87 -22.3 16.43 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.608 -0.516 . . . . 65.51 109.608 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.687 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -152.03 131.63 13.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.78 -1.1 . . . . 75.24 108.835 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG23 ' HE1' ' C' ' 117' ' ' MET . 84.2 mt -134.89 142.69 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.53 -1.285 . . . . 75.32 107.53 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 24.2 t -146.77 139.27 24.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.102 0.961 . . . . 72.31 108.45 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.43 116.89 5.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.187 -1.783 . . . . 62.51 106.187 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.609 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.3 mt-10 -121.26 140.28 52.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.065 0.546 . . . . 75.22 109.602 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.97 78.89 10.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.377 -0.972 . . . . 73.24 108.377 176.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.67 -32.31 6.04 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.37 2.047 . . . . 64.54 111.546 175.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 17.6 m-20 -100.71 31.15 3.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.525 1.13 . . . . 73.54 108.839 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.585 ' HB2' ' HZ1' ' C' ' 19' ' ' LYS . . . -59.6 -47.63 97.27 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 115.023 1.49 . . . . 64.05 115.023 -169.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.482 ' HB3' HD11 ' C' ' 83' ' ' ILE . 33.8 Cg_endo -88.87 -3.99 6.24 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.637 1.558 . . . . 75.12 112.591 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.424 ' HA ' HE21 ' D' ' 33' ' ' GLN . 21.0 t-160 -77.2 -40.95 43.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.326 1.05 . . . . 73.13 109.491 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.643 HG21 ' HA ' ' D' ' 73' ' ' ALA . 61.7 t -79.29 -15.89 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.677 0.791 . . . . 74.24 110.201 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -65.68 -25.99 67.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.596 0.758 . . . . 74.42 110.888 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.424 HE21 ' HA ' ' D' ' 30' ' ' HIS . 45.5 mt-30 -73.62 -17.96 61.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.396 0.678 . . . . 74.45 111.334 174.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -105.73 106.41 16.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.704 0.802 . . . . 72.41 109.452 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.96 51.37 2.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.792 0.837 . . . . 72.24 110.317 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -131.64 162.55 30.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.444 0.697 . . . . 75.14 109.622 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.33 110.51 29.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.302 1.041 . . . . 74.1 109.33 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.457 ' HA ' HD12 ' D' ' 68' ' ' LEU . 90.5 Cg_exo -49.21 150.98 6.78 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 124.132 3.221 . . . . 73.25 115.117 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -75.55 132.75 40.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.977 -0.749 . . . . 74.32 108.977 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.4 124.99 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.275 0.559 . . . . 75.12 110.633 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -110.49 110.71 21.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.019 -1.845 . . . . 73.35 106.019 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.9 tp -96.14 137.4 35.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.112 0.482 . . . . 74.55 110.448 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.581 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.4 m-20 -129.63 141.25 50.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.746 1.218 . . . . 75.31 108.1 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.67 147.55 44.97 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.095 -0.705 . . . . 75.51 109.095 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -154.1 145.97 23.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.351 -0.981 . . . . 72.45 108.351 -178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.9 t -114.28 164.87 13.32 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.092 0.557 . . . . 73.21 109.56 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.37 147.98 22.72 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.509 0.724 . . . . 63.32 109.424 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.7 p -135.12 151.98 51.21 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.056 -0.72 . . . . 71.23 109.056 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -157.1 117.1 3.48 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.18 -1.044 . . . . 71.42 108.18 -175.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -72.61 124.96 26.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.364 -0.606 . . . . 72.23 109.364 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.83 -40.69 12.28 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.69 -0.485 . . . . 72.21 109.69 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.64 4.32 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.183 -0.917 . . . . 62.42 110.327 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.34 116.97 4.66 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.21 -0.905 . . . . 72.14 110.177 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.0 2.96 4.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.391 1.476 . . . . 73.04 113.089 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.67 116.84 52.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.42 -0.956 . . . . 75.51 108.42 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.483 ' HB2' HD12 ' D' ' 86' ' ' ILE . 50.5 m-85 -129.08 127.47 41.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.628 -1.249 . . . . 75.21 107.628 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -96.13 137.23 35.5 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.035 0.934 . . . . 74.51 108.655 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.62 126.23 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.687 -1.227 . . . . 73.21 107.687 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.1 t -102.48 135.42 39.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.007 -0.738 . . . . 72.33 109.007 173.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -112.47 121.45 44.87 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.786 -0.82 . . . . 74.44 108.786 175.512 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -97.72 115.8 28.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.901 -0.777 . . . . 75.41 108.901 174.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.87 123.06 70.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.013 -1.106 . . . . 74.21 108.013 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.581 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -126.65 133.37 50.99 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.384 0.611 . . . . 62.42 110.088 -172.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 76.7 t -126.44 103.7 11.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.973 1.309 . . . . 73.33 109.118 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -97.53 93.17 6.29 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.069 -1.085 . . . . 55.43 108.069 172.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.86 133.99 41.61 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.198 -0.667 . . . . 55.34 109.198 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 59.2 p -140.78 131.7 26.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.802 0.841 . . . . 61.33 109.254 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' D' ' 38' ' ' PRO . 9.5 tp -107.12 107.63 18.7 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 75.11 108.474 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.72 -121.99 5.67 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.479 -0.782 . . . . 60.34 112.805 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.59 4.99 50.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.041 0.936 . . . . 73.34 110.981 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.36 147.21 35.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.697 0.399 . . . . 73.13 110.347 -163.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' THR . . . . . 0.456 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 99.7 m -58.48 141.53 51.47 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.785 0.834 . . . . 70.22 111.56 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.643 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -100.47 -68.14 0.82 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.602 1.161 . . . . 73.32 109.519 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.84 139.0 19.22 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.843 -0.617 . . . . 75.11 109.491 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.1 mt -101.06 152.81 20.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.95 -0.759 . . . . 75.13 108.95 173.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.649 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.5 t -159.26 143.4 15.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.826 0.45 . . . . 71.04 110.279 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -155.94 121.88 5.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.007 0.523 . . . . 74.03 109.667 171.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.03 114.86 43.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.326 0.651 . . . . 74.22 109.898 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.687 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -90.24 89.63 7.72 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.026 -0.731 . . . . 75.01 109.026 167.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.17 95.83 5.71 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.531 -1.213 . . . . 75.15 108.46 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 140.95 18.02 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.684 -0.566 . . . . 74.55 111.684 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -137.03 129.45 4.77 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.241 -1.144 . . . . 72.11 110.241 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.92 128.42 41.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.438 -0.949 . . . . 74.35 108.438 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.19 161.57 28.99 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.074 0.55 . . . . 74.44 110.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 32.8 m -116.42 108.89 16.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.984 0.914 . . . . 75.31 109.35 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.523 HG12 HD13 ' D' ' 98' ' ' LEU . 3.3 mp -109.57 119.4 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.399 0.68 . . . . 70.42 109.415 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.435 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -142.97 155.64 44.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.409 1.083 . . . . 54.33 109.226 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 -13.07 5.73 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 114.323 0.489 . . . . 70.33 114.323 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.514 ' HA ' ' HG2' ' D' ' 4' ' ' GLN . 5.5 tt -134.9 137.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.313 1.445 . . . . 72.12 107.822 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -161.56 175.15 12.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.794 0.837 . . . . 62.45 110.012 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.6 -133.38 13.04 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.255 0.347 . . . . 64.2 113.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -71.41 -38.07 71.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.149 0.979 . . . . 74.02 112.137 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.45 -32.74 70.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.149 0.579 . . . . 72.41 110.029 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.485 ' HG3' HG23 ' D' ' 86' ' ' ILE . 59.2 ttp -69.21 -37.72 78.22 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.689 -0.687 . . . . 73.24 110.363 174.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.79 70.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.095 0.558 . . . . 71.4 111.25 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.582 ' HA ' ' HE1' ' D' ' 137' ' ' PHE . 42.2 t-80 -71.56 -37.67 71.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.338 0.655 . . . . 63.01 110.744 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.56 -50.19 47.18 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.927 0.491 . . . . 74.14 111.203 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.523 HD13 HG12 ' D' ' 86' ' ' ILE . 9.9 mp -75.8 -25.11 56.07 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.802 0.841 . . . . 71.15 111.573 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.38 66.43 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 119.592 -0.56 . . . . 71.13 113.511 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.14 -66.43 0.52 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.474 0.546 . . . . 63.42 112.474 -174.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -62.19 -46.08 90.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.335 0.654 . . . . 75.21 112.425 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -67.11 -44.27 48.84 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-O 118.672 -0.68 . . . . 73.23 112.316 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.528 ' HB2' ' HZ ' ' D' ' 133' ' ' PHE . 77.0 Cg_exo -54.4 -32.29 71.99 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.418 2.079 . . . . 71.31 114.482 166.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -64.51 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.28 0.491 . . . . 74.02 111.741 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -67.8 -42.91 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 121.436 0.636 . . . . 75.33 110.019 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.467 HD22 ' HA3' ' D' ' 82' ' ' GLY . 97.2 mt -77.01 -27.64 54.72 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.834 -1.076 . . . . 73.11 112.725 -171.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.74 -45.89 88.14 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.891 1.071 . . . . 65.12 113.891 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -34.76 98.3 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.714 1.609 . . . . 73.41 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.88 -34.47 51.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 75.21 111.485 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.25 -46.82 69.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.279 0.632 . . . . 71.14 110.841 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -69.86 -33.47 72.3 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.215 -0.902 . . . . 73.24 110.669 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -66.32 -42.4 88.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.305 1.003 . . . . 75.24 111.005 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -59.69 -40.04 86.56 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.739 0.65 . . . . 71.33 110.139 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.649 HG12 ' SG ' ' D' ' 76' ' ' CYS . 53.7 mt -63.29 -50.39 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.051 0.845 . . . . 72.54 110.548 173.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 50.0 m -56.43 -44.62 80.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.129 0.972 . . . . 74.43 111.464 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.8 t -65.16 -44.95 86.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 114.68 -1.145 . . . . 74.25 110.429 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.17 -31.2 72.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.737 0.415 . . . . 75.3 112.074 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.8 t -70.49 -41.91 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.818 0.698 . . . . 73.34 110.483 176.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -73.38 -24.45 60.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.669 0.271 . . . . 72.33 110.97 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.418 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 92.2 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.602 0.761 . . . . 74.31 109.582 172.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.3 -3.66 88.65 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.766 0.666 . . . . 75.24 112.399 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.4 p 58.32 30.92 20.24 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.426 1.89 . . . . 71.02 112.208 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -95.03 169.38 9.51 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.714 1.606 . . . . 73.1 110.099 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.75 130.99 43.36 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.115 2.543 . . . . 71.24 112.625 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.27 147.49 16.65 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.251 1.02 . . . . 75.2 112.255 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -135.4 95.81 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.083 0.468 . . . . 73.23 110.499 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -100.97 114.41 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.914 -1.143 . . . . 72.15 107.914 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 98.7 mt -75.94 134.71 40.14 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.773 0.321 . . . . 71.52 110.514 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.59 142.03 91.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 65.14 111.078 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.3 131.24 27.66 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.41 2.073 . . . . 74.43 111.077 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.15 127.02 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.803 0.841 . . . . 72.32 110.219 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.55 77.97 9.75 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.919 . . . . 74.23 109.18 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.528 ' HZ ' ' HB2' ' D' ' 103' ' ' PRO . 45.2 p90 -67.45 -18.22 65.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.81 -1.086 . . . . 75.34 111.05 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' D' ' 138' ' ' MET . 24.0 t0 -59.74 -39.38 84.56 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.705 0.802 . . . . 71.45 111.763 176.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.406 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -57.97 -31.83 67.27 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.835 0.35 . . . . 73.03 111.804 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.96 -37.25 24.35 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.111 0.964 . . . . 74.32 109.201 176.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.582 ' HE1' ' HA ' ' D' ' 96' ' ' HIS . 76.6 t80 -62.9 -32.55 73.84 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.517 1.127 . . . . 75.42 111.266 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 45.8 mtt -59.34 -44.66 92.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.293 0.637 . . . . 74.04 110.205 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -60.78 -38.73 86.28 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.024 0.93 . . . . 75.54 111.115 -178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.82 -39.92 93.46 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.407 -0.815 . . . . 72.45 110.663 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.41 -28.88 64.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.789 0.836 . . . . 73.52 111.712 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -80.88 -0.15 37.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.005 0.522 . . . . 75.44 111.819 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -129.85 45.28 2.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.323 0.649 . . . . 73.11 109.585 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.97 156.29 17.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.734 0.814 . . . . 75.31 110.263 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.82 8.18 0.07 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.259 0.624 . . . . 74.31 111.887 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.9 120.63 4.73 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-O 120.091 -0.283 . . . . 64.12 112.523 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.98 132.85 42.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.954 -1.128 . . . . 71.34 107.954 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.02 81.54 1.08 Allowed Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.908 -0.477 . . . . 63.33 111.908 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.5 p -68.24 85.28 0.26 Allowed 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.379 0.609 . . . . 75.34 110.33 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -99.16 123.99 43.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.815 -0.63 . . . . 72.34 109.857 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.29 164.45 17.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.49 0.662 . . . . 75.42 110.328 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -125.73 152.38 45.4 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.522 -1.288 . . . . 75.51 107.522 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.69 95.0 0.47 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.226 -0.657 . . . . 74.32 109.226 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.85 -28.26 68.2 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.989 0.916 . . . . 75.32 110.523 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.306 0 O-C-N 124.687 1.242 . . . . 73.24 112.541 168.132 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.479 -0.563 . . . . 72.33 109.479 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -85.69 68.45 10.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.953 -0.758 . . . . 75.0 108.953 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.55 86.15 6.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.469 -0.937 . . . . 74.31 108.469 177.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -138.21 144.65 40.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.666 -1.152 . . . . 62.24 108.742 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . 0.459 ' HG2' ' H ' ' E' ' 113' ' ' ASP . 10.7 tt0 -144.58 -159.56 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 107.423 -1.325 . . . . 74.21 107.423 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . 0.459 ' H ' ' HG2' ' E' ' 112' ' ' GLN . 1.3 p30 -55.58 -31.3 62.07 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.202 0.601 . . . . 72.22 110.02 163.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' E' ' 116' ' ' TYR . 39.8 ttmt -97.78 137.72 36.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.636 1.174 . . . . 74.15 109.469 170.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.522 HD13 ' H ' ' E' ' 115' ' ' LEU . 0.0 OUTLIER -87.19 0.2 55.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.612 0.597 . . . . 74.13 112.612 -177.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . 0.467 ' H ' ' HG2' ' E' ' 114' ' ' LYS . 14.2 t80 -77.24 110.53 12.57 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 123.645 0.778 . . . . 75.1 109.505 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' E' ' 116' ' ' TYR . 3.9 Cg_endo -88.39 -66.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.849 3.033 . . . . 75.14 113.501 -169.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -157.82 138.33 12.85 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.826 0.85 . . . . 70.33 109.541 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 17.1 m -105.23 130.47 53.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.78 -0.822 . . . . 75.13 108.78 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.437 ' CD1' HG22 ' B' ' 46' ' ' THR . 1.2 p-90 -70.26 88.04 0.62 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.442 0.639 . . . . 74.44 112.394 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -72.46 -18.38 61.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.088 0.955 . . . . 73.03 111.086 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.8 5.67 3.88 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.973 0.909 . . . . 62.15 112.628 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . 0.466 HG12 ' H ' ' B' ' 46' ' ' THR . 7.3 p -54.23 131.44 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 C-N-CA 124.398 1.079 . . . . 74.43 111.476 172.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -153.97 -64.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.62 0.768 . . . . 72.24 108.982 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . 0.521 ' HB3' HD13 ' B' ' 44' ' ' LEU . 60.9 t80 54.85 92.59 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.58 1.152 . . . . 71.31 110.728 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -93.0 151.41 19.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.016 0.526 . . . . 72.54 110.408 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.79 168.1 18.26 Favored Glycine 0 C--O 1.244 0.744 0 CA-C-N 115.228 -0.896 . . . . 62.52 111.16 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -121.34 145.5 47.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.359 0.664 . . . . 65.22 110.422 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.28 178.4 6.87 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.598 -0.728 . . . . 73.31 109.613 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp 62.59 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 124.429 1.092 . . . . 74.43 109.01 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.78 -32.36 52.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.328 -0.851 . . . . 73.43 111.13 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -143.2 98.25 5.57 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.356 0.662 . . . . 74.31 110.632 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.46 43.94 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.233 2.622 . . . . 72.43 111.852 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.71 -25.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-N 115.333 -0.848 . . . . 71.32 112.427 -174.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.78 -143.07 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.975 -1.121 . . . . 75.01 107.975 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.588 HG22 ' H ' ' E' ' 137' ' ' GLU 0.308 30.8 m 52.56 -100.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 C-N-CA 125.486 1.515 . . . . 74.12 113.088 175.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . 0.588 ' H ' HG22 ' E' ' 136' ' ' VAL . 46.7 mt-10 56.5 -79.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.912 1.233 . . . . 65.53 113.413 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.67 34.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.176 0.99 . . . . 73.31 110.111 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.97 113.17 23.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.445 0.698 . . . . 75.31 109.627 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 22.5 m -83.98 -52.49 6.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.108 0.563 . . . . 71.3 110.853 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.95 87.47 5.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.419 -0.585 . . . . 73.14 109.419 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.53 140.67 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.612 0.765 . . . . 74.12 108.944 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 65.49 179.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.173 0.989 . . . . 70.44 111.202 -171.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.93 -68.56 0.64 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.782 -0.821 . . . . 75.33 108.782 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -163.74 -60.84 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.152 -1.425 . . . . 72.32 107.152 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . 0.478 ' HB3' ' HD2' ' E' ' 149' ' ' PRO . 22.6 m-20 -84.41 164.75 18.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.514 -0.767 . . . . 64.42 110.365 172.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 72.4 mt -95.21 -60.62 1.64 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.861 . . . . 72.13 110.181 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' C' ' 132' ' ' ASN . 37.7 tp -93.32 -50.21 0.27 Allowed Pre-proline 0 CA--C 1.562 1.43 0 CA-C-O 117.838 -1.077 . . . . 74.12 111.718 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' E' ' 146' ' ' ASP . 31.3 Cg_exo . . . . . 0 C--N 1.399 3.196 0 C-N-CA 122.218 1.945 . . . . 51.33 112.307 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.656 -0.127 . . . . 74.13 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 78.57 -34.86 0.17 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.855 1.662 . . . . 75.35 114.264 167.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.72 78.84 4.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.525 0.679 . . . . 71.01 109.255 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -91.78 -53.94 4.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.307 -0.861 . . . . 64.44 109.815 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . 0.505 HE22 ' HG3' ' F' ' 114' ' ' LYS . 0.0 OUTLIER -82.37 -64.89 1.09 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.168 -0.924 . . . . 73.22 109.938 -170.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 63.56 82.68 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.642 1.177 . . . . 74.2 112.264 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.505 ' HG3' HE22 ' F' ' 112' ' ' GLN . 49.3 mtmt -148.29 143.33 26.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 71.02 109.321 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.429 HD11 HG13 ' A' ' 86' ' ' ILE . 18.1 mt -84.79 77.84 10.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.788 -0.819 . . . . 75.13 108.788 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -133.69 126.12 18.81 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.616 -0.72 . . . . 74.31 109.71 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 95' ' ' ALA . 97.1 Cg_endo -73.33 147.98 42.69 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.685 2.256 . . . . 63.44 111.879 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -77.78 150.81 34.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.739 -0.467 . . . . 65.43 109.739 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 6.7 p -64.8 109.37 2.04 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.845 0.858 . . . . 65.14 110.811 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -128.18 150.09 50.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.994 -1.113 . . . . 74.45 107.994 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -147.87 -77.75 0.16 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.032 -0.729 . . . . 60.41 109.032 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . 58.18 -78.58 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.593 1.157 . . . . 72.43 111.605 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t 63.78 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.37 1.468 . . . . 72.51 111.93 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -111.15 -72.95 0.7 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.559 0.744 . . . . 75.14 109.009 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 56.6 -133.63 1.38 Allowed 'General case' 0 CA--C 1.554 1.117 0 O-C-N 124.228 0.955 . . . . 65.41 111.135 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 63.2 t30 72.47 142.09 0.06 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.668 1.187 . . . . 63.31 112.192 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.58 -162.68 27.32 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.223 -0.751 . . . . 44.52 111.223 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.99 130.09 35.1 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.704 0.402 . . . . 74.3 110.762 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.96 -118.55 0.13 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.076 0.95 . . . . 75.24 108.801 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 3.7 mp -82.1 91.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 N-CA-C 107.195 -1.409 . . . . 70.24 107.195 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.86 -16.09 62.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.255 0.622 . . . . 70.22 111.764 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -142.47 97.44 6.11 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 123.469 0.707 . . . . 75.35 109.61 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -86.78 174.57 5.56 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.533 2.155 . . . . 73.42 112.29 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.27 -32.5 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.179 0.592 . . . . 74.24 109.981 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 56.38 24.84 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.006 1.322 . . . . 73.42 113.868 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.99 158.31 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.391 0.676 . . . . 73.44 111.383 -172.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -102.34 -75.88 0.59 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.252 0.621 . . . . 74.31 110.821 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -153.82 168.97 24.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.708 0.803 . . . . 73.52 111.003 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.91 101.36 1.35 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.183 0.593 . . . . 75.11 110.07 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 18.0 m -67.99 -32.6 73.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.484 -0.78 . . . . 64.32 109.851 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 64.5 mt -78.73 120.19 23.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.892 -0.595 . . . . 71.43 109.49 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.435 HG13 ' H ' ' F' ' 143' ' ' TYR . 9.5 tp -147.92 177.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 N-CA-C 108.257 -1.016 . . . . 75.4 108.257 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . 0.435 ' H ' HG13 ' F' ' 142' ' ' ILE . 9.8 p90 -67.48 77.84 0.17 Allowed 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.898 0.856 . . . . 72.22 111.406 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -100.72 98.07 8.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.017 0.927 . . . . 71.44 109.158 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . 0.638 ' HZ3' ' HB3' ' F' ' 145' ' ' LYS . 0.4 OUTLIER -179.96 -41.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.321 1.448 . . . . 74.53 109.038 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -159.66 110.8 1.99 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.605 1.162 . . . . 74.34 108.618 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . 0.496 ' HB3' ' HD3' ' F' ' 149' ' ' PRO . 3.1 tt -90.33 -49.44 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.291 -1.003 . . . . 74.13 108.291 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 tt 58.17 64.3 3.83 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 124.469 1.108 . . . . 74.45 110.501 -172.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' F' ' 147' ' ' LEU . 51.0 Cg_exo . . . . . 0 C--N 1.384 2.44 0 C-N-CA 122.203 1.935 . . . . 74.31 112.581 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.708 -0.478 . . . . 70.33 109.708 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -83.72 -173.53 4.77 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.217 1.007 . . . . 74.23 110.319 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 79.66 -43.84 0.29 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 125.474 1.509 . . . . 71.22 111.946 174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.09 93.92 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.835 0.854 . . . . 74.31 111.084 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -89.53 2.7 54.26 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.693 0.797 . . . . 65.44 111.49 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.27 150.89 19.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.633 0.773 . . . . 71.25 109.093 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -67.39 111.19 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.069 0.548 . . . . 72.43 111.018 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.54 159.03 16.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.422 -0.808 . . . . 74.44 110.535 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.436 ' HG2' ' HA3' ' A' ' 88' ' ' GLY . 56.1 mtm -71.67 150.52 44.5 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.254 -0.647 . . . . 74.54 109.254 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.8 m -141.23 132.38 26.37 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.875 -0.787 . . . . 70.24 108.875 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -135.83 120.43 18.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.877 -1.157 . . . . 75.14 107.877 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 78.8 mt-30 -132.16 108.6 9.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.415 0.686 . . . . 72.4 109.347 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 pt -83.73 86.96 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.322 -0.992 . . . . 73.42 108.322 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -72.88 -39.53 66.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.946 -0.57 . . . . 62.34 111.496 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -172.07 146.78 2.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.317 -0.623 . . . . 73.44 109.317 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.433 HD13 ' HG2' ' C' ' 130' ' ' PRO . 94.7 mt -137.1 100.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.174 0.59 . . . . 74.42 109.433 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 26.6 m-85 -159.67 160.66 34.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.483 1.113 . . . . 74.23 110.701 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.472 HG22 ' SG ' ' A' ' 113' ' ' CYS . 30.5 p -71.64 129.18 38.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.445 -1.252 . . . . 74.14 111.117 -167.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -84.43 -38.67 19.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.416 0.627 . . . . 74.25 109.583 169.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.6 t70 -139.9 137.66 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.968 -1.014 . . . . 72.11 109.442 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.438 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 70.1 mt -132.65 146.1 33.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.077 1.351 . . . . 74.33 107.515 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.65 140.24 17.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.961 -0.755 . . . . 70.24 108.961 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 88.9 t80 -142.71 123.47 14.23 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 106.01 -1.848 . . . . 75.2 106.01 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -118.29 152.05 36.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.407 -0.96 . . . . 72.12 108.407 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.3 74.33 14.11 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.881 -1.526 . . . . 64.22 106.881 168.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.98 -20.71 25.22 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.556 2.171 . . . . 73.23 111.842 -172.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.445 ' O ' HG22 ' A' ' 31' ' ' VAL . 89.1 m-20 -118.46 29.93 7.49 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.425 1.09 . . . . 51.11 109.661 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.479 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -55.17 -49.47 92.09 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 113.182 0.808 . . . . 64.31 113.182 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 31.9 Cg_exo -61.99 -27.05 79.16 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.007 1.805 . . . . 72.43 113.373 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -73.41 -38.32 65.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.943 0.497 . . . . 74.01 110.502 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 27' ' ' ASN . 60.1 t -66.78 -34.44 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.524 0.73 . . . . 74.42 110.416 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -56.47 -31.09 63.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.39 1.076 . . . . 75.24 111.361 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -91.22 -45.56 8.57 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.456 1.102 . . . . 74.45 110.714 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.58 165.61 20.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.354 0.662 . . . . 74.23 112.193 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.15 126.19 28.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.845 -1.071 . . . . 54.44 110.894 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.17 82.28 7.13 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.576 -0.738 . . . . 65.34 110.21 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -142.88 79.12 14.99 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.039 -1.097 . . . . 72.53 108.039 171.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -86.65 144.07 7.49 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.616 2.211 . . . . 73.41 112.736 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -98.03 126.0 43.26 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.384 1.074 . . . . 75.14 108.151 175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.58 130.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.226 0.536 . . . . 64.1 110.749 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.535 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 63.1 tttm -119.62 112.32 19.16 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.079 -1.452 . . . . 73.4 107.079 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 mt -115.48 107.74 15.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.638 -0.875 . . . . 73.32 108.638 -167.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.8 m-20 -106.13 109.18 21.03 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 65.44 109.331 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.25 132.58 49.4 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.358 -0.608 . . . . 74.11 109.358 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.46 ' O ' HD22 ' A' ' 60' ' ' LEU . 16.3 t70 -142.55 141.65 32.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.13 0.972 . . . . 73.43 109.04 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.9 m -137.73 140.51 40.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.292 0.637 . . . . 75.25 110.428 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.93 134.73 14.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.599 0.76 . . . . 74.22 110.391 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.565 ' HB3' HG23 ' A' ' 58' ' ' VAL . 68.0 p -111.31 167.72 10.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.117 0.567 . . . . 73.34 110.297 173.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -168.58 119.13 0.76 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.583 -0.525 . . . . 65.44 109.583 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -69.09 108.07 3.43 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.252 0.621 . . . . 73.32 109.936 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.622 HD13 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -77.83 -41.59 36.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.584 0.754 . . . . 75.34 110.488 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -172.87 4.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.915 . . . . 73.12 109.779 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.28 105.18 0.31 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.976 0.51 . . . . 63.12 110.124 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 58.15 22.04 8.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.105 1.362 . . . . 74.04 112.984 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.2 t -108.33 120.82 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.089 -1.449 . . . . 71.35 107.089 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 136.09 41.2 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.813 -1.18 . . . . 75.35 107.813 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.622 ' HB2' HD13 ' A' ' 51' ' ' LEU . 30.4 tt0 -89.13 115.74 26.87 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.94 0.896 . . . . 72.33 108.789 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.565 HG23 ' HB3' ' A' ' 48' ' ' SER . 26.9 t -99.25 110.98 27.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 107.017 -1.475 . . . . 74.12 107.017 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.566 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -99.41 119.66 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.061 0.544 . . . . 73.31 109.671 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.66 112.47 24.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.038 -1.097 . . . . 72.43 108.038 175.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -101.29 106.67 17.88 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.901 0.881 . . . . 73.44 109.443 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.99 114.37 46.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.524 1.13 . . . . 71.04 109.137 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.1 m -102.83 146.51 28.17 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 50.1 t -142.01 107.16 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.716 1.206 . . . . 70.04 108.073 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.535 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.6 m -103.14 135.83 44.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.312 -0.625 . . . . 72.24 109.312 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.59 118.37 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.552 -1.277 . . . . 73.25 107.552 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -124.32 126.2 45.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.281 -0.637 . . . . 73.23 109.281 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.61 62.91 6.05 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.82 0.819 . . . . 75.34 109.134 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.77 -106.85 1.42 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.877 -1.289 . . . . 74.14 109.877 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -115.82 -26.22 7.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.799 0.84 . . . . 74.21 110.336 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.26 132.05 37.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.911 0.484 . . . . 75.22 109.832 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -71.81 110.89 6.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.931 0.892 . . . . 62.54 110.212 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.1 -57.23 13.97 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.064 0.945 . . . . 65.25 109.598 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -161.72 173.23 14.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.013 -1.449 . . . . 72.0 109.631 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.425 HD11 ' H ' ' A' ' 76' ' ' CYS . 47.3 tp -137.62 149.36 46.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.228 1.011 . . . . 70.11 109.752 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.5 m -136.82 139.95 42.11 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 124.652 1.181 . . . . 72.2 108.694 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -150.18 129.3 12.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.483 -0.562 . . . . 72.05 109.483 172.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.86 112.51 13.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.774 0.829 . . . . 74.2 109.393 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.3 mt-30 -85.75 82.5 8.17 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.741 -0.837 . . . . 70.2 108.741 171.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.65 93.58 3.65 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.235 -1.348 . . . . 72.35 109.545 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.17 146.1 20.92 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.195 -0.457 . . . . 61.14 112.056 -177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.537 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.47 122.97 2.51 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.156 -1.178 . . . . 73.31 110.156 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.9 mt -86.08 121.74 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.731 -0.84 . . . . 74.11 108.731 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -128.68 118.97 23.79 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.967 -1.123 . . . . 72.34 107.967 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.624 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 26.7 t -94.92 86.34 4.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.067 -1.086 . . . . 75.51 108.067 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -114.72 143.39 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.232 0.613 . . . . 72.13 110.756 -175.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.65 167.47 23.11 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.172 0.989 . . . . 61.23 110.885 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.436 ' HA3' ' HG2' ' A' ' 9' ' ' MET . . . 92.01 -6.18 79.0 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.256 -0.884 . . . . 72.21 113.66 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.26 146.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.566 0.746 . . . . 71.04 109.779 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 172.2 14.82 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.949 0.499 . . . . 72.43 110.375 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.18 -127.55 40.48 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.264 0.353 . . . . 74.41 113.391 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -74.4 -20.44 60.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.341 0.656 . . . . 75.43 112.015 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.27 -49.69 68.62 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.459 0.704 . . . . 75.35 109.962 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 94' ' ' MET . 9.9 tmm? -75.67 -37.25 59.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.478 -1.237 . . . . 75.44 110.755 -177.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.99 85.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.378 0.609 . . . . 70.5 110.758 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -65.7 -41.8 91.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.075 -0.966 . . . . 74.32 110.419 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.645 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.5 m -74.71 -26.91 60.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.467 0.914 . . . . 71.02 113.467 -173.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.68 -23.36 24.23 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.64 0.376 . . . . 73.14 111.149 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.47 -16.08 21.27 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.526 0.57 . . . . 71.3 114.526 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.9 -64.22 0.58 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.597 0.698 . . . . 63.1 111.636 -172.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 12.5 t80 -48.89 -65.92 0.49 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.577 1.151 . . . . 75.42 113.084 -174.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.31 -44.78 13.61 Favored Pre-proline 0 CA--C 1.559 1.317 0 CA-C-O 118.207 -0.902 . . . . 63.51 113.067 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.56 -31.82 87.43 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.839 1.693 . . . . 72.21 113.849 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -67.92 -34.13 76.03 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.131 0.423 . . . . 63.41 110.45 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.39 -41.23 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.691 0.796 . . . . 63.13 110.238 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.537 HD22 ' HA3' ' A' ' 82' ' ' GLY . 96.9 mt -70.53 -25.51 63.15 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.49 -0.777 . . . . 74.02 112.003 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -67.0 -43.23 46.19 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.675 1.361 . . . . 65.54 114.675 -167.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.4 -36.79 88.58 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.284 1.989 . . . . 72.21 113.596 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -76.07 -39.0 56.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.19 0.596 . . . . 74.34 111.523 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.38 92.4 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.58 0.352 . . . . 62.24 110.25 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.468 ' NH1' HD13 ' C' ' 105' ' ' ILE . 40.6 ttm180 -53.85 -51.81 62.41 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.813 1.32 . . . . 73.31 110.358 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.61 -42.67 99.21 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.086 -0.961 . . . . 75.33 112.022 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.472 ' SG ' HG22 ' A' ' 18' ' ' THR . 45.0 t -68.23 -39.02 82.43 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.654 0.596 . . . . 61.42 111.523 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.548 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 85.0 mt -64.51 -55.2 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.48 0.712 . . . . 72.24 109.626 176.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.503 HG23 ' HG3' ' A' ' 125' ' ' GLN . 64.8 m -58.43 -34.16 70.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.351 1.061 . . . . 73.42 111.792 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -65.28 -44.27 88.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.806 -0.634 . . . . 73.32 110.578 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.548 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 52.2 mtm -63.41 -40.75 98.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.712 0.405 . . . . 74.22 110.869 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 114' ' ' ILE . 97.1 t -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 O-C-N 124.191 0.932 . . . . 70.53 110.622 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -74.47 -31.35 62.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.943 -0.571 . . . . 72.31 111.16 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -69.44 -29.95 67.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.657 0.783 . . . . 65.31 110.042 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -3.66 82.98 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.569 -0.741 . . . . 71.44 112.985 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m 67.47 17.7 10.06 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.507 1.123 . . . . 72.1 110.783 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.54 157.12 37.7 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.911 0.884 . . . . 72.23 110.884 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.64 122.77 11.48 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.999 2.466 . . . . 74.53 112.478 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -53.17 136.52 36.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.951 1.3 . . . . 72.4 112.563 -176.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.7 mt -120.67 99.25 6.43 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.728 -0.841 . . . . 73.01 108.728 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -98.89 125.22 44.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.543 0.737 . . . . 74.11 109.391 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.21 138.26 45.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.806 0.843 . . . . 63.42 110.202 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.82 126.1 92.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.659 -0.497 . . . . 73.51 109.659 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -65.95 103.63 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.406 2.071 . . . . 73.24 112.388 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.1 143.16 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.744 0.818 . . . . 74.21 110.008 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -89.27 85.45 6.61 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.235 1.014 . . . . 74.24 110.606 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -36.5 72.5 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.65 1.18 . . . . 72.43 113.042 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.91 -41.68 70.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.536 0.734 . . . . 74.1 111.334 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.93 -32.14 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.922 0.489 . . . . 74.04 110.1 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -65.62 -35.85 82.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.751 0.82 . . . . 74.35 110.086 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -65.53 -46.14 80.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.818 0.447 . . . . 73.41 109.796 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.408 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 17.2 mmt -60.38 -39.76 88.43 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.523 0.729 . . . . 75.25 110.768 177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -60.53 -52.45 65.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 62.32 111.163 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -74.61 -30.14 61.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.298 0.239 . . . . 74.52 111.514 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.6 -49.15 78.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.38 0.672 . . . . 75.04 110.802 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -167.82 6.18 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.01 0.524 . . . . 70.22 111.181 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 60.47 26.75 16.36 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.959 0.904 . . . . 75.33 110.049 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -100.07 150.87 22.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.503 1.121 . . . . 74.35 109.859 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.44 -82.7 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.104 1.361 . . . . 71.44 111.008 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.29 -65.37 3.36 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 121.048 0.249 . . . . 63.52 112.902 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.38 162.67 22.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.249 1.42 . . . . 74.44 109.028 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.95 61.9 0.75 Allowed Glycine 0 C--N 1.348 1.218 0 N-CA-C 111.659 -0.576 . . . . 72.03 111.659 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.9 p -69.87 132.37 45.91 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.769 0.827 . . . . 73.33 110.871 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -149.99 79.0 1.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.673 -0.862 . . . . 75.23 108.673 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.29 76.67 1.28 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.712 1.244 . . . . 74.31 108.897 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -165.95 149.29 7.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.698 -1.592 . . . . 62.23 108.228 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 69.86 4.33 4.72 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.699 1.2 . . . . 72.22 112.779 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -49.62 9.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.409 1.084 . . . . 72.33 110.192 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.485 1.114 . . . . 60.22 111.657 176.258 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.495 -0.557 . . . . 65.43 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.0 p -176.12 62.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.381 1.073 . . . . 71.11 108.144 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -76.66 178.52 6.67 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.055 -0.975 . . . . 72.41 112.397 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -69.23 109.17 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.263 -1.335 . . . . 70.03 109.875 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -82.97 175.15 10.27 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.37 0.668 . . . . 71.34 110.251 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.82 74.38 0.44 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.14 1.376 . . . . 72.32 110.262 -170.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -117.73 156.71 27.79 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.783 0.833 . . . . 72.02 110.522 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.92 -30.12 68.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.962 0.905 . . . . 71.35 111.301 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.574 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.3 ptm 59.23 174.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.745 2.018 . . . . 62.35 115.003 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 95.9 m -154.65 136.61 14.6 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.131 1.373 . . . . 74.33 107.616 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -143.06 138.2 29.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.564 -0.532 . . . . 74.11 109.564 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.598 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 58.2 tt0 -155.16 140.82 17.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.822 0.849 . . . . 73.33 109.664 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.31 117.41 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 108.978 -0.749 . . . . 74.14 108.978 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.86 -50.3 9.35 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.803 0.274 . . . . 72.41 110.499 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -166.31 142.32 4.8 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.85 0.46 . . . . 75.21 109.822 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.5 mt -115.01 148.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.313 -1.366 . . . . 62.33 107.313 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.402 ' HE1' HG13 ' B' ' 83' ' ' ILE . 27.0 p90 -170.63 143.89 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.198 0.454 . . . . 73.23 110.973 -177.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.0 m -73.61 118.31 16.42 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.414 -0.812 . . . . 64.11 108.848 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -91.31 -29.24 17.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.567 0.747 . . . . 74.34 111.182 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.9 t70 -160.58 146.38 14.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.336 0.397 . . . . 72.15 111.19 -172.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.488 HG22 ' HE2' ' B' ' 117' ' ' MET . 46.7 mm -143.03 143.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 C-N-CA 125.975 1.71 . . . . 74.14 108.172 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.551 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.9 t -143.07 140.35 30.89 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.163 1.385 . . . . 70.44 107.285 171.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.434 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.3 t80 -151.64 126.78 9.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.316 -1.365 . . . . 73.35 107.316 171.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 138.46 53.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.901 0.88 . . . . 70.31 108.995 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.37 81.41 70.19 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 107.044 -1.465 . . . . 72.51 107.044 176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.49 -26.0 55.16 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.805 2.337 . . . . 74.2 111.979 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -126.48 32.92 5.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.361 1.064 . . . . 75.24 109.514 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.424 ' O ' HG12 ' B' ' 31' ' ' VAL . . . -47.54 -50.09 51.93 Favored Pre-proline 0 CA--C 1.565 1.538 0 C-N-CA 124.504 1.122 . . . . 72.13 113.347 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.484 ' HG2' ' HD1' ' B' ' 30' ' ' HIS . 58.4 Cg_endo -72.61 -12.06 26.6 Favored 'Trans proline' 0 C--N 1.391 2.763 0 C-N-CA 121.769 1.646 . . . . 74.02 113.774 176.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.484 ' HD1' ' HG2' ' B' ' 29' ' ' PRO . 29.3 m80 -97.07 -22.27 16.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.622 0.769 . . . . 73.42 112.515 -175.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.424 HG12 ' O ' ' B' ' 28' ' ' ALA . 8.3 p -68.63 -23.88 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.808 0.443 . . . . 74.22 112.1 -174.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.91 -29.91 71.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.396 0.678 . . . . 75.23 111.53 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.47 -30.77 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.285 0.634 . . . . 72.5 110.419 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.39 94.55 7.12 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 74.24 111.548 -172.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -94.19 81.1 4.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.361 0.665 . . . . 64.52 109.269 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -151.12 162.03 41.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.688 1.195 . . . . 75.4 108.517 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -75.05 113.84 28.97 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.222 1.009 . . . . 75.52 109.354 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.676 ' HB2' ' HB2' ' B' ' 66' ' ' ALA . 69.7 Cg_endo -71.92 147.47 49.65 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.348 2.032 . . . . 74.41 111.017 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 37.6 tt0 -51.7 106.43 0.14 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.588 0.755 . . . . 73.12 110.449 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.52 122.34 37.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.517 -1.29 . . . . 75.15 107.517 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -149.09 104.23 3.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.897 -0.592 . . . . 73.5 109.497 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.8 147.25 23.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.366 -0.833 . . . . 75.11 109.225 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.479 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -136.71 145.8 45.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.404 1.082 . . . . 61.11 108.096 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.563 HD22 ' CD1' ' E' ' 125' ' ' TYR . 1.9 mm? -124.61 163.04 22.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.146 -0.687 . . . . 71.51 109.146 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.0 t70 -164.04 139.21 6.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.832 -1.076 . . . . 71.31 108.946 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -122.43 115.63 22.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.546 0.738 . . . . 72.0 110.211 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.61 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -120.51 160.01 24.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 73.3 109.466 174.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 169.04 18.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.279 1.032 . . . . 75.2 109.354 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 1.5 m -149.42 135.11 18.64 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.395 -0.965 . . . . 72.34 108.395 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.85 100.44 12.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.285 -1.006 . . . . 75.15 108.285 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.9 mt -78.85 -31.28 45.62 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.603 -0.726 . . . . 73.31 110.315 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.72 -171.49 1.63 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.072 0.949 . . . . 73.41 110.648 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.96 124.86 24.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.798 -1.092 . . . . 64.12 109.533 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.37 -4.91 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.89 1.276 . . . . 64.32 112.31 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.73 97.16 5.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.602 0.761 . . . . 64.14 109.118 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -102.51 170.82 7.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.542 0.737 . . . . 73.02 110.131 172.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 8.8 tm-20 -145.76 103.01 3.74 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.018 -1.105 . . . . 75.44 108.018 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.07 125.9 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.178 0.591 . . . . 75.11 110.389 -175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.61 ' HB ' ' HB1' ' B' ' 47' ' ' ALA . 32.3 t -103.98 111.82 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.933 0.893 . . . . 75.45 109.147 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.72 110.23 22.1 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.041 -1.096 . . . . 72.42 108.041 176.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 66.8 ttt180 -97.23 116.23 29.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.344 0.658 . . . . 73.13 109.921 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -114.03 120.92 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.217 -1.031 . . . . 75.32 108.217 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.0 m -114.61 136.97 52.46 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.703 0.801 . . . . 72.25 109.191 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.578 HG22 HG21 ' B' ' 114' ' ' ILE . 52.8 t -115.99 132.9 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.588 1.155 . . . . 74.31 109.646 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -127.21 144.38 51.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.465 0.706 . . . . 65.4 109.667 170.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' B' ' 38' ' ' PRO . . . -143.76 150.85 39.2 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.362 -0.835 . . . . 73.14 110.333 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 m -134.78 136.8 42.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.21 0.604 . . . . 75.35 110.951 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 31.4 mt -129.95 99.59 5.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.282 1.033 . . . . 74.33 108.924 172.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -132.79 16.46 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.38 -0.827 . . . . 71.12 113.091 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -93.18 21.46 5.9 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.824 0.85 . . . . 72.41 111.364 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.74 161.07 41.38 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 123.834 0.853 . . . . 73.45 109.179 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -76.98 134.81 38.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.971 -0.559 . . . . 71.2 110.005 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.27 -65.59 0.94 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.488 -0.93 . . . . 75.13 108.488 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -155.38 160.37 40.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.757 . . . . 75.42 111.053 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -133.07 135.21 45.19 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.47 1.508 . . . . 74.32 107.093 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.47 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.3 t -139.15 158.06 44.85 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.362 -0.977 . . . . 53.04 108.362 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -165.28 128.04 2.18 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.146 -0.687 . . . . 75.11 109.146 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.1 t -126.01 146.55 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.832 0.853 . . . . 72.21 108.961 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -123.85 96.41 4.94 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.231 -1.026 . . . . 74.12 108.231 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.501 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -85.55 100.4 11.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.377 -0.971 . . . . 74.14 108.377 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.435 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.55 169.41 35.72 Favored Glycine 0 C--O 1.244 0.775 0 N-CA-C 111.163 -0.775 . . . . 64.02 111.163 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.8 128.63 1.65 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.44 -0.664 . . . . 63.11 111.44 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' B' ' 17' ' ' TYR . 38.3 mt -84.73 126.81 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.677 -0.861 . . . . 71.31 108.677 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -132.1 133.17 44.02 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.318 1.047 . . . . 75.2 108.658 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.598 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 26.6 m -93.3 97.59 10.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.802 -0.814 . . . . 72.44 108.802 173.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.617 HG12 HD12 ' B' ' 98' ' ' LEU . 2.6 pp -115.6 140.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.282 1.033 . . . . 74.43 110.463 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.37 172.35 18.5 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.901 0.88 . . . . 62.24 109.495 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.62 -58.65 5.02 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.249 -0.195 . . . . 44.44 112.642 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.484 HD12 ' HE2' ' B' ' 94' ' ' MET . 1.0 OUTLIER -55.01 127.49 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.519 0.728 . . . . 71.32 110.97 174.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.67 161.74 39.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 72.42 109.698 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.68 -131.32 10.96 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.908 -0.587 . . . . 65.45 112.225 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -76.39 -35.69 58.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.69 0.796 . . . . 73.3 110.944 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -64.71 -28.63 69.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.166 -0.925 . . . . 71.45 112.043 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.611 ' HE1' ' HB3' ' E' ' 115' ' ' LEU . 0.0 OUTLIER -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.453 0.701 . . . . 74.43 110.106 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.6 78.63 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.384 -0.825 . . . . 64.23 111.461 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -79.07 -23.7 44.01 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.607 0.763 . . . . 74.13 111.246 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.27 -66.32 0.91 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.582 0.353 . . . . 70.3 110.501 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.617 HD12 HG12 ' B' ' 86' ' ' ILE . 14.0 tp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.845 0.458 . . . . 75.24 111.451 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.28 -21.64 58.31 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.806 -0.634 . . . . 75.51 113.728 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -113.14 -56.0 2.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.306 0.553 . . . . 72.11 111.768 -176.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -68.52 -43.69 76.23 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.564 0.54 . . . . 74.52 112.359 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.532 ' SG ' HD13 ' B' ' 98' ' ' LEU . 75.3 m -63.73 -49.36 76.86 Favored Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 118.298 -0.858 . . . . 65.41 111.533 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.521 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 88.0 Cg_exo -56.73 -33.02 93.02 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.115 1.876 . . . . 75.1 114.143 168.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.38 -31.8 72.27 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.088 0.555 . . . . 73.35 110.859 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.91 -48.43 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.831 0.853 . . . . 73.35 109.615 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 65.4 mt -82.27 -12.64 57.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.326 -0.852 . . . . 75.31 111.919 -169.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.59 -47.91 55.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 117.78 -1.105 . . . . 75.53 113.049 -174.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.43 -36.09 98.81 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 121.909 1.739 . . . . 73.43 113.313 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.501 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 43.3 m-85 -70.51 -45.58 65.31 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.649 0.78 . . . . 75.35 110.474 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.05 99.49 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.7 0.8 . . . . 74.13 110.264 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -56.86 -54.96 40.47 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.83 1.652 . . . . 75.41 111.589 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.3 -31.94 73.34 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.733 0.646 . . . . 71.25 110.032 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.529 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.5 t -68.09 -41.97 81.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.536 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.578 HG21 HG22 ' B' ' 64' ' ' VAL . 62.8 mt -63.79 -51.88 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.133 0.573 . . . . 73.41 110.085 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.6 m -58.27 -34.24 70.28 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.139 0.976 . . . . 75.35 111.072 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.9 t -64.41 -54.65 29.4 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.129 -0.941 . . . . 72.21 109.414 173.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.529 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.9 mmt -61.88 -33.86 74.97 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.133 0.573 . . . . 63.31 112.13 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.9 -46.82 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.709 0.804 . . . . 75.41 110.934 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 74.7 p -70.01 -25.29 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.584 0.353 . . . . 71.14 110.999 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 85.1 mtt-85 -69.85 -20.23 63.42 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 118.783 -0.627 . . . . 73.44 111.172 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.2 12.18 61.95 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.12 -0.822 . . . . 70.35 114.365 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 17' ' ' TYR . 2.7 p 72.54 14.54 5.2 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.936 1.694 . . . . 72.12 112.169 -177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -91.14 154.18 44.86 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 122.725 0.41 . . . . 73.1 111.125 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -55.16 149.5 44.14 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 123.321 2.681 . . . . 65.33 113.06 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -59.02 123.25 15.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.39 1.076 . . . . 71.31 111.592 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.07 100.99 7.69 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.121 -1.066 . . . . 70.44 108.121 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -99.8 117.67 34.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 74.42 109.189 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.79 134.93 37.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.171 0.588 . . . . 74.23 110.16 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.05 139.81 36.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.801 0.84 . . . . 74.12 110.398 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.6 99.53 0.45 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.907 2.405 . . . . 74.54 111.972 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -90.81 126.07 43.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.753 -0.832 . . . . 75.13 108.753 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.23 113.23 11.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.531 -0.914 . . . . 70.0 108.531 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -63.88 -20.89 66.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.662 0.785 . . . . 74.03 110.859 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.079 1.352 . . . . 73.1 109.735 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.64 -31.31 63.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.481 -1.236 . . . . 73.35 110.682 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.3 -43.62 97.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.141 0.576 . . . . 75.14 110.075 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.432 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 60.2 t80 -70.82 -38.71 73.27 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.954 -1.021 . . . . 74.11 110.283 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.8 ttt -64.39 -36.15 83.22 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.607 0.763 . . . . 71.44 110.499 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.554 ' HB3' ' HD2' ' E' ' 124' ' ' ARG . 0.9 OUTLIER -75.5 -26.69 58.35 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.315 -0.857 . . . . 73.31 110.187 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -68.31 -31.28 70.6 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.029 0.531 . . . . 73.01 109.676 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 16.2 mt -85.31 3.25 40.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.186 0.594 . . . . 73.11 110.812 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 66.37 27.68 9.94 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.489 1.116 . . . . 75.42 110.898 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 63.69 20.7 12.36 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.994 1.317 . . . . 73.3 112.27 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -68.11 123.37 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.867 0.867 . . . . 73.13 111.707 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.97 -57.96 2.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.781 0.833 . . . . 64.41 109.649 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.32 74.67 0.61 Allowed Glycine 0 C--N 1.352 1.46 0 CA-C-N 115.685 -0.688 . . . . 74.42 113.973 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.95 148.84 36.11 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.002 0.921 . . . . 71.1 110.624 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.49 64.25 0.5 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 112.349 -0.301 . . . . 54.44 112.349 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.8 p -84.24 153.64 23.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.22 0.608 . . . . 72.31 110.229 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -132.56 137.55 47.15 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.743 0.817 . . . . 72.01 110.25 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -125.65 134.75 51.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.963 0.905 . . . . 63.45 110.556 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -138.41 101.96 4.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.999 0.92 . . . . 75.23 109.32 172.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -163.72 128.91 2.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.176 1.39 . . . . 72.53 108.058 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.03 142.93 23.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.134 0.574 . . . . 72.23 109.62 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 108.68 -0.859 . . . . 54.35 108.68 177.79 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.464 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 108.418 -0.956 . . . . 54.04 108.418 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -149.33 27.42 0.83 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.978 0.911 . . . . 72.32 110.199 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.78 100.75 0.21 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.186 0.995 . . . . 71.53 111.082 -173.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -91.48 135.59 33.74 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.299 -1.0 . . . . 74.51 108.299 172.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -74.06 110.76 8.61 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.273 -0.64 . . . . 70.33 109.273 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -71.71 86.58 0.93 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.258 0.623 . . . . 52.3 111.156 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 53.2 p -77.88 163.32 26.14 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.495 0.718 . . . . 74.02 109.8 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.89 81.82 0.15 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.022 0.929 . . . . 53.31 109.621 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.467 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 54.0 ttp 65.42 113.9 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.366 1.467 . . . . 73.11 111.812 -170.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.8 m -99.79 87.39 3.52 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.501 -1.296 . . . . 74.15 107.501 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -89.09 133.12 34.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.367 -0.833 . . . . 75.32 109.233 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 7.9 tt0 -151.81 144.95 24.6 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.937 -0.764 . . . . 73.14 108.937 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.429 HD13 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -92.52 136.88 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.386 -0.598 . . . . 74.35 109.386 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -105.24 -50.06 3.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.642 0.777 . . . . 74.04 110.281 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -163.18 142.64 8.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.049 0.54 . . . . 74.41 109.549 -173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.429 HG13 HD13 ' C' ' 13' ' ' ILE . 79.8 mt -128.24 134.84 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.417 -1.327 . . . . 74.31 107.417 174.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -171.16 153.79 3.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 73.25 111.336 -173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -79.11 120.74 24.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.168 -0.923 . . . . 74.12 109.471 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -74.26 -49.01 25.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.321 -0.992 . . . . 75.14 108.321 170.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -134.39 138.33 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.747 -1.569 . . . . 60.24 109.135 -167.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -142.73 139.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.711 -1.588 . . . . 75.22 106.711 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.88 149.52 18.15 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.83 -0.433 . . . . 53.23 109.83 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -154.34 108.8 3.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.124 -1.065 . . . . 74.25 108.124 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.79 122.13 42.61 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.076 -0.713 . . . . 65.14 109.076 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.81 93.42 20.51 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 108.423 -0.955 . . . . 75.22 108.423 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.68 -49.45 8.65 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.108 2.538 . . . . 63.24 111.697 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' C' ' 72' ' ' THR . 68.4 m-20 -103.79 53.19 0.75 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.429 -0.805 . . . . 74.11 109.036 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' HE3' ' D' ' 19' ' ' LYS . . . -59.11 -52.99 70.78 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.982 1.104 . . . . 73.15 113.982 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 39.4 Cg_exo -63.81 -21.72 69.28 Favored 'Trans proline' 0 C--N 1.398 3.139 0 C-N-CA 122.185 1.924 . . . . 73.31 112.909 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.431 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 13.6 m-70 -64.64 -18.95 65.41 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.291 1.036 . . . . 74.23 113.133 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.46 -37.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.087 0.955 . . . . 73.02 113.494 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -81.14 -36.4 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.054 0.941 . . . . 60.44 111.091 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -85.17 4.64 33.53 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 125.293 1.437 . . . . 71.12 111.08 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.617 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.2 ttmp? -107.81 153.18 23.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.376 1.07 . . . . 74.04 111.024 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.25 114.23 19.0 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.06 -1.459 . . . . 73.34 107.06 166.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -85.32 61.47 6.88 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.141 0.972 . . . . 74.41 112.504 -168.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -150.23 58.74 3.26 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.011 1.325 . . . . 73.14 107.598 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' E' ' 139' ' ' LEU . 92.5 Cg_endo -77.47 160.8 31.85 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.011 1.807 . . . . 71.33 111.364 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.45 103.94 13.2 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.896 -1.15 . . . . 71.34 107.896 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.82 97.41 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 114.963 -1.017 . . . . 65.11 108.642 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.483 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 50.7 mtpt -95.77 105.64 17.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.996 -0.742 . . . . 74.25 108.996 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -87.04 149.1 24.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.901 0.881 . . . . 73.31 109.609 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.3 t70 -149.17 127.41 12.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.314 -0.995 . . . . 72.35 108.314 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.78 149.68 50.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.228 0.467 . . . . 73.23 110.769 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 17.5 m-20 -140.81 161.1 38.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 64.35 109.826 176.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -130.48 136.06 48.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.054 0.941 . . . . 72.11 108.473 171.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.465 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -131.51 172.51 12.13 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.124 0.97 . . . . 74.13 108.507 176.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.7 p -164.61 160.14 19.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.927 0.491 . . . . 75.34 111.112 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -167.34 138.21 3.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.061 0.944 . . . . 74.04 109.452 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -77.87 117.5 19.29 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.88 -0.785 . . . . 75.23 108.88 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.684 HD12 ' HB2' ' C' ' 57' ' ' GLU . 40.5 mt -87.27 -37.97 16.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.734 0.413 . . . . 74.22 110.608 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.459 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -159.23 -172.05 3.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.262 -0.881 . . . . 71.33 110.682 -174.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.67 111.56 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.01 -0.995 . . . . 73.24 109.681 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 64.09 15.9 9.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.831 1.252 . . . . 71.43 112.314 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 89.1 t -118.0 103.79 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.298 -1.001 . . . . 74.33 108.298 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.44 ' CD1' ' HB ' ' C' ' 86' ' ' ILE . 14.9 m-85 -117.95 139.17 51.54 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.907 0.883 . . . . 72.42 108.959 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.684 ' HB2' HD12 ' C' ' 51' ' ' LEU . 35.2 tt0 -100.3 146.14 27.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.843 0.857 . . . . 74.23 109.355 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.38 144.33 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.747 -0.835 . . . . 75.44 108.747 165.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.465 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 58.2 t -119.63 107.14 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.886 0.875 . . . . 71.51 109.127 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -90.25 99.91 12.84 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.074 -1.084 . . . . 73.35 108.074 177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 75.6 ttt-85 -84.53 134.82 34.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.858 0.863 . . . . 74.24 109.385 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -129.05 148.13 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.794 -1.187 . . . . 73.04 107.794 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 57.5 m -138.9 135.35 34.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 75.31 107.5 171.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.635 HG23 HG21 ' C' ' 114' ' ' ILE . 47.1 t -118.36 113.33 41.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 107.659 -1.237 . . . . 75.31 107.659 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.483 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.1 m -98.33 134.35 41.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.749 -1.204 . . . . 74.5 107.749 171.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 94.82 3.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.231 -1.396 . . . . 74.12 107.231 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 14.1 m -144.76 143.48 30.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.279 0.632 . . . . 62.24 109.692 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.03 10.17 39.8 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.493 0.717 . . . . 70.55 109.578 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.27 -95.63 0.4 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.395 -1.082 . . . . 63.53 110.395 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.48 -32.98 16.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 74.11 109.261 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.617 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 8.7 tp10 -83.67 91.28 7.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.874 0.87 . . . . 61.32 109.484 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 28.3 m -86.75 135.88 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.284 -0.871 . . . . 73.32 110.232 -178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.59 -65.03 1.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.669 -0.863 . . . . 74.55 108.669 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.36 175.5 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.907 0.86 . . . . 74.13 112.332 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.455 HD23 HG21 ' C' ' 65' ' ' THR . 2.5 tm? -137.34 135.6 37.2 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 105.219 -2.141 . . . . 53.52 105.219 169.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.2 t -144.73 117.84 8.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.841 0.456 . . . . 70.21 109.983 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -121.06 131.35 54.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.03 135.41 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.194 0.998 . . . . 75.51 108.488 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.5 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.6 mt-30 -115.04 103.2 10.66 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.567 -0.901 . . . . 75.35 108.567 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.34 110.02 18.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.587 0.755 . . . . 74.32 109.618 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.02 146.65 22.14 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.178 -0.769 . . . . 70.12 111.178 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.51 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.52 118.66 0.99 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.913 -0.475 . . . . 74.12 111.913 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.482 HD13 HD12 ' C' ' 51' ' ' LEU . 8.7 mm -87.72 119.36 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.917 -0.771 . . . . 72.15 108.917 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -129.36 128.7 43.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.9 0.88 . . . . 74.34 109.237 -177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 24.5 m -70.82 108.74 4.62 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.305 -0.628 . . . . 73.4 109.305 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.44 ' HB ' ' CD1' ' C' ' 56' ' ' TYR . 43.5 mm -114.36 101.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.21 -1.034 . . . . 75.35 108.21 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.53 150.05 51.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.97 0.908 . . . . 72.32 109.754 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.37 28.76 Favored Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.349 0.5 . . . . 70.14 114.349 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' C' ' 9' ' ' MET . 17.8 tt -108.57 151.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.331 1.052 . . . . 74.53 110.134 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -164.13 154.68 15.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.185 0.594 . . . . 75.32 110.756 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.83 -148.61 19.31 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.369 0.509 . . . . 74.32 112.243 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.9 p -65.89 -21.18 66.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.946 0.898 . . . . 75.51 111.115 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -61.53 -51.1 70.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.173 0.989 . . . . 74.41 109.95 170.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 53.3 ttm -66.47 -35.82 81.22 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.901 -0.59 . . . . 75.13 110.376 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.2 95.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.497 0.719 . . . . 73.41 111.487 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' C' ' 134' ' ' ASP . 56.5 t-80 -68.5 -23.74 64.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.251 -0.886 . . . . 74.12 111.415 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.557 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 99.6 m -82.7 -51.33 7.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.221 0.608 . . . . 74.54 110.896 173.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.74 -42.67 66.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.735 1.214 . . . . 74.44 111.314 -163.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.61 11.53 46.45 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.02 -0.537 . . . . 73.24 113.438 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -146.12 -73.44 0.23 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.505 0.652 . . . . 73.22 111.963 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.557 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 92.0 t80 -65.22 -53.55 42.81 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.308 0.855 . . . . 74.11 113.308 -168.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.421 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 31.9 m -61.04 -44.55 94.75 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 123.126 0.57 . . . . 70.03 111.835 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 87.9 Cg_exo -55.23 -33.59 85.12 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.654 2.236 . . . . 75.12 114.536 166.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.19 -25.15 65.09 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 123.048 0.539 . . . . 74.24 111.762 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.468 HD13 ' NH1' ' A' ' 111' ' ' ARG . 38.4 mm -69.0 -39.67 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.476 -0.564 . . . . 74.31 109.476 171.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.51 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.5 mt -76.93 -26.89 54.58 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.843 -1.071 . . . . 73.21 111.811 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -56.03 -47.09 99.52 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.405 1.082 . . . . 72.44 113.807 -173.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.78 -40.16 86.22 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.031 1.821 . . . . 70.13 113.542 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.38 -45.76 71.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.224 0.61 . . . . 74.34 110.712 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.4 82.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.713 0.805 . . . . 74.24 110.665 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -65.83 -49.45 68.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.411 -1.268 . . . . 75.01 110.658 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.09 -29.74 66.79 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.416 0.686 . . . . 72.04 110.673 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.8 t -65.61 -40.43 92.61 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.408 0.683 . . . . 72.15 110.12 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.635 HG21 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -67.9 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.867 -0.606 . . . . 75.21 110.133 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 62.3 m -58.24 -29.56 65.85 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.823 0.849 . . . . 74.11 111.011 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.9 -51.51 18.31 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.37 -0.832 . . . . 75.44 109.715 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.563 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.17 -39.51 60.16 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.806 0.842 . . . . 72.3 112.369 177.66 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.463 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.6 t -68.85 -44.92 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.389 0.676 . . . . 73.1 110.259 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.07 -28.61 66.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.281 0.562 . . . . 74.41 110.926 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -67.21 -37.19 83.21 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 114.71 -1.132 . . . . 73.12 110.05 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.62 83.74 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 119.352 -0.693 . . . . 73.32 112.952 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.488 HG22 ' HB3' ' D' ' 17' ' ' TYR . 64.0 p 58.96 25.36 13.69 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.237 1.815 . . . . 73.21 112.833 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.433 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 84.3 m-85 -93.21 160.43 33.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.298 1.039 . . . . 74.31 108.923 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.542 ' HG2' HD22 ' E' ' 139' ' ' LEU . 35.5 Cg_endo -64.06 117.46 4.47 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.716 2.277 . . . . 70.24 112.418 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.12 134.72 44.17 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.467 1.107 . . . . 64.31 112.414 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.59 107.35 18.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.948 -1.13 . . . . 73.0 107.948 -174.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.67 100.64 13.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.266 -1.013 . . . . 73.02 108.266 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 134.36 48.63 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.339 0.655 . . . . 73.22 110.079 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.66 99.06 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.773 0.829 . . . . 75.31 110.974 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.433 ' HG2' HD13 ' A' ' 16' ' ' ILE . 24.0 Cg_exo -64.18 87.19 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.84 2.36 . . . . 72.01 112.702 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.33 111.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.682 -0.859 . . . . 75.52 108.682 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -109.44 103.12 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.962 -0.755 . . . . 63.13 108.962 -177.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.19 -29.24 69.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.21 1.004 . . . . 75.33 111.561 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.407 ' HB2' ' CE1' ' C' ' 96' ' ' HIS . 4.8 p-10 -76.21 -32.23 58.84 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.584 0.753 . . . . 75.21 110.584 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.89 -20.46 60.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.89 0.876 . . . . 73.12 111.626 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.84 -28.12 67.28 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.952 0.501 . . . . 75.53 110.696 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.403 ' HA ' ' HD1' ' C' ' 140' ' ' TYR . 78.7 t80 -69.36 -18.47 63.79 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.575 0.75 . . . . 74.44 111.733 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -69.03 -30.9 69.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.805 0.442 . . . . 71.33 110.111 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.1 -38.34 90.73 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.311 0.644 . . . . 64.54 109.851 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . 0.403 ' HD1' ' HA ' ' C' ' 137' ' ' PHE . 91.4 m-85 -71.42 -88.12 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.479 -0.782 . . . . 74.31 109.159 170.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.09 38.28 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.186 1.394 . . . . 74.44 111.034 172.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.508 ' HA ' HE21 ' C' ' 142' ' ' GLN . 0.0 OUTLIER -83.29 70.81 10.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.771 0.795 . . . . 74.4 110.301 -177.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.76 2.46 9.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.749 -1.114 . . . . 71.52 109.079 171.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -135.86 111.2 9.09 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 106.829 -1.545 . . . . 73.14 106.829 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 94.98 5.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.639 0.776 . . . . 71.12 109.887 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.67 128.46 9.47 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.447 0.467 . . . . 74.01 112.374 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -85.46 59.27 5.53 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.118 0.961 . . . . 73.32 108.857 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.13 67.93 0.05 OUTLIER Glycine 0 C--N 1.34 0.788 0 CA-C-N 114.898 -1.046 . . . . 73.21 110.829 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 20.7 m -71.65 -19.76 62.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.736 0.814 . . . . 74.44 110.706 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.48 40.58 0.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.867 1.267 . . . . 75.4 112.711 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.96 83.73 2.86 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.343 0.592 . . . . 73.15 110.524 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.37 72.85 10.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.566 -1.272 . . . . 73.01 107.566 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.75 74.62 3.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.693 0.758 . . . . 75.21 109.209 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -178.11 132.9 0.15 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.967 -1.469 . . . . 71.15 108.288 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.204 0 N-CA-C 108.565 -0.902 . . . . 63.33 108.565 179.247 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.972 -0.381 . . . . 75.4 109.972 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -119.61 107.61 13.47 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.97 -1.122 . . . . 63.52 107.97 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.82 -56.7 16.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.774 0.671 . . . . 74.12 110.661 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 69.03 174.03 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.848 1.259 . . . . 73.22 112.065 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.47 HD22 ' HA ' ' D' ' 87' ' ' ALA . 13.2 t-20 -160.57 86.25 0.73 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.129 -1.063 . . . . 72.55 108.129 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -147.58 106.52 3.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.498 0.719 . . . . 72.02 109.951 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -171.82 -176.34 1.72 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.226 1.411 . . . . 74.1 108.427 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 136.96 45.39 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.924 -0.769 . . . . 72.43 108.924 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.426 ' HG3' HG13 ' D' ' 89' ' ' ILE . 6.0 ttp -30.87 126.55 0.17 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.008 1.723 . . . . 72.21 114.004 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -139.32 136.8 35.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.778 0.831 . . . . 75.22 109.037 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -152.97 93.78 1.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 74.33 107.518 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.491 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.3 mt-30 -114.51 153.61 29.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.562 -0.744 . . . . 73.21 109.587 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.57 131.07 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.95 0.9 . . . . 74.21 109.16 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -109.42 -49.57 3.1 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.363 0.528 . . . . 63.3 111.909 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.31 121.08 0.73 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.509 0.559 . . . . 75.32 112.509 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.493 ' N ' HD13 ' D' ' 16' ' ' ILE . 1.7 mp -108.6 133.52 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.653 -1.239 . . . . 73.25 107.653 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.488 ' HB3' HG22 ' C' ' 122' ' ' THR . 36.1 p90 -161.89 176.05 11.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.911 0.862 . . . . 73.01 112.021 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -107.07 117.87 35.21 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.778 -1.101 . . . . 74.12 109.265 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 33.6 mtpt -85.47 -25.24 27.02 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.287 -0.634 . . . . 74.5 109.287 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.1 t70 -148.32 141.03 24.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.328 1.051 . . . . 63.03 109.869 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.563 HG23 ' HE1' ' C' ' 117' ' ' MET . 46.1 mt -138.41 142.96 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.445 1.498 . . . . 73.55 107.713 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -148.01 137.09 22.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.233 1.013 . . . . 73.33 108.852 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.561 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.4 t80 -153.86 119.54 5.25 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.117 -1.438 . . . . 75.25 107.117 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.0 118.54 19.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.394 0.677 . . . . 73.23 109.57 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.75 90.2 12.49 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.703 -0.851 . . . . 73.21 108.703 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.61 -46.44 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.964 2.443 . . . . 74.52 112.829 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 77.4 m-20 -103.31 43.51 1.08 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.279 1.032 . . . . 54.54 108.26 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.46 64.95 Favored Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 114.795 1.406 . . . . 74.32 114.795 -168.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.67 -3.86 12.0 Favored 'Trans proline' 0 C--N 1.393 2.88 0 CA-C-N 121.806 1.681 . . . . 74.32 113.865 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -84.6 -40.17 17.84 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.896 0.878 . . . . 65.14 110.454 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -82.26 -14.05 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.755 0.822 . . . . 74.23 109.923 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.21 -28.76 70.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.377 1.071 . . . . 74.15 110.96 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.403 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 61.0 mt-30 -72.64 -7.66 51.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.39 1.076 . . . . 75.3 111.293 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -111.78 111.81 23.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.423 1.089 . . . . 75.52 109.877 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.63 63.4 7.54 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.705 0.802 . . . . 71.34 110.052 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.468 ' HB3' HD21 ' D' ' 68' ' ' LEU . 65.7 t-105 -150.58 166.87 28.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.826 -0.805 . . . . 75.14 108.826 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.74 108.69 27.1 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.118 0.967 . . . . 75.41 110.471 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -43.24 144.94 1.55 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 124.506 3.471 . . . . 74.21 115.612 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.73 118.37 15.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.569 -0.741 . . . . 72.31 110.379 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.451 HG11 HG13 ' D' ' 64' ' ' VAL . 99.1 t -109.23 125.33 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.877 0.871 . . . . 73.52 111.02 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -111.54 120.95 43.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.68 -1.23 . . . . 74.31 107.68 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 155.66 16.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.403 -0.962 . . . . 74.1 108.403 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.6 t70 -143.59 140.89 30.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.887 0.875 . . . . 74.13 108.963 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.9 153.44 31.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.275 0.63 . . . . 75.42 110.544 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.9 t0 -165.75 152.7 10.04 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.579 1.152 . . . . 71.41 108.781 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -125.08 164.52 20.03 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.31 0.576 . . . . 74.11 110.279 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.559 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -156.86 167.53 30.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.529 1.131 . . . . 70.0 108.465 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.4 p -161.6 154.34 20.42 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.971 0.508 . . . . 61.03 110.97 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -154.95 149.62 26.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.513 1.125 . . . . 74.4 108.832 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -91.34 118.53 30.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.548 -0.908 . . . . 74.33 108.548 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.54 -38.49 12.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.099 0.56 . . . . 71.23 109.995 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.72 -177.11 6.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.662 0.744 . . . . 64.22 111.013 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.66 125.64 29.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.74 -1.118 . . . . 73.1 110.083 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 63.8 10.58 5.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.304 1.442 . . . . 72.4 112.308 -172.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.1 t -123.76 120.07 58.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.787 0.835 . . . . 74.55 109.025 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.497 ' HD1' ' HB ' ' D' ' 86' ' ' ILE . 64.3 m-85 -132.88 130.03 39.18 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.778 -0.823 . . . . 74.35 108.778 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.9 138.82 31.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.199 1.0 . . . . 65.22 108.888 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.66 123.92 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.228 -1.397 . . . . 73.34 107.228 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 48.1 t -102.25 130.73 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 75.4 108.808 175.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.519 HD23 HD11 ' D' ' 136' ' ' LEU . 0.0 OUTLIER -105.5 117.93 35.28 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.575 -1.268 . . . . 72.51 107.575 176.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -96.58 107.2 19.58 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.727 -1.212 . . . . 74.54 107.727 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.15 129.91 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.448 -0.945 . . . . 75.12 108.448 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -116.71 147.55 41.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.919 0.888 . . . . 73.34 109.65 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.499 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 23.7 t -134.11 128.72 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 73.54 108.442 174.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -124.83 119.64 29.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.08 139.3 53.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.311 0.644 . . . . 74.53 109.634 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 41.7 p -155.49 129.13 8.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.62 0.768 . . . . 70.04 109.415 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' D' ' 36' ' ' TRP . 15.5 tp -113.54 111.61 22.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.504 -0.925 . . . . 71.33 108.504 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.97 -144.98 26.73 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.876 0.735 . . . . 63.34 111.88 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.37 2.88 34.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.611 0.764 . . . . 64.25 112.021 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.1 pt-20 -123.81 152.16 42.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.777 0.831 . . . . 74.31 110.423 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 80.9 m -74.07 136.04 43.03 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.61 0.569 . . . . 73.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.58 -54.8 3.74 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.918 0.887 . . . . 73.24 109.436 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -161.52 164.04 29.85 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.78 -1.1 . . . . 73.2 109.312 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.79 152.53 50.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.102 1.361 . . . . 74.22 107.803 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.623 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.4 t -159.63 142.94 14.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.732 0.413 . . . . 62.32 110.784 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.45 127.54 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.169 0.588 . . . . 75.44 109.562 168.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.2 115.82 42.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 123.617 0.767 . . . . 75.4 109.549 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.702 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.3 mt-30 -89.86 87.13 6.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.867 0.841 . . . . 72.14 108.874 170.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.35 95.75 6.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 113.612 -1.631 . . . . 73.15 109.429 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.519 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 142.76 18.35 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.173 -0.371 . . . . 74.54 112.173 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.448 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.05 131.95 4.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.545 -0.622 . . . . 51.21 111.545 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.45 123.28 44.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 124.488 1.115 . . . . 65.52 108.78 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -126.16 131.77 51.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.935 0.894 . . . . 75.54 109.635 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.491 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 9.8 m -80.59 94.51 6.31 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.641 -0.874 . . . . 61.13 108.641 173.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.497 ' HB ' ' HD1' ' D' ' 56' ' ' TYR . 69.9 mt -108.5 111.02 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 71.55 109.205 -175.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.47 ' HA ' HD22 ' D' ' 5' ' ' ASN . . . -146.64 128.81 15.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.634 0.774 . . . . 64.2 109.822 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.76 50.13 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-O 119.756 -0.469 . . . . 62.33 113.705 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.436 HD11 HG23 ' D' ' 86' ' ' ILE . 2.9 mp -95.8 126.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.706 -1.591 . . . . 75.33 106.706 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.26 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.751 0.82 . . . . 75.21 111.35 -169.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.31 -141.84 39.89 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.039 -0.982 . . . . 72.12 112.719 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -90.38 -16.33 29.32 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.649 0.78 . . . . 74.42 110.02 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.46 -33.37 72.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.583 1.153 . . . . 73.32 111.123 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -64.1 -33.16 75.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.996 0.519 . . . . 74.32 111.694 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.58 80.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.201 0.6 . . . . 75.1 110.427 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -72.78 -36.19 67.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.907 -0.588 . . . . 71.51 110.925 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -64.33 -43.29 95.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.794 0.437 . . . . 55.11 110.053 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.6 tp -72.73 -35.98 67.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.175 0.99 . . . . 73.03 111.336 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.14 53.98 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.446 -0.641 . . . . 51.54 114.434 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.716 ' HB3' ' HB2' ' D' ' 137' ' ' PHE . . . -132.92 -60.27 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.741 0.77 . . . . 61.43 111.873 -175.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.22 -46.13 85.19 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.364 0.666 . . . . 73.51 112.145 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 33.4 m -71.62 -45.3 12.78 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-O 118.558 -0.734 . . . . 72.03 112.03 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.463 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.8 Cg_exo -57.82 -29.06 84.75 Favored 'Trans proline' 0 C--N 1.399 3.226 0 C-N-CA 122.446 2.097 . . . . 75.45 113.915 169.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.86 -32.29 73.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.262 0.625 . . . . 74.31 110.702 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.23 -34.56 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 123.661 0.785 . . . . 74.42 110.186 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.448 HD22 ' HA3' ' D' ' 82' ' ' GLY . 74.6 mt -82.5 -17.76 43.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.23 1.012 . . . . 74.0 112.39 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -65.78 -44.66 64.14 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.656 0.984 . . . . 72.31 113.656 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.86 -32.07 90.96 Favored 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 121.952 1.768 . . . . 71.3 112.873 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -80.16 -33.97 37.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 71.34 112.398 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.17 58.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.263 -0.643 . . . . 52.45 109.263 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -68.35 -31.7 71.27 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 114.883 -1.053 . . . . 75.13 111.213 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.13 -50.38 72.1 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 124.223 0.952 . . . . 75.21 110.692 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.3 t -59.02 -42.04 89.18 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.689 0.618 . . . . 65.32 110.52 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.623 HG12 ' SG ' ' D' ' 76' ' ' CYS . 99.5 mt -59.3 -52.84 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.314 1.045 . . . . 74.22 110.708 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.508 HG22 ' HG3' ' D' ' 125' ' ' GLN . 74.1 m -58.64 -41.82 86.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.882 0.873 . . . . 74.45 110.808 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.56 -43.97 88.19 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 114.65 -1.159 . . . . 70.12 110.448 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.41 -30.58 69.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.711 0.404 . . . . 74.55 111.459 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.92 -45.42 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.451 0.701 . . . . 75.12 110.029 173.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -74.26 -25.63 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.748 0.419 . . . . 74.03 110.967 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -75.63 -35.23 60.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.593 0.757 . . . . 74.42 109.255 172.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.38 -3.89 88.84 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.854 0.721 . . . . 62.11 112.039 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.5 p 58.05 34.69 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.71 2.004 . . . . 72.33 112.894 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -93.28 166.74 15.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.738 1.215 . . . . 73.23 108.989 171.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.56 132.26 44.89 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.097 1.864 . . . . 73.5 111.514 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.508 ' HG3' HG22 ' D' ' 115' ' ' THR . 31.6 tt0 -52.49 139.6 24.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.544 1.137 . . . . 74.21 112.406 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.705 ' HB2' HD12 ' F' ' 139' ' ' LEU . 46.7 tp -126.04 99.89 6.11 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.947 0.403 . . . . 74.35 110.862 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -100.15 117.81 35.18 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.179 -1.415 . . . . 75.14 107.179 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -73.17 123.16 23.1 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.624 -0.509 . . . . 65.1 109.624 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.66 147.07 84.73 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 124.635 1.209 . . . . 70.41 112.311 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.93 123.06 12.21 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.262 2.641 . . . . 73.12 113.555 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.75 145.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.828 0.851 . . . . 72.2 109.92 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' D' ' 134' ' ' ASP . 5.7 p-10 -68.25 118.48 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.328 -0.99 . . . . 63.02 108.328 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -50.08 -23.0 1.85 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.772 1.229 . . . . 75.24 113.969 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.515 ' HB2' HD21 ' D' ' 132' ' ' ASN . 4.9 m-20 -63.47 -38.79 92.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.88 0.872 . . . . 71.21 111.191 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.72 -24.17 66.92 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.084 0.554 . . . . 73.21 111.398 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.519 HD11 HD23 ' D' ' 60' ' ' LEU . 5.0 tt -83.28 -31.53 26.88 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.938 0.895 . . . . 74.25 109.265 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.716 ' HB2' ' HB3' ' D' ' 100' ' ' ALA . 47.1 t80 -62.2 -30.88 71.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.483 0.713 . . . . 73.44 110.993 175.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 16.4 mmt -58.25 -32.82 68.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.684 0.393 . . . . 73.54 110.696 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.496 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 20.3 m120 -65.99 -30.95 71.59 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.821 0.848 . . . . 61.33 112.116 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.43 -35.81 80.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.062 0.945 . . . . 74.21 111.326 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.33 -35.56 30.79 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.471 0.709 . . . . 74.45 111.735 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.496 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.8 pt20 -91.06 23.37 3.26 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.383 0.512 . . . . 74.14 112.383 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -121.3 90.41 3.31 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.444 0.64 . . . . 64.31 111.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 85.31 0.34 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 105.668 -1.975 . . . . 63.51 105.668 167.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.47 160.04 43.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.982 0.913 . . . . 63.0 110.182 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.42 155.67 8.11 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.109 -0.796 . . . . 74.42 111.109 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.32 127.67 7.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.474 0.71 . . . . 74.43 109.793 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 137.34 9.38 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.816 -0.514 . . . . 43.2 111.816 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.5 t -152.08 138.17 18.24 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.823 0.849 . . . . 62.24 109.244 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -140.38 86.73 2.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.205 0.602 . . . . 63.45 109.701 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.83 98.25 5.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.326 -0.991 . . . . 75.32 108.326 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -63.13 115.89 4.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 74.45 111.612 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.95 145.53 55.79 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.998 -0.741 . . . . 74.13 108.998 167.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -160.34 147.07 15.74 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.215 -0.661 . . . . 63.02 109.215 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.721 0.808 . . . . 71.41 109.515 -177.115 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.686 -0.487 . . . . 55.44 109.686 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -130.87 -169.54 2.18 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.271 1.028 . . . . 75.12 109.575 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.92 72.36 0.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.242 -0.651 . . . . 71.22 109.242 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -121.93 108.41 13.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.652 0.781 . . . . 75.12 109.065 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -65.31 -52.44 54.0 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.373 0.669 . . . . 75.55 110.707 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 53.68 -89.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.606 1.163 . . . . 73.24 109.432 -172.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -143.58 132.62 22.92 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.756 1.222 . . . . 72.02 107.92 165.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.611 ' HB3' ' HE1' ' B' ' 94' ' ' MET . 7.3 mp -72.56 120.97 18.92 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.087 0.955 . . . . 74.42 109.812 -175.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 81.7 t80 66.37 77.49 0.27 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 125.34 1.456 . . . . 74.31 110.349 -170.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -94.3 24.84 0.38 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.213 2.609 . . . . 73.0 112.984 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.44 -71.98 0.43 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.101 0.561 . . . . 73.41 111.892 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 67.6 m 55.65 88.94 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.792 0.837 . . . . 72.21 110.733 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -99.84 178.31 4.86 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.431 0.634 . . . . 72.23 110.403 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.0 -147.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.832 -1.076 . . . . 73.34 108.82 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.99 -27.44 68.87 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.618 0.767 . . . . 74.23 111.348 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 48.5 t 61.48 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.688 1.595 . . . . 74.25 110.43 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' B' ' 139' ' ' ASN . 0.1 OUTLIER -163.88 81.82 0.43 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.67 1.188 . . . . 74.52 108.407 176.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . 0.563 ' CD1' HD22 ' B' ' 44' ' ' LEU . 56.9 t80 -75.71 112.76 12.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.323 -0.853 . . . . 75.44 109.683 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -101.53 87.12 3.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.534 0.734 . . . . 73.34 109.301 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.26 108.41 3.5 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.781 -0.928 . . . . 61.01 110.781 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 27.41 3.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.28 0.632 . . . . 73.41 110.606 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . 0.45 ' HG ' HG13 ' E' ' 130' ' ' ILE . 2.5 pt? -50.85 -36.36 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.05 1.34 . . . . 71.11 112.296 -177.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . 0.45 HG13 ' HG ' ' E' ' 129' ' ' LEU . 50.5 mt -94.94 81.01 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.001 -1.111 . . . . 75.13 108.001 170.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.06 62.78 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.301 -0.863 . . . . 73.44 110.64 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -151.81 168.08 11.9 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.732 1.213 . . . . 75.42 108.436 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.87 98.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.574 2.183 . . . . 74.44 111.747 173.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 11.1 tp -89.55 32.95 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 CA-C-O 122.215 1.007 . . . . 74.31 110.274 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.57 6.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.639 0.776 . . . . 74.42 109.343 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.41 -16.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.685 -1.143 . . . . 74.53 109.267 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -73.25 88.75 1.52 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.79 -1.096 . . . . 65.13 111.033 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 25.09 1.74 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.506 -1.224 . . . . 74.42 109.308 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . 0.542 HD22 ' HG2' ' C' ' 124' ' ' PRO . 0.3 OUTLIER -100.6 83.29 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.559 0.744 . . . . 74.31 111.429 -177.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t -82.44 -64.94 1.08 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.049 -1.093 . . . . 71.43 108.049 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 45.91 -78.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.182 1.793 . . . . 75.04 113.522 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 26.2 pt -66.28 -32.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.299 1.44 . . . . 74.42 112.715 -174.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.88 -83.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.116 -0.469 . . . . 75.04 110.499 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 47.5 72.33 0.26 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.888 0.875 . . . . 63.45 111.77 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 75.39 -61.69 0.47 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.388 1.475 . . . . 75.34 111.276 -175.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.71 91.56 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.025 0.93 . . . . 74.21 110.867 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.48 -31.9 58.03 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.026 -0.988 . . . . 64.31 109.929 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 40.3 tp -149.93 92.97 4.01 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.114 -1.069 . . . . 73.25 108.114 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.376 1.988 0 C-N-CA 122.961 2.44 . . . . 64.52 111.81 177.898 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.904 0.383 . . . . 65.33 110.743 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.15 31.23 4.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.599 1.16 . . . . 74.14 109.407 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.97 134.85 54.8 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.531 -0.759 . . . . 74.32 110.232 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 76.9 t80 65.93 103.35 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.554 1.159 . . . . 75.24 110.815 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -122.21 -47.83 2.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.743 0.817 . . . . 71.12 109.085 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -90.03 167.43 12.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.678 -1.147 . . . . 71.2 111.031 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.65 117.85 30.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.85 1.26 . . . . 71.33 109.817 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 35.01 0.65 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.962 -1.125 . . . . 74.15 107.962 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -159.87 92.46 1.74 Allowed Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 114.318 -1.31 . . . . 75.5 107.951 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.416 ' HG3' ' HE3' ' A' ' 94' ' ' MET . 2.4 Cg_endo -80.58 -59.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.79 2.327 . . . . 73.31 111.729 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -159.6 177.56 10.77 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.391 1.077 . . . . 65.2 109.39 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 20.3 p -125.27 -171.04 2.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.354 1.061 . . . . 72.32 109.492 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . 0.499 ' NE1' ' HA ' ' F' ' 123' ' ' VAL . 21.3 t-105 -59.03 127.91 34.59 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.377 0.671 . . . . 74.23 111.896 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.01 160.91 21.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.025 0.93 . . . . 72.45 109.511 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . 76.9 -60.55 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.571 1.549 . . . . 55.14 111.353 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . 0.499 ' HA ' ' NE1' ' F' ' 120' ' ' TRP . 40.1 t 72.48 -76.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.419 1.487 . . . . 71.1 111.343 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.39 63.38 1.73 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.891 . . . . 73.51 109.985 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.37 78.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.256 -1.338 . . . . 70.44 109.344 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.76 117.49 18.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.413 -0.812 . . . . 71.11 109.501 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.92 110.01 0.23 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.843 -0.903 . . . . 70.41 110.843 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -75.41 -34.35 61.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.329 0.652 . . . . 75.42 109.5 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.05 -175.76 0.12 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.651 1.18 . . . . 74.32 110.815 -170.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 55.7 mt 60.3 73.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 124.313 1.045 . . . . 73.2 110.369 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.3 -62.1 1.79 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 115.242 -0.89 . . . . 73.14 110.112 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.08 102.45 6.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.424 -1.324 . . . . 75.42 107.424 170.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.33 172.27 6.07 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.536 2.157 . . . . 73.21 111.973 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.416 HG21 HG12 ' F' ' 136' ' ' VAL . 18.0 tt -110.95 128.36 67.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.7 -1.593 . . . . 74.13 106.7 163.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.7 72.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.631 0.772 . . . . 70.34 111.995 -171.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.416 HG12 HG21 ' F' ' 134' ' ' ILE . 14.3 m 49.17 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 C-N-CA 126.523 1.929 . . . . 71.42 114.553 -177.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -179.57 -76.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.715 1.206 . . . . 75.14 108.693 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.02 133.56 7.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.918 0.887 . . . . 74.23 109.343 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.705 HD12 ' HB2' ' D' ' 126' ' ' LEU . 48.4 mt -66.86 101.34 0.82 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.95 0.9 . . . . 73.14 110.69 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 57.9 p -66.15 -32.56 74.07 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.165 0.986 . . . . 64.54 111.126 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.96 116.46 21.6 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.076 -0.966 . . . . 74.02 109.924 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -172.62 -43.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.561 1.544 . . . . 74.35 108.074 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' F' ' 146' ' ' ASP . 64.4 m-85 -136.9 -58.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.653 1.581 . . . . 71.12 107.165 174.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 67.14 -66.49 0.19 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.07 1.748 . . . . 73.13 112.24 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.36 78.49 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.711 0.804 . . . . 65.14 109.23 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' F' ' 143' ' ' TYR . 18.6 m-20 66.28 156.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.196 1.398 . . . . 72.21 112.357 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . 0.463 HD13 ' HG3' ' B' ' 12' ' ' GLN . 68.0 mt -90.06 -26.32 20.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.714 -0.675 . . . . 74.23 110.908 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . 0.539 ' H ' ' HD2' ' F' ' 149' ' ' PRO . 1.8 tt -157.94 -51.91 0.01 OUTLIER Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 117.865 -1.064 . . . . 73.33 110.851 -175.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . 0.539 ' HD2' ' H ' ' F' ' 148' ' ' LEU . 19.8 Cg_endo . . . . . 0 C--N 1.407 3.623 0 C-N-CA 122.901 2.401 . . . . 74.34 113.441 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 108.424 -0.954 . . . . 73.14 108.424 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 m -85.71 71.47 10.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.623 0.769 . . . . 72.22 109.948 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.24 -69.36 0.84 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.297 0.639 . . . . 73.24 110.943 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.32 78.06 3.84 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.571 1.177 . . . . 75.11 110.028 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -166.47 156.9 12.25 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.897 -1.502 . . . . 75.25 107.889 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 70.41 -75.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.619 1.168 . . . . 74.11 111.201 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -71.19 91.92 0.97 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.692 . . . . 73.54 109.13 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -168.69 -67.38 0.02 OUTLIER 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.086 -0.961 . . . . 75.23 108.66 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.5 OUTLIER 60.66 177.09 0.1 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.506 1.122 . . . . 75.21 111.572 -174.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.1 m -153.39 124.18 7.3 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.809 -0.811 . . . . 75.13 108.809 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.01 114.0 9.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.401 -1.703 . . . . 75.04 106.401 159.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -138.78 121.07 15.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.335 -0.617 . . . . 74.31 109.335 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.453 HD12 ' HG2' ' C' ' 130' ' ' PRO . 25.0 pt -73.98 111.77 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 71.45 109.036 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -96.39 -43.32 7.71 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.764 -0.458 . . . . 71.31 109.764 -174.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -155.95 140.43 16.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.139 0.976 . . . . 74.44 108.865 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.558 HG21 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -128.72 112.53 26.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 106.122 -1.807 . . . . 74.15 106.122 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' HE2' ' HB2' ' B' ' 28' ' ' ALA . 28.8 p90 -157.64 169.14 25.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.252 0.548 . . . . 73.21 111.817 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -89.4 121.77 31.97 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.797 -0.816 . . . . 75.21 108.797 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.7 mtpt -87.51 -36.0 17.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.217 0.532 . . . . 72.02 109.751 175.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -146.83 140.44 25.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.108 -0.951 . . . . 73.5 108.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.41 HG23 ' N ' ' A' ' 22' ' ' SER . 70.5 mt -132.62 146.58 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.314 1.046 . . . . 73.43 108.671 179.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 21' ' ' ILE . 72.2 m -146.1 124.96 12.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.182 0.993 . . . . 73.11 109.229 175.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 83.3 t80 -123.91 126.89 47.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.192 -1.781 . . . . 75.01 106.192 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -134.73 108.36 7.95 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.994 -0.743 . . . . 72.04 108.994 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.72 82.42 59.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.975 0.91 . . . . 72.11 108.796 177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.2 -22.22 22.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.591 2.194 . . . . 72.14 111.576 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.469 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 89.3 m-20 -114.34 33.72 5.13 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.112 0.965 . . . . 75.43 109.953 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.57 98.99 Favored Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 123.827 0.851 . . . . 74.45 112.491 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD2' ' HD2' ' A' ' 30' ' ' HIS . 7.7 Cg_exo -74.81 -28.91 9.12 Favored 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 121.937 1.758 . . . . 74.44 112.747 172.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.469 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.2 m-70 -68.93 -28.22 66.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.543 0.737 . . . . 70.54 111.34 -172.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.549 HG12 ' HE1' ' A' ' 123' ' ' PHE . 9.4 p -63.96 -27.0 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.478 0.711 . . . . 70.54 111.587 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -68.12 -30.67 69.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.746 0.818 . . . . 72.33 110.583 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -75.89 -46.08 32.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.519 -0.764 . . . . 74.22 109.965 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.577 ' HE2' HD12 ' A' ' 68' ' ' LEU . 41.3 mtpt -81.73 157.37 24.58 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.676 -1.147 . . . . 64.44 110.66 -173.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -64.44 135.36 56.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.552 0.341 . . . . 60.12 111.008 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -84.29 64.88 8.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.111 0.958 . . . . 73.21 109.529 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -132.0 66.59 77.94 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.065 1.346 . . . . 71.51 108.01 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -87.54 156.04 7.78 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.053 1.835 . . . . 71.23 112.389 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.57 ' HG3' ' HE2' ' F' ' 128' ' ' LYS . 34.4 tt0 -96.34 124.22 40.26 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.509 -0.923 . . . . 74.03 108.509 177.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.549 HG12 HD12 ' F' ' 129' ' ' LEU . 9.1 t -90.59 99.59 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.825 0.85 . . . . 61.52 109.656 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 90.2 mttt -95.55 142.28 28.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.544 0.737 . . . . 74.33 110.424 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.06 112.28 12.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.458 -0.792 . . . . 72.42 109.795 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -115.32 113.55 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.231 1.012 . . . . 75.4 108.698 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.07 155.8 25.3 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.446 0.641 . . . . 74.41 111.449 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 15.8 t70 -149.16 154.95 39.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 65.3 109.059 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -133.41 132.82 41.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.809 0.844 . . . . 72.11 109.201 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.06 130.31 41.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.676 0.79 . . . . 71.54 109.681 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -88.65 155.27 19.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.299 0.64 . . . . 74.35 110.464 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.3 t -149.53 119.06 6.92 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 -176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.87 107.88 19.53 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.785 -0.82 . . . . 64.45 108.785 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.32 -27.98 20.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.863 -0.608 . . . . 74.01 110.659 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.94 -174.03 1.96 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.868 -1.06 . . . . 64.33 110.205 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.5 128.43 35.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.339 -0.846 . . . . 71.31 109.68 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 62.04 18.18 9.72 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.582 1.176 . . . . 72.11 111.813 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.0 107.31 17.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 124.482 1.113 . . . . 75.23 108.057 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.567 ' HH ' HD13 ' F' ' 115' ' ' LEU . 58.9 m-85 -125.97 124.48 40.84 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.786 0.834 . . . . 75.24 108.996 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.95 124.43 49.5 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.4 1.48 . . . . 72.14 108.666 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.38 134.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.187 -1.042 . . . . 73.13 108.187 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.568 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.6 t -106.6 125.33 62.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.048 -0.978 . . . . 71.4 108.387 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.39 107.53 19.92 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.45 -1.685 . . . . 75.41 106.45 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 5.3 ttp180 -94.46 97.08 9.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.11 -1.441 . . . . 73.13 107.11 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.8 132.57 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -126.29 126.7 44.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.381 -0.97 . . . . 73.34 108.381 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG23 HD12 ' A' ' 114' ' ' ILE . 89.8 t -120.78 129.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.3 -1.371 . . . . 71.34 107.3 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 34.5 m -125.51 137.61 53.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.036 -0.727 . . . . 71.14 109.036 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.18 105.8 10.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.948 -1.501 . . . . 74.31 106.948 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -130.71 125.9 35.09 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.621 -0.881 . . . . 63.24 108.621 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.577 HD12 ' HE2' ' A' ' 34' ' ' LYS . 1.3 pt? -91.07 84.25 5.69 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.992 -1.114 . . . . 74.21 107.992 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.85 -124.25 7.04 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.724 -1.125 . . . . 64.03 110.639 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.86 -26.9 21.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.801 0.841 . . . . 73.13 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -96.25 133.16 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 74.02 110.63 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -80.33 126.92 31.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.976 0.91 . . . . 73.35 110.844 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.75 -51.46 12.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.001 0.92 . . . . 70.25 109.189 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -161.95 168.3 23.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.148 0.979 . . . . 71.25 110.061 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.453 HD11 ' H ' ' A' ' 76' ' ' CYS . 40.6 tp -138.11 149.11 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.66 1.184 . . . . 73.53 109.221 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.453 ' H ' HD11 ' A' ' 75' ' ' LEU . 63.7 m -139.66 140.34 36.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.068 1.347 . . . . 74.3 108.947 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.37 132.63 18.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.71 0.804 . . . . 74.01 108.839 170.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.76 112.86 13.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.805 -0.813 . . . . 72.13 108.805 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.23 80.58 9.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.765 -1.107 . . . . 75.33 108.399 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.76 92.71 3.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.808 -1.087 . . . . 65.21 109.129 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -93.33 144.74 17.24 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.664 -0.574 . . . . 72.2 111.664 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.55 127.55 3.81 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.752 -0.539 . . . . 74.45 111.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.39 126.18 39.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.975 -1.12 . . . . 72.32 107.975 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.15 121.48 20.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.221 -0.659 . . . . 75.54 109.221 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -81.09 110.77 16.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.932 -0.766 . . . . 74.01 108.932 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.36 144.21 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.142 0.577 . . . . 73.21 110.684 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.4 162.75 22.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.998 . . . . 71.21 109.779 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.17 -6.83 48.47 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 115.99 -0.55 . . . . 74.24 114.47 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.93 155.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.461 1.104 . . . . 73.45 109.288 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -164.28 174.61 10.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.355 -0.609 . . . . 72.53 109.355 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.14 -125.17 29.37 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 116.112 -0.494 . . . . 70.3 112.75 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -73.16 -18.78 61.23 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.804 0.842 . . . . 74.43 111.945 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -70.71 -50.75 32.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.607 0.763 . . . . 75.41 109.59 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.467 ' HE3' ' HB3' ' F' ' 115' ' ' LEU . 50.5 ttm -75.23 -29.85 60.38 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.423 -0.808 . . . . 74.14 110.441 -179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.97 -44.08 97.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.143 0.577 . . . . 71.53 110.042 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.08 -49.52 77.34 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 115.518 -0.765 . . . . 75.35 110.688 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.592 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.3 m -69.17 -59.78 2.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 74.54 112.973 -171.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.75 -14.95 60.78 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.142 0.423 . . . . 74.45 112.142 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.42 -18.42 30.84 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.862 -0.41 . . . . 71.32 113.817 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.59 -69.17 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.492 0.646 . . . . 75.53 111.998 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.592 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 8.6 t80 -44.12 -57.89 3.15 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.1 1.36 . . . . 72.41 112.788 -174.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.7 -47.99 5.1 Favored Pre-proline 0 CA--C 1.559 1.325 0 CA-C-O 117.856 -1.069 . . . . 75.11 113.077 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.516 ' HA ' HD13 ' A' ' 106' ' ' LEU . 22.0 Cg_endo -62.63 -21.45 72.93 Favored 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.739 1.657 . . . . 62.43 113.398 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.06 -26.89 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.085 0.554 . . . . 73.01 110.213 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 33.4 mm -67.74 -41.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.356 0.598 . . . . 74.54 109.526 167.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.558 HD23 HG21 ' A' ' 16' ' ' ILE . 68.8 mt -71.46 -25.68 62.4 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.015 -0.993 . . . . 74.32 111.315 -175.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.05 -43.4 67.11 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 117.709 -1.139 . . . . 72.53 114.005 -170.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -55.47 -39.89 88.56 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.336 2.024 . . . . 71.43 113.633 170.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -77.08 -32.7 56.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.477 0.711 . . . . 73.2 111.871 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -46.68 70.03 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.343 -0.614 . . . . 75.12 109.343 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.504 ' NH1' HD13 ' C' ' 105' ' ' ILE . 35.4 ttm180 -53.5 -49.72 66.93 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.881 1.363 . . . . 75.0 110.443 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.61 -49.65 75.74 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.434 1.084 . . . . 75.1 110.849 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.2 -40.42 93.89 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 124.139 0.899 . . . . 71.54 111.584 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.541 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 80.1 mt -65.31 -59.22 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 123.832 0.707 . . . . 74.33 110.061 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.0 m -55.54 -33.29 63.69 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.516 1.135 . . . . 74.43 111.533 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -71.67 -43.63 65.68 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.42 -0.809 . . . . 73.2 110.545 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' A' ' 114' ' ' ILE . 49.9 mtm -59.29 -41.71 89.61 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.146 0.43 . . . . 75.12 110.756 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -57.16 -50.31 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.526 -1.216 . . . . 72.4 110.422 177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.48 -23.31 58.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.971 0.508 . . . . 70.23 111.692 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.46 -28.36 61.0 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.438 0.695 . . . . 74.45 109.609 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 8.07 71.85 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 115.537 -0.756 . . . . 71.42 112.497 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.573 HG22 ' HB3' ' B' ' 17' ' ' TYR . 7.1 t 48.13 43.74 18.69 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.693 1.997 . . . . 75.12 112.771 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.549 ' HE1' HG12 ' A' ' 31' ' ' VAL . 83.0 m-85 -99.1 158.54 32.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.749 -1.114 . . . . 75.21 108.657 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.62 149.86 64.81 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.602 2.201 . . . . 74.14 111.884 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -69.67 134.46 48.72 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.361 0.664 . . . . 74.3 111.704 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.11 112.19 23.4 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.544 -0.91 . . . . 71.23 108.544 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' C' ' 15' ' ' ARG . 80.5 m-20 -98.47 100.55 11.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.421 0.688 . . . . 74.34 109.531 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.518 ' HA ' HD21 ' F' ' 129' ' ' LEU . 7.6 mp -56.06 120.98 8.35 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.144 0.978 . . . . 75.05 110.05 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.58 85.88 Favored Pre-proline 0 C--O 1.242 0.695 0 O-C-N 123.56 0.537 . . . . 70.31 109.662 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.47 104.78 1.63 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.866 1.711 . . . . 75.35 111.692 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -99.93 110.76 27.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.618 -1.253 . . . . 72.51 107.618 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.411 HD22 ' HB2' ' A' ' 134' ' ' ASP . 11.4 t30 -79.86 90.93 5.31 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.613 -1.255 . . . . 71.52 107.613 176.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.938 -1.028 . . . . 75.31 111.166 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.411 ' HB2' HD22 ' A' ' 132' ' ' ASN . 4.7 m-20 -52.11 -38.69 58.22 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 125.121 1.368 . . . . 73.44 112.232 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.73 78.52 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.923 0.764 . . . . 72.42 111.888 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -75.02 -39.4 61.12 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.576 -0.527 . . . . 75.31 109.576 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -67.12 -29.06 68.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.542 0.737 . . . . 75.15 111.688 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.402 ' HA ' ' HE2' ' A' ' 138' ' ' MET . 24.7 mmt -62.41 -51.72 66.41 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.246 -0.65 . . . . 73.45 109.246 178.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -53.68 -30.08 41.74 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.246 0.966 . . . . 71.42 111.688 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -82.17 -46.77 13.34 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.907 0.883 . . . . 73.43 111.155 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 44.3 tp -69.7 -52.93 21.22 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.231 0.826 . . . . 74.41 113.231 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -170.14 29.38 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.369 0.604 . . . . 75.44 109.686 -171.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.537 ' HG3' ' H ' ' A' ' 144' ' ' GLN . 5.6 tp60 61.38 -151.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.357 1.063 . . . . 72.53 108.41 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.537 ' H ' ' HG3' ' A' ' 143' ' ' GLN . 41.1 mt-30 -74.86 73.02 2.1 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 119.991 1.268 . . . . 74.42 110.565 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 172.66 162.75 0.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.382 1.873 . . . . 73.12 107.7 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.03 -43.44 0.78 Allowed Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.914 -0.13 . . . . 54.31 113.118 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.62 170.72 14.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.25 0.62 . . . . 74.45 111.767 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.9 67.13 0.03 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.92 -0.872 . . . . 75.21 110.92 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.9 p -130.61 19.91 5.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.239 1.016 . . . . 74.12 110.923 -175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.21 62.19 5.81 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 122.401 1.096 . . . . 70.55 110.906 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -151.74 106.14 3.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.41 -0.959 . . . . 74.4 108.41 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -133.16 155.38 49.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.583 0.753 . . . . 74.51 111.069 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.36 148.3 27.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.831 1.253 . . . . 74.42 108.453 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 66.19 92.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.767 1.227 . . . . 72.41 110.907 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.945 0.898 . . . . 53.02 108.85 179.436 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' B' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.788 0.327 . . . . 73.41 110.354 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -161.25 95.68 1.05 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.168 -1.049 . . . . 72.31 108.168 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.23 77.7 3.76 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.451 0.701 . . . . 74.15 110.638 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -158.76 15.96 0.19 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.957 0.903 . . . . 74.44 111.322 -176.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -108.53 -177.27 3.27 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.857 0.863 . . . . 75.53 109.659 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.665 ' HA ' HE22 ' B' ' 93' ' ' GLN . 3.7 p-10 -102.13 166.28 10.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.094 0.558 . . . . 71.23 111.212 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.644 HG23 ' HA ' ' B' ' 89' ' ' ILE . 8.6 t -164.58 152.4 11.98 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.289 1.036 . . . . 54.12 109.947 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.85 -13.33 39.52 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.877 0.871 . . . . 72.14 110.305 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.421 ' SD ' HD12 ' B' ' 89' ' ' ILE . 17.1 ptm 53.55 -171.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.664 1.986 . . . . 74.12 114.262 175.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.2 m -138.75 103.62 4.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.633 -1.247 . . . . 61.24 107.633 174.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -110.72 146.58 36.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.441 0.696 . . . . 74.44 109.462 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.557 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 49.4 tt0 -164.54 141.4 6.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.285 0.634 . . . . 74.5 110.333 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.27 131.28 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 108.759 -0.83 . . . . 74.23 108.759 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -101.15 -50.83 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.15 -0.315 . . . . 63.42 110.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -157.43 140.93 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.514 -0.312 . . . . 74.32 110.183 -171.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.6 mt -123.16 134.68 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.867 -1.531 . . . . 75.43 106.867 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.573 ' HB3' HG22 ' A' ' 122' ' ' THR . 9.2 p90 -166.97 147.12 5.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.428 0.899 . . . . 72.41 113.428 -172.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.2 m -73.68 122.04 21.69 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.059 -1.428 . . . . 65.02 108.837 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -97.46 -29.05 13.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.669 0.788 . . . . 75.34 110.674 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 24.4 t70 -157.13 141.6 16.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.389 -0.369 . . . . 71.23 110.787 -169.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.437 HD12 HG21 ' B' ' 78' ' ' VAL . 47.0 mm -138.48 144.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.719 1.208 . . . . 74.51 109.366 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.55 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -136.98 138.44 40.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.948 1.299 . . . . 75.1 108.422 167.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -142.85 131.46 22.5 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.064 -1.828 . . . . 72.41 106.064 164.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.5 mt-10 -131.48 136.42 47.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.739 -0.837 . . . . 74.31 108.739 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.536 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -131.4 80.37 67.71 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 107.223 -1.399 . . . . 61.32 107.223 170.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.21 -33.48 60.1 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.527 2.151 . . . . 71.42 110.779 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -118.77 24.29 10.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.581 1.152 . . . . 74.1 110.0 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.626 ' HA ' ' HZ ' ' B' ' 123' ' ' PHE . . . -38.14 -56.18 2.11 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 115.053 1.501 . . . . 74.14 115.053 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.8 Cg_endo -82.21 -6.63 12.04 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.338 2.026 . . . . 73.25 113.332 -176.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.4 ' HA ' HE22 ' B' ' 33' ' ' GLN . 72.2 m80 -96.82 -24.22 16.0 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.696 0.798 . . . . 72.43 111.572 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.588 HG23 ' HA ' ' B' ' 73' ' ' ALA . 59.8 t -82.3 -6.66 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.584 0.754 . . . . 70.15 110.085 173.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.66 -43.27 72.26 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.277 1.031 . . . . 73.41 111.155 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.4 HE22 ' HA ' ' B' ' 30' ' ' HIS . 0.8 OUTLIER -72.81 -32.83 65.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.543 0.737 . . . . 74.14 110.151 -178.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.18 85.16 4.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.1 -0.955 . . . . 74.45 110.426 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.54 77.41 9.31 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.746 0.784 . . . . 72.23 108.967 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.442 ' HB2' HD23 ' B' ' 68' ' ' LEU . 5.9 m-90 -151.88 158.0 42.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.387 1.475 . . . . 74.24 108.294 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.94 113.74 45.33 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.151 -1.055 . . . . 71.01 108.151 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.568 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 56.7 Cg_endo -68.43 160.74 47.86 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.402 2.068 . . . . 75.14 112.572 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.0 tt0 -60.27 103.73 0.26 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.072 0.858 . . . . 71.35 110.046 175.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.13 135.41 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.064 -0.717 . . . . 65.31 109.064 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -142.41 134.99 28.08 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.871 -0.788 . . . . 73.12 108.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.23 123.49 48.37 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.751 -1.203 . . . . 74.11 107.751 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.636 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 8.8 m-20 -122.9 111.49 16.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.671 -1.233 . . . . 73.11 107.671 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.578 HD22 HG13 ' B' ' 131' ' ' VAL . 7.5 mp -100.31 143.3 30.66 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.365 0.666 . . . . 73.53 110.178 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.9 t70 -147.59 147.12 29.73 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.524 1.13 . . . . 65.43 108.129 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -132.53 124.56 28.72 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.311 0.644 . . . . 74.11 109.815 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.551 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.64 154.87 30.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.175 0.99 . . . . 71.32 108.49 173.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.1 p -145.46 161.18 40.33 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.236 0.614 . . . . 72.23 110.085 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.4 p -169.08 159.96 9.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.03 0.932 . . . . 74.2 109.482 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -118.08 134.98 54.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.06 0.544 . . . . 74.23 109.806 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.31 -49.18 5.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.86 0.864 . . . . 74.21 110.695 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 -172.8 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.331 -0.85 . . . . 74.03 110.376 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.55 107.62 1.77 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.36 1.037 . . . . 73.11 110.789 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.429 ' O ' ' HA ' ' B' ' 85' ' ' SER . 21.3 m-20 77.82 1.07 2.85 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 126.516 1.926 . . . . 62.2 111.3 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.57 88.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.341 -1.355 . . . . 75.21 107.341 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -95.75 165.69 12.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.604 -0.888 . . . . 71.33 108.604 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.81 113.74 7.98 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.754 -1.202 . . . . 73.33 107.754 -174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.09 127.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.39 0.676 . . . . 64.24 109.745 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 27.9 t -103.27 131.99 50.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.926 0.89 . . . . 71.34 109.308 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -116.21 112.04 21.05 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.401 -1.333 . . . . 73.52 107.401 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 28.7 ttm180 -100.02 121.95 42.16 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.853 -0.425 . . . . 75.4 109.853 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' B' ' 114' ' ' ILE . 17.4 t -117.22 133.64 63.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.477 -1.305 . . . . 71.43 107.477 168.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.636 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.4 m -119.09 134.35 55.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.063 -0.717 . . . . 64.02 109.063 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.567 HG23 HD12 ' B' ' 114' ' ' ILE . 63.7 t -117.15 104.8 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.91 0.884 . . . . 74.23 108.839 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.0 m -97.48 140.85 31.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.121 -1.399 . . . . 75.0 108.871 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -141.5 134.22 28.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.327 0.392 . . . . 74.31 110.359 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -140.36 135.83 32.54 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.31 0.644 . . . . 75.34 109.312 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 17.1 tp -136.55 124.0 22.11 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.227 0.611 . . . . 74.23 109.486 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.1 -116.85 4.47 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.656 -0.702 . . . . 72.1 111.505 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.81 19.75 13.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.352 1.061 . . . . 73.32 109.693 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -156.23 176.63 12.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.895 0.478 . . . . 74.12 111.038 -170.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -72.58 141.93 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.618 0.767 . . . . 74.21 110.563 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.588 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -94.32 -59.24 2.0 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.038 -0.727 . . . . 61.43 109.038 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -157.89 168.76 26.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.871 -1.059 . . . . 73.52 109.886 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 78.8 mt -141.04 140.69 34.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.37 1.468 . . . . 73.54 107.251 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.412 ' SG ' HG22 ' B' ' 114' ' ' ILE . 45.8 t -148.99 155.47 40.85 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.877 -0.786 . . . . 75.31 108.877 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.6 tt0 -164.49 138.47 5.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.899 -0.778 . . . . 74.44 108.899 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.437 HG21 HD12 ' B' ' 21' ' ' ILE . 92.4 t -134.54 145.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.93 0.892 . . . . 70.52 109.098 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.5 mt-30 -122.08 94.15 4.21 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.289 -1.004 . . . . 73.33 108.289 170.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -84.54 101.15 11.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.731 -0.84 . . . . 73.33 108.731 175.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.53 165.83 31.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.27 -0.732 . . . . 74.53 111.27 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.66 133.73 3.54 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 112.325 -0.31 . . . . 71.33 112.325 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 63.6 mt -86.32 123.39 39.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.875 -0.787 . . . . 75.03 108.875 171.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.28 135.24 46.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.627 1.171 . . . . 75.12 109.077 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 53.5 m -101.81 106.35 17.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.81 0.844 . . . . 71.22 109.009 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.6 HG12 HD23 ' E' ' 115' ' ' LEU . 0.2 OUTLIER -126.03 131.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.881 0.873 . . . . 74.35 109.417 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 160.6 40.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.136 0.974 . . . . 73.31 109.022 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 -29.09 3.98 Favored Glycine 0 N--CA 1.473 1.118 0 N-CA-C 114.281 0.472 . . . . 65.4 114.281 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.644 ' HA ' HG23 ' B' ' 7' ' ' THR . 16.0 tt -83.03 152.35 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.975 0.91 . . . . 73.23 110.352 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 166.07 32.7 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.172 0.511 . . . . 72.3 112.008 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.82 30.53 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 114.761 -1.109 . . . . 73.42 113.848 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 47.4 m -65.04 -33.81 76.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.97 0.908 . . . . 74.45 110.611 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.665 HE22 ' HA ' ' B' ' 6' ' ' ASN . 78.3 mt-30 -61.54 -51.98 66.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.109 -0.951 . . . . 74.15 110.381 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -62.6 -41.06 98.74 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.805 0.842 . . . . 73.43 111.388 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.8 81.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.007 0.817 . . . . 73.45 112.09 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -95.99 -12.32 25.17 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.539 0.336 . . . . 73.42 111.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -80.38 -65.02 1.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.659 -0.497 . . . . 74.21 109.659 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' E' ' 116' ' ' TYR . 20.6 tp -75.89 -28.31 58.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.085 -0.507 . . . . 73.31 110.468 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.2 -34.06 18.6 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.754 -0.657 . . . . 63.31 114.294 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.86 -41.3 2.12 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.05 0.925 . . . . 74.12 113.075 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -76.94 -39.93 48.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.803 0.441 . . . . 74.42 111.29 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 74.0 m -66.34 -45.51 59.9 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.698 -0.668 . . . . 74.21 110.782 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.445 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 85.6 Cg_exo -55.73 -35.74 93.85 Favored 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 122.49 2.127 . . . . 71.43 113.896 163.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.673 0.389 . . . . 71.2 111.425 -178.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.96 -44.51 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.078 0.951 . . . . 73.51 110.001 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 78.7 mt -75.43 -23.52 56.98 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.853 -1.067 . . . . 75.4 112.37 -173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.87 -48.07 95.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 113.936 1.087 . . . . 75.35 113.936 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.33 -34.47 94.13 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.153 1.902 . . . . 72.32 113.383 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.63 -43.82 62.75 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.228 0.611 . . . . 72.24 110.316 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.51 -39.57 80.45 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 123.49 0.716 . . . . 72.25 110.135 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -56.46 -63.98 1.02 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.749 1.22 . . . . 74.24 111.128 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.01 -28.69 69.67 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.112 0.882 . . . . 73.31 110.785 -171.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.505 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -69.27 -42.77 75.11 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.846 0.458 . . . . 72.24 110.843 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.567 HD12 HG23 ' B' ' 64' ' ' VAL . 93.5 mt -62.97 -53.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.204 0.602 . . . . 73.24 110.045 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -59.26 -33.11 70.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.508 -1.223 . . . . 70.54 110.796 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.3 t -62.87 -53.66 50.68 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.123 -0.944 . . . . 71.52 109.942 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.532 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 14.4 mmt -60.29 -34.99 74.54 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.195 0.598 . . . . 73.41 111.965 -175.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.77 -48.64 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.833 0.853 . . . . 65.13 111.005 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 61.0 p -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.915 0.486 . . . . 74.01 111.615 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.532 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 86.5 mtt-85 -68.18 -37.63 81.16 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.392 0.677 . . . . 73.14 109.324 171.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 11.88 54.29 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.133 0.895 . . . . 72.24 113.41 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.8 p 53.14 39.68 30.01 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.662 1.585 . . . . 71.21 112.341 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.626 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 65.5 m-85 -108.44 159.74 29.67 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 124.759 1.224 . . . . 73.4 110.336 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 106.66 0.2 Allowed 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 123.037 2.491 . . . . 53.12 112.483 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.487 ' HG2' ' HG2' ' C' ' 125' ' ' GLN . 12.9 pt20 -50.03 125.26 11.72 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.284 1.434 . . . . 70.44 111.598 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.29 112.97 25.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.276 -1.009 . . . . 73.3 108.276 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -90.38 129.73 36.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.688 0.795 . . . . 63.41 109.091 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -77.5 107.38 9.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.015 0.926 . . . . 73.14 109.214 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' E' ' 129' ' ' LEU . . . -68.26 152.55 96.45 Favored Pre-proline 0 CA--C 1.554 1.107 0 CA-C-N 115.704 -0.68 . . . . 74.43 109.695 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.4 111.21 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.427 2.752 . . . . 73.24 113.034 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.578 HG13 HD22 ' B' ' 44' ' ' LEU . 48.5 t -88.65 110.09 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.743 -1.577 . . . . 74.34 106.743 168.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.64 91.61 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.426 ' HB3' ' HZ2' ' E' ' 120' ' ' TRP . 97.7 m-85 -56.09 -42.76 77.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.091 0.956 . . . . 74.34 111.25 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.07 -54.59 45.31 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.49 -1.232 . . . . 72.53 110.908 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.1 63.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.449 -0.796 . . . . 72.11 112.164 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.469 HD13 ' HB2' ' E' ' 125' ' ' TYR . 5.6 tt -57.14 -55.21 37.64 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.196 0.998 . . . . 71.4 109.595 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -75.24 -28.77 60.01 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.686 -1.143 . . . . 72.42 110.587 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 51.3 ttm -61.3 -37.52 83.5 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.767 0.827 . . . . 72.34 111.035 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -75.08 -29.03 60.55 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.004 -0.998 . . . . 72.03 110.356 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -67.75 -33.08 74.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.185 0.594 . . . . 70.02 110.138 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 65.7 mt -90.3 35.69 0.87 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.802 0.841 . . . . 73.23 111.566 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -67.11 103.39 1.19 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 120.985 0.421 . . . . 64.01 110.34 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.51 -55.4 0.2 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.526 -0.916 . . . . 71.52 108.526 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -81.13 107.99 14.41 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.65 -0.5 . . . . 74.31 109.65 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.63 -29.9 68.34 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.113 0.965 . . . . 62.13 111.077 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.03 -151.99 24.14 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.306 -0.861 . . . . 61.2 111.359 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.05 159.02 22.79 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.006 0.923 . . . . 74.01 109.294 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.48 125.31 0.92 Allowed Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.584 -0.341 . . . . 42.24 112.356 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.6 t -140.45 119.89 13.12 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.448 -0.945 . . . . 74.24 108.448 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.09 142.9 32.86 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.414 0.685 . . . . 71.45 110.126 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.71 173.17 9.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.865 0.866 . . . . 73.34 111.435 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -131.87 144.71 51.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.259 -0.645 . . . . 75.02 109.259 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -95.37 174.99 6.75 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.169 0.588 . . . . 64.22 109.855 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.62 113.73 9.97 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.854 -0.795 . . . . 71.51 108.854 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.238 0 C-N-CA 123.679 0.792 . . . . 74.45 111.084 -171.551 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.884 -0.784 . . . . 74.54 108.884 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p -160.5 84.98 0.71 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.176 0.991 . . . . 75.31 109.166 -177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.23 126.47 6.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.504 -0.925 . . . . 73.22 108.504 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -173.28 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.657 -1.238 . . . . 75.33 107.657 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -95.83 177.76 5.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.838 -1.073 . . . . 70.34 110.428 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -78.73 107.72 11.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.314 -0.857 . . . . 74.45 108.924 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -66.94 -25.78 66.52 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 123.956 0.785 . . . . 74.44 110.214 173.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 61.86 117.86 0.02 OUTLIER 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.43 1.892 . . . . 75.43 112.976 175.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.472 ' HE2' HG12 ' C' ' 89' ' ' ILE . 38.2 ttm 64.32 114.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.502 1.121 . . . . 71.42 111.798 177.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -85.78 85.93 7.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.879 -0.786 . . . . 72.41 108.879 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.409 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -105.17 121.49 43.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.389 -1.278 . . . . 74.23 108.093 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.23 137.2 38.83 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.367 -0.605 . . . . 74.31 109.367 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 49.5 mt -81.29 121.51 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.105 -0.952 . . . . 74.0 109.241 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 23.0 mm-40 -89.47 -49.6 6.59 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.194 0.598 . . . . 72.43 109.965 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.431 ' HA ' HD22 ' A' ' 127' ' ' ASN . 53.2 ttt180 -164.01 122.69 1.91 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.61 0.364 . . . . 72.24 110.538 -176.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.62 136.33 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.436 ' HE2' ' HD3' ' C' ' 19' ' ' LYS . 36.0 p90 -169.07 165.65 11.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.108 0.956 . . . . 75.15 112.855 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -87.01 111.73 21.15 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.732 -1.576 . . . . 73.13 108.838 173.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 57.9 mmtt -65.29 -48.46 73.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.389 1.09 . . . . 74.13 108.49 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -134.62 140.4 46.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.133 -1.848 . . . . 70.34 109.207 -170.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.511 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.6 mt -137.13 143.45 34.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.074 -1.454 . . . . 71.51 107.074 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -160.63 151.04 18.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.389 0.614 . . . . 75.41 109.86 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -152.72 115.22 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.282 -1.377 . . . . 72.21 107.282 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -116.08 109.14 17.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.304 -0.628 . . . . 74.44 109.304 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.15 85.28 15.12 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.382 1.073 . . . . 71.41 108.113 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -35.23 20.29 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 121.927 1.751 . . . . 63.1 110.382 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 77.7 m-20 -98.55 30.58 3.19 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.712 1.205 . . . . 75.43 110.29 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.15 99.96 Favored Pre-proline 0 CA--C 1.57 1.727 0 C-N-CA 124.558 1.143 . . . . 62.52 112.591 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.35 -18.37 4.07 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.169 1.913 . . . . 75.44 113.189 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -69.75 -41.33 75.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.447 0.699 . . . . 74.41 110.529 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.714 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.1 p -66.63 -16.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.553 1.141 . . . . 75.31 112.311 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -62.36 -37.19 84.74 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.087 1.355 . . . . 74.45 112.059 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -118.77 24.93 10.57 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.826 0.822 . . . . 72.54 109.398 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.714 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 20.1 ttpp -123.53 176.12 6.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.05 0.54 . . . . 73.21 110.675 -170.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' C' ' 37' ' ' GLN . 5.0 p-10 -55.24 120.74 7.5 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.379 1.072 . . . . 71.33 111.203 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -90.02 63.31 5.88 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.899 -0.592 . . . . 74.43 109.525 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' C' ' 35' ' ' ASP . 15.4 pt20 -146.16 64.57 9.99 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-O 121.19 0.519 . . . . 71.32 111.147 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.04 134.12 8.05 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 121.724 1.616 . . . . 64.21 110.648 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -84.52 93.67 8.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.37 -1.344 . . . . 75.23 107.37 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 65.8 t -67.39 133.19 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.445 -1.252 . . . . 70.54 110.413 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -130.04 130.22 44.66 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.554 -1.276 . . . . 64.3 107.554 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.521 HD22 ' H ' ' C' ' 42' ' ' LEU . 2.4 pt? -95.49 133.3 39.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.367 -0.975 . . . . 71.03 108.367 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -118.88 141.03 49.02 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.955 -1.498 . . . . 74.2 106.955 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -134.06 143.03 47.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.047 0.451 . . . . 73.54 110.205 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -147.5 149.7 33.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.261 1.024 . . . . 64.01 108.655 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 14.5 t -130.99 144.1 51.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.809 0.444 . . . . 74.02 110.437 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.01 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.282 1.033 . . . . 75.4 108.433 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -130.83 142.37 50.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.834 0.453 . . . . 52.31 110.344 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -160.6 133.41 6.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.815 0.846 . . . . 72.54 109.814 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.21 133.44 40.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.11 0.564 . . . . 53.31 110.168 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.671 HD12 ' HB2' ' C' ' 57' ' ' GLU . 49.0 mt -102.7 -38.56 7.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.226 0.61 . . . . 72.42 110.253 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.452 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -152.19 178.77 9.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.835 0.854 . . . . 74.33 110.097 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.93 116.87 5.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.184 -0.916 . . . . 71.14 109.112 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.98 0.11 2.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.332 1.453 . . . . 75.43 113.11 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.452 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 53.4 t -109.69 108.43 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.301 -0.629 . . . . 75.43 109.301 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -113.59 161.65 17.17 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.923 0.889 . . . . 74.22 109.036 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.671 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.0 tt0 -124.25 141.45 52.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.985 0.914 . . . . 72.24 108.808 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 24.6 m -129.37 134.53 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 122.916 0.486 . . . . 74.14 109.933 168.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' C' ' 46' ' ' THR . 58.0 t -103.41 128.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.681 -1.229 . . . . 73.24 107.681 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.5 96.43 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.133 -1.062 . . . . 73.35 108.133 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -86.47 114.81 23.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.175 -1.375 . . . . 73.32 110.49 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' C' ' 114' ' ' ILE . 46.1 t -109.35 109.94 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.736 -0.838 . . . . 74.4 108.736 172.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -103.55 113.48 27.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.194 0.521 . . . . 73.41 109.603 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.553 HG22 HD12 ' C' ' 114' ' ' ILE . 71.1 t -100.8 109.75 26.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 123.571 0.748 . . . . 74.41 109.206 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 15.2 m -102.0 127.31 48.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.155 -0.683 . . . . 75.31 109.155 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.72 100.2 6.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.651 -1.24 . . . . 55.2 107.651 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -151.15 147.08 26.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.702 -0.681 . . . . 74.42 109.961 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.77 -14.56 56.27 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.254 -0.43 . . . . 75.23 109.919 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.47 -102.18 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 110.977 -0.849 . . . . 71.41 110.977 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.39 -23.38 26.14 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.685 -0.857 . . . . 73.32 108.685 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -79.67 100.87 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.269 1.028 . . . . 71.1 109.02 174.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.0 m -88.97 128.56 35.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.549 -0.75 . . . . 75.03 110.429 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.29 -56.71 4.45 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 62.22 107.914 170.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -154.87 155.92 35.22 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.002 -0.999 . . . . 63.41 110.816 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -121.7 143.63 49.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.358 -2.09 . . . . 75.42 105.358 170.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.6 t -147.08 145.66 29.71 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.258 -1.015 . . . . 73.11 108.258 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.0 128.33 6.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.86 0.362 . . . . 72.41 110.42 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -131.13 139.15 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.69 1.196 . . . . 72.33 108.495 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -113.66 94.69 4.96 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.515 -0.921 . . . . 75.31 108.515 171.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.428 ' O ' HD11 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.77 98.13 7.63 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.319 -0.855 . . . . 74.4 109.114 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.89 144.6 17.24 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.286 -0.726 . . . . 75.55 111.286 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -140.77 128.36 3.74 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 112.369 -0.292 . . . . 73.33 112.369 -172.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.458 HD13 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -91.43 122.96 43.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.898 -1.149 . . . . 75.11 107.898 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -137.84 121.77 17.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.613 0.765 . . . . 74.33 109.61 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 p -84.22 113.4 21.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 71.21 109.127 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 44.2 pt -115.18 127.47 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.577 0.703 . . . . 72.44 109.687 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.62 154.25 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.475 1.11 . . . . 74.53 108.485 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -18.82 38.97 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 120.426 -0.097 . . . . 75.25 112.866 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.472 HG12 ' HE2' ' C' ' 9' ' ' MET . 10.7 tp -123.3 151.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.89 0.876 . . . . 74.22 109.488 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.494 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 14.3 pt-20 -159.82 -179.58 7.96 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.041 0.537 . . . . 63.04 111.183 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.35 -149.35 50.85 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.456 -0.793 . . . . 74.23 114.3 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.7 p -60.79 -24.33 65.72 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.506 1.122 . . . . 74.21 112.002 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -67.72 -51.1 53.31 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.7 1.2 . . . . 71.11 111.189 178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.494 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 21.2 ptt? -70.88 -24.4 62.48 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.917 -0.401 . . . . 64.42 109.917 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.09 84.53 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.715 0.634 . . . . 73.41 110.7 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -63.87 -37.7 88.35 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.504 0.502 . . . . 75.24 110.667 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -65.54 -55.47 17.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.751 -0.463 . . . . 72.52 109.751 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.25 -16.26 63.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.792 0.837 . . . . 73.5 112.238 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.11 3.77 26.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.478 -0.624 . . . . 65.23 114.114 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.13 -64.73 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.558 0.679 . . . . 73.11 110.483 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.63 -55.36 31.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.958 0.503 . . . . 71.43 112.211 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.423 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 18.2 m -60.97 -47.09 96.52 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.574 -0.726 . . . . 74.32 111.883 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 70.6 Cg_exo -50.23 -38.9 52.39 Favored 'Trans proline' 0 C--N 1.396 3.045 0 C-N-CA 122.767 2.311 . . . . 75.02 114.478 165.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.46 -25.52 63.22 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.516 0.726 . . . . 75.13 111.765 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.504 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.54 -41.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.169 0.588 . . . . 74.14 109.665 171.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.428 HD11 ' O ' ' C' ' 80' ' ' GLN . 95.9 mt -75.3 -26.36 58.63 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.074 -0.966 . . . . 73.34 111.848 -175.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.4 -44.01 94.67 Favored Pre-proline 0 CA--C 1.565 1.534 0 CA-C-O 117.637 -1.173 . . . . 75.21 113.764 -172.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.76 -46.22 33.36 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.604 2.203 . . . . 74.21 113.752 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.28 -43.39 77.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.75 0.82 . . . . 72.51 110.908 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.47 98.81 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.637 -0.71 . . . . 72.33 110.317 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -57.48 -50.0 74.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.579 1.152 . . . . 73.33 111.053 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.63 -31.78 71.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.244 0.618 . . . . 73.33 110.212 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.7 t -71.37 -29.7 65.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.217 0.607 . . . . 74.33 111.221 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.553 HD12 HG22 ' C' ' 64' ' ' VAL . 80.8 mt -80.03 -48.65 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 75.03 110.248 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 43.4 m -60.57 -32.11 71.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.664 0.786 . . . . 72.54 110.818 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.8 t -61.63 -51.64 67.66 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.248 -0.887 . . . . 72.24 109.34 171.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.544 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.53 -38.96 92.03 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.71 1.204 . . . . 72.14 113.078 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -60.2 -45.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.199 1.0 . . . . 72.12 109.253 175.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -70.41 -31.11 68.17 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.159 -1.382 . . . . 73.43 111.544 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' C' ' 116' ' ' SER . 83.0 mtt-85 -70.63 -35.67 73.04 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.63 0.772 . . . . 73.43 109.891 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.2 -0.91 90.43 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.32 -0.711 . . . . 44.55 113.173 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p 59.14 62.6 1.8 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.704 1.602 . . . . 73.13 111.693 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 63.1 m-85 -123.57 161.98 42.92 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 114.39 -1.277 . . . . 73.12 110.096 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 30.7 Cg_endo -61.57 158.3 37.45 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.236 2.624 . . . . 74.14 114.317 -173.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.487 ' HG2' ' HG2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -59.61 119.69 8.05 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.022 0.929 . . . . 71.42 110.403 -175.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 54.3 tp -131.01 114.44 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.298 -0.865 . . . . 72.42 108.905 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -123.79 129.71 51.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.425 -0.954 . . . . 74.04 108.425 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 90.9 mt -86.79 121.76 29.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.174 0.59 . . . . 73.45 110.41 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.39 88.33 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 123.414 0.686 . . . . 74.04 110.19 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.453 ' HG2' HD12 ' A' ' 13' ' ' ILE . 42.4 Cg_endo -68.19 143.06 57.71 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.076 1.851 . . . . 74.12 112.136 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.6 108.78 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.773 -1.195 . . . . 74.42 107.773 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -98.48 90.7 4.86 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.463 0.649 . . . . 72.03 111.348 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -75.23 -29.61 60.31 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.925 -1.034 . . . . 75.34 109.425 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -63.28 -42.69 99.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.476 -1.238 . . . . 72.42 111.312 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.65 73.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.684 0.794 . . . . 64.34 111.916 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.85 -47.2 83.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.608 0.763 . . . . 75.21 109.744 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.73 -40.56 69.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.636 0.774 . . . . 75.21 110.972 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -55.06 -34.11 63.3 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.432 1.093 . . . . 74.24 112.636 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.11 -33.34 18.42 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.88 1.272 . . . . 74.52 113.74 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -160.02 0.02 OUTLIER 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 113.028 0.751 . . . . 75.03 113.028 -169.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.404 ' HB3' HE22 ' C' ' 143' ' ' GLN . 5.9 mp -95.41 135.0 37.6 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.805 -1.183 . . . . 73.11 107.805 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -125.46 122.77 37.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.888 0.475 . . . . 74.53 109.819 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.404 HE22 ' HB3' ' C' ' 141' ' ' LEU . 26.2 mp0 -125.39 29.31 6.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.312 0.645 . . . . 75.13 110.121 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -83.84 138.23 33.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.652 -0.499 . . . . 74.4 109.652 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.13 174.28 10.38 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.062 0.945 . . . . 63.43 111.211 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 153.36 57.68 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.472 -0.786 . . . . 72.15 111.702 178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -61.62 144.81 53.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.192 0.597 . . . . 72.22 110.074 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.1 147.79 21.11 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.121 0.263 . . . . 62.42 112.644 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 24.8 m -146.54 133.92 20.74 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.095 -1.446 . . . . 74.52 107.095 166.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.41 -53.36 29.85 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.339 -0.615 . . . . 73.33 109.339 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.1 78.19 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.885 1.674 . . . . 75.14 112.002 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -173.52 17.45 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.772 0.829 . . . . 75.24 109.825 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 75.42 3.09 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.138 -1.06 . . . . 75.44 108.138 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -178.02 117.84 0.09 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.256 1.023 . . . . 73.4 108.242 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.238 0 C-N-CA 123.138 0.575 . . . . 74.5 110.008 179.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.074 -0.713 . . . . 75.41 109.074 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 64.2 m 66.88 116.3 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.197 1.399 . . . . 74.23 111.117 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.2 -168.55 1.71 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.152 0.981 . . . . 75.23 111.097 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.79 -14.51 61.12 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.444 0.698 . . . . 62.43 110.896 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 50.2 t30 71.75 141.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.736 1.215 . . . . 75.24 111.916 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -104.62 174.67 5.78 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.359 -0.978 . . . . 63.23 108.359 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -71.86 76.01 0.88 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.236 1.017 . . . . 70.14 110.248 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.39 -25.46 12.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.545 1.138 . . . . 72.01 108.573 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' D' ' 87' ' ' ALA . 7.9 ttp -32.54 125.82 0.31 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.412 1.485 . . . . 74.35 113.189 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 30.8 m -122.57 142.74 50.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.631 -0.877 . . . . 72.21 108.631 173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' D' ' 85' ' ' SER . 57.3 t80 -154.09 101.36 2.4 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.125 -1.065 . . . . 71.23 108.125 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -132.08 147.0 52.42 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.837 0.855 . . . . 74.32 109.336 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -102.49 105.8 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.672 -0.862 . . . . 75.45 108.672 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -74.84 -45.23 44.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.4 1.08 . . . . 74.12 112.098 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.425 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 54.7 ttt180 -155.3 129.55 8.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.181 0.193 . . . . 72.45 110.512 -170.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.475 HD11 ' N ' ' D' ' 16' ' ' ILE . 2.5 mp -114.43 126.71 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.606 1.162 . . . . 75.05 107.877 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 38.0 p90 -162.87 177.32 9.37 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.946 0.879 . . . . 75.12 112.884 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -112.95 129.61 56.42 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.472 -1.24 . . . . 74.43 109.059 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -98.46 -25.05 14.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.758 0.423 . . . . 74.12 110.782 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.6 t70 -149.81 132.59 15.98 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.733 -0.839 . . . . 73.02 108.733 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.544 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.1 mt -131.83 146.62 33.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.805 -1.183 . . . . 72.54 107.805 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -148.35 142.46 26.0 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.315 1.046 . . . . 70.24 108.913 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.511 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.8 t80 -151.62 124.3 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.219 -1.771 . . . . 72.14 106.219 170.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -131.28 122.65 26.82 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.881 0.872 . . . . 75.33 109.18 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.65 85.0 13.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.573 -0.899 . . . . 73.15 108.573 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.83 -31.58 10.09 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.44 2.094 . . . . 71.33 113.056 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.9 m-20 -114.37 41.65 2.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.429 1.092 . . . . 71.52 108.639 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.41 ' HA ' ' HZ ' ' D' ' 123' ' ' PHE . . . -55.05 -52.75 68.45 Favored Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 115.306 1.595 . . . . 74.12 115.306 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.425 ' HB3' HD11 ' C' ' 83' ' ' ILE . 19.3 Cg_endo -91.06 2.69 4.6 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.8 1.667 . . . . 73.34 112.474 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.416 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 17.3 t-160 -84.39 -42.09 16.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.648 1.179 . . . . 62.54 108.954 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.655 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.2 t -78.16 -11.62 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 C-N-CA 123.595 0.758 . . . . 75.43 110.402 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -55.32 -36.41 66.21 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.954 0.902 . . . . 74.33 111.853 167.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -83.18 -1.72 53.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.653 0.781 . . . . 74.34 112.606 -172.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.407 ' HD3' ' HG ' ' D' ' 68' ' ' LEU . 14.3 ptpt -127.56 107.81 10.25 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.387 0.675 . . . . 73.45 111.155 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.19 92.6 8.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.165 0.986 . . . . 60.03 109.72 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.584 ' HB3' HD12 ' D' ' 68' ' ' LEU . 25.1 t-105 -161.6 166.85 26.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.593 -0.892 . . . . 72.21 108.593 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.8 111.64 39.14 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.284 1.034 . . . . 75.33 109.109 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.61 142.6 49.25 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.968 2.445 . . . . 71.33 113.263 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -75.8 122.55 24.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.144 -0.687 . . . . 65.55 109.144 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.415 HG13 HG13 ' D' ' 64' ' ' VAL . 61.6 t -99.24 135.34 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.836 0.854 . . . . 74.53 110.988 -173.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.627 ' HZ2' ' HB2' ' D' ' 43' ' ' ASP . 35.4 tttm -110.56 138.01 47.5 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.221 -1.029 . . . . 72.53 108.221 164.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.676 HD21 HD12 ' D' ' 128' ' ' LEU . 48.5 tp -101.76 142.41 33.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.024 -1.102 . . . . 71.23 108.024 171.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.627 ' HB2' ' HZ2' ' D' ' 41' ' ' LYS . 19.4 t70 -140.73 128.2 21.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.283 -1.006 . . . . 74.4 108.283 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.6 mt -118.48 150.4 39.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.032 0.533 . . . . 73.3 110.786 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.6 t70 -152.62 132.34 13.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.095 1.358 . . . . 74.52 107.699 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -109.21 153.21 24.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.195 0.522 . . . . 62.14 109.987 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.71 165.65 35.32 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.279 1.032 . . . . 71.43 108.692 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -166.56 161.52 16.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.273 0.629 . . . . 73.14 111.334 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -151.27 152.8 33.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.483 1.113 . . . . 71.42 108.843 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -92.04 119.06 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.031 -0.359 . . . . 73.44 110.031 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.549 HD11 ' HB2' ' D' ' 57' ' ' GLU . 30.9 mt -92.58 -35.79 13.37 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.071 0.548 . . . . 75.32 110.312 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.07 -176.41 5.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.808 0.843 . . . . 74.25 110.24 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.72 107.64 0.63 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.709 0.804 . . . . 72.02 110.525 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 5.9 m-20 62.21 15.91 7.93 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.191 0.996 . . . . 71.32 112.473 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 20.4 t -107.51 125.38 63.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.028 -1.101 . . . . 74.42 108.028 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.23 133.52 45.55 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.759 -0.655 . . . . 74.31 110.849 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.549 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.6 tt0 -87.29 111.8 21.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.557 -1.275 . . . . 74.55 107.557 168.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.71 120.04 47.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 N-CA-C 107.458 -1.312 . . . . 63.11 107.458 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 92.1 t -99.69 140.27 19.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 123.603 0.761 . . . . 74.31 109.488 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.72 122.58 38.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.487 -0.931 . . . . 71.23 108.487 179.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 43.3 ttm-85 -102.42 105.94 16.6 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.12 0.968 . . . . 71.33 108.496 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.3 t -105.97 120.65 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.208 -1.034 . . . . 65.43 108.208 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.8 m -123.96 130.71 53.04 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.413 0.685 . . . . 63.05 109.876 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.47 HG21 HD12 ' D' ' 114' ' ' ILE . 90.7 t -116.21 117.86 56.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.878 1.271 . . . . 64.41 109.35 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -111.88 93.73 4.6 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.886 -1.153 . . . . 72.51 107.886 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.57 137.18 42.79 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.304 0.641 . . . . 71.31 109.764 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 61.7 p -142.39 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.357 0.663 . . . . 75.11 109.52 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.584 HD12 ' HB3' ' D' ' 36' ' ' TRP . 15.2 tp -120.26 115.98 24.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.195 0.598 . . . . 71.33 109.422 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 -123.68 6.28 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.067 -0.813 . . . . 62.32 111.067 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.25 4.36 20.83 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.45 0.7 . . . . 73.11 110.663 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.03 162.98 16.26 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.711 0.805 . . . . 52.03 109.74 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.2 m -76.23 136.79 39.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.548 -0.538 . . . . 73.02 109.548 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.655 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -93.07 -55.28 3.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.25 -0.886 . . . . 71.31 109.434 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -163.14 154.61 17.39 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.137 -0.938 . . . . 74.34 109.745 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.84 148.42 48.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.723 1.209 . . . . 71.14 108.184 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 46.4 t -157.53 147.36 20.4 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.818 0.447 . . . . 64.22 110.244 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -156.45 133.23 10.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 75.13 109.482 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -133.22 117.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.163 0.585 . . . . 64.41 109.846 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -91.31 88.49 6.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.661 0.785 . . . . 70.41 110.053 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.57 102.61 9.89 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.881 1.272 . . . . 72.33 109.355 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.74 141.43 15.63 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.626 -0.589 . . . . 73.21 111.626 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.66 132.04 5.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.138 -0.785 . . . . 70.21 111.138 -177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -89.06 108.22 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.34 -0.615 . . . . 74.33 109.34 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.03 126.16 51.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.761 0.824 . . . . 73.43 110.09 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.458 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 42.7 m -78.2 114.36 17.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.823 0.849 . . . . 71.13 108.945 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 73.3 mt -108.14 144.11 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.131 -1.433 . . . . 72.11 107.131 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' D' ' 9' ' ' MET . . . -162.05 151.44 15.97 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.262 -0.644 . . . . 75.05 109.262 173.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 1.76 53.83 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 123.815 0.697 . . . . 74.54 114.782 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.52 139.36 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.443 0.697 . . . . 74.54 110.574 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 -171.0 3.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.046 0.939 . . . . 75.22 110.386 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.8 -133.79 14.12 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.52 0.512 . . . . 72.23 113.221 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -63.81 -37.54 87.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.688 0.795 . . . . 74.42 111.386 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -71.24 -36.45 71.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.96 0.504 . . . . 72.1 112.147 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -70.13 -34.7 73.39 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.443 0.565 . . . . 73.42 109.926 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.9 -31.38 69.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.643 0.777 . . . . 64.11 110.677 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -75.32 -30.41 60.32 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.65 1.18 . . . . 74.34 110.527 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' D' ' 102' ' ' CYS . 73.5 m -68.36 -51.32 45.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.557 -0.534 . . . . 75.21 109.557 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.22 -24.32 64.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.024 0.53 . . . . 75.0 111.441 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.46 -0.4 37.47 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.799 -1.0 . . . . 71.42 114.719 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.87 -62.58 0.11 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.47 1.135 . . . . 72.44 112.408 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.97 -49.34 29.74 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.775 0.657 . . . . 74.52 112.775 -164.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' D' ' 97' ' ' CYS . 58.7 m -63.9 -45.89 81.14 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.541 -0.742 . . . . 60.41 111.691 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.475 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 89.3 Cg_exo -54.06 -35.31 81.07 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.723 2.282 . . . . 74.45 113.83 166.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.244 0.618 . . . . 75.5 111.258 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -67.46 -43.33 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.561 0.744 . . . . 64.3 110.314 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 94.3 mt -75.52 -23.42 56.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.982 -1.008 . . . . 74.44 112.35 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -64.98 -42.42 61.97 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 117.917 -1.039 . . . . 62.32 113.694 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.05 -42.87 63.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.113 1.876 . . . . 72.14 113.4 170.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -72.83 -36.69 67.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.817 0.847 . . . . 73.23 111.619 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.57 -43.12 77.25 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.451 0.7 . . . . 75.12 110.462 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -59.58 -48.18 82.66 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.2 1.0 . . . . 73.24 110.291 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.53 -46.17 91.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.26 0.975 . . . . 73.31 111.372 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -57.84 -41.15 81.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.186 0.929 . . . . 72.51 110.575 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.484 HG22 ' SG ' ' D' ' 76' ' ' CYS . 84.3 mt -60.0 -58.64 6.32 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 O-C-N 123.924 0.765 . . . . 70.13 110.145 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 5.6 m -54.02 -41.74 68.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.645 1.178 . . . . 74.32 111.492 -170.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 39.9 t -65.06 -44.87 87.57 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.575 -1.193 . . . . 71.1 110.552 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.501 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 71.2 mtm -68.91 -31.25 70.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.041 0.537 . . . . 74.24 112.232 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.417 HG22 ' O ' ' D' ' 114' ' ' ILE . 89.7 t -70.56 -38.94 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.442 0.697 . . . . 74.44 110.058 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.95 -28.6 57.98 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.626 0.37 . . . . 63.35 110.803 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' D' ' 116' ' ' SER . 81.0 mtt-85 -70.37 -31.41 68.65 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.553 0.741 . . . . 75.35 109.34 171.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.55 8.52 64.89 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.324 -0.853 . . . . 64.33 112.58 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 36.8 p 55.71 26.25 9.18 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.401 1.881 . . . . 75.34 113.809 173.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.41 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 43.8 m-85 -96.9 164.88 17.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 73.45 108.858 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.401 ' HB3' HG23 ' F' ' 136' ' ' VAL . 20.0 Cg_endo -57.69 143.58 94.83 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.254 1.969 . . . . 75.3 110.027 175.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -65.0 150.95 47.17 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.368 0.531 . . . . 71.23 110.839 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.48 100.21 9.79 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.59 92.38 5.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.276 -1.009 . . . . 70.43 108.276 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.676 HD12 HD21 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -70.8 115.07 9.52 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.104 -1.073 . . . . 75.42 108.104 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.433 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -71.65 132.75 85.09 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.489 0.716 . . . . 65.01 111.445 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.5 Cg_exo -65.15 127.34 18.16 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.242 2.628 . . . . 64.52 112.458 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.61 152.07 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.864 0.866 . . . . 75.31 110.49 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -74.69 109.46 8.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.354 0.661 . . . . 75.14 110.607 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.52 -24.63 61.99 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.118 0.967 . . . . 73.01 111.702 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.54 -44.51 93.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.642 0.777 . . . . 74.22 110.748 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.62 71.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.516 0.727 . . . . 63.11 111.735 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.42 -45.29 60.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.303 1.041 . . . . 73.45 109.668 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -61.79 -30.38 70.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.508 1.123 . . . . 74.11 111.67 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 18.3 mmt -55.2 -48.8 73.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.15 0.5 . . . . 75.24 110.585 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -63.45 -34.91 78.79 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.038 -0.983 . . . . 73.2 111.495 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -57.54 -46.57 83.71 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.886 0.874 . . . . 75.15 111.488 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.57 -30.08 68.4 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.684 0.794 . . . . 72.2 111.931 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -84.57 8.98 14.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.781 0.833 . . . . 74.43 112.088 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -122.23 86.43 2.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.77 0.828 . . . . 73.32 109.692 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.91 97.99 2.98 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.502 0.668 . . . . 74.03 110.015 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.54 17.29 0.1 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.407 0.683 . . . . 74.31 111.411 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.19 83.99 1.37 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.611 -0.596 . . . . 73.1 111.611 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -118.34 143.95 46.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.84 0.856 . . . . 74.21 109.705 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.02 88.29 1.35 Allowed Glycine 0 C--N 1.344 0.99 0 O-C-N 123.429 0.455 . . . . 73.02 112.361 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -73.12 161.61 30.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.848 0.859 . . . . 62.23 110.638 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.1 131.38 28.31 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.083 0.468 . . . . 74.43 109.88 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.37 136.56 17.53 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.207 1.003 . . . . 74.05 108.615 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -135.85 149.08 48.92 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.505 1.122 . . . . 73.01 108.387 -175.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 64.01 -174.75 0.16 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.292 1.037 . . . . 64.33 111.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.66 176.49 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 64.2 109.853 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 108.569 -0.9 . . . . 72.34 108.569 175.284 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 110.004 -0.369 . . . . 74.33 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -122.66 155.79 35.68 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.983 0.913 . . . . 73.02 109.913 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.87 170.04 15.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.718 0.807 . . . . 63.14 110.904 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -130.16 172.57 11.64 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.591 -1.186 . . . . 74.34 108.16 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 67.28 -169.52 0.2 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.035 0.934 . . . . 64.45 111.665 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.22 -2.12 33.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.304 1.442 . . . . 74.55 112.075 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -92.92 62.8 3.71 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.786 -0.82 . . . . 71.33 108.786 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.6 HD23 HG12 ' B' ' 86' ' ' ILE . 1.9 pt? -86.43 73.51 10.12 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.571 -1.195 . . . . 74.44 109.891 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . 0.413 ' HB2' HD22 ' B' ' 98' ' ' LEU . 50.1 t80 -155.91 69.64 5.13 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.842 -1.072 . . . . 71.41 109.088 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.11 -30.58 2.63 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.572 2.181 . . . . 61.43 111.331 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.76 141.39 31.45 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.488 1.115 . . . . 74.0 109.061 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 23.7 m -141.0 156.6 46.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.815 -1.18 . . . . 73.43 107.815 173.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.444 ' HZ3' HD22 ' B' ' 136' ' ' LEU . 53.6 m95 -53.39 105.5 0.13 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.833 0.853 . . . . 73.13 111.933 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.3 -63.29 1.14 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.122 -0.944 . . . . 73.03 109.869 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.12 -67.66 0.52 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.01 -0.541 . . . . 73.42 110.903 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . 0.261 1.9 p 65.05 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 C-N-CA 127.577 2.351 . . . . 73.13 114.736 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.8 98.63 3.54 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.321 0.649 . . . . 72.54 110.155 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . 0.469 ' HB2' HD13 ' B' ' 136' ' ' LEU . 93.7 t80 -73.82 123.78 24.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.505 -0.77 . . . . 73.54 109.721 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.75 160.57 14.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.353 0.661 . . . . 72.14 109.827 172.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.07 -152.87 19.04 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.806 -0.518 . . . . 62.14 111.806 -175.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 159.59 43.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.731 0.812 . . . . 74.42 110.802 -173.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . 0.583 ' HB3' ' HB1' ' B' ' 129' ' ' ALA . 4.9 mp -129.52 83.41 2.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.65 -0.87 . . . . 75.21 108.65 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.22 -39.34 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.073 0.949 . . . . 75.04 109.664 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 62.06 -86.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.382 1.473 . . . . 75.42 111.024 -174.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -167.77 106.09 0.58 Allowed Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 107.743 -1.206 . . . . 74.25 107.743 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . 0.473 ' O ' HG22 ' E' ' 136' ' ' VAL . 50.4 Cg_endo -87.0 7.26 4.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.829 2.352 . . . . 72.45 113.664 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp 57.74 -81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.768 1.227 . . . . 65.12 109.756 -175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -175.95 36.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.701 1.6 . . . . 70.12 107.997 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.473 HG22 ' O ' ' E' ' 133' ' ' PRO . 22.0 m -90.29 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 123.114 1.435 . . . . 72.43 110.292 -175.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.59 66.14 1.95 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.2 -1.364 . . . . 71.55 109.35 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 70.48 159.06 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.14 1.376 . . . . 71.5 111.983 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -155.02 162.47 41.07 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.473 0.309 . . . . 75.23 111.039 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 31.0 t -162.32 158.05 23.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.055 0.942 . . . . 64.4 109.257 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 tt -164.98 -49.6 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.121 -0.696 . . . . 70.04 109.121 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 pt -79.54 -19.86 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 74.11 113.743 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -117.38 106.96 13.78 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.476 -0.935 . . . . 73.5 108.476 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.52 -55.17 2.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.477 0.711 . . . . 65.24 109.337 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -147.74 11.59 0.97 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.136 0.975 . . . . 73.2 110.105 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -124.47 142.95 50.92 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.143 0.977 . . . . 75.43 109.673 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 35.1 tp -170.56 -58.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.773 0.829 . . . . 74.3 109.098 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -144.35 79.81 12.48 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 109.09 -0.707 . . . . 63.13 109.09 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--N 1.382 2.295 0 C-N-CA 122.853 2.368 . . . . 74.14 111.275 174.875 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.501 -0.555 . . . . 72.11 109.501 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 -72.27 0.7 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.076 -1.083 . . . . 75.24 108.076 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.5 109.2 17.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.036 0.935 . . . . 62.13 110.922 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -76.35 -60.08 2.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 75.04 109.629 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -136.34 144.47 44.66 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.295 1.038 . . . . 75.42 110.148 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -116.51 142.38 46.95 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.666 0.786 . . . . 64.31 110.628 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.35 72.42 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.609 1.564 . . . . 73.42 112.591 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.567 HD13 ' HH ' ' A' ' 56' ' ' TYR . 10.8 mp -81.2 -15.01 56.94 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.233 -0.894 . . . . 73.0 110.578 172.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . 0.525 ' HH ' ' HA ' ' F' ' 119' ' ' THR . 31.4 t80 -71.21 109.69 5.85 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.18 0.992 . . . . 73.44 109.999 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.04 -52.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.575 2.184 . . . . 75.34 114.431 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -108.32 122.89 47.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.244 1.018 . . . . 74.22 110.256 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 119' ' ' THR . . . . . 0.525 ' HA ' ' HH ' ' F' ' 116' ' ' TYR . 34.6 p -87.42 137.73 32.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.969 0.908 . . . . 70.1 109.62 174.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -93.37 131.04 38.91 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.768 0.427 . . . . 74.23 110.813 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.98 86.66 1.12 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.336 0.655 . . . . 72.33 109.285 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.27 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.837 0.855 . . . . 72.43 110.599 172.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.64 131.11 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.769 -0.826 . . . . 74.33 108.769 171.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -113.88 -58.99 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.087 0.555 . . . . 74.43 111.061 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 63.48 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.052 0.941 . . . . 73.23 109.521 -171.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -54.13 -44.64 71.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.661 1.184 . . . . 73.32 112.72 -168.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -160.02 -141.72 3.21 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.289 -0.414 . . . . 75.11 112.898 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . 0.57 ' HE2' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -84.18 174.32 10.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.989 0.915 . . . . 73.54 110.976 -173.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.549 HD12 HG12 ' A' ' 40' ' ' VAL . 1.2 pp -134.43 6.18 3.52 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.359 1.063 . . . . 73.31 111.912 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . 0.404 HG23 HD11 ' F' ' 129' ' ' LEU . 15.9 pt -120.16 119.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.53 0.732 . . . . 72.03 109.519 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.24 -56.48 3.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.547 0.739 . . . . 60.11 110.107 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -93.59 112.58 57.32 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 108.653 -0.869 . . . . 71.4 108.653 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.27 75.68 4.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.604 2.203 . . . . 73.55 111.882 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.42 92.15 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-O 122.311 1.053 . . . . 64.22 110.382 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.44 24.84 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 114.689 -1.141 . . . . 72.43 108.657 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' D' ' 124' ' ' PRO . 11.3 p -144.58 133.23 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.413 -0.588 . . . . 75.1 109.413 -178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.68 -83.21 0.13 Allowed 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.184 0.594 . . . . 75.13 111.413 -167.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -167.63 161.42 13.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.34 1.056 . . . . 35.0 108.755 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.95 92.82 1.67 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.422 0.63 . . . . 64.51 110.69 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 15.6 m -90.57 -15.41 30.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.53 -1.214 . . . . 73.05 110.52 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.57 69.86 10.69 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.693 0.759 . . . . 73.55 110.055 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -138.72 117.4 13.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.999 -1.482 . . . . 73.32 106.999 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 59.95 -156.23 0.35 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.89 0.876 . . . . 62.55 109.165 -165.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -156.65 -66.22 0.1 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.235 0.471 . . . . 72.31 109.833 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.4 85.02 6.8 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.42 -0.955 . . . . 72.33 108.42 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.78 -167.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.711 1.204 . . . . 75.32 111.991 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 34.7 mt -100.16 -176.64 3.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.287 0.635 . . . . 72.44 109.526 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.23 101.49 9.99 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.449 0.7 . . . . 73.22 109.13 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 C--N 1.383 2.356 0 C-N-CA 123.357 2.704 . . . . 75.23 110.835 -179.848 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.577 0.227 . . . . 63.02 110.433 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -151.0 -149.54 0.31 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.693 1.197 . . . . 72.23 108.722 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 73.47 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.658 1.583 . . . . 72.24 112.166 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -148.57 121.73 8.92 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.829 -1.175 . . . . 73.25 107.829 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.26 142.59 55.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.751 0.821 . . . . 71.02 110.331 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -72.02 136.4 46.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.74 0.416 . . . . 72.12 110.156 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -95.25 128.08 41.81 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.519 0.728 . . . . 74.1 109.703 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.12 137.45 41.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.969 0.907 . . . . 73.33 110.353 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.6 mtt -95.54 132.73 40.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.75 0.42 . . . . 74.12 110.789 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.4 m -157.01 129.57 7.53 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.258 1.423 . . . . 74.3 108.342 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -139.91 114.27 9.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.362 -0.977 . . . . 72.22 108.362 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -150.46 136.73 18.69 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.733 0.301 . . . . 74.3 111.262 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.415 1.086 . . . . 74.21 110.67 169.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.14 -44.56 5.41 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 74.23 109.247 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.46 ' HD2' ' HZ ' ' B' ' 32' ' ' PHE . 78.3 mtt180 -158.79 153.32 24.36 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.328 1.051 . . . . 73.42 110.86 172.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.641 HG21 HD22 ' A' ' 106' ' ' LEU . 4.0 mp -123.2 119.62 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.116 -1.809 . . . . 74.54 106.116 173.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -160.03 167.77 27.13 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 120.947 0.403 . . . . 74.54 111.674 -170.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -91.31 118.29 30.37 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.861 -0.422 . . . . 73.34 109.861 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.04 -26.39 29.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.733 0.413 . . . . 75.2 111.052 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.43 148.3 21.39 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.221 -0.659 . . . . 73.44 109.221 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.603 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.6 mt -145.38 142.6 22.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.233 1.413 . . . . 75.13 107.522 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -148.0 136.73 21.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.401 0.681 . . . . 74.3 109.325 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 79.1 t80 -136.21 143.04 44.15 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.209 -1.404 . . . . 74.3 107.209 171.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.38 147.58 39.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.884 0.873 . . . . 75.03 109.159 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 72.09 11.72 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.613 -1.625 . . . . 64.21 106.613 167.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 -24.44 36.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.228 1.952 . . . . 65.34 111.188 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 58.9 m-20 -113.61 33.51 5.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.519 1.128 . . . . 62.54 109.09 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.98 99.34 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 123.834 0.854 . . . . 72.54 113.04 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.73 -29.31 35.95 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 121.637 1.558 . . . . 74.14 113.006 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.2 m-70 -74.46 -35.77 63.31 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.702 0.401 . . . . 75.43 111.653 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.29 -21.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 121.09 0.471 . . . . 73.03 110.712 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -74.77 -39.66 61.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.498 0.719 . . . . 63.43 110.399 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.22 -26.78 32.97 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.516 0.726 . . . . 75.32 110.771 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.45 173.38 10.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.43 0.692 . . . . 65.33 111.373 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -72.94 138.06 45.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.875 0.87 . . . . 70.24 110.722 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -84.88 69.62 10.78 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.801 0.81 . . . . 74.22 109.57 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -129.23 73.47 81.66 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.039 -0.982 . . . . 74.52 108.711 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.43 158.76 10.96 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.549 2.166 . . . . 62.33 112.173 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.43 127.89 44.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.769 -0.826 . . . . 71.33 108.769 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.419 HG12 ' HB3' ' F' ' 129' ' ' LEU . 46.0 t -72.03 94.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 123.75 0.656 . . . . 71.32 109.28 176.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -102.86 115.03 29.8 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.702 -1.221 . . . . 74.04 107.702 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.91 148.57 43.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.378 0.671 . . . . 75.34 109.702 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.595 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 27.7 m-20 -141.35 149.07 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.979 1.311 . . . . 74.52 108.847 170.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.92 160.93 22.46 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.064 -0.717 . . . . 75.22 109.064 169.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -159.28 144.64 15.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.492 0.717 . . . . 75.1 109.368 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 m -127.33 135.52 50.65 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.086 0.954 . . . . 74.44 108.829 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.83 133.02 45.57 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.157 0.983 . . . . 72.21 109.308 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -92.95 153.28 18.85 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.599 0.759 . . . . 73.25 110.59 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.7 t -160.45 138.91 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 72.54 108.622 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.9 122.17 42.6 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.92 -34.04 13.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.69 0.796 . . . . 74.0 111.976 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.87 -177.56 6.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 65.44 109.618 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.64 117.09 7.59 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.722 -0.844 . . . . 75.04 108.722 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 74.2 m-20 68.05 8.98 6.88 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.433 1.093 . . . . 71.51 112.776 -178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -112.09 106.38 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.777 -1.194 . . . . 74.51 107.777 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -107.78 162.51 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.594 0.711 . . . . 75.41 109.518 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -133.16 125.23 29.02 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.699 1.2 . . . . 74.42 108.35 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -107.49 121.01 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.212 -1.403 . . . . 75.53 107.212 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.501 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.4 t -99.53 136.73 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.538 -0.912 . . . . 73.14 108.538 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.08 114.1 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -104.7 128.6 52.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.871 0.868 . . . . 75.42 108.841 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -116.09 129.93 71.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.558 -0.904 . . . . 75.2 108.558 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 14.4 m -110.52 134.7 52.13 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.801 -0.815 . . . . 72.3 108.801 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 114' ' ' ILE . 53.0 t -135.18 106.57 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.437 1.095 . . . . 73.05 108.48 -174.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 45.6 m -104.25 138.31 40.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.413 -0.588 . . . . 75.23 109.413 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.31 112.17 17.8 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.167 -1.42 . . . . 54.22 107.167 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.7 m -130.95 129.37 42.08 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.195 0.598 . . . . 73.53 109.576 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.449 HD21 ' H ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -87.76 85.16 7.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.459 1.123 . . . . 73.2 108.479 177.254 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -86.65 1.28 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 114.23 -1.35 . . . . 64.32 111.237 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -121.74 -26.1 4.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.485 0.714 . . . . 74.41 110.878 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.78 127.51 32.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.956 0.502 . . . . 62.31 109.791 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.2 m -75.0 122.64 23.81 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.715 -0.476 . . . . 74.2 109.715 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.97 -51.66 11.92 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.59 -0.893 . . . . 73.23 108.59 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -166.73 169.58 13.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.479 -1.237 . . . . 74.34 110.239 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.417 HD11 ' H ' ' A' ' 76' ' ' CYS . 31.7 tp -137.13 143.34 42.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.252 1.021 . . . . 74.42 109.079 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.417 ' H ' HD11 ' A' ' 75' ' ' LEU . 21.2 m -135.5 136.69 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.334 1.054 . . . . 74.34 108.605 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.88 125.13 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.303 -0.628 . . . . 64.35 109.303 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.54 130.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 123.825 0.85 . . . . 71.51 109.653 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -103.41 90.92 3.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.375 1.07 . . . . 74.42 108.815 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.46 92.34 5.24 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.052 -1.092 . . . . 71.42 108.052 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.87 144.96 17.99 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.305 -0.718 . . . . 72.31 111.305 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.88 132.73 5.7 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.253 -0.739 . . . . 61.54 111.253 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.1 mt -85.12 128.71 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.435 -0.95 . . . . 75.41 108.435 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -134.98 118.26 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.636 -0.876 . . . . 74.14 108.636 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.4 t -85.29 99.09 10.9 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.621 -0.881 . . . . 75.24 108.621 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.87 141.8 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.818 0.847 . . . . 75.22 109.553 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB3' ' HB3' ' A' ' 54' ' ' ASP . . . -177.03 152.51 0.91 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.877 0.871 . . . . 72.11 110.965 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.33 64.69 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.463 0.477 . . . . 73.41 113.934 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.454 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.2 mp -110.98 147.59 14.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.512 -1.292 . . . . 70.02 107.512 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -142.19 176.07 9.26 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.906 0.882 . . . . 74.44 108.63 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.97 -152.72 52.51 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.238 -0.437 . . . . 70.44 113.172 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.481 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 26.0 p -70.74 -15.33 62.68 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.197 0.999 . . . . 74.42 112.617 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -73.55 -42.23 61.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.045 0.538 . . . . 74.3 110.448 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.493 ' HG2' ' HB3' ' F' ' 115' ' ' LEU . 1.3 tpt -76.69 -31.38 57.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.724 -0.473 . . . . 71.1 109.724 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' HB2' ' HA ' ' A' ' 92' ' ' THR . . . -64.79 -32.59 74.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.697 0.799 . . . . 71.42 111.167 174.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.465 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 5.6 t-80 -61.9 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.64 -0.709 . . . . 75.53 110.019 170.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.3 m -73.44 -47.55 40.76 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.592 0.59 . . . . 64.32 112.592 -173.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -86.62 -23.69 25.61 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 111.75 0.278 . . . . 74.41 111.75 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.85 5.22 34.48 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.25 -0.75 . . . . 63.51 113.949 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.768 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.52 -60.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.169 0.985 . . . . 74.35 112.21 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.606 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -53.03 -60.17 3.62 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.544 1.138 . . . . 73.43 111.052 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 69.7 m -61.4 -51.8 74.96 Favored Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 114.167 1.173 . . . . 71.31 114.167 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.62 -26.64 75.79 Favored 'Trans proline' 0 C--N 1.394 2.954 0 CA-C-N 121.914 1.719 . . . . 71.53 113.609 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.72 -26.2 44.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.957 0.503 . . . . 72.54 110.833 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 25.6 mm -67.02 -42.35 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 121.661 0.743 . . . . 71.4 109.681 171.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.641 HD22 HG21 ' A' ' 16' ' ' ILE . 50.3 mt -79.86 -29.36 40.03 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.562 -1.199 . . . . 75.3 112.484 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.3 -42.63 81.72 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.514 1.302 . . . . 60.51 114.514 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.21 -35.48 95.48 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.296 1.997 . . . . 65.34 113.429 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -85.23 -29.57 24.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.607 0.763 . . . . 74.24 111.222 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.87 76.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.999 0.52 . . . . 73.45 109.779 173.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -58.41 -48.51 80.44 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.546 1.154 . . . . 74.43 109.968 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' C' ' 108' ' ' PRO . 2.9 tm-20 -61.73 -44.85 96.11 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.014 0.821 . . . . 74.1 111.062 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.482 ' HA ' ' NH1' ' B' ' 120' ' ' ARG . 42.0 t -62.87 -41.21 99.3 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.909 0.756 . . . . 74.42 111.491 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.468 HG21 HG22 ' A' ' 64' ' ' VAL . 79.2 mt -66.28 -57.24 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.453 0.701 . . . . 74.45 110.534 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.413 HG21 ' HG3' ' A' ' 125' ' ' GLN . 94.4 m -53.45 -39.57 64.54 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.904 1.282 . . . . 72.24 111.778 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.24 -42.38 79.79 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.181 -0.918 . . . . 63.04 110.444 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.431 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 63.8 mtm -61.06 -37.73 83.68 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.731 0.412 . . . . 71.14 111.307 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 114' ' ' ILE . 80.9 t -59.66 -49.21 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.05 0.94 . . . . 72.03 110.458 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 83.5 p -71.59 -29.48 64.75 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.597 -0.728 . . . . 74.14 111.482 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.408 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -71.81 -29.89 64.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.588 0.755 . . . . 75.13 110.061 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.68 55.69 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.53 -0.759 . . . . 70.12 112.855 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.4 m 69.24 35.5 2.65 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-O 123.058 1.409 . . . . 62.31 109.63 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -115.33 149.94 43.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 114.818 -1.083 . . . . 73.42 109.34 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.85 151.96 73.61 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.561 2.174 . . . . 74.1 111.055 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.413 ' HG3' HG21 ' A' ' 115' ' ' THR . 2.3 tt0 -58.78 133.73 56.22 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.639 0.607 . . . . 73.41 112.639 -175.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.05 95.2 4.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.101 -1.074 . . . . 74.33 108.101 168.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -98.94 126.66 44.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.339 -0.985 . . . . 73.4 108.339 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -74.0 150.26 40.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.625 -0.716 . . . . 74.41 110.736 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.57 143.62 98.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.308 0.643 . . . . 63.24 110.881 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.96 109.58 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.475 2.117 . . . . 72.25 111.371 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.53 111.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.308 -1.738 . . . . 71.1 106.308 174.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.03 70.55 10.5 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.317 -1.364 . . . . 72.33 107.317 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -69.05 -28.76 66.83 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.699 -1.591 . . . . 74.1 111.374 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.768 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 6.4 p-10 -59.95 -47.69 84.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.858 -1.065 . . . . 72.31 111.264 172.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.33 65.76 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.943 0.497 . . . . 75.33 111.714 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.6 -38.16 83.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.204 0.602 . . . . 74.41 111.65 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -87.87 -43.54 11.74 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.294 0.638 . . . . 75.0 111.14 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -33.22 73.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.558 0.743 . . . . 72.41 111.995 -168.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -65.11 -31.93 73.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.233 0.54 . . . . 75.11 110.208 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -75.84 -35.34 59.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.33 -0.85 . . . . 73.42 110.56 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 43.0 tp -67.38 -51.6 50.07 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 112.483 0.549 . . . . 74.12 112.483 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -153.28 7.59 0.39 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 111.531 0.197 . . . . 74.33 111.531 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 61.45 -154.43 0.36 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.362 0.665 . . . . 71.53 111.656 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -75.31 79.4 2.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.798 0.839 . . . . 74.52 109.528 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.8 22.09 0.39 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.008 0.523 . . . . 43.13 111.651 -172.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.67 142.55 38.7 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 111.946 -0.461 . . . . 55.25 111.946 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -123.31 -73.19 0.65 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.456 0.628 . . . . 74.34 110.922 -171.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' C' ' 142' ' ' GLN . . . 100.71 169.93 28.83 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.645 -0.252 . . . . 72.51 112.754 -175.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -156.87 144.04 18.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 74.32 109.969 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.4 93.48 2.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.939 0.876 . . . . 75.34 108.835 167.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -79.04 -12.35 60.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.803 -1.544 . . . . 65.04 109.866 169.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.6 t60 80.93 -27.62 0.14 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.926 1.69 . . . . 71.54 112.487 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -59.24 144.52 45.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.634 0.773 . . . . 73.24 110.732 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.0 -37.37 64.44 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.741 0.416 . . . . 75.34 110.635 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 124.03 0.932 . . . . 75.44 109.063 -179.819 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.481 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.143 0.497 . . . . 74.24 110.245 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -169.5 157.18 7.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.561 1.144 . . . . 74.13 109.614 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.26 129.86 15.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.711 0.404 . . . . 71.51 111.499 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -169.48 139.46 2.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.882 1.273 . . . . 75.21 109.343 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -134.47 -18.48 1.95 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.7 0.8 . . . . 74.35 111.15 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -76.86 78.46 3.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.968 0.907 . . . . 74.54 109.805 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 25.7 p 70.86 -51.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.544 2.337 . . . . 63.32 114.743 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.85 -13.67 61.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.569 1.148 . . . . 74.11 113.068 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.509 ' SD ' HD13 ' B' ' 89' ' ' ILE . 18.8 ptm 53.21 -172.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.057 1.743 . . . . 74.1 113.29 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 98.0 m -140.13 127.72 21.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.706 0.802 . . . . 75.12 109.576 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.03 130.28 37.31 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -150.97 138.94 19.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.334 0.654 . . . . 72.11 109.237 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.53 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -90.17 128.68 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.451 -0.944 . . . . 74.32 108.451 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.471 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 10.4 mm100 -94.09 -49.87 5.56 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.314 -0.624 . . . . 74.24 109.314 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -164.05 146.07 9.04 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.678 -0.692 . . . . 75.02 109.17 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.15 145.78 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.047 -1.464 . . . . 74.22 107.047 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -169.71 146.28 3.23 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.452 0.569 . . . . 72.42 112.362 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -73.54 116.12 13.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.036 -0.984 . . . . 73.32 108.374 168.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -86.81 -34.16 19.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.672 -0.695 . . . . 75.55 110.691 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.48 142.09 18.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.645 -0.252 . . . . 61.33 110.56 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.472 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.0 mm -132.49 144.35 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.752 1.221 . . . . 71.43 109.081 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.453 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.0 t -141.88 131.91 24.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 75.21 107.591 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.603 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -144.64 122.31 11.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.158 -1.423 . . . . 71.41 107.158 169.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 48.2 mt-10 -124.64 134.72 52.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.556 0.743 . . . . 73.44 109.174 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.512 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -132.2 80.75 63.15 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.497 -0.927 . . . . 73.12 108.497 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.69 -31.88 19.97 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.983 2.455 . . . . 75.34 111.71 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 40.8 m-80 -117.99 28.53 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.133 0.973 . . . . 74.32 109.887 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -49.46 -50.41 65.73 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.013 1.325 . . . . 75.03 113.82 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -79.05 -12.31 14.56 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.123 1.882 . . . . 75.11 112.83 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.457 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 68.2 m-70 -98.49 -6.83 29.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.075 0.95 . . . . 74.23 111.681 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.428 HG13 ' HE1' ' B' ' 123' ' ' PHE . 6.9 p -68.59 -15.7 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.191 0.596 . . . . 74.42 111.26 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . 0.46 ' HZ ' ' HD2' ' A' ' 15' ' ' ARG . 75.8 m-85 -76.18 -7.78 55.58 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.724 0.81 . . . . 74.22 111.781 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -82.33 -32.3 29.45 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.689 0.757 . . . . 54.31 109.095 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.491 ' HZ1' ' HA3' ' B' ' 69' ' ' GLY . 12.4 mmmm -106.73 90.83 3.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.527 -1.215 . . . . 75.53 110.556 -162.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.56 84.97 2.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.943 0.402 . . . . 73.23 110.427 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -153.45 -179.45 7.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.477 1.511 . . . . 75.3 108.052 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -78.82 118.63 73.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.142 -1.058 . . . . 73.33 108.142 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.72 149.92 67.78 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.477 2.118 . . . . 73.51 110.994 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.42 104.21 3.71 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.587 -0.894 . . . . 71.04 108.587 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.465 HG11 HD21 ' B' ' 126' ' ' LEU . 39.4 t -95.72 137.06 24.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.485 -0.78 . . . . 73.0 110.189 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -130.04 119.29 22.89 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.266 1.026 . . . . 74.43 108.405 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.691 HD13 HG21 ' B' ' 64' ' ' VAL . 1.6 mm? -104.44 134.96 46.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.942 -0.762 . . . . 75.02 108.942 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -137.45 153.32 50.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.074 0.95 . . . . 65.34 109.573 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.15 150.07 42.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.987 0.915 . . . . 74.32 109.727 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.1 t70 -136.7 141.75 43.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.103 0.961 . . . . 71.14 108.624 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.2 p -113.41 104.34 12.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.44 0.696 . . . . 72.44 109.445 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.66 156.63 33.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.038 0.935 . . . . 71.24 109.014 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -145.11 173.78 11.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 75.05 110.462 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -156.61 133.96 10.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.985 0.914 . . . . 73.3 109.016 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -81.38 120.75 25.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.964 0.506 . . . . 71.42 110.835 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -88.08 -37.87 15.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.425 0.69 . . . . 74.13 110.114 174.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.5 -176.11 5.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.873 0.869 . . . . 74.12 110.618 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.73 116.19 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.696 -1.138 . . . . 71.45 109.527 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' B' ' 85' ' ' SER . 20.3 m-20 72.18 -5.1 1.83 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.493 1.517 . . . . 64.23 112.872 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -105.19 96.41 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.523 -0.917 . . . . 75.02 108.523 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -112.34 138.44 49.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.815 -0.629 . . . . 74.51 109.313 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -101.95 97.57 7.9 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 125.192 1.397 . . . . 72.03 107.518 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -90.9 121.02 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.91 0.884 . . . . 74.23 110.198 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.566 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -102.97 120.82 53.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.544 0.738 . . . . 74.23 110.315 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.2 121.54 34.68 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.908 -1.516 . . . . 63.4 106.908 170.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 61.6 ttt180 -110.5 108.93 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.275 -0.639 . . . . 74.42 109.275 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.63 121.14 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.304 -0.999 . . . . 71.24 108.304 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.1 m -116.29 130.64 56.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.097 0.475 . . . . 75.35 109.896 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.691 HG21 HD13 ' B' ' 42' ' ' LEU . 51.8 t -111.37 135.46 50.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.912 1.285 . . . . 74.44 110.132 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 30.9 m -124.76 144.58 50.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.604 -0.887 . . . . 73.43 108.604 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 125.31 11.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.387 -0.968 . . . . 71.45 108.387 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.4 m -138.62 134.5 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.084 -0.71 . . . . 72.44 109.084 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 22.4 tp -133.57 122.94 24.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.779 -0.823 . . . . 71.23 108.779 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . 0.491 ' HA3' ' HZ1' ' B' ' 34' ' ' LYS . . . 73.99 -131.39 13.82 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.594 0.559 . . . . 71.32 112.573 -176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -93.78 1.41 56.49 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 75.15 111.147 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.73 155.83 48.15 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.101 0.56 . . . . 75.42 110.984 -167.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 130.53 39.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.685 -0.689 . . . . 73.24 109.665 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.02 -56.19 4.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.576 0.751 . . . . 65.3 109.208 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.68 161.47 23.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.772 -1.104 . . . . 72.43 109.739 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 95.4 mt -132.53 146.96 52.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.886 1.275 . . . . 62.23 108.22 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -150.15 157.15 42.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.195 -0.668 . . . . 75.33 109.195 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.453 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.4 tt0 -165.43 131.48 2.67 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.408 -0.96 . . . . 74.05 108.408 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.437 HG21 HD12 ' B' ' 21' ' ' ILE . 98.1 t -125.02 144.0 36.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.897 0.879 . . . . 73.34 108.693 175.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 19.7 mt-30 -122.84 89.87 3.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.711 -0.848 . . . . 73.14 108.711 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -81.68 100.01 9.23 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.14 -0.937 . . . . 61.13 108.502 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.566 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.61 169.97 37.93 Favored Glycine 0 C--O 1.244 0.78 0 N-CA-C 111.062 -0.815 . . . . 74.14 111.062 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.11 127.36 1.43 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.086 -0.806 . . . . 64.23 111.086 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 21.3 mt -84.98 129.52 37.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.623 -1.251 . . . . 75.22 107.623 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -132.25 162.51 30.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.474 1.11 . . . . 64.53 108.572 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 73.7 m -129.11 108.17 10.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.616 0.767 . . . . 62.02 109.042 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.427 ' H ' HD12 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -119.02 127.28 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.175 1.39 . . . . 75.43 108.782 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.625 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -140.6 145.53 36.81 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.628 0.771 . . . . 54.34 110.118 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -29.81 3.86 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.66 0.6 . . . . 54.13 114.237 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.509 HD13 ' SD ' ' B' ' 9' ' ' MET . 19.4 tt -78.4 139.51 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.683 0.793 . . . . 75.23 110.718 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.31 165.87 35.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.753 0.821 . . . . 74.33 111.608 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' E' ' 112' ' ' GLN . . . 69.29 -131.61 24.88 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.285 -0.871 . . . . 75.22 114.104 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -66.08 -36.66 83.78 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.385 1.074 . . . . 73.21 110.731 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.46 -34.64 72.65 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.45 -1.25 . . . . 73.11 110.096 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.468 ' HG3' HD21 ' E' ' 115' ' ' LEU . 56.9 ttp -52.95 -53.05 55.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.646 1.178 . . . . 75.21 110.732 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.34 72.51 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.279 -0.873 . . . . 73.31 111.924 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.467 ' HD1' ' HD2' ' B' ' 137' ' ' PHE . 20.4 t60 -71.03 -25.15 62.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.963 0.905 . . . . 73.12 110.969 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.13 -69.08 0.71 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.467 0.307 . . . . 73.03 111.464 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.8 pp -73.45 -22.86 60.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.542 0.571 . . . . 75.25 112.542 -170.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.87 -25.58 24.52 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.462 0.476 . . . . 64.23 112.508 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -122.91 -54.95 1.81 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.383 0.512 . . . . 63.21 112.383 -170.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -72.61 -48.66 37.82 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.554 0.576 . . . . 74.32 112.554 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.451 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.9 m -59.69 -48.09 96.07 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 118.608 -0.71 . . . . 74.3 111.482 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.451 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 75.2 Cg_exo -57.11 -34.87 98.55 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.426 2.084 . . . . 71.4 114.117 169.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -63.14 -34.17 77.05 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 122.95 0.5 . . . . 74.23 111.054 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.37 -47.44 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.889 0.876 . . . . 73.12 110.401 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.3 mt -80.75 -19.6 44.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.954 -1.021 . . . . 74.52 112.742 -169.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -63.23 -46.85 85.75 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.41 -1.281 . . . . 62.54 113.63 -171.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.31 -37.0 97.63 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.055 1.837 . . . . 73.15 113.688 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -67.78 -48.92 64.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.101 0.56 . . . . 74.31 110.38 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.88 86.75 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.25 -0.886 . . . . 74.34 111.04 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.628 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.8 ttt180 -57.75 -57.83 11.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.679 1.591 . . . . 75.45 110.679 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.15 -31.09 71.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.07 -0.968 . . . . 72.1 110.538 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.472 ' SG ' HD13 ' B' ' 21' ' ' ILE . 5.2 t -70.9 -38.6 73.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.989 0.516 . . . . 71.51 111.361 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.658 HG21 HG22 ' B' ' 64' ' ' VAL . 77.3 mt -64.4 -50.13 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.267 0.627 . . . . 73.3 109.907 175.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.426 HG22 ' OG ' ' C' ' 119' ' ' SER . 20.6 m -58.16 -36.44 73.01 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.489 -1.232 . . . . 74.44 110.956 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.455 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.2 t -64.84 -45.37 86.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.357 -1.292 . . . . 64.44 110.719 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 38.0 mmt -59.44 -45.22 92.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.106 0.562 . . . . 74.5 111.711 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.642 0.777 . . . . 73.42 111.54 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.3 p -70.34 -28.4 65.11 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.725 -0.67 . . . . 73.32 112.086 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 113' ' ' CYS . 86.6 mtt-85 -67.07 -30.44 70.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.352 0.661 . . . . 75.32 111.232 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 13.26 39.64 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-O 119.613 -0.549 . . . . 73.52 112.94 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.6 p 54.81 23.65 5.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.441 1.896 . . . . 63.13 113.009 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG13 ' B' ' 31' ' ' VAL . 37.9 m-85 -89.97 156.92 46.53 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.76 0.824 . . . . 75.11 109.337 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.8 121.47 10.08 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 74.03 110.712 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.486 ' H ' ' HB2' ' C' ' 125' ' ' GLN . 4.9 pp0? -58.94 152.38 19.71 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.912 0.757 . . . . 65.21 112.284 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.465 HD21 HG11 ' B' ' 40' ' ' VAL . 1.4 tm? -111.32 105.5 14.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.766 -1.198 . . . . 75.24 107.766 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -90.85 112.59 24.49 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.963 -1.125 . . . . 73.33 107.963 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.628 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.13 117.98 10.68 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.676 -0.861 . . . . 74.25 108.676 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.65 87.64 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.636 0.585 . . . . 72.01 110.654 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.29 86.36 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.682 2.255 . . . . 74.3 112.571 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 80.7 t -91.13 110.79 22.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.585 -0.895 . . . . 74.13 108.585 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -88.61 109.79 20.39 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.165 -0.68 . . . . 73.24 109.165 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.86 -33.46 75.75 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.505 1.122 . . . . 73.42 109.826 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.45 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -59.93 -44.5 94.29 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.031 -1.441 . . . . 75.34 110.918 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.16 67.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.587 0.755 . . . . 74.34 111.557 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.35 -49.98 69.55 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.807 0.443 . . . . 75.3 110.393 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.467 ' HD2' ' HD1' ' B' ' 96' ' ' HIS . 68.5 t80 -69.95 -31.64 69.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.026 -0.534 . . . . 75.11 111.197 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 48.3 ttm -62.46 -37.16 84.86 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.732 0.813 . . . . 74.34 110.61 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -77.97 -21.02 51.59 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.741 -1.118 . . . . 71.42 110.747 -175.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -76.1 -24.14 54.97 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.392 0.677 . . . . 75.21 110.535 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.37 16.51 6.29 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.656 0.783 . . . . 72.31 110.022 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.575 ' HG2' ' HG2' ' B' ' 143' ' ' GLN . 29.6 tt0 67.54 -84.69 0.03 OUTLIER 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.647 1.579 . . . . 75.33 110.219 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.575 ' HG2' ' HG2' ' B' ' 142' ' ' GLN . 28.8 pt20 -171.81 15.65 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.32 1.048 . . . . 73.34 110.376 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -75.53 129.07 36.64 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.429 0.692 . . . . 71.23 110.064 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.44 99.58 11.75 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.241 0.616 . . . . 74.41 110.391 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.26 38.0 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.364 0.415 . . . . 65.55 113.331 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -79.0 155.33 28.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.933 0.893 . . . . 74.42 111.113 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -114.16 150.53 18.6 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.827 -0.624 . . . . 75.13 111.553 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.8 m -79.39 136.37 36.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.777 -0.823 . . . . 73.25 108.777 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.15 137.73 40.26 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.845 0.458 . . . . 75.43 110.195 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.19 125.07 22.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.7 0.8 . . . . 73.43 109.311 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -143.97 100.83 3.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.918 0.487 . . . . 71.52 109.737 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -64.14 150.91 44.63 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.222 0.609 . . . . 73.2 110.54 173.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.97 126.18 50.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.062 -0.718 . . . . 73.35 109.062 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.543 0.737 . . . . 72.42 110.309 179.356 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.827 0.346 . . . . 74.54 110.378 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -134.53 -59.06 0.82 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.421 0.688 . . . . 74.44 109.804 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.58 66.94 1.09 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.19 0.996 . . . . 75.23 111.005 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -68.7 -24.74 64.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.122 -1.399 . . . . 73.14 110.686 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -90.45 172.97 8.35 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.095 0.958 . . . . 72.3 109.699 173.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -79.6 98.74 7.02 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.855 -0.612 . . . . 73.15 109.717 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.185 0.993 . . . . 73.34 109.465 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -110.92 -80.97 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.516 -0.766 . . . . 75.22 109.457 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.1 ttt 64.17 133.89 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.326 1.45 . . . . 74.44 113.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -87.43 103.9 15.95 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 169.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -124.88 141.09 52.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.944 0.897 . . . . 65.23 109.162 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -160.76 123.34 3.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.179 0.592 . . . . 74.23 109.729 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -76.14 140.62 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.755 -0.832 . . . . 74.23 108.755 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.671 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -111.45 -49.71 2.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.679 0.792 . . . . 75.32 110.219 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -164.01 123.35 1.99 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.791 0.436 . . . . 75.33 110.04 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.9 mt -106.46 148.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.056 -1.09 . . . . 72.31 108.056 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.587 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 38.0 p90 -173.98 168.64 4.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.365 0.666 . . . . 73.35 110.325 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.0 p -86.62 117.7 25.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.156 0.582 . . . . 75.31 109.635 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.587 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 24.4 mmmt -66.86 -46.79 73.94 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.819 -0.808 . . . . 73.53 108.819 172.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.23 150.99 34.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.275 -1.329 . . . . 71.42 109.388 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.556 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.6 mt -142.46 142.47 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.791 1.636 . . . . 72.53 106.892 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -154.19 149.55 27.16 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.798 0.839 . . . . 74.33 109.183 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -152.16 128.38 10.51 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.467 -1.309 . . . . 75.21 107.467 172.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.59 130.75 36.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 63.24 108.45 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 82.67 15.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.841 -0.8 . . . . 73.31 108.841 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -67.37 -30.95 35.9 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.134 2.556 . . . . 71.55 112.366 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.79 34.01 3.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.831 0.852 . . . . 74.02 110.172 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.542 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -59.65 -56.81 31.98 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.058 -0.972 . . . . 75.25 112.534 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 14.9 Cg_exo -68.45 -27.5 33.49 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.838 1.692 . . . . 73.0 111.827 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.93 -23.33 65.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.755 1.222 . . . . 74.44 112.539 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.712 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 5.5 p -59.07 -20.99 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.481 0.712 . . . . 64.44 112.39 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.26 -41.44 99.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.349 1.06 . . . . 73.22 111.341 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -109.82 44.97 1.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.069 0.937 . . . . 71.55 109.511 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.712 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 22.3 ttpt -125.17 140.98 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.655 0.782 . . . . 75.34 110.794 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.44 132.85 39.89 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.105 0.962 . . . . 74.42 109.592 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -84.78 71.5 10.84 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.946 0.899 . . . . 73.51 111.317 -172.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -143.32 69.67 17.77 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.961 -1.018 . . . . 74.45 108.411 168.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.98 140.08 2.72 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.402 2.068 . . . . 64.23 111.121 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.92 111.39 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 107.495 -1.298 . . . . 74.43 107.495 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -75.85 98.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.272 -1.011 . . . . 74.42 108.272 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 59.9 tttm -98.22 105.26 17.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.47 1.108 . . . . 74.33 108.959 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -87.73 156.8 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.989 0.515 . . . . 72.23 110.021 -177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -144.8 105.82 4.18 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.476 0.711 . . . . 62.34 109.728 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.31 126.47 50.48 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.857 -0.794 . . . . 73.41 108.857 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.1 t70 -135.09 151.65 50.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.869 0.867 . . . . 73.45 109.019 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 3.1 m -133.48 127.48 33.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.127 0.571 . . . . 65.45 111.112 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.14 164.2 19.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.893 1.277 . . . . 62.44 108.483 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -154.43 145.44 22.68 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.959 0.345 . . . . 74.33 110.982 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -145.76 129.54 17.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.642 1.177 . . . . 73.31 109.378 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.66 119.95 21.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.253 -0.647 . . . . 75.54 109.253 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.426 HD13 HD13 ' C' ' 83' ' ' ILE . 84.2 mt -87.69 -38.38 15.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.348 0.659 . . . . 74.33 111.097 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.414 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -159.06 -172.93 3.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.437 -0.802 . . . . 72.12 110.518 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.2 105.13 0.84 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.796 1.239 . . . . 73.3 110.08 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 69.0 6.73 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.352 1.461 . . . . 75.42 113.019 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 91.9 t -103.07 118.16 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.947 -0.76 . . . . 71.11 108.947 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.1 158.42 32.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.871 0.868 . . . . 73.34 109.353 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -126.16 137.79 53.61 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.622 -1.621 . . . . 75.22 106.622 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.31 133.08 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 109.908 -0.405 . . . . 74.23 109.908 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 46' ' ' THR . 46.3 t -110.93 107.23 22.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.498 1.119 . . . . 73.04 108.918 -174.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.23 101.35 13.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.546 -1.279 . . . . 72.24 107.546 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.6 ttt180 -79.38 129.57 34.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.489 1.116 . . . . 73.43 109.121 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.39 105.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.857 -1.164 . . . . 74.41 107.857 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.5 m -103.08 113.85 27.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.534 -0.913 . . . . 73.14 108.534 170.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 79.6 t -101.34 108.42 23.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.175 -1.046 . . . . 75.34 108.175 178.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.499 HG21 HD23 ' C' ' 75' ' ' LEU . 4.0 m -99.06 140.35 33.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.323 -0.991 . . . . 72.15 108.323 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.41 95.34 4.23 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.712 -1.588 . . . . 62.3 106.712 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -147.02 132.46 18.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.533 0.333 . . . . 74.1 111.145 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 65.8 tp -67.79 -30.61 70.08 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.629 0.772 . . . . 73.35 109.952 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.67 -87.55 0.09 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.266 -1.134 . . . . 53.12 110.266 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -89.11 -25.01 22.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.636 0.774 . . . . 73.33 109.091 171.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -90.5 96.02 10.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.253 1.021 . . . . 73.44 109.266 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -89.31 133.36 34.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 70.01 110.784 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.453 ' HA ' ' NZ ' ' C' ' 34' ' ' LYS . . . -75.03 -59.51 2.7 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.145 0.978 . . . . 64.24 109.845 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.03 170.75 21.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.774 -1.103 . . . . 73.54 111.01 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.499 HD23 HG21 ' C' ' 65' ' ' THR . 2.9 tm? -136.03 140.88 44.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.127 -1.805 . . . . 75.51 106.127 173.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.22 150.85 34.47 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.522 -0.918 . . . . 71.24 108.522 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.58 131.2 9.76 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.687 -0.486 . . . . 71.42 109.687 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.76 115.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.27 -1.011 . . . . 52.3 108.27 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.458 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 75.7 mt-30 -88.15 91.27 8.71 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.506 -1.294 . . . . 72.24 107.506 174.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -82.39 115.14 21.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.672 -0.694 . . . . 73.32 109.41 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.66 179.57 23.51 Favored Glycine 0 C--O 1.244 0.723 0 O-C-N 123.452 0.47 . . . . 51.33 112.836 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.91 154.65 16.54 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.245 -0.477 . . . . 51.22 112.022 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.671 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.8 mm -102.4 123.5 55.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.684 -1.228 . . . . 74.32 107.684 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -136.37 120.23 17.45 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.979 -0.748 . . . . 64.41 108.979 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.4 p -78.32 118.3 20.39 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.819 -0.808 . . . . 74.42 108.819 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.24 107.04 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 107.284 -1.376 . . . . 75.03 107.284 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.64 169.75 17.4 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.165 0.507 . . . . 70.35 111.735 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.21 -58.42 2.75 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 115.145 -0.934 . . . . 75.51 112.576 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.18 -177.55 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.685 0.794 . . . . 75.52 112.211 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.12 -173.89 4.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.708 0.803 . . . . 75.13 110.884 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.11 -141.51 39.66 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 116.086 -0.506 . . . . 74.32 113.748 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 34.8 p -68.08 -18.47 64.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.013 0.925 . . . . 71.34 111.637 177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -68.9 -40.63 79.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.484 0.714 . . . . 74.23 110.522 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.74 -34.0 24.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.329 0.251 . . . . 50.31 110.755 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.45 -25.74 63.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.871 0.868 . . . . 73.41 111.764 -177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -57.54 -51.62 68.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.785 0.834 . . . . 75.02 110.324 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.48 -52.75 12.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.995 -0.548 . . . . 72.15 110.533 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.78 -25.91 67.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.438 0.695 . . . . 72.33 112.064 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.46 -29.06 8.55 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.055 -0.52 . . . . 72.25 113.847 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.07 -60.03 1.89 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.682 0.741 . . . . 64.34 111.202 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.01 -56.06 15.31 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.09 0.556 . . . . 65.32 112.235 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.483 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 59.5 m -56.9 -50.68 86.7 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.188 -0.911 . . . . 74.5 112.727 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 45.4 Cg_exo -61.16 -31.09 89.85 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.194 1.929 . . . . 73.54 113.286 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -72.82 -28.93 62.85 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.772 0.829 . . . . 73.34 110.374 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.85 -39.97 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.399 1.08 . . . . 75.4 109.85 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' C' ' 102' ' ' CYS . 68.9 mt -82.59 -16.31 48.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.336 -0.847 . . . . 73.12 111.397 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.64 -55.29 44.6 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.059 -0.972 . . . . 74.11 113.141 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.414 ' HB2' ' HG3' ' A' ' 112' ' ' GLU . 37.5 Cg_endo -63.43 -37.85 46.41 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.085 1.857 . . . . 74.14 113.207 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -63.33 -45.86 89.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.322 0.649 . . . . 71.43 111.25 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.45 96.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.62 -0.718 . . . . 72.24 110.831 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 6.2 ttp-105 -60.51 -43.13 97.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 75.53 110.583 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.77 -34.89 67.27 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.922 0.764 . . . . 63.44 110.387 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.451 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 34.0 t -68.53 -30.33 69.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.787 0.435 . . . . 75.53 111.339 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.43 ' O ' HG23 ' C' ' 118' ' ' VAL . 92.5 mt -77.81 -43.97 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.833 -0.622 . . . . 54.44 110.094 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 54.3 m -55.93 -36.83 68.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.603 0.761 . . . . 72.13 110.427 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.7 t -61.06 -53.75 53.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.228 -1.351 . . . . 72.14 109.535 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.478 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.76 -38.02 80.65 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.847 1.259 . . . . 72.23 113.28 -178.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.4 t -63.98 -49.27 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.705 0.802 . . . . 72.33 109.349 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.426 ' OG ' HG22 ' B' ' 115' ' ' THR . 33.7 t -68.74 -26.49 65.27 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.167 -0.924 . . . . 74.41 111.747 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.6 mtt-85 -68.83 -39.25 80.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.279 0.632 . . . . 73.32 109.482 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 10.35 60.51 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.626 0.579 . . . . 73.11 112.747 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p 56.38 40.68 29.65 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.055 1.742 . . . . 74.41 112.503 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.16 156.82 34.84 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.583 -1.189 . . . . 74.15 108.281 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.555 ' HD3' HG22 ' E' ' 136' ' ' VAL . 38.5 Cg_endo -65.28 171.47 9.11 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.084 2.523 . . . . 75.5 113.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.486 ' HB2' ' H ' ' B' ' 125' ' ' GLN . 51.3 tp60 -60.23 132.07 52.76 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.318 -0.856 . . . . 74.52 113.083 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.92 85.9 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.477 -1.305 . . . . 74.2 107.477 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -95.71 105.89 17.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.851 -1.166 . . . . 71.43 107.851 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -74.2 137.0 42.8 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 106.775 -1.565 . . . . 74.21 106.775 170.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -53.65 131.87 55.56 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 124.342 1.026 . . . . 72.13 111.506 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 16' ' ' ILE . 17.4 Cg_exo -68.09 89.22 0.38 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.512 2.141 . . . . 72.32 111.168 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.631 ' HA ' HD13 ' E' ' 148' ' ' LEU . 94.0 t -97.92 109.67 24.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.464 -0.789 . . . . 65.5 109.31 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' C' ' 135' ' ' ALA . 1.8 m-20 -104.77 83.0 1.95 Allowed 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.261 -1.015 . . . . 74.34 108.261 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.78 -44.58 69.84 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.107 -0.951 . . . . 75.41 111.267 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.47 -38.26 90.41 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.268 0.627 . . . . 73.14 110.946 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.427 ' HB2' ' HB3' ' C' ' 132' ' ' ASN . . . -73.51 -20.69 60.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.243 -0.889 . . . . 72.22 111.605 178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -70.29 -36.91 74.67 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 73.43 109.466 172.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -62.35 -39.89 94.6 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.773 0.829 . . . . 73.12 110.121 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 64.2 mtt -76.5 -28.98 56.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.034 0.933 . . . . 72.25 111.649 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.48 -43.46 98.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.794 1.237 . . . . 71.03 111.749 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -63.8 -88.03 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.136 0.897 . . . . 72.31 109.478 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 25.8 tp 31.94 68.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.875 1.67 . . . . 75.43 113.007 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.583 ' HB2' ' HA2' ' A' ' 148' ' ' GLY . 30.2 mm-40 -70.52 99.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.527 -0.76 . . . . 75.12 109.908 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -98.93 135.82 39.81 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.43 -1.259 . . . . 75.02 108.693 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -91.32 -171.84 3.08 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.217 0.607 . . . . 73.34 110.445 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 69.01 -176.82 0.21 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.469 1.108 . . . . 74.32 111.668 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.56 54.01 5.22 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.105 -0.498 . . . . 74.32 111.958 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.95 83.01 1.71 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.842 0.857 . . . . 72.24 109.021 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.3 -162.98 33.92 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.839 -0.619 . . . . 73.42 111.989 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.2 t -164.29 18.71 0.06 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.553 0.741 . . . . 74.31 110.783 -177.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.65 133.74 55.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.668 0.787 . . . . 72.42 111.46 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.6 163.36 12.73 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.549 1.139 . . . . 71.21 109.258 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -75.73 91.34 2.91 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.554 -0.906 . . . . 65.3 108.554 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -85.66 85.07 7.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.675 0.75 . . . . 72.43 109.02 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -86.04 146.61 26.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.804 -1.089 . . . . 70.05 109.597 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.423 0.689 . . . . 73.25 110.709 -178.066 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 110.387 -0.227 . . . . 73.53 110.387 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.1 t -108.12 164.84 11.95 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.595 0.758 . . . . 70.33 110.333 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.2 159.89 28.29 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.38 -0.373 . . . . 71.22 110.589 170.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.33 163.88 31.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.797 0.839 . . . . 71.02 110.593 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -172.16 156.27 3.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 75.43 109.735 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -153.86 152.26 30.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.815 0.846 . . . . 70.14 108.955 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.507 HG23 ' HG2' ' D' ' 8' ' ' GLU . 5.7 t -62.47 -33.03 74.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.363 0.665 . . . . 75.04 111.248 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.507 ' HG2' HG23 ' D' ' 7' ' ' THR . 34.7 mm-40 -105.37 166.26 10.55 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.008 0.923 . . . . 74.12 110.026 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.465 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.5 ptm -33.85 157.42 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 125.641 1.576 . . . . 75.21 114.648 165.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.2 m -144.0 140.25 29.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.279 1.032 . . . . 74.23 108.265 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' D' ' 85' ' ' SER . 78.5 t80 -155.57 113.64 3.4 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.346 -0.983 . . . . 75.31 108.346 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -134.81 131.05 37.0 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.421 0.688 . . . . 75.45 109.643 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -78.94 141.18 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.481 -0.933 . . . . 73.44 108.481 172.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -111.5 -46.03 3.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.682 0.393 . . . . 65.54 110.673 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.22 122.84 1.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.148 -0.315 . . . . 72.4 110.148 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.6 126.69 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 106.523 -1.658 . . . . 74.12 106.523 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -168.1 178.03 5.26 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.811 0.695 . . . . 73.01 111.538 -165.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.6 p -108.21 133.48 52.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.005 -0.998 . . . . 65.03 109.59 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.43 -32.92 9.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.428 -0.582 . . . . 75.34 109.428 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.619 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -144.21 138.61 28.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.867 -1.061 . . . . 64.34 108.898 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.478 HG21 ' HE1' ' C' ' 117' ' ' MET . 60.6 mt -141.15 149.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 72.13 108.199 176.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -152.74 145.39 24.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.249 0.62 . . . . 74.21 110.35 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.556 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.3 t80 -147.58 124.8 11.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.689 -1.597 . . . . 74.44 106.689 168.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.0 mp0 -120.16 142.04 49.32 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.692 -0.855 . . . . 75.52 108.692 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.467 ' HB3' ' HB1' ' D' ' 28' ' ' ALA . . . -148.28 73.75 10.88 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.355 -0.979 . . . . 71.01 108.355 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.38 -18.57 17.82 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.446 2.097 . . . . 73.2 111.553 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.463 ' O ' HG23 ' D' ' 31' ' ' VAL . 57.5 m-20 -114.23 23.88 12.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.136 0.974 . . . . 73.14 109.617 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.492 ' HA ' ' HZ ' ' D' ' 123' ' ' PHE . . . -48.0 -53.8 29.61 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.885 1.439 . . . . 74.32 114.885 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.524 ' HB3' HD11 ' C' ' 83' ' ' ILE . 28.6 Cg_endo -84.48 -4.32 10.09 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.482 1.454 . . . . 55.15 112.892 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.437 ' CE1' ' HG2' ' D' ' 71' ' ' GLU . 21.5 t-160 -80.62 -36.95 31.95 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.848 1.259 . . . . 73.54 109.522 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.463 HG23 ' O ' ' D' ' 27' ' ' ASN . 59.3 t -72.77 -25.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.332 0.653 . . . . 74.11 110.663 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.29 -28.99 57.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.07 0.948 . . . . 73.13 112.083 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -76.41 -15.32 59.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.324 0.65 . . . . 73.44 112.408 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -125.61 111.92 15.56 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.439 0.696 . . . . 74.44 110.641 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.25 87.33 7.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.975 0.91 . . . . 72.53 109.855 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.673 ' HB3' HD13 ' D' ' 68' ' ' LEU . 42.6 t-105 -160.01 158.08 29.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.724 -0.843 . . . . 75.22 108.724 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' F' ' 140' ' ' SER . 1.7 mp0 -74.44 116.82 56.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.077 0.551 . . . . 73.54 109.918 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.07 141.87 86.5 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.134 2.556 . . . . 73.45 113.593 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.61 113.38 4.18 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.55 -0.907 . . . . 72.52 108.55 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.418 HG12 HG11 ' D' ' 64' ' ' VAL . 61.8 t -99.09 106.57 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.65 -0.5 . . . . 74.42 109.65 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -87.41 109.39 19.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.194 -1.41 . . . . 75.54 107.194 167.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.77 156.29 16.39 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.52 -0.918 . . . . 74.14 108.52 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.498 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.7 t70 -151.2 155.74 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.157 0.583 . . . . 74.01 109.966 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -133.35 152.12 51.9 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.348 0.659 . . . . 74.43 110.824 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.5 t70 -153.36 151.51 30.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.006 1.322 . . . . 64.32 108.175 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -128.9 152.37 48.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.299 -0.63 . . . . 71.21 109.299 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.79 169.6 20.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.557 -0.905 . . . . 72.51 108.557 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -149.04 159.45 44.21 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.84 0.456 . . . . 75.41 110.737 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -155.7 119.26 4.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.115 0.966 . . . . 74.0 109.184 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.23 121.62 23.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.83 -0.433 . . . . 72.12 109.83 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.475 HD11 HG22 ' D' ' 83' ' ' ILE . 90.5 mt -99.63 -26.5 14.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.416 0.686 . . . . 73.33 110.889 179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.17 -177.01 3.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.026 0.93 . . . . 71.53 110.036 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.46 120.57 22.64 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.23 -1.026 . . . . 72.23 108.23 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 72.15 3.87 4.82 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.067 1.347 . . . . 72.33 112.742 -172.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.15 117.51 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.423 -0.584 . . . . 61.41 109.423 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -133.04 130.5 39.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.362 0.665 . . . . 73.21 109.468 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -87.16 140.1 29.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 64.1 108.372 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.34 132.87 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.76 -1.2 . . . . 75.31 107.76 169.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.72 130.94 57.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.564 1.145 . . . . 74.35 108.783 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 121.8 45.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.675 -0.861 . . . . 73.21 108.675 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.589 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.5 ttm-85 -106.88 99.17 8.76 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.891 -0.781 . . . . 74.34 108.891 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.59 104.13 15.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.199 -1.037 . . . . 71.41 108.199 172.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.498 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.2 m -99.3 148.12 24.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.152 -0.931 . . . . 74.52 110.022 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.515 HG21 HD12 ' D' ' 114' ' ' ILE . 25.3 t -138.43 132.98 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.629 1.572 . . . . 75.31 107.927 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -133.94 93.44 3.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.721 -1.215 . . . . 74.41 107.721 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.36 141.76 29.3 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.719 -0.673 . . . . 65.31 109.288 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -149.51 126.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.123 0.969 . . . . 71.31 108.975 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.673 HD13 ' HB3' ' D' ' 36' ' ' TRP . 19.7 tp -99.13 114.06 26.61 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.58 -0.896 . . . . 74.54 108.58 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.95 -113.33 4.13 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.7 0.625 . . . . 72.52 113.051 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 5.88 41.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.728 0.811 . . . . 72.33 111.205 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.437 ' HG2' ' CE1' ' D' ' 30' ' ' HIS . 9.7 tp10 -149.22 151.52 34.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.471 0.308 . . . . 71.43 111.336 -165.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' THR . . . . . 0.436 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 71.8 m -55.21 141.46 35.11 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.983 1.313 . . . . 75.02 111.711 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.402 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -106.99 -71.85 0.74 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.037 0.935 . . . . 73.05 109.522 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -147.54 137.63 22.99 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.367 0.603 . . . . 71.33 109.778 173.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 51.3 mt -105.03 154.02 20.69 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.397 1.079 . . . . 75.52 108.491 175.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.669 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.5 t -160.64 146.28 14.78 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.935 0.494 . . . . 75.12 110.043 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.05 126.48 6.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.379 -0.6 . . . . 65.03 109.379 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.71 116.88 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.787 0.435 . . . . 62.22 110.638 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.619 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.7 mt-30 -92.45 88.03 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.29 1.036 . . . . 73.35 110.084 170.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.2 98.73 7.48 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.679 -1.146 . . . . 73.14 108.857 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.38 141.89 17.01 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.627 -0.589 . . . . 72.45 111.627 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -139.72 132.16 5.47 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.291 -0.723 . . . . 62.15 111.291 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.475 HG22 HD11 ' D' ' 51' ' ' LEU . 58.0 mt -90.52 123.6 42.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 C-N-CA 123.93 0.892 . . . . 75.43 109.007 177.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -133.04 141.32 48.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.124 0.57 . . . . 71.44 109.684 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.433 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 33.2 m -100.17 105.23 16.81 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.726 0.81 . . . . 73.12 108.972 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mt -108.04 102.03 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.596 -0.89 . . . . 75.21 108.596 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.18 169.1 16.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.004 1.321 . . . . 74.53 109.879 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.42 -4.66 33.06 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 114.49 0.556 . . . . 75.13 114.49 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.44 151.41 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.96 0.904 . . . . 72.55 109.863 -170.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.15 177.02 8.07 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.014 0.926 . . . . 73.01 111.974 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -132.64 48.25 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 116.287 1.275 . . . . 74.45 116.287 165.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 8.5 t -62.94 -35.89 81.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 73.23 112.45 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -73.79 -39.42 64.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.774 0.43 . . . . 71.24 111.626 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.9 ptm -73.63 -31.95 63.78 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 110.022 -0.362 . . . . 75.2 110.022 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.75 70.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.438 0.695 . . . . 74.31 110.628 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -71.86 -33.36 68.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.159 0.984 . . . . 74.4 110.321 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.9 -52.1 53.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.157 -0.474 . . . . 72.21 110.548 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.59 -18.02 46.26 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.82 0.448 . . . . 73.4 112.114 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.65 -26.63 16.82 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-O 119.795 -0.447 . . . . 75.11 113.72 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.88 -59.36 1.27 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.932 0.493 . . . . 63.1 111.641 -174.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -67.29 -47.23 71.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.377 0.423 . . . . 74.34 111.972 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.4 m -67.61 -45.46 46.15 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 118.328 -0.844 . . . . 71.11 111.936 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.92 -35.23 98.47 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.359 2.039 . . . . 74.41 113.498 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.17 -32.96 74.71 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.415 0.686 . . . . 72.01 110.784 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.54 -45.06 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.416 0.687 . . . . 71.53 109.815 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' D' ' 82' ' ' GLY . 90.1 mt -73.68 -21.4 60.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.162 -0.926 . . . . 74.1 112.1 -174.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.416 ' HZ ' HD13 ' D' ' 128' ' ' LEU . 42.8 t80 -66.12 -46.81 62.89 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 113.934 1.087 . . . . 64.4 113.934 -168.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.67 -34.16 97.74 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.072 1.848 . . . . 74.43 112.768 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -76.03 -37.68 58.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.023 0.929 . . . . 72.53 111.026 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -49.94 67.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.565 0.746 . . . . 72.34 110.792 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -71.54 -31.88 67.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.862 -1.063 . . . . 75.1 111.186 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.02 -42.94 89.0 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.029 0.831 . . . . 74.2 110.707 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.437 ' SG ' HD11 ' D' ' 21' ' ' ILE . 43.0 t -58.5 -39.5 80.24 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.821 0.7 . . . . 75.24 110.259 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.669 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.0 mt -61.56 -54.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.69 0.796 . . . . 74.44 110.35 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.458 HG22 ' HG3' ' D' ' 125' ' ' GLN . 28.8 m -57.71 -39.06 76.35 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.463 1.105 . . . . 72.31 111.593 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -67.06 -43.61 82.23 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 114.855 -1.066 . . . . 75.4 110.141 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.65 -27.18 63.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.775 0.43 . . . . 74.23 111.738 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.1 t -67.96 -43.09 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.564 0.746 . . . . 72.44 109.651 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.457 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 94.1 p -74.27 -25.98 59.93 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.895 0.478 . . . . 71.12 111.225 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.451 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.6 mtt-85 -75.38 -32.17 60.72 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.456 0.703 . . . . 75.12 109.758 173.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.56 -0.37 89.92 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.62 -0.718 . . . . 64.44 111.991 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.7 p 63.39 27.27 15.23 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.68 1.992 . . . . 74.04 113.257 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 56.5 m-85 -94.07 162.3 27.11 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 124.707 1.203 . . . . 74.41 110.535 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.403 ' HG3' HG22 ' F' ' 136' ' ' VAL . 23.9 Cg_endo -59.1 140.91 97.22 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 123.483 2.789 . . . . 63.2 112.402 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.458 ' HG3' HG22 ' D' ' 115' ' ' THR . 34.1 tt0 -54.68 135.01 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.119 0.968 . . . . 75.34 112.722 -174.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.44 HD12 HD13 ' F' ' 142' ' ' ILE . 60.6 tp -126.02 102.5 7.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.892 0.877 . . . . 73.34 109.913 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -102.58 121.44 42.39 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.71 -0.848 . . . . 74.41 108.71 175.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.416 HD13 ' HZ ' ' D' ' 107' ' ' PHE . 0.1 OUTLIER -74.76 114.54 13.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.345 -0.983 . . . . 64.55 108.345 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.12 143.36 97.7 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 122.63 0.372 . . . . 73.14 110.898 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.81 132.22 22.81 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 72.4 112.887 -169.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.18 128.97 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.136 0.574 . . . . 73.35 109.771 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.73 93.3 7.9 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.88 -0.785 . . . . 72.34 108.88 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -62.04 -32.22 72.71 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.242 0.617 . . . . 72.34 111.101 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.66 -42.1 61.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.834 1.254 . . . . 72.15 111.911 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.89 92.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.056 0.847 . . . . 73.13 111.613 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 74.4 mt -76.47 -29.25 56.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.38 0.672 . . . . 72.05 111.124 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -69.51 -29.17 66.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.558 1.143 . . . . 72.14 110.986 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.6 mmt -52.45 -41.25 63.14 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.353 0.661 . . . . 73.4 110.717 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.14 -35.4 76.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.081 0.952 . . . . 75.14 112.124 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -54.08 -43.09 70.01 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.075 0.95 . . . . 71.25 111.514 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.05 -32.62 73.94 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.859 0.864 . . . . 75.45 111.018 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.33 1.44 55.77 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.687 0.795 . . . . 73.33 111.763 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -121.55 73.4 1.06 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.686 0.755 . . . . 75.23 110.597 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -148.01 91.39 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.866 -1.061 . . . . 74.41 109.441 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.2 17.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.692 1.197 . . . . 74.22 111.157 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.5 44.93 0.26 Allowed Glycine 0 C--N 1.353 1.479 0 C-N-CA 121.784 -0.246 . . . . 61.0 113.496 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.12 120.15 23.87 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.492 -0.929 . . . . 74.41 108.492 171.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.76 -69.01 0.01 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 117.846 0.293 . . . . 53.15 112.968 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 40.2 m -58.88 95.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.059 0.943 . . . . 74.14 112.059 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.26 80.21 1.47 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.22 -1.77 . . . . 73.14 106.22 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.63 132.61 34.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.059 -0.973 . . . . 70.33 108.814 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -135.79 80.05 1.81 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.638 1.175 . . . . 74.31 109.31 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -64.54 -54.48 31.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.81 0.844 . . . . 73.24 109.831 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -84.09 85.92 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.731 -1.211 . . . . 72.51 107.731 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 123.889 0.876 . . . . 75.32 109.27 -178.967 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.672 -0.492 . . . . 70.23 109.672 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -113.06 66.3 0.65 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.058 0.943 . . . . 73.42 109.078 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.03 150.16 37.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.812 0.845 . . . . 72.34 110.973 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -110.78 174.27 5.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.036 0.534 . . . . 74.31 110.857 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . 0.417 ' HB3' ' HA2' ' B' ' 91' ' ' GLY . 20.2 pt20 -146.1 138.25 25.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.277 1.031 . . . . 71.3 109.067 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -166.48 153.31 9.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.72 0.808 . . . . 72.51 108.915 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 48.04 -97.48 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.316 1.446 . . . . 73.43 110.816 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.468 HD21 ' HG3' ' B' ' 94' ' ' MET . 0.9 OUTLIER 176.9 56.88 0.0 OUTLIER 'General case' 0 C--N 1.353 0.759 0 N-CA-C 105.607 -1.997 . . . . 72.34 105.607 175.075 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -176.58 -58.38 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 CA-C-N 114.841 -1.072 . . . . 71.31 112.466 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.51 112.55 0.91 Allowed 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 123.403 2.736 . . . . 63.42 113.92 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -169.41 -48.51 0.02 OUTLIER 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.508 1.523 . . . . 73.54 108.177 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 38.0 m 62.34 98.76 0.03 OUTLIER 'General case' 0 C--N 1.366 1.31 0 C-N-CA 124.916 1.286 . . . . 75.25 109.674 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -66.25 93.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.683 0.754 . . . . 74.35 109.848 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.82 75.78 1.14 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.327 -0.851 . . . . 74.55 109.162 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.72 29.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.068 -0.969 . . . . 75.4 110.104 -171.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 m -92.64 31.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.208 0.603 . . . . 71.34 111.107 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.52 114.72 21.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.11 -0.7 . . . . 73.31 109.11 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -151.44 159.51 44.17 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.746 1.218 . . . . 64.42 108.427 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -67.03 140.94 57.7 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.46 7.49 77.74 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 119.787 -0.452 . . . . 72.43 114.075 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -118.64 -29.78 5.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 75.41 109.35 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' B' ' 42' ' ' LEU . 11.0 mp 69.82 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.607 1.163 . . . . 71.44 112.131 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.24 158.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.544 0.738 . . . . 75.42 112.511 -170.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.6 -69.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.376 0.67 . . . . 75.13 109.808 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 61.44 106.5 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.86 1.264 . . . . 74.43 110.814 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.31 -37.86 71.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.438 2.758 . . . . 71.14 113.516 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 2.7 pp -86.18 -19.95 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.304 -0.862 . . . . 70.22 111.966 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.22 78.57 0.24 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.937 1.295 . . . . 73.52 111.889 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' C' ' 124' ' ' PRO . 7.4 p -81.76 92.53 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 CA-C-O 121.741 0.781 . . . . 71.52 109.193 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . 0.497 ' HA ' ' HB3' ' C' ' 124' ' ' PRO . 3.1 tm-20 -140.39 -45.61 0.41 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.292 0.637 . . . . 64.43 111.19 -170.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.65 85.73 1.62 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.203 0.525 . . . . 73.13 111.304 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . 0.49 ' HB2' ' HG2' ' C' ' 124' ' ' PRO . 5.1 tt -103.32 120.53 40.95 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.086 -1.45 . . . . 75.42 107.086 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 57.0 m -145.97 -160.92 1.21 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.843 0.857 . . . . 75.02 109.509 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.96 48.7 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.38 1.072 . . . . 72.13 109.045 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 24.1 mt -111.54 -66.05 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.505 -1.225 . . . . 73.12 107.948 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -143.31 157.53 44.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.462 1.105 . . . . 62.3 110.046 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -91.9 -59.13 2.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.312 1.045 . . . . 60.21 110.701 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -138.56 -53.56 0.6 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.213 0.605 . . . . 74.3 110.223 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.22 142.61 43.4 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.005 0.431 . . . . 63.33 110.784 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.76 -59.46 1.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.019 -1.104 . . . . 75.41 108.019 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.631 HD13 ' HA ' ' C' ' 131' ' ' VAL . 6.2 mp -112.16 146.78 35.57 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.462 -1.31 . . . . 75.41 107.462 167.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo . . . . . 0 C--N 1.381 2.287 0 C-N-CA 123.513 2.809 . . . . 74.33 113.304 175.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.084 -0.339 . . . . 60.23 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.94 -168.99 1.85 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.317 0.647 . . . . 73.33 111.245 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 68.76 16.85 8.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.69 1.196 . . . . 73.05 112.907 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -55.35 103.95 0.11 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.124 -0.695 . . . . 72.23 109.124 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.52 82.77 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.204 0.94 . . . . 73.42 110.966 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.11 -31.61 66.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.997 -1.001 . . . . 72.41 109.302 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.8 mttm 63.87 79.72 0.25 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.867 1.267 . . . . 72.15 110.505 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.493 ' HB3' ' HG2' ' A' ' 94' ' ' MET . 81.9 mt -79.75 54.36 1.81 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.633 0.73 . . . . 62.4 109.933 172.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -124.67 62.94 35.7 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.756 1.223 . . . . 75.5 108.735 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 95' ' ' ALA . 3.3 Cg_endo -86.48 76.85 2.43 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.969 2.446 . . . . 70.52 111.99 -172.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.51 138.42 15.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.45 -0.796 . . . . 74.24 110.861 175.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 32.0 p -111.36 84.53 1.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.862 1.265 . . . . 75.15 107.835 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -136.58 -61.83 0.67 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.477 0.711 . . . . 75.44 109.825 -172.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.9 t70 68.07 151.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.791 1.236 . . . . 73.45 111.686 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.51 118.72 8.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.164 0.586 . . . . 72.43 112.115 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 m -75.99 -172.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 124.006 0.922 . . . . 74.3 110.818 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -76.44 173.29 11.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.134 0.493 . . . . 71.23 110.501 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.78 -67.33 0.44 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.365 0.666 . . . . 71.44 111.716 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -155.8 143.17 19.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.293 0.637 . . . . 75.34 109.964 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -140.76 128.95 3.94 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.134 -0.787 . . . . 62.13 111.134 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 65.44 88.54 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.819 1.247 . . . . 73.22 110.14 -172.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.419 ' HB3' HG12 ' A' ' 40' ' ' VAL . 44.8 tp -107.58 168.23 9.4 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.081 -0.963 . . . . 73.53 109.429 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 46.4 mm 80.61 -57.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 126.269 1.828 . . . . 74.13 110.13 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 76.57 -47.11 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.794 1.638 . . . . 70.35 112.471 176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.64 93.69 37.9 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.741 0.816 . . . . 71.52 109.403 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.88 89.62 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.409 2.072 . . . . 63.12 109.636 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -60.77 99.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 115.513 -0.767 . . . . 65.54 110.404 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.95 84.14 5.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.248 -0.887 . . . . 52.14 109.315 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.403 HG22 ' HG3' ' D' ' 124' ' ' PRO . 12.6 p -136.4 112.86 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 108.13 -1.063 . . . . 75.22 108.13 177.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.04 147.23 24.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.764 -0.458 . . . . 74.32 109.764 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 66.73 99.7 0.05 OUTLIER 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.375 1.47 . . . . 74.21 111.404 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.436 ' HG ' HD13 ' D' ' 126' ' ' LEU . 0.0 OUTLIER -67.69 88.68 0.24 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 108.034 -1.098 . . . . 74.44 108.034 176.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' F' F ' 140' ' ' SER . . . . . 0.408 ' H ' ' HG2' ' D' ' 37' ' ' GLN . 22.4 t -87.6 1.01 54.8 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.655 0.782 . . . . 60.1 111.88 -171.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.99 -8.61 27.61 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.426 0.528 . . . . 73.53 112.426 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.44 HD13 HD12 ' D' ' 126' ' ' LEU . 7.0 tt -77.87 113.22 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.306 -0.627 . . . . 74.22 109.306 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' F' ' 146' ' ' ASP . 58.5 m-85 76.35 -49.75 0.58 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.696 1.599 . . . . 72.32 113.029 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 50.5 t30 72.36 -79.21 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.438 1.495 . . . . 75.04 111.029 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -128.46 -27.39 2.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.615 0.766 . . . . 75.35 110.191 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' F' ' 143' ' ' TYR . 24.6 t70 -80.68 159.23 25.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.875 0.87 . . . . 75.05 110.667 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 tp -157.57 -74.95 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.699 -1.222 . . . . 74.52 107.699 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 40.1 tp -171.94 66.12 0.4 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.96 -1.496 . . . . 74.41 106.96 168.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 C--N 1.383 2.364 0 C-N-CA 122.729 2.286 . . . . 73.35 110.973 179.601 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 ttp . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.8 -0.445 . . . . 72.34 109.8 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -122.23 84.26 2.23 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.934 0.894 . . . . 74.12 108.918 169.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 81.89 8.5 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.233 -1.395 . . . . 70.03 107.233 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -129.8 131.21 46.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.04 0.936 . . . . 73.13 110.014 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -130.6 121.22 25.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.722 0.809 . . . . 73.01 109.707 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -72.56 155.11 40.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.872 -0.788 . . . . 75.34 108.872 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -67.49 80.59 0.16 Allowed 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.953 0.883 . . . . 71.41 111.733 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -138.12 -158.82 0.89 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.727 1.211 . . . . 73.32 109.303 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.11 140.13 58.77 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.182 0.593 . . . . 74.33 109.749 175.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 90.1 m -140.15 120.36 13.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.554 -1.276 . . . . 64.42 107.554 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -138.82 121.85 16.75 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.026 -0.731 . . . . 74.44 109.026 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.66 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 29.6 tt0 -134.12 111.7 10.54 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.585 0.754 . . . . 71.22 109.159 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.62 109.21 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 108.174 -1.047 . . . . 72.13 108.174 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.48 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -91.99 -40.53 11.06 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.407 -0.59 . . . . 74.53 109.407 -174.052 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -170.73 140.96 1.75 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.321 0.648 . . . . 74.5 110.083 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.554 HG21 HD23 ' A' ' 106' ' ' LEU . 3.9 mp -128.59 100.54 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.033 -1.469 . . . . 74.5 107.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -160.82 175.8 12.17 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.234 1.014 . . . . 75.2 110.157 -166.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -81.44 127.01 32.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.649 0.261 . . . . 71.1 110.692 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -83.27 -47.45 11.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.755 0.788 . . . . 74.44 109.045 165.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 12.0 t70 -136.86 139.36 41.61 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.529 -1.214 . . . . 74.24 109.595 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.555 HG22 ' SD ' ' A' ' 117' ' ' MET . 78.5 mt -128.21 136.06 61.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.876 -1.527 . . . . 74.41 106.876 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -146.16 108.24 4.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.162 -0.681 . . . . 73.55 109.162 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 89.8 t80 -112.56 119.26 37.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.959 -1.497 . . . . 73.14 106.959 173.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -127.99 111.93 14.09 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.038 -0.727 . . . . 73.21 109.038 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.19 84.68 4.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.613 -1.255 . . . . 74.31 107.613 171.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.38 -31.29 18.03 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.285 1.99 . . . . 74.32 111.428 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.7 m-20 -109.29 34.38 3.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.501 1.12 . . . . 73.43 108.767 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.24 -47.33 98.5 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.658 0.783 . . . . 62.35 113.059 -177.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -67.64 -24.59 41.31 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.229 1.953 . . . . 73.21 113.275 171.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 25.4 m80 -64.89 -38.11 89.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.613 0.365 . . . . 74.44 110.611 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.81 -25.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.79 0.436 . . . . 74.54 111.626 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.26 -38.44 90.33 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.108 0.563 . . . . 74.41 111.283 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -90.32 -21.19 22.16 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.902 0.481 . . . . 71.23 111.12 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' HZ1' HD21 ' A' ' 68' ' ' LEU . 6.1 tmtt? -82.0 148.79 28.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.036 0.934 . . . . 62.41 111.479 -172.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.42 139.34 57.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.638 0.775 . . . . 74.43 110.736 170.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -84.61 74.04 10.48 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.927 0.87 . . . . 74.41 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -139.38 74.12 35.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.779 -0.823 . . . . 62.22 108.779 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.46 141.51 4.01 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.433 2.088 . . . . 64.14 112.665 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.94 121.97 40.5 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.874 -1.158 . . . . 74.21 107.874 171.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.67 115.49 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.184 0.594 . . . . 73.31 110.542 -167.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -93.77 121.09 34.85 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.298 1.039 . . . . 71.52 109.15 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.0 129.36 55.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.463 0.705 . . . . 72.1 110.328 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -114.39 113.46 24.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.806 0.843 . . . . 74.5 108.8 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.24 118.27 36.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.487 -1.301 . . . . 74.21 107.487 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' O ' HD22 ' A' ' 60' ' ' LEU . 21.6 t70 -129.23 144.93 51.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.77 0.828 . . . . 73.33 109.782 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.4 m -142.13 135.72 29.33 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.273 0.629 . . . . 73.45 110.342 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.48 119.65 9.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.439 0.695 . . . . 72.02 110.928 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 t -91.73 154.21 19.12 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.374 -0.602 . . . . 74.33 109.374 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.3 t -161.86 115.94 1.9 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 117.932 0.333 . . . . 73.14 110.308 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.44 105.87 5.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.784 0.834 . . . . 74.32 111.651 -172.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 HD13 ' HB2' ' A' ' 57' ' ' GLU . 70.1 mt -77.93 -40.48 39.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.85 0.86 . . . . 75.25 111.253 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.99 -172.0 3.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.122 0.969 . . . . 74.41 109.542 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.07 100.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.323 0.649 . . . . 62.41 111.159 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.86 32.79 13.02 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.797 1.239 . . . . 71.54 113.083 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 49.1 t -108.51 121.64 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 106.715 -1.587 . . . . 71.44 106.715 167.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' F' ' 114' ' ' LYS . 2.1 m-85 -132.48 131.04 41.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.254 -0.647 . . . . 65.32 109.254 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HB2' HD13 ' A' ' 51' ' ' LEU . 41.1 tt0 -86.37 120.22 27.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.629 -0.878 . . . . 63.42 108.629 168.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.33 116.25 42.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.715 -1.217 . . . . 74.52 107.715 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.2 t -98.07 134.88 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.129 -0.693 . . . . 74.35 109.129 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -109.39 109.86 20.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.141 -1.429 . . . . 75.21 107.141 171.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -96.99 102.0 13.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.913 -1.143 . . . . 74.0 107.913 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.86 140.6 16.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.511 -1.292 . . . . 73.24 107.511 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -129.48 124.4 33.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.338 -0.616 . . . . 74.22 109.338 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG22 HG21 ' A' ' 114' ' ' ILE . 70.8 t -115.76 105.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.935 -1.135 . . . . 75.21 107.935 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.3 m -112.33 122.86 48.93 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.561 -0.903 . . . . 71.23 108.561 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.25 110.81 21.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.613 -1.625 . . . . 72.35 106.613 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -148.38 147.47 29.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 70.23 109.827 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.597 HD21 ' HZ1' ' A' ' 34' ' ' LYS . 28.1 tp -113.32 86.85 2.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.032 -1.099 . . . . 65.53 108.032 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.11 -93.12 1.5 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.15 -0.932 . . . . 74.31 111.472 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -116.04 -26.9 7.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.72 0.808 . . . . 74.41 111.014 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.0 tp10 -77.67 107.08 9.9 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.184 -1.043 . . . . 72.25 108.184 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -76.01 142.53 41.85 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.479 -0.563 . . . . 75.15 109.479 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.46 -58.68 2.47 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.377 -0.971 . . . . 74.44 108.377 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -168.89 176.76 5.3 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.558 0.743 . . . . 75.15 110.727 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.3 tp -139.42 141.82 37.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.186 1.395 . . . . 74.41 108.342 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.453 ' HB3' ' HE1' ' A' ' 117' ' ' MET . 35.3 m -147.69 97.79 2.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.943 0.497 . . . . 75.03 110.144 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.43 122.32 46.04 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.575 0.75 . . . . 74.34 109.622 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.11 115.0 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.535 0.734 . . . . 71.14 109.864 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -85.91 82.19 8.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.401 1.081 . . . . 74.22 108.207 172.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.49 93.57 3.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.899 -1.046 . . . . 72.33 108.97 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.47 145.91 18.66 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.138 -0.483 . . . . 61.55 111.9 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.515 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -140.56 122.76 2.22 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 110.205 -1.158 . . . . 75.31 110.205 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.582 HD13 ' HA ' ' B' ' 29' ' ' PRO . 54.9 mt -82.21 126.83 40.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.8 -0.815 . . . . 74.03 108.8 175.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -132.71 117.05 17.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.426 -0.953 . . . . 71.32 108.426 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 40.7 t -84.56 97.64 9.7 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.397 -0.964 . . . . 73.34 108.397 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 10' ' ' THR . 34.1 pt -120.21 125.67 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.696 0.76 . . . . 64.41 111.59 -172.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.73 158.82 43.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.0 1.32 . . . . 63.35 108.932 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.17 8.74 86.07 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.796 -0.447 . . . . 55.11 114.213 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.463 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -117.69 134.1 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.823 -0.806 . . . . 74.23 108.823 173.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.33 169.1 17.72 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.99 0.516 . . . . 71.34 111.198 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.95 -111.76 0.79 Allowed Glycine 0 C--N 1.358 1.773 0 O-C-N 124.774 1.296 . . . . 44.13 115.209 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.0 p -70.12 -35.84 74.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.176 0.99 . . . . 70.32 111.772 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.89 -47.56 82.77 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.268 0.627 . . . . 72.31 111.197 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' F' ' 115' ' ' LEU . 26.3 ptt? -72.13 -35.75 69.21 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.019 0.528 . . . . 74.02 111.333 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.09 81.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.546 0.738 . . . . 64.11 110.595 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -46.88 86.73 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.625 -1.171 . . . . 73.01 109.985 172.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.561 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.0 m -70.84 -37.66 73.16 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.048 0.758 . . . . 74.23 113.048 -172.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 HD22 HD13 ' A' ' 86' ' ' ILE . 77.8 mt -84.84 -18.86 33.56 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.926 0.343 . . . . 74.22 111.926 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.71 -10.85 54.97 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 119.831 -0.427 . . . . 61.24 113.268 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -73.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.734 -0.651 . . . . 61.25 112.642 -172.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.561 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.5 t80 -41.41 -54.92 2.94 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 124.882 1.273 . . . . 73.11 113.158 -175.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -78.6 -52.54 1.34 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-O 118.256 -0.878 . . . . 72.1 112.975 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.423 ' HA ' HD12 ' A' ' 106' ' ' LEU . 38.6 Cg_endo -64.67 -25.27 61.69 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.791 1.661 . . . . 72.1 114.448 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -71.62 -33.98 69.43 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.933 0.493 . . . . 75.15 110.454 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.0 mm -62.16 -42.37 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.273 0.629 . . . . 74.12 109.879 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.554 HD23 HG21 ' A' ' 16' ' ' ILE . 60.2 mt -72.89 -25.42 61.06 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.586 -0.734 . . . . 74.33 111.678 -174.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.58 -43.32 70.35 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 115.088 1.514 . . . . 71.43 115.088 -168.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.23 -34.52 98.66 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.114 1.876 . . . . 74.11 113.232 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 84.3 m-85 -80.0 -35.55 37.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.733 0.813 . . . . 73.44 111.158 -176.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.1 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.135 0.574 . . . . 75.32 109.574 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.407 ' NH1' HD13 ' C' ' 105' ' ' ILE . 32.1 ttm180 -53.79 -45.64 70.77 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.764 1.29 . . . . 75.41 110.466 177.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.08 -50.23 64.82 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.633 0.773 . . . . 71.42 111.352 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.2 t -56.09 -46.6 78.99 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.214 0.946 . . . . 73.13 110.659 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.555 HG21 HG22 ' A' ' 64' ' ' VAL . 11.6 mt -57.77 -54.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.104 0.878 . . . . 75.21 110.657 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.503 HG22 ' HG3' ' A' ' 125' ' ' GLN . 65.8 m -56.44 -39.54 73.3 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.73 0.644 . . . . 73.41 111.594 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.35 -39.27 81.93 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.474 -0.785 . . . . 74.41 109.814 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.591 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 17.6 mtp -61.17 -40.85 95.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.524 0.73 . . . . 64.21 110.92 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 114' ' ' ILE . 92.1 t -62.89 -46.5 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.268 1.027 . . . . 75.15 110.698 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.7 p -75.25 -37.05 61.18 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.575 -0.739 . . . . 74.34 111.211 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -66.31 -28.33 68.6 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.308 0.643 . . . . 73.44 109.909 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.01 -3.07 89.36 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.558 -0.747 . . . . 75.51 113.43 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 65.83 38.32 5.18 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.028 1.394 . . . . 70.31 110.541 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.05 150.53 43.72 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 115.025 -0.989 . . . . 75.32 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.7 130.53 40.43 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.935 2.423 . . . . 75.05 112.271 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HG3' HG22 ' A' ' 115' ' ' THR . 32.7 tt0 -58.46 127.31 31.49 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.064 0.853 . . . . 74.35 112.128 -175.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.9 mt -117.32 95.58 5.04 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.994 -1.113 . . . . 72.32 107.994 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -98.4 126.74 44.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.746 -0.835 . . . . 75.13 108.746 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.28 149.0 40.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.772 -0.649 . . . . 74.13 111.958 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.03 142.02 87.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.326 0.651 . . . . 65.52 110.142 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.41 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 5.4 Cg_endo -78.24 96.94 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.171 1.914 . . . . 74.31 110.785 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.65 HG12 ' HA ' ' F' ' 125' ' ' TYR . 16.9 m -99.66 114.04 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.752 0.787 . . . . 73.34 109.04 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -93.23 93.28 8.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.964 -1.016 . . . . 73.43 109.663 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -64.55 -26.59 68.48 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.306 -0.861 . . . . 70.32 111.316 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.3 -40.07 86.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.625 0.77 . . . . 72.24 110.214 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.33 -43.63 77.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.985 -1.007 . . . . 72.34 110.776 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.18 -50.14 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.141 0.977 . . . . 75.41 110.176 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -68.03 -31.35 70.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 74.15 111.501 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.534 ' SD ' HD22 ' A' ' 141' ' ' LEU . 11.5 tpt -71.17 -38.05 72.17 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.452 0.47 . . . . 73.31 111.157 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 41.3 m-80 -63.94 -19.49 65.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.058 0.543 . . . . 71.34 111.627 176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -90.58 -42.91 10.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.439 0.696 . . . . 74.15 110.305 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.534 HD22 ' SD ' ' A' ' 138' ' ' MET . 56.2 tp -65.79 -50.84 63.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.824 1.249 . . . . 73.53 112.497 -167.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -154.66 -1.11 0.17 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.109 0.564 . . . . 74.14 110.728 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.407 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 27.9 mp0 59.08 -165.04 0.2 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.73 1.212 . . . . 75.11 111.202 -172.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.74 90.99 0.07 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.672 1.189 . . . . 64.21 109.942 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.78 4.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.954 0.501 . . . . 74.51 110.388 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.436 ' HA3' ' HG2' ' C' ' 144' ' ' GLN . . . 152.54 -89.26 0.13 Allowed Glycine 0 C--N 1.349 1.26 0 O-C-N 123.511 0.507 . . . . 62.24 112.563 177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -119.38 158.21 26.61 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.587 -1.264 . . . . 73.34 107.587 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.46 -29.07 0.24 Allowed Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.346 -1.102 . . . . 63.33 110.346 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -145.51 159.62 42.83 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.132 0.973 . . . . 64.53 109.557 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.1 104.26 2.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.041 -1.837 . . . . 75.34 106.041 172.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 129.36 41.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.196 0.999 . . . . 75.41 112.324 -171.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -67.98 154.6 41.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.126 0.971 . . . . 75.2 110.754 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -52.72 133.07 36.97 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.39 1.076 . . . . 75.33 112.512 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -162.1 -62.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.931 0.892 . . . . 72.14 109.272 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.308 0 C-N-CA 124.653 1.181 . . . . 72.24 111.058 -179.546 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.228 -0.286 . . . . 70.11 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -125.17 141.38 52.14 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.716 0.806 . . . . 73.44 109.594 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -145.66 108.18 4.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.134 0.492 . . . . 74.12 110.172 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.74 -176.39 5.4 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.538 1.135 . . . . 75.4 108.122 164.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -91.83 168.51 11.39 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.687 -0.486 . . . . 72.15 109.687 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -144.17 148.15 34.61 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.346 -0.613 . . . . 75.34 109.346 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.6 m -96.2 158.27 15.52 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.298 1.039 . . . . 74.33 110.237 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 77.53 -64.91 0.29 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 126.008 1.723 . . . . 63.02 112.476 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm 50.66 -174.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 126.144 1.778 . . . . 74.01 114.205 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.3 m -148.2 131.34 16.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.73 0.812 . . . . 74.44 109.059 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.51 ' HD2' HD12 ' F' ' 147' ' ' LEU . 66.9 t80 -136.58 142.74 43.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.756 0.422 . . . . 74.31 110.397 172.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -155.92 140.49 16.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.317 1.047 . . . . 74.1 109.306 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.07 106.35 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.478 -1.304 . . . . 74.0 107.478 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -78.24 -46.42 20.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.68 0.392 . . . . 74.23 110.19 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -163.58 140.87 7.3 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.063 -0.517 . . . . 74.25 110.166 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.1 mt -117.96 144.84 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.342 -1.355 . . . . 75.13 107.342 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.429 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.7 p90 -170.12 147.0 3.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.592 0.633 . . . . 73.41 111.913 -177.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -72.92 119.22 16.87 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.666 -1.152 . . . . 73.52 108.069 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -90.95 -30.25 16.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.326 0.65 . . . . 75.35 110.851 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -158.02 138.94 13.15 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.583 0.552 . . . . 72.03 111.112 -171.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.457 HD12 HG21 ' B' ' 78' ' ' VAL . 47.8 mm -132.33 138.22 52.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 C-N-CA 124.635 1.174 . . . . 74.3 109.007 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -131.25 136.08 47.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.332 -1.359 . . . . 75.11 107.332 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.488 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.6 t80 -151.84 122.1 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.363 -1.347 . . . . 74.31 107.363 171.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.62 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 42.1 mt-10 -124.1 133.68 53.55 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.29 -1.004 . . . . 75.13 108.29 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.78 87.47 54.67 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.162 -0.681 . . . . 62.4 109.162 175.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.7 -22.99 36.62 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.158 1.905 . . . . 70.31 111.004 172.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -115.04 24.96 11.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.135 0.974 . . . . 74.14 111.148 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.81 -53.64 40.21 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 123.704 0.801 . . . . 75.51 111.133 164.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.582 ' HA ' HD13 ' A' ' 83' ' ' ILE . 69.2 Cg_endo -77.0 -22.78 11.16 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.907 1.738 . . . . 71.32 113.374 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -94.46 2.94 55.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.54 0.736 . . . . 74.01 111.662 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.83 -31.73 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.222 1.009 . . . . 74.43 112.813 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -74.12 -34.83 64.05 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.354 . . . . 74.42 110.772 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -68.93 -23.78 64.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.648 1.179 . . . . 64.03 110.962 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' B' ' 34' ' ' LYS . 10.6 mmpt? -75.9 100.27 4.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.253 0.621 . . . . 64.53 111.422 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -113.42 78.84 1.17 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.339 1.056 . . . . 75.25 111.149 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -176.89 178.22 1.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.626 1.97 . . . . 75.44 107.143 171.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.56 131.93 36.63 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.501 -0.926 . . . . 71.24 108.501 164.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.466 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 47.6 Cg_endo -67.7 133.6 30.12 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.165 1.91 . . . . 72.43 112.961 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 25.5 tt0 -51.21 117.18 2.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.811 1.244 . . . . 70.5 109.631 164.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 134.2 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.736 0.414 . . . . 60.32 110.604 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -142.85 101.83 3.92 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.343 1.057 . . . . 73.11 108.611 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -94.8 153.07 17.92 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.177 -0.675 . . . . 70.45 109.177 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -138.35 130.27 28.26 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.403 -0.962 . . . . 73.44 108.403 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.96 128.47 53.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.606 -1.257 . . . . 75.35 107.606 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.3 t70 -142.85 155.66 44.81 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.428 1.091 . . . . 61.12 108.777 -174.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.1 p -141.89 119.59 11.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.369 0.668 . . . . 64.33 110.358 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.99 119.07 25.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.372 -0.973 . . . . 72.2 108.372 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -117.0 164.54 14.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.637 0.375 . . . . 72.5 110.979 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -152.41 136.89 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.2 1.0 . . . . 73.31 109.03 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -80.8 121.62 26.16 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.227 -0.657 . . . . 75.3 109.227 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 45.6 mt -80.53 -39.87 27.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.564 -0.532 . . . . 70.54 109.564 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.25 -179.1 4.88 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.758 -1.11 . . . . 51.53 109.966 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.78 129.59 41.15 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.409 -0.814 . . . . 74.44 108.95 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' B' ' 85' ' ' SER . 2.5 m-20 71.07 1.49 3.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.479 1.112 . . . . 74.44 112.283 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 t -125.75 88.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.475 -0.935 . . . . 74.32 108.475 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -108.86 137.85 46.13 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.823 -0.806 . . . . 74.43 108.823 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -119.76 108.3 14.25 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.405 -0.961 . . . . 74.24 108.405 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -99.94 124.11 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.857 0.863 . . . . 51.23 109.188 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.535 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 24.9 t -103.33 124.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 109.575 -0.528 . . . . 62.2 109.575 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.458 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.3 116.48 29.04 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.001 -1.481 . . . . 73.21 107.001 171.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.502 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 43.1 ttt180 -105.17 107.82 19.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.144 0.577 . . . . 63.41 109.887 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' B' ' 114' ' ' ILE . 15.9 t -107.9 121.39 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.963 -0.754 . . . . 74.32 108.963 172.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -109.46 141.96 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.365 0.666 . . . . 72.33 109.532 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.575 HG23 HD12 ' B' ' 114' ' ' ILE . 43.0 t -124.88 127.0 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.997 0.919 . . . . 74.2 108.658 171.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -125.62 147.24 49.38 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.776 -0.824 . . . . 74.43 108.776 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.548 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.11 148.72 30.93 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.605 0.565 . . . . 64.44 111.418 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.1 m -133.99 126.71 30.84 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 115.327 -0.852 . . . . 72.51 108.743 174.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.511 HD13 ' HB3' ' B' ' 34' ' ' LYS . 1.7 tt -118.92 115.82 25.19 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.948 -1.501 . . . . 75.52 106.948 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -143.95 29.94 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.343 -0.703 . . . . 72.51 111.343 -170.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -92.3 19.74 6.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 71.25 112.197 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.44 178.93 8.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.321 0.648 . . . . 64.32 110.45 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.5 m -69.2 139.49 54.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.241 0.616 . . . . 75.03 110.551 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . . . -87.41 -65.2 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.108 0.956 . . . . 74.54 108.762 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -156.02 161.44 40.45 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 113.311 -1.768 . . . . 71.14 108.848 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.62 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 81.6 mt -132.17 143.17 49.78 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.079 -1.452 . . . . 75.34 107.079 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -155.87 152.22 28.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.882 -0.784 . . . . 70.12 108.882 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.1 tt0 -165.85 135.9 3.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.696 -0.853 . . . . 74.41 108.696 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.457 HG21 HD12 ' B' ' 21' ' ' ILE . 93.1 t -125.1 143.6 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.56 0.744 . . . . 53.1 109.022 174.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 23.3 mt-30 -123.69 91.05 3.39 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.549 -0.908 . . . . 74.22 108.549 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -83.8 101.06 11.34 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.366 -0.834 . . . . 55.44 109.622 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.1 164.9 32.58 Favored Glycine 0 C--O 1.243 0.661 0 O-C-N 123.419 0.449 . . . . 73.4 112.074 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.88 125.34 1.46 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.676 -0.57 . . . . 51.34 111.676 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.429 HG13 ' HE1' ' B' ' 17' ' ' TYR . 45.7 mt -85.23 119.64 34.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 108.17 -1.048 . . . . 74.22 108.17 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.94 151.3 43.74 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.851 0.86 . . . . 73.34 109.864 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.505 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 13.4 m -96.3 100.57 12.18 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.051 -1.092 . . . . 75.53 108.051 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.552 HG21 ' SD ' ' B' ' 94' ' ' MET . 12.3 mm -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.496 -0.557 . . . . 72.3 109.496 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -142.42 153.01 43.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.988 0.515 . . . . 71.31 111.077 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.01 -67.15 3.8 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.914 0.759 . . . . 72.24 112.212 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 tt -49.24 135.29 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.281 1.832 . . . . 75.31 112.325 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -151.74 177.14 10.69 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.658 0.383 . . . . 74.14 111.241 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.08 -133.57 34.0 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.39 -0.823 . . . . 74.31 113.636 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.1 m -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.279 1.032 . . . . 71.4 110.858 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -66.67 -47.62 71.9 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.869 -1.514 . . . . 74.15 109.719 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.552 ' SD ' HG21 ' B' ' 86' ' ' ILE . 11.4 tpt -70.57 -33.97 71.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.611 0.764 . . . . 73.45 111.301 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.813 0.445 . . . . 74.14 111.072 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -67.49 -37.49 82.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.81 0.844 . . . . 74.11 111.189 177.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -69.93 -45.25 67.9 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.5 0.667 . . . . 71.23 110.961 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.27 -38.17 66.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.526 1.13 . . . . 71.44 111.228 -172.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.24 4.81 60.67 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.508 -0.769 . . . . 74.41 114.38 -173.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.48 -61.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.865 0.833 . . . . 72.04 112.758 -175.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -64.63 -52.97 54.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.636 0.774 . . . . 73.54 112.148 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.447 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 77.8 m -62.06 -51.15 76.88 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.274 -0.87 . . . . 72.31 112.33 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.458 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 32.3 Cg_exo -61.38 -29.51 85.71 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 121.935 1.757 . . . . 74.03 113.764 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.46 -35.99 81.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.941 0.497 . . . . 71.25 111.221 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.75 -40.26 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 124.043 0.937 . . . . 72.22 110.166 172.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.85 -18.84 31.72 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.871 -1.059 . . . . 74.31 112.763 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -59.4 -45.95 98.96 Favored Pre-proline 0 N--CA 1.485 1.282 0 N-CA-C 114.301 1.223 . . . . 74.24 114.301 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.89 -43.27 48.06 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.347 2.032 . . . . 74.4 113.734 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -70.0 -44.02 70.22 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.247 -0.888 . . . . 73.23 110.561 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.31 96.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.451 0.7 . . . . 71.44 110.917 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.7 ttt180 -56.88 -58.55 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.491 1.517 . . . . 75.32 110.92 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.09 -38.83 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.729 1.212 . . . . 73.35 111.085 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.05 -46.95 75.97 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.286 -0.415 . . . . 75.04 110.935 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.575 HD12 HG23 ' B' ' 64' ' ' VAL . 50.7 mt -60.37 -53.4 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.743 0.417 . . . . 74.34 110.589 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -26.76 68.76 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.271 -0.877 . . . . 75.11 111.406 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.402 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.1 t -72.26 -50.07 30.13 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.138 0.575 . . . . 73.3 110.526 172.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.1 mmt -65.65 -35.06 79.68 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.441 0.696 . . . . 74.44 112.273 -173.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.65 -34.19 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.773 0.429 . . . . 75.21 110.751 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 33.2 t -67.63 -30.4 69.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.762 0.825 . . . . 73.1 110.565 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.428 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 92.6 mtt-85 -65.79 -26.77 67.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.702 0.801 . . . . 74.45 111.552 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 10.4 65.7 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-O 119.681 -0.51 . . . . 74.02 114.261 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 5.1 p 67.85 12.09 8.67 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.18 1.792 . . . . 62.52 113.129 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -85.88 159.1 55.36 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.877 -0.582 . . . . 74.25 110.311 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -41.81 124.94 2.85 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.512 2.808 . . . . 71.3 113.271 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.47 111.78 3.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.552 -0.749 . . . . 75.11 109.517 178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.9 94.79 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.154 -1.054 . . . . 73.22 108.154 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -91.66 121.73 33.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.847 -1.168 . . . . 75.44 107.847 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -73.8 144.83 45.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 74.14 110.92 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.37 144.88 54.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.274 -0.876 . . . . 64.25 109.686 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.657 ' HG3' HD13 ' D' ' 16' ' ' ILE . 37.0 Cg_endo -63.07 99.41 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.626 2.217 . . . . 65.14 112.327 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.38 132.03 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.307 0.575 . . . . 70.54 110.249 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.46 113.12 24.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.84 0.856 . . . . 75.2 108.983 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -72.81 -18.71 61.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.698 0.799 . . . . 72.24 111.841 -174.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.86 -41.6 95.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.199 0.6 . . . . 72.21 109.742 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.02 88.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.284 -0.871 . . . . 73.2 110.057 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.26 -33.33 73.35 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.442 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -74.9 -46.59 34.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.101 0.96 . . . . 73.44 111.321 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 65.7 mtt -79.21 -36.38 40.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.228 0.611 . . . . 73.23 111.598 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -77.54 -13.7 59.85 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.272 0.629 . . . . 71.14 111.09 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.75 -34.14 77.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.612 0.72 . . . . 73.15 109.972 171.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.36 9.74 27.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.607 -1.178 . . . . 71.13 110.511 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.591 ' HG3' ' HG2' ' B' ' 143' ' ' GLN . 6.7 tp60 60.68 -92.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.365 1.466 . . . . 73.24 109.996 -168.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.591 ' HG2' ' HG3' ' B' ' 142' ' ' GLN . 13.5 pt20 -169.52 156.03 6.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 74.15 109.037 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.71 128.3 10.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.66 -0.496 . . . . 73.13 109.66 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.03 -54.3 0.92 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.888 0.875 . . . . 74.34 109.089 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.7 -78.15 0.49 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.265 -0.88 . . . . 54.44 111.285 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -96.95 103.37 15.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.173 0.989 . . . . 72.01 108.864 174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.79 92.48 0.09 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.467 -0.653 . . . . 74.54 111.467 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.4 p -73.21 102.68 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.584 0.754 . . . . 72.41 112.078 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -80.6 106.78 12.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.302 1.041 . . . . 74.5 110.024 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -92.69 144.47 25.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.035 0.934 . . . . 64.15 110.108 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -120.2 99.14 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.516 0.726 . . . . 55.44 110.278 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -81.8 77.91 8.58 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.312 0.645 . . . . 75.2 109.933 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.82 84.75 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.68 -0.691 . . . . 52.52 109.638 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.399 -0.964 . . . . 73.24 108.399 -178.502 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.108 -0.33 . . . . 72.1 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.7 p -91.04 -92.29 0.14 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.153 0.581 . . . . 75.24 109.591 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.422 ' HB2' ' HD3' ' F' ' 124' ' ' ARG . 3.5 tm-20 -127.82 98.46 5.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.424 -0.954 . . . . 74.42 108.424 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -135.6 22.47 3.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.437 1.095 . . . . 74.34 108.874 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.406 HD21 ' H ' ' C' ' 5' ' ' ASN . 0.1 OUTLIER -89.09 100.49 13.25 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.115 0.959 . . . . 72.1 111.239 -171.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.571 ' HA ' ' HA2' ' C' ' 146' ' ' GLY . 2.6 p30 -146.65 79.78 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.453 1.101 . . . . 73.32 108.862 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -96.04 -67.13 0.87 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.117 -0.947 . . . . 74.52 109.477 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -169.42 168.44 9.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.369 1.067 . . . . 72.51 108.88 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.625 ' HE2' HD13 ' C' ' 89' ' ' ILE . 29.3 ttm 66.85 112.36 0.04 OUTLIER 'General case' 0 C--N 1.348 0.503 0 C-N-CA 125.934 1.694 . . . . 73.52 111.435 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -101.36 75.16 1.6 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.535 -1.283 . . . . 73.33 107.535 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' C' ' 85' ' ' SER . 56.6 t80 -84.8 118.06 24.24 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 108.221 -1.029 . . . . 64.35 108.221 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -147.49 131.97 17.68 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.725 -0.842 . . . . 63.4 108.725 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -75.95 125.65 35.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.75 -0.834 . . . . 74.44 108.75 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.3 mm-40 -95.11 -45.49 7.19 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 74.23 110.115 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.575 HH22 HD11 ' F' ' 134' ' ' ILE . 76.9 ttt180 -166.76 126.31 1.5 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.958 0.503 . . . . 75.12 109.888 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.01 144.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.974 -1.121 . . . . 73.22 107.974 174.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -177.97 161.22 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.454 0.645 . . . . 73.02 111.017 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -86.28 110.69 19.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.38 -0.827 . . . . 75.23 108.977 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.428 ' HD2' ' HB2' ' D' ' 28' ' ' ALA . 7.3 mmmt -72.23 -44.71 62.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.397 -0.964 . . . . 72.32 108.397 172.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.9 t70 -134.51 143.86 47.69 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.661 -1.154 . . . . 70.34 110.234 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.93 147.77 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.267 1.827 . . . . 74.13 106.444 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -157.55 151.64 24.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.066 0.546 . . . . 71.13 110.153 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -148.74 146.28 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.871 -1.159 . . . . 75.02 107.871 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 47.6 mt-10 -141.79 150.11 41.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.259 -1.385 . . . . 72.2 107.259 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.85 88.97 3.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.47 -45.58 17.65 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.832 2.355 . . . . 75.05 111.759 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.428 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 67.1 m-80 -98.79 40.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.733 -0.667 . . . . 71.42 110.594 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.19 -42.19 91.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.335 1.054 . . . . 62.12 113.32 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.95 -34.7 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 121.611 1.541 . . . . 72.12 112.833 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.428 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 38.1 t-80 -68.11 -19.49 64.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.064 1.346 . . . . 74.34 111.874 -172.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.544 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.1 p -48.58 -35.27 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 124.618 1.167 . . . . 73.15 113.55 175.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -59.18 -40.4 85.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.797 0.839 . . . . 71.24 111.35 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -115.6 18.31 15.9 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.364 -0.835 . . . . 75.32 111.331 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.544 ' HE2' HG23 ' C' ' 31' ' ' VAL . 0.0 OUTLIER -82.63 165.51 19.97 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.236 -0.653 . . . . 75.12 109.236 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.39 130.75 35.09 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.721 -0.844 . . . . 71.24 108.721 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -75.34 85.85 2.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.632 0.73 . . . . 74.11 110.075 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -154.27 68.8 6.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.562 -1.199 . . . . 72.01 107.773 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -91.95 112.34 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.334 2.023 . . . . 60.02 111.287 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.56 95.04 9.61 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 108.104 -1.073 . . . . 53.01 108.104 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.95 107.58 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.126 -0.943 . . . . 62.22 110.134 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.423 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.5 mttp -91.05 102.83 15.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 74.42 107.669 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.07 145.23 26.54 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.131 -1.063 . . . . 74.25 108.131 178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -139.91 137.82 35.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.874 0.87 . . . . 71.04 108.691 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.34 146.49 51.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.894 0.878 . . . . 74.33 109.149 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.04 154.71 28.06 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.045 0.938 . . . . 64.23 109.218 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -155.87 148.54 24.01 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.929 0.395 . . . . 64.21 110.384 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.78 163.35 33.59 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.04 0.936 . . . . 73.12 109.036 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.1 p -130.72 147.16 52.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.994 0.517 . . . . 73.33 110.048 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.0 p -143.97 129.06 18.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.73 0.812 . . . . 72.31 109.305 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -78.46 116.49 18.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.915 0.486 . . . . 73.03 110.295 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' C' ' 57' ' ' GLU . 47.2 mt -87.96 -45.77 9.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.799 0.84 . . . . 73.52 109.317 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.71 -179.49 6.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.39 -1.277 . . . . 64.33 109.343 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.38 109.57 0.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.929 0.768 . . . . 65.41 110.216 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.67 22.44 7.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.603 1.161 . . . . 74.42 112.018 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.1 105.61 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.511 1.124 . . . . 75.21 108.027 173.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -114.64 128.81 56.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.675 0.79 . . . . 74.53 110.07 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.614 ' HB2' HD12 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.98 115.29 22.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.595 0.758 . . . . 74.51 109.195 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.9 t -96.81 121.17 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.14 -1.059 . . . . 72.34 108.14 173.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.7 105.31 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.5 -0.926 . . . . 71.22 108.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -91.29 105.0 17.47 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.277 -1.008 . . . . 70.01 108.277 176.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -95.9 121.93 38.16 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.951 0.9 . . . . 75.43 110.194 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.448 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.8 t -107.35 146.67 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 107.909 -1.145 . . . . 74.54 107.909 169.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 23.4 m -139.46 120.69 14.82 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.495 0.664 . . . . 73.11 109.501 170.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.544 HG22 HG21 ' C' ' 114' ' ' ILE . 85.7 t -101.85 108.86 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.73 -1.123 . . . . 75.32 108.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.8 m -97.92 135.55 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.178 -1.415 . . . . 73.34 107.178 169.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.28 102.97 5.15 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.028 -1.471 . . . . 63.35 107.028 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 26.2 p -168.51 154.48 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.695 0.622 . . . . 52.23 110.838 -172.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -95.5 -42.81 8.27 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.187 -0.672 . . . . 74.13 109.187 171.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.42 -80.85 0.05 OUTLIER Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.781 -0.928 . . . . 55.41 110.781 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -89.4 -31.65 17.65 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.779 -0.823 . . . . 74.11 108.779 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.91 85.25 2.23 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.626 -0.715 . . . . 74.55 109.48 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 27.5 m -89.31 116.86 27.84 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.233 -0.44 . . . . 75.45 110.197 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.51 -64.78 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.511 -1.292 . . . . 63.25 107.511 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.81 171.61 16.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.545 0.688 . . . . 70.43 111.645 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.7 tm? -132.08 145.35 51.35 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.563 -2.014 . . . . 74.21 105.563 171.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -151.72 142.99 23.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.382 -0.97 . . . . 63.14 108.382 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -150.1 134.25 17.11 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.404 -0.591 . . . . 73.43 109.404 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.43 HG12 ' HA ' ' C' ' 110' ' ' ALA . 50.3 t -134.27 113.69 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.89 0.876 . . . . 74.25 108.661 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.745 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 54.3 mt-30 -91.05 90.13 7.71 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.525 -0.917 . . . . 73.25 108.525 171.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -78.81 103.77 8.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.84 -1.073 . . . . 74.1 109.48 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.74 144.74 22.28 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.458 -0.657 . . . . 72.13 111.458 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.05 117.1 0.9 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.557 -1.017 . . . . 74.5 110.557 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.506 HD13 HD12 ' C' ' 51' ' ' LEU . 12.0 mm -80.0 126.73 39.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.854 -1.165 . . . . 72.21 107.854 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.6 143.33 47.27 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.892 0.477 . . . . 75.21 109.812 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 15.6 m -82.1 107.14 14.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.656 -1.238 . . . . 75.15 107.656 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.4 99.72 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.095 -1.076 . . . . 75.0 108.095 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -128.75 159.31 36.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.362 1.065 . . . . 64.54 110.152 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -53.45 4.37 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.53 0.519 . . . . 72.13 113.435 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.625 HD13 ' HE2' ' C' ' 9' ' ' MET . 30.0 pt -80.92 150.82 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.872 0.869 . . . . 72.42 112.117 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -147.23 153.75 40.18 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.77 1.228 . . . . 72.44 108.85 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.64 -111.32 2.07 Favored Glycine 0 C--N 1.355 1.612 0 O-C-N 123.548 0.53 . . . . 74.04 114.136 170.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 24.9 p -50.6 -55.42 16.37 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.293 1.437 . . . . 74.24 112.868 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.38 -46.32 80.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.054 0.542 . . . . 74.4 111.502 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -68.83 -31.48 70.5 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.356 0.41 . . . . 75.42 111.484 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.61 75.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.166 0.587 . . . . 73.11 111.528 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -69.58 -29.46 67.01 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.837 -0.62 . . . . 71.43 110.846 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.34 -58.93 3.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.908 0.483 . . . . 62.13 110.486 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -73.36 -15.62 61.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.94 0.496 . . . . 74.21 111.652 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.32 7.73 58.46 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 119.588 -0.562 . . . . 64.13 113.822 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.426 ' HB3' ' HD2' ' C' ' 133' ' ' PHE . . . -159.43 -60.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.689 0.745 . . . . 71.14 112.152 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.41 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 65.1 t80 -73.41 -44.8 57.65 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.453 0.701 . . . . 74.21 112.788 -167.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.479 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 38.0 m -68.65 -47.2 34.44 Favored Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.14 0.576 . . . . 65.23 111.415 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 38.2 Cg_exo -64.48 -26.15 62.66 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.177 1.918 . . . . 74.45 114.192 173.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.484 ' ND2' HD21 ' C' ' 132' ' ' ASN . 29.2 t-20 -55.06 -49.05 72.6 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.894 0.877 . . . . 70.14 110.277 176.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.407 HD13 ' NH1' ' A' ' 111' ' ' ARG . 43.6 mm -56.96 -41.98 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 124.163 0.915 . . . . 71.11 110.897 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.1 mt -83.41 -23.0 32.55 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.126 -0.943 . . . . 72.13 112.566 -171.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.74 -50.34 87.25 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.57 -1.205 . . . . 71.24 113.494 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.41 -34.17 93.82 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.071 1.847 . . . . 72.34 112.918 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -68.0 -50.72 53.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.787 0.835 . . . . 73.23 111.448 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -65.31 -35.03 79.74 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 116.018 -0.537 . . . . 60.21 111.117 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.465 HH12 ' HG3' ' C' ' 130' ' ' PRO . 59.6 ttt180 -60.66 -48.51 81.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.797 1.639 . . . . 72.11 110.647 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.428 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 3.1 tm-20 -72.82 -33.62 66.31 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.873 0.469 . . . . 75.31 109.993 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.419 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 8.6 t -65.55 -28.73 69.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.979 0.512 . . . . 74.04 111.135 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.544 HG21 HG22 ' C' ' 64' ' ' VAL . 87.9 mt -78.77 -51.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.659 -0.7 . . . . 73.44 110.033 173.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 33.6 m -58.97 -28.56 66.44 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.251 0.548 . . . . 71.45 111.173 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 44.6 t -63.38 -55.27 25.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.266 1.026 . . . . 74.33 109.053 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -34.69 71.19 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.739 1.216 . . . . 73.22 112.774 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.9 t -66.2 -48.09 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.855 -0.794 . . . . 73.45 108.855 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -31.97 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.022 -0.99 . . . . 73.2 111.214 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.5 mtt-85 -66.94 -40.85 87.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.524 0.73 . . . . 72.11 109.437 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.73 3.93 62.52 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.826 0.704 . . . . 73.11 112.988 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 59.69 31.33 20.81 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.436 1.894 . . . . 75.53 112.994 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.98 153.47 43.42 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.078 0.951 . . . . 72.13 108.929 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 -169.89 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.91 2.406 . . . . 73.55 113.536 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -52.28 117.96 3.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.367 1.067 . . . . 74.12 113.138 -175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' E' ' 139' ' ' LEU . 2.8 tm? -139.55 104.39 4.93 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.033 -1.469 . . . . 74.12 107.033 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.12 131.1 38.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.672 1.189 . . . . 75.31 108.227 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -86.11 142.54 28.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.925 -0.398 . . . . 74.31 109.925 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 139.03 97.55 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.32 1.048 . . . . 54.32 111.922 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.465 ' HG3' HH12 ' C' ' 111' ' ' ARG . 27.0 Cg_exo -63.44 98.28 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.758 2.305 . . . . 74.33 112.837 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.86 109.17 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.05 -0.722 . . . . 71.51 109.05 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.484 HD21 ' ND2' ' C' ' 104' ' ' ASN . 19.2 m120 -115.36 102.99 10.35 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.79 0.836 . . . . 64.11 109.95 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.426 ' HD2' ' HB3' ' C' ' 100' ' ' ALA . 67.2 t80 -80.37 -24.18 39.97 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.58 0.705 . . . . 75.15 110.212 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -75.33 -39.0 59.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.406 1.083 . . . . 71.24 111.123 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.445 ' HA ' ' HG3' ' C' ' 138' ' ' MET . . . -59.96 -39.12 84.52 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.884 0.74 . . . . 64.54 111.395 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 46.9 tp -54.02 -45.01 71.44 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.276 1.03 . . . . 73.25 111.212 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -80.71 -36.56 32.01 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.245 -0.888 . . . . 73.32 111.772 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.445 ' HG3' ' HA ' ' C' ' 135' ' ' ALA . 0.0 OUTLIER -70.24 -29.01 65.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.029 0.381 . . . . 75.21 112.029 -170.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -59.07 -44.12 91.82 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 120.884 0.373 . . . . 74.33 110.646 172.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -71.62 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.514 -0.766 . . . . 73.03 109.303 171.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 53.9 tp -105.03 118.9 37.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.747 0.819 . . . . 73.52 109.926 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -73.83 177.45 5.53 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.819 0.848 . . . . 73.3 111.156 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -103.09 154.6 19.11 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.26 1.024 . . . . 72.14 110.879 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.436 ' HG2' ' HA3' ' A' ' 146' ' ' GLY . 35.1 mt-30 -75.4 157.84 33.59 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.231 0.612 . . . . 72.01 111.274 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.25 112.45 7.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.088 0.955 . . . . 63.1 109.163 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' C' ' 6' ' ' ASN . . . -118.95 67.37 0.37 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.46 -0.656 . . . . 72.34 111.46 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -122.08 179.38 4.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.459 0.704 . . . . 71.41 110.494 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.91 7.98 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.278 -0.874 . . . . 74.45 111.038 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -74.0 -68.96 0.47 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.05 -0.722 . . . . 72.45 109.05 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 44.22 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.964 1.305 . . . . 74.42 111.61 177.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.65 -39.92 85.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.214 -0.903 . . . . 73.5 110.725 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -175.61 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 O-C-N 124.638 1.211 . . . . 71.14 109.281 165.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -144.48 151.32 39.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.828 1.251 . . . . 72.12 108.605 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t70 65.57 107.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.216 1.006 . . . . 71.52 111.027 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 N-CA-C 109.245 -0.65 . . . . 74.25 109.245 179.426 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 109.686 -0.487 . . . . 74.45 109.686 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t 179.67 69.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 106.771 -1.566 . . . . 75.4 106.771 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.27 75.27 4.8 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.077 -0.965 . . . . 75.13 110.182 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -134.41 100.09 4.56 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.223 -1.029 . . . . 61.4 108.223 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.81 100.17 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.126 0.97 . . . . 74.52 109.089 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -57.47 131.81 51.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.376 0.67 . . . . 74.14 111.779 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -70.4 -40.21 74.02 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.406 0.683 . . . . 64.33 111.522 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -82.66 132.18 35.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.027 0.531 . . . . 73.43 109.72 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -30.4 135.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 125.367 1.667 . . . . 70.14 114.851 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.455 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 45.5 m -145.69 143.65 29.91 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.452 1.101 . . . . 74.25 109.202 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' D' ' 85' ' ' SER . 44.8 t80 -154.08 109.92 3.23 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.053 -1.091 . . . . 71.53 108.053 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.8 116.42 27.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.313 0.645 . . . . 64.01 110.259 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 30.9 pt -78.39 99.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.483 -0.932 . . . . 75.21 108.483 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -83.44 -45.31 13.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.944 -0.472 . . . . 74.23 111.669 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.422 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 20.5 ttt180 -164.71 126.6 2.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.597 -0.149 . . . . 75.3 110.597 -167.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.657 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -113.15 133.68 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.639 -1.245 . . . . 74.43 107.639 174.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.9 p90 -159.03 178.42 10.08 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.429 0.692 . . . . 71.42 111.782 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 58.2 p -107.36 132.19 53.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.619 -0.882 . . . . 73.34 108.619 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -96.21 -31.48 12.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.195 -0.298 . . . . 65.22 110.195 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.0 t70 -150.24 141.27 22.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.929 0.892 . . . . 74.11 108.916 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.535 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.1 mt -143.75 148.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.7 1.2 . . . . 64.0 107.921 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.6 t -151.64 145.46 25.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.331 1.053 . . . . 74.33 109.176 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -150.59 125.27 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.725 -1.954 . . . . 73.44 105.725 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -131.79 131.94 43.35 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.139 0.427 . . . . 71.54 110.104 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' D' ' 28' ' ' ALA . . . -145.55 79.69 11.22 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.779 -0.823 . . . . 75.13 108.779 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.77 -39.72 14.42 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.584 2.189 . . . . 73.32 111.303 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -98.79 24.73 7.27 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.811 . . . . 73.22 109.97 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' D' ' 25' ' ' ALA . . . -51.97 -49.13 85.77 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 115.132 1.53 . . . . 74.21 115.132 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.462 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.9 Cg_endo -84.83 -7.37 9.47 Favored 'Trans proline' 0 C--N 1.39 2.745 0 CA-C-N 121.791 1.675 . . . . 73.34 112.996 175.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -83.82 -40.15 19.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 74.11 109.813 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.42 -12.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.549 0.739 . . . . 72.21 110.712 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -56.82 -29.77 63.08 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.667 1.187 . . . . 75.02 111.815 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.89 -14.24 62.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.228 1.011 . . . . 64.32 112.124 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.632 ' HZ1' ' HB2' ' D' ' 71' ' ' GLU . 56.7 mtmt -123.42 108.76 13.06 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.805 0.842 . . . . 72.33 109.771 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.69 82.16 3.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.654 0.74 . . . . 64.14 110.383 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -148.63 165.46 31.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.193 0.997 . . . . 74.05 108.666 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.506 ' HB3' ' HG ' ' F' ' 141' ' ' LEU . 15.5 mp0 -69.52 110.67 6.8 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.281 1.433 . . . . 74.44 111.222 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 16.6 Cg_exo -71.12 124.07 10.2 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.058 2.505 . . . . 72.12 112.392 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -60.99 118.91 7.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.378 0.424 . . . . 74.54 110.807 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.464 HG21 HG13 ' D' ' 64' ' ' VAL . 2.3 p -98.91 128.0 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.797 0.839 . . . . 75.53 109.498 -176.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.493 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 9.3 tmtt? -99.29 117.0 32.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.046 -1.835 . . . . 74.41 106.046 170.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.448 HD22 HD22 ' D' ' 128' ' ' LEU . 53.2 tp -95.1 134.79 37.42 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.984 -1.117 . . . . 73.51 107.984 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.442 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.5 t70 -135.43 149.92 49.72 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.263 -1.384 . . . . 75.14 107.263 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -135.43 164.69 27.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.482 0.313 . . . . 72.24 111.195 -174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.579 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.9 t70 -171.23 156.18 4.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.514 1.125 . . . . 64.22 109.351 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -134.63 160.54 37.79 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.476 0.711 . . . . 74.31 110.003 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.594 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.1 162.83 39.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.056 0.942 . . . . 43.21 109.344 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -140.63 157.94 44.72 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.163 0.585 . . . . 71.23 110.803 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -161.15 130.2 4.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.571 1.148 . . . . 45.2 108.567 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -89.89 123.55 33.93 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 172.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.601 HD11 ' HB2' ' D' ' 57' ' ' GLU . 56.6 mt -97.94 -35.62 10.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.791 0.836 . . . . 63.55 110.056 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -160.32 -175.62 5.14 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.954 -1.021 . . . . 44.35 110.564 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.97 109.39 1.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.787 -1.097 . . . . 73.54 109.674 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.81 10.01 6.5 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.985 1.314 . . . . 75.12 112.925 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 89.1 t -109.02 118.33 56.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.233 -1.025 . . . . 71.12 108.233 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.63 129.83 44.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.066 -0.97 . . . . 73.43 109.74 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.601 ' HB2' HD11 ' D' ' 51' ' ' LEU . 35.3 tt0 -87.24 130.75 34.45 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.316 1.046 . . . . 73.13 108.683 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.0 145.0 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.142 -1.059 . . . . 72.05 108.142 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 85.6 t -117.46 142.46 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.017 0.927 . . . . 74.43 108.73 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 116.56 24.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.435 -1.321 . . . . 75.14 107.435 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.579 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -101.44 103.92 14.84 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.126 -1.064 . . . . 74.32 108.126 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.73 117.77 49.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.244 -1.021 . . . . 73.43 108.244 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 10.4 m -118.02 127.92 54.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.245 0.618 . . . . 74.5 110.385 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 73.4 t -114.63 123.78 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.322 1.449 . . . . 72.32 108.962 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.493 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 32.3 m -123.6 91.61 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.908 -1.145 . . . . 73.13 107.908 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 138.74 34.3 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.254 -0.647 . . . . 52.34 109.254 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -154.62 125.86 7.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.437 -0.801 . . . . 72.54 109.692 -173.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' D' ' 71' ' ' GLU . 46.4 tp -113.38 99.19 7.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.067 -0.716 . . . . 74.03 109.067 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.83 -128.74 9.08 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 112.157 -0.377 . . . . 63.03 112.157 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -90.33 14.54 12.52 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.307 1.043 . . . . 71.43 110.839 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.632 ' HB2' ' HZ1' ' D' ' 34' ' ' LYS . 3.3 tp10 -115.31 134.31 55.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.179 0.992 . . . . 73.2 111.431 -158.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.3 m -69.59 110.47 4.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.594 -0.891 . . . . 75.24 108.594 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 -66.83 0.84 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.66 -0.496 . . . . 74.41 109.66 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -154.35 136.6 14.85 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.399 0.619 . . . . 71.13 110.265 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.3 mt -105.12 152.49 22.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.649 1.18 . . . . 72.11 108.0 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.561 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 41.0 t -160.37 148.77 16.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.119 0.568 . . . . 62.41 109.963 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.7 125.75 6.59 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.818 -0.808 . . . . 75.21 108.818 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.413 0.685 . . . . 74.34 109.607 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -93.89 87.11 5.27 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.719 -0.845 . . . . 74.33 108.719 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.04 110.01 13.87 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.434 -1.257 . . . . 74.52 108.45 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.45 143.93 15.75 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.239 -0.344 . . . . 72.55 112.239 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.48 139.84 9.45 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.833 0.317 . . . . 71.33 112.347 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.35 123.17 40.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.806 0.842 . . . . 75.44 108.984 173.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.08 141.51 48.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.106 0.963 . . . . 74.05 108.729 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 17.4 m -102.37 112.69 25.5 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.315 -0.624 . . . . 72.02 109.315 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.99 103.56 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.245 -1.02 . . . . 75.53 108.245 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.455 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -131.55 153.48 49.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.442 1.097 . . . . 74.42 109.711 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 2.78 61.29 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.102 0.252 . . . . 71.21 113.367 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 44.9 mm -131.41 129.83 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.861 1.264 . . . . 74.04 108.317 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.65 179.1 7.02 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.191 0.997 . . . . 74.04 110.814 -174.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.0 -135.46 24.39 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.886 -0.597 . . . . 64.14 114.083 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -80.1 -21.85 42.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.936 0.894 . . . . 75.51 111.927 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.57 -40.4 73.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.959 0.504 . . . . 75.34 111.164 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -28.64 64.75 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 110.311 -0.255 . . . . 72.24 110.311 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.55 -32.76 66.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.475 0.71 . . . . 64.25 110.555 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -65.93 -43.43 88.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.257 0.623 . . . . 75.55 110.198 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.516 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 89.8 m -61.67 -42.33 98.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.437 0.295 . . . . 65.41 110.884 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.01 -40.02 65.54 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.065 0.546 . . . . 74.45 111.629 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.97 3.68 38.59 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-O 119.414 -0.659 . . . . 71.55 114.662 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.467 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -144.43 -63.24 0.37 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.979 0.889 . . . . 74.21 112.203 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.516 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 82.7 t80 -64.95 -58.19 6.79 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.372 0.508 . . . . 72.51 112.372 -170.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 66.1 m -59.94 -44.23 96.36 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 118.513 -0.756 . . . . 72.02 112.737 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.43 -37.5 94.76 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.419 2.079 . . . . 72.42 113.919 167.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.96 -28.54 66.73 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.446 0.698 . . . . 62.54 110.858 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.5 -40.63 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.398 0.618 . . . . 75.54 109.773 170.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.53 -18.97 58.42 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.23 -0.896 . . . . 61.24 112.008 -176.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -64.11 -43.4 74.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.293 1.22 . . . . 74.2 114.293 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.45 -39.94 63.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.051 1.834 . . . . 61.52 113.292 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . 0.433 ' HH ' ' HB3' ' B' ' 130' ' ' PRO . 98.8 m-85 -78.93 -30.18 44.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.746 0.818 . . . . 75.32 111.621 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.67 65.62 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.212 0.605 . . . . 71.03 109.641 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.44 -49.42 74.62 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.2 -1.364 . . . . 75.32 110.607 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.73 -45.9 92.48 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.041 0.838 . . . . 75.45 111.697 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.484 ' SG ' HD11 ' D' ' 21' ' ' ILE . 48.6 t -59.13 -40.97 87.1 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.715 0.635 . . . . 71.42 110.745 -178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.506 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.6 mt -61.79 -56.89 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 123.791 0.682 . . . . 70.42 109.873 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.537 HG22 ' HG3' ' D' ' 125' ' ' GLN . 41.0 m -54.11 -38.69 65.68 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.649 1.18 . . . . 75.14 111.787 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 38.0 t -66.8 -44.01 82.36 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.791 -1.095 . . . . 74.55 110.399 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.5 -29.77 65.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.116 0.566 . . . . 73.24 111.907 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.407 HG22 ' O ' ' D' ' 114' ' ' ILE . 75.9 t -68.16 -42.26 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 123.785 0.678 . . . . 74.11 109.336 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -75.63 -28.0 58.65 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.257 -0.429 . . . . 74.34 111.174 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.419 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 94.2 mtt-85 -69.97 -35.74 74.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.509 0.724 . . . . 74.01 109.614 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.53 0.16 77.03 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.794 0.683 . . . . 70.25 112.33 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.62 28.13 16.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.51 1.924 . . . . 75.44 112.677 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 37.4 m-85 -91.03 162.25 33.18 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.19 1.396 . . . . 74.23 110.683 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.423 ' HD3' HG11 ' F' ' 136' ' ' VAL . 18.6 Cg_endo -58.9 133.22 52.25 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.766 2.31 . . . . 75.02 111.853 177.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.537 ' HG3' HG22 ' D' ' 115' ' ' THR . 31.7 tt0 -56.62 137.84 53.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.874 0.869 . . . . 75.33 112.446 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.39 108.95 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.894 -1.151 . . . . 74.32 107.894 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -113.27 110.96 21.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.805 -0.813 . . . . 72.34 108.805 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.448 HD22 HD22 ' D' ' 42' ' ' LEU . 90.5 mt -69.2 135.58 50.8 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.133 0.573 . . . . 71.12 110.279 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.51 146.95 98.81 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.024 0.929 . . . . 64.42 111.42 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.43 ' HD2' HD13 ' F' ' 147' ' ' LEU . 13.7 Cg_exo -66.7 121.37 8.59 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.638 2.226 . . . . 74.43 111.269 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.74 118.8 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.338 0.655 . . . . 75.52 110.323 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -86.55 78.35 9.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.153 -1.054 . . . . 73.21 108.153 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.558 ' HA ' HD22 ' D' ' 136' ' ' LEU . 34.1 p90 -78.85 -10.32 59.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 74.11 111.333 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.467 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.6 m-20 -47.23 -51.21 19.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.8 1.24 . . . . 74.33 112.332 173.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.97 0.794 . . . . 71.1 111.695 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.558 HD22 ' HA ' ' D' ' 133' ' ' PHE . 3.3 mm? -71.07 -41.95 70.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.24 -0.891 . . . . 70.52 110.389 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.404 ' O ' HD11 ' D' ' 141' ' ' LEU . 49.4 m-85 -70.69 -32.08 69.19 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.329 0.651 . . . . 74.35 111.879 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.432 ' HE1' ' HB3' ' D' ' 134' ' ' ASP . 57.5 mtt -59.25 -41.72 89.42 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.943 0.497 . . . . 74.24 110.154 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.44 ' N ' HD21 ' D' ' 139' ' ' ASN . 0.8 OUTLIER -77.05 -42.33 38.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.968 -1.014 . . . . 72.53 110.713 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -63.74 -36.49 84.05 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.823 0.849 . . . . 74.34 111.874 -174.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.404 HD11 ' O ' ' D' ' 137' ' ' PHE . 5.6 mp -66.38 -29.32 69.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.411 0.684 . . . . 72.4 110.893 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -88.53 0.67 56.07 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.437 0.695 . . . . 75.21 111.282 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -137.51 49.69 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.001 0.921 . . . . 74.14 109.354 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -146.49 166.27 26.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.277 0.631 . . . . 72.01 110.519 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.25 170.6 7.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.962 0.905 . . . . 61.15 110.618 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -129.04 31.46 3.48 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 111.494 -0.643 . . . . 75.15 111.494 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.99 155.01 29.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.919 0.887 . . . . 71.22 111.517 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 148.31 44.98 0.03 OUTLIER Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.225 -0.443 . . . . 65.54 112.135 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.2 t -63.1 127.65 32.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.61 0.364 . . . . 65.4 110.063 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -163.77 -172.38 2.84 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.096 0.559 . . . . 73.22 110.004 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.95 -75.23 0.17 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.583 -0.525 . . . . 74.15 109.583 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.35 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.463 1.105 . . . . 75.54 112.095 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.32 128.9 39.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.777 0.431 . . . . 72.42 110.506 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.93 126.66 35.81 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.817 0.447 . . . . 71.42 110.238 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 C-N-CA 123.405 0.682 . . . . 71.43 109.844 175.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 110.172 -0.307 . . . . 64.32 110.172 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.8 6.8 5.76 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.624 1.569 . . . . 74.31 112.653 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.98 116.21 25.98 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.567 -0.901 . . . . 74.31 108.567 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.58 155.54 19.92 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.056 0.542 . . . . 72.12 110.795 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.36 147.03 51.79 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.834 0.854 . . . . 64.31 110.361 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -87.87 -22.57 24.35 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.573 -0.739 . . . . 73.54 110.392 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -126.92 129.13 47.58 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.804 0.841 . . . . 75.23 109.966 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 95.84 6.09 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.106 0.962 . . . . 75.51 109.007 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . 0.47 ' N ' ' HD3' ' E' ' 117' ' ' PRO . 0.1 OUTLIER -145.72 57.76 4.36 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.286 -0.87 . . . . 73.33 112.149 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.47 ' HD3' ' N ' ' E' ' 116' ' ' TYR . 4.4 Cg_exo -85.63 125.89 2.93 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.615 2.21 . . . . 72.32 110.249 166.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -141.32 85.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.128 0.49 . . . . 74.22 109.791 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 24.3 m -100.54 78.47 2.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.569 -0.741 . . . . 73.44 109.152 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -164.79 -71.25 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.479 -0.782 . . . . 74.4 109.667 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 58.05 36.5 26.07 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.892 0.877 . . . . 73.3 110.954 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 64.47 176.99 0.18 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.103 1.361 . . . . 72.54 112.905 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.62 4.94 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.632 -0.713 . . . . 75.32 109.891 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 67.63 -68.95 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.484 1.514 . . . . 74.12 112.28 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 43.0 t80 69.1 150.27 0.08 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.777 0.831 . . . . 70.44 109.618 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.88 148.92 29.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.932 0.493 . . . . 74.52 109.696 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.82 138.8 5.77 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.403 -0.817 . . . . 74.24 111.405 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.33 100.34 3.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.616 0.767 . . . . 75.12 110.053 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.45 -38.16 55.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.597 0.759 . . . . 74.1 110.636 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mt -84.99 79.86 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 109.009 -0.737 . . . . 72.45 109.009 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -162.81 82.62 0.51 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.597 -1.183 . . . . 73.13 108.553 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -156.87 90.41 2.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.391 -0.966 . . . . 63.14 108.391 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.13 37.61 0.5 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.485 2.79 . . . . 74.23 114.383 -170.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 39.7 pt -72.88 -1.81 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 112.53 0.567 . . . . 73.33 112.53 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.25 9.86 7.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.877 1.271 . . . . 72.4 113.32 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 83.6 t -80.24 -65.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 122.966 0.506 . . . . 75.15 109.718 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 72.5 -54.85 0.68 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 125.109 1.364 . . . . 72.33 112.815 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.72 166.97 31.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.014 1.325 . . . . 72.24 108.926 173.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . 0.432 ' HB2' HD22 ' C' ' 126' ' ' LEU . 7.4 mp -76.0 140.89 42.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.753 0.311 . . . . 74.11 110.802 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 37.7 m -90.97 169.02 11.24 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.05 0.94 . . . . 74.35 110.665 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 77.9 mt 62.38 28.7 17.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.75 1.22 . . . . 72.32 111.873 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -49.62 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.553 -0.749 . . . . 70.23 109.38 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -169.33 131.91 1.23 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.64 1.976 . . . . 72.01 107.237 171.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -80.26 -57.01 3.81 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.004 -0.739 . . . . 62.55 109.004 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . 0.499 ' HZ1' ' HB3' ' E' ' 145' ' ' LYS . 4.4 ttpm? -165.07 80.85 0.35 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.676 -1.231 . . . . 75.42 107.676 175.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.46 137.48 33.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.313 0.645 . . . . 74.44 110.58 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 -78.93 0.44 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.126 -1.064 . . . . 70.33 108.126 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . 0.45 ' HB2' ' HD3' ' E' ' 149' ' ' PRO . 6.5 mp -116.39 -53.38 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.515 -0.755 . . . . 74.44 110.581 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' E' ' 148' ' ' LEU . 4.2 Cg_exo . . . . . 0 C--N 1.398 3.174 0 C-N-CA 122.244 1.963 . . . . 64.44 111.914 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.962 -0.385 . . . . 62.21 109.962 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . 0.415 ' HZ1' ' HB2' ' F' ' 109' ' ' LYS . 0.1 OUTLIER -147.64 108.81 4.26 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.092 0.557 . . . . 73.3 110.394 177.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.17 146.38 23.77 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.587 -0.733 . . . . 61.2 109.062 168.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -90.84 26.21 2.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.447 0.699 . . . . 75.34 109.841 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 69.99 -54.34 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.492 1.917 . . . . 73.25 111.298 -172.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.8 21.24 12.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.758 1.223 . . . . 71.24 110.841 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . 0.431 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 13.9 mptt -67.29 104.88 1.59 Allowed 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.442 1.497 . . . . 75.1 109.24 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.458 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 7.9 mp 67.66 6.24 4.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.809 1.243 . . . . 74.12 111.836 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -126.38 78.83 71.32 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.368 -0.975 . . . . 62.42 108.368 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -99.52 2.72 0.95 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.733 2.289 . . . . 65.45 112.572 171.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.3 115.92 28.49 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.647 0.779 . . . . 70.03 110.539 -167.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 43.5 p -94.81 97.05 9.75 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.89 0.876 . . . . 75.13 109.595 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . 0.414 ' NE1' ' HA ' ' F' ' 123' ' ' VAL . 5.1 t-105 -83.13 144.96 29.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.696 -0.483 . . . . 75.14 109.696 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -142.65 -49.24 0.35 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.651 0.781 . . . . 72.44 111.341 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.53 72.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.5 0.556 . . . . 73.44 112.5 -173.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . 0.414 ' HA ' ' NE1' ' F' ' 120' ' ' TRP 0.298 4.1 p 47.42 -70.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 C-N-CA 126.93 2.092 . . . . 73.13 113.917 -173.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . 0.422 ' HD3' ' HB2' ' C' ' 3' ' ' GLU . 2.1 mmp_? 66.39 45.39 2.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.58 1.152 . . . . 74.32 110.989 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . 0.65 ' HA ' HG12 ' A' ' 131' ' ' VAL . 82.9 t80 -69.8 90.63 0.6 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.111 -1.44 . . . . 73.2 107.111 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.23 -92.13 0.05 OUTLIER 'General case' 0 C--N 1.35 0.624 0 CA-C-N 116.015 -0.539 . . . . 72.4 109.677 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.65 -79.31 0.13 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 111.794 -0.522 . . . . 53.11 111.794 -170.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 85.5 tttt 65.03 89.23 0.1 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.837 1.255 . . . . 72.21 109.171 -175.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.44 141.64 18.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.95 -1.023 . . . . 74.43 110.128 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 7.0 tp -162.94 27.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 124.628 1.171 . . . . 75.14 108.382 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.43 148.34 50.79 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.426 -0.806 . . . . 63.24 109.317 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . 0.419 ' HB2' ' HB2' ' F' ' 135' ' ' ALA . 28.7 p90 -61.95 126.06 86.48 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 109.5 -0.555 . . . . 74.3 109.5 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.05 -29.59 56.78 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.858 2.372 . . . . 74.51 112.149 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . 0.575 HD11 HH22 ' C' ' 15' ' ' ARG . 15.6 tt -177.3 -30.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 125.332 1.453 . . . . 75.42 108.866 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' F' ' 132' ' ' TYR . . . 65.47 73.94 0.39 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 125.592 1.557 . . . . 71.11 111.666 176.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.516 HG13 HG23 ' F' ' 134' ' ' ILE . 13.0 p -169.66 156.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.08 0.952 . . . . 72.21 108.498 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 -50.8 3.0 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.741 0.416 . . . . 65.3 111.62 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -169.74 165.77 9.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.847 0.859 . . . . 73.33 110.678 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.69 93.74 0.18 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.336 0.654 . . . . 75.21 109.375 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 32.3 t -86.78 35.69 0.69 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.399 1.079 . . . . 72.32 110.461 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . 0.506 ' HG ' ' HB3' ' D' ' 37' ' ' GLN . 64.3 mt -109.93 -160.91 0.73 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.86 1.264 . . . . 74.03 108.746 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 80.4 mt 74.12 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.316 1.046 . . . . 75.22 110.263 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -55.29 96.07 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.974 0.892 . . . . 63.03 110.849 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.02 123.37 28.3 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.874 . . . . 70.5 109.559 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 65.97 179.16 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.78 1.232 . . . . 75.52 110.643 -168.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.06 31.5 18.22 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.69 0.796 . . . . 65.11 112.422 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . 0.51 HD12 ' HD2' ' B' ' 11' ' ' PHE . 3.0 pp -85.88 45.19 1.19 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.008 0.923 . . . . 62.3 112.384 -172.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.0 mp 56.22 57.97 9.31 Favored Pre-proline 0 CA--C 1.571 1.78 0 C-N-CA 123.72 0.808 . . . . 61.13 110.069 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--N 1.391 2.809 0 C-N-CA 123.382 2.721 . . . . 64.32 111.015 178.814 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.133 -0.321 . . . . 71.43 110.133 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.0 p -165.76 173.15 10.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.719 1.208 . . . . 75.04 109.373 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.79 2.19 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.114 0.566 . . . . 74.1 111.437 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.26 -166.4 1.6 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 72.54 109.427 -173.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -62.92 135.97 57.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.807 0.843 . . . . 71.03 111.108 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -59.97 -41.09 91.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.615 0.766 . . . . 75.42 110.422 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m 61.21 70.68 0.59 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.738 1.274 . . . . 73.54 110.256 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -86.37 38.02 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.867 -1.06 . . . . 64.12 112.168 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.448 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 1.4 mpt? 70.43 141.09 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.107 1.363 . . . . 74.22 111.678 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m -141.51 111.94 6.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.267 -1.012 . . . . 71.53 108.267 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.416 ' HB3' HG12 ' A' ' 86' ' ' ILE . 19.0 p90 -134.87 117.38 15.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.924 0.89 . . . . 72.0 108.868 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -155.32 138.42 15.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.963 0.505 . . . . 63.24 110.386 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.481 HD13 ' H ' ' A' ' 13' ' ' ILE . 4.1 mp -68.15 116.38 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 72.1 109.319 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.97 -41.67 17.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.013 -0.736 . . . . 75.13 109.013 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.529 HH11 ' HD2' ' B' ' 32' ' ' PHE . 72.0 ttt180 -168.56 140.63 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.502 0.721 . . . . 74.23 109.072 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.24 137.78 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.592 -0.892 . . . . 72.11 108.592 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -173.68 167.71 4.47 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.399 0.619 . . . . 64.34 112.251 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -86.15 123.97 32.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.835 -0.802 . . . . 64.43 108.835 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -86.36 -32.14 21.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.438 0.637 . . . . 75.23 109.523 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.9 t70 -141.63 140.91 33.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.955 -1.021 . . . . 63.13 110.45 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.4 mt -141.59 145.38 24.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.949 1.7 . . . . 73.25 106.795 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -159.24 130.32 6.09 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.592 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 84.4 t80 -132.11 119.51 21.05 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.353 -1.351 . . . . 72.1 107.353 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -118.59 140.87 49.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.822 -0.807 . . . . 74.32 108.822 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.68 78.66 15.77 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 107.444 -1.317 . . . . 74.4 107.444 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 -29.98 61.88 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.519 2.146 . . . . 73.33 111.726 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 31.6 m-80 -117.01 40.71 2.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.879 0.872 . . . . 71.11 109.23 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.16 99.47 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.089 0.956 . . . . 64.13 113.2 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.25 -25.8 18.34 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.573 1.515 . . . . 72.1 112.462 171.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.6 m-70 -77.79 -33.37 52.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.793 -0.639 . . . . 63.1 112.223 -173.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG11 ' HE1' ' A' ' 123' ' ' PHE . 11.1 p -64.45 -22.17 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 120.958 0.409 . . . . 74.32 111.501 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -72.94 -29.54 63.18 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 63.42 110.681 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -82.7 -51.43 7.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.33 1.052 . . . . 75.15 110.574 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.569 ' HE3' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -82.22 133.89 35.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.829 0.852 . . . . 74.33 109.8 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -56.64 134.57 54.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.048 1.339 . . . . 73.45 113.221 -168.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -71.1 83.06 0.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.546 0.738 . . . . 74.44 112.419 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -137.01 78.87 39.78 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.272 1.029 . . . . 74.24 109.011 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -84.03 133.3 5.68 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.955 2.436 . . . . 74.04 112.389 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.4 116.25 29.26 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.905 -1.146 . . . . 75.23 107.905 171.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.53 119.73 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.309 0.643 . . . . 74.24 110.761 -173.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -110.18 138.44 46.55 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.958 -1.127 . . . . 75.35 107.958 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' F' ' 126' ' ' ASN . 0.6 OUTLIER -131.06 146.16 52.27 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.31 0.644 . . . . 74.34 111.388 -169.339 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.85 144.62 50.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.418 1.087 . . . . 74.13 109.382 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -138.27 136.69 36.75 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 62.25 109.182 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.712 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 17.4 t70 -158.13 149.29 21.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.786 0.434 . . . . 74.41 110.84 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.418 HG22 ' HG3' ' A' ' 103' ' ' PRO . 19.8 m -135.19 126.58 28.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.199 1.0 . . . . 74.14 110.176 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.49 110.26 10.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.073 0.549 . . . . 75.22 110.11 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -88.39 153.25 21.33 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.78 -0.822 . . . . 73.25 108.78 175.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -164.88 117.04 1.21 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.213 0.46 . . . . 70.43 110.197 -171.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.84 105.39 3.78 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.828 0.851 . . . . 75.21 110.629 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.447 HD12 HG22 ' A' ' 83' ' ' ILE . 97.6 mt -77.45 -37.72 50.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.804 0.842 . . . . 72.31 111.635 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.63 -174.11 4.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.255 1.022 . . . . 72.42 108.592 -174.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.42 97.42 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.108 0.563 . . . . 71.45 110.519 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 58.71 27.72 16.29 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.722 1.209 . . . . 74.1 112.661 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 86.1 t -103.91 121.09 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.884 -1.524 . . . . 74.45 106.884 165.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.84 130.04 50.59 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.277 -0.638 . . . . 75.22 109.277 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -85.86 118.81 25.58 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.008 0.923 . . . . 71.52 108.63 168.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.42 111.8 29.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.396 -1.335 . . . . 65.11 107.396 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.4 t -99.26 130.96 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.501 -0.555 . . . . 64.53 109.501 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -106.79 113.56 27.12 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.579 -0.897 . . . . 75.31 108.579 -174.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.712 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -87.45 102.69 14.79 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.973 -0.751 . . . . 73.31 108.973 174.372 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.04 130.34 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.341 -0.985 . . . . 72.43 108.341 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 m -121.18 133.21 55.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.352 -0.981 . . . . 72.35 108.352 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.412 HG22 HG21 ' A' ' 114' ' ' ILE . 75.8 t -131.15 104.61 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.976 -1.12 . . . . 73.1 107.976 -176.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -105.77 146.26 30.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.818 -0.808 . . . . 74.21 108.818 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.53 115.72 13.38 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.645 -1.243 . . . . 73.51 107.645 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -109.26 126.0 52.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.52 -0.548 . . . . 53.13 109.52 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.09 82.7 6.06 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 105.777 -1.935 . . . . 74.3 105.777 176.176 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.7 -127.18 7.83 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.435 -0.802 . . . . 64.12 111.665 -170.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.25 -14.72 30.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.972 0.509 . . . . 74.02 111.093 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -95.03 135.02 37.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.879 0.871 . . . . 75.32 109.511 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -65.34 129.25 39.06 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.01 0.524 . . . . 73.31 111.227 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.593 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -77.81 -58.05 3.47 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.093 -1.077 . . . . 64.44 108.093 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -166.91 165.74 15.87 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.641 -1.163 . . . . 73.54 110.437 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -134.73 145.14 48.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.535 1.134 . . . . 74.41 108.792 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.439 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 20.0 m -141.58 98.92 3.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.611 0.764 . . . . 73.23 109.44 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -109.28 129.21 55.52 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.625 -0.509 . . . . 72.54 109.625 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -130.51 132.82 64.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 123.753 0.821 . . . . 72.34 109.325 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.733 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.2 mt-30 -105.74 102.91 12.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.592 -0.731 . . . . 71.01 109.52 169.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.77 98.89 12.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.842 -1.072 . . . . 73.23 109.366 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.4 142.14 15.97 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.374 -0.69 . . . . 65.31 111.374 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -138.52 122.58 2.42 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.929 -0.868 . . . . 72.41 110.929 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 51' ' ' LEU . 51.7 mt -80.91 125.37 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.636 -0.876 . . . . 73.24 108.636 175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.8 121.58 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.203 0.601 . . . . 75.04 109.508 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -84.13 103.37 13.29 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.278 -1.008 . . . . 71.34 108.278 171.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.539 HD12 HD13 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.47 124.69 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.48 0.657 . . . . 73.44 109.811 -171.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.29 175.77 13.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.126 0.97 . . . . 63.4 111.045 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.23 -24.97 29.02 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.758 -0.656 . . . . 73.25 113.043 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 86' ' ' ILE . 13.6 pt -110.46 168.88 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.23 110.615 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.582 ' HA ' HD22 ' F' ' 115' ' ' LEU . 24.3 tt0 -150.85 -172.37 4.18 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.576 -1.193 . . . . 73.35 108.507 -171.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.547 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.46 -142.62 46.84 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.03 0.772 . . . . 74.44 115.03 171.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -77.29 -14.39 59.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.086 0.954 . . . . 72.45 111.561 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -47.96 69.9 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.763 0.825 . . . . 73.31 110.015 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.478 ' SD ' HD13 ' F' ' 115' ' ' LEU . 20.1 ttt -80.64 -35.83 33.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 74.14 111.074 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.46 ' HB1' ' HD2' ' F' ' 117' ' ' PRO . . . -57.88 -32.44 67.7 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.403 0.621 . . . . 71.51 111.447 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.28 -49.67 70.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.633 -1.167 . . . . 70.32 110.272 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 5.3 m -68.24 -63.22 1.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.701 1.0 . . . . 51.42 113.701 -170.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -12.35 60.04 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 118.88 0.764 . . . . 75.13 112.415 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.69 -6.07 44.16 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.178 -0.79 . . . . 74.34 114.5 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.19 -57.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 117.873 0.836 . . . . 64.01 111.786 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.563 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -55.69 -58.35 8.17 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.576 1.15 . . . . 71.23 112.045 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.96 -41.8 6.97 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 113.314 0.857 . . . . 64.24 113.314 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.511 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.9 Cg_endo -66.28 -24.86 50.2 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 121.624 1.55 . . . . 73.42 113.873 169.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -76.47 -22.35 54.66 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.941 0.791 . . . . 53.1 110.21 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mm -67.45 -43.02 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.267 0.627 . . . . 75.24 109.493 166.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 103' ' ' PRO . 90.3 mt -71.25 -31.44 67.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.042 -0.981 . . . . 74.51 111.99 -175.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.51 -43.33 84.01 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.819 1.044 . . . . 73.43 113.819 -168.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.82 -31.79 82.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.276 1.984 . . . . 73.44 113.835 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -83.38 -28.78 28.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.186 0.594 . . . . 65.02 111.863 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.99 77.49 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.296 -0.631 . . . . 53.35 109.296 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.495 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.2 ttm180 -65.84 -38.35 88.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.524 -1.216 . . . . 73.44 110.327 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -53.51 -54.21 40.47 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.215 1.006 . . . . 75.22 110.247 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -61.85 -50.96 70.15 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.936 -1.484 . . . . 71.22 111.24 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.452 ' O ' HG23 ' A' ' 118' ' ' VAL . 17.7 mt -62.41 -58.9 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.703 0.801 . . . . 75.35 111.371 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -54.49 -38.58 66.61 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.871 0.732 . . . . 65.25 111.088 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.5 t -65.88 -45.89 80.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.496 -0.775 . . . . 54.24 110.285 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.592 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 14.5 mtp -57.15 -41.83 79.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.595 0.758 . . . . 61.15 111.31 176.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.2 t -60.45 -47.67 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.901 0.881 . . . . 74.11 110.233 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.663 -0.699 . . . . 71.44 111.585 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -74.62 -30.53 61.69 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.738 0.815 . . . . 74.0 109.747 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.48 2.37 67.48 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.519 -0.764 . . . . 72.13 112.569 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 68.27 22.31 8.14 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.874 1.27 . . . . 74.11 110.552 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.422 ' HE1' HG11 ' A' ' 31' ' ' VAL . 24.6 m-85 -96.5 153.27 38.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.823 0.849 . . . . 74.42 110.288 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 123.73 14.54 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.652 2.235 . . . . 72.14 111.075 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.75 147.44 27.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 124.036 0.835 . . . . 62.12 111.747 -171.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.0 mt -111.95 105.77 14.28 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.717 -0.846 . . . . 65.53 108.717 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.13 93.05 6.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.535 -0.913 . . . . 74.33 108.535 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.436 HD12 ' HE2' ' F' ' 125' ' ' TYR . 0.2 OUTLIER -67.07 127.7 33.57 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.443 -175.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 137.56 94.75 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.544 0.738 . . . . 75.03 111.58 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HB3' HH22 ' A' ' 111' ' ' ARG . 34.1 Cg_endo -83.83 145.92 11.56 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.594 2.196 . . . . 61.21 113.02 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 114.21 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.636 -0.876 . . . . 63.52 108.636 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -85.4 75.21 10.25 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.691 0.758 . . . . 64.41 110.008 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -68.89 -28.31 66.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.591 -1.186 . . . . 74.23 109.895 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -64.44 -51.85 61.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.205 -0.907 . . . . 75.44 110.402 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.62 -34.53 78.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.772 0.829 . . . . 63.42 111.212 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -54.17 -50.22 67.53 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.31 1.044 . . . . 74.44 111.405 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.1 -26.42 25.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.929 -0.578 . . . . 73.42 111.028 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.591 ' SD ' HD22 ' A' ' 141' ' ' LEU . 13.9 tpt -71.3 -29.36 64.95 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.099 0.56 . . . . 75.11 111.278 -172.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -55.4 -52.33 63.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.44 0.696 . . . . 75.11 109.58 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 143' ' ' GLN . 68.3 t80 -65.85 -39.2 90.55 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.214 -0.903 . . . . 70.22 111.034 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.591 HD22 ' SD ' ' A' ' 138' ' ' MET . 23.7 tp -67.75 -8.54 36.42 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.115 0.966 . . . . 74.31 112.038 -173.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -149.11 31.81 0.76 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 122.601 0.361 . . . . 72.4 111.227 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.491 ' HG2' ' HA ' ' A' ' 140' ' ' TYR . 20.8 mm-40 -56.12 -43.97 78.67 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 122.623 0.369 . . . . 74.41 111.039 172.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -78.34 99.08 6.19 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.395 -0.594 . . . . 74.33 109.395 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.85 164.71 36.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.365 1.066 . . . . 72.01 109.097 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.88 110.82 0.99 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.103 -0.399 . . . . 72.32 112.103 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.63 148.37 22.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.487 0.715 . . . . 72.41 110.078 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.46 68.49 0.29 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.521 -0.632 . . . . 75.45 111.521 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.5 p -71.96 107.53 4.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.117 0.567 . . . . 73.11 110.189 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -100.44 115.31 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.477 0.711 . . . . 73.22 109.438 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -115.94 105.21 12.4 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.828 -0.805 . . . . 73.51 108.828 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -135.55 101.43 4.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.214 1.006 . . . . 73.24 108.848 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -101.52 127.1 48.37 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.096 -0.705 . . . . 74.32 109.096 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -139.41 127.83 22.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.855 -0.794 . . . . 74.23 108.855 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.275 0 N-CA-C 109.041 -0.726 . . . . 74.53 109.041 -178.202 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.755 -0.461 . . . . 71.22 109.755 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 p -71.54 152.23 43.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.538 0.735 . . . . 62.52 111.406 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.76 118.05 21.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.522 0.729 . . . . 63.44 109.817 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.68 88.21 1.28 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.219 1.009 . . . . 74.43 111.033 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.12 110.43 15.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.799 -1.091 . . . . 74.43 108.224 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.07 127.95 22.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.295 0.638 . . . . 73.03 110.1 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -143.01 70.61 1.32 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.398 1.079 . . . . 65.33 110.118 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -141.42 157.09 45.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.708 0.803 . . . . 72.52 109.768 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.419 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.3 ptm 40.8 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 126.591 1.956 . . . . 74.4 114.17 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.0 m -152.42 125.58 8.62 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.136 0.974 . . . . 74.22 108.604 171.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -136.24 127.87 28.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.37 -0.604 . . . . 74.51 109.37 163.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -158.02 141.53 15.38 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.998 -1.112 . . . . 74.11 107.998 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.28 123.14 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.555 -0.906 . . . . 74.24 108.555 170.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -83.29 -50.6 8.22 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.083 -0.34 . . . . 74.43 110.083 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.31 130.48 1.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.113 -0.494 . . . . 72.42 109.817 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.533 HG21 ' CD1' ' B' ' 109' ' ' TYR . 92.3 mt -114.22 146.04 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.651 -0.87 . . . . 70.01 108.651 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -163.49 155.41 17.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.413 0.625 . . . . 74.44 111.494 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.6 m -78.26 126.17 30.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.007 -0.997 . . . . 75.12 108.625 170.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.478 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.3 mtpt -98.18 -32.6 11.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.57 0.748 . . . . 75.45 111.175 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.51 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.3 t70 -155.8 139.9 16.46 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.07 -0.514 . . . . 73.34 111.523 -167.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.8 mm -147.14 145.69 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.658 1.583 . . . . 73.23 108.355 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.92 151.98 32.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.718 -0.845 . . . . 73.31 108.718 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.5 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -147.58 115.48 6.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.853 -1.536 . . . . 74.22 106.853 173.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.6 121.97 42.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.7 -0.852 . . . . 70.23 108.7 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -125.47 80.61 65.49 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.853 -1.166 . . . . 63.35 107.853 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.09 -45.63 0.64 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.55 2.167 . . . . 75.44 111.693 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -98.8 18.65 16.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.699 0.8 . . . . 74.32 110.743 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.582 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -48.11 -50.53 54.65 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 125.213 1.405 . . . . 61.22 114.239 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -20.77 25.9 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.879 1.72 . . . . 74.33 112.593 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -91.0 -28.37 18.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.769 0.828 . . . . 72.15 110.868 -173.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.01 -8.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.424 0.689 . . . . 73.23 110.256 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . 0.529 ' HD2' HH11 ' A' ' 15' ' ' ARG . 75.9 t80 -56.72 -33.94 66.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.929 1.292 . . . . 74.41 110.81 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -71.8 -29.52 64.54 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.037 -0.983 . . . . 72.51 111.27 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.505 ' HZ2' ' HG2' ' B' ' 71' ' ' GLU . 95.6 mttt -94.89 110.21 22.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.448 0.699 . . . . 75.24 111.086 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.22 81.72 1.86 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.455 -0.942 . . . . 71.51 108.455 171.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.767 ' HB2' HD21 ' B' ' 68' ' ' LEU . 51.0 m95 -149.94 178.07 9.27 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.461 1.104 . . . . 75.05 108.457 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -78.04 127.36 81.84 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.43 0.692 . . . . 74.23 110.026 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' B' ' 68' ' ' LEU . 72.6 Cg_endo -77.86 146.83 23.77 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.946 1.764 . . . . 72.34 112.212 168.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.75 103.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.061 0.945 . . . . 75.44 108.932 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -86.62 129.98 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.541 0.736 . . . . 73.42 109.493 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.587 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.1 tttm -136.14 128.48 30.17 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.419 -0.956 . . . . 74.42 108.419 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.02 153.87 26.2 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.646 -0.872 . . . . 75.12 108.646 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.607 -0.886 . . . . 75.35 108.607 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.72 138.2 40.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.891 0.876 . . . . 74.34 109.014 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.2 t70 -144.79 152.7 40.74 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.02 1.328 . . . . 73.51 108.308 -174.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.9 t -151.33 140.46 21.2 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.312 0.645 . . . . 72.31 109.381 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.68 124.47 17.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.8 -1.185 . . . . 65.14 107.8 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -97.29 160.99 14.01 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.686 -0.487 . . . . 75.31 109.686 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -149.41 155.37 40.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.006 -1.109 . . . . 75.11 108.006 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -124.78 129.17 49.94 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.364 0.665 . . . . 75.14 109.692 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.87 -45.06 10.02 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.324 0.649 . . . . 72.54 109.641 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.12 -176.09 5.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.295 -0.866 . . . . 71.41 110.093 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -61.9 125.96 25.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.0 -1.0 . . . . 62.01 109.055 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.36 2.85 3.47 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.134 1.374 . . . . 75.45 112.762 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 t -120.32 96.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.607 -0.886 . . . . 73.33 108.607 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.22 165.16 11.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.995 0.518 . . . . 74.21 110.159 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -142.97 95.44 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.288 -1.745 . . . . 74.22 106.288 177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.9 131.23 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.303 -0.628 . . . . 72.54 109.303 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.545 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.7 t -106.13 151.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.942 0.897 . . . . 75.32 109.952 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' B' ' 106' ' ' LEU . 1.0 OUTLIER -134.18 119.49 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.087 -1.449 . . . . 72.21 107.087 178.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.605 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 38.3 ttp180 -105.96 120.98 43.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.872 0.368 . . . . 74.23 110.846 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.06 128.15 63.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.927 -1.138 . . . . 74.31 107.927 168.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -120.78 130.28 53.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.378 -0.601 . . . . 73.55 109.378 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.426 HG22 HG23 ' B' ' 114' ' ' ILE . 98.7 t -118.22 134.14 62.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.276 -0.875 . . . . 74.41 109.055 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 98.6 m -125.58 137.65 53.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.901 -1.045 . . . . 70.45 108.489 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.73 125.36 19.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.508 -1.293 . . . . 74.21 107.508 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 p -136.46 123.44 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.286 -1.005 . . . . 74.11 108.286 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.767 HD21 ' HB2' ' B' ' 36' ' ' TRP . 3.2 tt -95.61 116.18 28.48 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.48 -0.933 . . . . 73.32 108.48 -172.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -114.06 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 124.11 0.881 . . . . 70.43 111.517 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.48 4.73 15.34 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.182 0.993 . . . . 71.51 111.637 -175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.505 ' HG2' ' HZ2' ' B' ' 34' ' ' LYS . 12.2 pt-20 -129.62 163.89 25.07 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.317 0.647 . . . . 74.31 110.023 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 12.6 m -67.21 148.59 51.57 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.446 0.466 . . . . 65.42 110.66 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.93 -56.83 2.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.578 0.751 . . . . 64.12 109.024 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -165.36 153.67 11.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.139 -0.937 . . . . 74.12 110.235 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -131.43 144.56 51.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 75.14 108.13 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 40.2 t -151.57 152.27 32.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.559 -0.534 . . . . 73.44 109.559 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -158.36 129.6 6.48 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.21 0.604 . . . . 74.32 109.416 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' B' ' 21' ' ' ILE . 82.7 t -124.56 148.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.812 0.845 . . . . 72.41 109.985 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.605 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 41.7 mt-30 -125.69 98.45 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.23 -1.026 . . . . 75.44 108.23 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.9 tp-100 -85.89 104.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.839 -0.619 . . . . 74.23 109.429 174.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.74 168.47 25.01 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 111.544 -0.622 . . . . 74.44 111.544 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.47 130.76 2.2 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.466 -0.397 . . . . 73.53 112.97 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -84.14 128.92 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.147 0.979 . . . . 74.51 109.018 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.61 140.85 44.91 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.34 1.056 . . . . 63.3 109.759 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -87.49 107.6 18.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.211 1.004 . . . . 73.42 109.032 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.406 HG13 HD22 ' B' ' 98' ' ' LEU . 17.6 mm -122.77 121.8 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.673 0.789 . . . . 71.44 110.478 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.36 167.68 29.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.074 0.55 . . . . 54.24 110.987 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 85.62 -45.19 3.45 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.97 -0.559 . . . . 65.21 113.398 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.462 ' HB ' HD23 ' E' ' 115' ' ' LEU . 41.2 mm -74.36 138.49 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.663 0.785 . . . . 62.3 109.763 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.03 -172.43 4.03 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.809 0.843 . . . . 75.04 111.149 -176.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.28 -113.52 5.98 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.742 0.651 . . . . 61.32 113.981 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -88.29 -35.6 17.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.723 0.809 . . . . 71.24 110.59 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -71.2 -18.98 62.45 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.096 -0.956 . . . . 74.41 111.599 -168.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.424 ' HB2' ' HB3' ' E' ' 115' ' ' LEU . 19.7 ptp -56.12 -28.78 59.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.992 0.917 . . . . 73.32 112.097 173.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.25 87.61 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.101 0.96 . . . . 72.22 112.358 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -88.99 -27.53 20.82 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.367 -0.833 . . . . 71.21 111.218 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.6 t -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.624 0.369 . . . . 74.53 111.821 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.406 HD22 HG13 ' B' ' 86' ' ' ILE . 77.4 mt -102.49 -35.08 8.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.749 0.42 . . . . 74.13 111.976 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.8 -23.25 53.53 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 120.029 -0.317 . . . . 73.31 113.842 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.35 -46.75 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.145 0.473 . . . . 51.04 112.047 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -77.1 -48.57 17.4 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.372 0.669 . . . . 75.15 110.796 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.463 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.2 m -60.72 -49.98 87.25 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.682 -0.675 . . . . 64.33 111.6 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.9 Cg_exo -56.77 -30.77 85.96 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.6 2.2 . . . . 71.04 114.496 171.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -63.36 -32.64 74.12 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.08 0.467 . . . . 64.43 110.965 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.2 mt -74.17 -44.54 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.864 0.866 . . . . 64.4 110.582 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.402 ' HB2' HD12 ' B' ' 60' ' ' LEU . 96.3 mt -72.36 -29.99 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.726 -1.125 . . . . 73.43 112.397 -172.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.452 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 80.5 t80 -59.93 -46.1 98.18 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 113.901 1.074 . . . . 71.2 113.901 -168.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.62 -41.75 72.51 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.233 1.955 . . . . 73.42 113.113 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.533 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.0 m-30 -64.26 -39.42 93.9 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.907 -1.042 . . . . 75.05 109.991 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.53 82.93 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.881 0.872 . . . . 74.4 110.961 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -57.23 -58.96 5.95 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.411 1.084 . . . . 74.25 111.752 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 -25.39 63.66 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.199 0.312 . . . . 70.14 110.267 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.426 ' O ' ' HG2' ' B' ' 117' ' ' MET . 13.4 t -70.2 -30.32 67.39 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.929 0.492 . . . . 74.32 111.626 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.426 HG23 HG22 ' B' ' 64' ' ' VAL . 88.6 mt -72.26 -55.92 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.082 0.553 . . . . 74.11 109.662 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.5 m -60.84 -27.98 68.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.54 -1.209 . . . . 74.54 111.411 -172.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.43 -46.02 84.99 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.915 0.886 . . . . 73.21 110.375 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.426 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.0 mmt -68.32 -31.3 70.63 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.095 0.558 . . . . 75.11 110.702 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.05 -38.96 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.956 0.902 . . . . 75.34 110.279 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.0 m -66.31 -37.74 86.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.726 0.81 . . . . 71.32 110.99 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -65.02 -38.8 92.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.275 -0.875 . . . . 75.44 109.351 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.35 -0.51 72.12 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 124.057 0.848 . . . . 64.25 113.877 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 55.39 36.26 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.596 1.558 . . . . 74.24 112.309 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -104.86 157.12 34.89 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.609 1.163 . . . . 65.44 110.282 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 129.39 33.87 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.119 2.546 . . . . 72.44 112.508 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -60.4 130.58 47.31 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.913 0.885 . . . . 74.53 112.514 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 90.2 mt -118.97 99.89 7.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.396 -0.965 . . . . 75.34 108.396 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.409 HD21 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -95.19 131.07 41.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.398 0.679 . . . . 74.51 109.469 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.452 ' HB3' ' CZ ' ' B' ' 107' ' ' PHE . 2.1 mm? -76.16 139.06 41.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.351 0.661 . . . . 71.01 110.922 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.38 141.44 45.8 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.027 0.931 . . . . 72.13 111.41 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.71 100.12 0.41 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.896 2.397 . . . . 74.15 112.46 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.87 133.36 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.759 0.824 . . . . 74.4 109.366 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.52 108.55 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.565 0.746 . . . . 75.12 111.219 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -59.95 -35.86 75.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.298 1.039 . . . . 72.04 110.167 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -56.69 14.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.228 -1.351 . . . . 75.04 111.954 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.74 68.84 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.625 0.77 . . . . 74.51 111.51 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.92 -42.26 85.67 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.268 1.027 . . . . 73.44 110.613 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -79.93 -16.85 54.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.308 0.643 . . . . 74.31 111.384 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 81.5 mmm -68.24 -29.21 67.97 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.378 0.271 . . . . 71.51 111.456 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.49 -25.49 57.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.52 0.328 . . . . 75.44 110.654 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -71.22 -31.48 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.435 0.694 . . . . 74.13 109.684 175.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 59.3 mt -105.06 35.22 2.88 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.944 0.897 . . . . 73.15 110.329 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.12 126.87 29.16 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.589 0.756 . . . . 75.43 111.23 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.05 -16.89 55.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.605 1.162 . . . . 74.44 113.39 -169.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.62 -0.47 8.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.295 0.638 . . . . 64.51 112.583 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.05 -25.55 61.83 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.57 0.748 . . . . 74.24 111.27 170.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.17 137.75 5.79 Favored Glycine 0 C--N 1.344 1.028 0 CA-C-N 116.078 -0.51 . . . . 54.33 112.159 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -150.2 145.37 26.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.957 0.903 . . . . 73.34 109.053 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.83 -145.62 17.71 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-O 119.391 -0.672 . . . . 53.02 111.579 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m 67.34 99.12 0.05 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.731 1.213 . . . . 64.22 111.472 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.18 -74.22 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 70.33 111.091 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.43 121.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.944 1.298 . . . . 75.43 111.69 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -142.76 164.86 28.95 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.841 0.353 . . . . 64.42 111.22 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.09 92.01 2.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.276 -0.875 . . . . 74.05 109.351 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -95.48 105.3 17.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.822 -0.626 . . . . 75.21 109.457 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.132 0 C-N-CA 123.306 0.642 . . . . 72.12 110.557 178.309 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.982 0.42 . . . . 74.21 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.0 p -168.25 109.18 0.55 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.619 0.768 . . . . 72.34 109.228 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -147.15 102.43 3.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.118 0.567 . . . . 73.32 111.301 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -98.51 110.29 22.91 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.554 -1.276 . . . . 65.34 107.554 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -153.38 107.45 3.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.137 0.575 . . . . 74.52 109.678 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -152.69 98.13 2.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.449 0.7 . . . . 64.55 109.552 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -110.76 8.66 22.55 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.689 0.795 . . . . 73.2 109.968 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -91.86 95.15 9.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.491 0.717 . . . . 74.54 110.027 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 56.7 ttp 65.65 126.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.189 1.396 . . . . 73.53 112.229 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.579 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 25.9 m -85.76 95.45 9.41 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.441 -0.948 . . . . 74.45 108.441 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -119.66 131.86 55.54 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.393 -1.276 . . . . 75.42 108.702 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -151.68 141.72 22.15 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.245 -0.65 . . . . 71.44 109.245 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.9 mt -76.49 116.34 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.525 -0.917 . . . . 73.05 108.525 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -88.33 -49.64 6.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.987 0.515 . . . . 73.0 110.217 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -159.13 138.8 11.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.96 -0.564 . . . . 63.14 109.48 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.84 135.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.1 -1.074 . . . . 73.14 108.1 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -171.57 158.22 5.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.514 0.674 . . . . 72.31 112.152 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -83.99 111.2 19.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.894 -1.048 . . . . 72.03 108.934 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -79.26 -46.68 17.3 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.717 0.77 . . . . 71.22 109.255 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.8 t70 -133.66 137.38 45.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.687 -1.142 . . . . 74.33 108.728 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.448 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -142.27 141.64 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.245 1.418 . . . . 65.45 107.379 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -155.24 143.14 19.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.811 -0.44 . . . . 72.52 109.811 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -142.64 141.95 31.99 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 107.54 -1.281 . . . . 72.43 107.54 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -140.08 142.6 36.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.563 -1.273 . . . . 71.02 107.563 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.55 ' HB1' ' HB1' ' C' ' 28' ' ' ALA . . . -142.15 84.28 11.72 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 108.86 -0.793 . . . . 73.53 108.86 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.59 -39.46 15.96 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.909 2.406 . . . . 70.01 112.212 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 88.4 m-20 -111.87 44.75 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.77 0.828 . . . . 71.44 109.658 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.55 ' HB1' ' HB1' ' C' ' 25' ' ' ALA . . . -56.41 -57.9 20.22 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.435 1.094 . . . . 63.0 113.709 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.509 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.3 Cg_exo -72.52 -26.54 16.63 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 122.013 1.809 . . . . 63.43 112.009 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.569 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.5 t60 -67.11 -21.73 65.84 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.298 1.439 . . . . 64.54 111.463 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.445 HG22 ' HE2' ' C' ' 34' ' ' LYS . 7.6 p -54.53 -24.1 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.15 0.58 . . . . 72.53 112.538 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -63.5 -40.75 97.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.296 1.038 . . . . 74.02 111.527 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -90.14 5.29 47.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.646 0.379 . . . . 74.15 111.043 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.51 ' HE3' ' HB3' ' C' ' 73' ' ' ALA . 4.7 ttpm? -100.74 146.76 26.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.097 0.959 . . . . 75.22 109.918 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -85.54 134.55 34.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.661 0.784 . . . . 74.33 109.185 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -69.22 71.29 0.26 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.406 1.083 . . . . 65.25 112.382 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -137.65 74.84 45.12 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 108.04 -1.096 . . . . 73.32 108.04 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.42 113.59 3.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.154 1.903 . . . . 72.32 109.591 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . 0.725 ' HG2' HD23 ' E' ' 141' ' ' LEU . 0.7 OUTLIER -84.56 83.79 7.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 105.021 -2.214 . . . . 63.34 105.021 174.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.602 HG13 HD11 ' C' ' 126' ' ' LEU . 31.9 m -71.7 128.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-N 115.215 -0.902 . . . . 75.34 111.824 -166.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -92.98 103.65 15.95 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.586 -1.635 . . . . 74.42 106.586 172.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -93.12 151.68 19.71 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.515 -0.766 . . . . 75.23 109.602 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.563 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 45.2 t0 -158.15 147.38 19.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.276 -0.875 . . . . 72.21 108.979 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 148.87 49.35 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 73.22 109.381 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.418 ' O ' HD22 ' C' ' 60' ' ' LEU . 12.0 m-20 -150.34 161.37 42.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.484 1.114 . . . . 74.41 108.904 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -138.71 154.23 48.56 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.125 -0.695 . . . . 75.32 109.125 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.65 151.43 43.06 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.576 -0.527 . . . . 72.42 109.576 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -123.58 143.52 50.16 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.365 0.666 . . . . 73.21 110.171 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -153.13 126.41 8.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.878 0.871 . . . . 73.4 108.701 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -82.61 127.0 32.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.239 -0.652 . . . . 74.45 109.239 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.562 HD13 HD13 ' C' ' 83' ' ' ILE . 59.9 mt -89.59 -42.05 11.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.209 0.604 . . . . 75.4 110.123 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.8 -174.37 4.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.471 0.708 . . . . 71.24 110.621 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.26 114.32 2.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.884 -1.053 . . . . 75.05 109.761 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 69.43 -4.59 1.31 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.196 1.399 . . . . 74.42 112.956 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.46 114.11 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.846 -0.798 . . . . 73.34 108.846 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -126.52 158.83 35.1 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.529 0.732 . . . . 74.43 109.962 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.78 138.36 53.84 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.308 1.043 . . . . 73.43 108.818 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.35 137.81 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.071 -1.085 . . . . 75.41 108.071 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.35 109.35 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.902 -0.777 . . . . 72.34 108.902 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.433 HD23 HG21 ' C' ' 62' ' ' VAL . 0.7 OUTLIER -87.47 102.92 15.03 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.182 -1.044 . . . . 73.54 108.182 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.594 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 18.7 ttp85 -82.79 106.58 14.74 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.936 -0.764 . . . . 70.22 108.936 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.5 t -99.68 132.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.682 -0.858 . . . . 75.25 108.682 173.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.563 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 55.2 m -115.18 130.51 56.94 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.827 0.851 . . . . 72.4 109.156 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.546 HG22 HG21 ' C' ' 114' ' ' ILE . 78.1 t -122.13 134.24 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.186 -1.37 . . . . 72.34 107.918 172.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -123.86 143.15 50.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.342 -1.355 . . . . 72.53 107.342 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.0 106.86 8.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.689 -1.226 . . . . 65.52 107.689 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -154.75 158.26 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.69 . . . . 74.21 110.079 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 tp -123.84 78.87 1.66 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.726 -1.953 . . . . 71.41 105.726 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.42 -119.78 4.96 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 115.71 -0.677 . . . . 64.24 112.231 -173.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.28 -20.84 26.28 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.625 0.77 . . . . 74.34 109.669 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.459 ' HG3' ' HD3' ' C' ' 34' ' ' LYS . 16.0 tp10 -71.42 86.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.512 1.125 . . . . 74.34 109.446 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 36.0 m -84.75 121.77 28.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.253 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.51 ' HB3' ' HE3' ' C' ' 34' ' ' LYS . . . -71.86 -55.51 7.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.165 -1.05 . . . . 61.31 108.165 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -162.86 173.27 13.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.808 -1.087 . . . . 72.3 111.423 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.92 143.52 45.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.759 -1.571 . . . . 74.22 106.759 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.8 t -149.45 130.43 14.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.693 0.397 . . . . 75.44 110.338 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -131.71 133.28 44.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.671 -0.863 . . . . 72.22 108.671 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -129.52 138.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.687 0.795 . . . . 72.44 108.914 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.594 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.1 mt-30 -113.23 98.59 7.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.585 -0.894 . . . . 75.1 108.585 173.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -84.87 103.84 14.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.361 -0.836 . . . . 75.4 109.688 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.13 148.78 21.65 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.887 -0.485 . . . . 74.15 111.887 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.34 121.32 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.688 -0.565 . . . . 75.13 111.688 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.562 HD13 HD13 ' C' ' 51' ' ' LEU . 8.5 mm -85.66 126.89 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.647 -0.872 . . . . 70.32 108.647 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -135.35 134.72 40.1 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.814 0.846 . . . . 73.43 109.473 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.6 p -81.18 116.57 21.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.414 -0.588 . . . . 74.03 109.414 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.44 111.4 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 72.11 108.511 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.579 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -147.51 169.61 19.2 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 71.55 110.339 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.07 -58.36 3.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.447 -0.661 . . . . 71.32 111.447 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.14 166.33 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 63.14 108.668 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.99 156.18 44.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.543 0.737 . . . . 73.22 110.537 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.39 -148.0 44.88 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.47 0.481 . . . . 70.14 114.155 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.52 ' HA ' ' HB1' ' C' ' 95' ' ' ALA . 32.4 p -69.38 -18.26 63.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.679 0.792 . . . . 73.35 112.098 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -63.7 -42.47 97.98 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.205 0.602 . . . . 73.01 110.285 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -82.92 -26.33 31.56 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.569 0.348 . . . . 74.24 110.884 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.52 ' HB1' ' HA ' ' C' ' 92' ' ' THR . . . -68.16 -22.05 64.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.666 0.786 . . . . 75.15 111.577 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -53.41 -48.75 68.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.934 0.494 . . . . 73.34 110.763 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -65.17 -47.63 76.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.714 -0.676 . . . . 73.53 110.162 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.32 -32.84 74.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.599 0.76 . . . . 75.01 110.925 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.8 -5.32 61.31 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-O 119.572 -0.571 . . . . 63.04 114.251 -171.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.53 -63.17 0.51 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.658 0.729 . . . . 72.22 111.243 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -62.93 -47.64 82.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.035 0.534 . . . . 75.11 112.419 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.69 -42.76 36.88 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.642 -0.695 . . . . 73.4 112.281 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.43 -38.91 89.59 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.266 1.977 . . . . 75.3 113.248 166.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.29 -29.16 70.53 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.973 0.509 . . . . 74.24 111.62 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.495 HD13 ' NH1' ' A' ' 111' ' ' ARG . 38.0 mm -69.9 -41.47 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.139 0.575 . . . . 73.42 110.052 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.478 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -75.8 -25.3 56.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.208 -0.905 . . . . 74.41 111.924 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -56.88 -46.25 99.88 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.596 1.158 . . . . 73.54 113.852 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.63 -40.24 85.09 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.359 2.04 . . . . 74.23 114.074 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.437 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 57.1 m-85 -71.24 -39.99 71.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.811 0.445 . . . . 74.41 110.34 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.2 94.66 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.489 -0.778 . . . . 74.31 110.546 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -59.27 -54.33 48.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.248 1.019 . . . . 75.21 109.91 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -62.33 -35.01 77.74 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.043 0.839 . . . . 60.12 111.1 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 26.1 t -71.24 -36.84 71.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.307 0.643 . . . . 71.42 110.973 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.546 HG21 HG22 ' C' ' 64' ' ' VAL . 77.8 mt -72.19 -50.1 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.4 -0.593 . . . . 74.51 109.4 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 78.6 m -57.19 -33.59 67.63 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.338 1.055 . . . . 73.21 110.793 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -64.52 -54.41 32.77 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 115.352 -0.84 . . . . 75.23 108.74 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.552 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.32 -40.16 70.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.808 1.243 . . . . 73.33 112.76 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.1 t -64.62 -48.44 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.803 0.841 . . . . 75.01 109.411 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.43 ' HB2' HE21 ' C' ' 125' ' ' GLN . 36.4 t -66.98 -28.06 67.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.606 -1.179 . . . . 71.41 111.335 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 77.1 mtt-85 -70.67 -37.38 73.66 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 123.738 0.815 . . . . 75.42 109.271 176.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.34 3.28 73.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.912 0.757 . . . . 74.21 113.363 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 66.0 p 60.28 28.45 18.06 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.036 1.734 . . . . 73.04 112.731 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.404 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 62.4 m-85 -97.46 161.76 24.86 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.545 1.138 . . . . 74.25 111.07 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.407 ' HB3' ' H ' ' E' ' 138' ' ' ALA . 20.1 Cg_endo -58.37 119.3 6.47 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.342 2.695 . . . . 70.41 112.384 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' C' ' 119' ' ' SER . 90.1 mt-30 -62.13 146.88 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.556 1.142 . . . . 72.51 113.416 -172.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.602 HD11 HG13 ' C' ' 40' ' ' VAL . 4.4 mm? -106.85 95.12 5.5 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.069 0.948 . . . . 71.11 108.958 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -90.35 90.83 8.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.325 -0.991 . . . . 73.33 108.325 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.73 126.18 29.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.909 -1.041 . . . . 75.11 110.807 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.67 156.12 86.86 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.091 0.956 . . . . 73.24 111.292 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.86 124.74 11.77 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.177 1.918 . . . . 72.32 111.851 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.96 138.01 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.041 0.537 . . . . 72.52 109.556 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.565 ' HB2' ' HB1' ' C' ' 135' ' ' ALA . 23.8 p30 -88.1 61.5 6.33 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.904 0.859 . . . . 71.32 110.234 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.98 -32.22 70.31 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.851 -1.068 . . . . 74.32 111.149 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.66 -33.97 64.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.71 0.404 . . . . 72.3 110.054 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' C' ' 132' ' ' ASN . . . -73.61 -30.59 63.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.694 -0.684 . . . . 74.23 112.573 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.32 -24.08 67.18 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.012 0.369 . . . . 71.33 110.914 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -74.45 -55.86 5.49 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.465 -0.569 . . . . 74.54 109.465 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 15.4 mmt -52.24 -28.15 17.59 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.394 1.257 . . . . 73.23 114.394 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.33 -29.41 9.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.034 1.334 . . . . 74.15 113.209 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -152.43 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.436 1.094 . . . . 75.32 112.486 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 24.8 tp 70.68 168.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.481 1.112 . . . . 73.03 111.065 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.56 -172.08 3.65 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.34 0.656 . . . . 75.14 109.353 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -59.33 124.88 21.46 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.805 0.691 . . . . 65.24 109.199 172.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -133.53 165.02 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 73.21 110.211 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.57 175.38 12.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.292 -0.867 . . . . 70.21 110.005 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.8 83.42 0.7 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.989 -0.445 . . . . 63.03 111.989 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -65.72 143.87 57.26 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.973 0.909 . . . . 54.31 111.213 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.08 -45.05 92.85 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 123.867 0.729 . . . . 62.43 113.607 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.9 t -99.16 159.95 14.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.876 -0.416 . . . . 74.02 109.876 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.22 157.66 46.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.439 0.696 . . . . 65.53 109.479 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.89 172.59 15.8 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.029 0.532 . . . . 71.42 109.787 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -83.45 76.06 9.96 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.455 0.645 . . . . 73.31 109.774 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -88.9 96.58 10.76 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.645 -0.872 . . . . 75.23 108.645 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.56 150.91 30.96 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.443 -0.798 . . . . 73.11 109.995 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 123.458 0.703 . . . . 72.41 110.101 -175.009 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.554 ' HE3' ' HA ' ' D' ' 155' ' ' ALA . 61.9 mtt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.186 -0.301 . . . . 64.21 110.186 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.4 m -146.24 120.92 9.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.507 0.723 . . . . 72.25 110.779 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.31 72.17 1.24 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.941 -1.874 . . . . 74.42 105.941 168.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -132.25 113.73 13.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.977 -1.011 . . . . 75.11 109.617 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -157.59 121.41 4.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.837 0.855 . . . . 74.21 109.722 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -133.06 -78.11 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.227 -1.027 . . . . 72.31 108.227 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -151.49 51.21 0.82 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.705 -1.22 . . . . 74.31 107.705 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -6.2 58.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.074 -0.966 . . . . 72.41 111.497 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.545 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.6 ptm -33.4 134.32 0.14 Allowed 'General case' 0 C--N 1.365 1.277 0 C-N-CA 124.745 1.218 . . . . 73.42 113.28 166.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 40.0 m -128.64 146.63 50.81 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.926 -0.768 . . . . 74.25 108.926 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.425 ' HA ' ' O ' ' D' ' 85' ' ' SER . 49.9 t80 -155.93 102.44 2.17 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.483 -1.303 . . . . 73.23 107.483 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.23 139.99 53.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.062 0.545 . . . . 74.03 110.027 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.58 110.2 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.194 0.998 . . . . 72.34 108.97 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -89.26 -47.43 8.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.04 0.136 . . . . 74.24 111.357 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.23 119.74 0.7 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 119.423 -0.323 . . . . 71.13 110.341 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.22 136.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.215 -1.031 . . . . 73.2 108.215 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -165.99 174.32 9.57 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.637 0.732 . . . . 65.11 111.769 -174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -101.73 128.12 48.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.388 -0.823 . . . . 74.41 109.088 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.45 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . 33.3 mtpt -98.46 -16.49 19.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.873 0.469 . . . . 70.04 110.244 176.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.727 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -161.2 141.88 11.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.277 1.031 . . . . 74.15 109.496 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.556 HD11 ' SG ' ' D' ' 113' ' ' CYS . 61.9 mt -144.49 145.22 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.426 . . . . 71.34 107.676 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -148.25 144.05 27.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.872 0.869 . . . . 74.0 109.631 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.448 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -152.7 127.1 9.28 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.774 -1.565 . . . . 74.54 106.774 172.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.4 mt-10 -133.61 120.81 21.18 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.434 0.693 . . . . 64.11 109.481 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.14 83.88 61.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.368 -0.975 . . . . 73.23 108.368 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.62 -50.47 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.083 2.522 . . . . 62.11 111.725 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.491 ' O ' HG21 ' D' ' 31' ' ' VAL . 56.2 m-20 -89.34 31.8 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.183 0.993 . . . . 71.14 109.765 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -48.73 96.43 Favored Pre-proline 0 CA--C 1.561 1.4 0 N-CA-C 114.736 1.384 . . . . 75.51 114.736 -170.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.19 -7.09 12.06 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.595 1.53 . . . . 75.14 112.558 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -83.78 -36.31 23.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.878 1.271 . . . . 74.05 110.123 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' D' ' 73' ' ' ALA . 92.0 t -69.43 -25.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.544 0.738 . . . . 75.23 110.207 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.23 -24.53 64.93 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.21 1.004 . . . . 72.15 111.974 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -81.54 -14.16 57.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.753 0.821 . . . . 75.52 112.209 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -121.33 110.72 16.45 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.999 0.919 . . . . 75.04 109.818 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 91.85 8.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.879 0.871 . . . . 72.4 110.621 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.636 ' HB3' HD13 ' D' ' 68' ' ' LEU . 38.6 t-105 -168.23 163.98 13.17 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.531 HE21 ' HG3' ' D' ' 124' ' ' PRO . 1.2 mp0 -90.87 116.15 65.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.302 0.641 . . . . 61.1 110.455 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.431 ' HG3' ' HB2' ' D' ' 68' ' ' LEU . 85.7 Cg_exo -47.35 149.03 4.46 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 124.855 3.703 . . . . 62.41 116.078 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 60.8 mm-40 -64.89 112.09 3.13 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.734 -0.839 . . . . 60.14 108.734 169.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.565 HG23 ' HG ' ' F' ' 139' ' ' LEU . 76.6 t -109.37 117.15 53.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.457 0.646 . . . . 65.3 110.801 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.74 147.65 23.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.497 -1.229 . . . . 61.25 108.074 164.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.42 154.96 45.49 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.079 -1.082 . . . . 74.32 108.079 176.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.56 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.2 t70 -150.43 155.84 40.31 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.38 0.672 . . . . 74.13 109.395 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -134.9 139.69 45.19 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.053 -0.721 . . . . 75.5 109.053 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 29.1 t70 -141.49 132.12 25.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 75.42 106.968 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -104.25 163.46 12.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.455 0.57 . . . . 75.2 110.754 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.571 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -160.92 172.42 16.97 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.068 0.947 . . . . 65.4 109.422 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.6 p -166.97 178.29 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.027 0.531 . . . . 65.44 111.138 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -169.89 118.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.979 1.312 . . . . 55.41 108.114 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -79.53 122.22 26.2 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.785 -0.45 . . . . 71.13 109.785 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.8 mt -90.11 -36.62 14.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.215 0.606 . . . . 73.42 109.88 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.45 -176.54 4.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.968 0.907 . . . . 73.31 110.721 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.39 122.49 16.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.956 -1.02 . . . . 75.22 109.165 175.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 65.89 1.24 1.78 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.027 1.331 . . . . 71.53 113.044 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.13 116.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.88 -0.785 . . . . 74.34 108.88 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.93 162.58 24.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.218 -1.03 . . . . 74.45 108.218 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' D' ' 51' ' ' LEU . 6.4 tm-20 -131.18 131.93 44.38 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 105.736 -1.95 . . . . 74.45 105.736 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.408 HG11 ' HD3' ' D' ' 103' ' ' PRO . 92.1 t -125.61 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.625 -0.88 . . . . 75.44 108.625 -174.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB2' ' D' ' 47' ' ' ALA . 58.5 t -116.95 138.58 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.521 0.728 . . . . 73.1 109.688 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.551 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -118.35 118.12 30.91 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.638 -1.245 . . . . 73.45 107.638 177.184 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.403 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 20.0 ttm-85 -99.24 103.22 15.06 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.287 1.035 . . . . 73.33 108.323 176.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.09 124.95 50.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.511 -0.922 . . . . 72.32 108.511 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.9 m -108.96 145.39 35.55 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.65 0.594 . . . . 72.54 110.066 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.27 133.39 52.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.843 1.257 . . . . 75.24 108.544 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 46.3 m -127.69 115.63 19.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.152 -1.055 . . . . 74.43 108.152 172.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -124.81 130.57 52.65 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.032 0.533 . . . . 74.33 109.935 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 70.2 m -142.08 130.08 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.756 0.822 . . . . 72.24 108.95 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' D' ' 36' ' ' TRP . 23.6 tp -105.35 108.21 19.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.879 -0.786 . . . . 73.32 108.879 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.44 -110.41 3.35 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.879 -0.888 . . . . 73.13 110.879 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.89 7.49 9.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 63.11 110.191 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.68 147.86 42.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.191 0.596 . . . . 73.34 111.162 -175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 100.0 m -65.54 115.12 5.42 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.78 0.675 . . . . 75.45 109.978 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.613 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -82.89 -63.98 1.26 Allowed 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.604 0.565 . . . . 74.23 110.35 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -156.13 139.03 15.31 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.567 -0.742 . . . . 72.05 109.794 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 66.9 mt -109.0 149.7 28.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.448 -1.316 . . . . 74.31 107.448 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.612 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.6 t -158.39 139.33 13.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.654 -0.212 . . . . 75.12 110.578 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -154.84 123.21 5.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.733 0.413 . . . . 65.44 109.954 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -123.8 117.6 51.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.443 0.697 . . . . 72.44 109.833 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.727 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.3 mt-30 -93.94 88.17 5.63 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.581 0.705 . . . . 71.32 109.266 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.446 ' O ' HD11 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.69 108.26 13.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.245 -1.343 . . . . 72.43 109.209 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.23 172.83 32.32 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.154 0.308 . . . . 71.23 112.394 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.25 138.32 4.57 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 111.822 -0.511 . . . . 64.23 111.822 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.7 mt -90.56 120.74 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.066 -0.716 . . . . 75.22 109.066 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -125.47 125.65 43.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.608 1.163 . . . . 71.14 109.226 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 14.9 m -82.42 95.38 7.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.99 -0.744 . . . . 71.41 108.99 176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.56 115.74 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.921 -0.77 . . . . 75.41 108.921 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.49 168.35 19.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.823 0.849 . . . . 75.14 110.698 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.5 -2.13 48.2 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.845 0.716 . . . . 70.43 114.676 173.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -135.51 157.31 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.327 1.051 . . . . 73.34 109.141 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.42 173.11 12.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.628 0.771 . . . . 64.03 111.098 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.49 -121.78 21.76 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.984 0.754 . . . . 65.21 114.984 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -68.85 -18.78 64.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.717 0.807 . . . . 75.21 112.654 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.433 ' HA ' HD22 ' D' ' 141' ' ' LEU . 11.6 mp0 -75.27 -48.53 22.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.22 0.608 . . . . 74.32 110.287 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -75.04 -25.78 58.96 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 116.678 -0.237 . . . . 70.13 110.379 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.42 75.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.38 0.672 . . . . 71.24 110.495 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.63 -36.35 82.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.881 0.872 . . . . 74.51 110.552 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . 0.535 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 91.0 m -67.56 -54.08 22.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.254 0.346 . . . . 74.4 111.04 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.62 -19.69 60.79 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 122.327 -0.233 . . . . 74.43 111.597 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.48 -27.2 10.06 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.298 -0.723 . . . . 74.11 114.175 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 -51.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.959 0.88 . . . . 72.52 112.891 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 49.2 t80 -73.33 -55.19 6.73 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.752 0.649 . . . . 72.35 112.752 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.3 m -60.46 -44.64 96.3 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 118.517 -0.754 . . . . 75.11 111.676 175.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.551 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.0 Cg_exo -53.02 -35.69 72.95 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.492 2.128 . . . . 73.43 114.046 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -66.15 -39.67 89.98 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.572 0.749 . . . . 71.52 109.721 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -63.7 -41.03 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.497 0.719 . . . . 73.3 110.079 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.446 HD11 ' O ' ' D' ' 80' ' ' GLN . 91.8 mt -75.43 -24.43 57.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.076 -0.965 . . . . 64.31 112.14 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -62.84 -42.49 78.34 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 117.881 -1.056 . . . . 72.11 113.697 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.29 -38.82 73.17 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 121.923 1.748 . . . . 75.2 113.59 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.55 -32.14 28.75 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.637 0.775 . . . . 73.42 111.831 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.75 74.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.236 0.614 . . . . 64.31 109.807 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 35.0 ttp180 -61.07 -45.9 92.87 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 124.338 1.024 . . . . 72.24 110.282 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -55.26 -50.25 69.99 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.539 1.149 . . . . 75.24 111.694 -174.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' D' ' 21' ' ' ILE . 42.0 t -60.97 -40.98 95.45 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.249 0.968 . . . . 71.12 111.217 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.612 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -60.19 -55.9 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.369 0.668 . . . . 74.55 110.204 173.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.2 m -53.51 -40.66 65.61 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.117 1.367 . . . . 73.11 110.65 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.3 t -69.51 -47.87 62.42 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.412 -1.267 . . . . 62.21 110.954 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.0 mtm -67.08 -30.95 71.13 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.078 0.399 . . . . 75.45 112.078 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -67.39 -46.06 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 123.557 0.535 . . . . 75.0 109.868 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -71.18 -25.28 62.46 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.477 -0.329 . . . . 63.14 110.757 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -75.69 -33.71 60.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.966 0.906 . . . . 74.52 109.511 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.56 1.05 67.88 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.552 -0.749 . . . . 61.15 112.537 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.5 p 56.04 40.44 30.31 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.265 1.826 . . . . 73.22 112.106 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.443 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 58.4 m-85 -103.68 169.68 7.06 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 125.075 1.35 . . . . 73.11 108.172 171.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.531 ' HG3' HE21 ' D' ' 37' ' ' GLN . 34.6 Cg_endo -62.92 138.92 71.08 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.899 1.732 . . . . 75.54 109.864 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -63.36 156.01 27.13 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.425 0.557 . . . . 75.2 111.176 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.413 HD21 HD12 ' F' ' 142' ' ' ILE . 2.8 tt -116.85 115.11 24.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.128 -1.064 . . . . 73.23 108.128 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -107.78 92.96 4.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.474 0.71 . . . . 74.42 109.642 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.442 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 68.9 mt -67.17 117.24 8.93 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.848 -0.614 . . . . 74.22 109.543 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 133.13 94.31 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 122.359 0.263 . . . . 74.23 110.494 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.18 109.29 2.79 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.222 1.948 . . . . 71.41 110.465 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 93.7 t -107.46 111.08 34.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.906 0.882 . . . . 72.01 109.046 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -83.1 73.2 10.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.024 0.916 . . . . 71.42 109.626 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -79.85 -14.57 58.56 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.904 -1.043 . . . . 74.33 109.764 176.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -50.87 -40.4 56.25 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.214 1.406 . . . . 73.53 111.495 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.55 64.95 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.47 1.106 . . . . 71.2 112.865 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.58 -45.04 73.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.416 0.686 . . . . 63.54 110.655 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.86 -34.86 67.02 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.787 -0.642 . . . . 74.15 110.661 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 16.2 ttp -67.91 -31.97 72.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.104 0.961 . . . . 71.31 110.443 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.46 -41.25 69.24 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.373 1.069 . . . . 63.51 111.206 173.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -66.79 -41.4 87.7 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.765 0.826 . . . . 74.12 111.304 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.607 ' HA ' HE21 ' D' ' 144' ' ' GLN . 10.9 mp -60.56 -34.12 73.7 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.744 0.652 . . . . 74.31 111.427 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' D' ' 138' ' ' MET . 45.5 mt-30 -81.05 2.35 27.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.244 0.617 . . . . 65.33 111.72 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -129.26 45.4 2.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.27 0.628 . . . . 72.5 109.42 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . 0.607 HE21 ' HA ' ' D' ' 141' ' ' LEU . 28.7 pt20 -161.96 148.94 13.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.313 -0.858 . . . . 75.23 109.75 176.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.14 150.07 16.38 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.46 0.704 . . . . 71.05 109.723 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.46 162.6 29.97 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 112.063 -0.415 . . . . 63.44 112.063 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.84 -177.4 4.54 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.383 1.073 . . . . 73.42 109.517 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.26 69.94 1.3 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.609 -0.596 . . . . 72.05 111.609 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 16.6 p -62.04 168.92 2.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.97 0.908 . . . . 74.43 112.628 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -82.18 38.41 0.54 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.876 0.87 . . . . 74.32 110.386 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 55.31 -164.32 0.13 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.4 1.48 . . . . 75.21 112.383 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -137.39 -39.02 0.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.417 0.687 . . . . 75.05 109.172 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -88.32 153.57 21.09 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.72 1.208 . . . . 75.25 109.268 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.65 -67.55 0.49 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.336 0.654 . . . . 75.44 110.752 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . 0.554 ' HA ' ' HE3' ' D' ' 1' ' ' MET . . . . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 123.752 0.821 . . . . 74.24 109.081 177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 108.96 -0.756 . . . . 74.33 108.96 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.84 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.772 1.229 . . . . 72.42 111.167 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.51 157.14 0.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.057 1.343 . . . . 70.25 111.878 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 79.8 t80 74.92 -48.32 0.64 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 126.064 1.746 . . . . 74.51 111.808 -176.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -62.34 161.37 11.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.358 1.063 . . . . 75.41 112.509 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.62 -178.09 6.81 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.657 -1.156 . . . . 63.03 111.307 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 114' ' ' LYS . . . . . 0.48 ' HZ1' ' HB3' ' E' ' 114' ' ' LYS . 0.0 OUTLIER 67.87 113.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.107 1.363 . . . . 74.3 109.14 -174.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' E' E ' 115' ' ' LEU . . . . . 0.462 HD23 ' HB ' ' B' ' 89' ' ' ILE . 6.3 mp -80.77 -101.94 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 118.759 -0.638 . . . . 74.04 111.447 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 59.77 111.72 0.02 OUTLIER Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.285 1.034 . . . . 65.15 111.835 -168.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 117' ' ' PRO . . . . . 0.407 ' HB2' ' HB2' ' E' ' 120' ' ' TRP . 92.8 Cg_exo -47.21 121.81 5.72 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.727 2.951 . . . . 73.44 113.401 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -63.36 84.48 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.943 0.897 . . . . 74.51 110.519 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 30.3 m 56.95 86.26 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.287 1.035 . . . . 72.03 111.034 -168.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 120' ' ' TRP . . . . . 0.407 ' HB2' ' HB2' ' E' ' 117' ' ' PRO . 73.2 t-105 -71.58 140.06 49.66 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.218 -0.66 . . . . 71.02 109.218 173.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -163.48 -153.57 0.24 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.12 -1.437 . . . . 73.54 107.12 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 76.16 -14.36 0.81 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.936 1.294 . . . . 74.14 112.933 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 p -70.37 85.29 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.942 1.353 . . . . 74.33 109.982 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -122.59 -52.62 1.91 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.209 -1.36 . . . . 73.14 109.632 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 69.19 -70.77 0.13 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.877 1.271 . . . . 72.32 110.767 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 68.07 103.49 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.742 1.217 . . . . 64.35 110.789 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -176.1 19.3 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.171 -0.468 . . . . 73.34 112.396 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -122.32 143.36 49.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.936 0.895 . . . . 72.03 109.482 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.81 -17.02 61.61 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.493 0.717 . . . . 74.32 112.841 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.07 103.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 CA-C-O 121.574 0.702 . . . . 71.34 110.615 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.22 -65.37 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.735 0.814 . . . . 73.13 110.221 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -108.52 150.49 40.74 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.812 0.845 . . . . 72.14 110.201 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.85 -21.78 18.27 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.594 2.196 . . . . 72.24 111.944 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 6.2 tt -78.11 86.47 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.57 1.176 . . . . 75.02 109.787 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -90.56 -14.0 33.4 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.447 -1.252 . . . . 73.03 109.652 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 t 70.75 -1.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 C-N-CA 126.177 1.791 . . . . 61.33 110.647 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.0 84.11 1.26 Allowed 'General case' 0 C--N 1.363 1.184 0 C-N-CA 124.036 0.934 . . . . 73.13 111.287 -174.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 138' ' ' ALA . . . . . 0.407 ' H ' ' HB3' ' C' ' 124' ' ' PRO . . . -174.01 102.66 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.914 1.286 . . . . 63.14 107.918 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.5 116.72 26.93 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.294 -0.632 . . . . 74.21 109.294 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 47.1 t -74.43 -68.68 0.51 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.387 0.675 . . . . 73.12 110.643 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 141' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' C' ' 39' ' ' GLU . 5.0 mp -96.78 110.1 22.64 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.484 -0.562 . . . . 71.25 109.484 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 10.5 tt -146.68 127.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.964 0.506 . . . . 75.42 110.968 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 1.4 t80 63.96 9.6 4.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.979 1.712 . . . . 70.31 112.885 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.81 114.71 25.72 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.29 -0.633 . . . . 64.31 109.29 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -143.54 -59.4 0.41 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.676 -1.231 . . . . 74.52 107.676 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -172.31 -55.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.076 0.95 . . . . 64.41 109.974 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 90.6 mt 63.62 162.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.442 1.497 . . . . 74.52 112.563 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -107.86 144.38 29.22 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 109.103 -0.702 . . . . 75.03 109.103 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo . . . . . 0 CA--C 1.563 1.933 0 C-N-CA 122.632 2.221 . . . . 75.34 111.558 168.1 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.661 -0.496 . . . . 72.13 109.661 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -71.86 87.21 0.99 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.779 0.799 . . . . 75.54 111.129 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 120.31 16.83 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.075 0.95 . . . . 72.4 110.72 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -108.26 136.48 47.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.065 0.546 . . . . 73.5 110.377 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -115.06 111.8 21.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.949 0.9 . . . . 73.34 109.442 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.89 104.29 13.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.497 0.719 . . . . 73.2 110.037 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -177.9 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.073 1.349 . . . . 74.0 109.507 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 115' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 90' ' ' GLU . 93.2 mt 63.7 32.55 13.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.426 1.09 . . . . 74.01 110.659 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.2 51.41 3.87 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 114.727 -1.124 . . . . 75.22 110.248 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 117' ' ' PRO . . . . . 0.46 ' HD2' ' HB1' ' A' ' 95' ' ' ALA . 56.2 Cg_endo -90.13 13.66 2.24 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.316 2.011 . . . . 52.32 112.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -145.41 108.11 4.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.907 0.883 . . . . 74.1 108.665 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 22.3 p -99.29 -42.61 6.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.37 1.068 . . . . 71.42 109.813 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 20.5 t90 57.46 76.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.075 1.35 . . . . 74.01 111.211 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.16 111.5 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.147 -0.933 . . . . 72.13 108.558 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.58 -58.17 0.22 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.911 0.884 . . . . 74.43 109.652 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.17 155.46 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.606 -0.724 . . . . 70.13 111.799 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -149.62 139.54 21.93 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.741 0.816 . . . . 73.24 109.398 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 125' ' ' TYR . . . . . 0.436 ' HE2' HD12 ' A' ' 128' ' ' LEU . 1.8 p90 -116.42 16.05 15.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.249 1.02 . . . . 74.2 111.181 -171.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 126' ' ' ASN . . . . . 0.46 ' HA ' HD12 ' A' ' 42' ' ' LEU . 7.2 t30 -68.89 99.01 0.99 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.543 0.737 . . . . 75.43 110.155 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 153.41 25.13 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.557 -1.017 . . . . 33.52 110.557 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -76.14 99.98 4.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.536 0.684 . . . . 74.4 110.17 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 129' ' ' LEU . . . . . 0.479 ' H ' HD23 ' F' ' 129' ' ' LEU . 0.7 OUTLIER -88.58 50.98 2.06 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.148 0.975 . . . . 73.12 108.871 171.431 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.02 124.45 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.696 -1.138 . . . . 75.23 109.141 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.91 144.23 41.22 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.878 -0.601 . . . . 73.35 110.049 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 132' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' F' ' 133' ' ' PRO . 57.4 t80 -59.88 122.53 66.32 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.57 -0.9 . . . . 73.53 108.57 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 133' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' F' ' 132' ' ' TYR . 4.0 Cg_exo -74.49 70.39 4.89 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.699 2.266 . . . . 74.53 111.328 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 11.9 tt -69.57 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 115.044 -0.98 . . . . 73.14 109.642 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.51 87.35 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.94 0.496 . . . . 54.34 109.97 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 136' ' ' VAL . . . . . 0.412 HG13 ' HD3' ' D' ' 124' ' ' PRO . 15.6 m -131.03 77.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.377 1.071 . . . . 62.31 110.464 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.02 -70.31 0.34 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.489 -0.778 . . . . 65.54 109.833 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 170.13 151.02 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.369 1.868 . . . . 74.34 107.187 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 139' ' ' LEU . . . . . 0.565 ' HG ' HG23 ' D' ' 40' ' ' VAL . 3.2 mm? -70.67 83.98 0.63 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.447 -0.575 . . . . 75.45 109.447 174.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 16.7 m -97.73 -22.84 16.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.392 1.077 . . . . 60.42 110.506 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.32 -5.82 25.66 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.856 0.862 . . . . 73.21 112.807 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 142' ' ' ILE . . . . . 0.413 HD12 HD21 ' D' ' 126' ' ' LEU . 10.8 tt -64.39 154.23 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.462 0 C-N-CA 124.245 1.018 . . . . 73.13 110.842 174.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 67.2 85.29 0.14 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.963 1.305 . . . . 75.22 109.423 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -64.61 -51.89 60.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.096 0.958 . . . . 62.1 111.721 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -86.83 -75.35 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.066 -0.346 . . . . 75.42 110.066 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -151.22 -174.95 4.97 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.065 0.46 . . . . 74.51 110.667 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.29 25.62 0.3 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.553 1.141 . . . . 70.24 109.942 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp 72.27 157.48 0.16 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 124.909 1.284 . . . . 73.34 111.068 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo . . . . . 0 C--N 1.395 2.979 0 C-N-CA 123.798 2.999 . . . . 74.34 114.575 -176.875 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 62.6 m . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 107.286 -1.376 . . . . 60.44 107.286 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -136.98 132.1 33.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.425 0.69 . . . . 61.1 109.27 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -137.77 134.95 35.87 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.746 0.418 . . . . 61.4 110.1 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 13' ' ' ILE . 1.5 pp -81.58 88.2 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 109.201 -0.666 . . . . 75.21 109.201 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -74.91 -41.71 59.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.297 0.639 . . . . 72.22 110.601 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 12.9 tpp85 -165.56 133.47 3.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.971 -0.559 . . . . 74.22 110.3 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.604 HD13 ' HG3' ' C' ' 130' ' ' PRO . 3.8 mp -131.04 120.26 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.386 -1.338 . . . . 63.12 107.386 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.404 ' CD1' ' HG3' ' A' ' 15' ' ' ARG . 4.7 p90 -164.06 176.21 9.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.696 0.799 . . . . 55.15 110.411 -169.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.44 HG21 ' SG ' ' A' ' 113' ' ' CYS . 78.7 p -92.69 117.9 30.48 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.201 -0.666 . . . . 64.43 109.201 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.9 mtpt -75.69 -30.52 59.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.909 -0.404 . . . . 63.22 109.909 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.59 143.13 19.55 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.543 -0.753 . . . . 64.34 109.63 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 68.4 mt -139.3 144.34 29.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.618 -1.252 . . . . 74.2 107.618 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -150.03 136.19 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.375 -0.602 . . . . 71.42 109.375 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.545 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -140.82 109.75 6.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.714 -1.587 . . . . 73.23 106.714 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.81 119.52 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.48 -0.563 . . . . 74.43 109.48 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.08 83.16 37.89 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.021 -1.103 . . . . 72.21 108.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.29 -18.48 34.49 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.728 2.285 . . . . 32.32 111.937 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -117.35 37.39 3.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.361 1.064 . . . . 71.41 109.749 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.13 93.18 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 114.379 1.252 . . . . 73.44 114.379 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.19 -25.13 8.87 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.698 1.599 . . . . 74.32 111.649 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -78.97 -14.23 59.33 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.935 1.694 . . . . 74.35 111.418 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.44 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 7.1 p -69.76 -22.31 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.692 0.797 . . . . 62.25 111.879 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.82 -25.59 66.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.808 0.843 . . . . 53.11 111.358 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -86.85 -34.06 19.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.239 1.016 . . . . 72.42 111.48 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.675 ' HD3' HD21 ' A' ' 68' ' ' LEU . 12.5 ptpt -80.57 171.76 14.63 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.224 0.535 . . . . 75.24 111.36 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.17 144.96 29.46 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.247 -0.888 . . . . 73.0 109.336 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -89.61 63.73 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.703 0.763 . . . . 74.31 110.956 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -149.08 82.37 7.11 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 114.941 -1.027 . . . . 63.1 108.352 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -85.39 170.01 9.46 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.675 2.25 . . . . 73.24 111.265 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.98 114.72 26.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.621 -0.881 . . . . 65.51 108.621 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.61 96.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.829 0.852 . . . . 63.42 109.532 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.6 tttm -102.45 116.44 32.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.538 1.135 . . . . 64.1 109.204 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.04 128.83 53.5 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.203 -1.036 . . . . 72.13 108.203 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.621 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 16.3 m-20 -115.06 131.04 57.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.084 0.954 . . . . 70.32 108.668 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.5 138.65 53.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.919 0.888 . . . . 73.13 109.657 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 26.5 t70 -155.43 146.81 22.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.67 0.788 . . . . 73.04 109.913 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.09 139.02 35.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.42 0.688 . . . . 62.43 110.617 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -139.86 154.34 47.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.236 1.014 . . . . 63.22 110.183 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -129.08 157.77 40.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.667 0.787 . . . . 73.15 108.947 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.3 t -161.45 115.47 1.97 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.256 -0.275 . . . . 61.43 110.256 -172.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -72.06 104.79 3.69 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 71.33 109.817 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 57' ' ' GLU . 65.1 mt -77.79 -41.35 37.67 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.194 0.998 . . . . 65.21 110.891 176.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.28 -175.62 4.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.644 -1.162 . . . . 52.23 108.379 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -58.63 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.865 0.466 . . . . 64.43 110.671 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 59.15 33.55 22.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.859 1.264 . . . . 62.24 112.483 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 61.5 t -112.95 118.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.717 -1.586 . . . . 75.01 106.717 167.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -129.6 131.69 46.56 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.766 -0.828 . . . . 75.33 108.766 -177.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.604 ' HB2' HD11 ' A' ' 51' ' ' LEU . 43.6 tt0 -89.25 121.07 31.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.697 0.799 . . . . 73.23 109.054 173.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 99.0 t -100.25 121.85 51.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 123.807 0.843 . . . . 75.32 108.775 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.5 t -108.5 133.66 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.666 -0.494 . . . . 64.14 109.666 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.94 116.0 31.19 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.067 -1.457 . . . . 73.03 107.067 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.591 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -91.78 102.3 14.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.635 -1.246 . . . . 63.44 107.635 170.318 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' A' ' 114' ' ' ILE . 2.9 t -101.18 130.33 50.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.036 -1.468 . . . . 73.53 107.036 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -132.04 125.99 32.8 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.221 0.534 . . . . 71.41 109.726 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 47.3 t -111.28 110.05 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.156 0.982 . . . . 73.4 109.167 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 26.3 m -101.12 135.94 41.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.667 -0.864 . . . . 73.43 108.667 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.52 103.85 7.57 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.751 -1.204 . . . . 54.21 107.751 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 m -143.67 128.06 17.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.203 0.601 . . . . 71.11 109.535 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.675 HD21 ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -94.28 84.93 4.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.502 -1.295 . . . . 73.13 107.502 172.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -116.89 4.66 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.539 -1.209 . . . . 40.14 111.277 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.01 -25.44 21.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 70.14 111.059 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.574 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 tp10 -81.25 96.05 7.14 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.556 -0.535 . . . . 73.34 109.556 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -75.31 129.0 36.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.313 0.645 . . . . 52.52 110.811 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.11 4.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.015 0.926 . . . . 75.32 108.917 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -164.94 173.99 11.02 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.586 -1.188 . . . . 71.51 110.62 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.9 tp -140.92 137.75 33.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.575 1.15 . . . . 60.22 108.449 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.0 m -127.54 141.96 51.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.802 1.241 . . . . 55.12 108.751 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.14 134.91 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.207 -0.664 . . . . 74.31 109.207 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.76 111.57 8.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 123.776 0.831 . . . . 73.54 108.991 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -85.52 84.53 7.59 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.437 -0.949 . . . . 50.33 108.437 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -80.17 96.36 6.53 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.697 -1.223 . . . . 72.23 107.697 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.99 146.33 16.55 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 111.665 -0.574 . . . . 75.33 111.665 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.98 133.9 5.72 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.027 -0.829 . . . . 73.01 111.027 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -85.79 127.49 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.075 -0.713 . . . . 71.13 109.075 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.6 118.95 18.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.155 -1.054 . . . . 74.1 108.155 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 54.0 p -89.52 94.04 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.837 -0.801 . . . . 33.53 108.837 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.75 HG12 HD11 ' A' ' 98' ' ' LEU . 2.8 pp -119.21 144.01 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.747 0.419 . . . . 72.54 111.259 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.31 177.52 3.08 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.273 1.429 . . . . 65.41 108.835 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.34 89.82 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.898 0.719 . . . . 73.34 114.898 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.1 150.15 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.069 -1.085 . . . . 75.42 108.069 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -128.55 173.63 10.09 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.484 -0.561 . . . . 74.13 109.484 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.83 -112.33 1.61 Allowed Glycine 0 C--N 1.352 1.434 0 O-C-N 124.832 1.333 . . . . 73.51 116.176 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.0 p -61.89 -50.81 70.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 70.11 111.5 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.43 -33.99 69.89 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.382 0.673 . . . . 70.51 112.118 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.1 tpp -63.85 -51.57 64.05 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.304 0.378 . . . . 60.11 110.381 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.56 -35.78 76.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.153 0.581 . . . . 62.21 111.067 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.423 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 59.7 t-80 -75.74 -22.22 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.118 0.967 . . . . 71.43 111.103 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HB3' HD22 ' A' ' 98' ' ' LEU . 43.3 t -70.61 -60.55 2.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.638 -0.505 . . . . 75.54 109.638 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.75 HD11 HG12 ' A' ' 86' ' ' ILE . 1.7 mm? -81.92 -23.14 36.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.837 -0.619 . . . . 72.22 111.822 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.32 -28.03 9.48 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 123.534 0.521 . . . . 74.4 113.857 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -112.97 -63.59 1.42 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.478 0.639 . . . . 72.11 111.004 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.3 -50.23 70.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.778 0.831 . . . . 73.35 112.55 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.0 m -65.12 -49.09 68.36 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.077 -0.963 . . . . 73.42 112.65 -172.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.57 -24.29 56.13 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 121.848 1.698 . . . . 73.25 112.703 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -74.03 -27.74 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.271 0.628 . . . . 53.45 110.44 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.23 -39.67 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.57 0.748 . . . . 73.23 109.718 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 mt -76.72 -24.86 53.07 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.339 -0.846 . . . . 71.52 111.692 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.05 -41.86 47.48 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 114.535 1.309 . . . . 75.23 114.535 -169.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.94 -38.73 76.84 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.034 1.823 . . . . 75.23 113.007 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -77.95 -31.87 51.18 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.684 -0.689 . . . . 74.45 111.245 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.69 72.7 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.357 0.663 . . . . 65.14 109.506 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.0 ttm180 -51.3 -52.85 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.988 1.43 . . . . 73.23 110.382 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.37 -47.81 80.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.724 -1.126 . . . . 72.22 111.86 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.521 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.4 t -59.88 -29.85 68.61 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.949 0.781 . . . . 42.44 111.77 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 118' ' ' VAL . 94.8 mt -73.29 -58.67 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.534 -0.543 . . . . 70.51 109.534 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -51.24 -39.85 57.55 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.093 1.357 . . . . 70.51 112.641 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -70.23 -40.66 74.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.082 -0.963 . . . . 74.22 111.283 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.17 -43.24 99.27 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 120.864 0.364 . . . . 64.45 110.585 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.8 t -57.17 -45.8 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 114.663 -1.153 . . . . 63.33 110.92 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -70.57 -30.9 67.72 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.529 -0.76 . . . . 74.13 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -68.96 -31.28 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.501 0.72 . . . . 73.13 110.86 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 3.52 65.65 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.447 -0.64 . . . . 62.41 113.418 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 67.25 35.17 4.54 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.419 1.104 . . . . 62.11 109.781 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -111.24 149.79 41.06 Favored Pre-proline 0 N--CA 1.478 0.926 0 CA-C-N 114.865 -1.061 . . . . 71.11 110.044 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.35 143.14 94.67 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.872 2.381 . . . . 72.24 112.808 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -53.72 138.62 34.81 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.856 0.862 . . . . 73.22 112.459 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 64' ' ' VAL . 1.4 tm? -120.93 109.28 14.91 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.579 -1.267 . . . . 70.54 107.579 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -98.97 127.17 44.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.764 0.825 . . . . 63.44 108.859 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 132.59 43.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.412 0.685 . . . . 73.5 109.817 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.58 130.04 86.23 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 118.68 -0.676 . . . . 54.13 109.848 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.61 115.65 2.82 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.341 2.027 . . . . 64.23 111.887 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.86 114.2 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.316 -1.364 . . . . 73.23 107.316 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -76.9 74.68 3.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.4 0.68 . . . . 53.31 109.97 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -55.6 -44.05 76.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 63.0 110.994 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 114.768 -1.105 . . . . 73.13 111.972 -178.975 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.505 ' HE3' HD12 ' B' ' 89' ' ' ILE . 19.4 ptm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.194 1.183 . . . . 73.45 114.194 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 32.8 m -152.79 127.51 9.49 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.188 -1.412 . . . . 70.21 107.188 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -124.3 154.46 40.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.963 -0.755 . . . . 71.53 108.963 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.657 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 50.2 tt0 -153.49 139.42 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.959 0.904 . . . . 72.14 109.829 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.689 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -97.55 113.15 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.092 -1.447 . . . . 72.22 107.092 166.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -77.76 -49.4 14.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.034 -0.416 . . . . 53.44 110.042 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -161.94 133.05 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.478 -0.328 . . . . 71.24 110.194 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.13 137.42 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 107.046 -1.465 . . . . 75.43 107.046 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.89 145.52 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.365 0.602 . . . . 74.14 111.744 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 65.6 m -75.81 115.15 15.21 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.907 -1.042 . . . . 44.25 108.698 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.449 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.1 mtpt -85.75 -31.39 22.43 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.088 0.555 . . . . 74.22 110.568 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.3 t70 -157.78 143.84 17.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.729 -0.668 . . . . 70.21 111.303 -168.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 37.6 mm -139.97 141.03 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 125.304 1.442 . . . . 65.21 108.646 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -141.26 132.39 26.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.601 -1.259 . . . . 75.12 107.601 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.554 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 84.5 t80 -144.27 109.71 5.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.244 -1.761 . . . . 75.4 106.244 170.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -119.18 117.3 28.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.013 -0.736 . . . . 74.34 109.013 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.36 86.1 7.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.708 -1.219 . . . . 75.51 107.708 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.57 -28.02 32.1 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.447 2.098 . . . . 73.53 110.811 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -107.0 27.77 8.67 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.745 1.218 . . . . 71.21 109.244 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.455 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -47.62 -57.39 9.98 Favored Pre-proline 0 CA--C 1.57 1.734 0 C-N-CA 124.67 1.188 . . . . 74.32 112.954 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 78.0 Cg_endo -82.48 -1.28 10.56 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 121.77 1.647 . . . . 74.14 112.843 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -99.57 -16.43 18.27 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.644 0.778 . . . . 73.04 111.885 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.18 -21.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.534 0.733 . . . . 72.34 112.784 -167.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -73.65 -16.72 61.21 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.517 0.192 . . . . 63.43 111.517 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -81.69 -4.87 57.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.664 0.786 . . . . 72.33 111.082 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' B' ' 68' ' ' LEU . 72.7 mmtt -106.51 102.17 11.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.573 1.149 . . . . 73.31 109.898 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -115.9 85.99 2.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 55.4 111.954 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.503 ' HB2' HD23 ' B' ' 68' ' ' LEU . 6.2 m0 -159.27 -170.5 3.0 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.678 1.991 . . . . 63.05 106.657 169.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -83.51 125.4 73.94 Favored Pre-proline 0 N--CA 1.478 0.925 0 N-CA-C 107.628 -1.249 . . . . 72.31 107.628 162.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.443 ' HA ' ' HG ' ' B' ' 68' ' ' LEU . 30.3 Cg_endo -62.68 132.64 38.52 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.08 1.853 . . . . 61.35 112.143 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -68.93 103.27 1.77 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.657 -1.156 . . . . 74.11 108.443 171.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.17 128.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.742 0.817 . . . . 63.14 110.079 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -121.75 109.74 15.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.642 1.177 . . . . 74.51 108.048 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.15 153.57 19.24 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.608 0.763 . . . . 51.25 110.64 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.615 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.0 m-20 -136.04 137.17 40.88 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.948 -1.13 . . . . 75.51 107.948 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.501 HD21 HG21 ' B' ' 131' ' ' VAL . 7.1 mp -115.78 132.64 56.58 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.083 -0.71 . . . . 52.04 109.083 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.9 t70 -139.05 155.94 47.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.846 1.258 . . . . 73.11 108.637 -173.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.32 140.11 39.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.759 0.824 . . . . 73.33 109.042 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.61 116.88 17.23 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.485 -1.302 . . . . 32.21 107.485 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -106.38 161.5 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.109 0.564 . . . . 64.04 110.733 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -160.48 136.04 8.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.688 -0.856 . . . . 72.03 108.688 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -88.4 120.27 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.649 -0.871 . . . . 64.4 108.649 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 mt -81.28 -39.33 25.41 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.259 0.552 . . . . 75.53 110.375 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -157.32 -177.86 6.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.789 -1.096 . . . . 62.54 110.016 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -69.87 130.66 42.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.068 -1.086 . . . . 74.33 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.49 -4.81 1.27 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.604 1.162 . . . . 75.24 112.761 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 60.0 t -123.08 116.96 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.628 0.771 . . . . 74.02 109.61 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.418 ' HD2' HG13 ' B' ' 58' ' ' VAL . 30.0 p90 -126.19 171.58 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.188 0.595 . . . . 74.33 109.418 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -144.71 108.15 4.61 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.625 -1.25 . . . . 74.51 107.625 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' B' ' 56' ' ' TYR . 29.5 m -104.47 137.47 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.148 -0.686 . . . . 72.31 109.148 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.38 119.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.149 -0.686 . . . . 63.03 109.149 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.02 114.32 26.84 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.54 -1.281 . . . . 74.43 107.54 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.5 ttt180 -106.24 122.29 45.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.78 0.832 . . . . 73.12 109.985 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -113.27 118.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.806 -0.813 . . . . 75.05 108.806 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 20.1 m -99.92 145.37 27.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.418 1.087 . . . . 61.42 108.513 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -136.57 130.17 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.702 0.801 . . . . 71.34 109.268 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -120.96 145.58 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.134 -1.062 . . . . 73.32 108.134 171.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.56 151.33 37.15 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.711 0.291 . . . . 62.15 110.36 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -162.25 143.24 10.41 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.672 1.232 . . . . 63.2 109.657 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.0 mp -112.38 137.08 51.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.249 -1.019 . . . . 72.04 108.249 168.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.13 -118.33 6.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.112 -0.795 . . . . 75.23 111.112 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.59 29.48 6.57 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.481 0.712 . . . . 71.1 110.506 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -145.4 142.92 29.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.113 0.565 . . . . 64.01 110.355 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 9.1 m -59.52 151.83 23.35 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.338 1.055 . . . . 72.04 112.137 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.623 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -112.27 -61.78 1.67 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.446 1.098 . . . . 62.22 108.926 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.8 156.88 28.28 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.79 -1.55 . . . . 74.42 108.94 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.37 141.93 49.11 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.335 -1.358 . . . . 70.55 107.335 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.1 t -154.21 152.48 30.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.454 -0.573 . . . . 72.04 109.454 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.15 140.71 5.34 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.264 -0.643 . . . . 72.35 109.264 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.3 t -133.66 146.79 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.079 0.952 . . . . 71.31 108.748 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 78.9 mt-30 -126.34 101.05 6.54 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.233 0.613 . . . . 74.21 109.443 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -90.8 105.34 17.75 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.531 -0.759 . . . . 74.45 109.801 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.36 156.19 23.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 111.532 -0.627 . . . . 61.24 111.532 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 126.56 1.96 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 111.862 -0.495 . . . . 61.03 111.862 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.0 126.18 40.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.575 -0.898 . . . . 72.24 108.575 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -131.51 155.95 46.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.223 1.009 . . . . 70.12 109.093 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.657 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 44.1 m -131.92 134.32 45.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.293 1.037 . . . . 65.24 109.627 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.72 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.7 pp -131.59 147.7 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.152 0.981 . . . . 71.52 111.006 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.5 149.7 27.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.436 1.094 . . . . 63.21 108.763 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.04 -47.25 2.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.12 0.39 . . . . 34.22 113.905 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.72 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -83.94 165.0 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.531 0.732 . . . . 74.25 112.073 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -167.9 163.51 13.87 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.729 0.811 . . . . 53.21 110.361 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -113.22 5.0 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.992 0.808 . . . . 61.54 113.143 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.7 m -74.08 -34.28 63.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.871 0.868 . . . . 64.45 111.052 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -32.9 74.15 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.039 0.535 . . . . 54.33 109.913 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 13.2 tpt -76.98 -43.98 32.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.476 0.71 . . . . 62.02 110.811 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.14 75.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.828 0.851 . . . . 54.13 111.321 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -70.81 -30.41 66.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.285 1.034 . . . . 62.31 111.084 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -69.47 -59.45 2.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.092 0.557 . . . . 74.22 110.384 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.45 -19.07 61.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.88 0.326 . . . . 65.04 111.88 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -22.07 43.66 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.493 0.557 . . . . 74.42 114.493 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.18 -55.26 0.44 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.189 0.494 . . . . 74.14 111.572 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -62.07 -45.53 93.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.742 0.817 . . . . 73.53 112.082 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 85.8 m -71.13 -47.15 14.33 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.546 -0.74 . . . . 71.31 112.222 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.2 Cg_exo -52.86 -31.5 52.37 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.249 1.966 . . . . 65.43 114.221 168.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -66.67 -36.64 83.02 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 122.941 0.496 . . . . 74.33 111.558 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.03 -45.21 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.592 0.757 . . . . 72.34 110.4 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.08 -25.24 40.13 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.043 -0.981 . . . . 63.3 113.058 -169.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.76 -47.85 94.69 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 117.399 -1.286 . . . . 71.22 113.975 -170.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.18 -41.12 50.73 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.333 2.022 . . . . 73.3 113.655 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -68.1 -51.73 43.04 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.609 -0.723 . . . . 72.41 110.99 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.97 91.71 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.564 0.745 . . . . 61.44 111.294 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 23.6 ttp180 -61.88 -58.93 6.05 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.256 1.422 . . . . 71.44 110.992 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -69.79 -26.42 64.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.728 -1.124 . . . . 75.3 111.098 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.451 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.3 t -68.63 -37.18 79.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.824 0.45 . . . . 24.11 111.062 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.61 -49.24 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.126 0.57 . . . . 62.34 109.768 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -69.68 -23.44 63.45 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.606 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.0 t -75.89 -29.1 58.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.697 0.799 . . . . 63.04 110.958 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 21.5 mmt -78.94 -26.68 43.63 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.766 0.426 . . . . 73.4 110.187 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' B' ' 125' ' ' GLN . 49.6 t -58.85 -41.82 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.96 0.904 . . . . 54.33 111.113 170.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.5 t -53.1 -38.72 62.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.401 1.081 . . . . 23.11 111.634 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.0 mtt-85 -76.67 -26.52 54.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.113 -0.949 . . . . 74.42 111.377 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.2 0.54 81.6 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-O 119.472 -0.626 . . . . 63.11 113.743 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p 63.12 18.91 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.112 1.765 . . . . 73.42 114.484 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' B' ' 118' ' ' VAL . 55.1 p90 -110.42 166.76 10.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-O 118.73 -0.652 . . . . 74.21 110.683 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.31 147.19 22.15 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.34 2.694 . . . . 74.12 114.539 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.556 ' HA ' HG11 ' B' ' 118' ' ' VAL . 5.0 pm0 -54.1 145.0 18.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.05 1.34 . . . . 73.33 113.729 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 126' ' ' LEU . 1.9 tm? -133.23 85.4 2.21 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.537 -1.283 . . . . 73.53 107.537 171.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -104.93 133.76 49.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.909 -1.145 . . . . 73.22 107.909 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.0 mm? -86.7 138.47 31.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.369 0.668 . . . . 53.4 109.544 -169.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.96 148.71 98.39 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.078 0.551 . . . . 73.21 110.603 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.31 112.93 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.804 2.336 . . . . 54.32 111.634 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.501 HG21 HD21 ' B' ' 44' ' ' LEU . 90.9 t -89.77 127.32 42.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.869 0.468 . . . . 62.52 109.829 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -80.41 83.18 6.28 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.739 0.816 . . . . 75.44 109.784 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -63.01 -29.09 70.55 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.615 0.766 . . . . 73.04 111.279 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.9 -53.53 17.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 62.03 110.257 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.63 77.38 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.272 0.629 . . . . 44.14 110.682 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 tt . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 124.249 1.02 . . . . 60.13 110.549 179.481 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.93 0.395 . . . . 65.13 111.838 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 35.6 m -83.83 85.47 7.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 73.35 108.399 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' C' ' 85' ' ' SER . 50.0 t80 -106.44 140.97 38.51 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.413 -1.267 . . . . 74.22 109.443 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 6.0 tp60 -145.68 137.39 25.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.831 0.452 . . . . 73.54 110.477 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.31 110.31 19.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.94 -1.133 . . . . 53.33 107.94 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 86.8 mm-40 -83.99 -49.22 9.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.867 -0.419 . . . . 70.2 109.867 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -169.1 136.8 1.89 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.693 -0.685 . . . . 73.31 109.627 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -117.06 138.93 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.744 -1.206 . . . . 71.35 107.744 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.515 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 20.7 p90 -176.46 144.02 0.51 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.6 0.36 . . . . 74.43 110.822 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -70.48 124.55 24.47 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.408 0.683 . . . . 54.12 110.124 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -77.07 -49.45 15.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.873 -1.158 . . . . 73.51 107.873 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -135.01 142.14 46.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.185 -1.371 . . . . 75.45 110.309 -174.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.2 mt -136.18 143.01 37.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.055 -1.832 . . . . 74.53 106.055 173.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -156.07 150.31 25.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.311 0.577 . . . . 72.41 109.954 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -148.76 138.79 22.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.627 -1.169 . . . . 71.31 108.034 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.1 132.12 35.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.768 -1.197 . . . . 74.13 107.768 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.12 80.93 16.4 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 64.23 107.254 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.83 -38.19 40.61 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.514 2.143 . . . . 73.34 110.996 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 1.1 m-20 -100.1 32.89 2.79 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.382 1.073 . . . . 73.33 109.914 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.75 -43.84 96.0 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.131 1.16 . . . . 72.11 114.131 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.88 -23.68 13.83 Favored 'Trans proline' 0 C--N 1.383 2.36 0 CA-C-N 121.435 1.548 . . . . 42.31 112.834 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 51.1 m80 -65.19 -20.38 66.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.532 0.733 . . . . 73.22 112.852 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' C' ' 34' ' ' LYS . 52.6 t -49.46 -32.07 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.284 1.034 . . . . 54.24 113.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.96 -39.88 96.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.893 0.477 . . . . 72.0 111.695 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.86 15.2 25.74 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.079 0.952 . . . . 75.35 111.261 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.686 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 3.4 ttpm? -108.68 137.02 47.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.873 0.869 . . . . 61.41 109.023 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 131.83 35.24 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.176 -1.046 . . . . 73.1 108.176 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -79.67 72.26 6.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.079 0.552 . . . . 74.2 109.813 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -143.28 48.15 0.92 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 123.79 0.836 . . . . 74.21 110.165 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.11 143.81 18.12 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 121.358 1.372 . . . . 75.23 110.841 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.11 115.21 24.35 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 54.21 108.789 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.99 107.5 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.391 -0.822 . . . . 61.55 110.24 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 7.3 tmtt? -92.45 104.56 16.87 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 106.375 -1.713 . . . . 74.02 106.375 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.403 HD13 ' HG ' ' C' ' 128' ' ' LEU . 13.5 tp -84.0 146.95 27.7 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.73 -1.211 . . . . 75.42 107.73 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.48 143.3 31.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.257 -1.386 . . . . 63.55 107.257 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 153.97 51.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.233 0.54 . . . . 60.33 111.379 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.8 t70 -151.38 153.26 34.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.784 1.234 . . . . 73.05 108.626 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -139.33 141.53 37.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.077 -0.712 . . . . 55.44 109.077 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -128.66 170.09 13.68 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.101 0.96 . . . . 74.52 109.106 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -147.14 144.66 29.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.457 0.703 . . . . 50.23 109.995 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 66.2 p -144.88 126.29 14.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.265 -1.013 . . . . 73.11 108.265 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.88 115.86 19.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' C' ' 57' ' ' GLU . 51.7 mt -89.36 -35.72 15.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.154 0.582 . . . . 75.3 109.635 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.59 -173.84 4.59 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 73.42 110.016 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.65 117.29 8.6 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.378 -0.828 . . . . 70.02 109.775 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 68.58 0.28 2.55 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.603 1.561 . . . . 74.24 112.364 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.72 108.99 24.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.744 -0.836 . . . . 75.23 108.744 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.26 123.53 41.66 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.529 1.132 . . . . 73.42 108.756 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.569 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.7 tt0 -83.34 139.05 33.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.253 -1.017 . . . . 75.55 108.253 169.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 95.6 t -118.93 131.86 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.357 -0.979 . . . . 62.22 108.357 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 60.5 t -110.1 102.5 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.745 -0.835 . . . . 73.21 108.745 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -90.56 109.19 20.34 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.109 -1.071 . . . . 65.3 108.109 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.703 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 65.2 mtt85 -95.75 132.7 40.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.814 0.845 . . . . 53.03 109.526 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.0 t -126.62 131.02 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -125.92 120.45 30.43 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.912 -0.773 . . . . 71.03 108.912 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.431 HG21 HG21 ' C' ' 114' ' ' ILE . 94.4 t -110.27 114.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.145 0.978 . . . . 65.31 108.82 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 16.3 m -98.81 139.16 34.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.868 -1.16 . . . . 52.4 107.868 168.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.98 110.65 7.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.024 -1.843 . . . . 44.31 106.024 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.499 ' HB3' HG23 ' C' ' 72' ' ' THR . 12.5 p -158.16 139.99 13.89 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.641 0.588 . . . . 74.4 110.689 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.0 tp -80.7 -23.85 39.24 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.473 -0.785 . . . . 71.44 109.276 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.04 -97.2 0.11 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 110.056 -1.217 . . . . 71.3 110.056 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -90.46 -31.93 16.6 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.651 -0.87 . . . . 74.1 108.651 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -69.93 84.04 0.49 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.018 -1.105 . . . . 63.53 108.018 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.499 HG23 ' HB3' ' C' ' 67' ' ' SER . 78.7 m -87.89 136.72 32.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.248 -1.342 . . . . 74.35 109.889 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.686 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -72.32 -73.56 0.19 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.92 -1.141 . . . . 55.13 107.92 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.0 167.59 29.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.736 0.779 . . . . 75.13 112.333 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -125.59 138.71 53.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 105.726 -1.953 . . . . 72.35 105.726 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -151.77 113.27 4.36 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 110.011 -0.366 . . . . 44.42 110.011 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -117.06 136.11 53.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.518 0.327 . . . . 74.42 110.129 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' C' ' 110' ' ' ALA . 25.4 t -125.25 114.16 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 55.24 108.673 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -90.26 92.7 9.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.472 -0.936 . . . . 65.4 108.472 171.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -78.16 136.54 37.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.687 -0.688 . . . . 74.24 109.345 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.42 153.04 17.67 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.3 -0.72 . . . . 55.11 111.3 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 121.19 1.08 Allowed Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 111.477 -0.649 . . . . 71.54 111.477 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.461 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.3 mm -81.71 120.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 107.685 -1.228 . . . . 71.32 107.685 174.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -131.83 138.01 48.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.512 0.725 . . . . 62.11 109.962 -174.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 58.9 m -89.89 113.93 25.62 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.552 -0.906 . . . . 64.43 108.552 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.6 100.55 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.96 -1.126 . . . . 71.42 107.96 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -130.74 152.68 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.914 0.886 . . . . 64.3 110.352 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.16 -39.3 2.8 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.02 -0.536 . . . . 73.44 112.209 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.57 160.01 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.256 0.622 . . . . 65.51 109.968 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.03 152.86 34.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.169 0.588 . . . . 75.22 110.551 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.45 -111.91 4.17 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.769 0.668 . . . . 24.43 113.198 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.3 p -73.73 -34.37 64.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.051 0.94 . . . . 54.44 111.693 -175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -70.26 -36.55 74.52 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.694 -0.484 . . . . 72.21 109.694 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.462 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 59.5 ttm -68.23 -36.46 79.53 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.913 -0.585 . . . . 63.3 110.174 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -33.09 74.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.638 0.775 . . . . 71.55 111.024 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -68.34 -35.57 77.96 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.14 0.576 . . . . 73.53 110.845 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 24.9 t -71.87 -62.65 1.34 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.638 0.375 . . . . 72.03 110.633 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.1 pp -75.71 -14.13 60.33 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.309 0.485 . . . . 70.31 112.309 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.31 -18.99 37.04 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.602 -0.555 . . . . 74.12 113.259 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.81 -56.48 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.786 0.793 . . . . 73.53 112.642 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -66.53 -61.15 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.61 0.364 . . . . 64.52 111.862 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 40.6 m -57.05 -45.45 99.95 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 124.08 0.952 . . . . 73.12 113.457 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.79 -25.2 46.12 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.798 1.666 . . . . 71.03 113.493 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.55 -29.16 65.55 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.754 0.422 . . . . 64.51 110.175 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.484 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.4 mm -68.4 -40.07 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.569 0.748 . . . . 61.4 109.939 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.6 mt -78.31 -26.28 46.88 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.99 -1.005 . . . . 74.22 112.307 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.0 -42.08 79.9 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.507 -1.235 . . . . 71.11 114.062 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.17 -43.63 55.56 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.158 1.905 . . . . 63.4 112.904 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -66.35 -41.31 89.73 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.66 0.784 . . . . 64.54 110.785 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.452 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -68.84 -44.8 72.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.665 -0.698 . . . . 43.4 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -50.95 -55.69 16.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.419 1.488 . . . . 62.4 110.995 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.31 -36.82 85.25 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.035 0.834 . . . . 71.22 109.931 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.531 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 12.0 t -66.47 -36.54 83.0 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.444 0.698 . . . . 74.01 111.566 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' C' ' 118' ' ' VAL . 95.1 mt -70.06 -49.51 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.379 0.672 . . . . 74.32 109.917 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -66.37 -30.23 70.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.109 0.564 . . . . 63.24 111.187 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -65.45 -45.87 82.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.113 -0.699 . . . . 65.41 109.113 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.563 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.73 -34.9 75.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.157 0.983 . . . . 54.05 112.404 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.466 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.1 t -62.49 -46.32 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.387 0.675 . . . . 72.35 109.542 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.4 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 29.7 t -67.48 -31.89 72.34 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.149 -0.932 . . . . 53.52 111.669 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.5 mtt-85 -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.376 0.67 . . . . 74.11 109.664 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.35 -4.37 86.86 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.804 0.69 . . . . 73.22 112.811 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.9 p 65.57 32.83 9.02 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.716 2.006 . . . . 63.51 113.085 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -89.09 166.49 21.58 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.587 1.155 . . . . 74.1 110.554 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.506 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 31.3 Cg_endo -63.77 112.93 1.95 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.074 1.849 . . . . 74.0 111.89 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.4 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 84.4 mt-30 -60.99 136.37 58.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.91 0.484 . . . . 74.45 111.023 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -144.6 123.33 12.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.195 -1.039 . . . . 73.33 108.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -103.32 123.73 47.34 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.824 0.45 . . . . 74.34 109.789 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.403 ' HG ' HD13 ' C' ' 42' ' ' LEU . 1.4 tm? -74.24 128.51 35.73 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.16 0.984 . . . . 74.32 109.546 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.5 146.43 98.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.797 0.839 . . . . 70.22 111.374 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.604 ' HG3' HD13 ' A' ' 16' ' ' ILE . 35.5 Cg_endo -61.41 136.09 61.59 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.896 2.397 . . . . 73.23 113.31 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.58 109.83 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.077 -1.082 . . . . 74.44 108.077 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -112.51 93.83 4.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.748 0.819 . . . . 42.2 110.666 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 124.77 1.228 . . . . 73.13 111.615 174.311 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.454 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.3 ptm . . . . . 0 CA--C 1.563 1.452 0 N-CA-C 114.622 1.341 . . . . 31.32 114.622 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 37.8 m -107.88 143.87 35.89 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.445 0.698 . . . . 70.51 109.318 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' D' ' 85' ' ' SER . 63.2 t80 -155.55 106.91 2.56 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.39 -0.967 . . . . 75.23 108.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -129.3 146.34 51.21 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.234 0.614 . . . . 74.23 109.614 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.78 109.82 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.568 -1.271 . . . . 61.4 107.568 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -82.69 -47.66 11.77 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.034 0.208 . . . . 74.24 111.46 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -170.11 129.25 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.58 -0.282 . . . . 74.43 111.175 -167.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.41 133.2 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.272 -1.381 . . . . 54.21 107.272 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -155.47 144.52 20.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.214 0.531 . . . . 63.14 111.551 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -79.31 115.03 18.71 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.441 -0.8 . . . . 61.35 109.193 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.2 mtpt -81.1 -24.5 37.67 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.957 -0.386 . . . . 73.11 109.957 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.737 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.9 t70 -153.99 141.59 19.88 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.027 -0.988 . . . . 61.11 109.724 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.563 HG21 ' HE2' ' C' ' 117' ' ' MET . 86.3 mt -139.65 149.55 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.216 1.406 . . . . 73.41 107.689 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -153.04 144.91 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.584 1.154 . . . . 74.43 108.404 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 85.4 t80 -152.29 115.3 4.65 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 105.928 -1.879 . . . . 72.25 105.928 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.1 mt-10 -127.23 111.41 13.92 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.7 0.4 . . . . 60.02 110.008 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 90.52 4.72 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.809 -1.182 . . . . 71.41 107.809 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.32 -40.56 1.57 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.663 2.242 . . . . 72.0 113.082 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' D' ' 30' ' ' HIS . 6.0 p-10 -113.56 43.96 1.68 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.321 1.048 . . . . 74.54 108.927 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.515 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.36 -49.23 86.43 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 115.786 1.773 . . . . 75.14 115.786 -169.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 -15.99 13.34 Favored 'Trans proline' 0 C--N 1.388 2.654 0 CA-C-N 122.102 1.786 . . . . 53.44 113.381 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.482 ' HB3' ' HB2' ' D' ' 27' ' ' ASN . 7.1 t-160 -77.08 -46.53 23.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.136 0.974 . . . . 73.01 111.199 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 14.2 p -70.59 -22.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-O 120.968 0.413 . . . . 74.15 110.989 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.17 -33.24 74.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.688 0.795 . . . . 72.45 111.051 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -72.78 -15.37 61.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.703 0.801 . . . . 65.04 111.156 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.5 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 89.7 mttt -93.0 106.82 18.72 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.227 -0.657 . . . . 73.43 109.227 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.41 89.63 7.07 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.285 -0.635 . . . . 71.2 109.285 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.516 ' HB3' HD21 ' D' ' 68' ' ' LEU . 6.3 t-105 -169.99 158.87 7.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 108.487 -0.931 . . . . 74.31 108.487 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -86.94 114.48 58.48 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.037 0.535 . . . . 64.22 110.458 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.79 140.58 86.5 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 123.407 2.738 . . . . 74.15 114.217 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.02 126.16 28.95 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.953 0.901 . . . . 55.05 109.863 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.49 HG13 HG13 ' D' ' 64' ' ' VAL . 47.9 t -99.58 112.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 72.13 110.258 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 1.4 tmtp? -88.09 122.14 31.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.028 -1.471 . . . . 70.22 107.028 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.08 115.4 27.43 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.773 -1.195 . . . . 50.11 107.773 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.643 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.7 m-20 -108.27 136.81 47.3 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.97 -1.122 . . . . 75.52 107.97 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.93 133.33 37.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.083 0.553 . . . . 52.33 109.922 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.8 t70 -142.06 157.25 45.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 73.43 108.198 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -132.29 158.13 42.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.833 0.853 . . . . 71.45 109.5 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.68 170.04 21.23 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.957 -0.757 . . . . 64.1 108.957 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 m -150.68 159.56 44.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.973 0.509 . . . . 75.14 109.965 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' D' ' 57' ' ' GLU . 40.3 t -152.06 127.07 9.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.479 -0.934 . . . . 55.24 108.479 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.53 117.8 24.65 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.44 -0.948 . . . . 63.14 108.44 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.2 mt -98.09 -29.73 13.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.171 0.588 . . . . 72.24 110.165 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -161.02 -179.03 7.19 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.033 0.933 . . . . 72.42 109.972 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -68.15 118.66 11.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.006 -0.997 . . . . 75.42 108.819 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 67.53 16.91 9.99 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.131 0.972 . . . . 74.33 112.032 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 76.8 t -127.33 117.12 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.449 -0.945 . . . . 74.3 108.449 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -135.2 129.31 33.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.785 -0.643 . . . . 74.31 109.787 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.3 tt0 -87.15 148.16 25.32 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.604 1.162 . . . . 73.14 108.394 167.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.498 HG13 HD11 ' D' ' 106' ' ' LEU . 4.1 p -134.5 138.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.734 -1.21 . . . . 75.22 107.734 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 94.7 t -108.84 136.85 43.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.072 -0.714 . . . . 64.23 109.072 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.56 116.99 29.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.024 -1.473 . . . . 72.31 107.024 174.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -97.46 98.21 9.75 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.36 -0.978 . . . . 54.41 108.36 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.1 116.64 39.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.282 -1.007 . . . . 71.24 108.282 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 33.3 m -125.46 132.51 52.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.04 -0.982 . . . . 73.44 109.04 -171.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.596 HG11 HD11 ' D' ' 126' ' ' LEU . 56.6 t -122.59 102.82 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.085 0.954 . . . . 55.31 109.059 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 25.3 m -95.81 91.95 6.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.98 -1.119 . . . . 74.42 107.98 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.51 139.61 31.53 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.598 -0.89 . . . . 75.11 108.598 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.8 p -151.99 135.43 16.05 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.625 0.578 . . . . 71.1 110.34 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' D' ' 36' ' ' TRP . 12.6 tp -112.78 106.09 14.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.714 -0.676 . . . . 74.03 109.318 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.94 -133.12 11.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.755 -0.657 . . . . 75.01 112.201 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 3.78 41.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.584 0.753 . . . . 72.03 111.617 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.5 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 9.5 tp10 -138.46 149.22 45.22 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.729 0.812 . . . . 65.33 109.17 -165.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -56.77 152.85 11.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.405 1.082 . . . . 75.43 111.206 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -107.26 -62.29 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.463 -0.94 . . . . 65.23 108.463 171.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.1 149.37 24.52 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.075 -0.966 . . . . 74.43 109.151 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.8 mt -112.03 151.19 29.62 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.982 -1.118 . . . . 72.04 107.982 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.509 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.7 t -158.42 146.77 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.401 0.438 . . . . 72.11 109.987 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.65 132.28 10.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.587 0.755 . . . . 74.01 109.062 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.5 113.2 22.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.425 -0.954 . . . . 72.14 108.425 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -89.45 81.79 6.53 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.038 -1.097 . . . . 63.3 108.038 171.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.427 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.9 tp-100 -79.7 99.75 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 112.914 -1.948 . . . . 75.51 109.216 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.24 161.66 31.64 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.91 -0.476 . . . . 35.21 111.91 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -164.86 136.23 4.11 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.626 -0.59 . . . . 63.11 111.626 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.96 137.08 22.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.591 0.756 . . . . 72.42 110.074 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.95 132.69 38.71 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.848 0.859 . . . . 54.42 109.533 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 5.7 m -75.52 95.89 3.4 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.352 -0.981 . . . . 74.5 108.352 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 53.4 mt -105.94 99.36 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.451 -0.944 . . . . 64.14 108.451 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -126.88 153.19 46.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.677 1.191 . . . . 74.04 108.778 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.06 -7.9 62.05 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.753 -0.471 . . . . 70.13 113.454 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.559 HD12 ' HG2' ' D' ' 93' ' ' GLN . 5.5 mm -137.97 129.27 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.938 0.895 . . . . 72.45 110.671 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.607 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 3.0 pp20? -148.36 -173.83 4.43 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.655 0.782 . . . . 73.13 110.232 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.42 -140.52 25.46 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.014 -0.326 . . . . 52.13 113.137 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -69.99 -25.11 63.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.202 0.601 . . . . 51.22 110.851 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.559 ' HG2' HD12 ' D' ' 89' ' ' ILE . 6.2 tp-100 -72.74 -32.07 65.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.278 0.631 . . . . 51.11 110.355 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.607 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 21.1 ttt -71.34 -42.41 68.56 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.826 -0.435 . . . . 73.22 109.826 171.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -27.62 69.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.863 0.465 . . . . 65.44 111.036 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.78 -52.76 8.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.676 0.79 . . . . 64.1 110.733 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.29 -51.64 62.51 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.944 0.402 . . . . 63.03 110.963 -172.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 22.5 tp -75.81 -19.3 59.06 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 73.05 110.929 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.41 -5.51 36.93 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.516 -0.602 . . . . 54.32 114.287 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.31 -61.9 0.72 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.941 0.871 . . . . 51.43 111.408 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.83 -47.32 54.0 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.444 0.465 . . . . 74.33 112.027 -171.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HG ' ' HZ ' ' D' ' 11' ' ' PHE . 59.8 m -64.75 -44.78 74.38 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 123.491 0.716 . . . . 63.34 111.722 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.499 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.9 Cg_exo -57.16 -34.89 98.6 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 122.513 2.142 . . . . 65.55 113.871 166.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.75 -34.43 78.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.082 0.553 . . . . 60.05 110.73 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.37 -33.43 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.796 . . . . 63.2 110.561 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.498 HD11 HG13 ' D' ' 58' ' ' VAL . 91.3 mt -79.38 -20.66 47.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.819 0.848 . . . . 63.24 112.603 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.05 -42.84 64.36 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 113.968 1.099 . . . . 73.1 113.968 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.81 -39.83 87.91 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.054 1.836 . . . . 70.34 113.281 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.67 -36.39 65.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.596 0.758 . . . . 72.34 111.38 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -51.07 70.07 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.297 0.639 . . . . 45.32 110.121 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.0 -48.09 79.28 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.777 1.298 . . . . 75.21 110.589 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.0 -43.16 99.29 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.364 1.04 . . . . 73.44 111.736 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.55 -41.62 97.64 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.553 0.533 . . . . 75.41 110.767 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.509 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.3 mt -67.7 -43.47 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.556 -0.747 . . . . 73.22 110.716 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.4 m -55.63 -46.37 77.41 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.996 0.918 . . . . 70.13 110.66 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.5 t -64.82 -46.93 79.87 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 114.026 -1.443 . . . . 44.54 110.578 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -64.49 -36.5 84.38 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.007 0.523 . . . . 65.21 112.089 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' D' ' 123' ' ' PHE . 45.3 t -67.18 -40.95 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.215 -0.902 . . . . 51.15 110.661 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -75.17 -23.53 57.74 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.416 0.287 . . . . 73.45 111.408 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.531 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 89.2 mtt-85 -74.56 -38.17 62.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.499 0.72 . . . . 73.34 109.723 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.42 1.55 76.11 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.541 -0.754 . . . . 33.45 112.391 173.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 60.13 23.51 12.78 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.852 2.061 . . . . 71.24 113.146 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.445 ' HB2' HG13 ' D' ' 118' ' ' VAL . 78.7 m-85 -80.6 161.16 65.22 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 124.862 1.265 . . . . 51.04 109.114 169.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.21 135.42 43.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.355 2.037 . . . . 73.24 112.234 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -48.45 130.92 17.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.048 1.339 . . . . 74.33 112.562 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.596 HD11 HG11 ' D' ' 64' ' ' VAL . 9.6 tt -108.71 112.49 24.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.618 0.767 . . . . 50.3 109.553 -171.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -124.74 92.71 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.388 0.675 . . . . 75.21 109.683 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 69.4 mt -68.53 132.68 47.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.124 0.569 . . . . 72.55 110.238 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.47 139.89 94.61 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.41 0.684 . . . . 64.55 111.234 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.94 127.66 20.99 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.828 2.352 . . . . 73.31 112.529 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.61 111.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.015 0.926 . . . . 71.03 109.849 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -84.73 101.81 12.51 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.656 -0.498 . . . . 71.13 109.656 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 N--CA 1.479 0.981 0 C-N-CA 123.43 0.692 . . . . 72.23 111.256 -175.861 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.47 -0.567 . . . . 61.12 109.47 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -139.09 114.47 9.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.298 -1.001 . . . . 74.42 108.298 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 96.5 mt-30 -133.66 122.35 23.31 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.216 -0.661 . . . . 72.34 109.216 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -82.27 88.93 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 108.722 -0.844 . . . . 72.24 108.722 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -77.28 -41.22 41.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.119 -0.491 . . . . 74.22 111.882 -165.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -153.94 137.27 15.77 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.209 1.003 . . . . 73.55 108.293 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.657 HD13 ' HG3' ' C' ' 130' ' ' PRO . 4.4 mp -130.6 119.19 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 106.927 -1.509 . . . . 73.04 106.927 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -152.93 174.68 13.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.456 0.702 . . . . 74.31 111.521 -172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -97.73 117.15 31.39 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.757 -0.831 . . . . 53.22 108.757 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 39.7 mtpt -80.73 -22.67 40.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.582 -0.281 . . . . 63.45 110.315 174.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 16.3 t70 -157.82 147.02 19.67 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.031 0.832 . . . . 74.02 109.637 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 94.7 mt -143.99 138.9 24.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 125.536 1.534 . . . . 43.15 106.944 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.2 t -153.64 108.39 3.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.955 0.502 . . . . 73.45 109.888 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.602 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 57.2 t80 -109.11 131.51 55.0 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 106.343 -1.725 . . . . 74.45 106.343 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -124.97 141.45 52.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.71 72.72 9.71 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.834 -1.173 . . . . 43.53 107.834 170.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.05 -25.46 19.37 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.433 2.089 . . . . 61.21 111.063 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -104.61 26.15 9.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.895 0.878 . . . . 50.02 110.602 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.73 -49.0 93.93 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 123.359 0.664 . . . . 61.14 112.788 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.3 Cg_exo -70.02 -23.09 30.02 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 121.779 1.653 . . . . 75.15 112.236 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.1 m80 -74.33 -21.07 59.88 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.617 -0.719 . . . . 75.31 111.271 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HE2' ' A' ' 123' ' ' PHE . 84.2 t -53.62 -25.8 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.625 0.602 . . . . 63.43 112.625 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -67.67 -40.85 84.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.313 0.645 . . . . 65.32 111.487 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.99 -14.01 34.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.415 0.686 . . . . 71.24 111.305 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? -75.27 146.09 41.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.808 0.443 . . . . 73.42 111.484 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -73.25 118.46 16.23 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.296 -1.001 . . . . 72.12 108.296 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -79.18 86.06 5.01 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.918 0.487 . . . . 72.32 111.039 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 35.1 tt0 -139.95 71.12 35.55 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.127 -1.064 . . . . 61.02 108.127 170.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -80.68 117.49 3.35 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.717 2.278 . . . . 44.42 112.073 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.72 110.72 22.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.166 -1.05 . . . . 71.42 108.166 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -82.69 92.7 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 122.498 1.142 . . . . 73.43 109.528 175.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -94.49 130.52 40.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.293 -1.322 . . . . 74.11 108.567 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.464 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.7 pt? -124.64 151.3 45.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.798 0.439 . . . . 60.44 111.378 -170.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -128.97 127.87 42.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.775 1.23 . . . . 71.33 108.483 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.22 133.86 55.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.106 0.562 . . . . 64.41 109.821 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 15.7 t70 -146.64 150.16 34.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.712 0.805 . . . . 75.25 109.666 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.0 m -142.02 127.22 18.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.887 0.875 . . . . 73.44 109.843 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -142.78 146.17 33.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.525 0.73 . . . . 63.32 109.767 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -105.7 169.98 8.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.618 0.767 . . . . 75.21 111.239 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -154.94 120.46 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.989 0.916 . . . . 35.51 108.829 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -77.81 114.57 16.8 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.964 -0.384 . . . . 62.04 109.964 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.6 mt -85.65 -40.71 15.89 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.605 0.762 . . . . 62.42 109.986 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.56 -174.62 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.333 -0.849 . . . . 75.4 110.144 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.3 117.26 6.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.31 -0.626 . . . . 74.11 109.31 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 71.96 2.53 4.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.934 1.293 . . . . 73.12 112.34 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -107.7 112.6 40.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.236 -1.024 . . . . 71.4 108.236 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.94 123.36 28.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.223 -0.658 . . . . 44.43 109.223 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.4 tt0 -88.28 140.9 29.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.856 0.862 . . . . 60.14 108.921 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.38 123.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.844 -1.169 . . . . 45.51 107.844 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.567 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 33.5 t -103.57 148.8 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.784 0.834 . . . . 54.12 109.82 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.68 117.6 26.14 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.407 -0.961 . . . . 73.3 108.407 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 1.7 mpp_? -88.93 106.87 18.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.38 -0.97 . . . . 71.12 108.38 171.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG21 ' HB1' ' A' ' 110' ' ' ALA . 7.7 t -111.17 114.11 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.144 -1.058 . . . . 65.42 108.144 169.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 27.5 m -110.41 130.55 55.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.095 -1.076 . . . . 71.02 108.095 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.16 108.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.105 -1.072 . . . . 63.04 108.105 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 16.1 m -110.67 133.86 52.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.908 -0.405 . . . . 73.43 109.908 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.47 105.31 15.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.097 -1.075 . . . . 52.44 108.097 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.8 m -118.06 127.16 53.53 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.155 0.582 . . . . 72.0 110.277 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.8 OUTLIER -88.99 85.71 6.77 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.862 0.839 . . . . 73.51 109.05 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.34 -88.97 1.3 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.301 -0.863 . . . . 70.41 111.049 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 -28.75 4.65 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.431 0.692 . . . . 75.52 110.804 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -79.04 134.15 36.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 72.22 109.657 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.3 m -85.88 121.37 28.43 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.099 0.408 . . . . 71.44 110.591 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.65 -58.16 7.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.52 0.728 . . . . 42.23 109.645 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -164.27 162.18 22.34 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.434 -1.257 . . . . 73.42 110.564 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.2 tp -117.54 147.72 42.54 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.452 1.101 . . . . 72.13 109.776 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.51 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 61.9 m -140.85 100.15 3.77 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.206 1.002 . . . . 72.34 109.482 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.99 126.56 44.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.132 0.973 . . . . 74.41 109.176 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -136.69 138.78 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.389 0.676 . . . . 51.42 109.764 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -105.52 96.84 6.79 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.577 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -84.56 98.94 10.43 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.109 -0.701 . . . . 71.11 109.109 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -112.39 144.96 17.96 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.606 -0.598 . . . . 71.04 111.606 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.87 146.79 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.374 -0.29 . . . . 64.02 112.374 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.69 128.06 39.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 108.692 -0.855 . . . . 45.24 108.692 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -128.92 118.16 22.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.323 -0.621 . . . . 73.05 109.323 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 20.5 m -83.54 87.04 7.01 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.471 -0.937 . . . . 74.21 108.471 176.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.96 138.49 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.849 0.859 . . . . 74.2 110.023 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.07 161.28 12.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.931 0.893 . . . . 64.31 110.881 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 4.24 85.24 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.738 -0.665 . . . . 54.52 114.665 172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.51 ' HB ' ' HE2' ' A' ' 94' ' ' MET . 46.2 mt -119.52 136.48 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.019 -1.104 . . . . 63.34 108.019 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.97 174.69 10.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.175 0.59 . . . . 74.23 109.812 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -144.75 49.24 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.239 -0.891 . . . . 73.43 113.579 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.623 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 41.2 p -71.21 -15.07 62.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.322 1.049 . . . . 73.45 112.318 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -63.56 -50.9 67.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.286 0.634 . . . . 71.42 110.424 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.558 ' SD ' ' HG ' ' A' ' 98' ' ' LEU . 56.1 tpp -83.14 -29.03 28.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.887 0.475 . . . . 70.32 111.054 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -62.21 -28.1 69.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 63.1 110.83 172.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -68.81 -54.68 14.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.862 -1.063 . . . . 72.15 109.78 166.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 4.2 m -64.46 -56.87 11.34 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.593 1.331 . . . . 73.5 114.593 -166.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.558 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 77.9 mt -69.71 -15.86 63.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.635 0.652 . . . . 71.4 112.3 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.55 -0.27 43.15 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.703 -0.498 . . . . 31.5 113.903 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.59 -65.91 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.049 0.54 . . . . 43.12 111.358 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.7 t80 -51.65 -52.95 43.86 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.779 1.232 . . . . 70.23 112.818 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -73.24 -48.48 7.41 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.309 -0.853 . . . . 72.12 112.644 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.54 -20.21 69.99 Favored 'Trans proline' 0 C--N 1.383 2.351 0 CA-C-N 121.153 1.448 . . . . 70.31 113.337 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.24 -41.84 80.58 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.452 0.701 . . . . 74.31 110.407 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.91 -37.35 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.432 0.693 . . . . 53.21 110.452 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.69 -26.36 34.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.357 -0.838 . . . . 72.11 112.133 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -62.56 -44.34 86.79 Favored Pre-proline 0 CA--C 1.566 1.568 0 N-CA-C 114.896 1.443 . . . . 74.2 114.896 -169.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 -39.48 43.55 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.884 1.723 . . . . 73.34 112.306 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -73.69 -31.32 63.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.416 0.687 . . . . 75.0 111.369 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.403 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.51 -51.77 61.23 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.327 0.651 . . . . 33.42 109.342 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.483 HH12 HD12 ' C' ' 105' ' ' ILE . 39.2 ttm180 -52.43 -51.5 58.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.477 -1.238 . . . . 72.42 110.966 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.19 -46.84 85.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.589 -0.732 . . . . 74.2 111.62 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.468 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.8 t -57.95 -38.92 76.86 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.599 0.562 . . . . 72.53 111.335 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 76' ' ' CYS . 95.9 mt -67.65 -52.65 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.231 1.012 . . . . 64.54 110.796 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.474 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -60.89 -34.0 73.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.495 1.118 . . . . 52.54 111.673 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -69.48 -39.97 77.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.585 -0.734 . . . . 73.25 109.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.8 mtm -63.51 -38.66 91.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.627 0.371 . . . . 74.24 110.781 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 76' ' ' CYS . 81.3 t -59.66 -49.65 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.829 0.851 . . . . 63.32 110.622 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.0 p -71.07 -34.09 70.84 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.022 -0.535 . . . . 73.21 111.638 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -68.8 -30.73 69.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.508 0.723 . . . . 64.14 109.873 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.66 -1.12 90.06 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.595 -0.729 . . . . 62.23 112.777 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m 65.33 46.45 2.6 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 122.831 1.3 . . . . 64.3 110.194 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG21 ' A' ' 31' ' ' VAL . 59.6 m-85 -121.16 149.67 52.06 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.29 -1.323 . . . . 74.3 109.095 173.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.99 140.1 91.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.395 2.063 . . . . 62.52 111.41 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.474 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -51.14 134.97 26.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.669 1.188 . . . . 70.13 113.315 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.412 HD22 HG11 ' A' ' 40' ' ' VAL . 86.8 mt -121.11 100.98 7.37 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.081 0.952 . . . . 73.02 108.762 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -117.29 105.02 11.74 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 55.24 109.542 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.26 150.72 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 64.32 109.509 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.82 93.23 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.62 0.768 . . . . 53.41 111.608 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.23 115.47 3.34 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.075 1.85 . . . . 64.34 110.74 170.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.64 113.07 32.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.806 -1.183 . . . . 64.31 107.806 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -82.71 72.89 9.78 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.5 1.143 . . . . 72.2 108.221 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -70.59 -20.91 62.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 113.522 -1.672 . . . . 74.22 109.647 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.529 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.4 t70 . . . . . 0 C--N 1.347 0.464 0 C-N-CA 124.184 0.994 . . . . 71.24 109.922 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.535 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.0 ptm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 113.036 0.754 . . . . 75.44 113.036 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.5 t -165.22 142.84 6.0 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 108.068 -1.086 . . . . 70.03 108.068 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -139.51 134.41 32.2 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.808 -0.812 . . . . 74.32 108.808 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -149.37 143.78 25.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.126 0.57 . . . . 60.25 110.195 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.87 122.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.623 -1.251 . . . . 72.23 107.623 170.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -85.82 -42.84 13.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.514 -0.55 . . . . 74.22 109.514 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -166.25 134.35 2.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.159 -0.473 . . . . 75.23 109.894 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.9 134.53 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 107.149 -1.426 . . . . 71.4 107.149 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -162.4 154.48 18.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.659 0.742 . . . . 73.4 112.093 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -80.51 127.3 32.27 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.421 -1.263 . . . . 61.32 108.676 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -97.31 -32.36 11.93 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.999 0.919 . . . . 33.21 110.884 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -160.07 143.47 13.96 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.176 0.297 . . . . 54.3 110.562 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.484 HD12 HG22 ' B' ' 78' ' ' VAL . 48.3 mm -136.68 138.0 46.83 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 C-N-CA 125.038 1.335 . . . . 75.45 108.616 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.0 t -134.7 139.5 45.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.103 -1.443 . . . . 74.43 107.103 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.1 t80 -153.33 112.57 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.322 -1.733 . . . . 72.54 106.322 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.41 112.8 17.35 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.146 -0.687 . . . . 61.2 109.146 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.51 83.17 1.88 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.293 -1.003 . . . . 52.2 108.293 174.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.67 -12.19 15.19 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.698 2.265 . . . . 71.05 112.079 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.424 ' O ' HG23 ' B' ' 31' ' ' VAL . 75.2 m-20 -125.57 24.19 7.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.973 0.909 . . . . 75.55 109.436 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.466 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.33 -52.55 35.09 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.351 1.241 . . . . 73.04 114.351 -174.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.74 -10.77 20.12 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.089 1.86 . . . . 71.54 113.625 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -94.16 -25.56 17.06 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.731 0.813 . . . . 73.15 111.075 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 27' ' ' ASN . 88.7 t -75.31 -19.16 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.838 0.855 . . . . 55.42 110.43 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -51.91 -42.25 62.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.632 1.173 . . . . 74.04 112.423 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -81.84 -12.71 58.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.265 0.626 . . . . 74.44 112.016 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.02 100.48 11.81 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.74 0.816 . . . . 63.22 110.843 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.05 78.1 7.5 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.658 0.783 . . . . 74.54 110.621 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.698 ' HB2' HD21 ' B' ' 68' ' ' LEU . 14.8 m-90 -150.41 161.55 42.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.236 1.015 . . . . 75.03 108.635 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.75 112.15 22.7 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.293 -1.002 . . . . 73.44 108.293 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 31.3 Cg_endo -62.36 117.99 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.637 2.225 . . . . 73.01 111.313 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.0 115.48 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.853 0.721 . . . . 73.43 110.816 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.529 HG21 HD21 ' B' ' 126' ' ' LEU . 27.5 m -97.49 136.75 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.849 0.833 . . . . 73.14 112.236 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -114.09 114.06 25.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.999 1.32 . . . . 64.44 108.036 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.419 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -115.66 140.5 49.13 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.469 -0.567 . . . . 53.33 109.469 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.87 147.14 52.46 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.684 0.794 . . . . 64.43 110.175 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -99.24 131.73 45.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.825 -1.079 . . . . 64.41 108.32 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 16.1 t70 -126.13 140.83 52.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.993 -1.114 . . . . 73.21 107.993 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -121.36 143.74 49.04 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.244 0.545 . . . . 75.01 110.422 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.81 157.9 43.65 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.502 1.121 . . . . 71.44 108.084 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -142.4 168.04 20.67 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.584 0.707 . . . . 42.22 109.676 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' B' ' 57' ' ' GLU . 41.4 t -150.94 157.36 42.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.207 -1.36 . . . . 74.0 107.352 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -121.0 115.86 23.98 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.34 -0.615 . . . . 75.52 109.34 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 68.8 mt -90.02 -35.46 15.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.402 0.681 . . . . 75.11 109.494 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 177.29 11.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 72.44 110.212 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.46 125.19 23.38 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.85 0.03 3.19 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.904 1.282 . . . . 71.33 112.826 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -112.62 96.11 4.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.716 0.806 . . . . 72.33 108.951 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.41 ' CD1' HD11 ' B' ' 86' ' ' ILE . 18.5 m-85 -111.24 139.57 46.53 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.505 0.669 . . . . 73.4 110.359 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' B' ' 49' ' ' SER . 7.1 tm-20 -103.59 97.09 7.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.165 -1.42 . . . . 72.43 107.165 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 121.69 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.604 0.761 . . . . 75.54 109.419 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.9 t -102.44 135.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.438 0.695 . . . . 64.25 109.916 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 117.83 31.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.35 -1.722 . . . . 71.12 106.35 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.6 ttp180 -112.43 113.54 25.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.871 0.367 . . . . 73.34 110.057 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.23 106.32 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.533 -1.284 . . . . 60.23 107.533 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -99.22 123.94 43.9 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.663 HG21 HG21 ' B' ' 114' ' ' ILE . 63.4 t -114.15 129.54 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.945 -1.025 . . . . 73.13 109.222 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -119.28 143.33 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.468 -1.308 . . . . 74.24 107.468 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -133.62 140.02 46.86 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.46 -0.571 . . . . 63.32 109.46 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 44.4 p -135.95 128.82 31.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.857 . . . . 73.41 108.899 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' B' ' 36' ' ' TRP . 2.4 tt -117.54 120.72 38.94 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.455 -1.313 . . . . 74.35 107.455 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -110.8 3.11 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.896 0.747 . . . . 64.5 111.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.39 3.13 13.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.141 0.976 . . . . 73.15 111.411 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.12 168.54 19.41 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.268 0.627 . . . . 74.2 111.441 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.0 m -67.06 120.87 14.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.062 -0.972 . . . . 74.12 110.481 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -75.49 -53.38 8.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.307 0.643 . . . . 74.14 109.508 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.98 170.84 16.08 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.369 -1.287 . . . . 73.34 109.735 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.88 154.25 45.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.889 1.275 . . . . 75.53 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -157.59 154.2 28.09 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.5 tt0 -164.56 130.59 2.89 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.573 -0.899 . . . . 72.12 108.573 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.484 HG22 HD12 ' B' ' 21' ' ' ILE . 94.5 t -125.62 142.34 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 109.136 -0.69 . . . . 71.22 109.136 173.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 48.9 mt-30 -117.39 99.67 7.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.609 -1.256 . . . . 75.35 107.609 169.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 47.1 tp60 -91.44 100.2 13.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.169 -1.049 . . . . 74.12 108.169 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -97.38 143.41 16.71 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.86 -0.896 . . . . 75.44 110.86 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.92 127.26 3.35 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 110.969 -0.852 . . . . 71.1 110.969 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.16 131.22 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.96 -1.126 . . . . 74.42 107.96 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -135.19 142.62 46.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.664 0.785 . . . . 64.44 110.703 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -90.68 105.77 18.05 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.349 -0.982 . . . . 63.13 108.349 169.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' B' ' 56' ' ' TYR . 1.6 pp -117.58 108.65 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.547 0.739 . . . . 41.32 110.19 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.94 44.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.581 0.752 . . . . 50.32 110.6 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 103.2 -71.3 0.29 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.835 -0.62 . . . . 74.32 112.3 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -73.6 158.35 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.691 0.396 . . . . 62.44 110.444 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 -176.32 5.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.478 0.711 . . . . 73.23 110.131 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.2 -131.52 50.0 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.584 0.552 . . . . 64.15 113.019 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.8 m -67.55 -24.27 65.51 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.593 0.757 . . . . 54.44 111.456 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.71 -37.15 65.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.312 0.645 . . . . 74.31 110.957 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 56.3 tpp -73.93 -31.5 63.08 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.77 -0.456 . . . . 71.32 109.77 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.22 83.08 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.748 -0.66 . . . . 63.21 111.049 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.46 -36.45 60.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.5 0.72 . . . . 73.32 110.35 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.82 -59.01 5.09 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 72.54 111.021 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.88 -18.72 59.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 73.24 110.949 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.05 1.2 67.46 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-O 119.672 -0.516 . . . . 54.34 114.184 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -153.69 -60.05 0.13 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.775 0.787 . . . . 60.11 112.518 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -65.91 -45.56 81.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.92 0.888 . . . . 73.42 111.335 -171.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 64.4 m -68.45 -49.88 29.47 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 115.442 -0.799 . . . . 53.5 112.187 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.39 -22.41 52.47 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.634 1.556 . . . . 54.3 113.799 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.38 -37.64 86.52 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.259 0.552 . . . . 70.04 110.859 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.93 -40.71 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 71.2 110.871 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 55.6 mt -80.98 -18.65 46.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.289 -0.869 . . . . 71.22 111.915 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.55 -48.03 96.48 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.571 1.323 . . . . 65.52 114.571 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.49 -31.66 80.41 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 121.596 1.531 . . . . 70.43 112.985 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.9 m-85 -68.26 -46.93 69.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.483 0.713 . . . . 65.43 110.817 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -57.64 -43.66 85.02 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.42 -0.809 . . . . 74.32 110.071 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 20.7 mtp-105 -51.26 -64.32 0.85 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.224 1.01 . . . . 72.55 111.434 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.54 -28.99 69.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.625 0.77 . . . . 64.21 110.842 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -71.48 -44.91 63.86 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.829 0.451 . . . . 45.13 110.574 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.663 HG21 HG21 ' B' ' 64' ' ' VAL . 57.0 mt -62.94 -51.26 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.61 0.764 . . . . 64.51 109.979 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.52 -37.7 79.02 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.944 -1.026 . . . . 72.41 111.041 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.7 t -60.65 -52.23 66.03 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.581 -0.736 . . . . 65.1 110.063 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.0 mmt -63.75 -38.84 92.61 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.174 0.589 . . . . 71.43 111.151 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 114' ' ' ILE . 83.2 t -60.6 -45.44 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.537 0.735 . . . . 72.32 110.739 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -69.5 -27.81 65.51 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.265 -0.88 . . . . 74.12 112.019 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.468 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 90.7 mtt-85 -68.9 -34.41 75.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.488 0.715 . . . . 70.3 110.222 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.2 7.72 55.28 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.823 0.702 . . . . 72.35 112.842 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p 55.78 32.01 18.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.111 1.764 . . . . 51.2 112.078 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -93.57 157.55 38.24 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.978 0.911 . . . . 71.15 109.985 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -47.73 147.4 7.08 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.82 3.013 . . . . 64.43 114.287 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.26 129.75 42.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.583 0.753 . . . . 73.43 109.721 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.529 HD21 HG21 ' B' ' 40' ' ' VAL . 2.2 tm? -126.09 111.18 14.37 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.407 -0.59 . . . . 65.13 109.407 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -111.02 134.81 52.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.267 1.027 . . . . 64.22 109.374 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.599 HD11 HD12 ' B' ' 114' ' ' ILE . 36.9 mt -87.46 134.77 33.55 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 109.296 -0.631 . . . . 73.25 109.296 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.41 148.52 85.95 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.17 0.588 . . . . 72.05 110.087 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 99.82 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.914 2.41 . . . . 62.11 112.518 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -90.38 110.46 22.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.883 -1.154 . . . . 74.32 107.883 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -69.6 101.79 1.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.067 -0.716 . . . . 65.53 109.067 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.417 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 48.6 m-85 -56.65 -33.93 66.81 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.503 1.121 . . . . 72.4 110.112 176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.64 -63.76 1.04 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.017 -1.447 . . . . 74.42 111.247 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.42 68.59 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.446 0.699 . . . . 52.32 111.708 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 123.912 0.885 . . . . 72.34 109.759 177.018 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 113.509 0.929 . . . . 74.05 113.509 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -99.0 111.5 23.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.903 0.881 . . . . 73.13 108.832 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.641 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 58.3 t80 -119.03 130.72 55.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.395 -0.965 . . . . 71.41 108.395 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -144.79 133.54 22.31 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.619 0.367 . . . . 73.13 110.218 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.436 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.7 tp -83.96 134.38 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.389 0.676 . . . . 62.33 109.309 171.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.446 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.0 mm-40 -101.99 -47.28 4.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.654 0.782 . . . . 74.01 109.556 176.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -168.95 138.85 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.959 0.503 . . . . 72.32 110.899 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 60.9 mt -111.01 148.03 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.55 1.14 . . . . 71.5 108.131 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -177.23 164.23 2.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.289 0.636 . . . . 74.13 110.692 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -84.57 119.08 24.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.649 -0.871 . . . . 62.42 108.649 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.537 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 25.1 mmtp -73.0 -48.2 38.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.446 -0.946 . . . . 64.11 108.446 168.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.0 t70 -136.92 144.08 43.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.22 -1.355 . . . . 73.0 110.093 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.4 mt -139.53 142.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.023 -1.473 . . . . 71.11 107.023 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -156.01 149.52 24.81 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.046 0.45 . . . . 65.2 110.453 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.88 108.51 3.48 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.815 -1.18 . . . . 75.44 107.815 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -117.41 110.82 18.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.234 -0.654 . . . . 64.15 109.234 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -112.91 93.85 26.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.664 -0.865 . . . . 54.23 108.664 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.67 -35.13 48.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.879 2.386 . . . . 73.15 112.118 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -108.41 36.91 2.65 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.361 -0.836 . . . . 75.45 109.379 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' C' ' 25' ' ' ALA . . . -58.85 -45.98 99.57 Favored Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.305 1.224 . . . . 70.32 114.305 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.51 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 24.1 Cg_exo -68.79 -37.3 12.07 Favored 'Trans proline' 0 C--N 1.389 2.699 0 CA-C-N 121.305 1.502 . . . . 75.12 112.678 171.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -66.84 -18.31 65.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.071 0.948 . . . . 72.52 112.771 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 12.1 p -41.72 -38.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 115.397 1.628 . . . . 70.45 115.397 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.4 -31.0 71.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.226 0.536 . . . . 74.22 111.625 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.31 15.4 22.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.086 0.954 . . . . 75.21 111.953 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 0.1 OUTLIER -89.96 174.96 7.38 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.326 0.512 . . . . 72.15 110.06 178.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.425 ' HB3' HD22 ' C' ' 68' ' ' LEU . 24.6 t0 -87.98 108.93 19.45 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.005 -0.739 . . . . 72.52 109.005 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -84.37 68.2 10.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.242 1.02 . . . . 74.13 112.034 -174.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -161.84 44.2 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 114.898 -1.046 . . . . 64.12 109.656 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.08 170.21 20.12 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 121.434 1.423 . . . . 64.11 112.2 -168.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -84.73 93.0 8.35 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.928 -1.138 . . . . 72.43 107.928 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.474 HG11 HD21 ' C' ' 126' ' ' LEU . 46.3 t -77.4 95.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 107.552 -1.277 . . . . 74.01 107.552 174.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.6 109.43 21.5 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.839 -1.073 . . . . 75.44 108.304 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.67 164.5 16.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.962 -0.563 . . . . 64.4 110.432 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 25.7 t70 -147.49 138.33 23.48 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.074 -1.084 . . . . 74.54 108.074 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.51 141.31 46.68 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.69 141.81 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.124 -0.695 . . . . 73.31 109.124 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' THR . . . . . 0.403 HG21 ' HA2' ' C' ' 99' ' ' GLY . 12.7 t -114.69 136.28 53.23 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.939 -0.763 . . . . 54.45 108.939 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.58 160.43 21.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.94 0.896 . . . . 45.3 108.633 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -141.91 147.22 36.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.748 0.419 . . . . 64.01 110.272 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -153.95 132.29 11.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.491 0.716 . . . . 75.44 109.682 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.29 117.65 19.75 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.001 -0.74 . . . . 72.12 109.001 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' C' ' 57' ' ' GLU . 74.1 mt -87.24 -45.48 10.59 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.463 0.705 . . . . 71.22 109.259 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.51 -170.99 3.76 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.536 -0.757 . . . . 71.42 110.781 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.39 107.09 0.72 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.248 -0.887 . . . . 60.04 109.987 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 73.46 -0.82 3.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.452 1.501 . . . . 71.52 112.562 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.05 115.5 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.741 -0.837 . . . . 73.03 108.741 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.73 125.52 36.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.875 0.87 . . . . 63.24 109.267 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.638 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.9 tt0 -83.9 143.13 30.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.768 0.427 . . . . 62.33 110.671 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -117.49 122.95 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.507 -1.294 . . . . 60.13 107.507 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.12 106.38 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.429 -0.952 . . . . 75.11 108.429 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.27 105.92 18.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.415 0.686 . . . . 71.21 109.487 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -81.71 131.67 35.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.472 -0.785 . . . . 72.03 110.283 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.1 t -124.09 122.87 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.089 -1.449 . . . . 65.34 107.089 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.9 m -119.49 145.13 46.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.202 -1.036 . . . . 74.45 108.202 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.05 108.42 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.564 -1.272 . . . . 72.34 107.564 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.5 m -104.12 111.5 24.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.676 -0.861 . . . . 72.23 108.676 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.22 16.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.337 -1.727 . . . . 65.05 106.337 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -151.18 133.06 15.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.692 0.397 . . . . 64.23 109.968 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' C' ' 35' ' ' ASP . 30.9 tp -67.82 -48.15 67.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.176 0.59 . . . . 63.35 110.464 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.16 -73.76 0.04 OUTLIER Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.144 -1.183 . . . . 54.43 110.144 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -101.03 -31.49 11.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.398 0.679 . . . . 75.44 109.28 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -73.4 101.13 3.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.693 0.797 . . . . 72.15 109.741 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -83.39 130.02 35.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.632 -0.507 . . . . 63.12 109.632 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.681 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -73.15 -66.56 0.66 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.11 -1.071 . . . . 73.42 108.11 167.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -161.62 174.75 12.88 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.572 0.701 . . . . 72.05 111.668 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -129.08 141.88 51.07 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 105.667 -1.975 . . . . 75.14 105.667 169.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.402 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.3 112.23 4.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.383 -0.599 . . . . 75.31 109.383 174.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -122.88 129.29 51.46 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.835 0.454 . . . . 74.54 110.018 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.27 134.85 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.448 -0.945 . . . . 73.34 108.448 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.641 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -115.16 90.59 3.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.487 -1.301 . . . . 70.12 107.487 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -79.11 108.65 12.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.549 -1.205 . . . . 32.1 109.891 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 146.05 20.15 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.958 -0.457 . . . . 61.02 111.958 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.68 120.84 1.24 Allowed Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 111.603 -0.599 . . . . 73.25 111.603 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.557 HD12 HD11 ' C' ' 51' ' ' LEU . 10.4 mm -87.07 110.77 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 109.114 -0.699 . . . . 75.23 109.114 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.436 ' CE2' HD13 ' C' ' 13' ' ' ILE . 77.2 m-85 -121.76 119.9 33.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.555 0.342 . . . . 75.0 110.207 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 m -84.16 114.34 21.71 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.409 -0.589 . . . . 71.41 109.409 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.275 0.63 . . . . 73.12 109.657 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.91 168.78 24.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.851 1.26 . . . . 65.53 108.582 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.35 -27.47 5.66 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 120.916 0.176 . . . . 73.21 112.934 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -122.8 158.87 27.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.725 1.21 . . . . 63.03 109.146 -176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.81 -175.56 5.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.665 0.386 . . . . 73.04 111.323 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.67 -146.33 40.08 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.606 -0.724 . . . . 73.43 113.729 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.7 p -68.32 -19.53 64.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.863 0.865 . . . . 34.31 111.588 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -65.97 -49.21 68.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.803 0.841 . . . . 73.13 110.722 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -25.68 56.86 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 116.476 -0.329 . . . . 43.52 110.746 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.82 74.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.038 0.535 . . . . 64.32 110.979 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.409 ' CE1' ' HA ' ' C' ' 134' ' ' ASP . 53.4 t-80 -70.9 -28.13 64.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.179 0.592 . . . . 74.14 110.488 174.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.66 -60.41 2.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.738 0.415 . . . . 53.11 109.985 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.418 HD23 ' SG ' ' C' ' 102' ' ' CYS . 87.8 mt -70.7 -14.86 62.61 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.475 0.71 . . . . 72.12 111.768 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' C' ' 46' ' ' THR . . . -110.36 3.92 29.69 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 114.848 0.699 . . . . 75.52 114.848 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -51.53 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 117.936 0.868 . . . . 75.3 111.374 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -70.32 -58.97 3.16 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.561 0.744 . . . . 74.45 111.578 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.641 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 32.7 m -58.02 -48.66 96.69 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.49 1.116 . . . . 64.43 112.986 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.75 -24.27 62.09 Favored 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 121.729 1.62 . . . . 44.52 114.052 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.88 -28.09 61.39 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 118.314 0.506 . . . . 71.31 110.393 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 HH12 ' A' ' 111' ' ' ARG . 45.0 mm -64.33 -31.99 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.145 0.498 . . . . 72.03 109.943 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.0 mt -86.86 -24.6 24.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.044 0.938 . . . . 74.42 112.247 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.43 -46.22 99.84 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.249 1.203 . . . . 72.33 114.249 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.91 -38.61 77.99 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.086 1.857 . . . . 61.35 113.247 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -66.56 -45.31 79.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.414 0.686 . . . . 70.24 110.487 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.61 90.76 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.568 -0.742 . . . . 63.22 110.88 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -64.53 -50.94 65.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.904 1.282 . . . . 65.15 110.62 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.36 -31.96 71.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.245 0.618 . . . . 75.5 109.695 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.66 -35.38 75.11 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 122.99 0.516 . . . . 72.42 111.204 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.412 ' O ' HG23 ' C' ' 118' ' ' VAL . 40.5 mt -70.71 -51.0 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 122.899 0.48 . . . . 61.41 110.137 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m -62.99 -28.88 70.4 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.286 0.634 . . . . 65.22 111.183 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.3 t -64.05 -52.19 60.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.826 -0.805 . . . . 73.33 108.826 171.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.52 -39.33 83.55 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.5 1.12 . . . . 75.3 112.755 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 98.8 t -61.69 -47.92 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.54 0.736 . . . . 73.11 109.583 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.6 t -68.28 -25.9 65.39 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.94 -1.027 . . . . 75.23 111.616 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -73.38 -40.12 64.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.429 0.692 . . . . 74.12 109.326 177.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.24 -1.08 79.81 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.673 0.608 . . . . 73.51 112.341 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.2 p 62.48 35.77 14.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.632 1.973 . . . . 64.02 112.816 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.464 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 95.2 m-85 -86.27 165.29 34.47 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 114.738 -1.119 . . . . 71.31 108.852 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 74.3 Cg_endo -69.01 -175.0 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.205 1.936 . . . . 70.11 112.933 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.77 114.19 2.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.361 -0.836 . . . . 74.15 110.618 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.474 HD21 HG11 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -138.65 92.64 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.129 -1.434 . . . . 71.33 107.129 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -123.4 131.8 53.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.334 1.054 . . . . 74.15 108.851 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 140.08 43.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.286 0.635 . . . . 74.33 110.892 -170.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.21 146.56 74.9 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.132 0.973 . . . . 72.03 112.061 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.657 ' HG3' HD13 ' A' ' 16' ' ' ILE . 58.5 Cg_endo -71.26 105.43 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.211 2.607 . . . . 71.25 112.877 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.19 111.15 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.778 -1.193 . . . . 71.14 107.778 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -111.33 92.14 3.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 72.55 110.853 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -78.71 -25.38 44.68 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.893 0.854 . . . . 65.52 109.341 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.409 ' HA ' ' CE1' ' C' ' 96' ' ' HIS . 1.4 p-10 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 125.471 1.508 . . . . 70.15 111.827 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.487 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 8.0 ptm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 115.342 1.608 . . . . 70.41 115.342 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -121.11 144.42 48.57 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.163 -0.926 . . . . 64.31 108.878 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' D' ' 85' ' ' SER . 33.4 t80 -154.0 102.55 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.253 -1.017 . . . . 74.32 108.253 175.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -121.06 118.3 29.42 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.882 -0.784 . . . . 74.02 108.882 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.2 102.47 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.914 -1.143 . . . . 74.31 107.914 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -77.63 -44.69 27.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.877 0.471 . . . . 72.53 111.302 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -161.76 132.21 4.97 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 119.838 -0.125 . . . . 74.21 111.137 -170.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.463 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -107.61 132.79 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.946 -1.502 . . . . 74.12 106.946 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.94 162.85 9.4 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-O 121.839 0.828 . . . . 62.52 111.945 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.438 HG21 HD11 ' D' ' 21' ' ' ILE . 67.7 p -95.37 126.91 40.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.711 -1.131 . . . . 74.24 109.833 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.51 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 47.5 mtpt -95.51 -29.04 14.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.009 0.524 . . . . 73.22 110.048 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -150.74 137.11 18.64 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 124.124 0.89 . . . . 63.51 109.271 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.1 mt -137.58 147.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.489 1.116 . . . . 73.13 108.056 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -150.86 143.92 24.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.153 0.981 . . . . 72.22 109.494 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 74.0 t80 -149.53 130.0 13.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.767 -1.938 . . . . 73.24 105.767 169.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.46 136.63 43.34 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.126 0.57 . . . . 64.54 109.829 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -125.03 84.6 58.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 123.594 0.758 . . . . 73.45 109.068 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.53 -46.93 6.32 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.186 2.591 . . . . 55.15 113.082 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -114.18 37.94 3.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.454 0.702 . . . . 74.54 109.617 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.824 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.48 -56.53 25.76 Favored Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.332 1.604 . . . . 65.1 115.332 -168.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.537 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 21.6 Cg_endo -87.62 -3.59 7.45 Favored 'Trans proline' 0 C--N 1.38 2.195 0 CA-C-N 121.496 1.57 . . . . 74.03 112.49 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -82.76 -41.99 18.52 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.267 1.427 . . . . 64.44 109.173 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.72 -21.84 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.121 -0.945 . . . . 53.54 110.145 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -60.53 -26.4 66.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.271 1.429 . . . . 64.43 112.571 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.07 -33.17 74.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.241 0.617 . . . . 75.21 110.6 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -95.34 98.35 10.52 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.571 -0.9 . . . . 73.2 108.571 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -80.25 95.29 6.27 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.213 0.53 . . . . 64.0 110.223 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.62 ' HB3' HD11 ' D' ' 68' ' ' LEU . 68.4 t-105 -160.88 165.96 29.27 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.677 0.791 . . . . 75.21 109.685 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.15 117.38 67.9 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.413 1.085 . . . . 74.1 110.631 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.27 144.0 94.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.499 2.799 . . . . 74.43 114.278 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.51 128.17 35.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.33 -0.619 . . . . 73.53 109.33 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.61 149.81 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.2 0.6 . . . . 62.52 110.434 -173.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 27.5 tptp -131.98 114.98 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.592 -1.262 . . . . 75.01 107.592 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.87 145.87 25.47 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.121 0.568 . . . . 73.1 110.045 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.531 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 33.2 t70 -145.46 138.94 26.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.587 -1.188 . . . . 55.04 108.442 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.15 134.8 35.02 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.368 -0.975 . . . . 74.44 108.368 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -144.31 146.2 32.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.668 1.187 . . . . 64.41 108.354 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -117.46 154.51 31.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.525 -0.546 . . . . 74.22 109.525 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.59 167.47 27.98 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.049 0.94 . . . . 31.44 109.446 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -158.43 166.12 32.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.121 0.486 . . . . 74.53 111.41 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -159.44 116.82 2.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.779 1.232 . . . . 74.23 107.911 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -79.54 123.34 27.49 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.095 -0.706 . . . . 64.43 109.095 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt -90.59 -41.04 11.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.015 0.526 . . . . 74.44 109.947 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.61 -177.47 6.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.282 -0.872 . . . . 74.22 110.611 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -64.78 120.16 11.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.398 -0.819 . . . . 72.51 109.241 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 65.34 17.31 10.94 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 74.32 111.767 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -120.75 120.45 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.31 -0.996 . . . . 74.12 108.31 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.443 ' HB2' HD12 ' D' ' 86' ' ' ILE . 64.1 m-85 -128.91 126.47 39.77 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.57 -0.9 . . . . 74.51 108.57 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -89.97 132.95 35.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.557 -1.646 . . . . 74.51 106.557 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.43 133.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.177 -1.045 . . . . 61.24 108.177 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 96.4 t -111.75 133.15 58.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.435 0.694 . . . . 75.53 109.395 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.428 HD11 ' HD1' ' D' ' 107' ' ' PHE . 0.9 OUTLIER -110.87 115.42 29.48 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.122 -1.066 . . . . 64.15 108.122 170.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -100.74 107.95 19.67 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.214 -1.032 . . . . 74.34 108.214 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.71 133.35 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.771 -0.826 . . . . 61.15 108.771 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 59.1 m -121.95 135.21 54.85 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.363 0.601 . . . . 71.22 109.646 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 131.53 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.846 1.258 . . . . 64.44 108.455 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 94.0 m -131.14 112.74 13.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.196 0.998 . . . . 65.1 108.86 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.83 48.31 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.744 0.818 . . . . 71.33 109.165 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.2 m -146.2 127.59 14.95 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.665 0.603 . . . . 64.2 109.67 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' D' ' 36' ' ' TRP . 47.5 tp -111.86 122.8 48.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.686 -0.857 . . . . 62.41 108.686 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 -115.68 5.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.599 0.562 . . . . 72.14 112.836 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -110.86 8.51 22.29 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.274 0.629 . . . . 72.11 111.825 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.08 164.27 30.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.226 0.611 . . . . 75.11 110.97 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -74.55 127.94 34.31 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.055 -0.52 . . . . 65.01 110.523 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.58 -61.29 1.87 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.259 1.023 . . . . 45.15 109.677 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.06 157.9 42.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.257 0.551 . . . . 72.31 111.321 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 79.0 mt -121.97 147.82 45.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.231 1.412 . . . . 60.23 107.586 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.8 t -158.57 141.65 14.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.457 0.303 . . . . 64.44 110.216 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.08 135.98 13.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.33 0.652 . . . . 74.42 109.788 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.94 119.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.097 0.559 . . . . 71.42 109.633 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -89.48 86.11 6.69 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.489 -0.93 . . . . 75.52 108.489 167.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -79.83 101.72 8.69 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.434 -1.257 . . . . 73.25 108.448 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.17 174.41 40.33 Favored Glycine 0 C--O 1.243 0.7 0 O-C-N 123.456 0.472 . . . . 64.52 112.143 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.95 135.5 2.84 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 111.654 -0.578 . . . . 64.14 111.654 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.8 129.96 38.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.513 -0.921 . . . . 74.43 108.513 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -132.28 135.78 46.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.491 0.717 . . . . 71.03 109.586 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.7 m -75.33 116.14 15.74 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.944 -1.132 . . . . 71.43 107.944 168.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' D' ' 56' ' ' TYR . 57.2 mt -121.23 101.72 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.634 -0.506 . . . . 73.34 109.634 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.63 152.6 48.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.406 1.082 . . . . 74.44 109.072 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 75.2 1.33 63.6 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.434 0.459 . . . . 63.31 113.587 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.519 HG23 ' HG2' ' D' ' 93' ' ' GLN . 53.7 mt -117.11 126.77 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 107.814 -1.18 . . . . 65.22 107.814 -174.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' D' ' 93' ' ' GLN . 7.5 pt-20 -145.84 148.86 33.33 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.973 0.731 . . . . 71.24 112.973 -163.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.09 -127.01 32.27 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.353 0.501 . . . . 62.14 114.197 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.9 p -70.34 -20.61 62.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.356 0.662 . . . . 65.04 111.32 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.519 ' HG2' HG23 ' D' ' 89' ' ' ILE . 55.9 tt0 -70.47 -41.47 72.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.737 0.815 . . . . 74.32 110.134 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -78.63 -29.42 45.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.288 0.235 . . . . 73.32 110.541 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.77 80.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.067 0.547 . . . . 53.12 110.272 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.01 -35.87 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.335 -0.848 . . . . 74.12 110.537 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -66.29 -43.08 87.36 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.941 0.496 . . . . 62.11 110.584 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.09 -21.91 42.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.331 0.652 . . . . 75.05 111.082 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 -19.79 38.65 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.932 -0.371 . . . . 63.41 113.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.79 -69.04 0.69 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.39 0.515 . . . . 72.43 112.39 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -65.07 -60.92 2.5 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.283 0.475 . . . . 73.41 112.283 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -58.07 -46.97 99.64 Favored Pre-proline 0 CA--C 1.565 1.537 0 C-N-CA 123.78 0.832 . . . . 74.14 113.122 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 -30.72 51.16 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.921 1.747 . . . . 52.21 113.266 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.82 -35.97 82.18 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.035 0.534 . . . . 63.24 110.646 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.16 -42.71 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.712 0.805 . . . . 73.21 110.35 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -78.67 -19.01 53.5 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.27 -0.877 . . . . 54.52 112.181 -174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.428 ' HD1' HD11 ' D' ' 60' ' ' LEU . 70.8 t80 -62.21 -45.72 90.67 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 113.759 1.022 . . . . 64.45 113.759 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.83 -36.91 75.9 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.113 1.875 . . . . 63.02 113.724 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -79.07 -33.84 44.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.893 0.877 . . . . 75.14 111.693 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.75 -48.47 71.79 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.874 0.47 . . . . 61.44 109.829 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -54.95 -50.82 67.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.368 -1.287 . . . . 73.53 111.013 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.98 -46.76 84.66 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.113 0.883 . . . . 75.33 110.8 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.11 -45.13 94.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 123.939 0.774 . . . . 50.1 110.947 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.561 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.49 -56.5 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.746 0.818 . . . . 63.25 110.897 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -53.03 -46.36 68.42 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.667 1.187 . . . . 64.25 111.796 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -62.84 -44.09 97.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.032 -0.985 . . . . 53.12 110.2 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.43 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 74.8 mtm -68.07 -32.93 73.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.103 0.561 . . . . 50.11 111.852 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.62 -39.18 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.269 0.628 . . . . 72.53 110.438 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -74.89 -26.26 59.52 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 122.547 0.339 . . . . 74.14 110.881 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -75.47 -32.27 60.55 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.664 0.786 . . . . 71.24 109.635 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -1.13 90.19 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 115.534 -0.757 . . . . 70.03 111.922 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p 59.81 22.79 11.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.591 1.957 . . . . 62.44 112.805 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -86.31 159.89 52.5 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.334 1.054 . . . . 74.44 109.514 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.7 118.08 4.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.529 2.153 . . . . 75.24 112.701 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -48.88 133.19 18.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.062 0.945 . . . . 71.44 112.393 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.6 107.86 11.46 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.953 -1.129 . . . . 71.52 107.953 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.57 107.76 18.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.481 0.712 . . . . 51.44 109.466 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.95 145.02 54.94 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.73 0.812 . . . . 73.14 111.166 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.62 148.06 36.5 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 122.917 0.487 . . . . 72.45 110.264 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.37 130.82 31.53 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.545 2.163 . . . . 73.0 111.984 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 p -108.13 109.61 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.486 0.714 . . . . 51.23 110.041 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -86.72 106.78 17.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.802 0.841 . . . . 74.34 108.744 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 . . . . . 0 N--CA 1.477 0.889 0 C-N-CA 123.039 0.536 . . . . 75.3 110.624 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.548 -0.908 . . . . 75.04 108.548 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -134.41 134.79 42.04 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.3 0.64 . . . . 73.45 109.351 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.437 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 92.4 mt-30 -132.82 123.85 26.89 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.592 -0.892 . . . . 73.25 108.592 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.69 103.95 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.897 -1.149 . . . . 74.53 107.897 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.61 -39.78 15.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 72.24 110.947 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.634 ' HD3' HG21 ' B' ' 122' ' ' THR . 0.1 OUTLIER -158.6 143.99 16.47 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.144 -0.455 . . . . 74.04 109.962 -175.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -145.85 100.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.505 -1.295 . . . . 72.13 107.505 171.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.594 ' HD1' ' HG3' ' A' ' 15' ' ' ARG . 71.6 m-85 -157.61 169.96 23.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.298 0.639 . . . . 73.32 109.779 -170.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.8 p -81.91 111.66 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.079 -0.51 . . . . 71.33 110.337 -173.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 35.4 mtpt -79.5 -32.52 42.44 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.768 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.97 145.1 27.2 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.702 0.627 . . . . 54.45 109.616 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -134.59 144.2 35.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 125.065 1.346 . . . . 65.23 107.567 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 25.9 t -148.69 130.67 15.29 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.753 0.821 . . . . 74.3 108.857 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.566 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 90.3 t80 -147.6 119.28 8.03 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 106.962 -1.496 . . . . 73.01 106.962 174.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.55 139.63 45.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.831 0.452 . . . . 74.45 109.84 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.23 80.32 72.65 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.221 1.008 . . . . 74.32 108.515 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.51 -43.46 21.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.299 2.666 . . . . 64.31 112.627 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 32.1 m-80 -113.09 37.47 3.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.187 -0.915 . . . . 74.4 109.656 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.616 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.37 -46.03 99.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 C-N-CA 124.121 0.968 . . . . 70.01 113.087 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.06 -22.97 29.96 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.976 1.784 . . . . 72.11 112.631 174.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.3 m-70 -78.11 -18.62 55.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.561 0.744 . . . . 73.42 111.656 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HE1' ' A' ' 123' ' ' PHE . 79.1 t -52.53 -28.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.876 0.87 . . . . 74.04 112.447 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -65.53 -42.65 91.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.11 0.781 . . . . 72.32 113.11 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -26.05 46.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.577 0.171 . . . . 72.11 110.665 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -76.73 152.08 35.81 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.101 0.56 . . . . 73.4 110.498 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -80.47 147.71 30.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.442 -0.947 . . . . 71.44 108.442 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 -79.05 75.33 5.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.911 0.884 . . . . 65.41 110.634 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.23 82.9 51.84 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.495 1.118 . . . . 54.3 108.639 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.85 123.41 5.21 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.927 2.418 . . . . 62.22 111.964 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -95.07 86.02 4.49 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.143 -1.428 . . . . 63.33 107.143 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 65' ' ' THR . 61.1 t -87.26 103.68 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.333 -1.303 . . . . 61.32 110.505 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -96.5 140.02 31.74 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.726 0.41 . . . . 65.13 110.392 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.1 mt -106.45 139.33 41.1 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.187 -1.042 . . . . 70.23 108.187 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.799 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -129.6 108.23 10.06 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.567 -1.271 . . . . 73.35 107.567 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.2 mp -103.72 130.59 51.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.367 -0.975 . . . . 75.22 108.367 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 60' ' ' LEU . 19.2 t70 -144.05 151.68 39.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.857 0.863 . . . . 72.24 110.205 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -139.24 138.63 36.99 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.597 0.759 . . . . 64.34 110.094 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 149.05 52.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.631 1.172 . . . . 63.25 109.716 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -96.15 170.35 9.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.293 0.637 . . . . 71.13 111.101 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.0 t -165.7 147.82 7.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.879 1.272 . . . . 73.2 108.526 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -111.98 133.52 54.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.488 -0.931 . . . . 74.11 108.488 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -104.69 -44.62 4.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.579 -0.526 . . . . 63.14 109.579 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.62 -174.35 4.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.583 -0.735 . . . . 73.11 110.38 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.27 117.84 6.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.345 1.058 . . . . 74.3 110.748 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 69.31 -8.2 0.74 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 125.533 1.533 . . . . 74.44 113.08 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.3 109.58 26.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.492 -0.929 . . . . 64.24 108.492 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.15 157.01 35.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.891 0.876 . . . . 72.22 108.763 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -132.46 118.91 19.91 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.53 0.732 . . . . 74.21 109.986 -174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -104.56 112.6 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.717 -1.216 . . . . 54.41 107.717 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -100.0 131.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 70.01 109.924 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -100.63 114.23 27.74 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.447 . . . . 72.02 107.092 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -99.22 104.1 16.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.722 -0.844 . . . . 73.05 108.722 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -95.49 141.96 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.382 -0.97 . . . . 74.42 108.382 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.799 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 85.6 m -125.78 141.13 52.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 171.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 76.9 t -135.24 110.86 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.616 1.166 . . . . 64.32 108.37 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 m -101.95 142.15 33.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.711 -0.848 . . . . 71.24 108.711 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.46 121.78 20.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.873 -1.158 . . . . 70.23 107.873 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -130.95 130.14 43.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.127 0.571 . . . . 65.43 110.135 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 78.4 mt -87.61 78.71 8.46 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.801 -1.185 . . . . 74.25 107.801 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.59 -106.73 2.17 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 114.392 -1.276 . . . . 61.51 112.219 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -89.12 -26.99 21.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.531 0.732 . . . . 72.31 109.984 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.24 131.3 44.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 73.43 109.627 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.1 m -76.19 128.73 35.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.066 0.46 . . . . 31.23 110.524 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -76.83 -56.4 4.63 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.235 1.014 . . . . 71.11 108.971 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -167.57 174.86 7.47 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.163 -0.926 . . . . 63.33 111.207 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 tp -143.05 150.48 39.61 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.845 1.258 . . . . 71.53 109.133 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.696 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 61.6 m -141.59 141.34 33.49 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.441 0.696 . . . . 74.03 110.681 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 56.4 mp0 -141.47 133.41 27.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.285 1.034 . . . . 73.33 108.321 170.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.42 108.4 5.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.265 -1.013 . . . . 71.3 108.265 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.81 80.39 8.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.207 -1.361 . . . . 71.11 107.645 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.12 92.5 3.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 114.046 -1.434 . . . . 74.32 107.886 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.24 145.62 21.42 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.374 -0.83 . . . . 54.35 111.3 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -135.52 120.25 2.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.772 -0.931 . . . . 51.22 110.772 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.5 mt -85.2 124.99 40.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.082 -1.081 . . . . 73.44 108.082 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -136.46 138.49 41.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.391 -0.966 . . . . 73.34 108.391 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 12' ' ' GLN . 13.7 p -96.42 105.25 17.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.368 -0.604 . . . . 52.42 109.368 172.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.86 132.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.215 0.606 . . . . 62.54 110.072 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.04 162.88 26.08 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.658 1.183 . . . . 72.43 109.666 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.83 -25.11 12.34 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 114.61 0.604 . . . . 32.34 114.61 171.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.42 152.26 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.303 0.552 . . . . 71.32 110.918 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 8.5 tt0 -155.89 -172.71 4.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.329 -0.619 . . . . 62.44 109.329 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.487 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.63 -153.25 48.79 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.637 -0.256 . . . . 71.13 113.244 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.6 p -65.35 -26.36 67.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.604 0.762 . . . . 75.52 111.318 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.33 -42.69 99.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.536 0.734 . . . . 74.12 110.641 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 47.0 ttp -64.13 -53.14 54.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.139 0.975 . . . . 74.22 110.926 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.08 -47.69 68.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 44.24 110.958 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -56.94 -47.71 80.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.617 -1.629 . . . . 72.23 111.192 173.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.1 m -71.37 -29.41 64.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.585 0.957 . . . . 72.04 113.585 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.9 mt -83.78 -38.8 20.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.049 0.54 . . . . 64.31 111.1 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.56 5.26 56.93 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.958 -0.565 . . . . 73.45 113.827 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -144.29 -66.67 0.34 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.784 0.792 . . . . 74.31 112.384 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.2 t80 -48.96 -56.58 8.45 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.194 0.998 . . . . 73.12 112.434 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.3 m -71.52 -44.56 12.76 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-O 118.389 -0.815 . . . . 53.21 112.471 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.28 -37.27 80.65 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.152 1.901 . . . . 72.53 113.732 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 61.8 m-20 -60.44 -40.61 91.7 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.108 0.963 . . . . 72.51 110.788 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.3 mm -64.7 -41.46 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.084 -0.962 . . . . 73.24 110.569 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.543 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.7 mt -75.24 -27.19 59.39 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.634 -0.712 . . . . 73.1 111.751 -173.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -63.15 -42.74 78.08 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.741 1.386 . . . . 74.11 114.741 -168.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -35.57 98.3 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 122.307 2.005 . . . . 41.3 113.603 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.8 -37.92 39.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.333 0.653 . . . . 73.33 111.399 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.46 98.56 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.669 -0.493 . . . . 33.22 109.669 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.524 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.5 ttm180 -57.23 -53.44 58.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.354 1.062 . . . . 74.1 110.908 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.95 -47.88 84.4 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.119 0.887 . . . . 63.22 111.008 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.15 -46.69 82.51 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.08 0.862 . . . . 61.43 111.126 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.599 HG21 HG21 ' A' ' 64' ' ' VAL . 98.9 mt -62.66 -52.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 123.709 0.63 . . . . 73.34 110.474 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 125' ' ' GLN . 87.7 m -56.13 -39.41 72.21 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.82 0.7 . . . . 74.43 111.596 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -66.47 -48.18 70.71 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.345 -0.843 . . . . 61.1 110.185 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.566 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mtp -54.36 -45.13 72.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.864 0.866 . . . . 74.03 111.486 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' ILE . 71.0 t -61.86 -47.41 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.943 -1.026 . . . . 75.41 110.852 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -71.38 -24.3 62.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.985 -0.552 . . . . 75.44 111.553 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -71.77 -27.06 62.7 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.302 0.641 . . . . 51.1 110.313 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.75 10.09 63.45 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 123.469 0.481 . . . . 72.12 113.045 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.567 HG22 ' HB3' ' B' ' 17' ' ' TYR . 5.9 t 51.97 24.62 2.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 127.03 2.132 . . . . 62.22 113.279 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE1' HG21 ' A' ' 31' ' ' VAL . 75.6 m-85 -86.55 151.84 53.72 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 115.628 -0.715 . . . . 60.54 109.177 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.24 129.0 32.89 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.717 2.278 . . . . 72.13 110.56 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.5 pt20 -55.81 142.52 34.56 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.156 0.91 . . . . 75.0 111.345 -169.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.403 ' HG ' HG11 ' A' ' 118' ' ' VAL . 51.2 mt -119.46 97.66 5.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.525 0.678 . . . . 71.02 109.231 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.57 123.06 42.52 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.308 -1.315 . . . . 53.52 108.067 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.471 HD11 HD12 ' A' ' 114' ' ' ILE . 69.3 mt -66.12 122.61 17.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.481 0.712 . . . . 74.43 110.565 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -53.29 136.65 50.23 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 119.012 -0.518 . . . . 73.02 110.293 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.43 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.628 2.218 . . . . 71.5 112.102 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 129' ' ' ALA . 53.9 t -100.25 112.86 34.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.17 -1.048 . . . . 74.34 108.17 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -85.42 92.12 8.4 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.243 -1.021 . . . . 73.05 108.243 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.41 -28.54 69.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.8 -0.636 . . . . 73.53 110.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.488 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 3.6 t70 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.082 0.953 . . . . 73.31 110.658 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.7 ptm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 114.695 1.368 . . . . 55.2 114.695 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.8 p -141.46 127.5 19.51 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.616 1.166 . . . . 74.11 108.096 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -122.46 128.09 50.42 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.667 -0.864 . . . . 72.22 108.667 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -142.84 140.82 31.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 63.41 109.176 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.669 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.82 141.52 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.601 -0.888 . . . . 74.53 108.601 172.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.602 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 20.2 mm-40 -106.68 -50.66 3.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.963 0.505 . . . . 70.24 109.884 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -168.49 149.03 4.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.976 0.91 . . . . 72.33 108.567 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.6 mt -128.3 149.31 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.708 -1.219 . . . . 65.23 107.708 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.567 ' HB3' HG22 ' A' ' 122' ' ' THR . 24.1 p90 -170.87 150.44 3.18 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.255 0.55 . . . . 63.21 112.436 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.7 m -72.98 122.3 21.48 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.012 -0.995 . . . . 65.14 108.535 167.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.7 mtpt -94.33 -33.74 13.08 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.799 0.839 . . . . 73.41 110.563 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 22.9 t70 -152.14 140.52 20.54 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.47 0.481 . . . . 72.1 111.103 -166.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -140.96 137.54 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.713 1.205 . . . . 74.42 108.315 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -139.81 108.3 5.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.333 -1.358 . . . . 70.1 107.333 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.5 t80 -126.11 108.25 11.17 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.451 -1.314 . . . . 63.34 107.451 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.96 111.42 18.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.327 -0.99 . . . . 61.42 108.327 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.59 86.97 3.12 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.53 -1.285 . . . . 45.13 107.53 170.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.31 -32.49 41.4 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.493 2.129 . . . . 63.32 110.951 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.47 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 15.7 m120 -111.87 30.43 7.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.501 -1.227 . . . . 73.45 109.97 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.3 -46.98 46.41 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.298 1.039 . . . . 51.32 111.964 167.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 73.6 Cg_endo -76.83 -16.75 16.12 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.086 1.858 . . . . 72.53 114.549 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 65.3 m80 -95.97 -16.19 21.86 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.872 0.693 . . . . 53.35 112.872 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.91 -11.79 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.742 0.417 . . . . 64.32 110.041 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.74 -43.93 94.01 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.584 0.754 . . . . 65.14 109.886 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' B' ' 30' ' ' HIS . 16.0 mp0 -81.03 -32.02 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.074 -0.512 . . . . 63.51 110.201 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.57 92.73 7.21 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.475 0.71 . . . . 71.15 111.093 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -89.31 105.98 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.579 -0.526 . . . . 74.53 109.579 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -172.98 169.23 4.75 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 74.33 109.453 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.36 114.67 49.18 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.877 0.871 . . . . 64.31 108.741 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 150.67 82.99 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.381 2.054 . . . . 74.22 112.392 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 104.94 1.18 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.773 -0.825 . . . . 73.22 108.773 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -97.57 154.35 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.885 0.85 . . . . 72.02 111.765 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.652 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 70.2 tttt -147.24 115.17 6.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.794 -1.548 . . . . 71.1 107.104 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -86.02 159.39 19.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.19 -1.041 . . . . 54.41 108.19 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.4 t70 -164.94 110.53 0.94 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.352 -0.61 . . . . 65.34 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.98 144.48 31.2 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.931 0.396 . . . . 72.54 109.985 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.68 141.97 47.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.558 1.143 . . . . 72.21 108.683 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -121.65 139.0 54.1 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.633 -0.506 . . . . 72.22 109.633 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.61 161.02 41.79 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.224 1.01 . . . . 24.22 109.227 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -144.01 170.23 16.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.071 0.548 . . . . 72.42 109.981 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -155.31 136.2 13.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.991 0.916 . . . . 73.14 108.624 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.91 120.58 29.39 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.073 0.549 . . . . 74.42 111.068 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.3 -37.54 17.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.328 -0.619 . . . . 64.51 109.328 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.96 -179.48 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.032 0.933 . . . . 71.32 110.676 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.54 125.27 26.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.925 -1.034 . . . . 71.13 109.537 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 65.42 10.44 6.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.473 1.109 . . . . 61.2 112.385 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -127.33 95.61 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.207 -1.035 . . . . 62.44 108.207 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -117.35 138.11 52.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.875 0.47 . . . . 73.51 109.883 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -102.02 103.47 14.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.761 -1.2 . . . . 73.15 107.761 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' B' ' 98' ' ' LEU . 48.7 t -95.3 129.26 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 62.3 109.48 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.9 t -109.55 129.65 64.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.928 0.891 . . . . 70.0 109.844 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -106.75 134.04 50.5 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.316 -1.364 . . . . 62.33 107.316 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.51 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 27.6 ttm180 -119.19 130.95 55.77 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.857 -0.794 . . . . 61.54 108.857 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.523 ' HB ' HD11 ' B' ' 114' ' ' ILE . 16.9 t -124.67 123.12 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.38 -0.97 . . . . 64.43 108.38 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 33.3 m -108.75 144.85 36.02 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.305 1.042 . . . . 73.21 109.512 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 114' ' ' ILE . 91.0 t -135.94 98.52 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.636 1.174 . . . . 41.12 108.21 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 27.4 m -83.07 139.3 33.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.939 -0.763 . . . . 42.33 108.939 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.69 140.06 21.37 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.839 0.456 . . . . 75.55 110.06 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.527 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.3 m -142.1 131.91 24.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.401 0.68 . . . . 72.51 109.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.19 108.3 20.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.157 -1.424 . . . . 73.54 107.157 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -118.83 5.75 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.803 -0.919 . . . . 71.02 110.803 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -111.93 4.59 18.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.276 0.63 . . . . 73.32 111.986 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.77 147.28 43.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.487 0.715 . . . . 72.45 110.013 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.3 m -66.05 127.13 30.9 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.021 0.528 . . . . 64.11 111.686 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.527 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -86.99 -54.5 4.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.267 -1.012 . . . . 53.5 108.267 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.88 157.52 24.04 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 114.739 -1.119 . . . . 72.4 110.062 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 84.5 mt -130.82 110.82 11.6 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 106.554 -1.647 . . . . 75.12 106.554 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -117.15 136.15 53.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 75.15 108.603 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.6 tt0 -157.61 135.09 10.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.094 -0.706 . . . . 71.44 109.094 -170.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.28 149.97 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.376 -0.829 . . . . 75.33 109.045 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 43.0 mt-30 -123.26 106.04 10.38 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.102 -1.073 . . . . 75.1 108.102 167.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -94.88 101.05 12.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.58 -0.896 . . . . 62.44 108.58 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.17 171.56 32.65 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.546 -0.622 . . . . 53.54 111.546 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.11 141.91 5.99 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.483 -0.647 . . . . 50.42 111.483 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 22.1 mt -92.72 128.05 44.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.811 -0.811 . . . . 72.44 108.811 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.06 134.82 47.64 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.048 0.939 . . . . 73.15 108.545 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 52.7 m -107.24 104.27 13.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.568 0.747 . . . . 44.32 109.002 175.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.509 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.14 121.15 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.691 1.196 . . . . 73.11 109.365 -176.003 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.5 159.08 40.44 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.908 0.883 . . . . 64.02 109.6 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.52 -43.63 2.77 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.622 0.577 . . . . 73.21 112.805 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.405 ' H ' HG13 ' B' ' 89' ' ' ILE . 1.7 pp -62.49 138.97 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.572 0.749 . . . . 72.33 111.105 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -150.3 172.06 15.98 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.128 0.971 . . . . 75.24 110.416 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.76 -128.98 43.86 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.173 0.921 . . . . 65.33 113.496 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.2 m -67.81 -30.3 69.68 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.78 0.832 . . . . 74.21 110.814 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -74.72 -33.64 62.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.796 -0.638 . . . . 75.43 111.543 -168.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -36.46 68.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.162 0.506 . . . . 75.53 110.299 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.14 -26.96 66.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.793 -1.094 . . . . 64.24 111.247 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -86.56 -34.6 19.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.384 1.074 . . . . 74.3 110.164 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.02 -63.36 1.32 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.258 0.623 . . . . 50.4 111.573 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.461 ' HB2' HG21 ' B' ' 58' ' ' VAL . 1.4 pp -93.75 -3.26 52.49 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.958 0.355 . . . . 65.03 111.958 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.11 -16.34 51.01 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.242 0.339 . . . . 61.41 112.674 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.37 -52.82 0.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.219 0.452 . . . . 55.32 112.219 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -70.94 -43.83 67.38 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 111.998 0.37 . . . . 73.13 111.998 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 90.7 m -61.86 -49.97 83.43 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.5 -0.762 . . . . 63.14 110.917 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 80.0 Cg_exo -54.72 -33.63 80.97 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.062 1.841 . . . . 70.35 113.805 168.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.81 -32.49 74.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.881 0.472 . . . . 75.24 111.186 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.86 -42.99 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.288 0.635 . . . . 60.01 110.169 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.85 -26.61 57.3 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.677 -1.147 . . . . 73.21 111.827 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.26 -49.86 82.39 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.726 1.01 . . . . 72.01 113.726 -170.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 35.3 Cg_endo -61.38 -31.32 88.47 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.704 1.603 . . . . 73.14 112.58 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.452 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.8 m-30 -69.06 -45.57 70.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.821 0.848 . . . . 71.2 110.25 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.98 89.38 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.335 -0.848 . . . . 62.15 110.798 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.409 ' HA ' HD23 ' B' ' 128' ' ' LEU . 33.9 ttt180 -59.31 -54.6 44.98 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.652 1.581 . . . . 74.44 111.35 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.57 -33.91 77.02 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.719 0.637 . . . . 52.13 109.854 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.515 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.9 t -68.35 -38.37 81.39 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.163 -0.471 . . . . 74.25 111.075 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.523 HD11 ' HB ' ' B' ' 62' ' ' VAL . 52.6 mt -64.04 -58.74 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.685 -0.487 . . . . 53.54 109.685 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -59.01 -31.3 68.69 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 124.18 0.925 . . . . 65.32 111.368 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -62.01 -54.38 42.4 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.387 0.675 . . . . 73.51 110.48 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -62.31 -36.63 82.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.19 0.596 . . . . 73.22 110.931 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.2 t -63.0 -42.65 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.074 0.949 . . . . 74.34 110.908 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.3 m -68.18 -31.86 71.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.328 0.651 . . . . 75.0 111.035 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 94.6 mtt-85 -68.65 -21.53 64.45 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.552 0.741 . . . . 73.55 110.921 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.11 15.12 61.93 Favored Glycine 0 C--N 1.356 1.685 0 CA-C-O 119.258 -0.746 . . . . 72.31 114.125 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.634 HG21 ' HD3' ' A' ' 15' ' ' ARG . 1.9 p 73.59 12.84 4.53 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 126.377 1.871 . . . . 71.53 113.247 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.24 149.82 43.66 Favored Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 122.183 -0.323 . . . . 70.35 111.163 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.21 163.11 24.11 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.243 2.629 . . . . 31.3 113.667 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.446 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 0.6 OUTLIER -63.57 115.35 4.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.232 1.013 . . . . 73.52 111.063 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 tt -130.11 97.47 4.46 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.074 -1.454 . . . . 72.35 107.074 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.75 136.07 33.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.527 -0.916 . . . . 70.11 108.527 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 111' ' ' ARG . 2.6 mm? -75.11 125.13 28.28 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.086 -0.709 . . . . 71.04 109.086 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.85 153.9 92.92 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 123.267 0.627 . . . . 41.41 111.056 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.39 99.06 0.35 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.089 2.526 . . . . 61.15 112.419 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 5.2 p -90.84 113.27 26.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 121.487 0.661 . . . . 60.53 109.336 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -76.55 101.9 5.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.967 -0.753 . . . . 61.5 108.967 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -59.74 -28.68 67.57 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.102 -0.954 . . . . 72.03 109.898 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.51 -52.72 58.68 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.589 1.556 . . . . 62.33 110.684 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.35 79.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.458 1.099 . . . . 60.2 111.173 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.477 0.922 0 O-C-N 123.81 0.694 . . . . 73.24 110.799 -178.335 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.984 0.421 . . . . 72.22 111.235 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -87.92 77.54 8.47 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.65 -0.87 . . . . 74.23 108.65 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -114.66 137.31 52.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.527 -0.76 . . . . 71.5 109.534 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -152.06 134.53 15.3 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.297 0.639 . . . . 73.14 109.483 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 pt -76.27 136.45 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.717 -0.674 . . . . 72.44 109.319 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -104.68 -49.04 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.887 0.475 . . . . 64.53 110.005 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -166.11 141.46 4.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.58 -0.736 . . . . 74.11 109.475 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.4 136.02 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.827 -1.175 . . . . 65.5 107.827 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.623 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 7.7 p90 -173.11 154.38 2.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.306 0.574 . . . . 53.54 111.697 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -77.0 116.64 17.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.342 -0.845 . . . . 55.22 109.052 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.5 mmtp -70.91 -48.59 52.82 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 107.972 -1.122 . . . . 74.02 107.972 169.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 6.0 t70 -137.02 141.14 42.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.479 -1.692 . . . . 63.44 109.548 -171.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.9 mt -136.57 141.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.321 -1.363 . . . . 71.53 107.321 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -150.23 141.84 23.55 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.395 -0.594 . . . . 62.4 109.395 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.85 141.71 31.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.529 -1.285 . . . . 75.34 107.529 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.79 144.0 31.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.569 -1.271 . . . . 73.31 107.569 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.478 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -150.47 83.18 6.0 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 108.386 -0.968 . . . . 44.3 108.386 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.07 -15.17 39.43 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.026 2.484 . . . . 75.01 112.69 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -126.1 37.89 4.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.171 0.988 . . . . 51.34 109.517 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' C' ' 25' ' ' ALA . . . -58.74 -51.74 79.69 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 113.809 1.04 . . . . 64.23 113.809 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.69 -24.53 7.27 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 121.64 1.56 . . . . 62.43 112.43 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.75 -22.54 65.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.661 1.184 . . . . 73.15 111.802 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.661 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 11.2 p -50.1 -32.29 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.353 1.061 . . . . 62.24 113.8 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.4 -31.01 70.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.341 0.656 . . . . 73.14 112.001 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -118.01 48.84 1.32 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.699 0.8 . . . . 72.41 110.355 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 14.6 ptpt -124.41 173.12 8.63 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.881 -0.414 . . . . 62.2 109.881 170.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.59 113.41 20.8 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.026 -1.101 . . . . 63.52 108.026 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -83.76 79.6 9.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.268 1.032 . . . . 71.45 110.81 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.719 ' HB3' HD13 ' C' ' 68' ' ' LEU . 48.4 tt0 -123.53 79.63 54.66 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.342 -1.355 . . . . 74.34 107.342 168.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 91.08 1.2 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.053 2.502 . . . . 72.04 111.973 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.61 91.96 8.42 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.9 -1.889 . . . . 63.51 105.9 169.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.5 141.03 15.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.367 -0.833 . . . . 72.44 109.354 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' C' ' 41' ' ' LYS . 4.3 ttmp? -127.13 103.75 7.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.031 -0.729 . . . . 72.25 109.031 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.698 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.6 pt? -89.9 160.71 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.853 . . . . 73.22 109.848 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.93 117.51 8.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.536 0.735 . . . . 41.1 109.216 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.43 120.21 39.64 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.86 -0.793 . . . . 62.1 108.86 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.2 140.93 46.84 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.715 1.206 . . . . 70.32 108.786 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 8.1 t -142.57 138.4 30.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.317 0.58 . . . . 65.12 110.455 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.26 177.32 5.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.143 0.977 . . . . 55.24 108.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -151.83 160.33 43.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 64.2 111.129 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -155.84 140.07 16.58 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.334 1.053 . . . . 75.41 108.614 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.46 115.35 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.497 -0.927 . . . . 64.14 108.497 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.585 HD11 HD12 ' C' ' 83' ' ' ILE . 47.5 mt -85.52 -42.62 14.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.005 -0.739 . . . . 63.12 109.005 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.56 179.78 8.08 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.515 -1.22 . . . . 63.53 109.103 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.06 128.01 34.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.001 -0.741 . . . . 75.43 109.001 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 70.55 -3.66 1.85 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.803 1.241 . . . . 64.31 112.487 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.29 111.22 35.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 108.771 -0.826 . . . . 73.35 108.771 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.34 125.47 42.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.601 0.761 . . . . 63.43 109.124 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.9 tt0 -84.5 137.75 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.696 0.798 . . . . 52.12 109.166 171.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.43 HG23 HD11 ' C' ' 106' ' ' LEU . 29.3 m -124.25 140.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 40.12 108.344 165.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' C' ' 46' ' ' THR . 47.5 t -117.51 103.6 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.397 -0.964 . . . . 65.24 108.397 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.64 96.8 10.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.258 -1.016 . . . . 72.21 108.258 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -85.67 126.78 34.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.817 -1.083 . . . . 73.44 109.663 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.9 t -115.18 134.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.276 -1.009 . . . . 43.33 108.276 171.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 4.4 m -118.98 141.71 48.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.581 HG21 HG21 ' C' ' 114' ' ' ILE . 86.3 t -128.64 117.24 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.668 1.187 . . . . 65.33 108.356 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -99.87 144.37 29.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.438 -1.319 . . . . 71.45 107.438 165.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.84 106.7 6.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.354 -1.721 . . . . 51.4 106.354 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -152.45 160.96 43.21 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.557 0.535 . . . . 72.41 110.815 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.719 HD13 ' HB3' ' C' ' 37' ' ' GLN . 20.0 tp -79.27 -50.26 11.19 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.172 -1.047 . . . . 70.15 108.172 162.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.4 -77.31 0.04 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.068 -1.213 . . . . 63.31 110.068 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -89.99 -31.3 17.28 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.229 -0.656 . . . . 75.21 109.229 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -78.05 93.38 4.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.277 1.031 . . . . 63.15 109.933 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -87.91 130.57 34.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.932 0.493 . . . . 42.33 111.65 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.25 -65.07 0.82 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.167 0.987 . . . . 61.33 108.943 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -156.54 164.0 38.72 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 123.797 0.686 . . . . 52.43 111.622 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.445 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -121.66 144.65 48.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.655 -1.609 . . . . 55.43 106.655 168.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.445 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -148.14 150.95 34.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.777 -0.823 . . . . 60.34 108.777 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -159.69 131.59 6.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.724 0.409 . . . . 62.11 110.078 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -129.95 114.64 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.867 0.867 . . . . 72.22 108.757 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 46.4 mt-30 -90.24 88.6 7.29 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.036 -1.098 . . . . 75.31 108.036 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -79.62 107.22 12.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.892 -1.049 . . . . 74.02 109.512 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.95 154.95 27.13 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 112.147 -0.381 . . . . 71.01 112.147 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.05 122.87 1.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.382 -0.687 . . . . 71.34 111.382 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.585 HD12 HD11 ' C' ' 51' ' ' LEU . 10.0 mm -87.9 123.47 40.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.397 -0.964 . . . . 70.22 108.397 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.32 123.33 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.555 0.742 . . . . 73.32 110.053 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -76.93 112.15 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.822 0.449 . . . . 55.43 109.821 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.42 112.12 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.308 -0.997 . . . . 74.12 108.308 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.01 165.66 30.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.741 0.817 . . . . 71.05 110.255 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -24.42 8.71 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.156 -0.474 . . . . 63.21 113.765 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' C' ' 93' ' ' GLN . 19.8 tt -123.48 151.66 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.403 1.081 . . . . 62.03 109.558 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.75 161.0 43.09 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.205 0.602 . . . . 63.14 110.606 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.1 -153.61 22.4 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 122.986 0.327 . . . . 72.12 112.856 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -59.53 -26.55 65.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.997 0.919 . . . . 73.41 110.454 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.561 ' HB3' HD11 ' C' ' 89' ' ' ILE . 36.8 mt-30 -61.1 -49.84 75.67 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.904 -1.498 . . . . 64.44 110.799 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -21.33 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 116.273 -0.422 . . . . 73.23 110.694 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.08 83.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.034 0.533 . . . . 64.24 110.57 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -66.09 -31.13 71.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.539 -0.755 . . . . 72.32 110.508 172.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.98 -59.27 2.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.67 0.388 . . . . 75.31 110.737 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.14 -51.05 16.79 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.434 0.694 . . . . 74.33 111.108 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.27 6.53 81.03 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.383 -0.676 . . . . 44.1 114.599 -169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.15 -57.22 0.37 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.906 0.853 . . . . 75.53 111.829 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -68.49 -54.05 19.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.289 0.636 . . . . 74.22 111.233 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.3 -46.96 99.07 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 123.863 0.865 . . . . 74.42 112.597 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.3 -33.55 58.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.954 1.769 . . . . 63.11 113.378 171.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.36 -21.6 63.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.918 0.487 . . . . 55.41 111.78 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.524 HD12 ' NH1' ' A' ' 111' ' ' ARG . 32.4 mm -73.75 -39.35 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.216 0.606 . . . . 73.13 109.492 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.543 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.5 mt -75.44 -26.85 58.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.077 -0.965 . . . . 63.14 111.735 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -54.98 -49.87 89.63 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-O 117.993 -1.003 . . . . 71.53 113.12 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.58 -39.96 73.97 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.227 1.951 . . . . 63.11 113.879 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.98 -45.27 67.71 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.132 0.573 . . . . 75.03 110.882 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.21 81.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.248 0.619 . . . . 70.23 110.09 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -63.73 -50.12 70.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.108 1.363 . . . . 72.14 111.244 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.46 -28.53 66.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.704 0.402 . . . . 72.01 110.109 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.6 t -69.33 -35.98 76.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.778 0.431 . . . . 74.32 110.71 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.581 HG21 HG21 ' C' ' 64' ' ' VAL . 93.4 mt -71.25 -53.23 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.49 -0.559 . . . . 72.25 109.49 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -61.32 -28.91 69.54 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.794 0.838 . . . . 71.01 111.336 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 38.9 t -65.94 -50.34 64.72 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.084 -0.71 . . . . 50.44 109.084 170.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.519 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.85 -31.89 71.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.954 0.901 . . . . 73.13 112.436 179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' C' ' 114' ' ' ILE . 43.9 t -71.66 -38.9 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -66.47 -29.9 70.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.853 0.861 . . . . 63.13 111.377 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -74.16 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.43 0.692 . . . . 71.23 109.893 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.52 -7.33 68.46 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.418 0.449 . . . . 75.04 112.417 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 63.14 30.25 16.06 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.937 2.095 . . . . 73.1 112.561 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -82.77 162.32 55.68 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.639 -1.164 . . . . 74.11 108.409 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 140.27 92.72 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.41 2.074 . . . . 74.13 111.639 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.446 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 13.1 mm100 -57.59 112.55 1.47 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.891 0.877 . . . . 71.15 111.897 -173.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.43 93.21 4.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.45 -0.945 . . . . 74.02 108.45 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.27 127.75 49.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 75.24 108.554 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.532 HD11 HG22 ' C' ' 64' ' ' VAL . 86.8 mt -81.39 144.69 31.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.039 0.535 . . . . 70.32 111.114 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.23 143.26 95.64 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.323 0.649 . . . . 70.51 110.421 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.52 139.49 76.45 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.634 2.223 . . . . 64.31 112.33 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.25 118.2 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 108.888 -0.782 . . . . 73.41 108.888 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -83.87 60.24 5.68 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.864 0.84 . . . . 71.41 109.99 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -78.91 -43.43 24.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.844 -1.071 . . . . 74.2 110.034 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 115.792 -0.64 . . . . 64.42 109.694 177.72 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.5 ttp . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.289 0.848 . . . . 75.22 113.289 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -122.95 142.41 50.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.588 0.755 . . . . 71.42 109.301 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -155.04 98.9 2.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.658 -1.238 . . . . 70.41 107.658 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.7 132.62 49.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.269 0.628 . . . . 65.24 109.82 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tp -89.61 128.21 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.15 0.58 . . . . 61.23 109.548 177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -99.62 -40.5 7.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.835 0.854 . . . . 74.24 111.037 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -163.04 123.44 2.31 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.772 -0.649 . . . . 72.1 110.471 -162.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.93 132.1 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.294 -1.373 . . . . 62.5 107.294 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.544 ' HE1' HG13 ' D' ' 83' ' ' ILE . 12.4 p90 -160.04 143.52 14.03 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.957 0.786 . . . . 74.54 111.476 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -76.1 117.48 17.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.943 -1.026 . . . . 73.21 108.917 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -82.59 -26.14 32.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.91 0.386 . . . . 64.21 109.99 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.7 t70 -154.11 141.69 19.85 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.848 -1.069 . . . . 63.21 109.437 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.519 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.1 mt -141.63 145.98 23.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.221 1.408 . . . . 73.21 107.544 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -147.34 141.72 26.35 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.986 0.914 . . . . 73.02 108.69 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.9 t80 -153.77 124.89 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.285 -1.746 . . . . 55.32 106.285 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.43 112.66 7.43 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.596 0.634 . . . . 71.11 110.27 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.9 91.37 12.6 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.38 0.672 . . . . 42.02 109.353 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.5 -43.87 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.759 2.306 . . . . 55.13 112.919 -175.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 23.8 m120 -99.63 43.42 1.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.754 0.822 . . . . 70.34 109.056 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.623 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.78 -52.36 73.04 Favored Pre-proline 0 CA--C 1.57 1.737 0 N-CA-C 114.742 1.386 . . . . 75.42 114.742 -169.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.5 -6.0 8.09 Favored 'Trans proline' 0 C--N 1.388 2.656 0 CA-C-N 121.524 1.58 . . . . 63.14 112.578 172.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 21.8 t-160 -81.09 -42.15 21.43 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.08 0.952 . . . . 74.35 110.048 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.11 -18.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.27 0.628 . . . . 74.24 110.052 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.98 -29.62 70.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.949 0.9 . . . . 75.41 110.876 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -68.55 -17.71 64.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 70.44 111.841 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.07 109.97 21.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.768 0.827 . . . . 72.02 110.168 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.73 81.99 5.91 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.99 0.916 . . . . 74.13 110.882 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -159.42 161.35 35.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.654 -0.499 . . . . 73.24 109.654 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -82.9 109.07 14.62 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.876 0.87 . . . . 74.54 109.792 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -50.19 140.37 33.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.44 2.76 . . . . 74.54 113.569 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.73 127.29 31.31 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.051 0.845 . . . . 63.24 110.116 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 88.7 t -96.33 105.84 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.734 -0.839 . . . . 63.3 108.734 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -102.78 108.85 20.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.217 -1.401 . . . . 74.12 107.217 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.647 HD13 HD21 ' D' ' 128' ' ' LEU . 1.5 pt? -116.3 149.85 38.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.065 0.46 . . . . 72.51 110.498 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.69 130.27 24.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.395 1.078 . . . . 51.25 108.289 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.21 131.13 54.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.222 0.609 . . . . 62.45 109.503 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -133.55 128.95 36.36 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.853 -1.166 . . . . 74.41 107.853 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -106.23 150.03 26.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.522 0.329 . . . . 74.55 110.211 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.13 169.02 22.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.8 0.84 . . . . 71.21 110.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.4 m -147.87 158.73 44.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.874 0.869 . . . . 65.21 110.019 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -155.35 118.42 4.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.17 -1.048 . . . . 64.33 108.17 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.62 123.14 24.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.147 -0.686 . . . . 64.44 109.147 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' D' ' 57' ' ' GLU . 51.2 mt -96.21 -31.54 12.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.547 . . . . 71.41 110.366 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 179.64 8.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.857 0.863 . . . . 75.31 110.088 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.06 121.34 18.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.906 -1.043 . . . . 71.43 109.274 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 68.24 17.01 9.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.994 1.318 . . . . 71.21 112.069 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.36 116.68 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.628 ' HB2' HD13 ' D' ' 86' ' ' ILE . 82.6 m-85 -129.15 129.83 45.64 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.736 -0.839 . . . . 71.11 108.736 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.5 tt0 -87.79 135.37 33.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.845 -1.071 . . . . 73.14 108.64 171.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.02 139.2 43.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.853 -1.166 . . . . 71.5 107.853 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.69 131.84 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.39 -0.967 . . . . 71.44 108.39 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -114.58 117.14 30.06 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.267 -1.383 . . . . 73.22 107.267 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 44.6 ttm-85 -95.78 98.72 10.66 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.59 -1.263 . . . . 61.42 107.59 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.567 HG21 ' HB1' ' D' ' 110' ' ' ALA . 47.6 t -99.21 113.81 35.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.031 -1.1 . . . . 71.12 108.031 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.2 m -117.3 132.23 56.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 72.31 109.232 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.28 107.1 10.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.964 0.906 . . . . 72.45 109.286 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.8 m -92.57 119.77 32.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.687 -0.857 . . . . 74.3 108.687 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.73 137.11 46.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.699 -0.852 . . . . 44.05 108.699 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.3 p -149.15 140.38 23.12 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.846 0.459 . . . . 55.3 109.951 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.86 130.18 41.36 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.386 -1.338 . . . . 73.44 107.386 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.23 -121.14 12.91 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.706 -0.557 . . . . 74.42 111.706 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.15 6.95 15.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.247 1.019 . . . . 74.1 111.402 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.95 150.19 34.13 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.118 0.567 . . . . 71.43 109.751 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -79.8 116.72 20.13 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.814 -0.439 . . . . 73.02 109.814 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.11 -56.08 10.14 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.824 0.849 . . . . 72.23 110.102 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.54 169.19 23.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.021 -0.991 . . . . 75.33 110.211 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.4 mt -124.41 153.26 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.759 1.224 . . . . 73.14 108.012 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.517 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.2 t -158.43 139.66 13.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.137 0.575 . . . . 64.04 109.638 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.27 130.66 8.79 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.896 -0.779 . . . . 70.43 108.896 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.5 t -129.74 115.29 33.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.076 -0.713 . . . . 72.33 109.076 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.2 mt-30 -89.36 83.4 6.41 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.302 1.048 . . . . 62.44 108.478 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.79 102.97 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.174 -1.83 . . . . 52.02 109.509 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.2 162.71 23.87 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 116.319 -0.401 . . . . 33.33 112.393 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.0 136.77 5.08 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.951 -0.86 . . . . 72.23 110.951 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.544 HG13 ' HE1' ' D' ' 17' ' ' TYR . 69.2 mt -89.48 120.83 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.814 -0.81 . . . . 73.13 108.814 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -121.4 147.12 46.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.565 -0.531 . . . . 64.41 109.565 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 66.1 m -94.58 106.94 18.94 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.794 -0.817 . . . . 74.01 108.794 170.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' D' ' 94' ' ' MET . 3.5 mp -107.26 107.69 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.33 -0.989 . . . . 63.55 108.33 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.46 148.81 50.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.121 0.568 . . . . 62.43 109.977 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -22.71 11.93 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.073 -0.512 . . . . 64.44 114.273 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.566 HG22 ' HB2' ' D' ' 94' ' ' MET . 32.5 mm -136.41 139.89 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.247 -1.39 . . . . 72.34 107.247 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.01 179.7 7.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.182 0.593 . . . . 72.01 109.996 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.64 -99.83 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.297 -0.41 . . . . 73.45 113.762 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.7 p -83.45 -56.1 3.93 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.077 0.551 . . . . 42.4 111.977 -168.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.03 -37.63 78.73 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 120.796 0.332 . . . . 62.31 110.85 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.653 ' HG2' HG21 ' D' ' 86' ' ' ILE . 44.5 tpp -77.31 -19.93 55.7 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.956 -0.565 . . . . 73.12 111.751 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.63 -32.49 70.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 120.996 0.427 . . . . 62.13 111.124 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -62.65 -40.57 97.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.244 -0.889 . . . . 74.25 110.988 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.409 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 38.5 t -72.26 -51.26 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.786 0.434 . . . . 73.04 110.27 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.5 HD13 ' HG3' ' D' ' 94' ' ' MET . 10.7 mp -67.37 -18.86 65.31 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.466 0.706 . . . . 73.3 111.796 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -2.94 56.96 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.372 -0.682 . . . . 61.21 114.056 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.69 -62.79 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.95 0.875 . . . . 53.03 111.999 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -71.06 -50.08 37.8 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.826 0.676 . . . . 72.12 112.826 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.431 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 18.6 m -62.67 -45.23 88.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.373 0.669 . . . . 62.14 111.877 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.547 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.9 Cg_exo -55.99 -37.63 95.85 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.985 1.79 . . . . 61.23 113.057 168.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.82 -32.47 74.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.537 0.735 . . . . 65.24 111.143 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.14 -41.97 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 123.283 0.633 . . . . 75.33 110.136 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.9 mt -77.42 -17.96 57.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.172 -0.922 . . . . 60.31 111.541 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.98 -44.19 89.09 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 114.181 1.178 . . . . 71.45 114.181 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.23 -41.9 56.28 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.156 1.904 . . . . 64.35 112.808 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.98 -32.62 51.38 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.153 -0.93 . . . . 73.13 111.597 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.567 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -62.86 -55.61 24.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.593 0.757 . . . . 63.41 109.441 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.07 -40.45 76.89 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.025 -1.443 . . . . 73.12 110.337 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 3.4 tm-20 -57.42 -53.55 56.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.73 0.812 . . . . 75.23 111.742 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.404 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.6 t -57.74 -42.22 83.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.018 0.824 . . . . 71.41 110.935 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.517 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.6 mt -63.35 -54.15 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.348 -0.842 . . . . 72.51 110.642 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.516 HG23 ' HG3' ' D' ' 125' ' ' GLN . 48.0 m -54.02 -38.03 64.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 71.24 111.389 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -73.02 -44.49 60.83 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.062 -0.972 . . . . 73.2 110.462 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 73.4 mtm -65.2 -31.02 71.98 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.785 0.434 . . . . 52.24 111.803 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' D' ' 123' ' ' PHE . 79.4 t -66.36 -47.55 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 124.008 0.817 . . . . 74.02 109.771 176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -70.49 -27.91 64.57 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 123.356 0.41 . . . . 73.12 111.06 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -73.5 -34.79 65.45 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.794 0.838 . . . . 73.05 110.044 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.45 -1.56 88.73 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.663 -0.698 . . . . 71.31 112.008 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 58.94 34.69 23.76 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.753 2.021 . . . . 72.42 112.784 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.448 ' HB2' HG13 ' D' ' 118' ' ' VAL . 68.7 m-85 -96.45 163.58 20.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.489 -1.232 . . . . 70.1 108.287 170.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.28 139.62 72.77 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.02 1.814 . . . . 74.1 111.025 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.516 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.3 tt0 -55.21 135.23 49.78 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.716 0.807 . . . . 73.31 112.189 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.403 HD23 HG21 ' D' ' 114' ' ' ILE . 58.7 tp -103.02 104.84 15.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.491 -0.929 . . . . 73.12 108.491 -175.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -98.42 84.5 3.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.205 -1.406 . . . . 75.42 107.205 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.647 HD21 HD13 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -63.78 115.41 4.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.07 -1.085 . . . . 74.43 108.07 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 135.35 90.67 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 124.153 0.908 . . . . 44.14 111.554 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 107.25 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.663 2.242 . . . . 71.54 111.567 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 m -107.33 144.38 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.69 0.796 . . . . 63.33 109.455 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -82.15 101.45 10.44 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.138 -0.69 . . . . 74.3 109.138 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.733 0.813 . . . . 74.5 111.374 178.429 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.064 -0.717 . . . . 35.31 109.064 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.58 130.44 53.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.621 -1.251 . . . . 74.13 107.621 167.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 30.9 tt0 -133.57 106.65 7.53 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.205 -0.665 . . . . 70.14 109.205 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -75.87 102.92 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.402 -1.333 . . . . 63.52 107.402 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 7.2 tp-100 -74.75 -43.16 56.38 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.796 -0.638 . . . . 72.35 110.8 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 178.36 156.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.281 1.032 . . . . 71.11 110.243 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.56 106.42 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.228 1.011 . . . . 72.13 108.555 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.491 ' CD1' HG22 ' B' ' 122' ' ' THR . 77.0 m-85 -148.39 157.66 43.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.388 0.675 . . . . 75.15 110.604 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -73.72 120.69 19.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.033 0.933 . . . . 73.44 110.526 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -88.81 -22.58 23.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.983 -0.553 . . . . 70.51 110.743 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -154.86 141.86 19.24 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.937 0.773 . . . . 62.35 110.278 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.8 mt -143.19 141.62 26.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.539 1.536 . . . . 60.04 107.534 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -149.97 135.17 18.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.285 -1.006 . . . . 75.43 108.285 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.625 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 74.0 t80 -138.08 111.59 8.11 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 106.099 -1.815 . . . . 74.4 106.099 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.87 118.81 32.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.801 0.44 . . . . 65.1 110.183 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.69 75.07 32.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.694 0.797 . . . . 70.4 109.726 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.12 -27.56 29.37 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.47 2.113 . . . . 72.44 110.656 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 31' ' ' VAL . 57.7 m-20 -96.69 24.96 5.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.08 -1.418 . . . . 72.45 109.777 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.14 99.86 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.985 0.914 . . . . 72.4 112.829 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.07 -16.35 40.38 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 121.714 1.609 . . . . 65.11 112.638 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -85.81 -20.5 29.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.662 0.785 . . . . 74.24 110.461 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' ASN . 46.3 t -68.97 -23.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.201 0.524 . . . . 72.34 110.459 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -67.98 -30.25 69.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.592 -0.731 . . . . 75.25 110.517 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -72.6 -30.39 64.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.964 0.906 . . . . 52.13 110.177 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -75.42 161.28 29.37 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.676 -0.693 . . . . 73.25 111.243 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.41 159.72 29.25 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.818 -1.083 . . . . 74.43 108.755 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.0 m-90 -82.82 57.25 3.74 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.322 0.582 . . . . 65.5 110.283 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -154.9 79.67 4.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.554 0.741 . . . . 63.41 109.406 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.98 155.89 23.29 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.202 1.935 . . . . 62.13 110.83 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.17 115.97 28.31 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.007 -1.109 . . . . 62.53 108.007 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 65' ' ' THR . 21.9 m -98.96 98.8 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.703 0.764 . . . . 74.33 110.921 -173.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.73 115.44 19.33 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.364 -0.976 . . . . 70.45 108.364 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 pt? -98.71 145.05 27.3 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.379 -0.6 . . . . 72.35 109.379 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.576 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.1 t70 -137.67 122.52 18.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.03 -1.1 . . . . 65.12 108.03 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD21 HG11 ' A' ' 131' ' ' VAL . 4.1 mp -102.62 118.12 36.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.837 -0.801 . . . . 71.12 108.837 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -132.12 137.27 47.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.484 0.714 . . . . 72.33 109.734 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.7 m -131.1 139.11 49.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.868 0.867 . . . . 55.24 109.631 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.76 115.32 5.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.668 0.787 . . . . 73.04 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.2 m -90.17 155.37 19.07 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.569 0.748 . . . . 74.54 110.51 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -149.57 161.15 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.534 1.134 . . . . 65.4 108.786 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -114.85 115.93 27.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.275 0.63 . . . . 71.51 109.719 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -90.04 -31.22 17.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.402 0.681 . . . . 72.54 111.471 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 -172.48 3.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.744 0.652 . . . . 71.21 110.365 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.74 105.65 1.03 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.209 1.003 . . . . 73.13 111.055 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 67.93 12.44 8.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.083 1.353 . . . . 73.35 112.733 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.33 106.86 19.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.48 -1.304 . . . . 73.11 107.48 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -113.16 123.96 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.967 -1.015 . . . . 72.43 109.146 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.7 119.86 38.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.147 -1.388 . . . . 75.0 108.548 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.24 123.61 53.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.676 -1.601 . . . . 75.12 106.676 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 99.4 t -104.19 130.0 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.635 -0.876 . . . . 44.14 108.635 173.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 113.14 26.49 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.574 -1.639 . . . . 75.21 106.574 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -100.22 101.99 13.15 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.969 -1.123 . . . . 64.45 107.969 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.3 t -95.11 126.79 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.278 -1.008 . . . . 52.34 108.278 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 23.2 m -110.55 133.95 52.84 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.24 105.85 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.166 -1.42 . . . . 62.43 107.166 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.0 m -103.78 130.35 51.3 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.732 -0.84 . . . . 54.02 108.732 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.36 109.69 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.147 -1.057 . . . . 73.22 108.147 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.3 m -136.61 128.5 29.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.035 -0.728 . . . . 54.24 109.035 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 tt -94.65 87.66 5.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.611 -1.625 . . . . 63.14 106.611 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.76 -121.3 5.4 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.528 -0.629 . . . . 64.32 111.528 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -90.8 -25.84 19.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.195 0.598 . . . . 72.12 111.602 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 125.79 34.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.774 -0.454 . . . . 63.25 109.774 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 m -74.36 134.37 42.48 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 115.776 -0.647 . . . . 62.41 109.658 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.63 -55.62 4.34 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -167.3 168.99 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.039 -0.982 . . . . 75.53 110.476 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.5 tp -132.52 143.68 49.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.644 1.178 . . . . 55.11 108.673 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.625 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 13.8 m -138.02 124.93 21.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.635 0.774 . . . . 64.14 109.432 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.41 125.77 23.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.106 -0.701 . . . . 52.25 109.106 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -131.89 114.69 25.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.979 0.912 . . . . 74.23 109.512 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 74.1 mt-30 -85.53 86.6 7.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.154 -0.93 . . . . 72.11 108.876 172.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.67 99.1 5.68 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.078 -0.965 . . . . 73.53 109.071 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.66 152.41 21.08 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.593 -0.603 . . . . 73.14 111.593 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.07 134.24 5.67 Favored Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.273 -1.131 . . . . 71.21 110.273 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 43.4 mt -87.85 125.71 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.255 -1.017 . . . . 72.24 108.255 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -131.82 120.23 22.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 48.3 t -92.2 100.83 13.37 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.177 -1.045 . . . . 65.31 108.177 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.425 HD13 HD21 ' A' ' 98' ' ' LEU . 50.5 pt -116.16 141.01 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.246 0.618 . . . . 74.13 110.515 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.39 174.32 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.115 0.966 . . . . 51.42 110.119 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.61 -32.1 5.47 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.129 -0.487 . . . . 71.32 112.791 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.47 156.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.872 0.869 . . . . 61.55 109.883 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.9 175.04 12.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.042 -0.725 . . . . 41.23 109.042 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.46 -144.52 37.41 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.871 -0.492 . . . . 54.33 111.871 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 11.2 t -65.41 -16.3 63.48 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.147 0.579 . . . . 73.23 112.151 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.19 -54.55 31.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.832 0.853 . . . . 72.2 110.204 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 56.3 ttm -72.22 -34.62 68.48 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.451 -0.795 . . . . 71.5 110.761 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -65.12 -41.29 95.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.537 0.735 . . . . 74.32 111.63 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -59.76 -40.28 87.62 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.678 -0.692 . . . . 55.33 110.159 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.768 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 8.6 m -76.08 -37.34 58.31 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.598 0.962 . . . . 74.52 113.598 -172.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD21 HD13 ' A' ' 86' ' ' ILE . 89.1 mt -85.41 -15.45 43.04 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.93 0.332 . . . . 71.33 110.578 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.59 -28.65 9.4 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.399 -0.667 . . . . 73.34 113.56 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.06 -55.71 0.71 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.255 1.027 . . . . 73.24 113.153 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.768 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.4 t80 -50.64 -65.04 0.63 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.722 0.809 . . . . 74.33 111.699 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.4 m -64.46 -45.67 77.42 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 118.209 -0.9 . . . . 63.32 112.848 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.68 -41.34 54.28 Favored 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.181 1.921 . . . . 73.31 113.69 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.444 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 21.4 t-20 -71.78 -32.24 67.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.371 0.669 . . . . 75.21 110.52 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 101' ' ' TYR . 24.3 mm -65.37 -35.27 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.781 0.832 . . . . 54.13 110.487 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -80.69 -20.42 42.97 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.168 0.987 . . . . 72.45 111.471 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.519 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 25.8 t80 -67.63 -43.39 40.18 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 114.263 1.209 . . . . 75.1 114.263 -168.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 36.3 Cg_exo -62.13 -34.89 78.12 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.78 1.653 . . . . 75.22 112.425 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -74.25 -40.99 62.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.445 0.698 . . . . 73.13 111.593 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.75 82.62 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.789 0.436 . . . . 72.13 109.923 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.5 ttm180 -53.88 -51.68 62.89 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.509 1.131 . . . . 74.43 110.164 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.72 -46.15 90.91 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.181 0.925 . . . . 72.11 110.881 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -57.75 -48.75 78.75 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.898 0.749 . . . . 32.54 110.773 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -61.93 -50.62 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.063 0.945 . . . . 73.15 110.499 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.575 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.2 m -57.24 -41.42 79.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.722 0.809 . . . . 51.14 111.33 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.14 -40.71 82.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.284 -0.871 . . . . 72.41 109.691 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.14 -42.06 89.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 73.15 110.951 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -63.65 -45.83 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.006 0.922 . . . . 70.02 110.952 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.4 p -73.88 -28.86 61.77 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.923 0.489 . . . . 65.31 111.429 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.407 HH12 ' HG3' ' B' ' 112' ' ' GLU . 83.0 mtt-85 -72.38 -28.42 62.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.504 0.721 . . . . 74.42 109.264 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.17 89.05 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.456 -0.793 . . . . 75.33 112.831 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.5 m 68.67 17.14 8.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.651 1.181 . . . . 52.31 111.515 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -92.03 161.01 34.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 74.22 110.739 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.62 123.88 14.77 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.469 2.113 . . . . 40.41 111.176 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.575 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.2 tt0 -54.45 141.3 31.27 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.869 1.268 . . . . 61.3 112.96 -175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.417 HD22 HG11 ' A' ' 40' ' ' VAL . 82.3 mt -125.63 96.11 4.67 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.593 0.757 . . . . 61.12 109.563 -177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.2 105.45 17.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.713 -0.847 . . . . 73.45 108.713 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.531 HD11 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -62.73 130.14 43.63 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.651 0.594 . . . . 71.41 110.0 -174.436 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.67 144.92 94.42 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 122.908 0.483 . . . . 63.43 111.2 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.587 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 73.7 Cg_exo -54.62 144.52 63.66 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 124.152 3.235 . . . . 73.44 115.153 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 44' ' ' LEU . 31.5 m -115.98 115.06 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.81 0.844 . . . . 63.35 109.873 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -89.41 65.72 7.21 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.625 0.77 . . . . 73.31 109.0 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.61 -33.11 41.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.384 -0.826 . . . . 73.21 109.857 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 73.23 110.037 171.683 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 115.036 1.495 . . . . 73.12 115.036 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -134.68 127.03 30.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.363 -1.347 . . . . 74.13 107.363 169.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -121.98 146.86 46.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.635 -0.876 . . . . 73.4 108.635 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -166.81 142.54 4.39 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.932 0.77 . . . . 75.42 110.145 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.07 120.41 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.393 -0.966 . . . . 75.01 108.393 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -79.88 -47.31 15.3 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.948 -0.39 . . . . 75.31 109.948 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -164.47 145.34 8.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.92 -0.582 . . . . 72.35 109.83 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -118.05 150.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 106.851 -1.537 . . . . 75.34 106.851 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -168.75 145.61 3.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.832 0.453 . . . . 73.21 111.172 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.3 m -73.04 117.24 14.53 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.037 -1.097 . . . . 74.52 108.037 167.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -83.94 -42.98 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.829 -0.623 . . . . 73.23 110.2 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 25.9 t70 -144.81 142.03 29.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.028 -0.533 . . . . 63.21 111.578 -168.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.3 mm -137.15 142.96 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.091 1.357 . . . . 73.54 108.053 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -141.35 137.97 32.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.924 -1.51 . . . . 73.33 106.924 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -152.01 110.04 3.69 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.778 -1.193 . . . . 73.52 107.778 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -118.72 111.89 19.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.869 -0.789 . . . . 74.04 108.869 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.8 85.92 3.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 109.116 -0.698 . . . . 75.12 109.116 170.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.8 -22.85 36.19 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.024 2.483 . . . . 72.3 110.8 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -125.03 29.89 6.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.88 1.272 . . . . 73.24 109.617 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.27 -48.11 45.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 125.191 1.397 . . . . 45.31 113.365 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.5 Cg_endo -84.65 -15.06 6.24 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.364 2.043 . . . . 74.12 112.771 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.92 -0.32 47.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.232 0.613 . . . . 63.43 111.6 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.475 HG23 HD12 ' B' ' 68' ' ' LEU . 11.2 p -69.46 -31.13 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.225 0.61 . . . . 75.5 110.919 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -71.66 -40.6 69.54 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.551 0.74 . . . . 61.44 110.96 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -81.1 -8.32 59.74 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.372 -0.831 . . . . 55.25 111.264 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' HD22 ' B' ' 68' ' ' LEU . 5.8 mmtp -100.13 109.1 21.38 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.057 0.943 . . . . 72.12 109.98 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -96.0 75.89 3.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.59 0.756 . . . . 75.13 111.903 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.441 ' HB2' HD23 ' B' ' 68' ' ' LEU . 4.8 m-90 -153.76 172.28 17.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.47 1.508 . . . . 74.01 107.159 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -90.24 119.49 69.22 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.655 -0.869 . . . . 64.42 108.655 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.19 102.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.117 2.544 . . . . 75.01 112.214 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.83 102.55 1.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.042 -0.526 . . . . 72.41 109.826 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.403 HG13 HG13 ' B' ' 64' ' ' VAL . 59.7 t -89.57 121.38 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 72.24 110.121 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -118.86 123.68 45.31 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.856 1.262 . . . . 65.23 108.52 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.479 HD21 HD22 ' B' ' 128' ' ' LEU . 6.4 mp -92.72 158.88 15.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.3 0.64 . . . . 74.31 110.279 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.59 110.76 3.68 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.948 -1.13 . . . . 63.22 107.948 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -104.99 150.19 25.13 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.37 0.605 . . . . 71.24 110.063 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -138.16 128.12 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.447 -1.252 . . . . 74.32 108.643 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -110.35 108.15 18.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.505 0.722 . . . . 42.12 109.335 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.54 153.94 33.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.242 1.017 . . . . 71.41 109.492 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -143.57 162.98 34.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.32 0.648 . . . . 54.44 109.508 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.7 p -150.6 150.4 31.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.161 0.584 . . . . 73.13 109.658 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -84.56 112.6 20.57 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.847 -0.797 . . . . 75.14 108.847 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.453 HD12 HG23 ' B' ' 83' ' ' ILE . 82.8 mt -88.93 -54.2 4.24 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.724 -0.473 . . . . 65.34 109.724 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -170.24 3.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.784 0.834 . . . . 61.22 110.004 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.84 117.38 7.46 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.19 -0.914 . . . . 74.41 110.19 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 71.41 -2.27 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.456 1.503 . . . . 55.31 112.092 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -106.51 103.15 14.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.784 0.833 . . . . 74.03 109.448 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -108.65 141.39 40.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.85 0.86 . . . . 64.13 109.641 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' B' ' 51' ' ' LEU . 15.5 tt0 -99.64 102.52 14.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.393 -0.965 . . . . 74.23 108.393 172.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.05 118.56 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.565 -0.902 . . . . 73.01 108.565 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.5 t -104.82 119.57 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.721 0.808 . . . . 74.15 109.164 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.24 129.45 39.29 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.674 -1.602 . . . . 74.31 106.674 171.158 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 24.7 ttp180 -121.31 108.25 13.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.723 -0.843 . . . . 73.44 108.723 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.519 ' HB ' HD11 ' B' ' 114' ' ' ILE . 19.9 t -105.17 120.04 55.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.865 -1.161 . . . . 62.44 107.865 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -113.54 126.96 55.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 73.32 108.962 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.632 HG21 HG21 ' B' ' 114' ' ' ILE . 42.0 t -113.65 119.26 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.432 1.093 . . . . 72.22 109.153 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -118.31 140.33 49.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.327 -0.99 . . . . 63.24 108.327 170.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.87 143.41 50.14 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.053 -1.091 . . . . 64.35 108.053 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.4 p -130.71 130.35 43.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.771 -0.455 . . . . 73.51 109.771 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 0.8 OUTLIER -110.31 112.66 24.76 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.146 -1.057 . . . . 64.3 108.146 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.69 -113.3 3.77 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.331 -1.107 . . . . 75.33 110.331 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.62 5.5 10.57 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.811 0.844 . . . . 74.43 111.164 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -114.43 166.84 11.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.523 0.729 . . . . 74.31 109.245 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 33.5 m -69.59 135.63 50.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.035 0.534 . . . . 72.42 110.707 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -87.31 -58.66 2.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.5 -1.296 . . . . 73.22 107.5 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -156.95 163.69 38.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.617 -1.174 . . . . 65.13 109.956 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 73.6 mt -124.74 143.27 50.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.822 -1.547 . . . . 74.53 106.822 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.3 151.89 29.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.507 -0.923 . . . . 60.32 108.507 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.1 tt0 -165.16 130.99 2.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.049 -0.723 . . . . 73.44 109.049 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.2 t -125.17 144.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 55.4 109.369 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 25.7 mt-30 -121.14 94.62 4.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.62 -1.252 . . . . 72.25 107.62 169.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -85.39 100.44 11.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.57 -0.9 . . . . 63.31 108.57 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.86 162.92 31.71 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.149 -0.78 . . . . 63.4 111.149 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.37 127.5 1.75 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.619 -0.592 . . . . 60.44 111.619 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.453 HG23 HD12 ' B' ' 51' ' ' LEU . 40.6 mt -85.08 126.0 40.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.691 0.796 . . . . 71.34 109.162 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.29 134.04 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.026 0.931 . . . . 71.41 108.748 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -100.98 100.56 11.19 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.029 0.932 . . . . 63.52 108.727 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.524 HG13 HD11 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -121.61 143.04 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.092 0.957 . . . . 71.52 110.813 -177.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.57 159.17 43.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 43.33 109.709 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.54 -44.42 2.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.359 0.412 . . . . 75.01 112.692 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.532 HG22 ' HB3' ' B' ' 93' ' ' GLN . 13.1 pt -65.64 140.27 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 74.04 111.828 177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -151.65 152.01 32.24 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.351 1.06 . . . . 52.44 108.36 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.92 -113.87 5.49 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 124.027 0.829 . . . . 34.24 113.284 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 68.4 m -65.79 -40.55 92.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.49 1.116 . . . . 72.22 111.609 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.532 ' HB3' HG22 ' B' ' 89' ' ' ILE . 90.0 mt-30 -65.81 -43.69 87.89 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.835 0.454 . . . . 54.23 111.172 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.43 ' HA ' HD12 ' B' ' 89' ' ' ILE . 14.2 tpt -69.37 -35.5 75.9 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.562 -0.745 . . . . 74.25 110.676 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 -24.96 59.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.289 -0.869 . . . . 63.34 110.99 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 25.8 t-80 -81.97 -29.54 32.1 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.274 0.63 . . . . 74.23 110.59 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -78.91 -68.09 0.69 Allowed 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 109.458 -0.571 . . . . 73.45 109.458 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.524 HD11 HG13 ' B' ' 86' ' ' ILE . 8.4 mp -73.5 -25.99 60.69 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.924 0.489 . . . . 62.44 112.289 -173.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.2 -30.13 23.39 Favored Glycine 0 C--N 1.334 0.457 0 O-C-N 123.368 0.417 . . . . 71.04 113.018 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -123.44 -56.58 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.734 0.642 . . . . 44.22 112.734 -170.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -72.94 -49.18 30.91 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.295 0.48 . . . . 75.11 112.295 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.3 m -60.39 -47.81 95.47 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.263 1.025 . . . . 71.03 111.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 72.7 Cg_exo -56.5 -37.77 96.66 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.985 1.79 . . . . 65.22 113.102 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.4 -29.94 70.21 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 75.02 110.892 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.39 -49.23 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.654 0.781 . . . . 64.13 109.774 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.83 -12.61 59.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 73.25 111.942 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.05 -48.0 61.37 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 118.141 -0.933 . . . . 74.22 112.944 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.46 -33.43 97.29 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.023 1.816 . . . . 74.52 113.488 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HE2' HG21 ' D' ' 115' ' ' THR . 53.8 m-85 -71.08 -44.47 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.426 0.69 . . . . 75.33 110.556 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.404 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -63.2 -38.77 92.5 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.883 0.873 . . . . 74.21 110.193 175.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.513 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 57.4 ttt-85 -60.3 -57.02 14.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.487 1.515 . . . . 71.41 111.087 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.407 ' HG3' HH12 ' A' ' 120' ' ' ARG . 14.5 tp10 -58.38 -33.49 69.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.923 0.889 . . . . 64.5 110.89 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' HB3' HG21 ' B' ' 78' ' ' VAL . 1.3 m -63.31 -54.94 29.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.312 0.645 . . . . 65.14 111.38 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.632 HG21 HG21 ' B' ' 64' ' ' VAL . 57.6 mt -58.86 -54.53 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.233 0.613 . . . . 60.33 110.05 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.3 m -55.9 -39.26 71.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.762 1.225 . . . . 71.25 111.663 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -62.04 -50.67 71.06 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 115.788 -0.642 . . . . 74.32 110.094 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -65.74 -33.71 76.49 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.441 0.696 . . . . 75.13 111.522 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 114' ' ' ILE . 76.9 t -63.26 -46.57 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.886 0.874 . . . . 73.52 110.192 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' B' ' 125' ' ' GLN . 23.3 m -68.35 -28.92 67.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.653 -0.703 . . . . 73.2 111.481 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 96.1 mtt-85 -72.3 -16.08 61.9 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 115.621 -0.718 . . . . 64.2 110.708 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.15 15.89 59.9 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.657 -1.079 . . . . 63.15 115.476 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.491 HG22 ' CD1' ' A' ' 17' ' ' TYR . 15.5 p 79.56 13.17 1.1 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 126.576 1.95 . . . . 71.13 112.507 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 119' ' ' SER . 96.6 m-85 -103.63 153.7 38.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 122.811 0.444 . . . . 72.32 110.597 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.08 153.26 59.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.856 2.371 . . . . 75.12 112.296 172.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 1.1 mp0 -64.86 115.11 5.0 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.445 0.465 . . . . 73.42 110.227 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -108.12 85.65 2.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.983 -1.117 . . . . 65.22 107.983 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -92.37 132.63 36.59 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.045 -0.979 . . . . 71.52 109.07 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.513 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 30.5 mt -81.0 147.85 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.42 -0.809 . . . . 71.24 111.439 -169.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.58 147.94 50.67 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.519 0.728 . . . . 65.23 109.639 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.85 97.9 0.41 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.912 2.408 . . . . 53.45 111.474 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.87 111.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 107.92 -1.141 . . . . 62.32 107.92 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.18 100.62 1.31 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.4 -0.818 . . . . 73.4 110.159 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -59.45 -33.2 70.99 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.115 -0.948 . . . . 74.35 109.649 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -65.13 -39.01 92.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.611 1.564 . . . . 75.21 112.175 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.12 73.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.791 0.436 . . . . 72.42 110.434 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 115.061 -0.972 . . . . 74.32 109.615 178.532 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.476 ' HG3' HG12 ' C' ' 89' ' ' ILE . 28.0 ttt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 121.537 0.684 . . . . 71.34 112.784 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 44.0 m -115.62 88.42 2.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.638 -0.71 . . . . 74.01 109.217 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.587 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 73.5 t80 -97.63 129.96 44.69 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.62 -0.882 . . . . 74.21 108.62 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -139.89 125.73 19.53 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.277 0.631 . . . . 53.13 109.367 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.3 mt -77.67 119.99 27.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.702 -0.851 . . . . 74.23 108.702 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.3 mm100 -83.95 -49.32 9.09 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.641 0.377 . . . . 74.42 110.038 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -170.09 145.36 2.83 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.682 0.614 . . . . 63.43 109.741 -171.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -133.11 133.95 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' D' ' 122' ' ' THR . 34.2 p90 -167.47 162.68 14.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.901 0.858 . . . . 75.3 111.676 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -83.38 120.52 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.064 -0.971 . . . . 71.45 109.462 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -73.35 -49.33 27.86 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.527 -0.916 . . . . 74.32 108.527 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.1 t70 -134.3 139.26 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.681 -1.145 . . . . 53.31 109.412 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -137.2 138.24 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.097 -1.446 . . . . 71.41 107.097 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 38.9 t -152.11 149.87 29.28 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.479 0.712 . . . . 51.13 109.118 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -155.67 138.47 15.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.08 -1.081 . . . . 72.34 108.08 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 56.4 mt-10 -135.1 148.25 49.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.284 1.034 . . . . 74.43 108.452 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -154.98 85.5 3.55 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 106.963 -1.495 . . . . 74.15 106.963 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 -50.12 4.15 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.328 2.018 . . . . 65.45 111.144 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.48 35.68 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.025 0.93 . . . . 63.24 110.517 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.3 -50.37 88.46 Favored Pre-proline 0 CA--C 1.565 1.519 0 C-N-CA 124.441 1.096 . . . . 63.13 113.81 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.81 -25.08 20.6 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 121.642 1.561 . . . . 64.54 112.126 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -67.93 -19.57 64.99 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.96 1.304 . . . . 74.33 112.809 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.17 -25.44 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 113.621 0.971 . . . . 65.25 113.621 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -65.79 -40.42 91.93 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.212 0.529 . . . . 71.0 110.667 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -98.75 13.59 31.73 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.258 1.023 . . . . 74.4 110.413 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 136.7 38.03 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.325 -0.62 . . . . 74.05 109.325 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -85.05 92.58 8.39 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.327 -1.731 . . . . 44.22 106.327 168.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -75.34 89.28 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.763 0.792 . . . . 74.52 112.028 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -150.27 67.74 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.018 -1.104 . . . . 43.24 108.018 163.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -91.85 154.46 3.38 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.651 2.234 . . . . 72.44 111.747 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -86.82 118.35 26.16 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.85 -0.796 . . . . 64.04 108.85 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.78 97.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.177 -1.046 . . . . 74.31 108.177 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 53.0 mtpt -95.2 101.28 13.01 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.342 -0.984 . . . . 73.34 108.342 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.654 HD23 HG22 ' C' ' 64' ' ' VAL . 2.9 tm? -102.13 129.77 48.57 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.116 -1.068 . . . . 54.31 108.116 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.31 131.92 45.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.048 0.939 . . . . 55.23 108.83 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 99.3 mt -123.78 148.47 46.63 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.825 0.85 . . . . 75.11 109.384 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.21 125.43 8.02 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.74 -0.837 . . . . 74.13 108.74 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -113.4 147.72 37.2 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.569 -0.53 . . . . 52.03 109.569 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.06 42.74 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.209 1.004 . . . . 71.01 108.435 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -137.8 145.96 42.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.722 0.409 . . . . 74.21 110.259 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.1 p -145.0 129.81 18.21 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.625 0.77 . . . . 72.11 109.691 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -74.36 118.18 17.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.026 0.53 . . . . 70.23 109.881 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.47 HD11 HD12 ' C' ' 83' ' ' ILE . 74.2 mt -84.67 -40.61 17.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.145 0.578 . . . . 73.55 109.774 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.09 -178.94 7.67 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.092 . . . . 73.3 109.399 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -62.75 124.87 22.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.967 -0.56 . . . . 53.01 109.993 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.03 -5.98 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.288 1.435 . . . . 60.5 111.944 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.28 114.78 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.061 0.944 . . . . 72.53 109.697 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.93 125.5 35.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.18 0.992 . . . . 70.14 108.869 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.412 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.7 tt0 -95.39 121.19 36.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.997 0.919 . . . . 71.33 109.935 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.73 132.41 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.596 -0.89 . . . . 73.24 108.596 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -126.28 112.53 30.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 124.164 0.985 . . . . 64.3 108.777 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.95 111.72 23.64 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.319 -0.993 . . . . 73.42 108.319 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.82 107.33 12.51 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.114 -0.699 . . . . 75.22 109.114 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -100.76 127.2 54.12 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 CA-C-N 114.956 -1.02 . . . . 71.22 108.408 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 48.4 m -131.43 130.23 42.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.405 -0.591 . . . . 74.24 109.405 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.654 HG22 HD23 ' C' ' 42' ' ' LEU . 86.0 t -120.11 120.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.11 109.302 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -114.45 130.0 56.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.544 -0.909 . . . . 70.12 108.544 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.33 93.62 4.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.904 -1.517 . . . . 75.12 106.904 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 78.7 p -158.56 140.42 13.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.282 0.633 . . . . 72.23 109.565 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.1 tp -77.99 -32.97 51.5 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.291 -0.633 . . . . 74.11 109.291 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.82 -82.67 0.06 OUTLIER Glycine 0 C--N 1.345 1.059 0 N-CA-C 110.4 -1.08 . . . . 62.1 110.4 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.88 -31.79 16.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.185 0.594 . . . . 60.43 109.841 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.46 96.08 7.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.22 0.608 . . . . 73.44 109.789 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -90.69 133.63 35.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.274 -0.876 . . . . 74.01 110.929 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.2 -56.91 3.76 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.406 -0.961 . . . . 53.21 108.406 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -160.74 175.34 12.72 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.745 -1.116 . . . . 75.23 111.952 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.5 tm? -141.29 146.65 37.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.387 1.875 . . . . 60.31 105.95 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.424 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.5 t -152.78 153.55 33.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.274 0.629 . . . . 50.12 109.315 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -159.64 136.47 9.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.707 0.403 . . . . 65.14 111.128 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' C' ' 110' ' ' ALA . 45.8 t -140.78 113.49 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.518 1.127 . . . . 72.41 108.881 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 66.1 mt-30 -91.97 97.76 11.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.252 -1.018 . . . . 73.43 108.252 173.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 53.9 tp60 -86.56 114.16 23.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.514 0.726 . . . . 64.43 109.755 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.27 145.07 15.86 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.201 -0.359 . . . . 74.32 112.201 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.539 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.72 132.81 4.55 Favored Glycine 0 CA--C 1.504 -0.601 0 N-CA-C 111.839 -0.504 . . . . 75.13 111.839 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.47 HD12 HD11 ' C' ' 51' ' ' LEU . 7.8 mm -87.29 121.59 38.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.226 -1.027 . . . . 43.3 108.226 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.34 123.8 26.06 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.607 0.763 . . . . 73.12 109.569 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 36.5 p -97.75 125.46 42.58 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.84 0.456 . . . . 50.11 110.167 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.77 132.74 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.381 -0.97 . . . . 75.14 108.381 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -137.01 147.79 46.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.581 0.752 . . . . 63.33 109.755 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.1 -53.02 3.89 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.936 -0.574 . . . . 60.11 111.726 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.476 HG12 ' HG3' ' C' ' 9' ' ' MET . 2.9 pp -96.78 164.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.858 0.863 . . . . 71.42 111.487 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -168.41 -170.62 1.29 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.891 1.276 . . . . 74.44 109.264 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.09 -121.98 26.13 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 119.77 -0.461 . . . . 64.23 113.427 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 18.2 p -65.22 -33.21 75.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.943 0.897 . . . . 63.12 112.281 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.57 -42.49 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.908 0.483 . . . . 61.21 110.908 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptm -76.1 -24.93 55.03 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.005 0.19 . . . . 74.31 110.644 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.88 -43.7 78.74 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.165 0.507 . . . . 74.44 110.269 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -67.79 -34.36 76.63 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.268 -0.878 . . . . 60.34 110.805 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.88 -54.8 11.83 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.767 0.427 . . . . 55.35 110.478 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.486 HD23 ' SG ' ' C' ' 102' ' ' CYS . 63.8 mt -76.45 -14.53 60.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.648 0.779 . . . . 65.42 111.569 -177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.48 -29.88 8.52 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.388 0.43 . . . . 73.11 113.483 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.3 -59.39 1.98 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.094 0.558 . . . . 71.22 110.93 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.411 ' O ' HG12 ' C' ' 105' ' ' ILE . 62.0 t80 -72.66 -55.43 6.83 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.206 0.941 . . . . 73.32 111.721 -164.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.486 ' SG ' HD23 ' C' ' 98' ' ' LEU . 61.0 m -58.45 -48.06 97.64 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 124.073 0.949 . . . . 72.25 112.804 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.5 Cg_exo -59.38 -34.25 97.55 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.296 1.998 . . . . 71.32 113.082 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.448 ' C ' HD21 ' C' ' 104' ' ' ASN . 0.1 OUTLIER -70.79 -33.85 71.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.64 0.776 . . . . 73.15 110.308 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.505 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -66.85 -42.17 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 122.851 0.46 . . . . 72.21 109.842 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.539 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.9 mt -68.88 -32.19 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.053 -0.976 . . . . 74.55 111.408 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.66 -53.52 59.39 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.315 1.228 . . . . 73.1 114.315 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.58 -34.41 95.3 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.325 2.016 . . . . 73.45 113.541 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.409 ' HE2' HG21 ' A' ' 115' ' ' THR . 47.9 m-85 -67.96 -45.72 73.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.541 0.737 . . . . 72.31 110.469 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.59 -35.71 80.87 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.421 -0.809 . . . . 74.24 110.946 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -65.32 -46.77 78.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.96 1.304 . . . . 64.05 110.363 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -68.39 -35.59 77.91 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 64.13 109.779 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.404 ' HB3' HG21 ' C' ' 78' ' ' VAL . 10.6 t -68.65 -31.39 70.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.884 0.473 . . . . 65.41 111.351 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.43 HD13 HG23 ' C' ' 64' ' ' VAL . 63.3 mt -74.32 -47.92 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 74.15 110.162 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.4 m -63.48 -28.92 70.29 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.063 0.545 . . . . 52.21 110.746 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.3 t -69.2 -46.75 66.68 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 123.861 0.865 . . . . 53.53 109.559 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.569 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.58 -39.9 89.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.214 1.005 . . . . 71.51 112.256 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.6 t -67.71 -38.78 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.95 0.9 . . . . 72.11 110.254 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 40.4 t -65.22 -37.66 87.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.564 -0.744 . . . . 74.43 111.069 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.5 mtt-85 -68.64 -35.89 77.87 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.247 -0.888 . . . . 70.21 109.469 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.55 1.91 80.46 Favored Glycine 0 C--N 1.354 1.54 0 O-C-N 123.801 0.688 . . . . 74.44 113.339 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' D' ' 17' ' ' TYR . 69.7 p 55.53 60.99 3.04 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.746 1.618 . . . . 33.51 111.853 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.46 ' HB2' HG13 ' C' ' 118' ' ' VAL . 86.7 m-85 -124.04 163.76 33.64 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 124.89 1.276 . . . . 74.02 108.822 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 97.2 Cg_endo -74.33 -169.26 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.948 2.432 . . . . 72.22 113.484 -174.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.413 ' HB3' ' OD1' ' C' ' 127' ' ' ASN . 21.0 mm-40 -54.41 112.02 0.91 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.059 -0.973 . . . . 71.34 111.591 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.462 HD11 HG11 ' C' ' 64' ' ' VAL . 3.1 tm? -108.07 87.01 2.4 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.426 -2.064 . . . . 72.05 105.426 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' C' ' 125' ' ' GLN . 12.1 m120 -95.31 97.53 9.92 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.311 -0.996 . . . . 54.23 108.311 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.516 HD23 ' H ' ' C' ' 129' ' ' ALA . 1.2 tt -63.6 149.21 46.93 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.205 -0.907 . . . . 73.42 108.99 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.516 ' H ' HD23 ' C' ' 128' ' ' LEU . . . -49.54 153.09 2.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.68 1.192 . . . . 74.53 112.76 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.11 -158.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.417 2.745 . . . . 62.21 114.959 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.5 m -93.94 155.19 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.838 0.828 . . . . 71.12 112.493 -168.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -69.83 110.62 5.07 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 113.776 -1.556 . . . . 64.43 110.936 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -44.54 -34.49 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.371 1.468 . . . . 70.41 114.305 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 CA--C 1.552 1.039 0 N-CA-C 112.197 0.443 . . . . 73.52 112.197 -176.027 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.458 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 7.1 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 113.602 0.964 . . . . 63.01 113.602 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 60.0 m -131.02 130.53 43.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 44.22 108.827 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.1 t80 -149.11 104.31 3.41 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.278 -1.008 . . . . 73.4 108.278 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -119.23 127.5 53.33 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.456 0.702 . . . . 65.2 109.732 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.25 117.52 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 108.529 -0.915 . . . . 73.1 108.529 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -95.4 -46.99 6.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.137 0.575 . . . . 71.32 112.429 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -164.6 134.29 3.81 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.741 0.246 . . . . 73.01 111.165 -168.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.438 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.8 mp -118.64 130.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.673 -1.232 . . . . 73.33 107.673 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.413 ' HB3' HG23 ' C' ' 122' ' ' THR . 39.7 p90 -168.34 150.24 5.16 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.883 0.849 . . . . 54.14 112.115 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -81.9 123.07 28.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.837 -1.074 . . . . 72.44 109.388 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.4 mtpt -92.47 -20.34 21.08 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 110.199 -0.297 . . . . 54.02 110.199 174.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.7 t70 -155.41 134.62 12.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.412 -0.813 . . . . 65.02 108.841 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.569 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.8 mt -139.79 148.56 22.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 124.807 1.243 . . . . 75.02 107.865 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.26 141.5 23.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.934 0.893 . . . . 72.24 109.284 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -153.29 132.76 12.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.811 -1.922 . . . . 74.41 105.811 171.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -135.23 145.25 47.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.69 0.796 . . . . 60.23 109.136 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -146.81 71.45 12.48 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.252 -1.018 . . . . 72.14 108.252 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.8 -26.08 19.49 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.683 2.255 . . . . 74.43 112.609 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.51 ' O ' HG23 ' D' ' 31' ' ' VAL . 28.8 m-20 -115.11 23.11 12.77 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.927 0.891 . . . . 35.42 109.629 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -48.04 -54.93 20.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 115.783 1.772 . . . . 71.45 115.783 -168.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' D' ' 32' ' ' PHE . 51.9 Cg_endo -76.1 -16.97 17.57 Favored 'Trans proline' 0 C--N 1.384 2.417 0 CA-C-N 121.162 1.451 . . . . 70.3 112.469 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.7 t-160 -77.18 -30.49 54.88 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.514 1.525 . . . . 71.51 109.782 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.7 t -77.26 -27.81 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.2 0.6 . . . . 64.52 110.384 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' D' ' 29' ' ' PRO . 18.4 m-30 -66.05 -21.08 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.74 0.416 . . . . 74.43 111.381 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -64.71 -33.46 76.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.495 0.718 . . . . 64.14 110.439 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.18 100.35 12.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.144 -1.058 . . . . 71.51 108.144 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.4 63.26 3.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.985 0.914 . . . . 40.44 111.532 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -143.62 160.11 41.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.444 -0.576 . . . . 71.41 109.444 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -81.52 107.08 7.09 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.784 1.234 . . . . 71.34 108.736 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.465 ' HA ' HD13 ' D' ' 68' ' ' LEU . 35.8 Cg_exo -44.28 151.41 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 124.204 3.269 . . . . 72.1 116.392 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' D' ' 67' ' ' SER . 7.6 tm-20 -61.44 138.32 58.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.222 -1.354 . . . . 71.23 110.226 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 106.24 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 122.603 0.361 . . . . 74.12 110.329 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -98.99 142.5 30.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 167.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.682 HD11 HD21 ' D' ' 128' ' ' LEU . 2.7 mm? -120.08 122.17 40.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.157 0.583 . . . . 63.34 109.438 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.785 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.0 m-20 -107.23 130.9 54.67 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.219 -1.4 . . . . 73.01 107.219 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.38 147.97 39.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.152 0.581 . . . . 72.43 110.638 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 28.5 t70 -164.98 154.32 12.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.265 1.026 . . . . 71.01 108.773 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -142.11 162.4 35.58 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.456 0.702 . . . . 71.51 109.432 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.43 163.34 40.12 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.776 0.83 . . . . 44.02 109.114 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -154.17 153.7 32.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.859 0.463 . . . . 73.34 109.918 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.4 p -150.28 146.67 26.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.987 0.915 . . . . 72.15 109.248 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -90.67 119.05 30.59 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.669 -0.863 . . . . 72.2 108.669 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -92.0 -31.47 15.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.073 0.549 . . . . 62.22 109.772 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.21 -170.21 1.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.063 0.945 . . . . 74.13 110.63 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.45 116.27 7.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.449 0.7 . . . . 63.04 110.374 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.91 17.21 9.82 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.475 1.11 . . . . 53.33 112.237 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.7 t -116.0 118.64 59.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 172.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.693 ' HB2' HD13 ' D' ' 86' ' ' ILE . 87.5 m-85 -136.45 130.1 32.12 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.55 -0.907 . . . . 61.13 108.55 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.0 tt0 -91.15 125.86 36.06 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.586 1.154 . . . . 62.41 109.629 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.74 125.59 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.085 -0.709 . . . . 71.43 109.085 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 60.9 t -104.96 133.85 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 74.15 109.428 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.78 125.43 53.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.584 -1.265 . . . . 53.23 107.584 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.0 ttm180 -104.95 102.49 12.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.009 -0.737 . . . . 73.24 109.009 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.19 118.01 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.821 -1.177 . . . . 72.44 107.821 168.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -116.96 136.32 53.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.992 0.517 . . . . 65.34 109.634 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.434 HG23 HD13 ' D' ' 114' ' ' ILE . 54.8 t -115.64 115.96 50.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.193 0.997 . . . . 74.33 109.141 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.0 m -103.19 115.95 31.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.846 -1.168 . . . . 73.34 107.846 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.62 54.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 64.44 110.065 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 74.1 p -139.27 146.34 40.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.654 0.782 . . . . 75.42 109.006 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' D' ' 38' ' ' PRO . 16.7 tp -134.76 106.05 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.535 -0.913 . . . . 52.33 108.535 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.16 -114.99 4.59 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.577 -0.738 . . . . 13.21 111.691 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 4.56 14.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.654 0.781 . . . . 73.42 110.2 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -123.53 162.55 22.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.492 0.717 . . . . 65.14 110.583 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.07 129.03 37.54 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.67 0.606 . . . . 75.43 109.888 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.3 -58.9 2.56 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.436 0.694 . . . . 64.14 109.452 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -161.33 166.14 27.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.64 -1.164 . . . . 75.12 109.21 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 95.4 mt -126.8 153.09 46.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.402 1.081 . . . . 71.35 108.271 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.41 144.99 17.39 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.063 0.545 . . . . 55.3 109.719 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.21 135.61 11.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.888 0.875 . . . . 73.43 109.151 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.72 114.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.515 -0.55 . . . . 65.33 109.515 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.5 mt-30 -90.48 87.02 6.6 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.041 0.924 . . . . 73.54 109.397 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.77 96.71 6.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.558 -1.655 . . . . 75.42 109.146 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.83 144.1 20.96 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.37 -0.692 . . . . 35.51 111.37 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.24 4.57 Favored Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 110.603 -0.999 . . . . 71.45 110.603 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -87.69 123.83 40.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.214 -1.402 . . . . 74.14 107.214 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -127.12 164.26 22.0 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.062 0.945 . . . . 73.42 108.475 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.1 t -113.18 106.43 14.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.904 -1.147 . . . . 73.34 107.904 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.693 HD13 ' HB2' ' D' ' 56' ' ' TYR . 3.6 mp -108.86 107.48 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.512 -0.922 . . . . 73.31 108.512 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -134.08 146.4 50.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.237 1.015 . . . . 70.15 109.583 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.13 -21.56 8.04 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 114.526 0.57 . . . . 44.13 114.526 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' D' ' 93' ' ' GLN . 12.1 tt -109.2 130.44 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.614 0.765 . . . . 74.22 108.99 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.64 -177.45 5.3 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.431 0.692 . . . . 75.1 111.673 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.53 -140.33 36.82 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.978 0.799 . . . . 72.13 113.408 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -81.43 -20.85 39.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.453 0.701 . . . . 74.31 111.437 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.481 ' HG3' HD11 ' D' ' 89' ' ' ILE . 7.2 tp60 -69.65 -40.24 76.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.189 0.596 . . . . 73.55 111.051 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.43 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 5.2 ppp? -69.34 -33.78 73.62 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.796 -0.446 . . . . 70.51 109.796 174.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.97 99.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.361 0.664 . . . . 75.25 110.812 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -72.32 -34.32 68.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.5 -0.773 . . . . 72.25 110.183 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.94 -36.73 85.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.342 0.657 . . . . 63.03 111.124 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.624 HD21 HG12 ' D' ' 86' ' ' ILE . 31.5 mt -80.17 -23.2 41.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.976 0.51 . . . . 62.4 111.013 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.75 -2.35 55.23 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.697 -0.502 . . . . 63.13 113.736 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.13 -60.43 0.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.617 0.709 . . . . 73.13 111.412 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.61 -40.99 66.05 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.942 0.497 . . . . 63.41 111.797 -171.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.472 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 68.8 m -69.26 -49.04 25.14 Favored Pre-proline 0 CA--C 1.559 1.313 0 CA-C-O 118.956 -0.545 . . . . 73.22 110.975 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.4 Cg_exo -52.13 -31.13 43.93 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.542 2.161 . . . . 43.22 114.566 168.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.66 -35.64 81.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.993 0.517 . . . . 74.11 110.755 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.19 -44.11 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.242 0.617 . . . . 62.4 110.251 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.8 -20.24 58.35 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.341 -0.845 . . . . 43.02 112.027 -172.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -65.48 -48.03 67.26 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.459 0.911 . . . . 74.33 113.459 -171.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.48 -34.01 88.06 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.884 1.722 . . . . 53.24 112.821 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.27 -35.68 47.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.863 0.865 . . . . 73.13 111.816 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.69 76.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.286 0.634 . . . . 72.05 109.963 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.4 HH12 ' HG3' ' D' ' 130' ' ' PRO . 14.4 ptt180 -75.11 -31.63 61.19 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.958 -1.019 . . . . 64.52 110.784 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.98 -49.71 75.01 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.007 0.817 . . . . 63.32 110.305 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.81 -40.47 84.22 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.853 0.72 . . . . 75.13 110.517 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.503 HG12 ' SG ' ' D' ' 76' ' ' CYS . 64.9 mt -57.58 -53.18 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 123.794 0.684 . . . . 44.45 110.236 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.465 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.0 m -57.62 -45.79 84.95 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 124.26 1.024 . . . . 74.14 111.17 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -64.31 -41.04 97.02 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.636 -1.166 . . . . 65.21 110.138 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -69.02 -33.53 73.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.111 0.565 . . . . 72.13 111.587 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' D' ' 114' ' ' ILE . 53.3 t -64.11 -46.76 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 O-C-N 123.823 0.702 . . . . 55.24 110.203 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.7 p -71.16 -29.46 65.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.617 0.367 . . . . 62.41 110.858 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.7 mtt-85 -70.55 -30.29 66.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.653 0.781 . . . . 71.35 110.1 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.63 7.16 81.98 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 123.724 0.64 . . . . 74.11 112.834 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 56.76 28.69 14.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.395 1.878 . . . . 71.43 113.262 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.74 158.59 34.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.883 0.873 . . . . 73.5 110.137 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.76 127.33 25.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.008 2.472 . . . . 65.21 112.932 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.465 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.0 tt0 -51.26 130.61 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.611 1.195 . . . . 71.01 112.201 -175.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.1 tp -115.19 100.89 8.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.63 0.372 . . . . 64.33 110.292 -176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -99.61 112.51 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.351 -1.352 . . . . 73.45 107.351 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.682 HD21 HD11 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -74.37 135.85 42.45 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 123.42 0.45 . . . . 75.35 110.592 -171.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.17 123.05 58.26 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 124.467 1.104 . . . . 60.51 110.933 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.4 ' HG3' HH12 ' D' ' 111' ' ' ARG . 43.0 Cg_exo -57.4 129.87 36.22 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.321 2.014 . . . . 74.24 111.238 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -123.73 110.55 26.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 109.194 -0.669 . . . . 65.13 109.194 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -77.28 95.57 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.794 -1.188 . . . . 73.03 107.794 167.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.476 0.83 0 CA-C-N 115.641 -0.709 . . . . 73.12 111.159 -176.117 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.675 0.274 . . . . 65.42 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.93 137.26 34.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.478 1.111 . . . . 74.12 108.394 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -160.69 136.76 8.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.269 0.227 . . . . 55.31 110.838 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.8 mp -69.18 114.48 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.077 -1.083 . . . . 73.24 108.077 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -95.29 -30.07 14.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.138 0.575 . . . . 71.54 111.176 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -166.03 148.41 7.17 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.682 -0.488 . . . . 73.35 109.682 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.45 HG12 ' HG3' ' C' ' 130' ' ' PRO . 2.5 pp -141.03 139.05 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.726 -1.213 . . . . 74.13 107.726 171.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 42.1 p90 -176.97 176.16 1.47 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.566 0.698 . . . . 74.24 110.949 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -99.73 111.07 23.43 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.042 0.937 . . . . 64.41 109.241 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -76.01 -28.92 57.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.957 -0.386 . . . . 63.1 109.957 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.0 t70 -150.61 147.77 27.82 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.955 -0.566 . . . . 73.43 110.126 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.4 mt -138.72 145.39 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.477 1.511 . . . . 73.21 107.398 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -154.22 117.58 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.662 0.385 . . . . 64.33 110.457 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.699 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.1 t80 -124.44 116.32 22.34 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.353 -1.351 . . . . 74.41 107.353 172.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -119.67 128.17 53.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.433 -0.58 . . . . 74.34 109.433 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.56 76.61 48.15 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 108.546 -0.909 . . . . 61.43 108.546 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 -18.23 22.4 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.68 2.253 . . . . 72.21 112.024 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 64.6 m-20 -115.76 30.72 7.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.934 0.893 . . . . 75.35 108.962 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -58.12 -46.33 99.68 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.864 0.866 . . . . 63.31 112.584 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 31.6 Cg_exo -62.92 -28.16 75.13 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.025 1.817 . . . . 62.4 113.21 169.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.1 m80 -73.13 -24.39 60.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.77 0.428 . . . . 75.04 111.327 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.41 -27.41 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 120.967 0.413 . . . . 61.2 110.819 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.593 ' HD2' HH11 ' B' ' 15' ' ' ARG . 81.9 t80 -74.86 -41.69 59.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.381 0.672 . . . . 72.01 110.239 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 30' ' ' HIS . 13.1 pt20 -80.3 -30.47 38.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.584 0.354 . . . . 50.44 111.556 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 3.8 mmmp? -82.36 156.85 24.0 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.883 0.873 . . . . 65.24 112.107 -176.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.59 140.4 54.41 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.473 -1.24 . . . . 74.13 110.757 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -88.24 63.92 7.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.634 0.731 . . . . 72.43 109.378 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -124.63 78.34 63.36 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.376 1.07 . . . . 73.42 108.819 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.87 167.2 24.14 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.985 2.457 . . . . 62.33 113.606 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -123.77 95.37 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.829 -1.545 . . . . 65.2 106.829 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.25 125.62 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.311 0.577 . . . . 75.54 110.391 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 35.5 mttp -120.85 114.77 22.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.391 1.077 . . . . 42.44 108.612 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.6 mt -111.1 107.26 16.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.734 -1.121 . . . . 73.44 108.778 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -114.46 145.23 42.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.606 1.162 . . . . 61.42 110.128 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.48 153.23 48.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 72.13 110.605 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.468 ' O ' HD23 ' A' ' 60' ' ' LEU . 20.7 t70 -157.86 143.47 17.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.383 1.073 . . . . 55.43 109.014 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.1 m -126.62 135.08 50.74 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.672 0.789 . . . . 71.13 109.584 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.55 132.48 40.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.075 0.95 . . . . 43.0 109.842 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -91.35 153.26 20.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.104 0.478 . . . . 64.23 110.445 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 t -150.82 138.28 19.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.079 1.352 . . . . 71.24 108.262 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -113.75 124.34 52.03 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.44 -0.578 . . . . 61.35 109.44 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.15 -44.07 7.11 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.566 0.746 . . . . 72.53 110.393 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 -173.45 4.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.461 -0.791 . . . . 73.03 109.982 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -63.02 112.66 2.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.302 0.641 . . . . 55.4 109.773 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 65.02 8.9 5.03 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.858 1.263 . . . . 62.51 113.038 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.01 109.93 25.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.004 -1.109 . . . . 71.14 108.004 172.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -119.94 123.82 44.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.491 0.716 . . . . 75.15 109.579 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -97.5 131.54 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.609 -1.178 . . . . 70.0 108.641 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.53 129.63 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.938 -1.134 . . . . 64.24 107.938 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.8 t -104.49 132.57 50.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.534 -0.913 . . . . 73.05 108.534 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -108.85 110.18 21.48 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.715 -1.587 . . . . 73.35 106.715 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -103.29 102.67 12.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.808 0.843 . . . . 73.33 108.792 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.41 134.48 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 114.686 -1.143 . . . . 74.54 109.295 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.7 m -120.39 141.37 50.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.092 -0.707 . . . . 62.23 109.092 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -138.54 107.83 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.926 1.29 . . . . 72.41 108.321 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 19.2 m -102.22 146.05 28.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.316 -0.624 . . . . 74.41 109.316 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.17 120.28 15.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.492 0.717 . . . . 70.2 109.146 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 49.1 m -128.56 125.15 37.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.998 0.519 . . . . 75.44 110.008 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.71 85.16 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.75 0.786 . . . . 71.02 109.054 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.3 -118.65 5.14 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.283 -1.326 . . . . 63.4 111.359 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -87.89 -31.98 19.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 71.0 109.347 174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.15 133.77 35.52 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.67 0.788 . . . . 74.45 109.469 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.6 m -78.94 136.68 37.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.094 -0.335 . . . . 73.45 110.094 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -82.57 -60.55 2.15 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.496 0.718 . . . . 53.13 109.112 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -165.83 176.13 8.15 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.628 -1.169 . . . . 75.31 111.098 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -138.62 145.82 40.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.34 1.456 . . . . 72.13 108.139 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.1 m -135.89 140.37 44.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.928 0.891 . . . . 74.04 109.838 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -150.33 130.7 13.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.179 0.592 . . . . 72.45 109.652 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.82 119.86 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.171 0.589 . . . . 73.3 110.362 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -89.26 83.12 6.45 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.445 1.098 . . . . 74.54 108.523 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.415 ' HG3' HD22 ' A' ' 106' ' ' LEU . 61.7 tp60 -76.49 94.39 3.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.279 -0.873 . . . . 72.14 109.443 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.93 144.16 17.93 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.772 -0.531 . . . . 73.42 111.772 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.86 124.18 2.77 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.811 -0.916 . . . . 62.23 110.811 -176.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.61 128.49 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.671 -0.863 . . . . 71.13 108.671 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -135.18 140.0 45.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.666 -0.864 . . . . 75.23 108.666 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.1 p -101.92 106.88 17.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 72.23 109.015 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.2 pt -125.19 131.55 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.335 0.654 . . . . 74.41 110.769 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.85 157.42 26.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.114 0.965 . . . . 73.5 110.207 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.16 64.86 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.067 -0.515 . . . . 61.04 114.383 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.63 145.48 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.643 0.721 . . . . 73.0 109.368 -177.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.9 tt0 -142.68 179.32 7.06 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.021 0.528 . . . . 74.53 109.956 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.73 -123.81 31.73 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 124.239 0.924 . . . . 72.01 114.738 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -74.86 -26.56 59.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 74.24 111.365 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -65.72 -48.66 71.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.744 0.817 . . . . 64.5 110.063 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.463 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 39.8 ttp -79.71 -33.29 41.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.202 -1.363 . . . . 44.35 110.6 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.58 92.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.27 0.557 . . . . 72.52 109.956 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -55.13 -47.54 74.92 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.547 -1.206 . . . . 74.44 111.092 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 35.3 m -71.33 -33.22 69.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.741 1.015 . . . . 74.32 113.741 -172.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.09 -30.09 39.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.809 0.443 . . . . 60.02 111.342 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.98 -17.61 31.92 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.633 -0.537 . . . . 31.42 114.292 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.52 -63.91 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.708 0.754 . . . . 62.0 112.614 -171.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.83 -56.39 12.42 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.085 0.954 . . . . 62.34 112.758 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.56 -48.62 12.05 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.315 -0.85 . . . . 72.42 113.113 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.3 -20.27 62.04 Favored 'Trans proline' 0 C--N 1.388 2.636 0 CA-C-N 121.111 1.432 . . . . 75.42 113.718 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.29 -42.8 92.72 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.017 0.527 . . . . 60.22 110.711 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -59.65 -41.85 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.97 0.89 . . . . 64.11 110.201 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.541 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.9 mt -74.99 -29.1 60.8 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 113.874 -1.512 . . . . 61.23 112.579 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.49 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 20.6 t80 -64.26 -45.17 78.46 Favored Pre-proline 0 CA--C 1.558 1.28 0 N-CA-C 114.866 1.432 . . . . 74.34 114.866 -167.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.88 -32.51 95.23 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 121.616 1.544 . . . . 70.34 113.046 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -79.73 -37.72 34.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.453 0.701 . . . . 74.11 112.349 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.19 71.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 110.01 -0.367 . . . . 53.22 110.01 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -53.51 -48.8 68.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.371 1.068 . . . . 44.35 110.102 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.26 -47.25 86.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.982 0.913 . . . . 62.2 111.613 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.546 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.3 t -60.37 -44.19 95.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 72.33 111.002 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 64' ' ' VAL . 15.3 mt -63.08 -51.79 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.31 1.044 . . . . 72.35 110.905 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.8 m -59.1 -36.4 75.08 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.258 1.023 . . . . 71.35 112.023 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.65 -39.72 80.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 75.43 110.115 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 46.5 mtm -63.08 -39.63 95.28 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.637 0.375 . . . . 74.51 110.533 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.88 -47.05 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.146 0.978 . . . . 74.02 111.207 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -72.61 -33.37 66.63 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.096 -0.502 . . . . 43.15 111.184 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.451 HH12 ' HG3' ' B' ' 112' ' ' GLU . 82.7 mtt-85 -69.39 -26.61 64.73 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.333 0.653 . . . . 71.41 110.138 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.61 1.07 88.7 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.683 -0.69 . . . . 75.52 112.861 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.4 m 69.56 18.14 7.78 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.392 1.077 . . . . 73.24 111.277 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.44 152.38 40.02 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 73.12 110.892 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.76 125.35 18.8 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.74 2.293 . . . . 63.21 112.0 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.548 ' HG3' HG23 ' A' ' 115' ' ' THR . 25.3 tt0 -50.34 136.66 19.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.859 1.264 . . . . 64.11 112.957 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.2 mt -125.61 104.62 8.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.837 0.855 . . . . 64.3 108.81 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -101.9 123.18 45.39 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.678 0.791 . . . . 50.25 109.103 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.49 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -73.4 120.44 19.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.909 -1.145 . . . . 75.51 107.909 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.09 129.07 85.92 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.864 0.727 . . . . 53.3 110.631 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.63 107.4 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.045 1.83 . . . . 75.25 111.741 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -98.96 110.84 27.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.51 -1.292 . . . . 64.11 107.51 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.12 82.04 8.54 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.437 -0.801 . . . . 55.24 109.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.22 -32.78 71.44 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.246 -1.343 . . . . 74.03 109.803 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 124.359 1.064 . . . . 62.4 111.606 173.881 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 112.494 0.553 . . . . 65.24 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.415 HG22 ' HB3' ' B' ' 87' ' ' ALA . 15.2 t -155.61 143.54 19.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.082 -0.71 . . . . 65.12 109.082 170.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -139.45 113.28 8.61 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.158 -1.052 . . . . 74.2 108.158 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 22.8 tt0 -133.11 139.76 47.29 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.487 0.715 . . . . 73.4 109.469 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.6 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -89.83 116.04 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.183 -1.043 . . . . 45.44 108.183 170.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 72.5 mt-30 -77.63 -40.83 40.58 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.753 -0.462 . . . . 64.23 109.753 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.593 HH11 ' HD2' ' A' ' 32' ' ' PHE . 18.6 ttt180 -166.42 137.89 3.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 65.2 108.846 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 57.8 mt -114.39 139.23 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 106.986 -1.487 . . . . 73.14 106.986 170.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -168.19 146.57 4.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.762 0.71 . . . . 71.42 112.298 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -73.35 120.83 19.51 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.655 -1.157 . . . . 64.2 108.711 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -96.44 -26.59 15.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.443 0.697 . . . . 74.53 111.242 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -161.26 141.74 11.04 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.055 0.222 . . . . 62.42 110.924 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -138.3 141.69 37.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 125.024 1.33 . . . . 53.25 109.035 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 35.0 t -140.12 124.22 17.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.166 -1.42 . . . . 63.44 107.166 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -138.61 111.41 7.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.396 -1.335 . . . . 75.32 107.396 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.98 117.51 29.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.671 -0.863 . . . . 74.04 108.671 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 84.68 6.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.492 -1.299 . . . . 72.33 107.492 168.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.63 -26.92 11.25 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.829 2.353 . . . . 54.53 112.649 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 1.8 m-20 -110.96 20.24 17.69 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 64.41 109.438 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.584 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.01 -60.52 1.65 Allowed Pre-proline 0 CA--C 1.574 1.89 0 C-N-CA 126.368 1.867 . . . . 25.12 114.931 -169.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 51.1 Cg_endo -85.0 -1.86 9.49 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.26 1.973 . . . . 61.41 113.57 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -96.74 -38.21 9.99 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 73.14 110.505 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.5 p -79.33 -14.16 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.478 -0.783 . . . . 52.34 110.114 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.06 -34.56 44.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.676 1.19 . . . . 73.2 111.798 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -73.15 -15.94 61.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.068 0.947 . . . . 75.13 112.028 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.593 ' HD3' HD12 ' B' ' 68' ' ' LEU . 89.6 mttt -105.52 109.37 21.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.148 0.979 . . . . 65.34 110.481 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.27 83.63 5.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.367 0.667 . . . . 62.25 110.407 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.572 ' HE3' HD11 ' B' ' 68' ' ' LEU . 3.6 m-90 -153.43 161.75 41.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.492 1.117 . . . . 74.21 109.378 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.31 119.94 73.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.207 -1.034 . . . . 73.3 108.207 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.14 167.72 26.04 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.787 2.325 . . . . 54.4 113.684 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.66 103.39 4.23 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.955 -1.128 . . . . 61.55 107.955 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.425 HG21 HD21 ' B' ' 126' ' ' LEU . 27.4 m -100.88 127.78 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.206 0.602 . . . . 74.2 110.261 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -106.63 124.6 49.85 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.608 -0.886 . . . . 64.41 108.608 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 mt -92.25 124.79 36.58 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.037 -1.098 . . . . 72.4 108.037 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.0 t70 -136.23 151.89 50.16 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 107.996 -1.113 . . . . 75.31 107.996 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.57 169.41 17.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.184 0.516 . . . . 54.04 111.674 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.9 t70 -159.39 142.72 14.49 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.755 1.222 . . . . 73.23 108.432 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -109.29 118.7 37.38 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.765 -0.828 . . . . 61.24 108.765 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.73 151.3 37.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 42.12 108.553 172.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -145.43 163.75 33.67 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 122.927 0.491 . . . . 63.42 110.511 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -157.83 136.54 11.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.679 1.191 . . . . 72.25 108.148 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -93.79 127.02 39.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.926 0.49 . . . . 74.42 110.032 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 -40.32 14.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.215 -0.661 . . . . 33.15 109.215 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.49 -178.83 5.13 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.779 1.232 . . . . 74.33 108.851 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -72.45 134.51 45.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.876 -0.787 . . . . 73.43 108.876 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.3 m-20 73.64 -3.87 2.38 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.404 1.481 . . . . 63.21 111.808 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.38 84.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.993 -1.114 . . . . 63.34 107.993 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.39 138.95 46.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.949 -0.759 . . . . 71.3 108.949 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -115.04 110.0 18.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.829 -1.174 . . . . 71.22 107.829 -172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' B' ' 98' ' ' LEU . 67.0 t -104.55 128.83 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.988 0.515 . . . . 71.11 110.187 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 39.6 t -102.37 119.91 51.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.538 1.135 . . . . 71.4 109.466 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -92.89 111.67 23.37 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.166 -1.42 . . . . 72.14 107.166 172.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.6 ttt180 -100.18 125.38 46.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.009 -0.737 . . . . 73.33 109.009 175.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.697 HG11 HD11 ' B' ' 128' ' ' LEU . 15.4 t -119.58 127.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.856 -0.794 . . . . 72.01 108.856 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 86.1 m -104.04 141.05 36.87 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.57 0.544 . . . . 54.32 110.11 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.71 HG21 HG21 ' B' ' 114' ' ' ILE . 53.0 t -133.3 122.18 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.491 1.116 . . . . 74.14 108.549 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -117.36 146.17 43.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.744 . . . . 63.23 108.993 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -145.0 133.41 21.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.755 -0.832 . . . . 71.52 108.755 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 63.6 p -138.52 136.34 36.0 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 122.877 0.471 . . . . 70.42 110.207 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.593 HD12 ' HD3' ' B' ' 34' ' ' LYS . 0.3 OUTLIER -110.44 107.86 17.67 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.891 -1.152 . . . . 52.24 107.891 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.33 -111.37 3.24 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 123.662 0.601 . . . . 34.15 112.755 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.87 2.46 23.47 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.216 0.606 . . . . 65.34 111.042 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 11.9 pt-20 -135.71 170.46 15.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.989 0.516 . . . . 73.44 110.441 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.1 m -71.84 143.57 49.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 73.25 110.334 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -98.4 -58.77 1.89 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.919 0.888 . . . . 74.21 109.07 173.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -161.04 164.34 30.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.313 -0.858 . . . . 74.34 110.353 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.26 141.59 45.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.911 1.284 . . . . 75.14 107.646 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.74 154.59 38.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.076 0.55 . . . . 62.43 109.87 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.2 tt0 -164.96 133.88 3.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.7 -0.852 . . . . 75.03 108.7 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.8 t -127.25 145.41 34.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.68 -0.859 . . . . 55.25 108.68 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -122.98 93.09 3.85 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.744 -0.835 . . . . 74.24 108.744 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -84.69 100.43 11.47 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.601 -0.889 . . . . 71.13 108.601 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 173.5 40.1 Favored Glycine 0 C--O 1.245 0.788 0 N-CA-C 111.775 -0.53 . . . . 72.32 111.775 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.5 133.2 2.71 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.697 -0.561 . . . . 44.43 111.697 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 36.7 mt -85.85 131.12 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.373 -0.973 . . . . 74.15 108.373 172.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.54 152.85 48.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.068 0.947 . . . . 72.42 109.626 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 14.8 m -123.59 105.05 9.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.052 0.941 . . . . 73.21 108.894 -172.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.62 HG21 HD11 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -134.46 141.89 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.101 0.56 . . . . 63.23 112.053 -169.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.415 ' HB3' HG22 ' B' ' 10' ' ' THR . . . -149.05 167.69 25.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.399 1.08 . . . . 74.42 109.734 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.75 -62.45 4.38 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.609 0.568 . . . . 61.01 112.328 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.5 pp -68.62 145.58 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.922 0.889 . . . . 75.12 111.992 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.33 175.52 13.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 71.55 110.45 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -122.26 29.23 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.883 0.74 . . . . 65.53 113.536 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -70.8 -33.59 70.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.889 0.875 . . . . 74.43 110.878 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.23 -29.86 61.91 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.274 -0.876 . . . . 73.33 110.779 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.429 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 0.3 OUTLIER -71.07 -43.9 66.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.552 0.741 . . . . 41.21 109.199 173.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.52 66.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.041 -0.981 . . . . 61.25 111.769 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.43 -38.56 65.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.979 0.512 . . . . 73.33 110.212 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.57 -59.14 2.87 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.368 -0.833 . . . . 75.53 110.83 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' B' ' 58' ' ' VAL . 6.1 mp -87.37 -14.05 41.76 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.756 0.651 . . . . 63.0 112.756 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.09 -37.15 8.5 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 120.151 -0.25 . . . . 13.01 112.668 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.15 -48.09 3.14 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.495 0.648 . . . . 63.14 111.841 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -79.38 -42.36 25.72 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.119 0.415 . . . . 75.33 112.119 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.644 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 96.6 m -61.19 -47.74 93.73 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.43 -0.795 . . . . 74.22 111.746 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -53.44 -35.2 74.87 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.03 1.82 . . . . 72.24 114.601 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.76 -33.2 75.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 118.173 0.442 . . . . 62.25 110.95 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.03 -47.11 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.071 0.948 . . . . 73.33 110.554 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' B' ' 60' ' ' LEU . 78.4 mt -78.82 -19.31 52.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.135 -0.938 . . . . 51.43 112.196 -172.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.523 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 66.6 t80 -62.92 -45.73 87.22 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.886 1.069 . . . . 71.12 113.886 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.25 -38.78 93.47 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 121.96 1.773 . . . . 75.43 113.352 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.442 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 77.2 m-85 -68.05 -45.55 73.58 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.091 0.556 . . . . 75.4 110.671 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -43.74 97.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.376 -0.829 . . . . 73.1 110.545 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -56.71 -54.79 42.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.31 1.444 . . . . 75.23 110.929 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.451 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.9 tp10 -59.26 -41.02 87.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.492 1.117 . . . . 63.41 111.018 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.8 t -68.78 -39.36 80.22 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.655 -0.248 . . . . 74.41 111.262 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.71 HG21 HG21 ' B' ' 64' ' ' VAL . 89.4 mt -62.58 -54.69 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.054 0.542 . . . . 61.53 109.79 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 39.2 m -61.78 -30.1 70.58 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 124.108 0.88 . . . . 65.51 111.526 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.6 t -67.06 -45.76 76.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.401 0.681 . . . . 74.35 110.483 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.4 mmt -67.98 -37.01 81.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.492 0.317 . . . . 64.41 110.739 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.18 -41.09 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.941 0.896 . . . . 63.31 110.195 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.444 ' OG ' HG21 ' C' ' 115' ' ' THR . 36.9 t -65.16 -34.99 79.7 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.807 -1.088 . . . . 60.3 111.248 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.546 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 85.5 mtt-85 -68.59 -28.43 66.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.207 0.603 . . . . 72.04 111.11 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.43 9.58 61.23 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.703 0.627 . . . . 75.54 112.623 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 77.0 p 52.53 55.07 9.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.99 1.716 . . . . 55.31 112.531 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -107.52 161.22 23.85 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-N 115.63 -0.714 . . . . 63.15 110.257 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.26 -167.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 123.312 2.675 . . . . 45.22 114.046 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.737 ' HB3' ' HA ' ' C' ' 124' ' ' PRO . 29.0 pt20 -62.76 122.65 16.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.217 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.425 HD21 HG21 ' B' ' 40' ' ' VAL . 1.1 tm? -151.28 81.77 1.31 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.758 -0.83 . . . . 71.11 108.758 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.13 135.96 36.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.742 0.817 . . . . 73.14 108.887 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.697 HD11 HG11 ' B' ' 62' ' ' VAL . 0.9 OUTLIER -64.55 131.33 46.73 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 123.969 0.793 . . . . 73.21 109.005 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 146.09 87.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.506 0.722 . . . . 75.21 110.858 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.22 108.74 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.016 2.477 . . . . 75.42 113.218 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.72 123.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.621 0.768 . . . . 74.21 110.171 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -87.22 92.54 9.1 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.384 0.674 . . . . 73.02 110.005 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -62.47 -41.48 98.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.306 -0.861 . . . . 61.5 109.754 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.6 -35.16 73.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.415 -1.72 . . . . 60.15 112.015 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.37 -49.78 45.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.433 0.693 . . . . 52.15 111.867 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 tt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.173 -0.677 . . . . 73.23 109.173 179.416 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 121.407 0.622 . . . . 73.52 112.588 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 55.0 m -85.1 98.06 10.22 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.151 -1.055 . . . . 73.33 108.151 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -108.67 129.0 55.34 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.345 -0.983 . . . . 72.23 108.345 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.32 125.3 16.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.846 -0.428 . . . . 75.34 109.846 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.648 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -75.92 133.64 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 108.533 -0.914 . . . . 70.21 108.533 175.166 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -107.74 -48.73 3.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.231 0.612 . . . . 74.2 110.689 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -162.06 136.15 6.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.673 0.389 . . . . 64.12 110.16 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.648 HG13 HD11 ' C' ' 13' ' ' ILE . 88.3 mt -119.87 140.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.037 -1.097 . . . . 74.23 108.037 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.522 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 25.8 p90 -173.77 161.33 3.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.229 0.538 . . . . 74.3 110.968 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -82.66 112.92 19.97 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.161 -0.927 . . . . 71.34 109.387 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -74.28 -33.27 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.195 -0.669 . . . . 60.14 109.195 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -146.52 147.17 30.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.367 -0.833 . . . . 74.13 110.233 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.8 mt -146.3 145.87 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.993 1.717 . . . . 65.22 106.842 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -162.96 151.97 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 122.87 0.468 . . . . 43.13 110.117 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.14 108.35 3.41 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.492 -0.929 . . . . 61.23 108.492 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.18 118.73 33.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.794 0.837 . . . . 71.41 109.218 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.58 83.81 48.12 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.55 1.14 . . . . 64.22 108.411 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.88 -19.06 31.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.732 2.288 . . . . 74.22 111.775 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' C' ' 72' ' ' THR . 77.9 m-20 -117.69 38.61 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.169 0.987 . . . . 73.43 109.51 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.07 -47.24 98.93 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 123.586 0.754 . . . . 73.22 112.705 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.97 -14.64 38.98 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.788 1.659 . . . . 74.44 113.852 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -67.61 -23.91 65.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 119.186 -0.435 . . . . 74.41 111.984 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.59 -29.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.727 0.811 . . . . 52.14 112.523 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.464 ' HE1' HH11 ' D' ' 15' ' ' ARG . 38.2 m-85 -68.75 -41.44 78.89 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.229 0.612 . . . . 70.21 111.315 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.26 5.78 49.45 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.047 -0.979 . . . . 63.12 110.527 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.42 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.6 ttmp? -93.47 145.85 24.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.66 0.784 . . . . 74.24 110.403 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.44 132.07 34.62 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.861 -1.162 . . . . 64.31 107.861 172.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -74.99 78.48 2.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 122.312 1.053 . . . . 72.31 111.575 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.436 ' O ' HD13 ' C' ' 68' ' ' LEU . 38.0 tt0 -157.56 65.13 3.33 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 113.924 -1.489 . . . . 53.2 108.327 168.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.08 150.81 4.75 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.653 1.569 . . . . 72.34 111.254 169.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -86.32 96.06 9.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.522 -1.288 . . . . 72.31 107.522 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.53 98.35 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.474 1.131 . . . . 44.3 108.86 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -91.18 116.84 29.14 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.805 -1.543 . . . . 73.02 108.331 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.589 HD13 HD11 ' C' ' 128' ' ' LEU . 30.1 tp -84.24 144.12 29.13 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.374 -0.973 . . . . 74.14 108.374 172.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.9 t70 -137.47 128.56 27.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.496 -1.298 . . . . 73.43 107.496 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.83 132.07 38.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.049 -0.723 . . . . 75.1 109.049 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -137.65 155.84 48.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.805 0.842 . . . . 72.54 109.009 174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -138.32 149.52 45.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.923 0.489 . . . . 62.22 109.921 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 167.59 21.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.768 0.827 . . . . 52.55 109.179 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.3 p -148.3 144.64 27.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.649 0.379 . . . . 72.23 111.062 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 75.9 p -147.66 145.77 29.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.062 0.945 . . . . 74.1 110.242 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -87.14 130.56 34.47 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.007 -0.738 . . . . 74.31 109.007 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.635 HD11 ' HB2' ' C' ' 57' ' ' GLU . 59.5 mt -106.37 -41.84 5.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.627 0.771 . . . . 61.34 109.944 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.18 -169.32 3.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.507 0.723 . . . . 45.32 110.736 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.83 108.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.132 -0.94 . . . . 55.22 109.396 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 52.1 m-20 69.97 -0.84 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.639 1.175 . . . . 61.34 113.269 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -96.68 113.95 32.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.533 0.733 . . . . 75.42 109.166 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.97 130.16 52.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.361 1.064 . . . . 74.32 108.71 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.635 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.6 tt0 -87.98 143.9 26.84 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.362 -0.835 . . . . 72.34 108.817 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.454 HG13 HD11 ' C' ' 106' ' ' LEU . 2.6 p -125.46 124.6 67.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.557 -0.905 . . . . 74.25 108.557 169.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.85 104.69 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.578 -1.267 . . . . 74.1 107.578 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.49 100.85 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.974 0.91 . . . . 73.34 108.759 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -81.65 124.15 29.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.573 0.749 . . . . 73.4 110.237 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.26 126.56 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.531 -1.285 . . . . 72.41 107.531 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.5 m -128.59 128.79 44.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.899 -0.778 . . . . 74.33 108.899 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.666 HG23 HD13 ' C' ' 114' ' ' ILE . 88.5 t -110.71 110.16 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.664 -0.865 . . . . 53.42 108.664 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.403 HG23 HD23 ' C' ' 75' ' ' LEU . 8.8 m -99.34 110.29 22.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.85 -0.796 . . . . 73.14 108.85 173.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.22 99.97 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.488 -1.301 . . . . 73.44 107.488 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -146.65 156.45 43.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.647 0.592 . . . . 50.53 109.865 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.436 HD13 ' O ' ' C' ' 37' ' ' GLN . 53.7 tp -111.8 80.18 1.29 Allowed 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.767 -1.568 . . . . 73.3 106.767 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.91 -96.2 0.18 Allowed Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.903 -1.044 . . . . 72.11 112.339 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -91.13 -31.94 16.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.847 0.859 . . . . 74.32 111.221 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.42 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 13.2 tp10 -87.22 93.13 9.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.652 0.781 . . . . 53.32 110.281 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 60.8 m -84.72 130.44 34.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.826 -0.624 . . . . 75.34 111.038 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.36 -55.76 4.67 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.028 0.931 . . . . 63.4 109.863 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -157.37 170.73 21.8 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.408 0.623 . . . . 74.12 111.721 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.403 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -143.51 111.5 6.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.723 -1.584 . . . . 64.42 106.723 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.8 t -111.02 143.98 40.86 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.981 -0.748 . . . . 74.32 108.981 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -147.55 117.8 7.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.203 0.601 . . . . 75.33 109.621 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.87 114.99 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.787 1.235 . . . . 74.32 109.234 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -94.16 102.62 14.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.141 -0.689 . . . . 70.24 109.141 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.622 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.1 tp-100 -87.56 109.4 19.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.471 0.708 . . . . 70.2 109.34 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.62 146.88 20.26 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.617 -0.593 . . . . 70.33 111.617 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.46 117.36 1.27 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.569 -0.613 . . . . 71.54 111.569 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' C' ' 51' ' ' LEU . 12.8 mm -83.01 126.09 40.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.614 -0.884 . . . . 63.42 108.614 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -140.62 138.33 34.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.649 0.38 . . . . 71.42 110.114 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -94.54 117.75 30.61 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.8 pp -116.12 142.06 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 122.72 0.408 . . . . 52.21 110.113 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -155.86 155.82 33.59 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.219 0.608 . . . . 75.41 110.443 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -45.81 3.32 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.195 -0.457 . . . . 70.4 112.556 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -88.7 151.03 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.8 0.84 . . . . 63.22 109.09 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.9 -179.45 7.66 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.858 0.463 . . . . 72.33 109.811 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 58.23 -137.33 50.1 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 115.268 0.867 . . . . 73.24 115.268 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -72.2 -20.09 61.63 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 73.45 112.39 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -80.12 -38.77 30.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.23 0.212 . . . . 65.44 110.863 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 16.9 ptt? -70.21 -31.81 69.41 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.443 -0.577 . . . . 72.04 109.443 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.07 71.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.474 -0.785 . . . . 64.01 110.433 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -61.67 -49.17 77.59 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.459 0.474 . . . . 75.13 110.173 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.96 -48.86 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.51 0.506 . . . . 73.45 110.478 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.69 -16.35 63.33 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.613 0.765 . . . . 63.23 111.38 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.0 10.8 20.62 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-O 119.622 -0.544 . . . . 73.31 114.279 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.15 -61.11 0.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.703 0.751 . . . . 64.35 111.02 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.4 -56.68 6.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.707 0.403 . . . . 61.13 111.673 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 60.7 m -56.81 -46.95 99.8 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.59 0.756 . . . . 63.3 111.951 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 92.1 Cg_exo -53.32 -38.35 82.06 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 122.512 2.141 . . . . 64.43 114.923 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -63.4 -36.44 83.75 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 123.81 0.844 . . . . 65.31 110.506 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.68 -40.21 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.586 0.755 . . . . 73.51 110.414 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.454 HD11 HG13 ' C' ' 58' ' ' VAL . 64.2 mt -85.72 -26.12 26.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.565 -1.198 . . . . 40.14 112.096 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -55.52 -47.58 98.32 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 113.809 1.04 . . . . 73.24 113.809 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.32 -40.43 82.02 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.277 1.984 . . . . 54.51 113.612 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -65.7 -43.37 89.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.165 0.586 . . . . 73.44 110.374 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.622 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -69.5 -33.74 73.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.414 -0.812 . . . . 73.51 111.241 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -64.98 -47.36 77.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 74.14 110.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -71.92 -33.0 67.92 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.695 -0.684 . . . . 73.02 109.552 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 47.9 t -69.12 -31.15 69.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.234 0.614 . . . . 72.1 111.089 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.666 HD13 HG23 ' C' ' 64' ' ' VAL . 63.3 mt -72.62 -51.52 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.04 0.536 . . . . 71.22 109.762 171.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.444 HG21 ' OG ' ' B' ' 119' ' ' SER . 39.9 m -61.73 -31.08 71.22 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.815 0.446 . . . . 73.33 111.143 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -60.18 -54.31 47.41 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.181 0.992 . . . . 62.21 108.995 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.423 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.82 -42.32 79.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.031 1.333 . . . . 65.24 112.475 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 85.5 t -66.02 -40.85 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 52.21 109.924 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -73.75 -24.04 59.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.935 -1.03 . . . . 73.14 111.645 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.3 mtt-85 -74.1 -40.06 62.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.254 -0.647 . . . . 64.11 109.254 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -1.24 65.31 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.824 0.703 . . . . 64.14 112.229 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 37.5 p 63.73 25.8 14.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.869 2.067 . . . . 53.53 112.83 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.12 158.77 63.8 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.049 0.94 . . . . 71.12 108.538 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' B' ' 125' ' ' GLN . 36.3 Cg_endo -61.25 151.32 79.89 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.799 2.333 . . . . 74.31 114.206 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -56.55 112.05 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.084 1.354 . . . . 60.12 111.761 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.06 90.15 3.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.524 -1.287 . . . . 62.01 107.524 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -91.31 110.38 21.68 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.527 -0.916 . . . . 62.54 108.527 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.589 HD11 HD13 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -77.19 134.17 38.72 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.095 0.958 . . . . 74.34 110.316 -171.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.79 144.96 83.61 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.252 1.021 . . . . 75.02 111.846 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.45 ' HG3' HG12 ' A' ' 16' ' ' ILE . 93.1 Cg_endo -78.54 104.13 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.816 2.344 . . . . 70.15 112.895 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.62 107.73 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.111 -1.441 . . . . 63.21 107.111 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -105.64 98.02 7.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.081 0.552 . . . . 70.35 109.803 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -67.1 -36.95 83.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.432 0.693 . . . . 64.04 110.1 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 114.449 -1.25 . . . . 74.52 111.702 -179.829 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 113.518 0.932 . . . . 75.32 113.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 90.3 m -142.55 139.96 31.59 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.409 1.084 . . . . 72.34 108.326 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.452 ' CE2' ' SG ' ' D' ' 102' ' ' CYS . 79.5 t80 -155.01 101.09 2.24 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.529 -1.285 . . . . 72.01 107.529 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.23 122.7 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.88 0.472 . . . . 73.12 109.825 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.13 119.75 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 109.138 -0.69 . . . . 61.34 109.138 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -98.67 -46.46 5.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.574 0.35 . . . . 64.2 110.586 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.464 HH11 ' HE1' ' C' ' 32' ' ' PHE . 34.5 ttt180 -165.07 120.08 1.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.505 -0.183 . . . . 72.21 110.505 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -103.06 136.91 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.77 -1.196 . . . . 50.53 107.77 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -164.37 177.59 8.12 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.826 0.85 . . . . 74.04 110.763 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -107.5 127.56 53.72 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.738 -0.665 . . . . 62.42 110.013 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 27.4 mtpt -95.54 -30.99 13.54 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.529 -0.545 . . . . 62.12 109.529 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.782 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -144.61 134.9 24.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.834 -0.802 . . . . 74.22 108.834 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.524 HG23 HG22 ' D' ' 78' ' ' VAL . 27.1 mt -139.04 147.7 24.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.144 -1.428 . . . . 74.43 107.144 174.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -155.13 147.47 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.986 0.422 . . . . 73.12 110.351 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.623 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 67.8 t80 -150.06 127.89 11.76 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.16 1.384 . . . . 71.31 107.351 173.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -126.61 148.06 49.83 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.039 0.936 . . . . 74.32 108.974 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.25 84.03 61.14 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.816 -0.809 . . . . 55.15 108.816 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.24 -48.06 5.3 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.789 2.993 . . . . 65.42 114.195 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -111.87 45.57 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.885 -0.783 . . . . 74.22 108.885 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.522 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.79 -59.34 9.06 Favored Pre-proline 0 CA--C 1.575 1.928 0 N-CA-C 115.703 1.742 . . . . 62.41 115.703 -166.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.66 -4.45 10.73 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 122.545 1.945 . . . . 72.11 112.99 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -84.15 -35.62 23.47 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.332 1.053 . . . . 72.12 110.476 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 p -84.31 -13.29 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.394 0.616 . . . . 71.43 110.411 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -30.7 69.71 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.862 -0.608 . . . . 74.4 109.939 166.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -72.38 -6.28 42.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.444 1.098 . . . . 31.12 111.943 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.408 ' HZ1' ' HG2' ' D' ' 70' ' ' GLU . 93.9 mttt -125.41 87.13 2.65 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.379 1.072 . . . . 51.41 109.225 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.23 93.86 5.95 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.172 0.987 . . . . 63.52 110.425 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.38 170.98 20.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.314 1.046 . . . . 73.42 109.815 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.59 107.37 7.12 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.191 -1.04 . . . . 62.22 108.191 166.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.63 153.92 76.25 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.945 2.43 . . . . 71.51 113.001 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.01 123.81 23.59 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.444 -0.947 . . . . 73.33 108.444 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.531 HG11 HD13 ' D' ' 126' ' ' LEU . 7.7 p -117.71 142.35 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.079 0.552 . . . . 74.52 110.283 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' D' ' 41' ' ' LYS . 11.4 mmpt? -109.77 123.83 50.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.344 1.058 . . . . 63.4 108.711 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.62 126.87 55.84 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.464 0.706 . . . . 75.23 110.566 -171.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -130.67 120.2 23.56 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.945 0.898 . . . . 62.25 109.168 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.629 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.8 pt? -108.48 132.56 53.69 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.219 -0.66 . . . . 42.32 109.219 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.449 ' O ' HD23 ' D' ' 60' ' ' LEU . 26.7 t70 -135.48 145.26 46.96 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.862 0.865 . . . . 64.11 108.967 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -123.59 155.58 37.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.852 0.834 . . . . 74.4 111.62 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.515 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.19 166.86 27.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 113.801 -1.545 . . . . 62.32 108.073 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.4 p -151.91 156.38 39.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.133 0.573 . . . . 70.23 109.568 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -158.51 119.03 3.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.774 0.83 . . . . 73.31 109.022 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.71 117.79 11.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.987 -0.746 . . . . 71.04 108.987 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.55 -36.38 17.61 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.306 -0.627 . . . . 74.1 109.306 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.84 -171.38 2.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 71.11 111.322 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -54.8 104.68 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.607 1.563 . . . . 55.45 111.371 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 58.33 20.65 7.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.19 0.996 . . . . 71.42 112.432 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 75.3 t -109.46 122.22 63.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 107.523 -1.288 . . . . 60.32 107.523 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -130.89 128.41 40.5 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.836 -0.801 . . . . 73.22 108.836 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -88.66 135.88 33.28 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.528 1.131 . . . . 72.4 108.464 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 81.3 t -117.87 139.83 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.34 -0.985 . . . . 71.23 108.34 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.6 t -115.78 141.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.237 -1.023 . . . . 41.15 108.237 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.36 118.61 24.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.287 -1.375 . . . . 73.04 107.287 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 4.3 tmm_? -107.28 97.86 7.57 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.963 -0.754 . . . . 53.31 108.963 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.02 125.74 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.876 -0.787 . . . . 74.04 108.876 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -113.1 144.43 42.65 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.691 0.796 . . . . 53.5 109.798 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.618 HG21 HG21 ' D' ' 114' ' ' ILE . 25.6 t -135.8 104.82 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.243 1.417 . . . . 62.14 108.367 -173.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 10.0 m -112.14 90.99 3.49 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.563 -1.273 . . . . 54.33 107.563 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.53 125.32 42.17 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.44 -0.578 . . . . 72.04 109.44 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.9 p -158.69 124.92 4.58 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.167 0.987 . . . . 71.55 109.539 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.85 130.07 43.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.556 -1.276 . . . . 74.32 107.556 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 -146.41 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.012 -0.54 . . . . 23.45 113.323 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' GLU . . . . . 0.408 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 10.5 pt-20 -88.03 11.11 16.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.207 1.003 . . . . 65.12 112.239 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.76 161.9 40.31 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.819 0.342 . . . . 63.43 111.428 -167.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -83.33 124.79 30.96 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.644 -0.707 . . . . 71.34 110.063 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.466 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -73.4 -63.84 1.11 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.125 0.97 . . . . 71.42 110.161 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -157.87 157.56 33.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.142 0.496 . . . . 64.13 111.065 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.96 146.62 47.45 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.408 1.083 . . . . 63.25 109.075 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -160.0 141.42 12.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.191 0.596 . . . . 65.14 110.334 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.41 122.34 5.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.374 -0.602 . . . . 71.52 109.374 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.524 HG22 HG23 ' D' ' 21' ' ' ILE . 47.8 t -124.48 123.95 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.446 0.698 . . . . 71.13 110.581 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.782 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.5 93.61 9.57 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.386 0.612 . . . . 74.33 109.396 164.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -79.69 109.88 14.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.979 -1.009 . . . . 74.44 108.371 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.69 149.37 19.1 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 111.735 -0.546 . . . . 64.4 111.735 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.479 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.22 130.52 4.02 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 110.885 -0.886 . . . . 62.53 110.885 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.77 126.34 41.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.022 -1.103 . . . . 74.24 108.022 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' D' ' 86' ' ' ILE . 49.3 m-85 -129.98 162.75 27.97 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.297 -0.631 . . . . 71.41 109.297 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -116.35 101.62 8.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.556 0.742 . . . . 71.24 109.354 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' D' ' 84' ' ' PHE . 3.8 mp -109.77 110.63 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.083 0.953 . . . . 64.32 110.097 -174.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.53 38.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.012 0.925 . . . . 74.53 109.829 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.76 -20.0 6.84 Favored Glycine 0 N--CA 1.477 1.432 0 N-CA-C 114.646 0.619 . . . . 63.01 114.646 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.452 HD11 ' HG3' ' D' ' 93' ' ' GLN . 4.4 tt -121.16 137.26 55.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 C-N-CA 124.237 1.015 . . . . 54.22 109.478 -174.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -150.69 -170.99 3.81 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.72 0.808 . . . . 71.13 110.822 -177.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.5 -140.81 26.76 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.32 0.387 . . . . 73.05 113.606 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -80.0 -24.44 40.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.52 0.728 . . . . 45.14 110.833 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.452 ' HG3' HD11 ' D' ' 89' ' ' ILE . 6.5 tp-100 -70.26 -36.95 74.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.135 0.574 . . . . 53.52 110.632 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -74.55 -33.6 62.76 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.668 -0.493 . . . . 65.43 109.668 174.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.76 81.2 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.361 0.601 . . . . 74.42 110.425 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -67.71 -44.81 76.79 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.972 -1.013 . . . . 73.11 111.231 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.96 -50.5 73.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.051 0.54 . . . . 65.03 110.699 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.34 -22.85 54.39 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.869 0.868 . . . . 73.53 111.316 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.2 -7.56 46.24 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 115.215 0.846 . . . . 75.14 115.215 -172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.28 -51.86 0.35 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.793 0.796 . . . . 71.34 110.965 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -71.8 -39.44 69.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.764 0.426 . . . . 74.11 112.057 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' CE2' ' D' ' 11' ' ' PHE . 57.7 m -73.37 -44.59 7.59 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.693 -0.67 . . . . 74.24 111.347 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.528 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 64.6 Cg_exo -56.64 -32.75 91.58 Favored 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 121.983 1.789 . . . . 71.33 113.244 168.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -63.82 -35.75 81.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.205 0.602 . . . . 64.33 110.669 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -65.75 -42.11 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.437 0.695 . . . . 63.31 110.111 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.479 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.0 mt -75.9 -19.26 58.97 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.075 -0.966 . . . . 65.4 112.318 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.23 -43.84 56.41 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 113.851 1.056 . . . . 74.14 113.851 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.99 -41.4 79.2 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.937 1.758 . . . . 75.03 113.512 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.43 -38.36 68.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.516 0.726 . . . . 74.22 111.525 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.65 79.35 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.486 0.714 . . . . 52.53 110.398 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -55.35 -52.37 63.72 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.507 1.129 . . . . 73.21 110.6 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.18 -43.95 93.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.894 0.746 . . . . 73.43 111.779 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 51.6 t -55.35 -40.3 71.07 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.764 0.665 . . . . 74.5 110.833 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.618 HG21 HG21 ' D' ' 64' ' ' VAL . 97.3 mt -65.83 -53.38 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.071 -0.968 . . . . 73.21 110.483 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.433 HG23 ' HG3' ' D' ' 125' ' ' GLN . 22.5 m -57.31 -35.99 70.53 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.252 1.021 . . . . 52.43 111.818 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.99 -45.69 76.86 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.204 -0.907 . . . . 74.45 110.139 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.425 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 79.1 mtm -65.6 -31.45 72.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.24 0.616 . . . . 72.02 111.7 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' D' ' 114' ' ' ILE . 71.2 t -66.25 -46.21 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.388 -0.824 . . . . 64.14 110.038 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.03 -25.44 60.95 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.333 -0.394 . . . . 74.32 111.428 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -74.39 -35.42 63.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.588 0.755 . . . . 61.02 109.676 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.67 -1.37 83.11 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 115.692 -0.685 . . . . 72.32 112.111 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p 57.19 36.29 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.2 1.8 . . . . 73.54 111.825 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.62 158.31 32.38 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 113.908 -1.496 . . . . 72.03 109.815 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.13 128.24 29.07 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.526 2.151 . . . . 65.24 113.07 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' D' ' 115' ' ' THR . 27.1 tt0 -52.39 140.97 20.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.052 1.341 . . . . 73.41 112.702 -175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.531 HD13 HG11 ' D' ' 40' ' ' VAL . 28.2 tp -112.99 126.77 55.86 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.11 -0.7 . . . . 73.54 109.11 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.467 ' HB3' HG13 ' B' ' 13' ' ' ILE . 94.3 m-20 -121.28 103.78 9.23 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.074 0.95 . . . . 70.0 109.025 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.76 119.75 12.36 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.641 0.776 . . . . 73.12 110.12 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.18 88.32 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.089 0.556 . . . . 73.52 110.602 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 110.7 1.36 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.464 2.109 . . . . 75.25 111.827 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.65 110.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.08 -1.082 . . . . 70.54 108.08 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -82.31 75.29 9.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.157 0.979 . . . . 73.53 109.375 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 28.4 t80 . . . . . 0 CA--C 1.549 0.916 0 CA-C-N 114.304 -1.316 . . . . 75.3 109.767 -179.751 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.6 m . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.498 -0.556 . . . . 62.35 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -133.17 112.38 11.68 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.744 -1.206 . . . . 74.33 107.744 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -140.06 110.5 6.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.27 -0.641 . . . . 75.3 109.27 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.424 HG13 ' CD2' ' A' ' 84' ' ' PHE . 1.5 mp -81.11 119.41 30.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 107.559 -1.274 . . . . 64.43 107.559 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.17 -41.49 16.97 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.014 -0.736 . . . . 72.14 109.014 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -168.07 137.47 2.51 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.328 -0.367 . . . . 74.33 110.561 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.642 HG23 HD23 ' A' ' 106' ' ' LEU . 92.0 mt -139.88 98.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.988 -1.115 . . . . 72.15 107.988 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.3 m-85 -163.45 166.02 23.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.102 0.961 . . . . 75.32 109.409 -167.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -74.18 126.33 30.34 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.075 -0.342 . . . . 73.4 110.075 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 41.2 mtpt -85.05 -44.41 13.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.392 0.615 . . . . 63.03 109.456 171.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.5 t70 -135.36 142.1 45.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.71 -1.132 . . . . 73.44 109.885 -176.052 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.5 mt -138.19 140.01 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.453 1.501 . . . . 73.11 107.684 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.74 128.65 10.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.618 . . . . 73.22 109.333 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.0 t80 -134.1 125.07 27.23 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.389 -1.338 . . . . 71.1 107.389 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.75 148.07 49.19 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.039 -0.726 . . . . 65.45 109.039 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.0 77.78 25.48 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 106.628 -1.619 . . . . 74.24 106.628 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.93 -31.86 36.98 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.749 2.299 . . . . 72.13 111.873 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -109.28 32.14 5.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.704 0.802 . . . . 73.41 109.524 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -46.8 99.07 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.262 1.025 . . . . 52.51 113.282 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.61 -12.99 29.73 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.688 1.592 . . . . 72.04 113.167 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -90.14 -11.82 40.06 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.762 0.825 . . . . 74.33 111.698 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 29.9 m -60.24 -15.09 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 113.617 0.969 . . . . 64.34 113.617 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.64 -41.19 65.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 72.35 110.844 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -89.84 -15.61 31.88 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.375 -0.83 . . . . 74.1 110.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 3.7 mmpt? -73.21 129.21 37.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.231 0.612 . . . . 73.32 111.096 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.64 116.73 12.34 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.153 -1.055 . . . . 75.23 108.153 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -71.52 83.49 0.83 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.816 0.817 . . . . 75.21 111.283 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -141.0 80.19 17.39 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.203 -1.777 . . . . 74.23 106.203 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.74 135.36 6.76 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.904 2.403 . . . . 70.31 111.597 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -94.2 100.77 12.78 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 105.862 -1.903 . . . . 55.12 105.862 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.01 90.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.751 0.786 . . . . 60.44 109.068 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 56.7 tttp -86.39 127.67 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.36 -1.291 . . . . 70.44 108.837 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 tp -123.16 144.31 49.43 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.707 -0.849 . . . . 74.03 108.707 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.32 144.74 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.752 -0.833 . . . . 75.14 108.752 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.96 124.06 17.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.15 0.58 . . . . 74.32 110.272 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 20.7 t70 -123.5 148.04 46.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.994 1.317 . . . . 62.41 109.513 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.6 m -139.54 136.77 34.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.039 0.536 . . . . 73.12 110.579 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -146.29 127.64 14.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.28 0.632 . . . . 54.01 110.527 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -89.07 161.13 16.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.579 0.752 . . . . 74.31 109.87 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 47.2 t -167.33 116.67 0.83 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.991 -0.374 . . . . 74.34 109.991 -174.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.25 104.17 3.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.452 0.701 . . . . 75.43 110.011 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 57' ' ' GLU . 86.6 mt -77.95 -38.8 44.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.861 0.865 . . . . 72.45 111.044 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.92 -172.35 4.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.889 0.875 . . . . 71.33 109.776 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -57.21 97.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.188 0.595 . . . . 73.53 111.183 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 10.4 m-20 58.39 32.95 22.68 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.201 1.4 . . . . 70.44 112.299 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 59.9 t -107.72 120.57 59.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.651 -1.611 . . . . 73.52 106.651 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.0 m-85 -130.89 128.5 40.69 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.952 -0.759 . . . . 75.32 108.952 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 51' ' ' LEU . 40.2 tt0 -91.81 123.16 34.99 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.901 -0.777 . . . . 72.3 108.901 172.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 33.2 m -99.75 122.09 51.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 107.543 -1.28 . . . . 70.43 107.543 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.497 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.9 t -100.49 130.13 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.14 -0.689 . . . . 75.55 109.14 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.7 112.97 26.26 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.425 -1.324 . . . . 73.31 107.425 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttm-85 -93.14 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.715 -1.217 . . . . 74.22 107.715 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.65 124.36 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.517 -0.92 . . . . 63.54 108.517 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -123.64 129.75 51.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.781 0.432 . . . . 62.45 109.952 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 53.0 t -123.63 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.541 1.136 . . . . 73.34 109.883 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 m -103.46 141.16 36.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.963 -0.384 . . . . 64.22 109.963 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.66 103.0 8.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.39 -1.337 . . . . 52.0 107.39 168.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 34.3 m -112.0 125.3 53.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.476 0.655 . . . . 73.41 109.401 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.9 mp -102.32 86.67 2.87 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.753 -1.943 . . . . 73.43 105.753 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -122.91 5.96 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.931 -0.868 . . . . 71.45 110.931 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.64 -23.78 24.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.235 0.614 . . . . 70.52 110.104 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.91 108.93 19.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.336 0.654 . . . . 65.13 111.17 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -74.39 117.35 16.11 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.373 0.669 . . . . 71.02 109.517 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -59.57 -54.86 41.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.553 0.741 . . . . 54.12 109.529 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -156.56 153.67 29.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.36 -1.291 . . . . 71.43 111.526 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -125.49 135.85 52.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.906 1.282 . . . . 73.22 108.732 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.0 m -120.35 140.61 51.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 71.01 109.247 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -147.43 125.59 12.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.784 -0.821 . . . . 71.33 108.784 166.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.34 109.64 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.211 1.005 . . . . 53.32 108.511 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 79.2 mt-30 -86.8 84.86 7.28 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.332 -0.849 . . . . 64.25 109.098 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -76.36 96.6 4.04 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.088 -1.414 . . . . 53.43 109.548 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.74 145.68 18.04 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.81 -0.516 . . . . 74.11 111.81 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.536 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.97 122.65 2.38 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.719 -0.952 . . . . 72.13 110.719 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 48.0 mt -82.3 125.02 39.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 109.268 -0.642 . . . . 74.32 109.268 174.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 13' ' ' ILE . 55.4 m-85 -130.93 120.35 23.44 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.698 -0.853 . . . . 71.43 108.698 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 36.1 t -96.35 107.02 19.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 24.04 109.111 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.612 ' HB ' HD13 ' A' ' 89' ' ' ILE . 42.9 pt -130.45 127.79 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.148 0.579 . . . . 73.2 110.767 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.85 134.18 27.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.627 0.771 . . . . 60.24 109.926 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.15 7.8 62.02 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 123.549 0.531 . . . . 60.34 113.237 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.612 HD13 ' HB ' ' A' ' 86' ' ' ILE . 4.5 mp -109.32 136.03 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.238 -1.023 . . . . 73.41 108.238 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 13.4 tt0 -159.62 -178.14 6.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.13 0.572 . . . . 72.54 109.52 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.515 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.39 -143.23 36.94 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.659 -0.246 . . . . 65.05 112.821 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -68.93 -17.79 64.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.063 0.945 . . . . 63.42 112.116 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.92 -57.7 5.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.599 0.76 . . . . 74.21 109.312 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.7 ttp -65.27 -40.42 93.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.93 1.292 . . . . 62.55 111.236 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.12 70.3 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.002 0.814 . . . . 75.31 110.044 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -64.27 -48.49 75.53 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 114.401 -1.272 . . . . 75.3 111.309 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 36.3 m -71.01 -45.23 64.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.969 1.1 . . . . 75.4 113.969 -165.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -83.26 -15.19 51.25 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.044 0.387 . . . . 74.41 112.044 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.56 -3.94 18.04 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 114.727 0.651 . . . . 73.34 114.727 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.97 -60.58 0.46 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.591 0.696 . . . . 70.1 110.941 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.507 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.2 t80 -57.55 -62.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.163 0.985 . . . . 74.52 112.394 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.01 -39.0 2.09 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.182 -1.372 . . . . 73.43 112.924 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HA ' HD12 ' A' ' 106' ' ' LEU . 10.4 Cg_endo -57.29 -37.86 96.53 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.703 1.602 . . . . 64.43 113.399 165.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.96 -37.71 86.7 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.079 0.4 . . . . 71.03 110.531 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 mm -58.26 -40.57 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.999 0.92 . . . . 51.33 110.946 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.642 HD23 HG23 ' A' ' 16' ' ' ILE . 94.6 mt -70.74 -31.54 68.41 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.672 -0.695 . . . . 64.23 111.84 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.08 -43.73 98.68 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 124.845 1.258 . . . . 64.14 114.251 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.32 -35.48 83.99 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.415 2.077 . . . . 70.43 114.219 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.02 -22.37 45.56 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.606 0.362 . . . . 75.22 111.485 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.4 65.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.531 -0.544 . . . . 71.11 109.531 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.414 HH22 ' HB3' ' A' ' 130' ' ' PRO . 42.1 ttm180 -56.75 -42.31 79.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.648 1.179 . . . . 75.01 110.975 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' HG2' HH12 ' B' ' 120' ' ' ARG . 21.9 tt0 -48.71 -56.55 8.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.211 1.404 . . . . 63.42 111.372 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.72 -48.69 68.44 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.82 -1.537 . . . . 74.53 111.363 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.8 mt -57.35 -54.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 124.14 0.9 . . . . 71.1 110.565 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -61.54 -34.48 75.63 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.83 0.706 . . . . 71.54 111.801 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -67.84 -44.92 76.06 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.248 -0.433 . . . . 61.44 110.347 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 mtp -55.62 -45.16 77.57 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.802 0.841 . . . . 62.43 110.978 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -61.89 -46.96 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.603 1.161 . . . . 72.4 111.135 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 88.3 p -73.06 -24.68 60.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.077 -0.511 . . . . 63.21 111.84 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.482 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.8 mtt-85 -74.96 -24.07 58.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.244 0.618 . . . . 64.14 110.627 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.31 16.23 24.67 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.537 0.523 . . . . 74.11 112.421 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 t 52.38 28.89 6.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.224 2.21 . . . . 71.14 112.848 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -94.06 140.11 22.79 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.133 -1.062 . . . . 74.12 108.133 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 144.25 99.53 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.53 2.154 . . . . 73.2 111.07 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -54.79 132.62 46.45 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.724 0.64 . . . . 64.33 112.338 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.08 98.85 4.54 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.607 -1.627 . . . . 73.34 106.607 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.21 126.15 43.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.481 0.658 . . . . 61.41 109.927 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 pp -68.91 141.47 55.02 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.598 -1.183 . . . . 73.04 111.382 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.18 142.54 84.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.402 0.681 . . . . 73.52 110.113 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.414 ' HB3' HH22 ' A' ' 111' ' ' ARG . 60.6 Cg_endo -74.57 136.68 21.7 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.408 2.072 . . . . 75.31 111.349 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.05 111.41 29.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.234 -1.395 . . . . 62.24 107.234 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -85.82 75.86 9.98 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.694 0.759 . . . . 75.21 110.621 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.16 -40.58 90.42 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.291 -1.322 . . . . 71.11 110.559 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.473 0.705 0 CA-C-N 115.258 -0.883 . . . . 75.0 111.67 175.672 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.9 ptm . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 114.243 1.201 . . . . 50.53 114.243 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.9 p -145.75 133.22 20.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.832 0.853 . . . . 72.41 108.805 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.442 ' HD1' HG22 ' B' ' 86' ' ' ILE . 91.4 t80 -129.71 139.17 51.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.648 0.779 . . . . 72.33 109.857 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -160.37 143.04 13.24 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.278 0.361 . . . . 71.54 111.494 173.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.61 HG21 HG13 ' B' ' 16' ' ' ILE . 3.7 mp -86.02 123.11 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.493 -0.928 . . . . 75.41 108.493 173.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -40.03 24.4 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.739 0.416 . . . . 73.55 110.395 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -161.36 136.62 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.274 -0.421 . . . . 74.31 110.43 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.61 HG13 HG21 ' B' ' 13' ' ' ILE . 67.0 mt -115.91 139.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 107.101 -1.444 . . . . 72.31 107.101 168.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.52 164.78 14.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.982 0.896 . . . . 74.33 112.461 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.5 m -96.87 125.61 41.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.066 -1.425 . . . . 74.44 108.821 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.445 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -97.64 -32.85 11.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.654 0.782 . . . . 74.12 110.372 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.18 138.58 18.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.966 -0.561 . . . . 51.23 110.641 -168.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.481 HD11 ' SG ' ' B' ' 113' ' ' CYS . 45.7 mm -141.01 142.17 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.381 1.473 . . . . 74.22 108.86 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 87.1 p -138.84 145.61 40.22 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.562 -0.903 . . . . 63.33 108.562 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.0 t80 -152.19 109.79 3.61 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.006 -1.479 . . . . 63.21 107.006 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -118.21 114.39 22.95 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.494 0.718 . . . . 72.22 109.213 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -109.54 87.27 5.13 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.904 0.882 . . . . 72.53 109.214 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.12 -24.98 16.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.781 2.321 . . . . 71.52 112.59 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.42 18.5 14.33 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.784 0.834 . . . . 74.13 110.447 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.807 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.37 -49.11 55.11 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 125.446 1.499 . . . . 50.41 114.249 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 18.1 Cg_exo -65.49 -29.19 53.35 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.103 1.868 . . . . 72.22 112.118 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -99.55 -8.97 23.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.011 0.925 . . . . 71.41 112.836 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.55 -14.07 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.597 0.592 . . . . 72.33 112.597 -167.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.82 -21.69 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.955 0.502 . . . . 73.02 111.583 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -76.57 -13.41 60.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.948 0.899 . . . . 63.02 111.37 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.661 ' HB3' HD22 ' B' ' 68' ' ' LEU . 35.5 mmtp -102.43 101.7 11.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.703 0.801 . . . . 71.22 110.85 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -96.13 84.47 3.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.36 -0.978 . . . . 72.53 108.36 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -164.69 166.38 20.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.43 1.092 . . . . 65.11 108.207 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.46 127.36 55.08 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-O 119.203 -0.427 . . . . 72.23 110.127 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.74 133.57 25.93 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.015 1.81 . . . . 74.31 112.086 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.92 107.34 5.25 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 108.441 -0.948 . . . . 75.33 108.441 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.08 133.99 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.965 0.412 . . . . 73.44 109.962 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -114.78 104.06 11.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.625 -0.88 . . . . 74.23 108.625 166.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' B' ' 42' ' ' LEU . 2.1 pp -94.92 141.52 28.55 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.876 -1.056 . . . . 71.1 108.823 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -162.9 147.16 11.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.913 -0.773 . . . . 71.14 108.913 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.96 152.5 24.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 74.11 109.933 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -141.33 150.47 42.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.047 1.339 . . . . 64.15 108.109 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -119.56 137.43 53.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 74.23 111.148 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -130.83 150.1 52.16 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.651 1.181 . . . . 60.33 108.133 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -142.67 162.21 36.06 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.689 0.395 . . . . 70.04 110.234 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -165.84 148.21 7.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.102 0.961 . . . . 70.51 109.206 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -119.29 125.33 48.83 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.075 -0.713 . . . . 62.31 109.075 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.71 -46.65 8.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.528 0.731 . . . . 73.21 110.053 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -148.7 178.1 8.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.076 -0.966 . . . . 44.45 110.133 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.42 114.06 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.04 0.936 . . . . 64.34 110.201 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 69.98 3.16 4.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.685 1.194 . . . . 53.11 112.913 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 61.7 t -108.66 95.76 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.673 -1.232 . . . . 73.3 107.673 176.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -112.83 135.98 52.98 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.52 -0.919 . . . . 72.52 108.52 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.59 107.3 16.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.882 0.873 . . . . 74.3 108.686 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.54 133.68 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.498 0.719 . . . . 74.45 109.828 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 35.4 t -112.33 120.8 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 70.04 109.686 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.95 121.37 35.35 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.497 -1.297 . . . . 73.23 107.497 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -111.05 119.48 39.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.378 -0.601 . . . . 71.04 109.378 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.83 111.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.544 -0.91 . . . . 64.32 108.544 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 49.6 m -97.35 135.99 38.45 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.236 -0.653 . . . . 75.31 109.236 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.596 HG11 HD13 ' B' ' 126' ' ' LEU . 79.5 t -132.69 134.1 58.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 123.485 0.714 . . . . 63.22 109.247 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.8 m -124.71 148.24 48.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.368 1.067 . . . . 74.23 108.167 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 148.49 32.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 122.803 0.441 . . . . 70.2 109.967 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 m -138.23 124.01 19.9 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.837 0.711 . . . . 74.42 109.934 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' B' ' 34' ' ' LYS . 0.7 OUTLIER -104.45 119.36 38.79 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.127 -1.064 . . . . 73.44 108.127 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -112.08 3.41 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.024 -0.83 . . . . 72.02 111.024 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -119.64 13.8 12.54 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.875 0.87 . . . . 51.11 110.949 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.36 167.41 22.98 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.667 0.787 . . . . 63.43 110.271 -170.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -62.09 134.46 56.62 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.663 0.602 . . . . 74.13 110.846 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -90.18 -57.68 2.76 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.911 -1.144 . . . . 73.11 107.911 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -160.92 169.08 23.33 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 113.697 -1.592 . . . . 73.23 109.779 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.2 mt -135.32 140.95 45.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.616 -1.624 . . . . 75.23 106.616 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -155.19 142.53 19.5 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.545 -0.539 . . . . 62.32 109.545 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -158.81 133.24 7.95 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.158 -0.682 . . . . 73.24 109.158 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.402 HG23 HG12 ' B' ' 114' ' ' ILE . 93.2 t -124.41 148.1 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.674 0.79 . . . . 51.13 109.342 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -123.16 100.52 6.91 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.439 -0.949 . . . . 75.04 108.439 169.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -86.91 99.05 11.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.269 -1.011 . . . . 73.24 108.269 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.65 157.92 26.92 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.147 -0.781 . . . . 74.21 111.147 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.75 134.03 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.958 -0.457 . . . . 45.35 111.958 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.9 121.22 39.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.739 -0.837 . . . . 72.42 108.739 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -123.82 136.45 54.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 74.3 110.091 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -99.26 108.37 20.91 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.606 1.162 . . . . 74.04 108.021 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.6 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.7 137.94 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.847 0.859 . . . . 71.23 108.825 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 132.26 10.17 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.16 -1.052 . . . . 60.22 108.16 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.6 11.36 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.385 -0.675 . . . . 54.03 113.744 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.605 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 27.2 pt -50.16 146.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 123.779 0.832 . . . . 73.01 111.989 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -150.71 156.27 40.98 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.043 0.757 . . . . 74.31 113.043 -167.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.66 -126.28 41.55 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.763 -1.562 . . . . 34.11 113.481 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.43 -38.09 42.19 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.57 0.748 . . . . 52.14 109.981 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.41 -21.95 65.55 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.634 -1.166 . . . . 73.35 110.839 -171.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.605 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 49.3 ttm -54.37 -49.23 70.32 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.275 1.03 . . . . 72.23 110.762 169.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.39 69.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.445 -1.252 . . . . 74.33 111.761 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 69.2 m-70 -74.76 -18.85 60.42 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.522 0.329 . . . . 65.02 111.875 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.59 -56.15 8.1 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.404 0.621 . . . . 65.44 110.324 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.404 HD23 ' SG ' ' B' ' 102' ' ' CYS . 87.3 mt -86.97 -22.34 25.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.215 -0.902 . . . . 64.41 112.026 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.74 -15.7 41.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 113.897 0.319 . . . . 23.12 113.897 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -129.51 -55.83 1.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 117.101 0.45 . . . . 72.33 111.955 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -70.22 -49.29 51.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.006 0.522 . . . . 74.42 111.547 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.5 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.18 -50.79 84.43 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.568 -0.729 . . . . 75.21 112.505 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.5 Cg_exo -58.53 -31.55 94.64 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.25 1.967 . . . . 72.12 113.577 173.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.43 -27.41 63.27 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.621 0.369 . . . . 60.52 111.231 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.405 HG23 ' NH2' ' D' ' 111' ' ' ARG . 97.5 mt -70.25 -43.36 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.591 0.756 . . . . 74.14 109.714 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.62 -17.71 61.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.047 -0.979 . . . . 71.44 111.529 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.35 -51.3 81.12 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.791 1.236 . . . . 71.05 113.886 -170.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.495 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 28.6 Cg_endo -60.29 -33.06 94.87 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.957 1.772 . . . . 75.45 113.047 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.13 -43.97 73.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.095 0.558 . . . . 75.22 111.038 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.69 98.38 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.268 0.627 . . . . 44.32 110.501 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 29.7 mtp-105 -54.21 -57.73 10.07 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.503 1.121 . . . . 73.21 111.427 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.59 -26.56 64.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.414 -0.812 . . . . 75.44 110.287 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.76 -46.32 69.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.446 0.299 . . . . 65.13 110.44 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.402 HG12 HG23 ' B' ' 78' ' ' VAL . 69.3 mt -60.97 -48.03 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.058 0.543 . . . . 73.41 109.585 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -55.15 -43.65 74.41 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.438 -1.256 . . . . 61.23 111.429 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -65.68 -45.02 84.45 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.648 -0.706 . . . . 51.35 110.838 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -71.91 -35.96 69.86 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.038 0.535 . . . . 74.42 111.392 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.618 HG22 ' HB2' ' B' ' 123' ' ' PHE . 9.1 p -75.35 -28.55 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.073 -0.512 . . . . 73.02 110.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 69.9 m -63.14 -35.64 80.95 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.437 0.695 . . . . 61.22 110.855 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.1 mtt-85 -69.57 -19.14 63.68 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 114.721 -1.127 . . . . 74.53 111.385 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 13.63 61.13 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.179 -0.789 . . . . 74.42 114.74 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.5 p 70.06 13.44 7.82 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.034 1.733 . . . . 71.12 113.038 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.618 ' HB2' HG22 ' B' ' 118' ' ' VAL . 73.2 m-85 -104.18 145.56 30.89 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 119.246 -0.407 . . . . 72.11 110.259 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.31 165.28 5.78 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.619 2.879 . . . . 53.12 113.825 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -61.06 155.66 19.8 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.297 -0.865 . . . . 73.33 111.915 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.596 HD13 HG11 ' B' ' 64' ' ' VAL . 87.6 mt -131.44 84.0 2.14 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.915 -0.772 . . . . 52.32 108.915 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.411 ' HB3' HH21 ' B' ' 111' ' ' ARG . 35.6 m-80 -106.65 100.36 9.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.788 -1.096 . . . . 74.11 108.376 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.58 133.88 53.21 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.169 -0.923 . . . . 63.03 109.312 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.54 150.13 94.19 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.074 0.55 . . . . 63.53 110.808 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.48 96.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.043 2.496 . . . . 73.0 112.565 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.43 117.56 33.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.567 -0.901 . . . . 43.22 108.567 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.15 97.63 5.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.024 -1.472 . . . . 73.12 107.024 170.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 19.2 m-85 -55.82 -30.2 61.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.135 0.974 . . . . 71.34 110.664 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.11 -36.45 81.79 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.614 -1.175 . . . . 72.34 111.076 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.14 -51.87 64.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.579 0.752 . . . . 71.13 111.127 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.484 1.264 0 O-C-N 123.731 0.644 . . . . 65.35 110.118 178.814 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.3 ttm . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.043 0.449 . . . . 73.01 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -85.56 87.34 7.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.146 -1.057 . . . . 34.24 108.146 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -105.58 136.41 45.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.874 -1.057 . . . . 72.53 109.19 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -152.92 132.83 13.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.246 0.618 . . . . 74.23 109.705 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.55 105.72 11.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.157 -1.053 . . . . 65.3 108.157 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.7 mm-40 -78.92 -41.58 29.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.893 -0.594 . . . . 64.1 110.11 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -170.79 157.17 5.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.668 0.605 . . . . 74.23 110.996 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.51 145.92 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 107.194 -1.41 . . . . 70.44 107.194 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -173.86 162.25 3.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.648 0.737 . . . . 73.14 109.866 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -80.14 111.76 16.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.868 -1.06 . . . . 63.43 108.249 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.86 -45.75 81.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.098 -1.075 . . . . 74.33 108.098 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.2 t70 -140.37 140.99 35.65 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 113.57 -1.65 . . . . 72.15 109.697 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.3 mt -131.46 145.58 34.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 106.907 -1.516 . . . . 72.54 106.907 170.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -153.82 146.63 24.34 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.338 0.59 . . . . 71.21 109.602 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -146.25 144.02 29.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.555 -1.276 . . . . 71.12 107.555 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -138.48 144.95 40.27 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.674 1.189 . . . . 73.23 107.835 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -150.6 80.04 7.02 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 106.683 -1.599 . . . . 63.34 106.683 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.73 -37.11 16.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.578 2.185 . . . . 63.11 111.349 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' C' ' 71' ' ' GLU . 1.7 m-20 -107.93 27.65 9.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.472 1.109 . . . . 72.22 109.439 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.508 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -50.17 -51.88 58.7 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.888 1.275 . . . . 53.01 113.889 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 66.3 Cg_endo -86.57 -19.21 2.91 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 121.67 1.58 . . . . 64.25 113.321 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -68.18 -21.64 64.88 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.983 0.913 . . . . 71.41 112.553 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.61 -5.49 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 123.343 0.657 . . . . 74.25 112.506 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.573 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 19.8 m-85 -67.42 -27.7 67.28 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.349 0.66 . . . . 65.23 112.451 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 29.0 7.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.485 0.714 . . . . 62.05 109.368 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.8 155.33 41.25 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.299 0.64 . . . . 72.4 111.253 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.71 129.99 39.48 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.385 -1.279 . . . . 73.33 110.572 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -84.53 65.65 9.09 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 122.19 0.995 . . . . 74.22 111.933 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -151.54 60.42 3.75 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 115.564 -0.744 . . . . 73.44 110.673 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.38 153.92 75.43 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.21 1.94 . . . . 72.23 110.498 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.72 109.15 17.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.828 -1.545 . . . . 71.01 106.828 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.424 HG13 HD11 ' C' ' 126' ' ' LEU . 77.8 t -75.25 106.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.891 -1.05 . . . . 70.11 110.646 -174.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.727 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 6.4 mtpm? -103.35 143.88 32.09 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.272 1.029 . . . . 61.33 108.323 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -128.87 164.05 23.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.79 0.436 . . . . 73.4 110.896 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.41 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.0 t70 -154.29 125.91 7.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.428 -0.805 . . . . 71.52 108.991 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -115.4 112.07 21.77 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.646 -1.242 . . . . 75.33 107.646 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -126.68 119.98 28.33 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.609 -1.256 . . . . 71.2 107.609 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -118.42 150.42 39.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.389 -0.597 . . . . 71.11 109.389 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.09 171.96 13.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 71.23 109.13 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -146.83 143.39 28.56 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.843 -0.799 . . . . 61.55 108.843 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.7 t -145.0 126.39 14.9 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.307 -0.997 . . . . 42.33 108.307 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -80.1 117.33 20.81 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.525 -0.546 . . . . 73.52 109.525 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' C' ' 57' ' ' GLU . 69.9 mt -86.73 -45.5 10.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.684 0.793 . . . . 55.05 110.087 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.79 -165.15 2.19 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.66 -0.7 . . . . 62.42 111.132 -173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.13 102.03 0.19 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.1 0.875 . . . . 60.22 110.966 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 63.72 18.5 11.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.154 0.982 . . . . 73.54 111.884 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -106.96 114.22 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.27 -1.011 . . . . 73.24 108.27 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -122.0 124.82 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.151 0.98 . . . . 54.4 108.891 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.616 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.8 tt0 -89.59 114.99 26.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.177 0.991 . . . . 75.32 109.245 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -95.86 129.47 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.089 -1.078 . . . . 73.52 108.089 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 t -120.64 106.53 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.667 -0.864 . . . . 65.12 108.667 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.9 102.41 14.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.473 -0.936 . . . . 64.53 108.473 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.407 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 33.3 ttm105 -79.51 107.3 12.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.587 -0.894 . . . . 74.13 108.587 168.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -99.96 124.28 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.137 -1.431 . . . . 60.44 107.137 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.9 m -123.74 119.59 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.785 -0.821 . . . . 73.33 108.785 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 77.7 t -111.01 129.41 66.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.739 -1.119 . . . . 64.54 108.626 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.727 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.5 m -122.69 138.17 54.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.722 0.809 . . . . 71.42 109.164 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.62 100.88 6.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.281 -1.377 . . . . 72.02 107.281 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -140.63 118.21 11.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.827 -0.805 . . . . 63.32 108.827 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.26 -40.18 85.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 75.44 110.238 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.12 -79.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.482 -1.047 . . . . 75.52 110.482 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.0 -32.01 16.95 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.727 0.811 . . . . 60.21 109.434 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.53 ' HG3' ' ND2' ' C' ' 27' ' ' ASN . 40.8 tt0 -88.69 121.32 30.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.194 0.997 . . . . 73.1 111.096 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.6 m -84.23 126.71 33.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.999 0.52 . . . . 72.15 110.107 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.93 -55.21 5.83 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.817 0.847 . . . . 72.32 109.105 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.57 165.44 34.49 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.581 -1.19 . . . . 74.13 110.84 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.474 HD23 HG23 ' C' ' 65' ' ' THR . 3.0 tm? -135.05 144.92 47.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.271 -1.381 . . . . 54.13 107.271 174.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.409 ' N ' HD13 ' C' ' 75' ' ' LEU . 43.6 t -144.8 143.96 30.91 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.158 -0.682 . . . . 72.1 109.158 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -153.17 134.18 14.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.143 0.577 . . . . 73.24 109.507 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' C' ' 110' ' ' ALA . 39.8 t -133.09 113.55 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.236 1.014 . . . . 72.43 108.444 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -92.73 90.6 7.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.914 0.885 . . . . 55.21 108.73 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.3 tp-100 -82.97 105.97 14.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.081 -0.963 . . . . 72.52 109.897 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.11 147.54 18.63 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.79 -0.524 . . . . 64.21 111.79 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.555 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.63 123.46 2.16 Favored Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.759 -0.937 . . . . 70.42 110.759 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.2 mm -80.65 118.51 28.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.931 -1.137 . . . . 72.24 107.931 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -132.75 130.8 40.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.468 0.707 . . . . 73.4 109.534 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 m -81.49 115.55 20.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.053 -0.721 . . . . 50.11 109.053 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.657 HG13 HD21 ' C' ' 98' ' ' LEU . 27.3 mm -116.73 100.89 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.404 -0.961 . . . . 71.23 108.404 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.92 168.45 19.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.323 0.649 . . . . 54.15 110.179 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.29 -56.27 4.25 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.028 -0.533 . . . . 70.43 112.354 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -104.01 163.08 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.826 0.85 . . . . 62.14 109.472 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.8 -177.12 5.55 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.729 0.412 . . . . 71.01 111.543 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.42 -144.76 48.9 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.485 -0.78 . . . . 53.43 114.818 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 43.7 p -68.67 -19.89 64.42 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.65 0.78 . . . . 73.31 111.863 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -67.02 -41.66 86.25 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.231 1.012 . . . . 74.3 110.305 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -83.14 -23.21 33.08 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.366 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -71.45 -25.8 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.096 0.559 . . . . 52.21 111.256 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 29.5 t-80 -63.58 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.796 0.438 . . . . 64.44 110.221 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.559 ' HG ' ' HG ' ' C' ' 102' ' ' CYS . 17.6 t -76.61 -60.36 2.38 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.202 -0.666 . . . . 62.35 109.202 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.657 HD21 HG13 ' C' ' 86' ' ' ILE . 98.6 mt -60.72 -26.83 67.45 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.062 0.945 . . . . 43.05 113.065 -174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.19 10.86 33.85 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.545 -0.586 . . . . 64.32 113.902 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -155.05 -60.64 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.584 0.692 . . . . 73.44 111.698 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' C' ' 104' ' ' ASN . 65.1 t80 -75.13 -42.47 56.21 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.877 0.695 . . . . 74.33 112.877 -170.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.559 ' HG ' ' HG ' ' C' ' 97' ' ' CYS . 63.3 m -66.44 -49.39 52.83 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.207 0.603 . . . . 55.24 111.708 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.46 -18.25 43.68 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 121.594 1.529 . . . . 73.24 113.265 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 27.1 t-20 -57.13 -41.75 79.65 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.549 0.69 . . . . 72.32 109.92 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.45 -38.58 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.141 -1.391 . . . . 64.14 110.875 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.555 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.5 mt -81.29 -34.25 32.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.193 -0.912 . . . . 72.13 112.369 -170.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -54.66 -45.73 99.48 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 124.299 1.04 . . . . 74.0 113.527 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.71 -52.03 7.4 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.795 2.33 . . . . 72.11 113.686 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -63.91 -48.71 75.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.357 -0.838 . . . . 74.13 111.732 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.52 -41.23 96.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.085 0.554 . . . . 72.51 111.735 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -64.16 -44.53 91.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.2 0.937 . . . . 62.42 110.592 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -70.65 -31.87 68.95 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.522 -0.763 . . . . 63.52 110.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.8 -34.2 77.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.093 0.557 . . . . 65.3 110.436 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.09 -42.21 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.369 0.668 . . . . 73.52 110.379 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 81.6 m -62.2 -30.93 71.42 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.004 0.522 . . . . 64.03 110.284 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -70.86 -54.18 12.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.634 0.773 . . . . 73.22 109.912 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.48 -45.93 66.35 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.482 1.113 . . . . 73.02 112.385 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.01 -42.33 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.907 0.883 . . . . 70.32 110.834 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -64.21 -32.53 74.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.933 -0.576 . . . . 74.2 111.02 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.49 -35.46 73.25 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.387 -0.824 . . . . 63.52 109.696 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.98 2.76 67.83 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.683 0.614 . . . . 72.53 113.188 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 54.38 48.12 21.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.088 1.755 . . . . 75.44 112.184 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 90.9 m-85 -115.02 149.29 42.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 114.083 -1.417 . . . . 72.24 108.091 169.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.5 154.98 22.52 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.654 2.902 . . . . 60.51 113.844 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -58.11 150.44 21.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.893 0.877 . . . . 74.11 112.753 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.424 HD11 HG13 ' C' ' 40' ' ' VAL . 1.9 tt -145.47 85.97 1.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.298 -1.371 . . . . 64.02 107.298 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.05 108.29 19.77 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.834 -1.076 . . . . 62.05 108.349 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 130.41 46.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.294 1.038 . . . . 74.22 109.964 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.32 137.17 97.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.677 0.791 . . . . 72.52 111.685 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.68 122.64 10.32 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.747 2.298 . . . . 75.53 112.04 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 109.86 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.137 -1.06 . . . . 44.24 108.137 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -87.2 63.62 7.92 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.978 0.911 . . . . 75.25 109.579 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -77.13 -43.95 32.21 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.021 -0.536 . . . . 72.23 110.582 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.829 0.851 . . . . 51.4 110.457 174.222 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.552 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 113.33 0.863 . . . . 73.22 113.33 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.4 m -132.88 139.56 47.47 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.152 -1.055 . . . . 62.34 108.152 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' D' ' 85' ' ' SER . 45.3 t80 -159.07 98.06 1.43 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.01 0.819 . . . . 72.31 108.792 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.21 115.39 24.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.61 0.764 . . . . 71.52 109.618 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' D' ' 84' ' ' PHE . 3.9 tp -77.61 104.38 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 108.408 -0.96 . . . . 70.32 108.408 171.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -84.62 -39.13 19.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.11 -0.95 . . . . 64.11 111.833 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.573 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 65.2 ttt180 -165.41 127.5 2.07 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.587 -0.279 . . . . 71.41 110.354 -166.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.508 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.4 mp -112.65 129.1 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.323 -1.362 . . . . 73.22 107.323 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -165.49 176.91 7.81 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 122.176 0.989 . . . . 74.14 113.117 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -108.32 119.36 39.26 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.02 -1.446 . . . . 65.13 108.36 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 39.7 mtpt -86.94 -17.94 31.94 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.32 -0.622 . . . . 73.44 109.32 173.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.769 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.5 t70 -155.7 140.24 16.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.924 . . . . 75.24 109.817 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' C' ' 117' ' ' MET . 58.5 mt -139.92 140.02 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.548 1.539 . . . . 75.33 107.786 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -143.84 136.84 27.49 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.457 0.703 . . . . 63.43 109.473 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.8 t80 -142.8 116.9 9.46 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.98 -1.859 . . . . 71.44 105.98 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' D' ' 26' ' ' PRO . 44.7 mt-10 -127.32 116.27 20.27 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.108 -0.701 . . . . 72.22 109.108 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -107.47 88.79 4.37 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 123.313 0.645 . . . . 75.34 109.559 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' D' ' 24' ' ' GLU . 16.6 Cg_exo -71.01 -38.7 4.78 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.222 2.615 . . . . 64.11 112.49 -173.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -118.24 40.86 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.221 1.008 . . . . 51.1 110.035 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.748 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.84 -57.8 17.56 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 114.976 1.473 . . . . 73.4 114.976 -169.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.53 -3.83 10.76 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 121.619 1.614 . . . . 65.44 112.266 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.98 -45.03 13.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.06 1.344 . . . . 74.31 109.804 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.97 -19.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.734 0.814 . . . . 73.41 110.312 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.5 -23.86 64.85 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.309 1.043 . . . . 75.24 111.791 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -79.61 -3.24 46.2 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.503 0.721 . . . . 73.12 111.769 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -121.59 110.02 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.635 0.774 . . . . 65.4 110.082 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.61 93.52 4.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.851 0.861 . . . . 73.41 109.744 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -169.05 158.37 8.48 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.45 1.1 . . . . 75.23 108.49 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -76.49 111.93 18.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.825 0.85 . . . . 70.01 110.033 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.64 128.1 26.93 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.048 2.498 . . . . 63.45 112.599 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -67.43 118.74 11.17 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.165 -0.679 . . . . 75.14 109.165 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.516 HG11 HD11 ' D' ' 126' ' ' LEU . 98.8 t -99.36 133.46 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.223 -0.899 . . . . 65.3 110.819 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -101.8 142.79 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.422 -0.955 . . . . 71.42 108.422 166.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.31 126.03 54.55 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.721 -0.844 . . . . 72.42 108.721 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 22.7 t70 -121.94 149.22 43.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.1 . . . . 74.11 108.142 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.16 151.39 49.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.863 0.465 . . . . 64.52 110.855 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.1 t70 -155.83 155.6 33.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.178 0.991 . . . . 73.3 108.82 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -133.45 160.03 38.62 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.278 0.631 . . . . 72.23 109.67 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 164.51 37.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.682 -0.858 . . . . 62.32 108.682 174.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -148.36 159.84 43.61 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.964 0.411 . . . . 62.31 111.136 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -160.86 126.71 3.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.33 1.052 . . . . 72.03 109.785 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.51 120.34 28.71 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.859 -0.793 . . . . 73.2 108.859 171.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -91.95 -40.96 10.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.766 -0.652 . . . . 72.54 110.182 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.59 -168.74 1.9 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.508 -0.769 . . . . 73.4 110.433 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.44 115.81 3.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.97 -1.013 . . . . 72.13 110.275 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.74 5.24 3.25 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.622 1.169 . . . . 64.24 112.318 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.93 120.23 59.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 107.531 -1.285 . . . . 74.02 107.531 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -131.47 161.79 31.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 64.22 108.96 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' D' ' 51' ' ' LEU . 6.6 tm-20 -132.43 136.92 47.08 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.085 -1.45 . . . . 63.54 107.085 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 134.8 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.748 -0.834 . . . . 73.52 108.748 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.5 t -107.48 128.18 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.752 0.821 . . . . 53.1 109.575 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -102.08 121.99 43.25 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.394 -1.336 . . . . 63.52 107.394 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.9 ttm180 -104.36 108.42 19.82 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.33 -0.989 . . . . 63.4 108.33 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.9 t -95.2 127.73 46.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 107.715 -1.217 . . . . 43.03 107.715 166.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.5 m -118.27 127.13 53.43 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.773 0.797 . . . . 53.54 109.846 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 53.7 t -115.01 114.29 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 125.879 1.671 . . . . 60.44 108.245 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -112.19 97.8 6.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.525 -0.917 . . . . 51.24 108.525 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.19 129.91 43.38 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.046 -0.724 . . . . 70.01 109.046 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 34.9 p -145.49 128.79 16.8 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.125 -0.695 . . . . 72.33 109.125 -175.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -123.23 123.91 41.83 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.476 -0.935 . . . . 54.14 108.476 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -116.0 4.57 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.516 0.51 . . . . 72.13 112.494 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -123.44 26.5 7.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.023 0.529 . . . . 64.33 110.464 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.69 155.19 49.39 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 123.64 0.776 . . . . 74.25 110.053 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -78.7 117.12 19.54 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 109.696 -0.483 . . . . 72.55 109.696 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.39 -61.55 1.79 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.589 0.755 . . . . 61.42 110.025 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.1 170.01 19.93 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.658 -1.156 . . . . 61.52 109.819 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 80.0 mt -126.74 145.54 50.56 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.385 1.074 . . . . 74.4 108.721 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.51 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.8 m -143.07 136.06 27.95 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.689 -1.226 . . . . 70.03 107.689 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -156.74 121.01 4.4 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.531 -0.914 . . . . 74.24 108.531 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -130.76 117.82 39.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 122.988 0.515 . . . . 52.55 109.635 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.769 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -89.74 87.46 7.0 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.057 0.848 . . . . 73.13 109.079 170.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -79.5 98.57 6.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.393 -1.276 . . . . 70.43 109.171 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.25 144.3 17.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 116.437 -0.347 . . . . 63.4 112.292 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -146.91 135.76 5.86 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.999 -0.441 . . . . 43.1 111.999 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.18 128.48 43.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 123.717 0.807 . . . . 71.01 109.877 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' D' ' 13' ' ' ILE . 63.4 m-85 -130.23 137.05 49.84 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 74.0 109.811 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 18.6 m -77.73 103.68 7.81 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.144 -1.058 . . . . 72.23 108.144 168.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.43 106.65 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.72 -0.844 . . . . 74.04 108.72 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -148.65 167.83 24.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.289 1.036 . . . . 72.5 109.628 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.14 6.08 67.72 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.49 -0.323 . . . . 71.32 113.799 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 tp -141.08 143.73 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 54.21 109.444 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 -172.05 4.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.107 0.563 . . . . 73.23 110.818 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.67 -138.82 22.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.52 0.513 . . . . 64.21 113.382 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -83.86 -24.2 30.99 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.509 0.724 . . . . 70.41 111.001 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -70.69 -32.97 70.39 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.11 0.564 . . . . 72.51 111.846 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -30.35 67.31 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 110.161 -0.311 . . . . 75.14 110.161 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.88 68.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.535 0.734 . . . . 74.34 110.405 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -65.2 -36.74 85.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.353 -0.84 . . . . 72.53 110.613 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.1 -47.29 65.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.995 -0.548 . . . . 63.34 110.022 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -73.15 -27.48 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.621 0.768 . . . . 74.45 111.452 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.34 5.06 33.38 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.361 -0.688 . . . . 70.12 114.526 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.46 -58.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 117.88 0.84 . . . . 62.15 111.534 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -70.92 -54.41 11.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.141 0.576 . . . . 71.33 112.17 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 66.2 m -62.11 -46.13 91.26 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 123.852 0.861 . . . . 73.14 112.072 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.529 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.6 Cg_exo -57.24 -36.05 98.97 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.409 2.073 . . . . 64.23 113.436 169.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -62.66 -34.74 77.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.95 0.5 . . . . 75.41 111.187 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -66.75 -40.22 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.007 0.923 . . . . 74.13 110.616 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' D' ' 82' ' ' GLY . 87.3 mt -74.51 -21.49 59.52 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.702 -0.681 . . . . 71.44 111.548 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -62.68 -46.0 88.5 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 114.143 1.164 . . . . 73.21 114.143 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -51.95 -38.22 68.61 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.056 1.837 . . . . 70.24 113.227 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -79.31 -34.71 42.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.099 0.96 . . . . 74.04 111.618 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -48.63 73.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.359 0.664 . . . . 71.11 109.862 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.405 ' NH2' HG23 ' B' ' 105' ' ' ILE . 41.5 ttp180 -57.54 -45.44 85.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.365 -1.289 . . . . 74.23 110.749 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.45 -46.5 89.8 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.097 0.873 . . . . 72.42 111.109 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.33 -41.7 85.19 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.719 0.637 . . . . 44.11 111.353 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.416 HG21 HG21 ' D' ' 64' ' ' VAL . 90.4 mt -63.14 -56.12 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.214 -0.903 . . . . 63.1 110.372 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.4 m -53.43 -39.03 64.06 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.582 1.153 . . . . 72.52 112.046 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -71.78 -41.05 68.81 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.422 -0.808 . . . . 65.21 110.813 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.29 -31.59 72.8 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.71 0.404 . . . . 74.33 111.408 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.416 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.2 t -68.23 -42.35 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 62.54 110.252 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 72.8 p -74.18 -26.4 60.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.36 0.264 . . . . 62.11 111.25 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.63 -29.69 59.25 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.548 0.739 . . . . 74.41 110.049 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 2.96 87.5 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.645 -0.707 . . . . 74.53 112.051 171.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 14.7 p 63.84 18.01 10.89 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.094 2.158 . . . . 63.11 114.267 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 59.6 m-85 -87.65 166.2 26.21 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.847 1.259 . . . . 73.13 109.948 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 56.5 Cg_endo -68.13 134.17 30.88 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.142 1.895 . . . . 75.24 111.143 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.37 143.47 34.31 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.201 0.6 . . . . 63.13 110.534 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.516 HD11 HG11 ' D' ' 40' ' ' VAL . 4.4 tt -110.5 111.62 22.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.282 -1.007 . . . . 74.31 108.282 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -98.96 87.11 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.16 117.1 7.98 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.109 -0.95 . . . . 71.21 108.647 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -53.84 136.57 55.62 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.89 0.876 . . . . 61.43 111.568 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 13.6 Cg_exo -68.91 122.59 9.5 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.222 1.948 . . . . 71.31 110.446 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.82 144.82 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.171 0.588 . . . . 73.3 109.415 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -74.3 94.68 2.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.467 -0.938 . . . . 62.44 108.467 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.481 1.08 0 CA-C-N 115.343 -0.844 . . . . 73.0 111.649 179.084 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 108.694 -0.854 . . . . 71.42 108.694 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -137.9 113.51 9.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.709 -0.848 . . . . 73.52 108.709 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -142.0 137.88 31.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 75.5 109.769 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.37 133.44 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 71.42 109.929 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.92 -42.31 11.28 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.65 -0.5 . . . . 72.35 109.65 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.541 ' HD2' HD12 ' A' ' 83' ' ' ILE . 11.9 ptp180 -175.56 146.07 0.76 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.067 -0.969 . . . . 72.3 109.39 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.505 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 77.2 mt -137.03 125.98 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.123 -1.065 . . . . 72.4 108.123 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.531 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 22.2 p90 -164.75 161.65 20.69 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.805 0.842 . . . . 74.32 110.635 -170.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -75.83 123.25 25.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.092 -0.504 . . . . 72.21 109.825 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.1 mtpt -86.99 -32.05 20.27 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.695 0.398 . . . . 70.41 109.999 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -147.28 144.94 29.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.524 -0.762 . . . . 64.3 109.907 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.2 mt -134.99 146.4 30.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 125.451 1.5 . . . . 63.32 107.674 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 t -149.33 138.78 21.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.306 0.642 . . . . 72.41 109.812 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -147.19 126.95 13.43 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.12 -1.437 . . . . 74.55 107.12 175.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.86 127.54 29.03 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.564 -0.902 . . . . 64.4 108.564 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -119.18 86.61 32.91 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 109.007 -0.738 . . . . 63.14 109.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -34.47 27.03 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.165 2.577 . . . . 73.11 113.081 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 2.4 m-80 -109.84 33.94 4.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.549 0.74 . . . . 70.3 109.926 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -52.88 -48.51 91.17 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 113.727 1.01 . . . . 73.21 113.727 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.5 Cg_exo -68.62 -30.94 27.53 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 121.674 1.582 . . . . 74.4 112.214 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -75.8 -21.89 56.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.697 0.799 . . . . 74.14 111.825 -170.336 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' ASN . 57.9 t -53.61 -27.24 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 123.773 0.829 . . . . 75.5 111.848 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -78.82 -39.03 36.67 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.746 0.818 . . . . 74.51 111.047 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -88.29 -26.64 22.17 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.302 0.641 . . . . 70.33 112.383 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HB2' HD12 ' A' ' 68' ' ' LEU . 55.8 mtpt -80.5 163.49 23.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.15 0.58 . . . . 62.31 111.234 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.06 115.84 15.13 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.457 0.703 . . . . 71.05 109.331 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -73.24 86.01 1.42 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.987 0.915 . . . . 75.4 111.445 -172.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.53 80.63 65.69 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 124.031 0.932 . . . . 74.55 108.899 171.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.45 121.71 8.47 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.876 2.384 . . . . 74.45 111.872 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.86 105.96 18.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.378 -0.971 . . . . 72.24 108.378 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.09 92.47 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.705 -0.85 . . . . 64.2 108.705 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.2 tttm -100.33 115.29 29.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.92 0.888 . . . . 72.31 109.139 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -100.84 141.91 33.05 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.028 0.531 . . . . 74.13 109.808 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.698 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.5 m-20 -128.19 111.68 13.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.265 -1.383 . . . . 74.52 107.265 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 131' ' ' VAL . 75.2 mt -109.74 119.89 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.753 -0.462 . . . . 72.51 109.753 -174.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -130.31 137.46 49.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.051 0.94 . . . . 74.11 109.463 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.6 m -117.07 132.97 56.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.572 0.749 . . . . 75.33 109.902 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.03 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.641 1.176 . . . . 74.4 109.036 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -132.54 158.94 40.86 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.594 0.758 . . . . 75.41 110.43 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -157.17 157.34 34.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.458 1.103 . . . . 75.05 110.009 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -113.95 136.97 52.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.776 0.83 . . . . 54.4 109.572 174.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.03 -33.91 3.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.134 0.573 . . . . 73.51 111.209 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.46 -174.04 4.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.232 0.613 . . . . 62.22 110.199 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.1 117.01 9.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.457 0.703 . . . . 72.13 109.487 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 67.62 14.65 9.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.481 1.112 . . . . 72.14 111.816 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -118.93 104.93 16.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.478 -0.934 . . . . 64.21 108.478 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -125.53 126.65 45.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.67 0.788 . . . . 75.24 109.116 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -92.48 130.04 38.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.747 1.219 . . . . 74.4 109.432 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.402 HG11 ' HD3' ' A' ' 103' ' ' PRO . 65.4 t -114.28 123.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.956 -1.127 . . . . 65.13 107.956 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.5 t -106.52 134.96 46.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.617 0.767 . . . . 61.52 109.277 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.9 113.93 27.83 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.296 -1.372 . . . . 64.31 107.296 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -96.6 100.72 12.27 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.988 -1.115 . . . . 75.35 107.988 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 HD22 ' A' ' 60' ' ' LEU . 11.1 t -101.84 131.61 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.525 -0.917 . . . . 73.1 108.525 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.698 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.1 m -116.6 137.15 52.4 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.784 -1.191 . . . . 63.32 107.784 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 114' ' ' ILE . 86.3 t -128.72 128.05 67.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.567 -2.012 . . . . 74.24 105.567 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 27.6 m -124.67 139.24 54.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.934 -1.506 . . . . 62.45 106.934 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.95 119.75 20.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.403 -0.962 . . . . 62.44 108.403 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 68.5 m -107.07 131.37 54.17 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.369 -0.604 . . . . 73.4 109.369 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -88.94 76.22 7.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.559 -1.275 . . . . 71.24 107.559 -175.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.36 -102.2 2.26 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.324 -1.51 . . . . 71.41 109.324 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.56 -27.82 4.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.373 0.669 . . . . 74.35 110.096 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.44 131.44 34.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.936 0.894 . . . . 73.24 108.59 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 24.5 m -62.01 130.17 44.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.052 . . . . 61.35 113.205 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -76.89 -59.3 2.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.433 1.093 . . . . 51.22 109.307 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -161.83 174.48 13.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.631 -1.168 . . . . 72.21 111.112 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.0 tp -137.69 145.26 42.38 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 71.24 108.329 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.566 ' HB3' HG23 ' A' ' 114' ' ' ILE . 70.2 m -146.99 104.44 3.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.914 0.885 . . . . 71.4 110.165 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.21 126.35 38.95 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.895 0.478 . . . . 72.11 109.774 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.89 112.49 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.871 0.868 . . . . 60.44 109.663 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -85.09 83.39 8.05 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.402 -0.962 . . . . 63.03 108.402 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.14 98.53 5.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.222 -0.899 . . . . 64.21 109.448 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.01 144.49 19.41 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.83 -0.508 . . . . 64.34 111.83 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.21 122.46 2.43 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.114 -1.194 . . . . 64.54 110.114 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.541 HD12 ' HD2' ' A' ' 15' ' ' ARG . 49.5 mt -88.5 129.13 40.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.275 -1.009 . . . . 72.32 108.275 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -129.1 126.02 38.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.652 0.381 . . . . 74.54 110.313 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 p -83.24 100.13 10.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.887 -0.782 . . . . 73.22 108.887 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.5 pt -112.8 137.1 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.798 0.839 . . . . 73.33 111.437 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.18 155.77 11.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.882 1.273 . . . . 33.32 108.964 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.89 86.54 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 120.154 -0.248 . . . . 64.01 113.63 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.47 140.9 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.994 0.918 . . . . 74.11 109.259 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 22.5 tt0 -155.47 177.74 11.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.864 0.466 . . . . 62.52 110.292 -174.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.1 -157.18 43.57 Favored Glycine 0 C--N 1.345 1.07 0 C-N-CA 123.936 0.779 . . . . 72.51 114.127 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 p -71.83 -13.84 61.79 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.797 0.839 . . . . 52.22 111.026 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.12 -46.66 88.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.317 1.047 . . . . 61.35 111.022 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.4 61.96 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.094 -0.335 . . . . 74.33 110.094 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.29 75.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.338 0.655 . . . . 63.42 110.704 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 6.3 t-80 -65.04 -48.12 74.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.764 1.226 . . . . 51.23 110.07 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 13.4 m -73.84 -26.02 60.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.955 1.094 . . . . 53.22 113.955 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.2 mt -97.31 -30.61 12.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.854 0.462 . . . . 74.42 111.332 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -20.34 49.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.098 -0.501 . . . . 73.14 113.217 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.7 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -132.77 -70.7 0.54 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.23 0.455 . . . . 71.3 112.23 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.672 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.1 t80 -45.0 -58.6 3.07 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 124.899 1.279 . . . . 73.01 113.9 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.5 m -72.08 -41.61 8.8 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.323 -0.846 . . . . 65.4 113.166 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD3' HG11 ' A' ' 58' ' ' VAL . 9.3 Cg_endo -60.72 -23.91 77.44 Favored 'Trans proline' 0 C--N 1.388 2.63 0 CA-C-N 121.281 1.493 . . . . 64.42 113.851 165.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -73.19 -35.52 66.4 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 118.71 0.686 . . . . 44.43 110.484 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.29 -41.87 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.236 0.615 . . . . 73.02 109.576 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.2 mt -71.47 -24.89 62.08 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.219 -0.901 . . . . 72.21 112.354 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.97 -44.05 70.23 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.825 -1.084 . . . . 74.51 113.859 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.89 -32.64 92.82 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.247 1.965 . . . . 71.4 113.577 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -75.94 -38.58 57.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.247 0.619 . . . . 74.22 110.959 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.53 -46.24 76.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.106 0.562 . . . . 63.11 109.629 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -50.67 -54.28 24.34 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.865 1.353 . . . . 75.52 110.478 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -58.1 -49.47 76.85 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.437 1.085 . . . . 64.03 111.748 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.448 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.1 t -58.99 -43.57 91.47 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.062 0.851 . . . . 64.42 110.934 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 76' ' ' CYS . 84.7 mt -60.55 -55.1 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 123.997 0.811 . . . . 71.22 110.265 174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -59.71 -34.57 73.08 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.768 1.227 . . . . 73.12 111.837 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.1 t -73.46 -42.13 62.33 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.648 -0.705 . . . . 74.32 110.137 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 7.5 mtp -57.47 -42.2 82.14 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.552 0.741 . . . . 74.42 111.128 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 114' ' ' ILE . 81.0 t -61.14 -46.76 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.619 1.167 . . . . 60.03 111.016 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.2 p -75.76 -26.54 57.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.864 0.466 . . . . 74.43 111.506 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.96 -29.22 64.04 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.566 0.747 . . . . 75.01 109.762 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 1.51 79.52 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.652 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.3 m 68.59 11.69 8.43 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.865 1.266 . . . . 63.22 111.558 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -87.09 150.25 49.32 Favored Pre-proline 0 C--O 1.243 0.75 0 CA-C-N 115.608 -0.724 . . . . 74.32 109.093 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -45.84 112.63 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.144 2.563 . . . . 73.22 112.698 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.05 122.8 10.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.854 1.262 . . . . 64.43 111.656 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.28 96.08 6.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.186 -1.042 . . . . 64.44 108.186 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -99.83 83.57 2.76 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.379 -0.971 . . . . 72.33 108.379 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.2 pt? -59.63 136.88 58.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.003 -0.998 . . . . 74.52 111.941 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.91 148.82 82.74 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.413 1.085 . . . . 65.15 112.018 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 129.74 36.21 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.477 . . . . 75.43 113.72 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.447 HG21 HD11 ' A' ' 44' ' ' LEU . 87.9 t -103.08 122.03 55.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.632 -0.877 . . . . 65.24 108.632 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -88.57 71.25 8.89 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.919 0.888 . . . . 54.41 111.006 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -61.43 -38.76 88.32 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.726 0.774 . . . . 52.42 109.263 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.7 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.9 t70 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.427 -1.26 . . . . 60.04 111.318 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.715 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.8 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 115.279 1.585 . . . . 74.42 115.279 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -137.05 136.92 38.82 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.335 -1.302 . . . . 72.02 107.785 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.04 124.46 40.71 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.32 -0.993 . . . . 74.24 108.32 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -137.43 110.34 7.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.151 0.58 . . . . 54.3 109.596 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.492 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -70.19 115.86 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 109.313 -0.625 . . . . 71.01 109.313 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.84 -51.62 6.28 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.263 0.554 . . . . 75.33 109.653 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -169.71 133.89 1.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.098 -0.956 . . . . 51.34 108.535 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' B' ' 109' ' ' TYR . 73.3 mt -114.75 146.13 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.539 -1.282 . . . . 73.03 107.539 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -168.02 149.67 5.32 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.598 0.592 . . . . 63.44 112.598 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -73.59 124.92 26.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.199 -0.91 . . . . 74.32 108.7 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 38.9 mtpt -98.31 -37.37 9.67 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.347 0.659 . . . . 55.34 110.858 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 26.8 m-20 -148.09 133.51 18.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.064 -0.517 . . . . 60.44 109.91 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.1 mm -130.01 142.58 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 74.12 109.74 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.629 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -133.68 135.34 44.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.311 1.444 . . . . 75.04 108.867 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.51 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.5 t80 -149.63 127.0 11.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.808 -1.182 . . . . 74.23 107.808 166.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.16 126.68 25.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.72 0.808 . . . . 74.55 109.297 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.585 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.19 88.0 53.15 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.136 -0.69 . . . . 72.42 109.136 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.37 -27.47 28.31 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.028 2.485 . . . . 53.11 112.034 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -117.61 28.98 8.11 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.146 0.979 . . . . 73.12 109.019 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.585 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -44.49 -54.19 12.91 Favored Pre-proline 0 C--N 1.366 1.312 0 C-N-CA 124.684 1.194 . . . . 74.44 112.331 167.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.0 Cg_exo -69.32 -19.79 37.77 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.339 2.026 . . . . 51.21 112.498 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 11.5 m-70 -96.67 2.98 52.69 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.238 1.015 . . . . 64.34 111.936 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.47 -32.69 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 112.861 0.689 . . . . 35.02 112.861 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -74.21 -26.69 60.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.17 0.509 . . . . 74.44 110.563 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.87 -16.66 61.12 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.807 1.243 . . . . 73.43 110.523 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 mmmt -101.91 95.46 6.39 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.979 0.912 . . . . 61.11 111.707 -170.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.75 87.14 3.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 64.13 111.062 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -176.96 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.698 1.599 . . . . 75.41 108.136 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -87.98 133.83 36.49 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.254 0.622 . . . . 73.42 109.727 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -65.5 134.78 39.75 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.005 1.803 . . . . 73.14 111.874 170.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.455 ' HG3' ' HE2' ' B' ' 41' ' ' LYS . 16.0 tp10 -63.95 103.93 0.65 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.253 0.621 . . . . 70.13 109.39 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.27 147.94 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 72.05 111.42 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.455 ' HE2' ' HG3' ' B' ' 39' ' ' GLU . 73.4 mmtt -136.48 143.92 44.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.74 1.216 . . . . 74.41 109.423 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -127.48 132.72 49.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.684 0.794 . . . . 74.34 109.269 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 11.6 m-20 -132.14 115.42 15.71 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.281 -1.007 . . . . 74.04 108.281 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.29 135.27 40.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.862 -0.792 . . . . 73.4 108.862 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 31.9 t70 -146.07 149.12 33.47 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.935 0.894 . . . . 75.22 108.953 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -128.97 123.81 33.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.48 0.712 . . . . 72.13 109.602 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -114.48 159.43 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.495 -1.298 . . . . 54.01 107.495 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -145.26 164.23 32.03 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.25 0.548 . . . . 75.53 111.028 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -153.58 143.03 21.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.591 -1.186 . . . . 74.45 107.983 169.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.06 104.9 14.71 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.927 -0.768 . . . . 74.04 108.927 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -73.51 -45.21 55.19 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.032 0.444 . . . . 72.22 109.808 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -178.07 6.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.012 -0.994 . . . . 72.22 110.005 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.35 128.67 35.9 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.957 -1.02 . . . . 61.23 109.186 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 67.42 10.73 7.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.635 1.174 . . . . 51.21 112.061 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.4 t -129.23 99.17 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.31 1.044 . . . . 73.51 108.781 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.925 0.869 . . . . 73.41 111.266 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.98 95.02 2.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.473 -2.418 . . . . 70.54 104.473 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.18 130.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.241 0.543 . . . . 75.12 109.612 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 32.9 t -102.03 143.46 14.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 114.953 -1.022 . . . . 52.23 109.172 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.7 OUTLIER -119.59 111.08 17.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.588 -1.264 . . . . 74.43 107.588 176.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.0 ttt180 -96.69 108.84 21.54 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.072 0.549 . . . . 64.34 110.23 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.1 t -105.88 118.83 54.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.445 -0.946 . . . . 70.21 108.445 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 38.0 m -103.92 141.34 36.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.565 0.746 . . . . 63.53 109.028 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.672 HG21 HG21 ' B' ' 114' ' ' ILE . 47.5 t -129.25 130.82 67.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.367 1.067 . . . . 73.41 108.901 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.3 m -125.42 140.07 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.896 -0.779 . . . . 73.12 108.896 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 131.37 26.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.608 -0.886 . . . . 64.13 108.608 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.486 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.0 p -133.29 126.26 31.06 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.808 -0.441 . . . . 64.11 109.808 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 0.9 OUTLIER -110.86 130.07 55.69 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.67 -1.604 . . . . 71.32 106.67 -176.232 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -119.09 5.7 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.585 -1.006 . . . . 34.21 110.585 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -120.35 3.81 10.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.654 0.782 . . . . 63.54 110.711 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -115.48 165.5 12.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.818 0.847 . . . . 61.22 110.145 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 42.6 m -70.23 131.6 44.46 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.711 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -86.16 -57.99 2.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.024 -1.102 . . . . 74.35 108.024 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -160.27 166.44 29.54 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.327 -1.306 . . . . 73.54 110.679 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.91 136.16 44.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.496 1.518 . . . . 72.34 107.033 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 50.0 t -143.23 147.49 34.92 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.443 -0.947 . . . . 61.45 108.443 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.3 tt0 -162.94 139.1 7.19 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.167 -0.679 . . . . 71.53 109.167 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' B' ' 113' ' ' CYS . 98.7 t -130.95 144.31 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.644 0.778 . . . . 64.45 109.021 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 78.4 mt-30 -122.82 92.91 3.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.624 -0.88 . . . . 73.55 108.624 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -85.43 102.73 13.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.823 -1.08 . . . . 52.2 109.296 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.31 168.71 29.87 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.617 -0.593 . . . . 71.31 111.617 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.25 128.56 1.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 112.084 -0.407 . . . . 51.02 112.084 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.7 mt -83.58 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.075 -1.083 . . . . 74.02 108.075 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -130.13 132.9 46.29 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.022 -0.733 . . . . 54.43 109.022 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -95.82 115.07 26.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.788 -0.819 . . . . 74.13 108.788 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.581 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -129.11 137.37 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.754 1.222 . . . . 64.42 109.212 -175.299 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.8 173.05 16.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.296 0.638 . . . . 60.14 109.896 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.59 -66.7 1.4 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.922 -0.471 . . . . 63.23 111.922 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.715 HG23 ' HB3' ' B' ' 9' ' ' MET . 8.3 pt -60.74 145.11 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.708 0.803 . . . . 71.12 111.887 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.54 146.26 24.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.061 -0.972 . . . . 63.31 109.411 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.08 7.64 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.416 0.448 . . . . 75.45 112.76 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.8 m -70.04 -50.14 44.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.656 0.783 . . . . 74.53 111.124 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -61.46 -24.94 66.91 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.925 0.89 . . . . 73.4 111.696 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.476 ' HA ' HD12 ' B' ' 89' ' ' ILE . 52.6 ttp -67.24 -40.21 86.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.503 1.121 . . . . 73.0 110.823 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.14 69.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.856 0.862 . . . . 23.33 111.991 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -65.45 -29.65 70.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.231 0.612 . . . . 75.41 111.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.2 -68.53 0.65 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.227 0.211 . . . . 73.44 111.437 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.497 HD23 ' SG ' ' B' ' 102' ' ' CYS . 94.1 mt -75.65 -22.89 56.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.256 0.465 . . . . 74.42 112.256 -172.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.75 -39.52 24.64 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.575 0.547 . . . . 61.12 112.327 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.15 -53.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.783 0.66 . . . . 73.53 112.783 -164.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -66.31 -45.38 80.53 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.311 0.644 . . . . 53.53 112.015 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.497 ' SG ' HD23 ' B' ' 98' ' ' LEU . 71.4 m -63.99 -50.06 71.51 Favored Pre-proline 0 CA--C 1.556 1.191 0 CA-C-O 118.373 -0.823 . . . . 70.33 110.61 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.2 Cg_exo -51.18 -33.03 42.61 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.624 2.216 . . . . 35.15 114.865 165.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -68.75 -25.27 64.65 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 118.355 0.525 . . . . 73.22 112.067 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -42.18 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.377 0.671 . . . . 75.31 109.77 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' B' ' 60' ' ' LEU . 95.8 mt -72.99 -24.73 60.8 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.025 -0.989 . . . . 63.12 110.926 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.17 -50.69 74.34 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.756 -1.116 . . . . 65.3 113.169 -169.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 37.6 Cg_endo -63.17 -32.42 74.29 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 121.638 1.558 . . . . 62.31 112.094 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.7 m-30 -66.42 -43.3 86.09 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.018 0.927 . . . . 70.44 110.454 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.31 87.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.962 0.905 . . . . 61.12 110.204 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -61.68 -52.99 62.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.649 1.58 . . . . 74.35 111.476 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.84 -33.61 75.59 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.079 0.862 . . . . 74.23 109.756 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.7 t -71.94 -34.99 69.47 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.854 -0.612 . . . . 70.15 111.059 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.672 HG21 HG21 ' B' ' 64' ' ' VAL . 53.1 mt -65.22 -54.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.122 -0.696 . . . . 74.34 109.122 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -58.97 -31.33 68.64 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.799 -1.092 . . . . 64.32 110.846 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.5 t -64.61 -55.5 19.92 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.652 0.781 . . . . 70.31 110.159 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.529 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 14.3 mmt -63.23 -36.75 84.69 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.702 0.401 . . . . 72.02 111.619 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.16 -51.63 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.056 0.942 . . . . 74.41 110.687 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.35 -20.24 60.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.067 0.547 . . . . 74.13 111.991 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.4 mtt-85 -68.89 -31.36 70.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.308 0.643 . . . . 75.55 110.28 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.5 14.59 57.64 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 123.854 0.721 . . . . 73.31 112.666 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.516 HG23 ' HB3' ' A' ' 17' ' ' TYR . 74.7 p 55.45 30.7 15.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.83 1.652 . . . . 73.22 112.492 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.46 155.45 39.65 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.928 0.891 . . . . 64.22 109.999 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.07 143.09 99.58 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.029 2.486 . . . . 72.34 113.034 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -59.08 123.11 15.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.76 1.224 . . . . 73.01 111.566 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.15 89.73 3.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.476 0.71 . . . . 71.05 109.849 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.37 100.14 12.52 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.224 -0.898 . . . . 64.12 110.377 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.49 151.02 42.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.203 1.001 . . . . 63.54 112.6 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.35 150.43 84.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.641 -0.709 . . . . 72.33 110.682 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.26 110.84 2.55 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.434 2.089 . . . . 64.22 110.044 176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.49 110.81 21.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 71.55 106.981 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -76.26 91.55 3.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.875 -1.528 . . . . 74.33 106.875 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -53.48 -40.24 65.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.89 -1.05 . . . . 61.21 110.399 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.74 -53.99 27.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.512 1.125 . . . . 72.3 111.688 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -22.38 64.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.613 0.765 . . . . 75.05 111.674 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 123.785 0.834 . . . . 54.34 109.793 178.689 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 52.7 ttp . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.145 0.497 . . . . 71.4 110.545 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.2 m -84.04 78.79 9.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.128 -1.064 . . . . 72.1 108.128 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.515 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 42.2 t80 -100.18 127.94 46.35 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.809 -1.541 . . . . 72.34 108.571 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -138.03 142.73 40.35 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.336 -0.616 . . . . 74.12 109.336 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.33 110.21 11.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.319 -0.855 . . . . 64.52 108.738 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.2 mm100 -77.67 -39.93 43.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.93 -0.577 . . . . 74.12 109.938 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.489 HH11 ' HD1' ' D' ' 32' ' ' PHE . 24.2 ttt180 179.27 124.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.393 0.677 . . . . 75.33 109.953 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 87.9 mt -110.08 138.62 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.818 -1.178 . . . . 63.33 107.818 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.9 p90 -174.17 154.1 2.16 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.752 0.657 . . . . 73.53 110.729 -175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.3 p -75.58 122.93 24.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.28 -0.873 . . . . 72.55 109.733 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -78.34 -50.58 11.51 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.218 -1.03 . . . . 53.4 108.218 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.5 t70 -133.53 139.19 46.47 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.551 -1.204 . . . . 74.3 109.939 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.37 140.06 38.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.794 -1.558 . . . . 60.25 106.794 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -160.7 150.75 17.74 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.119 0.485 . . . . 63.15 109.708 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 78.4 t80 -152.16 115.79 4.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.854 -1.165 . . . . 75.43 107.854 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.98 110.57 17.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.156 0.582 . . . . 72.15 110.432 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.6 86.24 34.29 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.405 1.082 . . . . 71.4 108.573 167.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.81 -32.31 29.87 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.414 2.076 . . . . 64.42 110.56 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -89.23 22.69 2.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.132 -1.394 . . . . 73.03 111.415 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.512 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -55.49 -43.59 99.22 Favored Pre-proline 0 CA--C 1.574 1.866 0 C-N-CA 124.226 1.011 . . . . 72.31 113.52 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -89.41 -17.96 1.75 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.958 1.772 . . . . 63.31 113.17 169.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.59 -31.69 68.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.535 1.134 . . . . 62.35 110.593 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.87 -2.45 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 124.473 1.109 . . . . 74.02 112.344 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -49.99 -41.72 47.61 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.389 1.476 . . . . 65.54 113.11 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -125.12 49.63 1.86 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.245 1.018 . . . . 73.44 108.499 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.79 149.29 47.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.82 -0.55 . . . . 61.14 111.22 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.2 132.91 50.33 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.285 -0.871 . . . . 75.43 110.406 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -83.52 65.86 8.63 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.026 0.917 . . . . 74.21 110.509 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -152.61 58.18 2.39 Favored Pre-proline 0 CA--C 1.558 1.281 0 CA-C-N 115.12 -0.946 . . . . 71.14 110.553 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.0 149.54 9.52 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.1 1.866 . . . . 70.42 110.8 165.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.24 113.63 24.04 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.284 0.634 . . . . 75.23 109.902 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -77.51 111.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.141 0.576 . . . . 72.1 109.747 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 26.6 mmmt -92.79 104.57 16.82 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.853 -1.165 . . . . 75.02 107.853 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.54 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.4 pt? -87.25 145.65 26.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.33 . . . . 70.41 110.194 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 30.2 t70 -140.88 109.02 5.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.11 -0.7 . . . . 73.22 109.11 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -117.22 125.68 51.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.951 -0.759 . . . . 72.01 108.951 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -143.92 160.53 40.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.446 1.098 . . . . 71.24 109.869 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -129.76 153.72 47.92 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.282 0.633 . . . . 75.5 109.651 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 164.58 26.32 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.067 0.947 . . . . 54.21 109.079 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.471 ' HB3' HD21 ' C' ' 98' ' ' LEU . 33.1 p -142.31 145.36 33.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.037 0.535 . . . . 64.14 110.5 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -145.99 126.38 14.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.379 1.072 . . . . 64.04 108.431 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.68 116.05 23.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.462 -0.94 . . . . 74.45 108.462 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.678 HD11 HD12 ' C' ' 83' ' ' ILE . 67.0 mt -85.41 -43.02 13.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.47 0.708 . . . . 75.42 110.17 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 -171.98 3.61 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.847 -1.069 . . . . 71.51 109.964 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.25 108.91 0.99 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.129 -0.941 . . . . 75.24 110.025 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 71.04 -3.08 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.972 1.309 . . . . 74.3 112.955 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -95.53 97.28 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.842 -1.169 . . . . 70.13 107.842 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -106.97 159.07 16.55 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.541 0.736 . . . . 75.23 110.119 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.99 120.26 31.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.426 1.09 . . . . 74.52 108.265 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.41 133.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.854 -1.165 . . . . 62.04 107.854 172.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.21 105.65 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.184 -0.673 . . . . 60.51 109.184 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.05 99.44 12.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.905 -1.146 . . . . 52.14 107.905 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.548 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.6 tmm_? -92.28 120.94 33.3 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.288 0.635 . . . . 74.54 110.151 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' C' ' 114' ' ' ILE . 37.2 t -112.09 125.33 69.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.569 -0.9 . . . . 65.32 108.569 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -118.53 123.66 45.64 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.486 -0.931 . . . . 71.33 108.486 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.45 HG23 HD13 ' C' ' 114' ' ' ILE . 76.3 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.989 -1.005 . . . . 63.13 108.725 174.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 5.7 m -98.46 136.54 38.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.579 -1.637 . . . . 75.31 106.579 169.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.22 106.65 6.83 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.985 -1.857 . . . . 74.23 105.985 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 12.5 p -164.46 158.12 18.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 123.622 0.576 . . . . 63.22 110.688 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -113.71 20.24 16.06 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.645 0.735 . . . . 41.14 110.181 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.86 -83.47 0.35 Allowed Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.437 -0.801 . . . . 75.14 111.166 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.12 -32.03 11.12 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.29 0.636 . . . . 54.22 110.423 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -82.35 91.36 6.79 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 108.896 -0.779 . . . . 71.3 108.896 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -81.87 128.22 33.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.543 . . . . 73.32 109.563 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -64.11 1.01 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.614 -1.254 . . . . 63.14 107.614 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -159.76 172.37 17.83 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 121.971 0.891 . . . . 73.23 111.524 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -129.25 140.67 51.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.627 -1.99 . . . . 63.4 105.627 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.39 144.32 29.66 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.402 -0.962 . . . . 61.3 108.402 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.97 128.71 7.88 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.602 -0.518 . . . . 54.45 109.602 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.13 123.22 58.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.01 -0.995 . . . . 61.14 108.567 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.548 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 74.1 mt-30 -98.25 91.28 5.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.224 -1.398 . . . . 72.1 107.224 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -78.34 102.53 7.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.868 -0.606 . . . . 72.51 109.572 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.19 145.44 23.22 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.417 -0.811 . . . . 64.45 111.186 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.533 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.6 116.06 0.76 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.343 -1.103 . . . . 41.32 110.343 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.678 HD12 HD11 ' C' ' 51' ' ' LEU . 12.7 mm -81.44 127.82 39.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 107.932 -1.136 . . . . 74.44 107.932 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.88 123.5 23.56 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.358 0.663 . . . . 63.54 109.553 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.5 p -77.04 106.54 8.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.729 -1.211 . . . . 73.31 107.729 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 48.3 mt -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.127 -1.064 . . . . 62.1 108.127 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.528 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -127.84 158.63 37.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.767 0.827 . . . . 50.44 110.25 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -51.76 3.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.828 -0.623 . . . . 71.51 113.029 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.7 tt -81.28 145.47 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.539 0.735 . . . . 74.25 109.978 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.12 -179.36 8.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.99 0.516 . . . . 62.22 110.759 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.26 -148.64 47.72 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.61 -0.723 . . . . 20.0 112.789 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 77.0 p -69.67 -18.05 63.53 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.22 1.008 . . . . 72.13 111.453 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -64.9 -46.19 82.76 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 73.54 110.108 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 57.5 ttp -68.07 -32.2 72.37 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.451 -0.795 . . . . 74.55 110.181 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.74 85.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.333 0.653 . . . . 53.32 110.981 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 46.7 t-80 -65.78 -32.75 74.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.719 0.808 . . . . 75.23 111.308 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.531 ' HG ' ' HG ' ' C' ' 102' ' ' CYS . 43.8 t -76.33 -55.34 5.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 54.44 110.294 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' C' ' 48' ' ' SER . 9.6 tt -65.64 -31.82 73.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.298 1.039 . . . . 65.2 111.225 -172.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.85 10.06 55.54 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.44 -0.644 . . . . 63.3 114.024 -175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.75 -59.03 0.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.776 0.788 . . . . 73.11 111.657 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -69.88 -55.54 9.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.449 0.7 . . . . 62.43 111.967 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.531 ' HG ' ' HG ' ' C' ' 97' ' ' CYS . 9.8 m -61.56 -45.82 93.85 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.635 0.774 . . . . 64.1 112.039 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.526 ' HB3' HD23 ' C' ' 60' ' ' LEU . 39.1 Cg_exo -61.05 -32.18 91.67 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.349 2.032 . . . . 73.24 113.501 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.95 -35.63 79.03 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.457 0.703 . . . . 72.32 110.882 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.42 -44.69 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.586 0.755 . . . . 73.15 110.254 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.533 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.7 mt -82.28 -23.96 34.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.869 -1.06 . . . . 72.43 112.506 -171.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.406 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 39.8 t80 -54.8 -48.22 96.15 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 124.84 1.256 . . . . 75.45 113.59 -172.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 23.3 Cg_exo -63.7 -34.44 62.48 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.932 1.755 . . . . 73.04 113.019 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -64.75 -44.75 89.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.105 0.562 . . . . 74.12 110.46 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.62 99.24 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.445 -0.798 . . . . 41.43 110.667 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.696 HH21 HD21 ' C' ' 127' ' ' ASN . 39.4 mtp180 -56.38 -53.39 57.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.966 0.906 . . . . 74.52 111.402 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.46 -32.76 71.89 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.711 0.632 . . . . 74.34 110.794 -173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.6 t -70.6 -29.96 66.5 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.565 0.346 . . . . 65.32 110.811 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.45 HD13 HG23 ' C' ' 64' ' ' VAL . 65.3 mt -73.65 -49.09 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.996 0.518 . . . . 74.34 109.724 171.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 92.3 m -59.47 -35.42 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.026 0.93 . . . . 73.03 111.454 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.1 t -63.31 -51.27 66.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.241 -0.891 . . . . 54.5 109.114 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.6 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -60.87 -32.72 72.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.754 0.822 . . . . 73.3 112.704 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.5 t -73.72 -37.6 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 53.44 110.141 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 63.6 p -75.54 -25.36 57.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.923 0.489 . . . . 71.23 110.745 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.6 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -70.49 -44.0 68.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.703 0.801 . . . . 71.21 109.567 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.33 -5.5 85.58 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.528 0.517 . . . . 44.14 112.618 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p 67.31 25.97 8.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.534 1.933 . . . . 64.11 113.336 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' C' ' 118' ' ' VAL . 98.6 m-85 -85.45 163.77 43.32 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.682 0.793 . . . . 64.23 109.794 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.38 151.36 30.11 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.128 2.552 . . . . 52.44 113.984 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.92 112.33 1.62 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.861 1.264 . . . . 60.41 110.069 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.4 107.75 10.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.846 -0.798 . . . . 73.32 108.846 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.696 HD21 HH21 ' C' ' 111' ' ' ARG . 6.8 p-10 -126.62 133.6 50.97 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.196 -1.409 . . . . 41.14 107.196 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.8 113.89 4.66 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.75 -1.204 . . . . 72.24 107.75 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.67 134.1 82.61 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.883 0.74 . . . . 63.31 110.846 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.505 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 52.7 Cg_exo -56.13 90.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.485 2.79 . . . . 41.02 113.248 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.67 110.37 30.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.537 -0.912 . . . . 75.02 108.537 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -85.7 89.32 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.62 -0.718 . . . . 74.44 110.509 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -40.81 93.36 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.568 -1.196 . . . . 71.14 109.13 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 CA--C 1.544 0.712 0 CA-C-N 113.68 -1.6 . . . . 72.21 112.969 175.64 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 114.363 1.246 . . . . 72.24 114.363 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.6 m -138.69 139.93 38.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.979 -1.489 . . . . 74.31 106.979 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.79 114.44 7.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.268 -1.012 . . . . 75.24 108.268 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -129.87 142.54 50.65 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.98 -0.748 . . . . 71.52 108.98 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.1 101.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.041 -1.466 . . . . 55.34 107.041 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -46.67 38.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.491 0.717 . . . . 61.23 111.221 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -166.9 133.77 2.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.957 -0.565 . . . . 74.14 110.072 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.509 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.7 mp -108.91 135.87 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.366 -1.346 . . . . 73.11 107.366 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -161.96 170.95 18.43 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 122.13 0.967 . . . . 73.3 112.423 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 46.6 p -104.55 119.17 38.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.679 -1.146 . . . . 71.01 109.088 172.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 36.7 mtpt -86.45 -30.79 21.78 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.056 -0.35 . . . . 61.25 110.056 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -145.9 137.59 25.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.61 . . . . 64.33 109.984 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.555 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.3 mt -134.41 148.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 73.43 108.242 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -148.26 140.97 24.57 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.294 1.037 . . . . 74.52 109.07 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.4 t80 -148.36 111.39 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.708 -1.96 . . . . 62.44 105.708 169.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -123.03 110.48 15.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.457 0.703 . . . . 71.21 109.348 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.2 88.14 2.97 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.063 -1.088 . . . . 62.52 108.063 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.12 -45.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.455 2.103 . . . . 74.34 112.405 -171.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.486 ' O ' HG23 ' D' ' 31' ' ' VAL . 20.2 m120 -102.9 42.33 1.16 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.048 0.939 . . . . 74.01 108.475 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -57.33 -51.96 77.8 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.225 1.194 . . . . 63.03 114.225 -169.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.59 -0.6 8.82 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 121.591 1.604 . . . . 72.42 112.968 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.485 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 13.6 t-160 -83.05 -26.7 30.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.67 1.188 . . . . 71.32 109.011 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.486 HG23 ' O ' ' D' ' 27' ' ' ASN . 93.2 t -82.31 -24.29 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.211 0.604 . . . . 71.34 110.114 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.489 ' HD1' HH11 ' C' ' 15' ' ' ARG . 60.5 t80 -53.98 -39.84 66.36 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.105 0.962 . . . . 72.13 112.542 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -79.37 -13.73 59.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.246 0.461 . . . . 73.42 112.246 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -111.5 100.68 9.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.069 -0.715 . . . . 75.52 109.069 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.39 89.24 4.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.011 0.524 . . . . 71.03 109.8 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.562 ' HB3' HD11 ' D' ' 68' ' ' LEU . 17.0 t-105 -159.21 158.24 32.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.027 -1.101 . . . . 74.33 108.027 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.66 112.52 35.05 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.474 0.709 . . . . 53.01 110.508 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -48.88 139.15 25.71 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.771 2.981 . . . . 71.52 114.058 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.12 121.69 16.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.529 -0.545 . . . . 73.53 109.529 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.13 115.69 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.085 0.469 . . . . 60.33 110.572 -174.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -87.26 146.28 26.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.491 1.116 . . . . 74.22 108.901 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -110.18 131.03 55.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.179 -0.675 . . . . 44.15 109.179 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.5 m-20 -133.37 142.72 48.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.652 1.181 . . . . 55.5 108.195 171.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -138.49 164.75 28.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.788 0.435 . . . . 72.3 110.707 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 29.3 t70 -168.43 155.36 7.55 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.498 1.119 . . . . 64.41 108.721 174.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -132.48 158.06 43.05 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.987 -0.745 . . . . 73.12 108.987 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.7 167.7 29.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.511 0.725 . . . . 63.34 109.632 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' D' ' 58' ' ' VAL . 56.5 p -159.6 153.6 23.3 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.791 0.836 . . . . 63.23 110.196 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.5 p -151.52 142.59 23.13 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.933 0.893 . . . . 73.22 108.627 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -90.69 117.51 29.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.058 0.543 . . . . 73.44 109.591 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.7 mt -89.62 -31.66 17.45 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.511 -0.552 . . . . 72.34 109.511 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.75 -177.84 4.97 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.121 -0.945 . . . . 60.43 109.852 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.58 119.67 10.27 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.565 -1.198 . . . . 51.03 108.946 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 71.58 2.78 4.41 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.263 1.425 . . . . 71.15 112.741 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -113.77 123.91 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.539 0.736 . . . . 71.42 109.391 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.26 130.42 35.13 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.775 0.43 . . . . 73.13 110.516 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.3 tt0 -92.86 112.05 23.88 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.35 -0.982 . . . . 63.0 108.35 167.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' D' ' 48' ' ' SER . 12.7 m -102.3 137.87 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 170.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.39 140.27 30.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.182 -0.673 . . . . 75.12 109.182 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -112.56 123.81 51.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.175 -1.046 . . . . 63.4 108.175 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.3 ttm-85 -105.44 101.94 11.44 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.207 -0.664 . . . . 72.13 109.207 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.42 119.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.868 -1.16 . . . . 73.35 107.868 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 18.0 m -125.35 142.71 51.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.622 0.725 . . . . 64.25 109.675 -172.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -137.35 123.62 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.881 1.273 . . . . 54.51 108.875 -170.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -115.72 108.48 16.41 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.788 -0.819 . . . . 62.21 108.788 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.1 53.88 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.322 -0.622 . . . . 75.44 109.322 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.7 p -142.0 125.79 17.04 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.174 0.59 . . . . 74.42 109.661 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' D' ' 36' ' ' TRP . 28.0 tp -99.72 116.64 32.29 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.575 -0.898 . . . . 71.15 108.575 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.2 -133.16 23.98 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.72 0.637 . . . . 73.11 112.432 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -92.1 21.6 4.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.43 0.692 . . . . 65.01 110.847 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -141.14 146.41 36.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.249 0.619 . . . . 63.5 111.157 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -68.67 130.8 43.88 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.249 0.619 . . . . 64.43 109.968 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.12 -64.12 1.15 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.574 0.75 . . . . 65.53 109.323 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.47 161.64 40.03 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.31 -0.859 . . . . 72.31 110.321 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -121.38 151.23 40.4 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.282 1.433 . . . . 72.14 107.163 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.7 t -156.98 141.53 16.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 110.153 -0.314 . . . . 71.15 110.153 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.92 137.67 14.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.654 0.782 . . . . 63.53 109.139 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' D' ' 113' ' ' CYS . 66.7 t -135.15 114.24 16.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.44 -0.578 . . . . 75.04 109.44 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.5 mt-30 -91.93 85.16 5.48 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.221 -0.9 . . . . 74.25 108.89 171.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -80.15 101.89 9.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.913 -1.494 . . . . 73.4 109.705 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.27 142.36 15.99 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.759 -0.537 . . . . 70.03 111.759 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.3 133.65 5.55 Favored Glycine 0 C--O 1.236 0.279 0 N-CA-C 111.77 -0.532 . . . . 73.24 111.77 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.87 128.85 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.602 -1.258 . . . . 70.21 107.602 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.59 144.6 51.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.788 0.835 . . . . 74.53 108.817 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -97.52 102.43 14.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.983 -0.747 . . . . 64.25 108.983 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.511 HG21 ' HG3' ' D' ' 94' ' ' MET . 3.4 mp -107.62 99.7 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 107.564 -1.273 . . . . 73.14 107.564 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.41 123.21 35.58 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.49 -0.559 . . . . 74.25 109.49 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.8 22.5 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-O 118.571 -1.127 . . . . 64.55 114.872 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 mt -140.41 140.31 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.57 1.185 . . . . 72.41 110.424 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.94 175.84 9.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.875 1.27 . . . . 72.11 109.856 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.36 -140.97 26.17 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 114.537 0.575 . . . . 71.35 114.537 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 43.1 p -66.31 -32.45 73.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 62.43 111.618 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -70.53 -40.96 73.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.436 0.694 . . . . 73.02 110.155 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.511 ' HG3' HG21 ' D' ' 86' ' ' ILE . 49.7 ttp -70.89 -32.68 69.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.533 -0.758 . . . . 72.01 110.564 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.24 83.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.226 0.61 . . . . 71.32 110.29 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -62.0 -34.0 75.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.698 0.799 . . . . 70.41 110.53 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -68.55 -51.43 42.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.919 -0.582 . . . . 73.24 110.387 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.4 -28.4 61.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.81 0.844 . . . . 54.21 112.597 -173.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.28 -4.44 25.45 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.216 -0.769 . . . . 70.34 114.393 -169.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -54.6 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.984 0.892 . . . . 73.34 110.629 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -73.15 -43.49 61.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.718 0.407 . . . . 74.04 111.931 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.426 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 63.4 m -70.35 -45.56 19.91 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 118.694 -0.67 . . . . 72.55 111.381 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.516 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.2 Cg_exo -53.89 -36.37 83.04 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.438 2.092 . . . . 74.35 113.229 165.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.97 -33.05 75.11 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.493 0.717 . . . . 54.11 110.928 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.4 -43.33 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.044 0.538 . . . . 70.05 110.059 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.88 -19.63 58.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.318 -0.855 . . . . 73.44 111.738 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.435 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 60.6 t80 -66.71 -42.26 43.65 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.946 -1.026 . . . . 74.24 113.413 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.43 -38.34 73.85 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.902 1.735 . . . . 75.34 112.993 168.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -78.57 -35.32 46.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.106 0.962 . . . . 64.43 112.115 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.74 -42.07 74.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.253 0.621 . . . . 75.51 109.553 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -62.42 -46.84 86.76 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.331 -1.304 . . . . 72.4 109.922 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 2.6 tm-20 -56.35 -48.97 75.7 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.292 0.995 . . . . 70.44 111.553 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.437 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -61.24 -41.22 96.53 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.04 0.837 . . . . 65.42 110.903 -177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.491 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.6 mt -63.29 -50.72 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.146 0.578 . . . . 74.3 110.105 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.8 m -54.03 -43.26 69.99 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.969 1.308 . . . . 75.14 111.134 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -69.16 -44.96 71.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.756 -1.111 . . . . 51.03 110.605 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.9 mtm -67.81 -33.2 74.33 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.671 0.388 . . . . 65.0 111.827 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.53 -42.52 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.944 0.897 . . . . 74.11 110.248 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -72.72 -29.45 63.37 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.668 0.387 . . . . 62.43 110.897 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -74.62 -26.98 60.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.859 0.864 . . . . 74.33 110.303 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.42 67.42 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.531 -0.758 . . . . 35.34 112.731 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.517 HG23 ' HB3' ' C' ' 17' ' ' TYR . 60.6 p 56.57 21.94 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 125.874 1.67 . . . . 65.21 113.243 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -95.41 154.85 39.26 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.751 0.82 . . . . 73.53 109.955 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.88 137.94 83.77 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.418 2.745 . . . . 74.22 112.671 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -57.8 124.91 20.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.774 0.672 . . . . 74.2 112.233 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.1 tt -108.51 99.05 8.48 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.727 -0.842 . . . . 53.14 108.727 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.61 103.07 14.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.553 -0.906 . . . . 60.52 108.553 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.498 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 0.2 OUTLIER -64.06 116.47 5.94 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.375 0.67 . . . . 53.1 109.636 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 145.33 99.12 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.305 0.642 . . . . 60.52 111.927 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.73 106.0 0.26 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.569 2.179 . . . . 72.23 111.508 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.04 147.82 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.205 0.602 . . . . 54.45 110.351 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -79.33 91.1 5.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.051 -0.522 . . . . 74.31 109.77 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.476 0.857 0 CA-C-N 115.849 -0.614 . . . . 71.41 110.624 178.283 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 110.233 -0.284 . . . . 41.34 110.233 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -139.3 115.73 10.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.089 -1.449 . . . . 75.42 107.089 168.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -149.79 134.47 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.545 0.338 . . . . 73.42 111.068 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 16' ' ' ILE . 2.7 pp -80.93 132.1 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.312 -0.996 . . . . 75.12 108.312 169.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -113.8 -38.37 4.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.962 0.505 . . . . 64.41 110.792 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -165.15 123.18 1.62 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.911 -0.403 . . . . 73.21 109.911 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.569 HD11 ' HB ' ' A' ' 13' ' ' ILE . 4.5 mp -121.71 123.39 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.083 -1.08 . . . . 74.42 108.083 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.669 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 9.5 p90 -172.23 176.58 3.37 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.511 0.724 . . . . 75.12 110.929 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -102.01 120.84 41.07 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 71.34 108.832 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HD3' HG22 ' A' ' 59' ' ' VAL . 18.5 ptmt -98.44 -27.62 13.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.196 0.198 . . . . 65.22 111.155 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.751 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 13.7 m-20 -137.77 129.52 28.46 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.759 -0.83 . . . . 64.0 108.759 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 78' ' ' VAL . 54.6 mt -132.34 137.46 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.144 -1.058 . . . . 53.32 108.144 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -145.19 127.23 15.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.8 0.84 . . . . 73.1 109.405 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.677 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.6 t80 -131.12 133.01 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.692 -1.595 . . . . 74.02 106.692 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -141.0 119.34 12.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.394 0.677 . . . . 75.42 109.522 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -125.12 82.1 62.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 107.831 -1.174 . . . . 61.25 107.831 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.31 -35.89 29.96 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.753 2.302 . . . . 72.43 111.369 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' THR . 78.5 m-20 -111.49 35.63 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.66 -1.155 . . . . 42.21 109.458 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.68 -47.14 99.46 Favored Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 123.988 0.915 . . . . 60.43 111.803 171.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 -13.86 25.3 Favored 'Trans proline' 0 C--N 1.403 3.42 0 C-N-CA 122.419 2.079 . . . . 54.24 113.428 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -69.82 -32.59 71.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.423 0.289 . . . . 74.0 110.46 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 17.5 t -64.98 -19.21 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.84 0.456 . . . . 74.51 110.793 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.64 -41.09 80.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.564 0.746 . . . . 75.13 111.3 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -99.89 -23.53 14.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.143 0.577 . . . . 63.32 111.55 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.2 mmtp -77.27 144.97 37.77 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.283 0.563 . . . . 64.52 111.767 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -79.82 158.1 26.87 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.91 -1.041 . . . . 73.33 110.067 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -90.22 80.17 6.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.054 0.931 . . . . 73.45 110.649 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -135.73 74.56 58.29 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.157 -1.383 . . . . 61.42 107.434 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -91.99 144.39 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.764 2.309 . . . . 62.31 112.567 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.1 115.6 27.8 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.848 -1.167 . . . . 74.43 107.848 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 65' ' ' THR . 85.0 t -95.26 135.94 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.545 0.738 . . . . 55.23 110.133 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 53.3 mtpt -120.62 143.4 48.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.439 0.695 . . . . 72.42 109.492 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -133.22 108.2 8.63 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.66 -1.154 . . . . 72.11 109.21 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -123.48 117.66 25.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.604 1.162 . . . . 64.2 108.662 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -118.4 159.91 22.61 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.075 0.95 . . . . 63.15 110.847 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' O ' HD23 ' A' ' 60' ' ' LEU . 24.1 t70 -157.83 148.66 21.02 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.38 0.672 . . . . 71.11 110.369 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 98' ' ' LEU . 78.4 m -131.72 134.49 45.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.509 0.724 . . . . 61.53 110.092 175.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.78 135.69 29.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.748 0.819 . . . . 72.14 109.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -113.96 157.88 21.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.131 0.572 . . . . 64.5 109.507 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -160.79 116.07 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.392 -0.595 . . . . 74.13 109.392 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -70.98 108.66 4.67 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.355 0.662 . . . . 61.43 110.18 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 57' ' ' GLU . 71.6 mt -79.04 -40.24 31.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.859 0.864 . . . . 72.35 110.89 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.28 -176.12 5.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.198 0.999 . . . . 71.54 109.004 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.79 102.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.347 0.659 . . . . 74.43 111.518 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 58.41 29.67 18.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.201 1.4 . . . . 75.32 112.631 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.3 t -112.13 122.22 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 106.5 -1.667 . . . . 71.54 106.5 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.64 133.43 38.2 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.492 -0.929 . . . . 73.34 108.492 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 35.0 tt0 -85.8 121.72 28.85 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.644 -0.873 . . . . 72.44 108.644 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.57 115.12 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.999 0.919 . . . . 73.13 108.715 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 19' ' ' LYS . 97.6 t -97.29 135.09 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.228 -0.896 . . . . 65.54 109.257 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -110.73 115.09 28.95 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.098 -1.445 . . . . 74.41 107.098 170.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -102.64 106.02 16.61 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.014 -0.735 . . . . 64.21 109.014 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 133.02 48.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.47 -0.937 . . . . 71.01 108.47 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -123.54 125.23 44.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.849 -0.797 . . . . 62.31 108.849 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 114' ' ' ILE . 61.4 t -118.42 130.83 72.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.624 -1.25 . . . . 73.52 107.624 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.2 m -127.7 149.45 50.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.497 -0.927 . . . . 63.41 108.497 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.24 121.26 13.69 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.256 -1.387 . . . . 61.23 107.256 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.6 m -144.47 129.24 18.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.102 0.561 . . . . 74.05 110.481 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.41 HD13 ' HD2' ' A' ' 34' ' ' LYS . 2.4 tt -88.04 80.92 7.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.452 -1.685 . . . . 71.41 106.452 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.77 -110.17 2.98 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.67 -1.15 . . . . 72.34 111.649 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.74 -26.31 18.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.081 0.952 . . . . 73.05 111.291 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -83.34 116.44 22.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.84 -0.8 . . . . 74.54 108.84 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 32.9 m -77.43 126.56 31.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 110.056 -0.35 . . . . 72.32 110.056 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.55 -52.39 9.12 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.382 -0.97 . . . . 61.32 108.382 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -161.95 170.33 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.06 -0.973 . . . . 73.31 111.204 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.5 tp -141.12 148.77 40.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.34 1.456 . . . . 73.45 107.936 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 62.4 m -142.82 139.74 31.04 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.488 1.115 . . . . 74.41 108.488 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -149.41 118.96 6.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.965 -0.754 . . . . 65.2 108.965 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 21' ' ' ILE . 54.8 t -122.82 118.89 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 121.124 0.488 . . . . 74.54 109.715 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 48.5 mt-30 -89.92 91.46 8.6 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.971 -1.013 . . . . 75.55 108.97 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -76.73 97.65 4.54 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.593 -1.185 . . . . 75.44 108.6 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.8 140.38 17.09 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.789 -0.924 . . . . 40.51 110.789 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.72 120.64 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.858 -1.297 . . . . 75.34 109.858 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 38.6 mt -81.75 129.26 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.703 -0.851 . . . . 63.33 108.703 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -135.73 122.15 20.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.857 -1.164 . . . . 62.43 107.857 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -90.96 105.97 18.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.044 -0.724 . . . . 33.1 109.044 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -122.01 135.03 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.349 0.66 . . . . 72.34 110.537 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.73 157.81 42.54 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.613 1.165 . . . . 71.12 109.476 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.21 -18.68 9.56 Favored Glycine 0 N--CA 1.471 1.004 0 N-CA-C 114.601 0.601 . . . . 52.43 114.601 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.98 133.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.319 -0.993 . . . . 71.55 108.319 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -147.39 174.32 11.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.875 0.87 . . . . 73.14 109.664 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.6 -115.42 7.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.623 -0.543 . . . . 44.01 113.182 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -71.26 -22.57 61.95 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.297 0.639 . . . . 63.23 111.418 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.42 -50.53 44.9 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.243 1.017 . . . . 73.42 110.789 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -27.65 52.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.012 -0.54 . . . . 74.3 110.14 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.94 94.68 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.334 0.654 . . . . 54.52 110.348 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 25.7 t-80 -65.58 -54.28 30.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.532 -1.213 . . . . 63.53 110.219 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.703 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 62.7 m -68.2 -59.34 3.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.047 0.758 . . . . 71.35 113.047 -168.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 46' ' ' THR . 92.6 mt -67.71 -25.72 65.8 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.234 0.457 . . . . 73.13 112.234 -177.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.24 -13.77 56.91 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.448 -0.64 . . . . 42.03 114.084 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.678 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -140.76 -67.27 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.775 0.788 . . . . 63.34 112.638 -173.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.703 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.34 -57.71 7.31 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 124.611 1.164 . . . . 54.22 113.423 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.6 m -71.69 -45.37 12.56 Favored Pre-proline 0 CA--C 1.559 1.312 0 CA-C-O 118.562 -0.732 . . . . 71.45 112.93 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.92 -25.25 74.19 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.548 1.499 . . . . 74.32 113.516 168.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -69.25 -37.47 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.45 -0.574 . . . . 72.25 109.45 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.03 -44.78 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.758 0.823 . . . . 64.11 110.489 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.85 -24.02 58.52 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.568 -0.742 . . . . 73.33 112.249 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -67.08 -44.57 50.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.109 1.151 . . . . 74.44 114.109 -169.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -34.65 96.12 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 122.12 1.88 . . . . 75.1 112.862 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.92 -43.13 36.69 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.659 0.784 . . . . 75.43 111.631 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -45.01 79.88 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.588 0.355 . . . . 51.34 110.439 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.51 HH12 HD12 ' C' ' 105' ' ' ILE . 29.3 ttm180 -48.53 -58.26 4.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.726 1.266 . . . . 63.24 109.545 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.98 -42.92 95.23 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.403 1.064 . . . . 73.45 111.909 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.91 -34.55 78.22 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.631 0.582 . . . . 75.34 111.572 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' A' ' 64' ' ' VAL . 4.4 mt -70.12 -53.11 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.097 0.559 . . . . 72.42 109.669 171.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 125' ' ' GLN . 62.2 m -58.8 -30.64 67.77 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.965 1.306 . . . . 72.52 111.759 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -71.74 -43.16 66.31 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.045 -0.979 . . . . 72.22 109.86 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.677 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.0 mtm -61.4 -36.85 81.42 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.747 0.419 . . . . 54.01 110.96 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' ILE . 48.7 t -65.93 -46.5 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 123.854 0.721 . . . . 64.35 110.595 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.427 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 84.9 p -71.68 -34.85 70.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.17 -0.468 . . . . 73.15 110.997 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -67.16 -32.09 72.96 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.703 0.801 . . . . 74.51 109.586 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.47 -1.42 65.35 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.196 -0.911 . . . . 74.23 112.837 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m 73.26 10.5 5.11 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.071 1.348 . . . . 73.22 111.627 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -88.04 157.62 50.99 Favored Pre-proline 0 C--O 1.245 0.864 0 N-CA-C 108.961 -0.755 . . . . 64.21 108.961 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.74 113.62 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.418 2.078 . . . . 64.52 111.058 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 119' ' ' SER . 17.6 tt0 -57.06 119.67 6.72 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.515 1.126 . . . . 75.23 110.717 -172.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.8 mt -104.93 101.44 11.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.321 0.648 . . . . 72.15 109.598 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.407 ' OD1' ' HB ' ' C' ' 16' ' ' ILE . 10.1 m-80 -100.07 105.76 17.44 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.523 -1.288 . . . . 75.41 107.523 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.449 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.5 mm? -74.62 157.79 34.79 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.988 0.915 . . . . 73.33 112.513 -167.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.35 142.81 87.23 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.86 0.864 . . . . 61.2 111.794 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HB3' HH22 ' A' ' 111' ' ' ARG . 72.8 Cg_endo -86.37 116.31 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.498 2.132 . . . . 70.13 112.827 170.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.29 114.03 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.254 -1.017 . . . . 62.13 108.254 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.89 99.35 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.684 -0.858 . . . . 71.52 108.684 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.678 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 61.8 t80 -69.63 -26.76 64.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.308 0.243 . . . . 64.14 110.516 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 72.41 110.369 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 114.124 1.157 . . . . 74.32 114.124 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' B' ' 87' ' ' ALA . 1.1 p -150.57 123.2 8.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.261 1.024 . . . . 72.02 108.412 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -119.74 126.08 50.21 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.547 -0.908 . . . . 70.12 108.547 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.3 tt0 -139.48 132.32 29.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.828 0.851 . . . . 64.02 109.145 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.97 114.82 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.369 -0.975 . . . . 75.42 108.369 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -82.83 -46.24 13.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.783 0.433 . . . . 75.14 110.257 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -164.55 142.24 6.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.573 -0.285 . . . . 73.25 111.176 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.54 141.46 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.231 -1.396 . . . . 71.54 107.231 168.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.471 ' HE1' HG13 ' B' ' 83' ' ' ILE . 14.5 p90 -170.53 151.09 3.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.816 0.673 . . . . 64.41 112.816 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -80.2 123.15 27.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.983 0.913 . . . . 73.3 108.93 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -97.02 -28.84 13.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.329 0.652 . . . . 73.21 110.974 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.683 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.2 t70 -154.09 140.03 18.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.207 -0.452 . . . . 75.02 109.984 -170.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 31.5 mm -133.95 143.57 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.412 1.085 . . . . 72.14 109.098 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -139.64 135.24 33.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.257 1.023 . . . . 73.1 108.81 168.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.61 107.9 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.172 -1.788 . . . . 74.23 106.172 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 22.1 mt-10 -119.07 112.98 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.495 -0.928 . . . . 54.54 108.495 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.21 86.48 21.18 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.974 -1.121 . . . . 73.14 107.974 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.97 -22.81 41.45 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.843 2.362 . . . . 72.12 112.99 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -115.94 22.53 12.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.83 0.852 . . . . 73.34 110.267 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.669 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -49.8 -53.08 45.85 Favored Pre-proline 0 CA--C 1.561 1.367 0 N-CA-C 114.54 1.311 . . . . 64.23 114.54 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.29 -21.39 41.53 Favored 'Trans proline' 0 C--N 1.392 2.82 0 CA-C-N 121.075 1.42 . . . . 75.32 112.646 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.99 1.96 43.03 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.346 1.058 . . . . 70.43 112.623 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' B' ' 123' ' ' PHE . 11.5 p -62.1 -25.83 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.785 1.031 . . . . 70.2 113.785 -167.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -75.84 -0.61 21.81 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.399 0.518 . . . . 61.44 112.399 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.77 -32.93 35.34 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.875 0.87 . . . . 73.11 110.027 165.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.653 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 75.7 mmtt -85.44 84.89 7.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.377 1.071 . . . . 71.33 110.454 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -116.4 83.0 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.546 0.738 . . . . 65.22 111.114 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -166.86 -171.76 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.276 1.43 . . . . 75.33 108.934 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.93 115.67 63.34 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.318 0.647 . . . . 72.23 109.593 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.07 153.37 28.55 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.525 2.15 . . . . 64.34 112.74 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.52 103.78 2.15 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.547 -0.909 . . . . 70.41 108.547 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.53 126.07 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.43 0.692 . . . . 64.33 110.472 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -110.5 127.89 55.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.952 1.301 . . . . 54.33 108.866 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.89 123.61 43.27 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 105.427 -2.064 . . . . 61.55 105.427 161.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.576 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.6 t70 -124.07 129.51 51.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.266 -1.383 . . . . 74.11 107.266 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.513 HD21 HG11 ' B' ' 131' ' ' VAL . 3.9 mp -106.19 136.65 45.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.753 -1.202 . . . . 60.05 107.753 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -154.71 156.37 36.26 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 71.3 108.691 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -146.27 137.04 24.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.488 0.661 . . . . 64.4 110.167 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.01 158.21 31.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.491 -1.67 . . . . 72.25 106.491 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -145.03 171.31 14.64 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.501 0.592 . . . . 51.34 111.425 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -151.61 135.82 16.71 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.382 -1.34 . . . . 75.12 107.382 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -100.83 110.17 22.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.88 0.764 . . . . 74.21 109.487 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.3 mt -72.34 -30.24 64.56 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.69 0.796 . . . . 73.41 112.002 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 179.18 8.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.861 0.864 . . . . 35.32 109.456 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.49 121.09 12.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.222 -0.899 . . . . 74.43 108.603 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 19.5 m-20 76.24 -5.72 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.992 1.717 . . . . 74.13 112.726 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -107.31 88.79 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.006 -1.109 . . . . 50.25 108.006 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.94 138.33 38.14 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.522 -0.918 . . . . 72.32 108.522 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -110.75 100.98 9.64 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.023 -1.473 . . . . 42.45 107.023 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.45 124.21 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.398 0.679 . . . . 73.04 109.762 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.599 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -106.03 116.34 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.778 0.831 . . . . 41.4 110.043 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.28 113.92 26.3 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.076 -1.083 . . . . 70.43 108.076 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -99.62 109.62 22.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.986 0.915 . . . . 74.12 109.829 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.8 t -106.24 119.24 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.912 -0.773 . . . . 71.22 108.912 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.1 m -106.08 146.94 29.52 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.292 1.037 . . . . 51.54 109.616 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.491 HG23 HD13 ' B' ' 114' ' ' ILE . 55.8 t -132.68 131.77 59.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.405 1.082 . . . . 74.32 108.572 173.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.0 m -124.44 136.5 54.09 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.521 -0.918 . . . . 60.35 108.521 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.8 131.06 30.61 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.745 -1.206 . . . . 52.15 107.745 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 66.4 p -137.57 134.24 35.39 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.071 0.548 . . . . 72.04 109.884 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.653 ' HB3' ' HD2' ' B' ' 34' ' ' LYS . 0.9 OUTLIER -113.6 117.78 32.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.336 -1.357 . . . . 75.24 107.336 -179.349 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.64 -130.25 10.14 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.793 -0.523 . . . . 55.23 111.793 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.27 31.67 5.21 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.893 0.877 . . . . 74.21 109.655 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.83 145.28 28.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.477 0.711 . . . . 61.45 110.082 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -68.12 132.14 46.68 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 122.863 0.465 . . . . 72.04 110.392 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.443 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.87 -55.39 3.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.079 . . . . 73.03 108.721 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -163.58 164.7 24.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.32 110.842 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 52.3 mt -133.42 145.34 50.19 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.203 1.401 . . . . 74.03 107.739 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.7 t -153.63 143.14 21.69 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.409 -0.96 . . . . 72.24 108.409 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -158.99 133.14 7.7 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.809 -0.812 . . . . 75.05 108.809 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' B' ' 113' ' ' CYS . 90.1 t -125.22 145.45 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.858 . . . . 70.21 108.916 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.7 mt-30 -119.97 93.59 4.11 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.332 -0.988 . . . . 75.42 108.332 171.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.439 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -84.01 100.23 10.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.52 -0.763 . . . . 63.24 109.263 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.41 166.47 36.42 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.71 -0.556 . . . . 73.11 111.71 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.47 126.66 1.51 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.462 -0.655 . . . . 53.25 111.462 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 33.5 mt -85.97 116.1 28.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 53.01 108.581 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.51 163.79 17.41 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.687 -0.857 . . . . 72.31 108.687 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.663 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.9 m -129.68 93.22 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.783 -1.191 . . . . 63.55 107.783 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' B' ' 97' ' ' CYS . 0.1 OUTLIER -112.31 111.68 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 107.969 -1.123 . . . . 73.15 107.969 -175.231 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' B' ' 54' ' ' ASP . . . -130.55 159.37 37.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.914 0.885 . . . . 53.2 110.499 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.48 -42.97 2.04 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.605 0.566 . . . . 64.02 114.096 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.455 HG12 ' HB3' ' B' ' 94' ' ' MET . 0.2 OUTLIER -74.58 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.942 0.897 . . . . 71.22 112.527 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.546 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.4 pt-20 -161.41 -178.2 6.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.917 -1.038 . . . . 74.32 110.547 166.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.62 -118.9 15.96 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.348 -0.842 . . . . 74.01 114.488 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -71.72 -35.64 70.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.685 0.794 . . . . 75.34 111.143 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -73.54 -35.41 65.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.801 0.441 . . . . 73.55 110.878 -171.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.546 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 24.2 ptt? -74.72 -25.65 59.27 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.45 0.3 . . . . 73.44 110.964 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.16 82.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.249 0.62 . . . . 64.1 111.266 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 16.8 m-70 -85.34 -21.34 28.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.202 0.601 . . . . 73.24 111.453 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' B' ' 86' ' ' ILE . 35.8 t -84.37 -62.74 1.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.926 0.394 . . . . 73.33 110.403 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.0 -27.0 61.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.819 0.448 . . . . 73.54 111.456 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.58 -1.31 60.45 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.422 -0.655 . . . . 51.34 114.381 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -150.16 -50.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.995 0.897 . . . . 72.23 112.674 -174.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -65.23 -49.34 70.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.455 0.702 . . . . 61.14 110.744 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.487 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.9 m -64.0 -51.73 61.36 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-O 118.538 -0.744 . . . . 72.41 111.575 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.4 Cg_exo -53.37 -34.56 71.53 Favored 'Trans proline' 0 C--N 1.403 3.405 0 C-N-CA 122.627 2.218 . . . . 73.32 114.726 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.73 -37.9 89.18 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.069 0.548 . . . . 62.12 111.163 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.59 -43.33 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.709 0.804 . . . . 52.24 110.038 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.28 -20.91 50.6 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.147 -0.933 . . . . 71.42 112.504 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -59.69 -51.59 79.87 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 117.844 -1.074 . . . . 73.22 113.769 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.06 -34.43 92.57 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 122.088 1.859 . . . . 44.13 113.285 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 89.1 m-85 -68.63 -49.74 56.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.695 0.798 . . . . 75.41 110.824 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.98 84.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.544 0.738 . . . . 70.41 110.808 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.46 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.8 ttt180 -62.67 -52.56 62.84 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 63.54 110.956 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.97 -38.33 90.69 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.135 -0.938 . . . . 62.4 110.167 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.433 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -69.31 -34.31 74.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.93 -0.577 . . . . 74.2 111.929 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.491 HD13 HG23 ' B' ' 64' ' ' VAL . 66.0 mt -64.66 -57.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.023 0.529 . . . . 71.24 109.584 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.3 m -60.4 -31.16 70.1 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.942 0.776 . . . . 64.52 111.5 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.2 t -62.84 -48.29 79.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.85 0.86 . . . . 63.21 110.917 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.2 mmt -67.83 -34.41 76.68 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.91 0.484 . . . . 61.04 110.867 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.519 HG11 HD13 ' B' ' 126' ' ' LEU . 74.1 t -63.21 -37.66 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 124.17 0.988 . . . . 72.23 110.86 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -63.83 -40.64 97.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.533 0.733 . . . . 53.45 110.866 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -64.39 -32.05 73.5 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.735 -1.12 . . . . 61.11 111.947 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.76 17.5 56.27 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.672 0.608 . . . . 54.01 113.697 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.403 HG23 ' HB3' ' A' ' 17' ' ' TYR . 73.0 p 60.53 26.74 16.39 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.616 1.566 . . . . 72.04 112.912 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.426 ' CE1' HG21 ' B' ' 31' ' ' VAL . 81.3 m-85 -91.84 156.79 42.31 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.395 0.678 . . . . 74.52 110.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.41 177.42 3.27 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 123.238 2.625 . . . . 75.3 114.241 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -67.26 124.32 22.78 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.825 -1.079 . . . . 65.2 111.62 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.519 HD13 HG11 ' B' ' 118' ' ' VAL . 11.0 mp -117.27 96.41 5.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.96 0.904 . . . . 71.35 109.36 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 92.63 8.5 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.08 0.467 . . . . 74.43 110.29 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.46 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 73.1 mt -67.27 141.9 57.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.175 0.59 . . . . 63.13 110.606 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 143.27 39.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.224 0.61 . . . . 55.34 110.558 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.7 123.34 12.48 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.129 2.552 . . . . 74.33 111.598 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.513 HG11 HD21 ' B' ' 44' ' ' LEU . 12.8 t -100.0 127.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.753 -0.462 . . . . 62.21 109.753 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.61 96.43 10.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.957 -1.127 . . . . 62.33 107.957 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' B' ' 44' ' ' LEU . 58.8 m-85 -59.17 -34.52 72.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 65.44 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.72 -39.09 93.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.384 -1.28 . . . . 73.31 111.198 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.19 78.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.322 0.649 . . . . 74.02 111.585 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.548 0.884 0 O-C-N 123.849 0.718 . . . . 62.53 110.274 178.293 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 44.6 ttp . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 121.243 0.544 . . . . 74.1 110.401 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 12.4 m -86.79 76.29 9.49 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.604 -1.258 . . . . 51.33 107.604 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -92.0 129.19 38.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.211 -0.904 . . . . 73.02 108.591 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.88 139.53 21.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.696 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -82.56 133.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 107.542 -1.281 . . . . 72.24 107.542 174.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.9 mm-40 -107.62 -46.91 3.72 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.355 0.662 . . . . 65.21 110.006 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -166.79 141.15 4.02 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.59 -0.732 . . . . 71.22 109.654 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.696 HG13 HD11 ' C' ' 13' ' ' ILE . 86.3 mt -129.39 142.01 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 106.926 -1.509 . . . . 70.24 106.926 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -174.03 160.46 3.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.624 0.77 . . . . 54.43 110.248 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.5 p -85.47 107.37 17.39 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.706 -0.679 . . . . 63.2 109.544 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -65.97 -41.84 90.64 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.281 -0.637 . . . . 52.14 109.281 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.6 t70 -147.8 147.12 29.5 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.768 -0.651 . . . . 75.15 109.815 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.2 mt -143.79 145.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.484 1.513 . . . . 64.42 106.965 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -157.96 150.07 22.09 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.081 0.553 . . . . 61.24 109.55 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -146.15 123.27 11.47 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.655 -1.239 . . . . 63.1 107.655 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 36.0 mt-10 -123.59 112.43 17.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.46 0.704 . . . . 60.43 109.558 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -118.22 85.92 25.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.69 -0.856 . . . . 71.23 108.69 172.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -36.33 10.79 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.586 2.19 . . . . 75.55 111.429 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 66.8 m-80 -106.45 36.05 2.75 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.151 -0.931 . . . . 73.11 110.156 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -56.11 -47.18 99.34 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.504 1.122 . . . . 65.32 112.536 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 16.4 Cg_endo -94.39 -10.04 1.48 Allowed 'Trans proline' 0 C--N 1.397 3.111 0 C-N-CA 122.257 1.971 . . . . 63.02 113.641 173.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-160 -71.96 -30.95 65.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.332 0.653 . . . . 73.25 111.282 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.576 HG11 ' HE1' ' C' ' 123' ' ' PHE . 7.6 p -76.76 -13.73 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.839 0.855 . . . . 75.44 111.832 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -51.51 -37.34 48.76 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.407 1.483 . . . . 73.43 113.259 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -126.54 26.49 6.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.399 0.68 . . . . 71.52 110.134 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -125.4 153.0 44.08 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.252 -0.905 . . . . 73.41 111.922 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.85 133.14 47.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.536 1.534 . . . . 61.15 112.586 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -86.1 104.76 15.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.691 0.796 . . . . 74.55 110.598 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -161.47 68.5 2.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.441 -0.948 . . . . 63.22 108.441 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -86.92 138.47 5.04 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.063 1.842 . . . . 71.21 110.959 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.46 97.62 9.08 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.771 -1.937 . . . . 71.13 105.771 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -79.37 99.45 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.812 -1.085 . . . . 63.41 110.837 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -93.51 117.1 29.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.278 -0.874 . . . . 63.41 110.185 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -92.02 148.29 22.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.686 -0.857 . . . . 53.15 108.686 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.9 t70 -146.77 112.45 5.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.16 -1.052 . . . . 73.24 108.16 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.37 111.56 24.04 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.043 -1.095 . . . . 73.24 108.043 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -123.61 158.55 31.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.686 1.195 . . . . 70.02 108.657 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -145.64 151.36 37.93 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.281 0.562 . . . . 64.22 109.742 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 173.8 11.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.541 1.136 . . . . 74.35 108.338 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.7 p -152.3 148.09 27.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 122.866 0.467 . . . . 61.14 110.016 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -145.38 125.47 13.68 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.675 -1.231 . . . . 75.15 107.675 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.44 115.16 22.4 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.369 -0.974 . . . . 74.12 108.369 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.594 HD11 HD12 ' C' ' 83' ' ' ILE . 58.9 mt -84.92 -39.33 18.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.458 0.703 . . . . 65.45 110.272 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.71 -173.33 4.06 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.021 -0.99 . . . . 43.35 110.384 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.28 111.73 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.34 -1.3 . . . . 74.1 110.322 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 64.8 17.52 11.03 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.611 1.164 . . . . 75.43 112.443 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.4 103.82 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.343 -0.984 . . . . 75.54 108.343 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -118.12 125.84 51.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.82 0.848 . . . . 71.0 109.933 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.5 tt0 -84.03 112.09 19.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.05 0.94 . . . . 65.31 109.306 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.72 129.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.745 -1.206 . . . . 74.32 107.745 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.42 105.23 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.68 100.38 12.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.192 -1.04 . . . . 63.33 108.192 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -93.43 111.33 22.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.097 1.359 . . . . 64.0 109.486 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' C' ' 114' ' ' ILE . 2.9 t -103.11 137.23 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.02 -0.733 . . . . 72.23 109.02 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 54.1 m -119.17 133.76 55.59 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.541 -0.911 . . . . 70.32 108.541 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.54 HG21 HG21 ' C' ' 114' ' ' ILE . 93.9 t -124.76 117.31 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.979 1.312 . . . . 61.33 107.49 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -117.02 134.4 54.79 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.937 -0.764 . . . . 71.21 108.937 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.0 95.52 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.889 -1.523 . . . . 63.52 106.889 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -149.07 123.16 9.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.367 0.267 . . . . 60.5 111.317 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -85.86 77.29 9.75 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.045 -1.095 . . . . 54.14 108.045 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.44 -93.23 0.24 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.169 -0.923 . . . . 74.23 112.643 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.4 -15.48 21.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.998 0.919 . . . . 65.31 111.522 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -98.1 95.42 7.43 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.088 0.555 . . . . 63.05 110.231 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.8 m -89.46 118.39 29.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.012 0.434 . . . . 65.12 111.242 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.83 -53.44 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.127 0.971 . . . . 63.43 108.846 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.15 168.48 27.3 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.454 -1.248 . . . . 63.11 111.844 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.4 tm? -140.65 146.31 37.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.39 -2.078 . . . . 72.5 105.39 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.8 t -153.33 130.81 11.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.179 -0.675 . . . . 64.3 109.179 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -136.36 129.55 31.48 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.757 -0.46 . . . . 50.51 109.757 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.71 114.67 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.857 . . . . 55.54 109.062 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.99 95.44 10.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.146 0.978 . . . . 64.43 108.701 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -83.67 105.76 14.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.851 -0.613 . . . . 72.51 109.685 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.24 144.37 21.63 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.565 -0.614 . . . . 61.43 111.565 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.43 117.16 0.93 Allowed Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 110.155 -1.178 . . . . 71.32 110.155 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.594 HD12 HD11 ' C' ' 51' ' ' LEU . 11.2 mm -81.52 122.33 36.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.093 -1.077 . . . . 73.2 108.093 176.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -131.2 128.75 40.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.731 0.812 . . . . 74.3 109.028 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.3 m -71.36 114.19 9.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.128 -0.693 . . . . 71.1 109.128 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 mm -116.85 101.24 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.957 0.903 . . . . 74.31 108.64 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -133.94 150.58 51.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.698 . . . . 52.41 109.76 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -47.12 3.58 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 121.247 0.36 . . . . 24.42 113.074 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.75 149.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.84 1.256 . . . . 65.44 110.527 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -160.6 155.93 24.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.935 0.494 . . . . 74.14 111.032 -174.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.09 -142.76 28.89 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.166 0.412 . . . . 51.02 113.687 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -61.42 -24.72 66.72 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.161 0.984 . . . . 74.44 111.821 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -58.95 -57.39 13.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.82 0.848 . . . . 75.23 110.097 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 26.6 ptm -74.41 -23.35 58.94 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.775 -0.648 . . . . 62.43 111.056 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.63 84.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.296 0.638 . . . . 65.14 111.064 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.51 -29.99 68.71 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.255 0.622 . . . . 75.51 110.955 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.37 -62.34 1.51 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.536 0.334 . . . . 73.35 110.296 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.8 pp -76.08 -12.92 60.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.172 0.589 . . . . 74.4 112.521 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.38 33.16 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.587 -0.563 . . . . 53.25 113.962 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' C' ' 133' ' ' PHE . . . -148.28 -56.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 117.626 0.713 . . . . 65.03 111.588 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -70.78 -61.46 1.76 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.684 0.394 . . . . 74.32 111.798 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 69.3 m -54.86 -45.5 99.7 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.97 0.908 . . . . 40.32 112.291 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -47.97 -48.57 15.94 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.757 2.304 . . . . 63.51 113.72 167.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -15.42 60.82 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.687 0.795 . . . . 71.34 113.114 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.51 HD12 HH12 ' A' ' 111' ' ' ARG . 36.3 mm -75.5 -40.89 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.279 -0.637 . . . . 75.42 109.279 169.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.418 HD21 ' HA3' ' C' ' 82' ' ' GLY . 67.8 mt -86.31 -17.92 33.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.178 0.991 . . . . 74.21 111.915 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.43 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 50.2 t80 -65.12 -46.63 73.17 Favored Pre-proline 0 CA--C 1.55 0.981 0 CA-C-O 117.535 -1.221 . . . . 63.2 113.031 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.89 -37.75 97.49 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.942 1.761 . . . . 63.13 112.634 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -65.28 -52.68 52.7 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 74.42 110.873 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.16 -35.17 79.77 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.151 0.58 . . . . 74.1 111.351 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.24 -53.11 61.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.573 1.149 . . . . 73.13 110.217 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.1 tm-20 -67.35 -34.94 78.36 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.837 0.711 . . . . 71.24 110.107 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 27.6 t -67.39 -32.92 74.16 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.071 0.548 . . . . 73.34 111.393 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.54 HG21 HG21 ' C' ' 64' ' ' VAL . 88.7 mt -73.11 -51.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.362 0.665 . . . . 74.1 110.223 172.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 34.8 m -63.03 -29.0 70.48 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.281 0.632 . . . . 51.23 110.929 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.4 t -65.44 -52.4 53.46 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.306 -0.861 . . . . 73.13 109.033 170.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.487 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -56.53 -40.44 75.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.889 1.276 . . . . 73.44 113.016 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -65.89 -45.2 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.667 0.787 . . . . 52.4 109.761 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.44 ' HB2' HE22 ' C' ' 125' ' ' GLN . 35.9 t -70.64 -24.01 62.63 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.153 -0.931 . . . . 53.34 111.26 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.4 mtt-85 -69.94 -36.41 75.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.472 0.709 . . . . 72.21 109.272 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.34 10.06 62.43 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 124.002 0.814 . . . . 51.44 112.79 172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.44 HG23 ' HB3' ' D' ' 17' ' ' TYR . 81.9 p 57.61 37.21 27.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.046 1.738 . . . . 44.02 113.425 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.576 ' HE1' HG11 ' C' ' 31' ' ' VAL . 61.1 m-85 -105.73 162.23 20.36 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.363 1.065 . . . . 73.12 110.216 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.99 146.0 97.02 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.107 2.538 . . . . 55.24 113.384 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.44 HE22 ' HB2' ' C' ' 119' ' ' SER . 1.8 mp0 -58.49 108.92 0.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.003 0.921 . . . . 74.2 109.632 173.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.2 tp -110.21 91.64 3.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.839 -1.171 . . . . 72.23 107.839 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -91.17 115.47 28.05 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.564 -0.902 . . . . 72.33 108.564 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.43 ' HB3' ' HZ ' ' C' ' 107' ' ' PHE . 2.3 tt -64.97 132.86 50.42 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.94 139.42 70.72 Favored Pre-proline 0 CA--C 1.549 0.921 0 O-C-N 124.11 0.882 . . . . 62.35 110.968 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.48 104.61 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.303 2.002 . . . . 72.14 111.296 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.0 107.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 108.402 -0.962 . . . . 74.42 108.402 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -113.23 89.52 3.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.498 0.719 . . . . 73.43 110.149 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.438 ' HD2' ' HB2' ' C' ' 100' ' ' ALA . 67.7 t80 -70.78 -30.32 66.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.049 -0.978 . . . . 72.13 109.428 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.245 1.018 . . . . 73.52 111.364 173.965 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.6 ttp . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 113.13 0.789 . . . . 75.14 113.13 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.0 m -115.26 135.15 54.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.173 -1.047 . . . . 73.13 108.173 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' D' ' 85' ' ' SER . 72.0 t80 -154.22 119.31 5.03 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.443 -0.947 . . . . 64.41 108.443 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -132.37 147.21 52.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.565 0.746 . . . . 64.42 110.371 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 122.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.916 -1.142 . . . . 72.3 107.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.3 -46.36 5.29 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.1 -0.375 . . . . 75.22 110.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -169.92 121.99 0.69 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.484 0.49 . . . . 72.42 110.606 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.63 131.76 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 107.469 -1.308 . . . . 63.31 107.469 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HE2' ' HG2' ' D' ' 19' ' ' LYS . 44.3 p90 -162.52 178.47 8.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.52 0.676 . . . . 64.42 111.794 -173.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.2 p -104.91 123.75 48.29 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.671 0.788 . . . . 44.51 109.654 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' HE2' ' D' ' 17' ' ' TYR . 32.3 mtpt -91.27 -22.96 20.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.965 -0.383 . . . . 61.23 109.965 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.9 t70 -155.11 141.73 18.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.521 0.728 . . . . 73.05 109.76 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.482 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.2 mt -140.84 147.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.01 1.324 . . . . 71.14 108.085 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.74 145.99 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.843 0.857 . . . . 61.35 109.34 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.3 t80 -148.97 124.93 10.63 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.649 -1.611 . . . . 61.21 106.649 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.6 mt-10 -124.31 142.16 51.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.581 0.753 . . . . 73.24 109.487 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.685 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -147.68 76.31 10.8 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.763 0.825 . . . . 64.13 109.081 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.54 -47.71 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.43 2.087 . . . . 72.01 111.622 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' D' ' 72' ' ' THR . 6.7 m120 -97.12 36.13 1.48 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.953 0.901 . . . . 74.44 108.955 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.685 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.47 -54.66 52.68 Favored Pre-proline 0 CA--C 1.559 1.289 0 N-CA-C 114.294 1.22 . . . . 33.11 114.294 -172.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.04 -7.3 14.23 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 121.237 1.477 . . . . 71.33 112.605 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -83.83 -38.81 20.74 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.214 1.406 . . . . 73.53 110.099 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -82.96 -20.83 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 73.44 110.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.23 -28.91 69.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.856 0.862 . . . . 73.23 110.688 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -67.04 -20.39 65.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.749 1.219 . . . . 75.31 111.557 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -100.86 111.59 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.271 1.029 . . . . 74.44 110.059 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -85.86 63.26 7.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.354 1.061 . . . . 73.13 111.108 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.523 ' HB3' HD11 ' D' ' 68' ' ' LEU . 48.2 t-105 -144.69 167.98 21.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.71 116.64 66.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.586 0.754 . . . . 73.34 110.031 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -50.61 133.93 39.17 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.642 2.894 . . . . 42.45 113.764 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.39 130.6 43.89 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.782 -0.451 . . . . 71.01 109.782 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.43 134.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.382 0.673 . . . . 53.53 110.786 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.1 tmtt? -130.6 121.38 25.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.428 -1.693 . . . . 72.11 106.428 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 146.9 26.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.102 0.561 . . . . 61.34 110.978 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.8 m-20 -137.14 122.95 20.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.215 1.406 . . . . 73.11 107.609 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -117.2 144.24 44.99 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.986 0.514 . . . . 71.42 110.943 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 2.6 t70 -146.82 154.02 40.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.511 1.124 . . . . 74.11 109.3 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -142.76 148.42 37.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.469 0.708 . . . . 71.13 109.775 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 168.0 25.01 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.651 1.18 . . . . 70.5 108.14 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -160.5 153.83 21.96 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.054 0.454 . . . . 74.41 111.244 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -154.36 119.6 5.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.717 1.207 . . . . 63.44 108.98 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.58 126.28 29.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.167 0.587 . . . . 73.53 109.543 175.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.66 -40.69 13.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.942 0.497 . . . . 75.33 109.701 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.14 -174.97 4.99 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.078 -0.964 . . . . 70.22 110.243 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -63.08 123.35 18.36 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.631 -0.713 . . . . 63.42 110.301 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.44 -2.24 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.873 1.269 . . . . 73.43 112.909 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.68 118.68 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.842 0.857 . . . . 63.44 108.868 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -128.97 128.53 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.877 -1.157 . . . . 75.51 107.877 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -97.13 141.33 30.4 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.824 -1.547 . . . . 64.15 106.824 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.26 130.55 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.052 -0.722 . . . . 73.42 109.052 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.82 138.84 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 123.916 0.887 . . . . 74.2 109.684 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.17 120.77 27.95 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.528 -1.286 . . . . 54.22 107.528 171.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -107.25 121.62 44.91 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.231 1.012 . . . . 75.54 109.32 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.59 122.49 67.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.613 -1.255 . . . . 73.11 107.613 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.6 m -121.2 131.81 54.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.743 0.817 . . . . 63.31 109.462 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.503 HG23 HD13 ' D' ' 114' ' ' ILE . 80.7 t -119.55 109.13 25.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.082 1.353 . . . . 70.14 109.261 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 23.6 m -94.89 117.68 30.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.144 -1.058 . . . . 74.55 108.144 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.92 133.07 51.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.464 -0.569 . . . . 62.24 109.464 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 51.2 p -145.83 134.82 22.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.069 0.548 . . . . 70.22 109.797 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' D' ' 36' ' ' TRP . 19.0 tp -117.87 118.94 33.37 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.105 -0.702 . . . . 63.13 109.105 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.09 -115.18 4.01 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.15 -0.78 . . . . 43.54 111.15 -170.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.19 9.06 10.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.032 0.933 . . . . 61.43 110.268 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.88 156.56 39.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.014 0.926 . . . . 64.3 110.298 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 99.1 m -68.83 123.99 22.47 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.654 0.782 . . . . 70.23 110.576 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.52 -57.28 3.21 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.707 0.803 . . . . 61.44 109.322 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.94 149.75 16.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.801 -1.091 . . . . 74.04 109.683 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -113.65 153.64 28.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.418 1.087 . . . . 62.3 108.209 172.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.594 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.8 t -156.09 142.41 18.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.106 0.562 . . . . 75.21 109.592 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.22 121.4 4.3 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.838 0.455 . . . . 64.41 110.075 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.448 HG22 HG23 ' D' ' 21' ' ' ILE . 60.3 t -126.31 115.26 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.316 0.647 . . . . 74.33 109.973 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.2 mt-30 -89.16 87.76 7.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.737 -0.838 . . . . 60.14 108.737 169.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -79.89 104.04 10.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.516 -1.22 . . . . 74.34 108.664 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.59 143.68 15.7 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.901 -0.479 . . . . 61.22 111.901 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.453 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.99 131.41 4.57 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.789 -0.524 . . . . 73.52 111.789 -171.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.8 123.03 40.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 C-N-CA 123.926 0.89 . . . . 64.44 108.761 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -128.64 163.05 25.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.925 0.89 . . . . 71.25 109.98 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.8 m -107.3 112.88 25.94 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.529 -0.915 . . . . 71.21 108.529 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.77 115.63 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 107.877 -1.157 . . . . 73.43 107.877 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -145.91 157.6 43.89 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.318 1.047 . . . . 54.21 109.785 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.44 -14.28 12.96 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.086 -0.506 . . . . 44.44 113.567 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.9 138.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.956 1.303 . . . . 74.11 109.312 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -152.4 -177.35 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.2 0.6 . . . . 73.34 110.718 174.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.64 -120.15 6.81 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.037 -0.529 . . . . 64.01 112.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -64.33 -39.3 93.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.805 0.842 . . . . 75.44 111.301 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.91 -37.63 72.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.738 0.415 . . . . 73.4 111.094 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.659 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 58.3 ttp -72.58 -36.1 68.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.596 0.359 . . . . 74.32 110.567 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.71 86.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.169 0.588 . . . . 61.42 110.392 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -68.3 -37.72 80.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.814 0.846 . . . . 73.44 110.809 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' D' ' 102' ' ' CYS . 33.3 t -68.68 -51.25 43.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.673 0.389 . . . . 61.43 110.158 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.41 -18.78 59.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.347 0.659 . . . . 65.41 111.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.61 -8.98 44.87 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.409 -0.662 . . . . 74.12 114.14 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.94 -63.19 0.35 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.878 0.839 . . . . 70.52 112.25 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.13 -56.52 11.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.397 0.888 . . . . 72.53 113.397 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' D' ' 97' ' ' CYS . 65.4 m -61.91 -43.27 86.51 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-O 118.594 -0.717 . . . . 75.32 111.606 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -51.6 -39.6 65.38 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.463 2.109 . . . . 61.02 114.121 164.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -69.98 -25.29 63.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.599 0.76 . . . . 74.5 111.063 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 48.2 mm -70.27 -40.61 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.349 0.66 . . . . 53.22 110.112 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.453 HD21 ' HA3' ' D' ' 82' ' ' GLY . 61.7 mt -77.06 -26.51 53.62 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.194 -0.912 . . . . 50.0 111.667 -174.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.505 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 85.4 t80 -53.97 -47.91 95.52 Favored Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 125.039 1.336 . . . . 73.43 114.469 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 80.7 Cg_exo -51.0 -41.07 57.97 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.431 2.087 . . . . 63.54 113.712 172.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -75.87 -34.98 60.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.892 0.877 . . . . 75.44 111.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.84 73.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.141 0.577 . . . . 71.24 109.894 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -56.45 -48.34 77.25 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.581 1.176 . . . . 70.23 110.234 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.45 -44.69 95.81 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.081 0.863 . . . . 74.51 111.121 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.6 t -61.38 -43.71 98.41 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.594 0.559 . . . . 73.21 110.856 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.594 HG12 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -57.11 -57.91 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.877 0.871 . . . . 63.51 110.23 173.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.587 HG23 ' HG3' ' D' ' 125' ' ' GLN . 87.9 m -53.79 -46.69 71.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.362 1.465 . . . . 73.02 112.02 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -62.55 -41.11 98.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.91 -1.041 . . . . 71.14 110.036 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.05 -33.8 72.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.144 0.578 . . . . 73.15 111.667 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -64.39 -43.3 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.594 0.758 . . . . 75.05 110.406 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.79 -33.51 66.32 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 116.105 -0.498 . . . . 73.54 110.704 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -68.06 -32.68 73.2 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.997 0.919 . . . . 75.0 110.42 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.04 81.86 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.719 -0.673 . . . . 52.45 112.849 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 56.18 45.15 23.85 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.446 1.498 . . . . 72.23 112.258 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -117.85 155.37 50.98 Favored Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.799 -1.092 . . . . 75.11 110.23 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.48 112.07 0.61 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.25 2.633 . . . . 53.22 112.321 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.587 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.9 tt0 -61.28 128.74 37.83 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.148 0.905 . . . . 75.2 112.025 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.25 120.29 41.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.878 -1.156 . . . . 64.34 107.878 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -112.72 95.13 5.25 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.864 -1.162 . . . . 62.03 107.864 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.505 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.2 OUTLIER -70.34 125.93 28.19 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.062 0.545 . . . . 72.12 109.642 -174.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 142.14 96.66 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.896 0.878 . . . . 73.41 111.508 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.4 124.9 6.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.948 2.432 . . . . 74.32 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -127.27 123.72 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.947 0.899 . . . . 54.52 109.481 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -76.82 94.83 3.93 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.894 -0.78 . . . . 75.33 108.894 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 118.815 -0.612 . . . . 74.24 111.256 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.232 0.183 0 N-CA-C 108.051 -1.092 . . . . 70.54 108.051 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -131.56 152.91 50.39 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.282 0.633 . . . . 74.4 110.316 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -155.84 123.24 5.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.565 0.746 . . . . 64.41 109.522 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -81.04 125.91 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.641 -1.615 . . . . 60.32 106.641 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HB3' HH11 ' A' ' 15' ' ' ARG . 88.3 mt-30 -109.83 -42.05 4.35 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 122.092 -0.38 . . . . 73.12 111.134 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.482 HH11 ' HB3' ' A' ' 14' ' ' GLN . 2.3 mpt_? -152.34 141.46 21.32 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.219 -1.03 . . . . 70.41 108.219 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.701 HG23 HD23 ' A' ' 106' ' ' LEU . 55.5 mt -141.13 101.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.025 -1.842 . . . . 74.12 106.025 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 73.0 m-85 -155.36 177.97 10.75 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.634 0.774 . . . . 75.0 110.287 -162.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.3 p -98.24 113.56 25.53 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.679 -0.691 . . . . 63.24 109.846 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -78.17 -32.61 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.802 -0.444 . . . . 73.43 109.802 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.0 t70 -149.02 147.63 28.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.999 -0.546 . . . . 73.42 109.735 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.8 mt -140.72 144.13 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.198 1.399 . . . . 73.41 107.803 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -157.4 120.9 4.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.77 0.319 . . . . 70.42 110.915 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.8 t80 -118.41 134.3 55.17 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.126 -1.435 . . . . 71.5 107.126 171.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -129.55 140.8 51.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.216 -1.031 . . . . 70.04 108.216 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -139.16 84.29 16.91 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.55 -0.907 . . . . 55.34 108.55 173.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.23 -49.64 1.85 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.986 2.457 . . . . 64.42 112.199 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 44.4 m-80 -103.28 43.92 1.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.605 0.762 . . . . 70.42 109.445 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -59.42 -51.95 77.71 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.125 0.97 . . . . 73.44 113.205 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -22.66 14.73 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.867 1.711 . . . . 73.43 111.939 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 7.5 t60 -83.04 -25.35 32.21 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.948 1.299 . . . . 53.23 111.992 -168.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.99 -26.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.915 0.886 . . . . 41.02 112.553 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.412 ' HD2' ' HZ2' ' A' ' 36' ' ' TRP . 70.2 m-85 -70.3 -34.73 73.09 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.621 0.768 . . . . 75.14 112.169 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -63.36 -36.32 83.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.199 0.999 . . . . 70.11 110.177 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.84 154.79 23.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.549 -1.205 . . . . 72.02 110.756 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.0 118.49 16.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.008 -0.738 . . . . 65.13 109.008 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.412 ' HZ2' ' HD2' ' A' ' 32' ' ' PHE . 5.5 m0 -60.47 86.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 71.31 112.298 -174.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -128.26 75.04 79.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.074 0.95 . . . . 71.42 108.579 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.16 139.88 7.36 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.589 2.193 . . . . 64.34 112.279 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -95.82 106.77 18.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.708 -1.59 . . . . 74.42 106.708 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -85.15 92.07 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 123.651 0.594 . . . . 51.4 109.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.462 ' NZ ' ' HB2' ' A' ' 67' ' ' SER . 10.7 mptt -75.82 133.03 40.74 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.944 -0.761 . . . . 73.51 108.944 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -121.56 115.79 23.45 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.466 -1.309 . . . . 74.13 107.466 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.5 m-20 -122.14 135.76 54.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.02 0.928 . . . . 73.41 108.707 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.0 mt -121.72 134.06 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.692 0.797 . . . . 64.22 109.11 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 33.8 t70 -142.17 144.66 33.53 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.896 0.478 . . . . 53.23 110.039 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -139.11 130.59 27.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.77 0.828 . . . . 50.52 110.73 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.45 149.27 42.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.958 0.903 . . . . 71.14 109.754 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.6 p -106.28 164.17 12.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.577 0.751 . . . . 63.52 109.628 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -153.97 131.16 11.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.056 0.942 . . . . 72.11 108.476 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -88.73 122.35 32.05 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.023 0.529 . . . . 74.13 110.563 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.2 mt -91.5 -44.71 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.164 -0.925 . . . . 53.52 109.106 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.18 176.82 10.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.626 -1.17 . . . . 73.12 109.532 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.84 114.62 10.12 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.919 -1.141 . . . . 71.22 107.919 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 75.23 3.52 4.06 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.314 1.446 . . . . 75.35 112.908 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 29.1 t -112.79 111.97 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 108.649 -0.871 . . . . 50.11 108.649 173.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -125.21 156.01 39.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.433 0.693 . . . . 75.34 110.054 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HB2' HD11 ' A' ' 51' ' ' LEU . 42.2 tt0 -131.5 117.78 19.26 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.155 0.982 . . . . 74.42 108.743 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.98 128.63 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.167 -1.049 . . . . 62.43 108.167 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -109.03 134.23 51.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.636 0.775 . . . . 73.44 109.197 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.15 118.75 37.57 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.447 -1.316 . . . . 74.54 107.447 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.55 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.26 101.75 13.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.166 -1.05 . . . . 73.12 108.166 171.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.4 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.3 t -95.32 132.77 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.78 -1.193 . . . . 72.1 107.78 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.0 m -118.24 133.12 56.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.844 -0.799 . . . . 61.32 108.844 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -132.52 105.07 8.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.798 -1.556 . . . . 62.31 106.798 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.8 m -113.21 129.45 56.51 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.929 -0.767 . . . . 64.13 108.929 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.89 105.42 11.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.742 -1.207 . . . . 73.2 107.742 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 23.9 m -121.66 127.82 51.22 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.674 -0.491 . . . . 61.31 109.674 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt -89.17 81.98 6.65 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.917 -1.512 . . . . 72.31 106.917 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -119.17 5.14 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.419 -0.81 . . . . 31.15 112.245 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.81 -14.66 41.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.776 0.83 . . . . 73.25 111.3 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.3 132.56 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.661 1.184 . . . . 72.13 109.336 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -83.83 131.37 34.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.856 0.36 . . . . 60.5 110.717 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.91 -54.11 5.34 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.883 0.873 . . . . 74.42 109.008 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -159.79 174.13 14.95 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.539 -0.755 . . . . 72.34 111.533 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 tp -141.18 148.4 39.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.571 1.548 . . . . 72.01 108.058 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 60.2 m -136.86 133.44 35.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.432 -0.951 . . . . 65.42 108.432 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.96 124.8 11.91 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.14 -0.689 . . . . 74.32 109.14 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.93 117.12 25.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 123.581 0.753 . . . . 72.31 109.45 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -84.79 85.1 7.49 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.309 -0.997 . . . . 72.55 108.309 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -81.21 92.44 6.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.774 -1.195 . . . . 61.33 107.774 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -103.66 143.67 15.78 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.762 -0.935 . . . . 63.31 110.762 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.51 141.82 11.44 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.308 -0.717 . . . . 74.12 111.308 -174.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.4 mt -88.37 120.76 37.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.981 -0.748 . . . . 74.41 108.981 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.88 118.1 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.45 1.1 . . . . 73.31 108.086 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -83.74 115.32 22.15 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.262 -1.014 . . . . 34.43 108.262 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.454 HG21 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -133.71 135.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.22 0.608 . . . . 44.13 109.38 -173.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 172.33 15.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.796 1.239 . . . . 71.52 109.669 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.34 -36.84 3.8 Favored Glycine 0 N--CA 1.465 0.613 0 CA-C-N 115.575 -0.738 . . . . 64.24 112.673 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -126.8 147.42 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.367 0.667 . . . . 70.42 110.374 -175.257 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.7 tt0 -135.98 -176.33 4.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.133 0.973 . . . . 74.44 108.951 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.504 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.49 -137.15 28.74 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.94 -0.367 . . . . 74.12 112.88 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -65.6 -20.79 66.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.917 0.887 . . . . 62.23 111.723 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.69 -53.33 22.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.012 0.925 . . . . 61.13 110.626 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -29.19 62.23 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 116.347 -0.388 . . . . 71.01 110.343 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.72 96.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.359 0.664 . . . . 62.51 109.862 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.3 t-80 -62.48 -39.01 92.08 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.328 -1.305 . . . . 74.11 110.741 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.671 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 7.1 m -78.35 -61.96 1.84 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.047 0.758 . . . . 50.4 113.047 -175.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 86' ' ' ILE . 95.0 mt -67.74 -22.7 65.22 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 75.03 112.471 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.06 -10.84 44.59 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.407 -0.663 . . . . 55.21 114.364 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -149.01 -52.6 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.979 1.474 . . . . 75.23 114.979 -169.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.4 t80 -55.24 -59.74 4.36 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.077 0.951 . . . . 72.32 110.25 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -67.88 -45.65 43.14 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 114.334 -1.303 . . . . 72.01 112.747 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.44 -42.2 41.97 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.661 2.241 . . . . 74.04 114.54 168.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -71.73 -30.75 65.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.794 0.438 . . . . 73.43 110.493 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.8 mm -70.54 -34.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 70.32 110.278 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.701 HD23 HG23 ' A' ' 16' ' ' ILE . 84.0 mt -73.29 -28.77 62.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.907 0.883 . . . . 74.15 111.305 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.81 -44.87 87.14 Favored Pre-proline 0 CA--C 1.568 1.647 0 N-CA-C 115.144 1.535 . . . . 72.5 115.144 -167.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.51 -31.31 80.36 Favored 'Trans proline' 0 C--N 1.387 2.589 0 CA-C-N 122.028 1.76 . . . . 72.0 113.257 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.82 -34.29 39.63 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.245 0.618 . . . . 72.52 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.82 77.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.55 -0.537 . . . . 71.11 109.55 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.54 HH12 HD12 ' C' ' 105' ' ' ILE . 38.4 ttm180 -52.6 -49.84 64.23 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.922 1.389 . . . . 64.14 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.36 -48.02 81.61 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.046 0.841 . . . . 75.3 111.196 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.5 t -60.39 -36.02 77.1 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.797 0.686 . . . . 62.21 111.491 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.463 HG21 HG21 ' A' ' 64' ' ' VAL . 87.4 mt -67.08 -58.68 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.678 0.791 . . . . 74.11 109.945 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 125' ' ' GLN . 69.0 m -56.09 -31.76 63.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.736 1.214 . . . . 71.03 111.438 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.2 -47.42 67.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.111 -0.95 . . . . 54.41 110.163 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.51 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -62.36 -38.24 88.79 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 122.696 0.399 . . . . 72.31 111.221 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.0 t -60.2 -49.56 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 O-C-N 123.968 0.792 . . . . 71.54 109.787 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -26.93 62.36 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.733 -0.667 . . . . 73.33 111.478 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.21 -31.09 65.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.385 0.674 . . . . 63.32 109.559 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 5.52 80.37 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.852 -0.613 . . . . 54.12 112.888 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 4.3 t 58.26 21.82 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.253 2.221 . . . . 73.22 113.902 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.2 148.11 44.11 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.982 -0.748 . . . . 74.15 108.982 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.45 128.17 26.81 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.026 2.484 . . . . 62.14 112.084 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -58.16 146.05 34.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.475 0.71 . . . . 71.32 111.532 -168.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.19 97.97 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.226 0.61 . . . . 73.12 109.376 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.19 108.05 20.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 55.12 108.532 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.444 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.6 mm? -74.4 148.58 41.07 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.745 0.818 . . . . 72.5 110.954 -173.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -69.68 129.91 90.87 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.141 0.576 . . . . 45.43 110.427 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 11.9 Cg_exo -67.89 108.72 1.75 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.027 . . . . 70.21 111.549 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.7 t -99.7 111.11 28.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.092 . . . . 42.01 108.053 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -82.17 86.25 6.66 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.995 0.902 . . . . 52.32 109.379 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -59.95 -32.36 70.74 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.511 -1.222 . . . . 64.12 110.656 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.446 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.4 p-10 . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 124.189 0.996 . . . . 72.13 111.577 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.486 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 6.7 ptt? . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 113.299 0.851 . . . . 64.31 113.299 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.2 t -156.11 131.78 9.65 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 107.849 -1.167 . . . . 61.02 107.849 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' B' ' 85' ' ' SER . 69.3 t80 -131.71 146.36 52.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.926 0.891 . . . . 61.03 109.494 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -159.37 142.85 14.63 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.638 0.375 . . . . 73.44 110.756 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.448 HD11 HD13 ' B' ' 105' ' ' ILE . 54.3 mt -89.53 123.3 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.284 -1.006 . . . . 73.51 108.284 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.1 -35.7 16.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.748 0.419 . . . . 73.11 109.935 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 62.1 ttt180 -163.77 146.65 9.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.49 0.316 . . . . 70.21 110.589 -171.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.47 139.77 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.807 -1.553 . . . . 70.43 106.807 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.453 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 15.0 p90 -173.03 168.34 4.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.038 0.923 . . . . 74.21 112.642 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 66.9 m -90.38 129.27 36.6 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.32 -1.309 . . . . 73.43 108.89 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 48.6 mtpt -98.17 -40.1 8.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.399 0.68 . . . . 73.22 110.573 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.2 t70 -146.8 135.11 21.78 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.589 -0.732 . . . . 52.05 109.896 -163.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.7 mm -136.3 140.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.713 1.205 . . . . 74.35 109.382 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -140.29 131.41 26.38 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.138 -1.43 . . . . 42.3 107.138 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.435 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -147.03 119.03 8.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.172 -1.418 . . . . 74.12 107.172 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.99 129.94 55.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.495 -0.928 . . . . 63.52 108.495 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -125.84 81.2 66.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 174.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.93 -27.73 20.51 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.649 2.233 . . . . 72.41 111.764 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.91 29.47 7.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.136 0.974 . . . . 74.41 109.839 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.57 -50.61 65.16 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.595 1.158 . . . . 74.21 113.179 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.69 -12.67 6.25 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 122.055 1.837 . . . . 71.33 113.277 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.429 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 30.2 m80 -93.7 3.82 54.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.883 0.873 . . . . 73.52 110.116 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.21 -14.37 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 123.751 0.82 . . . . 63.24 111.442 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -64.65 -30.9 71.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.494 0.718 . . . . 73.11 112.503 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.585 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 4.2 pt20 -85.19 -33.29 22.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.597 0.359 . . . . 74.32 110.104 171.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.598 ' HD3' ' HB3' ' B' ' 68' ' ' LEU . 95.8 mttt -109.48 66.49 0.63 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 74.43 111.984 -175.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.52 85.57 4.96 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 108.62 -0.881 . . . . 72.14 108.62 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -156.47 169.91 23.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.04 -0.726 . . . . 75.02 109.04 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.1 113.98 23.59 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.644 0.778 . . . . 75.35 110.609 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.629 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 2.8 Cg_exo -73.46 144.19 35.9 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.339 2.026 . . . . 74.22 111.9 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.01 103.2 1.78 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.466 -0.788 . . . . 74.53 109.204 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.41 135.75 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.241 -0.891 . . . . 71.22 110.782 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.625 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 97.1 mttt -132.12 101.21 5.31 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.357 1.063 . . . . 74.53 108.376 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.62 144.96 28.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.279 0.632 . . . . 75.13 109.828 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -148.25 139.21 23.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.757 -0.831 . . . . 75.44 108.757 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.31 133.17 53.83 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.965 0.906 . . . . 73.23 108.697 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.7 t70 -127.91 135.74 50.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 55.21 108.952 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -109.97 114.08 27.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.683 0.793 . . . . 75.14 110.324 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.2 151.68 36.39 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.118 0.967 . . . . 75.33 109.336 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -145.08 168.82 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.797 0.439 . . . . 74.41 111.157 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.0 p -153.75 154.49 34.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 74.43 108.92 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.96 103.27 13.37 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.179 -0.674 . . . . 63.45 109.179 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' B' ' 57' ' ' GLU . 67.4 mt -77.88 -34.16 51.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.19 -0.913 . . . . 74.11 110.631 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.94 -170.64 2.01 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.805 0.842 . . . . 65.14 110.256 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.58 108.79 2.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.746 -1.116 . . . . 63.14 109.39 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 72.31 2.58 4.38 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.376 1.47 . . . . 62.45 112.863 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.87 93.4 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.651 -1.24 . . . . 61.44 107.651 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -107.26 138.38 43.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.993 -1.003 . . . . 74.22 109.392 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' B' ' 51' ' ' LEU . 23.2 tt0 -98.87 127.43 44.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.537 -1.282 . . . . 71.42 107.537 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.27 122.05 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 108.06 -1.089 . . . . 61.24 108.06 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 45.5 t -102.91 114.07 41.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.256 -1.016 . . . . 35.34 108.256 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -91.24 127.12 36.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.75 -1.574 . . . . 72.22 106.75 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.3 ttt180 -119.0 120.77 38.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.613 -0.884 . . . . 63.32 108.613 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.576 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.2 t -112.85 112.94 42.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.966 -1.124 . . . . 53.43 107.966 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 43.0 m -93.96 135.88 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.273 -1.01 . . . . 71.23 108.273 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 114' ' ' ILE . 82.6 t -130.31 130.95 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.027 0.931 . . . . 73.11 109.15 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.8 m -125.1 148.23 48.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.006 -1.109 . . . . 65.01 108.006 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.09 132.74 17.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.053 -1.091 . . . . 72.23 108.053 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 14.0 m -139.87 137.11 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.372 0.269 . . . . 71.03 110.579 -172.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HB3' ' HD3' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -117.39 113.16 21.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.871 -1.159 . . . . 65.34 107.871 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.14 -129.59 18.04 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.624 0.578 . . . . 54.2 112.89 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -92.86 19.46 7.64 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 74.13 111.267 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.422 ' HB3' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 tp10 -147.96 159.3 44.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.588 0.355 . . . . 72.45 111.12 -171.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.7 m -71.23 137.48 48.69 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.477 0.711 . . . . 75.41 109.752 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.42 -56.63 3.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.078 -1.082 . . . . 64.1 108.078 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.49 171.32 17.25 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.731 -1.122 . . . . 74.14 110.674 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -141.1 146.17 36.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.609 1.564 . . . . 73.32 107.308 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.41 154.73 35.02 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.395 -0.595 . . . . 70.54 109.395 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.09 133.53 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.231 -0.655 . . . . 71.42 109.231 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.1 t -126.77 144.98 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.624 0.769 . . . . 72.2 109.138 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 75.3 mt-30 -123.15 94.8 4.37 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.816 -0.809 . . . . 74.32 108.816 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.81 98.82 9.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.926 -1.034 . . . . 72.05 109.106 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 143.85 17.6 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.83 -0.908 . . . . 61.32 110.83 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.64 130.66 3.86 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.259 -0.736 . . . . 74.04 111.259 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.57 126.24 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.88 -0.785 . . . . 74.52 108.88 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.65 162.08 33.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.471 1.109 . . . . 71.11 109.125 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.8 m -131.51 112.97 13.12 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.493 0.717 . . . . 64.24 109.735 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.447 HD12 ' N ' ' B' ' 86' ' ' ILE . 1.1 mp -125.29 114.9 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.119 -1.067 . . . . 63.13 108.119 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.22 147.15 45.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.281 0.632 . . . . 52.03 110.793 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.23 -40.15 2.53 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.818 0.699 . . . . 65.11 113.133 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' B' ' 93' ' ' GLN . 5.7 tp -91.01 148.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.049 0.54 . . . . 72.52 111.037 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.504 ' H ' HD12 ' B' ' 89' ' ' ILE . 10.2 pt-20 -156.47 164.14 38.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.616 0.766 . . . . 71.41 111.319 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.97 -137.57 18.79 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 114.908 -1.042 . . . . 52.14 113.435 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 43.4 m -65.63 -40.35 92.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.089 0.956 . . . . 61.31 111.921 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.702 ' HB2' HD11 ' B' ' 89' ' ' ILE . 2.3 mp0 -66.0 -36.85 84.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 74.31 111.054 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.413 ' HB2' HG13 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -75.34 -25.21 57.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.206 0.602 . . . . 65.31 110.66 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.93 64.54 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.47 0.708 . . . . 61.12 111.907 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -86.47 -20.31 28.29 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.232 0.613 . . . . 74.14 111.231 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.84 -62.6 1.33 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.431 0.292 . . . . 73.11 110.4 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.68 -16.43 41.86 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.093 -0.379 . . . . 70.42 111.532 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.32 -37.4 17.99 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 123.471 0.482 . . . . 61.21 112.669 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.42 -50.54 1.76 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.704 0.631 . . . . 63.12 112.704 -170.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -69.44 -54.57 13.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.259 0.624 . . . . 53.05 111.602 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.413 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.4 m -63.33 -46.83 85.13 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.54 -0.743 . . . . 73.04 112.015 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.6 Cg_exo -54.95 -38.25 93.12 Favored 'Trans proline' 0 C--N 1.391 2.782 0 C-N-CA 121.94 1.76 . . . . 64.44 113.901 170.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.73 -32.87 74.5 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.015 0.435 . . . . 75.32 111.083 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.448 HD13 HD11 ' B' ' 13' ' ' ILE . 94.8 mt -67.84 -44.25 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.262 1.025 . . . . 75.12 110.684 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.34 -26.1 46.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.022 0.929 . . . . 51.42 112.199 -172.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.413 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 49.3 t80 -59.43 -45.13 98.93 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.707 1.203 . . . . 74.53 113.986 -169.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 18.7 Cg_endo -58.23 -37.24 96.2 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.328 2.018 . . . . 73.31 113.984 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -70.36 -45.3 66.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.91 0.484 . . . . 72.23 110.368 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.467 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.84 -42.51 89.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.33 -0.85 . . . . 62.34 110.367 175.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 21.6 mtp-105 -52.21 -63.42 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.302 1.041 . . . . 74.31 111.391 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.44 -29.69 67.96 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.197 0.936 . . . . 64.31 110.639 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.8 t -70.81 -48.6 53.22 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.104 0.561 . . . . 71.45 111.086 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.601 HG21 HG21 ' B' ' 64' ' ' VAL . 48.2 mt -62.07 -51.86 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 123.417 0.687 . . . . 74.21 110.059 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -34.52 72.48 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.585 -1.189 . . . . 74.13 110.875 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -67.39 -50.2 60.65 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.534 -0.757 . . . . 43.01 110.392 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -63.48 -38.04 89.63 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.884 0.473 . . . . 72.11 111.421 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.99 -43.16 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.014 0.925 . . . . 63.44 110.767 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -62.68 -36.77 83.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.925 0.89 . . . . 61.0 111.055 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 93.6 mtt-85 -68.74 -20.62 64.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.138 -0.937 . . . . 75.4 111.472 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.07 16.63 59.87 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 119.482 -0.621 . . . . 72.23 114.209 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p 72.65 13.0 5.34 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 126.528 1.931 . . . . 71.2 112.836 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -97.94 152.83 38.27 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 122.641 0.376 . . . . 71.34 110.922 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.34 144.14 98.29 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.227 2.618 . . . . 71.33 112.001 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -61.41 129.24 40.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.527 0.731 . . . . 74.51 111.715 -172.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.19 86.86 2.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.694 -0.854 . . . . 75.1 108.694 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -90.64 118.4 30.06 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.672 -1.233 . . . . 70.31 107.672 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.55 ' HB2' ' HG2' ' B' ' 111' ' ' ARG . 2.4 mm? -77.47 128.34 34.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.277 -0.638 . . . . 75.53 109.277 -173.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.37 136.51 93.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.37 0.668 . . . . 60.12 110.626 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.544 ' HG2' HG21 ' D' ' 13' ' ' ILE . 19.0 Cg_endo -60.5 89.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.135 2.557 . . . . 73.31 112.796 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.55 118.95 39.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.721 -0.844 . . . . 74.33 108.721 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.67 114.59 7.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.564 0.745 . . . . 73.43 110.419 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 53.3 m-85 -64.75 -29.18 70.15 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.826 0.85 . . . . 62.41 110.268 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -66.64 -40.92 88.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.946 0.898 . . . . 72.41 110.807 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.07 68.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.453 0.701 . . . . 52.12 110.948 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 124.032 0.933 . . . . 75.34 109.314 173.889 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.683 ' HG2' ' HB ' ' C' ' 89' ' ' ILE . 69.0 mtp . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.131 0.491 . . . . 63.01 111.518 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.694 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 49.4 m -84.43 85.91 7.34 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.447 -1.316 . . . . 61.2 107.447 173.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.45 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 80.9 t80 -106.16 126.25 51.98 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.435 -1.257 . . . . 72.32 109.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -145.8 139.78 26.65 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.018 -0.734 . . . . 62.31 109.018 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.39 106.45 3.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.209 -1.034 . . . . 64.12 108.209 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.0 mm100 -77.29 -48.83 16.42 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 123.254 0.346 . . . . 72.33 110.343 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -166.87 149.29 6.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.526 -0.761 . . . . 74.45 109.438 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.2 mt -133.89 132.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 107.633 -1.247 . . . . 73.53 107.633 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.413 ' OH ' HD11 ' C' ' 83' ' ' ILE . 31.7 p90 -171.11 165.28 7.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.033 0.921 . . . . 62.23 112.849 -173.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -88.04 104.01 16.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.296 -1.32 . . . . 75.14 109.072 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 7.0 mtmt -71.1 -23.71 62.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.884 0.374 . . . . 64.03 110.201 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.5 t70 -158.25 140.7 14.38 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.603 -0.726 . . . . 72.12 109.319 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.1 mt -134.69 144.16 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.212 -1.403 . . . . 74.1 107.212 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -149.57 150.12 31.74 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.345 0.658 . . . . 54.11 109.276 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -155.69 118.75 4.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.256 -1.016 . . . . 75.32 108.256 175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.95 121.39 40.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.398 -0.964 . . . . 65.05 108.398 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.89 85.76 29.27 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.043 -1.095 . . . . 75.43 108.043 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.94 -37.81 10.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.59 2.193 . . . . 74.32 111.857 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.645 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 1.9 m-20 -107.69 39.8 1.85 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.91 -0.774 . . . . 72.22 108.91 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.575 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -51.65 -49.54 82.41 Favored Pre-proline 0 CA--C 1.563 1.448 0 N-CA-C 114.271 1.212 . . . . 72.42 114.271 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.666 ' HD3' ' HZ1' ' D' ' 19' ' ' LYS . 37.2 Cg_endo -86.99 -22.2 1.87 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 121.523 1.482 . . . . 62.42 112.831 173.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.645 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 25.1 t-80 -69.51 -23.49 63.62 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.119 0.968 . . . . 75.45 111.547 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 7.1 p -60.55 -23.4 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.85 0.86 . . . . 73.13 112.25 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.446 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 82.2 t80 -59.14 -41.18 87.68 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.147 0.979 . . . . 72.32 111.847 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -86.96 6.0 34.34 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.62 0.6 . . . . 73.51 112.62 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.532 ' HZ3' ' HA ' ' C' ' 31' ' ' VAL . 16.1 pttm -123.42 178.28 5.23 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.255 0.55 . . . . 73.44 110.736 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.62 133.97 33.72 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.484 -1.235 . . . . 70.33 110.003 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.467 ' HB3' ' HG3' ' C' ' 124' ' ' PRO . 20.4 m-90 -85.38 64.72 8.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.752 0.821 . . . . 74.12 111.041 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -144.37 62.98 10.59 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.466 1.107 . . . . 74.34 108.737 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.53 174.99 9.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.226 1.951 . . . . 45.31 110.847 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -85.36 115.83 23.33 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.901 -0.778 . . . . 71.51 108.901 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.13 101.18 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.564 -0.902 . . . . 74.21 108.564 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.81 98.47 11.62 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.552 -1.647 . . . . 62.13 106.552 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -89.38 162.36 15.83 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.42 0.288 . . . . 74.11 110.506 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -159.62 108.47 1.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.272 0.629 . . . . 65.43 109.575 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -107.57 141.15 39.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.104 0.961 . . . . 63.24 108.804 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.28 153.73 35.4 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.921 0.888 . . . . 64.12 108.69 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -131.76 133.84 45.21 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.405 -0.591 . . . . 71.43 109.405 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -113.24 172.25 7.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.536 1.135 . . . . 61.22 109.261 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.1 p -151.24 146.62 26.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.323 0.649 . . . . 75.22 109.971 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.538 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 10.1 m -144.14 149.07 35.91 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.577 -1.268 . . . . 64.1 107.577 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.13 114.55 28.75 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.649 -1.241 . . . . 72.02 107.649 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' C' ' 57' ' ' GLU . 24.9 mt -93.03 -36.89 12.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.394 0.678 . . . . 74.24 109.846 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.09 -175.64 5.53 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.922 -1.035 . . . . 55.23 110.039 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.24 108.5 1.09 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.399 -1.273 . . . . 72.54 110.016 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 70.6 -2.38 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.694 1.597 . . . . 72.23 113.106 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.0 t -98.61 102.81 13.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.412 -0.959 . . . . 74.12 108.412 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -110.19 160.21 16.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.539 0.736 . . . . 70.22 109.352 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.617 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.3 tt0 -120.51 127.27 52.04 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.142 0.977 . . . . 64.25 108.72 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.87 127.39 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.491 -1.3 . . . . 75.32 107.491 170.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 27.0 t -112.79 101.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.287 -1.005 . . . . 53.44 108.287 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.64 95.07 9.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.829 -1.174 . . . . 75.32 107.829 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -88.29 112.5 22.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.509 -1.223 . . . . 73.01 108.827 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.7 t -107.44 139.89 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.586 -0.894 . . . . 71.44 108.586 174.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -131.44 133.94 45.7 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.626 -0.879 . . . . 70.41 108.626 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.34 111.5 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.692 1.197 . . . . 74.11 108.6 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.537 HG23 HD23 ' C' ' 75' ' ' LEU . 2.4 m -99.06 146.57 25.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.835 -1.172 . . . . 72.04 107.835 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.86 107.99 7.22 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.945 -1.502 . . . . 54.2 106.945 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.441 ' HB3' HG23 ' C' ' 72' ' ' THR . 11.8 p -162.43 144.13 10.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.475 0.484 . . . . 65.1 110.577 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.9 tp -118.72 85.82 2.43 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.809 -1.182 . . . . 75.15 107.809 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -107.88 2.35 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 114.698 -1.137 . . . . 42.1 111.525 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.55 -32.89 17.94 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.708 -0.478 . . . . 71.22 109.708 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -75.12 84.17 2.34 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.605 0.762 . . . . 73.23 110.089 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.441 HG23 ' HB3' ' C' ' 67' ' ' SER . 61.4 m -81.89 126.29 31.72 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.053 -0.976 . . . . 64.22 110.145 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.94 -61.04 2.11 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.649 -0.871 . . . . 43.12 108.649 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -158.33 178.02 10.62 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.876 0.846 . . . . 71.01 112.259 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.537 HD23 HG23 ' C' ' 65' ' ' THR . 3.0 tm? -141.62 146.2 35.93 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.575 -2.009 . . . . 74.12 105.575 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -150.55 148.2 28.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.258 -1.016 . . . . 54.02 108.258 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.16 134.54 10.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.781 -0.452 . . . . 72.53 109.781 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -133.17 116.63 26.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 123.815 0.846 . . . . 70.24 108.921 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -87.8 86.17 7.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.342 -1.355 . . . . 74.41 107.342 169.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -79.48 96.1 5.99 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.936 -1.029 . . . . 73.51 108.832 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -88.48 144.35 18.35 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.244 -0.742 . . . . 63.23 111.244 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.18 119.93 1.3 Allowed Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 110.259 -1.136 . . . . 65.54 110.259 -175.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.562 HD12 HD11 ' C' ' 51' ' ' LEU . 7.4 mm -82.58 123.76 38.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.206 -1.035 . . . . 70.23 108.206 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.49 120.94 24.91 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.887 0.875 . . . . 71.44 108.829 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 22.0 p -77.93 109.81 12.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.987 -1.116 . . . . 75.14 107.987 170.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 27.2 pt -118.51 113.22 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.4 0.619 . . . . 74.23 109.352 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.694 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -123.83 156.23 36.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.823 0.849 . . . . 72.33 109.762 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.34 -35.8 3.52 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.572 0.545 . . . . 74.52 113.382 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.683 ' HB ' ' HG2' ' C' ' 9' ' ' MET . 19.3 tt -88.4 145.97 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.075 0.55 . . . . 70.33 110.667 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.78 -177.56 5.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.003 0.921 . . . . 73.52 110.403 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 60.67 -147.07 46.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.649 -0.705 . . . . 73.43 114.626 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -69.86 -19.18 63.45 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 61.52 111.863 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -71.12 -42.36 69.35 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.746 0.819 . . . . 75.2 110.566 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 25.9 ptt? -69.87 -28.57 65.76 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 110.223 -0.288 . . . . 60.25 110.223 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.29 90.26 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.75 0.656 . . . . 61.12 110.365 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -60.54 -39.38 87.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 74.05 110.783 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -63.21 -58.29 7.69 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.839 0.455 . . . . 74.13 110.952 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -77.12 -12.47 59.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.586 0.587 . . . . 73.44 112.586 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.9 9.79 21.13 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.341 -0.699 . . . . 43.31 114.739 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -53.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 117.764 0.782 . . . . 72.34 111.284 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.61 -59.84 2.55 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.368 0.667 . . . . 74.43 111.584 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 70.2 m -60.78 -44.89 96.47 Favored Pre-proline 0 CA--C 1.566 1.565 0 C-N-CA 124.465 1.106 . . . . 71.2 113.461 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.35 -20.86 48.16 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.005 1.803 . . . . 64.24 113.476 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -71.53 -30.63 66.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.994 0.517 . . . . 54.3 110.467 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.54 HD12 HH12 ' A' ' 111' ' ' ARG . 44.2 mm -68.2 -28.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 73.14 110.261 173.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.564 HD21 ' HA3' ' C' ' 82' ' ' GLY . 85.7 mt -86.47 -22.85 26.23 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.819 0.848 . . . . 73.53 112.182 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -53.77 -50.6 82.74 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.996 -1.002 . . . . 73.14 113.374 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.01 -36.5 96.57 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 122.022 1.815 . . . . 44.25 113.482 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.36 -44.44 62.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.139 0.576 . . . . 73.45 111.089 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -41.92 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.465 0.478 . . . . 54.25 109.887 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -60.28 -51.29 70.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.14 1.376 . . . . 73.42 111.142 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.2 tm-20 -70.81 -30.36 66.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.498 0.499 . . . . 64.42 110.291 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.0 t -69.86 -30.82 68.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.832 0.453 . . . . 74.34 111.178 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.461 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -77.3 -50.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.528 0.731 . . . . 70.3 109.949 175.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -62.98 -29.08 70.54 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.625 0.77 . . . . 74.14 111.228 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -64.91 -52.31 57.15 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.837 -0.801 . . . . 60.42 108.837 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.47 -38.71 78.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.435 1.094 . . . . 44.53 112.754 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.404 HG23 ' O ' ' C' ' 114' ' ' ILE . 87.5 t -61.86 -50.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.274 0.629 . . . . 60.21 109.864 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.1 t -71.14 -22.23 62.09 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.179 -0.919 . . . . 54.31 111.392 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -71.9 -37.11 70.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.067 -0.716 . . . . 72.15 109.067 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.28 3.76 79.95 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.905 0.753 . . . . 72.32 113.131 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.496 HG23 ' HB3' ' D' ' 17' ' ' TYR . 71.4 p 57.5 40.74 26.86 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.8 1.64 . . . . 51.01 112.153 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -99.29 165.04 15.55 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.758 1.223 . . . . 75.45 110.838 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' C' ' 36' ' ' TRP . 22.5 Cg_endo -57.48 147.36 78.85 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.572 2.848 . . . . 22.11 113.927 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -58.51 111.94 1.42 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.555 1.142 . . . . 75.11 111.522 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.6 tp -122.15 97.28 5.4 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.408 0.683 . . . . 73.53 109.319 -174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -101.35 115.9 31.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 74.22 108.709 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.13 134.56 50.74 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.956 -0.757 . . . . 72.15 108.956 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -64.35 132.35 95.32 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.077 0.551 . . . . 74.34 111.171 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 129' ' ' ALA . 13.2 Cg_exo -71.37 90.19 0.69 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.974 2.449 . . . . 75.14 112.783 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -100.12 112.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.737 0.815 . . . . 72.1 109.792 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -97.75 95.38 7.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.352 0.661 . . . . 72.42 109.384 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -65.86 -30.43 71.04 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.516 0.726 . . . . 72.44 111.348 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.279 0.562 . . . . 72.01 110.208 177.816 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.527 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.6 tpt . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 113.595 0.961 . . . . 70.42 113.595 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.1 m -143.36 140.54 30.55 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.747 0.819 . . . . 55.32 110.166 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 44.5 t80 -143.01 115.61 8.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.937 -1.505 . . . . 72.44 106.937 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 44.2 mt-30 -128.13 147.36 50.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.276 -0.639 . . . . 72.32 109.276 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.544 HG21 ' HG2' ' B' ' 130' ' ' PRO . 3.8 mp -103.6 121.0 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.992 -1.114 . . . . 60.3 107.992 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -101.45 -42.22 6.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.893 0.477 . . . . 73.31 111.891 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.518 ' HD3' HD12 ' D' ' 83' ' ' ILE . 47.4 ttt180 -163.7 123.83 2.16 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.701 -0.19 . . . . 73.41 110.616 -168.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.6 136.62 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.156 -1.424 . . . . 55.5 107.156 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.575 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 39.7 p90 -166.0 177.72 6.88 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.947 0.779 . . . . 70.12 111.32 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -101.89 117.47 34.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.206 -0.907 . . . . 65.34 109.073 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.666 ' HZ1' ' HD3' ' C' ' 29' ' ' PRO . 26.9 mtpp -80.53 -27.91 37.5 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.569 -0.287 . . . . 74.51 110.356 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.69 148.88 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.529 0.731 . . . . 70.14 109.13 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.551 HG21 ' HE2' ' C' ' 117' ' ' MET . 83.3 mt -143.44 147.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.97 1.308 . . . . 50.24 108.506 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -148.03 144.44 27.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.491 1.116 . . . . 71.44 109.275 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.433 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.61 126.29 8.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.154 -1.795 . . . . 64.03 106.154 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -128.65 141.13 51.44 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.206 0.602 . . . . 72.23 109.46 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.75 77.13 9.54 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.211 1.004 . . . . 53.02 108.349 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.54 -38.71 13.8 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.611 2.207 . . . . 71.4 111.421 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.505 HD21 ' HB ' ' D' ' 72' ' ' THR . 13.2 p30 -102.24 31.06 4.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.814 1.646 . . . . 63.12 109.746 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.515 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.07 -48.48 94.39 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 114.53 1.307 . . . . 74.32 114.53 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.29 -4.71 11.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 CA-C-N 121.299 1.5 . . . . 73.21 112.685 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.6 t-160 -81.39 -54.74 5.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 74.22 109.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' D' ' 73' ' ' ALA . 52.8 t -67.9 -16.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.918 0.887 . . . . 71.24 111.186 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -63.56 -18.28 63.7 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.323 1.049 . . . . 71.33 112.415 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.89 -16.09 57.49 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.163 0.585 . . . . 74.3 111.1 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.473 ' HZ3' ' HB3' ' D' ' 71' ' ' GLU . 49.8 mtmt -113.81 104.41 12.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.965 0.906 . . . . 71.24 110.187 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.47 95.34 8.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.006 0.522 . . . . 62.52 109.981 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.504 ' HB3' HD11 ' D' ' 68' ' ' LEU . 56.3 t-105 -161.69 158.53 26.11 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.73 110.11 8.98 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.121 0.969 . . . . 72.41 109.614 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.18 131.13 31.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.771 2.98 . . . . 72.5 113.312 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.06 119.55 13.53 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.56 -0.533 . . . . 63.31 109.56 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' D' ' 66' ' ' ALA . 9.3 m -98.83 120.77 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.42 0.688 . . . . 74.04 111.436 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -87.66 115.85 25.38 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.018 -1.104 . . . . 74.05 108.018 166.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -96.51 142.11 28.99 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.833 -0.803 . . . . 63.51 108.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.657 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -127.8 112.33 14.64 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.89 -1.152 . . . . 72.32 107.89 173.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -96.57 134.48 39.74 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.952 -0.759 . . . . 61.02 108.952 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.1 t70 -152.22 147.95 27.01 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.943 -1.132 . . . . 61.34 107.943 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -139.59 163.92 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.078 0.466 . . . . 75.34 110.28 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.06 163.05 39.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.148 0.979 . . . . 75.31 109.761 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -142.41 153.33 43.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.658 -0.867 . . . . 73.21 108.658 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -155.76 152.46 28.52 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.359 1.064 . . . . 72.34 108.352 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -99.42 134.09 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.502 -0.555 . . . . 41.42 109.502 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' D' ' 57' ' ' GLU . 46.4 mt -103.14 -41.37 6.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.709 0.804 . . . . 74.32 109.265 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.18 -171.83 3.52 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.205 -0.907 . . . . 74.5 109.95 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.28 122.84 18.04 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.559 -0.746 . . . . 73.44 109.233 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 63.78 9.17 4.23 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.527 1.131 . . . . 63.54 112.831 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -119.26 120.56 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.058 0.943 . . . . 72.34 108.486 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.423 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 73.0 m-85 -136.34 135.98 39.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.852 0.461 . . . . 74.14 110.246 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD21 ' D' ' 51' ' ' LEU . 6.2 tp10 -91.08 113.75 26.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.094 0.958 . . . . 63.31 109.378 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.44 127.82 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.659 -1.237 . . . . 61.41 107.659 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.2 t -113.36 146.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.433 0.693 . . . . 73.41 109.341 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -127.47 108.76 11.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.006 -1.109 . . . . 61.12 108.006 176.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.7 ttm-85 -85.13 107.05 17.02 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.201 -0.666 . . . . 71.31 109.201 170.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.0 t -105.29 103.95 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.013 -1.106 . . . . 75.5 108.013 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.657 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 45.3 m -96.61 135.84 37.96 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.888 -0.782 . . . . 73.03 108.888 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.462 HG23 HD13 ' D' ' 114' ' ' ILE . 64.1 t -122.35 127.41 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.194 -1.039 . . . . 72.23 108.194 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -129.03 93.55 3.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.706 -1.22 . . . . 71.13 107.706 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.601 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -95.95 148.97 22.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.181 0.592 . . . . 65.4 110.039 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -151.05 136.91 18.12 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.988 0.805 . . . . 71.41 109.525 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' D' ' 36' ' ' TRP . 24.9 tp -120.53 128.34 53.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.813 -0.81 . . . . 74.41 108.813 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.88 -119.39 8.12 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.193 0.308 . . . . 62.24 112.349 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.36 7.01 17.52 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.073 0.949 . . . . 71.2 109.783 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.473 ' HB3' ' HZ3' ' D' ' 34' ' ' LYS . 11.0 tp10 -116.46 145.88 42.96 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.497 1.119 . . . . 55.35 109.304 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 72' ' ' THR . . . . . 0.505 ' HB ' HD21 ' D' ' 27' ' ' ASN . 54.2 m -59.23 145.67 42.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.556 0.743 . . . . 72.31 109.038 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -106.57 -57.36 2.07 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.955 -0.387 . . . . 62.04 109.955 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.44 147.22 18.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.765 -0.652 . . . . 63.23 110.148 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 48.3 mt -110.69 149.15 30.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.538 1.135 . . . . 65.01 108.701 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -160.06 149.66 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.195 0.598 . . . . 62.21 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -156.61 141.0 16.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.506 -0.924 . . . . 61.31 108.506 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -136.37 118.66 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.301 -0.629 . . . . 75.01 109.301 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.5 85.75 6.59 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.534 -0.913 . . . . 74.33 108.534 170.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.58 102.15 8.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.517 -1.219 . . . . 63.54 108.7 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.8 142.96 15.86 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.315 -0.714 . . . . 65.23 111.315 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.88 132.19 5.63 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.415 -1.074 . . . . 52.2 110.415 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.518 HD12 ' HD3' ' D' ' 15' ' ' ARG . 89.7 mt -88.09 114.26 26.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.441 -0.948 . . . . 64.24 108.441 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.63 136.44 54.39 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.053 0.941 . . . . 74.34 109.461 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 6.5 m -79.31 105.98 11.01 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.923 -0.769 . . . . 63.52 108.923 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 37.3 mm -106.18 102.57 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.253 -1.018 . . . . 60.12 108.253 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.21 152.99 51.35 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.954 0.901 . . . . 63.23 109.535 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.89 -1.93 66.44 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 114.632 0.613 . . . . 62.14 114.632 174.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.86 125.76 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.011 -0.737 . . . . 74.11 109.011 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.94 -173.92 3.94 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.467 0.707 . . . . 70.12 111.075 -171.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 -134.58 25.14 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.782 -0.644 . . . . 52.42 113.05 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.803 0.841 . . . . 75.43 111.215 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -68.18 -38.47 82.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.645 0.778 . . . . 62.23 110.871 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.29 66.78 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.534 -0.303 . . . . 23.02 110.399 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.2 71.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.347 0.659 . . . . 63.22 111.113 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -67.66 -40.28 84.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 73.34 110.847 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -68.64 -52.3 32.75 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.061 -0.518 . . . . 60.11 110.624 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.56 -16.96 61.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.597 0.759 . . . . 75.03 111.637 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.04 -24.68 24.25 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.769 -0.462 . . . . 75.03 114.052 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.1 -57.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.679 0.74 . . . . 63.4 111.805 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -67.07 -50.75 60.71 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.798 0.839 . . . . 74.33 112.633 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.59 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 19.3 m -69.67 -44.79 24.65 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.307 0.643 . . . . 72.21 111.679 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.8 Cg_exo -58.72 -31.84 95.74 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.147 1.898 . . . . 70.31 113.416 169.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.95 -37.49 87.59 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.073 0.549 . . . . 72.33 110.721 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.57 -41.81 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.539 0.736 . . . . 72.02 109.976 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.8 -17.69 60.58 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.17 -0.923 . . . . 72.0 112.143 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -68.36 -42.7 29.85 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 113.607 0.966 . . . . 73.4 113.607 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.8 -37.14 84.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 122.072 1.848 . . . . 74.44 113.618 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 94.7 m-85 -81.37 -33.58 32.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.995 0.918 . . . . 72.34 111.431 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.63 66.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.383 0.673 . . . . 60.32 109.382 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.0 ttp180 -53.25 -53.42 51.08 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.964 -1.471 . . . . 73.3 110.458 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.9 -46.65 84.63 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.281 0.988 . . . . 63.41 111.838 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.43 -42.0 90.84 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.986 0.804 . . . . 70.4 111.175 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.462 HD13 HG23 ' D' ' 64' ' ' VAL . 75.9 mt -65.22 -53.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.666 0.604 . . . . 71.13 110.277 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.421 HG23 ' HG3' ' D' ' 125' ' ' GLN . 48.4 m -55.19 -40.54 70.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.701 1.2 . . . . 73.21 111.513 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.8 t -66.75 -43.21 84.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.59 -1.186 . . . . 64.41 110.436 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.4 mtm -67.77 -32.83 73.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.007 0.523 . . . . 73.32 112.163 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 83.4 t -67.41 -42.01 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.372 0.669 . . . . 70.31 109.764 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -76.08 -28.39 57.57 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.097 -0.502 . . . . 74.51 111.131 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -71.61 -32.48 68.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.644 0.778 . . . . 73.24 109.567 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 6.13 73.52 Favored Glycine 0 C--N 1.355 1.623 0 O-C-N 123.754 0.659 . . . . 33.34 112.544 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' C' ' 17' ' ' TYR . 63.3 p 57.58 21.46 7.16 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.83 2.052 . . . . 75.31 114.291 176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.39 157.6 58.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.928 0.891 . . . . 62.15 109.301 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.51 121.82 10.71 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.718 2.278 . . . . 62.34 111.477 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.421 ' HG3' HG23 ' D' ' 115' ' ' THR . 24.1 tt0 -48.29 132.23 16.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.009 1.324 . . . . 63.32 112.47 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -107.14 106.1 16.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -97.61 89.71 4.76 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.702 -1.222 . . . . 61.01 107.702 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 5.6 mp -62.9 112.51 2.6 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.786 0.679 . . . . 54.34 109.594 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.79 139.57 73.86 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.255 -0.646 . . . . 64.24 109.255 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.51 165.28 27.79 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.245 1.963 . . . . 62.33 112.727 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.81 138.7 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.368 -0.605 . . . . 73.53 109.368 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -74.81 95.26 2.88 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 108.955 -0.757 . . . . 74.51 108.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.474 0.757 0 CA-C-N 115.039 -0.982 . . . . 75.2 111.045 -179.83 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.0 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.62 -0.511 . . . . 70.41 109.62 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -139.85 115.33 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.326 -0.99 . . . . 74.42 108.326 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 55.2 mt-30 -134.25 122.65 23.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.154 0.582 . . . . 74.23 110.104 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.43 107.99 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.539 -0.911 . . . . 75.1 108.539 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -86.33 -40.33 15.57 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.443 0.297 . . . . 75.21 110.434 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.793 ' HD2' HG21 ' B' ' 122' ' ' THR . 10.1 tpp180 -167.68 134.4 2.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.471 -0.566 . . . . 65.12 109.471 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 91.6 mt -138.4 100.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.962 -0.755 . . . . 73.31 108.962 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.9 m-85 -164.09 176.16 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 74.32 109.693 -165.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -85.33 114.05 22.11 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.146 -0.479 . . . . 72.33 110.093 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -88.92 -34.47 16.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.727 0.298 . . . . 73.44 110.371 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.792 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 9.1 m-20 -137.38 147.0 45.14 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.482 0.658 . . . . 65.25 109.736 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.561 HD13 ' SD ' ' B' ' 117' ' ' MET . 66.9 mt -144.99 143.88 22.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 126.381 1.872 . . . . 72.24 106.508 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -158.79 121.36 3.64 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.607 -0.516 . . . . 72.21 109.607 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.633 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.9 t80 -119.8 136.62 54.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.428 -1.323 . . . . 65.45 107.428 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.38 148.8 51.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.578 0.751 . . . . 64.54 109.017 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.12 80.72 7.79 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.869 -1.16 . . . . 61.32 107.869 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -31.2 24.86 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.528 2.152 . . . . 62.45 111.667 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -112.53 34.29 4.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.544 1.138 . . . . 74.44 109.334 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.45 -47.1 99.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.444 1.097 . . . . 71.42 113.581 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.1 -20.9 32.64 Favored 'Trans proline' 0 C--N 1.392 2.828 0 CA-C-N 121.124 1.437 . . . . 75.51 112.421 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -79.87 -24.97 40.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.58 0.752 . . . . 64.51 111.656 -172.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.16 -22.32 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 112.461 0.541 . . . . 75.01 112.461 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -80.04 -35.02 37.78 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.297 1.039 . . . . 72.13 110.699 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -88.36 -18.04 29.28 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.178 0.591 . . . . 73.11 111.108 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 68' ' ' LEU . 96.4 mttt -75.59 167.15 22.43 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.864 0.69 . . . . 64.25 112.864 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.27 118.28 23.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.69 -1.141 . . . . 52.23 108.05 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.483 ' HA ' HD12 ' A' ' 68' ' ' LEU . 20.5 m-90 -73.33 85.72 1.46 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.759 0.79 . . . . 72.12 110.939 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -130.78 76.98 76.35 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.063 1.345 . . . . 74.23 108.195 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.46 111.86 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.717 2.278 . . . . 75.34 111.843 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -96.14 85.09 3.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.94 -1.504 . . . . 75.54 106.94 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.1 m -88.25 122.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.453 -1.248 . . . . 65.52 111.889 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -108.17 116.61 32.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.652 1.181 . . . . 72.04 109.111 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.04 108.24 19.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.181 0.593 . . . . 63.35 109.691 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.4 t70 -103.41 130.38 50.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.728 0.811 . . . . 61.43 109.601 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 131' ' ' VAL . 4.6 mp -110.43 119.75 40.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.509 -0.922 . . . . 70.01 108.509 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.485 ' O ' HD23 ' A' ' 60' ' ' LEU . 25.3 t70 -122.68 138.08 54.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.493 0.717 . . . . 72.35 109.532 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.7 m -133.35 143.69 49.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.938 0.495 . . . . 64.0 110.146 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.71 152.69 40.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.406 1.082 . . . . 74.01 109.395 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -130.96 155.97 45.89 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.515 -0.92 . . . . 64.25 108.515 172.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -163.26 116.43 1.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 117.882 0.31 . . . . 74.45 110.314 -173.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -70.22 105.62 3.02 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.992 0.917 . . . . 65.43 110.353 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 57' ' ' GLU . 44.9 mt -77.94 -39.9 41.25 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.309 1.044 . . . . 74.53 111.008 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.08 -171.81 3.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.822 -1.081 . . . . 43.32 109.447 -172.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.76 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.114 0.566 . . . . 74.23 110.5 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 9.4 m-20 54.6 31.4 15.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.117 1.367 . . . . 73.23 112.932 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 54.6 t -107.55 122.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.9 -1.519 . . . . 51.2 106.9 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 138.02 49.65 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.953 -0.758 . . . . 73.43 108.953 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' A' ' 51' ' ' LEU . 37.0 tt0 -86.92 121.87 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.987 -1.116 . . . . 73.3 107.987 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -99.29 118.58 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.446 -1.316 . . . . 72.25 107.446 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 90.9 t -98.18 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 123.28 0.632 . . . . 74.32 109.545 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -120.93 110.47 16.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.291 -1.744 . . . . 73.43 106.291 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.592 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 23.4 ttp180 -104.84 103.61 13.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.661 -0.866 . . . . 74.42 108.661 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.39 129.08 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.535 -1.211 . . . . 73.02 108.662 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 41.5 m -109.17 131.76 54.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.739 -0.837 . . . . 54.14 108.739 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 t -123.93 107.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.21 -1.404 . . . . 42.41 107.21 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -107.45 135.66 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.117 -1.068 . . . . 62.21 108.117 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.32 136.78 49.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.501 -1.296 . . . . 72.54 107.501 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.2 m -147.22 135.65 21.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.81 0.844 . . . . 75.24 109.651 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 2.3 mm? -87.23 86.52 7.28 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.868 -1.16 . . . . 73.13 107.868 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.57 -85.15 1.25 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.017 -0.992 . . . . 51.22 111.483 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -26.0 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.322 0.649 . . . . 64.24 111.312 -175.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -101.06 133.04 46.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.064 0.546 . . . . 64.23 109.965 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 m -65.44 146.35 54.99 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.154 0.982 . . . . 72.22 112.729 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -90.12 -65.56 1.0 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.833 1.253 . . . . 63.43 108.436 168.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -150.33 159.8 44.19 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.242 -1.345 . . . . 73.24 110.375 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.6 tp -134.72 116.84 15.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.231 1.012 . . . . 71.52 109.565 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.2 m -106.47 142.51 36.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 75.23 110.311 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -148.07 118.78 7.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.371 1.068 . . . . 72.53 108.838 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.32 116.73 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.136 0.425 . . . . 65.41 109.917 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.792 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 15.6 mp0 -85.57 86.51 7.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.434 -1.321 . . . . 70.13 107.434 169.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -77.01 96.01 4.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.085 -0.962 . . . . 63.31 108.607 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.84 146.0 18.1 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.274 -0.73 . . . . 75.42 111.274 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.18 123.89 2.53 Favored Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.265 -1.134 . . . . 71.4 110.265 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' B' ' 29' ' ' PRO . 56.4 mt -81.02 125.22 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.351 -0.611 . . . . 64.4 109.351 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -134.4 119.85 19.09 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.722 -0.844 . . . . 75.45 108.722 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 33.3 t -81.43 92.7 6.49 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.654 -0.869 . . . . 74.55 108.654 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' THR . 11.0 pt -125.89 127.21 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.558 0.743 . . . . 72.33 110.801 -170.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -160.89 171.11 19.32 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.981 0.913 . . . . 75.53 110.759 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.56 -24.07 32.35 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.391 -0.822 . . . . 72.22 113.135 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -109.5 146.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.94 0.496 . . . . 73.2 109.791 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -147.46 175.81 10.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.243 -0.889 . . . . 61.14 111.282 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.97 -132.46 33.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 114.683 -1.144 . . . . 73.04 112.642 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -69.48 -20.68 63.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.575 0.75 . . . . 75.24 111.882 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.08 -44.64 46.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.505 0.722 . . . . 74.15 110.736 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.7 tpt -80.73 -25.07 38.32 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.239 -0.437 . . . . 73.43 110.195 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.49 88.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.218 0.607 . . . . 73.23 109.837 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.87 -43.35 83.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.742 -1.117 . . . . 72.3 110.491 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.714 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.4 m -73.05 -34.34 66.22 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.595 0.961 . . . . 51.22 113.595 -171.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -91.42 -9.24 45.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.486 0.314 . . . . 75.51 111.556 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.65 5.88 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 113.665 0.226 . . . . 50.44 113.665 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.6 -65.7 0.71 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.806 0.842 . . . . 72.12 111.034 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.4 t80 -43.62 -61.51 1.37 Allowed 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 125.125 1.37 . . . . 72.43 113.193 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 83.6 m -72.63 -50.82 7.44 Favored Pre-proline 0 CA--C 1.556 1.194 0 CA-C-O 118.255 -0.878 . . . . 71.33 112.822 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.05 -17.94 61.7 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.718 1.612 . . . . 62.1 113.815 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.29 -48.25 68.23 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 72.3 108.592 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.0 mm -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.58 -1.191 . . . . 72.22 110.782 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.441 HD23 HG23 ' A' ' 16' ' ' ILE . 95.3 mt -71.47 -28.64 64.08 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.738 -0.665 . . . . 73.21 111.953 -173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -65.23 -43.54 65.67 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.373 1.249 . . . . 74.22 114.373 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -34.92 96.53 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.194 1.93 . . . . 71.22 113.381 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -80.96 -33.92 33.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 73.3 111.494 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.13 63.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 110.046 -0.353 . . . . 62.3 110.046 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.483 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.1 ttm180 -51.75 -45.06 63.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.678 1.191 . . . . 75.01 110.348 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.61 -50.32 71.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.026 0.93 . . . . 54.12 111.487 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.47 -39.96 95.12 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.178 0.924 . . . . 55.34 111.098 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.594 HG21 HG21 ' A' ' 64' ' ' VAL . 12.8 mt -64.33 -58.11 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.561 0.745 . . . . 73.13 110.374 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -53.02 -38.95 62.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.159 0.912 . . . . 73.3 111.289 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -66.34 -42.43 88.13 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.384 -0.826 . . . . 72.31 110.472 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.6 mtm -63.49 -37.73 88.42 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.982 0.513 . . . . 64.33 111.168 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.9 t -63.12 -45.41 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.281 1.032 . . . . 71.33 110.545 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.0 p -75.17 -29.63 60.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.02 -0.537 . . . . 61.44 111.327 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -72.05 -28.07 63.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 74.12 109.81 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.13 1.25 89.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.552 -0.749 . . . . 64.53 113.014 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 m 68.68 18.33 8.77 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.762 1.225 . . . . 60.44 111.578 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -90.37 154.37 46.56 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.702 0.801 . . . . 62.33 110.805 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -59.79 134.11 55.2 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.94 2.426 . . . . 74.31 112.253 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -62.7 132.34 51.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.605 0.762 . . . . 73.22 111.883 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.3 mt -113.0 114.4 26.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.018 -1.104 . . . . 75.32 108.018 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -97.4 100.86 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.993 -1.114 . . . . 45.12 107.993 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.63 135.78 57.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.235 0.614 . . . . 74.34 110.619 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.06 145.86 88.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.995 0.518 . . . . 74.4 110.99 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.5 119.92 7.03 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.941 1.761 . . . . 72.52 109.174 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 44' ' ' LEU . 97.5 t -95.64 111.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.251 -1.388 . . . . 74.4 107.251 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -82.12 66.17 7.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.937 -1.029 . . . . 74.42 109.318 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -68.8 -34.83 76.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.624 -0.716 . . . . 54.11 109.85 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 CA--C 1.544 0.74 0 O-C-N 123.958 0.786 . . . . 73.33 109.743 172.749 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.59 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.7 ptm . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 114.941 1.46 . . . . 61.34 114.941 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -143.39 122.36 12.8 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.184 -1.043 . . . . 63.13 108.184 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -110.51 134.86 51.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.027 0.931 . . . . 64.43 108.677 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -145.61 141.37 28.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.774 -0.824 . . . . 73.32 108.774 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.624 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -91.66 134.49 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.79 -0.818 . . . . 72.14 108.79 173.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -92.4 -50.3 5.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.129 0.572 . . . . 73.45 109.585 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -164.54 139.26 5.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.436 -0.802 . . . . 72.15 109.409 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -114.84 144.7 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 106.218 -1.771 . . . . 73.15 106.218 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.3 149.44 2.24 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.133 0.424 . . . . 72.22 110.908 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.486 HG21 HD11 ' B' ' 21' ' ' ILE . 26.8 m -80.14 121.66 25.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.353 -0.61 . . . . 73.11 109.353 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -87.7 -33.8 18.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.014 0.526 . . . . 72.34 110.203 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.4 t70 -146.99 127.97 14.54 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.13 -0.486 . . . . 65.4 110.75 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 34.3 mm -113.47 147.08 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.395 -1.335 . . . . 71.2 107.395 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -150.72 140.51 21.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.294 -0.632 . . . . 61.32 109.294 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 93.3 t80 -155.22 114.91 3.7 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 107.663 -1.236 . . . . 73.33 107.663 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.65 113.88 17.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.731 -1.211 . . . . 72.34 107.731 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.687 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -106.0 89.32 3.61 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.544 -0.91 . . . . 61.52 108.544 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.17 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.837 2.358 . . . . 63.42 112.602 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -127.26 29.58 5.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.013 0.925 . . . . 72.52 110.773 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.687 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -48.1 -55.8 16.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 C-N-CA 123.983 0.913 . . . . 64.41 112.419 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HA ' HD11 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -70.5 -16.66 34.45 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.845 1.697 . . . . 73.22 112.622 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -101.5 4.81 41.51 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.5 0.926 . . . . 71.44 113.5 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.68 -31.36 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 118.22 0.464 . . . . 71.3 111.775 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -73.35 -17.82 61.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.464 0.705 . . . . 72.44 110.958 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -79.43 -35.79 39.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.251 1.02 . . . . 62.43 110.813 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -108.02 110.28 21.95 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.39 0.676 . . . . 72.43 110.607 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -98.45 78.03 2.38 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.227 0.611 . . . . 75.31 110.374 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -151.35 161.6 42.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.374 -1.343 . . . . 71.43 107.374 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -85.3 133.5 42.43 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 122.722 0.409 . . . . 73.11 110.221 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.52 136.51 26.18 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.421 2.081 . . . . 73.42 112.799 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -66.63 104.16 1.23 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.8 0.84 . . . . 73.54 109.067 168.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.465 HG11 HD21 ' B' ' 126' ' ' LEU . 11.0 m -98.43 150.44 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.979 0.511 . . . . 72.55 110.423 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' B' ' 65' ' ' THR . 1.1 tmmt? -150.69 121.63 7.64 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.566 -0.901 . . . . 74.43 108.566 -175.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.487 HD11 HD12 ' B' ' 126' ' ' LEU . 2.2 mm? -96.49 134.69 39.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.795 0.838 . . . . 73.23 109.602 -173.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.607 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.6 m-20 -123.62 113.45 18.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.342 -0.984 . . . . 74.34 108.342 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -101.67 148.0 25.78 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.384 -0.599 . . . . 72.14 109.384 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -161.31 152.33 18.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.62 -1.252 . . . . 53.41 107.62 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -153.43 143.87 22.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.988 0.423 . . . . 55.01 110.73 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.66 161.16 35.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.991 1.316 . . . . 74.2 108.331 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.3 m -130.44 165.18 23.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.335 0.588 . . . . 71.02 110.729 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -151.54 146.29 25.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.067 1.347 . . . . 71.31 107.554 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.65 112.13 24.92 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.292 -0.632 . . . . 53.05 109.292 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.39 -34.49 25.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.015 0.436 . . . . 75.02 110.086 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -159.94 178.6 9.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.8 0.84 . . . . 44.01 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.46 117.29 5.51 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.649 -1.159 . . . . 72.42 109.524 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 71.53 -4.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.438 1.495 . . . . 73.22 112.542 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 78.7 t -104.93 95.23 3.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.399 -0.963 . . . . 71.34 108.399 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -107.58 136.4 47.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.629 -0.714 . . . . 74.01 110.435 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -101.48 100.75 11.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.539 -1.282 . . . . 73.14 107.539 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.18 127.32 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.243 1.017 . . . . 72.31 109.669 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.2 t -103.63 123.63 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.825 0.85 . . . . 52.15 110.036 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.94 134.38 35.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.926 -1.509 . . . . 75.23 106.926 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -120.51 121.74 39.09 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.08 0.952 . . . . 75.21 108.701 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -115.53 104.29 16.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.093 -1.447 . . . . 74.5 107.093 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 21.7 m -96.92 130.22 44.26 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.542 -0.91 . . . . 74.12 108.542 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.49 HG23 HD13 ' B' ' 114' ' ' ILE . 69.8 t -112.85 130.7 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.394 0.678 . . . . 72.13 109.401 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HE3' ' B' ' 41' ' ' LYS . 22.0 m -119.67 123.64 44.31 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.514 -0.921 . . . . 62.32 108.514 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 140.18 49.05 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 122.734 0.413 . . . . 73.41 109.984 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.552 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 22.5 p -138.2 126.71 23.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 62.34 110.152 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 2.6 tt -93.46 100.55 12.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.914 -1.513 . . . . 42.44 106.914 -176.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.39 -137.47 19.75 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 111.767 -0.533 . . . . 70.31 111.767 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.53 33.93 1.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.676 0.79 . . . . 60.11 110.387 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.28 146.7 24.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.058 0.943 . . . . 74.31 108.794 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -74.99 138.3 42.14 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.074 0.464 . . . . 72.34 111.388 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.552 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.07 -61.92 1.58 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.292 -1.003 . . . . 42.32 108.292 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.37 157.62 32.7 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.782 -1.099 . . . . 75.31 110.078 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.79 111.82 12.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.394 -1.335 . . . . 71.33 107.394 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.32 152.8 35.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.412 0.685 . . . . 53.41 109.538 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -155.61 134.64 12.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.514 -0.921 . . . . 75.51 108.514 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -129.07 141.36 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.366 -0.605 . . . . 62.24 109.366 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 51.4 mt-30 -118.88 100.88 7.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.378 1.071 . . . . 75.45 109.007 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -87.41 101.17 13.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.715 -0.675 . . . . 74.33 109.362 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 150.64 21.57 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.316 -0.714 . . . . 74.13 111.316 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.26 125.86 2.04 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 111.65 -0.58 . . . . 75.01 111.65 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.66 126.53 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.061 -1.088 . . . . 75.21 108.061 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -130.85 160.38 34.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.651 1.18 . . . . 72.24 108.855 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -130.79 108.06 9.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.934 0.893 . . . . 52.41 108.777 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.714 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -123.69 115.38 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.823 1.249 . . . . 62.25 109.428 -174.13 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 51.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.702 0.801 . . . . 65.32 110.275 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.01 -46.01 1.23 Allowed Glycine 0 C--N 1.345 1.031 0 O-C-N 123.548 0.53 . . . . 63.01 112.112 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -90.75 154.23 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.1 0.96 . . . . 71.4 111.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -159.46 156.81 28.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.694 0.398 . . . . 65.34 110.522 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.27 -116.45 7.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.245 -0.434 . . . . 53.21 112.749 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -67.75 -33.48 74.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.769 0.828 . . . . 64.21 111.044 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.14 -50.31 66.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.735 -0.666 . . . . 72.44 110.529 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 28.2 ttt -71.73 -28.19 63.5 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.287 -0.87 . . . . 74.43 110.944 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -38.14 85.81 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.805 -0.634 . . . . 54.12 110.688 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -70.47 -34.79 72.79 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.505 -0.771 . . . . 74.42 110.299 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.31 -48.39 56.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.171 0.588 . . . . 73.44 111.034 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.25 -16.85 44.76 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.524 0.73 . . . . 73.42 111.812 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.75 2.84 58.73 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.88 -0.4 . . . . 63.42 113.307 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.84 -55.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.276 0.538 . . . . 75.33 112.132 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -81.52 -50.98 8.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.942 0.497 . . . . 74.15 111.768 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.7 m -56.89 -49.6 92.94 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.712 -0.661 . . . . 74.42 112.518 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.45 -26.86 47.3 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.989 1.793 . . . . 73.45 112.842 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.99 -33.56 76.34 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.942 0.401 . . . . 72.12 110.995 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.21 -47.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.672 0.789 . . . . 72.31 110.189 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.22 -22.36 61.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.226 -0.897 . . . . 74.11 112.268 -172.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -63.66 -47.87 81.39 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 114.211 1.189 . . . . 75.3 114.211 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.42 -36.14 93.39 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.09 1.86 . . . . 72.15 113.352 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.41 ' HE2' HG21 ' D' ' 115' ' ' THR . 69.4 m-85 -70.93 -46.84 61.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.194 0.597 . . . . 73.11 110.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.09 94.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.467 0.707 . . . . 55.53 110.651 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -59.38 -56.0 27.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.885 0.874 . . . . 75.45 110.624 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -37.8 84.35 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.791 0.682 . . . . 75.35 110.057 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.5 m -57.08 -53.44 58.03 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 73.54 111.917 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.49 HD13 HG23 ' B' ' 64' ' ' VAL . 80.9 mt -60.73 -58.12 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.595 0.758 . . . . 75.45 111.065 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.3 m -63.56 -30.3 71.43 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.252 0.97 . . . . 70.44 111.206 -168.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 43.7 t -59.79 -56.59 19.91 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.684 -0.689 . . . . 50.23 109.397 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.642 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 19.1 mmt -61.57 -32.96 73.07 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.748 0.819 . . . . 73.53 112.158 -175.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.12 -50.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.027 0.931 . . . . 72.13 110.66 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 84.8 p -74.54 -20.1 60.09 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.292 0.637 . . . . 74.3 111.339 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.642 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.43 -33.48 75.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.786 0.834 . . . . 62.51 110.06 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.73 8.66 78.25 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.39 0.431 . . . . 73.31 112.622 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.793 HG21 ' HD2' ' A' ' 15' ' ' ARG . 4.8 p 69.09 15.05 8.77 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.64 1.976 . . . . 73.31 113.148 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.05 155.3 67.42 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.776 0.83 . . . . 74.41 111.104 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.56 128.79 30.85 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.518 2.812 . . . . 70.23 113.396 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.43 ' HG3' ' OE1' ' C' ' 125' ' ' GLN . 72.7 mt-30 -55.66 133.33 50.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.171 1.388 . . . . 74.34 112.516 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.487 HD12 HD11 ' B' ' 42' ' ' LEU . 3.7 mm? -109.51 82.36 1.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.929 -0.767 . . . . 74.31 108.929 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -91.84 96.23 10.29 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.933 -1.136 . . . . 71.14 107.933 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.19 128.63 35.92 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.179 -0.674 . . . . 75.32 109.179 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.95 148.5 94.57 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.033 0.933 . . . . 60.1 111.376 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.29 93.62 0.57 Allowed 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.177 1.918 . . . . 74.03 111.401 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.6 140.75 15.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.083 -0.962 . . . . 60.11 108.648 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -68.23 99.89 0.97 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.568 0.747 . . . . 65.0 110.339 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -56.34 -30.76 63.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.074 -0.966 . . . . 74.31 110.096 170.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.4 -56.91 13.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.063 1.345 . . . . 54.21 111.46 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.9 94.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.886 0.741 . . . . 62.54 111.74 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 123.69 0.796 . . . . 64.44 109.567 178.308 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.661 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 13.0 tmm? . . . . . 0 CA--C 1.559 1.297 0 N-CA-C 113.288 0.847 . . . . 60.52 113.288 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -94.22 105.79 17.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 53.55 110.023 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.661 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 80.3 t80 -122.61 143.18 49.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 71.21 109.232 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.76 140.47 17.04 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.177 0.591 . . . . 72.43 109.687 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.0 mt -79.11 117.88 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.251 -1.018 . . . . 74.24 108.251 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -88.9 -45.4 9.73 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.772 0.67 . . . . 74.44 110.064 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.8 144.45 6.02 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.887 0.475 . . . . 61.11 110.277 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.84 139.85 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.173 -1.047 . . . . 74.34 108.173 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.519 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 32.6 p90 -173.78 158.18 3.21 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.312 0.577 . . . . 75.32 111.136 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -82.47 116.92 22.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.502 -0.772 . . . . 63.24 109.513 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -78.09 -41.0 36.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.696 0.76 . . . . 73.41 109.074 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -140.41 140.02 35.39 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.55 -1.205 . . . . 62.21 109.741 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.9 mt -136.36 141.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.482 1.513 . . . . 54.22 107.093 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -158.61 148.8 19.78 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.189 0.519 . . . . 74.34 110.222 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -148.27 149.41 31.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -143.45 146.42 33.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.046 1.338 . . . . 72.34 107.714 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' D' ' 19' ' ' LYS . . . -149.77 82.79 6.53 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.83 -1.174 . . . . 54.52 107.83 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.25 -31.9 43.17 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.497 2.131 . . . . 62.1 111.996 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 79.0 m-20 -112.15 38.82 2.58 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 70.42 109.599 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -57.86 -48.79 96.53 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.512 1.125 . . . . 72.01 113.348 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.89 -21.14 8.47 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.729 1.619 . . . . 71.13 112.613 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.8 t-160 -67.56 -20.31 65.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.893 0.877 . . . . 75.33 111.686 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.518 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 11.7 p -46.03 -28.99 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 124.792 1.237 . . . . 42.34 114.212 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -66.92 -43.07 84.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.906 0.482 . . . . 72.32 111.824 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -127.66 39.15 3.92 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.536 0.684 . . . . 71.04 110.806 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -94.03 169.56 10.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 167.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.99 120.89 25.83 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.51 -0.922 . . . . 62.52 108.51 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t90 -78.44 81.61 4.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.481 0.657 . . . . 71.45 109.674 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -153.86 74.95 6.28 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.478 -1.237 . . . . 50.25 107.745 168.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.26 106.64 1.76 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.745 2.296 . . . . 74.53 110.611 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.67 94.89 8.74 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.323 -1.732 . . . . 64.22 106.323 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 96.4 t -86.07 102.33 11.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.549 -1.205 . . . . 52.22 110.198 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -90.29 101.83 14.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.255 -1.338 . . . . 63.24 108.007 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.56 ' H ' HD23 ' C' ' 42' ' ' LEU . 0.7 OUTLIER -89.11 147.49 24.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.978 -0.749 . . . . 72.21 108.978 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.3 t70 -142.69 136.19 28.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.631 0.772 . . . . 60.44 109.156 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 135.44 41.87 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.89 0.876 . . . . 72.1 109.085 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.34 152.06 30.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.445 1.098 . . . . 72.31 108.204 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -131.02 135.78 47.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.421 0.629 . . . . 62.12 110.896 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.52 170.64 8.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.975 -1.011 . . . . 52.32 108.747 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 59.5 p -150.86 151.22 31.93 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.654 0.382 . . . . 60.54 110.534 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.7 p -147.3 128.07 14.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.201 1.001 . . . . 70.21 109.189 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -72.2 118.15 14.72 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.629 -0.508 . . . . 71.45 109.629 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' C' ' 57' ' ' GLU . 54.9 mt -87.28 -43.83 11.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.214 -0.661 . . . . 71.44 109.214 176.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.97 -178.35 6.43 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.705 -1.134 . . . . 43.43 109.895 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.74 120.32 11.0 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.573 -0.74 . . . . 73.44 110.157 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 66.92 3.45 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.755 1.222 . . . . 70.23 112.872 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.99 113.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.907 0.883 . . . . 71.1 108.985 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.13 125.46 43.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.355 1.062 . . . . 63.12 108.717 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.569 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.7 tt0 -83.74 110.99 18.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.094 -0.706 . . . . 65.21 109.094 172.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -95.55 124.01 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.573 -1.269 . . . . 62.34 107.573 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.83 107.57 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.351 0.66 . . . . 74.45 109.245 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.52 104.89 16.9 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.556 -0.905 . . . . 71.53 108.556 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -90.78 121.29 32.52 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.066 1.346 . . . . 75.23 110.219 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.22 121.65 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.82 0.848 . . . . 73.42 109.302 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.0 m -103.34 141.58 35.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.901 -0.778 . . . . 72.13 108.901 166.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.576 HG21 HG21 ' C' ' 114' ' ' ILE . 87.3 t -129.45 112.32 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.094 -1.076 . . . . 75.51 108.094 173.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -108.16 106.95 17.38 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.684 -0.858 . . . . 62.34 108.684 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.94 100.61 10.1 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.851 -0.796 . . . . 63.51 108.851 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -156.81 146.5 20.73 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.111 -0.7 . . . . 54.45 109.111 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 tp -71.2 -44.97 64.36 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.501 -0.926 . . . . 62.52 108.501 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.75 -76.92 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.359 -1.096 . . . . 70.03 110.359 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.31 -33.29 16.16 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 74.14 109.376 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.4 93.72 0.9 Allowed 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.196 -1.038 . . . . 73.41 108.196 171.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -89.53 118.18 28.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.877 -0.601 . . . . 75.32 109.624 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.93 -57.73 4.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.308 -1.368 . . . . 75.23 107.308 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.42 158.69 27.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.123 -0.944 . . . . 65.02 110.725 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -126.21 143.97 50.94 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.254 -1.758 . . . . 41.31 106.254 170.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 34.9 t -150.89 147.52 27.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.634 -0.506 . . . . 72.44 109.634 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -156.53 129.76 8.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.831 -0.433 . . . . 70.31 109.831 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 36.9 t -127.49 114.73 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.177 0.991 . . . . 72.21 108.827 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 94.0 mt-30 -91.27 95.26 9.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.515 -0.921 . . . . 65.13 108.515 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.607 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 55.9 tp60 -83.22 108.62 16.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.594 -0.73 . . . . 74.12 109.817 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.53 150.47 25.67 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 111.809 -0.516 . . . . 70.24 111.809 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.97 118.06 0.88 Allowed Glycine 0 CA--C 1.501 -0.828 0 N-CA-C 110.556 -1.018 . . . . 50.43 110.556 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.475 HD12 HD11 ' C' ' 51' ' ' LEU . 15.4 mm -79.61 127.91 38.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.48 -1.304 . . . . 73.35 107.48 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -135.21 150.63 50.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 75.12 110.172 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -108.42 113.93 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.238 -0.892 . . . . 73.34 108.991 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 51.5 mt -116.01 110.19 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.984 0.914 . . . . 73.12 108.834 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.41 159.16 42.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 64.25 109.817 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -26.24 8.16 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.361 -0.381 . . . . 61.23 113.374 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' C' ' 93' ' ' GLN . 10.4 tt -123.43 159.19 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.643 0.777 . . . . 63.42 110.33 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -157.93 -177.35 6.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.437 0.695 . . . . 34.35 110.34 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -153.25 40.19 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.189 -0.459 . . . . 40.51 113.563 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 76.0 p -66.0 -21.16 66.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.55 0.74 . . . . 71.13 111.259 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.464 ' HB3' HD11 ' C' ' 89' ' ' ILE . 96.9 mt-30 -59.32 -51.68 68.92 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.012 0.925 . . . . 75.34 110.88 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.407 ' HB3' HG23 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -76.26 -23.76 54.47 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.329 -0.396 . . . . 73.44 110.916 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.78 97.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.235 0.614 . . . . 71.42 111.536 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.82 -26.87 64.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.615 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -69.95 -60.78 2.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 110.357 -0.238 . . . . 75.55 110.357 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 pp -72.89 -13.98 61.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.088 0.403 . . . . 65.21 112.088 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.99 -21.14 28.82 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.779 -0.456 . . . . 61.14 113.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.8 -59.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.392 0.596 . . . . 70.3 111.432 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -51.71 66.85 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.54 0.736 . . . . 75.54 112.365 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 m -68.13 -46.68 40.74 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.731 0.812 . . . . 61.13 112.506 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.57 -24.05 49.04 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.013 1.809 . . . . 64.42 113.793 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -69.88 -20.18 63.4 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 122.751 0.42 . . . . 71.43 112.006 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 ' NH1' ' A' ' 111' ' ' ARG . 36.4 mm -70.34 -41.4 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.365 0.602 . . . . 73.14 109.722 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.511 HD21 ' HA3' ' C' ' 82' ' ' GLY . 78.9 mt -81.67 -27.81 33.86 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.849 -1.069 . . . . 65.12 111.931 -171.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.524 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 49.1 t80 -56.26 -47.44 98.86 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 117.692 -1.147 . . . . 74.33 113.607 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.12 -42.1 67.23 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.345 2.03 . . . . 63.21 113.036 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.4 -47.52 76.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.976 0.91 . . . . 72.34 111.388 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.7 -37.47 86.53 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.796 -0.638 . . . . 61.33 110.894 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -62.16 -46.1 90.48 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.387 1.055 . . . . 64.54 110.134 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.11 -37.11 75.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.713 0.633 . . . . 74.14 110.705 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.5 t -64.7 -31.81 73.2 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.522 0.513 . . . . 60.41 110.793 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.576 HG21 HG21 ' C' ' 64' ' ' VAL . 96.1 mt -73.99 -49.16 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.911 -0.586 . . . . 71.51 110.756 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.0 m -57.8 -33.63 68.77 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.44 0.638 . . . . 52.04 110.703 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -65.84 -51.57 57.76 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.702 -1.135 . . . . 71.21 109.574 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.543 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.25 -37.09 74.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.769 1.228 . . . . 74.23 112.79 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.0 t -69.28 -43.51 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.809 0.844 . . . . 75.31 109.821 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.6 t -69.63 -25.39 63.91 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.12 -0.945 . . . . 73.34 110.988 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -71.54 -38.76 71.02 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 108.793 -0.818 . . . . 72.44 108.793 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.31 84.63 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 123.789 0.681 . . . . 71.42 113.043 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.6 p 62.88 29.81 16.56 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.437 1.895 . . . . 73.31 112.852 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -92.4 163.97 24.6 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 124.43 1.092 . . . . 70.51 111.246 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.62 177.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.065 3.177 . . . . 71.3 115.935 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.43 ' OE1' ' HG3' ' B' ' 125' ' ' GLN . 19.5 mm100 -60.42 112.12 1.84 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.708 1.203 . . . . 74.44 112.026 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -111.33 90.49 3.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.785 -1.561 . . . . 50.1 106.785 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -122.81 105.02 9.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.761 -1.2 . . . . 64.31 107.761 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.524 HD22 ' HZ ' ' C' ' 107' ' ' PHE . 2.8 tt -80.87 116.47 20.87 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.629 -0.878 . . . . 73.24 108.629 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 142.77 98.72 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.087 0.955 . . . . 41.52 111.739 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.446 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 18.3 Cg_endo -58.03 109.66 0.52 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.974 2.449 . . . . 70.41 112.847 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 p -97.89 110.39 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.943 -1.132 . . . . 75.45 107.943 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -102.44 78.39 1.72 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.684 -0.689 . . . . 72.21 111.1 -164.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -69.44 -29.16 66.81 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.18 -0.918 . . . . 75.13 110.508 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 CA--C 1.545 0.758 0 CA-C-N 115.724 -0.671 . . . . 73.34 109.923 178.337 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 CA--C 1.561 1.368 0 N-CA-C 114.716 1.376 . . . . 74.21 114.716 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.7 m -144.86 142.73 30.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 72.12 108.936 166.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.78 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 29.4 t80 -152.79 121.45 6.43 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.051 -1.092 . . . . 75.11 108.051 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -137.67 144.39 41.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.989 0.516 . . . . 75.32 109.765 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.3 mm -84.13 116.91 28.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.95 0.9 . . . . 72.23 108.657 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -101.46 -48.68 4.27 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.929 0.331 . . . . 70.42 111.753 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.425 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 35.3 ttt180 -173.96 128.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 111.923 0.342 . . . . 74.11 111.923 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.13 132.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 124.177 0.991 . . . . 64.42 108.373 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 18.2 p90 -163.13 176.02 10.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.692 0.797 . . . . 75.53 112.043 -172.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.452 HG21 HD11 ' D' ' 21' ' ' ILE . 76.8 p -111.05 126.59 54.97 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 64.01 109.636 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.524 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 35.3 mtpt -97.39 -14.41 21.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.78 0.432 . . . . 60.33 110.302 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -161.33 138.29 8.68 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.385 1.074 . . . . 73.51 109.136 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.543 HG21 ' HE2' ' C' ' 117' ' ' MET . 51.8 mt -140.68 144.49 27.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.787 -1.56 . . . . 64.41 106.787 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 20.3 t -150.23 143.5 25.01 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.024 -0.732 . . . . 61.4 109.024 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.54 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -152.39 125.7 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.67 -1.604 . . . . 63.41 106.67 173.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.0 mt-10 -126.59 142.02 51.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.995 0.918 . . . . 73.34 108.528 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 85.4 60.4 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.021 -1.103 . . . . 73.32 108.021 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.04 -45.08 8.45 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.448 2.765 . . . . 74.43 113.803 -167.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -114.53 44.56 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.154 0.982 . . . . 72.33 108.432 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.519 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -50.91 -57.86 12.23 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 115.808 1.781 . . . . 72.52 115.808 -167.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -85.25 -5.76 9.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 122.345 1.873 . . . . 74.1 112.636 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -84.07 -39.79 19.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.27 1.428 . . . . 64.12 109.947 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.03 -16.59 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.517 0.727 . . . . 64.13 109.828 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -55.46 -32.44 62.78 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.438 1.095 . . . . 74.13 111.789 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -67.72 -8.21 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.457 0.703 . . . . 74.41 112.531 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -125.47 106.19 9.61 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.295 1.038 . . . . 61.13 109.485 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -89.23 81.93 6.63 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.28 1.038 . . . . 74.51 110.478 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.577 ' HB3' HD11 ' D' ' 68' ' ' LEU . 33.5 t-105 -146.04 157.25 43.86 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.925 -1.139 . . . . 62.23 107.925 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -61.41 105.21 0.55 Allowed Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 125.161 1.384 . . . . 75.14 110.912 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.35 111.38 1.11 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.272 2.648 . . . . 72.32 111.883 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 113.27 2.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.378 0.671 . . . . 71.13 110.542 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.7 m -100.76 150.27 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 54.05 110.579 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -121.63 118.92 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.621 -1.992 . . . . 73.34 105.621 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.65 ' HG ' HD21 ' D' ' 128' ' ' LEU . 0.0 OUTLIER -96.38 151.45 19.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.726 -0.842 . . . . 44.33 108.726 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -149.79 144.15 25.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.421 0.688 . . . . 64.43 109.754 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -119.73 131.82 55.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.706 0.802 . . . . 72.41 110.01 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.7 t70 -134.04 117.71 16.96 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.539 -1.282 . . . . 72.52 107.539 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -103.5 156.91 17.41 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.218 0.533 . . . . 61.31 110.359 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 171.38 18.09 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.16 0.984 . . . . 71.34 109.076 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 48.5 p -150.45 163.32 38.69 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.458 0.703 . . . . 73.43 109.582 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -158.14 118.13 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.769 -1.197 . . . . 64.32 107.769 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -85.43 122.63 29.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.454 -0.572 . . . . 74.11 109.454 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.9 -40.55 12.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.51 0.724 . . . . 71.12 109.44 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.59 5.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.698 -1.137 . . . . 74.52 109.491 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.55 130.65 43.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.41 -0.589 . . . . 73.44 109.41 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.57 5.49 5.41 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.769 1.227 . . . . 72.13 111.635 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 99.9 t -126.95 115.29 40.85 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 124.658 1.183 . . . . 74.32 108.906 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 24.7 m-85 -134.27 127.26 31.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.076 -0.713 . . . . 60.41 109.076 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.67 114.43 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.84 1.256 . . . . 52.35 108.678 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.53 137.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.446 -0.946 . . . . 73.02 108.446 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 67.9 t -115.7 138.56 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.981 0.913 . . . . 72.34 108.921 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.593 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -126.48 119.6 27.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.386 -1.338 . . . . 72.41 107.386 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -102.85 98.69 8.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.518 -0.919 . . . . 73.52 108.518 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.15 130.92 40.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.962 -0.755 . . . . 70.52 108.962 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -123.4 143.32 50.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.894 -0.594 . . . . 61.41 110.062 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.418 HG23 HD13 ' D' ' 114' ' ' ILE . 70.8 t -130.1 125.41 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.486 1.114 . . . . 70.4 108.859 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 84.3 m -115.55 110.62 19.5 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.095 -1.076 . . . . 44.21 108.095 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.506 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -98.53 157.49 16.2 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.84 0.456 . . . . 62.25 109.8 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.5 p -158.34 137.28 11.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.656 -0.498 . . . . 53.53 109.656 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' D' ' 36' ' ' TRP . 18.1 tp -136.03 110.34 8.43 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.054 -1.091 . . . . 72.41 108.054 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.95 -127.35 7.97 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.596 0.56 . . . . 54.24 113.382 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -94.4 9.44 38.32 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.182 0.593 . . . . 74.52 111.838 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.45 163.93 31.51 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.249 0.547 . . . . 75.31 111.349 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -74.18 134.51 42.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.823 -1.08 . . . . 72.11 109.516 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.29 -53.03 5.26 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.49 0.716 . . . . 75.41 109.865 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.92 172.47 18.4 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.76 -1.109 . . . . 73.41 109.7 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 98.5 mt -138.68 149.57 45.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.241 1.417 . . . . 73.4 108.087 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.783 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -159.76 142.37 13.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.676 0.39 . . . . 53.44 110.671 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -155.94 126.85 6.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.941 0.496 . . . . 72.14 109.883 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.33 119.07 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.667 0.787 . . . . 64.44 110.074 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.745 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 87.3 mt-30 -89.22 88.09 7.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.715 0.769 . . . . 71.41 109.037 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -79.86 107.99 13.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.197 -1.365 . . . . 75.41 108.676 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.47 164.04 18.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 112.347 -0.301 . . . . 63.41 112.347 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.53 3.74 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.903 -0.479 . . . . 65.32 111.903 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -88.85 126.94 41.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.639 -0.875 . . . . 63.21 108.639 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -130.54 143.48 50.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.352 1.061 . . . . 73.52 109.101 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 12.9 m -80.66 101.18 9.08 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.816 -0.809 . . . . 70.11 108.816 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 43.1 mm -107.01 106.04 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.093 -1.076 . . . . 61.33 108.093 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.11 162.13 39.46 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.387 0.675 . . . . 65.34 110.849 -173.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 -0.2 55.33 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.926 0.73 . . . . 63.32 114.926 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.404 HD11 HG23 ' D' ' 86' ' ' ILE . 17.1 pt -134.03 141.21 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.879 0.872 . . . . 70.35 109.806 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.41 166.03 25.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.578 0.751 . . . . 74.54 110.873 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.75 -112.6 3.23 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.794 0.684 . . . . 74.13 114.018 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -72.57 -30.51 64.46 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.311 1.044 . . . . 74.21 111.353 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -67.05 -52.47 41.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 64.41 110.577 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.417 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 27.5 ptm -70.26 -29.91 66.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.818 -0.628 . . . . 64.14 110.545 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.48 77.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.895 0.478 . . . . 74.31 111.09 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -64.41 -43.01 95.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.329 0.652 . . . . 73.14 110.031 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.96 -49.36 77.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.884 0.473 . . . . 54.51 111.033 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' D' ' 94' ' ' MET . 88.2 mt -70.76 -22.32 62.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.637 0.775 . . . . 75.45 111.78 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.44 9.1 24.34 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.247 -0.752 . . . . 72.32 114.607 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.11 -75.77 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.021 0.91 . . . . 50.1 111.279 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -68.69 -50.91 47.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.276 0.843 . . . . 73.4 113.276 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.78 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 25.5 m -62.9 -46.32 87.5 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.743 -0.646 . . . . 64.22 111.849 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.593 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.2 Cg_exo -57.95 -33.93 97.74 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.47 2.113 . . . . 74.33 113.347 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.53 -29.68 69.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.462 0.705 . . . . 73.52 111.147 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.73 -38.6 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.492 0.663 . . . . 70.45 110.228 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 52.2 mt -81.55 -13.65 57.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.991 -1.004 . . . . 73.35 111.624 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.614 ' HZ ' HD22 ' D' ' 128' ' ' LEU . 56.9 t80 -69.04 -46.28 30.38 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.217 -0.897 . . . . 65.21 113.371 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 -32.42 90.88 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.085 1.857 . . . . 64.23 112.912 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.89 -35.39 38.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.767 0.827 . . . . 53.31 111.948 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.64 -51.91 63.12 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.111 0.564 . . . . 71.2 109.817 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -67.69 -34.24 76.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.15 -0.932 . . . . 73.41 111.552 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.94 -43.93 81.93 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.18 0.925 . . . . 75.0 110.159 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.7 t -57.53 -43.13 84.09 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 123.626 0.579 . . . . 25.04 109.929 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.783 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.2 mt -63.74 -46.1 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.188 -0.914 . . . . 71.42 110.749 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.41 HG21 ' HE2' ' B' ' 109' ' ' TYR . 94.0 m -55.76 -49.73 72.35 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.291 1.037 . . . . 53.51 110.527 -176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -65.3 -44.12 88.93 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 113.581 -1.645 . . . . 73.24 110.387 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.415 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 76.3 mtm -64.63 -35.92 82.57 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.894 0.478 . . . . 74.55 112.217 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.1 t -67.56 -44.77 86.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.441 0.696 . . . . 71.34 110.492 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.83 -25.73 62.1 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 122.478 0.311 . . . . 61.42 111.192 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -74.69 -34.81 62.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.641 0.777 . . . . 74.24 109.162 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 0.4 76.37 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 115.393 -0.821 . . . . 72.11 112.362 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.26 27.86 16.67 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 126.85 2.06 . . . . 72.12 112.907 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.557 ' HB2' HG13 ' D' ' 118' ' ' VAL . 37.3 m-85 -94.92 160.63 30.64 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.45 -1.25 . . . . 62.2 108.706 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -53.44 136.07 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 124.066 3.177 . . . . 53.3 113.571 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -55.0 128.06 31.84 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 124.303 1.002 . . . . 74.34 111.804 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.403 HD21 HG11 ' D' ' 64' ' ' VAL . 47.7 tp -117.15 95.63 5.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 74.01 110.805 -175.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -99.91 113.34 25.83 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.801 -1.185 . . . . 72.12 107.801 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.65 HD21 ' HG ' ' D' ' 42' ' ' LEU . 1.1 tt -74.57 124.66 27.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.768 -0.456 . . . . 71.12 109.768 -174.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -61.79 131.32 92.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.663 0.785 . . . . 74.25 110.99 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -77.78 127.4 8.68 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.65 2.233 . . . . 71.34 112.53 -170.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.37 112.5 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.451 0.643 . . . . 75.21 109.389 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -89.03 72.97 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.919 0.866 . . . . 55.14 109.413 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 CA--C 1.546 0.818 0 CA-C-N 114.789 -1.096 . . . . 73.22 110.866 178.233 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 108.103 -1.073 . . . . 63.14 108.103 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -139.79 119.44 13.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.359 0.663 . . . . 64.34 109.45 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -138.54 115.64 10.97 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.044 0.538 . . . . 72.0 110.103 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.475 HG13 ' HD2' ' A' ' 84' ' ' PHE . 2.9 mp -78.28 115.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.35 -1.352 . . . . 41.43 107.35 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -94.13 -44.41 8.02 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.601 0.36 . . . . 72.43 111.061 -171.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.566 ' HD3' HG21 ' B' ' 122' ' ' THR . 86.0 mtt180 -159.02 157.05 30.47 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.141 0.976 . . . . 75.44 110.228 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -144.63 101.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HD1' ' HB3' ' A' ' 15' ' ' ARG . 89.4 m-85 -159.87 177.66 10.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.943 1.297 . . . . 65.42 109.476 -165.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.411 HG21 ' SG ' ' A' ' 113' ' ' CYS . 73.2 p -90.84 135.58 33.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 122.241 -0.287 . . . . 64.2 110.735 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 42.4 mtpt -96.47 -48.64 5.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.178 -0.675 . . . . 75.21 109.178 168.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 27.8 t70 -133.26 137.23 45.96 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.271 -1.331 . . . . 74.12 109.28 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 79.4 mt -139.19 139.48 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 106.876 -1.527 . . . . 73.45 106.876 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -147.53 129.38 15.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.582 0.753 . . . . 51.32 109.458 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.575 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 81.7 t80 -142.1 125.06 16.16 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.076 -1.453 . . . . 74.21 107.076 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.78 116.45 14.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.029 -0.73 . . . . 70.42 109.029 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.64 82.99 48.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 108.878 -0.786 . . . . 74.34 108.878 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 -32.76 13.98 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.574 2.183 . . . . 62.14 111.294 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 72' ' ' THR . 80.5 m-20 -104.72 31.39 4.77 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.05 0.94 . . . . 74.25 109.859 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.93 98.26 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.991 0.916 . . . . 74.15 112.22 171.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -70.18 -14.97 35.36 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.962 1.775 . . . . 70.0 113.609 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 14.2 m170 -68.96 -46.59 67.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.758 -0.46 . . . . 71.33 109.758 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.8 -20.19 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.415 1.086 . . . . 73.43 112.153 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.22 -42.05 94.34 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.171 0.988 . . . . 65.04 111.107 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.95 -20.28 14.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.749 0.82 . . . . 72.12 111.652 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HD3' ' H ' ' A' ' 35' ' ' ASP . 3.9 tmtp? -83.79 163.37 20.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.261 1.024 . . . . 74.34 110.582 -171.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.634 ' H ' ' HD3' ' A' ' 34' ' ' LYS . 10.6 m-20 -63.69 143.53 57.76 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.207 1.003 . . . . 73.5 111.431 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -96.34 65.08 2.31 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.1 . . . . 73.23 110.609 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.44 77.38 9.72 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 109.558 -0.534 . . . . 70.34 109.558 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 7.6 Cg_endo -82.14 148.48 15.06 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.032 1.821 . . . . 64.13 111.037 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.23 99.87 12.04 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.768 -1.197 . . . . 64.04 107.768 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.458 HG22 HD13 ' A' ' 126' ' ' LEU . 26.8 t -76.69 95.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.138 -0.937 . . . . 73.33 109.946 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -79.87 131.9 35.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.148 0.979 . . . . 64.55 109.796 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.437 HD12 HG22 ' A' ' 64' ' ' VAL . 2.1 mm? -115.3 149.47 37.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.115 0.483 . . . . 72.24 110.789 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.6 m-20 -136.34 125.92 25.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.076 1.35 . . . . 70.42 107.611 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.4 mt -116.64 119.1 34.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.622 -0.881 . . . . 75.02 108.622 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -132.51 147.74 52.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.98 0.912 . . . . 71.31 109.979 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.4 m -142.84 128.67 19.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.428 0.691 . . . . 62.13 110.161 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.78 152.3 49.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.648 0.779 . . . . 44.31 109.395 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.5 m -127.2 167.34 16.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 42.41 109.597 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -168.25 122.06 0.9 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 122.978 0.174 . . . . 72.32 110.548 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -69.78 114.45 7.99 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.793 0.837 . . . . 64.21 110.905 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 57' ' ' GLU . 58.7 mt -83.54 -41.93 17.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.324 1.05 . . . . 51.24 110.955 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.12 178.78 7.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.549 1.14 . . . . 70.12 108.309 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.14 99.01 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.922 0.392 . . . . 42.01 110.151 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 1.4 m-20 69.53 29.89 4.19 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 113.803 -1.544 . . . . 74.4 111.696 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -114.8 121.73 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.132 -1.803 . . . . 63.41 106.132 164.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.488 ' CE2' ' HA ' ' A' ' 54' ' ' ASP . 4.0 m-85 -132.49 137.33 47.16 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.309 0.576 . . . . 72.11 109.616 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 51' ' ' LEU . 10.3 tt0 -87.09 114.14 23.44 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.283 -1.326 . . . . 75.2 108.645 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.39 110.16 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.05 -1.093 . . . . 54.15 108.05 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 97.4 t -98.45 137.79 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.523 0.729 . . . . 64.01 110.572 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.66 110.78 21.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.257 -1.386 . . . . 70.34 107.257 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -108.83 111.33 23.01 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.927 0.891 . . . . 75.21 109.386 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.1 t -110.71 128.79 66.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 123.578 0.751 . . . . 71.31 109.304 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.7 m -108.83 143.78 37.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.235 -0.654 . . . . 73.22 109.235 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.659 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.7 t -137.21 109.28 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.655 1.582 . . . . 73.2 107.759 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.4 m -114.81 119.49 36.81 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.651 -0.5 . . . . 74.24 109.651 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -103.28 107.33 18.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.738 -1.208 . . . . 25.24 107.738 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.0 m -129.79 128.63 42.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.917 0.487 . . . . 73.43 109.769 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.549 HD22 ' HE2' ' A' ' 34' ' ' LYS . 4.7 tt -101.44 85.49 2.79 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.162 -1.421 . . . . 55.31 107.162 172.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.86 2.19 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.204 -0.907 . . . . 73.41 111.756 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -88.16 -28.05 21.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.55 0.74 . . . . 64.42 110.779 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.46 125.5 35.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 71.55 110.212 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 23.1 m -88.02 114.92 25.11 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.95 -0.759 . . . . 73.14 108.95 169.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.89 -51.47 58.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.645 0.778 . . . . 72.04 109.347 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.483 ' HZ ' HD12 ' A' ' 126' ' ' LEU . 52.5 p90 -164.36 173.59 12.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.385 -1.28 . . . . 70.32 111.931 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.27 146.65 52.14 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.729 1.611 . . . . 72.02 107.921 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.659 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.5 m -141.92 138.99 32.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.165 0.986 . . . . 70.45 108.751 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -150.92 133.0 15.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.962 -0.755 . . . . 54.52 108.962 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 113' ' ' CYS . 47.0 t -131.53 115.62 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.458 0.703 . . . . 74.3 109.121 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 62.5 mt-30 -84.6 84.83 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.057 -1.09 . . . . 64.14 108.057 170.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -76.91 95.82 4.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.742 -1.117 . . . . 71.24 108.555 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.84 142.96 19.55 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.819 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -137.83 122.47 2.47 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.211 -1.556 . . . . 64.23 109.211 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -89.3 122.38 40.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HD2' HG13 ' A' ' 13' ' ' ILE . 29.3 m-85 -125.45 118.46 25.88 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.435 -2.061 . . . . 74.13 105.435 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -93.79 94.61 8.63 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.907 -1.146 . . . . 64.23 107.907 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -117.85 148.48 20.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 123.666 0.786 . . . . 73.25 110.136 -174.332 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -170.93 148.22 2.79 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.949 1.3 . . . . 75.34 109.351 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.44 6.64 62.53 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.167 0.292 . . . . 71.24 113.305 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.555 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.6 mp -127.33 136.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.116 -1.438 . . . . 72.24 107.116 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 175.58 11.19 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.312 0.505 . . . . 71.43 110.596 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 -152.14 48.15 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.262 -0.881 . . . . 70.53 112.767 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -65.48 -24.99 67.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.077 0.951 . . . . 43.14 112.429 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -59.65 -49.74 76.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.287 0.635 . . . . 73.14 109.969 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.555 ' SD ' ' HB ' ' A' ' 89' ' ' ILE . 2.5 tpt -80.86 -30.81 35.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.133 -0.939 . . . . 74.15 110.94 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -29.56 69.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.212 0.605 . . . . 52.53 110.842 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 36.6 t-80 -73.55 -36.96 65.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.988 -0.551 . . . . 75.25 110.522 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 53.3 t -76.78 -65.11 0.98 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.912 -0.131 . . . . 74.13 111.11 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.92 -29.27 70.46 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.954 0.502 . . . . 62.44 112.327 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.44 -22.77 36.17 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 114.333 0.493 . . . . 73.23 114.333 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -133.09 -49.85 0.87 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.534 0.667 . . . . 65.05 112.424 -170.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -71.84 -47.55 52.33 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.856 0.862 . . . . 74.21 111.742 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 73.9 m -67.32 -47.62 48.71 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.425 1.09 . . . . 74.11 112.675 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.26 -26.88 56.28 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.891 1.727 . . . . 72.12 112.825 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.72 -29.29 62.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.622 0.369 . . . . 74.42 110.436 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 49.7 mt -61.44 -47.04 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.752 0.821 . . . . 73.22 109.429 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -73.71 -20.4 60.54 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.698 -1.137 . . . . 61.41 112.053 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -64.65 -46.11 76.41 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 114.627 1.343 . . . . 64.11 114.627 -166.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.63 -35.13 98.91 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.932 1.754 . . . . 64.14 112.706 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -73.72 -36.46 65.22 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.369 -0.832 . . . . 73.33 111.609 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.17 -42.81 68.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.262 0.225 . . . . 74.1 110.453 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.435 HH22 ' HA ' ' A' ' 130' ' ' PRO . 38.2 ttm105 -52.13 -48.6 64.76 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.114 0.884 . . . . 61.11 110.289 175.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.36 -52.53 61.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.851 -1.068 . . . . 71.32 111.429 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.418 ' HB3' HG11 ' A' ' 78' ' ' VAL . 46.8 t -61.42 -29.21 69.8 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.908 0.755 . . . . 71.32 112.013 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.658 HG21 HG21 ' A' ' 64' ' ' VAL . 79.1 mt -71.68 -60.37 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.69 -0.686 . . . . 64.5 109.694 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -55.03 -30.31 59.29 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.548 1.139 . . . . 64.2 112.333 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 -44.49 72.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.69 -0.686 . . . . 70.13 109.992 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.9 mtm -61.11 -41.11 96.09 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.881 0.473 . . . . 52.23 110.58 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -58.23 -47.76 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.532 -1.213 . . . . 72.42 110.667 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -75.21 -26.95 59.35 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.894 -0.594 . . . . 75.23 111.411 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -71.71 -27.88 63.31 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.708 0.803 . . . . 74.12 109.852 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.65 3.78 77.2 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.494 -0.775 . . . . 45.34 112.642 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.3 m 68.06 14.6 9.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.943 1.297 . . . . 70.2 111.216 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -85.81 149.91 51.98 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.853 -0.795 . . . . 72.51 108.853 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.82 143.3 91.34 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.574 2.182 . . . . 71.11 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -61.48 132.69 54.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.685 0.394 . . . . 74.32 110.734 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.483 HD12 ' HZ ' ' A' ' 74' ' ' PHE . 63.8 mt -133.42 96.36 3.7 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.306 -0.998 . . . . 63.43 108.306 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -98.85 123.23 42.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.101 -0.5 . . . . 64.23 109.759 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.4 pt? -73.13 152.72 41.05 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.919 0.762 . . . . 74.03 110.576 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.62 147.85 68.82 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.37 1.068 . . . . 64.34 112.074 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' C' ' 13' ' ' ILE . 15.7 Cg_exo -68.59 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.404 2.07 . . . . 62.43 110.964 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.91 111.79 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.305 -0.998 . . . . 74.45 108.305 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.61 96.65 6.86 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.494 -0.928 . . . . 73.42 108.494 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -59.55 -23.41 62.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.472 -0.786 . . . . 75.01 110.258 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 19.0 t70 . . . . . 0 C--N 1.348 0.53 0 C-N-CA 123.997 0.919 . . . . 73.31 111.16 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 114.419 1.266 . . . . 72.54 114.419 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -140.34 122.22 15.51 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.248 -1.019 . . . . 71.44 108.248 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -123.95 141.0 52.43 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.321 -0.622 . . . . 75.44 109.321 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 59.8 tt0 -153.97 141.69 19.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.827 0.851 . . . . 71.45 109.161 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.674 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -94.41 117.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.39 -0.967 . . . . 71.34 108.39 175.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -87.04 -48.87 7.74 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.285 -0.416 . . . . 63.31 110.119 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -164.34 140.84 6.33 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.683 -0.488 . . . . 75.34 109.683 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -114.64 141.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.937 -1.505 . . . . 61.11 106.937 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -168.25 148.35 4.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.202 0.455 . . . . 73.14 111.825 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.2 m -74.24 126.82 31.46 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.071 -0.714 . . . . 73.12 109.071 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.2 mtpp -94.51 -41.0 9.58 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.385 -0.598 . . . . 64.01 109.385 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -139.62 141.46 37.09 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.771 -0.65 . . . . 74.14 110.533 -171.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.439 HD13 HG13 ' B' ' 78' ' ' VAL . 41.0 mm -135.81 143.09 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.161 1.384 . . . . 54.34 107.512 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 57.4 p -148.0 138.7 23.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.697 -0.853 . . . . 71.44 108.697 168.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 83.5 t80 -141.21 116.44 10.0 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 106.244 -1.761 . . . . 75.13 106.244 168.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.81 110.86 14.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.688 -1.597 . . . . 73.13 106.688 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -111.91 88.18 9.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.707 -0.849 . . . . 52.14 108.707 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.95 -26.59 51.28 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.007 2.472 . . . . 71.04 112.447 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -120.81 28.31 8.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.774 0.829 . . . . 72.22 110.054 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.531 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.94 -46.34 81.23 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 124.786 1.234 . . . . 54.24 113.669 171.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 84.1 Cg_endo -79.06 -15.15 13.14 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.717 1.611 . . . . 63.04 113.088 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -100.43 1.55 41.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.894 0.878 . . . . 72.13 112.899 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.46 -20.91 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.452 0.701 . . . . 62.0 111.786 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.06 -28.15 69.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 63.13 111.851 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -67.37 -46.64 72.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.663 -0.698 . . . . 74.45 109.587 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' B' ' 68' ' ' LEU . 79.2 mttt -111.86 74.83 0.88 Allowed 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.828 -1.078 . . . . 62.4 111.355 -171.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.94 82.75 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.162 -1.051 . . . . 61.24 108.162 167.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -153.78 165.61 35.49 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.37 -0.832 . . . . 63.55 109.041 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -77.99 120.67 82.15 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.804 -0.813 . . . . 64.21 108.804 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.401 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 98.7 Cg_endo -77.36 154.59 32.03 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.324 2.016 . . . . 64.32 112.068 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 22.1 mm-40 -64.75 115.4 5.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.02 -0.733 . . . . 74.33 109.02 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 p -83.8 122.32 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.607 -0.886 . . . . 72.44 108.607 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.568 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 93.4 mttt -126.44 100.38 6.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.604 -1.258 . . . . 62.02 107.604 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' B' ' 42' ' ' LEU . 1.5 pp -88.91 140.04 29.84 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.078 -0.965 . . . . 63.21 110.78 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.806 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.0 m-20 -136.8 145.47 44.56 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.473 -1.677 . . . . 62.01 106.473 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.39 161.54 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.903 -1.147 . . . . 74.14 107.903 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.8 t70 -159.16 143.22 15.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.192 -0.67 . . . . 73.14 109.192 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -107.34 109.67 21.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.931 -1.137 . . . . 70.32 107.931 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -113.91 154.52 27.4 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.121 -1.066 . . . . 50.14 108.121 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -143.78 162.7 35.36 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.356 0.598 . . . . 72.34 112.108 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -162.87 151.49 14.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.368 1.467 . . . . 52.33 108.4 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -123.14 127.3 48.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.13 -37.65 12.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.946 0.498 . . . . 73.34 110.047 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.93 -175.53 3.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.903 0.881 . . . . 71.45 110.758 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -72.98 124.47 25.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.963 -1.017 . . . . 74.54 108.631 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 68.69 11.95 8.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.072 1.349 . . . . 75.22 111.932 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.65 88.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.45 1.1 . . . . 52.11 108.171 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.498 ' HB2' HD11 ' B' ' 86' ' ' ILE . 3.5 t80 -97.85 166.21 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.101 -0.703 . . . . 62.24 109.101 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -140.3 100.1 3.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.097 -1.446 . . . . 72.51 107.097 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -95.8 137.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.985 0.514 . . . . 72.24 109.657 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 21.9 t -117.17 152.45 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.414 1.086 . . . . 71.35 109.131 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -127.89 119.65 26.05 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.158 -1.423 . . . . 75.54 107.158 176.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.5 ttt180 -105.45 106.37 16.84 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.042 -0.725 . . . . 73.14 109.042 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.42 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.2 t -106.33 111.91 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.329 -0.989 . . . . 71.25 108.329 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.806 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.0 m -106.05 125.94 51.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.357 -0.608 . . . . 54.42 109.357 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.404 HG23 HD13 ' B' ' 114' ' ' ILE . 82.7 t -120.32 99.46 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.209 1.003 . . . . 73.45 109.345 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 86.4 m -86.84 147.84 25.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.991 -1.004 . . . . 74.23 109.312 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.64 152.49 37.96 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.986 0.514 . . . . 51.11 110.287 175.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 41.1 p -147.01 128.83 15.31 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.301 0.376 . . . . 74.44 111.726 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 60.9 mt -91.42 100.65 13.39 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.222 -1.029 . . . . 72.34 108.222 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.51 -120.62 8.37 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.211 -0.904 . . . . 52.32 111.885 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.61 22.73 13.1 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.668 0.747 . . . . 73.22 110.145 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -137.1 144.49 43.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 74.45 109.298 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -68.87 136.86 53.3 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.751 0.31 . . . . 70.03 110.917 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.13 -65.29 1.03 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.411 -0.959 . . . . 51.32 108.411 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.27 166.78 29.86 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 114.658 -1.155 . . . . 72.53 110.018 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.2 mt -135.92 109.73 8.13 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.79 -1.559 . . . . 73.23 106.79 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -118.89 141.46 48.63 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.509 -0.923 . . . . 73.13 108.509 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -149.45 129.05 13.13 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.534 -0.913 . . . . 71.43 108.534 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.439 HG13 HD13 ' B' ' 21' ' ' ILE . 79.1 t -125.03 148.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 73.34 109.211 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 76.0 mt-30 -127.63 99.58 5.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 174.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -89.09 109.22 20.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.136 -0.938 . . . . 71.55 109.325 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.15 169.65 26.74 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 111.987 -0.445 . . . . 42.4 111.987 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.03 130.92 2.12 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.271 -0.731 . . . . 51.52 111.271 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.77 127.67 40.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -134.78 135.59 41.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.234 1.014 . . . . 63.32 109.282 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 6.6 m -88.57 121.51 31.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.115 0.966 . . . . 74.41 108.702 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pp -134.55 130.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.09 0.556 . . . . 63.43 110.545 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.99 153.09 33.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.672 0.789 . . . . 72.23 109.939 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.03 -53.84 4.51 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.641 0.588 . . . . 62.52 113.27 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.53 133.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.048 1.339 . . . . 72.3 111.526 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -150.58 176.0 11.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.58 0.752 . . . . 72.24 111.411 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.13 -136.76 35.21 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.066 -1.425 . . . . 64.44 113.199 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.5 m -65.59 -37.54 86.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.885 0.874 . . . . 71.1 111.079 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -65.26 -27.79 68.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.115 -1.402 . . . . 71.32 111.006 -172.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 -33.39 69.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.215 0.606 . . . . 62.4 110.604 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.35 70.49 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.189 0.596 . . . . 61.04 111.379 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -76.74 -23.02 53.01 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.332 0.653 . . . . 75.34 111.344 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.72 -64.97 1.0 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.736 0.414 . . . . 64.13 110.545 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 mt -80.05 -28.56 39.23 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.889 0.476 . . . . 73.24 111.766 -172.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.5 66.74 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-O 119.559 -0.578 . . . . 52.42 113.846 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 -57.05 0.34 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.87 0.835 . . . . 72.01 112.351 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.33 -47.56 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.268 0.627 . . . . 75.44 112.126 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -65.88 -46.38 65.15 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.641 -0.695 . . . . 71.22 111.377 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.457 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 94.6 Cg_exo -50.84 -38.67 57.92 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.491 2.127 . . . . 62.42 113.791 166.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -64.4 -29.73 70.79 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.243 0.46 . . . . 64.23 112.243 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.73 -42.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.724 -0.473 . . . . 63.22 109.724 172.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.19 -17.41 54.95 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.124 -0.944 . . . . 75.33 111.756 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.403 ' HZ ' ' HB3' ' B' ' 128' ' ' LEU . 65.1 t80 -61.97 -49.78 83.87 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.88 -1.057 . . . . 72.12 113.592 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.04 -39.38 70.06 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.44 2.093 . . . . 52.01 113.873 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.19 -46.57 49.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.642 -0.708 . . . . 74.31 111.114 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.44 78.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.616 0.766 . . . . 64.25 110.387 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -64.66 -50.8 65.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 75.03 110.549 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -34.68 78.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.162 0.585 . . . . 73.24 109.931 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.1 m -59.74 -52.83 63.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.751 0.82 . . . . 35.13 111.405 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 62' ' ' VAL . 69.2 mt -58.25 -56.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.661 0.785 . . . . 73.1 110.805 178.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -64.77 -31.94 73.39 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 124.154 0.909 . . . . 74.1 111.582 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.6 t -61.79 -50.4 72.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.01 0.524 . . . . 74.4 110.039 174.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.9 mmt -68.85 -34.09 74.89 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.4 0.68 . . . . 73.41 111.232 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.08 -43.16 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.843 0.857 . . . . 64.34 110.309 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 73.1 m -67.93 -30.34 69.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.367 -0.833 . . . . 71.13 111.995 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.524 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -68.38 -28.09 66.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.409 0.684 . . . . 74.51 110.927 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.78 17.09 59.88 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 114.334 0.494 . . . . 63.41 114.334 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.566 HG21 ' HD3' ' A' ' 15' ' ' ARG . 4.1 p 69.67 12.31 8.06 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.049 1.74 . . . . 73.03 113.233 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.84 144.56 30.42 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 109.162 -0.681 . . . . 72.25 109.162 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.58 146.29 54.34 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.944 2.43 . . . . 60.11 111.676 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.428 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 18.7 mp0 -64.48 114.43 4.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.514 0.509 . . . . 74.21 110.978 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.26 85.06 2.07 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.575 -1.269 . . . . 63.25 107.575 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -101.47 121.59 42.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.14 -1.391 . . . . 71.44 108.148 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.403 ' HB3' ' HZ ' ' B' ' 107' ' ' PHE . 0.2 OUTLIER -76.96 139.66 40.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.281 0.632 . . . . 61.12 109.548 -172.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 154.12 84.05 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 124.02 0.928 . . . . 51.33 111.047 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.13 92.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.252 2.635 . . . . 70.32 112.567 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.51 111.92 25.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.492 -0.776 . . . . 74.14 109.499 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.06 107.23 14.6 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.421 -0.955 . . . . 53.32 108.421 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -58.83 -37.19 75.88 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.363 1.04 . . . . 72.1 110.581 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.61 -52.74 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.872 -1.058 . . . . 73.43 110.724 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.02 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.87 0.731 . . . . 75.21 112.013 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 N--CA 1.471 0.624 0 O-C-N 124.193 0.933 . . . . 72.33 110.446 176.448 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.2 ttp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.038 0.447 . . . . 71.11 111.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.5 m -118.6 102.06 8.59 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.098 -1.445 . . . . 51.41 107.098 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -118.6 122.79 43.45 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.687 0.795 . . . . 71.14 109.242 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -137.28 136.19 37.81 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.513 -0.551 . . . . 71.44 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.605 HD11 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -68.55 123.45 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.04 -0.726 . . . . 52.41 109.04 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -103.25 -47.96 4.16 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.723 -0.671 . . . . 72.21 109.76 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -173.24 151.98 2.16 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.651 0.595 . . . . 73.14 110.407 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.605 HG13 HD11 ' C' ' 13' ' ' ILE . 89.6 mt -138.26 140.42 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.539 1.136 . . . . 62.32 108.354 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -172.02 158.53 4.72 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.762 0.791 . . . . 74.51 111.364 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.426 HG22 HE22 ' C' ' 80' ' ' GLN . 76.1 p -78.76 106.13 10.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.444 -1.253 . . . . 70.21 109.05 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 5.3 mmmm -66.85 -42.76 85.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.751 0.786 . . . . 61.0 109.638 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -144.53 141.47 29.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.502 -1.227 . . . . 72.31 109.341 -175.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.2 mt -135.82 146.2 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.182 -1.414 . . . . 43.44 107.182 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -154.82 149.27 26.25 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.229 0.538 . . . . 65.11 109.886 171.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -146.61 144.29 29.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.805 -1.089 . . . . 71.41 108.064 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -137.79 139.56 40.09 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.623 1.169 . . . . 74.13 107.89 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 79.29 66.25 Favored Pre-proline 0 C--O 1.241 0.652 0 N-CA-C 107.811 -1.181 . . . . 73.03 107.811 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.64 -22.04 64.89 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.641 2.227 . . . . 61.31 111.844 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 93.5 m-20 -125.91 47.24 2.27 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.448 1.099 . . . . 62.14 109.972 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -58.15 -54.96 50.29 Favored Pre-proline 0 CA--C 1.571 1.754 0 C-N-CA 124.279 1.031 . . . . 64.13 112.157 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 21.0 Cg_exo -66.85 -26.44 44.66 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 121.976 1.784 . . . . 43.23 112.74 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.648 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 21.2 m170 -66.39 -16.35 64.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.26 1.024 . . . . 71.44 113.304 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.627 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 7.9 p -48.59 -33.66 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 112.757 0.651 . . . . 73.54 112.757 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.413 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 92.6 m-85 -76.13 -30.53 58.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.473 0.709 . . . . 70.53 111.939 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -112.88 3.51 16.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.995 0.918 . . . . 74.35 112.866 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -89.97 172.73 8.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.425 0.557 . . . . 60.44 111.061 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.421 ' HB3' HD22 ' C' ' 68' ' ' LEU . 20.6 t70 -83.9 133.36 34.72 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.197 0.999 . . . . 75.1 110.451 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -75.31 78.26 2.4 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.705 0.802 . . . . 73.24 109.995 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.438 ' HB3' HD13 ' C' ' 68' ' ' LEU . 49.6 tt0 -164.48 78.49 1.44 Allowed Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.28 -1.378 . . . . 73.34 107.28 169.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.22 106.62 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.285 1.99 . . . . 70.25 111.885 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -84.29 92.14 7.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.372 -1.344 . . . . 61.52 107.372 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 89.3 t -84.71 110.54 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.904 -1.498 . . . . 74.31 109.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -93.05 115.68 28.34 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.323 -0.621 . . . . 74.33 109.323 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.39 126.7 34.56 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.06 -1.459 . . . . 74.43 107.06 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -120.32 132.93 55.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.414 -0.958 . . . . 73.23 108.414 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tt -134.35 117.83 16.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.392 -1.336 . . . . 71.32 107.392 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.61 149.9 52.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.962 1.305 . . . . 64.23 108.381 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -142.08 153.42 44.16 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.058 0.456 . . . . 75.32 110.032 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.96 178.35 10.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.654 1.182 . . . . 53.21 108.635 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -145.73 159.63 42.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.036 0.535 . . . . 74.44 110.333 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -145.65 126.91 14.82 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.912 0.885 . . . . 62.33 108.662 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.38 117.64 24.43 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.124 -0.695 . . . . 74.25 109.124 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' C' ' 57' ' ' GLU . 25.7 mt -100.93 -26.89 13.58 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.967 0.907 . . . . 73.45 110.48 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.03 -170.54 1.96 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.14 0.976 . . . . 41.32 109.918 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -69.7 101.7 1.73 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.564 -0.743 . . . . 73.23 109.606 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 74.82 6.92 4.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.538 1.535 . . . . 75.23 112.532 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.62 113.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.442 -0.947 . . . . 72.21 108.442 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.36 125.31 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.108 0.963 . . . . 74.0 109.307 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.72 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.2 tt0 -86.08 116.67 24.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.565 -0.902 . . . . 63.42 108.565 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.22 125.51 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.636 -1.246 . . . . 63.32 107.636 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.37 106.31 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.946 -1.131 . . . . 45.42 107.946 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.66 98.33 8.04 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.425 -0.954 . . . . 62.34 108.425 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -83.14 124.19 30.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.076 -0.966 . . . . 55.43 109.627 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.76 124.83 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.768 -1.197 . . . . 64.15 107.768 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -127.64 125.0 39.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 70.35 109.655 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.619 HG23 HD13 ' C' ' 114' ' ' ILE . 90.1 t -107.28 119.96 57.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.743 -0.836 . . . . 75.31 108.743 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.433 HG23 HD23 ' C' ' 75' ' ' LEU . 3.5 m -99.7 139.52 35.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.229 -1.397 . . . . 64.45 107.229 167.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.46 107.22 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.046 -1.464 . . . . 72.54 107.046 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 58.3 p -159.85 150.96 19.43 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.425 0.453 . . . . 73.4 111.29 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' C' ' 37' ' ' GLN . 66.0 tp -83.76 -48.17 10.39 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.701 -0.851 . . . . 63.53 108.701 165.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.56 -82.05 0.05 OUTLIER Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.553 -1.019 . . . . 52.24 110.553 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.95 -31.94 17.91 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.954 -0.758 . . . . 74.42 108.954 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.93 87.49 4.11 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.415 -0.957 . . . . 54.45 108.415 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.6 m -88.75 121.1 30.77 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.836 -0.62 . . . . 62.45 109.813 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.87 -61.73 1.9 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.923 -0.769 . . . . 74.42 108.923 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 74' ' ' PHE . . . . . 0.464 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 41.7 p90 -158.89 171.87 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.72 0.772 . . . . 63.1 112.112 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.433 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -137.28 135.45 37.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.235 -1.765 . . . . 72.43 106.235 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.9 t -137.98 136.76 37.26 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.279 -1.008 . . . . 54.15 108.279 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.2 120.96 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.868 0.467 . . . . 64.34 110.053 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.26 125.73 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.312 1.045 . . . . 52.43 109.585 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 1.7 mp0 -100.15 91.83 4.94 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.569 -1.271 . . . . 72.23 107.569 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.426 HE22 HG22 ' C' ' 18' ' ' THR . 8.4 tp-100 -82.12 100.13 9.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.015 -0.539 . . . . 73.41 109.59 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 145.54 22.99 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.918 -0.873 . . . . 60.14 110.918 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.521 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.63 121.49 1.39 Allowed Glycine 0 CA--C 1.5 -0.902 0 N-CA-C 111.281 -0.727 . . . . 52.43 111.281 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 18.3 mm -80.31 128.09 38.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 108.067 -1.086 . . . . 41.42 108.067 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.65 139.43 38.49 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.272 0.629 . . . . 63.42 109.483 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.7 p -91.73 104.7 17.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.188 -1.041 . . . . 73.15 108.188 170.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.45 100.18 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.15 -1.056 . . . . 73.01 108.15 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.22 161.47 31.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.999 0.92 . . . . 63.4 110.364 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.47 -18.39 33.79 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.365 0.506 . . . . 54.1 114.365 168.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.78 144.82 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.282 1.033 . . . . 74.11 110.218 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -146.12 149.74 34.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.929 0.491 . . . . 64.4 111.689 -167.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.03 24.72 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.383 -0.826 . . . . 34.04 113.486 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -64.22 -23.94 67.49 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.165 0.986 . . . . 53.31 111.46 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -58.26 -57.38 13.14 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.648 0.779 . . . . 70.0 110.23 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.441 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.8 ptt? -73.12 -25.91 61.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.451 -0.795 . . . . 63.04 110.956 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.43 78.59 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.595 0.56 . . . . 70.22 110.485 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -67.36 -30.94 70.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.528 -0.76 . . . . 74.12 111.064 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.07 -64.43 1.01 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 64.14 110.307 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.5 pp -73.79 -16.32 61.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.558 0.577 . . . . 70.13 112.558 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.44 -9.92 37.27 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 119.449 -0.64 . . . . 62.13 114.018 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.01 -52.56 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.967 0.884 . . . . 64.04 112.571 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -73.18 -51.55 17.41 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.906 0.482 . . . . 70.13 112.2 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.509 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.6 m -61.89 -47.12 92.24 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 123.413 0.685 . . . . 62.13 110.842 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.0 Cg_exo -53.1 -36.62 77.38 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.603 2.202 . . . . 72.32 114.513 168.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -63.3 -38.54 91.57 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.523 0.729 . . . . 73.44 110.974 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -39.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.443 0.697 . . . . 63.1 110.417 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.521 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.1 mt -80.67 -28.94 36.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.491 -0.777 . . . . 71.34 112.415 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -54.14 -47.12 98.23 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-O 118.012 -0.994 . . . . 54.04 113.603 -173.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.58 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.546 2.164 . . . . 73.15 114.155 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.56 -45.52 79.08 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.36 0.664 . . . . 74.03 110.504 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.04 82.67 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.224 -0.898 . . . . 75.31 110.826 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.55 -46.99 80.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.455 1.502 . . . . 75.55 110.355 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.78 -34.4 64.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.96 0.504 . . . . 64.03 110.118 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.8 t -66.42 -27.01 67.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.84 0.456 . . . . 63.22 111.017 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.619 HD13 HG23 ' C' ' 64' ' ' VAL . 77.0 mt -75.27 -54.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.922 -0.581 . . . . 42.43 109.916 171.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.8 m -62.35 -29.49 70.5 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.256 0.622 . . . . 74.41 111.696 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -67.01 -49.41 65.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.101 -0.703 . . . . 54.42 109.101 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.537 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.58 -35.18 77.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.13 0.972 . . . . 60.24 112.308 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.52 -47.5 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.42 0.688 . . . . 60.44 109.683 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.428 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 37.9 t -69.13 -27.04 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.155 -0.93 . . . . 73.41 111.211 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -71.34 -34.23 70.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 73.02 109.602 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.14 1.99 88.45 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.537 0.523 . . . . 72.21 112.494 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.8 p 60.15 35.79 21.11 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.591 1.956 . . . . 63.32 113.354 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.16 154.91 43.19 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.595 0.758 . . . . 72.5 109.817 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.91 169.75 8.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.345 2.696 . . . . 74.25 114.376 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -60.22 113.81 2.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.476 -1.238 . . . . 71.4 111.389 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.464 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 33.3 tp -134.88 115.12 13.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.791 0.836 . . . . 74.45 108.925 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -129.95 130.43 45.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.255 1.022 . . . . 70.42 108.404 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.2 140.45 40.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.731 0.412 . . . . 73.21 110.801 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.19 137.8 78.76 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.658 0.783 . . . . 51.1 110.675 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.67 107.86 1.54 Allowed 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.847 2.364 . . . . 71.23 112.211 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.43 110.93 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.326 -0.99 . . . . 65.1 108.326 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -103.24 89.2 3.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.524 0.73 . . . . 52.23 110.823 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -72.76 -31.85 65.21 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.771 0.796 . . . . 75.41 109.095 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 CA--C 1.541 0.612 0 CA-C-N 113.997 -1.456 . . . . 62.45 111.132 172.635 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.4 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 113.996 1.109 . . . . 71.41 113.996 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.3 m -138.46 122.08 17.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.06 0.944 . . . . 70.1 108.622 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -141.98 101.18 3.89 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.181 -1.044 . . . . 71.44 108.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -122.04 127.38 50.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.067 0.547 . . . . 63.12 110.086 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.37 112.21 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.983 -1.117 . . . . 75.03 107.983 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.97 -47.81 7.36 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 119.528 -0.273 . . . . 74.55 111.716 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.413 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 42.6 ttt85 -173.12 132.92 0.51 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.563 0.209 . . . . 63.03 111.563 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.3 134.45 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.513 -1.292 . . . . 74.5 107.513 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -162.83 177.83 8.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.893 0.854 . . . . 62.35 111.641 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.1 p -109.72 118.96 37.92 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.617 -1.174 . . . . 74.1 108.351 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 30.0 mtpt -85.46 -21.51 28.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.651 -0.5 . . . . 73.14 109.651 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.1 t70 -155.65 140.57 17.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.284 1.034 . . . . 72.32 108.657 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.537 HD12 ' HG3' ' C' ' 117' ' ' MET . 48.8 mt -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.521 -1.289 . . . . 75.41 107.521 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -153.24 140.38 19.4 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 123.748 0.655 . . . . 45.34 110.329 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.5 t80 -142.85 135.98 28.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.714 -1.587 . . . . 75.1 106.714 170.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.661 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -134.33 150.75 50.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.151 0.98 . . . . 41.23 108.538 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.63 77.69 10.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.82 -32.91 17.4 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.777 2.318 . . . . 75.24 113.545 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -114.75 41.7 2.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.935 0.894 . . . . 65.44 108.61 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.46 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -57.12 -56.28 35.32 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.64 1.348 . . . . 74.51 114.64 -169.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.45 -3.75 12.1 Favored 'Trans proline' 0 C--N 1.39 2.725 0 CA-C-N 122.11 1.789 . . . . 71.53 112.708 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -84.65 -42.73 15.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.382 1.073 . . . . 64.51 110.393 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.04 -10.17 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-O 121.18 0.514 . . . . 64.54 110.546 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.65 -36.88 77.29 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.918 -0.583 . . . . 74.13 110.262 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.51 110.594 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -98.93 70.59 1.84 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.011 -1.107 . . . . 72.53 108.011 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.71 88.8 0.99 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.33 1.062 . . . . 60.23 109.666 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.542 ' HB3' HD21 ' D' ' 68' ' ' LEU . 67.8 t-105 -160.46 170.63 20.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.398 -1.273 . . . . 71.13 108.468 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -71.75 110.09 6.96 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.937 1.295 . . . . 74.52 109.613 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.547 ' HA ' HD13 ' D' ' 68' ' ' LEU . 27.4 Cg_exo -65.66 141.9 68.35 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.227 2.618 . . . . 74.42 112.72 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.72 113.64 3.91 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.102 -0.703 . . . . 71.25 109.102 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.77 115.11 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.205 1.002 . . . . 61.43 110.593 -171.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -87.61 111.07 20.87 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 165.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.683 ' H ' HD23 ' D' ' 42' ' ' LEU . 2.0 pt? -96.76 148.2 23.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.451 -0.944 . . . . 64.54 108.451 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.4 t70 -151.38 151.94 32.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.775 0.43 . . . . 75.23 110.729 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.08 154.18 49.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.891 0.876 . . . . 73.51 109.97 170.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.3 t70 -152.36 137.58 17.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.426 1.091 . . . . 70.02 108.433 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -104.46 144.82 31.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 109.02 -0.733 . . . . 62.43 109.02 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.67 162.86 40.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.102 -1.073 . . . . 62.43 108.102 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.4 p -168.82 158.95 9.29 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.072 0.463 . . . . 73.42 111.916 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.7 p -152.11 119.58 6.01 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.685 1.194 . . . . 71.34 108.616 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.64 124.33 23.33 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.998 -0.742 . . . . 74.3 108.998 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 69.2 mt -87.96 -36.91 16.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.455 0.472 . . . . 72.21 109.925 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.99 -175.24 4.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.625 0.77 . . . . 61.22 111.061 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.97 124.51 20.98 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.938 -1.028 . . . . 70.12 109.141 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 19.0 m-20 66.54 -0.09 1.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.411 1.084 . . . . 74.14 113.112 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -116.05 118.06 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.051 0.94 . . . . 63.33 108.62 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.98 129.69 40.49 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.508 -0.923 . . . . 70.32 108.508 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.76 136.04 33.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.022 -1.103 . . . . 71.22 108.022 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' D' ' 102' ' ' CYS . 7.4 p -123.8 132.22 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.465 -0.939 . . . . 72.31 108.465 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 62.0 t -108.62 128.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 123.383 0.673 . . . . 70.31 109.199 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.58 114.89 27.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.945 -1.131 . . . . 74.41 107.945 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -97.14 133.09 42.25 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.645 -1.161 . . . . 73.02 108.623 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.73 120.2 44.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.523 -1.288 . . . . 62.21 107.523 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.6 m -116.95 137.41 52.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.563 0.745 . . . . 72.52 110.245 -172.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 75.3 t -125.41 117.73 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.621 1.168 . . . . 50.32 109.33 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 63.9 m -110.44 92.51 4.07 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.792 -1.188 . . . . 64.52 107.792 170.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.02 132.5 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.347 -0.612 . . . . 62.0 109.347 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.3 m -148.48 135.02 19.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.155 -1.054 . . . . 71.12 108.155 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' D' ' 38' ' ' PRO . 20.0 tp -113.83 124.9 53.35 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 117.789 0.268 . . . . 75.03 110.489 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.13 -110.66 3.17 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.722 -0.551 . . . . 62.14 111.722 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 4.31 9.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.589 0.756 . . . . 73.33 110.149 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.36 154.91 27.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.663 0.785 . . . . 45.31 109.435 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.0 m -74.62 141.28 44.68 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 110.045 -0.354 . . . . 64.42 110.045 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.416 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -97.7 -62.5 1.24 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.049 0.94 . . . . 74.33 109.421 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -158.17 138.23 12.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.373 -0.83 . . . . 75.44 109.235 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.661 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 92.3 mt -102.76 153.91 19.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.607 -0.886 . . . . 71.41 108.607 172.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.494 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 53.8 t -159.11 145.78 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.522 -0.547 . . . . 63.31 109.522 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -156.56 131.24 8.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.288 -1.005 . . . . 72.32 108.288 168.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -124.34 140.32 48.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.469 -0.937 . . . . 71.2 108.469 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -118.89 86.21 2.5 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.989 -1.115 . . . . 61.52 107.989 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.441 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.5 tp-100 -80.26 97.5 7.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.673 -1.603 . . . . 71.43 108.925 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.79 141.65 15.73 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.856 -0.498 . . . . 62.24 111.856 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 138.01 7.24 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.726 -0.55 . . . . 71.02 111.726 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.47 130.12 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.564 0.746 . . . . 60.35 109.064 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -132.67 142.48 49.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.564 0.746 . . . . 74.44 109.585 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -78.58 108.26 11.84 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.167 -1.049 . . . . 62.24 108.167 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 35.8 mm -106.7 100.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.093 -1.447 . . . . 72.53 107.093 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.706 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -144.88 158.24 43.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.136 -0.938 . . . . 74.1 109.709 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.52 -0.04 51.47 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.48 0.487 . . . . 63.3 113.75 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.22 128.67 68.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.918 1.287 . . . . 74.35 107.806 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 179.83 6.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.668 0.787 . . . . 52.54 111.245 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.1 -141.96 29.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.474 -0.785 . . . . 75.31 113.218 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 35.3 m -78.33 -18.94 54.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.599 0.76 . . . . 70.01 110.429 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -63.83 -46.4 85.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.347 0.659 . . . . 72.52 110.745 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -69.59 -26.7 64.59 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.405 0.441 . . . . 50.34 110.758 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.92 71.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.376 0.671 . . . . 74.33 110.947 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.79 -38.15 64.72 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.975 0.51 . . . . 70.13 110.737 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.91 -42.35 97.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.029 0.532 . . . . 53.11 110.953 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tt -78.49 -33.31 48.3 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.294 0.638 . . . . 62.11 109.613 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.43 58.97 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.138 -0.483 . . . . 74.22 114.281 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -52.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.493 0.647 . . . . 60.11 112.024 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -68.7 -43.7 75.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.658 0.614 . . . . 71.45 112.658 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.468 ' HB3' HG11 ' D' ' 58' ' ' VAL . 69.5 m -69.17 -43.05 23.7 Favored Pre-proline 0 CA--C 1.567 1.599 0 C-N-CA 122.943 0.497 . . . . 71.02 111.524 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.41 -34.48 89.28 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.765 2.31 . . . . 63.1 113.878 165.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -66.44 -26.52 67.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.708 0.803 . . . . 72.21 111.01 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.4 -41.23 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.62 0.724 . . . . 75.43 109.739 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.441 HD13 ' O ' ' D' ' 80' ' ' GLN . 94.4 mt -78.92 -14.41 59.24 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.688 -1.142 . . . . 63.13 111.836 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.414 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 55.7 t80 -61.98 -47.99 89.74 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.769 1.228 . . . . 73.54 113.745 -173.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 37.6 Cg_exo -59.98 -33.7 95.42 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 121.852 1.701 . . . . 71.44 112.682 175.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -76.18 -31.64 58.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 74.22 111.73 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.39 -56.26 19.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.076 0.55 . . . . 72.44 110.098 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -67.81 -32.42 72.95 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.508 -1.224 . . . . 74.22 110.787 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.29 -50.99 71.86 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.219 0.949 . . . . 73.44 110.155 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.5 t -58.61 -42.59 88.49 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.862 0.726 . . . . 74.25 110.867 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.421 HG12 ' SG ' ' D' ' 76' ' ' CYS . 73.8 mt -61.44 -52.53 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.342 0.657 . . . . 72.13 110.34 175.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.51 HG23 ' HG3' ' D' ' 125' ' ' GLN . 99.1 m -53.6 -47.33 70.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.553 1.141 . . . . 75.0 110.999 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.2 t -63.82 -42.05 97.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.5 -1.227 . . . . 73.32 110.322 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.8 mtm -69.61 -30.64 68.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.089 0.556 . . . . 64.23 111.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.3 t -74.02 -37.86 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.304 0.641 . . . . 61.13 110.514 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -74.05 -30.26 62.31 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 120.843 0.354 . . . . 73.33 110.497 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -72.25 -30.41 64.84 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.742 0.817 . . . . 74.4 109.606 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.93 4.21 81.04 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.481 -0.781 . . . . 52.13 112.599 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 81.4 p 60.6 34.19 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.238 1.815 . . . . 72.42 113.72 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.34 163.88 27.61 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 123.815 0.846 . . . . 75.1 112.13 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.47 125.3 5.92 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 124.375 3.383 . . . . 53.02 114.273 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.1 tt0 -55.04 130.36 41.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.656 1.182 . . . . 75.42 111.51 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.57 92.76 3.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.271 0.628 . . . . 50.2 109.596 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -100.86 113.49 26.48 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 14.7 tp -76.07 127.74 33.57 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.409 0.443 . . . . 74.45 109.831 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.77 138.96 82.46 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.555 0.742 . . . . 74.53 111.805 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.8 Cg_endo -75.43 96.29 1.03 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.298 1.999 . . . . 62.24 110.555 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.69 134.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.512 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -88.71 104.84 17.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.12 -1.067 . . . . 71.45 108.12 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 N--CA 1.478 0.974 0 C-N-CA 123.203 0.601 . . . . 72.21 110.984 -178.155 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 109.625 -0.509 . . . . 50.4 109.625 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -139.68 112.92 8.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.78 -1.193 . . . . 72.51 107.78 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -133.84 116.97 16.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.177 0.591 . . . . 72.12 109.77 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 16' ' ' ILE . 3.9 mp -77.66 115.32 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.264 -1.013 . . . . 74.43 108.264 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.06 -44.86 10.05 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.81 -0.441 . . . . 71.24 109.81 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -174.52 144.69 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.795 0.438 . . . . 72.21 110.616 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 13' ' ' ILE . 3.7 mp -117.87 123.7 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 64.32 107.725 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -152.51 148.22 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.597 0.713 . . . . 73.32 111.126 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -79.96 112.58 17.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.638 -1.165 . . . . 73.51 109.904 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -82.1 -21.65 36.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.589 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -153.04 141.44 20.68 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.312 -0.858 . . . . 72.24 109.947 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 71.4 mt -144.78 143.11 22.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.812 1.645 . . . . 74.31 106.779 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.6 t -158.4 124.58 4.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.423 0.452 . . . . 63.33 110.208 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 91.8 t80 -116.49 147.54 41.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.027 -1.471 . . . . 74.41 107.027 169.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -142.5 140.49 31.86 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.871 0.868 . . . . 62.02 109.543 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -152.14 68.14 7.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 106.685 -1.598 . . . . 54.11 106.685 170.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.02 -20.46 21.86 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.234 1.956 . . . . 75.01 110.948 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -105.86 16.12 25.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.37 1.068 . . . . 74.11 109.729 -179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.684 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -54.19 -45.49 99.14 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.166 1.173 . . . . 75.13 114.166 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -64.68 -26.93 60.71 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.93 1.753 . . . . 71.21 113.006 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -75.33 -33.5 61.14 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.781 0.832 . . . . 70.2 111.747 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG21 ' HE1' ' A' ' 123' ' ' PHE . 3.9 m -72.07 -23.62 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 122.923 0.489 . . . . 71.2 111.285 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -70.88 -31.37 68.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.794 -1.094 . . . . 52.43 110.232 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -76.53 -47.41 22.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.897 0.879 . . . . 73.24 110.381 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -82.65 167.1 18.58 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.5 -0.773 . . . . 65.5 111.928 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 116.21 6.34 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.778 -0.823 . . . . 63.34 108.778 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -84.88 63.98 8.37 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 122.583 1.182 . . . . 73.51 110.53 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -120.51 86.42 39.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 107.252 -1.388 . . . . 63.23 107.252 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.56 173.17 7.6 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.522 2.148 . . . . 73.43 113.154 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -96.6 124.36 40.56 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.5 90.17 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.499 -0.926 . . . . 74.11 108.499 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -96.39 127.91 42.83 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.016 -1.105 . . . . 74.02 108.016 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -134.21 145.97 49.69 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.064 -0.717 . . . . 75.31 109.064 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.74 148.5 39.1 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.023 -1.103 . . . . 75.5 108.023 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.8 147.58 40.98 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.197 -0.668 . . . . 72.14 109.197 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 11.6 t70 -154.11 137.28 15.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.966 0.906 . . . . 72.12 109.083 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -107.53 130.44 54.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.559 0.744 . . . . 62.1 109.634 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.74 150.6 52.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.184 0.994 . . . . 73.15 109.118 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -134.37 161.35 35.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.283 0.633 . . . . 73.45 110.816 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -152.29 152.75 32.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 63.42 108.753 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.38 123.43 48.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.146 -0.687 . . . . 63.33 109.146 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 57' ' ' GLU . 51.5 mt -101.81 -33.27 9.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.863 0.865 . . . . 64.11 110.725 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -165.57 -167.67 1.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.664 0.786 . . . . 74.44 110.64 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.16 99.37 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.215 1.006 . . . . 73.33 110.803 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 66.49 13.03 9.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.008 1.323 . . . . 72.44 112.303 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 56.5 t -99.54 111.04 28.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.541 -1.652 . . . . 71.32 106.541 167.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -119.79 168.84 10.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.526 -0.761 . . . . 72.44 109.167 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HB2' HD11 ' A' ' 51' ' ' LEU . 37.6 tt0 -132.51 134.53 45.12 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 125.065 1.346 . . . . 63.02 107.389 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.401 HG11 ' HD3' ' A' ' 103' ' ' PRO . 97.9 t -121.18 124.17 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 171.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.8 t -109.78 135.42 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.126 0.97 . . . . 43.03 109.338 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 121.28 44.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.681 -0.859 . . . . 75.22 108.681 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.23 105.09 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.472 0.709 . . . . 65.1 109.565 172.539 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.45 128.23 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.283 -1.006 . . . . 75.43 108.283 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -119.26 120.58 37.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.158 0.504 . . . . 73.5 109.832 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 114' ' ' ILE . 71.0 t -112.25 105.84 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.346 1.058 . . . . 71.11 108.549 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.9 m -110.83 138.23 47.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.063 -0.717 . . . . 63.51 109.063 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.13 127.75 40.4 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.024 -1.102 . . . . 72.24 108.024 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -141.36 125.62 17.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.891 0.477 . . . . 64.25 110.632 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.1 pt? -93.39 84.27 4.71 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.159 0.984 . . . . 72.44 108.369 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.41 -102.44 1.49 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.339 -1.301 . . . . 54.32 112.093 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -95.96 -24.26 16.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.56 0.744 . . . . 71.13 109.664 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -92.06 135.55 33.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.895 1.278 . . . . 52.3 109.482 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 80.9 m -77.93 133.01 38.14 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.72 -0.474 . . . . 65.14 109.72 170.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.8 -59.92 2.57 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.003 -0.74 . . . . 71.41 109.003 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -165.88 166.79 17.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.125 -1.398 . . . . 75.31 110.189 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.22 127.57 32.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.226 1.01 . . . . 60.3 108.697 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.543 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 57.1 m -119.27 137.72 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.993 0.917 . . . . 64.2 108.657 172.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.16 122.48 9.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.407 -0.96 . . . . 71.44 108.407 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.28 132.21 69.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.302 0.641 . . . . 73.04 109.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.733 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 48.7 mt-30 -96.98 90.57 5.24 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.427 -0.806 . . . . 74.14 109.428 166.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.8 95.49 6.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.725 -1.125 . . . . 52.31 108.34 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.37 161.33 26.29 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.188 -0.46 . . . . 71.24 112.092 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.44 140.67 7.37 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.835 -0.906 . . . . 41.21 110.835 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.7 mt -86.26 127.19 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 N-CA-C 108.635 -0.876 . . . . 62.15 108.635 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -133.19 118.13 18.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.374 -0.973 . . . . 72.53 108.374 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -88.0 100.56 13.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.777 -0.823 . . . . 75.53 108.777 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.5 pt -119.52 147.75 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.262 0.553 . . . . 71.15 111.428 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.53 164.69 6.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.978 1.711 . . . . 62.33 108.852 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.45 9.01 87.37 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.752 -0.471 . . . . 54.33 114.11 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -120.26 146.67 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.452 0.701 . . . . 71.42 109.94 176.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.16 170.78 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.318 0.647 . . . . 71.53 109.469 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.76 -125.55 37.25 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.776 0.672 . . . . 71.15 114.758 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -72.4 -37.94 68.56 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.884 0.874 . . . . 61.32 111.705 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.51 -35.06 78.2 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.114 0.566 . . . . 75.41 111.003 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 55.8 ttp -68.93 -45.73 70.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.952 0.901 . . . . 71.12 111.054 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.04 73.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.627 0.771 . . . . 74.44 111.478 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -66.05 -48.43 71.05 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.915 -1.039 . . . . 75.53 110.551 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 0.8 OUTLIER -68.81 -55.68 10.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.304 0.853 . . . . 74.32 113.304 -168.11 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.3 -25.67 55.06 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 122.113 -0.367 . . . . 73.25 111.382 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.07 -18.67 45.76 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 114.292 0.477 . . . . 70.04 114.292 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -135.98 -58.01 0.76 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.169 0.588 . . . . 71.41 111.638 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.672 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 1.4 t80 -54.88 -53.6 53.31 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.179 0.992 . . . . 74.32 113.065 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m -68.56 -49.58 29.53 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.616 -0.707 . . . . 72.03 112.684 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' HG11 ' A' ' 58' ' ' VAL . 38.3 Cg_endo -65.56 -15.41 49.4 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 121.637 1.558 . . . . 74.23 113.56 172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 35.3 t-20 -72.79 -35.74 67.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.469 -0.567 . . . . 73.54 109.469 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mm -65.75 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.471 0.709 . . . . 73.03 110.135 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.8 -24.26 60.89 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.102 -0.954 . . . . 64.33 111.557 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.14 -45.02 39.93 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 114.451 1.278 . . . . 73.42 114.451 -168.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.63 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 29.4 Cg_endo -62.83 -29.86 77.01 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 121.553 1.59 . . . . 71.14 112.511 174.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.518 ' HE2' ' HB3' ' C' ' 130' ' ' PRO . 11.6 m-85 -81.94 -26.23 34.19 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.882 0.473 . . . . 71.52 111.861 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.29 49.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.684 -0.858 . . . . 41.13 108.684 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.513 HH12 HD12 ' C' ' 105' ' ' ILE . 39.2 ttm180 -51.6 -48.15 63.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.026 -1.443 . . . . 73.23 110.913 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.48 -47.93 77.13 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.428 -0.806 . . . . 74.22 111.149 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.23 -32.95 73.68 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.401 0.681 . . . . 70.41 111.402 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.429 HG21 HG21 ' A' ' 64' ' ' VAL . 74.9 mt -71.71 -58.51 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.706 0.802 . . . . 71.23 110.139 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.403 HG23 ' HG3' ' A' ' 125' ' ' GLN . 88.0 m -56.23 -33.74 65.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.69 1.196 . . . . 74.04 111.955 -173.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -67.34 -44.0 80.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.341 -0.845 . . . . 52.41 110.583 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.0 mtm -65.17 -35.0 79.71 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.593 0.357 . . . . 72.14 111.253 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.65 -46.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.8 0.84 . . . . 71.51 110.286 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.4 p -74.25 -28.95 61.46 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.783 -0.644 . . . . 72.51 111.458 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -71.79 -29.79 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.453 0.701 . . . . 70.23 109.828 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.27 -0.18 85.78 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.627 -0.715 . . . . 71.5 112.685 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m 68.04 29.75 6.23 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.89 1.276 . . . . 54.24 110.8 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.611 ' HE1' HG21 ' A' ' 31' ' ' VAL . 83.2 m-85 -99.11 152.1 37.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 115.287 -0.87 . . . . 73.23 110.329 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.05 141.7 77.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.386 2.057 . . . . 72.5 111.353 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.3 tt0 -62.28 144.73 55.26 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.562 0.745 . . . . 72.24 112.312 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -146.48 103.01 3.64 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.336 -1.357 . . . . 55.34 107.336 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.17 119.11 37.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.419 0.688 . . . . 52.33 109.212 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.49 136.51 44.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.325 0.65 . . . . 71.41 110.404 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.21 138.36 86.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 45.32 111.36 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HB3' HH22 ' A' ' 111' ' ' ARG . 46.9 Cg_endo -77.84 112.24 3.25 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.981 1.788 . . . . 72.24 111.035 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.58 136.05 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.65 -0.87 . . . . 63.54 108.65 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.96 78.48 1.17 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.277 0.631 . . . . 74.33 110.771 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -77.02 -26.6 53.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.862 -1.063 . . . . 72.42 108.758 173.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 CA--C 1.546 0.806 0 CA-C-N 113.891 -1.504 . . . . 72.23 110.504 175.473 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 113.672 0.989 . . . . 52.41 113.672 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -160.49 143.08 13.07 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.499 -0.773 . . . . 73.22 109.877 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -132.43 113.36 13.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.832 -0.803 . . . . 75.02 108.832 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -125.78 140.11 52.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.256 1.022 . . . . 71.31 108.539 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.586 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.67 137.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.819 -0.808 . . . . 73.53 108.819 167.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -101.47 -51.58 3.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.726 0.41 . . . . 71.43 110.431 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -161.13 139.4 9.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.035 -0.357 . . . . 71.12 110.035 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.34 140.58 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 107.271 -1.381 . . . . 75.1 107.271 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -167.84 147.96 5.03 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.279 0.561 . . . . 72.15 112.151 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -74.34 119.36 18.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.923 -1.035 . . . . 64.42 108.724 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -93.92 -29.47 15.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.565 0.746 . . . . 72.23 111.807 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 29.4 t70 -160.2 142.72 13.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.625 0.25 . . . . 73.23 110.803 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.5 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 31.6 mm -143.83 145.57 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.837 1.255 . . . . 74.11 109.055 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -146.38 141.95 27.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.302 -1.369 . . . . 72.03 107.302 163.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.516 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -150.03 111.83 4.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.244 -1.761 . . . . 60.54 106.244 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -115.98 156.9 25.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.597 -0.89 . . . . 73.32 108.597 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -144.67 76.39 14.19 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 105.817 -1.92 . . . . 64.51 105.817 174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.02 -28.79 80.82 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.229 2.62 . . . . 74.54 113.212 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -124.48 29.31 6.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.855 . . . . 44.35 109.589 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -46.44 -53.39 24.19 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 115.162 1.541 . . . . 63.45 115.162 -172.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.83 -8.85 18.13 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.151 1.9 . . . . 74.31 113.433 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -97.75 -42.48 7.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.608 0.763 . . . . 71.25 110.65 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' B' ' 73' ' ' ALA . 61.8 t -73.69 -13.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.224 1.01 . . . . 63.53 110.181 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.73 -36.63 57.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.419 1.088 . . . . 73.51 111.342 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -70.6 -23.28 62.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.698 0.799 . . . . 72.4 112.488 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.98 111.24 20.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.688 0.795 . . . . 74.42 111.543 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.68 87.85 3.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.914 0.486 . . . . 54.53 109.904 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.684 ' HB3' HD21 ' B' ' 68' ' ' LEU . 29.9 t90 -154.36 157.31 38.39 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.016 -1.105 . . . . 75.04 108.016 174.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -67.1 116.87 40.47 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.368 0.667 . . . . 72.35 110.4 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.418 ' HG2' HD11 ' B' ' 126' ' ' LEU . 53.8 Cg_endo -67.87 127.53 16.31 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.057 1.838 . . . . 74.03 111.463 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.03 104.61 0.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.576 1.15 . . . . 73.24 109.848 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -91.65 136.01 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.314 0.578 . . . . 62.02 111.363 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -136.75 104.95 5.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.297 1.039 . . . . 63.15 108.572 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.498 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -86.49 167.85 14.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.193 0.597 . . . . 62.53 110.828 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 29.4 t70 -153.01 115.17 4.38 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.287 -0.869 . . . . 62.43 108.763 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.65 134.64 43.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.611 -0.885 . . . . 73.43 108.611 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.5 t70 -142.92 142.17 31.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.768 0.827 . . . . 64.4 109.612 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 42.7 p -118.55 116.19 26.14 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.411 -0.813 . . . . 71.23 109.76 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -114.81 152.31 32.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.135 -1.432 . . . . 71.3 107.135 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 62.3 m -143.53 169.96 16.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.019 0.438 . . . . 61.12 110.78 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -155.13 169.07 24.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.406 1.082 . . . . 22.31 108.679 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -125.1 128.03 47.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.713 0.805 . . . . 64.12 108.929 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -100.16 -22.65 15.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.429 0.691 . . . . 71.44 110.911 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.99 176.54 4.67 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.792 0.837 . . . . 74.35 110.207 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.69 122.26 13.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.702 -0.481 . . . . 63.44 109.702 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 72.37 -5.85 1.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.821 1.648 . . . . 64.21 112.705 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.4 t -103.78 100.84 11.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 N-CA-C 108.462 -0.94 . . . . 71.35 108.462 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.55 137.82 50.23 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.282 0.633 . . . . 73.33 109.699 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -110.29 97.39 6.87 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.349 -1.352 . . . . 74.42 107.349 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 57.8 t -95.97 123.55 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.363 0.665 . . . . 54.1 110.079 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 45.8 t -100.61 119.04 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.033 0.933 . . . . 74.31 110.108 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.16 114.19 26.27 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.219 -1.03 . . . . 73.43 108.219 177.373 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 29.3 ttm180 -99.51 117.62 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.932 0.396 . . . . 64.45 110.249 171.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -112.94 102.64 14.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.967 -1.123 . . . . 64.03 107.967 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 7.0 m -98.1 134.94 40.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.44 HG21 HG21 ' B' ' 114' ' ' ILE . 93.2 t -123.32 137.27 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.54 0.736 . . . . 70.11 109.941 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -121.33 146.44 46.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.213 1.005 . . . . 72.12 108.844 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -144.17 129.16 18.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.633 -0.877 . . . . 72.0 108.633 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -130.22 139.57 50.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.994 -0.743 . . . . 65.44 108.994 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' B' ' 36' ' ' TRP . 1.8 tt -124.99 105.98 9.61 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.964 -1.124 . . . . 72.24 107.964 -177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.28 -115.06 4.15 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.651 -0.704 . . . . 74.44 112.016 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -108.75 4.52 23.78 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.822 0.811 . . . . 73.24 111.509 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.86 169.5 17.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.934 0.494 . . . . 52.14 111.158 -173.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -73.62 133.11 43.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.51 -0.768 . . . . 70.14 110.26 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -85.44 -58.22 2.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.146 0.978 . . . . 74.22 108.378 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' PHE . . . . . 0.521 ' HZ ' HD12 ' B' ' 126' ' ' LEU . 45.4 p90 -164.3 161.51 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.548 -1.205 . . . . 73.13 110.246 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.73 152.12 47.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.08 1.352 . . . . 74.35 108.941 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.9 t -151.51 157.92 42.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.427 0.691 . . . . 41.04 109.408 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -165.77 128.48 2.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.76 -0.83 . . . . 73.44 108.76 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.4 ' HA ' HD13 ' B' ' 21' ' ' ILE . 65.7 t -126.17 143.6 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.044 -0.724 . . . . 64.24 109.044 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -124.75 102.36 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.531 -0.915 . . . . 54.13 108.531 172.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -94.04 100.66 12.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.132 -1.062 . . . . 71.0 108.132 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.66 144.18 16.93 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.452 -0.659 . . . . 55.33 111.452 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.48 127.47 3.64 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.694 -0.562 . . . . 74.54 111.694 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.16 125.99 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.33 -0.989 . . . . 71.32 108.33 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -131.43 161.44 32.46 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.363 1.065 . . . . 74.14 109.319 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -131.29 93.54 3.39 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.874 0.87 . . . . 73.43 108.725 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.526 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -117.33 139.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.999 0.92 . . . . 63.32 110.098 -176.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.91 168.82 26.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 60.45 109.792 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.55 -28.77 5.16 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 123.539 0.525 . . . . 32.42 113.513 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 pt -90.84 137.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.709 1.204 . . . . 65.32 110.552 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -149.31 149.8 31.48 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.022 0.929 . . . . 62.41 109.243 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.23 -118.78 9.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.704 -0.68 . . . . 74.3 113.367 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.3 m -65.22 -40.43 94.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.794 0.838 . . . . 70.25 110.339 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -63.06 -34.19 77.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.672 -1.149 . . . . 63.15 110.853 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.527 ' SD ' HD11 ' B' ' 98' ' ' LEU . 13.2 tmm? -79.94 -43.07 22.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.909 -1.041 . . . . 60.45 111.089 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.13 91.96 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.564 -0.744 . . . . 51.23 112.46 -168.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 3.0 p80 -82.82 -12.46 57.45 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.602 -0.272 . . . . 74.45 110.996 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -85.35 -68.68 0.71 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.614 -0.266 . . . . 73.11 110.355 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.527 HD11 ' SD ' ' B' ' 94' ' ' MET . 2.4 pp -85.07 -14.8 46.11 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.198 0.444 . . . . 52.13 112.198 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.2 -2.98 59.0 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.75 -0.472 . . . . 43.24 113.303 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -147.29 -60.86 0.28 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.274 0.537 . . . . 73.4 112.036 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.67 -43.52 89.06 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.914 0.485 . . . . 74.0 112.136 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.1 m -69.35 -44.72 26.95 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.198 0.599 . . . . 71.03 111.403 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.522 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 80.2 Cg_exo -53.3 -37.34 80.87 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.152 1.901 . . . . 73.53 113.731 164.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.35 -27.32 66.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.48 0.312 . . . . 72.23 111.798 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.53 -42.69 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.663 0.785 . . . . 44.31 110.009 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 mt -81.54 -15.63 54.25 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.791 -1.095 . . . . 71.43 111.243 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -60.17 -49.6 90.03 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 117.533 -1.223 . . . . 70.22 113.9 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.52 -32.21 96.01 Favored 'Trans proline' 0 C--N 1.38 2.202 0 CA-C-N 121.748 1.66 . . . . 61.13 112.913 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.38 -47.51 48.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.22 0.608 . . . . 75.24 110.413 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.46 86.72 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.635 -0.711 . . . . 73.1 110.294 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -58.97 -52.01 67.59 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.633 1.573 . . . . 63.25 111.313 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.32 -37.09 86.05 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.928 0.767 . . . . 74.31 110.313 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.8 t -65.79 -41.43 91.98 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 123.612 0.57 . . . . 74.13 111.49 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.44 HG21 HG21 ' B' ' 64' ' ' VAL . 72.6 mt -60.95 -53.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.449 0.7 . . . . 72.32 110.343 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -69.14 -24.1 64.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.762 -0.654 . . . . 73.11 111.403 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.8 t -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.09 0.556 . . . . 73.44 110.054 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -70.44 -32.04 69.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.485 0.314 . . . . 73.05 110.452 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.07 -35.76 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.836 0.854 . . . . 74.33 110.695 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 m -61.39 -46.51 89.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.267 0.627 . . . . 62.4 110.082 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -63.81 -36.5 84.09 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.738 -1.119 . . . . 74.02 111.189 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.9 -1.25 87.11 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.389 -0.673 . . . . 33.1 113.434 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 60.4 p 55.81 30.76 16.35 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.098 1.759 . . . . 65.23 112.598 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.38 162.87 38.51 Favored Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 124.565 1.146 . . . . 61.13 110.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.11 164.02 15.46 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 123.229 2.619 . . . . 74.34 113.649 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.6 OUTLIER -65.14 111.11 2.78 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.295 -0.866 . . . . 74.4 110.585 -172.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.521 HD12 ' HZ ' ' B' ' 74' ' ' PHE . 96.1 mt -135.05 83.58 2.03 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.779 -1.193 . . . . 74.44 107.779 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -101.07 122.61 43.87 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.362 -1.348 . . . . 71.42 107.362 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 33.6 tp -66.4 133.53 50.66 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.652 0.595 . . . . 72.45 111.034 -170.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.07 143.74 94.7 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.245 1.018 . . . . 71.1 111.67 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 87.24 0.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.911 2.407 . . . . 71.52 112.423 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 63.1 t -94.89 133.89 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.45 0.7 . . . . 72.22 110.526 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.96 113.74 26.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.33 1.052 . . . . 74.34 109.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.79 -29.4 67.76 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 63.34 111.916 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.6 -34.23 67.24 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.608 0.763 . . . . 63.35 110.763 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.78 -38.23 88.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.89 -0.595 . . . . 74.2 109.717 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 124.015 0.926 . . . . 74.41 109.69 176.269 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.0 ttp . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.255 0.55 . . . . 61.05 112.105 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -86.8 86.41 7.32 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.837 -0.801 . . . . 73.02 108.837 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.441 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 67.5 t80 -89.6 128.12 35.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.396 -0.594 . . . . 70.12 109.396 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.14 132.84 22.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.302 -0.629 . . . . 75.55 109.302 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.1 134.57 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.9 -0.778 . . . . 74.41 108.9 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -105.42 -51.44 3.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.523 0.329 . . . . 63.41 110.346 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -171.09 145.85 2.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.695 0.398 . . . . 73.42 109.934 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -124.05 138.45 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.116 -1.068 . . . . 44.11 108.116 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.681 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -170.94 146.18 2.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.547 0.339 . . . . 60.41 110.103 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -69.17 128.98 38.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.87 0.468 . . . . 73.44 110.448 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -84.48 -46.26 11.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.054 0.931 . . . . 72.21 108.869 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 8.0 t70 -134.79 136.95 42.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.175 -1.375 . . . . 74.31 109.325 -173.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -134.56 139.65 47.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.289 -1.374 . . . . 71.22 107.289 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.61 143.67 25.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.56 -0.745 . . . . 75.11 109.43 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -153.37 109.25 3.29 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.074 -1.084 . . . . 75.54 108.074 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.4 136.07 53.43 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.939 0.896 . . . . 74.33 109.106 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.78 91.7 10.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.46 -0.941 . . . . 62.41 108.46 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.95 -41.83 12.77 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 75.41 112.367 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 6.0 m120 -99.09 35.53 1.88 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.171 0.588 . . . . 74.13 109.687 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -59.55 -51.54 80.41 Favored Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 118.254 -0.879 . . . . 55.03 112.941 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 37.9 Cg_exo -64.79 -33.52 53.26 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 121.783 1.656 . . . . 75.51 112.351 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.522 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -66.58 -19.5 65.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.52 1.128 . . . . 64.43 112.41 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 3.2 p -58.5 -14.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 113.043 0.757 . . . . 64.34 113.043 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -55.41 -40.66 71.72 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.06 0.944 . . . . 75.11 111.341 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -114.74 40.25 2.64 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.432 1.093 . . . . 74.11 109.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.587 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 0.0 OUTLIER -83.61 144.13 29.65 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.975 0.91 . . . . 72.41 110.721 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -88.1 113.57 23.87 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.625 -1.25 . . . . 74.15 107.625 163.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -83.47 64.02 7.64 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.839 0.828 . . . . 71.42 110.161 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -142.44 52.58 2.47 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.977 1.311 . . . . 75.23 108.573 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.41 144.81 9.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.023 1.816 . . . . 54.25 111.697 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.25 95.92 8.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.54 -0.911 . . . . 72.44 108.54 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' C' ' 65' ' ' THR . 16.7 m -71.76 102.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.293 -0.867 . . . . 73.13 110.565 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.1 mttt -91.97 100.2 12.9 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.159 -1.052 . . . . 65.22 108.159 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.3 163.53 16.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.347 -0.612 . . . . 42.31 109.347 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.6 t70 -156.33 146.29 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.53 -0.915 . . . . 75.13 108.53 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -133.8 117.35 16.78 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 74.22 107.757 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.78 137.57 46.85 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.02 1.328 . . . . 75.43 107.861 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.8 t -113.11 149.82 32.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.428 0.633 . . . . 64.43 110.28 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.53 162.17 28.8 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.568 -1.196 . . . . 72.53 107.995 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -135.63 151.15 49.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.282 0.633 . . . . 53.54 109.7 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.4 t -149.91 125.99 10.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.098 -1.075 . . . . 71.34 108.098 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -83.63 120.52 26.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.184 -0.673 . . . . 74.21 109.184 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -92.79 -40.81 10.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.42 0.688 . . . . 63.01 109.842 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 175.3 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.832 -1.076 . . . . 64.32 109.339 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.67 123.74 18.34 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.542 0.526 . . . . 71.13 109.76 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 68.16 2.14 3.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.055 1.342 . . . . 73.12 113.554 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.76 112.35 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.46 -0.941 . . . . 54.42 108.46 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -125.05 122.51 37.44 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.513 0.673 . . . . 74.1 109.295 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.4 tt0 -85.46 138.36 32.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.161 -1.382 . . . . 75.13 108.303 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.552 HG23 HD11 ' C' ' 106' ' ' LEU . 17.5 m -130.25 143.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.975 -0.75 . . . . 75.32 108.975 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.67 105.12 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.312 -0.995 . . . . 73.02 108.312 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.8 tm? -92.54 104.39 16.7 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.168 -1.049 . . . . 74.22 108.168 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -79.07 124.07 27.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.386 1.074 . . . . 75.41 109.385 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' C' ' 114' ' ' ILE . 22.0 t -112.84 110.22 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.596 -1.261 . . . . 73.33 107.596 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.8 m -99.21 136.57 38.97 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.904 -1.147 . . . . 71.24 107.904 176.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 114' ' ' ILE . 64.9 t -135.94 113.16 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.135 0.974 . . . . 73.13 108.74 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 21.3 m -104.06 144.35 31.67 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.658 -0.867 . . . . 71.24 108.658 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.28 104.24 5.14 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.204 -1.036 . . . . 60.34 108.204 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.464 ' HB3' HG23 ' C' ' 72' ' ' THR . 56.5 p -159.91 169.16 24.1 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.113 0.565 . . . . 74.02 109.923 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -120.73 -40.82 2.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.954 -0.758 . . . . 72.3 108.954 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.36 -97.8 0.12 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 110.799 -0.92 . . . . 51.11 110.799 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -88.08 -27.86 21.69 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.645 -0.872 . . . . 61.54 108.645 170.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.33 87.92 1.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.356 -0.838 . . . . 75.13 109.334 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 67' ' ' SER . 64.6 m -88.03 136.68 32.86 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.44 -0.8 . . . . 74.21 109.476 171.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.39 -63.95 1.28 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.633 -0.877 . . . . 60.24 108.633 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.42 177.36 9.59 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.299 1.047 . . . . 75.12 111.96 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.3 tm? -135.31 143.75 46.35 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 105.009 -2.219 . . . . 63.52 105.009 168.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.9 t -149.49 144.15 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.106 -1.072 . . . . 61.52 108.106 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -158.85 131.24 6.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.557 -0.535 . . . . 74.52 109.557 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -126.98 120.75 56.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.975 -1.011 . . . . 74.42 108.725 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -99.15 90.39 4.57 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.807 -1.183 . . . . 74.13 107.807 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.96 108.86 13.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.261 -1.336 . . . . 63.21 109.511 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 158.69 29.71 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.977 -0.556 . . . . 34.55 112.266 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.22 126.23 1.56 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.365 -0.294 . . . . 42.42 112.365 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.527 HD12 HD11 ' C' ' 51' ' ' LEU . 12.2 mm -88.4 124.62 41.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.553 -0.906 . . . . 75.14 108.553 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.76 122.5 18.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.549 0.74 . . . . 63.42 109.674 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -90.36 110.44 21.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.965 0.506 . . . . 64.3 110.093 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.76 118.68 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 108.491 -0.929 . . . . 72.22 108.491 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.75 160.44 30.81 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.472 0.709 . . . . 70.04 111.531 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.87 -61.15 3.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.48 -0.782 . . . . 73.55 112.389 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.9 mm -91.02 145.71 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.007 0.923 . . . . 71.22 110.204 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 13.1 pt-20 -147.02 -171.31 3.74 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.3 1.04 . . . . 74.34 110.258 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 73.21 -143.34 32.95 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.171 -0.468 . . . . 72.4 113.316 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.9 p -66.84 -23.18 66.0 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.93 0.892 . . . . 73.33 111.914 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -71.06 -44.09 66.48 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.605 0.762 . . . . 63.12 110.994 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.495 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 21.6 ptt? -71.91 -32.96 67.89 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.447 -0.575 . . . . 65.24 109.447 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.15 -27.21 67.85 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.26 0.624 . . . . 44.15 110.989 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -73.42 -38.66 65.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.529 0.732 . . . . 75.0 110.411 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -67.97 -61.51 1.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.405 0.282 . . . . 73.51 111.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -76.3 -16.55 59.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.125 0.57 . . . . 74.22 112.142 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.96 -24.02 23.81 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.768 -0.462 . . . . 70.41 113.352 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.43 -59.05 1.1 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.393 0.596 . . . . 64.45 111.819 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -60.42 -57.27 13.46 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.74 0.816 . . . . 72.24 111.967 -172.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 47.4 m -62.05 -47.7 90.14 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 115.312 -0.858 . . . . 74.44 112.17 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.594 ' HB3' HD23 ' C' ' 60' ' ' LEU . 89.8 Cg_exo -54.03 -35.67 81.91 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.85 2.366 . . . . 75.55 114.594 169.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -21.16 60.1 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.09 0.556 . . . . 75.22 111.368 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.513 HD12 HH12 ' A' ' 111' ' ' ARG . 21.8 mm -77.48 -35.05 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.464 0.706 . . . . 75.23 109.945 171.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.552 HD11 HG23 ' C' ' 58' ' ' VAL . 98.8 mt -76.45 -38.77 54.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.222 0.609 . . . . 74.55 111.992 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.14 -41.35 74.15 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 124.359 1.063 . . . . 72.55 113.333 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.63 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 39.7 Cg_exo -43.9 -55.21 3.21 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.643 2.229 . . . . 75.14 115.883 168.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.19 -30.63 71.13 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.328 0.585 . . . . 72.24 110.343 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.6 73.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.093 -0.958 . . . . 71.13 111.274 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.481 ' HD3' ' CZ ' ' A' ' 109' ' ' TYR . 22.3 ttt180 -56.43 -51.76 67.18 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.492 0.717 . . . . 75.25 110.982 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.75 -31.32 69.23 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.451 0.47 . . . . 74.41 110.667 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.427 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 7.1 t -69.25 -28.11 66.03 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.664 0.386 . . . . 63.31 111.245 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.491 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.2 mt -79.17 -50.1 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.402 0.681 . . . . 74.02 110.141 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -65.55 -29.33 69.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.866 0.467 . . . . 61.53 111.353 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -63.98 -52.25 60.51 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.287 -0.634 . . . . 71.55 109.287 172.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.473 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.66 -40.69 75.93 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.629 1.172 . . . . 75.3 112.468 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 114' ' ' ILE . 78.6 t -65.75 -43.4 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.555 0.742 . . . . 74.14 110.383 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.418 ' HB2' HE22 ' C' ' 125' ' ' GLN . 37.9 t -69.6 -25.0 63.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.786 -0.643 . . . . 64.44 111.451 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.2 mtt-85 -72.03 -34.37 68.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.3 0.64 . . . . 74.24 109.994 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.67 6.34 74.15 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.618 0.574 . . . . 74.2 113.146 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.584 HG23 ' HB3' ' D' ' 17' ' ' TYR . 44.4 p 65.28 22.23 12.08 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.722 2.009 . . . . 73.45 113.268 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -84.52 162.12 51.77 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.84 0.856 . . . . 71.22 110.415 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.423 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 36.7 Cg_endo -64.06 151.05 86.98 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.657 2.238 . . . . 61.42 113.074 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.418 HE22 ' HB2' ' C' ' 119' ' ' SER . 24.4 mm-40 -60.26 112.36 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.965 0.906 . . . . 62.33 112.036 -172.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.61 90.35 3.28 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.346 0.658 . . . . 75.02 110.089 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.47 118.49 31.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.491 0.716 . . . . 74.34 109.937 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.458 ' O ' ' HD2' ' C' ' 111' ' ' ARG . 3.0 mm? -87.19 135.07 33.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.985 0.914 . . . . 73.01 109.233 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 141.86 87.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.451 0.7 . . . . 75.11 111.153 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HB3' ' HE2' ' A' ' 109' ' ' TYR . 38.5 Cg_endo -65.65 125.72 14.84 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.4 2.067 . . . . 63.0 111.302 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.43 114.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.526 -0.916 . . . . 71.13 108.526 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 132' ' ' ASN . . . . . 0.411 HD22 ' N ' ' C' ' 132' ' ' ASN . 0.8 OUTLIER -77.61 75.22 4.16 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.005 0.922 . . . . 72.22 109.958 -177.39 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.55 -43.61 18.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.733 0.413 . . . . 72.21 110.188 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 115.958 -0.565 . . . . 74.03 110.015 177.327 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.486 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 112.664 0.616 . . . . 44.21 112.664 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 32.7 m -115.36 143.08 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.782 0.433 . . . . 74.14 109.868 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.8 t80 -157.14 94.67 1.43 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.636 -1.246 . . . . 65.2 107.636 171.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -112.95 121.47 44.75 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.641 -0.709 . . . . 72.1 109.351 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.88 99.65 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 106.974 -1.491 . . . . 51.44 106.974 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -79.17 -46.92 16.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.682 -0.236 . . . . 73.1 110.915 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.496 ' HD3' HD12 ' D' ' 83' ' ' ILE . 43.4 ttt180 -169.04 131.66 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.213 -0.449 . . . . 61.04 111.964 -161.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.7 138.5 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.772 -1.195 . . . . 63.3 107.772 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' C' ' 122' ' ' THR . 10.1 p90 -164.76 177.3 8.07 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 121.872 0.844 . . . . 71.45 111.212 -176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -109.69 118.46 36.6 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.351 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.7 mtpt -88.57 -23.96 22.99 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.624 -0.51 . . . . 73.43 109.624 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.8 t70 -156.84 130.43 8.14 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.95 -1.023 . . . . 73.03 109.228 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.6 mt -128.09 135.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.261 1.024 . . . . 74.04 108.292 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -134.83 137.48 43.35 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.082 0.953 . . . . 70.13 108.473 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -149.5 120.55 7.72 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.318 -1.364 . . . . 72.43 107.318 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 1.8 mp0 -120.41 137.65 54.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.993 -0.743 . . . . 75.02 108.993 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.41 81.07 37.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.32 -0.993 . . . . 62.13 108.32 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.3 -44.1 0.33 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.753 2.302 . . . . 71.11 112.764 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' D' ' 72' ' ' THR . 81.4 m-20 -100.87 44.36 1.02 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.217 1.007 . . . . 64.34 108.637 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.681 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.74 -53.57 63.05 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 114.118 -1.401 . . . . 75.33 114.471 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.72 6.65 5.46 Favored 'Trans proline' 0 C--N 1.392 2.868 0 CA-C-N 121.972 1.74 . . . . 65.4 112.662 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.432 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 4.9 t-160 -85.06 -46.23 11.35 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.32 1.048 . . . . 65.24 109.323 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.88 -16.98 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.169 0.509 . . . . 72.11 110.699 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -56.54 -30.23 62.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.734 1.214 . . . . 75.14 111.854 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -82.7 -16.4 48.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.71 0.804 . . . . 72.03 111.056 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.612 ' HB3' HD23 ' D' ' 68' ' ' LEU . 85.7 mttt -109.53 112.41 24.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.005 0.922 . . . . 73.04 111.537 -173.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.91 71.65 1.67 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.812 0.845 . . . . 62.41 110.873 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -164.57 158.85 18.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.083 -0.71 . . . . 74.51 109.083 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -62.02 114.09 10.46 Favored Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.075 0.55 . . . . 54.24 111.436 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.614 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 43.6 Cg_exo -60.06 114.82 2.26 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 121.972 1.781 . . . . 64.42 109.647 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.31 121.66 10.69 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.207 0.942 . . . . 71.51 109.897 -174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -96.67 112.32 28.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.375 -0.829 . . . . 55.3 110.292 -168.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.599 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 63.0 tttt -87.07 142.02 28.23 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.922 -1.14 . . . . 72.03 107.922 167.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.39 139.88 49.12 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 9.2 t70 -141.9 149.1 39.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.725 -1.213 . . . . 74.42 107.725 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.29 166.32 24.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.053 0.541 . . . . 65.25 110.971 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.5 t70 -170.18 156.11 5.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.766 1.227 . . . . 70.33 108.033 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.1 t -135.08 161.18 36.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.061 0.545 . . . . 64.22 109.828 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.93 163.47 38.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.831 0.852 . . . . 62.31 109.076 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -148.93 153.48 38.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.138 0.575 . . . . 53.13 110.092 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -159.77 121.64 3.3 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.464 0.706 . . . . 52.45 109.366 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.5 124.88 26.11 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.134 -0.691 . . . . 71.43 109.134 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.6 mt -94.08 -33.69 13.28 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.799 0.44 . . . . 73.32 110.423 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.46 -172.02 2.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.002 -0.999 . . . . 73.12 110.595 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.1 116.42 6.48 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.804 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 10.1 m-20 63.32 19.29 11.6 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 73.24 112.068 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -119.53 120.5 63.71 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -130.4 129.38 42.99 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.881 -0.785 . . . . 65.22 108.881 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' D' ' 51' ' ' LEU . 10.3 tm-20 -100.8 137.45 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.801 -1.185 . . . . 74.35 107.801 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.525 HG11 ' HB3' ' D' ' 102' ' ' CYS . 4.2 p -127.17 134.17 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.673 -0.862 . . . . 75.53 108.673 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 80.3 t -106.08 131.08 56.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.153 0.581 . . . . 44.12 109.756 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -107.38 120.97 43.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.808 -1.553 . . . . 65.21 106.808 174.224 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.6 ttm-85 -105.39 107.36 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.711 -0.848 . . . . 73.22 108.711 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.4 t -107.44 124.29 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.052 0.941 . . . . 64.32 108.662 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 8.8 m -125.04 130.66 52.76 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.235 0.614 . . . . 72.34 110.124 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.64 107.45 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.382 1.073 . . . . 74.03 109.104 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.0 m -103.19 96.92 7.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.262 0.625 . . . . 73.44 109.583 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.18 124.73 41.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.972 -0.751 . . . . 72.43 108.972 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 69.5 m -147.31 130.48 16.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.673 0.789 . . . . 53.23 109.419 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' D' ' 34' ' ' LYS . 35.7 tp -116.81 121.8 42.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.355 -0.609 . . . . 43.22 109.355 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 -113.66 4.24 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.576 -0.609 . . . . 64.34 111.576 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.29 2.42 8.48 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.318 0.647 . . . . 63.45 110.944 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -115.46 150.96 35.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.045 0.538 . . . . 71.1 110.618 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 94.3 m -69.45 120.68 15.61 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 114.586 -1.188 . . . . 71.44 110.205 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.4 -59.64 2.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 122.941 0.496 . . . . 74.34 109.664 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.31 152.61 26.22 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.394 -0.821 . . . . 72.45 110.454 172.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -124.29 153.34 41.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.562 1.145 . . . . 75.31 109.823 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -158.31 146.17 18.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.64 -0.709 . . . . 72.0 110.356 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.88 132.11 11.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.8 -0.815 . . . . 72.41 108.8 172.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.59 124.24 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 122.744 0.418 . . . . 74.05 109.994 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.593 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 40.5 mt-30 -88.97 85.09 6.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.767 -0.827 . . . . 73.33 108.767 166.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.83 96.79 6.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.203 -1.362 . . . . 74.41 108.593 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.06 155.95 24.0 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.302 -0.408 . . . . 52.2 112.179 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.567 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -153.21 133.77 4.15 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.645 0.223 . . . . 71.21 112.683 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.496 HD12 ' HD3' ' D' ' 15' ' ' ARG . 68.5 mt -89.24 126.0 42.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 C-N-CA 124.067 0.947 . . . . 70.45 109.502 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.96 138.44 46.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.411 0.685 . . . . 75.02 109.835 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.9 m -91.66 100.15 12.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.472 0.709 . . . . 75.13 109.502 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.1 116.69 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.638 0.775 . . . . 55.03 110.384 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -147.67 162.5 39.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.228 1.011 . . . . 52.11 110.801 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.49 -20.19 6.36 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 114.879 0.712 . . . . 71.33 114.879 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -114.51 157.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.054 0.942 . . . . 72.23 110.493 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.24 -174.55 4.99 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.692 0.797 . . . . 63.44 110.84 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.67 -133.85 51.48 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.717 0.636 . . . . 74.03 113.711 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -73.9 -22.54 59.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.307 0.643 . . . . 73.53 110.722 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.34 -41.06 73.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.806 0.842 . . . . 72.4 111.041 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -75.12 -30.43 60.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.995 -0.372 . . . . 60.31 109.995 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.4 63.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.241 0.616 . . . . 64.53 110.949 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -79.45 -44.13 21.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.898 0.879 . . . . 73.22 110.693 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.8 t -66.5 -48.91 68.29 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.173 -0.467 . . . . 54.24 110.92 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.01 -39.5 25.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.693 0.797 . . . . 64.33 109.812 -176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -27.58 35.66 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.69 -0.505 . . . . 74.42 114.251 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.88 -53.2 2.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.852 0.826 . . . . 61.2 111.391 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -74.09 -44.97 52.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.546 0.573 . . . . 64.53 112.546 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.525 ' HB3' HG11 ' D' ' 58' ' ' VAL . 72.4 m -63.48 -46.48 84.02 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.417 -0.801 . . . . 63.34 112.499 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 31.9 Cg_exo -64.23 -30.07 64.36 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 122.12 1.88 . . . . 70.32 112.862 171.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.84 -31.36 71.92 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.334 0.654 . . . . 74.0 110.363 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -69.95 -42.83 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.501 0.721 . . . . 75.21 109.974 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.567 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -74.42 -18.47 60.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.87 -0.605 . . . . 71.44 111.72 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -68.26 -42.76 31.14 Favored Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 114.314 1.227 . . . . 73.23 114.314 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.66 -32.1 96.12 Favored 'Trans proline' 0 C--N 1.383 2.358 0 CA-C-N 121.627 1.617 . . . . 71.44 112.871 171.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -81.45 -30.06 33.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.386 0.674 . . . . 73.0 110.995 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.49 -53.98 43.62 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.641 -0.874 . . . . 72.3 108.641 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.12 -50.09 65.19 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 113.91 -1.495 . . . . 73.42 110.981 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.92 -44.17 93.72 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.924 0.765 . . . . 53.11 111.661 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 -41.47 86.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.567 0.542 . . . . 54.05 110.761 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.511 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.0 mt -66.26 -53.81 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.093 -0.958 . . . . 63.3 110.21 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.515 HG23 ' HG3' ' D' ' 125' ' ' GLN . 37.5 m -54.46 -38.35 66.29 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.771 1.228 . . . . 53.11 111.765 -176.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -70.19 -46.23 65.03 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.356 -0.838 . . . . 53.42 110.805 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.4 mtm -63.42 -33.07 74.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.782 0.433 . . . . 75.42 111.74 176.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' D' ' 123' ' ' PHE . 39.6 t -68.2 -40.66 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.922 -1.035 . . . . 60.13 110.225 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -76.08 -22.91 55.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.263 0.225 . . . . 65.04 111.335 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.427 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 85.1 mtt-85 -76.85 -33.08 57.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.503 0.721 . . . . 74.33 109.487 173.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 0.84 88.49 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 115.43 -0.804 . . . . 65.14 112.079 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 61.54 17.86 8.91 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.921 2.088 . . . . 71.31 113.417 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.52 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 30.1 m-85 -82.94 168.97 19.37 Favored Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.615 1.566 . . . . 75.4 110.634 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 52.5 Cg_endo -64.17 135.7 48.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.007 2.471 . . . . 60.22 113.135 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.515 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.2 tt0 -55.21 131.5 45.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.895 0.878 . . . . 64.32 111.778 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.88 97.62 7.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.92 0.888 . . . . 64.24 108.722 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -97.44 86.9 3.98 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.336 -0.987 . . . . 74.51 108.336 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.58 123.3 18.45 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.806 -1.088 . . . . 74.21 109.489 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.73 131.66 86.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 O-C-N 123.727 0.642 . . . . 75.23 110.768 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.37 115.36 3.3 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 121.966 1.777 . . . . 61.23 111.329 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.45 108.93 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.31 -0.626 . . . . 70.24 109.31 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -84.99 103.74 14.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.297 -0.865 . . . . 61.12 109.046 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.477 0.909 0 CA-C-N 115.393 -0.821 . . . . 75.02 111.173 -179.43 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 109.24 -0.652 . . . . 72.42 109.24 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' HG22 ' A' ' 86' ' ' ILE . 49.0 m-85 -136.35 112.14 9.48 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.291 -1.374 . . . . 75.04 107.291 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -132.77 134.44 44.72 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.042 0.537 . . . . 65.22 110.702 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.25 97.09 5.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 106.448 -1.686 . . . . 73.31 106.448 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -72.83 -40.2 65.97 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.216 0.606 . . . . 71.32 109.912 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -165.31 140.93 5.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.745 -0.835 . . . . 73.42 108.745 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.13 137.96 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.646 -0.872 . . . . 65.13 108.646 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -171.69 170.97 5.44 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.808 0.693 . . . . 72.01 111.195 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -91.06 117.95 30.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.446 -0.797 . . . . 71.35 109.213 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 34.4 mtpt -80.54 -28.84 37.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 110.04 -0.356 . . . . 63.1 110.04 172.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.3 t70 -149.13 142.16 24.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.582 -0.735 . . . . 62.42 110.301 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG23 ' SD ' ' A' ' 117' ' ' MET . 59.0 mt -134.66 136.18 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.29 -1.374 . . . . 74.52 107.29 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -142.98 129.7 20.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.461 -0.94 . . . . 72.35 108.461 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 89.3 t80 -144.36 122.53 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.375 -1.343 . . . . 63.4 107.375 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.63 143.69 51.14 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.148 -0.686 . . . . 72.4 109.148 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.22 73.98 63.05 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.503 -1.295 . . . . 64.2 107.503 171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.42 -32.03 20.84 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.588 2.192 . . . . 74.15 111.204 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' VAL . 86.5 m-20 -103.92 30.6 5.03 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.699 -1.137 . . . . 75.13 109.768 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -55.71 -46.53 99.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.578 -0.725 . . . . 61.22 112.7 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 38.4 Cg_exo -61.46 -28.28 83.43 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 121.828 1.686 . . . . 71.25 112.98 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -74.21 -32.92 63.22 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 116.038 -0.528 . . . . 71.21 110.448 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 27' ' ' ASN . 55.1 t -63.51 -27.54 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.511 0.596 . . . . 55.34 111.659 -176.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -71.09 -39.66 72.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.417 0.687 . . . . 75.31 111.591 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.77 -38.29 14.79 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.383 0.673 . . . . 71.31 111.125 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HB3' HD11 ' A' ' 68' ' ' LEU . 13.6 mmmm -82.03 157.81 24.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 62.44 109.243 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.43 ' O ' HD13 ' A' ' 68' ' ' LEU . 22.6 m-20 -71.77 118.03 14.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.762 0.425 . . . . 75.5 110.572 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -75.66 76.96 2.65 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.484 1.135 . . . . 75.02 110.374 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -136.99 82.67 30.15 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.182 -1.414 . . . . 74.43 107.182 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -87.11 155.8 8.35 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.53 2.153 . . . . 65.04 113.049 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.3 124.04 41.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.716 -1.216 . . . . 72.21 107.716 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 92.52 2.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 109.129 -0.693 . . . . 73.44 109.129 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.3 tttt -87.29 139.43 30.57 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.66 -1.237 . . . . 74.11 107.66 169.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 pt? -139.1 151.23 46.54 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.056 0.542 . . . . 74.04 109.959 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -131.15 136.08 48.01 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.421 0.688 . . . . 70.34 109.767 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.0 tp -103.91 128.78 51.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.057 0.943 . . . . 65.43 109.495 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 14.7 t70 -146.23 139.32 25.74 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.878 -0.786 . . . . 75.31 108.878 170.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.1 m -144.89 134.18 22.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.301 1.041 . . . . 74.52 109.124 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.501 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -159.66 133.09 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.635 0.374 . . . . 64.54 110.238 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 58' ' ' VAL . 59.9 p -91.38 177.06 6.34 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.29 0.636 . . . . 73.54 110.828 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 t -166.61 116.76 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.195 -0.669 . . . . 62.22 109.195 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -69.62 104.91 2.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.407 0.442 . . . . 75.42 109.968 -173.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 57' ' ' GLU . 49.7 mt -78.69 -37.27 42.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.659 0.784 . . . . 43.14 111.086 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.86 -173.5 4.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.648 0.779 . . . . 72.53 109.532 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.71 97.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.325 0.65 . . . . 75.14 111.166 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 6.0 m-20 60.1 31.01 20.41 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.47 1.108 . . . . 61.05 112.173 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.26 120.63 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.009 -1.478 . . . . 74.43 107.009 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.83 130.49 41.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.503 -0.925 . . . . 72.53 108.503 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.3 tt0 -86.13 117.98 25.3 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.86 -0.793 . . . . 72.43 108.86 171.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 48' ' ' SER . 47.2 t -98.73 118.64 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 107.406 -1.331 . . . . 73.13 107.406 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.513 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 36.2 t -102.45 131.47 50.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.4 -0.593 . . . . 54.44 109.4 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.59 115.1 29.76 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.197 -1.408 . . . . 75.32 107.197 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.666 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -89.89 100.88 13.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.002 -1.481 . . . . 74.41 107.002 172.295 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.53 124.36 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.14 -1.059 . . . . 65.24 108.14 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 13.5 m -112.22 138.9 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.413 -0.958 . . . . 44.12 108.413 172.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.1 t -133.63 107.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.893 1.277 . . . . 75.13 107.673 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 43.4 m -103.66 136.89 42.51 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.961 -0.755 . . . . 65.21 108.961 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.79 23.67 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.406 0.682 . . . . 73.51 109.364 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.3 m -143.22 142.73 31.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.421 0.688 . . . . 71.02 110.36 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.07 78.73 2.11 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 169.076 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.43 -99.31 1.08 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.647 -0.706 . . . . 73.54 112.287 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.41 -28.24 21.04 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.644 0.778 . . . . 74.24 110.834 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.561 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 5.4 tp10 -94.73 132.18 39.76 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.273 -0.64 . . . . 72.15 109.273 -174.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -82.4 130.82 35.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.203 -0.665 . . . . 73.4 109.203 170.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.92 -59.93 2.54 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.447 -0.945 . . . . 60.44 108.447 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -168.51 174.92 6.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.675 -1.148 . . . . 72.25 110.779 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 tp -132.12 144.87 51.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.551 1.141 . . . . 54.12 109.277 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.588 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.2 m -137.99 140.14 40.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.385 1.074 . . . . 64.24 109.477 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -149.32 130.32 14.38 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.46 -0.57 . . . . 71.13 109.46 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.18 110.79 18.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.689 0.796 . . . . 72.33 108.922 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -86.75 85.17 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.085 -0.962 . . . . 72.32 108.887 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD22 ' A' ' 106' ' ' LEU . 60.7 tp60 -79.08 96.52 5.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.478 -1.237 . . . . 74.13 108.728 -177.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.14 142.86 16.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.333 -0.707 . . . . 75.43 111.333 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.14 126.4 3.35 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 110.411 -1.076 . . . . 65.54 110.411 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.79 129.8 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -134.41 121.09 20.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.517 0.727 . . . . 74.11 109.928 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -91.06 95.99 10.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.481 -0.933 . . . . 75.24 108.481 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 11' ' ' PHE . 26.1 pt -130.04 131.88 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.793 0.837 . . . . 73.21 110.354 -171.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -168.99 176.9 5.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.39 0.676 . . . . 65.2 111.44 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.57 31.07 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.088 -0.96 . . . . 71.54 112.399 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.09 172.33 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 124.216 1.007 . . . . 74.13 110.159 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.3 tt0 -154.73 -169.14 3.12 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.69 -0.855 . . . . 64.51 108.69 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.552 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.2 -130.68 24.39 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 120.129 -0.262 . . . . 64.21 112.971 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -66.96 -32.85 74.37 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.857 0.863 . . . . 73.34 111.395 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.63 -39.66 80.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.776 0.83 . . . . 73.33 110.823 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.0 tpp -72.7 -41.78 64.91 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.354 0.409 . . . . 74.23 110.441 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.54 66.46 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 72.22 111.279 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -79.88 -37.71 34.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.51 0.724 . . . . 63.44 111.054 172.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HG ' ' HD2' ' A' ' 11' ' ' PHE . 53.9 t -63.03 -57.44 10.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.651 0.38 . . . . 74.32 111.955 -174.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' HA ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -95.18 -10.3 30.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.398 0.518 . . . . 64.21 112.398 -177.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.5 -21.26 15.12 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.156 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.43 -64.59 1.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.591 0.756 . . . . 73.32 110.257 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 97' ' ' CYS . 75.8 t80 -60.21 -53.12 61.53 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.166 0.986 . . . . 73.43 112.725 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 98' ' ' LEU . 84.4 m -60.21 -52.26 74.45 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.165 -0.921 . . . . 55.23 112.735 -176.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.86 -24.09 40.58 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.816 1.677 . . . . 71.05 113.233 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -73.61 -28.76 61.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.944 0.498 . . . . 72.15 110.605 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -68.84 -42.41 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.389 0.676 . . . . 74.13 109.418 168.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD21 ' HA3' ' A' ' 82' ' ' GLY . 88.7 mt -71.61 -25.96 62.38 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.962 -1.017 . . . . 71.32 111.768 -176.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -67.24 -44.61 48.66 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.81 -1.091 . . . . 72.51 113.823 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 20.6 Cg_endo -62.66 -33.27 77.82 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 121.875 1.717 . . . . 74.12 112.647 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -75.14 -34.36 61.62 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.181 0.592 . . . . 73.55 111.875 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.87 65.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.355 -0.609 . . . . 70.22 109.355 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.483 HH12 HD12 ' C' ' 105' ' ' ILE . 34.7 ttm180 -51.96 -51.68 55.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.121 1.368 . . . . 75.25 110.684 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.17 -48.48 81.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.253 0.971 . . . . 73.05 111.211 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.477 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.9 t -56.84 -45.76 82.17 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.297 0.998 . . . . 71.42 110.92 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.3 mt -63.59 -52.4 58.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 124.084 0.865 . . . . 72.3 110.551 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 125' ' ' GLN . 71.5 m -53.82 -43.77 69.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.816 0.847 . . . . 64.34 111.112 -176.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.38 -42.99 82.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.652 -1.158 . . . . 51.3 110.365 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.472 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mtp -56.5 -46.19 80.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.736 0.814 . . . . 55.15 111.25 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.1 t -60.99 -47.47 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.699 -1.137 . . . . 74.44 110.989 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -71.82 -26.57 62.45 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.995 -0.548 . . . . 71.41 111.246 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 40.0 mtt180 -72.88 -30.38 63.92 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.489 0.716 . . . . 73.11 110.017 172.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.04 0.48 78.87 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.564 -0.743 . . . . 22.13 112.543 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 66.89 37.85 3.87 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.804 1.242 . . . . 75.32 110.109 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -113.69 153.7 45.86 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.893 -1.048 . . . . 64.24 109.299 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.98 132.97 52.75 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.009 2.472 . . . . 74.42 112.189 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.52 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.7 pt20 -61.99 147.4 47.17 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.867 0.73 . . . . 64.2 111.262 -172.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -117.8 95.44 4.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.05 0.54 . . . . 75.55 109.555 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -100.76 97.24 7.9 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.699 -0.852 . . . . 71.4 108.699 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -73.39 136.99 44.4 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.659 -0.867 . . . . 72.2 108.659 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.68 148.48 91.07 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.039 0.535 . . . . 73.22 111.753 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -77.9 119.48 4.75 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.906 1.737 . . . . 74.41 111.458 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.81 111.52 31.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.519 -1.289 . . . . 71.41 107.519 170.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -86.99 93.0 9.23 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.253 0.621 . . . . 63.01 109.593 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -61.96 -27.92 69.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.42 -0.809 . . . . 61.41 108.859 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--N 1.352 0.686 0 CA-C-N 115.076 -0.965 . . . . 75.25 111.592 173.225 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.428 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 21.8 ptm . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 114.528 1.307 . . . . 72.21 114.528 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -152.78 125.64 8.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.763 1.225 . . . . 70.52 107.742 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -135.72 135.52 40.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.686 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 55.3 tt0 -150.42 142.33 23.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.809 0.844 . . . . 60.5 109.192 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.5 115.05 32.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.485 -1.302 . . . . 64.41 107.485 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -79.79 -48.31 13.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.933 -0.395 . . . . 72.11 109.933 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -167.74 136.32 2.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.743 -0.662 . . . . 73.01 109.747 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.1 mt -114.67 140.99 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.051 -1.463 . . . . 74.11 107.051 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -165.96 146.73 6.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.528 0.68 . . . . 74.2 111.077 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.615 HG21 HD11 ' B' ' 21' ' ' ILE . 40.6 m -77.44 117.07 18.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.108 -0.951 . . . . 71.44 109.078 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -86.92 -27.64 23.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.318 0.647 . . . . 72.52 110.82 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 21.1 t70 -150.9 139.68 20.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.272 -0.422 . . . . 73.51 111.097 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.615 HD11 HG21 ' B' ' 18' ' ' THR . 33.7 mm -128.66 143.5 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.126 1.37 . . . . 74.45 108.142 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.3 t -141.03 142.93 34.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.099 -1.075 . . . . 71.15 108.099 169.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -157.8 120.04 3.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.656 -1.609 . . . . 71.22 106.656 171.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.05 146.69 49.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.304 -0.628 . . . . 73.51 109.304 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -146.69 79.84 10.07 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.046 -1.094 . . . . 63.14 108.046 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.6 -25.46 20.87 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.067 2.511 . . . . 72.14 112.793 -172.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -116.66 19.39 14.57 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.872 0.869 . . . . 63.3 109.793 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.634 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -47.49 -52.69 35.14 Favored Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 115.313 1.597 . . . . 61.42 115.313 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.28 -11.42 19.21 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 121.839 1.693 . . . . 64.35 112.725 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -97.89 -26.24 14.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.657 0.783 . . . . 74.21 111.728 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.459 ' HB ' HD12 ' B' ' 68' ' ' LEU . 34.7 m -82.24 0.49 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.459 0.304 . . . . 73.11 111.176 175.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.99 -42.61 99.33 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.339 1.056 . . . . 72.32 110.892 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.25 -13.89 48.42 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.114 0.566 . . . . 74.53 111.479 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -83.95 78.69 9.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.386 0.674 . . . . 63.25 110.06 -170.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.91 102.59 5.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.791 -0.818 . . . . 53.12 108.791 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -159.56 162.6 35.42 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 73.45 108.059 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.49 109.19 29.88 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.546 -0.74 . . . . 73.34 109.032 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' B' ' 67' ' ' SER . 32.2 Cg_exo -56.15 131.03 43.42 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.648 2.232 . . . . 74.31 113.408 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.25 102.51 2.13 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 107.741 -1.207 . . . . 71.21 107.741 167.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' B' ' 65' ' ' THR . 23.7 m -97.6 146.35 7.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.2 -0.909 . . . . 52.04 110.765 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.84 118.87 19.49 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.514 -1.291 . . . . 71.43 107.514 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.422 ' HG ' HD12 ' B' ' 128' ' ' LEU . 2.4 tt -96.28 123.55 39.95 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.024 -1.843 . . . . 64.44 106.024 171.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.5 t70 -124.8 129.95 51.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.875 -0.787 . . . . 54.04 108.875 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.17 125.82 53.87 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.193 -1.04 . . . . 65.33 108.193 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.82 133.07 35.51 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -118.78 121.77 40.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.23 0.612 . . . . 63.12 111.21 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.38 160.93 19.83 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.799 1.24 . . . . 45.05 108.582 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 61.3 p -143.35 163.92 31.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 122.892 0.477 . . . . 71.13 110.3 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 159.32 43.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.485 1.114 . . . . 65.33 108.86 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -125.54 119.76 29.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.442 0.697 . . . . 73.05 109.133 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.2 -36.75 26.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.178 0.591 . . . . 73.22 110.566 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.33 -177.6 5.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.107 0.963 . . . . 52.34 109.915 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -66.1 118.58 10.05 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.597 -0.729 . . . . 74.02 110.105 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 71.67 3.17 4.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.524 1.53 . . . . 71.5 112.151 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.93 87.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.758 1.223 . . . . 73.52 108.329 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.445 ' CD1' HD11 ' B' ' 86' ' ' ILE . 12.2 m-85 -98.84 147.0 25.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.1 0.56 . . . . 75.54 109.587 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -131.79 100.31 5.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.016 -1.105 . . . . 72.35 108.016 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 29.8 m -94.22 138.1 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.858 -0.423 . . . . 53.3 109.858 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.08 114.11 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.631 0.773 . . . . 53.41 109.756 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.51 129.55 39.68 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.409 -1.33 . . . . 73.32 107.409 176.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -122.04 112.32 18.1 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.808 0.843 . . . . 75.15 109.157 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.05 125.77 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.619 -0.882 . . . . 70.22 108.619 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.2 m -117.91 146.85 43.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.215 0.531 . . . . 74.24 109.577 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.661 HG21 HG21 ' B' ' 114' ' ' ILE . 42.9 t -132.6 132.69 59.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.443 1.497 . . . . 54.22 108.723 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 100.0 m -126.13 143.74 51.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.924 -0.769 . . . . 70.41 108.924 169.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' B' ' 38' ' ' PRO . . . -135.54 140.25 44.57 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.743 -1.206 . . . . 73.11 107.743 171.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' B' ' 38' ' ' PRO . 17.1 m -129.51 128.83 43.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.795 0.438 . . . . 54.02 110.048 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.459 HD12 ' HB ' ' B' ' 31' ' ' VAL . 31.3 mt -114.69 102.25 9.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.499 -0.926 . . . . 73.34 108.499 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.99 -131.61 10.52 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.586 -0.734 . . . . 51.11 111.896 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -95.33 8.3 43.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.206 0.602 . . . . 73.3 110.632 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -135.81 166.52 23.09 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.645 0.778 . . . . 74.4 111.288 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -71.33 125.68 27.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.283 -0.871 . . . . 54.13 110.911 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' B' ' 31' ' ' VAL . . . -73.55 -62.86 1.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.527 0.731 . . . . 63.01 109.095 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -160.84 165.56 30.01 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 74.24 110.726 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.21 154.92 46.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.732 1.613 . . . . 55.42 108.366 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.0 t -160.76 132.09 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.199 -0.667 . . . . 52.43 109.199 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.436 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.4 tt0 -141.82 123.65 15.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.351 -0.981 . . . . 73.13 108.351 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -122.57 143.76 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.508 -0.553 . . . . 72.22 109.508 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.7 mt-30 -121.97 103.18 8.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.306 -0.861 . . . . 75.42 109.175 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.06 103.53 16.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.562 -0.745 . . . . 52.45 109.129 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.9 143.56 16.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.141 -0.784 . . . . 64.11 111.141 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.23 126.53 3.23 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 112.002 -0.439 . . . . 61.12 112.002 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 12.8 mt -85.85 131.83 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.557 -0.905 . . . . 74.44 108.557 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -138.06 137.16 37.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.977 0.911 . . . . 72.23 109.574 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.686 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 23.4 m -88.89 113.28 24.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.567 -0.901 . . . . 52.11 108.567 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.563 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -121.66 138.33 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.127 0.571 . . . . 71.41 110.411 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.02 163.36 37.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.011 0.924 . . . . 50.43 109.277 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.48 -48.25 3.93 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 122.663 0.173 . . . . 62.23 112.905 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -61.06 153.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.256 1.023 . . . . 53.23 111.857 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.423 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 0.3 OUTLIER -167.1 165.29 15.69 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.882 0.873 . . . . 53.44 110.149 176.352 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -119.68 19.3 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.44 0.462 . . . . 54.45 113.491 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.6 m -69.38 -31.67 70.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.93 0.892 . . . . 70.14 111.124 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.521 ' HB3' HG22 ' B' ' 89' ' ' ILE . 93.7 mt-30 -62.89 -52.57 62.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.446 0.699 . . . . 70.22 110.382 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.511 ' SD ' HD13 ' B' ' 89' ' ' ILE . 3.4 tpt -62.99 -45.14 93.8 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.456 -0.793 . . . . 65.11 110.628 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.47 78.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.372 0.669 . . . . 65.21 111.693 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -76.77 -33.13 58.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.324 0.649 . . . . 72.03 110.387 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -65.23 -52.4 54.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.136 0.575 . . . . 73.44 110.881 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.84 -20.36 31.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.877 0.471 . . . . 75.24 111.804 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -31.77 16.48 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.347 0.404 . . . . 52.2 113.258 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.05 1.82 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.916 0.487 . . . . 64.24 111.484 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -76.28 -41.93 47.19 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.187 0.81 . . . . 64.15 113.187 -168.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.407 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.3 m -63.76 -45.94 82.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 118.688 -0.672 . . . . 64.11 110.913 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 70.3 Cg_exo -56.57 -37.14 98.07 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.974 1.782 . . . . 64.35 113.514 166.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.36 -35.43 79.11 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.971 0.508 . . . . 73.33 111.416 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -66.13 -49.51 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.757 0.823 . . . . 64.33 110.162 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.34 -16.33 52.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.112 -0.949 . . . . 62.51 112.409 -168.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.56 -46.96 68.8 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 117.48 -1.248 . . . . 75.33 113.075 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.7 Cg_endo -58.6 -36.78 96.83 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.153 1.902 . . . . 53.31 112.688 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' B' ' 113' ' ' CYS . 74.7 m-85 -65.68 -49.42 68.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.399 0.68 . . . . 73.44 110.732 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -35.37 80.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.672 0.789 . . . . 64.31 110.96 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.735 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.0 ttp180 -59.78 -65.13 0.73 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.348 1.059 . . . . 74.22 110.479 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.15 -20.93 64.93 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.96 -1.018 . . . . 75.32 110.619 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.9 t -67.12 -49.62 64.26 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.709 -0.478 . . . . 72.43 109.709 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.661 HG21 HG21 ' B' ' 64' ' ' VAL . 91.4 mt -58.96 -54.44 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 123.731 0.645 . . . . 73.12 110.267 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.469 HG22 ' NE2' ' B' ' 125' ' ' GLN . 8.5 m -61.31 -29.17 69.71 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.105 0.962 . . . . 75.02 111.523 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -77.01 -35.36 57.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.447 0.699 . . . . 42.11 111.118 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.1 mmt -68.01 -30.86 70.21 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.893 0.378 . . . . 72.43 110.26 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.77 -39.23 83.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.97 0.908 . . . . 64.32 109.952 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.2 m -64.26 -32.46 74.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.523 0.729 . . . . 75.0 111.617 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.477 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.3 mtt-85 -71.32 -35.21 71.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.415 -0.811 . . . . 62.55 110.112 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.0 3.05 82.05 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.903 0.752 . . . . 55.01 112.951 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p 56.84 24.03 8.76 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.082 1.753 . . . . 71.35 112.649 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.05 156.09 42.5 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 65.42 110.137 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.2 140.58 93.22 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.052 2.501 . . . . 71.15 111.807 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.469 ' NE2' HG22 ' B' ' 115' ' ' THR . 14.7 mm100 -63.95 122.65 17.0 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.778 0.831 . . . . 75.44 112.493 -170.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -110.16 97.22 6.75 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.065 -1.457 . . . . 70.33 107.065 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -91.36 135.67 33.65 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.479 -0.782 . . . . 72.43 108.975 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.735 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -82.31 115.18 21.25 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.746 -0.835 . . . . 75.05 108.746 -173.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 137.92 88.47 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 124.404 1.065 . . . . 33.02 110.9 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.509 ' HG3' HD11 ' D' ' 16' ' ' ILE . 60.1 Cg_endo -66.6 99.05 0.42 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.739 2.293 . . . . 74.32 111.026 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.0 120.45 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.077 -1.083 . . . . 73.01 108.077 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.31 88.63 0.46 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.901 0.88 . . . . 74.44 110.515 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -52.92 -36.71 59.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.285 1.034 . . . . 75.23 112.221 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.22 -42.61 99.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.587 1.155 . . . . 73.03 111.892 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.92 -35.24 59.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.295 0.638 . . . . 71.14 110.597 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 123.614 0.766 . . . . 75.53 110.412 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.7 ttm . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.286 0.565 . . . . 74.25 112.246 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 21.7 m -84.84 92.78 8.35 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.321 -0.992 . . . . 71.32 108.321 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -116.41 125.85 52.61 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -151.76 134.24 15.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.207 0.603 . . . . 72.53 109.41 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.408 HG12 ' HE2' ' C' ' 84' ' ' PHE . 41.1 mt -74.81 109.0 7.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.555 -0.906 . . . . 70.22 108.555 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -85.88 -41.24 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.266 0.626 . . . . 72.13 111.175 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -170.77 142.95 2.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.957 -0.757 . . . . 63.22 108.957 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.0 mt -131.76 133.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.829 -0.804 . . . . 70.43 108.829 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.505 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 19.4 p90 -173.06 153.03 2.44 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.41 0.624 . . . . 64.31 111.509 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -74.76 125.09 28.0 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.954 -1.021 . . . . 73.43 109.782 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -77.64 -47.68 18.66 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.565 -1.272 . . . . 73.45 107.565 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -132.34 143.48 49.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.125 -1.398 . . . . 53.32 110.231 -171.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.2 mt -142.35 142.68 27.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.659 1.583 . . . . 73.45 106.767 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.48 148.71 21.66 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.163 0.506 . . . . 64.25 109.904 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -150.28 115.08 5.29 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.245 -1.391 . . . . 64.34 107.245 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -116.42 111.1 19.54 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.605 -0.517 . . . . 64.32 109.605 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.53 78.86 54.94 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 60.13 108.641 167.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.28 -28.61 39.76 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.045 1.83 . . . . 70.51 109.341 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 30' ' ' HIS . 2.2 m-20 -92.99 27.25 2.48 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.115 -1.402 . . . . 71.41 110.443 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.48 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.73 -50.17 89.44 Favored Pre-proline 0 CA--C 1.574 1.881 0 C-N-CA 123.746 0.818 . . . . 64.01 111.584 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 22.1 Cg_exo -66.1 -21.14 56.3 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.473 2.115 . . . . 75.41 113.247 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' C' ' 27' ' ' ASN . 12.6 m170 -60.59 -34.16 73.8 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 118.14 -0.933 . . . . 61.15 111.047 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.422 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.3 p -51.05 -31.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.196 0.813 . . . . 70.22 113.196 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -73.58 -29.18 62.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.811 0.844 . . . . 64.52 111.664 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.48 11.78 12.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.778 0.831 . . . . 73.53 112.217 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 18.5 ttpp -110.37 159.38 17.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 71.1 110.206 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.96 118.24 20.78 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.475 -0.784 . . . . 65.4 109.192 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -86.22 63.63 8.12 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.969 0.89 . . . . 73.32 110.862 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -145.2 72.95 14.56 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.177 -1.416 . . . . 75.54 107.177 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.56 151.61 4.3 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.787 2.325 . . . . 73.21 112.027 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.84 112.79 21.44 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.208 -1.034 . . . . 73.23 108.208 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.72 99.08 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 108.672 -0.862 . . . . 64.5 108.672 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 24.7 tptt -92.94 100.98 13.33 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.429 -1.322 . . . . 74.51 107.429 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -92.27 135.28 34.14 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.338 -0.986 . . . . 62.35 108.338 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.84 103.73 4.89 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.258 -1.016 . . . . 51.25 108.258 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -95.42 148.75 22.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.446 -0.576 . . . . 74.02 109.446 176.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -148.85 162.51 39.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.74 1.216 . . . . 71.53 107.976 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' C' ' 60' ' ' LEU . 10.2 t -145.65 137.14 25.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.344 0.657 . . . . 72.11 109.563 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.85 162.02 22.97 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.095 0.958 . . . . 61.42 108.985 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -139.31 143.78 38.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.894 0.477 . . . . 74.51 110.581 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -148.86 126.51 11.73 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.745 0.818 . . . . 74.43 109.518 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -88.29 120.22 29.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.539 -0.911 . . . . 71.24 108.539 173.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -91.2 -39.1 12.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.514 0.726 . . . . 63.21 110.699 -174.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.3 -175.54 5.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.477 -0.783 . . . . 61.21 110.305 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.6 105.39 1.51 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.028 0.931 . . . . 74.04 110.937 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 68.85 10.91 8.16 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.26 1.424 . . . . 73.41 112.979 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 76.2 t -105.34 113.71 42.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 64.32 108.341 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -117.5 160.47 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.056 0.942 . . . . 71.31 109.129 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.6 tt0 -127.58 146.69 50.45 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.055 1.342 . . . . 62.51 107.741 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.42 HG21 ' HG3' ' C' ' 103' ' ' PRO . 3.2 p -137.21 124.77 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.642 -0.873 . . . . 73.44 108.642 171.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.92 104.97 15.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.607 -0.886 . . . . 72.03 108.607 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.688 ' H ' HD23 ' C' ' 60' ' ' LEU . 0.8 OUTLIER -91.38 118.22 30.35 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.938 -0.393 . . . . 74.41 109.938 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -83.88 105.17 14.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.635 -0.876 . . . . 70.24 108.635 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.4 t -100.2 125.88 53.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.899 -1.149 . . . . 61.01 107.899 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 31.2 m -118.77 133.47 55.82 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.553 -0.906 . . . . 73.45 108.553 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.448 HG21 HG21 ' C' ' 114' ' ' ILE . 94.7 t -128.23 109.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.443 -0.947 . . . . 74.43 108.443 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 8.9 m -99.22 144.07 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.387 -0.968 . . . . 74.11 108.387 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.92 95.44 3.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.307 -1.738 . . . . 54.21 106.307 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -153.01 138.69 17.85 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.675 -0.491 . . . . 70.12 109.675 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.64 92.25 6.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.61 -79.31 1.26 Allowed Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.401 -0.818 . . . . 65.32 112.281 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -30.66 2.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.952 0.901 . . . . 74.14 110.617 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.62 102.59 0.93 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.754 0.821 . . . . 72.33 109.852 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -81.37 136.27 35.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.447 -0.797 . . . . 74.24 110.789 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.0 -55.45 3.68 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 55.2 107.485 163.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.67 175.07 9.15 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.844 0.831 . . . . 44.23 112.072 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.403 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -135.55 146.1 47.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.642 -1.984 . . . . 70.14 105.642 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.408 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.0 t -152.53 113.4 4.16 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.401 -0.592 . . . . 72.41 109.401 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -126.55 118.9 25.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.034 0.534 . . . . 63.42 109.852 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.84 134.05 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.825 0.85 . . . . 72.43 109.66 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.681 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -110.45 97.5 6.94 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.888 -1.153 . . . . 64.52 107.888 174.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -83.48 115.62 22.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.877 -0.602 . . . . 72.03 109.869 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.04 153.34 21.82 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.606 0.566 . . . . 61.43 111.775 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 119.99 0.97 Allowed Glycine 0 C--O 1.238 0.374 0 N-CA-C 111.195 -0.762 . . . . 74.3 111.195 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.7 mm -84.28 125.81 40.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.435 -0.95 . . . . 62.14 108.435 176.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.408 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.5 m-85 -137.62 135.08 36.26 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.967 0.907 . . . . 72.31 109.298 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -75.85 118.4 18.61 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.236 -1.024 . . . . 72.45 108.236 166.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 mm -122.29 110.0 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.802 -0.814 . . . . 55.21 108.802 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.77 165.18 31.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.658 0.783 . . . . 73.34 109.206 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.9 -50.54 3.96 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.404 -0.362 . . . . 72.33 112.22 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.73 141.89 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.705 0.802 . . . . 72.43 109.203 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -148.74 155.53 41.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.897 0.479 . . . . 74.31 110.862 -170.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.14 -145.41 28.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.865 0.728 . . . . 52.31 113.059 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.8 p -62.62 -28.33 69.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.996 . . . . 55.21 111.559 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -59.24 -49.0 79.53 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.535 0.734 . . . . 73.24 110.676 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -40.17 70.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 74.11 110.358 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.39 78.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.611 0.764 . . . . 73.41 110.904 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -70.97 -41.27 71.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.306 -0.861 . . . . 52.32 110.777 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.11 -51.71 65.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.664 0.386 . . . . 71.31 110.818 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.0 tp -75.87 -16.14 60.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.671 0.788 . . . . 73.21 111.087 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.89 3.32 31.89 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 119.511 -0.605 . . . . 53.44 114.113 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.37 -60.77 0.41 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.731 0.766 . . . . 51.43 110.851 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -68.44 -57.28 6.1 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.706 0.629 . . . . 73.0 111.835 -171.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.43 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 56.9 m -58.46 -45.95 99.65 Favored Pre-proline 0 CA--C 1.564 1.513 0 CA-C-O 118.415 -0.802 . . . . 74.52 111.901 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 44.3 Cg_exo -57.57 -37.12 98.1 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.278 1.985 . . . . 73.41 113.737 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -73.02 -26.55 61.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.767 0.427 . . . . 72.31 111.311 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 HH12 ' A' ' 111' ' ' ARG . 26.2 mm -65.56 -42.19 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.26 0.552 . . . . 75.45 109.587 169.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.3 mt -79.77 -19.26 49.06 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.651 -1.159 . . . . 74.13 111.882 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.5 -45.35 99.68 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.645 -1.169 . . . . 72.4 113.124 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 75.0 Cg_exo -52.91 -39.69 77.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.465 2.11 . . . . 74.21 113.262 172.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -68.98 -44.76 72.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.627 0.771 . . . . 74.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.02 99.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.216 0.606 . . . . 74.05 110.248 175.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -61.66 -49.41 76.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.84 1.256 . . . . 65.33 110.768 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.96 -33.83 74.34 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.684 0.615 . . . . 72.41 110.295 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -67.54 -37.33 82.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 75.43 110.975 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.448 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -71.54 -47.47 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.707 0.803 . . . . 74.52 110.631 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 41.6 m -67.07 -28.85 68.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.77 0.828 . . . . 72.01 111.076 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.1 t -68.61 -45.09 72.83 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.373 0.669 . . . . 71.41 109.442 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.58 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.91 -39.8 93.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.027 0.931 . . . . 63.14 111.941 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.31 -45.32 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.634 0.774 . . . . 72.15 109.917 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.1 t -64.92 -33.09 75.19 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.061 -0.972 . . . . 65.01 111.369 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -73.69 -33.59 64.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.596 0.758 . . . . 64.4 110.291 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.57 -3.98 90.14 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.55 0.531 . . . . 74.23 112.46 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 65.29 45.43 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.581 1.952 . . . . 71.22 112.182 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.4 m-85 -106.89 164.22 15.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-N 114.077 -1.42 . . . . 73.11 109.1 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 95.3 Cg_endo -72.33 179.65 4.84 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.752 2.301 . . . . 75.33 112.977 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -60.11 111.99 1.73 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.7 -0.682 . . . . 73.42 111.592 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.27 96.58 5.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 106.362 -1.718 . . . . 43.41 106.362 169.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.12 122.47 47.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.647 0.779 . . . . 74.43 109.511 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 57.0 mt -83.0 133.57 35.09 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.227 0.611 . . . . 55.15 109.402 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.74 143.19 78.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 123.509 0.506 . . . . 74.04 110.607 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.97 133.37 41.07 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.395 2.064 . . . . 64.14 111.726 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 p -102.0 111.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.458 -0.941 . . . . 62.14 108.458 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.75 57.68 4.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.446 0.698 . . . . 73.41 110.389 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -76.88 -21.53 54.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.817 0.818 . . . . 72.03 109.232 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 . . . . . 0 C--O 1.242 0.707 0 C-N-CA 124.534 1.134 . . . . 72.32 110.951 172.424 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.504 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.9 tpt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 113.848 1.055 . . . . 74.34 113.848 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -148.18 142.3 26.03 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.449 1.1 . . . . 75.23 109.12 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -164.2 103.5 0.86 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.67 -1.233 . . . . 73.34 107.67 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.536 ' HG3' ' HB2' ' D' ' 85' ' ' SER . 5.2 pt20 -149.51 127.08 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.528 0.731 . . . . 62.01 109.569 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.502 HD12 ' O ' ' D' ' 83' ' ' ILE . 3.3 tp -84.26 110.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 73.11 109.353 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -73.36 -40.99 63.95 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.332 1.053 . . . . 72.43 112.036 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.411 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 43.6 ttt180 -159.77 124.51 3.94 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.404 -0.221 . . . . 73.41 110.404 -166.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.509 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.2 mp -103.26 132.61 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 107.069 -1.456 . . . . 64.13 107.069 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 28.9 p90 -158.83 167.62 28.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.084 0.945 . . . . 71.4 111.724 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.425 HG21 HD11 ' D' ' 21' ' ' ILE . 73.6 p -102.52 120.21 40.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.038 -1.437 . . . . 74.12 109.426 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -87.63 -24.37 23.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 71.25 110.754 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.8 t70 -158.11 139.65 13.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.336 -0.847 . . . . 72.53 109.354 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.58 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.4 mt -139.82 144.88 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.828 -1.175 . . . . 54.32 107.828 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -149.77 144.82 26.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.141 0.976 . . . . 60.15 109.031 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.7 t80 -151.92 111.55 3.98 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.047 -1.834 . . . . 74.21 106.047 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.6 mt-10 -122.44 113.78 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.745 0.418 . . . . 53.14 110.527 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.61 81.22 54.48 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.983 0.913 . . . . 73.01 109.227 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.5 -37.56 5.41 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.619 2.213 . . . . 41.41 111.945 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.72 38.53 1.79 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.983 0.913 . . . . 75.13 108.699 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.7 -50.66 84.26 Favored Pre-proline 0 CA--C 1.575 1.904 0 N-CA-C 114.561 1.319 . . . . 63.01 114.561 -168.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.96 -12.72 4.89 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 121.757 1.638 . . . . 74.42 112.853 171.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -69.74 -40.07 76.41 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.625 1.17 . . . . 75.24 109.837 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.36 -18.13 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.139 0.576 . . . . 64.41 110.429 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -57.45 -35.53 70.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.362 0.665 . . . . 74.33 111.362 171.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -59.66 -25.28 64.6 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.91 0.756 . . . . 72.31 111.343 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -110.84 91.42 3.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.323 -1.362 . . . . 73.34 107.323 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.49 67.14 5.16 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 122.465 1.126 . . . . 45.33 110.929 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -128.3 158.23 38.75 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.791 -1.188 . . . . 61.03 107.791 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 20.9 mm-40 -84.73 118.23 70.54 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 122.849 0.459 . . . . 73.43 110.049 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.492 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 34.1 Cg_exo -64.59 158.76 48.19 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.845 3.03 . . . . 74.13 113.844 -172.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.2 tt0 -71.82 124.63 25.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.987 -0.745 . . . . 74.45 108.987 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.504 HG23 HG13 ' D' ' 64' ' ' VAL . 3.2 p -96.8 114.25 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.68 0.752 . . . . 73.05 110.088 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.575 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 8.9 tppt? -95.57 107.62 19.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.787 -1.19 . . . . 75.13 107.787 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -101.04 116.9 33.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.906 -0.405 . . . . 72.3 109.906 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.456 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.7 m-20 -116.66 124.85 50.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.739 0.816 . . . . 62.34 109.52 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.18 137.61 48.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.488 0.715 . . . . 74.53 110.108 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -146.33 146.71 30.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.899 1.28 . . . . 62.31 108.061 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -123.55 165.51 17.01 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.907 -0.405 . . . . 44.23 109.907 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -157.38 164.52 37.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.4 0.68 . . . . 70.24 109.789 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.0 p -156.22 153.4 29.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.01 0.524 . . . . 62.21 110.897 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 98.0 p -154.47 155.0 34.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 60.2 108.655 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -97.26 116.96 30.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.208 -0.664 . . . . 75.55 109.208 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' D' ' 57' ' ' GLU . 25.3 mt -92.5 -28.89 16.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.028 0.531 . . . . 72.11 110.123 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -164.19 -178.98 5.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.23 1.014 . . . . 70.34 110.623 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.36 117.12 8.16 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.548 -1.66 . . . . 61.43 110.513 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 63.18 21.25 12.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.26 1.424 . . . . 74.11 111.442 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 88.8 t -131.5 115.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 124.141 0.976 . . . . 74.01 109.137 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -132.74 130.27 39.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.511 -0.922 . . . . 63.51 108.511 -172.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.496 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.7 tt0 -86.54 138.08 32.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.62 0.768 . . . . 74.32 109.146 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.482 HG11 ' HD3' ' D' ' 103' ' ' PRO . 97.6 t -122.07 128.89 75.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.434 -1.321 . . . . 74.24 107.434 170.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 29.3 t -110.42 132.74 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.293 -0.632 . . . . 74.2 109.293 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.61 119.0 38.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.063 -1.088 . . . . 74.23 108.063 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.47 103.52 13.9 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.411 -0.959 . . . . 72.31 108.411 175.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.76 133.02 46.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.195 -1.039 . . . . 75.42 108.195 170.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 7.9 m -126.95 128.15 45.97 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.504 HG13 HG23 ' D' ' 40' ' ' VAL . 61.1 t -119.38 102.12 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.12 0.968 . . . . 70.0 108.658 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 96.0 m -106.19 100.89 10.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.613 0.765 . . . . 51.3 109.354 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -98.66 134.96 40.85 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.75 0.42 . . . . 71.12 110.11 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 40.8 p -146.32 140.15 26.22 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.613 -0.884 . . . . 73.24 108.613 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.62 119.13 25.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.529 -0.545 . . . . 62.35 109.529 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.1 -117.9 5.78 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.821 0.701 . . . . 73.01 113.238 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 5.33 46.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.88 . . . . 74.15 110.993 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.41 155.06 43.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.006 0.431 . . . . 73.53 111.434 -161.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -66.77 136.91 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.432 1.093 . . . . 62.12 110.726 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.35 -66.72 0.89 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.579 0.752 . . . . 64.25 109.526 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 151.22 26.23 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.629 0.772 . . . . 63.21 109.396 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.9 mt -118.95 154.25 33.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.889 0.876 . . . . 61.13 109.173 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 54.1 t -158.66 146.22 17.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.02 0.528 . . . . 73.14 110.894 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -156.52 137.77 13.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.65 -0.871 . . . . 53.23 108.65 167.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -135.31 116.21 19.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.41 0.684 . . . . 74.11 109.27 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 53.0 mt-30 -92.29 85.28 5.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.504 0.722 . . . . 74.31 109.059 171.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.84 100.83 8.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.805 1.242 . . . . 73.44 109.721 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 143.28 16.51 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.144 -0.382 . . . . 60.13 112.144 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.15 134.21 6.6 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.945 -0.462 . . . . 72.34 111.945 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.502 ' O ' HD12 ' D' ' 13' ' ' ILE . 60.1 mt -90.51 125.82 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.708 0.803 . . . . 71.11 109.142 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.23 129.26 49.7 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.446 0.699 . . . . 70.32 110.218 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' D' ' 12' ' ' GLN . 33.0 m -79.12 104.97 10.11 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 167.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.6 117.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.586 0.754 . . . . 63.45 110.09 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.97 43.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.612 0.765 . . . . 71.02 109.948 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 86.72 -20.79 22.03 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.086 -0.506 . . . . 23.13 114.292 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.26 144.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.738 0.815 . . . . 71.04 109.89 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -176.51 5.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.816 0.846 . . . . 60.12 110.256 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.59 -140.16 44.22 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.641 0.588 . . . . 40.34 114.188 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -63.03 -34.02 76.67 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.106 0.963 . . . . 60.45 111.397 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.48 -51.35 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.13 0.572 . . . . 73.32 109.743 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.82 -42.98 97.55 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.822 0.701 . . . . 75.11 111.256 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.63 97.07 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.827 0.704 . . . . 73.14 110.88 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -71.41 -34.27 70.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.811 . . . . 72.13 111.055 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.57 -48.05 76.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.746 0.418 . . . . 62.31 109.982 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -71.92 -18.19 62.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 122.797 0.439 . . . . 71.24 111.824 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.57 10.5 32.87 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.222 -0.765 . . . . 44.53 114.25 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.1 -64.22 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.948 0.874 . . . . 52.54 111.842 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -69.2 -40.1 78.23 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.409 0.683 . . . . 54.12 112.592 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.9 m -73.26 -44.84 7.88 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.478 0.711 . . . . 74.3 110.976 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.482 ' HD3' HG11 ' D' ' 58' ' ' VAL . 72.2 Cg_exo -54.85 -33.16 80.58 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.514 2.142 . . . . 55.52 113.694 166.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.16 -39.02 93.46 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.826 0.85 . . . . 73.12 109.948 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.15 -41.75 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.029 0.932 . . . . 74.53 110.868 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' D' ' 82' ' ' GLY . 93.5 mt -76.08 -20.16 57.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.406 -0.815 . . . . 74.22 112.27 -173.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -65.1 -41.96 57.46 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.789 1.033 . . . . 71.23 113.789 -170.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.29 -41.25 67.33 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.22 1.947 . . . . 60.41 113.317 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.9 m-85 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.766 0.826 . . . . 75.34 111.842 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -51.02 64.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 52.43 109.855 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -57.29 -44.52 84.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.557 -1.201 . . . . 70.34 111.332 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.48 -47.46 85.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.696 0.798 . . . . 71.33 111.528 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.15 -39.52 79.02 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.914 0.759 . . . . 53.45 110.972 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 114' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.7 -49.7 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.76 0.824 . . . . 73.5 110.842 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.433 HG23 ' HG3' ' D' ' 125' ' ' GLN . 30.2 m -57.06 -39.14 74.32 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.109 0.964 . . . . 73.23 111.578 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 36.4 t -65.89 -43.01 89.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.38 -0.827 . . . . 70.42 111.067 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.88 -35.16 74.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.813 0.445 . . . . 51.31 111.717 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.21 -40.92 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.27 -0.877 . . . . 64.34 110.315 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -71.19 -29.96 65.8 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.334 0.253 . . . . 53.11 110.886 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 93.8 mtt-85 -69.26 -32.82 72.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.044 0.538 . . . . 73.23 110.322 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.22 7.52 80.35 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.694 0.621 . . . . 74.22 113.0 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.4 p 53.71 36.08 22.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.787 1.635 . . . . 74.0 112.466 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -104.69 155.07 38.01 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.464 1.105 . . . . 75.34 109.815 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.55 141.15 97.13 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.416 2.744 . . . . 74.1 113.125 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.4 tt0 -54.46 133.71 45.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.398 1.079 . . . . 70.41 112.231 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.18 97.37 6.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.029 -1.1 . . . . 73.34 108.029 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -108.58 108.94 20.04 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.578 0.751 . . . . 62.3 109.435 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.24 139.88 44.63 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.729 0.812 . . . . 75.35 111.3 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -68.95 145.59 96.78 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.937 0.895 . . . . 62.14 111.957 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 18.6 Cg_exo -69.07 104.38 1.2 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.23 2.62 . . . . 74.42 112.137 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.02 110.35 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.219 -0.66 . . . . 41.0 109.219 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -88.04 92.67 9.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.532 -0.914 . . . . 75.25 108.532 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 122.828 0.451 . . . . 75.25 110.561 178.515 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.465 -0.568 . . . . 73.51 109.465 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HZ ' ' HG ' ' A' ' 102' ' ' CYS . 47.5 t80 -137.21 125.06 22.57 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.32 -0.993 . . . . 73.12 108.32 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -135.69 112.56 10.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.347 0.659 . . . . 75.12 109.721 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.8 mp -79.12 119.68 28.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.813 -1.18 . . . . 61.12 107.813 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 82.0 mm-40 -81.55 -41.51 21.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.651 0.594 . . . . 74.01 109.92 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.745 HH11 HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -173.47 163.96 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.319 1.048 . . . . 62.31 110.281 173.473 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' C' ' 130' ' ' PRO . 1.6 pp -144.03 101.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 64.7 m-85 -155.64 173.45 16.69 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.018 0.927 . . . . 72.35 109.886 -166.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.96 115.47 26.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.264 -0.425 . . . . 55.41 111.076 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -73.79 -44.74 55.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.967 -0.753 . . . . 64.13 108.967 171.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.8 t70 -135.78 148.35 48.73 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.757 -1.11 . . . . 75.11 110.368 -174.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.4 mt -145.13 142.75 22.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 126.021 1.728 . . . . 75.1 106.94 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -155.47 133.02 11.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.761 0.424 . . . . 72.32 110.403 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 77.1 t80 -127.28 131.11 50.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.241 -1.392 . . . . 74.14 107.241 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -129.24 126.51 39.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.235 0.614 . . . . 62.23 109.708 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 79.33 32.07 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.402 -0.962 . . . . 73.43 108.402 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.72 -11.87 20.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.771 2.314 . . . . 62.13 112.328 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -119.16 30.99 6.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.311 1.044 . . . . 73.14 109.112 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.27 99.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 N-CA-C 113.688 0.996 . . . . 62.41 113.688 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.17 -18.12 35.27 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 121.572 1.515 . . . . 60.41 113.277 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -80.12 -12.75 59.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.705 0.802 . . . . 75.14 112.765 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.12 -33.62 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 124.093 0.957 . . . . 73.43 112.806 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.27 -32.79 74.64 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.31 0.644 . . . . 74.34 111.637 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.72 -36.44 14.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 74.53 111.078 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.17 155.52 23.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.116 0.966 . . . . 75.34 111.517 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' HD11 ' A' ' 68' ' ' LEU . 7.6 m-20 -70.43 137.11 50.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.758 0.823 . . . . 60.12 110.007 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -88.36 61.66 6.28 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.87 -0.789 . . . . 61.11 108.87 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -142.45 58.56 7.6 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.972 0.909 . . . . 61.04 109.94 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.55 152.43 7.67 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.875 1.717 . . . . 71.45 112.208 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -93.28 117.51 30.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.583 -1.265 . . . . 73.5 107.583 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.68 136.25 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.971 0.508 . . . . 65.34 110.826 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -119.04 131.45 55.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.316 1.447 . . . . 65.13 108.913 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -97.53 152.2 19.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.986 -1.116 . . . . 72.12 107.986 170.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 62' ' ' VAL . 26.3 t70 -144.2 143.35 31.02 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.087 -1.079 . . . . 75.5 108.087 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -140.61 125.31 18.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.494 0.717 . . . . 64.13 109.837 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 12.8 t70 -132.54 142.91 49.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.047 0.939 . . . . 74.35 109.517 -177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.9 m -124.46 124.4 42.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.527 0.731 . . . . 75.45 110.404 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.56 8.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.362 0.665 . . . . 73.11 110.41 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.8 m -90.8 158.09 17.02 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.584 0.753 . . . . 60.34 109.585 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.5 t -162.13 118.35 2.01 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.085 0.402 . . . . 42.21 111.048 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.53 103.39 2.47 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.492 0.717 . . . . 72.03 110.74 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.766 HD11 ' HB2' ' A' ' 57' ' ' GLU . 48.2 mt -83.36 -34.54 25.59 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 71.41 110.862 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.36 -174.6 4.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.44 1.096 . . . . 43.43 108.908 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.84 96.32 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.433 0.458 . . . . 72.45 110.979 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.47 27.71 15.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.915 1.286 . . . . 73.32 112.278 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.18 113.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.784 -1.561 . . . . 74.31 106.784 168.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 49' ' ' SER . 22.7 m-85 -119.1 129.06 54.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.868 -0.79 . . . . 73.41 108.868 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.766 ' HB2' HD11 ' A' ' 51' ' ' LEU . 39.5 tt0 -83.32 114.99 21.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.906 -1.146 . . . . 65.14 107.906 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.85 111.26 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.314 -1.365 . . . . 73.05 107.314 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 80.7 t -97.16 136.11 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.353 1.061 . . . . 53.22 109.352 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -108.16 116.14 31.42 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.062 -0.718 . . . . 72.51 109.062 175.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -92.9 106.49 18.45 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.777 -0.823 . . . . 63.22 108.777 173.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 49.5 t -107.74 133.17 53.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.323 0.649 . . . . 72.21 109.666 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.1 m -121.95 138.96 54.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.574 -0.528 . . . . 72.25 109.574 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 114' ' ' ILE . 53.6 t -126.12 105.63 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.877 -1.527 . . . . 72.43 106.877 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.0 m -108.13 144.0 36.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.417 -0.957 . . . . 74.45 108.417 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.37 124.87 27.96 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.991 -1.115 . . . . 54.22 107.991 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -126.05 125.95 43.46 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.654 0.596 . . . . 72.44 109.829 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 35' ' ' ASP . 49.0 tp -91.86 73.3 5.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.035 0.934 . . . . 61.14 108.922 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.61 -92.12 0.78 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.715 -0.675 . . . . 74.52 112.847 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -98.84 -26.81 14.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.822 0.849 . . . . 72.32 111.23 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.37 138.01 44.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.575 0.75 . . . . 73.2 111.001 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -60.65 129.72 42.96 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.446 0.466 . . . . 71.41 110.202 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.86 -56.05 4.22 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.585 -0.524 . . . . 74.25 109.585 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.517 ' HE1' ' HG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -164.75 166.89 19.51 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.326 0.65 . . . . 61.02 109.77 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 76' ' ' CYS . 27.8 tp -143.79 146.4 33.07 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.201 0.6 . . . . 75.12 111.283 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.517 ' HG ' ' HE1' ' A' ' 74' ' ' PHE . 51.7 m -143.54 142.29 31.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.2 1.4 . . . . 73.14 109.88 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -148.45 123.53 10.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 70.11 109.602 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.18 130.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.609 0.764 . . . . 74.42 110.183 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 72.3 mt-30 -95.67 96.95 9.36 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.472 0.709 . . . . 64.31 109.57 168.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -83.21 93.94 7.78 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.026 -0.731 . . . . 74.22 109.026 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.2 144.4 19.24 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.823 -0.511 . . . . 63.54 111.823 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.37 122.25 2.03 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.445 -1.062 . . . . 65.41 110.445 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.745 HD12 HH11 ' A' ' 15' ' ' ARG . 33.8 mt -82.79 123.87 38.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.572 -0.899 . . . . 75.31 108.572 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -129.28 138.31 51.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.158 -0.682 . . . . 71.24 109.158 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.6 m -108.63 119.09 38.51 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.918 -1.141 . . . . 62.13 107.918 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.36 131.16 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 120.975 0.417 . . . . 65.22 110.829 -172.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.7 165.53 28.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.202 1.001 . . . . 61.41 110.88 -173.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.4 -33.19 6.38 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 116.063 -0.517 . . . . 72.01 112.86 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.85 178.26 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.085 0.954 . . . . 64.13 108.827 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 14.6 tt0 -161.64 -179.44 7.28 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 110.238 -0.282 . . . . 61.44 110.238 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.97 -147.96 40.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.561 0.585 . . . . 64.1 114.561 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -63.37 -26.76 68.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.371 1.068 . . . . 72.44 113.013 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.12 -41.05 82.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.194 0.598 . . . . 71.55 111.915 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 3.4 ptp -84.02 -33.86 24.42 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.717 -0.219 . . . . 62.3 111.39 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -24.15 67.77 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.227 0.537 . . . . 54.03 110.718 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -64.86 -54.49 30.17 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 70.41 109.984 164.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.6 m -65.73 -63.37 1.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.268 0.84 . . . . 71.21 113.268 -170.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.08 -8.07 34.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.862 0.756 . . . . 62.34 112.206 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.49 -4.0 40.47 Favored Glycine 0 C--N 1.36 1.911 0 N-CA-C 115.263 0.865 . . . . 61.31 115.263 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.02 -59.23 0.25 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.767 0.784 . . . . 51.44 111.025 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.0 t80 -53.46 -54.74 32.65 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 124.571 1.148 . . . . 71.44 112.949 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.576 ' HG ' ' HZ ' ' A' ' 11' ' ' PHE . 19.7 m -71.69 -42.02 10.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.384 0.674 . . . . 72.22 111.739 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.78 -39.02 78.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.463 2.109 . . . . 71.41 113.973 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -72.62 -24.45 61.07 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.367 0.667 . . . . 72.14 111.442 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.7 mm -69.13 -45.59 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.411 0.684 . . . . 71.34 109.407 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.31 -33.56 71.68 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.283 -0.871 . . . . 73.44 112.01 -173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.64 -44.7 92.34 Favored Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 114.56 1.318 . . . . 72.41 114.56 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.48 -32.25 96.02 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.111 1.874 . . . . 74.03 113.617 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.72 -32.46 31.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.423 0.689 . . . . 53.2 111.358 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.22 75.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.711 -0.477 . . . . 71.13 109.711 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -54.54 -49.05 71.21 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.67 1.231 . . . . 72.02 110.19 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.67 -51.46 69.68 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.162 0.914 . . . . 74.41 110.912 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.15 -45.56 79.59 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.192 0.933 . . . . 62.24 111.155 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 118' ' ' VAL . 5.7 mt -60.43 -58.49 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 74.43 110.189 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 125' ' ' GLN . 65.7 m -52.67 -40.5 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.988 0.915 . . . . 72.44 112.087 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.6 t -66.9 -43.24 83.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.212 -0.904 . . . . 74.23 109.981 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.452 ' SD ' HG23 ' A' ' 21' ' ' ILE . 10.9 mtp -58.36 -44.03 88.64 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.509 0.724 . . . . 60.32 110.954 174.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 114' ' ' ILE . 39.3 t -61.2 -46.0 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.626 0.77 . . . . 65.33 110.6 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.3 p -73.36 -30.66 63.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.34 -0.846 . . . . 74.23 111.111 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -69.75 -25.21 63.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.568 0.747 . . . . 73.03 109.782 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.95 0.02 84.08 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.649 -0.705 . . . . 54.41 112.682 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.0 m 69.98 12.19 7.79 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.823 1.249 . . . . 72.31 111.137 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -94.47 152.99 40.44 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 123.268 0.627 . . . . 74.55 110.37 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -54.11 120.45 7.97 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.776 2.317 . . . . 73.22 111.4 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.665 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.4 pt20 -60.08 160.22 8.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.961 0.904 . . . . 63.53 112.63 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.4 115.27 17.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.614 -0.884 . . . . 60.33 108.614 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.54 120.98 43.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.71 0.804 . . . . 74.21 109.194 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 64' ' ' VAL . 57.3 mt -73.36 135.38 44.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.753 0.821 . . . . 75.13 110.437 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.91 136.61 96.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.372 0.42 . . . . 65.41 110.569 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 29.7 Cg_endo -91.1 103.09 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.999 2.466 . . . . 61.32 112.311 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.1 116.04 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.028 -1.101 . . . . 64.24 108.028 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -69.83 106.48 3.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.474 -0.565 . . . . 72.24 109.474 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.59 -17.27 62.3 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.286 -0.87 . . . . 70.33 111.71 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.042 0.537 . . . . 71.03 111.479 174.857 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 11.7 ptm . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 114.758 1.392 . . . . 75.12 114.758 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -155.85 136.2 13.12 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.813 1.245 . . . . 75.42 108.003 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.566 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 8.5 t80 -134.84 112.16 10.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.509 -0.552 . . . . 74.41 109.509 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -127.03 115.94 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.786 -0.82 . . . . 74.14 108.786 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.5 135.76 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 116.455 -0.339 . . . . 73.13 110.218 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -98.47 -50.14 4.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.61 -0.885 . . . . 75.14 108.61 169.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -163.1 142.31 8.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.068 -0.515 . . . . 71.22 110.696 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.2 mt -116.89 142.26 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 106.403 -1.703 . . . . 70.42 106.403 165.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -167.74 142.12 3.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.136 0.425 . . . . 73.23 111.374 -173.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -72.19 121.48 19.41 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.189 -0.914 . . . . 73.32 108.808 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.456 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.8 mtpt -97.07 -24.87 15.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.472 0.709 . . . . 73.21 110.729 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -156.66 138.13 13.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.863 -0.608 . . . . 72.31 110.28 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.5 mm -132.63 148.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.752 1.221 . . . . 63.52 107.963 173.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -150.22 142.33 24.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.294 -0.867 . . . . 75.12 109.162 165.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.1 t80 -146.57 114.2 6.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.076 -1.824 . . . . 72.23 106.076 168.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.92 114.35 20.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.806 -0.813 . . . . 73.31 108.806 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.597 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.45 85.59 1.81 Allowed Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.418 -0.956 . . . . 53.12 108.418 171.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.76 -20.81 29.64 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.827 2.351 . . . . 54.35 111.289 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.496 ' O ' HG23 ' B' ' 31' ' ' VAL . 80.7 m-20 -125.98 20.2 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.532 1.133 . . . . 73.11 110.577 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.597 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -37.81 -55.0 2.24 Favored Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 125.671 1.589 . . . . 73.14 114.415 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 8.5 Cg_exo -69.56 -20.11 36.21 Favored 'Trans proline' 0 C--N 1.392 2.847 0 C-N-CA 123.057 2.505 . . . . 63.13 112.903 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -96.59 -27.45 14.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.026 0.93 . . . . 54.24 112.442 -171.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 27' ' ' ASN . 64.2 t -67.22 -22.78 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.119 0.568 . . . . 73.42 110.916 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -57.33 -38.3 73.86 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.214 0.606 . . . . 74.32 111.499 171.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -73.6 -15.59 61.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.915 0.886 . . . . 74.22 111.731 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -104.17 108.86 20.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.529 0.732 . . . . 63.52 111.16 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -100.03 86.02 3.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.489 0.716 . . . . 73.24 109.949 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.638 ' HB3' HD21 ' B' ' 68' ' ' LEU . 22.3 t90 -165.75 157.98 14.81 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.893 0.877 . . . . 74.23 109.107 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.7 121.35 84.92 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.4 109.536 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 146.69 52.37 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.48 2.12 . . . . 55.24 112.811 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.39 103.52 2.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.2 0.6 . . . . 73.54 109.503 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.769 HG11 HD21 ' B' ' 126' ' ' LEU . 23.0 t -106.46 144.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.316 0.646 . . . . 64.12 109.838 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -145.17 131.07 19.15 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.159 -1.052 . . . . 70.52 108.159 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.476 HD21 ' HG ' ' B' ' 128' ' ' LEU . 7.1 mp -88.49 165.98 14.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.455 -0.572 . . . . 74.24 109.455 173.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -160.76 142.85 12.5 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.348 -1.352 . . . . 64.01 107.348 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.63 170.01 10.46 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.243 0.544 . . . . 70.21 110.72 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.4 t70 -142.14 126.37 17.52 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.683 -1.144 . . . . 51.43 108.281 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 p -107.93 103.94 13.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.602 0.761 . . . . 73.43 109.202 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.56 133.2 34.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.646 0.778 . . . . 63.11 109.699 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.6 m -140.13 164.97 28.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.548 0.739 . . . . 72.13 109.113 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -151.63 139.73 20.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.838 0.455 . . . . 61.22 110.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -81.84 112.53 19.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.938 -0.764 . . . . 72.14 108.938 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.19 -51.93 12.19 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.424 0.631 . . . . 75.42 110.016 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.9 -172.35 3.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.47 1.108 . . . . 54.22 109.527 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 124.33 23.99 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.992 -0.744 . . . . 73.14 108.992 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 63.38 22.08 13.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.318 1.047 . . . . 72.25 112.152 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -138.75 123.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.097 -1.075 . . . . 71.34 108.097 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.487 ' HE1' ' HB2' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -130.88 -179.51 5.36 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.662 -0.496 . . . . 73.04 109.662 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -142.39 109.65 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.04 -1.096 . . . . 71.05 108.04 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.58 124.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.755 0.822 . . . . 73.31 109.397 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.1 t -106.69 122.31 60.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 N-CA-C 109.487 -0.561 . . . . 75.04 109.487 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.36 112.17 23.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.131 -1.433 . . . . 72.31 107.131 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 52.6 ttt180 -102.02 126.19 48.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.743 -0.465 . . . . 64.33 109.743 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.81 111.1 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.309 1.044 . . . . 62.44 108.882 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -94.79 138.59 32.4 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.761 -0.829 . . . . 65.54 108.761 170.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.5 t -131.52 130.03 62.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.107 0.963 . . . . 71.01 108.414 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.9 m -125.54 138.41 53.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.325 -0.621 . . . . 74.43 109.325 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 137.45 32.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.556 0.743 . . . . 74.31 109.289 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.3 p -144.03 124.82 14.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.284 0.634 . . . . 61.32 109.957 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.638 HD21 ' HB3' ' B' ' 36' ' ' TRP . 3.0 tt -95.63 112.8 24.44 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.78 -1.192 . . . . 71.22 107.78 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.13 -111.51 3.28 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.914 -0.874 . . . . 74.54 110.914 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.98 15.69 9.99 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.067 0.947 . . . . 72.42 110.612 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.63 141.12 48.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.5 1.12 . . . . 74.12 108.665 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 71.5 m -61.4 134.49 56.97 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.325 0.511 . . . . 63.1 110.517 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.4 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.86 -58.11 2.59 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.376 -0.972 . . . . 63.15 108.376 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.44 159.1 30.53 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.778 -1.101 . . . . 75.12 109.765 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.02 145.78 51.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.364 -1.347 . . . . 54.13 107.364 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.2 146.1 22.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.307 -0.627 . . . . 65.14 109.307 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -158.7 125.25 4.68 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.714 -0.476 . . . . 73.55 109.714 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.57 150.22 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 72.41 109.36 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -127.05 102.47 6.99 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.03 -0.73 . . . . 72.42 109.03 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -89.82 104.02 16.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.889 -0.596 . . . . 74.33 109.586 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.0 170.38 37.72 Favored Glycine 0 C--O 1.245 0.809 0 O-C-N 123.551 0.532 . . . . 71.52 112.133 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.56 125.84 1.36 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.913 -0.475 . . . . 52.33 111.913 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.7 mt -86.36 119.36 34.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.639 -0.874 . . . . 73.03 108.639 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.487 ' HB2' ' HE1' ' B' ' 56' ' ' TYR . 47.0 m-85 -121.83 135.05 54.9 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -100.61 120.87 40.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.203 1.001 . . . . 73.32 108.669 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.09 109.55 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.629 0.771 . . . . 73.13 111.528 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.74 140.12 50.11 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.704 0.801 . . . . 64.13 110.382 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.01 -26.91 14.51 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 111.993 -0.443 . . . . 60.05 111.993 -170.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' B' ' 94' ' ' MET . 2.1 mp -63.95 131.97 29.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 125.339 1.455 . . . . 62.11 110.897 -176.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -159.79 143.58 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.214 0.946 . . . . 73.14 109.716 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.35 -117.86 11.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.831 0.707 . . . . 64.13 113.997 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' THR . . . . . 0.579 ' HA ' ' HB3' ' B' ' 95' ' ' ALA . 39.3 m -65.88 -29.8 70.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.363 1.065 . . . . 73.4 111.898 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -49.9 -46.66 52.02 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 124.111 0.882 . . . . 73.52 111.064 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.52 ' HA ' ' HB3' ' B' ' 97' ' ' CYS . 9.1 ptm -94.18 -29.07 15.31 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.423 0.897 . . . . 74.14 113.423 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' B' ' 92' ' ' THR . . . -57.54 -28.86 63.89 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.912 0.778 . . . . 74.32 111.362 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.07 -32.72 17.41 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.257 1.023 . . . . 73.43 110.952 172.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.566 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 42.6 t -70.17 -66.82 0.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.923 0.489 . . . . 74.22 111.556 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.463 HD23 ' HE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -63.77 -18.71 64.34 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 118.07 0.396 . . . . 71.35 111.773 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.44 -20.25 58.92 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 116.126 -0.488 . . . . 32.42 113.858 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.61 -58.7 0.16 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.398 0.599 . . . . 72.24 112.543 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.37 -51.7 61.97 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.943 0.72 . . . . 74.01 112.943 -167.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 75.2 m -60.71 -48.52 92.9 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.545 -0.74 . . . . 72.31 111.263 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 96.5 Cg_exo -50.14 -35.52 42.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.373 2.049 . . . . 74.12 114.797 167.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -67.84 -35.67 78.99 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.355 0.525 . . . . 62.32 111.433 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.881 0.872 . . . . 70.54 110.1 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 74.6 mt -84.26 -20.49 32.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.793 -1.094 . . . . 71.03 112.401 -170.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -58.39 -48.94 96.05 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.047 -0.978 . . . . 73.25 113.311 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 76.9 Cg_exo -55.22 -39.76 89.29 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.571 2.181 . . . . 54.43 114.15 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.5 m-85 -65.89 -49.6 67.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.698 . . . . 74.41 111.257 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.86 96.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.678 0.791 . . . . 42.02 110.863 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.57 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.0 ttt-85 -63.11 -56.23 18.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.134 1.374 . . . . 72.34 111.457 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.89 -40.87 73.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.377 1.071 . . . . 72.23 110.83 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.543 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -65.93 -44.4 85.21 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.577 -0.283 . . . . 63.23 111.082 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.404 HD12 HD21 ' B' ' 128' ' ' LEU . 72.7 mt -60.52 -54.8 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 123.524 0.729 . . . . 74.21 110.992 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -58.36 -29.79 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.448 0.699 . . . . 72.44 111.501 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -70.16 -54.37 13.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.436 0.694 . . . . 73.31 110.131 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.3 mmt -63.2 -34.86 78.55 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.248 0.619 . . . . 74.12 111.866 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.8 -46.66 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.901 0.881 . . . . 62.22 110.902 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.44 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 80.4 p -73.58 -24.79 60.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.773 0.429 . . . . 73.11 111.714 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -63.42 -28.58 70.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.708 0.803 . . . . 74.41 110.637 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.99 17.28 59.55 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.249 -0.75 . . . . 53.11 113.631 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.2 p 70.19 13.35 7.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 126.231 1.813 . . . . 64.32 113.418 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -90.61 150.5 42.62 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 122.618 0.367 . . . . 72.51 110.373 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.8 159.13 18.31 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.363 2.709 . . . . 70.45 113.368 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.31 135.6 57.7 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.882 0.739 . . . . 71.41 110.112 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.769 HD21 HG11 ' B' ' 40' ' ' VAL . 1.3 tm? -108.61 110.91 22.48 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.796 -1.557 . . . . 72.24 106.796 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -91.62 94.25 9.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.798 -0.816 . . . . 64.41 108.798 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.57 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 5.4 mp -69.93 108.14 3.88 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.589 -1.263 . . . . 71.01 107.589 171.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.31 139.26 87.0 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.563 0.539 . . . . 72.45 110.081 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.49 82.72 0.68 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 122.194 1.929 . . . . 72.51 111.14 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -91.32 132.59 35.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 114.722 -1.126 . . . . 65.23 108.424 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -70.73 113.2 7.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.526 0.73 . . . . 53.13 110.299 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.12 -40.17 92.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.329 1.051 . . . . 71.23 110.788 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -61.42 -34.17 74.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.154 -0.93 . . . . 75.11 111.046 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.52 90.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.938 0.495 . . . . 64.53 111.163 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 109.208 -0.664 . . . . 72.24 109.208 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 CA--C 1.55 0.968 0 CA-C-O 121.885 0.85 . . . . 71.54 112.093 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -128.27 101.58 6.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.434 -1.321 . . . . 62.24 107.434 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.488 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -114.78 143.47 45.02 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.376 0.67 . . . . 65.33 110.181 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -147.84 144.62 28.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.274 0.629 . . . . 74.5 110.02 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -92.2 120.24 41.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.815 -0.809 . . . . 55.54 108.815 171.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -91.39 -38.32 12.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.53 0.332 . . . . 72.41 110.42 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.56 148.54 3.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.073 -0.343 . . . . 72.4 110.073 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -136.04 132.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.137 -1.06 . . . . 72.45 108.137 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.0 p90 -170.72 162.56 7.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.643 0.735 . . . . 54.44 112.09 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -87.39 117.35 26.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.826 -1.079 . . . . 54.02 110.203 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.508 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 6.8 mtmt -92.83 -7.52 46.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.411 0.284 . . . . 74.22 110.697 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.8 t70 -160.27 135.19 7.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.391 -0.966 . . . . 70.04 108.391 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.9 mt -149.05 139.11 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.014 -1.847 . . . . 72.44 106.014 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -158.92 151.04 21.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.063 0.459 . . . . 74.52 109.869 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.9 128.98 15.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.519 -1.289 . . . . 71.23 107.519 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.7 142.43 51.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.72 -0.844 . . . . 64.21 108.72 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -154.43 77.94 5.26 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.753 -0.832 . . . . 72.24 108.753 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 -30.5 22.87 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.48 2.12 . . . . 71.23 111.574 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' C' ' 72' ' ' THR . 37.4 m-20 -112.14 33.51 4.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.007 0.923 . . . . 75.43 109.371 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.556 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -54.29 -45.89 99.1 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.496 1.118 . . . . 71.01 113.583 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -75.57 -25.55 10.89 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.401 2.067 . . . . 74.2 113.4 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.13 -51.28 70.28 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.741 0.651 . . . . 73.01 111.256 -172.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.528 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 14.5 p -55.39 -25.53 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.423 1.089 . . . . 60.05 113.342 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -66.88 -42.82 84.93 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.84 0.456 . . . . 72.35 111.515 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -103.4 13.85 32.73 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.26 0.624 . . . . 73.52 110.29 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 24.3 ttpp -124.46 174.2 7.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.368 1.067 . . . . 72.4 109.434 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.415 ' N ' ' HG2' ' C' ' 34' ' ' LYS . 21.5 t70 -54.57 113.8 1.43 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.337 1.055 . . . . 43.22 110.958 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -86.85 64.97 8.77 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.879 0.847 . . . . 72.33 111.24 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -158.95 78.79 2.98 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.617 -0.883 . . . . 74.32 108.617 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -88.35 174.22 4.39 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.697 2.265 . . . . 74.51 111.574 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' C' ' 67' ' ' SER . 11.0 tp10 -85.8 107.63 17.73 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.052 -0.722 . . . . 65.33 109.052 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.96 99.98 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.274 -0.875 . . . . 71.44 108.988 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.8 tmtt? -107.41 103.22 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.292 -1.003 . . . . 70.24 108.292 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.643 HD13 ' H ' ' C' ' 42' ' ' LEU . 0.0 OUTLIER -87.25 155.37 20.1 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.141 -0.689 . . . . 72.11 109.141 173.531 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.1 t70 -150.95 143.82 24.55 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.998 -0.741 . . . . 63.15 108.998 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.98 145.72 48.39 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.467 -0.568 . . . . 73.15 109.467 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -156.99 149.98 23.78 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.78 0.832 . . . . 73.24 108.794 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -130.8 154.3 48.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.187 0.518 . . . . 74.2 110.214 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -140.8 171.13 14.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.022 . . . . 75.41 108.607 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 25.8 p -159.02 143.55 15.63 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.9 0.48 . . . . 65.05 110.35 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -149.84 128.02 12.03 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.859 0.863 . . . . 74.12 109.021 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.74 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.54 0.336 . . . . 71.43 110.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' C' ' 57' ' ' GLU . 31.7 mt -103.49 -30.12 10.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.835 0.854 . . . . 63.53 110.204 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.58 -178.43 6.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.88 0.872 . . . . 63.32 110.489 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -62.16 117.31 5.86 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.299 -0.864 . . . . 73.51 109.925 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.91 0.27 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.528 1.131 . . . . 75.04 113.171 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.2 t -103.8 114.81 44.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.215 0.531 . . . . 75.54 109.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -124.22 123.56 40.53 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.732 -1.21 . . . . 74.02 107.732 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.6 111.08 18.25 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.74 -0.837 . . . . 71.13 108.74 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.28 126.66 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.287 -1.005 . . . . 73.43 108.287 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 42.0 t -110.96 102.3 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.112 -1.07 . . . . 75.21 108.112 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.2 tm? -91.95 102.83 15.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.781 -0.822 . . . . 72.04 108.781 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -85.08 125.47 32.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.904 1.281 . . . . 63.21 110.866 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.2 t -119.27 141.73 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.313 1.045 . . . . 73.32 108.954 170.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.0 m -131.94 133.46 44.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.888 0.875 . . . . 70.44 109.256 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.737 HG23 HD13 ' C' ' 114' ' ' ILE . 93.2 t -116.74 117.18 54.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.345 -0.983 . . . . 74.0 108.345 167.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.43 HG23 HD23 ' C' ' 75' ' ' LEU . 13.9 m -105.15 141.92 35.84 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.597 -0.89 . . . . 53.12 108.597 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.02 93.04 2.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.176 -1.416 . . . . 75.42 107.176 176.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' C' ' 39' ' ' GLU . 59.6 p -161.85 131.84 4.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.874 0.47 . . . . 75.03 109.896 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.78 39.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.793 0.806 . . . . 74.35 109.911 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.89 -84.33 0.72 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.093 -0.803 . . . . 33.54 111.093 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.12 -31.34 17.14 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.712 0.805 . . . . 55.54 111.232 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -101.23 98.73 9.09 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.087 0.955 . . . . 73.02 110.252 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 32.2 m -88.88 118.31 28.5 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.96 0.504 . . . . 74.14 111.997 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -51.74 29.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.681 0.792 . . . . 62.13 109.071 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -162.52 174.72 12.29 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.98 -1.464 . . . . 73.24 110.621 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.4 tm? -145.56 146.39 31.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 73.22 105.773 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.451 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -151.4 132.64 14.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.715 -0.846 . . . . 63.14 108.715 175.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -141.38 134.47 29.22 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.431 -0.581 . . . . 73.24 109.431 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.19 140.4 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.032 . . . . 72.21 108.603 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.0 mt-30 -115.04 102.19 9.71 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.594 -0.891 . . . . 74.33 108.594 170.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.1 tp-100 -82.45 99.6 9.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.919 0.888 . . . . 73.31 109.552 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.65 144.85 22.43 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.317 -0.713 . . . . 53.42 111.317 174.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.27 118.94 1.35 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.211 -0.755 . . . . 73.1 111.211 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -80.97 122.17 35.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.984 -1.117 . . . . 60.53 107.984 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -135.54 154.57 51.33 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.014 0.525 . . . . 74.31 110.608 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -105.19 118.83 37.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.34 -0.985 . . . . 71.13 108.34 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.432 HG21 ' HG3' ' C' ' 94' ' ' MET . 3.8 mp -113.86 107.01 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.158 -1.423 . . . . 70.32 107.158 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.61 16.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.997 0.919 . . . . 64.23 110.341 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.92 -55.23 4.06 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.945 -0.57 . . . . 44.21 112.686 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -110.02 175.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.731 0.812 . . . . 54.21 111.139 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.2 pt-20 -163.78 -176.21 4.5 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.795 -0.638 . . . . 73.3 110.78 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.23 -124.8 28.49 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.333 -0.394 . . . . 61.22 113.768 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -60.58 -36.76 79.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.122 0.969 . . . . 51.12 111.175 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -66.93 -42.18 85.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.621 -1.172 . . . . 71.53 110.991 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.507 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 58.8 ttm -71.84 -36.53 70.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.951 0.501 . . . . 74.14 110.385 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.27 94.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.282 0.633 . . . . 55.45 111.075 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.73 -27.62 66.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.603 0.761 . . . . 65.11 111.134 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 36.6 t -72.81 -62.46 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 110.047 -0.353 . . . . 74.24 110.047 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.23 -17.83 62.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.829 0.452 . . . . 70.4 112.126 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.61 -10.83 46.09 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.433 -0.649 . . . . 71.25 114.181 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.83 -56.18 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 117.874 0.837 . . . . 40.31 112.343 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -70.68 -49.43 47.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.14 0.576 . . . . 73.43 112.128 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.522 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.9 m -63.4 -46.36 84.51 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.358 0.663 . . . . 61.52 111.247 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.1 Cg_exo -55.54 -36.67 94.87 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.686 2.257 . . . . 74.53 114.73 169.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -58.4 -38.7 77.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.356 0.662 . . . . 65.42 111.265 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.01 -41.94 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.116 -0.947 . . . . 75.21 110.403 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.65 -20.0 28.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.589 -1.187 . . . . 64.3 112.428 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.46 -50.55 87.43 Favored Pre-proline 0 CA--C 1.554 1.103 0 CA-C-O 117.772 -1.108 . . . . 74.05 113.147 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 -37.9 94.43 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.238 1.959 . . . . 62.22 113.365 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -67.92 -51.32 49.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.788 0.835 . . . . 75.32 111.605 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -59.64 -35.83 75.16 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.038 0.935 . . . . 74.5 110.891 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -65.39 -47.92 74.67 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.707 -1.588 . . . . 74.03 110.527 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.518 0.511 . . . . 74.05 110.234 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.3 t -69.0 -29.23 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.82 0.448 . . . . 72.41 110.817 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.737 HD13 HG23 ' C' ' 64' ' ' VAL . 80.1 mt -75.89 -49.02 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.701 -0.681 . . . . 72.44 109.945 169.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.525 HG23 ' HG3' ' C' ' 125' ' ' GLN . 54.1 m -52.83 -41.92 64.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 73.32 111.491 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.5 t -63.0 -49.02 76.3 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.303 -1.317 . . . . 74.34 109.377 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.516 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.76 -42.11 88.13 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.564 1.145 . . . . 73.4 112.959 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.34 -43.69 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 109.519 -0.549 . . . . 62.43 109.519 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.7 t -71.79 -25.88 62.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.001 0.92 . . . . 61.23 111.7 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.4 mtt-85 -71.44 -33.86 69.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.393 0.677 . . . . 73.01 109.577 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.4 11.2 56.64 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 124.041 0.838 . . . . 71.21 112.703 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.538 HG23 ' HB3' ' D' ' 17' ' ' TYR . 68.1 p 57.02 26.4 11.88 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.256 1.822 . . . . 71.4 112.918 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.417 ' HE1' HG11 ' C' ' 31' ' ' VAL . 69.0 m-85 -94.83 146.78 31.99 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.68 -0.859 . . . . 64.4 108.68 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -60.91 146.55 97.47 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.94 2.427 . . . . 72.02 112.647 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.525 ' HG3' HG23 ' C' ' 115' ' ' THR . 19.8 mp0 -59.1 125.37 23.31 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.837 0.855 . . . . 53.42 112.467 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -109.7 90.46 3.31 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.048 -1.834 . . . . 65.32 106.048 168.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -91.07 109.34 20.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.57 132.22 48.18 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.074 0.859 . . . . 72.33 109.713 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.89 132.58 89.43 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 123.558 0.536 . . . . 71.23 111.056 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.568 ' HG3' HD11 ' A' ' 16' ' ' ILE . 61.3 Cg_endo -69.75 102.81 1.07 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.905 2.403 . . . . 73.35 112.491 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 6.8 p -105.33 122.63 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.072 0.549 . . . . 72.01 109.853 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -109.12 81.54 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.567 0.747 . . . . 62.11 110.386 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -72.89 -31.8 64.94 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.806 -0.813 . . . . 75.02 108.806 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.539 0.549 0 CA-C-N 114.401 -1.272 . . . . 74.53 111.269 170.232 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.452 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 12.1 tpt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 112.797 0.666 . . . . 70.22 112.797 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 92.5 m -143.05 141.59 31.33 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.096 0.958 . . . . 61.3 110.282 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -160.91 90.21 0.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.263 -1.755 . . . . 73.14 106.263 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -114.03 150.23 34.24 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.854 -0.612 . . . . 72.13 110.377 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.4 120.86 43.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.767 0.827 . . . . 73.03 109.057 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -100.27 -49.54 4.23 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.014 0.196 . . . . 74.24 110.575 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -167.81 118.72 0.83 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.559 -0.163 . . . . 73.15 110.559 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.04 134.26 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.065 -1.458 . . . . 74.12 107.065 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.538 ' HB3' HG23 ' C' ' 122' ' ' THR . 37.2 p90 -164.96 177.35 7.89 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.528 0.68 . . . . 64.1 111.705 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -97.43 124.16 41.52 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.181 -0.918 . . . . 63.04 109.053 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.3 mtpt -88.61 -27.54 21.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.61 -0.515 . . . . 65.35 109.61 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.3 t70 -150.06 145.09 26.17 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.426 -0.806 . . . . 72.43 109.784 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.516 HG21 ' HE2' ' C' ' 117' ' ' MET . 64.0 mt -144.99 149.08 17.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.411 1.484 . . . . 72.42 107.667 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -151.87 144.88 24.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.553 0.741 . . . . 64.45 109.528 171.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.4 t80 -154.1 123.81 6.69 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.089 -1.448 . . . . 61.31 107.089 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 49.1 mt-10 -131.36 142.5 50.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.252 0.548 . . . . 75.41 110.089 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.68 74.49 10.36 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.404 1.082 . . . . 74.21 108.144 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.4 -43.39 4.32 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 121.906 1.738 . . . . 73.23 110.937 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.448 ' O ' HG23 ' D' ' 31' ' ' VAL . 6.1 m120 -92.17 25.49 2.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.601 1.16 . . . . 65.22 109.769 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HD2' ' C' ' 19' ' ' LYS . . . -54.64 -56.73 23.99 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.326 1.232 . . . . 71.23 114.326 -168.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.89 -19.09 18.47 Favored 'Trans proline' 0 C--N 1.386 2.553 0 CA-C-N 121.437 1.549 . . . . 72.23 112.089 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 1.4 t60 -70.87 -36.76 72.95 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.018 1.327 . . . . 71.15 110.342 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' D' ' 73' ' ' ALA . 84.5 t -79.0 -33.98 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.38 0.672 . . . . 74.13 110.68 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -60.82 -20.83 62.39 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.737 0.643 . . . . 64.21 112.737 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -64.8 -32.96 74.89 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 64.42 110.621 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -91.52 105.91 18.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.25 1.02 . . . . 63.2 108.813 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.08 89.81 5.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.287 0.635 . . . . 71.31 109.595 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.595 ' HB3' HD11 ' D' ' 68' ' ' LEU . 41.5 t-105 -163.75 158.45 20.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.479 0.712 . . . . 73.41 109.854 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.66 115.13 61.93 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.917 0.887 . . . . 75.23 110.148 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -51.64 166.71 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 125.029 3.819 . . . . 64.33 116.667 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -98.22 113.24 25.1 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.439 -1.255 . . . . 72.44 108.316 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.591 HG13 HG13 ' D' ' 64' ' ' VAL . 45.0 t -98.43 111.37 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.661 0.784 . . . . 53.34 110.767 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -86.85 117.36 25.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.796 -1.557 . . . . 71.45 106.796 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 tp -96.33 141.74 29.3 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.251 -0.648 . . . . 74.24 109.251 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.6 t70 -129.87 146.77 51.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.826 -1.175 . . . . 74.5 107.826 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 44' ' ' LEU . . . . . 0.485 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.9 pt? -125.94 141.69 51.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.347 0.659 . . . . 74.44 110.049 -171.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.3 t70 -157.74 150.84 23.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.835 0.854 . . . . 65.12 109.212 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -130.77 158.07 41.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 60.2 108.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.14 173.7 14.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.99 -0.55 . . . . 63.11 109.929 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.574 ' HB3' HD21 ' D' ' 98' ' ' LEU . 66.0 p -157.65 158.82 36.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.056 0.543 . . . . 43.42 110.745 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.31 118.27 2.25 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.215 1.006 . . . . 50.15 108.434 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -77.9 117.19 19.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.796 -0.816 . . . . 73.22 108.796 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.61 -35.07 14.45 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.861 -0.609 . . . . 55.54 110.406 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.17 -179.09 7.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.562 -0.745 . . . . 62.44 110.433 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.23 116.26 9.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.133 -0.939 . . . . 75.3 109.65 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.7 9.29 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.784 1.234 . . . . 63.24 112.502 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.26 114.29 46.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.629 -0.878 . . . . 71.34 108.629 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -125.04 129.42 50.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.15 0.98 . . . . 73.01 108.741 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.1 117.47 34.42 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 124.222 1.009 . . . . 73.51 108.664 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.495 HG11 ' HD3' ' D' ' 103' ' ' PRO . 43.6 t -100.52 135.82 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.243 -1.021 . . . . 71.14 108.243 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 84.5 t -113.72 146.56 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.74 0.816 . . . . 65.1 109.072 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.47 124.92 42.44 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.079 -1.452 . . . . 73.43 107.079 176.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.9 ttm-85 -104.68 105.13 15.09 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.71 -0.848 . . . . 74.02 108.71 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.17 103.08 14.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.844 -1.169 . . . . 71.34 107.844 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 37.8 m -102.08 129.14 48.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.249 0.619 . . . . 73.23 109.805 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.591 HG13 HG13 ' D' ' 40' ' ' VAL . 74.2 t -129.1 102.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.435 1.094 . . . . 54.23 109.15 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 61.8 m -102.07 108.09 19.41 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.433 -0.951 . . . . 50.05 108.433 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.37 141.85 41.14 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.081 -0.711 . . . . 54.12 109.081 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.1 p -147.56 126.4 12.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.394 -0.821 . . . . 63.22 109.58 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' D' ' 36' ' ' TRP . 30.8 tp -99.87 110.44 22.8 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.521 -0.918 . . . . 72.51 108.521 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.46 -124.09 6.39 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.402 -0.679 . . . . 73.33 111.402 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 5.67 46.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.287 0.635 . . . . 74.25 110.966 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.18 144.85 47.48 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.382 0.673 . . . . 71.1 111.319 -170.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -63.64 125.23 23.6 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.57 0.748 . . . . 71.31 110.551 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.41 -73.83 0.5 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.286 1.034 . . . . 65.22 109.648 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -144.17 138.02 27.84 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-O 121.246 0.546 . . . . 51.12 110.127 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.6 mt -103.08 148.14 26.09 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.257 1.023 . . . . 70.23 108.413 175.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.0 t -160.22 146.41 15.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.082 0.553 . . . . 72.12 110.381 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -157.18 127.6 6.47 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.063 -0.717 . . . . 65.44 109.063 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.429 HG22 HG23 ' D' ' 21' ' ' ILE . 67.7 t -126.73 115.89 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.857 0.463 . . . . 71.33 109.9 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.639 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.3 mt-30 -91.79 87.16 6.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.5 0.72 . . . . 71.01 109.181 170.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -79.43 108.44 12.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.566 -1.197 . . . . 75.34 108.81 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.43 141.69 15.4 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.693 -0.563 . . . . 33.31 111.693 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.408 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.41 130.49 5.13 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.045 -0.822 . . . . 53.21 111.045 -175.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.1 mt -88.97 116.45 30.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.701 1.2 . . . . 71.23 108.995 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -120.7 143.87 48.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.747 0.819 . . . . 73.32 109.237 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -98.29 96.84 8.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.905 -0.776 . . . . 75.51 108.905 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.65 109.16 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.401 -0.963 . . . . 54.55 108.401 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -140.66 168.65 19.29 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.14 0.976 . . . . 45.45 109.527 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.18 -15.09 30.01 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 114.189 0.435 . . . . 74.42 114.189 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -139.4 153.54 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.579 0.752 . . . . 64.31 110.144 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . 0.504 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -149.81 -170.24 3.59 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.778 0.831 . . . . 75.21 110.662 177.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.36 -142.33 26.98 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.002 -0.544 . . . . 61.24 113.843 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -73.94 -21.0 60.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.483 0.713 . . . . 70.34 111.762 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.35 -47.98 66.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.191 0.597 . . . . 72.34 110.273 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 23.5 ptt? -71.94 -27.27 62.68 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.349 0.406 . . . . 70.53 110.608 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.41 67.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.45 0.7 . . . . 55.3 111.25 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.6 t-80 -71.93 -29.32 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.593 0.757 . . . . 54.2 110.663 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.14 -43.45 78.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 110.327 -0.249 . . . . 63.2 110.327 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' D' ' 48' ' ' SER . 9.2 tt -75.36 -45.23 40.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.524 0.73 . . . . 61.12 110.712 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.73 6.97 79.87 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.769 -0.462 . . . . 52.04 114.063 -172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -147.09 -63.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.489 0.645 . . . . 63.11 111.8 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.6 -40.26 84.77 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.632 0.604 . . . . 61.43 112.632 -169.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.12 -44.66 14.09 Favored Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.413 0.685 . . . . 73.4 111.575 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.584 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.7 Cg_exo -54.66 -32.62 76.21 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 122.815 2.343 . . . . 72.53 113.448 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' D' ' 133' ' ' PHE . 4.1 t-20 -64.8 -36.62 84.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.178 0.591 . . . . 64.15 110.915 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.9 -42.82 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.577 0.751 . . . . 73.42 110.07 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.408 HD21 ' HA3' ' D' ' 82' ' ' GLY . 84.1 mt -76.8 -20.63 56.18 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.943 -1.026 . . . . 74.13 112.053 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -64.09 -45.73 79.81 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 114.55 1.315 . . . . 75.23 114.55 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 108' ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 22.1 Cg_endo -59.16 -35.2 98.21 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.656 1.571 . . . . 73.53 112.683 174.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.9 -36.21 64.73 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.822 0.849 . . . . 72.53 111.601 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.35 -50.59 69.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.835 0.854 . . . . 73.41 109.947 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -55.76 -48.68 74.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.996 -1.456 . . . . 63.35 111.225 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -62.99 -45.88 90.33 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.637 0.775 . . . . 74.23 111.278 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.9 t -55.45 -39.28 70.11 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.942 0.776 . . . . 73.11 111.002 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.544 HG21 HD12 ' D' ' 126' ' ' LEU . 52.8 mt -66.62 -50.92 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.373 -0.83 . . . . 74.4 110.779 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.6 m -58.79 -38.5 78.7 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.898 0.749 . . . . 55.23 111.54 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 38.5 t -63.69 -44.87 92.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.268 -0.878 . . . . 73.23 110.538 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -67.47 -35.15 78.62 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.95 0.5 . . . . 71.1 111.538 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.22 -40.37 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.972 0.909 . . . . 72.5 110.672 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.52 -32.83 66.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 120.959 0.409 . . . . 74.02 110.718 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' D' ' 116' ' ' SER . 94.5 mtt-85 -67.39 -31.83 72.32 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.698 0.799 . . . . 74.15 110.204 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 121' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -87.93 6.07 84.0 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.896 0.747 . . . . 75.4 112.983 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' C' ' 17' ' ' TYR . 48.8 p 54.74 27.61 9.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 126.199 1.8 . . . . 73.35 113.408 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -92.25 159.9 36.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.43 1.092 . . . . 63.22 110.686 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.17 138.29 85.6 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.405 2.736 . . . . 62.35 112.259 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -50.99 129.97 24.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.726 1.266 . . . . 65.3 112.758 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.544 HD12 HG21 ' D' ' 114' ' ' ILE . 2.7 tm? -115.9 95.74 5.26 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.32 107.714 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -133.83 114.58 13.5 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.872 -1.158 . . . . 52.23 107.872 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.6 148.96 40.3 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.652 -0.704 . . . . 64.52 110.417 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.79 162.93 64.58 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.997 -1.001 . . . . 71.21 109.966 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.34 154.94 49.43 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.255 1.97 . . . . 70.52 112.868 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.63 139.43 23.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 115.683 -0.69 . . . . 53.34 109.378 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -68.44 117.54 10.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.949 -0.759 . . . . 62.33 108.949 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' D' ' 104' ' ' ASN . 33.3 p90 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 123.982 0.913 . . . . 74.02 113.388 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 108.553 -0.906 . . . . 72.21 108.553 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.419 ' HZ ' ' SG ' ' A' ' 102' ' ' CYS . 1.2 t80 -139.76 114.84 9.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.625 -0.88 . . . . 75.05 108.625 167.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -155.63 137.29 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.24 0.616 . . . . 71.43 109.668 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.646 ' H ' HD12 ' A' ' 13' ' ' ILE . 2.5 mp -75.96 131.72 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.474 -0.935 . . . . 74.52 108.474 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 -35.79 12.52 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.808 0.276 . . . . 65.41 111.052 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 137.58 12.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 121.999 0.12 . . . . 75.15 110.821 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.438 HG13 HG21 ' A' ' 13' ' ' ILE . 2.3 mp -122.88 118.84 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.058 -1.46 . . . . 74.1 107.058 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 43.7 p90 -166.55 177.57 6.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.218 1.008 . . . . 74.13 113.031 -171.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -102.68 124.02 47.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.253 -1.34 . . . . 73.33 108.875 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.9 mtpt -91.58 -24.05 19.7 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.03 0.443 . . . . 73.41 110.071 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -153.21 138.26 17.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.937 -1.029 . . . . 71.14 109.308 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 74.5 mt -141.93 143.64 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.088 1.355 . . . . 63.23 107.593 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -155.8 139.16 15.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.343 0.592 . . . . 71.33 110.136 170.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -131.14 134.88 46.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.32 -1.733 . . . . 74.35 106.32 171.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.08 118.74 12.34 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.132 -0.692 . . . . 70.13 109.132 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.51 82.11 59.14 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 107.205 -1.405 . . . . 73.34 107.205 173.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.39 -29.8 20.31 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.171 1.914 . . . . 64.21 110.344 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.624 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 7.4 m120 -110.14 31.69 5.7 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.904 -1.044 . . . . 72.11 109.598 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.547 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.58 -44.58 99.23 Favored Pre-proline 0 CA--C 1.565 1.525 0 C-N-CA 123.736 0.815 . . . . 75.53 112.276 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.64 -20.07 20.72 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 121.735 1.623 . . . . 75.13 112.786 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.1 m80 -85.25 -20.01 30.74 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.851 0.461 . . . . 64.32 111.945 -171.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG11 ' HE2' ' A' ' 123' ' ' PHE . 9.8 p -71.61 -19.19 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 120.968 0.414 . . . . 71.13 111.297 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -78.73 -41.68 30.18 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.572 0.749 . . . . 75.03 110.745 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -75.95 -29.0 58.14 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.904 0.482 . . . . 64.03 110.63 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 33.8 mmtp -83.2 169.45 15.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.273 0.629 . . . . 75.32 110.543 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.14 128.96 37.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.557 -0.905 . . . . 75.23 108.557 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HH2' ' NH2' ' B' ' 15' ' ' ARG . 2.8 t90 -84.78 68.31 10.4 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.148 0.975 . . . . 71.22 108.6 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.36 76.38 10.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 114.226 -1.352 . . . . 75.34 107.638 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -85.52 166.83 10.43 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.298 1.999 . . . . 45.35 111.389 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.19 128.53 42.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.35 -1.352 . . . . 70.15 107.35 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.519 0.676 . . . . 73.15 110.358 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 1.7 ttpp -116.65 115.62 26.02 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.916 -1.142 . . . . 72.21 107.916 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.15 106.48 15.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.342 -0.984 . . . . 64.14 108.342 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.591 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -109.02 111.67 23.44 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.816 -0.809 . . . . 73.21 108.816 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.43 122.6 46.94 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.564 -0.532 . . . . 65.03 109.564 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -139.03 135.25 34.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.171 0.989 . . . . 61.13 109.399 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.8 m -107.52 138.57 43.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.278 0.631 . . . . 64.31 109.607 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.29 150.22 52.24 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.659 1.183 . . . . 63.53 108.012 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.2 m -124.38 161.18 26.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.144 0.497 . . . . 74.44 111.208 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 t -150.21 147.41 27.66 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.995 1.318 . . . . 64.34 108.768 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -112.85 124.52 52.78 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.947 -0.76 . . . . 62.32 108.947 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.72 -36.38 9.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.983 0.513 . . . . 71.04 110.471 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.69 -174.23 4.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.584 0.754 . . . . 62.43 110.2 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.39 117.57 8.81 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 24.8 m-20 67.89 5.26 4.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.531 1.133 . . . . 64.23 112.583 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -108.78 104.52 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.52 -1.289 . . . . 74.3 107.52 173.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -122.58 146.47 47.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.499 0.666 . . . . 72.33 110.714 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 112.58 15.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.185 -1.413 . . . . 72.53 107.185 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 98' ' ' LEU . 30.8 m -102.91 126.62 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.077 -1.082 . . . . 41.42 108.077 174.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.536 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.4 t -102.97 129.39 54.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.721 0.808 . . . . 72.12 109.342 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.401 HD11 ' HD1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -98.84 112.13 24.32 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.59 -1.263 . . . . 73.2 107.59 -177.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -103.17 106.89 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.638 0.775 . . . . 74.13 109.883 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.32 133.3 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.836 -1.074 . . . . 65.42 109.15 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.4 m -116.34 143.13 45.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.604 -0.888 . . . . 71.04 108.604 171.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 37.1 t -133.94 130.73 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.138 -1.43 . . . . 60.15 107.138 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -132.46 139.08 47.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.007 -0.368 . . . . 71.45 110.007 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.84 105.32 12.57 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.131 -1.063 . . . . 61.42 108.131 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -133.24 126.21 31.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.906 0.483 . . . . 53.23 110.525 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.12 86.33 4.56 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.14 -1.429 . . . . 74.32 107.14 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.99 -85.06 1.0 Allowed Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.448 -0.661 . . . . 73.15 111.448 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -118.1 -27.32 6.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 73.53 110.015 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.508 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -77.8 91.77 4.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.042 0.537 . . . . 75.41 109.853 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 85.1 m -73.79 105.97 5.31 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 122.894 0.477 . . . . 61.05 110.205 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.53 72.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.493 1.117 . . . . 43.53 110.061 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -161.35 173.07 15.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.078 -1.419 . . . . 70.41 111.548 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 76' ' ' CYS . 25.4 tp -142.06 147.97 37.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.67 1.588 . . . . 72.42 107.904 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.2 m -144.91 140.27 28.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.449 1.1 . . . . 70.42 109.266 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -149.55 120.32 7.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.32 -0.622 . . . . 71.33 109.32 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 113' ' ' CYS . 58.7 t -128.75 113.29 28.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.622 0.769 . . . . 74.15 109.684 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.8 mt-30 -89.88 90.89 8.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.552 0.741 . . . . 74.5 109.581 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -80.97 98.97 8.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.224 1.01 . . . . 75.23 109.007 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -98.55 144.58 17.31 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 112.152 -0.379 . . . . 55.11 112.152 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.86 132.44 6.03 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 110.994 -0.842 . . . . 70.23 110.994 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.0 mt -83.86 129.77 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.695 -0.854 . . . . 64.24 108.695 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -129.79 120.11 24.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.122 0.569 . . . . 70.13 109.703 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -82.8 110.85 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.88 -0.785 . . . . 75.11 108.88 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 22.3 pt -120.9 157.3 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.369 0.668 . . . . 75.23 109.973 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.93 146.64 1.56 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.471 0.708 . . . . 62.43 110.47 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.74 -25.39 23.6 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 114.963 0.745 . . . . 72.31 114.963 169.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.2 pt -109.9 134.85 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.674 0.737 . . . . 62.43 109.857 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.29 172.11 12.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.587 . . . . 70.02 109.965 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -132.95 44.51 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.213 0.321 . . . . 62.2 113.578 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 27.1 p -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.987 0.915 . . . . 65.3 112.228 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -63.98 -54.53 33.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.405 0.682 . . . . 73.23 110.38 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -24.82 39.98 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.542 -0.754 . . . . 75.34 110.785 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -70.9 -28.1 64.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.744 0.418 . . . . 72.42 111.011 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.31 -51.06 26.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.357 0.663 . . . . 73.12 109.784 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 6.1 m -73.84 -35.63 64.83 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.706 1.002 . . . . 74.23 113.706 -167.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB3' HG11 ' A' ' 58' ' ' VAL . 88.8 mt -87.4 -23.61 24.48 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.011 0.369 . . . . 75.25 111.003 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.15 -20.53 35.59 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 114.434 0.534 . . . . 61.42 114.434 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -138.05 -60.16 0.63 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.202 0.601 . . . . 54.24 111.59 -170.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 9.7 t80 -52.68 -56.28 16.59 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.411 1.084 . . . . 71.43 112.26 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.419 ' SG ' ' HZ ' ' A' ' 11' ' ' PHE . 82.2 m -74.49 -44.3 5.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.454 -1.26 . . . . 62.2 114.314 -171.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.38 -27.51 85.18 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.914 1.719 . . . . 61.34 112.439 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -73.86 -32.19 63.53 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 122.811 0.444 . . . . 70.23 110.663 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.6 mm -65.89 -42.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.706 0.802 . . . . 64.32 109.935 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.03 -18.39 60.34 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.128 -0.942 . . . . 60.22 111.292 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.401 ' HD1' HD11 ' A' ' 60' ' ' LEU . 24.6 t80 -70.92 -43.38 13.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.543 -1.218 . . . . 73.33 114.158 -170.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.526 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 32.1 Cg_endo -63.12 -27.51 73.35 Favored 'Trans proline' 0 C--N 1.383 2.38 0 CA-C-N 122.087 1.781 . . . . 71.13 112.363 172.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.44 -41.01 48.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.442 0.697 . . . . 74.51 111.7 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.88 75.7 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.994 -0.373 . . . . 54.12 109.994 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.441 ' NH1' HD12 ' C' ' 105' ' ' ILE . 39.0 ttm180 -55.29 -49.73 71.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.547 1.155 . . . . 73.55 109.873 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.03 -47.82 84.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.188 0.93 . . . . 64.11 111.176 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB3' HG11 ' A' ' 78' ' ' VAL . 34.4 t -65.1 -37.01 86.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.95 0.781 . . . . 72.2 111.637 -174.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.574 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 92.3 mt -67.21 -60.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.179 -0.674 . . . . 62.35 109.179 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.528 HG23 ' HG3' ' A' ' 125' ' ' GLN . 66.4 m -50.73 -37.35 41.21 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.84 1.338 . . . . 71.15 112.309 -176.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.9 t -69.38 -43.83 72.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.71 -0.677 . . . . 43.2 110.065 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 44.0 mtm -62.9 -38.64 91.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.798 0.439 . . . . 72.14 111.063 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 114' ' ' ILE . 87.0 t -57.66 -50.24 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.34 1.025 . . . . 65.41 110.005 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -73.7 -28.53 61.78 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.644 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -70.47 -27.73 64.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.495 0.718 . . . . 72.3 109.96 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 5.99 69.82 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.748 0.655 . . . . 61.22 113.331 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.522 HG22 HH21 ' B' ' 15' ' ' ARG . 6.5 m 64.87 27.98 12.78 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.833 1.253 . . . . 70.33 110.753 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG11 ' A' ' 31' ' ' VAL . 90.1 m-85 -97.45 153.85 38.21 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.455 1.102 . . . . 62.14 109.337 172.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -65.96 143.31 72.17 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.104 1.87 . . . . 60.22 111.37 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.528 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -59.07 137.67 57.85 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 124.191 0.932 . . . . 74.24 112.565 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.15 102.0 5.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.399 -0.963 . . . . 73.11 108.399 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.984 -0.747 . . . . 63.23 108.984 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.53 139.33 56.96 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 71.01 109.837 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.12 128.54 92.45 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 122.983 0.513 . . . . 73.33 111.226 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 2.7 Cg_exo -76.43 89.36 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.964 2.443 . . . . 60.02 112.456 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.61 115.02 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.808 0.843 . . . . 73.53 109.434 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.95 106.03 5.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.446 0.698 . . . . 75.32 110.314 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.97 -6.26 58.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.732 0.813 . . . . 73.02 111.978 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.49 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 2.0 m-20 . . . . . 0 N--CA 1.481 1.089 0 O-C-N 123.438 0.461 . . . . 75.32 110.519 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.51 ' HB3' HG23 ' B' ' 89' ' ' ILE . 22.5 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 116.216 1.932 . . . . 61.23 116.216 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.8 m -143.25 118.96 10.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.494 -1.685 . . . . 71.1 107.763 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -120.22 134.93 55.15 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.092 -0.707 . . . . 74.52 109.092 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -151.19 127.79 10.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.051 -0.722 . . . . 73.44 109.051 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.482 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -86.05 143.39 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.234 -0.654 . . . . 54.12 109.234 173.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -109.3 -48.46 3.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.032 0.533 . . . . 64.55 109.58 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.522 HH21 HG22 ' A' ' 122' ' ' THR . 16.0 ttt180 -158.17 149.91 21.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.463 -0.335 . . . . 63.13 110.948 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -127.96 144.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.594 -1.632 . . . . 73.33 106.594 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -171.66 147.12 2.25 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.493 0.317 . . . . 73.13 111.342 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -73.79 119.36 17.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.605 -0.887 . . . . 61.55 108.605 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -92.26 -33.69 14.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.966 0.506 . . . . 74.4 110.362 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.2 t70 -151.78 143.2 23.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.836 -168.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.1 mm -140.96 147.12 22.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.715 1.606 . . . . 72.11 107.59 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -150.33 140.27 21.93 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.888 -0.782 . . . . 52.22 108.888 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -145.65 125.2 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.506 -1.294 . . . . 74.32 107.506 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -128.54 122.46 31.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.685 0.794 . . . . 64.05 109.338 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.14 84.8 9.48 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.121 -1.437 . . . . 53.3 107.121 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.22 -31.53 35.58 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.646 2.231 . . . . 72.21 111.951 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -124.31 27.41 7.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.07 0.948 . . . . 50.34 110.138 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.751 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.14 -53.13 17.81 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 125.395 1.478 . . . . 74.32 114.741 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.21 -9.24 14.0 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.904 1.736 . . . . 74.03 112.891 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -95.68 -33.39 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.687 0.795 . . . . 63.22 110.54 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' B' ' 34' ' ' LYS . 8.7 p -81.36 -8.38 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.854 0.862 . . . . 60.32 110.379 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -59.29 -37.43 77.68 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.784 0.833 . . . . 74.33 110.232 171.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -69.83 -26.94 64.47 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.513 0.725 . . . . 71.32 111.168 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' HG23 ' B' ' 31' ' ' VAL . 84.7 mttt -87.02 97.45 10.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.205 0.602 . . . . 72.35 110.391 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.09 77.88 9.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.091 0.472 . . . . 53.33 110.352 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.479 ' HB2' HD11 ' B' ' 68' ' ' LEU . 17.1 m-90 -151.84 168.88 23.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.414 1.086 . . . . 75.45 108.283 176.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -86.41 115.73 63.24 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.795 -1.187 . . . . 74.33 107.795 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 30.8 Cg_endo -62.44 139.67 77.89 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.248 1.966 . . . . 51.41 111.195 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.1 104.06 0.68 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.036 -0.728 . . . . 53.31 109.036 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.435 HG11 HD23 ' B' ' 126' ' ' LEU . 27.2 m -92.05 158.52 2.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.109 -0.951 . . . . 74.34 111.56 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -149.04 118.84 7.05 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.286 -1.325 . . . . 61.31 108.551 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.95 148.87 25.15 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.027 -0.731 . . . . 74.12 109.027 163.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.87 110.27 2.86 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.57 -1.271 . . . . 64.14 107.57 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.436 HD22 HG11 ' B' ' 131' ' ' VAL . 5.6 mp -101.71 152.09 21.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.932 0.893 . . . . 73.25 109.85 -174.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.439 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 13.7 t70 -145.82 144.66 30.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.198 1.399 . . . . 62.31 108.42 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -114.05 141.14 47.83 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.342 -0.614 . . . . 75.52 109.342 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.69 154.92 49.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.014 0.926 . . . . 63.32 109.026 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -145.05 163.22 34.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.328 0.651 . . . . 74.54 110.781 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -152.47 139.26 18.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.476 1.11 . . . . 70.13 108.17 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -96.27 118.02 31.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.427 -0.583 . . . . 65.4 109.427 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -90.41 -39.81 12.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.691 -0.485 . . . . 74.34 109.691 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.92 -171.64 3.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.309 -0.86 . . . . 60.24 110.332 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.84 119.76 8.84 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 114.946 -1.024 . . . . 72.43 109.927 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.7 -1.73 1.56 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.575 1.15 . . . . 71.12 112.777 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.6 t -104.33 106.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.617 -0.882 . . . . 54.34 108.617 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.08 134.82 54.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.196 0.522 . . . . 74.53 110.224 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -100.32 97.43 8.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.482 -1.673 . . . . 65.11 106.482 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.29 124.5 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.853 0.861 . . . . 74.13 109.121 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.703 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 38.4 t -100.68 142.97 14.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.122 -0.696 . . . . 60.53 109.122 177.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -116.29 121.01 40.75 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.576 -1.268 . . . . 63.23 107.576 173.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.439 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 58.0 ttt180 -106.76 116.77 32.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.249 1.02 . . . . 64.51 109.545 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -114.79 120.23 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.963 -1.125 . . . . 75.21 107.963 171.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -116.03 133.36 56.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.227 0.611 . . . . 73.25 109.403 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.642 HG21 HG21 ' B' ' 114' ' ' ILE . 38.7 t -114.28 136.35 51.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.406 1.083 . . . . 74.3 110.586 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -125.1 145.18 50.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.672 1.189 . . . . 62.22 108.303 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.08 141.61 25.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.006 -0.738 . . . . 71.32 109.006 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.3 p -146.37 134.96 22.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.716 0.635 . . . . 73.04 109.829 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' B' ' 36' ' ' TRP . 14.4 tp -132.24 122.23 24.87 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.805 -0.813 . . . . 74.11 108.805 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.93 -128.21 8.32 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.868 0.73 . . . . 71.12 112.215 -174.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.67 19.62 20.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.519 0.728 . . . . 74.42 110.927 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -156.54 167.05 31.63 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.808 0.443 . . . . 60.54 111.83 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -70.56 136.39 49.24 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.406 -0.815 . . . . 74.23 110.275 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -89.71 -54.81 3.89 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.117 0.967 . . . . 61.11 109.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.73 167.58 29.12 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.267 -0.879 . . . . 75.25 110.971 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.57 145.12 34.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.868 1.667 . . . . 73.53 107.553 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -151.14 159.43 44.46 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.175 -0.676 . . . . 51.33 109.175 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.78 136.62 3.7 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.989 -0.745 . . . . 70.31 108.989 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.8 t -130.0 144.87 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.967 -0.753 . . . . 71.42 108.967 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 71.3 mt-30 -128.18 97.66 4.84 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.237 -0.653 . . . . 71.43 109.237 173.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -88.15 103.13 15.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.028 -0.987 . . . . 72.33 108.881 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.01 147.46 19.28 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.602 -0.599 . . . . 70.12 111.602 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.15 126.54 2.74 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.535 -0.626 . . . . 54.05 111.535 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -85.57 117.95 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.412 -0.958 . . . . 72.22 108.412 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -124.49 167.07 14.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 74.44 109.816 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -132.47 114.59 14.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.13 0.972 . . . . 75.04 109.157 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.2 pp -118.96 135.84 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.15 0.98 . . . . 62.32 110.429 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 166.66 32.4 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.732 0.813 . . . . 55.24 109.42 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.84 -61.79 4.71 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.267 0.355 . . . . 54.31 112.398 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.684 HD13 ' SD ' ' B' ' 94' ' ' MET . 1.1 pp -56.97 150.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.877 0.871 . . . . 61.44 112.802 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.53 164.01 36.52 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.69 0.796 . . . . 74.22 110.659 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -120.72 23.69 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.803 0.689 . . . . 71.44 113.312 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.2 m -67.95 -35.23 78.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.282 0.633 . . . . 64.02 111.588 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -68.91 -43.33 75.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.103 0.561 . . . . 71.44 110.726 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.684 ' SD ' HD13 ' B' ' 89' ' ' ILE . 5.3 tpt -67.85 -43.45 79.45 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.952 -0.567 . . . . 74.24 110.327 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.57 75.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.206 0.603 . . . . 63.31 111.899 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.44 -32.0 58.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.665 0.786 . . . . 74.5 110.776 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.81 -52.87 17.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.889 0.476 . . . . 64.43 111.225 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' B' ' 94' ' ' MET . 4.5 pp -69.71 -26.36 64.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.058 0.543 . . . . 71.3 110.786 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 3.15 63.24 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-O 119.246 -0.752 . . . . 53.03 114.839 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -154.11 -53.52 0.1 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.853 0.826 . . . . 70.03 112.138 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.6 -56.03 16.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.556 0.742 . . . . 54.51 111.206 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.9 m -61.51 -50.22 83.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.253 -0.879 . . . . 64.05 112.191 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.6 Cg_exo -55.06 -36.43 92.8 Favored 'Trans proline' 0 C--N 1.399 3.194 0 C-N-CA 122.287 1.991 . . . . 63.42 113.975 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.22 -33.82 76.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.65 0.38 . . . . 60.05 111.323 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.18 -44.61 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 60.11 110.446 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HB2' HD12 ' B' ' 60' ' ' LEU . 77.3 mt -83.29 -19.4 36.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.913 -1.04 . . . . 71.34 112.637 -169.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.41 -45.84 94.58 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 117.677 -1.154 . . . . 70.11 113.689 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.61 -43.25 46.51 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.656 2.238 . . . . 63.21 113.977 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 73.7 m-85 -65.94 -44.92 83.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.873 0.733 . . . . 71.13 110.506 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.55 87.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.656 -0.702 . . . . 74.14 111.06 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.69 -53.57 54.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.044 1.338 . . . . 74.11 110.953 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -40.68 95.21 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.722 0.639 . . . . 75.45 110.223 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.468 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -66.66 -33.26 75.26 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 123.814 0.696 . . . . 73.13 111.853 -174.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.642 HG21 HG21 ' B' ' 64' ' ' VAL . 71.3 mt -68.24 -52.63 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.398 -0.593 . . . . 73.51 109.398 172.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.5 m -59.12 -28.65 66.74 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 124.176 0.922 . . . . 74.23 111.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -66.99 -53.17 34.03 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 115.297 -0.865 . . . . 70.04 109.658 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.49 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 20.6 mmt -64.3 -34.72 78.78 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 123.455 0.472 . . . . 60.15 111.95 -176.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.78 -48.39 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.906 0.882 . . . . 74.42 110.665 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -72.41 -24.22 61.2 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.872 -0.604 . . . . 64.31 111.448 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -67.5 -32.68 73.67 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.359 0.664 . . . . 72.54 109.907 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.23 8.69 75.81 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.96 0.788 . . . . 64.0 113.282 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 17' ' ' TYR . 69.9 p 57.7 34.07 24.01 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.976 1.71 . . . . 73.03 113.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.22 156.27 39.07 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.808 0.843 . . . . 73.44 110.18 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 179.57 0.55 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.124 2.549 . . . . 74.11 113.542 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -56.68 113.88 1.82 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.501 -0.772 . . . . 75.42 111.254 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.435 HD23 HG11 ' B' ' 40' ' ' VAL . 3.2 tm? -129.22 100.91 5.78 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.486 -1.672 . . . . 73.04 106.486 172.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -131.44 134.11 45.87 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.691 -0.855 . . . . 74.1 108.691 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.3 132.93 35.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.553 0.741 . . . . 73.04 110.419 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.69 154.0 81.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.047 0.939 . . . . 73.53 110.151 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.401 ' HD3' HD13 ' D' ' 16' ' ' ILE . 35.8 Cg_endo -59.98 114.18 1.97 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.931 2.421 . . . . 51.4 111.845 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.436 HG11 HD22 ' B' ' 44' ' ' LEU . 90.7 t -90.0 118.15 34.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.644 -0.707 . . . . 55.3 109.998 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.91 93.47 3.78 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.292 -0.632 . . . . 74.42 109.292 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 91.6 m-85 -62.65 -35.76 80.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.673 -1.149 . . . . 71.04 110.858 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -63.69 -39.53 94.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.516 -1.22 . . . . 63.45 110.961 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.61 -27.48 58.49 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.705 0.628 . . . . 62.12 111.807 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.121 -0.696 . . . . 71.32 109.121 178.555 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.747 0.308 . . . . 64.23 111.305 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -85.92 93.43 8.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.218 -0.66 . . . . 74.21 109.218 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.458 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.9 t80 -118.97 123.56 44.87 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.983 -1.008 . . . . 72.4 108.392 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -137.84 140.96 40.76 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.707 0.403 . . . . 72.44 110.068 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.608 HD11 HG13 ' C' ' 16' ' ' ILE . 5.6 tp -85.27 136.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.128 0.571 . . . . 74.23 109.854 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.9 mm100 -109.55 -50.64 2.96 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.615 -0.721 . . . . 74.14 109.74 174.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -169.02 138.65 2.18 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.655 -0.702 . . . . 73.51 109.41 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.608 HG13 HD11 ' C' ' 13' ' ' ILE . 88.4 mt -122.39 144.57 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.6 -1.259 . . . . 73.44 107.6 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.5 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -174.24 165.26 4.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.364 0.602 . . . . 75.21 110.612 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.411 HG22 HE22 ' C' ' 80' ' ' GLN . 81.4 p -85.04 107.35 17.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.997 -1.001 . . . . 72.24 109.802 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.423 ' HZ3' ' HD3' ' D' ' 29' ' ' PRO . 23.6 mmmt -65.86 -35.03 79.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.761 -0.654 . . . . 74.44 109.877 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -150.53 144.4 25.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.98 -1.009 . . . . 74.24 109.549 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.3 mt -139.28 140.45 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.64 -1.615 . . . . 74.25 106.64 172.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.43 147.6 17.56 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.799 -0.445 . . . . 74.31 109.799 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -147.32 116.67 6.98 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.192 -1.04 . . . . 72.54 108.192 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.94 120.44 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.77 0.828 . . . . 74.53 108.99 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -124.2 85.58 54.96 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 73.15 108.583 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.12 -32.58 33.82 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.725 2.284 . . . . 75.32 111.595 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 73.6 m-20 -114.56 38.4 3.11 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.023 0.929 . . . . 70.25 109.422 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.83 -50.98 85.09 Favored Pre-proline 0 CA--C 1.569 1.682 0 N-CA-C 114.333 1.234 . . . . 64.21 114.333 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.2 Cg_exo -73.6 -28.59 11.7 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 121.871 1.714 . . . . 74.1 111.554 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.407 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 80.5 t60 -68.0 -20.67 65.04 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.33 1.052 . . . . 64.31 112.583 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -62.07 -16.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 118.117 0.417 . . . . 74.14 111.827 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.43 -43.53 76.93 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.492 -0.558 . . . . 71.33 109.492 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -92.07 51.24 1.77 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.62 1.168 . . . . 75.12 109.379 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.01 148.11 47.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.099 0.56 . . . . 71.23 110.997 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.47 129.28 37.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.19 -1.041 . . . . 72.45 108.19 164.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -83.93 69.5 10.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.799 0.809 . . . . 74.44 110.738 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.63 73.19 13.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.103 1.361 . . . . 71.54 107.46 165.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.59 118.87 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.215 1.943 . . . . 64.24 111.419 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.52 116.11 22.95 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.388 -0.968 . . . . 71.15 108.388 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.44 101.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 114.743 -1.117 . . . . 51.03 108.827 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.45 103.9 16.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 74.31 108.258 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.26 133.15 33.71 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.187 -0.671 . . . . 64.41 109.187 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.5 t70 -119.63 143.64 47.57 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.763 1.225 . . . . 73.51 108.148 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.22 148.94 49.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.668 0.787 . . . . 74.21 109.173 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -156.18 150.79 25.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.657 0.783 . . . . 62.33 109.034 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -133.88 146.59 50.71 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.849 0.46 . . . . 70.04 110.236 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.99 144.8 30.34 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.5 -0.926 . . . . 74.13 108.5 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.3 p -126.99 147.04 50.13 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.156 0.583 . . . . 40.31 110.172 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -147.14 127.81 14.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.068 0.947 . . . . 54.43 108.941 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -81.41 117.62 22.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.232 -0.655 . . . . 74.11 109.232 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 23.8 mt -87.94 -40.63 13.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.566 0.747 . . . . 74.15 109.974 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -150.37 -177.42 5.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.806 -1.088 . . . . 74.24 110.282 -177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.83 109.43 1.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.512 -1.222 . . . . 71.24 110.11 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 70.22 7.67 6.32 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.165 1.386 . . . . 70.24 112.895 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 70.4 t -110.32 105.74 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.352 0.661 . . . . 73.35 109.593 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.99 129.06 56.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.195 0.998 . . . . 72.12 109.989 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.9 tt0 -85.61 143.78 28.25 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.157 -0.683 . . . . 72.45 109.157 165.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.437 HG13 HD11 ' C' ' 106' ' ' LEU . 5.0 p -132.07 134.95 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.094 -1.076 . . . . 72.43 108.094 169.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.74 105.92 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.352 -0.981 . . . . 73.04 108.352 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.97 108.01 19.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.756 -1.201 . . . . 61.02 107.756 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -79.05 123.48 27.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.21 1.004 . . . . 64.14 109.136 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.88 122.33 68.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.843 -1.169 . . . . 55.22 107.843 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 19.7 m -125.62 123.87 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.62 HG23 HD13 ' C' ' 114' ' ' ILE . 97.4 t -105.0 123.6 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.516 0.726 . . . . 54.42 109.107 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -113.96 115.0 26.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.701 -0.852 . . . . 73.33 108.701 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.785 -1.561 . . . . 70.32 106.785 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -154.71 -178.11 6.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.498 0.555 . . . . 74.23 112.498 -166.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -134.3 29.99 3.6 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.198 1.399 . . . . 61.41 107.784 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.35 -108.14 1.31 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.02 -0.991 . . . . 52.24 110.972 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.34 -31.39 18.94 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.598 -0.89 . . . . 72.41 108.598 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.95 91.79 0.21 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.743 1.217 . . . . 71.3 109.839 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.3 m -89.71 128.19 36.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.417 -0.811 . . . . 53.4 111.063 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 -58.45 3.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.058 -1.09 . . . . 71.31 108.058 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.33 144.59 22.07 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.051 -0.977 . . . . 73.54 110.747 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.458 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -105.04 145.75 30.03 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.662 -1.607 . . . . 72.15 106.662 163.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.458 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -150.42 143.23 24.66 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.182 -0.673 . . . . 72.11 109.182 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.09 131.9 17.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 71.45 109.95 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.86 123.52 62.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.684 -0.858 . . . . 75.44 108.684 168.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -97.84 104.33 16.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.037 -1.097 . . . . 75.42 108.037 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -91.98 114.47 27.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.17 0.588 . . . . 73.24 109.64 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.72 146.69 17.23 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.918 -0.473 . . . . 62.53 111.918 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.562 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.45 123.36 2.15 Favored Glycine 0 CA--C 1.505 -0.554 0 N-CA-C 111.302 -0.719 . . . . 72.04 111.302 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.539 HD12 HD11 ' C' ' 51' ' ' LEU . 7.1 mm -83.49 122.92 38.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.424 -0.954 . . . . 73.23 108.424 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -134.75 125.22 26.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.799 0.839 . . . . 71.5 109.633 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -80.48 109.47 15.02 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.35 -0.611 . . . . 52.4 109.35 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 60.3 mt -114.99 120.63 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.838 0.855 . . . . 71.44 109.567 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.66 163.17 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.367 1.067 . . . . 75.14 109.847 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.27 -36.41 3.42 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.283 -0.417 . . . . 50.32 112.385 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -112.75 141.23 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.647 1.179 . . . . 62.03 109.631 -173.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.95 156.39 42.2 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.615 0.766 . . . . 64.34 110.33 -175.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 -141.63 20.43 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.167 -0.47 . . . . 62.3 113.379 172.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -64.77 -28.66 69.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.805 0.842 . . . . 74.31 111.503 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.93 -46.39 89.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.871 0.868 . . . . 73.21 109.997 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.53 -35.24 75.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.985 -1.007 . . . . 63.04 110.259 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.16 -27.33 67.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.536 0.734 . . . . 72.3 111.654 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.29 -57.58 8.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.198 0.599 . . . . 73.33 110.439 171.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.0 -41.57 98.21 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.822 0.701 . . . . 75.01 111.195 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp -76.79 -27.18 55.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.413 1.085 . . . . 52.3 110.997 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.19 -5.32 46.7 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-O 119.378 -0.679 . . . . 63.15 114.325 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -135.32 -56.68 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.706 0.753 . . . . 64.34 111.59 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -68.98 -54.13 16.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.973 0.36 . . . . 71.14 111.973 -173.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 21.7 m -59.83 -46.29 98.33 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.673 -0.68 . . . . 62.01 111.317 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 56.6 Cg_exo -50.21 -39.53 52.12 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.106 2.538 . . . . 72.02 114.714 167.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.49 -23.9 61.89 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.296 0.638 . . . . 71.42 112.183 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.441 HD12 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -75.4 -33.17 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 109.596 -0.52 . . . . 74.22 109.596 172.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.562 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.7 mt -82.61 -28.36 30.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.152 0.981 . . . . 74.54 112.56 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.04 -46.16 99.89 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.535 -1.222 . . . . 73.24 113.586 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 73.9 Cg_exo -54.36 -41.63 74.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.236 1.957 . . . . 70.24 113.609 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.98 -46.31 68.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.523 0.729 . . . . 70.2 110.571 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -61.13 -40.64 94.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.512 -0.767 . . . . 72.12 111.17 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -62.26 -51.97 65.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.2 -1.364 . . . . 75.24 110.728 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.62 -31.29 70.35 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 123.607 0.567 . . . . 74.12 110.175 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.422 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.5 t -71.29 -29.88 65.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.886 0.474 . . . . 51.23 110.963 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.62 HD13 HG23 ' C' ' 64' ' ' VAL . 88.0 mt -74.32 -50.54 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.464 -0.569 . . . . 72.31 109.464 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -56.69 -33.69 66.69 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.17 0.988 . . . . 50.24 111.112 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -51.43 55.58 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.648 -1.16 . . . . 74.02 109.674 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.22 -33.87 71.51 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.631 0.772 . . . . 72.12 112.493 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.7 t -67.22 -48.26 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 73.43 109.717 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 70.0 p -70.61 -26.83 63.68 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.343 -0.844 . . . . 73.14 110.654 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -70.78 -34.57 71.92 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.048 -0.978 . . . . 73.34 109.766 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.01 86.89 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.216 -0.769 . . . . 42.45 113.083 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.484 HG23 ' HB3' ' D' ' 17' ' ' TYR . 73.2 p 58.04 35.13 24.94 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.88 1.672 . . . . 73.33 111.91 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -97.73 164.46 17.45 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.096 1.358 . . . . 74.1 110.451 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -53.7 142.02 62.83 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 123.528 2.818 . . . . 64.13 113.568 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.7 115.58 3.75 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.427 1.091 . . . . 63.13 110.325 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 63.0 tp -111.57 124.03 51.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.494 1.118 . . . . 74.21 110.446 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -133.88 120.86 20.93 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.835 0.854 . . . . 71.41 109.924 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.65 140.69 29.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.328 0.651 . . . . 70.15 110.845 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 148.88 50.0 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 123.86 0.864 . . . . 63.23 110.092 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.52 145.57 37.89 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.305 2.003 . . . . 74.33 112.194 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.77 110.62 25.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.835 -1.172 . . . . 52.02 107.835 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -90.85 58.23 3.77 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.724 0.773 . . . . 71.31 109.861 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -80.97 -46.36 15.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.827 -1.079 . . . . 75.44 108.609 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 17.2 t70 . . . . . 0 C--N 1.354 0.765 0 CA-C-N 115.393 -0.821 . . . . 72.51 109.796 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 114.513 1.301 . . . . 42.32 114.513 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.4 m -119.97 142.05 49.11 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.794 0.837 . . . . 72.24 108.919 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' D' ' 85' ' ' SER . 83.2 t80 -150.35 108.8 3.79 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.558 -0.904 . . . . 73.21 108.558 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.41 131.52 51.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.781 0.833 . . . . 75.14 109.995 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.74 104.79 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.843 -1.169 . . . . 72.4 107.843 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -79.39 -47.65 15.38 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.98 0.733 . . . . 71.21 112.98 -170.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -159.2 121.16 3.43 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.369 -0.234 . . . . 71.54 110.369 -165.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.406 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.9 mp -105.47 129.34 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.459 -1.312 . . . . 64.32 107.459 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.484 ' HB3' HG23 ' C' ' 122' ' ' THR . 38.7 p90 -165.87 178.09 6.73 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-O 121.876 0.846 . . . . 70.44 112.153 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.472 HG21 HD11 ' D' ' 21' ' ' ILE . 70.8 p -107.82 125.58 51.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.536 -1.211 . . . . 71.15 109.488 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 28.5 mtpt -97.87 -22.3 16.43 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.608 -0.516 . . . . 65.51 109.608 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -152.03 131.63 13.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.78 -1.1 . . . . 75.24 108.835 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.574 HD13 ' HE3' ' C' ' 117' ' ' MET . 84.2 mt -134.89 142.69 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.53 -1.285 . . . . 74.12 107.53 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 24.2 t -146.77 139.27 24.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.102 0.961 . . . . 62.54 108.45 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.43 116.89 5.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.187 -1.783 . . . . 62.51 106.187 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.3 mt-10 -121.26 140.28 52.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.065 0.546 . . . . 75.22 109.602 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -146.97 78.89 10.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.377 -0.972 . . . . 73.24 108.377 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.67 -32.31 6.04 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.37 2.047 . . . . 64.45 111.546 175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.424 ' O ' HG23 ' D' ' 31' ' ' VAL . 5.1 m120 -100.71 31.15 3.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.525 1.13 . . . . 62.24 108.839 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -59.6 -47.63 97.27 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 115.023 1.49 . . . . 64.05 115.023 -169.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HZ3' ' C' ' 19' ' ' LYS . 33.8 Cg_endo -88.87 -3.99 6.24 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.637 1.558 . . . . 75.12 112.591 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -77.2 -40.95 43.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.326 1.05 . . . . 71.33 109.491 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' D' ' 73' ' ' ALA . 61.7 t -79.29 -15.89 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.677 0.791 . . . . 72.03 110.201 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -65.68 -25.99 67.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.596 0.758 . . . . 70.12 110.888 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -73.62 -17.96 61.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.396 0.678 . . . . 62.4 111.334 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -105.73 106.41 16.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.704 0.802 . . . . 64.41 109.452 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.96 51.37 2.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.792 0.837 . . . . 65.11 110.317 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -131.64 162.55 30.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.444 0.697 . . . . 75.14 109.622 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.33 110.51 29.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.302 1.041 . . . . 74.1 109.33 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' D' ' 68' ' ' LEU . 90.5 Cg_exo -49.21 150.98 6.78 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 124.132 3.221 . . . . 73.25 115.117 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -75.55 132.75 40.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.977 -0.749 . . . . 74.32 108.977 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.4 124.99 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.275 0.559 . . . . 73.52 110.633 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -110.49 110.71 21.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.019 -1.845 . . . . 73.35 106.019 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.9 tp -96.14 137.4 35.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.112 0.482 . . . . 74.22 110.448 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.595 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.4 m-20 -129.63 141.25 50.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.746 1.218 . . . . 75.31 108.1 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.67 147.55 44.97 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.095 -0.705 . . . . 71.44 109.095 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.5 t70 -154.1 145.97 23.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.351 -0.981 . . . . 43.23 108.351 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.9 t -114.28 164.87 13.32 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.092 0.557 . . . . 73.21 109.56 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.37 147.98 22.72 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.509 0.724 . . . . 54.33 109.424 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.7 p -135.12 151.98 51.21 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.056 -0.72 . . . . 71.23 109.056 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -157.1 117.1 3.48 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.18 -1.044 . . . . 62.05 108.18 -175.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -72.61 124.96 26.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.364 -0.606 . . . . 72.23 109.364 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.83 -40.69 12.28 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.69 -0.485 . . . . 70.25 109.69 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.64 4.32 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.183 -0.917 . . . . 51.41 110.327 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.34 116.97 4.66 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.21 -0.905 . . . . 72.14 110.177 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.0 2.96 4.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.391 1.476 . . . . 72.31 113.089 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.67 116.84 52.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.42 -0.956 . . . . 75.34 108.42 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.488 ' HB2' HD13 ' D' ' 86' ' ' ILE . 50.5 m-85 -129.08 127.47 41.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.628 -1.249 . . . . 75.21 107.628 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -96.13 137.23 35.5 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.035 0.934 . . . . 72.02 108.655 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.62 126.23 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.687 -1.227 . . . . 73.21 107.687 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.1 t -102.48 135.42 39.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.007 -0.738 . . . . 70.41 109.007 173.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -112.47 121.45 44.87 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.786 -0.82 . . . . 74.44 108.786 175.512 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.8 ttm-85 -97.72 115.8 28.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.901 -0.777 . . . . 72.21 108.901 174.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.87 123.06 70.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.013 -1.106 . . . . 74.21 108.013 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -126.65 133.37 50.99 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.384 0.611 . . . . 61.02 110.088 -172.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 76.7 t -126.44 103.7 11.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.973 1.309 . . . . 61.31 109.118 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -97.53 93.17 6.29 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.069 -1.085 . . . . 55.43 108.069 172.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.86 133.99 41.61 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.198 -0.667 . . . . 55.34 109.198 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 59.2 p -140.78 131.7 26.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.802 0.841 . . . . 61.33 109.254 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' D' ' 38' ' ' PRO . 9.5 tp -107.12 107.63 18.7 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 73.03 108.474 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.72 -121.99 5.67 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.479 -0.782 . . . . 60.34 112.805 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.59 4.99 50.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.041 0.936 . . . . 60.44 110.981 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.36 147.21 35.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.697 0.399 . . . . 64.3 110.347 -163.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -58.48 141.53 51.47 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.785 0.834 . . . . 70.22 111.56 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -100.47 -68.14 0.82 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.602 1.161 . . . . 73.32 109.519 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.84 139.0 19.22 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.843 -0.617 . . . . 75.11 109.491 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.606 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.1 mt -101.06 152.81 20.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.95 -0.759 . . . . 75.13 108.95 173.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.654 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.5 t -159.26 143.4 15.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.826 0.45 . . . . 71.04 110.279 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -155.94 121.88 5.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.007 0.523 . . . . 61.41 109.667 171.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.03 114.86 43.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.326 0.651 . . . . 74.22 109.898 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.686 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -90.24 89.63 7.72 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.026 -0.731 . . . . 75.01 109.026 167.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.17 95.83 5.71 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.531 -1.213 . . . . 75.15 108.46 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 140.95 18.02 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.684 -0.566 . . . . 74.55 111.684 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.03 129.45 4.77 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.241 -1.144 . . . . 72.11 110.241 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.92 128.42 41.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.438 -0.949 . . . . 74.35 108.438 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.19 161.57 28.99 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.074 0.55 . . . . 74.44 110.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 32.8 m -116.42 108.89 16.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.984 0.914 . . . . 75.31 109.35 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.51 HG12 HD11 ' D' ' 98' ' ' LEU . 3.3 mp -109.57 119.4 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.399 0.68 . . . . 70.42 109.415 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.97 155.64 44.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.409 1.083 . . . . 45.22 109.226 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 -13.07 5.73 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 114.323 0.489 . . . . 64.54 114.323 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.501 HG23 HG23 ' D' ' 86' ' ' ILE . 5.5 tt -134.9 137.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.313 1.445 . . . . 71.21 107.822 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -161.56 175.15 12.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.794 0.837 . . . . 62.11 110.012 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.6 -133.38 13.04 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.255 0.347 . . . . 62.2 113.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -71.41 -38.07 71.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.149 0.979 . . . . 74.02 112.137 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.45 -32.74 70.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.149 0.579 . . . . 72.41 110.029 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.489 ' HG3' HG21 ' D' ' 86' ' ' ILE . 59.2 ttp -69.21 -37.72 78.22 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.689 -0.687 . . . . 73.24 110.363 174.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.79 70.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.095 0.558 . . . . 70.1 111.25 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -71.56 -37.67 71.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.338 0.655 . . . . 63.01 110.744 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.56 -50.19 47.18 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.927 0.491 . . . . 74.14 111.203 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.51 HD11 HG12 ' D' ' 86' ' ' ILE . 9.9 mp -75.8 -25.11 56.07 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.802 0.841 . . . . 65.15 111.573 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.38 66.43 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 119.592 -0.56 . . . . 71.13 113.511 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.14 -66.43 0.52 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.474 0.546 . . . . 62.2 112.474 -174.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -62.19 -46.08 90.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.335 0.654 . . . . 73.43 112.425 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -67.11 -44.27 48.84 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-O 118.672 -0.68 . . . . 72.54 112.316 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.52 ' HB2' ' HZ ' ' D' ' 133' ' ' PHE . 77.0 Cg_exo -54.4 -32.29 71.99 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.418 2.079 . . . . 71.31 114.482 166.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -64.51 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.28 0.491 . . . . 63.21 111.741 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -67.8 -42.91 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 121.436 0.636 . . . . 71.43 110.019 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.467 HD21 ' HA3' ' D' ' 82' ' ' GLY . 97.2 mt -77.01 -27.64 54.72 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.834 -1.076 . . . . 73.11 112.725 -171.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.74 -45.89 88.14 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.891 1.071 . . . . 65.12 113.891 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -34.76 98.3 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.714 1.609 . . . . 73.41 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.88 -34.47 51.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 75.13 111.485 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.25 -46.82 69.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.279 0.632 . . . . 70.33 110.841 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -69.86 -33.47 72.3 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.215 -0.902 . . . . 54.41 110.669 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -66.32 -42.4 88.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.305 1.003 . . . . 75.24 111.005 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -59.69 -40.04 86.56 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.739 0.65 . . . . 61.31 110.139 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.654 HG12 ' SG ' ' D' ' 76' ' ' CYS . 53.7 mt -63.29 -50.39 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.051 0.845 . . . . 63.15 110.548 173.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 50.0 m -56.43 -44.62 80.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.129 0.972 . . . . 74.43 111.464 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.8 t -65.16 -44.95 86.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 114.68 -1.145 . . . . 71.25 110.429 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.17 -31.2 72.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.737 0.415 . . . . 71.34 112.074 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.416 HG23 ' O ' ' D' ' 114' ' ' ILE . 55.8 t -70.49 -41.91 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.818 0.698 . . . . 72.41 110.483 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -73.38 -24.45 60.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.669 0.271 . . . . 72.33 110.97 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 92.2 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.602 0.761 . . . . 72.31 109.582 172.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.3 -3.66 88.65 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.766 0.666 . . . . 75.24 112.399 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.4 p 58.32 30.92 20.24 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.426 1.89 . . . . 61.44 112.208 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -95.03 169.38 9.51 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.714 1.606 . . . . 73.1 110.099 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.75 130.99 43.36 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.115 2.543 . . . . 62.51 112.625 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -55.27 147.49 16.65 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.251 1.02 . . . . 61.53 112.255 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -135.4 95.81 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.083 0.468 . . . . 53.23 110.499 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -100.97 114.41 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.914 -1.143 . . . . 70.43 107.914 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 98.7 mt -75.94 134.71 40.14 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.773 0.321 . . . . 71.03 110.514 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.59 142.03 91.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 65.14 111.078 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.3 131.24 27.66 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.41 2.073 . . . . 53.1 111.077 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.15 127.02 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.803 0.841 . . . . 72.32 110.219 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.55 77.97 9.75 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.919 . . . . 52.25 109.18 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.52 ' HZ ' ' HB2' ' D' ' 103' ' ' PRO . 45.2 p90 . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 114.81 -1.086 . . . . 72.45 111.05 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.8 m . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 108.875 -0.787 . . . . 62.35 108.875 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -135.83 120.43 18.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.877 -1.157 . . . . 75.14 107.877 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 78.8 mt-30 -132.16 108.6 9.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.415 0.686 . . . . 62.43 109.347 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 pt -83.73 86.96 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.322 -0.992 . . . . 72.35 108.322 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -72.88 -39.53 66.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.946 -0.57 . . . . 61.34 111.496 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -172.07 146.78 2.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.317 -0.623 . . . . 73.14 109.317 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.474 HD12 ' HG2' ' C' ' 130' ' ' PRO . 94.7 mt -137.1 100.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.174 0.59 . . . . 74.42 109.433 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 26.6 m-85 -159.67 160.66 34.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.483 1.113 . . . . 74.23 110.701 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.48 HG21 ' SG ' ' A' ' 113' ' ' CYS . 30.5 p -71.64 129.18 38.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.445 -1.252 . . . . 74.14 111.117 -167.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -84.43 -38.67 19.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.416 0.627 . . . . 63.31 109.583 169.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.6 t70 -139.9 137.66 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.968 -1.014 . . . . 71.4 109.442 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -132.65 146.1 33.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.077 1.351 . . . . 63.24 107.515 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.65 140.24 17.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.961 -0.755 . . . . 54.33 108.961 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 88.9 t80 -142.71 123.47 14.23 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 106.01 -1.848 . . . . 75.2 106.01 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -118.29 152.05 36.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.407 -0.96 . . . . 72.12 108.407 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -145.3 74.33 14.11 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.881 -1.526 . . . . 64.22 106.881 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.98 -20.71 25.22 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.556 2.171 . . . . 73.23 111.842 -172.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 31' ' ' VAL . 89.1 m-20 -118.46 29.93 7.49 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.425 1.09 . . . . 51.11 109.661 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.17 -49.47 92.09 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 113.182 0.808 . . . . 64.31 113.182 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 31.9 Cg_exo -61.99 -27.05 79.16 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.007 1.805 . . . . 71.31 113.373 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -73.41 -38.32 65.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.943 0.497 . . . . 60.25 110.502 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 27' ' ' ASN . 60.1 t -66.78 -34.44 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.524 0.73 . . . . 74.11 110.416 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -56.47 -31.09 63.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.39 1.076 . . . . 53.1 111.361 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -91.22 -45.56 8.57 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.456 1.102 . . . . 62.02 110.714 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.58 165.61 20.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.354 0.662 . . . . 53.04 112.193 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.15 126.19 28.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.845 -1.071 . . . . 54.44 110.894 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.17 82.28 7.13 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.576 -0.738 . . . . 64.4 110.21 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -142.88 79.12 14.99 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.039 -1.097 . . . . 61.13 108.039 171.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -86.65 144.07 7.49 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.616 2.211 . . . . 63.14 112.736 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -98.03 126.0 43.26 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.384 1.074 . . . . 62.21 108.151 175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.58 130.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.226 0.536 . . . . 64.1 110.749 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 63.1 tttm -119.62 112.32 19.16 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.079 -1.452 . . . . 73.4 107.079 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 mt -115.48 107.74 15.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.638 -0.875 . . . . 64.23 108.638 -167.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.8 m-20 -106.13 109.18 21.03 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 55.53 109.331 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.25 132.58 49.4 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.358 -0.608 . . . . 74.11 109.358 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 60' ' ' LEU . 16.3 t70 -142.55 141.65 32.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.13 0.972 . . . . 73.43 109.04 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.9 m -137.73 140.51 40.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.292 0.637 . . . . 73.42 110.428 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.93 134.73 14.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.599 0.76 . . . . 53.12 110.391 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 58' ' ' VAL . 68.0 p -111.31 167.72 10.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.117 0.567 . . . . 73.34 110.297 173.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -168.58 119.13 0.76 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.583 -0.525 . . . . 65.44 109.583 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -69.09 108.07 3.43 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.252 0.621 . . . . 73.32 109.936 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.66 HD11 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -77.83 -41.59 36.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.584 0.754 . . . . 74.32 110.488 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -172.87 4.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.915 . . . . 73.12 109.779 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.28 105.18 0.31 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.976 0.51 . . . . 63.12 110.124 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 58.15 22.04 8.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.105 1.362 . . . . 74.04 112.984 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.2 t -108.33 120.82 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.089 -1.449 . . . . 71.14 107.089 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 136.09 41.2 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.813 -1.18 . . . . 74.42 107.813 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 51' ' ' LEU . 30.4 tt0 -89.13 115.74 26.87 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.94 0.896 . . . . 72.33 108.789 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 48' ' ' SER . 26.9 t -99.25 110.98 27.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 107.017 -1.475 . . . . 64.42 107.017 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -99.41 119.66 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.061 0.544 . . . . 73.31 109.671 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.66 112.47 24.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.038 -1.097 . . . . 72.43 108.038 175.149 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -101.29 106.67 17.88 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.901 0.881 . . . . 73.44 109.443 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.99 114.37 46.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.524 1.13 . . . . 64.34 109.137 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.1 m -102.83 146.51 28.17 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 50.1 t -142.01 107.16 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.716 1.206 . . . . 70.04 108.073 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.6 m -103.14 135.83 44.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.312 -0.625 . . . . 72.24 109.312 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.59 118.37 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.552 -1.277 . . . . 73.25 107.552 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -124.32 126.2 45.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.281 -0.637 . . . . 63.01 109.281 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.47 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.61 62.91 6.05 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.82 0.819 . . . . 71.52 109.134 -179.277 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.77 -106.85 1.42 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.877 -1.289 . . . . 14.0 109.877 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -115.82 -26.22 7.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.799 0.84 . . . . 74.21 110.336 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.26 132.05 37.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.911 0.484 . . . . 75.22 109.832 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -71.81 110.89 6.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.931 0.892 . . . . 62.54 110.212 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.47 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -59.1 -57.23 13.97 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.064 0.945 . . . . 65.25 109.598 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -161.72 173.23 14.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.013 -1.449 . . . . 72.0 109.631 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 76' ' ' CYS . 47.3 tp -137.62 149.36 46.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.228 1.011 . . . . 70.11 109.752 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.536 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.5 m -136.82 139.95 42.11 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 124.652 1.181 . . . . 72.2 108.694 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -150.18 129.3 12.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.483 -0.562 . . . . 72.05 109.483 172.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.86 112.51 13.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.774 0.829 . . . . 74.2 109.393 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.3 mt-30 -85.75 82.5 8.17 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.741 -0.837 . . . . 65.05 108.741 171.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.65 93.58 3.65 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.235 -1.348 . . . . 72.35 109.545 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.17 146.1 20.92 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.195 -0.457 . . . . 61.14 112.056 -177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.47 122.97 2.51 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.156 -1.178 . . . . 50.11 110.156 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.9 mt -86.08 121.74 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.731 -0.84 . . . . 34.11 108.731 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -128.68 118.97 23.79 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.967 -1.123 . . . . 72.34 107.967 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 26.7 t -94.92 86.34 4.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.067 -1.086 . . . . 42.14 108.067 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -114.72 143.39 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.232 0.613 . . . . 72.13 110.756 -175.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.65 167.47 23.11 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.172 0.989 . . . . 61.23 110.885 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -6.18 79.0 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.256 -0.884 . . . . 72.21 113.66 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.26 146.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.566 0.746 . . . . 62.42 109.779 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 172.2 14.82 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.949 0.499 . . . . 72.43 110.375 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.18 -127.55 40.48 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.264 0.353 . . . . 74.41 113.391 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -74.4 -20.44 60.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.341 0.656 . . . . 64.14 112.015 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.27 -49.69 68.62 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.459 0.704 . . . . 71.32 109.962 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.9 tmm? -75.67 -37.25 59.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.478 -1.237 . . . . 75.44 110.755 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.99 85.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.378 0.609 . . . . 70.41 110.758 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -65.7 -41.8 91.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.075 -0.966 . . . . 72.52 110.419 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.5 m -74.71 -26.91 60.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.467 0.914 . . . . 71.02 113.467 -173.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.68 -23.36 24.23 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.64 0.376 . . . . 73.14 111.149 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.47 -16.08 21.27 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.526 0.57 . . . . 43.51 114.526 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.9 -64.22 0.58 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.597 0.698 . . . . 63.1 111.636 -172.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 12.5 t80 -48.89 -65.92 0.49 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.577 1.151 . . . . 73.42 113.084 -174.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.31 -44.78 13.61 Favored Pre-proline 0 CA--C 1.559 1.317 0 CA-C-O 118.207 -0.902 . . . . 63.51 113.067 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.56 -31.82 87.43 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.839 1.693 . . . . 62.54 113.849 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -67.92 -34.13 76.03 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.131 0.423 . . . . 63.41 110.45 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.39 -41.23 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.691 0.796 . . . . 60.33 110.238 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.9 mt -70.53 -25.51 63.15 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.49 -0.777 . . . . 41.22 112.003 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -67.0 -43.23 46.19 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.675 1.361 . . . . 65.54 114.675 -167.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.4 -36.79 88.58 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.284 1.989 . . . . 72.21 113.596 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -76.07 -39.0 56.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.19 0.596 . . . . 70.22 111.523 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.38 92.4 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.58 0.352 . . . . 62.24 110.25 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HD12 ' C' ' 105' ' ' ILE . 40.6 ttm180 -53.85 -51.81 62.41 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.813 1.32 . . . . 73.31 110.358 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.61 -42.67 99.21 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.086 -0.961 . . . . 75.33 112.022 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.48 ' SG ' HG21 ' A' ' 18' ' ' THR . 45.0 t -68.23 -39.02 82.43 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.654 0.596 . . . . 61.42 111.523 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.529 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 85.0 mt -64.51 -55.2 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.48 0.712 . . . . 45.03 109.626 176.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 125' ' ' GLN . 64.8 m -58.43 -34.16 70.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.351 1.061 . . . . 73.42 111.792 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -65.28 -44.27 88.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.806 -0.634 . . . . 62.22 110.578 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.529 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 52.2 mtm -63.41 -40.75 98.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.712 0.405 . . . . 74.11 110.869 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.1 t -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 O-C-N 124.191 0.932 . . . . 44.11 110.622 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -74.47 -31.35 62.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.943 -0.571 . . . . 71.24 111.16 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -69.44 -29.95 67.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.657 0.783 . . . . 65.31 110.042 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -3.66 82.98 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.569 -0.741 . . . . 71.44 112.985 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m 67.47 17.7 10.06 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.507 1.123 . . . . 72.1 110.783 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.54 157.12 37.7 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.911 0.884 . . . . 72.23 110.884 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.64 122.77 11.48 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.999 2.466 . . . . 74.53 112.478 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.553 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -53.17 136.52 36.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.951 1.3 . . . . 72.4 112.563 -176.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.7 mt -120.67 99.25 6.43 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.728 -0.841 . . . . 73.01 108.728 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -98.89 125.22 44.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.543 0.737 . . . . 60.4 109.391 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.21 138.26 45.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.806 0.843 . . . . 54.5 110.202 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.82 126.1 92.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.659 -0.497 . . . . 73.51 109.659 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -65.95 103.63 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.406 2.071 . . . . 73.24 112.388 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.1 143.16 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.744 0.818 . . . . 52.33 110.008 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -89.27 85.45 6.61 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.235 1.014 . . . . 71.3 110.606 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -36.5 72.5 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.65 1.18 . . . . 64.43 113.042 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 123.536 0.734 . . . . 61.41 111.334 -175.982 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.594 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.3 ptm . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 115.003 1.482 . . . . 62.35 115.003 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 95.9 m -154.65 136.61 14.6 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.131 1.373 . . . . 42.44 107.616 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -143.06 138.2 29.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.564 -0.532 . . . . 73.52 109.564 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.608 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 58.2 tt0 -155.16 140.82 17.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.822 0.849 . . . . 61.31 109.664 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.31 117.41 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 108.978 -0.749 . . . . 74.14 108.978 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.86 -50.3 9.35 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.803 0.274 . . . . 72.41 110.499 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -166.31 142.32 4.8 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.85 0.46 . . . . 75.21 109.822 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.5 mt -115.01 148.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.313 -1.366 . . . . 53.23 107.313 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' B' ' 83' ' ' ILE . 27.0 p90 -170.63 143.89 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.198 0.454 . . . . 73.23 110.973 -177.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.0 m -73.61 118.31 16.42 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.414 -0.812 . . . . 61.44 108.848 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -91.31 -29.24 17.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.567 0.747 . . . . 74.34 111.182 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.9 t70 -160.58 146.38 14.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.336 0.397 . . . . 72.15 111.19 -172.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.7 mm -143.03 143.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 C-N-CA 125.975 1.71 . . . . 74.14 108.172 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.9 t -143.07 140.35 30.89 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.163 1.385 . . . . 54.11 107.285 171.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.3 t80 -151.64 126.78 9.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.316 -1.365 . . . . 73.35 107.316 171.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 138.46 53.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.901 0.88 . . . . 43.04 108.995 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -129.37 81.41 70.19 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 107.044 -1.465 . . . . 63.32 107.044 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.49 -26.0 55.16 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.805 2.337 . . . . 71.12 111.979 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -126.48 32.92 5.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.361 1.064 . . . . 75.24 109.514 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.54 -50.09 51.93 Favored Pre-proline 0 CA--C 1.565 1.538 0 C-N-CA 124.504 1.122 . . . . 72.13 113.347 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.61 -12.06 26.6 Favored 'Trans proline' 0 C--N 1.391 2.763 0 C-N-CA 121.769 1.646 . . . . 74.02 113.774 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -97.07 -22.27 16.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.622 0.769 . . . . 73.13 112.515 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 28' ' ' ALA . 8.3 p -68.63 -23.88 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.808 0.443 . . . . 74.22 112.1 -174.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.91 -29.91 71.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.396 0.678 . . . . 73.4 111.53 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.47 -30.77 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.285 0.634 . . . . 72.5 110.419 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.39 94.55 7.12 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 74.24 111.548 -172.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -94.19 81.1 4.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.361 0.665 . . . . 54.34 109.269 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -151.12 162.03 41.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.688 1.195 . . . . 74.24 108.517 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -75.05 113.84 28.97 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.222 1.009 . . . . 61.41 109.354 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.684 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 69.7 Cg_endo -71.92 147.47 49.65 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.348 2.032 . . . . 74.41 111.017 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 37.6 tt0 -51.7 106.43 0.14 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.588 0.755 . . . . 71.55 110.449 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.52 122.34 37.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.517 -1.29 . . . . 64.12 107.517 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -149.09 104.23 3.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.897 -0.592 . . . . 71.11 109.497 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.8 147.25 23.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.366 -0.833 . . . . 73.04 109.225 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -136.71 145.8 45.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.404 1.082 . . . . 61.11 108.096 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.61 163.04 22.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.146 -0.687 . . . . 71.51 109.146 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.0 t70 -164.04 139.21 6.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.832 -1.076 . . . . 71.31 108.946 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -122.43 115.63 22.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.546 0.738 . . . . 72.0 110.211 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -120.51 160.01 24.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 73.3 109.466 174.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 169.04 18.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.279 1.032 . . . . 63.23 109.354 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 1.5 m -149.42 135.11 18.64 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.395 -0.965 . . . . 72.34 108.395 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.85 100.44 12.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.285 -1.006 . . . . 75.15 108.285 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.9 mt -78.85 -31.28 45.62 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.603 -0.726 . . . . 62.3 110.315 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.72 -171.49 1.63 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.072 0.949 . . . . 73.41 110.648 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.96 124.86 24.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.798 -1.092 . . . . 64.12 109.533 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.37 -4.91 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.89 1.276 . . . . 60.54 112.31 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.73 97.16 5.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.602 0.761 . . . . 55.4 109.118 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -102.51 170.82 7.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.542 0.737 . . . . 73.02 110.131 172.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 8.8 tm-20 -145.76 103.01 3.74 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.018 -1.105 . . . . 70.34 108.018 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.07 125.9 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.178 0.591 . . . . 54.24 110.389 -175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 32.3 t -103.98 111.82 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.933 0.893 . . . . 75.45 109.147 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.72 110.23 22.1 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.041 -1.096 . . . . 72.22 108.041 176.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 66.8 ttt180 -97.23 116.23 29.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.344 0.658 . . . . 62.0 109.921 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -114.03 120.92 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.217 -1.031 . . . . 75.32 108.217 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.0 m -114.61 136.97 52.46 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.703 0.801 . . . . 33.54 109.191 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.687 HG21 HG21 ' B' ' 114' ' ' ILE . 52.8 t -115.99 132.9 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.588 1.155 . . . . 74.31 109.646 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -127.21 144.38 51.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.465 0.706 . . . . 65.4 109.667 170.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -143.76 150.85 39.2 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.362 -0.835 . . . . 73.14 110.333 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 m -134.78 136.8 42.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.21 0.604 . . . . 75.35 110.951 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 31.4 mt -129.95 99.59 5.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.282 1.033 . . . . 73.12 108.924 172.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -132.79 16.46 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.38 -0.827 . . . . 71.12 113.091 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -93.18 21.46 5.9 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.824 0.85 . . . . 72.41 111.364 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.74 161.07 41.38 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 123.834 0.853 . . . . 73.45 109.179 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -76.98 134.81 38.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.971 -0.559 . . . . 62.03 110.005 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.27 -65.59 0.94 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.488 -0.93 . . . . 75.13 108.488 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -155.38 160.37 40.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.757 . . . . 75.42 111.053 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -133.07 135.21 45.19 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.47 1.508 . . . . 74.12 107.093 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.3 t -139.15 158.06 44.85 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.362 -0.977 . . . . 53.04 108.362 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -165.28 128.04 2.18 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.146 -0.687 . . . . 73.13 109.146 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.1 t -126.01 146.55 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.832 0.853 . . . . 71.03 108.961 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -123.85 96.41 4.94 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.231 -1.026 . . . . 73.33 108.231 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -85.55 100.4 11.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.377 -0.971 . . . . 74.14 108.377 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.55 169.41 35.72 Favored Glycine 0 C--O 1.244 0.775 0 N-CA-C 111.163 -0.775 . . . . 64.02 111.163 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.8 128.63 1.65 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.44 -0.664 . . . . 33.44 111.44 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.4 HG13 ' HE1' ' B' ' 17' ' ' TYR . 38.3 mt -84.73 126.81 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.677 -0.861 . . . . 65.15 108.677 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -132.1 133.17 44.02 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.318 1.047 . . . . 74.3 108.658 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 26.6 m -93.3 97.59 10.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.802 -0.814 . . . . 72.44 108.802 173.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.61 HG12 HD13 ' B' ' 98' ' ' LEU . 2.6 pp -115.6 140.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.282 1.033 . . . . 64.3 110.463 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.37 172.35 18.5 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.901 0.88 . . . . 62.24 109.495 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.62 -58.65 5.02 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.249 -0.195 . . . . 44.44 112.642 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.473 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.0 OUTLIER -55.01 127.49 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.519 0.728 . . . . 71.2 110.97 174.657 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.67 161.74 39.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 32.0 109.698 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.68 -131.32 10.96 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.908 -0.587 . . . . 65.45 112.225 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -76.39 -35.69 58.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.69 0.796 . . . . 73.3 110.944 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -64.71 -28.63 69.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.166 -0.925 . . . . 71.45 112.043 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.486 ' HE1' HD22 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.453 0.701 . . . . 73.13 110.106 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.6 78.63 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.384 -0.825 . . . . 64.23 111.461 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 27.7 t-80 -79.07 -23.7 44.01 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.607 0.763 . . . . 74.12 111.246 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.27 -66.32 0.91 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.582 0.353 . . . . 70.3 110.501 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.61 HD13 HG12 ' B' ' 86' ' ' ILE . 14.0 tp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.845 0.458 . . . . 61.42 111.451 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.28 -21.64 58.31 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.806 -0.634 . . . . 75.51 113.728 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -113.14 -56.0 2.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.306 0.553 . . . . 72.11 111.768 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -68.52 -43.69 76.23 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.564 0.54 . . . . 74.52 112.359 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.542 ' SG ' HD12 ' B' ' 98' ' ' LEU . 75.3 m -63.73 -49.36 76.86 Favored Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 118.298 -0.858 . . . . 40.35 111.533 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.488 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 88.0 Cg_exo -56.73 -33.02 93.02 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.115 1.876 . . . . 71.42 114.143 168.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.38 -31.8 72.27 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.088 0.555 . . . . 73.35 110.859 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.91 -48.43 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.831 0.853 . . . . 72.35 109.615 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 65.4 mt -82.27 -12.64 57.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.326 -0.852 . . . . 75.31 111.919 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.59 -47.91 55.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 117.78 -1.105 . . . . 74.23 113.049 -174.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.43 -36.09 98.81 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 121.909 1.739 . . . . 73.43 113.313 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.507 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 43.3 m-85 -70.51 -45.58 65.31 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.649 0.78 . . . . 75.35 110.474 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.05 99.49 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.7 0.8 . . . . 61.03 110.264 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -56.86 -54.96 40.47 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.83 1.652 . . . . 70.14 111.589 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.3 -31.94 73.34 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.733 0.646 . . . . 71.25 110.032 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.5 t -68.09 -41.97 81.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.536 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.687 HG21 HG21 ' B' ' 64' ' ' VAL . 62.8 mt -63.79 -51.88 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.133 0.573 . . . . 73.41 110.085 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.6 m -58.27 -34.24 70.28 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.139 0.976 . . . . 74.33 111.072 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.9 t -64.41 -54.65 29.4 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.129 -0.941 . . . . 72.21 109.414 173.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.9 mmt -61.88 -33.86 74.97 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.133 0.573 . . . . 63.31 112.13 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.9 -46.82 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.709 0.804 . . . . 72.31 110.934 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 74.7 p -70.01 -25.29 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.584 0.353 . . . . 64.1 110.999 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.518 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 85.1 mtt-85 -69.85 -20.23 63.42 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 118.783 -0.627 . . . . 62.52 111.172 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.2 12.18 61.95 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.12 -0.822 . . . . 70.35 114.365 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.7 p 72.54 14.54 5.2 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.936 1.694 . . . . 72.12 112.169 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -91.14 154.18 44.86 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 122.725 0.41 . . . . 73.1 111.125 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -55.16 149.5 44.14 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 123.321 2.681 . . . . 65.33 113.06 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -59.02 123.25 15.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.39 1.076 . . . . 71.31 111.592 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.07 100.99 7.69 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.121 -1.066 . . . . 54.55 108.121 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -99.8 117.67 34.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 74.42 109.189 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.79 134.93 37.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.171 0.588 . . . . 61.42 110.16 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.05 139.81 36.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.801 0.84 . . . . 74.12 110.398 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.6 99.53 0.45 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.907 2.405 . . . . 74.54 111.972 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -90.81 126.07 43.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.753 -0.832 . . . . 75.13 108.753 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.23 113.23 11.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.531 -0.914 . . . . 70.0 108.531 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -63.88 -20.89 66.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.662 0.785 . . . . 74.03 110.859 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.079 1.352 . . . . 73.1 109.735 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.64 -31.31 63.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.481 -1.236 . . . . 54.13 110.682 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 N--CA 1.486 1.331 0 C-N-CA 123.141 0.576 . . . . 75.14 110.075 176.823 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.475 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 54.0 ttp . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 121.291 0.567 . . . . 73.11 111.812 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.8 m -99.79 87.39 3.52 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.501 -1.296 . . . . 74.15 107.501 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.448 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 20.5 t80 -89.09 133.12 34.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.367 -0.833 . . . . 74.43 109.233 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 57.5 tt0 -151.81 144.95 24.6 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.937 -0.764 . . . . 63.44 108.937 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.5 HD11 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -92.52 136.88 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.386 -0.598 . . . . 72.23 109.386 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -105.24 -50.06 3.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.642 0.777 . . . . 74.04 110.281 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -163.18 142.64 8.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.049 0.54 . . . . 74.41 109.549 -173.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.5 HG13 HD11 ' C' ' 13' ' ' ILE . 79.8 mt -128.24 134.84 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.417 -1.327 . . . . 71.31 107.417 174.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.561 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 5.7 p90 -171.16 153.79 3.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 71.41 111.336 -173.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -79.11 120.74 24.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.168 -0.923 . . . . 74.12 109.471 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -74.26 -49.01 25.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.321 -0.992 . . . . 75.14 108.321 170.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -134.39 138.33 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.747 -1.569 . . . . 60.24 109.135 -167.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -142.73 139.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.711 -1.588 . . . . 64.11 106.711 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.88 149.52 18.15 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.83 -0.433 . . . . 53.23 109.83 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -154.34 108.8 3.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.124 -1.065 . . . . 74.25 108.124 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.79 122.13 42.61 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.076 -0.713 . . . . 53.21 109.076 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.81 93.42 20.51 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 108.423 -0.955 . . . . 75.22 108.423 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.68 -49.45 8.65 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.108 2.538 . . . . 63.24 111.697 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' C' ' 72' ' ' THR . 68.4 m-20 -103.79 53.19 0.75 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.429 -0.805 . . . . 74.11 109.036 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.11 -52.99 70.78 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.982 1.104 . . . . 73.15 113.982 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 39.4 Cg_exo -63.81 -21.72 69.28 Favored 'Trans proline' 0 C--N 1.398 3.139 0 C-N-CA 122.185 1.924 . . . . 72.05 112.909 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.44 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 13.6 m-70 -64.64 -18.95 65.41 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.291 1.036 . . . . 74.23 113.133 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.46 -37.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.087 0.955 . . . . 73.02 113.494 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -81.14 -36.4 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.054 0.941 . . . . 54.41 111.091 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -85.17 4.64 33.53 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 125.293 1.437 . . . . 53.24 111.08 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.627 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.2 ttmp? -107.81 153.18 23.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.376 1.07 . . . . 71.33 111.024 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.25 114.23 19.0 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.06 -1.459 . . . . 73.34 107.06 166.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -85.32 61.47 6.88 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.141 0.972 . . . . 74.41 112.504 -168.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -150.23 58.74 3.26 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.011 1.325 . . . . 71.31 107.598 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.47 160.8 31.85 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.011 1.807 . . . . 71.25 111.364 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.45 103.94 13.2 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.896 -1.15 . . . . 70.32 107.896 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.82 97.41 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 114.963 -1.017 . . . . 65.11 108.642 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 50.7 mtpt -95.77 105.64 17.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.996 -0.742 . . . . 74.25 108.996 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -87.04 149.1 24.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.901 0.881 . . . . 73.31 109.609 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.492 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.3 t70 -149.17 127.41 12.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.314 -0.995 . . . . 72.35 108.314 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.78 149.68 50.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.228 0.467 . . . . 73.23 110.769 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 17.5 m-20 -140.81 161.1 38.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 64.35 109.826 176.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -130.48 136.06 48.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.054 0.941 . . . . 64.43 108.473 171.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -131.51 172.51 12.13 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.124 0.97 . . . . 61.33 108.507 176.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.7 p -164.61 160.14 19.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.927 0.491 . . . . 23.01 111.112 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -167.34 138.21 3.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.061 0.944 . . . . 74.04 109.452 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -77.87 117.5 19.29 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.88 -0.785 . . . . 74.2 108.88 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.5 mt -87.27 -37.97 16.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.734 0.413 . . . . 54.52 110.608 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -159.23 -172.05 3.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.262 -0.881 . . . . 50.22 110.682 -174.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.67 111.56 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.01 -0.995 . . . . 64.21 109.681 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 64.09 15.9 9.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.831 1.252 . . . . 63.11 112.314 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 89.1 t -118.0 103.79 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.298 -1.001 . . . . 71.43 108.298 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.443 ' CD1' ' HB ' ' C' ' 86' ' ' ILE . 14.9 m-85 -117.95 139.17 51.54 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.907 0.883 . . . . 72.42 108.959 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.612 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.2 tt0 -100.3 146.14 27.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.843 0.857 . . . . 65.21 109.355 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.38 144.33 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.747 -0.835 . . . . 75.44 108.747 165.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 58.2 t -119.63 107.14 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.886 0.875 . . . . 64.1 109.127 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.25 99.91 12.84 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.074 -1.084 . . . . 64.3 108.074 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 75.6 ttt-85 -84.53 134.82 34.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.858 0.863 . . . . 73.12 109.385 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.412 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -129.05 148.13 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.794 -1.187 . . . . 71.33 107.794 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 57.5 m -138.9 135.35 34.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 75.31 107.5 171.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.542 HG23 HD13 ' C' ' 114' ' ' ILE . 47.1 t -118.36 113.33 41.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 107.659 -1.237 . . . . 75.31 107.659 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.1 m -98.33 134.35 41.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.749 -1.204 . . . . 74.5 107.749 171.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 94.82 3.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.231 -1.396 . . . . 74.12 107.231 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 14.1 m -144.76 143.48 30.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.279 0.632 . . . . 62.24 109.692 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.03 10.17 39.8 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.493 0.717 . . . . 70.55 109.578 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.27 -95.63 0.4 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.395 -1.082 . . . . 35.53 110.395 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.48 -32.98 16.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 72.22 109.261 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.627 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 8.7 tp10 -83.67 91.28 7.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.874 0.87 . . . . 61.32 109.484 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 28.3 m -86.75 135.88 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.284 -0.871 . . . . 72.32 110.232 -178.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.59 -65.03 1.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.669 -0.863 . . . . 71.52 108.669 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.36 175.5 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.907 0.86 . . . . 74.13 112.332 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.463 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -137.34 135.6 37.2 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 105.219 -2.141 . . . . 53.52 105.219 169.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.2 t -144.73 117.84 8.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.841 0.456 . . . . 70.21 109.983 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -121.06 131.35 54.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.03 135.41 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.194 0.998 . . . . 75.51 108.488 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.6 mt-30 -115.04 103.2 10.66 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.567 -0.901 . . . . 74.4 108.567 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -85.34 110.02 18.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.587 0.755 . . . . 64.34 109.618 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.02 146.65 22.14 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.178 -0.769 . . . . 63.42 111.178 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.545 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.52 118.66 0.99 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.913 -0.475 . . . . 41.35 111.913 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.493 HD12 ' CD1' ' C' ' 51' ' ' LEU . 8.7 mm -87.72 119.36 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.917 -0.771 . . . . 65.53 108.917 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.434 ' CE2' HD13 ' C' ' 13' ' ' ILE . 98.9 m-85 -129.36 128.7 43.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.9 0.88 . . . . 74.34 109.237 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 24.5 m -70.82 108.74 4.62 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.305 -0.628 . . . . 73.4 109.305 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' C' ' 56' ' ' TYR . 43.5 mm -114.36 101.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.21 -1.034 . . . . 74.31 108.21 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -133.53 150.05 51.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.97 0.908 . . . . 64.02 109.754 -177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.37 28.76 Favored Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.349 0.5 . . . . 70.14 114.349 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' C' ' 9' ' ' MET . 17.8 tt -108.57 151.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.331 1.052 . . . . 74.53 110.134 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -164.13 154.68 15.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.185 0.594 . . . . 74.42 110.756 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.83 -148.61 19.31 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.369 0.509 . . . . 74.32 112.243 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.9 p -65.89 -21.18 66.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.946 0.898 . . . . 75.51 111.115 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -61.53 -51.1 70.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.173 0.989 . . . . 74.0 109.95 170.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 53.3 ttm -66.47 -35.82 81.22 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.901 -0.59 . . . . 75.13 110.376 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.2 95.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.497 0.719 . . . . 73.41 111.487 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 56.5 t-80 -68.5 -23.74 64.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.251 -0.886 . . . . 74.12 111.415 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 99.6 m -82.7 -51.33 7.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.221 0.608 . . . . 60.14 110.896 173.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.74 -42.67 66.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.735 1.214 . . . . 70.11 111.314 -163.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.61 11.53 46.45 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.02 -0.537 . . . . 73.24 113.438 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' C' ' 134' ' ' ASP . . . -146.12 -73.44 0.23 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.505 0.652 . . . . 73.22 111.963 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.58 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 92.0 t80 -65.22 -53.55 42.81 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.308 0.855 . . . . 74.11 113.308 -168.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.448 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 31.9 m -61.04 -44.55 94.75 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 123.126 0.57 . . . . 70.03 111.835 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 87.9 Cg_exo -55.23 -33.59 85.12 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.654 2.236 . . . . 63.3 114.536 166.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.19 -25.15 65.09 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 123.048 0.539 . . . . 73.03 111.762 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.46 HD12 ' NH1' ' A' ' 111' ' ' ARG . 38.4 mm -69.0 -39.67 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.476 -0.564 . . . . 74.31 109.476 171.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.545 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.5 mt -76.93 -26.89 54.58 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.843 -1.071 . . . . 72.23 111.811 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -56.03 -47.09 99.52 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.405 1.082 . . . . 62.11 113.807 -173.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.78 -40.16 86.22 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.031 1.821 . . . . 61.45 113.542 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.38 -45.76 71.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.224 0.61 . . . . 74.34 110.712 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.4 82.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.713 0.805 . . . . 44.2 110.665 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -65.83 -49.45 68.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.411 -1.268 . . . . 55.32 110.658 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.09 -29.74 66.79 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.416 0.686 . . . . 62.14 110.673 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.8 t -65.61 -40.43 92.61 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.408 0.683 . . . . 45.1 110.12 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.542 HD13 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -67.9 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.867 -0.606 . . . . 74.44 110.133 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 62.3 m -58.24 -29.56 65.85 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.823 0.849 . . . . 73.35 111.011 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.9 -51.51 18.31 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.37 -0.832 . . . . 71.45 109.715 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.585 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.17 -39.51 60.16 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.806 0.842 . . . . 52.3 112.369 177.66 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.6 t -68.85 -44.92 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.389 0.676 . . . . 72.31 110.259 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.07 -28.61 66.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.281 0.562 . . . . 63.52 110.926 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -67.21 -37.19 83.21 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 114.71 -1.132 . . . . 73.12 110.05 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.62 83.74 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 119.352 -0.693 . . . . 73.32 112.952 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' D' ' 17' ' ' TYR . 64.0 p 58.96 25.36 13.69 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.237 1.815 . . . . 25.31 112.833 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.441 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 84.3 m-85 -93.21 160.43 33.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.298 1.039 . . . . 74.31 108.923 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.06 117.46 4.47 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.716 2.277 . . . . 70.24 112.418 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.12 134.72 44.17 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.467 1.107 . . . . 64.31 112.414 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.59 107.35 18.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.948 -1.13 . . . . 73.0 107.948 -174.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.67 100.64 13.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.266 -1.013 . . . . 73.02 108.266 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 134.36 48.63 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.339 0.655 . . . . 73.22 110.079 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.66 99.06 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.773 0.829 . . . . 75.31 110.974 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.474 ' HG2' HD12 ' A' ' 16' ' ' ILE . 24.0 Cg_exo -64.18 87.19 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.84 2.36 . . . . 72.01 112.702 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.33 111.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.682 -0.859 . . . . 75.52 108.682 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -109.44 103.12 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.962 -0.755 . . . . 63.13 108.962 -177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.19 -29.24 69.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.21 1.004 . . . . 75.33 111.561 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.469 ' HB3' ' HB1' ' C' ' 100' ' ' ALA . 4.8 p-10 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 123.584 0.753 . . . . 74.53 110.584 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.439 ' HG3' HG13 ' D' ' 89' ' ' ILE . 6.0 ttp . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 114.004 1.112 . . . . 72.21 114.004 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -139.32 136.8 35.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.778 0.831 . . . . 74.2 109.037 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -152.97 93.78 1.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 74.33 107.518 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.3 mt-30 -114.51 153.61 29.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.562 -0.744 . . . . 73.21 109.587 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.57 131.07 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.95 0.9 . . . . 74.21 109.16 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -109.42 -49.57 3.1 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.363 0.528 . . . . 63.3 111.909 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.31 121.08 0.73 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.509 0.559 . . . . 70.05 112.509 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.43 HD12 ' N ' ' D' ' 16' ' ' ILE . 1.7 mp -108.6 133.52 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.653 -1.239 . . . . 73.25 107.653 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' C' ' 122' ' ' THR . 36.1 p90 -161.89 176.05 11.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.911 0.862 . . . . 72.34 112.021 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -107.07 117.87 35.21 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.778 -1.101 . . . . 74.12 109.265 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.447 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.6 mtpt -85.47 -25.24 27.02 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.287 -0.634 . . . . 74.5 109.287 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.712 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.1 t70 -148.32 141.03 24.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.328 1.051 . . . . 55.0 109.869 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.585 HD13 ' HE3' ' C' ' 117' ' ' MET . 46.1 mt -138.41 142.96 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.445 1.498 . . . . 73.55 107.713 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -148.01 137.09 22.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.233 1.013 . . . . 65.01 108.852 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.4 t80 -153.86 119.54 5.25 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.117 -1.438 . . . . 75.25 107.117 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.0 118.54 19.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.394 0.677 . . . . 73.23 109.57 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.75 90.2 12.49 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.703 -0.851 . . . . 73.21 108.703 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.61 -46.44 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.964 2.443 . . . . 51.1 112.829 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.4 m-20 -103.31 43.51 1.08 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.279 1.032 . . . . 50.32 108.26 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.02 -53.46 64.95 Favored Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 114.795 1.406 . . . . 63.35 114.795 -168.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.67 -3.86 12.0 Favored 'Trans proline' 0 C--N 1.393 2.88 0 CA-C-N 121.806 1.681 . . . . 74.22 113.865 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.448 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -84.6 -40.17 17.84 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.896 0.878 . . . . 65.14 110.454 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -82.26 -14.05 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.755 0.822 . . . . 74.01 109.923 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.21 -28.76 70.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.377 1.071 . . . . 74.15 110.96 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -72.64 -7.66 51.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.39 1.076 . . . . 61.44 111.293 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -111.78 111.81 23.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.423 1.089 . . . . 75.52 109.877 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.63 63.4 7.54 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.705 0.802 . . . . 61.22 110.052 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.506 ' HB3' HD21 ' D' ' 68' ' ' LEU . 65.7 t-105 -150.58 166.87 28.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.826 -0.805 . . . . 74.21 108.826 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -89.74 108.69 27.1 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.118 0.967 . . . . 63.32 110.471 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -43.24 144.94 1.55 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 124.506 3.471 . . . . 74.21 115.612 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.73 118.37 15.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.569 -0.741 . . . . 71.23 110.379 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.441 HG13 HG13 ' D' ' 64' ' ' VAL . 99.1 t -109.23 125.33 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.877 0.871 . . . . 64.1 111.02 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -111.54 120.95 43.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.68 -1.23 . . . . 62.44 107.68 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 155.66 16.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.403 -0.962 . . . . 74.1 108.403 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.6 t70 -143.59 140.89 30.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.887 0.875 . . . . 73.32 108.963 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.9 153.44 31.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.275 0.63 . . . . 63.3 110.544 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.9 t0 -165.75 152.7 10.04 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.579 1.152 . . . . 62.51 108.781 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -125.08 164.52 20.03 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.31 0.576 . . . . 51.1 110.279 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.86 167.53 30.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.529 1.131 . . . . 61.54 108.465 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.4 p -161.6 154.34 20.42 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.971 0.508 . . . . 61.03 110.97 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -154.95 149.62 26.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.513 1.125 . . . . 74.4 108.832 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -91.34 118.53 30.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.548 -0.908 . . . . 74.33 108.548 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.54 -38.49 12.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.099 0.56 . . . . 52.34 109.995 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.72 -177.11 6.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.662 0.744 . . . . 62.11 111.013 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.66 125.64 29.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.74 -1.118 . . . . 73.1 110.083 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 63.8 10.58 5.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.304 1.442 . . . . 70.24 112.308 -172.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.1 t -123.76 120.07 58.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.787 0.835 . . . . 71.13 109.025 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.501 ' HD1' ' HB ' ' D' ' 86' ' ' ILE . 64.3 m-85 -132.88 130.03 39.18 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.778 -0.823 . . . . 74.35 108.778 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.9 138.82 31.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.199 1.0 . . . . 64.24 108.888 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.66 123.92 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.228 -1.397 . . . . 73.34 107.228 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.1 t -102.25 130.73 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 74.54 108.808 175.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.5 117.93 35.28 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.575 -1.268 . . . . 71.3 107.575 176.359 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -96.58 107.2 19.58 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.727 -1.212 . . . . 74.54 107.727 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.15 129.91 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.448 -0.945 . . . . 73.25 108.448 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -116.71 147.55 41.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.919 0.888 . . . . 72.33 109.65 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 23.7 t -134.11 128.72 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 73.11 108.442 174.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -124.83 119.64 29.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.08 139.3 53.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.311 0.644 . . . . 62.42 109.634 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 41.7 p -155.49 129.13 8.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.62 0.768 . . . . 52.31 109.415 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' D' ' 36' ' ' TRP . 15.5 tp -113.54 111.61 22.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.504 -0.925 . . . . 64.3 108.504 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.97 -144.98 26.73 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.876 0.735 . . . . 63.34 111.88 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.37 2.88 34.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.611 0.764 . . . . 64.25 112.021 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.448 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.1 pt-20 -123.81 152.16 42.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.777 0.831 . . . . 74.31 110.423 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 80.9 m -74.07 136.04 43.03 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.61 0.569 . . . . 73.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.58 -54.8 3.74 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.918 0.887 . . . . 73.24 109.436 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -161.52 164.04 29.85 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.78 -1.1 . . . . 65.13 109.312 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.79 152.53 50.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.102 1.361 . . . . 74.22 107.803 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.639 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.4 t -159.63 142.94 14.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.732 0.413 . . . . 52.43 110.784 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.45 127.54 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.169 0.588 . . . . 73.05 109.562 168.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.2 115.82 42.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 123.617 0.767 . . . . 64.0 109.549 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.712 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.3 mt-30 -89.86 87.13 6.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.867 0.841 . . . . 72.14 108.874 170.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.35 95.75 6.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 113.612 -1.631 . . . . 73.15 109.429 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 142.76 18.35 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.173 -0.371 . . . . 53.12 112.173 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.05 131.95 4.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.545 -0.622 . . . . 42.01 111.545 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.45 123.28 44.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 124.488 1.115 . . . . 65.52 108.78 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -126.16 131.77 51.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.935 0.894 . . . . 72.54 109.635 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 9.8 m -80.59 94.51 6.31 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.641 -0.874 . . . . 24.34 108.641 173.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.501 ' HB ' ' HD1' ' D' ' 56' ' ' TYR . 69.9 mt -108.5 111.02 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 63.22 109.205 -175.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.64 128.81 15.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.634 0.774 . . . . 43.21 109.822 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.76 50.13 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-O 119.756 -0.469 . . . . 62.33 113.705 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.483 HD13 HG23 ' D' ' 86' ' ' ILE . 2.9 mp -95.8 126.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.706 -1.591 . . . . 71.23 106.706 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.26 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.751 0.82 . . . . 75.21 111.35 -169.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.31 -141.84 39.89 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.039 -0.982 . . . . 72.12 112.719 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -90.38 -16.33 29.32 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.649 0.78 . . . . 74.42 110.02 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.46 -33.37 72.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.583 1.153 . . . . 53.43 111.123 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -64.1 -33.16 75.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.996 0.519 . . . . 74.32 111.694 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.58 80.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.201 0.6 . . . . 73.23 110.427 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -72.78 -36.19 67.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.907 -0.588 . . . . 60.42 110.925 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -64.33 -43.29 95.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.794 0.437 . . . . 34.13 110.053 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.6 tp -72.73 -35.98 67.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.175 0.99 . . . . 71.25 111.336 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.14 53.98 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.446 -0.641 . . . . 51.54 114.434 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.448 ' HB1' ' HD1' ' D' ' 133' ' ' PHE . . . -132.92 -60.27 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.741 0.77 . . . . 61.43 111.873 -175.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.22 -46.13 85.19 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.364 0.666 . . . . 73.51 112.145 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 33.4 m -71.62 -45.3 12.78 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-O 118.558 -0.734 . . . . 72.03 112.03 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.48 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.8 Cg_exo -57.82 -29.06 84.75 Favored 'Trans proline' 0 C--N 1.399 3.226 0 C-N-CA 122.446 2.097 . . . . 75.45 113.915 169.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.86 -32.29 73.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.262 0.625 . . . . 53.31 110.702 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.23 -34.56 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 123.661 0.785 . . . . 74.41 110.186 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.6 mt -82.5 -17.76 43.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.23 1.012 . . . . 65.02 112.39 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -65.78 -44.66 64.14 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.656 0.984 . . . . 72.31 113.656 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.86 -32.07 90.96 Favored 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 121.952 1.768 . . . . 64.52 112.873 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -80.16 -33.97 37.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 71.34 112.398 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.17 58.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.263 -0.643 . . . . 52.42 109.263 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -68.35 -31.7 71.27 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 114.883 -1.053 . . . . 72.45 111.213 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.13 -50.38 72.1 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 124.223 0.952 . . . . 72.41 110.692 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.3 t -59.02 -42.04 89.18 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.689 0.618 . . . . 65.32 110.52 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.639 HG12 ' SG ' ' D' ' 76' ' ' CYS . 99.5 mt -59.3 -52.84 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.314 1.045 . . . . 74.22 110.708 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.523 HG23 ' HG3' ' D' ' 125' ' ' GLN . 74.1 m -58.64 -41.82 86.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.882 0.873 . . . . 74.45 110.808 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.56 -43.97 88.19 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 114.65 -1.159 . . . . 70.12 110.448 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.41 -30.58 69.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.711 0.404 . . . . 63.31 111.459 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' D' ' 123' ' ' PHE . 55.0 t -66.92 -45.42 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.451 0.701 . . . . 72.4 110.029 173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -74.26 -25.63 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.748 0.419 . . . . 73.04 110.967 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -75.63 -35.23 60.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.593 0.757 . . . . 65.13 109.255 172.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.38 -3.89 88.84 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.854 0.721 . . . . 62.11 112.039 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.5 p 58.05 34.69 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.71 2.004 . . . . 72.33 112.894 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.472 ' HB2' HG13 ' D' ' 118' ' ' VAL . 51.1 m-85 -93.28 166.74 15.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.738 1.215 . . . . 73.23 108.989 171.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.56 132.26 44.89 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.097 1.864 . . . . 73.32 111.514 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.523 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.6 tt0 -52.49 139.6 24.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.544 1.137 . . . . 74.21 112.406 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.425 HD21 HG11 ' D' ' 40' ' ' VAL . 46.7 tp -126.04 99.89 6.11 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.947 0.403 . . . . 72.22 110.862 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -100.15 117.81 35.18 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.179 -1.415 . . . . 75.14 107.179 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -73.17 123.16 23.1 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.624 -0.509 . . . . 61.13 109.624 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.66 147.07 84.73 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 124.635 1.209 . . . . 64.2 112.311 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.93 123.06 12.21 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.262 2.641 . . . . 73.12 113.555 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.75 145.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.828 0.851 . . . . 72.2 109.92 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -68.25 118.48 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.328 -0.99 . . . . 54.41 108.328 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.448 ' HD1' ' HB1' ' D' ' 100' ' ' ALA . 23.2 p90 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 124.772 1.229 . . . . 74.2 113.969 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 108.809 -0.811 . . . . 75.13 108.809 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.01 114.0 9.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.401 -1.703 . . . . 74.31 106.401 159.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -138.78 121.07 15.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.335 -0.617 . . . . 70.43 109.335 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.448 HD12 ' HG2' ' C' ' 130' ' ' PRO . 25.0 pt -73.98 111.77 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 64.55 109.036 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -96.39 -43.32 7.71 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.764 -0.458 . . . . 64.21 109.764 -174.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -155.95 140.43 16.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.139 0.976 . . . . 64.31 108.865 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.555 HG23 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -128.72 112.53 26.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 106.122 -1.807 . . . . 63.33 106.122 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 28.8 p90 -157.64 169.14 25.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.252 0.548 . . . . 72.15 111.817 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -89.4 121.77 31.97 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.797 -0.816 . . . . 74.33 108.797 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.7 mtpt -87.51 -36.0 17.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.217 0.532 . . . . 71.33 109.751 175.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -146.83 140.44 25.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.108 -0.951 . . . . 55.22 108.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.5 mt -132.62 146.58 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.314 1.046 . . . . 73.43 108.671 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.2 m -146.1 124.96 12.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.182 0.993 . . . . 73.11 109.229 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 83.3 t80 -123.91 126.89 47.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.192 -1.781 . . . . 75.01 106.192 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -134.73 108.36 7.95 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.994 -0.743 . . . . 70.23 108.994 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.72 82.42 59.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.975 0.91 . . . . 53.34 108.796 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.2 -22.22 22.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.591 2.194 . . . . 72.14 111.576 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 89.3 m-20 -114.34 33.72 5.13 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.112 0.965 . . . . 75.43 109.953 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.48 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.37 -46.57 98.99 Favored Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 123.827 0.851 . . . . 74.45 112.491 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 7.7 Cg_exo -74.81 -28.91 9.12 Favored 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 121.937 1.758 . . . . 64.11 112.747 172.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 5.4 m80 -68.93 -28.22 66.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.543 0.737 . . . . 55.0 111.34 -172.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.53 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.4 p -63.96 -27.0 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.478 0.711 . . . . 63.23 111.587 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -68.12 -30.67 69.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.746 0.818 . . . . 72.33 110.583 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -75.89 -46.08 32.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.519 -0.764 . . . . 73.13 109.965 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HB3' HD11 ' A' ' 68' ' ' LEU . 41.3 mtpt -81.73 157.37 24.58 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.676 -1.147 . . . . 62.43 110.66 -173.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -64.44 135.36 56.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.552 0.341 . . . . 60.12 111.008 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -84.29 64.88 8.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.111 0.958 . . . . 73.21 109.529 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -132.0 66.59 77.94 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.065 1.346 . . . . 63.13 108.01 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -87.54 156.04 7.78 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.053 1.835 . . . . 71.23 112.389 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.34 124.22 40.26 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.509 -0.923 . . . . 54.24 108.509 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.1 t -90.59 99.59 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.825 0.85 . . . . 51.35 109.656 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 90.2 mttt -95.55 142.28 28.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.544 0.737 . . . . 71.45 110.424 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.06 112.28 12.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.458 -0.792 . . . . 70.44 109.795 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -115.32 113.55 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.231 1.012 . . . . 75.13 108.698 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.07 155.8 25.3 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.446 0.641 . . . . 41.4 111.449 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 15.8 t70 -149.16 154.95 39.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 54.34 109.059 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -133.41 132.82 41.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.809 0.844 . . . . 63.22 109.201 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.06 130.31 41.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.676 0.79 . . . . 62.51 109.681 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -88.65 155.27 19.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.299 0.64 . . . . 74.35 110.464 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.3 t -149.53 119.06 6.92 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 -176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.87 107.88 19.53 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.785 -0.82 . . . . 64.45 108.785 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.32 -27.98 20.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.863 -0.608 . . . . 74.01 110.659 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.94 -174.03 1.96 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.868 -1.06 . . . . 42.42 110.205 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.5 128.43 35.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.339 -0.846 . . . . 54.14 109.68 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 62.04 18.18 9.72 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.582 1.176 . . . . 72.11 111.813 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.0 107.31 17.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 124.482 1.113 . . . . 64.13 108.057 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -125.97 124.48 40.84 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.786 0.834 . . . . 75.24 108.996 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.95 124.43 49.5 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.4 1.48 . . . . 62.12 108.666 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.38 134.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.187 -1.042 . . . . 73.0 108.187 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.6 t -106.6 125.33 62.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.048 -0.978 . . . . 61.44 108.387 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.39 107.53 19.92 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.45 -1.685 . . . . 73.35 106.45 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 5.3 ttp180 -94.46 97.08 9.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.11 -1.441 . . . . 60.13 107.11 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.8 132.57 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -126.29 126.7 44.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.381 -0.97 . . . . 73.34 108.381 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.479 HG23 HD13 ' A' ' 114' ' ' ILE . 89.8 t -120.78 129.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.3 -1.371 . . . . 71.34 107.3 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 34.5 m -125.51 137.61 53.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.036 -0.727 . . . . 71.14 109.036 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.18 105.8 10.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.948 -1.501 . . . . 63.25 106.948 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -130.71 125.9 35.09 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.621 -0.881 . . . . 63.24 108.621 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.3 pt? -91.07 84.25 5.69 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.992 -1.114 . . . . 64.21 107.992 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.85 -124.25 7.04 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.724 -1.125 . . . . 62.12 110.639 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.86 -26.9 21.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.801 0.841 . . . . 61.54 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -96.25 133.16 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 74.02 110.63 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -80.33 126.92 31.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.976 0.91 . . . . 70.35 110.844 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.75 -51.46 12.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.001 0.92 . . . . 65.31 109.189 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -161.95 168.3 23.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.148 0.979 . . . . 71.25 110.061 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 76' ' ' CYS . 40.6 tp -138.11 149.11 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.66 1.184 . . . . 72.22 109.221 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.435 ' H ' HD12 ' A' ' 75' ' ' LEU . 63.7 m -139.66 140.34 36.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.068 1.347 . . . . 74.3 108.947 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.37 132.63 18.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.71 0.804 . . . . 74.01 108.839 170.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.76 112.86 13.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.805 -0.813 . . . . 64.12 108.805 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.23 80.58 9.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.765 -1.107 . . . . 75.33 108.399 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -76.76 92.71 3.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.808 -1.087 . . . . 65.21 109.129 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -93.33 144.74 17.24 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.664 -0.574 . . . . 71.41 111.664 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.55 127.55 3.81 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.752 -0.539 . . . . 74.45 111.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.39 126.18 39.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.975 -1.12 . . . . 72.32 107.975 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.15 121.48 20.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.221 -0.659 . . . . 75.54 109.221 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -81.09 110.77 16.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.932 -0.766 . . . . 74.01 108.932 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.36 144.21 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.142 0.577 . . . . 72.31 110.684 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.4 162.75 22.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.998 . . . . 64.12 109.779 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.17 -6.83 48.47 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 115.99 -0.55 . . . . 74.24 114.47 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.93 155.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.461 1.104 . . . . 71.13 109.288 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -164.28 174.61 10.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.355 -0.609 . . . . 72.53 109.355 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.14 -125.17 29.37 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 116.112 -0.494 . . . . 63.43 112.75 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -73.16 -18.78 61.23 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.804 0.842 . . . . 71.32 111.945 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -70.71 -50.75 32.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.607 0.763 . . . . 72.32 109.59 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -75.23 -29.85 60.38 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.423 -0.808 . . . . 74.14 110.441 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.97 -44.08 97.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.143 0.577 . . . . 71.53 110.042 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.08 -49.52 77.34 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 115.518 -0.765 . . . . 73.55 110.688 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.3 m -69.17 -59.78 2.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 74.54 112.973 -171.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.75 -14.95 60.78 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.142 0.423 . . . . 63.3 112.142 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.42 -18.42 30.84 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.862 -0.41 . . . . 43.42 113.817 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.59 -69.17 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.492 0.646 . . . . 74.01 111.998 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 8.6 t80 -44.12 -57.89 3.15 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.1 1.36 . . . . 72.41 112.788 -174.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.7 -47.99 5.1 Favored Pre-proline 0 CA--C 1.559 1.325 0 CA-C-O 117.856 -1.069 . . . . 75.11 113.077 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HA ' HD12 ' A' ' 106' ' ' LEU . 22.0 Cg_endo -62.63 -21.45 72.93 Favored 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.739 1.657 . . . . 42.55 113.398 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -80.06 -26.89 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.085 0.554 . . . . 65.2 110.213 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 33.4 mm -67.74 -41.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.356 0.598 . . . . 64.13 109.526 167.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 16' ' ' ILE . 68.8 mt -71.46 -25.68 62.4 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.015 -0.993 . . . . 72.22 111.315 -175.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.05 -43.4 67.11 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 117.709 -1.139 . . . . 72.53 114.005 -170.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.9 Cg_exo -55.47 -39.89 88.56 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.336 2.024 . . . . 71.43 113.633 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -77.08 -32.7 56.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.477 0.711 . . . . 72.52 111.871 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -46.68 70.03 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.343 -0.614 . . . . 44.22 109.343 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.499 ' NH1' HD12 ' C' ' 105' ' ' ILE . 35.4 ttm180 -53.5 -49.72 66.93 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.881 1.363 . . . . 75.0 110.443 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.61 -49.65 75.74 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.434 1.084 . . . . 75.1 110.849 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.2 -40.42 93.89 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 124.139 0.899 . . . . 71.54 111.584 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 64' ' ' VAL . 80.1 mt -65.31 -59.22 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 123.832 0.707 . . . . 74.32 110.061 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.0 m -55.54 -33.29 63.69 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.516 1.135 . . . . 74.43 111.533 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -71.67 -43.63 65.68 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.42 -0.809 . . . . 72.03 110.545 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 49.9 mtm -59.29 -41.71 89.61 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.146 0.43 . . . . 75.12 110.756 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.5 t -57.16 -50.31 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.526 -1.216 . . . . 61.13 110.422 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.48 -23.31 58.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.971 0.508 . . . . 70.23 111.692 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.46 -28.36 61.0 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.438 0.695 . . . . 74.25 109.609 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 8.07 71.85 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 115.537 -0.756 . . . . 53.41 112.497 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.626 HG22 ' HB3' ' B' ' 17' ' ' TYR . 7.1 t 48.13 43.74 18.69 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.693 1.997 . . . . 51.53 112.771 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.53 ' HE1' HG11 ' A' ' 31' ' ' VAL . 83.0 m-85 -99.1 158.54 32.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.749 -1.114 . . . . 61.31 108.657 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.62 149.86 64.81 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.602 2.201 . . . . 74.14 111.884 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -69.67 134.46 48.72 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.361 0.664 . . . . 63.32 111.704 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.11 112.19 23.4 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.544 -0.91 . . . . 71.23 108.544 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' C' ' 15' ' ' ARG . 80.5 m-20 -98.47 100.55 11.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.421 0.688 . . . . 74.34 109.531 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.06 120.98 8.35 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.144 0.978 . . . . 70.24 110.05 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.58 85.88 Favored Pre-proline 0 C--O 1.242 0.695 0 O-C-N 123.56 0.537 . . . . 43.51 109.662 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.47 104.78 1.63 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.866 1.711 . . . . 75.35 111.692 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -99.93 110.76 27.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.618 -1.253 . . . . 72.51 107.618 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.86 90.93 5.31 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.613 -1.255 . . . . 71.52 107.613 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.938 -1.028 . . . . 75.31 111.166 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.217 -0.616 0 C-N-CA 125.121 1.368 . . . . 71.11 112.232 177.044 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.442 ' SD ' HD12 ' B' ' 89' ' ' ILE . 17.1 ptm . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 114.262 1.208 . . . . 54.34 114.262 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.2 m -138.75 103.62 4.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.633 -1.247 . . . . 61.24 107.633 174.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -110.72 146.58 36.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.441 0.696 . . . . 74.44 109.462 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 49.4 tt0 -164.54 141.4 6.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.285 0.634 . . . . 55.13 110.333 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.27 131.28 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 108.759 -0.83 . . . . 74.23 108.759 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -101.15 -50.83 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.15 -0.315 . . . . 63.42 110.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -157.43 140.93 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.514 -0.312 . . . . 70.2 110.183 -171.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.6 mt -123.16 134.68 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.867 -1.531 . . . . 75.43 106.867 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.626 ' HB3' HG22 ' A' ' 122' ' ' THR . 9.2 p90 -166.97 147.12 5.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.428 0.899 . . . . 43.23 113.428 -172.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.2 m -73.68 122.04 21.69 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.059 -1.428 . . . . 63.05 108.837 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.9 mtpt -97.46 -29.05 13.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.669 0.788 . . . . 75.34 110.674 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 24.4 t70 -157.13 141.6 16.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.389 -0.369 . . . . 71.23 110.787 -169.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.429 HD12 HG22 ' B' ' 78' ' ' VAL . 47.0 mm -138.48 144.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.719 1.208 . . . . 72.42 109.366 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.562 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -136.98 138.44 40.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.948 1.299 . . . . 63.33 108.422 167.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -142.85 131.46 22.5 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.064 -1.828 . . . . 72.41 106.064 164.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.5 mt-10 -131.48 136.42 47.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.739 -0.837 . . . . 74.31 108.739 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -131.4 80.37 67.71 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 107.223 -1.399 . . . . 61.21 107.223 170.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.21 -33.48 60.1 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.527 2.151 . . . . 52.33 110.779 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.448 ' O ' HG23 ' B' ' 31' ' ' VAL . 83.4 m-20 -118.77 24.29 10.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.581 1.152 . . . . 74.1 110.0 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -38.14 -56.18 2.11 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 115.053 1.501 . . . . 55.01 115.053 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.8 Cg_endo -82.21 -6.63 12.04 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.338 2.026 . . . . 40.24 113.332 -176.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.443 ' HA ' HE22 ' B' ' 33' ' ' GLN . 72.2 m80 -96.82 -24.22 16.0 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.696 0.798 . . . . 72.43 111.572 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' B' ' 73' ' ' ALA . 59.8 t -82.3 -6.66 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.584 0.754 . . . . 70.15 110.085 173.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.66 -43.27 72.26 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.277 1.031 . . . . 73.41 111.155 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.443 HE22 ' HA ' ' B' ' 30' ' ' HIS . 0.8 OUTLIER -72.81 -32.83 65.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.543 0.737 . . . . 74.14 110.151 -178.417 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.18 85.16 4.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.1 -0.955 . . . . 55.45 110.426 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.54 77.41 9.31 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.746 0.784 . . . . 71.33 108.967 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.474 ' HB2' HD21 ' B' ' 68' ' ' LEU . 5.9 m-90 -151.88 158.0 42.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.387 1.475 . . . . 73.12 108.294 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.94 113.74 45.33 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.151 -1.055 . . . . 64.32 108.151 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 56.7 Cg_endo -68.43 160.74 47.86 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.402 2.068 . . . . 73.4 112.572 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.0 tt0 -60.27 103.73 0.26 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.072 0.858 . . . . 71.35 110.046 175.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.13 135.41 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.064 -0.717 . . . . 62.11 109.064 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -142.41 134.99 28.08 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.871 -0.788 . . . . 72.11 108.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.23 123.49 48.37 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.751 -1.203 . . . . 74.11 107.751 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.628 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 8.8 m-20 -122.9 111.49 16.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.671 -1.233 . . . . 71.51 107.671 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.603 HD21 HG11 ' B' ' 131' ' ' VAL . 7.5 mp -100.31 143.3 30.66 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.365 0.666 . . . . 60.43 110.178 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.9 t70 -147.59 147.12 29.73 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.524 1.13 . . . . 65.43 108.129 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -132.53 124.56 28.72 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.311 0.644 . . . . 72.14 109.815 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.64 154.87 30.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.175 0.99 . . . . 40.33 108.49 173.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.1 p -145.46 161.18 40.33 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.236 0.614 . . . . 72.23 110.085 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.4 p -169.08 159.96 9.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.03 0.932 . . . . 74.2 109.482 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -118.08 134.98 54.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.06 0.544 . . . . 61.01 109.806 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.31 -49.18 5.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.86 0.864 . . . . 74.21 110.695 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 -172.8 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.331 -0.85 . . . . 54.0 110.376 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.55 107.62 1.77 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.36 1.037 . . . . 73.11 110.789 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' B' ' 85' ' ' SER . 21.3 m-20 77.82 1.07 2.85 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 126.516 1.926 . . . . 62.2 111.3 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.57 88.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.341 -1.355 . . . . 74.52 107.341 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -95.75 165.69 12.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.604 -0.888 . . . . 71.33 108.604 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.81 113.74 7.98 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.754 -1.202 . . . . 73.33 107.754 -174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.09 127.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.39 0.676 . . . . 64.24 109.745 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 27.9 t -103.27 131.99 50.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.926 0.89 . . . . 71.32 109.308 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -116.21 112.04 21.05 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.401 -1.333 . . . . 73.52 107.401 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 28.7 ttm180 -100.02 121.95 42.16 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.853 -0.425 . . . . 75.4 109.853 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' B' ' 114' ' ' ILE . 17.4 t -117.22 133.64 63.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.477 -1.305 . . . . 71.41 107.477 168.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.4 m -119.09 134.35 55.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.063 -0.717 . . . . 63.43 109.063 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.569 HG23 HD13 ' B' ' 114' ' ' ILE . 63.7 t -117.15 104.8 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.91 0.884 . . . . 73.0 108.839 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.0 m -97.48 140.85 31.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.121 -1.399 . . . . 75.0 108.871 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -141.5 134.22 28.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.327 0.392 . . . . 43.13 110.359 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -140.36 135.83 32.54 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.31 0.644 . . . . 72.14 109.312 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 17.1 tp -136.55 124.0 22.11 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.227 0.611 . . . . 74.23 109.486 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.1 -116.85 4.47 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.656 -0.702 . . . . 64.42 111.505 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.81 19.75 13.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.352 1.061 . . . . 73.32 109.693 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -156.23 176.63 12.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.895 0.478 . . . . 74.12 111.038 -170.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -72.58 141.93 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.618 0.767 . . . . 73.34 110.563 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -94.32 -59.24 2.0 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.038 -0.727 . . . . 42.12 109.038 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -157.89 168.76 26.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.871 -1.059 . . . . 73.52 109.886 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 78.8 mt -141.04 140.69 34.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.37 1.468 . . . . 63.21 107.251 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.8 t -148.99 155.47 40.85 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.877 -0.786 . . . . 75.31 108.877 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.6 tt0 -164.49 138.47 5.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.899 -0.778 . . . . 74.21 108.899 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.429 HG22 HD12 ' B' ' 21' ' ' ILE . 92.4 t -134.54 145.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.93 0.892 . . . . 65.22 109.098 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.5 mt-30 -122.08 94.15 4.21 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.289 -1.004 . . . . 73.33 108.289 170.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.417 ' O ' HD13 ' B' ' 106' ' ' LEU . 55.1 tp60 -84.54 101.15 11.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.731 -0.84 . . . . 73.33 108.731 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.53 165.83 31.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.27 -0.732 . . . . 60.44 111.27 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.66 133.73 3.54 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 112.325 -0.31 . . . . 71.33 112.325 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.479 HG13 ' HE1' ' B' ' 17' ' ' TYR . 63.6 mt -86.32 123.39 39.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.875 -0.787 . . . . 71.42 108.875 171.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.28 135.24 46.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.627 1.171 . . . . 75.12 109.077 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.568 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 53.5 m -101.81 106.35 17.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.81 0.844 . . . . 71.22 109.009 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.57 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -126.03 131.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.881 0.873 . . . . 74.35 109.417 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 160.6 40.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.136 0.974 . . . . 73.31 109.022 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 -29.09 3.98 Favored Glycine 0 N--CA 1.473 1.118 0 N-CA-C 114.281 0.472 . . . . 65.4 114.281 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.442 HD12 ' SD ' ' B' ' 9' ' ' MET . 16.0 tt -83.03 152.35 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.975 0.91 . . . . 51.41 110.352 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 166.07 32.7 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.172 0.511 . . . . 72.3 112.008 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.82 30.53 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 114.761 -1.109 . . . . 40.41 113.848 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 47.4 m -65.04 -33.81 76.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.97 0.908 . . . . 72.24 110.611 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.54 -51.98 66.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.109 -0.951 . . . . 72.31 110.381 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -62.6 -41.06 98.74 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.805 0.842 . . . . 54.32 111.388 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.8 81.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.007 0.817 . . . . 73.45 112.09 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -95.99 -12.32 25.17 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.539 0.336 . . . . 64.44 111.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -80.38 -65.02 1.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.659 -0.497 . . . . 74.21 109.659 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 20.6 tp -75.89 -28.31 58.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.085 -0.507 . . . . 63.34 110.468 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.2 -34.06 18.6 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.754 -0.657 . . . . 50.03 114.294 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.86 -41.3 2.12 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.05 0.925 . . . . 65.21 113.075 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -76.94 -39.93 48.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.803 0.441 . . . . 74.42 111.29 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -66.34 -45.51 59.9 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.698 -0.668 . . . . 74.21 110.782 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.432 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 85.6 Cg_exo -55.73 -35.74 93.85 Favored 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 122.49 2.127 . . . . 63.55 113.896 163.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.673 0.389 . . . . 55.52 111.425 -178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.96 -44.51 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.078 0.951 . . . . 72.44 110.001 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.417 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.7 mt -75.43 -23.52 56.98 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.853 -1.067 . . . . 75.4 112.37 -173.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.87 -48.07 95.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 113.936 1.087 . . . . 75.35 113.936 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.33 -34.47 94.13 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.153 1.902 . . . . 72.32 113.383 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.63 -43.82 62.75 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.228 0.611 . . . . 64.25 110.316 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.51 -39.57 80.45 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 123.49 0.716 . . . . 72.25 110.135 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 61.0 ttt180 -56.46 -63.98 1.02 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.749 1.22 . . . . 73.11 111.128 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.01 -28.69 69.67 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.112 0.882 . . . . 73.31 110.785 -171.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -69.27 -42.77 75.11 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.846 0.458 . . . . 40.52 110.843 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.569 HD13 HG23 ' B' ' 64' ' ' VAL . 93.5 mt -62.97 -53.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.204 0.602 . . . . 73.24 110.045 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -59.26 -33.11 70.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.508 -1.223 . . . . 70.54 110.796 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.3 t -62.87 -53.66 50.68 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.123 -0.944 . . . . 62.32 109.942 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.54 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 14.4 mmt -60.29 -34.99 74.54 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.195 0.598 . . . . 52.41 111.965 -175.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.77 -48.64 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.833 0.853 . . . . 65.13 111.005 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 61.0 p -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.915 0.486 . . . . 72.33 111.615 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.54 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 86.5 mtt-85 -68.18 -37.63 81.16 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.392 0.677 . . . . 73.14 109.324 171.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 11.88 54.29 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.133 0.895 . . . . 72.24 113.41 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.8 p 53.14 39.68 30.01 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.662 1.585 . . . . 64.43 112.341 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.596 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 65.5 m-85 -108.44 159.74 29.67 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 124.759 1.224 . . . . 73.4 110.336 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 106.66 0.2 Allowed 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 123.037 2.491 . . . . 51.41 112.483 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' C' ' 125' ' ' GLN . 12.9 pt20 -50.03 125.26 11.72 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.284 1.434 . . . . 65.44 111.598 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.29 112.97 25.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.276 -1.009 . . . . 73.3 108.276 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -90.38 129.73 36.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.688 0.795 . . . . 63.41 109.091 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.453 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -77.5 107.38 9.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.015 0.926 . . . . 63.13 109.214 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.26 152.55 96.45 Favored Pre-proline 0 CA--C 1.554 1.107 0 CA-C-N 115.704 -0.68 . . . . 63.21 109.695 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.4 111.21 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.427 2.752 . . . . 73.24 113.034 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' VAL . . . . . 0.603 HG11 HD21 ' B' ' 44' ' ' LEU . 48.5 t -88.65 110.09 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.743 -1.577 . . . . 53.15 106.743 168.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.64 91.61 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -56.09 -42.76 77.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.091 0.956 . . . . 72.44 111.25 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.07 -54.59 45.31 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.49 -1.232 . . . . 72.32 110.908 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.1 63.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.449 -0.796 . . . . 72.11 112.164 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 124.196 0.998 . . . . 71.21 109.595 -176.723 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.2 ttm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.397 0.618 . . . . 52.31 111.798 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -85.78 85.93 7.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.879 -0.786 . . . . 72.41 108.879 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.405 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -105.17 121.49 43.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.389 -1.278 . . . . 73.31 108.093 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.23 137.2 38.83 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.367 -0.605 . . . . 64.3 109.367 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 49.5 mt -81.29 121.51 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.105 -0.952 . . . . 74.0 109.241 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -89.47 -49.6 6.59 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.194 0.598 . . . . 72.43 109.965 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.487 ' HA ' HD21 ' A' ' 127' ' ' ASN . 53.2 ttt180 -164.01 122.69 1.91 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.61 0.364 . . . . 72.24 110.538 -176.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.62 136.33 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.468 -0.938 . . . . 71.44 108.468 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 36.0 p90 -169.07 165.65 11.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.108 0.956 . . . . 74.43 112.855 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -87.01 111.73 21.15 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.732 -1.576 . . . . 65.43 108.838 173.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 57.9 mmtt -65.29 -48.46 73.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.389 1.09 . . . . 74.13 108.49 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -134.62 140.4 46.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.133 -1.848 . . . . 70.34 109.207 -170.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.6 mt -137.13 143.45 34.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.074 -1.454 . . . . 64.41 107.074 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -160.63 151.04 18.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.389 0.614 . . . . 45.12 109.86 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -152.72 115.22 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.282 -1.377 . . . . 72.21 107.282 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -116.08 109.14 17.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.304 -0.628 . . . . 74.44 109.304 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.15 85.28 15.12 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.382 1.073 . . . . 64.31 108.113 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -35.23 20.29 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 121.927 1.751 . . . . 35.33 110.382 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 77.7 m-20 -98.55 30.58 3.19 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.712 1.205 . . . . 75.43 110.29 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.15 99.96 Favored Pre-proline 0 CA--C 1.57 1.727 0 C-N-CA 124.558 1.143 . . . . 62.52 112.591 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.35 -18.37 4.07 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.169 1.913 . . . . 73.32 113.189 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.434 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -69.75 -41.33 75.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.447 0.699 . . . . 73.44 110.529 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.695 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.1 p -66.63 -16.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.553 1.141 . . . . 75.31 112.311 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -62.36 -37.19 84.74 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.087 1.355 . . . . 72.24 112.059 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -118.77 24.93 10.57 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.826 0.822 . . . . 72.54 109.398 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 20.1 ttpp -123.53 176.12 6.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.05 0.54 . . . . 51.42 110.675 -170.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' C' ' 37' ' ' GLN . 5.0 p-10 -55.24 120.74 7.5 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.379 1.072 . . . . 71.33 111.203 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -90.02 63.31 5.88 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.899 -0.592 . . . . 74.43 109.525 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' C' ' 35' ' ' ASP . 15.4 pt20 -146.16 64.57 9.99 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-O 121.19 0.519 . . . . 65.14 111.147 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.04 134.12 8.05 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 121.724 1.616 . . . . 64.21 110.648 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -84.52 93.67 8.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.37 -1.344 . . . . 75.23 107.37 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 65.8 t -67.39 133.19 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.445 -1.252 . . . . 70.54 110.413 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -130.04 130.22 44.66 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.554 -1.276 . . . . 64.3 107.554 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.596 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.4 pt? -95.49 133.3 39.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.367 -0.975 . . . . 71.03 108.367 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -118.88 141.03 49.02 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.955 -1.498 . . . . 74.2 106.955 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -134.06 143.03 47.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.047 0.451 . . . . 64.45 110.205 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -147.5 149.7 33.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.261 1.024 . . . . 64.01 108.655 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 14.5 t -130.99 144.1 51.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.809 0.444 . . . . 74.02 110.437 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.01 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.282 1.033 . . . . 75.4 108.433 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -130.83 142.37 50.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.834 0.453 . . . . 52.02 110.344 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -160.6 133.41 6.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.815 0.846 . . . . 72.42 109.814 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.21 133.44 40.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.11 0.564 . . . . 53.22 110.168 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' C' ' 57' ' ' GLU . 49.0 mt -102.7 -38.56 7.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.226 0.61 . . . . 72.42 110.253 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.19 178.77 9.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.835 0.854 . . . . 62.31 110.097 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.93 116.87 5.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.184 -0.916 . . . . 63.5 109.112 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.98 0.11 2.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.332 1.453 . . . . 75.43 113.11 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 53.4 t -109.69 108.43 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.301 -0.629 . . . . 75.43 109.301 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -113.59 161.65 17.17 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.923 0.889 . . . . 70.21 109.036 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.53 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.0 tt0 -124.25 141.45 52.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.985 0.914 . . . . 72.24 108.808 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.41 HG23 HD11 ' C' ' 106' ' ' LEU . 24.6 m -129.37 134.53 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 122.916 0.486 . . . . 70.24 109.933 168.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' C' ' 46' ' ' THR . 58.0 t -103.41 128.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.681 -1.229 . . . . 73.24 107.681 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.5 96.43 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.133 -1.062 . . . . 73.35 108.133 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -86.47 114.81 23.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.175 -1.375 . . . . 62.13 110.49 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.35 109.94 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.736 -0.838 . . . . 65.03 108.736 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -103.55 113.48 27.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.194 0.521 . . . . 71.23 109.603 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.513 HG23 HD13 ' C' ' 114' ' ' ILE . 71.1 t -100.8 109.75 26.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 123.571 0.748 . . . . 55.03 109.206 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 15.2 m -102.0 127.31 48.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.155 -0.683 . . . . 64.1 109.155 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.72 100.2 6.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.651 -1.24 . . . . 55.2 107.651 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -151.15 147.08 26.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.702 -0.681 . . . . 74.42 109.961 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.77 -14.56 56.27 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.254 -0.43 . . . . 73.41 109.919 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.47 -102.18 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 110.977 -0.849 . . . . 71.41 110.977 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.39 -23.38 26.14 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.685 -0.857 . . . . 64.54 108.685 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -79.67 100.87 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.269 1.028 . . . . 64.0 109.02 174.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.0 m -88.97 128.56 35.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.549 -0.75 . . . . 74.21 110.429 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.29 -56.71 4.45 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 44.15 107.914 170.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -154.87 155.92 35.22 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.002 -0.999 . . . . 63.41 110.816 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.406 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -121.7 143.63 49.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.358 -2.09 . . . . 73.4 105.358 170.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.6 t -147.08 145.66 29.71 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.258 -1.015 . . . . 63.01 108.258 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.0 128.33 6.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.86 0.362 . . . . 72.41 110.42 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -131.13 139.15 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.69 1.196 . . . . 63.24 108.495 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -113.66 94.69 4.96 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.515 -0.921 . . . . 75.31 108.515 171.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.462 ' O ' HD13 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.77 98.13 7.63 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.319 -0.855 . . . . 74.4 109.114 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.89 144.6 17.24 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.286 -0.726 . . . . 73.22 111.286 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -140.77 128.36 3.74 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 112.369 -0.292 . . . . 71.02 112.369 -172.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -91.43 122.96 43.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.898 -1.149 . . . . 64.22 107.898 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -137.84 121.77 17.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.613 0.765 . . . . 72.41 109.61 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 p -84.22 113.4 21.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 64.4 109.127 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 44.2 pt -115.18 127.47 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.577 0.703 . . . . 60.43 109.687 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.62 154.25 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.475 1.11 . . . . 62.31 108.485 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -18.82 38.97 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 120.426 -0.097 . . . . 75.25 112.866 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' C' ' 93' ' ' GLN . 10.7 tp -123.3 151.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.89 0.876 . . . . 71.13 109.488 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.497 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 14.3 pt-20 -159.82 -179.58 7.96 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.041 0.537 . . . . 63.04 111.183 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.35 -149.35 50.85 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.456 -0.793 . . . . 64.54 114.3 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.7 p -60.79 -24.33 65.72 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.506 1.122 . . . . 74.21 112.002 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.421 ' HB3' HD11 ' C' ' 89' ' ' ILE . 84.1 mt-30 -67.72 -51.1 53.31 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.7 1.2 . . . . 64.32 111.189 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.497 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 21.2 ptt? -70.88 -24.4 62.48 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.917 -0.401 . . . . 61.25 109.917 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.09 84.53 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.715 0.634 . . . . 73.41 110.7 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -63.87 -37.7 88.35 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.504 0.502 . . . . 62.23 110.667 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -65.54 -55.47 17.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.751 -0.463 . . . . 72.44 109.751 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.25 -16.26 63.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.792 0.837 . . . . 71.51 112.238 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.11 3.77 26.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.478 -0.624 . . . . 62.34 114.114 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.13 -64.73 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.558 0.679 . . . . 71.54 110.483 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.63 -55.36 31.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.958 0.503 . . . . 55.03 112.211 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 18.2 m -60.97 -47.09 96.52 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.574 -0.726 . . . . 64.12 111.883 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 70.6 Cg_exo -50.23 -38.9 52.39 Favored 'Trans proline' 0 C--N 1.396 3.045 0 C-N-CA 122.767 2.311 . . . . 71.11 114.478 165.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -70.46 -25.52 63.22 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.516 0.726 . . . . 75.13 111.765 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.499 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.54 -41.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.169 0.588 . . . . 74.03 109.665 171.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.462 HD13 ' O ' ' C' ' 80' ' ' GLN . 95.9 mt -75.3 -26.36 58.63 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.074 -0.966 . . . . 63.13 111.848 -175.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.4 -44.01 94.67 Favored Pre-proline 0 CA--C 1.565 1.534 0 CA-C-O 117.637 -1.173 . . . . 73.24 113.764 -172.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.76 -46.22 33.36 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.604 2.203 . . . . 74.21 113.752 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.28 -43.39 77.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.75 0.82 . . . . 72.51 110.908 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.47 98.81 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.637 -0.71 . . . . 63.22 110.317 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -57.48 -50.0 74.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.579 1.152 . . . . 73.21 111.053 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.63 -31.78 71.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.244 0.618 . . . . 70.44 110.212 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.7 t -71.37 -29.7 65.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.217 0.607 . . . . 74.33 111.221 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.513 HD13 HG23 ' C' ' 64' ' ' VAL . 80.8 mt -80.03 -48.65 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 73.13 110.248 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 43.4 m -60.57 -32.11 71.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.664 0.786 . . . . 72.54 110.818 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -61.63 -51.64 67.66 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.248 -0.887 . . . . 72.24 109.34 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.545 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.53 -38.96 92.03 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.71 1.204 . . . . 72.13 113.078 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.0 t -60.2 -45.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.199 1.0 . . . . 72.12 109.253 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -70.41 -31.11 68.17 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.159 -1.382 . . . . 73.43 111.544 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -70.63 -35.67 73.04 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.63 0.772 . . . . 73.43 109.891 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.2 -0.91 90.43 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.32 -0.711 . . . . 44.55 113.173 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p 59.14 62.6 1.8 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.704 1.602 . . . . 73.13 111.693 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 63.1 m-85 -123.57 161.98 42.92 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 114.39 -1.277 . . . . 73.12 110.096 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 30.7 Cg_endo -61.57 158.3 37.45 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.236 2.624 . . . . 73.34 114.317 -173.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -59.61 119.69 8.05 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.022 0.929 . . . . 64.24 110.403 -175.086 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 54.3 tp -131.01 114.44 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.298 -0.865 . . . . 45.13 108.905 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -123.79 129.71 51.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.425 -0.954 . . . . 74.04 108.425 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 90.9 mt -86.79 121.76 29.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.174 0.59 . . . . 64.21 110.41 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.39 88.33 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 123.414 0.686 . . . . 61.12 110.19 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.448 ' HG2' HD12 ' A' ' 13' ' ' ILE . 42.4 Cg_endo -68.19 143.06 57.71 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.076 1.851 . . . . 65.35 112.136 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.6 108.78 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.773 -1.195 . . . . 65.35 107.773 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -98.48 90.7 4.86 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.463 0.649 . . . . 72.03 111.348 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -75.23 -29.61 60.31 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.925 -1.034 . . . . 75.11 109.425 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 CA--C 1.544 0.744 0 CA-C-N 114.476 -1.238 . . . . 65.04 111.312 177.021 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' D' ' 87' ' ' ALA . 7.9 ttp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 113.189 0.811 . . . . 64.53 113.189 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.8 m -122.57 142.74 50.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.631 -0.877 . . . . 72.21 108.631 173.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' D' ' 85' ' ' SER . 57.3 t80 -154.09 101.36 2.4 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.125 -1.065 . . . . 61.44 108.125 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -132.08 147.0 52.42 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.837 0.855 . . . . 74.32 109.336 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -102.49 105.8 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.672 -0.862 . . . . 72.52 108.672 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -74.84 -45.23 44.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.4 1.08 . . . . 74.12 112.098 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.421 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 54.7 ttt180 -155.3 129.55 8.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.181 0.193 . . . . 72.45 110.512 -170.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.509 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.5 mp -114.43 126.71 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.606 1.162 . . . . 74.14 107.877 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.421 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 38.0 p90 -162.87 177.32 9.37 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.946 0.879 . . . . 73.03 112.884 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -112.95 129.61 56.42 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.472 -1.24 . . . . 62.25 109.059 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -98.46 -25.05 14.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.758 0.423 . . . . 74.12 110.782 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.6 t70 -149.81 132.59 15.98 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.733 -0.839 . . . . 73.02 108.733 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.545 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.1 mt -131.83 146.62 33.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.805 -1.183 . . . . 71.23 107.805 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -148.35 142.46 26.0 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.315 1.046 . . . . 70.24 108.913 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.8 t80 -151.62 124.3 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.219 -1.771 . . . . 71.42 106.219 170.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -131.28 122.65 26.82 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.881 0.872 . . . . 75.33 109.18 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.65 85.0 13.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.573 -0.899 . . . . 60.01 108.573 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.83 -31.58 10.09 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.44 2.094 . . . . 71.33 113.056 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.9 m-20 -114.37 41.65 2.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.429 1.092 . . . . 53.33 108.639 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -55.05 -52.75 68.45 Favored Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 115.306 1.595 . . . . 63.14 115.306 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' NZ ' ' C' ' 19' ' ' LYS . 19.3 Cg_endo -91.06 2.69 4.6 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.8 1.667 . . . . 65.42 112.474 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 17.3 t-160 -84.39 -42.09 16.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.648 1.179 . . . . 61.52 108.954 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.2 t -78.16 -11.62 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 C-N-CA 123.595 0.758 . . . . 74.01 110.402 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -55.32 -36.41 66.21 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.954 0.902 . . . . 74.33 111.853 167.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.18 -1.72 53.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.653 0.781 . . . . 71.0 112.606 -172.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.422 ' HD3' ' HG ' ' D' ' 68' ' ' LEU . 14.3 ptpt -127.56 107.81 10.25 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.387 0.675 . . . . 73.45 111.155 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.19 92.6 8.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.165 0.986 . . . . 60.03 109.72 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.593 ' HB3' HD11 ' D' ' 68' ' ' LEU . 25.1 t-105 -161.6 166.85 26.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.593 -0.892 . . . . 71.54 108.593 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.8 111.64 39.14 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.284 1.034 . . . . 75.33 109.109 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.61 142.6 49.25 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.968 2.445 . . . . 71.33 113.263 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -75.8 122.55 24.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.144 -0.687 . . . . 63.44 109.144 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.421 HG13 HG13 ' D' ' 64' ' ' VAL . 61.6 t -99.24 135.34 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.836 0.854 . . . . 72.34 110.988 -173.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -110.56 138.01 47.5 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.221 -1.029 . . . . 72.04 108.221 164.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.698 HD22 HD11 ' D' ' 128' ' ' LEU . 48.5 tp -101.76 142.41 33.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.024 -1.102 . . . . 61.51 108.024 171.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.587 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.4 t70 -140.73 128.2 21.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.283 -1.006 . . . . 74.4 108.283 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.6 mt -118.48 150.4 39.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.032 0.533 . . . . 70.11 110.786 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.6 t70 -152.62 132.34 13.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.095 1.358 . . . . 74.52 107.699 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -109.21 153.21 24.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.195 0.522 . . . . 54.25 109.987 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.71 165.65 35.32 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.279 1.032 . . . . 71.43 108.692 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -166.56 161.52 16.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.273 0.629 . . . . 64.33 111.334 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -151.27 152.8 33.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.483 1.113 . . . . 71.42 108.843 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -92.04 119.06 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.031 -0.359 . . . . 72.21 110.031 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' D' ' 57' ' ' GLU . 30.9 mt -92.58 -35.79 13.37 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.071 0.548 . . . . 75.32 110.312 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.07 -176.41 5.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.808 0.843 . . . . 65.51 110.24 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.72 107.64 0.63 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.709 0.804 . . . . 63.44 110.525 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 5.9 m-20 62.21 15.91 7.93 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.191 0.996 . . . . 71.32 112.473 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 20.4 t -107.51 125.38 63.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.028 -1.101 . . . . 71.14 108.028 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.23 133.52 45.55 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.759 -0.655 . . . . 74.31 110.849 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.6 tt0 -87.29 111.8 21.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.557 -1.275 . . . . 73.33 107.557 168.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.71 120.04 47.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 N-CA-C 107.458 -1.312 . . . . 53.14 107.458 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 92.1 t -99.69 140.27 19.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 123.603 0.761 . . . . 64.34 109.488 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.72 122.58 38.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.487 -0.931 . . . . 71.23 108.487 179.093 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 43.3 ttm-85 -102.42 105.94 16.6 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.12 0.968 . . . . 65.35 108.496 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.3 t -105.97 120.65 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.208 -1.034 . . . . 62.34 108.208 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.8 m -123.96 130.71 53.04 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.413 0.685 . . . . 63.05 109.876 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.521 HG23 HD13 ' D' ' 114' ' ' ILE . 90.7 t -116.21 117.86 56.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.878 1.271 . . . . 60.54 109.35 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -111.88 93.73 4.6 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.886 -1.153 . . . . 61.52 107.886 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.57 137.18 42.79 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.304 0.641 . . . . 71.31 109.764 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.7 p -142.39 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.357 0.663 . . . . 75.11 109.52 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' D' ' 36' ' ' TRP . 15.2 tp -120.26 115.98 24.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.195 0.598 . . . . 53.22 109.422 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 -123.68 6.28 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.067 -0.813 . . . . 42.31 111.067 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.25 4.36 20.83 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.45 0.7 . . . . 73.11 110.663 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.03 162.98 16.26 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.711 0.805 . . . . 52.03 109.74 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.2 m -76.23 136.79 39.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.548 -0.538 . . . . 71.14 109.548 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -93.07 -55.28 3.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.25 -0.886 . . . . 71.31 109.434 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -163.14 154.61 17.39 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.137 -0.938 . . . . 72.5 109.745 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.84 148.42 48.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.723 1.209 . . . . 51.33 108.184 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' D' ' 114' ' ' ILE . 46.4 t -157.53 147.36 20.4 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.818 0.447 . . . . 64.22 110.244 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -156.45 133.23 10.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 74.14 109.482 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -133.22 117.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.163 0.585 . . . . 64.41 109.846 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -91.31 88.49 6.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.661 0.785 . . . . 70.41 110.053 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -80.57 102.61 9.89 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.881 1.272 . . . . 70.23 109.355 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.74 141.43 15.63 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.626 -0.589 . . . . 43.12 111.626 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.66 132.04 5.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.138 -0.785 . . . . 70.21 111.138 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -89.06 108.22 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.34 -0.615 . . . . 73.11 109.34 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.03 126.16 51.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.761 0.824 . . . . 73.43 110.09 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 42.7 m -78.2 114.36 17.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.823 0.849 . . . . 71.13 108.945 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 73.3 mt -108.14 144.11 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.131 -1.433 . . . . 65.34 107.131 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' D' ' 9' ' ' MET . . . -162.05 151.44 15.97 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.262 -0.644 . . . . 75.05 109.262 173.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 1.76 53.83 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 123.815 0.697 . . . . 74.52 114.782 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.52 139.36 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.443 0.697 . . . . 53.13 110.574 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 -171.0 3.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.046 0.939 . . . . 75.22 110.386 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.8 -133.79 14.12 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.52 0.512 . . . . 71.33 113.221 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -63.81 -37.54 87.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.688 0.795 . . . . 64.01 111.386 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -71.24 -36.45 71.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.96 0.504 . . . . 55.42 112.147 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -70.13 -34.7 73.39 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.443 0.565 . . . . 64.14 109.926 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.9 -31.38 69.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.643 0.777 . . . . 63.24 110.677 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -75.32 -30.41 60.32 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.65 1.18 . . . . 74.34 110.527 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.485 ' HB3' ' SG ' ' D' ' 102' ' ' CYS . 73.5 m -68.36 -51.32 45.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.557 -0.534 . . . . 72.43 109.557 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.22 -24.32 64.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.024 0.53 . . . . 51.33 111.441 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.46 -0.4 37.47 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.799 -1.0 . . . . 71.42 114.719 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.87 -62.58 0.11 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.47 1.135 . . . . 55.21 112.408 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.97 -49.34 29.74 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.775 0.657 . . . . 70.15 112.775 -164.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' D' ' 97' ' ' CYS . 58.7 m -63.9 -45.89 81.14 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.541 -0.742 . . . . 53.41 111.691 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.448 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 89.3 Cg_exo -54.06 -35.31 81.07 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.723 2.282 . . . . 74.45 113.83 166.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.244 0.618 . . . . 63.12 111.258 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -67.46 -43.33 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.561 0.744 . . . . 64.3 110.314 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.3 mt -75.52 -23.42 56.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.982 -1.008 . . . . 74.44 112.35 -173.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -64.98 -42.42 61.97 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 117.917 -1.039 . . . . 62.23 113.694 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.05 -42.87 63.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.113 1.876 . . . . 70.3 113.4 170.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -72.83 -36.69 67.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.817 0.847 . . . . 73.23 111.619 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.57 -43.12 77.25 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.451 0.7 . . . . 73.1 110.462 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -59.58 -48.18 82.66 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.2 1.0 . . . . 54.1 110.291 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.53 -46.17 91.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.26 0.975 . . . . 72.12 111.372 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -57.84 -41.15 81.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.186 0.929 . . . . 72.44 110.575 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.521 HD13 HG23 ' D' ' 64' ' ' VAL . 84.3 mt -60.0 -58.64 6.32 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 O-C-N 123.924 0.765 . . . . 70.13 110.145 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 5.6 m -54.02 -41.74 68.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.645 1.178 . . . . 61.02 111.492 -170.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -65.06 -44.87 87.57 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.575 -1.193 . . . . 71.1 110.552 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.2 mtm -68.91 -31.25 70.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.041 0.537 . . . . 73.41 112.232 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.7 t -70.56 -38.94 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.442 0.697 . . . . 74.3 110.058 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.95 -28.6 57.98 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.626 0.37 . . . . 63.35 110.803 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -70.37 -31.41 68.65 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.553 0.741 . . . . 75.22 109.34 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.55 8.52 64.89 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.324 -0.853 . . . . 60.03 112.58 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.417 ' HG1' ' HE ' ' C' ' 15' ' ' ARG . 36.8 p 55.71 26.25 9.18 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.401 1.881 . . . . 75.34 113.809 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 43.8 m-85 -96.9 164.88 17.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 73.45 108.858 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.69 143.58 94.83 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.254 1.969 . . . . 75.3 110.027 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -65.0 150.95 47.17 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.368 0.531 . . . . 55.32 110.839 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.48 100.21 9.79 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.59 92.38 5.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.276 -1.009 . . . . 62.11 108.276 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.698 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -70.8 115.07 9.52 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.104 -1.073 . . . . 75.42 108.104 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -71.65 132.75 85.09 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.489 0.716 . . . . 53.35 111.445 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.5 Cg_exo -65.15 127.34 18.16 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.242 2.628 . . . . 64.52 112.458 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.61 152.07 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.864 0.866 . . . . 54.12 110.49 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -74.69 109.46 8.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.354 0.661 . . . . 75.14 110.607 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 124.118 0.967 . . . . 73.01 111.702 -178.975 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 108.342 -0.985 . . . . 64.15 108.342 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -139.91 114.27 9.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.362 -0.977 . . . . 72.22 108.362 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -150.46 136.73 18.69 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.733 0.301 . . . . 74.3 111.262 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.415 1.086 . . . . 72.15 110.67 169.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.14 -44.56 5.41 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 74.23 109.247 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD2' ' HZ ' ' B' ' 32' ' ' PHE . 78.3 mtt180 -158.79 153.32 24.36 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.328 1.051 . . . . 73.42 110.86 172.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.658 HG23 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -123.2 119.62 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.116 -1.809 . . . . 65.41 106.116 173.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 34.9 p90 -160.03 167.77 27.13 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 120.947 0.403 . . . . 74.54 111.674 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -91.31 118.29 30.37 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.861 -0.422 . . . . 73.34 109.861 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.04 -26.39 29.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.733 0.413 . . . . 74.55 111.052 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.43 148.3 21.39 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.221 -0.659 . . . . 73.44 109.221 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.6 mt -145.38 142.6 22.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.233 1.413 . . . . 64.22 107.522 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -148.0 136.73 21.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.401 0.681 . . . . 74.3 109.325 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 79.1 t80 -136.21 143.04 44.15 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.209 -1.404 . . . . 54.22 107.209 171.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.38 147.58 39.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.884 0.873 . . . . 74.14 109.159 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 72.09 11.72 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.613 -1.625 . . . . 52.33 106.613 167.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 -24.44 36.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.228 1.952 . . . . 54.11 111.188 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 58.9 m-20 -113.61 33.51 5.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.519 1.128 . . . . 62.54 109.09 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.98 99.34 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 123.834 0.854 . . . . 72.54 113.04 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.73 -29.31 35.95 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 121.637 1.558 . . . . 74.14 113.006 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.2 m-70 -74.46 -35.77 63.31 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.702 0.401 . . . . 75.43 111.653 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.29 -21.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 121.09 0.471 . . . . 64.53 110.712 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -74.77 -39.66 61.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.498 0.719 . . . . 63.43 110.399 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.22 -26.78 32.97 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.516 0.726 . . . . 64.04 110.771 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.45 173.38 10.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.43 0.692 . . . . 64.41 111.373 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -72.94 138.06 45.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.875 0.87 . . . . 60.14 110.722 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -84.88 69.62 10.78 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.801 0.81 . . . . 74.22 109.57 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -129.23 73.47 81.66 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.039 -0.982 . . . . 70.02 108.711 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.43 158.76 10.96 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.549 2.166 . . . . 44.11 112.173 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.43 127.89 44.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.769 -0.826 . . . . 71.33 108.769 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.03 94.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 123.75 0.656 . . . . 55.44 109.28 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -102.86 115.03 29.8 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.702 -1.221 . . . . 73.44 107.702 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.91 148.57 43.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.378 0.671 . . . . 75.34 109.702 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 27.7 m-20 -141.35 149.07 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.979 1.311 . . . . 74.52 108.847 170.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.92 160.93 22.46 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.064 -0.717 . . . . 52.23 109.064 169.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -159.28 144.64 15.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.492 0.717 . . . . 75.1 109.368 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 m -127.33 135.52 50.65 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.086 0.954 . . . . 74.44 108.829 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.83 133.02 45.57 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.157 0.983 . . . . 61.42 109.308 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -92.95 153.28 18.85 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.599 0.759 . . . . 62.02 110.59 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.7 t -160.45 138.91 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 72.54 108.622 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.9 122.17 42.6 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.92 -34.04 13.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.69 0.796 . . . . 61.21 111.976 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -155.87 -177.56 6.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 65.44 109.618 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.64 117.09 7.59 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.722 -0.844 . . . . 74.52 108.722 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 68.05 8.98 6.88 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.433 1.093 . . . . 71.51 112.776 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 38.5 t -112.09 106.38 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.777 -1.194 . . . . 62.43 107.777 174.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -107.78 162.51 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.594 0.711 . . . . 74.21 109.518 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -133.16 125.23 29.02 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.699 1.2 . . . . 73.25 108.35 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -107.49 121.01 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.212 -1.403 . . . . 72.11 107.212 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.4 t -99.53 136.73 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.538 -0.912 . . . . 54.02 108.538 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.08 114.1 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -104.7 128.6 52.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.871 0.868 . . . . 74.55 108.841 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -116.09 129.93 71.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.558 -0.904 . . . . 73.11 108.558 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 14.4 m -110.52 134.7 52.13 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.801 -0.815 . . . . 72.3 108.801 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 114' ' ' ILE . 53.0 t -135.18 106.57 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.437 1.095 . . . . 53.22 108.48 -174.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 45.6 m -104.25 138.31 40.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.413 -0.588 . . . . 75.23 109.413 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.31 112.17 17.8 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.167 -1.42 . . . . 52.34 107.167 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.7 m -130.95 129.37 42.08 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.195 0.598 . . . . 73.53 109.576 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -87.76 85.16 7.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.459 1.123 . . . . 72.1 108.479 177.254 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -86.65 1.28 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 114.23 -1.35 . . . . 64.32 111.237 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -121.74 -26.1 4.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.485 0.714 . . . . 50.01 110.878 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.78 127.51 32.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.956 0.502 . . . . 62.31 109.791 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.2 m -75.0 122.64 23.81 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.715 -0.476 . . . . 63.02 109.715 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.97 -51.66 11.92 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.59 -0.893 . . . . 64.32 108.59 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -166.73 169.58 13.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.479 -1.237 . . . . 63.04 110.239 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 76' ' ' CYS . 31.7 tp -137.13 143.34 42.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.252 1.021 . . . . 74.42 109.079 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.408 ' H ' HD12 ' A' ' 75' ' ' LEU . 21.2 m -135.5 136.69 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.334 1.054 . . . . 74.34 108.605 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.88 125.13 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.303 -0.628 . . . . 63.14 109.303 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.54 130.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 123.825 0.85 . . . . 71.51 109.653 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -103.41 90.92 3.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.375 1.07 . . . . 74.42 108.815 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.46 92.34 5.24 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.052 -1.092 . . . . 71.42 108.052 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.87 144.96 17.99 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.305 -0.718 . . . . 62.31 111.305 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.88 132.73 5.7 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.253 -0.739 . . . . 51.41 111.253 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.1 mt -85.12 128.71 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.435 -0.95 . . . . 75.41 108.435 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -134.98 118.26 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.636 -0.876 . . . . 74.14 108.636 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.4 t -85.29 99.09 10.9 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.621 -0.881 . . . . 75.24 108.621 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.87 141.8 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.818 0.847 . . . . 75.22 109.553 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.03 152.51 0.91 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.877 0.871 . . . . 72.11 110.965 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.33 64.69 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.463 0.477 . . . . 73.41 113.934 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.456 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.2 mp -110.98 147.59 14.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.512 -1.292 . . . . 70.02 107.512 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -142.19 176.07 9.26 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.906 0.882 . . . . 74.44 108.63 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.97 -152.72 52.51 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.238 -0.437 . . . . 70.44 113.172 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 26.0 p -70.74 -15.33 62.68 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.197 0.999 . . . . 74.42 112.617 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -73.55 -42.23 61.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.045 0.538 . . . . 74.3 110.448 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.456 ' SD ' ' HB ' ' A' ' 89' ' ' ILE . 1.3 tpt -76.69 -31.38 57.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.724 -0.473 . . . . 60.04 109.724 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -64.79 -32.59 74.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.697 0.799 . . . . 42.55 111.167 174.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 5.6 t-80 -61.9 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.64 -0.709 . . . . 75.53 110.019 170.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.3 m -73.44 -47.55 40.76 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.592 0.59 . . . . 62.4 112.592 -173.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -86.62 -23.69 25.61 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 111.75 0.278 . . . . 74.33 111.75 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.85 5.22 34.48 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.25 -0.75 . . . . 63.51 113.949 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.786 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.52 -60.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.169 0.985 . . . . 64.23 112.21 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -53.03 -60.17 3.62 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.544 1.138 . . . . 73.43 111.052 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 69.7 m -61.4 -51.8 74.96 Favored Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 114.167 1.173 . . . . 71.31 114.167 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.62 -26.64 75.79 Favored 'Trans proline' 0 C--N 1.394 2.954 0 CA-C-N 121.914 1.719 . . . . 70.3 113.609 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.72 -26.2 44.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.957 0.503 . . . . 72.42 110.833 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 101' ' ' TYR . 25.6 mm -67.02 -42.35 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 121.661 0.743 . . . . 62.11 109.681 171.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.658 HD23 HG23 ' A' ' 16' ' ' ILE . 50.3 mt -79.86 -29.36 40.03 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.562 -1.199 . . . . 75.12 112.484 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.3 -42.63 81.72 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.514 1.302 . . . . 60.51 114.514 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.21 -35.48 95.48 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.296 1.997 . . . . 65.34 113.429 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -85.23 -29.57 24.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.607 0.763 . . . . 63.31 111.222 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.87 76.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.999 0.52 . . . . 73.45 109.779 173.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -58.41 -48.51 80.44 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.546 1.154 . . . . 74.43 109.968 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.73 -44.85 96.11 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.014 0.821 . . . . 72.14 111.062 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.48 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.0 t -62.87 -41.21 99.3 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.909 0.756 . . . . 74.42 111.491 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 79.2 mt -66.28 -57.24 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.453 0.701 . . . . 62.33 110.534 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.472 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.4 m -53.45 -39.57 64.54 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.904 1.282 . . . . 72.24 111.778 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.24 -42.38 79.79 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.181 -0.918 . . . . 63.04 110.444 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 63.8 mtm -61.06 -37.73 83.68 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.731 0.412 . . . . 55.35 111.307 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 80.9 t -59.66 -49.21 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.05 0.94 . . . . 72.03 110.458 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 83.5 p -71.59 -29.48 64.75 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.597 -0.728 . . . . 61.12 111.482 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -71.81 -29.89 64.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.588 0.755 . . . . 75.13 110.061 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.68 55.69 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.53 -0.759 . . . . 64.52 112.855 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.408 HG23 ' HB2' ' D' ' 125' ' ' GLN . 30.4 m 69.24 35.5 2.65 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-O 123.058 1.409 . . . . 62.31 109.63 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -115.33 149.94 43.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 114.818 -1.083 . . . . 73.42 109.34 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.85 151.96 73.61 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.561 2.174 . . . . 74.1 111.055 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.472 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.3 tt0 -58.78 133.73 56.22 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.639 0.607 . . . . 73.41 112.639 -175.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.05 95.2 4.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.101 -1.074 . . . . 61.35 108.101 168.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -98.94 126.66 44.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.339 -0.985 . . . . 73.4 108.339 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.7 mm? -74.0 150.26 40.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.625 -0.716 . . . . 74.41 110.736 -175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.57 143.62 98.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.308 0.643 . . . . 63.24 110.881 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.96 109.58 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.475 2.117 . . . . 72.25 111.371 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.53 111.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.308 -1.738 . . . . 63.23 106.308 174.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -84.03 70.55 10.5 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.317 -1.364 . . . . 72.33 107.317 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -69.05 -28.76 66.83 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.699 -1.591 . . . . 63.21 111.374 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.786 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.4 p-10 . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 114.858 -1.065 . . . . 72.24 111.264 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.514 ' SD ' HD12 ' B' ' 89' ' ' ILE . 18.8 ptm . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 113.29 0.848 . . . . 72.04 113.29 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 98.0 m -140.13 127.72 21.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.706 0.802 . . . . 75.12 109.576 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.03 130.28 37.31 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -150.97 138.94 19.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.334 0.654 . . . . 72.11 109.237 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.596 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -90.17 128.68 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.451 -0.944 . . . . 74.32 108.451 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.468 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 10.4 mm100 -94.09 -49.87 5.56 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.314 -0.624 . . . . 74.24 109.314 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -164.05 146.07 9.04 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.678 -0.692 . . . . 75.02 109.17 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.15 145.78 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.047 -1.464 . . . . 61.22 107.047 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -169.71 146.28 3.23 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.452 0.569 . . . . 72.42 112.362 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -73.54 116.12 13.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.036 -0.984 . . . . 61.33 108.374 168.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -86.81 -34.16 19.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.672 -0.695 . . . . 63.44 110.691 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.48 142.09 18.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.645 -0.252 . . . . 61.33 110.56 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -132.49 144.35 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.752 1.221 . . . . 61.43 109.081 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.0 t -141.88 131.91 24.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 75.21 107.591 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.631 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -144.64 122.31 11.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.158 -1.423 . . . . 70.52 107.158 169.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 48.2 mt-10 -124.64 134.72 52.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.556 0.743 . . . . 73.44 109.174 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.939 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -132.2 80.75 63.15 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.497 -0.927 . . . . 52.04 108.497 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.69 -31.88 19.97 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.983 2.455 . . . . 70.13 111.71 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -117.99 28.53 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.133 0.973 . . . . 71.41 109.887 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.939 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -49.46 -50.41 65.73 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.013 1.325 . . . . 62.22 113.82 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.6 Cg_exo -79.05 -12.31 14.56 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.123 1.882 . . . . 54.31 112.83 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -98.49 -6.83 29.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.075 0.95 . . . . 74.23 111.681 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.405 HG11 ' HE1' ' B' ' 123' ' ' PHE . 6.9 p -68.59 -15.7 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.191 0.596 . . . . 74.02 111.26 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' PHE . . . . . 0.463 ' HZ ' ' HD2' ' A' ' 15' ' ' ARG . 75.8 m-85 -76.18 -7.78 55.58 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.724 0.81 . . . . 61.51 111.781 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -82.33 -32.3 29.45 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.689 0.757 . . . . 42.14 109.095 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -106.73 90.83 3.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.527 -1.215 . . . . 75.53 110.556 -162.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.56 84.97 2.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.943 0.402 . . . . 73.23 110.427 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -153.45 -179.45 7.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.477 1.511 . . . . 70.12 108.052 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -78.82 118.63 73.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.142 -1.058 . . . . 73.33 108.142 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.72 149.92 67.78 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.477 2.118 . . . . 65.32 110.994 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.42 104.21 3.71 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.587 -0.894 . . . . 71.04 108.587 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.449 HG11 HD21 ' B' ' 126' ' ' LEU . 39.4 t -95.72 137.06 24.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.485 -0.78 . . . . 72.02 110.189 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -130.04 119.29 22.89 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.266 1.026 . . . . 73.4 108.405 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.73 HD12 HG22 ' B' ' 64' ' ' VAL . 1.6 mm? -104.44 134.96 46.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.942 -0.762 . . . . 51.32 108.942 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -137.45 153.32 50.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.074 0.95 . . . . 54.42 109.573 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.15 150.07 42.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.987 0.915 . . . . 74.32 109.727 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.1 t70 -136.7 141.75 43.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.103 0.961 . . . . 71.14 108.624 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.2 p -113.41 104.34 12.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.44 0.696 . . . . 72.44 109.445 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.66 156.63 33.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.038 0.935 . . . . 71.24 109.014 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -145.11 173.78 11.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 75.05 110.462 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -156.61 133.96 10.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.985 0.914 . . . . 73.3 109.016 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -81.38 120.75 25.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.964 0.506 . . . . 44.15 110.835 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -88.08 -37.87 15.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.425 0.69 . . . . 73.25 110.114 174.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.5 -176.11 5.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.873 0.869 . . . . 74.12 110.618 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.73 116.19 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.696 -1.138 . . . . 61.54 109.527 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' B' ' 85' ' ' SER . 20.3 m-20 72.18 -5.1 1.83 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.493 1.517 . . . . 51.21 112.872 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -105.19 96.41 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.523 -0.917 . . . . 75.02 108.523 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -112.34 138.44 49.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.815 -0.629 . . . . 74.51 109.313 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.401 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.5 tm-20 -101.95 97.57 7.9 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 125.192 1.397 . . . . 72.03 107.518 -178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -90.9 121.02 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.91 0.884 . . . . 74.23 110.198 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -102.97 120.82 53.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.544 0.738 . . . . 72.41 110.315 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.2 121.54 34.68 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.908 -1.516 . . . . 63.4 106.908 170.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 61.6 ttt180 -110.5 108.93 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.275 -0.639 . . . . 71.24 109.275 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.63 121.14 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.304 -0.999 . . . . 70.24 108.304 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.1 m -116.29 130.64 56.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.097 0.475 . . . . 75.35 109.896 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.767 HG21 HG21 ' B' ' 114' ' ' ILE . 51.8 t -111.37 135.46 50.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.912 1.285 . . . . 72.12 110.132 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 30.9 m -124.76 144.58 50.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.604 -0.887 . . . . 55.21 108.604 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 125.31 11.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.387 -0.968 . . . . 51.44 108.387 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.4 m -138.62 134.5 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.084 -0.71 . . . . 63.35 109.084 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 22.4 tp -133.57 122.94 24.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.779 -0.823 . . . . 71.23 108.779 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.99 -131.39 13.82 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.594 0.559 . . . . 71.32 112.573 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -93.78 1.41 56.49 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 75.15 111.147 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.73 155.83 48.15 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.101 0.56 . . . . 61.35 110.984 -167.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 130.53 39.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.685 -0.689 . . . . 73.24 109.665 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.02 -56.19 4.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.576 0.751 . . . . 65.3 109.208 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.68 161.47 23.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.772 -1.104 . . . . 55.12 109.739 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 95.4 mt -132.53 146.96 52.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.886 1.275 . . . . 53.12 108.22 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.0 t -150.15 157.15 42.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.195 -0.668 . . . . 70.24 109.195 175.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.4 tt0 -165.43 131.48 2.67 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.408 -0.96 . . . . 73.41 108.408 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.1 t -125.02 144.0 36.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.897 0.879 . . . . 63.55 108.693 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.504 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 70.4 mt-30 -122.84 89.87 3.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.711 -0.848 . . . . 73.14 108.711 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -81.68 100.01 9.23 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.14 -0.937 . . . . 61.13 108.502 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.61 169.97 37.93 Favored Glycine 0 C--O 1.244 0.78 0 N-CA-C 111.062 -0.815 . . . . 74.14 111.062 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.11 127.36 1.43 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.086 -0.806 . . . . 64.23 111.086 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 21.3 mt -84.98 129.52 37.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.623 -1.251 . . . . 71.35 107.623 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -132.25 162.51 30.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.474 1.11 . . . . 64.53 108.572 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 73.7 m -129.11 108.17 10.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.616 0.767 . . . . 54.13 109.042 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.481 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -119.02 127.28 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.175 1.39 . . . . 71.44 108.782 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -140.6 145.53 36.81 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.628 0.771 . . . . 54.34 110.118 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -29.81 3.86 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.66 0.6 . . . . 52.13 114.237 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.514 HD12 ' SD ' ' B' ' 9' ' ' MET . 19.4 tt -78.4 139.51 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.683 0.793 . . . . 51.35 110.718 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.31 165.87 35.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.753 0.821 . . . . 74.33 111.608 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.29 -131.61 24.88 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.285 -0.871 . . . . 54.14 114.104 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -66.08 -36.66 83.78 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.385 1.074 . . . . 65.52 110.731 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.46 -34.64 72.65 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.45 -1.25 . . . . 73.11 110.096 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 56.9 ttp -52.95 -53.05 55.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.646 1.178 . . . . 65.22 110.732 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.34 72.51 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.279 -0.873 . . . . 52.24 111.924 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 20.4 t60 -71.03 -25.15 62.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.963 0.905 . . . . 61.21 110.969 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.13 -69.08 0.71 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.467 0.307 . . . . 22.42 111.464 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.8 pp -73.45 -22.86 60.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.542 0.571 . . . . 61.24 112.542 -170.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.87 -25.58 24.52 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.462 0.476 . . . . 64.23 112.508 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -122.91 -54.95 1.81 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.383 0.512 . . . . 63.21 112.383 -170.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -72.61 -48.66 37.82 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.554 0.576 . . . . 74.32 112.554 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.48 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.9 m -59.69 -48.09 96.07 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 118.608 -0.71 . . . . 74.3 111.482 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 75.2 Cg_exo -57.11 -34.87 98.55 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.426 2.084 . . . . 63.32 114.117 169.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -63.14 -34.17 77.05 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 122.95 0.5 . . . . 74.23 111.054 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.37 -47.44 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.889 0.876 . . . . 73.12 110.401 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.408 ' HB2' HD12 ' B' ' 60' ' ' LEU . 83.3 mt -80.75 -19.6 44.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.954 -1.021 . . . . 74.52 112.742 -169.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -63.23 -46.85 85.75 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.41 -1.281 . . . . 62.54 113.63 -171.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.31 -37.0 97.63 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.055 1.837 . . . . 42.5 113.688 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -67.78 -48.92 64.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.101 0.56 . . . . 74.31 110.38 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.88 86.75 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.25 -0.886 . . . . 74.34 111.04 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.621 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.8 ttt180 -57.75 -57.83 11.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.679 1.591 . . . . 61.44 110.679 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.15 -31.09 71.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.07 -0.968 . . . . 72.1 110.538 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.42 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.2 t -70.9 -38.6 73.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.989 0.516 . . . . 63.51 111.361 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.767 HG21 HG21 ' B' ' 64' ' ' VAL . 77.3 mt -64.4 -50.13 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.267 0.627 . . . . 72.22 109.907 175.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.447 HG21 ' OG ' ' C' ' 119' ' ' SER . 20.6 m -58.16 -36.44 73.01 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.489 -1.232 . . . . 72.21 110.956 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.2 t -64.84 -45.37 86.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.357 -1.292 . . . . 64.44 110.719 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 38.0 mmt -59.44 -45.22 92.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.106 0.562 . . . . 64.55 111.711 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.642 0.777 . . . . 73.22 111.54 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.3 p -70.34 -28.4 65.11 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.725 -0.67 . . . . 65.25 112.086 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 86.6 mtt-85 -67.07 -30.44 70.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.352 0.661 . . . . 72.41 111.232 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 13.26 39.64 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-O 119.613 -0.549 . . . . 73.52 112.94 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.6 p 54.81 23.65 5.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.441 1.896 . . . . 63.13 113.009 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.405 ' HE1' HG11 ' B' ' 31' ' ' VAL . 37.9 m-85 -89.97 156.92 46.53 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.76 0.824 . . . . 75.11 109.337 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.8 121.47 10.08 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 74.03 110.712 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.548 ' H ' ' HB2' ' C' ' 125' ' ' GLN . 4.9 pp0? -58.94 152.38 19.71 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.912 0.757 . . . . 65.21 112.284 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.449 HD21 HG11 ' B' ' 40' ' ' VAL . 1.4 tm? -111.32 105.5 14.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.766 -1.198 . . . . 74.51 107.766 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -90.85 112.59 24.49 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.963 -1.125 . . . . 73.33 107.963 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.621 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.13 117.98 10.68 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.676 -0.861 . . . . 74.25 108.676 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.65 87.64 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.636 0.585 . . . . 72.01 110.654 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.422 ' HG2' HD13 ' D' ' 13' ' ' ILE . 37.4 Cg_endo -63.29 86.36 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.682 2.255 . . . . 73.34 112.571 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 80.7 t -91.13 110.79 22.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.585 -0.895 . . . . 74.13 108.585 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -88.61 109.79 20.39 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.86 -33.46 75.75 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.505 1.122 . . . . 73.42 109.826 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 134' ' ' ASP . . . . . 0.446 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -59.93 -44.5 94.29 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.031 -1.441 . . . . 72.13 110.918 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.16 67.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.587 0.755 . . . . 64.11 111.557 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 122.807 0.443 . . . . 75.3 110.393 177.121 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 113.58 0.956 . . . . 62.41 113.58 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -87.43 103.9 15.95 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 169.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -124.88 141.09 52.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.944 0.897 . . . . 64.32 109.162 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -160.76 123.34 3.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.179 0.592 . . . . 74.23 109.729 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -76.14 140.62 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.755 -0.832 . . . . 65.52 108.755 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.661 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.2 mm100 -111.45 -49.71 2.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.679 0.792 . . . . 75.32 110.219 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -164.01 123.35 1.99 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.791 0.436 . . . . 74.21 110.04 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.9 mt -106.46 148.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.056 -1.09 . . . . 64.34 108.056 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.596 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 38.0 p90 -173.98 168.64 4.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.365 0.666 . . . . 73.35 110.325 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.0 p -86.62 117.7 25.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.156 0.582 . . . . 74.51 109.635 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.596 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 24.4 mmmt -66.86 -46.79 73.94 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.819 -0.808 . . . . 71.33 108.819 172.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.23 150.99 34.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.275 -1.329 . . . . 71.42 109.388 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.6 mt -142.46 142.47 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.791 1.636 . . . . 54.11 106.892 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -154.19 149.55 27.16 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.798 0.839 . . . . 62.02 109.183 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 80.4 t80 -152.16 128.38 10.51 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.467 -1.309 . . . . 75.21 107.467 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.59 130.75 36.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 63.24 108.45 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 82.67 15.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.841 -0.8 . . . . 64.35 108.841 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -67.37 -30.95 35.9 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.134 2.556 . . . . 71.55 112.366 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.79 34.01 3.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.831 0.852 . . . . 74.02 110.172 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -59.65 -56.81 31.98 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.058 -0.972 . . . . 75.25 112.534 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 14.9 Cg_exo -68.45 -27.5 33.49 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.838 1.692 . . . . 73.0 111.827 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.93 -23.33 65.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.755 1.222 . . . . 74.44 112.539 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.723 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 5.5 p -59.07 -20.99 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.481 0.712 . . . . 64.44 112.39 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.26 -41.44 99.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.349 1.06 . . . . 73.22 111.341 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -109.82 44.97 1.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.069 0.937 . . . . 64.52 109.511 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 22.3 ttpt -125.17 140.98 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.655 0.782 . . . . 75.34 110.794 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.44 132.85 39.89 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.105 0.962 . . . . 74.42 109.592 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -84.78 71.5 10.84 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.946 0.899 . . . . 73.51 111.317 -172.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -143.32 69.67 17.77 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.961 -1.018 . . . . 74.45 108.411 168.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.98 140.08 2.72 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.402 2.068 . . . . 64.23 111.121 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.92 111.39 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 107.495 -1.298 . . . . 74.43 107.495 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -75.85 98.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.272 -1.011 . . . . 64.31 108.272 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 59.9 tttm -98.22 105.26 17.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.47 1.108 . . . . 74.33 108.959 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.509 HD12 HG22 ' C' ' 64' ' ' VAL . 2.2 mm? -87.73 156.8 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.989 0.515 . . . . 72.23 110.021 -177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -144.8 105.82 4.18 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.476 0.711 . . . . 60.12 109.728 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.31 126.47 50.48 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.857 -0.794 . . . . 60.13 108.857 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.1 t70 -135.09 151.65 50.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.869 0.867 . . . . 73.45 109.019 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 3.1 m -133.48 127.48 33.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.127 0.571 . . . . 65.45 111.112 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.14 164.2 19.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.893 1.277 . . . . 62.44 108.483 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -154.43 145.44 22.68 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.959 0.345 . . . . 74.33 110.982 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -145.76 129.54 17.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.642 1.177 . . . . 73.31 109.378 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.66 119.95 21.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.253 -0.647 . . . . 75.54 109.253 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.476 HD11 HD12 ' C' ' 83' ' ' ILE . 84.2 mt -87.69 -38.38 15.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.348 0.659 . . . . 74.3 111.097 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -159.06 -172.93 3.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.437 -0.802 . . . . 72.01 110.518 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.2 105.13 0.84 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.796 1.239 . . . . 73.3 110.08 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 69.0 6.73 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.352 1.461 . . . . 70.34 113.019 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 91.9 t -103.07 118.16 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.947 -0.76 . . . . 71.11 108.947 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.1 158.42 32.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.871 0.868 . . . . 71.13 109.353 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -126.16 137.79 53.61 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.622 -1.621 . . . . 75.22 106.622 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.31 133.08 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 109.908 -0.405 . . . . 74.23 109.908 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 46' ' ' THR . 46.3 t -110.93 107.23 22.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.498 1.119 . . . . 73.04 108.918 -174.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.23 101.35 13.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.546 -1.279 . . . . 72.24 107.546 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.6 ttt180 -79.38 129.57 34.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.489 1.116 . . . . 64.51 109.121 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.39 105.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.857 -1.164 . . . . 74.33 107.857 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.5 m -103.08 113.85 27.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.534 -0.913 . . . . 72.33 108.534 170.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.509 HG22 HD12 ' C' ' 42' ' ' LEU . 79.6 t -101.34 108.42 23.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.175 -1.046 . . . . 75.34 108.175 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.506 HG23 HD23 ' C' ' 75' ' ' LEU . 4.0 m -99.06 140.35 33.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.323 -0.991 . . . . 72.15 108.323 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.41 95.34 4.23 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.712 -1.588 . . . . 52.41 106.712 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -147.02 132.46 18.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.533 0.333 . . . . 74.1 111.145 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 65.8 tp -67.79 -30.61 70.08 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.629 0.772 . . . . 72.4 109.952 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.67 -87.55 0.09 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.266 -1.134 . . . . 52.3 110.266 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -89.11 -25.01 22.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.636 0.774 . . . . 71.44 109.091 171.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -90.5 96.02 10.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.253 1.021 . . . . 60.04 109.266 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -89.31 133.36 34.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 70.01 110.784 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.449 ' HA ' ' NZ ' ' C' ' 34' ' ' LYS . . . -75.03 -59.51 2.7 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.145 0.978 . . . . 63.33 109.845 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.03 170.75 21.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.774 -1.103 . . . . 73.54 111.01 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.506 HD23 HG23 ' C' ' 65' ' ' THR . 2.9 tm? -136.03 140.88 44.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.127 -1.805 . . . . 75.51 106.127 173.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.22 150.85 34.47 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.522 -0.918 . . . . 63.32 108.522 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.58 131.2 9.76 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.687 -0.486 . . . . 71.42 109.687 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.76 115.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.27 -1.011 . . . . 45.3 108.27 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 75.7 mt-30 -88.15 91.27 8.71 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.506 -1.294 . . . . 71.23 107.506 174.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -82.39 115.14 21.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.672 -0.694 . . . . 73.32 109.41 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.66 179.57 23.51 Favored Glycine 0 C--O 1.244 0.723 0 O-C-N 123.452 0.47 . . . . 44.33 112.836 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.91 154.65 16.54 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.245 -0.477 . . . . 51.22 112.022 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.8 mm -102.4 123.5 55.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.684 -1.228 . . . . 74.32 107.684 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -136.37 120.23 17.45 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.979 -0.748 . . . . 64.41 108.979 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.4 p -78.32 118.3 20.39 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.819 -0.808 . . . . 65.3 108.819 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.24 107.04 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 107.284 -1.376 . . . . 73.35 107.284 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.64 169.75 17.4 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.165 0.507 . . . . 70.35 111.735 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.21 -58.42 2.75 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 115.145 -0.934 . . . . 75.51 112.576 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.18 -177.55 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.685 0.794 . . . . 62.43 112.211 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.12 -173.89 4.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.708 0.803 . . . . 75.13 110.884 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.11 -141.51 39.66 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 116.086 -0.506 . . . . 73.15 113.748 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 92' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 34.8 p -68.08 -18.47 64.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.013 0.925 . . . . 71.34 111.637 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -68.9 -40.63 79.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.484 0.714 . . . . 74.23 110.522 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.74 -34.0 24.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.329 0.251 . . . . 43.14 110.755 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 95' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -70.45 -25.74 63.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.871 0.868 . . . . 52.22 111.764 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -57.54 -51.62 68.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.785 0.834 . . . . 73.02 110.324 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.48 -52.75 12.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.995 -0.548 . . . . 72.15 110.533 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.78 -25.91 67.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.438 0.695 . . . . 54.55 112.064 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.46 -29.06 8.55 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.055 -0.52 . . . . 43.0 113.847 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -117.07 -60.03 1.89 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.682 0.741 . . . . 60.4 111.202 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.01 -56.06 15.31 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.09 0.556 . . . . 64.22 112.235 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 59.5 m -56.9 -50.68 86.7 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.188 -0.911 . . . . 62.14 112.727 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 45.4 Cg_exo -61.16 -31.09 89.85 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.194 1.929 . . . . 73.54 113.286 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -72.82 -28.93 62.85 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.772 0.829 . . . . 72.4 110.374 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.85 -39.97 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.399 1.08 . . . . 75.4 109.85 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' C' ' 102' ' ' CYS . 68.9 mt -82.59 -16.31 48.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.336 -0.847 . . . . 72.21 111.397 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.64 -55.29 44.6 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.059 -0.972 . . . . 74.11 113.141 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.43 -37.85 46.41 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.085 1.857 . . . . 41.4 113.207 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -63.33 -45.86 89.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.322 0.649 . . . . 64.12 111.25 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.45 96.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.62 -0.718 . . . . 54.5 110.831 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 6.2 ttp-105 -60.51 -43.13 97.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 75.33 110.583 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.77 -34.89 67.27 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.922 0.764 . . . . 63.44 110.387 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.456 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 34.0 t -68.53 -30.33 69.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.787 0.435 . . . . 75.53 111.339 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 118' ' ' VAL . 92.5 mt -77.81 -43.97 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.833 -0.622 . . . . 54.44 110.094 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 54.3 m -55.93 -36.83 68.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.603 0.761 . . . . 72.13 110.427 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.7 t -61.06 -53.75 53.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.228 -1.351 . . . . 63.32 109.535 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -38.02 80.65 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.847 1.259 . . . . 53.42 113.28 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.4 t -63.98 -49.27 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.705 0.802 . . . . 72.33 109.349 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.447 ' OG ' HG21 ' B' ' 115' ' ' THR . 33.7 t -68.74 -26.49 65.27 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.167 -0.924 . . . . 74.41 111.747 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.6 mtt-85 -68.83 -39.25 80.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.279 0.632 . . . . 73.12 109.482 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 10.35 60.51 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.626 0.579 . . . . 73.11 112.747 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p 56.38 40.68 29.65 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.055 1.742 . . . . 74.41 112.503 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.16 156.82 34.84 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.583 -1.189 . . . . 74.15 108.281 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 171.47 9.11 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.084 2.523 . . . . 72.43 113.858 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.548 ' HB2' ' H ' ' B' ' 125' ' ' GLN . 51.3 tp60 -60.23 132.07 52.76 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.318 -0.856 . . . . 64.23 113.083 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.92 85.9 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.477 -1.305 . . . . 71.02 107.477 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -95.71 105.89 17.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.851 -1.166 . . . . 71.43 107.851 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' C' ' 128' ' ' LEU . 1.1 tm? -74.2 137.0 42.8 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 106.775 -1.565 . . . . 61.33 106.775 170.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -53.65 131.87 55.56 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 124.342 1.026 . . . . 72.13 111.506 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.428 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.4 Cg_exo -68.09 89.22 0.38 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.512 2.141 . . . . 71.4 111.168 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 94.0 t -97.92 109.67 24.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.464 -0.789 . . . . 62.35 109.31 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -104.77 83.0 1.95 Allowed 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.261 -1.015 . . . . 74.34 108.261 176.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.78 -44.58 69.84 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.107 -0.951 . . . . 75.41 111.267 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.482 1.127 0 C-N-CA 123.268 0.627 . . . . 73.14 110.946 177.296 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.495 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.5 ptm . . . . . 0 CA--C 1.562 1.414 0 N-CA-C 114.648 1.351 . . . . 74.41 114.648 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.2 m -144.0 140.25 29.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.279 1.032 . . . . 55.32 108.265 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' D' ' 85' ' ' SER . 78.5 t80 -155.57 113.64 3.4 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -134.81 131.05 37.0 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.421 0.688 . . . . 74.24 109.643 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' B' ' 130' ' ' PRO . 2.7 pp -78.94 141.18 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.481 -0.933 . . . . 71.02 108.481 172.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -111.5 -46.03 3.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.682 0.393 . . . . 62.13 110.673 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.22 122.84 1.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.148 -0.315 . . . . 72.4 110.148 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.6 126.69 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 106.523 -1.658 . . . . 55.53 106.523 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -168.1 178.03 5.26 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.811 0.695 . . . . 73.01 111.538 -165.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.6 p -108.21 133.48 52.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.005 -0.998 . . . . 65.03 109.59 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.43 -32.92 9.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.428 -0.582 . . . . 73.11 109.428 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -144.21 138.61 28.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.867 -1.061 . . . . 64.34 108.898 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.15 149.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 44.23 108.199 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -152.74 145.39 24.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.249 0.62 . . . . 64.43 110.35 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.564 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.3 t80 -147.58 124.8 11.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.689 -1.597 . . . . 74.44 106.689 168.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.0 mp0 -120.16 142.04 49.32 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.692 -0.855 . . . . 63.23 108.692 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.28 73.75 10.88 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.355 -0.979 . . . . 71.01 108.355 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.38 -18.57 17.82 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.446 2.097 . . . . 73.14 111.553 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.505 ' O ' HG23 ' D' ' 31' ' ' VAL . 10.4 m120 -114.23 23.88 12.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.136 0.974 . . . . 73.14 109.617 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -48.0 -53.8 29.61 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.885 1.439 . . . . 74.32 114.885 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.533 ' HB3' HD11 ' C' ' 83' ' ' ILE . 28.6 Cg_endo -84.48 -4.32 10.09 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.482 1.454 . . . . 42.15 112.892 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -80.62 -36.95 31.95 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.848 1.259 . . . . 73.54 109.522 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 27' ' ' ASN . 59.3 t -72.77 -25.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.332 0.653 . . . . 74.11 110.663 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.29 -28.99 57.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.07 0.948 . . . . 73.13 112.083 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -76.41 -15.32 59.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.324 0.65 . . . . 71.34 112.408 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -125.61 111.92 15.56 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.439 0.696 . . . . 65.04 110.641 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.25 87.33 7.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.975 0.91 . . . . 72.53 109.855 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.689 ' HB3' HD11 ' D' ' 68' ' ' LEU . 42.6 t-105 -160.01 158.08 29.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.724 -0.843 . . . . 75.22 108.724 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.44 116.82 56.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.077 0.551 . . . . 70.44 109.918 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.07 141.87 86.5 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.134 2.556 . . . . 61.5 113.593 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.61 113.38 4.18 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.55 -0.907 . . . . 72.52 108.55 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.428 HG13 HG13 ' D' ' 64' ' ' VAL . 61.8 t -99.09 106.57 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.65 -0.5 . . . . 74.42 109.65 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -87.41 109.39 19.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.194 -1.41 . . . . 62.02 107.194 167.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.77 156.29 16.39 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.52 -0.918 . . . . 60.55 108.52 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.7 t70 -151.2 155.74 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.157 0.583 . . . . 74.01 109.966 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -133.35 152.12 51.9 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.348 0.659 . . . . 52.32 110.824 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.5 t70 -153.36 151.51 30.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.006 1.322 . . . . 64.32 108.175 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -128.9 152.37 48.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.299 -0.63 . . . . 52.4 109.299 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.79 169.6 20.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.557 -0.905 . . . . 65.53 108.557 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -149.04 159.45 44.21 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.84 0.456 . . . . 53.43 110.737 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -155.7 119.26 4.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.115 0.966 . . . . 74.0 109.184 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.23 121.62 23.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.83 -0.433 . . . . 64.51 109.83 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.63 -26.5 14.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.416 0.686 . . . . 73.33 110.889 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.17 -177.01 3.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.026 0.93 . . . . 64.52 110.036 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.46 120.57 22.64 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.23 -1.026 . . . . 54.44 108.23 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 72.15 3.87 4.82 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.067 1.347 . . . . 65.5 112.742 -172.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.15 117.51 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.423 -0.584 . . . . 61.13 109.423 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -133.04 130.5 39.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.362 0.665 . . . . 73.21 109.468 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -87.16 140.1 29.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 64.1 108.372 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.34 132.87 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.76 -1.2 . . . . 53.31 107.76 169.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.72 130.94 57.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.564 1.145 . . . . 44.15 108.783 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 121.8 45.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.675 -0.861 . . . . 73.21 108.675 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.5 ttm-85 -106.88 99.17 8.76 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.891 -0.781 . . . . 73.1 108.891 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.59 104.13 15.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.199 -1.037 . . . . 71.41 108.199 172.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.2 m -99.3 148.12 24.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.152 -0.931 . . . . 74.52 110.022 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 25.3 t -138.43 132.98 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.629 1.572 . . . . 62.44 107.927 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -133.94 93.44 3.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.721 -1.215 . . . . 74.41 107.721 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.36 141.76 29.3 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.719 -0.673 . . . . 54.01 109.288 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -149.51 126.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.123 0.969 . . . . 71.31 108.975 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' D' ' 36' ' ' TRP . 19.7 tp -99.13 114.06 26.61 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.58 -0.896 . . . . 70.54 108.58 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.95 -113.33 4.13 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.7 0.625 . . . . 72.52 113.051 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 5.88 41.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.728 0.811 . . . . 72.33 111.205 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -149.22 151.52 34.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.471 0.308 . . . . 54.32 111.336 -165.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 71.8 m -55.21 141.46 35.11 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.983 1.313 . . . . 62.51 111.711 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -106.99 -71.85 0.74 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.037 0.935 . . . . 65.11 109.522 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -147.54 137.63 22.99 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.367 0.603 . . . . 64.3 109.778 173.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 51.3 mt -105.03 154.02 20.69 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.397 1.079 . . . . 75.52 108.491 175.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.68 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.5 t -160.64 146.28 14.78 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.935 0.494 . . . . 75.12 110.043 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.05 126.48 6.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.379 -0.6 . . . . 63.22 109.379 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.71 116.88 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.787 0.435 . . . . 62.22 110.638 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.7 mt-30 -92.45 88.03 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.29 1.036 . . . . 70.41 110.084 170.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -80.2 98.73 7.48 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.679 -1.146 . . . . 70.43 108.857 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.38 141.89 17.01 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.627 -0.589 . . . . 71.04 111.627 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.72 132.16 5.47 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.291 -0.723 . . . . 62.15 111.291 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.52 123.6 42.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 C-N-CA 123.93 0.892 . . . . 75.43 109.007 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -133.04 141.32 48.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.124 0.57 . . . . 71.44 109.684 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 33.2 m -100.17 105.23 16.81 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.726 0.81 . . . . 72.53 108.972 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mt -108.04 102.03 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.596 -0.89 . . . . 75.21 108.596 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.18 169.1 16.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.004 1.321 . . . . 74.53 109.879 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.42 -4.66 33.06 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 114.49 0.556 . . . . 73.33 114.49 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.44 151.41 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.96 0.904 . . . . 60.22 109.863 -170.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.15 177.02 8.07 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.014 0.926 . . . . 64.12 111.974 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -132.64 48.25 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 116.287 1.275 . . . . 74.45 116.287 165.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 8.5 t -62.94 -35.89 81.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 72.5 112.45 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -73.79 -39.42 64.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.774 0.43 . . . . 71.24 111.626 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.9 ptm -73.63 -31.95 63.78 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 110.022 -0.362 . . . . 75.2 110.022 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.75 70.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.438 0.695 . . . . 62.02 110.628 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -71.86 -33.36 68.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.159 0.984 . . . . 74.4 110.321 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.9 -52.1 53.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.157 -0.474 . . . . 72.21 110.548 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.59 -18.02 46.26 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.82 0.448 . . . . 73.14 112.114 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.65 -26.63 16.82 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-O 119.795 -0.447 . . . . 71.0 113.72 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.88 -59.36 1.27 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.932 0.493 . . . . 63.1 111.641 -174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -67.29 -47.23 71.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.377 0.423 . . . . 71.34 111.972 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.4 m -67.61 -45.46 46.15 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 118.328 -0.844 . . . . 71.11 111.936 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.92 -35.23 98.47 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.359 2.039 . . . . 74.41 113.498 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.17 -32.96 74.71 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.415 0.686 . . . . 72.01 110.784 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.54 -45.06 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.416 0.687 . . . . 71.53 109.815 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.478 HD21 ' HA3' ' D' ' 82' ' ' GLY . 90.1 mt -73.68 -21.4 60.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.162 -0.926 . . . . 74.1 112.1 -174.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.422 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 42.8 t80 -66.12 -46.81 62.89 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 113.934 1.087 . . . . 64.4 113.934 -168.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.67 -34.16 97.74 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.072 1.848 . . . . 74.43 112.768 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -76.03 -37.68 58.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.023 0.929 . . . . 64.13 111.026 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -49.94 67.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.565 0.746 . . . . 72.34 110.792 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -71.54 -31.88 67.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.862 -1.063 . . . . 73.13 111.186 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.02 -42.94 89.0 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.029 0.831 . . . . 74.2 110.707 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 -39.5 80.24 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.821 0.7 . . . . 75.24 110.259 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.68 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.0 mt -61.56 -54.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.69 0.796 . . . . 62.11 110.35 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.446 HG23 ' HG3' ' D' ' 125' ' ' GLN . 28.8 m -57.71 -39.06 76.35 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.463 1.105 . . . . 72.31 111.593 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -67.06 -43.61 82.23 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 114.855 -1.066 . . . . 75.4 110.141 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.65 -27.18 63.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.775 0.43 . . . . 74.23 111.738 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.1 t -67.96 -43.09 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.564 0.746 . . . . 72.44 109.651 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 94.1 p -74.27 -25.98 59.93 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.895 0.478 . . . . 71.12 111.225 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.6 mtt-85 -75.38 -32.17 60.72 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.456 0.703 . . . . 75.12 109.758 173.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.56 -0.37 89.92 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.62 -0.718 . . . . 64.44 111.991 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.7 p 63.39 27.27 15.23 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.68 1.992 . . . . 62.42 113.257 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.472 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 56.5 m-85 -94.07 162.3 27.11 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 124.707 1.203 . . . . 65.33 110.535 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.1 140.91 97.22 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 123.483 2.789 . . . . 63.2 112.402 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.446 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.1 tt0 -54.68 135.01 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.119 0.968 . . . . 75.34 112.722 -174.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -126.02 102.5 7.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.892 0.877 . . . . 73.34 109.913 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -102.58 121.44 42.39 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.71 -0.848 . . . . 74.41 108.71 175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.422 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.1 OUTLIER -74.76 114.54 13.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.345 -0.983 . . . . 53.55 108.345 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.12 143.36 97.7 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 122.63 0.372 . . . . 73.14 110.898 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.81 132.22 22.81 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 62.55 112.887 -169.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.18 128.97 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.136 0.574 . . . . 73.35 109.771 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.73 93.3 7.9 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.88 -0.785 . . . . 72.15 108.88 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 123.242 0.617 . . . . 72.34 111.101 -178.976 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 90.1 m . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 107.554 -1.276 . . . . 45.21 107.554 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -138.82 121.85 16.75 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.026 -0.731 . . . . 74.12 109.026 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 29.6 tt0 -134.12 111.7 10.54 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.585 0.754 . . . . 60.34 109.159 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.62 109.21 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 108.174 -1.047 . . . . 72.13 108.174 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -91.99 -40.53 11.06 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.407 -0.59 . . . . 74.53 109.407 -174.052 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -170.73 140.96 1.75 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.321 0.648 . . . . 61.04 110.083 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.602 HG23 HD23 ' A' ' 106' ' ' LEU . 3.9 mp -128.59 100.54 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.033 -1.469 . . . . 74.5 107.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -160.82 175.8 12.17 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.234 1.014 . . . . 73.44 110.157 -166.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -81.44 127.01 32.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.649 0.261 . . . . 71.1 110.692 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.4 mtpt -83.27 -47.45 11.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.755 0.788 . . . . 72.22 109.045 165.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 12.0 t70 -136.86 139.36 41.61 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.529 -1.214 . . . . 64.21 109.595 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.521 HG23 ' SD ' ' A' ' 117' ' ' MET . 78.5 mt -128.21 136.06 61.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.876 -1.527 . . . . 74.41 106.876 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -146.16 108.24 4.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.162 -0.681 . . . . 65.0 109.162 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 89.8 t80 -112.56 119.26 37.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.959 -1.497 . . . . 61.01 106.959 173.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -127.99 111.93 14.09 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.038 -0.727 . . . . 73.21 109.038 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -111.19 84.68 4.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.613 -1.255 . . . . 70.45 107.613 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.38 -31.29 18.03 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.285 1.99 . . . . 64.52 111.428 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.7 m-20 -109.29 34.38 3.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.501 1.12 . . . . 64.41 108.767 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -59.24 -47.33 98.5 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.658 0.783 . . . . 53.15 113.059 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.8 Cg_exo -67.64 -24.59 41.31 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.229 1.953 . . . . 73.21 113.275 171.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 25.4 m80 -64.89 -38.11 89.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.613 0.365 . . . . 73.34 110.611 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.81 -25.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.79 0.436 . . . . 64.11 111.626 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.26 -38.44 90.33 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.108 0.563 . . . . 72.32 111.283 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -90.32 -21.19 22.16 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.902 0.481 . . . . 71.23 111.12 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 6.1 tmtt? -82.0 148.79 28.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.036 0.934 . . . . 55.14 111.479 -172.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.42 139.34 57.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.638 0.775 . . . . 74.25 110.736 170.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -84.61 74.04 10.48 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.927 0.87 . . . . 74.41 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -139.38 74.12 35.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.779 -0.823 . . . . 54.34 108.779 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.46 141.51 4.01 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.433 2.088 . . . . 64.14 112.665 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.94 121.97 40.5 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.874 -1.158 . . . . 74.21 107.874 171.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.67 115.49 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.184 0.594 . . . . 73.31 110.542 -167.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -93.77 121.09 34.85 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.298 1.039 . . . . 71.52 109.15 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.0 129.36 55.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.463 0.705 . . . . 72.1 110.328 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -114.39 113.46 24.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.806 0.843 . . . . 74.5 108.8 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.24 118.27 36.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.487 -1.301 . . . . 63.45 107.487 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' O ' HD23 ' A' ' 60' ' ' LEU . 21.6 t70 -129.23 144.93 51.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.77 0.828 . . . . 73.33 109.782 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.4 m -142.13 135.72 29.33 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.273 0.629 . . . . 54.55 110.342 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.48 119.65 9.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.439 0.695 . . . . 72.02 110.928 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 t -91.73 154.21 19.12 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.374 -0.602 . . . . 63.15 109.374 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.3 t -161.86 115.94 1.9 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 117.932 0.333 . . . . 70.42 110.308 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -73.44 105.87 5.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.784 0.834 . . . . 72.03 111.651 -172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 57' ' ' GLU . 70.1 mt -77.93 -40.48 39.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.85 0.86 . . . . 64.35 111.253 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.99 -172.0 3.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.122 0.969 . . . . 61.03 109.542 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.07 100.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.323 0.649 . . . . 62.41 111.159 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.86 32.79 13.02 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.797 1.239 . . . . 65.0 113.083 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 49.1 t -108.51 121.64 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 106.715 -1.587 . . . . 71.44 106.715 167.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -132.48 131.04 41.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.254 -0.647 . . . . 65.32 109.254 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.1 tt0 -86.37 120.22 27.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.629 -0.878 . . . . 63.42 108.629 168.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.33 116.25 42.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.715 -1.217 . . . . 54.3 107.715 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.2 t -98.07 134.88 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.129 -0.693 . . . . 74.35 109.129 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -109.39 109.86 20.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.141 -1.429 . . . . 75.21 107.141 171.079 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -96.99 102.0 13.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.913 -1.143 . . . . 74.0 107.913 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.86 140.6 16.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.511 -1.292 . . . . 73.24 107.511 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -129.48 124.4 33.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.338 -0.616 . . . . 74.12 109.338 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 114' ' ' ILE . 70.8 t -115.76 105.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.935 -1.135 . . . . 50.45 107.935 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.3 m -112.33 122.86 48.93 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.561 -0.903 . . . . 71.23 108.561 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.25 110.81 21.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.613 -1.625 . . . . 72.35 106.613 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -148.38 147.47 29.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 70.23 109.827 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.451 HD23 ' NZ ' ' A' ' 34' ' ' LYS . 28.1 tp -113.32 86.85 2.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.032 -1.099 . . . . 60.2 108.032 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.11 -93.12 1.5 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.15 -0.932 . . . . 74.31 111.472 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -116.04 -26.9 7.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.72 0.808 . . . . 73.14 111.014 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.0 tp10 -77.67 107.08 9.9 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.184 -1.043 . . . . 72.25 108.184 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -76.01 142.53 41.85 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.479 -0.563 . . . . 63.41 109.479 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.46 -58.68 2.47 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.377 -0.971 . . . . 74.44 108.377 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -168.89 176.76 5.3 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.558 0.743 . . . . 75.15 110.727 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.3 tp -139.42 141.82 37.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.186 1.395 . . . . 72.42 108.342 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 35.3 m -147.69 97.79 2.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.943 0.497 . . . . 75.03 110.144 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.43 122.32 46.04 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.575 0.75 . . . . 71.42 109.622 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.11 115.0 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.535 0.734 . . . . 71.14 109.864 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -85.91 82.19 8.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.401 1.081 . . . . 74.22 108.207 172.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -76.49 93.57 3.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.899 -1.046 . . . . 72.33 108.97 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.47 145.91 18.66 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.138 -0.483 . . . . 52.53 111.9 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.56 122.76 2.22 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 110.205 -1.158 . . . . 75.31 110.205 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.617 HD11 ' HA ' ' B' ' 29' ' ' PRO . 54.9 mt -82.21 126.83 40.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.8 -0.815 . . . . 70.34 108.8 175.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -132.71 117.05 17.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.426 -0.953 . . . . 61.33 108.426 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.682 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 40.7 t -84.56 97.64 9.7 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.397 -0.964 . . . . 73.34 108.397 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 10' ' ' THR . 34.1 pt -120.21 125.67 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.696 0.76 . . . . 51.04 111.59 -172.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.73 158.82 43.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.0 1.32 . . . . 54.33 108.932 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.17 8.74 86.07 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.796 -0.447 . . . . 52.22 114.213 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -117.69 134.1 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.823 -0.806 . . . . 74.23 108.823 173.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.33 169.1 17.72 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.99 0.516 . . . . 63.35 111.198 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.95 -111.76 0.79 Allowed Glycine 0 C--N 1.358 1.773 0 O-C-N 124.774 1.296 . . . . 43.41 115.209 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.0 p -70.12 -35.84 74.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.176 0.99 . . . . 70.32 111.772 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.89 -47.56 82.77 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.268 0.627 . . . . 72.31 111.197 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -72.13 -35.75 69.21 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.019 0.528 . . . . 74.02 111.333 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.09 81.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.546 0.738 . . . . 62.32 110.595 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -46.88 86.73 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.625 -1.171 . . . . 73.01 109.985 172.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.0 m -70.84 -37.66 73.16 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.048 0.758 . . . . 74.23 113.048 -172.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 86' ' ' ILE . 77.8 mt -84.84 -18.86 33.56 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.926 0.343 . . . . 65.14 111.926 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.71 -10.85 54.97 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 119.831 -0.427 . . . . 61.24 113.268 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -73.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.734 -0.651 . . . . 61.25 112.642 -172.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.5 t80 -41.41 -54.92 2.94 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 124.882 1.273 . . . . 73.11 113.158 -175.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -78.6 -52.54 1.34 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-O 118.256 -0.878 . . . . 72.1 112.975 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' HD12 ' A' ' 106' ' ' LEU . 38.6 Cg_endo -64.67 -25.27 61.69 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.791 1.661 . . . . 72.1 114.448 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -71.62 -33.98 69.43 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.933 0.493 . . . . 75.15 110.454 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.0 mm -62.16 -42.37 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.273 0.629 . . . . 55.43 109.879 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.602 HD23 HG23 ' A' ' 16' ' ' ILE . 60.2 mt -72.89 -25.42 61.06 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.586 -0.734 . . . . 74.33 111.678 -174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.58 -43.32 70.35 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 115.088 1.514 . . . . 71.43 115.088 -168.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.23 -34.52 98.66 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.114 1.876 . . . . 61.3 113.232 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -80.0 -35.55 37.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.733 0.813 . . . . 73.44 111.158 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.1 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.135 0.574 . . . . 62.1 109.574 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -53.79 -45.64 70.77 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.764 1.29 . . . . 75.41 110.466 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.08 -50.23 64.82 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.633 0.773 . . . . 61.45 111.352 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.2 t -56.09 -46.6 78.99 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.214 0.946 . . . . 34.21 110.659 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 64' ' ' VAL . 11.6 mt -57.77 -54.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.104 0.878 . . . . 74.22 110.657 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 125' ' ' GLN . 65.8 m -56.44 -39.54 73.3 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.73 0.644 . . . . 53.34 111.594 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.35 -39.27 81.93 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.474 -0.785 . . . . 62.33 109.814 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.521 ' SD ' HG23 ' A' ' 21' ' ' ILE . 17.6 mtp -61.17 -40.85 95.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.524 0.73 . . . . 63.53 110.92 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 114' ' ' ILE . 92.1 t -62.89 -46.5 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.268 1.027 . . . . 75.15 110.698 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.7 p -75.25 -37.05 61.18 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.575 -0.739 . . . . 74.34 111.211 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -66.31 -28.33 68.6 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.308 0.643 . . . . 73.44 109.909 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.01 -3.07 89.36 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.558 -0.747 . . . . 33.34 113.43 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 65.83 38.32 5.18 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.028 1.394 . . . . 70.31 110.541 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.05 150.53 43.72 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 115.025 -0.989 . . . . 75.32 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.7 130.53 40.43 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.935 2.423 . . . . 75.05 112.271 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.7 tt0 -58.46 127.31 31.49 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.064 0.853 . . . . 74.35 112.128 -175.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.9 mt -117.32 95.58 5.04 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.994 -1.113 . . . . 72.32 107.994 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -98.4 126.74 44.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.746 -0.835 . . . . 74.24 108.746 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.28 149.0 40.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.772 -0.649 . . . . 65.21 111.958 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.03 142.02 87.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.326 0.651 . . . . 65.52 110.142 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -78.24 96.94 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.171 1.914 . . . . 50.1 110.785 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.66 114.04 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.752 0.787 . . . . 73.34 109.04 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -93.23 93.28 8.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.964 -1.016 . . . . 73.43 109.663 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -64.55 -26.59 68.48 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.306 -0.861 . . . . 62.31 111.316 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 123.625 0.77 . . . . 72.24 110.214 -175.987 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 114.205 1.187 . . . . 74.01 114.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.3 m -148.2 131.34 16.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.73 0.812 . . . . 74.44 109.059 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' B' ' 85' ' ' SER . 66.9 t80 -136.58 142.74 43.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.756 0.422 . . . . 74.31 110.397 172.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -155.92 140.49 16.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.317 1.047 . . . . 74.1 109.306 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.07 106.35 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.478 -1.304 . . . . 63.51 107.478 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -78.24 -46.42 20.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.68 0.392 . . . . 74.13 110.19 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -163.58 140.87 7.3 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.063 -0.517 . . . . 71.02 110.166 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.1 mt -117.96 144.84 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.342 -1.355 . . . . 73.41 107.342 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.432 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.7 p90 -170.12 147.0 3.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.592 0.633 . . . . 73.13 111.913 -177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -72.92 119.22 16.87 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.666 -1.152 . . . . 73.52 108.069 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -90.95 -30.25 16.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.326 0.65 . . . . 75.35 110.851 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -158.02 138.94 13.15 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.583 0.552 . . . . 72.03 111.112 -171.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.467 HD12 HG22 ' B' ' 78' ' ' VAL . 47.8 mm -132.33 138.22 52.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 C-N-CA 124.635 1.174 . . . . 63.34 109.007 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -131.25 136.08 47.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.332 -1.359 . . . . 51.23 107.332 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.6 t80 -151.84 122.1 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.363 -1.347 . . . . 64.5 107.363 171.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 42.1 mt-10 -124.1 133.68 53.55 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.29 -1.004 . . . . 71.42 108.29 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -128.78 87.47 54.67 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.162 -0.681 . . . . 53.05 109.162 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.7 -22.99 36.62 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.158 1.905 . . . . 62.11 111.004 172.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -115.04 24.96 11.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.135 0.974 . . . . 71.25 111.148 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.81 -53.64 40.21 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 123.704 0.801 . . . . 70.33 111.133 164.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.617 ' HA ' HD11 ' A' ' 83' ' ' ILE . 69.2 Cg_endo -77.0 -22.78 11.16 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.907 1.738 . . . . 71.32 113.374 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -94.46 2.94 55.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.54 0.736 . . . . 73.45 111.662 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.83 -31.73 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.222 1.009 . . . . 74.43 112.813 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -74.12 -34.83 64.05 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.354 . . . . 62.33 110.772 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -68.93 -23.78 64.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.648 1.179 . . . . 44.42 110.962 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' B' ' 34' ' ' LYS . 10.6 mmpt? -75.9 100.27 4.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.253 0.621 . . . . 64.1 111.422 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -113.42 78.84 1.17 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.339 1.056 . . . . 75.25 111.149 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -176.89 178.22 1.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.626 1.97 . . . . 75.44 107.143 171.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.56 131.93 36.63 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.501 -0.926 . . . . 54.24 108.501 164.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 47.6 Cg_endo -67.7 133.6 30.12 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.165 1.91 . . . . 72.43 112.961 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 25.5 tt0 -51.21 117.18 2.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.811 1.244 . . . . 61.4 109.631 164.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 134.2 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.736 0.414 . . . . 60.32 110.604 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -142.85 101.83 3.92 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.343 1.057 . . . . 64.03 108.611 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -94.8 153.07 17.92 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.177 -0.675 . . . . 70.45 109.177 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -138.35 130.27 28.26 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.403 -0.962 . . . . 72.13 108.403 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.96 128.47 53.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.606 -1.257 . . . . 63.34 107.606 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.3 t70 -142.85 155.66 44.81 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.428 1.091 . . . . 61.12 108.777 -174.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.1 p -141.89 119.59 11.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.369 0.668 . . . . 43.44 110.358 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.99 119.07 25.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.372 -0.973 . . . . 72.2 108.372 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -117.0 164.54 14.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.637 0.375 . . . . 70.43 110.979 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -152.41 136.89 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.2 1.0 . . . . 73.31 109.03 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -80.8 121.62 26.16 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.227 -0.657 . . . . 75.3 109.227 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 45.6 mt -80.53 -39.87 27.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.564 -0.532 . . . . 70.54 109.564 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.25 -179.1 4.88 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.758 -1.11 . . . . 51.53 109.966 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.78 129.59 41.15 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.409 -0.814 . . . . 73.45 108.95 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' B' ' 85' ' ' SER . 2.5 m-20 71.07 1.49 3.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.479 1.112 . . . . 74.44 112.283 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 t -125.75 88.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.475 -0.935 . . . . 73.43 108.475 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -108.86 137.85 46.13 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.823 -0.806 . . . . 72.43 108.823 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -119.76 108.3 14.25 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.405 -0.961 . . . . 61.24 108.405 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -99.94 124.11 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.857 0.863 . . . . 51.23 109.188 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 24.9 t -103.33 124.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 109.575 -0.528 . . . . 62.2 109.575 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.3 116.48 29.04 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.001 -1.481 . . . . 73.21 107.001 171.279 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.502 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 43.1 ttt180 -105.17 107.82 19.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.144 0.577 . . . . 63.41 109.887 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -107.9 121.39 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.963 -0.754 . . . . 61.13 108.963 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -109.46 141.96 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.365 0.666 . . . . 72.33 109.532 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.591 HG21 HG21 ' B' ' 114' ' ' ILE . 43.0 t -124.88 127.0 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.997 0.919 . . . . 74.2 108.658 171.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -125.62 147.24 49.38 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.776 -0.824 . . . . 62.34 108.776 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.11 148.72 30.93 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.605 0.565 . . . . 64.44 111.418 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.1 m -133.99 126.71 30.84 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 115.327 -0.852 . . . . 54.4 108.743 174.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 1.7 tt -118.92 115.82 25.19 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.948 -1.501 . . . . 61.41 106.948 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -143.95 29.94 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.343 -0.703 . . . . 72.51 111.343 -170.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -92.3 19.74 6.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 62.13 112.197 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.44 178.93 8.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.321 0.648 . . . . 63.55 110.45 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.5 m -69.2 139.49 54.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.241 0.616 . . . . 65.35 110.551 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -87.41 -65.2 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.108 0.956 . . . . 63.32 108.762 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -156.02 161.44 40.45 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 113.311 -1.768 . . . . 55.11 108.848 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 81.6 mt -132.17 143.17 49.78 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.079 -1.452 . . . . 74.25 107.079 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -155.87 152.22 28.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.882 -0.784 . . . . 53.23 108.882 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.1 tt0 -165.85 135.9 3.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.696 -0.853 . . . . 74.41 108.696 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' B' ' 113' ' ' CYS . 93.1 t -125.1 143.6 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.56 0.744 . . . . 52.33 109.022 174.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 23.3 mt-30 -123.69 91.05 3.39 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.549 -0.908 . . . . 63.03 108.549 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -83.8 101.06 11.34 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.366 -0.834 . . . . 55.44 109.622 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.1 164.9 32.58 Favored Glycine 0 C--O 1.243 0.661 0 O-C-N 123.419 0.449 . . . . 73.4 112.074 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.88 125.34 1.46 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.676 -0.57 . . . . 51.34 111.676 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.432 HG13 ' HE1' ' B' ' 17' ' ' TYR . 45.7 mt -85.23 119.64 34.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 108.17 -1.048 . . . . 72.21 108.17 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.94 151.3 43.74 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.851 0.86 . . . . 60.31 109.864 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 13.4 m -96.3 100.57 12.18 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.051 -1.092 . . . . 65.02 108.051 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.554 HG21 ' SD ' ' B' ' 94' ' ' MET . 12.3 mm -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.496 -0.557 . . . . 63.24 109.496 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -142.42 153.01 43.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.988 0.515 . . . . 64.42 111.077 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.01 -67.15 3.8 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.914 0.759 . . . . 52.33 112.212 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 tt -49.24 135.29 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.281 1.832 . . . . 73.22 112.325 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -151.74 177.14 10.69 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.658 0.383 . . . . 74.14 111.241 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.08 -133.57 34.0 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.39 -0.823 . . . . 71.12 113.636 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.1 m -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.279 1.032 . . . . 60.13 110.858 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -66.67 -47.62 71.9 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.869 -1.514 . . . . 70.04 109.719 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.554 ' SD ' HG21 ' B' ' 86' ' ' ILE . 11.4 tpt -70.57 -33.97 71.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.611 0.764 . . . . 54.13 111.301 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.813 0.445 . . . . 74.14 111.072 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 27.2 t-80 -67.49 -37.49 82.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.81 0.844 . . . . 74.11 111.189 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -69.93 -45.25 67.9 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.5 0.667 . . . . 62.24 110.961 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.27 -38.17 66.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.526 1.13 . . . . 54.42 111.228 -172.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.24 4.81 60.67 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.508 -0.769 . . . . 74.41 114.38 -173.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -150.48 -61.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.865 0.833 . . . . 72.04 112.758 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -64.63 -52.97 54.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.636 0.774 . . . . 73.54 112.148 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.476 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 77.8 m -62.06 -51.15 76.88 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.274 -0.87 . . . . 72.31 112.33 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 32.3 Cg_exo -61.38 -29.51 85.71 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 121.935 1.757 . . . . 74.03 113.764 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.46 -35.99 81.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.941 0.497 . . . . 71.25 111.221 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.75 -40.26 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 124.043 0.937 . . . . 72.22 110.166 172.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.85 -18.84 31.72 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.871 -1.059 . . . . 63.52 112.763 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -59.4 -45.95 98.96 Favored Pre-proline 0 N--CA 1.485 1.282 0 N-CA-C 114.301 1.223 . . . . 74.24 114.301 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.89 -43.27 48.06 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.347 2.032 . . . . 74.4 113.734 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -70.0 -44.02 70.22 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.247 -0.888 . . . . 72.43 110.561 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.31 96.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.451 0.7 . . . . 71.44 110.917 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.588 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.7 ttt180 -56.88 -58.55 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.491 1.517 . . . . 75.32 110.92 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.09 -38.83 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.729 1.212 . . . . 70.15 111.085 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.05 -46.95 75.97 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.286 -0.415 . . . . 75.04 110.935 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.591 HG21 HG21 ' B' ' 64' ' ' VAL . 50.7 mt -60.37 -53.4 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.743 0.417 . . . . 62.34 110.589 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -26.76 68.76 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.271 -0.877 . . . . 72.35 111.406 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 48.1 t -72.26 -50.07 30.13 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.138 0.575 . . . . 51.43 110.526 172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.1 mmt -65.65 -35.06 79.68 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.441 0.696 . . . . 64.3 112.273 -173.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.65 -34.19 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.773 0.429 . . . . 63.43 110.751 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 33.2 t -67.63 -30.4 69.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.762 0.825 . . . . 73.1 110.565 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.422 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 92.6 mtt-85 -65.79 -26.77 67.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.702 0.801 . . . . 73.04 111.552 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 10.4 65.7 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-O 119.681 -0.51 . . . . 62.03 114.261 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 5.1 p 67.85 12.09 8.67 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.18 1.792 . . . . 62.52 113.129 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -85.88 159.1 55.36 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.877 -0.582 . . . . 74.25 110.311 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -41.81 124.94 2.85 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.512 2.808 . . . . 71.3 113.271 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.414 ' HB2' HE21 ' C' ' 125' ' ' GLN . 53.3 tt0 -65.47 111.78 3.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.552 -0.749 . . . . 72.45 109.517 178.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.9 94.79 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.154 -1.054 . . . . 73.22 108.154 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -91.66 121.73 33.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.847 -1.168 . . . . 75.44 107.847 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.588 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -73.8 144.83 45.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 74.14 110.92 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.37 144.88 54.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.274 -0.876 . . . . 64.25 109.686 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.69 ' HG3' HD13 ' D' ' 16' ' ' ILE . 37.0 Cg_endo -63.07 99.41 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.626 2.217 . . . . 50.43 112.327 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.38 132.03 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.307 0.575 . . . . 65.01 110.249 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.46 113.12 24.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.84 0.856 . . . . 50.2 108.983 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -72.81 -18.71 61.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.698 0.799 . . . . 62.02 111.841 -174.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.86 -41.6 95.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.199 0.6 . . . . 62.12 109.742 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.02 88.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.284 -0.871 . . . . 55.45 110.057 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 CA--C 1.548 0.894 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.442 178.149 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 29.3 ttm . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.305 0.574 . . . . 73.52 111.435 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -101.36 75.16 1.6 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.535 -1.283 . . . . 72.21 107.535 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' C' ' 85' ' ' SER . 56.6 t80 -84.8 118.06 24.24 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 108.221 -1.029 . . . . 54.33 108.221 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -147.49 131.97 17.68 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.725 -0.842 . . . . 41.35 108.725 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -75.95 125.65 35.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.75 -0.834 . . . . 74.4 108.75 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.3 mm-40 -95.11 -45.49 7.19 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 72.12 110.115 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -166.76 126.31 1.5 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.958 0.503 . . . . 74.21 109.888 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.01 144.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.974 -1.121 . . . . 73.2 107.974 174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -177.97 161.22 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.454 0.645 . . . . 73.02 111.017 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -86.28 110.69 19.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.38 -0.827 . . . . 72.23 108.977 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.473 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 7.3 mmmt -72.23 -44.71 62.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.397 -0.964 . . . . 72.32 108.397 172.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.9 t70 -134.51 143.86 47.69 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.661 -1.154 . . . . 70.34 110.234 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.93 147.77 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.267 1.827 . . . . 74.13 106.444 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -157.55 151.64 24.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.066 0.546 . . . . 71.13 110.153 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -148.74 146.28 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.871 -1.159 . . . . 75.02 107.871 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 47.6 mt-10 -141.79 150.11 41.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.259 -1.385 . . . . 71.32 107.259 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -154.85 88.97 3.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.47 -45.58 17.65 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.832 2.355 . . . . 75.05 111.759 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 67.1 m-80 -98.79 40.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.733 -0.667 . . . . 62.11 110.594 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.19 -42.19 91.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.335 1.054 . . . . 61.42 113.32 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.95 -34.7 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 121.611 1.541 . . . . 64.53 112.833 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 38.1 t-80 -68.11 -19.49 64.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.064 1.346 . . . . 73.21 111.874 -172.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.562 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.1 p -48.58 -35.27 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 124.618 1.167 . . . . 73.15 113.55 175.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -59.18 -40.4 85.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.797 0.839 . . . . 71.24 111.35 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -115.6 18.31 15.9 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.364 -0.835 . . . . 72.41 111.331 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.562 ' HE2' HG23 ' C' ' 31' ' ' VAL . 0.0 OUTLIER -82.63 165.51 19.97 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.236 -0.653 . . . . 75.12 109.236 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.39 130.75 35.09 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.721 -0.844 . . . . 71.24 108.721 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -75.34 85.85 2.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.632 0.73 . . . . 74.03 110.075 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -154.27 68.8 6.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.562 -1.199 . . . . 64.31 107.773 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -91.95 112.34 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.334 2.023 . . . . 60.02 111.287 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.56 95.04 9.61 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 108.104 -1.073 . . . . 53.01 108.104 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.95 107.58 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.126 -0.943 . . . . 44.45 110.134 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.5 mttp -91.05 102.83 15.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 72.13 107.669 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.503 HD23 HG22 ' C' ' 64' ' ' VAL . 3.1 tm? -87.07 145.23 26.54 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.131 -1.063 . . . . 74.25 108.131 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -139.91 137.82 35.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.874 0.87 . . . . 71.04 108.691 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.34 146.49 51.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.894 0.878 . . . . 60.42 109.149 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.04 154.71 28.06 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.045 0.938 . . . . 54.23 109.218 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -155.87 148.54 24.01 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.929 0.395 . . . . 64.21 110.384 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.78 163.35 33.59 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.04 0.936 . . . . 73.12 109.036 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.1 p -130.72 147.16 52.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.994 0.517 . . . . 53.2 110.048 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.0 p -143.97 129.06 18.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.73 0.812 . . . . 72.24 109.305 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -78.46 116.49 18.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.915 0.486 . . . . 73.03 110.295 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' C' ' 57' ' ' GLU . 47.2 mt -87.96 -45.77 9.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.799 0.84 . . . . 73.05 109.317 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.71 -179.49 6.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.39 -1.277 . . . . 60.44 109.343 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.38 109.57 0.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.929 0.768 . . . . 65.41 110.216 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.67 22.44 7.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.603 1.161 . . . . 64.22 112.018 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.1 105.61 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.511 1.124 . . . . 62.54 108.027 173.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -114.64 128.81 56.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.675 0.79 . . . . 74.53 110.07 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.98 115.29 22.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.595 0.758 . . . . 74.35 109.195 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.9 t -96.81 121.17 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.14 -1.059 . . . . 44.12 108.14 173.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.7 105.31 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.5 -0.926 . . . . 50.31 108.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.3 tm? -91.29 105.0 17.47 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.277 -1.008 . . . . 70.01 108.277 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -95.9 121.93 38.16 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.951 0.9 . . . . 70.24 110.194 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.8 t -107.35 146.67 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 107.909 -1.145 . . . . 74.54 107.909 169.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 23.4 m -139.46 120.69 14.82 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.495 0.664 . . . . 62.31 109.501 170.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.503 HG22 HD23 ' C' ' 42' ' ' LEU . 85.7 t -101.85 108.86 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.73 -1.123 . . . . 75.32 108.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.8 m -97.92 135.55 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.178 -1.415 . . . . 73.34 107.178 169.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.28 102.97 5.15 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.028 -1.471 . . . . 63.35 107.028 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.438 ' HB3' HG23 ' C' ' 72' ' ' THR . 26.2 p -168.51 154.48 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.695 0.622 . . . . 51.44 110.838 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -95.5 -42.81 8.27 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.187 -0.672 . . . . 52.42 109.187 171.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.42 -80.85 0.05 OUTLIER Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.781 -0.928 . . . . 55.41 110.781 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -89.4 -31.65 17.65 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.779 -0.823 . . . . 73.11 108.779 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.91 85.25 2.23 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.626 -0.715 . . . . 74.55 109.48 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.438 HG23 ' HB3' ' C' ' 67' ' ' SER . 27.5 m -89.31 116.86 27.84 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.233 -0.44 . . . . 75.45 110.197 172.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.51 -64.78 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.511 -1.292 . . . . 55.14 107.511 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.81 171.61 16.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.545 0.688 . . . . 54.13 111.645 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.7 tm? -132.08 145.35 51.35 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.563 -2.014 . . . . 73.21 105.563 171.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -151.72 142.99 23.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.382 -0.97 . . . . 62.34 108.382 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -150.1 134.25 17.11 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.404 -0.591 . . . . 73.43 109.404 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' C' ' 110' ' ' ALA . 50.3 t -134.27 113.69 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.89 0.876 . . . . 65.34 108.661 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 54.3 mt-30 -91.05 90.13 7.71 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.525 -0.917 . . . . 73.25 108.525 171.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 61.3 tp60 -78.81 103.77 8.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.84 -1.073 . . . . 74.1 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.74 144.74 22.28 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.458 -0.657 . . . . 72.13 111.458 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.05 117.1 0.9 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.557 -1.017 . . . . 74.5 110.557 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.525 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -80.0 126.73 39.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.854 -1.165 . . . . 60.21 107.854 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.6 143.33 47.27 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.892 0.477 . . . . 73.44 109.812 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 15.6 m -82.1 107.14 14.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.656 -1.238 . . . . 75.15 107.656 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.4 99.72 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.095 -1.076 . . . . 73.42 108.095 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -128.75 159.31 36.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.362 1.065 . . . . 62.43 110.152 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -53.45 4.37 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.53 0.519 . . . . 72.13 113.435 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' C' ' 94' ' ' MET . 30.0 pt -80.92 150.82 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.872 0.869 . . . . 65.12 112.117 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -147.23 153.75 40.18 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.77 1.228 . . . . 72.44 108.85 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.64 -111.32 2.07 Favored Glycine 0 C--N 1.355 1.612 0 O-C-N 123.548 0.53 . . . . 74.04 114.136 170.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 24.9 p -50.6 -55.42 16.37 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.293 1.437 . . . . 74.24 112.868 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.38 -46.32 80.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.054 0.542 . . . . 73.55 111.502 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.405 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.0 ptt? -68.83 -31.48 70.5 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.356 0.41 . . . . 75.42 111.484 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.61 75.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.166 0.587 . . . . 73.11 111.528 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -69.58 -29.46 67.01 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.837 -0.62 . . . . 71.43 110.846 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.34 -58.93 3.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.908 0.483 . . . . 42.45 110.486 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -73.36 -15.62 61.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.94 0.496 . . . . 74.21 111.652 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.32 7.73 58.46 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 119.588 -0.562 . . . . 64.13 113.822 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB2' ' HD2' ' C' ' 133' ' ' PHE . . . -159.43 -60.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.689 0.745 . . . . 71.14 112.152 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -73.41 -44.8 57.65 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.453 0.701 . . . . 74.21 112.788 -167.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 38.0 m -68.65 -47.2 34.44 Favored Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.14 0.576 . . . . 53.41 111.415 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 38.2 Cg_exo -64.48 -26.15 62.66 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.177 1.918 . . . . 74.45 114.192 173.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -55.06 -49.05 72.6 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.894 0.877 . . . . 70.14 110.277 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -56.96 -41.98 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 124.163 0.915 . . . . 71.11 110.897 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.1 mt -83.41 -23.0 32.55 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.126 -0.943 . . . . 63.43 112.566 -171.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.74 -50.34 87.25 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.57 -1.205 . . . . 64.32 113.494 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.41 -34.17 93.82 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.071 1.847 . . . . 72.34 112.918 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -68.0 -50.72 53.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.787 0.835 . . . . 73.11 111.448 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -65.31 -35.03 79.74 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 116.018 -0.537 . . . . 50.21 111.117 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.473 HH12 ' HG3' ' C' ' 130' ' ' PRO . 59.6 ttt180 -60.66 -48.51 81.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.797 1.639 . . . . 60.14 110.647 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.422 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 3.1 tm-20 -72.82 -33.62 66.31 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.873 0.469 . . . . 74.41 109.993 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.423 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 8.6 t -65.55 -28.73 69.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.979 0.512 . . . . 74.04 111.135 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.468 HD13 HG23 ' C' ' 64' ' ' VAL . 87.9 mt -78.77 -51.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.659 -0.7 . . . . 54.32 110.033 173.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 33.6 m -58.97 -28.56 66.44 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.251 0.548 . . . . 71.45 111.173 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 44.6 t -63.38 -55.27 25.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.266 1.026 . . . . 74.33 109.053 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.473 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -34.69 71.19 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.739 1.216 . . . . 73.22 112.774 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.9 t -66.2 -48.09 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.855 -0.794 . . . . 73.45 108.855 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -31.97 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.022 -0.99 . . . . 70.33 111.214 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.5 mtt-85 -66.94 -40.85 87.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.524 0.73 . . . . 72.11 109.437 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.73 3.93 62.52 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.826 0.704 . . . . 71.14 112.988 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 59.69 31.33 20.81 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.436 1.894 . . . . 65.21 112.994 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.98 153.47 43.42 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.078 0.951 . . . . 72.13 108.929 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 -169.89 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.91 2.406 . . . . 73.55 113.536 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' B' ' 125' ' ' GLN . 50.9 mm-40 -52.28 117.96 3.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.367 1.067 . . . . 71.52 113.138 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.55 104.39 4.93 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.033 -1.469 . . . . 72.33 107.033 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.12 131.1 38.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.672 1.189 . . . . 64.31 108.227 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -86.11 142.54 28.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.925 -0.398 . . . . 74.13 109.925 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 139.03 97.55 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.32 1.048 . . . . 53.41 111.922 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.473 ' HG3' HH12 ' C' ' 111' ' ' ARG . 27.0 Cg_exo -63.44 98.28 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.758 2.305 . . . . 74.33 112.837 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.86 109.17 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.05 -0.722 . . . . 71.51 109.05 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -115.36 102.99 10.35 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.79 0.836 . . . . 64.11 109.95 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' C' ' 100' ' ' ALA . 67.2 t80 -80.37 -24.18 39.97 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.58 0.705 . . . . 75.15 110.212 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.406 1.083 . . . . 71.24 111.123 176.087 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 114.851 1.426 . . . . 64.41 114.851 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 45.5 m -145.69 143.65 29.91 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.452 1.101 . . . . 72.43 109.202 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' D' ' 85' ' ' SER . 44.8 t80 -154.08 109.92 3.23 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.053 -1.091 . . . . 71.53 108.053 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.8 116.42 27.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.313 0.645 . . . . 64.01 110.259 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 30.9 pt -78.39 99.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.483 -0.932 . . . . 75.21 108.483 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -83.44 -45.31 13.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.944 -0.472 . . . . 74.23 111.669 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.422 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 20.5 ttt180 -164.71 126.6 2.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.597 -0.149 . . . . 75.3 110.597 -167.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.69 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -113.15 133.68 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.639 -1.245 . . . . 62.44 107.639 174.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.9 p90 -159.03 178.42 10.08 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.429 0.692 . . . . 71.42 111.782 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 58.2 p -107.36 132.19 53.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.619 -0.882 . . . . 73.34 108.619 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.0 mtpt -96.21 -31.48 12.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.195 -0.298 . . . . 62.54 110.195 175.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.0 t70 -150.24 141.27 22.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.929 0.892 . . . . 74.11 108.916 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.1 mt -143.75 148.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.7 1.2 . . . . 50.05 107.921 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.6 t -151.64 145.46 25.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.331 1.053 . . . . 72.21 109.176 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -150.59 125.27 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.725 -1.954 . . . . 73.44 105.725 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -131.79 131.94 43.35 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.139 0.427 . . . . 71.1 110.104 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.55 79.69 11.22 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.779 -0.823 . . . . 75.13 108.779 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.77 -39.72 14.42 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.584 2.189 . . . . 73.32 111.303 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -98.79 24.73 7.27 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.811 . . . . 52.33 109.97 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.513 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -51.97 -49.13 85.77 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 115.132 1.53 . . . . 43.45 115.132 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.83 -7.37 9.47 Favored 'Trans proline' 0 C--N 1.39 2.745 0 CA-C-N 121.791 1.675 . . . . 62.33 112.996 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -83.82 -40.15 19.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 74.11 109.813 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.42 -12.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.549 0.739 . . . . 62.51 110.712 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -56.82 -29.77 63.08 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.667 1.187 . . . . 74.53 111.815 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -70.89 -14.24 62.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.228 1.011 . . . . 64.32 112.124 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.42 108.76 13.06 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.805 0.842 . . . . 64.11 109.771 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.69 82.16 3.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.654 0.74 . . . . 64.14 110.383 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -148.63 165.46 31.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.193 0.997 . . . . 74.05 108.666 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.5 mp0 -69.52 110.67 6.8 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.281 1.433 . . . . 74.44 111.222 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 16.6 Cg_exo -71.12 124.07 10.2 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.058 2.505 . . . . 70.45 112.392 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -60.99 118.91 7.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.378 0.424 . . . . 72.04 110.807 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.484 HG23 HG13 ' D' ' 64' ' ' VAL . 2.3 p -98.91 128.0 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.797 0.839 . . . . 43.15 109.498 -176.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 9.3 tmtt? -99.29 117.0 32.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.046 -1.835 . . . . 74.41 106.046 170.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.467 HD22 HD22 ' D' ' 128' ' ' LEU . 53.2 tp -95.1 134.79 37.42 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.984 -1.117 . . . . 65.14 107.984 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.5 t70 -135.43 149.92 49.72 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.263 -1.384 . . . . 75.14 107.263 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -135.43 164.69 27.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.482 0.313 . . . . 63.41 111.195 -174.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.9 t70 -171.23 156.18 4.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.514 1.125 . . . . 63.12 109.351 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -134.63 160.54 37.79 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.476 0.711 . . . . 73.42 110.003 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.1 162.83 39.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.056 0.942 . . . . 43.21 109.344 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -140.63 157.94 44.72 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.163 0.585 . . . . 71.23 110.803 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -161.15 130.2 4.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.571 1.148 . . . . 34.11 108.567 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -89.89 123.55 33.93 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.09 -0.707 . . . . 73.42 109.09 172.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' D' ' 57' ' ' GLU . 56.6 mt -97.94 -35.62 10.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.791 0.836 . . . . 62.11 110.056 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -160.32 -175.62 5.14 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.954 -1.021 . . . . 44.02 110.564 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.97 109.39 1.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.787 -1.097 . . . . 62.23 109.674 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.81 10.01 6.5 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.985 1.314 . . . . 75.12 112.925 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 89.1 t -109.02 118.33 56.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.233 -1.025 . . . . 62.52 108.233 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.63 129.83 44.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.066 -0.97 . . . . 73.43 109.74 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.615 ' HB2' HD11 ' D' ' 51' ' ' LEU . 35.3 tt0 -87.24 130.75 34.45 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.316 1.046 . . . . 73.13 108.683 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.0 145.0 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.142 -1.059 . . . . 72.05 108.142 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 85.6 t -117.46 142.46 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.017 0.927 . . . . 74.13 108.73 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 116.56 24.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.435 -1.321 . . . . 63.1 107.435 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -101.44 103.92 14.84 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.126 -1.064 . . . . 53.32 108.126 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.73 117.77 49.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.244 -1.021 . . . . 72.03 108.244 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 10.4 m -118.02 127.92 54.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.245 0.618 . . . . 74.5 110.385 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 73.4 t -114.63 123.78 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.322 1.449 . . . . 63.42 108.962 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 32.3 m -123.6 91.61 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.908 -1.145 . . . . 73.13 107.908 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 138.74 34.3 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.254 -0.647 . . . . 52.34 109.254 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -154.62 125.86 7.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.437 -0.801 . . . . 72.54 109.692 -173.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' D' ' 71' ' ' GLU . 46.4 tp -113.38 99.19 7.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.067 -0.716 . . . . 74.03 109.067 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.83 -128.74 9.08 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 112.157 -0.377 . . . . 61.35 112.157 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -90.33 14.54 12.52 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.307 1.043 . . . . 71.43 110.839 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' D' ' 68' ' ' LEU . 3.3 tp10 -115.31 134.31 55.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.179 0.992 . . . . 73.2 111.431 -158.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.3 m -69.59 110.47 4.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.594 -0.891 . . . . 75.24 108.594 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 -66.83 0.84 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.66 -0.496 . . . . 61.31 109.66 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -154.35 136.6 14.85 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.399 0.619 . . . . 71.13 110.265 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.3 mt -105.12 152.49 22.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.649 1.18 . . . . 52.42 108.0 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 41.0 t -160.37 148.77 16.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.119 0.568 . . . . 33.33 109.963 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.7 125.75 6.59 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.818 -0.808 . . . . 75.21 108.818 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.413 0.685 . . . . 74.34 109.607 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -93.89 87.11 5.27 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.719 -0.845 . . . . 73.25 108.719 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -79.04 110.01 13.87 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.434 -1.257 . . . . 64.12 108.45 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.45 143.93 15.75 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.239 -0.344 . . . . 72.55 112.239 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.48 139.84 9.45 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.833 0.317 . . . . 71.33 112.347 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.35 123.17 40.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.806 0.842 . . . . 71.31 108.984 173.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.08 141.51 48.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.106 0.963 . . . . 71.33 108.729 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 17.4 m -102.37 112.69 25.5 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.315 -0.624 . . . . 70.51 109.315 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.99 103.56 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.245 -1.02 . . . . 73.14 108.245 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.55 153.48 49.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.442 1.097 . . . . 74.42 109.711 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 2.78 61.29 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.102 0.252 . . . . 71.21 113.367 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 44.9 mm -131.41 129.83 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.861 1.264 . . . . 74.04 108.317 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.65 179.1 7.02 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.191 0.997 . . . . 74.04 110.814 -174.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.0 -135.46 24.39 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.886 -0.597 . . . . 63.11 114.083 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -80.1 -21.85 42.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.936 0.894 . . . . 75.51 111.927 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.57 -40.4 73.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.959 0.504 . . . . 75.34 111.164 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -28.64 64.75 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 110.311 -0.255 . . . . 72.24 110.311 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.55 -32.76 66.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.475 0.71 . . . . 64.25 110.555 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -65.93 -43.43 88.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.257 0.623 . . . . 73.35 110.198 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.54 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 89.8 m -61.67 -42.33 98.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.437 0.295 . . . . 65.41 110.884 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.01 -40.02 65.54 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.065 0.546 . . . . 63.31 111.629 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.97 3.68 38.59 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-O 119.414 -0.659 . . . . 71.55 114.662 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.43 -63.24 0.37 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.979 0.889 . . . . 74.21 112.203 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 82.7 t80 -64.95 -58.19 6.79 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.372 0.508 . . . . 72.51 112.372 -170.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 66.1 m -59.94 -44.23 96.36 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 118.513 -0.756 . . . . 72.02 112.737 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.43 -37.5 94.76 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.419 2.079 . . . . 63.22 113.919 167.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.96 -28.54 66.73 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.446 0.698 . . . . 54.34 110.858 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.5 -40.63 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.398 0.618 . . . . 63.23 109.773 170.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.422 HD21 ' HA3' ' D' ' 82' ' ' GLY . 82.7 mt -76.53 -18.97 58.42 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.23 -0.896 . . . . 61.24 112.008 -176.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -64.11 -43.4 74.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.293 1.22 . . . . 73.44 114.293 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.45 -39.94 63.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.051 1.834 . . . . 61.52 113.292 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -78.93 -30.18 44.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.746 0.818 . . . . 75.32 111.621 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.67 65.62 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.212 0.605 . . . . 63.4 109.641 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.44 -49.42 74.62 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.2 -1.364 . . . . 75.32 110.607 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.73 -45.9 92.48 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.041 0.838 . . . . 75.45 111.697 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -59.13 -40.97 87.1 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.715 0.635 . . . . 71.42 110.745 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.52 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.6 mt -61.79 -56.89 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 123.791 0.682 . . . . 70.42 109.873 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' D' ' 125' ' ' GLN . 41.0 m -54.11 -38.69 65.68 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.649 1.18 . . . . 75.14 111.787 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -66.8 -44.01 82.36 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.791 -1.095 . . . . 73.31 110.399 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.5 -29.77 65.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.116 0.566 . . . . 73.24 111.907 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.9 t -68.16 -42.26 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 123.785 0.678 . . . . 73.43 109.336 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -75.63 -28.0 58.65 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.257 -0.429 . . . . 64.02 111.174 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.423 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 94.2 mtt-85 -69.97 -35.74 74.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.509 0.724 . . . . 74.01 109.614 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.53 0.16 77.03 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.794 0.683 . . . . 34.45 112.33 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.62 28.13 16.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.51 1.924 . . . . 72.44 112.677 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.406 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 37.4 m-85 -91.03 162.25 33.18 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.19 1.396 . . . . 73.52 110.683 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.9 133.22 52.25 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.766 2.31 . . . . 75.02 111.853 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.7 tt0 -56.62 137.84 53.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.874 0.869 . . . . 75.33 112.446 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.39 108.95 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.894 -1.151 . . . . 73.22 107.894 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -113.27 110.96 21.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.805 -0.813 . . . . 72.34 108.805 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.467 HD22 HD22 ' D' ' 42' ' ' LEU . 90.5 mt -69.2 135.58 50.8 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.133 0.573 . . . . 62.41 110.279 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.51 146.95 98.81 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.024 0.929 . . . . 64.42 111.42 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -66.7 121.37 8.59 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.638 2.226 . . . . 74.43 111.269 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.74 118.8 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.338 0.655 . . . . 75.52 110.323 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -86.55 78.35 9.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.153 -1.054 . . . . 73.21 108.153 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 74.11 111.333 178.214 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 108.267 -1.012 . . . . 71.53 108.267 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' HG12 ' A' ' 86' ' ' ILE . 19.0 p90 -134.87 117.38 15.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.924 0.89 . . . . 72.0 108.868 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -155.32 138.42 15.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.963 0.505 . . . . 52.52 110.386 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 13' ' ' ILE . 4.1 mp -68.15 116.38 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 72.1 109.319 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.97 -41.67 17.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.013 -0.736 . . . . 61.44 109.013 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.537 HH11 ' HD2' ' B' ' 32' ' ' PHE . 72.0 ttt180 -168.56 140.63 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.502 0.721 . . . . 62.32 109.072 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.24 137.78 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.592 -0.892 . . . . 72.11 108.592 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -173.68 167.71 4.47 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.399 0.619 . . . . 64.34 112.251 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -86.15 123.97 32.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.835 -0.802 . . . . 64.43 108.835 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -86.36 -32.14 21.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.438 0.637 . . . . 62.33 109.523 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.735 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.9 t70 -141.63 140.91 33.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.955 -1.021 . . . . 63.13 110.45 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.4 mt -141.59 145.38 24.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.949 1.7 . . . . 71.42 106.795 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -159.24 130.32 6.09 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.722 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 84.4 t80 -132.11 119.51 21.05 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.353 -1.351 . . . . 64.33 107.353 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -118.59 140.87 49.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.822 -0.807 . . . . 74.32 108.822 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.68 78.66 15.77 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 107.444 -1.317 . . . . 74.4 107.444 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 -29.98 61.88 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.519 2.146 . . . . 73.33 111.726 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 16.1 m120 -117.01 40.71 2.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.879 0.872 . . . . 71.11 109.23 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.16 99.47 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.089 0.956 . . . . 64.13 113.2 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.25 -25.8 18.34 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.573 1.515 . . . . 71.41 112.462 171.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.6 m-70 -77.79 -33.37 52.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.793 -0.639 . . . . 63.1 112.223 -173.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' A' ' 123' ' ' PHE . 11.1 p -64.45 -22.17 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 120.958 0.409 . . . . 73.2 111.501 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -72.94 -29.54 63.18 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 63.42 110.681 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -82.7 -51.43 7.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.33 1.052 . . . . 63.14 110.574 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HE3' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -82.22 133.89 35.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.829 0.852 . . . . 74.33 109.8 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 68' ' ' LEU . 18.7 t70 -56.64 134.57 54.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.048 1.339 . . . . 73.45 113.221 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -71.1 83.06 0.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.546 0.738 . . . . 74.44 112.419 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -137.01 78.87 39.78 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.272 1.029 . . . . 74.24 109.011 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -84.03 133.3 5.68 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.955 2.436 . . . . 64.12 112.389 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.4 116.25 29.26 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.905 -1.146 . . . . 75.23 107.905 171.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.53 119.73 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.309 0.643 . . . . 65.44 110.761 -173.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -110.18 138.44 46.55 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.958 -1.127 . . . . 75.35 107.958 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.06 146.16 52.27 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.31 0.644 . . . . 71.14 111.388 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.85 144.62 50.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.418 1.087 . . . . 43.41 109.382 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -138.27 136.69 36.75 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 62.25 109.182 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 17.4 t70 -158.13 149.29 21.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.786 0.434 . . . . 73.52 110.84 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 m -135.19 126.58 28.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.199 1.0 . . . . 54.34 110.176 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.49 110.26 10.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.073 0.549 . . . . 73.01 110.11 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -88.39 153.25 21.33 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.78 -0.822 . . . . 63.14 108.78 175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -164.88 117.04 1.21 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.213 0.46 . . . . 52.14 110.197 -171.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.84 105.39 3.78 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.828 0.851 . . . . 75.21 110.629 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 57' ' ' GLU . 97.6 mt -77.45 -37.72 50.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.804 0.842 . . . . 62.14 111.635 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -145.63 -174.11 4.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.255 1.022 . . . . 72.42 108.592 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.42 97.42 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.108 0.563 . . . . 62.51 110.519 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 58.71 27.72 16.29 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.722 1.209 . . . . 74.1 112.661 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 86.1 t -103.91 121.09 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.884 -1.524 . . . . 64.22 106.884 165.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.84 130.04 50.59 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.277 -0.638 . . . . 71.4 109.277 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 51' ' ' LEU . 42.2 tt0 -85.86 118.81 25.58 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.008 0.923 . . . . 71.52 108.63 168.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.42 111.8 29.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.396 -1.335 . . . . 65.11 107.396 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.4 t -99.26 130.96 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.501 -0.555 . . . . 51.44 109.501 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -106.79 113.56 27.12 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.579 -0.897 . . . . 75.31 108.579 -174.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -87.45 102.69 14.79 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.973 -0.751 . . . . 73.31 108.973 174.372 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.04 130.34 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.341 -0.985 . . . . 71.34 108.341 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 m -121.18 133.21 55.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.352 -0.981 . . . . 72.35 108.352 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.15 104.61 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.976 -1.12 . . . . 73.1 107.976 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -105.77 146.26 30.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.818 -0.808 . . . . 74.21 108.818 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.53 115.72 13.38 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.645 -1.243 . . . . 72.15 107.645 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -109.26 126.0 52.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.52 -0.548 . . . . 53.13 109.52 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.09 82.7 6.06 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 105.777 -1.935 . . . . 71.21 105.777 176.176 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.7 -127.18 7.83 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.435 -0.802 . . . . 64.12 111.665 -170.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.25 -14.72 30.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.972 0.509 . . . . 74.02 111.093 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -95.03 135.02 37.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.879 0.871 . . . . 75.32 109.511 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -65.34 129.25 39.06 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.01 0.524 . . . . 64.13 111.227 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -77.81 -58.05 3.47 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.093 -1.077 . . . . 64.44 108.093 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -166.91 165.74 15.87 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.641 -1.163 . . . . 73.54 110.437 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -134.73 145.14 48.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.535 1.134 . . . . 65.34 108.792 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.722 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 20.0 m -141.58 98.92 3.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.611 0.764 . . . . 73.23 109.44 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -109.28 129.21 55.52 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.625 -0.509 . . . . 71.43 109.625 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -130.51 132.82 64.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 123.753 0.821 . . . . 72.34 109.325 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.735 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.2 mt-30 -105.74 102.91 12.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.592 -0.731 . . . . 61.14 109.52 169.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -89.77 98.89 12.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.842 -1.072 . . . . 71.23 109.366 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.4 142.14 15.97 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.374 -0.69 . . . . 62.44 111.374 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.52 122.58 2.42 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.929 -0.868 . . . . 72.41 110.929 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -80.91 125.37 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.636 -0.876 . . . . 63.42 108.636 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.8 121.58 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.203 0.601 . . . . 75.04 109.508 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -84.13 103.37 13.29 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.278 -1.008 . . . . 53.14 108.278 171.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.585 HD11 HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.47 124.69 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.48 0.657 . . . . 72.32 109.811 -171.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.29 175.77 13.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.126 0.97 . . . . 63.4 111.045 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.23 -24.97 29.02 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.758 -0.656 . . . . 24.14 113.043 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.585 HD11 HD11 ' A' ' 86' ' ' ILE . 13.6 pt -110.46 168.88 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.23 110.615 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.545 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 24.3 tt0 -150.85 -172.37 4.18 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.576 -1.193 . . . . 63.42 108.507 -171.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.545 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.46 -142.62 46.84 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.03 0.772 . . . . 62.32 115.03 171.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -77.29 -14.39 59.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.086 0.954 . . . . 62.13 111.561 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -47.96 69.9 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.763 0.825 . . . . 73.31 110.015 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ttt -80.64 -35.83 33.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 51.23 111.074 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.44 67.7 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.403 0.621 . . . . 61.13 111.447 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.28 -49.67 70.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.633 -1.167 . . . . 64.23 110.272 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.598 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 5.3 m -68.24 -63.22 1.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.701 1.0 . . . . 42.42 113.701 -170.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -12.35 60.04 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 118.88 0.764 . . . . 72.2 112.415 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.69 -6.07 44.16 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.178 -0.79 . . . . 74.34 114.5 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.19 -57.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 117.873 0.836 . . . . 62.15 111.786 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -55.69 -58.35 8.17 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.576 1.15 . . . . 71.23 112.045 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.96 -41.8 6.97 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 113.314 0.857 . . . . 53.22 113.314 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.9 Cg_endo -66.28 -24.86 50.2 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 121.624 1.55 . . . . 73.42 113.873 169.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -76.47 -22.35 54.66 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.941 0.791 . . . . 53.1 110.21 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mm -67.45 -43.02 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.267 0.627 . . . . 75.24 109.493 166.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.3 mt -71.25 -31.44 67.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.042 -0.981 . . . . 74.51 111.99 -175.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.51 -43.33 84.01 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.819 1.044 . . . . 73.43 113.819 -168.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.82 -31.79 82.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.276 1.984 . . . . 62.43 113.835 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -83.38 -28.78 28.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.186 0.594 . . . . 65.02 111.863 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.99 77.49 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.296 -0.631 . . . . 45.25 109.296 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.462 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.2 ttm180 -65.84 -38.35 88.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.524 -1.216 . . . . 73.44 110.327 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -53.51 -54.21 40.47 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.215 1.006 . . . . 75.22 110.247 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -61.85 -50.96 70.15 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.936 -1.484 . . . . 71.22 111.24 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 118' ' ' VAL . 17.7 mt -62.41 -58.9 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.703 0.801 . . . . 60.11 111.371 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -54.49 -38.58 66.61 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.871 0.732 . . . . 43.31 111.088 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.5 t -65.88 -45.89 80.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.496 -0.775 . . . . 42.05 110.285 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.5 mtp -57.15 -41.83 79.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.595 0.758 . . . . 42.42 111.31 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.2 t -60.45 -47.67 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.901 0.881 . . . . 64.31 110.233 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.663 -0.699 . . . . 64.25 111.585 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -74.62 -30.53 61.69 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.738 0.815 . . . . 73.54 109.747 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.48 2.37 67.48 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.519 -0.764 . . . . 65.5 112.569 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 68.27 22.31 8.14 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.874 1.27 . . . . 63.41 110.552 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.411 ' HE1' HG11 ' A' ' 31' ' ' VAL . 24.6 m-85 -96.5 153.27 38.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.823 0.849 . . . . 74.42 110.288 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 123.73 14.54 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.652 2.235 . . . . 61.53 111.075 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.75 147.44 27.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 124.036 0.835 . . . . 62.12 111.747 -171.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.0 mt -111.95 105.77 14.28 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.717 -0.846 . . . . 62.34 108.717 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.13 93.05 6.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.535 -0.913 . . . . 63.05 108.535 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.07 127.7 33.57 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.443 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 137.56 94.75 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.544 0.738 . . . . 75.03 111.58 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.434 ' HB3' HH22 ' A' ' 111' ' ' ARG . 34.1 Cg_endo -83.83 145.92 11.56 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.594 2.196 . . . . 61.21 113.02 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 114.21 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.636 -0.876 . . . . 60.44 108.636 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -85.4 75.21 10.25 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.691 0.758 . . . . 64.41 110.008 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -68.89 -28.31 66.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.591 -1.186 . . . . 74.23 109.895 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 115.205 -0.907 . . . . 75.44 110.402 175.584 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.3 ptm . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 114.17 1.174 . . . . 74.4 114.17 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.0 m -152.42 125.58 8.62 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.136 0.974 . . . . 52.02 108.604 171.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -136.24 127.87 28.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.37 -0.604 . . . . 61.33 109.37 163.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -158.02 141.53 15.38 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.998 -1.112 . . . . 74.11 107.998 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.28 123.14 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 170.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -83.29 -50.6 8.22 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.083 -0.34 . . . . 74.43 110.083 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.31 130.48 1.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.113 -0.494 . . . . 72.42 109.817 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' B' ' 109' ' ' TYR . 92.3 mt -114.22 146.04 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.651 -0.87 . . . . 70.01 108.651 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -163.49 155.41 17.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.413 0.625 . . . . 74.44 111.494 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.6 m -78.26 126.17 30.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.007 -0.997 . . . . 75.12 108.625 170.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.506 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.3 mtpt -98.18 -32.6 11.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.57 0.748 . . . . 74.14 111.175 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.3 t70 -155.8 139.9 16.46 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.07 -0.514 . . . . 70.12 111.523 -167.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.8 mm -147.14 145.69 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.658 1.583 . . . . 64.3 108.355 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.92 151.98 32.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.718 -0.845 . . . . 73.31 108.718 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -147.58 115.48 6.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.853 -1.536 . . . . 74.22 106.853 173.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.6 121.97 42.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.7 -0.852 . . . . 54.12 108.7 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.866 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -125.47 80.61 65.49 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.853 -1.166 . . . . 54.25 107.853 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.09 -45.63 0.64 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.55 2.167 . . . . 60.53 111.693 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -98.8 18.65 16.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.699 0.8 . . . . 73.21 110.743 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.866 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.11 -50.53 54.65 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 125.213 1.405 . . . . 60.43 114.239 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -20.77 25.9 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.879 1.72 . . . . 74.33 112.593 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -91.0 -28.37 18.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.769 0.828 . . . . 71.01 110.868 -173.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.01 -8.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.424 0.689 . . . . 55.41 110.256 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' PHE . . . . . 0.537 ' HD2' HH11 ' A' ' 15' ' ' ARG . 75.9 t80 -56.72 -33.94 66.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.929 1.292 . . . . 64.33 110.81 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -71.8 -29.52 64.54 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.037 -0.983 . . . . 64.53 111.27 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.447 ' HD3' HD22 ' B' ' 68' ' ' LEU . 95.6 mttt -94.89 110.21 22.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.448 0.699 . . . . 73.11 111.086 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.22 81.72 1.86 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.455 -0.942 . . . . 71.51 108.455 171.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.792 ' HB2' HD21 ' B' ' 68' ' ' LEU . 51.0 m95 -149.94 178.07 9.27 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.461 1.104 . . . . 71.0 108.457 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -78.04 127.36 81.84 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.43 0.692 . . . . 74.23 110.026 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' B' ' 68' ' ' LEU . 72.6 Cg_endo -77.86 146.83 23.77 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.946 1.764 . . . . 65.33 112.212 168.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.75 103.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.061 0.945 . . . . 73.42 108.932 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -86.62 129.98 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.541 0.736 . . . . 73.42 109.493 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.607 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.1 tttm -136.14 128.48 30.17 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.419 -0.956 . . . . 70.41 108.419 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.02 153.87 26.2 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.646 -0.872 . . . . 75.12 108.646 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.607 -0.886 . . . . 75.35 108.607 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.72 138.2 40.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.891 0.876 . . . . 74.34 109.014 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.2 t70 -144.79 152.7 40.74 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.02 1.328 . . . . 73.51 108.308 -174.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.9 t -151.33 140.46 21.2 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.312 0.645 . . . . 71.15 109.381 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.68 124.47 17.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.8 -1.185 . . . . 53.42 107.8 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -97.29 160.99 14.01 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.686 -0.487 . . . . 75.31 109.686 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 57' ' ' GLU . 32.7 t -149.41 155.37 40.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.006 -1.109 . . . . 62.11 108.006 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -124.78 129.17 49.94 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.364 0.665 . . . . 75.14 109.692 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.87 -45.06 10.02 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.324 0.649 . . . . 65.12 109.641 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.12 -176.09 5.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.295 -0.866 . . . . 71.41 110.093 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -61.9 125.96 25.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.0 -1.0 . . . . 62.01 109.055 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.36 2.85 3.47 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.134 1.374 . . . . 64.51 112.762 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 t -120.32 96.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.607 -0.886 . . . . 73.31 108.607 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.22 165.16 11.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.995 0.518 . . . . 44.35 110.159 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' B' ' 49' ' ' SER . 6.3 tm-20 -142.97 95.44 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.288 -1.745 . . . . 74.22 106.288 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.9 131.23 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.303 -0.628 . . . . 44.55 109.303 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.7 t -106.13 151.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.942 0.897 . . . . 75.32 109.952 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.18 119.49 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.087 -1.449 . . . . 72.21 107.087 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.607 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 38.3 ttp180 -105.96 120.98 43.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.872 0.368 . . . . 74.23 110.846 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' B' ' 114' ' ' ILE . 23.5 t -108.06 128.15 63.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.927 -1.138 . . . . 73.0 107.927 168.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -120.78 130.28 53.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.378 -0.601 . . . . 73.04 109.378 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.495 HG23 HD13 ' B' ' 114' ' ' ILE . 98.7 t -118.22 134.14 62.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.276 -0.875 . . . . 74.41 109.055 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 98.6 m -125.58 137.65 53.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.901 -1.045 . . . . 64.45 108.489 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.73 125.36 19.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.508 -1.293 . . . . 74.21 107.508 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 p -136.46 123.44 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.286 -1.005 . . . . 74.11 108.286 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' B' ' 36' ' ' TRP . 3.2 tt -95.61 116.18 28.48 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.48 -0.933 . . . . 73.32 108.48 -172.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -114.06 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 124.11 0.881 . . . . 43.52 111.517 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.48 4.73 15.34 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.182 0.993 . . . . 71.51 111.637 -175.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 12.2 pt-20 -129.62 163.89 25.07 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.317 0.647 . . . . 74.31 110.023 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 12.6 m -67.21 148.59 51.57 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.446 0.466 . . . . 61.14 110.66 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.93 -56.83 2.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.578 0.751 . . . . 64.12 109.024 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -165.36 153.67 11.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.139 -0.937 . . . . 74.12 110.235 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -131.43 144.56 51.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 75.14 108.13 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 40.2 t -151.57 152.27 32.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.559 -0.534 . . . . 73.44 109.559 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -158.36 129.6 6.48 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.21 0.604 . . . . 74.32 109.416 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.454 HG22 ' CD1' ' B' ' 21' ' ' ILE . 82.7 t -124.56 148.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.812 0.845 . . . . 72.41 109.985 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.607 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 41.7 mt-30 -125.69 98.45 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.23 -1.026 . . . . 63.11 108.23 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.9 tp-100 -85.89 104.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.839 -0.619 . . . . 74.23 109.429 174.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.74 168.47 25.01 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 111.544 -0.622 . . . . 71.13 111.544 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.47 130.76 2.2 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.466 -0.397 . . . . 71.42 112.97 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -84.14 128.92 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.147 0.979 . . . . 71.21 109.018 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.61 140.85 44.91 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.34 1.056 . . . . 63.3 109.759 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -87.49 107.6 18.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.211 1.004 . . . . 73.42 109.032 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.412 HG13 HD21 ' B' ' 98' ' ' LEU . 17.6 mm -122.77 121.8 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.673 0.789 . . . . 64.43 110.478 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.36 167.68 29.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.074 0.55 . . . . 54.24 110.987 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 85.62 -45.19 3.45 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.97 -0.559 . . . . 65.21 113.398 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.411 HG21 ' HB2' ' B' ' 97' ' ' CYS . 41.2 mm -74.36 138.49 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.663 0.785 . . . . 61.15 109.763 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.03 -172.43 4.03 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.809 0.843 . . . . 75.04 111.149 -176.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.28 -113.52 5.98 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.742 0.651 . . . . 53.42 113.981 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -88.29 -35.6 17.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.723 0.809 . . . . 61.33 110.59 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -71.2 -18.98 62.45 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.096 -0.956 . . . . 74.41 111.599 -168.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ptp -56.12 -28.78 59.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.992 0.917 . . . . 73.32 112.097 173.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.25 87.61 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.101 0.96 . . . . 65.4 112.358 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -88.99 -27.53 20.82 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.367 -0.833 . . . . 71.21 111.218 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' CYS . . . . . 0.411 ' HB2' HG21 ' B' ' 89' ' ' ILE . 48.6 t -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.624 0.369 . . . . 64.14 111.821 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.412 HD21 HG13 ' B' ' 86' ' ' ILE . 77.4 mt -102.49 -35.08 8.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.749 0.42 . . . . 72.21 111.976 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.8 -23.25 53.53 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 120.029 -0.317 . . . . 72.15 113.842 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.35 -46.75 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.145 0.473 . . . . 51.04 112.047 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -77.1 -48.57 17.4 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.372 0.669 . . . . 74.45 110.796 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.2 m -60.72 -49.98 87.25 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.682 -0.675 . . . . 64.33 111.6 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.9 Cg_exo -56.77 -30.77 85.96 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.6 2.2 . . . . 71.04 114.496 171.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -63.36 -32.64 74.12 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.08 0.467 . . . . 64.43 110.965 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.2 mt -74.17 -44.54 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.864 0.866 . . . . 33.21 110.582 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' B' ' 80' ' ' GLN . 96.3 mt -72.36 -29.99 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.726 -1.125 . . . . 64.02 112.397 -172.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 80.5 t80 -59.93 -46.1 98.18 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 113.901 1.074 . . . . 71.2 113.901 -168.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.62 -41.75 72.51 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.233 1.955 . . . . 73.14 113.113 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.452 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.0 m-30 -64.26 -39.42 93.9 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.907 -1.042 . . . . 75.05 109.991 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.53 82.93 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.881 0.872 . . . . 74.4 110.961 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -57.23 -58.96 5.95 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.411 1.084 . . . . 73.22 111.752 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 -25.39 63.66 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.199 0.312 . . . . 64.31 110.267 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.435 ' O ' ' HG2' ' B' ' 117' ' ' MET . 13.4 t -70.2 -30.32 67.39 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.929 0.492 . . . . 51.21 111.626 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.495 HD13 HG23 ' B' ' 64' ' ' VAL . 88.6 mt -72.26 -55.92 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.082 0.553 . . . . 70.25 109.662 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.5 m -60.84 -27.98 68.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.54 -1.209 . . . . 73.54 111.411 -172.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.43 -46.02 84.99 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.915 0.886 . . . . 73.21 110.375 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.0 mmt -68.32 -31.3 70.63 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.095 0.558 . . . . 75.11 110.702 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.05 -38.96 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.956 0.902 . . . . 75.34 110.279 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.0 m -66.31 -37.74 86.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.726 0.81 . . . . 61.13 110.99 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -65.02 -38.8 92.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.275 -0.875 . . . . 75.23 109.351 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.35 -0.51 72.12 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 124.057 0.848 . . . . 64.25 113.877 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 55.39 36.26 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.596 1.558 . . . . 72.05 112.309 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -104.86 157.12 34.89 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.609 1.163 . . . . 62.43 110.282 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 129.39 33.87 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.119 2.546 . . . . 60.32 112.508 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -60.4 130.58 47.31 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.913 0.885 . . . . 62.53 112.514 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 90.2 mt -118.97 99.89 7.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.396 -0.965 . . . . 74.21 108.396 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ASN . . . . . 0.429 HD22 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -95.19 131.07 41.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.398 0.679 . . . . 73.23 109.469 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.456 ' HB3' ' CZ ' ' B' ' 107' ' ' PHE . 2.1 mm? -76.16 139.06 41.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.351 0.661 . . . . 71.01 110.922 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.38 141.44 45.8 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.027 0.931 . . . . 54.11 111.41 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.71 100.12 0.41 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.896 2.397 . . . . 70.34 112.46 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.87 133.36 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.759 0.824 . . . . 74.4 109.366 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.52 108.55 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.565 0.746 . . . . 64.43 111.219 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -59.95 -35.86 75.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.298 1.039 . . . . 72.04 110.167 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -56.69 14.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.228 -1.351 . . . . 75.04 111.954 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.74 68.84 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.625 0.77 . . . . 74.51 111.51 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 CA--C 1.55 0.96 0 C-N-CA 124.268 1.027 . . . . 64.11 110.613 176.347 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.336 0.589 . . . . 73.53 112.229 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 25.9 m -85.76 95.45 9.41 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.441 -0.948 . . . . 50.33 108.441 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -119.66 131.86 55.54 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.393 -1.276 . . . . 70.42 108.702 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -151.68 141.72 22.15 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.245 -0.65 . . . . 71.44 109.245 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.9 mt -76.49 116.34 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.525 -0.917 . . . . 71.55 108.525 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -88.33 -49.64 6.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.987 0.515 . . . . 64.0 110.217 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -159.13 138.8 11.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.96 -0.564 . . . . 62.04 109.48 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.84 135.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.1 -1.074 . . . . 54.31 108.1 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -171.57 158.22 5.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.514 0.674 . . . . 63.53 112.152 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -83.99 111.2 19.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.894 -1.048 . . . . 72.03 108.934 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -79.26 -46.68 17.3 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.717 0.77 . . . . 71.22 109.255 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.8 t70 -133.66 137.38 45.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.687 -1.142 . . . . 74.33 108.728 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -142.27 141.64 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.245 1.418 . . . . 64.23 107.379 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -155.24 143.14 19.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.811 -0.44 . . . . 72.52 109.811 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -142.64 141.95 31.99 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 107.54 -1.281 . . . . 72.43 107.54 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -140.08 142.6 36.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.563 -1.273 . . . . 71.02 107.563 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' D' ' 19' ' ' LYS . . . -142.15 84.28 11.72 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 108.86 -0.793 . . . . 73.25 108.86 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.59 -39.46 15.96 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.909 2.406 . . . . 60.4 112.212 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 88.4 m-20 -111.87 44.75 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.77 0.828 . . . . 63.33 109.658 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -56.41 -57.9 20.22 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.435 1.094 . . . . 54.14 113.709 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.3 Cg_exo -72.52 -26.54 16.63 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 122.013 1.809 . . . . 63.43 112.009 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.569 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.5 t60 -67.11 -21.73 65.84 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.298 1.439 . . . . 64.54 111.463 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.433 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.6 p -54.53 -24.1 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.15 0.58 . . . . 62.3 112.538 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -63.5 -40.75 97.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.296 1.038 . . . . 74.02 111.527 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.0 pt20 -90.14 5.29 47.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.646 0.379 . . . . 74.15 111.043 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 73' ' ' ALA . 4.7 ttpm? -100.74 146.76 26.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.097 0.959 . . . . 73.12 109.918 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -85.54 134.55 34.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.661 0.784 . . . . 74.33 109.185 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -69.22 71.29 0.26 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.406 1.083 . . . . 64.3 112.382 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -137.65 74.84 45.12 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 108.04 -1.096 . . . . 71.51 108.04 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.42 113.59 3.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.154 1.903 . . . . 63.44 109.591 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.56 83.79 7.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 105.021 -2.214 . . . . 63.34 105.021 174.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.607 HG11 HD11 ' C' ' 126' ' ' LEU . 31.9 m -71.7 128.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-N 115.215 -0.902 . . . . 72.22 111.824 -166.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -92.98 103.65 15.95 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.586 -1.635 . . . . 74.42 106.586 172.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -93.12 151.68 19.71 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.515 -0.766 . . . . 75.23 109.602 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 45.2 t0 -158.15 147.38 19.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.276 -0.875 . . . . 72.21 108.979 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 148.87 49.35 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 53.4 109.381 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.428 ' O ' HD23 ' C' ' 60' ' ' LEU . 12.0 m-20 -150.34 161.37 42.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.484 1.114 . . . . 74.41 108.904 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -138.71 154.23 48.56 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.125 -0.695 . . . . 73.5 109.125 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.65 151.43 43.06 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.576 -0.527 . . . . 53.04 109.576 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -123.58 143.52 50.16 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.365 0.666 . . . . 62.33 110.171 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -153.13 126.41 8.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.878 0.871 . . . . 72.23 108.701 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -82.61 127.0 32.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.239 -0.652 . . . . 62.42 109.239 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.659 HD11 HD12 ' C' ' 83' ' ' ILE . 59.9 mt -89.59 -42.05 11.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.209 0.604 . . . . 64.12 110.123 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.8 -174.37 4.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.471 0.708 . . . . 71.24 110.621 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.26 114.32 2.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.884 -1.053 . . . . 75.05 109.761 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 69.43 -4.59 1.31 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.196 1.399 . . . . 74.42 112.956 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.46 114.11 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.846 -0.798 . . . . 73.34 108.846 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -126.52 158.83 35.1 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.529 0.732 . . . . 73.21 109.962 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.78 138.36 53.84 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.308 1.043 . . . . 73.43 108.818 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.35 137.81 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.071 -1.085 . . . . 60.52 108.071 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.35 109.35 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.902 -0.777 . . . . 65.23 108.902 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.428 HD23 ' O ' ' C' ' 45' ' ' ASP . 0.7 OUTLIER -87.47 102.92 15.03 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.182 -1.044 . . . . 61.05 108.182 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.601 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 18.7 ttp85 -82.79 106.58 14.74 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.936 -0.764 . . . . 70.22 108.936 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.5 t -99.68 132.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.682 -0.858 . . . . 75.25 108.682 173.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 55.2 m -115.18 130.51 56.94 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.827 0.851 . . . . 72.4 109.156 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.498 HG11 ' HG ' ' C' ' 126' ' ' LEU . 78.1 t -122.13 134.24 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.186 -1.37 . . . . 71.41 107.918 172.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -123.86 143.15 50.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.342 -1.355 . . . . 54.51 107.342 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.0 106.86 8.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.689 -1.226 . . . . 62.41 107.689 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -154.75 158.26 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.69 . . . . 74.13 110.079 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 tp -123.84 78.87 1.66 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.726 -1.953 . . . . 71.41 105.726 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.42 -119.78 4.96 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 115.71 -0.677 . . . . 55.42 112.231 -173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.28 -20.84 26.28 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.625 0.77 . . . . 62.42 109.669 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.488 ' HG3' ' HD3' ' C' ' 34' ' ' LYS . 16.0 tp10 -71.42 86.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.512 1.125 . . . . 71.24 109.446 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 36.0 m -84.75 121.77 28.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.253 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.512 ' HB2' ' HE3' ' C' ' 34' ' ' LYS . . . -71.86 -55.51 7.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.165 -1.05 . . . . 61.31 108.165 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -162.86 173.27 13.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.808 -1.087 . . . . 72.3 111.423 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.92 143.52 45.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.759 -1.571 . . . . 74.22 106.759 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -149.45 130.43 14.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.693 0.397 . . . . 73.44 110.338 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -131.71 133.28 44.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.671 -0.863 . . . . 72.22 108.671 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -129.52 138.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.687 0.795 . . . . 71.44 108.914 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.601 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.1 mt-30 -113.23 98.59 7.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.585 -0.894 . . . . 74.24 108.585 173.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -84.87 103.84 14.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.361 -0.836 . . . . 70.2 109.688 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.13 148.78 21.65 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.887 -0.485 . . . . 74.15 111.887 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.34 121.32 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.688 -0.565 . . . . 61.23 111.688 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.659 HD12 HD11 ' C' ' 51' ' ' LEU . 8.5 mm -85.66 126.89 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.647 -0.872 . . . . 63.32 108.647 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -135.35 134.72 40.1 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.814 0.846 . . . . 73.43 109.473 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.6 p -81.18 116.57 21.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.414 -0.588 . . . . 74.03 109.414 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.44 111.4 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 54.41 108.511 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.51 169.61 19.2 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 50.02 110.339 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.07 -58.36 3.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.447 -0.661 . . . . 71.32 111.447 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.14 166.33 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 61.22 108.668 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.99 156.18 44.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.543 0.737 . . . . 73.22 110.537 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.39 -148.0 44.88 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.47 0.481 . . . . 14.44 114.155 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' THR . . . . . 0.593 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 32.4 p -69.38 -18.26 63.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.679 0.792 . . . . 73.35 112.098 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.7 -42.47 97.98 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.205 0.602 . . . . 71.03 110.285 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -82.92 -26.33 31.56 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.569 0.348 . . . . 74.22 110.884 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 95' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -68.16 -22.05 64.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.666 0.786 . . . . 74.41 111.577 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -53.41 -48.75 68.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.934 0.494 . . . . 73.34 110.763 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -65.17 -47.63 76.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.714 -0.676 . . . . 62.41 110.162 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.32 -32.84 74.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.599 0.76 . . . . 74.0 110.925 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.8 -5.32 61.31 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-O 119.572 -0.571 . . . . 63.04 114.251 -171.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.53 -63.17 0.51 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.658 0.729 . . . . 72.22 111.243 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -62.93 -47.64 82.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.035 0.534 . . . . 72.1 112.419 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.69 -42.76 36.88 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.642 -0.695 . . . . 71.45 112.281 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.43 -38.91 89.59 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.266 1.977 . . . . 54.11 113.248 166.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.29 -29.16 70.53 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.973 0.509 . . . . 74.24 111.62 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.462 HD12 ' NH1' ' A' ' 111' ' ' ARG . 38.0 mm -69.9 -41.47 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.139 0.575 . . . . 60.02 110.052 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.542 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -75.8 -25.3 56.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.208 -0.905 . . . . 71.3 111.924 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -56.88 -46.25 99.88 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.596 1.158 . . . . 73.54 113.852 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.63 -40.24 85.09 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.359 2.04 . . . . 73.2 114.074 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.437 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 57.1 m-85 -71.24 -39.99 71.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.811 0.445 . . . . 74.41 110.34 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.2 94.66 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.489 -0.778 . . . . 74.31 110.546 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -59.27 -54.33 48.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.248 1.019 . . . . 64.45 109.91 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -62.33 -35.01 77.74 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.043 0.839 . . . . 60.12 111.1 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 26.1 t -71.24 -36.84 71.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.307 0.643 . . . . 71.42 110.973 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.469 ' O ' HG23 ' C' ' 118' ' ' VAL . 77.8 mt -72.19 -50.1 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.4 -0.593 . . . . 70.35 109.4 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 78.6 m -57.19 -33.59 67.63 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.338 1.055 . . . . 73.21 110.793 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -64.52 -54.41 32.77 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 115.352 -0.84 . . . . 74.13 108.74 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.32 -40.16 70.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.808 1.243 . . . . 71.54 112.76 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.1 t -64.62 -48.44 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.803 0.841 . . . . 71.24 109.411 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.4 t -66.98 -28.06 67.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.606 -1.179 . . . . 71.41 111.335 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.4 HH12 ' CD ' ' D' ' 112' ' ' GLU . 77.1 mtt-85 -70.67 -37.38 73.66 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 123.738 0.815 . . . . 62.52 109.271 176.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.34 3.28 73.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.912 0.757 . . . . 74.21 113.363 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.449 HG23 ' HB3' ' D' ' 17' ' ' TYR . 66.0 p 60.28 28.45 18.06 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.036 1.734 . . . . 73.04 112.731 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -97.46 161.76 24.86 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.545 1.138 . . . . 74.25 111.07 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.37 119.3 6.47 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.342 2.695 . . . . 70.41 112.384 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -62.13 146.88 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.556 1.142 . . . . 54.42 113.416 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.607 HD11 HG11 ' C' ' 40' ' ' VAL . 4.4 mm? -106.85 95.12 5.5 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.069 0.948 . . . . 65.5 108.958 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -90.35 90.83 8.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.73 126.18 29.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.909 -1.041 . . . . 75.11 110.807 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.67 156.12 86.86 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.091 0.956 . . . . 65.53 111.292 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.86 124.74 11.77 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.177 1.918 . . . . 72.32 111.851 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.96 138.01 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.041 0.537 . . . . 70.25 109.556 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -88.1 61.5 6.33 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.904 0.859 . . . . 65.33 110.234 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.98 -32.22 70.31 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.851 -1.068 . . . . 74.32 111.149 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 122.71 0.404 . . . . 72.3 110.054 175.292 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 9' ' ' MET . . . . . 0.559 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.6 ptm . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.28 0.844 . . . . 73.42 113.28 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 40.0 m -128.64 146.63 50.81 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.926 -0.768 . . . . 74.25 108.926 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.476 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 49.9 t80 -155.93 102.44 2.17 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.483 -1.303 . . . . 73.23 107.483 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.23 139.99 53.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.062 0.545 . . . . 64.32 110.027 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.58 110.2 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.194 0.998 . . . . 62.41 108.97 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -89.26 -47.43 8.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.04 0.136 . . . . 74.12 111.357 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.23 119.74 0.7 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 119.423 -0.323 . . . . 71.13 110.341 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.22 136.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.215 -1.031 . . . . 73.2 108.215 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.449 ' HB3' HG23 ' C' ' 122' ' ' THR . 40.0 p90 -165.99 174.32 9.57 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.637 0.732 . . . . 65.11 111.769 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -101.73 128.12 48.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.388 -0.823 . . . . 73.1 109.088 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.3 mtpt -98.46 -16.49 19.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.873 0.469 . . . . 63.01 110.244 176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -161.2 141.88 11.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.277 1.031 . . . . 71.42 109.496 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.9 mt -144.49 145.22 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.426 . . . . 71.34 107.676 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -148.25 144.05 27.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.872 0.869 . . . . 74.0 109.631 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -152.7 127.1 9.28 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.774 -1.565 . . . . 74.11 106.774 172.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.4 mt-10 -133.61 120.81 21.18 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.434 0.693 . . . . 63.33 109.481 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -130.14 83.88 61.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.368 -0.975 . . . . 73.23 108.368 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.62 -50.47 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.083 2.522 . . . . 62.11 111.725 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.511 ' O ' HG23 ' D' ' 31' ' ' VAL . 11.8 m120 -89.34 31.8 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.183 0.993 . . . . 70.24 109.765 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -58.41 -48.73 96.43 Favored Pre-proline 0 CA--C 1.561 1.4 0 N-CA-C 114.736 1.384 . . . . 75.51 114.736 -170.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.19 -7.09 12.06 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.595 1.53 . . . . 71.22 112.558 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -83.78 -36.31 23.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.878 1.271 . . . . 74.05 110.123 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' D' ' 73' ' ' ALA . 92.0 t -69.43 -25.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.544 0.738 . . . . 53.41 110.207 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.23 -24.53 64.93 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.21 1.004 . . . . 51.54 111.974 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -81.54 -14.16 57.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.753 0.821 . . . . 74.0 112.209 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -121.33 110.72 16.45 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.999 0.919 . . . . 62.21 109.818 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 91.85 8.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.879 0.871 . . . . 72.4 110.621 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.656 ' HB3' HD11 ' D' ' 68' ' ' LEU . 38.6 t-105 -168.23 163.98 13.17 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.87 116.15 65.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.302 0.641 . . . . 42.2 110.455 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.417 ' HG3' ' HB2' ' D' ' 68' ' ' LEU . 85.7 Cg_exo -47.35 149.03 4.46 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 124.855 3.703 . . . . 60.12 116.078 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 60.8 mm-40 -64.89 112.09 3.13 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.734 -0.839 . . . . 53.33 108.734 169.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' D' ' 66' ' ' ALA . 76.6 t -109.37 117.15 53.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.457 0.646 . . . . 61.53 110.801 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.74 147.65 23.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.497 -1.229 . . . . 61.25 108.074 164.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.42 HD13 ' H ' ' D' ' 42' ' ' LEU . 0.0 OUTLIER -128.42 154.96 45.49 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.079 -1.082 . . . . 63.43 108.079 176.245 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.2 t70 -150.43 155.84 40.31 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.38 0.672 . . . . 74.13 109.395 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -134.9 139.69 45.19 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.053 -0.721 . . . . 75.5 109.053 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.49 132.12 25.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 55.43 106.968 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -104.25 163.46 12.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.455 0.57 . . . . 75.2 110.754 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -160.92 172.42 16.97 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.068 0.947 . . . . 62.12 109.422 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.6 p -166.97 178.29 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.027 0.531 . . . . 65.44 111.138 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -169.89 118.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.979 1.312 . . . . 55.41 108.114 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -79.53 122.22 26.2 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.785 -0.45 . . . . 71.13 109.785 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.11 -36.62 14.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.215 0.606 . . . . 73.42 109.88 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.45 -176.54 4.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.968 0.907 . . . . 73.31 110.721 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.39 122.49 16.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.956 -1.02 . . . . 75.22 109.165 175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 65.89 1.24 1.78 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.027 1.331 . . . . 71.53 113.044 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.13 116.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.88 -0.785 . . . . 55.34 108.88 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.93 162.58 24.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.218 -1.03 . . . . 74.45 108.218 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -131.18 131.93 44.38 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 105.736 -1.95 . . . . 74.45 105.736 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.61 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.625 -0.88 . . . . 75.44 108.625 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 58.5 t -116.95 138.58 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.521 0.728 . . . . 73.1 109.688 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -118.35 118.12 30.91 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.638 -1.245 . . . . 43.23 107.638 177.184 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.0 ttm-85 -99.24 103.22 15.06 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.287 1.035 . . . . 65.14 108.323 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.09 124.95 50.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.511 -0.922 . . . . 72.32 108.511 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.9 m -108.96 145.39 35.55 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.65 0.594 . . . . 72.54 110.066 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.27 133.39 52.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.843 1.257 . . . . 73.02 108.544 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 46.3 m -127.69 115.63 19.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.152 -1.055 . . . . 74.43 108.152 172.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -124.81 130.57 52.65 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.032 0.533 . . . . 54.54 109.935 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.2 m -142.08 130.08 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.756 0.822 . . . . 72.24 108.95 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' D' ' 36' ' ' TRP . 23.6 tp -105.35 108.21 19.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.879 -0.786 . . . . 65.32 108.879 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.44 -110.41 3.35 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.879 -0.888 . . . . 61.23 110.879 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.89 7.49 9.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 63.11 110.191 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.68 147.86 42.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.191 0.596 . . . . 73.34 111.162 -175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 100.0 m -65.54 115.12 5.42 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.78 0.675 . . . . 61.5 109.978 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.665 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.89 -63.98 1.26 Allowed 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.604 0.565 . . . . 74.23 110.35 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -156.13 139.03 15.31 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.567 -0.742 . . . . 70.32 109.794 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 66.9 mt -109.0 149.7 28.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.448 -1.316 . . . . 74.31 107.448 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.6 t -158.39 139.33 13.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.654 -0.212 . . . . 65.42 110.578 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -154.84 123.21 5.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.733 0.413 . . . . 60.43 109.954 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -123.8 117.6 51.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.443 0.697 . . . . 63.33 109.833 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.728 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.3 mt-30 -93.94 88.17 5.63 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.581 0.705 . . . . 71.25 109.266 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.451 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.69 108.26 13.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.245 -1.343 . . . . 72.43 109.209 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.23 172.83 32.32 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.154 0.308 . . . . 63.23 112.394 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.25 138.32 4.57 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 111.822 -0.511 . . . . 64.23 111.822 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.7 mt -90.56 120.74 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.066 -0.716 . . . . 65.3 109.066 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -125.47 125.65 43.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.608 1.163 . . . . 71.14 109.226 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.9 m -82.42 95.38 7.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.99 -0.744 . . . . 71.41 108.99 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.56 115.74 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.921 -0.77 . . . . 45.31 108.921 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.49 168.35 19.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.823 0.849 . . . . 65.05 110.698 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 88' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.5 -2.13 48.2 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.845 0.716 . . . . 61.23 114.676 173.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -135.51 157.31 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.327 1.051 . . . . 64.21 109.141 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.42 173.11 12.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.628 0.771 . . . . 64.03 111.098 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.49 -121.78 21.76 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.984 0.754 . . . . 50.02 114.984 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -68.85 -18.78 64.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.717 0.807 . . . . 75.21 112.654 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -75.27 -48.53 22.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.22 0.608 . . . . 74.24 110.287 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -75.04 -25.78 58.96 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 116.678 -0.237 . . . . 63.42 110.379 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.42 75.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.38 0.672 . . . . 62.41 110.495 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.63 -36.35 82.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.881 0.872 . . . . 74.32 110.552 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 97' ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 91.0 m -67.56 -54.08 22.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.254 0.346 . . . . 74.4 111.04 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.62 -19.69 60.79 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 122.327 -0.233 . . . . 54.15 111.597 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.48 -27.2 10.06 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.298 -0.723 . . . . 74.11 114.175 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 -51.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.959 0.88 . . . . 72.52 112.891 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 101' ' ' TYR . . . . . 0.543 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 49.2 t80 -73.33 -55.19 6.73 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.752 0.649 . . . . 72.35 112.752 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.476 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 58.3 m -60.46 -44.64 96.3 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 118.517 -0.754 . . . . 62.43 111.676 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.56 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.0 Cg_exo -53.02 -35.69 72.95 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.492 2.128 . . . . 61.23 114.046 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -66.15 -39.67 89.98 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.572 0.749 . . . . 71.52 109.721 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -63.7 -41.03 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.497 0.719 . . . . 73.3 110.079 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.451 HD13 ' O ' ' D' ' 80' ' ' GLN . 91.8 mt -75.43 -24.43 57.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.076 -0.965 . . . . 64.24 112.14 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -62.84 -42.49 78.34 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 117.881 -1.056 . . . . 35.51 113.697 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.29 -38.82 73.17 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 121.923 1.748 . . . . 75.2 113.59 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.55 -32.14 28.75 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.637 0.775 . . . . 71.23 111.831 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.75 74.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.236 0.614 . . . . 64.31 109.807 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 35.0 ttp180 -61.07 -45.9 92.87 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 124.338 1.024 . . . . 72.24 110.282 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.7 tm-20 -55.26 -50.25 69.99 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.539 1.149 . . . . 75.24 111.694 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' D' ' 21' ' ' ILE . 42.0 t -60.97 -40.98 95.45 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.249 0.968 . . . . 33.41 111.217 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.626 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -60.19 -55.9 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.369 0.668 . . . . 61.23 110.204 173.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.2 m -53.51 -40.66 65.61 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.117 1.367 . . . . 73.11 110.65 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.3 t -69.51 -47.87 62.42 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.412 -1.267 . . . . 62.21 110.954 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.0 mtm -67.08 -30.95 71.13 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.078 0.399 . . . . 75.45 112.078 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -67.39 -46.06 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 123.557 0.535 . . . . 61.24 109.868 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -71.18 -25.28 62.46 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.477 -0.329 . . . . 54.2 110.757 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -75.69 -33.71 60.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.966 0.906 . . . . 74.52 109.511 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.56 1.05 67.88 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.552 -0.749 . . . . 61.15 112.537 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.5 p 56.04 40.44 30.31 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.265 1.826 . . . . 71.22 112.106 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 58.4 m-85 -103.68 169.68 7.06 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 125.075 1.35 . . . . 73.11 108.172 171.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 34.6 Cg_endo -62.92 138.92 71.08 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.899 1.732 . . . . 75.54 109.864 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -63.36 156.01 27.13 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.425 0.557 . . . . 75.2 111.176 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.85 115.11 24.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.128 -1.064 . . . . 64.22 108.128 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -107.78 92.96 4.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.474 0.71 . . . . 74.42 109.642 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.448 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 68.9 mt -67.17 117.24 8.93 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.848 -0.614 . . . . 74.22 109.543 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 133.13 94.31 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 122.359 0.263 . . . . 74.23 110.494 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.18 109.29 2.79 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.222 1.948 . . . . 61.44 110.465 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 93.7 t -107.46 111.08 34.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.906 0.882 . . . . 72.01 109.046 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -83.1 73.2 10.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.024 0.916 . . . . 71.42 109.626 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.477 0.909 0 CA-C-N 114.904 -1.043 . . . . 72.34 109.764 176.326 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.385 -0.598 . . . . 61.43 109.385 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 p -176.94 -62.92 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.351 1.06 . . . . 64.3 109.716 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.79 81.14 5.11 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.663 0.785 . . . . 64.41 109.865 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -143.48 33.99 1.3 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.742 1.258 . . . . 65.33 107.618 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -72.88 84.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.86 -1.518 . . . . 52.0 108.646 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -101.65 157.67 16.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.75 -1.204 . . . . 61.24 107.75 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -80.01 62.16 4.12 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.465 1.126 . . . . 73.21 110.637 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -92.53 -48.53 6.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 73.15 109.426 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.457 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -65.06 149.43 49.89 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.48 0.657 . . . . 73.34 112.49 -173.308 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 62.6 m -147.85 116.52 6.69 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.286 -1.376 . . . . 60.44 107.286 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -136.98 132.1 33.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.425 0.69 . . . . 61.1 109.27 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -137.77 134.95 35.87 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.746 0.418 . . . . 61.4 110.1 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 13' ' ' ILE . 1.5 pp -81.58 88.2 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 109.201 -0.666 . . . . 75.21 109.201 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -74.91 -41.71 59.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.297 0.639 . . . . 72.22 110.601 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 12.9 tpp85 -165.56 133.47 3.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.971 -0.559 . . . . 74.22 110.3 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.604 HD13 ' HG3' ' C' ' 130' ' ' PRO . 3.8 mp -131.04 120.26 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.386 -1.338 . . . . 63.12 107.386 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.404 ' CD1' ' HG3' ' A' ' 15' ' ' ARG . 4.7 p90 -164.06 176.21 9.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.696 0.799 . . . . 55.15 110.411 -169.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.44 HG21 ' SG ' ' A' ' 113' ' ' CYS . 78.7 p -92.69 117.9 30.48 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.201 -0.666 . . . . 64.43 109.201 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.9 mtpt -75.69 -30.52 59.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.909 -0.404 . . . . 63.22 109.909 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.59 143.13 19.55 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.543 -0.753 . . . . 64.34 109.63 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 68.4 mt -139.3 144.34 29.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.618 -1.252 . . . . 74.2 107.618 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -150.03 136.19 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.375 -0.602 . . . . 71.42 109.375 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -140.82 109.75 6.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.714 -1.587 . . . . 73.23 106.714 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.81 119.52 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.48 -0.563 . . . . 74.43 109.48 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.08 83.16 37.89 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.021 -1.103 . . . . 72.21 108.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.29 -18.48 34.49 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.728 2.285 . . . . 32.32 111.937 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -117.35 37.39 3.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.361 1.064 . . . . 71.41 109.749 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.13 93.18 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 114.379 1.252 . . . . 73.44 114.379 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.19 -25.13 8.87 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.698 1.599 . . . . 74.32 111.649 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -78.97 -14.23 59.33 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.935 1.694 . . . . 74.35 111.418 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.44 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 7.1 p -69.76 -22.31 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.692 0.797 . . . . 62.25 111.879 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.82 -25.59 66.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.808 0.843 . . . . 53.11 111.358 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -86.85 -34.06 19.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.239 1.016 . . . . 72.42 111.48 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.675 ' HD3' HD21 ' A' ' 68' ' ' LEU . 12.5 ptpt -80.57 171.76 14.63 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.224 0.535 . . . . 75.24 111.36 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.17 144.96 29.46 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.247 -0.888 . . . . 73.0 109.336 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -89.61 63.73 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.703 0.763 . . . . 74.31 110.956 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -149.08 82.37 7.11 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 114.941 -1.027 . . . . 63.1 108.352 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -85.39 170.01 9.46 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.675 2.25 . . . . 73.24 111.265 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.98 114.72 26.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.621 -0.881 . . . . 65.51 108.621 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' ' HG3' ' F' ' 128' ' ' LYS . 59.5 t -75.61 96.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.829 0.852 . . . . 63.42 109.532 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.6 tttm -102.45 116.44 32.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.538 1.135 . . . . 64.1 109.204 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.04 128.83 53.5 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.203 -1.036 . . . . 72.13 108.203 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.621 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 16.3 m-20 -115.06 131.04 57.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.084 0.954 . . . . 70.32 108.668 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.5 138.65 53.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.919 0.888 . . . . 73.13 109.657 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 26.5 t70 -155.43 146.81 22.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.67 0.788 . . . . 73.04 109.913 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.09 139.02 35.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.42 0.688 . . . . 62.43 110.617 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -139.86 154.34 47.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.236 1.014 . . . . 63.22 110.183 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -129.08 157.77 40.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.667 0.787 . . . . 73.15 108.947 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.3 t -161.45 115.47 1.97 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.256 -0.275 . . . . 61.43 110.256 -172.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -72.06 104.79 3.69 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 71.33 109.817 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 57' ' ' GLU . 65.1 mt -77.79 -41.35 37.67 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.194 0.998 . . . . 65.21 110.891 176.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.28 -175.62 4.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.644 -1.162 . . . . 52.23 108.379 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -58.63 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.865 0.466 . . . . 64.43 110.671 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 59.15 33.55 22.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.859 1.264 . . . . 62.24 112.483 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 61.5 t -112.95 118.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.717 -1.586 . . . . 75.01 106.717 167.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -129.6 131.69 46.56 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.766 -0.828 . . . . 75.33 108.766 -177.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.604 ' HB2' HD11 ' A' ' 51' ' ' LEU . 43.6 tt0 -89.25 121.07 31.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.697 0.799 . . . . 73.23 109.054 173.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 99.0 t -100.25 121.85 51.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 123.807 0.843 . . . . 75.32 108.775 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.5 t -108.5 133.66 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.666 -0.494 . . . . 64.14 109.666 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.94 116.0 31.19 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.067 -1.457 . . . . 73.03 107.067 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.591 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -91.78 102.3 14.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.635 -1.246 . . . . 63.44 107.635 170.318 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' A' ' 114' ' ' ILE . 2.9 t -101.18 130.33 50.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.036 -1.468 . . . . 73.53 107.036 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -132.04 125.99 32.8 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.221 0.534 . . . . 71.41 109.726 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 47.3 t -111.28 110.05 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.156 0.982 . . . . 73.4 109.167 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 26.3 m -101.12 135.94 41.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.667 -0.864 . . . . 73.43 108.667 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.52 103.85 7.57 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.751 -1.204 . . . . 54.21 107.751 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 m -143.67 128.06 17.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.203 0.601 . . . . 71.11 109.535 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.675 HD21 ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -94.28 84.93 4.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.502 -1.295 . . . . 73.13 107.502 172.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -116.89 4.66 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.539 -1.209 . . . . 40.14 111.277 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.01 -25.44 21.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 70.14 111.059 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.574 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 tp10 -81.25 96.05 7.14 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.556 -0.535 . . . . 73.34 109.556 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -75.31 129.0 36.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.313 0.645 . . . . 52.52 110.811 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.11 4.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.015 0.926 . . . . 75.32 108.917 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -164.94 173.99 11.02 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.586 -1.188 . . . . 71.51 110.62 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.9 tp -140.92 137.75 33.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.575 1.15 . . . . 60.22 108.449 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.0 m -127.54 141.96 51.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.802 1.241 . . . . 55.12 108.751 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.14 134.91 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.207 -0.664 . . . . 74.31 109.207 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.76 111.57 8.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 123.776 0.831 . . . . 73.54 108.991 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -85.52 84.53 7.59 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.437 -0.949 . . . . 50.33 108.437 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -80.17 96.36 6.53 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.697 -1.223 . . . . 72.23 107.697 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.99 146.33 16.55 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 111.665 -0.574 . . . . 75.33 111.665 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.98 133.9 5.72 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.027 -0.829 . . . . 73.01 111.027 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -85.79 127.49 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.075 -0.713 . . . . 71.13 109.075 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.6 118.95 18.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.155 -1.054 . . . . 74.1 108.155 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 54.0 p -89.52 94.04 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.837 -0.801 . . . . 33.53 108.837 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.75 HG12 HD11 ' A' ' 98' ' ' LEU . 2.8 pp -119.21 144.01 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.747 0.419 . . . . 72.54 111.259 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.31 177.52 3.08 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.273 1.429 . . . . 65.41 108.835 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 83.53 3.34 89.82 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.898 0.719 . . . . 73.34 114.898 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.1 150.15 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.069 -1.085 . . . . 75.42 108.069 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -128.55 173.63 10.09 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.484 -0.561 . . . . 74.13 109.484 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.83 -112.33 1.61 Allowed Glycine 0 C--N 1.352 1.434 0 O-C-N 124.832 1.333 . . . . 73.51 116.176 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.0 p -61.89 -50.81 70.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 70.11 111.5 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.43 -33.99 69.89 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.382 0.673 . . . . 70.51 112.118 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.1 tpp -63.85 -51.57 64.05 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.304 0.378 . . . . 60.11 110.381 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.56 -35.78 76.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.153 0.581 . . . . 62.21 111.067 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.423 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 59.7 t-80 -75.74 -22.22 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.118 0.967 . . . . 71.43 111.103 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HB3' HD22 ' A' ' 98' ' ' LEU . 43.3 t -70.61 -60.55 2.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.638 -0.505 . . . . 75.54 109.638 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.75 HD11 HG12 ' A' ' 86' ' ' ILE . 1.7 mm? -81.92 -23.14 36.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.837 -0.619 . . . . 72.22 111.822 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.32 -28.03 9.48 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 123.534 0.521 . . . . 74.4 113.857 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -112.97 -63.59 1.42 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.478 0.639 . . . . 72.11 111.004 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.3 -50.23 70.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.778 0.831 . . . . 73.35 112.55 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.0 m -65.12 -49.09 68.36 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.077 -0.963 . . . . 73.42 112.65 -172.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.57 -24.29 56.13 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 121.848 1.698 . . . . 73.25 112.703 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -74.03 -27.74 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.271 0.628 . . . . 53.45 110.44 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.23 -39.67 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.57 0.748 . . . . 73.23 109.718 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 mt -76.72 -24.86 53.07 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.339 -0.846 . . . . 71.52 111.692 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.05 -41.86 47.48 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 114.535 1.309 . . . . 75.23 114.535 -169.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.94 -38.73 76.84 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.034 1.823 . . . . 75.23 113.007 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -77.95 -31.87 51.18 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.684 -0.689 . . . . 74.45 111.245 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.69 72.7 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.357 0.663 . . . . 65.14 109.506 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.0 ttm180 -51.3 -52.85 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.988 1.43 . . . . 73.23 110.382 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.37 -47.81 80.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.724 -1.126 . . . . 72.22 111.86 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.521 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.4 t -59.88 -29.85 68.61 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.949 0.781 . . . . 42.44 111.77 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 118' ' ' VAL . 94.8 mt -73.29 -58.67 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.534 -0.543 . . . . 70.51 109.534 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -51.24 -39.85 57.55 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.093 1.357 . . . . 70.51 112.641 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -70.23 -40.66 74.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.082 -0.963 . . . . 74.22 111.283 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.17 -43.24 99.27 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 120.864 0.364 . . . . 64.45 110.585 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.8 t -57.17 -45.8 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 114.663 -1.153 . . . . 63.33 110.92 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -70.57 -30.9 67.72 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.529 -0.76 . . . . 74.13 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -68.96 -31.28 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.501 0.72 . . . . 73.13 110.86 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 3.52 65.65 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.447 -0.64 . . . . 62.41 113.418 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 67.25 35.17 4.54 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.419 1.104 . . . . 62.11 109.781 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -111.24 149.79 41.06 Favored Pre-proline 0 N--CA 1.478 0.926 0 CA-C-N 114.865 -1.061 . . . . 71.11 110.044 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.35 143.14 94.67 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.872 2.381 . . . . 72.24 112.808 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -53.72 138.62 34.81 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.856 0.862 . . . . 73.22 112.459 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 64' ' ' VAL . 1.4 tm? -120.93 109.28 14.91 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.579 -1.267 . . . . 70.54 107.579 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -98.97 127.17 44.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.764 0.825 . . . . 63.44 108.859 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 132.59 43.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.412 0.685 . . . . 73.5 109.817 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.58 130.04 86.23 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 118.68 -0.676 . . . . 54.13 109.848 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.61 115.65 2.82 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.341 2.027 . . . . 64.23 111.887 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.86 114.2 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.316 -1.364 . . . . 73.23 107.316 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 21.6 p-10 -76.9 74.68 3.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.4 0.68 . . . . 53.31 109.97 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -55.6 -44.05 76.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 63.0 110.994 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.46 -52.48 38.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.768 -1.105 . . . . 73.13 111.972 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 132' ' ' ASN . . . -71.16 -43.44 67.5 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.739 0.649 . . . . 53.41 111.611 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.36 -35.09 78.66 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.729 0.812 . . . . 63.14 111.569 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.34 -46.83 81.79 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 110.072 -0.344 . . . . 73.32 110.072 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 77.1 mmm -73.57 -29.21 62.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.88 -0.6 . . . . 75.4 111.367 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -58.59 -60.32 3.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.858 1.263 . . . . 73.44 109.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -64.13 -31.62 72.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.809 -1.087 . . . . 75.22 111.98 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.7 tt -55.86 -48.31 75.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.83 0.852 . . . . 70.43 110.737 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -172.9 -13.8 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.845 0.716 . . . . 74.33 111.886 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -88.83 46.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.423 0.63 . . . . 73.5 111.161 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' C' ' 1' ' ' MET . 48.7 mt-30 -72.81 -12.22 60.9 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.256 -0.884 . . . . 75.22 111.977 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.71 22.21 3.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.229 1.012 . . . . 73.2 109.687 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.2 158.04 15.69 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.768 -0.651 . . . . 53.02 113.177 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.706 ' HG3' ' HB ' ' C' ' 7' ' ' THR . 29.6 tt0 -143.32 124.93 14.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.345 0.658 . . . . 72.35 109.872 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.01 92.61 0.35 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.826 -0.509 . . . . 75.21 111.826 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -77.76 161.99 27.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.231 0.612 . . . . 74.31 110.113 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 133.82 54.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.639 0.776 . . . . 70.1 110.383 -176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.59 123.46 21.39 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 109.15 -0.685 . . . . 70.02 109.15 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.584 ' HA ' ' HE2' ' C' ' 137' ' ' PHE . 44.9 m80 -80.45 88.51 5.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.595 -0.73 . . . . 65.32 109.436 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -93.13 139.81 30.18 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.678 -1.147 . . . . 74.35 110.181 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.77 -69.47 0.29 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.006 0.923 . . . . 73.22 110.585 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 124.382 1.073 . . . . 71.12 108.345 179.765 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 109.222 -0.659 . . . . 61.45 109.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -147.42 -70.32 0.23 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.014 -1.106 . . . . 73.12 108.014 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 56.79 23.61 8.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.499 1.119 . . . . 64.4 112.514 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -87.84 93.21 9.39 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.687 -0.857 . . . . 75.42 108.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -63.45 108.6 1.38 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.764 0.826 . . . . 75.22 110.617 -175.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.53 132.65 45.83 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.297 0.998 . . . . 74.05 110.152 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -138.85 161.6 36.88 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.398 1.079 . . . . 70.2 108.912 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.2 -38.79 91.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.254 0.622 . . . . 72.1 110.147 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.505 ' HE3' HD12 ' B' ' 89' ' ' ILE . 19.4 ptm 47.49 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.17 1.788 . . . . 73.45 114.194 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 32.8 m -152.79 127.51 9.49 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.188 -1.412 . . . . 70.21 107.188 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -124.3 154.46 40.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.963 -0.755 . . . . 71.53 108.963 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.657 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 50.2 tt0 -153.49 139.42 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.959 0.904 . . . . 72.14 109.829 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.689 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -97.55 113.15 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.092 -1.447 . . . . 72.22 107.092 166.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -77.76 -49.4 14.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.034 -0.416 . . . . 53.44 110.042 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -161.94 133.05 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.478 -0.328 . . . . 71.24 110.194 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.13 137.42 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 107.046 -1.465 . . . . 75.43 107.046 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.89 145.52 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.365 0.602 . . . . 74.14 111.744 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 65.6 m -75.81 115.15 15.21 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.907 -1.042 . . . . 44.25 108.698 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.449 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.1 mtpt -85.75 -31.39 22.43 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.088 0.555 . . . . 74.22 110.568 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.3 t70 -157.78 143.84 17.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.729 -0.668 . . . . 70.21 111.303 -168.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 37.6 mm -139.97 141.03 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 125.304 1.442 . . . . 65.21 108.646 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -141.26 132.39 26.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.601 -1.259 . . . . 75.12 107.601 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.554 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 84.5 t80 -144.27 109.71 5.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.244 -1.761 . . . . 75.4 106.244 170.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -119.18 117.3 28.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.013 -0.736 . . . . 74.34 109.013 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.36 86.1 7.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.708 -1.219 . . . . 75.51 107.708 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.57 -28.02 32.1 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.447 2.098 . . . . 73.53 110.811 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -107.0 27.77 8.67 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.745 1.218 . . . . 71.21 109.244 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.455 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -47.62 -57.39 9.98 Favored Pre-proline 0 CA--C 1.57 1.734 0 C-N-CA 124.67 1.188 . . . . 74.32 112.954 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 78.0 Cg_endo -82.48 -1.28 10.56 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 121.77 1.647 . . . . 74.14 112.843 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -99.57 -16.43 18.27 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.644 0.778 . . . . 73.04 111.885 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.18 -21.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.534 0.733 . . . . 72.34 112.784 -167.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -73.65 -16.72 61.21 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.517 0.192 . . . . 63.43 111.517 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -81.69 -4.87 57.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.664 0.786 . . . . 72.33 111.082 176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' B' ' 68' ' ' LEU . 72.7 mmtt -106.51 102.17 11.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.573 1.149 . . . . 73.31 109.898 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -115.9 85.99 2.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 55.4 111.954 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.503 ' HB2' HD23 ' B' ' 68' ' ' LEU . 6.2 m0 -159.27 -170.5 3.0 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.678 1.991 . . . . 63.05 106.657 169.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -83.51 125.4 73.94 Favored Pre-proline 0 N--CA 1.478 0.925 0 N-CA-C 107.628 -1.249 . . . . 72.31 107.628 162.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.443 ' HA ' ' HG ' ' B' ' 68' ' ' LEU . 30.3 Cg_endo -62.68 132.64 38.52 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.08 1.853 . . . . 61.35 112.143 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -68.93 103.27 1.77 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.657 -1.156 . . . . 74.11 108.443 171.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.17 128.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.742 0.817 . . . . 63.14 110.079 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -121.75 109.74 15.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.642 1.177 . . . . 74.51 108.048 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.492 HD21 HD12 ' E' ' 129' ' ' LEU . 1.6 pp -92.15 153.57 19.24 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.608 0.763 . . . . 51.25 110.64 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.615 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.0 m-20 -136.04 137.17 40.88 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.948 -1.13 . . . . 75.51 107.948 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.501 HD21 HG21 ' B' ' 131' ' ' VAL . 7.1 mp -115.78 132.64 56.58 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.083 -0.71 . . . . 52.04 109.083 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.9 t70 -139.05 155.94 47.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.846 1.258 . . . . 73.11 108.637 -173.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.32 140.11 39.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.759 0.824 . . . . 73.33 109.042 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.61 116.88 17.23 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.485 -1.302 . . . . 32.21 107.485 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -106.38 161.5 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.109 0.564 . . . . 64.04 110.733 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -160.48 136.04 8.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.688 -0.856 . . . . 72.03 108.688 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -88.4 120.27 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.649 -0.871 . . . . 64.4 108.649 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 mt -81.28 -39.33 25.41 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.259 0.552 . . . . 75.53 110.375 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -157.32 -177.86 6.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.789 -1.096 . . . . 62.54 110.016 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -69.87 130.66 42.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.068 -1.086 . . . . 74.33 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.49 -4.81 1.27 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.604 1.162 . . . . 75.24 112.761 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 60.0 t -123.08 116.96 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.628 0.771 . . . . 74.02 109.61 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.418 ' HD2' HG13 ' B' ' 58' ' ' VAL . 30.0 p90 -126.19 171.58 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.188 0.595 . . . . 74.33 109.418 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -144.71 108.15 4.61 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.625 -1.25 . . . . 74.51 107.625 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' B' ' 56' ' ' TYR . 29.5 m -104.47 137.47 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.148 -0.686 . . . . 72.31 109.148 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.38 119.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.149 -0.686 . . . . 63.03 109.149 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.02 114.32 26.84 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.54 -1.281 . . . . 74.43 107.54 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.5 ttt180 -106.24 122.29 45.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.78 0.832 . . . . 73.12 109.985 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -113.27 118.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.806 -0.813 . . . . 75.05 108.806 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 20.1 m -99.92 145.37 27.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.418 1.087 . . . . 61.42 108.513 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -136.57 130.17 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.702 0.801 . . . . 71.34 109.268 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -120.96 145.58 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.134 -1.062 . . . . 73.32 108.134 171.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.56 151.33 37.15 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.711 0.291 . . . . 62.15 110.36 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -162.25 143.24 10.41 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.672 1.232 . . . . 63.2 109.657 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.0 mp -112.38 137.08 51.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.249 -1.019 . . . . 72.04 108.249 168.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.13 -118.33 6.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.112 -0.795 . . . . 75.23 111.112 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.59 29.48 6.57 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.481 0.712 . . . . 71.1 110.506 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -145.4 142.92 29.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.113 0.565 . . . . 64.01 110.355 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 9.1 m -59.52 151.83 23.35 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.338 1.055 . . . . 72.04 112.137 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.623 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -112.27 -61.78 1.67 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.446 1.098 . . . . 62.22 108.926 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.8 156.88 28.28 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.79 -1.55 . . . . 74.42 108.94 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.37 141.93 49.11 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.335 -1.358 . . . . 70.55 107.335 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.1 t -154.21 152.48 30.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.454 -0.573 . . . . 72.04 109.454 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.15 140.71 5.34 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.264 -0.643 . . . . 72.35 109.264 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.3 t -133.66 146.79 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.079 0.952 . . . . 71.31 108.748 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 78.9 mt-30 -126.34 101.05 6.54 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.233 0.613 . . . . 74.21 109.443 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -90.8 105.34 17.75 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.531 -0.759 . . . . 74.45 109.801 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.36 156.19 23.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 111.532 -0.627 . . . . 61.24 111.532 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 126.56 1.96 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 111.862 -0.495 . . . . 61.03 111.862 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.0 126.18 40.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.575 -0.898 . . . . 72.24 108.575 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -131.51 155.95 46.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.223 1.009 . . . . 70.12 109.093 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.657 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 44.1 m -131.92 134.32 45.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.293 1.037 . . . . 65.24 109.627 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.72 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.7 pp -131.59 147.7 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.152 0.981 . . . . 71.52 111.006 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.5 149.7 27.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.436 1.094 . . . . 63.21 108.763 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.04 -47.25 2.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.12 0.39 . . . . 34.22 113.905 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.72 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -83.94 165.0 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.531 0.732 . . . . 74.25 112.073 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -167.9 163.51 13.87 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.729 0.811 . . . . 53.21 110.361 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -113.22 5.0 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.992 0.808 . . . . 61.54 113.143 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.7 m -74.08 -34.28 63.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.871 0.868 . . . . 64.45 111.052 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -32.9 74.15 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.039 0.535 . . . . 54.33 109.913 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 13.2 tpt -76.98 -43.98 32.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.476 0.71 . . . . 62.02 110.811 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.14 75.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.828 0.851 . . . . 54.13 111.321 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -70.81 -30.41 66.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.285 1.034 . . . . 62.31 111.084 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -69.47 -59.45 2.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.092 0.557 . . . . 74.22 110.384 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.45 -19.07 61.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.88 0.326 . . . . 65.04 111.88 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -22.07 43.66 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.493 0.557 . . . . 74.42 114.493 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.18 -55.26 0.44 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.189 0.494 . . . . 74.14 111.572 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -62.07 -45.53 93.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.742 0.817 . . . . 73.53 112.082 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 85.8 m -71.13 -47.15 14.33 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.546 -0.74 . . . . 71.31 112.222 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.2 Cg_exo -52.86 -31.5 52.37 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.249 1.966 . . . . 65.43 114.221 168.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -66.67 -36.64 83.02 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 122.941 0.496 . . . . 74.33 111.558 176.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.03 -45.21 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.592 0.757 . . . . 72.34 110.4 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.08 -25.24 40.13 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.043 -0.981 . . . . 63.3 113.058 -169.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.76 -47.85 94.69 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 117.399 -1.286 . . . . 71.22 113.975 -170.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.18 -41.12 50.73 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.333 2.022 . . . . 73.3 113.655 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -68.1 -51.73 43.04 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.609 -0.723 . . . . 72.41 110.99 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.97 91.71 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.564 0.745 . . . . 61.44 111.294 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 23.6 ttp180 -61.88 -58.93 6.05 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.256 1.422 . . . . 71.44 110.992 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -69.79 -26.42 64.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.728 -1.124 . . . . 75.3 111.098 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.451 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.3 t -68.63 -37.18 79.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.824 0.45 . . . . 24.11 111.062 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.61 -49.24 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.126 0.57 . . . . 62.34 109.768 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -69.68 -23.44 63.45 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.606 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.0 t -75.89 -29.1 58.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.697 0.799 . . . . 63.04 110.958 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 21.5 mmt -78.94 -26.68 43.63 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.766 0.426 . . . . 73.4 110.187 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' B' ' 125' ' ' GLN . 49.6 t -58.85 -41.82 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.96 0.904 . . . . 54.33 111.113 170.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.5 t -53.1 -38.72 62.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.401 1.081 . . . . 23.11 111.634 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.0 mtt-85 -76.67 -26.52 54.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.113 -0.949 . . . . 74.42 111.377 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.2 0.54 81.6 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-O 119.472 -0.626 . . . . 63.11 113.743 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p 63.12 18.91 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.112 1.765 . . . . 73.42 114.484 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' B' ' 118' ' ' VAL . 55.1 p90 -110.42 166.76 10.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-O 118.73 -0.652 . . . . 74.21 110.683 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.31 147.19 22.15 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.34 2.694 . . . . 74.12 114.539 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.556 ' HA ' HG11 ' B' ' 118' ' ' VAL . 5.0 pm0 -54.1 145.0 18.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.05 1.34 . . . . 73.33 113.729 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 126' ' ' LEU . 1.9 tm? -133.23 85.4 2.21 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.537 -1.283 . . . . 73.53 107.537 171.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -104.93 133.76 49.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.909 -1.145 . . . . 73.22 107.909 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.0 mm? -86.7 138.47 31.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.369 0.668 . . . . 53.4 109.544 -169.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' E' ' 131' ' ' ALA . . . -67.96 148.71 98.39 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.078 0.551 . . . . 73.21 110.603 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.31 112.93 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.804 2.336 . . . . 54.32 111.634 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.501 HG21 HD21 ' B' ' 44' ' ' LEU . 90.9 t -89.77 127.32 42.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.869 0.468 . . . . 62.52 109.829 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -80.41 83.18 6.28 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.739 0.816 . . . . 75.44 109.784 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -63.01 -29.09 70.55 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.615 0.766 . . . . 73.04 111.279 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.9 -53.53 17.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 62.03 110.257 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.63 77.38 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.272 0.629 . . . . 44.14 110.682 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.462 HD21 ' N ' ' E' ' 124' ' ' ARG . 7.3 tt -67.75 -38.34 83.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.249 1.02 . . . . 60.13 110.549 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -63.0 -37.75 88.46 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.442 0.697 . . . . 62.55 109.959 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.9 mtt -68.39 -38.86 81.74 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.895 -0.593 . . . . 75.13 109.993 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -74.55 -15.12 60.86 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.282 0.633 . . . . 75.3 111.611 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -72.66 -40.2 66.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.171 0.588 . . . . 74.21 110.105 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 pp -121.51 26.96 8.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.419 0.687 . . . . 64.44 111.73 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 64.39 -78.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.481 1.512 . . . . 74.45 112.944 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -129.21 144.98 51.41 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.256 0.622 . . . . 75.33 109.998 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -65.2 117.69 8.15 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.83 0.707 . . . . 73.53 109.438 173.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.75 91.78 1.41 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.782 -1.192 . . . . 41.11 107.782 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.91 -71.99 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 116.122 -0.49 . . . . 64.22 113.929 -168.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 69.15 148.76 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.762 1.225 . . . . 63.43 111.506 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.83 -154.92 24.4 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 119.456 -0.636 . . . . 50.11 111.737 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 68.7 m 56.81 73.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.892 0.877 . . . . 74.25 110.291 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -92.98 142.78 26.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.803 -1.089 . . . . 70.04 110.749 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.41 94.69 6.85 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.367 -0.605 . . . . 62.23 109.367 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -89.68 49.64 1.77 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.126 0.571 . . . . 75.42 109.862 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -66.49 91.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.527 0.731 . . . . 71.41 110.9 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 160.77 16.19 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.118 0.967 . . . . 64.41 108.872 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 74.41 108.819 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.501 ' HA ' ' HB3' ' A' ' 144' ' ' GLN . 83.0 mtp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.908 -0.404 . . . . 75.21 109.908 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -93.43 90.7 6.83 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.229 -1.026 . . . . 64.34 108.229 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -80.41 67.82 6.38 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.925 0.869 . . . . 63.44 110.346 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -105.95 -0.85 24.69 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.615 1.166 . . . . 71.1 110.548 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -122.63 141.22 51.96 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.736 1.214 . . . . 73.41 110.206 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -87.7 10.27 18.77 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.457 0.91 . . . . 61.31 113.457 -169.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.706 ' HB ' ' HG3' ' A' ' 147' ' ' GLU . 14.4 t -61.7 -26.27 67.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.097 0.559 . . . . 73.32 112.037 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -72.32 -37.97 68.79 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.102 0.561 . . . . 62.41 111.052 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.9 ttp 63.97 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.93 1.292 . . . . 65.13 111.838 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 35.6 m -83.83 85.47 7.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 73.35 108.399 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' C' ' 85' ' ' SER . 50.0 t80 -106.44 140.97 38.51 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.413 -1.267 . . . . 74.22 109.443 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 6.0 tp60 -145.68 137.39 25.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.831 0.452 . . . . 73.54 110.477 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.445 ' HB ' HD22 ' F' ' 129' ' ' LEU . 25.5 mm -86.31 110.31 19.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.94 -1.133 . . . . 53.33 107.94 172.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 86.8 mm-40 -83.99 -49.22 9.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.867 -0.419 . . . . 70.2 109.867 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -169.1 136.8 1.89 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.693 -0.685 . . . . 73.31 109.627 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -117.06 138.93 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.744 -1.206 . . . . 71.35 107.744 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.515 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 20.7 p90 -176.46 144.02 0.51 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.6 0.36 . . . . 74.43 110.822 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.9 p -70.48 124.55 24.47 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.408 0.683 . . . . 54.12 110.124 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -77.07 -49.45 15.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.873 -1.158 . . . . 73.51 107.873 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -135.01 142.14 46.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.185 -1.371 . . . . 75.45 110.309 -174.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.2 mt -136.18 143.01 37.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.055 -1.832 . . . . 74.53 106.055 173.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -156.07 150.31 25.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.311 0.577 . . . . 72.41 109.954 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -148.76 138.79 22.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.627 -1.169 . . . . 71.31 108.034 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.1 132.12 35.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.768 -1.197 . . . . 74.13 107.768 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.12 80.93 16.4 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 64.23 107.254 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.83 -38.19 40.61 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.514 2.143 . . . . 73.34 110.996 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 1.1 m-20 -100.1 32.89 2.79 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.382 1.073 . . . . 73.33 109.914 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.75 -43.84 96.0 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.131 1.16 . . . . 72.11 114.131 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.88 -23.68 13.83 Favored 'Trans proline' 0 C--N 1.383 2.36 0 CA-C-N 121.435 1.548 . . . . 42.31 112.834 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 51.1 m80 -65.19 -20.38 66.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.532 0.733 . . . . 73.22 112.852 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' C' ' 34' ' ' LYS . 52.6 t -49.46 -32.07 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.284 1.034 . . . . 54.24 113.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.96 -39.88 96.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.893 0.477 . . . . 72.0 111.695 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.86 15.2 25.74 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.079 0.952 . . . . 75.35 111.261 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.686 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 3.4 ttpm? -108.68 137.02 47.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.873 0.869 . . . . 61.41 109.023 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 131.83 35.24 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.176 -1.046 . . . . 73.1 108.176 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -79.67 72.26 6.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.079 0.552 . . . . 74.2 109.813 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -143.28 48.15 0.92 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 123.79 0.836 . . . . 74.21 110.165 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.11 143.81 18.12 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 121.358 1.372 . . . . 75.23 110.841 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.11 115.21 24.35 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 54.21 108.789 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.99 107.5 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.391 -0.822 . . . . 61.55 110.24 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 7.3 tmtt? -92.45 104.56 16.87 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 106.375 -1.713 . . . . 74.02 106.375 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.403 HD13 ' HG ' ' C' ' 128' ' ' LEU . 13.5 tp -84.0 146.95 27.7 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.73 -1.211 . . . . 75.42 107.73 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.48 143.3 31.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.257 -1.386 . . . . 63.55 107.257 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 153.97 51.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.233 0.54 . . . . 60.33 111.379 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.8 t70 -151.38 153.26 34.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.784 1.234 . . . . 73.05 108.626 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -139.33 141.53 37.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.077 -0.712 . . . . 55.44 109.077 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -128.66 170.09 13.68 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.101 0.96 . . . . 74.52 109.106 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -147.14 144.66 29.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.457 0.703 . . . . 50.23 109.995 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 66.2 p -144.88 126.29 14.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.265 -1.013 . . . . 73.11 108.265 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.88 115.86 19.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' C' ' 57' ' ' GLU . 51.7 mt -89.36 -35.72 15.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.154 0.582 . . . . 75.3 109.635 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.59 -173.84 4.59 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 73.42 110.016 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.65 117.29 8.6 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.378 -0.828 . . . . 70.02 109.775 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 68.58 0.28 2.55 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.603 1.561 . . . . 74.24 112.364 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.72 108.99 24.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.744 -0.836 . . . . 75.23 108.744 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.26 123.53 41.66 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.529 1.132 . . . . 73.42 108.756 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.569 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.7 tt0 -83.34 139.05 33.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.253 -1.017 . . . . 75.55 108.253 169.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 95.6 t -118.93 131.86 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.357 -0.979 . . . . 62.22 108.357 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 60.5 t -110.1 102.5 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.745 -0.835 . . . . 73.21 108.745 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -90.56 109.19 20.34 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.109 -1.071 . . . . 65.3 108.109 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.703 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 65.2 mtt85 -95.75 132.7 40.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.814 0.845 . . . . 53.03 109.526 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.0 t -126.62 131.02 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -125.92 120.45 30.43 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.912 -0.773 . . . . 71.03 108.912 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.431 HG21 HG21 ' C' ' 114' ' ' ILE . 94.4 t -110.27 114.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.145 0.978 . . . . 65.31 108.82 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 16.3 m -98.81 139.16 34.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.868 -1.16 . . . . 52.4 107.868 168.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.98 110.65 7.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.024 -1.843 . . . . 44.31 106.024 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.499 ' HB3' HG23 ' C' ' 72' ' ' THR . 12.5 p -158.16 139.99 13.89 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.641 0.588 . . . . 74.4 110.689 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.0 tp -80.7 -23.85 39.24 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.473 -0.785 . . . . 71.44 109.276 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.04 -97.2 0.11 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 110.056 -1.217 . . . . 71.3 110.056 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -90.46 -31.93 16.6 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.651 -0.87 . . . . 74.1 108.651 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -69.93 84.04 0.49 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.018 -1.105 . . . . 63.53 108.018 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.499 HG23 ' HB3' ' C' ' 67' ' ' SER . 78.7 m -87.89 136.72 32.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.248 -1.342 . . . . 74.35 109.889 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.686 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -72.32 -73.56 0.19 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.92 -1.141 . . . . 55.13 107.92 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.0 167.59 29.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.736 0.779 . . . . 75.13 112.333 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -125.59 138.71 53.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 105.726 -1.953 . . . . 72.35 105.726 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -151.77 113.27 4.36 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 110.011 -0.366 . . . . 44.42 110.011 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -117.06 136.11 53.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.518 0.327 . . . . 74.42 110.129 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' C' ' 110' ' ' ALA . 25.4 t -125.25 114.16 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 55.24 108.673 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -90.26 92.7 9.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.472 -0.936 . . . . 65.4 108.472 171.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -78.16 136.54 37.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.687 -0.688 . . . . 74.24 109.345 177.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.42 153.04 17.67 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.3 -0.72 . . . . 55.11 111.3 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 121.19 1.08 Allowed Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 111.477 -0.649 . . . . 71.54 111.477 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.461 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.3 mm -81.71 120.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 107.685 -1.228 . . . . 71.32 107.685 174.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -131.83 138.01 48.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.512 0.725 . . . . 62.11 109.962 -174.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 58.9 m -89.89 113.93 25.62 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.552 -0.906 . . . . 64.43 108.552 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.6 100.55 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.96 -1.126 . . . . 71.42 107.96 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -130.74 152.68 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.914 0.886 . . . . 64.3 110.352 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.16 -39.3 2.8 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.02 -0.536 . . . . 73.44 112.209 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.57 160.01 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.256 0.622 . . . . 65.51 109.968 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.03 152.86 34.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.169 0.588 . . . . 75.22 110.551 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.45 -111.91 4.17 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.769 0.668 . . . . 24.43 113.198 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.3 p -73.73 -34.37 64.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.051 0.94 . . . . 54.44 111.693 -175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -70.26 -36.55 74.52 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.694 -0.484 . . . . 72.21 109.694 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.462 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 59.5 ttm -68.23 -36.46 79.53 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.913 -0.585 . . . . 63.3 110.174 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -33.09 74.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.638 0.775 . . . . 71.55 111.024 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -68.34 -35.57 77.96 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.14 0.576 . . . . 73.53 110.845 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 24.9 t -71.87 -62.65 1.34 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.638 0.375 . . . . 72.03 110.633 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.1 pp -75.71 -14.13 60.33 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.309 0.485 . . . . 70.31 112.309 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.31 -18.99 37.04 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.602 -0.555 . . . . 74.12 113.259 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.81 -56.48 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.786 0.793 . . . . 73.53 112.642 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -66.53 -61.15 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.61 0.364 . . . . 64.52 111.862 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 40.6 m -57.05 -45.45 99.95 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 124.08 0.952 . . . . 73.12 113.457 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.79 -25.2 46.12 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.798 1.666 . . . . 71.03 113.493 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -70.55 -29.16 65.55 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.754 0.422 . . . . 64.51 110.175 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.484 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.4 mm -68.4 -40.07 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.569 0.748 . . . . 61.4 109.939 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.6 mt -78.31 -26.28 46.88 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.99 -1.005 . . . . 74.22 112.307 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.0 -42.08 79.9 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.507 -1.235 . . . . 71.11 114.062 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.17 -43.63 55.56 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.158 1.905 . . . . 63.4 112.904 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -66.35 -41.31 89.73 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.66 0.784 . . . . 64.54 110.785 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.452 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -68.84 -44.8 72.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.665 -0.698 . . . . 43.4 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -50.95 -55.69 16.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.419 1.488 . . . . 62.4 110.995 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.31 -36.82 85.25 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.035 0.834 . . . . 71.22 109.931 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.531 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 12.0 t -66.47 -36.54 83.0 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.444 0.698 . . . . 74.01 111.566 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' C' ' 118' ' ' VAL . 95.1 mt -70.06 -49.51 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.379 0.672 . . . . 74.32 109.917 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 19.6 m -66.37 -30.23 70.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.109 0.564 . . . . 63.24 111.187 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -65.45 -45.87 82.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.113 -0.699 . . . . 65.41 109.113 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.563 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.73 -34.9 75.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.157 0.983 . . . . 54.05 112.404 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.466 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.1 t -62.49 -46.32 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.387 0.675 . . . . 72.35 109.542 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.4 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 29.7 t -67.48 -31.89 72.34 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.149 -0.932 . . . . 53.52 111.669 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.5 mtt-85 -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.376 0.67 . . . . 74.11 109.664 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.35 -4.37 86.86 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.804 0.69 . . . . 73.22 112.811 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.9 p 65.57 32.83 9.02 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.716 2.006 . . . . 63.51 113.085 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -89.09 166.49 21.58 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.587 1.155 . . . . 74.1 110.554 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.506 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 31.3 Cg_endo -63.77 112.93 1.95 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.074 1.849 . . . . 74.0 111.89 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.4 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 84.4 mt-30 -60.99 136.37 58.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.91 0.484 . . . . 74.45 111.023 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.729 HD21 ' HB ' ' E' ' 142' ' ' ILE . 38.9 tp -144.6 123.33 12.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.195 -1.039 . . . . 73.33 108.195 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -103.32 123.73 47.34 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.824 0.45 . . . . 74.34 109.789 -176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.403 ' HG ' HD13 ' C' ' 42' ' ' LEU . 1.4 tm? -74.24 128.51 35.73 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.16 0.984 . . . . 74.32 109.546 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.5 146.43 98.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.797 0.839 . . . . 70.22 111.374 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.604 ' HG3' HD13 ' A' ' 16' ' ' ILE . 35.5 Cg_endo -61.41 136.09 61.59 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.896 2.397 . . . . 73.23 113.31 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.58 109.83 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.077 -1.082 . . . . 74.44 108.077 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.417 ' H ' HD13 ' E' ' 148' ' ' LEU . 28.9 m-80 -112.51 93.83 4.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.748 0.819 . . . . 42.2 110.666 -174.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.39 -55.05 39.77 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.77 1.228 . . . . 73.13 111.615 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.71 -19.68 58.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.567 0.747 . . . . 73.22 111.837 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.0 tp -55.62 -29.81 59.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.675 0.79 . . . . 73.4 112.117 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.584 ' HE2' ' HA ' ' A' ' 152' ' ' HIS . 92.7 m-85 -73.48 -32.39 64.28 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.334 0.654 . . . . 74.54 111.501 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.1 mtp -74.85 -33.65 62.17 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.85 0.86 . . . . 72.41 110.127 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -67.72 -39.92 84.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.565 1.146 . . . . 55.42 110.097 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.48 -80.08 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.699 1.199 . . . . 73.14 110.051 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.1 tp -52.63 101.9 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.501 1.12 . . . . 75.12 111.763 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -81.79 144.96 30.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.778 -1.101 . . . . 71.54 108.157 171.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -73.67 -83.94 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.194 0.309 . . . . 64.11 111.27 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 179.38 -59.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.715 0.806 . . . . 75.54 108.862 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.57 159.88 28.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.416 1.086 . . . . 73.41 111.972 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.16 -44.05 0.02 OUTLIER Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.802 -0.519 . . . . 45.44 111.802 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.49 114.94 14.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.41 0.684 . . . . 73.41 110.68 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.36 -101.68 2.44 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.751 -0.94 . . . . 74.24 110.751 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.1 m 66.62 165.21 0.2 Allowed 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.573 1.149 . . . . 71.24 110.62 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 75.11 104.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.993 1.317 . . . . 72.11 111.582 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.97 -90.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.655 1.182 . . . . 74.3 109.328 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 60.66 -89.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.533 1.533 . . . . 74.21 113.402 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -171.23 151.13 3.08 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.193 0.597 . . . . 62.42 110.068 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -97.68 -37.4 9.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 71.21 110.604 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 54.14 110.589 -176.63 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.962 -0.385 . . . . 72.42 109.962 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.7 p -155.4 145.05 21.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.5 1.12 . . . . 70.14 108.939 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.76 -55.09 14.4 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.827 0.704 . . . . 63.23 110.067 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 60.56 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.139 1.376 . . . . 74.42 112.85 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -127.67 90.39 3.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.107 -1.072 . . . . 61.41 108.107 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.08 138.13 11.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.091 -0.707 . . . . 74.13 109.091 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -99.48 -4.33 31.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.862 0.865 . . . . 74.12 111.593 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -69.4 -19.49 63.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.178 0.591 . . . . 74.44 112.035 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.454 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.3 ptm -33.62 151.82 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.115 1.366 . . . . 31.32 114.622 165.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 37.8 m -107.88 143.87 35.89 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.445 0.698 . . . . 70.51 109.318 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' D' ' 85' ' ' SER . 63.2 t80 -155.55 106.91 2.56 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.39 -0.967 . . . . 75.23 108.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -129.3 146.34 51.21 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.234 0.614 . . . . 74.23 109.614 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.78 109.82 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.568 -1.271 . . . . 61.4 107.568 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -82.69 -47.66 11.77 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.034 0.208 . . . . 74.24 111.46 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -170.11 129.25 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.58 -0.282 . . . . 74.43 111.175 -167.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.41 133.2 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.272 -1.381 . . . . 54.21 107.272 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -155.47 144.52 20.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.214 0.531 . . . . 63.14 111.551 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -79.31 115.03 18.71 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.441 -0.8 . . . . 61.35 109.193 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.2 mtpt -81.1 -24.5 37.67 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.957 -0.386 . . . . 73.11 109.957 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.737 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.9 t70 -153.99 141.59 19.88 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.027 -0.988 . . . . 61.11 109.724 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.563 HG21 ' HE2' ' C' ' 117' ' ' MET . 86.3 mt -139.65 149.55 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.216 1.406 . . . . 73.41 107.689 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -153.04 144.91 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.584 1.154 . . . . 74.43 108.404 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 85.4 t80 -152.29 115.3 4.65 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 105.928 -1.879 . . . . 72.25 105.928 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.1 mt-10 -127.23 111.41 13.92 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.7 0.4 . . . . 60.02 110.008 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 90.52 4.72 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.809 -1.182 . . . . 71.41 107.809 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.32 -40.56 1.57 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.663 2.242 . . . . 72.0 113.082 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' D' ' 30' ' ' HIS . 6.0 p-10 -113.56 43.96 1.68 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.321 1.048 . . . . 74.54 108.927 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.515 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.36 -49.23 86.43 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 115.786 1.773 . . . . 75.14 115.786 -169.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 -15.99 13.34 Favored 'Trans proline' 0 C--N 1.388 2.654 0 CA-C-N 122.102 1.786 . . . . 53.44 113.381 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.482 ' HB3' ' HB2' ' D' ' 27' ' ' ASN . 7.1 t-160 -77.08 -46.53 23.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.136 0.974 . . . . 73.01 111.199 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 14.2 p -70.59 -22.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-O 120.968 0.413 . . . . 74.15 110.989 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.17 -33.24 74.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.688 0.795 . . . . 72.45 111.051 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -72.78 -15.37 61.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.703 0.801 . . . . 65.04 111.156 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.5 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 89.7 mttt -93.0 106.82 18.72 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.227 -0.657 . . . . 73.43 109.227 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.41 89.63 7.07 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.285 -0.635 . . . . 71.2 109.285 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.516 ' HB3' HD21 ' D' ' 68' ' ' LEU . 6.3 t-105 -169.99 158.87 7.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 108.487 -0.931 . . . . 74.31 108.487 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' F' ' 140' ' ' SER . 29.9 mm-40 -86.94 114.48 58.48 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.037 0.535 . . . . 64.22 110.458 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.79 140.58 86.5 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 123.407 2.738 . . . . 74.15 114.217 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.02 126.16 28.95 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.953 0.901 . . . . 55.05 109.863 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.49 HG13 HG13 ' D' ' 64' ' ' VAL . 47.9 t -99.58 112.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 72.13 110.258 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 1.4 tmtp? -88.09 122.14 31.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.028 -1.471 . . . . 70.22 107.028 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.08 115.4 27.43 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.773 -1.195 . . . . 50.11 107.773 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.643 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.7 m-20 -108.27 136.81 47.3 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.97 -1.122 . . . . 75.52 107.97 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.93 133.33 37.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.083 0.553 . . . . 52.33 109.922 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.8 t70 -142.06 157.25 45.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 73.43 108.198 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -132.29 158.13 42.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.833 0.853 . . . . 71.45 109.5 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.68 170.04 21.23 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.957 -0.757 . . . . 64.1 108.957 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' D' ' 152' ' ' HIS . 39.6 m -150.68 159.56 44.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.973 0.509 . . . . 75.14 109.965 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' D' ' 57' ' ' GLU . 40.3 t -152.06 127.07 9.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.479 -0.934 . . . . 55.24 108.479 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.53 117.8 24.65 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.44 -0.948 . . . . 63.14 108.44 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.2 mt -98.09 -29.73 13.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.171 0.588 . . . . 72.24 110.165 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -161.02 -179.03 7.19 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.033 0.933 . . . . 72.42 109.972 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -68.15 118.66 11.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.006 -0.997 . . . . 75.42 108.819 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 67.53 16.91 9.99 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.131 0.972 . . . . 74.33 112.032 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 76.8 t -127.33 117.12 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.449 -0.945 . . . . 74.3 108.449 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -135.2 129.31 33.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.785 -0.643 . . . . 74.31 109.787 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.3 tt0 -87.15 148.16 25.32 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.604 1.162 . . . . 73.14 108.394 167.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.498 HG13 HD11 ' D' ' 106' ' ' LEU . 4.1 p -134.5 138.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.734 -1.21 . . . . 75.22 107.734 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 94.7 t -108.84 136.85 43.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.072 -0.714 . . . . 64.23 109.072 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.56 116.99 29.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.024 -1.473 . . . . 72.31 107.024 174.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -97.46 98.21 9.75 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.36 -0.978 . . . . 54.41 108.36 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.1 116.64 39.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.282 -1.007 . . . . 71.24 108.282 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 33.3 m -125.46 132.51 52.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.04 -0.982 . . . . 73.44 109.04 -171.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.596 HG11 HD11 ' D' ' 126' ' ' LEU . 56.6 t -122.59 102.82 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.085 0.954 . . . . 55.31 109.059 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 25.3 m -95.81 91.95 6.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.98 -1.119 . . . . 74.42 107.98 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.51 139.61 31.53 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.598 -0.89 . . . . 75.11 108.598 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.8 p -151.99 135.43 16.05 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.625 0.578 . . . . 71.1 110.34 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' D' ' 36' ' ' TRP . 12.6 tp -112.78 106.09 14.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.714 -0.676 . . . . 74.03 109.318 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.94 -133.12 11.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.755 -0.657 . . . . 75.01 112.201 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 3.78 41.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.584 0.753 . . . . 72.03 111.617 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.5 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 9.5 tp10 -138.46 149.22 45.22 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.729 0.812 . . . . 65.33 109.17 -165.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -56.77 152.85 11.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.405 1.082 . . . . 75.43 111.206 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -107.26 -62.29 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.463 -0.94 . . . . 65.23 108.463 171.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.1 149.37 24.52 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.075 -0.966 . . . . 74.43 109.151 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.8 mt -112.03 151.19 29.62 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.982 -1.118 . . . . 72.04 107.982 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.509 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.7 t -158.42 146.77 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.401 0.438 . . . . 72.11 109.987 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.65 132.28 10.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.587 0.755 . . . . 74.01 109.062 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.5 113.2 22.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.425 -0.954 . . . . 72.14 108.425 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -89.45 81.79 6.53 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.038 -1.097 . . . . 63.3 108.038 171.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.427 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.9 tp-100 -79.7 99.75 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 112.914 -1.948 . . . . 75.51 109.216 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.24 161.66 31.64 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.91 -0.476 . . . . 35.21 111.91 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -164.86 136.23 4.11 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.626 -0.59 . . . . 63.11 111.626 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.96 137.08 22.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.591 0.756 . . . . 72.42 110.074 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.95 132.69 38.71 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.848 0.859 . . . . 54.42 109.533 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 5.7 m -75.52 95.89 3.4 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.352 -0.981 . . . . 74.5 108.352 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 53.4 mt -105.94 99.36 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.451 -0.944 . . . . 64.14 108.451 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -126.88 153.19 46.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.677 1.191 . . . . 74.04 108.778 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.06 -7.9 62.05 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.753 -0.471 . . . . 70.13 113.454 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.559 HD12 ' HG2' ' D' ' 93' ' ' GLN . 5.5 mm -137.97 129.27 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.938 0.895 . . . . 72.45 110.671 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.607 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 3.0 pp20? -148.36 -173.83 4.43 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.655 0.782 . . . . 73.13 110.232 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.42 -140.52 25.46 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.014 -0.326 . . . . 52.13 113.137 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -69.99 -25.11 63.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.202 0.601 . . . . 51.22 110.851 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.559 ' HG2' HD12 ' D' ' 89' ' ' ILE . 6.2 tp-100 -72.74 -32.07 65.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.278 0.631 . . . . 51.11 110.355 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.607 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 21.1 ttt -71.34 -42.41 68.56 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.826 -0.435 . . . . 73.22 109.826 171.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -27.62 69.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.863 0.465 . . . . 65.44 111.036 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.78 -52.76 8.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.676 0.79 . . . . 64.1 110.733 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.29 -51.64 62.51 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.944 0.402 . . . . 63.03 110.963 -172.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 22.5 tp -75.81 -19.3 59.06 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 73.05 110.929 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.41 -5.51 36.93 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.516 -0.602 . . . . 54.32 114.287 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.31 -61.9 0.72 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.941 0.871 . . . . 51.43 111.408 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.83 -47.32 54.0 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.444 0.465 . . . . 74.33 112.027 -171.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HG ' ' HZ ' ' D' ' 11' ' ' PHE . 59.8 m -64.75 -44.78 74.38 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 123.491 0.716 . . . . 63.34 111.722 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.499 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.9 Cg_exo -57.16 -34.89 98.6 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 122.513 2.142 . . . . 65.55 113.871 166.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.75 -34.43 78.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.082 0.553 . . . . 60.05 110.73 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.37 -33.43 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.796 . . . . 63.2 110.561 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.498 HD11 HG13 ' D' ' 58' ' ' VAL . 91.3 mt -79.38 -20.66 47.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.819 0.848 . . . . 63.24 112.603 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.05 -42.84 64.36 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 113.968 1.099 . . . . 73.1 113.968 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.81 -39.83 87.91 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.054 1.836 . . . . 70.34 113.281 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.67 -36.39 65.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.596 0.758 . . . . 72.34 111.38 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -51.07 70.07 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.297 0.639 . . . . 45.32 110.121 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.0 -48.09 79.28 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.777 1.298 . . . . 75.21 110.589 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.0 -43.16 99.29 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.364 1.04 . . . . 73.44 111.736 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.55 -41.62 97.64 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.553 0.533 . . . . 75.41 110.767 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.509 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.3 mt -67.7 -43.47 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.556 -0.747 . . . . 73.22 110.716 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.4 m -55.63 -46.37 77.41 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.996 0.918 . . . . 70.13 110.66 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.5 t -64.82 -46.93 79.87 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 114.026 -1.443 . . . . 44.54 110.578 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -64.49 -36.5 84.38 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.007 0.523 . . . . 65.21 112.089 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' D' ' 123' ' ' PHE . 45.3 t -67.18 -40.95 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.215 -0.902 . . . . 51.15 110.661 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -75.17 -23.53 57.74 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.416 0.287 . . . . 73.45 111.408 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.531 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 89.2 mtt-85 -74.56 -38.17 62.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.499 0.72 . . . . 73.34 109.723 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.42 1.55 76.11 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.541 -0.754 . . . . 33.45 112.391 173.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 60.13 23.51 12.78 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.852 2.061 . . . . 71.24 113.146 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.445 ' HB2' HG13 ' D' ' 118' ' ' VAL . 78.7 m-85 -80.6 161.16 65.22 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 124.862 1.265 . . . . 51.04 109.114 169.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.21 135.42 43.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.355 2.037 . . . . 73.24 112.234 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -48.45 130.92 17.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.048 1.339 . . . . 74.33 112.562 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.596 HD11 HG11 ' D' ' 64' ' ' VAL . 9.6 tt -108.71 112.49 24.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.618 0.767 . . . . 50.3 109.553 -171.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -124.74 92.71 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.388 0.675 . . . . 75.21 109.683 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 69.4 mt -68.53 132.68 47.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.124 0.569 . . . . 72.55 110.238 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.47 139.89 94.61 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.41 0.684 . . . . 64.55 111.234 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.94 127.66 20.99 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.828 2.352 . . . . 73.31 112.529 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.61 111.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.015 0.926 . . . . 71.03 109.849 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -84.73 101.81 12.51 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.656 -0.498 . . . . 71.13 109.656 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.95 -22.26 62.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.43 0.692 . . . . 72.23 111.256 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.81 -50.46 70.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.552 1.141 . . . . 73.34 111.716 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.35 80.13 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.616 0.573 . . . . 71.31 111.708 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.06 -39.99 90.56 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.247 -0.888 . . . . 72.1 109.875 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -66.48 -32.16 73.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.794 0.838 . . . . 74.44 111.079 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 16.4 mmt -59.48 -46.51 88.59 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.314 0.578 . . . . 63.55 110.075 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -71.18 -31.39 67.59 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.677 -1.147 . . . . 64.53 111.365 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -57.12 -36.84 71.14 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.715 0.806 . . . . 74.42 112.436 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.13 -44.13 87.62 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 64.51 111.752 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -87.67 3.36 48.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.823 0.449 . . . . 72.33 111.55 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -120.67 71.18 0.92 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.738 0.78 . . . . 75.0 109.627 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -143.8 102.04 3.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.234 -1.348 . . . . 71.11 107.995 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.29 -27.87 60.92 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.531 0.681 . . . . 72.12 109.939 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.2 -166.37 39.6 Favored Glycine 0 C--O 1.242 0.595 0 CA-C-N 114.472 -1.24 . . . . 75.35 110.194 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 61.41 -172.56 0.14 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.972 0.909 . . . . 73.11 112.341 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.32 92.91 0.14 Allowed Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.738 -0.545 . . . . 71.14 111.738 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -134.36 146.74 50.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.218 0.607 . . . . 73.03 110.248 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.13 175.92 10.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.632 1.173 . . . . 74.32 109.788 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -149.55 122.66 8.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.009 0.524 . . . . 64.42 109.881 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 152' ' ' HIS . . . . . 0.468 ' HB3' ' HB2' ' D' ' 48' ' ' SER . 72.4 m80 -140.62 100.2 3.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.906 0.882 . . . . 73.45 108.854 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -161.38 116.03 2.03 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.308 0.643 . . . . 61.12 109.481 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -142.57 153.87 43.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.302 -0.999 . . . . 74.22 108.302 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.751 -0.642 . . . . 74.14 109.968 -176.925 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 110.158 -0.312 . . . . 70.3 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.76 91.96 1.17 Allowed 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.632 0.582 . . . . 75.01 110.019 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.09 84.72 7.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.298 -1.001 . . . . 62.24 108.298 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -74.64 79.77 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.625 0.726 . . . . 71.14 109.445 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -168.87 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.146 1.378 . . . . 73.42 108.999 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.76 -54.48 34.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.539 0.736 . . . . 74.34 110.62 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.598 ' HG2' ' H ' ' E' ' 115' ' ' LEU . 30.0 ttpt 67.46 -163.18 0.22 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.269 1.028 . . . . 73.54 110.316 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.598 ' H ' ' HG2' ' E' ' 114' ' ' LYS . 78.7 mt -92.57 36.44 1.01 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.559 0.744 . . . . 71.42 111.456 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.67 71.32 15.43 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.178 -0.675 . . . . 70.04 109.178 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -93.64 4.15 3.06 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 123.084 2.523 . . . . 65.14 113.043 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -157.35 142.3 16.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.637 -0.875 . . . . 64.24 108.637 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -100.32 -48.59 4.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.831 0.853 . . . . 64.35 110.846 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 65.42 88.89 0.1 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.805 1.242 . . . . 73.11 109.883 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -134.12 76.37 1.65 Allowed 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.571 -1.27 . . . . 72.51 107.571 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -167.38 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.696 -0.684 . . . . 55.32 111.267 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 t 55.55 80.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.021 0.928 . . . . 74.13 108.925 -159.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 124' ' ' ARG . . . . . 0.462 ' N ' HD21 ' B' ' 136' ' ' LEU . 48.1 ttt85 -74.22 75.24 1.81 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.88 0.872 . . . . 75.43 110.164 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -97.0 95.47 7.83 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 108.355 -0.98 . . . . 72.44 108.355 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -94.77 6.73 48.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.572 0.749 . . . . 72.44 111.476 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -114.84 59.21 0.42 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.211 -0.355 . . . . 73.42 112.211 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -58.24 130.26 45.84 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.636 0.774 . . . . 64.11 111.334 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 129' ' ' LEU . . . . . 0.492 HD12 HD21 ' B' ' 42' ' ' LEU . 1.2 pp -139.51 -166.24 2.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.383 1.073 . . . . 74.42 109.596 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 tt -123.27 -45.66 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.353 0.661 . . . . 61.4 109.371 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 131' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' B' ' 129' ' ' ALA . . . -167.69 -169.06 1.1 Allowed 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.408 1.083 . . . . 74.21 109.103 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -65.75 134.88 95.36 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.928 -1.034 . . . . 73.14 108.837 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.68 87.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.389 2.726 . . . . 74.41 113.445 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 19.2 tt -174.89 124.19 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.263 1.425 . . . . 72.35 107.991 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.84 103.61 14.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.087 0.555 . . . . 64.13 110.544 -174.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.8 -9.4 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.004 0.921 . . . . 71.15 109.877 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -78.08 76.09 4.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.936 1.294 . . . . 74.42 110.466 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.55 109.41 0.73 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.9 0.88 . . . . 62.23 109.632 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 139' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' C' ' 126' ' ' LEU . 24.0 tp -165.89 133.71 2.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.522 0.729 . . . . 74.21 109.955 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -139.73 -151.81 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 76.6 mt 67.6 17.24 9.93 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.273 1.029 . . . . 63.33 112.154 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 142' ' ' ILE . . . . . 0.729 ' HB ' HD21 ' C' ' 126' ' ' LEU . 6.7 tt -84.43 126.94 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.321 1.048 . . . . 75.22 109.129 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 54.9 89.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.895 0.878 . . . . 63.15 111.356 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -65.97 -22.8 66.49 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.456 -0.793 . . . . 74.25 110.052 173.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -97.66 -176.55 3.51 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.386 1.074 . . . . 74.31 111.094 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -83.37 -166.37 1.35 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.555 1.142 . . . . 73.34 110.871 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.49 169.64 17.89 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.215 1.006 . . . . 74.4 110.448 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.417 HD13 ' H ' ' C' ' 132' ' ' ASN . 9.9 tt -85.01 112.45 43.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 109.15 -0.685 . . . . 74.12 109.15 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 C--N 1.38 2.235 0 C-N-CA 123.568 2.845 . . . . 63.25 112.247 174.566 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.725 -0.472 . . . . 74.21 109.725 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -133.29 8.12 3.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.006 0.922 . . . . 72.15 110.927 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.01 101.95 0.76 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.244 0.617 . . . . 74.21 111.037 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 47.2 t80 66.19 121.73 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.248 1.819 . . . . 72.45 113.579 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -162.84 -79.41 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.7 -1.592 . . . . 74.51 106.7 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 54.24 90.37 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.254 1.422 . . . . 73.13 112.205 169.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.1 154.43 41.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.652 -0.704 . . . . 74.03 111.351 -174.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.83 -37.64 85.22 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.11 -0.7 . . . . 71.2 109.11 169.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -117.73 87.31 26.38 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.591 0.757 . . . . 74.52 109.633 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.04 -70.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.85 2.367 . . . . 73.23 110.499 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 24.2 t80 58.75 92.04 0.04 OUTLIER 'General case' 0 C--N 1.363 1.184 0 C-N-CA 125.32 1.448 . . . . 71.44 111.779 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 2.0 m -64.25 -55.57 20.56 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.592 -0.731 . . . . 75.22 110.662 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 50.91 43.53 28.6 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.909 1.284 . . . . 74.35 111.484 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -87.47 37.69 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.071 -1.422 . . . . 65.11 110.082 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.02 29.86 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.549 1.14 . . . . 25.13 110.214 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -60.58 118.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.418 0.687 . . . . 43.23 111.28 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -155.96 126.28 6.67 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.184 -0.462 . . . . 71.43 110.274 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -155.27 154.55 32.31 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.368 1.467 . . . . 74.35 108.042 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -64.92 -69.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.77 0.428 . . . . 44.2 111.268 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.65 -98.81 0.41 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 110.948 -0.861 . . . . 72.13 110.948 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 128' ' ' LYS . . . . . 0.712 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 2.9 mppt? -81.89 157.45 24.35 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.924 -0.398 . . . . 70.11 109.924 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.445 HD22 ' HB ' ' C' ' 13' ' ' ILE . 1.0 OUTLIER -140.06 -8.62 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.873 0.869 . . . . 65.14 111.42 175.382 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 pt -68.91 137.13 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.101 0.56 . . . . 72.32 110.326 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.76 -55.37 0.73 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.088 0.555 . . . . 64.41 110.841 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -85.15 108.12 14.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.176 -0.676 . . . . 73.35 109.176 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.33 73.55 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.392 2.728 . . . . 73.12 111.758 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.431 HG12 HG13 ' F' ' 136' ' ' VAL . 16.0 tt -62.89 125.84 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 116.141 -0.481 . . . . 75.22 110.403 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.19 96.2 2.73 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.302 0.641 . . . . 75.41 109.498 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.632 HG23 ' H ' ' F' ' 137' ' ' GLU . 2.8 m -127.56 -85.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.813 0.845 . . . . 72.1 110.544 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 137' ' ' GLU . . . . . 0.632 ' H ' HG23 ' F' ' 136' ' ' VAL . 44.8 tt0 55.07 -80.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.5 1.52 . . . . 74.33 112.391 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -128.08 126.17 40.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.091 . . . . 71.33 108.972 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.58 119.17 9.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.244 1.018 . . . . 63.12 111.589 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 140' ' ' SER . . . . . 0.438 ' HB2' ' HG3' ' D' ' 37' ' ' GLN . 18.8 m -93.25 170.23 9.79 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.991 0.916 . . . . 73.14 108.866 172.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt 67.56 11.26 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.6 1.16 . . . . 75.13 111.775 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.05 125.22 40.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.498 0.719 . . . . 44.54 109.22 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 13.6 t80 63.63 -176.05 0.16 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.205 1.002 . . . . 75.32 110.381 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -103.02 -171.0 1.87 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.808 0.843 . . . . 75.11 109.53 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -98.76 32.88 2.45 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.683 -1.229 . . . . 64.51 107.683 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -76.55 -79.34 0.11 Allowed 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.954 -0.758 . . . . 71.14 108.954 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 4.8 tt 50.54 75.52 0.18 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.792 1.237 . . . . 71.34 109.825 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 131.98 85.55 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 116.159 -0.473 . . . . 64.44 110.66 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--N 1.377 2.04 0 C-N-CA 122.756 2.304 . . . . 70.5 112.074 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.63 -0.507 . . . . 75.33 109.63 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -162.66 -70.71 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 60.34 108.933 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -121.07 122.84 40.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 73.31 108.838 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 66.7 84.11 0.16 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.481 1.112 . . . . 71.2 110.925 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -107.25 92.22 3.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.226 -1.027 . . . . 64.13 108.226 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -136.72 -10.72 1.82 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.029 0.932 . . . . 71.05 110.671 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -95.56 -57.81 2.29 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.826 0.45 . . . . 70.14 110.534 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.24 -46.24 51.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.721 0.808 . . . . 73.11 111.783 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.8 mtt -139.26 144.46 38.41 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.686 0.794 . . . . 74.22 109.255 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.5 m -146.94 129.84 16.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.007 0.923 . . . . 61.12 109.47 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -139.09 114.47 9.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.298 -1.001 . . . . 74.42 108.298 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 96.5 mt-30 -133.66 122.35 23.31 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.216 -0.661 . . . . 72.34 109.216 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -82.27 88.93 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 108.722 -0.844 . . . . 72.24 108.722 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -77.28 -41.22 41.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.119 -0.491 . . . . 74.22 111.882 -165.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -153.94 137.27 15.77 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.209 1.003 . . . . 73.55 108.293 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.657 HD13 ' HG3' ' C' ' 130' ' ' PRO . 4.4 mp -130.6 119.19 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 106.927 -1.509 . . . . 73.04 106.927 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -152.93 174.68 13.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.456 0.702 . . . . 74.31 111.521 -172.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -97.73 117.15 31.39 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.757 -0.831 . . . . 53.22 108.757 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 39.7 mtpt -80.73 -22.67 40.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.582 -0.281 . . . . 63.45 110.315 174.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 16.3 t70 -157.82 147.02 19.67 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.031 0.832 . . . . 74.02 109.637 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 94.7 mt -143.99 138.9 24.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 125.536 1.534 . . . . 43.15 106.944 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.2 t -153.64 108.39 3.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.955 0.502 . . . . 73.45 109.888 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.602 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 57.2 t80 -109.11 131.51 55.0 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 106.343 -1.725 . . . . 74.45 106.343 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -124.97 141.45 52.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.71 72.72 9.71 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.834 -1.173 . . . . 43.53 107.834 170.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.05 -25.46 19.37 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.433 2.089 . . . . 61.21 111.063 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -104.61 26.15 9.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.895 0.878 . . . . 50.02 110.602 177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.73 -49.0 93.93 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 123.359 0.664 . . . . 61.14 112.788 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.3 Cg_exo -70.02 -23.09 30.02 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 121.779 1.653 . . . . 75.15 112.236 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 9.1 m80 -74.33 -21.07 59.88 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.617 -0.719 . . . . 75.31 111.271 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HE2' ' A' ' 123' ' ' PHE . 84.2 t -53.62 -25.8 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.625 0.602 . . . . 63.43 112.625 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -67.67 -40.85 84.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.313 0.645 . . . . 65.32 111.487 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.99 -14.01 34.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.415 0.686 . . . . 71.24 111.305 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? -75.27 146.09 41.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.808 0.443 . . . . 73.42 111.484 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -73.25 118.46 16.23 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.296 -1.001 . . . . 72.12 108.296 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -79.18 86.06 5.01 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.918 0.487 . . . . 72.32 111.039 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 35.1 tt0 -139.95 71.12 35.55 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.127 -1.064 . . . . 61.02 108.127 170.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -80.68 117.49 3.35 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.717 2.278 . . . . 44.42 112.073 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.72 110.72 22.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.166 -1.05 . . . . 71.42 108.166 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -82.69 92.7 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 122.498 1.142 . . . . 73.43 109.528 175.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -94.49 130.52 40.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.293 -1.322 . . . . 74.11 108.567 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.479 HD11 ' HD2' ' F' ' 125' ' ' TYR . 2.7 pt? -124.64 151.3 45.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.798 0.439 . . . . 60.44 111.378 -170.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -128.97 127.87 42.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.775 1.23 . . . . 71.33 108.483 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' F' ' 123' ' ' VAL . 79.9 mt -118.22 133.86 55.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.106 0.562 . . . . 64.41 109.821 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 15.7 t70 -146.64 150.16 34.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.712 0.805 . . . . 75.25 109.666 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.0 m -142.02 127.22 18.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.887 0.875 . . . . 73.44 109.843 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -142.78 146.17 33.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.525 0.73 . . . . 63.32 109.767 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -105.7 169.98 8.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.618 0.767 . . . . 75.21 111.239 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -154.94 120.46 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.989 0.916 . . . . 35.51 108.829 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -77.81 114.57 16.8 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.964 -0.384 . . . . 62.04 109.964 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.6 mt -85.65 -40.71 15.89 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.605 0.762 . . . . 62.42 109.986 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.56 -174.62 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.333 -0.849 . . . . 75.4 110.144 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.3 117.26 6.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.31 -0.626 . . . . 74.11 109.31 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 71.96 2.53 4.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.934 1.293 . . . . 73.12 112.34 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -107.7 112.6 40.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.236 -1.024 . . . . 71.4 108.236 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.94 123.36 28.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.223 -0.658 . . . . 44.43 109.223 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.4 tt0 -88.28 140.9 29.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.856 0.862 . . . . 60.14 108.921 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.38 123.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.844 -1.169 . . . . 45.51 107.844 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.567 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 33.5 t -103.57 148.8 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.784 0.834 . . . . 54.12 109.82 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.68 117.6 26.14 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.407 -0.961 . . . . 73.3 108.407 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 1.7 mpp_? -88.93 106.87 18.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.38 -0.97 . . . . 71.12 108.38 171.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG21 ' HB1' ' A' ' 110' ' ' ALA . 7.7 t -111.17 114.11 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.144 -1.058 . . . . 65.42 108.144 169.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 27.5 m -110.41 130.55 55.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.095 -1.076 . . . . 71.02 108.095 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.16 108.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.105 -1.072 . . . . 63.04 108.105 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 16.1 m -110.67 133.86 52.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.908 -0.405 . . . . 73.43 109.908 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.47 105.31 15.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.097 -1.075 . . . . 52.44 108.097 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.8 m -118.06 127.16 53.53 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.155 0.582 . . . . 72.0 110.277 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.8 OUTLIER -88.99 85.71 6.77 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.862 0.839 . . . . 73.51 109.05 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.34 -88.97 1.3 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.301 -0.863 . . . . 70.41 111.049 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 -28.75 4.65 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.431 0.692 . . . . 75.52 110.804 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -79.04 134.15 36.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 72.22 109.657 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.3 m -85.88 121.37 28.43 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.099 0.408 . . . . 71.44 110.591 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.65 -58.16 7.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.52 0.728 . . . . 42.23 109.645 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -164.27 162.18 22.34 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.434 -1.257 . . . . 73.42 110.564 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.2 tp -117.54 147.72 42.54 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.452 1.101 . . . . 72.13 109.776 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.51 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 61.9 m -140.85 100.15 3.77 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.206 1.002 . . . . 72.34 109.482 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.99 126.56 44.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.132 0.973 . . . . 74.41 109.176 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -136.69 138.78 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.389 0.676 . . . . 51.42 109.764 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -105.52 96.84 6.79 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.577 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -84.56 98.94 10.43 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.109 -0.701 . . . . 71.11 109.109 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -112.39 144.96 17.96 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.606 -0.598 . . . . 71.04 111.606 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.87 146.79 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.374 -0.29 . . . . 64.02 112.374 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.69 128.06 39.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 108.692 -0.855 . . . . 45.24 108.692 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -128.92 118.16 22.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.323 -0.621 . . . . 73.05 109.323 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 20.5 m -83.54 87.04 7.01 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.471 -0.937 . . . . 74.21 108.471 176.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.96 138.49 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.849 0.859 . . . . 74.2 110.023 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.07 161.28 12.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.931 0.893 . . . . 64.31 110.881 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 4.24 85.24 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.738 -0.665 . . . . 54.52 114.665 172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.572 ' HB ' ' HE2' ' A' ' 94' ' ' MET . 46.2 mt -119.52 136.48 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.019 -1.104 . . . . 63.34 108.019 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.97 174.69 10.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.175 0.59 . . . . 74.23 109.812 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -144.75 49.24 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.239 -0.891 . . . . 73.43 113.579 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.623 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 41.2 p -71.21 -15.07 62.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.322 1.049 . . . . 73.45 112.318 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -63.56 -50.9 67.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.286 0.634 . . . . 71.42 110.424 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.572 ' HE2' ' HB ' ' A' ' 89' ' ' ILE . 56.1 tpp -83.14 -29.03 28.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.887 0.475 . . . . 70.32 111.054 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -62.21 -28.1 69.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 63.1 110.83 172.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -68.81 -54.68 14.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.862 -1.063 . . . . 72.15 109.78 166.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 4.2 m -64.46 -56.87 11.34 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.593 1.331 . . . . 73.5 114.593 -166.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.558 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 77.9 mt -69.71 -15.86 63.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.635 0.652 . . . . 71.4 112.3 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.55 -0.27 43.15 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.703 -0.498 . . . . 31.5 113.903 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.59 -65.91 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.049 0.54 . . . . 43.12 111.358 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.7 t80 -51.65 -52.95 43.86 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.779 1.232 . . . . 70.23 112.818 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -73.24 -48.48 7.41 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.309 -0.853 . . . . 72.12 112.644 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.54 -20.21 69.99 Favored 'Trans proline' 0 C--N 1.383 2.351 0 CA-C-N 121.153 1.448 . . . . 70.31 113.337 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.24 -41.84 80.58 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.452 0.701 . . . . 74.31 110.407 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.91 -37.35 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.432 0.693 . . . . 53.21 110.452 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.69 -26.36 34.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.357 -0.838 . . . . 72.11 112.133 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -62.56 -44.34 86.79 Favored Pre-proline 0 CA--C 1.566 1.568 0 N-CA-C 114.896 1.443 . . . . 74.2 114.896 -169.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 -39.48 43.55 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.884 1.723 . . . . 73.34 112.306 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -73.69 -31.32 63.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.416 0.687 . . . . 75.0 111.369 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.403 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.51 -51.77 61.23 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.327 0.651 . . . . 33.42 109.342 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.483 HH12 HD12 ' C' ' 105' ' ' ILE . 39.2 ttm180 -52.43 -51.5 58.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.477 -1.238 . . . . 72.42 110.966 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.19 -46.84 85.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.589 -0.732 . . . . 74.2 111.62 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.468 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.8 t -57.95 -38.92 76.86 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.599 0.562 . . . . 72.53 111.335 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 76' ' ' CYS . 95.9 mt -67.65 -52.65 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.231 1.012 . . . . 64.54 110.796 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.474 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -60.89 -34.0 73.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.495 1.118 . . . . 52.54 111.673 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -69.48 -39.97 77.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.585 -0.734 . . . . 73.25 109.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.8 mtm -63.51 -38.66 91.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.627 0.371 . . . . 74.24 110.781 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 76' ' ' CYS . 81.3 t -59.66 -49.65 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.829 0.851 . . . . 63.32 110.622 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.0 p -71.07 -34.09 70.84 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.022 -0.535 . . . . 73.21 111.638 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -68.8 -30.73 69.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.508 0.723 . . . . 64.14 109.873 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.66 -1.12 90.06 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.595 -0.729 . . . . 62.23 112.777 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m 65.33 46.45 2.6 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 122.831 1.3 . . . . 64.3 110.194 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG21 ' A' ' 31' ' ' VAL . 59.6 m-85 -121.16 149.67 52.06 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.29 -1.323 . . . . 74.3 109.095 173.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.99 140.1 91.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.395 2.063 . . . . 62.52 111.41 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.474 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -51.14 134.97 26.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.669 1.188 . . . . 70.13 113.315 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.412 HD22 HG11 ' A' ' 40' ' ' VAL . 86.8 mt -121.11 100.98 7.37 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.081 0.952 . . . . 73.02 108.762 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -117.29 105.02 11.74 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 55.24 109.542 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.26 150.72 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 64.32 109.509 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.82 93.23 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.62 0.768 . . . . 53.41 111.608 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.23 115.47 3.34 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.075 1.85 . . . . 64.34 110.74 170.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.64 113.07 32.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.806 -1.183 . . . . 64.31 107.806 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -82.71 72.89 9.78 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.5 1.143 . . . . 72.2 108.221 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -70.59 -20.91 62.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 113.522 -1.672 . . . . 74.22 109.647 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.529 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.4 t70 -59.01 -47.3 85.68 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.184 0.994 . . . . 71.24 109.922 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.33 -30.83 69.77 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.275 0.985 . . . . 75.31 112.347 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.6 tp -58.5 -49.27 77.99 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.722 0.409 . . . . 63.35 111.206 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -85.79 -28.33 24.6 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.169 -0.469 . . . . 72.14 110.678 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.573 ' SD ' HD23 ' A' ' 141' ' ' LEU . 13.0 tpt -66.9 -30.08 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.638 0.375 . . . . 71.54 111.23 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 91.4 m-20 -61.5 -35.31 77.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.174 0.589 . . . . 70.2 110.915 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -79.04 -36.83 40.41 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.913 -0.585 . . . . 72.35 110.393 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.573 HD23 ' SD ' ' A' ' 138' ' ' MET . 47.6 tp -67.97 -49.86 59.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.162 0.985 . . . . 61.25 112.124 -172.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -159.9 15.35 0.14 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.113 0.565 . . . . 73.03 110.256 -173.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 21.5 mm-40 57.98 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.367 1.067 . . . . 74.11 111.363 -173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -156.04 113.21 3.21 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.737 -0.838 . . . . 73.0 108.737 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.07 165.0 2.86 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.612 1.165 . . . . 70.41 110.005 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' C' ' 140' ' ' TYR . . . 91.99 121.64 2.8 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.783 -0.454 . . . . 63.22 112.196 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -105.05 100.54 10.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.665 0.733 . . . . 73.21 109.621 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.65 76.94 1.81 Allowed Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.462 -1.055 . . . . 61.14 110.462 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -118.36 107.54 13.98 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.678 0.791 . . . . 70.22 110.471 -173.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.27 84.77 0.72 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.057 -1.09 . . . . 60.25 108.057 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.432 ' HG2' ' HE1' ' C' ' 133' ' ' PHE . 36.2 mt-10 -76.93 91.94 3.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.31 -0.859 . . . . 74.1 109.226 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -89.28 145.03 25.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.361 1.064 . . . . 74.4 109.973 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -78.02 91.22 4.23 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.983 -0.747 . . . . 74.3 108.983 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.26 132.51 46.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.21 1.004 . . . . 74.14 110.031 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.562 ' H ' ' HD3' ' E' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 124.113 0.965 . . . . 73.24 110.327 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.938 -0.393 . . . . 73.55 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -146.12 132.55 19.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.616 -0.883 . . . . 53.22 108.616 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.55 159.49 15.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.322 0.649 . . . . 74.43 111.226 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -123.16 87.25 2.72 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.108 -1.071 . . . . 75.45 108.108 172.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -110.41 167.29 10.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.729 . . . . 40.42 110.316 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -76.31 135.8 39.58 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.114 -1.069 . . . . 54.33 108.114 166.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -67.0 -28.86 68.59 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.706 0.403 . . . . 71.24 111.024 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 67.73 -70.86 0.11 Allowed 'General case' 0 C--N 1.362 1.136 0 C-N-CA 125.535 1.534 . . . . 71.21 110.496 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.535 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.0 ptm 58.58 -178.22 0.08 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.158 1.783 . . . . 75.44 113.036 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.5 t -165.22 142.84 6.0 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 108.068 -1.086 . . . . 70.03 108.068 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -139.51 134.41 32.2 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.808 -0.812 . . . . 74.32 108.808 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -149.37 143.78 25.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.126 0.57 . . . . 60.25 110.195 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.87 122.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.623 -1.251 . . . . 72.23 107.623 170.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -85.82 -42.84 13.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.514 -0.55 . . . . 74.22 109.514 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -166.25 134.35 2.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.159 -0.473 . . . . 75.23 109.894 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.9 134.53 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 107.149 -1.426 . . . . 71.4 107.149 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -162.4 154.48 18.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.659 0.742 . . . . 73.4 112.093 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -80.51 127.3 32.27 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.421 -1.263 . . . . 61.32 108.676 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -97.31 -32.36 11.93 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.999 0.919 . . . . 33.21 110.884 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -160.07 143.47 13.96 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.176 0.297 . . . . 54.3 110.562 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.484 HD12 HG22 ' B' ' 78' ' ' VAL . 48.3 mm -136.68 138.0 46.83 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 C-N-CA 125.038 1.335 . . . . 75.45 108.616 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.0 t -134.7 139.5 45.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.103 -1.443 . . . . 74.43 107.103 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.1 t80 -153.33 112.57 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.322 -1.733 . . . . 72.54 106.322 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.41 112.8 17.35 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.146 -0.687 . . . . 61.2 109.146 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.51 83.17 1.88 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.293 -1.003 . . . . 52.2 108.293 174.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.67 -12.19 15.19 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.698 2.265 . . . . 71.05 112.079 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.424 ' O ' HG23 ' B' ' 31' ' ' VAL . 75.2 m-20 -125.57 24.19 7.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.973 0.909 . . . . 75.55 109.436 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.466 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.33 -52.55 35.09 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.351 1.241 . . . . 73.04 114.351 -174.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.74 -10.77 20.12 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.089 1.86 . . . . 71.54 113.625 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -94.16 -25.56 17.06 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.731 0.813 . . . . 73.15 111.075 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 27' ' ' ASN . 88.7 t -75.31 -19.16 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.838 0.855 . . . . 55.42 110.43 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -51.91 -42.25 62.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.632 1.173 . . . . 74.04 112.423 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -81.84 -12.71 58.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.265 0.626 . . . . 74.44 112.016 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.02 100.48 11.81 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.74 0.816 . . . . 63.22 110.843 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.05 78.1 7.5 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.658 0.783 . . . . 74.54 110.621 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.698 ' HB2' HD21 ' B' ' 68' ' ' LEU . 14.8 m-90 -150.41 161.55 42.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.236 1.015 . . . . 75.03 108.635 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.75 112.15 22.7 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.293 -1.002 . . . . 73.44 108.293 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 31.3 Cg_endo -62.36 117.99 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.637 2.225 . . . . 73.01 111.313 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.0 115.48 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.853 0.721 . . . . 73.43 110.816 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.529 HG21 HD21 ' B' ' 126' ' ' LEU . 27.5 m -97.49 136.75 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.849 0.833 . . . . 73.14 112.236 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -114.09 114.06 25.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.999 1.32 . . . . 64.44 108.036 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.419 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -115.66 140.5 49.13 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.469 -0.567 . . . . 53.33 109.469 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.87 147.14 52.46 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.684 0.794 . . . . 64.43 110.175 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -99.24 131.73 45.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.825 -1.079 . . . . 64.41 108.32 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 16.1 t70 -126.13 140.83 52.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.993 -1.114 . . . . 73.21 107.993 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -121.36 143.74 49.04 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.244 0.545 . . . . 75.01 110.422 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.81 157.9 43.65 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.502 1.121 . . . . 71.44 108.084 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -142.4 168.04 20.67 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.584 0.707 . . . . 42.22 109.676 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' B' ' 57' ' ' GLU . 41.4 t -150.94 157.36 42.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.207 -1.36 . . . . 74.0 107.352 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -121.0 115.86 23.98 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.34 -0.615 . . . . 75.52 109.34 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 68.8 mt -90.02 -35.46 15.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.402 0.681 . . . . 75.11 109.494 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 177.29 11.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 72.44 110.212 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.46 125.19 23.38 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.85 0.03 3.19 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.904 1.282 . . . . 71.33 112.826 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -112.62 96.11 4.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.716 0.806 . . . . 72.33 108.951 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.41 ' CD1' HD11 ' B' ' 86' ' ' ILE . 18.5 m-85 -111.24 139.57 46.53 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.505 0.669 . . . . 73.4 110.359 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' B' ' 49' ' ' SER . 7.1 tm-20 -103.59 97.09 7.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.165 -1.42 . . . . 72.43 107.165 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 121.69 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.604 0.761 . . . . 75.54 109.419 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.9 t -102.44 135.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.438 0.695 . . . . 64.25 109.916 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 117.83 31.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.35 -1.722 . . . . 71.12 106.35 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.6 ttp180 -112.43 113.54 25.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.871 0.367 . . . . 73.34 110.057 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.23 106.32 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.533 -1.284 . . . . 60.23 107.533 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -99.22 123.94 43.9 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.663 HG21 HG21 ' B' ' 114' ' ' ILE . 63.4 t -114.15 129.54 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.945 -1.025 . . . . 73.13 109.222 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -119.28 143.33 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.468 -1.308 . . . . 74.24 107.468 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -133.62 140.02 46.86 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.46 -0.571 . . . . 63.32 109.46 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 44.4 p -135.95 128.82 31.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.857 . . . . 73.41 108.899 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' B' ' 36' ' ' TRP . 2.4 tt -117.54 120.72 38.94 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.455 -1.313 . . . . 74.35 107.455 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -110.8 3.11 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.896 0.747 . . . . 64.5 111.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.39 3.13 13.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.141 0.976 . . . . 73.15 111.411 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.12 168.54 19.41 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.268 0.627 . . . . 74.2 111.441 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.0 m -67.06 120.87 14.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.062 -0.972 . . . . 74.12 110.481 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -75.49 -53.38 8.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.307 0.643 . . . . 74.14 109.508 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.98 170.84 16.08 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.369 -1.287 . . . . 73.34 109.735 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.88 154.25 45.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.889 1.275 . . . . 75.53 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -157.59 154.2 28.09 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.5 tt0 -164.56 130.59 2.89 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.573 -0.899 . . . . 72.12 108.573 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.484 HG22 HD12 ' B' ' 21' ' ' ILE . 94.5 t -125.62 142.34 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 109.136 -0.69 . . . . 71.22 109.136 173.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 48.9 mt-30 -117.39 99.67 7.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.609 -1.256 . . . . 75.35 107.609 169.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 47.1 tp60 -91.44 100.2 13.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.169 -1.049 . . . . 74.12 108.169 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -97.38 143.41 16.71 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.86 -0.896 . . . . 75.44 110.86 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.92 127.26 3.35 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 110.969 -0.852 . . . . 71.1 110.969 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.16 131.22 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.96 -1.126 . . . . 74.42 107.96 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -135.19 142.62 46.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.664 0.785 . . . . 64.44 110.703 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -90.68 105.77 18.05 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.349 -0.982 . . . . 63.13 108.349 169.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' B' ' 56' ' ' TYR . 1.6 pp -117.58 108.65 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.547 0.739 . . . . 41.32 110.19 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.94 44.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.581 0.752 . . . . 50.32 110.6 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 103.2 -71.3 0.29 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.835 -0.62 . . . . 74.32 112.3 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -73.6 158.35 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.691 0.396 . . . . 62.44 110.444 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 -176.32 5.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.478 0.711 . . . . 73.23 110.131 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.2 -131.52 50.0 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.584 0.552 . . . . 64.15 113.019 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.8 m -67.55 -24.27 65.51 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.593 0.757 . . . . 54.44 111.456 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.71 -37.15 65.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.312 0.645 . . . . 74.31 110.957 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 56.3 tpp -73.93 -31.5 63.08 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.77 -0.456 . . . . 71.32 109.77 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.539 ' HA ' ' HD1' ' E' ' 116' ' ' TYR . . . -65.63 -36.22 83.08 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.748 -0.66 . . . . 63.21 111.049 174.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.46 -36.45 60.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.5 0.72 . . . . 73.32 110.35 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.82 -59.01 5.09 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 72.54 111.021 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' E' ' 116' ' ' TYR . 7.0 mp -75.88 -18.72 59.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 73.24 110.949 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.05 1.2 67.46 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-O 119.672 -0.516 . . . . 54.34 114.184 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -153.69 -60.05 0.13 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.775 0.787 . . . . 60.11 112.518 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -65.91 -45.56 81.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.92 0.888 . . . . 73.42 111.335 -171.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 64.4 m -68.45 -49.88 29.47 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 115.442 -0.799 . . . . 53.5 112.187 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.39 -22.41 52.47 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.634 1.556 . . . . 54.3 113.799 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.38 -37.64 86.52 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.259 0.552 . . . . 70.04 110.859 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.93 -40.71 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 71.2 110.871 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 55.6 mt -80.98 -18.65 46.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.289 -0.869 . . . . 71.22 111.915 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.55 -48.03 96.48 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.571 1.323 . . . . 65.52 114.571 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.49 -31.66 80.41 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 121.596 1.531 . . . . 70.43 112.985 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.9 m-85 -68.26 -46.93 69.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.483 0.713 . . . . 65.43 110.817 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -57.64 -43.66 85.02 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.42 -0.809 . . . . 74.32 110.071 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 20.7 mtp-105 -51.26 -64.32 0.85 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.224 1.01 . . . . 72.55 111.434 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.54 -28.99 69.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.625 0.77 . . . . 64.21 110.842 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -71.48 -44.91 63.86 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.829 0.451 . . . . 45.13 110.574 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.663 HG21 HG21 ' B' ' 64' ' ' VAL . 57.0 mt -62.94 -51.26 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.61 0.764 . . . . 64.51 109.979 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.52 -37.7 79.02 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.944 -1.026 . . . . 72.41 111.041 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.7 t -60.65 -52.23 66.03 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.581 -0.736 . . . . 65.1 110.063 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.0 mmt -63.75 -38.84 92.61 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.174 0.589 . . . . 71.43 111.151 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 114' ' ' ILE . 83.2 t -60.6 -45.44 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.537 0.735 . . . . 72.32 110.739 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -69.5 -27.81 65.51 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.265 -0.88 . . . . 74.12 112.019 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.468 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 90.7 mtt-85 -68.9 -34.41 75.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.488 0.715 . . . . 70.3 110.222 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.2 7.72 55.28 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.823 0.702 . . . . 72.35 112.842 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p 55.78 32.01 18.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.111 1.764 . . . . 51.2 112.078 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -93.57 157.55 38.24 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.978 0.911 . . . . 71.15 109.985 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -47.73 147.4 7.08 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.82 3.013 . . . . 64.43 114.287 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -62.26 129.75 42.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.583 0.753 . . . . 73.43 109.721 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.529 HD21 HG21 ' B' ' 40' ' ' VAL . 2.2 tm? -126.09 111.18 14.37 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.407 -0.59 . . . . 65.13 109.407 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -111.02 134.81 52.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.267 1.027 . . . . 64.22 109.374 178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.599 HD11 HD12 ' B' ' 114' ' ' ILE . 36.9 mt -87.46 134.77 33.55 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 109.296 -0.631 . . . . 73.25 109.296 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.41 148.52 85.95 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.17 0.588 . . . . 72.05 110.087 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 99.82 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.914 2.41 . . . . 62.11 112.518 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -90.38 110.46 22.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.883 -1.154 . . . . 74.32 107.883 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -69.6 101.79 1.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.067 -0.716 . . . . 65.53 109.067 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.417 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 48.6 m-85 -56.65 -33.93 66.81 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.503 1.121 . . . . 72.4 110.112 176.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.64 -63.76 1.04 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.017 -1.447 . . . . 74.42 111.247 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.42 68.59 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.446 0.699 . . . . 52.32 111.708 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.86 -52.36 65.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.912 0.885 . . . . 72.34 109.759 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.461 ' HE1' ' HB3' ' E' ' 122' ' ' ALA . 27.9 t80 -91.35 -29.87 16.86 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.35 -0.841 . . . . 73.44 112.199 -170.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 33.4 mmt -75.49 -29.65 59.62 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.798 0.439 . . . . 72.3 111.176 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -76.35 -28.57 56.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.909 -0.404 . . . . 73.34 109.909 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -70.01 -25.57 63.65 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.041 -0.527 . . . . 73.23 110.217 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.4 mt -117.96 35.46 4.71 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.22 1.008 . . . . 64.34 110.236 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.08 109.79 0.71 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 120.856 0.36 . . . . 74.02 110.379 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -158.84 -0.03 0.09 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.84 0.856 . . . . 70.12 109.764 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.77 112.58 6.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 108.069 -1.086 . . . . 73.3 108.069 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.01 150.21 34.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.975 0.91 . . . . 72.35 109.174 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.04 91.8 0.28 Allowed Glycine 0 C--N 1.342 0.908 0 O-C-N 123.137 0.273 . . . . 54.31 112.456 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.64 128.54 33.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.224 0.609 . . . . 64.3 110.119 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.45 -144.11 16.31 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.919 -0.378 . . . . 73.01 112.299 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 35.4 m 63.49 90.93 0.08 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.8 1.24 . . . . 71.25 111.475 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.54 48.13 2.28 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.759 0.824 . . . . 72.31 109.754 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' D' ' 2' ' ' SER . 37.4 tt0 -47.31 120.29 3.11 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.928 1.291 . . . . 73.33 112.528 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -142.11 78.74 1.64 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.463 -0.94 . . . . 75.11 108.463 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.67 112.73 23.32 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.108 0.963 . . . . 73.33 108.918 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -141.34 139.48 33.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.811 0.845 . . . . 73.22 109.718 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 C-N-CA 123.348 0.659 . . . . 74.45 109.512 -176.873 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.982 -0.377 . . . . 72.14 109.982 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m -78.47 80.1 4.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.952 -0.759 . . . . 73.42 108.952 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.07 96.35 1.74 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.195 -0.911 . . . . 70.21 110.358 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 67.07 100.56 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.78 1.232 . . . . 71.14 111.546 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.97 162.21 33.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.493 0.717 . . . . 75.13 109.241 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -126.41 118.24 24.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.639 0.776 . . . . 62.23 109.095 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' C' ' 143' ' ' GLN . 23.2 p -117.88 106.21 12.74 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.901 0.88 . . . . 52.32 109.742 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.5 ' HG3' ' H ' ' C' ' 9' ' ' MET . 7.4 pt-20 -60.69 -68.01 0.34 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 122.976 0.51 . . . . 61.44 111.365 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.5 ' H ' ' HG3' ' C' ' 8' ' ' GLU . 27.9 ttt 52.65 111.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.75 1.62 . . . . 74.05 113.509 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -99.0 111.5 23.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.903 0.881 . . . . 73.13 108.832 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.641 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 58.3 t80 -119.03 130.72 55.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.395 -0.965 . . . . 71.41 108.395 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -144.79 133.54 22.31 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.619 0.367 . . . . 73.13 110.218 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.436 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.7 tp -83.96 134.38 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.389 0.676 . . . . 62.33 109.309 171.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.446 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.0 mm-40 -101.99 -47.28 4.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.654 0.782 . . . . 74.01 109.556 176.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -168.95 138.85 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.959 0.503 . . . . 72.32 110.899 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 60.9 mt -111.01 148.03 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.55 1.14 . . . . 71.5 108.131 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -177.23 164.23 2.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.289 0.636 . . . . 74.13 110.692 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -84.57 119.08 24.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.649 -0.871 . . . . 62.42 108.649 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.537 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 25.1 mmtp -73.0 -48.2 38.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.446 -0.946 . . . . 64.11 108.446 168.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.0 t70 -136.92 144.08 43.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.22 -1.355 . . . . 73.0 110.093 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.4 mt -139.53 142.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.023 -1.473 . . . . 71.11 107.023 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -156.01 149.52 24.81 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.046 0.45 . . . . 65.2 110.453 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.88 108.51 3.48 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.815 -1.18 . . . . 75.44 107.815 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -117.41 110.82 18.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.234 -0.654 . . . . 64.15 109.234 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -112.91 93.85 26.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.664 -0.865 . . . . 54.23 108.664 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.67 -35.13 48.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.879 2.386 . . . . 73.15 112.118 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -108.41 36.91 2.65 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.361 -0.836 . . . . 75.45 109.379 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' C' ' 25' ' ' ALA . . . -58.85 -45.98 99.57 Favored Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.305 1.224 . . . . 70.32 114.305 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.51 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 24.1 Cg_exo -68.79 -37.3 12.07 Favored 'Trans proline' 0 C--N 1.389 2.699 0 CA-C-N 121.305 1.502 . . . . 75.12 112.678 171.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -66.84 -18.31 65.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.071 0.948 . . . . 72.52 112.771 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 12.1 p -41.72 -38.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 115.397 1.628 . . . . 70.45 115.397 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.4 -31.0 71.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.226 0.536 . . . . 74.22 111.625 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.31 15.4 22.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.086 0.954 . . . . 75.21 111.953 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 0.1 OUTLIER -89.96 174.96 7.38 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.326 0.512 . . . . 72.15 110.06 178.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.425 ' HB3' HD22 ' C' ' 68' ' ' LEU . 24.6 t0 -87.98 108.93 19.45 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.005 -0.739 . . . . 72.52 109.005 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -84.37 68.2 10.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.242 1.02 . . . . 74.13 112.034 -174.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -161.84 44.2 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 114.898 -1.046 . . . . 64.12 109.656 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.08 170.21 20.12 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 121.434 1.423 . . . . 64.11 112.2 -168.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -84.73 93.0 8.35 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.928 -1.138 . . . . 72.43 107.928 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.474 HG11 HD21 ' C' ' 126' ' ' LEU . 46.3 t -77.4 95.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 107.552 -1.277 . . . . 74.01 107.552 174.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.6 109.43 21.5 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.839 -1.073 . . . . 75.44 108.304 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.67 164.5 16.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.962 -0.563 . . . . 64.4 110.432 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 25.7 t70 -147.49 138.33 23.48 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.074 -1.084 . . . . 74.54 108.074 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.51 141.31 46.68 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.69 141.81 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.124 -0.695 . . . . 73.31 109.124 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.403 HG21 ' HA2' ' C' ' 99' ' ' GLY . 12.7 t -114.69 136.28 53.23 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.939 -0.763 . . . . 54.45 108.939 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.58 160.43 21.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.94 0.896 . . . . 45.3 108.633 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -141.91 147.22 36.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.748 0.419 . . . . 64.01 110.272 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -153.95 132.29 11.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.491 0.716 . . . . 75.44 109.682 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.29 117.65 19.75 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.001 -0.74 . . . . 72.12 109.001 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' C' ' 57' ' ' GLU . 74.1 mt -87.24 -45.48 10.59 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.463 0.705 . . . . 71.22 109.259 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.51 -170.99 3.76 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.536 -0.757 . . . . 71.42 110.781 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.39 107.09 0.72 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.248 -0.887 . . . . 60.04 109.987 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 73.46 -0.82 3.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.452 1.501 . . . . 71.52 112.562 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.05 115.5 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.741 -0.837 . . . . 73.03 108.741 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.73 125.52 36.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.875 0.87 . . . . 63.24 109.267 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.638 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.9 tt0 -83.9 143.13 30.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.768 0.427 . . . . 62.33 110.671 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -117.49 122.95 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.507 -1.294 . . . . 60.13 107.507 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.12 106.38 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.429 -0.952 . . . . 75.11 108.429 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.27 105.92 18.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.415 0.686 . . . . 71.21 109.487 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -81.71 131.67 35.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.472 -0.785 . . . . 72.03 110.283 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.1 t -124.09 122.87 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.089 -1.449 . . . . 65.34 107.089 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.9 m -119.49 145.13 46.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.202 -1.036 . . . . 74.45 108.202 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.05 108.42 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.564 -1.272 . . . . 72.34 107.564 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.5 m -104.12 111.5 24.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.676 -0.861 . . . . 72.23 108.676 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.22 16.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.337 -1.727 . . . . 65.05 106.337 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -151.18 133.06 15.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.692 0.397 . . . . 64.23 109.968 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' C' ' 35' ' ' ASP . 30.9 tp -67.82 -48.15 67.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.176 0.59 . . . . 63.35 110.464 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.16 -73.76 0.04 OUTLIER Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.144 -1.183 . . . . 54.43 110.144 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -101.03 -31.49 11.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.398 0.679 . . . . 75.44 109.28 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -73.4 101.13 3.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.693 0.797 . . . . 72.15 109.741 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -83.39 130.02 35.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.632 -0.507 . . . . 63.12 109.632 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.681 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -73.15 -66.56 0.66 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.11 -1.071 . . . . 73.42 108.11 167.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -161.62 174.75 12.88 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.572 0.701 . . . . 72.05 111.668 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -129.08 141.88 51.07 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 105.667 -1.975 . . . . 75.14 105.667 169.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.402 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.3 112.23 4.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.383 -0.599 . . . . 75.31 109.383 174.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -122.88 129.29 51.46 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.835 0.454 . . . . 74.54 110.018 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.27 134.85 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.448 -0.945 . . . . 73.34 108.448 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.641 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -115.16 90.59 3.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.487 -1.301 . . . . 70.12 107.487 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 60.6 tp60 -79.11 108.65 12.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.549 -1.205 . . . . 32.1 109.891 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 146.05 20.15 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.958 -0.457 . . . . 61.02 111.958 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.68 120.84 1.24 Allowed Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 111.603 -0.599 . . . . 73.25 111.603 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.557 HD12 HD11 ' C' ' 51' ' ' LEU . 10.4 mm -87.07 110.77 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 109.114 -0.699 . . . . 75.23 109.114 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.436 ' CE2' HD13 ' C' ' 13' ' ' ILE . 77.2 m-85 -121.76 119.9 33.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.555 0.342 . . . . 75.0 110.207 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 m -84.16 114.34 21.71 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.409 -0.589 . . . . 71.41 109.409 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.275 0.63 . . . . 73.12 109.657 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.91 168.78 24.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.851 1.26 . . . . 65.53 108.582 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.35 -27.47 5.66 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 120.916 0.176 . . . . 73.21 112.934 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -122.8 158.87 27.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.725 1.21 . . . . 63.03 109.146 -176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.81 -175.56 5.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.665 0.386 . . . . 73.04 111.323 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.67 -146.33 40.08 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.606 -0.724 . . . . 73.43 113.729 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.7 p -68.32 -19.53 64.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.863 0.865 . . . . 34.31 111.588 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -65.97 -49.21 68.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.803 0.841 . . . . 73.13 110.722 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -25.68 56.86 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 116.476 -0.329 . . . . 43.52 110.746 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.82 74.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.038 0.535 . . . . 64.32 110.979 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.409 ' CE1' ' HA ' ' C' ' 134' ' ' ASP . 53.4 t-80 -70.9 -28.13 64.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.179 0.592 . . . . 74.14 110.488 174.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.66 -60.41 2.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.738 0.415 . . . . 53.11 109.985 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.418 HD23 ' SG ' ' C' ' 102' ' ' CYS . 87.8 mt -70.7 -14.86 62.61 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.475 0.71 . . . . 72.12 111.768 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' C' ' 46' ' ' THR . . . -110.36 3.92 29.69 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 114.848 0.699 . . . . 75.52 114.848 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -51.53 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 117.936 0.868 . . . . 75.3 111.374 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -70.32 -58.97 3.16 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.561 0.744 . . . . 74.45 111.578 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.641 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 32.7 m -58.02 -48.66 96.69 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.49 1.116 . . . . 64.43 112.986 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.75 -24.27 62.09 Favored 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 121.729 1.62 . . . . 44.52 114.052 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.88 -28.09 61.39 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 118.314 0.506 . . . . 71.31 110.393 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 HH12 ' A' ' 111' ' ' ARG . 45.0 mm -64.33 -31.99 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.145 0.498 . . . . 72.03 109.943 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.0 mt -86.86 -24.6 24.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.044 0.938 . . . . 74.42 112.247 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.43 -46.22 99.84 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.249 1.203 . . . . 72.33 114.249 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.91 -38.61 77.99 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.086 1.857 . . . . 61.35 113.247 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -66.56 -45.31 79.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.414 0.686 . . . . 70.24 110.487 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.61 90.76 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.568 -0.742 . . . . 63.22 110.88 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -64.53 -50.94 65.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.904 1.282 . . . . 65.15 110.62 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.36 -31.96 71.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.245 0.618 . . . . 75.5 109.695 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.66 -35.38 75.11 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 122.99 0.516 . . . . 72.42 111.204 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.412 ' O ' HG23 ' C' ' 118' ' ' VAL . 40.5 mt -70.71 -51.0 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 122.899 0.48 . . . . 61.41 110.137 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m -62.99 -28.88 70.4 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.286 0.634 . . . . 65.22 111.183 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.3 t -64.05 -52.19 60.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.826 -0.805 . . . . 73.33 108.826 171.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.52 -39.33 83.55 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.5 1.12 . . . . 75.3 112.755 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 98.8 t -61.69 -47.92 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.54 0.736 . . . . 73.11 109.583 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.6 t -68.28 -25.9 65.39 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.94 -1.027 . . . . 75.23 111.616 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -73.38 -40.12 64.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.429 0.692 . . . . 74.12 109.326 177.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.24 -1.08 79.81 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.673 0.608 . . . . 73.51 112.341 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.2 p 62.48 35.77 14.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.632 1.973 . . . . 64.02 112.816 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.464 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 95.2 m-85 -86.27 165.29 34.47 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 114.738 -1.119 . . . . 71.31 108.852 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 74.3 Cg_endo -69.01 -175.0 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.205 1.936 . . . . 70.11 112.933 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.77 114.19 2.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.361 -0.836 . . . . 74.15 110.618 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.474 HD21 HG11 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -138.65 92.64 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.129 -1.434 . . . . 71.33 107.129 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -123.4 131.8 53.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.334 1.054 . . . . 74.15 108.851 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 140.08 43.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.286 0.635 . . . . 74.33 110.892 -170.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.21 146.56 74.9 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.132 0.973 . . . . 72.03 112.061 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.657 ' HG3' HD13 ' A' ' 16' ' ' ILE . 58.5 Cg_endo -71.26 105.43 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.211 2.607 . . . . 71.25 112.877 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.19 111.15 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.778 -1.193 . . . . 71.14 107.778 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 31.5 m-80 -111.33 92.14 3.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 72.55 110.853 -173.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.432 ' HE1' ' HG2' ' A' ' 151' ' ' GLU . 57.9 t80 -78.71 -25.38 44.68 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.893 0.854 . . . . 65.52 109.341 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.409 ' HA ' ' CE1' ' C' ' 96' ' ' HIS . 1.4 p-10 -70.73 -60.71 2.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.471 1.508 . . . . 70.15 111.827 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -58.71 -31.19 68.03 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.311 1.044 . . . . 44.51 112.568 -170.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.408 ' O ' ' HD1' ' C' ' 140' ' ' TYR . 55.8 tp -57.89 -56.62 19.66 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.195 0.934 . . . . 62.52 110.195 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -76.99 -22.01 53.83 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.814 0.446 . . . . 72.11 111.662 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -63.05 -51.15 67.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.387 0.675 . . . . 71.45 111.858 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.14 -37.25 72.28 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 123.623 0.577 . . . . 74.01 110.967 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 146' ' ' GLY . 49.0 m-85 -71.5 -84.07 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.115 0.966 . . . . 73.32 112.257 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 tp -137.06 106.91 6.23 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.669 0.787 . . . . 72.52 109.6 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -160.02 -75.66 0.07 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.907 -0.405 . . . . 63.53 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.43 ' HA ' ' OG1' ' C' ' 7' ' ' THR . 22.0 tm0? -141.32 106.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.574 -1.269 . . . . 72.34 107.574 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -132.1 91.21 2.92 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.952 -0.759 . . . . 72.43 108.952 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.62 126.13 4.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.725 -1.125 . . . . 74.21 108.953 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 179.28 38.61 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.375 0.422 . . . . 71.12 112.349 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -164.62 170.68 15.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.049 0.94 . . . . 61.25 109.487 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.18 146.5 50.39 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.796 0.236 . . . . 50.34 112.964 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 42.8 p -97.92 -175.77 3.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.948 0.899 . . . . 75.5 111.017 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 135.35 43.45 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.784 -1.562 . . . . 75.33 106.784 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -130.75 22.85 5.01 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.836 0.454 . . . . 72.4 111.598 -170.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m80 65.79 36.61 6.09 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.484 1.114 . . . . 54.05 110.079 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.74 144.22 39.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.748 -0.66 . . . . 71.13 111.69 -173.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.9 t70 51.37 68.18 0.83 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.975 1.31 . . . . 75.11 111.97 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.334 0 CA-C-N 114.952 -1.022 . . . . 60.31 108.838 178.19 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.762 . . . . 71.33 108.944 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' SER . . . . . 0.529 ' HA ' ' HG3' ' B' ' 151' ' ' GLU . 37.6 t -130.16 128.47 41.83 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 65.23 109.326 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.69 173.49 10.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.157 0.983 . . . . 65.42 110.142 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -154.97 144.75 21.54 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.62 -0.882 . . . . 73.35 108.62 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -69.4 82.47 0.38 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.468 0.652 . . . . 72.12 110.194 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -98.85 35.27 1.9 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.221 1.008 . . . . 71.13 109.383 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -69.25 -12.04 61.33 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.123 0.969 . . . . 74.04 111.669 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.78 -16.78 62.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.074 0.949 . . . . 75.14 111.589 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.487 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 8.0 ptm -33.05 149.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.342 1.608 . . . . 70.41 115.342 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -121.11 144.42 48.57 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.163 -0.926 . . . . 64.31 108.878 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' D' ' 85' ' ' SER . 33.4 t80 -154.0 102.55 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.253 -1.017 . . . . 74.32 108.253 175.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -121.06 118.3 29.42 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.882 -0.784 . . . . 74.02 108.882 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.2 102.47 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.914 -1.143 . . . . 74.31 107.914 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -77.63 -44.69 27.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.877 0.471 . . . . 72.53 111.302 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -161.76 132.21 4.97 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 119.838 -0.125 . . . . 74.21 111.137 -170.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.463 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -107.61 132.79 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.946 -1.502 . . . . 74.12 106.946 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.94 162.85 9.4 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-O 121.839 0.828 . . . . 62.52 111.945 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.438 HG21 HD11 ' D' ' 21' ' ' ILE . 67.7 p -95.37 126.91 40.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.711 -1.131 . . . . 74.24 109.833 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.51 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 47.5 mtpt -95.51 -29.04 14.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.009 0.524 . . . . 73.22 110.048 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -150.74 137.11 18.64 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 124.124 0.89 . . . . 63.51 109.271 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.1 mt -137.58 147.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.489 1.116 . . . . 73.13 108.056 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -150.86 143.92 24.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.153 0.981 . . . . 72.22 109.494 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 74.0 t80 -149.53 130.0 13.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.767 -1.938 . . . . 73.24 105.767 169.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.46 136.63 43.34 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.126 0.57 . . . . 64.54 109.829 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -125.03 84.6 58.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 123.594 0.758 . . . . 73.45 109.068 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.53 -46.93 6.32 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.186 2.591 . . . . 55.15 113.082 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -114.18 37.94 3.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.454 0.702 . . . . 74.54 109.617 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.824 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.48 -56.53 25.76 Favored Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.332 1.604 . . . . 65.1 115.332 -168.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.537 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 21.6 Cg_endo -87.62 -3.59 7.45 Favored 'Trans proline' 0 C--N 1.38 2.195 0 CA-C-N 121.496 1.57 . . . . 74.03 112.49 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -82.76 -41.99 18.52 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.267 1.427 . . . . 64.44 109.173 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.72 -21.84 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.121 -0.945 . . . . 53.54 110.145 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -60.53 -26.4 66.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.271 1.429 . . . . 64.43 112.571 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.07 -33.17 74.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.241 0.617 . . . . 75.21 110.6 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -95.34 98.35 10.52 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.571 -0.9 . . . . 73.2 108.571 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' F' ' 135' ' ' ALA . 17.3 p-10 -80.25 95.29 6.27 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.213 0.53 . . . . 64.0 110.223 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.62 ' HB3' HD11 ' D' ' 68' ' ' LEU . 68.4 t-105 -160.88 165.96 29.27 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.677 0.791 . . . . 75.21 109.685 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -81.15 117.38 67.9 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.413 1.085 . . . . 74.1 110.631 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.27 144.0 94.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.499 2.799 . . . . 74.43 114.278 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.51 128.17 35.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.33 -0.619 . . . . 73.53 109.33 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.512 HG11 HG23 ' F' ' 142' ' ' ILE . 15.0 p -98.61 149.81 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.2 0.6 . . . . 62.52 110.434 -173.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 27.5 tptp -131.98 114.98 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.592 -1.262 . . . . 75.01 107.592 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.87 145.87 25.47 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.121 0.568 . . . . 73.1 110.045 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.531 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 33.2 t70 -145.46 138.94 26.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.587 -1.188 . . . . 55.04 108.442 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.15 134.8 35.02 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.368 -0.975 . . . . 74.44 108.368 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -144.31 146.2 32.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.668 1.187 . . . . 64.41 108.354 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -117.46 154.51 31.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.525 -0.546 . . . . 74.22 109.525 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.59 167.47 27.98 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.049 0.94 . . . . 31.44 109.446 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -158.43 166.12 32.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.121 0.486 . . . . 74.53 111.41 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -159.44 116.82 2.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.779 1.232 . . . . 74.23 107.911 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -79.54 123.34 27.49 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.095 -0.706 . . . . 64.43 109.095 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt -90.59 -41.04 11.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.015 0.526 . . . . 74.44 109.947 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.61 -177.47 6.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.282 -0.872 . . . . 74.22 110.611 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -64.78 120.16 11.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.398 -0.819 . . . . 72.51 109.241 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 65.34 17.31 10.94 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 74.32 111.767 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -120.75 120.45 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.31 -0.996 . . . . 74.12 108.31 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.443 ' HB2' HD12 ' D' ' 86' ' ' ILE . 64.1 m-85 -128.91 126.47 39.77 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.57 -0.9 . . . . 74.51 108.57 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -89.97 132.95 35.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.557 -1.646 . . . . 74.51 106.557 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.43 133.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.177 -1.045 . . . . 61.24 108.177 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 96.4 t -111.75 133.15 58.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.435 0.694 . . . . 75.53 109.395 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.428 HD11 ' HD1' ' D' ' 107' ' ' PHE . 0.9 OUTLIER -110.87 115.42 29.48 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.122 -1.066 . . . . 64.15 108.122 170.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -100.74 107.95 19.67 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.214 -1.032 . . . . 74.34 108.214 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.71 133.35 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.771 -0.826 . . . . 61.15 108.771 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 59.1 m -121.95 135.21 54.85 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.363 0.601 . . . . 71.22 109.646 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 131.53 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.846 1.258 . . . . 64.44 108.455 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 94.0 m -131.14 112.74 13.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.196 0.998 . . . . 65.1 108.86 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.83 48.31 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.744 0.818 . . . . 71.33 109.165 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.2 m -146.2 127.59 14.95 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.665 0.603 . . . . 64.2 109.67 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' D' ' 36' ' ' TRP . 47.5 tp -111.86 122.8 48.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.686 -0.857 . . . . 62.41 108.686 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 -115.68 5.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.599 0.562 . . . . 72.14 112.836 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -110.86 8.51 22.29 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.274 0.629 . . . . 72.11 111.825 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.08 164.27 30.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.226 0.611 . . . . 75.11 110.97 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -74.55 127.94 34.31 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.055 -0.52 . . . . 65.01 110.523 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.58 -61.29 1.87 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.259 1.023 . . . . 45.15 109.677 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.06 157.9 42.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.257 0.551 . . . . 72.31 111.321 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 79.0 mt -121.97 147.82 45.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.231 1.412 . . . . 60.23 107.586 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.8 t -158.57 141.65 14.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.457 0.303 . . . . 64.44 110.216 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.08 135.98 13.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.33 0.652 . . . . 74.42 109.788 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.94 119.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.097 0.559 . . . . 71.42 109.633 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -89.48 86.11 6.69 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.489 -0.93 . . . . 75.52 108.489 167.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -79.83 101.72 8.69 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.434 -1.257 . . . . 73.25 108.448 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.17 174.41 40.33 Favored Glycine 0 C--O 1.243 0.7 0 O-C-N 123.456 0.472 . . . . 64.52 112.143 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.95 135.5 2.84 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 111.654 -0.578 . . . . 64.14 111.654 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.8 129.96 38.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.513 -0.921 . . . . 74.43 108.513 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -132.28 135.78 46.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.491 0.717 . . . . 71.03 109.586 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.7 m -75.33 116.14 15.74 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.944 -1.132 . . . . 71.43 107.944 168.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' D' ' 56' ' ' TYR . 57.2 mt -121.23 101.72 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.634 -0.506 . . . . 73.34 109.634 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.63 152.6 48.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.406 1.082 . . . . 74.44 109.072 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 75.2 1.33 63.6 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.434 0.459 . . . . 63.31 113.587 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.519 HG23 ' HG2' ' D' ' 93' ' ' GLN . 53.7 mt -117.11 126.77 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 107.814 -1.18 . . . . 65.22 107.814 -174.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' D' ' 93' ' ' GLN . 7.5 pt-20 -145.84 148.86 33.33 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.973 0.731 . . . . 71.24 112.973 -163.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.09 -127.01 32.27 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.353 0.501 . . . . 62.14 114.197 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.9 p -70.34 -20.61 62.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.356 0.662 . . . . 65.04 111.32 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.519 ' HG2' HG23 ' D' ' 89' ' ' ILE . 55.9 tt0 -70.47 -41.47 72.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.737 0.815 . . . . 74.32 110.134 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -78.63 -29.42 45.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.288 0.235 . . . . 73.32 110.541 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.77 80.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.067 0.547 . . . . 53.12 110.272 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.01 -35.87 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.335 -0.848 . . . . 74.12 110.537 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -66.29 -43.08 87.36 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.941 0.496 . . . . 62.11 110.584 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.09 -21.91 42.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.331 0.652 . . . . 75.05 111.082 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 -19.79 38.65 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.932 -0.371 . . . . 63.41 113.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.79 -69.04 0.69 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.39 0.515 . . . . 72.43 112.39 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -65.07 -60.92 2.5 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.283 0.475 . . . . 73.41 112.283 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -58.07 -46.97 99.64 Favored Pre-proline 0 CA--C 1.565 1.537 0 C-N-CA 123.78 0.832 . . . . 74.14 113.122 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 -30.72 51.16 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.921 1.747 . . . . 52.21 113.266 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.82 -35.97 82.18 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.035 0.534 . . . . 63.24 110.646 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.16 -42.71 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.712 0.805 . . . . 73.21 110.35 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -78.67 -19.01 53.5 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.27 -0.877 . . . . 54.52 112.181 -174.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.428 ' HD1' HD11 ' D' ' 60' ' ' LEU . 70.8 t80 -62.21 -45.72 90.67 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 113.759 1.022 . . . . 64.45 113.759 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.83 -36.91 75.9 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.113 1.875 . . . . 63.02 113.724 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -79.07 -33.84 44.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.893 0.877 . . . . 75.14 111.693 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.75 -48.47 71.79 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.874 0.47 . . . . 61.44 109.829 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -54.95 -50.82 67.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.368 -1.287 . . . . 73.53 111.013 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.98 -46.76 84.66 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.113 0.883 . . . . 75.33 110.8 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.11 -45.13 94.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 123.939 0.774 . . . . 50.1 110.947 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.561 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.49 -56.5 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.746 0.818 . . . . 63.25 110.897 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -53.03 -46.36 68.42 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.667 1.187 . . . . 64.25 111.796 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -62.84 -44.09 97.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.032 -0.985 . . . . 53.12 110.2 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.43 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 74.8 mtm -68.07 -32.93 73.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.103 0.561 . . . . 50.11 111.852 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.62 -39.18 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.269 0.628 . . . . 72.53 110.438 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -74.89 -26.26 59.52 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 122.547 0.339 . . . . 74.14 110.881 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -75.47 -32.27 60.55 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.664 0.786 . . . . 71.24 109.635 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -1.13 90.19 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 115.534 -0.757 . . . . 70.03 111.922 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p 59.81 22.79 11.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.591 1.957 . . . . 62.44 112.805 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -86.31 159.89 52.5 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.334 1.054 . . . . 74.44 109.514 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.622 ' HA ' ' H ' ' F' ' 137' ' ' GLU . 52.8 Cg_exo -53.7 118.08 4.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.529 2.153 . . . . 75.24 112.701 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -48.88 133.19 18.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.062 0.945 . . . . 71.44 112.393 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.6 107.86 11.46 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.953 -1.129 . . . . 71.52 107.953 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.57 107.76 18.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.481 0.712 . . . . 51.44 109.466 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.95 145.02 54.94 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.73 0.812 . . . . 73.14 111.166 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.62 148.06 36.5 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 122.917 0.487 . . . . 72.45 110.264 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.37 130.82 31.53 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.545 2.163 . . . . 73.0 111.984 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 p -108.13 109.61 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.486 0.714 . . . . 51.23 110.041 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -86.72 106.78 17.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.802 0.841 . . . . 74.34 108.744 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -78.09 -33.71 50.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.039 0.536 . . . . 75.3 110.624 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.04 -45.08 91.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.777 1.231 . . . . 70.22 111.583 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.96 79.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.41 0.684 . . . . 51.14 112.15 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.65 -25.75 45.04 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.469 0.707 . . . . 74.32 110.648 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -69.72 -32.51 71.12 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.778 0.831 . . . . 75.44 110.28 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.5 mmt -61.18 -36.55 80.15 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.31 0.576 . . . . 74.2 109.52 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.7 -34.42 77.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.857 -1.065 . . . . 65.15 111.122 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.85 -30.91 68.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.63 0.372 . . . . 74.43 111.68 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 mp -71.23 -36.13 71.72 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.978 -0.451 . . . . 73.52 111.344 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -91.06 -0.76 57.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.059 0.544 . . . . 75.11 111.687 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -142.66 89.2 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.202 -1.407 . . . . 72.35 107.202 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -140.12 122.88 16.42 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.751 -0.463 . . . . 52.13 109.751 -169.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.43 166.79 22.66 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.371 1.068 . . . . 74.34 109.184 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.28 115.05 7.41 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.515 0.51 . . . . 61.02 111.832 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -104.64 134.63 47.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.345 0.658 . . . . 75.41 110.257 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.36 0.36 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.353 -0.699 . . . . 74.21 111.353 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 56.1 p -67.97 83.2 0.21 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.236 1.014 . . . . 54.13 111.345 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -110.38 -153.93 0.53 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.483 1.113 . . . . 54.02 109.878 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.54 54.95 1.82 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.533 1.133 . . . . 62.21 109.694 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -141.78 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.018 -1.446 . . . . 73.35 108.859 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 62.88 79.74 0.25 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.067 0.947 . . . . 74.44 109.277 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 66.89 172.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.966 1.306 . . . . 74.44 111.524 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.482 0 C-N-CA 123.375 0.67 . . . . 37.71 109.598 -177.81 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 108.953 -0.758 . . . . 75.31 108.953 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -123.18 103.18 8.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.31 0.644 . . . . 74.15 110.4 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.32 129.25 35.08 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.805 0.842 . . . . 73.14 109.345 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.76 94.78 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.484 -0.561 . . . . 74.12 109.484 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 112' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' E' ' 117' ' ' PRO . 11.5 pt20 -150.62 126.76 10.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.912 0.885 . . . . 75.33 109.085 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -142.58 -43.46 0.32 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.719 0.408 . . . . 52.42 111.428 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.85 161.91 29.13 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.059 0.544 . . . . 61.41 110.852 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 mt -50.05 140.25 12.79 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.78 1.232 . . . . 70.52 113.124 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 116' ' ' TYR . . . . . 0.539 ' HD1' ' HA ' ' B' ' 95' ' ' ALA . 10.6 t80 59.78 58.49 4.73 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 124.79 1.306 . . . . 71.4 109.618 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.63 ' HB2' ' HB2' ' E' ' 112' ' ' GLN . 90.4 Cg_endo -77.92 -1.83 11.98 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.881 2.388 . . . . 71.54 113.308 -169.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -145.48 116.72 7.92 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.765 -0.828 . . . . 43.45 108.765 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 60.5 p -85.13 133.12 34.22 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.05 0.94 . . . . 70.53 108.82 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -76.78 89.84 3.43 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.113 0.959 . . . . 74.54 109.818 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.7 -45.25 65.32 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.235 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 122' ' ' ALA . . . . . 0.461 ' HB3' ' HE1' ' B' ' 137' ' ' PHE . . . -71.28 85.67 0.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.451 0.643 . . . . 60.34 111.194 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.51 131.54 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.551 1.14 . . . . 65.22 108.774 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -165.48 132.47 2.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.776 0.431 . . . . 73.34 110.828 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -140.56 92.62 2.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.295 0.569 . . . . 74.31 109.972 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.12 67.52 0.79 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.959 0.903 . . . . 74.12 108.968 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -134.02 87.31 0.26 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.17 -0.923 . . . . 61.42 111.205 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -63.9 141.03 58.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.021 0.528 . . . . 63.13 110.745 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -153.12 161.19 42.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.246 0.618 . . . . 61.41 110.303 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 10.0 tp -156.42 168.7 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.625 -0.88 . . . . 73.52 108.625 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.39 147.82 47.28 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.394 0.678 . . . . 54.1 110.669 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -61.67 153.37 71.32 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.866 0.867 . . . . 71.41 112.573 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.98 94.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.996 2.464 . . . . 61.35 112.154 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 7.2 tt -161.05 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.683 1.193 . . . . 70.41 108.662 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.46 65.13 1.6 Allowed 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.546 1.139 . . . . 72.04 109.822 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 14.2 p -65.9 -13.89 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.935 -1.029 . . . . 75.2 111.214 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.27 82.65 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.543 1.137 . . . . 73.44 112.029 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -164.3 25.95 0.07 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.476 -1.238 . . . . 74.41 109.899 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.96 27.17 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.247 1.019 . . . . 72.11 110.543 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.6 p -73.58 -13.53 61.04 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.338 1.055 . . . . 55.23 111.419 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.39 83.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.848 0.859 . . . . 74.55 108.925 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 142' ' ' ILE . . . . . 0.47 HG12 ' HB ' ' C' ' 40' ' ' VAL . 23.9 mt -123.94 -57.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.66 1.184 . . . . 74.01 108.13 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.89 164.44 29.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.09 1.356 . . . . 71.22 108.672 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -130.39 -17.3 3.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.333 0.494 . . . . 73.21 112.333 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 145' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 155' ' ' ALA . 27.1 mtpp -76.45 -177.55 4.2 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.88 0.472 . . . . 65.34 110.343 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.43 -87.58 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.072 0.549 . . . . 74.55 110.278 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 68.9 mt -156.49 -66.17 0.11 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.183 -1.043 . . . . 71.12 108.183 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.24 -51.96 0.18 Allowed Pre-proline 0 CA--C 1.565 1.544 0 CA-C-N 115.272 -0.876 . . . . 73.1 109.806 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 C--N 1.394 2.947 0 C-N-CA 121.832 1.688 . . . . 73.34 113.59 175.625 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.593 -0.892 . . . . 74.53 108.593 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 68.53 85.05 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.022 0.929 . . . . 70.24 109.604 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 71.83 -70.03 0.17 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.283 1.433 . . . . 60.01 111.212 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -70.45 97.32 1.27 Allowed 'General case' 0 C--O 1.246 0.897 0 C-N-CA 123.86 0.864 . . . . 72.43 110.124 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 127.94 34.63 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.49 -0.929 . . . . 51.22 108.49 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -72.91 84.83 1.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.351 0.596 . . . . 74.21 110.476 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -99.28 59.46 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.731 -0.84 . . . . 72.34 108.731 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.536 ' H ' HD23 ' F' ' 115' ' ' LEU . 2.2 pt? -65.96 83.84 0.08 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.744 -1.116 . . . . 74.34 109.394 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -148.16 157.35 42.89 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.188 0.995 . . . . 72.32 110.759 -170.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 98' ' ' LEU . 65.3 Cg_endo -84.07 154.07 12.84 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.263 2.642 . . . . 74.32 113.097 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -70.19 137.24 50.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 60.32 109.888 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 48.7 p -80.73 80.55 7.17 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.653 0.781 . . . . 71.42 110.508 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -100.89 157.57 16.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.13 0.972 . . . . 75.33 111.183 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.41 11.38 35.05 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.828 0.851 . . . . 74.41 109.95 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.45 -22.02 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.414 0.685 . . . . 74.31 111.641 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 22.9 m -68.23 -24.76 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.87 0.868 . . . . 75.21 112.193 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -50.63 -55.9 14.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.357 1.063 . . . . 75.12 112.033 -171.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 125' ' ' TYR . . . . . 0.479 ' HD2' HD11 ' A' ' 42' ' ' LEU . 63.9 t80 66.88 167.38 0.23 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.621 1.168 . . . . 72.45 112.729 170.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -158.28 144.28 17.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 72.24 109.198 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.15 105.86 0.19 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.154 -0.778 . . . . 73.13 111.154 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -87.09 105.61 17.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.953 0.501 . . . . 73.02 110.041 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.51 106.49 17.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.828 -0.434 . . . . 64.02 109.828 174.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 10.8 tp -84.9 -19.12 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 124.122 0.969 . . . . 53.43 110.501 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 69.23 -76.81 0.06 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.516 1.526 . . . . 54.5 110.966 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -171.84 132.67 0.78 Allowed Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 124.255 1.022 . . . . 74.34 108.454 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.09 78.2 1.48 Allowed 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.821 2.347 . . . . 72.1 111.92 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.431 HG13 HG13 ' F' ' 136' ' ' VAL . 6.8 tp -86.09 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.744 -1.116 . . . . 62.34 108.538 175.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.466 ' H ' ' HB2' ' D' ' 35' ' ' ASP . . . -75.67 86.05 2.71 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.167 0.508 . . . . 74.52 109.899 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.431 HG13 HG13 ' F' ' 134' ' ' ILE . 10.6 m -122.79 170.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.579 1.152 . . . . 61.22 110.632 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 137' ' ' GLU . . . . . 0.622 ' H ' ' HA ' ' D' ' 124' ' ' PRO . 0.5 OUTLIER 53.26 33.23 15.01 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.927 1.291 . . . . 62.03 112.875 177.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 18.7 2.2 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.185 0.994 . . . . 72.5 110.507 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.637 ' HG ' HD11 ' F' ' 142' ' ' ILE . 16.1 tp -76.39 82.65 3.13 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.907 0.861 . . . . 64.5 110.532 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 61.3 p -111.39 13.01 21.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.276 -1.329 . . . . 61.25 111.067 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.07 15.26 1.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.245 0.618 . . . . 73.04 111.343 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.637 HD11 ' HG ' ' F' ' 139' ' ' LEU . 2.8 mm -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.143 -1.058 . . . . 63.23 108.143 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 67.07 -74.7 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.463 1.505 . . . . 75.42 110.815 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 68.69 -80.74 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.363 1.465 . . . . 72.24 110.632 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -90.16 123.32 33.88 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.119 0.568 . . . . 75.04 109.649 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 44.66 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.529 1.532 . . . . 63.3 113.61 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.79 -72.7 0.15 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.549 -0.908 . . . . 72.34 108.549 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 tt -168.78 73.04 0.78 Allowed Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 106.316 -1.735 . . . . 53.15 106.316 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 C--N 1.377 2.044 0 C-N-CA 123.354 2.702 . . . . 65.13 111.421 178.566 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.333 -0.247 . . . . 72.21 110.333 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -91.83 93.99 9.11 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.926 -0.768 . . . . 73.31 108.926 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.02 -70.76 0.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.342 -0.984 . . . . 72.42 108.342 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -88.27 91.32 8.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.765 . . . . 53.3 108.933 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -66.2 -40.56 90.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 70.43 109.419 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -93.34 98.13 11.04 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.311 -0.859 . . . . 74.05 109.437 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -99.99 101.41 12.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.425 0.69 . . . . 74.43 110.121 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -130.96 86.91 2.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.109 0.964 . . . . 75.22 109.653 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.9 OUTLIER -93.58 149.33 21.31 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.922 . . . . 74.42 109.752 177.267 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m -144.93 100.95 3.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.548 -0.908 . . . . 75.04 108.548 169.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -134.41 134.79 42.04 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.3 0.64 . . . . 73.45 109.351 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.437 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 92.4 mt-30 -132.82 123.85 26.89 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.592 -0.892 . . . . 73.25 108.592 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.69 103.95 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.897 -1.149 . . . . 74.53 107.897 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.61 -39.78 15.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 72.24 110.947 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.634 ' HD3' HG21 ' B' ' 122' ' ' THR . 0.1 OUTLIER -158.6 143.99 16.47 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.144 -0.455 . . . . 74.04 109.962 -175.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -145.85 100.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.505 -1.295 . . . . 72.13 107.505 171.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.594 ' HD1' ' HG3' ' A' ' 15' ' ' ARG . 71.6 m-85 -157.61 169.96 23.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.298 0.639 . . . . 73.32 109.779 -170.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.8 p -81.91 111.66 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.079 -0.51 . . . . 71.33 110.337 -173.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 35.4 mtpt -79.5 -32.52 42.44 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.768 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.97 145.1 27.2 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.702 0.627 . . . . 54.45 109.616 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -134.59 144.2 35.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 125.065 1.346 . . . . 65.23 107.567 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 25.9 t -148.69 130.67 15.29 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.753 0.821 . . . . 74.3 108.857 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.566 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 90.3 t80 -147.6 119.28 8.03 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 106.962 -1.496 . . . . 73.01 106.962 174.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.55 139.63 45.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.831 0.452 . . . . 74.45 109.84 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.23 80.32 72.65 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.221 1.008 . . . . 74.32 108.515 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.51 -43.46 21.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.299 2.666 . . . . 64.31 112.627 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 32.1 m-80 -113.09 37.47 3.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.187 -0.915 . . . . 74.4 109.656 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.616 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.37 -46.03 99.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 C-N-CA 124.121 0.968 . . . . 70.01 113.087 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.06 -22.97 29.96 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.976 1.784 . . . . 72.11 112.631 174.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.3 m-70 -78.11 -18.62 55.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.561 0.744 . . . . 73.42 111.656 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HE1' ' A' ' 123' ' ' PHE . 79.1 t -52.53 -28.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.876 0.87 . . . . 74.04 112.447 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -65.53 -42.65 91.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.11 0.781 . . . . 72.32 113.11 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.37 -26.05 46.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.577 0.171 . . . . 72.11 110.665 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -76.73 152.08 35.81 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.101 0.56 . . . . 73.4 110.498 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -80.47 147.71 30.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.442 -0.947 . . . . 71.44 108.442 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 -79.05 75.33 5.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.911 0.884 . . . . 65.41 110.634 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.23 82.9 51.84 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.495 1.118 . . . . 54.3 108.639 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.85 123.41 5.21 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.927 2.418 . . . . 62.22 111.964 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -95.07 86.02 4.49 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.143 -1.428 . . . . 63.33 107.143 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 65' ' ' THR . 61.1 t -87.26 103.68 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.333 -1.303 . . . . 61.32 110.505 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.533 ' HA ' ' HA3' ' F' ' 127' ' ' GLY . 56.2 tttm -96.5 140.02 31.74 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.726 0.41 . . . . 65.13 110.392 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.1 mt -106.45 139.33 41.1 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.187 -1.042 . . . . 70.23 108.187 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.799 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -129.6 108.23 10.06 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.567 -1.271 . . . . 73.35 107.567 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.2 mp -103.72 130.59 51.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.367 -0.975 . . . . 75.22 108.367 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 60' ' ' LEU . 19.2 t70 -144.05 151.68 39.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.857 0.863 . . . . 72.24 110.205 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -139.24 138.63 36.99 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.597 0.759 . . . . 64.34 110.094 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 149.05 52.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.631 1.172 . . . . 63.25 109.716 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -96.15 170.35 9.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.293 0.637 . . . . 71.13 111.101 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.0 t -165.7 147.82 7.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.879 1.272 . . . . 73.2 108.526 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -111.98 133.52 54.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.488 -0.931 . . . . 74.11 108.488 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -104.69 -44.62 4.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.579 -0.526 . . . . 63.14 109.579 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.62 -174.35 4.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.583 -0.735 . . . . 73.11 110.38 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.27 117.84 6.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.345 1.058 . . . . 74.3 110.748 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 69.31 -8.2 0.74 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 125.533 1.533 . . . . 74.44 113.08 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.3 109.58 26.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.492 -0.929 . . . . 64.24 108.492 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.15 157.01 35.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.891 0.876 . . . . 72.22 108.763 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -132.46 118.91 19.91 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.53 0.732 . . . . 74.21 109.986 -174.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -104.56 112.6 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.717 -1.216 . . . . 54.41 107.717 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -100.0 131.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 70.01 109.924 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -100.63 114.23 27.74 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.447 . . . . 72.02 107.092 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -99.22 104.1 16.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.722 -0.844 . . . . 73.05 108.722 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -95.49 141.96 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.382 -0.97 . . . . 74.42 108.382 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.799 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 85.6 m -125.78 141.13 52.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 171.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 76.9 t -135.24 110.86 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.616 1.166 . . . . 64.32 108.37 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 m -101.95 142.15 33.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.711 -0.848 . . . . 71.24 108.711 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.46 121.78 20.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.873 -1.158 . . . . 70.23 107.873 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -130.95 130.14 43.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.127 0.571 . . . . 65.43 110.135 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 78.4 mt -87.61 78.71 8.46 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.801 -1.185 . . . . 74.25 107.801 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.59 -106.73 2.17 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 114.392 -1.276 . . . . 61.51 112.219 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -89.12 -26.99 21.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.531 0.732 . . . . 72.31 109.984 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.24 131.3 44.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 73.43 109.627 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.1 m -76.19 128.73 35.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.066 0.46 . . . . 31.23 110.524 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -76.83 -56.4 4.63 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.235 1.014 . . . . 71.11 108.971 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -167.57 174.86 7.47 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.163 -0.926 . . . . 63.33 111.207 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 tp -143.05 150.48 39.61 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.845 1.258 . . . . 71.53 109.133 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.696 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 61.6 m -141.59 141.34 33.49 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.441 0.696 . . . . 74.03 110.681 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 56.4 mp0 -141.47 133.41 27.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.285 1.034 . . . . 73.33 108.321 170.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.42 108.4 5.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.265 -1.013 . . . . 71.3 108.265 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.81 80.39 8.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.207 -1.361 . . . . 71.11 107.645 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.12 92.5 3.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 114.046 -1.434 . . . . 74.32 107.886 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.24 145.62 21.42 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.374 -0.83 . . . . 54.35 111.3 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -135.52 120.25 2.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.772 -0.931 . . . . 51.22 110.772 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.5 mt -85.2 124.99 40.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.082 -1.081 . . . . 73.44 108.082 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -136.46 138.49 41.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.391 -0.966 . . . . 73.34 108.391 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 12' ' ' GLN . 13.7 p -96.42 105.25 17.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.368 -0.604 . . . . 52.42 109.368 172.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.86 132.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.215 0.606 . . . . 62.54 110.072 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.04 162.88 26.08 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.658 1.183 . . . . 72.43 109.666 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.83 -25.11 12.34 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 114.61 0.604 . . . . 32.34 114.61 171.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.42 152.26 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.303 0.552 . . . . 71.32 110.918 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 8.5 tt0 -155.89 -172.71 4.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.329 -0.619 . . . . 62.44 109.329 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.487 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.63 -153.25 48.79 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.637 -0.256 . . . . 71.13 113.244 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.451 ' HB ' HD21 ' A' ' 141' ' ' LEU . 32.6 p -65.35 -26.36 67.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.604 0.762 . . . . 75.52 111.318 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.33 -42.69 99.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.536 0.734 . . . . 74.12 110.641 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 47.0 ttp -64.13 -53.14 54.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.139 0.975 . . . . 74.22 110.926 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.08 -47.69 68.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 44.24 110.958 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -56.94 -47.71 80.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.617 -1.629 . . . . 72.23 111.192 173.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.1 m -71.37 -29.41 64.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.585 0.957 . . . . 72.04 113.585 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.9 mt -83.78 -38.8 20.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.049 0.54 . . . . 64.31 111.1 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.56 5.26 56.93 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.958 -0.565 . . . . 73.45 113.827 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -144.29 -66.67 0.34 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.784 0.792 . . . . 74.31 112.384 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.2 t80 -48.96 -56.58 8.45 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.194 0.998 . . . . 73.12 112.434 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.3 m -71.52 -44.56 12.76 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-O 118.389 -0.815 . . . . 53.21 112.471 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.28 -37.27 80.65 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.152 1.901 . . . . 72.53 113.732 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 61.8 m-20 -60.44 -40.61 91.7 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.108 0.963 . . . . 72.51 110.788 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.3 mm -64.7 -41.46 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.084 -0.962 . . . . 73.24 110.569 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.543 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.7 mt -75.24 -27.19 59.39 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.634 -0.712 . . . . 73.1 111.751 -173.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -63.15 -42.74 78.08 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.741 1.386 . . . . 74.11 114.741 -168.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -35.57 98.3 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 122.307 2.005 . . . . 41.3 113.603 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.8 -37.92 39.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.333 0.653 . . . . 73.33 111.399 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.46 98.56 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.669 -0.493 . . . . 33.22 109.669 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.524 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.5 ttm180 -57.23 -53.44 58.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.354 1.062 . . . . 74.1 110.908 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.95 -47.88 84.4 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.119 0.887 . . . . 63.22 111.008 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.15 -46.69 82.51 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.08 0.862 . . . . 61.43 111.126 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.599 HG21 HG21 ' A' ' 64' ' ' VAL . 98.9 mt -62.66 -52.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 123.709 0.63 . . . . 73.34 110.474 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 125' ' ' GLN . 87.7 m -56.13 -39.41 72.21 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.82 0.7 . . . . 74.43 111.596 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -66.47 -48.18 70.71 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.345 -0.843 . . . . 61.1 110.185 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.566 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mtp -54.36 -45.13 72.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.864 0.866 . . . . 74.03 111.486 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' ILE . 71.0 t -61.86 -47.41 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.943 -1.026 . . . . 75.41 110.852 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -71.38 -24.3 62.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.985 -0.552 . . . . 75.44 111.553 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -71.77 -27.06 62.7 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.302 0.641 . . . . 51.1 110.313 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.75 10.09 63.45 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 123.469 0.481 . . . . 72.12 113.045 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.567 HG22 ' HB3' ' B' ' 17' ' ' TYR . 5.9 t 51.97 24.62 2.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 127.03 2.132 . . . . 62.22 113.279 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE1' HG21 ' A' ' 31' ' ' VAL . 75.6 m-85 -86.55 151.84 53.72 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 115.628 -0.715 . . . . 60.54 109.177 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.24 129.0 32.89 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.717 2.278 . . . . 72.13 110.56 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.5 pt20 -55.81 142.52 34.56 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.156 0.91 . . . . 75.0 111.345 -169.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.403 ' HG ' HG11 ' A' ' 118' ' ' VAL . 51.2 mt -119.46 97.66 5.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.525 0.678 . . . . 71.02 109.231 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.57 123.06 42.52 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.308 -1.315 . . . . 53.52 108.067 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.471 HD11 HD12 ' A' ' 114' ' ' ILE . 69.3 mt -66.12 122.61 17.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.481 0.712 . . . . 74.43 110.565 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -53.29 136.65 50.23 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 119.012 -0.518 . . . . 73.02 110.293 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.43 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.628 2.218 . . . . 71.5 112.102 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 129' ' ' ALA . 53.9 t -100.25 112.86 34.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.17 -1.048 . . . . 74.34 108.17 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -85.42 92.12 8.4 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.243 -1.021 . . . . 73.05 108.243 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.41 -28.54 69.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.8 -0.636 . . . . 73.53 110.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.488 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 3.6 t70 -68.53 -52.09 35.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.082 0.953 . . . . 73.31 110.658 -171.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.18 88.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.024 -0.989 . . . . 65.25 110.688 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.406 ' HA ' HD21 ' A' ' 139' ' ' ASN . 7.2 tt -60.05 -46.2 90.34 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 124.188 0.93 . . . . 71.04 109.887 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.93 -40.15 91.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.057 -0.974 . . . . 73.12 109.973 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 mmt -63.54 -56.32 16.89 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.783 0.677 . . . . 74.22 111.507 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.406 HD21 ' HA ' ' A' ' 136' ' ' LEU . 12.3 p30 -65.14 -31.99 73.46 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.172 0.295 . . . . 74.14 111.483 -174.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -66.79 -52.31 45.46 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.379 0.424 . . . . 72.33 110.068 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.451 HD21 ' HB ' ' A' ' 92' ' ' THR . 55.4 tp -56.18 -51.26 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.782 -1.099 . . . . 54.32 111.49 -171.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 170.78 -17.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 125.002 1.439 . . . . 74.52 110.811 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.24 91.23 6.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.624 0.726 . . . . 72.12 110.408 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -58.3 -30.41 66.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.263 1.425 . . . . 72.21 112.57 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.57 -75.53 0.54 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.273 0.629 . . . . 35.42 110.846 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.24 96.08 0.8 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.648 -0.581 . . . . 52.32 111.648 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' C' ' 145' ' ' ALA . 7.5 pt-20 -115.32 125.03 52.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.443 0.697 . . . . 63.31 110.185 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.86 87.79 0.08 OUTLIER Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.362 -1.095 . . . . 52.05 110.362 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -157.82 38.85 0.27 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.969 0.89 . . . . 52.42 109.537 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 77.27 1.09 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 122.187 0.994 . . . . 73.13 109.622 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -105.96 133.38 50.76 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.443 -1.318 . . . . 72.53 107.443 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -123.93 -70.0 0.78 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.67 0.388 . . . . 74.52 110.428 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -169.93 111.4 0.44 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.784 0.434 . . . . 71.35 110.394 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.04 108.79 18.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.768 0.827 . . . . 71.31 110.306 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.808 -1.182 . . . . 73.41 107.808 177.229 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.321 -0.251 . . . . 74.05 110.321 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -169.67 154.25 5.38 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.406 0.682 . . . . 63.23 110.931 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 57.7 83.06 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.791 1.236 . . . . 72.41 111.665 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -174.46 -169.95 0.48 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.856 0.862 . . . . 75.3 110.253 -173.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.63 -171.85 2.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.897 0.879 . . . . 74.52 109.913 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.88 87.3 0.36 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.745 0.783 . . . . 63.21 109.994 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -142.96 170.93 14.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.45 -1.25 . . . . 73.04 108.937 -173.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 71.7 111.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.653 1.581 . . . . 73.31 112.104 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.7 ptm 53.49 175.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.652 1.981 . . . . 55.2 114.695 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.8 p -141.46 127.5 19.51 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.616 1.166 . . . . 74.11 108.096 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -122.46 128.09 50.42 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.667 -0.864 . . . . 72.22 108.667 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -142.84 140.82 31.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 63.41 109.176 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.669 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.82 141.52 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.601 -0.888 . . . . 74.53 108.601 172.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.602 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 20.2 mm-40 -106.68 -50.66 3.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.963 0.505 . . . . 70.24 109.884 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -168.49 149.03 4.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.976 0.91 . . . . 72.33 108.567 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.6 mt -128.3 149.31 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.708 -1.219 . . . . 65.23 107.708 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.567 ' HB3' HG22 ' A' ' 122' ' ' THR . 24.1 p90 -170.87 150.44 3.18 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.255 0.55 . . . . 63.21 112.436 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.7 m -72.98 122.3 21.48 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.012 -0.995 . . . . 65.14 108.535 167.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.7 mtpt -94.33 -33.74 13.08 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.799 0.839 . . . . 73.41 110.563 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 22.9 t70 -152.14 140.52 20.54 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.47 0.481 . . . . 72.1 111.103 -166.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -140.96 137.54 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.713 1.205 . . . . 74.42 108.315 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -139.81 108.3 5.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.333 -1.358 . . . . 70.1 107.333 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.5 t80 -126.11 108.25 11.17 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.451 -1.314 . . . . 63.34 107.451 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.96 111.42 18.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.327 -0.99 . . . . 61.42 108.327 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.59 86.97 3.12 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.53 -1.285 . . . . 45.13 107.53 170.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.31 -32.49 41.4 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.493 2.129 . . . . 63.32 110.951 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.47 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 15.7 m120 -111.87 30.43 7.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.501 -1.227 . . . . 73.45 109.97 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.3 -46.98 46.41 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.298 1.039 . . . . 51.32 111.964 167.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 73.6 Cg_endo -76.83 -16.75 16.12 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.086 1.858 . . . . 72.53 114.549 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 65.3 m80 -95.97 -16.19 21.86 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.872 0.693 . . . . 53.35 112.872 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.91 -11.79 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.742 0.417 . . . . 64.32 110.041 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.74 -43.93 94.01 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.584 0.754 . . . . 65.14 109.886 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' B' ' 30' ' ' HIS . 16.0 mp0 -81.03 -32.02 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.074 -0.512 . . . . 63.51 110.201 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.57 92.73 7.21 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.475 0.71 . . . . 71.15 111.093 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -89.31 105.98 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.579 -0.526 . . . . 74.53 109.579 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -172.98 169.23 4.75 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 74.33 109.453 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.36 114.67 49.18 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.877 0.871 . . . . 64.31 108.741 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 150.67 82.99 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.381 2.054 . . . . 74.22 112.392 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 104.94 1.18 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.773 -0.825 . . . . 73.22 108.773 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -97.57 154.35 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.885 0.85 . . . . 72.02 111.765 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.652 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 70.2 tttt -147.24 115.17 6.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.794 -1.548 . . . . 71.1 107.104 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -86.02 159.39 19.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.19 -1.041 . . . . 54.41 108.19 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.4 t70 -164.94 110.53 0.94 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.352 -0.61 . . . . 65.34 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.661 ' HB2' HG11 ' E' ' 123' ' ' VAL . 6.3 mp -102.98 144.48 31.2 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.931 0.396 . . . . 72.54 109.985 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.68 141.97 47.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.558 1.143 . . . . 72.21 108.683 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -121.65 139.0 54.1 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.633 -0.506 . . . . 72.22 109.633 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.61 161.02 41.79 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.224 1.01 . . . . 24.22 109.227 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -144.01 170.23 16.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.071 0.548 . . . . 72.42 109.981 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -155.31 136.2 13.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.991 0.916 . . . . 73.14 108.624 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.91 120.58 29.39 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.073 0.549 . . . . 74.42 111.068 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.3 -37.54 17.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.328 -0.619 . . . . 64.51 109.328 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.96 -179.48 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.032 0.933 . . . . 71.32 110.676 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.54 125.27 26.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.925 -1.034 . . . . 71.13 109.537 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 65.42 10.44 6.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.473 1.109 . . . . 61.2 112.385 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -127.33 95.61 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.207 -1.035 . . . . 62.44 108.207 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.427 ' HE1' HD12 ' E' ' 115' ' ' LEU . 75.8 m-85 -117.35 138.11 52.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.875 0.47 . . . . 73.51 109.883 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -102.02 103.47 14.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.761 -1.2 . . . . 73.15 107.761 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' B' ' 98' ' ' LEU . 48.7 t -95.3 129.26 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 62.3 109.48 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.9 t -109.55 129.65 64.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.928 0.891 . . . . 70.0 109.844 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -106.75 134.04 50.5 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.316 -1.364 . . . . 62.33 107.316 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.51 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 27.6 ttm180 -119.19 130.95 55.77 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.857 -0.794 . . . . 61.54 108.857 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.523 ' HB ' HD11 ' B' ' 114' ' ' ILE . 16.9 t -124.67 123.12 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.38 -0.97 . . . . 64.43 108.38 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 33.3 m -108.75 144.85 36.02 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.305 1.042 . . . . 73.21 109.512 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 114' ' ' ILE . 91.0 t -135.94 98.52 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.636 1.174 . . . . 41.12 108.21 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 27.4 m -83.07 139.3 33.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.939 -0.763 . . . . 42.33 108.939 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.69 140.06 21.37 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.839 0.456 . . . . 75.55 110.06 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.527 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.3 m -142.1 131.91 24.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.401 0.68 . . . . 72.51 109.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.19 108.3 20.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.157 -1.424 . . . . 73.54 107.157 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -118.83 5.75 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.803 -0.919 . . . . 71.02 110.803 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -111.93 4.59 18.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.276 0.63 . . . . 73.32 111.986 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.77 147.28 43.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.487 0.715 . . . . 72.45 110.013 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.3 m -66.05 127.13 30.9 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.021 0.528 . . . . 64.11 111.686 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.527 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -86.99 -54.5 4.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.267 -1.012 . . . . 53.5 108.267 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.88 157.52 24.04 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 114.739 -1.119 . . . . 72.4 110.062 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 84.5 mt -130.82 110.82 11.6 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 106.554 -1.647 . . . . 75.12 106.554 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -117.15 136.15 53.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 75.15 108.603 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.6 tt0 -157.61 135.09 10.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.094 -0.706 . . . . 71.44 109.094 -170.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.28 149.97 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.376 -0.829 . . . . 75.33 109.045 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 43.0 mt-30 -123.26 106.04 10.38 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.102 -1.073 . . . . 75.1 108.102 167.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -94.88 101.05 12.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.58 -0.896 . . . . 62.44 108.58 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.17 171.56 32.65 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.546 -0.622 . . . . 53.54 111.546 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.11 141.91 5.99 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.483 -0.647 . . . . 50.42 111.483 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 22.1 mt -92.72 128.05 44.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.811 -0.811 . . . . 72.44 108.811 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.06 134.82 47.64 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.048 0.939 . . . . 73.15 108.545 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 52.7 m -107.24 104.27 13.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.568 0.747 . . . . 44.32 109.002 175.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.509 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.14 121.15 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.691 1.196 . . . . 73.11 109.365 -176.003 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.5 159.08 40.44 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.908 0.883 . . . . 64.02 109.6 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.52 -43.63 2.77 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.622 0.577 . . . . 73.21 112.805 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.405 ' H ' HG13 ' B' ' 89' ' ' ILE . 1.7 pp -62.49 138.97 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.572 0.749 . . . . 72.33 111.105 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -150.3 172.06 15.98 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.128 0.971 . . . . 75.24 110.416 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.76 -128.98 43.86 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.173 0.921 . . . . 65.33 113.496 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.2 m -67.81 -30.3 69.68 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.78 0.832 . . . . 74.21 110.814 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -74.72 -33.64 62.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.796 -0.638 . . . . 75.43 111.543 -168.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' E' ' 115' ' ' LEU . 0.0 OUTLIER -72.39 -36.46 68.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.162 0.506 . . . . 75.53 110.299 174.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.14 -26.96 66.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.793 -1.094 . . . . 64.24 111.247 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -86.56 -34.6 19.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.384 1.074 . . . . 74.3 110.164 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.02 -63.36 1.32 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.258 0.623 . . . . 50.4 111.573 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.461 ' HB2' HG21 ' B' ' 58' ' ' VAL . 1.4 pp -93.75 -3.26 52.49 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.958 0.355 . . . . 65.03 111.958 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.11 -16.34 51.01 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.242 0.339 . . . . 61.41 112.674 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.37 -52.82 0.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.219 0.452 . . . . 55.32 112.219 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -70.94 -43.83 67.38 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 111.998 0.37 . . . . 73.13 111.998 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 90.7 m -61.86 -49.97 83.43 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.5 -0.762 . . . . 63.14 110.917 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 80.0 Cg_exo -54.72 -33.63 80.97 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.062 1.841 . . . . 70.35 113.805 168.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.81 -32.49 74.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.881 0.472 . . . . 75.24 111.186 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.86 -42.99 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.288 0.635 . . . . 60.01 110.169 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.85 -26.61 57.3 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.677 -1.147 . . . . 73.21 111.827 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.26 -49.86 82.39 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.726 1.01 . . . . 72.01 113.726 -170.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 35.3 Cg_endo -61.38 -31.32 88.47 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.704 1.603 . . . . 73.14 112.58 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.452 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.8 m-30 -69.06 -45.57 70.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.821 0.848 . . . . 71.2 110.25 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.98 89.38 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.335 -0.848 . . . . 62.15 110.798 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.409 ' HA ' HD23 ' B' ' 128' ' ' LEU . 33.9 ttt180 -59.31 -54.6 44.98 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.652 1.581 . . . . 74.44 111.35 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.57 -33.91 77.02 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.719 0.637 . . . . 52.13 109.854 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.515 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.9 t -68.35 -38.37 81.39 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.163 -0.471 . . . . 74.25 111.075 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.523 HD11 ' HB ' ' B' ' 62' ' ' VAL . 52.6 mt -64.04 -58.74 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.685 -0.487 . . . . 53.54 109.685 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -59.01 -31.3 68.69 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 124.18 0.925 . . . . 65.32 111.368 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -62.01 -54.38 42.4 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.387 0.675 . . . . 73.51 110.48 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -62.31 -36.63 82.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.19 0.596 . . . . 73.22 110.931 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.2 t -63.0 -42.65 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.074 0.949 . . . . 74.34 110.908 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.3 m -68.18 -31.86 71.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.328 0.651 . . . . 75.0 111.035 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 94.6 mtt-85 -68.65 -21.53 64.45 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.552 0.741 . . . . 73.55 110.921 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.11 15.12 61.93 Favored Glycine 0 C--N 1.356 1.685 0 CA-C-O 119.258 -0.746 . . . . 72.31 114.125 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.634 HG21 ' HD3' ' A' ' 15' ' ' ARG . 1.9 p 73.59 12.84 4.53 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 126.377 1.871 . . . . 71.53 113.247 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.24 149.82 43.66 Favored Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 122.183 -0.323 . . . . 70.35 111.163 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.21 163.11 24.11 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.243 2.629 . . . . 31.3 113.667 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.446 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 0.6 OUTLIER -63.57 115.35 4.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.232 1.013 . . . . 73.52 111.063 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 tt -130.11 97.47 4.46 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.074 -1.454 . . . . 72.35 107.074 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.75 136.07 33.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.527 -0.916 . . . . 70.11 108.527 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 111' ' ' ARG . 2.6 mm? -75.11 125.13 28.28 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.086 -0.709 . . . . 71.04 109.086 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' E' ' 129' ' ' LEU . . . -71.85 153.9 92.92 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 123.267 0.627 . . . . 41.41 111.056 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.39 99.06 0.35 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.089 2.526 . . . . 61.15 112.419 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 5.2 p -90.84 113.27 26.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 121.487 0.661 . . . . 60.53 109.336 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -76.55 101.9 5.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.967 -0.753 . . . . 61.5 108.967 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -59.74 -28.68 67.57 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.102 -0.954 . . . . 72.03 109.898 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.51 -52.72 58.68 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.589 1.556 . . . . 62.33 110.684 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.35 79.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.458 1.099 . . . . 60.2 111.173 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.652 ' HG ' ' HA ' ' E' ' 123' ' ' VAL . 2.9 tm? -58.84 -54.59 45.42 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.81 0.694 . . . . 73.24 110.799 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.89 -38.71 92.08 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.749 0.656 . . . . 65.22 111.065 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.0 mmm -71.32 -36.24 71.51 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.901 0.48 . . . . 65.43 111.004 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.44 -25.96 54.97 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.197 0.599 . . . . 73.24 111.21 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -61.16 -37.19 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.591 0.756 . . . . 73.12 111.247 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 pp -120.25 23.04 11.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.21 1.004 . . . . 72.15 111.196 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -79.69 96.5 6.24 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.014 0.525 . . . . 63.54 109.665 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -163.18 -35.76 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.569 0.748 . . . . 74.42 110.583 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.57 88.94 0.08 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.804 1.242 . . . . 70.0 108.821 -171.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.15 91.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.822 0.849 . . . . 64.22 111.713 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.68 -163.14 54.36 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.897 -0.592 . . . . 71.54 113.895 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.56 -175.76 5.57 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.728 0.811 . . . . 62.24 110.167 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.35 125.86 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.696 -0.562 . . . . 73.42 111.696 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.4 p -105.55 135.42 46.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.468 0.707 . . . . 54.53 110.134 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -136.97 100.95 4.43 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.714 0.805 . . . . 73.43 109.098 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.99 143.8 26.19 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.87 0.868 . . . . 72.51 110.53 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -129.75 163.63 25.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.915 0.886 . . . . 71.11 109.556 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -158.28 128.85 6.21 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.682 -0.858 . . . . 73.05 108.682 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -136.13 95.03 3.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.057 0.543 . . . . 71.25 109.813 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 123.372 0.669 . . . . 62.23 110.253 178.208 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.989 -0.745 . . . . 73.51 108.989 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -99.44 39.6 1.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.697 0.799 . . . . 62.13 111.655 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.66 82.7 4.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.934 1.35 . . . . 65.32 109.224 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' F' ' 123' ' ' VAL . 23.3 mm-40 -86.11 84.29 7.54 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.876 -1.056 . . . . 73.12 108.647 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -73.7 91.04 1.86 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.655 -1.157 . . . . 65.55 110.703 -172.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -153.13 100.04 2.44 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.089 -1.078 . . . . 64.23 108.089 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 34.9 p -113.75 -4.69 13.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.393 0.677 . . . . 75.53 111.807 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.43 140.36 30.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.986 -0.375 . . . . 74.52 109.986 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.5 ttm 63.97 115.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.469 1.508 . . . . 72.22 111.235 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -87.92 77.54 8.47 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.65 -0.87 . . . . 74.23 108.65 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -114.66 137.31 52.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.527 -0.76 . . . . 71.5 109.534 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -152.06 134.53 15.3 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.297 0.639 . . . . 73.14 109.483 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 pt -76.27 136.45 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.717 -0.674 . . . . 72.44 109.319 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -104.68 -49.04 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.887 0.475 . . . . 64.53 110.005 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -166.11 141.46 4.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.58 -0.736 . . . . 74.11 109.475 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.4 136.02 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.827 -1.175 . . . . 65.5 107.827 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.623 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 7.7 p90 -173.11 154.38 2.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.306 0.574 . . . . 53.54 111.697 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -77.0 116.64 17.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.342 -0.845 . . . . 55.22 109.052 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.5 mmtp -70.91 -48.59 52.82 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 107.972 -1.122 . . . . 74.02 107.972 169.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 6.0 t70 -137.02 141.14 42.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.479 -1.692 . . . . 63.44 109.548 -171.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.9 mt -136.57 141.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.321 -1.363 . . . . 71.53 107.321 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -150.23 141.84 23.55 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.395 -0.594 . . . . 62.4 109.395 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.85 141.71 31.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.529 -1.285 . . . . 75.34 107.529 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.79 144.0 31.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.569 -1.271 . . . . 73.31 107.569 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.478 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -150.47 83.18 6.0 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 108.386 -0.968 . . . . 44.3 108.386 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.07 -15.17 39.43 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.026 2.484 . . . . 75.01 112.69 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -126.1 37.89 4.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.171 0.988 . . . . 51.34 109.517 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' C' ' 25' ' ' ALA . . . -58.74 -51.74 79.69 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 113.809 1.04 . . . . 64.23 113.809 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.69 -24.53 7.27 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 121.64 1.56 . . . . 62.43 112.43 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.75 -22.54 65.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.661 1.184 . . . . 73.15 111.802 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.661 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 11.2 p -50.1 -32.29 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.353 1.061 . . . . 62.24 113.8 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.4 -31.01 70.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.341 0.656 . . . . 73.14 112.001 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -118.01 48.84 1.32 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.699 0.8 . . . . 72.41 110.355 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 14.6 ptpt -124.41 173.12 8.63 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.881 -0.414 . . . . 62.2 109.881 170.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.59 113.41 20.8 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.026 -1.101 . . . . 63.52 108.026 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -83.76 79.6 9.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.268 1.032 . . . . 71.45 110.81 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.719 ' HB3' HD13 ' C' ' 68' ' ' LEU . 48.4 tt0 -123.53 79.63 54.66 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.342 -1.355 . . . . 74.34 107.342 168.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.486 ' HG2' ' HG ' ' E' ' 139' ' ' LEU . 2.8 Cg_exo -77.13 91.08 1.2 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.053 2.502 . . . . 72.04 111.973 -173.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.61 91.96 8.42 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.9 -1.889 . . . . 63.51 105.9 169.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.5 141.03 15.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.367 -0.833 . . . . 72.44 109.354 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' C' ' 41' ' ' LYS . 4.3 ttmp? -127.13 103.75 7.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.031 -0.729 . . . . 72.25 109.031 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.698 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.6 pt? -89.9 160.71 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.853 . . . . 73.22 109.848 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.93 117.51 8.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.536 0.735 . . . . 41.1 109.216 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.43 120.21 39.64 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.86 -0.793 . . . . 62.1 108.86 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.2 140.93 46.84 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.715 1.206 . . . . 70.32 108.786 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 8.1 t -142.57 138.4 30.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.317 0.58 . . . . 65.12 110.455 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.26 177.32 5.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.143 0.977 . . . . 55.24 108.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -151.83 160.33 43.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 64.2 111.129 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -155.84 140.07 16.58 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.334 1.053 . . . . 75.41 108.614 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.46 115.35 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.497 -0.927 . . . . 64.14 108.497 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.585 HD11 HD12 ' C' ' 83' ' ' ILE . 47.5 mt -85.52 -42.62 14.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.005 -0.739 . . . . 63.12 109.005 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.56 179.78 8.08 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.515 -1.22 . . . . 63.53 109.103 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.06 128.01 34.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.001 -0.741 . . . . 75.43 109.001 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 70.55 -3.66 1.85 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.803 1.241 . . . . 64.31 112.487 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.29 111.22 35.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 108.771 -0.826 . . . . 73.35 108.771 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.34 125.47 42.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.601 0.761 . . . . 63.43 109.124 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.9 tt0 -84.5 137.75 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.696 0.798 . . . . 52.12 109.166 171.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.43 HG23 HD11 ' C' ' 106' ' ' LEU . 29.3 m -124.25 140.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 40.12 108.344 165.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' C' ' 46' ' ' THR . 47.5 t -117.51 103.6 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.397 -0.964 . . . . 65.24 108.397 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.64 96.8 10.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.258 -1.016 . . . . 72.21 108.258 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -85.67 126.78 34.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.817 -1.083 . . . . 73.44 109.663 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.9 t -115.18 134.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.276 -1.009 . . . . 43.33 108.276 171.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 4.4 m -118.98 141.71 48.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.581 HG21 HG21 ' C' ' 114' ' ' ILE . 86.3 t -128.64 117.24 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.668 1.187 . . . . 65.33 108.356 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -99.87 144.37 29.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.438 -1.319 . . . . 71.45 107.438 165.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.84 106.7 6.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.354 -1.721 . . . . 51.4 106.354 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -152.45 160.96 43.21 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.557 0.535 . . . . 72.41 110.815 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.719 HD13 ' HB3' ' C' ' 37' ' ' GLN . 20.0 tp -79.27 -50.26 11.19 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.172 -1.047 . . . . 70.15 108.172 162.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.4 -77.31 0.04 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.068 -1.213 . . . . 63.31 110.068 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -89.99 -31.3 17.28 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.229 -0.656 . . . . 75.21 109.229 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -78.05 93.38 4.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.277 1.031 . . . . 63.15 109.933 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -87.91 130.57 34.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.932 0.493 . . . . 42.33 111.65 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.25 -65.07 0.82 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.167 0.987 . . . . 61.33 108.943 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -156.54 164.0 38.72 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 123.797 0.686 . . . . 52.43 111.622 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.445 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -121.66 144.65 48.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.655 -1.609 . . . . 55.43 106.655 168.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.445 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -148.14 150.95 34.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.777 -0.823 . . . . 60.34 108.777 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -159.69 131.59 6.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.724 0.409 . . . . 62.11 110.078 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -129.95 114.64 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.867 0.867 . . . . 72.22 108.757 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 46.4 mt-30 -90.24 88.6 7.29 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.036 -1.098 . . . . 75.31 108.036 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 64.1 tp60 -79.62 107.22 12.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.892 -1.049 . . . . 74.02 109.512 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.95 154.95 27.13 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 112.147 -0.381 . . . . 71.01 112.147 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.05 122.87 1.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.382 -0.687 . . . . 71.34 111.382 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.585 HD12 HD11 ' C' ' 51' ' ' LEU . 10.0 mm -87.9 123.47 40.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.397 -0.964 . . . . 70.22 108.397 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.32 123.33 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.555 0.742 . . . . 73.32 110.053 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -76.93 112.15 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.822 0.449 . . . . 55.43 109.821 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.42 112.12 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.308 -0.997 . . . . 74.12 108.308 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.01 165.66 30.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.741 0.817 . . . . 71.05 110.255 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -24.42 8.71 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.156 -0.474 . . . . 63.21 113.765 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' C' ' 93' ' ' GLN . 19.8 tt -123.48 151.66 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.403 1.081 . . . . 62.03 109.558 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.75 161.0 43.09 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.205 0.602 . . . . 63.14 110.606 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.1 -153.61 22.4 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 122.986 0.327 . . . . 72.12 112.856 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -59.53 -26.55 65.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.997 0.919 . . . . 73.41 110.454 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.561 ' HB3' HD11 ' C' ' 89' ' ' ILE . 36.8 mt-30 -61.1 -49.84 75.67 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.904 -1.498 . . . . 64.44 110.799 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -21.33 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 116.273 -0.422 . . . . 73.23 110.694 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.08 83.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.034 0.533 . . . . 64.24 110.57 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -66.09 -31.13 71.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.539 -0.755 . . . . 72.32 110.508 172.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.98 -59.27 2.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.67 0.388 . . . . 75.31 110.737 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.14 -51.05 16.79 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.434 0.694 . . . . 74.33 111.108 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.27 6.53 81.03 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.383 -0.676 . . . . 44.1 114.599 -169.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.15 -57.22 0.37 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.906 0.853 . . . . 75.53 111.829 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -68.49 -54.05 19.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.289 0.636 . . . . 74.22 111.233 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.3 -46.96 99.07 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 123.863 0.865 . . . . 74.42 112.597 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.3 -33.55 58.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.954 1.769 . . . . 63.11 113.378 171.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.36 -21.6 63.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.918 0.487 . . . . 55.41 111.78 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.524 HD12 ' NH1' ' A' ' 111' ' ' ARG . 32.4 mm -73.75 -39.35 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.216 0.606 . . . . 73.13 109.492 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.543 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.5 mt -75.44 -26.85 58.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.077 -0.965 . . . . 63.14 111.735 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -54.98 -49.87 89.63 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-O 117.993 -1.003 . . . . 71.53 113.12 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.58 -39.96 73.97 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.227 1.951 . . . . 63.11 113.879 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.98 -45.27 67.71 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.132 0.573 . . . . 75.03 110.882 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.21 81.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.248 0.619 . . . . 70.23 110.09 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -63.73 -50.12 70.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.108 1.363 . . . . 72.14 111.244 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.46 -28.53 66.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.704 0.402 . . . . 72.01 110.109 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.6 t -69.33 -35.98 76.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.778 0.431 . . . . 74.32 110.71 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.581 HG21 HG21 ' C' ' 64' ' ' VAL . 93.4 mt -71.25 -53.23 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.49 -0.559 . . . . 72.25 109.49 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -61.32 -28.91 69.54 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.794 0.838 . . . . 71.01 111.336 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 38.9 t -65.94 -50.34 64.72 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.084 -0.71 . . . . 50.44 109.084 170.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.519 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.85 -31.89 71.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.954 0.901 . . . . 73.13 112.436 179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' C' ' 114' ' ' ILE . 43.9 t -71.66 -38.9 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -66.47 -29.9 70.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.853 0.861 . . . . 63.13 111.377 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -74.16 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.43 0.692 . . . . 71.23 109.893 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.52 -7.33 68.46 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.418 0.449 . . . . 75.04 112.417 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 63.14 30.25 16.06 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.937 2.095 . . . . 73.1 112.561 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -82.77 162.32 55.68 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.639 -1.164 . . . . 74.11 108.409 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 140.27 92.72 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.41 2.074 . . . . 74.13 111.639 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.446 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 13.1 mm100 -57.59 112.55 1.47 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.891 0.877 . . . . 71.15 111.897 -173.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.43 93.21 4.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.45 -0.945 . . . . 74.02 108.45 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.27 127.75 49.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 75.24 108.554 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.532 HD11 HG22 ' C' ' 64' ' ' VAL . 86.8 mt -81.39 144.69 31.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.039 0.535 . . . . 70.32 111.114 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.23 143.26 95.64 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.323 0.649 . . . . 70.51 110.421 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.52 139.49 76.45 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.634 2.223 . . . . 64.31 112.33 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.25 118.2 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 108.888 -0.782 . . . . 73.41 108.888 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.556 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 4.2 m-20 -83.87 60.24 5.68 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.864 0.84 . . . . 71.41 109.99 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -78.91 -43.43 24.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.844 -1.071 . . . . 74.2 110.034 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -70.99 -37.09 72.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.792 -0.64 . . . . 64.42 109.694 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -62.27 -29.82 70.69 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 124.267 1.027 . . . . 63.31 111.757 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.623 HD12 HD21 ' E' ' 148' ' ' LEU . 9.5 tt -52.93 -51.11 62.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.85 0.86 . . . . 61.43 110.246 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -74.47 -27.14 60.44 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.624 -0.716 . . . . 74.15 111.279 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 95.8 mmm -69.41 -31.05 69.16 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.288 0.635 . . . . 55.2 111.462 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.81 -39.35 94.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.779 0.675 . . . . 52.13 110.171 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.52 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.524 -0.762 . . . . 73.45 110.779 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 58.42 167.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.246 1.018 . . . . 60.11 112.545 -168.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.56 92.82 0.9 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.524 -0.762 . . . . 73.22 109.14 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -160.69 135.42 7.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.189 -0.914 . . . . 64.3 109.077 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -86.59 149.1 25.17 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.548 0.739 . . . . 65.32 110.086 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 147' ' ' GLU . . . -144.68 -168.35 2.89 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.113 0.965 . . . . 71.44 109.061 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.18 99.64 0.14 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.773 -0.931 . . . . 72.3 110.773 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.36 171.74 0.74 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.749 0.82 . . . . 73.41 112.034 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.42 -47.28 1.27 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.699 -0.682 . . . . 44.03 111.903 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -69.78 123.5 21.58 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.705 -0.85 . . . . 63.21 108.705 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.03 -8.18 55.79 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.363 0.665 . . . . 64.43 112.634 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -150.76 174.87 12.55 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.386 0.674 . . . . 63.33 110.768 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -82.46 90.59 6.75 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.788 0.804 . . . . 75.45 109.976 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -145.91 173.47 12.11 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.687 0.795 . . . . 71.43 109.589 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.03 160.42 31.32 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.198 -0.456 . . . . 63.32 109.918 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 108.743 -0.836 . . . . 52.51 108.743 -179.217 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.287 -0.634 . . . . 62.32 109.287 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -124.86 13.55 8.54 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.421 1.089 . . . . 63.33 110.599 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 60.97 91.33 0.06 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 73.44 109.249 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.95 93.25 0.11 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.971 -1.013 . . . . 54.02 110.247 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.64 102.21 14.84 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.921 0.888 . . . . 72.42 109.26 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -61.78 -30.09 70.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.477 1.111 . . . . 70.31 111.836 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 m -67.38 -45.74 75.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.315 0.646 . . . . 75.42 111.433 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -87.67 -14.28 40.34 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 118.886 -0.578 . . . . 74.23 111.65 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.5 ttp -30.24 125.31 0.16 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.906 1.283 . . . . 75.22 113.289 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -122.95 142.41 50.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.588 0.755 . . . . 71.42 109.301 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -155.04 98.9 2.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.658 -1.238 . . . . 70.41 107.658 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.7 132.62 49.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.269 0.628 . . . . 65.24 109.82 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tp -89.61 128.21 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.15 0.58 . . . . 61.23 109.548 177.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -99.62 -40.5 7.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.835 0.854 . . . . 74.24 111.037 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -163.04 123.44 2.31 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.772 -0.649 . . . . 72.1 110.471 -162.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.93 132.1 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.294 -1.373 . . . . 62.5 107.294 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.544 ' HE1' HG13 ' D' ' 83' ' ' ILE . 12.4 p90 -160.04 143.52 14.03 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.957 0.786 . . . . 74.54 111.476 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -76.1 117.48 17.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.943 -1.026 . . . . 73.21 108.917 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -82.59 -26.14 32.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.91 0.386 . . . . 64.21 109.99 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.7 t70 -154.11 141.69 19.85 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.848 -1.069 . . . . 63.21 109.437 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.519 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.1 mt -141.63 145.98 23.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.221 1.408 . . . . 73.21 107.544 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -147.34 141.72 26.35 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.986 0.914 . . . . 73.02 108.69 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.9 t80 -153.77 124.89 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.285 -1.746 . . . . 55.32 106.285 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.43 112.66 7.43 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.596 0.634 . . . . 71.11 110.27 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.9 91.37 12.6 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.38 0.672 . . . . 42.02 109.353 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.5 -43.87 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.759 2.306 . . . . 55.13 112.919 -175.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 23.8 m120 -99.63 43.42 1.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.754 0.822 . . . . 70.34 109.056 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.623 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.78 -52.36 73.04 Favored Pre-proline 0 CA--C 1.57 1.737 0 N-CA-C 114.742 1.386 . . . . 75.42 114.742 -169.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.5 -6.0 8.09 Favored 'Trans proline' 0 C--N 1.388 2.656 0 CA-C-N 121.524 1.58 . . . . 63.14 112.578 172.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 21.8 t-160 -81.09 -42.15 21.43 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.08 0.952 . . . . 74.35 110.048 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.11 -18.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.27 0.628 . . . . 74.24 110.052 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.98 -29.62 70.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.949 0.9 . . . . 75.41 110.876 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -68.55 -17.71 64.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 70.44 111.841 177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.07 109.97 21.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.768 0.827 . . . . 72.02 110.168 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' F' ' 135' ' ' ALA . 4.8 m-20 -79.73 81.99 5.91 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.99 0.916 . . . . 74.13 110.882 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -159.42 161.35 35.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.654 -0.499 . . . . 73.24 109.654 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.433 ' HG3' ' HA ' ' F' ' 139' ' ' LEU . 2.6 mp0 -82.9 109.07 14.62 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.876 0.87 . . . . 74.54 109.792 173.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -50.19 140.37 33.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.44 2.76 . . . . 74.54 113.569 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.446 ' HG3' HD22 ' F' ' 141' ' ' LEU . 36.2 tt0 -57.73 127.29 31.31 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.051 0.845 . . . . 63.24 110.116 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' F' ' 142' ' ' ILE . 88.7 t -96.33 105.84 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.734 -0.839 . . . . 63.3 108.734 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -102.78 108.85 20.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.217 -1.401 . . . . 74.12 107.217 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.647 HD13 HD21 ' D' ' 128' ' ' LEU . 1.5 pt? -116.3 149.85 38.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.065 0.46 . . . . 72.51 110.498 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.69 130.27 24.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.395 1.078 . . . . 51.25 108.289 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.21 131.13 54.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.222 0.609 . . . . 62.45 109.503 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -133.55 128.95 36.36 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.853 -1.166 . . . . 74.41 107.853 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -106.23 150.03 26.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.522 0.329 . . . . 74.55 110.211 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.13 169.02 22.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.8 0.84 . . . . 71.21 110.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.4 m -147.87 158.73 44.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.874 0.869 . . . . 65.21 110.019 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -155.35 118.42 4.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.17 -1.048 . . . . 64.33 108.17 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.62 123.14 24.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.147 -0.686 . . . . 64.44 109.147 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' D' ' 57' ' ' GLU . 51.2 mt -96.21 -31.54 12.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.547 . . . . 71.41 110.366 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 179.64 8.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.857 0.863 . . . . 75.31 110.088 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.06 121.34 18.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.906 -1.043 . . . . 71.43 109.274 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 68.24 17.01 9.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.994 1.318 . . . . 71.21 112.069 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.36 116.68 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.628 ' HB2' HD13 ' D' ' 86' ' ' ILE . 82.6 m-85 -129.15 129.83 45.64 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.736 -0.839 . . . . 71.11 108.736 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.5 tt0 -87.79 135.37 33.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.845 -1.071 . . . . 73.14 108.64 171.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.02 139.2 43.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.853 -1.166 . . . . 71.5 107.853 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.69 131.84 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.39 -0.967 . . . . 71.44 108.39 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -114.58 117.14 30.06 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.267 -1.383 . . . . 73.22 107.267 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 44.6 ttm-85 -95.78 98.72 10.66 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.59 -1.263 . . . . 61.42 107.59 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.567 HG21 ' HB1' ' D' ' 110' ' ' ALA . 47.6 t -99.21 113.81 35.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.031 -1.1 . . . . 71.12 108.031 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.2 m -117.3 132.23 56.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 72.31 109.232 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.28 107.1 10.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.964 0.906 . . . . 72.45 109.286 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.8 m -92.57 119.77 32.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.687 -0.857 . . . . 74.3 108.687 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.73 137.11 46.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.699 -0.852 . . . . 44.05 108.699 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.3 p -149.15 140.38 23.12 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.846 0.459 . . . . 55.3 109.951 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.86 130.18 41.36 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.386 -1.338 . . . . 73.44 107.386 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.23 -121.14 12.91 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.706 -0.557 . . . . 74.42 111.706 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.15 6.95 15.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.247 1.019 . . . . 74.1 111.402 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.95 150.19 34.13 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.118 0.567 . . . . 71.43 109.751 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -79.8 116.72 20.13 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.814 -0.439 . . . . 73.02 109.814 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.11 -56.08 10.14 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.824 0.849 . . . . 72.23 110.102 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.54 169.19 23.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.021 -0.991 . . . . 75.33 110.211 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.4 mt -124.41 153.26 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.759 1.224 . . . . 73.14 108.012 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.517 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.2 t -158.43 139.66 13.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.137 0.575 . . . . 64.04 109.638 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.27 130.66 8.79 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.896 -0.779 . . . . 70.43 108.896 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.5 t -129.74 115.29 33.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.076 -0.713 . . . . 72.33 109.076 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.2 mt-30 -89.36 83.4 6.41 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.302 1.048 . . . . 62.44 108.478 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.79 102.97 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.174 -1.83 . . . . 52.02 109.509 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.2 162.71 23.87 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 116.319 -0.401 . . . . 33.33 112.393 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.0 136.77 5.08 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.951 -0.86 . . . . 72.23 110.951 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.544 HG13 ' HE1' ' D' ' 17' ' ' TYR . 69.2 mt -89.48 120.83 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.814 -0.81 . . . . 73.13 108.814 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -121.4 147.12 46.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.565 -0.531 . . . . 64.41 109.565 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 66.1 m -94.58 106.94 18.94 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.794 -0.817 . . . . 74.01 108.794 170.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' D' ' 94' ' ' MET . 3.5 mp -107.26 107.69 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.33 -0.989 . . . . 63.55 108.33 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.46 148.81 50.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.121 0.568 . . . . 62.43 109.977 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -22.71 11.93 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.073 -0.512 . . . . 64.44 114.273 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.566 HG22 ' HB2' ' D' ' 94' ' ' MET . 32.5 mm -136.41 139.89 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.247 -1.39 . . . . 72.34 107.247 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.01 179.7 7.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.182 0.593 . . . . 72.01 109.996 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.64 -99.83 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.297 -0.41 . . . . 73.45 113.762 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.7 p -83.45 -56.1 3.93 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.077 0.551 . . . . 42.4 111.977 -168.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.03 -37.63 78.73 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 120.796 0.332 . . . . 62.31 110.85 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.653 ' HG2' HG21 ' D' ' 86' ' ' ILE . 44.5 tpp -77.31 -19.93 55.7 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.956 -0.565 . . . . 73.12 111.751 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.63 -32.49 70.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 120.996 0.427 . . . . 62.13 111.124 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -62.65 -40.57 97.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.244 -0.889 . . . . 74.25 110.988 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.409 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 38.5 t -72.26 -51.26 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.786 0.434 . . . . 73.04 110.27 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.5 HD13 ' HG3' ' D' ' 94' ' ' MET . 10.7 mp -67.37 -18.86 65.31 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.466 0.706 . . . . 73.3 111.796 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -2.94 56.96 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.372 -0.682 . . . . 61.21 114.056 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.69 -62.79 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.95 0.875 . . . . 53.03 111.999 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -71.06 -50.08 37.8 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.826 0.676 . . . . 72.12 112.826 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.431 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 18.6 m -62.67 -45.23 88.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.373 0.669 . . . . 62.14 111.877 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.547 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.9 Cg_exo -55.99 -37.63 95.85 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.985 1.79 . . . . 61.23 113.057 168.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.82 -32.47 74.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.537 0.735 . . . . 65.24 111.143 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.14 -41.97 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 123.283 0.633 . . . . 75.33 110.136 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.9 mt -77.42 -17.96 57.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.172 -0.922 . . . . 60.31 111.541 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.98 -44.19 89.09 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 114.181 1.178 . . . . 71.45 114.181 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.23 -41.9 56.28 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.156 1.904 . . . . 64.35 112.808 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.98 -32.62 51.38 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.153 -0.93 . . . . 73.13 111.597 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.567 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -62.86 -55.61 24.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.593 0.757 . . . . 63.41 109.441 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.07 -40.45 76.89 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.025 -1.443 . . . . 73.12 110.337 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 3.4 tm-20 -57.42 -53.55 56.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.73 0.812 . . . . 75.23 111.742 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.404 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.6 t -57.74 -42.22 83.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.018 0.824 . . . . 71.41 110.935 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.517 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.6 mt -63.35 -54.15 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.348 -0.842 . . . . 72.51 110.642 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.516 HG23 ' HG3' ' D' ' 125' ' ' GLN . 48.0 m -54.02 -38.03 64.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 71.24 111.389 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -73.02 -44.49 60.83 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.062 -0.972 . . . . 73.2 110.462 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 73.4 mtm -65.2 -31.02 71.98 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.785 0.434 . . . . 52.24 111.803 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' D' ' 123' ' ' PHE . 79.4 t -66.36 -47.55 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 124.008 0.817 . . . . 74.02 109.771 176.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -70.49 -27.91 64.57 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 123.356 0.41 . . . . 73.12 111.06 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -73.5 -34.79 65.45 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.794 0.838 . . . . 73.05 110.044 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.45 -1.56 88.73 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.663 -0.698 . . . . 71.31 112.008 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 58.94 34.69 23.76 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.753 2.021 . . . . 72.42 112.784 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.448 ' HB2' HG13 ' D' ' 118' ' ' VAL . 68.7 m-85 -96.45 163.58 20.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.489 -1.232 . . . . 70.1 108.287 170.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.28 139.62 72.77 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.02 1.814 . . . . 74.1 111.025 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.516 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.3 tt0 -55.21 135.23 49.78 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.716 0.807 . . . . 73.31 112.189 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.403 HD23 HG21 ' D' ' 114' ' ' ILE . 58.7 tp -103.02 104.84 15.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.491 -0.929 . . . . 73.12 108.491 -175.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -98.42 84.5 3.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.205 -1.406 . . . . 75.42 107.205 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.647 HD21 HD13 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -63.78 115.41 4.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.07 -1.085 . . . . 74.43 108.07 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 135.35 90.67 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 124.153 0.908 . . . . 44.14 111.554 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 107.25 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.663 2.242 . . . . 71.54 111.567 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 m -107.33 144.38 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.69 0.796 . . . . 63.33 109.455 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.461 ' H ' HD21 ' F' ' 148' ' ' LEU . 50.5 t-20 -82.15 101.45 10.44 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.138 -0.69 . . . . 74.3 109.138 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -62.17 -31.9 72.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.733 0.813 . . . . 74.5 111.374 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -40.23 80.08 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.93 0.769 . . . . 72.3 110.33 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -34.17 77.13 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.111 0.564 . . . . 54.51 111.276 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.71 -32.51 57.88 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.622 -0.717 . . . . 74.12 109.566 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.28 -31.99 73.41 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.875 0.87 . . . . 63.42 110.412 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 14.2 mmt -57.52 -46.9 83.28 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.553 0.692 . . . . 73.41 109.187 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.467 -1.242 . . . . 71.14 111.2 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -59.23 -41.93 89.86 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.625 0.77 . . . . 73.13 111.237 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.44 -30.67 71.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.324 0.649 . . . . 74.13 111.066 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -82.66 3.35 29.33 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.63 0.772 . . . . 70.52 111.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -120.91 92.46 3.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.148 0.979 . . . . 74.1 109.331 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -143.7 133.71 24.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.495 0.718 . . . . 71.23 109.687 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.5 168.81 17.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.924 0.89 . . . . 51.31 110.209 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.08 142.25 13.74 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.076 -0.81 . . . . 73.41 111.076 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -137.52 123.24 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.121 -1.066 . . . . 60.35 108.121 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.63 142.58 9.3 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 111.339 -0.705 . . . . 64.34 111.339 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.3 m -132.46 124.69 29.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.147 0.579 . . . . 72.31 110.065 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.84 159.86 32.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.338 0.655 . . . . 63.12 110.013 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -80.45 149.62 30.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.066 0.546 . . . . 72.02 110.245 -176.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -73.57 -34.95 65.38 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.447 -0.575 . . . . 72.02 109.447 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.6 104.61 0.94 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.065 -1.457 . . . . 63.3 107.065 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.84 103.62 10.8 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.103 -0.703 . . . . 35.14 109.103 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 C-N-CA 123.21 0.604 . . . . 72.23 110.185 179.327 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 119.848 -0.12 . . . . 71.21 110.75 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 66.58 28.87 9.18 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.55 1.14 . . . . 65.11 112.671 173.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.06 -16.93 1.64 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.01 0.524 . . . . 71.24 111.944 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.76 142.72 33.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.495 0.718 . . . . 75.23 109.46 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -65.68 127.5 32.16 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.928 0.768 . . . . 74.15 110.887 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -77.67 -77.21 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.068 -1.086 . . . . 73.04 108.068 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt 174.58 -46.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.103 1.361 . . . . 73.42 107.569 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.427 HD12 ' HE1' ' B' ' 56' ' ' TYR . 27.1 mt 50.38 75.14 0.19 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.96 1.413 . . . . 74.13 110.698 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 116' ' ' TYR . . . . . 0.425 ' HA ' HD11 ' B' ' 98' ' ' LEU . 72.6 t80 -166.65 136.33 2.47 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 115.493 -0.776 . . . . 75.15 109.211 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -54.05 133.85 57.12 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.919 2.413 . . . . 74.13 112.988 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.41 -40.29 25.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.054 1.342 . . . . 73.41 112.369 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 22.6 p -143.46 -55.16 0.39 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.331 1.052 . . . . 74.1 108.627 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 5.7 t90 80.43 -19.86 0.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 126.315 1.846 . . . . 71.1 110.48 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.87 -87.96 0.03 OUTLIER 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.774 1.63 . . . . 52.54 111.183 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.86 143.05 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.959 0.904 . . . . 74.4 109.13 -173.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 123' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' B' ' 44' ' ' LEU . 8.1 p -74.47 94.19 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-O 122.292 1.044 . . . . 55.2 110.525 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -89.02 91.49 8.85 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.636 -0.875 . . . . 61.25 108.636 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -105.28 -171.2 1.87 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.919 -1.037 . . . . 61.15 108.951 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -74.43 4.15 6.4 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.106 0.78 . . . . 74.21 113.106 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.75 0.89 Allowed Glycine 0 C--N 1.351 1.406 0 N-CA-C 111.915 -0.474 . . . . 72.21 111.915 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.85 107.74 12.87 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.449 -0.574 . . . . 74.31 109.449 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 129' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . 0.0 OUTLIER -62.36 -20.67 64.64 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.192 0.997 . . . . 73.25 112.343 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.435 HG13 HD13 ' E' ' 129' ' ' LEU . 52.2 mt -66.24 95.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.347 1.059 . . . . 61.11 109.967 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.55 -43.84 46.51 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.991 0.516 . . . . 74.21 110.293 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.22 116.79 4.07 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.846 0.858 . . . . 62.12 109.153 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.52 164.78 10.8 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.481 2.121 . . . . 73.11 112.359 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.98 -45.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.152 0.581 . . . . 73.13 110.026 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.97 -34.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.712 1.605 . . . . 74.22 112.86 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t 68.56 12.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 125.366 1.466 . . . . 70.21 110.282 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 62.38 171.17 0.13 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 125.584 1.554 . . . . 75.41 113.064 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.54 115.52 5.84 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.885 -0.598 . . . . 72.5 109.665 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 139' ' ' LEU . . . . . 0.486 ' HG ' ' HG2' ' C' ' 38' ' ' PRO . 9.8 mp -65.55 89.33 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.875 0.734 . . . . 61.14 109.428 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 18.6 m -88.88 176.36 7.07 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.336 -1.302 . . . . 55.12 109.826 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 56.5 mt 68.39 5.04 4.53 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.624 1.17 . . . . 73.55 112.126 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 30.6 pt -78.1 -41.74 27.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 123.305 0.642 . . . . 75.33 109.554 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -160.41 119.09 2.64 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.141 1.776 . . . . 72.44 107.27 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.01 -73.4 0.23 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.943 -0.762 . . . . 72.43 108.943 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -144.96 -165.25 2.12 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.327 1.051 . . . . 64.23 109.112 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.28 -172.36 0.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.75 1.22 . . . . 73.31 111.303 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -152.73 -76.69 0.12 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.436 -1.32 . . . . 60.12 107.436 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.623 HD21 HD12 ' C' ' 136' ' ' LEU . 9.6 tt -161.68 96.28 1.28 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.523 -1.288 . . . . 64.31 107.523 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.561 1.866 0 C-N-CA 123.235 2.623 . . . . 74.13 111.258 174.985 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.704 -0.48 . . . . 74.32 109.704 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.48 103.89 5.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.584 0.753 . . . . 74.21 109.054 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.82 161.06 22.09 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.722 -0.473 . . . . 52.03 109.722 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.1 -170.09 2.15 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.246 1.018 . . . . 61.44 109.214 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 73.99 165.95 0.29 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.557 1.143 . . . . 72.24 111.798 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.89 149.04 21.58 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.135 -0.939 . . . . 72.13 110.22 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' F' ' 114' ' ' LYS . 0.4 OUTLIER -92.08 83.51 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.064 -1.087 . . . . 74.31 108.064 175.159 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.7 103.37 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.48 -0.782 . . . . 75.32 110.175 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -170.21 79.33 0.61 Allowed Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.113 0.883 . . . . 73.44 109.507 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.6 -52.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.429 2.086 . . . . 72.44 112.174 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -89.3 -171.76 3.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 75.31 109.108 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 76.1 m -134.63 -74.51 0.47 Allowed 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.086 0.554 . . . . 74.22 110.327 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -171.96 132.21 0.68 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.643 -1.243 . . . . 73.42 107.643 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.47 -161.11 0.57 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.974 0.51 . . . . 73.12 110.582 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.05 44.6 0.95 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.234 1.014 . . . . 51.2 112.189 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.403 ' HA ' ' OE1' ' C' ' 4' ' ' GLN . 16.1 t -84.54 71.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 N-CA-C 108.24 -1.022 . . . . 72.13 108.24 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -92.77 -52.61 4.54 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.539 -1.21 . . . . 73.04 109.156 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 68.48 136.07 0.03 OUTLIER 'General case' 0 C--N 1.356 0.873 0 O-C-N 125.192 1.558 . . . . 73.53 112.817 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -83.1 -172.01 3.89 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.172 -0.922 . . . . 65.43 109.111 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 127' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 41' ' ' LYS . . . -158.33 83.93 0.13 Allowed Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.533 -0.841 . . . . 64.52 115.117 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -131.83 20.61 4.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.249 1.02 . . . . 74.24 108.562 167.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 pp -85.85 138.27 32.16 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.844 -0.616 . . . . 75.24 111.229 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 tp -161.56 134.58 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.817 1.247 . . . . 62.15 107.782 174.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.13 -62.49 1.41 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.618 -0.512 . . . . 73.34 109.618 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -167.07 119.71 0.77 Allowed Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.307 -0.861 . . . . 73.01 109.07 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.35 79.03 3.2 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.836 2.357 . . . . 63.54 111.072 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.427 HG23 HG22 ' F' ' 136' ' ' VAL . 7.8 tt -62.33 141.75 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 115.729 -0.669 . . . . 64.42 110.146 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' D' ' 35' ' ' ASP . . . -69.17 79.91 0.34 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.375 0.67 . . . . 60.1 111.046 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.427 HG22 HG23 ' F' ' 134' ' ' ILE . 34.7 m -139.8 147.6 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.865 1.266 . . . . 73.0 108.781 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.37 -74.96 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.499 -1.297 . . . . 73.51 107.499 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.28 113.69 20.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.995 0.918 . . . . 31.3 109.003 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.433 ' HA ' ' HG3' ' D' ' 37' ' ' GLN . 28.5 tp -64.46 100.56 0.37 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.236 1.014 . . . . 74.51 110.755 177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 25.6 m -94.72 -160.83 0.81 Allowed 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.362 -1.29 . . . . 75.14 109.353 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 141' ' ' LEU . . . . . 0.446 HD22 ' HG3' ' D' ' 39' ' ' GLU . 0.5 OUTLIER 70.77 34.43 2.01 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.29 1.036 . . . . 72.24 109.164 -177.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.573 ' HA ' ' HB ' ' D' ' 40' ' ' VAL . 14.8 mm -69.48 122.3 20.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-N 114.964 -1.016 . . . . 75.22 108.636 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 70.2 121.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.47 1.108 . . . . 75.05 110.571 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -68.99 -45.29 70.96 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.317 -0.623 . . . . 64.25 109.317 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -74.86 -82.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.22 -0.9 . . . . 71.04 110.472 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -169.98 148.59 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.366 0.666 . . . . 64.24 110.241 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 147' ' ' LEU . . . . . 0.431 HD23 HD13 ' F' ' 148' ' ' LEU . 6.4 tt -88.76 93.46 9.58 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.154 -1.054 . . . . 72.32 108.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 148' ' ' LEU . . . . . 0.461 HD21 ' H ' ' D' ' 132' ' ' ASN . 9.9 mp 68.42 147.82 0.12 Allowed Pre-proline 0 N--CA 1.488 1.465 0 C-N-CA 124.516 1.127 . . . . 34.35 111.373 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--N 1.376 1.989 0 C-N-CA 122.339 2.026 . . . . 75.32 111.234 -178.584 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.131 -0.322 . . . . 72.01 110.131 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -84.06 107.38 16.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.624 0.77 . . . . 75.24 109.109 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.15 38.57 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 74.5 110.311 -170.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.22 133.6 54.71 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.515 0.726 . . . . 73.31 109.547 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -156.08 144.72 20.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.519 0.728 . . . . 73.41 109.27 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.07 134.65 30.06 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.103 -0.703 . . . . 72.03 109.103 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -145.47 -43.0 0.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.547 0.739 . . . . 62.23 109.417 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 63.3 98.26 0.04 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 125.366 1.466 . . . . 71.5 109.8 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.633 ' HB3' HG23 ' A' ' 89' ' ' ILE . 1.9 ppp? -160.36 162.3 33.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.589 0.756 . . . . 43.41 110.962 -174.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 154' ' ' ASP . 20.4 m -153.37 123.99 7.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.837 1.255 . . . . 35.31 109.064 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.58 130.44 53.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.621 -1.251 . . . . 74.13 107.621 167.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 30.9 tt0 -133.57 106.65 7.53 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.205 -0.665 . . . . 70.14 109.205 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -75.87 102.92 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.402 -1.333 . . . . 63.52 107.402 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 7.2 tp-100 -74.75 -43.16 56.38 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.796 -0.638 . . . . 72.35 110.8 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 178.36 156.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.281 1.032 . . . . 71.11 110.243 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.56 106.42 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.228 1.011 . . . . 72.13 108.555 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' CD1' HG22 ' B' ' 122' ' ' THR . 77.0 m-85 -148.39 157.66 43.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.388 0.675 . . . . 75.15 110.604 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -73.72 120.69 19.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.033 0.933 . . . . 73.44 110.526 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -88.81 -22.58 23.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.983 -0.553 . . . . 70.51 110.743 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -154.86 141.86 19.24 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.937 0.773 . . . . 62.35 110.278 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.8 mt -143.19 141.62 26.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.539 1.536 . . . . 60.04 107.534 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -149.97 135.17 18.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.285 -1.006 . . . . 75.43 108.285 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.625 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 74.0 t80 -138.08 111.59 8.11 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 106.099 -1.815 . . . . 74.4 106.099 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.87 118.81 32.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.801 0.44 . . . . 65.1 110.183 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.69 75.07 32.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.694 0.797 . . . . 70.4 109.726 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.12 -27.56 29.37 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.47 2.113 . . . . 72.44 110.656 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 31' ' ' VAL . 57.7 m-20 -96.69 24.96 5.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.08 -1.418 . . . . 72.45 109.777 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.14 99.86 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.985 0.914 . . . . 72.4 112.829 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.07 -16.35 40.38 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 121.714 1.609 . . . . 65.11 112.638 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -85.81 -20.5 29.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.662 0.785 . . . . 74.24 110.461 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' ASN . 46.3 t -68.97 -23.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.201 0.524 . . . . 72.34 110.459 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -67.98 -30.25 69.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.592 -0.731 . . . . 75.25 110.517 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -72.6 -30.39 64.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.964 0.906 . . . . 52.13 110.177 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -75.42 161.28 29.37 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.676 -0.693 . . . . 73.25 111.243 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.41 159.72 29.25 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.818 -1.083 . . . . 74.43 108.755 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.0 m-90 -82.82 57.25 3.74 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.322 0.582 . . . . 65.5 110.283 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -154.9 79.67 4.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.554 0.741 . . . . 63.41 109.406 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.98 155.89 23.29 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.202 1.935 . . . . 62.13 110.83 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.17 115.97 28.31 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.007 -1.109 . . . . 62.53 108.007 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 65' ' ' THR . 21.9 m -98.96 98.8 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.703 0.764 . . . . 74.33 110.921 -173.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.73 115.44 19.33 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.364 -0.976 . . . . 70.45 108.364 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 pt? -98.71 145.05 27.3 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.379 -0.6 . . . . 72.35 109.379 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.576 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.1 t70 -137.67 122.52 18.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.03 -1.1 . . . . 65.12 108.03 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD21 HG11 ' A' ' 131' ' ' VAL . 4.1 mp -102.62 118.12 36.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.837 -0.801 . . . . 71.12 108.837 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -132.12 137.27 47.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.484 0.714 . . . . 72.33 109.734 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.7 m -131.1 139.11 49.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.868 0.867 . . . . 55.24 109.631 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.76 115.32 5.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.668 0.787 . . . . 73.04 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.2 m -90.17 155.37 19.07 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.569 0.748 . . . . 74.54 110.51 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -149.57 161.15 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.534 1.134 . . . . 65.4 108.786 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -114.85 115.93 27.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.275 0.63 . . . . 71.51 109.719 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -90.04 -31.22 17.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.402 0.681 . . . . 72.54 111.471 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 -172.48 3.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.744 0.652 . . . . 71.21 110.365 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.74 105.65 1.03 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.209 1.003 . . . . 73.13 111.055 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 67.93 12.44 8.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.083 1.353 . . . . 73.35 112.733 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.33 106.86 19.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.48 -1.304 . . . . 73.11 107.48 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -113.16 123.96 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.967 -1.015 . . . . 72.43 109.146 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.7 119.86 38.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.147 -1.388 . . . . 75.0 108.548 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.24 123.61 53.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.676 -1.601 . . . . 75.12 106.676 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 99.4 t -104.19 130.0 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.635 -0.876 . . . . 44.14 108.635 173.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 113.14 26.49 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.574 -1.639 . . . . 75.21 106.574 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -100.22 101.99 13.15 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.969 -1.123 . . . . 64.45 107.969 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.3 t -95.11 126.79 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.278 -1.008 . . . . 52.34 108.278 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 23.2 m -110.55 133.95 52.84 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.24 105.85 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.166 -1.42 . . . . 62.43 107.166 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.0 m -103.78 130.35 51.3 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.732 -0.84 . . . . 54.02 108.732 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.36 109.69 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.147 -1.057 . . . . 73.22 108.147 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.3 m -136.61 128.5 29.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.035 -0.728 . . . . 54.24 109.035 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 tt -94.65 87.66 5.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.611 -1.625 . . . . 63.14 106.611 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.76 -121.3 5.4 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.528 -0.629 . . . . 64.32 111.528 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -90.8 -25.84 19.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.195 0.598 . . . . 72.12 111.602 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 125.79 34.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.774 -0.454 . . . . 63.25 109.774 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 m -74.36 134.37 42.48 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 115.776 -0.647 . . . . 62.41 109.658 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.63 -55.62 4.34 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -167.3 168.99 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.039 -0.982 . . . . 75.53 110.476 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.5 tp -132.52 143.68 49.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.644 1.178 . . . . 55.11 108.673 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.625 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 13.8 m -138.02 124.93 21.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.635 0.774 . . . . 64.14 109.432 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.41 125.77 23.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.106 -0.701 . . . . 52.25 109.106 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -131.89 114.69 25.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.979 0.912 . . . . 74.23 109.512 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 74.1 mt-30 -85.53 86.6 7.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.154 -0.93 . . . . 72.11 108.876 172.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.67 99.1 5.68 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.078 -0.965 . . . . 73.53 109.071 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.66 152.41 21.08 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.593 -0.603 . . . . 73.14 111.593 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.07 134.24 5.67 Favored Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.273 -1.131 . . . . 71.21 110.273 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 43.4 mt -87.85 125.71 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.255 -1.017 . . . . 72.24 108.255 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -131.82 120.23 22.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 48.3 t -92.2 100.83 13.37 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.177 -1.045 . . . . 65.31 108.177 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.425 HD13 HD21 ' A' ' 98' ' ' LEU . 50.5 pt -116.16 141.01 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.246 0.618 . . . . 74.13 110.515 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.39 174.32 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.115 0.966 . . . . 51.42 110.119 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 91.61 -32.1 5.47 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.129 -0.487 . . . . 71.32 112.791 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 9' ' ' MET . 2.1 pp -112.47 156.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.872 0.869 . . . . 61.55 109.883 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.9 175.04 12.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.042 -0.725 . . . . 41.23 109.042 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.46 -144.52 37.41 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.871 -0.492 . . . . 54.33 111.871 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 11.2 t -65.41 -16.3 63.48 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.147 0.579 . . . . 73.23 112.151 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.19 -54.55 31.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.832 0.853 . . . . 72.2 110.204 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.579 ' SD ' ' HB3' ' F' ' 115' ' ' LEU . 56.3 ttm -72.22 -34.62 68.48 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.451 -0.795 . . . . 71.5 110.761 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -65.12 -41.29 95.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.537 0.735 . . . . 74.32 111.63 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -59.76 -40.28 87.62 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.678 -0.692 . . . . 55.33 110.159 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.768 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 8.6 m -76.08 -37.34 58.31 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.598 0.962 . . . . 74.52 113.598 -172.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD21 HD13 ' A' ' 86' ' ' ILE . 89.1 mt -85.41 -15.45 43.04 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.93 0.332 . . . . 71.33 110.578 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.59 -28.65 9.4 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.399 -0.667 . . . . 73.34 113.56 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.06 -55.71 0.71 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.255 1.027 . . . . 73.24 113.153 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.768 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.4 t80 -50.64 -65.04 0.63 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.722 0.809 . . . . 74.33 111.699 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.4 m -64.46 -45.67 77.42 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 118.209 -0.9 . . . . 63.32 112.848 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.68 -41.34 54.28 Favored 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.181 1.921 . . . . 73.31 113.69 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.444 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 21.4 t-20 -71.78 -32.24 67.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.371 0.669 . . . . 75.21 110.52 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 101' ' ' TYR . 24.3 mm -65.37 -35.27 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.781 0.832 . . . . 54.13 110.487 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -80.69 -20.42 42.97 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.168 0.987 . . . . 72.45 111.471 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.519 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 25.8 t80 -67.63 -43.39 40.18 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 114.263 1.209 . . . . 75.1 114.263 -168.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 36.3 Cg_exo -62.13 -34.89 78.12 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.78 1.653 . . . . 75.22 112.425 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -74.25 -40.99 62.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.445 0.698 . . . . 73.13 111.593 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.75 82.62 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.789 0.436 . . . . 72.13 109.923 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.5 ttm180 -53.88 -51.68 62.89 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.509 1.131 . . . . 74.43 110.164 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.72 -46.15 90.91 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.181 0.925 . . . . 72.11 110.881 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -57.75 -48.75 78.75 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.898 0.749 . . . . 32.54 110.773 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -61.93 -50.62 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.063 0.945 . . . . 73.15 110.499 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.575 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.2 m -57.24 -41.42 79.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.722 0.809 . . . . 51.14 111.33 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.14 -40.71 82.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.284 -0.871 . . . . 72.41 109.691 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.14 -42.06 89.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 73.15 110.951 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -63.65 -45.83 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.006 0.922 . . . . 70.02 110.952 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.4 p -73.88 -28.86 61.77 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.923 0.489 . . . . 65.31 111.429 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.407 HH12 ' HG3' ' B' ' 112' ' ' GLU . 83.0 mtt-85 -72.38 -28.42 62.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.504 0.721 . . . . 74.42 109.264 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.17 89.05 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.456 -0.793 . . . . 75.33 112.831 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.5 m 68.67 17.14 8.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.651 1.181 . . . . 52.31 111.515 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -92.03 161.01 34.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 74.22 110.739 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.62 123.88 14.77 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.469 2.113 . . . . 40.41 111.176 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.575 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.2 tt0 -54.45 141.3 31.27 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.869 1.268 . . . . 61.3 112.96 -175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.417 HD22 HG11 ' A' ' 40' ' ' VAL . 82.3 mt -125.63 96.11 4.67 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.593 0.757 . . . . 61.12 109.563 -177.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.2 105.45 17.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.713 -0.847 . . . . 73.45 108.713 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.531 HD11 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -62.73 130.14 43.63 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.651 0.594 . . . . 71.41 110.0 -174.436 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.41 ' HB3' ' HE1' ' F' ' 125' ' ' TYR . . . -69.67 144.92 94.42 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 122.908 0.483 . . . . 63.43 111.2 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 73.7 Cg_exo -54.62 144.52 63.66 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 124.152 3.235 . . . . 73.44 115.153 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 44' ' ' LEU . 31.5 m -115.98 115.06 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.81 0.844 . . . . 63.35 109.873 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 9.5 m120 -89.41 65.72 7.21 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.625 0.77 . . . . 73.31 109.0 174.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.61 -33.11 41.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.384 -0.826 . . . . 73.21 109.857 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.48 ' O ' ' HG2' ' A' ' 138' ' ' MET . 5.6 m-20 -58.62 -46.51 86.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 73.23 110.037 171.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.407 0.683 . . . . 72.3 111.649 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.59 -36.42 76.21 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.948 0.78 . . . . 73.53 110.83 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -68.32 -49.47 60.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.792 -0.64 . . . . 62.33 110.421 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 33.8 mmt -57.09 -44.95 83.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.573 0.749 . . . . 64.44 112.92 -170.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 2.2 p-10 -68.04 -34.89 77.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.763 0.316 . . . . 75.13 111.702 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.01 -45.13 59.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.583 -0.735 . . . . 74.01 109.807 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.16 -47.87 66.87 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 64.32 112.108 -172.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -149.78 -13.03 0.28 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.255 0.465 . . . . 73.13 112.255 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 59.5 tt0 63.47 -78.27 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.174 1.39 . . . . 64.12 110.629 -168.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.57 80.32 8.06 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.431 -0.951 . . . . 72.5 108.431 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.85 109.16 5.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.738 -0.665 . . . . 64.11 110.308 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.63 140.49 42.71 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.738 0.649 . . . . 65.11 113.023 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.9 141.19 58.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.39 0.676 . . . . 74.24 111.26 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.11 122.01 2.01 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.044 -0.526 . . . . 25.3 111.896 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.7 p -98.12 164.08 12.48 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.541 0.736 . . . . 64.24 110.239 173.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.81 172.78 9.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.777 0.831 . . . . 70.23 111.154 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.13 -56.26 2.6 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.721 -1.214 . . . . 64.32 107.721 168.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -158.86 -175.5 5.33 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 75.53 110.207 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -134.32 175.22 9.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.309 1.443 . . . . 63.3 108.608 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.487 ' H ' HG23 ' A' ' 10' ' ' THR . 5.5 m-20 58.55 20.79 7.93 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.142 0.977 . . . . 61.21 111.192 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.395 1.078 . . . . 64.41 108.882 -174.15 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.264 -0.643 . . . . 73.14 109.264 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 55.4 p -108.78 113.88 27.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.373 0.669 . . . . 53.43 109.625 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.67 97.08 1.29 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.902 -0.777 . . . . 72.42 108.902 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 28.1 mp0 -131.53 11.63 4.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.043 0.937 . . . . 75.32 109.491 173.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -133.26 -86.43 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.723 0.809 . . . . 75.33 109.131 -164.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -176.54 80.3 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.099 1.36 . . . . 62.33 108.651 168.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -150.47 -172.2 4.12 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.926 -0.579 . . . . 71.35 109.895 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 68.82 137.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.903 1.281 . . . . 72.23 111.217 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm 51.67 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.16 1.784 . . . . 73.12 115.036 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -134.68 127.03 30.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.363 -1.347 . . . . 74.13 107.363 169.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -121.98 146.86 46.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.635 -0.876 . . . . 73.4 108.635 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.53 ' HA ' ' HG ' ' F' ' 147' ' ' LEU . 23.9 tt0 -166.81 142.54 4.39 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.932 0.77 . . . . 75.42 110.145 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.07 120.41 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.393 -0.966 . . . . 75.01 108.393 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -79.88 -47.31 15.3 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.948 -0.39 . . . . 75.31 109.948 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -164.47 145.34 8.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.92 -0.582 . . . . 72.35 109.83 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -118.05 150.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 106.851 -1.537 . . . . 75.34 106.851 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -168.75 145.61 3.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.832 0.453 . . . . 73.21 111.172 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.3 m -73.04 117.24 14.53 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.037 -1.097 . . . . 74.52 108.037 167.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -83.94 -42.98 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.829 -0.623 . . . . 73.23 110.2 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 25.9 t70 -144.81 142.03 29.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.028 -0.533 . . . . 63.21 111.578 -168.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.3 mm -137.15 142.96 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.091 1.357 . . . . 73.54 108.053 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -141.35 137.97 32.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.924 -1.51 . . . . 73.33 106.924 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -152.01 110.04 3.69 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.778 -1.193 . . . . 73.52 107.778 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -118.72 111.89 19.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.869 -0.789 . . . . 74.04 108.869 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.8 85.92 3.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 109.116 -0.698 . . . . 75.12 109.116 170.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.8 -22.85 36.19 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.024 2.483 . . . . 72.3 110.8 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -125.03 29.89 6.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.88 1.272 . . . . 73.24 109.617 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.27 -48.11 45.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 125.191 1.397 . . . . 45.31 113.365 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.5 Cg_endo -84.65 -15.06 6.24 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.364 2.043 . . . . 74.12 112.771 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.92 -0.32 47.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.232 0.613 . . . . 63.43 111.6 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.475 HG23 HD12 ' B' ' 68' ' ' LEU . 11.2 p -69.46 -31.13 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.225 0.61 . . . . 75.5 110.919 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -71.66 -40.6 69.54 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.551 0.74 . . . . 61.44 110.96 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -81.1 -8.32 59.74 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.372 -0.831 . . . . 55.25 111.264 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' HD22 ' B' ' 68' ' ' LEU . 5.8 mmtp -100.13 109.1 21.38 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.057 0.943 . . . . 72.12 109.98 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -96.0 75.89 3.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.59 0.756 . . . . 75.13 111.903 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.441 ' HB2' HD23 ' B' ' 68' ' ' LEU . 4.8 m-90 -153.76 172.28 17.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.47 1.508 . . . . 74.01 107.159 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -90.24 119.49 69.22 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.655 -0.869 . . . . 64.42 108.655 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.19 102.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.117 2.544 . . . . 75.01 112.214 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.83 102.55 1.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.042 -0.526 . . . . 72.41 109.826 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.403 HG13 HG13 ' B' ' 64' ' ' VAL . 59.7 t -89.57 121.38 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 72.24 110.121 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -118.86 123.68 45.31 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.856 1.262 . . . . 65.23 108.52 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.479 HD21 HD22 ' B' ' 128' ' ' LEU . 6.4 mp -92.72 158.88 15.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.3 0.64 . . . . 74.31 110.279 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.59 110.76 3.68 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.948 -1.13 . . . . 63.22 107.948 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -104.99 150.19 25.13 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.37 0.605 . . . . 71.24 110.063 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -138.16 128.12 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.447 -1.252 . . . . 74.32 108.643 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -110.35 108.15 18.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.505 0.722 . . . . 42.12 109.335 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.54 153.94 33.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.242 1.017 . . . . 71.41 109.492 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -143.57 162.98 34.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.32 0.648 . . . . 54.44 109.508 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.7 p -150.6 150.4 31.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.161 0.584 . . . . 73.13 109.658 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -84.56 112.6 20.57 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.847 -0.797 . . . . 75.14 108.847 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.453 HD12 HG23 ' B' ' 83' ' ' ILE . 82.8 mt -88.93 -54.2 4.24 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.724 -0.473 . . . . 65.34 109.724 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -170.24 3.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.784 0.834 . . . . 61.22 110.004 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.84 117.38 7.46 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.19 -0.914 . . . . 74.41 110.19 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 71.41 -2.27 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.456 1.503 . . . . 55.31 112.092 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -106.51 103.15 14.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.784 0.833 . . . . 74.03 109.448 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -108.65 141.39 40.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.85 0.86 . . . . 64.13 109.641 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' B' ' 51' ' ' LEU . 15.5 tt0 -99.64 102.52 14.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.393 -0.965 . . . . 74.23 108.393 172.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.05 118.56 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.565 -0.902 . . . . 73.01 108.565 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.5 t -104.82 119.57 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.721 0.808 . . . . 74.15 109.164 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.24 129.45 39.29 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.674 -1.602 . . . . 74.31 106.674 171.158 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 24.7 ttp180 -121.31 108.25 13.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.723 -0.843 . . . . 73.44 108.723 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.519 ' HB ' HD11 ' B' ' 114' ' ' ILE . 19.9 t -105.17 120.04 55.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.865 -1.161 . . . . 62.44 107.865 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -113.54 126.96 55.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 73.32 108.962 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.632 HG21 HG21 ' B' ' 114' ' ' ILE . 42.0 t -113.65 119.26 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.432 1.093 . . . . 72.22 109.153 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -118.31 140.33 49.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.327 -0.99 . . . . 63.24 108.327 170.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.87 143.41 50.14 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.053 -1.091 . . . . 64.35 108.053 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.4 p -130.71 130.35 43.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.771 -0.455 . . . . 73.51 109.771 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 0.8 OUTLIER -110.31 112.66 24.76 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.146 -1.057 . . . . 64.3 108.146 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.69 -113.3 3.77 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.331 -1.107 . . . . 75.33 110.331 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.62 5.5 10.57 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.811 0.844 . . . . 74.43 111.164 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -114.43 166.84 11.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.523 0.729 . . . . 74.31 109.245 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 33.5 m -69.59 135.63 50.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.035 0.534 . . . . 72.42 110.707 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -87.31 -58.66 2.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.5 -1.296 . . . . 73.22 107.5 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -156.95 163.69 38.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.617 -1.174 . . . . 65.13 109.956 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 73.6 mt -124.74 143.27 50.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.822 -1.547 . . . . 74.53 106.822 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.3 151.89 29.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.507 -0.923 . . . . 60.32 108.507 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.1 tt0 -165.16 130.99 2.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.049 -0.723 . . . . 73.44 109.049 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.2 t -125.17 144.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 55.4 109.369 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 25.7 mt-30 -121.14 94.62 4.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.62 -1.252 . . . . 72.25 107.62 169.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -85.39 100.44 11.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.57 -0.9 . . . . 63.31 108.57 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.86 162.92 31.71 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.149 -0.78 . . . . 63.4 111.149 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.37 127.5 1.75 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.619 -0.592 . . . . 60.44 111.619 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.453 HG23 HD12 ' B' ' 51' ' ' LEU . 40.6 mt -85.08 126.0 40.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.691 0.796 . . . . 71.34 109.162 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.29 134.04 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.026 0.931 . . . . 71.41 108.748 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -100.98 100.56 11.19 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.029 0.932 . . . . 63.52 108.727 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.524 HG13 HD11 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -121.61 143.04 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.092 0.957 . . . . 71.52 110.813 -177.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.57 159.17 43.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 43.33 109.709 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.54 -44.42 2.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.359 0.412 . . . . 75.01 112.692 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.532 HG22 ' HB3' ' B' ' 93' ' ' GLN . 13.1 pt -65.64 140.27 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 74.04 111.828 177.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -151.65 152.01 32.24 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.351 1.06 . . . . 52.44 108.36 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.623 ' HA2' ' HD2' ' E' ' 117' ' ' PRO . . . 58.92 -113.87 5.49 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 124.027 0.829 . . . . 34.24 113.284 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 68.4 m -65.79 -40.55 92.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.49 1.116 . . . . 72.22 111.609 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.532 ' HB3' HG22 ' B' ' 89' ' ' ILE . 90.0 mt-30 -65.81 -43.69 87.89 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.835 0.454 . . . . 54.23 111.172 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.549 ' HE2' HD12 ' E' ' 115' ' ' LEU . 14.2 tpt -69.37 -35.5 75.9 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.562 -0.745 . . . . 74.25 110.676 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 -24.96 59.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.289 -0.869 . . . . 63.34 110.99 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 25.8 t-80 -81.97 -29.54 32.1 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.274 0.63 . . . . 74.23 110.59 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -78.91 -68.09 0.69 Allowed 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 109.458 -0.571 . . . . 73.45 109.458 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.524 HD11 HG13 ' B' ' 86' ' ' ILE . 8.4 mp -73.5 -25.99 60.69 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.924 0.489 . . . . 62.44 112.289 -173.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.2 -30.13 23.39 Favored Glycine 0 C--N 1.334 0.457 0 O-C-N 123.368 0.417 . . . . 71.04 113.018 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -123.44 -56.58 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.734 0.642 . . . . 44.22 112.734 -170.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -72.94 -49.18 30.91 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.295 0.48 . . . . 75.11 112.295 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.3 m -60.39 -47.81 95.47 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.263 1.025 . . . . 71.03 111.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 72.7 Cg_exo -56.5 -37.77 96.66 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.985 1.79 . . . . 65.22 113.102 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.4 -29.94 70.21 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 75.02 110.892 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.39 -49.23 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.654 0.781 . . . . 64.13 109.774 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.83 -12.61 59.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 73.25 111.942 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.05 -48.0 61.37 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 118.141 -0.933 . . . . 74.22 112.944 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.46 -33.43 97.29 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.023 1.816 . . . . 74.52 113.488 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HE2' HG21 ' D' ' 115' ' ' THR . 53.8 m-85 -71.08 -44.47 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.426 0.69 . . . . 75.33 110.556 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.404 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -63.2 -38.77 92.5 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.883 0.873 . . . . 74.21 110.193 175.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.513 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 57.4 ttt-85 -60.3 -57.02 14.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.487 1.515 . . . . 71.41 111.087 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.407 ' HG3' HH12 ' A' ' 120' ' ' ARG . 14.5 tp10 -58.38 -33.49 69.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.923 0.889 . . . . 64.5 110.89 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' HB3' HG21 ' B' ' 78' ' ' VAL . 1.3 m -63.31 -54.94 29.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.312 0.645 . . . . 65.14 111.38 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.632 HG21 HG21 ' B' ' 64' ' ' VAL . 57.6 mt -58.86 -54.53 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.233 0.613 . . . . 60.33 110.05 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.3 m -55.9 -39.26 71.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.762 1.225 . . . . 71.25 111.663 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -62.04 -50.67 71.06 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 115.788 -0.642 . . . . 74.32 110.094 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -65.74 -33.71 76.49 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.441 0.696 . . . . 75.13 111.522 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 114' ' ' ILE . 76.9 t -63.26 -46.57 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.886 0.874 . . . . 73.52 110.192 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' B' ' 125' ' ' GLN . 23.3 m -68.35 -28.92 67.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.653 -0.703 . . . . 73.2 111.481 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 96.1 mtt-85 -72.3 -16.08 61.9 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 115.621 -0.718 . . . . 64.2 110.708 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.15 15.89 59.9 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.657 -1.079 . . . . 63.15 115.476 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.491 HG22 ' CD1' ' A' ' 17' ' ' TYR . 15.5 p 79.56 13.17 1.1 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 126.576 1.95 . . . . 71.13 112.507 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 119' ' ' SER . 96.6 m-85 -103.63 153.7 38.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 122.811 0.444 . . . . 72.32 110.597 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.08 153.26 59.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.856 2.371 . . . . 75.12 112.296 172.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 1.1 mp0 -64.86 115.11 5.0 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.445 0.465 . . . . 73.42 110.227 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -108.12 85.65 2.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.983 -1.117 . . . . 65.22 107.983 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -92.37 132.63 36.59 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.045 -0.979 . . . . 71.52 109.07 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.513 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 30.5 mt -81.0 147.85 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.42 -0.809 . . . . 71.24 111.439 -169.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.58 147.94 50.67 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.519 0.728 . . . . 65.23 109.639 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.85 97.9 0.41 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.912 2.408 . . . . 53.45 111.474 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.87 111.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 107.92 -1.141 . . . . 62.32 107.92 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.18 100.62 1.31 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.4 -0.818 . . . . 73.4 110.159 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -59.45 -33.2 70.99 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.115 -0.948 . . . . 74.35 109.649 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -65.13 -39.01 92.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.611 1.564 . . . . 75.21 112.175 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.12 73.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.791 0.436 . . . . 72.42 110.434 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.91 -36.95 67.37 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.061 -0.972 . . . . 74.32 109.615 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.93 -43.46 87.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.253 1.021 . . . . 73.23 109.758 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.01 -36.79 77.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.257 1.023 . . . . 72.24 110.343 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -74.46 -21.52 59.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.339 -1.3 . . . . 71.23 111.086 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -65.06 -47.27 77.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.488 0.715 . . . . 60.0 110.34 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.97 20.19 6.96 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.494 0.718 . . . . 71.15 110.555 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 64.5 -166.96 0.22 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 124.799 1.24 . . . . 70.4 112.106 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -108.85 165.54 11.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 63.42 110.125 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -121.71 -78.91 0.6 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.325 0.65 . . . . 71.22 110.422 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.35 170.89 0.16 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.44 1.096 . . . . 74.32 112.132 -171.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.63 -150.91 5.86 Favored Glycine 0 C--O 1.238 0.396 0 CA-C-N 115.316 -0.857 . . . . 35.23 111.67 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.13 -177.94 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 71.13 110.59 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.65 165.26 29.16 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.417 -0.673 . . . . 72.22 111.417 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.5 p -113.91 158.62 20.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.701 . . . . 54.44 111.099 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.49 143.04 44.31 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 106.901 -1.518 . . . . 73.24 106.901 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.11 152.49 30.77 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.904 0.482 . . . . 63.13 111.76 -171.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -151.95 81.51 1.27 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.415 1.086 . . . . 74.04 108.724 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 134.59 51.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.332 -0.988 . . . . 65.22 108.332 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -72.56 135.98 45.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.576 0.351 . . . . 74.35 110.656 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.761 0.824 . . . . 72.25 109.985 177.66 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.833 -0.062 . . . . 43.42 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t -152.44 -49.3 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.512 -0.28 . . . . 72.1 111.558 -172.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 58.03 81.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.967 0.907 . . . . 73.34 109.554 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.63 ' HB2' ' H ' ' C' ' 149' ' ' THR . 22.4 mp0 -70.26 126.47 29.76 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.845 -0.616 . . . . 64.34 109.986 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -64.71 111.64 2.85 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.169 0.918 . . . . 60.42 111.242 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -68.45 145.06 54.43 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.711 1.204 . . . . 63.05 111.114 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -155.91 154.98 32.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.479 0.712 . . . . 54.5 109.685 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 57.58 88.06 0.06 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.925 1.29 . . . . 71.21 111.823 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.476 ' HG3' HG12 ' C' ' 89' ' ' ILE . 28.0 ttt 64.71 116.46 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.09 1.356 . . . . 71.34 112.784 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 44.0 m -115.62 88.42 2.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.638 -0.71 . . . . 74.01 109.217 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.587 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 73.5 t80 -97.63 129.96 44.69 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.62 -0.882 . . . . 74.21 108.62 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -139.89 125.73 19.53 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.277 0.631 . . . . 53.13 109.367 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.3 mt -77.67 119.99 27.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.702 -0.851 . . . . 74.23 108.702 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.3 mm100 -83.95 -49.32 9.09 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.641 0.377 . . . . 74.42 110.038 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.631 HH22 HG21 ' F' ' 134' ' ' ILE . 50.7 ttt180 -170.09 145.36 2.83 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.682 0.614 . . . . 63.43 109.741 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -133.11 133.95 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' D' ' 122' ' ' THR . 34.2 p90 -167.47 162.68 14.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.901 0.858 . . . . 75.3 111.676 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -83.38 120.52 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.064 -0.971 . . . . 71.45 109.462 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -73.35 -49.33 27.86 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.527 -0.916 . . . . 74.32 108.527 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.1 t70 -134.3 139.26 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.681 -1.145 . . . . 53.31 109.412 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -137.2 138.24 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.097 -1.446 . . . . 71.41 107.097 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 38.9 t -152.11 149.87 29.28 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.479 0.712 . . . . 51.13 109.118 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -155.67 138.47 15.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.08 -1.081 . . . . 72.34 108.08 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 56.4 mt-10 -135.1 148.25 49.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.284 1.034 . . . . 74.43 108.452 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -154.98 85.5 3.55 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 106.963 -1.495 . . . . 74.15 106.963 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 -50.12 4.15 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.328 2.018 . . . . 65.45 111.144 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.48 35.68 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.025 0.93 . . . . 63.24 110.517 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.3 -50.37 88.46 Favored Pre-proline 0 CA--C 1.565 1.519 0 C-N-CA 124.441 1.096 . . . . 63.13 113.81 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.81 -25.08 20.6 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 121.642 1.561 . . . . 64.54 112.126 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -67.93 -19.57 64.99 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.96 1.304 . . . . 74.33 112.809 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.17 -25.44 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 113.621 0.971 . . . . 65.25 113.621 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -65.79 -40.42 91.93 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.212 0.529 . . . . 71.0 110.667 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -98.75 13.59 31.73 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.258 1.023 . . . . 74.4 110.413 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 136.7 38.03 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.325 -0.62 . . . . 74.05 109.325 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -85.05 92.58 8.39 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.327 -1.731 . . . . 44.22 106.327 168.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -75.34 89.28 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.763 0.792 . . . . 74.52 112.028 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -150.27 67.74 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.018 -1.104 . . . . 43.24 108.018 163.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -91.85 154.46 3.38 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.651 2.234 . . . . 72.44 111.747 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -86.82 118.35 26.16 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.85 -0.796 . . . . 64.04 108.85 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.78 97.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.177 -1.046 . . . . 74.31 108.177 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 53.0 mtpt -95.2 101.28 13.01 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.342 -0.984 . . . . 73.34 108.342 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.654 HD23 HG22 ' C' ' 64' ' ' VAL . 2.9 tm? -102.13 129.77 48.57 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.116 -1.068 . . . . 54.31 108.116 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.31 131.92 45.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.048 0.939 . . . . 55.23 108.83 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 99.3 mt -123.78 148.47 46.63 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.825 0.85 . . . . 75.11 109.384 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.21 125.43 8.02 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.74 -0.837 . . . . 74.13 108.74 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -113.4 147.72 37.2 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.569 -0.53 . . . . 52.03 109.569 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.06 42.74 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.209 1.004 . . . . 71.01 108.435 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -137.8 145.96 42.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.722 0.409 . . . . 74.21 110.259 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.1 p -145.0 129.81 18.21 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.625 0.77 . . . . 72.11 109.691 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -74.36 118.18 17.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.026 0.53 . . . . 70.23 109.881 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.47 HD11 HD12 ' C' ' 83' ' ' ILE . 74.2 mt -84.67 -40.61 17.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.145 0.578 . . . . 73.55 109.774 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.09 -178.94 7.67 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.092 . . . . 73.3 109.399 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -62.75 124.87 22.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.967 -0.56 . . . . 53.01 109.993 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.03 -5.98 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.288 1.435 . . . . 60.5 111.944 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.28 114.78 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.061 0.944 . . . . 72.53 109.697 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.93 125.5 35.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.18 0.992 . . . . 70.14 108.869 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.412 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.7 tt0 -95.39 121.19 36.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.997 0.919 . . . . 71.33 109.935 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.73 132.41 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.596 -0.89 . . . . 73.24 108.596 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -126.28 112.53 30.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 124.164 0.985 . . . . 64.3 108.777 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.95 111.72 23.64 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.319 -0.993 . . . . 73.42 108.319 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.82 107.33 12.51 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.114 -0.699 . . . . 75.22 109.114 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -100.76 127.2 54.12 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 CA-C-N 114.956 -1.02 . . . . 71.22 108.408 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 48.4 m -131.43 130.23 42.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.405 -0.591 . . . . 74.24 109.405 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.654 HG22 HD23 ' C' ' 42' ' ' LEU . 86.0 t -120.11 120.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.11 109.302 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -114.45 130.0 56.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.544 -0.909 . . . . 70.12 108.544 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.33 93.62 4.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.904 -1.517 . . . . 75.12 106.904 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 78.7 p -158.56 140.42 13.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.282 0.633 . . . . 72.23 109.565 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.1 tp -77.99 -32.97 51.5 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.291 -0.633 . . . . 74.11 109.291 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.82 -82.67 0.06 OUTLIER Glycine 0 C--N 1.345 1.059 0 N-CA-C 110.4 -1.08 . . . . 62.1 110.4 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.88 -31.79 16.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.185 0.594 . . . . 60.43 109.841 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.46 96.08 7.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.22 0.608 . . . . 73.44 109.789 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -90.69 133.63 35.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.274 -0.876 . . . . 74.01 110.929 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.2 -56.91 3.76 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.406 -0.961 . . . . 53.21 108.406 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -160.74 175.34 12.72 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.745 -1.116 . . . . 75.23 111.952 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.5 tm? -141.29 146.65 37.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.387 1.875 . . . . 60.31 105.95 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.424 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.5 t -152.78 153.55 33.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.274 0.629 . . . . 50.12 109.315 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -159.64 136.47 9.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.707 0.403 . . . . 65.14 111.128 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' C' ' 110' ' ' ALA . 45.8 t -140.78 113.49 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.518 1.127 . . . . 72.41 108.881 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 66.1 mt-30 -91.97 97.76 11.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.252 -1.018 . . . . 73.43 108.252 173.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 53.9 tp60 -86.56 114.16 23.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.514 0.726 . . . . 64.43 109.755 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.27 145.07 15.86 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.201 -0.359 . . . . 74.32 112.201 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.539 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.72 132.81 4.55 Favored Glycine 0 CA--C 1.504 -0.601 0 N-CA-C 111.839 -0.504 . . . . 75.13 111.839 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.47 HD12 HD11 ' C' ' 51' ' ' LEU . 7.8 mm -87.29 121.59 38.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.226 -1.027 . . . . 43.3 108.226 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.34 123.8 26.06 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.607 0.763 . . . . 73.12 109.569 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 36.5 p -97.75 125.46 42.58 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.84 0.456 . . . . 50.11 110.167 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.77 132.74 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.381 -0.97 . . . . 75.14 108.381 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -137.01 147.79 46.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.581 0.752 . . . . 63.33 109.755 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.1 -53.02 3.89 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.936 -0.574 . . . . 60.11 111.726 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.476 HG12 ' HG3' ' C' ' 9' ' ' MET . 2.9 pp -96.78 164.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.858 0.863 . . . . 71.42 111.487 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -168.41 -170.62 1.29 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.891 1.276 . . . . 74.44 109.264 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.09 -121.98 26.13 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 119.77 -0.461 . . . . 64.23 113.427 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 18.2 p -65.22 -33.21 75.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.943 0.897 . . . . 63.12 112.281 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.57 -42.49 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.908 0.483 . . . . 61.21 110.908 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptm -76.1 -24.93 55.03 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.005 0.19 . . . . 74.31 110.644 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.88 -43.7 78.74 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.165 0.507 . . . . 74.44 110.269 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -67.79 -34.36 76.63 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.268 -0.878 . . . . 60.34 110.805 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.88 -54.8 11.83 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.767 0.427 . . . . 55.35 110.478 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.486 HD23 ' SG ' ' C' ' 102' ' ' CYS . 63.8 mt -76.45 -14.53 60.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.648 0.779 . . . . 65.42 111.569 -177.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.48 -29.88 8.52 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.388 0.43 . . . . 73.11 113.483 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.3 -59.39 1.98 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.094 0.558 . . . . 71.22 110.93 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.411 ' O ' HG12 ' C' ' 105' ' ' ILE . 62.0 t80 -72.66 -55.43 6.83 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.206 0.941 . . . . 73.32 111.721 -164.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.486 ' SG ' HD23 ' C' ' 98' ' ' LEU . 61.0 m -58.45 -48.06 97.64 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 124.073 0.949 . . . . 72.25 112.804 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.5 Cg_exo -59.38 -34.25 97.55 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.296 1.998 . . . . 71.32 113.082 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.448 ' C ' HD21 ' C' ' 104' ' ' ASN . 0.1 OUTLIER -70.79 -33.85 71.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.64 0.776 . . . . 73.15 110.308 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.505 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -66.85 -42.17 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 122.851 0.46 . . . . 72.21 109.842 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.539 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.9 mt -68.88 -32.19 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.053 -0.976 . . . . 74.55 111.408 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.66 -53.52 59.39 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.315 1.228 . . . . 73.1 114.315 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.58 -34.41 95.3 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.325 2.016 . . . . 73.45 113.541 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.409 ' HE2' HG21 ' A' ' 115' ' ' THR . 47.9 m-85 -67.96 -45.72 73.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.541 0.737 . . . . 72.31 110.469 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.59 -35.71 80.87 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.421 -0.809 . . . . 74.24 110.946 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -65.32 -46.77 78.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.96 1.304 . . . . 64.05 110.363 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -68.39 -35.59 77.91 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 64.13 109.779 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.404 ' HB3' HG21 ' C' ' 78' ' ' VAL . 10.6 t -68.65 -31.39 70.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.884 0.473 . . . . 65.41 111.351 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.43 HD13 HG23 ' C' ' 64' ' ' VAL . 63.3 mt -74.32 -47.92 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 74.15 110.162 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.4 m -63.48 -28.92 70.29 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.063 0.545 . . . . 52.21 110.746 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.3 t -69.2 -46.75 66.68 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 123.861 0.865 . . . . 53.53 109.559 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.569 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.58 -39.9 89.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.214 1.005 . . . . 71.51 112.256 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.6 t -67.71 -38.78 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.95 0.9 . . . . 72.11 110.254 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 40.4 t -65.22 -37.66 87.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.564 -0.744 . . . . 74.43 111.069 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.5 mtt-85 -68.64 -35.89 77.87 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.247 -0.888 . . . . 70.21 109.469 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.55 1.91 80.46 Favored Glycine 0 C--N 1.354 1.54 0 O-C-N 123.801 0.688 . . . . 74.44 113.339 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' D' ' 17' ' ' TYR . 69.7 p 55.53 60.99 3.04 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.746 1.618 . . . . 33.51 111.853 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.46 ' HB2' HG13 ' C' ' 118' ' ' VAL . 86.7 m-85 -124.04 163.76 33.64 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 124.89 1.276 . . . . 74.02 108.822 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.662 ' HG3' ' HB ' ' E' ' 136' ' ' VAL . 97.2 Cg_endo -74.33 -169.26 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.948 2.432 . . . . 72.22 113.484 -174.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.413 ' HB3' ' OD1' ' C' ' 127' ' ' ASN . 21.0 mm-40 -54.41 112.02 0.91 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.059 -0.973 . . . . 71.34 111.591 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.462 HD11 HG11 ' C' ' 64' ' ' VAL . 3.1 tm? -108.07 87.01 2.4 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.426 -2.064 . . . . 72.05 105.426 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' C' ' 125' ' ' GLN . 12.1 m120 -95.31 97.53 9.92 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.311 -0.996 . . . . 54.23 108.311 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.516 HD23 ' H ' ' C' ' 129' ' ' ALA . 1.2 tt -63.6 149.21 46.93 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.205 -0.907 . . . . 73.42 108.99 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.516 ' H ' HD23 ' C' ' 128' ' ' LEU . . . -49.54 153.09 2.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.68 1.192 . . . . 74.53 112.76 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.11 -158.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.417 2.745 . . . . 62.21 114.959 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 20.5 m -93.94 155.19 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.838 0.828 . . . . 71.12 112.493 -168.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -69.83 110.62 5.07 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 113.776 -1.556 . . . . 64.43 110.936 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -44.54 -34.49 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.371 1.468 . . . . 70.41 114.305 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' C' ' 137' ' ' PHE . 17.6 t0 -65.38 -19.23 65.86 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 112.197 0.443 . . . . 73.52 112.197 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -29.21 59.32 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.783 0.833 . . . . 63.13 112.141 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.568 HD22 HD11 ' E' ' 148' ' ' LEU . 26.8 tp -64.8 -29.56 70.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.236 0.614 . . . . 75.23 110.617 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.443 ' HD2' ' HA ' ' C' ' 134' ' ' ASP . 97.2 m-85 -66.94 -20.29 65.87 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.691 -0.686 . . . . 74.51 112.622 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -69.25 -41.67 76.62 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.324 -0.621 . . . . 75.53 109.324 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -60.79 -36.97 80.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.674 -1.148 . . . . 63.24 110.742 -176.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.468 ' HD1' ' HG3' ' A' ' 138' ' ' MET . 16.9 t80 -59.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 O-C-N 124.416 1.073 . . . . 72.41 109.553 164.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 49.3 tp 70.64 -88.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.63 1.172 . . . . 74.24 108.741 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -149.69 -75.48 0.16 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.45 0.7 . . . . 72.43 109.781 171.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -144.71 21.92 1.63 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.326 0.651 . . . . 71.43 111.529 -171.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -55.94 123.52 14.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.96 0.904 . . . . 61.44 111.445 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.58 77.69 1.39 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.033 0.933 . . . . 53.24 108.705 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.3 69.12 0.54 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.573 -0.74 . . . . 53.12 112.459 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 111.62 15.0 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.657 -1.238 . . . . 73.54 107.657 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.3 -124.37 1.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.47 -0.628 . . . . 51.53 112.644 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.63 ' H ' ' HB2' ' C' ' 4' ' ' GLN . 8.1 m 63.46 26.61 14.92 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.574 1.15 . . . . 74.14 109.932 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -87.46 121.73 30.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.932 -1.031 . . . . 71.1 111.287 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -152.69 125.82 8.57 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.896 1.278 . . . . 70.22 110.107 173.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -98.61 114.65 27.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.435 0.694 . . . . 75.03 109.469 170.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -78.92 107.78 11.91 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.03 -0.73 . . . . 74.13 109.03 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.24 125.89 30.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.032 -0.729 . . . . 71.12 109.032 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 C-N-CA 123.777 0.831 . . . . 64.55 109.758 -178.382 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 107.986 -1.116 . . . . 72.31 107.986 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 24.5 t 69.64 57.38 0.33 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.848 1.343 . . . . 62.1 110.558 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.69 80.38 1.54 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.764 -1.107 . . . . 70.25 109.705 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -131.19 -62.68 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.525 -0.762 . . . . 72.03 109.925 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 59.54 32.6 21.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.994 0.918 . . . . 51.1 110.933 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -59.18 140.53 55.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.533 -1.212 . . . . 71.12 109.986 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -71.93 73.16 0.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.783 0.833 . . . . 65.05 110.179 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 174.3 111.73 0.02 OUTLIER 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.222 1.809 . . . . 72.35 106.306 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.458 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 7.1 ttp -33.17 128.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.79 1.236 . . . . 63.01 113.602 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 60.0 m -131.02 130.53 43.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 44.22 108.827 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.1 t80 -149.11 104.31 3.41 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.278 -1.008 . . . . 73.4 108.278 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -119.23 127.5 53.33 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.456 0.702 . . . . 65.2 109.732 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.25 117.52 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 108.529 -0.915 . . . . 73.1 108.529 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -95.4 -46.99 6.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.137 0.575 . . . . 71.32 112.429 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -164.6 134.29 3.81 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.741 0.246 . . . . 73.01 111.165 -168.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.438 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.8 mp -118.64 130.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.673 -1.232 . . . . 73.33 107.673 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.413 ' HB3' HG23 ' C' ' 122' ' ' THR . 39.7 p90 -168.34 150.24 5.16 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.883 0.849 . . . . 54.14 112.115 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -81.9 123.07 28.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.837 -1.074 . . . . 72.44 109.388 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.4 mtpt -92.47 -20.34 21.08 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 110.199 -0.297 . . . . 54.02 110.199 174.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.7 t70 -155.41 134.62 12.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.412 -0.813 . . . . 65.02 108.841 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.569 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.8 mt -139.79 148.56 22.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 124.807 1.243 . . . . 75.02 107.865 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.26 141.5 23.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.934 0.893 . . . . 72.24 109.284 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -153.29 132.76 12.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.811 -1.922 . . . . 74.41 105.811 171.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -135.23 145.25 47.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.69 0.796 . . . . 60.23 109.136 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -146.81 71.45 12.48 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.252 -1.018 . . . . 72.14 108.252 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.8 -26.08 19.49 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.683 2.255 . . . . 74.43 112.609 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.51 ' O ' HG23 ' D' ' 31' ' ' VAL . 28.8 m-20 -115.11 23.11 12.77 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.927 0.891 . . . . 35.42 109.629 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -48.04 -54.93 20.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 115.783 1.772 . . . . 71.45 115.783 -168.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' D' ' 32' ' ' PHE . 51.9 Cg_endo -76.1 -16.97 17.57 Favored 'Trans proline' 0 C--N 1.384 2.417 0 CA-C-N 121.162 1.451 . . . . 70.3 112.469 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.7 t-160 -77.18 -30.49 54.88 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.514 1.525 . . . . 71.51 109.782 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.7 t -77.26 -27.81 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.2 0.6 . . . . 64.52 110.384 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' D' ' 29' ' ' PRO . 18.4 m-30 -66.05 -21.08 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.74 0.416 . . . . 74.43 111.381 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -64.71 -33.46 76.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.495 0.718 . . . . 64.14 110.439 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.18 100.35 12.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.144 -1.058 . . . . 71.51 108.144 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.4 63.26 3.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.985 0.914 . . . . 40.44 111.532 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -143.62 160.11 41.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.444 -0.576 . . . . 71.41 109.444 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.521 ' HB3' ' H ' ' F' ' 140' ' ' SER . 2.3 mp0 -81.52 107.08 7.09 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.784 1.234 . . . . 71.34 108.736 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.465 ' HA ' HD13 ' D' ' 68' ' ' LEU . 35.8 Cg_exo -44.28 151.41 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 124.204 3.269 . . . . 72.1 116.392 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.564 ' HG2' HD22 ' F' ' 141' ' ' LEU . 7.6 tm-20 -61.44 138.32 58.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.222 -1.354 . . . . 71.23 110.226 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 106.24 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 122.603 0.361 . . . . 74.12 110.329 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -98.99 142.5 30.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 167.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.682 HD11 HD21 ' D' ' 128' ' ' LEU . 2.7 mm? -120.08 122.17 40.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.157 0.583 . . . . 63.34 109.438 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.785 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.0 m-20 -107.23 130.9 54.67 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.219 -1.4 . . . . 73.01 107.219 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.38 147.97 39.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.152 0.581 . . . . 72.43 110.638 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 28.5 t70 -164.98 154.32 12.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.265 1.026 . . . . 71.01 108.773 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -142.11 162.4 35.58 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.456 0.702 . . . . 71.51 109.432 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.43 163.34 40.12 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.776 0.83 . . . . 44.02 109.114 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -154.17 153.7 32.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.859 0.463 . . . . 73.34 109.918 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.4 p -150.28 146.67 26.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.987 0.915 . . . . 72.15 109.248 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -90.67 119.05 30.59 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.669 -0.863 . . . . 72.2 108.669 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -92.0 -31.47 15.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.073 0.549 . . . . 62.22 109.772 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.21 -170.21 1.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.063 0.945 . . . . 74.13 110.63 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.45 116.27 7.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.449 0.7 . . . . 63.04 110.374 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.91 17.21 9.82 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.475 1.11 . . . . 53.33 112.237 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.7 t -116.0 118.64 59.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 172.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.693 ' HB2' HD13 ' D' ' 86' ' ' ILE . 87.5 m-85 -136.45 130.1 32.12 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.55 -0.907 . . . . 61.13 108.55 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.0 tt0 -91.15 125.86 36.06 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.586 1.154 . . . . 62.41 109.629 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.74 125.59 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.085 -0.709 . . . . 71.43 109.085 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 60.9 t -104.96 133.85 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 74.15 109.428 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.78 125.43 53.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.584 -1.265 . . . . 53.23 107.584 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.0 ttm180 -104.95 102.49 12.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.009 -0.737 . . . . 73.24 109.009 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.19 118.01 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.821 -1.177 . . . . 72.44 107.821 168.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -116.96 136.32 53.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.992 0.517 . . . . 65.34 109.634 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.434 HG23 HD13 ' D' ' 114' ' ' ILE . 54.8 t -115.64 115.96 50.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.193 0.997 . . . . 74.33 109.141 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.0 m -103.19 115.95 31.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.846 -1.168 . . . . 73.34 107.846 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.62 54.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 64.44 110.065 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 74.1 p -139.27 146.34 40.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.654 0.782 . . . . 75.42 109.006 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' D' ' 38' ' ' PRO . 16.7 tp -134.76 106.05 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.535 -0.913 . . . . 52.33 108.535 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.16 -114.99 4.59 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.577 -0.738 . . . . 13.21 111.691 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 4.56 14.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.654 0.781 . . . . 73.42 110.2 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -123.53 162.55 22.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.492 0.717 . . . . 65.14 110.583 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.07 129.03 37.54 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.67 0.606 . . . . 75.43 109.888 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.3 -58.9 2.56 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.436 0.694 . . . . 64.14 109.452 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -161.33 166.14 27.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.64 -1.164 . . . . 75.12 109.21 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 95.4 mt -126.8 153.09 46.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.402 1.081 . . . . 71.35 108.271 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.41 144.99 17.39 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.063 0.545 . . . . 55.3 109.719 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.21 135.61 11.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.888 0.875 . . . . 73.43 109.151 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.72 114.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.515 -0.55 . . . . 65.33 109.515 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.5 mt-30 -90.48 87.02 6.6 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.041 0.924 . . . . 73.54 109.397 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.77 96.71 6.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.558 -1.655 . . . . 75.42 109.146 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.83 144.1 20.96 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.37 -0.692 . . . . 35.51 111.37 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.24 4.57 Favored Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 110.603 -0.999 . . . . 71.45 110.603 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -87.69 123.83 40.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.214 -1.402 . . . . 74.14 107.214 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -127.12 164.26 22.0 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.062 0.945 . . . . 73.42 108.475 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.1 t -113.18 106.43 14.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.904 -1.147 . . . . 73.34 107.904 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.693 HD13 ' HB2' ' D' ' 56' ' ' TYR . 3.6 mp -108.86 107.48 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.512 -0.922 . . . . 73.31 108.512 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -134.08 146.4 50.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.237 1.015 . . . . 70.15 109.583 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.13 -21.56 8.04 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 114.526 0.57 . . . . 44.13 114.526 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' D' ' 93' ' ' GLN . 12.1 tt -109.2 130.44 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.614 0.765 . . . . 74.22 108.99 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.64 -177.45 5.3 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.431 0.692 . . . . 75.1 111.673 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.53 -140.33 36.82 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.978 0.799 . . . . 72.13 113.408 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -81.43 -20.85 39.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.453 0.701 . . . . 74.31 111.437 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.481 ' HG3' HD11 ' D' ' 89' ' ' ILE . 7.2 tp60 -69.65 -40.24 76.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.189 0.596 . . . . 73.55 111.051 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.43 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 5.2 ppp? -69.34 -33.78 73.62 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.796 -0.446 . . . . 70.51 109.796 174.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.97 99.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.361 0.664 . . . . 75.25 110.812 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -72.32 -34.32 68.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.5 -0.773 . . . . 72.25 110.183 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.94 -36.73 85.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.342 0.657 . . . . 63.03 111.124 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.624 HD21 HG12 ' D' ' 86' ' ' ILE . 31.5 mt -80.17 -23.2 41.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.976 0.51 . . . . 62.4 111.013 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.75 -2.35 55.23 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.697 -0.502 . . . . 63.13 113.736 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.13 -60.43 0.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.617 0.709 . . . . 73.13 111.412 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.61 -40.99 66.05 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.942 0.497 . . . . 63.41 111.797 -171.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.472 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 68.8 m -69.26 -49.04 25.14 Favored Pre-proline 0 CA--C 1.559 1.313 0 CA-C-O 118.956 -0.545 . . . . 73.22 110.975 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.4 Cg_exo -52.13 -31.13 43.93 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.542 2.161 . . . . 43.22 114.566 168.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.66 -35.64 81.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.993 0.517 . . . . 74.11 110.755 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.19 -44.11 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.242 0.617 . . . . 62.4 110.251 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.8 -20.24 58.35 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.341 -0.845 . . . . 43.02 112.027 -172.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -65.48 -48.03 67.26 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.459 0.911 . . . . 74.33 113.459 -171.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.48 -34.01 88.06 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.884 1.722 . . . . 53.24 112.821 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.27 -35.68 47.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.863 0.865 . . . . 73.13 111.816 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.69 76.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.286 0.634 . . . . 72.05 109.963 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.4 HH12 ' HG3' ' D' ' 130' ' ' PRO . 14.4 ptt180 -75.11 -31.63 61.19 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.958 -1.019 . . . . 64.52 110.784 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.98 -49.71 75.01 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.007 0.817 . . . . 63.32 110.305 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.81 -40.47 84.22 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.853 0.72 . . . . 75.13 110.517 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.503 HG12 ' SG ' ' D' ' 76' ' ' CYS . 64.9 mt -57.58 -53.18 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 123.794 0.684 . . . . 44.45 110.236 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.465 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.0 m -57.62 -45.79 84.95 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 124.26 1.024 . . . . 74.14 111.17 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -64.31 -41.04 97.02 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.636 -1.166 . . . . 65.21 110.138 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -69.02 -33.53 73.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.111 0.565 . . . . 72.13 111.587 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' D' ' 114' ' ' ILE . 53.3 t -64.11 -46.76 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 O-C-N 123.823 0.702 . . . . 55.24 110.203 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.7 p -71.16 -29.46 65.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.617 0.367 . . . . 62.41 110.858 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.7 mtt-85 -70.55 -30.29 66.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.653 0.781 . . . . 71.35 110.1 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.63 7.16 81.98 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 123.724 0.64 . . . . 74.11 112.834 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 56.76 28.69 14.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.395 1.878 . . . . 71.43 113.262 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.74 158.59 34.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.883 0.873 . . . . 73.5 110.137 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.76 127.33 25.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.008 2.472 . . . . 65.21 112.932 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.465 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.0 tt0 -51.26 130.61 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.611 1.195 . . . . 71.01 112.201 -175.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.1 tp -115.19 100.89 8.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.63 0.372 . . . . 64.33 110.292 -176.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -99.61 112.51 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.351 -1.352 . . . . 73.45 107.351 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.682 HD21 HD11 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -74.37 135.85 42.45 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 123.42 0.45 . . . . 75.35 110.592 -171.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.17 123.05 58.26 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 124.467 1.104 . . . . 60.51 110.933 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.588 ' HD2' HD12 ' F' ' 147' ' ' LEU . 43.0 Cg_exo -57.4 129.87 36.22 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.321 2.014 . . . . 74.24 111.238 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' F' ' 148' ' ' LEU . 51.6 t -123.73 110.55 26.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 109.194 -0.669 . . . . 65.13 109.194 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -77.28 95.57 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.794 -1.188 . . . . 73.03 107.794 167.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.21 -30.92 71.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.641 -0.709 . . . . 73.12 111.159 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.45 -51.6 59.02 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.354 0.662 . . . . 74.5 109.549 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.5 91.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 65.24 111.519 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.56 -47.3 84.72 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.243 0.964 . . . . 70.22 109.992 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -77.23 -30.94 54.78 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.995 0.518 . . . . 73.15 111.292 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 61.2 mtm -62.49 -23.03 66.71 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 119.251 -0.404 . . . . 73.33 111.944 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -51.12 -44.05 61.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.497 0.719 . . . . 75.14 111.342 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.99 -40.58 91.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.807 0.843 . . . . 74.33 111.648 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.31 -30.47 71.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.233 0.613 . . . . 41.12 111.003 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -79.7 2.58 22.17 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.123 0.969 . . . . 70.22 111.976 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -130.16 89.83 2.86 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.266 1.026 . . . . 51.14 109.363 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -166.39 173.09 10.3 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.315 1.046 . . . . 73.55 109.91 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.65 -32.32 28.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.14 0.576 . . . . 72.03 110.751 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.61 -95.83 1.32 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.195 -0.457 . . . . 52.2 112.705 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -94.47 109.79 21.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.707 0.803 . . . . 74.44 111.19 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.08 -134.9 2.88 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.251 -0.431 . . . . 50.53 112.81 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 21.0 m -68.2 -16.95 64.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 74.41 112.019 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -60.91 -27.78 68.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.524 1.13 . . . . 65.2 112.358 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -40.72 73.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.78 0.832 . . . . 61.12 110.174 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -84.34 104.59 14.49 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.15 -0.932 . . . . 71.33 108.955 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -75.52 82.24 2.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.318 0.647 . . . . 72.34 109.367 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.08 142.96 30.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.066 -0.97 . . . . 75.42 109.995 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.764 -0.636 . . . . 43.24 110.627 -178.06 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.356 -0.609 . . . . 64.15 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -76.36 -23.87 54.16 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.059 0.544 . . . . 73.4 110.886 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.51 81.44 8.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.653 0.781 . . . . 62.3 109.473 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.88 -37.69 26.51 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.651 -0.704 . . . . 65.3 110.562 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -105.69 161.53 14.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.141 0.976 . . . . 73.52 111.076 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -161.4 145.63 13.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.57 0.748 . . . . 63.12 110.294 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.52 ' H ' ' HD3' ' E' ' 114' ' ' LYS . 0.0 OUTLIER -134.52 142.27 46.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.696 1.198 . . . . 50.14 108.254 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.549 HD12 ' HE2' ' B' ' 94' ' ' MET . 82.7 mt -89.38 -32.95 17.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.522 0.329 . . . . 61.3 110.709 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -103.76 100.26 19.13 Favored Pre-proline 0 C--N 1.357 0.93 0 N-CA-C 109.689 -0.486 . . . . 74.11 109.689 171.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.623 ' HD2' ' HA2' ' B' ' 91' ' ' GLY . 26.4 Cg_endo -92.72 5.35 3.3 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.947 2.431 . . . . 71.02 111.303 163.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -76.09 141.84 41.88 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.686 0.794 . . . . 65.4 109.771 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 55.7 m -77.07 87.51 3.57 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.469 0.708 . . . . 65.24 110.408 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.74 85.58 3.59 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.979 -1.119 . . . . 72.42 107.979 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -129.26 22.6 5.62 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.784 -1.098 . . . . 64.35 109.839 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.15 -89.29 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 118.951 -0.547 . . . . 70.03 110.518 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t 37.83 67.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 125.014 1.326 . . . . 74.35 111.164 -173.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -51.66 9.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.999 -0.546 . . . . 74.13 110.12 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 64.36 -174.87 0.17 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.591 1.156 . . . . 75.25 111.396 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -157.33 153.87 28.07 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.455 0.702 . . . . 75.11 110.019 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -96.62 25.92 24.18 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.896 -0.593 . . . . 73.02 113.133 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 128' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' E' ' 131' ' ' ALA . 2.8 tmtp? -112.34 114.92 27.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.357 -1.349 . . . . 64.22 107.357 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 129' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' B' ' 128' ' ' LEU . 6.2 tt -145.26 -54.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.161 -1.052 . . . . 75.23 108.161 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' E' ' 129' ' ' LEU . 3.4 mp -79.44 84.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.682 -0.858 . . . . 74.42 108.682 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 131' ' ' ALA . . . . . 0.426 ' HB2' ' HE2' ' E' ' 128' ' ' LYS . . . -85.27 -36.0 21.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.965 -1.016 . . . . 73.52 109.522 174.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.69 103.03 53.78 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.132 -1.062 . . . . 73.1 108.132 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.76 46.94 2.16 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.898 2.398 . . . . 62.41 111.593 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 7.3 tp -71.56 84.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 122.472 1.129 . . . . 25.3 109.579 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.51 -21.82 57.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.36 -1.291 . . . . 72.4 111.183 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.662 ' HB ' ' HG3' ' C' ' 124' ' ' PRO . 73.7 t 62.05 -86.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.599 1.16 . . . . 53.24 109.958 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 59.48 -165.27 0.2 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.211 1.004 . . . . 71.51 111.897 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 66.01 14.53 9.65 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.198 0.999 . . . . 71.54 111.753 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 31.27 6.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.714 1.206 . . . . 72.44 109.821 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 48.2 m -93.88 9.25 38.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.713 -0.676 . . . . 61.42 111.005 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 141' ' ' LEU . . . . . 0.638 ' H ' HD23 ' E' ' 141' ' ' LEU . 1.4 pt? -78.23 83.31 4.49 Favored 'General case' 0 C--N 1.361 1.066 0 CA-C-O 122.325 1.06 . . . . 75.14 109.19 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 142' ' ' ILE . . . . . 0.573 HG12 ' H ' ' E' ' 143' ' ' TYR . 13.3 tt -128.74 -177.62 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-N 114.414 -1.266 . . . . 74.04 107.97 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 143' ' ' TYR . . . . . 0.573 ' H ' HG12 ' E' ' 142' ' ' ILE . 83.6 m-85 -54.49 103.12 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.028 0.931 . . . . 74.43 112.293 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -120.72 96.04 4.96 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.311 -0.996 . . . . 62.03 108.311 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 145' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' E' ' 146' ' ' ASP . 58.8 tttm -171.15 178.32 3.37 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.381 1.072 . . . . 73.44 108.468 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 146' ' ' ASP . . . . . 0.423 ' H ' ' HG2' ' E' ' 145' ' ' LYS . 5.9 p-10 -69.48 79.96 0.4 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.127 0.965 . . . . 54.04 111.221 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.93 -10.02 49.36 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.476 -0.784 . . . . 70.32 110.609 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.568 HD11 HD22 ' C' ' 136' ' ' LEU . 3.9 tp -177.83 87.5 0.24 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.154 1.381 . . . . 70.21 108.944 175.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 CA--C 1.561 1.849 0 C-N-CA 123.215 2.61 . . . . 74.0 111.839 172.674 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.027 -0.36 . . . . 75.33 110.027 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -74.5 130.33 39.4 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.698 0.799 . . . . 70.11 110.4 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.86 114.69 8.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.912 0.885 . . . . 71.03 110.58 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.16 -63.04 1.07 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.965 0.906 . . . . 74.44 109.152 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 39.95 73.0 0.13 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.126 1.771 . . . . 72.22 114.004 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -107.38 92.69 4.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.114 -1.069 . . . . 71.55 108.114 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -119.93 141.55 49.53 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.544 0.737 . . . . 63.44 109.894 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.579 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 89.6 mt -70.7 100.06 1.8 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.9 0.88 . . . . 62.42 110.662 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -159.71 84.11 2.23 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.44 -0.948 . . . . 75.25 108.44 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -95.03 -173.27 0.28 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.352 2.701 . . . . 71.24 113.998 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 118' ' ' PHE . . . . . 0.48 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 47.0 t80 62.11 84.46 0.14 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.75 1.62 . . . . 73.2 110.81 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 3.3 t -69.44 86.63 0.44 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.075 -0.966 . . . . 54.11 110.845 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -158.22 144.37 17.23 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.744 -1.117 . . . . 75.34 109.067 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -165.62 97.89 0.67 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.914 0.886 . . . . 72.22 109.003 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.92 94.08 2.43 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.965 -0.754 . . . . 72.34 108.965 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.5 121.35 8.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.559 0.744 . . . . 75.22 109.988 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 mtt180 -125.61 176.17 7.06 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 106.744 -1.576 . . . . 74.41 106.744 167.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 125' ' ' TYR . . . . . 0.41 ' HE1' ' HB3' ' A' ' 129' ' ' ALA . 49.4 t80 -159.37 117.64 2.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.988 -1.486 . . . . 74.01 106.988 167.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 126' ' ' ASN . . . . . 0.484 HD22 ' N ' ' F' ' 126' ' ' ASN . 0.8 OUTLIER -96.42 -55.94 2.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.454 -0.943 . . . . 75.22 108.454 177.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.43 -144.3 47.55 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.988 0.805 . . . . 32.54 113.37 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -165.34 119.17 1.23 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.019 -1.104 . . . . 73.55 108.019 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 40' ' ' VAL . 22.6 tp -128.14 167.18 17.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 74.31 110.365 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 59.5 mt 69.62 86.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.494 1.518 . . . . 60.33 109.068 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.98 -52.88 5.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.22 -0.9 . . . . 63.03 110.682 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.98 106.9 6.84 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.309 0.644 . . . . 75.42 109.657 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.32 179.25 6.34 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.989 2.459 . . . . 74.43 112.39 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.631 HG21 HH22 ' C' ' 15' ' ' ARG . 13.5 tt -166.76 146.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.547 0.739 . . . . 62.24 109.357 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.72 119.57 16.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.165 0.586 . . . . 72.32 109.888 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.69 30.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.025 0.93 . . . . 75.13 111.293 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.92 -63.56 1.13 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.143 0.977 . . . . 72.34 109.988 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.6 151.28 28.65 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.216 -1.356 . . . . 64.13 108.187 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' D' ' 37' ' ' GLN . 15.5 tp -82.02 139.88 34.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.074 0.55 . . . . 71.25 109.653 -175.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 140' ' ' SER . . . . . 0.521 ' H ' ' HB3' ' D' ' 37' ' ' GLN . 22.0 t -78.48 179.16 7.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.561 0.744 . . . . 62.14 110.875 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 141' ' ' LEU . . . . . 0.564 HD22 ' HG2' ' D' ' 39' ' ' GLU . 6.4 mp 61.21 21.79 12.2 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.308 1.043 . . . . 74.22 112.188 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 9.3 tp -72.2 144.02 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.851 -0.796 . . . . 75.44 108.851 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 143' ' ' TYR . . . . . 0.729 ' HB3' ' HB2' ' F' ' 146' ' ' ASP . 90.2 m-85 -69.21 95.88 0.79 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.265 0.626 . . . . 72.25 110.777 -174.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -66.84 114.91 6.06 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.332 -0.849 . . . . 61.32 109.662 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 145' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' F' ' 145' ' ' LYS . 3.3 ttmp? 74.52 -5.47 2.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.307 1.443 . . . . 54.34 112.564 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 146' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' F' ' 143' ' ' TYR . 32.3 m-20 -93.89 47.09 1.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.584 0.707 . . . . 74.32 109.589 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 147' ' ' LEU . . . . . 0.588 HD12 ' HD2' ' D' ' 130' ' ' PRO . 2.1 mm? -99.36 105.24 17.19 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.361 -1.348 . . . . 73.03 107.361 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 148' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' D' ' 131' ' ' VAL . 5.4 mp -92.8 101.19 4.83 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 123.639 0.776 . . . . 74.11 108.99 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo . . . . . 0 C--N 1.377 2.045 0 C-N-CA 122.682 2.255 . . . . 44.01 111.966 -178.564 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.823 -0.436 . . . . 52.33 109.823 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.7 p -170.04 -42.12 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.034 0.934 . . . . 74.03 108.784 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 62.28 23.48 13.9 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.491 1.116 . . . . 71.51 112.107 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -137.45 -5.39 1.8 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.503 0.721 . . . . 73.41 111.527 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.55 155.58 37.35 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.663 0.785 . . . . 75.32 111.371 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -95.91 23.62 6.19 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.104 0.962 . . . . 64.35 110.27 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 m -83.03 2.39 35.21 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.741 0.817 . . . . 70.33 111.07 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.78 155.14 21.96 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.975 0.91 . . . . 72.12 109.472 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -65.86 131.22 45.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.927 -0.768 . . . . 55.05 108.927 171.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.3 m -151.91 131.1 12.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.154 0.582 . . . . 65.42 110.387 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.93 137.26 34.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.478 1.111 . . . . 74.12 108.394 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -160.69 136.76 8.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.269 0.227 . . . . 55.31 110.838 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.8 mp -69.18 114.48 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.077 -1.083 . . . . 73.24 108.077 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -95.29 -30.07 14.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.138 0.575 . . . . 71.54 111.176 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -166.03 148.41 7.17 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.682 -0.488 . . . . 73.35 109.682 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.45 HG12 ' HG3' ' C' ' 130' ' ' PRO . 2.5 pp -141.03 139.05 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.726 -1.213 . . . . 74.13 107.726 171.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.584 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 42.1 p90 -176.97 176.16 1.47 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.566 0.698 . . . . 74.24 110.949 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -99.73 111.07 23.43 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.042 0.937 . . . . 64.41 109.241 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -76.01 -28.92 57.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.957 -0.386 . . . . 63.1 109.957 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.0 t70 -150.61 147.77 27.82 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.955 -0.566 . . . . 73.43 110.126 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.4 mt -138.72 145.39 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.477 1.511 . . . . 73.21 107.398 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -154.22 117.58 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.662 0.385 . . . . 64.33 110.457 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.699 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.1 t80 -124.44 116.32 22.34 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.353 -1.351 . . . . 74.41 107.353 172.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -119.67 128.17 53.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.433 -0.58 . . . . 74.34 109.433 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.56 76.61 48.15 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 108.546 -0.909 . . . . 61.43 108.546 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 -18.23 22.4 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.68 2.253 . . . . 72.21 112.024 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 64.6 m-20 -115.76 30.72 7.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.934 0.893 . . . . 75.35 108.962 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -58.12 -46.33 99.68 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.864 0.866 . . . . 63.31 112.584 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 31.6 Cg_exo -62.92 -28.16 75.13 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.025 1.817 . . . . 62.4 113.21 169.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.1 m80 -73.13 -24.39 60.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.77 0.428 . . . . 75.04 111.327 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.41 -27.41 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 120.967 0.413 . . . . 61.2 110.819 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.593 ' HD2' HH11 ' B' ' 15' ' ' ARG . 81.9 t80 -74.86 -41.69 59.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.381 0.672 . . . . 72.01 110.239 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 30' ' ' HIS . 13.1 pt20 -80.3 -30.47 38.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.584 0.354 . . . . 50.44 111.556 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 3.8 mmmp? -82.36 156.85 24.0 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.883 0.873 . . . . 65.24 112.107 -176.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.59 140.4 54.41 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.473 -1.24 . . . . 74.13 110.757 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -88.24 63.92 7.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.634 0.731 . . . . 72.43 109.378 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -124.63 78.34 63.36 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.376 1.07 . . . . 73.42 108.819 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.87 167.2 24.14 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.985 2.457 . . . . 62.33 113.606 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -123.77 95.37 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.829 -1.545 . . . . 65.2 106.829 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.25 125.62 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.311 0.577 . . . . 75.54 110.391 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 35.5 mttp -120.85 114.77 22.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.391 1.077 . . . . 42.44 108.612 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.515 HD12 ' HA3' ' F' ' 127' ' ' GLY . 72.6 mt -111.1 107.26 16.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.734 -1.121 . . . . 73.44 108.778 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -114.46 145.23 42.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.606 1.162 . . . . 61.42 110.128 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.48 153.23 48.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 72.13 110.605 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.468 ' O ' HD23 ' A' ' 60' ' ' LEU . 20.7 t70 -157.86 143.47 17.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.383 1.073 . . . . 55.43 109.014 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.1 m -126.62 135.08 50.74 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.672 0.789 . . . . 71.13 109.584 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.55 132.48 40.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.075 0.95 . . . . 43.0 109.842 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -91.35 153.26 20.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.104 0.478 . . . . 64.23 110.445 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 t -150.82 138.28 19.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.079 1.352 . . . . 71.24 108.262 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -113.75 124.34 52.03 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.44 -0.578 . . . . 61.35 109.44 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.15 -44.07 7.11 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.566 0.746 . . . . 72.53 110.393 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 -173.45 4.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.461 -0.791 . . . . 73.03 109.982 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -63.02 112.66 2.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.302 0.641 . . . . 55.4 109.773 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 65.02 8.9 5.03 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.858 1.263 . . . . 62.51 113.038 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.01 109.93 25.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.004 -1.109 . . . . 71.14 108.004 172.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -119.94 123.82 44.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.491 0.716 . . . . 75.15 109.579 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -97.5 131.54 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.609 -1.178 . . . . 70.0 108.641 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.53 129.63 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.938 -1.134 . . . . 64.24 107.938 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.8 t -104.49 132.57 50.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.534 -0.913 . . . . 73.05 108.534 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -108.85 110.18 21.48 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.715 -1.587 . . . . 73.35 106.715 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -103.29 102.67 12.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.808 0.843 . . . . 73.33 108.792 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.41 134.48 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 114.686 -1.143 . . . . 74.54 109.295 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.7 m -120.39 141.37 50.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.092 -0.707 . . . . 62.23 109.092 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -138.54 107.83 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.926 1.29 . . . . 72.41 108.321 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 19.2 m -102.22 146.05 28.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.316 -0.624 . . . . 74.41 109.316 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.17 120.28 15.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.492 0.717 . . . . 70.2 109.146 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 49.1 m -128.56 125.15 37.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.998 0.519 . . . . 75.44 110.008 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.71 85.16 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.75 0.786 . . . . 71.02 109.054 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.3 -118.65 5.14 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.283 -1.326 . . . . 63.4 111.359 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -87.89 -31.98 19.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 71.0 109.347 174.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.15 133.77 35.52 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.67 0.788 . . . . 74.45 109.469 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.6 m -78.94 136.68 37.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.094 -0.335 . . . . 73.45 110.094 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -82.57 -60.55 2.15 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.496 0.718 . . . . 53.13 109.112 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -165.83 176.13 8.15 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.628 -1.169 . . . . 75.31 111.098 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -138.62 145.82 40.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.34 1.456 . . . . 72.13 108.139 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.1 m -135.89 140.37 44.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.928 0.891 . . . . 74.04 109.838 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -150.33 130.7 13.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.179 0.592 . . . . 72.45 109.652 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.82 119.86 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.171 0.589 . . . . 73.3 110.362 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -89.26 83.12 6.45 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.445 1.098 . . . . 74.54 108.523 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' HG3' HD22 ' A' ' 106' ' ' LEU . 61.7 tp60 -76.49 94.39 3.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.279 -0.873 . . . . 72.14 109.443 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.93 144.16 17.93 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.772 -0.531 . . . . 73.42 111.772 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.86 124.18 2.77 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.811 -0.916 . . . . 62.23 110.811 -176.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.61 128.49 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.671 -0.863 . . . . 71.13 108.671 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -135.18 140.0 45.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.666 -0.864 . . . . 75.23 108.666 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.1 p -101.92 106.88 17.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 72.23 109.015 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.2 pt -125.19 131.55 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.335 0.654 . . . . 74.41 110.769 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.85 157.42 26.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.114 0.965 . . . . 73.5 110.207 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.16 64.86 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.067 -0.515 . . . . 61.04 114.383 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.63 145.48 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.643 0.721 . . . . 73.0 109.368 -177.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.9 tt0 -142.68 179.32 7.06 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.021 0.528 . . . . 74.53 109.956 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.73 -123.81 31.73 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 124.239 0.924 . . . . 72.01 114.738 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.729 ' HB ' HD11 ' A' ' 141' ' ' LEU . 66.6 p -74.86 -26.56 59.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 74.24 111.365 -172.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -65.72 -48.66 71.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.744 0.817 . . . . 64.5 110.063 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.435 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 39.8 ttp -79.71 -33.29 41.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.202 -1.363 . . . . 44.35 110.6 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.58 92.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.27 0.557 . . . . 72.52 109.956 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -55.13 -47.54 74.92 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.547 -1.206 . . . . 74.44 111.092 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 35.3 m -71.33 -33.22 69.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.741 1.015 . . . . 74.32 113.741 -172.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.446 HD12 ' HD2' ' F' ' 117' ' ' PRO . 86.3 mt -80.09 -30.09 39.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.809 0.443 . . . . 60.02 111.342 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.98 -17.61 31.92 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.633 -0.537 . . . . 31.42 114.292 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.52 -63.91 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.708 0.754 . . . . 62.0 112.614 -171.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.83 -56.39 12.42 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.085 0.954 . . . . 62.34 112.758 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.56 -48.62 12.05 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.315 -0.85 . . . . 72.42 113.113 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.3 -20.27 62.04 Favored 'Trans proline' 0 C--N 1.388 2.636 0 CA-C-N 121.111 1.432 . . . . 75.42 113.718 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.29 -42.8 92.72 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.017 0.527 . . . . 60.22 110.711 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -59.65 -41.85 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.97 0.89 . . . . 64.11 110.201 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.541 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.9 mt -74.99 -29.1 60.8 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 113.874 -1.512 . . . . 61.23 112.579 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.49 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 20.6 t80 -64.26 -45.17 78.46 Favored Pre-proline 0 CA--C 1.558 1.28 0 N-CA-C 114.866 1.432 . . . . 74.34 114.866 -167.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.88 -32.51 95.23 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 121.616 1.544 . . . . 70.34 113.046 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -79.73 -37.72 34.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.453 0.701 . . . . 74.11 112.349 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.19 71.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 110.01 -0.367 . . . . 53.22 110.01 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -53.51 -48.8 68.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.371 1.068 . . . . 44.35 110.102 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.26 -47.25 86.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.982 0.913 . . . . 62.2 111.613 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.546 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.3 t -60.37 -44.19 95.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 72.33 111.002 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 64' ' ' VAL . 15.3 mt -63.08 -51.79 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.31 1.044 . . . . 72.35 110.905 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.8 m -59.1 -36.4 75.08 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.258 1.023 . . . . 71.35 112.023 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.65 -39.72 80.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 75.43 110.115 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 46.5 mtm -63.08 -39.63 95.28 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.637 0.375 . . . . 74.51 110.533 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.88 -47.05 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.146 0.978 . . . . 74.02 111.207 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -72.61 -33.37 66.63 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.096 -0.502 . . . . 43.15 111.184 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.451 HH12 ' HG3' ' B' ' 112' ' ' GLU . 82.7 mtt-85 -69.39 -26.61 64.73 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.333 0.653 . . . . 71.41 110.138 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.61 1.07 88.7 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.683 -0.69 . . . . 75.52 112.861 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.4 m 69.56 18.14 7.78 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.392 1.077 . . . . 73.24 111.277 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.44 152.38 40.02 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 73.12 110.892 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.76 125.35 18.8 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.74 2.293 . . . . 63.21 112.0 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.548 ' HG3' HG23 ' A' ' 115' ' ' THR . 25.3 tt0 -50.34 136.66 19.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.859 1.264 . . . . 64.11 112.957 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.2 mt -125.61 104.62 8.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.837 0.855 . . . . 64.3 108.81 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -101.9 123.18 45.39 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.678 0.791 . . . . 50.25 109.103 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.49 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -73.4 120.44 19.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.909 -1.145 . . . . 75.51 107.909 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.09 129.07 85.92 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.864 0.727 . . . . 53.3 110.631 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.63 107.4 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.045 1.83 . . . . 75.25 111.741 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -98.96 110.84 27.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.51 -1.292 . . . . 64.11 107.51 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.12 82.04 8.54 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.437 -0.801 . . . . 55.24 109.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.22 -32.78 71.44 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.246 -1.343 . . . . 74.03 109.803 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.5 -49.67 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.359 1.064 . . . . 62.4 111.606 173.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.88 99.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.944 0.498 . . . . 71.5 111.72 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.38 -44.11 84.04 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.418 0.687 . . . . 72.2 110.497 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.59 -35.94 81.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.644 -0.707 . . . . 75.41 109.795 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.592 ' HB3' ' HA ' ' A' ' 144' ' ' GLN . 92.0 mmm -71.05 -41.77 70.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.783 0.433 . . . . 74.04 110.804 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -56.45 -38.65 71.93 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.232 0.613 . . . . 72.23 110.746 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -73.27 -40.58 64.48 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.95 -1.023 . . . . 64.13 110.993 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.729 HD11 ' HB ' ' A' ' 92' ' ' THR . 18.7 tp -66.66 -50.39 63.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.295 1.038 . . . . 74.5 111.368 -170.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -168.94 28.76 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.125 -0.943 . . . . 70.02 110.092 -170.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.453 ' HB3' ' HG3' ' C' ' 144' ' ' GLN . 79.5 mt-30 62.27 34.21 16.07 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.883 0.873 . . . . 73.33 111.484 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 138' ' ' MET . 79.7 mt-30 69.3 141.1 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.067 1.747 . . . . 75.44 110.776 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.85 155.98 24.39 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.54 0.736 . . . . 61.34 109.431 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.09 162.49 24.77 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.366 0.416 . . . . 74.24 113.433 -174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -152.14 117.46 5.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.323 0.649 . . . . 75.54 109.978 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.48 102.62 1.63 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.591 -1.004 . . . . 72.43 110.591 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.0 m -59.16 -51.46 69.9 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.495 0.664 . . . . 71.24 109.852 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -174.88 171.57 3.09 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.97 -1.468 . . . . 73.45 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.15 68.8 1.47 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.277 -1.008 . . . . 64.33 108.277 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -132.24 167.78 19.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.878 0.871 . . . . 74.21 110.802 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -159.97 88.82 0.84 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.906 -1.146 . . . . 74.23 107.906 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.99 83.43 7.79 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.286 -1.005 . . . . 74.33 108.286 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 124.761 1.224 . . . . 55.32 110.883 -173.896 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.491 -0.559 . . . . 65.13 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.0 m -144.57 98.28 3.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.23 1.012 . . . . 73.44 108.884 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.64 134.51 35.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.569 0.748 . . . . 74.01 110.308 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -63.4 147.88 50.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.475 1.11 . . . . 73.52 112.016 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.63 170.72 14.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.992 0.517 . . . . 74.52 110.863 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -93.77 -29.3 15.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.57 0.348 . . . . 54.23 111.764 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.588 HG21 ' HA ' ' B' ' 150' ' ' GLU . 28.1 m -92.27 99.76 12.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.023 0.44 . . . . 65.24 111.839 -174.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -172.59 -59.13 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.466 1.106 . . . . 72.34 108.319 165.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.8 ptm 48.02 -172.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.0 1.72 . . . . 65.24 112.494 -169.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.415 HG22 ' HB3' ' B' ' 87' ' ' ALA . 15.2 t -155.61 143.54 19.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.082 -0.71 . . . . 65.12 109.082 170.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -139.45 113.28 8.61 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.158 -1.052 . . . . 74.2 108.158 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 22.8 tt0 -133.11 139.76 47.29 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.487 0.715 . . . . 73.4 109.469 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.6 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -89.83 116.04 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.183 -1.043 . . . . 45.44 108.183 170.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 72.5 mt-30 -77.63 -40.83 40.58 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.753 -0.462 . . . . 64.23 109.753 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.593 HH11 ' HD2' ' A' ' 32' ' ' PHE . 18.6 ttt180 -166.42 137.89 3.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 65.2 108.846 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 57.8 mt -114.39 139.23 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 106.986 -1.487 . . . . 73.14 106.986 170.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -168.19 146.57 4.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.762 0.71 . . . . 71.42 112.298 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -73.35 120.83 19.51 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.655 -1.157 . . . . 64.2 108.711 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -96.44 -26.59 15.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.443 0.697 . . . . 74.53 111.242 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -161.26 141.74 11.04 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.055 0.222 . . . . 62.42 110.924 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -138.3 141.69 37.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 125.024 1.33 . . . . 53.25 109.035 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 35.0 t -140.12 124.22 17.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.166 -1.42 . . . . 63.44 107.166 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -138.61 111.41 7.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.396 -1.335 . . . . 75.32 107.396 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.98 117.51 29.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.671 -0.863 . . . . 74.04 108.671 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 84.68 6.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.492 -1.299 . . . . 72.33 107.492 168.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.63 -26.92 11.25 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.829 2.353 . . . . 54.53 112.649 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 1.8 m-20 -110.96 20.24 17.69 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 64.41 109.438 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.584 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.01 -60.52 1.65 Allowed Pre-proline 0 CA--C 1.574 1.89 0 C-N-CA 126.368 1.867 . . . . 25.12 114.931 -169.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 51.1 Cg_endo -85.0 -1.86 9.49 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.26 1.973 . . . . 61.41 113.57 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -96.74 -38.21 9.99 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 73.14 110.505 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.5 p -79.33 -14.16 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.478 -0.783 . . . . 52.34 110.114 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.06 -34.56 44.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.676 1.19 . . . . 73.2 111.798 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -73.15 -15.94 61.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.068 0.947 . . . . 75.13 112.028 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.593 ' HD3' HD12 ' B' ' 68' ' ' LEU . 89.6 mttt -105.52 109.37 21.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.148 0.979 . . . . 65.34 110.481 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.27 83.63 5.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.367 0.667 . . . . 62.25 110.407 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.572 ' HE3' HD11 ' B' ' 68' ' ' LEU . 3.6 m-90 -153.43 161.75 41.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.492 1.117 . . . . 74.21 109.378 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.31 119.94 73.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.207 -1.034 . . . . 73.3 108.207 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.14 167.72 26.04 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.787 2.325 . . . . 54.4 113.684 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.66 103.39 4.23 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.955 -1.128 . . . . 61.55 107.955 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.425 HG21 HD21 ' B' ' 126' ' ' LEU . 27.4 m -100.88 127.78 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.206 0.602 . . . . 74.2 110.261 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -106.63 124.6 49.85 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.608 -0.886 . . . . 64.41 108.608 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 mt -92.25 124.79 36.58 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.037 -1.098 . . . . 72.4 108.037 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.0 t70 -136.23 151.89 50.16 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 107.996 -1.113 . . . . 75.31 107.996 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.57 169.41 17.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.184 0.516 . . . . 54.04 111.674 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.9 t70 -159.39 142.72 14.49 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.755 1.222 . . . . 73.23 108.432 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.454 HG21 ' CD1' ' E' ' 120' ' ' TRP . 6.5 t -109.29 118.7 37.38 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.765 -0.828 . . . . 61.24 108.765 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.73 151.3 37.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 42.12 108.553 172.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -145.43 163.75 33.67 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 122.927 0.491 . . . . 63.42 110.511 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -157.83 136.54 11.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.679 1.191 . . . . 72.25 108.148 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -93.79 127.02 39.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.926 0.49 . . . . 74.42 110.032 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 -40.32 14.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.215 -0.661 . . . . 33.15 109.215 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.49 -178.83 5.13 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.779 1.232 . . . . 74.33 108.851 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -72.45 134.51 45.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.876 -0.787 . . . . 73.43 108.876 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.3 m-20 73.64 -3.87 2.38 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.404 1.481 . . . . 63.21 111.808 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.38 84.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.993 -1.114 . . . . 63.34 107.993 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.39 138.95 46.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.949 -0.759 . . . . 71.3 108.949 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -115.04 110.0 18.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.829 -1.174 . . . . 71.22 107.829 -172.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' B' ' 98' ' ' LEU . 67.0 t -104.55 128.83 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.988 0.515 . . . . 71.11 110.187 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 39.6 t -102.37 119.91 51.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.538 1.135 . . . . 71.4 109.466 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -92.89 111.67 23.37 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.166 -1.42 . . . . 72.14 107.166 172.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.6 ttt180 -100.18 125.38 46.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.009 -0.737 . . . . 73.33 109.009 175.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.697 HG11 HD11 ' B' ' 128' ' ' LEU . 15.4 t -119.58 127.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.856 -0.794 . . . . 72.01 108.856 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 86.1 m -104.04 141.05 36.87 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.57 0.544 . . . . 54.32 110.11 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.71 HG21 HG21 ' B' ' 114' ' ' ILE . 53.0 t -133.3 122.18 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.491 1.116 . . . . 74.14 108.549 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -117.36 146.17 43.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.744 . . . . 63.23 108.993 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -145.0 133.41 21.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.755 -0.832 . . . . 71.52 108.755 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 63.6 p -138.52 136.34 36.0 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 122.877 0.471 . . . . 70.42 110.207 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.593 HD12 ' HD3' ' B' ' 34' ' ' LYS . 0.3 OUTLIER -110.44 107.86 17.67 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.891 -1.152 . . . . 52.24 107.891 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.33 -111.37 3.24 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 123.662 0.601 . . . . 34.15 112.755 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.87 2.46 23.47 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.216 0.606 . . . . 65.34 111.042 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 11.9 pt-20 -135.71 170.46 15.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.989 0.516 . . . . 73.44 110.441 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.1 m -71.84 143.57 49.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 73.25 110.334 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -98.4 -58.77 1.89 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.919 0.888 . . . . 74.21 109.07 173.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -161.04 164.34 30.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.313 -0.858 . . . . 74.34 110.353 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.26 141.59 45.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.911 1.284 . . . . 75.14 107.646 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.74 154.59 38.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.076 0.55 . . . . 62.43 109.87 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.2 tt0 -164.96 133.88 3.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.7 -0.852 . . . . 75.03 108.7 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.8 t -127.25 145.41 34.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.68 -0.859 . . . . 55.25 108.68 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -122.98 93.09 3.85 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.744 -0.835 . . . . 74.24 108.744 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -84.69 100.43 11.47 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.601 -0.889 . . . . 71.13 108.601 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 173.5 40.1 Favored Glycine 0 C--O 1.245 0.788 0 N-CA-C 111.775 -0.53 . . . . 72.32 111.775 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.5 133.2 2.71 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.697 -0.561 . . . . 44.43 111.697 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 36.7 mt -85.85 131.12 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.373 -0.973 . . . . 74.15 108.373 172.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.54 152.85 48.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.068 0.947 . . . . 72.42 109.626 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 14.8 m -123.59 105.05 9.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.052 0.941 . . . . 73.21 108.894 -172.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.62 HG21 HD11 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -134.46 141.89 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.101 0.56 . . . . 63.23 112.053 -169.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.415 ' HB3' HG22 ' B' ' 10' ' ' THR . . . -149.05 167.69 25.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.399 1.08 . . . . 74.42 109.734 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.75 -62.45 4.38 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.609 0.568 . . . . 61.01 112.328 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.5 pp -68.62 145.58 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.922 0.889 . . . . 75.12 111.992 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.33 175.52 13.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 71.55 110.45 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -122.26 29.23 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.883 0.74 . . . . 65.53 113.536 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -70.8 -33.59 70.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.889 0.875 . . . . 74.43 110.878 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.23 -29.86 61.91 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.274 -0.876 . . . . 73.33 110.779 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.662 ' HG3' ' HB3' ' E' ' 115' ' ' LEU . 0.3 OUTLIER -71.07 -43.9 66.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.552 0.741 . . . . 41.21 109.199 173.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.52 66.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.041 -0.981 . . . . 61.25 111.769 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.43 -38.56 65.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.979 0.512 . . . . 73.33 110.212 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.57 -59.14 2.87 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.368 -0.833 . . . . 75.53 110.83 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' B' ' 58' ' ' VAL . 6.1 mp -87.37 -14.05 41.76 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.756 0.651 . . . . 63.0 112.756 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.09 -37.15 8.5 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 120.151 -0.25 . . . . 13.01 112.668 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.15 -48.09 3.14 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.495 0.648 . . . . 63.14 111.841 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -79.38 -42.36 25.72 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.119 0.415 . . . . 75.33 112.119 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.644 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 96.6 m -61.19 -47.74 93.73 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.43 -0.795 . . . . 74.22 111.746 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -53.44 -35.2 74.87 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.03 1.82 . . . . 72.24 114.601 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.76 -33.2 75.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 118.173 0.442 . . . . 62.25 110.95 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.03 -47.11 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.071 0.948 . . . . 73.33 110.554 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' B' ' 60' ' ' LEU . 78.4 mt -78.82 -19.31 52.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.135 -0.938 . . . . 51.43 112.196 -172.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.523 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 66.6 t80 -62.92 -45.73 87.22 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.886 1.069 . . . . 71.12 113.886 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.25 -38.78 93.47 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 121.96 1.773 . . . . 75.43 113.352 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.442 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 77.2 m-85 -68.05 -45.55 73.58 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.091 0.556 . . . . 75.4 110.671 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -43.74 97.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.376 -0.829 . . . . 73.1 110.545 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -56.71 -54.79 42.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.31 1.444 . . . . 75.23 110.929 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.451 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.9 tp10 -59.26 -41.02 87.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.492 1.117 . . . . 63.41 111.018 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.8 t -68.78 -39.36 80.22 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.655 -0.248 . . . . 74.41 111.262 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.71 HG21 HG21 ' B' ' 64' ' ' VAL . 89.4 mt -62.58 -54.69 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.054 0.542 . . . . 61.53 109.79 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 39.2 m -61.78 -30.1 70.58 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 124.108 0.88 . . . . 65.51 111.526 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.6 t -67.06 -45.76 76.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.401 0.681 . . . . 74.35 110.483 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.4 mmt -67.98 -37.01 81.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.492 0.317 . . . . 64.41 110.739 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.18 -41.09 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.941 0.896 . . . . 63.31 110.195 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.444 ' OG ' HG21 ' C' ' 115' ' ' THR . 36.9 t -65.16 -34.99 79.7 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.807 -1.088 . . . . 60.3 111.248 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.546 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 85.5 mtt-85 -68.59 -28.43 66.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.207 0.603 . . . . 72.04 111.11 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.43 9.58 61.23 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.703 0.627 . . . . 75.54 112.623 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 77.0 p 52.53 55.07 9.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.99 1.716 . . . . 55.31 112.531 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -107.52 161.22 23.85 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-N 115.63 -0.714 . . . . 63.15 110.257 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.26 -167.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 123.312 2.675 . . . . 45.22 114.046 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.737 ' HB3' ' HA ' ' C' ' 124' ' ' PRO . 29.0 pt20 -62.76 122.65 16.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.217 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.425 HD21 HG21 ' B' ' 40' ' ' VAL . 1.1 tm? -151.28 81.77 1.31 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.758 -0.83 . . . . 71.11 108.758 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.13 135.96 36.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.742 0.817 . . . . 73.14 108.887 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.697 HD11 HG11 ' B' ' 62' ' ' VAL . 0.9 OUTLIER -64.55 131.33 46.73 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 123.969 0.793 . . . . 73.21 109.005 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 146.09 87.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.506 0.722 . . . . 75.21 110.858 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.22 108.74 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.016 2.477 . . . . 75.42 113.218 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.72 123.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.621 0.768 . . . . 74.21 110.171 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -87.22 92.54 9.1 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.384 0.674 . . . . 73.02 110.005 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -62.47 -41.48 98.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.306 -0.861 . . . . 61.5 109.754 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.6 -35.16 73.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.415 -1.72 . . . . 60.15 112.015 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.37 -49.78 45.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.433 0.693 . . . . 52.15 111.867 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.79 -43.8 97.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.173 -0.677 . . . . 73.23 109.173 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -68.31 -33.62 74.66 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.009 -0.996 . . . . 74.21 110.857 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -71.35 -34.2 70.29 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.619 0.768 . . . . 65.53 109.97 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -75.34 -13.93 60.45 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.08 0.552 . . . . 52.23 110.92 177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.93 -34.1 24.55 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.838 -0.801 . . . . 72.51 108.838 168.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 55.2 mt -102.14 29.25 5.21 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.574 0.75 . . . . 64.24 111.167 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -65.35 -23.14 66.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.693 0.797 . . . . 73.54 112.941 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.6 81.96 2.61 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.74 0.816 . . . . 65.44 109.762 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 59.6 124.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.856 1.663 . . . . 74.3 113.516 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.95 83.33 2.12 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.474 0.71 . . . . 43.2 109.674 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.47 -161.45 29.59 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.468 -0.787 . . . . 53.2 113.224 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.42 -167.69 1.93 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.482 1.113 . . . . 61.34 109.218 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.41 -87.16 0.39 Allowed Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.787 -0.525 . . . . 64.54 111.787 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -159.39 159.51 33.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.84 0.856 . . . . 71.12 109.935 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.588 ' HA ' HG21 ' B' ' 7' ' ' THR . 47.9 mt-10 -133.7 119.59 19.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.643 0.777 . . . . 63.43 109.425 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.555 ' H ' HG21 ' B' ' 7' ' ' THR . 9.2 pt-20 -149.13 173.3 13.57 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.282 1.033 . . . . 73.23 110.362 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -136.97 121.87 18.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.874 0.87 . . . . 75.45 108.988 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -87.48 146.42 25.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.884 . . . . 72.44 110.285 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.48 110.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.759 0.823 . . . . 70.34 110.276 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.074 0.95 . . . . 53.21 110.477 -177.373 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 109.872 -0.418 . . . . 63.2 109.872 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -162.92 173.95 13.0 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.197 1.399 . . . . 74.54 109.385 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.41 89.36 2.64 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.156 -1.053 . . . . 63.5 108.156 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 55.03 61.85 2.77 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.322 1.049 . . . . 74.43 110.45 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -127.03 -62.23 1.12 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 107.37 -1.344 . . . . 74.21 107.37 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.6 17.23 10.26 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.672 1.189 . . . . 64.25 112.519 171.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -99.1 146.72 25.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.329 1.052 . . . . 71.13 110.259 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 151.92 44.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.666 0.786 . . . . 75.33 111.395 174.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt 64.74 116.0 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.074 1.349 . . . . 73.52 112.588 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 55.0 m -85.1 98.06 10.22 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.151 -1.055 . . . . 73.33 108.151 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -108.67 129.0 55.34 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.345 -0.983 . . . . 72.23 108.345 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -142.32 125.3 16.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.846 -0.428 . . . . 75.34 109.846 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.648 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -75.92 133.64 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 108.533 -0.914 . . . . 70.21 108.533 175.166 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -107.74 -48.73 3.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.231 0.612 . . . . 74.2 110.689 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -162.06 136.15 6.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.673 0.389 . . . . 64.12 110.16 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.648 HG13 HD11 ' C' ' 13' ' ' ILE . 88.3 mt -119.87 140.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.037 -1.097 . . . . 74.23 108.037 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.522 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 25.8 p90 -173.77 161.33 3.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.229 0.538 . . . . 74.3 110.968 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -82.66 112.92 19.97 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.161 -0.927 . . . . 71.34 109.387 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -74.28 -33.27 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.195 -0.669 . . . . 60.14 109.195 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -146.52 147.17 30.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.367 -0.833 . . . . 74.13 110.233 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.8 mt -146.3 145.87 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.993 1.717 . . . . 65.22 106.842 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -162.96 151.97 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 122.87 0.468 . . . . 43.13 110.117 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.14 108.35 3.41 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.492 -0.929 . . . . 61.23 108.492 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.18 118.73 33.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.794 0.837 . . . . 71.41 109.218 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.58 83.81 48.12 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.55 1.14 . . . . 64.22 108.411 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.88 -19.06 31.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.732 2.288 . . . . 74.22 111.775 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' C' ' 72' ' ' THR . 77.9 m-20 -117.69 38.61 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.169 0.987 . . . . 73.43 109.51 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.07 -47.24 98.93 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 123.586 0.754 . . . . 73.22 112.705 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.97 -14.64 38.98 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.788 1.659 . . . . 74.44 113.852 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -67.61 -23.91 65.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 119.186 -0.435 . . . . 74.41 111.984 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.59 -29.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.727 0.811 . . . . 52.14 112.523 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.468 ' HA ' HD12 ' E' ' 134' ' ' ILE . 38.2 m-85 -68.75 -41.44 78.89 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.229 0.612 . . . . 70.21 111.315 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.26 5.78 49.45 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.047 -0.979 . . . . 63.12 110.527 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.42 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.6 ttmp? -93.47 145.85 24.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.66 0.784 . . . . 74.24 110.403 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.44 132.07 34.62 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.861 -1.162 . . . . 64.31 107.861 172.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -74.99 78.48 2.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 122.312 1.053 . . . . 72.31 111.575 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.436 ' O ' HD13 ' C' ' 68' ' ' LEU . 38.0 tt0 -157.56 65.13 3.33 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 113.924 -1.489 . . . . 53.2 108.327 168.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.08 150.81 4.75 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.653 1.569 . . . . 72.34 111.254 169.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.411 ' HG3' HD22 ' E' ' 141' ' ' LEU . 37.8 tt0 -86.32 96.06 9.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.522 -1.288 . . . . 72.31 107.522 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.53 98.35 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.474 1.131 . . . . 44.3 108.86 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -91.18 116.84 29.14 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.805 -1.543 . . . . 73.02 108.331 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.589 HD13 HD11 ' C' ' 128' ' ' LEU . 30.1 tp -84.24 144.12 29.13 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.374 -0.973 . . . . 74.14 108.374 172.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.9 t70 -137.47 128.56 27.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.496 -1.298 . . . . 73.43 107.496 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.83 132.07 38.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.049 -0.723 . . . . 75.1 109.049 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -137.65 155.84 48.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.805 0.842 . . . . 72.54 109.009 174.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -138.32 149.52 45.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.923 0.489 . . . . 62.22 109.921 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 167.59 21.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.768 0.827 . . . . 52.55 109.179 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.3 p -148.3 144.64 27.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.649 0.379 . . . . 72.23 111.062 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 75.9 p -147.66 145.77 29.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.062 0.945 . . . . 74.1 110.242 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -87.14 130.56 34.47 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.007 -0.738 . . . . 74.31 109.007 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.635 HD11 ' HB2' ' C' ' 57' ' ' GLU . 59.5 mt -106.37 -41.84 5.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.627 0.771 . . . . 61.34 109.944 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.18 -169.32 3.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.507 0.723 . . . . 45.32 110.736 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.83 108.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.132 -0.94 . . . . 55.22 109.396 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 52.1 m-20 69.97 -0.84 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.639 1.175 . . . . 61.34 113.269 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -96.68 113.95 32.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.533 0.733 . . . . 75.42 109.166 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.97 130.16 52.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.361 1.064 . . . . 74.32 108.71 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.635 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.6 tt0 -87.98 143.9 26.84 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.362 -0.835 . . . . 72.34 108.817 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.454 HG13 HD11 ' C' ' 106' ' ' LEU . 2.6 p -125.46 124.6 67.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.557 -0.905 . . . . 74.25 108.557 169.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.85 104.69 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.578 -1.267 . . . . 74.1 107.578 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.49 100.85 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.974 0.91 . . . . 73.34 108.759 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -81.65 124.15 29.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.573 0.749 . . . . 73.4 110.237 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.26 126.56 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.531 -1.285 . . . . 72.41 107.531 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.5 m -128.59 128.79 44.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.899 -0.778 . . . . 74.33 108.899 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.666 HG23 HD13 ' C' ' 114' ' ' ILE . 88.5 t -110.71 110.16 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.664 -0.865 . . . . 53.42 108.664 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.403 HG23 HD23 ' C' ' 75' ' ' LEU . 8.8 m -99.34 110.29 22.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.85 -0.796 . . . . 73.14 108.85 173.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.22 99.97 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.488 -1.301 . . . . 73.44 107.488 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -146.65 156.45 43.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.647 0.592 . . . . 50.53 109.865 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.436 HD13 ' O ' ' C' ' 37' ' ' GLN . 53.7 tp -111.8 80.18 1.29 Allowed 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.767 -1.568 . . . . 73.3 106.767 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.91 -96.2 0.18 Allowed Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.903 -1.044 . . . . 72.11 112.339 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -91.13 -31.94 16.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.847 0.859 . . . . 74.32 111.221 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.42 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 13.2 tp10 -87.22 93.13 9.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.652 0.781 . . . . 53.32 110.281 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 60.8 m -84.72 130.44 34.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.826 -0.624 . . . . 75.34 111.038 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.36 -55.76 4.67 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.028 0.931 . . . . 63.4 109.863 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -157.37 170.73 21.8 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.408 0.623 . . . . 74.12 111.721 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.403 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -143.51 111.5 6.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.723 -1.584 . . . . 64.42 106.723 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.8 t -111.02 143.98 40.86 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.981 -0.748 . . . . 74.32 108.981 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -147.55 117.8 7.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.203 0.601 . . . . 75.33 109.621 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.87 114.99 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.787 1.235 . . . . 74.32 109.234 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -94.16 102.62 14.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.141 -0.689 . . . . 70.24 109.141 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.622 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.1 tp-100 -87.56 109.4 19.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.471 0.708 . . . . 70.2 109.34 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.62 146.88 20.26 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.617 -0.593 . . . . 70.33 111.617 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.46 117.36 1.27 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.569 -0.613 . . . . 71.54 111.569 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' C' ' 51' ' ' LEU . 12.8 mm -83.01 126.09 40.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.614 -0.884 . . . . 63.42 108.614 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -140.62 138.33 34.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.649 0.38 . . . . 71.42 110.114 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -94.54 117.75 30.61 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.8 pp -116.12 142.06 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 122.72 0.408 . . . . 52.21 110.113 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -155.86 155.82 33.59 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.219 0.608 . . . . 75.41 110.443 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -45.81 3.32 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.195 -0.457 . . . . 70.4 112.556 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -88.7 151.03 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.8 0.84 . . . . 63.22 109.09 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.9 -179.45 7.66 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.858 0.463 . . . . 72.33 109.811 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 58.23 -137.33 50.1 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 115.268 0.867 . . . . 73.24 115.268 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -72.2 -20.09 61.63 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 73.45 112.39 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -80.12 -38.77 30.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.23 0.212 . . . . 65.44 110.863 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 16.9 ptt? -70.21 -31.81 69.41 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.443 -0.577 . . . . 72.04 109.443 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.07 71.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.474 -0.785 . . . . 64.01 110.433 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -61.67 -49.17 77.59 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.459 0.474 . . . . 75.13 110.173 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.96 -48.86 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.51 0.506 . . . . 73.45 110.478 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.69 -16.35 63.33 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.613 0.765 . . . . 63.23 111.38 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.0 10.8 20.62 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-O 119.622 -0.544 . . . . 73.31 114.279 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.15 -61.11 0.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.703 0.751 . . . . 64.35 111.02 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.4 -56.68 6.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.707 0.403 . . . . 61.13 111.673 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 60.7 m -56.81 -46.95 99.8 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.59 0.756 . . . . 63.3 111.951 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 92.1 Cg_exo -53.32 -38.35 82.06 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 122.512 2.141 . . . . 64.43 114.923 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -63.4 -36.44 83.75 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 123.81 0.844 . . . . 65.31 110.506 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.68 -40.21 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.586 0.755 . . . . 73.51 110.414 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.454 HD11 HG13 ' C' ' 58' ' ' VAL . 64.2 mt -85.72 -26.12 26.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.565 -1.198 . . . . 40.14 112.096 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -55.52 -47.58 98.32 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 113.809 1.04 . . . . 73.24 113.809 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.32 -40.43 82.02 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.277 1.984 . . . . 54.51 113.612 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -65.7 -43.37 89.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.165 0.586 . . . . 73.44 110.374 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.622 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -69.5 -33.74 73.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.414 -0.812 . . . . 73.51 111.241 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -64.98 -47.36 77.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 74.14 110.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -71.92 -33.0 67.92 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.695 -0.684 . . . . 73.02 109.552 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 47.9 t -69.12 -31.15 69.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.234 0.614 . . . . 72.1 111.089 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.666 HD13 HG23 ' C' ' 64' ' ' VAL . 63.3 mt -72.62 -51.52 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.04 0.536 . . . . 71.22 109.762 171.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.444 HG21 ' OG ' ' B' ' 119' ' ' SER . 39.9 m -61.73 -31.08 71.22 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.815 0.446 . . . . 73.33 111.143 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -60.18 -54.31 47.41 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.181 0.992 . . . . 62.21 108.995 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.423 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.82 -42.32 79.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.031 1.333 . . . . 65.24 112.475 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 85.5 t -66.02 -40.85 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 52.21 109.924 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -73.75 -24.04 59.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.935 -1.03 . . . . 73.14 111.645 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.3 mtt-85 -74.1 -40.06 62.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.254 -0.647 . . . . 64.11 109.254 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -1.24 65.31 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.824 0.703 . . . . 64.14 112.229 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 37.5 p 63.73 25.8 14.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.869 2.067 . . . . 53.53 112.83 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.12 158.77 63.8 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.049 0.94 . . . . 71.12 108.538 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' B' ' 125' ' ' GLN . 36.3 Cg_endo -61.25 151.32 79.89 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.799 2.333 . . . . 74.31 114.206 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -56.55 112.05 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.084 1.354 . . . . 60.12 111.761 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.06 90.15 3.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.524 -1.287 . . . . 62.01 107.524 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -91.31 110.38 21.68 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.527 -0.916 . . . . 62.54 108.527 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.589 HD11 HD13 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -77.19 134.17 38.72 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.095 0.958 . . . . 74.34 110.316 -171.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.79 144.96 83.61 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.252 1.021 . . . . 75.02 111.846 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.45 ' HG3' HG12 ' A' ' 16' ' ' ILE . 93.1 Cg_endo -78.54 104.13 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.816 2.344 . . . . 70.15 112.895 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.62 107.73 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.111 -1.441 . . . . 63.21 107.111 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -105.64 98.02 7.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.081 0.552 . . . . 70.35 109.803 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -67.1 -36.95 83.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.432 0.693 . . . . 64.04 110.1 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -56.94 -48.96 77.08 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.449 -1.25 . . . . 74.52 111.702 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.27 63.24 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.04 0.936 . . . . 22.33 112.844 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.717 HD11 HD21 ' E' ' 148' ' ' LEU . 8.3 mp -69.79 -47.61 62.23 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.267 0.627 . . . . 62.04 110.507 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.97 -27.05 61.59 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.391 0.676 . . . . 73.41 111.617 -174.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 94.3 mmm -71.47 -39.7 70.75 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.145 0.578 . . . . 73.22 111.417 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -71.59 -38.79 70.84 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 110.123 -0.325 . . . . 72.14 110.123 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -55.19 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.695 0.798 . . . . 74.22 110.916 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.3 87.39 3.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.447 0.642 . . . . 73.24 109.381 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -69.96 158.32 35.83 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.436 -1.256 . . . . 64.2 110.946 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -114.56 -71.06 0.76 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.527 0.331 . . . . 62.22 110.33 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 143' ' ' GLN . 0.5 OUTLIER 57.03 86.91 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.684 1.194 . . . . 64.11 110.323 -171.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.33 -172.11 3.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.039 -0.982 . . . . 35.22 108.595 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.17 83.67 0.04 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 112.005 -0.438 . . . . 75.21 112.005 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.71 89.47 0.55 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.32 -1.363 . . . . 73.04 107.32 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -123.25 60.39 0.59 Allowed Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.19 -0.913 . . . . 72.41 112.456 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 p -64.14 178.13 0.72 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.002 0.521 . . . . 64.42 111.371 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -64.73 139.82 58.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.051 0.54 . . . . 70.21 111.538 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.18 101.47 0.41 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.015 0.926 . . . . 72.11 108.836 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -78.79 102.98 8.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.566 0.747 . . . . 73.45 110.818 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -147.85 102.77 3.44 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 71.42 108.536 168.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.05 169.13 9.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.555 1.142 . . . . 62.13 110.086 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.359 0 C-N-CA 123.637 0.775 . . . . 37.61 110.544 -175.586 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 111.14 0.052 . . . . 73.24 111.14 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -140.38 150.99 44.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.989 0.516 . . . . 63.51 110.326 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -171.55 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.195 0.998 . . . . 74.45 109.346 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 66.45 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.794 1.238 . . . . 60.34 108.654 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.538 ' HB3' ' HG2' ' D' ' 8' ' ' GLU . 17.5 t-20 177.21 145.4 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.067 1.347 . . . . 55.42 108.084 167.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -63.81 -32.98 74.67 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.288 0.635 . . . . 64.3 112.239 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.486 HG22 ' OD1' ' D' ' 5' ' ' ASN . 4.3 t -82.78 -19.47 37.7 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 117.659 0.209 . . . . 74.04 111.196 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' D' ' 5' ' ' ASN . 27.1 mm-40 -70.11 -16.02 63.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 119.114 -0.47 . . . . 65.51 111.773 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 19.3 ttt -32.16 133.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.528 1.131 . . . . 75.32 113.518 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 90.3 m -142.55 139.96 31.59 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.409 1.084 . . . . 72.34 108.326 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.452 ' CE2' ' SG ' ' D' ' 102' ' ' CYS . 79.5 t80 -155.01 101.09 2.24 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.529 -1.285 . . . . 72.01 107.529 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.23 122.7 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.88 0.472 . . . . 73.12 109.825 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.13 119.75 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 109.138 -0.69 . . . . 61.34 109.138 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -98.67 -46.46 5.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.574 0.35 . . . . 64.2 110.586 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.617 HH12 HG21 ' E' ' 134' ' ' ILE . 34.5 ttt180 -165.07 120.08 1.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.505 -0.183 . . . . 72.21 110.505 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -103.06 136.91 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.77 -1.196 . . . . 50.53 107.77 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -164.37 177.59 8.12 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.826 0.85 . . . . 74.04 110.763 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -107.5 127.56 53.72 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.738 -0.665 . . . . 62.42 110.013 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 27.4 mtpt -95.54 -30.99 13.54 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.529 -0.545 . . . . 62.12 109.529 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.782 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -144.61 134.9 24.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.834 -0.802 . . . . 74.22 108.834 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.524 HG23 HG22 ' D' ' 78' ' ' VAL . 27.1 mt -139.04 147.7 24.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.144 -1.428 . . . . 74.43 107.144 174.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -155.13 147.47 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.986 0.422 . . . . 73.12 110.351 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.623 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 67.8 t80 -150.06 127.89 11.76 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.16 1.384 . . . . 71.31 107.351 173.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -126.61 148.06 49.83 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.039 0.936 . . . . 74.32 108.974 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.25 84.03 61.14 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.816 -0.809 . . . . 55.15 108.816 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.24 -48.06 5.3 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.789 2.993 . . . . 65.42 114.195 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -111.87 45.57 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.885 -0.783 . . . . 74.22 108.885 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.522 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.79 -59.34 9.06 Favored Pre-proline 0 CA--C 1.575 1.928 0 N-CA-C 115.703 1.742 . . . . 62.41 115.703 -166.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.66 -4.45 10.73 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 122.545 1.945 . . . . 72.11 112.99 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -84.15 -35.62 23.47 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.332 1.053 . . . . 72.12 110.476 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 p -84.31 -13.29 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.394 0.616 . . . . 71.43 110.411 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -30.7 69.71 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.862 -0.608 . . . . 74.4 109.939 166.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -72.38 -6.28 42.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.444 1.098 . . . . 31.12 111.943 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.408 ' HZ1' ' HG2' ' D' ' 70' ' ' GLU . 93.9 mttt -125.41 87.13 2.65 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.379 1.072 . . . . 51.41 109.225 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.504 ' HB2' ' HA ' ' F' ' 134' ' ' ILE . 7.2 p-10 -80.23 93.86 5.95 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.172 0.987 . . . . 63.52 110.425 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.38 170.98 20.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.314 1.046 . . . . 73.42 109.815 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -80.59 107.37 7.12 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.191 -1.04 . . . . 62.22 108.191 166.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.63 153.92 76.25 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.945 2.43 . . . . 71.51 113.001 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.01 123.81 23.59 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.444 -0.947 . . . . 73.33 108.444 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.531 HG11 HD13 ' D' ' 126' ' ' LEU . 7.7 p -117.71 142.35 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.079 0.552 . . . . 74.52 110.283 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' D' ' 41' ' ' LYS . 11.4 mmpt? -109.77 123.83 50.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.344 1.058 . . . . 63.4 108.711 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.62 126.87 55.84 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.464 0.706 . . . . 75.23 110.566 -171.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -130.67 120.2 23.56 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.945 0.898 . . . . 62.25 109.168 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.629 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.8 pt? -108.48 132.56 53.69 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.219 -0.66 . . . . 42.32 109.219 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.449 ' O ' HD23 ' D' ' 60' ' ' LEU . 26.7 t70 -135.48 145.26 46.96 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.862 0.865 . . . . 64.11 108.967 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -123.59 155.58 37.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.852 0.834 . . . . 74.4 111.62 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.515 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.19 166.86 27.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 113.801 -1.545 . . . . 62.32 108.073 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.4 p -151.91 156.38 39.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.133 0.573 . . . . 70.23 109.568 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -158.51 119.03 3.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.774 0.83 . . . . 73.31 109.022 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.71 117.79 11.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.987 -0.746 . . . . 71.04 108.987 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.55 -36.38 17.61 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.306 -0.627 . . . . 74.1 109.306 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.84 -171.38 2.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 71.11 111.322 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -54.8 104.68 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.607 1.563 . . . . 55.45 111.371 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 58.33 20.65 7.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.19 0.996 . . . . 71.42 112.432 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 75.3 t -109.46 122.22 63.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 107.523 -1.288 . . . . 60.32 107.523 170.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -130.89 128.41 40.5 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.836 -0.801 . . . . 73.22 108.836 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -88.66 135.88 33.28 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.528 1.131 . . . . 72.4 108.464 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 81.3 t -117.87 139.83 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.34 -0.985 . . . . 71.23 108.34 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.6 t -115.78 141.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.237 -1.023 . . . . 41.15 108.237 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.36 118.61 24.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.287 -1.375 . . . . 73.04 107.287 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 4.3 tmm_? -107.28 97.86 7.57 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.963 -0.754 . . . . 53.31 108.963 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.02 125.74 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.876 -0.787 . . . . 74.04 108.876 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -113.1 144.43 42.65 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.691 0.796 . . . . 53.5 109.798 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.618 HG21 HG21 ' D' ' 114' ' ' ILE . 25.6 t -135.8 104.82 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.243 1.417 . . . . 62.14 108.367 -173.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 10.0 m -112.14 90.99 3.49 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.563 -1.273 . . . . 54.33 107.563 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.53 125.32 42.17 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.44 -0.578 . . . . 72.04 109.44 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.9 p -158.69 124.92 4.58 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.167 0.987 . . . . 71.55 109.539 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.85 130.07 43.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.556 -1.276 . . . . 74.32 107.556 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 -146.41 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.012 -0.54 . . . . 23.45 113.323 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' GLU . . . . . 0.408 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 10.5 pt-20 -88.03 11.11 16.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.207 1.003 . . . . 65.12 112.239 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.76 161.9 40.31 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.819 0.342 . . . . 63.43 111.428 -167.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -83.33 124.79 30.96 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.644 -0.707 . . . . 71.34 110.063 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.466 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -73.4 -63.84 1.11 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.125 0.97 . . . . 71.42 110.161 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -157.87 157.56 33.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.142 0.496 . . . . 64.13 111.065 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.96 146.62 47.45 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.408 1.083 . . . . 63.25 109.075 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -160.0 141.42 12.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.191 0.596 . . . . 65.14 110.334 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.41 122.34 5.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.374 -0.602 . . . . 71.52 109.374 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.524 HG22 HG23 ' D' ' 21' ' ' ILE . 47.8 t -124.48 123.95 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.446 0.698 . . . . 71.13 110.581 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.782 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.5 93.61 9.57 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.386 0.612 . . . . 74.33 109.396 164.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -79.69 109.88 14.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.979 -1.009 . . . . 74.44 108.371 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.69 149.37 19.1 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 111.735 -0.546 . . . . 64.4 111.735 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.479 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.22 130.52 4.02 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 110.885 -0.886 . . . . 62.53 110.885 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.77 126.34 41.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.022 -1.103 . . . . 74.24 108.022 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' D' ' 86' ' ' ILE . 49.3 m-85 -129.98 162.75 27.97 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.297 -0.631 . . . . 71.41 109.297 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -116.35 101.62 8.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.556 0.742 . . . . 71.24 109.354 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' D' ' 84' ' ' PHE . 3.8 mp -109.77 110.63 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.083 0.953 . . . . 64.32 110.097 -174.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.53 38.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.012 0.925 . . . . 74.53 109.829 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.76 -20.0 6.84 Favored Glycine 0 N--CA 1.477 1.432 0 N-CA-C 114.646 0.619 . . . . 63.01 114.646 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.452 HD11 ' HG3' ' D' ' 93' ' ' GLN . 4.4 tt -121.16 137.26 55.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 C-N-CA 124.237 1.015 . . . . 54.22 109.478 -174.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -150.69 -170.99 3.81 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.72 0.808 . . . . 71.13 110.822 -177.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.5 -140.81 26.76 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.32 0.387 . . . . 73.05 113.606 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -80.0 -24.44 40.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.52 0.728 . . . . 45.14 110.833 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.452 ' HG3' HD11 ' D' ' 89' ' ' ILE . 6.5 tp-100 -70.26 -36.95 74.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.135 0.574 . . . . 53.52 110.632 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -74.55 -33.6 62.76 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.668 -0.493 . . . . 65.43 109.668 174.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.76 81.2 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.361 0.601 . . . . 74.42 110.425 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.508 ' HB2' HD11 ' D' ' 141' ' ' LEU . 8.2 t-80 -67.71 -44.81 76.79 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.972 -1.013 . . . . 73.11 111.231 172.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.96 -50.5 73.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.051 0.54 . . . . 65.03 110.699 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.34 -22.85 54.39 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.869 0.868 . . . . 73.53 111.316 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.2 -7.56 46.24 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 115.215 0.846 . . . . 75.14 115.215 -172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.28 -51.86 0.35 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.793 0.796 . . . . 71.34 110.965 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -71.8 -39.44 69.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.764 0.426 . . . . 74.11 112.057 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' CE2' ' D' ' 11' ' ' PHE . 57.7 m -73.37 -44.59 7.59 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.693 -0.67 . . . . 74.24 111.347 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.528 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 64.6 Cg_exo -56.64 -32.75 91.58 Favored 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 121.983 1.789 . . . . 71.33 113.244 168.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -63.82 -35.75 81.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.205 0.602 . . . . 64.33 110.669 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -65.75 -42.11 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.437 0.695 . . . . 63.31 110.111 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.479 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.0 mt -75.9 -19.26 58.97 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.075 -0.966 . . . . 65.4 112.318 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.23 -43.84 56.41 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 113.851 1.056 . . . . 74.14 113.851 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.99 -41.4 79.2 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.937 1.758 . . . . 75.03 113.512 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.43 -38.36 68.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.516 0.726 . . . . 74.22 111.525 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.65 79.35 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.486 0.714 . . . . 52.53 110.398 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -55.35 -52.37 63.72 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.507 1.129 . . . . 73.21 110.6 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.18 -43.95 93.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.894 0.746 . . . . 73.43 111.779 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 51.6 t -55.35 -40.3 71.07 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.764 0.665 . . . . 74.5 110.833 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.618 HG21 HG21 ' D' ' 64' ' ' VAL . 97.3 mt -65.83 -53.38 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.071 -0.968 . . . . 73.21 110.483 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.433 HG23 ' HG3' ' D' ' 125' ' ' GLN . 22.5 m -57.31 -35.99 70.53 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.252 1.021 . . . . 52.43 111.818 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.99 -45.69 76.86 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.204 -0.907 . . . . 74.45 110.139 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.425 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 79.1 mtm -65.6 -31.45 72.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.24 0.616 . . . . 72.02 111.7 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' D' ' 114' ' ' ILE . 71.2 t -66.25 -46.21 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.388 -0.824 . . . . 64.14 110.038 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.03 -25.44 60.95 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.333 -0.394 . . . . 74.32 111.428 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -74.39 -35.42 63.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.588 0.755 . . . . 61.02 109.676 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.67 -1.37 83.11 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 115.692 -0.685 . . . . 72.32 112.111 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p 57.19 36.29 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.2 1.8 . . . . 73.54 111.825 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.62 158.31 32.38 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 113.908 -1.496 . . . . 72.03 109.815 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.503 ' HB2' HD11 ' F' ' 139' ' ' LEU . 73.1 Cg_exo -54.13 128.24 29.07 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.526 2.151 . . . . 65.24 113.07 174.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' D' ' 115' ' ' THR . 27.1 tt0 -52.39 140.97 20.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.052 1.341 . . . . 73.41 112.702 -175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.531 HD13 HG11 ' D' ' 40' ' ' VAL . 28.2 tp -112.99 126.77 55.86 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.11 -0.7 . . . . 73.54 109.11 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.467 ' HB3' HG13 ' B' ' 13' ' ' ILE . 94.3 m-20 -121.28 103.78 9.23 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.074 0.95 . . . . 70.0 109.025 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.76 119.75 12.36 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.641 0.776 . . . . 73.12 110.12 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.18 88.32 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.089 0.556 . . . . 73.52 110.602 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 110.7 1.36 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.464 2.109 . . . . 75.25 111.827 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.65 110.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.08 -1.082 . . . . 70.54 108.08 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 59.3 t30 -82.31 75.29 9.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.157 0.979 . . . . 73.53 109.375 -176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.505 ' HA ' HD22 ' F' ' 148' ' ' LEU . 28.4 t80 -78.51 -24.05 46.0 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.304 -1.316 . . . . 75.3 109.767 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -52.66 -34.96 54.02 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.585 1.554 . . . . 71.45 111.287 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.459 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -63.32 -31.96 73.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.04 0.936 . . . . 71.13 112.992 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 46.8 tp -66.22 -37.34 85.33 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.254 0.549 . . . . 74.25 110.379 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.4 ' O ' HD13 ' D' ' 141' ' ' LEU . 62.7 m-85 -66.15 -28.54 68.86 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.168 -0.924 . . . . 54.4 112.872 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.3 mmt -52.35 -50.07 63.08 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.041 0.448 . . . . 72.42 110.041 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -66.32 -49.19 67.86 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.946 -1.025 . . . . 62.01 110.389 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.58 1.552 . . . . 73.32 112.285 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' D' ' 96' ' ' HIS . 8.0 mp -67.16 -51.14 57.48 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.304 1.042 . . . . 70.31 110.958 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -77.2 -4.04 42.66 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 116.069 -0.514 . . . . 65.41 112.144 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -122.41 41.85 3.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.459 -0.941 . . . . 74.41 108.459 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -162.96 -71.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.808 1.643 . . . . 75.52 107.637 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.23 89.55 0.03 OUTLIER 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.225 1.41 . . . . 43.34 111.022 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.92 -168.66 12.7 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 116.234 -0.439 . . . . 52.3 112.389 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.47 121.78 21.54 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.828 -0.804 . . . . 74.43 108.828 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.41 65.0 0.6 Allowed Glycine 0 C--N 1.341 0.835 0 N-CA-C 111.455 -0.658 . . . . 75.3 111.455 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.9 t -156.92 175.52 13.97 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.878 -0.786 . . . . 64.2 108.878 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 -53.63 0.71 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.012 0.525 . . . . 74.52 110.131 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 175.61 132.98 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.211 1.004 . . . . 74.42 108.318 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -119.97 118.02 29.58 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.619 -1.252 . . . . 74.45 107.619 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -65.23 101.34 0.54 Allowed 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.366 0.603 . . . . 73.01 110.666 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.75 122.89 26.59 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.087 -1.415 . . . . 65.2 108.424 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.135 0.974 . . . . 65.44 108.726 -178.369 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 108.851 -0.796 . . . . 61.04 108.851 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.58 36.01 26.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.421 1.088 . . . . 64.21 112.204 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.8 63.89 6.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.438 0.695 . . . . 74.53 109.507 175.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -78.17 143.87 36.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.526 -0.761 . . . . 73.14 109.88 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -77.76 84.05 4.1 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.985 -0.552 . . . . 72.24 110.352 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.23 166.65 23.15 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.019 -0.991 . . . . 75.31 109.271 171.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.45 -73.85 0.09 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.165 0.586 . . . . 52.1 109.683 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.662 ' HB3' ' HG3' ' B' ' 94' ' ' MET . 6.7 mp -141.01 -33.14 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.478 0.711 . . . . 71.23 111.699 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -125.85 83.64 62.34 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 123.11 0.564 . . . . 75.3 111.065 -166.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.54 -17.44 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.014 2.476 . . . . 70.33 113.394 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -109.31 118.8 37.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.472 0.709 . . . . 71.32 109.873 -164.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 44.6 p -116.86 60.53 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.958 0.903 . . . . 75.33 110.222 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.454 ' CD1' HG21 ' B' ' 46' ' ' THR . 15.1 m95 64.14 -82.19 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.978 1.311 . . . . 55.11 113.165 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 27.7 t70 67.79 153.06 0.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.959 1.304 . . . . 64.0 110.952 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 59.34 34.9 23.04 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.159 0.984 . . . . 71.43 111.716 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.6 87.99 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.099 -0.955 . . . . 72.02 109.72 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -142.61 92.22 2.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.763 -1.199 . . . . 74.21 107.763 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -84.91 67.97 10.35 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.158 -1.053 . . . . 73.35 108.158 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -82.8 80.57 8.84 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.447 -0.946 . . . . 61.12 108.447 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.2 110.09 1.23 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.286 -1.324 . . . . 52.3 109.997 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.89 102.64 0.8 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.723 -0.473 . . . . 71.44 109.723 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 pp -161.14 148.41 15.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.086 0.954 . . . . 72.13 110.023 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 7.3 tp -157.94 89.2 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.61 0.764 . . . . 73.43 109.354 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 56.85 -150.65 0.43 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.262 1.025 . . . . 60.12 111.081 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -98.48 124.3 47.08 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.658 -1.238 . . . . 73.33 107.658 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.09 106.99 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.9 2.4 . . . . 74.21 113.696 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 134' ' ' ILE . . . . . 0.617 HG21 HH12 ' D' ' 15' ' ' ARG . 7.7 tt -167.84 120.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.167 0.987 . . . . 73.13 109.532 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.98 89.66 7.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.398 0.679 . . . . 32.11 110.324 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 t -86.22 -22.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.878 0.471 . . . . 62.31 109.91 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 66.25 -170.97 0.19 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.594 1.158 . . . . 72.33 113.139 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.59 119.88 24.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.28 0.632 . . . . 64.41 110.311 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.39 126.45 37.48 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.234 1.014 . . . . 74.3 109.864 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -150.58 110.89 4.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.48 0.712 . . . . 54.15 109.869 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 141' ' ' LEU . . . . . 0.411 HD22 ' HG3' ' C' ' 39' ' ' GLU . 3.6 tt -159.82 78.82 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.359 -1.349 . . . . 72.13 107.359 177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 15.7 pt -137.79 -50.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.56 0.744 . . . . 71.22 110.505 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -143.76 -59.89 0.4 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.054 -1.461 . . . . 64.02 107.054 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 73.89 -4.25 2.31 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.365 1.466 . . . . 62.31 113.297 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -133.93 -76.67 0.47 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.579 0.752 . . . . 71.3 109.852 172.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.82 96.66 10.55 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.169 0.987 . . . . 64.3 110.041 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.52 -56.89 4.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.761 -1.2 . . . . 62.23 107.761 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.717 HD21 HD11 ' C' ' 136' ' ' LEU . 5.9 tt -170.55 96.39 0.45 Allowed Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 107.392 -1.336 . . . . 72.25 107.392 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.57 2.281 0 C-N-CA 123.316 2.678 . . . . 74.23 111.928 174.498 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.002 -0.37 . . . . 71.43 110.002 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -133.57 158.03 44.21 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.255 1.022 . . . . 73.44 109.468 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 119.1 6.42 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.961 0.905 . . . . 73.22 108.765 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -117.44 95.13 4.82 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 70.35 108.546 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.35 22.62 10.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.763 0.825 . . . . 73.31 110.695 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.19 113.1 1.97 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.348 1.059 . . . . 75.15 110.148 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -166.44 152.18 8.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.023 -0.732 . . . . 73.51 109.023 -171.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.414 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 11.6 tp -78.51 72.59 5.04 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.09 -0.707 . . . . 63.43 109.09 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -154.86 87.72 3.32 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.147 0.979 . . . . 74.11 108.675 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 117' ' ' PRO . . . . . 0.446 ' HD2' HD12 ' A' ' 98' ' ' LEU . 44.3 Cg_endo -91.89 9.04 2.87 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 123.185 2.59 . . . . 53.03 113.834 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -78.63 94.58 5.06 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.339 -0.615 . . . . 72.24 109.339 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 32.6 m -133.71 87.72 2.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.161 -1.051 . . . . 63.53 108.161 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 120' ' ' TRP . . . . . 0.453 ' CZ2' ' HB3' ' F' ' 122' ' ' ALA . 59.3 t90 -159.13 148.06 18.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.911 0.885 . . . . 75.13 109.349 -176.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -146.68 98.16 3.02 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 55.41 110.372 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 122' ' ' ALA . . . . . 0.453 ' HB3' ' CZ2' ' F' ' 120' ' ' TRP . . . -167.9 83.76 0.2 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.798 0.839 . . . . 64.24 109.677 169.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.09 136.05 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.363 0.665 . . . . 60.03 110.512 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.8 146.56 50.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.991 0.916 . . . . 74.14 108.836 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 125' ' ' TYR . . . . . 0.422 ' HE2' ' HA ' ' A' ' 43' ' ' ASP . 32.5 p90 -151.6 147.51 26.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.859 0.864 . . . . 72.33 109.32 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -145.7 -173.89 4.26 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.407 0.683 . . . . 75.42 110.201 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 127' ' ' GLY . . . . . 0.515 ' HA3' HD12 ' A' ' 42' ' ' LEU . . . -157.9 87.76 0.12 Allowed Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.251 -0.431 . . . . 62.33 112.231 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -76.47 -75.37 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.147 -1.057 . . . . 75.34 108.147 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.443 ' HB3' ' H ' ' F' ' 130' ' ' ILE . 9.2 mp 47.58 -146.94 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.734 1.213 . . . . 73.14 111.751 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.443 ' H ' ' HB3' ' F' ' 129' ' ' LEU . 37.4 mm 58.21 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.708 1.203 . . . . 60.05 110.91 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.07 111.17 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.1 -0.955 . . . . 74.14 109.135 177.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 40.6 t80 69.14 112.87 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.94 1.296 . . . . 72.15 110.785 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.42 150.02 19.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.712 2.275 . . . . 73.13 112.264 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.504 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 14.8 tt -142.03 118.02 6.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 109.23 -0.656 . . . . 72.34 109.23 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.23 95.66 5.04 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.033 -0.729 . . . . 65.51 109.033 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 13.6 m -82.49 79.07 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 122.238 1.018 . . . . 75.24 110.354 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -115.13 -176.68 2.96 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.108 -0.951 . . . . 75.42 110.79 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.26 134.22 44.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.485 0.714 . . . . 14.34 112.834 -169.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' D' ' 124' ' ' PRO . 10.3 mp -83.47 43.17 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.612 1.165 . . . . 51.14 110.465 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 31.9 m -75.4 -13.74 60.42 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.345 0.658 . . . . 74.03 111.333 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.41 -27.34 65.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.151 0.98 . . . . 74.52 112.965 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.52 HG21 ' H ' ' D' ' 40' ' ' VAL . 2.9 pp -78.22 2.27 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.524 0.73 . . . . 75.33 112.81 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -103.01 156.82 17.41 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.686 0.794 . . . . 72.31 111.153 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -145.65 45.84 1.29 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.991 0.916 . . . . 71.43 108.532 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt 73.08 -18.35 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.466 1.506 . . . . 70.11 112.886 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.83 92.32 2.51 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.049 0.94 . . . . 60.51 110.493 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 87.2 mt -119.16 35.13 4.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.3 1.04 . . . . 73.42 108.388 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 148' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' D' ' 133' ' ' PHE . 8.5 mp 59.43 67.2 1.94 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 114.059 -1.428 . . . . 71.1 109.589 -163.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.389 2.689 0 C-N-CA 123.762 2.975 . . . . 71.14 111.6 -178.656 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.765 0.317 . . . . 64.35 110.184 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -74.94 92.69 2.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.134 0.574 . . . . 73.34 109.477 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -94.93 33.61 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.654 -0.703 . . . . 53.3 111.094 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -78.79 91.62 4.74 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.139 -1.06 . . . . 62.11 108.139 170.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.439 0.696 . . . . 71.31 110.475 -173.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -149.66 128.7 12.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.188 -0.671 . . . . 73.32 109.188 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -78.91 83.93 4.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.144 -0.687 . . . . 73.44 109.144 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.64 -165.66 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.053 -0.976 . . . . 72.41 110.295 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.46 ' SD ' HG13 ' A' ' 89' ' ' ILE . 58.3 mtt 74.93 177.52 0.22 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.385 1.074 . . . . 51.24 111.96 170.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.6 m -140.93 130.67 24.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.624 0.769 . . . . 62.35 109.498 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -133.17 112.38 11.68 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.744 -1.206 . . . . 74.33 107.744 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -140.06 110.5 6.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.27 -0.641 . . . . 75.3 109.27 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' E' ' 147' ' ' LEU . 1.5 mp -81.11 119.41 30.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 107.559 -1.274 . . . . 64.43 107.559 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.17 -41.49 16.97 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.014 -0.736 . . . . 72.14 109.014 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -168.07 137.47 2.51 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.328 -0.367 . . . . 74.33 110.561 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.642 HG23 HD23 ' A' ' 106' ' ' LEU . 92.0 mt -139.88 98.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.988 -1.115 . . . . 72.15 107.988 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.3 m-85 -163.45 166.02 23.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.102 0.961 . . . . 75.32 109.409 -167.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -74.18 126.33 30.34 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.075 -0.342 . . . . 73.4 110.075 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 41.2 mtpt -85.05 -44.41 13.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.392 0.615 . . . . 63.03 109.456 171.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.5 t70 -135.36 142.1 45.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.71 -1.132 . . . . 73.44 109.885 -176.052 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.5 mt -138.19 140.01 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.453 1.501 . . . . 73.11 107.684 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.74 128.65 10.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.618 . . . . 73.22 109.333 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.0 t80 -134.1 125.07 27.23 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.389 -1.338 . . . . 71.1 107.389 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.75 148.07 49.19 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.039 -0.726 . . . . 65.45 109.039 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.0 77.78 25.48 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 106.628 -1.619 . . . . 74.24 106.628 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.93 -31.86 36.98 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.749 2.299 . . . . 72.13 111.873 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -109.28 32.14 5.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.704 0.802 . . . . 73.41 109.524 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -46.8 99.07 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.262 1.025 . . . . 52.51 113.282 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.61 -12.99 29.73 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.688 1.592 . . . . 72.04 113.167 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -90.14 -11.82 40.06 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.762 0.825 . . . . 74.33 111.698 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 29.9 m -60.24 -15.09 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 113.617 0.969 . . . . 64.34 113.617 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.64 -41.19 65.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 72.35 110.844 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -89.84 -15.61 31.88 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.375 -0.83 . . . . 74.1 110.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 3.7 mmpt? -73.21 129.21 37.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.231 0.612 . . . . 73.32 111.096 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.64 116.73 12.34 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.153 -1.055 . . . . 75.23 108.153 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -71.52 83.49 0.83 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.816 0.817 . . . . 75.21 111.283 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -141.0 80.19 17.39 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.203 -1.777 . . . . 74.23 106.203 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.74 135.36 6.76 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.904 2.403 . . . . 70.31 111.597 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -94.2 100.77 12.78 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 105.862 -1.903 . . . . 55.12 105.862 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.01 90.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.751 0.786 . . . . 60.44 109.068 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 56.7 tttp -86.39 127.67 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.36 -1.291 . . . . 70.44 108.837 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 tp -123.16 144.31 49.43 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.707 -0.849 . . . . 74.03 108.707 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.32 144.74 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.752 -0.833 . . . . 75.14 108.752 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.96 124.06 17.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.15 0.58 . . . . 74.32 110.272 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 20.7 t70 -123.5 148.04 46.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.994 1.317 . . . . 62.41 109.513 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.6 m -139.54 136.77 34.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.039 0.536 . . . . 73.12 110.579 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -146.29 127.64 14.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.28 0.632 . . . . 54.01 110.527 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -89.07 161.13 16.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.579 0.752 . . . . 74.31 109.87 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 47.2 t -167.33 116.67 0.83 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.991 -0.374 . . . . 74.34 109.991 -174.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -71.25 104.17 3.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.452 0.701 . . . . 75.43 110.011 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 57' ' ' GLU . 86.6 mt -77.95 -38.8 44.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.861 0.865 . . . . 72.45 111.044 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.92 -172.35 4.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.889 0.875 . . . . 71.33 109.776 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -57.21 97.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.188 0.595 . . . . 73.53 111.183 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 10.4 m-20 58.39 32.95 22.68 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.201 1.4 . . . . 70.44 112.299 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 59.9 t -107.72 120.57 59.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.651 -1.611 . . . . 73.52 106.651 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.0 m-85 -130.89 128.5 40.69 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.952 -0.759 . . . . 75.32 108.952 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 51' ' ' LEU . 40.2 tt0 -91.81 123.16 34.99 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.901 -0.777 . . . . 72.3 108.901 172.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 33.2 m -99.75 122.09 51.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 107.543 -1.28 . . . . 70.43 107.543 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.497 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.9 t -100.49 130.13 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.14 -0.689 . . . . 75.55 109.14 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.7 112.97 26.26 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.425 -1.324 . . . . 73.31 107.425 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttm-85 -93.14 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.715 -1.217 . . . . 74.22 107.715 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.65 124.36 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.517 -0.92 . . . . 63.54 108.517 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -123.64 129.75 51.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.781 0.432 . . . . 62.45 109.952 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 53.0 t -123.63 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.541 1.136 . . . . 73.34 109.883 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 m -103.46 141.16 36.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.963 -0.384 . . . . 64.22 109.963 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.66 103.0 8.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.39 -1.337 . . . . 52.0 107.39 168.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 34.3 m -112.0 125.3 53.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.476 0.655 . . . . 73.41 109.401 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.9 mp -102.32 86.67 2.87 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.753 -1.943 . . . . 73.43 105.753 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -122.91 5.96 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.931 -0.868 . . . . 71.45 110.931 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.64 -23.78 24.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.235 0.614 . . . . 70.52 110.104 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.91 108.93 19.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.336 0.654 . . . . 65.13 111.17 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -74.39 117.35 16.11 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.373 0.669 . . . . 71.02 109.517 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -59.57 -54.86 41.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.553 0.741 . . . . 54.12 109.529 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -156.56 153.67 29.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.36 -1.291 . . . . 71.43 111.526 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -125.49 135.85 52.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.906 1.282 . . . . 73.22 108.732 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.0 m -120.35 140.61 51.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 71.01 109.247 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -147.43 125.59 12.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.784 -0.821 . . . . 71.33 108.784 166.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.34 109.64 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.211 1.005 . . . . 53.32 108.511 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 79.2 mt-30 -86.8 84.86 7.28 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.332 -0.849 . . . . 64.25 109.098 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -76.36 96.6 4.04 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.088 -1.414 . . . . 53.43 109.548 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.74 145.68 18.04 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.81 -0.516 . . . . 74.11 111.81 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.536 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.97 122.65 2.38 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.719 -0.952 . . . . 72.13 110.719 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 48.0 mt -82.3 125.02 39.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 109.268 -0.642 . . . . 74.32 109.268 174.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 13' ' ' ILE . 55.4 m-85 -130.93 120.35 23.44 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.698 -0.853 . . . . 71.43 108.698 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 36.1 t -96.35 107.02 19.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 24.04 109.111 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.612 ' HB ' HD13 ' A' ' 89' ' ' ILE . 42.9 pt -130.45 127.79 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.148 0.579 . . . . 73.2 110.767 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.85 134.18 27.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.627 0.771 . . . . 60.24 109.926 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.15 7.8 62.02 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 123.549 0.531 . . . . 60.34 113.237 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.612 HD13 ' HB ' ' A' ' 86' ' ' ILE . 4.5 mp -109.32 136.03 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.238 -1.023 . . . . 73.41 108.238 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 13.4 tt0 -159.62 -178.14 6.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.13 0.572 . . . . 72.54 109.52 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.515 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.39 -143.23 36.94 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.659 -0.246 . . . . 65.05 112.821 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -68.93 -17.79 64.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.063 0.945 . . . . 63.42 112.116 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -67.92 -57.7 5.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.599 0.76 . . . . 74.21 109.312 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.7 ttp -65.27 -40.42 93.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.93 1.292 . . . . 62.55 111.236 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.12 70.3 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.002 0.814 . . . . 75.31 110.044 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -64.27 -48.49 75.53 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 114.401 -1.272 . . . . 75.3 111.309 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 36.3 m -71.01 -45.23 64.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.969 1.1 . . . . 75.4 113.969 -165.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -83.26 -15.19 51.25 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.044 0.387 . . . . 74.41 112.044 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.56 -3.94 18.04 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 114.727 0.651 . . . . 73.34 114.727 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.97 -60.58 0.46 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.591 0.696 . . . . 70.1 110.941 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.507 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.2 t80 -57.55 -62.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.163 0.985 . . . . 74.52 112.394 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.01 -39.0 2.09 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.182 -1.372 . . . . 73.43 112.924 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HA ' HD12 ' A' ' 106' ' ' LEU . 10.4 Cg_endo -57.29 -37.86 96.53 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.703 1.602 . . . . 64.43 113.399 165.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.96 -37.71 86.7 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.079 0.4 . . . . 71.03 110.531 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 mm -58.26 -40.57 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.999 0.92 . . . . 51.33 110.946 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.642 HD23 HG23 ' A' ' 16' ' ' ILE . 94.6 mt -70.74 -31.54 68.41 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.672 -0.695 . . . . 64.23 111.84 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.08 -43.73 98.68 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 124.845 1.258 . . . . 64.14 114.251 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.32 -35.48 83.99 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.415 2.077 . . . . 70.43 114.219 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.02 -22.37 45.56 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.606 0.362 . . . . 75.22 111.485 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.4 65.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.531 -0.544 . . . . 71.11 109.531 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.414 HH22 ' HB3' ' A' ' 130' ' ' PRO . 42.1 ttm180 -56.75 -42.31 79.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.648 1.179 . . . . 75.01 110.975 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' HG2' HH12 ' B' ' 120' ' ' ARG . 21.9 tt0 -48.71 -56.55 8.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.211 1.404 . . . . 63.42 111.372 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.72 -48.69 68.44 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.82 -1.537 . . . . 74.53 111.363 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.8 mt -57.35 -54.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 124.14 0.9 . . . . 71.1 110.565 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -61.54 -34.48 75.63 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.83 0.706 . . . . 71.54 111.801 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -67.84 -44.92 76.06 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.248 -0.433 . . . . 61.44 110.347 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 mtp -55.62 -45.16 77.57 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.802 0.841 . . . . 62.43 110.978 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -61.89 -46.96 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.603 1.161 . . . . 72.4 111.135 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 88.3 p -73.06 -24.68 60.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.077 -0.511 . . . . 63.21 111.84 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.482 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.8 mtt-85 -74.96 -24.07 58.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.244 0.618 . . . . 64.14 110.627 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.31 16.23 24.67 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.537 0.523 . . . . 74.11 112.421 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 t 52.38 28.89 6.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.224 2.21 . . . . 71.14 112.848 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -94.06 140.11 22.79 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.133 -1.062 . . . . 74.12 108.133 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 144.25 99.53 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.53 2.154 . . . . 73.2 111.07 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -54.79 132.62 46.45 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.724 0.64 . . . . 64.33 112.338 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.08 98.85 4.54 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.607 -1.627 . . . . 73.34 106.607 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.21 126.15 43.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.481 0.658 . . . . 61.41 109.927 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 pp -68.91 141.47 55.02 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.598 -1.183 . . . . 73.04 111.382 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.18 142.54 84.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.402 0.681 . . . . 73.52 110.113 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.414 ' HB3' HH22 ' A' ' 111' ' ' ARG . 60.6 Cg_endo -74.57 136.68 21.7 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.408 2.072 . . . . 75.31 111.349 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.05 111.41 29.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.234 -1.395 . . . . 62.24 107.234 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -85.82 75.86 9.98 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.694 0.759 . . . . 75.21 110.621 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.16 -40.58 90.42 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.291 -1.322 . . . . 71.11 110.559 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -50.69 73.0 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.258 -0.883 . . . . 75.0 111.67 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.12 90.73 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.691 0.619 . . . . 64.24 110.805 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.01 -46.94 84.46 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.115 0.566 . . . . 73.24 110.802 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.25 -49.83 25.61 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.826 -0.625 . . . . 71.42 110.408 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.557 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 59.0 mtp -80.41 -23.29 40.47 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.228 0.825 . . . . 73.2 113.228 -166.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -61.28 -39.25 89.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.345 0.593 . . . . 74.55 109.419 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -80.3 -34.64 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.835 -1.075 . . . . 74.44 110.819 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 64.6 tp -67.32 -53.74 26.99 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.072 0.549 . . . . 72.34 111.504 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -158.49 -0.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.559 0.744 . . . . 72.42 112.422 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 66.12 163.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.778 1.231 . . . . 71.33 112.005 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -69.5 100.11 1.36 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.892 -0.505 . . . . 75.13 109.852 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.48 16.28 5.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.1 0.96 . . . . 71.42 109.995 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.33 145.04 17.45 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.729 -0.669 . . . . 75.13 113.121 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -113.01 135.71 53.48 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.153 0.981 . . . . 72.31 109.197 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.27 77.98 2.03 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.569 -0.613 . . . . 73.24 111.569 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 m -71.46 117.29 12.82 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.355 0.662 . . . . 75.13 110.764 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -69.06 93.16 0.56 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.321 0.648 . . . . 64.21 110.979 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -79.8 -42.15 25.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.076 -1.453 . . . . 70.25 107.076 163.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 62.58 100.66 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.679 . . . . 74.42 112.936 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -74.07 110.62 8.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.07 -1.085 . . . . 61.35 108.07 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -84.11 -68.98 0.67 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.318 0.647 . . . . 73.0 110.729 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' E' ' 143' ' ' TYR . . . . . . . . 0 C--O 1.245 0.856 0 CA-C-N 115.262 -0.881 . . . . 64.44 110.144 -169.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.674 -0.861 . . . . 72.41 108.674 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.6 m -69.93 94.73 0.87 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.597 -0.52 . . . . 64.32 109.597 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.64 99.42 0.32 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.391 -0.822 . . . . 52.32 109.286 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -170.06 174.94 5.25 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.504 1.122 . . . . 73.31 108.558 -176.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.633 HD21 ' N ' ' E' ' 108' ' ' ASP . 88.9 m-20 76.28 164.62 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.011 1.324 . . . . 72.51 111.786 173.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -142.55 -54.51 0.42 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.139 0.975 . . . . 73.02 108.676 -172.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.532 HG22 ' H ' ' B' ' 9' ' ' MET . 21.5 m 71.17 150.1 0.09 Allowed 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.096 1.358 . . . . 71.41 111.807 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -39.16 72.69 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.838 -0.43 . . . . 64.44 109.838 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.532 ' H ' HG22 ' B' ' 7' ' ' THR . 15.9 ptm 50.65 -177.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.788 2.035 . . . . 50.53 114.243 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.9 p -145.75 133.22 20.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.832 0.853 . . . . 72.41 108.805 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.442 ' HD1' HG22 ' B' ' 86' ' ' ILE . 91.4 t80 -129.71 139.17 51.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.648 0.779 . . . . 72.33 109.857 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' F' ' 145' ' ' LYS . 49.5 tp60 -160.37 143.04 13.24 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.278 0.361 . . . . 71.54 111.494 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.61 HG21 HG13 ' B' ' 16' ' ' ILE . 3.7 mp -86.02 123.11 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.493 -0.928 . . . . 75.41 108.493 173.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -40.03 24.4 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.739 0.416 . . . . 73.55 110.395 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -161.36 136.62 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.274 -0.421 . . . . 74.31 110.43 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.61 HG13 HG21 ' B' ' 13' ' ' ILE . 67.0 mt -115.91 139.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 107.101 -1.444 . . . . 72.31 107.101 168.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.52 164.78 14.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.982 0.896 . . . . 74.33 112.461 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.5 m -96.87 125.61 41.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.066 -1.425 . . . . 74.44 108.821 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.445 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -97.64 -32.85 11.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.654 0.782 . . . . 74.12 110.372 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.18 138.58 18.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.966 -0.561 . . . . 51.23 110.641 -168.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.481 HD11 ' SG ' ' B' ' 113' ' ' CYS . 45.7 mm -141.01 142.17 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.381 1.473 . . . . 74.22 108.86 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 87.1 p -138.84 145.61 40.22 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.562 -0.903 . . . . 63.33 108.562 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.0 t80 -152.19 109.79 3.61 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.006 -1.479 . . . . 63.21 107.006 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -118.21 114.39 22.95 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.494 0.718 . . . . 72.22 109.213 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -109.54 87.27 5.13 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.904 0.882 . . . . 72.53 109.214 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.12 -24.98 16.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.781 2.321 . . . . 71.52 112.59 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.42 18.5 14.33 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.784 0.834 . . . . 74.13 110.447 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.807 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.37 -49.11 55.11 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 125.446 1.499 . . . . 50.41 114.249 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 18.1 Cg_exo -65.49 -29.19 53.35 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.103 1.868 . . . . 72.22 112.118 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -99.55 -8.97 23.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.011 0.925 . . . . 71.41 112.836 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.55 -14.07 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.597 0.592 . . . . 72.33 112.597 -167.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.82 -21.69 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.955 0.502 . . . . 73.02 111.583 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -76.57 -13.41 60.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.948 0.899 . . . . 63.02 111.37 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.661 ' HB3' HD22 ' B' ' 68' ' ' LEU . 35.5 mmtp -102.43 101.7 11.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.703 0.801 . . . . 71.22 110.85 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -96.13 84.47 3.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.36 -0.978 . . . . 72.53 108.36 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -164.69 166.38 20.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.43 1.092 . . . . 65.11 108.207 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.46 127.36 55.08 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-O 119.203 -0.427 . . . . 72.23 110.127 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.74 133.57 25.93 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.015 1.81 . . . . 74.31 112.086 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.92 107.34 5.25 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 108.441 -0.948 . . . . 75.33 108.441 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.08 133.99 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.965 0.412 . . . . 73.44 109.962 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -114.78 104.06 11.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.625 -0.88 . . . . 74.23 108.625 166.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' B' ' 42' ' ' LEU . 2.1 pp -94.92 141.52 28.55 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.876 -1.056 . . . . 71.1 108.823 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -162.9 147.16 11.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.913 -0.773 . . . . 71.14 108.913 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.96 152.5 24.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 74.11 109.933 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -141.33 150.47 42.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.047 1.339 . . . . 64.15 108.109 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.486 HG21 ' NE1' ' E' ' 120' ' ' TRP . 39.4 p -119.56 137.43 53.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 74.23 111.148 -175.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -130.83 150.1 52.16 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.651 1.181 . . . . 60.33 108.133 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -142.67 162.21 36.06 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.689 0.395 . . . . 70.04 110.234 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -165.84 148.21 7.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.102 0.961 . . . . 70.51 109.206 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -119.29 125.33 48.83 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.075 -0.713 . . . . 62.31 109.075 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.71 -46.65 8.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.528 0.731 . . . . 73.21 110.053 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -148.7 178.1 8.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.076 -0.966 . . . . 44.45 110.133 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.42 114.06 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.04 0.936 . . . . 64.34 110.201 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 69.98 3.16 4.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.685 1.194 . . . . 53.11 112.913 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 61.7 t -108.66 95.76 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.673 -1.232 . . . . 73.3 107.673 176.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -112.83 135.98 52.98 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.52 -0.919 . . . . 72.52 108.52 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.59 107.3 16.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.882 0.873 . . . . 74.3 108.686 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.54 133.68 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.498 0.719 . . . . 74.45 109.828 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 35.4 t -112.33 120.8 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 70.04 109.686 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.95 121.37 35.35 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.497 -1.297 . . . . 73.23 107.497 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -111.05 119.48 39.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.378 -0.601 . . . . 71.04 109.378 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.83 111.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.544 -0.91 . . . . 64.32 108.544 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 49.6 m -97.35 135.99 38.45 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.236 -0.653 . . . . 75.31 109.236 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.596 HG11 HD13 ' B' ' 126' ' ' LEU . 79.5 t -132.69 134.1 58.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 123.485 0.714 . . . . 63.22 109.247 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.8 m -124.71 148.24 48.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.368 1.067 . . . . 74.23 108.167 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 148.49 32.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 122.803 0.441 . . . . 70.2 109.967 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 m -138.23 124.01 19.9 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.837 0.711 . . . . 74.42 109.934 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' B' ' 34' ' ' LYS . 0.7 OUTLIER -104.45 119.36 38.79 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.127 -1.064 . . . . 73.44 108.127 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -112.08 3.41 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.024 -0.83 . . . . 72.02 111.024 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -119.64 13.8 12.54 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.875 0.87 . . . . 51.11 110.949 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.36 167.41 22.98 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.667 0.787 . . . . 63.43 110.271 -170.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -62.09 134.46 56.62 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.663 0.602 . . . . 74.13 110.846 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -90.18 -57.68 2.76 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.911 -1.144 . . . . 73.11 107.911 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -160.92 169.08 23.33 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 113.697 -1.592 . . . . 73.23 109.779 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.2 mt -135.32 140.95 45.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.616 -1.624 . . . . 75.23 106.616 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -155.19 142.53 19.5 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.545 -0.539 . . . . 62.32 109.545 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -158.81 133.24 7.95 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.158 -0.682 . . . . 73.24 109.158 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.402 HG23 HG12 ' B' ' 114' ' ' ILE . 93.2 t -124.41 148.1 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.674 0.79 . . . . 51.13 109.342 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -123.16 100.52 6.91 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.439 -0.949 . . . . 75.04 108.439 169.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -86.91 99.05 11.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.269 -1.011 . . . . 73.24 108.269 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.65 157.92 26.92 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.147 -0.781 . . . . 74.21 111.147 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.75 134.03 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.958 -0.457 . . . . 45.35 111.958 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.9 121.22 39.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.739 -0.837 . . . . 72.42 108.739 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -123.82 136.45 54.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 74.3 110.091 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -99.26 108.37 20.91 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.606 1.162 . . . . 74.04 108.021 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.6 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.7 137.94 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.847 0.859 . . . . 71.23 108.825 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 132.26 10.17 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.16 -1.052 . . . . 60.22 108.16 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.6 11.36 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.385 -0.675 . . . . 54.03 113.744 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.605 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 27.2 pt -50.16 146.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 123.779 0.832 . . . . 73.01 111.989 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -150.71 156.27 40.98 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.043 0.757 . . . . 74.31 113.043 -167.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.66 -126.28 41.55 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.763 -1.562 . . . . 34.11 113.481 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.43 -38.09 42.19 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.57 0.748 . . . . 52.14 109.981 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -67.41 -21.95 65.55 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.634 -1.166 . . . . 73.35 110.839 -171.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.605 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 49.3 ttm -54.37 -49.23 70.32 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.275 1.03 . . . . 72.23 110.762 169.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.39 69.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.445 -1.252 . . . . 74.33 111.761 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 69.2 m-70 -74.76 -18.85 60.42 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.522 0.329 . . . . 65.02 111.875 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.59 -56.15 8.1 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.404 0.621 . . . . 65.44 110.324 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.404 HD23 ' SG ' ' B' ' 102' ' ' CYS . 87.3 mt -86.97 -22.34 25.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.215 -0.902 . . . . 64.41 112.026 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.74 -15.7 41.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 113.897 0.319 . . . . 23.12 113.897 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -129.51 -55.83 1.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 117.101 0.45 . . . . 72.33 111.955 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -70.22 -49.29 51.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.006 0.522 . . . . 74.42 111.547 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.5 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.18 -50.79 84.43 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.568 -0.729 . . . . 75.21 112.505 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.5 Cg_exo -58.53 -31.55 94.64 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.25 1.967 . . . . 72.12 113.577 173.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.43 -27.41 63.27 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.621 0.369 . . . . 60.52 111.231 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.405 HG23 ' NH2' ' D' ' 111' ' ' ARG . 97.5 mt -70.25 -43.36 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.591 0.756 . . . . 74.14 109.714 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.62 -17.71 61.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.047 -0.979 . . . . 71.44 111.529 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.35 -51.3 81.12 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.791 1.236 . . . . 71.05 113.886 -170.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.495 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 28.6 Cg_endo -60.29 -33.06 94.87 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.957 1.772 . . . . 75.45 113.047 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.13 -43.97 73.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.095 0.558 . . . . 75.22 111.038 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.69 98.38 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.268 0.627 . . . . 44.32 110.501 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 29.7 mtp-105 -54.21 -57.73 10.07 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.503 1.121 . . . . 73.21 111.427 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.59 -26.56 64.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.414 -0.812 . . . . 75.44 110.287 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.76 -46.32 69.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.446 0.299 . . . . 65.13 110.44 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.402 HG12 HG23 ' B' ' 78' ' ' VAL . 69.3 mt -60.97 -48.03 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.058 0.543 . . . . 73.41 109.585 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -55.15 -43.65 74.41 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.438 -1.256 . . . . 61.23 111.429 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -65.68 -45.02 84.45 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.648 -0.706 . . . . 51.35 110.838 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -71.91 -35.96 69.86 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.038 0.535 . . . . 74.42 111.392 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.618 HG22 ' HB2' ' B' ' 123' ' ' PHE . 9.1 p -75.35 -28.55 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.073 -0.512 . . . . 73.02 110.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 69.9 m -63.14 -35.64 80.95 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.437 0.695 . . . . 61.22 110.855 173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.1 mtt-85 -69.57 -19.14 63.68 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 114.721 -1.127 . . . . 74.53 111.385 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 13.63 61.13 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.179 -0.789 . . . . 74.42 114.74 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.5 p 70.06 13.44 7.82 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.034 1.733 . . . . 71.12 113.038 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.618 ' HB2' HG22 ' B' ' 118' ' ' VAL . 73.2 m-85 -104.18 145.56 30.89 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 119.246 -0.407 . . . . 72.11 110.259 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.31 165.28 5.78 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.619 2.879 . . . . 53.12 113.825 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -61.06 155.66 19.8 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.297 -0.865 . . . . 73.33 111.915 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.596 HD13 HG11 ' B' ' 64' ' ' VAL . 87.6 mt -131.44 84.0 2.14 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.915 -0.772 . . . . 52.32 108.915 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.411 ' HB3' HH21 ' B' ' 111' ' ' ARG . 35.6 m-80 -106.65 100.36 9.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.788 -1.096 . . . . 74.11 108.376 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.58 133.88 53.21 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.169 -0.923 . . . . 63.03 109.312 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.54 150.13 94.19 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.074 0.55 . . . . 63.53 110.808 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.48 96.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.043 2.496 . . . . 73.0 112.565 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.43 117.56 33.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.567 -0.901 . . . . 43.22 108.567 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.15 97.63 5.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.024 -1.472 . . . . 73.12 107.024 170.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 19.2 m-85 -55.82 -30.2 61.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.135 0.974 . . . . 71.34 110.664 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.11 -36.45 81.79 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.614 -1.175 . . . . 72.34 111.076 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.14 -51.87 64.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.579 0.752 . . . . 71.13 111.127 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.91 -32.74 74.59 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.731 0.644 . . . . 65.35 110.118 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 0.2 OUTLIER -62.91 -45.02 94.48 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.532 0.733 . . . . 74.32 109.18 175.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.0 mmt -66.91 -28.59 68.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.759 0.823 . . . . 73.24 111.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -72.54 -38.58 67.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.194 0.598 . . . . 72.34 110.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.65 -25.43 66.57 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.351 -0.84 . . . . 74.24 110.655 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 49.2 mt -105.77 18.61 21.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 64.32 111.54 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.13 74.74 0.68 Allowed 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.982 0.896 . . . . 73.51 110.265 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -151.63 145.22 24.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.295 1.438 . . . . 75.32 108.291 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.73 140.24 15.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.55 0.74 . . . . 73.51 109.335 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.31 -48.52 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.43 0.692 . . . . 45.11 110.264 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.54 -167.49 54.33 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.421 -0.809 . . . . 75.43 112.668 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.37 162.09 24.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.743 0.817 . . . . 70.23 109.415 174.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.93 14.09 8.81 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.005 -0.543 . . . . 44.55 111.785 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.1 m -65.07 116.49 6.53 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.844 0.858 . . . . 75.03 110.191 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -151.58 133.28 14.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.965 0.906 . . . . 62.51 109.273 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -156.58 167.75 29.48 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.718 -0.845 . . . . 64.2 108.718 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 72.2 t60 75.68 136.26 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.954 1.302 . . . . 75.1 111.967 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -121.28 140.16 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.249 1.019 . . . . 74.4 109.182 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.72 174.34 8.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.89 0.476 . . . . 72.12 109.867 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 N-CA-C 109.103 -0.703 . . . . 65.52 109.103 178.394 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.106 -0.701 . . . . 75.42 109.106 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.401 ' HB3' ' HB1' ' F' ' 122' ' ' ALA . 21.6 p -105.23 104.03 13.68 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.819 0.847 . . . . 65.15 110.451 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -101.31 13.92 33.57 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.516 0.726 . . . . 62.53 111.193 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -79.19 73.55 5.77 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 74.42 108.842 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -100.43 103.16 14.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.909 0.883 . . . . 75.32 109.356 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.13 -30.28 0.63 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.764 0.826 . . . . 75.34 110.316 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m 71.04 -74.27 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.364 1.466 . . . . 72.01 110.999 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 64.79 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.263 1.425 . . . . 74.25 111.154 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.3 ttm 66.01 123.93 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.793 1.237 . . . . 73.01 111.441 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -85.56 87.34 7.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.146 -1.057 . . . . 34.24 108.146 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -105.58 136.41 45.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.874 -1.057 . . . . 72.53 109.19 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -152.92 132.83 13.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.246 0.618 . . . . 74.23 109.705 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.55 105.72 11.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.157 -1.053 . . . . 65.3 108.157 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.7 mm-40 -78.92 -41.58 29.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.893 -0.594 . . . . 64.1 110.11 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 ttt85 -170.79 157.17 5.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.668 0.605 . . . . 74.23 110.996 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.51 145.92 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 107.194 -1.41 . . . . 70.44 107.194 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -173.86 162.25 3.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.648 0.737 . . . . 73.14 109.866 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -80.14 111.76 16.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.868 -1.06 . . . . 63.43 108.249 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.86 -45.75 81.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.098 -1.075 . . . . 74.33 108.098 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.2 t70 -140.37 140.99 35.65 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 113.57 -1.65 . . . . 72.15 109.697 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.3 mt -131.46 145.58 34.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 106.907 -1.516 . . . . 72.54 106.907 170.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -153.82 146.63 24.34 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.338 0.59 . . . . 71.21 109.602 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -146.25 144.02 29.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.555 -1.276 . . . . 71.12 107.555 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -138.48 144.95 40.27 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.674 1.189 . . . . 73.23 107.835 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -150.6 80.04 7.02 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 106.683 -1.599 . . . . 63.34 106.683 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.73 -37.11 16.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.578 2.185 . . . . 63.11 111.349 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' C' ' 71' ' ' GLU . 1.7 m-20 -107.93 27.65 9.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.472 1.109 . . . . 72.22 109.439 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.508 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -50.17 -51.88 58.7 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.888 1.275 . . . . 53.01 113.889 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 66.3 Cg_endo -86.57 -19.21 2.91 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 121.67 1.58 . . . . 64.25 113.321 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -68.18 -21.64 64.88 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.983 0.913 . . . . 71.41 112.553 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.61 -5.49 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 123.343 0.657 . . . . 74.25 112.506 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.573 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 19.8 m-85 -67.42 -27.7 67.28 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.349 0.66 . . . . 65.23 112.451 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 29.0 7.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.485 0.714 . . . . 62.05 109.368 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.8 155.33 41.25 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.299 0.64 . . . . 72.4 111.253 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.71 129.99 39.48 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.385 -1.279 . . . . 73.33 110.572 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' E' ' 137' ' ' GLU . 32.0 p90 -84.53 65.65 9.09 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 122.19 0.995 . . . . 74.22 111.933 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -151.54 60.42 3.75 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 115.564 -0.744 . . . . 73.44 110.673 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' E' ' 139' ' ' LEU . 14.8 Cg_exo -67.38 153.92 75.43 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.21 1.94 . . . . 72.23 110.498 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.72 109.15 17.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.828 -1.545 . . . . 71.01 106.828 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.424 HG13 HD11 ' C' ' 126' ' ' LEU . 77.8 t -75.25 106.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.891 -1.05 . . . . 70.11 110.646 -174.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.727 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 6.4 mtpm? -103.35 143.88 32.09 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.272 1.029 . . . . 61.33 108.323 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -128.87 164.05 23.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.79 0.436 . . . . 73.4 110.896 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.41 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.0 t70 -154.29 125.91 7.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.428 -0.805 . . . . 71.52 108.991 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -115.4 112.07 21.77 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.646 -1.242 . . . . 75.33 107.646 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -126.68 119.98 28.33 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.609 -1.256 . . . . 71.2 107.609 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -118.42 150.42 39.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.389 -0.597 . . . . 71.11 109.389 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.09 171.96 13.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 71.23 109.13 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -146.83 143.39 28.56 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.843 -0.799 . . . . 61.55 108.843 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.7 t -145.0 126.39 14.9 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.307 -0.997 . . . . 42.33 108.307 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -80.1 117.33 20.81 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.525 -0.546 . . . . 73.52 109.525 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' C' ' 57' ' ' GLU . 69.9 mt -86.73 -45.5 10.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.684 0.793 . . . . 55.05 110.087 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.79 -165.15 2.19 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.66 -0.7 . . . . 62.42 111.132 -173.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.13 102.03 0.19 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.1 0.875 . . . . 60.22 110.966 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 63.72 18.5 11.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.154 0.982 . . . . 73.54 111.884 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -106.96 114.22 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.27 -1.011 . . . . 73.24 108.27 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -122.0 124.82 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.151 0.98 . . . . 54.4 108.891 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.616 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.8 tt0 -89.59 114.99 26.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.177 0.991 . . . . 75.32 109.245 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -95.86 129.47 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.089 -1.078 . . . . 73.52 108.089 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 t -120.64 106.53 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.667 -0.864 . . . . 65.12 108.667 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.9 102.41 14.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.473 -0.936 . . . . 64.53 108.473 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.407 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 33.3 ttm105 -79.51 107.3 12.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.587 -0.894 . . . . 74.13 108.587 168.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -99.96 124.28 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.137 -1.431 . . . . 60.44 107.137 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.9 m -123.74 119.59 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.785 -0.821 . . . . 73.33 108.785 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 77.7 t -111.01 129.41 66.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.739 -1.119 . . . . 64.54 108.626 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.727 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.5 m -122.69 138.17 54.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.722 0.809 . . . . 71.42 109.164 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.62 100.88 6.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.281 -1.377 . . . . 72.02 107.281 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -140.63 118.21 11.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.827 -0.805 . . . . 63.32 108.827 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.26 -40.18 85.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 75.44 110.238 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.12 -79.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.482 -1.047 . . . . 75.52 110.482 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.0 -32.01 16.95 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.727 0.811 . . . . 60.21 109.434 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.53 ' HG3' ' ND2' ' C' ' 27' ' ' ASN . 40.8 tt0 -88.69 121.32 30.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.194 0.997 . . . . 73.1 111.096 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.6 m -84.23 126.71 33.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.999 0.52 . . . . 72.15 110.107 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.93 -55.21 5.83 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.817 0.847 . . . . 72.32 109.105 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.57 165.44 34.49 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.581 -1.19 . . . . 74.13 110.84 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.474 HD23 HG23 ' C' ' 65' ' ' THR . 3.0 tm? -135.05 144.92 47.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.271 -1.381 . . . . 54.13 107.271 174.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.409 ' N ' HD13 ' C' ' 75' ' ' LEU . 43.6 t -144.8 143.96 30.91 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.158 -0.682 . . . . 72.1 109.158 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -153.17 134.18 14.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.143 0.577 . . . . 73.24 109.507 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' C' ' 110' ' ' ALA . 39.8 t -133.09 113.55 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.236 1.014 . . . . 72.43 108.444 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -92.73 90.6 7.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.914 0.885 . . . . 55.21 108.73 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.3 tp-100 -82.97 105.97 14.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.081 -0.963 . . . . 72.52 109.897 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.11 147.54 18.63 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.79 -0.524 . . . . 64.21 111.79 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.555 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.63 123.46 2.16 Favored Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.759 -0.937 . . . . 70.42 110.759 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.2 mm -80.65 118.51 28.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.931 -1.137 . . . . 72.24 107.931 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -132.75 130.8 40.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.468 0.707 . . . . 73.4 109.534 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 m -81.49 115.55 20.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.053 -0.721 . . . . 50.11 109.053 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.657 HG13 HD21 ' C' ' 98' ' ' LEU . 27.3 mm -116.73 100.89 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.404 -0.961 . . . . 71.23 108.404 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.92 168.45 19.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.323 0.649 . . . . 54.15 110.179 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.29 -56.27 4.25 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.028 -0.533 . . . . 70.43 112.354 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -104.01 163.08 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.826 0.85 . . . . 62.14 109.472 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.8 -177.12 5.55 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.729 0.412 . . . . 71.01 111.543 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.42 -144.76 48.9 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.485 -0.78 . . . . 53.43 114.818 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 43.7 p -68.67 -19.89 64.42 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.65 0.78 . . . . 73.31 111.863 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -67.02 -41.66 86.25 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.231 1.012 . . . . 74.3 110.305 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -83.14 -23.21 33.08 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.366 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -71.45 -25.8 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.096 0.559 . . . . 52.21 111.256 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 29.5 t-80 -63.58 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.796 0.438 . . . . 64.44 110.221 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.559 ' HG ' ' HG ' ' C' ' 102' ' ' CYS . 17.6 t -76.61 -60.36 2.38 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.202 -0.666 . . . . 62.35 109.202 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.657 HD21 HG13 ' C' ' 86' ' ' ILE . 98.6 mt -60.72 -26.83 67.45 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.062 0.945 . . . . 43.05 113.065 -174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.19 10.86 33.85 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.545 -0.586 . . . . 64.32 113.902 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -155.05 -60.64 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.584 0.692 . . . . 73.44 111.698 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' C' ' 104' ' ' ASN . 65.1 t80 -75.13 -42.47 56.21 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.877 0.695 . . . . 74.33 112.877 -170.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.559 ' HG ' ' HG ' ' C' ' 97' ' ' CYS . 63.3 m -66.44 -49.39 52.83 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.207 0.603 . . . . 55.24 111.708 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.46 -18.25 43.68 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 121.594 1.529 . . . . 73.24 113.265 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 27.1 t-20 -57.13 -41.75 79.65 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.549 0.69 . . . . 72.32 109.92 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.45 -38.58 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.141 -1.391 . . . . 64.14 110.875 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.555 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.5 mt -81.29 -34.25 32.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.193 -0.912 . . . . 72.13 112.369 -170.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -54.66 -45.73 99.48 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 124.299 1.04 . . . . 74.0 113.527 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.71 -52.03 7.4 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.795 2.33 . . . . 72.11 113.686 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -63.91 -48.71 75.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.357 -0.838 . . . . 74.13 111.732 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.52 -41.23 96.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.085 0.554 . . . . 72.51 111.735 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -64.16 -44.53 91.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.2 0.937 . . . . 62.42 110.592 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -70.65 -31.87 68.95 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.522 -0.763 . . . . 63.52 110.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.8 -34.2 77.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.093 0.557 . . . . 65.3 110.436 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.09 -42.21 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.369 0.668 . . . . 73.52 110.379 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 81.6 m -62.2 -30.93 71.42 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.004 0.522 . . . . 64.03 110.284 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -70.86 -54.18 12.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.634 0.773 . . . . 73.22 109.912 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.48 -45.93 66.35 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.482 1.113 . . . . 73.02 112.385 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.01 -42.33 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.907 0.883 . . . . 70.32 110.834 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -64.21 -32.53 74.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.933 -0.576 . . . . 74.2 111.02 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.49 -35.46 73.25 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.387 -0.824 . . . . 63.52 109.696 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.98 2.76 67.83 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.683 0.614 . . . . 72.53 113.188 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 54.38 48.12 21.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.088 1.755 . . . . 75.44 112.184 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 90.9 m-85 -115.02 149.29 42.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 114.083 -1.417 . . . . 72.24 108.091 169.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.5 154.98 22.52 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.654 2.902 . . . . 60.51 113.844 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -58.11 150.44 21.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.893 0.877 . . . . 74.11 112.753 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.424 HD11 HG13 ' C' ' 40' ' ' VAL . 1.9 tt -145.47 85.97 1.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.298 -1.371 . . . . 64.02 107.298 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.05 108.29 19.77 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.834 -1.076 . . . . 62.05 108.349 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 130.41 46.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.294 1.038 . . . . 74.22 109.964 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.32 137.17 97.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.677 0.791 . . . . 72.52 111.685 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.433 ' HG2' HD21 ' E' ' 147' ' ' LEU . 35.9 Cg_endo -65.68 122.64 10.32 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.747 2.298 . . . . 75.53 112.04 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 109.86 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.137 -1.06 . . . . 44.24 108.137 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.678 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 4.0 m-20 -87.2 63.62 7.92 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.978 0.911 . . . . 75.25 109.579 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -77.13 -43.95 32.21 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.021 -0.536 . . . . 72.23 110.582 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.41 -39.32 90.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.829 0.851 . . . . 51.4 110.457 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -69.62 -31.22 69.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.533 -1.212 . . . . 64.43 111.455 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 47.7 tp -59.67 -31.04 69.19 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.541 1.136 . . . . 54.42 112.282 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.44 -43.16 77.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.845 0.458 . . . . 74.33 110.464 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 68.5 mtm -77.73 -41.71 36.79 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.622 0.769 . . . . 72.1 112.014 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.83 -36.13 70.1 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.571 0.748 . . . . 75.45 111.657 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -68.35 -88.91 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.154 -0.927 . . . . 75.43 109.217 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tt 25.34 -97.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.941 2.096 . . . . 74.3 111.973 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 164.82 124.37 0.01 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.126 2.57 . . . . 75.31 105.9 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -132.19 126.16 32.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.338 -1.356 . . . . 64.33 107.338 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -167.74 106.29 0.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.303 0.641 . . . . 72.14 109.583 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -166.35 160.95 16.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.961 0.904 . . . . 72.43 109.364 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.75 174.64 20.97 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.711 -0.556 . . . . 75.15 111.711 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -151.48 -39.86 0.12 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.566 0.746 . . . . 64.32 109.423 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.99 -150.13 17.65 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 114.915 -1.039 . . . . 65.33 110.892 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 96.2 m -149.03 129.78 14.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.816 0.846 . . . . 71.0 109.134 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.03 104.01 2.0 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.888 -1.153 . . . . 71.02 107.888 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.86 126.15 26.69 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.157 0.983 . . . . 74.44 111.703 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -132.61 60.56 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.217 1.007 . . . . 62.44 108.594 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -120.6 101.53 7.81 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.992 -1.004 . . . . 71.33 109.752 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -77.4 135.91 38.36 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.34 -0.615 . . . . 54.43 109.34 173.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 123.688 0.795 . . . . 72.05 109.217 179.494 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.764 -0.458 . . . . 70.44 109.764 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 74.0 m -76.54 81.82 3.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.783 0.802 . . . . 70.23 109.75 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 51.27 1.17 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.369 -1.287 . . . . 73.32 108.533 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -60.03 105.64 0.42 Allowed 'General case' 0 C--N 1.348 0.535 0 CA-C-N 114.269 -1.332 . . . . 72.32 110.462 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -62.21 145.86 52.39 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.393 -0.821 . . . . 75.15 109.246 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -60.42 -63.33 1.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.519 -0.919 . . . . 75.33 108.519 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m 64.99 178.4 0.19 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.121 0.968 . . . . 71.42 110.372 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.13 143.85 43.11 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.108 -0.995 . . . . 75.23 109.725 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.552 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm -31.88 128.26 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.497 1.519 . . . . 73.22 113.33 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.4 m -132.88 139.56 47.47 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.152 -1.055 . . . . 62.34 108.152 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' D' ' 85' ' ' SER . 45.3 t80 -159.07 98.06 1.43 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.01 0.819 . . . . 72.31 108.792 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.21 115.39 24.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.61 0.764 . . . . 71.52 109.618 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' D' ' 84' ' ' PHE . 3.9 tp -77.61 104.38 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 108.408 -0.96 . . . . 70.32 108.408 171.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -84.62 -39.13 19.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.11 -0.95 . . . . 64.11 111.833 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.573 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 65.2 ttt180 -165.41 127.5 2.07 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.587 -0.279 . . . . 71.41 110.354 -166.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.508 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.4 mp -112.65 129.1 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.323 -1.362 . . . . 73.22 107.323 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -165.49 176.91 7.81 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 122.176 0.989 . . . . 74.14 113.117 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -108.32 119.36 39.26 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.02 -1.446 . . . . 65.13 108.36 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 39.7 mtpt -86.94 -17.94 31.94 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.32 -0.622 . . . . 73.44 109.32 173.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.769 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.5 t70 -155.7 140.24 16.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.924 . . . . 75.24 109.817 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' C' ' 117' ' ' MET . 58.5 mt -139.92 140.02 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.548 1.539 . . . . 75.33 107.786 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -143.84 136.84 27.49 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.457 0.703 . . . . 63.43 109.473 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.8 t80 -142.8 116.9 9.46 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.98 -1.859 . . . . 71.44 105.98 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' D' ' 26' ' ' PRO . 44.7 mt-10 -127.32 116.27 20.27 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.108 -0.701 . . . . 72.22 109.108 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -107.47 88.79 4.37 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 123.313 0.645 . . . . 75.34 109.559 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' D' ' 24' ' ' GLU . 16.6 Cg_exo -71.01 -38.7 4.78 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.222 2.615 . . . . 64.11 112.49 -173.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -118.24 40.86 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.221 1.008 . . . . 51.1 110.035 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.748 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.84 -57.8 17.56 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 114.976 1.473 . . . . 73.4 114.976 -169.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.53 -3.83 10.76 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 121.619 1.614 . . . . 65.44 112.266 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.98 -45.03 13.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.06 1.344 . . . . 74.31 109.804 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.97 -19.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.734 0.814 . . . . 73.41 110.312 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.5 -23.86 64.85 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.309 1.043 . . . . 75.24 111.791 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -79.61 -3.24 46.2 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.503 0.721 . . . . 73.12 111.769 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -121.59 110.02 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.635 0.774 . . . . 65.4 110.082 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.61 93.52 4.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.851 0.861 . . . . 73.41 109.744 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -169.05 158.37 8.48 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.45 1.1 . . . . 75.23 108.49 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' F' ' 139' ' ' LEU . 1.8 mp0 -76.49 111.93 18.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.825 0.85 . . . . 70.01 110.033 174.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.438 ' HD2' HD13 ' F' ' 139' ' ' LEU . 84.5 Cg_exo -52.64 128.1 26.93 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.048 2.498 . . . . 63.45 112.599 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -67.43 118.74 11.17 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.165 -0.679 . . . . 75.14 109.165 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.516 HG11 HD11 ' D' ' 126' ' ' LEU . 98.8 t -99.36 133.46 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.223 -0.899 . . . . 65.3 110.819 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -101.8 142.79 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.422 -0.955 . . . . 71.42 108.422 166.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.31 126.03 54.55 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.721 -0.844 . . . . 72.42 108.721 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 22.7 t70 -121.94 149.22 43.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.1 . . . . 74.11 108.142 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.16 151.39 49.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.863 0.465 . . . . 64.52 110.855 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.1 t70 -155.83 155.6 33.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.178 0.991 . . . . 73.3 108.82 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -133.45 160.03 38.62 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.278 0.631 . . . . 72.23 109.67 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 164.51 37.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.682 -0.858 . . . . 62.32 108.682 174.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -148.36 159.84 43.61 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.964 0.411 . . . . 62.31 111.136 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -160.86 126.71 3.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.33 1.052 . . . . 72.03 109.785 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -87.51 120.34 28.71 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.859 -0.793 . . . . 73.2 108.859 171.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -91.95 -40.96 10.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.766 -0.652 . . . . 72.54 110.182 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.59 -168.74 1.9 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.508 -0.769 . . . . 73.4 110.433 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.44 115.81 3.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.97 -1.013 . . . . 72.13 110.275 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.74 5.24 3.25 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.622 1.169 . . . . 64.24 112.318 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.93 120.23 59.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 107.531 -1.285 . . . . 74.02 107.531 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -131.47 161.79 31.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 64.22 108.96 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' D' ' 51' ' ' LEU . 6.6 tm-20 -132.43 136.92 47.08 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.085 -1.45 . . . . 63.54 107.085 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 134.8 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.748 -0.834 . . . . 73.52 108.748 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.5 t -107.48 128.18 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.752 0.821 . . . . 53.1 109.575 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -102.08 121.99 43.25 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.394 -1.336 . . . . 63.52 107.394 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.9 ttm180 -104.36 108.42 19.82 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.33 -0.989 . . . . 63.4 108.33 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.9 t -95.2 127.73 46.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 107.715 -1.217 . . . . 43.03 107.715 166.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.5 m -118.27 127.13 53.43 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.773 0.797 . . . . 53.54 109.846 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 53.7 t -115.01 114.29 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 125.879 1.671 . . . . 60.44 108.245 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -112.19 97.8 6.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.525 -0.917 . . . . 51.24 108.525 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.19 129.91 43.38 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.046 -0.724 . . . . 70.01 109.046 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 34.9 p -145.49 128.79 16.8 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.125 -0.695 . . . . 72.33 109.125 -175.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -123.23 123.91 41.83 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.476 -0.935 . . . . 54.14 108.476 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -116.0 4.57 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.516 0.51 . . . . 72.13 112.494 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -123.44 26.5 7.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.023 0.529 . . . . 64.33 110.464 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.69 155.19 49.39 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 123.64 0.776 . . . . 74.25 110.053 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -78.7 117.12 19.54 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 109.696 -0.483 . . . . 72.55 109.696 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.39 -61.55 1.79 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.589 0.755 . . . . 61.42 110.025 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.1 170.01 19.93 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.658 -1.156 . . . . 61.52 109.819 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 80.0 mt -126.74 145.54 50.56 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.385 1.074 . . . . 74.4 108.721 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.51 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.8 m -143.07 136.06 27.95 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.689 -1.226 . . . . 70.03 107.689 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -156.74 121.01 4.4 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.531 -0.914 . . . . 74.24 108.531 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -130.76 117.82 39.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 122.988 0.515 . . . . 52.55 109.635 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.769 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -89.74 87.46 7.0 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.057 0.848 . . . . 73.13 109.079 170.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -79.5 98.57 6.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.393 -1.276 . . . . 70.43 109.171 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.25 144.3 17.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 116.437 -0.347 . . . . 63.4 112.292 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -146.91 135.76 5.86 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.999 -0.441 . . . . 43.1 111.999 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.18 128.48 43.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 123.717 0.807 . . . . 71.01 109.877 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' D' ' 13' ' ' ILE . 63.4 m-85 -130.23 137.05 49.84 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 74.0 109.811 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 18.6 m -77.73 103.68 7.81 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.144 -1.058 . . . . 72.23 108.144 168.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.43 106.65 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.72 -0.844 . . . . 74.04 108.72 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -148.65 167.83 24.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.289 1.036 . . . . 72.5 109.628 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.14 6.08 67.72 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.49 -0.323 . . . . 71.32 113.799 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 tp -141.08 143.73 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 54.21 109.444 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 -172.05 4.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.107 0.563 . . . . 73.23 110.818 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.67 -138.82 22.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.52 0.513 . . . . 64.21 113.382 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -83.86 -24.2 30.99 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.509 0.724 . . . . 70.41 111.001 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -70.69 -32.97 70.39 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.11 0.564 . . . . 72.51 111.846 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -30.35 67.31 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 110.161 -0.311 . . . . 75.14 110.161 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.88 68.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.535 0.734 . . . . 74.34 110.405 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -65.2 -36.74 85.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.353 -0.84 . . . . 72.53 110.613 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.1 -47.29 65.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.995 -0.548 . . . . 63.34 110.022 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -73.15 -27.48 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.621 0.768 . . . . 74.45 111.452 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.34 5.06 33.38 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.361 -0.688 . . . . 70.12 114.526 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.46 -58.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 117.88 0.84 . . . . 62.15 111.534 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -70.92 -54.41 11.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.141 0.576 . . . . 71.33 112.17 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 66.2 m -62.11 -46.13 91.26 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 123.852 0.861 . . . . 73.14 112.072 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.529 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.6 Cg_exo -57.24 -36.05 98.97 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.409 2.073 . . . . 64.23 113.436 169.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -62.66 -34.74 77.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.95 0.5 . . . . 75.41 111.187 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -66.75 -40.22 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.007 0.923 . . . . 74.13 110.616 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' D' ' 82' ' ' GLY . 87.3 mt -74.51 -21.49 59.52 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.702 -0.681 . . . . 71.44 111.548 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -62.68 -46.0 88.5 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 114.143 1.164 . . . . 73.21 114.143 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -51.95 -38.22 68.61 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.056 1.837 . . . . 70.24 113.227 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -79.31 -34.71 42.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.099 0.96 . . . . 74.04 111.618 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -48.63 73.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.359 0.664 . . . . 71.11 109.862 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.405 ' NH2' HG23 ' B' ' 105' ' ' ILE . 41.5 ttp180 -57.54 -45.44 85.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.365 -1.289 . . . . 74.23 110.749 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.45 -46.5 89.8 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.097 0.873 . . . . 72.42 111.109 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.33 -41.7 85.19 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.719 0.637 . . . . 44.11 111.353 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.416 HG21 HG21 ' D' ' 64' ' ' VAL . 90.4 mt -63.14 -56.12 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.214 -0.903 . . . . 63.1 110.372 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.4 m -53.43 -39.03 64.06 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.582 1.153 . . . . 72.52 112.046 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -71.78 -41.05 68.81 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.422 -0.808 . . . . 65.21 110.813 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.29 -31.59 72.8 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.71 0.404 . . . . 74.33 111.408 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.416 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.2 t -68.23 -42.35 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 62.54 110.252 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 72.8 p -74.18 -26.4 60.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.36 0.264 . . . . 62.11 111.25 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.63 -29.69 59.25 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.548 0.739 . . . . 74.41 110.049 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 2.96 87.5 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.645 -0.707 . . . . 74.53 112.051 171.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 14.7 p 63.84 18.01 10.89 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.094 2.158 . . . . 63.11 114.267 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 59.6 m-85 -87.65 166.2 26.21 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.847 1.259 . . . . 73.13 109.948 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 56.5 Cg_endo -68.13 134.17 30.88 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.142 1.895 . . . . 75.24 111.143 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.37 143.47 34.31 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.201 0.6 . . . . 63.13 110.534 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.516 HD11 HG11 ' D' ' 40' ' ' VAL . 4.4 tt -110.5 111.62 22.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.282 -1.007 . . . . 74.31 108.282 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -98.96 87.11 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.16 117.1 7.98 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.109 -0.95 . . . . 71.21 108.647 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HB2' HE22 ' B' ' 12' ' ' GLN . . . -53.84 136.57 55.62 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.89 0.876 . . . . 61.43 111.568 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 13.6 Cg_exo -68.91 122.59 9.5 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.222 1.948 . . . . 71.31 110.446 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.82 144.82 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.171 0.588 . . . . 73.3 109.415 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -74.3 94.68 2.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.467 -0.938 . . . . 62.44 108.467 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -61.84 -30.23 70.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.343 -0.844 . . . . 73.0 111.649 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.77 -50.52 66.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.777 0.831 . . . . 74.23 110.417 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.23 76.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.402 0.681 . . . . 61.3 111.93 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.42 -37.12 63.43 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.393 -0.822 . . . . 72.41 109.588 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -69.26 -30.44 68.57 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.756 0.822 . . . . 70.33 110.967 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 43.0 mtt -63.42 -32.73 74.25 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.501 0.72 . . . . 71.54 110.776 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -67.88 -38.32 82.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.158 0.583 . . . . 74.41 110.329 174.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.94 -39.61 90.15 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.152 0.981 . . . . 75.42 111.558 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.98 -29.64 70.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.393 0.677 . . . . 70.52 111.617 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -83.2 6.92 17.74 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.804 0.842 . . . . 73.04 111.87 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -120.6 90.9 3.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.964 0.905 . . . . 73.32 109.268 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -142.53 153.89 43.99 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.959 1.304 . . . . 65.51 108.587 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.57 146.49 25.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.702 0.401 . . . . 72.03 110.859 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.22 113.15 4.17 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.221 -0.752 . . . . 42.13 111.221 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.73 108.21 13.25 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.448 0.699 . . . . 72.53 110.685 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.92 139.46 25.22 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.013 -0.835 . . . . 70.14 111.013 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 43.2 p -99.85 -58.46 1.91 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 117.65 0.725 . . . . 55.51 109.967 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 58.63 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.761 1.224 . . . . 75.1 110.373 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.32 161.79 27.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.509 0.724 . . . . 75.14 110.784 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -92.47 157.3 16.64 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.487 1.115 . . . . 72.33 109.397 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -101.54 -101.12 0.26 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 109.284 -0.636 . . . . 72.11 109.284 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -158.07 13.84 0.21 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.915 0.886 . . . . 71.54 111.319 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 C-N-CA 124.553 1.141 . . . . 73.33 110.845 -172.174 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 108' ' ' ASP . . . . . 0.633 ' N ' HD21 ' B' ' 5' ' ' ASN . 22.0 t70 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 109.444 -0.576 . . . . 74.24 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -154.79 -144.94 0.15 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.0 1.32 . . . . 65.21 107.598 -171.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.39 91.46 0.08 Allowed 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.627 -0.509 . . . . 63.51 109.627 170.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -82.89 161.03 22.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.11 0.964 . . . . 74.21 110.911 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -71.51 178.86 3.26 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.154 0.982 . . . . 72.23 111.891 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.84 158.86 33.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.923 0.489 . . . . 64.45 110.507 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 68.68 129.81 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.993 1.317 . . . . 72.55 111.457 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.522 HD22 HG12 ' B' ' 86' ' ' ILE . 5.6 mp -86.96 48.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 74.21 109.964 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -168.85 90.9 0.6 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.977 -0.749 . . . . 75.02 108.977 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.587 ' HD3' ' SD ' ' B' ' 94' ' ' MET . 93.6 Cg_endo -86.23 -2.12 8.61 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.874 2.382 . . . . 74.0 113.78 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.21 163.61 12.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.625 0.77 . . . . 70.23 110.206 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 25.4 p -90.23 -48.74 6.96 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.639 0.776 . . . . 52.14 109.752 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.486 ' NE1' HG21 ' B' ' 46' ' ' THR . 3.8 t-105 60.09 35.08 21.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 71.24 110.777 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -77.45 -28.83 52.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.798 0.839 . . . . 34.54 110.746 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.05 81.88 5.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.728 0.811 . . . . 73.43 110.539 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -126.96 113.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.003 0.921 . . . . 71.24 109.064 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -137.03 142.42 42.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.996 0.918 . . . . 70.43 109.991 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -146.81 56.92 1.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.261 1.029 . . . . 74.45 109.47 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -77.09 80.81 3.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.664 -1.153 . . . . 72.35 109.408 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.69 -48.68 0.3 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.942 -0.572 . . . . 64.35 112.197 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt 65.77 85.8 0.14 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.654 1.181 . . . . 75.12 109.944 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.02 140.95 14.9 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.945 -0.761 . . . . 71.23 108.945 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 tt -162.62 -53.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.157 0.583 . . . . 72.43 110.676 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 131.69 52.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.323 0.649 . . . . 73.23 110.483 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 132' ' ' TYR . . . . . 0.722 ' HB3' ' HB2' ' E' ' 135' ' ' ALA . 61.6 t80 -70.04 140.59 88.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 107.955 -1.128 . . . . 74.43 107.955 168.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.74 -40.32 31.33 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.549 2.833 . . . . 64.51 114.656 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 134' ' ' ILE . . . . . 0.457 HG23 ' HD1' ' C' ' 32' ' ' PHE . 0.3 OUTLIER -118.97 38.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.695 1.236 . . . . 71.43 109.409 -176.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' E' ' 132' ' ' TYR . . . -87.0 34.26 0.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.018 . . . . 71.13 111.087 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 24.7 t 65.29 112.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 C-N-CA 125.458 1.503 . . . . 74.54 110.421 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 137' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 37.5 tt0 -79.75 162.84 24.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.428 -0.952 . . . . 73.32 108.428 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -46.16 128.39 9.47 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.813 1.245 . . . . 41.23 112.473 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 139' ' ' LEU . . . . . 0.473 ' HG ' ' HD2' ' C' ' 38' ' ' PRO . 10.1 mp -61.13 93.24 0.03 OUTLIER 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.289 0.993 . . . . 55.34 110.01 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.1 m -78.08 -7.91 57.56 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.149 . . . . 75.32 111.397 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 tt -91.22 105.41 17.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.07 -1.085 . . . . 72.45 108.07 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 14.9 tt -168.38 153.57 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.677 0.791 . . . . 74.11 109.209 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 143' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 155' ' ' ALA . 26.5 p90 -67.89 159.54 30.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.44 0.696 . . . . 55.42 110.582 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.22 90.05 1.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.389 -0.597 . . . . 74.22 109.389 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 145' ' ' LYS . . . . . 0.541 ' HA ' ' HE3' ' E' ' 145' ' ' LYS . 0.7 OUTLIER -132.8 82.86 2.02 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.488 -0.56 . . . . 73.34 109.488 178.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.43 -156.01 0.23 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.399 1.08 . . . . 74.5 111.77 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 147' ' ' LEU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 13' ' ' ILE . 3.7 tt -151.83 142.74 23.02 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.002 -1.481 . . . . 61.55 107.002 172.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.407 ' N ' HD23 ' E' ' 147' ' ' LEU . 7.1 mp -56.55 137.25 76.94 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 123.544 0.738 . . . . 75.21 110.746 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--N 1.377 2.065 0 C-N-CA 122.754 2.303 . . . . 65.21 111.869 173.823 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.013 -0.366 . . . . 52.22 110.013 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 63.97 39.48 7.98 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.954 1.301 . . . . 71.54 111.98 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.35 -76.04 0.45 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.071 0.548 . . . . 40.14 110.433 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 66.6 t80 71.85 -22.82 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.38 1.472 . . . . 75.5 113.655 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -60.87 -30.83 70.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.202 1.001 . . . . 75.23 111.56 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 31.2 t70 55.89 -94.38 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.98 1.312 . . . . 72.31 111.409 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -161.91 122.65 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.408 0.683 . . . . 75.13 109.296 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 89' ' ' ILE . 16.1 tp -94.57 59.28 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.161 0.584 . . . . 54.41 109.875 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -168.61 63.16 0.54 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.626 0.771 . . . . 65.42 109.734 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.27 10.82 2.65 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.109 2.539 . . . . 70.45 113.562 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -110.45 132.29 54.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.177 0.591 . . . . 72.33 109.862 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 66.9 p -106.28 124.29 49.36 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.03 0.932 . . . . 63.21 109.276 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.64 77.96 6.22 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.45 0.7 . . . . 75.22 110.482 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.91 98.23 9.66 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.785 -1.561 . . . . 65.5 106.785 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 122' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' C' ' 2' ' ' SER . . . -151.9 -87.53 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.376 0.67 . . . . 64.33 109.819 -174.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -176.41 150.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.398 1.079 . . . . 73.12 108.942 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -76.49 -59.92 2.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.246 -1.02 . . . . 73.25 108.246 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -167.4 -178.19 3.92 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.283 -0.872 . . . . 73.15 109.932 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.68 124.63 6.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.214 -0.661 . . . . 54.0 109.214 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.51 162.25 10.29 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.348 0.405 . . . . 64.32 113.176 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 128' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' F' ' 128' ' ' LYS . 0.0 OUTLIER -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.949 1.3 . . . . 54.12 108.717 175.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -151.25 146.89 26.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.12 0.568 . . . . 63.45 109.769 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 10.8 tp -132.21 1.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 124.562 1.145 . . . . 71.41 108.637 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 63.61 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.328 1.451 . . . . 53.15 110.37 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -163.78 118.32 1.08 Allowed Pre-proline 0 C--O 1.245 0.828 0 N-CA-C 107.482 -1.303 . . . . 42.53 107.482 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.05 84.66 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.293 1.995 . . . . 73.41 111.037 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.406 HG12 HG13 ' F' ' 136' ' ' VAL . 9.4 tt -68.1 -31.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 115.423 -0.808 . . . . 64.42 110.206 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 73.67 -9.74 1.17 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.767 1.227 . . . . 61.33 114.209 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.406 HG13 HG12 ' F' ' 134' ' ' ILE . 20.0 m -53.97 134.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.216 0.606 . . . . 52.35 111.137 176.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -156.39 142.54 18.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.19 0.596 . . . . 75.51 110.231 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.14 79.74 0.14 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 124.575 1.172 . . . . 42.31 111.866 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.438 HD13 ' HD2' ' D' ' 38' ' ' PRO . 20.3 tp -65.7 100.62 0.55 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.601 -0.727 . . . . 72.11 109.954 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 37.5 m -116.45 -125.19 0.28 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 114.526 -1.216 . . . . 63.55 109.33 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 79.6 mt 64.84 19.63 11.9 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.684 1.194 . . . . 75.42 112.072 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.65 172.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.157 0.983 . . . . 54.32 109.824 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -59.0 137.52 57.9 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.223 0.609 . . . . 61.01 110.163 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 144' ' ' ASN . . . . . 0.405 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 28.7 p30 -152.52 161.26 42.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.498 0.319 . . . . 64.34 111.59 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 145' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' B' ' 12' ' ' GLN . 49.3 tttm 78.36 -42.27 0.33 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.991 2.116 . . . . 74.43 111.866 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.48 146.23 42.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.641 0.776 . . . . 71.22 110.397 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 19.0 tp -129.41 5.87 5.23 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.038 0.935 . . . . 75.12 109.788 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp 54.88 73.03 0.95 Allowed Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.342 1.457 . . . . 72.21 111.006 -172.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 122.599 2.2 . . . . 54.22 112.67 -178.757 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 111.556 0.206 . . . . 72.52 111.556 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 p -84.37 124.7 31.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.944 0.498 . . . . 64.14 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -153.76 139.81 18.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.372 1.069 . . . . 75.34 109.402 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -121.79 -170.01 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 53.43 109.945 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -60.83 112.13 1.92 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.954 -1.128 . . . . 70.44 107.954 172.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -72.45 -77.4 0.1 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.975 0.91 . . . . 71.21 110.849 -168.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -143.48 107.08 4.61 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.923 0.889 . . . . 70.13 108.946 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.02 89.44 1.12 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.93 -1.137 . . . . 70.11 107.93 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 89' ' ' ILE . 65.4 mtt -143.8 175.89 9.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.273 1.029 . . . . 73.0 109.902 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -141.9 99.42 3.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 71.42 108.694 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -137.9 113.51 9.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.709 -0.848 . . . . 73.52 108.709 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -142.0 137.88 31.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 75.5 109.769 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.37 133.44 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 71.42 109.929 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.92 -42.31 11.28 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.65 -0.5 . . . . 72.35 109.65 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.541 ' HD2' HD12 ' A' ' 83' ' ' ILE . 11.9 ptp180 -175.56 146.07 0.76 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.067 -0.969 . . . . 72.3 109.39 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.505 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 77.2 mt -137.03 125.98 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.123 -1.065 . . . . 72.4 108.123 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.531 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 22.2 p90 -164.75 161.65 20.69 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.805 0.842 . . . . 74.32 110.635 -170.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -75.83 123.25 25.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.092 -0.504 . . . . 72.21 109.825 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.1 mtpt -86.99 -32.05 20.27 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.695 0.398 . . . . 70.41 109.999 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -147.28 144.94 29.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.524 -0.762 . . . . 64.3 109.907 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.2 mt -134.99 146.4 30.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 125.451 1.5 . . . . 63.32 107.674 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 t -149.33 138.78 21.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.306 0.642 . . . . 72.41 109.812 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -147.19 126.95 13.43 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.12 -1.437 . . . . 74.55 107.12 175.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.86 127.54 29.03 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.564 -0.902 . . . . 64.4 108.564 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -119.18 86.61 32.91 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 109.007 -0.738 . . . . 63.14 109.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -34.47 27.03 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.165 2.577 . . . . 73.11 113.081 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 2.4 m-80 -109.84 33.94 4.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.549 0.74 . . . . 70.3 109.926 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -52.88 -48.51 91.17 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 113.727 1.01 . . . . 73.21 113.727 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.5 Cg_exo -68.62 -30.94 27.53 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 121.674 1.582 . . . . 74.4 112.214 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -75.8 -21.89 56.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.697 0.799 . . . . 74.14 111.825 -170.336 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' ASN . 57.9 t -53.61 -27.24 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 123.773 0.829 . . . . 75.5 111.848 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -78.82 -39.03 36.67 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.746 0.818 . . . . 74.51 111.047 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -88.29 -26.64 22.17 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.302 0.641 . . . . 70.33 112.383 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HB2' HD12 ' A' ' 68' ' ' LEU . 55.8 mtpt -80.5 163.49 23.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.15 0.58 . . . . 62.31 111.234 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.06 115.84 15.13 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.457 0.703 . . . . 71.05 109.331 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.592 ' HZ3' ' HB2' ' F' ' 133' ' ' PRO . 23.1 p-90 -73.24 86.01 1.42 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.987 0.915 . . . . 75.4 111.445 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.53 80.63 65.69 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 124.031 0.932 . . . . 74.55 108.899 171.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.45 121.71 8.47 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.876 2.384 . . . . 74.45 111.872 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.86 105.96 18.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.378 -0.971 . . . . 72.24 108.378 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.09 92.47 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.705 -0.85 . . . . 64.2 108.705 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.2 tttm -100.33 115.29 29.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.92 0.888 . . . . 72.31 109.139 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.422 HD11 ' HG ' ' F' ' 129' ' ' LEU . 4.2 mp -100.84 141.91 33.05 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.028 0.531 . . . . 74.13 109.808 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.698 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.5 m-20 -128.19 111.68 13.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.265 -1.383 . . . . 74.52 107.265 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 131' ' ' VAL . 75.2 mt -109.74 119.89 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.753 -0.462 . . . . 72.51 109.753 -174.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -130.31 137.46 49.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.051 0.94 . . . . 74.11 109.463 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.6 m -117.07 132.97 56.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.572 0.749 . . . . 75.33 109.902 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.03 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.641 1.176 . . . . 74.4 109.036 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -132.54 158.94 40.86 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.594 0.758 . . . . 75.41 110.43 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -157.17 157.34 34.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.458 1.103 . . . . 75.05 110.009 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -113.95 136.97 52.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.776 0.83 . . . . 54.4 109.572 174.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.03 -33.91 3.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.134 0.573 . . . . 73.51 111.209 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.46 -174.04 4.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.232 0.613 . . . . 62.22 110.199 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.1 117.01 9.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.457 0.703 . . . . 72.13 109.487 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 67.62 14.65 9.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.481 1.112 . . . . 72.14 111.816 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -118.93 104.93 16.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.478 -0.934 . . . . 64.21 108.478 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -125.53 126.65 45.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.67 0.788 . . . . 75.24 109.116 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -92.48 130.04 38.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.747 1.219 . . . . 74.4 109.432 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.402 HG11 ' HD3' ' A' ' 103' ' ' PRO . 65.4 t -114.28 123.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.956 -1.127 . . . . 65.13 107.956 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.5 t -106.52 134.96 46.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.617 0.767 . . . . 61.52 109.277 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.9 113.93 27.83 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.296 -1.372 . . . . 64.31 107.296 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -96.6 100.72 12.27 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.988 -1.115 . . . . 75.35 107.988 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 HD22 ' A' ' 60' ' ' LEU . 11.1 t -101.84 131.61 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.525 -0.917 . . . . 73.1 108.525 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.698 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.1 m -116.6 137.15 52.4 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.784 -1.191 . . . . 63.32 107.784 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 114' ' ' ILE . 86.3 t -128.72 128.05 67.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.567 -2.012 . . . . 74.24 105.567 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 27.6 m -124.67 139.24 54.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.934 -1.506 . . . . 62.45 106.934 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.95 119.75 20.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.403 -0.962 . . . . 62.44 108.403 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 68.5 m -107.07 131.37 54.17 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.369 -0.604 . . . . 73.4 109.369 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -88.94 76.22 7.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.559 -1.275 . . . . 71.24 107.559 -175.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.36 -102.2 2.26 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.324 -1.51 . . . . 71.41 109.324 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.56 -27.82 4.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.373 0.669 . . . . 74.35 110.096 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.44 131.44 34.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.936 0.894 . . . . 73.24 108.59 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 24.5 m -62.01 130.17 44.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.052 . . . . 61.35 113.205 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -76.89 -59.3 2.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.433 1.093 . . . . 51.22 109.307 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -161.83 174.48 13.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.631 -1.168 . . . . 72.21 111.112 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.0 tp -137.69 145.26 42.38 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 71.24 108.329 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.566 ' HB3' HG23 ' A' ' 114' ' ' ILE . 70.2 m -146.99 104.44 3.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.914 0.885 . . . . 71.4 110.165 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.21 126.35 38.95 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.895 0.478 . . . . 72.11 109.774 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.89 112.49 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.871 0.868 . . . . 60.44 109.663 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -85.09 83.39 8.05 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.402 -0.962 . . . . 63.03 108.402 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.14 98.53 5.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.222 -0.899 . . . . 64.21 109.448 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.01 144.49 19.41 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.83 -0.508 . . . . 64.34 111.83 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.21 122.46 2.43 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.114 -1.194 . . . . 64.54 110.114 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.541 HD12 ' HD2' ' A' ' 15' ' ' ARG . 49.5 mt -88.5 129.13 40.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.275 -1.009 . . . . 72.32 108.275 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -129.1 126.02 38.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.652 0.381 . . . . 74.54 110.313 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 p -83.24 100.13 10.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.887 -0.782 . . . . 73.22 108.887 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.5 pt -112.8 137.1 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.798 0.839 . . . . 73.33 111.437 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.18 155.77 11.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.882 1.273 . . . . 33.32 108.964 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.89 86.54 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 120.154 -0.248 . . . . 64.01 113.63 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 HG22 ' SD ' ' A' ' 9' ' ' MET . 44.7 pt -110.47 140.9 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.994 0.918 . . . . 74.11 109.259 -173.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 22.5 tt0 -155.47 177.74 11.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.864 0.466 . . . . 62.52 110.292 -174.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.1 -157.18 43.57 Favored Glycine 0 C--N 1.345 1.07 0 C-N-CA 123.936 0.779 . . . . 72.51 114.127 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 p -71.83 -13.84 61.79 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.797 0.839 . . . . 52.22 111.026 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.12 -46.66 88.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.317 1.047 . . . . 61.35 111.022 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.4 61.96 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.094 -0.335 . . . . 74.33 110.094 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.29 75.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.338 0.655 . . . . 63.42 110.704 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 6.3 t-80 -65.04 -48.12 74.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.764 1.226 . . . . 51.23 110.07 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 13.4 m -73.84 -26.02 60.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.955 1.094 . . . . 53.22 113.955 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.2 mt -97.31 -30.61 12.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.854 0.462 . . . . 74.42 111.332 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -20.34 49.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.098 -0.501 . . . . 73.14 113.217 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.7 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -132.77 -70.7 0.54 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.23 0.455 . . . . 71.3 112.23 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.672 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.1 t80 -45.0 -58.6 3.07 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 124.899 1.279 . . . . 73.01 113.9 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.5 m -72.08 -41.61 8.8 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.323 -0.846 . . . . 65.4 113.166 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD3' HG11 ' A' ' 58' ' ' VAL . 9.3 Cg_endo -60.72 -23.91 77.44 Favored 'Trans proline' 0 C--N 1.388 2.63 0 CA-C-N 121.281 1.493 . . . . 64.42 113.851 165.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -73.19 -35.52 66.4 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 118.71 0.686 . . . . 44.43 110.484 172.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.29 -41.87 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.236 0.615 . . . . 73.02 109.576 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.2 mt -71.47 -24.89 62.08 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.219 -0.901 . . . . 72.21 112.354 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.97 -44.05 70.23 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.825 -1.084 . . . . 74.51 113.859 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.89 -32.64 92.82 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.247 1.965 . . . . 71.4 113.577 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -75.94 -38.58 57.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.247 0.619 . . . . 74.22 110.959 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.53 -46.24 76.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.106 0.562 . . . . 63.11 109.629 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -50.67 -54.28 24.34 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.865 1.353 . . . . 75.52 110.478 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -58.1 -49.47 76.85 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.437 1.085 . . . . 64.03 111.748 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.448 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.1 t -58.99 -43.57 91.47 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.062 0.851 . . . . 64.42 110.934 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 76' ' ' CYS . 84.7 mt -60.55 -55.1 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 123.997 0.811 . . . . 71.22 110.265 174.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -59.71 -34.57 73.08 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.768 1.227 . . . . 73.12 111.837 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.1 t -73.46 -42.13 62.33 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.648 -0.705 . . . . 74.32 110.137 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 7.5 mtp -57.47 -42.2 82.14 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.552 0.741 . . . . 74.42 111.128 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 114' ' ' ILE . 81.0 t -61.14 -46.76 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.619 1.167 . . . . 60.03 111.016 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.2 p -75.76 -26.54 57.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.864 0.466 . . . . 74.43 111.506 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.96 -29.22 64.04 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.566 0.747 . . . . 75.01 109.762 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 1.51 79.52 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.652 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.3 m 68.59 11.69 8.43 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.865 1.266 . . . . 63.22 111.558 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -87.09 150.25 49.32 Favored Pre-proline 0 C--O 1.243 0.75 0 CA-C-N 115.608 -0.724 . . . . 74.32 109.093 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -45.84 112.63 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.144 2.563 . . . . 73.22 112.698 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.05 122.8 10.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.854 1.262 . . . . 64.43 111.656 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.28 96.08 6.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.186 -1.042 . . . . 64.44 108.186 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -99.83 83.57 2.76 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.379 -0.971 . . . . 72.33 108.379 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.2 pt? -59.63 136.88 58.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.003 -0.998 . . . . 74.52 111.941 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.91 148.82 82.74 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.413 1.085 . . . . 65.15 112.018 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 129.74 36.21 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.477 . . . . 75.43 113.72 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.447 HG21 HD11 ' A' ' 44' ' ' LEU . 87.9 t -103.08 122.03 55.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.632 -0.877 . . . . 65.24 108.632 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 25.0 p-10 -88.57 71.25 8.89 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.919 0.888 . . . . 54.41 111.006 -173.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -61.43 -38.76 88.32 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.726 0.774 . . . . 52.42 109.263 176.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.7 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.9 t70 -71.38 -40.78 70.36 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.427 -1.26 . . . . 60.04 111.318 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.666 ' HB3' ' HB2' ' A' ' 132' ' ' ASN . . . -78.75 -29.54 45.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 114.558 -1.201 . . . . 54.12 112.08 -171.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.94 -47.33 86.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.996 -0.742 . . . . 64.15 108.996 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -69.46 -37.44 77.32 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.593 -0.73 . . . . 75.33 110.415 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -62.67 -35.77 80.75 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.885 0.874 . . . . 64.12 111.209 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -57.39 -55.77 30.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.342 0.657 . . . . 70.45 109.832 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -69.16 -33.01 72.73 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.997 -1.001 . . . . 74.32 112.105 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.91 -53.34 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.707 0.629 . . . . 61.42 111.277 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.407 ' H ' ' H ' ' A' ' 143' ' ' GLN . 87.1 mt-30 -160.13 -13.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.093 0.957 . . . . 74.24 111.058 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.407 ' H ' ' H ' ' A' ' 142' ' ' GLN . 51.3 tt0 56.47 81.95 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.256 1.022 . . . . 61.0 109.72 -164.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -93.8 129.25 40.25 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.961 -0.563 . . . . 75.53 110.169 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.01 -49.3 3.66 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 72.25 109.183 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.98 174.43 24.5 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.974 -0.557 . . . . 75.15 112.608 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.9 149.22 17.85 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.056 -0.72 . . . . 71.14 109.056 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.51 -163.32 36.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.181 -0.463 . . . . 54.42 112.654 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.0 m -129.16 -38.98 1.57 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.609 1.164 . . . . 73.42 109.769 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 75.47 149.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.788 1.305 . . . . 73.0 111.649 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 66.7 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.681 1.192 . . . . 64.15 111.146 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -128.72 -21.5 3.4 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.276 0.63 . . . . 75.32 111.473 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -162.93 150.16 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.553 0.341 . . . . 65.42 110.923 -171.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.4 t70 68.47 93.81 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.423 1.489 . . . . 62.14 111.655 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.431 1.093 . . . . 54.04 108.193 176.006 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.04 -0.726 . . . . 51.45 109.04 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.7 m -87.04 167.94 13.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.864 0.865 . . . . 70.55 111.456 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.15 126.06 30.3 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.46 -0.791 . . . . 71.1 109.912 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -81.94 72.57 8.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.484 0.714 . . . . 73.2 110.112 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 m120 59.87 -84.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.073 1.349 . . . . 62.24 111.254 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -167.31 12.44 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.483 1.113 . . . . 61.41 110.765 -178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.5 t -76.85 162.72 27.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.892 0.477 . . . . 75.23 110.69 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 66.88 -173.85 0.19 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.87 1.268 . . . . 71.23 111.513 -171.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.715 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.8 ptm 56.4 173.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 126.457 1.903 . . . . 74.42 115.279 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -137.05 136.92 38.82 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.335 -1.302 . . . . 72.02 107.785 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.04 124.46 40.71 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.32 -0.993 . . . . 74.24 108.32 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -137.43 110.34 7.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.151 0.58 . . . . 54.3 109.596 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.492 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -70.19 115.86 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 109.313 -0.625 . . . . 71.01 109.313 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.84 -51.62 6.28 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.263 0.554 . . . . 75.33 109.653 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -169.71 133.89 1.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.098 -0.956 . . . . 51.34 108.535 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' B' ' 109' ' ' TYR . 73.3 mt -114.75 146.13 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.539 -1.282 . . . . 73.03 107.539 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -168.02 149.67 5.32 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.598 0.592 . . . . 63.44 112.598 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -73.59 124.92 26.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.199 -0.91 . . . . 74.32 108.7 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 38.9 mtpt -98.31 -37.37 9.67 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.347 0.659 . . . . 55.34 110.858 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 26.8 m-20 -148.09 133.51 18.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.064 -0.517 . . . . 60.44 109.91 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.1 mm -130.01 142.58 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 74.12 109.74 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.629 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -133.68 135.34 44.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.311 1.444 . . . . 75.04 108.867 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.51 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.5 t80 -149.63 127.0 11.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.808 -1.182 . . . . 74.23 107.808 166.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.16 126.68 25.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.72 0.808 . . . . 74.55 109.297 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.585 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.19 88.0 53.15 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.136 -0.69 . . . . 72.42 109.136 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.37 -27.47 28.31 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.028 2.485 . . . . 53.11 112.034 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -117.61 28.98 8.11 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.146 0.979 . . . . 73.12 109.019 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.585 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -44.49 -54.19 12.91 Favored Pre-proline 0 C--N 1.366 1.312 0 C-N-CA 124.684 1.194 . . . . 74.44 112.331 167.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.0 Cg_exo -69.32 -19.79 37.77 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.339 2.026 . . . . 51.21 112.498 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 11.5 m-70 -96.67 2.98 52.69 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.238 1.015 . . . . 64.34 111.936 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.47 -32.69 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 112.861 0.689 . . . . 35.02 112.861 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -74.21 -26.69 60.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.17 0.509 . . . . 74.44 110.563 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.87 -16.66 61.12 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.807 1.243 . . . . 73.43 110.523 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 mmmt -101.91 95.46 6.39 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.979 0.912 . . . . 61.11 111.707 -170.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.75 87.14 3.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 64.13 111.062 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -176.96 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.698 1.599 . . . . 75.41 108.136 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -87.98 133.83 36.49 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.254 0.622 . . . . 73.42 109.727 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -65.5 134.78 39.75 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.005 1.803 . . . . 73.14 111.874 170.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.455 ' HG3' ' HE2' ' B' ' 41' ' ' LYS . 16.0 tp10 -63.95 103.93 0.65 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.253 0.621 . . . . 70.13 109.39 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.27 147.94 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 72.05 111.42 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.455 ' HE2' ' HG3' ' B' ' 39' ' ' GLU . 73.4 mmtt -136.48 143.92 44.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.74 1.216 . . . . 74.41 109.423 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -127.48 132.72 49.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.684 0.794 . . . . 74.34 109.269 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 11.6 m-20 -132.14 115.42 15.71 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.281 -1.007 . . . . 74.04 108.281 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.29 135.27 40.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.862 -0.792 . . . . 73.4 108.862 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 31.9 t70 -146.07 149.12 33.47 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.935 0.894 . . . . 75.22 108.953 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.43 HG21 ' HE1' ' E' ' 120' ' ' TRP . 40.9 p -128.97 123.81 33.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.48 0.712 . . . . 72.13 109.602 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -114.48 159.43 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.495 -1.298 . . . . 54.01 107.495 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -145.26 164.23 32.03 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.25 0.548 . . . . 75.53 111.028 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -153.58 143.03 21.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.591 -1.186 . . . . 74.45 107.983 169.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.06 104.9 14.71 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.927 -0.768 . . . . 74.04 108.927 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -73.51 -45.21 55.19 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.032 0.444 . . . . 72.22 109.808 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -178.07 6.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.012 -0.994 . . . . 72.22 110.005 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.35 128.67 35.9 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.957 -1.02 . . . . 61.23 109.186 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 67.42 10.73 7.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.635 1.174 . . . . 51.21 112.061 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.4 t -129.23 99.17 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.31 1.044 . . . . 73.51 108.781 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.925 0.869 . . . . 73.41 111.266 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.98 95.02 2.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.473 -2.418 . . . . 70.54 104.473 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.18 130.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.241 0.543 . . . . 75.12 109.612 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 32.9 t -102.03 143.46 14.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 114.953 -1.022 . . . . 52.23 109.172 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.7 OUTLIER -119.59 111.08 17.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.588 -1.264 . . . . 74.43 107.588 176.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.0 ttt180 -96.69 108.84 21.54 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.072 0.549 . . . . 64.34 110.23 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.1 t -105.88 118.83 54.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.445 -0.946 . . . . 70.21 108.445 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 38.0 m -103.92 141.34 36.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.565 0.746 . . . . 63.53 109.028 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.672 HG21 HG21 ' B' ' 114' ' ' ILE . 47.5 t -129.25 130.82 67.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.367 1.067 . . . . 73.41 108.901 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.3 m -125.42 140.07 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.896 -0.779 . . . . 73.12 108.896 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 131.37 26.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.608 -0.886 . . . . 64.13 108.608 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.486 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.0 p -133.29 126.26 31.06 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.808 -0.441 . . . . 64.11 109.808 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 0.9 OUTLIER -110.86 130.07 55.69 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.67 -1.604 . . . . 71.32 106.67 -176.232 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -119.09 5.7 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.585 -1.006 . . . . 34.21 110.585 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -120.35 3.81 10.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.654 0.782 . . . . 63.54 110.711 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -115.48 165.5 12.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.818 0.847 . . . . 61.22 110.145 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 42.6 m -70.23 131.6 44.46 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.711 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -86.16 -57.99 2.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.024 -1.102 . . . . 74.35 108.024 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -160.27 166.44 29.54 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.327 -1.306 . . . . 73.54 110.679 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.91 136.16 44.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.496 1.518 . . . . 72.34 107.033 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 50.0 t -143.23 147.49 34.92 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.443 -0.947 . . . . 61.45 108.443 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.3 tt0 -162.94 139.1 7.19 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.167 -0.679 . . . . 71.53 109.167 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' B' ' 113' ' ' CYS . 98.7 t -130.95 144.31 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.644 0.778 . . . . 64.45 109.021 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 78.4 mt-30 -122.82 92.91 3.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.624 -0.88 . . . . 73.55 108.624 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -85.43 102.73 13.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.823 -1.08 . . . . 52.2 109.296 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.31 168.71 29.87 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.617 -0.593 . . . . 71.31 111.617 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.25 128.56 1.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 112.084 -0.407 . . . . 51.02 112.084 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.7 mt -83.58 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.075 -1.083 . . . . 74.02 108.075 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -130.13 132.9 46.29 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.022 -0.733 . . . . 54.43 109.022 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -95.82 115.07 26.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.788 -0.819 . . . . 74.13 108.788 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.581 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -129.11 137.37 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.754 1.222 . . . . 64.42 109.212 -175.299 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.8 173.05 16.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.296 0.638 . . . . 60.14 109.896 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.59 -66.7 1.4 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.922 -0.471 . . . . 63.23 111.922 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.715 HG23 ' HB3' ' B' ' 9' ' ' MET . 8.3 pt -60.74 145.11 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.708 0.803 . . . . 71.12 111.887 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.54 146.26 24.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.061 -0.972 . . . . 63.31 109.411 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.08 7.64 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.416 0.448 . . . . 75.45 112.76 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.8 m -70.04 -50.14 44.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.656 0.783 . . . . 74.53 111.124 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -61.46 -24.94 66.91 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.925 0.89 . . . . 73.4 111.696 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' E' ' 115' ' ' LEU . 52.6 ttp -67.24 -40.21 86.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.503 1.121 . . . . 73.0 110.823 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.14 69.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.856 0.862 . . . . 23.33 111.991 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -65.45 -29.65 70.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.231 0.612 . . . . 75.41 111.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.2 -68.53 0.65 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.227 0.211 . . . . 73.44 111.437 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.497 HD23 ' SG ' ' B' ' 102' ' ' CYS . 94.1 mt -75.65 -22.89 56.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.256 0.465 . . . . 74.42 112.256 -172.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.75 -39.52 24.64 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.575 0.547 . . . . 61.12 112.327 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.15 -53.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.783 0.66 . . . . 73.53 112.783 -164.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -66.31 -45.38 80.53 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.311 0.644 . . . . 53.53 112.015 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.497 ' SG ' HD23 ' B' ' 98' ' ' LEU . 71.4 m -63.99 -50.06 71.51 Favored Pre-proline 0 CA--C 1.556 1.191 0 CA-C-O 118.373 -0.823 . . . . 70.33 110.61 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.2 Cg_exo -51.18 -33.03 42.61 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.624 2.216 . . . . 35.15 114.865 165.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 49.7 m-20 -68.75 -25.27 64.65 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 118.355 0.525 . . . . 73.22 112.067 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -42.18 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.377 0.671 . . . . 75.31 109.77 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' B' ' 60' ' ' LEU . 95.8 mt -72.99 -24.73 60.8 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.025 -0.989 . . . . 63.12 110.926 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.17 -50.69 74.34 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.756 -1.116 . . . . 65.3 113.169 -169.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 37.6 Cg_endo -63.17 -32.42 74.29 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 121.638 1.558 . . . . 62.31 112.094 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.7 m-30 -66.42 -43.3 86.09 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.018 0.927 . . . . 70.44 110.454 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.31 87.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.962 0.905 . . . . 61.12 110.204 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -61.68 -52.99 62.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.649 1.58 . . . . 74.35 111.476 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.84 -33.61 75.59 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.079 0.862 . . . . 74.23 109.756 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.7 t -71.94 -34.99 69.47 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.854 -0.612 . . . . 70.15 111.059 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.672 HG21 HG21 ' B' ' 64' ' ' VAL . 53.1 mt -65.22 -54.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.122 -0.696 . . . . 74.34 109.122 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -58.97 -31.33 68.64 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.799 -1.092 . . . . 64.32 110.846 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.5 t -64.61 -55.5 19.92 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.652 0.781 . . . . 70.31 110.159 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.529 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 14.3 mmt -63.23 -36.75 84.69 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.702 0.401 . . . . 72.02 111.619 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.16 -51.63 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.056 0.942 . . . . 74.41 110.687 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.35 -20.24 60.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.067 0.547 . . . . 74.13 111.991 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.4 mtt-85 -68.89 -31.36 70.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.308 0.643 . . . . 75.55 110.28 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.5 14.59 57.64 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 123.854 0.721 . . . . 73.31 112.666 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.516 HG23 ' HB3' ' A' ' 17' ' ' TYR . 74.7 p 55.45 30.7 15.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.83 1.652 . . . . 73.22 112.492 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.46 155.45 39.65 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.928 0.891 . . . . 64.22 109.999 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.07 143.09 99.58 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.029 2.486 . . . . 72.34 113.034 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -59.08 123.11 15.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.76 1.224 . . . . 73.01 111.566 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.15 89.73 3.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.476 0.71 . . . . 71.05 109.849 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.37 100.14 12.52 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.224 -0.898 . . . . 64.12 110.377 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.49 151.02 42.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.203 1.001 . . . . 63.54 112.6 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' E' ' 130' ' ' ILE . . . -75.35 150.43 84.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.641 -0.709 . . . . 72.33 110.682 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.26 110.84 2.55 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.434 2.089 . . . . 64.22 110.044 176.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.49 110.81 21.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 71.55 106.981 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -76.26 91.55 3.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.875 -1.528 . . . . 74.33 106.875 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -53.48 -40.24 65.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.89 -1.05 . . . . 61.21 110.399 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.74 -53.99 27.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.512 1.125 . . . . 72.3 111.688 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -22.38 64.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.613 0.765 . . . . 75.05 111.674 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.33 -51.71 68.38 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.785 0.834 . . . . 54.34 109.793 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.5 ' HB2' ' HZ3' ' E' ' 120' ' ' TRP . 26.8 t80 -76.88 -28.74 55.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.835 -0.621 . . . . 74.44 110.541 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 59.6 ttp -65.39 -31.14 72.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.027 0.531 . . . . 75.02 110.71 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -75.61 -30.85 59.69 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 74.11 110.376 175.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -65.09 -35.59 81.62 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.98 0.419 . . . . 74.11 109.981 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 39.8 mt -93.96 36.02 1.13 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.035 0.934 . . . . 34.34 109.906 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -57.6 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.07 0.948 . . . . 73.25 111.562 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -136.56 -170.56 2.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.722 1.209 . . . . 71.23 108.672 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.38 136.91 53.47 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.661 0.784 . . . . 71.24 110.074 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.51 137.54 4.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.118 1.367 . . . . 72.31 108.361 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.98 156.44 19.54 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.801 -0.238 . . . . 72.11 113.139 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -112.92 71.19 0.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.596 0.712 . . . . 71.42 111.127 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.06 87.66 1.57 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 114.852 -1.067 . . . . 41.52 110.675 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.0 p -123.68 -91.2 0.55 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.067 -0.716 . . . . 71.53 109.067 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 62.05 134.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.656 1.582 . . . . 75.25 113.744 171.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -151.42 119.74 6.38 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.685 -0.857 . . . . 75.44 108.685 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -123.95 111.8 16.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.886 0.874 . . . . 71.51 108.916 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -73.83 119.74 18.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.144 0.978 . . . . 55.04 110.452 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -113.99 65.31 0.66 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.173 0.989 . . . . 73.12 108.713 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.494 -0.928 . . . . 64.22 108.494 179.687 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 37.2 tpp . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.463 -0.569 . . . . 74.45 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 65.0 p -80.82 152.17 28.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.823 -0.626 . . . . 74.21 109.901 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.57 115.5 7.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.701 -0.851 . . . . 73.23 108.701 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -91.18 56.44 3.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.713 0.805 . . . . 74.31 110.871 -170.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -75.66 118.21 18.25 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.129 -0.941 . . . . 74.51 110.362 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -152.41 -87.31 0.06 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.466 -0.938 . . . . 64.11 108.466 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 175.73 144.37 0.07 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.896 2.078 . . . . 73.43 107.253 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.7 67.81 1.31 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.035 0.934 . . . . 75.1 108.671 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 52.7 ttp 65.1 116.34 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.495 -1.229 . . . . 71.4 110.545 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.2 m -84.04 78.79 9.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.128 -1.064 . . . . 72.1 108.128 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.515 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 42.2 t80 -100.18 127.94 46.35 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.809 -1.541 . . . . 72.34 108.571 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -138.03 142.73 40.35 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.336 -0.616 . . . . 74.12 109.336 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.33 110.21 11.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.319 -0.855 . . . . 64.52 108.738 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.2 mm100 -77.67 -39.93 43.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.93 -0.577 . . . . 74.12 109.938 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.489 HH11 ' HD1' ' D' ' 32' ' ' PHE . 24.2 ttt180 179.27 124.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.393 0.677 . . . . 75.33 109.953 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 87.9 mt -110.08 138.62 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.818 -1.178 . . . . 63.33 107.818 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.9 p90 -174.17 154.1 2.16 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.752 0.657 . . . . 73.53 110.729 -175.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.3 p -75.58 122.93 24.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.28 -0.873 . . . . 72.55 109.733 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -78.34 -50.58 11.51 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.218 -1.03 . . . . 53.4 108.218 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.5 t70 -133.53 139.19 46.47 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.551 -1.204 . . . . 74.3 109.939 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.37 140.06 38.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.794 -1.558 . . . . 60.25 106.794 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -160.7 150.75 17.74 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.119 0.485 . . . . 63.15 109.708 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 78.4 t80 -152.16 115.79 4.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.854 -1.165 . . . . 75.43 107.854 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.98 110.57 17.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.156 0.582 . . . . 72.15 110.432 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.6 86.24 34.29 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.405 1.082 . . . . 71.4 108.573 167.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.81 -32.31 29.87 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.414 2.076 . . . . 64.42 110.56 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -89.23 22.69 2.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.132 -1.394 . . . . 73.03 111.415 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.512 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -55.49 -43.59 99.22 Favored Pre-proline 0 CA--C 1.574 1.866 0 C-N-CA 124.226 1.011 . . . . 72.31 113.52 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -89.41 -17.96 1.75 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.958 1.772 . . . . 63.31 113.17 169.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.59 -31.69 68.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.535 1.134 . . . . 62.35 110.593 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.87 -2.45 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 124.473 1.109 . . . . 74.02 112.344 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.654 ' HA ' HD12 ' E' ' 134' ' ' ILE . 74.4 t80 -49.99 -41.72 47.61 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.389 1.476 . . . . 65.54 113.11 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -125.12 49.63 1.86 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.245 1.018 . . . . 73.44 108.499 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.79 149.29 47.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.82 -0.55 . . . . 61.14 111.22 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.2 132.91 50.33 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.285 -0.871 . . . . 75.43 110.406 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.807 ' HB3' ' HA ' ' E' ' 136' ' ' VAL . 29.1 p90 -83.52 65.86 8.63 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.026 0.917 . . . . 74.21 110.509 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -152.61 58.18 2.39 Favored Pre-proline 0 CA--C 1.558 1.281 0 CA-C-N 115.12 -0.946 . . . . 71.14 110.553 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.0 149.54 9.52 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.1 1.866 . . . . 70.42 110.8 165.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.24 113.63 24.04 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.284 0.634 . . . . 75.23 109.902 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -77.51 111.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.141 0.576 . . . . 72.1 109.747 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 26.6 mmmt -92.79 104.57 16.82 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.853 -1.165 . . . . 75.02 107.853 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.54 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.4 pt? -87.25 145.65 26.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.33 . . . . 70.41 110.194 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 30.2 t70 -140.88 109.02 5.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.11 -0.7 . . . . 73.22 109.11 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -117.22 125.68 51.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.951 -0.759 . . . . 72.01 108.951 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -143.92 160.53 40.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.446 1.098 . . . . 71.24 109.869 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -129.76 153.72 47.92 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.282 0.633 . . . . 75.5 109.651 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 164.58 26.32 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.067 0.947 . . . . 54.21 109.079 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.471 ' HB3' HD21 ' C' ' 98' ' ' LEU . 33.1 p -142.31 145.36 33.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.037 0.535 . . . . 64.14 110.5 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -145.99 126.38 14.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.379 1.072 . . . . 64.04 108.431 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.68 116.05 23.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.462 -0.94 . . . . 74.45 108.462 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.678 HD11 HD12 ' C' ' 83' ' ' ILE . 67.0 mt -85.41 -43.02 13.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.47 0.708 . . . . 75.42 110.17 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 -171.98 3.61 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.847 -1.069 . . . . 71.51 109.964 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.25 108.91 0.99 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.129 -0.941 . . . . 75.24 110.025 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 71.04 -3.08 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.972 1.309 . . . . 74.3 112.955 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -95.53 97.28 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.842 -1.169 . . . . 70.13 107.842 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -106.97 159.07 16.55 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.541 0.736 . . . . 75.23 110.119 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.99 120.26 31.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.426 1.09 . . . . 74.52 108.265 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.41 133.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.854 -1.165 . . . . 62.04 107.854 172.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.21 105.65 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.184 -0.673 . . . . 60.51 109.184 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.05 99.44 12.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.905 -1.146 . . . . 52.14 107.905 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.548 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.6 tmm_? -92.28 120.94 33.3 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.288 0.635 . . . . 74.54 110.151 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' C' ' 114' ' ' ILE . 37.2 t -112.09 125.33 69.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.569 -0.9 . . . . 65.32 108.569 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -118.53 123.66 45.64 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.486 -0.931 . . . . 71.33 108.486 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.45 HG23 HD13 ' C' ' 114' ' ' ILE . 76.3 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.989 -1.005 . . . . 63.13 108.725 174.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 5.7 m -98.46 136.54 38.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.579 -1.637 . . . . 75.31 106.579 169.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.22 106.65 6.83 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.985 -1.857 . . . . 74.23 105.985 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 12.5 p -164.46 158.12 18.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 123.622 0.576 . . . . 63.22 110.688 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -113.71 20.24 16.06 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.645 0.735 . . . . 41.14 110.181 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.86 -83.47 0.35 Allowed Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.437 -0.801 . . . . 75.14 111.166 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.12 -32.03 11.12 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.29 0.636 . . . . 54.22 110.423 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -82.35 91.36 6.79 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 108.896 -0.779 . . . . 71.3 108.896 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -81.87 128.22 33.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.543 . . . . 73.32 109.563 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -64.11 1.01 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.614 -1.254 . . . . 63.14 107.614 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -159.76 172.37 17.83 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 121.971 0.891 . . . . 73.23 111.524 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -129.25 140.67 51.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.627 -1.99 . . . . 63.4 105.627 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.39 144.32 29.66 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.402 -0.962 . . . . 61.3 108.402 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.97 128.71 7.88 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.602 -0.518 . . . . 54.45 109.602 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.13 123.22 58.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.01 -0.995 . . . . 61.14 108.567 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.548 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 74.1 mt-30 -98.25 91.28 5.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.224 -1.398 . . . . 72.1 107.224 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -78.34 102.53 7.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.868 -0.606 . . . . 72.51 109.572 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.19 145.44 23.22 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.417 -0.811 . . . . 64.45 111.186 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.533 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.6 116.06 0.76 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.343 -1.103 . . . . 41.32 110.343 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.678 HD12 HD11 ' C' ' 51' ' ' LEU . 12.7 mm -81.44 127.82 39.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 107.932 -1.136 . . . . 74.44 107.932 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.88 123.5 23.56 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.358 0.663 . . . . 63.54 109.553 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.5 p -77.04 106.54 8.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.729 -1.211 . . . . 73.31 107.729 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 48.3 mt -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.127 -1.064 . . . . 62.1 108.127 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.528 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -127.84 158.63 37.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.767 0.827 . . . . 50.44 110.25 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -51.76 3.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.828 -0.623 . . . . 71.51 113.029 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.7 tt -81.28 145.47 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.539 0.735 . . . . 74.25 109.978 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.12 -179.36 8.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.99 0.516 . . . . 62.22 110.759 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.26 -148.64 47.72 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.61 -0.723 . . . . 20.0 112.789 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 77.0 p -69.67 -18.05 63.53 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.22 1.008 . . . . 72.13 111.453 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -64.9 -46.19 82.76 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 73.54 110.108 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 57.5 ttp -68.07 -32.2 72.37 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.451 -0.795 . . . . 74.55 110.181 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.74 85.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.333 0.653 . . . . 53.32 110.981 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 46.7 t-80 -65.78 -32.75 74.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.719 0.808 . . . . 75.23 111.308 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.531 ' HG ' ' HG ' ' C' ' 102' ' ' CYS . 43.8 t -76.33 -55.34 5.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 54.44 110.294 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' C' ' 48' ' ' SER . 9.6 tt -65.64 -31.82 73.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.298 1.039 . . . . 65.2 111.225 -172.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.85 10.06 55.54 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.44 -0.644 . . . . 63.3 114.024 -175.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.75 -59.03 0.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.776 0.788 . . . . 73.11 111.657 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -69.88 -55.54 9.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.449 0.7 . . . . 62.43 111.967 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.531 ' HG ' ' HG ' ' C' ' 97' ' ' CYS . 9.8 m -61.56 -45.82 93.85 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.635 0.774 . . . . 64.1 112.039 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.526 ' HB3' HD23 ' C' ' 60' ' ' LEU . 39.1 Cg_exo -61.05 -32.18 91.67 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.349 2.032 . . . . 73.24 113.501 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.95 -35.63 79.03 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.457 0.703 . . . . 72.32 110.882 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.42 -44.69 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.586 0.755 . . . . 73.15 110.254 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.533 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.7 mt -82.28 -23.96 34.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.869 -1.06 . . . . 72.43 112.506 -171.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.406 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 39.8 t80 -54.8 -48.22 96.15 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 124.84 1.256 . . . . 75.45 113.59 -172.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 23.3 Cg_exo -63.7 -34.44 62.48 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.932 1.755 . . . . 73.04 113.019 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -64.75 -44.75 89.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.105 0.562 . . . . 74.12 110.46 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.62 99.24 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.445 -0.798 . . . . 41.43 110.667 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.696 HH21 HD21 ' C' ' 127' ' ' ASN . 39.4 mtp180 -56.38 -53.39 57.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.966 0.906 . . . . 74.52 111.402 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.46 -32.76 71.89 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.711 0.632 . . . . 74.34 110.794 -173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.6 t -70.6 -29.96 66.5 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.565 0.346 . . . . 65.32 110.811 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.45 HD13 HG23 ' C' ' 64' ' ' VAL . 65.3 mt -73.65 -49.09 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.996 0.518 . . . . 74.34 109.724 171.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 92.3 m -59.47 -35.42 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.026 0.93 . . . . 73.03 111.454 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.1 t -63.31 -51.27 66.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.241 -0.891 . . . . 54.5 109.114 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.6 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -60.87 -32.72 72.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.754 0.822 . . . . 73.3 112.704 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.5 t -73.72 -37.6 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 53.44 110.141 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 63.6 p -75.54 -25.36 57.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.923 0.489 . . . . 71.23 110.745 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.6 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -70.49 -44.0 68.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.703 0.801 . . . . 71.21 109.567 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.33 -5.5 85.58 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.528 0.517 . . . . 44.14 112.618 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p 67.31 25.97 8.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.534 1.933 . . . . 64.11 113.336 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' C' ' 118' ' ' VAL . 98.6 m-85 -85.45 163.77 43.32 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.682 0.793 . . . . 64.23 109.794 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.38 151.36 30.11 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.128 2.552 . . . . 52.44 113.984 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.92 112.33 1.62 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.861 1.264 . . . . 60.41 110.069 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.4 107.75 10.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.846 -0.798 . . . . 73.32 108.846 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.696 HD21 HH21 ' C' ' 111' ' ' ARG . 6.8 p-10 -126.62 133.6 50.97 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.196 -1.409 . . . . 41.14 107.196 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.8 113.89 4.66 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.75 -1.204 . . . . 72.24 107.75 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.67 134.1 82.61 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.883 0.74 . . . . 63.31 110.846 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.505 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 52.7 Cg_exo -56.13 90.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.485 2.79 . . . . 41.02 113.248 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.67 110.37 30.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.537 -0.912 . . . . 75.02 108.537 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -85.7 89.32 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.62 -0.718 . . . . 74.44 110.509 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -40.81 93.36 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.568 -1.196 . . . . 71.14 109.13 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -53.47 -38.47 63.65 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.68 -1.6 . . . . 72.21 112.969 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.49 77.95 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.611 0.765 . . . . 43.14 112.846 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.0 -47.77 79.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.689 -0.486 . . . . 72.15 109.689 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.486 ' HA ' ' HD1' ' C' ' 140' ' ' TYR . 80.3 m-85 -82.41 -14.44 55.16 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.767 0.827 . . . . 74.32 112.63 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.24 -44.51 75.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.488 0.715 . . . . 61.43 109.844 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -64.18 -35.16 79.9 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.768 0.668 . . . . 74.21 111.431 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' C' ' 137' ' ' PHE . 65.6 m-85 -53.95 -83.9 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.13 0.972 . . . . 75.5 110.759 170.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.623 ' H ' HD23 ' C' ' 141' ' ' LEU . 1.3 pt? -102.66 100.65 10.72 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.645 0.736 . . . . 53.51 109.135 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -89.12 47.55 1.51 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.184 0.994 . . . . 74.12 109.554 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.33 75.84 8.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.613 0.72 . . . . 75.54 111.513 -170.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 15.0 mm100 -141.79 88.98 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.871 -1.529 . . . . 75.15 106.871 172.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.62 96.48 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.514 . . . . 75.04 110.382 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.3 83.0 0.05 OUTLIER Glycine 0 C--N 1.335 0.484 0 N-CA-C 109.522 -1.431 . . . . 62.3 109.522 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -49.52 144.3 5.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.444 1.098 . . . . 74.34 113.06 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.34 47.43 1.04 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 111.024 -0.83 . . . . 42.2 111.024 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 53.1 p -62.67 97.39 0.1 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.08 0.552 . . . . 60.43 109.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -83.28 -173.07 4.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.081 -0.963 . . . . 62.24 110.748 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.01 106.76 5.91 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.987 -1.486 . . . . 63.44 106.987 165.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -53.06 103.64 0.08 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.46 1.1 . . . . 74.24 111.055 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.1 158.11 23.63 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.835 -1.075 . . . . 71.25 111.405 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -147.0 113.45 5.95 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.131 -0.692 . . . . 72.22 109.131 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 108.962 -0.755 . . . . 51.14 108.962 -176.848 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.195 0.521 . . . . 42.43 110.267 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -146.21 156.77 43.63 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.952 -1.129 . . . . 53.12 107.952 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -166.98 108.99 0.67 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.596 0.358 . . . . 73.23 110.368 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.639 ' HB2' ' H ' ' D' ' 90' ' ' GLU . 83.9 mm-40 -120.9 122.9 41.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.644 -0.873 . . . . 73.33 108.644 173.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -133.16 70.82 1.46 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.011 -1.477 . . . . 72.2 107.011 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -111.46 155.88 22.52 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.191 -1.368 . . . . 73.24 109.892 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -79.35 11.52 2.9 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.051 0.941 . . . . 74.42 111.883 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -77.07 -24.91 51.89 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.708 -0.62 . . . . 74.11 111.388 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp -31.89 128.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.855 1.347 . . . . 72.24 114.363 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.6 m -138.69 139.93 38.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.979 -1.489 . . . . 74.31 106.979 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.79 114.44 7.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.268 -1.012 . . . . 75.24 108.268 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -129.87 142.54 50.65 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.98 -0.748 . . . . 71.52 108.98 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.1 101.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.041 -1.466 . . . . 55.34 107.041 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -46.67 38.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.491 0.717 . . . . 61.23 111.221 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -166.9 133.77 2.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.957 -0.565 . . . . 74.14 110.072 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.509 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.7 mp -108.91 135.87 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.366 -1.346 . . . . 73.11 107.366 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -161.96 170.95 18.43 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 122.13 0.967 . . . . 73.3 112.423 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 46.6 p -104.55 119.17 38.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.679 -1.146 . . . . 71.01 109.088 172.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 36.7 mtpt -86.45 -30.79 21.78 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.056 -0.35 . . . . 61.25 110.056 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -145.9 137.59 25.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.61 . . . . 64.33 109.984 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.555 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.3 mt -134.41 148.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 73.43 108.242 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -148.26 140.97 24.57 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.294 1.037 . . . . 74.52 109.07 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.4 t80 -148.36 111.39 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.708 -1.96 . . . . 62.44 105.708 169.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -123.03 110.48 15.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.457 0.703 . . . . 71.21 109.348 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.2 88.14 2.97 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.063 -1.088 . . . . 62.52 108.063 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.12 -45.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.455 2.103 . . . . 74.34 112.405 -171.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.486 ' O ' HG23 ' D' ' 31' ' ' VAL . 20.2 m120 -102.9 42.33 1.16 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.048 0.939 . . . . 74.01 108.475 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -57.33 -51.96 77.8 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.225 1.194 . . . . 63.03 114.225 -169.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.59 -0.6 8.82 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 121.591 1.604 . . . . 72.42 112.968 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.485 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 13.6 t-160 -83.05 -26.7 30.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.67 1.188 . . . . 71.32 109.011 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.486 HG23 ' O ' ' D' ' 27' ' ' ASN . 93.2 t -82.31 -24.29 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.211 0.604 . . . . 71.34 110.114 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.489 ' HD1' HH11 ' C' ' 15' ' ' ARG . 60.5 t80 -53.98 -39.84 66.36 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.105 0.962 . . . . 72.13 112.542 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -79.37 -13.73 59.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.246 0.461 . . . . 73.42 112.246 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -111.5 100.68 9.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.069 -0.715 . . . . 75.52 109.069 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.39 89.24 4.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.011 0.524 . . . . 71.03 109.8 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.562 ' HB3' HD11 ' D' ' 68' ' ' LEU . 17.0 t-105 -159.21 158.24 32.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.027 -1.101 . . . . 74.33 108.027 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -81.66 112.52 35.05 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.474 0.709 . . . . 53.01 110.508 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -48.88 139.15 25.71 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.771 2.981 . . . . 71.52 114.058 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.12 121.69 16.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.529 -0.545 . . . . 73.53 109.529 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' F' ' 142' ' ' ILE . 17.8 t -100.13 115.69 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.085 0.469 . . . . 60.33 110.572 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -87.26 146.28 26.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.491 1.116 . . . . 74.22 108.901 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -110.18 131.03 55.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.179 -0.675 . . . . 44.15 109.179 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.5 m-20 -133.37 142.72 48.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.652 1.181 . . . . 55.5 108.195 171.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -138.49 164.75 28.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.788 0.435 . . . . 72.3 110.707 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 29.3 t70 -168.43 155.36 7.55 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.498 1.119 . . . . 64.41 108.721 174.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -132.48 158.06 43.05 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.987 -0.745 . . . . 73.12 108.987 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.7 167.7 29.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.511 0.725 . . . . 63.34 109.632 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' D' ' 58' ' ' VAL . 56.5 p -159.6 153.6 23.3 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.791 0.836 . . . . 63.23 110.196 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.5 p -151.52 142.59 23.13 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.933 0.893 . . . . 73.22 108.627 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -90.69 117.51 29.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.058 0.543 . . . . 73.44 109.591 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.7 mt -89.62 -31.66 17.45 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.511 -0.552 . . . . 72.34 109.511 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.75 -177.84 4.97 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.121 -0.945 . . . . 60.43 109.852 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.58 119.67 10.27 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.565 -1.198 . . . . 51.03 108.946 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 71.58 2.78 4.41 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.263 1.425 . . . . 71.15 112.741 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -113.77 123.91 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.539 0.736 . . . . 71.42 109.391 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.26 130.42 35.13 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.775 0.43 . . . . 73.13 110.516 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.3 tt0 -92.86 112.05 23.88 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.35 -0.982 . . . . 63.0 108.35 167.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' D' ' 48' ' ' SER . 12.7 m -102.3 137.87 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 170.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.39 140.27 30.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.182 -0.673 . . . . 75.12 109.182 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -112.56 123.81 51.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.175 -1.046 . . . . 63.4 108.175 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.3 ttm-85 -105.44 101.94 11.44 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.207 -0.664 . . . . 72.13 109.207 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.42 119.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.868 -1.16 . . . . 73.35 107.868 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 18.0 m -125.35 142.71 51.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.622 0.725 . . . . 64.25 109.675 -172.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -137.35 123.62 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.881 1.273 . . . . 54.51 108.875 -170.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -115.72 108.48 16.41 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.788 -0.819 . . . . 62.21 108.788 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.1 53.88 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.322 -0.622 . . . . 75.44 109.322 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.7 p -142.0 125.79 17.04 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.174 0.59 . . . . 74.42 109.661 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' D' ' 36' ' ' TRP . 28.0 tp -99.72 116.64 32.29 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.575 -0.898 . . . . 71.15 108.575 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.2 -133.16 23.98 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.72 0.637 . . . . 73.11 112.432 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -92.1 21.6 4.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.43 0.692 . . . . 65.01 110.847 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -141.14 146.41 36.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.249 0.619 . . . . 63.5 111.157 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -68.67 130.8 43.88 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.249 0.619 . . . . 64.43 109.968 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.12 -64.12 1.15 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.574 0.75 . . . . 65.53 109.323 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.47 161.64 40.03 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.31 -0.859 . . . . 72.31 110.321 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -121.38 151.23 40.4 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.282 1.433 . . . . 72.14 107.163 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.7 t -156.98 141.53 16.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 110.153 -0.314 . . . . 71.15 110.153 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.92 137.67 14.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.654 0.782 . . . . 63.53 109.139 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' D' ' 113' ' ' CYS . 66.7 t -135.15 114.24 16.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.44 -0.578 . . . . 75.04 109.44 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.5 mt-30 -91.93 85.16 5.48 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.221 -0.9 . . . . 74.25 108.89 171.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -80.15 101.89 9.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.913 -1.494 . . . . 73.4 109.705 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.27 142.36 15.99 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.759 -0.537 . . . . 70.03 111.759 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.3 133.65 5.55 Favored Glycine 0 C--O 1.236 0.279 0 N-CA-C 111.77 -0.532 . . . . 73.24 111.77 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.87 128.85 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.602 -1.258 . . . . 70.21 107.602 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.59 144.6 51.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.788 0.835 . . . . 74.53 108.817 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -97.52 102.43 14.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.983 -0.747 . . . . 64.25 108.983 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.511 HG21 ' HG3' ' D' ' 94' ' ' MET . 3.4 mp -107.62 99.7 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 107.564 -1.273 . . . . 73.14 107.564 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.41 123.21 35.58 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.49 -0.559 . . . . 74.25 109.49 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.8 22.5 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-O 118.571 -1.127 . . . . 64.55 114.872 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 mt -140.41 140.31 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.57 1.185 . . . . 72.41 110.424 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.639 ' H ' ' HB2' ' D' ' 4' ' ' GLN . 42.7 mt-10 -136.94 175.84 9.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.875 1.27 . . . . 72.11 109.856 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.36 -140.97 26.17 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 114.537 0.575 . . . . 71.35 114.537 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 43.1 p -66.31 -32.45 73.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 62.43 111.618 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -70.53 -40.96 73.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.436 0.694 . . . . 73.02 110.155 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.511 ' HG3' HG21 ' D' ' 86' ' ' ILE . 49.7 ttp -70.89 -32.68 69.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.533 -0.758 . . . . 72.01 110.564 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.24 83.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.226 0.61 . . . . 71.32 110.29 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -62.0 -34.0 75.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.698 0.799 . . . . 70.41 110.53 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -68.55 -51.43 42.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.919 -0.582 . . . . 73.24 110.387 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.4 -28.4 61.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.81 0.844 . . . . 54.21 112.597 -173.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.28 -4.44 25.45 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.216 -0.769 . . . . 70.34 114.393 -169.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -54.6 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.984 0.892 . . . . 73.34 110.629 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -73.15 -43.49 61.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.718 0.407 . . . . 74.04 111.931 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.426 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 63.4 m -70.35 -45.56 19.91 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 118.694 -0.67 . . . . 72.55 111.381 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.516 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.2 Cg_exo -53.89 -36.37 83.04 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.438 2.092 . . . . 74.35 113.229 165.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.97 -33.05 75.11 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.493 0.717 . . . . 54.11 110.928 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.4 -43.33 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.044 0.538 . . . . 70.05 110.059 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.88 -19.63 58.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.318 -0.855 . . . . 73.44 111.738 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.435 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 60.6 t80 -66.71 -42.26 43.65 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.946 -1.026 . . . . 74.24 113.413 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.43 -38.34 73.85 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.902 1.735 . . . . 75.34 112.993 168.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -78.57 -35.32 46.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.106 0.962 . . . . 64.43 112.115 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.74 -42.07 74.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.253 0.621 . . . . 75.51 109.553 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -62.42 -46.84 86.76 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.331 -1.304 . . . . 72.4 109.922 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 2.6 tm-20 -56.35 -48.97 75.7 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.292 0.995 . . . . 70.44 111.553 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.437 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -61.24 -41.22 96.53 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.04 0.837 . . . . 65.42 110.903 -177.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.491 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.6 mt -63.29 -50.72 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.146 0.578 . . . . 74.3 110.105 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.8 m -54.03 -43.26 69.99 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.969 1.308 . . . . 75.14 111.134 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -69.16 -44.96 71.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.756 -1.111 . . . . 51.03 110.605 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.9 mtm -67.81 -33.2 74.33 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.671 0.388 . . . . 65.0 111.827 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.53 -42.52 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.944 0.897 . . . . 74.11 110.248 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -72.72 -29.45 63.37 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.668 0.387 . . . . 62.43 110.897 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -74.62 -26.98 60.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.859 0.864 . . . . 74.33 110.303 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.42 67.42 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.531 -0.758 . . . . 35.34 112.731 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.517 HG23 ' HB3' ' C' ' 17' ' ' TYR . 60.6 p 56.57 21.94 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 125.874 1.67 . . . . 65.21 113.243 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -95.41 154.85 39.26 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.751 0.82 . . . . 73.53 109.955 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.88 137.94 83.77 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.418 2.745 . . . . 74.22 112.671 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -57.8 124.91 20.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.774 0.672 . . . . 74.2 112.233 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.478 HD12 HD23 ' F' ' 139' ' ' LEU . 5.1 tt -108.51 99.05 8.48 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.727 -0.842 . . . . 53.14 108.727 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.61 103.07 14.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.553 -0.906 . . . . 60.52 108.553 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.498 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 0.2 OUTLIER -64.06 116.47 5.94 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.375 0.67 . . . . 53.1 109.636 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 145.33 99.12 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.305 0.642 . . . . 60.52 111.927 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.73 106.0 0.26 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.569 2.179 . . . . 72.23 111.508 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.04 147.82 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.205 0.602 . . . . 54.45 110.351 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -79.33 91.1 5.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.051 -0.522 . . . . 74.31 109.77 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.14 -22.24 55.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.849 -0.614 . . . . 71.41 110.624 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -53.53 -41.09 66.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.318 1.047 . . . . 74.22 112.062 -178.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -54.22 43.2 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 123.959 0.787 . . . . 54.54 110.797 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.67 -42.11 96.42 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.543 0.737 . . . . 52.51 111.584 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -65.18 -42.32 93.73 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.166 0.986 . . . . 73.32 110.627 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 7.4 ttp -62.07 -46.31 89.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.033 . . . . 63.24 110.824 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -60.64 -41.71 95.46 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.081 0.553 . . . . 72.32 110.676 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.8 -41.98 99.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.283 1.033 . . . . 74.12 111.913 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.52 -30.14 71.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.333 0.653 . . . . 63.0 111.737 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -82.24 1.24 37.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.295 0.638 . . . . 72.31 111.326 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -127.11 44.5 2.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.524 0.73 . . . . 73.32 109.611 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -164.24 143.25 7.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.044 0.538 . . . . 63.31 111.431 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.04 99.71 0.21 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.326 1.45 . . . . 45.24 107.272 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.59 81.65 0.07 OUTLIER Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.615 -0.594 . . . . 63.44 111.615 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -89.28 113.34 24.59 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.701 0.8 . . . . 71.04 109.524 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.61 -118.9 0.88 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.112 -0.795 . . . . 74.31 111.112 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 25.8 m 67.29 111.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.836 1.254 . . . . 71.13 111.863 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.15 90.44 2.37 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.173 -1.047 . . . . 74.33 108.173 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.86 74.04 3.48 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.727 -0.669 . . . . 73.03 109.22 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -89.32 70.71 8.19 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.584 -0.895 . . . . 60.23 108.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -78.76 92.2 4.78 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.047 -1.094 . . . . 73.05 108.047 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.76 -21.94 16.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.773 -0.648 . . . . 74.24 110.263 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.09 0 N-CA-C 108.934 -0.765 . . . . 50.5 108.934 170.693 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 109.282 -0.636 . . . . 73.1 109.282 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 60.69 49.6 6.21 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.794 0.838 . . . . 65.23 109.505 -168.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -86.19 106.28 17.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.233 -0.894 . . . . 74.34 110.246 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.04 129.76 55.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.757 0.823 . . . . 75.2 109.141 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.09 79.85 2.92 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 71.23 109.353 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.41 167.77 20.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.727 -1.124 . . . . 72.24 109.327 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 160.38 4.55 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.697 0.399 . . . . 62.51 111.472 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.565 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.6 mp -62.75 -15.23 52.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.605 0.965 . . . . 75.22 113.605 -165.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -114.73 90.81 23.31 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.564 -0.902 . . . . 73.3 108.564 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -88.98 -171.5 0.57 Allowed 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.28 2.653 . . . . 72.33 112.392 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 62.71 -176.42 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.669 1.187 . . . . 72.33 111.957 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.35 27.36 4.11 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.24 -1.022 . . . . 74.2 108.24 172.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.5 ' HZ3' ' HB2' ' B' ' 137' ' ' PHE . 8.9 m95 62.61 -88.02 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.516 -1.22 . . . . 70.12 110.36 -166.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 35.5 t70 67.64 143.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.025 1.33 . . . . 62.41 112.598 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.5 11.32 8.31 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.912 1.285 . . . . 65.44 112.261 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 86.4 t -89.22 100.76 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.565 1.146 . . . . 74.44 109.797 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.97 98.42 3.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.057 -1.09 . . . . 72.12 108.057 175.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -73.39 89.61 1.63 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.621 -0.718 . . . . 72.23 109.478 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -130.0 94.14 3.65 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.281 -1.377 . . . . 74.12 107.281 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 156.37 130.07 1.23 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.443 -1.063 . . . . 63.21 110.443 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 74.02 -59.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.512 1.525 . . . . 73.43 112.298 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.88 -142.16 0.77 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.525 0.73 . . . . 60.21 109.537 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' B' ' 129' ' ' ALA . 24.2 pt -65.75 -10.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 118.994 0.816 . . . . 73.35 112.679 -177.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.4 -74.04 0.09 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.373 1.469 . . . . 73.43 112.677 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.21 94.57 48.46 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.986 0.914 . . . . 63.24 110.174 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.9 -20.65 25.54 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.587 2.191 . . . . 63.1 112.337 166.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 134' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' C' ' 32' ' ' PHE . 7.3 pt 55.6 -171.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 126.653 1.981 . . . . 53.31 113.093 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.481 ' O ' HG13 ' E' ' 134' ' ' ILE . . . -76.26 165.78 24.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.263 0.625 . . . . 61.32 110.45 172.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.807 ' HA ' ' HB3' ' C' ' 36' ' ' TRP . 19.1 t 67.71 68.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 122.657 1.218 . . . . 74.54 110.171 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.12 -28.86 13.55 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.911 -1.495 . . . . 71.2 110.047 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -130.0 140.29 50.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.526 1.131 . . . . 64.4 109.233 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 25.8 tp -134.46 118.91 17.89 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.683 0.793 . . . . 75.2 109.649 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.0 p -152.29 80.49 1.24 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.799 0.84 . . . . 54.43 109.206 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -151.96 89.85 1.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 106.841 -1.54 . . . . 72.22 106.841 175.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 142' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' C' ' 42' ' ' LEU . 11.3 tt -163.83 -143.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 106.538 -1.653 . . . . 74.43 106.538 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 143' ' ' TYR . . . . . 0.512 ' H ' HG12 ' E' ' 142' ' ' ILE . 21.6 p90 -75.56 67.55 2.08 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 119.784 1.174 . . . . 75.01 110.339 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -70.03 113.12 6.92 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.445 -0.798 . . . . 51.51 110.399 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt 63.49 26.56 14.85 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.702 1.201 . . . . 70.44 112.261 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.53 -70.73 0.23 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.514 0.725 . . . . 74.25 111.574 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 63.47 -168.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.294 1.038 . . . . 75.22 112.596 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.46 156.21 62.46 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.917 0.887 . . . . 73.02 109.55 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.564 2.021 0 C-N-CA 122.203 1.935 . . . . 70.54 111.227 170.345 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.872 -0.418 . . . . 73.13 109.872 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.94 151.22 46.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.066 0.546 . . . . 61.23 110.478 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.17 8.81 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.515 -0.766 . . . . 74.4 110.51 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 60.51 89.73 0.07 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.808 1.243 . . . . 72.1 110.305 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 69.64 -179.7 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.504 1.522 . . . . 64.0 111.611 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -157.41 147.43 20.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.794 -1.187 . . . . 70.25 107.794 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -80.83 78.47 7.61 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.289 -0.634 . . . . 74.22 109.289 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 80.1 mt -64.57 104.4 0.8 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.999 -1.0 . . . . 74.22 110.107 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -144.55 149.7 44.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.269 1.028 . . . . 73.11 109.614 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.76 137.21 34.94 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.893 2.395 . . . . 73.14 112.121 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -58.76 -47.59 84.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.767 0.827 . . . . 75.23 111.528 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 95.6 m -157.61 126.25 5.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.018 0.927 . . . . 75.23 109.717 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -151.9 88.54 1.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.69 -1.226 . . . . 70.31 107.69 169.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -130.51 -3.21 4.28 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.943 0.897 . . . . 61.02 111.276 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.35 97.62 6.9 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.653 0.781 . . . . 71.55 109.637 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.85 99.38 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.568 0.747 . . . . 71.33 109.195 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -82.89 77.88 9.56 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.801 . . . . 74.34 109.536 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -80.82 125.82 30.56 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.938 -0.764 . . . . 72.03 108.938 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.8 -171.03 3.72 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.057 0.943 . . . . 62.35 109.444 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.92 176.09 45.33 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.001 -0.545 . . . . 72.33 111.748 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -91.0 106.23 18.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.232 0.613 . . . . 64.12 109.678 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 42' ' ' LEU . 2.7 mm? -62.99 -44.23 96.59 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.178 0.591 . . . . 60.53 111.025 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.52 168.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.578 1.151 . . . . 74.24 108.96 172.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.03 19.0 0.37 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.212 0.605 . . . . 73.41 110.722 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.64 103.49 5.89 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 61.11 109.591 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 133' ' ' PRO . . . . . 0.592 ' HB2' ' HZ3' ' A' ' 36' ' ' TRP . 41.1 Cg_endo -89.05 45.84 0.9 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.014 2.476 . . . . 65.0 112.753 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.67 116.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 CA-C-O 121.198 0.523 . . . . 64.33 111.002 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.7 86.61 4.65 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.407 -0.815 . . . . 63.24 109.208 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.615 HG23 ' H ' ' F' ' 137' ' ' GLU . 2.5 m -80.98 -69.82 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.074 -0.966 . . . . 71.53 109.923 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 137' ' ' GLU . . . . . 0.615 ' H ' HG23 ' F' ' 136' ' ' VAL . 3.8 mm-40 52.7 -82.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 125.65 1.58 . . . . 73.24 113.287 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.65 148.12 35.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.367 0.667 . . . . 72.35 109.68 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.478 HD23 HD12 ' D' ' 126' ' ' LEU . 10.4 tp -94.34 112.26 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.288 0.635 . . . . 73.24 110.863 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 52.0 p -100.75 -160.34 0.79 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.358 1.063 . . . . 64.25 110.394 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mp 64.25 26.5 13.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.953 1.301 . . . . 74.44 110.856 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.608 ' HB ' ' HB ' ' D' ' 40' ' ' VAL . 10.3 tt -144.39 155.55 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.491 1.516 . . . . 55.23 107.961 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 65.02 25.86 12.63 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.805 1.242 . . . . 71.13 109.98 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.72 115.44 3.65 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.357 -1.292 . . . . 63.31 109.071 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? 79.59 -48.69 0.38 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.728 1.611 . . . . 73.44 111.934 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -146.1 155.22 42.61 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.002 0.521 . . . . 73.21 110.753 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.76 -42.1 95.38 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.741 1.216 . . . . 64.43 111.62 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 62.0 tp -123.92 85.88 53.84 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.704 -1.221 . . . . 74.31 107.704 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.376 2.005 0 C-N-CA 123.319 2.679 . . . . 51.34 112.718 -178.727 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.362 -0.236 . . . . 72.33 110.362 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -81.22 159.08 24.65 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.476 0.71 . . . . 51.54 109.094 167.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.39 110.87 3.26 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.494 0.496 . . . . 75.23 110.465 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -66.18 -42.02 89.45 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.209 -1.404 . . . . 74.32 107.209 169.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 64.49 -69.91 0.08 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.946 2.098 . . . . 75.11 113.57 163.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -60.12 92.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.451 1.1 . . . . 64.42 111.325 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 t -117.1 106.11 13.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.024 -1.473 . . . . 74.12 107.024 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.26 -70.55 0.19 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.637 0.775 . . . . 65.04 111.265 -172.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.8 mtt -142.11 138.06 31.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.127 0.971 . . . . 71.42 108.833 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -142.92 134.73 26.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.618 0.767 . . . . 41.34 110.233 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -139.3 115.73 10.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.089 -1.449 . . . . 75.42 107.089 168.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -149.79 134.47 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.545 0.338 . . . . 73.42 111.068 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 16' ' ' ILE . 2.7 pp -80.93 132.1 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.312 -0.996 . . . . 75.12 108.312 169.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -113.8 -38.37 4.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.962 0.505 . . . . 64.41 110.792 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -165.15 123.18 1.62 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.911 -0.403 . . . . 73.21 109.911 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.569 HD11 ' HB ' ' A' ' 13' ' ' ILE . 4.5 mp -121.71 123.39 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.083 -1.08 . . . . 74.42 108.083 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.669 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 9.5 p90 -172.23 176.58 3.37 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.511 0.724 . . . . 75.12 110.929 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -102.01 120.84 41.07 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 71.34 108.832 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HD3' HG22 ' A' ' 59' ' ' VAL . 18.5 ptmt -98.44 -27.62 13.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.196 0.198 . . . . 65.22 111.155 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.751 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 13.7 m-20 -137.77 129.52 28.46 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.759 -0.83 . . . . 64.0 108.759 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 78' ' ' VAL . 54.6 mt -132.34 137.46 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.144 -1.058 . . . . 53.32 108.144 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -145.19 127.23 15.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.8 0.84 . . . . 73.1 109.405 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.677 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.6 t80 -131.12 133.01 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.692 -1.595 . . . . 74.02 106.692 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -141.0 119.34 12.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.394 0.677 . . . . 75.42 109.522 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -125.12 82.1 62.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 107.831 -1.174 . . . . 61.25 107.831 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.31 -35.89 29.96 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.753 2.302 . . . . 72.43 111.369 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' THR . 78.5 m-20 -111.49 35.63 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.66 -1.155 . . . . 42.21 109.458 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.68 -47.14 99.46 Favored Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 123.988 0.915 . . . . 60.43 111.803 171.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 -13.86 25.3 Favored 'Trans proline' 0 C--N 1.403 3.42 0 C-N-CA 122.419 2.079 . . . . 54.24 113.428 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -69.82 -32.59 71.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.423 0.289 . . . . 74.0 110.46 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 17.5 t -64.98 -19.21 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.84 0.456 . . . . 74.51 110.793 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.64 -41.09 80.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.564 0.746 . . . . 75.13 111.3 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -99.89 -23.53 14.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.143 0.577 . . . . 63.32 111.55 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.2 mmtp -77.27 144.97 37.77 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.283 0.563 . . . . 64.52 111.767 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -79.82 158.1 26.87 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.91 -1.041 . . . . 73.33 110.067 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -90.22 80.17 6.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.054 0.931 . . . . 73.45 110.649 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -135.73 74.56 58.29 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.157 -1.383 . . . . 61.42 107.434 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -91.99 144.39 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.764 2.309 . . . . 62.31 112.567 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.1 115.6 27.8 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.848 -1.167 . . . . 74.43 107.848 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 65' ' ' THR . 85.0 t -95.26 135.94 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.545 0.738 . . . . 55.23 110.133 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 53.3 mtpt -120.62 143.4 48.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.439 0.695 . . . . 72.42 109.492 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -133.22 108.2 8.63 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.66 -1.154 . . . . 72.11 109.21 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -123.48 117.66 25.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.604 1.162 . . . . 64.2 108.662 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -118.4 159.91 22.61 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.075 0.95 . . . . 63.15 110.847 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' O ' HD23 ' A' ' 60' ' ' LEU . 24.1 t70 -157.83 148.66 21.02 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.38 0.672 . . . . 71.11 110.369 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 98' ' ' LEU . 78.4 m -131.72 134.49 45.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.509 0.724 . . . . 61.53 110.092 175.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.78 135.69 29.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.748 0.819 . . . . 72.14 109.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -113.96 157.88 21.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.131 0.572 . . . . 64.5 109.507 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -160.79 116.07 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.392 -0.595 . . . . 74.13 109.392 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -70.98 108.66 4.67 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.355 0.662 . . . . 61.43 110.18 -173.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 57' ' ' GLU . 71.6 mt -79.04 -40.24 31.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.859 0.864 . . . . 72.35 110.89 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.28 -176.12 5.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.198 0.999 . . . . 71.54 109.004 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.79 102.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.347 0.659 . . . . 74.43 111.518 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 58.41 29.67 18.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.201 1.4 . . . . 75.32 112.631 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.3 t -112.13 122.22 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 106.5 -1.667 . . . . 71.54 106.5 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.64 133.43 38.2 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.492 -0.929 . . . . 73.34 108.492 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 35.0 tt0 -85.8 121.72 28.85 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.644 -0.873 . . . . 72.44 108.644 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.57 115.12 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.999 0.919 . . . . 73.13 108.715 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 19' ' ' LYS . 97.6 t -97.29 135.09 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.228 -0.896 . . . . 65.54 109.257 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -110.73 115.09 28.95 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.098 -1.445 . . . . 74.41 107.098 170.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -102.64 106.02 16.61 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.014 -0.735 . . . . 64.21 109.014 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 133.02 48.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.47 -0.937 . . . . 71.01 108.47 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -123.54 125.23 44.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.849 -0.797 . . . . 62.31 108.849 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 114' ' ' ILE . 61.4 t -118.42 130.83 72.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.624 -1.25 . . . . 73.52 107.624 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.2 m -127.7 149.45 50.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.497 -0.927 . . . . 63.41 108.497 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.24 121.26 13.69 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.256 -1.387 . . . . 61.23 107.256 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.6 m -144.47 129.24 18.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.102 0.561 . . . . 74.05 110.481 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.41 HD13 ' HD2' ' A' ' 34' ' ' LYS . 2.4 tt -88.04 80.92 7.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.452 -1.685 . . . . 71.41 106.452 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.77 -110.17 2.98 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.67 -1.15 . . . . 72.34 111.649 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.74 -26.31 18.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.081 0.952 . . . . 73.05 111.291 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -83.34 116.44 22.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.84 -0.8 . . . . 74.54 108.84 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 32.9 m -77.43 126.56 31.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 110.056 -0.35 . . . . 72.32 110.056 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.55 -52.39 9.12 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.382 -0.97 . . . . 61.32 108.382 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -161.95 170.33 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.06 -0.973 . . . . 73.31 111.204 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.5 tp -141.12 148.77 40.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.34 1.456 . . . . 73.45 107.936 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 62.4 m -142.82 139.74 31.04 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.488 1.115 . . . . 74.41 108.488 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -149.41 118.96 6.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.965 -0.754 . . . . 65.2 108.965 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 21' ' ' ILE . 54.8 t -122.82 118.89 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 121.124 0.488 . . . . 74.54 109.715 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 48.5 mt-30 -89.92 91.46 8.6 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.971 -1.013 . . . . 75.55 108.97 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -76.73 97.65 4.54 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.593 -1.185 . . . . 75.44 108.6 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.8 140.38 17.09 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.789 -0.924 . . . . 40.51 110.789 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.72 120.64 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.858 -1.297 . . . . 75.34 109.858 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 38.6 mt -81.75 129.26 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.703 -0.851 . . . . 63.33 108.703 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -135.73 122.15 20.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.857 -1.164 . . . . 62.43 107.857 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -90.96 105.97 18.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.044 -0.724 . . . . 33.1 109.044 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -122.01 135.03 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.349 0.66 . . . . 72.34 110.537 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.73 157.81 42.54 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.613 1.165 . . . . 71.12 109.476 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.21 -18.68 9.56 Favored Glycine 0 N--CA 1.471 1.004 0 N-CA-C 114.601 0.601 . . . . 52.43 114.601 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.98 133.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.319 -0.993 . . . . 71.55 108.319 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -147.39 174.32 11.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.875 0.87 . . . . 73.14 109.664 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.6 -115.42 7.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.623 -0.543 . . . . 44.01 113.182 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -71.26 -22.57 61.95 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.297 0.639 . . . . 63.23 111.418 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.42 -50.53 44.9 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.243 1.017 . . . . 73.42 110.789 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -27.65 52.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.012 -0.54 . . . . 74.3 110.14 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.94 94.68 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.334 0.654 . . . . 54.52 110.348 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 25.7 t-80 -65.58 -54.28 30.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.532 -1.213 . . . . 63.53 110.219 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.703 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 62.7 m -68.2 -59.34 3.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.047 0.758 . . . . 71.35 113.047 -168.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 46' ' ' THR . 92.6 mt -67.71 -25.72 65.8 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.234 0.457 . . . . 73.13 112.234 -177.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.24 -13.77 56.91 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.448 -0.64 . . . . 42.03 114.084 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.678 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -140.76 -67.27 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.775 0.788 . . . . 63.34 112.638 -173.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.703 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.34 -57.71 7.31 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 124.611 1.164 . . . . 54.22 113.423 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.6 m -71.69 -45.37 12.56 Favored Pre-proline 0 CA--C 1.559 1.312 0 CA-C-O 118.562 -0.732 . . . . 71.45 112.93 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.92 -25.25 74.19 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.548 1.499 . . . . 74.32 113.516 168.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -69.25 -37.47 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.45 -0.574 . . . . 72.25 109.45 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.03 -44.78 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.758 0.823 . . . . 64.11 110.489 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.85 -24.02 58.52 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.568 -0.742 . . . . 73.33 112.249 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -67.08 -44.57 50.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.109 1.151 . . . . 74.44 114.109 -169.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -34.65 96.12 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 122.12 1.88 . . . . 75.1 112.862 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.92 -43.13 36.69 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.659 0.784 . . . . 75.43 111.631 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -45.01 79.88 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.588 0.355 . . . . 51.34 110.439 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.51 HH12 HD12 ' C' ' 105' ' ' ILE . 29.3 ttm180 -48.53 -58.26 4.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.726 1.266 . . . . 63.24 109.545 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.98 -42.92 95.23 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.403 1.064 . . . . 73.45 111.909 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.91 -34.55 78.22 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.631 0.582 . . . . 75.34 111.572 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' A' ' 64' ' ' VAL . 4.4 mt -70.12 -53.11 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.097 0.559 . . . . 72.42 109.669 171.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 125' ' ' GLN . 62.2 m -58.8 -30.64 67.77 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.965 1.306 . . . . 72.52 111.759 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -71.74 -43.16 66.31 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.045 -0.979 . . . . 72.22 109.86 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.677 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.0 mtm -61.4 -36.85 81.42 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.747 0.419 . . . . 54.01 110.96 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' ILE . 48.7 t -65.93 -46.5 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 123.854 0.721 . . . . 64.35 110.595 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.427 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 84.9 p -71.68 -34.85 70.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.17 -0.468 . . . . 73.15 110.997 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -67.16 -32.09 72.96 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.703 0.801 . . . . 74.51 109.586 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.47 -1.42 65.35 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.196 -0.911 . . . . 74.23 112.837 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m 73.26 10.5 5.11 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.071 1.348 . . . . 73.22 111.627 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -88.04 157.62 50.99 Favored Pre-proline 0 C--O 1.245 0.864 0 N-CA-C 108.961 -0.755 . . . . 64.21 108.961 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.74 113.62 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.418 2.078 . . . . 64.52 111.058 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 119' ' ' SER . 17.6 tt0 -57.06 119.67 6.72 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.515 1.126 . . . . 75.23 110.717 -172.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.8 mt -104.93 101.44 11.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.321 0.648 . . . . 72.15 109.598 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.407 ' OD1' ' HB ' ' C' ' 16' ' ' ILE . 10.1 m-80 -100.07 105.76 17.44 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.523 -1.288 . . . . 75.41 107.523 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.449 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.5 mm? -74.62 157.79 34.79 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.988 0.915 . . . . 73.33 112.513 -167.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' F' ' 129' ' ' LEU . . . -71.35 142.81 87.23 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.86 0.864 . . . . 61.2 111.794 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HB3' HH22 ' A' ' 111' ' ' ARG . 72.8 Cg_endo -86.37 116.31 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.498 2.132 . . . . 70.13 112.827 170.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.29 114.03 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.254 -1.017 . . . . 62.13 108.254 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.89 99.35 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.684 -0.858 . . . . 71.52 108.684 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.678 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 61.8 t80 -69.63 -26.76 64.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.308 0.243 . . . . 64.14 110.516 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.22 -38.62 68.68 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 72.41 110.369 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.03 -48.56 81.15 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.452 0.701 . . . . 63.53 110.81 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -71.56 -37.16 71.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.223 1.009 . . . . 54.01 112.047 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.47 -50.8 42.0 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.732 -0.47 . . . . 72.34 109.732 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.432 ' HB3' ' HB2' ' A' ' 145' ' ' ALA . 97.1 mmm -66.37 -25.39 66.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.221 0.609 . . . . 75.41 110.875 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.689 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 4.0 t-20 -64.16 -42.67 96.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.28 1.032 . . . . 64.41 111.053 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -77.35 -33.07 55.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.362 -0.836 . . . . 74.02 110.572 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.48 -49.86 61.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.431 0.692 . . . . 74.41 110.987 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -155.7 -3.17 0.13 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 116.106 -0.497 . . . . 75.03 111.281 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.689 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.6 tt0 70.79 -73.1 0.1 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.305 1.442 . . . . 72.13 111.205 -174.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -74.74 99.64 3.78 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.853 0.861 . . . . 63.4 109.075 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 138' ' ' MET . . . -91.09 96.14 10.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.578 -0.527 . . . . 74.25 109.578 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.16 -74.15 2.37 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.607 -0.724 . . . . 72.21 113.382 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 65.23 119.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.542 1.537 . . . . 75.13 110.549 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.58 174.88 50.14 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.426 -0.67 . . . . 62.15 111.426 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.6 t -165.74 175.24 8.95 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.258 0.623 . . . . 74.4 110.732 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.75 29.28 1.72 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 107.79 -1.189 . . . . 61.24 107.79 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 58.35 -90.57 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.453 1.501 . . . . 64.35 109.962 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 173.7 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.902 1.281 . . . . 64.0 109.746 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.54 86.69 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.21 1.404 . . . . 61.23 109.51 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.26 112.95 24.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.409 0.684 . . . . 50.33 110.256 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 123.407 0.683 . . . . 73.45 109.678 177.697 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.943 -0.391 . . . . 64.0 109.943 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.9 t -95.39 176.9 6.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.375 0.67 . . . . 55.22 109.595 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' B' ' 93' ' ' GLN . 0.3 OUTLIER -151.99 -74.28 0.14 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.012 -1.477 . . . . 43.31 107.012 175.346 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.92 -23.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.446 1.099 . . . . 74.45 109.144 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 67.3 35.75 4.25 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.595 1.158 . . . . 71.33 111.381 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 61.34 -165.2 0.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.561 1.144 . . . . 73.31 111.036 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.532 HG23 ' HB3' ' B' ' 151' ' ' GLU . 25.0 m 64.4 14.36 8.75 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.886 1.327 . . . . 62.23 110.351 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.49 -144.01 0.17 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 105.751 -1.944 . . . . 74.33 105.751 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptm 50.85 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.092 1.357 . . . . 74.32 114.124 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' B' ' 87' ' ' ALA . 1.1 p -150.57 123.2 8.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.261 1.024 . . . . 72.02 108.412 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -119.74 126.08 50.21 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.547 -0.908 . . . . 70.12 108.547 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.3 tt0 -139.48 132.32 29.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.828 0.851 . . . . 64.02 109.145 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.97 114.82 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.369 -0.975 . . . . 75.42 108.369 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -82.83 -46.24 13.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.783 0.433 . . . . 75.14 110.257 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -164.55 142.24 6.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.573 -0.285 . . . . 73.25 111.176 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.54 141.46 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.231 -1.396 . . . . 71.54 107.231 168.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.471 ' HE1' HG13 ' B' ' 83' ' ' ILE . 14.5 p90 -170.53 151.09 3.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.816 0.673 . . . . 64.41 112.816 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -80.2 123.15 27.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.983 0.913 . . . . 73.3 108.93 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -97.02 -28.84 13.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.329 0.652 . . . . 73.21 110.974 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.683 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.2 t70 -154.09 140.03 18.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.207 -0.452 . . . . 75.02 109.984 -170.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 31.5 mm -133.95 143.57 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.412 1.085 . . . . 72.14 109.098 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -139.64 135.24 33.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.257 1.023 . . . . 73.1 108.81 168.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.61 107.9 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.172 -1.788 . . . . 74.23 106.172 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 22.1 mt-10 -119.07 112.98 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.495 -0.928 . . . . 54.54 108.495 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.21 86.48 21.18 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.974 -1.121 . . . . 73.14 107.974 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.97 -22.81 41.45 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.843 2.362 . . . . 72.12 112.99 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -115.94 22.53 12.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.83 0.852 . . . . 73.34 110.267 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.669 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -49.8 -53.08 45.85 Favored Pre-proline 0 CA--C 1.561 1.367 0 N-CA-C 114.54 1.311 . . . . 64.23 114.54 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.29 -21.39 41.53 Favored 'Trans proline' 0 C--N 1.392 2.82 0 CA-C-N 121.075 1.42 . . . . 75.32 112.646 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.99 1.96 43.03 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.346 1.058 . . . . 70.43 112.623 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' B' ' 123' ' ' PHE . 11.5 p -62.1 -25.83 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.785 1.031 . . . . 70.2 113.785 -167.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -75.84 -0.61 21.81 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.399 0.518 . . . . 61.44 112.399 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.77 -32.93 35.34 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.875 0.87 . . . . 73.11 110.027 165.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.653 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 75.7 mmtt -85.44 84.89 7.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.377 1.071 . . . . 71.33 110.454 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -116.4 83.0 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.546 0.738 . . . . 65.22 111.114 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -166.86 -171.76 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.276 1.43 . . . . 75.33 108.934 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.93 115.67 63.34 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.318 0.647 . . . . 72.23 109.593 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.07 153.37 28.55 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.525 2.15 . . . . 64.34 112.74 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.52 103.78 2.15 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.547 -0.909 . . . . 70.41 108.547 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.53 126.07 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.43 0.692 . . . . 64.33 110.472 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -110.5 127.89 55.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.952 1.301 . . . . 54.33 108.866 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.89 123.61 43.27 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 105.427 -2.064 . . . . 61.55 105.427 161.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.576 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.6 t70 -124.07 129.51 51.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.266 -1.383 . . . . 74.11 107.266 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.513 HD21 HG11 ' B' ' 131' ' ' VAL . 3.9 mp -106.19 136.65 45.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.753 -1.202 . . . . 60.05 107.753 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.437 ' HA ' ' NE1' ' E' ' 120' ' ' TRP . 37.9 t70 -154.71 156.37 36.26 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 71.3 108.691 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -146.27 137.04 24.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.488 0.661 . . . . 64.4 110.167 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.01 158.21 31.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.491 -1.67 . . . . 72.25 106.491 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -145.03 171.31 14.64 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.501 0.592 . . . . 51.34 111.425 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -151.61 135.82 16.71 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.382 -1.34 . . . . 75.12 107.382 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -100.83 110.17 22.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.88 0.764 . . . . 74.21 109.487 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.3 mt -72.34 -30.24 64.56 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.69 0.796 . . . . 73.41 112.002 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 179.18 8.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.861 0.864 . . . . 35.32 109.456 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.49 121.09 12.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.222 -0.899 . . . . 74.43 108.603 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 19.5 m-20 76.24 -5.72 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.992 1.717 . . . . 74.13 112.726 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -107.31 88.79 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.006 -1.109 . . . . 50.25 108.006 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.94 138.33 38.14 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.522 -0.918 . . . . 72.32 108.522 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -110.75 100.98 9.64 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.023 -1.473 . . . . 42.45 107.023 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.45 124.21 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.398 0.679 . . . . 73.04 109.762 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.599 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -106.03 116.34 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.778 0.831 . . . . 41.4 110.043 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.28 113.92 26.3 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.076 -1.083 . . . . 70.43 108.076 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -99.62 109.62 22.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.986 0.915 . . . . 74.12 109.829 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.8 t -106.24 119.24 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.912 -0.773 . . . . 71.22 108.912 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.1 m -106.08 146.94 29.52 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.292 1.037 . . . . 51.54 109.616 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.491 HG23 HD13 ' B' ' 114' ' ' ILE . 55.8 t -132.68 131.77 59.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.405 1.082 . . . . 74.32 108.572 173.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.0 m -124.44 136.5 54.09 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.521 -0.918 . . . . 60.35 108.521 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.8 131.06 30.61 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.745 -1.206 . . . . 52.15 107.745 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 66.4 p -137.57 134.24 35.39 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.071 0.548 . . . . 72.04 109.884 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.653 ' HB3' ' HD2' ' B' ' 34' ' ' LYS . 0.9 OUTLIER -113.6 117.78 32.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.336 -1.357 . . . . 75.24 107.336 -179.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.64 -130.25 10.14 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.793 -0.523 . . . . 55.23 111.793 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.27 31.67 5.21 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.893 0.877 . . . . 74.21 109.655 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.83 145.28 28.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.477 0.711 . . . . 61.45 110.082 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -68.12 132.14 46.68 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 122.863 0.465 . . . . 72.04 110.392 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.443 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.87 -55.39 3.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.079 . . . . 73.03 108.721 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -163.58 164.7 24.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.32 110.842 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 52.3 mt -133.42 145.34 50.19 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.203 1.401 . . . . 74.03 107.739 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.7 t -153.63 143.14 21.69 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.409 -0.96 . . . . 72.24 108.409 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -158.99 133.14 7.7 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.809 -0.812 . . . . 75.05 108.809 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' B' ' 113' ' ' CYS . 90.1 t -125.22 145.45 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.858 . . . . 70.21 108.916 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.7 mt-30 -119.97 93.59 4.11 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.332 -0.988 . . . . 75.42 108.332 171.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.439 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -84.01 100.23 10.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.52 -0.763 . . . . 63.24 109.263 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.41 166.47 36.42 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.71 -0.556 . . . . 73.11 111.71 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.47 126.66 1.51 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.462 -0.655 . . . . 53.25 111.462 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 33.5 mt -85.97 116.1 28.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 53.01 108.581 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.51 163.79 17.41 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.687 -0.857 . . . . 72.31 108.687 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.663 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.9 m -129.68 93.22 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.783 -1.191 . . . . 63.55 107.783 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' B' ' 97' ' ' CYS . 0.1 OUTLIER -112.31 111.68 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 107.969 -1.123 . . . . 73.15 107.969 -175.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' B' ' 54' ' ' ASP . . . -130.55 159.37 37.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.914 0.885 . . . . 53.2 110.499 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.48 -42.97 2.04 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.605 0.566 . . . . 64.02 114.096 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.455 HG12 ' HB3' ' B' ' 94' ' ' MET . 0.2 OUTLIER -74.58 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.942 0.897 . . . . 71.22 112.527 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.546 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.4 pt-20 -161.41 -178.2 6.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.917 -1.038 . . . . 74.32 110.547 166.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.62 -118.9 15.96 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.348 -0.842 . . . . 74.01 114.488 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -71.72 -35.64 70.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.685 0.794 . . . . 75.34 111.143 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HB2' ' HG3' ' B' ' 3' ' ' GLU . 1.6 tt0 -73.54 -35.41 65.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.801 0.441 . . . . 73.55 110.878 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.546 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 24.2 ptt? -74.72 -25.65 59.27 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.45 0.3 . . . . 73.44 110.964 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.16 82.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.249 0.62 . . . . 64.1 111.266 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 16.8 m-70 -85.34 -21.34 28.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.202 0.601 . . . . 73.24 111.453 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' B' ' 86' ' ' ILE . 35.8 t -84.37 -62.74 1.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.926 0.394 . . . . 73.33 110.403 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.0 -27.0 61.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.819 0.448 . . . . 73.54 111.456 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.58 -1.31 60.45 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.422 -0.655 . . . . 51.34 114.381 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -150.16 -50.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.995 0.897 . . . . 72.23 112.674 -174.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -65.23 -49.34 70.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.455 0.702 . . . . 61.14 110.744 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.487 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.9 m -64.0 -51.73 61.36 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-O 118.538 -0.744 . . . . 72.41 111.575 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.4 Cg_exo -53.37 -34.56 71.53 Favored 'Trans proline' 0 C--N 1.403 3.405 0 C-N-CA 122.627 2.218 . . . . 73.32 114.726 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.73 -37.9 89.18 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.069 0.548 . . . . 62.12 111.163 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.59 -43.33 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.709 0.804 . . . . 52.24 110.038 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.28 -20.91 50.6 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.147 -0.933 . . . . 71.42 112.504 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -59.69 -51.59 79.87 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 117.844 -1.074 . . . . 73.22 113.769 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.06 -34.43 92.57 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 122.088 1.859 . . . . 44.13 113.285 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 89.1 m-85 -68.63 -49.74 56.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.695 0.798 . . . . 75.41 110.824 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.98 84.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.544 0.738 . . . . 70.41 110.808 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.46 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.8 ttt180 -62.67 -52.56 62.84 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 63.54 110.956 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.97 -38.33 90.69 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.135 -0.938 . . . . 62.4 110.167 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.433 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -69.31 -34.31 74.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.93 -0.577 . . . . 74.2 111.929 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.491 HD13 HG23 ' B' ' 64' ' ' VAL . 66.0 mt -64.66 -57.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.023 0.529 . . . . 71.24 109.584 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.3 m -60.4 -31.16 70.1 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.942 0.776 . . . . 64.52 111.5 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.2 t -62.84 -48.29 79.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.85 0.86 . . . . 63.21 110.917 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.2 mmt -67.83 -34.41 76.68 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.91 0.484 . . . . 61.04 110.867 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.519 HG11 HD13 ' B' ' 126' ' ' LEU . 74.1 t -63.21 -37.66 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 124.17 0.988 . . . . 72.23 110.86 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -63.83 -40.64 97.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.533 0.733 . . . . 53.45 110.866 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -64.39 -32.05 73.5 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.735 -1.12 . . . . 61.11 111.947 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.76 17.5 56.27 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.672 0.608 . . . . 54.01 113.697 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.403 HG23 ' HB3' ' A' ' 17' ' ' TYR . 73.0 p 60.53 26.74 16.39 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.616 1.566 . . . . 72.04 112.912 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.426 ' CE1' HG21 ' B' ' 31' ' ' VAL . 81.3 m-85 -91.84 156.79 42.31 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.395 0.678 . . . . 74.52 110.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.41 177.42 3.27 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 123.238 2.625 . . . . 75.3 114.241 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -67.26 124.32 22.78 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.825 -1.079 . . . . 65.2 111.62 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.519 HD13 HG11 ' B' ' 118' ' ' VAL . 11.0 mp -117.27 96.41 5.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.96 0.904 . . . . 71.35 109.36 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.694 HD21 HG23 ' E' ' 130' ' ' ILE . 0.2 OUTLIER -91.75 92.63 8.5 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.08 0.467 . . . . 74.43 110.29 173.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.46 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 73.1 mt -67.27 141.9 57.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.175 0.59 . . . . 63.13 110.606 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 143.27 39.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.224 0.61 . . . . 55.34 110.558 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.7 123.34 12.48 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.129 2.552 . . . . 74.33 111.598 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.513 HG11 HD21 ' B' ' 44' ' ' LEU . 12.8 t -100.0 127.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.753 -0.462 . . . . 62.21 109.753 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.61 96.43 10.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.957 -1.127 . . . . 62.33 107.957 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.463 ' HD1' ' HH2' ' E' ' 120' ' ' TRP . 58.8 m-85 -59.17 -34.52 72.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 65.44 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.72 -39.09 93.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.384 -1.28 . . . . 73.31 111.198 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.19 78.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.322 0.649 . . . . 74.02 111.585 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.63 -49.63 74.41 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.849 0.718 . . . . 62.53 110.274 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -75.07 -20.42 59.52 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.687 -0.688 . . . . 74.12 112.588 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.714 ' SD ' ' HB2' ' B' ' 145' ' ' ALA . 71.8 mtm -74.8 -38.28 62.15 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.938 -0.393 . . . . 54.41 109.938 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -74.53 -19.55 60.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.994 0.518 . . . . 74.43 110.96 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.167 0.508 . . . . 63.21 110.389 170.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.6 mt -100.76 13.46 34.86 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.87 0.868 . . . . 73.2 111.497 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 63.37 51.81 2.54 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.221 1.008 . . . . 72.14 110.082 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 56.32 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.456 1.503 . . . . 73.41 110.839 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -132.61 109.06 9.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.367 0.667 . . . . 61.31 109.797 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.714 ' HB2' ' SD ' ' B' ' 138' ' ' MET . . . -145.4 154.03 41.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.098 0.959 . . . . 64.34 110.27 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.22 121.71 1.12 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.483 -0.647 . . . . 73.24 111.483 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -78.97 111.94 15.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.971 -0.751 . . . . 74.32 108.971 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.07 61.05 0.23 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 112.27 -0.332 . . . . 73.44 112.27 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 83.3 m -122.78 83.46 2.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.953 0.901 . . . . 63.21 108.724 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.616 ' HA ' HD23 ' F' ' 148' ' ' LEU . 43.3 mt-10 -135.54 152.43 51.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 74.42 109.23 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.532 ' HB3' HG23 ' B' ' 7' ' ' THR . 9.7 tp10 69.74 143.64 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.462 1.505 . . . . 74.43 111.408 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -84.82 143.72 28.9 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.893 -0.78 . . . . 54.01 108.893 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.83 84.69 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.738 -1.578 . . . . 74.4 106.738 166.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -93.25 108.99 20.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.134 -0.939 . . . . 75.23 109.173 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.315 0.646 . . . . 70.43 109.356 178.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' F' ' 122' ' ' ALA . 64.9 mtt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -149.44 145.59 27.0 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.787 0.835 . . . . 63.3 109.378 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.63 178.9 7.01 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.958 0.903 . . . . 64.14 109.648 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 66.38 141.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.296 1.438 . . . . 74.32 111.73 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -161.16 136.15 7.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.229 0.612 . . . . 71.02 110.726 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -128.61 93.63 3.67 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.422 -1.325 . . . . 72.22 107.422 170.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -67.4 99.0 0.69 Allowed 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.348 -0.842 . . . . 64.02 110.981 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.34 131.31 46.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.79 -0.818 . . . . 72.11 108.79 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 44.6 ttp 63.88 112.68 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.706 1.254 . . . . 74.1 110.401 -166.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 12.4 m -86.79 76.29 9.49 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.604 -1.258 . . . . 51.33 107.604 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -92.0 129.19 38.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.211 -0.904 . . . . 73.02 108.591 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.88 139.53 21.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.696 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -82.56 133.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 107.542 -1.281 . . . . 72.24 107.542 174.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.9 mm-40 -107.62 -46.91 3.72 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.355 0.662 . . . . 65.21 110.006 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -166.79 141.15 4.02 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.59 -0.732 . . . . 71.22 109.654 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.696 HG13 HD11 ' C' ' 13' ' ' ILE . 86.3 mt -129.39 142.01 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 106.926 -1.509 . . . . 70.24 106.926 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -174.03 160.46 3.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.624 0.77 . . . . 54.43 110.248 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.5 p -85.47 107.37 17.39 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.706 -0.679 . . . . 63.2 109.544 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -65.97 -41.84 90.64 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.281 -0.637 . . . . 52.14 109.281 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.6 t70 -147.8 147.12 29.5 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.768 -0.651 . . . . 75.15 109.815 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.2 mt -143.79 145.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.484 1.513 . . . . 64.42 106.965 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -157.96 150.07 22.09 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.081 0.553 . . . . 61.24 109.55 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -146.15 123.27 11.47 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.655 -1.239 . . . . 63.1 107.655 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 36.0 mt-10 -123.59 112.43 17.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.46 0.704 . . . . 60.43 109.558 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -118.22 85.92 25.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.69 -0.856 . . . . 71.23 108.69 172.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -36.33 10.79 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.586 2.19 . . . . 75.55 111.429 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 66.8 m-80 -106.45 36.05 2.75 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.151 -0.931 . . . . 73.11 110.156 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -56.11 -47.18 99.34 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.504 1.122 . . . . 65.32 112.536 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 16.4 Cg_endo -94.39 -10.04 1.48 Allowed 'Trans proline' 0 C--N 1.397 3.111 0 C-N-CA 122.257 1.971 . . . . 63.02 113.641 173.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-160 -71.96 -30.95 65.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.332 0.653 . . . . 73.25 111.282 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.576 HG11 ' HE1' ' C' ' 123' ' ' PHE . 7.6 p -76.76 -13.73 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.839 0.855 . . . . 75.44 111.832 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -51.51 -37.34 48.76 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.407 1.483 . . . . 73.43 113.259 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -126.54 26.49 6.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.399 0.68 . . . . 71.52 110.134 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -125.4 153.0 44.08 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.252 -0.905 . . . . 73.41 111.922 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.85 133.14 47.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.536 1.534 . . . . 61.15 112.586 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.521 ' HB3' ' HB1' ' E' ' 135' ' ' ALA . 24.2 p90 -86.1 104.76 15.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.691 0.796 . . . . 74.55 110.598 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -161.47 68.5 2.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.441 -0.948 . . . . 63.22 108.441 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -86.92 138.47 5.04 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.063 1.842 . . . . 71.21 110.959 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.46 97.62 9.08 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.771 -1.937 . . . . 71.13 105.771 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -79.37 99.45 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.812 -1.085 . . . . 63.41 110.837 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -93.51 117.1 29.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.278 -0.874 . . . . 63.41 110.185 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -92.02 148.29 22.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.686 -0.857 . . . . 53.15 108.686 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.9 t70 -146.77 112.45 5.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.16 -1.052 . . . . 73.24 108.16 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.37 111.56 24.04 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.043 -1.095 . . . . 73.24 108.043 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -123.61 158.55 31.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.686 1.195 . . . . 70.02 108.657 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -145.64 151.36 37.93 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.281 0.562 . . . . 64.22 109.742 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 173.8 11.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.541 1.136 . . . . 74.35 108.338 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.7 p -152.3 148.09 27.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 122.866 0.467 . . . . 61.14 110.016 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -145.38 125.47 13.68 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.675 -1.231 . . . . 75.15 107.675 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.44 115.16 22.4 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.369 -0.974 . . . . 74.12 108.369 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.594 HD11 HD12 ' C' ' 83' ' ' ILE . 58.9 mt -84.92 -39.33 18.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.458 0.703 . . . . 65.45 110.272 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.71 -173.33 4.06 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.021 -0.99 . . . . 43.35 110.384 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.28 111.73 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.34 -1.3 . . . . 74.1 110.322 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 64.8 17.52 11.03 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.611 1.164 . . . . 75.43 112.443 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.4 103.82 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.343 -0.984 . . . . 75.54 108.343 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -118.12 125.84 51.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.82 0.848 . . . . 71.0 109.933 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.5 tt0 -84.03 112.09 19.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.05 0.94 . . . . 65.31 109.306 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.72 129.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.745 -1.206 . . . . 74.32 107.745 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.42 105.23 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.68 100.38 12.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.192 -1.04 . . . . 63.33 108.192 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -93.43 111.33 22.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.097 1.359 . . . . 64.0 109.486 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' C' ' 114' ' ' ILE . 2.9 t -103.11 137.23 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.02 -0.733 . . . . 72.23 109.02 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 54.1 m -119.17 133.76 55.59 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.541 -0.911 . . . . 70.32 108.541 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.54 HG21 HG21 ' C' ' 114' ' ' ILE . 93.9 t -124.76 117.31 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.979 1.312 . . . . 61.33 107.49 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -117.02 134.4 54.79 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.937 -0.764 . . . . 71.21 108.937 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.0 95.52 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.889 -1.523 . . . . 63.52 106.889 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -149.07 123.16 9.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.367 0.267 . . . . 60.5 111.317 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -85.86 77.29 9.75 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.045 -1.095 . . . . 54.14 108.045 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.44 -93.23 0.24 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.169 -0.923 . . . . 74.23 112.643 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.4 -15.48 21.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.998 0.919 . . . . 65.31 111.522 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -98.1 95.42 7.43 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.088 0.555 . . . . 63.05 110.231 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.8 m -89.46 118.39 29.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.012 0.434 . . . . 65.12 111.242 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.83 -53.44 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.127 0.971 . . . . 63.43 108.846 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.15 168.48 27.3 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.454 -1.248 . . . . 63.11 111.844 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.4 tm? -140.65 146.31 37.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.39 -2.078 . . . . 72.5 105.39 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.8 t -153.33 130.81 11.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.179 -0.675 . . . . 64.3 109.179 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -136.36 129.55 31.48 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.757 -0.46 . . . . 50.51 109.757 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.71 114.67 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.857 . . . . 55.54 109.062 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.99 95.44 10.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.146 0.978 . . . . 64.43 108.701 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -83.67 105.76 14.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.851 -0.613 . . . . 72.51 109.685 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.24 144.37 21.63 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.565 -0.614 . . . . 61.43 111.565 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.43 117.16 0.93 Allowed Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 110.155 -1.178 . . . . 71.32 110.155 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.594 HD12 HD11 ' C' ' 51' ' ' LEU . 11.2 mm -81.52 122.33 36.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.093 -1.077 . . . . 73.2 108.093 176.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -131.2 128.75 40.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.731 0.812 . . . . 74.3 109.028 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.3 m -71.36 114.19 9.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.128 -0.693 . . . . 71.1 109.128 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 mm -116.85 101.24 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.957 0.903 . . . . 74.31 108.64 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -133.94 150.58 51.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.698 . . . . 52.41 109.76 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -47.12 3.58 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 121.247 0.36 . . . . 24.42 113.074 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.75 149.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.84 1.256 . . . . 65.44 110.527 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -160.6 155.93 24.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.935 0.494 . . . . 74.14 111.032 -174.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.09 -142.76 28.89 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.166 0.412 . . . . 51.02 113.687 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -61.42 -24.72 66.72 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.161 0.984 . . . . 74.44 111.821 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -58.95 -57.39 13.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.82 0.848 . . . . 75.23 110.097 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 26.6 ptm -74.41 -23.35 58.94 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.775 -0.648 . . . . 62.43 111.056 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.63 84.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.296 0.638 . . . . 65.14 111.064 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.51 -29.99 68.71 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.255 0.622 . . . . 75.51 110.955 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.37 -62.34 1.51 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.536 0.334 . . . . 73.35 110.296 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.8 pp -76.08 -12.92 60.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.172 0.589 . . . . 74.4 112.521 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.38 33.16 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.587 -0.563 . . . . 53.25 113.962 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' C' ' 133' ' ' PHE . . . -148.28 -56.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 117.626 0.713 . . . . 65.03 111.588 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -70.78 -61.46 1.76 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.684 0.394 . . . . 74.32 111.798 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 69.3 m -54.86 -45.5 99.7 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.97 0.908 . . . . 40.32 112.291 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -47.97 -48.57 15.94 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.757 2.304 . . . . 63.51 113.72 167.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.63 -15.42 60.82 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.687 0.795 . . . . 71.34 113.114 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.51 HD12 HH12 ' A' ' 111' ' ' ARG . 36.3 mm -75.5 -40.89 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.279 -0.637 . . . . 75.42 109.279 169.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.418 HD21 ' HA3' ' C' ' 82' ' ' GLY . 67.8 mt -86.31 -17.92 33.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.178 0.991 . . . . 74.21 111.915 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.43 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 50.2 t80 -65.12 -46.63 73.17 Favored Pre-proline 0 CA--C 1.55 0.981 0 CA-C-O 117.535 -1.221 . . . . 63.2 113.031 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.89 -37.75 97.49 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.942 1.761 . . . . 63.13 112.634 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -65.28 -52.68 52.7 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 74.42 110.873 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.16 -35.17 79.77 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.151 0.58 . . . . 74.1 111.351 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.24 -53.11 61.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.573 1.149 . . . . 73.13 110.217 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.1 tm-20 -67.35 -34.94 78.36 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.837 0.711 . . . . 71.24 110.107 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 27.6 t -67.39 -32.92 74.16 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.071 0.548 . . . . 73.34 111.393 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.54 HG21 HG21 ' C' ' 64' ' ' VAL . 88.7 mt -73.11 -51.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.362 0.665 . . . . 74.1 110.223 172.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 34.8 m -63.03 -29.0 70.48 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.281 0.632 . . . . 51.23 110.929 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.4 t -65.44 -52.4 53.46 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.306 -0.861 . . . . 73.13 109.033 170.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.487 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -56.53 -40.44 75.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.889 1.276 . . . . 73.44 113.016 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -65.89 -45.2 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.667 0.787 . . . . 52.4 109.761 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.44 ' HB2' HE22 ' C' ' 125' ' ' GLN . 35.9 t -70.64 -24.01 62.63 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.153 -0.931 . . . . 53.34 111.26 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.4 mtt-85 -69.94 -36.41 75.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.472 0.709 . . . . 72.21 109.272 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.34 10.06 62.43 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 124.002 0.814 . . . . 51.44 112.79 172.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.44 HG23 ' HB3' ' D' ' 17' ' ' TYR . 81.9 p 57.61 37.21 27.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.046 1.738 . . . . 44.02 113.425 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.576 ' HE1' HG11 ' C' ' 31' ' ' VAL . 61.1 m-85 -105.73 162.23 20.36 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.363 1.065 . . . . 73.12 110.216 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.422 ' HB3' ' HA ' ' E' ' 136' ' ' VAL . 25.5 Cg_endo -59.99 146.0 97.02 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.107 2.538 . . . . 55.24 113.384 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.44 HE22 ' HB2' ' C' ' 119' ' ' SER . 1.8 mp0 -58.49 108.92 0.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.003 0.921 . . . . 74.2 109.632 173.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.2 tp -110.21 91.64 3.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.839 -1.171 . . . . 72.23 107.839 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -91.17 115.47 28.05 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.564 -0.902 . . . . 72.33 108.564 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.43 ' HB3' ' HZ ' ' C' ' 107' ' ' PHE . 2.3 tt -64.97 132.86 50.42 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.94 139.42 70.72 Favored Pre-proline 0 CA--C 1.549 0.921 0 O-C-N 124.11 0.882 . . . . 62.35 110.968 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.48 104.61 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.303 2.002 . . . . 72.14 111.296 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.0 107.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 108.402 -0.962 . . . . 74.42 108.402 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -113.23 89.52 3.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.498 0.719 . . . . 73.43 110.149 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.438 ' HD2' ' HB2' ' C' ' 100' ' ' ALA . 67.7 t80 -70.78 -30.32 66.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.049 -0.978 . . . . 72.13 109.428 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.08 -39.5 82.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.245 1.018 . . . . 73.52 111.364 173.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.13 70.28 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.719 0.808 . . . . 55.42 111.885 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.9 -39.38 94.04 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.637 0.775 . . . . 74.35 110.776 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -74.04 -41.05 62.38 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.656 -1.156 . . . . 62.33 110.509 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.668 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 25.8 ttt -65.67 -45.23 83.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.165 0.986 . . . . 61.5 112.37 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -65.28 -38.19 89.52 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.339 0.399 . . . . 72.55 110.174 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.88 -88.04 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 O-C-N 124.321 1.013 . . . . 73.12 111.479 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.21 82.92 1.81 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.954 0.902 . . . . 52.14 108.604 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.668 ' HB2' ' HA ' ' C' ' 138' ' ' MET . 27.8 tt0 -94.5 99.08 11.3 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.054 -0.721 . . . . 75.32 109.054 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -65.06 125.54 25.24 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.018 -0.992 . . . . 62.0 110.231 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.08 170.17 19.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.48 0.657 . . . . 55.41 111.674 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.7 -177.2 6.1 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 125.138 1.375 . . . . 54.21 108.22 173.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.03 -37.21 0.32 Allowed Glycine 0 N--CA 1.471 1.018 0 N-CA-C 111.529 -0.628 . . . . 72.32 111.529 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 61.42 84.86 0.13 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.887 1.275 . . . . 73.42 111.59 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.58 -127.31 44.65 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 124.036 0.835 . . . . 63.23 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -176.27 178.17 1.41 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.484 1.113 . . . . 72.43 109.072 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -134.27 139.82 45.99 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.552 0.741 . . . . 72.0 109.361 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -147.6 150.08 33.76 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.232 -1.025 . . . . 64.11 108.232 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 63.95 83.69 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.51 1.124 . . . . 62.31 110.677 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.73 -35.38 67.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.237 -0.892 . . . . 74.45 111.514 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.85 163.29 38.43 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.293 0.637 . . . . 72.54 111.266 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.039 0 C-N-CA 123.867 0.867 . . . . 72.34 111.045 -177.647 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.152 -0.684 . . . . 74.21 109.152 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -59.81 95.12 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.767 0.827 . . . . 71.45 110.323 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -74.59 114.06 12.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.899 0.88 . . . . 73.23 109.479 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -155.37 -170.29 3.41 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 122.834 0.454 . . . . 73.1 110.186 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -68.42 79.94 0.26 Allowed 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 122.299 1.047 . . . . 73.31 110.128 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.405 1.082 . . . . 73.12 108.618 -172.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.5 m 64.18 31.86 12.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.772 1.229 . . . . 72.11 109.143 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.25 76.68 4.76 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.255 -1.339 . . . . 71.31 107.898 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.6 ttp -34.27 125.99 0.47 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.469 1.508 . . . . 75.14 113.13 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.0 m -115.26 135.15 54.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.173 -1.047 . . . . 73.13 108.173 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' D' ' 85' ' ' SER . 72.0 t80 -154.22 119.31 5.03 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.443 -0.947 . . . . 64.41 108.443 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -132.37 147.21 52.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.565 0.746 . . . . 64.42 110.371 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 122.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.916 -1.142 . . . . 72.3 107.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -100.3 -46.36 5.29 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.1 -0.375 . . . . 75.22 110.224 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -169.92 121.99 0.69 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.484 0.49 . . . . 72.42 110.606 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.63 131.76 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 107.469 -1.308 . . . . 63.31 107.469 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HE2' ' HG2' ' D' ' 19' ' ' LYS . 44.3 p90 -162.52 178.47 8.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.52 0.676 . . . . 64.42 111.794 -173.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.2 p -104.91 123.75 48.29 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.671 0.788 . . . . 44.51 109.654 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' HE2' ' D' ' 17' ' ' TYR . 32.3 mtpt -91.27 -22.96 20.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.965 -0.383 . . . . 61.23 109.965 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.9 t70 -155.11 141.73 18.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.521 0.728 . . . . 73.05 109.76 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.482 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.2 mt -140.84 147.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.01 1.324 . . . . 71.14 108.085 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.74 145.99 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.843 0.857 . . . . 61.35 109.34 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.3 t80 -148.97 124.93 10.63 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.649 -1.611 . . . . 61.21 106.649 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.6 mt-10 -124.31 142.16 51.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.581 0.753 . . . . 73.24 109.487 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.685 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -147.68 76.31 10.8 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.763 0.825 . . . . 64.13 109.081 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.54 -47.71 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.43 2.087 . . . . 72.01 111.622 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' D' ' 72' ' ' THR . 6.7 m120 -97.12 36.13 1.48 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.953 0.901 . . . . 74.44 108.955 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.685 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.47 -54.66 52.68 Favored Pre-proline 0 CA--C 1.559 1.289 0 N-CA-C 114.294 1.22 . . . . 33.11 114.294 -172.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.04 -7.3 14.23 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 121.237 1.477 . . . . 71.33 112.605 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -83.83 -38.81 20.74 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.214 1.406 . . . . 73.53 110.099 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -82.96 -20.83 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 73.44 110.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.23 -28.91 69.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.856 0.862 . . . . 73.23 110.688 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -67.04 -20.39 65.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.749 1.219 . . . . 75.31 111.557 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -100.86 111.59 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.271 1.029 . . . . 74.44 110.059 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -85.86 63.26 7.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.354 1.061 . . . . 73.13 111.108 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.523 ' HB3' HD11 ' D' ' 68' ' ' LEU . 48.2 t-105 -144.69 167.98 21.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.71 116.64 66.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.586 0.754 . . . . 73.34 110.031 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.436 ' O ' HD11 ' F' ' 139' ' ' LEU . 95.2 Cg_exo -50.61 133.93 39.17 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.642 2.894 . . . . 42.45 113.764 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.39 130.6 43.89 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.782 -0.451 . . . . 71.01 109.782 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.43 134.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.382 0.673 . . . . 53.53 110.786 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.1 tmtt? -130.6 121.38 25.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.428 -1.693 . . . . 72.11 106.428 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 146.9 26.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.102 0.561 . . . . 61.34 110.978 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.8 m-20 -137.14 122.95 20.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.215 1.406 . . . . 73.11 107.609 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -117.2 144.24 44.99 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.986 0.514 . . . . 71.42 110.943 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 2.6 t70 -146.82 154.02 40.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.511 1.124 . . . . 74.11 109.3 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -142.76 148.42 37.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.469 0.708 . . . . 71.13 109.775 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 168.0 25.01 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.651 1.18 . . . . 70.5 108.14 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -160.5 153.83 21.96 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.054 0.454 . . . . 74.41 111.244 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -154.36 119.6 5.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.717 1.207 . . . . 63.44 108.98 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.58 126.28 29.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.167 0.587 . . . . 73.53 109.543 175.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.66 -40.69 13.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.942 0.497 . . . . 75.33 109.701 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.14 -174.97 4.99 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.078 -0.964 . . . . 70.22 110.243 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -63.08 123.35 18.36 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.631 -0.713 . . . . 63.42 110.301 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.44 -2.24 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.873 1.269 . . . . 73.43 112.909 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.68 118.68 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.842 0.857 . . . . 63.44 108.868 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -128.97 128.53 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.877 -1.157 . . . . 75.51 107.877 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -97.13 141.33 30.4 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.824 -1.547 . . . . 64.15 106.824 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.26 130.55 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.052 -0.722 . . . . 73.42 109.052 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.82 138.84 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 123.916 0.887 . . . . 74.2 109.684 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.17 120.77 27.95 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.528 -1.286 . . . . 54.22 107.528 171.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -107.25 121.62 44.91 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.231 1.012 . . . . 75.54 109.32 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.59 122.49 67.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.613 -1.255 . . . . 73.11 107.613 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.6 m -121.2 131.81 54.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.743 0.817 . . . . 63.31 109.462 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.503 HG23 HD13 ' D' ' 114' ' ' ILE . 80.7 t -119.55 109.13 25.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.082 1.353 . . . . 70.14 109.261 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 23.6 m -94.89 117.68 30.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.144 -1.058 . . . . 74.55 108.144 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.92 133.07 51.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.464 -0.569 . . . . 62.24 109.464 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 51.2 p -145.83 134.82 22.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.069 0.548 . . . . 70.22 109.797 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' D' ' 36' ' ' TRP . 19.0 tp -117.87 118.94 33.37 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.105 -0.702 . . . . 63.13 109.105 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.09 -115.18 4.01 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.15 -0.78 . . . . 43.54 111.15 -170.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.19 9.06 10.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.032 0.933 . . . . 61.43 110.268 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.88 156.56 39.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.014 0.926 . . . . 64.3 110.298 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 99.1 m -68.83 123.99 22.47 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.654 0.782 . . . . 70.23 110.576 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.52 -57.28 3.21 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.707 0.803 . . . . 61.44 109.322 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.94 149.75 16.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.801 -1.091 . . . . 74.04 109.683 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -113.65 153.64 28.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.418 1.087 . . . . 62.3 108.209 172.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.594 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.8 t -156.09 142.41 18.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.106 0.562 . . . . 75.21 109.592 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.22 121.4 4.3 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.838 0.455 . . . . 64.41 110.075 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.448 HG22 HG23 ' D' ' 21' ' ' ILE . 60.3 t -126.31 115.26 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.316 0.647 . . . . 74.33 109.973 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.2 mt-30 -89.16 87.76 7.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.737 -0.838 . . . . 60.14 108.737 169.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -79.89 104.04 10.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.516 -1.22 . . . . 74.34 108.664 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.59 143.68 15.7 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.901 -0.479 . . . . 61.22 111.901 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.453 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.99 131.41 4.57 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.789 -0.524 . . . . 73.52 111.789 -171.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.4 mt -88.8 123.03 40.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 C-N-CA 123.926 0.89 . . . . 64.44 108.761 175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -128.64 163.05 25.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.925 0.89 . . . . 71.25 109.98 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.8 m -107.3 112.88 25.94 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.529 -0.915 . . . . 71.21 108.529 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.77 115.63 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 107.877 -1.157 . . . . 73.43 107.877 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -145.91 157.6 43.89 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.318 1.047 . . . . 54.21 109.785 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.44 -14.28 12.96 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.086 -0.506 . . . . 44.44 113.567 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.9 138.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.956 1.303 . . . . 74.11 109.312 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -152.4 -177.35 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.2 0.6 . . . . 73.34 110.718 174.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.64 -120.15 6.81 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.037 -0.529 . . . . 64.01 112.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' THR . . . . . 0.504 ' HB ' HD23 ' D' ' 141' ' ' LEU . 23.9 p -64.33 -39.3 93.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.805 0.842 . . . . 75.44 111.301 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.91 -37.63 72.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.738 0.415 . . . . 73.4 111.094 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.659 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 58.3 ttp -72.58 -36.1 68.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.596 0.359 . . . . 74.32 110.567 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.71 86.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.169 0.588 . . . . 61.42 110.392 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -68.3 -37.72 80.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.814 0.846 . . . . 73.44 110.809 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' D' ' 102' ' ' CYS . 33.3 t -68.68 -51.25 43.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.673 0.389 . . . . 61.43 110.158 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.41 -18.78 59.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.347 0.659 . . . . 65.41 111.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.61 -8.98 44.87 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.409 -0.662 . . . . 74.12 114.14 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.94 -63.19 0.35 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.878 0.839 . . . . 70.52 112.25 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.13 -56.52 11.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.397 0.888 . . . . 72.53 113.397 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' D' ' 97' ' ' CYS . 65.4 m -61.91 -43.27 86.51 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-O 118.594 -0.717 . . . . 75.32 111.606 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -51.6 -39.6 65.38 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.463 2.109 . . . . 61.02 114.121 164.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -69.98 -25.29 63.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.599 0.76 . . . . 74.5 111.063 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 48.2 mm -70.27 -40.61 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.349 0.66 . . . . 53.22 110.112 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.453 HD21 ' HA3' ' D' ' 82' ' ' GLY . 61.7 mt -77.06 -26.51 53.62 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.194 -0.912 . . . . 50.0 111.667 -174.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.505 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 85.4 t80 -53.97 -47.91 95.52 Favored Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 125.039 1.336 . . . . 73.43 114.469 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 80.7 Cg_exo -51.0 -41.07 57.97 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.431 2.087 . . . . 63.54 113.712 172.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -75.87 -34.98 60.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.892 0.877 . . . . 75.44 111.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.84 73.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.141 0.577 . . . . 71.24 109.894 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -56.45 -48.34 77.25 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.581 1.176 . . . . 70.23 110.234 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.45 -44.69 95.81 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.081 0.863 . . . . 74.51 111.121 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.6 t -61.38 -43.71 98.41 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.594 0.559 . . . . 73.21 110.856 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.594 HG12 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -57.11 -57.91 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.877 0.871 . . . . 63.51 110.23 173.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.587 HG23 ' HG3' ' D' ' 125' ' ' GLN . 87.9 m -53.79 -46.69 71.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.362 1.465 . . . . 73.02 112.02 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -62.55 -41.11 98.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.91 -1.041 . . . . 71.14 110.036 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.05 -33.8 72.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.144 0.578 . . . . 73.15 111.667 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -64.39 -43.3 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.594 0.758 . . . . 75.05 110.406 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.79 -33.51 66.32 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 116.105 -0.498 . . . . 73.54 110.704 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -68.06 -32.68 73.2 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.997 0.919 . . . . 75.0 110.42 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.04 81.86 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.719 -0.673 . . . . 52.45 112.849 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 56.18 45.15 23.85 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.446 1.498 . . . . 72.23 112.258 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -117.85 155.37 50.98 Favored Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.799 -1.092 . . . . 75.11 110.23 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.48 112.07 0.61 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.25 2.633 . . . . 53.22 112.321 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.587 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.9 tt0 -61.28 128.74 37.83 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.148 0.905 . . . . 75.2 112.025 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.25 120.29 41.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.878 -1.156 . . . . 64.34 107.878 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -112.72 95.13 5.25 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.864 -1.162 . . . . 62.03 107.864 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.505 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.2 OUTLIER -70.34 125.93 28.19 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.062 0.545 . . . . 72.12 109.642 -174.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 142.14 96.66 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.896 0.878 . . . . 73.41 111.508 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.4 124.9 6.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.948 2.432 . . . . 74.32 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -127.27 123.72 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.947 0.899 . . . . 54.52 109.481 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -76.82 94.83 3.93 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.894 -0.78 . . . . 75.33 108.894 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.47 ' HA ' HD23 ' D' ' 136' ' ' LEU . 19.7 p90 -85.31 -16.83 38.72 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.815 -0.612 . . . . 74.24 111.256 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' D' ' 138' ' ' MET . 2.2 m-20 -48.61 -50.75 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.077 0.951 . . . . 64.12 111.482 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' B' ' 150' ' ' GLU . . . -51.14 -38.08 49.94 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 124.298 0.999 . . . . 54.12 113.112 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' D' ' 133' ' ' PHE . 2.9 mm? -78.67 -35.6 44.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.231 0.613 . . . . 65.43 110.777 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -63.67 -28.96 70.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.316 0.646 . . . . 63.33 111.948 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 59.4 mtt -56.1 -31.18 63.01 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.522 0.729 . . . . 72.32 111.877 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -74.41 -38.85 62.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.321 0.649 . . . . 75.24 110.523 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -56.0 -36.2 67.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.646 0.778 . . . . 70.32 111.836 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' D' ' 92' ' ' THR . 10.7 mp -62.19 -34.61 76.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.22 0.608 . . . . 71.13 111.011 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -89.01 0.01 57.04 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.779 0.831 . . . . 73.43 111.088 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -126.47 48.07 2.2 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.577 1.151 . . . . 55.42 108.735 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -146.12 107.87 4.31 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.299 -0.864 . . . . 74.5 109.462 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.36 169.07 18.4 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.169 0.988 . . . . 62.12 110.122 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.86 148.96 13.6 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.987 -0.551 . . . . 74.23 112.528 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.98 173.44 9.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.629 0.771 . . . . 75.24 110.542 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.82 141.19 3.06 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.614 -0.548 . . . . 63.02 112.492 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 29.1 m -75.2 96.04 3.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.466 0.706 . . . . 64.4 109.855 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.34 164.88 26.04 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.364 0.666 . . . . 73.32 111.793 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 58.1 -87.21 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.961 1.304 . . . . 63.31 110.397 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.5 t60 43.88 35.53 1.13 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.623 1.569 . . . . 73.12 112.596 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -69.21 126.26 29.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.1 0.56 . . . . 71.13 111.024 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.22 167.14 21.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.606 0.762 . . . . 74.11 110.756 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 123.683 0.793 . . . . 73.21 109.527 -178.644 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.117 -0.327 . . . . 63.22 110.117 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp 70.25 89.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.097 1.359 . . . . 63.14 110.208 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.69 142.98 57.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.345 1.058 . . . . 71.32 112.888 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.5 155.56 37.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.036 0.934 . . . . 70.33 110.796 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -120.43 158.83 26.36 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.203 1.001 . . . . 74.31 109.901 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.27 -44.16 92.46 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.191 0.997 . . . . 54.43 111.097 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -76.8 148.98 36.28 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.233 -0.894 . . . . 75.12 110.217 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.57 ' H ' HD23 ' E' ' 115' ' ' LEU . 2.2 pt? -76.48 18.29 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.514 1.302 . . . . 61.35 114.514 -164.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -124.99 87.19 55.74 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.899 -1.149 . . . . 71.31 107.899 164.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.21 -30.16 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.943 2.429 . . . . 62.4 113.799 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -70.2 132.6 46.01 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.284 0.634 . . . . 54.21 110.135 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -86.06 30.27 0.69 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.976 0.91 . . . . 61.23 110.558 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.463 ' HH2' ' HD1' ' B' ' 133' ' ' PHE . 73.8 t-105 59.05 88.98 0.06 Allowed 'General case' 0 C--N 1.359 1.022 0 C-N-CA 124.508 1.123 . . . . 64.02 110.21 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -94.39 -68.75 0.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.283 -0.871 . . . . 64.14 111.073 -168.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.39 113.18 16.16 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.281 0.633 . . . . 71.24 111.846 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 1.1 m -128.2 -111.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 C-N-CA 124.879 1.272 . . . . 51.3 109.835 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.23 22.57 11.95 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.494 1.117 . . . . 74.15 112.349 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -79.2 126.65 31.03 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.788 -0.449 . . . . 73.22 109.788 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -168.91 -166.86 0.68 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 107.246 -1.39 . . . . 62.43 107.246 170.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.51 -43.92 3.03 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 118.017 0.371 . . . . 71.4 113.554 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -73.06 -81.24 0.06 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.631 -0.507 . . . . 52.21 109.631 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 54.97 -90.65 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.386 1.074 . . . . 72.05 111.17 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.694 HG23 HD21 ' B' ' 127' ' ' ASN . 72.2 mt -129.01 80.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 106.833 -1.543 . . . . 73.41 106.833 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.21 -40.57 71.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.49 -0.777 . . . . 74.31 110.141 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -118.83 96.08 49.75 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 60.43 110.596 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.37 78.46 3.4 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.105 1.87 . . . . 54.11 110.353 164.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 40.4 mm -68.49 90.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.383 0.673 . . . . 54.44 110.339 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 135' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' C' ' 36' ' ' TRP . . . 61.88 24.76 14.79 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.955 -1.02 . . . . 72.55 112.728 170.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.422 ' HA ' ' HB3' ' C' ' 124' ' ' PRO . 33.8 m -83.51 72.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 123.049 1.404 . . . . 70.33 111.211 -174.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.75 -179.81 4.07 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 114.463 -1.244 . . . . 61.13 109.279 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.5 -31.37 64.0 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.595 1.158 . . . . 63.3 112.077 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp 61.88 31.95 18.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.557 1.143 . . . . 74.51 110.836 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 19.8 m -91.02 55.5 2.92 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.687 -1.142 . . . . 74.33 111.16 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.78 -32.12 40.9 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.439 -0.8 . . . . 62.34 110.48 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 25.6 pt -85.91 159.14 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.47 -0.786 . . . . 62.42 110.715 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 71.07 154.01 0.13 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.465 1.506 . . . . 71.32 112.124 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -148.55 -73.72 0.19 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.967 -0.56 . . . . 71.24 109.934 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.17 -43.41 9.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.549 0.74 . . . . 75.2 110.365 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.59 159.13 18.44 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.123 0.569 . . . . 54.05 110.314 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 pp -104.81 -10.19 17.55 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.034 0.934 . . . . 73.43 110.874 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 49.2 tp -103.32 114.98 64.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.978 0.911 . . . . 74.24 109.031 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--N 1.382 2.304 0 C-N-CA 122.893 2.395 . . . . 62.25 112.219 179.514 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.995 0.426 . . . . 75.03 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -132.57 -42.08 0.94 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.594 1.158 . . . . 71.13 108.232 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.17 82.41 1.83 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.29 -1.323 . . . . 62.4 107.878 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.91 87.04 7.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.437 0.695 . . . . 71.42 110.329 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 57.82 86.98 0.07 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.469 1.107 . . . . 61.52 111.994 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -131.0 -174.29 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.726 -0.842 . . . . 71.31 108.726 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -72.06 95.64 1.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.945 0.898 . . . . 63.4 110.755 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.44 20.65 18.33 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.583 1.153 . . . . 62.34 110.879 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 116' ' ' TYR . . . . . 0.416 ' H ' ' HD2' ' F' ' 117' ' ' PRO . 58.1 t80 -176.66 -54.52 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.835 1.254 . . . . 72.11 111.391 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 117' ' ' PRO . . . . . 0.416 ' HD2' ' H ' ' F' ' 116' ' ' TYR . 73.0 Cg_endo -70.38 106.98 1.87 Allowed 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.818 1.678 . . . . 74.33 113.025 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -120.71 147.55 45.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 71.23 109.733 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 11.3 t -90.82 113.43 25.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.373 0.669 . . . . 61.35 110.113 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -162.62 160.34 25.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 65.33 109.67 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -150.34 -47.26 0.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.51 0.724 . . . . 71.25 110.592 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 122' ' ' ALA . . . . . 0.557 ' HB2' ' SD ' ' C' ' 1' ' ' MET . . . -68.42 83.13 0.26 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.014 0.526 . . . . 55.42 111.72 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 85.0 t -98.65 -66.46 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.782 0.833 . . . . 63.21 108.843 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.99 143.37 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.391 1.476 . . . . 63.42 111.82 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -149.4 138.16 21.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.691 -0.855 . . . . 75.33 108.691 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -148.26 161.69 41.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.064 0.945 . . . . 62.42 109.367 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.2 104.32 2.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.696 -0.562 . . . . 75.35 111.696 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.69 -12.15 24.19 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.518 0.727 . . . . 74.32 110.62 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 129' ' ' ALA . 3.4 mm? 62.96 21.32 12.81 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.698 1.199 . . . . 74.43 112.651 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 38.1 mm -79.94 85.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.659 -0.867 . . . . 72.52 108.659 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.73 -54.37 3.91 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.995 -1.002 . . . . 74.23 110.357 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -150.25 115.98 3.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 115.952 -0.567 . . . . 71.35 110.174 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.22 75.52 5.01 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.073 2.515 . . . . 61.44 112.725 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 9.6 tt -72.96 148.95 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.086 -1.079 . . . . 71.25 108.086 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.47 -77.23 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.684 0.794 . . . . 52.24 112.176 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 31.1 t 64.96 -3.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 C-N-CA 125.001 1.32 . . . . 50.23 113.069 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.01 -70.34 0.26 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.951 0.9 . . . . 73.2 110.678 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.62 47.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.092 0.472 . . . . 73.23 110.393 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.436 HD11 ' O ' ' D' ' 38' ' ' PRO . 9.8 tp -100.5 84.41 2.77 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.149 -1.426 . . . . 71.44 107.149 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -68.28 -16.63 64.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.131 -1.395 . . . . 74.35 112.98 -169.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.73 92.71 2.5 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.015 0.436 . . . . 75.14 109.993 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 13.0 tt -157.06 146.31 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.787 0.835 . . . . 74.24 109.308 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -66.17 139.06 58.1 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.299 0.639 . . . . 64.15 111.229 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -122.39 -10.12 8.48 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 74.52 109.859 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.97 -34.22 77.27 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.751 1.22 . . . . 53.41 110.429 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.15 97.56 7.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.979 -1.01 . . . . 75.03 109.89 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt -158.48 115.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.178 -1.416 . . . . 71.13 107.178 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 148' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' B' ' 150' ' ' GLU . 5.9 mp -86.94 116.12 64.95 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 109.121 -0.696 . . . . 71.34 109.121 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.853 3.036 . . . . 73.41 112.422 176.418 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.821 -0.437 . . . . 63.31 109.821 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 p -133.81 88.42 2.47 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.807 0.843 . . . . 73.32 109.853 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -89.21 114.07 25.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.055 0.942 . . . . 65.25 109.407 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.24 -66.26 0.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.201 -1.037 . . . . 74.23 108.201 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -170.71 138.69 1.44 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.568 1.147 . . . . 74.03 108.431 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -74.61 -93.38 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.328 0.651 . . . . 74.42 109.341 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -163.58 -60.31 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.35 1.06 . . . . 75.43 108.379 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 60.75 87.75 0.09 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.468 -1.242 . . . . 44.1 110.93 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -60.36 134.16 56.8 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.914 -0.585 . . . . 74.04 110.374 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 m -141.01 101.98 4.16 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.051 -1.092 . . . . 70.54 108.051 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -131.56 152.91 50.39 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.282 0.633 . . . . 74.4 110.316 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -155.84 123.24 5.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.565 0.746 . . . . 64.41 109.522 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -81.04 125.91 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.641 -1.615 . . . . 60.32 106.641 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HB3' HH11 ' A' ' 15' ' ' ARG . 88.3 mt-30 -109.83 -42.05 4.35 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 122.092 -0.38 . . . . 73.12 111.134 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.482 HH11 ' HB3' ' A' ' 14' ' ' GLN . 2.3 mpt_? -152.34 141.46 21.32 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.219 -1.03 . . . . 70.41 108.219 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.701 HG23 HD23 ' A' ' 106' ' ' LEU . 55.5 mt -141.13 101.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.025 -1.842 . . . . 74.12 106.025 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 73.0 m-85 -155.36 177.97 10.75 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.634 0.774 . . . . 75.0 110.287 -162.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.3 p -98.24 113.56 25.53 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.679 -0.691 . . . . 63.24 109.846 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -78.17 -32.61 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.802 -0.444 . . . . 73.43 109.802 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.0 t70 -149.02 147.63 28.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.999 -0.546 . . . . 73.42 109.735 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.8 mt -140.72 144.13 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.198 1.399 . . . . 73.41 107.803 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -157.4 120.9 4.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.77 0.319 . . . . 70.42 110.915 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.8 t80 -118.41 134.3 55.17 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.126 -1.435 . . . . 71.5 107.126 171.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -129.55 140.8 51.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.216 -1.031 . . . . 70.04 108.216 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -139.16 84.29 16.91 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.55 -0.907 . . . . 55.34 108.55 173.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.23 -49.64 1.85 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.986 2.457 . . . . 64.42 112.199 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 44.4 m-80 -103.28 43.92 1.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.605 0.762 . . . . 70.42 109.445 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -59.42 -51.95 77.71 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.125 0.97 . . . . 73.44 113.205 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -22.66 14.73 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.867 1.711 . . . . 73.43 111.939 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 7.5 t60 -83.04 -25.35 32.21 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.948 1.299 . . . . 53.23 111.992 -168.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.99 -26.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.915 0.886 . . . . 41.02 112.553 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.412 ' HD2' ' HZ2' ' A' ' 36' ' ' TRP . 70.2 m-85 -70.3 -34.73 73.09 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.621 0.768 . . . . 75.14 112.169 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -63.36 -36.32 83.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.199 0.999 . . . . 70.11 110.177 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.84 154.79 23.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.549 -1.205 . . . . 72.02 110.756 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.0 118.49 16.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.008 -0.738 . . . . 65.13 109.008 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.412 ' HZ2' ' HD2' ' A' ' 32' ' ' PHE . 5.5 m0 -60.47 86.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 71.31 112.298 -174.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -128.26 75.04 79.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.074 0.95 . . . . 71.42 108.579 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.16 139.88 7.36 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.589 2.193 . . . . 64.34 112.279 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -95.82 106.77 18.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.708 -1.59 . . . . 74.42 106.708 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' F' ' 128' ' ' LYS . 47.4 t -85.15 92.07 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 123.651 0.594 . . . . 51.4 109.537 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.462 ' NZ ' ' HB2' ' A' ' 67' ' ' SER . 10.7 mptt -75.82 133.03 40.74 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.944 -0.761 . . . . 73.51 108.944 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD12 ' HD2' ' F' ' 125' ' ' TYR . 2.2 tm? -121.56 115.79 23.45 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.466 -1.309 . . . . 74.13 107.466 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.5 m-20 -122.14 135.76 54.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.02 0.928 . . . . 73.41 108.707 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.0 mt -121.72 134.06 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.692 0.797 . . . . 64.22 109.11 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 33.8 t70 -142.17 144.66 33.53 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.896 0.478 . . . . 53.23 110.039 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -139.11 130.59 27.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.77 0.828 . . . . 50.52 110.73 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.45 149.27 42.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.958 0.903 . . . . 71.14 109.754 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.6 p -106.28 164.17 12.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.577 0.751 . . . . 63.52 109.628 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -153.97 131.16 11.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.056 0.942 . . . . 72.11 108.476 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -88.73 122.35 32.05 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.023 0.529 . . . . 74.13 110.563 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.2 mt -91.5 -44.71 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.164 -0.925 . . . . 53.52 109.106 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.18 176.82 10.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.626 -1.17 . . . . 73.12 109.532 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.673 ' H ' ' HB1' ' F' ' 110' ' ' ALA . 9.6 t70 -71.84 114.62 10.12 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.919 -1.141 . . . . 71.22 107.919 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 75.23 3.52 4.06 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.314 1.446 . . . . 75.35 112.908 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 29.1 t -112.79 111.97 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 108.649 -0.871 . . . . 50.11 108.649 173.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -125.21 156.01 39.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.433 0.693 . . . . 75.34 110.054 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HB2' HD11 ' A' ' 51' ' ' LEU . 42.2 tt0 -131.5 117.78 19.26 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.155 0.982 . . . . 74.42 108.743 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.98 128.63 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.167 -1.049 . . . . 62.43 108.167 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -109.03 134.23 51.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.636 0.775 . . . . 73.44 109.197 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.15 118.75 37.57 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.447 -1.316 . . . . 74.54 107.447 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.55 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.26 101.75 13.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.166 -1.05 . . . . 73.12 108.166 171.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.4 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.3 t -95.32 132.77 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.78 -1.193 . . . . 72.1 107.78 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.0 m -118.24 133.12 56.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.844 -0.799 . . . . 61.32 108.844 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -132.52 105.07 8.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.798 -1.556 . . . . 62.31 106.798 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.8 m -113.21 129.45 56.51 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.929 -0.767 . . . . 64.13 108.929 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.89 105.42 11.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.742 -1.207 . . . . 73.2 107.742 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 23.9 m -121.66 127.82 51.22 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.674 -0.491 . . . . 61.31 109.674 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt -89.17 81.98 6.65 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.917 -1.512 . . . . 72.31 106.917 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -119.17 5.14 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.419 -0.81 . . . . 31.15 112.245 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.81 -14.66 41.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.776 0.83 . . . . 73.25 111.3 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.3 132.56 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.661 1.184 . . . . 72.13 109.336 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -83.83 131.37 34.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.856 0.36 . . . . 60.5 110.717 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.91 -54.11 5.34 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.883 0.873 . . . . 74.42 109.008 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -159.79 174.13 14.95 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.539 -0.755 . . . . 72.34 111.533 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 tp -141.18 148.4 39.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.571 1.548 . . . . 72.01 108.058 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 60.2 m -136.86 133.44 35.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.432 -0.951 . . . . 65.42 108.432 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.96 124.8 11.91 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.14 -0.689 . . . . 74.32 109.14 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.93 117.12 25.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 123.581 0.753 . . . . 72.31 109.45 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -84.79 85.1 7.49 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.309 -0.997 . . . . 72.55 108.309 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -81.21 92.44 6.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.774 -1.195 . . . . 61.33 107.774 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -103.66 143.67 15.78 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.762 -0.935 . . . . 63.31 110.762 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.51 141.82 11.44 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.308 -0.717 . . . . 74.12 111.308 -174.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.4 mt -88.37 120.76 37.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.981 -0.748 . . . . 74.41 108.981 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.88 118.1 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.45 1.1 . . . . 73.31 108.086 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -83.74 115.32 22.15 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.262 -1.014 . . . . 34.43 108.262 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.454 HG21 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -133.71 135.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.22 0.608 . . . . 44.13 109.38 -173.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 172.33 15.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.796 1.239 . . . . 71.52 109.669 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.34 -36.84 3.8 Favored Glycine 0 N--CA 1.465 0.613 0 CA-C-N 115.575 -0.738 . . . . 64.24 112.673 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -126.8 147.42 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.367 0.667 . . . . 70.42 110.374 -175.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HG3' HD12 ' F' ' 115' ' ' LEU . 21.7 tt0 -135.98 -176.33 4.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.133 0.973 . . . . 74.44 108.951 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.504 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.49 -137.15 28.74 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.94 -0.367 . . . . 74.12 112.88 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -65.6 -20.79 66.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.917 0.887 . . . . 62.23 111.723 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.69 -53.33 22.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.012 0.925 . . . . 61.13 110.626 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -29.19 62.23 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 116.347 -0.388 . . . . 71.01 110.343 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.72 96.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.359 0.664 . . . . 62.51 109.862 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.3 t-80 -62.48 -39.01 92.08 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.328 -1.305 . . . . 74.11 110.741 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.671 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 7.1 m -78.35 -61.96 1.84 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.047 0.758 . . . . 50.4 113.047 -175.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 86' ' ' ILE . 95.0 mt -67.74 -22.7 65.22 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 75.03 112.471 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.06 -10.84 44.59 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.407 -0.663 . . . . 55.21 114.364 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -149.01 -52.6 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.979 1.474 . . . . 75.23 114.979 -169.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.4 t80 -55.24 -59.74 4.36 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.077 0.951 . . . . 72.32 110.25 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -67.88 -45.65 43.14 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 114.334 -1.303 . . . . 72.01 112.747 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.44 -42.2 41.97 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.661 2.241 . . . . 74.04 114.54 168.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -71.73 -30.75 65.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.794 0.438 . . . . 73.43 110.493 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.8 mm -70.54 -34.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 70.32 110.278 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.701 HD23 HG23 ' A' ' 16' ' ' ILE . 84.0 mt -73.29 -28.77 62.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.907 0.883 . . . . 74.15 111.305 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.81 -44.87 87.14 Favored Pre-proline 0 CA--C 1.568 1.647 0 N-CA-C 115.144 1.535 . . . . 72.5 115.144 -167.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.51 -31.31 80.36 Favored 'Trans proline' 0 C--N 1.387 2.589 0 CA-C-N 122.028 1.76 . . . . 72.0 113.257 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.82 -34.29 39.63 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.245 0.618 . . . . 72.52 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.82 77.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.55 -0.537 . . . . 71.11 109.55 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.54 HH12 HD12 ' C' ' 105' ' ' ILE . 38.4 ttm180 -52.6 -49.84 64.23 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.922 1.389 . . . . 64.14 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.36 -48.02 81.61 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.046 0.841 . . . . 75.3 111.196 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.5 t -60.39 -36.02 77.1 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.797 0.686 . . . . 62.21 111.491 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.463 HG21 HG21 ' A' ' 64' ' ' VAL . 87.4 mt -67.08 -58.68 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.678 0.791 . . . . 74.11 109.945 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 125' ' ' GLN . 69.0 m -56.09 -31.76 63.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.736 1.214 . . . . 71.03 111.438 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.2 -47.42 67.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.111 -0.95 . . . . 54.41 110.163 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.51 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -62.36 -38.24 88.79 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 122.696 0.399 . . . . 72.31 111.221 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.0 t -60.2 -49.56 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 O-C-N 123.968 0.792 . . . . 71.54 109.787 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -26.93 62.36 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.733 -0.667 . . . . 73.33 111.478 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.21 -31.09 65.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.385 0.674 . . . . 63.32 109.559 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 5.52 80.37 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.852 -0.613 . . . . 54.12 112.888 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 4.3 t 58.26 21.82 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.253 2.221 . . . . 73.22 113.902 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.2 148.11 44.11 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.982 -0.748 . . . . 74.15 108.982 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.45 128.17 26.81 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.026 2.484 . . . . 62.14 112.084 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -58.16 146.05 34.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.475 0.71 . . . . 71.32 111.532 -168.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.19 97.97 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.226 0.61 . . . . 73.12 109.376 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.19 108.05 20.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 55.12 108.532 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.444 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.6 mm? -74.4 148.58 41.07 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.745 0.818 . . . . 72.5 110.954 -173.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -69.68 129.91 90.87 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.141 0.576 . . . . 45.43 110.427 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 11.9 Cg_exo -67.89 108.72 1.75 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.027 . . . . 70.21 111.549 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.7 t -99.7 111.11 28.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.092 . . . . 42.01 108.053 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -82.17 86.25 6.66 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.995 0.902 . . . . 52.32 109.379 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -59.95 -32.36 70.74 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.511 -1.222 . . . . 64.12 110.656 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.446 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.4 p-10 -65.7 -30.69 71.41 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.189 0.996 . . . . 72.13 111.577 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.8 73.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.933 -0.576 . . . . 64.35 110.647 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.92 -42.16 93.32 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.028 0.931 . . . . 73.53 112.391 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 25.7 m-85 -59.87 -47.16 86.87 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.663 0.385 . . . . 63.31 110.834 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.519 ' HB3' ' HG3' ' A' ' 144' ' ' GLN . 85.0 mmm -73.58 -28.46 61.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.324 0.65 . . . . 51.01 111.165 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -69.61 -35.29 75.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.213 1.405 . . . . 62.42 110.459 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -85.32 -31.31 23.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.649 -0.705 . . . . 61.44 110.441 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 tp -67.34 -48.69 66.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.663 0.785 . . . . 72.1 111.495 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -159.01 17.56 0.18 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 116.497 -0.32 . . . . 65.44 110.793 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 55.12 70.17 0.66 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.98 0.912 . . . . 62.34 111.22 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.519 ' HG3' ' HB3' ' A' ' 138' ' ' MET . 4.5 pt20 -154.35 178.85 9.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.484 -0.78 . . . . 73.44 110.491 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.66 163.84 31.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.799 0.84 . . . . 71.44 109.529 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.4 51.38 4.55 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 112.618 -0.193 . . . . 75.44 112.618 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.73 127.7 53.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.005 -1.109 . . . . 52.33 108.005 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.76 155.17 7.07 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.439 -0.645 . . . . 42.21 111.586 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m 59.88 109.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.105 1.362 . . . . 73.32 113.292 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.75 169.09 11.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.184 0.594 . . . . 73.35 109.76 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' H ' ' HD1' ' C' ' 137' ' ' PHE . 42.5 mt-10 65.03 -172.3 0.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.925 1.29 . . . . 54.31 112.575 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -158.02 119.14 3.5 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.746 -0.835 . . . . 53.42 108.746 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 133.02 54.33 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.983 -0.747 . . . . 73.11 108.983 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.87 107.7 0.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.092 0.957 . . . . 72.12 111.36 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.251 0 C-N-CA 124.278 1.031 . . . . 72.34 108.804 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.64 0.257 . . . . 61.12 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m -139.02 155.33 48.05 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.432 0.693 . . . . 73.52 109.637 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.31 16.04 2.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.866 0.866 . . . . 72.03 111.252 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -72.68 -18.14 61.58 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.589 1.156 . . . . 75.14 110.506 170.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.3 m120 71.54 -76.95 0.06 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.374 1.47 . . . . 74.1 111.629 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -68.07 137.41 54.98 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.91 0.884 . . . . 74.35 110.808 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.715 ' HB ' HD13 ' B' ' 89' ' ' ILE . 89.3 m -146.41 129.74 16.72 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.922 -1.14 . . . . 73.34 107.922 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -68.88 -35.51 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.3 1.04 . . . . 64.01 110.764 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.486 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 6.7 ptt? 51.91 -163.21 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.591 1.556 . . . . 64.31 113.299 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.2 t -156.11 131.78 9.65 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 107.849 -1.167 . . . . 61.02 107.849 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' B' ' 85' ' ' SER . 69.3 t80 -131.71 146.36 52.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.926 0.891 . . . . 61.03 109.494 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.743 ' HB2' ' HA ' ' F' ' 146' ' ' ASP . 20.1 tt0 -159.37 142.85 14.63 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.638 0.375 . . . . 73.44 110.756 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.448 HD11 HD13 ' B' ' 105' ' ' ILE . 54.3 mt -89.53 123.3 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.284 -1.006 . . . . 73.51 108.284 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.1 -35.7 16.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.748 0.419 . . . . 73.11 109.935 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 62.1 ttt180 -163.77 146.65 9.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.49 0.316 . . . . 70.21 110.589 -171.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.47 139.77 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.807 -1.553 . . . . 70.43 106.807 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.453 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 15.0 p90 -173.03 168.34 4.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.038 0.923 . . . . 74.21 112.642 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 66.9 m -90.38 129.27 36.6 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.32 -1.309 . . . . 73.43 108.89 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 48.6 mtpt -98.17 -40.1 8.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.399 0.68 . . . . 73.22 110.573 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.2 t70 -146.8 135.11 21.78 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.589 -0.732 . . . . 52.05 109.896 -163.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.7 mm -136.3 140.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.713 1.205 . . . . 74.35 109.382 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -140.29 131.41 26.38 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.138 -1.43 . . . . 42.3 107.138 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.435 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -147.03 119.03 8.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.172 -1.418 . . . . 74.12 107.172 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.99 129.94 55.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.495 -0.928 . . . . 63.52 108.495 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -125.84 81.2 66.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 174.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.93 -27.73 20.51 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.649 2.233 . . . . 72.41 111.764 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.91 29.47 7.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.136 0.974 . . . . 74.41 109.839 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.57 -50.61 65.16 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.595 1.158 . . . . 74.21 113.179 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.69 -12.67 6.25 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 122.055 1.837 . . . . 71.33 113.277 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.429 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 30.2 m80 -93.7 3.82 54.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.883 0.873 . . . . 73.52 110.116 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.21 -14.37 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 123.751 0.82 . . . . 63.24 111.442 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -64.65 -30.9 71.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.494 0.718 . . . . 73.11 112.503 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.585 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 4.2 pt20 -85.19 -33.29 22.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.597 0.359 . . . . 74.32 110.104 171.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.598 ' HD3' ' HB3' ' B' ' 68' ' ' LEU . 95.8 mttt -109.48 66.49 0.63 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 74.43 111.984 -175.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.52 85.57 4.96 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 108.62 -0.881 . . . . 72.14 108.62 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -156.47 169.91 23.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.04 -0.726 . . . . 75.02 109.04 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.1 113.98 23.59 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.644 0.778 . . . . 75.35 110.609 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.629 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 2.8 Cg_exo -73.46 144.19 35.9 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.339 2.026 . . . . 74.22 111.9 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.01 103.2 1.78 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.466 -0.788 . . . . 74.53 109.204 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.41 135.75 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.241 -0.891 . . . . 71.22 110.782 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.625 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 97.1 mttt -132.12 101.21 5.31 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.357 1.063 . . . . 74.53 108.376 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.62 144.96 28.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.279 0.632 . . . . 75.13 109.828 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -148.25 139.21 23.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.757 -0.831 . . . . 75.44 108.757 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.31 133.17 53.83 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.965 0.906 . . . . 73.23 108.697 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.7 t70 -127.91 135.74 50.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 55.21 108.952 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -109.97 114.08 27.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.683 0.793 . . . . 75.14 110.324 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.2 151.68 36.39 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.118 0.967 . . . . 75.33 109.336 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -145.08 168.82 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.797 0.439 . . . . 74.41 111.157 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.0 p -153.75 154.49 34.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 74.43 108.92 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.96 103.27 13.37 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.179 -0.674 . . . . 63.45 109.179 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' B' ' 57' ' ' GLU . 67.4 mt -77.88 -34.16 51.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.19 -0.913 . . . . 74.11 110.631 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.94 -170.64 2.01 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.805 0.842 . . . . 65.14 110.256 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.58 108.79 2.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.746 -1.116 . . . . 63.14 109.39 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 72.31 2.58 4.38 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.376 1.47 . . . . 62.45 112.863 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.87 93.4 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.651 -1.24 . . . . 61.44 107.651 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -107.26 138.38 43.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.993 -1.003 . . . . 74.22 109.392 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' B' ' 51' ' ' LEU . 23.2 tt0 -98.87 127.43 44.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.537 -1.282 . . . . 71.42 107.537 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.27 122.05 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 108.06 -1.089 . . . . 61.24 108.06 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 45.5 t -102.91 114.07 41.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.256 -1.016 . . . . 35.34 108.256 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -91.24 127.12 36.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.75 -1.574 . . . . 72.22 106.75 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.3 ttt180 -119.0 120.77 38.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.613 -0.884 . . . . 63.32 108.613 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.576 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.2 t -112.85 112.94 42.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.966 -1.124 . . . . 53.43 107.966 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 43.0 m -93.96 135.88 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.273 -1.01 . . . . 71.23 108.273 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 114' ' ' ILE . 82.6 t -130.31 130.95 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.027 0.931 . . . . 73.11 109.15 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.8 m -125.1 148.23 48.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.006 -1.109 . . . . 65.01 108.006 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.09 132.74 17.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.053 -1.091 . . . . 72.23 108.053 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 14.0 m -139.87 137.11 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.372 0.269 . . . . 71.03 110.579 -172.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HB3' ' HD3' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -117.39 113.16 21.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.871 -1.159 . . . . 65.34 107.871 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.14 -129.59 18.04 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.624 0.578 . . . . 54.2 112.89 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -92.86 19.46 7.64 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 74.13 111.267 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.422 ' HB3' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 tp10 -147.96 159.3 44.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.588 0.355 . . . . 72.45 111.12 -171.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.7 m -71.23 137.48 48.69 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.477 0.711 . . . . 75.41 109.752 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.42 -56.63 3.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.078 -1.082 . . . . 64.1 108.078 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.49 171.32 17.25 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.731 -1.122 . . . . 74.14 110.674 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -141.1 146.17 36.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.609 1.564 . . . . 73.32 107.308 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.41 154.73 35.02 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.395 -0.595 . . . . 70.54 109.395 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.09 133.53 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.231 -0.655 . . . . 71.42 109.231 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.1 t -126.77 144.98 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.624 0.769 . . . . 72.2 109.138 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 75.3 mt-30 -123.15 94.8 4.37 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.816 -0.809 . . . . 74.32 108.816 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.81 98.82 9.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.926 -1.034 . . . . 72.05 109.106 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 143.85 17.6 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.83 -0.908 . . . . 61.32 110.83 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.64 130.66 3.86 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.259 -0.736 . . . . 74.04 111.259 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.57 126.24 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.88 -0.785 . . . . 74.52 108.88 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.65 162.08 33.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.471 1.109 . . . . 71.11 109.125 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.8 m -131.51 112.97 13.12 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.493 0.717 . . . . 64.24 109.735 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.447 HD12 ' N ' ' B' ' 86' ' ' ILE . 1.1 mp -125.29 114.9 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.119 -1.067 . . . . 63.13 108.119 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.22 147.15 45.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.281 0.632 . . . . 52.03 110.793 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.23 -40.15 2.53 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.818 0.699 . . . . 65.11 113.133 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.715 HD13 ' HB ' ' B' ' 7' ' ' THR . 5.7 tp -91.01 148.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.049 0.54 . . . . 72.52 111.037 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.504 ' H ' HD12 ' B' ' 89' ' ' ILE . 10.2 pt-20 -156.47 164.14 38.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.616 0.766 . . . . 71.41 111.319 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.97 -137.57 18.79 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 114.908 -1.042 . . . . 52.14 113.435 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 43.4 m -65.63 -40.35 92.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.089 0.956 . . . . 61.31 111.921 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.702 ' HB2' HD11 ' B' ' 89' ' ' ILE . 2.3 mp0 -66.0 -36.85 84.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 74.31 111.054 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.413 ' HB2' HG13 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -75.34 -25.21 57.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.206 0.602 . . . . 65.31 110.66 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' E' ' 117' ' ' PRO . . . -61.41 -21.93 64.54 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.47 0.708 . . . . 61.12 111.907 173.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -86.47 -20.31 28.29 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.232 0.613 . . . . 74.14 111.231 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.84 -62.6 1.33 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.431 0.292 . . . . 73.11 110.4 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.68 -16.43 41.86 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.093 -0.379 . . . . 70.42 111.532 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.32 -37.4 17.99 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 123.471 0.482 . . . . 61.21 112.669 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.42 -50.54 1.76 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.704 0.631 . . . . 63.12 112.704 -170.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -69.44 -54.57 13.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.259 0.624 . . . . 53.05 111.602 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.413 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.4 m -63.33 -46.83 85.13 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.54 -0.743 . . . . 73.04 112.015 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.6 Cg_exo -54.95 -38.25 93.12 Favored 'Trans proline' 0 C--N 1.391 2.782 0 C-N-CA 121.94 1.76 . . . . 64.44 113.901 170.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.73 -32.87 74.5 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.015 0.435 . . . . 75.32 111.083 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.448 HD13 HD11 ' B' ' 13' ' ' ILE . 94.8 mt -67.84 -44.25 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.262 1.025 . . . . 75.12 110.684 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.34 -26.1 46.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.022 0.929 . . . . 51.42 112.199 -172.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.413 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 49.3 t80 -59.43 -45.13 98.93 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.707 1.203 . . . . 74.53 113.986 -169.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 18.7 Cg_endo -58.23 -37.24 96.2 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.328 2.018 . . . . 73.31 113.984 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -70.36 -45.3 66.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.91 0.484 . . . . 72.23 110.368 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.467 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.84 -42.51 89.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.33 -0.85 . . . . 62.34 110.367 175.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 21.6 mtp-105 -52.21 -63.42 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.302 1.041 . . . . 74.31 111.391 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.44 -29.69 67.96 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.197 0.936 . . . . 64.31 110.639 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.8 t -70.81 -48.6 53.22 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.104 0.561 . . . . 71.45 111.086 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.601 HG21 HG21 ' B' ' 64' ' ' VAL . 48.2 mt -62.07 -51.86 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 123.417 0.687 . . . . 74.21 110.059 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -34.52 72.48 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.585 -1.189 . . . . 74.13 110.875 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -67.39 -50.2 60.65 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.534 -0.757 . . . . 43.01 110.392 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -63.48 -38.04 89.63 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.884 0.473 . . . . 72.11 111.421 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.99 -43.16 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.014 0.925 . . . . 63.44 110.767 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -62.68 -36.77 83.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.925 0.89 . . . . 61.0 111.055 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 93.6 mtt-85 -68.74 -20.62 64.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.138 -0.937 . . . . 75.4 111.472 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.07 16.63 59.87 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 119.482 -0.621 . . . . 72.23 114.209 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p 72.65 13.0 5.34 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 126.528 1.931 . . . . 71.2 112.836 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -97.94 152.83 38.27 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 122.641 0.376 . . . . 71.34 110.922 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.34 144.14 98.29 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.227 2.618 . . . . 71.33 112.001 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -61.41 129.24 40.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.527 0.731 . . . . 74.51 111.715 -172.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.19 86.86 2.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.694 -0.854 . . . . 75.1 108.694 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -90.64 118.4 30.06 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.672 -1.233 . . . . 70.31 107.672 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.55 ' HB2' ' HG2' ' B' ' 111' ' ' ARG . 2.4 mm? -77.47 128.34 34.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.277 -0.638 . . . . 75.53 109.277 -173.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.37 136.51 93.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.37 0.668 . . . . 60.12 110.626 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.544 ' HG2' HG21 ' D' ' 13' ' ' ILE . 19.0 Cg_endo -60.5 89.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.135 2.557 . . . . 73.31 112.796 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.55 118.95 39.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.721 -0.844 . . . . 74.33 108.721 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.67 114.59 7.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.564 0.745 . . . . 73.43 110.419 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 53.3 m-85 -64.75 -29.18 70.15 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.826 0.85 . . . . 62.41 110.268 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -66.64 -40.92 88.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.946 0.898 . . . . 72.41 110.807 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.07 68.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.453 0.701 . . . . 52.12 110.948 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 tt -60.05 -43.82 95.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.032 0.933 . . . . 75.34 109.314 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -63.84 -39.03 93.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.535 0.734 . . . . 73.41 111.233 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 24.5 mmt -65.91 -35.9 81.89 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.75 0.42 . . . . 73.12 110.181 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -77.67 -23.93 49.51 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.253 1.021 . . . . 73.51 110.805 177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -71.65 -30.32 65.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.194 0.998 . . . . 73.15 109.618 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.53 21.32 5.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.148 0.979 . . . . 72.51 110.423 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 68.65 -74.25 0.08 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.215 1.406 . . . . 74.41 109.815 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -166.18 147.06 6.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.084 0.953 . . . . 74.31 108.786 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -146.8 136.78 23.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.186 0.594 . . . . 73.23 109.92 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.07 126.24 34.63 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.372 -0.974 . . . . 64.15 108.372 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.86 86.69 1.51 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.768 -0.533 . . . . 63.45 111.768 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.44 132.65 48.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.041 0.536 . . . . 74.13 110.901 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.52 -179.44 32.31 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.414 -0.357 . . . . 64.33 112.694 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.7 t -139.3 -171.45 3.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.497 1.119 . . . . 75.41 108.258 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.31 142.61 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.533 0.606 . . . . 74.41 111.326 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.34 -50.11 6.15 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.885 -1.154 . . . . 73.33 107.885 164.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 3.4 t60 61.71 35.69 16.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.94 1.296 . . . . 75.01 110.577 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.83 115.37 4.3 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.762 0.825 . . . . 72.23 109.878 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -75.86 164.24 26.41 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.218 0.607 . . . . 40.54 111.451 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 CA-C-N 115.476 -0.783 . . . . 63.33 110.259 178.63 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 119.594 -0.241 . . . . 64.5 111.005 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 60.14 46.72 10.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.624 0.726 . . . . 75.21 110.2 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.5 130.33 35.01 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.774 -1.103 . . . . 64.12 110.047 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 65.22 94.46 0.06 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.67 1.588 . . . . 63.32 111.837 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -157.57 74.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.644 -1.613 . . . . 75.51 106.644 164.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -167.64 18.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.631 -1.168 . . . . 72.21 111.052 -173.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -92.02 100.44 13.09 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.876 -0.416 . . . . 61.42 109.876 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -73.31 173.33 9.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.476 0.711 . . . . 72.21 109.632 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.683 ' HG2' ' HB ' ' C' ' 89' ' ' ILE . 69.0 mtp 65.38 119.77 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.553 1.141 . . . . 63.01 111.518 -174.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.694 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 49.4 m -84.43 85.91 7.34 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.447 -1.316 . . . . 61.2 107.447 173.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.45 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 80.9 t80 -106.16 126.25 51.98 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.435 -1.257 . . . . 72.32 109.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -145.8 139.78 26.65 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.018 -0.734 . . . . 62.31 109.018 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.39 106.45 3.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.209 -1.034 . . . . 64.12 108.209 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.8 mm-40 -77.29 -48.83 16.42 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 123.254 0.346 . . . . 72.33 110.343 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -166.87 149.29 6.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.526 -0.761 . . . . 74.45 109.438 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.2 mt -133.89 132.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 107.633 -1.247 . . . . 73.53 107.633 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.413 ' OH ' HD11 ' C' ' 83' ' ' ILE . 31.7 p90 -171.11 165.28 7.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.033 0.921 . . . . 62.23 112.849 -173.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -88.04 104.01 16.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.296 -1.32 . . . . 75.14 109.072 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 7.0 mtmt -71.1 -23.71 62.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.884 0.374 . . . . 64.03 110.201 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.5 t70 -158.25 140.7 14.38 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.603 -0.726 . . . . 72.12 109.319 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.1 mt -134.69 144.16 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.212 -1.403 . . . . 74.1 107.212 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -149.57 150.12 31.74 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.345 0.658 . . . . 54.11 109.276 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -155.69 118.75 4.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.256 -1.016 . . . . 75.32 108.256 175.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.95 121.39 40.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.398 -0.964 . . . . 65.05 108.398 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.89 85.76 29.27 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.043 -1.095 . . . . 75.43 108.043 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.94 -37.81 10.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.59 2.193 . . . . 74.32 111.857 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.645 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 1.9 m-20 -107.69 39.8 1.85 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.91 -0.774 . . . . 72.22 108.91 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.575 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -51.65 -49.54 82.41 Favored Pre-proline 0 CA--C 1.563 1.448 0 N-CA-C 114.271 1.212 . . . . 72.42 114.271 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.666 ' HD3' ' HZ1' ' D' ' 19' ' ' LYS . 37.2 Cg_endo -86.99 -22.2 1.87 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 121.523 1.482 . . . . 62.42 112.831 173.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.645 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 25.1 t-80 -69.51 -23.49 63.62 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.119 0.968 . . . . 75.45 111.547 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 7.1 p -60.55 -23.4 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.85 0.86 . . . . 73.13 112.25 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.446 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 82.2 t80 -59.14 -41.18 87.68 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.147 0.979 . . . . 72.32 111.847 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -86.96 6.0 34.34 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.62 0.6 . . . . 73.51 112.62 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.532 ' HZ3' ' HA ' ' C' ' 31' ' ' VAL . 16.1 pttm -123.42 178.28 5.23 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.255 0.55 . . . . 73.44 110.736 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.62 133.97 33.72 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.484 -1.235 . . . . 70.33 110.003 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.467 ' HB3' ' HG3' ' C' ' 124' ' ' PRO . 20.4 m-90 -85.38 64.72 8.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.752 0.821 . . . . 74.12 111.041 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -144.37 62.98 10.59 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.466 1.107 . . . . 74.34 108.737 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.53 174.99 9.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.226 1.951 . . . . 45.31 110.847 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.445 ' HA ' HD11 ' E' ' 141' ' ' LEU . 43.1 tt0 -85.36 115.83 23.33 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.901 -0.778 . . . . 71.51 108.901 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.436 ' H ' HD21 ' E' ' 141' ' ' LEU . 88.6 t -75.13 101.18 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.564 -0.902 . . . . 74.21 108.564 173.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.81 98.47 11.62 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.552 -1.647 . . . . 62.13 106.552 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -89.38 162.36 15.83 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.42 0.288 . . . . 74.11 110.506 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -159.62 108.47 1.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.272 0.629 . . . . 65.43 109.575 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -107.57 141.15 39.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.104 0.961 . . . . 63.24 108.804 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.28 153.73 35.4 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.921 0.888 . . . . 64.12 108.69 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -131.76 133.84 45.21 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.405 -0.591 . . . . 71.43 109.405 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -113.24 172.25 7.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.536 1.135 . . . . 61.22 109.261 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.1 p -151.24 146.62 26.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.323 0.649 . . . . 75.22 109.971 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.538 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 10.1 m -144.14 149.07 35.91 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.577 -1.268 . . . . 64.1 107.577 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.13 114.55 28.75 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.649 -1.241 . . . . 72.02 107.649 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' C' ' 57' ' ' GLU . 24.9 mt -93.03 -36.89 12.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.394 0.678 . . . . 74.24 109.846 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.09 -175.64 5.53 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.922 -1.035 . . . . 55.23 110.039 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.24 108.5 1.09 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.399 -1.273 . . . . 72.54 110.016 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 70.6 -2.38 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.694 1.597 . . . . 72.23 113.106 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.0 t -98.61 102.81 13.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.412 -0.959 . . . . 74.12 108.412 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -110.19 160.21 16.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.539 0.736 . . . . 70.22 109.352 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.617 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.3 tt0 -120.51 127.27 52.04 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.142 0.977 . . . . 64.25 108.72 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.87 127.39 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.491 -1.3 . . . . 75.32 107.491 170.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 27.0 t -112.79 101.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.287 -1.005 . . . . 53.44 108.287 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.64 95.07 9.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.829 -1.174 . . . . 75.32 107.829 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -88.29 112.5 22.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.509 -1.223 . . . . 73.01 108.827 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.7 t -107.44 139.89 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.586 -0.894 . . . . 71.44 108.586 174.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -131.44 133.94 45.7 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.626 -0.879 . . . . 70.41 108.626 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.34 111.5 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.692 1.197 . . . . 74.11 108.6 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.537 HG23 HD23 ' C' ' 75' ' ' LEU . 2.4 m -99.06 146.57 25.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.835 -1.172 . . . . 72.04 107.835 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.86 107.99 7.22 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.945 -1.502 . . . . 54.2 106.945 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.441 ' HB3' HG23 ' C' ' 72' ' ' THR . 11.8 p -162.43 144.13 10.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.475 0.484 . . . . 65.1 110.577 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.9 tp -118.72 85.82 2.43 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.809 -1.182 . . . . 75.15 107.809 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -107.88 2.35 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 114.698 -1.137 . . . . 42.1 111.525 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.55 -32.89 17.94 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.708 -0.478 . . . . 71.22 109.708 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -75.12 84.17 2.34 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.605 0.762 . . . . 73.23 110.089 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.441 HG23 ' HB3' ' C' ' 67' ' ' SER . 61.4 m -81.89 126.29 31.72 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.053 -0.976 . . . . 64.22 110.145 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.94 -61.04 2.11 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.649 -0.871 . . . . 43.12 108.649 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -158.33 178.02 10.62 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.876 0.846 . . . . 71.01 112.259 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.537 HD23 HG23 ' C' ' 65' ' ' THR . 3.0 tm? -141.62 146.2 35.93 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.575 -2.009 . . . . 74.12 105.575 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -150.55 148.2 28.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.258 -1.016 . . . . 54.02 108.258 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.16 134.54 10.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.781 -0.452 . . . . 72.53 109.781 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -133.17 116.63 26.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 123.815 0.846 . . . . 70.24 108.921 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 49.3 mt-30 -87.8 86.17 7.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.342 -1.355 . . . . 74.41 107.342 169.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -79.48 96.1 5.99 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.936 -1.029 . . . . 73.51 108.832 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -88.48 144.35 18.35 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.244 -0.742 . . . . 63.23 111.244 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.18 119.93 1.3 Allowed Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 110.259 -1.136 . . . . 65.54 110.259 -175.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.562 HD12 HD11 ' C' ' 51' ' ' LEU . 7.4 mm -82.58 123.76 38.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.206 -1.035 . . . . 70.23 108.206 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.49 120.94 24.91 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.887 0.875 . . . . 71.44 108.829 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 22.0 p -77.93 109.81 12.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.987 -1.116 . . . . 75.14 107.987 170.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 27.2 pt -118.51 113.22 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.4 0.619 . . . . 74.23 109.352 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.694 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -123.83 156.23 36.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.823 0.849 . . . . 72.33 109.762 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.34 -35.8 3.52 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.572 0.545 . . . . 74.52 113.382 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.683 ' HB ' ' HG2' ' C' ' 9' ' ' MET . 19.3 tt -88.4 145.97 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.075 0.55 . . . . 70.33 110.667 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.78 -177.56 5.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.003 0.921 . . . . 73.52 110.403 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 60.67 -147.07 46.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.649 -0.705 . . . . 73.43 114.626 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -69.86 -19.18 63.45 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 61.52 111.863 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -71.12 -42.36 69.35 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.746 0.819 . . . . 75.2 110.566 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 25.9 ptt? -69.87 -28.57 65.76 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 110.223 -0.288 . . . . 60.25 110.223 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.29 90.26 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.75 0.656 . . . . 61.12 110.365 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -60.54 -39.38 87.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 74.05 110.783 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -63.21 -58.29 7.69 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.839 0.455 . . . . 74.13 110.952 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -77.12 -12.47 59.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.586 0.587 . . . . 73.44 112.586 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.9 9.79 21.13 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.341 -0.699 . . . . 43.31 114.739 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -53.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 117.764 0.782 . . . . 72.34 111.284 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.61 -59.84 2.55 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.368 0.667 . . . . 74.43 111.584 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 70.2 m -60.78 -44.89 96.47 Favored Pre-proline 0 CA--C 1.566 1.565 0 C-N-CA 124.465 1.106 . . . . 71.2 113.461 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.35 -20.86 48.16 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.005 1.803 . . . . 64.24 113.476 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -71.53 -30.63 66.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.994 0.517 . . . . 54.3 110.467 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.54 HD12 HH12 ' A' ' 111' ' ' ARG . 44.2 mm -68.2 -28.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 73.14 110.261 173.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.564 HD21 ' HA3' ' C' ' 82' ' ' GLY . 85.7 mt -86.47 -22.85 26.23 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.819 0.848 . . . . 73.53 112.182 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -53.77 -50.6 82.74 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.996 -1.002 . . . . 73.14 113.374 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.01 -36.5 96.57 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 122.022 1.815 . . . . 44.25 113.482 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.36 -44.44 62.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.139 0.576 . . . . 73.45 111.089 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -41.92 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.465 0.478 . . . . 54.25 109.887 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -60.28 -51.29 70.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.14 1.376 . . . . 73.42 111.142 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.2 tm-20 -70.81 -30.36 66.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.498 0.499 . . . . 64.42 110.291 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.0 t -69.86 -30.82 68.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.832 0.453 . . . . 74.34 111.178 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.461 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -77.3 -50.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.528 0.731 . . . . 70.3 109.949 175.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -62.98 -29.08 70.54 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.625 0.77 . . . . 74.14 111.228 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -64.91 -52.31 57.15 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.837 -0.801 . . . . 60.42 108.837 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.47 -38.71 78.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.435 1.094 . . . . 44.53 112.754 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.404 HG23 ' O ' ' C' ' 114' ' ' ILE . 87.5 t -61.86 -50.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.274 0.629 . . . . 60.21 109.864 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.1 t -71.14 -22.23 62.09 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.179 -0.919 . . . . 54.31 111.392 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -71.9 -37.11 70.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.067 -0.716 . . . . 72.15 109.067 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.28 3.76 79.95 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.905 0.753 . . . . 72.32 113.131 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.496 HG23 ' HB3' ' D' ' 17' ' ' TYR . 71.4 p 57.5 40.74 26.86 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.8 1.64 . . . . 51.01 112.153 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -99.29 165.04 15.55 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.758 1.223 . . . . 75.45 110.838 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' C' ' 36' ' ' TRP . 22.5 Cg_endo -57.48 147.36 78.85 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.572 2.848 . . . . 22.11 113.927 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -58.51 111.94 1.42 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.555 1.142 . . . . 75.11 111.522 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.6 tp -122.15 97.28 5.4 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.408 0.683 . . . . 73.53 109.319 -174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -101.35 115.9 31.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 74.22 108.709 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.13 134.56 50.74 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.956 -0.757 . . . . 72.15 108.956 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -64.35 132.35 95.32 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.077 0.551 . . . . 74.34 111.171 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 129' ' ' ALA . 13.2 Cg_exo -71.37 90.19 0.69 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.974 2.449 . . . . 75.14 112.783 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' E' ' 147' ' ' LEU . 67.0 t -100.12 112.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.737 0.815 . . . . 72.1 109.792 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -97.75 95.38 7.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.352 0.661 . . . . 72.42 109.384 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -65.86 -30.43 71.04 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.516 0.726 . . . . 72.44 111.348 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.86 -47.24 69.5 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.279 0.562 . . . . 72.01 110.208 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.89 63.14 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 114.763 -1.108 . . . . 40.42 111.911 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.565 HD11 ' HD2' ' E' ' 149' ' ' PRO . 10.4 tt -50.04 -39.51 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 125.243 1.417 . . . . 65.2 112.67 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.436 ' HD1' ' H ' ' A' ' 151' ' ' GLU . 81.9 m-85 -72.19 -46.88 54.43 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.963 0.905 . . . . 64.41 111.226 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.84 -26.33 62.33 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.427 1.091 . . . . 34.31 112.284 -176.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -67.63 -34.59 77.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 70.31 110.535 177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -68.84 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 O-C-N 123.637 0.585 . . . . 74.51 110.949 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp 55.42 177.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.179 0.992 . . . . 73.33 112.702 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 59.72 121.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.863 1.665 . . . . 74.44 113.377 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -70.2 93.13 0.8 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.321 0.648 . . . . 74.52 109.484 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 64.16 108.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.025 1.33 . . . . 71.43 112.476 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.77 169.37 14.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.842 0.857 . . . . 63.32 111.794 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.58 -130.35 6.33 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.869 -0.605 . . . . 74.51 111.631 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -159.93 141.14 12.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.565 0.746 . . . . 73.04 110.43 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.56 62.13 0.65 Allowed Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.033 -0.827 . . . . 51.03 111.033 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 71.2 p -68.07 97.24 0.68 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.247 1.019 . . . . 71.14 111.068 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -89.06 112.46 23.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 74.32 109.944 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.91 138.8 41.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.723 0.809 . . . . 73.44 110.58 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -98.97 143.43 29.26 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.702 -0.851 . . . . 75.32 108.702 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -71.3 127.22 31.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.192 -1.04 . . . . 61.24 108.192 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.81 -21.63 47.43 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.475 0.31 . . . . 61.35 110.837 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.771 1.228 . . . . 62.3 110.402 -173.96 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.134 -0.321 . . . . 73.42 110.134 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -164.44 179.27 6.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.14 0.976 . . . . 74.54 108.843 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.55 135.74 35.02 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 108.615 -0.883 . . . . 74.22 108.615 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -82.54 -61.78 1.79 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 54.53 110.289 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.97 106.69 1.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.12 -0.946 . . . . 73.05 110.226 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -76.04 84.96 2.92 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.52 -0.918 . . . . 75.01 108.52 173.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -71.44 168.93 16.44 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.092 -1.413 . . . . 71.24 108.695 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.74 106.26 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.527 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.6 tpt -28.87 124.95 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.107 1.763 . . . . 70.42 113.595 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.1 m -143.36 140.54 30.55 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.747 0.819 . . . . 55.32 110.166 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 44.5 t80 -143.01 115.61 8.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.937 -1.505 . . . . 72.44 106.937 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 44.2 mt-30 -128.13 147.36 50.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.276 -0.639 . . . . 72.32 109.276 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.544 HG21 ' HG2' ' B' ' 130' ' ' PRO . 3.8 mp -103.6 121.0 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.992 -1.114 . . . . 60.3 107.992 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -101.45 -42.22 6.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.893 0.477 . . . . 73.31 111.891 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.518 ' HD3' HD12 ' D' ' 83' ' ' ILE . 47.4 ttt180 -163.7 123.83 2.16 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.701 -0.19 . . . . 73.41 110.616 -168.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.6 136.62 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.156 -1.424 . . . . 55.5 107.156 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.575 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 39.7 p90 -166.0 177.72 6.88 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.947 0.779 . . . . 70.12 111.32 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -101.89 117.47 34.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.206 -0.907 . . . . 65.34 109.073 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.666 ' HZ1' ' HD3' ' C' ' 29' ' ' PRO . 26.9 mtpp -80.53 -27.91 37.5 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.569 -0.287 . . . . 74.51 110.356 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.69 148.88 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.529 0.731 . . . . 70.14 109.13 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.551 HG21 ' HE2' ' C' ' 117' ' ' MET . 83.3 mt -143.44 147.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.97 1.308 . . . . 50.24 108.506 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -148.03 144.44 27.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.491 1.116 . . . . 71.44 109.275 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.433 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.61 126.29 8.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.154 -1.795 . . . . 64.03 106.154 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -128.65 141.13 51.44 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.206 0.602 . . . . 72.23 109.46 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.75 77.13 9.54 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.211 1.004 . . . . 53.02 108.349 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.54 -38.71 13.8 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.611 2.207 . . . . 71.4 111.421 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.505 HD21 ' HB ' ' D' ' 72' ' ' THR . 13.2 p30 -102.24 31.06 4.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.814 1.646 . . . . 63.12 109.746 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.515 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.07 -48.48 94.39 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 114.53 1.307 . . . . 74.32 114.53 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.29 -4.71 11.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 CA-C-N 121.299 1.5 . . . . 73.21 112.685 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.6 t-160 -81.39 -54.74 5.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 74.22 109.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' D' ' 73' ' ' ALA . 52.8 t -67.9 -16.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.918 0.887 . . . . 71.24 111.186 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -63.56 -18.28 63.7 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.323 1.049 . . . . 71.33 112.415 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.89 -16.09 57.49 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.163 0.585 . . . . 74.3 111.1 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.473 ' HZ3' ' HB3' ' D' ' 71' ' ' GLU . 49.8 mtmt -113.81 104.41 12.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.965 0.906 . . . . 71.24 110.187 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.47 95.34 8.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.006 0.522 . . . . 62.52 109.981 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.504 ' HB3' HD11 ' D' ' 68' ' ' LEU . 56.3 t-105 -161.69 158.53 26.11 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.73 110.11 8.98 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.121 0.969 . . . . 72.41 109.614 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.519 ' HD2' HD22 ' F' ' 139' ' ' LEU . 31.3 Cg_exo -63.18 131.13 31.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.771 2.98 . . . . 72.5 113.312 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.06 119.55 13.53 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.56 -0.533 . . . . 63.31 109.56 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' D' ' 66' ' ' ALA . 9.3 m -98.83 120.77 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.42 0.688 . . . . 74.04 111.436 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -87.66 115.85 25.38 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.018 -1.104 . . . . 74.05 108.018 166.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -96.51 142.11 28.99 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.833 -0.803 . . . . 63.51 108.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.657 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -127.8 112.33 14.64 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.89 -1.152 . . . . 72.32 107.89 173.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -96.57 134.48 39.74 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.952 -0.759 . . . . 61.02 108.952 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.1 t70 -152.22 147.95 27.01 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.943 -1.132 . . . . 61.34 107.943 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -139.59 163.92 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.078 0.466 . . . . 75.34 110.28 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.06 163.05 39.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.148 0.979 . . . . 75.31 109.761 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -142.41 153.33 43.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.658 -0.867 . . . . 73.21 108.658 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -155.76 152.46 28.52 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.359 1.064 . . . . 72.34 108.352 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -99.42 134.09 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.502 -0.555 . . . . 41.42 109.502 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' D' ' 57' ' ' GLU . 46.4 mt -103.14 -41.37 6.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.709 0.804 . . . . 74.32 109.265 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.18 -171.83 3.52 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.205 -0.907 . . . . 74.5 109.95 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.28 122.84 18.04 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.559 -0.746 . . . . 73.44 109.233 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 63.78 9.17 4.23 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.527 1.131 . . . . 63.54 112.831 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -119.26 120.56 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.058 0.943 . . . . 72.34 108.486 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.423 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 73.0 m-85 -136.34 135.98 39.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.852 0.461 . . . . 74.14 110.246 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD21 ' D' ' 51' ' ' LEU . 6.2 tp10 -91.08 113.75 26.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.094 0.958 . . . . 63.31 109.378 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.44 127.82 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.659 -1.237 . . . . 61.41 107.659 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.2 t -113.36 146.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.433 0.693 . . . . 73.41 109.341 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -127.47 108.76 11.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.006 -1.109 . . . . 61.12 108.006 176.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.7 ttm-85 -85.13 107.05 17.02 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.201 -0.666 . . . . 71.31 109.201 170.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.0 t -105.29 103.95 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.013 -1.106 . . . . 75.5 108.013 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.657 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 45.3 m -96.61 135.84 37.96 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.888 -0.782 . . . . 73.03 108.888 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.462 HG23 HD13 ' D' ' 114' ' ' ILE . 64.1 t -122.35 127.41 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.194 -1.039 . . . . 72.23 108.194 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -129.03 93.55 3.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.706 -1.22 . . . . 71.13 107.706 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.601 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -95.95 148.97 22.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.181 0.592 . . . . 65.4 110.039 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -151.05 136.91 18.12 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.988 0.805 . . . . 71.41 109.525 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' D' ' 36' ' ' TRP . 24.9 tp -120.53 128.34 53.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.813 -0.81 . . . . 74.41 108.813 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.88 -119.39 8.12 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.193 0.308 . . . . 62.24 112.349 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.36 7.01 17.52 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.073 0.949 . . . . 71.2 109.783 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.473 ' HB3' ' HZ3' ' D' ' 34' ' ' LYS . 11.0 tp10 -116.46 145.88 42.96 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.497 1.119 . . . . 55.35 109.304 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 72' ' ' THR . . . . . 0.505 ' HB ' HD21 ' D' ' 27' ' ' ASN . 54.2 m -59.23 145.67 42.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.556 0.743 . . . . 72.31 109.038 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -106.57 -57.36 2.07 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.955 -0.387 . . . . 62.04 109.955 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.44 147.22 18.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.765 -0.652 . . . . 63.23 110.148 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 48.3 mt -110.69 149.15 30.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.538 1.135 . . . . 65.01 108.701 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -160.06 149.66 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.195 0.598 . . . . 62.21 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -156.61 141.0 16.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.506 -0.924 . . . . 61.31 108.506 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -136.37 118.66 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.301 -0.629 . . . . 75.01 109.301 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.5 85.75 6.59 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.534 -0.913 . . . . 74.33 108.534 170.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.58 102.15 8.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.517 -1.219 . . . . 63.54 108.7 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.8 142.96 15.86 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.315 -0.714 . . . . 65.23 111.315 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.88 132.19 5.63 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.415 -1.074 . . . . 52.2 110.415 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.518 HD12 ' HD3' ' D' ' 15' ' ' ARG . 89.7 mt -88.09 114.26 26.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.441 -0.948 . . . . 64.24 108.441 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.63 136.44 54.39 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.053 0.941 . . . . 74.34 109.461 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 6.5 m -79.31 105.98 11.01 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.923 -0.769 . . . . 63.52 108.923 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 37.3 mm -106.18 102.57 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.253 -1.018 . . . . 60.12 108.253 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.21 152.99 51.35 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.954 0.901 . . . . 63.23 109.535 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.89 -1.93 66.44 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 114.632 0.613 . . . . 62.14 114.632 174.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.86 125.76 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.011 -0.737 . . . . 74.11 109.011 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.94 -173.92 3.94 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.467 0.707 . . . . 70.12 111.075 -171.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 -134.58 25.14 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.782 -0.644 . . . . 52.42 113.05 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.803 0.841 . . . . 75.43 111.215 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -68.18 -38.47 82.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.645 0.778 . . . . 62.23 110.871 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.29 66.78 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.534 -0.303 . . . . 23.02 110.399 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.2 71.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.347 0.659 . . . . 63.22 111.113 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -67.66 -40.28 84.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 73.34 110.847 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -68.64 -52.3 32.75 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.061 -0.518 . . . . 60.11 110.624 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.56 -16.96 61.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.597 0.759 . . . . 75.03 111.637 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.04 -24.68 24.25 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.769 -0.462 . . . . 75.03 114.052 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.1 -57.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.679 0.74 . . . . 63.4 111.805 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -67.07 -50.75 60.71 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.798 0.839 . . . . 74.33 112.633 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.59 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 19.3 m -69.67 -44.79 24.65 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.307 0.643 . . . . 72.21 111.679 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.8 Cg_exo -58.72 -31.84 95.74 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.147 1.898 . . . . 70.31 113.416 169.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.95 -37.49 87.59 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.073 0.549 . . . . 72.33 110.721 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.57 -41.81 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.539 0.736 . . . . 72.02 109.976 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.8 -17.69 60.58 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.17 -0.923 . . . . 72.0 112.143 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -68.36 -42.7 29.85 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 113.607 0.966 . . . . 73.4 113.607 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.8 -37.14 84.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 122.072 1.848 . . . . 74.44 113.618 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 94.7 m-85 -81.37 -33.58 32.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.995 0.918 . . . . 72.34 111.431 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.63 66.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.383 0.673 . . . . 60.32 109.382 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.0 ttp180 -53.25 -53.42 51.08 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.964 -1.471 . . . . 73.3 110.458 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.9 -46.65 84.63 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.281 0.988 . . . . 63.41 111.838 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.43 -42.0 90.84 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.986 0.804 . . . . 70.4 111.175 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.462 HD13 HG23 ' D' ' 64' ' ' VAL . 75.9 mt -65.22 -53.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.666 0.604 . . . . 71.13 110.277 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.421 HG23 ' HG3' ' D' ' 125' ' ' GLN . 48.4 m -55.19 -40.54 70.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.701 1.2 . . . . 73.21 111.513 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.8 t -66.75 -43.21 84.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.59 -1.186 . . . . 64.41 110.436 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.4 mtm -67.77 -32.83 73.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.007 0.523 . . . . 73.32 112.163 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 83.4 t -67.41 -42.01 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.372 0.669 . . . . 70.31 109.764 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -76.08 -28.39 57.57 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.097 -0.502 . . . . 74.51 111.131 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -71.61 -32.48 68.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.644 0.778 . . . . 73.24 109.567 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 6.13 73.52 Favored Glycine 0 C--N 1.355 1.623 0 O-C-N 123.754 0.659 . . . . 33.34 112.544 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' C' ' 17' ' ' TYR . 63.3 p 57.58 21.46 7.16 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.83 2.052 . . . . 75.31 114.291 176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.39 157.6 58.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.928 0.891 . . . . 62.15 109.301 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.51 121.82 10.71 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.718 2.278 . . . . 62.34 111.477 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.421 ' HG3' HG23 ' D' ' 115' ' ' THR . 24.1 tt0 -48.29 132.23 16.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.009 1.324 . . . . 63.32 112.47 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' F' ' 142' ' ' ILE . 61.4 tp -107.14 106.1 16.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -97.61 89.71 4.76 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.702 -1.222 . . . . 61.01 107.702 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.52 ' HA ' HG12 ' F' ' 142' ' ' ILE . 5.6 mp -62.9 112.51 2.6 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.786 0.679 . . . . 54.34 109.594 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' F' ' 147' ' ' LEU . . . -74.79 139.57 73.86 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.255 -0.646 . . . . 64.24 109.255 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.51 165.28 27.79 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.245 1.963 . . . . 62.33 112.727 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.81 138.7 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.368 -0.605 . . . . 73.53 109.368 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -74.81 95.26 2.88 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 108.955 -0.757 . . . . 74.51 108.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -59.68 -39.61 85.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.039 -0.982 . . . . 75.2 111.045 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.32 -54.87 34.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.458 1.103 . . . . 60.34 111.846 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.84 74.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.074 0.549 . . . . 73.35 112.332 -173.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.86 -41.24 75.12 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.314 0.646 . . . . 75.44 109.524 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.447 ' O ' HD13 ' D' ' 141' ' ' LEU . 58.8 t80 -64.13 -31.61 72.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.373 1.069 . . . . 73.31 111.185 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.7 mmt -53.72 -51.55 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.361 0.664 . . . . 62.12 111.097 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.69 -30.61 64.38 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.766 -1.107 . . . . 54.33 111.145 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -58.01 -35.91 71.92 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.708 0.803 . . . . 71.13 111.62 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.447 HD13 ' O ' ' D' ' 137' ' ' PHE . 8.4 mp -61.17 -45.53 94.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.229 0.612 . . . . 74.52 111.687 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -82.35 3.93 25.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.071 0.397 . . . . 73.4 112.071 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -121.26 87.68 2.8 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.65 0.78 . . . . 64.02 109.766 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.1 84.93 1.78 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.856 -1.165 . . . . 55.11 107.856 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.73 -3.93 1.44 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.655 0.782 . . . . 70.04 110.985 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.39 127.48 12.31 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.634 -0.586 . . . . 43.14 111.634 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.35 -26.38 68.0 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.313 0.645 . . . . 74.52 111.668 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.78 -149.09 51.56 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.569 0.543 . . . . 55.54 112.519 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 72.5 p -125.79 137.44 53.79 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 15.01 108.816 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -70.79 91.84 0.85 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.132 -0.692 . . . . 73.02 109.132 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -94.04 113.53 25.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.301 -0.863 . . . . 70.24 110.038 -174.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -154.28 169.83 22.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.286 1.034 . . . . 73.21 109.33 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.09 151.35 44.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.928 0.491 . . . . 72.54 110.712 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -94.84 -42.04 8.9 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.401 0.68 . . . . 70.14 109.532 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.84 0 CA-C-N 115.655 -0.702 . . . . 64.41 109.629 175.76 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.865 -0.42 . . . . 73.53 109.865 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -139.16 55.5 1.7 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.062 -1.459 . . . . 61.22 107.062 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 73.16 178.74 0.23 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.645 1.578 . . . . 74.4 111.439 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -143.62 -173.11 3.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.391 0.677 . . . . 65.53 110.576 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.91 171.29 15.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.116 0.966 . . . . 73.25 110.907 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -80.06 177.95 8.58 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.419 0.687 . . . . 75.1 111.466 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm 64.75 85.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.649 1.179 . . . . 73.13 109.507 -167.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' B' ' 90' ' ' GLU . 26.3 tp -80.59 80.75 6.99 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.868 -1.06 . . . . 61.04 109.336 -176.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -164.95 77.97 1.36 Allowed Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 124.395 1.078 . . . . 75.35 109.368 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' B' ' 95' ' ' ALA . 96.5 Cg_endo -90.12 -178.98 1.66 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.567 2.178 . . . . 72.44 113.542 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 62.45 -93.52 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.432 1.493 . . . . 70.34 111.931 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 24.2 m 57.23 89.35 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.742 0.817 . . . . 64.33 110.792 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -66.39 114.61 5.55 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.264 0.554 . . . . 74.43 109.802 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.29 34.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.484 1.135 . . . . 42.12 110.229 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.73 85.29 0.7 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.197 -1.038 . . . . 71.24 108.197 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 34.1 m -74.05 -35.0 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.234 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? 65.56 -72.27 0.07 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.731 1.613 . . . . 72.53 111.603 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 125' ' ' TYR . . . . . 0.412 ' HB3' ' H ' ' E' ' 126' ' ' ASN . 7.1 m-85 64.33 -137.4 0.28 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.195 0.998 . . . . 75.2 110.658 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 126' ' ' ASN . . . . . 0.412 ' H ' ' HB3' ' E' ' 125' ' ' TYR . 59.3 t30 -147.77 151.48 36.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.84 -0.8 . . . . 72.51 108.84 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.66 70.18 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 124.222 0.951 . . . . 42.25 114.182 -171.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -96.2 -40.97 8.92 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.712 -0.477 . . . . 63.04 109.712 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 42.5 tp 69.4 -63.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.857 1.663 . . . . 74.51 112.434 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 24.7 pt -62.48 89.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 CA-C-O 122.383 1.087 . . . . 74.42 112.654 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.56 85.52 3.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.921 -1.036 . . . . 62.32 109.613 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -133.31 132.72 22.22 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 107.763 -1.199 . . . . 54.1 107.763 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.93 -30.0 46.27 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.348 2.699 . . . . 75.42 115.145 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 pp -127.28 165.99 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.956 0.502 . . . . 73.43 111.112 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -140.45 113.07 8.05 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.937 -1.134 . . . . 41.21 107.937 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.83 138.12 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 123.559 0.744 . . . . 63.14 111.437 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -163.54 0.87 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.827 0.851 . . . . 60.14 111.606 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -96.83 104.47 16.48 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.472 0.709 . . . . 74.52 109.585 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 41.6 tp -76.74 124.64 27.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.297 0.639 . . . . 43.14 111.002 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -173.0 129.89 0.48 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.68 1.192 . . . . 64.14 108.479 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 141' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' C' ' 39' ' ' GLU . 2.3 pt? -155.83 19.15 0.38 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.866 0.866 . . . . 72.41 110.039 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 31.7 pt -93.35 158.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.262 1.025 . . . . 72.04 111.288 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 60.17 76.57 0.36 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.658 1.183 . . . . 73.23 112.211 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -91.41 70.44 5.99 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 108.916 -0.772 . . . . 63.25 108.916 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 47.4 tttm 178.78 -71.51 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.292 1.437 . . . . 71.43 108.529 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -178.58 169.32 1.73 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.969 1.308 . . . . 53.14 108.613 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 147' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' C' ' 131' ' ' VAL . 71.6 mt -75.72 -27.87 58.33 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.093 0.557 . . . . 74.42 111.094 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 6.1 mp -104.43 125.85 33.05 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.28 1.032 . . . . 74.15 109.118 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 149' ' ' PRO . . . . . 0.565 ' HD2' HD11 ' C' ' 136' ' ' LEU . 43.2 Cg_endo . . . . . 0 CA--C 1.566 2.082 0 C-N-CA 122.46 2.106 . . . . 65.11 111.569 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.926 -0.398 . . . . 73.32 109.926 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.28 112.57 18.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.918 0.887 . . . . 62.44 109.459 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 110' ' ' ALA . . . . . 0.673 ' HB1' ' H ' ' A' ' 53' ' ' ASP . . . 69.05 3.39 4.03 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.055 1.131 . . . . 44.14 114.055 165.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -90.15 -35.53 15.34 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.414 0.552 . . . . 75.32 111.043 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -61.81 140.46 58.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.762 0.825 . . . . 61.21 110.955 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.36 123.1 13.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.438 1.095 . . . . 75.14 112.522 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' F' ' 115' ' ' LEU . 67.0 tttt -138.39 155.59 48.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.042 1.737 . . . . 74.1 106.897 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.541 HD12 ' HG3' ' A' ' 90' ' ' GLU . 26.4 tp 77.33 -29.24 0.17 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.073 1.349 . . . . 65.04 112.735 167.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.12 76.48 59.64 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 124.292 1.037 . . . . 70.54 110.12 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -90.59 -2.28 5.13 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.406 2.07 . . . . 73.14 112.376 165.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -80.22 113.44 18.39 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.941 0.896 . . . . 72.04 109.361 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 70.6 p -79.19 87.45 4.92 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.535 0.734 . . . . 71.24 110.261 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -73.09 114.24 11.04 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.211 0.605 . . . . 74.42 110.376 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.52 87.83 1.33 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.287 0.635 . . . . 52.11 109.944 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.59 24.91 0.46 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 74.35 109.175 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.34 97.49 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.141 -0.936 . . . . 64.4 110.657 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -160.33 140.05 11.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.301 1.04 . . . . 73.21 108.754 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 125' ' ' TYR . . . . . 0.439 ' HD2' HD12 ' A' ' 42' ' ' LEU . 43.1 t80 -154.34 66.71 0.71 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.277 -1.009 . . . . 65.22 108.277 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -77.61 -178.22 5.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.047 -0.979 . . . . 62.54 112.442 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 106.54 -130.09 10.03 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.616 -0.993 . . . . 70.14 110.616 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 128' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 23.7 pttm -161.5 163.17 30.45 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.25 0.62 . . . . 74.5 110.885 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.35 136.81 35.17 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.179 0.591 . . . . 65.2 109.641 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 tp -157.98 138.98 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.023 0.929 . . . . 72.12 108.745 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.29 -72.4 0.62 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.232 -0.655 . . . . 51.34 109.232 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -137.08 105.56 8.74 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 108.483 -0.932 . . . . 63.42 108.483 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.21 78.78 3.12 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.749 2.299 . . . . 71.21 111.335 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 14.8 tt -63.91 -40.27 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.775 -0.648 . . . . 70.21 109.421 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.19 46.49 10.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 51.34 111.867 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 5.4 m -60.26 119.81 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.226 -0.897 . . . . 75.33 111.373 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.82 146.47 33.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.082 0.953 . . . . 73.2 109.527 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.5 117.36 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.45 1.1 . . . . 74.44 111.583 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.519 HD22 ' HD2' ' D' ' 38' ' ' PRO . 28.4 tp -66.06 99.46 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.684 1.194 . . . . 63.55 110.714 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.6 m -110.49 14.52 22.49 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.04 -0.982 . . . . 65.35 111.245 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.15 7.02 5.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.388 0.675 . . . . 54.23 112.535 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' D' ' 126' ' ' LEU . 9.8 tp -62.54 -39.79 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.018 0.927 . . . . 74.12 111.372 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -146.3 168.16 21.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.738 1.215 . . . . 73.32 109.088 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.22 156.87 39.32 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 120.757 0.313 . . . . 72.21 111.463 -173.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 145' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' F' ' 145' ' ' LYS . 0.6 OUTLIER 64.65 49.96 2.2 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.896 1.678 . . . . 71.34 111.822 175.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 146' ' ' ASP . . . . . 0.743 ' HA ' ' HB2' ' B' ' 12' ' ' GLN . 13.5 m-20 53.29 30.39 10.02 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.87 1.268 . . . . 74.25 113.469 171.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 147' ' ' LEU . . . . . 0.548 HD11 ' HB1' ' D' ' 129' ' ' ALA . 86.2 mt 60.78 -172.48 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.217 1.007 . . . . 70.45 113.418 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.96 161.89 23.35 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 114.575 -1.193 . . . . 74.42 108.643 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 CA--C 1.57 2.288 0 C-N-CA 122.08 1.853 . . . . 55.1 112.42 169.457 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 110.415 -0.217 . . . . 72.25 110.415 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -130.14 107.53 9.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.917 0.887 . . . . 73.42 110.014 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.96 63.63 0.41 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.985 0.898 . . . . 74.42 110.492 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -127.46 109.91 12.22 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.509 -1.293 . . . . 72.01 107.509 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -69.93 146.26 51.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.705 0.802 . . . . 71.52 111.11 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.81 163.96 23.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.498 0.719 . . . . 64.41 110.989 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -69.72 157.1 37.93 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.103 -0.953 . . . . 73.14 110.069 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.98 161.54 21.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.75 0.42 . . . . 73.23 110.059 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 73.17 160.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.777 1.231 . . . . 73.32 111.214 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.0 m -145.96 134.16 21.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.657 0.783 . . . . 70.41 109.62 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -139.85 115.33 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.326 -0.99 . . . . 74.42 108.326 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 55.2 mt-30 -134.25 122.65 23.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.154 0.582 . . . . 74.23 110.104 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.43 107.99 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.539 -0.911 . . . . 75.1 108.539 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -86.33 -40.33 15.57 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.443 0.297 . . . . 75.21 110.434 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.793 ' HD2' HG21 ' B' ' 122' ' ' THR . 10.1 tpp180 -167.68 134.4 2.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.471 -0.566 . . . . 65.12 109.471 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 91.6 mt -138.4 100.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.962 -0.755 . . . . 73.31 108.962 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.9 m-85 -164.09 176.16 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 74.32 109.693 -165.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -85.33 114.05 22.11 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.146 -0.479 . . . . 72.33 110.093 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -88.92 -34.47 16.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.727 0.298 . . . . 73.44 110.371 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.792 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 9.1 m-20 -137.38 147.0 45.14 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.482 0.658 . . . . 65.25 109.736 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.561 HD13 ' SD ' ' B' ' 117' ' ' MET . 66.9 mt -144.99 143.88 22.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 126.381 1.872 . . . . 72.24 106.508 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -158.79 121.36 3.64 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.607 -0.516 . . . . 72.21 109.607 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.633 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.9 t80 -119.8 136.62 54.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.428 -1.323 . . . . 65.45 107.428 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.38 148.8 51.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.578 0.751 . . . . 64.54 109.017 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.12 80.72 7.79 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.869 -1.16 . . . . 61.32 107.869 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -31.2 24.86 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.528 2.152 . . . . 62.45 111.667 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -112.53 34.29 4.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.544 1.138 . . . . 74.44 109.334 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.45 -47.1 99.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.444 1.097 . . . . 71.42 113.581 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.1 -20.9 32.64 Favored 'Trans proline' 0 C--N 1.392 2.828 0 CA-C-N 121.124 1.437 . . . . 75.51 112.421 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -79.87 -24.97 40.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.58 0.752 . . . . 64.51 111.656 -172.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.16 -22.32 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 112.461 0.541 . . . . 75.01 112.461 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -80.04 -35.02 37.78 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.297 1.039 . . . . 72.13 110.699 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -88.36 -18.04 29.28 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.178 0.591 . . . . 73.11 111.108 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 68' ' ' LEU . 96.4 mttt -75.59 167.15 22.43 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.864 0.69 . . . . 64.25 112.864 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.27 118.28 23.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.69 -1.141 . . . . 52.23 108.05 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.483 ' HA ' HD12 ' A' ' 68' ' ' LEU . 20.5 m-90 -73.33 85.72 1.46 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.759 0.79 . . . . 72.12 110.939 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -130.78 76.98 76.35 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.063 1.345 . . . . 74.23 108.195 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.46 111.86 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.717 2.278 . . . . 75.34 111.843 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -96.14 85.09 3.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.94 -1.504 . . . . 75.54 106.94 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.1 m -88.25 122.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.453 -1.248 . . . . 65.52 111.889 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -108.17 116.61 32.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.652 1.181 . . . . 72.04 109.111 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.04 108.24 19.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.181 0.593 . . . . 63.35 109.691 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.4 t70 -103.41 130.38 50.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.728 0.811 . . . . 61.43 109.601 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 131' ' ' VAL . 4.6 mp -110.43 119.75 40.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.509 -0.922 . . . . 70.01 108.509 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.485 ' O ' HD23 ' A' ' 60' ' ' LEU . 25.3 t70 -122.68 138.08 54.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.493 0.717 . . . . 72.35 109.532 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.7 m -133.35 143.69 49.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.938 0.495 . . . . 64.0 110.146 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.71 152.69 40.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.406 1.082 . . . . 74.01 109.395 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -130.96 155.97 45.89 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.515 -0.92 . . . . 64.25 108.515 172.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -163.26 116.43 1.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 117.882 0.31 . . . . 74.45 110.314 -173.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -70.22 105.62 3.02 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.992 0.917 . . . . 65.43 110.353 -177.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 57' ' ' GLU . 44.9 mt -77.94 -39.9 41.25 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.309 1.044 . . . . 74.53 111.008 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.08 -171.81 3.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.822 -1.081 . . . . 43.32 109.447 -172.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.76 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.114 0.566 . . . . 74.23 110.5 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 9.4 m-20 54.6 31.4 15.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.117 1.367 . . . . 73.23 112.932 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 54.6 t -107.55 122.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.9 -1.519 . . . . 51.2 106.9 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 138.02 49.65 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.953 -0.758 . . . . 73.43 108.953 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' A' ' 51' ' ' LEU . 37.0 tt0 -86.92 121.87 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.987 -1.116 . . . . 73.3 107.987 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -99.29 118.58 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.446 -1.316 . . . . 72.25 107.446 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.44 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 90.9 t -98.18 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 123.28 0.632 . . . . 74.32 109.545 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -120.93 110.47 16.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.291 -1.744 . . . . 73.43 106.291 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.592 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 23.4 ttp180 -104.84 103.61 13.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.661 -0.866 . . . . 74.42 108.661 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.39 129.08 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.535 -1.211 . . . . 73.02 108.662 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 41.5 m -109.17 131.76 54.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.739 -0.837 . . . . 54.14 108.739 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 t -123.93 107.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.21 -1.404 . . . . 42.41 107.21 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -107.45 135.66 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.117 -1.068 . . . . 62.21 108.117 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.32 136.78 49.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.501 -1.296 . . . . 72.54 107.501 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.2 m -147.22 135.65 21.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.81 0.844 . . . . 75.24 109.651 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 2.3 mm? -87.23 86.52 7.28 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.868 -1.16 . . . . 73.13 107.868 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.57 -85.15 1.25 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.017 -0.992 . . . . 51.22 111.483 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -26.0 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.322 0.649 . . . . 64.24 111.312 -175.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -101.06 133.04 46.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.064 0.546 . . . . 64.23 109.965 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 m -65.44 146.35 54.99 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.154 0.982 . . . . 72.22 112.729 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -90.12 -65.56 1.0 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.833 1.253 . . . . 63.43 108.436 168.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -150.33 159.8 44.19 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.242 -1.345 . . . . 73.24 110.375 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.6 tp -134.72 116.84 15.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.231 1.012 . . . . 71.52 109.565 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.2 m -106.47 142.51 36.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 75.23 110.311 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -148.07 118.78 7.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.371 1.068 . . . . 72.53 108.838 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.32 116.73 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.136 0.425 . . . . 65.41 109.917 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.792 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 15.6 mp0 -85.57 86.51 7.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.434 -1.321 . . . . 70.13 107.434 169.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -77.01 96.01 4.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.085 -0.962 . . . . 63.31 108.607 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.84 146.0 18.1 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.274 -0.73 . . . . 75.42 111.274 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.18 123.89 2.53 Favored Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.265 -1.134 . . . . 71.4 110.265 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' B' ' 29' ' ' PRO . 56.4 mt -81.02 125.22 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.351 -0.611 . . . . 64.4 109.351 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -134.4 119.85 19.09 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.722 -0.844 . . . . 75.45 108.722 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 33.3 t -81.43 92.7 6.49 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.654 -0.869 . . . . 74.55 108.654 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' THR . 11.0 pt -125.89 127.21 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.558 0.743 . . . . 72.33 110.801 -170.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -160.89 171.11 19.32 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.981 0.913 . . . . 75.53 110.759 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.56 -24.07 32.35 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.391 -0.822 . . . . 72.22 113.135 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -109.5 146.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.94 0.496 . . . . 73.2 109.791 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -147.46 175.81 10.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.243 -0.889 . . . . 61.14 111.282 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.97 -132.46 33.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 114.683 -1.144 . . . . 73.04 112.642 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -69.48 -20.68 63.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.575 0.75 . . . . 75.24 111.882 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.08 -44.64 46.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.505 0.722 . . . . 74.15 110.736 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.571 ' HG2' HD22 ' F' ' 115' ' ' LEU . 9.7 tpt -80.73 -25.07 38.32 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.239 -0.437 . . . . 73.43 110.195 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' F' ' 117' ' ' PRO . . . -66.22 -38.49 88.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.218 0.607 . . . . 73.23 109.837 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.87 -43.35 83.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.742 -1.117 . . . . 72.3 110.491 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.714 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.4 m -73.05 -34.34 66.22 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.595 0.961 . . . . 51.22 113.595 -171.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.435 HD12 ' H ' ' F' ' 116' ' ' TYR . 84.3 mt -91.42 -9.24 45.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.486 0.314 . . . . 75.51 111.556 176.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.65 5.88 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 113.665 0.226 . . . . 50.44 113.665 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.6 -65.7 0.71 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.806 0.842 . . . . 72.12 111.034 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.4 t80 -43.62 -61.51 1.37 Allowed 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 125.125 1.37 . . . . 72.43 113.193 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 83.6 m -72.63 -50.82 7.44 Favored Pre-proline 0 CA--C 1.556 1.194 0 CA-C-O 118.255 -0.878 . . . . 71.33 112.822 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.05 -17.94 61.7 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.718 1.612 . . . . 62.1 113.815 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.29 -48.25 68.23 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 72.3 108.592 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.0 mm -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.58 -1.191 . . . . 72.22 110.782 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.441 HD23 HG23 ' A' ' 16' ' ' ILE . 95.3 mt -71.47 -28.64 64.08 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.738 -0.665 . . . . 73.21 111.953 -173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -65.23 -43.54 65.67 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.373 1.249 . . . . 74.22 114.373 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -34.92 96.53 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.194 1.93 . . . . 71.22 113.381 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -80.96 -33.92 33.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 73.3 111.494 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.13 63.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 110.046 -0.353 . . . . 62.3 110.046 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.483 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.1 ttm180 -51.75 -45.06 63.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.678 1.191 . . . . 75.01 110.348 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.61 -50.32 71.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.026 0.93 . . . . 54.12 111.487 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.47 -39.96 95.12 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.178 0.924 . . . . 55.34 111.098 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.594 HG21 HG21 ' A' ' 64' ' ' VAL . 12.8 mt -64.33 -58.11 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.561 0.745 . . . . 73.13 110.374 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -53.02 -38.95 62.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.159 0.912 . . . . 73.3 111.289 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -66.34 -42.43 88.13 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.384 -0.826 . . . . 72.31 110.472 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.6 mtm -63.49 -37.73 88.42 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.982 0.513 . . . . 64.33 111.168 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.9 t -63.12 -45.41 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.281 1.032 . . . . 71.33 110.545 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.0 p -75.17 -29.63 60.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.02 -0.537 . . . . 61.44 111.327 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -72.05 -28.07 63.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 74.12 109.81 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.13 1.25 89.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.552 -0.749 . . . . 64.53 113.014 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 m 68.68 18.33 8.77 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.762 1.225 . . . . 60.44 111.578 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -90.37 154.37 46.56 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.702 0.801 . . . . 62.33 110.805 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -59.79 134.11 55.2 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.94 2.426 . . . . 74.31 112.253 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -62.7 132.34 51.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.605 0.762 . . . . 73.22 111.883 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.3 mt -113.0 114.4 26.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.018 -1.104 . . . . 75.32 108.018 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -97.4 100.86 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.993 -1.114 . . . . 45.12 107.993 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.63 135.78 57.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.235 0.614 . . . . 74.34 110.619 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.592 ' HB2' ' HG ' ' F' ' 129' ' ' LEU . . . -61.06 145.86 88.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.995 0.518 . . . . 74.4 110.99 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.5 119.92 7.03 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.941 1.761 . . . . 72.52 109.174 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 44' ' ' LEU . 97.5 t -95.64 111.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.251 -1.388 . . . . 74.4 107.251 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -82.12 66.17 7.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.937 -1.029 . . . . 74.42 109.318 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -68.8 -34.83 76.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.624 -0.716 . . . . 54.11 109.85 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 138' ' ' MET . 2.1 m-20 -56.58 -53.01 62.58 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.958 0.786 . . . . 73.33 109.743 172.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.65 -28.64 64.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.577 0.751 . . . . 74.32 111.434 -177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' F' ' 123' ' ' VAL . 56.4 tp -65.25 -48.23 74.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.449 1.099 . . . . 73.44 110.201 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.04 -28.18 65.26 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.976 -1.011 . . . . 74.31 110.236 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 14.3 mmt -65.54 -34.01 77.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.077 -0.487 . . . . 75.23 112.079 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -56.71 -32.15 65.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.259 0.552 . . . . 60.13 110.699 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.73 -39.7 23.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.932 -1.031 . . . . 74.12 110.865 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.4 tp -71.66 -52.41 18.04 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.411 0.893 . . . . 75.12 113.411 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -169.35 20.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.048 0.539 . . . . 73.53 110.438 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 65.79 -159.64 0.27 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.983 -1.118 . . . . 72.15 107.983 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.625 ' HG2' ' HB3' ' C' ' 6' ' ' ASN . 0.2 OUTLIER -73.82 74.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.026 1.284 . . . . 61.55 111.92 -173.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.658 ' HB1' ' HB3' ' C' ' 145' ' ' ALA . . . -179.68 128.38 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.73 1.612 . . . . 70.23 107.973 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.52 -39.84 0.24 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 117.845 0.293 . . . . 72.42 112.898 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -83.95 171.36 13.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.585 0.707 . . . . 73.04 112.359 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 67.4 -137.7 33.26 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 113.811 -1.54 . . . . 74.32 112.883 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.8 m 61.79 80.05 0.23 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.082 0.953 . . . . 70.11 111.123 171.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -145.03 166.35 25.59 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.084 0.469 . . . . 75.31 111.89 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.55 -47.95 0.08 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.807 -1.088 . . . . 74.32 110.581 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -71.9 90.56 1.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.547 0.689 . . . . 74.42 111.975 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -84.89 -17.48 37.75 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.757 -1.111 . . . . 61.44 109.267 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.06 143.45 49.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.661 0.784 . . . . 73.41 110.528 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.364 0 N-CA-C 109.0 -0.741 . . . . 61.04 109.0 177.98 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.524 ' HA ' ' HB3' ' B' ' 141' ' ' LEU . 61.1 mtt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 110.003 -0.369 . . . . 53.1 110.003 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.3 m 63.61 80.84 0.22 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.6 1.188 . . . . 71.1 110.857 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -118.28 145.76 44.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.966 -1.015 . . . . 74.24 109.604 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -165.41 11.34 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.601 0.593 . . . . 75.23 112.601 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -74.17 161.37 30.04 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.284 0.493 . . . . 75.24 111.63 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -134.86 -177.89 4.83 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.887 0.875 . . . . 73.0 108.954 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -70.53 78.33 0.57 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.117 0.96 . . . . 62.22 108.912 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.94 -156.72 0.74 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.992 1.317 . . . . 72.13 109.217 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.59 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.7 ptm 56.18 -177.35 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 126.049 1.74 . . . . 61.34 114.941 170.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -143.39 122.36 12.8 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.184 -1.043 . . . . 63.13 108.184 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -110.51 134.86 51.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.027 0.931 . . . . 64.43 108.677 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -145.61 141.37 28.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.774 -0.824 . . . . 73.32 108.774 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.624 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -91.66 134.49 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.79 -0.818 . . . . 72.14 108.79 173.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -92.4 -50.3 5.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.129 0.572 . . . . 73.45 109.585 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -164.54 139.26 5.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.436 -0.802 . . . . 72.15 109.409 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -114.84 144.7 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 106.218 -1.771 . . . . 73.15 106.218 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.3 149.44 2.24 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.133 0.424 . . . . 72.22 110.908 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.486 HG21 HD11 ' B' ' 21' ' ' ILE . 26.8 m -80.14 121.66 25.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.353 -0.61 . . . . 73.11 109.353 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -87.7 -33.8 18.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.014 0.526 . . . . 72.34 110.203 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.4 t70 -146.99 127.97 14.54 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.13 -0.486 . . . . 65.4 110.75 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 34.3 mm -113.47 147.08 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.395 -1.335 . . . . 71.2 107.395 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -150.72 140.51 21.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.294 -0.632 . . . . 61.32 109.294 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 93.3 t80 -155.22 114.91 3.7 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 107.663 -1.236 . . . . 73.33 107.663 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.65 113.88 17.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.731 -1.211 . . . . 72.34 107.731 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.687 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -106.0 89.32 3.61 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.544 -0.91 . . . . 61.52 108.544 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.17 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.837 2.358 . . . . 63.42 112.602 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -127.26 29.58 5.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.013 0.925 . . . . 72.52 110.773 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.687 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -48.1 -55.8 16.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 C-N-CA 123.983 0.913 . . . . 64.41 112.419 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HA ' HD11 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -70.5 -16.66 34.45 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.845 1.697 . . . . 73.22 112.622 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -101.5 4.81 41.51 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.5 0.926 . . . . 71.44 113.5 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.68 -31.36 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 118.22 0.464 . . . . 71.3 111.775 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -73.35 -17.82 61.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.464 0.705 . . . . 72.44 110.958 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -79.43 -35.79 39.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.251 1.02 . . . . 62.43 110.813 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -108.02 110.28 21.95 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.39 0.676 . . . . 72.43 110.607 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -98.45 78.03 2.38 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.227 0.611 . . . . 75.31 110.374 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -151.35 161.6 42.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.374 -1.343 . . . . 71.43 107.374 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -85.3 133.5 42.43 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 122.722 0.409 . . . . 73.11 110.221 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.52 136.51 26.18 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.421 2.081 . . . . 73.42 112.799 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -66.63 104.16 1.23 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.8 0.84 . . . . 73.54 109.067 168.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.465 HG11 HD21 ' B' ' 126' ' ' LEU . 11.0 m -98.43 150.44 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.979 0.511 . . . . 72.55 110.423 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' B' ' 65' ' ' THR . 1.1 tmmt? -150.69 121.63 7.64 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.566 -0.901 . . . . 74.43 108.566 -175.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.487 HD11 HD12 ' B' ' 126' ' ' LEU . 2.2 mm? -96.49 134.69 39.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.795 0.838 . . . . 73.23 109.602 -173.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.607 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.6 m-20 -123.62 113.45 18.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.342 -0.984 . . . . 74.34 108.342 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -101.67 148.0 25.78 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.384 -0.599 . . . . 72.14 109.384 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -161.31 152.33 18.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.62 -1.252 . . . . 53.41 107.62 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -153.43 143.87 22.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.988 0.423 . . . . 55.01 110.73 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.66 161.16 35.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.991 1.316 . . . . 74.2 108.331 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.3 m -130.44 165.18 23.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.335 0.588 . . . . 71.02 110.729 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -151.54 146.29 25.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.067 1.347 . . . . 71.31 107.554 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.65 112.13 24.92 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.292 -0.632 . . . . 53.05 109.292 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.39 -34.49 25.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.015 0.436 . . . . 75.02 110.086 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -159.94 178.6 9.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.8 0.84 . . . . 44.01 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.46 117.29 5.51 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.649 -1.159 . . . . 72.42 109.524 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 71.53 -4.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.438 1.495 . . . . 73.22 112.542 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 78.7 t -104.93 95.23 3.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.399 -0.963 . . . . 71.34 108.399 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -107.58 136.4 47.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.629 -0.714 . . . . 74.01 110.435 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -101.48 100.75 11.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.539 -1.282 . . . . 73.14 107.539 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.18 127.32 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.243 1.017 . . . . 72.31 109.669 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.2 t -103.63 123.63 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.825 0.85 . . . . 52.15 110.036 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.94 134.38 35.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.926 -1.509 . . . . 75.23 106.926 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -120.51 121.74 39.09 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.08 0.952 . . . . 75.21 108.701 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -115.53 104.29 16.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.093 -1.447 . . . . 74.5 107.093 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 21.7 m -96.92 130.22 44.26 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.542 -0.91 . . . . 74.12 108.542 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.49 HG23 HD13 ' B' ' 114' ' ' ILE . 69.8 t -112.85 130.7 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.394 0.678 . . . . 72.13 109.401 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HE3' ' B' ' 41' ' ' LYS . 22.0 m -119.67 123.64 44.31 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.514 -0.921 . . . . 62.32 108.514 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 140.18 49.05 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 122.734 0.413 . . . . 73.41 109.984 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.552 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 22.5 p -138.2 126.71 23.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 62.34 110.152 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 2.6 tt -93.46 100.55 12.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.914 -1.513 . . . . 42.44 106.914 -176.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.39 -137.47 19.75 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 111.767 -0.533 . . . . 70.31 111.767 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.53 33.93 1.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.676 0.79 . . . . 60.11 110.387 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.28 146.7 24.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.058 0.943 . . . . 74.31 108.794 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -74.99 138.3 42.14 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.074 0.464 . . . . 72.34 111.388 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.552 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.07 -61.92 1.58 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.292 -1.003 . . . . 42.32 108.292 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.37 157.62 32.7 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.782 -1.099 . . . . 75.31 110.078 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.79 111.82 12.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.394 -1.335 . . . . 71.33 107.394 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.32 152.8 35.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.412 0.685 . . . . 53.41 109.538 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -155.61 134.64 12.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.514 -0.921 . . . . 75.51 108.514 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -129.07 141.36 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.366 -0.605 . . . . 62.24 109.366 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 51.4 mt-30 -118.88 100.88 7.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.378 1.071 . . . . 75.45 109.007 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -87.41 101.17 13.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.715 -0.675 . . . . 74.33 109.362 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 150.64 21.57 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.316 -0.714 . . . . 74.13 111.316 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.26 125.86 2.04 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 111.65 -0.58 . . . . 75.01 111.65 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.66 126.53 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.061 -1.088 . . . . 75.21 108.061 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -130.85 160.38 34.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.651 1.18 . . . . 72.24 108.855 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -130.79 108.06 9.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.934 0.893 . . . . 52.41 108.777 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.714 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -123.69 115.38 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.823 1.249 . . . . 62.25 109.428 -174.13 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 51.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.702 0.801 . . . . 65.32 110.275 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.01 -46.01 1.23 Allowed Glycine 0 C--N 1.345 1.031 0 O-C-N 123.548 0.53 . . . . 63.01 112.112 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -90.75 154.23 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.1 0.96 . . . . 71.4 111.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' E' ' 115' ' ' LEU . 35.0 tt0 -159.46 156.81 28.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.694 0.398 . . . . 65.34 110.522 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.27 -116.45 7.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.245 -0.434 . . . . 53.21 112.749 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -67.75 -33.48 74.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.769 0.828 . . . . 64.21 111.044 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.14 -50.31 66.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.735 -0.666 . . . . 72.44 110.529 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.593 ' SD ' ' HB3' ' E' ' 115' ' ' LEU . 28.2 ttt -71.73 -28.19 63.5 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.287 -0.87 . . . . 74.43 110.944 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -38.14 85.81 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.805 -0.634 . . . . 54.12 110.688 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -70.47 -34.79 72.79 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.505 -0.771 . . . . 74.42 110.299 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.31 -48.39 56.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.171 0.588 . . . . 73.44 111.034 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.25 -16.85 44.76 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.524 0.73 . . . . 73.42 111.812 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.75 2.84 58.73 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.88 -0.4 . . . . 63.42 113.307 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.84 -55.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.276 0.538 . . . . 75.33 112.132 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -81.52 -50.98 8.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.942 0.497 . . . . 74.15 111.768 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.7 m -56.89 -49.6 92.94 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.712 -0.661 . . . . 74.42 112.518 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.45 -26.86 47.3 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.989 1.793 . . . . 73.45 112.842 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.99 -33.56 76.34 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.942 0.401 . . . . 72.12 110.995 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.21 -47.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.672 0.789 . . . . 72.31 110.189 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.22 -22.36 61.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.226 -0.897 . . . . 74.11 112.268 -172.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -63.66 -47.87 81.39 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 114.211 1.189 . . . . 75.3 114.211 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.42 -36.14 93.39 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.09 1.86 . . . . 72.15 113.352 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.41 ' HE2' HG21 ' D' ' 115' ' ' THR . 69.4 m-85 -70.93 -46.84 61.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.194 0.597 . . . . 73.11 110.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.09 94.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.467 0.707 . . . . 55.53 110.651 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -59.38 -56.0 27.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.885 0.874 . . . . 75.45 110.624 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -37.8 84.35 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.791 0.682 . . . . 75.35 110.057 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.5 m -57.08 -53.44 58.03 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 73.54 111.917 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.49 HD13 HG23 ' B' ' 64' ' ' VAL . 80.9 mt -60.73 -58.12 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.595 0.758 . . . . 75.45 111.065 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.3 m -63.56 -30.3 71.43 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.252 0.97 . . . . 70.44 111.206 -168.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 43.7 t -59.79 -56.59 19.91 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.684 -0.689 . . . . 50.23 109.397 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.642 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 19.1 mmt -61.57 -32.96 73.07 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.748 0.819 . . . . 73.53 112.158 -175.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.12 -50.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.027 0.931 . . . . 72.13 110.66 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 84.8 p -74.54 -20.1 60.09 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.292 0.637 . . . . 74.3 111.339 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.642 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.43 -33.48 75.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.786 0.834 . . . . 62.51 110.06 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.73 8.66 78.25 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.39 0.431 . . . . 73.31 112.622 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.793 HG21 ' HD2' ' A' ' 15' ' ' ARG . 4.8 p 69.09 15.05 8.77 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.64 1.976 . . . . 73.31 113.148 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.05 155.3 67.42 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.776 0.83 . . . . 74.41 111.104 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.56 128.79 30.85 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.518 2.812 . . . . 70.23 113.396 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.43 ' HG3' ' OE1' ' C' ' 125' ' ' GLN . 72.7 mt-30 -55.66 133.33 50.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.171 1.388 . . . . 74.34 112.516 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.487 HD12 HD11 ' B' ' 42' ' ' LEU . 3.7 mm? -109.51 82.36 1.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.929 -0.767 . . . . 74.31 108.929 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -91.84 96.23 10.29 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.933 -1.136 . . . . 71.14 107.933 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.445 HD21 ' HE2' ' E' ' 125' ' ' TYR . 0.8 OUTLIER -75.19 128.63 35.92 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.179 -0.674 . . . . 75.32 109.179 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.95 148.5 94.57 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.033 0.933 . . . . 60.1 111.376 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.29 93.62 0.57 Allowed 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.177 1.918 . . . . 74.03 111.401 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.6 140.75 15.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.083 -0.962 . . . . 60.11 108.648 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -68.23 99.89 0.97 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.568 0.747 . . . . 65.0 110.339 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -56.34 -30.76 63.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.074 -0.966 . . . . 74.31 110.096 170.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.4 -56.91 13.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.063 1.345 . . . . 54.21 111.46 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.9 94.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.886 0.741 . . . . 62.54 111.74 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' E' ' 123' ' ' VAL . 4.0 tt -59.87 -45.93 90.89 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.69 0.796 . . . . 64.44 109.567 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 88.3 t80 -64.85 -40.88 95.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.874 -1.057 . . . . 64.35 111.456 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 98.2 mmm -68.1 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.799 0.44 . . . . 74.24 111.201 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -76.35 -17.83 59.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.226 0.611 . . . . 71.44 111.287 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -76.43 -30.8 57.56 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.932 -0.396 . . . . 73.31 109.932 171.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' B' ' 1' ' ' MET . 72.0 mt -81.1 39.13 0.49 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.2 1.0 . . . . 65.24 112.745 -173.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -81.73 79.55 8.26 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.976 -1.078 . . . . 73.32 110.634 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -139.25 161.71 36.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.248 1.019 . . . . 74.51 108.45 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.8 -60.67 2.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.801 0.44 . . . . 73.24 110.11 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.23 108.85 4.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.635 . . . . 73.21 110.405 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.68 60.87 0.64 Allowed Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.491 -1.044 . . . . 71.1 110.491 172.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -69.94 101.49 1.78 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.831 0.852 . . . . 75.41 110.653 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.89 78.84 1.18 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.68 -0.968 . . . . 31.33 110.68 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 66.1 p -79.12 162.93 25.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.768 0.827 . . . . 74.31 112.447 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.8 153.1 23.2 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.817 0.847 . . . . 72.1 111.383 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -143.74 80.94 1.68 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.117 0.961 . . . . 73.15 110.207 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -99.15 133.6 43.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.559 -0.746 . . . . 74.01 110.182 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -107.7 140.36 40.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.918 0.887 . . . . 64.52 110.533 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.96 -60.73 2.26 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.603 0.761 . . . . 74.3 109.333 172.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.999 0.92 . . . . 71.45 108.972 -179.695 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -72.98 -70.34 0.36 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.182 0.593 . . . . 75.3 110.31 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.599 ' HB3' ' HB2' ' C' ' 145' ' ' ALA . 39.4 tt0 -121.7 144.88 48.53 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.38 0.61 . . . . 70.02 110.46 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.47 169.54 17.61 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.636 1.574 . . . . 74.24 107.502 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 17.2 m120 74.03 115.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.353 1.061 . . . . 74.43 112.403 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.625 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 41.8 t30 -161.68 161.66 29.54 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 73.11 108.822 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -58.81 118.39 5.67 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.023 0.929 . . . . 64.1 111.028 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.53 -40.86 66.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.099 0.96 . . . . 72.31 110.534 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.661 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 13.0 tmm? 65.73 125.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.077 1.351 . . . . 60.52 113.288 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -94.22 105.79 17.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 53.55 110.023 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.661 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 80.3 t80 -122.61 143.18 49.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 71.21 109.232 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.76 140.47 17.04 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.177 0.591 . . . . 72.43 109.687 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.0 mt -79.11 117.88 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.251 -1.018 . . . . 74.24 108.251 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -88.9 -45.4 9.73 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.772 0.67 . . . . 74.44 110.064 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.617 HH11 ' HB3' ' F' ' 132' ' ' TYR . 51.3 ttt85 -165.8 144.45 6.02 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.887 0.475 . . . . 61.11 110.277 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.84 139.85 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.173 -1.047 . . . . 74.34 108.173 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.519 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 32.6 p90 -173.78 158.18 3.21 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.312 0.577 . . . . 75.32 111.136 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -82.47 116.92 22.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.502 -0.772 . . . . 63.24 109.513 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -78.09 -41.0 36.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.696 0.76 . . . . 73.41 109.074 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -140.41 140.02 35.39 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.55 -1.205 . . . . 62.21 109.741 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.9 mt -136.36 141.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.482 1.513 . . . . 54.22 107.093 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -158.61 148.8 19.78 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.189 0.519 . . . . 74.34 110.222 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -148.27 149.41 31.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -143.45 146.42 33.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.046 1.338 . . . . 72.34 107.714 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' D' ' 19' ' ' LYS . . . -149.77 82.79 6.53 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.83 -1.174 . . . . 54.52 107.83 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.25 -31.9 43.17 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.497 2.131 . . . . 62.1 111.996 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 79.0 m-20 -112.15 38.82 2.58 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 70.42 109.599 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -57.86 -48.79 96.53 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.512 1.125 . . . . 72.01 113.348 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.89 -21.14 8.47 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.729 1.619 . . . . 71.13 112.613 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.8 t-160 -67.56 -20.31 65.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.893 0.877 . . . . 75.33 111.686 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.518 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 11.7 p -46.03 -28.99 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 124.792 1.237 . . . . 42.34 114.212 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -66.92 -43.07 84.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.906 0.482 . . . . 72.32 111.824 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -127.66 39.15 3.92 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.536 0.684 . . . . 71.04 110.806 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -94.03 169.56 10.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 167.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.99 120.89 25.83 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.51 -0.922 . . . . 62.52 108.51 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t90 -78.44 81.61 4.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.481 0.657 . . . . 71.45 109.674 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -153.86 74.95 6.28 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.478 -1.237 . . . . 50.25 107.745 168.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.26 106.64 1.76 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.745 2.296 . . . . 74.53 110.611 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.67 94.89 8.74 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.323 -1.732 . . . . 64.22 106.323 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.539 HG21 HD21 ' E' ' 139' ' ' LEU . 96.4 t -86.07 102.33 11.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.549 -1.205 . . . . 52.22 110.198 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -90.29 101.83 14.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.255 -1.338 . . . . 63.24 108.007 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.56 ' H ' HD23 ' C' ' 42' ' ' LEU . 0.7 OUTLIER -89.11 147.49 24.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.978 -0.749 . . . . 72.21 108.978 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.3 t70 -142.69 136.19 28.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.631 0.772 . . . . 60.44 109.156 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 135.44 41.87 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.89 0.876 . . . . 72.1 109.085 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.34 152.06 30.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.445 1.098 . . . . 72.31 108.204 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -131.02 135.78 47.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.421 0.629 . . . . 62.12 110.896 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.52 170.64 8.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.975 -1.011 . . . . 52.32 108.747 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 59.5 p -150.86 151.22 31.93 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.654 0.382 . . . . 60.54 110.534 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.7 p -147.3 128.07 14.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.201 1.001 . . . . 70.21 109.189 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -72.2 118.15 14.72 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.629 -0.508 . . . . 71.45 109.629 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' C' ' 57' ' ' GLU . 54.9 mt -87.28 -43.83 11.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.214 -0.661 . . . . 71.44 109.214 176.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.97 -178.35 6.43 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.705 -1.134 . . . . 43.43 109.895 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.74 120.32 11.0 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.573 -0.74 . . . . 73.44 110.157 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 66.92 3.45 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.755 1.222 . . . . 70.23 112.872 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.99 113.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.907 0.883 . . . . 71.1 108.985 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.13 125.46 43.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.355 1.062 . . . . 63.12 108.717 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.569 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.7 tt0 -83.74 110.99 18.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.094 -0.706 . . . . 65.21 109.094 172.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -95.55 124.01 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.573 -1.269 . . . . 62.34 107.573 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.83 107.57 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.351 0.66 . . . . 74.45 109.245 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.52 104.89 16.9 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.556 -0.905 . . . . 71.53 108.556 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -90.78 121.29 32.52 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.066 1.346 . . . . 75.23 110.219 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.22 121.65 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.82 0.848 . . . . 73.42 109.302 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.0 m -103.34 141.58 35.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.901 -0.778 . . . . 72.13 108.901 166.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.576 HG21 HG21 ' C' ' 114' ' ' ILE . 87.3 t -129.45 112.32 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.094 -1.076 . . . . 75.51 108.094 173.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -108.16 106.95 17.38 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.684 -0.858 . . . . 62.34 108.684 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.94 100.61 10.1 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.851 -0.796 . . . . 63.51 108.851 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -156.81 146.5 20.73 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.111 -0.7 . . . . 54.45 109.111 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 tp -71.2 -44.97 64.36 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.501 -0.926 . . . . 62.52 108.501 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.75 -76.92 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.359 -1.096 . . . . 70.03 110.359 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.31 -33.29 16.16 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 74.14 109.376 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.4 93.72 0.9 Allowed 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.196 -1.038 . . . . 73.41 108.196 171.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -89.53 118.18 28.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.877 -0.601 . . . . 75.32 109.624 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.93 -57.73 4.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.308 -1.368 . . . . 75.23 107.308 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.42 158.69 27.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.123 -0.944 . . . . 65.02 110.725 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -126.21 143.97 50.94 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.254 -1.758 . . . . 41.31 106.254 170.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 34.9 t -150.89 147.52 27.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.634 -0.506 . . . . 72.44 109.634 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -156.53 129.76 8.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.831 -0.433 . . . . 70.31 109.831 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 36.9 t -127.49 114.73 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.177 0.991 . . . . 72.21 108.827 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 94.0 mt-30 -91.27 95.26 9.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.515 -0.921 . . . . 65.13 108.515 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.607 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 55.9 tp60 -83.22 108.62 16.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.594 -0.73 . . . . 74.12 109.817 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.53 150.47 25.67 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 111.809 -0.516 . . . . 70.24 111.809 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.97 118.06 0.88 Allowed Glycine 0 CA--C 1.501 -0.828 0 N-CA-C 110.556 -1.018 . . . . 50.43 110.556 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.475 HD12 HD11 ' C' ' 51' ' ' LEU . 15.4 mm -79.61 127.91 38.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.48 -1.304 . . . . 73.35 107.48 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -135.21 150.63 50.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 75.12 110.172 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -108.42 113.93 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.238 -0.892 . . . . 73.34 108.991 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 51.5 mt -116.01 110.19 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.984 0.914 . . . . 73.12 108.834 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.41 159.16 42.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 64.25 109.817 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -26.24 8.16 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.361 -0.381 . . . . 61.23 113.374 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' C' ' 93' ' ' GLN . 10.4 tt -123.43 159.19 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.643 0.777 . . . . 63.42 110.33 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -157.93 -177.35 6.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.437 0.695 . . . . 34.35 110.34 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -153.25 40.19 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.189 -0.459 . . . . 40.51 113.563 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 76.0 p -66.0 -21.16 66.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.55 0.74 . . . . 71.13 111.259 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.464 ' HB3' HD11 ' C' ' 89' ' ' ILE . 96.9 mt-30 -59.32 -51.68 68.92 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.012 0.925 . . . . 75.34 110.88 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.407 ' HB3' HG23 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -76.26 -23.76 54.47 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.329 -0.396 . . . . 73.44 110.916 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.78 97.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.235 0.614 . . . . 71.42 111.536 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.82 -26.87 64.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.615 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -69.95 -60.78 2.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 110.357 -0.238 . . . . 75.55 110.357 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 pp -72.89 -13.98 61.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.088 0.403 . . . . 65.21 112.088 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.99 -21.14 28.82 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.779 -0.456 . . . . 61.14 113.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.8 -59.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.392 0.596 . . . . 70.3 111.432 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -51.71 66.85 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.54 0.736 . . . . 75.54 112.365 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 m -68.13 -46.68 40.74 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.731 0.812 . . . . 61.13 112.506 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.57 -24.05 49.04 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.013 1.809 . . . . 64.42 113.793 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -69.88 -20.18 63.4 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 122.751 0.42 . . . . 71.43 112.006 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 ' NH1' ' A' ' 111' ' ' ARG . 36.4 mm -70.34 -41.4 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.365 0.602 . . . . 73.14 109.722 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.511 HD21 ' HA3' ' C' ' 82' ' ' GLY . 78.9 mt -81.67 -27.81 33.86 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.849 -1.069 . . . . 65.12 111.931 -171.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.524 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 49.1 t80 -56.26 -47.44 98.86 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 117.692 -1.147 . . . . 74.33 113.607 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.12 -42.1 67.23 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.345 2.03 . . . . 63.21 113.036 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.4 -47.52 76.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.976 0.91 . . . . 72.34 111.388 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.7 -37.47 86.53 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.796 -0.638 . . . . 61.33 110.894 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -62.16 -46.1 90.48 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.387 1.055 . . . . 64.54 110.134 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.11 -37.11 75.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.713 0.633 . . . . 74.14 110.705 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.5 t -64.7 -31.81 73.2 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.522 0.513 . . . . 60.41 110.793 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.576 HG21 HG21 ' C' ' 64' ' ' VAL . 96.1 mt -73.99 -49.16 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.911 -0.586 . . . . 71.51 110.756 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.0 m -57.8 -33.63 68.77 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.44 0.638 . . . . 52.04 110.703 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -65.84 -51.57 57.76 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.702 -1.135 . . . . 71.21 109.574 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.543 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.25 -37.09 74.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.769 1.228 . . . . 74.23 112.79 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.0 t -69.28 -43.51 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.809 0.844 . . . . 75.31 109.821 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.6 t -69.63 -25.39 63.91 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.12 -0.945 . . . . 73.34 110.988 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -71.54 -38.76 71.02 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 108.793 -0.818 . . . . 72.44 108.793 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.31 84.63 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 123.789 0.681 . . . . 71.42 113.043 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.6 p 62.88 29.81 16.56 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.437 1.895 . . . . 73.31 112.852 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -92.4 163.97 24.6 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 124.43 1.092 . . . . 70.51 111.246 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' E' ' 136' ' ' VAL . 19.5 Cg_endo -55.62 177.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.065 3.177 . . . . 71.3 115.935 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.43 ' OE1' ' HG3' ' B' ' 125' ' ' GLN . 19.5 mm100 -60.42 112.12 1.84 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.708 1.203 . . . . 74.44 112.026 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -111.33 90.49 3.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.785 -1.561 . . . . 50.1 106.785 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -122.81 105.02 9.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.761 -1.2 . . . . 64.31 107.761 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.524 HD22 ' HZ ' ' C' ' 107' ' ' PHE . 2.8 tt -80.87 116.47 20.87 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.629 -0.878 . . . . 73.24 108.629 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 142.77 98.72 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.087 0.955 . . . . 41.52 111.739 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.446 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 18.3 Cg_endo -58.03 109.66 0.52 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.974 2.449 . . . . 70.41 112.847 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 p -97.89 110.39 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.943 -1.132 . . . . 75.45 107.943 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -102.44 78.39 1.72 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.684 -0.689 . . . . 72.21 111.1 -164.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -69.44 -29.16 66.81 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.18 -0.918 . . . . 75.13 110.508 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -69.92 -50.12 45.31 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.724 -0.671 . . . . 73.34 109.923 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.418 ' HA ' ' HB2' ' C' ' 138' ' ' MET . . . -68.55 -23.21 64.48 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.453 1.101 . . . . 74.45 111.903 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 tt -54.56 -52.1 63.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.66 0.784 . . . . 60.24 109.007 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.71 -32.79 53.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.447 -0.797 . . . . 70.13 111.661 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.418 ' HB2' ' HA ' ' C' ' 135' ' ' ALA . 96.3 mmm -68.68 -30.73 69.47 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 111.913 0.338 . . . . 51.12 111.913 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -71.21 -41.13 70.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.869 0.468 . . . . 64.21 110.266 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -70.76 -83.75 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.583 0.753 . . . . 71.41 111.847 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.94 1.61 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.085 1.354 . . . . 60.01 112.149 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' C' ' 143' ' ' GLN . 52.6 tt0 54.31 -82.39 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.697 1.599 . . . . 23.33 111.278 -170.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' C' ' 142' ' ' GLN . 12.9 mm-40 -132.71 138.14 47.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.776 0.831 . . . . 64.5 109.674 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -153.14 -85.59 0.07 Allowed 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 107.295 -1.372 . . . . 74.5 107.295 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.658 ' HB3' ' HB1' ' A' ' 145' ' ' ALA . . . -174.88 177.24 2.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.875 . . . . 75.3 110.981 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.47 146.19 12.19 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.665 -0.974 . . . . 33.53 110.665 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.54 161.37 29.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.115 0.566 . . . . 72.42 110.501 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.68 162.04 37.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.696 -0.684 . . . . 51.23 113.561 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 70.4 m -140.36 -54.84 0.52 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.914 -1.143 . . . . 24.52 107.914 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -172.81 -40.59 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.006 0.922 . . . . 72.42 110.714 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 62.46 -89.46 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.588 1.155 . . . . 51.0 109.07 -162.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 50.21 41.36 23.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.047 1.339 . . . . 73.42 112.8 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.89 153.49 20.86 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.406 1.082 . . . . 51.45 112.987 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 65.37 -86.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.45 1.5 . . . . 72.2 110.864 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.44 -0.948 . . . . 63.25 108.44 177.575 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 111.537 0.199 . . . . 52.42 111.537 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -98.47 121.97 41.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.605 -0.517 . . . . 74.32 109.605 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.71 82.7 2.09 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.674 0.79 . . . . 74.24 109.683 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -147.37 161.31 41.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.495 -0.775 . . . . 61.24 110.439 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -154.11 47.46 0.61 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.7 -1.593 . . . . 72.22 106.7 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -84.17 5.76 25.1 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.993 -1.003 . . . . 75.31 111.842 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -67.23 98.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.156 0.982 . . . . 75.3 109.763 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -81.62 66.0 6.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.36 1.064 . . . . 70.04 110.778 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.8 ttt -34.09 141.27 0.05 Allowed 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.716 1.376 . . . . 74.21 114.716 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.7 m -144.86 142.73 30.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 72.12 108.936 166.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.78 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 29.4 t80 -152.79 121.45 6.43 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.051 -1.092 . . . . 75.11 108.051 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -137.67 144.39 41.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.989 0.516 . . . . 75.32 109.765 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.3 mm -84.13 116.91 28.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.95 0.9 . . . . 72.23 108.657 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -101.46 -48.68 4.27 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.929 0.331 . . . . 70.42 111.753 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.425 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 35.3 ttt180 -173.96 128.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 111.923 0.342 . . . . 74.11 111.923 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.13 132.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 124.177 0.991 . . . . 64.42 108.373 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 18.2 p90 -163.13 176.02 10.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.692 0.797 . . . . 75.53 112.043 -172.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.452 HG21 HD11 ' D' ' 21' ' ' ILE . 76.8 p -111.05 126.59 54.97 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 64.01 109.636 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.524 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 35.3 mtpt -97.39 -14.41 21.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.78 0.432 . . . . 60.33 110.302 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -161.33 138.29 8.68 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.385 1.074 . . . . 73.51 109.136 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.543 HG21 ' HE2' ' C' ' 117' ' ' MET . 51.8 mt -140.68 144.49 27.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.787 -1.56 . . . . 64.41 106.787 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 20.3 t -150.23 143.5 25.01 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.024 -0.732 . . . . 61.4 109.024 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.54 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -152.39 125.7 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.67 -1.604 . . . . 63.41 106.67 173.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.0 mt-10 -126.59 142.02 51.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.995 0.918 . . . . 73.34 108.528 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 85.4 60.4 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.021 -1.103 . . . . 73.32 108.021 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.04 -45.08 8.45 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.448 2.765 . . . . 74.43 113.803 -167.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -114.53 44.56 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.154 0.982 . . . . 72.33 108.432 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.519 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -50.91 -57.86 12.23 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 115.808 1.781 . . . . 72.52 115.808 -167.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -85.25 -5.76 9.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 122.345 1.873 . . . . 74.1 112.636 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -84.07 -39.79 19.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.27 1.428 . . . . 64.12 109.947 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.03 -16.59 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.517 0.727 . . . . 64.13 109.828 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -55.46 -32.44 62.78 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.438 1.095 . . . . 74.13 111.789 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -67.72 -8.21 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.457 0.703 . . . . 74.41 112.531 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -125.47 106.19 9.61 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.295 1.038 . . . . 61.13 109.485 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -89.23 81.93 6.63 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.28 1.038 . . . . 74.51 110.478 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.577 ' HB3' HD11 ' D' ' 68' ' ' LEU . 33.5 t-105 -146.04 157.25 43.86 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.925 -1.139 . . . . 62.23 107.925 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.436 ' OE1' HG23 ' F' ' 136' ' ' VAL . 2.8 mp0 -61.41 105.21 0.55 Allowed Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 125.161 1.384 . . . . 75.14 110.912 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.543 ' HD2' HD22 ' F' ' 139' ' ' LEU . 45.1 Cg_exo -61.35 111.38 1.11 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.272 2.648 . . . . 72.32 111.883 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 113.27 2.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.378 0.671 . . . . 71.13 110.542 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.7 m -100.76 150.27 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 54.05 110.579 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -121.63 118.92 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.621 -1.992 . . . . 73.34 105.621 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.65 ' HG ' HD21 ' D' ' 128' ' ' LEU . 0.0 OUTLIER -96.38 151.45 19.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.726 -0.842 . . . . 44.33 108.726 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -149.79 144.15 25.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.421 0.688 . . . . 64.43 109.754 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -119.73 131.82 55.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.706 0.802 . . . . 72.41 110.01 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.7 t70 -134.04 117.71 16.96 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.539 -1.282 . . . . 72.52 107.539 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -103.5 156.91 17.41 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.218 0.533 . . . . 61.31 110.359 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 171.38 18.09 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.16 0.984 . . . . 71.34 109.076 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 48.5 p -150.45 163.32 38.69 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.458 0.703 . . . . 73.43 109.582 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -158.14 118.13 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.769 -1.197 . . . . 64.32 107.769 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -85.43 122.63 29.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.454 -0.572 . . . . 74.11 109.454 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.9 -40.55 12.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.51 0.724 . . . . 71.12 109.44 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.59 5.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.698 -1.137 . . . . 74.52 109.491 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.55 130.65 43.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.41 -0.589 . . . . 73.44 109.41 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.57 5.49 5.41 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.769 1.227 . . . . 72.13 111.635 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 99.9 t -126.95 115.29 40.85 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 124.658 1.183 . . . . 74.32 108.906 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 24.7 m-85 -134.27 127.26 31.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.076 -0.713 . . . . 60.41 109.076 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.67 114.43 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.84 1.256 . . . . 52.35 108.678 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.53 137.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.446 -0.946 . . . . 73.02 108.446 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 67.9 t -115.7 138.56 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.981 0.913 . . . . 72.34 108.921 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.593 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -126.48 119.6 27.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.386 -1.338 . . . . 72.41 107.386 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -102.85 98.69 8.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.518 -0.919 . . . . 73.52 108.518 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.15 130.92 40.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.962 -0.755 . . . . 70.52 108.962 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -123.4 143.32 50.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.894 -0.594 . . . . 61.41 110.062 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.418 HG23 HD13 ' D' ' 114' ' ' ILE . 70.8 t -130.1 125.41 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.486 1.114 . . . . 70.4 108.859 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 84.3 m -115.55 110.62 19.5 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.095 -1.076 . . . . 44.21 108.095 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.506 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -98.53 157.49 16.2 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.84 0.456 . . . . 62.25 109.8 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.5 p -158.34 137.28 11.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.656 -0.498 . . . . 53.53 109.656 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' D' ' 36' ' ' TRP . 18.1 tp -136.03 110.34 8.43 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.054 -1.091 . . . . 72.41 108.054 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.95 -127.35 7.97 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.596 0.56 . . . . 54.24 113.382 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -94.4 9.44 38.32 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.182 0.593 . . . . 74.52 111.838 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.45 163.93 31.51 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.249 0.547 . . . . 75.31 111.349 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -74.18 134.51 42.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.823 -1.08 . . . . 72.11 109.516 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.29 -53.03 5.26 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.49 0.716 . . . . 75.41 109.865 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.92 172.47 18.4 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.76 -1.109 . . . . 73.41 109.7 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 98.5 mt -138.68 149.57 45.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.241 1.417 . . . . 73.4 108.087 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.783 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -159.76 142.37 13.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.676 0.39 . . . . 53.44 110.671 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -155.94 126.85 6.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.941 0.496 . . . . 72.14 109.883 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.33 119.07 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.667 0.787 . . . . 64.44 110.074 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.745 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 87.3 mt-30 -89.22 88.09 7.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.715 0.769 . . . . 71.41 109.037 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 61.8 tp60 -79.86 107.99 13.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.197 -1.365 . . . . 75.41 108.676 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.47 164.04 18.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 112.347 -0.301 . . . . 63.41 112.347 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.53 3.74 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.903 -0.479 . . . . 65.32 111.903 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -88.85 126.94 41.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.639 -0.875 . . . . 63.21 108.639 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -130.54 143.48 50.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.352 1.061 . . . . 73.52 109.101 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 12.9 m -80.66 101.18 9.08 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.816 -0.809 . . . . 70.11 108.816 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 43.1 mm -107.01 106.04 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.093 -1.076 . . . . 61.33 108.093 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.11 162.13 39.46 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.387 0.675 . . . . 65.34 110.849 -173.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 -0.2 55.33 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.926 0.73 . . . . 63.32 114.926 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.404 HD11 HG23 ' D' ' 86' ' ' ILE . 17.1 pt -134.03 141.21 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.879 0.872 . . . . 70.35 109.806 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.41 166.03 25.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.578 0.751 . . . . 74.54 110.873 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.75 -112.6 3.23 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.794 0.684 . . . . 74.13 114.018 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -72.57 -30.51 64.46 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.311 1.044 . . . . 74.21 111.353 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -67.05 -52.47 41.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 64.41 110.577 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.417 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 27.5 ptm -70.26 -29.91 66.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.818 -0.628 . . . . 64.14 110.545 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.48 77.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.895 0.478 . . . . 74.31 111.09 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -64.41 -43.01 95.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.329 0.652 . . . . 73.14 110.031 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.96 -49.36 77.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.884 0.473 . . . . 54.51 111.033 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' D' ' 94' ' ' MET . 88.2 mt -70.76 -22.32 62.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.637 0.775 . . . . 75.45 111.78 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.44 9.1 24.34 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.247 -0.752 . . . . 72.32 114.607 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.11 -75.77 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.021 0.91 . . . . 50.1 111.279 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -68.69 -50.91 47.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.276 0.843 . . . . 73.4 113.276 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.78 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 25.5 m -62.9 -46.32 87.5 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.743 -0.646 . . . . 64.22 111.849 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.593 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.2 Cg_exo -57.95 -33.93 97.74 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.47 2.113 . . . . 74.33 113.347 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.53 -29.68 69.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.462 0.705 . . . . 73.52 111.147 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.73 -38.6 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.492 0.663 . . . . 70.45 110.228 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 52.2 mt -81.55 -13.65 57.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.991 -1.004 . . . . 73.35 111.624 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.614 ' HZ ' HD22 ' D' ' 128' ' ' LEU . 56.9 t80 -69.04 -46.28 30.38 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.217 -0.897 . . . . 65.21 113.371 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 -32.42 90.88 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.085 1.857 . . . . 64.23 112.912 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.89 -35.39 38.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.767 0.827 . . . . 53.31 111.948 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.64 -51.91 63.12 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.111 0.564 . . . . 71.2 109.817 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -67.69 -34.24 76.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.15 -0.932 . . . . 73.41 111.552 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.94 -43.93 81.93 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.18 0.925 . . . . 75.0 110.159 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.7 t -57.53 -43.13 84.09 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 123.626 0.579 . . . . 25.04 109.929 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.783 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.2 mt -63.74 -46.1 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.188 -0.914 . . . . 71.42 110.749 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.41 HG21 ' HE2' ' B' ' 109' ' ' TYR . 94.0 m -55.76 -49.73 72.35 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.291 1.037 . . . . 53.51 110.527 -176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -65.3 -44.12 88.93 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 113.581 -1.645 . . . . 73.24 110.387 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.415 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 76.3 mtm -64.63 -35.92 82.57 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.894 0.478 . . . . 74.55 112.217 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.1 t -67.56 -44.77 86.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.441 0.696 . . . . 71.34 110.492 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.83 -25.73 62.1 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 122.478 0.311 . . . . 61.42 111.192 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -74.69 -34.81 62.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.641 0.777 . . . . 74.24 109.162 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 0.4 76.37 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 115.393 -0.821 . . . . 72.11 112.362 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.26 27.86 16.67 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 126.85 2.06 . . . . 72.12 112.907 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.557 ' HB2' HG13 ' D' ' 118' ' ' VAL . 37.3 m-85 -94.92 160.63 30.64 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.45 -1.25 . . . . 62.2 108.706 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' F' ' 136' ' ' VAL . 16.3 Cg_endo -53.44 136.07 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 124.066 3.177 . . . . 53.3 113.571 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -55.0 128.06 31.84 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 124.303 1.002 . . . . 74.34 111.804 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.708 HD13 ' HG ' ' F' ' 139' ' ' LEU . 47.7 tp -117.15 95.63 5.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 74.01 110.805 -175.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -99.91 113.34 25.83 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.801 -1.185 . . . . 72.12 107.801 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.65 HD21 ' HG ' ' D' ' 42' ' ' LEU . 1.1 tt -74.57 124.66 27.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.768 -0.456 . . . . 71.12 109.768 -174.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -61.79 131.32 92.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.663 0.785 . . . . 74.25 110.99 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -77.78 127.4 8.68 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.65 2.233 . . . . 71.34 112.53 -170.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.37 112.5 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.451 0.643 . . . . 75.21 109.389 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -89.03 72.97 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.919 0.866 . . . . 55.14 109.413 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.71 -24.23 61.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.789 -1.096 . . . . 73.22 110.866 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.64 -42.53 97.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.926 0.89 . . . . 72.33 110.846 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' D' ' 138' ' ' MET . . . -68.62 -22.93 64.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.728 -0.669 . . . . 73.35 112.796 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.96 -49.2 75.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.423 0.689 . . . . 75.34 110.813 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' D' ' 140' ' ' TYR . 64.2 t80 -81.19 -30.08 34.43 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 72.51 110.533 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.459 ' HB3' ' HA ' ' D' ' 135' ' ' ALA . 30.2 ttm -57.51 -37.58 73.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 73.12 111.109 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -68.08 -30.15 69.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.468 -0.787 . . . . 70.44 110.818 -179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' D' ' 137' ' ' PHE . 87.0 t80 -58.27 -35.35 71.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.549 0.739 . . . . 64.0 111.399 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.28 -32.44 73.44 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.172 0.589 . . . . 74.41 110.676 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -87.42 -0.37 56.69 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.485 0.714 . . . . 74.4 111.014 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -121.65 47.23 1.91 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.748 -1.204 . . . . 75.13 107.748 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -171.52 -61.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.556 -1.202 . . . . 71.32 108.135 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 57.67 29.75 17.78 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.569 1.147 . . . . 74.13 111.774 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.51 -122.11 0.59 Allowed Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.758 -0.655 . . . . 72.31 113.486 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -97.51 -178.99 4.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.877 0.871 . . . . 72.43 110.549 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.78 -54.53 3.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.781 -0.928 . . . . 65.12 110.781 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -173.92 159.49 3.38 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.879 0.872 . . . . 73.01 110.679 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -106.96 99.13 8.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.565 -1.272 . . . . 75.31 107.565 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.33 95.53 6.39 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.727 0.411 . . . . 74.12 111.367 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -84.94 73.24 10.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.613 -1.625 . . . . 65.43 106.613 163.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -147.63 152.71 38.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.538 -1.21 . . . . 65.44 109.113 -167.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -76.7 72.59 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.908 0.861 . . . . 73.25 109.82 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.746 -1.115 . . . . 72.11 108.373 -174.557 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.16 -0.311 . . . . 75.52 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 156.49 21.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.568 0.747 . . . . 72.33 109.14 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.53 -15.83 60.34 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.441 0.696 . . . . 75.43 111.225 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 78.5 t80 70.71 154.59 0.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.323 1.449 . . . . 55.34 111.028 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.38 70.83 4.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.342 0.591 . . . . 72.31 109.554 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.38 -59.01 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.6 -0.889 . . . . 45.1 108.6 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -133.75 178.62 6.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.198 0.999 . . . . 74.53 110.061 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.593 ' HB3' ' SD ' ' B' ' 94' ' ' MET . 6.9 mp -66.42 -32.81 74.42 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 109.136 -0.691 . . . . 71.12 109.136 169.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -117.93 86.11 24.58 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.104 0.962 . . . . 75.54 109.06 172.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -98.72 24.57 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.508 2.805 . . . . 73.45 112.166 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -96.52 149.69 21.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.51 0.724 . . . . 54.14 109.998 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 9.5 t -103.3 138.19 40.41 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.698 0.799 . . . . 52.54 111.762 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -121.24 108.73 14.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.095 -1.076 . . . . 71.33 108.095 174.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.43 -7.31 0.89 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.662 0.785 . . . . 75.44 111.382 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.7 122.21 38.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.294 0.638 . . . . 73.11 109.957 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 123' ' ' VAL . . . . . 0.486 ' HA ' HD21 ' B' ' 136' ' ' LEU . 65.1 t -127.46 131.79 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.585 1.154 . . . . 74.13 108.773 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -127.87 138.58 52.73 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.054 0.942 . . . . 70.14 109.497 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 125' ' ' TYR . . . . . 0.445 ' HE2' HD21 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -135.49 -75.54 0.45 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 73.05 109.658 178.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.86 32.69 22.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.109 0.964 . . . . 71.12 110.673 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.24 139.75 23.7 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.046 -0.979 . . . . 72.04 113.496 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -105.88 88.49 2.83 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.127 0.971 . . . . 62.4 110.451 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.73 -63.91 1.2 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.386 -0.825 . . . . 73.01 110.499 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 19.2 mt -79.2 -2.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.64 0.776 . . . . 70.21 110.783 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.75 -24.4 67.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.36 0.664 . . . . 74.53 112.002 174.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -80.41 128.88 71.22 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 108.665 -0.865 . . . . 62.25 108.665 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 9.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.201 2.601 . . . . 72.01 114.972 -168.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.7 137.31 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 122.895 0.478 . . . . 54.42 109.883 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -109.11 -81.3 0.57 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.311 -0.626 . . . . 61.41 109.311 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' C' ' 124' ' ' PRO . 23.8 t 53.03 30.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.313 1.054 . . . . 74.24 109.986 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.05 161.38 24.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.423 -0.808 . . . . 73.23 111.17 -171.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 68.12 -96.88 0.04 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 125.309 1.444 . . . . 54.53 109.651 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 139' ' ' LEU . . . . . 0.539 HD21 HG21 ' C' ' 40' ' ' VAL . 18.3 tp 169.36 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.151 0.98 . . . . 71.3 109.451 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 15.1 t 77.49 -71.58 0.11 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.49 1.516 . . . . 42.31 110.957 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 tt -108.47 112.98 25.66 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.466 -0.568 . . . . 54.11 109.466 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 142' ' ' ILE . . . . . 0.455 ' HB ' HD23 ' E' ' 139' ' ' LEU . 10.3 tt -160.38 142.55 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.159 0.984 . . . . 71.14 109.416 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 9.2 t80 67.57 177.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.568 1.147 . . . . 75.12 111.101 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -100.55 169.19 9.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.486 0.714 . . . . 70.34 111.034 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.9 -48.92 76.87 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.512 -0.767 . . . . 74.23 109.904 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -92.01 159.66 15.61 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.62 -0.718 . . . . 72.3 110.563 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.48 -50.56 44.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.953 0.901 . . . . 75.22 111.298 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.9 95.68 34.85 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 73.52 109.018 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.379 2.159 0 C-N-CA 123.037 2.492 . . . . 72.12 112.157 178.469 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.116 -0.327 . . . . 74.12 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -155.51 140.38 17.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.341 0.656 . . . . 73.25 110.315 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.66 161.97 38.63 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.728 1.211 . . . . 63.41 109.217 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -75.37 81.09 2.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.144 -1.058 . . . . 73.31 108.144 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -68.57 -30.53 69.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.837 -1.074 . . . . 74.14 111.452 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.18 132.65 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.121 0.568 . . . . 64.31 110.051 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -77.15 -69.26 0.54 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.567 -0.531 . . . . 73.32 109.567 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' A' ' 94' ' ' MET . 19.3 mt 58.67 -179.86 0.07 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 125.177 1.391 . . . . 74.12 112.088 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 116' ' ' TYR . . . . . 0.435 ' H ' HD12 ' A' ' 98' ' ' LEU . 12.6 t80 71.98 150.61 0.13 Allowed Pre-proline 0 N--CA 1.496 1.86 0 C-N-CA 124.599 1.16 . . . . 75.24 112.211 166.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 117' ' ' PRO . . . . . 0.433 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 10.2 Cg_endo -54.1 141.99 67.41 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.911 2.407 . . . . 71.22 114.467 171.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -94.42 -168.58 1.87 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.851 1.26 . . . . 75.35 110.126 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 97.7 m -85.16 122.9 30.02 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.845 0.858 . . . . 71.23 111.781 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -152.57 -39.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.205 -1.035 . . . . 74.33 108.205 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 64.0 14.22 8.29 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.311 1.445 . . . . 74.23 114.748 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.27 84.43 5.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.562 -0.903 . . . . 54.05 108.562 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.509 ' HA ' HD21 ' A' ' 136' ' ' LEU . 69.7 t -107.35 123.08 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.241 1.016 . . . . 63.4 109.609 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.42 137.24 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.183 0.993 . . . . 73.1 108.572 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -147.34 -47.55 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.363 0.665 . . . . 71.21 110.46 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -169.8 -74.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.603 0.761 . . . . 72.14 110.116 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.81 -102.22 0.23 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.75 -0.94 . . . . 41.43 110.75 -174.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -85.2 -61.6 1.73 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.199 0.6 . . . . 75.14 109.625 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.592 ' HG ' ' HB2' ' A' ' 129' ' ' ALA . 1.6 tm? 65.46 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.749 1.62 . . . . 71.51 110.64 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -153.23 124.29 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.965 0.906 . . . . 73.03 108.556 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.23 157.15 42.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.472 0.709 . . . . 70.33 110.245 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 132' ' ' TYR . . . . . 0.617 ' HB3' HH11 ' C' ' 15' ' ' ARG . 2.2 m-85 59.01 54.09 4.85 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.934 1.293 . . . . 61.12 111.966 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 133' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' F' ' 132' ' ' TYR . 49.3 Cg_endo -95.47 52.88 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.396 2.73 . . . . 63.0 111.626 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.457 HG12 HG12 ' F' ' 136' ' ' VAL . 8.1 tt -55.8 115.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-N 115.039 -0.982 . . . . 73.41 110.847 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.04 83.03 2.26 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.465 -0.789 . . . . 70.45 110.849 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.457 HG12 HG12 ' F' ' 134' ' ' ILE . 13.9 p -165.11 81.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 122.597 1.189 . . . . 70.2 108.266 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -97.6 -22.97 16.2 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.907 -1.042 . . . . 71.42 111.477 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.37 133.99 55.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.943 0.897 . . . . 51.43 109.488 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.708 ' HG ' HD13 ' D' ' 126' ' ' LEU . 0.9 OUTLIER -70.15 -50.55 39.28 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.901 -0.777 . . . . 61.3 108.901 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m 72.57 -49.74 0.7 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 125.169 1.388 . . . . 65.5 113.913 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.62 56.93 3.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.528 1.131 . . . . 65.02 110.828 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.631 HD11 ' HG ' ' D' ' 128' ' ' LEU . 4.8 tp -117.28 126.05 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.529 0.732 . . . . 65.11 110.154 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 143' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' F' ' 145' ' ' LYS . 44.9 t80 66.85 -74.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.6 . . . . 75.32 110.694 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 59.8 t30 56.44 76.83 0.28 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.157 . . . . 73.11 111.501 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 145' ' ' LYS . . . . . 0.507 ' HB3' ' CE1' ' F' ' 143' ' ' TYR . 0.1 OUTLIER -171.01 171.28 5.91 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.527 -1.215 . . . . 72.33 108.225 -176.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.11 -2.57 4.3 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.938 1.088 . . . . 74.5 113.938 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 76.3 mt 70.39 10.89 7.35 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.332 1.053 . . . . 75.42 111.696 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 66.8 tp -154.9 106.57 2.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.936 -1.135 . . . . 73.43 107.936 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.564 2.014 0 C-N-CA 122.432 2.088 . . . . 71.22 112.527 -178.773 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.978 -0.379 . . . . 74.03 109.978 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -156.36 108.5 2.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.595 1.158 . . . . 71.04 108.811 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.59 87.46 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.637 -0.875 . . . . 70.15 108.637 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -123.43 -59.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.67 0.388 . . . . 74.33 111.348 -171.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 76.22 -28.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.449 1.499 . . . . 73.32 112.438 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 77.32 -70.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.643 1.577 . . . . 74.43 111.855 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.4 p -108.91 -80.57 0.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.432 0.693 . . . . 73.33 110.141 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -169.19 -54.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.592 1.157 . . . . 74.24 108.046 -175.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.58 136.64 33.7 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.103 -0.953 . . . . 71.14 110.446 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -141.56 127.26 19.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.463 1.105 . . . . 63.14 108.103 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -139.79 119.44 13.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.359 0.663 . . . . 64.34 109.45 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -138.54 115.64 10.97 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.044 0.538 . . . . 72.0 110.103 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.475 HG13 ' HD2' ' A' ' 84' ' ' PHE . 2.9 mp -78.28 115.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.35 -1.352 . . . . 41.43 107.35 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -94.13 -44.41 8.02 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.601 0.36 . . . . 72.43 111.061 -171.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.566 ' HD3' HG21 ' B' ' 122' ' ' THR . 86.0 mtt180 -159.02 157.05 30.47 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.141 0.976 . . . . 75.44 110.228 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -144.63 101.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HD1' ' HB3' ' A' ' 15' ' ' ARG . 89.4 m-85 -159.87 177.66 10.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.943 1.297 . . . . 65.42 109.476 -165.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.411 HG21 ' SG ' ' A' ' 113' ' ' CYS . 73.2 p -90.84 135.58 33.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 122.241 -0.287 . . . . 64.2 110.735 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 42.4 mtpt -96.47 -48.64 5.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.178 -0.675 . . . . 75.21 109.178 168.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 27.8 t70 -133.26 137.23 45.96 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.271 -1.331 . . . . 74.12 109.28 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 79.4 mt -139.19 139.48 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 106.876 -1.527 . . . . 73.45 106.876 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -147.53 129.38 15.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.582 0.753 . . . . 51.32 109.458 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.575 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 81.7 t80 -142.1 125.06 16.16 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.076 -1.453 . . . . 74.21 107.076 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.78 116.45 14.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.029 -0.73 . . . . 70.42 109.029 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.64 82.99 48.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 108.878 -0.786 . . . . 74.34 108.878 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 -32.76 13.98 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.574 2.183 . . . . 62.14 111.294 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 72' ' ' THR . 80.5 m-20 -104.72 31.39 4.77 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.05 0.94 . . . . 74.25 109.859 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.93 98.26 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.991 0.916 . . . . 74.15 112.22 171.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -70.18 -14.97 35.36 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.962 1.775 . . . . 70.0 113.609 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 14.2 m170 -68.96 -46.59 67.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.758 -0.46 . . . . 71.33 109.758 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.8 -20.19 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.415 1.086 . . . . 73.43 112.153 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.22 -42.05 94.34 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.171 0.988 . . . . 65.04 111.107 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.95 -20.28 14.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.749 0.82 . . . . 72.12 111.652 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HD3' ' H ' ' A' ' 35' ' ' ASP . 3.9 tmtp? -83.79 163.37 20.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.261 1.024 . . . . 74.34 110.582 -171.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.634 ' H ' ' HD3' ' A' ' 34' ' ' LYS . 10.6 m-20 -63.69 143.53 57.76 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.207 1.003 . . . . 73.5 111.431 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -96.34 65.08 2.31 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.1 . . . . 73.23 110.609 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.44 77.38 9.72 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 109.558 -0.534 . . . . 70.34 109.558 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 7.6 Cg_endo -82.14 148.48 15.06 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.032 1.821 . . . . 64.13 111.037 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.23 99.87 12.04 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.768 -1.197 . . . . 64.04 107.768 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG22 HD13 ' A' ' 126' ' ' LEU . 26.8 t -76.69 95.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.138 -0.937 . . . . 73.33 109.946 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HA ' ' HG2' ' F' ' 128' ' ' LYS . 35.2 tttm -79.87 131.9 35.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.148 0.979 . . . . 64.55 109.796 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.437 HD12 HG22 ' A' ' 64' ' ' VAL . 2.1 mm? -115.3 149.47 37.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.115 0.483 . . . . 72.24 110.789 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.6 m-20 -136.34 125.92 25.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.076 1.35 . . . . 70.42 107.611 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.4 mt -116.64 119.1 34.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.622 -0.881 . . . . 75.02 108.622 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -132.51 147.74 52.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.98 0.912 . . . . 71.31 109.979 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.4 m -142.84 128.67 19.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.428 0.691 . . . . 62.13 110.161 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.78 152.3 49.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.648 0.779 . . . . 44.31 109.395 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.5 m -127.2 167.34 16.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 42.41 109.597 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -168.25 122.06 0.9 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 122.978 0.174 . . . . 72.32 110.548 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -69.78 114.45 7.99 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.793 0.837 . . . . 64.21 110.905 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 57' ' ' GLU . 58.7 mt -83.54 -41.93 17.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.324 1.05 . . . . 51.24 110.955 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.12 178.78 7.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.549 1.14 . . . . 70.12 108.309 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.14 99.01 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.922 0.392 . . . . 42.01 110.151 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 1.4 m-20 69.53 29.89 4.19 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 113.803 -1.544 . . . . 74.4 111.696 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -114.8 121.73 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.132 -1.803 . . . . 63.41 106.132 164.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.488 ' CE2' ' HA ' ' A' ' 54' ' ' ASP . 4.0 m-85 -132.49 137.33 47.16 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.309 0.576 . . . . 72.11 109.616 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 51' ' ' LEU . 10.3 tt0 -87.09 114.14 23.44 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.283 -1.326 . . . . 75.2 108.645 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.39 110.16 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.05 -1.093 . . . . 54.15 108.05 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 97.4 t -98.45 137.79 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.523 0.729 . . . . 64.01 110.572 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.66 110.78 21.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.257 -1.386 . . . . 70.34 107.257 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -108.83 111.33 23.01 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.927 0.891 . . . . 75.21 109.386 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.1 t -110.71 128.79 66.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 123.578 0.751 . . . . 71.31 109.304 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.7 m -108.83 143.78 37.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.235 -0.654 . . . . 73.22 109.235 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.659 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.7 t -137.21 109.28 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.655 1.582 . . . . 73.2 107.759 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.4 m -114.81 119.49 36.81 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.651 -0.5 . . . . 74.24 109.651 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -103.28 107.33 18.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.738 -1.208 . . . . 25.24 107.738 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.0 m -129.79 128.63 42.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.917 0.487 . . . . 73.43 109.769 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.549 HD22 ' HE2' ' A' ' 34' ' ' LYS . 4.7 tt -101.44 85.49 2.79 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.162 -1.421 . . . . 55.31 107.162 172.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.86 2.19 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.204 -0.907 . . . . 73.41 111.756 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -88.16 -28.05 21.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.55 0.74 . . . . 64.42 110.779 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.46 125.5 35.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 71.55 110.212 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 23.1 m -88.02 114.92 25.11 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.95 -0.759 . . . . 73.14 108.95 169.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.89 -51.47 58.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.645 0.778 . . . . 72.04 109.347 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.483 ' HZ ' HD12 ' A' ' 126' ' ' LEU . 52.5 p90 -164.36 173.59 12.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.385 -1.28 . . . . 70.32 111.931 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.27 146.65 52.14 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.729 1.611 . . . . 72.02 107.921 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.659 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.5 m -141.92 138.99 32.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.165 0.986 . . . . 70.45 108.751 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -150.92 133.0 15.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.962 -0.755 . . . . 54.52 108.962 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 113' ' ' CYS . 47.0 t -131.53 115.62 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.458 0.703 . . . . 74.3 109.121 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 62.5 mt-30 -84.6 84.83 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.057 -1.09 . . . . 64.14 108.057 170.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -76.91 95.82 4.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.742 -1.117 . . . . 71.24 108.555 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.84 142.96 19.55 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.819 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -137.83 122.47 2.47 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.211 -1.556 . . . . 64.23 109.211 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -89.3 122.38 40.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HD2' HG13 ' A' ' 13' ' ' ILE . 29.3 m-85 -125.45 118.46 25.88 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.435 -2.061 . . . . 74.13 105.435 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -93.79 94.61 8.63 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.907 -1.146 . . . . 64.23 107.907 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -117.85 148.48 20.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 123.666 0.786 . . . . 73.25 110.136 -174.332 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -170.93 148.22 2.79 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.949 1.3 . . . . 75.34 109.351 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.44 6.64 62.53 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.167 0.292 . . . . 71.24 113.305 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.555 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.6 mp -127.33 136.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.116 -1.438 . . . . 72.24 107.116 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 175.58 11.19 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.312 0.505 . . . . 71.43 110.596 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 -152.14 48.15 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.262 -0.881 . . . . 70.53 112.767 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -65.48 -24.99 67.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.077 0.951 . . . . 43.14 112.429 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -59.65 -49.74 76.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.287 0.635 . . . . 73.14 109.969 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.778 ' SD ' HD12 ' F' ' 115' ' ' LEU . 2.5 tpt -80.86 -30.81 35.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.133 -0.939 . . . . 74.15 110.94 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -29.56 69.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.212 0.605 . . . . 52.53 110.842 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 36.6 t-80 -73.55 -36.96 65.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.988 -0.551 . . . . 75.25 110.522 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 53.3 t -76.78 -65.11 0.98 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.912 -0.131 . . . . 74.13 111.11 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.92 -29.27 70.46 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.954 0.502 . . . . 62.44 112.327 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.44 -22.77 36.17 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 114.333 0.493 . . . . 73.23 114.333 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -133.09 -49.85 0.87 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.534 0.667 . . . . 65.05 112.424 -170.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -71.84 -47.55 52.33 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.856 0.862 . . . . 74.21 111.742 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 73.9 m -67.32 -47.62 48.71 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.425 1.09 . . . . 74.11 112.675 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.26 -26.88 56.28 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.891 1.727 . . . . 72.12 112.825 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.72 -29.29 62.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.622 0.369 . . . . 74.42 110.436 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 49.7 mt -61.44 -47.04 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.752 0.821 . . . . 73.22 109.429 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -73.71 -20.4 60.54 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.698 -1.137 . . . . 61.41 112.053 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -64.65 -46.11 76.41 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 114.627 1.343 . . . . 64.11 114.627 -166.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.63 -35.13 98.91 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.932 1.754 . . . . 64.14 112.706 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -73.72 -36.46 65.22 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.369 -0.832 . . . . 73.33 111.609 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.17 -42.81 68.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.262 0.225 . . . . 74.1 110.453 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.435 HH22 ' HA ' ' A' ' 130' ' ' PRO . 38.2 ttm105 -52.13 -48.6 64.76 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.114 0.884 . . . . 61.11 110.289 175.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.36 -52.53 61.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.851 -1.068 . . . . 71.32 111.429 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.418 ' HB3' HG11 ' A' ' 78' ' ' VAL . 46.8 t -61.42 -29.21 69.8 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.908 0.755 . . . . 71.32 112.013 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.658 HG21 HG21 ' A' ' 64' ' ' VAL . 79.1 mt -71.68 -60.37 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.69 -0.686 . . . . 64.5 109.694 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -55.03 -30.31 59.29 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.548 1.139 . . . . 64.2 112.333 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 -44.49 72.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.69 -0.686 . . . . 70.13 109.992 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.9 mtm -61.11 -41.11 96.09 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.881 0.473 . . . . 52.23 110.58 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -58.23 -47.76 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.532 -1.213 . . . . 72.42 110.667 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -75.21 -26.95 59.35 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.894 -0.594 . . . . 75.23 111.411 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -71.71 -27.88 63.31 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.708 0.803 . . . . 74.12 109.852 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.65 3.78 77.2 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.494 -0.775 . . . . 45.34 112.642 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.3 m 68.06 14.6 9.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.943 1.297 . . . . 70.2 111.216 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -85.81 149.91 51.98 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.853 -0.795 . . . . 72.51 108.853 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.82 143.3 91.34 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.574 2.182 . . . . 71.11 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -61.48 132.69 54.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.685 0.394 . . . . 74.32 110.734 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.483 HD12 ' HZ ' ' A' ' 74' ' ' PHE . 63.8 mt -133.42 96.36 3.7 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.306 -0.998 . . . . 63.43 108.306 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -98.85 123.23 42.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.101 -0.5 . . . . 64.23 109.759 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.4 pt? -73.13 152.72 41.05 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.919 0.762 . . . . 74.03 110.576 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.62 147.85 68.82 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.37 1.068 . . . . 64.34 112.074 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' C' ' 13' ' ' ILE . 15.7 Cg_exo -68.59 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.404 2.07 . . . . 62.43 110.964 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.91 111.79 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.305 -0.998 . . . . 74.45 108.305 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.61 96.65 6.86 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.494 -0.928 . . . . 73.42 108.494 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -59.55 -23.41 62.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.472 -0.786 . . . . 75.01 110.258 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 19.0 t70 -62.23 -51.31 68.26 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 123.997 0.919 . . . . 73.31 111.16 175.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.24 -30.67 69.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.622 0.576 . . . . 71.1 111.83 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.212 0.605 . . . . 61.44 110.894 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 140' ' ' TYR . 41.8 t80 -87.49 -23.05 24.55 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.749 0.42 . . . . 71.13 111.487 -177.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.8 tpt -77.47 -33.88 54.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.707 -0.849 . . . . 72.12 108.707 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.06 -54.01 47.4 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.301 -1.318 . . . . 74.11 109.722 166.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.457 ' HB3' ' HA ' ' A' ' 137' ' ' PHE . 90.8 t80 -63.5 -29.1 70.43 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.102 0.961 . . . . 75.42 111.91 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.5 tp -50.26 -47.29 55.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.577 1.151 . . . . 71.14 111.477 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -168.54 -16.13 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.65 0.594 . . . . 64.43 111.971 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.55 -53.9 12.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.591 0.356 . . . . 74.13 111.947 -167.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 70.77 -64.51 0.37 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.86 1.264 . . . . 74.01 111.551 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.91 131.67 21.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.777 0.831 . . . . 64.24 109.357 172.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.76 173.9 43.36 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.53 -0.628 . . . . 62.53 111.53 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -108.45 149.25 29.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.254 0.622 . . . . 73.23 109.8 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.51 97.72 0.63 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.202 -0.759 . . . . 53.02 111.202 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -67.43 98.94 0.69 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.439 0.696 . . . . 62.1 110.931 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.75 93.99 5.67 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.777 -0.823 . . . . 73.44 108.777 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -108.38 134.13 51.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.236 -1.024 . . . . 75.11 108.236 170.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -73.97 93.34 2.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.952 0.901 . . . . 70.02 109.253 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -70.04 101.0 1.71 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.308 -0.86 . . . . 73.4 110.199 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.01 140.49 57.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.099 -0.955 . . . . 64.43 110.598 -177.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 O-C-N 124.271 0.982 . . . . 72.43 110.728 -177.581 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' E' ' 112' ' ' GLN . 10.6 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 108.998 -0.742 . . . . 74.51 108.998 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.8 m -149.04 95.41 2.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.929 0.891 . . . . 73.1 109.412 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.77 84.39 2.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.191 0.996 . . . . 74.15 108.348 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -82.82 100.34 10.26 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 114.722 -1.126 . . . . 73.52 110.404 -172.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -168.32 163.02 12.88 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.354 1.062 . . . . 74.23 109.194 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -72.71 87.12 1.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.141 -1.059 . . . . 64.22 108.141 168.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 24.6 p -87.02 133.45 33.58 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.046 -0.979 . . . . 75.13 108.37 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.01 -21.15 43.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.343 1.057 . . . . 71.54 112.33 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.9 ptm 58.96 -179.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.571 1.949 . . . . 72.54 114.419 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -140.34 122.22 15.51 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.248 -1.019 . . . . 71.44 108.248 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -123.95 141.0 52.43 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.321 -0.622 . . . . 75.44 109.321 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 59.8 tt0 -153.97 141.69 19.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.827 0.851 . . . . 71.45 109.161 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.674 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -94.41 117.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.39 -0.967 . . . . 71.34 108.39 175.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -87.04 -48.87 7.74 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.285 -0.416 . . . . 63.31 110.119 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -164.34 140.84 6.33 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.683 -0.488 . . . . 75.34 109.683 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -114.64 141.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.937 -1.505 . . . . 61.11 106.937 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -168.25 148.35 4.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.202 0.455 . . . . 73.14 111.825 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.2 m -74.24 126.82 31.46 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.071 -0.714 . . . . 73.12 109.071 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.2 mtpp -94.51 -41.0 9.58 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.385 -0.598 . . . . 64.01 109.385 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -139.62 141.46 37.09 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.771 -0.65 . . . . 74.14 110.533 -171.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.439 HD13 HG13 ' B' ' 78' ' ' VAL . 41.0 mm -135.81 143.09 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.161 1.384 . . . . 54.34 107.512 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 57.4 p -148.0 138.7 23.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.697 -0.853 . . . . 71.44 108.697 168.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 83.5 t80 -141.21 116.44 10.0 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 106.244 -1.761 . . . . 75.13 106.244 168.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.81 110.86 14.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.688 -1.597 . . . . 73.13 106.688 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -111.91 88.18 9.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.707 -0.849 . . . . 52.14 108.707 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.95 -26.59 51.28 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.007 2.472 . . . . 71.04 112.447 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -120.81 28.31 8.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.774 0.829 . . . . 72.22 110.054 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.531 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.94 -46.34 81.23 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 124.786 1.234 . . . . 54.24 113.669 171.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 84.1 Cg_endo -79.06 -15.15 13.14 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.717 1.611 . . . . 63.04 113.088 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -100.43 1.55 41.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.894 0.878 . . . . 72.13 112.899 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.46 -20.91 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.452 0.701 . . . . 62.0 111.786 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.06 -28.15 69.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 63.13 111.851 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -67.37 -46.64 72.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.663 -0.698 . . . . 74.45 109.587 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' B' ' 68' ' ' LEU . 79.2 mttt -111.86 74.83 0.88 Allowed 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.828 -1.078 . . . . 62.4 111.355 -171.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.94 82.75 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.162 -1.051 . . . . 61.24 108.162 167.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -153.78 165.61 35.49 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.37 -0.832 . . . . 63.55 109.041 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -77.99 120.67 82.15 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.804 -0.813 . . . . 64.21 108.804 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.401 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 98.7 Cg_endo -77.36 154.59 32.03 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.324 2.016 . . . . 64.32 112.068 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 22.1 mm-40 -64.75 115.4 5.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.02 -0.733 . . . . 74.33 109.02 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 p -83.8 122.32 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.607 -0.886 . . . . 72.44 108.607 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.568 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 93.4 mttt -126.44 100.38 6.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.604 -1.258 . . . . 62.02 107.604 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.462 HD22 ' HE1' ' E' ' 125' ' ' TYR . 1.5 pp -88.91 140.04 29.84 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.078 -0.965 . . . . 63.21 110.78 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.806 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.0 m-20 -136.8 145.47 44.56 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.473 -1.677 . . . . 62.01 106.473 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.66 ' HG ' HG12 ' E' ' 123' ' ' VAL . 1.3 pt? -140.39 161.54 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.903 -1.147 . . . . 74.14 107.903 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.8 t70 -159.16 143.22 15.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.192 -0.67 . . . . 73.14 109.192 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -107.34 109.67 21.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.931 -1.137 . . . . 70.32 107.931 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -113.91 154.52 27.4 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.121 -1.066 . . . . 50.14 108.121 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -143.78 162.7 35.36 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.356 0.598 . . . . 72.34 112.108 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -162.87 151.49 14.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.368 1.467 . . . . 52.33 108.4 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -123.14 127.3 48.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.13 -37.65 12.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.946 0.498 . . . . 73.34 110.047 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.93 -175.53 3.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.903 0.881 . . . . 71.45 110.758 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -72.98 124.47 25.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.963 -1.017 . . . . 74.54 108.631 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 68.69 11.95 8.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.072 1.349 . . . . 75.22 111.932 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.65 88.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.45 1.1 . . . . 52.11 108.171 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.498 ' HB2' HD11 ' B' ' 86' ' ' ILE . 3.5 t80 -97.85 166.21 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.101 -0.703 . . . . 62.24 109.101 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -140.3 100.1 3.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.097 -1.446 . . . . 72.51 107.097 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -95.8 137.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.985 0.514 . . . . 72.24 109.657 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 21.9 t -117.17 152.45 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.414 1.086 . . . . 71.35 109.131 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -127.89 119.65 26.05 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.158 -1.423 . . . . 75.54 107.158 176.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.5 ttt180 -105.45 106.37 16.84 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.042 -0.725 . . . . 73.14 109.042 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.42 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.2 t -106.33 111.91 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.329 -0.989 . . . . 71.25 108.329 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.806 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.0 m -106.05 125.94 51.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.357 -0.608 . . . . 54.42 109.357 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.404 HG23 HD13 ' B' ' 114' ' ' ILE . 82.7 t -120.32 99.46 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.209 1.003 . . . . 73.45 109.345 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 86.4 m -86.84 147.84 25.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.991 -1.004 . . . . 74.23 109.312 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.64 152.49 37.96 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.986 0.514 . . . . 51.11 110.287 175.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 41.1 p -147.01 128.83 15.31 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.301 0.376 . . . . 74.44 111.726 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 60.9 mt -91.42 100.65 13.39 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.222 -1.029 . . . . 72.34 108.222 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.51 -120.62 8.37 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.211 -0.904 . . . . 52.32 111.885 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.61 22.73 13.1 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.668 0.747 . . . . 73.22 110.145 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -137.1 144.49 43.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 74.45 109.298 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -68.87 136.86 53.3 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.751 0.31 . . . . 70.03 110.917 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.13 -65.29 1.03 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.411 -0.959 . . . . 51.32 108.411 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.27 166.78 29.86 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 114.658 -1.155 . . . . 72.53 110.018 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.2 mt -135.92 109.73 8.13 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.79 -1.559 . . . . 73.23 106.79 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -118.89 141.46 48.63 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.509 -0.923 . . . . 73.13 108.509 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -149.45 129.05 13.13 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.534 -0.913 . . . . 71.43 108.534 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.439 HG13 HD13 ' B' ' 21' ' ' ILE . 79.1 t -125.03 148.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 73.34 109.211 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 76.0 mt-30 -127.63 99.58 5.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 174.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -89.09 109.22 20.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.136 -0.938 . . . . 71.55 109.325 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.15 169.65 26.74 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 111.987 -0.445 . . . . 42.4 111.987 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.03 130.92 2.12 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.271 -0.731 . . . . 51.52 111.271 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.77 127.67 40.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -134.78 135.59 41.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.234 1.014 . . . . 63.32 109.282 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 6.6 m -88.57 121.51 31.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.115 0.966 . . . . 74.41 108.702 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pp -134.55 130.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.09 0.556 . . . . 63.43 110.545 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.99 153.09 33.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.672 0.789 . . . . 72.23 109.939 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.03 -53.84 4.51 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.641 0.588 . . . . 62.52 113.27 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.53 133.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.048 1.339 . . . . 72.3 111.526 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -150.58 176.0 11.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.58 0.752 . . . . 72.24 111.411 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.13 -136.76 35.21 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.066 -1.425 . . . . 64.44 113.199 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.5 m -65.59 -37.54 86.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.885 0.874 . . . . 71.1 111.079 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -65.26 -27.79 68.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.115 -1.402 . . . . 71.32 111.006 -172.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 -33.39 69.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.215 0.606 . . . . 62.4 110.604 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.35 70.49 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.189 0.596 . . . . 61.04 111.379 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -76.74 -23.02 53.01 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.332 0.653 . . . . 75.34 111.344 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.72 -64.97 1.0 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.736 0.414 . . . . 64.13 110.545 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 mt -80.05 -28.56 39.23 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.889 0.476 . . . . 73.24 111.766 -172.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.5 66.74 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-O 119.559 -0.578 . . . . 52.42 113.846 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 -57.05 0.34 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.87 0.835 . . . . 72.01 112.351 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.33 -47.56 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.268 0.627 . . . . 75.44 112.126 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -65.88 -46.38 65.15 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.641 -0.695 . . . . 71.22 111.377 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.457 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 94.6 Cg_exo -50.84 -38.67 57.92 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.491 2.127 . . . . 62.42 113.791 166.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -64.4 -29.73 70.79 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.243 0.46 . . . . 64.23 112.243 178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.73 -42.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.724 -0.473 . . . . 63.22 109.724 172.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.19 -17.41 54.95 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.124 -0.944 . . . . 75.33 111.756 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.403 ' HZ ' ' HB3' ' B' ' 128' ' ' LEU . 65.1 t80 -61.97 -49.78 83.87 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.88 -1.057 . . . . 72.12 113.592 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.04 -39.38 70.06 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.44 2.093 . . . . 52.01 113.873 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.19 -46.57 49.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.642 -0.708 . . . . 74.31 111.114 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.44 78.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.616 0.766 . . . . 64.25 110.387 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -64.66 -50.8 65.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 75.03 110.549 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -34.68 78.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.162 0.585 . . . . 73.24 109.931 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.1 m -59.74 -52.83 63.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.751 0.82 . . . . 35.13 111.405 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 62' ' ' VAL . 69.2 mt -58.25 -56.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.661 0.785 . . . . 73.1 110.805 178.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -64.77 -31.94 73.39 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 124.154 0.909 . . . . 74.1 111.582 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.6 t -61.79 -50.4 72.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.01 0.524 . . . . 74.4 110.039 174.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.9 mmt -68.85 -34.09 74.89 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.4 0.68 . . . . 73.41 111.232 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.08 -43.16 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.843 0.857 . . . . 64.34 110.309 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 73.1 m -67.93 -30.34 69.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.367 -0.833 . . . . 71.13 111.995 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.524 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -68.38 -28.09 66.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.409 0.684 . . . . 74.51 110.927 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.78 17.09 59.88 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 114.334 0.494 . . . . 63.41 114.334 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.566 HG21 ' HD3' ' A' ' 15' ' ' ARG . 4.1 p 69.67 12.31 8.06 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.049 1.74 . . . . 73.03 113.233 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.84 144.56 30.42 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 109.162 -0.681 . . . . 72.25 109.162 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.58 146.29 54.34 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.944 2.43 . . . . 60.11 111.676 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.428 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 18.7 mp0 -64.48 114.43 4.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.514 0.509 . . . . 74.21 110.978 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.26 85.06 2.07 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.575 -1.269 . . . . 63.25 107.575 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -101.47 121.59 42.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.14 -1.391 . . . . 71.44 108.148 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.403 ' HB3' ' HZ ' ' B' ' 107' ' ' PHE . 0.2 OUTLIER -76.96 139.66 40.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.281 0.632 . . . . 61.12 109.548 -172.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 154.12 84.05 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 124.02 0.928 . . . . 51.33 111.047 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.13 92.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.252 2.635 . . . . 70.32 112.567 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.51 111.92 25.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.492 -0.776 . . . . 74.14 109.499 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -82.06 107.23 14.6 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.421 -0.955 . . . . 53.32 108.421 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -58.83 -37.19 75.88 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.363 1.04 . . . . 72.1 110.581 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.61 -52.74 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.872 -1.058 . . . . 73.43 110.724 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.02 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.87 0.731 . . . . 75.21 112.013 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.593 HD22 ' HD2' ' E' ' 125' ' ' TYR . 56.3 tp -59.31 -49.01 79.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.193 0.933 . . . . 72.33 110.446 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -77.5 -16.71 58.56 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.721 -0.672 . . . . 74.15 111.378 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 57.2 mtm -66.85 -15.44 63.62 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.749 0.42 . . . . 65.24 111.993 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -77.85 -28.28 50.05 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.676 0.79 . . . . 64.02 110.436 173.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -70.08 -30.67 67.96 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.175 0.59 . . . . 74.4 109.598 169.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -90.35 20.28 4.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.271 1.029 . . . . 74.44 111.276 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.26 97.69 1.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.666 -1.235 . . . . 73.4 107.666 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -133.36 114.27 13.53 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.221 1.008 . . . . 71.34 109.044 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 56.26 82.34 0.11 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.646 1.179 . . . . 60.01 110.123 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.38 93.0 8.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.227 -0.657 . . . . 74.34 109.227 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.08 86.92 0.13 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.147 -0.781 . . . . 70.42 111.147 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.72 128.61 14.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.991 -1.115 . . . . 72.52 107.991 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.78 162.65 32.23 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 123.006 0.191 . . . . 61.32 113.103 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -157.95 147.29 19.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.647 1.179 . . . . 62.53 108.987 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -137.57 134.16 35.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.47 0.708 . . . . 74.21 109.477 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -163.69 166.06 22.61 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 65.22 109.041 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 m80 72.44 75.36 0.15 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.881 1.272 . . . . 75.23 109.932 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.46 151.54 46.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.793 -1.094 . . . . 74.25 111.469 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -162.21 95.34 0.94 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.582 -0.896 . . . . 74.32 108.582 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 108.523 -0.917 . . . . 74.31 108.523 179.692 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.679 0.752 . . . . 73.44 109.283 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.8 t -103.75 -29.17 11.21 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.015 -0.993 . . . . 73.14 108.848 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.08 157.24 33.13 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.705 0.802 . . . . 73.02 109.482 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -150.35 153.62 36.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.445 0.698 . . . . 65.45 109.793 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.49 ' HA ' ' OE1' ' C' ' 144' ' ' GLN . 19.0 m120 -122.57 28.04 7.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.396 0.678 . . . . 70.31 111.496 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -76.12 86.18 2.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.624 0.77 . . . . 74.41 109.571 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.546 ' HB ' ' HA ' ' C' ' 145' ' ' ALA . 4.1 m -144.99 174.53 10.94 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.83 -0.804 . . . . 72.42 108.83 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.477 ' H ' HG22 ' C' ' 7' ' ' THR . 7.7 mp0 -61.39 175.36 0.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.431 1.092 . . . . 72.33 112.31 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.2 ttp 65.4 119.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.905 1.282 . . . . 71.11 111.462 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.5 m -118.6 102.06 8.59 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.098 -1.445 . . . . 51.41 107.098 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -118.6 122.79 43.45 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.687 0.795 . . . . 71.14 109.242 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -137.28 136.19 37.81 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.513 -0.551 . . . . 71.44 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.605 HD11 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -68.55 123.45 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.04 -0.726 . . . . 52.41 109.04 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -103.25 -47.96 4.16 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.723 -0.671 . . . . 72.21 109.76 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.506 HH22 ' CG1' ' F' ' 134' ' ' ILE . 20.4 ttt180 -173.24 151.98 2.16 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.651 0.595 . . . . 73.14 110.407 -176.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.605 HG13 HD11 ' C' ' 13' ' ' ILE . 89.6 mt -138.26 140.42 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.539 1.136 . . . . 62.32 108.354 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -172.02 158.53 4.72 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.762 0.791 . . . . 74.51 111.364 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.426 HG22 HE22 ' C' ' 80' ' ' GLN . 76.1 p -78.76 106.13 10.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.444 -1.253 . . . . 70.21 109.05 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 5.3 mmmm -66.85 -42.76 85.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.751 0.786 . . . . 61.0 109.638 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -144.53 141.47 29.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.502 -1.227 . . . . 72.31 109.341 -175.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.2 mt -135.82 146.2 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.182 -1.414 . . . . 43.44 107.182 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -154.82 149.27 26.25 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.229 0.538 . . . . 65.11 109.886 171.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -146.61 144.29 29.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.805 -1.089 . . . . 71.41 108.064 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -137.79 139.56 40.09 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.623 1.169 . . . . 74.13 107.89 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 79.29 66.25 Favored Pre-proline 0 C--O 1.241 0.652 0 N-CA-C 107.811 -1.181 . . . . 73.03 107.811 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.64 -22.04 64.89 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.641 2.227 . . . . 61.31 111.844 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 93.5 m-20 -125.91 47.24 2.27 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.448 1.099 . . . . 62.14 109.972 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -58.15 -54.96 50.29 Favored Pre-proline 0 CA--C 1.571 1.754 0 C-N-CA 124.279 1.031 . . . . 64.13 112.157 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 21.0 Cg_exo -66.85 -26.44 44.66 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 121.976 1.784 . . . . 43.23 112.74 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.648 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 21.2 m170 -66.39 -16.35 64.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.26 1.024 . . . . 71.44 113.304 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.627 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 7.9 p -48.59 -33.66 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 112.757 0.651 . . . . 73.54 112.757 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.66 ' HE2' ' HB3' ' E' ' 132' ' ' TYR . 92.6 m-85 -76.13 -30.53 58.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.473 0.709 . . . . 70.53 111.939 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -112.88 3.51 16.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.995 0.918 . . . . 74.35 112.866 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -89.97 172.73 8.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.425 0.557 . . . . 60.44 111.061 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.421 ' HB3' HD22 ' C' ' 68' ' ' LEU . 20.6 t70 -83.9 133.36 34.72 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.197 0.999 . . . . 75.1 110.451 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -75.31 78.26 2.4 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.705 0.802 . . . . 73.24 109.995 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.438 ' HB3' HD13 ' C' ' 68' ' ' LEU . 49.6 tt0 -164.48 78.49 1.44 Allowed Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.28 -1.378 . . . . 73.34 107.28 169.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.418 ' HG2' ' HA ' ' E' ' 139' ' ' LEU . 73.7 Cg_endo -85.22 106.62 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.285 1.99 . . . . 70.25 111.885 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -84.29 92.14 7.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.372 -1.344 . . . . 61.52 107.372 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.414 ' O ' HG12 ' E' ' 142' ' ' ILE . 89.3 t -84.71 110.54 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.904 -1.498 . . . . 74.31 109.385 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -93.05 115.68 28.34 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.323 -0.621 . . . . 74.33 109.323 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.39 126.7 34.56 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.06 -1.459 . . . . 74.43 107.06 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -120.32 132.93 55.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.414 -0.958 . . . . 73.23 108.414 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tt -134.35 117.83 16.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.392 -1.336 . . . . 71.32 107.392 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.61 149.9 52.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.962 1.305 . . . . 64.23 108.381 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -142.08 153.42 44.16 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.058 0.456 . . . . 75.32 110.032 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.96 178.35 10.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.654 1.182 . . . . 53.21 108.635 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -145.73 159.63 42.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.036 0.535 . . . . 74.44 110.333 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -145.65 126.91 14.82 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.912 0.885 . . . . 62.33 108.662 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.38 117.64 24.43 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.124 -0.695 . . . . 74.25 109.124 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' C' ' 57' ' ' GLU . 25.7 mt -100.93 -26.89 13.58 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.967 0.907 . . . . 73.45 110.48 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.03 -170.54 1.96 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.14 0.976 . . . . 41.32 109.918 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -69.7 101.7 1.73 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.564 -0.743 . . . . 73.23 109.606 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 74.82 6.92 4.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.538 1.535 . . . . 75.23 112.532 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.62 113.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.442 -0.947 . . . . 72.21 108.442 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.36 125.31 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.108 0.963 . . . . 74.0 109.307 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.72 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.2 tt0 -86.08 116.67 24.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.565 -0.902 . . . . 63.42 108.565 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.22 125.51 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.636 -1.246 . . . . 63.32 107.636 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.37 106.31 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.946 -1.131 . . . . 45.42 107.946 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.66 98.33 8.04 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.425 -0.954 . . . . 62.34 108.425 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -83.14 124.19 30.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.076 -0.966 . . . . 55.43 109.627 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.76 124.83 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.768 -1.197 . . . . 64.15 107.768 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -127.64 125.0 39.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 70.35 109.655 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.619 HG23 HD13 ' C' ' 114' ' ' ILE . 90.1 t -107.28 119.96 57.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.743 -0.836 . . . . 75.31 108.743 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.433 HG23 HD23 ' C' ' 75' ' ' LEU . 3.5 m -99.7 139.52 35.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.229 -1.397 . . . . 64.45 107.229 167.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.46 107.22 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.046 -1.464 . . . . 72.54 107.046 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 58.3 p -159.85 150.96 19.43 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.425 0.453 . . . . 73.4 111.29 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' C' ' 37' ' ' GLN . 66.0 tp -83.76 -48.17 10.39 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.701 -0.851 . . . . 63.53 108.701 165.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.56 -82.05 0.05 OUTLIER Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.553 -1.019 . . . . 52.24 110.553 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.95 -31.94 17.91 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.954 -0.758 . . . . 74.42 108.954 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.93 87.49 4.11 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.415 -0.957 . . . . 54.45 108.415 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.6 m -88.75 121.1 30.77 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.836 -0.62 . . . . 62.45 109.813 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.87 -61.73 1.9 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.923 -0.769 . . . . 74.42 108.923 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.464 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 41.7 p90 -158.89 171.87 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.72 0.772 . . . . 63.1 112.112 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.433 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -137.28 135.45 37.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.235 -1.765 . . . . 72.43 106.235 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.9 t -137.98 136.76 37.26 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.279 -1.008 . . . . 54.15 108.279 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.2 120.96 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.868 0.467 . . . . 64.34 110.053 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.26 125.73 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.312 1.045 . . . . 52.43 109.585 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 1.7 mp0 -100.15 91.83 4.94 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.569 -1.271 . . . . 72.23 107.569 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.426 HE22 HG22 ' C' ' 18' ' ' THR . 8.4 tp-100 -82.12 100.13 9.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.015 -0.539 . . . . 73.41 109.59 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 145.54 22.99 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.918 -0.873 . . . . 60.14 110.918 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.521 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.63 121.49 1.39 Allowed Glycine 0 CA--C 1.5 -0.902 0 N-CA-C 111.281 -0.727 . . . . 52.43 111.281 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 18.3 mm -80.31 128.09 38.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 108.067 -1.086 . . . . 41.42 108.067 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.65 139.43 38.49 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.272 0.629 . . . . 63.42 109.483 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.7 p -91.73 104.7 17.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.188 -1.041 . . . . 73.15 108.188 170.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.45 100.18 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.15 -1.056 . . . . 73.01 108.15 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.22 161.47 31.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.999 0.92 . . . . 63.4 110.364 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.47 -18.39 33.79 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.365 0.506 . . . . 54.1 114.365 168.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.78 144.82 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.282 1.033 . . . . 74.11 110.218 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -146.12 149.74 34.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.929 0.491 . . . . 64.4 111.689 -167.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.03 24.72 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.383 -0.826 . . . . 34.04 113.486 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -64.22 -23.94 67.49 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.165 0.986 . . . . 53.31 111.46 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -58.26 -57.38 13.14 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.648 0.779 . . . . 70.0 110.23 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.441 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.8 ptt? -73.12 -25.91 61.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.451 -0.795 . . . . 63.04 110.956 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.43 78.59 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.595 0.56 . . . . 70.22 110.485 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -67.36 -30.94 70.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.528 -0.76 . . . . 74.12 111.064 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.07 -64.43 1.01 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 64.14 110.307 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.5 pp -73.79 -16.32 61.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.558 0.577 . . . . 70.13 112.558 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.44 -9.92 37.27 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 119.449 -0.64 . . . . 62.13 114.018 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.01 -52.56 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.967 0.884 . . . . 64.04 112.571 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -73.18 -51.55 17.41 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.906 0.482 . . . . 70.13 112.2 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.509 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.6 m -61.89 -47.12 92.24 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 123.413 0.685 . . . . 62.13 110.842 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.0 Cg_exo -53.1 -36.62 77.38 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.603 2.202 . . . . 72.32 114.513 168.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -63.3 -38.54 91.57 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.523 0.729 . . . . 73.44 110.974 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -39.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.443 0.697 . . . . 63.1 110.417 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.521 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.1 mt -80.67 -28.94 36.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.491 -0.777 . . . . 71.34 112.415 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -54.14 -47.12 98.23 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-O 118.012 -0.994 . . . . 54.04 113.603 -173.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.58 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.546 2.164 . . . . 73.15 114.155 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.56 -45.52 79.08 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.36 0.664 . . . . 74.03 110.504 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.04 82.67 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.224 -0.898 . . . . 75.31 110.826 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.55 -46.99 80.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.455 1.502 . . . . 75.55 110.355 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.78 -34.4 64.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.96 0.504 . . . . 64.03 110.118 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.8 t -66.42 -27.01 67.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.84 0.456 . . . . 63.22 111.017 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.619 HD13 HG23 ' C' ' 64' ' ' VAL . 77.0 mt -75.27 -54.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.922 -0.581 . . . . 42.43 109.916 171.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.8 m -62.35 -29.49 70.5 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.256 0.622 . . . . 74.41 111.696 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -67.01 -49.41 65.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.101 -0.703 . . . . 54.42 109.101 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.537 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.58 -35.18 77.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.13 0.972 . . . . 60.24 112.308 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.52 -47.5 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.42 0.688 . . . . 60.44 109.683 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.428 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 37.9 t -69.13 -27.04 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.155 -0.93 . . . . 73.41 111.211 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -71.34 -34.23 70.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 73.02 109.602 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.14 1.99 88.45 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.537 0.523 . . . . 72.21 112.494 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.8 p 60.15 35.79 21.11 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.591 1.956 . . . . 63.32 113.354 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.16 154.91 43.19 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.595 0.758 . . . . 72.5 109.817 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.91 169.75 8.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.345 2.696 . . . . 74.25 114.376 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -60.22 113.81 2.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.476 -1.238 . . . . 71.4 111.389 -173.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.464 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 33.3 tp -134.88 115.12 13.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.791 0.836 . . . . 74.45 108.925 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -129.95 130.43 45.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.255 1.022 . . . . 70.42 108.404 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.2 140.45 40.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.731 0.412 . . . . 73.21 110.801 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.19 137.8 78.76 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.658 0.783 . . . . 51.1 110.675 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.67 107.86 1.54 Allowed 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.847 2.364 . . . . 71.23 112.211 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.43 110.93 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.326 -0.99 . . . . 65.1 108.326 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -103.24 89.2 3.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.524 0.73 . . . . 52.23 110.823 -175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -72.76 -31.85 65.21 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.771 0.796 . . . . 75.41 109.095 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.84 -53.0 62.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.997 -1.456 . . . . 62.45 111.132 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' C' ' 138' ' ' MET . . . -64.26 -28.27 69.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.521 0.728 . . . . 64.2 112.354 -174.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.591 ' HB2' HD21 ' E' ' 148' ' ' LEU . 45.6 tp -56.09 -58.39 8.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.876 0.871 . . . . 72.22 110.691 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.8 -14.59 57.94 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.204 -0.907 . . . . 73.14 111.616 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.53 ' HB3' ' HA ' ' C' ' 135' ' ' ALA . 24.4 ttt -71.71 -31.21 66.49 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.792 0.437 . . . . 60.34 110.607 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -57.71 -38.7 75.7 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.236 -0.283 . . . . 74.12 110.236 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -72.59 -85.88 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.657 0.783 . . . . 73.25 111.232 171.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 11.7 tp -102.35 -177.33 3.37 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.287 1.035 . . . . 74.04 110.596 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.421 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 28.3 tt0 95.21 -15.61 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 126.483 1.913 . . . . 72.41 111.895 174.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.09 159.01 22.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.891 0.477 . . . . 63.2 110.17 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' C' ' 5' ' ' ASN . 6.1 tp-100 58.36 75.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.597 1.186 . . . . 71.34 110.215 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.546 ' HA ' ' HB ' ' C' ' 7' ' ' THR . . . -175.55 -176.55 0.9 Allowed 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.51 -1.223 . . . . 54.11 108.968 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.63 -143.6 16.12 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 123.152 0.282 . . . . 61.34 112.931 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -144.23 172.68 12.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.96 0.904 . . . . 73.34 110.634 -174.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.55 108.86 0.22 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 116.197 -0.456 . . . . 55.33 112.133 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -147.77 152.51 37.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.782 0.833 . . . . 74.5 109.463 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.46 133.26 45.14 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.331 0.652 . . . . 73.13 109.716 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.57 135.92 35.49 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 106.855 -1.535 . . . . 72.53 106.855 172.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -128.77 136.46 50.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.877 0.471 . . . . 63.33 110.101 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.13 127.74 54.08 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.904 0.882 . . . . 74.41 109.143 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 10.7 40.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.714 0.806 . . . . 64.41 110.177 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 124.087 0.955 . . . . 43.41 110.771 178.535 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.236 -0.653 . . . . 70.02 109.236 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t 72.4 154.86 0.15 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.975 1.31 . . . . 72.2 112.423 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -78.81 91.51 4.74 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.951 -1.022 . . . . 74.12 109.726 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -71.95 93.47 1.36 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.555 0.742 . . . . 71.22 110.662 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -76.49 124.1 27.05 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.15 -0.932 . . . . 72.41 108.921 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -151.7 144.12 24.13 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.914 -0.772 . . . . 74.41 108.914 -177.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -107.42 173.66 6.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.909 . . . . 64.01 109.881 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.91 86.32 0.13 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.659 1.184 . . . . 73.1 109.144 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.4 ttp -32.24 127.24 0.25 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.109 1.364 . . . . 71.41 113.996 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.3 m -138.46 122.08 17.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.06 0.944 . . . . 70.1 108.622 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -141.98 101.18 3.89 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.181 -1.044 . . . . 71.44 108.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -122.04 127.38 50.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.067 0.547 . . . . 63.12 110.086 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.37 112.21 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.983 -1.117 . . . . 75.03 107.983 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.97 -47.81 7.36 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 119.528 -0.273 . . . . 74.55 111.716 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.413 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 42.6 ttt85 -173.12 132.92 0.51 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.563 0.209 . . . . 63.03 111.563 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.3 134.45 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.513 -1.292 . . . . 74.5 107.513 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -162.83 177.83 8.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.893 0.854 . . . . 62.35 111.641 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.1 p -109.72 118.96 37.92 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.617 -1.174 . . . . 74.1 108.351 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 30.0 mtpt -85.46 -21.51 28.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.651 -0.5 . . . . 73.14 109.651 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.1 t70 -155.65 140.57 17.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.284 1.034 . . . . 72.32 108.657 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.537 HD12 ' HG3' ' C' ' 117' ' ' MET . 48.8 mt -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.521 -1.289 . . . . 75.41 107.521 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -153.24 140.38 19.4 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 123.748 0.655 . . . . 45.34 110.329 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.5 t80 -142.85 135.98 28.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.714 -1.587 . . . . 75.1 106.714 170.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.661 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -134.33 150.75 50.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.151 0.98 . . . . 41.23 108.538 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.63 77.69 10.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.82 -32.91 17.4 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.777 2.318 . . . . 75.24 113.545 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -114.75 41.7 2.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.935 0.894 . . . . 65.44 108.61 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.46 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -57.12 -56.28 35.32 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.64 1.348 . . . . 74.51 114.64 -169.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.45 -3.75 12.1 Favored 'Trans proline' 0 C--N 1.39 2.725 0 CA-C-N 122.11 1.789 . . . . 71.53 112.708 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -84.65 -42.73 15.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.382 1.073 . . . . 64.51 110.393 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.04 -10.17 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-O 121.18 0.514 . . . . 64.54 110.546 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.429 ' HZ ' ' HB2' ' F' ' 132' ' ' TYR . 31.0 t80 -59.65 -36.88 77.29 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.918 -0.583 . . . . 74.13 110.262 166.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.51 110.594 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -98.93 70.59 1.84 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.011 -1.107 . . . . 72.53 108.011 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.71 88.8 0.99 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.33 1.062 . . . . 60.23 109.666 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.542 ' HB3' HD21 ' D' ' 68' ' ' LEU . 67.8 t-105 -160.46 170.63 20.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.398 -1.273 . . . . 71.13 108.468 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -71.75 110.09 6.96 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.937 1.295 . . . . 74.52 109.613 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.547 ' HA ' HD13 ' D' ' 68' ' ' LEU . 27.4 Cg_exo -65.66 141.9 68.35 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.227 2.618 . . . . 74.42 112.72 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.72 113.64 3.91 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.102 -0.703 . . . . 71.25 109.102 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.77 115.11 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.205 1.002 . . . . 61.43 110.593 -171.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -87.61 111.07 20.87 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 165.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.683 ' H ' HD23 ' D' ' 42' ' ' LEU . 2.0 pt? -96.76 148.2 23.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.451 -0.944 . . . . 64.54 108.451 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.4 t70 -151.38 151.94 32.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.775 0.43 . . . . 75.23 110.729 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.08 154.18 49.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.891 0.876 . . . . 73.51 109.97 170.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.3 t70 -152.36 137.58 17.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.426 1.091 . . . . 70.02 108.433 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -104.46 144.82 31.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 109.02 -0.733 . . . . 62.43 109.02 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.67 162.86 40.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.102 -1.073 . . . . 62.43 108.102 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.4 p -168.82 158.95 9.29 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.072 0.463 . . . . 73.42 111.916 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.7 p -152.11 119.58 6.01 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.685 1.194 . . . . 71.34 108.616 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.64 124.33 23.33 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.998 -0.742 . . . . 74.3 108.998 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 69.2 mt -87.96 -36.91 16.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.455 0.472 . . . . 72.21 109.925 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.99 -175.24 4.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.625 0.77 . . . . 61.22 111.061 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.97 124.51 20.98 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.938 -1.028 . . . . 70.12 109.141 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 19.0 m-20 66.54 -0.09 1.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.411 1.084 . . . . 74.14 113.112 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -116.05 118.06 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.051 0.94 . . . . 63.33 108.62 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.98 129.69 40.49 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.508 -0.923 . . . . 70.32 108.508 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.76 136.04 33.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.022 -1.103 . . . . 71.22 108.022 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' D' ' 102' ' ' CYS . 7.4 p -123.8 132.22 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.465 -0.939 . . . . 72.31 108.465 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 62.0 t -108.62 128.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 123.383 0.673 . . . . 70.31 109.199 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.58 114.89 27.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.945 -1.131 . . . . 74.41 107.945 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -97.14 133.09 42.25 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.645 -1.161 . . . . 73.02 108.623 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.73 120.2 44.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.523 -1.288 . . . . 62.21 107.523 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.6 m -116.95 137.41 52.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.563 0.745 . . . . 72.52 110.245 -172.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 75.3 t -125.41 117.73 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.621 1.168 . . . . 50.32 109.33 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 63.9 m -110.44 92.51 4.07 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.792 -1.188 . . . . 64.52 107.792 170.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.02 132.5 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.347 -0.612 . . . . 62.0 109.347 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.3 m -148.48 135.02 19.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.155 -1.054 . . . . 71.12 108.155 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' D' ' 38' ' ' PRO . 20.0 tp -113.83 124.9 53.35 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 117.789 0.268 . . . . 75.03 110.489 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.13 -110.66 3.17 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.722 -0.551 . . . . 62.14 111.722 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 4.31 9.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.589 0.756 . . . . 73.33 110.149 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.36 154.91 27.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.663 0.785 . . . . 45.31 109.435 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.0 m -74.62 141.28 44.68 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 110.045 -0.354 . . . . 64.42 110.045 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.416 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -97.7 -62.5 1.24 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.049 0.94 . . . . 74.33 109.421 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -158.17 138.23 12.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.373 -0.83 . . . . 75.44 109.235 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.661 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 92.3 mt -102.76 153.91 19.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.607 -0.886 . . . . 71.41 108.607 172.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.494 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 53.8 t -159.11 145.78 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.522 -0.547 . . . . 63.31 109.522 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -156.56 131.24 8.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.288 -1.005 . . . . 72.32 108.288 168.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -124.34 140.32 48.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.469 -0.937 . . . . 71.2 108.469 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -118.89 86.21 2.5 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.989 -1.115 . . . . 61.52 107.989 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.441 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.5 tp-100 -80.26 97.5 7.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.673 -1.603 . . . . 71.43 108.925 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.79 141.65 15.73 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.856 -0.498 . . . . 62.24 111.856 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 138.01 7.24 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.726 -0.55 . . . . 71.02 111.726 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.47 130.12 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.564 0.746 . . . . 60.35 109.064 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -132.67 142.48 49.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.564 0.746 . . . . 74.44 109.585 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -78.58 108.26 11.84 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.167 -1.049 . . . . 62.24 108.167 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 35.8 mm -106.7 100.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.093 -1.447 . . . . 72.53 107.093 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.706 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -144.88 158.24 43.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.136 -0.938 . . . . 74.1 109.709 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.52 -0.04 51.47 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.48 0.487 . . . . 63.3 113.75 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.22 128.67 68.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.918 1.287 . . . . 74.35 107.806 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 179.83 6.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.668 0.787 . . . . 52.54 111.245 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.1 -141.96 29.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.474 -0.785 . . . . 75.31 113.218 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 35.3 m -78.33 -18.94 54.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.599 0.76 . . . . 70.01 110.429 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -63.83 -46.4 85.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.347 0.659 . . . . 72.52 110.745 -178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -69.59 -26.7 64.59 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.405 0.441 . . . . 50.34 110.758 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.92 71.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.376 0.671 . . . . 74.33 110.947 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.79 -38.15 64.72 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.975 0.51 . . . . 70.13 110.737 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.91 -42.35 97.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.029 0.532 . . . . 53.11 110.953 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tt -78.49 -33.31 48.3 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.294 0.638 . . . . 62.11 109.613 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.43 58.97 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.138 -0.483 . . . . 74.22 114.281 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -52.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.493 0.647 . . . . 60.11 112.024 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -68.7 -43.7 75.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.658 0.614 . . . . 71.45 112.658 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.468 ' HB3' HG11 ' D' ' 58' ' ' VAL . 69.5 m -69.17 -43.05 23.7 Favored Pre-proline 0 CA--C 1.567 1.599 0 C-N-CA 122.943 0.497 . . . . 71.02 111.524 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.41 -34.48 89.28 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.765 2.31 . . . . 63.1 113.878 165.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -66.44 -26.52 67.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.708 0.803 . . . . 72.21 111.01 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.4 -41.23 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.62 0.724 . . . . 75.43 109.739 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.441 HD13 ' O ' ' D' ' 80' ' ' GLN . 94.4 mt -78.92 -14.41 59.24 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.688 -1.142 . . . . 63.13 111.836 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.414 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 55.7 t80 -61.98 -47.99 89.74 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.769 1.228 . . . . 73.54 113.745 -173.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 37.6 Cg_exo -59.98 -33.7 95.42 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 121.852 1.701 . . . . 71.44 112.682 175.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -76.18 -31.64 58.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 74.22 111.73 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.39 -56.26 19.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.076 0.55 . . . . 72.44 110.098 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -67.81 -32.42 72.95 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.508 -1.224 . . . . 74.22 110.787 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.29 -50.99 71.86 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.219 0.949 . . . . 73.44 110.155 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.5 t -58.61 -42.59 88.49 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.862 0.726 . . . . 74.25 110.867 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.421 HG12 ' SG ' ' D' ' 76' ' ' CYS . 73.8 mt -61.44 -52.53 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.342 0.657 . . . . 72.13 110.34 175.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.51 HG23 ' HG3' ' D' ' 125' ' ' GLN . 99.1 m -53.6 -47.33 70.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.553 1.141 . . . . 75.0 110.999 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.2 t -63.82 -42.05 97.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.5 -1.227 . . . . 73.32 110.322 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.8 mtm -69.61 -30.64 68.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.089 0.556 . . . . 64.23 111.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.3 t -74.02 -37.86 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.304 0.641 . . . . 61.13 110.514 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -74.05 -30.26 62.31 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 120.843 0.354 . . . . 73.33 110.497 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -72.25 -30.41 64.84 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.742 0.817 . . . . 74.4 109.606 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.93 4.21 81.04 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.481 -0.781 . . . . 52.13 112.599 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 81.4 p 60.6 34.19 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.238 1.815 . . . . 72.42 113.72 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.34 163.88 27.61 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 123.815 0.846 . . . . 75.1 112.13 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.47 125.3 5.92 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 124.375 3.383 . . . . 53.02 114.273 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.1 tt0 -55.04 130.36 41.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.656 1.182 . . . . 75.42 111.51 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.57 92.76 3.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.271 0.628 . . . . 50.2 109.596 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -100.86 113.49 26.48 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 14.7 tp -76.07 127.74 33.57 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.409 0.443 . . . . 74.45 109.831 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.77 138.96 82.46 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.555 0.742 . . . . 74.53 111.805 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.8 Cg_endo -75.43 96.29 1.03 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.298 1.999 . . . . 62.24 110.555 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.69 134.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.512 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -88.71 104.84 17.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.12 -1.067 . . . . 71.45 108.12 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.56 -33.43 75.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.203 0.601 . . . . 72.21 110.984 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 -42.43 96.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.629 0.771 . . . . 43.14 110.313 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.48 93.63 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.281 0.632 . . . . 74.24 110.922 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.469 HD13 HD21 ' F' ' 148' ' ' LEU . 55.8 tp -66.78 -33.64 76.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.325 0.65 . . . . 70.53 111.03 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.05 -47.52 77.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.674 0.79 . . . . 74.44 109.77 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -73.65 -19.19 60.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.481 0.712 . . . . 73.1 111.273 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -35.03 78.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.928 -0.767 . . . . 55.02 108.928 173.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -69.37 -26.89 64.89 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 120.691 0.282 . . . . 75.42 110.965 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.21 -32.34 68.71 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.54 -0.725 . . . . 53.12 111.152 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -91.78 -1.21 57.47 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.693 0.397 . . . . 73.02 111.575 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -147.02 91.25 1.98 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.562 1.145 . . . . 72.12 109.116 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -139.59 18.47 2.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.839 0.856 . . . . 72.43 110.595 -174.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.51 -50.75 10.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.531 0.732 . . . . 74.54 110.459 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.38 50.54 0.02 OUTLIER Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.881 -0.488 . . . . 72.4 111.881 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.5 126.5 45.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.728 1.211 . . . . 75.3 109.074 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.55 2.01 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.647 -0.581 . . . . 43.32 111.647 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 45.0 p -89.23 141.31 28.64 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.567 0.747 . . . . 75.33 110.104 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -106.53 -93.13 0.39 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.505 -1.294 . . . . 65.21 107.505 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 57.67 164.33 0.03 OUTLIER 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.447 1.499 . . . . 71.24 112.989 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -162.87 177.74 9.0 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.555 -0.748 . . . . 64.04 110.137 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.96 117.47 7.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.487 -1.233 . . . . 74.42 108.603 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.6 -60.9 2.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.141 0.576 . . . . 64.14 110.346 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.092 0.957 . . . . 42.22 108.552 177.009 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.573 -0.158 . . . . 73.43 110.573 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -126.45 27.6 6.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.445 1.098 . . . . 74.31 109.83 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.73 83.49 4.09 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 110.017 -0.364 . . . . 72.43 110.017 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -65.85 -52.98 45.75 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.717 0.807 . . . . 74.22 110.414 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 112' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' B' ' 1' ' ' MET . 49.8 tp60 63.02 12.66 6.09 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.497 1.119 . . . . 64.35 111.842 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -61.97 -35.72 79.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.178 0.991 . . . . 63.13 110.087 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.56 163.31 16.28 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.17 -1.377 . . . . 74.13 108.251 168.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.97 77.77 4.47 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.06 -0.718 . . . . 72.14 109.06 173.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -177.31 71.44 0.23 Allowed Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.772 1.629 . . . . 75.25 107.767 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -93.22 162.23 2.52 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.169 2.579 . . . . 72.0 112.874 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 62.81 -175.54 0.15 Allowed 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.085 0.954 . . . . 74.52 110.845 172.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -160.03 173.69 15.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.97 0.508 . . . . 75.11 110.132 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.79 132.89 40.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.852 0.861 . . . . 70.5 110.808 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.66 -19.57 23.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.599 0.76 . . . . 61.32 111.186 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.43 99.8 2.22 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.288 0.635 . . . . 61.32 110.19 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 123' ' ' VAL . . . . . 0.66 HG12 ' HG ' ' B' ' 44' ' ' LEU . 5.4 t -87.51 69.08 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.797 -0.816 . . . . 74.12 108.797 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -161.01 147.15 14.7 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.137 0.575 . . . . 73.35 110.916 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 125' ' ' TYR . . . . . 0.593 ' HD2' HD22 ' B' ' 136' ' ' LEU . 1.3 p90 -134.75 133.43 39.9 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.146 0.978 . . . . 72.44 109.036 169.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -128.98 173.79 10.11 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.253 1.021 . . . . 73.4 109.843 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.18 -145.74 16.51 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.915 -0.584 . . . . 74.15 111.663 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.01 85.01 2.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.665 0.786 . . . . 73.12 109.812 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.75 149.75 20.92 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.842 -0.617 . . . . 74.41 110.745 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt 61.31 78.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.084 1.354 . . . . 73.31 110.57 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -120.05 21.83 11.68 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.379 -0.828 . . . . 73.42 109.682 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 132' ' ' TYR . . . . . 0.66 ' HB3' ' HE2' ' C' ' 32' ' ' PHE . 98.4 m-85 -116.54 91.38 33.77 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 75.32 110.239 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.22 127.58 6.81 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.913 2.408 . . . . 60.23 112.516 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 134' ' ' ILE . . . . . 0.551 HG23 HG22 ' C' ' 31' ' ' VAL . 48.3 mm -94.74 128.73 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.656 0.783 . . . . 74.23 109.043 176.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.57 15.5 3.73 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.255 0.622 . . . . 73.35 112.319 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.507 ' H ' HG22 ' E' ' 134' ' ' ILE . 12.5 p -146.78 140.04 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.767 0.827 . . . . 73.11 109.491 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.85 -177.86 4.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.564 1.146 . . . . 72.13 109.283 170.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.37 56.81 6.88 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.166 0.916 . . . . 74.3 110.387 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 139' ' ' LEU . . . . . 0.418 ' HA ' ' HG2' ' C' ' 38' ' ' PRO . 7.4 mp -68.5 92.36 0.44 Allowed 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.067 -0.969 . . . . 54.42 109.8 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 30.9 p -151.29 110.32 3.9 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.086 -0.961 . . . . 74.24 108.725 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 tt -160.02 44.98 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.803 -1.554 . . . . 72.31 106.803 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 142' ' ' ILE . . . . . 0.414 HG12 ' O ' ' C' ' 40' ' ' VAL . 5.4 mt -118.74 -70.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.551 -0.749 . . . . 73.34 109.851 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -115.9 138.38 51.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.557 0.743 . . . . 72.13 109.672 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -81.6 -36.06 29.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.21 0.604 . . . . 74.13 110.149 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -166.72 -68.38 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.279 -1.378 . . . . 70.45 107.279 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 146' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' E' ' 149' ' ' PRO . 6.0 m-20 61.36 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.105 1.362 . . . . 71.51 113.057 167.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 147' ' ' LEU . . . . . 0.456 HD11 ' H ' ' A' ' 13' ' ' ILE . 2.4 tt 59.69 75.62 0.39 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.646 1.178 . . . . 65.32 109.114 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' C' ' 136' ' ' LEU . 57.1 tp 61.68 80.39 0.25 Allowed Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.268 1.027 . . . . 72.42 110.668 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 149' ' ' PRO . . . . . 0.575 ' HG3' ' HB3' ' E' ' 146' ' ' ASP . 8.1 Cg_endo . . . . . 0 CA--C 1.56 1.811 0 C-N-CA 123.024 2.483 . . . . 74.42 111.599 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 27.8 t70 . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.136 -0.691 . . . . 75.02 109.136 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -90.22 -59.31 2.22 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.91 88.92 2.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.267 1.027 . . . . 55.33 108.353 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -135.12 -53.06 0.79 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.122 0.969 . . . . 72.23 108.544 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 60.15 114.22 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 63.23 110.221 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 113' ' ' ASP . . . . . 0.412 ' O ' HD22 ' F' ' 115' ' ' LEU . 28.7 t70 -69.88 86.95 0.52 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.435 0.694 . . . . 73.45 110.327 -173.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -84.56 130.77 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.905 0.882 . . . . 61.2 110.707 -176.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -149.51 143.14 25.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.766 -1.106 . . . . 42.33 110.61 -156.702 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -149.27 163.12 26.56 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.397 1.079 . . . . 64.31 110.962 -172.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.86 -169.47 0.76 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.875 2.383 . . . . 75.04 111.897 165.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -153.22 158.4 41.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.739 0.816 . . . . 65.53 108.999 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -81.31 139.22 35.52 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.14 -0.689 . . . . 75.12 109.14 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -145.67 -73.84 0.23 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 119.196 -0.43 . . . . 74.01 111.138 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 59.04 153.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.955 1.302 . . . . 74.4 112.403 -170.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.85 13.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.907 -0.495 . . . . 74.4 111.639 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.19 -27.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.936 0.495 . . . . 65.23 111.75 -172.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? 63.63 60.53 1.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.644 1.178 . . . . 74.21 108.372 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -66.18 103.15 0.93 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.927 -1.033 . . . . 74.11 111.706 -168.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -140.92 24.05 2.2 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.764 1.226 . . . . 71.31 107.835 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.36 126.69 10.24 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-N 115.042 -0.981 . . . . 51.05 112.214 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 128' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 41' ' ' LYS . 52.2 mtmt -106.37 140.52 39.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.559 0.743 . . . . 75.2 110.983 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 128' ' ' LEU . 2.3 pt? -142.13 -172.15 3.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.832 0.853 . . . . 62.43 109.869 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 11.0 tt -156.04 -30.63 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.824 0.85 . . . . 74.14 110.508 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 64.38 -154.14 0.3 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.745 1.218 . . . . 71.02 110.093 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 132' ' ' TYR . . . . . 0.429 ' HB2' ' HZ ' ' D' ' 32' ' ' PHE . 13.7 p90 -119.28 88.21 37.17 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 121.385 0.612 . . . . 74.21 111.102 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -93.72 -176.21 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.376 2.717 . . . . 74.31 112.98 175.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.506 ' CG1' HH22 ' C' ' 15' ' ' ARG . 10.6 mm -94.85 122.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.355 -0.98 . . . . 74.13 108.355 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.62 -75.44 0.2 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.457 0.703 . . . . 54.31 110.393 -175.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m 42.86 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 126.577 1.951 . . . . 74.12 114.856 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -136.39 -68.3 0.5 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.841 1.256 . . . . 73.32 108.164 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.27 -169.62 3.42 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.528 -1.669 . . . . 74.43 107.497 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.43 HD11 ' O ' ' D' ' 38' ' ' PRO . 0.0 OUTLIER -83.57 -57.2 3.33 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.279 -0.637 . . . . 74.12 109.279 178.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m 69.1 -12.54 0.4 Allowed 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.063 1.505 . . . . 70.41 115.063 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.93 -24.5 55.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.58 0.627 . . . . 72.13 111.523 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.455 HG22 HD22 ' D' ' 42' ' ' LEU . 18.7 pt -67.25 121.6 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.198 -0.668 . . . . 44.03 109.198 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 74.06 -60.66 0.52 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.429 1.492 . . . . 73.24 111.61 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 40.0 t30 63.89 95.13 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.942 1.297 . . . . 74.24 110.809 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 65.67 -72.33 0.08 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 74.54 111.516 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.24 94.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.365 1.066 . . . . 64.13 110.684 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.86 102.08 1.19 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.347 -1.353 . . . . 72.12 107.347 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 148' ' ' LEU . . . . . 0.469 HD21 HD13 ' D' ' 136' ' ' LEU . 55.0 tp 65.5 85.45 0.16 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 124.569 1.148 . . . . 70.21 109.321 -170.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.028 0 C-N-CA 123.13 2.553 . . . . 72.03 111.349 176.601 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.413 0.149 . . . . 72.42 111.023 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 p -163.4 142.91 8.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.807 0.843 . . . . 64.02 109.733 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.47 146.85 36.22 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.562 -0.533 . . . . 75.42 109.562 170.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.14 140.9 29.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.333 0.587 . . . . 73.15 110.441 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -126.99 -177.11 3.92 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.29 1.036 . . . . 62.15 109.456 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.6 79.16 5.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.981 0.896 . . . . 55.15 110.858 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 t -164.57 135.32 4.15 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.675 -1.148 . . . . 75.42 108.788 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 55.32 -159.36 0.2 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.987 0.915 . . . . 73.4 111.989 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 75.0 mtm 66.57 135.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.743 1.217 . . . . 70.1 110.701 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.0 m -139.75 112.08 7.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.121 0.568 . . . . 50.4 109.625 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -139.68 112.92 8.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.78 -1.193 . . . . 72.51 107.78 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -133.84 116.97 16.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.177 0.591 . . . . 72.12 109.77 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 16' ' ' ILE . 3.9 mp -77.66 115.32 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.264 -1.013 . . . . 74.43 108.264 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.06 -44.86 10.05 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.81 -0.441 . . . . 71.24 109.81 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -174.52 144.69 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.795 0.438 . . . . 72.21 110.616 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 13' ' ' ILE . 3.7 mp -117.87 123.7 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 64.32 107.725 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -152.51 148.22 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.597 0.713 . . . . 73.32 111.126 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -79.96 112.58 17.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.638 -1.165 . . . . 73.51 109.904 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -82.1 -21.65 36.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.589 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -153.04 141.44 20.68 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.312 -0.858 . . . . 72.24 109.947 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 71.4 mt -144.78 143.11 22.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.812 1.645 . . . . 74.31 106.779 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.6 t -158.4 124.58 4.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.423 0.452 . . . . 63.33 110.208 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 91.8 t80 -116.49 147.54 41.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.027 -1.471 . . . . 74.41 107.027 169.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -142.5 140.49 31.86 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.871 0.868 . . . . 62.02 109.543 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -152.14 68.14 7.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 106.685 -1.598 . . . . 54.11 106.685 170.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.02 -20.46 21.86 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.234 1.956 . . . . 75.01 110.948 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -105.86 16.12 25.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.37 1.068 . . . . 74.11 109.729 -179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.684 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -54.19 -45.49 99.14 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.166 1.173 . . . . 75.13 114.166 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -64.68 -26.93 60.71 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.93 1.753 . . . . 71.21 113.006 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -75.33 -33.5 61.14 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.781 0.832 . . . . 70.2 111.747 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG21 ' HE1' ' A' ' 123' ' ' PHE . 3.9 m -72.07 -23.62 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 122.923 0.489 . . . . 71.2 111.285 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -70.88 -31.37 68.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.794 -1.094 . . . . 52.43 110.232 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -76.53 -47.41 22.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.897 0.879 . . . . 73.24 110.381 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -82.65 167.1 18.58 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.5 -0.773 . . . . 65.5 111.928 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 116.21 6.34 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.778 -0.823 . . . . 63.34 108.778 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.712 ' HE1' ' HB1' ' F' ' 135' ' ' ALA . 38.0 p90 -84.88 63.98 8.37 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 122.583 1.182 . . . . 73.51 110.53 -171.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -120.51 86.42 39.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 107.252 -1.388 . . . . 63.23 107.252 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.56 173.17 7.6 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.522 2.148 . . . . 73.43 113.154 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -96.6 124.36 40.56 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.5 90.17 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.499 -0.926 . . . . 74.11 108.499 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -96.39 127.91 42.83 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.016 -1.105 . . . . 74.02 108.016 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD21 ' HA3' ' F' ' 127' ' ' GLY . 4.0 pp -134.21 145.97 49.69 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.064 -0.717 . . . . 75.31 109.064 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.74 148.5 39.1 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.023 -1.103 . . . . 75.5 108.023 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.8 147.58 40.98 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.197 -0.668 . . . . 72.14 109.197 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 11.6 t70 -154.11 137.28 15.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.966 0.906 . . . . 72.12 109.083 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -107.53 130.44 54.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.559 0.744 . . . . 62.1 109.634 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.74 150.6 52.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.184 0.994 . . . . 73.15 109.118 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -134.37 161.35 35.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.283 0.633 . . . . 73.45 110.816 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -152.29 152.75 32.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 63.42 108.753 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.38 123.43 48.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.146 -0.687 . . . . 63.33 109.146 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 57' ' ' GLU . 51.5 mt -101.81 -33.27 9.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.863 0.865 . . . . 64.11 110.725 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -165.57 -167.67 1.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.664 0.786 . . . . 74.44 110.64 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.16 99.37 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.215 1.006 . . . . 73.33 110.803 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 66.49 13.03 9.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.008 1.323 . . . . 72.44 112.303 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 56.5 t -99.54 111.04 28.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.541 -1.652 . . . . 71.32 106.541 167.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -119.79 168.84 10.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.526 -0.761 . . . . 72.44 109.167 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HB2' HD11 ' A' ' 51' ' ' LEU . 37.6 tt0 -132.51 134.53 45.12 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 125.065 1.346 . . . . 63.02 107.389 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.401 HG11 ' HD3' ' A' ' 103' ' ' PRO . 97.9 t -121.18 124.17 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 171.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.8 t -109.78 135.42 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.126 0.97 . . . . 43.03 109.338 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 121.28 44.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.681 -0.859 . . . . 75.22 108.681 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.23 105.09 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.472 0.709 . . . . 65.1 109.565 172.539 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.45 128.23 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.283 -1.006 . . . . 75.43 108.283 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -119.26 120.58 37.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.158 0.504 . . . . 73.5 109.832 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 114' ' ' ILE . 71.0 t -112.25 105.84 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.346 1.058 . . . . 71.11 108.549 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.9 m -110.83 138.23 47.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.063 -0.717 . . . . 63.51 109.063 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.13 127.75 40.4 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.024 -1.102 . . . . 72.24 108.024 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -141.36 125.62 17.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.891 0.477 . . . . 64.25 110.632 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.1 pt? -93.39 84.27 4.71 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.159 0.984 . . . . 72.44 108.369 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.41 -102.44 1.49 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.339 -1.301 . . . . 54.32 112.093 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -95.96 -24.26 16.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.56 0.744 . . . . 71.13 109.664 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -92.06 135.55 33.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.895 1.278 . . . . 52.3 109.482 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 80.9 m -77.93 133.01 38.14 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.72 -0.474 . . . . 65.14 109.72 170.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.8 -59.92 2.57 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.003 -0.74 . . . . 71.41 109.003 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -165.88 166.79 17.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.125 -1.398 . . . . 75.31 110.189 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.22 127.57 32.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.226 1.01 . . . . 60.3 108.697 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.543 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 57.1 m -119.27 137.72 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.993 0.917 . . . . 64.2 108.657 172.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.16 122.48 9.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.407 -0.96 . . . . 71.44 108.407 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.28 132.21 69.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.302 0.641 . . . . 73.04 109.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.733 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 48.7 mt-30 -96.98 90.57 5.24 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.427 -0.806 . . . . 74.14 109.428 166.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.8 95.49 6.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.725 -1.125 . . . . 52.31 108.34 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.37 161.33 26.29 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.188 -0.46 . . . . 71.24 112.092 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.44 140.67 7.37 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.835 -0.906 . . . . 41.21 110.835 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.7 mt -86.26 127.19 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 N-CA-C 108.635 -0.876 . . . . 62.15 108.635 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -133.19 118.13 18.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.374 -0.973 . . . . 72.53 108.374 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -88.0 100.56 13.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.777 -0.823 . . . . 75.53 108.777 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.5 pt -119.52 147.75 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.262 0.553 . . . . 71.15 111.428 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HA ' HD21 ' F' ' 115' ' ' LEU . . . -171.53 164.69 6.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.978 1.711 . . . . 62.33 108.852 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.45 9.01 87.37 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.752 -0.471 . . . . 54.33 114.11 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -120.26 146.67 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.452 0.701 . . . . 71.42 109.94 176.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.16 170.78 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.318 0.647 . . . . 71.53 109.469 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.76 -125.55 37.25 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.776 0.672 . . . . 71.15 114.758 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -72.4 -37.94 68.56 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.884 0.874 . . . . 61.32 111.705 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.51 -35.06 78.2 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.114 0.566 . . . . 75.41 111.003 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' F' ' 115' ' ' LEU . 55.8 ttp -68.93 -45.73 70.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.952 0.901 . . . . 71.12 111.054 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' HA ' ' HG3' ' F' ' 117' ' ' PRO . . . -60.84 -34.04 73.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.627 0.771 . . . . 74.44 111.478 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -66.05 -48.43 71.05 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.915 -1.039 . . . . 75.53 110.551 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 0.8 OUTLIER -68.81 -55.68 10.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.304 0.853 . . . . 74.32 113.304 -168.11 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.507 HD21 ' HD3' ' F' ' 117' ' ' PRO . 4.1 pp -76.3 -25.67 55.06 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 122.113 -0.367 . . . . 73.25 111.382 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.07 -18.67 45.76 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 114.292 0.477 . . . . 70.04 114.292 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -135.98 -58.01 0.76 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.169 0.588 . . . . 71.41 111.638 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.672 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 1.4 t80 -54.88 -53.6 53.31 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.179 0.992 . . . . 74.32 113.065 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m -68.56 -49.58 29.53 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.616 -0.707 . . . . 72.03 112.684 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' HG11 ' A' ' 58' ' ' VAL . 38.3 Cg_endo -65.56 -15.41 49.4 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 121.637 1.558 . . . . 74.23 113.56 172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 35.3 t-20 -72.79 -35.74 67.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.469 -0.567 . . . . 73.54 109.469 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mm -65.75 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.471 0.709 . . . . 73.03 110.135 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.8 -24.26 60.89 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.102 -0.954 . . . . 64.33 111.557 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.14 -45.02 39.93 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 114.451 1.278 . . . . 73.42 114.451 -168.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.63 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 29.4 Cg_endo -62.83 -29.86 77.01 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 121.553 1.59 . . . . 71.14 112.511 174.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.518 ' HE2' ' HB3' ' C' ' 130' ' ' PRO . 11.6 m-85 -81.94 -26.23 34.19 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.882 0.473 . . . . 71.52 111.861 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.29 49.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.684 -0.858 . . . . 41.13 108.684 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.513 HH12 HD12 ' C' ' 105' ' ' ILE . 39.2 ttm180 -51.6 -48.15 63.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.026 -1.443 . . . . 73.23 110.913 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.48 -47.93 77.13 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.428 -0.806 . . . . 74.22 111.149 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.23 -32.95 73.68 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.401 0.681 . . . . 70.41 111.402 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.429 HG21 HG21 ' A' ' 64' ' ' VAL . 74.9 mt -71.71 -58.51 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.706 0.802 . . . . 71.23 110.139 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.403 HG23 ' HG3' ' A' ' 125' ' ' GLN . 88.0 m -56.23 -33.74 65.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.69 1.196 . . . . 74.04 111.955 -173.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -67.34 -44.0 80.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.341 -0.845 . . . . 52.41 110.583 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.0 mtm -65.17 -35.0 79.71 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.593 0.357 . . . . 72.14 111.253 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.65 -46.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.8 0.84 . . . . 71.51 110.286 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.4 p -74.25 -28.95 61.46 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.783 -0.644 . . . . 72.51 111.458 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -71.79 -29.79 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.453 0.701 . . . . 70.23 109.828 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.27 -0.18 85.78 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.627 -0.715 . . . . 71.5 112.685 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m 68.04 29.75 6.23 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.89 1.276 . . . . 54.24 110.8 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.611 ' HE1' HG21 ' A' ' 31' ' ' VAL . 83.2 m-85 -99.11 152.1 37.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 115.287 -0.87 . . . . 73.23 110.329 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.05 141.7 77.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.386 2.057 . . . . 72.5 111.353 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.3 tt0 -62.28 144.73 55.26 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.562 0.745 . . . . 72.24 112.312 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -146.48 103.01 3.64 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.336 -1.357 . . . . 55.34 107.336 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.17 119.11 37.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.419 0.688 . . . . 52.33 109.212 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.49 136.51 44.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.325 0.65 . . . . 71.41 110.404 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.21 138.36 86.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 45.32 111.36 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HB3' HH22 ' A' ' 111' ' ' ARG . 46.9 Cg_endo -77.84 112.24 3.25 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.981 1.788 . . . . 72.24 111.035 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.58 136.05 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.65 -0.87 . . . . 63.54 108.65 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 4.1 m-20 -72.96 78.48 1.17 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.277 0.631 . . . . 74.33 110.771 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -77.02 -26.6 53.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.862 -1.063 . . . . 72.42 108.758 173.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.54 -48.42 75.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.891 -1.504 . . . . 72.23 110.504 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -79.57 -19.31 49.71 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.597 -0.729 . . . . 71.44 111.806 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.7 -33.19 75.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.942 0.497 . . . . 72.45 110.374 174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -67.41 -27.6 67.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.063 -0.517 . . . . 75.12 110.892 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.451 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 66.0 mtp -68.12 -22.17 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.525 0.33 . . . . 71.2 111.506 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 13.4 m120 -66.78 -27.55 67.68 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.367 0.667 . . . . 74.53 111.144 172.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -85.98 -35.6 20.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.783 0.833 . . . . 74.42 110.475 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 63.4 tp -63.17 -50.0 72.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.955 0.902 . . . . 75.34 111.971 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.36 25.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.355 -0.609 . . . . 72.05 109.355 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.5 tt0 62.35 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.341 1.457 . . . . 44.31 111.333 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -153.94 110.76 3.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.82 -0.808 . . . . 73.44 108.82 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.12 151.6 33.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.648 0.779 . . . . 45.31 110.038 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.51 -169.04 12.04 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 111.57 -0.612 . . . . 45.41 111.57 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.44 156.73 37.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.803 0.441 . . . . 63.12 110.747 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.29 41.57 2.05 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.465 -0.788 . . . . 43.34 112.486 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.5 p -69.98 84.92 0.51 Allowed 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.603 0.716 . . . . 51.42 109.715 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 149.83 32.34 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.235 -0.893 . . . . 63.24 110.774 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 49.36 50.35 18.24 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.069 1.348 . . . . 74.55 112.999 166.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -74.04 90.54 2.0 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.353 0.597 . . . . 73.33 109.57 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.12 120.45 40.46 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.981 -1.008 . . . . 75.42 110.713 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.04 82.34 1.93 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.209 1.004 . . . . 73.23 108.376 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 109.088 -0.708 . . . . 42.54 109.088 -179.583 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.917 -0.772 . . . . 62.33 108.917 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 t 65.43 26.11 11.91 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 124.343 1.057 . . . . 65.14 109.606 -163.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -164.31 160.57 21.09 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 125.063 1.345 . . . . 75.34 108.179 -170.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -166.7 132.79 2.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.842 0.457 . . . . 72.23 110.184 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' B' ' 90' ' ' GLU . 42.5 t30 -148.72 136.93 21.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.581 -0.896 . . . . 61.23 108.581 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -135.12 135.91 41.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.646 0.779 . . . . 70.14 109.281 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.634 HG22 ' H ' ' B' ' 8' ' ' GLU . 5.2 m -118.75 -159.94 0.78 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 107.386 -1.339 . . . . 71.31 107.386 174.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.634 ' H ' HG22 ' B' ' 7' ' ' THR . 19.6 mm-40 -62.56 -27.38 69.14 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.076 1.307 . . . . 61.0 110.767 175.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ptm 57.91 -179.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.779 2.032 . . . . 52.41 113.672 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -160.49 143.08 13.07 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.499 -0.773 . . . . 73.22 109.877 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -132.43 113.36 13.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.832 -0.803 . . . . 75.02 108.832 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -125.78 140.11 52.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.256 1.022 . . . . 71.31 108.539 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.586 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.67 137.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.819 -0.808 . . . . 73.53 108.819 167.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -101.47 -51.58 3.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.726 0.41 . . . . 71.43 110.431 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -161.13 139.4 9.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.035 -0.357 . . . . 71.12 110.035 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.34 140.58 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 107.271 -1.381 . . . . 75.1 107.271 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -167.84 147.96 5.03 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.279 0.561 . . . . 72.15 112.151 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -74.34 119.36 18.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.923 -1.035 . . . . 64.42 108.724 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -93.92 -29.47 15.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.565 0.746 . . . . 72.23 111.807 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 29.4 t70 -160.2 142.72 13.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.625 0.25 . . . . 73.23 110.803 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.5 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 31.6 mm -143.83 145.57 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.837 1.255 . . . . 74.11 109.055 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -146.38 141.95 27.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.302 -1.369 . . . . 72.03 107.302 163.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.516 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -150.03 111.83 4.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.244 -1.761 . . . . 60.54 106.244 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -115.98 156.9 25.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.597 -0.89 . . . . 73.32 108.597 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -144.67 76.39 14.19 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 105.817 -1.92 . . . . 64.51 105.817 174.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.02 -28.79 80.82 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.229 2.62 . . . . 74.54 113.212 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -124.48 29.31 6.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.855 . . . . 44.35 109.589 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -46.44 -53.39 24.19 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 115.162 1.541 . . . . 63.45 115.162 -172.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.83 -8.85 18.13 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.151 1.9 . . . . 74.31 113.433 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -97.75 -42.48 7.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.608 0.763 . . . . 71.25 110.65 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' B' ' 73' ' ' ALA . 61.8 t -73.69 -13.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.224 1.01 . . . . 63.53 110.181 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.73 -36.63 57.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.419 1.088 . . . . 73.51 111.342 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -70.6 -23.28 62.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.698 0.799 . . . . 72.4 112.488 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.98 111.24 20.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.688 0.795 . . . . 74.42 111.543 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.68 87.85 3.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.914 0.486 . . . . 54.53 109.904 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.684 ' HB3' HD21 ' B' ' 68' ' ' LEU . 29.9 t90 -154.36 157.31 38.39 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.016 -1.105 . . . . 75.04 108.016 174.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -67.1 116.87 40.47 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.368 0.667 . . . . 72.35 110.4 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.418 ' HG2' HD11 ' B' ' 126' ' ' LEU . 53.8 Cg_endo -67.87 127.53 16.31 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.057 1.838 . . . . 74.03 111.463 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.03 104.61 0.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.576 1.15 . . . . 73.24 109.848 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -91.65 136.01 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.314 0.578 . . . . 62.02 111.363 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -136.75 104.95 5.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.297 1.039 . . . . 63.15 108.572 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.498 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -86.49 167.85 14.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.193 0.597 . . . . 62.53 110.828 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 29.4 t70 -153.01 115.17 4.38 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.287 -0.869 . . . . 62.43 108.763 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.65 134.64 43.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.611 -0.885 . . . . 73.43 108.611 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.5 t70 -142.92 142.17 31.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.768 0.827 . . . . 64.4 109.612 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 42.7 p -118.55 116.19 26.14 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.411 -0.813 . . . . 71.23 109.76 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -114.81 152.31 32.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.135 -1.432 . . . . 71.3 107.135 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 62.3 m -143.53 169.96 16.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.019 0.438 . . . . 61.12 110.78 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -155.13 169.07 24.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.406 1.082 . . . . 22.31 108.679 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -125.1 128.03 47.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.713 0.805 . . . . 64.12 108.929 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -100.16 -22.65 15.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.429 0.691 . . . . 71.44 110.911 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.99 176.54 4.67 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.792 0.837 . . . . 74.35 110.207 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.69 122.26 13.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.702 -0.481 . . . . 63.44 109.702 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 72.37 -5.85 1.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.821 1.648 . . . . 64.21 112.705 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.4 t -103.78 100.84 11.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 N-CA-C 108.462 -0.94 . . . . 71.35 108.462 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.55 137.82 50.23 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.282 0.633 . . . . 73.33 109.699 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -110.29 97.39 6.87 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.349 -1.352 . . . . 74.42 107.349 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 57.8 t -95.97 123.55 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.363 0.665 . . . . 54.1 110.079 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 45.8 t -100.61 119.04 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.033 0.933 . . . . 74.31 110.108 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.16 114.19 26.27 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.219 -1.03 . . . . 73.43 108.219 177.373 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 29.3 ttm180 -99.51 117.62 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.932 0.396 . . . . 64.45 110.249 171.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -112.94 102.64 14.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.967 -1.123 . . . . 64.03 107.967 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 7.0 m -98.1 134.94 40.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.44 HG21 HG21 ' B' ' 114' ' ' ILE . 93.2 t -123.32 137.27 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.54 0.736 . . . . 70.11 109.941 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -121.33 146.44 46.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.213 1.005 . . . . 72.12 108.844 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -144.17 129.16 18.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.633 -0.877 . . . . 72.0 108.633 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -130.22 139.57 50.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.994 -0.743 . . . . 65.44 108.994 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' B' ' 36' ' ' TRP . 1.8 tt -124.99 105.98 9.61 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.964 -1.124 . . . . 72.24 107.964 -177.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.28 -115.06 4.15 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.651 -0.704 . . . . 74.44 112.016 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -108.75 4.52 23.78 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.822 0.811 . . . . 73.24 111.509 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.86 169.5 17.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.934 0.494 . . . . 52.14 111.158 -173.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -73.62 133.11 43.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.51 -0.768 . . . . 70.14 110.26 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -85.44 -58.22 2.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.146 0.978 . . . . 74.22 108.378 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.521 ' HZ ' HD12 ' B' ' 126' ' ' LEU . 45.4 p90 -164.3 161.51 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.548 -1.205 . . . . 73.13 110.246 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.73 152.12 47.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.08 1.352 . . . . 74.35 108.941 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.9 t -151.51 157.92 42.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.427 0.691 . . . . 41.04 109.408 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -165.77 128.48 2.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.76 -0.83 . . . . 73.44 108.76 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.4 ' HA ' HD13 ' B' ' 21' ' ' ILE . 65.7 t -126.17 143.6 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.044 -0.724 . . . . 64.24 109.044 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -124.75 102.36 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.531 -0.915 . . . . 54.13 108.531 172.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -94.04 100.66 12.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.132 -1.062 . . . . 71.0 108.132 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.66 144.18 16.93 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.452 -0.659 . . . . 55.33 111.452 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.48 127.47 3.64 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.694 -0.562 . . . . 74.54 111.694 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.16 125.99 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.33 -0.989 . . . . 71.32 108.33 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -131.43 161.44 32.46 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.363 1.065 . . . . 74.14 109.319 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -131.29 93.54 3.39 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.874 0.87 . . . . 73.43 108.725 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.526 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -117.33 139.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.999 0.92 . . . . 63.32 110.098 -176.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.91 168.82 26.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 60.45 109.792 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.55 -28.77 5.16 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 123.539 0.525 . . . . 32.42 113.513 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 pt -90.84 137.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.709 1.204 . . . . 65.32 110.552 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' B' ' 5' ' ' ASN . 42.4 mt-10 -149.31 149.8 31.48 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.022 0.929 . . . . 62.41 109.243 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.23 -118.78 9.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.704 -0.68 . . . . 74.3 113.367 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.3 m -65.22 -40.43 94.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.794 0.838 . . . . 70.25 110.339 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -63.06 -34.19 77.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.672 -1.149 . . . . 63.15 110.853 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.527 ' SD ' HD11 ' B' ' 98' ' ' LEU . 13.2 tmm? -79.94 -43.07 22.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.909 -1.041 . . . . 60.45 111.089 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.13 91.96 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.564 -0.744 . . . . 51.23 112.46 -168.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 3.0 p80 -82.82 -12.46 57.45 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.602 -0.272 . . . . 74.45 110.996 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -85.35 -68.68 0.71 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.614 -0.266 . . . . 73.11 110.355 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.527 HD11 ' SD ' ' B' ' 94' ' ' MET . 2.4 pp -85.07 -14.8 46.11 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.198 0.444 . . . . 52.13 112.198 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.2 -2.98 59.0 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.75 -0.472 . . . . 43.24 113.303 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -147.29 -60.86 0.28 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.274 0.537 . . . . 73.4 112.036 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.67 -43.52 89.06 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.914 0.485 . . . . 74.0 112.136 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.1 m -69.35 -44.72 26.95 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.198 0.599 . . . . 71.03 111.403 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.522 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 80.2 Cg_exo -53.3 -37.34 80.87 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.152 1.901 . . . . 73.53 113.731 164.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.35 -27.32 66.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.48 0.312 . . . . 72.23 111.798 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.53 -42.69 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.663 0.785 . . . . 44.31 110.009 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 mt -81.54 -15.63 54.25 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.791 -1.095 . . . . 71.43 111.243 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -60.17 -49.6 90.03 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 117.533 -1.223 . . . . 70.22 113.9 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.52 -32.21 96.01 Favored 'Trans proline' 0 C--N 1.38 2.202 0 CA-C-N 121.748 1.66 . . . . 61.13 112.913 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.38 -47.51 48.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.22 0.608 . . . . 75.24 110.413 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.46 86.72 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.635 -0.711 . . . . 73.1 110.294 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -58.97 -52.01 67.59 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.633 1.573 . . . . 63.25 111.313 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.32 -37.09 86.05 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.928 0.767 . . . . 74.31 110.313 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.8 t -65.79 -41.43 91.98 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 123.612 0.57 . . . . 74.13 111.49 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.44 HG21 HG21 ' B' ' 64' ' ' VAL . 72.6 mt -60.95 -53.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.449 0.7 . . . . 72.32 110.343 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -69.14 -24.1 64.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.762 -0.654 . . . . 73.11 111.403 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.8 t -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.09 0.556 . . . . 73.44 110.054 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -70.44 -32.04 69.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.485 0.314 . . . . 73.05 110.452 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.07 -35.76 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.836 0.854 . . . . 74.33 110.695 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 m -61.39 -46.51 89.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.267 0.627 . . . . 62.4 110.082 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -63.81 -36.5 84.09 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.738 -1.119 . . . . 74.02 111.189 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.9 -1.25 87.11 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.389 -0.673 . . . . 33.1 113.434 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 60.4 p 55.81 30.76 16.35 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.098 1.759 . . . . 65.23 112.598 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.38 162.87 38.51 Favored Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 124.565 1.146 . . . . 61.13 110.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.11 164.02 15.46 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 123.229 2.619 . . . . 74.34 113.649 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.6 OUTLIER -65.14 111.11 2.78 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.295 -0.866 . . . . 74.4 110.585 -172.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.521 HD12 ' HZ ' ' B' ' 74' ' ' PHE . 96.1 mt -135.05 83.58 2.03 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.779 -1.193 . . . . 74.44 107.779 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -101.07 122.61 43.87 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.362 -1.348 . . . . 71.42 107.362 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 33.6 tp -66.4 133.53 50.66 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.652 0.595 . . . . 72.45 111.034 -170.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.07 143.74 94.7 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.245 1.018 . . . . 71.1 111.67 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 87.24 0.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.911 2.407 . . . . 71.52 112.423 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 63.1 t -94.89 133.89 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.45 0.7 . . . . 72.22 110.526 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.96 113.74 26.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.33 1.052 . . . . 74.34 109.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.79 -29.4 67.76 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 63.34 111.916 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.6 -34.23 67.24 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.608 0.763 . . . . 63.35 110.763 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.78 -38.23 88.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.89 -0.595 . . . . 74.2 109.717 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.53 HD11 HG12 ' E' ' 123' ' ' VAL . 2.4 tm? -64.8 -40.38 95.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.015 0.926 . . . . 74.41 109.69 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.12 -47.52 80.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.69 0.796 . . . . 72.41 110.759 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 64.4 mtt -70.45 -38.35 74.49 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.578 -0.737 . . . . 73.11 110.432 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -75.97 -18.56 59.27 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.331 0.652 . . . . 75.42 111.594 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' E' ' 122' ' ' ALA . 25.2 t80 -53.85 -46.37 71.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.602 1.161 . . . . 63.52 110.15 177.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 pp -118.96 22.23 12.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.179 -1.373 . . . . 62.02 110.596 -174.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 61.57 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.966 1.307 . . . . 72.21 111.426 -170.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -69.31 81.69 0.37 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.946 0.879 . . . . 74.21 111.239 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.31 95.06 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.53 -1.656 . . . . 51.22 106.53 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.09 157.58 36.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.101 0.96 . . . . 71.43 108.801 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.87 63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.06 -0.816 . . . . 43.42 111.06 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.0 48.75 1.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.319 1.047 . . . . 65.32 110.984 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.64 78.52 0.73 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.296 -0.722 . . . . 63.14 111.296 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.0 t -149.31 162.13 40.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.531 0.732 . . . . 71.52 109.911 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -143.07 -174.6 4.24 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.272 1.029 . . . . 72.43 108.805 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 143.41 18.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.433 -0.58 . . . . 53.11 109.433 173.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -91.84 102.23 14.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.577 -0.897 . . . . 73.24 108.577 172.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -141.32 109.37 5.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.025 0.93 . . . . 71.42 109.023 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -155.33 142.97 19.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.998 0.519 . . . . 74.14 109.712 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.39 0 O-C-N 124.606 1.191 . . . . 37.61 111.216 -178.359 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.927 -0.397 . . . . 63.41 109.927 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -155.32 26.55 0.41 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.597 1.559 . . . . 71.4 108.253 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -91.28 -25.35 19.5 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.543 1.137 . . . . 62.14 112.796 -164.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.584 ' HB3' ' HG2' ' C' ' 150' ' ' GLU . 0.5 OUTLIER -69.83 166.34 19.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 120.867 0.365 . . . . 71.34 111.194 174.263 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -128.93 -64.85 0.9 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.844 0.458 . . . . 63.31 109.954 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.99 79.87 0.21 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.17 0.988 . . . . 55.25 111.088 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.1 p -134.65 18.9 3.57 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.559 0.743 . . . . 62.23 110.529 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -104.64 78.87 1.49 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.909 0.883 . . . . 74.12 109.842 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.0 ttp 65.61 112.31 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.005 1.722 . . . . 61.05 112.105 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -86.8 86.41 7.32 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.837 -0.801 . . . . 73.02 108.837 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.441 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 67.5 t80 -89.6 128.12 35.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.396 -0.594 . . . . 70.12 109.396 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.14 132.84 22.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.302 -0.629 . . . . 75.55 109.302 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.1 134.57 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.9 -0.778 . . . . 74.41 108.9 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -105.42 -51.44 3.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.523 0.329 . . . . 63.41 110.346 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -171.09 145.85 2.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.695 0.398 . . . . 73.42 109.934 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -124.05 138.45 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.116 -1.068 . . . . 44.11 108.116 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.681 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -170.94 146.18 2.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.547 0.339 . . . . 60.41 110.103 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -69.17 128.98 38.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.87 0.468 . . . . 73.44 110.448 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -84.48 -46.26 11.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.054 0.931 . . . . 72.21 108.869 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 8.0 t70 -134.79 136.95 42.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.175 -1.375 . . . . 74.31 109.325 -173.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -134.56 139.65 47.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.289 -1.374 . . . . 71.22 107.289 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.61 143.67 25.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.56 -0.745 . . . . 75.11 109.43 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -153.37 109.25 3.29 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.074 -1.084 . . . . 75.54 108.074 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.4 136.07 53.43 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.939 0.896 . . . . 74.33 109.106 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.78 91.7 10.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.46 -0.941 . . . . 62.41 108.46 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.95 -41.83 12.77 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 75.41 112.367 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 6.0 m120 -99.09 35.53 1.88 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.171 0.588 . . . . 74.13 109.687 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -59.55 -51.54 80.41 Favored Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 118.254 -0.879 . . . . 55.03 112.941 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 37.9 Cg_exo -64.79 -33.52 53.26 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 121.783 1.656 . . . . 75.51 112.351 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.522 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -66.58 -19.5 65.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.52 1.128 . . . . 64.43 112.41 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 3.2 p -58.5 -14.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 113.043 0.757 . . . . 64.34 113.043 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -55.41 -40.66 71.72 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.06 0.944 . . . . 75.11 111.341 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -114.74 40.25 2.64 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.432 1.093 . . . . 74.11 109.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.587 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 0.0 OUTLIER -83.61 144.13 29.65 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.975 0.91 . . . . 72.41 110.721 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -88.1 113.57 23.87 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.625 -1.25 . . . . 74.15 107.625 163.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -83.47 64.02 7.64 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.839 0.828 . . . . 71.42 110.161 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.495 ' HG2' ' HB3' ' E' ' 140' ' ' SER . 74.1 mt-30 -142.44 52.58 2.47 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.977 1.311 . . . . 75.23 108.573 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.41 144.81 9.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.023 1.816 . . . . 54.25 111.697 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.585 ' HA ' HD22 ' E' ' 141' ' ' LEU . 38.5 tt0 -84.25 95.92 8.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.54 -0.911 . . . . 72.44 108.54 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' C' ' 65' ' ' THR . 16.7 m -71.76 102.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.293 -0.867 . . . . 73.13 110.565 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.1 mttt -91.97 100.2 12.9 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.159 -1.052 . . . . 65.22 108.159 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.3 163.53 16.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.347 -0.612 . . . . 42.31 109.347 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.6 t70 -156.33 146.29 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.53 -0.915 . . . . 75.13 108.53 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -133.8 117.35 16.78 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 74.22 107.757 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.78 137.57 46.85 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.02 1.328 . . . . 75.43 107.861 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.8 t -113.11 149.82 32.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.428 0.633 . . . . 64.43 110.28 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.53 162.17 28.8 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.568 -1.196 . . . . 72.53 107.995 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -135.63 151.15 49.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.282 0.633 . . . . 53.54 109.7 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.4 t -149.91 125.99 10.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.098 -1.075 . . . . 71.34 108.098 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -83.63 120.52 26.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.184 -0.673 . . . . 74.21 109.184 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -92.79 -40.81 10.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.42 0.688 . . . . 63.01 109.842 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 175.3 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.832 -1.076 . . . . 64.32 109.339 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.67 123.74 18.34 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.542 0.526 . . . . 71.13 109.76 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 68.16 2.14 3.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.055 1.342 . . . . 73.12 113.554 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.76 112.35 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.46 -0.941 . . . . 54.42 108.46 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -125.05 122.51 37.44 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.513 0.673 . . . . 74.1 109.295 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.4 tt0 -85.46 138.36 32.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.161 -1.382 . . . . 75.13 108.303 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.552 HG23 HD11 ' C' ' 106' ' ' LEU . 17.5 m -130.25 143.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.975 -0.75 . . . . 75.32 108.975 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.67 105.12 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.312 -0.995 . . . . 73.02 108.312 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.8 tm? -92.54 104.39 16.7 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.168 -1.049 . . . . 74.22 108.168 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -79.07 124.07 27.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.386 1.074 . . . . 75.41 109.385 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' C' ' 114' ' ' ILE . 22.0 t -112.84 110.22 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.596 -1.261 . . . . 73.33 107.596 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.8 m -99.21 136.57 38.97 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.904 -1.147 . . . . 71.24 107.904 176.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 114' ' ' ILE . 64.9 t -135.94 113.16 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.135 0.974 . . . . 73.13 108.74 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 21.3 m -104.06 144.35 31.67 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.658 -0.867 . . . . 71.24 108.658 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.28 104.24 5.14 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.204 -1.036 . . . . 60.34 108.204 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.464 ' HB3' HG23 ' C' ' 72' ' ' THR . 56.5 p -159.91 169.16 24.1 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.113 0.565 . . . . 74.02 109.923 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -120.73 -40.82 2.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.954 -0.758 . . . . 72.3 108.954 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.36 -97.8 0.12 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 110.799 -0.92 . . . . 51.11 110.799 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -88.08 -27.86 21.69 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.645 -0.872 . . . . 61.54 108.645 170.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.33 87.92 1.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.356 -0.838 . . . . 75.13 109.334 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 67' ' ' SER . 64.6 m -88.03 136.68 32.86 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.44 -0.8 . . . . 74.21 109.476 171.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.39 -63.95 1.28 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.633 -0.877 . . . . 60.24 108.633 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.42 177.36 9.59 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.299 1.047 . . . . 75.12 111.96 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.3 tm? -135.31 143.75 46.35 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 105.009 -2.219 . . . . 63.52 105.009 168.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.9 t -149.49 144.15 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.106 -1.072 . . . . 61.52 108.106 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -158.85 131.24 6.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.557 -0.535 . . . . 74.52 109.557 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -126.98 120.75 56.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.975 -1.011 . . . . 74.42 108.725 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -99.15 90.39 4.57 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.807 -1.183 . . . . 74.13 107.807 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.96 108.86 13.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.261 -1.336 . . . . 63.21 109.511 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 158.69 29.71 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.977 -0.556 . . . . 34.55 112.266 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.22 126.23 1.56 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.365 -0.294 . . . . 42.42 112.365 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.527 HD12 HD11 ' C' ' 51' ' ' LEU . 12.2 mm -88.4 124.62 41.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.553 -0.906 . . . . 75.14 108.553 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.76 122.5 18.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.549 0.74 . . . . 63.42 109.674 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -90.36 110.44 21.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.965 0.506 . . . . 64.3 110.093 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.76 118.68 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 108.491 -0.929 . . . . 72.22 108.491 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.75 160.44 30.81 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.472 0.709 . . . . 70.04 111.531 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.87 -61.15 3.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.48 -0.782 . . . . 73.55 112.389 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.9 mm -91.02 145.71 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.007 0.923 . . . . 71.22 110.204 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 13.1 pt-20 -147.02 -171.31 3.74 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.3 1.04 . . . . 74.34 110.258 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 73.21 -143.34 32.95 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.171 -0.468 . . . . 72.4 113.316 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.9 p -66.84 -23.18 66.0 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.93 0.892 . . . . 73.33 111.914 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -71.06 -44.09 66.48 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.605 0.762 . . . . 63.12 110.994 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.495 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 21.6 ptt? -71.91 -32.96 67.89 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.447 -0.575 . . . . 65.24 109.447 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.15 -27.21 67.85 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.26 0.624 . . . . 44.15 110.989 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -73.42 -38.66 65.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.529 0.732 . . . . 75.0 110.411 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -67.97 -61.51 1.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.405 0.282 . . . . 73.51 111.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -76.3 -16.55 59.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.125 0.57 . . . . 74.22 112.142 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.96 -24.02 23.81 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.768 -0.462 . . . . 70.41 113.352 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.43 -59.05 1.1 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.393 0.596 . . . . 64.45 111.819 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -60.42 -57.27 13.46 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.74 0.816 . . . . 72.24 111.967 -172.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 47.4 m -62.05 -47.7 90.14 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 115.312 -0.858 . . . . 74.44 112.17 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.594 ' HB3' HD23 ' C' ' 60' ' ' LEU . 89.8 Cg_exo -54.03 -35.67 81.91 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.85 2.366 . . . . 75.55 114.594 169.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -21.16 60.1 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.09 0.556 . . . . 75.22 111.368 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.513 HD12 HH12 ' A' ' 111' ' ' ARG . 21.8 mm -77.48 -35.05 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.464 0.706 . . . . 75.23 109.945 171.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.552 HD11 HG23 ' C' ' 58' ' ' VAL . 98.8 mt -76.45 -38.77 54.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.222 0.609 . . . . 74.55 111.992 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.14 -41.35 74.15 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 124.359 1.063 . . . . 72.55 113.333 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.63 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 39.7 Cg_exo -43.9 -55.21 3.21 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.643 2.229 . . . . 75.14 115.883 168.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.19 -30.63 71.13 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.328 0.585 . . . . 72.24 110.343 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.6 73.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.093 -0.958 . . . . 71.13 111.274 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.481 ' HD3' ' CZ ' ' A' ' 109' ' ' TYR . 22.3 ttt180 -56.43 -51.76 67.18 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.492 0.717 . . . . 75.25 110.982 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.75 -31.32 69.23 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.451 0.47 . . . . 74.41 110.667 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.427 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 7.1 t -69.25 -28.11 66.03 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.664 0.386 . . . . 63.31 111.245 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.491 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.2 mt -79.17 -50.1 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.402 0.681 . . . . 74.02 110.141 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -65.55 -29.33 69.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.866 0.467 . . . . 61.53 111.353 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -63.98 -52.25 60.51 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.287 -0.634 . . . . 71.55 109.287 172.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.473 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.66 -40.69 75.93 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.629 1.172 . . . . 75.3 112.468 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 114' ' ' ILE . 78.6 t -65.75 -43.4 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.555 0.742 . . . . 74.14 110.383 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.418 ' HB2' HE22 ' C' ' 125' ' ' GLN . 37.9 t -69.6 -25.0 63.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.786 -0.643 . . . . 64.44 111.451 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.2 mtt-85 -72.03 -34.37 68.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.3 0.64 . . . . 74.24 109.994 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.67 6.34 74.15 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.618 0.574 . . . . 74.2 113.146 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.584 HG23 ' HB3' ' D' ' 17' ' ' TYR . 44.4 p 65.28 22.23 12.08 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.722 2.009 . . . . 73.45 113.268 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -84.52 162.12 51.77 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.84 0.856 . . . . 71.22 110.415 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.479 ' HD3' HG13 ' E' ' 136' ' ' VAL . 36.7 Cg_endo -64.06 151.05 86.98 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.657 2.238 . . . . 61.42 113.074 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.418 HE22 ' HB2' ' C' ' 119' ' ' SER . 24.4 mm-40 -60.26 112.36 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.965 0.906 . . . . 62.33 112.036 -172.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.61 90.35 3.28 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.346 0.658 . . . . 75.02 110.089 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.47 118.49 31.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.491 0.716 . . . . 74.34 109.937 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.458 ' O ' ' HD2' ' C' ' 111' ' ' ARG . 3.0 mm? -87.19 135.07 33.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.985 0.914 . . . . 73.01 109.233 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 141.86 87.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.451 0.7 . . . . 75.11 111.153 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HB3' ' HE2' ' A' ' 109' ' ' TYR . 38.5 Cg_endo -65.65 125.72 14.84 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.4 2.067 . . . . 63.0 111.302 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.43 114.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.526 -0.916 . . . . 71.13 108.526 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.642 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -77.61 75.22 4.16 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.005 0.922 . . . . 72.22 109.958 -177.39 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.55 -43.61 18.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.733 0.413 . . . . 72.21 110.188 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.95 -45.66 60.26 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.958 -0.565 . . . . 74.03 110.015 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -63.74 -20.7 65.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.83 -1.077 . . . . 75.24 111.984 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 28.8 tp -64.22 -37.51 87.73 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.62 0.768 . . . . 75.13 110.765 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -79.92 -31.3 40.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.059 0.544 . . . . 64.22 110.728 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.528 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 85.4 mtp -64.21 -44.03 93.2 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.083 0.553 . . . . 55.04 111.739 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -68.39 -34.65 76.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.085 0.241 . . . . 73.3 110.436 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -63.99 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.903 0.881 . . . . 73.01 110.954 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 57.3 tp -142.17 95.19 2.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.017 0.527 . . . . 73.33 109.677 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.528 ' HB3' ' HA ' ' C' ' 138' ' ' MET . 53.9 tt0 -170.32 112.55 0.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.956 0.903 . . . . 52.31 109.129 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.92 7.3 3.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.754 0.821 . . . . 44.31 111.005 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -83.05 175.81 9.72 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.893 0.877 . . . . 73.53 111.127 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.74 82.98 0.17 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.375 1.07 . . . . 74.13 110.423 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.7 -34.7 0.02 OUTLIER Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.366 -0.834 . . . . 73.32 111.749 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -83.43 112.72 20.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.16 -1.052 . . . . 70.1 108.16 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.37 -162.53 10.37 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.585 -0.734 . . . . 44.01 111.758 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.5 t -72.81 82.84 1.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.697 0.76 . . . . 65.04 109.896 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.584 ' HG2' ' HB3' ' C' ' 4' ' ' GLN . 11.7 pt-20 -70.46 -31.56 68.77 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.12 -0.946 . . . . 71.25 110.93 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' C' ' 150' ' ' GLU . 1.8 pp20? -135.69 144.28 45.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.854 0.862 . . . . 72.3 109.72 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 177.5 116.29 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 72.35 108.048 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -78.31 145.39 35.36 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.918 -0.771 . . . . 50.3 108.918 168.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.96 95.81 0.06 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.312 1.045 . . . . 75.23 111.482 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.885 0 C-N-CA 124.054 0.941 . . . . 53.12 109.779 -175.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.324 -0.621 . . . . 74.3 109.324 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m -149.88 90.97 1.74 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.066 0.947 . . . . 63.32 108.907 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.9 118.42 36.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.24 -1.393 . . . . 52.15 107.24 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -68.17 119.23 12.42 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 74.24 110.717 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -76.43 104.88 7.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.075 -1.454 . . . . 71.42 107.075 164.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.32 87.76 0.12 Allowed 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.617 0.722 . . . . 74.42 109.493 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -128.71 170.11 13.68 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 125.21 1.404 . . . . 71.14 108.124 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.48 83.37 0.82 Allowed 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.342 -0.614 . . . . 63.32 109.342 172.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.486 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm -32.18 129.99 0.17 Allowed 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.316 1.446 . . . . 44.21 112.664 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 32.7 m -115.36 143.08 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.782 0.433 . . . . 74.14 109.868 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.8 t80 -157.14 94.67 1.43 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.636 -1.246 . . . . 65.2 107.636 171.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -112.95 121.47 44.75 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.641 -0.709 . . . . 72.1 109.351 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.88 99.65 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 106.974 -1.491 . . . . 51.44 106.974 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -79.17 -46.92 16.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.682 -0.236 . . . . 73.1 110.915 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.496 ' HD3' HD12 ' D' ' 83' ' ' ILE . 43.4 ttt180 -169.04 131.66 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.213 -0.449 . . . . 61.04 111.964 -161.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.7 138.5 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.772 -1.195 . . . . 63.3 107.772 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' C' ' 122' ' ' THR . 10.1 p90 -164.76 177.3 8.07 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 121.872 0.844 . . . . 71.45 111.212 -176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -109.69 118.46 36.6 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.351 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.7 mtpt -88.57 -23.96 22.99 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.624 -0.51 . . . . 73.43 109.624 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.8 t70 -156.84 130.43 8.14 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.95 -1.023 . . . . 73.03 109.228 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.6 mt -128.09 135.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.261 1.024 . . . . 74.04 108.292 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -134.83 137.48 43.35 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.082 0.953 . . . . 70.13 108.473 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -149.5 120.55 7.72 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.318 -1.364 . . . . 72.43 107.318 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 1.8 mp0 -120.41 137.65 54.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.993 -0.743 . . . . 75.02 108.993 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.41 81.07 37.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.32 -0.993 . . . . 62.13 108.32 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.3 -44.1 0.33 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.753 2.302 . . . . 71.11 112.764 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' D' ' 72' ' ' THR . 81.4 m-20 -100.87 44.36 1.02 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.217 1.007 . . . . 64.34 108.637 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.681 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.74 -53.57 63.05 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 114.118 -1.401 . . . . 75.33 114.471 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.72 6.65 5.46 Favored 'Trans proline' 0 C--N 1.392 2.868 0 CA-C-N 121.972 1.74 . . . . 65.4 112.662 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.432 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 4.9 t-160 -85.06 -46.23 11.35 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.32 1.048 . . . . 65.24 109.323 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.88 -16.98 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.169 0.509 . . . . 72.11 110.699 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -56.54 -30.23 62.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.734 1.214 . . . . 75.14 111.854 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -82.7 -16.4 48.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.71 0.804 . . . . 72.03 111.056 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.612 ' HB3' HD23 ' D' ' 68' ' ' LEU . 85.7 mttt -109.53 112.41 24.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.005 0.922 . . . . 73.04 111.537 -173.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.416 ' HA ' HD11 ' F' ' 139' ' ' LEU . 3.8 m-20 -99.91 71.65 1.67 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.812 0.845 . . . . 62.41 110.873 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -164.57 158.85 18.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.083 -0.71 . . . . 74.51 109.083 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.505 ' HB3' HD12 ' F' ' 141' ' ' LEU . 26.9 tp60 -62.02 114.09 10.46 Favored Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.075 0.55 . . . . 54.24 111.436 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.614 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 43.6 Cg_exo -60.06 114.82 2.26 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 121.972 1.781 . . . . 64.42 109.647 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.31 121.66 10.69 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.207 0.942 . . . . 71.51 109.897 -174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -96.67 112.32 28.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.375 -0.829 . . . . 55.3 110.292 -168.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.599 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 63.0 tttt -87.07 142.02 28.23 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.922 -1.14 . . . . 72.03 107.922 167.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.39 139.88 49.12 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 9.2 t70 -141.9 149.1 39.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.725 -1.213 . . . . 74.42 107.725 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.29 166.32 24.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.053 0.541 . . . . 65.25 110.971 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.5 t70 -170.18 156.11 5.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.766 1.227 . . . . 70.33 108.033 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.1 t -135.08 161.18 36.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.061 0.545 . . . . 64.22 109.828 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.93 163.47 38.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.831 0.852 . . . . 62.31 109.076 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -148.93 153.48 38.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.138 0.575 . . . . 53.13 110.092 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -159.77 121.64 3.3 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.464 0.706 . . . . 52.45 109.366 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.5 124.88 26.11 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.134 -0.691 . . . . 71.43 109.134 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.6 mt -94.08 -33.69 13.28 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.799 0.44 . . . . 73.32 110.423 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.46 -172.02 2.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.002 -0.999 . . . . 73.12 110.595 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.1 116.42 6.48 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.804 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 10.1 m-20 63.32 19.29 11.6 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 73.24 112.068 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -119.53 120.5 63.71 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -130.4 129.38 42.99 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.881 -0.785 . . . . 65.22 108.881 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' D' ' 51' ' ' LEU . 10.3 tm-20 -100.8 137.45 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.801 -1.185 . . . . 74.35 107.801 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.525 HG11 ' HB3' ' D' ' 102' ' ' CYS . 4.2 p -127.17 134.17 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.673 -0.862 . . . . 75.53 108.673 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 80.3 t -106.08 131.08 56.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.153 0.581 . . . . 44.12 109.756 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -107.38 120.97 43.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.808 -1.553 . . . . 65.21 106.808 174.224 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.6 ttm-85 -105.39 107.36 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.711 -0.848 . . . . 73.22 108.711 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.4 t -107.44 124.29 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.052 0.941 . . . . 64.32 108.662 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 8.8 m -125.04 130.66 52.76 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.235 0.614 . . . . 72.34 110.124 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.64 107.45 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.382 1.073 . . . . 74.03 109.104 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.0 m -103.19 96.92 7.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.262 0.625 . . . . 73.44 109.583 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.18 124.73 41.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.972 -0.751 . . . . 72.43 108.972 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 69.5 m -147.31 130.48 16.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.673 0.789 . . . . 53.23 109.419 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' D' ' 34' ' ' LYS . 35.7 tp -116.81 121.8 42.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.355 -0.609 . . . . 43.22 109.355 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 -113.66 4.24 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.576 -0.609 . . . . 64.34 111.576 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.29 2.42 8.48 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.318 0.647 . . . . 63.45 110.944 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -115.46 150.96 35.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.045 0.538 . . . . 71.1 110.618 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 94.3 m -69.45 120.68 15.61 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 114.586 -1.188 . . . . 71.44 110.205 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.4 -59.64 2.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 122.941 0.496 . . . . 74.34 109.664 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.31 152.61 26.22 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.394 -0.821 . . . . 72.45 110.454 172.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -124.29 153.34 41.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.562 1.145 . . . . 75.31 109.823 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -158.31 146.17 18.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.64 -0.709 . . . . 72.0 110.356 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.88 132.11 11.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.8 -0.815 . . . . 72.41 108.8 172.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.59 124.24 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 122.744 0.418 . . . . 74.05 109.994 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.593 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 40.5 mt-30 -88.97 85.09 6.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.767 -0.827 . . . . 73.33 108.767 166.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.83 96.79 6.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.203 -1.362 . . . . 74.41 108.593 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.06 155.95 24.0 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.302 -0.408 . . . . 52.2 112.179 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.567 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -153.21 133.77 4.15 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.645 0.223 . . . . 71.21 112.683 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.496 HD12 ' HD3' ' D' ' 15' ' ' ARG . 68.5 mt -89.24 126.0 42.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 C-N-CA 124.067 0.947 . . . . 70.45 109.502 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.96 138.44 46.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.411 0.685 . . . . 75.02 109.835 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.9 m -91.66 100.15 12.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.472 0.709 . . . . 75.13 109.502 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.1 116.69 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.638 0.775 . . . . 55.03 110.384 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -147.67 162.5 39.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.228 1.011 . . . . 52.11 110.801 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.49 -20.19 6.36 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 114.879 0.712 . . . . 71.33 114.879 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -114.51 157.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.054 0.942 . . . . 72.23 110.493 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.24 -174.55 4.99 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.692 0.797 . . . . 63.44 110.84 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.67 -133.85 51.48 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.717 0.636 . . . . 74.03 113.711 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -73.9 -22.54 59.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.307 0.643 . . . . 73.53 110.722 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.34 -41.06 73.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.806 0.842 . . . . 72.4 111.041 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -75.12 -30.43 60.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.995 -0.372 . . . . 60.31 109.995 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.4 63.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.241 0.616 . . . . 64.53 110.949 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -79.45 -44.13 21.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.898 0.879 . . . . 73.22 110.693 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.8 t -66.5 -48.91 68.29 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.173 -0.467 . . . . 54.24 110.92 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.01 -39.5 25.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.693 0.797 . . . . 64.33 109.812 -176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -27.58 35.66 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.69 -0.505 . . . . 74.42 114.251 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.88 -53.2 2.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.852 0.826 . . . . 61.2 111.391 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -74.09 -44.97 52.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.546 0.573 . . . . 64.53 112.546 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.525 ' HB3' HG11 ' D' ' 58' ' ' VAL . 72.4 m -63.48 -46.48 84.02 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.417 -0.801 . . . . 63.34 112.499 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 31.9 Cg_exo -64.23 -30.07 64.36 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 122.12 1.88 . . . . 70.32 112.862 171.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.84 -31.36 71.92 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.334 0.654 . . . . 74.0 110.363 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -69.95 -42.83 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.501 0.721 . . . . 75.21 109.974 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.567 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -74.42 -18.47 60.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.87 -0.605 . . . . 71.44 111.72 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -68.26 -42.76 31.14 Favored Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 114.314 1.227 . . . . 73.23 114.314 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.66 -32.1 96.12 Favored 'Trans proline' 0 C--N 1.383 2.358 0 CA-C-N 121.627 1.617 . . . . 71.44 112.871 171.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -81.45 -30.06 33.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.386 0.674 . . . . 73.0 110.995 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.49 -53.98 43.62 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.641 -0.874 . . . . 72.3 108.641 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.12 -50.09 65.19 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 113.91 -1.495 . . . . 73.42 110.981 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.92 -44.17 93.72 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.924 0.765 . . . . 53.11 111.661 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 -41.47 86.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.567 0.542 . . . . 54.05 110.761 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.511 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.0 mt -66.26 -53.81 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.093 -0.958 . . . . 63.3 110.21 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.515 HG23 ' HG3' ' D' ' 125' ' ' GLN . 37.5 m -54.46 -38.35 66.29 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.771 1.228 . . . . 53.11 111.765 -176.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -70.19 -46.23 65.03 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.356 -0.838 . . . . 53.42 110.805 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.4 mtm -63.42 -33.07 74.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.782 0.433 . . . . 75.42 111.74 176.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' D' ' 123' ' ' PHE . 39.6 t -68.2 -40.66 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.922 -1.035 . . . . 60.13 110.225 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -76.08 -22.91 55.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.263 0.225 . . . . 65.04 111.335 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.427 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 85.1 mtt-85 -76.85 -33.08 57.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.503 0.721 . . . . 74.33 109.487 173.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 0.84 88.49 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 115.43 -0.804 . . . . 65.14 112.079 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 61.54 17.86 8.91 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.921 2.088 . . . . 71.31 113.417 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.52 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 30.1 m-85 -82.94 168.97 19.37 Favored Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.615 1.566 . . . . 75.4 110.634 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 52.5 Cg_endo -64.17 135.7 48.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.007 2.471 . . . . 60.22 113.135 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.515 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.2 tt0 -55.21 131.5 45.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.895 0.878 . . . . 64.32 111.778 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.88 97.62 7.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.92 0.888 . . . . 64.24 108.722 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -97.44 86.9 3.98 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.336 -0.987 . . . . 74.51 108.336 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.58 123.3 18.45 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.806 -1.088 . . . . 74.21 109.489 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.73 131.66 86.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 O-C-N 123.727 0.642 . . . . 75.23 110.768 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.37 115.36 3.3 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 121.966 1.777 . . . . 61.23 111.329 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.45 108.93 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.31 -0.626 . . . . 70.24 109.31 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' D' ' 134' ' ' ASP . 18.6 t-20 -84.99 103.74 14.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.297 -0.865 . . . . 61.12 109.046 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -73.24 -22.36 60.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.393 -0.821 . . . . 75.02 111.173 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.515 ' HB2' HD21 ' D' ' 132' ' ' ASN . 20.9 m-20 -58.01 -54.48 46.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.69 1.196 . . . . 63.35 112.477 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.79 84.73 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.967 0.792 . . . . 72.41 111.865 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 40.5 tp -73.57 -43.52 59.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.791 0.837 . . . . 70.53 110.976 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.52 -29.38 64.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.488 0.715 . . . . 74.35 110.715 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 34.7 ttm -60.18 -27.15 66.89 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.567 1.147 . . . . 52.03 111.89 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -72.63 -30.49 64.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.727 0.811 . . . . 73.41 111.535 178.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.39 -31.63 72.33 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.004 0.922 . . . . 70.32 111.383 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.36 -27.36 68.46 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.647 0.779 . . . . 71.14 111.195 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -89.39 0.62 56.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.432 0.693 . . . . 54.4 111.625 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.02 51.08 2.15 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 73.3 110.0 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -141.99 124.53 15.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.358 0.599 . . . . 71.32 109.967 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.96 148.8 10.4 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.556 1.142 . . . . 63.02 108.547 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.75 120.63 3.07 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.025 -0.43 . . . . 22.12 112.025 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.56 74.94 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.987 -1.116 . . . . 43.52 107.987 172.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.43 140.36 21.89 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.34 -0.845 . . . . 30.44 112.307 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -134.3 174.33 10.63 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.505 0.722 . . . . 52.23 110.288 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.1 153.89 37.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.691 0.796 . . . . 65.51 109.832 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.04 134.25 34.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.582 0.753 . . . . 74.15 109.471 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -115.41 114.22 24.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.276 -1.009 . . . . 55.42 108.276 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -81.11 64.64 5.93 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.659 0.743 . . . . 71.21 110.183 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.57 116.32 22.53 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.387 -0.824 . . . . 71.14 110.023 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.077 0.951 . . . . 73.42 109.203 -175.309 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.614 0.245 . . . . 74.22 110.415 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.05 123.0 28.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.062 -0.517 . . . . 71.21 110.571 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.27 104.9 3.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.236 1.014 . . . . 44.14 108.601 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -126.76 128.67 46.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 75.32 110.566 -172.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -71.27 133.79 46.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.958 -0.756 . . . . 75.21 108.958 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -158.57 -83.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.137 -0.32 . . . . 74.32 110.137 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -149.31 -177.13 5.67 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.132 0.973 . . . . 70.02 110.334 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.47 ' HG ' ' HG3' ' B' ' 94' ' ' MET . 6.7 mp -83.69 71.81 10.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.776 0.83 . . . . 73.21 109.916 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -146.97 156.35 47.37 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.414 1.085 . . . . 71.45 109.705 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.29 133.34 40.02 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 121.995 1.796 . . . . 75.12 111.102 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -68.38 -150.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.393 1.077 . . . . 74.42 111.308 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 39.8 m -45.38 -56.9 4.47 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.513 1.125 . . . . 75.11 113.092 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 73.55 -27.59 0.19 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.934 1.294 . . . . 65.03 112.97 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.1 81.6 1.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.087 0.955 . . . . 62.21 110.072 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 122' ' ' ALA . . . . . 0.405 ' HB3' ' CE1' ' B' ' 140' ' ' TYR . . . -168.4 17.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.113 1.365 . . . . 75.34 109.814 174.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 123' ' ' VAL . . . . . 0.53 HG12 HD11 ' B' ' 136' ' ' LEU . 11.7 m -70.87 76.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.908 0.883 . . . . 54.43 110.715 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -63.15 -38.17 90.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.159 -0.928 . . . . 73.44 111.461 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.67 -148.63 0.48 Allowed 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.408 1.068 . . . . 72.45 110.467 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 67.48 170.09 0.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.886 0.874 . . . . 75.1 111.452 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.05 -114.78 3.5 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.439 -0.664 . . . . 41.22 111.439 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -103.28 66.7 0.9 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.822 0.82 . . . . 51.11 109.961 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.16 -54.55 3.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.09 0.956 . . . . 70.43 109.277 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.87 73.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.59 -1.263 . . . . 72.14 107.59 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.93 82.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.427 -1.26 . . . . 55.2 111.743 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -133.17 142.43 44.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.853 . . . . 64.25 109.993 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -89.07 25.67 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.241 2.627 . . . . 65.54 113.104 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 19.2 pt -64.18 127.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.798 0.839 . . . . 61.51 110.636 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.28 59.03 4.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.055 0.942 . . . . 75.52 111.681 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.479 HG13 ' HD3' ' C' ' 124' ' ' PRO . 14.3 t -91.51 58.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 108.043 -1.095 . . . . 72.15 108.043 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.74 -44.59 2.93 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.225 -0.898 . . . . 74.44 111.324 -170.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.06 36.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.476 0.711 . . . . 75.21 110.463 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 mp -86.41 117.23 25.07 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.297 -1.001 . . . . 74.22 108.297 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 140' ' ' SER . . . . . 0.495 ' HB3' ' HG2' ' C' ' 37' ' ' GLN . 45.4 t -63.82 -36.69 84.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.929 0.492 . . . . 71.11 111.094 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 141' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' C' ' 39' ' ' GLU . 3.7 tt -104.18 110.59 22.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.079 -1.082 . . . . 61.52 108.079 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 7.5 tt -167.46 117.89 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.891 0.876 . . . . 74.03 110.155 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 61.41 160.36 0.06 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.736 1.215 . . . . 74.2 114.075 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -159.26 64.79 0.39 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.617 -1.174 . . . . 61.42 108.364 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt 69.55 -2.31 1.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.045 1.338 . . . . 70.51 112.705 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.78 25.65 1.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.562 0.745 . . . . 63.23 111.83 -173.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 147' ' ' LEU . . . . . 0.448 HD12 ' N ' ' E' ' 148' ' ' LEU . 3.4 pp -62.19 -31.62 72.16 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.986 0.514 . . . . 75.04 110.877 169.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.448 ' N ' HD12 ' E' ' 147' ' ' LEU . 39.8 tp -169.69 87.82 0.57 Allowed Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.093 1.357 . . . . 75.41 107.523 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 CA--C 1.563 1.954 0 C-N-CA 122.681 2.254 . . . . 51.35 112.34 178.318 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.118 -0.697 . . . . 74.51 109.118 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -69.22 -54.6 13.92 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.551 0.532 . . . . 74.03 111.095 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 53.82 57.29 6.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 122.014 0.911 . . . . 73.43 111.24 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -91.61 12.11 22.11 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.966 -1.015 . . . . 74.3 112.939 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.94 -59.59 5.02 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.369 0.667 . . . . 75.15 110.976 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -169.1 112.46 0.53 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.914 0.886 . . . . 73.14 109.311 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -160.81 176.3 11.63 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.706 0.802 . . . . 74.4 109.728 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.817 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 8.8 mp 61.0 45.55 9.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.425 1.09 . . . . 62.34 112.116 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -140.19 114.7 7.64 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 107.946 -1.131 . . . . 74.4 107.946 167.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 117' ' ' PRO . . . . . 0.507 ' HD3' HD21 ' A' ' 98' ' ' LEU . 16.8 Cg_endo -99.91 -162.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.769 2.979 . . . . 71.51 114.369 -169.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -62.61 155.89 24.85 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.6 -1.182 . . . . 73.41 110.589 167.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 10.0 t -77.48 -19.97 55.11 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.574 0.35 . . . . 73.14 111.308 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 25.9 t90 69.43 -68.75 0.18 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.132 1.373 . . . . 74.53 111.388 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 t70 69.48 87.48 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.131 . . . . 72.24 110.894 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.61 103.36 0.1 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 24.14 109.178 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.6 107.77 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.442 0.697 . . . . 72.24 110.099 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 124' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' F' ' 124' ' ' ARG . 4.0 tpm_? -106.03 85.72 2.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.762 -1.199 . . . . 73.35 107.762 172.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -115.75 143.3 45.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.763 0.825 . . . . 74.12 109.452 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -128.78 144.61 51.21 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.56 0.744 . . . . 71.44 109.635 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 127' ' ' GLY . . . . . 0.433 ' HA3' HD21 ' A' ' 42' ' ' LEU . . . -148.12 21.39 1.41 Allowed Glycine 0 C--N 1.347 1.156 0 O-C-N 123.235 0.334 . . . . 71.44 113.222 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.28 65.96 8.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.976 0.894 . . . . 75.31 108.776 176.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' F' ' 129' ' ' LEU . 3.7 pp -102.18 -14.96 16.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.304 -1.316 . . . . 73.43 110.782 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 13.9 tt -66.03 88.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-O 122.863 1.316 . . . . 73.11 109.693 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -137.08 -41.34 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.931 -1.486 . . . . 73.35 109.425 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -62.79 108.93 1.94 Allowed Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 123.65 0.78 . . . . 71.52 111.087 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.04 111.75 2.74 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.697 2.264 . . . . 74.15 111.109 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 6.0 tp -167.63 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 122.364 1.078 . . . . 64.32 108.853 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.712 ' HB1' ' HE1' ' A' ' 36' ' ' TRP . . . -78.99 112.38 16.13 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.059 -1.089 . . . . 73.32 108.059 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.507 ' HA ' HD13 ' F' ' 139' ' ' LEU . 16.2 t -72.83 -8.15 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 124.355 1.062 . . . . 71.21 110.641 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -69.61 -32.92 71.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.444 1.497 . . . . 73.41 111.074 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.86 -27.38 66.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.265 0.626 . . . . 53.12 110.274 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' F' ' 136' ' ' VAL . 7.0 mp -80.16 2.08 25.63 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.483 -0.78 . . . . 71.31 111.836 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.4 m -110.3 105.68 14.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.206 0.603 . . . . 62.34 110.365 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 141' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' D' ' 37' ' ' GLN . 80.0 mt -130.78 -49.7 1.04 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.248 1.019 . . . . 64.24 108.894 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm 67.48 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 125.396 1.478 . . . . 71.22 112.526 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -55.05 145.06 21.63 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.746 1.218 . . . . 75.33 112.074 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -157.06 127.18 6.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.96 0.504 . . . . 75.45 110.36 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 145' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' F' ' 145' ' ' LYS . 6.0 mmpt? -144.19 -46.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.197 0.999 . . . . 73.03 109.715 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -138.05 -59.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.189 -1.041 . . . . 73.13 108.189 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 62.4 mt 65.05 22.6 12.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.997 1.319 . . . . 54.41 111.434 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 8.1 mp 55.17 74.68 0.69 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.864 1.266 . . . . 74.01 111.114 -174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.379 2.155 0 C-N-CA 122.771 2.314 . . . . 62.13 112.858 -178.686 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.461 -0.57 . . . . 63.2 109.461 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.453 ' HB3' HE22 ' A' ' 4' ' ' GLN . 38.7 m -150.02 91.25 1.76 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.128 0.571 . . . . 53.31 110.104 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.52 92.24 3.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.725 0.81 . . . . 75.33 109.101 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.453 HE22 ' HB3' ' A' ' 2' ' ' SER . 0.1 OUTLIER -136.83 144.03 43.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.055 0.942 . . . . 64.34 109.017 177.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.13 72.08 10.14 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.675 0.75 . . . . 75.3 110.199 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -93.88 -166.69 1.55 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.014 -0.994 . . . . 54.34 110.059 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.431 HG23 ' SD ' ' A' ' 9' ' ' MET . 8.8 t -62.64 154.95 27.59 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.364 0.666 . . . . 71.33 111.495 176.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -91.46 130.19 37.33 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.541 -0.754 . . . . 72.1 108.998 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.431 ' SD ' HG23 ' A' ' 7' ' ' THR . 3.6 mpp? -98.62 137.86 36.65 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.072 -0.714 . . . . 72.45 109.072 175.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.9 m -140.24 130.06 24.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 72.42 109.24 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' HG22 ' A' ' 86' ' ' ILE . 49.0 m-85 -136.35 112.14 9.48 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.291 -1.374 . . . . 75.04 107.291 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -132.77 134.44 44.72 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.042 0.537 . . . . 65.22 110.702 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.699 ' HB ' HD13 ' E' ' 147' ' ' LEU . 3.3 mp -86.25 97.09 5.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 106.448 -1.686 . . . . 73.31 106.448 167.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -72.83 -40.2 65.97 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.216 0.606 . . . . 71.32 109.912 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -165.31 140.93 5.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.745 -0.835 . . . . 73.42 108.745 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.13 137.96 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.646 -0.872 . . . . 65.13 108.646 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -171.69 170.97 5.44 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.808 0.693 . . . . 72.01 111.195 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -91.06 117.95 30.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.446 -0.797 . . . . 71.35 109.213 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 34.4 mtpt -80.54 -28.84 37.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 110.04 -0.356 . . . . 63.1 110.04 172.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.3 t70 -149.13 142.16 24.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.582 -0.735 . . . . 62.42 110.301 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG23 ' SD ' ' A' ' 117' ' ' MET . 59.0 mt -134.66 136.18 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.29 -1.374 . . . . 74.52 107.29 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -142.98 129.7 20.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.461 -0.94 . . . . 72.35 108.461 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 89.3 t80 -144.36 122.53 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.375 -1.343 . . . . 63.4 107.375 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.63 143.69 51.14 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.148 -0.686 . . . . 72.4 109.148 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.22 73.98 63.05 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.503 -1.295 . . . . 64.2 107.503 171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.42 -32.03 20.84 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.588 2.192 . . . . 74.15 111.204 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' VAL . 86.5 m-20 -103.92 30.6 5.03 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.699 -1.137 . . . . 75.13 109.768 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -55.71 -46.53 99.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.578 -0.725 . . . . 61.22 112.7 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 38.4 Cg_exo -61.46 -28.28 83.43 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 121.828 1.686 . . . . 71.25 112.98 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -74.21 -32.92 63.22 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 116.038 -0.528 . . . . 71.21 110.448 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 27' ' ' ASN . 55.1 t -63.51 -27.54 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.511 0.596 . . . . 55.34 111.659 -176.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -71.09 -39.66 72.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.417 0.687 . . . . 75.31 111.591 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.77 -38.29 14.79 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.383 0.673 . . . . 71.31 111.125 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HB3' HD11 ' A' ' 68' ' ' LEU . 13.6 mmmm -82.03 157.81 24.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 62.44 109.243 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.43 ' O ' HD13 ' A' ' 68' ' ' LEU . 22.6 m-20 -71.77 118.03 14.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.762 0.425 . . . . 75.5 110.572 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -75.66 76.96 2.65 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.484 1.135 . . . . 75.02 110.374 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -136.99 82.67 30.15 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.182 -1.414 . . . . 74.43 107.182 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -87.11 155.8 8.35 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.53 2.153 . . . . 65.04 113.049 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.3 124.04 41.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.716 -1.216 . . . . 72.21 107.716 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 92.52 2.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 109.129 -0.693 . . . . 73.44 109.129 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.3 tttt -87.29 139.43 30.57 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.66 -1.237 . . . . 74.11 107.66 169.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 pt? -139.1 151.23 46.54 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.056 0.542 . . . . 74.04 109.959 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -131.15 136.08 48.01 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.421 0.688 . . . . 70.34 109.767 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.0 tp -103.91 128.78 51.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.057 0.943 . . . . 65.43 109.495 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 14.7 t70 -146.23 139.32 25.74 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.878 -0.786 . . . . 75.31 108.878 170.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.1 m -144.89 134.18 22.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.301 1.041 . . . . 74.52 109.124 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.501 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -159.66 133.09 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.635 0.374 . . . . 64.54 110.238 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 58' ' ' VAL . 59.9 p -91.38 177.06 6.34 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.29 0.636 . . . . 73.54 110.828 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.559 ' HA ' ' HD2' ' F' ' 114' ' ' LYS . 34.4 t -166.61 116.76 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.195 -0.669 . . . . 62.22 109.195 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -69.62 104.91 2.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.407 0.442 . . . . 75.42 109.968 -173.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 57' ' ' GLU . 49.7 mt -78.69 -37.27 42.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.659 0.784 . . . . 43.14 111.086 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.86 -173.5 4.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.648 0.779 . . . . 72.53 109.532 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.71 97.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.325 0.65 . . . . 75.14 111.166 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 6.0 m-20 60.1 31.01 20.41 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.47 1.108 . . . . 61.05 112.173 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.26 120.63 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.009 -1.478 . . . . 74.43 107.009 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.83 130.49 41.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.503 -0.925 . . . . 72.53 108.503 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.3 tt0 -86.13 117.98 25.3 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.86 -0.793 . . . . 72.43 108.86 171.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 48' ' ' SER . 47.2 t -98.73 118.64 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 107.406 -1.331 . . . . 73.13 107.406 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.513 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 36.2 t -102.45 131.47 50.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.4 -0.593 . . . . 54.44 109.4 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.59 115.1 29.76 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.197 -1.408 . . . . 75.32 107.197 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.666 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -89.89 100.88 13.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.002 -1.481 . . . . 74.41 107.002 172.295 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.53 124.36 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.14 -1.059 . . . . 65.24 108.14 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 13.5 m -112.22 138.9 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.413 -0.958 . . . . 44.12 108.413 172.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.1 t -133.63 107.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.893 1.277 . . . . 75.13 107.673 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 43.4 m -103.66 136.89 42.51 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.961 -0.755 . . . . 65.21 108.961 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.79 23.67 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.406 0.682 . . . . 73.51 109.364 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.3 m -143.22 142.73 31.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.421 0.688 . . . . 71.02 110.36 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.07 78.73 2.11 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 169.076 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.43 -99.31 1.08 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.647 -0.706 . . . . 73.54 112.287 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.41 -28.24 21.04 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.644 0.778 . . . . 74.24 110.834 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.561 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 5.4 tp10 -94.73 132.18 39.76 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.273 -0.64 . . . . 72.15 109.273 -174.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -82.4 130.82 35.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.203 -0.665 . . . . 73.4 109.203 170.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.92 -59.93 2.54 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.447 -0.945 . . . . 60.44 108.447 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -168.51 174.92 6.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.675 -1.148 . . . . 72.25 110.779 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 tp -132.12 144.87 51.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.551 1.141 . . . . 54.12 109.277 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.588 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.2 m -137.99 140.14 40.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.385 1.074 . . . . 64.24 109.477 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -149.32 130.32 14.38 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.46 -0.57 . . . . 71.13 109.46 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.18 110.79 18.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.689 0.796 . . . . 72.33 108.922 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -86.75 85.17 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.085 -0.962 . . . . 72.32 108.887 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD22 ' A' ' 106' ' ' LEU . 60.7 tp60 -79.08 96.52 5.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.478 -1.237 . . . . 74.13 108.728 -177.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.14 142.86 16.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.333 -0.707 . . . . 75.43 111.333 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.14 126.4 3.35 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 110.411 -1.076 . . . . 65.54 110.411 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.79 129.8 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -134.41 121.09 20.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.517 0.727 . . . . 74.11 109.928 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -91.06 95.99 10.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.481 -0.933 . . . . 75.24 108.481 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 11' ' ' PHE . 26.1 pt -130.04 131.88 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.793 0.837 . . . . 73.21 110.354 -171.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -168.99 176.9 5.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.39 0.676 . . . . 65.2 111.44 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.57 31.07 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.088 -0.96 . . . . 71.54 112.399 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.09 172.33 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 124.216 1.007 . . . . 74.13 110.159 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.3 tt0 -154.73 -169.14 3.12 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.69 -0.855 . . . . 64.51 108.69 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.552 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.2 -130.68 24.39 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 120.129 -0.262 . . . . 64.21 112.971 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -66.96 -32.85 74.37 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.857 0.863 . . . . 73.34 111.395 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.63 -39.66 80.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.776 0.83 . . . . 73.33 110.823 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.0 tpp -72.7 -41.78 64.91 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.354 0.409 . . . . 74.23 110.441 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.54 66.46 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 72.22 111.279 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -79.88 -37.71 34.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.51 0.724 . . . . 63.44 111.054 172.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HG ' ' HD2' ' A' ' 11' ' ' PHE . 53.9 t -63.03 -57.44 10.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.651 0.38 . . . . 74.32 111.955 -174.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' F' ' 116' ' ' TYR . 0.5 OUTLIER -95.18 -10.3 30.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.398 0.518 . . . . 64.21 112.398 -177.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.5 -21.26 15.12 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.156 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.43 -64.59 1.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.591 0.756 . . . . 73.32 110.257 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 97' ' ' CYS . 75.8 t80 -60.21 -53.12 61.53 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.166 0.986 . . . . 73.43 112.725 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 98' ' ' LEU . 84.4 m -60.21 -52.26 74.45 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.165 -0.921 . . . . 55.23 112.735 -176.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.86 -24.09 40.58 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.816 1.677 . . . . 71.05 113.233 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -73.61 -28.76 61.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.944 0.498 . . . . 72.15 110.605 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -68.84 -42.41 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.389 0.676 . . . . 74.13 109.418 168.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD21 ' HA3' ' A' ' 82' ' ' GLY . 88.7 mt -71.61 -25.96 62.38 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.962 -1.017 . . . . 71.32 111.768 -176.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -67.24 -44.61 48.66 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.81 -1.091 . . . . 72.51 113.823 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 20.6 Cg_endo -62.66 -33.27 77.82 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 121.875 1.717 . . . . 74.12 112.647 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -75.14 -34.36 61.62 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.181 0.592 . . . . 73.55 111.875 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.87 65.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.355 -0.609 . . . . 70.22 109.355 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.483 HH12 HD12 ' C' ' 105' ' ' ILE . 34.7 ttm180 -51.96 -51.68 55.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.121 1.368 . . . . 75.25 110.684 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.17 -48.48 81.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.253 0.971 . . . . 73.05 111.211 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.477 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.9 t -56.84 -45.76 82.17 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.297 0.998 . . . . 71.42 110.92 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.3 mt -63.59 -52.4 58.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 124.084 0.865 . . . . 72.3 110.551 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 125' ' ' GLN . 71.5 m -53.82 -43.77 69.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.816 0.847 . . . . 64.34 111.112 -176.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.38 -42.99 82.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.652 -1.158 . . . . 51.3 110.365 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.472 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mtp -56.5 -46.19 80.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.736 0.814 . . . . 55.15 111.25 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.1 t -60.99 -47.47 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.699 -1.137 . . . . 74.44 110.989 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -71.82 -26.57 62.45 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.995 -0.548 . . . . 71.41 111.246 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 40.0 mtt180 -72.88 -30.38 63.92 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.489 0.716 . . . . 73.11 110.017 172.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.04 0.48 78.87 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.564 -0.743 . . . . 22.13 112.543 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 66.89 37.85 3.87 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.804 1.242 . . . . 75.32 110.109 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -113.69 153.7 45.86 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.893 -1.048 . . . . 64.24 109.299 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.98 132.97 52.75 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.009 2.472 . . . . 74.42 112.189 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.52 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.7 pt20 -61.99 147.4 47.17 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.867 0.73 . . . . 64.2 111.262 -172.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -117.8 95.44 4.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.05 0.54 . . . . 75.55 109.555 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -100.76 97.24 7.9 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.699 -0.852 . . . . 71.4 108.699 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -73.39 136.99 44.4 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.659 -0.867 . . . . 72.2 108.659 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.68 148.48 91.07 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.039 0.535 . . . . 73.22 111.753 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -77.9 119.48 4.75 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.906 1.737 . . . . 74.41 111.458 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.81 111.52 31.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.519 -1.289 . . . . 71.41 107.519 170.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -86.99 93.0 9.23 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.253 0.621 . . . . 63.01 109.593 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -61.96 -27.92 69.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.42 -0.809 . . . . 61.41 108.859 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.25 -55.46 28.19 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 115.076 -0.965 . . . . 75.25 111.592 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.59 82.08 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.168 0.918 . . . . 60.25 112.081 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.58 -34.25 75.47 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.931 0.769 . . . . 72.24 112.094 -175.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -88.87 -23.22 22.82 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.511 0.724 . . . . 72.4 111.301 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 14.7 mmt -75.98 -53.6 8.14 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.857 -0.592 . . . . 75.11 109.599 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' C' ' 145' ' ' ALA . 3.8 p30 -60.85 -33.63 73.35 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.62 0.575 . . . . 71.31 109.552 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.485 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 2.7 t80 -53.0 -59.62 4.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.889 1.276 . . . . 74.34 111.256 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.89 -53.64 43.45 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.827 0.704 . . . . 74.31 111.045 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.484 ' HG2' ' HG2' ' C' ' 144' ' ' GLN . 1.1 tm0? 174.32 -21.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.989 1.316 . . . . 53.13 110.597 174.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 57.21 101.08 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.406 1.483 . . . . 62.25 112.636 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -172.19 135.37 0.77 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.625 1.17 . . . . 75.05 109.061 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.612 0.765 . . . . 72.34 109.419 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.8 76.1 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 111.503 -0.639 . . . . 54.04 111.503 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.72 137.09 34.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.76 -0.83 . . . . 74.24 108.76 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.89 164.45 20.67 Favored Glycine 0 C--N 1.344 0.988 0 O-C-N 123.666 0.604 . . . . 43.2 112.589 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.3 m -98.9 120.04 38.67 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.621 0.768 . . . . 74.4 109.672 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 150' ' ' GLU . 6.8 pt-20 -77.69 91.77 4.08 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 108.636 -0.875 . . . . 74.41 108.636 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.675 ' HG3' ' HB2' ' E' ' 146' ' ' ASP . 1.9 tm-20 -67.72 96.54 0.56 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.366 1.067 . . . . 72.41 110.753 -171.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 176.01 149.86 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.661 1.584 . . . . 71.21 107.523 171.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -167.67 -76.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.748 0.419 . . . . 53.31 110.454 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.434 ' H ' ' H ' ' A' ' 155' ' ' ALA . 32.1 t70 -154.56 -15.1 0.12 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.268 1.027 . . . . 52.04 110.118 -171.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.434 ' H ' ' H ' ' A' ' 154' ' ' ASP . . . . . . . . 0 C--O 1.245 0.842 0 C-N-CA 124.292 1.037 . . . . 70.51 110.494 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 108.966 -0.753 . . . . 72.14 108.966 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -141.34 156.85 45.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.696 0.798 . . . . 54.12 110.258 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -138.09 153.45 49.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.389 0.676 . . . . 62.01 109.566 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -84.37 33.89 0.51 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.552 1.141 . . . . 74.2 111.933 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -132.13 152.3 51.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.534 1.134 . . . . 74.04 108.872 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -64.73 89.34 0.07 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.487 0.715 . . . . 53.14 109.272 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -141.17 -2.27 1.29 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.816 1.247 . . . . 62.11 109.238 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.63 126.24 39.8 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 107.726 -1.213 . . . . 71.34 107.726 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.428 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 21.8 ptm 50.76 177.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 126.497 1.919 . . . . 72.21 114.528 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -152.78 125.64 8.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.763 1.225 . . . . 70.52 107.742 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -135.72 135.52 40.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.686 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 55.3 tt0 -150.42 142.33 23.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.809 0.844 . . . . 60.5 109.192 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.5 115.05 32.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.485 -1.302 . . . . 64.41 107.485 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -79.79 -48.31 13.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.933 -0.395 . . . . 72.11 109.933 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -167.74 136.32 2.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.743 -0.662 . . . . 73.01 109.747 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.1 mt -114.67 140.99 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.051 -1.463 . . . . 74.11 107.051 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -165.96 146.73 6.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.528 0.68 . . . . 74.2 111.077 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.615 HG21 HD11 ' B' ' 21' ' ' ILE . 40.6 m -77.44 117.07 18.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.108 -0.951 . . . . 71.44 109.078 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -86.92 -27.64 23.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.318 0.647 . . . . 72.52 110.82 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 21.1 t70 -150.9 139.68 20.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.272 -0.422 . . . . 73.51 111.097 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.615 HD11 HG21 ' B' ' 18' ' ' THR . 33.7 mm -128.66 143.5 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.126 1.37 . . . . 74.45 108.142 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.3 t -141.03 142.93 34.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.099 -1.075 . . . . 71.15 108.099 169.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -157.8 120.04 3.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.656 -1.609 . . . . 71.22 106.656 171.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.05 146.69 49.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.304 -0.628 . . . . 73.51 109.304 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -146.69 79.84 10.07 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.046 -1.094 . . . . 63.14 108.046 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.6 -25.46 20.87 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.067 2.511 . . . . 72.14 112.793 -172.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -116.66 19.39 14.57 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.872 0.869 . . . . 63.3 109.793 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.634 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -47.49 -52.69 35.14 Favored Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 115.313 1.597 . . . . 61.42 115.313 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.28 -11.42 19.21 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 121.839 1.693 . . . . 64.35 112.725 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -97.89 -26.24 14.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.657 0.783 . . . . 74.21 111.728 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.459 ' HB ' HD12 ' B' ' 68' ' ' LEU . 34.7 m -82.24 0.49 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.459 0.304 . . . . 73.11 111.176 175.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.99 -42.61 99.33 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.339 1.056 . . . . 72.32 110.892 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.25 -13.89 48.42 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.114 0.566 . . . . 74.53 111.479 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -83.95 78.69 9.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.386 0.674 . . . . 63.25 110.06 -170.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.91 102.59 5.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.791 -0.818 . . . . 53.12 108.791 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -159.56 162.6 35.42 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 73.45 108.059 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.49 109.19 29.88 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.546 -0.74 . . . . 73.34 109.032 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' B' ' 67' ' ' SER . 32.2 Cg_exo -56.15 131.03 43.42 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.648 2.232 . . . . 74.31 113.408 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.25 102.51 2.13 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 107.741 -1.207 . . . . 71.21 107.741 167.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' B' ' 65' ' ' THR . 23.7 m -97.6 146.35 7.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.2 -0.909 . . . . 52.04 110.765 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.84 118.87 19.49 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.514 -1.291 . . . . 71.43 107.514 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.668 ' H ' HD22 ' E' ' 129' ' ' LEU . 2.4 tt -96.28 123.55 39.95 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.024 -1.843 . . . . 64.44 106.024 171.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.5 t70 -124.8 129.95 51.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.875 -0.787 . . . . 54.04 108.875 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.17 125.82 53.87 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.193 -1.04 . . . . 65.33 108.193 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.82 133.07 35.51 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.424 HG21 ' HE1' ' E' ' 120' ' ' TRP . 36.9 p -118.78 121.77 40.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.23 0.612 . . . . 63.12 111.21 -174.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.38 160.93 19.83 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.799 1.24 . . . . 45.05 108.582 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 61.3 p -143.35 163.92 31.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 122.892 0.477 . . . . 71.13 110.3 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 159.32 43.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.485 1.114 . . . . 65.33 108.86 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -125.54 119.76 29.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.442 0.697 . . . . 73.05 109.133 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.2 -36.75 26.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.178 0.591 . . . . 73.22 110.566 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.33 -177.6 5.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.107 0.963 . . . . 52.34 109.915 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -66.1 118.58 10.05 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.597 -0.729 . . . . 74.02 110.105 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 71.67 3.17 4.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.524 1.53 . . . . 71.5 112.151 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.93 87.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.758 1.223 . . . . 73.52 108.329 177.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.445 ' CD1' HD11 ' B' ' 86' ' ' ILE . 12.2 m-85 -98.84 147.0 25.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.1 0.56 . . . . 75.54 109.587 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -131.79 100.31 5.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.016 -1.105 . . . . 72.35 108.016 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 29.8 m -94.22 138.1 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.858 -0.423 . . . . 53.3 109.858 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.08 114.11 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.631 0.773 . . . . 53.41 109.756 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.51 129.55 39.68 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.409 -1.33 . . . . 73.32 107.409 176.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -122.04 112.32 18.1 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.808 0.843 . . . . 75.15 109.157 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.05 125.77 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.619 -0.882 . . . . 70.22 108.619 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.2 m -117.91 146.85 43.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.215 0.531 . . . . 74.24 109.577 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.661 HG21 HG21 ' B' ' 114' ' ' ILE . 42.9 t -132.6 132.69 59.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.443 1.497 . . . . 54.22 108.723 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 100.0 m -126.13 143.74 51.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.924 -0.769 . . . . 70.41 108.924 169.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' B' ' 38' ' ' PRO . . . -135.54 140.25 44.57 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.743 -1.206 . . . . 73.11 107.743 171.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' B' ' 38' ' ' PRO . 17.1 m -129.51 128.83 43.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.795 0.438 . . . . 54.02 110.048 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.459 HD12 ' HB ' ' B' ' 31' ' ' VAL . 31.3 mt -114.69 102.25 9.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.499 -0.926 . . . . 73.34 108.499 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.99 -131.61 10.52 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.586 -0.734 . . . . 51.11 111.896 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -95.33 8.3 43.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.206 0.602 . . . . 73.3 110.632 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -135.81 166.52 23.09 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.645 0.778 . . . . 74.4 111.288 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -71.33 125.68 27.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.283 -0.871 . . . . 54.13 110.911 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' B' ' 31' ' ' VAL . . . -73.55 -62.86 1.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.527 0.731 . . . . 63.01 109.095 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -160.84 165.56 30.01 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 74.24 110.726 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.21 154.92 46.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.732 1.613 . . . . 55.42 108.366 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.0 t -160.76 132.09 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.199 -0.667 . . . . 52.43 109.199 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.436 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.4 tt0 -141.82 123.65 15.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.351 -0.981 . . . . 73.13 108.351 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -122.57 143.76 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.508 -0.553 . . . . 72.22 109.508 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.7 mt-30 -121.97 103.18 8.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.306 -0.861 . . . . 75.42 109.175 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.06 103.53 16.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.562 -0.745 . . . . 52.45 109.129 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.9 143.56 16.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.141 -0.784 . . . . 64.11 111.141 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.23 126.53 3.23 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 112.002 -0.439 . . . . 61.12 112.002 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 12.8 mt -85.85 131.83 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.557 -0.905 . . . . 74.44 108.557 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -138.06 137.16 37.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.977 0.911 . . . . 72.23 109.574 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.686 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 23.4 m -88.89 113.28 24.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.567 -0.901 . . . . 52.11 108.567 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.563 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -121.66 138.33 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.127 0.571 . . . . 71.41 110.411 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.02 163.36 37.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.011 0.924 . . . . 50.43 109.277 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.48 -48.25 3.93 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 122.663 0.173 . . . . 62.23 112.905 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -61.06 153.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.256 1.023 . . . . 53.23 111.857 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.423 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 0.3 OUTLIER -167.1 165.29 15.69 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.882 0.873 . . . . 53.44 110.149 176.352 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -119.68 19.3 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.44 0.462 . . . . 54.45 113.491 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.6 m -69.38 -31.67 70.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.93 0.892 . . . . 70.14 111.124 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.521 ' HB3' HG22 ' B' ' 89' ' ' ILE . 93.7 mt-30 -62.89 -52.57 62.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.446 0.699 . . . . 70.22 110.382 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.511 ' SD ' HD13 ' B' ' 89' ' ' ILE . 3.4 tpt -62.99 -45.14 93.8 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.456 -0.793 . . . . 65.11 110.628 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.47 78.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.372 0.669 . . . . 65.21 111.693 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -76.77 -33.13 58.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.324 0.649 . . . . 72.03 110.387 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -65.23 -52.4 54.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.136 0.575 . . . . 73.44 110.881 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.84 -20.36 31.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.877 0.471 . . . . 75.24 111.804 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -31.77 16.48 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.347 0.404 . . . . 52.2 113.258 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.05 1.82 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.916 0.487 . . . . 64.24 111.484 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -76.28 -41.93 47.19 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.187 0.81 . . . . 64.15 113.187 -168.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.407 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.3 m -63.76 -45.94 82.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 118.688 -0.672 . . . . 64.11 110.913 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 70.3 Cg_exo -56.57 -37.14 98.07 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.974 1.782 . . . . 64.35 113.514 166.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.36 -35.43 79.11 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.971 0.508 . . . . 73.33 111.416 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -66.13 -49.51 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.757 0.823 . . . . 64.33 110.162 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.34 -16.33 52.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.112 -0.949 . . . . 62.51 112.409 -168.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.56 -46.96 68.8 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 117.48 -1.248 . . . . 75.33 113.075 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.7 Cg_endo -58.6 -36.78 96.83 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.153 1.902 . . . . 53.31 112.688 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' B' ' 113' ' ' CYS . 74.7 m-85 -65.68 -49.42 68.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.399 0.68 . . . . 73.44 110.732 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -35.37 80.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.672 0.789 . . . . 64.31 110.96 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.735 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.0 ttp180 -59.78 -65.13 0.73 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.348 1.059 . . . . 74.22 110.479 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.15 -20.93 64.93 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.96 -1.018 . . . . 75.32 110.619 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.9 t -67.12 -49.62 64.26 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.709 -0.478 . . . . 72.43 109.709 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.661 HG21 HG21 ' B' ' 64' ' ' VAL . 91.4 mt -58.96 -54.44 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 123.731 0.645 . . . . 73.12 110.267 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.469 HG22 ' NE2' ' B' ' 125' ' ' GLN . 8.5 m -61.31 -29.17 69.71 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.105 0.962 . . . . 75.02 111.523 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -77.01 -35.36 57.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.447 0.699 . . . . 42.11 111.118 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.1 mmt -68.01 -30.86 70.21 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.893 0.378 . . . . 72.43 110.26 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.77 -39.23 83.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.97 0.908 . . . . 64.32 109.952 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.2 m -64.26 -32.46 74.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.523 0.729 . . . . 75.0 111.617 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.477 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.3 mtt-85 -71.32 -35.21 71.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.415 -0.811 . . . . 62.55 110.112 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.0 3.05 82.05 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.903 0.752 . . . . 55.01 112.951 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p 56.84 24.03 8.76 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.082 1.753 . . . . 71.35 112.649 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.05 156.09 42.5 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 65.42 110.137 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.2 140.58 93.22 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.052 2.501 . . . . 71.15 111.807 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.469 ' NE2' HG22 ' B' ' 115' ' ' THR . 14.7 mm100 -63.95 122.65 17.0 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.778 0.831 . . . . 75.44 112.493 -170.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -110.16 97.22 6.75 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.065 -1.457 . . . . 70.33 107.065 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -91.36 135.67 33.65 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.479 -0.782 . . . . 72.43 108.975 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.735 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -82.31 115.18 21.25 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.746 -0.835 . . . . 75.05 108.746 -173.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 137.92 88.47 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 124.404 1.065 . . . . 33.02 110.9 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.509 ' HG3' HD11 ' D' ' 16' ' ' ILE . 60.1 Cg_endo -66.6 99.05 0.42 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.739 2.293 . . . . 74.32 111.026 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.0 120.45 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.077 -1.083 . . . . 73.01 108.077 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.31 88.63 0.46 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.901 0.88 . . . . 74.44 110.515 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -52.92 -36.71 59.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.285 1.034 . . . . 75.23 112.221 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.22 -42.61 99.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.587 1.155 . . . . 73.03 111.892 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.92 -35.24 59.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.295 0.638 . . . . 71.14 110.597 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.22 -43.5 95.95 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.614 0.766 . . . . 75.53 110.412 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -67.33 -40.26 85.92 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.635 -1.166 . . . . 71.15 110.41 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.9 ttt -66.87 -37.17 83.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 74.24 111.352 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 42.4 m-80 -86.15 -18.74 31.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.884 0.474 . . . . 73.33 110.927 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.83 -27.18 63.67 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.429 -0.582 . . . . 73.21 109.429 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -114.79 30.98 6.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.382 1.073 . . . . 64.12 110.188 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.437 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 23.8 tp60 -65.75 102.74 0.79 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.849 0.46 . . . . 63.34 111.831 -170.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -166.36 145.0 5.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.396 1.078 . . . . 62.32 108.684 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -65.62 -65.15 0.71 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.424 0.69 . . . . 73.41 112.476 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.88 -167.41 0.21 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.415 1.072 . . . . 63.33 110.257 -167.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 72.77 0.03 OUTLIER Glycine 0 C--N 1.348 1.239 0 C-N-CA 120.662 -0.78 . . . . 64.43 114.102 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.77 142.42 24.54 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.789 -0.819 . . . . 62.45 108.789 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.22 -19.21 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.991 -0.55 . . . . 53.43 112.962 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 74.2 p -77.59 161.29 27.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.886 0.474 . . . . 70.53 109.936 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -76.5 -33.06 58.65 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.197 -0.456 . . . . 65.41 111.422 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 73.85 -56.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.446 1.498 . . . . 74.51 107.928 -160.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 85.07 132.0 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.59 1.556 . . . . 63.13 111.862 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -81.73 168.12 18.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.57 0.748 . . . . 70.41 110.462 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.41 -60.92 0.41 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.317 -0.623 . . . . 70.21 109.317 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.236 0 C-N-CA 125.076 1.351 . . . . 63.11 111.965 175.879 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 109.724 -0.473 . . . . 75.31 109.724 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -116.97 90.96 3.45 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.083 -1.451 . . . . 72.5 107.083 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -84.21 136.53 33.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.752 -0.658 . . . . 74.51 111.886 -166.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.83 162.98 31.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.86 1.264 . . . . 63.21 109.375 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -165.94 132.14 2.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.519 -0.548 . . . . 63.41 109.519 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.91 90.89 1.49 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.918 -0.771 . . . . 70.34 108.918 173.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.2 p -79.76 118.58 21.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.288 -0.869 . . . . 72.41 109.764 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.01 179.23 5.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.366 0.666 . . . . 74.34 109.762 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.7 ttm 65.49 115.97 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.536 1.135 . . . . 74.25 112.246 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 21.7 m -84.84 92.78 8.35 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.321 -0.992 . . . . 71.32 108.321 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -116.41 125.85 52.61 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -151.76 134.24 15.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.207 0.603 . . . . 72.53 109.41 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.408 HG12 ' HE2' ' C' ' 84' ' ' PHE . 41.1 mt -74.81 109.0 7.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.555 -0.906 . . . . 70.22 108.555 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -85.88 -41.24 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.266 0.626 . . . . 72.13 111.175 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -170.77 142.95 2.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.957 -0.757 . . . . 63.22 108.957 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.0 mt -131.76 133.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.829 -0.804 . . . . 70.43 108.829 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.505 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 19.4 p90 -173.06 153.03 2.44 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.41 0.624 . . . . 64.31 111.509 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -74.76 125.09 28.0 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.954 -1.021 . . . . 73.43 109.782 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -77.64 -47.68 18.66 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.565 -1.272 . . . . 73.45 107.565 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -132.34 143.48 49.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.125 -1.398 . . . . 53.32 110.231 -171.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.2 mt -142.35 142.68 27.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.659 1.583 . . . . 73.45 106.767 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.48 148.71 21.66 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.163 0.506 . . . . 64.25 109.904 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -150.28 115.08 5.29 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.245 -1.391 . . . . 64.34 107.245 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -116.42 111.1 19.54 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.605 -0.517 . . . . 64.32 109.605 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.53 78.86 54.94 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 60.13 108.641 167.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.28 -28.61 39.76 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.045 1.83 . . . . 70.51 109.341 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 30' ' ' HIS . 2.2 m-20 -92.99 27.25 2.48 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.115 -1.402 . . . . 71.41 110.443 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.48 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.73 -50.17 89.44 Favored Pre-proline 0 CA--C 1.574 1.881 0 C-N-CA 123.746 0.818 . . . . 64.01 111.584 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 22.1 Cg_exo -66.1 -21.14 56.3 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.473 2.115 . . . . 75.41 113.247 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' C' ' 27' ' ' ASN . 12.6 m170 -60.59 -34.16 73.8 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 118.14 -0.933 . . . . 61.15 111.047 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.422 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.3 p -51.05 -31.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.196 0.813 . . . . 70.22 113.196 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -73.58 -29.18 62.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.811 0.844 . . . . 64.52 111.664 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.48 11.78 12.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.778 0.831 . . . . 73.53 112.217 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 18.5 ttpp -110.37 159.38 17.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 71.1 110.206 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.96 118.24 20.78 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.475 -0.784 . . . . 65.4 109.192 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -86.22 63.63 8.12 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.969 0.89 . . . . 73.32 110.862 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -145.2 72.95 14.56 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.177 -1.416 . . . . 75.54 107.177 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.56 151.61 4.3 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.787 2.325 . . . . 73.21 112.027 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.84 112.79 21.44 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.208 -1.034 . . . . 73.23 108.208 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.72 99.08 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 108.672 -0.862 . . . . 64.5 108.672 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 24.7 tptt -92.94 100.98 13.33 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.429 -1.322 . . . . 74.51 107.429 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -92.27 135.28 34.14 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.338 -0.986 . . . . 62.35 108.338 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.84 103.73 4.89 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.258 -1.016 . . . . 51.25 108.258 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -95.42 148.75 22.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.446 -0.576 . . . . 74.02 109.446 176.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -148.85 162.51 39.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.74 1.216 . . . . 71.53 107.976 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' C' ' 60' ' ' LEU . 10.2 t -145.65 137.14 25.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.344 0.657 . . . . 72.11 109.563 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.85 162.02 22.97 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.095 0.958 . . . . 61.42 108.985 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -139.31 143.78 38.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.894 0.477 . . . . 74.51 110.581 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -148.86 126.51 11.73 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.745 0.818 . . . . 74.43 109.518 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -88.29 120.22 29.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.539 -0.911 . . . . 71.24 108.539 173.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -91.2 -39.1 12.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.514 0.726 . . . . 63.21 110.699 -174.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.3 -175.54 5.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.477 -0.783 . . . . 61.21 110.305 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.6 105.39 1.51 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.028 0.931 . . . . 74.04 110.937 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 68.85 10.91 8.16 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.26 1.424 . . . . 73.41 112.979 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 76.2 t -105.34 113.71 42.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 64.32 108.341 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -117.5 160.47 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.056 0.942 . . . . 71.31 109.129 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.6 tt0 -127.58 146.69 50.45 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.055 1.342 . . . . 62.51 107.741 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.42 HG21 ' HG3' ' C' ' 103' ' ' PRO . 3.2 p -137.21 124.77 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.642 -0.873 . . . . 73.44 108.642 171.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.92 104.97 15.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.607 -0.886 . . . . 72.03 108.607 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.688 ' H ' HD23 ' C' ' 60' ' ' LEU . 0.8 OUTLIER -91.38 118.22 30.35 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.938 -0.393 . . . . 74.41 109.938 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -83.88 105.17 14.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.635 -0.876 . . . . 70.24 108.635 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.4 t -100.2 125.88 53.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.899 -1.149 . . . . 61.01 107.899 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 31.2 m -118.77 133.47 55.82 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.553 -0.906 . . . . 73.45 108.553 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.448 HG21 HG21 ' C' ' 114' ' ' ILE . 94.7 t -128.23 109.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.443 -0.947 . . . . 74.43 108.443 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 8.9 m -99.22 144.07 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.387 -0.968 . . . . 74.11 108.387 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.92 95.44 3.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.307 -1.738 . . . . 54.21 106.307 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -153.01 138.69 17.85 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.675 -0.491 . . . . 70.12 109.675 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.64 92.25 6.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.61 -79.31 1.26 Allowed Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.401 -0.818 . . . . 65.32 112.281 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -30.66 2.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.952 0.901 . . . . 74.14 110.617 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.62 102.59 0.93 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.754 0.821 . . . . 72.33 109.852 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -81.37 136.27 35.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.447 -0.797 . . . . 74.24 110.789 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.0 -55.45 3.68 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 55.2 107.485 163.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.67 175.07 9.15 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.844 0.831 . . . . 44.23 112.072 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.403 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -135.55 146.1 47.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.642 -1.984 . . . . 70.14 105.642 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.408 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.0 t -152.53 113.4 4.16 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.401 -0.592 . . . . 72.41 109.401 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -126.55 118.9 25.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.034 0.534 . . . . 63.42 109.852 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.84 134.05 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.825 0.85 . . . . 72.43 109.66 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.681 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -110.45 97.5 6.94 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.888 -1.153 . . . . 64.52 107.888 174.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -83.48 115.62 22.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.877 -0.602 . . . . 72.03 109.869 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.04 153.34 21.82 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.606 0.566 . . . . 61.43 111.775 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 119.99 0.97 Allowed Glycine 0 C--O 1.238 0.374 0 N-CA-C 111.195 -0.762 . . . . 74.3 111.195 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.7 mm -84.28 125.81 40.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.435 -0.95 . . . . 62.14 108.435 176.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.408 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.5 m-85 -137.62 135.08 36.26 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.967 0.907 . . . . 72.31 109.298 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -75.85 118.4 18.61 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.236 -1.024 . . . . 72.45 108.236 166.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 mm -122.29 110.0 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.802 -0.814 . . . . 55.21 108.802 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.77 165.18 31.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.658 0.783 . . . . 73.34 109.206 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.9 -50.54 3.96 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.404 -0.362 . . . . 72.33 112.22 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.73 141.89 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.705 0.802 . . . . 72.43 109.203 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -148.74 155.53 41.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.897 0.479 . . . . 74.31 110.862 -170.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.14 -145.41 28.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.865 0.728 . . . . 52.31 113.059 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.8 p -62.62 -28.33 69.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.996 . . . . 55.21 111.559 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -59.24 -49.0 79.53 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.535 0.734 . . . . 73.24 110.676 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -40.17 70.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 74.11 110.358 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.39 78.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.611 0.764 . . . . 73.41 110.904 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -70.97 -41.27 71.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.306 -0.861 . . . . 52.32 110.777 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.11 -51.71 65.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.664 0.386 . . . . 71.31 110.818 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.0 tp -75.87 -16.14 60.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.671 0.788 . . . . 73.21 111.087 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.89 3.32 31.89 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 119.511 -0.605 . . . . 53.44 114.113 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.37 -60.77 0.41 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.731 0.766 . . . . 51.43 110.851 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -68.44 -57.28 6.1 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.706 0.629 . . . . 73.0 111.835 -171.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.43 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 56.9 m -58.46 -45.95 99.65 Favored Pre-proline 0 CA--C 1.564 1.513 0 CA-C-O 118.415 -0.802 . . . . 74.52 111.901 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 44.3 Cg_exo -57.57 -37.12 98.1 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.278 1.985 . . . . 73.41 113.737 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -73.02 -26.55 61.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.767 0.427 . . . . 72.31 111.311 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 HH12 ' A' ' 111' ' ' ARG . 26.2 mm -65.56 -42.19 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.26 0.552 . . . . 75.45 109.587 169.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.3 mt -79.77 -19.26 49.06 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.651 -1.159 . . . . 74.13 111.882 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.5 -45.35 99.68 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.645 -1.169 . . . . 72.4 113.124 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 75.0 Cg_exo -52.91 -39.69 77.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.465 2.11 . . . . 74.21 113.262 172.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -68.98 -44.76 72.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.627 0.771 . . . . 74.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.02 99.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.216 0.606 . . . . 74.05 110.248 175.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -61.66 -49.41 76.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.84 1.256 . . . . 65.33 110.768 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.96 -33.83 74.34 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.684 0.615 . . . . 72.41 110.295 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -67.54 -37.33 82.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 75.43 110.975 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.448 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -71.54 -47.47 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.707 0.803 . . . . 74.52 110.631 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 41.6 m -67.07 -28.85 68.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.77 0.828 . . . . 72.01 111.076 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.1 t -68.61 -45.09 72.83 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.373 0.669 . . . . 71.41 109.442 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.58 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.91 -39.8 93.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.027 0.931 . . . . 63.14 111.941 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.31 -45.32 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.634 0.774 . . . . 72.15 109.917 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.1 t -64.92 -33.09 75.19 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.061 -0.972 . . . . 65.01 111.369 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -73.69 -33.59 64.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.596 0.758 . . . . 64.4 110.291 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.57 -3.98 90.14 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.55 0.531 . . . . 74.23 112.46 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 65.29 45.43 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.581 1.952 . . . . 71.22 112.182 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.4 m-85 -106.89 164.22 15.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-N 114.077 -1.42 . . . . 73.11 109.1 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' E' ' 136' ' ' VAL . 95.3 Cg_endo -72.33 179.65 4.84 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.752 2.301 . . . . 75.33 112.977 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -60.11 111.99 1.73 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.7 -0.682 . . . . 73.42 111.592 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.27 96.58 5.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 106.362 -1.718 . . . . 43.41 106.362 169.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.12 122.47 47.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.647 0.779 . . . . 74.43 109.511 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 57.0 mt -83.0 133.57 35.09 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.227 0.611 . . . . 55.15 109.402 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.74 143.19 78.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 123.509 0.506 . . . . 74.04 110.607 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.513 ' HG2' HD11 ' E' ' 147' ' ' LEU . 28.0 Cg_endo -62.97 133.37 41.07 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.395 2.064 . . . . 64.14 111.726 175.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 p -102.0 111.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.458 -0.941 . . . . 62.14 108.458 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.785 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 1.0 OUTLIER -83.75 57.68 4.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.446 0.698 . . . . 73.41 110.389 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -76.88 -21.53 54.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.817 0.818 . . . . 72.03 109.232 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -79.78 -47.41 15.27 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.534 1.134 . . . . 72.32 110.951 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.785 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -64.88 -47.66 77.03 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 124.417 1.073 . . . . 61.31 112.186 -170.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.473 HD13 ' HD2' ' E' ' 149' ' ' PRO . 56.7 tp -54.02 -43.88 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.859 0.724 . . . . 73.12 112.405 -175.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.83 -32.73 40.64 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.416 0.524 . . . . 75.43 112.416 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.0 ptm -78.19 -30.04 48.78 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.741 0.246 . . . . 72.52 111.194 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.13 -37.94 69.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.882 0.873 . . . . 65.11 109.956 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -70.7 -151.32 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 123.748 0.819 . . . . 60.23 109.285 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.511 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 14.3 tp 65.12 -172.01 0.18 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.271 1.028 . . . . 73.21 109.627 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.511 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 0.0 OUTLIER -147.52 91.86 2.02 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 122.091 0.948 . . . . 74.31 110.087 175.44 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 51.7 mt-30 -116.2 114.0 23.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.744 -1.206 . . . . 72.12 107.744 174.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.484 ' HG2' ' HG2' ' A' ' 142' ' ' GLN . 77.5 mt-30 -108.64 138.54 44.79 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.338 0.655 . . . . 72.1 110.569 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 140' ' ' TYR . . . -96.72 159.52 14.88 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.101 0.96 . . . . 40.34 109.218 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.63 166.19 29.69 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.738 -0.665 . . . . 70.43 111.691 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.08 141.9 8.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 106.848 -1.538 . . . . 70.4 106.848 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.51 124.42 1.38 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.081 -0.807 . . . . 75.55 111.081 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -119.48 151.03 39.25 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 122.883 0.473 . . . . 73.13 110.727 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -164.56 113.75 1.14 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.609 1.164 . . . . 73.24 108.517 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.07 172.67 17.74 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.198 1.399 . . . . 73.23 108.783 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -167.31 122.04 1.03 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.673 0.789 . . . . 72.33 109.199 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.96 -38.11 84.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.77 0.828 . . . . 73.13 111.295 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.79 105.13 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.561 1.145 . . . . 62.34 110.328 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 123.52 0.728 . . . . 74.34 110.68 -178.525 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.618 -0.512 . . . . 65.43 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -144.54 -170.91 3.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.632 0.773 . . . . 52.24 109.076 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -144.44 88.84 1.96 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.287 0.635 . . . . 74.23 109.52 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -90.12 154.62 19.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.13 -0.693 . . . . 61.31 109.13 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.79 128.1 34.76 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.189 -1.041 . . . . 74.24 108.189 170.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.61 127.64 32.42 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.855 0.722 . . . . 65.13 110.276 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.2 p -85.39 175.3 8.95 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.387 0.675 . . . . 51.21 109.504 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.23 -178.58 1.35 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.849 0.459 . . . . 73.31 109.964 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.504 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.9 tpt -30.81 123.07 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 74.34 113.848 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -148.18 142.3 26.03 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.449 1.1 . . . . 75.23 109.12 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -164.2 103.5 0.86 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.67 -1.233 . . . . 73.34 107.67 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.536 ' HG3' ' HB2' ' D' ' 85' ' ' SER . 5.2 pt20 -149.51 127.08 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.528 0.731 . . . . 62.01 109.569 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.502 HD12 ' O ' ' D' ' 83' ' ' ILE . 3.3 tp -84.26 110.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 73.11 109.353 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.431 ' O ' ' HB1' ' E' ' 131' ' ' ALA . 74.9 mt-30 -73.36 -40.99 63.95 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.332 1.053 . . . . 72.43 112.036 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.466 HH12 HG12 ' E' ' 134' ' ' ILE . 43.6 ttt180 -159.77 124.51 3.94 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.404 -0.221 . . . . 73.41 110.404 -166.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.509 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.2 mp -103.26 132.61 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 107.069 -1.456 . . . . 64.13 107.069 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 28.9 p90 -158.83 167.62 28.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.084 0.945 . . . . 71.4 111.724 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.425 HG21 HD11 ' D' ' 21' ' ' ILE . 73.6 p -102.52 120.21 40.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.038 -1.437 . . . . 74.12 109.426 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -87.63 -24.37 23.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 71.25 110.754 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.8 t70 -158.11 139.65 13.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.336 -0.847 . . . . 72.53 109.354 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.58 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.4 mt -139.82 144.88 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.828 -1.175 . . . . 54.32 107.828 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -149.77 144.82 26.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.141 0.976 . . . . 60.15 109.031 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.7 t80 -151.92 111.55 3.98 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.047 -1.834 . . . . 74.21 106.047 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.6 mt-10 -122.44 113.78 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.745 0.418 . . . . 53.14 110.527 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.61 81.22 54.48 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.983 0.913 . . . . 73.01 109.227 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.5 -37.56 5.41 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.619 2.213 . . . . 41.41 111.945 178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -103.72 38.53 1.79 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.983 0.913 . . . . 75.13 108.699 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.7 -50.66 84.26 Favored Pre-proline 0 CA--C 1.575 1.904 0 N-CA-C 114.561 1.319 . . . . 63.01 114.561 -168.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.96 -12.72 4.89 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 121.757 1.638 . . . . 74.42 112.853 171.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -69.74 -40.07 76.41 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.625 1.17 . . . . 75.24 109.837 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.36 -18.13 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.139 0.576 . . . . 64.41 110.429 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -57.45 -35.53 70.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.362 0.665 . . . . 74.33 111.362 171.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -59.66 -25.28 64.6 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.91 0.756 . . . . 72.31 111.343 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -110.84 91.42 3.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.323 -1.362 . . . . 73.34 107.323 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.49 67.14 5.16 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 122.465 1.126 . . . . 45.33 110.929 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -128.3 158.23 38.75 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.791 -1.188 . . . . 61.03 107.791 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 20.9 mm-40 -84.73 118.23 70.54 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 122.849 0.459 . . . . 73.43 110.049 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.492 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 34.1 Cg_exo -64.59 158.76 48.19 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.845 3.03 . . . . 74.13 113.844 -172.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.2 tt0 -71.82 124.63 25.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.987 -0.745 . . . . 74.45 108.987 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.504 HG23 HG13 ' D' ' 64' ' ' VAL . 3.2 p -96.8 114.25 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.68 0.752 . . . . 73.05 110.088 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.575 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 8.9 tppt? -95.57 107.62 19.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.787 -1.19 . . . . 75.13 107.787 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -101.04 116.9 33.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.906 -0.405 . . . . 72.3 109.906 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.456 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.7 m-20 -116.66 124.85 50.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.739 0.816 . . . . 62.34 109.52 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.18 137.61 48.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.488 0.715 . . . . 74.53 110.108 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -146.33 146.71 30.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.899 1.28 . . . . 62.31 108.061 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -123.55 165.51 17.01 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.907 -0.405 . . . . 44.23 109.907 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -157.38 164.52 37.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.4 0.68 . . . . 70.24 109.789 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.0 p -156.22 153.4 29.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.01 0.524 . . . . 62.21 110.897 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 98.0 p -154.47 155.0 34.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 60.2 108.655 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -97.26 116.96 30.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.208 -0.664 . . . . 75.55 109.208 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' D' ' 57' ' ' GLU . 25.3 mt -92.5 -28.89 16.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.028 0.531 . . . . 72.11 110.123 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -164.19 -178.98 5.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.23 1.014 . . . . 70.34 110.623 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.36 117.12 8.16 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.548 -1.66 . . . . 61.43 110.513 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 63.18 21.25 12.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.26 1.424 . . . . 74.11 111.442 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 88.8 t -131.5 115.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 124.141 0.976 . . . . 74.01 109.137 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -132.74 130.27 39.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.511 -0.922 . . . . 63.51 108.511 -172.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.496 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.7 tt0 -86.54 138.08 32.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.62 0.768 . . . . 74.32 109.146 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.482 HG11 ' HD3' ' D' ' 103' ' ' PRO . 97.6 t -122.07 128.89 75.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.434 -1.321 . . . . 74.24 107.434 170.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 29.3 t -110.42 132.74 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.293 -0.632 . . . . 74.2 109.293 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.61 119.0 38.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.063 -1.088 . . . . 74.23 108.063 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.47 103.52 13.9 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.411 -0.959 . . . . 72.31 108.411 175.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.76 133.02 46.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.195 -1.039 . . . . 75.42 108.195 170.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 7.9 m -126.95 128.15 45.97 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.504 HG13 HG23 ' D' ' 40' ' ' VAL . 61.1 t -119.38 102.12 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.12 0.968 . . . . 70.0 108.658 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 96.0 m -106.19 100.89 10.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.613 0.765 . . . . 51.3 109.354 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -98.66 134.96 40.85 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.75 0.42 . . . . 71.12 110.11 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 40.8 p -146.32 140.15 26.22 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.613 -0.884 . . . . 73.24 108.613 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.62 119.13 25.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.529 -0.545 . . . . 62.35 109.529 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.1 -117.9 5.78 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.821 0.701 . . . . 73.01 113.238 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 5.33 46.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.88 . . . . 74.15 110.993 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.41 155.06 43.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.006 0.431 . . . . 73.53 111.434 -161.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 98.2 m -66.77 136.91 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.432 1.093 . . . . 62.12 110.726 174.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.35 -66.72 0.89 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.579 0.752 . . . . 64.25 109.526 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 151.22 26.23 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.629 0.772 . . . . 63.21 109.396 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.9 mt -118.95 154.25 33.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.889 0.876 . . . . 61.13 109.173 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 54.1 t -158.66 146.22 17.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.02 0.528 . . . . 73.14 110.894 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -156.52 137.77 13.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.65 -0.871 . . . . 53.23 108.65 167.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -135.31 116.21 19.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.41 0.684 . . . . 74.11 109.27 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 53.0 mt-30 -92.29 85.28 5.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.504 0.722 . . . . 74.31 109.059 171.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.84 100.83 8.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.805 1.242 . . . . 73.44 109.721 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 143.28 16.51 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.144 -0.382 . . . . 60.13 112.144 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.15 134.21 6.6 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.945 -0.462 . . . . 72.34 111.945 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.502 ' O ' HD12 ' D' ' 13' ' ' ILE . 60.1 mt -90.51 125.82 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.708 0.803 . . . . 71.11 109.142 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.23 129.26 49.7 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.446 0.699 . . . . 70.32 110.218 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' D' ' 12' ' ' GLN . 33.0 m -79.12 104.97 10.11 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 167.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.6 117.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.586 0.754 . . . . 63.45 110.09 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.97 43.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.612 0.765 . . . . 71.02 109.948 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 86.72 -20.79 22.03 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.086 -0.506 . . . . 23.13 114.292 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.26 144.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.738 0.815 . . . . 71.04 109.89 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -176.51 5.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.816 0.846 . . . . 60.12 110.256 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.59 -140.16 44.22 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.641 0.588 . . . . 40.34 114.188 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -63.03 -34.02 76.67 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.106 0.963 . . . . 60.45 111.397 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.48 -51.35 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.13 0.572 . . . . 73.32 109.743 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.82 -42.98 97.55 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.822 0.701 . . . . 75.11 111.256 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.63 97.07 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.827 0.704 . . . . 73.14 110.88 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -71.41 -34.27 70.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.811 . . . . 72.13 111.055 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.57 -48.05 76.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.746 0.418 . . . . 62.31 109.982 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -71.92 -18.19 62.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 122.797 0.439 . . . . 71.24 111.824 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.57 10.5 32.87 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.222 -0.765 . . . . 44.53 114.25 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.1 -64.22 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.948 0.874 . . . . 52.54 111.842 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -69.2 -40.1 78.23 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.409 0.683 . . . . 54.12 112.592 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.9 m -73.26 -44.84 7.88 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.478 0.711 . . . . 74.3 110.976 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.482 ' HD3' HG11 ' D' ' 58' ' ' VAL . 72.2 Cg_exo -54.85 -33.16 80.58 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.514 2.142 . . . . 55.52 113.694 166.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.16 -39.02 93.46 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.826 0.85 . . . . 73.12 109.948 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.15 -41.75 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.029 0.932 . . . . 74.53 110.868 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' D' ' 82' ' ' GLY . 93.5 mt -76.08 -20.16 57.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.406 -0.815 . . . . 74.22 112.27 -173.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -65.1 -41.96 57.46 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.789 1.033 . . . . 71.23 113.789 -170.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.29 -41.25 67.33 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.22 1.947 . . . . 60.41 113.317 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.9 m-85 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.766 0.826 . . . . 75.34 111.842 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -51.02 64.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 52.43 109.855 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -57.29 -44.52 84.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.557 -1.201 . . . . 70.34 111.332 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.48 -47.46 85.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.696 0.798 . . . . 71.33 111.528 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.15 -39.52 79.02 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.914 0.759 . . . . 53.45 110.972 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 114' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.7 -49.7 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.76 0.824 . . . . 73.5 110.842 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.433 HG23 ' HG3' ' D' ' 125' ' ' GLN . 30.2 m -57.06 -39.14 74.32 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.109 0.964 . . . . 73.23 111.578 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 36.4 t -65.89 -43.01 89.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.38 -0.827 . . . . 70.42 111.067 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.88 -35.16 74.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.813 0.445 . . . . 51.31 111.717 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.21 -40.92 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.27 -0.877 . . . . 64.34 110.315 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -71.19 -29.96 65.8 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.334 0.253 . . . . 53.11 110.886 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 93.8 mtt-85 -69.26 -32.82 72.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.044 0.538 . . . . 73.23 110.322 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.22 7.52 80.35 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.694 0.621 . . . . 74.22 113.0 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.4 p 53.71 36.08 22.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.787 1.635 . . . . 74.0 112.466 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -104.69 155.07 38.01 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.464 1.105 . . . . 75.34 109.815 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.55 141.15 97.13 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.416 2.744 . . . . 74.1 113.125 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.4 tt0 -54.46 133.71 45.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.398 1.079 . . . . 70.41 112.231 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.468 HD23 ' HG ' ' F' ' 139' ' ' LEU . 3.2 tm? -112.18 97.37 6.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.029 -1.1 . . . . 73.34 108.029 -173.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -108.58 108.94 20.04 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.578 0.751 . . . . 62.3 109.435 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.24 139.88 44.63 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.729 0.812 . . . . 75.35 111.3 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -68.95 145.59 96.78 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.937 0.895 . . . . 62.14 111.957 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 18.6 Cg_exo -69.07 104.38 1.2 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.23 2.62 . . . . 74.42 112.137 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.02 110.35 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.219 -0.66 . . . . 41.0 109.219 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -88.04 92.67 9.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.532 -0.914 . . . . 75.25 108.532 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -65.66 -33.49 76.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.828 0.451 . . . . 75.25 110.561 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.0 -42.86 77.05 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.89 0.876 . . . . 73.41 110.813 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.39 -60.04 4.1 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 124.26 0.975 . . . . 73.23 111.007 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' F' ' 149' ' ' PRO . 8.6 mp -61.16 -34.62 75.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.202 0.601 . . . . 71.15 112.103 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -62.34 -62.33 1.84 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 74.33 110.002 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.6 ptp -65.32 -28.35 69.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.524 -0.762 . . . . 61.34 111.223 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.409 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 95.1 m-20 -70.35 -42.95 71.16 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 123.818 0.699 . . . . 64.42 110.829 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.25 0.344 . . . . 74.24 110.455 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.74 -46.13 80.05 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.281 0.632 . . . . 73.42 111.472 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.5 pt20 -76.27 2.21 13.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.731 0.412 . . . . 73.42 111.986 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -121.2 44.61 2.48 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.811 0.844 . . . . 63.34 109.319 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -145.73 123.7 12.05 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.743 1.217 . . . . 61.22 107.817 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.44 143.2 44.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 44.21 110.582 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.83 -154.02 19.9 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.772 0.67 . . . . 44.01 111.459 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.6 148.12 50.77 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.624 0.77 . . . . 64.25 110.534 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.52 -176.25 18.36 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.773 -0.649 . . . . 74.53 111.652 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.9 p -74.97 88.45 2.36 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.373 0.669 . . . . 73.13 112.154 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.8 73.73 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.591 1.186 . . . . 65.15 109.462 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -72.75 121.23 19.53 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.502 -1.226 . . . . 72.22 110.984 -172.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -122.27 123.74 42.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.681 0.792 . . . . 75.41 109.322 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -118.26 -179.5 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.908 0.883 . . . . 73.42 110.372 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.74 115.5 21.01 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.834 -0.802 . . . . 71.21 108.834 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 123.206 0.602 . . . . 63.43 110.925 -179.262 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.861 -0.422 . . . . 60.41 109.861 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -115.39 54.23 0.81 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.364 0.602 . . . . 72.14 111.138 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.22 -42.59 15.76 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.808 -0.812 . . . . 53.52 108.808 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 21.0 t80 76.84 -57.05 0.54 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.284 1.834 . . . . 62.41 112.274 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 61.24 75.74 0.4 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.507 1.123 . . . . 75.42 110.847 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -177.57 -59.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.787 -1.097 . . . . 53.34 109.13 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -58.58 -32.2 68.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.329 1.052 . . . . 72.44 112.491 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.462 ' O ' ' HD3' ' E' ' 117' ' ' PRO . 37.1 tp 78.34 -52.48 0.49 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.526 1.53 . . . . 71.15 111.663 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -86.68 94.26 0.36 Allowed Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.648 1.179 . . . . 74.32 108.669 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' E' ' 115' ' ' LEU . 50.0 Cg_endo -102.17 5.89 0.49 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.158 2.572 . . . . 64.14 113.509 -172.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -152.97 120.73 6.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.107 0.563 . . . . 62.23 109.754 -168.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 70.7 p -82.6 107.35 15.18 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.977 0.798 . . . . 75.01 109.238 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.424 ' HE1' HG21 ' B' ' 46' ' ' THR . 18.1 t-105 -75.26 105.76 6.45 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.794 0.807 . . . . 71.31 111.158 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.93 115.47 28.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.484 -1.234 . . . . 65.41 108.805 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.53 33.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.385 0.674 . . . . 54.22 111.44 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 18.3 m -83.69 2.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.258 0.836 . . . . 73.1 113.258 -168.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 74.25 -69.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 72.15 110.374 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 65.0 t80 74.68 133.8 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.484 1.514 . . . . 64.51 112.841 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -170.91 144.51 2.2 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.628 1.171 . . . . 70.15 109.232 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 145.11 -137.82 7.35 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 111.172 -0.771 . . . . 61.34 111.172 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.64 87.82 2.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.865 0.841 . . . . 75.52 109.804 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 129' ' ' LEU . . . . . 0.668 HD22 ' H ' ' B' ' 42' ' ' LEU . 2.2 pp -97.69 2.99 50.33 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.366 -1.288 . . . . 73.25 110.785 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -85.51 145.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.98 -0.748 . . . . 71.5 108.98 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 131' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' D' ' 14' ' ' GLN . . . -61.03 -71.56 0.14 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.746 0.818 . . . . 72.41 110.592 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -162.82 147.68 9.45 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.009 0.924 . . . . 75.01 108.6 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.19 101.4 0.34 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.947 2.431 . . . . 75.43 112.964 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 134' ' ' ILE . . . . . 0.466 HG12 HH12 ' D' ' 15' ' ' ARG . 6.1 tp -129.93 120.92 50.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 107.965 -1.124 . . . . 73.22 107.965 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.89 139.06 39.21 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.104 -0.702 . . . . 45.21 109.104 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.545 ' HB ' ' HD3' ' C' ' 124' ' ' PRO . 16.5 m -126.64 -19.85 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.73 0.812 . . . . 73.03 111.069 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 67.46 127.69 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.56 1.544 . . . . 52.21 110.586 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.38 74.82 1.38 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.349 0.659 . . . . 64.51 110.129 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.33 138.04 57.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.6 0.76 . . . . 70.14 111.869 -172.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 22.8 p -150.16 27.26 0.77 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.0 0.92 . . . . 64.31 110.438 -171.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 141' ' ' LEU . . . . . 0.68 ' H ' HD23 ' E' ' 141' ' ' LEU . 2.0 pt? -89.51 42.46 1.09 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.177 0.989 . . . . 72.12 109.703 177.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.78 -67.1 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.407 1.083 . . . . 73.22 108.631 -175.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.94 100.86 3.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.52 1.128 . . . . 71.23 109.322 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -90.73 94.98 9.91 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.328 -0.99 . . . . 72.41 108.328 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 145' ' ' LYS . . . . . 0.524 ' HG2' ' H ' ' E' ' 146' ' ' ASP . 2.3 ttmp? 68.59 -163.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.268 1.027 . . . . 74.33 110.19 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 146' ' ' ASP . . . . . 0.675 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . 34.3 t70 65.01 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.006 1.323 . . . . 73.23 110.993 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 147' ' ' LEU . . . . . 0.699 HD13 ' HB ' ' A' ' 13' ' ' ILE . 1.2 tt -145.88 143.5 29.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.698 -0.853 . . . . 63.45 108.698 -177.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.62 ' HB2' ' HB2' ' C' ' 132' ' ' ASN . 4.8 mp -70.69 135.16 85.92 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.579 0.752 . . . . 74.25 109.671 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 149' ' ' PRO . . . . . 0.473 ' HD2' HD13 ' C' ' 136' ' ' LEU . 8.1 Cg_exo . . . . . 0 CA--C 1.562 1.884 0 C-N-CA 122.365 2.044 . . . . 63.13 110.657 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.398 0.618 . . . . 63.25 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.2 90.11 7.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.088 0.955 . . . . 61.12 109.457 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.45 88.93 2.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.932 0.893 . . . . 74.24 109.405 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.79 86.88 3.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.08 -0.711 . . . . 70.05 109.08 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -77.13 146.67 37.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.662 -1.154 . . . . 71.4 110.396 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -61.91 120.21 10.32 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.047 -1.094 . . . . 75.25 108.047 167.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.559 ' HD2' ' HA ' ' A' ' 49' ' ' SER . 11.0 tppt? -57.45 -48.75 78.33 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.257 0.973 . . . . 75.21 110.233 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 35.7 tp -170.66 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.364 -1.289 . . . . 75.25 107.855 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 116' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 98' ' ' LEU . 35.1 p90 -75.22 123.23 88.66 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.802 -1.09 . . . . 73.01 111.495 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.77 -166.13 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 123.161 2.574 . . . . 53.42 110.369 158.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 52.4 t80 57.26 87.28 0.06 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.294 1.037 . . . . 60.4 112.17 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 57.3 m -110.39 105.17 14.08 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.61 0.764 . . . . 75.34 109.175 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -109.56 156.7 19.84 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.831 0.852 . . . . 71.3 110.817 -175.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -125.35 131.97 52.9 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.648 0.779 . . . . 74.41 110.155 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -168.63 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.907 0.883 . . . . 74.4 111.104 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.37 155.12 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.053 0.541 . . . . 71.02 111.727 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -144.56 121.94 11.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.572 -0.74 . . . . 71.1 109.447 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -105.16 150.17 25.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.996 0.918 . . . . 65.35 109.569 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -161.2 151.06 17.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.257 -1.016 . . . . 73.41 108.257 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -72.47 -93.23 0.09 OUTLIER Glycine 0 C--N 1.347 1.156 0 O-C-N 123.606 0.566 . . . . 44.52 111.824 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 60.65 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.109 1.364 . . . . 75.31 111.892 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' F' ' 129' ' ' LEU . 1.2 pp -68.61 132.5 47.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.751 0.82 . . . . 64.45 111.924 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 56.5 mt -134.51 148.63 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.697 1.199 . . . . 72.01 108.316 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.22 123.81 23.07 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.656 -0.498 . . . . 62.23 109.656 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -71.0 125.42 92.01 Favored Pre-proline 0 CA--C 1.555 1.15 0 O-C-N 123.301 0.375 . . . . 74.13 110.332 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -94.9 164.2 1.71 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.857 2.372 . . . . 70.4 112.753 171.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.5 HG12 ' H ' ' F' ' 135' ' ' ALA . 14.4 tt -89.86 -177.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 107.33 -1.359 . . . . 73.1 107.33 166.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.5 ' H ' HG12 ' F' ' 134' ' ' ILE . . . -62.07 88.31 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.577 0.626 . . . . 55.25 110.331 174.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.52 96.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 70.35 110.461 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -145.14 -70.87 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.006 0.922 . . . . 62.24 109.116 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.34 128.77 10.64 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.736 0.814 . . . . 63.52 109.085 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.468 ' HG ' HD23 ' D' ' 126' ' ' LEU . 0.6 OUTLIER -66.01 96.74 0.33 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.071 0.948 . . . . 73.22 109.366 -176.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -80.06 172.58 13.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.865 0.866 . . . . 65.33 110.163 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 57.5 mt 65.03 30.45 11.71 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.433 1.093 . . . . 63.31 109.482 -163.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.48 HD12 HG11 ' D' ' 40' ' ' VAL . 10.2 tp -70.9 148.15 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.299 -1.319 . . . . 73.23 109.41 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -58.09 139.2 55.18 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.69 0.796 . . . . 72.23 111.373 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -106.4 -41.37 5.32 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.969 0.508 . . . . 75.13 110.302 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -82.26 70.84 9.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.307 0.575 . . . . 74.13 109.967 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 146' ' ' ASP . . . . . 0.585 ' HA ' ' HG3' ' F' ' 149' ' ' PRO . 28.8 t0 -164.66 173.65 11.66 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.838 -1.074 . . . . 73.43 108.305 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 tt 64.18 71.42 0.48 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.757 -1.571 . . . . 73.32 106.757 -168.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mp 60.08 73.77 0.62 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 114.593 -1.185 . . . . 72.02 110.34 -171.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 149' ' ' PRO . . . . . 0.641 ' HD2' HD21 ' D' ' 136' ' ' LEU . 27.5 Cg_exo . . . . . 0 C--N 1.384 2.399 0 C-N-CA 122.701 2.267 . . . . 54.45 111.537 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 110.126 -0.324 . . . . 62.05 110.126 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -65.21 105.26 1.06 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.729 0.812 . . . . 63.02 110.703 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -79.66 86.23 5.3 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.337 0.655 . . . . 74.35 109.891 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -153.12 154.7 35.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.96 0.904 . . . . 73.3 110.235 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -118.12 -45.41 2.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.537 0.735 . . . . 73.43 109.788 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 60.65 63.05 1.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.691 1.196 . . . . 72.12 111.129 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -131.32 154.76 48.21 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.402 0.681 . . . . 63.24 110.839 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 61.48 71.88 0.53 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.573 1.149 . . . . 73.32 111.583 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -99.14 152.8 19.47 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.774 -1.103 . . . . 71.2 109.782 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.0 m -143.11 113.69 7.46 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.496 0.718 . . . . 73.51 109.465 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HZ ' ' HG ' ' A' ' 102' ' ' CYS . 47.5 t80 -137.21 125.06 22.57 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.32 -0.993 . . . . 73.12 108.32 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -135.69 112.56 10.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.347 0.659 . . . . 75.12 109.721 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.8 mp -79.12 119.68 28.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.813 -1.18 . . . . 61.12 107.813 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 82.0 mm-40 -81.55 -41.51 21.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.651 0.594 . . . . 74.01 109.92 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.745 HH11 HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -173.47 163.96 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.319 1.048 . . . . 62.31 110.281 173.473 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' C' ' 130' ' ' PRO . 1.6 pp -144.03 101.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 64.7 m-85 -155.64 173.45 16.69 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.018 0.927 . . . . 72.35 109.886 -166.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.96 115.47 26.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.264 -0.425 . . . . 55.41 111.076 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -73.79 -44.74 55.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.967 -0.753 . . . . 64.13 108.967 171.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.8 t70 -135.78 148.35 48.73 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.757 -1.11 . . . . 75.11 110.368 -174.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.4 mt -145.13 142.75 22.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 126.021 1.728 . . . . 75.1 106.94 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -155.47 133.02 11.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.761 0.424 . . . . 72.32 110.403 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 77.1 t80 -127.28 131.11 50.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.241 -1.392 . . . . 74.14 107.241 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -129.24 126.51 39.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.235 0.614 . . . . 62.23 109.708 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 79.33 32.07 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.402 -0.962 . . . . 73.43 108.402 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.72 -11.87 20.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.771 2.314 . . . . 62.13 112.328 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -119.16 30.99 6.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.311 1.044 . . . . 73.14 109.112 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.27 99.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 N-CA-C 113.688 0.996 . . . . 62.41 113.688 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.17 -18.12 35.27 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 121.572 1.515 . . . . 60.41 113.277 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -80.12 -12.75 59.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.705 0.802 . . . . 75.14 112.765 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.12 -33.62 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 124.093 0.957 . . . . 73.43 112.806 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.27 -32.79 74.64 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.31 0.644 . . . . 74.34 111.637 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -90.72 -36.44 14.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 74.53 111.078 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.17 155.52 23.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.116 0.966 . . . . 75.34 111.517 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' HD11 ' A' ' 68' ' ' LEU . 7.6 m-20 -70.43 137.11 50.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.758 0.823 . . . . 60.12 110.007 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -88.36 61.66 6.28 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.87 -0.789 . . . . 61.11 108.87 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -142.45 58.56 7.6 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.972 0.909 . . . . 61.04 109.94 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.55 152.43 7.67 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.875 1.717 . . . . 71.45 112.208 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -93.28 117.51 30.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.583 -1.265 . . . . 73.5 107.583 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.68 136.25 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.971 0.508 . . . . 65.34 110.826 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -119.04 131.45 55.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.316 1.447 . . . . 65.13 108.913 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.436 HD23 HD21 ' F' ' 129' ' ' LEU . 4.6 pp -97.53 152.2 19.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.986 -1.116 . . . . 72.12 107.986 170.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 62' ' ' VAL . 26.3 t70 -144.2 143.35 31.02 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.087 -1.079 . . . . 75.5 108.087 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -140.61 125.31 18.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.494 0.717 . . . . 64.13 109.837 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 12.8 t70 -132.54 142.91 49.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.047 0.939 . . . . 74.35 109.517 -177.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.9 m -124.46 124.4 42.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.527 0.731 . . . . 75.45 110.404 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.56 8.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.362 0.665 . . . . 73.11 110.41 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.8 m -90.8 158.09 17.02 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.584 0.753 . . . . 60.34 109.585 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.5 t -162.13 118.35 2.01 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.085 0.402 . . . . 42.21 111.048 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.53 103.39 2.47 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.492 0.717 . . . . 72.03 110.74 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.766 HD11 ' HB2' ' A' ' 57' ' ' GLU . 48.2 mt -83.36 -34.54 25.59 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 71.41 110.862 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.36 -174.6 4.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.44 1.096 . . . . 43.43 108.908 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.84 96.32 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.433 0.458 . . . . 72.45 110.979 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.47 27.71 15.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.915 1.286 . . . . 73.32 112.278 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.18 113.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.784 -1.561 . . . . 74.31 106.784 168.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 49' ' ' SER . 22.7 m-85 -119.1 129.06 54.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.868 -0.79 . . . . 73.41 108.868 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.766 ' HB2' HD11 ' A' ' 51' ' ' LEU . 39.5 tt0 -83.32 114.99 21.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.906 -1.146 . . . . 65.14 107.906 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.85 111.26 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.314 -1.365 . . . . 73.05 107.314 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 80.7 t -97.16 136.11 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.353 1.061 . . . . 53.22 109.352 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -108.16 116.14 31.42 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.062 -0.718 . . . . 72.51 109.062 175.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -92.9 106.49 18.45 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.777 -0.823 . . . . 63.22 108.777 173.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 49.5 t -107.74 133.17 53.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.323 0.649 . . . . 72.21 109.666 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.1 m -121.95 138.96 54.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.574 -0.528 . . . . 72.25 109.574 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 114' ' ' ILE . 53.6 t -126.12 105.63 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.877 -1.527 . . . . 72.43 106.877 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.0 m -108.13 144.0 36.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.417 -0.957 . . . . 74.45 108.417 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.37 124.87 27.96 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.991 -1.115 . . . . 54.22 107.991 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -126.05 125.95 43.46 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.654 0.596 . . . . 72.44 109.829 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 35' ' ' ASP . 49.0 tp -91.86 73.3 5.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.035 0.934 . . . . 61.14 108.922 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.61 -92.12 0.78 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.715 -0.675 . . . . 74.52 112.847 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -98.84 -26.81 14.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.822 0.849 . . . . 72.32 111.23 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.37 138.01 44.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.575 0.75 . . . . 73.2 111.001 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -60.65 129.72 42.96 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.446 0.466 . . . . 71.41 110.202 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.86 -56.05 4.22 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.585 -0.524 . . . . 74.25 109.585 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.517 ' HE1' ' HG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -164.75 166.89 19.51 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.326 0.65 . . . . 61.02 109.77 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 76' ' ' CYS . 27.8 tp -143.79 146.4 33.07 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.201 0.6 . . . . 75.12 111.283 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.517 ' HG ' ' HE1' ' A' ' 74' ' ' PHE . 51.7 m -143.54 142.29 31.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.2 1.4 . . . . 73.14 109.88 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -148.45 123.53 10.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 70.11 109.602 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.18 130.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.609 0.764 . . . . 74.42 110.183 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 72.3 mt-30 -95.67 96.95 9.36 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.472 0.709 . . . . 64.31 109.57 168.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -83.21 93.94 7.78 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.026 -0.731 . . . . 74.22 109.026 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.2 144.4 19.24 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.823 -0.511 . . . . 63.54 111.823 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.37 122.25 2.03 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.445 -1.062 . . . . 65.41 110.445 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.745 HD12 HH11 ' A' ' 15' ' ' ARG . 33.8 mt -82.79 123.87 38.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.572 -0.899 . . . . 75.31 108.572 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -129.28 138.31 51.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.158 -0.682 . . . . 71.24 109.158 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.6 m -108.63 119.09 38.51 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.918 -1.141 . . . . 62.13 107.918 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.36 131.16 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 120.975 0.417 . . . . 65.22 110.829 -172.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.7 165.53 28.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.202 1.001 . . . . 61.41 110.88 -173.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.4 -33.19 6.38 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 116.063 -0.517 . . . . 72.01 112.86 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.85 178.26 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.085 0.954 . . . . 64.13 108.827 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 14.6 tt0 -161.64 -179.44 7.28 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 110.238 -0.282 . . . . 61.44 110.238 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.97 -147.96 40.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.561 0.585 . . . . 64.1 114.561 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -63.37 -26.76 68.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.371 1.068 . . . . 72.44 113.013 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.12 -41.05 82.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.194 0.598 . . . . 71.55 111.915 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.707 ' SD ' ' HG ' ' F' ' 115' ' ' LEU . 3.4 ptp -84.02 -33.86 24.42 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.717 -0.219 . . . . 62.3 111.39 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -24.15 67.77 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.227 0.537 . . . . 54.03 110.718 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -64.86 -54.49 30.17 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 70.41 109.984 164.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.6 m -65.73 -63.37 1.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.268 0.84 . . . . 71.21 113.268 -170.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.08 -8.07 34.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.862 0.756 . . . . 62.34 112.206 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.49 -4.0 40.47 Favored Glycine 0 C--N 1.36 1.911 0 N-CA-C 115.263 0.865 . . . . 61.31 115.263 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.02 -59.23 0.25 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.767 0.784 . . . . 51.44 111.025 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.0 t80 -53.46 -54.74 32.65 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 124.571 1.148 . . . . 71.44 112.949 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.576 ' HG ' ' HZ ' ' A' ' 11' ' ' PHE . 19.7 m -71.69 -42.02 10.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.384 0.674 . . . . 72.22 111.739 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.78 -39.02 78.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.463 2.109 . . . . 71.41 113.973 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -72.62 -24.45 61.07 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.367 0.667 . . . . 72.14 111.442 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.7 mm -69.13 -45.59 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.411 0.684 . . . . 71.34 109.407 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.31 -33.56 71.68 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.283 -0.871 . . . . 73.44 112.01 -173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.64 -44.7 92.34 Favored Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 114.56 1.318 . . . . 72.41 114.56 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.48 -32.25 96.02 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.111 1.874 . . . . 74.03 113.617 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.72 -32.46 31.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.423 0.689 . . . . 53.2 111.358 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.22 75.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.711 -0.477 . . . . 71.13 109.711 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -54.54 -49.05 71.21 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.67 1.231 . . . . 72.02 110.19 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.67 -51.46 69.68 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.162 0.914 . . . . 74.41 110.912 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.15 -45.56 79.59 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.192 0.933 . . . . 62.24 111.155 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 118' ' ' VAL . 5.7 mt -60.43 -58.49 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 74.43 110.189 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 125' ' ' GLN . 65.7 m -52.67 -40.5 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.988 0.915 . . . . 72.44 112.087 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.6 t -66.9 -43.24 83.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.212 -0.904 . . . . 74.23 109.981 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.452 ' SD ' HG23 ' A' ' 21' ' ' ILE . 10.9 mtp -58.36 -44.03 88.64 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.509 0.724 . . . . 60.32 110.954 174.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 114' ' ' ILE . 39.3 t -61.2 -46.0 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.626 0.77 . . . . 65.33 110.6 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.3 p -73.36 -30.66 63.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.34 -0.846 . . . . 74.23 111.111 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -69.75 -25.21 63.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.568 0.747 . . . . 73.03 109.782 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.95 0.02 84.08 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.649 -0.705 . . . . 54.41 112.682 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.0 m 69.98 12.19 7.79 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.823 1.249 . . . . 72.31 111.137 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -94.47 152.99 40.44 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 123.268 0.627 . . . . 74.55 110.37 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -54.11 120.45 7.97 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.776 2.317 . . . . 73.22 111.4 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.665 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.4 pt20 -60.08 160.22 8.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.961 0.904 . . . . 63.53 112.63 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.4 115.27 17.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.614 -0.884 . . . . 60.33 108.614 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.54 120.98 43.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.71 0.804 . . . . 74.21 109.194 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 64' ' ' VAL . 57.3 mt -73.36 135.38 44.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.753 0.821 . . . . 75.13 110.437 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.91 136.61 96.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.372 0.42 . . . . 65.41 110.569 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 29.7 Cg_endo -91.1 103.09 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.999 2.466 . . . . 61.32 112.311 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.43 HG21 ' H ' ' F' ' 126' ' ' ASN . 45.3 t -121.1 116.04 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.028 -1.101 . . . . 64.24 108.028 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -69.83 106.48 3.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.474 -0.565 . . . . 72.24 109.474 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.59 -17.27 62.3 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.286 -0.87 . . . . 70.33 111.71 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -60.09 -39.22 85.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.042 0.537 . . . . 71.03 111.479 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.83 70.23 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.157 0.91 . . . . 70.53 111.534 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.77 -39.84 80.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.742 0.817 . . . . 63.1 110.955 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.411 ' HE2' HD13 ' A' ' 141' ' ' LEU . 46.8 t80 -89.24 -20.91 23.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.407 -0.36 . . . . 73.3 111.951 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.23 -43.36 99.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.395 0.678 . . . . 64.45 110.837 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 8.8 p30 -65.49 -21.11 66.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.045 -0.98 . . . . 65.55 111.701 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -92.15 -34.83 14.18 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.507 0.723 . . . . 75.5 110.692 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.411 HD13 ' HE2' ' A' ' 137' ' ' PHE . 62.4 tp -68.14 -51.75 42.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.771 0.828 . . . . 75.43 112.438 -170.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -147.83 -15.11 0.37 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.144 0.978 . . . . 74.14 109.378 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 1.1 tm0? 62.92 -77.03 0.03 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.374 1.469 . . . . 63.51 111.228 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -65.01 -53.04 52.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.934 0.894 . . . . 73.25 110.659 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.75 -171.06 0.16 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.317 1.047 . . . . 75.03 110.979 -174.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.13 92.67 0.09 OUTLIER Glycine 0 C--N 1.344 1.011 0 N-CA-C 112.09 -0.404 . . . . 54.25 112.09 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.21 136.43 35.84 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.958 0.503 . . . . 75.1 110.128 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.43 -8.37 85.12 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.776 0.672 . . . . 71.15 112.687 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 155' ' ' ALA . 75.0 p -70.23 128.73 37.26 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.045 0.938 . . . . 73.54 110.348 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -153.55 -40.25 0.1 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.919 0.487 . . . . 72.04 111.846 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.414 ' HB3' ' OD2' ' A' ' 154' ' ' ASP . 2.9 tt0 -93.72 -88.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 118.806 -0.616 . . . . 72.0 110.41 -173.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p-80 -174.01 -43.76 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.696 0.628 . . . . 74.34 112.696 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -66.56 -17.04 64.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.248 0.547 . . . . 64.1 111.227 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 151' ' ' GLU . 14.0 p-10 -102.56 100.5 10.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.248 1.419 . . . . 72.51 109.674 177.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' A' ' 149' ' ' THR . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 117.86 -1.067 . . . . 71.05 109.533 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 109.949 -0.389 . . . . 62.33 109.949 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -149.52 152.14 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.88 0.872 . . . . 50.42 109.418 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.35 78.93 1.35 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.97 -1.122 . . . . 75.42 107.97 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -135.77 134.34 38.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.914 0.486 . . . . 62.05 109.995 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.01 107.33 12.71 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.812 -0.81 . . . . 72.52 108.812 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -166.71 -164.59 0.66 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.447 -0.945 . . . . 70.22 108.447 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 43.7 p -79.63 68.28 5.64 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.99 0.9 . . . . 72.53 110.063 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' B' ' 9' ' ' MET . 21.9 tt0 -121.7 -162.89 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 106.889 -1.523 . . . . 72.44 106.889 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.491 ' H ' ' HG2' ' B' ' 8' ' ' GLU . 11.7 ptm 59.32 169.78 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.096 1.758 . . . . 75.12 114.758 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -155.85 136.2 13.12 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.813 1.245 . . . . 75.42 108.003 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.566 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 8.5 t80 -134.84 112.16 10.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.509 -0.552 . . . . 74.41 109.509 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -127.03 115.94 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.786 -0.82 . . . . 74.14 108.786 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.5 135.76 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 116.455 -0.339 . . . . 73.13 110.218 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -98.47 -50.14 4.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.61 -0.885 . . . . 75.14 108.61 169.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -163.1 142.31 8.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.068 -0.515 . . . . 71.22 110.696 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 81.2 mt -116.89 142.26 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 106.403 -1.703 . . . . 70.42 106.403 165.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -167.74 142.12 3.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.136 0.425 . . . . 73.23 111.374 -173.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -72.19 121.48 19.41 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.189 -0.914 . . . . 73.32 108.808 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.456 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.8 mtpt -97.07 -24.87 15.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.472 0.709 . . . . 73.21 110.729 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -156.66 138.13 13.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.863 -0.608 . . . . 72.31 110.28 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.5 mm -132.63 148.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.752 1.221 . . . . 63.52 107.963 173.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -150.22 142.33 24.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.294 -0.867 . . . . 75.12 109.162 165.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.1 t80 -146.57 114.2 6.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.076 -1.824 . . . . 72.23 106.076 168.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.92 114.35 20.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.806 -0.813 . . . . 73.31 108.806 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.597 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.45 85.59 1.81 Allowed Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.418 -0.956 . . . . 53.12 108.418 171.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.76 -20.81 29.64 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.827 2.351 . . . . 54.35 111.289 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.496 ' O ' HG23 ' B' ' 31' ' ' VAL . 80.7 m-20 -125.98 20.2 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.532 1.133 . . . . 73.11 110.577 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.597 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -37.81 -55.0 2.24 Favored Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 125.671 1.589 . . . . 73.14 114.415 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 8.5 Cg_exo -69.56 -20.11 36.21 Favored 'Trans proline' 0 C--N 1.392 2.847 0 C-N-CA 123.057 2.505 . . . . 63.13 112.903 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -96.59 -27.45 14.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.026 0.93 . . . . 54.24 112.442 -171.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 27' ' ' ASN . 64.2 t -67.22 -22.78 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.119 0.568 . . . . 73.42 110.916 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -57.33 -38.3 73.86 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.214 0.606 . . . . 74.32 111.499 171.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -73.6 -15.59 61.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.915 0.886 . . . . 74.22 111.731 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -104.17 108.86 20.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.529 0.732 . . . . 63.52 111.16 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -100.03 86.02 3.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.489 0.716 . . . . 73.24 109.949 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.638 ' HB3' HD21 ' B' ' 68' ' ' LEU . 22.3 t90 -165.75 157.98 14.81 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.893 0.877 . . . . 74.23 109.107 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.7 121.35 84.92 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.4 109.536 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 146.69 52.37 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.48 2.12 . . . . 55.24 112.811 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.39 103.52 2.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.2 0.6 . . . . 73.54 109.503 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.769 HG11 HD21 ' B' ' 126' ' ' LEU . 23.0 t -106.46 144.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.316 0.646 . . . . 64.12 109.838 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -145.17 131.07 19.15 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.159 -1.052 . . . . 70.52 108.159 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.476 HD21 ' HG ' ' B' ' 128' ' ' LEU . 7.1 mp -88.49 165.98 14.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.455 -0.572 . . . . 74.24 109.455 173.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -160.76 142.85 12.5 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.348 -1.352 . . . . 64.01 107.348 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.63 170.01 10.46 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.243 0.544 . . . . 70.21 110.72 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.4 t70 -142.14 126.37 17.52 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.683 -1.144 . . . . 51.43 108.281 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 p -107.93 103.94 13.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.602 0.761 . . . . 73.43 109.202 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.56 133.2 34.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.646 0.778 . . . . 63.11 109.699 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.442 ' HB2' ' CE1' ' E' ' 116' ' ' TYR . 8.6 m -140.13 164.97 28.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.548 0.739 . . . . 72.13 109.113 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -151.63 139.73 20.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.838 0.455 . . . . 61.22 110.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -81.84 112.53 19.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.938 -0.764 . . . . 72.14 108.938 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.19 -51.93 12.19 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.424 0.631 . . . . 75.42 110.016 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.9 -172.35 3.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.47 1.108 . . . . 54.22 109.527 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 124.33 23.99 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.992 -0.744 . . . . 73.14 108.992 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 63.38 22.08 13.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.318 1.047 . . . . 72.25 112.152 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -138.75 123.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.097 -1.075 . . . . 71.34 108.097 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.487 ' HE1' ' HB2' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -130.88 -179.51 5.36 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.662 -0.496 . . . . 73.04 109.662 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -142.39 109.65 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.04 -1.096 . . . . 71.05 108.04 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.58 124.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.755 0.822 . . . . 73.31 109.397 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.1 t -106.69 122.31 60.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 N-CA-C 109.487 -0.561 . . . . 75.04 109.487 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.36 112.17 23.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.131 -1.433 . . . . 72.31 107.131 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 52.6 ttt180 -102.02 126.19 48.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.743 -0.465 . . . . 64.33 109.743 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.81 111.1 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.309 1.044 . . . . 62.44 108.882 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -94.79 138.59 32.4 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.761 -0.829 . . . . 65.54 108.761 170.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.5 t -131.52 130.03 62.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.107 0.963 . . . . 71.01 108.414 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.9 m -125.54 138.41 53.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.325 -0.621 . . . . 74.43 109.325 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 137.45 32.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.556 0.743 . . . . 74.31 109.289 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.3 p -144.03 124.82 14.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.284 0.634 . . . . 61.32 109.957 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.638 HD21 ' HB3' ' B' ' 36' ' ' TRP . 3.0 tt -95.63 112.8 24.44 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.78 -1.192 . . . . 71.22 107.78 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.13 -111.51 3.28 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.914 -0.874 . . . . 74.54 110.914 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.98 15.69 9.99 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.067 0.947 . . . . 72.42 110.612 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.63 141.12 48.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.5 1.12 . . . . 74.12 108.665 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 71.5 m -61.4 134.49 56.97 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.325 0.511 . . . . 63.1 110.517 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.4 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.86 -58.11 2.59 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.376 -0.972 . . . . 63.15 108.376 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.44 159.1 30.53 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.778 -1.101 . . . . 75.12 109.765 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.02 145.78 51.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.364 -1.347 . . . . 54.13 107.364 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.2 146.1 22.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.307 -0.627 . . . . 65.14 109.307 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -158.7 125.25 4.68 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.714 -0.476 . . . . 73.55 109.714 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.57 150.22 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 72.41 109.36 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -127.05 102.47 6.99 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.03 -0.73 . . . . 72.42 109.03 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -89.82 104.02 16.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.889 -0.596 . . . . 74.33 109.586 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.0 170.38 37.72 Favored Glycine 0 C--O 1.245 0.809 0 O-C-N 123.551 0.532 . . . . 71.52 112.133 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.56 125.84 1.36 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.913 -0.475 . . . . 52.33 111.913 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.7 mt -86.36 119.36 34.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.639 -0.874 . . . . 73.03 108.639 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.487 ' HB2' ' HE1' ' B' ' 56' ' ' TYR . 47.0 m-85 -121.83 135.05 54.9 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -100.61 120.87 40.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.203 1.001 . . . . 73.32 108.669 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.09 109.55 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.629 0.771 . . . . 73.13 111.528 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.74 140.12 50.11 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.704 0.801 . . . . 64.13 110.382 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.01 -26.91 14.51 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 111.993 -0.443 . . . . 60.05 111.993 -170.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' B' ' 94' ' ' MET . 2.1 mp -63.95 131.97 29.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 125.339 1.455 . . . . 62.11 110.897 -176.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -159.79 143.58 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.214 0.946 . . . . 73.14 109.716 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.35 -117.86 11.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.831 0.707 . . . . 64.13 113.997 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.579 ' HA ' ' HB3' ' B' ' 95' ' ' ALA . 39.3 m -65.88 -29.8 70.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.363 1.065 . . . . 73.4 111.898 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -49.9 -46.66 52.02 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 124.111 0.882 . . . . 73.52 111.064 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.52 ' HA ' ' HB3' ' B' ' 97' ' ' CYS . 9.1 ptm -94.18 -29.07 15.31 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.423 0.897 . . . . 74.14 113.423 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' B' ' 92' ' ' THR . . . -57.54 -28.86 63.89 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.912 0.778 . . . . 74.32 111.362 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.07 -32.72 17.41 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.257 1.023 . . . . 73.43 110.952 172.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.566 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 42.6 t -70.17 -66.82 0.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.923 0.489 . . . . 74.22 111.556 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.539 HD21 ' HD2' ' E' ' 117' ' ' PRO . 0.8 OUTLIER -63.77 -18.71 64.34 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 118.07 0.396 . . . . 71.35 111.773 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.44 -20.25 58.92 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 116.126 -0.488 . . . . 32.42 113.858 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.61 -58.7 0.16 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.398 0.599 . . . . 72.24 112.543 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.37 -51.7 61.97 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.943 0.72 . . . . 74.01 112.943 -167.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 75.2 m -60.71 -48.52 92.9 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.545 -0.74 . . . . 72.31 111.263 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 96.5 Cg_exo -50.14 -35.52 42.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.373 2.049 . . . . 74.12 114.797 167.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -67.84 -35.67 78.99 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.355 0.525 . . . . 62.32 111.433 177.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.881 0.872 . . . . 70.54 110.1 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 74.6 mt -84.26 -20.49 32.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.793 -1.094 . . . . 71.03 112.401 -170.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -58.39 -48.94 96.05 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.047 -0.978 . . . . 73.25 113.311 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 76.9 Cg_exo -55.22 -39.76 89.29 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.571 2.181 . . . . 54.43 114.15 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.5 m-85 -65.89 -49.6 67.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.698 . . . . 74.41 111.257 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.86 96.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.678 0.791 . . . . 42.02 110.863 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.57 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.0 ttt-85 -63.11 -56.23 18.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.134 1.374 . . . . 72.34 111.457 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.89 -40.87 73.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.377 1.071 . . . . 72.23 110.83 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.543 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -65.93 -44.4 85.21 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.577 -0.283 . . . . 63.23 111.082 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.404 HD12 HD21 ' B' ' 128' ' ' LEU . 72.7 mt -60.52 -54.8 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 123.524 0.729 . . . . 74.21 110.992 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -58.36 -29.79 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.448 0.699 . . . . 72.44 111.501 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -70.16 -54.37 13.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.436 0.694 . . . . 73.31 110.131 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.3 mmt -63.2 -34.86 78.55 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.248 0.619 . . . . 74.12 111.866 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.8 -46.66 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.901 0.881 . . . . 62.22 110.902 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.44 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 80.4 p -73.58 -24.79 60.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.773 0.429 . . . . 73.11 111.714 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -63.42 -28.58 70.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.708 0.803 . . . . 74.41 110.637 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.99 17.28 59.55 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.249 -0.75 . . . . 53.11 113.631 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.2 p 70.19 13.35 7.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 126.231 1.813 . . . . 64.32 113.418 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -90.61 150.5 42.62 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 122.618 0.367 . . . . 72.51 110.373 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.8 159.13 18.31 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.363 2.709 . . . . 70.45 113.368 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.31 135.6 57.7 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.882 0.739 . . . . 71.41 110.112 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.769 HD21 HG11 ' B' ' 40' ' ' VAL . 1.3 tm? -108.61 110.91 22.48 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.796 -1.557 . . . . 72.24 106.796 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -91.62 94.25 9.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.798 -0.816 . . . . 64.41 108.798 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.57 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 5.4 mp -69.93 108.14 3.88 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.589 -1.263 . . . . 71.01 107.589 171.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.31 139.26 87.0 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.563 0.539 . . . . 72.45 110.081 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.49 82.72 0.68 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 122.194 1.929 . . . . 72.51 111.14 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' E' ' 125' ' ' TYR . 66.1 t -91.32 132.59 35.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 114.722 -1.126 . . . . 65.23 108.424 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -70.73 113.2 7.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.526 0.73 . . . . 53.13 110.299 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.12 -40.17 92.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.329 1.051 . . . . 71.23 110.788 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' B' ' 138' ' ' MET . 4.2 p30 -61.42 -34.17 74.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.154 -0.93 . . . . 75.11 111.046 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.52 90.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.938 0.495 . . . . 64.53 111.163 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.421 ' HB3' ' CH2' ' E' ' 120' ' ' TRP . 0.2 OUTLIER -67.2 -34.43 77.5 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.208 -0.664 . . . . 72.24 109.208 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.55 -41.32 97.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.064 0.945 . . . . 65.23 111.127 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 19.6 mmt -63.34 -37.81 88.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 120.974 0.416 . . . . 74.04 110.218 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.458 ' HA ' ' HG3' ' B' ' 142' ' ' GLN . 36.0 m-80 -76.43 -22.04 55.17 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.544 -0.753 . . . . 64.15 112.322 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -68.24 -32.98 73.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.667 0.387 . . . . 73.13 110.741 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.86 4.62 52.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.734 0.414 . . . . 65.33 111.818 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' B' ' 139' ' ' ASN . 5.4 pp0? -132.82 174.91 9.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.484 0.713 . . . . 70.15 109.708 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -150.64 157.42 42.96 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.079 -0.711 . . . . 75.21 109.079 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.41 86.31 0.43 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.028 -1.101 . . . . 71.22 108.028 168.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.75 120.51 26.11 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.888 -1.051 . . . . 75.31 111.087 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.39 58.84 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.401 -0.68 . . . . 72.33 111.401 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 61.94 25.93 15.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.815 1.246 . . . . 74.32 112.067 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.92 -9.89 11.74 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.927 -0.579 . . . . 32.14 112.598 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.503 HG21 ' HB3' ' B' ' 154' ' ' ASP . 21.0 m -70.57 131.26 43.7 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.241 0.616 . . . . 73.02 111.874 -174.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -63.98 -36.97 85.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.379 0.671 . . . . 72.45 110.822 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.22 119.18 16.06 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.683 -0.69 . . . . 55.23 109.153 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -79.62 -8.38 59.15 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.597 0.759 . . . . 74.51 111.937 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -68.73 -30.71 69.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.798 0.839 . . . . 71.01 109.89 170.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' B' ' 149' ' ' THR . 25.2 t70 -111.17 144.67 39.96 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.674 0.79 . . . . 62.04 109.786 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 122.984 0.514 . . . . 61.03 110.285 -178.944 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.795 -0.446 . . . . 73.32 109.795 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -148.15 89.63 1.75 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.045 0.938 . . . . 75.02 108.776 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.56 79.47 4.06 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.067 0.937 . . . . 72.23 110.275 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -77.81 78.82 4.31 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.314 1.054 . . . . 73.02 108.916 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -74.61 112.5 10.87 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.76 -1.563 . . . . 73.4 111.081 -174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -154.53 132.05 11.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.524 -0.547 . . . . 73.24 109.524 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -119.81 -17.0 8.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.291 1.037 . . . . 72.24 109.773 174.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -89.5 106.73 18.65 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.721 0.809 . . . . 74.24 109.61 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.5 ' H ' HG23 ' C' ' 89' ' ' ILE . 54.2 ttp 65.68 115.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.421 1.488 . . . . 71.54 112.093 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -128.27 101.58 6.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.434 -1.321 . . . . 62.24 107.434 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.488 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -114.78 143.47 45.02 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.376 0.67 . . . . 65.33 110.181 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -147.84 144.62 28.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.274 0.629 . . . . 74.5 110.02 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -92.2 120.24 41.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.815 -0.809 . . . . 55.54 108.815 171.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -91.39 -38.32 12.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.53 0.332 . . . . 72.41 110.42 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.56 148.54 3.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.073 -0.343 . . . . 72.4 110.073 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -136.04 132.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.137 -1.06 . . . . 72.45 108.137 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.0 p90 -170.72 162.56 7.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.643 0.735 . . . . 54.44 112.09 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -87.39 117.35 26.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.826 -1.079 . . . . 54.02 110.203 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.508 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 6.8 mtmt -92.83 -7.52 46.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.411 0.284 . . . . 74.22 110.697 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.8 t70 -160.27 135.19 7.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.391 -0.966 . . . . 70.04 108.391 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.9 mt -149.05 139.11 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.014 -1.847 . . . . 72.44 106.014 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -158.92 151.04 21.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.063 0.459 . . . . 74.52 109.869 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.9 128.98 15.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.519 -1.289 . . . . 71.23 107.519 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.7 142.43 51.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.72 -0.844 . . . . 64.21 108.72 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -154.43 77.94 5.26 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.753 -0.832 . . . . 72.24 108.753 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 -30.5 22.87 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.48 2.12 . . . . 71.23 111.574 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' C' ' 72' ' ' THR . 37.4 m-20 -112.14 33.51 4.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.007 0.923 . . . . 75.43 109.371 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.556 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -54.29 -45.89 99.1 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.496 1.118 . . . . 71.01 113.583 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -75.57 -25.55 10.89 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.401 2.067 . . . . 74.2 113.4 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.13 -51.28 70.28 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.741 0.651 . . . . 73.01 111.256 -172.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.528 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 14.5 p -55.39 -25.53 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.423 1.089 . . . . 60.05 113.342 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -66.88 -42.82 84.93 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.84 0.456 . . . . 72.35 111.515 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -103.4 13.85 32.73 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.26 0.624 . . . . 73.52 110.29 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 24.3 ttpp -124.46 174.2 7.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.368 1.067 . . . . 72.4 109.434 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.415 ' N ' ' HG2' ' C' ' 34' ' ' LYS . 21.5 t70 -54.57 113.8 1.43 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.337 1.055 . . . . 43.22 110.958 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -86.85 64.97 8.77 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.879 0.847 . . . . 72.33 111.24 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -158.95 78.79 2.98 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.617 -0.883 . . . . 74.32 108.617 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -88.35 174.22 4.39 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.697 2.265 . . . . 74.51 111.574 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' C' ' 67' ' ' SER . 11.0 tp10 -85.8 107.63 17.73 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.052 -0.722 . . . . 65.33 109.052 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.657 ' H ' HD12 ' E' ' 141' ' ' LEU . 57.4 t -74.96 99.98 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.274 -0.875 . . . . 71.44 108.988 176.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.8 tmtt? -107.41 103.22 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.292 -1.003 . . . . 70.24 108.292 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.643 HD13 ' H ' ' C' ' 42' ' ' LEU . 0.0 OUTLIER -87.25 155.37 20.1 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.141 -0.689 . . . . 72.11 109.141 173.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.1 t70 -150.95 143.82 24.55 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.998 -0.741 . . . . 63.15 108.998 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.98 145.72 48.39 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.467 -0.568 . . . . 73.15 109.467 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -156.99 149.98 23.78 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.78 0.832 . . . . 73.24 108.794 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -130.8 154.3 48.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.187 0.518 . . . . 74.2 110.214 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -140.8 171.13 14.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.022 . . . . 75.41 108.607 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 25.8 p -159.02 143.55 15.63 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.9 0.48 . . . . 65.05 110.35 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -149.84 128.02 12.03 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.859 0.863 . . . . 74.12 109.021 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.74 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.54 0.336 . . . . 71.43 110.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' C' ' 57' ' ' GLU . 31.7 mt -103.49 -30.12 10.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.835 0.854 . . . . 63.53 110.204 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.58 -178.43 6.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.88 0.872 . . . . 63.32 110.489 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -62.16 117.31 5.86 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.299 -0.864 . . . . 73.51 109.925 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.91 0.27 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.528 1.131 . . . . 75.04 113.171 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.2 t -103.8 114.81 44.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.215 0.531 . . . . 75.54 109.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -124.22 123.56 40.53 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.732 -1.21 . . . . 74.02 107.732 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.6 111.08 18.25 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.74 -0.837 . . . . 71.13 108.74 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.28 126.66 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.287 -1.005 . . . . 73.43 108.287 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 42.0 t -110.96 102.3 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.112 -1.07 . . . . 75.21 108.112 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.2 tm? -91.95 102.83 15.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.781 -0.822 . . . . 72.04 108.781 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -85.08 125.47 32.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.904 1.281 . . . . 63.21 110.866 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.2 t -119.27 141.73 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.313 1.045 . . . . 73.32 108.954 170.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.0 m -131.94 133.46 44.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.888 0.875 . . . . 70.44 109.256 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.737 HG23 HD13 ' C' ' 114' ' ' ILE . 93.2 t -116.74 117.18 54.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.345 -0.983 . . . . 74.0 108.345 167.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.43 HG23 HD23 ' C' ' 75' ' ' LEU . 13.9 m -105.15 141.92 35.84 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.597 -0.89 . . . . 53.12 108.597 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.02 93.04 2.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.176 -1.416 . . . . 75.42 107.176 176.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' C' ' 39' ' ' GLU . 59.6 p -161.85 131.84 4.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.874 0.47 . . . . 75.03 109.896 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.78 39.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.793 0.806 . . . . 74.35 109.911 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.89 -84.33 0.72 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.093 -0.803 . . . . 33.54 111.093 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.12 -31.34 17.14 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.712 0.805 . . . . 55.54 111.232 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -101.23 98.73 9.09 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.087 0.955 . . . . 73.02 110.252 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 32.2 m -88.88 118.31 28.5 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.96 0.504 . . . . 74.14 111.997 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -51.74 29.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.681 0.792 . . . . 62.13 109.071 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -162.52 174.72 12.29 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.98 -1.464 . . . . 73.24 110.621 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.4 tm? -145.56 146.39 31.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 73.22 105.773 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.451 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -151.4 132.64 14.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.715 -0.846 . . . . 63.14 108.715 175.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -141.38 134.47 29.22 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.431 -0.581 . . . . 73.24 109.431 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.19 140.4 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.032 . . . . 72.21 108.603 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.0 mt-30 -115.04 102.19 9.71 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.594 -0.891 . . . . 74.33 108.594 170.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.1 tp-100 -82.45 99.6 9.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.919 0.888 . . . . 73.31 109.552 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.65 144.85 22.43 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.317 -0.713 . . . . 53.42 111.317 174.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.27 118.94 1.35 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.211 -0.755 . . . . 73.1 111.211 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -80.97 122.17 35.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.984 -1.117 . . . . 60.53 107.984 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -135.54 154.57 51.33 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.014 0.525 . . . . 74.31 110.608 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -105.19 118.83 37.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.34 -0.985 . . . . 71.13 108.34 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.432 HG21 ' HG3' ' C' ' 94' ' ' MET . 3.8 mp -113.86 107.01 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.158 -1.423 . . . . 70.32 107.158 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.61 16.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.997 0.919 . . . . 64.23 110.341 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.92 -55.23 4.06 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.945 -0.57 . . . . 44.21 112.686 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.5 HG23 ' H ' ' C' ' 9' ' ' MET . 2.6 pp -110.02 175.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.731 0.812 . . . . 54.21 111.139 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.2 pt-20 -163.78 -176.21 4.5 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.795 -0.638 . . . . 73.3 110.78 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.23 -124.8 28.49 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.333 -0.394 . . . . 61.22 113.768 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -60.58 -36.76 79.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.122 0.969 . . . . 51.12 111.175 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -66.93 -42.18 85.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.621 -1.172 . . . . 71.53 110.991 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.507 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 58.8 ttm -71.84 -36.53 70.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.951 0.501 . . . . 74.14 110.385 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.27 94.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.282 0.633 . . . . 55.45 111.075 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.73 -27.62 66.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.603 0.761 . . . . 65.11 111.134 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 36.6 t -72.81 -62.46 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 110.047 -0.353 . . . . 74.24 110.047 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.23 -17.83 62.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.829 0.452 . . . . 70.4 112.126 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.61 -10.83 46.09 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.433 -0.649 . . . . 71.25 114.181 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.83 -56.18 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 117.874 0.837 . . . . 40.31 112.343 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -70.68 -49.43 47.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.14 0.576 . . . . 73.43 112.128 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.522 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.9 m -63.4 -46.36 84.51 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.358 0.663 . . . . 61.52 111.247 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.1 Cg_exo -55.54 -36.67 94.87 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.686 2.257 . . . . 74.53 114.73 169.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -58.4 -38.7 77.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.356 0.662 . . . . 65.42 111.265 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.01 -41.94 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.116 -0.947 . . . . 75.21 110.403 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.65 -20.0 28.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.589 -1.187 . . . . 64.3 112.428 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.46 -50.55 87.43 Favored Pre-proline 0 CA--C 1.554 1.103 0 CA-C-O 117.772 -1.108 . . . . 74.05 113.147 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 -37.9 94.43 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.238 1.959 . . . . 62.22 113.365 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -67.92 -51.32 49.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.788 0.835 . . . . 75.32 111.605 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -59.64 -35.83 75.16 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.038 0.935 . . . . 74.5 110.891 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -65.39 -47.92 74.67 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.707 -1.588 . . . . 74.03 110.527 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.518 0.511 . . . . 74.05 110.234 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.3 t -69.0 -29.23 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.82 0.448 . . . . 72.41 110.817 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.737 HD13 HG23 ' C' ' 64' ' ' VAL . 80.1 mt -75.89 -49.02 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.701 -0.681 . . . . 72.44 109.945 169.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.525 HG23 ' HG3' ' C' ' 125' ' ' GLN . 54.1 m -52.83 -41.92 64.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 73.32 111.491 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.5 t -63.0 -49.02 76.3 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.303 -1.317 . . . . 74.34 109.377 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.516 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.76 -42.11 88.13 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.564 1.145 . . . . 73.4 112.959 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.34 -43.69 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 109.519 -0.549 . . . . 62.43 109.519 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.7 t -71.79 -25.88 62.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.001 0.92 . . . . 61.23 111.7 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.4 mtt-85 -71.44 -33.86 69.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.393 0.677 . . . . 73.01 109.577 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.4 11.2 56.64 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 124.041 0.838 . . . . 71.21 112.703 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.538 HG23 ' HB3' ' D' ' 17' ' ' TYR . 68.1 p 57.02 26.4 11.88 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.256 1.822 . . . . 71.4 112.918 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.417 ' HE1' HG11 ' C' ' 31' ' ' VAL . 69.0 m-85 -94.83 146.78 31.99 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.68 -0.859 . . . . 64.4 108.68 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -60.91 146.55 97.47 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.94 2.427 . . . . 72.02 112.647 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.525 ' HG3' HG23 ' C' ' 115' ' ' THR . 19.8 mp0 -59.1 125.37 23.31 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.837 0.855 . . . . 53.42 112.467 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -109.7 90.46 3.31 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.048 -1.834 . . . . 65.32 106.048 168.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -91.07 109.34 20.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.57 132.22 48.18 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.074 0.859 . . . . 72.33 109.713 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.89 132.58 89.43 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 123.558 0.536 . . . . 71.23 111.056 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.568 ' HG3' HD11 ' A' ' 16' ' ' ILE . 61.3 Cg_endo -69.75 102.81 1.07 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.905 2.403 . . . . 73.35 112.491 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 6.8 p -105.33 122.63 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.072 0.549 . . . . 72.01 109.853 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -109.12 81.54 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.567 0.747 . . . . 62.11 110.386 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -72.89 -31.8 64.94 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.806 -0.813 . . . . 75.02 108.806 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.75 -57.59 8.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.401 -1.272 . . . . 74.53 111.269 170.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' C' ' 138' ' ' MET . . . -71.6 -24.21 61.85 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.845 0.858 . . . . 55.25 111.457 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.471 HD22 HD11 ' E' ' 148' ' ' LEU . 63.2 tp -60.55 -53.74 53.81 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.984 0.803 . . . . 72.03 110.42 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -77.19 -23.05 51.52 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.138 -0.483 . . . . 74.34 110.61 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.569 ' HA ' HD23 ' C' ' 141' ' ' LEU . 27.6 ttt -71.03 -38.62 72.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.338 0.655 . . . . 70.24 111.696 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -67.99 -33.43 74.61 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 110.205 -0.294 . . . . 72.34 110.205 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -66.27 -88.69 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 118.977 -0.535 . . . . 72.42 110.541 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' C' ' 138' ' ' MET . 1.3 mm? 48.51 84.68 0.03 OUTLIER 'General case' 0 C--N 1.368 1.371 0 C-N-CA 124.003 0.921 . . . . 75.05 110.574 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -69.29 86.81 0.41 Allowed 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.287 0.565 . . . . 72.34 110.172 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -158.75 179.5 9.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.415 1.086 . . . . 72.21 109.402 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -133.69 137.53 45.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.269 0.627 . . . . 75.13 110.07 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.45 133.96 55.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 72.15 110.204 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.18 159.2 28.4 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.783 0.677 . . . . 64.33 111.437 178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.42 138.15 35.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.2 0.6 . . . . 75.51 110.218 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.62 -131.75 5.63 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.067 -0.813 . . . . 73.13 111.067 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -130.83 83.36 2.11 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.144 0.973 . . . . 64.34 109.156 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -120.01 123.66 44.01 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.437 -0.801 . . . . 73.21 109.514 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -77.82 109.79 12.13 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.651 0.739 . . . . 73.25 111.037 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -80.87 84.3 6.41 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.475 -0.784 . . . . 75.13 109.629 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -130.75 129.41 42.44 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.778 1.231 . . . . 61.03 107.733 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.11 136.71 39.84 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.063 0.545 . . . . 70.12 110.676 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 C-N-CA 123.891 0.876 . . . . 73.21 111.137 -174.676 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 110.11 -0.329 . . . . 72.51 110.11 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.5 m 65.95 -79.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.601 1.16 . . . . 63.2 111.527 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -78.68 110.48 13.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.776 0.83 . . . . 73.25 110.054 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -75.02 81.17 2.21 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.198 -0.668 . . . . 75.12 109.198 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -117.6 -29.55 5.73 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.975 0.91 . . . . 72.11 110.533 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 61.86 84.33 0.14 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.676 1.191 . . . . 72.05 110.446 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 m -147.48 -34.98 0.24 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.936 1.294 . . . . 74.53 107.859 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.57 115.39 4.65 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.359 -1.291 . . . . 64.35 110.233 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.452 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 12.1 tpt -33.03 128.56 0.26 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.805 1.242 . . . . 70.22 112.797 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 92.5 m -143.05 141.59 31.33 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.096 0.958 . . . . 61.3 110.282 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -160.91 90.21 0.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.263 -1.755 . . . . 73.14 106.263 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -114.03 150.23 34.24 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.854 -0.612 . . . . 72.13 110.377 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.4 120.86 43.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.767 0.827 . . . . 73.03 109.057 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -100.27 -49.54 4.23 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.014 0.196 . . . . 74.24 110.575 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -167.81 118.72 0.83 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.559 -0.163 . . . . 73.15 110.559 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.04 134.26 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.065 -1.458 . . . . 74.12 107.065 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.538 ' HB3' HG23 ' C' ' 122' ' ' THR . 37.2 p90 -164.96 177.35 7.89 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.528 0.68 . . . . 64.1 111.705 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -97.43 124.16 41.52 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.181 -0.918 . . . . 63.04 109.053 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.3 mtpt -88.61 -27.54 21.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.61 -0.515 . . . . 65.35 109.61 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.3 t70 -150.06 145.09 26.17 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.426 -0.806 . . . . 72.43 109.784 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.516 HG21 ' HE2' ' C' ' 117' ' ' MET . 64.0 mt -144.99 149.08 17.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.411 1.484 . . . . 72.42 107.667 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -151.87 144.88 24.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.553 0.741 . . . . 64.45 109.528 171.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.4 t80 -154.1 123.81 6.69 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.089 -1.448 . . . . 61.31 107.089 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 49.1 mt-10 -131.36 142.5 50.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.252 0.548 . . . . 75.41 110.089 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.68 74.49 10.36 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.404 1.082 . . . . 74.21 108.144 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.4 -43.39 4.32 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 121.906 1.738 . . . . 73.23 110.937 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.448 ' O ' HG23 ' D' ' 31' ' ' VAL . 6.1 m120 -92.17 25.49 2.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.601 1.16 . . . . 65.22 109.769 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HD2' ' C' ' 19' ' ' LYS . . . -54.64 -56.73 23.99 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.326 1.232 . . . . 71.23 114.326 -168.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.89 -19.09 18.47 Favored 'Trans proline' 0 C--N 1.386 2.553 0 CA-C-N 121.437 1.549 . . . . 72.23 112.089 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 1.4 t60 -70.87 -36.76 72.95 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.018 1.327 . . . . 71.15 110.342 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' D' ' 73' ' ' ALA . 84.5 t -79.0 -33.98 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.38 0.672 . . . . 74.13 110.68 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -60.82 -20.83 62.39 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.737 0.643 . . . . 64.21 112.737 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -64.8 -32.96 74.89 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 64.42 110.621 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -91.52 105.91 18.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.25 1.02 . . . . 63.2 108.813 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.08 89.81 5.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.287 0.635 . . . . 71.31 109.595 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.595 ' HB3' HD11 ' D' ' 68' ' ' LEU . 41.5 t-105 -163.75 158.45 20.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.479 0.712 . . . . 73.41 109.854 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' F' ' 136' ' ' VAL . 1.7 mp0 -87.66 115.13 61.93 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.917 0.887 . . . . 75.23 110.148 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -51.64 166.71 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 125.029 3.819 . . . . 64.33 116.667 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' F' ' 141' ' ' LEU . 20.8 mt-10 -98.22 113.24 25.1 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.439 -1.255 . . . . 72.44 108.316 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.591 HG13 HG13 ' D' ' 64' ' ' VAL . 45.0 t -98.43 111.37 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.661 0.784 . . . . 53.34 110.767 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -86.85 117.36 25.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.796 -1.557 . . . . 71.45 106.796 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 tp -96.33 141.74 29.3 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.251 -0.648 . . . . 74.24 109.251 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.6 t70 -129.87 146.77 51.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.826 -1.175 . . . . 74.5 107.826 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.485 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.9 pt? -125.94 141.69 51.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.347 0.659 . . . . 74.44 110.049 -171.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.3 t70 -157.74 150.84 23.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.835 0.854 . . . . 65.12 109.212 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -130.77 158.07 41.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 60.2 108.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.14 173.7 14.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.99 -0.55 . . . . 63.11 109.929 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.574 ' HB3' HD21 ' D' ' 98' ' ' LEU . 66.0 p -157.65 158.82 36.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.056 0.543 . . . . 43.42 110.745 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.31 118.27 2.25 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.215 1.006 . . . . 50.15 108.434 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -77.9 117.19 19.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.796 -0.816 . . . . 73.22 108.796 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.61 -35.07 14.45 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.861 -0.609 . . . . 55.54 110.406 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.17 -179.09 7.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.562 -0.745 . . . . 62.44 110.433 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.23 116.26 9.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.133 -0.939 . . . . 75.3 109.65 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.7 9.29 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.784 1.234 . . . . 63.24 112.502 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.26 114.29 46.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.629 -0.878 . . . . 71.34 108.629 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -125.04 129.42 50.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.15 0.98 . . . . 73.01 108.741 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.1 117.47 34.42 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 124.222 1.009 . . . . 73.51 108.664 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.495 HG11 ' HD3' ' D' ' 103' ' ' PRO . 43.6 t -100.52 135.82 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.243 -1.021 . . . . 71.14 108.243 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 84.5 t -113.72 146.56 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.74 0.816 . . . . 65.1 109.072 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.47 124.92 42.44 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.079 -1.452 . . . . 73.43 107.079 176.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.9 ttm-85 -104.68 105.13 15.09 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.71 -0.848 . . . . 74.02 108.71 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.17 103.08 14.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.844 -1.169 . . . . 71.34 107.844 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 37.8 m -102.08 129.14 48.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.249 0.619 . . . . 73.23 109.805 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.591 HG13 HG13 ' D' ' 40' ' ' VAL . 74.2 t -129.1 102.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.435 1.094 . . . . 54.23 109.15 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 61.8 m -102.07 108.09 19.41 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.433 -0.951 . . . . 50.05 108.433 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.37 141.85 41.14 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.081 -0.711 . . . . 54.12 109.081 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.1 p -147.56 126.4 12.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.394 -0.821 . . . . 63.22 109.58 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' D' ' 36' ' ' TRP . 30.8 tp -99.87 110.44 22.8 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.521 -0.918 . . . . 72.51 108.521 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.46 -124.09 6.39 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.402 -0.679 . . . . 73.33 111.402 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 5.67 46.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.287 0.635 . . . . 74.25 110.966 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.18 144.85 47.48 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.382 0.673 . . . . 71.1 111.319 -170.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -63.64 125.23 23.6 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.57 0.748 . . . . 71.31 110.551 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.41 -73.83 0.5 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.286 1.034 . . . . 65.22 109.648 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -144.17 138.02 27.84 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-O 121.246 0.546 . . . . 51.12 110.127 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.6 mt -103.08 148.14 26.09 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.257 1.023 . . . . 70.23 108.413 175.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.0 t -160.22 146.41 15.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.082 0.553 . . . . 72.12 110.381 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -157.18 127.6 6.47 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.063 -0.717 . . . . 65.44 109.063 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.429 HG22 HG23 ' D' ' 21' ' ' ILE . 67.7 t -126.73 115.89 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.857 0.463 . . . . 71.33 109.9 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.639 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.3 mt-30 -91.79 87.16 6.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.5 0.72 . . . . 71.01 109.181 170.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -79.43 108.44 12.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.566 -1.197 . . . . 75.34 108.81 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.43 141.69 15.4 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.693 -0.563 . . . . 33.31 111.693 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.408 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.41 130.49 5.13 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.045 -0.822 . . . . 53.21 111.045 -175.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.1 mt -88.97 116.45 30.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.701 1.2 . . . . 71.23 108.995 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -120.7 143.87 48.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.747 0.819 . . . . 73.32 109.237 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -98.29 96.84 8.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.905 -0.776 . . . . 75.51 108.905 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.65 109.16 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.401 -0.963 . . . . 54.55 108.401 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -140.66 168.65 19.29 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.14 0.976 . . . . 45.45 109.527 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.18 -15.09 30.01 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 114.189 0.435 . . . . 74.42 114.189 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -139.4 153.54 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.579 0.752 . . . . 64.31 110.144 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.504 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -149.81 -170.24 3.59 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.778 0.831 . . . . 75.21 110.662 177.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.36 -142.33 26.98 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.002 -0.544 . . . . 61.24 113.843 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -73.94 -21.0 60.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.483 0.713 . . . . 70.34 111.762 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.35 -47.98 66.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.191 0.597 . . . . 72.34 110.273 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 23.5 ptt? -71.94 -27.27 62.68 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.349 0.406 . . . . 70.53 110.608 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.41 67.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.45 0.7 . . . . 55.3 111.25 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.6 t-80 -71.93 -29.32 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.593 0.757 . . . . 54.2 110.663 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.14 -43.45 78.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 110.327 -0.249 . . . . 63.2 110.327 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' D' ' 48' ' ' SER . 9.2 tt -75.36 -45.23 40.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.524 0.73 . . . . 61.12 110.712 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.73 6.97 79.87 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.769 -0.462 . . . . 52.04 114.063 -172.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' D' ' 137' ' ' PHE . . . -147.09 -63.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.489 0.645 . . . . 63.11 111.8 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.6 -40.26 84.77 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.632 0.604 . . . . 61.43 112.632 -169.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.12 -44.66 14.09 Favored Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.413 0.685 . . . . 73.4 111.575 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.584 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.7 Cg_exo -54.66 -32.62 76.21 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 122.815 2.343 . . . . 72.53 113.448 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' D' ' 133' ' ' PHE . 4.1 t-20 -64.8 -36.62 84.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.178 0.591 . . . . 64.15 110.915 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.9 -42.82 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.577 0.751 . . . . 73.42 110.07 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.408 HD21 ' HA3' ' D' ' 82' ' ' GLY . 84.1 mt -76.8 -20.63 56.18 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.943 -1.026 . . . . 74.13 112.053 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -64.09 -45.73 79.81 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 114.55 1.315 . . . . 75.23 114.55 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 108' ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 22.1 Cg_endo -59.16 -35.2 98.21 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.656 1.571 . . . . 73.53 112.683 174.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.9 -36.21 64.73 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.822 0.849 . . . . 72.53 111.601 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.35 -50.59 69.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.835 0.854 . . . . 73.41 109.947 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -55.76 -48.68 74.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.996 -1.456 . . . . 63.35 111.225 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -62.99 -45.88 90.33 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.637 0.775 . . . . 74.23 111.278 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.9 t -55.45 -39.28 70.11 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.942 0.776 . . . . 73.11 111.002 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.544 HG21 HD12 ' D' ' 126' ' ' LEU . 52.8 mt -66.62 -50.92 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.373 -0.83 . . . . 74.4 110.779 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.6 m -58.79 -38.5 78.7 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.898 0.749 . . . . 55.23 111.54 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 38.5 t -63.69 -44.87 92.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.268 -0.878 . . . . 73.23 110.538 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -67.47 -35.15 78.62 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.95 0.5 . . . . 71.1 111.538 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.22 -40.37 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.972 0.909 . . . . 72.5 110.672 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.52 -32.83 66.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 120.959 0.409 . . . . 74.02 110.718 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' D' ' 116' ' ' SER . 94.5 mtt-85 -67.39 -31.83 72.32 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.698 0.799 . . . . 74.15 110.204 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 121' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -87.93 6.07 84.0 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.896 0.747 . . . . 75.4 112.983 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' C' ' 17' ' ' TYR . 48.8 p 54.74 27.61 9.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 126.199 1.8 . . . . 73.35 113.408 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -92.25 159.9 36.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.43 1.092 . . . . 63.22 110.686 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.17 138.29 85.6 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.405 2.736 . . . . 62.35 112.259 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -50.99 129.97 24.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.726 1.266 . . . . 65.3 112.758 -173.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.544 HD12 HG21 ' D' ' 114' ' ' ILE . 2.7 tm? -115.9 95.74 5.26 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.32 107.714 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -133.83 114.58 13.5 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.872 -1.158 . . . . 52.23 107.872 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.6 148.96 40.3 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.652 -0.704 . . . . 64.52 110.417 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.79 162.93 64.58 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.997 -1.001 . . . . 71.21 109.966 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.34 154.94 49.43 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.255 1.97 . . . . 70.52 112.868 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.63 139.43 23.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 115.683 -0.69 . . . . 53.34 109.378 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -68.44 117.54 10.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.949 -0.759 . . . . 62.33 108.949 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' D' ' 104' ' ' ASN . 33.3 p90 -53.94 -28.47 37.33 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.982 0.913 . . . . 74.02 113.388 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.29 -39.51 69.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.175 0.99 . . . . 71.52 111.753 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.72 88.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.324 0.649 . . . . 52.21 111.424 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.76 -44.3 93.88 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.359 0.664 . . . . 63.45 109.385 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.762 ' HB2' ' HB2' ' D' ' 100' ' ' ALA . 75.8 t80 -64.58 -49.36 71.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.984 -1.007 . . . . 74.45 111.617 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.3 ptp -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.748 0.419 . . . . 75.13 111.071 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.57 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 4.9 m-20 -68.31 -37.67 80.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 119.208 -0.425 . . . . 62.13 110.855 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -47.43 -38.41 13.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.249 1.019 . . . . 74.13 112.504 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.54 -46.6 75.58 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.551 -0.749 . . . . 54.22 110.871 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -91.22 38.75 0.97 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.015 0.926 . . . . 75.15 112.582 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 18.7 mm100 -117.4 79.02 1.28 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.092 0.949 . . . . 74.15 110.3 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -144.39 73.25 1.37 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.612 -1.625 . . . . 71.33 106.612 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.19 120.01 3.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.223 -1.353 . . . . 72.1 109.185 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.99 40.2 0.67 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 110.033 -1.227 . . . . 75.33 110.033 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.55 81.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.064 0.946 . . . . 75.02 111.617 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.85 103.48 0.01 OUTLIER Glycine 0 C--N 1.346 1.102 0 O-C-N 123.451 0.469 . . . . 24.42 112.899 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 55.6 p -61.43 -32.89 72.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.216 0.606 . . . . 73.44 110.49 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 61.53 33.54 18.38 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.889 1.276 . . . . 63.02 110.789 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -73.6 139.93 45.86 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.434 -0.803 . . . . 73.33 111.675 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -148.63 81.0 1.45 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.789 0.836 . . . . 74.4 109.006 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.36 106.93 18.83 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.807 -0.812 . . . . 74.24 108.807 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.43 58.22 1.25 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.542 1.137 . . . . 62.31 108.828 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 CA-C-N 114.357 -1.292 . . . . 70.21 109.005 -175.326 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.337 -0.246 . . . . 73.41 110.337 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -136.05 64.07 1.57 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.572 -1.27 . . . . 74.52 107.572 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.19 -155.87 0.34 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.364 1.066 . . . . 74.44 110.479 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -150.19 -82.02 0.11 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.501 -0.555 . . . . 73.11 109.501 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -110.49 -37.24 5.54 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.967 -0.753 . . . . 73.45 108.967 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 113' ' ' ASP . . . . . 0.47 ' CB ' ' HB3' ' E' ' 116' ' ' TYR . 5.2 m-20 -63.04 148.88 46.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.901 -1.045 . . . . 74.24 109.968 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -73.1 -63.79 1.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.717 0.635 . . . . 65.34 111.699 -170.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.435 ' HB3' ' SD ' ' B' ' 94' ' ' MET . 7.1 mp -93.89 -38.81 11.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.242 0.217 . . . . 64.42 111.009 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 116' ' ' TYR . . . . . 0.47 ' HB3' ' CB ' ' E' ' 113' ' ' ASP . 63.9 t80 -48.19 109.8 1.24 Allowed Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 124.84 1.256 . . . . 74.25 111.867 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.539 ' HD2' HD21 ' B' ' 98' ' ' LEU . 95.4 Cg_endo -78.4 -51.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.04 2.493 . . . . 70.13 113.224 -170.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -166.17 -50.14 0.03 OUTLIER 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.5 0.72 . . . . 75.13 110.361 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 59.5 m 63.09 112.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.84 1.256 . . . . 73.35 110.351 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.421 ' CH2' ' HB3' ' B' ' 136' ' ' LEU . 5.1 p-90 -55.2 124.48 17.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.354 1.062 . . . . 70.05 112.332 -175.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.93 84.22 2.11 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.036 -0.727 . . . . 72.44 109.036 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.5 34.64 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.367 1.067 . . . . 64.44 110.02 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.99 66.75 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 122.85 1.31 . . . . 73.24 110.875 -175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -66.29 -35.24 79.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.68 -1.146 . . . . 73.34 110.285 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 125' ' ' TYR . . . . . 0.449 ' CE1' ' HB ' ' B' ' 131' ' ' VAL . 21.2 t80 64.04 28.68 14.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.176 0.99 . . . . 65.14 111.045 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -72.14 143.71 48.86 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.789 -1.096 . . . . 70.32 110.751 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.35 -172.96 39.43 Favored Glycine 0 C--O 1.242 0.654 0 CA-C-N 115.519 -0.764 . . . . 53.05 111.685 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.57 82.07 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.007 0.523 . . . . 72.24 109.856 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.69 111.47 23.97 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.105 -0.702 . . . . 75.15 109.105 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 8.7 tp -166.23 -42.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.174 0.99 . . . . 72.45 109.08 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 64.1 -170.2 0.19 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.75 1.22 . . . . 61.21 110.902 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -108.1 102.85 47.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.335 -0.617 . . . . 71.24 109.335 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.55 119.64 5.83 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.07 1.847 . . . . 52.43 111.206 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 tp -67.03 105.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.462 0.649 . . . . 55.15 109.737 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.17 84.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.159 -0.928 . . . . 65.14 109.558 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.78 -26.58 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.961 -1.018 . . . . 74.51 112.148 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.82 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.659 1.583 . . . . 71.04 113.346 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.68 -2.49 36.32 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.499 1.12 . . . . 74.32 113.311 -173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 60.6 tp -74.44 83.28 1.96 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.527 0.68 . . . . 65.31 109.995 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 63.0 m -153.94 -71.17 0.14 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.278 -1.008 . . . . 72.0 108.278 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 141' ' ' LEU . . . . . 0.657 HD12 ' H ' ' C' ' 40' ' ' VAL . 89.6 mt 61.57 14.37 5.91 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.726 1.211 . . . . 74.31 112.854 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.94 143.52 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.514 0.726 . . . . 63.24 110.211 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.9 103.07 1.71 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 121.56 0.695 . . . . 74.12 109.984 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -96.28 32.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.15 0.98 . . . . 71.33 111.281 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -153.68 -69.83 0.14 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 70.34 110.2 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.19 75.82 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.556 0.742 . . . . 65.41 110.096 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 10.5 tt -62.89 -45.02 94.5 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.175 -0.92 . . . . 73.13 110.001 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.471 HD11 HD22 ' C' ' 136' ' ' LEU . 56.8 tp -160.42 91.18 1.68 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.979 -1.119 . . . . 74.44 107.979 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 C--N 1.375 1.928 0 C-N-CA 123.121 2.547 . . . . 74.04 111.729 179.094 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.573 0.225 . . . . 73.44 110.704 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.83 125.26 29.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.355 0.662 . . . . 74.21 110.317 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.91 140.57 9.38 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.568 0.747 . . . . 61.13 110.095 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -107.55 113.77 27.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.605 0.762 . . . . 72.14 110.043 175.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.74 158.52 18.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.41 0.684 . . . . 62.21 109.642 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 113' ' ' ASP . . . . . 0.422 ' HA ' ' CD2' ' F' ' 116' ' ' TYR . 21.0 t70 82.21 87.66 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.421 1.488 . . . . 73.13 111.699 167.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -136.49 132.14 34.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.924 0.89 . . . . 75.02 109.015 167.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.707 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 8.5 mp 67.99 0.71 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.916 1.286 . . . . 74.03 113.525 167.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 116' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' F' ' 113' ' ' ASP . 18.5 m-85 -69.47 153.63 95.6 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 123.475 0.71 . . . . 72.32 112.465 -169.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.17 -168.78 0.63 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.779 2.319 . . . . 44.0 113.966 -171.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -84.55 160.32 20.5 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.139 -0.937 . . . . 73.45 109.797 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -65.97 -28.55 68.98 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.619 0.575 . . . . 70.54 110.785 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 m95 67.77 174.9 0.27 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.083 1.353 . . . . 73.41 110.892 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -160.25 -77.66 0.06 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.721 -0.474 . . . . 60.35 109.721 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.63 81.06 6.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.295 0.638 . . . . 75.14 110.414 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.91 83.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 106.958 -1.497 . . . . 45.55 106.958 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -87.05 62.36 7.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.159 -0.928 . . . . 73.33 108.981 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.88 124.44 33.1 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.12 -1.4 . . . . 65.22 107.727 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 126' ' ' ASN . . . . . 0.43 ' H ' HG21 ' A' ' 131' ' ' VAL . 1.4 m-20 -66.67 92.01 0.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.413 0.685 . . . . 75.43 109.916 -176.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.52 135.13 11.98 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.798 -0.637 . . . . 73.45 111.778 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -147.94 -58.62 0.25 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.155 -1.054 . . . . 61.52 108.155 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.436 HD21 HD23 ' A' ' 42' ' ' LEU . 80.2 mt 76.83 -25.01 0.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.297 1.439 . . . . 44.41 114.459 163.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 tp -71.14 88.52 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 122.358 1.075 . . . . 64.0 109.328 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.32 164.4 25.58 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.194 -1.366 . . . . 50.23 109.355 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -70.09 108.17 3.13 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.285 0.634 . . . . 75.53 109.895 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -96.98 -157.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.347 2.698 . . . . 42.14 111.736 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 13.5 tt -162.97 130.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.976 -1.12 . . . . 71.4 107.976 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.87 93.42 2.65 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.614 0.765 . . . . 60.14 109.209 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.413 ' HA ' ' NE2' ' D' ' 37' ' ' GLN . 15.3 m -111.73 117.5 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.541 -0.754 . . . . 73.11 111.189 -174.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.64 -65.26 0.7 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.912 0.885 . . . . 73.21 109.919 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.26 -74.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.207 -1.405 . . . . 74.42 107.207 172.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.468 ' HG ' HD23 ' D' ' 126' ' ' LEU . 0.3 OUTLIER -171.79 120.83 0.47 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.761 -1.57 . . . . 71.02 106.761 172.309 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' F' F ' 140' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' D' ' 37' ' ' GLN . 28.7 t -78.14 -73.86 0.29 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.168 0.587 . . . . 71.45 110.887 -172.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 141' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' D' ' 39' ' ' GLU . 4.3 mp -87.89 109.86 20.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.698 -0.853 . . . . 62.42 108.698 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.53 ' HA ' ' HB ' ' D' ' 40' ' ' VAL . 14.2 tt -132.32 150.55 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 62.44 109.215 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 76.95 138.82 0.07 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.366 1.467 . . . . 74.4 110.872 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -84.54 71.67 10.73 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.776 -0.824 . . . . 50.23 108.776 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -175.79 -73.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.889 -1.523 . . . . 60.45 106.889 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -161.78 -79.29 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.307 1.043 . . . . 75.03 108.527 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tt 174.32 145.51 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.868 1.667 . . . . 73.2 106.599 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 tp -111.78 92.96 18.7 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.924 -0.769 . . . . 74.25 108.924 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.562 1.882 0 C-N-CA 123.508 2.805 . . . . 52.11 112.275 177.537 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.367 -0.605 . . . . 74.41 109.367 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.7 m -152.32 123.0 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.398 1.079 . . . . 70.22 108.71 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.052 -0.722 . . . . 74.32 109.052 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 65.25 144.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.252 1.821 . . . . 72.3 113.122 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -74.63 -27.72 60.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 61.43 111.183 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.41 86.87 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 124.192 0.997 . . . . 73.11 111.884 -172.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -65.42 -49.69 68.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.023 -0.99 . . . . 71.01 108.707 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -174.72 93.62 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 113.554 -1.657 . . . . 75.41 107.925 167.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 87.9 mtp -140.49 132.93 28.49 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.975 -0.75 . . . . 62.03 108.975 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -149.21 118.7 6.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.553 -0.906 . . . . 72.21 108.553 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' HZ ' ' SG ' ' A' ' 102' ' ' CYS . 1.2 t80 -139.76 114.84 9.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.625 -0.88 . . . . 75.05 108.625 167.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -155.63 137.29 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.24 0.616 . . . . 71.43 109.668 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.646 ' H ' HD12 ' A' ' 13' ' ' ILE . 2.5 mp -75.96 131.72 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.474 -0.935 . . . . 74.52 108.474 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 -35.79 12.52 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.808 0.276 . . . . 65.41 111.052 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 137.58 12.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 121.999 0.12 . . . . 75.15 110.821 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.438 HG13 HG21 ' A' ' 13' ' ' ILE . 2.3 mp -122.88 118.84 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.058 -1.46 . . . . 74.1 107.058 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 43.7 p90 -166.55 177.57 6.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.218 1.008 . . . . 74.13 113.031 -171.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -102.68 124.02 47.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.253 -1.34 . . . . 73.33 108.875 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.9 mtpt -91.58 -24.05 19.7 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.03 0.443 . . . . 73.41 110.071 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -153.21 138.26 17.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.937 -1.029 . . . . 71.14 109.308 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 74.5 mt -141.93 143.64 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.088 1.355 . . . . 63.23 107.593 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -155.8 139.16 15.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.343 0.592 . . . . 71.33 110.136 170.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -131.14 134.88 46.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.32 -1.733 . . . . 74.35 106.32 171.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.08 118.74 12.34 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.132 -0.692 . . . . 70.13 109.132 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.51 82.11 59.14 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 107.205 -1.405 . . . . 73.34 107.205 173.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.39 -29.8 20.31 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.171 1.914 . . . . 64.21 110.344 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.624 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 7.4 m120 -110.14 31.69 5.7 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.904 -1.044 . . . . 72.11 109.598 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.547 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.58 -44.58 99.23 Favored Pre-proline 0 CA--C 1.565 1.525 0 C-N-CA 123.736 0.815 . . . . 75.53 112.276 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.64 -20.07 20.72 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 121.735 1.623 . . . . 75.13 112.786 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 6.1 m80 -85.25 -20.01 30.74 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.851 0.461 . . . . 64.32 111.945 -171.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG11 ' HE2' ' A' ' 123' ' ' PHE . 9.8 p -71.61 -19.19 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 120.968 0.414 . . . . 71.13 111.297 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -78.73 -41.68 30.18 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.572 0.749 . . . . 75.03 110.745 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -75.95 -29.0 58.14 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.904 0.482 . . . . 64.03 110.63 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 33.8 mmtp -83.2 169.45 15.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.273 0.629 . . . . 75.32 110.543 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.14 128.96 37.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.557 -0.905 . . . . 75.23 108.557 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HH2' ' NH2' ' B' ' 15' ' ' ARG . 2.8 t90 -84.78 68.31 10.4 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.148 0.975 . . . . 71.22 108.6 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.36 76.38 10.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 114.226 -1.352 . . . . 75.34 107.638 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -85.52 166.83 10.43 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.298 1.999 . . . . 45.35 111.389 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.19 128.53 42.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.35 -1.352 . . . . 70.15 107.35 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.519 0.676 . . . . 73.15 110.358 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 1.7 ttpp -116.65 115.62 26.02 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.916 -1.142 . . . . 72.21 107.916 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.15 106.48 15.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.342 -0.984 . . . . 64.14 108.342 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.591 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -109.02 111.67 23.44 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.816 -0.809 . . . . 73.21 108.816 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.43 122.6 46.94 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.564 -0.532 . . . . 65.03 109.564 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -139.03 135.25 34.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.171 0.989 . . . . 61.13 109.399 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.8 m -107.52 138.57 43.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.278 0.631 . . . . 64.31 109.607 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.29 150.22 52.24 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.659 1.183 . . . . 63.53 108.012 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.2 m -124.38 161.18 26.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.144 0.497 . . . . 74.44 111.208 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 t -150.21 147.41 27.66 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.995 1.318 . . . . 64.34 108.768 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -112.85 124.52 52.78 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.947 -0.76 . . . . 62.32 108.947 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.72 -36.38 9.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.983 0.513 . . . . 71.04 110.471 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.69 -174.23 4.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.584 0.754 . . . . 62.43 110.2 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.39 117.57 8.81 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 24.8 m-20 67.89 5.26 4.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.531 1.133 . . . . 64.23 112.583 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -108.78 104.52 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.52 -1.289 . . . . 74.3 107.52 173.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -122.58 146.47 47.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.499 0.666 . . . . 72.33 110.714 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 112.58 15.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.185 -1.413 . . . . 72.53 107.185 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 98' ' ' LEU . 30.8 m -102.91 126.62 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.077 -1.082 . . . . 41.42 108.077 174.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.536 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.4 t -102.97 129.39 54.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.721 0.808 . . . . 72.12 109.342 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD11 ' HD1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -98.84 112.13 24.32 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.59 -1.263 . . . . 73.2 107.59 -177.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -103.17 106.89 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.638 0.775 . . . . 74.13 109.883 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.32 133.3 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.836 -1.074 . . . . 65.42 109.15 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.4 m -116.34 143.13 45.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.604 -0.888 . . . . 71.04 108.604 171.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 37.1 t -133.94 130.73 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.138 -1.43 . . . . 60.15 107.138 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -132.46 139.08 47.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.007 -0.368 . . . . 71.45 110.007 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.84 105.32 12.57 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.131 -1.063 . . . . 61.42 108.131 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -133.24 126.21 31.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.906 0.483 . . . . 53.23 110.525 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.12 86.33 4.56 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.14 -1.429 . . . . 74.32 107.14 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.99 -85.06 1.0 Allowed Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.448 -0.661 . . . . 73.15 111.448 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -118.1 -27.32 6.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 73.53 110.015 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.508 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -77.8 91.77 4.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.042 0.537 . . . . 75.41 109.853 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 85.1 m -73.79 105.97 5.31 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 122.894 0.477 . . . . 61.05 110.205 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.53 72.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.493 1.117 . . . . 43.53 110.061 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -161.35 173.07 15.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.078 -1.419 . . . . 70.41 111.548 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 76' ' ' CYS . 25.4 tp -142.06 147.97 37.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.67 1.588 . . . . 72.42 107.904 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.2 m -144.91 140.27 28.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.449 1.1 . . . . 70.42 109.266 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -149.55 120.32 7.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.32 -0.622 . . . . 71.33 109.32 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 113' ' ' CYS . 58.7 t -128.75 113.29 28.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.622 0.769 . . . . 74.15 109.684 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.8 mt-30 -89.88 90.89 8.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.552 0.741 . . . . 74.5 109.581 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -80.97 98.97 8.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.224 1.01 . . . . 75.23 109.007 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -98.55 144.58 17.31 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 112.152 -0.379 . . . . 55.11 112.152 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.86 132.44 6.03 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 110.994 -0.842 . . . . 70.23 110.994 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.0 mt -83.86 129.77 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.695 -0.854 . . . . 64.24 108.695 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -129.79 120.11 24.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.122 0.569 . . . . 70.13 109.703 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -82.8 110.85 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.88 -0.785 . . . . 75.11 108.88 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 22.3 pt -120.9 157.3 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.369 0.668 . . . . 75.23 109.973 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.93 146.64 1.56 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.471 0.708 . . . . 62.43 110.47 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.74 -25.39 23.6 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 114.963 0.745 . . . . 72.31 114.963 169.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.2 pt -109.9 134.85 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.674 0.737 . . . . 62.43 109.857 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.29 172.11 12.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.587 . . . . 70.02 109.965 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -132.95 44.51 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.213 0.321 . . . . 62.2 113.578 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 27.1 p -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.987 0.915 . . . . 65.3 112.228 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -63.98 -54.53 33.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.405 0.682 . . . . 73.23 110.38 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -24.82 39.98 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.542 -0.754 . . . . 75.34 110.785 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -70.9 -28.1 64.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.744 0.418 . . . . 72.42 111.011 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.31 -51.06 26.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.357 0.663 . . . . 73.12 109.784 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 6.1 m -73.84 -35.63 64.83 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.706 1.002 . . . . 74.23 113.706 -167.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB3' HG11 ' A' ' 58' ' ' VAL . 88.8 mt -87.4 -23.61 24.48 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.011 0.369 . . . . 75.25 111.003 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.15 -20.53 35.59 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 114.434 0.534 . . . . 61.42 114.434 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -138.05 -60.16 0.63 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.202 0.601 . . . . 54.24 111.59 -170.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 9.7 t80 -52.68 -56.28 16.59 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.411 1.084 . . . . 71.43 112.26 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.419 ' SG ' ' HZ ' ' A' ' 11' ' ' PHE . 82.2 m -74.49 -44.3 5.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.454 -1.26 . . . . 62.2 114.314 -171.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.38 -27.51 85.18 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.914 1.719 . . . . 61.34 112.439 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -73.86 -32.19 63.53 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 122.811 0.444 . . . . 70.23 110.663 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.6 mm -65.89 -42.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.706 0.802 . . . . 64.32 109.935 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.03 -18.39 60.34 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.128 -0.942 . . . . 60.22 111.292 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.401 ' HD1' HD11 ' A' ' 60' ' ' LEU . 24.6 t80 -70.92 -43.38 13.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.543 -1.218 . . . . 73.33 114.158 -170.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.526 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 32.1 Cg_endo -63.12 -27.51 73.35 Favored 'Trans proline' 0 C--N 1.383 2.38 0 CA-C-N 122.087 1.781 . . . . 71.13 112.363 172.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.44 -41.01 48.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.442 0.697 . . . . 74.51 111.7 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.88 75.7 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.994 -0.373 . . . . 54.12 109.994 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.441 ' NH1' HD12 ' C' ' 105' ' ' ILE . 39.0 ttm180 -55.29 -49.73 71.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.547 1.155 . . . . 73.55 109.873 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.03 -47.82 84.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.188 0.93 . . . . 64.11 111.176 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB3' HG11 ' A' ' 78' ' ' VAL . 34.4 t -65.1 -37.01 86.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.95 0.781 . . . . 72.2 111.637 -174.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.574 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 92.3 mt -67.21 -60.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.179 -0.674 . . . . 62.35 109.179 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.528 HG23 ' HG3' ' A' ' 125' ' ' GLN . 66.4 m -50.73 -37.35 41.21 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.84 1.338 . . . . 71.15 112.309 -176.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.9 t -69.38 -43.83 72.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.71 -0.677 . . . . 43.2 110.065 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 44.0 mtm -62.9 -38.64 91.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.798 0.439 . . . . 72.14 111.063 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 114' ' ' ILE . 87.0 t -57.66 -50.24 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.34 1.025 . . . . 65.41 110.005 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -73.7 -28.53 61.78 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.644 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -70.47 -27.73 64.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.495 0.718 . . . . 72.3 109.96 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 5.99 69.82 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.748 0.655 . . . . 61.22 113.331 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.522 HG22 HH21 ' B' ' 15' ' ' ARG . 6.5 m 64.87 27.98 12.78 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.833 1.253 . . . . 70.33 110.753 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG11 ' A' ' 31' ' ' VAL . 90.1 m-85 -97.45 153.85 38.21 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.455 1.102 . . . . 62.14 109.337 172.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -65.96 143.31 72.17 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.104 1.87 . . . . 60.22 111.37 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.528 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -59.07 137.67 57.85 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 124.191 0.932 . . . . 74.24 112.565 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.15 102.0 5.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.399 -0.963 . . . . 73.11 108.399 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.403 ' H ' HD11 ' F' ' 130' ' ' ILE . 87.8 m-20 -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.984 -0.747 . . . . 63.23 108.984 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.53 139.33 56.96 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 71.01 109.837 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.12 128.54 92.45 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 122.983 0.513 . . . . 73.33 111.226 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 2.7 Cg_exo -76.43 89.36 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.964 2.443 . . . . 60.02 112.456 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.61 115.02 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.808 0.843 . . . . 73.53 109.434 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.95 106.03 5.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.446 0.698 . . . . 75.32 110.314 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.97 -6.26 58.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.732 0.813 . . . . 73.02 111.978 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.49 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 2.0 m-20 -52.9 -51.91 59.49 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.438 0.461 . . . . 75.32 110.519 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.06 66.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.207 0.942 . . . . 75.03 112.249 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.14 -52.13 60.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.713 0.805 . . . . 72.21 109.503 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -68.68 -31.36 70.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.945 -0.571 . . . . 71.14 110.901 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 93.1 mmm -66.5 -38.55 87.48 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 119.191 -0.433 . . . . 75.4 111.103 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -56.3 -30.38 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 123.549 0.531 . . . . 72.04 111.074 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -80.42 -39.0 29.11 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.696 0.799 . . . . 53.42 111.114 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 tt -66.72 -57.76 6.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.042 0.537 . . . . 72.13 110.829 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.419 ' H ' ' H ' ' A' ' 143' ' ' GLN . 11.6 mm100 -173.34 -16.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 125.606 1.562 . . . . 73.33 109.896 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.419 ' H ' ' H ' ' A' ' 142' ' ' GLN . 34.4 tt0 79.81 -48.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.264 1.825 . . . . 74.13 110.272 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -83.56 137.3 33.9 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.291 1.037 . . . . 63.45 109.922 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.41 152.66 44.5 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.884 0.874 . . . . 63.41 109.175 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.02 112.62 0.53 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.24 -0.436 . . . . 73.14 112.643 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 174.99 9.51 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.347 0.659 . . . . 74.12 109.905 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 68.76 0.12 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.479 -1.048 . . . . 34.22 110.479 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.0 m -70.51 90.13 0.73 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.459 0.704 . . . . 51.12 110.866 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -88.87 172.2 9.36 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 61.11 110.424 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -156.04 157.92 36.93 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.29 -0.868 . . . . 63.1 109.361 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -151.51 66.34 0.88 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.634 0.774 . . . . 71.32 109.377 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -80.36 134.05 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.912 -0.585 . . . . 55.43 110.573 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.28 107.73 19.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.279 0.632 . . . . 62.13 109.373 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.155 0 C-N-CA 123.533 0.733 . . . . 73.43 110.001 179.908 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.512 0.196 . . . . 62.13 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -81.37 -0.26 40.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.703 0.801 . . . . 54.4 112.138 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 65.19 -175.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.527 1.131 . . . . 54.21 113.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -93.91 150.73 20.11 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.327 1.051 . . . . 72.42 110.8 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.44 166.01 0.27 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 124.542 1.151 . . . . 75.13 112.22 172.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.487 ' HB2' ' HA3' ' B' ' 148' ' ' GLY . 1.8 m-20 -70.45 82.8 0.57 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.353 0.661 . . . . 74.45 110.388 174.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -77.91 99.29 5.94 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.549 -0.908 . . . . 55.44 108.549 170.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' B' ' 9' ' ' MET . 5.8 tt0 -154.99 -153.71 0.46 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.426 -1.324 . . . . 74.55 107.426 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.516 ' H ' ' HG2' ' B' ' 8' ' ' GLU . 22.5 ptm 52.85 176.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.216 1.932 . . . . 61.23 116.216 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.8 m -143.25 118.96 10.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.494 -1.685 . . . . 71.1 107.763 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -120.22 134.93 55.15 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.092 -0.707 . . . . 74.52 109.092 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -151.19 127.79 10.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.051 -0.722 . . . . 73.44 109.051 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.482 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -86.05 143.39 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.234 -0.654 . . . . 54.12 109.234 173.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -109.3 -48.46 3.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.032 0.533 . . . . 64.55 109.58 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.522 HH21 HG22 ' A' ' 122' ' ' THR . 16.0 ttt180 -158.17 149.91 21.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.463 -0.335 . . . . 63.13 110.948 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -127.96 144.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.594 -1.632 . . . . 73.33 106.594 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -171.66 147.12 2.25 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.493 0.317 . . . . 73.13 111.342 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -73.79 119.36 17.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.605 -0.887 . . . . 61.55 108.605 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -92.26 -33.69 14.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.966 0.506 . . . . 74.4 110.362 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.2 t70 -151.78 143.2 23.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.836 -168.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.1 mm -140.96 147.12 22.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.715 1.606 . . . . 72.11 107.59 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -150.33 140.27 21.93 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.888 -0.782 . . . . 52.22 108.888 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -145.65 125.2 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.506 -1.294 . . . . 74.32 107.506 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -128.54 122.46 31.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.685 0.794 . . . . 64.05 109.338 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.14 84.8 9.48 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.121 -1.437 . . . . 53.3 107.121 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.22 -31.53 35.58 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.646 2.231 . . . . 72.21 111.951 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -124.31 27.41 7.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.07 0.948 . . . . 50.34 110.138 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.751 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.14 -53.13 17.81 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 125.395 1.478 . . . . 74.32 114.741 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.21 -9.24 14.0 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.904 1.736 . . . . 74.03 112.891 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -95.68 -33.39 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.687 0.795 . . . . 63.22 110.54 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' B' ' 34' ' ' LYS . 8.7 p -81.36 -8.38 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.854 0.862 . . . . 60.32 110.379 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -59.29 -37.43 77.68 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.784 0.833 . . . . 74.33 110.232 171.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -69.83 -26.94 64.47 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.513 0.725 . . . . 71.32 111.168 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' HG23 ' B' ' 31' ' ' VAL . 84.7 mttt -87.02 97.45 10.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.205 0.602 . . . . 72.35 110.391 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.09 77.88 9.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.091 0.472 . . . . 53.33 110.352 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.479 ' HB2' HD11 ' B' ' 68' ' ' LEU . 17.1 m-90 -151.84 168.88 23.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.414 1.086 . . . . 75.45 108.283 176.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -86.41 115.73 63.24 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.795 -1.187 . . . . 74.33 107.795 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 30.8 Cg_endo -62.44 139.67 77.89 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.248 1.966 . . . . 51.41 111.195 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.1 104.06 0.68 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.036 -0.728 . . . . 53.31 109.036 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.435 HG11 HD23 ' B' ' 126' ' ' LEU . 27.2 m -92.05 158.52 2.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.109 -0.951 . . . . 74.34 111.56 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -149.04 118.84 7.05 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.286 -1.325 . . . . 61.31 108.551 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.95 148.87 25.15 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.027 -0.731 . . . . 74.12 109.027 163.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.87 110.27 2.86 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.57 -1.271 . . . . 64.14 107.57 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' E' ' 125' ' ' TYR . 5.6 mp -101.71 152.09 21.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.932 0.893 . . . . 73.25 109.85 -174.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.439 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 13.7 t70 -145.82 144.66 30.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.198 1.399 . . . . 62.31 108.42 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.509 ' H ' HG11 ' E' ' 123' ' ' VAL . 11.9 t -114.05 141.14 47.83 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.342 -0.614 . . . . 75.52 109.342 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.69 154.92 49.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.014 0.926 . . . . 63.32 109.026 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -145.05 163.22 34.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.328 0.651 . . . . 74.54 110.781 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -152.47 139.26 18.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.476 1.11 . . . . 70.13 108.17 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -96.27 118.02 31.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.427 -0.583 . . . . 65.4 109.427 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -90.41 -39.81 12.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.691 -0.485 . . . . 74.34 109.691 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.92 -171.64 3.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.309 -0.86 . . . . 60.24 110.332 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.84 119.76 8.84 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 114.946 -1.024 . . . . 72.43 109.927 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.7 -1.73 1.56 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.575 1.15 . . . . 71.12 112.777 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.6 t -104.33 106.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.617 -0.882 . . . . 54.34 108.617 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.08 134.82 54.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.196 0.522 . . . . 74.53 110.224 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -100.32 97.43 8.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.482 -1.673 . . . . 65.11 106.482 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.29 124.5 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.853 0.861 . . . . 74.13 109.121 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.703 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 38.4 t -100.68 142.97 14.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.122 -0.696 . . . . 60.53 109.122 177.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -116.29 121.01 40.75 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.576 -1.268 . . . . 63.23 107.576 173.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.439 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 58.0 ttt180 -106.76 116.77 32.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.249 1.02 . . . . 64.51 109.545 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -114.79 120.23 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.963 -1.125 . . . . 75.21 107.963 171.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -116.03 133.36 56.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.227 0.611 . . . . 73.25 109.403 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.642 HG21 HG21 ' B' ' 114' ' ' ILE . 38.7 t -114.28 136.35 51.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.406 1.083 . . . . 74.3 110.586 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -125.1 145.18 50.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.672 1.189 . . . . 62.22 108.303 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.08 141.61 25.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.006 -0.738 . . . . 71.32 109.006 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.3 p -146.37 134.96 22.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.716 0.635 . . . . 73.04 109.829 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' B' ' 36' ' ' TRP . 14.4 tp -132.24 122.23 24.87 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.805 -0.813 . . . . 74.11 108.805 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.93 -128.21 8.32 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.868 0.73 . . . . 71.12 112.215 -174.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.67 19.62 20.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.519 0.728 . . . . 74.42 110.927 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -156.54 167.05 31.63 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.808 0.443 . . . . 60.54 111.83 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -70.56 136.39 49.24 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.406 -0.815 . . . . 74.23 110.275 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -89.71 -54.81 3.89 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.117 0.967 . . . . 61.11 109.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.73 167.58 29.12 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.267 -0.879 . . . . 75.25 110.971 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.57 145.12 34.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.868 1.667 . . . . 73.53 107.553 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -151.14 159.43 44.46 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.175 -0.676 . . . . 51.33 109.175 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.78 136.62 3.7 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.989 -0.745 . . . . 70.31 108.989 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.8 t -130.0 144.87 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.967 -0.753 . . . . 71.42 108.967 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 71.3 mt-30 -128.18 97.66 4.84 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.237 -0.653 . . . . 71.43 109.237 173.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -88.15 103.13 15.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.028 -0.987 . . . . 72.33 108.881 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.01 147.46 19.28 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.602 -0.599 . . . . 70.12 111.602 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.15 126.54 2.74 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.535 -0.626 . . . . 54.05 111.535 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -85.57 117.95 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.412 -0.958 . . . . 72.22 108.412 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -124.49 167.07 14.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 74.44 109.816 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -132.47 114.59 14.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.13 0.972 . . . . 75.04 109.157 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.2 pp -118.96 135.84 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.15 0.98 . . . . 62.32 110.429 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 166.66 32.4 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.732 0.813 . . . . 55.24 109.42 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.84 -61.79 4.71 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.267 0.355 . . . . 54.31 112.398 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.684 HD13 ' SD ' ' B' ' 94' ' ' MET . 1.1 pp -56.97 150.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.877 0.871 . . . . 61.44 112.802 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.53 164.01 36.52 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.69 0.796 . . . . 74.22 110.659 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -120.72 23.69 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.803 0.689 . . . . 71.44 113.312 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.2 m -67.95 -35.23 78.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.282 0.633 . . . . 64.02 111.588 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -68.91 -43.33 75.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.103 0.561 . . . . 71.44 110.726 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.684 ' SD ' HD13 ' B' ' 89' ' ' ILE . 5.3 tpt -67.85 -43.45 79.45 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.952 -0.567 . . . . 74.24 110.327 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.57 75.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.206 0.603 . . . . 63.31 111.899 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -76.44 -32.0 58.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.665 0.786 . . . . 74.5 110.776 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.81 -52.87 17.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.889 0.476 . . . . 64.43 111.225 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' B' ' 94' ' ' MET . 4.5 pp -69.71 -26.36 64.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.058 0.543 . . . . 71.3 110.786 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 3.15 63.24 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-O 119.246 -0.752 . . . . 53.03 114.839 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -154.11 -53.52 0.1 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.853 0.826 . . . . 70.03 112.138 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.6 -56.03 16.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.556 0.742 . . . . 54.51 111.206 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.9 m -61.51 -50.22 83.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.253 -0.879 . . . . 64.05 112.191 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.6 Cg_exo -55.06 -36.43 92.8 Favored 'Trans proline' 0 C--N 1.399 3.194 0 C-N-CA 122.287 1.991 . . . . 63.42 113.975 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.22 -33.82 76.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.65 0.38 . . . . 60.05 111.323 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.18 -44.61 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 60.11 110.446 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HB2' HD12 ' B' ' 60' ' ' LEU . 77.3 mt -83.29 -19.4 36.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.913 -1.04 . . . . 71.34 112.637 -169.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.41 -45.84 94.58 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 117.677 -1.154 . . . . 70.11 113.689 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.61 -43.25 46.51 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.656 2.238 . . . . 63.21 113.977 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 73.7 m-85 -65.94 -44.92 83.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.873 0.733 . . . . 71.13 110.506 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.55 87.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.656 -0.702 . . . . 74.14 111.06 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.69 -53.57 54.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.044 1.338 . . . . 74.11 110.953 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -40.68 95.21 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.722 0.639 . . . . 75.45 110.223 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.468 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -66.66 -33.26 75.26 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 123.814 0.696 . . . . 73.13 111.853 -174.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.642 HG21 HG21 ' B' ' 64' ' ' VAL . 71.3 mt -68.24 -52.63 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.398 -0.593 . . . . 73.51 109.398 172.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.5 m -59.12 -28.65 66.74 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 124.176 0.922 . . . . 74.23 111.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -66.99 -53.17 34.03 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 115.297 -0.865 . . . . 70.04 109.658 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.49 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 20.6 mmt -64.3 -34.72 78.78 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 123.455 0.472 . . . . 60.15 111.95 -176.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.78 -48.39 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.906 0.882 . . . . 74.42 110.665 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -72.41 -24.22 61.2 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.872 -0.604 . . . . 64.31 111.448 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -67.5 -32.68 73.67 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.359 0.664 . . . . 72.54 109.907 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.23 8.69 75.81 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.96 0.788 . . . . 64.0 113.282 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 17' ' ' TYR . 69.9 p 57.7 34.07 24.01 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.976 1.71 . . . . 73.03 113.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.22 156.27 39.07 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.808 0.843 . . . . 73.44 110.18 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 179.57 0.55 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.124 2.549 . . . . 74.11 113.542 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -56.68 113.88 1.82 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.501 -0.772 . . . . 75.42 111.254 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.435 HD23 HG11 ' B' ' 40' ' ' VAL . 3.2 tm? -129.22 100.91 5.78 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.486 -1.672 . . . . 73.04 106.486 172.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -131.44 134.11 45.87 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.691 -0.855 . . . . 74.1 108.691 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.3 132.93 35.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.553 0.741 . . . . 73.04 110.419 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.69 154.0 81.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.047 0.939 . . . . 73.53 110.151 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.401 ' HD3' HD13 ' D' ' 16' ' ' ILE . 35.8 Cg_endo -59.98 114.18 1.97 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.931 2.421 . . . . 51.4 111.845 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.436 HG11 HD22 ' B' ' 44' ' ' LEU . 90.7 t -90.0 118.15 34.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.644 -0.707 . . . . 55.3 109.998 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.91 93.47 3.78 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.292 -0.632 . . . . 74.42 109.292 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 91.6 m-85 -62.65 -35.76 80.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.673 -1.149 . . . . 71.04 110.858 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -63.69 -39.53 94.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.516 -1.22 . . . . 63.45 110.961 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.61 -27.48 58.49 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.705 0.628 . . . . 62.12 111.807 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.401 HD12 ' HZ3' ' E' ' 120' ' ' TRP . 1.6 tm? -77.5 -42.63 34.97 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.121 -0.696 . . . . 71.32 109.121 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -66.46 -29.19 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.572 0.749 . . . . 74.4 110.321 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 57.6 ttp -57.64 -33.29 68.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.054 0.942 . . . . 73.44 112.13 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -74.25 -25.76 59.82 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.886 0.475 . . . . 74.24 111.478 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.38 -48.88 77.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.636 0.775 . . . . 71.51 111.237 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' B' ' 144' ' ' GLN . 0.5 OUTLIER -106.03 8.24 32.26 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.735 -0.666 . . . . 62.41 111.584 -176.217 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.57 91.94 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.718 1.207 . . . . 73.41 111.025 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 70.61 143.05 0.05 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.254 1.422 . . . . 74.43 111.462 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' GLN . . . . . 0.459 ' HB3' HD11 ' B' ' 141' ' ' LEU . 18.9 pt20 -152.81 170.8 19.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.308 0.643 . . . . 75.2 110.708 172.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.86 139.32 43.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.105 -0.952 . . . . 72.12 109.085 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.87 32.85 0.34 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.166 0.291 . . . . 75.43 112.787 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -80.2 89.85 5.48 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.579 0.752 . . . . 60.15 109.172 176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' B' ' 6' ' ' ASN . . . 161.51 95.44 0.11 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.513 -0.767 . . . . 32.32 111.582 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.1 t -142.45 3.21 1.49 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.368 0.667 . . . . 74.41 110.528 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.93 143.78 56.62 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 122.736 0.414 . . . . 74.24 110.629 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 151.27 45.87 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.45 1.1 . . . . 73.01 112.514 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -164.01 1.95 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.689 -1.141 . . . . 75.42 109.86 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -133.98 165.8 24.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.015 0.926 . . . . 74.51 109.617 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.03 8.41 8.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.718 0.807 . . . . 64.51 109.364 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.021 1.328 . . . . 71.43 108.05 173.919 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 17.5 tpt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 109.759 -0.46 . . . . 64.14 109.759 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t 67.14 166.68 0.23 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.153 1.381 . . . . 64.04 110.867 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 63.51 77.12 0.34 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.155 0.982 . . . . 64.25 108.503 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -101.26 174.93 5.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.618 0.767 . . . . 54.13 111.083 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.69 -9.04 52.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.46 1.104 . . . . 73.42 112.545 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -49.09 146.4 3.52 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.088 1.355 . . . . 72.14 110.789 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.7 p -47.39 120.55 3.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.765 1.226 . . . . 51.13 112.98 -171.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.52 -71.78 0.32 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.723 -1.126 . . . . 75.32 111.196 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 57.1 ttp 62.75 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.717 1.207 . . . . 64.23 111.305 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -85.92 93.43 8.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.218 -0.66 . . . . 74.21 109.218 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.458 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.9 t80 -118.97 123.56 44.87 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.983 -1.008 . . . . 72.4 108.392 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -137.84 140.96 40.76 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.707 0.403 . . . . 72.44 110.068 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.608 HD11 HG13 ' C' ' 16' ' ' ILE . 5.6 tp -85.27 136.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.128 0.571 . . . . 74.23 109.854 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 13.9 mm100 -109.55 -50.64 2.96 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.615 -0.721 . . . . 74.14 109.74 174.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -169.02 138.65 2.18 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.655 -0.702 . . . . 73.51 109.41 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.608 HG13 HD11 ' C' ' 13' ' ' ILE . 88.4 mt -122.39 144.57 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.6 -1.259 . . . . 73.44 107.6 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.5 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -174.24 165.26 4.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.364 0.602 . . . . 75.21 110.612 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.411 HG22 HE22 ' C' ' 80' ' ' GLN . 81.4 p -85.04 107.35 17.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.997 -1.001 . . . . 72.24 109.802 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.423 ' HZ3' ' HD3' ' D' ' 29' ' ' PRO . 23.6 mmmt -65.86 -35.03 79.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.761 -0.654 . . . . 74.44 109.877 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -150.53 144.4 25.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.98 -1.009 . . . . 74.24 109.549 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.3 mt -139.28 140.45 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.64 -1.615 . . . . 74.25 106.64 172.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.43 147.6 17.56 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.799 -0.445 . . . . 74.31 109.799 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -147.32 116.67 6.98 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.192 -1.04 . . . . 72.54 108.192 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.94 120.44 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.77 0.828 . . . . 74.53 108.99 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -124.2 85.58 54.96 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 73.15 108.583 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.12 -32.58 33.82 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.725 2.284 . . . . 75.32 111.595 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 73.6 m-20 -114.56 38.4 3.11 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.023 0.929 . . . . 70.25 109.422 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.83 -50.98 85.09 Favored Pre-proline 0 CA--C 1.569 1.682 0 N-CA-C 114.333 1.234 . . . . 64.21 114.333 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.2 Cg_exo -73.6 -28.59 11.7 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 121.871 1.714 . . . . 74.1 111.554 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.407 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 80.5 t60 -68.0 -20.67 65.04 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.33 1.052 . . . . 64.31 112.583 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -62.07 -16.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 118.117 0.417 . . . . 74.14 111.827 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.43 -43.53 76.93 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.492 -0.558 . . . . 71.33 109.492 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -92.07 51.24 1.77 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.62 1.168 . . . . 75.12 109.379 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.01 148.11 47.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.099 0.56 . . . . 71.23 110.997 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.47 129.28 37.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.19 -1.041 . . . . 72.45 108.19 164.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -83.93 69.5 10.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.799 0.809 . . . . 74.44 110.738 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.63 73.19 13.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.103 1.361 . . . . 71.54 107.46 165.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.59 118.87 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.215 1.943 . . . . 64.24 111.419 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.52 116.11 22.95 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.388 -0.968 . . . . 71.15 108.388 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.44 101.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 114.743 -1.117 . . . . 51.03 108.827 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.45 103.9 16.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 74.31 108.258 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.26 133.15 33.71 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.187 -0.671 . . . . 64.41 109.187 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.5 t70 -119.63 143.64 47.57 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.763 1.225 . . . . 73.51 108.148 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.22 148.94 49.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.668 0.787 . . . . 74.21 109.173 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -156.18 150.79 25.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.657 0.783 . . . . 62.33 109.034 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -133.88 146.59 50.71 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.849 0.46 . . . . 70.04 110.236 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.99 144.8 30.34 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.5 -0.926 . . . . 74.13 108.5 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.3 p -126.99 147.04 50.13 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.156 0.583 . . . . 40.31 110.172 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -147.14 127.81 14.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.068 0.947 . . . . 54.43 108.941 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -81.41 117.62 22.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.232 -0.655 . . . . 74.11 109.232 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 23.8 mt -87.94 -40.63 13.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.566 0.747 . . . . 74.15 109.974 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -150.37 -177.42 5.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.806 -1.088 . . . . 74.24 110.282 -177.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.83 109.43 1.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.512 -1.222 . . . . 71.24 110.11 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 70.22 7.67 6.32 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.165 1.386 . . . . 70.24 112.895 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 70.4 t -110.32 105.74 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.352 0.661 . . . . 73.35 109.593 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.99 129.06 56.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.195 0.998 . . . . 72.12 109.989 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.9 tt0 -85.61 143.78 28.25 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.157 -0.683 . . . . 72.45 109.157 165.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.437 HG13 HD11 ' C' ' 106' ' ' LEU . 5.0 p -132.07 134.95 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.094 -1.076 . . . . 72.43 108.094 169.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.74 105.92 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.352 -0.981 . . . . 73.04 108.352 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.97 108.01 19.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.756 -1.201 . . . . 61.02 107.756 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -79.05 123.48 27.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.21 1.004 . . . . 64.14 109.136 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.88 122.33 68.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.843 -1.169 . . . . 55.22 107.843 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 19.7 m -125.62 123.87 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.62 HG23 HD13 ' C' ' 114' ' ' ILE . 97.4 t -105.0 123.6 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.516 0.726 . . . . 54.42 109.107 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -113.96 115.0 26.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.701 -0.852 . . . . 73.33 108.701 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.785 -1.561 . . . . 70.32 106.785 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -154.71 -178.11 6.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.498 0.555 . . . . 74.23 112.498 -166.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -134.3 29.99 3.6 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.198 1.399 . . . . 61.41 107.784 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.35 -108.14 1.31 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.02 -0.991 . . . . 52.24 110.972 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.34 -31.39 18.94 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.598 -0.89 . . . . 72.41 108.598 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.95 91.79 0.21 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.743 1.217 . . . . 71.3 109.839 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.3 m -89.71 128.19 36.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.417 -0.811 . . . . 53.4 111.063 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 -58.45 3.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.058 -1.09 . . . . 71.31 108.058 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.33 144.59 22.07 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.051 -0.977 . . . . 73.54 110.747 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.458 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -105.04 145.75 30.03 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.662 -1.607 . . . . 72.15 106.662 163.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.458 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -150.42 143.23 24.66 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.182 -0.673 . . . . 72.11 109.182 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.09 131.9 17.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 71.45 109.95 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.86 123.52 62.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.684 -0.858 . . . . 75.44 108.684 168.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -97.84 104.33 16.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.037 -1.097 . . . . 75.42 108.037 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -91.98 114.47 27.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.17 0.588 . . . . 73.24 109.64 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.72 146.69 17.23 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.918 -0.473 . . . . 62.53 111.918 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.562 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.45 123.36 2.15 Favored Glycine 0 CA--C 1.505 -0.554 0 N-CA-C 111.302 -0.719 . . . . 72.04 111.302 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.539 HD12 HD11 ' C' ' 51' ' ' LEU . 7.1 mm -83.49 122.92 38.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.424 -0.954 . . . . 73.23 108.424 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -134.75 125.22 26.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.799 0.839 . . . . 71.5 109.633 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -80.48 109.47 15.02 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.35 -0.611 . . . . 52.4 109.35 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 60.3 mt -114.99 120.63 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.838 0.855 . . . . 71.44 109.567 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.66 163.17 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.367 1.067 . . . . 75.14 109.847 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.27 -36.41 3.42 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.283 -0.417 . . . . 50.32 112.385 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -112.75 141.23 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.647 1.179 . . . . 62.03 109.631 -173.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.95 156.39 42.2 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.615 0.766 . . . . 64.34 110.33 -175.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 -141.63 20.43 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.167 -0.47 . . . . 62.3 113.379 172.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -64.77 -28.66 69.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.805 0.842 . . . . 74.31 111.503 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.93 -46.39 89.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.871 0.868 . . . . 73.21 109.997 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.53 -35.24 75.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.985 -1.007 . . . . 63.04 110.259 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.16 -27.33 67.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.536 0.734 . . . . 72.3 111.654 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.29 -57.58 8.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.198 0.599 . . . . 73.33 110.439 171.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.0 -41.57 98.21 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.822 0.701 . . . . 75.01 111.195 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp -76.79 -27.18 55.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.413 1.085 . . . . 52.3 110.997 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.19 -5.32 46.7 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-O 119.378 -0.679 . . . . 63.15 114.325 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -135.32 -56.68 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.706 0.753 . . . . 64.34 111.59 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -68.98 -54.13 16.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.973 0.36 . . . . 71.14 111.973 -173.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 21.7 m -59.83 -46.29 98.33 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.673 -0.68 . . . . 62.01 111.317 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 56.6 Cg_exo -50.21 -39.53 52.12 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.106 2.538 . . . . 72.02 114.714 167.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.49 -23.9 61.89 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.296 0.638 . . . . 71.42 112.183 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.441 HD12 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -75.4 -33.17 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 109.596 -0.52 . . . . 74.22 109.596 172.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.562 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.7 mt -82.61 -28.36 30.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.152 0.981 . . . . 74.54 112.56 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.04 -46.16 99.89 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.535 -1.222 . . . . 73.24 113.586 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 73.9 Cg_exo -54.36 -41.63 74.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.236 1.957 . . . . 70.24 113.609 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.98 -46.31 68.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.523 0.729 . . . . 70.2 110.571 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -61.13 -40.64 94.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.512 -0.767 . . . . 72.12 111.17 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -62.26 -51.97 65.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.2 -1.364 . . . . 75.24 110.728 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.62 -31.29 70.35 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 123.607 0.567 . . . . 74.12 110.175 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.422 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.5 t -71.29 -29.88 65.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.886 0.474 . . . . 51.23 110.963 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.62 HD13 HG23 ' C' ' 64' ' ' VAL . 88.0 mt -74.32 -50.54 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.464 -0.569 . . . . 72.31 109.464 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -56.69 -33.69 66.69 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.17 0.988 . . . . 50.24 111.112 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -51.43 55.58 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.648 -1.16 . . . . 74.02 109.674 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.22 -33.87 71.51 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.631 0.772 . . . . 72.12 112.493 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.7 t -67.22 -48.26 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 73.43 109.717 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 70.0 p -70.61 -26.83 63.68 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.343 -0.844 . . . . 73.14 110.654 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -70.78 -34.57 71.92 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.048 -0.978 . . . . 73.34 109.766 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.01 86.89 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.216 -0.769 . . . . 42.45 113.083 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.484 HG23 ' HB3' ' D' ' 17' ' ' TYR . 73.2 p 58.04 35.13 24.94 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.88 1.672 . . . . 73.33 111.91 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -97.73 164.46 17.45 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.096 1.358 . . . . 74.1 110.451 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -53.7 142.02 62.83 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 123.528 2.818 . . . . 64.13 113.568 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.7 115.58 3.75 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.427 1.091 . . . . 63.13 110.325 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 63.0 tp -111.57 124.03 51.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.494 1.118 . . . . 74.21 110.446 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -133.88 120.86 20.93 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.835 0.854 . . . . 71.41 109.924 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.65 140.69 29.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.328 0.651 . . . . 70.15 110.845 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 148.88 50.0 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 123.86 0.864 . . . . 63.23 110.092 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.52 145.57 37.89 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.305 2.003 . . . . 74.33 112.194 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.77 110.62 25.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.835 -1.172 . . . . 52.02 107.835 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 8.5 m120 -90.85 58.23 3.77 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.724 0.773 . . . . 71.31 109.861 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -80.97 -46.36 15.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.827 -1.079 . . . . 75.44 108.609 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 17.2 t70 -71.23 -42.63 68.64 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.393 -0.821 . . . . 72.51 109.796 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -63.88 -24.68 67.83 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.01 -0.996 . . . . 54.33 111.99 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 -33.13 66.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.185 0.594 . . . . 75.21 110.346 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.35 -34.39 67.97 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.869 0.468 . . . . 73.33 111.252 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.9 mtt -79.29 -30.08 42.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.875 0.47 . . . . 75.12 111.661 175.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.28 -44.32 92.06 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.04 0.936 . . . . 65.44 109.835 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.65 -80.61 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 113.952 -1.476 . . . . 72.31 109.221 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 32.2 tp 73.74 -71.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.506 1.523 . . . . 71.33 110.499 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 57.03 89.13 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 62.04 111.28 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -162.38 142.5 9.8 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.788 . . . . 72.44 109.174 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -137.79 95.27 3.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 106.901 -1.518 . . . . 64.03 106.901 176.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.61 -42.81 11.8 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.396 0.678 . . . . 72.15 110.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.03 179.07 29.93 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.451 -0.795 . . . . 62.23 112.458 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.52 -62.95 1.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.48 1.112 . . . . 70.34 111.355 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.69 67.58 1.91 Allowed Glycine 0 C--N 1.351 1.382 0 O-C-N 123.433 0.458 . . . . 71.45 113.75 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.5 t -146.06 155.94 43.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.932 0.493 . . . . 73.32 110.834 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -106.67 108.17 19.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.949 0.9 . . . . 60.52 109.342 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.45 -38.52 91.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.338 1.055 . . . . 74.42 111.114 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -59.37 -30.89 68.74 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.375 -0.83 . . . . 74.03 111.172 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -73.66 102.78 4.03 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.997 -0.547 . . . . 72.23 109.707 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.49 -13.83 56.03 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.084 0.954 . . . . 60.34 110.725 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 123.775 0.83 . . . . 51.4 110.829 -178.78 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 108.992 -0.744 . . . . 74.15 108.992 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t 55.67 78.28 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.106 0.963 . . . . 65.12 110.221 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.76 -25.24 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.753 -0.658 . . . . 63.11 111.005 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' GLN . . . . . 0.542 ' HG2' ' HA ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -63.44 88.41 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.706 0.802 . . . . 64.42 110.291 -176.172 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -160.38 3.9 0.07 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.375 1.07 . . . . 71.2 109.448 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -125.96 161.04 28.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.974 0.91 . . . . 75.01 111.123 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -96.77 8.77 43.54 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.547 0.739 . . . . 73.12 110.333 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.59 -6.97 49.94 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.978 0.911 . . . . 65.22 111.211 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp -28.25 125.3 0.1 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.221 1.808 . . . . 42.32 114.513 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.4 m -119.97 142.05 49.11 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.794 0.837 . . . . 72.24 108.919 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' D' ' 85' ' ' SER . 83.2 t80 -150.35 108.8 3.79 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.558 -0.904 . . . . 73.21 108.558 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.41 131.52 51.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.781 0.833 . . . . 75.14 109.995 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.74 104.79 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.843 -1.169 . . . . 72.4 107.843 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -79.39 -47.65 15.38 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.98 0.733 . . . . 71.21 112.98 -170.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -159.2 121.16 3.43 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.369 -0.234 . . . . 71.54 110.369 -165.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.406 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.9 mp -105.47 129.34 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.459 -1.312 . . . . 64.32 107.459 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.484 ' HB3' HG23 ' C' ' 122' ' ' THR . 38.7 p90 -165.87 178.09 6.73 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-O 121.876 0.846 . . . . 70.44 112.153 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.472 HG21 HD11 ' D' ' 21' ' ' ILE . 70.8 p -107.82 125.58 51.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.536 -1.211 . . . . 71.15 109.488 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 28.5 mtpt -97.87 -22.3 16.43 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.608 -0.516 . . . . 65.51 109.608 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -152.03 131.63 13.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.78 -1.1 . . . . 75.24 108.835 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.574 HD13 ' HE3' ' C' ' 117' ' ' MET . 84.2 mt -134.89 142.69 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.53 -1.285 . . . . 74.12 107.53 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 24.2 t -146.77 139.27 24.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.102 0.961 . . . . 62.54 108.45 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.43 116.89 5.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.187 -1.783 . . . . 62.51 106.187 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.3 mt-10 -121.26 140.28 52.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.065 0.546 . . . . 75.22 109.602 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -146.97 78.89 10.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.377 -0.972 . . . . 73.24 108.377 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.67 -32.31 6.04 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.37 2.047 . . . . 64.45 111.546 175.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.424 ' O ' HG23 ' D' ' 31' ' ' VAL . 5.1 m120 -100.71 31.15 3.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.525 1.13 . . . . 62.24 108.839 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -59.6 -47.63 97.27 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 115.023 1.49 . . . . 64.05 115.023 -169.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HZ3' ' C' ' 19' ' ' LYS . 33.8 Cg_endo -88.87 -3.99 6.24 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.637 1.558 . . . . 75.12 112.591 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -77.2 -40.95 43.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.326 1.05 . . . . 71.33 109.491 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' D' ' 73' ' ' ALA . 61.7 t -79.29 -15.89 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.677 0.791 . . . . 72.03 110.201 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -65.68 -25.99 67.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.596 0.758 . . . . 70.12 110.888 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -73.62 -17.96 61.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.396 0.678 . . . . 62.4 111.334 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -105.73 106.41 16.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.704 0.802 . . . . 64.41 109.452 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.96 51.37 2.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.792 0.837 . . . . 65.11 110.317 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -131.64 162.55 30.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.444 0.697 . . . . 75.14 109.622 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.33 110.51 29.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.302 1.041 . . . . 74.1 109.33 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' D' ' 68' ' ' LEU . 90.5 Cg_exo -49.21 150.98 6.78 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 124.132 3.221 . . . . 73.25 115.117 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -75.55 132.75 40.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.977 -0.749 . . . . 74.32 108.977 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.4 124.99 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.275 0.559 . . . . 73.52 110.633 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -110.49 110.71 21.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.019 -1.845 . . . . 73.35 106.019 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.9 tp -96.14 137.4 35.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.112 0.482 . . . . 74.22 110.448 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.595 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.4 m-20 -129.63 141.25 50.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.746 1.218 . . . . 75.31 108.1 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.67 147.55 44.97 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.095 -0.705 . . . . 71.44 109.095 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.5 t70 -154.1 145.97 23.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.351 -0.981 . . . . 43.23 108.351 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.9 t -114.28 164.87 13.32 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.092 0.557 . . . . 73.21 109.56 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.37 147.98 22.72 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.509 0.724 . . . . 54.33 109.424 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.7 p -135.12 151.98 51.21 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.056 -0.72 . . . . 71.23 109.056 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -157.1 117.1 3.48 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.18 -1.044 . . . . 62.05 108.18 -175.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -72.61 124.96 26.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.364 -0.606 . . . . 72.23 109.364 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.83 -40.69 12.28 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.69 -0.485 . . . . 70.25 109.69 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.64 4.32 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.183 -0.917 . . . . 51.41 110.327 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.34 116.97 4.66 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.21 -0.905 . . . . 72.14 110.177 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.0 2.96 4.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.391 1.476 . . . . 72.31 113.089 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.67 116.84 52.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.42 -0.956 . . . . 75.34 108.42 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.488 ' HB2' HD13 ' D' ' 86' ' ' ILE . 50.5 m-85 -129.08 127.47 41.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.628 -1.249 . . . . 75.21 107.628 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -96.13 137.23 35.5 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.035 0.934 . . . . 72.02 108.655 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.62 126.23 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.687 -1.227 . . . . 73.21 107.687 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.1 t -102.48 135.42 39.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.007 -0.738 . . . . 70.41 109.007 173.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -112.47 121.45 44.87 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.786 -0.82 . . . . 74.44 108.786 175.512 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.8 ttm-85 -97.72 115.8 28.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.901 -0.777 . . . . 72.21 108.901 174.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.87 123.06 70.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.013 -1.106 . . . . 74.21 108.013 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -126.65 133.37 50.99 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.384 0.611 . . . . 61.02 110.088 -172.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 76.7 t -126.44 103.7 11.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.973 1.309 . . . . 61.31 109.118 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -97.53 93.17 6.29 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.069 -1.085 . . . . 55.43 108.069 172.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.86 133.99 41.61 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.198 -0.667 . . . . 55.34 109.198 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 59.2 p -140.78 131.7 26.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.802 0.841 . . . . 61.33 109.254 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' D' ' 38' ' ' PRO . 9.5 tp -107.12 107.63 18.7 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 73.03 108.474 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.72 -121.99 5.67 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.479 -0.782 . . . . 60.34 112.805 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.59 4.99 50.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.041 0.936 . . . . 60.44 110.981 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.36 147.21 35.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.697 0.399 . . . . 64.3 110.347 -163.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -58.48 141.53 51.47 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.785 0.834 . . . . 70.22 111.56 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -100.47 -68.14 0.82 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.602 1.161 . . . . 73.32 109.519 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.84 139.0 19.22 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.843 -0.617 . . . . 75.11 109.491 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.606 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.1 mt -101.06 152.81 20.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.95 -0.759 . . . . 75.13 108.95 173.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.654 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.5 t -159.26 143.4 15.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.826 0.45 . . . . 71.04 110.279 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -155.94 121.88 5.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.007 0.523 . . . . 61.41 109.667 171.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.03 114.86 43.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.326 0.651 . . . . 74.22 109.898 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.686 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -90.24 89.63 7.72 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.026 -0.731 . . . . 75.01 109.026 167.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.17 95.83 5.71 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.531 -1.213 . . . . 75.15 108.46 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 140.95 18.02 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.684 -0.566 . . . . 74.55 111.684 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.03 129.45 4.77 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.241 -1.144 . . . . 72.11 110.241 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.92 128.42 41.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.438 -0.949 . . . . 74.35 108.438 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.19 161.57 28.99 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.074 0.55 . . . . 74.44 110.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 32.8 m -116.42 108.89 16.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.984 0.914 . . . . 75.31 109.35 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.51 HG12 HD11 ' D' ' 98' ' ' LEU . 3.3 mp -109.57 119.4 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.399 0.68 . . . . 70.42 109.415 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.97 155.64 44.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.409 1.083 . . . . 45.22 109.226 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 -13.07 5.73 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 114.323 0.489 . . . . 64.54 114.323 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.542 ' HA ' ' HG2' ' D' ' 4' ' ' GLN . 5.5 tt -134.9 137.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.313 1.445 . . . . 71.21 107.822 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -161.56 175.15 12.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.794 0.837 . . . . 62.11 110.012 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.6 -133.38 13.04 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.255 0.347 . . . . 62.2 113.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -71.41 -38.07 71.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.149 0.979 . . . . 74.02 112.137 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.45 -32.74 70.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.149 0.579 . . . . 72.41 110.029 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.489 ' HG3' HG21 ' D' ' 86' ' ' ILE . 59.2 ttp -69.21 -37.72 78.22 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.689 -0.687 . . . . 73.24 110.363 174.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.79 70.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.095 0.558 . . . . 70.1 111.25 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.584 ' HA ' ' HE1' ' D' ' 137' ' ' PHE . 42.2 t-80 -71.56 -37.67 71.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.338 0.655 . . . . 63.01 110.744 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.56 -50.19 47.18 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.927 0.491 . . . . 74.14 111.203 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.51 HD11 HG12 ' D' ' 86' ' ' ILE . 9.9 mp -75.8 -25.11 56.07 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.802 0.841 . . . . 65.15 111.573 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.38 66.43 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 119.592 -0.56 . . . . 71.13 113.511 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.14 -66.43 0.52 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.474 0.546 . . . . 62.2 112.474 -174.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -62.19 -46.08 90.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.335 0.654 . . . . 73.43 112.425 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -67.11 -44.27 48.84 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-O 118.672 -0.68 . . . . 72.54 112.316 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.52 ' HB2' ' HZ ' ' D' ' 133' ' ' PHE . 77.0 Cg_exo -54.4 -32.29 71.99 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.418 2.079 . . . . 71.31 114.482 166.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -64.51 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.28 0.491 . . . . 63.21 111.741 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -67.8 -42.91 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 121.436 0.636 . . . . 71.43 110.019 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.467 HD21 ' HA3' ' D' ' 82' ' ' GLY . 97.2 mt -77.01 -27.64 54.72 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.834 -1.076 . . . . 73.11 112.725 -171.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.74 -45.89 88.14 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.891 1.071 . . . . 65.12 113.891 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -34.76 98.3 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.714 1.609 . . . . 73.41 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.88 -34.47 51.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 75.13 111.485 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.25 -46.82 69.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.279 0.632 . . . . 70.33 110.841 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -69.86 -33.47 72.3 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.215 -0.902 . . . . 54.41 110.669 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -66.32 -42.4 88.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.305 1.003 . . . . 75.24 111.005 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -59.69 -40.04 86.56 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.739 0.65 . . . . 61.31 110.139 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.654 HG12 ' SG ' ' D' ' 76' ' ' CYS . 53.7 mt -63.29 -50.39 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.051 0.845 . . . . 63.15 110.548 173.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 50.0 m -56.43 -44.62 80.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.129 0.972 . . . . 74.43 111.464 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.8 t -65.16 -44.95 86.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 114.68 -1.145 . . . . 71.25 110.429 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.17 -31.2 72.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.737 0.415 . . . . 71.34 112.074 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.416 HG23 ' O ' ' D' ' 114' ' ' ILE . 55.8 t -70.49 -41.91 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.818 0.698 . . . . 72.41 110.483 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -73.38 -24.45 60.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.669 0.271 . . . . 72.33 110.97 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 92.2 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.602 0.761 . . . . 72.31 109.582 172.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.3 -3.66 88.65 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.766 0.666 . . . . 75.24 112.399 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.4 p 58.32 30.92 20.24 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.426 1.89 . . . . 61.44 112.208 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -95.03 169.38 9.51 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.714 1.606 . . . . 73.1 110.099 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.417 ' HD3' HG11 ' F' ' 136' ' ' VAL . 16.1 Cg_endo -55.75 130.99 43.36 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.115 2.543 . . . . 62.51 112.625 175.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -55.27 147.49 16.65 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.251 1.02 . . . . 61.53 112.255 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -135.4 95.81 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.083 0.468 . . . . 53.23 110.499 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -100.97 114.41 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.914 -1.143 . . . . 70.43 107.914 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 98.7 mt -75.94 134.71 40.14 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.773 0.321 . . . . 71.03 110.514 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.59 142.03 91.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 65.14 111.078 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.3 131.24 27.66 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.41 2.073 . . . . 53.1 111.077 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.15 127.02 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.803 0.841 . . . . 72.32 110.219 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.55 77.97 9.75 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.919 . . . . 52.25 109.18 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.52 ' HZ ' ' HB2' ' D' ' 103' ' ' PRO . 45.2 p90 -67.45 -18.22 65.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.81 -1.086 . . . . 72.45 111.05 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' D' ' 138' ' ' MET . 24.0 t0 -59.74 -39.38 84.56 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.705 0.802 . . . . 71.45 111.763 176.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.97 -31.83 67.27 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.835 0.35 . . . . 73.03 111.804 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.96 -37.25 24.35 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.111 0.964 . . . . 74.32 109.201 176.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.584 ' HE1' ' HA ' ' D' ' 96' ' ' HIS . 76.6 t80 -62.9 -32.55 73.84 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.517 1.127 . . . . 64.21 111.266 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 45.8 mtt -59.34 -44.66 92.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.293 0.637 . . . . 71.04 110.205 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -60.78 -38.73 86.28 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.024 0.93 . . . . 54.44 111.115 -178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.82 -39.92 93.46 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.407 -0.815 . . . . 64.01 110.663 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.41 -28.88 64.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.789 0.836 . . . . 73.52 111.712 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -80.88 -0.15 37.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.005 0.522 . . . . 64.11 111.819 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -129.85 45.28 2.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.323 0.649 . . . . 73.11 109.585 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.97 156.29 17.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.734 0.814 . . . . 62.44 110.263 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.82 8.18 0.07 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.259 0.624 . . . . 70.01 111.887 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.9 120.63 4.73 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-O 120.091 -0.283 . . . . 64.12 112.523 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.98 132.85 42.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.954 -1.128 . . . . 64.24 107.954 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.02 81.54 1.08 Allowed Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.908 -0.477 . . . . 63.33 111.908 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.5 p -68.24 85.28 0.26 Allowed 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.379 0.609 . . . . 55.1 110.33 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -99.16 123.99 43.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.815 -0.63 . . . . 62.33 109.857 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.29 164.45 17.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.49 0.662 . . . . 61.25 110.328 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -125.73 152.38 45.4 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.522 -1.288 . . . . 75.51 107.522 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.69 95.0 0.47 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.226 -0.657 . . . . 74.32 109.226 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.85 -28.26 68.2 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.989 0.916 . . . . 72.21 110.523 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.306 0 O-C-N 124.687 1.242 . . . . 73.24 112.541 168.132 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.479 -0.563 . . . . 72.33 109.479 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -85.69 68.45 10.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.953 -0.758 . . . . 75.0 108.953 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.55 86.15 6.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.469 -0.937 . . . . 74.31 108.469 177.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -138.21 144.65 40.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.666 -1.152 . . . . 62.24 108.742 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 112' ' ' GLN . . . . . 0.474 ' HG2' ' H ' ' E' ' 113' ' ' ASP . 10.7 tt0 -144.58 -159.56 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 107.423 -1.325 . . . . 62.22 107.423 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 113' ' ' ASP . . . . . 0.474 ' H ' ' HG2' ' E' ' 112' ' ' GLN . 1.3 p30 -55.58 -31.3 62.07 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.202 0.601 . . . . 72.22 110.02 163.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 114' ' ' LYS . . . . . 0.551 ' HG2' ' H ' ' E' ' 116' ' ' TYR . 39.8 ttmt -97.78 137.72 36.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.636 1.174 . . . . 64.4 109.469 170.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.587 HD13 ' H ' ' E' ' 115' ' ' LEU . 0.0 OUTLIER -87.19 0.2 55.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.612 0.597 . . . . 74.03 112.612 -177.084 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 116' ' ' TYR . . . . . 0.551 ' H ' ' HG2' ' E' ' 114' ' ' LYS . 14.2 t80 -77.24 110.53 12.57 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 123.645 0.778 . . . . 64.41 109.505 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' E' ' 116' ' ' TYR . 3.9 Cg_endo -88.39 -66.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.849 3.033 . . . . 75.14 113.501 -169.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -157.82 138.33 12.85 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.826 0.85 . . . . 70.33 109.541 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 17.1 m -105.23 130.47 53.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.78 -0.822 . . . . 75.13 108.78 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.444 ' CD1' HG21 ' B' ' 46' ' ' THR . 1.2 p-90 -70.26 88.04 0.62 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.442 0.639 . . . . 71.24 112.394 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -72.46 -18.38 61.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.088 0.955 . . . . 73.03 111.086 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.8 5.67 3.88 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.973 0.909 . . . . 61.54 112.628 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 123' ' ' VAL . . . . . 0.509 HG11 ' H ' ' B' ' 46' ' ' THR . 7.3 p -54.23 131.44 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 C-N-CA 124.398 1.079 . . . . 74.32 111.476 172.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -153.97 -64.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.62 0.768 . . . . 72.02 108.982 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 125' ' ' TYR . . . . . 0.529 ' HB3' HD13 ' B' ' 44' ' ' LEU . 60.9 t80 54.85 92.59 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.58 1.152 . . . . 71.31 110.728 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -93.0 151.41 19.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.016 0.526 . . . . 72.54 110.408 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.79 168.1 18.26 Favored Glycine 0 C--O 1.244 0.744 0 CA-C-N 115.228 -0.896 . . . . 44.33 111.16 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -121.34 145.5 47.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.359 0.664 . . . . 60.45 110.422 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.28 178.4 6.87 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.598 -0.728 . . . . 63.2 109.613 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp 62.59 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 124.429 1.092 . . . . 74.34 109.01 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.78 -32.36 52.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.328 -0.851 . . . . 51.12 111.13 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -143.2 98.25 5.57 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.356 0.662 . . . . 74.31 110.632 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.46 43.94 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.233 2.622 . . . . 72.24 111.852 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 134' ' ' ILE . . . . . 0.406 ' H ' HG13 ' E' ' 134' ' ' ILE . 2.7 pp -69.71 -25.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-N 115.333 -0.848 . . . . 62.3 112.427 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.78 -143.07 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.975 -1.121 . . . . 75.01 107.975 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.593 HG23 ' H ' ' E' ' 137' ' ' GLU 0.308 30.8 m 52.56 -100.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 C-N-CA 125.486 1.515 . . . . 74.12 113.088 175.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 137' ' ' GLU . . . . . 0.593 ' H ' HG23 ' E' ' 136' ' ' VAL . 46.7 mt-10 56.5 -79.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.912 1.233 . . . . 65.53 113.413 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.67 34.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.176 0.99 . . . . 71.53 110.111 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.97 113.17 23.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.445 0.698 . . . . 75.31 109.627 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 22.5 m -83.98 -52.49 6.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.108 0.563 . . . . 71.3 110.853 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.95 87.47 5.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.419 -0.585 . . . . 73.14 109.419 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.53 140.67 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.612 0.765 . . . . 74.12 108.944 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 65.49 179.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.173 0.989 . . . . 70.44 111.202 -171.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.93 -68.56 0.64 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.782 -0.821 . . . . 75.33 108.782 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -163.74 -60.84 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.152 -1.425 . . . . 71.42 107.152 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 146' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' E' ' 149' ' ' PRO . 22.6 m-20 -84.41 164.75 18.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.514 -0.767 . . . . 64.42 110.365 172.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 72.4 mt -95.21 -60.62 1.64 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.861 . . . . 72.13 110.181 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' C' ' 132' ' ' ASN . 37.7 tp -93.32 -50.21 0.27 Allowed Pre-proline 0 CA--C 1.562 1.43 0 CA-C-O 117.838 -1.077 . . . . 63.43 111.718 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 149' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' E' ' 146' ' ' ASP . 31.3 Cg_exo . . . . . 0 C--N 1.399 3.196 0 C-N-CA 122.218 1.945 . . . . 51.33 112.307 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.656 -0.127 . . . . 74.13 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 78.57 -34.86 0.17 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.855 1.662 . . . . 75.04 114.264 167.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.72 78.84 4.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.525 0.679 . . . . 61.35 109.255 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -91.78 -53.94 4.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.307 -0.861 . . . . 64.44 109.815 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 112' ' ' GLN . . . . . 0.516 HE22 ' HG3' ' F' ' 114' ' ' LYS . 0.0 OUTLIER -82.37 -64.89 1.09 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.168 -0.924 . . . . 73.22 109.938 -170.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 63.56 82.68 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.642 1.177 . . . . 71.24 112.264 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.516 ' HG3' HE22 ' F' ' 112' ' ' GLN . 49.3 mtmt -148.29 143.33 26.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 62.33 109.321 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.412 HD12 HG13 ' A' ' 86' ' ' ILE . 18.1 mt -84.79 77.84 10.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.788 -0.819 . . . . 65.1 108.788 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -133.69 126.12 18.81 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.616 -0.72 . . . . 74.31 109.71 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 117' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 95' ' ' ALA . 97.1 Cg_endo -73.33 147.98 42.69 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.685 2.256 . . . . 63.44 111.879 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -77.78 150.81 34.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.739 -0.467 . . . . 64.24 109.739 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 6.7 p -64.8 109.37 2.04 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.845 0.858 . . . . 65.14 110.811 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -128.18 150.09 50.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.994 -1.113 . . . . 74.45 107.994 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -147.87 -77.75 0.16 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.032 -0.729 . . . . 53.52 109.032 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . 58.18 -78.58 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.593 1.157 . . . . 62.54 111.605 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t 63.78 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.37 1.468 . . . . 72.51 111.93 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -111.15 -72.95 0.7 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.559 0.744 . . . . 75.14 109.009 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 56.6 -133.63 1.38 Allowed 'General case' 0 CA--C 1.554 1.117 0 O-C-N 124.228 0.955 . . . . 65.41 111.135 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 63.2 t30 72.47 142.09 0.06 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.668 1.187 . . . . 62.04 112.192 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.58 -162.68 27.32 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.223 -0.751 . . . . 34.5 111.223 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.99 130.09 35.1 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.704 0.402 . . . . 73.51 110.762 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.96 -118.55 0.13 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.076 0.95 . . . . 75.24 108.801 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.432 ' H ' HD12 ' F' ' 130' ' ' ILE . 3.7 mp -82.1 91.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 N-CA-C 107.195 -1.409 . . . . 70.24 107.195 172.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.86 -16.09 62.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.255 0.622 . . . . 70.22 111.764 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -142.47 97.44 6.11 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 123.469 0.707 . . . . 73.41 109.61 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -86.78 174.57 5.56 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.533 2.155 . . . . 71.53 112.29 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.27 -32.5 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.179 0.592 . . . . 64.32 109.981 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 56.38 24.84 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.006 1.322 . . . . 71.32 113.868 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.417 HG11 ' HD3' ' D' ' 124' ' ' PRO . 7.5 p -96.99 158.31 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.391 0.676 . . . . 73.44 111.383 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -102.34 -75.88 0.59 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.252 0.621 . . . . 74.31 110.821 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -153.82 168.97 24.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.708 0.803 . . . . 63.31 111.003 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.91 101.36 1.35 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.183 0.593 . . . . 73.1 110.07 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 18.0 m -67.99 -32.6 73.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.484 -0.78 . . . . 61.22 109.851 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 64.5 mt -78.73 120.19 23.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.892 -0.595 . . . . 60.1 109.49 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.436 HG13 ' H ' ' F' ' 143' ' ' TYR . 9.5 tp -147.92 177.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 N-CA-C 108.257 -1.016 . . . . 62.45 108.257 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 143' ' ' TYR . . . . . 0.436 ' H ' HG13 ' F' ' 142' ' ' ILE . 9.8 p90 -67.48 77.84 0.17 Allowed 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.898 0.856 . . . . 60.1 111.406 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -100.72 98.07 8.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.017 0.927 . . . . 71.44 109.158 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 145' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' F' ' 145' ' ' LYS . 0.4 OUTLIER -179.96 -41.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.321 1.448 . . . . 60.23 109.038 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -159.66 110.8 1.99 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.605 1.162 . . . . 74.34 108.618 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 147' ' ' LEU . . . . . 0.498 ' HB3' ' HD3' ' F' ' 149' ' ' PRO . 3.1 tt -90.33 -49.44 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.291 -1.003 . . . . 74.13 108.291 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 tt 58.17 64.3 3.83 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 124.469 1.108 . . . . 74.45 110.501 -172.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 149' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' F' ' 147' ' ' LEU . 51.0 Cg_exo . . . . . 0 C--N 1.384 2.44 0 C-N-CA 122.203 1.935 . . . . 60.22 112.581 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.708 -0.478 . . . . 70.33 109.708 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -83.72 -173.53 4.77 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.217 1.007 . . . . 74.23 110.319 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 79.66 -43.84 0.29 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 125.474 1.509 . . . . 71.22 111.946 174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.09 93.92 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.835 0.854 . . . . 74.31 111.084 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -89.53 2.7 54.26 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.693 0.797 . . . . 63.21 111.49 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.27 150.89 19.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.633 0.773 . . . . 71.25 109.093 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -67.39 111.19 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.069 0.548 . . . . 72.43 111.018 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.54 159.03 16.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.422 -0.808 . . . . 74.44 110.535 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.438 ' HG2' ' HA3' ' A' ' 88' ' ' GLY . 56.1 mtm -71.67 150.52 44.5 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.254 -0.647 . . . . 74.54 109.254 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.8 m -141.23 132.38 26.37 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.875 -0.787 . . . . 62.35 108.875 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -135.83 120.43 18.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.877 -1.157 . . . . 75.14 107.877 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 78.8 mt-30 -132.16 108.6 9.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.415 0.686 . . . . 62.43 109.347 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 pt -83.73 86.96 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.322 -0.992 . . . . 72.35 108.322 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -72.88 -39.53 66.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.946 -0.57 . . . . 61.34 111.496 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -172.07 146.78 2.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.317 -0.623 . . . . 73.14 109.317 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.474 HD12 ' HG2' ' C' ' 130' ' ' PRO . 94.7 mt -137.1 100.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.174 0.59 . . . . 74.42 109.433 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 26.6 m-85 -159.67 160.66 34.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.483 1.113 . . . . 74.23 110.701 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.48 HG21 ' SG ' ' A' ' 113' ' ' CYS . 30.5 p -71.64 129.18 38.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.445 -1.252 . . . . 74.14 111.117 -167.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -84.43 -38.67 19.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.416 0.627 . . . . 63.31 109.583 169.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.6 t70 -139.9 137.66 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.968 -1.014 . . . . 71.4 109.442 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -132.65 146.1 33.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.077 1.351 . . . . 63.24 107.515 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.65 140.24 17.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.961 -0.755 . . . . 54.33 108.961 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 88.9 t80 -142.71 123.47 14.23 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 106.01 -1.848 . . . . 75.2 106.01 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -118.29 152.05 36.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.407 -0.96 . . . . 72.12 108.407 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -145.3 74.33 14.11 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.881 -1.526 . . . . 64.22 106.881 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.98 -20.71 25.22 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.556 2.171 . . . . 73.23 111.842 -172.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 31' ' ' VAL . 89.1 m-20 -118.46 29.93 7.49 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.425 1.09 . . . . 51.11 109.661 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.17 -49.47 92.09 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 113.182 0.808 . . . . 64.31 113.182 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 31.9 Cg_exo -61.99 -27.05 79.16 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.007 1.805 . . . . 71.31 113.373 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -73.41 -38.32 65.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.943 0.497 . . . . 60.25 110.502 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 27' ' ' ASN . 60.1 t -66.78 -34.44 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.524 0.73 . . . . 74.11 110.416 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -56.47 -31.09 63.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.39 1.076 . . . . 53.1 111.361 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -91.22 -45.56 8.57 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.456 1.102 . . . . 62.02 110.714 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.58 165.61 20.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.354 0.662 . . . . 53.04 112.193 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.15 126.19 28.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.845 -1.071 . . . . 54.44 110.894 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.17 82.28 7.13 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.576 -0.738 . . . . 64.4 110.21 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -142.88 79.12 14.99 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.039 -1.097 . . . . 61.13 108.039 171.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -86.65 144.07 7.49 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.616 2.211 . . . . 63.14 112.736 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -98.03 126.0 43.26 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.384 1.074 . . . . 62.21 108.151 175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.58 130.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.226 0.536 . . . . 64.1 110.749 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 63.1 tttm -119.62 112.32 19.16 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.079 -1.452 . . . . 73.4 107.079 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 mt -115.48 107.74 15.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.638 -0.875 . . . . 64.23 108.638 -167.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.8 m-20 -106.13 109.18 21.03 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 55.53 109.331 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.25 132.58 49.4 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.358 -0.608 . . . . 74.11 109.358 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 60' ' ' LEU . 16.3 t70 -142.55 141.65 32.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.13 0.972 . . . . 73.43 109.04 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.9 m -137.73 140.51 40.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.292 0.637 . . . . 73.42 110.428 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.93 134.73 14.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.599 0.76 . . . . 53.12 110.391 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 58' ' ' VAL . 68.0 p -111.31 167.72 10.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.117 0.567 . . . . 73.34 110.297 173.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -168.58 119.13 0.76 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.583 -0.525 . . . . 65.44 109.583 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -69.09 108.07 3.43 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.252 0.621 . . . . 73.32 109.936 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.66 HD11 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -77.83 -41.59 36.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.584 0.754 . . . . 74.32 110.488 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -172.87 4.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.915 . . . . 73.12 109.779 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.28 105.18 0.31 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.976 0.51 . . . . 63.12 110.124 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 58.15 22.04 8.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.105 1.362 . . . . 74.04 112.984 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.2 t -108.33 120.82 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.089 -1.449 . . . . 71.14 107.089 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 136.09 41.2 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.813 -1.18 . . . . 74.42 107.813 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 51' ' ' LEU . 30.4 tt0 -89.13 115.74 26.87 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.94 0.896 . . . . 72.33 108.789 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 48' ' ' SER . 26.9 t -99.25 110.98 27.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 107.017 -1.475 . . . . 64.42 107.017 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -99.41 119.66 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.061 0.544 . . . . 73.31 109.671 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.66 112.47 24.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.038 -1.097 . . . . 72.43 108.038 175.149 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -101.29 106.67 17.88 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.901 0.881 . . . . 73.44 109.443 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.99 114.37 46.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.524 1.13 . . . . 64.34 109.137 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.1 m -102.83 146.51 28.17 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 50.1 t -142.01 107.16 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.716 1.206 . . . . 70.04 108.073 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.6 m -103.14 135.83 44.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.312 -0.625 . . . . 72.24 109.312 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.59 118.37 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.552 -1.277 . . . . 73.25 107.552 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -124.32 126.2 45.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.281 -0.637 . . . . 63.01 109.281 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.47 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.61 62.91 6.05 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.82 0.819 . . . . 71.52 109.134 -179.277 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.77 -106.85 1.42 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.877 -1.289 . . . . 14.0 109.877 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -115.82 -26.22 7.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.799 0.84 . . . . 74.21 110.336 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.26 132.05 37.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.911 0.484 . . . . 75.22 109.832 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -71.81 110.89 6.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.931 0.892 . . . . 62.54 110.212 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.47 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -59.1 -57.23 13.97 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.064 0.945 . . . . 65.25 109.598 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -161.72 173.23 14.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.013 -1.449 . . . . 72.0 109.631 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 76' ' ' CYS . 47.3 tp -137.62 149.36 46.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.228 1.011 . . . . 70.11 109.752 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.536 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.5 m -136.82 139.95 42.11 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 124.652 1.181 . . . . 72.2 108.694 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -150.18 129.3 12.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.483 -0.562 . . . . 72.05 109.483 172.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.86 112.51 13.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.774 0.829 . . . . 74.2 109.393 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.3 mt-30 -85.75 82.5 8.17 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.741 -0.837 . . . . 65.05 108.741 171.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.65 93.58 3.65 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.235 -1.348 . . . . 72.35 109.545 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.17 146.1 20.92 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.195 -0.457 . . . . 61.14 112.056 -177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.47 122.97 2.51 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.156 -1.178 . . . . 50.11 110.156 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.9 mt -86.08 121.74 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.731 -0.84 . . . . 34.11 108.731 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -128.68 118.97 23.79 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.967 -1.123 . . . . 72.34 107.967 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 26.7 t -94.92 86.34 4.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.067 -1.086 . . . . 42.14 108.067 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -114.72 143.39 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.232 0.613 . . . . 72.13 110.756 -175.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.65 167.47 23.11 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.172 0.989 . . . . 61.23 110.885 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 9' ' ' MET . . . 92.01 -6.18 79.0 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.256 -0.884 . . . . 72.21 113.66 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.26 146.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.566 0.746 . . . . 62.42 109.779 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 172.2 14.82 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.949 0.499 . . . . 72.43 110.375 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.18 -127.55 40.48 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.264 0.353 . . . . 74.41 113.391 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -74.4 -20.44 60.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.341 0.656 . . . . 64.14 112.015 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.27 -49.69 68.62 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.459 0.704 . . . . 71.32 109.962 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.9 tmm? -75.67 -37.25 59.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.478 -1.237 . . . . 75.44 110.755 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.99 85.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.378 0.609 . . . . 70.41 110.758 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -65.7 -41.8 91.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.075 -0.966 . . . . 72.52 110.419 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.5 m -74.71 -26.91 60.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.467 0.914 . . . . 71.02 113.467 -173.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.68 -23.36 24.23 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.64 0.376 . . . . 73.14 111.149 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' F' ' 120' ' ' TRP . . . -103.47 -16.08 21.27 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.526 0.57 . . . . 43.51 114.526 -176.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.9 -64.22 0.58 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.597 0.698 . . . . 63.1 111.636 -172.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 12.5 t80 -48.89 -65.92 0.49 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.577 1.151 . . . . 73.42 113.084 -174.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.31 -44.78 13.61 Favored Pre-proline 0 CA--C 1.559 1.317 0 CA-C-O 118.207 -0.902 . . . . 63.51 113.067 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.56 -31.82 87.43 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.839 1.693 . . . . 62.54 113.849 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -67.92 -34.13 76.03 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.131 0.423 . . . . 63.41 110.45 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.39 -41.23 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.691 0.796 . . . . 60.33 110.238 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.9 mt -70.53 -25.51 63.15 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.49 -0.777 . . . . 41.22 112.003 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -67.0 -43.23 46.19 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.675 1.361 . . . . 65.54 114.675 -167.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.4 -36.79 88.58 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.284 1.989 . . . . 72.21 113.596 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -76.07 -39.0 56.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.19 0.596 . . . . 70.22 111.523 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.38 92.4 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.58 0.352 . . . . 62.24 110.25 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HD12 ' C' ' 105' ' ' ILE . 40.6 ttm180 -53.85 -51.81 62.41 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.813 1.32 . . . . 73.31 110.358 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.61 -42.67 99.21 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.086 -0.961 . . . . 75.33 112.022 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.48 ' SG ' HG21 ' A' ' 18' ' ' THR . 45.0 t -68.23 -39.02 82.43 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.654 0.596 . . . . 61.42 111.523 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.529 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 85.0 mt -64.51 -55.2 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.48 0.712 . . . . 45.03 109.626 176.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 125' ' ' GLN . 64.8 m -58.43 -34.16 70.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.351 1.061 . . . . 73.42 111.792 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -65.28 -44.27 88.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.806 -0.634 . . . . 62.22 110.578 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.529 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 52.2 mtm -63.41 -40.75 98.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.712 0.405 . . . . 74.11 110.869 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.1 t -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 O-C-N 124.191 0.932 . . . . 44.11 110.622 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -74.47 -31.35 62.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.943 -0.571 . . . . 71.24 111.16 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -69.44 -29.95 67.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.657 0.783 . . . . 65.31 110.042 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -3.66 82.98 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.569 -0.741 . . . . 71.44 112.985 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m 67.47 17.7 10.06 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.507 1.123 . . . . 72.1 110.783 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.54 157.12 37.7 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.911 0.884 . . . . 72.23 110.884 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.64 122.77 11.48 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.999 2.466 . . . . 74.53 112.478 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.553 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -53.17 136.52 36.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.951 1.3 . . . . 72.4 112.563 -176.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.7 mt -120.67 99.25 6.43 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.728 -0.841 . . . . 73.01 108.728 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -98.89 125.22 44.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.543 0.737 . . . . 60.4 109.391 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.21 138.26 45.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.806 0.843 . . . . 54.5 110.202 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.82 126.1 92.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.659 -0.497 . . . . 73.51 109.659 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -65.95 103.63 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.406 2.071 . . . . 73.24 112.388 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.1 143.16 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.744 0.818 . . . . 52.33 110.008 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -89.27 85.45 6.61 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.235 1.014 . . . . 71.3 110.606 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -36.5 72.5 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.65 1.18 . . . . 64.43 113.042 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.91 -41.68 70.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.536 0.734 . . . . 61.41 111.334 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.93 -32.14 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.922 0.489 . . . . 63.53 110.1 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -65.62 -35.85 82.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.751 0.82 . . . . 74.35 110.086 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -65.53 -46.14 80.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.818 0.447 . . . . 73.41 109.796 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.2 mmt -60.38 -39.76 88.43 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.523 0.729 . . . . 72.22 110.768 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -60.53 -52.45 65.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 54.44 111.163 177.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -74.61 -30.14 61.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.298 0.239 . . . . 74.52 111.514 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.6 -49.15 78.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.38 0.672 . . . . 61.23 110.802 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -167.82 6.18 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.01 0.524 . . . . 70.22 111.181 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 60.47 26.75 16.36 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.959 0.904 . . . . 75.33 110.049 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -100.07 150.87 22.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.503 1.121 . . . . 72.45 109.859 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.44 -82.7 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.104 1.361 . . . . 63.25 111.008 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.29 -65.37 3.36 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 121.048 0.249 . . . . 62.31 112.902 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.38 162.67 22.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.249 1.42 . . . . 74.44 109.028 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.95 61.9 0.75 Allowed Glycine 0 C--N 1.348 1.218 0 N-CA-C 111.659 -0.576 . . . . 71.45 111.659 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.9 p -69.87 132.37 45.91 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.769 0.827 . . . . 73.33 110.871 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -149.99 79.0 1.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.673 -0.862 . . . . 75.23 108.673 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.29 76.67 1.28 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.712 1.244 . . . . 74.31 108.897 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -165.95 149.29 7.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.698 -1.592 . . . . 51.33 108.228 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 69.86 4.33 4.72 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.699 1.2 . . . . 51.11 112.779 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -49.62 9.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.409 1.084 . . . . 72.33 110.192 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.485 1.114 . . . . 60.22 111.657 176.258 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.495 -0.557 . . . . 65.43 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.0 p -176.12 62.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.381 1.073 . . . . 71.11 108.144 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -76.66 178.52 6.67 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.055 -0.975 . . . . 72.05 112.397 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -69.23 109.17 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.263 -1.335 . . . . 70.03 109.875 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -82.97 175.15 10.27 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.37 0.668 . . . . 51.13 110.251 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.82 74.38 0.44 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.14 1.376 . . . . 72.32 110.262 -170.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -117.73 156.71 27.79 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.783 0.833 . . . . 70.21 110.522 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.92 -30.12 68.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.962 0.905 . . . . 71.34 111.301 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.594 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.3 ptm 59.23 174.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.745 2.018 . . . . 62.35 115.003 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 95.9 m -154.65 136.61 14.6 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.131 1.373 . . . . 42.44 107.616 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -143.06 138.2 29.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.564 -0.532 . . . . 73.52 109.564 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.608 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 58.2 tt0 -155.16 140.82 17.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.822 0.849 . . . . 61.31 109.664 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.31 117.41 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 108.978 -0.749 . . . . 74.14 108.978 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.86 -50.3 9.35 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.803 0.274 . . . . 72.41 110.499 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -166.31 142.32 4.8 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.85 0.46 . . . . 75.21 109.822 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.5 mt -115.01 148.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.313 -1.366 . . . . 53.23 107.313 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' B' ' 83' ' ' ILE . 27.0 p90 -170.63 143.89 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.198 0.454 . . . . 73.23 110.973 -177.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.0 m -73.61 118.31 16.42 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.414 -0.812 . . . . 61.44 108.848 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -91.31 -29.24 17.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.567 0.747 . . . . 74.34 111.182 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.9 t70 -160.58 146.38 14.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.336 0.397 . . . . 72.15 111.19 -172.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.7 mm -143.03 143.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 C-N-CA 125.975 1.71 . . . . 74.14 108.172 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.9 t -143.07 140.35 30.89 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.163 1.385 . . . . 54.11 107.285 171.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.3 t80 -151.64 126.78 9.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.316 -1.365 . . . . 73.35 107.316 171.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 138.46 53.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.901 0.88 . . . . 43.04 108.995 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -129.37 81.41 70.19 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 107.044 -1.465 . . . . 63.32 107.044 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.49 -26.0 55.16 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.805 2.337 . . . . 71.12 111.979 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -126.48 32.92 5.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.361 1.064 . . . . 75.24 109.514 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.54 -50.09 51.93 Favored Pre-proline 0 CA--C 1.565 1.538 0 C-N-CA 124.504 1.122 . . . . 72.13 113.347 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.61 -12.06 26.6 Favored 'Trans proline' 0 C--N 1.391 2.763 0 C-N-CA 121.769 1.646 . . . . 74.02 113.774 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -97.07 -22.27 16.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.622 0.769 . . . . 73.13 112.515 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 28' ' ' ALA . 8.3 p -68.63 -23.88 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.808 0.443 . . . . 74.22 112.1 -174.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.91 -29.91 71.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.396 0.678 . . . . 73.4 111.53 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.47 -30.77 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.285 0.634 . . . . 72.5 110.419 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.39 94.55 7.12 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 74.24 111.548 -172.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -94.19 81.1 4.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.361 0.665 . . . . 54.34 109.269 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -151.12 162.03 41.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.688 1.195 . . . . 74.24 108.517 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -75.05 113.84 28.97 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.222 1.009 . . . . 61.41 109.354 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.684 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 69.7 Cg_endo -71.92 147.47 49.65 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.348 2.032 . . . . 74.41 111.017 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 37.6 tt0 -51.7 106.43 0.14 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.588 0.755 . . . . 71.55 110.449 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.52 122.34 37.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.517 -1.29 . . . . 64.12 107.517 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -149.09 104.23 3.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.897 -0.592 . . . . 71.11 109.497 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.8 147.25 23.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.366 -0.833 . . . . 73.04 109.225 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -136.71 145.8 45.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.404 1.082 . . . . 61.11 108.096 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.586 HD21 ' CD1' ' E' ' 125' ' ' TYR . 1.9 mm? -124.61 163.04 22.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.146 -0.687 . . . . 71.51 109.146 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.0 t70 -164.04 139.21 6.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.832 -1.076 . . . . 71.31 108.946 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -122.43 115.63 22.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.546 0.738 . . . . 72.0 110.211 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -120.51 160.01 24.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 73.3 109.466 174.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 169.04 18.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.279 1.032 . . . . 63.23 109.354 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 1.5 m -149.42 135.11 18.64 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.395 -0.965 . . . . 72.34 108.395 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.85 100.44 12.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.285 -1.006 . . . . 75.15 108.285 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.9 mt -78.85 -31.28 45.62 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.603 -0.726 . . . . 62.3 110.315 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.72 -171.49 1.63 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.072 0.949 . . . . 73.41 110.648 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.96 124.86 24.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.798 -1.092 . . . . 64.12 109.533 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.37 -4.91 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.89 1.276 . . . . 60.54 112.31 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.73 97.16 5.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.602 0.761 . . . . 55.4 109.118 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -102.51 170.82 7.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.542 0.737 . . . . 73.02 110.131 172.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 8.8 tm-20 -145.76 103.01 3.74 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.018 -1.105 . . . . 70.34 108.018 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.07 125.9 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.178 0.591 . . . . 54.24 110.389 -175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 32.3 t -103.98 111.82 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.933 0.893 . . . . 75.45 109.147 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.72 110.23 22.1 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.041 -1.096 . . . . 72.22 108.041 176.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 66.8 ttt180 -97.23 116.23 29.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.344 0.658 . . . . 62.0 109.921 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -114.03 120.92 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.217 -1.031 . . . . 75.32 108.217 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.0 m -114.61 136.97 52.46 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.703 0.801 . . . . 33.54 109.191 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.687 HG21 HG21 ' B' ' 114' ' ' ILE . 52.8 t -115.99 132.9 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.588 1.155 . . . . 74.31 109.646 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -127.21 144.38 51.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.465 0.706 . . . . 65.4 109.667 170.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -143.76 150.85 39.2 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.362 -0.835 . . . . 73.14 110.333 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 m -134.78 136.8 42.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.21 0.604 . . . . 75.35 110.951 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 31.4 mt -129.95 99.59 5.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.282 1.033 . . . . 73.12 108.924 172.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -132.79 16.46 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.38 -0.827 . . . . 71.12 113.091 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -93.18 21.46 5.9 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.824 0.85 . . . . 72.41 111.364 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.74 161.07 41.38 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 123.834 0.853 . . . . 73.45 109.179 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -76.98 134.81 38.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.971 -0.559 . . . . 62.03 110.005 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.27 -65.59 0.94 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.488 -0.93 . . . . 75.13 108.488 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -155.38 160.37 40.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.757 . . . . 75.42 111.053 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -133.07 135.21 45.19 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.47 1.508 . . . . 74.12 107.093 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.3 t -139.15 158.06 44.85 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.362 -0.977 . . . . 53.04 108.362 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -165.28 128.04 2.18 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.146 -0.687 . . . . 73.13 109.146 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.1 t -126.01 146.55 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.832 0.853 . . . . 71.03 108.961 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -123.85 96.41 4.94 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.231 -1.026 . . . . 73.33 108.231 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -85.55 100.4 11.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.377 -0.971 . . . . 74.14 108.377 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.55 169.41 35.72 Favored Glycine 0 C--O 1.244 0.775 0 N-CA-C 111.163 -0.775 . . . . 64.02 111.163 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.8 128.63 1.65 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.44 -0.664 . . . . 33.44 111.44 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.4 HG13 ' HE1' ' B' ' 17' ' ' TYR . 38.3 mt -84.73 126.81 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.677 -0.861 . . . . 65.15 108.677 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -132.1 133.17 44.02 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.318 1.047 . . . . 74.3 108.658 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 26.6 m -93.3 97.59 10.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.802 -0.814 . . . . 72.44 108.802 173.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.61 HG12 HD13 ' B' ' 98' ' ' LEU . 2.6 pp -115.6 140.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.282 1.033 . . . . 64.3 110.463 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.37 172.35 18.5 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.901 0.88 . . . . 62.24 109.495 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.62 -58.65 5.02 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.249 -0.195 . . . . 44.44 112.642 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.473 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.0 OUTLIER -55.01 127.49 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.519 0.728 . . . . 71.2 110.97 174.657 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.67 161.74 39.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 32.0 109.698 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.68 -131.32 10.96 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.908 -0.587 . . . . 65.45 112.225 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -76.39 -35.69 58.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.69 0.796 . . . . 73.3 110.944 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -64.71 -28.63 69.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.166 -0.925 . . . . 71.45 112.043 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.454 ' HE1' HD22 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.453 0.701 . . . . 73.13 110.106 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.6 78.63 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.384 -0.825 . . . . 64.23 111.461 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 27.7 t-80 -79.07 -23.7 44.01 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.607 0.763 . . . . 74.12 111.246 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.27 -66.32 0.91 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.582 0.353 . . . . 70.3 110.501 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.61 HD13 HG12 ' B' ' 86' ' ' ILE . 14.0 tp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.845 0.458 . . . . 61.42 111.451 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.28 -21.64 58.31 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.806 -0.634 . . . . 75.51 113.728 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -113.14 -56.0 2.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.306 0.553 . . . . 72.11 111.768 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -68.52 -43.69 76.23 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.564 0.54 . . . . 74.52 112.359 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.542 ' SG ' HD12 ' B' ' 98' ' ' LEU . 75.3 m -63.73 -49.36 76.86 Favored Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 118.298 -0.858 . . . . 40.35 111.533 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.488 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 88.0 Cg_exo -56.73 -33.02 93.02 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.115 1.876 . . . . 71.42 114.143 168.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.38 -31.8 72.27 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.088 0.555 . . . . 73.35 110.859 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.91 -48.43 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.831 0.853 . . . . 72.35 109.615 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 65.4 mt -82.27 -12.64 57.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.326 -0.852 . . . . 75.31 111.919 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.59 -47.91 55.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 117.78 -1.105 . . . . 74.23 113.049 -174.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.43 -36.09 98.81 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 121.909 1.739 . . . . 73.43 113.313 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.507 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 43.3 m-85 -70.51 -45.58 65.31 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.649 0.78 . . . . 75.35 110.474 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.05 99.49 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.7 0.8 . . . . 61.03 110.264 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -56.86 -54.96 40.47 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.83 1.652 . . . . 70.14 111.589 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.3 -31.94 73.34 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.733 0.646 . . . . 71.25 110.032 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.5 t -68.09 -41.97 81.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.536 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.687 HG21 HG21 ' B' ' 64' ' ' VAL . 62.8 mt -63.79 -51.88 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.133 0.573 . . . . 73.41 110.085 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.6 m -58.27 -34.24 70.28 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.139 0.976 . . . . 74.33 111.072 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.9 t -64.41 -54.65 29.4 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.129 -0.941 . . . . 72.21 109.414 173.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.9 mmt -61.88 -33.86 74.97 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.133 0.573 . . . . 63.31 112.13 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.9 -46.82 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.709 0.804 . . . . 72.31 110.934 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 74.7 p -70.01 -25.29 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.584 0.353 . . . . 64.1 110.999 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.518 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 85.1 mtt-85 -69.85 -20.23 63.42 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 118.783 -0.627 . . . . 62.52 111.172 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.2 12.18 61.95 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.12 -0.822 . . . . 70.35 114.365 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.7 p 72.54 14.54 5.2 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.936 1.694 . . . . 72.12 112.169 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -91.14 154.18 44.86 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 122.725 0.41 . . . . 73.1 111.125 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -55.16 149.5 44.14 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 123.321 2.681 . . . . 65.33 113.06 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -59.02 123.25 15.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.39 1.076 . . . . 71.31 111.592 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.07 100.99 7.69 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.121 -1.066 . . . . 54.55 108.121 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -99.8 117.67 34.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 74.42 109.189 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.79 134.93 37.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.171 0.588 . . . . 61.42 110.16 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.05 139.81 36.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.801 0.84 . . . . 74.12 110.398 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.6 99.53 0.45 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.907 2.405 . . . . 74.54 111.972 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -90.81 126.07 43.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.753 -0.832 . . . . 75.13 108.753 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.23 113.23 11.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.531 -0.914 . . . . 70.0 108.531 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -63.88 -20.89 66.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.662 0.785 . . . . 74.03 110.859 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.079 1.352 . . . . 73.1 109.735 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.64 -31.31 63.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.481 -1.236 . . . . 54.13 110.682 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.3 -43.62 97.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.141 0.576 . . . . 75.14 110.075 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.447 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 60.2 t80 -70.82 -38.71 73.27 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.954 -1.021 . . . . 73.05 110.283 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.8 ttt -64.39 -36.15 83.22 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.607 0.763 . . . . 71.42 110.499 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.567 ' HB3' ' HD2' ' E' ' 124' ' ' ARG . 0.9 OUTLIER -75.5 -26.69 58.35 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.315 -0.857 . . . . 71.31 110.187 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -68.31 -31.28 70.6 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.029 0.531 . . . . 73.01 109.676 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 16.2 mt -85.31 3.25 40.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.186 0.594 . . . . 73.11 110.812 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 66.37 27.68 9.94 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.489 1.116 . . . . 75.42 110.898 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 63.69 20.7 12.36 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.994 1.317 . . . . 55.41 112.27 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -68.11 123.37 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.867 0.867 . . . . 71.14 111.707 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.97 -57.96 2.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.781 0.833 . . . . 53.21 109.649 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.32 74.67 0.61 Allowed Glycine 0 C--N 1.352 1.46 0 CA-C-N 115.685 -0.688 . . . . 74.42 113.973 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.95 148.84 36.11 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.002 0.921 . . . . 54.34 110.624 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.49 64.25 0.5 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 112.349 -0.301 . . . . 54.44 112.349 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.8 p -84.24 153.64 23.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.22 0.608 . . . . 64.11 110.229 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -132.56 137.55 47.15 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.743 0.817 . . . . 62.21 110.25 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -125.65 134.75 51.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.963 0.905 . . . . 54.41 110.556 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -138.41 101.96 4.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.999 0.92 . . . . 75.23 109.32 172.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -163.72 128.91 2.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.176 1.39 . . . . 64.0 108.058 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.03 142.93 23.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.134 0.574 . . . . 61.5 109.62 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 108.68 -0.859 . . . . 54.35 108.68 177.79 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 108.418 -0.956 . . . . 54.04 108.418 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -149.33 27.42 0.83 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.978 0.911 . . . . 72.32 110.199 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.78 100.75 0.21 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.186 0.995 . . . . 64.44 111.082 -173.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -91.48 135.59 33.74 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.299 -1.0 . . . . 74.51 108.299 172.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -74.06 110.76 8.61 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.273 -0.64 . . . . 70.33 109.273 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -71.71 86.58 0.93 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.258 0.623 . . . . 52.3 111.156 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 53.2 p -77.88 163.32 26.14 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.495 0.718 . . . . 74.02 109.8 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.89 81.82 0.15 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.022 0.929 . . . . 53.31 109.621 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 54.0 ttp 65.42 113.9 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.366 1.467 . . . . 73.11 111.812 -170.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.8 m -99.79 87.39 3.52 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.501 -1.296 . . . . 74.15 107.501 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.448 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 20.5 t80 -89.09 133.12 34.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.367 -0.833 . . . . 74.43 109.233 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 57.5 tt0 -151.81 144.95 24.6 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.937 -0.764 . . . . 63.44 108.937 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.5 HD11 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -92.52 136.88 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.386 -0.598 . . . . 72.23 109.386 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -105.24 -50.06 3.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.642 0.777 . . . . 74.04 110.281 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -163.18 142.64 8.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.049 0.54 . . . . 74.41 109.549 -173.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.5 HG13 HD11 ' C' ' 13' ' ' ILE . 79.8 mt -128.24 134.84 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.417 -1.327 . . . . 71.31 107.417 174.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.561 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 5.7 p90 -171.16 153.79 3.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 71.41 111.336 -173.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -79.11 120.74 24.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.168 -0.923 . . . . 74.12 109.471 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -74.26 -49.01 25.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.321 -0.992 . . . . 75.14 108.321 170.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -134.39 138.33 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.747 -1.569 . . . . 60.24 109.135 -167.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -142.73 139.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.711 -1.588 . . . . 64.11 106.711 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.88 149.52 18.15 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.83 -0.433 . . . . 53.23 109.83 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -154.34 108.8 3.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.124 -1.065 . . . . 74.25 108.124 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.79 122.13 42.61 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.076 -0.713 . . . . 53.21 109.076 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.81 93.42 20.51 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 108.423 -0.955 . . . . 75.22 108.423 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.68 -49.45 8.65 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.108 2.538 . . . . 63.24 111.697 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' C' ' 72' ' ' THR . 68.4 m-20 -103.79 53.19 0.75 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.429 -0.805 . . . . 74.11 109.036 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.11 -52.99 70.78 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.982 1.104 . . . . 73.15 113.982 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 39.4 Cg_exo -63.81 -21.72 69.28 Favored 'Trans proline' 0 C--N 1.398 3.139 0 C-N-CA 122.185 1.924 . . . . 72.05 112.909 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.44 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 13.6 m-70 -64.64 -18.95 65.41 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.291 1.036 . . . . 74.23 113.133 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.46 -37.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.087 0.955 . . . . 73.02 113.494 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -81.14 -36.4 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.054 0.941 . . . . 54.41 111.091 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -85.17 4.64 33.53 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 125.293 1.437 . . . . 53.24 111.08 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.627 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.2 ttmp? -107.81 153.18 23.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.376 1.07 . . . . 71.33 111.024 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.25 114.23 19.0 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.06 -1.459 . . . . 73.34 107.06 166.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -85.32 61.47 6.88 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.141 0.972 . . . . 74.41 112.504 -168.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -150.23 58.74 3.26 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.011 1.325 . . . . 71.31 107.598 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' E' ' 139' ' ' LEU . 92.5 Cg_endo -77.47 160.8 31.85 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.011 1.807 . . . . 71.25 111.364 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.45 103.94 13.2 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.896 -1.15 . . . . 70.32 107.896 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.82 97.41 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 114.963 -1.017 . . . . 65.11 108.642 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 50.7 mtpt -95.77 105.64 17.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.996 -0.742 . . . . 74.25 108.996 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -87.04 149.1 24.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.901 0.881 . . . . 73.31 109.609 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.492 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.3 t70 -149.17 127.41 12.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.314 -0.995 . . . . 72.35 108.314 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.78 149.68 50.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.228 0.467 . . . . 73.23 110.769 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 17.5 m-20 -140.81 161.1 38.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 64.35 109.826 176.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -130.48 136.06 48.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.054 0.941 . . . . 64.43 108.473 171.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -131.51 172.51 12.13 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.124 0.97 . . . . 61.33 108.507 176.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.7 p -164.61 160.14 19.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.927 0.491 . . . . 23.01 111.112 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -167.34 138.21 3.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.061 0.944 . . . . 74.04 109.452 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -77.87 117.5 19.29 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.88 -0.785 . . . . 74.2 108.88 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.5 mt -87.27 -37.97 16.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.734 0.413 . . . . 54.52 110.608 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -159.23 -172.05 3.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.262 -0.881 . . . . 50.22 110.682 -174.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.67 111.56 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.01 -0.995 . . . . 64.21 109.681 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 64.09 15.9 9.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.831 1.252 . . . . 63.11 112.314 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 89.1 t -118.0 103.79 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.298 -1.001 . . . . 71.43 108.298 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.443 ' CD1' ' HB ' ' C' ' 86' ' ' ILE . 14.9 m-85 -117.95 139.17 51.54 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.907 0.883 . . . . 72.42 108.959 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.612 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.2 tt0 -100.3 146.14 27.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.843 0.857 . . . . 65.21 109.355 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.38 144.33 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.747 -0.835 . . . . 75.44 108.747 165.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 58.2 t -119.63 107.14 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.886 0.875 . . . . 64.1 109.127 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.25 99.91 12.84 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.074 -1.084 . . . . 64.3 108.074 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 75.6 ttt-85 -84.53 134.82 34.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.858 0.863 . . . . 73.12 109.385 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.412 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -129.05 148.13 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.794 -1.187 . . . . 71.33 107.794 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 57.5 m -138.9 135.35 34.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 75.31 107.5 171.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.542 HG23 HD13 ' C' ' 114' ' ' ILE . 47.1 t -118.36 113.33 41.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 107.659 -1.237 . . . . 75.31 107.659 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.1 m -98.33 134.35 41.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.749 -1.204 . . . . 74.5 107.749 171.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 94.82 3.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.231 -1.396 . . . . 74.12 107.231 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 14.1 m -144.76 143.48 30.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.279 0.632 . . . . 62.24 109.692 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.03 10.17 39.8 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.493 0.717 . . . . 70.55 109.578 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.27 -95.63 0.4 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.395 -1.082 . . . . 35.53 110.395 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.48 -32.98 16.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 72.22 109.261 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.627 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 8.7 tp10 -83.67 91.28 7.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.874 0.87 . . . . 61.32 109.484 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 28.3 m -86.75 135.88 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.284 -0.871 . . . . 72.32 110.232 -178.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.59 -65.03 1.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.669 -0.863 . . . . 71.52 108.669 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.36 175.5 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.907 0.86 . . . . 74.13 112.332 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.463 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -137.34 135.6 37.2 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 105.219 -2.141 . . . . 53.52 105.219 169.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.2 t -144.73 117.84 8.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.841 0.456 . . . . 70.21 109.983 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -121.06 131.35 54.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.03 135.41 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.194 0.998 . . . . 75.51 108.488 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.6 mt-30 -115.04 103.2 10.66 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.567 -0.901 . . . . 74.4 108.567 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -85.34 110.02 18.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.587 0.755 . . . . 64.34 109.618 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.02 146.65 22.14 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.178 -0.769 . . . . 63.42 111.178 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.545 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.52 118.66 0.99 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.913 -0.475 . . . . 41.35 111.913 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.493 HD12 ' CD1' ' C' ' 51' ' ' LEU . 8.7 mm -87.72 119.36 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.917 -0.771 . . . . 65.53 108.917 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.434 ' CE2' HD13 ' C' ' 13' ' ' ILE . 98.9 m-85 -129.36 128.7 43.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.9 0.88 . . . . 74.34 109.237 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 24.5 m -70.82 108.74 4.62 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.305 -0.628 . . . . 73.4 109.305 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' C' ' 56' ' ' TYR . 43.5 mm -114.36 101.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.21 -1.034 . . . . 74.31 108.21 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -133.53 150.05 51.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.97 0.908 . . . . 64.02 109.754 -177.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.37 28.76 Favored Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.349 0.5 . . . . 70.14 114.349 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' C' ' 9' ' ' MET . 17.8 tt -108.57 151.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.331 1.052 . . . . 74.53 110.134 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -164.13 154.68 15.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.185 0.594 . . . . 74.42 110.756 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.83 -148.61 19.31 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.369 0.509 . . . . 74.32 112.243 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.9 p -65.89 -21.18 66.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.946 0.898 . . . . 75.51 111.115 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -61.53 -51.1 70.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.173 0.989 . . . . 74.0 109.95 170.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 53.3 ttm -66.47 -35.82 81.22 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.901 -0.59 . . . . 75.13 110.376 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.2 95.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.497 0.719 . . . . 73.41 111.487 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 56.5 t-80 -68.5 -23.74 64.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.251 -0.886 . . . . 74.12 111.415 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 99.6 m -82.7 -51.33 7.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.221 0.608 . . . . 60.14 110.896 173.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.74 -42.67 66.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.735 1.214 . . . . 70.11 111.314 -163.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.61 11.53 46.45 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.02 -0.537 . . . . 73.24 113.438 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' C' ' 134' ' ' ASP . . . -146.12 -73.44 0.23 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.505 0.652 . . . . 73.22 111.963 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.58 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 92.0 t80 -65.22 -53.55 42.81 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.308 0.855 . . . . 74.11 113.308 -168.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.448 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 31.9 m -61.04 -44.55 94.75 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 123.126 0.57 . . . . 70.03 111.835 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 87.9 Cg_exo -55.23 -33.59 85.12 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.654 2.236 . . . . 63.3 114.536 166.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.19 -25.15 65.09 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 123.048 0.539 . . . . 73.03 111.762 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.46 HD12 ' NH1' ' A' ' 111' ' ' ARG . 38.4 mm -69.0 -39.67 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.476 -0.564 . . . . 74.31 109.476 171.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.545 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.5 mt -76.93 -26.89 54.58 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.843 -1.071 . . . . 72.23 111.811 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -56.03 -47.09 99.52 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.405 1.082 . . . . 62.11 113.807 -173.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.78 -40.16 86.22 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.031 1.821 . . . . 61.45 113.542 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.38 -45.76 71.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.224 0.61 . . . . 74.34 110.712 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.4 82.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.713 0.805 . . . . 44.2 110.665 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -65.83 -49.45 68.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.411 -1.268 . . . . 55.32 110.658 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.09 -29.74 66.79 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.416 0.686 . . . . 62.14 110.673 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.8 t -65.61 -40.43 92.61 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.408 0.683 . . . . 45.1 110.12 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.542 HD13 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -67.9 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.867 -0.606 . . . . 74.44 110.133 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 62.3 m -58.24 -29.56 65.85 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.823 0.849 . . . . 73.35 111.011 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.9 -51.51 18.31 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.37 -0.832 . . . . 71.45 109.715 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.585 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.17 -39.51 60.16 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.806 0.842 . . . . 52.3 112.369 177.66 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.6 t -68.85 -44.92 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.389 0.676 . . . . 72.31 110.259 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.07 -28.61 66.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.281 0.562 . . . . 63.52 110.926 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -67.21 -37.19 83.21 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 114.71 -1.132 . . . . 73.12 110.05 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.62 83.74 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 119.352 -0.693 . . . . 73.32 112.952 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' D' ' 17' ' ' TYR . 64.0 p 58.96 25.36 13.69 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.237 1.815 . . . . 25.31 112.833 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.441 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 84.3 m-85 -93.21 160.43 33.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.298 1.039 . . . . 74.31 108.923 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.573 ' HG2' HD21 ' E' ' 139' ' ' LEU . 35.5 Cg_endo -64.06 117.46 4.47 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.716 2.277 . . . . 70.24 112.418 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.12 134.72 44.17 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.467 1.107 . . . . 64.31 112.414 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.59 107.35 18.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.948 -1.13 . . . . 73.0 107.948 -174.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.67 100.64 13.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.266 -1.013 . . . . 73.02 108.266 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 134.36 48.63 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.339 0.655 . . . . 73.22 110.079 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.66 99.06 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.773 0.829 . . . . 75.31 110.974 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.474 ' HG2' HD12 ' A' ' 16' ' ' ILE . 24.0 Cg_exo -64.18 87.19 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.84 2.36 . . . . 72.01 112.702 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.33 111.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.682 -0.859 . . . . 75.52 108.682 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -109.44 103.12 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.962 -0.755 . . . . 63.13 108.962 -177.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.19 -29.24 69.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.21 1.004 . . . . 75.33 111.561 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.469 ' HB3' ' HB1' ' C' ' 100' ' ' ALA . 4.8 p-10 -76.21 -32.23 58.84 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.584 0.753 . . . . 74.53 110.584 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.89 -20.46 60.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.89 0.876 . . . . 51.34 111.626 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.84 -28.12 67.28 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.952 0.501 . . . . 74.12 110.696 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.407 ' HA ' ' HD1' ' C' ' 140' ' ' TYR . 78.7 t80 -69.36 -18.47 63.79 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.575 0.75 . . . . 72.2 111.733 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -69.03 -30.9 69.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.805 0.442 . . . . 64.23 110.111 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.1 -38.34 90.73 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.311 0.644 . . . . 64.54 109.851 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' TYR . . . . . 0.407 ' HD1' ' HA ' ' C' ' 137' ' ' PHE . 91.4 m-85 -71.42 -88.12 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.479 -0.782 . . . . 74.31 109.159 170.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.09 38.28 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.186 1.394 . . . . 74.02 111.034 172.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -83.29 70.81 10.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.771 0.795 . . . . 74.4 110.301 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.76 2.46 9.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.749 -1.114 . . . . 71.52 109.079 171.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -135.86 111.2 9.09 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 106.829 -1.545 . . . . 72.13 106.829 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 94.98 5.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.639 0.776 . . . . 71.12 109.887 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.67 128.46 9.47 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.447 0.467 . . . . 74.01 112.374 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -85.46 59.27 5.53 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.118 0.961 . . . . 73.32 108.857 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.13 67.93 0.05 OUTLIER Glycine 0 C--N 1.34 0.788 0 CA-C-N 114.898 -1.046 . . . . 73.21 110.829 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 20.7 m -71.65 -19.76 62.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.736 0.814 . . . . 52.12 110.706 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.48 40.58 0.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.867 1.267 . . . . 63.04 112.711 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.96 83.73 2.86 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.343 0.592 . . . . 73.15 110.524 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.37 72.85 10.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.566 -1.272 . . . . 73.01 107.566 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.75 74.62 3.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.693 0.758 . . . . 73.05 109.209 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -178.11 132.9 0.15 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.967 -1.469 . . . . 71.15 108.288 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.204 0 N-CA-C 108.565 -0.902 . . . . 62.33 108.565 179.247 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.972 -0.381 . . . . 73.02 109.972 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -119.61 107.61 13.47 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.97 -1.122 . . . . 63.52 107.97 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.82 -56.7 16.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.774 0.671 . . . . 54.4 110.661 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 69.03 174.03 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.848 1.259 . . . . 73.22 112.065 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 5' ' ' ASN . . . . . 0.489 HD21 ' HA ' ' D' ' 87' ' ' ALA . 13.2 t-20 -160.57 86.25 0.73 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.129 -1.063 . . . . 72.55 108.129 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -147.58 106.52 3.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.498 0.719 . . . . 63.31 109.951 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -171.82 -176.34 1.72 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.226 1.411 . . . . 71.24 108.427 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 136.96 45.39 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.924 -0.769 . . . . 63.02 108.924 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.439 ' HG3' HG13 ' D' ' 89' ' ' ILE . 6.0 ttp -30.87 126.55 0.17 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.008 1.723 . . . . 72.21 114.004 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -139.32 136.8 35.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.778 0.831 . . . . 74.2 109.037 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -152.97 93.78 1.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 74.33 107.518 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.3 mt-30 -114.51 153.61 29.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.562 -0.744 . . . . 73.21 109.587 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.57 131.07 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.95 0.9 . . . . 74.21 109.16 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -109.42 -49.57 3.1 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.363 0.528 . . . . 63.3 111.909 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.31 121.08 0.73 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.509 0.559 . . . . 70.05 112.509 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.43 HD12 ' N ' ' D' ' 16' ' ' ILE . 1.7 mp -108.6 133.52 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.653 -1.239 . . . . 73.25 107.653 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' C' ' 122' ' ' THR . 36.1 p90 -161.89 176.05 11.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.911 0.862 . . . . 72.34 112.021 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -107.07 117.87 35.21 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.778 -1.101 . . . . 74.12 109.265 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.447 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.6 mtpt -85.47 -25.24 27.02 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.287 -0.634 . . . . 74.5 109.287 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.712 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.1 t70 -148.32 141.03 24.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.328 1.051 . . . . 55.0 109.869 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.585 HD13 ' HE3' ' C' ' 117' ' ' MET . 46.1 mt -138.41 142.96 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.445 1.498 . . . . 73.55 107.713 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -148.01 137.09 22.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.233 1.013 . . . . 65.01 108.852 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.4 t80 -153.86 119.54 5.25 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.117 -1.438 . . . . 75.25 107.117 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.0 118.54 19.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.394 0.677 . . . . 73.23 109.57 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.75 90.2 12.49 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.703 -0.851 . . . . 73.21 108.703 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.61 -46.44 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.964 2.443 . . . . 51.1 112.829 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.4 m-20 -103.31 43.51 1.08 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.279 1.032 . . . . 50.32 108.26 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.02 -53.46 64.95 Favored Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 114.795 1.406 . . . . 63.35 114.795 -168.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.67 -3.86 12.0 Favored 'Trans proline' 0 C--N 1.393 2.88 0 CA-C-N 121.806 1.681 . . . . 74.22 113.865 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.448 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -84.6 -40.17 17.84 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.896 0.878 . . . . 65.14 110.454 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -82.26 -14.05 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.755 0.822 . . . . 74.01 109.923 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.21 -28.76 70.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.377 1.071 . . . . 74.15 110.96 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -72.64 -7.66 51.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.39 1.076 . . . . 61.44 111.293 178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -111.78 111.81 23.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.423 1.089 . . . . 75.52 109.877 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.63 63.4 7.54 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.705 0.802 . . . . 61.22 110.052 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.506 ' HB3' HD21 ' D' ' 68' ' ' LEU . 65.7 t-105 -150.58 166.87 28.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.826 -0.805 . . . . 74.21 108.826 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -89.74 108.69 27.1 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.118 0.967 . . . . 63.32 110.471 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -43.24 144.94 1.55 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 124.506 3.471 . . . . 74.21 115.612 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.73 118.37 15.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.569 -0.741 . . . . 71.23 110.379 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.512 HG21 HD13 ' F' ' 139' ' ' LEU . 99.1 t -109.23 125.33 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.877 0.871 . . . . 64.1 111.02 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -111.54 120.95 43.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.68 -1.23 . . . . 62.44 107.68 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 155.66 16.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.403 -0.962 . . . . 74.1 108.403 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.6 t70 -143.59 140.89 30.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.887 0.875 . . . . 73.32 108.963 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.9 153.44 31.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.275 0.63 . . . . 63.3 110.544 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.9 t0 -165.75 152.7 10.04 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.579 1.152 . . . . 62.51 108.781 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -125.08 164.52 20.03 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.31 0.576 . . . . 51.1 110.279 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.86 167.53 30.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.529 1.131 . . . . 61.54 108.465 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.4 p -161.6 154.34 20.42 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.971 0.508 . . . . 61.03 110.97 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -154.95 149.62 26.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.513 1.125 . . . . 74.4 108.832 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -91.34 118.53 30.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.548 -0.908 . . . . 74.33 108.548 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.54 -38.49 12.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.099 0.56 . . . . 52.34 109.995 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.72 -177.11 6.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.662 0.744 . . . . 62.11 111.013 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.66 125.64 29.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.74 -1.118 . . . . 73.1 110.083 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 63.8 10.58 5.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.304 1.442 . . . . 70.24 112.308 -172.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.1 t -123.76 120.07 58.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.787 0.835 . . . . 71.13 109.025 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.501 ' HD1' ' HB ' ' D' ' 86' ' ' ILE . 64.3 m-85 -132.88 130.03 39.18 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.778 -0.823 . . . . 74.35 108.778 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.9 138.82 31.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.199 1.0 . . . . 64.24 108.888 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.66 123.92 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.228 -1.397 . . . . 73.34 107.228 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.1 t -102.25 130.73 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 74.54 108.808 175.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.534 HD21 HD11 ' D' ' 136' ' ' LEU . 0.0 OUTLIER -105.5 117.93 35.28 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.575 -1.268 . . . . 71.3 107.575 176.359 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -96.58 107.2 19.58 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.727 -1.212 . . . . 74.54 107.727 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.15 129.91 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.448 -0.945 . . . . 73.25 108.448 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -116.71 147.55 41.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.919 0.888 . . . . 72.33 109.65 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 23.7 t -134.11 128.72 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 73.11 108.442 174.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -124.83 119.64 29.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.08 139.3 53.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.311 0.644 . . . . 62.42 109.634 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 41.7 p -155.49 129.13 8.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.62 0.768 . . . . 52.31 109.415 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' D' ' 36' ' ' TRP . 15.5 tp -113.54 111.61 22.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.504 -0.925 . . . . 64.3 108.504 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.97 -144.98 26.73 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.876 0.735 . . . . 63.34 111.88 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.37 2.88 34.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.611 0.764 . . . . 64.25 112.021 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.448 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.1 pt-20 -123.81 152.16 42.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.777 0.831 . . . . 74.31 110.423 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 80.9 m -74.07 136.04 43.03 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.61 0.569 . . . . 73.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.58 -54.8 3.74 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.918 0.887 . . . . 73.24 109.436 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -161.52 164.04 29.85 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.78 -1.1 . . . . 65.13 109.312 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.79 152.53 50.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.102 1.361 . . . . 74.22 107.803 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.639 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.4 t -159.63 142.94 14.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.732 0.413 . . . . 52.43 110.784 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.45 127.54 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.169 0.588 . . . . 73.05 109.562 168.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.2 115.82 42.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 123.617 0.767 . . . . 64.0 109.549 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.712 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.3 mt-30 -89.86 87.13 6.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.867 0.841 . . . . 72.14 108.874 170.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.35 95.75 6.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 113.612 -1.631 . . . . 73.15 109.429 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 142.76 18.35 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.173 -0.371 . . . . 53.12 112.173 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.05 131.95 4.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.545 -0.622 . . . . 42.01 111.545 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.45 123.28 44.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 124.488 1.115 . . . . 65.52 108.78 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -126.16 131.77 51.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.935 0.894 . . . . 72.54 109.635 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 9.8 m -80.59 94.51 6.31 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.641 -0.874 . . . . 24.34 108.641 173.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.501 ' HB ' ' HD1' ' D' ' 56' ' ' TYR . 69.9 mt -108.5 111.02 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 63.22 109.205 -175.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.489 ' HA ' HD21 ' D' ' 5' ' ' ASN . . . -146.64 128.81 15.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.634 0.774 . . . . 43.21 109.822 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.76 50.13 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-O 119.756 -0.469 . . . . 62.33 113.705 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.483 HD13 HG23 ' D' ' 86' ' ' ILE . 2.9 mp -95.8 126.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.706 -1.591 . . . . 71.23 106.706 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.26 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.751 0.82 . . . . 75.21 111.35 -169.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.31 -141.84 39.89 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.039 -0.982 . . . . 72.12 112.719 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -90.38 -16.33 29.32 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.649 0.78 . . . . 74.42 110.02 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.46 -33.37 72.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.583 1.153 . . . . 53.43 111.123 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -64.1 -33.16 75.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.996 0.519 . . . . 74.32 111.694 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.58 80.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.201 0.6 . . . . 73.23 110.427 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -72.78 -36.19 67.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.907 -0.588 . . . . 60.42 110.925 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -64.33 -43.29 95.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.794 0.437 . . . . 34.13 110.053 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.6 tp -72.73 -35.98 67.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.175 0.99 . . . . 71.25 111.336 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.14 53.98 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.446 -0.641 . . . . 51.54 114.434 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' D' ' 137' ' ' PHE . . . -132.92 -60.27 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.741 0.77 . . . . 61.43 111.873 -175.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.22 -46.13 85.19 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.364 0.666 . . . . 73.51 112.145 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 33.4 m -71.62 -45.3 12.78 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-O 118.558 -0.734 . . . . 72.03 112.03 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.48 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.8 Cg_exo -57.82 -29.06 84.75 Favored 'Trans proline' 0 C--N 1.399 3.226 0 C-N-CA 122.446 2.097 . . . . 75.45 113.915 169.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.86 -32.29 73.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.262 0.625 . . . . 53.31 110.702 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.23 -34.56 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 123.661 0.785 . . . . 74.41 110.186 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.6 mt -82.5 -17.76 43.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.23 1.012 . . . . 65.02 112.39 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -65.78 -44.66 64.14 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.656 0.984 . . . . 72.31 113.656 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.86 -32.07 90.96 Favored 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 121.952 1.768 . . . . 64.52 112.873 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -80.16 -33.97 37.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 71.34 112.398 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.17 58.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.263 -0.643 . . . . 52.42 109.263 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -68.35 -31.7 71.27 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 114.883 -1.053 . . . . 72.45 111.213 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.13 -50.38 72.1 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 124.223 0.952 . . . . 72.41 110.692 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.3 t -59.02 -42.04 89.18 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.689 0.618 . . . . 65.32 110.52 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.639 HG12 ' SG ' ' D' ' 76' ' ' CYS . 99.5 mt -59.3 -52.84 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.314 1.045 . . . . 74.22 110.708 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.523 HG23 ' HG3' ' D' ' 125' ' ' GLN . 74.1 m -58.64 -41.82 86.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.882 0.873 . . . . 74.45 110.808 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.56 -43.97 88.19 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 114.65 -1.159 . . . . 70.12 110.448 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.41 -30.58 69.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.711 0.404 . . . . 63.31 111.459 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' D' ' 123' ' ' PHE . 55.0 t -66.92 -45.42 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.451 0.701 . . . . 72.4 110.029 173.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -74.26 -25.63 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.748 0.419 . . . . 73.04 110.967 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -75.63 -35.23 60.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.593 0.757 . . . . 65.13 109.255 172.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.38 -3.89 88.84 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.854 0.721 . . . . 62.11 112.039 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.5 p 58.05 34.69 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.71 2.004 . . . . 72.33 112.894 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.472 ' HB2' HG13 ' D' ' 118' ' ' VAL . 51.1 m-85 -93.28 166.74 15.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.738 1.215 . . . . 73.23 108.989 171.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.56 132.26 44.89 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.097 1.864 . . . . 73.32 111.514 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.523 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.6 tt0 -52.49 139.6 24.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.544 1.137 . . . . 74.21 112.406 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.758 ' HB2' HD12 ' F' ' 139' ' ' LEU . 46.7 tp -126.04 99.89 6.11 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.947 0.403 . . . . 72.22 110.862 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -100.15 117.81 35.18 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.179 -1.415 . . . . 75.14 107.179 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -73.17 123.16 23.1 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.624 -0.509 . . . . 61.13 109.624 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.66 147.07 84.73 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 124.635 1.209 . . . . 64.2 112.311 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.93 123.06 12.21 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.262 2.641 . . . . 73.12 113.555 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.75 145.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.828 0.851 . . . . 72.2 109.92 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -68.25 118.48 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.328 -0.99 . . . . 54.41 108.328 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.448 ' HD1' ' HB1' ' D' ' 100' ' ' ALA . 23.2 p90 -50.08 -23.0 1.85 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.772 1.229 . . . . 74.2 113.969 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.47 -38.79 92.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.88 0.872 . . . . 71.21 111.191 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.72 -24.17 66.92 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.084 0.554 . . . . 51.53 111.398 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.534 HD11 HD21 ' D' ' 60' ' ' LEU . 5.0 tt -83.28 -31.53 26.88 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.938 0.895 . . . . 74.25 109.265 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.768 ' HB2' ' HB2' ' D' ' 100' ' ' ALA . 47.1 t80 -62.2 -30.88 71.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.483 0.713 . . . . 64.45 110.993 175.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 16.4 mmt -58.25 -32.82 68.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.684 0.393 . . . . 61.12 110.696 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.519 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 20.3 m120 -65.99 -30.95 71.59 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.821 0.848 . . . . 61.33 112.116 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.43 -35.81 80.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.062 0.945 . . . . 74.15 111.326 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.33 -35.56 30.79 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.471 0.709 . . . . 74.45 111.735 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.519 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.8 pt20 -91.06 23.37 3.26 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.383 0.512 . . . . 74.12 112.383 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -121.3 90.41 3.31 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.444 0.64 . . . . 64.31 111.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 85.31 0.34 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 105.668 -1.975 . . . . 63.51 105.668 167.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.47 160.04 43.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.982 0.913 . . . . 63.0 110.182 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.42 155.67 8.11 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.109 -0.796 . . . . 72.44 111.109 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.32 127.67 7.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.474 0.71 . . . . 74.13 109.793 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 137.34 9.38 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.816 -0.514 . . . . 42.45 111.816 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.5 t -152.08 138.17 18.24 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.823 0.849 . . . . 62.24 109.244 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -140.38 86.73 2.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.205 0.602 . . . . 53.51 109.701 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.83 98.25 5.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.326 -0.991 . . . . 75.32 108.326 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -63.13 115.89 4.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 62.24 111.612 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.95 145.53 55.79 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.998 -0.741 . . . . 63.43 108.998 167.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -160.34 147.07 15.74 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.215 -0.661 . . . . 63.02 109.215 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.721 0.808 . . . . 71.41 109.515 -177.115 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.686 -0.487 . . . . 55.44 109.686 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -130.87 -169.54 2.18 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.271 1.028 . . . . 75.12 109.575 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.92 72.36 0.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.242 -0.651 . . . . 63.23 109.242 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -121.93 108.41 13.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.652 0.781 . . . . 75.12 109.065 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -65.31 -52.44 54.0 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.373 0.669 . . . . 75.55 110.707 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 53.68 -89.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.606 1.163 . . . . 73.24 109.432 -172.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -143.58 132.62 22.92 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.756 1.222 . . . . 53.14 107.92 165.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 mp -72.56 120.97 18.92 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.087 0.955 . . . . 70.31 109.812 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 81.7 t80 66.37 77.49 0.27 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 125.34 1.456 . . . . 74.31 110.349 -170.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -94.3 24.84 0.38 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.213 2.609 . . . . 73.0 112.984 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.44 -71.98 0.43 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.101 0.561 . . . . 73.41 111.892 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 67.6 m 55.65 88.94 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.792 0.837 . . . . 64.34 110.733 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -99.84 178.31 4.86 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.431 0.634 . . . . 72.23 110.403 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.0 -147.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.832 -1.076 . . . . 73.34 108.82 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.99 -27.44 68.87 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.618 0.767 . . . . 71.41 111.348 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 48.5 t 61.48 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.688 1.595 . . . . 74.25 110.43 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 124' ' ' ARG . . . . . 0.567 ' HD2' ' HB3' ' B' ' 139' ' ' ASN . 0.1 OUTLIER -163.88 81.82 0.43 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.67 1.188 . . . . 74.52 108.407 176.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 125' ' ' TYR . . . . . 0.586 ' CD1' HD21 ' B' ' 44' ' ' LEU . 56.9 t80 -75.71 112.76 12.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.323 -0.853 . . . . 72.33 109.683 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -101.53 87.12 3.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.534 0.734 . . . . 73.34 109.301 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.26 108.41 3.5 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.781 -0.928 . . . . 61.01 110.781 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 27.41 3.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.28 0.632 . . . . 73.41 110.606 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 129' ' ' LEU . . . . . 0.46 ' HG ' HG13 ' E' ' 130' ' ' ILE . 2.5 pt? -50.85 -36.36 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.05 1.34 . . . . 62.25 112.296 -177.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 130' ' ' ILE . . . . . 0.46 HG13 ' HG ' ' E' ' 129' ' ' LEU . 50.5 mt -94.94 81.01 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.001 -1.111 . . . . 75.13 108.001 170.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.06 62.78 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.301 -0.863 . . . . 73.44 110.64 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -151.81 168.08 11.9 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.732 1.213 . . . . 74.02 108.436 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.87 98.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.574 2.183 . . . . 74.44 111.747 173.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 11.1 tp -89.55 32.95 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 CA-C-O 122.215 1.007 . . . . 74.31 110.274 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.57 6.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.639 0.776 . . . . 74.42 109.343 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.41 -16.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.685 -1.143 . . . . 74.53 109.267 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 137' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' E' ' 137' ' ' GLU . 7.0 pt-20 -73.25 88.75 1.52 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.79 -1.096 . . . . 65.13 111.033 175.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 25.09 1.74 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.506 -1.224 . . . . 74.42 109.308 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 139' ' ' LEU . . . . . 0.573 HD21 ' HG2' ' C' ' 124' ' ' PRO . 0.3 OUTLIER -100.6 83.29 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.559 0.744 . . . . 62.21 111.429 -177.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t -82.44 -64.94 1.08 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.049 -1.093 . . . . 62.41 108.049 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 45.91 -78.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.182 1.793 . . . . 75.04 113.522 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 26.2 pt -66.28 -32.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.299 1.44 . . . . 53.51 112.715 -174.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.88 -83.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.116 -0.469 . . . . 75.04 110.499 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 47.5 72.33 0.26 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.888 0.875 . . . . 63.45 111.77 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 75.39 -61.69 0.47 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.388 1.475 . . . . 75.34 111.276 -175.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.71 91.56 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.025 0.93 . . . . 74.21 110.867 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.48 -31.9 58.03 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.026 -0.988 . . . . 64.31 109.929 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 40.3 tp -149.93 92.97 4.01 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.114 -1.069 . . . . 73.25 108.114 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.376 1.988 0 C-N-CA 122.961 2.44 . . . . 64.52 111.81 177.898 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.904 0.383 . . . . 65.33 110.743 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.15 31.23 4.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.599 1.16 . . . . 72.24 109.407 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.97 134.85 54.8 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.531 -0.759 . . . . 74.32 110.232 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 76.9 t80 65.93 103.35 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.554 1.159 . . . . 75.24 110.815 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -122.21 -47.83 2.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.743 0.817 . . . . 71.12 109.085 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -90.03 167.43 12.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.678 -1.147 . . . . 65.45 111.031 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.65 117.85 30.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.85 1.26 . . . . 71.33 109.817 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 35.01 0.65 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.962 -1.125 . . . . 74.15 107.962 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -159.87 92.46 1.74 Allowed Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 114.318 -1.31 . . . . 74.23 107.951 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 -59.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.79 2.327 . . . . 73.31 111.729 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -159.6 177.56 10.77 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.391 1.077 . . . . 63.54 109.39 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 20.3 p -125.27 -171.04 2.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.354 1.061 . . . . 72.32 109.492 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 120' ' ' TRP . . . . . 0.516 ' NE1' ' HA ' ' F' ' 123' ' ' VAL . 21.3 t-105 -59.03 127.91 34.59 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.377 0.671 . . . . 73.12 111.896 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.01 160.91 21.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.025 0.93 . . . . 62.45 109.511 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . 76.9 -60.55 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.571 1.549 . . . . 34.12 111.353 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.516 ' HA ' ' NE1' ' F' ' 120' ' ' TRP . 40.1 t 72.48 -76.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.419 1.487 . . . . 71.1 111.343 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.39 63.38 1.73 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.891 . . . . 73.1 109.985 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.37 78.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.256 -1.338 . . . . 70.44 109.344 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.76 117.49 18.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.413 -0.812 . . . . 61.53 109.501 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.92 110.01 0.23 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.843 -0.903 . . . . 70.41 110.843 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -75.41 -34.35 61.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.329 0.652 . . . . 75.42 109.5 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.05 -175.76 0.12 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.651 1.18 . . . . 72.45 110.815 -170.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 55.7 mt 60.3 73.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 124.313 1.045 . . . . 64.1 110.369 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.3 -62.1 1.79 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 115.242 -0.89 . . . . 71.14 110.112 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.08 102.45 6.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.424 -1.324 . . . . 75.42 107.424 170.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.33 172.27 6.07 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.536 2.157 . . . . 73.21 111.973 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 18.0 tt -110.95 128.36 67.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.7 -1.593 . . . . 74.13 106.7 163.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.7 72.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.631 0.772 . . . . 70.34 111.995 -171.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 14.3 m 49.17 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 C-N-CA 126.523 1.929 . . . . 71.03 114.553 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -179.57 -76.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.715 1.206 . . . . 74.34 108.693 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.02 133.56 7.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.918 0.887 . . . . 73.31 109.343 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.758 HD12 ' HB2' ' D' ' 126' ' ' LEU . 48.4 mt -66.86 101.34 0.82 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.95 0.9 . . . . 34.44 110.69 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 57.9 p -66.15 -32.56 74.07 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.165 0.986 . . . . 64.54 111.126 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.96 116.46 21.6 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.076 -0.966 . . . . 74.02 109.924 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -172.62 -43.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.561 1.544 . . . . 74.35 108.074 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 143' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' F' ' 146' ' ' ASP . 64.4 m-85 -136.9 -58.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.653 1.581 . . . . 65.45 107.165 174.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 67.14 -66.49 0.19 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.07 1.748 . . . . 71.51 112.24 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 145' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' F' ' 145' ' ' LYS . 0.5 OUTLIER -73.36 78.49 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.711 0.804 . . . . 41.44 109.23 173.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' F' F ' 146' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' F' ' 143' ' ' TYR . 18.6 m-20 66.28 156.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.196 1.398 . . . . 51.13 112.357 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 147' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' B' ' 12' ' ' GLN . 68.0 mt -90.06 -26.32 20.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.714 -0.675 . . . . 70.31 110.908 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 148' ' ' LEU . . . . . 0.622 ' H ' ' HD2' ' F' ' 149' ' ' PRO . 1.8 tt -157.94 -51.91 0.01 OUTLIER Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 117.865 -1.064 . . . . 73.33 110.851 -175.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 149' ' ' PRO . . . . . 0.622 ' HD2' ' H ' ' F' ' 148' ' ' LEU . 19.8 Cg_endo . . . . . 0 C--N 1.407 3.623 0 C-N-CA 122.901 2.401 . . . . 74.34 113.441 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 108.424 -0.954 . . . . 64.33 108.424 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 m -85.71 71.47 10.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.623 0.769 . . . . 45.01 109.948 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.24 -69.36 0.84 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.297 0.639 . . . . 50.31 110.943 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -77.32 78.06 3.84 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.571 1.177 . . . . 71.35 110.028 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -166.47 156.9 12.25 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.897 -1.502 . . . . 75.25 107.889 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 70.41 -75.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.619 1.168 . . . . 71.42 111.201 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -71.19 91.92 0.97 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.692 . . . . 73.54 109.13 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -168.69 -67.38 0.02 OUTLIER 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.086 -0.961 . . . . 74.11 108.66 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.5 OUTLIER 60.66 177.09 0.1 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.506 1.122 . . . . 74.43 111.572 -174.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.1 m -153.39 124.18 7.3 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.809 -0.811 . . . . 75.13 108.809 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.01 114.0 9.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.401 -1.703 . . . . 74.31 106.401 159.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -138.78 121.07 15.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.335 -0.617 . . . . 70.43 109.335 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.448 HD12 ' HG2' ' C' ' 130' ' ' PRO . 25.0 pt -73.98 111.77 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 64.55 109.036 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -96.39 -43.32 7.71 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.764 -0.458 . . . . 64.21 109.764 -174.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -155.95 140.43 16.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.139 0.976 . . . . 64.31 108.865 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.555 HG23 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -128.72 112.53 26.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 106.122 -1.807 . . . . 63.33 106.122 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 28.8 p90 -157.64 169.14 25.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.252 0.548 . . . . 72.15 111.817 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -89.4 121.77 31.97 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.797 -0.816 . . . . 74.33 108.797 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.7 mtpt -87.51 -36.0 17.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.217 0.532 . . . . 71.33 109.751 175.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -146.83 140.44 25.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.108 -0.951 . . . . 55.22 108.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.5 mt -132.62 146.58 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.314 1.046 . . . . 73.43 108.671 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.2 m -146.1 124.96 12.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.182 0.993 . . . . 73.11 109.229 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 83.3 t80 -123.91 126.89 47.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.192 -1.781 . . . . 75.01 106.192 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -134.73 108.36 7.95 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.994 -0.743 . . . . 70.23 108.994 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.72 82.42 59.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.975 0.91 . . . . 53.34 108.796 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.2 -22.22 22.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.591 2.194 . . . . 72.14 111.576 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 89.3 m-20 -114.34 33.72 5.13 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.112 0.965 . . . . 75.43 109.953 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.48 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.37 -46.57 98.99 Favored Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 123.827 0.851 . . . . 74.45 112.491 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 7.7 Cg_exo -74.81 -28.91 9.12 Favored 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 121.937 1.758 . . . . 64.11 112.747 172.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 5.4 m80 -68.93 -28.22 66.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.543 0.737 . . . . 55.0 111.34 -172.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.53 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.4 p -63.96 -27.0 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.478 0.711 . . . . 63.23 111.587 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -68.12 -30.67 69.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.746 0.818 . . . . 72.33 110.583 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -75.89 -46.08 32.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.519 -0.764 . . . . 73.13 109.965 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HB3' HD11 ' A' ' 68' ' ' LEU . 41.3 mtpt -81.73 157.37 24.58 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.676 -1.147 . . . . 62.43 110.66 -173.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -64.44 135.36 56.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.552 0.341 . . . . 60.12 111.008 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -84.29 64.88 8.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.111 0.958 . . . . 73.21 109.529 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -132.0 66.59 77.94 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.065 1.346 . . . . 63.13 108.01 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -87.54 156.04 7.78 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.053 1.835 . . . . 71.23 112.389 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.581 ' HG3' ' HE2' ' F' ' 128' ' ' LYS . 34.4 tt0 -96.34 124.22 40.26 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.509 -0.923 . . . . 54.24 108.509 177.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.555 HG11 HD11 ' F' ' 129' ' ' LEU . 9.1 t -90.59 99.59 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.825 0.85 . . . . 51.35 109.656 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 90.2 mttt -95.55 142.28 28.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.544 0.737 . . . . 71.45 110.424 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.06 112.28 12.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.458 -0.792 . . . . 70.44 109.795 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -115.32 113.55 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.231 1.012 . . . . 75.13 108.698 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.07 155.8 25.3 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.446 0.641 . . . . 41.4 111.449 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 15.8 t70 -149.16 154.95 39.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 54.34 109.059 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -133.41 132.82 41.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.809 0.844 . . . . 63.22 109.201 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.06 130.31 41.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.676 0.79 . . . . 62.51 109.681 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -88.65 155.27 19.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.299 0.64 . . . . 74.35 110.464 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.3 t -149.53 119.06 6.92 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 -176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.87 107.88 19.53 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.785 -0.82 . . . . 64.45 108.785 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.32 -27.98 20.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.863 -0.608 . . . . 74.01 110.659 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.94 -174.03 1.96 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.868 -1.06 . . . . 42.42 110.205 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.5 128.43 35.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.339 -0.846 . . . . 54.14 109.68 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 62.04 18.18 9.72 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.582 1.176 . . . . 72.11 111.813 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.0 107.31 17.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 124.482 1.113 . . . . 64.13 108.057 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -125.97 124.48 40.84 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.786 0.834 . . . . 75.24 108.996 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.95 124.43 49.5 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.4 1.48 . . . . 62.12 108.666 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.38 134.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.187 -1.042 . . . . 73.0 108.187 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.6 t -106.6 125.33 62.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.048 -0.978 . . . . 61.44 108.387 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.39 107.53 19.92 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.45 -1.685 . . . . 73.35 106.45 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 5.3 ttp180 -94.46 97.08 9.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.11 -1.441 . . . . 60.13 107.11 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.8 132.57 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -126.29 126.7 44.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.381 -0.97 . . . . 73.34 108.381 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.479 HG23 HD13 ' A' ' 114' ' ' ILE . 89.8 t -120.78 129.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.3 -1.371 . . . . 71.34 107.3 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 34.5 m -125.51 137.61 53.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.036 -0.727 . . . . 71.14 109.036 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.18 105.8 10.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.948 -1.501 . . . . 63.25 106.948 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -130.71 125.9 35.09 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.621 -0.881 . . . . 63.24 108.621 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.3 pt? -91.07 84.25 5.69 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.992 -1.114 . . . . 64.21 107.992 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.85 -124.25 7.04 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.724 -1.125 . . . . 62.12 110.639 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.86 -26.9 21.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.801 0.841 . . . . 61.54 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -96.25 133.16 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 74.02 110.63 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -80.33 126.92 31.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.976 0.91 . . . . 70.35 110.844 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.75 -51.46 12.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.001 0.92 . . . . 65.31 109.189 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -161.95 168.3 23.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.148 0.979 . . . . 71.25 110.061 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 76' ' ' CYS . 40.6 tp -138.11 149.11 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.66 1.184 . . . . 72.22 109.221 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.435 ' H ' HD12 ' A' ' 75' ' ' LEU . 63.7 m -139.66 140.34 36.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.068 1.347 . . . . 74.3 108.947 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.37 132.63 18.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.71 0.804 . . . . 74.01 108.839 170.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.76 112.86 13.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.805 -0.813 . . . . 64.12 108.805 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.23 80.58 9.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.765 -1.107 . . . . 75.33 108.399 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -76.76 92.71 3.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.808 -1.087 . . . . 65.21 109.129 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -93.33 144.74 17.24 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.664 -0.574 . . . . 71.41 111.664 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.55 127.55 3.81 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.752 -0.539 . . . . 74.45 111.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.39 126.18 39.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.975 -1.12 . . . . 72.32 107.975 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.15 121.48 20.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.221 -0.659 . . . . 75.54 109.221 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -81.09 110.77 16.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.932 -0.766 . . . . 74.01 108.932 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.36 144.21 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.142 0.577 . . . . 72.31 110.684 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.4 162.75 22.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.998 . . . . 64.12 109.779 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 78.17 -6.83 48.47 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 115.99 -0.55 . . . . 74.24 114.47 173.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.93 155.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.461 1.104 . . . . 71.13 109.288 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -164.28 174.61 10.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.355 -0.609 . . . . 72.53 109.355 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.14 -125.17 29.37 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 116.112 -0.494 . . . . 63.43 112.75 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -73.16 -18.78 61.23 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.804 0.842 . . . . 71.32 111.945 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -70.71 -50.75 32.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.607 0.763 . . . . 72.32 109.59 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -75.23 -29.85 60.38 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.423 -0.808 . . . . 74.14 110.441 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.97 -44.08 97.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.143 0.577 . . . . 71.53 110.042 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.08 -49.52 77.34 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 115.518 -0.765 . . . . 73.55 110.688 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.3 m -69.17 -59.78 2.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 74.54 112.973 -171.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.75 -14.95 60.78 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.142 0.423 . . . . 63.3 112.142 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.42 -18.42 30.84 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.862 -0.41 . . . . 43.42 113.817 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.59 -69.17 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.492 0.646 . . . . 74.01 111.998 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 8.6 t80 -44.12 -57.89 3.15 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.1 1.36 . . . . 72.41 112.788 -174.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.7 -47.99 5.1 Favored Pre-proline 0 CA--C 1.559 1.325 0 CA-C-O 117.856 -1.069 . . . . 75.11 113.077 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HA ' HD12 ' A' ' 106' ' ' LEU . 22.0 Cg_endo -62.63 -21.45 72.93 Favored 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.739 1.657 . . . . 42.55 113.398 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -80.06 -26.89 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.085 0.554 . . . . 65.2 110.213 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 33.4 mm -67.74 -41.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.356 0.598 . . . . 64.13 109.526 167.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 16' ' ' ILE . 68.8 mt -71.46 -25.68 62.4 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.015 -0.993 . . . . 72.22 111.315 -175.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.05 -43.4 67.11 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 117.709 -1.139 . . . . 72.53 114.005 -170.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.9 Cg_exo -55.47 -39.89 88.56 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.336 2.024 . . . . 71.43 113.633 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -77.08 -32.7 56.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.477 0.711 . . . . 72.52 111.871 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -46.68 70.03 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.343 -0.614 . . . . 44.22 109.343 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.499 ' NH1' HD12 ' C' ' 105' ' ' ILE . 35.4 ttm180 -53.5 -49.72 66.93 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.881 1.363 . . . . 75.0 110.443 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.61 -49.65 75.74 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.434 1.084 . . . . 75.1 110.849 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.2 -40.42 93.89 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 124.139 0.899 . . . . 71.54 111.584 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 64' ' ' VAL . 80.1 mt -65.31 -59.22 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 123.832 0.707 . . . . 74.32 110.061 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.0 m -55.54 -33.29 63.69 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.516 1.135 . . . . 74.43 111.533 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -71.67 -43.63 65.68 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.42 -0.809 . . . . 72.03 110.545 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 49.9 mtm -59.29 -41.71 89.61 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.146 0.43 . . . . 75.12 110.756 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.5 t -57.16 -50.31 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.526 -1.216 . . . . 61.13 110.422 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.48 -23.31 58.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.971 0.508 . . . . 70.23 111.692 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.46 -28.36 61.0 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.438 0.695 . . . . 74.25 109.609 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 8.07 71.85 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 115.537 -0.756 . . . . 53.41 112.497 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.626 HG22 ' HB3' ' B' ' 17' ' ' TYR . 7.1 t 48.13 43.74 18.69 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.693 1.997 . . . . 51.53 112.771 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.53 ' HE1' HG11 ' A' ' 31' ' ' VAL . 83.0 m-85 -99.1 158.54 32.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.749 -1.114 . . . . 61.31 108.657 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.62 149.86 64.81 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.602 2.201 . . . . 74.14 111.884 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -69.67 134.46 48.72 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.361 0.664 . . . . 63.32 111.704 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.11 112.19 23.4 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.544 -0.91 . . . . 71.23 108.544 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' C' ' 15' ' ' ARG . 80.5 m-20 -98.47 100.55 11.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.421 0.688 . . . . 74.34 109.531 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' F' ' 129' ' ' LEU . 7.6 mp -56.06 120.98 8.35 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.144 0.978 . . . . 70.24 110.05 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.58 85.88 Favored Pre-proline 0 C--O 1.242 0.695 0 O-C-N 123.56 0.537 . . . . 43.51 109.662 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.47 104.78 1.63 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.866 1.711 . . . . 75.35 111.692 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -99.93 110.76 27.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.618 -1.253 . . . . 72.51 107.618 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -79.86 90.93 5.31 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.613 -1.255 . . . . 71.52 107.613 176.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.938 -1.028 . . . . 75.31 111.166 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -52.11 -38.69 58.22 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 125.121 1.368 . . . . 71.11 112.232 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.73 78.52 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.923 0.764 . . . . 72.42 111.888 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -75.02 -39.4 61.12 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.576 -0.527 . . . . 55.2 109.576 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -67.12 -29.06 68.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.542 0.737 . . . . 70.33 111.688 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.7 mmt -62.41 -51.72 66.41 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.246 -0.65 . . . . 73.45 109.246 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -53.68 -30.08 41.74 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.246 0.966 . . . . 71.42 111.688 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -82.17 -46.77 13.34 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.907 0.883 . . . . 71.45 111.155 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 44.3 tp -69.7 -52.93 21.22 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.231 0.826 . . . . 74.41 113.231 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -170.14 29.38 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.369 0.604 . . . . 75.44 109.686 -171.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.52 ' HG3' ' H ' ' A' ' 144' ' ' GLN . 5.6 tp60 61.38 -151.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.357 1.063 . . . . 72.53 108.41 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.52 ' H ' ' HG3' ' A' ' 143' ' ' GLN . 41.1 mt-30 -74.86 73.02 2.1 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 119.991 1.268 . . . . 74.42 110.565 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 172.66 162.75 0.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.382 1.873 . . . . 33.31 107.7 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.03 -43.44 0.78 Allowed Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.914 -0.13 . . . . 13.04 113.118 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.62 170.72 14.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.25 0.62 . . . . 45.21 111.767 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.9 67.13 0.03 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.92 -0.872 . . . . 72.04 110.92 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.9 p -130.61 19.91 5.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.239 1.016 . . . . 74.12 110.923 -175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.21 62.19 5.81 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 122.401 1.096 . . . . 70.55 110.906 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -151.74 106.14 3.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.41 -0.959 . . . . 74.4 108.41 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -133.16 155.38 49.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.583 0.753 . . . . 74.14 111.069 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.36 148.3 27.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.831 1.253 . . . . 60.53 108.453 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 66.19 92.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.767 1.227 . . . . 43.44 110.907 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.945 0.898 . . . . 52.44 108.85 179.436 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.788 0.327 . . . . 64.42 110.354 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -161.25 95.68 1.05 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.168 -1.049 . . . . 72.31 108.168 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.23 77.7 3.76 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.451 0.701 . . . . 74.15 110.638 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -158.76 15.96 0.19 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.957 0.903 . . . . 74.44 111.322 -176.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -108.53 -177.27 3.27 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.857 0.863 . . . . 64.1 109.659 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -102.13 166.28 10.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.094 0.558 . . . . 60.33 111.212 -177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.656 HG21 ' HA ' ' B' ' 89' ' ' ILE . 8.6 t -164.58 152.4 11.98 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.289 1.036 . . . . 54.12 109.947 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.85 -13.33 39.52 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.877 0.871 . . . . 72.14 110.305 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.442 ' SD ' HD12 ' B' ' 89' ' ' ILE . 17.1 ptm 53.55 -171.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.664 1.986 . . . . 54.34 114.262 175.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.2 m -138.75 103.62 4.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.633 -1.247 . . . . 61.24 107.633 174.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -110.72 146.58 36.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.441 0.696 . . . . 74.44 109.462 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 49.4 tt0 -164.54 141.4 6.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.285 0.634 . . . . 55.13 110.333 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.27 131.28 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 108.759 -0.83 . . . . 74.23 108.759 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -101.15 -50.83 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.15 -0.315 . . . . 63.42 110.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -157.43 140.93 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.514 -0.312 . . . . 70.2 110.183 -171.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.6 mt -123.16 134.68 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.867 -1.531 . . . . 75.43 106.867 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.626 ' HB3' HG22 ' A' ' 122' ' ' THR . 9.2 p90 -166.97 147.12 5.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.428 0.899 . . . . 43.23 113.428 -172.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.2 m -73.68 122.04 21.69 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.059 -1.428 . . . . 63.05 108.837 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.9 mtpt -97.46 -29.05 13.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.669 0.788 . . . . 75.34 110.674 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 24.4 t70 -157.13 141.6 16.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.389 -0.369 . . . . 71.23 110.787 -169.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.429 HD12 HG22 ' B' ' 78' ' ' VAL . 47.0 mm -138.48 144.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.719 1.208 . . . . 72.42 109.366 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.562 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -136.98 138.44 40.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.948 1.299 . . . . 63.33 108.422 167.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -142.85 131.46 22.5 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.064 -1.828 . . . . 72.41 106.064 164.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.5 mt-10 -131.48 136.42 47.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.739 -0.837 . . . . 74.31 108.739 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -131.4 80.37 67.71 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 107.223 -1.399 . . . . 61.21 107.223 170.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.21 -33.48 60.1 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.527 2.151 . . . . 52.33 110.779 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.448 ' O ' HG23 ' B' ' 31' ' ' VAL . 83.4 m-20 -118.77 24.29 10.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.581 1.152 . . . . 74.1 110.0 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -38.14 -56.18 2.11 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 115.053 1.501 . . . . 55.01 115.053 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.8 Cg_endo -82.21 -6.63 12.04 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.338 2.026 . . . . 40.24 113.332 -176.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.443 ' HA ' HE22 ' B' ' 33' ' ' GLN . 72.2 m80 -96.82 -24.22 16.0 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.696 0.798 . . . . 72.43 111.572 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' B' ' 73' ' ' ALA . 59.8 t -82.3 -6.66 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.584 0.754 . . . . 70.15 110.085 173.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.66 -43.27 72.26 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.277 1.031 . . . . 73.41 111.155 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.443 HE22 ' HA ' ' B' ' 30' ' ' HIS . 0.8 OUTLIER -72.81 -32.83 65.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.543 0.737 . . . . 74.14 110.151 -178.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.18 85.16 4.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.1 -0.955 . . . . 55.45 110.426 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.54 77.41 9.31 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.746 0.784 . . . . 71.33 108.967 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.474 ' HB2' HD21 ' B' ' 68' ' ' LEU . 5.9 m-90 -151.88 158.0 42.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.387 1.475 . . . . 73.12 108.294 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.94 113.74 45.33 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.151 -1.055 . . . . 64.32 108.151 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 56.7 Cg_endo -68.43 160.74 47.86 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.402 2.068 . . . . 73.4 112.572 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.0 tt0 -60.27 103.73 0.26 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.072 0.858 . . . . 71.35 110.046 175.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.13 135.41 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.064 -0.717 . . . . 62.11 109.064 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -142.41 134.99 28.08 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.871 -0.788 . . . . 72.11 108.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.23 123.49 48.37 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.751 -1.203 . . . . 74.11 107.751 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.628 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 8.8 m-20 -122.9 111.49 16.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.671 -1.233 . . . . 71.51 107.671 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.603 HD21 HG11 ' B' ' 131' ' ' VAL . 7.5 mp -100.31 143.3 30.66 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.365 0.666 . . . . 60.43 110.178 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.9 t70 -147.59 147.12 29.73 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.524 1.13 . . . . 65.43 108.129 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -132.53 124.56 28.72 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.311 0.644 . . . . 72.14 109.815 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.64 154.87 30.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.175 0.99 . . . . 40.33 108.49 173.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.1 p -145.46 161.18 40.33 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.236 0.614 . . . . 72.23 110.085 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.4 p -169.08 159.96 9.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.03 0.932 . . . . 74.2 109.482 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -118.08 134.98 54.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.06 0.544 . . . . 61.01 109.806 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.31 -49.18 5.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.86 0.864 . . . . 74.21 110.695 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 -172.8 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.331 -0.85 . . . . 54.0 110.376 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.55 107.62 1.77 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.36 1.037 . . . . 73.11 110.789 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' B' ' 85' ' ' SER . 21.3 m-20 77.82 1.07 2.85 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 126.516 1.926 . . . . 62.2 111.3 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.57 88.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.341 -1.355 . . . . 74.52 107.341 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -95.75 165.69 12.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.604 -0.888 . . . . 71.33 108.604 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.81 113.74 7.98 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.754 -1.202 . . . . 73.33 107.754 -174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.09 127.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.39 0.676 . . . . 64.24 109.745 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 27.9 t -103.27 131.99 50.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.926 0.89 . . . . 71.32 109.308 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -116.21 112.04 21.05 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.401 -1.333 . . . . 73.52 107.401 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 28.7 ttm180 -100.02 121.95 42.16 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.853 -0.425 . . . . 75.4 109.853 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' B' ' 114' ' ' ILE . 17.4 t -117.22 133.64 63.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.477 -1.305 . . . . 71.41 107.477 168.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.4 m -119.09 134.35 55.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.063 -0.717 . . . . 63.43 109.063 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.569 HG23 HD13 ' B' ' 114' ' ' ILE . 63.7 t -117.15 104.8 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.91 0.884 . . . . 73.0 108.839 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.0 m -97.48 140.85 31.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.121 -1.399 . . . . 75.0 108.871 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -141.5 134.22 28.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.327 0.392 . . . . 43.13 110.359 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -140.36 135.83 32.54 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.31 0.644 . . . . 72.14 109.312 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 17.1 tp -136.55 124.0 22.11 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.227 0.611 . . . . 74.23 109.486 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.1 -116.85 4.47 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.656 -0.702 . . . . 64.42 111.505 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.81 19.75 13.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.352 1.061 . . . . 73.32 109.693 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -156.23 176.63 12.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.895 0.478 . . . . 74.12 111.038 -170.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -72.58 141.93 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.618 0.767 . . . . 73.34 110.563 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -94.32 -59.24 2.0 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.038 -0.727 . . . . 42.12 109.038 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -157.89 168.76 26.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.871 -1.059 . . . . 73.52 109.886 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 78.8 mt -141.04 140.69 34.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.37 1.468 . . . . 63.21 107.251 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.8 t -148.99 155.47 40.85 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.877 -0.786 . . . . 75.31 108.877 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.6 tt0 -164.49 138.47 5.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.899 -0.778 . . . . 74.21 108.899 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.429 HG22 HD12 ' B' ' 21' ' ' ILE . 92.4 t -134.54 145.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.93 0.892 . . . . 65.22 109.098 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.5 mt-30 -122.08 94.15 4.21 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.289 -1.004 . . . . 73.33 108.289 170.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.417 ' O ' HD13 ' B' ' 106' ' ' LEU . 55.1 tp60 -84.54 101.15 11.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.731 -0.84 . . . . 73.33 108.731 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.53 165.83 31.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.27 -0.732 . . . . 60.44 111.27 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.66 133.73 3.54 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 112.325 -0.31 . . . . 71.33 112.325 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.479 HG13 ' HE1' ' B' ' 17' ' ' TYR . 63.6 mt -86.32 123.39 39.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.875 -0.787 . . . . 71.42 108.875 171.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.28 135.24 46.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.627 1.171 . . . . 75.12 109.077 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.568 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 53.5 m -101.81 106.35 17.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.81 0.844 . . . . 71.22 109.009 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.613 HG12 HD21 ' E' ' 115' ' ' LEU . 0.2 OUTLIER -126.03 131.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.881 0.873 . . . . 74.35 109.417 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 160.6 40.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.136 0.974 . . . . 73.31 109.022 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 -29.09 3.98 Favored Glycine 0 N--CA 1.473 1.118 0 N-CA-C 114.281 0.472 . . . . 65.4 114.281 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.656 ' HA ' HG21 ' B' ' 7' ' ' THR . 16.0 tt -83.03 152.35 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.975 0.91 . . . . 51.41 110.352 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 166.07 32.7 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.172 0.511 . . . . 72.3 112.008 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.82 30.53 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 114.761 -1.109 . . . . 40.41 113.848 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 47.4 m -65.04 -33.81 76.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.97 0.908 . . . . 72.24 110.611 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.54 -51.98 66.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.109 -0.951 . . . . 72.31 110.381 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -62.6 -41.06 98.74 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.805 0.842 . . . . 54.32 111.388 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.8 81.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.007 0.817 . . . . 73.45 112.09 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -95.99 -12.32 25.17 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.539 0.336 . . . . 64.44 111.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -80.38 -65.02 1.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.659 -0.497 . . . . 74.21 109.659 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' E' ' 116' ' ' TYR . 20.6 tp -75.89 -28.31 58.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.085 -0.507 . . . . 63.34 110.468 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.2 -34.06 18.6 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.754 -0.657 . . . . 50.03 114.294 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.86 -41.3 2.12 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.05 0.925 . . . . 65.21 113.075 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -76.94 -39.93 48.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.803 0.441 . . . . 74.42 111.29 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -66.34 -45.51 59.9 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.698 -0.668 . . . . 74.21 110.782 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.432 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 85.6 Cg_exo -55.73 -35.74 93.85 Favored 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 122.49 2.127 . . . . 63.55 113.896 163.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.673 0.389 . . . . 55.52 111.425 -178.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.96 -44.51 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.078 0.951 . . . . 72.44 110.001 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.417 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.7 mt -75.43 -23.52 56.98 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.853 -1.067 . . . . 75.4 112.37 -173.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.87 -48.07 95.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 113.936 1.087 . . . . 75.35 113.936 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.33 -34.47 94.13 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.153 1.902 . . . . 72.32 113.383 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.63 -43.82 62.75 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.228 0.611 . . . . 64.25 110.316 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.51 -39.57 80.45 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 123.49 0.716 . . . . 72.25 110.135 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 61.0 ttt180 -56.46 -63.98 1.02 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.749 1.22 . . . . 73.11 111.128 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.01 -28.69 69.67 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.112 0.882 . . . . 73.31 110.785 -171.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -69.27 -42.77 75.11 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.846 0.458 . . . . 40.52 110.843 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.569 HD13 HG23 ' B' ' 64' ' ' VAL . 93.5 mt -62.97 -53.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.204 0.602 . . . . 73.24 110.045 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -59.26 -33.11 70.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.508 -1.223 . . . . 70.54 110.796 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.3 t -62.87 -53.66 50.68 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.123 -0.944 . . . . 62.32 109.942 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.54 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 14.4 mmt -60.29 -34.99 74.54 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.195 0.598 . . . . 52.41 111.965 -175.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.77 -48.64 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.833 0.853 . . . . 65.13 111.005 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 61.0 p -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.915 0.486 . . . . 72.33 111.615 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.54 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 86.5 mtt-85 -68.18 -37.63 81.16 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.392 0.677 . . . . 73.14 109.324 171.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 11.88 54.29 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.133 0.895 . . . . 72.24 113.41 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.8 p 53.14 39.68 30.01 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.662 1.585 . . . . 64.43 112.341 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.596 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 65.5 m-85 -108.44 159.74 29.67 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 124.759 1.224 . . . . 73.4 110.336 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 106.66 0.2 Allowed 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 123.037 2.491 . . . . 51.41 112.483 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' C' ' 125' ' ' GLN . 12.9 pt20 -50.03 125.26 11.72 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.284 1.434 . . . . 65.44 111.598 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.29 112.97 25.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.276 -1.009 . . . . 73.3 108.276 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -90.38 129.73 36.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.688 0.795 . . . . 63.41 109.091 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.453 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -77.5 107.38 9.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.015 0.926 . . . . 63.13 109.214 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' E' ' 129' ' ' LEU . . . -68.26 152.55 96.45 Favored Pre-proline 0 CA--C 1.554 1.107 0 CA-C-N 115.704 -0.68 . . . . 63.21 109.695 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.4 111.21 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.427 2.752 . . . . 73.24 113.034 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.603 HG11 HD21 ' B' ' 44' ' ' LEU . 48.5 t -88.65 110.09 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.743 -1.577 . . . . 53.15 106.743 168.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.64 91.61 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.42 ' HB3' ' HZ2' ' E' ' 120' ' ' TRP . 97.7 m-85 -56.09 -42.76 77.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.091 0.956 . . . . 72.44 111.25 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.07 -54.59 45.31 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.49 -1.232 . . . . 72.32 110.908 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.1 63.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.449 -0.796 . . . . 72.11 112.164 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' E' ' 125' ' ' TYR . 5.6 tt -57.14 -55.21 37.64 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.196 0.998 . . . . 71.21 109.595 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -75.24 -28.77 60.01 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.686 -1.143 . . . . 72.13 110.587 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 51.3 ttm -61.3 -37.52 83.5 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.767 0.827 . . . . 72.34 111.035 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -75.08 -29.03 60.55 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.004 -0.998 . . . . 72.03 110.356 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -67.75 -33.08 74.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.185 0.594 . . . . 70.02 110.138 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 65.7 mt -90.3 35.69 0.87 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.802 0.841 . . . . 70.2 111.566 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -67.11 103.39 1.19 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 120.985 0.421 . . . . 62.11 110.34 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.51 -55.4 0.2 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.526 -0.916 . . . . 71.52 108.526 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -81.13 107.99 14.41 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.65 -0.5 . . . . 74.31 109.65 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.63 -29.9 68.34 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.113 0.965 . . . . 23.14 111.077 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.03 -151.99 24.14 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.306 -0.861 . . . . 61.2 111.359 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.05 159.02 22.79 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.006 0.923 . . . . 54.32 109.294 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.48 125.31 0.92 Allowed Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.584 -0.341 . . . . 42.24 112.356 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.6 t -140.45 119.89 13.12 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.448 -0.945 . . . . 74.24 108.448 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.09 142.9 32.86 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.414 0.685 . . . . 54.42 110.126 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.71 173.17 9.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.865 0.866 . . . . 73.34 111.435 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -131.87 144.71 51.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.259 -0.645 . . . . 75.02 109.259 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -95.37 174.99 6.75 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.169 0.588 . . . . 60.12 109.855 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.62 113.73 9.97 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.854 -0.795 . . . . 63.53 108.854 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.238 0 C-N-CA 123.679 0.792 . . . . 74.45 111.084 -171.551 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.884 -0.784 . . . . 74.54 108.884 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p -160.5 84.98 0.71 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.176 0.991 . . . . 73.23 109.166 -177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.23 126.47 6.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.504 -0.925 . . . . 62.23 108.504 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -173.28 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.657 -1.238 . . . . 73.43 107.657 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -95.83 177.76 5.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.838 -1.073 . . . . 63.04 110.428 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -78.73 107.72 11.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.314 -0.857 . . . . 74.45 108.924 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -66.94 -25.78 66.52 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 123.956 0.785 . . . . 74.44 110.214 173.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.41 ' HA ' ' HA3' ' C' ' 146' ' ' GLY . 36.8 tt0 61.86 117.86 0.02 OUTLIER 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.43 1.892 . . . . 75.14 112.976 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.2 ttm 64.32 114.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.502 1.121 . . . . 52.31 111.798 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -85.78 85.93 7.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.879 -0.786 . . . . 72.41 108.879 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.405 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -105.17 121.49 43.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.389 -1.278 . . . . 73.31 108.093 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.23 137.2 38.83 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.367 -0.605 . . . . 64.3 109.367 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 49.5 mt -81.29 121.51 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.105 -0.952 . . . . 74.0 109.241 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -89.47 -49.6 6.59 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.194 0.598 . . . . 72.43 109.965 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.487 ' HA ' HD21 ' A' ' 127' ' ' ASN . 53.2 ttt180 -164.01 122.69 1.91 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.61 0.364 . . . . 72.24 110.538 -176.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.62 136.33 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.468 -0.938 . . . . 71.44 108.468 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 36.0 p90 -169.07 165.65 11.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.108 0.956 . . . . 74.43 112.855 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -87.01 111.73 21.15 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.732 -1.576 . . . . 65.43 108.838 173.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 57.9 mmtt -65.29 -48.46 73.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.389 1.09 . . . . 74.13 108.49 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -134.62 140.4 46.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.133 -1.848 . . . . 70.34 109.207 -170.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.6 mt -137.13 143.45 34.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.074 -1.454 . . . . 64.41 107.074 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -160.63 151.04 18.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.389 0.614 . . . . 45.12 109.86 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -152.72 115.22 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.282 -1.377 . . . . 72.21 107.282 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -116.08 109.14 17.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.304 -0.628 . . . . 74.44 109.304 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.15 85.28 15.12 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.382 1.073 . . . . 64.31 108.113 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -35.23 20.29 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 121.927 1.751 . . . . 35.33 110.382 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 77.7 m-20 -98.55 30.58 3.19 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.712 1.205 . . . . 75.43 110.29 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.15 99.96 Favored Pre-proline 0 CA--C 1.57 1.727 0 C-N-CA 124.558 1.143 . . . . 62.52 112.591 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.35 -18.37 4.07 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.169 1.913 . . . . 73.32 113.189 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.434 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -69.75 -41.33 75.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.447 0.699 . . . . 73.44 110.529 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.695 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.1 p -66.63 -16.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.553 1.141 . . . . 75.31 112.311 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.403 ' HA ' HG12 ' E' ' 134' ' ' ILE . 57.5 t80 -62.36 -37.19 84.74 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.087 1.355 . . . . 72.24 112.059 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -118.77 24.93 10.57 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.826 0.822 . . . . 72.54 109.398 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 20.1 ttpp -123.53 176.12 6.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.05 0.54 . . . . 51.42 110.675 -170.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' C' ' 37' ' ' GLN . 5.0 p-10 -55.24 120.74 7.5 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.379 1.072 . . . . 71.33 111.203 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -90.02 63.31 5.88 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.899 -0.592 . . . . 74.43 109.525 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' C' ' 35' ' ' ASP . 15.4 pt20 -146.16 64.57 9.99 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-O 121.19 0.519 . . . . 65.14 111.147 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.04 134.12 8.05 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 121.724 1.616 . . . . 64.21 110.648 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -84.52 93.67 8.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.37 -1.344 . . . . 75.23 107.37 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 65.8 t -67.39 133.19 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.445 -1.252 . . . . 70.54 110.413 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -130.04 130.22 44.66 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.554 -1.276 . . . . 64.3 107.554 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.596 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.4 pt? -95.49 133.3 39.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.367 -0.975 . . . . 71.03 108.367 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -118.88 141.03 49.02 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.955 -1.498 . . . . 74.2 106.955 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -134.06 143.03 47.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.047 0.451 . . . . 64.45 110.205 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -147.5 149.7 33.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.261 1.024 . . . . 64.01 108.655 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 14.5 t -130.99 144.1 51.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.809 0.444 . . . . 74.02 110.437 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.01 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.282 1.033 . . . . 75.4 108.433 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -130.83 142.37 50.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.834 0.453 . . . . 52.02 110.344 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -160.6 133.41 6.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.815 0.846 . . . . 72.42 109.814 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.21 133.44 40.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.11 0.564 . . . . 53.22 110.168 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' C' ' 57' ' ' GLU . 49.0 mt -102.7 -38.56 7.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.226 0.61 . . . . 72.42 110.253 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.19 178.77 9.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.835 0.854 . . . . 62.31 110.097 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.93 116.87 5.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.184 -0.916 . . . . 63.5 109.112 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.98 0.11 2.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.332 1.453 . . . . 75.43 113.11 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 53.4 t -109.69 108.43 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.301 -0.629 . . . . 75.43 109.301 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -113.59 161.65 17.17 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.923 0.889 . . . . 70.21 109.036 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.53 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.0 tt0 -124.25 141.45 52.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.985 0.914 . . . . 72.24 108.808 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.41 HG23 HD11 ' C' ' 106' ' ' LEU . 24.6 m -129.37 134.53 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 122.916 0.486 . . . . 70.24 109.933 168.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' C' ' 46' ' ' THR . 58.0 t -103.41 128.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.681 -1.229 . . . . 73.24 107.681 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.5 96.43 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.133 -1.062 . . . . 73.35 108.133 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -86.47 114.81 23.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.175 -1.375 . . . . 62.13 110.49 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.35 109.94 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.736 -0.838 . . . . 65.03 108.736 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -103.55 113.48 27.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.194 0.521 . . . . 71.23 109.603 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.513 HG23 HD13 ' C' ' 114' ' ' ILE . 71.1 t -100.8 109.75 26.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 123.571 0.748 . . . . 55.03 109.206 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 15.2 m -102.0 127.31 48.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.155 -0.683 . . . . 64.1 109.155 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.72 100.2 6.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.651 -1.24 . . . . 55.2 107.651 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -151.15 147.08 26.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.702 -0.681 . . . . 74.42 109.961 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.77 -14.56 56.27 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.254 -0.43 . . . . 73.41 109.919 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.47 -102.18 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 110.977 -0.849 . . . . 71.41 110.977 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.39 -23.38 26.14 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.685 -0.857 . . . . 64.54 108.685 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -79.67 100.87 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.269 1.028 . . . . 64.0 109.02 174.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.0 m -88.97 128.56 35.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.549 -0.75 . . . . 74.21 110.429 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.29 -56.71 4.45 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 44.15 107.914 170.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -154.87 155.92 35.22 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.002 -0.999 . . . . 63.41 110.816 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.406 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -121.7 143.63 49.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.358 -2.09 . . . . 73.4 105.358 170.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.6 t -147.08 145.66 29.71 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.258 -1.015 . . . . 63.01 108.258 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.0 128.33 6.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.86 0.362 . . . . 72.41 110.42 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -131.13 139.15 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.69 1.196 . . . . 63.24 108.495 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -113.66 94.69 4.96 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.515 -0.921 . . . . 75.31 108.515 171.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.462 ' O ' HD13 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.77 98.13 7.63 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.319 -0.855 . . . . 74.4 109.114 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.89 144.6 17.24 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.286 -0.726 . . . . 73.22 111.286 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -140.77 128.36 3.74 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 112.369 -0.292 . . . . 71.02 112.369 -172.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -91.43 122.96 43.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.898 -1.149 . . . . 64.22 107.898 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -137.84 121.77 17.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.613 0.765 . . . . 72.41 109.61 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 p -84.22 113.4 21.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 64.4 109.127 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 44.2 pt -115.18 127.47 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.577 0.703 . . . . 60.43 109.687 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.62 154.25 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.475 1.11 . . . . 62.31 108.485 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -18.82 38.97 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 120.426 -0.097 . . . . 75.25 112.866 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' C' ' 93' ' ' GLN . 10.7 tp -123.3 151.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.89 0.876 . . . . 71.13 109.488 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.497 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 14.3 pt-20 -159.82 -179.58 7.96 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.041 0.537 . . . . 63.04 111.183 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.35 -149.35 50.85 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.456 -0.793 . . . . 64.54 114.3 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.7 p -60.79 -24.33 65.72 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.506 1.122 . . . . 74.21 112.002 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.421 ' HB3' HD11 ' C' ' 89' ' ' ILE . 16.0 mt-30 -67.72 -51.1 53.31 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.7 1.2 . . . . 64.32 111.189 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.497 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 21.2 ptt? -70.88 -24.4 62.48 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.917 -0.401 . . . . 61.25 109.917 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.09 84.53 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.715 0.634 . . . . 73.41 110.7 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -63.87 -37.7 88.35 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.504 0.502 . . . . 62.23 110.667 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -65.54 -55.47 17.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.751 -0.463 . . . . 72.44 109.751 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.25 -16.26 63.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.792 0.837 . . . . 71.51 112.238 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.11 3.77 26.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.478 -0.624 . . . . 62.34 114.114 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.13 -64.73 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.558 0.679 . . . . 71.54 110.483 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.63 -55.36 31.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.958 0.503 . . . . 55.03 112.211 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 18.2 m -60.97 -47.09 96.52 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.574 -0.726 . . . . 64.12 111.883 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 70.6 Cg_exo -50.23 -38.9 52.39 Favored 'Trans proline' 0 C--N 1.396 3.045 0 C-N-CA 122.767 2.311 . . . . 71.11 114.478 165.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -70.46 -25.52 63.22 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.516 0.726 . . . . 75.13 111.765 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.499 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.54 -41.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.169 0.588 . . . . 74.03 109.665 171.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.462 HD13 ' O ' ' C' ' 80' ' ' GLN . 95.9 mt -75.3 -26.36 58.63 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.074 -0.966 . . . . 63.13 111.848 -175.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.4 -44.01 94.67 Favored Pre-proline 0 CA--C 1.565 1.534 0 CA-C-O 117.637 -1.173 . . . . 73.24 113.764 -172.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.76 -46.22 33.36 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.604 2.203 . . . . 74.21 113.752 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.28 -43.39 77.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.75 0.82 . . . . 72.51 110.908 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.47 98.81 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.637 -0.71 . . . . 63.22 110.317 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -57.48 -50.0 74.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.579 1.152 . . . . 73.21 111.053 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.63 -31.78 71.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.244 0.618 . . . . 70.44 110.212 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.7 t -71.37 -29.7 65.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.217 0.607 . . . . 74.33 111.221 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.513 HD13 HG23 ' C' ' 64' ' ' VAL . 80.8 mt -80.03 -48.65 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 73.13 110.248 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 43.4 m -60.57 -32.11 71.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.664 0.786 . . . . 72.54 110.818 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -61.63 -51.64 67.66 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.248 -0.887 . . . . 72.24 109.34 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.545 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.53 -38.96 92.03 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.71 1.204 . . . . 72.13 113.078 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.0 t -60.2 -45.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.199 1.0 . . . . 72.12 109.253 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -70.41 -31.11 68.17 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.159 -1.382 . . . . 73.43 111.544 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -70.63 -35.67 73.04 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.63 0.772 . . . . 73.43 109.891 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.2 -0.91 90.43 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.32 -0.711 . . . . 44.55 113.173 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p 59.14 62.6 1.8 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.704 1.602 . . . . 73.13 111.693 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 63.1 m-85 -123.57 161.98 42.92 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 114.39 -1.277 . . . . 73.12 110.096 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 30.7 Cg_endo -61.57 158.3 37.45 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.236 2.624 . . . . 73.34 114.317 -173.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -59.61 119.69 8.05 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.022 0.929 . . . . 64.24 110.403 -175.086 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 54.3 tp -131.01 114.44 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.298 -0.865 . . . . 45.13 108.905 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -123.79 129.71 51.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.425 -0.954 . . . . 74.04 108.425 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 90.9 mt -86.79 121.76 29.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.174 0.59 . . . . 64.21 110.41 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.39 88.33 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 123.414 0.686 . . . . 61.12 110.19 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.448 ' HG2' HD12 ' A' ' 13' ' ' ILE . 42.4 Cg_endo -68.19 143.06 57.71 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.076 1.851 . . . . 65.35 112.136 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.6 108.78 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.773 -1.195 . . . . 65.35 107.773 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -98.48 90.7 4.86 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.463 0.649 . . . . 72.03 111.348 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -75.23 -29.61 60.31 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.925 -1.034 . . . . 75.11 109.425 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -63.28 -42.69 99.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.476 -1.238 . . . . 65.04 111.312 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.65 73.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.684 0.794 . . . . 51.44 111.916 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.85 -47.2 83.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.608 0.763 . . . . 72.55 109.744 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.73 -40.56 69.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.636 0.774 . . . . 75.21 110.972 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -55.06 -34.11 63.3 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.432 1.093 . . . . 74.24 112.636 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.11 -33.34 18.42 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.88 1.272 . . . . 71.34 113.74 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -160.02 0.02 OUTLIER 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 113.028 0.751 . . . . 75.03 113.028 -169.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.41 135.0 37.6 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.805 -1.183 . . . . 72.31 107.805 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -125.46 122.77 37.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.888 0.475 . . . . 74.53 109.819 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -125.39 29.31 6.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.312 0.645 . . . . 74.42 110.121 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -83.84 138.23 33.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.652 -0.499 . . . . 74.4 109.652 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.13 174.28 10.38 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.062 0.945 . . . . 53.13 111.211 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' C' ' 8' ' ' GLU . . . 153.36 57.68 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.472 -0.786 . . . . 62.4 111.702 178.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -61.62 144.81 53.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.192 0.597 . . . . 62.02 110.074 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.1 147.79 21.11 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.121 0.263 . . . . 62.42 112.644 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 24.8 m -146.54 133.92 20.74 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.095 -1.446 . . . . 55.23 107.095 166.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.41 -53.36 29.85 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.339 -0.615 . . . . 73.33 109.339 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.1 78.19 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.885 1.674 . . . . 75.14 112.002 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -173.52 17.45 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.772 0.829 . . . . 70.12 109.825 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 75.42 3.09 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.138 -1.06 . . . . 75.44 108.138 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -178.02 117.84 0.09 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.256 1.023 . . . . 73.4 108.242 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.238 0 C-N-CA 123.138 0.575 . . . . 74.5 110.008 179.92 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.074 -0.713 . . . . 64.23 109.074 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 64.2 m 66.88 116.3 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.197 1.399 . . . . 73.44 111.117 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.2 -168.55 1.71 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.152 0.981 . . . . 75.23 111.097 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.79 -14.51 61.12 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.444 0.698 . . . . 54.5 110.896 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 50.2 t30 71.75 141.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.736 1.215 . . . . 75.22 111.916 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -104.62 174.67 5.78 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.359 -0.978 . . . . 63.23 108.359 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -71.86 76.01 0.88 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.236 1.017 . . . . 70.14 110.248 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.39 -25.46 12.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.545 1.138 . . . . 72.01 108.573 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' D' ' 87' ' ' ALA . 7.9 ttp -32.54 125.82 0.31 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.412 1.485 . . . . 64.53 113.189 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.8 m -122.57 142.74 50.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.631 -0.877 . . . . 72.21 108.631 173.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' D' ' 85' ' ' SER . 57.3 t80 -154.09 101.36 2.4 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.125 -1.065 . . . . 61.44 108.125 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -132.08 147.0 52.42 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.837 0.855 . . . . 74.32 109.336 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -102.49 105.8 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.672 -0.862 . . . . 72.52 108.672 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -74.84 -45.23 44.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.4 1.08 . . . . 74.12 112.098 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.421 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 54.7 ttt180 -155.3 129.55 8.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.181 0.193 . . . . 72.45 110.512 -170.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.509 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.5 mp -114.43 126.71 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.606 1.162 . . . . 74.14 107.877 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.421 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 38.0 p90 -162.87 177.32 9.37 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.946 0.879 . . . . 73.03 112.884 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -112.95 129.61 56.42 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.472 -1.24 . . . . 62.25 109.059 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -98.46 -25.05 14.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.758 0.423 . . . . 74.12 110.782 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.6 t70 -149.81 132.59 15.98 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.733 -0.839 . . . . 73.02 108.733 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.545 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.1 mt -131.83 146.62 33.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.805 -1.183 . . . . 71.23 107.805 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -148.35 142.46 26.0 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.315 1.046 . . . . 70.24 108.913 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.8 t80 -151.62 124.3 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.219 -1.771 . . . . 71.42 106.219 170.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -131.28 122.65 26.82 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.881 0.872 . . . . 75.33 109.18 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.65 85.0 13.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.573 -0.899 . . . . 60.01 108.573 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.83 -31.58 10.09 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.44 2.094 . . . . 71.33 113.056 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.9 m-20 -114.37 41.65 2.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.429 1.092 . . . . 53.33 108.639 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -55.05 -52.75 68.45 Favored Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 115.306 1.595 . . . . 63.14 115.306 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' NZ ' ' C' ' 19' ' ' LYS . 19.3 Cg_endo -91.06 2.69 4.6 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.8 1.667 . . . . 65.42 112.474 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 17.3 t-160 -84.39 -42.09 16.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.648 1.179 . . . . 61.52 108.954 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.2 t -78.16 -11.62 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 C-N-CA 123.595 0.758 . . . . 74.01 110.402 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -55.32 -36.41 66.21 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.954 0.902 . . . . 74.33 111.853 167.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -83.18 -1.72 53.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.653 0.781 . . . . 71.0 112.606 -172.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.422 ' HD3' ' HG ' ' D' ' 68' ' ' LEU . 14.3 ptpt -127.56 107.81 10.25 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.387 0.675 . . . . 73.45 111.155 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.19 92.6 8.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.165 0.986 . . . . 60.03 109.72 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.593 ' HB3' HD11 ' D' ' 68' ' ' LEU . 25.1 t-105 -161.6 166.85 26.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.593 -0.892 . . . . 71.54 108.593 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.8 111.64 39.14 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.284 1.034 . . . . 75.33 109.109 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.61 142.6 49.25 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.968 2.445 . . . . 71.33 113.263 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -75.8 122.55 24.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.144 -0.687 . . . . 63.44 109.144 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.421 HG13 HG13 ' D' ' 64' ' ' VAL . 61.6 t -99.24 135.34 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.836 0.854 . . . . 72.34 110.988 -173.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -110.56 138.01 47.5 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.221 -1.029 . . . . 72.04 108.221 164.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.698 HD22 HD11 ' D' ' 128' ' ' LEU . 48.5 tp -101.76 142.41 33.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.024 -1.102 . . . . 61.51 108.024 171.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.587 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.4 t70 -140.73 128.2 21.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.283 -1.006 . . . . 74.4 108.283 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.6 mt -118.48 150.4 39.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.032 0.533 . . . . 70.11 110.786 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.6 t70 -152.62 132.34 13.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.095 1.358 . . . . 74.52 107.699 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -109.21 153.21 24.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.195 0.522 . . . . 54.25 109.987 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.71 165.65 35.32 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.279 1.032 . . . . 71.43 108.692 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -166.56 161.52 16.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.273 0.629 . . . . 64.33 111.334 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -151.27 152.8 33.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.483 1.113 . . . . 71.42 108.843 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -92.04 119.06 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.031 -0.359 . . . . 72.21 110.031 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' D' ' 57' ' ' GLU . 30.9 mt -92.58 -35.79 13.37 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.071 0.548 . . . . 75.32 110.312 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.07 -176.41 5.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.808 0.843 . . . . 65.51 110.24 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.72 107.64 0.63 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.709 0.804 . . . . 63.44 110.525 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 5.9 m-20 62.21 15.91 7.93 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.191 0.996 . . . . 71.32 112.473 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 20.4 t -107.51 125.38 63.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.028 -1.101 . . . . 71.14 108.028 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.23 133.52 45.55 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.759 -0.655 . . . . 74.31 110.849 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.6 tt0 -87.29 111.8 21.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.557 -1.275 . . . . 73.33 107.557 168.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.71 120.04 47.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 N-CA-C 107.458 -1.312 . . . . 53.14 107.458 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 92.1 t -99.69 140.27 19.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 123.603 0.761 . . . . 64.34 109.488 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.72 122.58 38.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.487 -0.931 . . . . 71.23 108.487 179.093 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 43.3 ttm-85 -102.42 105.94 16.6 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.12 0.968 . . . . 65.35 108.496 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.3 t -105.97 120.65 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.208 -1.034 . . . . 62.34 108.208 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.8 m -123.96 130.71 53.04 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.413 0.685 . . . . 63.05 109.876 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.521 HG23 HD13 ' D' ' 114' ' ' ILE . 90.7 t -116.21 117.86 56.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.878 1.271 . . . . 60.54 109.35 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -111.88 93.73 4.6 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.886 -1.153 . . . . 61.52 107.886 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.57 137.18 42.79 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.304 0.641 . . . . 71.31 109.764 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.7 p -142.39 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.357 0.663 . . . . 75.11 109.52 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' D' ' 36' ' ' TRP . 15.2 tp -120.26 115.98 24.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.195 0.598 . . . . 53.22 109.422 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 -123.68 6.28 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.067 -0.813 . . . . 42.31 111.067 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.25 4.36 20.83 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.45 0.7 . . . . 73.11 110.663 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.03 162.98 16.26 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.711 0.805 . . . . 52.03 109.74 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.2 m -76.23 136.79 39.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.548 -0.538 . . . . 71.14 109.548 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -93.07 -55.28 3.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.25 -0.886 . . . . 71.31 109.434 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -163.14 154.61 17.39 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.137 -0.938 . . . . 72.5 109.745 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.84 148.42 48.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.723 1.209 . . . . 51.33 108.184 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' D' ' 114' ' ' ILE . 46.4 t -157.53 147.36 20.4 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.818 0.447 . . . . 64.22 110.244 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -156.45 133.23 10.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 74.14 109.482 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -133.22 117.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.163 0.585 . . . . 64.41 109.846 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -91.31 88.49 6.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.661 0.785 . . . . 70.41 110.053 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -80.57 102.61 9.89 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.881 1.272 . . . . 70.23 109.355 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.74 141.43 15.63 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.626 -0.589 . . . . 43.12 111.626 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.66 132.04 5.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.138 -0.785 . . . . 70.21 111.138 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -89.06 108.22 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.34 -0.615 . . . . 73.11 109.34 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.03 126.16 51.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.761 0.824 . . . . 73.43 110.09 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 42.7 m -78.2 114.36 17.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.823 0.849 . . . . 71.13 108.945 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 73.3 mt -108.14 144.11 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.131 -1.433 . . . . 65.34 107.131 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' D' ' 9' ' ' MET . . . -162.05 151.44 15.97 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.262 -0.644 . . . . 75.05 109.262 173.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 1.76 53.83 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 123.815 0.697 . . . . 74.52 114.782 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.52 139.36 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.443 0.697 . . . . 53.13 110.574 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 -171.0 3.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.046 0.939 . . . . 75.22 110.386 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.8 -133.79 14.12 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.52 0.512 . . . . 71.33 113.221 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -63.81 -37.54 87.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.688 0.795 . . . . 64.01 111.386 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -71.24 -36.45 71.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.96 0.504 . . . . 55.42 112.147 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -70.13 -34.7 73.39 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.443 0.565 . . . . 64.14 109.926 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.9 -31.38 69.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.643 0.777 . . . . 63.24 110.677 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -75.32 -30.41 60.32 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.65 1.18 . . . . 74.34 110.527 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.485 ' HB3' ' SG ' ' D' ' 102' ' ' CYS . 73.5 m -68.36 -51.32 45.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.557 -0.534 . . . . 72.43 109.557 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.22 -24.32 64.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.024 0.53 . . . . 51.33 111.441 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.46 -0.4 37.47 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.799 -1.0 . . . . 71.42 114.719 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.87 -62.58 0.11 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.47 1.135 . . . . 55.21 112.408 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.97 -49.34 29.74 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.775 0.657 . . . . 70.15 112.775 -164.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' D' ' 97' ' ' CYS . 58.7 m -63.9 -45.89 81.14 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.541 -0.742 . . . . 53.41 111.691 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.448 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 89.3 Cg_exo -54.06 -35.31 81.07 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.723 2.282 . . . . 74.45 113.83 166.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.244 0.618 . . . . 63.12 111.258 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -67.46 -43.33 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.561 0.744 . . . . 64.3 110.314 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.3 mt -75.52 -23.42 56.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.982 -1.008 . . . . 74.44 112.35 -173.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -64.98 -42.42 61.97 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 117.917 -1.039 . . . . 62.23 113.694 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.05 -42.87 63.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.113 1.876 . . . . 70.3 113.4 170.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -72.83 -36.69 67.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.817 0.847 . . . . 73.23 111.619 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.57 -43.12 77.25 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.451 0.7 . . . . 73.1 110.462 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -59.58 -48.18 82.66 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.2 1.0 . . . . 54.1 110.291 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.53 -46.17 91.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.26 0.975 . . . . 72.12 111.372 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -57.84 -41.15 81.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.186 0.929 . . . . 72.44 110.575 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.521 HD13 HG23 ' D' ' 64' ' ' VAL . 84.3 mt -60.0 -58.64 6.32 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 O-C-N 123.924 0.765 . . . . 70.13 110.145 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 5.6 m -54.02 -41.74 68.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.645 1.178 . . . . 61.02 111.492 -170.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -65.06 -44.87 87.57 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.575 -1.193 . . . . 71.1 110.552 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.2 mtm -68.91 -31.25 70.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.041 0.537 . . . . 73.41 112.232 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.7 t -70.56 -38.94 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.442 0.697 . . . . 74.3 110.058 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.95 -28.6 57.98 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.626 0.37 . . . . 63.35 110.803 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -70.37 -31.41 68.65 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.553 0.741 . . . . 75.22 109.34 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.55 8.52 64.89 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.324 -0.853 . . . . 60.03 112.58 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.417 ' HG1' ' HE ' ' C' ' 15' ' ' ARG . 36.8 p 55.71 26.25 9.18 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.401 1.881 . . . . 75.34 113.809 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 43.8 m-85 -96.9 164.88 17.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 73.45 108.858 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.69 143.58 94.83 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.254 1.969 . . . . 75.3 110.027 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -65.0 150.95 47.17 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.368 0.531 . . . . 55.32 110.839 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.48 100.21 9.79 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.59 92.38 5.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.276 -1.009 . . . . 62.11 108.276 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.698 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -70.8 115.07 9.52 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.104 -1.073 . . . . 75.42 108.104 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -71.65 132.75 85.09 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.489 0.716 . . . . 53.35 111.445 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.5 Cg_exo -65.15 127.34 18.16 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.242 2.628 . . . . 64.52 112.458 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.61 152.07 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.864 0.866 . . . . 54.12 110.49 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -74.69 109.46 8.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.354 0.661 . . . . 75.14 110.607 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.52 -24.63 61.99 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.118 0.967 . . . . 73.01 111.702 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.54 -44.51 93.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.642 0.777 . . . . 72.04 110.748 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.62 71.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.516 0.727 . . . . 51.2 111.735 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.42 -45.29 60.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.303 1.041 . . . . 73.45 109.668 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -61.79 -30.38 70.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.508 1.123 . . . . 73.41 111.67 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 18.3 mmt -55.2 -48.8 73.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.15 0.5 . . . . 75.24 110.585 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -63.45 -34.91 78.79 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.038 -0.983 . . . . 62.21 111.495 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -57.54 -46.57 83.71 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.886 0.874 . . . . 71.13 111.488 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.57 -30.08 68.4 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.684 0.794 . . . . 72.05 111.931 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -84.57 8.98 14.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.781 0.833 . . . . 74.43 112.088 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -122.23 86.43 2.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.77 0.828 . . . . 70.41 109.692 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.91 97.99 2.98 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.502 0.668 . . . . 74.03 110.015 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.54 17.29 0.1 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.407 0.683 . . . . 50.41 111.411 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.19 83.99 1.37 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.611 -0.596 . . . . 53.12 111.611 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -118.34 143.95 46.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.84 0.856 . . . . 72.33 109.705 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.02 88.29 1.35 Allowed Glycine 0 C--N 1.344 0.99 0 O-C-N 123.429 0.455 . . . . 73.02 112.361 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -73.12 161.61 30.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.848 0.859 . . . . 62.23 110.638 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.1 131.38 28.31 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.083 0.468 . . . . 74.12 109.88 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.37 136.56 17.53 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.207 1.003 . . . . 74.05 108.615 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -135.85 149.08 48.92 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.505 1.122 . . . . 73.01 108.387 -175.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 64.01 -174.75 0.16 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.292 1.037 . . . . 64.33 111.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.66 176.49 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 64.2 109.853 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 108.569 -0.9 . . . . 72.34 108.569 175.284 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 110.004 -0.369 . . . . 74.33 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -122.66 155.79 35.68 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.983 0.913 . . . . 72.0 109.913 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.87 170.04 15.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.718 0.807 . . . . 63.14 110.904 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -130.16 172.57 11.64 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.591 -1.186 . . . . 74.34 108.16 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 67.28 -169.52 0.2 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.035 0.934 . . . . 64.45 111.665 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.22 -2.12 33.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.304 1.442 . . . . 64.34 112.075 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -92.92 62.8 3.71 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.786 -0.82 . . . . 63.15 108.786 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.629 ' H ' HD23 ' E' ' 115' ' ' LEU . 1.9 pt? -86.43 73.51 10.12 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.571 -1.195 . . . . 74.44 109.891 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 116' ' ' TYR . . . . . 0.423 ' HB2' HD23 ' B' ' 98' ' ' LEU . 50.1 t80 -155.91 69.64 5.13 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.842 -1.072 . . . . 71.41 109.088 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.11 -30.58 2.63 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.572 2.181 . . . . 53.04 111.331 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.76 141.39 31.45 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.488 1.115 . . . . 73.12 109.061 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 23.7 m -141.0 156.6 46.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.815 -1.18 . . . . 71.1 107.815 173.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.451 ' HZ3' HD22 ' B' ' 136' ' ' LEU . 53.6 m95 -53.39 105.5 0.13 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.833 0.853 . . . . 72.02 111.933 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.3 -63.29 1.14 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.122 -0.944 . . . . 71.53 109.869 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.12 -67.66 0.52 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.01 -0.541 . . . . 73.42 110.903 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . 0.261 1.9 p 65.05 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 C-N-CA 127.577 2.351 . . . . 72.43 114.736 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.8 98.63 3.54 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.321 0.649 . . . . 72.21 110.155 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 125' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' B' ' 136' ' ' LEU . 93.7 t80 -73.82 123.78 24.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.505 -0.77 . . . . 73.54 109.721 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -97.75 160.57 14.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.353 0.661 . . . . 51.03 109.827 172.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.07 -152.87 19.04 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.806 -0.518 . . . . 45.42 111.806 -175.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 159.59 43.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.731 0.812 . . . . 72.43 110.802 -173.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 129' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' B' ' 129' ' ' ALA . 4.9 mp -129.52 83.41 2.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.65 -0.87 . . . . 75.21 108.65 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.22 -39.34 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.073 0.949 . . . . 73.01 109.664 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 62.06 -86.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.382 1.473 . . . . 73.2 111.024 -174.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -167.77 106.09 0.58 Allowed Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 107.743 -1.206 . . . . 74.25 107.743 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 133' ' ' PRO . . . . . 0.485 ' O ' HG22 ' E' ' 136' ' ' VAL . 50.4 Cg_endo -87.0 7.26 4.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.829 2.352 . . . . 72.45 113.664 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 134' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' C' ' 32' ' ' PHE . 3.8 mp 57.74 -81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.768 1.227 . . . . 60.12 109.756 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -175.95 36.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.701 1.6 . . . . 65.31 107.997 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.485 HG22 ' O ' ' E' ' 133' ' ' PRO . 22.0 m -90.29 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 123.114 1.435 . . . . 71.21 110.292 -175.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.59 66.14 1.95 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.2 -1.364 . . . . 71.55 109.35 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 70.48 159.06 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.14 1.376 . . . . 71.5 111.983 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -155.02 162.47 41.07 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.473 0.309 . . . . 74.41 111.039 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 31.0 t -162.32 158.05 23.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.055 0.942 . . . . 63.13 109.257 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 tt -164.98 -49.6 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.121 -0.696 . . . . 65.22 109.121 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 pt -79.54 -19.86 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 73.31 113.743 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -117.38 106.96 13.78 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.476 -0.935 . . . . 73.5 108.476 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.52 -55.17 2.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.477 0.711 . . . . 65.24 109.337 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -147.74 11.59 0.97 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.136 0.975 . . . . 53.41 110.105 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -124.47 142.95 50.92 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.143 0.977 . . . . 75.43 109.673 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 35.1 tp -170.56 -58.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.773 0.829 . . . . 74.3 109.098 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -144.35 79.81 12.48 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 109.09 -0.707 . . . . 25.01 109.09 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--N 1.382 2.295 0 C-N-CA 122.853 2.368 . . . . 73.05 111.275 174.875 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.501 -0.555 . . . . 44.33 109.501 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 -72.27 0.7 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.076 -1.083 . . . . 64.42 108.076 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.5 109.2 17.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.036 0.935 . . . . 62.13 110.922 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -76.35 -60.08 2.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 75.04 109.629 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -136.34 144.47 44.66 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.295 1.038 . . . . 75.42 110.148 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -116.51 142.38 46.95 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.666 0.786 . . . . 64.31 110.628 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.35 72.42 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.609 1.564 . . . . 61.52 112.591 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.2 -15.01 56.94 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.233 -0.894 . . . . 72.24 110.578 172.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -71.21 109.69 5.85 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.18 0.992 . . . . 73.44 109.999 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.04 -52.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.575 2.184 . . . . 73.24 114.431 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -108.32 122.89 47.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.244 1.018 . . . . 72.13 110.256 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 34.6 p -87.42 137.73 32.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.969 0.908 . . . . 61.41 109.62 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -93.37 131.04 38.91 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.768 0.427 . . . . 74.23 110.813 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.98 86.66 1.12 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.336 0.655 . . . . 72.33 109.285 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.27 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.837 0.855 . . . . 72.43 110.599 172.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.64 131.11 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.769 -0.826 . . . . 73.54 108.769 171.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -113.88 -58.99 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.087 0.555 . . . . 74.43 111.061 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 63.48 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.052 0.941 . . . . 63.41 109.521 -171.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -54.13 -44.64 71.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.661 1.184 . . . . 65.1 112.72 -168.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -160.02 -141.72 3.21 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.289 -0.414 . . . . 64.2 112.898 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 128' ' ' LYS . . . . . 0.581 ' HE2' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -84.18 174.32 10.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.989 0.915 . . . . 73.54 110.976 -173.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.555 HD11 HG11 ' A' ' 40' ' ' VAL . 1.2 pp -134.43 6.18 3.52 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.359 1.063 . . . . 65.51 111.912 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 130' ' ' ILE . . . . . 0.414 HG23 HD12 ' F' ' 129' ' ' LEU . 15.9 pt -120.16 119.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.53 0.732 . . . . 72.03 109.519 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.24 -56.48 3.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.547 0.739 . . . . 41.13 110.107 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -93.59 112.58 57.32 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 108.653 -0.869 . . . . 71.4 108.653 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.27 75.68 4.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.604 2.203 . . . . 73.55 111.882 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.42 92.15 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-O 122.311 1.053 . . . . 63.52 110.382 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.44 24.84 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 114.689 -1.141 . . . . 71.23 108.657 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 p -144.58 133.23 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.413 -0.588 . . . . 75.1 109.413 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.68 -83.21 0.13 Allowed 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.184 0.594 . . . . 75.13 111.413 -167.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -167.63 161.42 13.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.34 1.056 . . . . 35.0 108.755 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.95 92.82 1.67 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.422 0.63 . . . . 64.51 110.69 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 15.6 m -90.57 -15.41 30.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.53 -1.214 . . . . 73.05 110.52 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.57 69.86 10.69 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.693 0.759 . . . . 63.23 110.055 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -138.72 117.4 13.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.999 -1.482 . . . . 73.32 106.999 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 59.95 -156.23 0.35 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.89 0.876 . . . . 62.55 109.165 -165.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -156.65 -66.22 0.1 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.235 0.471 . . . . 72.31 109.833 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.4 85.02 6.8 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.42 -0.955 . . . . 72.33 108.42 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.78 -167.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.711 1.204 . . . . 75.32 111.991 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 34.7 mt -100.16 -176.64 3.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.287 0.635 . . . . 72.3 109.526 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.23 101.49 9.99 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.449 0.7 . . . . 72.24 109.13 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 C--N 1.383 2.356 0 C-N-CA 123.357 2.704 . . . . 75.23 110.835 -179.848 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.577 0.227 . . . . 63.02 110.433 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -151.0 -149.54 0.31 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.693 1.197 . . . . 72.23 108.722 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 73.47 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.658 1.583 . . . . 64.44 112.166 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -148.57 121.73 8.92 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.829 -1.175 . . . . 65.54 107.829 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.26 142.59 55.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.751 0.821 . . . . 64.43 110.331 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -72.02 136.4 46.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.74 0.416 . . . . 72.12 110.156 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -95.25 128.08 41.81 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.519 0.728 . . . . 74.1 109.703 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.12 137.45 41.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.969 0.907 . . . . 73.33 110.353 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.6 mtt -95.54 132.73 40.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.75 0.42 . . . . 61.43 110.789 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.4 m -157.01 129.57 7.53 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.258 1.423 . . . . 64.15 108.342 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -139.91 114.27 9.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.362 -0.977 . . . . 72.22 108.362 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -150.46 136.73 18.69 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.733 0.301 . . . . 74.3 111.262 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.415 1.086 . . . . 72.15 110.67 169.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.14 -44.56 5.41 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 74.23 109.247 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD2' ' HZ ' ' B' ' 32' ' ' PHE . 78.3 mtt180 -158.79 153.32 24.36 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.328 1.051 . . . . 73.42 110.86 172.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.658 HG23 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -123.2 119.62 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.116 -1.809 . . . . 65.41 106.116 173.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 34.9 p90 -160.03 167.77 27.13 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 120.947 0.403 . . . . 74.54 111.674 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -91.31 118.29 30.37 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.861 -0.422 . . . . 73.34 109.861 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.04 -26.39 29.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.733 0.413 . . . . 74.55 111.052 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.43 148.3 21.39 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.221 -0.659 . . . . 73.44 109.221 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.6 mt -145.38 142.6 22.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.233 1.413 . . . . 64.22 107.522 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -148.0 136.73 21.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.401 0.681 . . . . 74.3 109.325 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 79.1 t80 -136.21 143.04 44.15 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.209 -1.404 . . . . 54.22 107.209 171.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.38 147.58 39.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.884 0.873 . . . . 74.14 109.159 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 72.09 11.72 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.613 -1.625 . . . . 52.33 106.613 167.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 -24.44 36.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.228 1.952 . . . . 54.11 111.188 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 58.9 m-20 -113.61 33.51 5.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.519 1.128 . . . . 62.54 109.09 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.98 99.34 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 123.834 0.854 . . . . 72.54 113.04 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.73 -29.31 35.95 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 121.637 1.558 . . . . 74.14 113.006 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.2 m-70 -74.46 -35.77 63.31 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.702 0.401 . . . . 75.43 111.653 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.29 -21.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 121.09 0.471 . . . . 64.53 110.712 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -74.77 -39.66 61.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.498 0.719 . . . . 63.43 110.399 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.22 -26.78 32.97 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.516 0.726 . . . . 64.04 110.771 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.45 173.38 10.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.43 0.692 . . . . 64.41 111.373 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -72.94 138.06 45.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.875 0.87 . . . . 60.14 110.722 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -84.88 69.62 10.78 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.801 0.81 . . . . 74.22 109.57 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -129.23 73.47 81.66 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.039 -0.982 . . . . 70.02 108.711 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.43 158.76 10.96 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.549 2.166 . . . . 44.11 112.173 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.43 127.89 44.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.769 -0.826 . . . . 71.33 108.769 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' F' ' 129' ' ' LEU . 46.0 t -72.03 94.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 123.75 0.656 . . . . 55.44 109.28 176.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -102.86 115.03 29.8 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.702 -1.221 . . . . 73.44 107.702 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.91 148.57 43.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.378 0.671 . . . . 75.34 109.702 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 27.7 m-20 -141.35 149.07 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.979 1.311 . . . . 74.52 108.847 170.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.92 160.93 22.46 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.064 -0.717 . . . . 52.23 109.064 169.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -159.28 144.64 15.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.492 0.717 . . . . 75.1 109.368 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 m -127.33 135.52 50.65 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.086 0.954 . . . . 74.44 108.829 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.83 133.02 45.57 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.157 0.983 . . . . 61.42 109.308 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -92.95 153.28 18.85 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.599 0.759 . . . . 62.02 110.59 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.7 t -160.45 138.91 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 72.54 108.622 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.9 122.17 42.6 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.92 -34.04 13.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.69 0.796 . . . . 61.21 111.976 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -155.87 -177.56 6.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 65.44 109.618 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.64 117.09 7.59 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.722 -0.844 . . . . 74.52 108.722 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 68.05 8.98 6.88 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.433 1.093 . . . . 71.51 112.776 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 38.5 t -112.09 106.38 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.777 -1.194 . . . . 62.43 107.777 174.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -107.78 162.51 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.594 0.711 . . . . 74.21 109.518 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -133.16 125.23 29.02 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.699 1.2 . . . . 73.25 108.35 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -107.49 121.01 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.212 -1.403 . . . . 72.11 107.212 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.4 t -99.53 136.73 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.538 -0.912 . . . . 54.02 108.538 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.08 114.1 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -104.7 128.6 52.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.871 0.868 . . . . 74.55 108.841 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -116.09 129.93 71.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.558 -0.904 . . . . 73.11 108.558 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 14.4 m -110.52 134.7 52.13 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.801 -0.815 . . . . 72.3 108.801 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 114' ' ' ILE . 53.0 t -135.18 106.57 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.437 1.095 . . . . 53.22 108.48 -174.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 45.6 m -104.25 138.31 40.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.413 -0.588 . . . . 75.23 109.413 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.31 112.17 17.8 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.167 -1.42 . . . . 52.34 107.167 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.7 m -130.95 129.37 42.08 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.195 0.598 . . . . 73.53 109.576 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -87.76 85.16 7.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.459 1.123 . . . . 72.1 108.479 177.254 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -86.65 1.28 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 114.23 -1.35 . . . . 64.32 111.237 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -121.74 -26.1 4.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.485 0.714 . . . . 50.01 110.878 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.78 127.51 32.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.956 0.502 . . . . 62.31 109.791 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.2 m -75.0 122.64 23.81 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.715 -0.476 . . . . 63.02 109.715 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.97 -51.66 11.92 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.59 -0.893 . . . . 64.32 108.59 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -166.73 169.58 13.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.479 -1.237 . . . . 63.04 110.239 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 76' ' ' CYS . 31.7 tp -137.13 143.34 42.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.252 1.021 . . . . 74.42 109.079 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.408 ' H ' HD12 ' A' ' 75' ' ' LEU . 21.2 m -135.5 136.69 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.334 1.054 . . . . 74.34 108.605 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.88 125.13 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.303 -0.628 . . . . 63.14 109.303 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.54 130.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 123.825 0.85 . . . . 71.51 109.653 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -103.41 90.92 3.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.375 1.07 . . . . 74.42 108.815 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.46 92.34 5.24 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.052 -1.092 . . . . 71.42 108.052 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.87 144.96 17.99 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.305 -0.718 . . . . 62.31 111.305 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.88 132.73 5.7 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.253 -0.739 . . . . 51.41 111.253 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.1 mt -85.12 128.71 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.435 -0.95 . . . . 75.41 108.435 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -134.98 118.26 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.636 -0.876 . . . . 74.14 108.636 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.4 t -85.29 99.09 10.9 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.621 -0.881 . . . . 75.24 108.621 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.87 141.8 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.818 0.847 . . . . 75.22 109.553 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.03 152.51 0.91 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.877 0.871 . . . . 72.11 110.965 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.33 64.69 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.463 0.477 . . . . 73.41 113.934 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.456 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.2 mp -110.98 147.59 14.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.512 -1.292 . . . . 70.02 107.512 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -142.19 176.07 9.26 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.906 0.882 . . . . 74.44 108.63 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.97 -152.72 52.51 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.238 -0.437 . . . . 70.44 113.172 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 26.0 p -70.74 -15.33 62.68 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.197 0.999 . . . . 74.42 112.617 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -73.55 -42.23 61.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.045 0.538 . . . . 74.3 110.448 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.503 ' HG2' ' HB3' ' F' ' 115' ' ' LEU . 1.3 tpt -76.69 -31.38 57.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.724 -0.473 . . . . 60.04 109.724 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -64.79 -32.59 74.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.697 0.799 . . . . 42.55 111.167 174.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 5.6 t-80 -61.9 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.64 -0.709 . . . . 75.53 110.019 170.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.3 m -73.44 -47.55 40.76 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.592 0.59 . . . . 62.4 112.592 -173.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD22 ' O ' ' F' ' 115' ' ' LEU . 8.4 mp -86.62 -23.69 25.61 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 111.75 0.278 . . . . 74.33 111.75 -174.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.85 5.22 34.48 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.25 -0.75 . . . . 63.51 113.949 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.786 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.52 -60.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.169 0.985 . . . . 64.23 112.21 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -53.03 -60.17 3.62 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.544 1.138 . . . . 73.43 111.052 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 69.7 m -61.4 -51.8 74.96 Favored Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 114.167 1.173 . . . . 71.31 114.167 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.62 -26.64 75.79 Favored 'Trans proline' 0 C--N 1.394 2.954 0 CA-C-N 121.914 1.719 . . . . 70.3 113.609 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.72 -26.2 44.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.957 0.503 . . . . 72.42 110.833 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 101' ' ' TYR . 25.6 mm -67.02 -42.35 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 121.661 0.743 . . . . 62.11 109.681 171.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.658 HD23 HG23 ' A' ' 16' ' ' ILE . 50.3 mt -79.86 -29.36 40.03 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.562 -1.199 . . . . 75.12 112.484 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.3 -42.63 81.72 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.514 1.302 . . . . 60.51 114.514 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.21 -35.48 95.48 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.296 1.997 . . . . 65.34 113.429 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -85.23 -29.57 24.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.607 0.763 . . . . 63.31 111.222 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.87 76.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.999 0.52 . . . . 73.45 109.779 173.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -58.41 -48.51 80.44 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.546 1.154 . . . . 74.43 109.968 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.73 -44.85 96.11 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.014 0.821 . . . . 72.14 111.062 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.48 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.0 t -62.87 -41.21 99.3 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.909 0.756 . . . . 74.42 111.491 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 79.2 mt -66.28 -57.24 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.453 0.701 . . . . 62.33 110.534 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.472 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.4 m -53.45 -39.57 64.54 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.904 1.282 . . . . 72.24 111.778 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.24 -42.38 79.79 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.181 -0.918 . . . . 63.04 110.444 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 63.8 mtm -61.06 -37.73 83.68 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.731 0.412 . . . . 55.35 111.307 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 80.9 t -59.66 -49.21 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.05 0.94 . . . . 72.03 110.458 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 83.5 p -71.59 -29.48 64.75 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.597 -0.728 . . . . 61.12 111.482 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -71.81 -29.89 64.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.588 0.755 . . . . 75.13 110.061 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.68 55.69 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.53 -0.759 . . . . 64.52 112.855 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.408 HG23 ' HB2' ' D' ' 125' ' ' GLN . 30.4 m 69.24 35.5 2.65 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-O 123.058 1.409 . . . . 62.31 109.63 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -115.33 149.94 43.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 114.818 -1.083 . . . . 73.42 109.34 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.85 151.96 73.61 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.561 2.174 . . . . 74.1 111.055 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.472 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.3 tt0 -58.78 133.73 56.22 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.639 0.607 . . . . 73.41 112.639 -175.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.05 95.2 4.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.101 -1.074 . . . . 61.35 108.101 168.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -98.94 126.66 44.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.339 -0.985 . . . . 73.4 108.339 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.7 mm? -74.0 150.26 40.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.625 -0.716 . . . . 74.41 110.736 -175.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.57 143.62 98.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.308 0.643 . . . . 63.24 110.881 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.96 109.58 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.475 2.117 . . . . 72.25 111.371 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.53 111.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.308 -1.738 . . . . 63.23 106.308 174.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -84.03 70.55 10.5 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.317 -1.364 . . . . 72.33 107.317 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -69.05 -28.76 66.83 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.699 -1.591 . . . . 63.21 111.374 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.786 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.4 p-10 -59.95 -47.69 84.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.858 -1.065 . . . . 72.24 111.264 172.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.33 65.76 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.943 0.497 . . . . 75.33 111.714 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.6 -38.16 83.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.204 0.602 . . . . 73.04 111.65 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -87.87 -43.54 11.74 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.294 0.638 . . . . 73.4 111.14 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -33.22 73.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.558 0.743 . . . . 41.44 111.995 -168.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -65.11 -31.93 73.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.233 0.54 . . . . 75.11 110.208 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -75.84 -35.34 59.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.33 -0.85 . . . . 73.42 110.56 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 43.0 tp -67.38 -51.6 50.07 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 112.483 0.549 . . . . 74.12 112.483 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -153.28 7.59 0.39 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 111.531 0.197 . . . . 74.33 111.531 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 61.45 -154.43 0.36 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.362 0.665 . . . . 71.53 111.656 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -75.31 79.4 2.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.798 0.839 . . . . 74.52 109.528 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.8 22.09 0.39 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.008 0.523 . . . . 30.44 111.651 -172.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.67 142.55 38.7 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 111.946 -0.461 . . . . 53.14 111.946 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -123.31 -73.19 0.65 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.456 0.628 . . . . 65.04 110.922 -171.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.58 ' HA2' ' HB2' ' C' ' 142' ' ' GLN . . . 100.71 169.93 28.83 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.645 -0.252 . . . . 71.4 112.754 -175.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -156.87 144.04 18.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 74.32 109.969 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.4 93.48 2.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.939 0.876 . . . . 75.34 108.835 167.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -79.04 -12.35 60.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.803 -1.544 . . . . 62.43 109.866 169.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.6 t60 80.93 -27.62 0.14 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.926 1.69 . . . . 71.54 112.487 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -59.24 144.52 45.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.634 0.773 . . . . 65.02 110.732 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.0 -37.37 64.44 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.741 0.416 . . . . 75.34 110.635 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 124.03 0.932 . . . . 74.12 109.063 -179.819 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.143 0.497 . . . . 71.41 110.245 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -169.5 157.18 7.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.561 1.144 . . . . 54.13 109.614 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.26 129.86 15.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.711 0.404 . . . . 71.51 111.499 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -169.48 139.46 2.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.882 1.273 . . . . 75.21 109.343 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -134.47 -18.48 1.95 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.7 0.8 . . . . 71.55 111.15 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -76.86 78.46 3.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.968 0.907 . . . . 74.54 109.805 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 25.7 p 70.86 -51.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.544 2.337 . . . . 63.32 114.743 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.85 -13.67 61.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.569 1.148 . . . . 74.11 113.068 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.514 ' SD ' HD12 ' B' ' 89' ' ' ILE . 18.8 ptm 53.21 -172.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.057 1.743 . . . . 72.04 113.29 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 98.0 m -140.13 127.72 21.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.706 0.802 . . . . 75.12 109.576 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.03 130.28 37.31 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -150.97 138.94 19.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.334 0.654 . . . . 72.11 109.237 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.596 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -90.17 128.68 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.451 -0.944 . . . . 74.32 108.451 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.468 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 10.4 mm100 -94.09 -49.87 5.56 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.314 -0.624 . . . . 74.24 109.314 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -164.05 146.07 9.04 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.678 -0.692 . . . . 75.02 109.17 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.15 145.78 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.047 -1.464 . . . . 61.22 107.047 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -169.71 146.28 3.23 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.452 0.569 . . . . 72.42 112.362 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -73.54 116.12 13.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.036 -0.984 . . . . 61.33 108.374 168.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -86.81 -34.16 19.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.672 -0.695 . . . . 63.44 110.691 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.48 142.09 18.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.645 -0.252 . . . . 61.33 110.56 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -132.49 144.35 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.752 1.221 . . . . 61.43 109.081 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.0 t -141.88 131.91 24.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 75.21 107.591 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.631 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -144.64 122.31 11.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.158 -1.423 . . . . 70.52 107.158 169.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 48.2 mt-10 -124.64 134.72 52.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.556 0.743 . . . . 73.44 109.174 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.939 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -132.2 80.75 63.15 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.497 -0.927 . . . . 52.04 108.497 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.69 -31.88 19.97 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.983 2.455 . . . . 70.13 111.71 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -117.99 28.53 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.133 0.973 . . . . 71.41 109.887 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.939 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -49.46 -50.41 65.73 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.013 1.325 . . . . 62.22 113.82 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.6 Cg_exo -79.05 -12.31 14.56 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.123 1.882 . . . . 54.31 112.83 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -98.49 -6.83 29.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.075 0.95 . . . . 74.23 111.681 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.405 HG11 ' HE1' ' B' ' 123' ' ' PHE . 6.9 p -68.59 -15.7 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.191 0.596 . . . . 74.02 111.26 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.463 ' HZ ' ' HD2' ' A' ' 15' ' ' ARG . 75.8 m-85 -76.18 -7.78 55.58 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.724 0.81 . . . . 61.51 111.781 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -82.33 -32.3 29.45 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.689 0.757 . . . . 42.14 109.095 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -106.73 90.83 3.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.527 -1.215 . . . . 75.53 110.556 -162.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.56 84.97 2.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.943 0.402 . . . . 73.23 110.427 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -153.45 -179.45 7.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.477 1.511 . . . . 70.12 108.052 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -78.82 118.63 73.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.142 -1.058 . . . . 73.33 108.142 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.72 149.92 67.78 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.477 2.118 . . . . 65.32 110.994 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.42 104.21 3.71 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.587 -0.894 . . . . 71.04 108.587 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.449 HG11 HD21 ' B' ' 126' ' ' LEU . 39.4 t -95.72 137.06 24.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.485 -0.78 . . . . 72.02 110.189 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -130.04 119.29 22.89 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.266 1.026 . . . . 73.4 108.405 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.73 HD12 HG22 ' B' ' 64' ' ' VAL . 1.6 mm? -104.44 134.96 46.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.942 -0.762 . . . . 51.32 108.942 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -137.45 153.32 50.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.074 0.95 . . . . 54.42 109.573 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.15 150.07 42.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.987 0.915 . . . . 74.32 109.727 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.1 t70 -136.7 141.75 43.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.103 0.961 . . . . 71.14 108.624 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.2 p -113.41 104.34 12.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.44 0.696 . . . . 72.44 109.445 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.66 156.63 33.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.038 0.935 . . . . 71.24 109.014 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -145.11 173.78 11.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 75.05 110.462 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -156.61 133.96 10.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.985 0.914 . . . . 73.3 109.016 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -81.38 120.75 25.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.964 0.506 . . . . 44.15 110.835 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -88.08 -37.87 15.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.425 0.69 . . . . 73.25 110.114 174.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.5 -176.11 5.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.873 0.869 . . . . 74.12 110.618 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.73 116.19 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.696 -1.138 . . . . 61.54 109.527 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' B' ' 85' ' ' SER . 20.3 m-20 72.18 -5.1 1.83 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.493 1.517 . . . . 51.21 112.872 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -105.19 96.41 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.523 -0.917 . . . . 75.02 108.523 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -112.34 138.44 49.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.815 -0.629 . . . . 74.51 109.313 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.401 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.5 tm-20 -101.95 97.57 7.9 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 125.192 1.397 . . . . 72.03 107.518 -178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -90.9 121.02 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.91 0.884 . . . . 74.23 110.198 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -102.97 120.82 53.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.544 0.738 . . . . 72.41 110.315 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.2 121.54 34.68 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.908 -1.516 . . . . 63.4 106.908 170.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 61.6 ttt180 -110.5 108.93 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.275 -0.639 . . . . 71.24 109.275 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.63 121.14 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.304 -0.999 . . . . 70.24 108.304 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.1 m -116.29 130.64 56.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.097 0.475 . . . . 75.35 109.896 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.767 HG21 HG21 ' B' ' 114' ' ' ILE . 51.8 t -111.37 135.46 50.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.912 1.285 . . . . 72.12 110.132 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 30.9 m -124.76 144.58 50.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.604 -0.887 . . . . 55.21 108.604 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 125.31 11.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.387 -0.968 . . . . 51.44 108.387 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.4 m -138.62 134.5 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.084 -0.71 . . . . 63.35 109.084 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 22.4 tp -133.57 122.94 24.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.779 -0.823 . . . . 71.23 108.779 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.99 -131.39 13.82 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.594 0.559 . . . . 71.32 112.573 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -93.78 1.41 56.49 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 75.15 111.147 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.73 155.83 48.15 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.101 0.56 . . . . 61.35 110.984 -167.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 130.53 39.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.685 -0.689 . . . . 73.24 109.665 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.02 -56.19 4.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.576 0.751 . . . . 65.3 109.208 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.68 161.47 23.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.772 -1.104 . . . . 55.12 109.739 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 95.4 mt -132.53 146.96 52.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.886 1.275 . . . . 53.12 108.22 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.0 t -150.15 157.15 42.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.195 -0.668 . . . . 70.24 109.195 175.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.4 tt0 -165.43 131.48 2.67 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.408 -0.96 . . . . 73.41 108.408 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.1 t -125.02 144.0 36.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.897 0.879 . . . . 63.55 108.693 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.504 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 70.4 mt-30 -122.84 89.87 3.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.711 -0.848 . . . . 73.14 108.711 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -81.68 100.01 9.23 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.14 -0.937 . . . . 61.13 108.502 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.61 169.97 37.93 Favored Glycine 0 C--O 1.244 0.78 0 N-CA-C 111.062 -0.815 . . . . 74.14 111.062 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.11 127.36 1.43 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.086 -0.806 . . . . 64.23 111.086 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 21.3 mt -84.98 129.52 37.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.623 -1.251 . . . . 71.35 107.623 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -132.25 162.51 30.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.474 1.11 . . . . 64.53 108.572 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 73.7 m -129.11 108.17 10.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.616 0.767 . . . . 54.13 109.042 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.481 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -119.02 127.28 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.175 1.39 . . . . 71.44 108.782 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -140.6 145.53 36.81 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.628 0.771 . . . . 54.34 110.118 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -29.81 3.86 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.66 0.6 . . . . 52.13 114.237 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.514 HD12 ' SD ' ' B' ' 9' ' ' MET . 19.4 tt -78.4 139.51 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.683 0.793 . . . . 51.35 110.718 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.31 165.87 35.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.753 0.821 . . . . 74.33 111.608 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' E' ' 112' ' ' GLN . . . 69.29 -131.61 24.88 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.285 -0.871 . . . . 54.14 114.104 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -66.08 -36.66 83.78 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.385 1.074 . . . . 65.52 110.731 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.46 -34.64 72.65 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.45 -1.25 . . . . 73.11 110.096 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.465 ' HG3' HD23 ' E' ' 115' ' ' LEU . 56.9 ttp -52.95 -53.05 55.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.646 1.178 . . . . 65.22 110.732 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.34 72.51 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.279 -0.873 . . . . 52.24 111.924 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 20.4 t60 -71.03 -25.15 62.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.963 0.905 . . . . 61.21 110.969 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.13 -69.08 0.71 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.467 0.307 . . . . 22.42 111.464 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.8 pp -73.45 -22.86 60.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.542 0.571 . . . . 61.24 112.542 -170.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.87 -25.58 24.52 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.462 0.476 . . . . 64.23 112.508 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -122.91 -54.95 1.81 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.383 0.512 . . . . 63.21 112.383 -170.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -72.61 -48.66 37.82 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.554 0.576 . . . . 74.32 112.554 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.48 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.9 m -59.69 -48.09 96.07 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 118.608 -0.71 . . . . 74.3 111.482 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 75.2 Cg_exo -57.11 -34.87 98.55 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.426 2.084 . . . . 63.32 114.117 169.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -63.14 -34.17 77.05 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 122.95 0.5 . . . . 74.23 111.054 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.37 -47.44 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.889 0.876 . . . . 73.12 110.401 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.408 ' HB2' HD12 ' B' ' 60' ' ' LEU . 83.3 mt -80.75 -19.6 44.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.954 -1.021 . . . . 74.52 112.742 -169.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -63.23 -46.85 85.75 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.41 -1.281 . . . . 62.54 113.63 -171.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.31 -37.0 97.63 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.055 1.837 . . . . 42.5 113.688 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -67.78 -48.92 64.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.101 0.56 . . . . 74.31 110.38 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.88 86.75 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.25 -0.886 . . . . 74.34 111.04 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.621 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.8 ttt180 -57.75 -57.83 11.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.679 1.591 . . . . 61.44 110.679 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.15 -31.09 71.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.07 -0.968 . . . . 72.1 110.538 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.42 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.2 t -70.9 -38.6 73.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.989 0.516 . . . . 63.51 111.361 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.767 HG21 HG21 ' B' ' 64' ' ' VAL . 77.3 mt -64.4 -50.13 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.267 0.627 . . . . 72.22 109.907 175.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.447 HG21 ' OG ' ' C' ' 119' ' ' SER . 20.6 m -58.16 -36.44 73.01 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.489 -1.232 . . . . 72.21 110.956 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.2 t -64.84 -45.37 86.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.357 -1.292 . . . . 64.44 110.719 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 38.0 mmt -59.44 -45.22 92.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.106 0.562 . . . . 64.55 111.711 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.642 0.777 . . . . 73.22 111.54 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.3 p -70.34 -28.4 65.11 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.725 -0.67 . . . . 65.25 112.086 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 86.6 mtt-85 -67.07 -30.44 70.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.352 0.661 . . . . 72.41 111.232 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 13.26 39.64 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-O 119.613 -0.549 . . . . 73.52 112.94 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.6 p 54.81 23.65 5.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.441 1.896 . . . . 63.13 113.009 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.405 ' HE1' HG11 ' B' ' 31' ' ' VAL . 37.9 m-85 -89.97 156.92 46.53 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.76 0.824 . . . . 75.11 109.337 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.8 121.47 10.08 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 74.03 110.712 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.548 ' H ' ' HB2' ' C' ' 125' ' ' GLN . 4.9 pp0? -58.94 152.38 19.71 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.912 0.757 . . . . 65.21 112.284 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.449 HD21 HG11 ' B' ' 40' ' ' VAL . 1.4 tm? -111.32 105.5 14.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.766 -1.198 . . . . 74.51 107.766 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -90.85 112.59 24.49 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.963 -1.125 . . . . 73.33 107.963 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.621 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.13 117.98 10.68 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.676 -0.861 . . . . 74.25 108.676 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.65 87.64 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.636 0.585 . . . . 72.01 110.654 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.422 ' HG2' HD13 ' D' ' 13' ' ' ILE . 37.4 Cg_endo -63.29 86.36 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.682 2.255 . . . . 73.34 112.571 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 80.7 t -91.13 110.79 22.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.585 -0.895 . . . . 74.13 108.585 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -88.61 109.79 20.39 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.86 -33.46 75.75 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.505 1.122 . . . . 73.42 109.826 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.446 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -59.93 -44.5 94.29 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.031 -1.441 . . . . 72.13 110.918 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.16 67.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.587 0.755 . . . . 64.11 111.557 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.35 -49.98 69.55 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.807 0.443 . . . . 75.3 110.393 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -69.95 -31.64 69.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.026 -0.534 . . . . 75.11 111.197 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 48.3 ttm -62.46 -37.16 84.86 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.732 0.813 . . . . 71.33 110.61 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -77.97 -21.02 51.59 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.741 -1.118 . . . . 71.42 110.747 -175.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -76.1 -24.14 54.97 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.392 0.677 . . . . 71.44 110.535 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.37 16.51 6.29 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.656 0.783 . . . . 72.31 110.022 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.592 ' HG2' ' HG2' ' B' ' 143' ' ' GLN . 29.6 tt0 67.54 -84.69 0.03 OUTLIER 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.647 1.579 . . . . 65.21 110.219 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLN . . . . . 0.592 ' HG2' ' HG2' ' B' ' 142' ' ' GLN . 28.8 pt20 -171.81 15.65 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.32 1.048 . . . . 73.34 110.376 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -75.53 129.07 36.64 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.429 0.692 . . . . 71.23 110.064 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.44 99.58 11.75 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.241 0.616 . . . . 74.41 110.391 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.26 38.0 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.364 0.415 . . . . 42.24 113.331 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -79.0 155.33 28.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.933 0.893 . . . . 74.42 111.113 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -114.16 150.53 18.6 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.827 -0.624 . . . . 62.42 111.553 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.8 m -79.39 136.37 36.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.777 -0.823 . . . . 73.25 108.777 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.15 137.73 40.26 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.845 0.458 . . . . 75.43 110.195 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.405 ' OE2' ' HG3' ' B' ' 153' ' ' GLN . 1.0 OUTLIER -62.19 125.07 22.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.7 0.8 . . . . 64.22 109.311 177.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -143.97 100.83 3.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.918 0.487 . . . . 54.35 109.737 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.405 ' HG3' ' OE2' ' B' ' 151' ' ' GLU . 95.5 mt-30 -64.14 150.91 44.63 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.222 0.609 . . . . 73.2 110.54 173.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.97 126.18 50.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.062 -0.718 . . . . 73.35 109.062 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.543 0.737 . . . . 44.33 110.309 179.356 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.827 0.346 . . . . 73.03 110.378 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -134.53 -59.06 0.82 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.421 0.688 . . . . 74.44 109.804 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.58 66.94 1.09 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.19 0.996 . . . . 75.23 111.005 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -68.7 -24.74 64.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.122 -1.399 . . . . 62.42 110.686 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -90.45 172.97 8.35 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.095 0.958 . . . . 72.3 109.699 173.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -79.6 98.74 7.02 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.855 -0.612 . . . . 54.11 109.717 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.185 0.993 . . . . 73.34 109.465 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -110.92 -80.97 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.516 -0.766 . . . . 75.22 109.457 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.1 ttt 64.17 133.89 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.326 1.45 . . . . 62.41 113.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -87.43 103.9 15.95 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 169.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -124.88 141.09 52.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.944 0.897 . . . . 64.32 109.162 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -160.76 123.34 3.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.179 0.592 . . . . 74.23 109.729 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -76.14 140.62 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.755 -0.832 . . . . 65.52 108.755 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.661 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.2 mm100 -111.45 -49.71 2.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.679 0.792 . . . . 75.32 110.219 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -164.01 123.35 1.99 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.791 0.436 . . . . 74.21 110.04 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.9 mt -106.46 148.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.056 -1.09 . . . . 64.34 108.056 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.596 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 38.0 p90 -173.98 168.64 4.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.365 0.666 . . . . 73.35 110.325 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.0 p -86.62 117.7 25.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.156 0.582 . . . . 74.51 109.635 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.596 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 24.4 mmmt -66.86 -46.79 73.94 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.819 -0.808 . . . . 71.33 108.819 172.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.23 150.99 34.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.275 -1.329 . . . . 71.42 109.388 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.6 mt -142.46 142.47 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.791 1.636 . . . . 54.11 106.892 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -154.19 149.55 27.16 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.798 0.839 . . . . 62.02 109.183 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 80.4 t80 -152.16 128.38 10.51 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.467 -1.309 . . . . 75.21 107.467 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.59 130.75 36.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 63.24 108.45 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 82.67 15.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.841 -0.8 . . . . 64.35 108.841 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -67.37 -30.95 35.9 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.134 2.556 . . . . 71.55 112.366 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.79 34.01 3.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.831 0.852 . . . . 74.02 110.172 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -59.65 -56.81 31.98 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.058 -0.972 . . . . 75.25 112.534 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 14.9 Cg_exo -68.45 -27.5 33.49 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.838 1.692 . . . . 73.0 111.827 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.93 -23.33 65.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.755 1.222 . . . . 74.44 112.539 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.723 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 5.5 p -59.07 -20.99 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.481 0.712 . . . . 64.44 112.39 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.26 -41.44 99.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.349 1.06 . . . . 73.22 111.341 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -109.82 44.97 1.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.069 0.937 . . . . 64.52 109.511 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 22.3 ttpt -125.17 140.98 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.655 0.782 . . . . 75.34 110.794 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.44 132.85 39.89 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.105 0.962 . . . . 74.42 109.592 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -84.78 71.5 10.84 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.946 0.899 . . . . 73.51 111.317 -172.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -143.32 69.67 17.77 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.961 -1.018 . . . . 74.45 108.411 168.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.98 140.08 2.72 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.402 2.068 . . . . 64.23 111.121 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.92 111.39 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 107.495 -1.298 . . . . 74.43 107.495 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -75.85 98.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.272 -1.011 . . . . 64.31 108.272 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 59.9 tttm -98.22 105.26 17.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.47 1.108 . . . . 74.33 108.959 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.509 HD12 HG22 ' C' ' 64' ' ' VAL . 2.2 mm? -87.73 156.8 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.989 0.515 . . . . 72.23 110.021 -177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -144.8 105.82 4.18 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.476 0.711 . . . . 60.12 109.728 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.31 126.47 50.48 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.857 -0.794 . . . . 60.13 108.857 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.1 t70 -135.09 151.65 50.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.869 0.867 . . . . 73.45 109.019 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 3.1 m -133.48 127.48 33.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.127 0.571 . . . . 65.45 111.112 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.14 164.2 19.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.893 1.277 . . . . 62.44 108.483 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -154.43 145.44 22.68 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.959 0.345 . . . . 74.33 110.982 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -145.76 129.54 17.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.642 1.177 . . . . 73.31 109.378 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.66 119.95 21.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.253 -0.647 . . . . 75.54 109.253 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.476 HD11 HD12 ' C' ' 83' ' ' ILE . 84.2 mt -87.69 -38.38 15.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.348 0.659 . . . . 74.3 111.097 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -159.06 -172.93 3.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.437 -0.802 . . . . 72.01 110.518 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.2 105.13 0.84 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.796 1.239 . . . . 73.3 110.08 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 69.0 6.73 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.352 1.461 . . . . 70.34 113.019 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 91.9 t -103.07 118.16 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.947 -0.76 . . . . 71.11 108.947 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.1 158.42 32.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.871 0.868 . . . . 71.13 109.353 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -126.16 137.79 53.61 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.622 -1.621 . . . . 75.22 106.622 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.31 133.08 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 109.908 -0.405 . . . . 74.23 109.908 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 46' ' ' THR . 46.3 t -110.93 107.23 22.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.498 1.119 . . . . 73.04 108.918 -174.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.23 101.35 13.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.546 -1.279 . . . . 72.24 107.546 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.6 ttt180 -79.38 129.57 34.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.489 1.116 . . . . 64.51 109.121 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.39 105.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.857 -1.164 . . . . 74.33 107.857 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.5 m -103.08 113.85 27.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.534 -0.913 . . . . 72.33 108.534 170.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.509 HG22 HD12 ' C' ' 42' ' ' LEU . 79.6 t -101.34 108.42 23.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.175 -1.046 . . . . 75.34 108.175 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.506 HG23 HD23 ' C' ' 75' ' ' LEU . 4.0 m -99.06 140.35 33.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.323 -0.991 . . . . 72.15 108.323 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.41 95.34 4.23 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.712 -1.588 . . . . 52.41 106.712 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -147.02 132.46 18.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.533 0.333 . . . . 74.1 111.145 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 65.8 tp -67.79 -30.61 70.08 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.629 0.772 . . . . 72.4 109.952 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.67 -87.55 0.09 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.266 -1.134 . . . . 52.3 110.266 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -89.11 -25.01 22.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.636 0.774 . . . . 71.44 109.091 171.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -90.5 96.02 10.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.253 1.021 . . . . 60.04 109.266 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -89.31 133.36 34.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 70.01 110.784 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.449 ' HA ' ' NZ ' ' C' ' 34' ' ' LYS . . . -75.03 -59.51 2.7 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.145 0.978 . . . . 63.33 109.845 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.03 170.75 21.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.774 -1.103 . . . . 73.54 111.01 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.506 HD23 HG23 ' C' ' 65' ' ' THR . 2.9 tm? -136.03 140.88 44.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.127 -1.805 . . . . 75.51 106.127 173.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.22 150.85 34.47 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.522 -0.918 . . . . 63.32 108.522 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.58 131.2 9.76 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.687 -0.486 . . . . 71.42 109.687 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.76 115.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.27 -1.011 . . . . 45.3 108.27 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 75.7 mt-30 -88.15 91.27 8.71 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.506 -1.294 . . . . 71.23 107.506 174.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -82.39 115.14 21.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.672 -0.694 . . . . 73.32 109.41 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.66 179.57 23.51 Favored Glycine 0 C--O 1.244 0.723 0 O-C-N 123.452 0.47 . . . . 44.33 112.836 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.91 154.65 16.54 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.245 -0.477 . . . . 51.22 112.022 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.8 mm -102.4 123.5 55.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.684 -1.228 . . . . 74.32 107.684 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -136.37 120.23 17.45 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.979 -0.748 . . . . 64.41 108.979 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.4 p -78.32 118.3 20.39 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.819 -0.808 . . . . 65.3 108.819 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.24 107.04 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 107.284 -1.376 . . . . 73.35 107.284 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.64 169.75 17.4 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.165 0.507 . . . . 70.35 111.735 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.21 -58.42 2.75 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 115.145 -0.934 . . . . 75.51 112.576 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.18 -177.55 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.685 0.794 . . . . 62.43 112.211 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.12 -173.89 4.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.708 0.803 . . . . 75.13 110.884 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.11 -141.51 39.66 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 116.086 -0.506 . . . . 73.15 113.748 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 34.8 p -68.08 -18.47 64.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.013 0.925 . . . . 71.34 111.637 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -68.9 -40.63 79.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.484 0.714 . . . . 74.23 110.522 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.74 -34.0 24.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.329 0.251 . . . . 43.14 110.755 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -70.45 -25.74 63.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.871 0.868 . . . . 52.22 111.764 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -57.54 -51.62 68.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.785 0.834 . . . . 73.02 110.324 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.48 -52.75 12.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.995 -0.548 . . . . 72.15 110.533 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.78 -25.91 67.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.438 0.695 . . . . 54.55 112.064 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.46 -29.06 8.55 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.055 -0.52 . . . . 43.0 113.847 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -117.07 -60.03 1.89 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.682 0.741 . . . . 60.4 111.202 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.01 -56.06 15.31 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.09 0.556 . . . . 64.22 112.235 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 59.5 m -56.9 -50.68 86.7 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.188 -0.911 . . . . 62.14 112.727 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 45.4 Cg_exo -61.16 -31.09 89.85 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.194 1.929 . . . . 73.54 113.286 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -72.82 -28.93 62.85 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.772 0.829 . . . . 72.4 110.374 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.85 -39.97 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.399 1.08 . . . . 75.4 109.85 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' C' ' 102' ' ' CYS . 68.9 mt -82.59 -16.31 48.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.336 -0.847 . . . . 72.21 111.397 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.64 -55.29 44.6 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.059 -0.972 . . . . 74.11 113.141 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.43 -37.85 46.41 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.085 1.857 . . . . 41.4 113.207 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -63.33 -45.86 89.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.322 0.649 . . . . 64.12 111.25 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.45 96.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.62 -0.718 . . . . 54.5 110.831 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 6.2 ttp-105 -60.51 -43.13 97.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 75.33 110.583 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.77 -34.89 67.27 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.922 0.764 . . . . 63.44 110.387 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.456 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 34.0 t -68.53 -30.33 69.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.787 0.435 . . . . 75.53 111.339 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 118' ' ' VAL . 92.5 mt -77.81 -43.97 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.833 -0.622 . . . . 54.44 110.094 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 54.3 m -55.93 -36.83 68.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.603 0.761 . . . . 72.13 110.427 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.7 t -61.06 -53.75 53.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.228 -1.351 . . . . 63.32 109.535 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -38.02 80.65 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.847 1.259 . . . . 53.42 113.28 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.4 t -63.98 -49.27 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.705 0.802 . . . . 72.33 109.349 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.447 ' OG ' HG21 ' B' ' 115' ' ' THR . 33.7 t -68.74 -26.49 65.27 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.167 -0.924 . . . . 74.41 111.747 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.6 mtt-85 -68.83 -39.25 80.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.279 0.632 . . . . 73.12 109.482 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 10.35 60.51 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.626 0.579 . . . . 73.11 112.747 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p 56.38 40.68 29.65 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.055 1.742 . . . . 74.41 112.503 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.16 156.82 34.84 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.583 -1.189 . . . . 74.15 108.281 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.584 ' HD3' HG22 ' E' ' 136' ' ' VAL . 38.5 Cg_endo -65.28 171.47 9.11 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.084 2.523 . . . . 72.43 113.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.548 ' HB2' ' H ' ' B' ' 125' ' ' GLN . 51.3 tp60 -60.23 132.07 52.76 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.318 -0.856 . . . . 64.23 113.083 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.92 85.9 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.477 -1.305 . . . . 71.02 107.477 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -95.71 105.89 17.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.851 -1.166 . . . . 71.43 107.851 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' C' ' 128' ' ' LEU . 1.1 tm? -74.2 137.0 42.8 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 106.775 -1.565 . . . . 61.33 106.775 170.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -53.65 131.87 55.56 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 124.342 1.026 . . . . 72.13 111.506 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.428 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.4 Cg_exo -68.09 89.22 0.38 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.512 2.141 . . . . 71.4 111.168 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.646 ' HA ' HD11 ' E' ' 148' ' ' LEU . 94.0 t -97.92 109.67 24.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.464 -0.789 . . . . 62.35 109.31 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.499 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 1.8 m-20 -104.77 83.0 1.95 Allowed 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.261 -1.015 . . . . 74.34 108.261 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.78 -44.58 69.84 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.107 -0.951 . . . . 75.41 111.267 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.47 -38.26 90.41 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.268 0.627 . . . . 73.14 110.946 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -73.51 -20.69 60.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.243 -0.889 . . . . 51.15 111.605 178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -70.29 -36.91 74.67 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 73.43 109.466 172.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -62.35 -39.89 94.6 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.773 0.829 . . . . 73.12 110.121 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 64.2 mtt -76.5 -28.98 56.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.034 0.933 . . . . 72.25 111.649 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.48 -43.46 98.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.794 1.237 . . . . 62.52 111.749 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -63.8 -88.03 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.136 0.897 . . . . 64.34 109.478 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 25.8 tp 31.94 68.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.875 1.67 . . . . 75.43 113.007 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.58 ' HB2' ' HA2' ' A' ' 148' ' ' GLY . 30.2 mm-40 -70.52 99.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.527 -0.76 . . . . 64.2 109.908 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -98.93 135.82 39.81 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.43 -1.259 . . . . 75.02 108.693 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -91.32 -171.84 3.08 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.217 0.607 . . . . 65.11 110.445 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 69.01 -176.82 0.21 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.469 1.108 . . . . 74.32 111.668 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.56 54.01 5.22 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.105 -0.498 . . . . 74.32 111.958 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.95 83.01 1.71 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.842 0.857 . . . . 62.34 109.021 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.3 -162.98 33.92 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.839 -0.619 . . . . 73.42 111.989 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.2 t -164.29 18.71 0.06 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.553 0.741 . . . . 72.42 110.783 -177.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.65 133.74 55.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.668 0.787 . . . . 72.42 111.46 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.6 163.36 12.73 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.549 1.139 . . . . 64.44 109.258 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -75.73 91.34 2.91 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.554 -0.906 . . . . 65.3 108.554 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -85.66 85.07 7.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.675 0.75 . . . . 63.12 109.02 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -86.04 146.61 26.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.804 -1.089 . . . . 63.33 109.597 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.423 0.689 . . . . 73.25 110.709 -178.066 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 110.387 -0.227 . . . . 54.51 110.387 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.1 t -108.12 164.84 11.95 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.595 0.758 . . . . 52.34 110.333 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.2 159.89 28.29 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.38 -0.373 . . . . 45.24 110.589 170.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.33 163.88 31.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.797 0.839 . . . . 71.02 110.593 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -172.16 156.27 3.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 73.2 109.735 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -153.86 152.26 30.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.815 0.846 . . . . 50.53 108.955 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.509 HG23 ' HG2' ' D' ' 8' ' ' GLU . 5.7 t -62.47 -33.03 74.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.363 0.665 . . . . 75.04 111.248 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.509 ' HG2' HG23 ' D' ' 7' ' ' THR . 34.7 mm-40 -105.37 166.26 10.55 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.008 0.923 . . . . 74.12 110.026 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.495 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.5 ptm -33.85 157.42 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 125.641 1.576 . . . . 74.41 114.648 165.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.2 m -144.0 140.25 29.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.279 1.032 . . . . 55.32 108.265 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' D' ' 85' ' ' SER . 78.5 t80 -155.57 113.64 3.4 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -134.81 131.05 37.0 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.421 0.688 . . . . 74.24 109.643 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' B' ' 130' ' ' PRO . 2.7 pp -78.94 141.18 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.481 -0.933 . . . . 71.02 108.481 172.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -111.5 -46.03 3.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.682 0.393 . . . . 62.13 110.673 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.22 122.84 1.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.148 -0.315 . . . . 72.4 110.148 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.6 126.69 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 106.523 -1.658 . . . . 55.53 106.523 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -168.1 178.03 5.26 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.811 0.695 . . . . 73.01 111.538 -165.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.6 p -108.21 133.48 52.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.005 -0.998 . . . . 65.03 109.59 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.43 -32.92 9.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.428 -0.582 . . . . 73.11 109.428 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -144.21 138.61 28.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.867 -1.061 . . . . 64.34 108.898 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.15 149.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 44.23 108.199 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -152.74 145.39 24.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.249 0.62 . . . . 64.43 110.35 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.564 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.3 t80 -147.58 124.8 11.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.689 -1.597 . . . . 74.44 106.689 168.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.0 mp0 -120.16 142.04 49.32 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.692 -0.855 . . . . 63.23 108.692 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.28 73.75 10.88 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.355 -0.979 . . . . 71.01 108.355 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.38 -18.57 17.82 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.446 2.097 . . . . 73.14 111.553 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.505 ' O ' HG23 ' D' ' 31' ' ' VAL . 10.4 m120 -114.23 23.88 12.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.136 0.974 . . . . 73.14 109.617 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -48.0 -53.8 29.61 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.885 1.439 . . . . 74.32 114.885 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.533 ' HB3' HD11 ' C' ' 83' ' ' ILE . 28.6 Cg_endo -84.48 -4.32 10.09 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.482 1.454 . . . . 42.15 112.892 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -80.62 -36.95 31.95 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.848 1.259 . . . . 73.54 109.522 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 27' ' ' ASN . 59.3 t -72.77 -25.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.332 0.653 . . . . 74.11 110.663 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.29 -28.99 57.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.07 0.948 . . . . 73.13 112.083 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -76.41 -15.32 59.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.324 0.65 . . . . 71.34 112.408 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -125.61 111.92 15.56 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.439 0.696 . . . . 65.04 110.641 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.25 87.33 7.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.975 0.91 . . . . 72.53 109.855 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.689 ' HB3' HD11 ' D' ' 68' ' ' LEU . 42.6 t-105 -160.01 158.08 29.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.724 -0.843 . . . . 75.22 108.724 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.451 ' HG2' ' H ' ' F' ' 140' ' ' SER . 1.7 mp0 -74.44 116.82 56.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.077 0.551 . . . . 70.44 109.918 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.07 141.87 86.5 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.134 2.556 . . . . 61.5 113.593 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.61 113.38 4.18 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.55 -0.907 . . . . 72.52 108.55 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.428 HG13 HG13 ' D' ' 64' ' ' VAL . 61.8 t -99.09 106.57 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.65 -0.5 . . . . 74.42 109.65 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -87.41 109.39 19.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.194 -1.41 . . . . 62.02 107.194 167.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.77 156.29 16.39 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.52 -0.918 . . . . 60.55 108.52 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.7 t70 -151.2 155.74 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.157 0.583 . . . . 74.01 109.966 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -133.35 152.12 51.9 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.348 0.659 . . . . 52.32 110.824 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.5 t70 -153.36 151.51 30.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.006 1.322 . . . . 64.32 108.175 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -128.9 152.37 48.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.299 -0.63 . . . . 52.4 109.299 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.79 169.6 20.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.557 -0.905 . . . . 65.53 108.557 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -149.04 159.45 44.21 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.84 0.456 . . . . 53.43 110.737 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -155.7 119.26 4.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.115 0.966 . . . . 74.0 109.184 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.23 121.62 23.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.83 -0.433 . . . . 64.51 109.83 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.63 -26.5 14.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.416 0.686 . . . . 73.33 110.889 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.17 -177.01 3.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.026 0.93 . . . . 64.52 110.036 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.46 120.57 22.64 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.23 -1.026 . . . . 54.44 108.23 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 72.15 3.87 4.82 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.067 1.347 . . . . 65.5 112.742 -172.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.15 117.51 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.423 -0.584 . . . . 61.13 109.423 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -133.04 130.5 39.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.362 0.665 . . . . 73.21 109.468 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -87.16 140.1 29.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 64.1 108.372 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.34 132.87 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.76 -1.2 . . . . 53.31 107.76 169.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.72 130.94 57.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.564 1.145 . . . . 44.15 108.783 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 121.8 45.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.675 -0.861 . . . . 73.21 108.675 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.5 ttm-85 -106.88 99.17 8.76 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.891 -0.781 . . . . 73.1 108.891 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.59 104.13 15.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.199 -1.037 . . . . 71.41 108.199 172.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.2 m -99.3 148.12 24.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.152 -0.931 . . . . 74.52 110.022 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 25.3 t -138.43 132.98 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.629 1.572 . . . . 62.44 107.927 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -133.94 93.44 3.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.721 -1.215 . . . . 74.41 107.721 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.36 141.76 29.3 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.719 -0.673 . . . . 54.01 109.288 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -149.51 126.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.123 0.969 . . . . 71.31 108.975 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' D' ' 36' ' ' TRP . 19.7 tp -99.13 114.06 26.61 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.58 -0.896 . . . . 70.54 108.58 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.95 -113.33 4.13 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.7 0.625 . . . . 72.52 113.051 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 5.88 41.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.728 0.811 . . . . 72.33 111.205 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -149.22 151.52 34.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.471 0.308 . . . . 54.32 111.336 -165.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 71.8 m -55.21 141.46 35.11 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.983 1.313 . . . . 62.51 111.711 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -106.99 -71.85 0.74 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.037 0.935 . . . . 65.11 109.522 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -147.54 137.63 22.99 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.367 0.603 . . . . 64.3 109.778 173.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 51.3 mt -105.03 154.02 20.69 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.397 1.079 . . . . 75.52 108.491 175.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.68 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.5 t -160.64 146.28 14.78 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.935 0.494 . . . . 75.12 110.043 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.05 126.48 6.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.379 -0.6 . . . . 63.22 109.379 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.71 116.88 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.787 0.435 . . . . 62.22 110.638 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.7 mt-30 -92.45 88.03 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.29 1.036 . . . . 70.41 110.084 170.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -80.2 98.73 7.48 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.679 -1.146 . . . . 70.43 108.857 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.38 141.89 17.01 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.627 -0.589 . . . . 71.04 111.627 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.72 132.16 5.47 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.291 -0.723 . . . . 62.15 111.291 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.52 123.6 42.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 C-N-CA 123.93 0.892 . . . . 75.43 109.007 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -133.04 141.32 48.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.124 0.57 . . . . 71.44 109.684 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 33.2 m -100.17 105.23 16.81 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.726 0.81 . . . . 72.53 108.972 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mt -108.04 102.03 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.596 -0.89 . . . . 75.21 108.596 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.18 169.1 16.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.004 1.321 . . . . 74.53 109.879 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.42 -4.66 33.06 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 114.49 0.556 . . . . 73.33 114.49 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.44 151.41 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.96 0.904 . . . . 60.22 109.863 -170.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.15 177.02 8.07 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.014 0.926 . . . . 64.12 111.974 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -132.64 48.25 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 116.287 1.275 . . . . 74.45 116.287 165.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 8.5 t -62.94 -35.89 81.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 72.5 112.45 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.79 -39.42 64.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.774 0.43 . . . . 71.24 111.626 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.9 ptm -73.63 -31.95 63.78 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 110.022 -0.362 . . . . 75.2 110.022 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.75 70.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.438 0.695 . . . . 62.02 110.628 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -71.86 -33.36 68.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.159 0.984 . . . . 74.4 110.321 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.9 -52.1 53.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.157 -0.474 . . . . 72.21 110.548 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.59 -18.02 46.26 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.82 0.448 . . . . 73.14 112.114 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.65 -26.63 16.82 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-O 119.795 -0.447 . . . . 71.0 113.72 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.88 -59.36 1.27 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.932 0.493 . . . . 63.1 111.641 -174.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -67.29 -47.23 71.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.377 0.423 . . . . 71.34 111.972 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.4 m -67.61 -45.46 46.15 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 118.328 -0.844 . . . . 71.11 111.936 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.92 -35.23 98.47 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.359 2.039 . . . . 74.41 113.498 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.17 -32.96 74.71 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.415 0.686 . . . . 72.01 110.784 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.54 -45.06 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.416 0.687 . . . . 71.53 109.815 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.478 HD21 ' HA3' ' D' ' 82' ' ' GLY . 90.1 mt -73.68 -21.4 60.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.162 -0.926 . . . . 74.1 112.1 -174.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.422 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 42.8 t80 -66.12 -46.81 62.89 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 113.934 1.087 . . . . 64.4 113.934 -168.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.67 -34.16 97.74 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.072 1.848 . . . . 74.43 112.768 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -76.03 -37.68 58.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.023 0.929 . . . . 64.13 111.026 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -49.94 67.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.565 0.746 . . . . 72.34 110.792 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -71.54 -31.88 67.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.862 -1.063 . . . . 73.13 111.186 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.02 -42.94 89.0 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.029 0.831 . . . . 74.2 110.707 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 -39.5 80.24 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.821 0.7 . . . . 75.24 110.259 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.68 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.0 mt -61.56 -54.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.69 0.796 . . . . 62.11 110.35 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.446 HG23 ' HG3' ' D' ' 125' ' ' GLN . 28.8 m -57.71 -39.06 76.35 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.463 1.105 . . . . 72.31 111.593 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -67.06 -43.61 82.23 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 114.855 -1.066 . . . . 75.4 110.141 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.65 -27.18 63.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.775 0.43 . . . . 74.23 111.738 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.1 t -67.96 -43.09 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.564 0.746 . . . . 72.44 109.651 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 94.1 p -74.27 -25.98 59.93 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.895 0.478 . . . . 71.12 111.225 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.6 mtt-85 -75.38 -32.17 60.72 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.456 0.703 . . . . 75.12 109.758 173.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.56 -0.37 89.92 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.62 -0.718 . . . . 64.44 111.991 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.7 p 63.39 27.27 15.23 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.68 1.992 . . . . 62.42 113.257 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.472 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 56.5 m-85 -94.07 162.3 27.11 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 124.707 1.203 . . . . 65.33 110.535 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.1 140.91 97.22 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 123.483 2.789 . . . . 63.2 112.402 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.446 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.1 tt0 -54.68 135.01 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.119 0.968 . . . . 75.34 112.722 -174.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.46 HD13 ' HG ' ' F' ' 139' ' ' LEU . 60.6 tp -126.02 102.5 7.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.892 0.877 . . . . 73.34 109.913 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -102.58 121.44 42.39 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.71 -0.848 . . . . 74.41 108.71 175.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.422 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.1 OUTLIER -74.76 114.54 13.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.345 -0.983 . . . . 53.55 108.345 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' F' ' 143' ' ' TYR . . . -67.12 143.36 97.7 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 122.63 0.372 . . . . 73.14 110.898 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.81 132.22 22.81 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 62.55 112.887 -169.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.18 128.97 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.136 0.574 . . . . 73.35 109.771 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.73 93.3 7.9 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.88 -0.785 . . . . 72.15 108.88 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -62.04 -32.22 72.71 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.242 0.617 . . . . 72.34 111.101 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.66 -42.1 61.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.834 1.254 . . . . 72.15 111.911 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.89 92.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.056 0.847 . . . . 73.13 111.613 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 74.4 mt -76.47 -29.25 56.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.38 0.672 . . . . 55.4 111.124 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -69.51 -29.17 66.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.558 1.143 . . . . 62.24 110.986 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.6 mmt -52.45 -41.25 63.14 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.353 0.661 . . . . 72.05 110.717 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.14 -35.4 76.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.081 0.952 . . . . 75.14 112.124 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -54.08 -43.09 70.01 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.075 0.95 . . . . 70.24 111.514 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.05 -32.62 73.94 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.859 0.864 . . . . 60.34 111.018 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -89.33 1.44 55.77 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.687 0.795 . . . . 73.33 111.763 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -121.55 73.4 1.06 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.686 0.755 . . . . 75.23 110.597 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -148.01 91.39 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.866 -1.061 . . . . 74.41 109.441 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.2 17.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.692 1.197 . . . . 74.22 111.157 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.5 44.93 0.26 Allowed Glycine 0 C--N 1.353 1.479 0 C-N-CA 121.784 -0.246 . . . . 45.14 113.496 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.12 120.15 23.87 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.492 -0.929 . . . . 74.41 108.492 171.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.76 -69.01 0.01 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 117.846 0.293 . . . . 25.3 112.968 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 40.2 m -58.88 95.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.059 0.943 . . . . 52.32 112.059 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.26 80.21 1.47 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.22 -1.77 . . . . 73.14 106.22 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.63 132.61 34.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.059 -0.973 . . . . 70.33 108.814 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -135.79 80.05 1.81 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.638 1.175 . . . . 74.31 109.31 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -64.54 -54.48 31.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.81 0.844 . . . . 70.33 109.831 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -84.09 85.92 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.731 -1.211 . . . . 72.51 107.731 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 123.889 0.876 . . . . 71.54 109.27 -178.967 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.672 -0.492 . . . . 70.23 109.672 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -113.06 66.3 0.65 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.058 0.943 . . . . 65.12 109.078 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.03 150.16 37.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.812 0.845 . . . . 72.34 110.973 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -110.78 174.27 5.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.036 0.534 . . . . 74.31 110.857 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 112' ' ' GLN . . . . . 0.44 ' HB3' ' HA2' ' B' ' 91' ' ' GLY . 20.2 pt20 -146.1 138.25 25.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.277 1.031 . . . . 70.53 109.067 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -166.48 153.31 9.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.72 0.808 . . . . 72.51 108.915 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 48.04 -97.48 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.316 1.446 . . . . 73.43 110.816 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.465 HD23 ' HG3' ' B' ' 94' ' ' MET . 0.9 OUTLIER 176.9 56.88 0.0 OUTLIER 'General case' 0 C--N 1.353 0.759 0 N-CA-C 105.607 -1.997 . . . . 63.22 105.607 175.075 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -176.58 -58.38 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 CA-C-N 114.841 -1.072 . . . . 71.31 112.466 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.51 112.55 0.91 Allowed 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 123.403 2.736 . . . . 63.42 113.92 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -169.41 -48.51 0.02 OUTLIER 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.508 1.523 . . . . 62.14 108.177 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 38.0 m 62.34 98.76 0.03 OUTLIER 'General case' 0 C--N 1.366 1.31 0 C-N-CA 124.916 1.286 . . . . 64.13 109.674 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -66.25 93.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.683 0.754 . . . . 71.04 109.848 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.82 75.78 1.14 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.327 -0.851 . . . . 62.02 109.162 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.72 29.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.068 -0.969 . . . . 75.4 110.104 -171.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 m -92.64 31.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.208 0.603 . . . . 65.21 111.107 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.52 114.72 21.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.11 -0.7 . . . . 73.31 109.11 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -151.44 159.51 44.17 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.746 1.218 . . . . 64.42 108.427 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -67.03 140.94 57.7 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.46 7.49 77.74 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 119.787 -0.452 . . . . 72.43 114.075 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -118.64 -29.78 5.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 75.24 109.35 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 129' ' ' LEU . . . . . 0.433 HD13 ' HB2' ' B' ' 42' ' ' LEU . 11.0 mp 69.82 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.607 1.163 . . . . 71.44 112.131 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.24 158.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.544 0.738 . . . . 75.42 112.511 -170.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.6 -69.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.376 0.67 . . . . 73.52 109.808 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 61.44 106.5 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.86 1.264 . . . . 71.33 110.814 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.31 -37.86 71.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.438 2.758 . . . . 65.41 113.516 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 2.7 pp -86.18 -19.95 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.304 -0.862 . . . . 60.14 111.966 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.22 78.57 0.24 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.937 1.295 . . . . 72.23 111.889 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 136' ' ' VAL . . . . . 0.584 HG22 ' HD3' ' C' ' 124' ' ' PRO . 7.4 p -81.76 92.53 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 CA-C-O 121.741 0.781 . . . . 71.52 109.193 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 137' ' ' GLU . . . . . 0.521 ' HA ' ' HB3' ' C' ' 124' ' ' PRO . 3.1 tm-20 -140.39 -45.61 0.41 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.292 0.637 . . . . 50.33 111.19 -170.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.65 85.73 1.62 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.203 0.525 . . . . 53.23 111.304 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 139' ' ' LEU . . . . . 0.511 ' HB2' ' HG2' ' C' ' 124' ' ' PRO . 5.1 tt -103.32 120.53 40.95 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.086 -1.45 . . . . 75.42 107.086 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 57.0 m -145.97 -160.92 1.21 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.843 0.857 . . . . 75.02 109.509 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.96 48.7 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.38 1.072 . . . . 72.13 109.045 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 24.1 mt -111.54 -66.05 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.505 -1.225 . . . . 73.12 107.948 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -143.31 157.53 44.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.462 1.105 . . . . 62.3 110.046 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -91.9 -59.13 2.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.312 1.045 . . . . 52.14 110.701 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -138.56 -53.56 0.6 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.213 0.605 . . . . 64.43 110.223 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.22 142.61 43.4 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.005 0.431 . . . . 61.32 110.784 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.76 -59.46 1.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.019 -1.104 . . . . 75.41 108.019 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' C' ' 131' ' ' VAL . 6.2 mp -112.16 146.78 35.57 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.462 -1.31 . . . . 75.41 107.462 167.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo . . . . . 0 C--N 1.381 2.287 0 C-N-CA 123.513 2.809 . . . . 74.33 113.304 175.903 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.084 -0.339 . . . . 60.23 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.94 -168.99 1.85 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.317 0.647 . . . . 73.33 111.245 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 68.76 16.85 8.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.69 1.196 . . . . 73.05 112.907 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -55.35 103.95 0.11 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.124 -0.695 . . . . 72.23 109.124 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.52 82.77 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.204 0.94 . . . . 73.42 110.966 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.11 -31.61 66.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.997 -1.001 . . . . 72.41 109.302 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.8 mttm 63.87 79.72 0.25 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.867 1.267 . . . . 71.23 110.505 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 94' ' ' MET . 81.9 mt -79.75 54.36 1.81 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.633 0.73 . . . . 61.22 109.933 172.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -124.67 62.94 35.7 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.756 1.223 . . . . 74.32 108.735 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.48 76.85 2.43 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.969 2.446 . . . . 70.52 111.99 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.51 138.42 15.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.45 -0.796 . . . . 74.24 110.861 175.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 32.0 p -111.36 84.53 1.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.862 1.265 . . . . 75.15 107.835 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -136.58 -61.83 0.67 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.477 0.711 . . . . 73.04 109.825 -172.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.9 t70 68.07 151.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.791 1.236 . . . . 73.45 111.686 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.51 118.72 8.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.164 0.586 . . . . 65.15 112.115 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 m -75.99 -172.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 124.006 0.922 . . . . 71.13 110.818 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -76.44 173.29 11.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.134 0.493 . . . . 71.23 110.501 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.78 -67.33 0.44 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.365 0.666 . . . . 63.31 111.716 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -155.8 143.17 19.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.293 0.637 . . . . 75.34 109.964 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -140.76 128.95 3.94 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.134 -0.787 . . . . 44.3 111.134 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 65.44 88.54 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.819 1.247 . . . . 64.25 110.14 -172.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.419 ' HB3' HG11 ' A' ' 40' ' ' VAL . 44.8 tp -107.58 168.23 9.4 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.081 -0.963 . . . . 73.53 109.429 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 46.4 mm 80.61 -57.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 126.269 1.828 . . . . 72.43 110.13 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 76.57 -47.11 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.794 1.638 . . . . 70.35 112.471 176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.64 93.69 37.9 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.741 0.816 . . . . 63.3 109.403 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.88 89.62 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.409 2.072 . . . . 63.12 109.636 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -60.77 99.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 115.513 -0.767 . . . . 65.54 110.404 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.95 84.14 5.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.248 -0.887 . . . . 52.14 109.315 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.4 112.86 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 108.13 -1.063 . . . . 75.22 108.13 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.04 147.23 24.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.764 -0.458 . . . . 74.32 109.764 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 66.73 99.7 0.05 OUTLIER 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.375 1.47 . . . . 74.2 111.404 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.46 ' HG ' HD13 ' D' ' 126' ' ' LEU . 0.0 OUTLIER -67.69 88.68 0.24 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 108.034 -1.098 . . . . 74.44 108.034 176.387 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' F' F ' 140' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' D' ' 37' ' ' GLN . 22.4 t -87.6 1.01 54.8 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.655 0.782 . . . . 60.1 111.88 -171.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.99 -8.61 27.61 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.426 0.528 . . . . 61.21 112.426 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.436 HD12 HD11 ' D' ' 126' ' ' LEU . 7.0 tt -77.87 113.22 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.306 -0.627 . . . . 72.43 109.306 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 143' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' F' ' 146' ' ' ASP . 58.5 m-85 76.35 -49.75 0.58 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.696 1.599 . . . . 72.32 113.029 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 50.5 t30 72.36 -79.21 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.438 1.495 . . . . 75.04 111.029 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -128.46 -27.39 2.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.615 0.766 . . . . 75.35 110.191 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 146' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' F' ' 143' ' ' TYR . 24.6 t70 -80.68 159.23 25.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.875 0.87 . . . . 75.05 110.667 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 tp -157.57 -74.95 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.699 -1.222 . . . . 74.52 107.699 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 40.1 tp -171.94 66.12 0.4 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.96 -1.496 . . . . 65.12 106.96 168.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 C--N 1.383 2.364 0 C-N-CA 122.729 2.286 . . . . 55.41 110.973 179.601 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 ttp . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.8 -0.445 . . . . 60.22 109.8 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -122.23 84.26 2.23 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.934 0.894 . . . . 74.12 108.918 169.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 81.89 8.5 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.233 -1.395 . . . . 70.03 107.233 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -129.8 131.21 46.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.04 0.936 . . . . 63.43 110.014 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -130.6 121.22 25.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.722 0.809 . . . . 73.01 109.707 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -72.56 155.11 40.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.872 -0.788 . . . . 55.22 108.872 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -67.49 80.59 0.16 Allowed 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.953 0.883 . . . . 53.35 111.733 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -138.12 -158.82 0.89 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.727 1.211 . . . . 73.23 109.303 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.11 140.13 58.77 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.182 0.593 . . . . 63.22 109.749 175.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 90.1 m -140.15 120.36 13.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.554 -1.276 . . . . 45.21 107.554 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -138.82 121.85 16.75 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.026 -0.731 . . . . 74.12 109.026 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 29.6 tt0 -134.12 111.7 10.54 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.585 0.754 . . . . 60.34 109.159 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.62 109.21 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 108.174 -1.047 . . . . 72.13 108.174 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -91.99 -40.53 11.06 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.407 -0.59 . . . . 74.53 109.407 -174.052 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -170.73 140.96 1.75 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.321 0.648 . . . . 61.04 110.083 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.602 HG23 HD23 ' A' ' 106' ' ' LEU . 3.9 mp -128.59 100.54 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.033 -1.469 . . . . 74.5 107.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -160.82 175.8 12.17 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.234 1.014 . . . . 73.44 110.157 -166.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -81.44 127.01 32.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.649 0.261 . . . . 71.1 110.692 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.4 mtpt -83.27 -47.45 11.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.755 0.788 . . . . 72.22 109.045 165.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 12.0 t70 -136.86 139.36 41.61 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.529 -1.214 . . . . 64.21 109.595 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.521 HG23 ' SD ' ' A' ' 117' ' ' MET . 78.5 mt -128.21 136.06 61.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.876 -1.527 . . . . 74.41 106.876 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -146.16 108.24 4.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.162 -0.681 . . . . 65.0 109.162 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 89.8 t80 -112.56 119.26 37.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.959 -1.497 . . . . 61.01 106.959 173.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -127.99 111.93 14.09 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.038 -0.727 . . . . 73.21 109.038 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -111.19 84.68 4.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.613 -1.255 . . . . 70.45 107.613 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.38 -31.29 18.03 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.285 1.99 . . . . 64.52 111.428 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.7 m-20 -109.29 34.38 3.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.501 1.12 . . . . 64.41 108.767 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -59.24 -47.33 98.5 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.658 0.783 . . . . 53.15 113.059 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.8 Cg_exo -67.64 -24.59 41.31 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.229 1.953 . . . . 73.21 113.275 171.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 25.4 m80 -64.89 -38.11 89.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.613 0.365 . . . . 73.34 110.611 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.81 -25.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.79 0.436 . . . . 64.11 111.626 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.26 -38.44 90.33 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.108 0.563 . . . . 72.32 111.283 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -90.32 -21.19 22.16 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.902 0.481 . . . . 71.23 111.12 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 6.1 tmtt? -82.0 148.79 28.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.036 0.934 . . . . 55.14 111.479 -172.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.42 139.34 57.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.638 0.775 . . . . 74.25 110.736 170.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -84.61 74.04 10.48 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.927 0.87 . . . . 74.41 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -139.38 74.12 35.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.779 -0.823 . . . . 54.34 108.779 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.46 141.51 4.01 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.433 2.088 . . . . 64.14 112.665 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.94 121.97 40.5 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.874 -1.158 . . . . 74.21 107.874 171.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.67 115.49 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.184 0.594 . . . . 73.31 110.542 -167.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -93.77 121.09 34.85 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.298 1.039 . . . . 71.52 109.15 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.0 129.36 55.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.463 0.705 . . . . 72.1 110.328 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -114.39 113.46 24.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.806 0.843 . . . . 74.5 108.8 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.24 118.27 36.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.487 -1.301 . . . . 63.45 107.487 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' O ' HD23 ' A' ' 60' ' ' LEU . 21.6 t70 -129.23 144.93 51.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.77 0.828 . . . . 73.33 109.782 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.4 m -142.13 135.72 29.33 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.273 0.629 . . . . 54.55 110.342 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.48 119.65 9.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.439 0.695 . . . . 72.02 110.928 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 t -91.73 154.21 19.12 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.374 -0.602 . . . . 63.15 109.374 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.3 t -161.86 115.94 1.9 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 117.932 0.333 . . . . 70.42 110.308 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -73.44 105.87 5.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.784 0.834 . . . . 72.03 111.651 -172.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 57' ' ' GLU . 70.1 mt -77.93 -40.48 39.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.85 0.86 . . . . 64.35 111.253 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.99 -172.0 3.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.122 0.969 . . . . 61.03 109.542 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.07 100.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.323 0.649 . . . . 62.41 111.159 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 52.86 32.79 13.02 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.797 1.239 . . . . 65.0 113.083 -174.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 49.1 t -108.51 121.64 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 106.715 -1.587 . . . . 71.44 106.715 167.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' F' ' 114' ' ' LYS . 2.1 m-85 -132.48 131.04 41.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.254 -0.647 . . . . 65.32 109.254 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.1 tt0 -86.37 120.22 27.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.629 -0.878 . . . . 63.42 108.629 168.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.33 116.25 42.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.715 -1.217 . . . . 54.3 107.715 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.2 t -98.07 134.88 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.129 -0.693 . . . . 74.35 109.129 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -109.39 109.86 20.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.141 -1.429 . . . . 75.21 107.141 171.079 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -96.99 102.0 13.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.913 -1.143 . . . . 74.0 107.913 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.86 140.6 16.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.511 -1.292 . . . . 73.24 107.511 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -129.48 124.4 33.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.338 -0.616 . . . . 74.12 109.338 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 114' ' ' ILE . 70.8 t -115.76 105.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.935 -1.135 . . . . 50.45 107.935 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.3 m -112.33 122.86 48.93 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.561 -0.903 . . . . 71.23 108.561 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.25 110.81 21.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.613 -1.625 . . . . 72.35 106.613 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -148.38 147.47 29.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 70.23 109.827 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.451 HD23 ' NZ ' ' A' ' 34' ' ' LYS . 28.1 tp -113.32 86.85 2.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.032 -1.099 . . . . 60.2 108.032 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.11 -93.12 1.5 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.15 -0.932 . . . . 74.31 111.472 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -116.04 -26.9 7.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.72 0.808 . . . . 73.14 111.014 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.0 tp10 -77.67 107.08 9.9 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.184 -1.043 . . . . 72.25 108.184 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -76.01 142.53 41.85 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.479 -0.563 . . . . 63.41 109.479 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.46 -58.68 2.47 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.377 -0.971 . . . . 74.44 108.377 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -168.89 176.76 5.3 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.558 0.743 . . . . 75.15 110.727 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.3 tp -139.42 141.82 37.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.186 1.395 . . . . 72.42 108.342 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 35.3 m -147.69 97.79 2.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.943 0.497 . . . . 75.03 110.144 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.43 122.32 46.04 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.575 0.75 . . . . 71.42 109.622 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.11 115.0 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.535 0.734 . . . . 71.14 109.864 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -85.91 82.19 8.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.401 1.081 . . . . 74.22 108.207 172.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -76.49 93.57 3.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.899 -1.046 . . . . 72.33 108.97 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.47 145.91 18.66 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.138 -0.483 . . . . 52.53 111.9 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.56 122.76 2.22 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 110.205 -1.158 . . . . 75.31 110.205 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.617 HD11 ' HA ' ' B' ' 29' ' ' PRO . 54.9 mt -82.21 126.83 40.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.8 -0.815 . . . . 70.34 108.8 175.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -132.71 117.05 17.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.426 -0.953 . . . . 61.33 108.426 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.682 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 40.7 t -84.56 97.64 9.7 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.397 -0.964 . . . . 73.34 108.397 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 10' ' ' THR . 34.1 pt -120.21 125.67 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.696 0.76 . . . . 51.04 111.59 -172.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.73 158.82 43.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.0 1.32 . . . . 54.33 108.932 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.17 8.74 86.07 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.796 -0.447 . . . . 52.22 114.213 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -117.69 134.1 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.823 -0.806 . . . . 74.23 108.823 173.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.33 169.1 17.72 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.99 0.516 . . . . 63.35 111.198 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.95 -111.76 0.79 Allowed Glycine 0 C--N 1.358 1.773 0 O-C-N 124.774 1.296 . . . . 43.41 115.209 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.0 p -70.12 -35.84 74.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.176 0.99 . . . . 70.32 111.772 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.89 -47.56 82.77 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.268 0.627 . . . . 72.31 111.197 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' F' ' 115' ' ' LEU . 26.3 ptt? -72.13 -35.75 69.21 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.019 0.528 . . . . 74.02 111.333 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.09 81.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.546 0.738 . . . . 62.32 110.595 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -46.88 86.73 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.625 -1.171 . . . . 73.01 109.985 172.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.0 m -70.84 -37.66 73.16 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.048 0.758 . . . . 74.23 113.048 -172.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 86' ' ' ILE . 77.8 mt -84.84 -18.86 33.56 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.926 0.343 . . . . 65.14 111.926 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.71 -10.85 54.97 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 119.831 -0.427 . . . . 61.24 113.268 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -73.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.734 -0.651 . . . . 61.25 112.642 -172.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.5 t80 -41.41 -54.92 2.94 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 124.882 1.273 . . . . 73.11 113.158 -175.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -78.6 -52.54 1.34 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-O 118.256 -0.878 . . . . 72.1 112.975 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' HD12 ' A' ' 106' ' ' LEU . 38.6 Cg_endo -64.67 -25.27 61.69 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.791 1.661 . . . . 72.1 114.448 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -71.62 -33.98 69.43 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.933 0.493 . . . . 75.15 110.454 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.0 mm -62.16 -42.37 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.273 0.629 . . . . 55.43 109.879 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.602 HD23 HG23 ' A' ' 16' ' ' ILE . 60.2 mt -72.89 -25.42 61.06 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.586 -0.734 . . . . 74.33 111.678 -174.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.58 -43.32 70.35 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 115.088 1.514 . . . . 71.43 115.088 -168.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.23 -34.52 98.66 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.114 1.876 . . . . 61.3 113.232 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -80.0 -35.55 37.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.733 0.813 . . . . 73.44 111.158 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.1 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.135 0.574 . . . . 62.1 109.574 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -53.79 -45.64 70.77 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.764 1.29 . . . . 75.41 110.466 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.08 -50.23 64.82 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.633 0.773 . . . . 61.45 111.352 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.2 t -56.09 -46.6 78.99 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.214 0.946 . . . . 34.21 110.659 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 64' ' ' VAL . 11.6 mt -57.77 -54.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.104 0.878 . . . . 74.22 110.657 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 125' ' ' GLN . 65.8 m -56.44 -39.54 73.3 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.73 0.644 . . . . 53.34 111.594 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.35 -39.27 81.93 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.474 -0.785 . . . . 62.33 109.814 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.521 ' SD ' HG23 ' A' ' 21' ' ' ILE . 17.6 mtp -61.17 -40.85 95.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.524 0.73 . . . . 63.53 110.92 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 114' ' ' ILE . 92.1 t -62.89 -46.5 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.268 1.027 . . . . 75.15 110.698 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.7 p -75.25 -37.05 61.18 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.575 -0.739 . . . . 74.34 111.211 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -66.31 -28.33 68.6 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.308 0.643 . . . . 73.44 109.909 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.01 -3.07 89.36 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.558 -0.747 . . . . 33.34 113.43 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 65.83 38.32 5.18 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.028 1.394 . . . . 70.31 110.541 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.05 150.53 43.72 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 115.025 -0.989 . . . . 75.32 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.7 130.53 40.43 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.935 2.423 . . . . 75.05 112.271 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.7 tt0 -58.46 127.31 31.49 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.064 0.853 . . . . 74.35 112.128 -175.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.9 mt -117.32 95.58 5.04 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.994 -1.113 . . . . 72.32 107.994 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -98.4 126.74 44.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.746 -0.835 . . . . 74.24 108.746 176.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.28 149.0 40.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.772 -0.649 . . . . 65.21 111.958 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.03 142.02 87.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.326 0.651 . . . . 65.52 110.142 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -78.24 96.94 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.171 1.914 . . . . 50.1 110.785 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.677 HG11 ' HA ' ' F' ' 125' ' ' TYR . 16.9 m -99.66 114.04 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.752 0.787 . . . . 73.34 109.04 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -93.23 93.28 8.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.964 -1.016 . . . . 73.43 109.663 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -64.55 -26.59 68.48 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.306 -0.861 . . . . 62.31 111.316 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.3 -40.07 86.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.625 0.77 . . . . 72.24 110.214 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.33 -43.63 77.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.985 -1.007 . . . . 72.34 110.776 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.18 -50.14 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.141 0.977 . . . . 75.41 110.176 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -68.03 -31.35 70.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 53.33 111.501 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.542 ' SD ' HD23 ' A' ' 141' ' ' LEU . 11.5 tpt -71.17 -38.05 72.17 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.452 0.47 . . . . 61.44 111.157 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 41.3 m-80 -63.94 -19.49 65.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.058 0.543 . . . . 71.34 111.627 176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -90.58 -42.91 10.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.439 0.696 . . . . 73.23 110.305 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.542 HD23 ' SD ' ' A' ' 138' ' ' MET . 56.2 tp -65.79 -50.84 63.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.824 1.249 . . . . 73.53 112.497 -167.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -154.66 -1.11 0.17 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.109 0.564 . . . . 42.24 110.728 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 27.9 mp0 59.08 -165.04 0.2 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.73 1.212 . . . . 75.0 111.202 -172.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.74 90.99 0.07 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.672 1.189 . . . . 64.21 109.942 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.78 4.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.954 0.501 . . . . 74.51 110.388 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.465 ' HA3' ' HG2' ' C' ' 144' ' ' GLN . . . 152.54 -89.26 0.13 Allowed Glycine 0 C--N 1.349 1.26 0 O-C-N 123.511 0.507 . . . . 34.44 112.563 177.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -119.38 158.21 26.61 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.587 -1.264 . . . . 73.34 107.587 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.46 -29.07 0.24 Allowed Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.346 -1.102 . . . . 63.33 110.346 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -145.51 159.62 42.83 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.132 0.973 . . . . 64.53 109.557 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.1 104.26 2.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.041 -1.837 . . . . 75.34 106.041 172.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 129.36 41.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.196 0.999 . . . . 74.05 112.324 -171.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -67.98 154.6 41.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.126 0.971 . . . . 75.2 110.754 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -52.72 133.07 36.97 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.39 1.076 . . . . 73.51 112.512 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -162.1 -62.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.931 0.892 . . . . 53.13 109.272 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.308 0 C-N-CA 124.653 1.181 . . . . 72.24 111.058 -179.546 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.228 -0.286 . . . . 70.11 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -125.17 141.38 52.14 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.716 0.806 . . . . 73.44 109.594 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -145.66 108.18 4.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.134 0.492 . . . . 71.31 110.172 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.74 -176.39 5.4 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.538 1.135 . . . . 75.4 108.122 164.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -91.83 168.51 11.39 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.687 -0.486 . . . . 72.15 109.687 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -144.17 148.15 34.61 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.346 -0.613 . . . . 72.52 109.346 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.6 m -96.2 158.27 15.52 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.298 1.039 . . . . 74.33 110.237 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 77.53 -64.91 0.29 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 126.008 1.723 . . . . 63.02 112.476 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm 50.66 -174.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 126.144 1.778 . . . . 74.01 114.205 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.3 m -148.2 131.34 16.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.73 0.812 . . . . 74.44 109.059 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' F' ' 147' ' ' LEU . 66.9 t80 -136.58 142.74 43.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.756 0.422 . . . . 74.31 110.397 172.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -155.92 140.49 16.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.317 1.047 . . . . 74.1 109.306 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.07 106.35 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.478 -1.304 . . . . 63.51 107.478 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -78.24 -46.42 20.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.68 0.392 . . . . 74.13 110.19 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -163.58 140.87 7.3 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.063 -0.517 . . . . 71.02 110.166 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.1 mt -117.96 144.84 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.342 -1.355 . . . . 73.41 107.342 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.432 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.7 p90 -170.12 147.0 3.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.592 0.633 . . . . 73.13 111.913 -177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -72.92 119.22 16.87 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.666 -1.152 . . . . 73.52 108.069 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -90.95 -30.25 16.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.326 0.65 . . . . 75.35 110.851 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -158.02 138.94 13.15 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.583 0.552 . . . . 72.03 111.112 -171.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.467 HD12 HG22 ' B' ' 78' ' ' VAL . 47.8 mm -132.33 138.22 52.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 C-N-CA 124.635 1.174 . . . . 63.34 109.007 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -131.25 136.08 47.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.332 -1.359 . . . . 51.23 107.332 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.6 t80 -151.84 122.1 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.363 -1.347 . . . . 64.5 107.363 171.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 42.1 mt-10 -124.1 133.68 53.55 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.29 -1.004 . . . . 71.42 108.29 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -128.78 87.47 54.67 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.162 -0.681 . . . . 53.05 109.162 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.7 -22.99 36.62 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.158 1.905 . . . . 62.11 111.004 172.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -115.04 24.96 11.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.135 0.974 . . . . 71.25 111.148 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.81 -53.64 40.21 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 123.704 0.801 . . . . 70.33 111.133 164.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.617 ' HA ' HD11 ' A' ' 83' ' ' ILE . 69.2 Cg_endo -77.0 -22.78 11.16 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.907 1.738 . . . . 71.32 113.374 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -94.46 2.94 55.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.54 0.736 . . . . 73.45 111.662 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.83 -31.73 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.222 1.009 . . . . 74.43 112.813 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -74.12 -34.83 64.05 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.354 . . . . 62.33 110.772 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -68.93 -23.78 64.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.648 1.179 . . . . 44.42 110.962 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' B' ' 34' ' ' LYS . 10.6 mmpt? -75.9 100.27 4.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.253 0.621 . . . . 64.1 111.422 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -113.42 78.84 1.17 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.339 1.056 . . . . 75.25 111.149 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -176.89 178.22 1.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.626 1.97 . . . . 75.44 107.143 171.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.56 131.93 36.63 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.501 -0.926 . . . . 54.24 108.501 164.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 47.6 Cg_endo -67.7 133.6 30.12 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.165 1.91 . . . . 72.43 112.961 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 25.5 tt0 -51.21 117.18 2.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.811 1.244 . . . . 61.4 109.631 164.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 134.2 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.736 0.414 . . . . 60.32 110.604 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -142.85 101.83 3.92 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.343 1.057 . . . . 64.03 108.611 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -94.8 153.07 17.92 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.177 -0.675 . . . . 70.45 109.177 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -138.35 130.27 28.26 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.403 -0.962 . . . . 72.13 108.403 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.96 128.47 53.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.606 -1.257 . . . . 63.34 107.606 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.3 t70 -142.85 155.66 44.81 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.428 1.091 . . . . 61.12 108.777 -174.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.1 p -141.89 119.59 11.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.369 0.668 . . . . 43.44 110.358 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.99 119.07 25.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.372 -0.973 . . . . 72.2 108.372 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -117.0 164.54 14.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.637 0.375 . . . . 70.43 110.979 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -152.41 136.89 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.2 1.0 . . . . 73.31 109.03 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -80.8 121.62 26.16 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.227 -0.657 . . . . 75.3 109.227 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 45.6 mt -80.53 -39.87 27.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.564 -0.532 . . . . 70.54 109.564 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.25 -179.1 4.88 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.758 -1.11 . . . . 51.53 109.966 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.78 129.59 41.15 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.409 -0.814 . . . . 73.45 108.95 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' B' ' 85' ' ' SER . 2.5 m-20 71.07 1.49 3.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.479 1.112 . . . . 74.44 112.283 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 t -125.75 88.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.475 -0.935 . . . . 73.43 108.475 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -108.86 137.85 46.13 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.823 -0.806 . . . . 72.43 108.823 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -119.76 108.3 14.25 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.405 -0.961 . . . . 61.24 108.405 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -99.94 124.11 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.857 0.863 . . . . 51.23 109.188 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 24.9 t -103.33 124.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 109.575 -0.528 . . . . 62.2 109.575 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.3 116.48 29.04 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.001 -1.481 . . . . 73.21 107.001 171.279 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.502 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 43.1 ttt180 -105.17 107.82 19.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.144 0.577 . . . . 63.41 109.887 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -107.9 121.39 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.963 -0.754 . . . . 61.13 108.963 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -109.46 141.96 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.365 0.666 . . . . 72.33 109.532 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.591 HG21 HG21 ' B' ' 114' ' ' ILE . 43.0 t -124.88 127.0 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.997 0.919 . . . . 74.2 108.658 171.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -125.62 147.24 49.38 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.776 -0.824 . . . . 62.34 108.776 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.11 148.72 30.93 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.605 0.565 . . . . 64.44 111.418 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.1 m -133.99 126.71 30.84 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 115.327 -0.852 . . . . 54.4 108.743 174.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 1.7 tt -118.92 115.82 25.19 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.948 -1.501 . . . . 61.41 106.948 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -143.95 29.94 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.343 -0.703 . . . . 72.51 111.343 -170.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -92.3 19.74 6.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 62.13 112.197 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.44 178.93 8.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.321 0.648 . . . . 63.55 110.45 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.5 m -69.2 139.49 54.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.241 0.616 . . . . 65.35 110.551 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -87.41 -65.2 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.108 0.956 . . . . 63.32 108.762 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -156.02 161.44 40.45 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 113.311 -1.768 . . . . 55.11 108.848 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 81.6 mt -132.17 143.17 49.78 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.079 -1.452 . . . . 74.25 107.079 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -155.87 152.22 28.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.882 -0.784 . . . . 53.23 108.882 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.1 tt0 -165.85 135.9 3.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.696 -0.853 . . . . 74.41 108.696 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' B' ' 113' ' ' CYS . 93.1 t -125.1 143.6 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.56 0.744 . . . . 52.33 109.022 174.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 23.3 mt-30 -123.69 91.05 3.39 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.549 -0.908 . . . . 63.03 108.549 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -83.8 101.06 11.34 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.366 -0.834 . . . . 55.44 109.622 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.1 164.9 32.58 Favored Glycine 0 C--O 1.243 0.661 0 O-C-N 123.419 0.449 . . . . 73.4 112.074 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.88 125.34 1.46 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.676 -0.57 . . . . 51.34 111.676 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.432 HG13 ' HE1' ' B' ' 17' ' ' TYR . 45.7 mt -85.23 119.64 34.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 108.17 -1.048 . . . . 72.21 108.17 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.94 151.3 43.74 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.851 0.86 . . . . 60.31 109.864 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 13.4 m -96.3 100.57 12.18 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.051 -1.092 . . . . 65.02 108.051 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.554 HG21 ' SD ' ' B' ' 94' ' ' MET . 12.3 mm -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.496 -0.557 . . . . 63.24 109.496 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -142.42 153.01 43.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.988 0.515 . . . . 64.42 111.077 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.01 -67.15 3.8 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.914 0.759 . . . . 52.33 112.212 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 tt -49.24 135.29 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.281 1.832 . . . . 73.22 112.325 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -151.74 177.14 10.69 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.658 0.383 . . . . 74.14 111.241 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.08 -133.57 34.0 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.39 -0.823 . . . . 71.12 113.636 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.1 m -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.279 1.032 . . . . 60.13 110.858 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -66.67 -47.62 71.9 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.869 -1.514 . . . . 70.04 109.719 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.554 ' SD ' HG21 ' B' ' 86' ' ' ILE . 11.4 tpt -70.57 -33.97 71.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.611 0.764 . . . . 54.13 111.301 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.813 0.445 . . . . 74.14 111.072 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 27.2 t-80 -67.49 -37.49 82.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.81 0.844 . . . . 74.11 111.189 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -69.93 -45.25 67.9 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.5 0.667 . . . . 62.24 110.961 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.27 -38.17 66.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.526 1.13 . . . . 54.42 111.228 -172.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.24 4.81 60.67 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.508 -0.769 . . . . 74.41 114.38 -173.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -150.48 -61.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.865 0.833 . . . . 72.04 112.758 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -64.63 -52.97 54.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.636 0.774 . . . . 73.54 112.148 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.476 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 77.8 m -62.06 -51.15 76.88 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.274 -0.87 . . . . 72.31 112.33 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 32.3 Cg_exo -61.38 -29.51 85.71 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 121.935 1.757 . . . . 74.03 113.764 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.46 -35.99 81.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.941 0.497 . . . . 71.25 111.221 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.75 -40.26 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 124.043 0.937 . . . . 72.22 110.166 172.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.85 -18.84 31.72 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.871 -1.059 . . . . 63.52 112.763 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -59.4 -45.95 98.96 Favored Pre-proline 0 N--CA 1.485 1.282 0 N-CA-C 114.301 1.223 . . . . 74.24 114.301 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.89 -43.27 48.06 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.347 2.032 . . . . 74.4 113.734 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -70.0 -44.02 70.22 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.247 -0.888 . . . . 72.43 110.561 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.31 96.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.451 0.7 . . . . 71.44 110.917 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.588 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.7 ttt180 -56.88 -58.55 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.491 1.517 . . . . 75.32 110.92 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.09 -38.83 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.729 1.212 . . . . 70.15 111.085 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.05 -46.95 75.97 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.286 -0.415 . . . . 75.04 110.935 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.591 HG21 HG21 ' B' ' 64' ' ' VAL . 50.7 mt -60.37 -53.4 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.743 0.417 . . . . 62.34 110.589 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -26.76 68.76 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.271 -0.877 . . . . 72.35 111.406 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 48.1 t -72.26 -50.07 30.13 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.138 0.575 . . . . 51.43 110.526 172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.1 mmt -65.65 -35.06 79.68 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.441 0.696 . . . . 64.3 112.273 -173.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.65 -34.19 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.773 0.429 . . . . 63.43 110.751 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 33.2 t -67.63 -30.4 69.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.762 0.825 . . . . 73.1 110.565 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.422 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 92.6 mtt-85 -65.79 -26.77 67.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.702 0.801 . . . . 73.04 111.552 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 10.4 65.7 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-O 119.681 -0.51 . . . . 62.03 114.261 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 5.1 p 67.85 12.09 8.67 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.18 1.792 . . . . 62.52 113.129 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -85.88 159.1 55.36 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.877 -0.582 . . . . 74.25 110.311 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -41.81 124.94 2.85 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.512 2.808 . . . . 71.3 113.271 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.414 ' HB2' HE21 ' C' ' 125' ' ' GLN . 53.3 tt0 -65.47 111.78 3.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.552 -0.749 . . . . 72.45 109.517 178.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.9 94.79 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.154 -1.054 . . . . 73.22 108.154 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -91.66 121.73 33.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.847 -1.168 . . . . 75.44 107.847 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.588 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -73.8 144.83 45.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 74.14 110.92 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.37 144.88 54.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.274 -0.876 . . . . 64.25 109.686 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.69 ' HG3' HD13 ' D' ' 16' ' ' ILE . 37.0 Cg_endo -63.07 99.41 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.626 2.217 . . . . 50.43 112.327 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.38 132.03 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.307 0.575 . . . . 65.01 110.249 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.46 113.12 24.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.84 0.856 . . . . 50.2 108.983 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -72.81 -18.71 61.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.698 0.799 . . . . 62.02 111.841 -174.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.86 -41.6 95.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.199 0.6 . . . . 62.12 109.742 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.02 88.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.284 -0.871 . . . . 55.45 110.057 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.26 -33.33 73.35 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.442 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -74.9 -46.59 34.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.101 0.96 . . . . 73.44 111.321 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 65.7 mtt -79.21 -36.38 40.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.228 0.611 . . . . 71.22 111.598 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -77.54 -13.7 59.85 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.272 0.629 . . . . 71.14 111.09 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.75 -34.14 77.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.612 0.72 . . . . 70.03 109.972 171.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.36 9.74 27.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.607 -1.178 . . . . 52.4 110.511 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.604 ' HG3' ' HG2' ' B' ' 143' ' ' GLN . 6.7 tp60 60.68 -92.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.365 1.466 . . . . 71.45 109.996 -168.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLN . . . . . 0.604 ' HG2' ' HG3' ' B' ' 142' ' ' GLN . 13.5 pt20 -169.52 156.03 6.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 72.2 109.037 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.71 128.3 10.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.66 -0.496 . . . . 70.11 109.66 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.03 -54.3 0.92 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.888 0.875 . . . . 74.34 109.089 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.7 -78.15 0.49 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.265 -0.88 . . . . 44.44 111.285 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -96.95 103.37 15.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.173 0.989 . . . . 72.01 108.864 174.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.79 92.48 0.09 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.467 -0.653 . . . . 74.54 111.467 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.4 p -73.21 102.68 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.584 0.754 . . . . 72.14 112.078 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -80.6 106.78 12.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.302 1.041 . . . . 74.5 110.024 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -92.69 144.47 25.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.035 0.934 . . . . 64.11 110.108 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -120.2 99.14 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.516 0.726 . . . . 55.44 110.278 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -81.8 77.91 8.58 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.312 0.645 . . . . 75.2 109.933 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.82 84.75 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.68 -0.691 . . . . 52.52 109.638 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.399 -0.964 . . . . 61.34 108.399 -178.502 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.108 -0.33 . . . . 72.1 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.7 p -91.04 -92.29 0.14 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.153 0.581 . . . . 71.3 109.591 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.438 ' HB2' ' HD3' ' F' ' 124' ' ' ARG . 3.5 tm-20 -127.82 98.46 5.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.424 -0.954 . . . . 74.42 108.424 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -135.6 22.47 3.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.437 1.095 . . . . 74.34 108.874 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 30.5 p-10 -89.09 100.49 13.25 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.115 0.959 . . . . 71.24 111.239 -171.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.568 ' HA ' ' HA2' ' C' ' 146' ' ' GLY . 2.6 p30 -146.65 79.78 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.453 1.101 . . . . 73.32 108.862 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -96.04 -67.13 0.87 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.117 -0.947 . . . . 74.52 109.477 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -169.42 168.44 9.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.369 1.067 . . . . 72.51 108.88 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 29.3 ttm 66.85 112.36 0.04 OUTLIER 'General case' 0 C--N 1.348 0.503 0 C-N-CA 125.934 1.694 . . . . 73.52 111.435 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -101.36 75.16 1.6 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.535 -1.283 . . . . 72.21 107.535 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' C' ' 85' ' ' SER . 56.6 t80 -84.8 118.06 24.24 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 108.221 -1.029 . . . . 54.33 108.221 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -147.49 131.97 17.68 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.725 -0.842 . . . . 41.35 108.725 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -75.95 125.65 35.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.75 -0.834 . . . . 74.4 108.75 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.6 mm100 -95.11 -45.49 7.19 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 72.12 110.115 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.6 HH22 HD12 ' F' ' 134' ' ' ILE . 76.9 ttt180 -166.76 126.31 1.5 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.958 0.503 . . . . 74.21 109.888 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.01 144.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.974 -1.121 . . . . 73.2 107.974 174.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -177.97 161.22 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.454 0.645 . . . . 73.02 111.017 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -86.28 110.69 19.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.38 -0.827 . . . . 72.23 108.977 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.473 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 7.3 mmmt -72.23 -44.71 62.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.397 -0.964 . . . . 72.32 108.397 172.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.9 t70 -134.51 143.86 47.69 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.661 -1.154 . . . . 70.34 110.234 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.93 147.77 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.267 1.827 . . . . 74.13 106.444 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -157.55 151.64 24.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.066 0.546 . . . . 71.13 110.153 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -148.74 146.28 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.871 -1.159 . . . . 75.02 107.871 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 47.6 mt-10 -141.79 150.11 41.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.259 -1.385 . . . . 71.32 107.259 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -154.85 88.97 3.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.47 -45.58 17.65 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.832 2.355 . . . . 75.05 111.759 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 67.1 m-80 -98.79 40.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.733 -0.667 . . . . 62.11 110.594 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.19 -42.19 91.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.335 1.054 . . . . 61.42 113.32 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.95 -34.7 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 121.611 1.541 . . . . 64.53 112.833 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 38.1 t-80 -68.11 -19.49 64.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.064 1.346 . . . . 73.21 111.874 -172.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.562 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.1 p -48.58 -35.27 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 124.618 1.167 . . . . 73.15 113.55 175.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -59.18 -40.4 85.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.797 0.839 . . . . 71.24 111.35 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -115.6 18.31 15.9 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.364 -0.835 . . . . 72.41 111.331 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.562 ' HE2' HG23 ' C' ' 31' ' ' VAL . 0.0 OUTLIER -82.63 165.51 19.97 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.236 -0.653 . . . . 75.12 109.236 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.39 130.75 35.09 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.721 -0.844 . . . . 71.24 108.721 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -75.34 85.85 2.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.632 0.73 . . . . 74.03 110.075 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -154.27 68.8 6.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.562 -1.199 . . . . 64.31 107.773 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -91.95 112.34 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.334 2.023 . . . . 60.02 111.287 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.56 95.04 9.61 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 108.104 -1.073 . . . . 53.01 108.104 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.95 107.58 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.126 -0.943 . . . . 44.45 110.134 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.5 mttp -91.05 102.83 15.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 72.13 107.669 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.503 HD23 HG22 ' C' ' 64' ' ' VAL . 3.1 tm? -87.07 145.23 26.54 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.131 -1.063 . . . . 74.25 108.131 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -139.91 137.82 35.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.874 0.87 . . . . 71.04 108.691 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.34 146.49 51.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.894 0.878 . . . . 60.42 109.149 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.04 154.71 28.06 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.045 0.938 . . . . 54.23 109.218 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -155.87 148.54 24.01 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.929 0.395 . . . . 64.21 110.384 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.78 163.35 33.59 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.04 0.936 . . . . 73.12 109.036 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.1 p -130.72 147.16 52.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.994 0.517 . . . . 53.2 110.048 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.0 p -143.97 129.06 18.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.73 0.812 . . . . 72.24 109.305 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -78.46 116.49 18.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.915 0.486 . . . . 73.03 110.295 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' C' ' 57' ' ' GLU . 47.2 mt -87.96 -45.77 9.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.799 0.84 . . . . 73.05 109.317 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.71 -179.49 6.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.39 -1.277 . . . . 60.44 109.343 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.38 109.57 0.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.929 0.768 . . . . 65.41 110.216 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.67 22.44 7.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.603 1.161 . . . . 64.22 112.018 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.1 105.61 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.511 1.124 . . . . 62.54 108.027 173.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -114.64 128.81 56.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.675 0.79 . . . . 74.53 110.07 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.98 115.29 22.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.595 0.758 . . . . 74.35 109.195 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.9 t -96.81 121.17 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.14 -1.059 . . . . 44.12 108.14 173.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.7 105.31 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.5 -0.926 . . . . 50.31 108.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.3 tm? -91.29 105.0 17.47 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.277 -1.008 . . . . 70.01 108.277 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -95.9 121.93 38.16 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.951 0.9 . . . . 70.24 110.194 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.8 t -107.35 146.67 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 107.909 -1.145 . . . . 74.54 107.909 169.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 23.4 m -139.46 120.69 14.82 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.495 0.664 . . . . 62.31 109.501 170.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.503 HG22 HD23 ' C' ' 42' ' ' LEU . 85.7 t -101.85 108.86 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.73 -1.123 . . . . 75.32 108.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.8 m -97.92 135.55 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.178 -1.415 . . . . 73.34 107.178 169.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.28 102.97 5.15 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.028 -1.471 . . . . 63.35 107.028 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.438 ' HB3' HG23 ' C' ' 72' ' ' THR . 26.2 p -168.51 154.48 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.695 0.622 . . . . 51.44 110.838 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -95.5 -42.81 8.27 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.187 -0.672 . . . . 52.42 109.187 171.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.42 -80.85 0.05 OUTLIER Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.781 -0.928 . . . . 55.41 110.781 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -89.4 -31.65 17.65 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.779 -0.823 . . . . 73.11 108.779 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.91 85.25 2.23 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.626 -0.715 . . . . 74.55 109.48 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.438 HG23 ' HB3' ' C' ' 67' ' ' SER . 27.5 m -89.31 116.86 27.84 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.233 -0.44 . . . . 75.45 110.197 172.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.51 -64.78 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.511 -1.292 . . . . 55.14 107.511 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.81 171.61 16.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.545 0.688 . . . . 54.13 111.645 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.7 tm? -132.08 145.35 51.35 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.563 -2.014 . . . . 73.21 105.563 171.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -151.72 142.99 23.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.382 -0.97 . . . . 62.34 108.382 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -150.1 134.25 17.11 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.404 -0.591 . . . . 73.43 109.404 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' C' ' 110' ' ' ALA . 50.3 t -134.27 113.69 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.89 0.876 . . . . 65.34 108.661 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 54.3 mt-30 -91.05 90.13 7.71 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.525 -0.917 . . . . 73.25 108.525 171.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 61.3 tp60 -78.81 103.77 8.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.84 -1.073 . . . . 74.1 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.74 144.74 22.28 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.458 -0.657 . . . . 72.13 111.458 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.05 117.1 0.9 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.557 -1.017 . . . . 74.5 110.557 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.525 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -80.0 126.73 39.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.854 -1.165 . . . . 60.21 107.854 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.6 143.33 47.27 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.892 0.477 . . . . 73.44 109.812 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 15.6 m -82.1 107.14 14.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.656 -1.238 . . . . 75.15 107.656 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.4 99.72 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.095 -1.076 . . . . 73.42 108.095 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -128.75 159.31 36.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.362 1.065 . . . . 62.43 110.152 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -53.45 4.37 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.53 0.519 . . . . 72.13 113.435 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' C' ' 94' ' ' MET . 30.0 pt -80.92 150.82 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.872 0.869 . . . . 65.12 112.117 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -147.23 153.75 40.18 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.77 1.228 . . . . 72.44 108.85 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.64 -111.32 2.07 Favored Glycine 0 C--N 1.355 1.612 0 O-C-N 123.548 0.53 . . . . 74.04 114.136 170.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 24.9 p -50.6 -55.42 16.37 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.293 1.437 . . . . 74.24 112.868 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.38 -46.32 80.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.054 0.542 . . . . 73.55 111.502 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.405 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.0 ptt? -68.83 -31.48 70.5 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.356 0.41 . . . . 75.42 111.484 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.61 75.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.166 0.587 . . . . 73.11 111.528 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -69.58 -29.46 67.01 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.837 -0.62 . . . . 71.43 110.846 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.34 -58.93 3.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.908 0.483 . . . . 42.45 110.486 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -73.36 -15.62 61.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.94 0.496 . . . . 74.21 111.652 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.32 7.73 58.46 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 119.588 -0.562 . . . . 64.13 113.822 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB2' ' HD2' ' C' ' 133' ' ' PHE . . . -159.43 -60.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.689 0.745 . . . . 71.14 112.152 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -73.41 -44.8 57.65 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.453 0.701 . . . . 74.21 112.788 -167.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 38.0 m -68.65 -47.2 34.44 Favored Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.14 0.576 . . . . 53.41 111.415 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 38.2 Cg_exo -64.48 -26.15 62.66 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.177 1.918 . . . . 74.45 114.192 173.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -55.06 -49.05 72.6 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.894 0.877 . . . . 70.14 110.277 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -56.96 -41.98 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 124.163 0.915 . . . . 71.11 110.897 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.1 mt -83.41 -23.0 32.55 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.126 -0.943 . . . . 63.43 112.566 -171.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.74 -50.34 87.25 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.57 -1.205 . . . . 64.32 113.494 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.41 -34.17 93.82 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.071 1.847 . . . . 72.34 112.918 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -68.0 -50.72 53.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.787 0.835 . . . . 73.11 111.448 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -65.31 -35.03 79.74 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 116.018 -0.537 . . . . 50.21 111.117 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.473 HH12 ' HG3' ' C' ' 130' ' ' PRO . 59.6 ttt180 -60.66 -48.51 81.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.797 1.639 . . . . 60.14 110.647 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.422 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 3.1 tm-20 -72.82 -33.62 66.31 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.873 0.469 . . . . 74.41 109.993 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.423 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 8.6 t -65.55 -28.73 69.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.979 0.512 . . . . 74.04 111.135 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.468 HD13 HG23 ' C' ' 64' ' ' VAL . 87.9 mt -78.77 -51.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.659 -0.7 . . . . 54.32 110.033 173.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 33.6 m -58.97 -28.56 66.44 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.251 0.548 . . . . 71.45 111.173 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 44.6 t -63.38 -55.27 25.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.266 1.026 . . . . 74.33 109.053 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.473 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -34.69 71.19 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.739 1.216 . . . . 73.22 112.774 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.9 t -66.2 -48.09 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.855 -0.794 . . . . 73.45 108.855 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -31.97 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.022 -0.99 . . . . 70.33 111.214 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.5 mtt-85 -66.94 -40.85 87.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.524 0.73 . . . . 72.11 109.437 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.73 3.93 62.52 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.826 0.704 . . . . 71.14 112.988 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 59.69 31.33 20.81 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.436 1.894 . . . . 65.21 112.994 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.98 153.47 43.42 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.078 0.951 . . . . 72.13 108.929 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 -169.89 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.91 2.406 . . . . 73.55 113.536 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' B' ' 125' ' ' GLN . 50.9 mm-40 -52.28 117.96 3.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.367 1.067 . . . . 71.52 113.138 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' E' ' 139' ' ' LEU . 2.8 tm? -139.55 104.39 4.93 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.033 -1.469 . . . . 72.33 107.033 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.12 131.1 38.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.672 1.189 . . . . 64.31 108.227 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -86.11 142.54 28.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.925 -0.398 . . . . 74.13 109.925 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 139.03 97.55 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.32 1.048 . . . . 53.41 111.922 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.473 ' HG3' HH12 ' C' ' 111' ' ' ARG . 27.0 Cg_exo -63.44 98.28 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.758 2.305 . . . . 74.33 112.837 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.86 109.17 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.05 -0.722 . . . . 71.51 109.05 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -115.36 102.99 10.35 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.79 0.836 . . . . 64.11 109.95 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' C' ' 100' ' ' ALA . 67.2 t80 -80.37 -24.18 39.97 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.58 0.705 . . . . 75.15 110.212 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -75.33 -39.0 59.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.406 1.083 . . . . 71.24 111.123 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.479 ' HA ' ' HG3' ' C' ' 138' ' ' MET . . . -59.96 -39.12 84.52 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.884 0.74 . . . . 60.41 111.395 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 46.9 tp -54.02 -45.01 71.44 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.276 1.03 . . . . 73.25 111.212 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -80.71 -36.56 32.01 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.245 -0.888 . . . . 73.32 111.772 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.479 ' HG3' ' HA ' ' C' ' 135' ' ' ALA . 0.0 OUTLIER -70.24 -29.01 65.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.029 0.381 . . . . 75.21 112.029 -170.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -59.07 -44.12 91.82 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 120.884 0.373 . . . . 74.33 110.646 172.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -71.62 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.514 -0.766 . . . . 70.42 109.303 171.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 53.9 tp -105.03 118.9 37.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.747 0.819 . . . . 62.0 109.926 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -73.83 177.45 5.53 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.819 0.848 . . . . 61.45 111.156 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -103.09 154.6 19.11 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.26 1.024 . . . . 72.14 110.879 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.465 ' HG2' ' HA3' ' A' ' 146' ' ' GLY . 35.1 mt-30 -75.4 157.84 33.59 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.231 0.612 . . . . 72.01 111.274 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.25 112.45 7.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.088 0.955 . . . . 52.42 109.163 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' C' ' 6' ' ' ASN . . . -118.95 67.37 0.37 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.46 -0.656 . . . . 72.34 111.46 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -122.08 179.38 4.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.459 0.704 . . . . 60.12 110.494 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.91 7.98 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.278 -0.874 . . . . 74.45 111.038 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -74.0 -68.96 0.47 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.05 -0.722 . . . . 72.45 109.05 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 44.22 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.964 1.305 . . . . 74.42 111.61 177.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.65 -39.92 85.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.214 -0.903 . . . . 73.5 110.725 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -175.61 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 O-C-N 124.638 1.211 . . . . 71.14 109.281 165.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -144.48 151.32 39.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.828 1.251 . . . . 72.12 108.605 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t70 65.57 107.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.216 1.006 . . . . 63.2 111.027 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 N-CA-C 109.245 -0.65 . . . . 72.23 109.245 179.426 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 109.686 -0.487 . . . . 74.45 109.686 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t 179.67 69.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 106.771 -1.566 . . . . 75.4 106.771 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.27 75.27 4.8 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.077 -0.965 . . . . 75.13 110.182 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -134.41 100.09 4.56 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.223 -1.029 . . . . 61.4 108.223 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.81 100.17 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.126 0.97 . . . . 74.52 109.089 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -57.47 131.81 51.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.376 0.67 . . . . 74.14 111.779 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -70.4 -40.21 74.02 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.406 0.683 . . . . 64.33 111.522 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -82.66 132.18 35.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.027 0.531 . . . . 73.43 109.72 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -30.4 135.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 125.367 1.667 . . . . 64.41 114.851 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 45.5 m -145.69 143.65 29.91 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.452 1.101 . . . . 72.43 109.202 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' D' ' 85' ' ' SER . 44.8 t80 -154.08 109.92 3.23 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.053 -1.091 . . . . 71.53 108.053 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.8 116.42 27.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.313 0.645 . . . . 64.01 110.259 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 30.9 pt -78.39 99.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.483 -0.932 . . . . 75.21 108.483 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -83.44 -45.31 13.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.944 -0.472 . . . . 74.23 111.669 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.422 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 20.5 ttt180 -164.71 126.6 2.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.597 -0.149 . . . . 75.3 110.597 -167.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.69 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -113.15 133.68 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.639 -1.245 . . . . 62.44 107.639 174.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.9 p90 -159.03 178.42 10.08 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.429 0.692 . . . . 71.42 111.782 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 58.2 p -107.36 132.19 53.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.619 -0.882 . . . . 73.34 108.619 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.0 mtpt -96.21 -31.48 12.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.195 -0.298 . . . . 62.54 110.195 175.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.0 t70 -150.24 141.27 22.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.929 0.892 . . . . 74.11 108.916 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.1 mt -143.75 148.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.7 1.2 . . . . 50.05 107.921 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.6 t -151.64 145.46 25.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.331 1.053 . . . . 72.21 109.176 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -150.59 125.27 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.725 -1.954 . . . . 73.44 105.725 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -131.79 131.94 43.35 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.139 0.427 . . . . 71.1 110.104 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.55 79.69 11.22 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.779 -0.823 . . . . 75.13 108.779 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.77 -39.72 14.42 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.584 2.189 . . . . 73.32 111.303 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -98.79 24.73 7.27 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.811 . . . . 52.33 109.97 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.513 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -51.97 -49.13 85.77 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 115.132 1.53 . . . . 43.45 115.132 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.83 -7.37 9.47 Favored 'Trans proline' 0 C--N 1.39 2.745 0 CA-C-N 121.791 1.675 . . . . 62.33 112.996 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -83.82 -40.15 19.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 74.11 109.813 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.42 -12.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.549 0.739 . . . . 62.51 110.712 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -56.82 -29.77 63.08 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.667 1.187 . . . . 74.53 111.815 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -70.89 -14.24 62.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.228 1.011 . . . . 64.32 112.124 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.42 108.76 13.06 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.805 0.842 . . . . 64.11 109.771 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.69 82.16 3.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.654 0.74 . . . . 64.14 110.383 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -148.63 165.46 31.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.193 0.997 . . . . 74.05 108.666 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.481 ' HB3' ' HG ' ' F' ' 141' ' ' LEU . 15.5 mp0 -69.52 110.67 6.8 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.281 1.433 . . . . 74.44 111.222 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 16.6 Cg_exo -71.12 124.07 10.2 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.058 2.505 . . . . 70.45 112.392 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -60.99 118.91 7.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.378 0.424 . . . . 72.04 110.807 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.484 HG23 HG13 ' D' ' 64' ' ' VAL . 2.3 p -98.91 128.0 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.797 0.839 . . . . 43.15 109.498 -176.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 9.3 tmtt? -99.29 117.0 32.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.046 -1.835 . . . . 74.41 106.046 170.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.467 HD22 HD22 ' D' ' 128' ' ' LEU . 53.2 tp -95.1 134.79 37.42 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.984 -1.117 . . . . 65.14 107.984 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.5 t70 -135.43 149.92 49.72 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.263 -1.384 . . . . 75.14 107.263 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -135.43 164.69 27.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.482 0.313 . . . . 63.41 111.195 -174.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.9 t70 -171.23 156.18 4.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.514 1.125 . . . . 63.12 109.351 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -134.63 160.54 37.79 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.476 0.711 . . . . 73.42 110.003 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.1 162.83 39.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.056 0.942 . . . . 43.21 109.344 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -140.63 157.94 44.72 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.163 0.585 . . . . 71.23 110.803 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -161.15 130.2 4.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.571 1.148 . . . . 34.11 108.567 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -89.89 123.55 33.93 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.09 -0.707 . . . . 73.42 109.09 172.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' D' ' 57' ' ' GLU . 56.6 mt -97.94 -35.62 10.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.791 0.836 . . . . 62.11 110.056 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -160.32 -175.62 5.14 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.954 -1.021 . . . . 44.02 110.564 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.97 109.39 1.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.787 -1.097 . . . . 62.23 109.674 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.81 10.01 6.5 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.985 1.314 . . . . 75.12 112.925 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 89.1 t -109.02 118.33 56.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.233 -1.025 . . . . 62.52 108.233 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.63 129.83 44.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.066 -0.97 . . . . 73.43 109.74 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.615 ' HB2' HD11 ' D' ' 51' ' ' LEU . 35.3 tt0 -87.24 130.75 34.45 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.316 1.046 . . . . 73.13 108.683 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.0 145.0 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.142 -1.059 . . . . 72.05 108.142 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 85.6 t -117.46 142.46 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.017 0.927 . . . . 74.13 108.73 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 116.56 24.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.435 -1.321 . . . . 63.1 107.435 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -101.44 103.92 14.84 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.126 -1.064 . . . . 53.32 108.126 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.73 117.77 49.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.244 -1.021 . . . . 72.03 108.244 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 10.4 m -118.02 127.92 54.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.245 0.618 . . . . 74.5 110.385 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 73.4 t -114.63 123.78 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.322 1.449 . . . . 63.42 108.962 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 32.3 m -123.6 91.61 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.908 -1.145 . . . . 73.13 107.908 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 138.74 34.3 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.254 -0.647 . . . . 52.34 109.254 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -154.62 125.86 7.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.437 -0.801 . . . . 72.54 109.692 -173.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' D' ' 71' ' ' GLU . 46.4 tp -113.38 99.19 7.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.067 -0.716 . . . . 74.03 109.067 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.83 -128.74 9.08 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 112.157 -0.377 . . . . 61.35 112.157 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -90.33 14.54 12.52 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.307 1.043 . . . . 71.43 110.839 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' D' ' 68' ' ' LEU . 3.3 tp10 -115.31 134.31 55.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.179 0.992 . . . . 73.2 111.431 -158.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.3 m -69.59 110.47 4.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.594 -0.891 . . . . 75.24 108.594 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 -66.83 0.84 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.66 -0.496 . . . . 61.31 109.66 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -154.35 136.6 14.85 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.399 0.619 . . . . 71.13 110.265 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.3 mt -105.12 152.49 22.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.649 1.18 . . . . 52.42 108.0 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 41.0 t -160.37 148.77 16.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.119 0.568 . . . . 33.33 109.963 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.7 125.75 6.59 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.818 -0.808 . . . . 75.21 108.818 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.413 0.685 . . . . 74.34 109.607 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -93.89 87.11 5.27 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.719 -0.845 . . . . 73.25 108.719 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -79.04 110.01 13.87 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.434 -1.257 . . . . 64.12 108.45 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.45 143.93 15.75 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.239 -0.344 . . . . 72.55 112.239 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.48 139.84 9.45 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.833 0.317 . . . . 71.33 112.347 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.35 123.17 40.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.806 0.842 . . . . 71.31 108.984 173.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.08 141.51 48.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.106 0.963 . . . . 71.33 108.729 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 17.4 m -102.37 112.69 25.5 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.315 -0.624 . . . . 70.51 109.315 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.99 103.56 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.245 -1.02 . . . . 73.14 108.245 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.55 153.48 49.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.442 1.097 . . . . 74.42 109.711 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 2.78 61.29 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.102 0.252 . . . . 71.21 113.367 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 44.9 mm -131.41 129.83 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.861 1.264 . . . . 74.04 108.317 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.65 179.1 7.02 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.191 0.997 . . . . 74.04 110.814 -174.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.0 -135.46 24.39 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.886 -0.597 . . . . 63.11 114.083 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -80.1 -21.85 42.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.936 0.894 . . . . 75.51 111.927 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.57 -40.4 73.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.959 0.504 . . . . 75.34 111.164 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -28.64 64.75 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 110.311 -0.255 . . . . 72.24 110.311 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.55 -32.76 66.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.475 0.71 . . . . 64.25 110.555 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -65.93 -43.43 88.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.257 0.623 . . . . 73.35 110.198 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.54 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 89.8 m -61.67 -42.33 98.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.437 0.295 . . . . 65.41 110.884 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.01 -40.02 65.54 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.065 0.546 . . . . 63.31 111.629 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.97 3.68 38.59 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-O 119.414 -0.659 . . . . 71.55 114.662 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -144.43 -63.24 0.37 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.979 0.889 . . . . 74.21 112.203 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 82.7 t80 -64.95 -58.19 6.79 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.372 0.508 . . . . 72.51 112.372 -170.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 66.1 m -59.94 -44.23 96.36 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 118.513 -0.756 . . . . 72.02 112.737 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.43 -37.5 94.76 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.419 2.079 . . . . 63.22 113.919 167.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.96 -28.54 66.73 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.446 0.698 . . . . 54.34 110.858 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.5 -40.63 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.398 0.618 . . . . 63.23 109.773 170.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.422 HD21 ' HA3' ' D' ' 82' ' ' GLY . 82.7 mt -76.53 -18.97 58.42 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.23 -0.896 . . . . 61.24 112.008 -176.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -64.11 -43.4 74.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.293 1.22 . . . . 73.44 114.293 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.45 -39.94 63.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.051 1.834 . . . . 61.52 113.292 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -78.93 -30.18 44.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.746 0.818 . . . . 75.32 111.621 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.67 65.62 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.212 0.605 . . . . 63.4 109.641 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.44 -49.42 74.62 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.2 -1.364 . . . . 75.32 110.607 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.73 -45.9 92.48 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.041 0.838 . . . . 75.45 111.697 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -59.13 -40.97 87.1 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.715 0.635 . . . . 71.42 110.745 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.52 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.6 mt -61.79 -56.89 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 123.791 0.682 . . . . 70.42 109.873 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' D' ' 125' ' ' GLN . 41.0 m -54.11 -38.69 65.68 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.649 1.18 . . . . 75.14 111.787 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -66.8 -44.01 82.36 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.791 -1.095 . . . . 73.31 110.399 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.5 -29.77 65.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.116 0.566 . . . . 73.24 111.907 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.9 t -68.16 -42.26 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 123.785 0.678 . . . . 73.43 109.336 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -75.63 -28.0 58.65 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.257 -0.429 . . . . 64.02 111.174 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.423 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 94.2 mtt-85 -69.97 -35.74 74.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.509 0.724 . . . . 74.01 109.614 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.53 0.16 77.03 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.794 0.683 . . . . 34.45 112.33 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.62 28.13 16.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.51 1.924 . . . . 72.44 112.677 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.406 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 37.4 m-85 -91.03 162.25 33.18 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.19 1.396 . . . . 73.52 110.683 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.435 ' HD3' HG11 ' F' ' 136' ' ' VAL . 18.6 Cg_endo -58.9 133.22 52.25 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.766 2.31 . . . . 75.02 111.853 177.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.7 tt0 -56.62 137.84 53.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.874 0.869 . . . . 75.33 112.446 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.39 108.95 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.894 -1.151 . . . . 73.22 107.894 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -113.27 110.96 21.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.805 -0.813 . . . . 72.34 108.805 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.467 HD22 HD22 ' D' ' 42' ' ' LEU . 90.5 mt -69.2 135.58 50.8 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.133 0.573 . . . . 62.41 110.279 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.51 146.95 98.81 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.024 0.929 . . . . 64.42 111.42 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -66.7 121.37 8.59 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.638 2.226 . . . . 74.43 111.269 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.74 118.8 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.338 0.655 . . . . 75.52 110.323 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -86.55 78.35 9.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.153 -1.054 . . . . 73.21 108.153 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.565 ' HA ' HD23 ' D' ' 136' ' ' LEU . 34.1 p90 -78.85 -10.32 59.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 74.11 111.333 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.466 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.6 m-20 -47.23 -51.21 19.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.8 1.24 . . . . 74.33 112.332 173.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.97 0.794 . . . . 71.1 111.695 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' D' ' 133' ' ' PHE . 3.3 mm? -71.07 -41.95 70.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.24 -0.891 . . . . 54.14 110.389 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.445 ' O ' HD13 ' D' ' 141' ' ' LEU . 49.4 m-85 -70.69 -32.08 69.19 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.329 0.651 . . . . 74.35 111.879 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.4 ' HE3' ' HB3' ' D' ' 134' ' ' ASP . 57.5 mtt -59.25 -41.72 89.42 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.943 0.497 . . . . 72.34 110.154 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -77.05 -42.33 38.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.968 -1.014 . . . . 61.41 110.713 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -63.74 -36.49 84.05 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.823 0.849 . . . . 74.34 111.874 -174.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.445 HD13 ' O ' ' D' ' 137' ' ' PHE . 5.6 mp -66.38 -29.32 69.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.411 0.684 . . . . 72.02 110.893 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -88.53 0.67 56.07 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.437 0.695 . . . . 75.21 111.282 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -137.51 49.69 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.001 0.921 . . . . 71.22 109.354 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -146.49 166.27 26.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.277 0.631 . . . . 61.25 110.519 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.25 170.6 7.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.962 0.905 . . . . 61.15 110.618 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -129.04 31.46 3.48 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 111.494 -0.643 . . . . 62.14 111.494 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.99 155.01 29.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.919 0.887 . . . . 62.42 111.517 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 148.31 44.98 0.03 OUTLIER Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.225 -0.443 . . . . 60.24 112.135 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.2 t -63.1 127.65 32.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.61 0.364 . . . . 65.4 110.063 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -163.77 -172.38 2.84 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.096 0.559 . . . . 64.42 110.004 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.95 -75.23 0.17 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.583 -0.525 . . . . 74.15 109.583 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.35 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.463 1.105 . . . . 73.04 112.095 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.32 128.9 39.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.777 0.431 . . . . 72.42 110.506 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.93 126.66 35.81 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.817 0.447 . . . . 71.42 110.238 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 C-N-CA 123.405 0.682 . . . . 71.3 109.844 175.965 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 110.172 -0.307 . . . . 64.32 110.172 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.8 6.8 5.76 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.624 1.569 . . . . 65.25 112.653 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.98 116.21 25.98 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.567 -0.901 . . . . 51.42 108.567 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.58 155.54 19.92 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.056 0.542 . . . . 72.12 110.795 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.36 147.03 51.79 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.834 0.854 . . . . 64.31 110.361 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -87.87 -22.57 24.35 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.573 -0.739 . . . . 73.54 110.392 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -126.92 129.13 47.58 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.804 0.841 . . . . 73.24 109.966 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 95.84 6.09 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.106 0.962 . . . . 75.51 109.007 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 116' ' ' TYR . . . . . 0.477 ' N ' ' HD3' ' E' ' 117' ' ' PRO . 0.1 OUTLIER -145.72 57.76 4.36 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.286 -0.87 . . . . 72.12 112.149 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' E' ' 116' ' ' TYR . 4.4 Cg_exo -85.63 125.89 2.93 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.615 2.21 . . . . 72.32 110.249 166.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -141.32 85.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.128 0.49 . . . . 64.31 109.791 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 24.3 m -100.54 78.47 2.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.569 -0.741 . . . . 72.01 109.152 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -164.79 -71.25 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.479 -0.782 . . . . 74.4 109.667 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 58.05 36.5 26.07 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.892 0.877 . . . . 73.3 110.954 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 64.47 176.99 0.18 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.103 1.361 . . . . 70.02 112.905 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.62 4.94 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.632 -0.713 . . . . 74.2 109.891 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 67.63 -68.95 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.484 1.514 . . . . 73.34 112.28 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 43.0 t80 69.1 150.27 0.08 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.777 0.831 . . . . 62.41 109.618 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.88 148.92 29.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.932 0.493 . . . . 74.52 109.696 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.82 138.8 5.77 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.403 -0.817 . . . . 74.24 111.405 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.33 100.34 3.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.616 0.767 . . . . 72.14 110.053 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.45 -38.16 55.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.597 0.759 . . . . 74.1 110.636 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mt -84.99 79.86 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 109.009 -0.737 . . . . 72.3 109.009 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -162.81 82.62 0.51 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.597 -1.183 . . . . 73.13 108.553 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -156.87 90.41 2.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.391 -0.966 . . . . 63.14 108.391 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.13 37.61 0.5 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.485 2.79 . . . . 73.02 114.383 -170.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 39.7 pt -72.88 -1.81 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 112.53 0.567 . . . . 72.5 112.53 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.25 9.86 7.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.877 1.271 . . . . 62.2 113.32 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 83.6 t -80.24 -65.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 122.966 0.506 . . . . 75.15 109.718 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 72.5 -54.85 0.68 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 125.109 1.364 . . . . 72.33 112.815 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.72 166.97 31.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.014 1.325 . . . . 32.33 108.926 173.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 139' ' ' LEU . . . . . 0.446 ' HB2' HD23 ' C' ' 126' ' ' LEU . 7.4 mp -76.0 140.89 42.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.753 0.311 . . . . 73.21 110.802 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 37.7 m -90.97 169.02 11.24 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.05 0.94 . . . . 74.35 110.665 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 77.9 mt 62.38 28.7 17.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.75 1.22 . . . . 72.32 111.873 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -49.62 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.553 -0.749 . . . . 70.23 109.38 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -169.33 131.91 1.23 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.64 1.976 . . . . 72.01 107.237 171.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -80.26 -57.01 3.81 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.004 -0.739 . . . . 54.4 109.004 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -165.07 80.85 0.35 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.676 -1.231 . . . . 64.23 107.676 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.46 137.48 33.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.313 0.645 . . . . 74.44 110.58 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 -78.93 0.44 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.126 -1.064 . . . . 65.11 108.126 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 148' ' ' LEU . . . . . 0.447 ' HB2' ' HD3' ' E' ' 149' ' ' PRO . 6.5 mp -116.39 -53.38 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.515 -0.755 . . . . 74.44 110.581 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 149' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' E' ' 148' ' ' LEU . 4.2 Cg_exo . . . . . 0 C--N 1.398 3.174 0 C-N-CA 122.244 1.963 . . . . 54.44 111.914 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.962 -0.385 . . . . 62.21 109.962 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.64 108.81 4.26 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.092 0.557 . . . . 73.3 110.394 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.17 146.38 23.77 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.587 -0.733 . . . . 53.4 109.062 168.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -90.84 26.21 2.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.447 0.699 . . . . 64.11 109.841 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 69.99 -54.34 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.492 1.917 . . . . 73.25 111.298 -172.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.8 21.24 12.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.758 1.223 . . . . 71.24 110.841 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 114' ' ' LYS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 13.9 mptt -67.29 104.88 1.59 Allowed 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.442 1.497 . . . . 74.21 109.24 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.474 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 7.9 mp 67.66 6.24 4.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.809 1.243 . . . . 62.22 111.836 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -126.38 78.83 71.32 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.368 -0.975 . . . . 62.42 108.368 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -99.52 2.72 0.95 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.733 2.289 . . . . 65.45 112.572 171.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.3 115.92 28.49 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.647 0.779 . . . . 70.03 110.539 -167.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 43.5 p -94.81 97.05 9.75 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.89 0.876 . . . . 70.41 109.595 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 120' ' ' TRP . . . . . 0.409 ' NE1' ' HA ' ' F' ' 123' ' ' VAL . 5.1 t-105 -83.13 144.96 29.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.696 -0.483 . . . . 75.14 109.696 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -142.65 -49.24 0.35 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.651 0.781 . . . . 72.44 111.341 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.53 72.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.5 0.556 . . . . 72.02 112.5 -173.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 123' ' ' VAL . . . . . 0.409 ' HA ' ' NE1' ' F' ' 120' ' ' TRP 0.298 4.1 p 47.42 -70.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 C-N-CA 126.93 2.092 . . . . 72.23 113.917 -173.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' F' F ' 124' ' ' ARG . . . . . 0.438 ' HD3' ' HB2' ' C' ' 3' ' ' GLU . 2.1 mmp_? 66.39 45.39 2.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.58 1.152 . . . . 74.32 110.989 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 125' ' ' TYR . . . . . 0.677 ' HA ' HG11 ' A' ' 131' ' ' VAL . 82.9 t80 -69.8 90.63 0.6 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.111 -1.44 . . . . 72.13 107.111 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.23 -92.13 0.05 OUTLIER 'General case' 0 C--N 1.35 0.624 0 CA-C-N 116.015 -0.539 . . . . 62.21 109.677 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.65 -79.31 0.13 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 111.794 -0.522 . . . . 44.31 111.794 -170.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 85.5 tttt 65.03 89.23 0.1 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.837 1.255 . . . . 72.21 109.171 -175.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.44 141.64 18.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.95 -1.023 . . . . 74.43 110.128 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 7.0 tp -162.94 27.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 124.628 1.171 . . . . 70.34 108.382 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.43 148.34 50.79 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.426 -0.806 . . . . 51.04 109.317 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 132' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' F' ' 135' ' ' ALA . 28.7 p90 -61.95 126.06 86.48 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 109.5 -0.555 . . . . 63.33 109.5 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.05 -29.59 56.78 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.858 2.372 . . . . 73.25 112.149 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 134' ' ' ILE . . . . . 0.6 HD12 HH22 ' C' ' 15' ' ' ARG . 15.6 tt -177.3 -30.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 125.332 1.453 . . . . 74.2 108.866 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 135' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' F' ' 132' ' ' TYR . . . 65.47 73.94 0.39 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 125.592 1.557 . . . . 71.11 111.666 176.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.487 HG12 HG23 ' F' ' 134' ' ' ILE . 13.0 p -169.66 156.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.08 0.952 . . . . 72.21 108.498 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 -50.8 3.0 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.741 0.416 . . . . 65.3 111.62 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -169.74 165.77 9.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.847 0.859 . . . . 72.13 110.678 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.69 93.74 0.18 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.336 0.654 . . . . 61.41 109.375 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 32.3 t -86.78 35.69 0.69 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.399 1.079 . . . . 65.32 110.461 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 141' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 37' ' ' GLN . 64.3 mt -109.93 -160.91 0.73 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.86 1.264 . . . . 74.03 108.746 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 80.4 mt 74.12 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.316 1.046 . . . . 64.21 110.263 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -55.29 96.07 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.974 0.892 . . . . 63.03 110.849 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.02 123.37 28.3 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.874 . . . . 70.5 109.559 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 65.97 179.16 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.78 1.232 . . . . 54.5 110.643 -168.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.06 31.5 18.22 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.69 0.796 . . . . 53.1 112.422 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 147' ' ' LEU . . . . . 0.552 HD11 ' HD2' ' B' ' 11' ' ' PHE . 3.0 pp -85.88 45.19 1.19 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.008 0.923 . . . . 62.3 112.384 -172.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.0 mp 56.22 57.97 9.31 Favored Pre-proline 0 CA--C 1.571 1.78 0 C-N-CA 123.72 0.808 . . . . 60.14 110.069 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--N 1.391 2.809 0 C-N-CA 123.382 2.721 . . . . 62.42 111.015 178.814 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.133 -0.321 . . . . 55.33 110.133 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.0 p -165.76 173.15 10.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.719 1.208 . . . . 75.04 109.373 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.79 2.19 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.114 0.566 . . . . 65.31 111.437 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.26 -166.4 1.6 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 72.54 109.427 -173.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -62.92 135.97 57.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.807 0.843 . . . . 71.03 111.108 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -59.97 -41.09 91.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.615 0.766 . . . . 73.31 110.422 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m 61.21 70.68 0.59 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.738 1.274 . . . . 65.41 110.256 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -86.37 38.02 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.867 -1.06 . . . . 63.35 112.168 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.465 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 1.4 mpt? 70.43 141.09 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.107 1.363 . . . . 65.2 111.678 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m -141.51 111.94 6.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.267 -1.012 . . . . 71.53 108.267 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' HG12 ' A' ' 86' ' ' ILE . 19.0 p90 -134.87 117.38 15.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.924 0.89 . . . . 72.0 108.868 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -155.32 138.42 15.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.963 0.505 . . . . 52.52 110.386 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 13' ' ' ILE . 4.1 mp -68.15 116.38 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 72.1 109.319 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.97 -41.67 17.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.013 -0.736 . . . . 61.44 109.013 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.537 HH11 ' HD2' ' B' ' 32' ' ' PHE . 72.0 ttt180 -168.56 140.63 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.502 0.721 . . . . 62.32 109.072 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.24 137.78 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.592 -0.892 . . . . 72.11 108.592 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -173.68 167.71 4.47 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.399 0.619 . . . . 64.34 112.251 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -86.15 123.97 32.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.835 -0.802 . . . . 64.43 108.835 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -86.36 -32.14 21.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.438 0.637 . . . . 62.33 109.523 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.735 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.9 t70 -141.63 140.91 33.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.955 -1.021 . . . . 63.13 110.45 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.4 mt -141.59 145.38 24.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.949 1.7 . . . . 71.42 106.795 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -159.24 130.32 6.09 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.722 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 84.4 t80 -132.11 119.51 21.05 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.353 -1.351 . . . . 64.33 107.353 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -118.59 140.87 49.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.822 -0.807 . . . . 74.32 108.822 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.68 78.66 15.77 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 107.444 -1.317 . . . . 74.4 107.444 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 -29.98 61.88 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.519 2.146 . . . . 73.33 111.726 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 16.1 m120 -117.01 40.71 2.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.879 0.872 . . . . 71.11 109.23 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.16 99.47 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.089 0.956 . . . . 64.13 113.2 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.25 -25.8 18.34 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.573 1.515 . . . . 71.41 112.462 171.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.6 m-70 -77.79 -33.37 52.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.793 -0.639 . . . . 63.1 112.223 -173.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' A' ' 123' ' ' PHE . 11.1 p -64.45 -22.17 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 120.958 0.409 . . . . 73.2 111.501 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -72.94 -29.54 63.18 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 63.42 110.681 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -82.7 -51.43 7.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.33 1.052 . . . . 63.14 110.574 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HE3' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -82.22 133.89 35.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.829 0.852 . . . . 74.33 109.8 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 68' ' ' LEU . 18.7 t70 -56.64 134.57 54.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.048 1.339 . . . . 73.45 113.221 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -71.1 83.06 0.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.546 0.738 . . . . 74.44 112.419 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -137.01 78.87 39.78 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.272 1.029 . . . . 74.24 109.011 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -84.03 133.3 5.68 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.955 2.436 . . . . 64.12 112.389 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.4 116.25 29.26 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.905 -1.146 . . . . 75.23 107.905 171.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.53 119.73 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.309 0.643 . . . . 65.44 110.761 -173.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -110.18 138.44 46.55 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.958 -1.127 . . . . 75.35 107.958 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' F' ' 126' ' ' ASN . 0.6 OUTLIER -131.06 146.16 52.27 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.31 0.644 . . . . 71.14 111.388 -169.339 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.85 144.62 50.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.418 1.087 . . . . 43.41 109.382 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -138.27 136.69 36.75 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 62.25 109.182 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 17.4 t70 -158.13 149.29 21.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.786 0.434 . . . . 73.52 110.84 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 m -135.19 126.58 28.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.199 1.0 . . . . 54.34 110.176 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.49 110.26 10.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.073 0.549 . . . . 73.01 110.11 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -88.39 153.25 21.33 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.78 -0.822 . . . . 63.14 108.78 175.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -164.88 117.04 1.21 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.213 0.46 . . . . 52.14 110.197 -171.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.84 105.39 3.78 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.828 0.851 . . . . 75.21 110.629 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 57' ' ' GLU . 97.6 mt -77.45 -37.72 50.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.804 0.842 . . . . 62.14 111.635 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -145.63 -174.11 4.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.255 1.022 . . . . 72.42 108.592 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.42 97.42 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.108 0.563 . . . . 62.51 110.519 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 58.71 27.72 16.29 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.722 1.209 . . . . 74.1 112.661 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 86.1 t -103.91 121.09 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.884 -1.524 . . . . 64.22 106.884 165.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.84 130.04 50.59 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.277 -0.638 . . . . 71.4 109.277 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 51' ' ' LEU . 42.2 tt0 -85.86 118.81 25.58 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.008 0.923 . . . . 71.52 108.63 168.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.42 111.8 29.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.396 -1.335 . . . . 65.11 107.396 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.4 t -99.26 130.96 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.501 -0.555 . . . . 51.44 109.501 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -106.79 113.56 27.12 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.579 -0.897 . . . . 75.31 108.579 -174.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -87.45 102.69 14.79 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.973 -0.751 . . . . 73.31 108.973 174.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.04 130.34 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.341 -0.985 . . . . 71.34 108.341 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 m -121.18 133.21 55.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.352 -0.981 . . . . 72.35 108.352 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.15 104.61 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.976 -1.12 . . . . 73.1 107.976 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -105.77 146.26 30.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.818 -0.808 . . . . 74.21 108.818 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.53 115.72 13.38 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.645 -1.243 . . . . 72.15 107.645 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -109.26 126.0 52.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.52 -0.548 . . . . 53.13 109.52 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.09 82.7 6.06 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 105.777 -1.935 . . . . 71.21 105.777 176.176 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.7 -127.18 7.83 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.435 -0.802 . . . . 64.12 111.665 -170.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.25 -14.72 30.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.972 0.509 . . . . 74.02 111.093 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -95.03 135.02 37.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.879 0.871 . . . . 75.32 109.511 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -65.34 129.25 39.06 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.01 0.524 . . . . 64.13 111.227 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -77.81 -58.05 3.47 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.093 -1.077 . . . . 64.44 108.093 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -166.91 165.74 15.87 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.641 -1.163 . . . . 73.54 110.437 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -134.73 145.14 48.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.535 1.134 . . . . 65.34 108.792 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.722 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 20.0 m -141.58 98.92 3.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.611 0.764 . . . . 73.23 109.44 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -109.28 129.21 55.52 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.625 -0.509 . . . . 71.43 109.625 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -130.51 132.82 64.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 123.753 0.821 . . . . 72.34 109.325 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.735 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.2 mt-30 -105.74 102.91 12.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.592 -0.731 . . . . 61.14 109.52 169.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.4 tp60 -89.77 98.89 12.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.842 -1.072 . . . . 71.23 109.366 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.4 142.14 15.97 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.374 -0.69 . . . . 62.44 111.374 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.52 122.58 2.42 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.929 -0.868 . . . . 72.41 110.929 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -80.91 125.37 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.636 -0.876 . . . . 63.42 108.636 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.8 121.58 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.203 0.601 . . . . 75.04 109.508 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -84.13 103.37 13.29 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.278 -1.008 . . . . 53.14 108.278 171.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.585 HD11 HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.47 124.69 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.48 0.657 . . . . 72.32 109.811 -171.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.29 175.77 13.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.126 0.97 . . . . 63.4 111.045 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.23 -24.97 29.02 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.758 -0.656 . . . . 24.14 113.043 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.585 HD11 HD11 ' A' ' 86' ' ' ILE . 13.6 pt -110.46 168.88 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.23 110.615 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' HA ' HD22 ' F' ' 115' ' ' LEU . 24.3 tt0 -150.85 -172.37 4.18 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.576 -1.193 . . . . 63.42 108.507 -171.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.545 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.46 -142.62 46.84 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.03 0.772 . . . . 62.32 115.03 171.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -77.29 -14.39 59.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.086 0.954 . . . . 62.13 111.561 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.407 ' HG3' HD11 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -67.0 -47.96 69.9 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.763 0.825 . . . . 73.31 110.015 -177.143 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.467 ' SD ' HD13 ' F' ' 115' ' ' LEU . 20.1 ttt -80.64 -35.83 33.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 51.23 111.074 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB2' ' HD2' ' F' ' 117' ' ' PRO . . . -57.88 -32.44 67.7 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.403 0.621 . . . . 61.13 111.447 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.28 -49.67 70.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.633 -1.167 . . . . 64.23 110.272 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.598 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 5.3 m -68.24 -63.22 1.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.701 1.0 . . . . 42.42 113.701 -170.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -12.35 60.04 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 118.88 0.764 . . . . 72.2 112.415 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.69 -6.07 44.16 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.178 -0.79 . . . . 74.34 114.5 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.19 -57.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 117.873 0.836 . . . . 62.15 111.786 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -55.69 -58.35 8.17 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.576 1.15 . . . . 71.23 112.045 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.96 -41.8 6.97 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 113.314 0.857 . . . . 53.22 113.314 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.9 Cg_endo -66.28 -24.86 50.2 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 121.624 1.55 . . . . 73.42 113.873 169.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -76.47 -22.35 54.66 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.941 0.791 . . . . 53.1 110.21 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mm -67.45 -43.02 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.267 0.627 . . . . 75.24 109.493 166.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.3 mt -71.25 -31.44 67.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.042 -0.981 . . . . 74.51 111.99 -175.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.51 -43.33 84.01 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.819 1.044 . . . . 73.43 113.819 -168.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.82 -31.79 82.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.276 1.984 . . . . 62.43 113.835 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -83.38 -28.78 28.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.186 0.594 . . . . 65.02 111.863 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.99 77.49 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.296 -0.631 . . . . 45.25 109.296 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.462 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.2 ttm180 -65.84 -38.35 88.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.524 -1.216 . . . . 73.44 110.327 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -53.51 -54.21 40.47 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.215 1.006 . . . . 75.22 110.247 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -61.85 -50.96 70.15 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.936 -1.484 . . . . 71.22 111.24 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 118' ' ' VAL . 17.7 mt -62.41 -58.9 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.703 0.801 . . . . 60.11 111.371 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -54.49 -38.58 66.61 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.871 0.732 . . . . 43.31 111.088 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.5 t -65.88 -45.89 80.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.496 -0.775 . . . . 42.05 110.285 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.5 mtp -57.15 -41.83 79.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.595 0.758 . . . . 42.42 111.31 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.2 t -60.45 -47.67 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.901 0.881 . . . . 64.31 110.233 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.663 -0.699 . . . . 64.25 111.585 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -74.62 -30.53 61.69 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.738 0.815 . . . . 73.54 109.747 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.48 2.37 67.48 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.519 -0.764 . . . . 65.5 112.569 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 68.27 22.31 8.14 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.874 1.27 . . . . 63.41 110.552 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.411 ' HE1' HG11 ' A' ' 31' ' ' VAL . 24.6 m-85 -96.5 153.27 38.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.823 0.849 . . . . 74.42 110.288 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 123.73 14.54 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.652 2.235 . . . . 61.53 111.075 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.75 147.44 27.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 124.036 0.835 . . . . 62.12 111.747 -171.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.0 mt -111.95 105.77 14.28 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.717 -0.846 . . . . 62.34 108.717 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.13 93.05 6.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.535 -0.913 . . . . 63.05 108.535 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' F' ' 125' ' ' TYR . 0.2 OUTLIER -67.07 127.7 33.57 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.443 -175.298 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 137.56 94.75 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.544 0.738 . . . . 75.03 111.58 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.434 ' HB3' HH22 ' A' ' 111' ' ' ARG . 34.1 Cg_endo -83.83 145.92 11.56 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.594 2.196 . . . . 61.21 113.02 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 114.21 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.636 -0.876 . . . . 60.44 108.636 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 36.1 m-80 -85.4 75.21 10.25 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.691 0.758 . . . . 64.41 110.008 176.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -68.89 -28.31 66.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.591 -1.186 . . . . 74.23 109.895 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -64.44 -51.85 61.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.205 -0.907 . . . . 75.44 110.402 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.62 -34.53 78.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.772 0.829 . . . . 63.42 111.212 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -54.17 -50.22 67.53 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.31 1.044 . . . . 74.44 111.405 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.1 -26.42 25.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.929 -0.578 . . . . 73.42 111.028 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.602 ' SD ' HD23 ' A' ' 141' ' ' LEU . 13.9 tpt -71.3 -29.36 64.95 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.099 0.56 . . . . 75.11 111.278 -172.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -55.4 -52.33 63.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.44 0.696 . . . . 73.0 109.58 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.51 ' HA ' ' HG2' ' A' ' 143' ' ' GLN . 68.3 t80 -65.85 -39.2 90.55 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.214 -0.903 . . . . 63.12 111.034 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.602 HD23 ' SD ' ' A' ' 138' ' ' MET . 23.7 tp -67.75 -8.54 36.42 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.115 0.966 . . . . 74.31 112.038 -173.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -149.11 31.81 0.76 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 122.601 0.361 . . . . 62.21 111.227 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 140' ' ' TYR . 20.8 mm-40 -56.12 -43.97 78.67 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 122.623 0.369 . . . . 74.41 111.039 172.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -78.34 99.08 6.19 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.395 -0.594 . . . . 63.11 109.395 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.85 164.71 36.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.365 1.066 . . . . 72.01 109.097 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.88 110.82 0.99 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.103 -0.399 . . . . 64.11 112.103 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.63 148.37 22.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.487 0.715 . . . . 70.41 110.078 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.46 68.49 0.29 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.521 -0.632 . . . . 61.43 111.521 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.5 p -71.96 107.53 4.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.117 0.567 . . . . 73.11 110.189 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -100.44 115.31 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.477 0.711 . . . . 73.22 109.438 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -115.94 105.21 12.4 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.828 -0.805 . . . . 73.51 108.828 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -135.55 101.43 4.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.214 1.006 . . . . 73.24 108.848 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -101.52 127.1 48.37 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.096 -0.705 . . . . 72.13 109.096 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -139.41 127.83 22.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.855 -0.794 . . . . 74.23 108.855 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.275 0 N-CA-C 109.041 -0.726 . . . . 74.53 109.041 -178.202 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.755 -0.461 . . . . 71.22 109.755 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 p -71.54 152.23 43.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.538 0.735 . . . . 62.52 111.406 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.76 118.05 21.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.522 0.729 . . . . 45.23 109.817 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.68 88.21 1.28 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.219 1.009 . . . . 63.21 111.033 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.12 110.43 15.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.799 -1.091 . . . . 73.4 108.224 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.07 127.95 22.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.295 0.638 . . . . 71.13 110.1 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -143.01 70.61 1.32 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.398 1.079 . . . . 65.33 110.118 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -141.42 157.09 45.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.708 0.803 . . . . 72.52 109.768 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.3 ptm 40.8 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 126.591 1.956 . . . . 74.4 114.17 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.0 m -152.42 125.58 8.62 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.136 0.974 . . . . 52.02 108.604 171.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -136.24 127.87 28.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.37 -0.604 . . . . 61.33 109.37 163.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -158.02 141.53 15.38 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.998 -1.112 . . . . 74.11 107.998 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.28 123.14 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 170.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -83.29 -50.6 8.22 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.083 -0.34 . . . . 74.43 110.083 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.31 130.48 1.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.113 -0.494 . . . . 72.42 109.817 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' B' ' 109' ' ' TYR . 92.3 mt -114.22 146.04 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.651 -0.87 . . . . 70.01 108.651 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -163.49 155.41 17.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.413 0.625 . . . . 74.44 111.494 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.6 m -78.26 126.17 30.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.007 -0.997 . . . . 75.12 108.625 170.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.506 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.3 mtpt -98.18 -32.6 11.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.57 0.748 . . . . 74.14 111.175 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.3 t70 -155.8 139.9 16.46 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.07 -0.514 . . . . 70.12 111.523 -167.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.8 mm -147.14 145.69 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.658 1.583 . . . . 64.3 108.355 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.92 151.98 32.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.718 -0.845 . . . . 73.31 108.718 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -147.58 115.48 6.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.853 -1.536 . . . . 74.22 106.853 173.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.6 121.97 42.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.7 -0.852 . . . . 54.12 108.7 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.866 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -125.47 80.61 65.49 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.853 -1.166 . . . . 54.25 107.853 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.09 -45.63 0.64 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.55 2.167 . . . . 60.53 111.693 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -98.8 18.65 16.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.699 0.8 . . . . 73.21 110.743 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.866 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.11 -50.53 54.65 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 125.213 1.405 . . . . 60.43 114.239 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -20.77 25.9 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.879 1.72 . . . . 74.33 112.593 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 21.6 m80 -91.0 -28.37 18.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.769 0.828 . . . . 71.01 110.868 -173.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.01 -8.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.424 0.689 . . . . 55.41 110.256 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.537 ' HD2' HH11 ' A' ' 15' ' ' ARG . 75.9 t80 -56.72 -33.94 66.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.929 1.292 . . . . 64.33 110.81 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -71.8 -29.52 64.54 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.037 -0.983 . . . . 64.53 111.27 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.447 ' HD3' HD22 ' B' ' 68' ' ' LEU . 95.6 mttt -94.89 110.21 22.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.448 0.699 . . . . 73.11 111.086 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.22 81.72 1.86 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.455 -0.942 . . . . 71.51 108.455 171.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.792 ' HB2' HD21 ' B' ' 68' ' ' LEU . 51.0 m95 -149.94 178.07 9.27 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.461 1.104 . . . . 71.0 108.457 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -78.04 127.36 81.84 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.43 0.692 . . . . 74.23 110.026 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' B' ' 68' ' ' LEU . 72.6 Cg_endo -77.86 146.83 23.77 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.946 1.764 . . . . 65.33 112.212 168.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.75 103.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.061 0.945 . . . . 73.42 108.932 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -86.62 129.98 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.541 0.736 . . . . 73.42 109.493 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.607 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.1 tttm -136.14 128.48 30.17 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.419 -0.956 . . . . 70.41 108.419 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.02 153.87 26.2 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.646 -0.872 . . . . 75.12 108.646 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.607 -0.886 . . . . 75.35 108.607 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.72 138.2 40.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.891 0.876 . . . . 74.34 109.014 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.2 t70 -144.79 152.7 40.74 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.02 1.328 . . . . 73.51 108.308 -174.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.9 t -151.33 140.46 21.2 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.312 0.645 . . . . 71.15 109.381 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.68 124.47 17.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.8 -1.185 . . . . 53.42 107.8 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -97.29 160.99 14.01 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.686 -0.487 . . . . 75.31 109.686 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 57' ' ' GLU . 32.7 t -149.41 155.37 40.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.006 -1.109 . . . . 62.11 108.006 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -124.78 129.17 49.94 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.364 0.665 . . . . 75.14 109.692 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.87 -45.06 10.02 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.324 0.649 . . . . 65.12 109.641 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.12 -176.09 5.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.295 -0.866 . . . . 71.41 110.093 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -61.9 125.96 25.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.0 -1.0 . . . . 62.01 109.055 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.36 2.85 3.47 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.134 1.374 . . . . 64.51 112.762 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 t -120.32 96.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.607 -0.886 . . . . 73.31 108.607 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.22 165.16 11.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.995 0.518 . . . . 44.35 110.159 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' B' ' 49' ' ' SER . 6.3 tm-20 -142.97 95.44 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.288 -1.745 . . . . 74.22 106.288 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.9 131.23 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.303 -0.628 . . . . 44.55 109.303 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.7 t -106.13 151.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.942 0.897 . . . . 75.32 109.952 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.18 119.49 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.087 -1.449 . . . . 72.21 107.087 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.607 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 38.3 ttp180 -105.96 120.98 43.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.872 0.368 . . . . 74.23 110.846 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' B' ' 114' ' ' ILE . 23.5 t -108.06 128.15 63.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.927 -1.138 . . . . 73.0 107.927 168.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -120.78 130.28 53.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.378 -0.601 . . . . 73.04 109.378 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.495 HG23 HD13 ' B' ' 114' ' ' ILE . 98.7 t -118.22 134.14 62.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.276 -0.875 . . . . 74.41 109.055 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 98.6 m -125.58 137.65 53.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.901 -1.045 . . . . 64.45 108.489 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.73 125.36 19.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.508 -1.293 . . . . 74.21 107.508 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 p -136.46 123.44 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.286 -1.005 . . . . 74.11 108.286 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' B' ' 36' ' ' TRP . 3.2 tt -95.61 116.18 28.48 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.48 -0.933 . . . . 73.32 108.48 -172.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -114.06 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 124.11 0.881 . . . . 43.52 111.517 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.48 4.73 15.34 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.182 0.993 . . . . 71.51 111.637 -175.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 12.2 pt-20 -129.62 163.89 25.07 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.317 0.647 . . . . 74.31 110.023 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 12.6 m -67.21 148.59 51.57 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.446 0.466 . . . . 61.14 110.66 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.93 -56.83 2.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.578 0.751 . . . . 64.12 109.024 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -165.36 153.67 11.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.139 -0.937 . . . . 74.12 110.235 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -131.43 144.56 51.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 75.14 108.13 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 40.2 t -151.57 152.27 32.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.559 -0.534 . . . . 73.44 109.559 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -158.36 129.6 6.48 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.21 0.604 . . . . 74.32 109.416 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.454 HG22 ' CD1' ' B' ' 21' ' ' ILE . 82.7 t -124.56 148.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.812 0.845 . . . . 72.41 109.985 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.607 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 41.7 mt-30 -125.69 98.45 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.23 -1.026 . . . . 63.11 108.23 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.9 tp-100 -85.89 104.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.839 -0.619 . . . . 74.23 109.429 174.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.74 168.47 25.01 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 111.544 -0.622 . . . . 71.13 111.544 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.47 130.76 2.2 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.466 -0.397 . . . . 71.42 112.97 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -84.14 128.92 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.147 0.979 . . . . 71.21 109.018 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.61 140.85 44.91 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.34 1.056 . . . . 63.3 109.759 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -87.49 107.6 18.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.211 1.004 . . . . 73.42 109.032 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.412 HG13 HD21 ' B' ' 98' ' ' LEU . 17.6 mm -122.77 121.8 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.673 0.789 . . . . 64.43 110.478 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.36 167.68 29.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.074 0.55 . . . . 54.24 110.987 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 85.62 -45.19 3.45 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.97 -0.559 . . . . 65.21 113.398 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.47 ' HB ' HD21 ' E' ' 115' ' ' LEU . 41.2 mm -74.36 138.49 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.663 0.785 . . . . 61.15 109.763 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.03 -172.43 4.03 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.809 0.843 . . . . 75.04 111.149 -176.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.28 -113.52 5.98 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.742 0.651 . . . . 53.42 113.981 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -88.29 -35.6 17.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.723 0.809 . . . . 61.33 110.59 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -71.2 -18.98 62.45 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.096 -0.956 . . . . 74.41 111.599 -168.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' E' ' 115' ' ' LEU . 19.7 ptp -56.12 -28.78 59.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.992 0.917 . . . . 73.32 112.097 173.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.25 87.61 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.101 0.96 . . . . 65.4 112.358 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -88.99 -27.53 20.82 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.367 -0.833 . . . . 71.21 111.218 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' CYS . . . . . 0.411 ' HB2' HG21 ' B' ' 89' ' ' ILE . 48.6 t -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.624 0.369 . . . . 64.14 111.821 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.412 HD21 HG13 ' B' ' 86' ' ' ILE . 77.4 mt -102.49 -35.08 8.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.749 0.42 . . . . 72.21 111.976 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.8 -23.25 53.53 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 120.029 -0.317 . . . . 72.15 113.842 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.35 -46.75 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.145 0.473 . . . . 51.04 112.047 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -77.1 -48.57 17.4 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.372 0.669 . . . . 74.45 110.796 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.2 m -60.72 -49.98 87.25 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.682 -0.675 . . . . 64.33 111.6 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.9 Cg_exo -56.77 -30.77 85.96 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.6 2.2 . . . . 71.04 114.496 171.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -63.36 -32.64 74.12 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.08 0.467 . . . . 64.43 110.965 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.2 mt -74.17 -44.54 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.864 0.866 . . . . 33.21 110.582 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' B' ' 80' ' ' GLN . 96.3 mt -72.36 -29.99 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.726 -1.125 . . . . 64.02 112.397 -172.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 80.5 t80 -59.93 -46.1 98.18 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 113.901 1.074 . . . . 71.2 113.901 -168.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.62 -41.75 72.51 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.233 1.955 . . . . 73.14 113.113 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.452 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.0 m-30 -64.26 -39.42 93.9 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.907 -1.042 . . . . 75.05 109.991 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.53 82.93 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.881 0.872 . . . . 74.4 110.961 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -57.23 -58.96 5.95 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.411 1.084 . . . . 73.22 111.752 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 -25.39 63.66 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.199 0.312 . . . . 64.31 110.267 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.435 ' O ' ' HG2' ' B' ' 117' ' ' MET . 13.4 t -70.2 -30.32 67.39 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.929 0.492 . . . . 51.21 111.626 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.495 HD13 HG23 ' B' ' 64' ' ' VAL . 88.6 mt -72.26 -55.92 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.082 0.553 . . . . 70.25 109.662 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.5 m -60.84 -27.98 68.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.54 -1.209 . . . . 73.54 111.411 -172.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.43 -46.02 84.99 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.915 0.886 . . . . 73.21 110.375 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.0 mmt -68.32 -31.3 70.63 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.095 0.558 . . . . 75.11 110.702 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.05 -38.96 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.956 0.902 . . . . 75.34 110.279 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.0 m -66.31 -37.74 86.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.726 0.81 . . . . 61.13 110.99 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -65.02 -38.8 92.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.275 -0.875 . . . . 75.23 109.351 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.35 -0.51 72.12 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 124.057 0.848 . . . . 64.25 113.877 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 55.39 36.26 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.596 1.558 . . . . 72.05 112.309 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -104.86 157.12 34.89 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.609 1.163 . . . . 62.43 110.282 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 129.39 33.87 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.119 2.546 . . . . 60.32 112.508 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -60.4 130.58 47.31 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.913 0.885 . . . . 62.53 112.514 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 90.2 mt -118.97 99.89 7.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.396 -0.965 . . . . 74.21 108.396 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.429 HD22 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -95.19 131.07 41.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.398 0.679 . . . . 73.23 109.469 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.456 ' HB3' ' CZ ' ' B' ' 107' ' ' PHE . 2.1 mm? -76.16 139.06 41.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.351 0.661 . . . . 71.01 110.922 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.38 141.44 45.8 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.027 0.931 . . . . 54.11 111.41 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.71 100.12 0.41 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.896 2.397 . . . . 70.34 112.46 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.87 133.36 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.759 0.824 . . . . 74.4 109.366 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.52 108.55 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.565 0.746 . . . . 64.43 111.219 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -59.95 -35.86 75.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.298 1.039 . . . . 72.04 110.167 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -56.69 14.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.228 -1.351 . . . . 75.04 111.954 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.74 68.84 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.625 0.77 . . . . 74.51 111.51 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.92 -42.26 85.67 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.268 1.027 . . . . 64.11 110.613 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -79.93 -16.85 54.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.308 0.643 . . . . 74.31 111.384 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 81.5 mmm -68.24 -29.21 67.97 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.378 0.271 . . . . 64.05 111.456 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.49 -25.49 57.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.52 0.328 . . . . 75.44 110.654 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' E' ' 122' ' ' ALA . 30.1 t80 -71.22 -31.48 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.435 0.694 . . . . 72.33 109.684 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 59.3 mt -105.06 35.22 2.88 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.944 0.897 . . . . 71.42 110.329 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.12 126.87 29.16 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.589 0.756 . . . . 73.15 111.23 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.05 -16.89 55.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.605 1.162 . . . . 71.45 113.39 -169.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.62 -0.47 8.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.295 0.638 . . . . 62.35 112.583 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.05 -25.55 61.83 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.57 0.748 . . . . 74.24 111.27 170.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.17 137.75 5.79 Favored Glycine 0 C--N 1.344 1.028 0 CA-C-N 116.078 -0.51 . . . . 54.33 112.159 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -150.2 145.37 26.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.957 0.903 . . . . 72.21 109.053 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.83 -145.62 17.71 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-O 119.391 -0.672 . . . . 50.21 111.579 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m 67.34 99.12 0.05 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.731 1.213 . . . . 64.04 111.472 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.18 -74.22 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 64.54 111.091 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.43 121.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.944 1.298 . . . . 54.21 111.69 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -142.76 164.86 28.95 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.841 0.353 . . . . 52.41 111.22 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.09 92.01 2.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.276 -0.875 . . . . 74.05 109.351 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -95.48 105.3 17.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.822 -0.626 . . . . 75.21 109.457 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.132 0 C-N-CA 123.306 0.642 . . . . 72.12 110.557 178.309 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.982 0.42 . . . . 64.41 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.0 p -168.25 109.18 0.55 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.619 0.768 . . . . 72.34 109.228 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -147.15 102.43 3.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.118 0.567 . . . . 73.32 111.301 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -98.51 110.29 22.91 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.554 -1.276 . . . . 54.24 107.554 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -153.38 107.45 3.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.137 0.575 . . . . 64.32 109.678 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -152.69 98.13 2.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.449 0.7 . . . . 64.55 109.552 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -110.76 8.66 22.55 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.689 0.795 . . . . 63.45 109.968 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -91.86 95.15 9.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.491 0.717 . . . . 71.34 110.027 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 56.7 ttp 65.65 126.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.189 1.396 . . . . 73.53 112.229 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 25.9 m -85.76 95.45 9.41 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.441 -0.948 . . . . 50.33 108.441 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -119.66 131.86 55.54 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.393 -1.276 . . . . 70.42 108.702 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -151.68 141.72 22.15 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.245 -0.65 . . . . 71.44 109.245 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.9 mt -76.49 116.34 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.525 -0.917 . . . . 71.55 108.525 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -88.33 -49.64 6.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.987 0.515 . . . . 64.0 110.217 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -159.13 138.8 11.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.96 -0.564 . . . . 62.04 109.48 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.84 135.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.1 -1.074 . . . . 54.31 108.1 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -171.57 158.22 5.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.514 0.674 . . . . 63.53 112.152 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -83.99 111.2 19.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.894 -1.048 . . . . 72.03 108.934 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -79.26 -46.68 17.3 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.717 0.77 . . . . 71.22 109.255 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.8 t70 -133.66 137.38 45.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.687 -1.142 . . . . 74.33 108.728 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -142.27 141.64 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.245 1.418 . . . . 64.23 107.379 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -155.24 143.14 19.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.811 -0.44 . . . . 72.52 109.811 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -142.64 141.95 31.99 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 107.54 -1.281 . . . . 72.43 107.54 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -140.08 142.6 36.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.563 -1.273 . . . . 71.02 107.563 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' D' ' 19' ' ' LYS . . . -142.15 84.28 11.72 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 108.86 -0.793 . . . . 73.25 108.86 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.59 -39.46 15.96 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.909 2.406 . . . . 60.4 112.212 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 88.4 m-20 -111.87 44.75 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.77 0.828 . . . . 63.33 109.658 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -56.41 -57.9 20.22 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.435 1.094 . . . . 54.14 113.709 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.3 Cg_exo -72.52 -26.54 16.63 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 122.013 1.809 . . . . 63.43 112.009 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.569 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.5 t60 -67.11 -21.73 65.84 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.298 1.439 . . . . 64.54 111.463 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.433 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.6 p -54.53 -24.1 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.15 0.58 . . . . 62.3 112.538 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -63.5 -40.75 97.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.296 1.038 . . . . 74.02 111.527 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.0 pt20 -90.14 5.29 47.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.646 0.379 . . . . 74.15 111.043 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 73' ' ' ALA . 4.7 ttpm? -100.74 146.76 26.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.097 0.959 . . . . 73.12 109.918 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -85.54 134.55 34.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.661 0.784 . . . . 74.33 109.185 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -69.22 71.29 0.26 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.406 1.083 . . . . 64.3 112.382 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -137.65 74.84 45.12 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 108.04 -1.096 . . . . 71.51 108.04 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.42 113.59 3.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.154 1.903 . . . . 63.44 109.591 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 39' ' ' GLU . . . . . 0.726 ' HG2' HD22 ' E' ' 141' ' ' LEU . 0.7 OUTLIER -84.56 83.79 7.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 105.021 -2.214 . . . . 63.34 105.021 174.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.607 HG11 HD11 ' C' ' 126' ' ' LEU . 31.9 m -71.7 128.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-N 115.215 -0.902 . . . . 72.22 111.824 -166.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -92.98 103.65 15.95 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.586 -1.635 . . . . 74.42 106.586 172.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -93.12 151.68 19.71 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.515 -0.766 . . . . 75.23 109.602 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 45.2 t0 -158.15 147.38 19.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.276 -0.875 . . . . 72.21 108.979 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 148.87 49.35 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 53.4 109.381 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.428 ' O ' HD23 ' C' ' 60' ' ' LEU . 12.0 m-20 -150.34 161.37 42.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.484 1.114 . . . . 74.41 108.904 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -138.71 154.23 48.56 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.125 -0.695 . . . . 73.5 109.125 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.65 151.43 43.06 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.576 -0.527 . . . . 53.04 109.576 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -123.58 143.52 50.16 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.365 0.666 . . . . 62.33 110.171 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -153.13 126.41 8.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.878 0.871 . . . . 72.23 108.701 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -82.61 127.0 32.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.239 -0.652 . . . . 62.42 109.239 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.659 HD11 HD12 ' C' ' 83' ' ' ILE . 59.9 mt -89.59 -42.05 11.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.209 0.604 . . . . 64.12 110.123 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.8 -174.37 4.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.471 0.708 . . . . 71.24 110.621 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.26 114.32 2.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.884 -1.053 . . . . 75.05 109.761 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 69.43 -4.59 1.31 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.196 1.399 . . . . 74.42 112.956 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.46 114.11 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.846 -0.798 . . . . 73.34 108.846 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -126.52 158.83 35.1 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.529 0.732 . . . . 73.21 109.962 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.78 138.36 53.84 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.308 1.043 . . . . 73.43 108.818 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.35 137.81 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.071 -1.085 . . . . 60.52 108.071 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.35 109.35 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.902 -0.777 . . . . 65.23 108.902 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.428 HD23 ' O ' ' C' ' 45' ' ' ASP . 0.7 OUTLIER -87.47 102.92 15.03 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.182 -1.044 . . . . 61.05 108.182 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.601 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 18.7 ttp85 -82.79 106.58 14.74 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.936 -0.764 . . . . 70.22 108.936 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.5 t -99.68 132.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.682 -0.858 . . . . 75.25 108.682 173.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 55.2 m -115.18 130.51 56.94 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.827 0.851 . . . . 72.4 109.156 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.498 HG11 ' HG ' ' C' ' 126' ' ' LEU . 78.1 t -122.13 134.24 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.186 -1.37 . . . . 71.41 107.918 172.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -123.86 143.15 50.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.342 -1.355 . . . . 54.51 107.342 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.0 106.86 8.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.689 -1.226 . . . . 62.41 107.689 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -154.75 158.26 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.69 . . . . 74.13 110.079 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 tp -123.84 78.87 1.66 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.726 -1.953 . . . . 71.41 105.726 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.42 -119.78 4.96 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 115.71 -0.677 . . . . 55.42 112.231 -173.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.28 -20.84 26.28 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.625 0.77 . . . . 62.42 109.669 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.488 ' HG3' ' HD3' ' C' ' 34' ' ' LYS . 16.0 tp10 -71.42 86.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.512 1.125 . . . . 71.24 109.446 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 36.0 m -84.75 121.77 28.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.253 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.512 ' HB2' ' HE3' ' C' ' 34' ' ' LYS . . . -71.86 -55.51 7.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.165 -1.05 . . . . 61.31 108.165 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -162.86 173.27 13.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.808 -1.087 . . . . 72.3 111.423 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.92 143.52 45.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.759 -1.571 . . . . 74.22 106.759 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -149.45 130.43 14.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.693 0.397 . . . . 73.44 110.338 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -131.71 133.28 44.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.671 -0.863 . . . . 72.22 108.671 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -129.52 138.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.687 0.795 . . . . 71.44 108.914 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.601 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.1 mt-30 -113.23 98.59 7.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.585 -0.894 . . . . 74.24 108.585 173.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 63.7 tp60 -84.87 103.84 14.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.361 -0.836 . . . . 70.2 109.688 -178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.13 148.78 21.65 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.887 -0.485 . . . . 74.15 111.887 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.34 121.32 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.688 -0.565 . . . . 61.23 111.688 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.659 HD12 HD11 ' C' ' 51' ' ' LEU . 8.5 mm -85.66 126.89 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.647 -0.872 . . . . 63.32 108.647 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -135.35 134.72 40.1 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.814 0.846 . . . . 73.43 109.473 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.6 p -81.18 116.57 21.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.414 -0.588 . . . . 74.03 109.414 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.44 111.4 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 54.41 108.511 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.51 169.61 19.2 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 50.02 110.339 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.07 -58.36 3.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.447 -0.661 . . . . 71.32 111.447 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.14 166.33 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 61.22 108.668 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.99 156.18 44.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.543 0.737 . . . . 73.22 110.537 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.39 -148.0 44.88 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.47 0.481 . . . . 14.44 114.155 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.593 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 32.4 p -69.38 -18.26 63.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.679 0.792 . . . . 73.35 112.098 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -63.7 -42.47 97.98 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.205 0.602 . . . . 71.03 110.285 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -82.92 -26.33 31.56 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.569 0.348 . . . . 74.22 110.884 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -68.16 -22.05 64.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.666 0.786 . . . . 74.41 111.577 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -53.41 -48.75 68.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.934 0.494 . . . . 73.34 110.763 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -65.17 -47.63 76.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.714 -0.676 . . . . 62.41 110.162 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.32 -32.84 74.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.599 0.76 . . . . 74.0 110.925 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.8 -5.32 61.31 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-O 119.572 -0.571 . . . . 63.04 114.251 -171.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.53 -63.17 0.51 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.658 0.729 . . . . 72.22 111.243 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -62.93 -47.64 82.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.035 0.534 . . . . 72.1 112.419 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.69 -42.76 36.88 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.642 -0.695 . . . . 71.45 112.281 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.43 -38.91 89.59 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.266 1.977 . . . . 54.11 113.248 166.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.29 -29.16 70.53 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.973 0.509 . . . . 74.24 111.62 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.462 HD12 ' NH1' ' A' ' 111' ' ' ARG . 38.0 mm -69.9 -41.47 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.139 0.575 . . . . 60.02 110.052 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.542 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -75.8 -25.3 56.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.208 -0.905 . . . . 71.3 111.924 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -56.88 -46.25 99.88 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.596 1.158 . . . . 73.54 113.852 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.63 -40.24 85.09 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.359 2.04 . . . . 73.2 114.074 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.437 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 57.1 m-85 -71.24 -39.99 71.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.811 0.445 . . . . 74.41 110.34 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.2 94.66 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.489 -0.778 . . . . 74.31 110.546 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -59.27 -54.33 48.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.248 1.019 . . . . 64.45 109.91 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -62.33 -35.01 77.74 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.043 0.839 . . . . 60.12 111.1 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 26.1 t -71.24 -36.84 71.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.307 0.643 . . . . 71.42 110.973 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.469 ' O ' HG23 ' C' ' 118' ' ' VAL . 77.8 mt -72.19 -50.1 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.4 -0.593 . . . . 70.35 109.4 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 78.6 m -57.19 -33.59 67.63 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.338 1.055 . . . . 73.21 110.793 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -64.52 -54.41 32.77 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 115.352 -0.84 . . . . 74.13 108.74 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.32 -40.16 70.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.808 1.243 . . . . 71.54 112.76 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.1 t -64.62 -48.44 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.803 0.841 . . . . 71.24 109.411 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 36.4 t -66.98 -28.06 67.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.606 -1.179 . . . . 71.41 111.335 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.4 HH12 ' CD ' ' D' ' 112' ' ' GLU . 77.1 mtt-85 -70.67 -37.38 73.66 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 123.738 0.815 . . . . 62.52 109.271 176.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.34 3.28 73.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.912 0.757 . . . . 74.21 113.363 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.449 HG23 ' HB3' ' D' ' 17' ' ' TYR . 66.0 p 60.28 28.45 18.06 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.036 1.734 . . . . 73.04 112.731 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -97.46 161.76 24.86 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.545 1.138 . . . . 74.25 111.07 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.431 ' HB3' ' H ' ' E' ' 138' ' ' ALA . 20.1 Cg_endo -58.37 119.3 6.47 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.342 2.695 . . . . 70.41 112.384 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -62.13 146.88 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.556 1.142 . . . . 54.42 113.416 -172.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.607 HD11 HG11 ' C' ' 40' ' ' VAL . 4.4 mm? -106.85 95.12 5.5 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.069 0.948 . . . . 65.5 108.958 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -90.35 90.83 8.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.73 126.18 29.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.909 -1.041 . . . . 75.11 110.807 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.67 156.12 86.86 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.091 0.956 . . . . 65.53 111.292 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.86 124.74 11.77 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.177 1.918 . . . . 72.32 111.851 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.96 138.01 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.041 0.537 . . . . 70.25 109.556 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.632 ' HB2' ' HB3' ' C' ' 135' ' ' ALA . 23.8 p30 -88.1 61.5 6.33 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.904 0.859 . . . . 65.33 110.234 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.98 -32.22 70.31 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.851 -1.068 . . . . 74.32 111.149 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.66 -33.97 64.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.71 0.404 . . . . 72.3 110.054 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' C' ' 132' ' ' ASN . . . -73.61 -30.59 63.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.694 -0.684 . . . . 62.35 112.573 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.32 -24.08 67.18 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.012 0.369 . . . . 64.2 110.914 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -74.45 -55.86 5.49 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.465 -0.569 . . . . 74.54 109.465 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 15.4 mmt -52.24 -28.15 17.59 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.394 1.257 . . . . 62.5 114.394 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.33 -29.41 9.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.034 1.334 . . . . 74.15 113.209 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -152.43 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.436 1.094 . . . . 75.22 112.486 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 24.8 tp 70.68 168.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.481 1.112 . . . . 64.23 111.065 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.56 -172.08 3.65 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.34 0.656 . . . . 74.31 109.353 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -59.33 124.88 21.46 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.805 0.691 . . . . 63.13 109.199 172.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -133.53 165.02 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 71.43 110.211 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.57 175.38 12.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.292 -0.867 . . . . 70.21 110.005 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.8 83.42 0.7 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.989 -0.445 . . . . 62.22 111.989 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -65.72 143.87 57.26 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.973 0.909 . . . . 52.11 111.213 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.08 -45.05 92.85 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 123.867 0.729 . . . . 62.43 113.607 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.9 t -99.16 159.95 14.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.876 -0.416 . . . . 54.54 109.876 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.22 157.66 46.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.439 0.696 . . . . 52.33 109.479 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.89 172.59 15.8 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.029 0.532 . . . . 71.13 109.787 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -83.45 76.06 9.96 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.455 0.645 . . . . 73.31 109.774 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -88.9 96.58 10.76 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.645 -0.872 . . . . 73.12 108.645 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.56 150.91 30.96 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.443 -0.798 . . . . 71.44 109.995 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 123.458 0.703 . . . . 72.41 110.101 -175.009 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.186 -0.301 . . . . 64.21 110.186 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.4 m -146.24 120.92 9.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.507 0.723 . . . . 61.12 110.779 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.31 72.17 1.24 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.941 -1.874 . . . . 74.42 105.941 168.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -132.25 113.73 13.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.977 -1.011 . . . . 75.11 109.617 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -157.59 121.41 4.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.837 0.855 . . . . 70.41 109.722 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -133.06 -78.11 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.227 -1.027 . . . . 72.31 108.227 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -151.49 51.21 0.82 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.705 -1.22 . . . . 74.31 107.705 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -6.2 58.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.074 -0.966 . . . . 72.01 111.497 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.559 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.6 ptm -33.4 134.32 0.14 Allowed 'General case' 0 C--N 1.365 1.277 0 C-N-CA 124.745 1.218 . . . . 73.42 113.28 166.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 40.0 m -128.64 146.63 50.81 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.926 -0.768 . . . . 74.25 108.926 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.476 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 49.9 t80 -155.93 102.44 2.17 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.483 -1.303 . . . . 73.23 107.483 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.23 139.99 53.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.062 0.545 . . . . 64.32 110.027 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.58 110.2 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.194 0.998 . . . . 62.41 108.97 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -89.26 -47.43 8.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.04 0.136 . . . . 74.12 111.357 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.23 119.74 0.7 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 119.423 -0.323 . . . . 71.13 110.341 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.22 136.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.215 -1.031 . . . . 73.2 108.215 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.449 ' HB3' HG23 ' C' ' 122' ' ' THR . 40.0 p90 -165.99 174.32 9.57 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.637 0.732 . . . . 65.11 111.769 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -101.73 128.12 48.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.388 -0.823 . . . . 73.1 109.088 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.3 mtpt -98.46 -16.49 19.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.873 0.469 . . . . 63.01 110.244 176.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -161.2 141.88 11.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.277 1.031 . . . . 71.42 109.496 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.9 mt -144.49 145.22 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.426 . . . . 71.34 107.676 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -148.25 144.05 27.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.872 0.869 . . . . 74.0 109.631 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -152.7 127.1 9.28 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.774 -1.565 . . . . 74.11 106.774 172.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.4 mt-10 -133.61 120.81 21.18 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.434 0.693 . . . . 63.33 109.481 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -130.14 83.88 61.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.368 -0.975 . . . . 73.23 108.368 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.62 -50.47 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.083 2.522 . . . . 62.11 111.725 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.511 ' O ' HG23 ' D' ' 31' ' ' VAL . 11.8 m120 -89.34 31.8 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.183 0.993 . . . . 70.24 109.765 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -58.41 -48.73 96.43 Favored Pre-proline 0 CA--C 1.561 1.4 0 N-CA-C 114.736 1.384 . . . . 75.51 114.736 -170.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.19 -7.09 12.06 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.595 1.53 . . . . 71.22 112.558 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -83.78 -36.31 23.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.878 1.271 . . . . 74.05 110.123 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' D' ' 73' ' ' ALA . 92.0 t -69.43 -25.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.544 0.738 . . . . 53.41 110.207 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.23 -24.53 64.93 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.21 1.004 . . . . 51.54 111.974 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -81.54 -14.16 57.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.753 0.821 . . . . 74.0 112.209 -177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -121.33 110.72 16.45 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.999 0.919 . . . . 62.21 109.818 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 91.85 8.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.879 0.871 . . . . 72.4 110.621 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.656 ' HB3' HD11 ' D' ' 68' ' ' LEU . 38.6 t-105 -168.23 163.98 13.17 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.87 116.15 65.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.302 0.641 . . . . 42.2 110.455 176.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.417 ' HG3' ' HB2' ' D' ' 68' ' ' LEU . 85.7 Cg_exo -47.35 149.03 4.46 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 124.855 3.703 . . . . 60.12 116.078 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 60.8 mm-40 -64.89 112.09 3.13 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.734 -0.839 . . . . 53.33 108.734 169.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.574 HG21 ' HG ' ' F' ' 139' ' ' LEU . 76.6 t -109.37 117.15 53.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.457 0.646 . . . . 61.53 110.801 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.74 147.65 23.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.497 -1.229 . . . . 61.25 108.074 164.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.42 HD13 ' H ' ' D' ' 42' ' ' LEU . 0.0 OUTLIER -128.42 154.96 45.49 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.079 -1.082 . . . . 63.43 108.079 176.245 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.2 t70 -150.43 155.84 40.31 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.38 0.672 . . . . 74.13 109.395 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -134.9 139.69 45.19 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.053 -0.721 . . . . 75.5 109.053 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.49 132.12 25.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 55.43 106.968 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -104.25 163.46 12.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.455 0.57 . . . . 75.2 110.754 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -160.92 172.42 16.97 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.068 0.947 . . . . 62.12 109.422 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.6 p -166.97 178.29 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.027 0.531 . . . . 65.44 111.138 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -169.89 118.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.979 1.312 . . . . 55.41 108.114 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -79.53 122.22 26.2 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.785 -0.45 . . . . 71.13 109.785 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.11 -36.62 14.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.215 0.606 . . . . 73.42 109.88 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.45 -176.54 4.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.968 0.907 . . . . 73.31 110.721 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.39 122.49 16.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.956 -1.02 . . . . 75.22 109.165 175.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 65.89 1.24 1.78 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.027 1.331 . . . . 71.53 113.044 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.13 116.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.88 -0.785 . . . . 55.34 108.88 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.93 162.58 24.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.218 -1.03 . . . . 74.45 108.218 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -131.18 131.93 44.38 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 105.736 -1.95 . . . . 74.45 105.736 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.61 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.625 -0.88 . . . . 75.44 108.625 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 58.5 t -116.95 138.58 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.521 0.728 . . . . 73.1 109.688 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -118.35 118.12 30.91 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.638 -1.245 . . . . 43.23 107.638 177.184 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.0 ttm-85 -99.24 103.22 15.06 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.287 1.035 . . . . 65.14 108.323 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.09 124.95 50.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.511 -0.922 . . . . 72.32 108.511 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.9 m -108.96 145.39 35.55 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.65 0.594 . . . . 72.54 110.066 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.27 133.39 52.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.843 1.257 . . . . 73.02 108.544 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 46.3 m -127.69 115.63 19.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.152 -1.055 . . . . 74.43 108.152 172.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -124.81 130.57 52.65 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.032 0.533 . . . . 54.54 109.935 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.2 m -142.08 130.08 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.756 0.822 . . . . 72.24 108.95 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' D' ' 36' ' ' TRP . 23.6 tp -105.35 108.21 19.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.879 -0.786 . . . . 65.32 108.879 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.44 -110.41 3.35 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.879 -0.888 . . . . 61.23 110.879 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.89 7.49 9.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 63.11 110.191 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.68 147.86 42.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.191 0.596 . . . . 73.34 111.162 -175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 100.0 m -65.54 115.12 5.42 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.78 0.675 . . . . 61.5 109.978 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.665 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.89 -63.98 1.26 Allowed 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.604 0.565 . . . . 74.23 110.35 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -156.13 139.03 15.31 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.567 -0.742 . . . . 70.32 109.794 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 66.9 mt -109.0 149.7 28.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.448 -1.316 . . . . 74.31 107.448 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.6 t -158.39 139.33 13.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.654 -0.212 . . . . 65.42 110.578 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -154.84 123.21 5.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.733 0.413 . . . . 60.43 109.954 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -123.8 117.6 51.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.443 0.697 . . . . 63.33 109.833 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.728 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.3 mt-30 -93.94 88.17 5.63 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.581 0.705 . . . . 71.25 109.266 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.451 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.69 108.26 13.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.245 -1.343 . . . . 72.43 109.209 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.23 172.83 32.32 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.154 0.308 . . . . 63.23 112.394 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.25 138.32 4.57 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 111.822 -0.511 . . . . 64.23 111.822 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.7 mt -90.56 120.74 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.066 -0.716 . . . . 65.3 109.066 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -125.47 125.65 43.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.608 1.163 . . . . 71.14 109.226 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.9 m -82.42 95.38 7.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.99 -0.744 . . . . 71.41 108.99 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.56 115.74 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.921 -0.77 . . . . 45.31 108.921 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.49 168.35 19.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.823 0.849 . . . . 65.05 110.698 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.5 -2.13 48.2 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.845 0.716 . . . . 61.23 114.676 173.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -135.51 157.31 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.327 1.051 . . . . 64.21 109.141 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.42 173.11 12.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.628 0.771 . . . . 64.03 111.098 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.49 -121.78 21.76 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.984 0.754 . . . . 50.02 114.984 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -68.85 -18.78 64.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.717 0.807 . . . . 75.21 112.654 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.428 ' HA ' HD21 ' D' ' 141' ' ' LEU . 11.6 mp0 -75.27 -48.53 22.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.22 0.608 . . . . 74.24 110.287 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -75.04 -25.78 58.96 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 116.678 -0.237 . . . . 63.42 110.379 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.42 75.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.38 0.672 . . . . 62.41 110.495 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.63 -36.35 82.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.881 0.872 . . . . 74.32 110.552 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 97' ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 91.0 m -67.56 -54.08 22.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.254 0.346 . . . . 74.4 111.04 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.62 -19.69 60.79 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 122.327 -0.233 . . . . 54.15 111.597 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.48 -27.2 10.06 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.298 -0.723 . . . . 74.11 114.175 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 -51.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.959 0.88 . . . . 72.52 112.891 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 101' ' ' TYR . . . . . 0.543 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 49.2 t80 -73.33 -55.19 6.73 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.752 0.649 . . . . 72.35 112.752 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.476 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 58.3 m -60.46 -44.64 96.3 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 118.517 -0.754 . . . . 62.43 111.676 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.56 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.0 Cg_exo -53.02 -35.69 72.95 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.492 2.128 . . . . 61.23 114.046 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -66.15 -39.67 89.98 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.572 0.749 . . . . 71.52 109.721 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -63.7 -41.03 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.497 0.719 . . . . 73.3 110.079 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.451 HD13 ' O ' ' D' ' 80' ' ' GLN . 91.8 mt -75.43 -24.43 57.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.076 -0.965 . . . . 64.24 112.14 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -62.84 -42.49 78.34 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 117.881 -1.056 . . . . 35.51 113.697 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.29 -38.82 73.17 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 121.923 1.748 . . . . 75.2 113.59 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.55 -32.14 28.75 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.637 0.775 . . . . 71.23 111.831 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.75 74.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.236 0.614 . . . . 64.31 109.807 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 35.0 ttp180 -61.07 -45.9 92.87 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 124.338 1.024 . . . . 72.24 110.282 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.7 tm-20 -55.26 -50.25 69.99 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.539 1.149 . . . . 75.24 111.694 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' D' ' 21' ' ' ILE . 42.0 t -60.97 -40.98 95.45 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.249 0.968 . . . . 33.41 111.217 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.626 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -60.19 -55.9 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.369 0.668 . . . . 61.23 110.204 173.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.2 m -53.51 -40.66 65.61 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.117 1.367 . . . . 73.11 110.65 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.3 t -69.51 -47.87 62.42 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.412 -1.267 . . . . 62.21 110.954 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.0 mtm -67.08 -30.95 71.13 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.078 0.399 . . . . 75.45 112.078 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -67.39 -46.06 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 123.557 0.535 . . . . 61.24 109.868 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -71.18 -25.28 62.46 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.477 -0.329 . . . . 54.2 110.757 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -75.69 -33.71 60.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.966 0.906 . . . . 74.52 109.511 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.56 1.05 67.88 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.552 -0.749 . . . . 61.15 112.537 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.5 p 56.04 40.44 30.31 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.265 1.826 . . . . 71.22 112.106 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 58.4 m-85 -103.68 169.68 7.06 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 125.075 1.35 . . . . 73.11 108.172 171.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 34.6 Cg_endo -62.92 138.92 71.08 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.899 1.732 . . . . 75.54 109.864 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -63.36 156.01 27.13 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.425 0.557 . . . . 75.2 111.176 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.401 HD21 HD12 ' F' ' 142' ' ' ILE . 2.8 tt -116.85 115.11 24.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.128 -1.064 . . . . 64.22 108.128 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -107.78 92.96 4.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.474 0.71 . . . . 74.42 109.642 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.448 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 68.9 mt -67.17 117.24 8.93 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.848 -0.614 . . . . 74.22 109.543 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 133.13 94.31 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 122.359 0.263 . . . . 74.23 110.494 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.18 109.29 2.79 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.222 1.948 . . . . 61.44 110.465 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 93.7 t -107.46 111.08 34.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.906 0.882 . . . . 72.01 109.046 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -83.1 73.2 10.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.024 0.916 . . . . 71.42 109.626 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -79.85 -14.57 58.56 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.904 -1.043 . . . . 72.34 109.764 176.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -50.87 -40.4 56.25 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.214 1.406 . . . . 73.53 111.495 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.55 64.95 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.47 1.106 . . . . 71.2 112.865 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.58 -45.04 73.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.416 0.686 . . . . 63.22 110.655 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.86 -34.86 67.02 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.787 -0.642 . . . . 64.43 110.661 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 16.2 ttp -67.91 -31.97 72.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.104 0.961 . . . . 71.31 110.443 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.46 -41.25 69.24 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.373 1.069 . . . . 45.33 111.206 173.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -66.79 -41.4 87.7 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.765 0.826 . . . . 74.12 111.304 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' D' ' 93' ' ' GLN . 10.9 mp -60.56 -34.12 73.7 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.744 0.652 . . . . 72.31 111.427 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' D' ' 138' ' ' MET . 45.5 mt-30 -81.05 2.35 27.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.244 0.617 . . . . 65.33 111.72 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -129.26 45.4 2.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.27 0.628 . . . . 72.5 109.42 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -161.96 148.94 13.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.313 -0.858 . . . . 75.23 109.75 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.14 150.07 16.38 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.46 0.704 . . . . 71.05 109.723 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.46 162.6 29.97 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 112.063 -0.415 . . . . 43.13 112.063 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.84 -177.4 4.54 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.383 1.073 . . . . 73.42 109.517 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.26 69.94 1.3 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.609 -0.596 . . . . 42.45 111.609 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 16.6 p -62.04 168.92 2.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.97 0.908 . . . . 74.43 112.628 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -82.18 38.41 0.54 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.876 0.87 . . . . 70.35 110.386 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 55.31 -164.32 0.13 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.4 1.48 . . . . 65.31 112.383 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -137.39 -39.02 0.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.417 0.687 . . . . 75.05 109.172 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -88.32 153.57 21.09 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.72 1.208 . . . . 75.14 109.268 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.65 -67.55 0.49 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.336 0.654 . . . . 61.44 110.752 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 123.752 0.821 . . . . 64.01 109.081 177.359 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 108.96 -0.756 . . . . 74.33 108.96 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.84 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.772 1.229 . . . . 72.42 111.167 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.51 157.14 0.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.057 1.343 . . . . 70.25 111.878 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 79.8 t80 74.92 -48.32 0.64 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 126.064 1.746 . . . . 74.51 111.808 -176.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -62.34 161.37 11.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.358 1.063 . . . . 73.24 112.509 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.62 -178.09 6.81 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.657 -1.156 . . . . 63.03 111.307 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.87 113.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.107 1.363 . . . . 74.3 109.14 -174.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 115' ' ' LEU . . . . . 0.47 HD21 ' HB ' ' B' ' 89' ' ' ILE . 6.3 mp -80.77 -101.94 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 118.759 -0.638 . . . . 74.04 111.447 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 116' ' ' TYR . . . . . 0.411 ' H ' HD12 ' B' ' 98' ' ' LEU . 2.6 m-30 59.77 111.72 0.02 OUTLIER Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.285 1.034 . . . . 65.15 111.835 -168.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 117' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' E' ' 120' ' ' TRP . 92.8 Cg_exo -47.21 121.81 5.72 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.727 2.951 . . . . 73.44 113.401 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -63.36 84.48 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.943 0.897 . . . . 74.43 110.519 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 30.3 m 56.95 86.26 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.287 1.035 . . . . 72.03 111.034 -168.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 120' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' E' ' 117' ' ' PRO . 73.2 t-105 -71.58 140.06 49.66 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.218 -0.66 . . . . 71.02 109.218 173.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -163.48 -153.57 0.24 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.12 -1.437 . . . . 70.23 107.12 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 122' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' B' ' 140' ' ' TYR . . . 76.16 -14.36 0.81 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.936 1.294 . . . . 71.32 112.933 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 p -70.37 85.29 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.942 1.353 . . . . 73.31 109.982 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -122.59 -52.62 1.91 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.209 -1.36 . . . . 73.14 109.632 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 69.19 -70.77 0.13 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.877 1.271 . . . . 72.32 110.767 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 68.07 103.49 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.742 1.217 . . . . 64.35 110.789 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -176.1 19.3 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.171 -0.468 . . . . 73.34 112.396 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -122.32 143.36 49.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.936 0.895 . . . . 72.03 109.482 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.81 -17.02 61.61 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.493 0.717 . . . . 74.32 112.841 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.07 103.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 CA-C-O 121.574 0.702 . . . . 71.34 110.615 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.22 -65.37 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.735 0.814 . . . . 63.42 110.221 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -108.52 150.49 40.74 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.812 0.845 . . . . 72.14 110.201 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.85 -21.78 18.27 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.594 2.196 . . . . 64.11 111.944 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 6.2 tt -78.11 86.47 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.57 1.176 . . . . 71.42 109.787 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -90.56 -14.0 33.4 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.447 -1.252 . . . . 62.4 109.652 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 t 70.75 -1.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 C-N-CA 126.177 1.791 . . . . 54.44 110.647 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.0 84.11 1.26 Allowed 'General case' 0 C--N 1.363 1.184 0 C-N-CA 124.036 0.934 . . . . 73.13 111.287 -174.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 138' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' C' ' 124' ' ' PRO . . . -174.01 102.66 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.914 1.286 . . . . 40.45 107.918 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.5 116.72 26.93 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.294 -0.632 . . . . 74.21 109.294 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 47.1 t -74.43 -68.68 0.51 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.387 0.675 . . . . 73.12 110.643 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 141' ' ' LEU . . . . . 0.726 HD22 ' HG2' ' C' ' 39' ' ' GLU . 5.0 mp -96.78 110.1 22.64 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.484 -0.562 . . . . 71.25 109.484 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 10.5 tt -146.68 127.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.964 0.506 . . . . 63.12 110.968 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 1.4 t80 63.96 9.6 4.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.979 1.712 . . . . 64.14 112.885 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.81 114.71 25.72 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.29 -0.633 . . . . 64.31 109.29 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -143.54 -59.4 0.41 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.676 -1.231 . . . . 74.52 107.676 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -172.31 -55.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.076 0.95 . . . . 64.41 109.974 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 90.6 mt 63.62 162.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.442 1.497 . . . . 60.44 112.563 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -107.86 144.38 29.22 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 109.103 -0.702 . . . . 75.03 109.103 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo . . . . . 0 CA--C 1.563 1.933 0 C-N-CA 122.632 2.221 . . . . 62.35 111.558 168.1 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.661 -0.496 . . . . 71.41 109.661 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -71.86 87.21 0.99 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.779 0.799 . . . . 75.54 111.129 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 120.31 16.83 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.075 0.95 . . . . 72.4 110.72 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -108.26 136.48 47.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.065 0.546 . . . . 73.5 110.377 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -115.06 111.8 21.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.949 0.9 . . . . 73.34 109.442 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.89 104.29 13.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.497 0.719 . . . . 73.2 110.037 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -177.9 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.073 1.349 . . . . 72.31 109.507 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 115' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 90' ' ' GLU . 93.2 mt 63.7 32.55 13.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.426 1.09 . . . . 71.34 110.659 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.2 51.41 3.87 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 114.727 -1.124 . . . . 75.22 110.248 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 117' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 95' ' ' ALA . 56.2 Cg_endo -90.13 13.66 2.24 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.316 2.011 . . . . 52.32 112.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -145.41 108.11 4.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.907 0.883 . . . . 74.1 108.665 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 22.3 p -99.29 -42.61 6.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.37 1.068 . . . . 71.42 109.813 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 20.5 t90 57.46 76.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.075 1.35 . . . . 71.21 111.211 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.16 111.5 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.147 -0.933 . . . . 71.5 108.558 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.58 -58.17 0.22 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.911 0.884 . . . . 64.35 109.652 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.17 155.46 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.606 -0.724 . . . . 70.04 111.799 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -149.62 139.54 21.93 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.741 0.816 . . . . 71.32 109.398 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 125' ' ' TYR . . . . . 0.433 ' CE2' HD11 ' A' ' 128' ' ' LEU . 1.8 p90 -116.42 16.05 15.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.249 1.02 . . . . 74.2 111.181 -171.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 126' ' ' ASN . . . . . 0.468 ' HA ' HD11 ' A' ' 42' ' ' LEU . 7.2 t30 -68.89 99.01 0.99 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.543 0.737 . . . . 75.31 110.155 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 153.41 25.13 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.557 -1.017 . . . . 21.13 110.557 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -76.14 99.98 4.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.536 0.684 . . . . 74.34 110.17 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 129' ' ' LEU . . . . . 0.538 ' H ' HD23 ' F' ' 129' ' ' LEU . 0.7 OUTLIER -88.58 50.98 2.06 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.148 0.975 . . . . 73.12 108.871 171.431 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.02 124.45 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.696 -1.138 . . . . 75.23 109.141 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.91 144.23 41.22 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.878 -0.601 . . . . 54.44 110.049 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 132' ' ' TYR . . . . . 0.42 ' HA ' ' HD3' ' F' ' 133' ' ' PRO . 57.4 t80 -59.88 122.53 66.32 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.57 -0.9 . . . . 72.24 108.57 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 133' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' F' ' 132' ' ' TYR . 4.0 Cg_exo -74.49 70.39 4.89 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.699 2.266 . . . . 60.21 111.328 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 11.9 tt -69.57 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 115.044 -0.98 . . . . 64.43 109.642 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.51 87.35 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.94 0.496 . . . . 54.34 109.97 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 136' ' ' VAL . . . . . 0.43 HG12 ' HD3' ' D' ' 124' ' ' PRO . 15.6 m -131.03 77.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.377 1.071 . . . . 62.31 110.464 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.02 -70.31 0.34 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.489 -0.778 . . . . 65.54 109.833 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 170.13 151.02 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.369 1.868 . . . . 74.34 107.187 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 139' ' ' LEU . . . . . 0.574 ' HG ' HG21 ' D' ' 40' ' ' VAL . 3.2 mm? -70.67 83.98 0.63 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.447 -0.575 . . . . 75.45 109.447 174.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 16.7 m -97.73 -22.84 16.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.392 1.077 . . . . 30.42 110.506 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.32 -5.82 25.66 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.856 0.862 . . . . 73.21 112.807 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 142' ' ' ILE . . . . . 0.401 HD12 HD21 ' D' ' 126' ' ' LEU . 10.8 tt -64.39 154.23 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.462 0 C-N-CA 124.245 1.018 . . . . 73.13 110.842 174.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 67.2 85.29 0.14 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.963 1.305 . . . . 75.22 109.423 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -64.61 -51.89 60.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.096 0.958 . . . . 62.1 111.721 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -86.83 -75.35 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.066 -0.346 . . . . 75.42 110.066 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -151.22 -174.95 4.97 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.065 0.46 . . . . 64.42 110.667 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.29 25.62 0.3 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.553 1.141 . . . . 70.24 109.942 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp 72.27 157.48 0.16 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 124.909 1.284 . . . . 53.41 111.068 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo . . . . . 0 C--N 1.395 2.979 0 C-N-CA 123.798 2.999 . . . . 74.32 114.575 -176.875 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 62.6 m . . . . . 0 CA--C 1.532 0.287 0 N-CA-C 107.286 -1.376 . . . . 60.44 107.286 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -136.98 132.1 33.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.425 0.69 . . . . 61.1 109.27 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -137.77 134.95 35.87 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.746 0.418 . . . . 61.4 110.1 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 13' ' ' ILE . 1.5 pp -81.58 88.2 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 109.201 -0.666 . . . . 75.21 109.201 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -74.91 -41.71 59.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.297 0.639 . . . . 72.22 110.601 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 12.9 tpp85 -165.56 133.47 3.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.971 -0.559 . . . . 74.22 110.3 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.604 HD13 ' HG3' ' C' ' 130' ' ' PRO . 3.8 mp -131.04 120.26 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.386 -1.338 . . . . 63.12 107.386 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.404 ' CD1' ' HG3' ' A' ' 15' ' ' ARG . 4.7 p90 -164.06 176.21 9.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.696 0.799 . . . . 55.15 110.411 -169.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.44 HG21 ' SG ' ' A' ' 113' ' ' CYS . 78.7 p -92.69 117.9 30.48 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.201 -0.666 . . . . 64.43 109.201 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.9 mtpt -75.69 -30.52 59.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.909 -0.404 . . . . 63.22 109.909 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.59 143.13 19.55 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.543 -0.753 . . . . 64.34 109.63 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 68.4 mt -139.3 144.34 29.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.618 -1.252 . . . . 74.2 107.618 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -150.03 136.19 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.375 -0.602 . . . . 71.42 109.375 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.545 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -140.82 109.75 6.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.714 -1.587 . . . . 73.23 106.714 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.81 119.52 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.48 -0.563 . . . . 74.43 109.48 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.08 83.16 37.89 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.021 -1.103 . . . . 72.21 108.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.29 -18.48 34.49 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.728 2.285 . . . . 32.32 111.937 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -117.35 37.39 3.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.361 1.064 . . . . 71.41 109.749 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.13 93.18 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 114.379 1.252 . . . . 73.44 114.379 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.19 -25.13 8.87 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.698 1.599 . . . . 74.32 111.649 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -78.97 -14.23 59.33 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.935 1.694 . . . . 74.35 111.418 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.44 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 7.1 p -69.76 -22.31 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.692 0.797 . . . . 62.25 111.879 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.82 -25.59 66.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.808 0.843 . . . . 53.11 111.358 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -86.85 -34.06 19.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.239 1.016 . . . . 72.42 111.48 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.675 ' HD3' HD21 ' A' ' 68' ' ' LEU . 12.5 ptpt -80.57 171.76 14.63 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.224 0.535 . . . . 75.24 111.36 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.17 144.96 29.46 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.247 -0.888 . . . . 73.0 109.336 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -89.61 63.73 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.703 0.763 . . . . 74.31 110.956 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -149.08 82.37 7.11 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 114.941 -1.027 . . . . 63.1 108.352 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -85.39 170.01 9.46 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.675 2.25 . . . . 73.24 111.265 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.98 114.72 26.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.621 -0.881 . . . . 65.51 108.621 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.5 t -75.61 96.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.829 0.852 . . . . 63.42 109.532 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.6 tttm -102.45 116.44 32.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.538 1.135 . . . . 64.1 109.204 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.04 128.83 53.5 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.203 -1.036 . . . . 72.13 108.203 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.621 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 16.3 m-20 -115.06 131.04 57.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.084 0.954 . . . . 70.32 108.668 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.5 138.65 53.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.919 0.888 . . . . 73.13 109.657 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 26.5 t70 -155.43 146.81 22.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.67 0.788 . . . . 73.04 109.913 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.09 139.02 35.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.42 0.688 . . . . 62.43 110.617 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -139.86 154.34 47.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.236 1.014 . . . . 63.22 110.183 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -129.08 157.77 40.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.667 0.787 . . . . 73.15 108.947 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.3 t -161.45 115.47 1.97 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.256 -0.275 . . . . 61.43 110.256 -172.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -72.06 104.79 3.69 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 71.33 109.817 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 57' ' ' GLU . 65.1 mt -77.79 -41.35 37.67 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.194 0.998 . . . . 65.21 110.891 176.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.28 -175.62 4.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.644 -1.162 . . . . 52.23 108.379 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -58.63 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.865 0.466 . . . . 64.43 110.671 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 59.15 33.55 22.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.859 1.264 . . . . 62.24 112.483 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 61.5 t -112.95 118.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.717 -1.586 . . . . 75.01 106.717 167.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -129.6 131.69 46.56 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.766 -0.828 . . . . 75.33 108.766 -177.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.604 ' HB2' HD11 ' A' ' 51' ' ' LEU . 43.6 tt0 -89.25 121.07 31.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.697 0.799 . . . . 73.23 109.054 173.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 99.0 t -100.25 121.85 51.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 123.807 0.843 . . . . 75.32 108.775 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.5 t -108.5 133.66 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.666 -0.494 . . . . 64.14 109.666 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.94 116.0 31.19 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.067 -1.457 . . . . 73.03 107.067 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.591 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -91.78 102.3 14.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.635 -1.246 . . . . 63.44 107.635 170.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' A' ' 114' ' ' ILE . 2.9 t -101.18 130.33 50.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.036 -1.468 . . . . 73.53 107.036 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -132.04 125.99 32.8 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.221 0.534 . . . . 71.41 109.726 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 47.3 t -111.28 110.05 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.156 0.982 . . . . 73.4 109.167 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 26.3 m -101.12 135.94 41.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.667 -0.864 . . . . 73.43 108.667 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.52 103.85 7.57 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.751 -1.204 . . . . 54.21 107.751 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 m -143.67 128.06 17.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.203 0.601 . . . . 71.11 109.535 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.675 HD21 ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -94.28 84.93 4.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.502 -1.295 . . . . 73.13 107.502 172.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -116.89 4.66 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.539 -1.209 . . . . 40.14 111.277 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.01 -25.44 21.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 70.14 111.059 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.574 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 tp10 -81.25 96.05 7.14 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.556 -0.535 . . . . 73.34 109.556 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -75.31 129.0 36.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.313 0.645 . . . . 52.52 110.811 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.11 4.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.015 0.926 . . . . 75.32 108.917 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -164.94 173.99 11.02 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.586 -1.188 . . . . 71.51 110.62 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.9 tp -140.92 137.75 33.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.575 1.15 . . . . 60.22 108.449 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.0 m -127.54 141.96 51.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.802 1.241 . . . . 55.12 108.751 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.14 134.91 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.207 -0.664 . . . . 74.31 109.207 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.76 111.57 8.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 123.776 0.831 . . . . 73.54 108.991 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -85.52 84.53 7.59 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.437 -0.949 . . . . 50.33 108.437 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.17 96.36 6.53 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.697 -1.223 . . . . 72.23 107.697 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.99 146.33 16.55 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 111.665 -0.574 . . . . 75.33 111.665 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.98 133.9 5.72 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.027 -0.829 . . . . 73.01 111.027 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -85.79 127.49 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.075 -0.713 . . . . 71.13 109.075 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.6 118.95 18.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.155 -1.054 . . . . 74.1 108.155 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 54.0 p -89.52 94.04 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.837 -0.801 . . . . 33.53 108.837 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.75 HG12 HD11 ' A' ' 98' ' ' LEU . 2.8 pp -119.21 144.01 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.747 0.419 . . . . 72.54 111.259 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.31 177.52 3.08 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.273 1.429 . . . . 65.41 108.835 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.53 3.34 89.82 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.898 0.719 . . . . 73.34 114.898 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.1 150.15 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.069 -1.085 . . . . 75.42 108.069 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -128.55 173.63 10.09 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.484 -0.561 . . . . 74.13 109.484 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.83 -112.33 1.61 Allowed Glycine 0 C--N 1.352 1.434 0 O-C-N 124.832 1.333 . . . . 73.51 116.176 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.0 p -61.89 -50.81 70.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 70.11 111.5 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.43 -33.99 69.89 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.382 0.673 . . . . 70.51 112.118 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.1 tpp -63.85 -51.57 64.05 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.304 0.378 . . . . 60.11 110.381 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.56 -35.78 76.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.153 0.581 . . . . 62.21 111.067 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.423 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 59.7 t-80 -75.74 -22.22 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.118 0.967 . . . . 71.43 111.103 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HB3' HD22 ' A' ' 98' ' ' LEU . 43.3 t -70.61 -60.55 2.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.638 -0.505 . . . . 75.54 109.638 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.75 HD11 HG12 ' A' ' 86' ' ' ILE . 1.7 mm? -81.92 -23.14 36.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.837 -0.619 . . . . 72.22 111.822 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.32 -28.03 9.48 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 123.534 0.521 . . . . 74.4 113.857 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -112.97 -63.59 1.42 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.478 0.639 . . . . 72.11 111.004 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.3 -50.23 70.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.778 0.831 . . . . 73.35 112.55 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.0 m -65.12 -49.09 68.36 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.077 -0.963 . . . . 73.42 112.65 -172.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.57 -24.29 56.13 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 121.848 1.698 . . . . 73.25 112.703 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -74.03 -27.74 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.271 0.628 . . . . 53.45 110.44 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.23 -39.67 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.57 0.748 . . . . 73.23 109.718 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 mt -76.72 -24.86 53.07 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.339 -0.846 . . . . 71.52 111.692 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.05 -41.86 47.48 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 114.535 1.309 . . . . 75.23 114.535 -169.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.94 -38.73 76.84 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.034 1.823 . . . . 75.23 113.007 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -77.95 -31.87 51.18 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.684 -0.689 . . . . 74.45 111.245 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.69 72.7 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.357 0.663 . . . . 65.14 109.506 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.0 ttm180 -51.3 -52.85 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.988 1.43 . . . . 73.23 110.382 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.37 -47.81 80.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.724 -1.126 . . . . 72.22 111.86 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.521 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.4 t -59.88 -29.85 68.61 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.949 0.781 . . . . 42.44 111.77 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 118' ' ' VAL . 94.8 mt -73.29 -58.67 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.534 -0.543 . . . . 70.51 109.534 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -51.24 -39.85 57.55 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.093 1.357 . . . . 70.51 112.641 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -70.23 -40.66 74.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.082 -0.963 . . . . 74.22 111.283 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.17 -43.24 99.27 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 120.864 0.364 . . . . 64.45 110.585 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.8 t -57.17 -45.8 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 114.663 -1.153 . . . . 63.33 110.92 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -70.57 -30.9 67.72 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.529 -0.76 . . . . 74.13 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -68.96 -31.28 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.501 0.72 . . . . 73.13 110.86 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 3.52 65.65 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.447 -0.64 . . . . 62.41 113.418 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 67.25 35.17 4.54 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.419 1.104 . . . . 62.11 109.781 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -111.24 149.79 41.06 Favored Pre-proline 0 N--CA 1.478 0.926 0 CA-C-N 114.865 -1.061 . . . . 71.11 110.044 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.35 143.14 94.67 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.872 2.381 . . . . 72.24 112.808 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -53.72 138.62 34.81 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.856 0.862 . . . . 73.22 112.459 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 64' ' ' VAL . 1.4 tm? -120.93 109.28 14.91 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.579 -1.267 . . . . 70.54 107.579 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -98.97 127.17 44.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.764 0.825 . . . . 63.44 108.859 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 132.59 43.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.412 0.685 . . . . 73.5 109.817 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.58 130.04 86.23 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 118.68 -0.676 . . . . 54.13 109.848 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.61 115.65 2.82 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.341 2.027 . . . . 64.23 111.887 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.86 114.2 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.316 -1.364 . . . . 73.23 107.316 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.6 p-10 -76.9 74.68 3.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.4 0.68 . . . . 53.31 109.97 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -55.6 -44.05 76.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 63.0 110.994 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 114.768 -1.105 . . . . 73.13 111.972 -178.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.505 ' HE3' HD12 ' B' ' 89' ' ' ILE . 19.4 ptm . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 114.194 1.183 . . . . 73.45 114.194 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 32.8 m -152.79 127.51 9.49 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.188 -1.412 . . . . 70.21 107.188 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -124.3 154.46 40.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.963 -0.755 . . . . 71.53 108.963 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.657 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 50.2 tt0 -153.49 139.42 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.959 0.904 . . . . 72.14 109.829 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.689 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -97.55 113.15 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.092 -1.447 . . . . 72.22 107.092 166.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -77.76 -49.4 14.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.034 -0.416 . . . . 53.44 110.042 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -161.94 133.05 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.478 -0.328 . . . . 71.24 110.194 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.13 137.42 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 107.046 -1.465 . . . . 75.43 107.046 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.89 145.52 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.365 0.602 . . . . 74.14 111.744 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 65.6 m -75.81 115.15 15.21 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.907 -1.042 . . . . 44.25 108.698 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.449 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.1 mtpt -85.75 -31.39 22.43 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.088 0.555 . . . . 74.22 110.568 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.3 t70 -157.78 143.84 17.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.729 -0.668 . . . . 70.21 111.303 -168.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 37.6 mm -139.97 141.03 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 125.304 1.442 . . . . 65.21 108.646 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -141.26 132.39 26.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.601 -1.259 . . . . 75.12 107.601 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.554 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 84.5 t80 -144.27 109.71 5.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.244 -1.761 . . . . 75.4 106.244 170.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -119.18 117.3 28.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.013 -0.736 . . . . 74.34 109.013 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.36 86.1 7.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.708 -1.219 . . . . 75.51 107.708 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.57 -28.02 32.1 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.447 2.098 . . . . 73.53 110.811 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -107.0 27.77 8.67 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.745 1.218 . . . . 71.21 109.244 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.455 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -47.62 -57.39 9.98 Favored Pre-proline 0 CA--C 1.57 1.734 0 C-N-CA 124.67 1.188 . . . . 74.32 112.954 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 78.0 Cg_endo -82.48 -1.28 10.56 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 121.77 1.647 . . . . 74.14 112.843 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.421 ' HA ' HE21 ' B' ' 33' ' ' GLN . 2.8 m-70 -99.57 -16.43 18.27 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.644 0.778 . . . . 73.04 111.885 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.18 -21.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.534 0.733 . . . . 72.34 112.784 -167.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -73.65 -16.72 61.21 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.517 0.192 . . . . 63.43 111.517 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.421 HE21 ' HA ' ' B' ' 30' ' ' HIS . 41.0 mt-30 -81.69 -4.87 57.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.664 0.786 . . . . 72.33 111.082 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' B' ' 68' ' ' LEU . 72.7 mmtt -106.51 102.17 11.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.573 1.149 . . . . 73.31 109.898 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -115.9 85.99 2.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 55.4 111.954 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.503 ' HB2' HD23 ' B' ' 68' ' ' LEU . 6.2 m0 -159.27 -170.5 3.0 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.678 1.991 . . . . 63.05 106.657 169.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -83.51 125.4 73.94 Favored Pre-proline 0 N--CA 1.478 0.925 0 N-CA-C 107.628 -1.249 . . . . 72.31 107.628 162.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.443 ' HA ' ' HG ' ' B' ' 68' ' ' LEU . 30.3 Cg_endo -62.68 132.64 38.52 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.08 1.853 . . . . 61.35 112.143 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -68.93 103.27 1.77 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.657 -1.156 . . . . 74.11 108.443 171.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.17 128.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.742 0.817 . . . . 63.14 110.079 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -121.75 109.74 15.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.642 1.177 . . . . 74.51 108.048 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 pp -92.15 153.57 19.24 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.608 0.763 . . . . 51.25 110.64 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.615 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.0 m-20 -136.04 137.17 40.88 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.948 -1.13 . . . . 75.51 107.948 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.501 HD21 HG21 ' B' ' 131' ' ' VAL . 7.1 mp -115.78 132.64 56.58 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.083 -0.71 . . . . 52.04 109.083 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.9 t70 -139.05 155.94 47.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.846 1.258 . . . . 73.11 108.637 -173.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.32 140.11 39.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.759 0.824 . . . . 73.33 109.042 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.61 116.88 17.23 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.485 -1.302 . . . . 32.21 107.485 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -106.38 161.5 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.109 0.564 . . . . 64.04 110.733 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -160.48 136.04 8.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.688 -0.856 . . . . 72.03 108.688 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -88.4 120.27 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.649 -0.871 . . . . 64.4 108.649 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 mt -81.28 -39.33 25.41 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.259 0.552 . . . . 75.53 110.375 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -157.32 -177.86 6.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.789 -1.096 . . . . 62.54 110.016 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -69.87 130.66 42.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.068 -1.086 . . . . 74.33 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.49 -4.81 1.27 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.604 1.162 . . . . 75.24 112.761 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 60.0 t -123.08 116.96 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.628 0.771 . . . . 74.02 109.61 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.418 ' HD2' HG13 ' B' ' 58' ' ' VAL . 30.0 p90 -126.19 171.58 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.188 0.595 . . . . 74.33 109.418 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -144.71 108.15 4.61 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.625 -1.25 . . . . 74.51 107.625 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' B' ' 56' ' ' TYR . 29.5 m -104.47 137.47 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.148 -0.686 . . . . 72.31 109.148 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.38 119.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.149 -0.686 . . . . 63.03 109.149 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.02 114.32 26.84 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.54 -1.281 . . . . 74.43 107.54 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.5 ttt180 -106.24 122.29 45.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.78 0.832 . . . . 73.12 109.985 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -113.27 118.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.806 -0.813 . . . . 75.05 108.806 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 20.1 m -99.92 145.37 27.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.418 1.087 . . . . 61.42 108.513 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -136.57 130.17 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.702 0.801 . . . . 71.34 109.268 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -120.96 145.58 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.134 -1.062 . . . . 73.32 108.134 171.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.56 151.33 37.15 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.711 0.291 . . . . 62.15 110.36 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -162.25 143.24 10.41 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.672 1.232 . . . . 63.2 109.657 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.0 mp -112.38 137.08 51.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.249 -1.019 . . . . 72.04 108.249 168.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.13 -118.33 6.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.112 -0.795 . . . . 75.23 111.112 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.59 29.48 6.57 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.481 0.712 . . . . 71.1 110.506 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -145.4 142.92 29.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.113 0.565 . . . . 64.01 110.355 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 9.1 m -59.52 151.83 23.35 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.338 1.055 . . . . 72.04 112.137 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.623 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -112.27 -61.78 1.67 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.446 1.098 . . . . 62.22 108.926 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.8 156.88 28.28 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.79 -1.55 . . . . 74.42 108.94 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.37 141.93 49.11 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.335 -1.358 . . . . 70.55 107.335 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.1 t -154.21 152.48 30.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.454 -0.573 . . . . 72.04 109.454 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.15 140.71 5.34 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.264 -0.643 . . . . 72.35 109.264 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.3 t -133.66 146.79 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.079 0.952 . . . . 71.31 108.748 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.7 mt-30 -126.34 101.05 6.54 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.233 0.613 . . . . 74.21 109.443 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -90.8 105.34 17.75 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.531 -0.759 . . . . 74.45 109.801 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.36 156.19 23.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 111.532 -0.627 . . . . 61.24 111.532 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 126.56 1.96 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 111.862 -0.495 . . . . 61.03 111.862 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.0 126.18 40.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.575 -0.898 . . . . 72.24 108.575 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -131.51 155.95 46.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.223 1.009 . . . . 70.12 109.093 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.657 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 44.1 m -131.92 134.32 45.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.293 1.037 . . . . 65.24 109.627 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.72 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.7 pp -131.59 147.7 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.152 0.981 . . . . 71.52 111.006 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.5 149.7 27.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.436 1.094 . . . . 63.21 108.763 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.04 -47.25 2.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.12 0.39 . . . . 34.22 113.905 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.72 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -83.94 165.0 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.531 0.732 . . . . 74.25 112.073 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -167.9 163.51 13.87 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.729 0.811 . . . . 53.21 110.361 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -113.22 5.0 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.992 0.808 . . . . 61.54 113.143 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.7 m -74.08 -34.28 63.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.871 0.868 . . . . 64.45 111.052 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -32.9 74.15 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.039 0.535 . . . . 54.33 109.913 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 13.2 tpt -76.98 -43.98 32.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.476 0.71 . . . . 62.02 110.811 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.14 75.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.828 0.851 . . . . 54.13 111.321 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -70.81 -30.41 66.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.285 1.034 . . . . 62.31 111.084 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -69.47 -59.45 2.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.092 0.557 . . . . 74.22 110.384 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.45 -19.07 61.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.88 0.326 . . . . 65.04 111.88 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -22.07 43.66 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.493 0.557 . . . . 74.42 114.493 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.18 -55.26 0.44 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.189 0.494 . . . . 74.14 111.572 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -62.07 -45.53 93.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.742 0.817 . . . . 73.53 112.082 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 85.8 m -71.13 -47.15 14.33 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.546 -0.74 . . . . 71.31 112.222 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.2 Cg_exo -52.86 -31.5 52.37 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.249 1.966 . . . . 65.43 114.221 168.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -36.64 83.02 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 122.941 0.496 . . . . 74.33 111.558 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.03 -45.21 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.592 0.757 . . . . 72.34 110.4 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.08 -25.24 40.13 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.043 -0.981 . . . . 63.3 113.058 -169.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.76 -47.85 94.69 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 117.399 -1.286 . . . . 71.22 113.975 -170.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.18 -41.12 50.73 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.333 2.022 . . . . 73.3 113.655 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -68.1 -51.73 43.04 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.609 -0.723 . . . . 72.41 110.99 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.97 91.71 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.564 0.745 . . . . 61.44 111.294 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 23.6 ttp180 -61.88 -58.93 6.05 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.256 1.422 . . . . 71.44 110.992 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -69.79 -26.42 64.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.728 -1.124 . . . . 75.3 111.098 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.451 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.3 t -68.63 -37.18 79.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.824 0.45 . . . . 24.11 111.062 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.61 -49.24 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.126 0.57 . . . . 62.34 109.768 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -69.68 -23.44 63.45 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.606 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.0 t -75.89 -29.1 58.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.697 0.799 . . . . 63.04 110.958 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 21.5 mmt -78.94 -26.68 43.63 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.766 0.426 . . . . 73.4 110.187 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' B' ' 125' ' ' GLN . 49.6 t -58.85 -41.82 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.96 0.904 . . . . 54.33 111.113 170.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.5 t -53.1 -38.72 62.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.401 1.081 . . . . 23.11 111.634 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.0 mtt-85 -76.67 -26.52 54.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.113 -0.949 . . . . 74.42 111.377 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.2 0.54 81.6 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-O 119.472 -0.626 . . . . 63.11 113.743 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p 63.12 18.91 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.112 1.765 . . . . 73.42 114.484 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' B' ' 118' ' ' VAL . 55.1 p90 -110.42 166.76 10.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-O 118.73 -0.652 . . . . 74.21 110.683 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.31 147.19 22.15 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.34 2.694 . . . . 74.12 114.539 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.556 ' HA ' HG11 ' B' ' 118' ' ' VAL . 5.0 pm0 -54.1 145.0 18.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.05 1.34 . . . . 73.33 113.729 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 126' ' ' LEU . 1.9 tm? -133.23 85.4 2.21 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.537 -1.283 . . . . 73.53 107.537 171.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -104.93 133.76 49.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.909 -1.145 . . . . 73.22 107.909 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.0 mm? -86.7 138.47 31.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.369 0.668 . . . . 53.4 109.544 -169.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.96 148.71 98.39 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.078 0.551 . . . . 73.21 110.603 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.31 112.93 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.804 2.336 . . . . 54.32 111.634 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.501 HG21 HD21 ' B' ' 44' ' ' LEU . 90.9 t -89.77 127.32 42.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.869 0.468 . . . . 62.52 109.829 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -80.41 83.18 6.28 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.739 0.816 . . . . 75.44 109.784 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -63.01 -29.09 70.55 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.615 0.766 . . . . 73.04 111.279 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.9 -53.53 17.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 62.03 110.257 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.63 77.38 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.272 0.629 . . . . 44.14 110.682 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 tt . . . . . 0 N--CA 1.476 0.846 0 C-N-CA 124.249 1.02 . . . . 60.13 110.549 179.481 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.93 0.395 . . . . 65.13 111.838 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 35.6 m -83.83 85.47 7.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 73.35 108.399 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' C' ' 85' ' ' SER . 50.0 t80 -106.44 140.97 38.51 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.413 -1.267 . . . . 74.22 109.443 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 6.0 tp60 -145.68 137.39 25.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.831 0.452 . . . . 73.54 110.477 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 25.5 mm -86.31 110.31 19.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.94 -1.133 . . . . 53.33 107.94 172.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 86.8 mm-40 -83.99 -49.22 9.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.867 -0.419 . . . . 70.2 109.867 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -169.1 136.8 1.89 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.693 -0.685 . . . . 73.31 109.627 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -117.06 138.93 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.744 -1.206 . . . . 71.35 107.744 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.515 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 20.7 p90 -176.46 144.02 0.51 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.6 0.36 . . . . 74.43 110.822 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.435 HG22 ' NE2' ' C' ' 80' ' ' GLN . 81.9 p -70.48 124.55 24.47 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.408 0.683 . . . . 54.12 110.124 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -77.07 -49.45 15.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.873 -1.158 . . . . 73.51 107.873 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -135.01 142.14 46.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.185 -1.371 . . . . 75.45 110.309 -174.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.2 mt -136.18 143.01 37.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.055 -1.832 . . . . 74.53 106.055 173.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -156.07 150.31 25.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.311 0.577 . . . . 72.41 109.954 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -148.76 138.79 22.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.627 -1.169 . . . . 71.31 108.034 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.1 132.12 35.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.768 -1.197 . . . . 74.13 107.768 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.12 80.93 16.4 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 64.23 107.254 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.83 -38.19 40.61 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.514 2.143 . . . . 73.34 110.996 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 1.1 m-20 -100.1 32.89 2.79 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.382 1.073 . . . . 73.33 109.914 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.75 -43.84 96.0 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.131 1.16 . . . . 72.11 114.131 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.88 -23.68 13.83 Favored 'Trans proline' 0 C--N 1.383 2.36 0 CA-C-N 121.435 1.548 . . . . 42.31 112.834 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 51.1 m80 -65.19 -20.38 66.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.532 0.733 . . . . 73.22 112.852 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' C' ' 34' ' ' LYS . 52.6 t -49.46 -32.07 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.284 1.034 . . . . 54.24 113.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.96 -39.88 96.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.893 0.477 . . . . 72.0 111.695 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.86 15.2 25.74 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.079 0.952 . . . . 75.35 111.261 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.686 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 3.4 ttpm? -108.68 137.02 47.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.873 0.869 . . . . 61.41 109.023 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 131.83 35.24 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.176 -1.046 . . . . 73.1 108.176 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -79.67 72.26 6.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.079 0.552 . . . . 74.2 109.813 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -143.28 48.15 0.92 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 123.79 0.836 . . . . 74.21 110.165 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.11 143.81 18.12 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 121.358 1.372 . . . . 75.23 110.841 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.11 115.21 24.35 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 54.21 108.789 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.99 107.5 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.391 -0.822 . . . . 61.55 110.24 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 7.3 tmtt? -92.45 104.56 16.87 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 106.375 -1.713 . . . . 74.02 106.375 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.403 HD13 ' HG ' ' C' ' 128' ' ' LEU . 13.5 tp -84.0 146.95 27.7 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.73 -1.211 . . . . 75.42 107.73 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.48 143.3 31.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.257 -1.386 . . . . 63.55 107.257 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 153.97 51.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.233 0.54 . . . . 60.33 111.379 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.8 t70 -151.38 153.26 34.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.784 1.234 . . . . 73.05 108.626 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -139.33 141.53 37.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.077 -0.712 . . . . 55.44 109.077 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -128.66 170.09 13.68 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.101 0.96 . . . . 74.52 109.106 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -147.14 144.66 29.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.457 0.703 . . . . 50.23 109.995 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 66.2 p -144.88 126.29 14.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.265 -1.013 . . . . 73.11 108.265 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.88 115.86 19.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' C' ' 57' ' ' GLU . 51.7 mt -89.36 -35.72 15.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.154 0.582 . . . . 75.3 109.635 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.59 -173.84 4.59 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 73.42 110.016 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.65 117.29 8.6 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.378 -0.828 . . . . 70.02 109.775 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 68.58 0.28 2.55 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.603 1.561 . . . . 74.24 112.364 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.72 108.99 24.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.744 -0.836 . . . . 75.23 108.744 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.26 123.53 41.66 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.529 1.132 . . . . 73.42 108.756 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.569 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.7 tt0 -83.34 139.05 33.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.253 -1.017 . . . . 75.55 108.253 169.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 95.6 t -118.93 131.86 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.357 -0.979 . . . . 62.22 108.357 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 60.5 t -110.1 102.5 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.745 -0.835 . . . . 73.21 108.745 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -90.56 109.19 20.34 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.109 -1.071 . . . . 65.3 108.109 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.703 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 65.2 mtt85 -95.75 132.7 40.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.814 0.845 . . . . 53.03 109.526 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.0 t -126.62 131.02 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -125.92 120.45 30.43 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.912 -0.773 . . . . 71.03 108.912 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.431 HG21 HG21 ' C' ' 114' ' ' ILE . 94.4 t -110.27 114.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.145 0.978 . . . . 65.31 108.82 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 16.3 m -98.81 139.16 34.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.868 -1.16 . . . . 52.4 107.868 168.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.98 110.65 7.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.024 -1.843 . . . . 44.31 106.024 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.499 ' HB3' HG23 ' C' ' 72' ' ' THR . 12.5 p -158.16 139.99 13.89 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.641 0.588 . . . . 74.4 110.689 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.0 tp -80.7 -23.85 39.24 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.473 -0.785 . . . . 71.44 109.276 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.04 -97.2 0.11 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 110.056 -1.217 . . . . 71.3 110.056 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -90.46 -31.93 16.6 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.651 -0.87 . . . . 74.1 108.651 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -69.93 84.04 0.49 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.018 -1.105 . . . . 63.53 108.018 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.499 HG23 ' HB3' ' C' ' 67' ' ' SER . 78.7 m -87.89 136.72 32.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.248 -1.342 . . . . 74.35 109.889 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.686 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -72.32 -73.56 0.19 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.92 -1.141 . . . . 55.13 107.92 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.0 167.59 29.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.736 0.779 . . . . 75.13 112.333 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -125.59 138.71 53.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 105.726 -1.953 . . . . 72.35 105.726 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -151.77 113.27 4.36 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 110.011 -0.366 . . . . 44.42 110.011 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -117.06 136.11 53.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.518 0.327 . . . . 74.42 110.129 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' C' ' 110' ' ' ALA . 25.4 t -125.25 114.16 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 55.24 108.673 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -90.26 92.7 9.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.472 -0.936 . . . . 65.4 108.472 171.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.435 ' NE2' HG22 ' C' ' 18' ' ' THR . 7.5 tp-100 -78.16 136.54 37.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.687 -0.688 . . . . 74.24 109.345 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.42 153.04 17.67 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.3 -0.72 . . . . 55.11 111.3 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 121.19 1.08 Allowed Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 111.477 -0.649 . . . . 71.54 111.477 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.461 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.3 mm -81.71 120.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 107.685 -1.228 . . . . 71.32 107.685 174.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -131.83 138.01 48.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.512 0.725 . . . . 62.11 109.962 -174.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 58.9 m -89.89 113.93 25.62 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.552 -0.906 . . . . 64.43 108.552 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.6 100.55 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.96 -1.126 . . . . 71.42 107.96 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -130.74 152.68 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.914 0.886 . . . . 64.3 110.352 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.16 -39.3 2.8 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.02 -0.536 . . . . 73.44 112.209 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.57 160.01 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.256 0.622 . . . . 65.51 109.968 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.03 152.86 34.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.169 0.588 . . . . 75.22 110.551 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.45 -111.91 4.17 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.769 0.668 . . . . 24.43 113.198 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.3 p -73.73 -34.37 64.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.051 0.94 . . . . 54.44 111.693 -175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.26 -36.55 74.52 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.694 -0.484 . . . . 72.21 109.694 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.462 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 59.5 ttm -68.23 -36.46 79.53 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.913 -0.585 . . . . 63.3 110.174 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -33.09 74.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.638 0.775 . . . . 71.55 111.024 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -68.34 -35.57 77.96 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.14 0.576 . . . . 73.53 110.845 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 24.9 t -71.87 -62.65 1.34 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.638 0.375 . . . . 72.03 110.633 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.1 pp -75.71 -14.13 60.33 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.309 0.485 . . . . 70.31 112.309 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.31 -18.99 37.04 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.602 -0.555 . . . . 74.12 113.259 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.81 -56.48 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.786 0.793 . . . . 73.53 112.642 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -66.53 -61.15 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.61 0.364 . . . . 64.52 111.862 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 40.6 m -57.05 -45.45 99.95 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 124.08 0.952 . . . . 73.12 113.457 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.79 -25.2 46.12 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.798 1.666 . . . . 71.03 113.493 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -70.55 -29.16 65.55 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.754 0.422 . . . . 64.51 110.175 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.484 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.4 mm -68.4 -40.07 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.569 0.748 . . . . 61.4 109.939 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.6 mt -78.31 -26.28 46.88 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.99 -1.005 . . . . 74.22 112.307 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.0 -42.08 79.9 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.507 -1.235 . . . . 71.11 114.062 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.17 -43.63 55.56 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.158 1.905 . . . . 63.4 112.904 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -66.35 -41.31 89.73 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.66 0.784 . . . . 64.54 110.785 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.452 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -68.84 -44.8 72.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.665 -0.698 . . . . 43.4 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -50.95 -55.69 16.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.419 1.488 . . . . 62.4 110.995 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.31 -36.82 85.25 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.035 0.834 . . . . 71.22 109.931 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.531 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 12.0 t -66.47 -36.54 83.0 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.444 0.698 . . . . 74.01 111.566 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' C' ' 118' ' ' VAL . 95.1 mt -70.06 -49.51 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.379 0.672 . . . . 74.32 109.917 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.409 HG21 HD21 ' C' ' 127' ' ' ASN . 19.6 m -66.37 -30.23 70.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.109 0.564 . . . . 63.24 111.187 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -65.45 -45.87 82.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.113 -0.699 . . . . 65.41 109.113 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.563 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.73 -34.9 75.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.157 0.983 . . . . 54.05 112.404 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.466 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.1 t -62.49 -46.32 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.387 0.675 . . . . 72.35 109.542 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.4 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 29.7 t -67.48 -31.89 72.34 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.149 -0.932 . . . . 53.52 111.669 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.5 mtt-85 -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.376 0.67 . . . . 74.11 109.664 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.35 -4.37 86.86 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.804 0.69 . . . . 73.22 112.811 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.9 p 65.57 32.83 9.02 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.716 2.006 . . . . 63.51 113.085 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -89.09 166.49 21.58 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.587 1.155 . . . . 74.1 110.554 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.506 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 31.3 Cg_endo -63.77 112.93 1.95 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.074 1.849 . . . . 74.0 111.89 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.4 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 84.4 mt-30 -60.99 136.37 58.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.91 0.484 . . . . 74.45 111.023 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 38.9 tp -144.6 123.33 12.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.195 -1.039 . . . . 73.33 108.195 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.409 HD21 HG21 ' C' ' 115' ' ' THR . 26.8 m120 -103.32 123.73 47.34 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.824 0.45 . . . . 74.34 109.789 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.403 ' HG ' HD13 ' C' ' 42' ' ' LEU . 1.4 tm? -74.24 128.51 35.73 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.16 0.984 . . . . 74.32 109.546 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.5 146.43 98.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.797 0.839 . . . . 70.22 111.374 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.604 ' HG3' HD13 ' A' ' 16' ' ' ILE . 35.5 Cg_endo -61.41 136.09 61.59 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.896 2.397 . . . . 73.23 113.31 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.58 109.83 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.077 -1.082 . . . . 74.44 108.077 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -112.51 93.83 4.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.748 0.819 . . . . 42.2 110.666 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 124.77 1.228 . . . . 73.13 111.615 174.311 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.454 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.3 ptm . . . . . 0 CA--C 1.563 1.452 0 N-CA-C 114.622 1.341 . . . . 31.32 114.622 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 37.8 m -107.88 143.87 35.89 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.445 0.698 . . . . 70.51 109.318 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' D' ' 85' ' ' SER . 63.2 t80 -155.55 106.91 2.56 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.39 -0.967 . . . . 75.23 108.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -129.3 146.34 51.21 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.234 0.614 . . . . 74.23 109.614 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.78 109.82 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.568 -1.271 . . . . 61.4 107.568 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -82.69 -47.66 11.77 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.034 0.208 . . . . 74.24 111.46 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -170.11 129.25 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.58 -0.282 . . . . 74.43 111.175 -167.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.41 133.2 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.272 -1.381 . . . . 54.21 107.272 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -155.47 144.52 20.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.214 0.531 . . . . 63.14 111.551 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -79.31 115.03 18.71 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.441 -0.8 . . . . 61.35 109.193 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.2 mtpt -81.1 -24.5 37.67 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.957 -0.386 . . . . 73.11 109.957 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.737 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.9 t70 -153.99 141.59 19.88 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.027 -0.988 . . . . 61.11 109.724 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.563 HG21 ' HE2' ' C' ' 117' ' ' MET . 86.3 mt -139.65 149.55 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.216 1.406 . . . . 73.41 107.689 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -153.04 144.91 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.584 1.154 . . . . 74.43 108.404 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 85.4 t80 -152.29 115.3 4.65 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 105.928 -1.879 . . . . 72.25 105.928 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.1 mt-10 -127.23 111.41 13.92 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.7 0.4 . . . . 60.02 110.008 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 90.52 4.72 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.809 -1.182 . . . . 71.41 107.809 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.32 -40.56 1.57 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.663 2.242 . . . . 72.0 113.082 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' D' ' 30' ' ' HIS . 5.0 p30 -113.56 43.96 1.68 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.321 1.048 . . . . 74.54 108.927 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.515 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.36 -49.23 86.43 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 115.786 1.773 . . . . 75.14 115.786 -169.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 -15.99 13.34 Favored 'Trans proline' 0 C--N 1.388 2.654 0 CA-C-N 122.102 1.786 . . . . 53.44 113.381 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.482 ' HB3' ' HB2' ' D' ' 27' ' ' ASN . 7.1 t-160 -77.08 -46.53 23.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.136 0.974 . . . . 73.01 111.199 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.2 p -70.59 -22.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-O 120.968 0.413 . . . . 74.15 110.989 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.17 -33.24 74.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.688 0.795 . . . . 72.45 111.051 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -72.78 -15.37 61.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.703 0.801 . . . . 65.04 111.156 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.5 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 89.7 mttt -93.0 106.82 18.72 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.227 -0.657 . . . . 73.43 109.227 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.41 89.63 7.07 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.285 -0.635 . . . . 71.2 109.285 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.516 ' HB3' HD21 ' D' ' 68' ' ' LEU . 6.3 t-105 -169.99 158.87 7.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 108.487 -0.931 . . . . 74.31 108.487 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -86.94 114.48 58.48 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.037 0.535 . . . . 64.22 110.458 175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.79 140.58 86.5 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 123.407 2.738 . . . . 74.15 114.217 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.02 126.16 28.95 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.953 0.901 . . . . 55.05 109.863 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.49 HG13 HG13 ' D' ' 64' ' ' VAL . 47.9 t -99.58 112.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 72.13 110.258 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 1.4 tmtp? -88.09 122.14 31.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.028 -1.471 . . . . 70.22 107.028 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.08 115.4 27.43 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.773 -1.195 . . . . 50.11 107.773 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.643 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.7 m-20 -108.27 136.81 47.3 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.97 -1.122 . . . . 75.52 107.97 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.93 133.33 37.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.083 0.553 . . . . 52.33 109.922 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.8 t70 -142.06 157.25 45.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 73.43 108.198 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -132.29 158.13 42.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.833 0.853 . . . . 71.45 109.5 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.68 170.04 21.23 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.957 -0.757 . . . . 64.1 108.957 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 39.6 m -150.68 159.56 44.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.973 0.509 . . . . 75.14 109.965 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' D' ' 57' ' ' GLU . 40.3 t -152.06 127.07 9.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.479 -0.934 . . . . 55.24 108.479 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.53 117.8 24.65 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.44 -0.948 . . . . 63.14 108.44 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.2 mt -98.09 -29.73 13.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.171 0.588 . . . . 72.24 110.165 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -161.02 -179.03 7.19 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.033 0.933 . . . . 72.42 109.972 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -68.15 118.66 11.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.006 -0.997 . . . . 75.42 108.819 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 67.53 16.91 9.99 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.131 0.972 . . . . 74.33 112.032 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 76.8 t -127.33 117.12 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.449 -0.945 . . . . 74.3 108.449 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -135.2 129.31 33.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.785 -0.643 . . . . 74.31 109.787 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.3 tt0 -87.15 148.16 25.32 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.604 1.162 . . . . 73.14 108.394 167.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.498 HG13 HD11 ' D' ' 106' ' ' LEU . 4.1 p -134.5 138.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.734 -1.21 . . . . 75.22 107.734 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 94.7 t -108.84 136.85 43.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.072 -0.714 . . . . 64.23 109.072 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.56 116.99 29.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.024 -1.473 . . . . 72.31 107.024 174.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -97.46 98.21 9.75 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.36 -0.978 . . . . 54.41 108.36 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.1 116.64 39.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.282 -1.007 . . . . 71.24 108.282 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 33.3 m -125.46 132.51 52.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.04 -0.982 . . . . 73.44 109.04 -171.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.596 HG11 HD11 ' D' ' 126' ' ' LEU . 56.6 t -122.59 102.82 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.085 0.954 . . . . 55.31 109.059 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 25.3 m -95.81 91.95 6.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.98 -1.119 . . . . 74.42 107.98 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.51 139.61 31.53 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.598 -0.89 . . . . 75.11 108.598 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.8 p -151.99 135.43 16.05 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.625 0.578 . . . . 71.1 110.34 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' D' ' 36' ' ' TRP . 12.6 tp -112.78 106.09 14.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.714 -0.676 . . . . 74.03 109.318 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.94 -133.12 11.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.755 -0.657 . . . . 75.01 112.201 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 3.78 41.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.584 0.753 . . . . 72.03 111.617 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.5 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 9.5 tp10 -138.46 149.22 45.22 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.729 0.812 . . . . 65.33 109.17 -165.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -56.77 152.85 11.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.405 1.082 . . . . 75.43 111.206 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -107.26 -62.29 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.463 -0.94 . . . . 65.23 108.463 171.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.1 149.37 24.52 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.075 -0.966 . . . . 74.43 109.151 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.8 mt -112.03 151.19 29.62 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.982 -1.118 . . . . 72.04 107.982 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.509 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.7 t -158.42 146.77 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.401 0.438 . . . . 72.11 109.987 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.65 132.28 10.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.587 0.755 . . . . 74.01 109.062 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.5 113.2 22.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.425 -0.954 . . . . 72.14 108.425 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -89.45 81.79 6.53 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.038 -1.097 . . . . 63.3 108.038 171.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.427 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.9 tp-100 -79.7 99.75 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 112.914 -1.948 . . . . 75.51 109.216 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.24 161.66 31.64 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.91 -0.476 . . . . 35.21 111.91 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -164.86 136.23 4.11 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.626 -0.59 . . . . 63.11 111.626 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.96 137.08 22.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.591 0.756 . . . . 72.42 110.074 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.95 132.69 38.71 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.848 0.859 . . . . 54.42 109.533 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 5.7 m -75.52 95.89 3.4 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.352 -0.981 . . . . 74.5 108.352 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 53.4 mt -105.94 99.36 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.451 -0.944 . . . . 64.14 108.451 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -126.88 153.19 46.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.677 1.191 . . . . 74.04 108.778 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.06 -7.9 62.05 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.753 -0.471 . . . . 70.13 113.454 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.559 HD12 ' HG2' ' D' ' 93' ' ' GLN . 5.5 mm -137.97 129.27 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.938 0.895 . . . . 72.45 110.671 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.607 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 3.0 pp20? -148.36 -173.83 4.43 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.655 0.782 . . . . 73.13 110.232 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.42 -140.52 25.46 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.014 -0.326 . . . . 52.13 113.137 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -69.99 -25.11 63.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.202 0.601 . . . . 51.22 110.851 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.559 ' HG2' HD12 ' D' ' 89' ' ' ILE . 6.2 tp-100 -72.74 -32.07 65.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.278 0.631 . . . . 51.11 110.355 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.607 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 21.1 ttt -71.34 -42.41 68.56 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.826 -0.435 . . . . 73.22 109.826 171.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -27.62 69.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.863 0.465 . . . . 65.44 111.036 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.78 -52.76 8.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.676 0.79 . . . . 64.1 110.733 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.29 -51.64 62.51 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.944 0.402 . . . . 63.03 110.963 -172.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 22.5 tp -75.81 -19.3 59.06 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 73.05 110.929 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.41 -5.51 36.93 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.516 -0.602 . . . . 54.32 114.287 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.31 -61.9 0.72 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.941 0.871 . . . . 51.43 111.408 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.83 -47.32 54.0 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.444 0.465 . . . . 74.33 112.027 -171.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HG ' ' HZ ' ' D' ' 11' ' ' PHE . 59.8 m -64.75 -44.78 74.38 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 123.491 0.716 . . . . 63.34 111.722 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.499 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.9 Cg_exo -57.16 -34.89 98.6 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 122.513 2.142 . . . . 65.55 113.871 166.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.75 -34.43 78.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.082 0.553 . . . . 60.05 110.73 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.37 -33.43 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.796 . . . . 63.2 110.561 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.498 HD11 HG13 ' D' ' 58' ' ' VAL . 91.3 mt -79.38 -20.66 47.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.819 0.848 . . . . 63.24 112.603 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.05 -42.84 64.36 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 113.968 1.099 . . . . 73.1 113.968 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.81 -39.83 87.91 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.054 1.836 . . . . 70.34 113.281 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.67 -36.39 65.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.596 0.758 . . . . 72.34 111.38 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -51.07 70.07 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.297 0.639 . . . . 45.32 110.121 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.0 -48.09 79.28 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.777 1.298 . . . . 75.21 110.589 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.0 -43.16 99.29 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.364 1.04 . . . . 73.44 111.736 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.55 -41.62 97.64 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.553 0.533 . . . . 75.41 110.767 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.509 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.3 mt -67.7 -43.47 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.556 -0.747 . . . . 73.22 110.716 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.4 m -55.63 -46.37 77.41 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.996 0.918 . . . . 70.13 110.66 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.5 t -64.82 -46.93 79.87 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 114.026 -1.443 . . . . 44.54 110.578 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -64.49 -36.5 84.38 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.007 0.523 . . . . 65.21 112.089 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' D' ' 123' ' ' PHE . 45.3 t -67.18 -40.95 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.215 -0.902 . . . . 51.15 110.661 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -75.17 -23.53 57.74 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.416 0.287 . . . . 73.45 111.408 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.531 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 89.2 mtt-85 -74.56 -38.17 62.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.499 0.72 . . . . 73.34 109.723 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.42 1.55 76.11 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.541 -0.754 . . . . 33.45 112.391 173.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 60.13 23.51 12.78 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.852 2.061 . . . . 71.24 113.146 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.445 ' HB2' HG13 ' D' ' 118' ' ' VAL . 78.7 m-85 -80.6 161.16 65.22 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 124.862 1.265 . . . . 51.04 109.114 169.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.21 135.42 43.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.355 2.037 . . . . 73.24 112.234 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -48.45 130.92 17.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.048 1.339 . . . . 74.33 112.562 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.596 HD11 HG11 ' D' ' 64' ' ' VAL . 9.6 tt -108.71 112.49 24.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.618 0.767 . . . . 50.3 109.553 -171.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -124.74 92.71 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.388 0.675 . . . . 75.21 109.683 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 69.4 mt -68.53 132.68 47.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.124 0.569 . . . . 72.55 110.238 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.47 139.89 94.61 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.41 0.684 . . . . 64.55 111.234 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.94 127.66 20.99 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.828 2.352 . . . . 73.31 112.529 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.61 111.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.015 0.926 . . . . 71.03 109.849 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -84.73 101.81 12.51 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.656 -0.498 . . . . 71.13 109.656 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 . . . . . 0 N--CA 1.479 0.981 0 C-N-CA 123.43 0.692 . . . . 72.23 111.256 -175.861 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.5 m . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 109.47 -0.567 . . . . 61.12 109.47 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -139.09 114.47 9.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.298 -1.001 . . . . 74.42 108.298 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 96.5 mt-30 -133.66 122.35 23.31 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.216 -0.661 . . . . 72.34 109.216 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -82.27 88.93 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 108.722 -0.844 . . . . 72.24 108.722 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -77.28 -41.22 41.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.119 -0.491 . . . . 74.22 111.882 -165.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -153.94 137.27 15.77 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.209 1.003 . . . . 73.55 108.293 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.657 HD13 ' HG3' ' C' ' 130' ' ' PRO . 4.4 mp -130.6 119.19 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 106.927 -1.509 . . . . 73.04 106.927 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -152.93 174.68 13.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.456 0.702 . . . . 74.31 111.521 -172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -97.73 117.15 31.39 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.757 -0.831 . . . . 53.22 108.757 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 39.7 mtpt -80.73 -22.67 40.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.582 -0.281 . . . . 63.45 110.315 174.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 16.3 t70 -157.82 147.02 19.67 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.031 0.832 . . . . 74.02 109.637 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 94.7 mt -143.99 138.9 24.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 125.536 1.534 . . . . 43.15 106.944 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.2 t -153.64 108.39 3.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.955 0.502 . . . . 73.45 109.888 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.602 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 57.2 t80 -109.11 131.51 55.0 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 106.343 -1.725 . . . . 74.45 106.343 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -124.97 141.45 52.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.71 72.72 9.71 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.834 -1.173 . . . . 43.53 107.834 170.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.05 -25.46 19.37 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.433 2.089 . . . . 61.21 111.063 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.445 ' HA ' ' CD2' ' A' ' 30' ' ' HIS . 92.1 m-20 -104.61 26.15 9.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.895 0.878 . . . . 50.02 110.602 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.73 -49.0 93.93 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 123.359 0.664 . . . . 61.14 112.788 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.3 Cg_exo -70.02 -23.09 30.02 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 121.779 1.653 . . . . 75.15 112.236 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.445 ' CD2' ' HA ' ' A' ' 27' ' ' ASN . 9.4 m-70 -74.33 -21.07 59.88 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.617 -0.719 . . . . 75.31 111.271 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HE2' ' A' ' 123' ' ' PHE . 84.2 t -53.62 -25.8 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.625 0.602 . . . . 63.43 112.625 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -67.67 -40.85 84.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.313 0.645 . . . . 65.32 111.487 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.99 -14.01 34.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.415 0.686 . . . . 71.24 111.305 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? -75.27 146.09 41.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.808 0.443 . . . . 73.42 111.484 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -73.25 118.46 16.23 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.296 -1.001 . . . . 72.12 108.296 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -79.18 86.06 5.01 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.918 0.487 . . . . 72.32 111.039 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 35.1 tt0 -139.95 71.12 35.55 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.127 -1.064 . . . . 61.02 108.127 170.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -80.68 117.49 3.35 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.717 2.278 . . . . 44.42 112.073 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.72 110.72 22.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.166 -1.05 . . . . 71.42 108.166 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -82.69 92.7 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 122.498 1.142 . . . . 73.43 109.528 175.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -94.49 130.52 40.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.293 -1.322 . . . . 74.11 108.567 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.464 HD23 ' H ' ' A' ' 42' ' ' LEU . 2.7 pt? -124.64 151.3 45.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.798 0.439 . . . . 60.44 111.378 -170.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -128.97 127.87 42.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.775 1.23 . . . . 71.33 108.483 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 79.9 mt -118.22 133.86 55.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.106 0.562 . . . . 64.41 109.821 179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 15.7 t70 -146.64 150.16 34.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.712 0.805 . . . . 75.25 109.666 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.0 m -142.02 127.22 18.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.887 0.875 . . . . 73.44 109.843 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -142.78 146.17 33.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.525 0.73 . . . . 63.32 109.767 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -105.7 169.98 8.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.618 0.767 . . . . 75.21 111.239 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -154.94 120.46 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.989 0.916 . . . . 35.51 108.829 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -77.81 114.57 16.8 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.964 -0.384 . . . . 62.04 109.964 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.6 mt -85.65 -40.71 15.89 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.605 0.762 . . . . 62.42 109.986 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.56 -174.62 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.333 -0.849 . . . . 75.4 110.144 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.3 117.26 6.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.31 -0.626 . . . . 74.11 109.31 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 71.96 2.53 4.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.934 1.293 . . . . 73.12 112.34 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -107.7 112.6 40.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.236 -1.024 . . . . 71.4 108.236 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.94 123.36 28.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.223 -0.658 . . . . 44.43 109.223 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.4 tt0 -88.28 140.9 29.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.856 0.862 . . . . 60.14 108.921 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.38 123.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.844 -1.169 . . . . 45.51 107.844 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.567 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 33.5 t -103.57 148.8 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.784 0.834 . . . . 54.12 109.82 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.68 117.6 26.14 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.407 -0.961 . . . . 73.3 108.407 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 1.7 mpp_? -88.93 106.87 18.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.38 -0.97 . . . . 71.12 108.38 171.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG21 ' HB1' ' A' ' 110' ' ' ALA . 7.7 t -111.17 114.11 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.144 -1.058 . . . . 65.42 108.144 169.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 27.5 m -110.41 130.55 55.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.095 -1.076 . . . . 71.02 108.095 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.16 108.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.105 -1.072 . . . . 63.04 108.105 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 16.1 m -110.67 133.86 52.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.908 -0.405 . . . . 73.43 109.908 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.47 105.31 15.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.097 -1.075 . . . . 52.44 108.097 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.8 m -118.06 127.16 53.53 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.155 0.582 . . . . 72.0 110.277 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.8 OUTLIER -88.99 85.71 6.77 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.862 0.839 . . . . 73.51 109.05 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.34 -88.97 1.3 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.301 -0.863 . . . . 70.41 111.049 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 -28.75 4.65 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.431 0.692 . . . . 75.52 110.804 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -79.04 134.15 36.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 72.22 109.657 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.3 m -85.88 121.37 28.43 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.099 0.408 . . . . 71.44 110.591 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.65 -58.16 7.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.52 0.728 . . . . 42.23 109.645 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -164.27 162.18 22.34 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.434 -1.257 . . . . 73.42 110.564 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.2 tp -117.54 147.72 42.54 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.452 1.101 . . . . 72.13 109.776 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.51 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 61.9 m -140.85 100.15 3.77 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.206 1.002 . . . . 72.34 109.482 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.99 126.56 44.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.132 0.973 . . . . 74.41 109.176 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -136.69 138.78 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.389 0.676 . . . . 51.42 109.764 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -105.52 96.84 6.79 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.577 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -84.56 98.94 10.43 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.109 -0.701 . . . . 71.11 109.109 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -112.39 144.96 17.96 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.606 -0.598 . . . . 71.04 111.606 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.87 146.79 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.374 -0.29 . . . . 64.02 112.374 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.69 128.06 39.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 108.692 -0.855 . . . . 45.24 108.692 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -128.92 118.16 22.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.323 -0.621 . . . . 73.05 109.323 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 20.5 m -83.54 87.04 7.01 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.471 -0.937 . . . . 74.21 108.471 176.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.96 138.49 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.849 0.859 . . . . 74.2 110.023 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.07 161.28 12.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.931 0.893 . . . . 64.31 110.881 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 4.24 85.24 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.738 -0.665 . . . . 54.52 114.665 172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.51 ' HB ' ' HE2' ' A' ' 94' ' ' MET . 46.2 mt -119.52 136.48 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.019 -1.104 . . . . 63.34 108.019 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.97 174.69 10.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.175 0.59 . . . . 74.23 109.812 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -144.75 49.24 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.239 -0.891 . . . . 73.43 113.579 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.623 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 41.2 p -71.21 -15.07 62.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.322 1.049 . . . . 73.45 112.318 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -63.56 -50.9 67.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.286 0.634 . . . . 71.42 110.424 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.558 ' SD ' ' HG ' ' A' ' 98' ' ' LEU . 56.1 tpp -83.14 -29.03 28.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.887 0.475 . . . . 70.32 111.054 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -62.21 -28.1 69.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 63.1 110.83 172.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -68.81 -54.68 14.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.862 -1.063 . . . . 72.15 109.78 166.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 4.2 m -64.46 -56.87 11.34 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.593 1.331 . . . . 73.5 114.593 -166.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.558 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 77.9 mt -69.71 -15.86 63.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.635 0.652 . . . . 71.4 112.3 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.55 -0.27 43.15 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.703 -0.498 . . . . 31.5 113.903 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.59 -65.91 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.049 0.54 . . . . 43.12 111.358 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.7 t80 -51.65 -52.95 43.86 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.779 1.232 . . . . 70.23 112.818 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -73.24 -48.48 7.41 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.309 -0.853 . . . . 72.12 112.644 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.54 -20.21 69.99 Favored 'Trans proline' 0 C--N 1.383 2.351 0 CA-C-N 121.153 1.448 . . . . 70.31 113.337 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.24 -41.84 80.58 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.452 0.701 . . . . 74.31 110.407 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.91 -37.35 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.432 0.693 . . . . 53.21 110.452 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.69 -26.36 34.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.357 -0.838 . . . . 72.11 112.133 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -62.56 -44.34 86.79 Favored Pre-proline 0 CA--C 1.566 1.568 0 N-CA-C 114.896 1.443 . . . . 74.2 114.896 -169.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 -39.48 43.55 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.884 1.723 . . . . 73.34 112.306 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -73.69 -31.32 63.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.416 0.687 . . . . 75.0 111.369 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.403 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.51 -51.77 61.23 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.327 0.651 . . . . 33.42 109.342 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.483 HH12 HD12 ' C' ' 105' ' ' ILE . 39.2 ttm180 -52.43 -51.5 58.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.477 -1.238 . . . . 72.42 110.966 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.19 -46.84 85.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.589 -0.732 . . . . 74.2 111.62 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.468 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.8 t -57.95 -38.92 76.86 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.599 0.562 . . . . 72.53 111.335 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 76' ' ' CYS . 95.9 mt -67.65 -52.65 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.231 1.012 . . . . 64.54 110.796 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.474 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -60.89 -34.0 73.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.495 1.118 . . . . 52.54 111.673 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -69.48 -39.97 77.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.585 -0.734 . . . . 73.25 109.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.8 mtm -63.51 -38.66 91.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.627 0.371 . . . . 74.24 110.781 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 76' ' ' CYS . 81.3 t -59.66 -49.65 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.829 0.851 . . . . 63.32 110.622 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.0 p -71.07 -34.09 70.84 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.022 -0.535 . . . . 73.21 111.638 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -68.8 -30.73 69.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.508 0.723 . . . . 64.14 109.873 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.66 -1.12 90.06 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.595 -0.729 . . . . 62.23 112.777 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m 65.33 46.45 2.6 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 122.831 1.3 . . . . 64.3 110.194 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG21 ' A' ' 31' ' ' VAL . 59.6 m-85 -121.16 149.67 52.06 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.29 -1.323 . . . . 74.3 109.095 173.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.99 140.1 91.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.395 2.063 . . . . 62.52 111.41 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.474 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -51.14 134.97 26.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.669 1.188 . . . . 70.13 113.315 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.412 HD22 HG11 ' A' ' 40' ' ' VAL . 86.8 mt -121.11 100.98 7.37 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.081 0.952 . . . . 73.02 108.762 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -117.29 105.02 11.74 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 55.24 109.542 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.26 150.72 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 64.32 109.509 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.82 93.23 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.62 0.768 . . . . 53.41 111.608 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.23 115.47 3.34 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.075 1.85 . . . . 64.34 110.74 170.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.64 113.07 32.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.806 -1.183 . . . . 64.31 107.806 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -82.71 72.89 9.78 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.5 1.143 . . . . 72.2 108.221 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -70.59 -20.91 62.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 113.522 -1.672 . . . . 74.22 109.647 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.529 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.4 t70 . . . . . 0 C--N 1.347 0.464 0 C-N-CA 124.184 0.994 . . . . 71.24 109.922 176.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.535 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.0 ptm . . . . . 0 N--CA 1.474 0.767 0 N-CA-C 113.036 0.754 . . . . 75.44 113.036 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.5 t -165.22 142.84 6.0 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 108.068 -1.086 . . . . 70.03 108.068 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -139.51 134.41 32.2 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.808 -0.812 . . . . 74.32 108.808 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -149.37 143.78 25.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.126 0.57 . . . . 60.25 110.195 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.87 122.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.623 -1.251 . . . . 72.23 107.623 170.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -85.82 -42.84 13.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.514 -0.55 . . . . 74.22 109.514 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -166.25 134.35 2.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.159 -0.473 . . . . 75.23 109.894 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.9 134.53 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 107.149 -1.426 . . . . 71.4 107.149 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -162.4 154.48 18.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.659 0.742 . . . . 73.4 112.093 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -80.51 127.3 32.27 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.421 -1.263 . . . . 61.32 108.676 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -97.31 -32.36 11.93 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.999 0.919 . . . . 33.21 110.884 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -160.07 143.47 13.96 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.176 0.297 . . . . 54.3 110.562 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.484 HD12 HG22 ' B' ' 78' ' ' VAL . 48.3 mm -136.68 138.0 46.83 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 C-N-CA 125.038 1.335 . . . . 75.45 108.616 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.0 t -134.7 139.5 45.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.103 -1.443 . . . . 74.43 107.103 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.1 t80 -153.33 112.57 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.322 -1.733 . . . . 72.54 106.322 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.41 112.8 17.35 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.146 -0.687 . . . . 61.2 109.146 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.51 83.17 1.88 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.293 -1.003 . . . . 52.2 108.293 174.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.67 -12.19 15.19 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.698 2.265 . . . . 71.05 112.079 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.424 ' O ' HG23 ' B' ' 31' ' ' VAL . 75.2 m-20 -125.57 24.19 7.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.973 0.909 . . . . 75.55 109.436 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.466 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.33 -52.55 35.09 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.351 1.241 . . . . 73.04 114.351 -174.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.74 -10.77 20.12 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.089 1.86 . . . . 71.54 113.625 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -94.16 -25.56 17.06 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.731 0.813 . . . . 73.15 111.075 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 27' ' ' ASN . 88.7 t -75.31 -19.16 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.838 0.855 . . . . 55.42 110.43 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -51.91 -42.25 62.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.632 1.173 . . . . 74.04 112.423 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -81.84 -12.71 58.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.265 0.626 . . . . 74.44 112.016 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.02 100.48 11.81 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.74 0.816 . . . . 63.22 110.843 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.05 78.1 7.5 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.658 0.783 . . . . 74.54 110.621 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.698 ' HB2' HD21 ' B' ' 68' ' ' LEU . 14.8 m-90 -150.41 161.55 42.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.236 1.015 . . . . 75.03 108.635 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.75 112.15 22.7 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.293 -1.002 . . . . 73.44 108.293 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 31.3 Cg_endo -62.36 117.99 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.637 2.225 . . . . 73.01 111.313 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.0 115.48 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.853 0.721 . . . . 73.43 110.816 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.529 HG21 HD21 ' B' ' 126' ' ' LEU . 27.5 m -97.49 136.75 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.849 0.833 . . . . 73.14 112.236 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -114.09 114.06 25.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.999 1.32 . . . . 64.44 108.036 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.419 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -115.66 140.5 49.13 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.469 -0.567 . . . . 53.33 109.469 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.87 147.14 52.46 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.684 0.794 . . . . 64.43 110.175 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -99.24 131.73 45.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.825 -1.079 . . . . 64.41 108.32 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 16.1 t70 -126.13 140.83 52.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.993 -1.114 . . . . 73.21 107.993 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -121.36 143.74 49.04 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.244 0.545 . . . . 75.01 110.422 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.81 157.9 43.65 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.502 1.121 . . . . 71.44 108.084 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -142.4 168.04 20.67 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.584 0.707 . . . . 42.22 109.676 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' B' ' 57' ' ' GLU . 41.4 t -150.94 157.36 42.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.207 -1.36 . . . . 74.0 107.352 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -121.0 115.86 23.98 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.34 -0.615 . . . . 75.52 109.34 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 68.8 mt -90.02 -35.46 15.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.402 0.681 . . . . 75.11 109.494 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 177.29 11.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 72.44 110.212 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.46 125.19 23.38 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.85 0.03 3.19 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.904 1.282 . . . . 71.33 112.826 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -112.62 96.11 4.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.716 0.806 . . . . 72.33 108.951 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.41 ' CD1' HD11 ' B' ' 86' ' ' ILE . 18.5 m-85 -111.24 139.57 46.53 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.505 0.669 . . . . 73.4 110.359 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' B' ' 49' ' ' SER . 7.1 tm-20 -103.59 97.09 7.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.165 -1.42 . . . . 72.43 107.165 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 121.69 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.604 0.761 . . . . 75.54 109.419 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.9 t -102.44 135.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.438 0.695 . . . . 64.25 109.916 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 117.83 31.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.35 -1.722 . . . . 71.12 106.35 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.6 ttp180 -112.43 113.54 25.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.871 0.367 . . . . 73.34 110.057 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.23 106.32 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.533 -1.284 . . . . 60.23 107.533 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -99.22 123.94 43.9 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.663 HG21 HG21 ' B' ' 114' ' ' ILE . 63.4 t -114.15 129.54 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.945 -1.025 . . . . 73.13 109.222 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -119.28 143.33 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.468 -1.308 . . . . 74.24 107.468 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -133.62 140.02 46.86 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.46 -0.571 . . . . 63.32 109.46 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 44.4 p -135.95 128.82 31.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.857 . . . . 73.41 108.899 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' B' ' 36' ' ' TRP . 2.4 tt -117.54 120.72 38.94 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.455 -1.313 . . . . 74.35 107.455 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -110.8 3.11 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.896 0.747 . . . . 64.5 111.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.39 3.13 13.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.141 0.976 . . . . 73.15 111.411 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.12 168.54 19.41 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.268 0.627 . . . . 74.2 111.441 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.0 m -67.06 120.87 14.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.062 -0.972 . . . . 74.12 110.481 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -75.49 -53.38 8.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.307 0.643 . . . . 74.14 109.508 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.98 170.84 16.08 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.369 -1.287 . . . . 73.34 109.735 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.88 154.25 45.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.889 1.275 . . . . 75.53 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -157.59 154.2 28.09 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.5 tt0 -164.56 130.59 2.89 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.573 -0.899 . . . . 72.12 108.573 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.484 HG22 HD12 ' B' ' 21' ' ' ILE . 94.5 t -125.62 142.34 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 109.136 -0.69 . . . . 71.22 109.136 173.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 48.9 mt-30 -117.39 99.67 7.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.609 -1.256 . . . . 75.35 107.609 169.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -91.44 100.2 13.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.169 -1.049 . . . . 74.12 108.169 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -97.38 143.41 16.71 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.86 -0.896 . . . . 75.44 110.86 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.92 127.26 3.35 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 110.969 -0.852 . . . . 71.1 110.969 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.16 131.22 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.96 -1.126 . . . . 74.42 107.96 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -135.19 142.62 46.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.664 0.785 . . . . 64.44 110.703 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -90.68 105.77 18.05 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.349 -0.982 . . . . 63.13 108.349 169.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' B' ' 56' ' ' TYR . 1.6 pp -117.58 108.65 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.547 0.739 . . . . 41.32 110.19 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.94 44.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.581 0.752 . . . . 50.32 110.6 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 103.2 -71.3 0.29 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.835 -0.62 . . . . 74.32 112.3 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -73.6 158.35 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.691 0.396 . . . . 62.44 110.444 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 -176.32 5.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.478 0.711 . . . . 73.23 110.131 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.2 -131.52 50.0 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.584 0.552 . . . . 64.15 113.019 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.8 m -67.55 -24.27 65.51 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.593 0.757 . . . . 54.44 111.456 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.71 -37.15 65.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.312 0.645 . . . . 74.31 110.957 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 56.3 tpp -73.93 -31.5 63.08 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.77 -0.456 . . . . 71.32 109.77 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.22 83.08 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.748 -0.66 . . . . 63.21 111.049 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.46 -36.45 60.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.5 0.72 . . . . 73.32 110.35 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.82 -59.01 5.09 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 72.54 111.021 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.88 -18.72 59.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 73.24 110.949 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.05 1.2 67.46 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-O 119.672 -0.516 . . . . 54.34 114.184 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -153.69 -60.05 0.13 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.775 0.787 . . . . 60.11 112.518 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -65.91 -45.56 81.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.92 0.888 . . . . 73.42 111.335 -171.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 64.4 m -68.45 -49.88 29.47 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 115.442 -0.799 . . . . 53.5 112.187 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.39 -22.41 52.47 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.634 1.556 . . . . 54.3 113.799 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.38 -37.64 86.52 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.259 0.552 . . . . 70.04 110.859 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.93 -40.71 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 71.2 110.871 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 55.6 mt -80.98 -18.65 46.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.289 -0.869 . . . . 71.22 111.915 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.55 -48.03 96.48 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.571 1.323 . . . . 65.52 114.571 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.49 -31.66 80.41 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 121.596 1.531 . . . . 70.43 112.985 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.9 m-85 -68.26 -46.93 69.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.483 0.713 . . . . 65.43 110.817 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -57.64 -43.66 85.02 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.42 -0.809 . . . . 74.32 110.071 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 20.7 mtp-105 -51.26 -64.32 0.85 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.224 1.01 . . . . 72.55 111.434 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.54 -28.99 69.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.625 0.77 . . . . 64.21 110.842 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -71.48 -44.91 63.86 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.829 0.451 . . . . 45.13 110.574 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.663 HG21 HG21 ' B' ' 64' ' ' VAL . 57.0 mt -62.94 -51.26 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.61 0.764 . . . . 64.51 109.979 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.52 -37.7 79.02 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.944 -1.026 . . . . 72.41 111.041 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.7 t -60.65 -52.23 66.03 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.581 -0.736 . . . . 65.1 110.063 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.0 mmt -63.75 -38.84 92.61 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.174 0.589 . . . . 71.43 111.151 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 114' ' ' ILE . 83.2 t -60.6 -45.44 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.537 0.735 . . . . 72.32 110.739 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -69.5 -27.81 65.51 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.265 -0.88 . . . . 74.12 112.019 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.468 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 90.7 mtt-85 -68.9 -34.41 75.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.488 0.715 . . . . 70.3 110.222 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.2 7.72 55.28 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.823 0.702 . . . . 72.35 112.842 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p 55.78 32.01 18.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.111 1.764 . . . . 51.2 112.078 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -93.57 157.55 38.24 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.978 0.911 . . . . 71.15 109.985 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -47.73 147.4 7.08 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.82 3.013 . . . . 64.43 114.287 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.628 HE22 ' HB2' ' B' ' 127' ' ' ASN . 21.7 tm0? -62.26 129.75 42.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.583 0.753 . . . . 73.43 109.721 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.529 HD21 HG21 ' B' ' 40' ' ' VAL . 2.2 tm? -126.09 111.18 14.37 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.407 -0.59 . . . . 65.13 109.407 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.628 ' HB2' HE22 ' B' ' 125' ' ' GLN . 41.0 t30 -111.02 134.81 52.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.267 1.027 . . . . 64.22 109.374 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.599 HD11 HD12 ' B' ' 114' ' ' ILE . 36.9 mt -87.46 134.77 33.55 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 109.296 -0.631 . . . . 73.25 109.296 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.41 148.52 85.95 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.17 0.588 . . . . 72.05 110.087 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 99.82 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.914 2.41 . . . . 62.11 112.518 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -90.38 110.46 22.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.883 -1.154 . . . . 74.32 107.883 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -69.6 101.79 1.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.067 -0.716 . . . . 65.53 109.067 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.417 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 48.6 m-85 -56.65 -33.93 66.81 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.503 1.121 . . . . 72.4 110.112 176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.64 -63.76 1.04 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.017 -1.447 . . . . 74.42 111.247 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.42 68.59 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.446 0.699 . . . . 52.32 111.708 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tt . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 123.912 0.885 . . . . 72.34 109.759 177.018 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 113.509 0.929 . . . . 74.05 113.509 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -99.0 111.5 23.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.903 0.881 . . . . 73.13 108.832 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.641 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 58.3 t80 -119.03 130.72 55.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.395 -0.965 . . . . 71.41 108.395 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -144.79 133.54 22.31 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.619 0.367 . . . . 73.13 110.218 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.436 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.7 tp -83.96 134.38 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.389 0.676 . . . . 62.33 109.309 171.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.446 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.0 mm-40 -101.99 -47.28 4.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.654 0.782 . . . . 74.01 109.556 176.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -168.95 138.85 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.959 0.503 . . . . 72.32 110.899 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 60.9 mt -111.01 148.03 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.55 1.14 . . . . 71.5 108.131 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -177.23 164.23 2.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.289 0.636 . . . . 74.13 110.692 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -84.57 119.08 24.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.649 -0.871 . . . . 62.42 108.649 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.537 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 25.1 mmtp -73.0 -48.2 38.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.446 -0.946 . . . . 64.11 108.446 168.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.0 t70 -136.92 144.08 43.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.22 -1.355 . . . . 73.0 110.093 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.4 mt -139.53 142.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.023 -1.473 . . . . 71.11 107.023 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -156.01 149.52 24.81 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.046 0.45 . . . . 65.2 110.453 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.88 108.51 3.48 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.815 -1.18 . . . . 75.44 107.815 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -117.41 110.82 18.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.234 -0.654 . . . . 64.15 109.234 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -112.91 93.85 26.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.664 -0.865 . . . . 54.23 108.664 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.67 -35.13 48.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.879 2.386 . . . . 73.15 112.118 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -108.41 36.91 2.65 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.361 -0.836 . . . . 75.45 109.379 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' C' ' 25' ' ' ALA . . . -58.85 -45.98 99.57 Favored Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.305 1.224 . . . . 70.32 114.305 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.51 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 24.1 Cg_exo -68.79 -37.3 12.07 Favored 'Trans proline' 0 C--N 1.389 2.699 0 CA-C-N 121.305 1.502 . . . . 75.12 112.678 171.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -66.84 -18.31 65.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.071 0.948 . . . . 72.52 112.771 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 12.1 p -41.72 -38.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 115.397 1.628 . . . . 70.45 115.397 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.4 -31.0 71.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.226 0.536 . . . . 74.22 111.625 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.31 15.4 22.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.086 0.954 . . . . 75.21 111.953 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 0.1 OUTLIER -89.96 174.96 7.38 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.326 0.512 . . . . 72.15 110.06 178.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.425 ' HB3' HD22 ' C' ' 68' ' ' LEU . 24.6 t0 -87.98 108.93 19.45 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.005 -0.739 . . . . 72.52 109.005 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -84.37 68.2 10.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.242 1.02 . . . . 74.13 112.034 -174.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -161.84 44.2 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 114.898 -1.046 . . . . 64.12 109.656 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.08 170.21 20.12 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 121.434 1.423 . . . . 64.11 112.2 -168.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -84.73 93.0 8.35 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.928 -1.138 . . . . 72.43 107.928 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.474 HG11 HD21 ' C' ' 126' ' ' LEU . 46.3 t -77.4 95.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 107.552 -1.277 . . . . 74.01 107.552 174.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.6 109.43 21.5 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.839 -1.073 . . . . 75.44 108.304 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.67 164.5 16.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.962 -0.563 . . . . 64.4 110.432 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 25.7 t70 -147.49 138.33 23.48 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.074 -1.084 . . . . 74.54 108.074 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.51 141.31 46.68 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.69 141.81 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.124 -0.695 . . . . 73.31 109.124 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . 0.403 HG21 ' HA2' ' C' ' 99' ' ' GLY . 12.7 t -114.69 136.28 53.23 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.939 -0.763 . . . . 54.45 108.939 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.58 160.43 21.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.94 0.896 . . . . 45.3 108.633 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -141.91 147.22 36.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.748 0.419 . . . . 64.01 110.272 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -153.95 132.29 11.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.491 0.716 . . . . 75.44 109.682 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.29 117.65 19.75 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.001 -0.74 . . . . 72.12 109.001 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' C' ' 57' ' ' GLU . 74.1 mt -87.24 -45.48 10.59 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.463 0.705 . . . . 71.22 109.259 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.51 -170.99 3.76 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.536 -0.757 . . . . 71.42 110.781 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.39 107.09 0.72 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.248 -0.887 . . . . 60.04 109.987 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 73.46 -0.82 3.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.452 1.501 . . . . 71.52 112.562 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.05 115.5 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.741 -0.837 . . . . 73.03 108.741 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.73 125.52 36.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.875 0.87 . . . . 63.24 109.267 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.638 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.9 tt0 -83.9 143.13 30.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.768 0.427 . . . . 62.33 110.671 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -117.49 122.95 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.507 -1.294 . . . . 60.13 107.507 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.12 106.38 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.429 -0.952 . . . . 75.11 108.429 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.27 105.92 18.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.415 0.686 . . . . 71.21 109.487 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -81.71 131.67 35.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.472 -0.785 . . . . 72.03 110.283 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.1 t -124.09 122.87 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.089 -1.449 . . . . 65.34 107.089 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.9 m -119.49 145.13 46.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.202 -1.036 . . . . 74.45 108.202 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.05 108.42 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.564 -1.272 . . . . 72.34 107.564 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.5 m -104.12 111.5 24.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.676 -0.861 . . . . 72.23 108.676 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.22 16.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.337 -1.727 . . . . 65.05 106.337 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -151.18 133.06 15.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.692 0.397 . . . . 64.23 109.968 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' C' ' 35' ' ' ASP . 30.9 tp -67.82 -48.15 67.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.176 0.59 . . . . 63.35 110.464 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.16 -73.76 0.04 OUTLIER Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.144 -1.183 . . . . 54.43 110.144 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -101.03 -31.49 11.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.398 0.679 . . . . 75.44 109.28 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -73.4 101.13 3.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.693 0.797 . . . . 72.15 109.741 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -83.39 130.02 35.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.632 -0.507 . . . . 63.12 109.632 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.681 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -73.15 -66.56 0.66 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.11 -1.071 . . . . 73.42 108.11 167.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -161.62 174.75 12.88 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.572 0.701 . . . . 72.05 111.668 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -129.08 141.88 51.07 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 105.667 -1.975 . . . . 75.14 105.667 169.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.402 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.3 112.23 4.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.383 -0.599 . . . . 75.31 109.383 174.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -122.88 129.29 51.46 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.835 0.454 . . . . 74.54 110.018 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.27 134.85 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.448 -0.945 . . . . 73.34 108.448 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.641 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -115.16 90.59 3.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.487 -1.301 . . . . 70.12 107.487 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.11 108.65 12.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.549 -1.205 . . . . 32.1 109.891 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 146.05 20.15 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.958 -0.457 . . . . 61.02 111.958 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.68 120.84 1.24 Allowed Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 111.603 -0.599 . . . . 73.25 111.603 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.557 HD12 HD11 ' C' ' 51' ' ' LEU . 10.4 mm -87.07 110.77 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 109.114 -0.699 . . . . 75.23 109.114 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.436 ' CE2' HD13 ' C' ' 13' ' ' ILE . 77.2 m-85 -121.76 119.9 33.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.555 0.342 . . . . 75.0 110.207 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 m -84.16 114.34 21.71 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.409 -0.589 . . . . 71.41 109.409 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.275 0.63 . . . . 73.12 109.657 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.91 168.78 24.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.851 1.26 . . . . 65.53 108.582 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.35 -27.47 5.66 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 120.916 0.176 . . . . 73.21 112.934 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -122.8 158.87 27.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.725 1.21 . . . . 63.03 109.146 -176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.81 -175.56 5.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.665 0.386 . . . . 73.04 111.323 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.67 -146.33 40.08 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.606 -0.724 . . . . 73.43 113.729 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.7 p -68.32 -19.53 64.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.863 0.865 . . . . 34.31 111.588 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -65.97 -49.21 68.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.803 0.841 . . . . 73.13 110.722 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -25.68 56.86 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 116.476 -0.329 . . . . 43.52 110.746 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.82 74.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.038 0.535 . . . . 64.32 110.979 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.409 ' CE1' ' HA ' ' C' ' 134' ' ' ASP . 53.4 t-80 -70.9 -28.13 64.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.179 0.592 . . . . 74.14 110.488 174.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.66 -60.41 2.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.738 0.415 . . . . 53.11 109.985 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.418 HD23 ' SG ' ' C' ' 102' ' ' CYS . 87.8 mt -70.7 -14.86 62.61 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.475 0.71 . . . . 72.12 111.768 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' C' ' 46' ' ' THR . . . -110.36 3.92 29.69 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 114.848 0.699 . . . . 75.52 114.848 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -51.53 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 117.936 0.868 . . . . 75.3 111.374 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -70.32 -58.97 3.16 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.561 0.744 . . . . 74.45 111.578 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.641 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 32.7 m -58.02 -48.66 96.69 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.49 1.116 . . . . 64.43 112.986 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.75 -24.27 62.09 Favored 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 121.729 1.62 . . . . 44.52 114.052 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.88 -28.09 61.39 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 118.314 0.506 . . . . 71.31 110.393 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 HH12 ' A' ' 111' ' ' ARG . 45.0 mm -64.33 -31.99 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.145 0.498 . . . . 72.03 109.943 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.0 mt -86.86 -24.6 24.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.044 0.938 . . . . 74.42 112.247 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.43 -46.22 99.84 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.249 1.203 . . . . 72.33 114.249 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.91 -38.61 77.99 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.086 1.857 . . . . 61.35 113.247 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -66.56 -45.31 79.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.414 0.686 . . . . 70.24 110.487 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.61 90.76 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.568 -0.742 . . . . 63.22 110.88 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -64.53 -50.94 65.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.904 1.282 . . . . 65.15 110.62 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.36 -31.96 71.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.245 0.618 . . . . 75.5 109.695 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.66 -35.38 75.11 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 122.99 0.516 . . . . 72.42 111.204 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.412 ' O ' HG23 ' C' ' 118' ' ' VAL . 40.5 mt -70.71 -51.0 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 122.899 0.48 . . . . 61.41 110.137 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m -62.99 -28.88 70.4 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.286 0.634 . . . . 65.22 111.183 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.3 t -64.05 -52.19 60.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.826 -0.805 . . . . 73.33 108.826 171.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.52 -39.33 83.55 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.5 1.12 . . . . 75.3 112.755 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 98.8 t -61.69 -47.92 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.54 0.736 . . . . 73.11 109.583 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.6 t -68.28 -25.9 65.39 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.94 -1.027 . . . . 75.23 111.616 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -73.38 -40.12 64.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.429 0.692 . . . . 74.12 109.326 177.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.24 -1.08 79.81 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.673 0.608 . . . . 73.51 112.341 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.2 p 62.48 35.77 14.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.632 1.973 . . . . 64.02 112.816 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.464 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 95.2 m-85 -86.27 165.29 34.47 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 114.738 -1.119 . . . . 71.31 108.852 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 74.3 Cg_endo -69.01 -175.0 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.205 1.936 . . . . 70.11 112.933 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.77 114.19 2.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.361 -0.836 . . . . 74.15 110.618 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.474 HD21 HG11 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -138.65 92.64 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.129 -1.434 . . . . 71.33 107.129 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -123.4 131.8 53.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.334 1.054 . . . . 74.15 108.851 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 140.08 43.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.286 0.635 . . . . 74.33 110.892 -170.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.21 146.56 74.9 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.132 0.973 . . . . 72.03 112.061 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.657 ' HG3' HD13 ' A' ' 16' ' ' ILE . 58.5 Cg_endo -71.26 105.43 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.211 2.607 . . . . 71.25 112.877 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.19 111.15 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.778 -1.193 . . . . 71.14 107.778 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -111.33 92.14 3.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 72.55 110.853 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -78.71 -25.38 44.68 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.893 0.854 . . . . 65.52 109.341 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.409 ' HA ' ' CE1' ' C' ' 96' ' ' HIS . 1.4 p-10 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 125.471 1.508 . . . . 70.15 111.827 176.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.487 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 8.0 ptm . . . . . 0 N--CA 1.486 1.333 0 N-CA-C 115.342 1.608 . . . . 70.41 115.342 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -121.11 144.42 48.57 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.163 -0.926 . . . . 64.31 108.878 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' D' ' 85' ' ' SER . 33.4 t80 -154.0 102.55 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.253 -1.017 . . . . 74.32 108.253 175.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -121.06 118.3 29.42 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.882 -0.784 . . . . 74.02 108.882 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.2 102.47 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.914 -1.143 . . . . 74.31 107.914 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -77.63 -44.69 27.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.877 0.471 . . . . 72.53 111.302 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -161.76 132.21 4.97 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 119.838 -0.125 . . . . 74.21 111.137 -170.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.463 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -107.61 132.79 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.946 -1.502 . . . . 74.12 106.946 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.94 162.85 9.4 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-O 121.839 0.828 . . . . 62.52 111.945 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.438 HG21 HD11 ' D' ' 21' ' ' ILE . 67.7 p -95.37 126.91 40.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.711 -1.131 . . . . 74.24 109.833 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.51 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 47.5 mtpt -95.51 -29.04 14.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.009 0.524 . . . . 73.22 110.048 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -150.74 137.11 18.64 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 124.124 0.89 . . . . 63.51 109.271 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.1 mt -137.58 147.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.489 1.116 . . . . 73.13 108.056 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -150.86 143.92 24.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.153 0.981 . . . . 72.22 109.494 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 74.0 t80 -149.53 130.0 13.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.767 -1.938 . . . . 73.24 105.767 169.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.46 136.63 43.34 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.126 0.57 . . . . 64.54 109.829 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -125.03 84.6 58.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 123.594 0.758 . . . . 73.45 109.068 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.53 -46.93 6.32 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.186 2.591 . . . . 55.15 113.082 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -114.18 37.94 3.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.454 0.702 . . . . 74.54 109.617 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.824 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.48 -56.53 25.76 Favored Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.332 1.604 . . . . 65.1 115.332 -168.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.537 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 21.6 Cg_endo -87.62 -3.59 7.45 Favored 'Trans proline' 0 C--N 1.38 2.195 0 CA-C-N 121.496 1.57 . . . . 74.03 112.49 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -82.76 -41.99 18.52 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.267 1.427 . . . . 64.44 109.173 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.72 -21.84 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.121 -0.945 . . . . 53.54 110.145 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -60.53 -26.4 66.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.271 1.429 . . . . 64.43 112.571 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.07 -33.17 74.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.241 0.617 . . . . 75.21 110.6 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -95.34 98.35 10.52 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.571 -0.9 . . . . 73.2 108.571 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -80.25 95.29 6.27 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.213 0.53 . . . . 64.0 110.223 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.62 ' HB3' HD11 ' D' ' 68' ' ' LEU . 68.4 t-105 -160.88 165.96 29.27 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.677 0.791 . . . . 75.21 109.685 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.15 117.38 67.9 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.413 1.085 . . . . 74.1 110.631 177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.27 144.0 94.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.499 2.799 . . . . 74.43 114.278 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.51 128.17 35.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.33 -0.619 . . . . 73.53 109.33 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 p -98.61 149.81 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.2 0.6 . . . . 62.52 110.434 -173.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 27.5 tptp -131.98 114.98 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.592 -1.262 . . . . 75.01 107.592 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.87 145.87 25.47 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.121 0.568 . . . . 73.1 110.045 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.531 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 33.2 t70 -145.46 138.94 26.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.587 -1.188 . . . . 55.04 108.442 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.15 134.8 35.02 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.368 -0.975 . . . . 74.44 108.368 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -144.31 146.2 32.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.668 1.187 . . . . 64.41 108.354 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -117.46 154.51 31.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.525 -0.546 . . . . 74.22 109.525 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.59 167.47 27.98 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.049 0.94 . . . . 31.44 109.446 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -158.43 166.12 32.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.121 0.486 . . . . 74.53 111.41 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -159.44 116.82 2.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.779 1.232 . . . . 74.23 107.911 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -79.54 123.34 27.49 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.095 -0.706 . . . . 64.43 109.095 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt -90.59 -41.04 11.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.015 0.526 . . . . 74.44 109.947 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.61 -177.47 6.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.282 -0.872 . . . . 74.22 110.611 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -64.78 120.16 11.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.398 -0.819 . . . . 72.51 109.241 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 65.34 17.31 10.94 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 74.32 111.767 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -120.75 120.45 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.31 -0.996 . . . . 74.12 108.31 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.443 ' HB2' HD12 ' D' ' 86' ' ' ILE . 64.1 m-85 -128.91 126.47 39.77 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.57 -0.9 . . . . 74.51 108.57 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -89.97 132.95 35.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.557 -1.646 . . . . 74.51 106.557 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.43 133.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.177 -1.045 . . . . 61.24 108.177 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 96.4 t -111.75 133.15 58.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.435 0.694 . . . . 75.53 109.395 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.428 HD11 ' HD1' ' D' ' 107' ' ' PHE . 0.9 OUTLIER -110.87 115.42 29.48 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.122 -1.066 . . . . 64.15 108.122 170.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -100.74 107.95 19.67 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.214 -1.032 . . . . 74.34 108.214 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.71 133.35 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.771 -0.826 . . . . 61.15 108.771 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 59.1 m -121.95 135.21 54.85 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.363 0.601 . . . . 71.22 109.646 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 131.53 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.846 1.258 . . . . 64.44 108.455 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 94.0 m -131.14 112.74 13.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.196 0.998 . . . . 65.1 108.86 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.83 48.31 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.744 0.818 . . . . 71.33 109.165 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.2 m -146.2 127.59 14.95 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.665 0.603 . . . . 64.2 109.67 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' D' ' 36' ' ' TRP . 47.5 tp -111.86 122.8 48.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.686 -0.857 . . . . 62.41 108.686 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 -115.68 5.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.599 0.562 . . . . 72.14 112.836 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -110.86 8.51 22.29 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.274 0.629 . . . . 72.11 111.825 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.08 164.27 30.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.226 0.611 . . . . 75.11 110.97 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -74.55 127.94 34.31 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.055 -0.52 . . . . 65.01 110.523 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.58 -61.29 1.87 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.259 1.023 . . . . 45.15 109.677 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.06 157.9 42.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.257 0.551 . . . . 72.31 111.321 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 79.0 mt -121.97 147.82 45.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.231 1.412 . . . . 60.23 107.586 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.8 t -158.57 141.65 14.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.457 0.303 . . . . 64.44 110.216 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.08 135.98 13.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.33 0.652 . . . . 74.42 109.788 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.94 119.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.097 0.559 . . . . 71.42 109.633 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -89.48 86.11 6.69 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.489 -0.93 . . . . 75.52 108.489 167.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.83 101.72 8.69 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.434 -1.257 . . . . 73.25 108.448 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.17 174.41 40.33 Favored Glycine 0 C--O 1.243 0.7 0 O-C-N 123.456 0.472 . . . . 64.52 112.143 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.95 135.5 2.84 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 111.654 -0.578 . . . . 64.14 111.654 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.8 129.96 38.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.513 -0.921 . . . . 74.43 108.513 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -132.28 135.78 46.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.491 0.717 . . . . 71.03 109.586 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.7 m -75.33 116.14 15.74 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.944 -1.132 . . . . 71.43 107.944 168.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' D' ' 56' ' ' TYR . 57.2 mt -121.23 101.72 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.634 -0.506 . . . . 73.34 109.634 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.63 152.6 48.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.406 1.082 . . . . 74.44 109.072 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 75.2 1.33 63.6 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.434 0.459 . . . . 63.31 113.587 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.519 HG23 ' HG2' ' D' ' 93' ' ' GLN . 53.7 mt -117.11 126.77 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 107.814 -1.18 . . . . 65.22 107.814 -174.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' D' ' 93' ' ' GLN . 7.5 pt-20 -145.84 148.86 33.33 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.973 0.731 . . . . 71.24 112.973 -163.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.09 -127.01 32.27 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.353 0.501 . . . . 62.14 114.197 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.9 p -70.34 -20.61 62.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.356 0.662 . . . . 65.04 111.32 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.519 ' HG2' HG23 ' D' ' 89' ' ' ILE . 55.9 tt0 -70.47 -41.47 72.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.737 0.815 . . . . 74.32 110.134 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -78.63 -29.42 45.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.288 0.235 . . . . 73.32 110.541 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.77 80.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.067 0.547 . . . . 53.12 110.272 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.01 -35.87 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.335 -0.848 . . . . 74.12 110.537 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -66.29 -43.08 87.36 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.941 0.496 . . . . 62.11 110.584 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.09 -21.91 42.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.331 0.652 . . . . 75.05 111.082 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 -19.79 38.65 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.932 -0.371 . . . . 63.41 113.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.79 -69.04 0.69 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.39 0.515 . . . . 72.43 112.39 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -65.07 -60.92 2.5 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.283 0.475 . . . . 73.41 112.283 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -58.07 -46.97 99.64 Favored Pre-proline 0 CA--C 1.565 1.537 0 C-N-CA 123.78 0.832 . . . . 74.14 113.122 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 -30.72 51.16 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.921 1.747 . . . . 52.21 113.266 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.82 -35.97 82.18 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.035 0.534 . . . . 63.24 110.646 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.16 -42.71 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.712 0.805 . . . . 73.21 110.35 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -78.67 -19.01 53.5 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.27 -0.877 . . . . 54.52 112.181 -174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.428 ' HD1' HD11 ' D' ' 60' ' ' LEU . 70.8 t80 -62.21 -45.72 90.67 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 113.759 1.022 . . . . 64.45 113.759 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.83 -36.91 75.9 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.113 1.875 . . . . 63.02 113.724 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -79.07 -33.84 44.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.893 0.877 . . . . 75.14 111.693 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.75 -48.47 71.79 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.874 0.47 . . . . 61.44 109.829 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -54.95 -50.82 67.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.368 -1.287 . . . . 73.53 111.013 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.98 -46.76 84.66 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.113 0.883 . . . . 75.33 110.8 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.11 -45.13 94.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 123.939 0.774 . . . . 50.1 110.947 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.561 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.49 -56.5 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.746 0.818 . . . . 63.25 110.897 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -53.03 -46.36 68.42 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.667 1.187 . . . . 64.25 111.796 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -62.84 -44.09 97.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.032 -0.985 . . . . 53.12 110.2 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.43 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 74.8 mtm -68.07 -32.93 73.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.103 0.561 . . . . 50.11 111.852 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.62 -39.18 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.269 0.628 . . . . 72.53 110.438 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -74.89 -26.26 59.52 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 122.547 0.339 . . . . 74.14 110.881 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -75.47 -32.27 60.55 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.664 0.786 . . . . 71.24 109.635 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -1.13 90.19 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 115.534 -0.757 . . . . 70.03 111.922 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p 59.81 22.79 11.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.591 1.957 . . . . 62.44 112.805 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -86.31 159.89 52.5 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.334 1.054 . . . . 74.44 109.514 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -53.7 118.08 4.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.529 2.153 . . . . 75.24 112.701 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -48.88 133.19 18.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.062 0.945 . . . . 71.44 112.393 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.6 107.86 11.46 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.953 -1.129 . . . . 71.52 107.953 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -102.57 107.76 18.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.481 0.712 . . . . 51.44 109.466 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.95 145.02 54.94 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.73 0.812 . . . . 73.14 111.166 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.62 148.06 36.5 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 122.917 0.487 . . . . 72.45 110.264 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.37 130.82 31.53 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.545 2.163 . . . . 73.0 111.984 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 p -108.13 109.61 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.486 0.714 . . . . 51.23 110.041 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -86.72 106.78 17.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.802 0.841 . . . . 74.34 108.744 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 . . . . . 0 N--CA 1.477 0.889 0 C-N-CA 123.039 0.536 . . . . 75.3 110.624 179.329 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 108.548 -0.908 . . . . 75.04 108.548 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -134.41 134.79 42.04 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.3 0.64 . . . . 73.45 109.351 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.437 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 92.4 mt-30 -132.82 123.85 26.89 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.592 -0.892 . . . . 73.25 108.592 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.69 103.95 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.897 -1.149 . . . . 74.53 107.897 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.61 -39.78 15.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 72.24 110.947 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.634 ' HD3' HG21 ' B' ' 122' ' ' THR . 0.1 OUTLIER -158.6 143.99 16.47 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.144 -0.455 . . . . 74.04 109.962 -175.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -145.85 100.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.505 -1.295 . . . . 72.13 107.505 171.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.594 ' HD1' ' HG3' ' A' ' 15' ' ' ARG . 71.6 m-85 -157.61 169.96 23.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.298 0.639 . . . . 73.32 109.779 -170.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.8 p -81.91 111.66 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.079 -0.51 . . . . 71.33 110.337 -173.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 35.4 mtpt -79.5 -32.52 42.44 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.768 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.97 145.1 27.2 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.702 0.627 . . . . 54.45 109.616 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -134.59 144.2 35.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 125.065 1.346 . . . . 65.23 107.567 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 25.9 t -148.69 130.67 15.29 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.753 0.821 . . . . 74.3 108.857 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.566 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 90.3 t80 -147.6 119.28 8.03 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 106.962 -1.496 . . . . 73.01 106.962 174.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.55 139.63 45.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.831 0.452 . . . . 74.45 109.84 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.23 80.32 72.65 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.221 1.008 . . . . 74.32 108.515 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.51 -43.46 21.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.299 2.666 . . . . 64.31 112.627 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 32.1 m-80 -113.09 37.47 3.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.187 -0.915 . . . . 74.4 109.656 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.616 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.37 -46.03 99.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 C-N-CA 124.121 0.968 . . . . 70.01 113.087 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.06 -22.97 29.96 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.976 1.784 . . . . 72.11 112.631 174.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.3 m-70 -78.11 -18.62 55.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.561 0.744 . . . . 73.42 111.656 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HE1' ' A' ' 123' ' ' PHE . 79.1 t -52.53 -28.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.876 0.87 . . . . 74.04 112.447 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -65.53 -42.65 91.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.11 0.781 . . . . 72.32 113.11 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 30' ' ' HIS . 3.6 pp0? -78.37 -26.05 46.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.577 0.171 . . . . 72.11 110.665 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -76.73 152.08 35.81 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.101 0.56 . . . . 73.4 110.498 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -80.47 147.71 30.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.442 -0.947 . . . . 71.44 108.442 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 -79.05 75.33 5.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.911 0.884 . . . . 65.41 110.634 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.23 82.9 51.84 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.495 1.118 . . . . 54.3 108.639 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.85 123.41 5.21 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.927 2.418 . . . . 62.22 111.964 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -95.07 86.02 4.49 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.143 -1.428 . . . . 63.33 107.143 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 65' ' ' THR . 61.1 t -87.26 103.68 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.333 -1.303 . . . . 61.32 110.505 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -96.5 140.02 31.74 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.726 0.41 . . . . 65.13 110.392 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.1 mt -106.45 139.33 41.1 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.187 -1.042 . . . . 70.23 108.187 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.799 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -129.6 108.23 10.06 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.567 -1.271 . . . . 73.35 107.567 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.2 mp -103.72 130.59 51.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.367 -0.975 . . . . 75.22 108.367 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 60' ' ' LEU . 19.2 t70 -144.05 151.68 39.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.857 0.863 . . . . 72.24 110.205 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -139.24 138.63 36.99 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.597 0.759 . . . . 64.34 110.094 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 149.05 52.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.631 1.172 . . . . 63.25 109.716 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -96.15 170.35 9.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.293 0.637 . . . . 71.13 111.101 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.0 t -165.7 147.82 7.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.879 1.272 . . . . 73.2 108.526 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -111.98 133.52 54.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.488 -0.931 . . . . 74.11 108.488 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -104.69 -44.62 4.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.579 -0.526 . . . . 63.14 109.579 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.62 -174.35 4.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.583 -0.735 . . . . 73.11 110.38 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.27 117.84 6.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.345 1.058 . . . . 74.3 110.748 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 69.31 -8.2 0.74 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 125.533 1.533 . . . . 74.44 113.08 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.3 109.58 26.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.492 -0.929 . . . . 64.24 108.492 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.15 157.01 35.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.891 0.876 . . . . 72.22 108.763 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -132.46 118.91 19.91 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.53 0.732 . . . . 74.21 109.986 -174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -104.56 112.6 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.717 -1.216 . . . . 54.41 107.717 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -100.0 131.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 70.01 109.924 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -100.63 114.23 27.74 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.447 . . . . 72.02 107.092 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -99.22 104.1 16.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.722 -0.844 . . . . 73.05 108.722 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -95.49 141.96 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.382 -0.97 . . . . 74.42 108.382 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.799 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 85.6 m -125.78 141.13 52.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 171.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 76.9 t -135.24 110.86 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.616 1.166 . . . . 64.32 108.37 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 m -101.95 142.15 33.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.711 -0.848 . . . . 71.24 108.711 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.46 121.78 20.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.873 -1.158 . . . . 70.23 107.873 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -130.95 130.14 43.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.127 0.571 . . . . 65.43 110.135 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 78.4 mt -87.61 78.71 8.46 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.801 -1.185 . . . . 74.25 107.801 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.59 -106.73 2.17 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 114.392 -1.276 . . . . 61.51 112.219 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -89.12 -26.99 21.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.531 0.732 . . . . 72.31 109.984 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.24 131.3 44.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 73.43 109.627 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.1 m -76.19 128.73 35.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.066 0.46 . . . . 31.23 110.524 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -76.83 -56.4 4.63 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.235 1.014 . . . . 71.11 108.971 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -167.57 174.86 7.47 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.163 -0.926 . . . . 63.33 111.207 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 tp -143.05 150.48 39.61 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.845 1.258 . . . . 71.53 109.133 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.696 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 61.6 m -141.59 141.34 33.49 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.441 0.696 . . . . 74.03 110.681 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 56.4 mp0 -141.47 133.41 27.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.285 1.034 . . . . 73.33 108.321 170.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.42 108.4 5.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.265 -1.013 . . . . 71.3 108.265 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.81 80.39 8.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.207 -1.361 . . . . 71.11 107.645 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.12 92.5 3.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 114.046 -1.434 . . . . 74.32 107.886 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.24 145.62 21.42 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.374 -0.83 . . . . 54.35 111.3 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -135.52 120.25 2.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.772 -0.931 . . . . 51.22 110.772 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.5 mt -85.2 124.99 40.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.082 -1.081 . . . . 73.44 108.082 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -136.46 138.49 41.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.391 -0.966 . . . . 73.34 108.391 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 12' ' ' GLN . 13.7 p -96.42 105.25 17.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.368 -0.604 . . . . 52.42 109.368 172.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.86 132.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.215 0.606 . . . . 62.54 110.072 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.04 162.88 26.08 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.658 1.183 . . . . 72.43 109.666 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.83 -25.11 12.34 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 114.61 0.604 . . . . 32.34 114.61 171.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.42 152.26 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.303 0.552 . . . . 71.32 110.918 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 8.5 tt0 -155.89 -172.71 4.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.329 -0.619 . . . . 62.44 109.329 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.487 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.63 -153.25 48.79 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.637 -0.256 . . . . 71.13 113.244 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 32.6 p -65.35 -26.36 67.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.604 0.762 . . . . 75.52 111.318 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.33 -42.69 99.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.536 0.734 . . . . 74.12 110.641 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 47.0 ttp -64.13 -53.14 54.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.139 0.975 . . . . 74.22 110.926 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.08 -47.69 68.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 44.24 110.958 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -56.94 -47.71 80.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.617 -1.629 . . . . 72.23 111.192 173.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.1 m -71.37 -29.41 64.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.585 0.957 . . . . 72.04 113.585 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.9 mt -83.78 -38.8 20.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.049 0.54 . . . . 64.31 111.1 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.56 5.26 56.93 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.958 -0.565 . . . . 73.45 113.827 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -144.29 -66.67 0.34 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.784 0.792 . . . . 74.31 112.384 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.2 t80 -48.96 -56.58 8.45 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.194 0.998 . . . . 73.12 112.434 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.3 m -71.52 -44.56 12.76 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-O 118.389 -0.815 . . . . 53.21 112.471 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.28 -37.27 80.65 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.152 1.901 . . . . 72.53 113.732 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 61.8 m-20 -60.44 -40.61 91.7 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.108 0.963 . . . . 72.51 110.788 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.3 mm -64.7 -41.46 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.084 -0.962 . . . . 73.24 110.569 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.543 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.7 mt -75.24 -27.19 59.39 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.634 -0.712 . . . . 73.1 111.751 -173.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -63.15 -42.74 78.08 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.741 1.386 . . . . 74.11 114.741 -168.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -35.57 98.3 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 122.307 2.005 . . . . 41.3 113.603 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.8 -37.92 39.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.333 0.653 . . . . 73.33 111.399 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.46 98.56 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.669 -0.493 . . . . 33.22 109.669 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.524 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.5 ttm180 -57.23 -53.44 58.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.354 1.062 . . . . 74.1 110.908 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.95 -47.88 84.4 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.119 0.887 . . . . 63.22 111.008 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.15 -46.69 82.51 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.08 0.862 . . . . 61.43 111.126 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.599 HG21 HG21 ' A' ' 64' ' ' VAL . 98.9 mt -62.66 -52.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 123.709 0.63 . . . . 73.34 110.474 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 125' ' ' GLN . 87.7 m -56.13 -39.41 72.21 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.82 0.7 . . . . 74.43 111.596 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -66.47 -48.18 70.71 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.345 -0.843 . . . . 61.1 110.185 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.566 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mtp -54.36 -45.13 72.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.864 0.866 . . . . 74.03 111.486 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' ILE . 71.0 t -61.86 -47.41 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.943 -1.026 . . . . 75.41 110.852 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -71.38 -24.3 62.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.985 -0.552 . . . . 75.44 111.553 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -71.77 -27.06 62.7 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.302 0.641 . . . . 51.1 110.313 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.75 10.09 63.45 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 123.469 0.481 . . . . 72.12 113.045 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.567 HG22 ' HB3' ' B' ' 17' ' ' TYR . 5.9 t 51.97 24.62 2.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 127.03 2.132 . . . . 62.22 113.279 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE1' HG21 ' A' ' 31' ' ' VAL . 75.6 m-85 -86.55 151.84 53.72 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 115.628 -0.715 . . . . 60.54 109.177 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.24 129.0 32.89 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.717 2.278 . . . . 72.13 110.56 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.5 pt20 -55.81 142.52 34.56 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.156 0.91 . . . . 75.0 111.345 -169.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.403 ' HG ' HG11 ' A' ' 118' ' ' VAL . 51.2 mt -119.46 97.66 5.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.525 0.678 . . . . 71.02 109.231 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.57 123.06 42.52 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.308 -1.315 . . . . 53.52 108.067 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.471 HD11 HD12 ' A' ' 114' ' ' ILE . 69.3 mt -66.12 122.61 17.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.481 0.712 . . . . 74.43 110.565 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -53.29 136.65 50.23 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 119.012 -0.518 . . . . 73.02 110.293 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.43 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.628 2.218 . . . . 71.5 112.102 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 129' ' ' ALA . 53.9 t -100.25 112.86 34.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.17 -1.048 . . . . 74.34 108.17 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -85.42 92.12 8.4 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.243 -1.021 . . . . 73.05 108.243 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.41 -28.54 69.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.8 -0.636 . . . . 73.53 110.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.488 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 3.6 t70 . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 124.082 0.953 . . . . 73.31 110.658 -171.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.7 ptm . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 114.695 1.368 . . . . 55.2 114.695 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.8 p -141.46 127.5 19.51 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.616 1.166 . . . . 74.11 108.096 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -122.46 128.09 50.42 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.667 -0.864 . . . . 72.22 108.667 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -142.84 140.82 31.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 63.41 109.176 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.669 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.82 141.52 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.601 -0.888 . . . . 74.53 108.601 172.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.602 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 20.2 mm-40 -106.68 -50.66 3.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.963 0.505 . . . . 70.24 109.884 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -168.49 149.03 4.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.976 0.91 . . . . 72.33 108.567 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.6 mt -128.3 149.31 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.708 -1.219 . . . . 65.23 107.708 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.567 ' HB3' HG22 ' A' ' 122' ' ' THR . 24.1 p90 -170.87 150.44 3.18 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.255 0.55 . . . . 63.21 112.436 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.7 m -72.98 122.3 21.48 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.012 -0.995 . . . . 65.14 108.535 167.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.7 mtpt -94.33 -33.74 13.08 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.799 0.839 . . . . 73.41 110.563 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 22.9 t70 -152.14 140.52 20.54 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.47 0.481 . . . . 72.1 111.103 -166.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -140.96 137.54 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.713 1.205 . . . . 74.42 108.315 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -139.81 108.3 5.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.333 -1.358 . . . . 70.1 107.333 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.5 t80 -126.11 108.25 11.17 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.451 -1.314 . . . . 63.34 107.451 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.96 111.42 18.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.327 -0.99 . . . . 61.42 108.327 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.59 86.97 3.12 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.53 -1.285 . . . . 45.13 107.53 170.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.31 -32.49 41.4 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.493 2.129 . . . . 63.32 110.951 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.47 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 87.0 m-20 -111.87 30.43 7.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.501 -1.227 . . . . 73.45 109.97 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.3 -46.98 46.41 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.298 1.039 . . . . 51.32 111.964 167.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 73.6 Cg_endo -76.83 -16.75 16.12 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.086 1.858 . . . . 72.53 114.549 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 65.3 m80 -95.97 -16.19 21.86 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.872 0.693 . . . . 53.35 112.872 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.91 -11.79 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.742 0.417 . . . . 64.32 110.041 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.74 -43.93 94.01 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.584 0.754 . . . . 65.14 109.886 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' B' ' 30' ' ' HIS . 16.0 mp0 -81.03 -32.02 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.074 -0.512 . . . . 63.51 110.201 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.57 92.73 7.21 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.475 0.71 . . . . 71.15 111.093 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -89.31 105.98 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.579 -0.526 . . . . 74.53 109.579 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -172.98 169.23 4.75 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 74.33 109.453 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.36 114.67 49.18 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.877 0.871 . . . . 64.31 108.741 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 150.67 82.99 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.381 2.054 . . . . 74.22 112.392 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 104.94 1.18 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.773 -0.825 . . . . 73.22 108.773 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -97.57 154.35 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.885 0.85 . . . . 72.02 111.765 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.652 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 70.2 tttt -147.24 115.17 6.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.794 -1.548 . . . . 71.1 107.104 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -86.02 159.39 19.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.19 -1.041 . . . . 54.41 108.19 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.4 t70 -164.94 110.53 0.94 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.352 -0.61 . . . . 65.34 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.3 mp -102.98 144.48 31.2 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.931 0.396 . . . . 72.54 109.985 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.68 141.97 47.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.558 1.143 . . . . 72.21 108.683 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -121.65 139.0 54.1 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.633 -0.506 . . . . 72.22 109.633 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.61 161.02 41.79 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.224 1.01 . . . . 24.22 109.227 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -144.01 170.23 16.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.071 0.548 . . . . 72.42 109.981 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -155.31 136.2 13.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.991 0.916 . . . . 73.14 108.624 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.91 120.58 29.39 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.073 0.549 . . . . 74.42 111.068 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.3 -37.54 17.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.328 -0.619 . . . . 64.51 109.328 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.96 -179.48 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.032 0.933 . . . . 71.32 110.676 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.54 125.27 26.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.925 -1.034 . . . . 71.13 109.537 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 65.42 10.44 6.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.473 1.109 . . . . 61.2 112.385 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -127.33 95.61 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.207 -1.035 . . . . 62.44 108.207 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -117.35 138.11 52.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.875 0.47 . . . . 73.51 109.883 -176.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -102.02 103.47 14.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.761 -1.2 . . . . 73.15 107.761 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' B' ' 98' ' ' LEU . 48.7 t -95.3 129.26 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 62.3 109.48 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.9 t -109.55 129.65 64.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.928 0.891 . . . . 70.0 109.844 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -106.75 134.04 50.5 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.316 -1.364 . . . . 62.33 107.316 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.51 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 27.6 ttm180 -119.19 130.95 55.77 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.857 -0.794 . . . . 61.54 108.857 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.523 ' HB ' HD11 ' B' ' 114' ' ' ILE . 16.9 t -124.67 123.12 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.38 -0.97 . . . . 64.43 108.38 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 33.3 m -108.75 144.85 36.02 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.305 1.042 . . . . 73.21 109.512 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 114' ' ' ILE . 91.0 t -135.94 98.52 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.636 1.174 . . . . 41.12 108.21 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 27.4 m -83.07 139.3 33.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.939 -0.763 . . . . 42.33 108.939 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.69 140.06 21.37 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.839 0.456 . . . . 75.55 110.06 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.527 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.3 m -142.1 131.91 24.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.401 0.68 . . . . 72.51 109.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.19 108.3 20.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.157 -1.424 . . . . 73.54 107.157 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -118.83 5.75 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.803 -0.919 . . . . 71.02 110.803 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -111.93 4.59 18.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.276 0.63 . . . . 73.32 111.986 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.77 147.28 43.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.487 0.715 . . . . 72.45 110.013 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.3 m -66.05 127.13 30.9 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.021 0.528 . . . . 64.11 111.686 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.527 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -86.99 -54.5 4.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.267 -1.012 . . . . 53.5 108.267 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.88 157.52 24.04 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 114.739 -1.119 . . . . 72.4 110.062 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 84.5 mt -130.82 110.82 11.6 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 106.554 -1.647 . . . . 75.12 106.554 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -117.15 136.15 53.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 75.15 108.603 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.6 tt0 -157.61 135.09 10.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.094 -0.706 . . . . 71.44 109.094 -170.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.28 149.97 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.376 -0.829 . . . . 75.33 109.045 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 43.0 mt-30 -123.26 106.04 10.38 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.102 -1.073 . . . . 75.1 108.102 167.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -94.88 101.05 12.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.58 -0.896 . . . . 62.44 108.58 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.17 171.56 32.65 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.546 -0.622 . . . . 53.54 111.546 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.11 141.91 5.99 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.483 -0.647 . . . . 50.42 111.483 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 22.1 mt -92.72 128.05 44.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.811 -0.811 . . . . 72.44 108.811 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.06 134.82 47.64 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.048 0.939 . . . . 73.15 108.545 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 52.7 m -107.24 104.27 13.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.568 0.747 . . . . 44.32 109.002 175.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.509 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.14 121.15 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.691 1.196 . . . . 73.11 109.365 -176.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.5 159.08 40.44 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.908 0.883 . . . . 64.02 109.6 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.52 -43.63 2.77 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.622 0.577 . . . . 73.21 112.805 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.405 ' H ' HG13 ' B' ' 89' ' ' ILE . 1.7 pp -62.49 138.97 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.572 0.749 . . . . 72.33 111.105 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -150.3 172.06 15.98 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.128 0.971 . . . . 75.24 110.416 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.76 -128.98 43.86 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.173 0.921 . . . . 65.33 113.496 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.2 m -67.81 -30.3 69.68 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.78 0.832 . . . . 74.21 110.814 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -74.72 -33.64 62.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.796 -0.638 . . . . 75.43 111.543 -168.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.39 -36.46 68.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.162 0.506 . . . . 75.53 110.299 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.14 -26.96 66.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.793 -1.094 . . . . 64.24 111.247 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -86.56 -34.6 19.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.384 1.074 . . . . 74.3 110.164 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.02 -63.36 1.32 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.258 0.623 . . . . 50.4 111.573 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.461 ' HB2' HG21 ' B' ' 58' ' ' VAL . 1.4 pp -93.75 -3.26 52.49 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.958 0.355 . . . . 65.03 111.958 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.11 -16.34 51.01 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.242 0.339 . . . . 61.41 112.674 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.37 -52.82 0.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.219 0.452 . . . . 55.32 112.219 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -70.94 -43.83 67.38 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 111.998 0.37 . . . . 73.13 111.998 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 90.7 m -61.86 -49.97 83.43 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.5 -0.762 . . . . 63.14 110.917 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 80.0 Cg_exo -54.72 -33.63 80.97 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.062 1.841 . . . . 70.35 113.805 168.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.81 -32.49 74.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.881 0.472 . . . . 75.24 111.186 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.86 -42.99 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.288 0.635 . . . . 60.01 110.169 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.85 -26.61 57.3 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.677 -1.147 . . . . 73.21 111.827 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.26 -49.86 82.39 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.726 1.01 . . . . 72.01 113.726 -170.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 35.3 Cg_endo -61.38 -31.32 88.47 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.704 1.603 . . . . 73.14 112.58 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.452 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.8 m-30 -69.06 -45.57 70.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.821 0.848 . . . . 71.2 110.25 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.98 89.38 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.335 -0.848 . . . . 62.15 110.798 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.409 ' HA ' HD23 ' B' ' 128' ' ' LEU . 33.9 ttt180 -59.31 -54.6 44.98 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.652 1.581 . . . . 74.44 111.35 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.57 -33.91 77.02 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.719 0.637 . . . . 52.13 109.854 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.515 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.9 t -68.35 -38.37 81.39 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.163 -0.471 . . . . 74.25 111.075 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.523 HD11 ' HB ' ' B' ' 62' ' ' VAL . 52.6 mt -64.04 -58.74 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.685 -0.487 . . . . 53.54 109.685 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -59.01 -31.3 68.69 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 124.18 0.925 . . . . 65.32 111.368 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -62.01 -54.38 42.4 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.387 0.675 . . . . 73.51 110.48 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -62.31 -36.63 82.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.19 0.596 . . . . 73.22 110.931 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.2 t -63.0 -42.65 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.074 0.949 . . . . 74.34 110.908 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.3 m -68.18 -31.86 71.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.328 0.651 . . . . 75.0 111.035 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 94.6 mtt-85 -68.65 -21.53 64.45 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.552 0.741 . . . . 73.55 110.921 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.11 15.12 61.93 Favored Glycine 0 C--N 1.356 1.685 0 CA-C-O 119.258 -0.746 . . . . 72.31 114.125 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.634 HG21 ' HD3' ' A' ' 15' ' ' ARG . 1.9 p 73.59 12.84 4.53 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 126.377 1.871 . . . . 71.53 113.247 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.24 149.82 43.66 Favored Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 122.183 -0.323 . . . . 70.35 111.163 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.21 163.11 24.11 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.243 2.629 . . . . 31.3 113.667 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.446 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 0.6 OUTLIER -63.57 115.35 4.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.232 1.013 . . . . 73.52 111.063 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 tt -130.11 97.47 4.46 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.074 -1.454 . . . . 72.35 107.074 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.75 136.07 33.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.527 -0.916 . . . . 70.11 108.527 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 111' ' ' ARG . 2.6 mm? -75.11 125.13 28.28 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.086 -0.709 . . . . 71.04 109.086 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.85 153.9 92.92 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 123.267 0.627 . . . . 41.41 111.056 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.39 99.06 0.35 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.089 2.526 . . . . 61.15 112.419 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 5.2 p -90.84 113.27 26.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 121.487 0.661 . . . . 60.53 109.336 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -76.55 101.9 5.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.967 -0.753 . . . . 61.5 108.967 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -59.74 -28.68 67.57 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.102 -0.954 . . . . 72.03 109.898 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.51 -52.72 58.68 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.589 1.556 . . . . 62.33 110.684 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.35 79.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.458 1.099 . . . . 60.2 111.173 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.477 0.922 0 O-C-N 123.81 0.694 . . . . 73.24 110.799 -178.335 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.984 0.421 . . . . 72.22 111.235 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -87.92 77.54 8.47 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.65 -0.87 . . . . 74.23 108.65 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -114.66 137.31 52.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.527 -0.76 . . . . 71.5 109.534 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -152.06 134.53 15.3 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.297 0.639 . . . . 73.14 109.483 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 pt -76.27 136.45 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.717 -0.674 . . . . 72.44 109.319 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -104.68 -49.04 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.887 0.475 . . . . 64.53 110.005 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -166.11 141.46 4.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.58 -0.736 . . . . 74.11 109.475 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.4 136.02 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.827 -1.175 . . . . 65.5 107.827 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.623 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 7.7 p90 -173.11 154.38 2.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.306 0.574 . . . . 53.54 111.697 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -77.0 116.64 17.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.342 -0.845 . . . . 55.22 109.052 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.5 mmtp -70.91 -48.59 52.82 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 107.972 -1.122 . . . . 74.02 107.972 169.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 6.0 t70 -137.02 141.14 42.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.479 -1.692 . . . . 63.44 109.548 -171.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.9 mt -136.57 141.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.321 -1.363 . . . . 71.53 107.321 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -150.23 141.84 23.55 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.395 -0.594 . . . . 62.4 109.395 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.85 141.71 31.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.529 -1.285 . . . . 75.34 107.529 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.79 144.0 31.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.569 -1.271 . . . . 73.31 107.569 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.478 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -150.47 83.18 6.0 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 108.386 -0.968 . . . . 44.3 108.386 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.07 -15.17 39.43 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.026 2.484 . . . . 75.01 112.69 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -126.1 37.89 4.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.171 0.988 . . . . 51.34 109.517 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' C' ' 25' ' ' ALA . . . -58.74 -51.74 79.69 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 113.809 1.04 . . . . 64.23 113.809 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.69 -24.53 7.27 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 121.64 1.56 . . . . 62.43 112.43 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.75 -22.54 65.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.661 1.184 . . . . 73.15 111.802 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.661 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 11.2 p -50.1 -32.29 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.353 1.061 . . . . 62.24 113.8 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.4 -31.01 70.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.341 0.656 . . . . 73.14 112.001 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -118.01 48.84 1.32 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.699 0.8 . . . . 72.41 110.355 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 14.6 ptpt -124.41 173.12 8.63 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.881 -0.414 . . . . 62.2 109.881 170.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.59 113.41 20.8 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.026 -1.101 . . . . 63.52 108.026 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -83.76 79.6 9.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.268 1.032 . . . . 71.45 110.81 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.719 ' HB3' HD13 ' C' ' 68' ' ' LEU . 48.4 tt0 -123.53 79.63 54.66 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.342 -1.355 . . . . 74.34 107.342 168.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 91.08 1.2 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.053 2.502 . . . . 72.04 111.973 -173.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.61 91.96 8.42 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.9 -1.889 . . . . 63.51 105.9 169.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.5 141.03 15.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.367 -0.833 . . . . 72.44 109.354 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' C' ' 41' ' ' LYS . 4.3 ttmp? -127.13 103.75 7.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.031 -0.729 . . . . 72.25 109.031 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.698 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.6 pt? -89.9 160.71 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.853 . . . . 73.22 109.848 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.93 117.51 8.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.536 0.735 . . . . 41.1 109.216 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.43 120.21 39.64 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.86 -0.793 . . . . 62.1 108.86 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.2 140.93 46.84 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.715 1.206 . . . . 70.32 108.786 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 8.1 t -142.57 138.4 30.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.317 0.58 . . . . 65.12 110.455 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.26 177.32 5.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.143 0.977 . . . . 55.24 108.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -151.83 160.33 43.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 64.2 111.129 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -155.84 140.07 16.58 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.334 1.053 . . . . 75.41 108.614 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.46 115.35 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.497 -0.927 . . . . 64.14 108.497 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.585 HD11 HD12 ' C' ' 83' ' ' ILE . 47.5 mt -85.52 -42.62 14.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.005 -0.739 . . . . 63.12 109.005 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.56 179.78 8.08 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.515 -1.22 . . . . 63.53 109.103 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.06 128.01 34.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.001 -0.741 . . . . 75.43 109.001 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 70.55 -3.66 1.85 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.803 1.241 . . . . 64.31 112.487 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.29 111.22 35.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 108.771 -0.826 . . . . 73.35 108.771 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.34 125.47 42.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.601 0.761 . . . . 63.43 109.124 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.9 tt0 -84.5 137.75 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.696 0.798 . . . . 52.12 109.166 171.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.43 HG23 HD11 ' C' ' 106' ' ' LEU . 29.3 m -124.25 140.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 40.12 108.344 165.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' C' ' 46' ' ' THR . 47.5 t -117.51 103.6 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.397 -0.964 . . . . 65.24 108.397 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.64 96.8 10.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.258 -1.016 . . . . 72.21 108.258 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -85.67 126.78 34.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.817 -1.083 . . . . 73.44 109.663 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.9 t -115.18 134.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.276 -1.009 . . . . 43.33 108.276 171.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 4.4 m -118.98 141.71 48.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.581 HG21 HG21 ' C' ' 114' ' ' ILE . 86.3 t -128.64 117.24 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.668 1.187 . . . . 65.33 108.356 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -99.87 144.37 29.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.438 -1.319 . . . . 71.45 107.438 165.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.84 106.7 6.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.354 -1.721 . . . . 51.4 106.354 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -152.45 160.96 43.21 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.557 0.535 . . . . 72.41 110.815 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.719 HD13 ' HB3' ' C' ' 37' ' ' GLN . 20.0 tp -79.27 -50.26 11.19 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.172 -1.047 . . . . 70.15 108.172 162.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.4 -77.31 0.04 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.068 -1.213 . . . . 63.31 110.068 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -89.99 -31.3 17.28 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.229 -0.656 . . . . 75.21 109.229 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -78.05 93.38 4.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.277 1.031 . . . . 63.15 109.933 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -87.91 130.57 34.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.932 0.493 . . . . 42.33 111.65 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.25 -65.07 0.82 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.167 0.987 . . . . 61.33 108.943 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -156.54 164.0 38.72 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 123.797 0.686 . . . . 52.43 111.622 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.445 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -121.66 144.65 48.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.655 -1.609 . . . . 55.43 106.655 168.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.445 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -148.14 150.95 34.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.777 -0.823 . . . . 60.34 108.777 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -159.69 131.59 6.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.724 0.409 . . . . 62.11 110.078 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -129.95 114.64 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.867 0.867 . . . . 72.22 108.757 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.5 mt-30 -90.24 88.6 7.29 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.036 -1.098 . . . . 75.31 108.036 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.62 107.22 12.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.892 -1.049 . . . . 74.02 109.512 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.95 154.95 27.13 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 112.147 -0.381 . . . . 71.01 112.147 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.05 122.87 1.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.382 -0.687 . . . . 71.34 111.382 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.585 HD12 HD11 ' C' ' 51' ' ' LEU . 10.0 mm -87.9 123.47 40.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.397 -0.964 . . . . 70.22 108.397 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.32 123.33 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.555 0.742 . . . . 73.32 110.053 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -76.93 112.15 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.822 0.449 . . . . 55.43 109.821 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.42 112.12 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.308 -0.997 . . . . 74.12 108.308 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.01 165.66 30.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.741 0.817 . . . . 71.05 110.255 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -24.42 8.71 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.156 -0.474 . . . . 63.21 113.765 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' C' ' 93' ' ' GLN . 19.8 tt -123.48 151.66 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.403 1.081 . . . . 62.03 109.558 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.75 161.0 43.09 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.205 0.602 . . . . 63.14 110.606 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.1 -153.61 22.4 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 122.986 0.327 . . . . 72.12 112.856 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -59.53 -26.55 65.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.997 0.919 . . . . 73.41 110.454 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.561 ' HB3' HD11 ' C' ' 89' ' ' ILE . 36.8 mt-30 -61.1 -49.84 75.67 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.904 -1.498 . . . . 64.44 110.799 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -21.33 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 116.273 -0.422 . . . . 73.23 110.694 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.08 83.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.034 0.533 . . . . 64.24 110.57 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -66.09 -31.13 71.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.539 -0.755 . . . . 72.32 110.508 172.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.98 -59.27 2.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.67 0.388 . . . . 75.31 110.737 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.14 -51.05 16.79 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.434 0.694 . . . . 74.33 111.108 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.27 6.53 81.03 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.383 -0.676 . . . . 44.1 114.599 -169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.15 -57.22 0.37 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.906 0.853 . . . . 75.53 111.829 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -68.49 -54.05 19.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.289 0.636 . . . . 74.22 111.233 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.3 -46.96 99.07 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 123.863 0.865 . . . . 74.42 112.597 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.3 -33.55 58.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.954 1.769 . . . . 63.11 113.378 171.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.36 -21.6 63.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.918 0.487 . . . . 55.41 111.78 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.524 HD12 ' NH1' ' A' ' 111' ' ' ARG . 32.4 mm -73.75 -39.35 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.216 0.606 . . . . 73.13 109.492 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.543 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.5 mt -75.44 -26.85 58.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.077 -0.965 . . . . 63.14 111.735 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -54.98 -49.87 89.63 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-O 117.993 -1.003 . . . . 71.53 113.12 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.58 -39.96 73.97 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.227 1.951 . . . . 63.11 113.879 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.98 -45.27 67.71 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.132 0.573 . . . . 75.03 110.882 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.21 81.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.248 0.619 . . . . 70.23 110.09 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -63.73 -50.12 70.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.108 1.363 . . . . 72.14 111.244 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.46 -28.53 66.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.704 0.402 . . . . 72.01 110.109 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.6 t -69.33 -35.98 76.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.778 0.431 . . . . 74.32 110.71 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.581 HG21 HG21 ' C' ' 64' ' ' VAL . 93.4 mt -71.25 -53.23 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.49 -0.559 . . . . 72.25 109.49 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -61.32 -28.91 69.54 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.794 0.838 . . . . 71.01 111.336 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 38.9 t -65.94 -50.34 64.72 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.084 -0.71 . . . . 50.44 109.084 170.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.519 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.85 -31.89 71.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.954 0.901 . . . . 73.13 112.436 179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' C' ' 114' ' ' ILE . 43.9 t -71.66 -38.9 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -66.47 -29.9 70.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.853 0.861 . . . . 63.13 111.377 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -74.16 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.43 0.692 . . . . 71.23 109.893 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.52 -7.33 68.46 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.418 0.449 . . . . 75.04 112.417 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 63.14 30.25 16.06 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.937 2.095 . . . . 73.1 112.561 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -82.77 162.32 55.68 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.639 -1.164 . . . . 74.11 108.409 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 140.27 92.72 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.41 2.074 . . . . 74.13 111.639 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.446 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 13.1 mm100 -57.59 112.55 1.47 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.891 0.877 . . . . 71.15 111.897 -173.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.43 93.21 4.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.45 -0.945 . . . . 74.02 108.45 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.27 127.75 49.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 75.24 108.554 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.532 HD11 HG22 ' C' ' 64' ' ' VAL . 86.8 mt -81.39 144.69 31.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.039 0.535 . . . . 70.32 111.114 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.23 143.26 95.64 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.323 0.649 . . . . 70.51 110.421 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.52 139.49 76.45 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.634 2.223 . . . . 64.31 112.33 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.25 118.2 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 108.888 -0.782 . . . . 73.41 108.888 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -83.87 60.24 5.68 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.864 0.84 . . . . 71.41 109.99 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -78.91 -43.43 24.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.844 -1.071 . . . . 74.2 110.034 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 115.792 -0.64 . . . . 64.42 109.694 177.72 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.5 ttp . . . . . 0 N--CA 1.497 1.918 0 N-CA-C 113.289 0.848 . . . . 75.22 113.289 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -122.95 142.41 50.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.588 0.755 . . . . 71.42 109.301 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -155.04 98.9 2.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.658 -1.238 . . . . 70.41 107.658 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.7 132.62 49.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.269 0.628 . . . . 65.24 109.82 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tp -89.61 128.21 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.15 0.58 . . . . 61.23 109.548 177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -99.62 -40.5 7.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.835 0.854 . . . . 74.24 111.037 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -163.04 123.44 2.31 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.772 -0.649 . . . . 72.1 110.471 -162.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.93 132.1 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.294 -1.373 . . . . 62.5 107.294 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.544 ' HE1' HG13 ' D' ' 83' ' ' ILE . 12.4 p90 -160.04 143.52 14.03 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.957 0.786 . . . . 74.54 111.476 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -76.1 117.48 17.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.943 -1.026 . . . . 73.21 108.917 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -82.59 -26.14 32.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.91 0.386 . . . . 64.21 109.99 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.7 t70 -154.11 141.69 19.85 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.848 -1.069 . . . . 63.21 109.437 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.519 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.1 mt -141.63 145.98 23.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.221 1.408 . . . . 73.21 107.544 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -147.34 141.72 26.35 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.986 0.914 . . . . 73.02 108.69 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.9 t80 -153.77 124.89 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.285 -1.746 . . . . 55.32 106.285 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.43 112.66 7.43 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.596 0.634 . . . . 71.11 110.27 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.9 91.37 12.6 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.38 0.672 . . . . 42.02 109.353 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.5 -43.87 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.759 2.306 . . . . 55.13 112.919 -175.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 44.6 m-80 -99.63 43.42 1.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.754 0.822 . . . . 70.34 109.056 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.623 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.78 -52.36 73.04 Favored Pre-proline 0 CA--C 1.57 1.737 0 N-CA-C 114.742 1.386 . . . . 75.42 114.742 -169.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.5 -6.0 8.09 Favored 'Trans proline' 0 C--N 1.388 2.656 0 CA-C-N 121.524 1.58 . . . . 63.14 112.578 172.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.51 ' HA ' HE21 ' D' ' 33' ' ' GLN . 21.8 t-160 -81.09 -42.15 21.43 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.08 0.952 . . . . 74.35 110.048 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.11 -18.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.27 0.628 . . . . 74.24 110.052 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.98 -29.62 70.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.949 0.9 . . . . 75.41 110.876 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.51 HE21 ' HA ' ' D' ' 30' ' ' HIS . 43.5 mt-30 -68.55 -17.71 64.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 70.44 111.841 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.07 109.97 21.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.768 0.827 . . . . 72.02 110.168 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -79.73 81.99 5.91 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.99 0.916 . . . . 74.13 110.882 -177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -159.42 161.35 35.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.654 -0.499 . . . . 73.24 109.654 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -82.9 109.07 14.62 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.876 0.87 . . . . 74.54 109.792 173.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -50.19 140.37 33.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.44 2.76 . . . . 74.54 113.569 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -57.73 127.29 31.31 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.051 0.845 . . . . 63.24 110.116 175.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 88.7 t -96.33 105.84 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.734 -0.839 . . . . 63.3 108.734 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -102.78 108.85 20.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.217 -1.401 . . . . 74.12 107.217 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.647 HD13 HD21 ' D' ' 128' ' ' LEU . 1.5 pt? -116.3 149.85 38.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.065 0.46 . . . . 72.51 110.498 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.69 130.27 24.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.395 1.078 . . . . 51.25 108.289 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.21 131.13 54.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.222 0.609 . . . . 62.45 109.503 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -133.55 128.95 36.36 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.853 -1.166 . . . . 74.41 107.853 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -106.23 150.03 26.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.522 0.329 . . . . 74.55 110.211 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.13 169.02 22.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.8 0.84 . . . . 71.21 110.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.4 m -147.87 158.73 44.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.874 0.869 . . . . 65.21 110.019 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -155.35 118.42 4.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.17 -1.048 . . . . 64.33 108.17 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.62 123.14 24.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.147 -0.686 . . . . 64.44 109.147 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' D' ' 57' ' ' GLU . 51.2 mt -96.21 -31.54 12.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.547 . . . . 71.41 110.366 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 179.64 8.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.857 0.863 . . . . 75.31 110.088 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.06 121.34 18.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.906 -1.043 . . . . 71.43 109.274 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 68.24 17.01 9.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.994 1.318 . . . . 71.21 112.069 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.36 116.68 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.628 ' HB2' HD13 ' D' ' 86' ' ' ILE . 82.6 m-85 -129.15 129.83 45.64 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.736 -0.839 . . . . 71.11 108.736 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.5 tt0 -87.79 135.37 33.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.845 -1.071 . . . . 73.14 108.64 171.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.02 139.2 43.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.853 -1.166 . . . . 71.5 107.853 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.69 131.84 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.39 -0.967 . . . . 71.44 108.39 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -114.58 117.14 30.06 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.267 -1.383 . . . . 73.22 107.267 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 44.6 ttm-85 -95.78 98.72 10.66 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.59 -1.263 . . . . 61.42 107.59 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.567 HG21 ' HB1' ' D' ' 110' ' ' ALA . 47.6 t -99.21 113.81 35.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.031 -1.1 . . . . 71.12 108.031 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.2 m -117.3 132.23 56.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 72.31 109.232 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.28 107.1 10.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.964 0.906 . . . . 72.45 109.286 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.8 m -92.57 119.77 32.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.687 -0.857 . . . . 74.3 108.687 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.73 137.11 46.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.699 -0.852 . . . . 44.05 108.699 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.3 p -149.15 140.38 23.12 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.846 0.459 . . . . 55.3 109.951 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.86 130.18 41.36 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.386 -1.338 . . . . 73.44 107.386 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.23 -121.14 12.91 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.706 -0.557 . . . . 74.42 111.706 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.15 6.95 15.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.247 1.019 . . . . 74.1 111.402 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.95 150.19 34.13 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.118 0.567 . . . . 71.43 109.751 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -79.8 116.72 20.13 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.814 -0.439 . . . . 73.02 109.814 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.11 -56.08 10.14 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.824 0.849 . . . . 72.23 110.102 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.54 169.19 23.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.021 -0.991 . . . . 75.33 110.211 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.4 mt -124.41 153.26 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.759 1.224 . . . . 73.14 108.012 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.517 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.2 t -158.43 139.66 13.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.137 0.575 . . . . 64.04 109.638 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.27 130.66 8.79 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.896 -0.779 . . . . 70.43 108.896 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.5 t -129.74 115.29 33.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.076 -0.713 . . . . 72.33 109.076 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.2 mt-30 -89.36 83.4 6.41 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.302 1.048 . . . . 62.44 108.478 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.79 102.97 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.174 -1.83 . . . . 52.02 109.509 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.2 162.71 23.87 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 116.319 -0.401 . . . . 33.33 112.393 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.0 136.77 5.08 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.951 -0.86 . . . . 72.23 110.951 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.544 HG13 ' HE1' ' D' ' 17' ' ' TYR . 69.2 mt -89.48 120.83 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.814 -0.81 . . . . 73.13 108.814 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -121.4 147.12 46.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.565 -0.531 . . . . 64.41 109.565 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 66.1 m -94.58 106.94 18.94 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.794 -0.817 . . . . 74.01 108.794 170.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' D' ' 94' ' ' MET . 3.5 mp -107.26 107.69 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.33 -0.989 . . . . 63.55 108.33 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.46 148.81 50.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.121 0.568 . . . . 62.43 109.977 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -22.71 11.93 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.073 -0.512 . . . . 64.44 114.273 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.566 HG22 ' HB2' ' D' ' 94' ' ' MET . 32.5 mm -136.41 139.89 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.247 -1.39 . . . . 72.34 107.247 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.01 179.7 7.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.182 0.593 . . . . 72.01 109.996 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.64 -99.83 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.297 -0.41 . . . . 73.45 113.762 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.7 p -83.45 -56.1 3.93 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.077 0.551 . . . . 42.4 111.977 -168.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.03 -37.63 78.73 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 120.796 0.332 . . . . 62.31 110.85 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.653 ' HG2' HG21 ' D' ' 86' ' ' ILE . 44.5 tpp -77.31 -19.93 55.7 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.956 -0.565 . . . . 73.12 111.751 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.63 -32.49 70.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 120.996 0.427 . . . . 62.13 111.124 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -62.65 -40.57 97.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.244 -0.889 . . . . 74.25 110.988 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.409 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 38.5 t -72.26 -51.26 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.786 0.434 . . . . 73.04 110.27 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.5 HD13 ' HG3' ' D' ' 94' ' ' MET . 10.7 mp -67.37 -18.86 65.31 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.466 0.706 . . . . 73.3 111.796 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -2.94 56.96 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.372 -0.682 . . . . 61.21 114.056 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.69 -62.79 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.95 0.875 . . . . 53.03 111.999 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -71.06 -50.08 37.8 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.826 0.676 . . . . 72.12 112.826 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.431 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 18.6 m -62.67 -45.23 88.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.373 0.669 . . . . 62.14 111.877 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.547 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.9 Cg_exo -55.99 -37.63 95.85 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.985 1.79 . . . . 61.23 113.057 168.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.82 -32.47 74.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.537 0.735 . . . . 65.24 111.143 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.14 -41.97 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 123.283 0.633 . . . . 75.33 110.136 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.9 mt -77.42 -17.96 57.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.172 -0.922 . . . . 60.31 111.541 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.98 -44.19 89.09 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 114.181 1.178 . . . . 71.45 114.181 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.23 -41.9 56.28 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.156 1.904 . . . . 64.35 112.808 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.98 -32.62 51.38 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.153 -0.93 . . . . 73.13 111.597 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.567 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -62.86 -55.61 24.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.593 0.757 . . . . 63.41 109.441 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.07 -40.45 76.89 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.025 -1.443 . . . . 73.12 110.337 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 3.4 tm-20 -57.42 -53.55 56.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.73 0.812 . . . . 75.23 111.742 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.404 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.6 t -57.74 -42.22 83.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.018 0.824 . . . . 71.41 110.935 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.517 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.6 mt -63.35 -54.15 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.348 -0.842 . . . . 72.51 110.642 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.516 HG23 ' HG3' ' D' ' 125' ' ' GLN . 48.0 m -54.02 -38.03 64.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 71.24 111.389 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -73.02 -44.49 60.83 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.062 -0.972 . . . . 73.2 110.462 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 73.4 mtm -65.2 -31.02 71.98 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.785 0.434 . . . . 52.24 111.803 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' D' ' 123' ' ' PHE . 79.4 t -66.36 -47.55 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 124.008 0.817 . . . . 74.02 109.771 176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -70.49 -27.91 64.57 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 123.356 0.41 . . . . 73.12 111.06 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -73.5 -34.79 65.45 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.794 0.838 . . . . 73.05 110.044 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.45 -1.56 88.73 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.663 -0.698 . . . . 71.31 112.008 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 58.94 34.69 23.76 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.753 2.021 . . . . 72.42 112.784 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.448 ' HB2' HG13 ' D' ' 118' ' ' VAL . 68.7 m-85 -96.45 163.58 20.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.489 -1.232 . . . . 70.1 108.287 170.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.28 139.62 72.77 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.02 1.814 . . . . 74.1 111.025 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.516 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.3 tt0 -55.21 135.23 49.78 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.716 0.807 . . . . 73.31 112.189 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.403 HD23 HG21 ' D' ' 114' ' ' ILE . 58.7 tp -103.02 104.84 15.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.491 -0.929 . . . . 73.12 108.491 -175.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -98.42 84.5 3.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.205 -1.406 . . . . 75.42 107.205 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.647 HD21 HD13 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -63.78 115.41 4.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.07 -1.085 . . . . 74.43 108.07 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 135.35 90.67 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 124.153 0.908 . . . . 44.14 111.554 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 107.25 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.663 2.242 . . . . 71.54 111.567 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 m -107.33 144.38 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.69 0.796 . . . . 63.33 109.455 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -82.15 101.45 10.44 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.138 -0.69 . . . . 74.3 109.138 -178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.733 0.813 . . . . 74.5 111.374 178.429 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 20.4 m . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.064 -0.717 . . . . 35.31 109.064 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.58 130.44 53.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.621 -1.251 . . . . 74.13 107.621 167.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 30.9 tt0 -133.57 106.65 7.53 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.205 -0.665 . . . . 70.14 109.205 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -75.87 102.92 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.402 -1.333 . . . . 63.52 107.402 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 7.2 tp-100 -74.75 -43.16 56.38 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.796 -0.638 . . . . 72.35 110.8 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 178.36 156.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.281 1.032 . . . . 71.11 110.243 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.56 106.42 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.228 1.011 . . . . 72.13 108.555 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.491 ' CD1' HG22 ' B' ' 122' ' ' THR . 77.0 m-85 -148.39 157.66 43.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.388 0.675 . . . . 75.15 110.604 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -73.72 120.69 19.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.033 0.933 . . . . 73.44 110.526 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -88.81 -22.58 23.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.983 -0.553 . . . . 70.51 110.743 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -154.86 141.86 19.24 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.937 0.773 . . . . 62.35 110.278 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.8 mt -143.19 141.62 26.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.539 1.536 . . . . 60.04 107.534 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -149.97 135.17 18.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.285 -1.006 . . . . 75.43 108.285 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.625 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 74.0 t80 -138.08 111.59 8.11 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 106.099 -1.815 . . . . 74.4 106.099 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.87 118.81 32.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.801 0.44 . . . . 65.1 110.183 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.69 75.07 32.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.694 0.797 . . . . 70.4 109.726 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.12 -27.56 29.37 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.47 2.113 . . . . 72.44 110.656 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 31' ' ' VAL . 57.7 m-20 -96.69 24.96 5.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.08 -1.418 . . . . 72.45 109.777 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.14 99.86 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.985 0.914 . . . . 72.4 112.829 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.07 -16.35 40.38 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 121.714 1.609 . . . . 65.11 112.638 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -85.81 -20.5 29.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.662 0.785 . . . . 74.24 110.461 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' ASN . 46.3 t -68.97 -23.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.201 0.524 . . . . 72.34 110.459 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -67.98 -30.25 69.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.592 -0.731 . . . . 75.25 110.517 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -72.6 -30.39 64.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.964 0.906 . . . . 52.13 110.177 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -75.42 161.28 29.37 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.676 -0.693 . . . . 73.25 111.243 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.41 159.72 29.25 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.818 -1.083 . . . . 74.43 108.755 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.0 m-90 -82.82 57.25 3.74 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.322 0.582 . . . . 65.5 110.283 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -154.9 79.67 4.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.554 0.741 . . . . 63.41 109.406 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.98 155.89 23.29 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.202 1.935 . . . . 62.13 110.83 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.17 115.97 28.31 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.007 -1.109 . . . . 62.53 108.007 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 65' ' ' THR . 21.9 m -98.96 98.8 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.703 0.764 . . . . 74.33 110.921 -173.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.73 115.44 19.33 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.364 -0.976 . . . . 70.45 108.364 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 pt? -98.71 145.05 27.3 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.379 -0.6 . . . . 72.35 109.379 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.576 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.1 t70 -137.67 122.52 18.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.03 -1.1 . . . . 65.12 108.03 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.466 HD21 HG11 ' A' ' 131' ' ' VAL . 4.1 mp -102.62 118.12 36.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.837 -0.801 . . . . 71.12 108.837 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -132.12 137.27 47.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.484 0.714 . . . . 72.33 109.734 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.7 m -131.1 139.11 49.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.868 0.867 . . . . 55.24 109.631 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.76 115.32 5.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.668 0.787 . . . . 73.04 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.2 m -90.17 155.37 19.07 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.569 0.748 . . . . 74.54 110.51 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -149.57 161.15 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.534 1.134 . . . . 65.4 108.786 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -114.85 115.93 27.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.275 0.63 . . . . 71.51 109.719 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -90.04 -31.22 17.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.402 0.681 . . . . 72.54 111.471 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 -172.48 3.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.744 0.652 . . . . 71.21 110.365 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.74 105.65 1.03 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.209 1.003 . . . . 73.13 111.055 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 67.93 12.44 8.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.083 1.353 . . . . 73.35 112.733 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.33 106.86 19.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.48 -1.304 . . . . 73.11 107.48 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -113.16 123.96 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.967 -1.015 . . . . 72.43 109.146 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.7 119.86 38.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.147 -1.388 . . . . 75.0 108.548 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.24 123.61 53.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.676 -1.601 . . . . 75.12 106.676 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 99.4 t -104.19 130.0 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.635 -0.876 . . . . 44.14 108.635 173.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 113.14 26.49 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.574 -1.639 . . . . 75.21 106.574 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -100.22 101.99 13.15 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.969 -1.123 . . . . 64.45 107.969 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.3 t -95.11 126.79 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.278 -1.008 . . . . 52.34 108.278 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 23.2 m -110.55 133.95 52.84 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.24 105.85 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.166 -1.42 . . . . 62.43 107.166 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.0 m -103.78 130.35 51.3 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.732 -0.84 . . . . 54.02 108.732 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.36 109.69 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.147 -1.057 . . . . 73.22 108.147 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.3 m -136.61 128.5 29.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.035 -0.728 . . . . 54.24 109.035 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 tt -94.65 87.66 5.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.611 -1.625 . . . . 63.14 106.611 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.76 -121.3 5.4 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.528 -0.629 . . . . 64.32 111.528 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -90.8 -25.84 19.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.195 0.598 . . . . 72.12 111.602 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 125.79 34.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.774 -0.454 . . . . 63.25 109.774 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 m -74.36 134.37 42.48 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 115.776 -0.647 . . . . 62.41 109.658 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.63 -55.62 4.34 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -167.3 168.99 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.039 -0.982 . . . . 75.53 110.476 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.5 tp -132.52 143.68 49.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.644 1.178 . . . . 55.11 108.673 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.625 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 13.8 m -138.02 124.93 21.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.635 0.774 . . . . 64.14 109.432 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.41 125.77 23.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.106 -0.701 . . . . 52.25 109.106 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -131.89 114.69 25.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.979 0.912 . . . . 74.23 109.512 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 74.1 mt-30 -85.53 86.6 7.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.154 -0.93 . . . . 72.11 108.876 172.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.67 99.1 5.68 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.078 -0.965 . . . . 73.53 109.071 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.66 152.41 21.08 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.593 -0.603 . . . . 73.14 111.593 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.07 134.24 5.67 Favored Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.273 -1.131 . . . . 71.21 110.273 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 43.4 mt -87.85 125.71 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.255 -1.017 . . . . 72.24 108.255 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -131.82 120.23 22.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 48.3 t -92.2 100.83 13.37 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.177 -1.045 . . . . 65.31 108.177 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.425 HD13 HD21 ' A' ' 98' ' ' LEU . 50.5 pt -116.16 141.01 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.246 0.618 . . . . 74.13 110.515 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.39 174.32 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.115 0.966 . . . . 51.42 110.119 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.61 -32.1 5.47 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.129 -0.487 . . . . 71.32 112.791 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.47 156.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.872 0.869 . . . . 61.55 109.883 -176.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.9 175.04 12.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.042 -0.725 . . . . 41.23 109.042 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.46 -144.52 37.41 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.871 -0.492 . . . . 54.33 111.871 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 11.2 t -65.41 -16.3 63.48 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.147 0.579 . . . . 73.23 112.151 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.19 -54.55 31.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.832 0.853 . . . . 72.2 110.204 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 56.3 ttm -72.22 -34.62 68.48 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.451 -0.795 . . . . 71.5 110.761 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -65.12 -41.29 95.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.537 0.735 . . . . 74.32 111.63 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -59.76 -40.28 87.62 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.678 -0.692 . . . . 55.33 110.159 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.768 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 8.6 m -76.08 -37.34 58.31 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.598 0.962 . . . . 74.52 113.598 -172.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.425 HD21 HD13 ' A' ' 86' ' ' ILE . 89.1 mt -85.41 -15.45 43.04 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.93 0.332 . . . . 71.33 110.578 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.59 -28.65 9.4 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.399 -0.667 . . . . 73.34 113.56 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.06 -55.71 0.71 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.255 1.027 . . . . 73.24 113.153 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.768 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.4 t80 -50.64 -65.04 0.63 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.722 0.809 . . . . 74.33 111.699 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.4 m -64.46 -45.67 77.42 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 118.209 -0.9 . . . . 63.32 112.848 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.68 -41.34 54.28 Favored 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.181 1.921 . . . . 73.31 113.69 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.444 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 21.4 t-20 -71.78 -32.24 67.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.371 0.669 . . . . 75.21 110.52 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 101' ' ' TYR . 24.3 mm -65.37 -35.27 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.781 0.832 . . . . 54.13 110.487 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -80.69 -20.42 42.97 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.168 0.987 . . . . 72.45 111.471 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.519 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 25.8 t80 -67.63 -43.39 40.18 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 114.263 1.209 . . . . 75.1 114.263 -168.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 36.3 Cg_exo -62.13 -34.89 78.12 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.78 1.653 . . . . 75.22 112.425 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -74.25 -40.99 62.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.445 0.698 . . . . 73.13 111.593 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.75 82.62 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.789 0.436 . . . . 72.13 109.923 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.5 ttm180 -53.88 -51.68 62.89 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.509 1.131 . . . . 74.43 110.164 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.72 -46.15 90.91 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.181 0.925 . . . . 72.11 110.881 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -57.75 -48.75 78.75 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.898 0.749 . . . . 32.54 110.773 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -61.93 -50.62 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.063 0.945 . . . . 73.15 110.499 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.575 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.2 m -57.24 -41.42 79.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.722 0.809 . . . . 51.14 111.33 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.14 -40.71 82.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.284 -0.871 . . . . 72.41 109.691 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.14 -42.06 89.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 73.15 110.951 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -63.65 -45.83 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.006 0.922 . . . . 70.02 110.952 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.4 p -73.88 -28.86 61.77 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.923 0.489 . . . . 65.31 111.429 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.407 HH12 ' HG3' ' B' ' 112' ' ' GLU . 83.0 mtt-85 -72.38 -28.42 62.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.504 0.721 . . . . 74.42 109.264 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.17 89.05 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.456 -0.793 . . . . 75.33 112.831 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.5 m 68.67 17.14 8.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.651 1.181 . . . . 52.31 111.515 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -92.03 161.01 34.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 74.22 110.739 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.62 123.88 14.77 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.469 2.113 . . . . 40.41 111.176 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.575 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.2 tt0 -54.45 141.3 31.27 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.869 1.268 . . . . 61.3 112.96 -175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.417 HD22 HG11 ' A' ' 40' ' ' VAL . 82.3 mt -125.63 96.11 4.67 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.593 0.757 . . . . 61.12 109.563 -177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.2 105.45 17.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.713 -0.847 . . . . 73.45 108.713 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.531 HD11 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -62.73 130.14 43.63 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.651 0.594 . . . . 71.41 110.0 -174.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.67 144.92 94.42 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 122.908 0.483 . . . . 63.43 111.2 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.587 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 73.7 Cg_exo -54.62 144.52 63.66 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 124.152 3.235 . . . . 73.44 115.153 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 44' ' ' LEU . 31.5 m -115.98 115.06 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.81 0.844 . . . . 63.35 109.873 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -89.41 65.72 7.21 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.625 0.77 . . . . 73.31 109.0 174.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.61 -33.11 41.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.384 -0.826 . . . . 73.21 109.857 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 73.23 110.037 171.683 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 115.036 1.495 . . . . 73.12 115.036 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -134.68 127.03 30.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.363 -1.347 . . . . 74.13 107.363 169.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -121.98 146.86 46.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.635 -0.876 . . . . 73.4 108.635 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -166.81 142.54 4.39 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.932 0.77 . . . . 75.42 110.145 169.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.07 120.41 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.393 -0.966 . . . . 75.01 108.393 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -79.88 -47.31 15.3 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.948 -0.39 . . . . 75.31 109.948 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -164.47 145.34 8.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.92 -0.582 . . . . 72.35 109.83 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -118.05 150.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 106.851 -1.537 . . . . 75.34 106.851 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -168.75 145.61 3.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.832 0.453 . . . . 73.21 111.172 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.3 m -73.04 117.24 14.53 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.037 -1.097 . . . . 74.52 108.037 167.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -83.94 -42.98 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.829 -0.623 . . . . 73.23 110.2 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 25.9 t70 -144.81 142.03 29.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.028 -0.533 . . . . 63.21 111.578 -168.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.3 mm -137.15 142.96 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.091 1.357 . . . . 73.54 108.053 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -141.35 137.97 32.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.924 -1.51 . . . . 73.33 106.924 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -152.01 110.04 3.69 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.778 -1.193 . . . . 73.52 107.778 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -118.72 111.89 19.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.869 -0.789 . . . . 74.04 108.869 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.8 85.92 3.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 109.116 -0.698 . . . . 75.12 109.116 170.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.8 -22.85 36.19 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.024 2.483 . . . . 72.3 110.8 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -125.03 29.89 6.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.88 1.272 . . . . 73.24 109.617 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.27 -48.11 45.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 125.191 1.397 . . . . 45.31 113.365 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.5 Cg_endo -84.65 -15.06 6.24 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.364 2.043 . . . . 74.12 112.771 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.92 -0.32 47.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.232 0.613 . . . . 63.43 111.6 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.475 HG23 HD12 ' B' ' 68' ' ' LEU . 11.2 p -69.46 -31.13 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.225 0.61 . . . . 75.5 110.919 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -71.66 -40.6 69.54 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.551 0.74 . . . . 61.44 110.96 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -81.1 -8.32 59.74 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.372 -0.831 . . . . 55.25 111.264 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' HD22 ' B' ' 68' ' ' LEU . 5.8 mmtp -100.13 109.1 21.38 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.057 0.943 . . . . 72.12 109.98 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -96.0 75.89 3.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.59 0.756 . . . . 75.13 111.903 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.441 ' HB2' HD23 ' B' ' 68' ' ' LEU . 4.8 m-90 -153.76 172.28 17.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.47 1.508 . . . . 74.01 107.159 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -90.24 119.49 69.22 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.655 -0.869 . . . . 64.42 108.655 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.19 102.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.117 2.544 . . . . 75.01 112.214 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.83 102.55 1.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.042 -0.526 . . . . 72.41 109.826 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.403 HG13 HG13 ' B' ' 64' ' ' VAL . 59.7 t -89.57 121.38 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 72.24 110.121 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -118.86 123.68 45.31 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.856 1.262 . . . . 65.23 108.52 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.479 HD21 HD22 ' B' ' 128' ' ' LEU . 6.4 mp -92.72 158.88 15.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.3 0.64 . . . . 74.31 110.279 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.59 110.76 3.68 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.948 -1.13 . . . . 63.22 107.948 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -104.99 150.19 25.13 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.37 0.605 . . . . 71.24 110.063 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -138.16 128.12 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.447 -1.252 . . . . 74.32 108.643 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -110.35 108.15 18.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.505 0.722 . . . . 42.12 109.335 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.54 153.94 33.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.242 1.017 . . . . 71.41 109.492 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -143.57 162.98 34.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.32 0.648 . . . . 54.44 109.508 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.7 p -150.6 150.4 31.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.161 0.584 . . . . 73.13 109.658 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -84.56 112.6 20.57 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.847 -0.797 . . . . 75.14 108.847 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.453 HD12 HG23 ' B' ' 83' ' ' ILE . 82.8 mt -88.93 -54.2 4.24 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.724 -0.473 . . . . 65.34 109.724 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -170.24 3.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.784 0.834 . . . . 61.22 110.004 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.84 117.38 7.46 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.19 -0.914 . . . . 74.41 110.19 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 71.41 -2.27 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.456 1.503 . . . . 55.31 112.092 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -106.51 103.15 14.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.784 0.833 . . . . 74.03 109.448 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -108.65 141.39 40.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.85 0.86 . . . . 64.13 109.641 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' B' ' 51' ' ' LEU . 15.5 tt0 -99.64 102.52 14.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.393 -0.965 . . . . 74.23 108.393 172.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.05 118.56 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.565 -0.902 . . . . 73.01 108.565 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.5 t -104.82 119.57 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.721 0.808 . . . . 74.15 109.164 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.24 129.45 39.29 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.674 -1.602 . . . . 74.31 106.674 171.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 24.7 ttp180 -121.31 108.25 13.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.723 -0.843 . . . . 73.44 108.723 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.519 ' HB ' HD11 ' B' ' 114' ' ' ILE . 19.9 t -105.17 120.04 55.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.865 -1.161 . . . . 62.44 107.865 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -113.54 126.96 55.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 73.32 108.962 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.632 HG21 HG21 ' B' ' 114' ' ' ILE . 42.0 t -113.65 119.26 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.432 1.093 . . . . 72.22 109.153 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -118.31 140.33 49.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.327 -0.99 . . . . 63.24 108.327 170.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.87 143.41 50.14 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.053 -1.091 . . . . 64.35 108.053 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.4 p -130.71 130.35 43.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.771 -0.455 . . . . 73.51 109.771 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 0.8 OUTLIER -110.31 112.66 24.76 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.146 -1.057 . . . . 64.3 108.146 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.69 -113.3 3.77 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.331 -1.107 . . . . 75.33 110.331 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.62 5.5 10.57 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.811 0.844 . . . . 74.43 111.164 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -114.43 166.84 11.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.523 0.729 . . . . 74.31 109.245 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 33.5 m -69.59 135.63 50.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.035 0.534 . . . . 72.42 110.707 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -87.31 -58.66 2.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.5 -1.296 . . . . 73.22 107.5 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -156.95 163.69 38.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.617 -1.174 . . . . 65.13 109.956 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 73.6 mt -124.74 143.27 50.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.822 -1.547 . . . . 74.53 106.822 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.3 151.89 29.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.507 -0.923 . . . . 60.32 108.507 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.1 tt0 -165.16 130.99 2.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.049 -0.723 . . . . 73.44 109.049 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.2 t -125.17 144.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 55.4 109.369 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 25.7 mt-30 -121.14 94.62 4.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.62 -1.252 . . . . 72.25 107.62 169.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -85.39 100.44 11.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.57 -0.9 . . . . 63.31 108.57 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.86 162.92 31.71 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.149 -0.78 . . . . 63.4 111.149 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.37 127.5 1.75 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.619 -0.592 . . . . 60.44 111.619 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.453 HG23 HD12 ' B' ' 51' ' ' LEU . 40.6 mt -85.08 126.0 40.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.691 0.796 . . . . 71.34 109.162 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.29 134.04 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.026 0.931 . . . . 71.41 108.748 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -100.98 100.56 11.19 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.029 0.932 . . . . 63.52 108.727 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.524 HG13 HD11 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -121.61 143.04 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.092 0.957 . . . . 71.52 110.813 -177.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.57 159.17 43.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 43.33 109.709 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.54 -44.42 2.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.359 0.412 . . . . 75.01 112.692 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.532 HG22 ' HB3' ' B' ' 93' ' ' GLN . 13.1 pt -65.64 140.27 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 74.04 111.828 177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -151.65 152.01 32.24 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.351 1.06 . . . . 52.44 108.36 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.92 -113.87 5.49 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 124.027 0.829 . . . . 34.24 113.284 176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 68.4 m -65.79 -40.55 92.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.49 1.116 . . . . 72.22 111.609 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.532 ' HB3' HG22 ' B' ' 89' ' ' ILE . 90.0 mt-30 -65.81 -43.69 87.89 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.835 0.454 . . . . 54.23 111.172 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.43 ' HA ' HD12 ' B' ' 89' ' ' ILE . 14.2 tpt -69.37 -35.5 75.9 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.562 -0.745 . . . . 74.25 110.676 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 -24.96 59.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.289 -0.869 . . . . 63.34 110.99 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 25.8 t-80 -81.97 -29.54 32.1 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.274 0.63 . . . . 74.23 110.59 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -78.91 -68.09 0.69 Allowed 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 109.458 -0.571 . . . . 73.45 109.458 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.524 HD11 HG13 ' B' ' 86' ' ' ILE . 8.4 mp -73.5 -25.99 60.69 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.924 0.489 . . . . 62.44 112.289 -173.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.2 -30.13 23.39 Favored Glycine 0 C--N 1.334 0.457 0 O-C-N 123.368 0.417 . . . . 71.04 113.018 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -123.44 -56.58 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.734 0.642 . . . . 44.22 112.734 -170.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -72.94 -49.18 30.91 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.295 0.48 . . . . 75.11 112.295 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.3 m -60.39 -47.81 95.47 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.263 1.025 . . . . 71.03 111.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 72.7 Cg_exo -56.5 -37.77 96.66 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.985 1.79 . . . . 65.22 113.102 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.4 -29.94 70.21 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 75.02 110.892 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.39 -49.23 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.654 0.781 . . . . 64.13 109.774 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.83 -12.61 59.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 73.25 111.942 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.05 -48.0 61.37 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 118.141 -0.933 . . . . 74.22 112.944 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.46 -33.43 97.29 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.023 1.816 . . . . 74.52 113.488 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HE2' HG21 ' D' ' 115' ' ' THR . 53.8 m-85 -71.08 -44.47 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.426 0.69 . . . . 75.33 110.556 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.404 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -63.2 -38.77 92.5 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.883 0.873 . . . . 74.21 110.193 175.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.513 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 57.4 ttt-85 -60.3 -57.02 14.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.487 1.515 . . . . 71.41 111.087 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.407 ' HG3' HH12 ' A' ' 120' ' ' ARG . 14.5 tp10 -58.38 -33.49 69.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.923 0.889 . . . . 64.5 110.89 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.512 ' HB3' HG21 ' B' ' 78' ' ' VAL . 1.3 m -63.31 -54.94 29.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.312 0.645 . . . . 65.14 111.38 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.632 HG21 HG21 ' B' ' 64' ' ' VAL . 57.6 mt -58.86 -54.53 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.233 0.613 . . . . 60.33 110.05 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.3 m -55.9 -39.26 71.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.762 1.225 . . . . 71.25 111.663 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -62.04 -50.67 71.06 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 115.788 -0.642 . . . . 74.32 110.094 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -65.74 -33.71 76.49 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.441 0.696 . . . . 75.13 111.522 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 114' ' ' ILE . 76.9 t -63.26 -46.57 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.886 0.874 . . . . 73.52 110.192 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' B' ' 125' ' ' GLN . 23.3 m -68.35 -28.92 67.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.653 -0.703 . . . . 73.2 111.481 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 96.1 mtt-85 -72.3 -16.08 61.9 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 115.621 -0.718 . . . . 64.2 110.708 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.15 15.89 59.9 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.657 -1.079 . . . . 63.15 115.476 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.491 HG22 ' CD1' ' A' ' 17' ' ' TYR . 15.5 p 79.56 13.17 1.1 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 126.576 1.95 . . . . 71.13 112.507 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 119' ' ' SER . 96.6 m-85 -103.63 153.7 38.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 122.811 0.444 . . . . 72.32 110.597 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.08 153.26 59.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.856 2.371 . . . . 75.12 112.296 172.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 1.1 mp0 -64.86 115.11 5.0 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.445 0.465 . . . . 73.42 110.227 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -108.12 85.65 2.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.983 -1.117 . . . . 65.22 107.983 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -92.37 132.63 36.59 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.045 -0.979 . . . . 71.52 109.07 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.513 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 30.5 mt -81.0 147.85 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.42 -0.809 . . . . 71.24 111.439 -169.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.58 147.94 50.67 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.519 0.728 . . . . 65.23 109.639 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.85 97.9 0.41 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.912 2.408 . . . . 53.45 111.474 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.87 111.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 107.92 -1.141 . . . . 62.32 107.92 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.18 100.62 1.31 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.4 -0.818 . . . . 73.4 110.159 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -59.45 -33.2 70.99 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.115 -0.948 . . . . 74.35 109.649 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -65.13 -39.01 92.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.611 1.564 . . . . 75.21 112.175 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.12 73.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.791 0.436 . . . . 72.42 110.434 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 115.061 -0.972 . . . . 74.32 109.615 178.532 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.476 ' HG3' HG12 ' C' ' 89' ' ' ILE . 28.0 ttt . . . . . 0 N--CA 1.479 0.984 0 CA-C-O 121.537 0.684 . . . . 71.34 112.784 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 44.0 m -115.62 88.42 2.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.638 -0.71 . . . . 74.01 109.217 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.587 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 73.5 t80 -97.63 129.96 44.69 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.62 -0.882 . . . . 74.21 108.62 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -139.89 125.73 19.53 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.277 0.631 . . . . 53.13 109.367 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.3 mt -77.67 119.99 27.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.702 -0.851 . . . . 74.23 108.702 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 32.5 mm-40 -83.95 -49.32 9.09 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.641 0.377 . . . . 74.42 110.038 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -170.09 145.36 2.83 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.682 0.614 . . . . 63.43 109.741 -171.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -133.11 133.95 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' D' ' 122' ' ' THR . 34.2 p90 -167.47 162.68 14.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.901 0.858 . . . . 75.3 111.676 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -83.38 120.52 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.064 -0.971 . . . . 71.45 109.462 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -73.35 -49.33 27.86 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.527 -0.916 . . . . 74.32 108.527 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.1 t70 -134.3 139.26 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.681 -1.145 . . . . 53.31 109.412 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -137.2 138.24 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.097 -1.446 . . . . 71.41 107.097 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 38.9 t -152.11 149.87 29.28 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.479 0.712 . . . . 51.13 109.118 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -155.67 138.47 15.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.08 -1.081 . . . . 72.34 108.08 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 56.4 mt-10 -135.1 148.25 49.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.284 1.034 . . . . 74.43 108.452 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -154.98 85.5 3.55 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 106.963 -1.495 . . . . 74.15 106.963 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 -50.12 4.15 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.328 2.018 . . . . 65.45 111.144 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.48 35.68 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.025 0.93 . . . . 63.24 110.517 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.3 -50.37 88.46 Favored Pre-proline 0 CA--C 1.565 1.519 0 C-N-CA 124.441 1.096 . . . . 63.13 113.81 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.81 -25.08 20.6 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 121.642 1.561 . . . . 64.54 112.126 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -67.93 -19.57 64.99 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.96 1.304 . . . . 74.33 112.809 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.17 -25.44 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 113.621 0.971 . . . . 65.25 113.621 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -65.79 -40.42 91.93 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.212 0.529 . . . . 71.0 110.667 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -98.75 13.59 31.73 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.258 1.023 . . . . 74.4 110.413 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 136.7 38.03 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.325 -0.62 . . . . 74.05 109.325 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -85.05 92.58 8.39 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.327 -1.731 . . . . 44.22 106.327 168.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -75.34 89.28 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.763 0.792 . . . . 74.52 112.028 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -150.27 67.74 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.018 -1.104 . . . . 43.24 108.018 163.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -91.85 154.46 3.38 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.651 2.234 . . . . 72.44 111.747 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -86.82 118.35 26.16 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.85 -0.796 . . . . 64.04 108.85 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.78 97.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.177 -1.046 . . . . 74.31 108.177 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 53.0 mtpt -95.2 101.28 13.01 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.342 -0.984 . . . . 73.34 108.342 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.654 HD23 HG22 ' C' ' 64' ' ' VAL . 2.9 tm? -102.13 129.77 48.57 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.116 -1.068 . . . . 54.31 108.116 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.31 131.92 45.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.048 0.939 . . . . 55.23 108.83 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 99.3 mt -123.78 148.47 46.63 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.825 0.85 . . . . 75.11 109.384 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.21 125.43 8.02 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.74 -0.837 . . . . 74.13 108.74 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -113.4 147.72 37.2 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.569 -0.53 . . . . 52.03 109.569 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.06 42.74 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.209 1.004 . . . . 71.01 108.435 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -137.8 145.96 42.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.722 0.409 . . . . 74.21 110.259 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.1 p -145.0 129.81 18.21 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.625 0.77 . . . . 72.11 109.691 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -74.36 118.18 17.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.026 0.53 . . . . 70.23 109.881 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.47 HD11 HD12 ' C' ' 83' ' ' ILE . 74.2 mt -84.67 -40.61 17.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.145 0.578 . . . . 73.55 109.774 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.09 -178.94 7.67 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.092 . . . . 73.3 109.399 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -62.75 124.87 22.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.967 -0.56 . . . . 53.01 109.993 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.03 -5.98 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.288 1.435 . . . . 60.5 111.944 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.28 114.78 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.061 0.944 . . . . 72.53 109.697 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.93 125.5 35.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.18 0.992 . . . . 70.14 108.869 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.412 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.7 tt0 -95.39 121.19 36.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.997 0.919 . . . . 71.33 109.935 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.73 132.41 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.596 -0.89 . . . . 73.24 108.596 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -126.28 112.53 30.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 124.164 0.985 . . . . 64.3 108.777 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.95 111.72 23.64 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.319 -0.993 . . . . 73.42 108.319 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.82 107.33 12.51 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.114 -0.699 . . . . 75.22 109.114 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -100.76 127.2 54.12 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 CA-C-N 114.956 -1.02 . . . . 71.22 108.408 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 48.4 m -131.43 130.23 42.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.405 -0.591 . . . . 74.24 109.405 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.654 HG22 HD23 ' C' ' 42' ' ' LEU . 86.0 t -120.11 120.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.11 109.302 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -114.45 130.0 56.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.544 -0.909 . . . . 70.12 108.544 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.33 93.62 4.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.904 -1.517 . . . . 75.12 106.904 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 78.7 p -158.56 140.42 13.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.282 0.633 . . . . 72.23 109.565 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.1 tp -77.99 -32.97 51.5 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.291 -0.633 . . . . 74.11 109.291 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.82 -82.67 0.06 OUTLIER Glycine 0 C--N 1.345 1.059 0 N-CA-C 110.4 -1.08 . . . . 62.1 110.4 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.88 -31.79 16.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.185 0.594 . . . . 60.43 109.841 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.46 96.08 7.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.22 0.608 . . . . 73.44 109.789 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -90.69 133.63 35.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.274 -0.876 . . . . 74.01 110.929 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.2 -56.91 3.76 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.406 -0.961 . . . . 53.21 108.406 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -160.74 175.34 12.72 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.745 -1.116 . . . . 75.23 111.952 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.5 tm? -141.29 146.65 37.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.387 1.875 . . . . 60.31 105.95 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.424 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.5 t -152.78 153.55 33.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.274 0.629 . . . . 50.12 109.315 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -159.64 136.47 9.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.707 0.403 . . . . 65.14 111.128 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' C' ' 110' ' ' ALA . 45.8 t -140.78 113.49 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.518 1.127 . . . . 72.41 108.881 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 66.1 mt-30 -91.97 97.76 11.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.252 -1.018 . . . . 73.43 108.252 173.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 6.8 tp-100 -86.56 114.16 23.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.514 0.726 . . . . 64.43 109.755 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.27 145.07 15.86 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.201 -0.359 . . . . 74.32 112.201 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.539 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.72 132.81 4.55 Favored Glycine 0 CA--C 1.504 -0.601 0 N-CA-C 111.839 -0.504 . . . . 75.13 111.839 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.47 HD12 HD11 ' C' ' 51' ' ' LEU . 7.8 mm -87.29 121.59 38.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.226 -1.027 . . . . 43.3 108.226 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.34 123.8 26.06 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.607 0.763 . . . . 73.12 109.569 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 36.5 p -97.75 125.46 42.58 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.84 0.456 . . . . 50.11 110.167 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.77 132.74 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.381 -0.97 . . . . 75.14 108.381 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -137.01 147.79 46.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.581 0.752 . . . . 63.33 109.755 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.1 -53.02 3.89 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.936 -0.574 . . . . 60.11 111.726 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.476 HG12 ' HG3' ' C' ' 9' ' ' MET . 2.9 pp -96.78 164.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.858 0.863 . . . . 71.42 111.487 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -168.41 -170.62 1.29 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.891 1.276 . . . . 74.44 109.264 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.09 -121.98 26.13 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 119.77 -0.461 . . . . 64.23 113.427 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 18.2 p -65.22 -33.21 75.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.943 0.897 . . . . 63.12 112.281 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.57 -42.49 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.908 0.483 . . . . 61.21 110.908 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptm -76.1 -24.93 55.03 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.005 0.19 . . . . 74.31 110.644 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.88 -43.7 78.74 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.165 0.507 . . . . 74.44 110.269 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -67.79 -34.36 76.63 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.268 -0.878 . . . . 60.34 110.805 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.88 -54.8 11.83 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.767 0.427 . . . . 55.35 110.478 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.486 HD23 ' SG ' ' C' ' 102' ' ' CYS . 63.8 mt -76.45 -14.53 60.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.648 0.779 . . . . 65.42 111.569 -177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.48 -29.88 8.52 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.388 0.43 . . . . 73.11 113.483 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.3 -59.39 1.98 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.094 0.558 . . . . 71.22 110.93 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.411 ' O ' HG12 ' C' ' 105' ' ' ILE . 62.0 t80 -72.66 -55.43 6.83 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.206 0.941 . . . . 73.32 111.721 -164.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.486 ' SG ' HD23 ' C' ' 98' ' ' LEU . 61.0 m -58.45 -48.06 97.64 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 124.073 0.949 . . . . 72.25 112.804 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.5 Cg_exo -59.38 -34.25 97.55 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.296 1.998 . . . . 71.32 113.082 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.581 HD21 ' HB ' ' C' ' 131' ' ' VAL . 38.5 t-20 -70.79 -33.85 71.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.64 0.776 . . . . 73.15 110.308 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.505 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -66.85 -42.17 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 122.851 0.46 . . . . 72.21 109.842 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.539 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.9 mt -68.88 -32.19 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.053 -0.976 . . . . 74.55 111.408 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.66 -53.52 59.39 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.315 1.228 . . . . 73.1 114.315 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.58 -34.41 95.3 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.325 2.016 . . . . 73.45 113.541 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.409 ' HE2' HG21 ' A' ' 115' ' ' THR . 47.9 m-85 -67.96 -45.72 73.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.541 0.737 . . . . 72.31 110.469 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.59 -35.71 80.87 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.421 -0.809 . . . . 74.24 110.946 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -65.32 -46.77 78.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.96 1.304 . . . . 64.05 110.363 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -68.39 -35.59 77.91 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 64.13 109.779 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.404 ' HB3' HG21 ' C' ' 78' ' ' VAL . 10.6 t -68.65 -31.39 70.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.884 0.473 . . . . 65.41 111.351 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.43 HD13 HG23 ' C' ' 64' ' ' VAL . 63.3 mt -74.32 -47.92 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 74.15 110.162 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.4 m -63.48 -28.92 70.29 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.063 0.545 . . . . 52.21 110.746 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.3 t -69.2 -46.75 66.68 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 123.861 0.865 . . . . 53.53 109.559 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.569 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.58 -39.9 89.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.214 1.005 . . . . 71.51 112.256 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.6 t -67.71 -38.78 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.95 0.9 . . . . 72.11 110.254 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 40.4 t -65.22 -37.66 87.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.564 -0.744 . . . . 74.43 111.069 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.5 mtt-85 -68.64 -35.89 77.87 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.247 -0.888 . . . . 70.21 109.469 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.55 1.91 80.46 Favored Glycine 0 C--N 1.354 1.54 0 O-C-N 123.801 0.688 . . . . 74.44 113.339 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' D' ' 17' ' ' TYR . 69.7 p 55.53 60.99 3.04 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.746 1.618 . . . . 33.51 111.853 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.46 ' HB2' HG13 ' C' ' 118' ' ' VAL . 86.7 m-85 -124.04 163.76 33.64 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 124.89 1.276 . . . . 74.02 108.822 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 97.2 Cg_endo -74.33 -169.26 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.948 2.432 . . . . 72.22 113.484 -174.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.413 ' HB3' ' OD1' ' C' ' 127' ' ' ASN . 21.0 mm-40 -54.41 112.02 0.91 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.059 -0.973 . . . . 71.34 111.591 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.462 HD11 HG11 ' C' ' 64' ' ' VAL . 3.1 tm? -108.07 87.01 2.4 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.426 -2.064 . . . . 72.05 105.426 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' C' ' 125' ' ' GLN . 12.1 m120 -95.31 97.53 9.92 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.311 -0.996 . . . . 54.23 108.311 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.516 HD23 ' H ' ' C' ' 129' ' ' ALA . 1.2 tt -63.6 149.21 46.93 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.205 -0.907 . . . . 73.42 108.99 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.516 ' H ' HD23 ' C' ' 128' ' ' LEU . . . -49.54 153.09 2.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.68 1.192 . . . . 74.53 112.76 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.11 -158.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.417 2.745 . . . . 62.21 114.959 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . 0.581 ' HB ' HD21 ' C' ' 104' ' ' ASN . 20.5 m -93.94 155.19 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.838 0.828 . . . . 71.12 112.493 -168.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -69.83 110.62 5.07 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 113.776 -1.556 . . . . 64.43 110.936 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -44.54 -34.49 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.371 1.468 . . . . 70.41 114.305 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 CA--C 1.552 1.039 0 N-CA-C 112.197 0.443 . . . . 73.52 112.197 -176.027 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.458 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 7.1 ttp . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 113.602 0.964 . . . . 63.01 113.602 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 60.0 m -131.02 130.53 43.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 44.22 108.827 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.1 t80 -149.11 104.31 3.41 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.278 -1.008 . . . . 73.4 108.278 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -119.23 127.5 53.33 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.456 0.702 . . . . 65.2 109.732 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.25 117.52 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 108.529 -0.915 . . . . 73.1 108.529 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -95.4 -46.99 6.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.137 0.575 . . . . 71.32 112.429 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -164.6 134.29 3.81 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.741 0.246 . . . . 73.01 111.165 -168.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.438 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.8 mp -118.64 130.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.673 -1.232 . . . . 73.33 107.673 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.413 ' HB3' HG23 ' C' ' 122' ' ' THR . 39.7 p90 -168.34 150.24 5.16 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.883 0.849 . . . . 54.14 112.115 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -81.9 123.07 28.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.837 -1.074 . . . . 72.44 109.388 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.4 mtpt -92.47 -20.34 21.08 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 110.199 -0.297 . . . . 54.02 110.199 174.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.7 t70 -155.41 134.62 12.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.412 -0.813 . . . . 65.02 108.841 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.569 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.8 mt -139.79 148.56 22.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 124.807 1.243 . . . . 75.02 107.865 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.26 141.5 23.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.934 0.893 . . . . 72.24 109.284 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -153.29 132.76 12.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.811 -1.922 . . . . 74.41 105.811 171.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -135.23 145.25 47.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.69 0.796 . . . . 60.23 109.136 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -146.81 71.45 12.48 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.252 -1.018 . . . . 72.14 108.252 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.8 -26.08 19.49 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.683 2.255 . . . . 74.43 112.609 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.51 ' O ' HG23 ' D' ' 31' ' ' VAL . 28.8 m-20 -115.11 23.11 12.77 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.927 0.891 . . . . 35.42 109.629 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -48.04 -54.93 20.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 115.783 1.772 . . . . 71.45 115.783 -168.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' D' ' 32' ' ' PHE . 51.9 Cg_endo -76.1 -16.97 17.57 Favored 'Trans proline' 0 C--N 1.384 2.417 0 CA-C-N 121.162 1.451 . . . . 70.3 112.469 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.7 t-160 -77.18 -30.49 54.88 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.514 1.525 . . . . 71.51 109.782 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.7 t -77.26 -27.81 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.2 0.6 . . . . 64.52 110.384 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' D' ' 29' ' ' PRO . 18.4 m-30 -66.05 -21.08 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.74 0.416 . . . . 74.43 111.381 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 75.7 mt-30 -64.71 -33.46 76.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.495 0.718 . . . . 64.14 110.439 174.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.18 100.35 12.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.144 -1.058 . . . . 71.51 108.144 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.4 63.26 3.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.985 0.914 . . . . 40.44 111.532 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -143.62 160.11 41.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.444 -0.576 . . . . 71.41 109.444 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -81.52 107.08 7.09 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.784 1.234 . . . . 71.34 108.736 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.465 ' HA ' HD13 ' D' ' 68' ' ' LEU . 35.8 Cg_exo -44.28 151.41 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 124.204 3.269 . . . . 72.1 116.392 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' D' ' 67' ' ' SER . 7.6 tm-20 -61.44 138.32 58.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.222 -1.354 . . . . 71.23 110.226 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 106.24 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 122.603 0.361 . . . . 74.12 110.329 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -98.99 142.5 30.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 167.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.682 HD11 HD21 ' D' ' 128' ' ' LEU . 2.7 mm? -120.08 122.17 40.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.157 0.583 . . . . 63.34 109.438 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.785 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.0 m-20 -107.23 130.9 54.67 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.219 -1.4 . . . . 73.01 107.219 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.38 147.97 39.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.152 0.581 . . . . 72.43 110.638 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 28.5 t70 -164.98 154.32 12.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.265 1.026 . . . . 71.01 108.773 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -142.11 162.4 35.58 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.456 0.702 . . . . 71.51 109.432 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.43 163.34 40.12 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.776 0.83 . . . . 44.02 109.114 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -154.17 153.7 32.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.859 0.463 . . . . 73.34 109.918 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.4 p -150.28 146.67 26.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.987 0.915 . . . . 72.15 109.248 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -90.67 119.05 30.59 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.669 -0.863 . . . . 72.2 108.669 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -92.0 -31.47 15.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.073 0.549 . . . . 62.22 109.772 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.21 -170.21 1.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.063 0.945 . . . . 74.13 110.63 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.45 116.27 7.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.449 0.7 . . . . 63.04 110.374 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.91 17.21 9.82 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.475 1.11 . . . . 53.33 112.237 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.7 t -116.0 118.64 59.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 172.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.693 ' HB2' HD13 ' D' ' 86' ' ' ILE . 87.5 m-85 -136.45 130.1 32.12 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.55 -0.907 . . . . 61.13 108.55 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.0 tt0 -91.15 125.86 36.06 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.586 1.154 . . . . 62.41 109.629 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.74 125.59 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.085 -0.709 . . . . 71.43 109.085 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 60.9 t -104.96 133.85 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 74.15 109.428 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.78 125.43 53.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.584 -1.265 . . . . 53.23 107.584 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.0 ttm180 -104.95 102.49 12.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.009 -0.737 . . . . 73.24 109.009 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.19 118.01 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.821 -1.177 . . . . 72.44 107.821 168.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -116.96 136.32 53.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.992 0.517 . . . . 65.34 109.634 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.434 HG23 HD13 ' D' ' 114' ' ' ILE . 54.8 t -115.64 115.96 50.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.193 0.997 . . . . 74.33 109.141 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.0 m -103.19 115.95 31.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.846 -1.168 . . . . 73.34 107.846 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.62 54.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 64.44 110.065 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 74.1 p -139.27 146.34 40.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.654 0.782 . . . . 75.42 109.006 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' D' ' 38' ' ' PRO . 16.7 tp -134.76 106.05 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.535 -0.913 . . . . 52.33 108.535 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.16 -114.99 4.59 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.577 -0.738 . . . . 13.21 111.691 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 4.56 14.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.654 0.781 . . . . 73.42 110.2 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -123.53 162.55 22.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.492 0.717 . . . . 65.14 110.583 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.07 129.03 37.54 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.67 0.606 . . . . 75.43 109.888 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.3 -58.9 2.56 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.436 0.694 . . . . 64.14 109.452 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -161.33 166.14 27.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.64 -1.164 . . . . 75.12 109.21 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 95.4 mt -126.8 153.09 46.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.402 1.081 . . . . 71.35 108.271 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.41 144.99 17.39 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.063 0.545 . . . . 55.3 109.719 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.21 135.61 11.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.888 0.875 . . . . 73.43 109.151 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.72 114.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.515 -0.55 . . . . 65.33 109.515 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.5 mt-30 -90.48 87.02 6.6 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.041 0.924 . . . . 73.54 109.397 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.77 96.71 6.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.558 -1.655 . . . . 75.42 109.146 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.83 144.1 20.96 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.37 -0.692 . . . . 35.51 111.37 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.24 4.57 Favored Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 110.603 -0.999 . . . . 71.45 110.603 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -87.69 123.83 40.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.214 -1.402 . . . . 74.14 107.214 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -127.12 164.26 22.0 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.062 0.945 . . . . 73.42 108.475 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.1 t -113.18 106.43 14.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.904 -1.147 . . . . 73.34 107.904 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.693 HD13 ' HB2' ' D' ' 56' ' ' TYR . 3.6 mp -108.86 107.48 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.512 -0.922 . . . . 73.31 108.512 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -134.08 146.4 50.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.237 1.015 . . . . 70.15 109.583 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.13 -21.56 8.04 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 114.526 0.57 . . . . 44.13 114.526 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' D' ' 93' ' ' GLN . 12.1 tt -109.2 130.44 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.614 0.765 . . . . 74.22 108.99 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.64 -177.45 5.3 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.431 0.692 . . . . 75.1 111.673 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.53 -140.33 36.82 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.978 0.799 . . . . 72.13 113.408 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -81.43 -20.85 39.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.453 0.701 . . . . 74.31 111.437 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.481 ' HG3' HD11 ' D' ' 89' ' ' ILE . 7.2 tp60 -69.65 -40.24 76.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.189 0.596 . . . . 73.55 111.051 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.43 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 5.2 ppp? -69.34 -33.78 73.62 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.796 -0.446 . . . . 70.51 109.796 174.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.97 99.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.361 0.664 . . . . 75.25 110.812 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -72.32 -34.32 68.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.5 -0.773 . . . . 72.25 110.183 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.94 -36.73 85.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.342 0.657 . . . . 63.03 111.124 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.624 HD21 HG12 ' D' ' 86' ' ' ILE . 31.5 mt -80.17 -23.2 41.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.976 0.51 . . . . 62.4 111.013 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.75 -2.35 55.23 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.697 -0.502 . . . . 63.13 113.736 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.13 -60.43 0.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.617 0.709 . . . . 73.13 111.412 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.61 -40.99 66.05 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.942 0.497 . . . . 63.41 111.797 -171.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.472 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 68.8 m -69.26 -49.04 25.14 Favored Pre-proline 0 CA--C 1.559 1.313 0 CA-C-O 118.956 -0.545 . . . . 73.22 110.975 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.4 Cg_exo -52.13 -31.13 43.93 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.542 2.161 . . . . 43.22 114.566 168.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.66 -35.64 81.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.993 0.517 . . . . 74.11 110.755 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.19 -44.11 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.242 0.617 . . . . 62.4 110.251 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.8 -20.24 58.35 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.341 -0.845 . . . . 43.02 112.027 -172.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -65.48 -48.03 67.26 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.459 0.911 . . . . 74.33 113.459 -171.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.48 -34.01 88.06 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.884 1.722 . . . . 53.24 112.821 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.27 -35.68 47.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.863 0.865 . . . . 73.13 111.816 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.69 76.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.286 0.634 . . . . 72.05 109.963 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.4 HH12 ' HG3' ' D' ' 130' ' ' PRO . 14.4 ptt180 -75.11 -31.63 61.19 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.958 -1.019 . . . . 64.52 110.784 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.98 -49.71 75.01 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.007 0.817 . . . . 63.32 110.305 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.81 -40.47 84.22 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.853 0.72 . . . . 75.13 110.517 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.503 HG12 ' SG ' ' D' ' 76' ' ' CYS . 64.9 mt -57.58 -53.18 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 123.794 0.684 . . . . 44.45 110.236 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.465 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.0 m -57.62 -45.79 84.95 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 124.26 1.024 . . . . 74.14 111.17 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -64.31 -41.04 97.02 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.636 -1.166 . . . . 65.21 110.138 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -69.02 -33.53 73.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.111 0.565 . . . . 72.13 111.587 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' D' ' 114' ' ' ILE . 53.3 t -64.11 -46.76 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 O-C-N 123.823 0.702 . . . . 55.24 110.203 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.7 p -71.16 -29.46 65.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.617 0.367 . . . . 62.41 110.858 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.7 mtt-85 -70.55 -30.29 66.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.653 0.781 . . . . 71.35 110.1 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.63 7.16 81.98 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 123.724 0.64 . . . . 74.11 112.834 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 56.76 28.69 14.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.395 1.878 . . . . 71.43 113.262 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.74 158.59 34.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.883 0.873 . . . . 73.5 110.137 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.76 127.33 25.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.008 2.472 . . . . 65.21 112.932 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.465 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.0 tt0 -51.26 130.61 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.611 1.195 . . . . 71.01 112.201 -175.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.1 tp -115.19 100.89 8.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.63 0.372 . . . . 64.33 110.292 -176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -99.61 112.51 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.351 -1.352 . . . . 73.45 107.351 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.682 HD21 HD11 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -74.37 135.85 42.45 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 123.42 0.45 . . . . 75.35 110.592 -171.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.17 123.05 58.26 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 124.467 1.104 . . . . 60.51 110.933 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.4 ' HG3' HH12 ' D' ' 111' ' ' ARG . 43.0 Cg_exo -57.4 129.87 36.22 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.321 2.014 . . . . 74.24 111.238 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 51.6 t -123.73 110.55 26.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 109.194 -0.669 . . . . 65.13 109.194 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -77.28 95.57 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.794 -1.188 . . . . 73.03 107.794 167.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.476 0.83 0 CA-C-N 115.641 -0.709 . . . . 73.12 111.159 -176.117 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.3 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.675 0.274 . . . . 65.42 110.387 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.93 137.26 34.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.478 1.111 . . . . 74.12 108.394 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -160.69 136.76 8.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.269 0.227 . . . . 55.31 110.838 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.8 mp -69.18 114.48 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.077 -1.083 . . . . 73.24 108.077 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -95.29 -30.07 14.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.138 0.575 . . . . 71.54 111.176 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -166.03 148.41 7.17 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.682 -0.488 . . . . 73.35 109.682 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.45 HG12 ' HG3' ' C' ' 130' ' ' PRO . 2.5 pp -141.03 139.05 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.726 -1.213 . . . . 74.13 107.726 171.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 42.1 p90 -176.97 176.16 1.47 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.566 0.698 . . . . 74.24 110.949 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -99.73 111.07 23.43 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.042 0.937 . . . . 64.41 109.241 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -76.01 -28.92 57.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.957 -0.386 . . . . 63.1 109.957 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.0 t70 -150.61 147.77 27.82 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.955 -0.566 . . . . 73.43 110.126 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.4 mt -138.72 145.39 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.477 1.511 . . . . 73.21 107.398 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -154.22 117.58 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.662 0.385 . . . . 64.33 110.457 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.699 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.1 t80 -124.44 116.32 22.34 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.353 -1.351 . . . . 74.41 107.353 172.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -119.67 128.17 53.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.433 -0.58 . . . . 74.34 109.433 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.56 76.61 48.15 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 108.546 -0.909 . . . . 61.43 108.546 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 -18.23 22.4 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.68 2.253 . . . . 72.21 112.024 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 64.6 m-20 -115.76 30.72 7.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.934 0.893 . . . . 75.35 108.962 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -58.12 -46.33 99.68 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.864 0.866 . . . . 63.31 112.584 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 31.6 Cg_exo -62.92 -28.16 75.13 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.025 1.817 . . . . 62.4 113.21 169.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.1 m80 -73.13 -24.39 60.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.77 0.428 . . . . 75.04 111.327 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.41 -27.41 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 120.967 0.413 . . . . 61.2 110.819 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.593 ' HD2' HH11 ' B' ' 15' ' ' ARG . 81.9 t80 -74.86 -41.69 59.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.381 0.672 . . . . 72.01 110.239 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 30' ' ' HIS . 13.1 pt20 -80.3 -30.47 38.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.584 0.354 . . . . 50.44 111.556 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 3.8 mmmp? -82.36 156.85 24.0 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.883 0.873 . . . . 65.24 112.107 -176.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.59 140.4 54.41 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.473 -1.24 . . . . 74.13 110.757 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -88.24 63.92 7.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.634 0.731 . . . . 72.43 109.378 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -124.63 78.34 63.36 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.376 1.07 . . . . 73.42 108.819 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.87 167.2 24.14 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.985 2.457 . . . . 62.33 113.606 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -123.77 95.37 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.829 -1.545 . . . . 65.2 106.829 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.25 125.62 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.311 0.577 . . . . 75.54 110.391 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 35.5 mttp -120.85 114.77 22.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.391 1.077 . . . . 42.44 108.612 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.6 mt -111.1 107.26 16.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.734 -1.121 . . . . 73.44 108.778 -171.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -114.46 145.23 42.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.606 1.162 . . . . 61.42 110.128 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.48 153.23 48.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 72.13 110.605 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.468 ' O ' HD23 ' A' ' 60' ' ' LEU . 20.7 t70 -157.86 143.47 17.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.383 1.073 . . . . 55.43 109.014 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.1 m -126.62 135.08 50.74 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.672 0.789 . . . . 71.13 109.584 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.55 132.48 40.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.075 0.95 . . . . 43.0 109.842 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -91.35 153.26 20.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.104 0.478 . . . . 64.23 110.445 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 t -150.82 138.28 19.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.079 1.352 . . . . 71.24 108.262 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -113.75 124.34 52.03 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.44 -0.578 . . . . 61.35 109.44 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.15 -44.07 7.11 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.566 0.746 . . . . 72.53 110.393 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 -173.45 4.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.461 -0.791 . . . . 73.03 109.982 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -63.02 112.66 2.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.302 0.641 . . . . 55.4 109.773 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 65.02 8.9 5.03 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.858 1.263 . . . . 62.51 113.038 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.01 109.93 25.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.004 -1.109 . . . . 71.14 108.004 172.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -119.94 123.82 44.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.491 0.716 . . . . 75.15 109.579 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -97.5 131.54 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.609 -1.178 . . . . 70.0 108.641 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.53 129.63 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.938 -1.134 . . . . 64.24 107.938 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.8 t -104.49 132.57 50.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.534 -0.913 . . . . 73.05 108.534 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -108.85 110.18 21.48 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.715 -1.587 . . . . 73.35 106.715 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -103.29 102.67 12.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.808 0.843 . . . . 73.33 108.792 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.41 134.48 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 114.686 -1.143 . . . . 74.54 109.295 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.7 m -120.39 141.37 50.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.092 -0.707 . . . . 62.23 109.092 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -138.54 107.83 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.926 1.29 . . . . 72.41 108.321 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 19.2 m -102.22 146.05 28.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.316 -0.624 . . . . 74.41 109.316 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.17 120.28 15.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.492 0.717 . . . . 70.2 109.146 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 49.1 m -128.56 125.15 37.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.998 0.519 . . . . 75.44 110.008 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.71 85.16 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.75 0.786 . . . . 71.02 109.054 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.3 -118.65 5.14 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.283 -1.326 . . . . 63.4 111.359 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -87.89 -31.98 19.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 71.0 109.347 174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.15 133.77 35.52 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.67 0.788 . . . . 74.45 109.469 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.6 m -78.94 136.68 37.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.094 -0.335 . . . . 73.45 110.094 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -82.57 -60.55 2.15 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.496 0.718 . . . . 53.13 109.112 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -165.83 176.13 8.15 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.628 -1.169 . . . . 75.31 111.098 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -138.62 145.82 40.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.34 1.456 . . . . 72.13 108.139 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.1 m -135.89 140.37 44.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.928 0.891 . . . . 74.04 109.838 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -150.33 130.7 13.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.179 0.592 . . . . 72.45 109.652 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.82 119.86 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.171 0.589 . . . . 73.3 110.362 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -89.26 83.12 6.45 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.445 1.098 . . . . 74.54 108.523 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.415 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.7 tp-100 -76.49 94.39 3.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.279 -0.873 . . . . 72.14 109.443 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.93 144.16 17.93 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.772 -0.531 . . . . 73.42 111.772 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.86 124.18 2.77 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.811 -0.916 . . . . 62.23 110.811 -176.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.61 128.49 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.671 -0.863 . . . . 71.13 108.671 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -135.18 140.0 45.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.666 -0.864 . . . . 75.23 108.666 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.1 p -101.92 106.88 17.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 72.23 109.015 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.2 pt -125.19 131.55 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.335 0.654 . . . . 74.41 110.769 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.85 157.42 26.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.114 0.965 . . . . 73.5 110.207 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.16 64.86 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.067 -0.515 . . . . 61.04 114.383 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.63 145.48 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.643 0.721 . . . . 73.0 109.368 -177.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.9 tt0 -142.68 179.32 7.06 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.021 0.528 . . . . 74.53 109.956 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.73 -123.81 31.73 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 124.239 0.924 . . . . 72.01 114.738 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -74.86 -26.56 59.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 74.24 111.365 -172.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -65.72 -48.66 71.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.744 0.817 . . . . 64.5 110.063 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.463 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 39.8 ttp -79.71 -33.29 41.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.202 -1.363 . . . . 44.35 110.6 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.58 92.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.27 0.557 . . . . 72.52 109.956 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -55.13 -47.54 74.92 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.547 -1.206 . . . . 74.44 111.092 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 35.3 m -71.33 -33.22 69.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.741 1.015 . . . . 74.32 113.741 -172.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.3 mt -80.09 -30.09 39.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.809 0.443 . . . . 60.02 111.342 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.98 -17.61 31.92 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.633 -0.537 . . . . 31.42 114.292 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.52 -63.91 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.708 0.754 . . . . 62.0 112.614 -171.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.83 -56.39 12.42 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.085 0.954 . . . . 62.34 112.758 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.56 -48.62 12.05 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.315 -0.85 . . . . 72.42 113.113 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.3 -20.27 62.04 Favored 'Trans proline' 0 C--N 1.388 2.636 0 CA-C-N 121.111 1.432 . . . . 75.42 113.718 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.29 -42.8 92.72 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.017 0.527 . . . . 60.22 110.711 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -59.65 -41.85 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.97 0.89 . . . . 64.11 110.201 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.541 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.9 mt -74.99 -29.1 60.8 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 113.874 -1.512 . . . . 61.23 112.579 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.49 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 20.6 t80 -64.26 -45.17 78.46 Favored Pre-proline 0 CA--C 1.558 1.28 0 N-CA-C 114.866 1.432 . . . . 74.34 114.866 -167.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.88 -32.51 95.23 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 121.616 1.544 . . . . 70.34 113.046 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -79.73 -37.72 34.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.453 0.701 . . . . 74.11 112.349 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.19 71.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 110.01 -0.367 . . . . 53.22 110.01 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -53.51 -48.8 68.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.371 1.068 . . . . 44.35 110.102 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.26 -47.25 86.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.982 0.913 . . . . 62.2 111.613 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.546 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.3 t -60.37 -44.19 95.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 72.33 111.002 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 64' ' ' VAL . 15.3 mt -63.08 -51.79 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.31 1.044 . . . . 72.35 110.905 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.8 m -59.1 -36.4 75.08 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.258 1.023 . . . . 71.35 112.023 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.65 -39.72 80.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 75.43 110.115 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 46.5 mtm -63.08 -39.63 95.28 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.637 0.375 . . . . 74.51 110.533 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.88 -47.05 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.146 0.978 . . . . 74.02 111.207 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -72.61 -33.37 66.63 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.096 -0.502 . . . . 43.15 111.184 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.451 HH12 ' HG3' ' B' ' 112' ' ' GLU . 82.7 mtt-85 -69.39 -26.61 64.73 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.333 0.653 . . . . 71.41 110.138 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.61 1.07 88.7 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.683 -0.69 . . . . 75.52 112.861 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.4 m 69.56 18.14 7.78 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.392 1.077 . . . . 73.24 111.277 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.44 152.38 40.02 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 73.12 110.892 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.76 125.35 18.8 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.74 2.293 . . . . 63.21 112.0 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.548 ' HG3' HG23 ' A' ' 115' ' ' THR . 25.3 tt0 -50.34 136.66 19.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.859 1.264 . . . . 64.11 112.957 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.2 mt -125.61 104.62 8.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.837 0.855 . . . . 64.3 108.81 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -101.9 123.18 45.39 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.678 0.791 . . . . 50.25 109.103 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.49 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -73.4 120.44 19.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.909 -1.145 . . . . 75.51 107.909 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.09 129.07 85.92 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.864 0.727 . . . . 53.3 110.631 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.63 107.4 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.045 1.83 . . . . 75.25 111.741 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -98.96 110.84 27.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.51 -1.292 . . . . 64.11 107.51 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.12 82.04 8.54 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.437 -0.801 . . . . 55.24 109.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.22 -32.78 71.44 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.246 -1.343 . . . . 74.03 109.803 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 . . . . . 0 CA--C 1.545 0.761 0 C-N-CA 124.359 1.064 . . . . 62.4 111.606 173.881 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.8 ptm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 112.494 0.553 . . . . 65.24 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.415 HG22 ' HB3' ' B' ' 87' ' ' ALA . 15.2 t -155.61 143.54 19.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.082 -0.71 . . . . 65.12 109.082 170.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -139.45 113.28 8.61 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.158 -1.052 . . . . 74.2 108.158 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 22.8 tt0 -133.11 139.76 47.29 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.487 0.715 . . . . 73.4 109.469 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.6 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -89.83 116.04 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.183 -1.043 . . . . 45.44 108.183 170.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 72.5 mt-30 -77.63 -40.83 40.58 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.753 -0.462 . . . . 64.23 109.753 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.593 HH11 ' HD2' ' A' ' 32' ' ' PHE . 18.6 ttt180 -166.42 137.89 3.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 65.2 108.846 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 57.8 mt -114.39 139.23 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 106.986 -1.487 . . . . 73.14 106.986 170.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -168.19 146.57 4.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.762 0.71 . . . . 71.42 112.298 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -73.35 120.83 19.51 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.655 -1.157 . . . . 64.2 108.711 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -96.44 -26.59 15.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.443 0.697 . . . . 74.53 111.242 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -161.26 141.74 11.04 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.055 0.222 . . . . 62.42 110.924 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -138.3 141.69 37.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 125.024 1.33 . . . . 53.25 109.035 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 35.0 t -140.12 124.22 17.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.166 -1.42 . . . . 63.44 107.166 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -138.61 111.41 7.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.396 -1.335 . . . . 75.32 107.396 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.98 117.51 29.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.671 -0.863 . . . . 74.04 108.671 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 84.68 6.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.492 -1.299 . . . . 72.33 107.492 168.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.63 -26.92 11.25 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.829 2.353 . . . . 54.53 112.649 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 1.8 m-20 -110.96 20.24 17.69 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 64.41 109.438 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.584 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.01 -60.52 1.65 Allowed Pre-proline 0 CA--C 1.574 1.89 0 C-N-CA 126.368 1.867 . . . . 25.12 114.931 -169.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 51.1 Cg_endo -85.0 -1.86 9.49 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.26 1.973 . . . . 61.41 113.57 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -96.74 -38.21 9.99 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 73.14 110.505 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.5 p -79.33 -14.16 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.478 -0.783 . . . . 52.34 110.114 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.06 -34.56 44.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.676 1.19 . . . . 73.2 111.798 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -73.15 -15.94 61.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.068 0.947 . . . . 75.13 112.028 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.593 ' HD3' HD12 ' B' ' 68' ' ' LEU . 89.6 mttt -105.52 109.37 21.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.148 0.979 . . . . 65.34 110.481 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.27 83.63 5.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.367 0.667 . . . . 62.25 110.407 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.572 ' HE3' HD11 ' B' ' 68' ' ' LEU . 3.6 m-90 -153.43 161.75 41.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.492 1.117 . . . . 74.21 109.378 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.31 119.94 73.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.207 -1.034 . . . . 73.3 108.207 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.14 167.72 26.04 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.787 2.325 . . . . 54.4 113.684 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.66 103.39 4.23 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.955 -1.128 . . . . 61.55 107.955 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.425 HG21 HD21 ' B' ' 126' ' ' LEU . 27.4 m -100.88 127.78 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.206 0.602 . . . . 74.2 110.261 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -106.63 124.6 49.85 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.608 -0.886 . . . . 64.41 108.608 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 mt -92.25 124.79 36.58 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.037 -1.098 . . . . 72.4 108.037 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.0 t70 -136.23 151.89 50.16 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 107.996 -1.113 . . . . 75.31 107.996 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.57 169.41 17.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.184 0.516 . . . . 54.04 111.674 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.9 t70 -159.39 142.72 14.49 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.755 1.222 . . . . 73.23 108.432 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 6.5 t -109.29 118.7 37.38 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.765 -0.828 . . . . 61.24 108.765 174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.73 151.3 37.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 42.12 108.553 172.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -145.43 163.75 33.67 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 122.927 0.491 . . . . 63.42 110.511 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -157.83 136.54 11.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.679 1.191 . . . . 72.25 108.148 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -93.79 127.02 39.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.926 0.49 . . . . 74.42 110.032 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 -40.32 14.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.215 -0.661 . . . . 33.15 109.215 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.49 -178.83 5.13 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.779 1.232 . . . . 74.33 108.851 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -72.45 134.51 45.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.876 -0.787 . . . . 73.43 108.876 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.3 m-20 73.64 -3.87 2.38 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.404 1.481 . . . . 63.21 111.808 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.38 84.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.993 -1.114 . . . . 63.34 107.993 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.39 138.95 46.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.949 -0.759 . . . . 71.3 108.949 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -115.04 110.0 18.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.829 -1.174 . . . . 71.22 107.829 -172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' B' ' 98' ' ' LEU . 67.0 t -104.55 128.83 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.988 0.515 . . . . 71.11 110.187 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 39.6 t -102.37 119.91 51.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.538 1.135 . . . . 71.4 109.466 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -92.89 111.67 23.37 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.166 -1.42 . . . . 72.14 107.166 172.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.6 ttt180 -100.18 125.38 46.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.009 -0.737 . . . . 73.33 109.009 175.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.697 HG11 HD11 ' B' ' 128' ' ' LEU . 15.4 t -119.58 127.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.856 -0.794 . . . . 72.01 108.856 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 86.1 m -104.04 141.05 36.87 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.57 0.544 . . . . 54.32 110.11 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.71 HG21 HG21 ' B' ' 114' ' ' ILE . 53.0 t -133.3 122.18 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.491 1.116 . . . . 74.14 108.549 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -117.36 146.17 43.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.744 . . . . 63.23 108.993 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -145.0 133.41 21.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.755 -0.832 . . . . 71.52 108.755 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 63.6 p -138.52 136.34 36.0 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 122.877 0.471 . . . . 70.42 110.207 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.593 HD12 ' HD3' ' B' ' 34' ' ' LYS . 0.3 OUTLIER -110.44 107.86 17.67 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.891 -1.152 . . . . 52.24 107.891 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.33 -111.37 3.24 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 123.662 0.601 . . . . 34.15 112.755 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.87 2.46 23.47 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.216 0.606 . . . . 65.34 111.042 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 11.9 pt-20 -135.71 170.46 15.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.989 0.516 . . . . 73.44 110.441 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.1 m -71.84 143.57 49.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 73.25 110.334 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -98.4 -58.77 1.89 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.919 0.888 . . . . 74.21 109.07 173.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -161.04 164.34 30.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.313 -0.858 . . . . 74.34 110.353 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.26 141.59 45.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.911 1.284 . . . . 75.14 107.646 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.74 154.59 38.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.076 0.55 . . . . 62.43 109.87 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.2 tt0 -164.96 133.88 3.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.7 -0.852 . . . . 75.03 108.7 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.8 t -127.25 145.41 34.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.68 -0.859 . . . . 55.25 108.68 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -122.98 93.09 3.85 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.744 -0.835 . . . . 74.24 108.744 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -84.69 100.43 11.47 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.601 -0.889 . . . . 71.13 108.601 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 173.5 40.1 Favored Glycine 0 C--O 1.245 0.788 0 N-CA-C 111.775 -0.53 . . . . 72.32 111.775 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.5 133.2 2.71 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.697 -0.561 . . . . 44.43 111.697 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 36.7 mt -85.85 131.12 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.373 -0.973 . . . . 74.15 108.373 172.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.54 152.85 48.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.068 0.947 . . . . 72.42 109.626 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 14.8 m -123.59 105.05 9.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.052 0.941 . . . . 73.21 108.894 -172.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.62 HG21 HD11 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -134.46 141.89 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.101 0.56 . . . . 63.23 112.053 -169.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.415 ' HB3' HG22 ' B' ' 10' ' ' THR . . . -149.05 167.69 25.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.399 1.08 . . . . 74.42 109.734 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.75 -62.45 4.38 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.609 0.568 . . . . 61.01 112.328 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.5 pp -68.62 145.58 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.922 0.889 . . . . 75.12 111.992 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.33 175.52 13.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 71.55 110.45 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -122.26 29.23 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.883 0.74 . . . . 65.53 113.536 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -70.8 -33.59 70.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.889 0.875 . . . . 74.43 110.878 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.23 -29.86 61.91 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.274 -0.876 . . . . 73.33 110.779 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.429 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 0.3 OUTLIER -71.07 -43.9 66.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.552 0.741 . . . . 41.21 109.199 173.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.52 66.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.041 -0.981 . . . . 61.25 111.769 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.43 -38.56 65.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.979 0.512 . . . . 73.33 110.212 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.57 -59.14 2.87 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.368 -0.833 . . . . 75.53 110.83 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' B' ' 58' ' ' VAL . 6.1 mp -87.37 -14.05 41.76 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.756 0.651 . . . . 63.0 112.756 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.09 -37.15 8.5 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 120.151 -0.25 . . . . 13.01 112.668 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.15 -48.09 3.14 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.495 0.648 . . . . 63.14 111.841 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -79.38 -42.36 25.72 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.119 0.415 . . . . 75.33 112.119 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.644 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 96.6 m -61.19 -47.74 93.73 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.43 -0.795 . . . . 74.22 111.746 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -53.44 -35.2 74.87 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.03 1.82 . . . . 72.24 114.601 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.76 -33.2 75.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 118.173 0.442 . . . . 62.25 110.95 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.03 -47.11 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.071 0.948 . . . . 73.33 110.554 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' B' ' 60' ' ' LEU . 78.4 mt -78.82 -19.31 52.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.135 -0.938 . . . . 51.43 112.196 -172.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.523 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 66.6 t80 -62.92 -45.73 87.22 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.886 1.069 . . . . 71.12 113.886 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.25 -38.78 93.47 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 121.96 1.773 . . . . 75.43 113.352 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.442 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 77.2 m-85 -68.05 -45.55 73.58 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.091 0.556 . . . . 75.4 110.671 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -43.74 97.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.376 -0.829 . . . . 73.1 110.545 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -56.71 -54.79 42.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.31 1.444 . . . . 75.23 110.929 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.451 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.9 tp10 -59.26 -41.02 87.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.492 1.117 . . . . 63.41 111.018 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.8 t -68.78 -39.36 80.22 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.655 -0.248 . . . . 74.41 111.262 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.71 HG21 HG21 ' B' ' 64' ' ' VAL . 89.4 mt -62.58 -54.69 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.054 0.542 . . . . 61.53 109.79 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 39.2 m -61.78 -30.1 70.58 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 124.108 0.88 . . . . 65.51 111.526 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.6 t -67.06 -45.76 76.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.401 0.681 . . . . 74.35 110.483 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.4 mmt -67.98 -37.01 81.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.492 0.317 . . . . 64.41 110.739 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.18 -41.09 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.941 0.896 . . . . 63.31 110.195 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.444 ' OG ' HG21 ' C' ' 115' ' ' THR . 36.9 t -65.16 -34.99 79.7 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.807 -1.088 . . . . 60.3 111.248 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.546 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 85.5 mtt-85 -68.59 -28.43 66.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.207 0.603 . . . . 72.04 111.11 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.43 9.58 61.23 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.703 0.627 . . . . 75.54 112.623 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 77.0 p 52.53 55.07 9.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.99 1.716 . . . . 55.31 112.531 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -107.52 161.22 23.85 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-N 115.63 -0.714 . . . . 63.15 110.257 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.26 -167.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 123.312 2.675 . . . . 45.22 114.046 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.737 ' HB3' ' HA ' ' C' ' 124' ' ' PRO . 29.0 pt20 -62.76 122.65 16.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.217 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.425 HD21 HG21 ' B' ' 40' ' ' VAL . 1.1 tm? -151.28 81.77 1.31 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.758 -0.83 . . . . 71.11 108.758 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.13 135.96 36.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.742 0.817 . . . . 73.14 108.887 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.697 HD11 HG11 ' B' ' 62' ' ' VAL . 0.9 OUTLIER -64.55 131.33 46.73 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 123.969 0.793 . . . . 73.21 109.005 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 146.09 87.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.506 0.722 . . . . 75.21 110.858 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.22 108.74 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.016 2.477 . . . . 75.42 113.218 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.72 123.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.621 0.768 . . . . 74.21 110.171 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -87.22 92.54 9.1 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.384 0.674 . . . . 73.02 110.005 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -62.47 -41.48 98.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.306 -0.861 . . . . 61.5 109.754 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.6 -35.16 73.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.415 -1.72 . . . . 60.15 112.015 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.37 -49.78 45.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.433 0.693 . . . . 52.15 111.867 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 tt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 109.173 -0.677 . . . . 73.23 109.173 179.416 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 CA--C 1.55 0.962 0 CA-C-O 121.407 0.622 . . . . 73.52 112.588 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 55.0 m -85.1 98.06 10.22 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.151 -1.055 . . . . 73.33 108.151 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -108.67 129.0 55.34 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.345 -0.983 . . . . 72.23 108.345 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.414 HE21 ' NE2' ' C' ' 14' ' ' GLN . 29.9 tt0 -142.32 125.3 16.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.846 -0.428 . . . . 75.34 109.846 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.648 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -75.92 133.64 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 108.533 -0.914 . . . . 70.21 108.533 175.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.414 ' NE2' HE21 ' C' ' 12' ' ' GLN . 29.9 mm-40 -107.74 -48.73 3.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.231 0.612 . . . . 74.2 110.689 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -162.06 136.15 6.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.673 0.389 . . . . 64.12 110.16 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.648 HG13 HD11 ' C' ' 13' ' ' ILE . 88.3 mt -119.87 140.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.037 -1.097 . . . . 74.23 108.037 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.522 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 25.8 p90 -173.77 161.33 3.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.229 0.538 . . . . 74.3 110.968 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -82.66 112.92 19.97 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.161 -0.927 . . . . 71.34 109.387 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -74.28 -33.27 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.195 -0.669 . . . . 60.14 109.195 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -146.52 147.17 30.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.367 -0.833 . . . . 74.13 110.233 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.8 mt -146.3 145.87 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.993 1.717 . . . . 65.22 106.842 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -162.96 151.97 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 122.87 0.468 . . . . 43.13 110.117 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.14 108.35 3.41 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.492 -0.929 . . . . 61.23 108.492 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.18 118.73 33.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.794 0.837 . . . . 71.41 109.218 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.58 83.81 48.12 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.55 1.14 . . . . 64.22 108.411 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.88 -19.06 31.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.732 2.288 . . . . 74.22 111.775 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' C' ' 72' ' ' THR . 77.9 m-20 -117.69 38.61 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.169 0.987 . . . . 73.43 109.51 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.07 -47.24 98.93 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 123.586 0.754 . . . . 73.22 112.705 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.97 -14.64 38.98 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.788 1.659 . . . . 74.44 113.852 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -67.61 -23.91 65.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 119.186 -0.435 . . . . 74.41 111.984 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.59 -29.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.727 0.811 . . . . 52.14 112.523 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.464 ' HE1' HH11 ' D' ' 15' ' ' ARG . 38.2 m-85 -68.75 -41.44 78.89 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.229 0.612 . . . . 70.21 111.315 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.26 5.78 49.45 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.047 -0.979 . . . . 63.12 110.527 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.42 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.6 ttmp? -93.47 145.85 24.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.66 0.784 . . . . 74.24 110.403 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.44 132.07 34.62 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.861 -1.162 . . . . 64.31 107.861 172.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -74.99 78.48 2.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 122.312 1.053 . . . . 72.31 111.575 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.436 ' O ' HD13 ' C' ' 68' ' ' LEU . 38.0 tt0 -157.56 65.13 3.33 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 113.924 -1.489 . . . . 53.2 108.327 168.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.08 150.81 4.75 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.653 1.569 . . . . 72.34 111.254 169.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -86.32 96.06 9.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.522 -1.288 . . . . 72.31 107.522 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.53 98.35 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.474 1.131 . . . . 44.3 108.86 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -91.18 116.84 29.14 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.805 -1.543 . . . . 73.02 108.331 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.589 HD13 HD11 ' C' ' 128' ' ' LEU . 30.1 tp -84.24 144.12 29.13 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.374 -0.973 . . . . 74.14 108.374 172.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.9 t70 -137.47 128.56 27.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.496 -1.298 . . . . 73.43 107.496 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.83 132.07 38.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.049 -0.723 . . . . 75.1 109.049 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -137.65 155.84 48.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.805 0.842 . . . . 72.54 109.009 174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -138.32 149.52 45.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.923 0.489 . . . . 62.22 109.921 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 167.59 21.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.768 0.827 . . . . 52.55 109.179 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.3 p -148.3 144.64 27.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.649 0.379 . . . . 72.23 111.062 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 75.9 p -147.66 145.77 29.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.062 0.945 . . . . 74.1 110.242 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -87.14 130.56 34.47 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.007 -0.738 . . . . 74.31 109.007 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.635 HD11 ' HB2' ' C' ' 57' ' ' GLU . 59.5 mt -106.37 -41.84 5.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.627 0.771 . . . . 61.34 109.944 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.18 -169.32 3.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.507 0.723 . . . . 45.32 110.736 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.83 108.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.132 -0.94 . . . . 55.22 109.396 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 52.1 m-20 69.97 -0.84 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.639 1.175 . . . . 61.34 113.269 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -96.68 113.95 32.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.533 0.733 . . . . 75.42 109.166 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.97 130.16 52.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.361 1.064 . . . . 74.32 108.71 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.635 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.6 tt0 -87.98 143.9 26.84 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.362 -0.835 . . . . 72.34 108.817 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.454 HG13 HD11 ' C' ' 106' ' ' LEU . 2.6 p -125.46 124.6 67.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.557 -0.905 . . . . 74.25 108.557 169.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.85 104.69 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.578 -1.267 . . . . 74.1 107.578 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.49 100.85 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.974 0.91 . . . . 73.34 108.759 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -81.65 124.15 29.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.573 0.749 . . . . 73.4 110.237 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.26 126.56 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.531 -1.285 . . . . 72.41 107.531 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.5 m -128.59 128.79 44.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.899 -0.778 . . . . 74.33 108.899 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.666 HG23 HD13 ' C' ' 114' ' ' ILE . 88.5 t -110.71 110.16 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.664 -0.865 . . . . 53.42 108.664 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.403 HG23 HD23 ' C' ' 75' ' ' LEU . 8.8 m -99.34 110.29 22.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.85 -0.796 . . . . 73.14 108.85 173.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.22 99.97 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.488 -1.301 . . . . 73.44 107.488 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -146.65 156.45 43.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.647 0.592 . . . . 50.53 109.865 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.436 HD13 ' O ' ' C' ' 37' ' ' GLN . 53.7 tp -111.8 80.18 1.29 Allowed 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.767 -1.568 . . . . 73.3 106.767 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.91 -96.2 0.18 Allowed Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.903 -1.044 . . . . 72.11 112.339 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -91.13 -31.94 16.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.847 0.859 . . . . 74.32 111.221 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.42 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 13.2 tp10 -87.22 93.13 9.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.652 0.781 . . . . 53.32 110.281 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 60.8 m -84.72 130.44 34.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.826 -0.624 . . . . 75.34 111.038 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.36 -55.76 4.67 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.028 0.931 . . . . 63.4 109.863 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -157.37 170.73 21.8 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.408 0.623 . . . . 74.12 111.721 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.403 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -143.51 111.5 6.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.723 -1.584 . . . . 64.42 106.723 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.8 t -111.02 143.98 40.86 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.981 -0.748 . . . . 74.32 108.981 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -147.55 117.8 7.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.203 0.601 . . . . 75.33 109.621 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.87 114.99 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.787 1.235 . . . . 74.32 109.234 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -94.16 102.62 14.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.141 -0.689 . . . . 70.24 109.141 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.622 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.1 tp-100 -87.56 109.4 19.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.471 0.708 . . . . 70.2 109.34 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.62 146.88 20.26 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.617 -0.593 . . . . 70.33 111.617 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.46 117.36 1.27 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.569 -0.613 . . . . 71.54 111.569 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' C' ' 51' ' ' LEU . 12.8 mm -83.01 126.09 40.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.614 -0.884 . . . . 63.42 108.614 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -140.62 138.33 34.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.649 0.38 . . . . 71.42 110.114 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -94.54 117.75 30.61 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.8 pp -116.12 142.06 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 122.72 0.408 . . . . 52.21 110.113 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -155.86 155.82 33.59 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.219 0.608 . . . . 75.41 110.443 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -45.81 3.32 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.195 -0.457 . . . . 70.4 112.556 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -88.7 151.03 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.8 0.84 . . . . 63.22 109.09 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.9 -179.45 7.66 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.858 0.463 . . . . 72.33 109.811 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 58.23 -137.33 50.1 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 115.268 0.867 . . . . 73.24 115.268 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -72.2 -20.09 61.63 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 73.45 112.39 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -80.12 -38.77 30.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.23 0.212 . . . . 65.44 110.863 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 16.9 ptt? -70.21 -31.81 69.41 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.443 -0.577 . . . . 72.04 109.443 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.07 71.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.474 -0.785 . . . . 64.01 110.433 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -61.67 -49.17 77.59 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.459 0.474 . . . . 75.13 110.173 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.96 -48.86 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.51 0.506 . . . . 73.45 110.478 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.69 -16.35 63.33 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.613 0.765 . . . . 63.23 111.38 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.0 10.8 20.62 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-O 119.622 -0.544 . . . . 73.31 114.279 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.15 -61.11 0.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.703 0.751 . . . . 64.35 111.02 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.4 -56.68 6.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.707 0.403 . . . . 61.13 111.673 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 60.7 m -56.81 -46.95 99.8 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.59 0.756 . . . . 63.3 111.951 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 92.1 Cg_exo -53.32 -38.35 82.06 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 122.512 2.141 . . . . 64.43 114.923 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -63.4 -36.44 83.75 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 123.81 0.844 . . . . 65.31 110.506 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.68 -40.21 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.586 0.755 . . . . 73.51 110.414 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.454 HD11 HG13 ' C' ' 58' ' ' VAL . 64.2 mt -85.72 -26.12 26.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.565 -1.198 . . . . 40.14 112.096 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -55.52 -47.58 98.32 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 113.809 1.04 . . . . 73.24 113.809 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.32 -40.43 82.02 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.277 1.984 . . . . 54.51 113.612 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -65.7 -43.37 89.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.165 0.586 . . . . 73.44 110.374 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.622 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -69.5 -33.74 73.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.414 -0.812 . . . . 73.51 111.241 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -64.98 -47.36 77.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 74.14 110.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -71.92 -33.0 67.92 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.695 -0.684 . . . . 73.02 109.552 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 47.9 t -69.12 -31.15 69.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.234 0.614 . . . . 72.1 111.089 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.666 HD13 HG23 ' C' ' 64' ' ' VAL . 63.3 mt -72.62 -51.52 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.04 0.536 . . . . 71.22 109.762 171.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.444 HG21 ' OG ' ' B' ' 119' ' ' SER . 39.9 m -61.73 -31.08 71.22 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.815 0.446 . . . . 73.33 111.143 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -60.18 -54.31 47.41 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.181 0.992 . . . . 62.21 108.995 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.423 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.82 -42.32 79.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.031 1.333 . . . . 65.24 112.475 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 85.5 t -66.02 -40.85 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 52.21 109.924 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -73.75 -24.04 59.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.935 -1.03 . . . . 73.14 111.645 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.3 mtt-85 -74.1 -40.06 62.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.254 -0.647 . . . . 64.11 109.254 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -1.24 65.31 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.824 0.703 . . . . 64.14 112.229 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 37.5 p 63.73 25.8 14.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.869 2.067 . . . . 53.53 112.83 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.12 158.77 63.8 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.049 0.94 . . . . 71.12 108.538 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' B' ' 125' ' ' GLN . 36.3 Cg_endo -61.25 151.32 79.89 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.799 2.333 . . . . 74.31 114.206 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -56.55 112.05 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.084 1.354 . . . . 60.12 111.761 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.06 90.15 3.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.524 -1.287 . . . . 62.01 107.524 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -91.31 110.38 21.68 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.527 -0.916 . . . . 62.54 108.527 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.589 HD11 HD13 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -77.19 134.17 38.72 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.095 0.958 . . . . 74.34 110.316 -171.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.79 144.96 83.61 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.252 1.021 . . . . 75.02 111.846 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.45 ' HG3' HG12 ' A' ' 16' ' ' ILE . 93.1 Cg_endo -78.54 104.13 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.816 2.344 . . . . 70.15 112.895 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.62 107.73 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.111 -1.441 . . . . 63.21 107.111 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -105.64 98.02 7.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.081 0.552 . . . . 70.35 109.803 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -67.1 -36.95 83.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.432 0.693 . . . . 64.04 110.1 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 CA--C 1.535 0.374 0 CA-C-N 114.449 -1.25 . . . . 74.52 111.702 -179.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 113.518 0.932 . . . . 75.32 113.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 90.3 m -142.55 139.96 31.59 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.409 1.084 . . . . 72.34 108.326 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.452 ' CE2' ' SG ' ' D' ' 102' ' ' CYS . 79.5 t80 -155.01 101.09 2.24 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.529 -1.285 . . . . 72.01 107.529 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.23 122.7 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.88 0.472 . . . . 73.12 109.825 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.13 119.75 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 109.138 -0.69 . . . . 61.34 109.138 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.442 HE22 HG22 ' D' ' 55' ' ' VAL . 40.9 mt-30 -98.67 -46.46 5.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.574 0.35 . . . . 64.2 110.586 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.464 HH11 ' HE1' ' C' ' 32' ' ' PHE . 34.5 ttt180 -165.07 120.08 1.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.505 -0.183 . . . . 72.21 110.505 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -103.06 136.91 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.77 -1.196 . . . . 50.53 107.77 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -164.37 177.59 8.12 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.826 0.85 . . . . 74.04 110.763 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -107.5 127.56 53.72 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.738 -0.665 . . . . 62.42 110.013 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 27.4 mtpt -95.54 -30.99 13.54 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.529 -0.545 . . . . 62.12 109.529 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.782 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -144.61 134.9 24.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.834 -0.802 . . . . 74.22 108.834 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.524 HG23 HG22 ' D' ' 78' ' ' VAL . 27.1 mt -139.04 147.7 24.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.144 -1.428 . . . . 74.43 107.144 174.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -155.13 147.47 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.986 0.422 . . . . 73.12 110.351 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.623 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 67.8 t80 -150.06 127.89 11.76 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.16 1.384 . . . . 71.31 107.351 173.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -126.61 148.06 49.83 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.039 0.936 . . . . 74.32 108.974 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.25 84.03 61.14 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.816 -0.809 . . . . 55.15 108.816 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.24 -48.06 5.3 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.789 2.993 . . . . 65.42 114.195 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -111.87 45.57 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.885 -0.783 . . . . 74.22 108.885 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.522 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.79 -59.34 9.06 Favored Pre-proline 0 CA--C 1.575 1.928 0 N-CA-C 115.703 1.742 . . . . 62.41 115.703 -166.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.66 -4.45 10.73 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 122.545 1.945 . . . . 72.11 112.99 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -84.15 -35.62 23.47 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.332 1.053 . . . . 72.12 110.476 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 p -84.31 -13.29 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.394 0.616 . . . . 71.43 110.411 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -30.7 69.71 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.862 -0.608 . . . . 74.4 109.939 166.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -72.38 -6.28 42.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.444 1.098 . . . . 31.12 111.943 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.408 ' HZ1' ' HG2' ' D' ' 70' ' ' GLU . 93.9 mttt -125.41 87.13 2.65 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.379 1.072 . . . . 51.41 109.225 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -80.23 93.86 5.95 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.172 0.987 . . . . 63.52 110.425 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.38 170.98 20.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.314 1.046 . . . . 73.42 109.815 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' D' ' 124' ' ' PRO . 1.8 mp0 -80.59 107.37 7.12 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.191 -1.04 . . . . 62.22 108.191 166.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.63 153.92 76.25 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.945 2.43 . . . . 71.51 113.001 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.01 123.81 23.59 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.444 -0.947 . . . . 73.33 108.444 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.531 HG11 HD13 ' D' ' 126' ' ' LEU . 7.7 p -117.71 142.35 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.079 0.552 . . . . 74.52 110.283 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' D' ' 41' ' ' LYS . 11.4 mmpt? -109.77 123.83 50.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.344 1.058 . . . . 63.4 108.711 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.62 126.87 55.84 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.464 0.706 . . . . 75.23 110.566 -171.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -130.67 120.2 23.56 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.945 0.898 . . . . 62.25 109.168 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.629 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.8 pt? -108.48 132.56 53.69 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.219 -0.66 . . . . 42.32 109.219 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.449 ' O ' HD23 ' D' ' 60' ' ' LEU . 26.7 t70 -135.48 145.26 46.96 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.862 0.865 . . . . 64.11 108.967 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -123.59 155.58 37.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.852 0.834 . . . . 74.4 111.62 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.515 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.19 166.86 27.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 113.801 -1.545 . . . . 62.32 108.073 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.4 p -151.91 156.38 39.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.133 0.573 . . . . 70.23 109.568 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -158.51 119.03 3.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.774 0.83 . . . . 73.31 109.022 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.71 117.79 11.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.987 -0.746 . . . . 71.04 108.987 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.55 -36.38 17.61 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.306 -0.627 . . . . 74.1 109.306 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.84 -171.38 2.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 71.11 111.322 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -54.8 104.68 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.607 1.563 . . . . 55.45 111.371 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 58.33 20.65 7.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.19 0.996 . . . . 71.42 112.432 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.442 HG22 HE22 ' D' ' 14' ' ' GLN . 75.3 t -109.46 122.22 63.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 107.523 -1.288 . . . . 60.32 107.523 170.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -130.89 128.41 40.5 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.836 -0.801 . . . . 73.22 108.836 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -88.66 135.88 33.28 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.528 1.131 . . . . 72.4 108.464 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 81.3 t -117.87 139.83 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.34 -0.985 . . . . 71.23 108.34 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.6 t -115.78 141.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.237 -1.023 . . . . 41.15 108.237 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.36 118.61 24.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.287 -1.375 . . . . 73.04 107.287 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 4.3 tmm_? -107.28 97.86 7.57 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.963 -0.754 . . . . 53.31 108.963 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.02 125.74 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.876 -0.787 . . . . 74.04 108.876 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -113.1 144.43 42.65 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.691 0.796 . . . . 53.5 109.798 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.618 HG21 HG21 ' D' ' 114' ' ' ILE . 25.6 t -135.8 104.82 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.243 1.417 . . . . 62.14 108.367 -173.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 10.0 m -112.14 90.99 3.49 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.563 -1.273 . . . . 54.33 107.563 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.53 125.32 42.17 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.44 -0.578 . . . . 72.04 109.44 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.9 p -158.69 124.92 4.58 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.167 0.987 . . . . 71.55 109.539 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.85 130.07 43.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.556 -1.276 . . . . 74.32 107.556 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 -146.41 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.012 -0.54 . . . . 23.45 113.323 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . 0.408 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 10.5 pt-20 -88.03 11.11 16.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.207 1.003 . . . . 65.12 112.239 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.76 161.9 40.31 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.819 0.342 . . . . 63.43 111.428 -167.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -83.33 124.79 30.96 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.644 -0.707 . . . . 71.34 110.063 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.466 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -73.4 -63.84 1.11 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.125 0.97 . . . . 71.42 110.161 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -157.87 157.56 33.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.142 0.496 . . . . 64.13 111.065 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.96 146.62 47.45 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.408 1.083 . . . . 63.25 109.075 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -160.0 141.42 12.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.191 0.596 . . . . 65.14 110.334 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.41 122.34 5.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.374 -0.602 . . . . 71.52 109.374 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.524 HG22 HG23 ' D' ' 21' ' ' ILE . 47.8 t -124.48 123.95 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.446 0.698 . . . . 71.13 110.581 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.782 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.5 93.61 9.57 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.386 0.612 . . . . 74.33 109.396 164.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.69 109.88 14.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.979 -1.009 . . . . 74.44 108.371 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.69 149.37 19.1 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 111.735 -0.546 . . . . 64.4 111.735 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.479 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.22 130.52 4.02 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 110.885 -0.886 . . . . 62.53 110.885 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.77 126.34 41.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.022 -1.103 . . . . 74.24 108.022 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' D' ' 86' ' ' ILE . 49.3 m-85 -129.98 162.75 27.97 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.297 -0.631 . . . . 71.41 109.297 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -116.35 101.62 8.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.556 0.742 . . . . 71.24 109.354 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' D' ' 84' ' ' PHE . 3.8 mp -109.77 110.63 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.083 0.953 . . . . 64.32 110.097 -174.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.53 38.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.012 0.925 . . . . 74.53 109.829 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.76 -20.0 6.84 Favored Glycine 0 N--CA 1.477 1.432 0 N-CA-C 114.646 0.619 . . . . 63.01 114.646 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.452 HD11 ' HG3' ' D' ' 93' ' ' GLN . 4.4 tt -121.16 137.26 55.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 C-N-CA 124.237 1.015 . . . . 54.22 109.478 -174.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -150.69 -170.99 3.81 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.72 0.808 . . . . 71.13 110.822 -177.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.5 -140.81 26.76 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.32 0.387 . . . . 73.05 113.606 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -80.0 -24.44 40.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.52 0.728 . . . . 45.14 110.833 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.452 ' HG3' HD11 ' D' ' 89' ' ' ILE . 6.5 tp-100 -70.26 -36.95 74.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.135 0.574 . . . . 53.52 110.632 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -74.55 -33.6 62.76 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.668 -0.493 . . . . 65.43 109.668 174.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.76 81.2 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.361 0.601 . . . . 74.42 110.425 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -67.71 -44.81 76.79 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.972 -1.013 . . . . 73.11 111.231 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.96 -50.5 73.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.051 0.54 . . . . 65.03 110.699 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.34 -22.85 54.39 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.869 0.868 . . . . 73.53 111.316 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.2 -7.56 46.24 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 115.215 0.846 . . . . 75.14 115.215 -172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.28 -51.86 0.35 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.793 0.796 . . . . 71.34 110.965 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -71.8 -39.44 69.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.764 0.426 . . . . 74.11 112.057 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' CE2' ' D' ' 11' ' ' PHE . 57.7 m -73.37 -44.59 7.59 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.693 -0.67 . . . . 74.24 111.347 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.528 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 64.6 Cg_exo -56.64 -32.75 91.58 Favored 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 121.983 1.789 . . . . 71.33 113.244 168.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -63.82 -35.75 81.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.205 0.602 . . . . 64.33 110.669 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -65.75 -42.11 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.437 0.695 . . . . 63.31 110.111 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.479 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.0 mt -75.9 -19.26 58.97 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.075 -0.966 . . . . 65.4 112.318 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.23 -43.84 56.41 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 113.851 1.056 . . . . 74.14 113.851 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.99 -41.4 79.2 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.937 1.758 . . . . 75.03 113.512 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.43 -38.36 68.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.516 0.726 . . . . 74.22 111.525 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.65 79.35 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.486 0.714 . . . . 52.53 110.398 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -55.35 -52.37 63.72 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.507 1.129 . . . . 73.21 110.6 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.18 -43.95 93.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.894 0.746 . . . . 73.43 111.779 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 51.6 t -55.35 -40.3 71.07 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.764 0.665 . . . . 74.5 110.833 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.618 HG21 HG21 ' D' ' 64' ' ' VAL . 97.3 mt -65.83 -53.38 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.071 -0.968 . . . . 73.21 110.483 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.433 HG23 ' HG3' ' D' ' 125' ' ' GLN . 22.5 m -57.31 -35.99 70.53 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.252 1.021 . . . . 52.43 111.818 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.99 -45.69 76.86 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.204 -0.907 . . . . 74.45 110.139 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.425 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 79.1 mtm -65.6 -31.45 72.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.24 0.616 . . . . 72.02 111.7 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' D' ' 114' ' ' ILE . 71.2 t -66.25 -46.21 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.388 -0.824 . . . . 64.14 110.038 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.03 -25.44 60.95 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.333 -0.394 . . . . 74.32 111.428 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -74.39 -35.42 63.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.588 0.755 . . . . 61.02 109.676 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.67 -1.37 83.11 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 115.692 -0.685 . . . . 72.32 112.111 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p 57.19 36.29 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.2 1.8 . . . . 73.54 111.825 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.62 158.31 32.38 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 113.908 -1.496 . . . . 72.03 109.815 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.441 ' HB3' HE21 ' D' ' 37' ' ' GLN . 73.1 Cg_exo -54.13 128.24 29.07 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.526 2.151 . . . . 65.24 113.07 174.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' D' ' 115' ' ' THR . 27.1 tt0 -52.39 140.97 20.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.052 1.341 . . . . 73.41 112.702 -175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.531 HD13 HG11 ' D' ' 40' ' ' VAL . 28.2 tp -112.99 126.77 55.86 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.11 -0.7 . . . . 73.54 109.11 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.467 ' HB3' HG13 ' B' ' 13' ' ' ILE . 94.3 m-20 -121.28 103.78 9.23 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.074 0.95 . . . . 70.0 109.025 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.76 119.75 12.36 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.641 0.776 . . . . 73.12 110.12 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.18 88.32 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.089 0.556 . . . . 73.52 110.602 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 110.7 1.36 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.464 2.109 . . . . 75.25 111.827 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.65 110.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.08 -1.082 . . . . 70.54 108.08 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -82.31 75.29 9.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.157 0.979 . . . . 73.53 109.375 -176.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 28.4 t80 . . . . . 0 CA--C 1.549 0.916 0 CA-C-N 114.304 -1.316 . . . . 75.3 109.767 -179.751 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.6 m . . . . . 0 N--CA 1.471 0.594 0 N-CA-C 109.498 -0.556 . . . . 62.35 109.498 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -133.17 112.38 11.68 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.744 -1.206 . . . . 74.33 107.744 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -140.06 110.5 6.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.27 -0.641 . . . . 75.3 109.27 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.424 HG13 ' CD2' ' A' ' 84' ' ' PHE . 1.5 mp -81.11 119.41 30.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 107.559 -1.274 . . . . 64.43 107.559 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.17 -41.49 16.97 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.014 -0.736 . . . . 72.14 109.014 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -168.07 137.47 2.51 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.328 -0.367 . . . . 74.33 110.561 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.642 HG23 HD23 ' A' ' 106' ' ' LEU . 92.0 mt -139.88 98.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.988 -1.115 . . . . 72.15 107.988 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.3 m-85 -163.45 166.02 23.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.102 0.961 . . . . 75.32 109.409 -167.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -74.18 126.33 30.34 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.075 -0.342 . . . . 73.4 110.075 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 41.2 mtpt -85.05 -44.41 13.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.392 0.615 . . . . 63.03 109.456 171.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.5 t70 -135.36 142.1 45.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.71 -1.132 . . . . 73.44 109.885 -176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.5 mt -138.19 140.01 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.453 1.501 . . . . 73.11 107.684 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.74 128.65 10.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.618 . . . . 73.22 109.333 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.0 t80 -134.1 125.07 27.23 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.389 -1.338 . . . . 71.1 107.389 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.75 148.07 49.19 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.039 -0.726 . . . . 65.45 109.039 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.0 77.78 25.48 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 106.628 -1.619 . . . . 74.24 106.628 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.93 -31.86 36.98 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.749 2.299 . . . . 72.13 111.873 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -109.28 32.14 5.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.704 0.802 . . . . 73.41 109.524 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -46.8 99.07 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.262 1.025 . . . . 52.51 113.282 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.61 -12.99 29.73 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.688 1.592 . . . . 72.04 113.167 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -90.14 -11.82 40.06 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.762 0.825 . . . . 74.33 111.698 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 29.9 m -60.24 -15.09 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 113.617 0.969 . . . . 64.34 113.617 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.64 -41.19 65.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 72.35 110.844 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -89.84 -15.61 31.88 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.375 -0.83 . . . . 74.1 110.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 3.7 mmpt? -73.21 129.21 37.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.231 0.612 . . . . 73.32 111.096 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.64 116.73 12.34 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.153 -1.055 . . . . 75.23 108.153 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -71.52 83.49 0.83 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.816 0.817 . . . . 75.21 111.283 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -141.0 80.19 17.39 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.203 -1.777 . . . . 74.23 106.203 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.74 135.36 6.76 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.904 2.403 . . . . 70.31 111.597 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -94.2 100.77 12.78 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 105.862 -1.903 . . . . 55.12 105.862 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.01 90.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.751 0.786 . . . . 60.44 109.068 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 56.7 tttp -86.39 127.67 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.36 -1.291 . . . . 70.44 108.837 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 tp -123.16 144.31 49.43 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.707 -0.849 . . . . 74.03 108.707 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.32 144.74 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.752 -0.833 . . . . 75.14 108.752 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.96 124.06 17.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.15 0.58 . . . . 74.32 110.272 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 20.7 t70 -123.5 148.04 46.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.994 1.317 . . . . 62.41 109.513 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.6 m -139.54 136.77 34.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.039 0.536 . . . . 73.12 110.579 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -146.29 127.64 14.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.28 0.632 . . . . 54.01 110.527 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -89.07 161.13 16.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.579 0.752 . . . . 74.31 109.87 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 47.2 t -167.33 116.67 0.83 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.991 -0.374 . . . . 74.34 109.991 -174.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.63 HE21 ' H ' ' A' ' 54' ' ' ASP . 62.8 tt0 -71.25 104.17 3.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.452 0.701 . . . . 75.43 110.011 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 57' ' ' GLU . 86.6 mt -77.95 -38.8 44.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.861 0.865 . . . . 72.45 111.044 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.92 -172.35 4.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.889 0.875 . . . . 71.33 109.776 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -57.21 97.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.188 0.595 . . . . 73.53 111.183 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.63 ' H ' HE21 ' A' ' 50' ' ' GLN . 10.4 m-20 58.39 32.95 22.68 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.201 1.4 . . . . 70.44 112.299 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 59.9 t -107.72 120.57 59.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.651 -1.611 . . . . 73.52 106.651 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.0 m-85 -130.89 128.5 40.69 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.952 -0.759 . . . . 75.32 108.952 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 51' ' ' LEU . 40.2 tt0 -91.81 123.16 34.99 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.901 -0.777 . . . . 72.3 108.901 172.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 33.2 m -99.75 122.09 51.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 107.543 -1.28 . . . . 70.43 107.543 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.497 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.9 t -100.49 130.13 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.14 -0.689 . . . . 75.55 109.14 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.7 112.97 26.26 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.425 -1.324 . . . . 73.31 107.425 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttm-85 -93.14 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.715 -1.217 . . . . 74.22 107.715 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.65 124.36 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.517 -0.92 . . . . 63.54 108.517 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -123.64 129.75 51.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.781 0.432 . . . . 62.45 109.952 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 53.0 t -123.63 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.541 1.136 . . . . 73.34 109.883 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 m -103.46 141.16 36.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.963 -0.384 . . . . 64.22 109.963 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.66 103.0 8.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.39 -1.337 . . . . 52.0 107.39 168.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 34.3 m -112.0 125.3 53.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.476 0.655 . . . . 73.41 109.401 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.9 mp -102.32 86.67 2.87 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.753 -1.943 . . . . 73.43 105.753 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -122.91 5.96 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.931 -0.868 . . . . 71.45 110.931 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.64 -23.78 24.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.235 0.614 . . . . 70.52 110.104 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.91 108.93 19.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.336 0.654 . . . . 65.13 111.17 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -74.39 117.35 16.11 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.373 0.669 . . . . 71.02 109.517 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -59.57 -54.86 41.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.553 0.741 . . . . 54.12 109.529 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -156.56 153.67 29.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.36 -1.291 . . . . 71.43 111.526 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -125.49 135.85 52.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.906 1.282 . . . . 73.22 108.732 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.0 m -120.35 140.61 51.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 71.01 109.247 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -147.43 125.59 12.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.784 -0.821 . . . . 71.33 108.784 166.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.34 109.64 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.211 1.005 . . . . 53.32 108.511 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 79.2 mt-30 -86.8 84.86 7.28 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.332 -0.849 . . . . 64.25 109.098 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.36 96.6 4.04 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.088 -1.414 . . . . 53.43 109.548 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.74 145.68 18.04 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.81 -0.516 . . . . 74.11 111.81 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.536 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.97 122.65 2.38 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.719 -0.952 . . . . 72.13 110.719 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 48.0 mt -82.3 125.02 39.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 109.268 -0.642 . . . . 74.32 109.268 174.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 13' ' ' ILE . 55.4 m-85 -130.93 120.35 23.44 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.698 -0.853 . . . . 71.43 108.698 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 36.1 t -96.35 107.02 19.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 24.04 109.111 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.612 ' HB ' HD13 ' A' ' 89' ' ' ILE . 42.9 pt -130.45 127.79 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.148 0.579 . . . . 73.2 110.767 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.85 134.18 27.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.627 0.771 . . . . 60.24 109.926 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.15 7.8 62.02 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 123.549 0.531 . . . . 60.34 113.237 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.612 HD13 ' HB ' ' A' ' 86' ' ' ILE . 4.5 mp -109.32 136.03 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.238 -1.023 . . . . 73.41 108.238 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 13.4 tt0 -159.62 -178.14 6.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.13 0.572 . . . . 72.54 109.52 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.515 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.39 -143.23 36.94 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.659 -0.246 . . . . 65.05 112.821 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -68.93 -17.79 64.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.063 0.945 . . . . 63.42 112.116 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.92 -57.7 5.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.599 0.76 . . . . 74.21 109.312 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.7 ttp -65.27 -40.42 93.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.93 1.292 . . . . 62.55 111.236 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.12 70.3 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.002 0.814 . . . . 75.31 110.044 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -64.27 -48.49 75.53 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 114.401 -1.272 . . . . 75.3 111.309 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 36.3 m -71.01 -45.23 64.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.969 1.1 . . . . 75.4 113.969 -165.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -83.26 -15.19 51.25 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.044 0.387 . . . . 74.41 112.044 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.56 -3.94 18.04 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 114.727 0.651 . . . . 73.34 114.727 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.97 -60.58 0.46 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.591 0.696 . . . . 70.1 110.941 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.507 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.2 t80 -57.55 -62.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.163 0.985 . . . . 74.52 112.394 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.01 -39.0 2.09 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.182 -1.372 . . . . 73.43 112.924 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HA ' HD12 ' A' ' 106' ' ' LEU . 10.4 Cg_endo -57.29 -37.86 96.53 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.703 1.602 . . . . 64.43 113.399 165.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.96 -37.71 86.7 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.079 0.4 . . . . 71.03 110.531 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 mm -58.26 -40.57 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.999 0.92 . . . . 51.33 110.946 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.642 HD23 HG23 ' A' ' 16' ' ' ILE . 94.6 mt -70.74 -31.54 68.41 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.672 -0.695 . . . . 64.23 111.84 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.08 -43.73 98.68 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 124.845 1.258 . . . . 64.14 114.251 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.32 -35.48 83.99 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.415 2.077 . . . . 70.43 114.219 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.02 -22.37 45.56 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.606 0.362 . . . . 75.22 111.485 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.4 65.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.531 -0.544 . . . . 71.11 109.531 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.414 HH22 ' HB3' ' A' ' 130' ' ' PRO . 42.1 ttm180 -56.75 -42.31 79.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.648 1.179 . . . . 75.01 110.975 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.405 ' HG2' HH12 ' B' ' 120' ' ' ARG . 21.9 tt0 -48.71 -56.55 8.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.211 1.404 . . . . 63.42 111.372 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.72 -48.69 68.44 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.82 -1.537 . . . . 74.53 111.363 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.8 mt -57.35 -54.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 124.14 0.9 . . . . 71.1 110.565 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -61.54 -34.48 75.63 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.83 0.706 . . . . 71.54 111.801 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -67.84 -44.92 76.06 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.248 -0.433 . . . . 61.44 110.347 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 mtp -55.62 -45.16 77.57 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.802 0.841 . . . . 62.43 110.978 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -61.89 -46.96 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.603 1.161 . . . . 72.4 111.135 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 88.3 p -73.06 -24.68 60.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.077 -0.511 . . . . 63.21 111.84 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.482 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.8 mtt-85 -74.96 -24.07 58.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.244 0.618 . . . . 64.14 110.627 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.31 16.23 24.67 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.537 0.523 . . . . 74.11 112.421 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 t 52.38 28.89 6.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.224 2.21 . . . . 71.14 112.848 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -94.06 140.11 22.79 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.133 -1.062 . . . . 74.12 108.133 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 144.25 99.53 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.53 2.154 . . . . 73.2 111.07 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -54.79 132.62 46.45 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.724 0.64 . . . . 64.33 112.338 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.08 98.85 4.54 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.607 -1.627 . . . . 73.34 106.607 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' C' ' 15' ' ' ARG . 8.0 p30 -98.21 126.15 43.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.481 0.658 . . . . 61.41 109.927 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 pp -68.91 141.47 55.02 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.598 -1.183 . . . . 73.04 111.382 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.18 142.54 84.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.402 0.681 . . . . 73.52 110.113 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.414 ' HB3' HH22 ' A' ' 111' ' ' ARG . 60.6 Cg_endo -74.57 136.68 21.7 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.408 2.072 . . . . 75.31 111.349 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.05 111.41 29.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.234 -1.395 . . . . 62.24 107.234 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -85.82 75.86 9.98 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.694 0.759 . . . . 75.21 110.621 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.16 -40.58 90.42 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.291 -1.322 . . . . 71.11 110.559 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.473 0.705 0 CA-C-N 115.258 -0.883 . . . . 75.0 111.67 175.672 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.9 ptm . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 114.243 1.201 . . . . 50.53 114.243 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.9 p -145.75 133.22 20.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.832 0.853 . . . . 72.41 108.805 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.442 ' HD1' HG22 ' B' ' 86' ' ' ILE . 91.4 t80 -129.71 139.17 51.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.648 0.779 . . . . 72.33 109.857 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -160.37 143.04 13.24 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.278 0.361 . . . . 71.54 111.494 173.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.61 HG21 HG13 ' B' ' 16' ' ' ILE . 3.7 mp -86.02 123.11 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.493 -0.928 . . . . 75.41 108.493 173.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -40.03 24.4 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.739 0.416 . . . . 73.55 110.395 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -161.36 136.62 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.274 -0.421 . . . . 74.31 110.43 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.61 HG13 HG21 ' B' ' 13' ' ' ILE . 67.0 mt -115.91 139.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 107.101 -1.444 . . . . 72.31 107.101 168.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.52 164.78 14.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.982 0.896 . . . . 74.33 112.461 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.5 m -96.87 125.61 41.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.066 -1.425 . . . . 74.44 108.821 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.445 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -97.64 -32.85 11.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.654 0.782 . . . . 74.12 110.372 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.18 138.58 18.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.966 -0.561 . . . . 51.23 110.641 -168.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.481 HD11 ' SG ' ' B' ' 113' ' ' CYS . 45.7 mm -141.01 142.17 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.381 1.473 . . . . 74.22 108.86 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 87.1 p -138.84 145.61 40.22 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.562 -0.903 . . . . 63.33 108.562 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.0 t80 -152.19 109.79 3.61 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.006 -1.479 . . . . 63.21 107.006 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -118.21 114.39 22.95 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.494 0.718 . . . . 72.22 109.213 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -109.54 87.27 5.13 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.904 0.882 . . . . 72.53 109.214 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.12 -24.98 16.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.781 2.321 . . . . 71.52 112.59 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.42 18.5 14.33 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.784 0.834 . . . . 74.13 110.447 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.807 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.37 -49.11 55.11 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 125.446 1.499 . . . . 50.41 114.249 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 18.1 Cg_exo -65.49 -29.19 53.35 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.103 1.868 . . . . 72.22 112.118 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -99.55 -8.97 23.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.011 0.925 . . . . 71.41 112.836 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.55 -14.07 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.597 0.592 . . . . 72.33 112.597 -167.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.82 -21.69 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.955 0.502 . . . . 73.02 111.583 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -76.57 -13.41 60.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.948 0.899 . . . . 63.02 111.37 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.661 ' HB3' HD22 ' B' ' 68' ' ' LEU . 35.5 mmtp -102.43 101.7 11.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.703 0.801 . . . . 71.22 110.85 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -96.13 84.47 3.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.36 -0.978 . . . . 72.53 108.36 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -164.69 166.38 20.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.43 1.092 . . . . 65.11 108.207 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.46 127.36 55.08 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-O 119.203 -0.427 . . . . 72.23 110.127 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.74 133.57 25.93 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.015 1.81 . . . . 74.31 112.086 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.92 107.34 5.25 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 108.441 -0.948 . . . . 75.33 108.441 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.08 133.99 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.965 0.412 . . . . 73.44 109.962 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -114.78 104.06 11.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.625 -0.88 . . . . 74.23 108.625 166.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' B' ' 42' ' ' LEU . 2.1 pp -94.92 141.52 28.55 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.876 -1.056 . . . . 71.1 108.823 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -162.9 147.16 11.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.913 -0.773 . . . . 71.14 108.913 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.96 152.5 24.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 74.11 109.933 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -141.33 150.47 42.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.047 1.339 . . . . 64.15 108.109 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 39.4 p -119.56 137.43 53.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 74.23 111.148 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -130.83 150.1 52.16 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.651 1.181 . . . . 60.33 108.133 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -142.67 162.21 36.06 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.689 0.395 . . . . 70.04 110.234 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -165.84 148.21 7.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.102 0.961 . . . . 70.51 109.206 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -119.29 125.33 48.83 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.075 -0.713 . . . . 62.31 109.075 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.71 -46.65 8.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.528 0.731 . . . . 73.21 110.053 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -148.7 178.1 8.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.076 -0.966 . . . . 44.45 110.133 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.42 114.06 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.04 0.936 . . . . 64.34 110.201 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 69.98 3.16 4.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.685 1.194 . . . . 53.11 112.913 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 61.7 t -108.66 95.76 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.673 -1.232 . . . . 73.3 107.673 176.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -112.83 135.98 52.98 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.52 -0.919 . . . . 72.52 108.52 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.59 107.3 16.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.882 0.873 . . . . 74.3 108.686 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.54 133.68 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.498 0.719 . . . . 74.45 109.828 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 35.4 t -112.33 120.8 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 70.04 109.686 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.95 121.37 35.35 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.497 -1.297 . . . . 73.23 107.497 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -111.05 119.48 39.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.378 -0.601 . . . . 71.04 109.378 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.83 111.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.544 -0.91 . . . . 64.32 108.544 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 49.6 m -97.35 135.99 38.45 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.236 -0.653 . . . . 75.31 109.236 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.596 HG11 HD13 ' B' ' 126' ' ' LEU . 79.5 t -132.69 134.1 58.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 123.485 0.714 . . . . 63.22 109.247 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.8 m -124.71 148.24 48.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.368 1.067 . . . . 74.23 108.167 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 148.49 32.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 122.803 0.441 . . . . 70.2 109.967 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 m -138.23 124.01 19.9 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.837 0.711 . . . . 74.42 109.934 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' B' ' 34' ' ' LYS . 0.7 OUTLIER -104.45 119.36 38.79 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.127 -1.064 . . . . 73.44 108.127 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -112.08 3.41 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.024 -0.83 . . . . 72.02 111.024 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -119.64 13.8 12.54 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.875 0.87 . . . . 51.11 110.949 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.36 167.41 22.98 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.667 0.787 . . . . 63.43 110.271 -170.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -62.09 134.46 56.62 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.663 0.602 . . . . 74.13 110.846 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -90.18 -57.68 2.76 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.911 -1.144 . . . . 73.11 107.911 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -160.92 169.08 23.33 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 113.697 -1.592 . . . . 73.23 109.779 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.2 mt -135.32 140.95 45.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.616 -1.624 . . . . 75.23 106.616 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -155.19 142.53 19.5 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.545 -0.539 . . . . 62.32 109.545 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -158.81 133.24 7.95 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.158 -0.682 . . . . 73.24 109.158 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.402 HG23 HG12 ' B' ' 114' ' ' ILE . 93.2 t -124.41 148.1 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.674 0.79 . . . . 51.13 109.342 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -123.16 100.52 6.91 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.439 -0.949 . . . . 75.04 108.439 169.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.91 99.05 11.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.269 -1.011 . . . . 73.24 108.269 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.65 157.92 26.92 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.147 -0.781 . . . . 74.21 111.147 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.75 134.03 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.958 -0.457 . . . . 45.35 111.958 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.9 121.22 39.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.739 -0.837 . . . . 72.42 108.739 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -123.82 136.45 54.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 74.3 110.091 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -99.26 108.37 20.91 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.606 1.162 . . . . 74.04 108.021 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.6 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.7 137.94 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.847 0.859 . . . . 71.23 108.825 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 132.26 10.17 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.16 -1.052 . . . . 60.22 108.16 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.6 11.36 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.385 -0.675 . . . . 54.03 113.744 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.605 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 27.2 pt -50.16 146.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 123.779 0.832 . . . . 73.01 111.989 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -150.71 156.27 40.98 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.043 0.757 . . . . 74.31 113.043 -167.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.66 -126.28 41.55 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.763 -1.562 . . . . 34.11 113.481 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.43 -38.09 42.19 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.57 0.748 . . . . 52.14 109.981 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.41 -21.95 65.55 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.634 -1.166 . . . . 73.35 110.839 -171.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.605 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 49.3 ttm -54.37 -49.23 70.32 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.275 1.03 . . . . 72.23 110.762 169.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.39 69.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.445 -1.252 . . . . 74.33 111.761 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 69.2 m-70 -74.76 -18.85 60.42 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.522 0.329 . . . . 65.02 111.875 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.59 -56.15 8.1 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.404 0.621 . . . . 65.44 110.324 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.404 HD23 ' SG ' ' B' ' 102' ' ' CYS . 87.3 mt -86.97 -22.34 25.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.215 -0.902 . . . . 64.41 112.026 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.74 -15.7 41.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 113.897 0.319 . . . . 23.12 113.897 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -129.51 -55.83 1.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 117.101 0.45 . . . . 72.33 111.955 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -70.22 -49.29 51.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.006 0.522 . . . . 74.42 111.547 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.5 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.18 -50.79 84.43 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.568 -0.729 . . . . 75.21 112.505 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.5 Cg_exo -58.53 -31.55 94.64 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.25 1.967 . . . . 72.12 113.577 173.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.43 -27.41 63.27 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.621 0.369 . . . . 60.52 111.231 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.405 HG23 ' NH2' ' D' ' 111' ' ' ARG . 97.5 mt -70.25 -43.36 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.591 0.756 . . . . 74.14 109.714 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.62 -17.71 61.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.047 -0.979 . . . . 71.44 111.529 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.35 -51.3 81.12 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.791 1.236 . . . . 71.05 113.886 -170.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.495 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 28.6 Cg_endo -60.29 -33.06 94.87 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.957 1.772 . . . . 75.45 113.047 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.13 -43.97 73.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.095 0.558 . . . . 75.22 111.038 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.69 98.38 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.268 0.627 . . . . 44.32 110.501 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 29.7 mtp-105 -54.21 -57.73 10.07 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.503 1.121 . . . . 73.21 111.427 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.59 -26.56 64.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.414 -0.812 . . . . 75.44 110.287 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.76 -46.32 69.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.446 0.299 . . . . 65.13 110.44 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.402 HG12 HG23 ' B' ' 78' ' ' VAL . 69.3 mt -60.97 -48.03 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.058 0.543 . . . . 73.41 109.585 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -55.15 -43.65 74.41 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.438 -1.256 . . . . 61.23 111.429 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -65.68 -45.02 84.45 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.648 -0.706 . . . . 51.35 110.838 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -71.91 -35.96 69.86 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.038 0.535 . . . . 74.42 111.392 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.618 HG22 ' HB2' ' B' ' 123' ' ' PHE . 9.1 p -75.35 -28.55 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.073 -0.512 . . . . 73.02 110.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.448 ' HA ' HE22 ' C' ' 125' ' ' GLN . 69.9 m -63.14 -35.64 80.95 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.437 0.695 . . . . 61.22 110.855 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.1 mtt-85 -69.57 -19.14 63.68 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 114.721 -1.127 . . . . 74.53 111.385 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 13.63 61.13 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.179 -0.789 . . . . 74.42 114.74 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.5 p 70.06 13.44 7.82 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.034 1.733 . . . . 71.12 113.038 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.618 ' HB2' HG22 ' B' ' 118' ' ' VAL . 73.2 m-85 -104.18 145.56 30.89 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 119.246 -0.407 . . . . 72.11 110.259 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.31 165.28 5.78 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.619 2.879 . . . . 53.12 113.825 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -61.06 155.66 19.8 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.297 -0.865 . . . . 73.33 111.915 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.596 HD13 HG11 ' B' ' 64' ' ' VAL . 87.6 mt -131.44 84.0 2.14 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.915 -0.772 . . . . 52.32 108.915 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.411 ' HB3' HH21 ' B' ' 111' ' ' ARG . 35.6 m-80 -106.65 100.36 9.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.788 -1.096 . . . . 74.11 108.376 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.58 133.88 53.21 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.169 -0.923 . . . . 63.03 109.312 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.54 150.13 94.19 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.074 0.55 . . . . 63.53 110.808 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.48 96.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.043 2.496 . . . . 73.0 112.565 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.43 117.56 33.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.567 -0.901 . . . . 43.22 108.567 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.15 97.63 5.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.024 -1.472 . . . . 73.12 107.024 170.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 19.2 m-85 -55.82 -30.2 61.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.135 0.974 . . . . 71.34 110.664 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.11 -36.45 81.79 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.614 -1.175 . . . . 72.34 111.076 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.14 -51.87 64.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.579 0.752 . . . . 71.13 111.127 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? . . . . . 0 N--CA 1.484 1.264 0 O-C-N 123.731 0.644 . . . . 65.35 110.118 178.814 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.3 ttm . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.043 0.449 . . . . 73.01 111.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -85.56 87.34 7.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.146 -1.057 . . . . 34.24 108.146 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -105.58 136.41 45.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.874 -1.057 . . . . 72.53 109.19 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -152.92 132.83 13.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.246 0.618 . . . . 74.23 109.705 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.55 105.72 11.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.157 -1.053 . . . . 65.3 108.157 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.7 mm-40 -78.92 -41.58 29.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.893 -0.594 . . . . 64.1 110.11 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.438 ' HA ' HD21 ' A' ' 127' ' ' ASN . 23.2 ttt85 -170.79 157.17 5.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.668 0.605 . . . . 74.23 110.996 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.51 145.92 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 107.194 -1.41 . . . . 70.44 107.194 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -173.86 162.25 3.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.648 0.737 . . . . 73.14 109.866 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -80.14 111.76 16.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.868 -1.06 . . . . 63.43 108.249 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.86 -45.75 81.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.098 -1.075 . . . . 74.33 108.098 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.2 t70 -140.37 140.99 35.65 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 113.57 -1.65 . . . . 72.15 109.697 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.3 mt -131.46 145.58 34.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 106.907 -1.516 . . . . 72.54 106.907 170.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -153.82 146.63 24.34 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.338 0.59 . . . . 71.21 109.602 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -146.25 144.02 29.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.555 -1.276 . . . . 71.12 107.555 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -138.48 144.95 40.27 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.674 1.189 . . . . 73.23 107.835 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -150.6 80.04 7.02 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 106.683 -1.599 . . . . 63.34 106.683 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.73 -37.11 16.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.578 2.185 . . . . 63.11 111.349 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' C' ' 71' ' ' GLU . 1.7 m-20 -107.93 27.65 9.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.472 1.109 . . . . 72.22 109.439 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.508 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -50.17 -51.88 58.7 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.888 1.275 . . . . 53.01 113.889 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 66.3 Cg_endo -86.57 -19.21 2.91 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 121.67 1.58 . . . . 64.25 113.321 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -68.18 -21.64 64.88 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.983 0.913 . . . . 71.41 112.553 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.61 -5.49 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 123.343 0.657 . . . . 74.25 112.506 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.573 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 19.8 m-85 -67.42 -27.7 67.28 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.349 0.66 . . . . 65.23 112.451 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 29.0 7.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.485 0.714 . . . . 62.05 109.368 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.8 155.33 41.25 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.299 0.64 . . . . 72.4 111.253 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.71 129.99 39.48 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.385 -1.279 . . . . 73.33 110.572 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 32.0 p90 -84.53 65.65 9.09 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 122.19 0.995 . . . . 74.22 111.933 -176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -151.54 60.42 3.75 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 115.564 -0.744 . . . . 73.44 110.673 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -67.38 153.92 75.43 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.21 1.94 . . . . 72.23 110.498 175.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.72 109.15 17.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.828 -1.545 . . . . 71.01 106.828 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.424 HG13 HD11 ' C' ' 126' ' ' LEU . 77.8 t -75.25 106.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.891 -1.05 . . . . 70.11 110.646 -174.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.727 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 6.4 mtpm? -103.35 143.88 32.09 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.272 1.029 . . . . 61.33 108.323 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -128.87 164.05 23.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.79 0.436 . . . . 73.4 110.896 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.41 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.0 t70 -154.29 125.91 7.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.428 -0.805 . . . . 71.52 108.991 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -115.4 112.07 21.77 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.646 -1.242 . . . . 75.33 107.646 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -126.68 119.98 28.33 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.609 -1.256 . . . . 71.2 107.609 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -118.42 150.42 39.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.389 -0.597 . . . . 71.11 109.389 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.09 171.96 13.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 71.23 109.13 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -146.83 143.39 28.56 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.843 -0.799 . . . . 61.55 108.843 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.7 t -145.0 126.39 14.9 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.307 -0.997 . . . . 42.33 108.307 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -80.1 117.33 20.81 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.525 -0.546 . . . . 73.52 109.525 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' C' ' 57' ' ' GLU . 69.9 mt -86.73 -45.5 10.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.684 0.793 . . . . 55.05 110.087 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.79 -165.15 2.19 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.66 -0.7 . . . . 62.42 111.132 -173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.13 102.03 0.19 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.1 0.875 . . . . 60.22 110.966 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 63.72 18.5 11.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.154 0.982 . . . . 73.54 111.884 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -106.96 114.22 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.27 -1.011 . . . . 73.24 108.27 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -122.0 124.82 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.151 0.98 . . . . 54.4 108.891 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.616 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.8 tt0 -89.59 114.99 26.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.177 0.991 . . . . 75.32 109.245 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -95.86 129.47 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.089 -1.078 . . . . 73.52 108.089 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 t -120.64 106.53 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.667 -0.864 . . . . 65.12 108.667 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.9 102.41 14.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.473 -0.936 . . . . 64.53 108.473 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.407 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 33.3 ttm105 -79.51 107.3 12.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.587 -0.894 . . . . 74.13 108.587 168.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -99.96 124.28 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.137 -1.431 . . . . 60.44 107.137 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.9 m -123.74 119.59 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.785 -0.821 . . . . 73.33 108.785 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 77.7 t -111.01 129.41 66.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.739 -1.119 . . . . 64.54 108.626 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.727 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.5 m -122.69 138.17 54.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.722 0.809 . . . . 71.42 109.164 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.62 100.88 6.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.281 -1.377 . . . . 72.02 107.281 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -140.63 118.21 11.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.827 -0.805 . . . . 63.32 108.827 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.26 -40.18 85.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 75.44 110.238 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.12 -79.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.482 -1.047 . . . . 75.52 110.482 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.0 -32.01 16.95 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.727 0.811 . . . . 60.21 109.434 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.53 ' HG3' ' ND2' ' C' ' 27' ' ' ASN . 40.8 tt0 -88.69 121.32 30.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.194 0.997 . . . . 73.1 111.096 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.6 m -84.23 126.71 33.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.999 0.52 . . . . 72.15 110.107 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.93 -55.21 5.83 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.817 0.847 . . . . 72.32 109.105 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.57 165.44 34.49 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.581 -1.19 . . . . 74.13 110.84 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.474 HD23 HG23 ' C' ' 65' ' ' THR . 3.0 tm? -135.05 144.92 47.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.271 -1.381 . . . . 54.13 107.271 174.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.409 ' N ' HD13 ' C' ' 75' ' ' LEU . 43.6 t -144.8 143.96 30.91 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.158 -0.682 . . . . 72.1 109.158 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -153.17 134.18 14.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.143 0.577 . . . . 73.24 109.507 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' C' ' 110' ' ' ALA . 39.8 t -133.09 113.55 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.236 1.014 . . . . 72.43 108.444 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -92.73 90.6 7.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.914 0.885 . . . . 55.21 108.73 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.3 tp-100 -82.97 105.97 14.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.081 -0.963 . . . . 72.52 109.897 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.11 147.54 18.63 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.79 -0.524 . . . . 64.21 111.79 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.555 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.63 123.46 2.16 Favored Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.759 -0.937 . . . . 70.42 110.759 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.2 mm -80.65 118.51 28.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.931 -1.137 . . . . 72.24 107.931 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -132.75 130.8 40.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.468 0.707 . . . . 73.4 109.534 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 m -81.49 115.55 20.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.053 -0.721 . . . . 50.11 109.053 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.657 HG13 HD21 ' C' ' 98' ' ' LEU . 27.3 mm -116.73 100.89 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.404 -0.961 . . . . 71.23 108.404 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.92 168.45 19.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.323 0.649 . . . . 54.15 110.179 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.29 -56.27 4.25 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.028 -0.533 . . . . 70.43 112.354 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -104.01 163.08 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.826 0.85 . . . . 62.14 109.472 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.8 -177.12 5.55 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.729 0.412 . . . . 71.01 111.543 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.42 -144.76 48.9 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.485 -0.78 . . . . 53.43 114.818 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 43.7 p -68.67 -19.89 64.42 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.65 0.78 . . . . 73.31 111.863 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -67.02 -41.66 86.25 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.231 1.012 . . . . 74.3 110.305 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -83.14 -23.21 33.08 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.366 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -71.45 -25.8 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.096 0.559 . . . . 52.21 111.256 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 29.5 t-80 -63.58 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.796 0.438 . . . . 64.44 110.221 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.559 ' HG ' ' HG ' ' C' ' 102' ' ' CYS . 17.6 t -76.61 -60.36 2.38 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.202 -0.666 . . . . 62.35 109.202 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.657 HD21 HG13 ' C' ' 86' ' ' ILE . 98.6 mt -60.72 -26.83 67.45 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.062 0.945 . . . . 43.05 113.065 -174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.19 10.86 33.85 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.545 -0.586 . . . . 64.32 113.902 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -155.05 -60.64 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.584 0.692 . . . . 73.44 111.698 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' C' ' 104' ' ' ASN . 65.1 t80 -75.13 -42.47 56.21 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.877 0.695 . . . . 74.33 112.877 -170.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.559 ' HG ' ' HG ' ' C' ' 97' ' ' CYS . 63.3 m -66.44 -49.39 52.83 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.207 0.603 . . . . 55.24 111.708 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.46 -18.25 43.68 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 121.594 1.529 . . . . 73.24 113.265 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 27.1 t-20 -57.13 -41.75 79.65 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.549 0.69 . . . . 72.32 109.92 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.45 -38.58 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.141 -1.391 . . . . 64.14 110.875 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.555 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.5 mt -81.29 -34.25 32.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.193 -0.912 . . . . 72.13 112.369 -170.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -54.66 -45.73 99.48 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 124.299 1.04 . . . . 74.0 113.527 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.71 -52.03 7.4 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.795 2.33 . . . . 72.11 113.686 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -63.91 -48.71 75.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.357 -0.838 . . . . 74.13 111.732 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.52 -41.23 96.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.085 0.554 . . . . 72.51 111.735 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -64.16 -44.53 91.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.2 0.937 . . . . 62.42 110.592 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -70.65 -31.87 68.95 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.522 -0.763 . . . . 63.52 110.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.8 -34.2 77.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.093 0.557 . . . . 65.3 110.436 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.09 -42.21 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.369 0.668 . . . . 73.52 110.379 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 81.6 m -62.2 -30.93 71.42 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.004 0.522 . . . . 64.03 110.284 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -70.86 -54.18 12.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.634 0.773 . . . . 73.22 109.912 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.48 -45.93 66.35 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.482 1.113 . . . . 73.02 112.385 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.01 -42.33 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.907 0.883 . . . . 70.32 110.834 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -64.21 -32.53 74.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.933 -0.576 . . . . 74.2 111.02 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.49 -35.46 73.25 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.387 -0.824 . . . . 63.52 109.696 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.98 2.76 67.83 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.683 0.614 . . . . 72.53 113.188 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 54.38 48.12 21.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.088 1.755 . . . . 75.44 112.184 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 90.9 m-85 -115.02 149.29 42.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 114.083 -1.417 . . . . 72.24 108.091 169.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.5 154.98 22.52 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.654 2.902 . . . . 60.51 113.844 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.448 HE22 ' HA ' ' B' ' 119' ' ' SER . 87.8 mt-30 -58.11 150.44 21.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.893 0.877 . . . . 74.11 112.753 -173.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.424 HD11 HG13 ' C' ' 40' ' ' VAL . 1.9 tt -145.47 85.97 1.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.298 -1.371 . . . . 64.02 107.298 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.05 108.29 19.77 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.834 -1.076 . . . . 62.05 108.349 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 130.41 46.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.294 1.038 . . . . 74.22 109.964 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.32 137.17 97.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.677 0.791 . . . . 72.52 111.685 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -65.68 122.64 10.32 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.747 2.298 . . . . 75.53 112.04 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 109.86 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.137 -1.06 . . . . 44.24 108.137 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -87.2 63.62 7.92 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.978 0.911 . . . . 75.25 109.579 -177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -77.13 -43.95 32.21 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.021 -0.536 . . . . 72.23 110.582 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 . . . . . 0 N--CA 1.482 1.139 0 C-N-CA 123.829 0.851 . . . . 51.4 110.457 174.222 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.552 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 113.33 0.863 . . . . 73.22 113.33 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.4 m -132.88 139.56 47.47 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.152 -1.055 . . . . 62.34 108.152 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' D' ' 85' ' ' SER . 45.3 t80 -159.07 98.06 1.43 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.01 0.819 . . . . 72.31 108.792 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.21 115.39 24.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.61 0.764 . . . . 71.52 109.618 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' D' ' 84' ' ' PHE . 3.9 tp -77.61 104.38 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 108.408 -0.96 . . . . 70.32 108.408 171.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -84.62 -39.13 19.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.11 -0.95 . . . . 64.11 111.833 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.573 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 65.2 ttt180 -165.41 127.5 2.07 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.587 -0.279 . . . . 71.41 110.354 -166.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.508 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.4 mp -112.65 129.1 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.323 -1.362 . . . . 73.22 107.323 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -165.49 176.91 7.81 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 122.176 0.989 . . . . 74.14 113.117 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -108.32 119.36 39.26 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.02 -1.446 . . . . 65.13 108.36 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 39.7 mtpt -86.94 -17.94 31.94 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.32 -0.622 . . . . 73.44 109.32 173.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.769 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.5 t70 -155.7 140.24 16.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.924 . . . . 75.24 109.817 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' C' ' 117' ' ' MET . 58.5 mt -139.92 140.02 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.548 1.539 . . . . 75.33 107.786 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -143.84 136.84 27.49 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.457 0.703 . . . . 63.43 109.473 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.8 t80 -142.8 116.9 9.46 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.98 -1.859 . . . . 71.44 105.98 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' D' ' 26' ' ' PRO . 44.7 mt-10 -127.32 116.27 20.27 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.108 -0.701 . . . . 72.22 109.108 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -107.47 88.79 4.37 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 123.313 0.645 . . . . 75.34 109.559 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' D' ' 24' ' ' GLU . 16.6 Cg_exo -71.01 -38.7 4.78 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.222 2.615 . . . . 64.11 112.49 -173.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 85.3 m-20 -118.24 40.86 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.221 1.008 . . . . 51.1 110.035 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.748 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.84 -57.8 17.56 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 114.976 1.473 . . . . 73.4 114.976 -169.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.53 -3.83 10.76 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 121.619 1.614 . . . . 65.44 112.266 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.98 -45.03 13.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.06 1.344 . . . . 74.31 109.804 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.97 -19.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.734 0.814 . . . . 73.41 110.312 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.5 -23.86 64.85 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.309 1.043 . . . . 75.24 111.791 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -79.61 -3.24 46.2 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.503 0.721 . . . . 73.12 111.769 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -121.59 110.02 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.635 0.774 . . . . 65.4 110.082 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.61 93.52 4.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.851 0.861 . . . . 73.41 109.744 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -169.05 158.37 8.48 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.45 1.1 . . . . 75.23 108.49 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -76.49 111.93 18.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.825 0.85 . . . . 70.01 110.033 174.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -52.64 128.1 26.93 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.048 2.498 . . . . 63.45 112.599 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -67.43 118.74 11.17 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.165 -0.679 . . . . 75.14 109.165 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.516 HG11 HD11 ' D' ' 126' ' ' LEU . 98.8 t -99.36 133.46 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.223 -0.899 . . . . 65.3 110.819 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -101.8 142.79 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.422 -0.955 . . . . 71.42 108.422 166.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.31 126.03 54.55 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.721 -0.844 . . . . 72.42 108.721 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 22.7 t70 -121.94 149.22 43.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.1 . . . . 74.11 108.142 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.16 151.39 49.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.863 0.465 . . . . 64.52 110.855 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.1 t70 -155.83 155.6 33.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.178 0.991 . . . . 73.3 108.82 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -133.45 160.03 38.62 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.278 0.631 . . . . 72.23 109.67 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 164.51 37.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.682 -0.858 . . . . 62.32 108.682 174.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -148.36 159.84 43.61 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.964 0.411 . . . . 62.31 111.136 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -160.86 126.71 3.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.33 1.052 . . . . 72.03 109.785 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.51 120.34 28.71 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.859 -0.793 . . . . 73.2 108.859 171.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -91.95 -40.96 10.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.766 -0.652 . . . . 72.54 110.182 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.59 -168.74 1.9 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.508 -0.769 . . . . 73.4 110.433 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.44 115.81 3.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.97 -1.013 . . . . 72.13 110.275 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.74 5.24 3.25 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.622 1.169 . . . . 64.24 112.318 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.93 120.23 59.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 107.531 -1.285 . . . . 74.02 107.531 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -131.47 161.79 31.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 64.22 108.96 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' D' ' 51' ' ' LEU . 6.6 tm-20 -132.43 136.92 47.08 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.085 -1.45 . . . . 63.54 107.085 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 134.8 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.748 -0.834 . . . . 73.52 108.748 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.5 t -107.48 128.18 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.752 0.821 . . . . 53.1 109.575 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -102.08 121.99 43.25 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.394 -1.336 . . . . 63.52 107.394 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.9 ttm180 -104.36 108.42 19.82 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.33 -0.989 . . . . 63.4 108.33 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.9 t -95.2 127.73 46.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 107.715 -1.217 . . . . 43.03 107.715 166.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.5 m -118.27 127.13 53.43 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.773 0.797 . . . . 53.54 109.846 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 53.7 t -115.01 114.29 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 125.879 1.671 . . . . 60.44 108.245 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -112.19 97.8 6.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.525 -0.917 . . . . 51.24 108.525 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.19 129.91 43.38 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.046 -0.724 . . . . 70.01 109.046 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 34.9 p -145.49 128.79 16.8 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.125 -0.695 . . . . 72.33 109.125 -175.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -123.23 123.91 41.83 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.476 -0.935 . . . . 54.14 108.476 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -116.0 4.57 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.516 0.51 . . . . 72.13 112.494 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -123.44 26.5 7.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.023 0.529 . . . . 64.33 110.464 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.454 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.0 pt-20 -137.69 155.19 49.39 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 123.64 0.776 . . . . 74.25 110.053 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -78.7 117.12 19.54 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 109.696 -0.483 . . . . 72.55 109.696 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.39 -61.55 1.79 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.589 0.755 . . . . 61.42 110.025 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.1 170.01 19.93 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.658 -1.156 . . . . 61.52 109.819 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 80.0 mt -126.74 145.54 50.56 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.385 1.074 . . . . 74.4 108.721 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.51 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.8 m -143.07 136.06 27.95 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.689 -1.226 . . . . 70.03 107.689 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -156.74 121.01 4.4 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.531 -0.914 . . . . 74.24 108.531 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -130.76 117.82 39.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 122.988 0.515 . . . . 52.55 109.635 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.769 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -89.74 87.46 7.0 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.057 0.848 . . . . 73.13 109.079 170.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.5 98.57 6.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.393 -1.276 . . . . 70.43 109.171 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.25 144.3 17.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 116.437 -0.347 . . . . 63.4 112.292 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -146.91 135.76 5.86 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.999 -0.441 . . . . 43.1 111.999 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.18 128.48 43.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 123.717 0.807 . . . . 71.01 109.877 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' D' ' 13' ' ' ILE . 63.4 m-85 -130.23 137.05 49.84 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 74.0 109.811 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 18.6 m -77.73 103.68 7.81 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.144 -1.058 . . . . 72.23 108.144 168.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.43 106.65 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.72 -0.844 . . . . 74.04 108.72 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -148.65 167.83 24.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.289 1.036 . . . . 72.5 109.628 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.14 6.08 67.72 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.49 -0.323 . . . . 71.32 113.799 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 tp -141.08 143.73 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 54.21 109.444 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 -172.05 4.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.107 0.563 . . . . 73.23 110.818 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.67 -138.82 22.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.52 0.513 . . . . 64.21 113.382 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -83.86 -24.2 30.99 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.509 0.724 . . . . 70.41 111.001 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -70.69 -32.97 70.39 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.11 0.564 . . . . 72.51 111.846 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -30.35 67.31 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 110.161 -0.311 . . . . 75.14 110.161 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.88 68.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.535 0.734 . . . . 74.34 110.405 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -65.2 -36.74 85.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.353 -0.84 . . . . 72.53 110.613 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.1 -47.29 65.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.995 -0.548 . . . . 63.34 110.022 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -73.15 -27.48 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.621 0.768 . . . . 74.45 111.452 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.34 5.06 33.38 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.361 -0.688 . . . . 70.12 114.526 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.46 -58.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 117.88 0.84 . . . . 62.15 111.534 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -70.92 -54.41 11.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.141 0.576 . . . . 71.33 112.17 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 66.2 m -62.11 -46.13 91.26 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 123.852 0.861 . . . . 73.14 112.072 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.529 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.6 Cg_exo -57.24 -36.05 98.97 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.409 2.073 . . . . 64.23 113.436 169.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -62.66 -34.74 77.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.95 0.5 . . . . 75.41 111.187 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -66.75 -40.22 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.007 0.923 . . . . 74.13 110.616 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' D' ' 82' ' ' GLY . 87.3 mt -74.51 -21.49 59.52 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.702 -0.681 . . . . 71.44 111.548 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -62.68 -46.0 88.5 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 114.143 1.164 . . . . 73.21 114.143 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -51.95 -38.22 68.61 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.056 1.837 . . . . 70.24 113.227 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -79.31 -34.71 42.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.099 0.96 . . . . 74.04 111.618 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -48.63 73.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.359 0.664 . . . . 71.11 109.862 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.405 ' NH2' HG23 ' B' ' 105' ' ' ILE . 41.5 ttp180 -57.54 -45.44 85.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.365 -1.289 . . . . 74.23 110.749 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.45 -46.5 89.8 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.097 0.873 . . . . 72.42 111.109 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.33 -41.7 85.19 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.719 0.637 . . . . 44.11 111.353 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.416 HG21 HG21 ' D' ' 64' ' ' VAL . 90.4 mt -63.14 -56.12 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.214 -0.903 . . . . 63.1 110.372 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.4 m -53.43 -39.03 64.06 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.582 1.153 . . . . 72.52 112.046 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -71.78 -41.05 68.81 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.422 -0.808 . . . . 65.21 110.813 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.29 -31.59 72.8 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.71 0.404 . . . . 74.33 111.408 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.416 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.2 t -68.23 -42.35 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 62.54 110.252 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 72.8 p -74.18 -26.4 60.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.36 0.264 . . . . 62.11 111.25 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.63 -29.69 59.25 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.548 0.739 . . . . 74.41 110.049 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 2.96 87.5 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.645 -0.707 . . . . 74.53 112.051 171.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 14.7 p 63.84 18.01 10.89 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.094 2.158 . . . . 63.11 114.267 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 59.6 m-85 -87.65 166.2 26.21 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.847 1.259 . . . . 73.13 109.948 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 56.5 Cg_endo -68.13 134.17 30.88 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.142 1.895 . . . . 75.24 111.143 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.37 143.47 34.31 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.201 0.6 . . . . 63.13 110.534 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.516 HD11 HG11 ' D' ' 40' ' ' VAL . 4.4 tt -110.5 111.62 22.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.282 -1.007 . . . . 74.31 108.282 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -98.96 87.11 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.16 117.1 7.98 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.109 -0.95 . . . . 71.21 108.647 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -53.84 136.57 55.62 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.89 0.876 . . . . 61.43 111.568 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 13.6 Cg_exo -68.91 122.59 9.5 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.222 1.948 . . . . 71.31 110.446 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.82 144.82 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.171 0.588 . . . . 73.3 109.415 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -74.3 94.68 2.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.467 -0.938 . . . . 62.44 108.467 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 N--CA 1.481 1.08 0 CA-C-N 115.343 -0.844 . . . . 73.0 111.649 179.084 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m . . . . . 0 CA--C 1.542 0.643 0 N-CA-C 108.694 -0.854 . . . . 71.42 108.694 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -137.9 113.51 9.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.709 -0.848 . . . . 73.52 108.709 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -142.0 137.88 31.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 75.5 109.769 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.37 133.44 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 71.42 109.929 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.92 -42.31 11.28 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.65 -0.5 . . . . 72.35 109.65 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.541 ' HD2' HD12 ' A' ' 83' ' ' ILE . 11.9 ptp180 -175.56 146.07 0.76 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.067 -0.969 . . . . 72.3 109.39 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.505 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 77.2 mt -137.03 125.98 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.123 -1.065 . . . . 72.4 108.123 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.531 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 22.2 p90 -164.75 161.65 20.69 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.805 0.842 . . . . 74.32 110.635 -170.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -75.83 123.25 25.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.092 -0.504 . . . . 72.21 109.825 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.1 mtpt -86.99 -32.05 20.27 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.695 0.398 . . . . 70.41 109.999 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -147.28 144.94 29.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.524 -0.762 . . . . 64.3 109.907 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.2 mt -134.99 146.4 30.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 125.451 1.5 . . . . 63.32 107.674 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 t -149.33 138.78 21.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.306 0.642 . . . . 72.41 109.812 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -147.19 126.95 13.43 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.12 -1.437 . . . . 74.55 107.12 175.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.86 127.54 29.03 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.564 -0.902 . . . . 64.4 108.564 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -119.18 86.61 32.91 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 109.007 -0.738 . . . . 63.14 109.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -34.47 27.03 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.165 2.577 . . . . 73.11 113.081 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 2.4 m-80 -109.84 33.94 4.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.549 0.74 . . . . 70.3 109.926 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -52.88 -48.51 91.17 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 113.727 1.01 . . . . 73.21 113.727 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.5 Cg_exo -68.62 -30.94 27.53 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 121.674 1.582 . . . . 74.4 112.214 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -75.8 -21.89 56.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.697 0.799 . . . . 74.14 111.825 -170.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' ASN . 57.9 t -53.61 -27.24 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 123.773 0.829 . . . . 75.5 111.848 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -78.82 -39.03 36.67 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.746 0.818 . . . . 74.51 111.047 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -88.29 -26.64 22.17 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.302 0.641 . . . . 70.33 112.383 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HB2' HD12 ' A' ' 68' ' ' LEU . 55.8 mtpt -80.5 163.49 23.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.15 0.58 . . . . 62.31 111.234 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.06 115.84 15.13 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.457 0.703 . . . . 71.05 109.331 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -73.24 86.01 1.42 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.987 0.915 . . . . 75.4 111.445 -172.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.53 80.63 65.69 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 124.031 0.932 . . . . 74.55 108.899 171.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.45 121.71 8.47 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.876 2.384 . . . . 74.45 111.872 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.86 105.96 18.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.378 -0.971 . . . . 72.24 108.378 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.09 92.47 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.705 -0.85 . . . . 64.2 108.705 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.2 tttm -100.33 115.29 29.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.92 0.888 . . . . 72.31 109.139 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mp -100.84 141.91 33.05 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.028 0.531 . . . . 74.13 109.808 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.698 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.5 m-20 -128.19 111.68 13.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.265 -1.383 . . . . 74.52 107.265 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 131' ' ' VAL . 75.2 mt -109.74 119.89 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.753 -0.462 . . . . 72.51 109.753 -174.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -130.31 137.46 49.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.051 0.94 . . . . 74.11 109.463 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.6 m -117.07 132.97 56.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.572 0.749 . . . . 75.33 109.902 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.03 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.641 1.176 . . . . 74.4 109.036 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -132.54 158.94 40.86 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.594 0.758 . . . . 75.41 110.43 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -157.17 157.34 34.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.458 1.103 . . . . 75.05 110.009 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -113.95 136.97 52.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.776 0.83 . . . . 54.4 109.572 174.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.03 -33.91 3.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.134 0.573 . . . . 73.51 111.209 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.46 -174.04 4.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.232 0.613 . . . . 62.22 110.199 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.1 117.01 9.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.457 0.703 . . . . 72.13 109.487 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 67.62 14.65 9.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.481 1.112 . . . . 72.14 111.816 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -118.93 104.93 16.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.478 -0.934 . . . . 64.21 108.478 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -125.53 126.65 45.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.67 0.788 . . . . 75.24 109.116 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -92.48 130.04 38.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.747 1.219 . . . . 74.4 109.432 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.402 HG11 ' HD3' ' A' ' 103' ' ' PRO . 65.4 t -114.28 123.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.956 -1.127 . . . . 65.13 107.956 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.5 t -106.52 134.96 46.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.617 0.767 . . . . 61.52 109.277 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.9 113.93 27.83 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.296 -1.372 . . . . 64.31 107.296 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -96.6 100.72 12.27 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.988 -1.115 . . . . 75.35 107.988 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 HD22 ' A' ' 60' ' ' LEU . 11.1 t -101.84 131.61 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.525 -0.917 . . . . 73.1 108.525 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.698 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.1 m -116.6 137.15 52.4 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.784 -1.191 . . . . 63.32 107.784 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 114' ' ' ILE . 86.3 t -128.72 128.05 67.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.567 -2.012 . . . . 74.24 105.567 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 27.6 m -124.67 139.24 54.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.934 -1.506 . . . . 62.45 106.934 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.95 119.75 20.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.403 -0.962 . . . . 62.44 108.403 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 68.5 m -107.07 131.37 54.17 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.369 -0.604 . . . . 73.4 109.369 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -88.94 76.22 7.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.559 -1.275 . . . . 71.24 107.559 -175.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.36 -102.2 2.26 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.324 -1.51 . . . . 71.41 109.324 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.56 -27.82 4.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.373 0.669 . . . . 74.35 110.096 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.44 131.44 34.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.936 0.894 . . . . 73.24 108.59 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 24.5 m -62.01 130.17 44.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.052 . . . . 61.35 113.205 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -76.89 -59.3 2.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.433 1.093 . . . . 51.22 109.307 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -161.83 174.48 13.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.631 -1.168 . . . . 72.21 111.112 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.0 tp -137.69 145.26 42.38 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 71.24 108.329 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.566 ' HB3' HG23 ' A' ' 114' ' ' ILE . 70.2 m -146.99 104.44 3.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.914 0.885 . . . . 71.4 110.165 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.21 126.35 38.95 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.895 0.478 . . . . 72.11 109.774 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.89 112.49 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.871 0.868 . . . . 60.44 109.663 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -85.09 83.39 8.05 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.402 -0.962 . . . . 63.03 108.402 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.14 98.53 5.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.222 -0.899 . . . . 64.21 109.448 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.01 144.49 19.41 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.83 -0.508 . . . . 64.34 111.83 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.21 122.46 2.43 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.114 -1.194 . . . . 64.54 110.114 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.541 HD12 ' HD2' ' A' ' 15' ' ' ARG . 49.5 mt -88.5 129.13 40.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.275 -1.009 . . . . 72.32 108.275 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -129.1 126.02 38.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.652 0.381 . . . . 74.54 110.313 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 p -83.24 100.13 10.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.887 -0.782 . . . . 73.22 108.887 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.5 pt -112.8 137.1 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.798 0.839 . . . . 73.33 111.437 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.18 155.77 11.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.882 1.273 . . . . 33.32 108.964 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.89 86.54 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 120.154 -0.248 . . . . 64.01 113.63 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 44.7 pt -110.47 140.9 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.994 0.918 . . . . 74.11 109.259 -173.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 22.5 tt0 -155.47 177.74 11.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.864 0.466 . . . . 62.52 110.292 -174.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.1 -157.18 43.57 Favored Glycine 0 C--N 1.345 1.07 0 C-N-CA 123.936 0.779 . . . . 72.51 114.127 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 p -71.83 -13.84 61.79 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.797 0.839 . . . . 52.22 111.026 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.12 -46.66 88.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.317 1.047 . . . . 61.35 111.022 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.4 61.96 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.094 -0.335 . . . . 74.33 110.094 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.29 75.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.338 0.655 . . . . 63.42 110.704 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 6.3 t-80 -65.04 -48.12 74.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.764 1.226 . . . . 51.23 110.07 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 13.4 m -73.84 -26.02 60.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.955 1.094 . . . . 53.22 113.955 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.2 mt -97.31 -30.61 12.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.854 0.462 . . . . 74.42 111.332 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -20.34 49.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.098 -0.501 . . . . 73.14 113.217 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.7 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -132.77 -70.7 0.54 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.23 0.455 . . . . 71.3 112.23 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.672 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.1 t80 -45.0 -58.6 3.07 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 124.899 1.279 . . . . 73.01 113.9 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.5 m -72.08 -41.61 8.8 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.323 -0.846 . . . . 65.4 113.166 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD3' HG11 ' A' ' 58' ' ' VAL . 9.3 Cg_endo -60.72 -23.91 77.44 Favored 'Trans proline' 0 C--N 1.388 2.63 0 CA-C-N 121.281 1.493 . . . . 64.42 113.851 165.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.558 HD21 ' HB2' ' A' ' 133' ' ' PHE . 32.9 m-80 -73.19 -35.52 66.4 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 118.71 0.686 . . . . 44.43 110.484 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.29 -41.87 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.236 0.615 . . . . 73.02 109.576 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.2 mt -71.47 -24.89 62.08 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.219 -0.901 . . . . 72.21 112.354 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.97 -44.05 70.23 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.825 -1.084 . . . . 74.51 113.859 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.89 -32.64 92.82 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.247 1.965 . . . . 71.4 113.577 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -75.94 -38.58 57.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.247 0.619 . . . . 74.22 110.959 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.53 -46.24 76.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.106 0.562 . . . . 63.11 109.629 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -50.67 -54.28 24.34 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.865 1.353 . . . . 75.52 110.478 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -58.1 -49.47 76.85 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.437 1.085 . . . . 64.03 111.748 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.448 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.1 t -58.99 -43.57 91.47 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.062 0.851 . . . . 64.42 110.934 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 76' ' ' CYS . 84.7 mt -60.55 -55.1 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 123.997 0.811 . . . . 71.22 110.265 174.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -59.71 -34.57 73.08 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.768 1.227 . . . . 73.12 111.837 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.1 t -73.46 -42.13 62.33 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.648 -0.705 . . . . 74.32 110.137 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 7.5 mtp -57.47 -42.2 82.14 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.552 0.741 . . . . 74.42 111.128 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 114' ' ' ILE . 81.0 t -61.14 -46.76 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.619 1.167 . . . . 60.03 111.016 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.2 p -75.76 -26.54 57.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.864 0.466 . . . . 74.43 111.506 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.96 -29.22 64.04 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.566 0.747 . . . . 75.01 109.762 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 1.51 79.52 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.652 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.3 m 68.59 11.69 8.43 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.865 1.266 . . . . 63.22 111.558 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -87.09 150.25 49.32 Favored Pre-proline 0 C--O 1.243 0.75 0 CA-C-N 115.608 -0.724 . . . . 74.32 109.093 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -45.84 112.63 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.144 2.563 . . . . 73.22 112.698 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.05 122.8 10.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.854 1.262 . . . . 64.43 111.656 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.28 96.08 6.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.186 -1.042 . . . . 64.44 108.186 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -99.83 83.57 2.76 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.379 -0.971 . . . . 72.33 108.379 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.2 pt? -59.63 136.88 58.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.003 -0.998 . . . . 74.52 111.941 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.91 148.82 82.74 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.413 1.085 . . . . 65.15 112.018 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 129.74 36.21 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.477 . . . . 75.43 113.72 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.447 HG21 HD11 ' A' ' 44' ' ' LEU . 87.9 t -103.08 122.03 55.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.632 -0.877 . . . . 65.24 108.632 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -88.57 71.25 8.89 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.919 0.888 . . . . 54.41 111.006 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.558 ' HB2' HD21 ' A' ' 104' ' ' ASN . 39.6 m-85 -61.43 -38.76 88.32 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.726 0.774 . . . . 52.42 109.263 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.7 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.9 t70 . . . . . 0 N--CA 1.472 0.661 0 CA-C-N 114.427 -1.26 . . . . 60.04 111.318 -174.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.715 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.8 ptm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 115.279 1.585 . . . . 74.42 115.279 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -137.05 136.92 38.82 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.335 -1.302 . . . . 72.02 107.785 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.04 124.46 40.71 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.32 -0.993 . . . . 74.24 108.32 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.43 110.34 7.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.151 0.58 . . . . 54.3 109.596 -177.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.492 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -70.19 115.86 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 109.313 -0.625 . . . . 71.01 109.313 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.84 -51.62 6.28 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.263 0.554 . . . . 75.33 109.653 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -169.71 133.89 1.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.098 -0.956 . . . . 51.34 108.535 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' B' ' 109' ' ' TYR . 73.3 mt -114.75 146.13 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.539 -1.282 . . . . 73.03 107.539 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -168.02 149.67 5.32 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.598 0.592 . . . . 63.44 112.598 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -73.59 124.92 26.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.199 -0.91 . . . . 74.32 108.7 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 38.9 mtpt -98.31 -37.37 9.67 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.347 0.659 . . . . 55.34 110.858 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 26.8 m-20 -148.09 133.51 18.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.064 -0.517 . . . . 60.44 109.91 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.1 mm -130.01 142.58 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 74.12 109.74 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.629 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -133.68 135.34 44.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.311 1.444 . . . . 75.04 108.867 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.51 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.5 t80 -149.63 127.0 11.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.808 -1.182 . . . . 74.23 107.808 166.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.16 126.68 25.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.72 0.808 . . . . 74.55 109.297 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.585 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.19 88.0 53.15 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.136 -0.69 . . . . 72.42 109.136 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.37 -27.47 28.31 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.028 2.485 . . . . 53.11 112.034 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -117.61 28.98 8.11 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.146 0.979 . . . . 73.12 109.019 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.585 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -44.49 -54.19 12.91 Favored Pre-proline 0 C--N 1.366 1.312 0 C-N-CA 124.684 1.194 . . . . 74.44 112.331 167.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.0 Cg_exo -69.32 -19.79 37.77 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.339 2.026 . . . . 51.21 112.498 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 11.5 m-70 -96.67 2.98 52.69 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.238 1.015 . . . . 64.34 111.936 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.47 -32.69 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 112.861 0.689 . . . . 35.02 112.861 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -74.21 -26.69 60.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.17 0.509 . . . . 74.44 110.563 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.87 -16.66 61.12 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.807 1.243 . . . . 73.43 110.523 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 mmmt -101.91 95.46 6.39 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.979 0.912 . . . . 61.11 111.707 -170.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.75 87.14 3.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 64.13 111.062 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -176.96 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.698 1.599 . . . . 75.41 108.136 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -87.98 133.83 36.49 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.254 0.622 . . . . 73.42 109.727 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -65.5 134.78 39.75 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.005 1.803 . . . . 73.14 111.874 170.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.455 ' HG3' ' HE2' ' B' ' 41' ' ' LYS . 16.0 tp10 -63.95 103.93 0.65 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.253 0.621 . . . . 70.13 109.39 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.27 147.94 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 72.05 111.42 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.455 ' HE2' ' HG3' ' B' ' 39' ' ' GLU . 73.4 mmtt -136.48 143.92 44.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.74 1.216 . . . . 74.41 109.423 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -127.48 132.72 49.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.684 0.794 . . . . 74.34 109.269 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 11.6 m-20 -132.14 115.42 15.71 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.281 -1.007 . . . . 74.04 108.281 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.29 135.27 40.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.862 -0.792 . . . . 73.4 108.862 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 31.9 t70 -146.07 149.12 33.47 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.935 0.894 . . . . 75.22 108.953 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -128.97 123.81 33.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.48 0.712 . . . . 72.13 109.602 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -114.48 159.43 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.495 -1.298 . . . . 54.01 107.495 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -145.26 164.23 32.03 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.25 0.548 . . . . 75.53 111.028 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -153.58 143.03 21.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.591 -1.186 . . . . 74.45 107.983 169.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.06 104.9 14.71 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.927 -0.768 . . . . 74.04 108.927 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -73.51 -45.21 55.19 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.032 0.444 . . . . 72.22 109.808 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -178.07 6.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.012 -0.994 . . . . 72.22 110.005 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.35 128.67 35.9 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.957 -1.02 . . . . 61.23 109.186 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 67.42 10.73 7.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.635 1.174 . . . . 51.21 112.061 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.4 t -129.23 99.17 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.31 1.044 . . . . 73.51 108.781 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.925 0.869 . . . . 73.41 111.266 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.98 95.02 2.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.473 -2.418 . . . . 70.54 104.473 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.18 130.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.241 0.543 . . . . 75.12 109.612 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 32.9 t -102.03 143.46 14.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 114.953 -1.022 . . . . 52.23 109.172 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.7 OUTLIER -119.59 111.08 17.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.588 -1.264 . . . . 74.43 107.588 176.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.0 ttt180 -96.69 108.84 21.54 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.072 0.549 . . . . 64.34 110.23 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.1 t -105.88 118.83 54.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.445 -0.946 . . . . 70.21 108.445 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 38.0 m -103.92 141.34 36.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.565 0.746 . . . . 63.53 109.028 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.672 HG21 HG21 ' B' ' 114' ' ' ILE . 47.5 t -129.25 130.82 67.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.367 1.067 . . . . 73.41 108.901 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.3 m -125.42 140.07 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.896 -0.779 . . . . 73.12 108.896 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 131.37 26.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.608 -0.886 . . . . 64.13 108.608 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.486 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.0 p -133.29 126.26 31.06 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.808 -0.441 . . . . 64.11 109.808 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 0.9 OUTLIER -110.86 130.07 55.69 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.67 -1.604 . . . . 71.32 106.67 -176.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -119.09 5.7 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.585 -1.006 . . . . 34.21 110.585 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -120.35 3.81 10.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.654 0.782 . . . . 63.54 110.711 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -115.48 165.5 12.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.818 0.847 . . . . 61.22 110.145 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 42.6 m -70.23 131.6 44.46 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.711 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -86.16 -57.99 2.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.024 -1.102 . . . . 74.35 108.024 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -160.27 166.44 29.54 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.327 -1.306 . . . . 73.54 110.679 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.91 136.16 44.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.496 1.518 . . . . 72.34 107.033 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 50.0 t -143.23 147.49 34.92 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.443 -0.947 . . . . 61.45 108.443 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.3 tt0 -162.94 139.1 7.19 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.167 -0.679 . . . . 71.53 109.167 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' B' ' 113' ' ' CYS . 98.7 t -130.95 144.31 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.644 0.778 . . . . 64.45 109.021 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 26.4 mt-30 -122.82 92.91 3.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.624 -0.88 . . . . 73.55 108.624 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -85.43 102.73 13.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.823 -1.08 . . . . 52.2 109.296 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.31 168.71 29.87 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.617 -0.593 . . . . 71.31 111.617 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.25 128.56 1.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 112.084 -0.407 . . . . 51.02 112.084 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.7 mt -83.58 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.075 -1.083 . . . . 74.02 108.075 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -130.13 132.9 46.29 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.022 -0.733 . . . . 54.43 109.022 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -95.82 115.07 26.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.788 -0.819 . . . . 74.13 108.788 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.581 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -129.11 137.37 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.754 1.222 . . . . 64.42 109.212 -175.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.8 173.05 16.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.296 0.638 . . . . 60.14 109.896 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.59 -66.7 1.4 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.922 -0.471 . . . . 63.23 111.922 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.715 HG23 ' HB3' ' B' ' 9' ' ' MET . 8.3 pt -60.74 145.11 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.708 0.803 . . . . 71.12 111.887 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.54 146.26 24.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.061 -0.972 . . . . 63.31 109.411 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.08 7.64 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.416 0.448 . . . . 75.45 112.76 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.8 m -70.04 -50.14 44.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.656 0.783 . . . . 74.53 111.124 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -61.46 -24.94 66.91 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.925 0.89 . . . . 73.4 111.696 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.476 ' HA ' HD12 ' B' ' 89' ' ' ILE . 52.6 ttp -67.24 -40.21 86.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.503 1.121 . . . . 73.0 110.823 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.14 69.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.856 0.862 . . . . 23.33 111.991 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -65.45 -29.65 70.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.231 0.612 . . . . 75.41 111.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.2 -68.53 0.65 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.227 0.211 . . . . 73.44 111.437 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.497 HD23 ' SG ' ' B' ' 102' ' ' CYS . 94.1 mt -75.65 -22.89 56.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.256 0.465 . . . . 74.42 112.256 -172.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.75 -39.52 24.64 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.575 0.547 . . . . 61.12 112.327 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.15 -53.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.783 0.66 . . . . 73.53 112.783 -164.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -66.31 -45.38 80.53 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.311 0.644 . . . . 53.53 112.015 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.497 ' SG ' HD23 ' B' ' 98' ' ' LEU . 71.4 m -63.99 -50.06 71.51 Favored Pre-proline 0 CA--C 1.556 1.191 0 CA-C-O 118.373 -0.823 . . . . 70.33 110.61 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.2 Cg_exo -51.18 -33.03 42.61 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.624 2.216 . . . . 35.15 114.865 165.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.75 -25.27 64.65 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 118.355 0.525 . . . . 73.22 112.067 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -42.18 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.377 0.671 . . . . 75.31 109.77 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' B' ' 60' ' ' LEU . 95.8 mt -72.99 -24.73 60.8 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.025 -0.989 . . . . 63.12 110.926 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.17 -50.69 74.34 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.756 -1.116 . . . . 65.3 113.169 -169.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 37.6 Cg_endo -63.17 -32.42 74.29 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 121.638 1.558 . . . . 62.31 112.094 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.7 m-30 -66.42 -43.3 86.09 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.018 0.927 . . . . 70.44 110.454 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.31 87.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.962 0.905 . . . . 61.12 110.204 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -61.68 -52.99 62.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.649 1.58 . . . . 74.35 111.476 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.84 -33.61 75.59 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.079 0.862 . . . . 74.23 109.756 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.7 t -71.94 -34.99 69.47 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.854 -0.612 . . . . 70.15 111.059 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.672 HG21 HG21 ' B' ' 64' ' ' VAL . 53.1 mt -65.22 -54.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.122 -0.696 . . . . 74.34 109.122 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -58.97 -31.33 68.64 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.799 -1.092 . . . . 64.32 110.846 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.5 t -64.61 -55.5 19.92 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.652 0.781 . . . . 70.31 110.159 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.529 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 14.3 mmt -63.23 -36.75 84.69 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.702 0.401 . . . . 72.02 111.619 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.16 -51.63 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.056 0.942 . . . . 74.41 110.687 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.35 -20.24 60.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.067 0.547 . . . . 74.13 111.991 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.4 mtt-85 -68.89 -31.36 70.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.308 0.643 . . . . 75.55 110.28 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.5 14.59 57.64 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 123.854 0.721 . . . . 73.31 112.666 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.516 HG23 ' HB3' ' A' ' 17' ' ' TYR . 74.7 p 55.45 30.7 15.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.83 1.652 . . . . 73.22 112.492 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.46 155.45 39.65 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.928 0.891 . . . . 64.22 109.999 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.07 143.09 99.58 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.029 2.486 . . . . 72.34 113.034 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -59.08 123.11 15.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.76 1.224 . . . . 73.01 111.566 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.15 89.73 3.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.476 0.71 . . . . 71.05 109.849 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.37 100.14 12.52 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.224 -0.898 . . . . 64.12 110.377 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.49 151.02 42.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.203 1.001 . . . . 63.54 112.6 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.35 150.43 84.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.641 -0.709 . . . . 72.33 110.682 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.26 110.84 2.55 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.434 2.089 . . . . 64.22 110.044 176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.49 110.81 21.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 71.55 106.981 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -76.26 91.55 3.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.875 -1.528 . . . . 74.33 106.875 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -53.48 -40.24 65.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.89 -1.05 . . . . 61.21 110.399 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.74 -53.99 27.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.512 1.125 . . . . 72.3 111.688 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -22.38 64.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.613 0.765 . . . . 75.05 111.674 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 tt . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 123.785 0.834 . . . . 54.34 109.793 178.689 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 52.7 ttp . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.145 0.497 . . . . 71.4 110.545 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.2 m -84.04 78.79 9.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.128 -1.064 . . . . 72.1 108.128 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.515 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 42.2 t80 -100.18 127.94 46.35 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.809 -1.541 . . . . 72.34 108.571 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -138.03 142.73 40.35 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.336 -0.616 . . . . 74.12 109.336 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.33 110.21 11.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.319 -0.855 . . . . 64.52 108.738 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.5 mm-40 -77.67 -39.93 43.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.93 -0.577 . . . . 74.12 109.938 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.489 HH11 ' HD1' ' D' ' 32' ' ' PHE . 24.2 ttt180 179.27 124.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.393 0.677 . . . . 75.33 109.953 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 87.9 mt -110.08 138.62 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.818 -1.178 . . . . 63.33 107.818 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.9 p90 -174.17 154.1 2.16 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.752 0.657 . . . . 73.53 110.729 -175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.3 p -75.58 122.93 24.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.28 -0.873 . . . . 72.55 109.733 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -78.34 -50.58 11.51 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.218 -1.03 . . . . 53.4 108.218 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.5 t70 -133.53 139.19 46.47 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.551 -1.204 . . . . 74.3 109.939 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.37 140.06 38.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.794 -1.558 . . . . 60.25 106.794 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -160.7 150.75 17.74 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.119 0.485 . . . . 63.15 109.708 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 78.4 t80 -152.16 115.79 4.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.854 -1.165 . . . . 75.43 107.854 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.98 110.57 17.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.156 0.582 . . . . 72.15 110.432 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.6 86.24 34.29 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.405 1.082 . . . . 71.4 108.573 167.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.81 -32.31 29.87 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.414 2.076 . . . . 64.42 110.56 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -89.23 22.69 2.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.132 -1.394 . . . . 73.03 111.415 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.512 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -55.49 -43.59 99.22 Favored Pre-proline 0 CA--C 1.574 1.866 0 C-N-CA 124.226 1.011 . . . . 72.31 113.52 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -89.41 -17.96 1.75 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.958 1.772 . . . . 63.31 113.17 169.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.59 -31.69 68.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.535 1.134 . . . . 62.35 110.593 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.87 -2.45 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 124.473 1.109 . . . . 74.02 112.344 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -49.99 -41.72 47.61 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.389 1.476 . . . . 65.54 113.11 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -125.12 49.63 1.86 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.245 1.018 . . . . 73.44 108.499 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.79 149.29 47.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.82 -0.55 . . . . 61.14 111.22 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.2 132.91 50.33 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.285 -0.871 . . . . 75.43 110.406 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -83.52 65.86 8.63 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.026 0.917 . . . . 74.21 110.509 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -152.61 58.18 2.39 Favored Pre-proline 0 CA--C 1.558 1.281 0 CA-C-N 115.12 -0.946 . . . . 71.14 110.553 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.0 149.54 9.52 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.1 1.866 . . . . 70.42 110.8 165.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.24 113.63 24.04 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.284 0.634 . . . . 75.23 109.902 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -77.51 111.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.141 0.576 . . . . 72.1 109.747 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 26.6 mmmt -92.79 104.57 16.82 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.853 -1.165 . . . . 75.02 107.853 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.54 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.4 pt? -87.25 145.65 26.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.33 . . . . 70.41 110.194 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 30.2 t70 -140.88 109.02 5.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.11 -0.7 . . . . 73.22 109.11 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -117.22 125.68 51.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.951 -0.759 . . . . 72.01 108.951 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -143.92 160.53 40.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.446 1.098 . . . . 71.24 109.869 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -129.76 153.72 47.92 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.282 0.633 . . . . 75.5 109.651 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 164.58 26.32 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.067 0.947 . . . . 54.21 109.079 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.471 ' HB3' HD21 ' C' ' 98' ' ' LEU . 33.1 p -142.31 145.36 33.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.037 0.535 . . . . 64.14 110.5 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -145.99 126.38 14.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.379 1.072 . . . . 64.04 108.431 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.68 116.05 23.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.462 -0.94 . . . . 74.45 108.462 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.678 HD11 HD12 ' C' ' 83' ' ' ILE . 67.0 mt -85.41 -43.02 13.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.47 0.708 . . . . 75.42 110.17 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 -171.98 3.61 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.847 -1.069 . . . . 71.51 109.964 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.25 108.91 0.99 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.129 -0.941 . . . . 75.24 110.025 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 71.04 -3.08 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.972 1.309 . . . . 74.3 112.955 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -95.53 97.28 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.842 -1.169 . . . . 70.13 107.842 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -106.97 159.07 16.55 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.541 0.736 . . . . 75.23 110.119 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.99 120.26 31.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.426 1.09 . . . . 74.52 108.265 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.41 133.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.854 -1.165 . . . . 62.04 107.854 172.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.21 105.65 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.184 -0.673 . . . . 60.51 109.184 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.05 99.44 12.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.905 -1.146 . . . . 52.14 107.905 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.548 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.6 tmm_? -92.28 120.94 33.3 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.288 0.635 . . . . 74.54 110.151 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' C' ' 114' ' ' ILE . 37.2 t -112.09 125.33 69.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.569 -0.9 . . . . 65.32 108.569 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -118.53 123.66 45.64 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.486 -0.931 . . . . 71.33 108.486 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.45 HG23 HD13 ' C' ' 114' ' ' ILE . 76.3 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.989 -1.005 . . . . 63.13 108.725 174.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 5.7 m -98.46 136.54 38.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.579 -1.637 . . . . 75.31 106.579 169.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.22 106.65 6.83 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.985 -1.857 . . . . 74.23 105.985 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 12.5 p -164.46 158.12 18.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 123.622 0.576 . . . . 63.22 110.688 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -113.71 20.24 16.06 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.645 0.735 . . . . 41.14 110.181 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.86 -83.47 0.35 Allowed Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.437 -0.801 . . . . 75.14 111.166 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.12 -32.03 11.12 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.29 0.636 . . . . 54.22 110.423 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -82.35 91.36 6.79 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 108.896 -0.779 . . . . 71.3 108.896 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -81.87 128.22 33.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.543 . . . . 73.32 109.563 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -64.11 1.01 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.614 -1.254 . . . . 63.14 107.614 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -159.76 172.37 17.83 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 121.971 0.891 . . . . 73.23 111.524 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -129.25 140.67 51.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.627 -1.99 . . . . 63.4 105.627 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.39 144.32 29.66 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.402 -0.962 . . . . 61.3 108.402 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.97 128.71 7.88 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.602 -0.518 . . . . 54.45 109.602 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.13 123.22 58.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.01 -0.995 . . . . 61.14 108.567 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.548 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 74.1 mt-30 -98.25 91.28 5.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.224 -1.398 . . . . 72.1 107.224 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -78.34 102.53 7.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.868 -0.606 . . . . 72.51 109.572 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.19 145.44 23.22 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.417 -0.811 . . . . 64.45 111.186 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.533 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.6 116.06 0.76 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.343 -1.103 . . . . 41.32 110.343 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.678 HD12 HD11 ' C' ' 51' ' ' LEU . 12.7 mm -81.44 127.82 39.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 107.932 -1.136 . . . . 74.44 107.932 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.88 123.5 23.56 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.358 0.663 . . . . 63.54 109.553 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.5 p -77.04 106.54 8.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.729 -1.211 . . . . 73.31 107.729 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 48.3 mt -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.127 -1.064 . . . . 62.1 108.127 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.528 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -127.84 158.63 37.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.767 0.827 . . . . 50.44 110.25 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -51.76 3.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.828 -0.623 . . . . 71.51 113.029 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.7 tt -81.28 145.47 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.539 0.735 . . . . 74.25 109.978 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.12 -179.36 8.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.99 0.516 . . . . 62.22 110.759 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.26 -148.64 47.72 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.61 -0.723 . . . . 20.0 112.789 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 77.0 p -69.67 -18.05 63.53 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.22 1.008 . . . . 72.13 111.453 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -64.9 -46.19 82.76 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 73.54 110.108 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 57.5 ttp -68.07 -32.2 72.37 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.451 -0.795 . . . . 74.55 110.181 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.74 85.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.333 0.653 . . . . 53.32 110.981 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 46.7 t-80 -65.78 -32.75 74.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.719 0.808 . . . . 75.23 111.308 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.531 ' HG ' ' HG ' ' C' ' 102' ' ' CYS . 43.8 t -76.33 -55.34 5.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 54.44 110.294 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' C' ' 48' ' ' SER . 9.6 tt -65.64 -31.82 73.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.298 1.039 . . . . 65.2 111.225 -172.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.85 10.06 55.54 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.44 -0.644 . . . . 63.3 114.024 -175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.75 -59.03 0.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.776 0.788 . . . . 73.11 111.657 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -69.88 -55.54 9.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.449 0.7 . . . . 62.43 111.967 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.531 ' HG ' ' HG ' ' C' ' 97' ' ' CYS . 9.8 m -61.56 -45.82 93.85 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.635 0.774 . . . . 64.1 112.039 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.526 ' HB3' HD23 ' C' ' 60' ' ' LEU . 39.1 Cg_exo -61.05 -32.18 91.67 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.349 2.032 . . . . 73.24 113.501 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.95 -35.63 79.03 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.457 0.703 . . . . 72.32 110.882 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.42 -44.69 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.586 0.755 . . . . 73.15 110.254 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.533 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.7 mt -82.28 -23.96 34.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.869 -1.06 . . . . 72.43 112.506 -171.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.406 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 39.8 t80 -54.8 -48.22 96.15 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 124.84 1.256 . . . . 75.45 113.59 -172.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 23.3 Cg_exo -63.7 -34.44 62.48 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.932 1.755 . . . . 73.04 113.019 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -64.75 -44.75 89.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.105 0.562 . . . . 74.12 110.46 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.62 99.24 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.445 -0.798 . . . . 41.43 110.667 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.5 ' HD3' ' HA ' ' C' ' 108' ' ' PRO . 39.4 mtp180 -56.38 -53.39 57.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.966 0.906 . . . . 74.52 111.402 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.46 -32.76 71.89 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.711 0.632 . . . . 74.34 110.794 -173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.6 t -70.6 -29.96 66.5 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.565 0.346 . . . . 65.32 110.811 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.45 HD13 HG23 ' C' ' 64' ' ' VAL . 65.3 mt -73.65 -49.09 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.996 0.518 . . . . 74.34 109.724 171.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 92.3 m -59.47 -35.42 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.026 0.93 . . . . 73.03 111.454 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.1 t -63.31 -51.27 66.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.241 -0.891 . . . . 54.5 109.114 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.6 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -60.87 -32.72 72.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.754 0.822 . . . . 73.3 112.704 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.5 t -73.72 -37.6 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 53.44 110.141 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 63.6 p -75.54 -25.36 57.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.923 0.489 . . . . 71.23 110.745 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.6 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -70.49 -44.0 68.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.703 0.801 . . . . 71.21 109.567 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.33 -5.5 85.58 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.528 0.517 . . . . 44.14 112.618 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p 67.31 25.97 8.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.534 1.933 . . . . 64.11 113.336 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' C' ' 118' ' ' VAL . 98.6 m-85 -85.45 163.77 43.32 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.682 0.793 . . . . 64.23 109.794 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.38 151.36 30.11 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.128 2.552 . . . . 52.44 113.984 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.488 HE22 HD22 ' C' ' 127' ' ' ASN . 0.6 OUTLIER -58.92 112.33 1.62 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.861 1.264 . . . . 60.41 110.069 -173.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.4 107.75 10.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.846 -0.798 . . . . 73.32 108.846 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.488 HD22 HE22 ' C' ' 125' ' ' GLN . 6.0 p30 -126.62 133.6 50.97 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.196 -1.409 . . . . 41.14 107.196 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.8 113.89 4.66 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.75 -1.204 . . . . 72.24 107.75 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.67 134.1 82.61 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.883 0.74 . . . . 63.31 110.846 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.505 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 52.7 Cg_exo -56.13 90.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.485 2.79 . . . . 41.02 113.248 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.67 110.37 30.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.537 -0.912 . . . . 75.02 108.537 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -85.7 89.32 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.62 -0.718 . . . . 74.44 110.509 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -40.81 93.36 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.568 -1.196 . . . . 71.14 109.13 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 . . . . . 0 CA--C 1.544 0.712 0 CA-C-N 113.68 -1.6 . . . . 72.21 112.969 175.64 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 114.363 1.246 . . . . 72.24 114.363 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.6 m -138.69 139.93 38.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.979 -1.489 . . . . 74.31 106.979 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.79 114.44 7.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.268 -1.012 . . . . 75.24 108.268 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -129.87 142.54 50.65 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.98 -0.748 . . . . 71.52 108.98 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.1 101.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.041 -1.466 . . . . 55.34 107.041 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -46.67 38.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.491 0.717 . . . . 61.23 111.221 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -166.9 133.77 2.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.957 -0.565 . . . . 74.14 110.072 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.509 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.7 mp -108.91 135.87 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.366 -1.346 . . . . 73.11 107.366 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -161.96 170.95 18.43 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 122.13 0.967 . . . . 73.3 112.423 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 46.6 p -104.55 119.17 38.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.679 -1.146 . . . . 71.01 109.088 172.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 36.7 mtpt -86.45 -30.79 21.78 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.056 -0.35 . . . . 61.25 110.056 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -145.9 137.59 25.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.61 . . . . 64.33 109.984 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.555 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.3 mt -134.41 148.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 73.43 108.242 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -148.26 140.97 24.57 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.294 1.037 . . . . 74.52 109.07 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.4 t80 -148.36 111.39 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.708 -1.96 . . . . 62.44 105.708 169.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -123.03 110.48 15.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.457 0.703 . . . . 71.21 109.348 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.2 88.14 2.97 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.063 -1.088 . . . . 62.52 108.063 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.12 -45.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.455 2.103 . . . . 74.34 112.405 -171.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.486 ' O ' HG23 ' D' ' 31' ' ' VAL . 36.3 m-80 -102.9 42.33 1.16 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.048 0.939 . . . . 74.01 108.475 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -57.33 -51.96 77.8 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.225 1.194 . . . . 63.03 114.225 -169.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.59 -0.6 8.82 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 121.591 1.604 . . . . 72.42 112.968 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.485 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 13.6 t-160 -83.05 -26.7 30.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.67 1.188 . . . . 71.32 109.011 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.486 HG23 ' O ' ' D' ' 27' ' ' ASN . 93.2 t -82.31 -24.29 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.211 0.604 . . . . 71.34 110.114 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.489 ' HD1' HH11 ' C' ' 15' ' ' ARG . 60.5 t80 -53.98 -39.84 66.36 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.105 0.962 . . . . 72.13 112.542 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -79.37 -13.73 59.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.246 0.461 . . . . 73.42 112.246 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -111.5 100.68 9.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.069 -0.715 . . . . 75.52 109.069 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.39 89.24 4.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.011 0.524 . . . . 71.03 109.8 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.562 ' HB3' HD11 ' D' ' 68' ' ' LEU . 17.0 t-105 -159.21 158.24 32.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.027 -1.101 . . . . 74.33 108.027 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -81.66 112.52 35.05 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.474 0.709 . . . . 53.01 110.508 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -48.88 139.15 25.71 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.771 2.981 . . . . 71.52 114.058 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.12 121.69 16.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.529 -0.545 . . . . 73.53 109.529 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.13 115.69 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.085 0.469 . . . . 60.33 110.572 -174.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -87.26 146.28 26.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.491 1.116 . . . . 74.22 108.901 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -110.18 131.03 55.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.179 -0.675 . . . . 44.15 109.179 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.5 m-20 -133.37 142.72 48.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.652 1.181 . . . . 55.5 108.195 171.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -138.49 164.75 28.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.788 0.435 . . . . 72.3 110.707 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 29.3 t70 -168.43 155.36 7.55 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.498 1.119 . . . . 64.41 108.721 174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -132.48 158.06 43.05 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.987 -0.745 . . . . 73.12 108.987 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.7 167.7 29.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.511 0.725 . . . . 63.34 109.632 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' D' ' 58' ' ' VAL . 56.5 p -159.6 153.6 23.3 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.791 0.836 . . . . 63.23 110.196 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.5 p -151.52 142.59 23.13 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.933 0.893 . . . . 73.22 108.627 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -90.69 117.51 29.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.058 0.543 . . . . 73.44 109.591 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.7 mt -89.62 -31.66 17.45 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.511 -0.552 . . . . 72.34 109.511 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.75 -177.84 4.97 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.121 -0.945 . . . . 60.43 109.852 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.58 119.67 10.27 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.565 -1.198 . . . . 51.03 108.946 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 71.58 2.78 4.41 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.263 1.425 . . . . 71.15 112.741 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -113.77 123.91 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.539 0.736 . . . . 71.42 109.391 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.26 130.42 35.13 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.775 0.43 . . . . 73.13 110.516 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.3 tt0 -92.86 112.05 23.88 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.35 -0.982 . . . . 63.0 108.35 167.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' D' ' 48' ' ' SER . 12.7 m -102.3 137.87 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 170.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.39 140.27 30.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.182 -0.673 . . . . 75.12 109.182 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -112.56 123.81 51.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.175 -1.046 . . . . 63.4 108.175 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.3 ttm-85 -105.44 101.94 11.44 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.207 -0.664 . . . . 72.13 109.207 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.42 119.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.868 -1.16 . . . . 73.35 107.868 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 18.0 m -125.35 142.71 51.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.622 0.725 . . . . 64.25 109.675 -172.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -137.35 123.62 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.881 1.273 . . . . 54.51 108.875 -170.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -115.72 108.48 16.41 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.788 -0.819 . . . . 62.21 108.788 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.1 53.88 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.322 -0.622 . . . . 75.44 109.322 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.7 p -142.0 125.79 17.04 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.174 0.59 . . . . 74.42 109.661 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' D' ' 36' ' ' TRP . 28.0 tp -99.72 116.64 32.29 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.575 -0.898 . . . . 71.15 108.575 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.2 -133.16 23.98 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.72 0.637 . . . . 73.11 112.432 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -92.1 21.6 4.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.43 0.692 . . . . 65.01 110.847 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -141.14 146.41 36.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.249 0.619 . . . . 63.5 111.157 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -68.67 130.8 43.88 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.249 0.619 . . . . 64.43 109.968 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.12 -64.12 1.15 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.574 0.75 . . . . 65.53 109.323 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.47 161.64 40.03 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.31 -0.859 . . . . 72.31 110.321 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -121.38 151.23 40.4 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.282 1.433 . . . . 72.14 107.163 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.7 t -156.98 141.53 16.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 110.153 -0.314 . . . . 71.15 110.153 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.92 137.67 14.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.654 0.782 . . . . 63.53 109.139 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' D' ' 113' ' ' CYS . 66.7 t -135.15 114.24 16.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.44 -0.578 . . . . 75.04 109.44 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.5 mt-30 -91.93 85.16 5.48 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.221 -0.9 . . . . 74.25 108.89 171.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -80.15 101.89 9.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.913 -1.494 . . . . 73.4 109.705 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.27 142.36 15.99 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.759 -0.537 . . . . 70.03 111.759 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.3 133.65 5.55 Favored Glycine 0 C--O 1.236 0.279 0 N-CA-C 111.77 -0.532 . . . . 73.24 111.77 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.87 128.85 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.602 -1.258 . . . . 70.21 107.602 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.59 144.6 51.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.788 0.835 . . . . 74.53 108.817 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -97.52 102.43 14.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.983 -0.747 . . . . 64.25 108.983 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.511 HG21 ' HG3' ' D' ' 94' ' ' MET . 3.4 mp -107.62 99.7 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 107.564 -1.273 . . . . 73.14 107.564 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.41 123.21 35.58 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.49 -0.559 . . . . 74.25 109.49 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.8 22.5 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-O 118.571 -1.127 . . . . 64.55 114.872 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 mt -140.41 140.31 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.57 1.185 . . . . 72.41 110.424 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.94 175.84 9.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.875 1.27 . . . . 72.11 109.856 -174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.36 -140.97 26.17 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 114.537 0.575 . . . . 71.35 114.537 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 43.1 p -66.31 -32.45 73.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 62.43 111.618 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -70.53 -40.96 73.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.436 0.694 . . . . 73.02 110.155 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.511 ' HG3' HG21 ' D' ' 86' ' ' ILE . 49.7 ttp -70.89 -32.68 69.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.533 -0.758 . . . . 72.01 110.564 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.24 83.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.226 0.61 . . . . 71.32 110.29 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -62.0 -34.0 75.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.698 0.799 . . . . 70.41 110.53 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -68.55 -51.43 42.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.919 -0.582 . . . . 73.24 110.387 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.4 -28.4 61.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.81 0.844 . . . . 54.21 112.597 -173.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.28 -4.44 25.45 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.216 -0.769 . . . . 70.34 114.393 -169.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -54.6 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.984 0.892 . . . . 73.34 110.629 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -73.15 -43.49 61.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.718 0.407 . . . . 74.04 111.931 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.426 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 63.4 m -70.35 -45.56 19.91 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 118.694 -0.67 . . . . 72.55 111.381 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.516 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.2 Cg_exo -53.89 -36.37 83.04 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.438 2.092 . . . . 74.35 113.229 165.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.97 -33.05 75.11 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.493 0.717 . . . . 54.11 110.928 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.4 -43.33 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.044 0.538 . . . . 70.05 110.059 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.88 -19.63 58.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.318 -0.855 . . . . 73.44 111.738 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.435 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 60.6 t80 -66.71 -42.26 43.65 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.946 -1.026 . . . . 74.24 113.413 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.43 -38.34 73.85 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.902 1.735 . . . . 75.34 112.993 168.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -78.57 -35.32 46.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.106 0.962 . . . . 64.43 112.115 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.74 -42.07 74.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.253 0.621 . . . . 75.51 109.553 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -62.42 -46.84 86.76 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.331 -1.304 . . . . 72.4 109.922 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 2.6 tm-20 -56.35 -48.97 75.7 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.292 0.995 . . . . 70.44 111.553 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.437 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -61.24 -41.22 96.53 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.04 0.837 . . . . 65.42 110.903 -177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.491 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.6 mt -63.29 -50.72 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.146 0.578 . . . . 74.3 110.105 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.8 m -54.03 -43.26 69.99 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.969 1.308 . . . . 75.14 111.134 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -69.16 -44.96 71.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.756 -1.111 . . . . 51.03 110.605 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.9 mtm -67.81 -33.2 74.33 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.671 0.388 . . . . 65.0 111.827 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.53 -42.52 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.944 0.897 . . . . 74.11 110.248 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -72.72 -29.45 63.37 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.668 0.387 . . . . 62.43 110.897 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -74.62 -26.98 60.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.859 0.864 . . . . 74.33 110.303 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.42 67.42 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.531 -0.758 . . . . 35.34 112.731 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.517 HG23 ' HB3' ' C' ' 17' ' ' TYR . 60.6 p 56.57 21.94 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 125.874 1.67 . . . . 65.21 113.243 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -95.41 154.85 39.26 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.751 0.82 . . . . 73.53 109.955 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.88 137.94 83.77 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.418 2.745 . . . . 74.22 112.671 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -57.8 124.91 20.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.774 0.672 . . . . 74.2 112.233 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.1 tt -108.51 99.05 8.48 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.727 -0.842 . . . . 53.14 108.727 -177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.61 103.07 14.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.553 -0.906 . . . . 60.52 108.553 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.498 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 0.2 OUTLIER -64.06 116.47 5.94 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.375 0.67 . . . . 53.1 109.636 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 145.33 99.12 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.305 0.642 . . . . 60.52 111.927 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.73 106.0 0.26 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.569 2.179 . . . . 72.23 111.508 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.04 147.82 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.205 0.602 . . . . 54.45 110.351 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -79.33 91.1 5.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.051 -0.522 . . . . 74.31 109.77 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.476 0.857 0 CA-C-N 115.849 -0.614 . . . . 71.41 110.624 178.283 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 110.233 -0.284 . . . . 41.34 110.233 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -139.3 115.73 10.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.089 -1.449 . . . . 75.42 107.089 168.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -149.79 134.47 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.545 0.338 . . . . 73.42 111.068 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 16' ' ' ILE . 2.7 pp -80.93 132.1 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.312 -0.996 . . . . 75.12 108.312 169.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -113.8 -38.37 4.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.962 0.505 . . . . 64.41 110.792 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -165.15 123.18 1.62 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.911 -0.403 . . . . 73.21 109.911 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.569 HD11 ' HB ' ' A' ' 13' ' ' ILE . 4.5 mp -121.71 123.39 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.083 -1.08 . . . . 74.42 108.083 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.669 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 9.5 p90 -172.23 176.58 3.37 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.511 0.724 . . . . 75.12 110.929 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -102.01 120.84 41.07 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 71.34 108.832 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HD3' HG22 ' A' ' 59' ' ' VAL . 18.5 ptmt -98.44 -27.62 13.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.196 0.198 . . . . 65.22 111.155 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.751 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 13.7 m-20 -137.77 129.52 28.46 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.759 -0.83 . . . . 64.0 108.759 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 78' ' ' VAL . 54.6 mt -132.34 137.46 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.144 -1.058 . . . . 53.32 108.144 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -145.19 127.23 15.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.8 0.84 . . . . 73.1 109.405 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.677 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.6 t80 -131.12 133.01 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.692 -1.595 . . . . 74.02 106.692 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -141.0 119.34 12.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.394 0.677 . . . . 75.42 109.522 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -125.12 82.1 62.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 107.831 -1.174 . . . . 61.25 107.831 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.31 -35.89 29.96 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.753 2.302 . . . . 72.43 111.369 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' THR . 78.5 m-20 -111.49 35.63 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.66 -1.155 . . . . 42.21 109.458 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.68 -47.14 99.46 Favored Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 123.988 0.915 . . . . 60.43 111.803 171.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 -13.86 25.3 Favored 'Trans proline' 0 C--N 1.403 3.42 0 C-N-CA 122.419 2.079 . . . . 54.24 113.428 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -69.82 -32.59 71.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.423 0.289 . . . . 74.0 110.46 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.565 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 17.5 t -64.98 -19.21 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.84 0.456 . . . . 74.51 110.793 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.64 -41.09 80.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.564 0.746 . . . . 75.13 111.3 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -99.89 -23.53 14.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.143 0.577 . . . . 63.32 111.55 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.2 mmtp -77.27 144.97 37.77 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.283 0.563 . . . . 64.52 111.767 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -79.82 158.1 26.87 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.91 -1.041 . . . . 73.33 110.067 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -90.22 80.17 6.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.054 0.931 . . . . 73.45 110.649 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -135.73 74.56 58.29 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.157 -1.383 . . . . 61.42 107.434 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -91.99 144.39 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.764 2.309 . . . . 62.31 112.567 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.1 115.6 27.8 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.848 -1.167 . . . . 74.43 107.848 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 65' ' ' THR . 85.0 t -95.26 135.94 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.545 0.738 . . . . 55.23 110.133 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 53.3 mtpt -120.62 143.4 48.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.439 0.695 . . . . 72.42 109.492 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -133.22 108.2 8.63 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.66 -1.154 . . . . 72.11 109.21 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -123.48 117.66 25.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.604 1.162 . . . . 64.2 108.662 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -118.4 159.91 22.61 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.075 0.95 . . . . 63.15 110.847 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.476 ' O ' HD23 ' A' ' 60' ' ' LEU . 24.1 t70 -157.83 148.66 21.02 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.38 0.672 . . . . 71.11 110.369 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 98' ' ' LEU . 78.4 m -131.72 134.49 45.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.509 0.724 . . . . 61.53 110.092 175.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.78 135.69 29.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.748 0.819 . . . . 72.14 109.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -113.96 157.88 21.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.131 0.572 . . . . 64.5 109.507 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -160.79 116.07 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.392 -0.595 . . . . 74.13 109.392 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.654 HE21 ' H ' ' A' ' 54' ' ' ASP . 62.6 tt0 -70.98 108.66 4.67 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.355 0.662 . . . . 61.43 110.18 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 57' ' ' GLU . 71.6 mt -79.04 -40.24 31.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.859 0.864 . . . . 72.35 110.89 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.28 -176.12 5.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.198 0.999 . . . . 71.54 109.004 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.79 102.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.347 0.659 . . . . 74.43 111.518 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.654 ' H ' HE21 ' A' ' 50' ' ' GLN . 3.6 m-20 58.41 29.67 18.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.201 1.4 . . . . 75.32 112.631 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.3 t -112.13 122.22 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 106.5 -1.667 . . . . 71.54 106.5 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.64 133.43 38.2 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.492 -0.929 . . . . 73.34 108.492 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 35.0 tt0 -85.8 121.72 28.85 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.644 -0.873 . . . . 72.44 108.644 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.57 115.12 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.999 0.919 . . . . 73.13 108.715 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 19' ' ' LYS . 97.6 t -97.29 135.09 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.228 -0.896 . . . . 65.54 109.257 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -110.73 115.09 28.95 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.098 -1.445 . . . . 74.41 107.098 170.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -102.64 106.02 16.61 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.014 -0.735 . . . . 64.21 109.014 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 133.02 48.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.47 -0.937 . . . . 71.01 108.47 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -123.54 125.23 44.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.849 -0.797 . . . . 62.31 108.849 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 114' ' ' ILE . 61.4 t -118.42 130.83 72.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.624 -1.25 . . . . 73.52 107.624 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.2 m -127.7 149.45 50.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.497 -0.927 . . . . 63.41 108.497 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.24 121.26 13.69 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.256 -1.387 . . . . 61.23 107.256 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.6 m -144.47 129.24 18.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.102 0.561 . . . . 74.05 110.481 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.41 HD13 ' HD2' ' A' ' 34' ' ' LYS . 2.4 tt -88.04 80.92 7.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.452 -1.685 . . . . 71.41 106.452 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.77 -110.17 2.98 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.67 -1.15 . . . . 72.34 111.649 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.74 -26.31 18.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.081 0.952 . . . . 73.05 111.291 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -83.34 116.44 22.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.84 -0.8 . . . . 74.54 108.84 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 32.9 m -77.43 126.56 31.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 110.056 -0.35 . . . . 72.32 110.056 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.55 -52.39 9.12 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.382 -0.97 . . . . 61.32 108.382 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -161.95 170.33 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.06 -0.973 . . . . 73.31 111.204 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.5 tp -141.12 148.77 40.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.34 1.456 . . . . 73.45 107.936 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 62.4 m -142.82 139.74 31.04 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.488 1.115 . . . . 74.41 108.488 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -149.41 118.96 6.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.965 -0.754 . . . . 65.2 108.965 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 21' ' ' ILE . 54.8 t -122.82 118.89 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 121.124 0.488 . . . . 74.54 109.715 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 48.5 mt-30 -89.92 91.46 8.6 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.971 -1.013 . . . . 75.55 108.97 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.73 97.65 4.54 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.593 -1.185 . . . . 75.44 108.6 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.8 140.38 17.09 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.789 -0.924 . . . . 40.51 110.789 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.72 120.64 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.858 -1.297 . . . . 75.34 109.858 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 38.6 mt -81.75 129.26 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.703 -0.851 . . . . 63.33 108.703 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -135.73 122.15 20.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.857 -1.164 . . . . 62.43 107.857 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -90.96 105.97 18.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.044 -0.724 . . . . 33.1 109.044 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -122.01 135.03 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.349 0.66 . . . . 72.34 110.537 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.73 157.81 42.54 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.613 1.165 . . . . 71.12 109.476 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.21 -18.68 9.56 Favored Glycine 0 N--CA 1.471 1.004 0 N-CA-C 114.601 0.601 . . . . 52.43 114.601 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.98 133.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.319 -0.993 . . . . 71.55 108.319 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -147.39 174.32 11.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.875 0.87 . . . . 73.14 109.664 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.6 -115.42 7.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.623 -0.543 . . . . 44.01 113.182 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -71.26 -22.57 61.95 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.297 0.639 . . . . 63.23 111.418 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.42 -50.53 44.9 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.243 1.017 . . . . 73.42 110.789 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -27.65 52.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.012 -0.54 . . . . 74.3 110.14 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.94 94.68 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.334 0.654 . . . . 54.52 110.348 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 25.7 t-80 -65.58 -54.28 30.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.532 -1.213 . . . . 63.53 110.219 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.703 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 62.7 m -68.2 -59.34 3.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.047 0.758 . . . . 71.35 113.047 -168.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 46' ' ' THR . 92.6 mt -67.71 -25.72 65.8 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.234 0.457 . . . . 73.13 112.234 -177.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.24 -13.77 56.91 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.448 -0.64 . . . . 42.03 114.084 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.678 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -140.76 -67.27 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.775 0.788 . . . . 63.34 112.638 -173.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.703 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.34 -57.71 7.31 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 124.611 1.164 . . . . 54.22 113.423 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.6 m -71.69 -45.37 12.56 Favored Pre-proline 0 CA--C 1.559 1.312 0 CA-C-O 118.562 -0.732 . . . . 71.45 112.93 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.92 -25.25 74.19 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.548 1.499 . . . . 74.32 113.516 168.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -69.25 -37.47 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.45 -0.574 . . . . 72.25 109.45 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.03 -44.78 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.758 0.823 . . . . 64.11 110.489 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.85 -24.02 58.52 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.568 -0.742 . . . . 73.33 112.249 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -67.08 -44.57 50.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.109 1.151 . . . . 74.44 114.109 -169.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -34.65 96.12 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 122.12 1.88 . . . . 75.1 112.862 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.92 -43.13 36.69 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.659 0.784 . . . . 75.43 111.631 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -45.01 79.88 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.588 0.355 . . . . 51.34 110.439 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.51 HH12 HD12 ' C' ' 105' ' ' ILE . 29.3 ttm180 -48.53 -58.26 4.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.726 1.266 . . . . 63.24 109.545 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.98 -42.92 95.23 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.403 1.064 . . . . 73.45 111.909 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.91 -34.55 78.22 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.631 0.582 . . . . 75.34 111.572 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' A' ' 64' ' ' VAL . 4.4 mt -70.12 -53.11 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.097 0.559 . . . . 72.42 109.669 171.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 125' ' ' GLN . 62.2 m -58.8 -30.64 67.77 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.965 1.306 . . . . 72.52 111.759 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -71.74 -43.16 66.31 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.045 -0.979 . . . . 72.22 109.86 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.677 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.0 mtm -61.4 -36.85 81.42 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.747 0.419 . . . . 54.01 110.96 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' ILE . 48.7 t -65.93 -46.5 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 123.854 0.721 . . . . 64.35 110.595 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.427 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 84.9 p -71.68 -34.85 70.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.17 -0.468 . . . . 73.15 110.997 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -67.16 -32.09 72.96 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.703 0.801 . . . . 74.51 109.586 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.47 -1.42 65.35 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.196 -0.911 . . . . 74.23 112.837 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m 73.26 10.5 5.11 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.071 1.348 . . . . 73.22 111.627 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -88.04 157.62 50.99 Favored Pre-proline 0 C--O 1.245 0.864 0 N-CA-C 108.961 -0.755 . . . . 64.21 108.961 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.74 113.62 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.418 2.078 . . . . 64.52 111.058 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 119' ' ' SER . 17.6 tt0 -57.06 119.67 6.72 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.515 1.126 . . . . 75.23 110.717 -172.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.8 mt -104.93 101.44 11.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.321 0.648 . . . . 72.15 109.598 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.407 ' OD1' ' HB ' ' C' ' 16' ' ' ILE . 10.1 m-80 -100.07 105.76 17.44 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.523 -1.288 . . . . 75.41 107.523 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.449 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.5 mm? -74.62 157.79 34.79 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.988 0.915 . . . . 73.33 112.513 -167.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.35 142.81 87.23 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.86 0.864 . . . . 61.2 111.794 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HB3' HH22 ' A' ' 111' ' ' ARG . 72.8 Cg_endo -86.37 116.31 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.498 2.132 . . . . 70.13 112.827 170.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.29 114.03 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.254 -1.017 . . . . 62.13 108.254 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.89 99.35 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.684 -0.858 . . . . 71.52 108.684 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.678 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 61.8 t80 -69.63 -26.76 64.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.308 0.243 . . . . 64.14 110.516 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 72.41 110.369 174.777 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.496 1.871 0 N-CA-C 114.124 1.157 . . . . 74.32 114.124 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' B' ' 87' ' ' ALA . 1.1 p -150.57 123.2 8.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.261 1.024 . . . . 72.02 108.412 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -119.74 126.08 50.21 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.547 -0.908 . . . . 70.12 108.547 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.3 tt0 -139.48 132.32 29.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.828 0.851 . . . . 64.02 109.145 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.97 114.82 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.369 -0.975 . . . . 75.42 108.369 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -82.83 -46.24 13.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.783 0.433 . . . . 75.14 110.257 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -164.55 142.24 6.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.573 -0.285 . . . . 73.25 111.176 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.54 141.46 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.231 -1.396 . . . . 71.54 107.231 168.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.471 ' HE1' HG13 ' B' ' 83' ' ' ILE . 14.5 p90 -170.53 151.09 3.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.816 0.673 . . . . 64.41 112.816 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -80.2 123.15 27.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.983 0.913 . . . . 73.3 108.93 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -97.02 -28.84 13.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.329 0.652 . . . . 73.21 110.974 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.683 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.2 t70 -154.09 140.03 18.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.207 -0.452 . . . . 75.02 109.984 -170.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 31.5 mm -133.95 143.57 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.412 1.085 . . . . 72.14 109.098 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -139.64 135.24 33.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.257 1.023 . . . . 73.1 108.81 168.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.61 107.9 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.172 -1.788 . . . . 74.23 106.172 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 22.1 mt-10 -119.07 112.98 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.495 -0.928 . . . . 54.54 108.495 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.21 86.48 21.18 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.974 -1.121 . . . . 73.14 107.974 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.97 -22.81 41.45 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.843 2.362 . . . . 72.12 112.99 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -115.94 22.53 12.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.83 0.852 . . . . 73.34 110.267 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.669 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -49.8 -53.08 45.85 Favored Pre-proline 0 CA--C 1.561 1.367 0 N-CA-C 114.54 1.311 . . . . 64.23 114.54 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.29 -21.39 41.53 Favored 'Trans proline' 0 C--N 1.392 2.82 0 CA-C-N 121.075 1.42 . . . . 75.32 112.646 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.99 1.96 43.03 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.346 1.058 . . . . 70.43 112.623 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' B' ' 123' ' ' PHE . 11.5 p -62.1 -25.83 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.785 1.031 . . . . 70.2 113.785 -167.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -75.84 -0.61 21.81 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.399 0.518 . . . . 61.44 112.399 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -80.77 -32.93 35.34 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.875 0.87 . . . . 73.11 110.027 165.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.653 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 75.7 mmtt -85.44 84.89 7.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.377 1.071 . . . . 71.33 110.454 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -116.4 83.0 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.546 0.738 . . . . 65.22 111.114 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -166.86 -171.76 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.276 1.43 . . . . 75.33 108.934 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.93 115.67 63.34 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.318 0.647 . . . . 72.23 109.593 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.07 153.37 28.55 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.525 2.15 . . . . 64.34 112.74 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.52 103.78 2.15 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.547 -0.909 . . . . 70.41 108.547 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.53 126.07 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.43 0.692 . . . . 64.33 110.472 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -110.5 127.89 55.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.952 1.301 . . . . 54.33 108.866 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.89 123.61 43.27 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 105.427 -2.064 . . . . 61.55 105.427 161.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.576 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.6 t70 -124.07 129.51 51.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.266 -1.383 . . . . 74.11 107.266 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.513 HD21 HG11 ' B' ' 131' ' ' VAL . 3.9 mp -106.19 136.65 45.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.753 -1.202 . . . . 60.05 107.753 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -154.71 156.37 36.26 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 71.3 108.691 177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -146.27 137.04 24.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.488 0.661 . . . . 64.4 110.167 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.01 158.21 31.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.491 -1.67 . . . . 72.25 106.491 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -145.03 171.31 14.64 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.501 0.592 . . . . 51.34 111.425 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -151.61 135.82 16.71 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.382 -1.34 . . . . 75.12 107.382 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -100.83 110.17 22.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.88 0.764 . . . . 74.21 109.487 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.3 mt -72.34 -30.24 64.56 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.69 0.796 . . . . 73.41 112.002 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 179.18 8.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.861 0.864 . . . . 35.32 109.456 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.49 121.09 12.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.222 -0.899 . . . . 74.43 108.603 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 19.5 m-20 76.24 -5.72 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.992 1.717 . . . . 74.13 112.726 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -107.31 88.79 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.006 -1.109 . . . . 50.25 108.006 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.94 138.33 38.14 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.522 -0.918 . . . . 72.32 108.522 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -110.75 100.98 9.64 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.023 -1.473 . . . . 42.45 107.023 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.45 124.21 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.398 0.679 . . . . 73.04 109.762 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.599 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -106.03 116.34 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.778 0.831 . . . . 41.4 110.043 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.28 113.92 26.3 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.076 -1.083 . . . . 70.43 108.076 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -99.62 109.62 22.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.986 0.915 . . . . 74.12 109.829 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.8 t -106.24 119.24 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.912 -0.773 . . . . 71.22 108.912 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.1 m -106.08 146.94 29.52 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.292 1.037 . . . . 51.54 109.616 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.491 HG23 HD13 ' B' ' 114' ' ' ILE . 55.8 t -132.68 131.77 59.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.405 1.082 . . . . 74.32 108.572 173.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.0 m -124.44 136.5 54.09 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.521 -0.918 . . . . 60.35 108.521 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.8 131.06 30.61 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.745 -1.206 . . . . 52.15 107.745 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 66.4 p -137.57 134.24 35.39 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.071 0.548 . . . . 72.04 109.884 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.653 ' HB3' ' HD2' ' B' ' 34' ' ' LYS . 0.9 OUTLIER -113.6 117.78 32.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.336 -1.357 . . . . 75.24 107.336 -179.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.64 -130.25 10.14 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.793 -0.523 . . . . 55.23 111.793 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.27 31.67 5.21 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.893 0.877 . . . . 74.21 109.655 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.83 145.28 28.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.477 0.711 . . . . 61.45 110.082 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -68.12 132.14 46.68 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 122.863 0.465 . . . . 72.04 110.392 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.443 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.87 -55.39 3.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.079 . . . . 73.03 108.721 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -163.58 164.7 24.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.32 110.842 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 52.3 mt -133.42 145.34 50.19 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.203 1.401 . . . . 74.03 107.739 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.7 t -153.63 143.14 21.69 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.409 -0.96 . . . . 72.24 108.409 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -158.99 133.14 7.7 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.809 -0.812 . . . . 75.05 108.809 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' B' ' 113' ' ' CYS . 90.1 t -125.22 145.45 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.858 . . . . 70.21 108.916 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.7 mt-30 -119.97 93.59 4.11 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.332 -0.988 . . . . 75.42 108.332 171.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.439 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -84.01 100.23 10.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.52 -0.763 . . . . 63.24 109.263 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.41 166.47 36.42 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.71 -0.556 . . . . 73.11 111.71 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.47 126.66 1.51 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.462 -0.655 . . . . 53.25 111.462 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 33.5 mt -85.97 116.1 28.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 53.01 108.581 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.51 163.79 17.41 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.687 -0.857 . . . . 72.31 108.687 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.663 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.9 m -129.68 93.22 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.783 -1.191 . . . . 63.55 107.783 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' B' ' 97' ' ' CYS . 0.1 OUTLIER -112.31 111.68 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 107.969 -1.123 . . . . 73.15 107.969 -175.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' B' ' 54' ' ' ASP . . . -130.55 159.37 37.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.914 0.885 . . . . 53.2 110.499 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.48 -42.97 2.04 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.605 0.566 . . . . 64.02 114.096 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.455 HG12 ' HB3' ' B' ' 94' ' ' MET . 0.2 OUTLIER -74.58 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.942 0.897 . . . . 71.22 112.527 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.546 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.4 pt-20 -161.41 -178.2 6.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.917 -1.038 . . . . 74.32 110.547 166.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.62 -118.9 15.96 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.348 -0.842 . . . . 74.01 114.488 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -71.72 -35.64 70.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.685 0.794 . . . . 75.34 111.143 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -73.54 -35.41 65.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.801 0.441 . . . . 73.55 110.878 -171.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.546 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 24.2 ptt? -74.72 -25.65 59.27 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.45 0.3 . . . . 73.44 110.964 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.16 82.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.249 0.62 . . . . 64.1 111.266 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 16.8 m-70 -85.34 -21.34 28.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.202 0.601 . . . . 73.24 111.453 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' B' ' 86' ' ' ILE . 35.8 t -84.37 -62.74 1.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.926 0.394 . . . . 73.33 110.403 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.0 -27.0 61.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.819 0.448 . . . . 73.54 111.456 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.58 -1.31 60.45 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.422 -0.655 . . . . 51.34 114.381 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -150.16 -50.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.995 0.897 . . . . 72.23 112.674 -174.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -65.23 -49.34 70.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.455 0.702 . . . . 61.14 110.744 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.487 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.9 m -64.0 -51.73 61.36 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-O 118.538 -0.744 . . . . 72.41 111.575 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.4 Cg_exo -53.37 -34.56 71.53 Favored 'Trans proline' 0 C--N 1.403 3.405 0 C-N-CA 122.627 2.218 . . . . 73.32 114.726 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.73 -37.9 89.18 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.069 0.548 . . . . 62.12 111.163 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.59 -43.33 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.709 0.804 . . . . 52.24 110.038 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.28 -20.91 50.6 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.147 -0.933 . . . . 71.42 112.504 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -59.69 -51.59 79.87 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 117.844 -1.074 . . . . 73.22 113.769 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.06 -34.43 92.57 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 122.088 1.859 . . . . 44.13 113.285 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 89.1 m-85 -68.63 -49.74 56.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.695 0.798 . . . . 75.41 110.824 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.98 84.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.544 0.738 . . . . 70.41 110.808 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.46 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.8 ttt180 -62.67 -52.56 62.84 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 63.54 110.956 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.97 -38.33 90.69 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.135 -0.938 . . . . 62.4 110.167 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.433 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -69.31 -34.31 74.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.93 -0.577 . . . . 74.2 111.929 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.491 HD13 HG23 ' B' ' 64' ' ' VAL . 66.0 mt -64.66 -57.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.023 0.529 . . . . 71.24 109.584 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.3 m -60.4 -31.16 70.1 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.942 0.776 . . . . 64.52 111.5 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.2 t -62.84 -48.29 79.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.85 0.86 . . . . 63.21 110.917 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.2 mmt -67.83 -34.41 76.68 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.91 0.484 . . . . 61.04 110.867 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.519 HG11 HD13 ' B' ' 126' ' ' LEU . 74.1 t -63.21 -37.66 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 124.17 0.988 . . . . 72.23 110.86 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -63.83 -40.64 97.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.533 0.733 . . . . 53.45 110.866 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -64.39 -32.05 73.5 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.735 -1.12 . . . . 61.11 111.947 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.76 17.5 56.27 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.672 0.608 . . . . 54.01 113.697 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.403 HG23 ' HB3' ' A' ' 17' ' ' TYR . 73.0 p 60.53 26.74 16.39 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.616 1.566 . . . . 72.04 112.912 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.426 ' CE1' HG21 ' B' ' 31' ' ' VAL . 81.3 m-85 -91.84 156.79 42.31 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.395 0.678 . . . . 74.52 110.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.41 177.42 3.27 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 123.238 2.625 . . . . 75.3 114.241 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -67.26 124.32 22.78 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.825 -1.079 . . . . 65.2 111.62 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.519 HD13 HG11 ' B' ' 118' ' ' VAL . 11.0 mp -117.27 96.41 5.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.96 0.904 . . . . 71.35 109.36 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.75 92.63 8.5 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.08 0.467 . . . . 74.43 110.29 173.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.46 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 73.1 mt -67.27 141.9 57.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.175 0.59 . . . . 63.13 110.606 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 143.27 39.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.224 0.61 . . . . 55.34 110.558 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.7 123.34 12.48 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.129 2.552 . . . . 74.33 111.598 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.513 HG11 HD21 ' B' ' 44' ' ' LEU . 12.8 t -100.0 127.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.753 -0.462 . . . . 62.21 109.753 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.61 96.43 10.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.957 -1.127 . . . . 62.33 107.957 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' B' ' 44' ' ' LEU . 58.8 m-85 -59.17 -34.52 72.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 65.44 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.72 -39.09 93.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.384 -1.28 . . . . 73.31 111.198 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.19 78.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.322 0.649 . . . . 74.02 111.585 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 CA--C 1.548 0.884 0 O-C-N 123.849 0.718 . . . . 62.53 110.274 178.293 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 44.6 ttp . . . . . 0 CA--C 1.549 0.93 0 CA-C-O 121.243 0.544 . . . . 74.1 110.401 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 12.4 m -86.79 76.29 9.49 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.604 -1.258 . . . . 51.33 107.604 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -92.0 129.19 38.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.211 -0.904 . . . . 73.02 108.591 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.88 139.53 21.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.696 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -82.56 133.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 107.542 -1.281 . . . . 72.24 107.542 174.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.9 mm-40 -107.62 -46.91 3.72 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.355 0.662 . . . . 65.21 110.006 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -166.79 141.15 4.02 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.59 -0.732 . . . . 71.22 109.654 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.696 HG13 HD11 ' C' ' 13' ' ' ILE . 86.3 mt -129.39 142.01 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 106.926 -1.509 . . . . 70.24 106.926 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -174.03 160.46 3.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.624 0.77 . . . . 54.43 110.248 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.5 p -85.47 107.37 17.39 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.706 -0.679 . . . . 63.2 109.544 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -65.97 -41.84 90.64 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.281 -0.637 . . . . 52.14 109.281 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.6 t70 -147.8 147.12 29.5 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.768 -0.651 . . . . 75.15 109.815 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.2 mt -143.79 145.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.484 1.513 . . . . 64.42 106.965 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -157.96 150.07 22.09 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.081 0.553 . . . . 61.24 109.55 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -146.15 123.27 11.47 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.655 -1.239 . . . . 63.1 107.655 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 36.0 mt-10 -123.59 112.43 17.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.46 0.704 . . . . 60.43 109.558 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -118.22 85.92 25.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.69 -0.856 . . . . 71.23 108.69 172.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -36.33 10.79 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.586 2.19 . . . . 75.55 111.429 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 66.8 m-80 -106.45 36.05 2.75 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.151 -0.931 . . . . 73.11 110.156 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -56.11 -47.18 99.34 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.504 1.122 . . . . 65.32 112.536 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 16.4 Cg_endo -94.39 -10.04 1.48 Allowed 'Trans proline' 0 C--N 1.397 3.111 0 C-N-CA 122.257 1.971 . . . . 63.02 113.641 173.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-160 -71.96 -30.95 65.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.332 0.653 . . . . 73.25 111.282 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.576 HG11 ' HE1' ' C' ' 123' ' ' PHE . 7.6 p -76.76 -13.73 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.839 0.855 . . . . 75.44 111.832 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -51.51 -37.34 48.76 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.407 1.483 . . . . 73.43 113.259 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -126.54 26.49 6.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.399 0.68 . . . . 71.52 110.134 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -125.4 153.0 44.08 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.252 -0.905 . . . . 73.41 111.922 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.85 133.14 47.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.536 1.534 . . . . 61.15 112.586 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -86.1 104.76 15.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.691 0.796 . . . . 74.55 110.598 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -161.47 68.5 2.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.441 -0.948 . . . . 63.22 108.441 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -86.92 138.47 5.04 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.063 1.842 . . . . 71.21 110.959 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.46 97.62 9.08 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.771 -1.937 . . . . 71.13 105.771 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -79.37 99.45 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.812 -1.085 . . . . 63.41 110.837 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -93.51 117.1 29.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.278 -0.874 . . . . 63.41 110.185 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -92.02 148.29 22.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.686 -0.857 . . . . 53.15 108.686 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.9 t70 -146.77 112.45 5.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.16 -1.052 . . . . 73.24 108.16 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.37 111.56 24.04 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.043 -1.095 . . . . 73.24 108.043 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -123.61 158.55 31.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.686 1.195 . . . . 70.02 108.657 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -145.64 151.36 37.93 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.281 0.562 . . . . 64.22 109.742 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 173.8 11.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.541 1.136 . . . . 74.35 108.338 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.7 p -152.3 148.09 27.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 122.866 0.467 . . . . 61.14 110.016 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -145.38 125.47 13.68 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.675 -1.231 . . . . 75.15 107.675 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.44 115.16 22.4 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.369 -0.974 . . . . 74.12 108.369 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.594 HD11 HD12 ' C' ' 83' ' ' ILE . 58.9 mt -84.92 -39.33 18.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.458 0.703 . . . . 65.45 110.272 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.71 -173.33 4.06 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.021 -0.99 . . . . 43.35 110.384 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.28 111.73 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.34 -1.3 . . . . 74.1 110.322 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 64.8 17.52 11.03 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.611 1.164 . . . . 75.43 112.443 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.4 103.82 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.343 -0.984 . . . . 75.54 108.343 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -118.12 125.84 51.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.82 0.848 . . . . 71.0 109.933 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.5 tt0 -84.03 112.09 19.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.05 0.94 . . . . 65.31 109.306 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.72 129.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.745 -1.206 . . . . 74.32 107.745 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.42 105.23 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.68 100.38 12.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.192 -1.04 . . . . 63.33 108.192 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -93.43 111.33 22.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.097 1.359 . . . . 64.0 109.486 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' C' ' 114' ' ' ILE . 2.9 t -103.11 137.23 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.02 -0.733 . . . . 72.23 109.02 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 54.1 m -119.17 133.76 55.59 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.541 -0.911 . . . . 70.32 108.541 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.54 HG21 HG21 ' C' ' 114' ' ' ILE . 93.9 t -124.76 117.31 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.979 1.312 . . . . 61.33 107.49 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -117.02 134.4 54.79 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.937 -0.764 . . . . 71.21 108.937 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.0 95.52 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.889 -1.523 . . . . 63.52 106.889 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -149.07 123.16 9.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.367 0.267 . . . . 60.5 111.317 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -85.86 77.29 9.75 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.045 -1.095 . . . . 54.14 108.045 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.44 -93.23 0.24 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.169 -0.923 . . . . 74.23 112.643 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.4 -15.48 21.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.998 0.919 . . . . 65.31 111.522 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -98.1 95.42 7.43 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.088 0.555 . . . . 63.05 110.231 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.8 m -89.46 118.39 29.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.012 0.434 . . . . 65.12 111.242 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.83 -53.44 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.127 0.971 . . . . 63.43 108.846 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.15 168.48 27.3 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.454 -1.248 . . . . 63.11 111.844 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.4 tm? -140.65 146.31 37.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.39 -2.078 . . . . 72.5 105.39 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.8 t -153.33 130.81 11.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.179 -0.675 . . . . 64.3 109.179 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -136.36 129.55 31.48 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.757 -0.46 . . . . 50.51 109.757 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.71 114.67 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.857 . . . . 55.54 109.062 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.99 95.44 10.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.146 0.978 . . . . 64.43 108.701 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -83.67 105.76 14.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.851 -0.613 . . . . 72.51 109.685 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.24 144.37 21.63 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.565 -0.614 . . . . 61.43 111.565 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.43 117.16 0.93 Allowed Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 110.155 -1.178 . . . . 71.32 110.155 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.594 HD12 HD11 ' C' ' 51' ' ' LEU . 11.2 mm -81.52 122.33 36.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.093 -1.077 . . . . 73.2 108.093 176.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -131.2 128.75 40.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.731 0.812 . . . . 74.3 109.028 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.3 m -71.36 114.19 9.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.128 -0.693 . . . . 71.1 109.128 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 mm -116.85 101.24 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.957 0.903 . . . . 74.31 108.64 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -133.94 150.58 51.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.698 . . . . 52.41 109.76 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -47.12 3.58 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 121.247 0.36 . . . . 24.42 113.074 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.75 149.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.84 1.256 . . . . 65.44 110.527 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -160.6 155.93 24.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.935 0.494 . . . . 74.14 111.032 -174.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.09 -142.76 28.89 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.166 0.412 . . . . 51.02 113.687 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -61.42 -24.72 66.72 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.161 0.984 . . . . 74.44 111.821 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -58.95 -57.39 13.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.82 0.848 . . . . 75.23 110.097 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 26.6 ptm -74.41 -23.35 58.94 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.775 -0.648 . . . . 62.43 111.056 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.63 84.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.296 0.638 . . . . 65.14 111.064 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.51 -29.99 68.71 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.255 0.622 . . . . 75.51 110.955 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.37 -62.34 1.51 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.536 0.334 . . . . 73.35 110.296 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.8 pp -76.08 -12.92 60.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.172 0.589 . . . . 74.4 112.521 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.38 33.16 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.587 -0.563 . . . . 53.25 113.962 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' C' ' 133' ' ' PHE . . . -148.28 -56.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 117.626 0.713 . . . . 65.03 111.588 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -70.78 -61.46 1.76 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.684 0.394 . . . . 74.32 111.798 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 69.3 m -54.86 -45.5 99.7 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.97 0.908 . . . . 40.32 112.291 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -47.97 -48.57 15.94 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.757 2.304 . . . . 63.51 113.72 167.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.541 HD21 ' HA ' ' C' ' 132' ' ' ASN . 4.8 m-20 -74.63 -15.42 60.82 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.687 0.795 . . . . 71.34 113.114 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.51 HD12 HH12 ' A' ' 111' ' ' ARG . 36.3 mm -75.5 -40.89 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.279 -0.637 . . . . 75.42 109.279 169.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.418 HD21 ' HA3' ' C' ' 82' ' ' GLY . 67.8 mt -86.31 -17.92 33.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.178 0.991 . . . . 74.21 111.915 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.43 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 50.2 t80 -65.12 -46.63 73.17 Favored Pre-proline 0 CA--C 1.55 0.981 0 CA-C-O 117.535 -1.221 . . . . 63.2 113.031 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.89 -37.75 97.49 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.942 1.761 . . . . 63.13 112.634 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -65.28 -52.68 52.7 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 74.42 110.873 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.16 -35.17 79.77 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.151 0.58 . . . . 74.1 111.351 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.24 -53.11 61.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.573 1.149 . . . . 73.13 110.217 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.1 tm-20 -67.35 -34.94 78.36 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.837 0.711 . . . . 71.24 110.107 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 27.6 t -67.39 -32.92 74.16 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.071 0.548 . . . . 73.34 111.393 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.54 HG21 HG21 ' C' ' 64' ' ' VAL . 88.7 mt -73.11 -51.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.362 0.665 . . . . 74.1 110.223 172.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 34.8 m -63.03 -29.0 70.48 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.281 0.632 . . . . 51.23 110.929 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.4 t -65.44 -52.4 53.46 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.306 -0.861 . . . . 73.13 109.033 170.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.487 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -56.53 -40.44 75.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.889 1.276 . . . . 73.44 113.016 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -65.89 -45.2 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.667 0.787 . . . . 52.4 109.761 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.44 ' HB2' HE22 ' C' ' 125' ' ' GLN . 35.9 t -70.64 -24.01 62.63 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.153 -0.931 . . . . 53.34 111.26 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.4 mtt-85 -69.94 -36.41 75.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.472 0.709 . . . . 72.21 109.272 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.34 10.06 62.43 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 124.002 0.814 . . . . 51.44 112.79 172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.44 HG23 ' HB3' ' D' ' 17' ' ' TYR . 81.9 p 57.61 37.21 27.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.046 1.738 . . . . 44.02 113.425 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.576 ' HE1' HG11 ' C' ' 31' ' ' VAL . 61.1 m-85 -105.73 162.23 20.36 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.363 1.065 . . . . 73.12 110.216 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.99 146.0 97.02 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.107 2.538 . . . . 55.24 113.384 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.44 HE22 ' HB2' ' C' ' 119' ' ' SER . 1.8 mp0 -58.49 108.92 0.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.003 0.921 . . . . 74.2 109.632 173.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.2 tp -110.21 91.64 3.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.839 -1.171 . . . . 72.23 107.839 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -91.17 115.47 28.05 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.564 -0.902 . . . . 72.33 108.564 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.43 ' HB3' ' HZ ' ' C' ' 107' ' ' PHE . 2.3 tt -64.97 132.86 50.42 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.94 139.42 70.72 Favored Pre-proline 0 CA--C 1.549 0.921 0 O-C-N 124.11 0.882 . . . . 62.35 110.968 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.48 104.61 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.303 2.002 . . . . 72.14 111.296 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.0 107.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 108.402 -0.962 . . . . 74.42 108.402 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.541 ' HA ' HD21 ' C' ' 104' ' ' ASN . 15.3 m120 -113.23 89.52 3.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.498 0.719 . . . . 73.43 110.149 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.438 ' HD2' ' HB2' ' C' ' 100' ' ' ALA . 67.7 t80 -70.78 -30.32 66.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.049 -0.978 . . . . 72.13 109.428 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 124.245 1.018 . . . . 73.52 111.364 173.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.6 ttp . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 113.13 0.789 . . . . 75.14 113.13 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.0 m -115.26 135.15 54.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.173 -1.047 . . . . 73.13 108.173 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' D' ' 85' ' ' SER . 72.0 t80 -154.22 119.31 5.03 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.443 -0.947 . . . . 64.41 108.443 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -132.37 147.21 52.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.565 0.746 . . . . 64.42 110.371 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 122.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.916 -1.142 . . . . 72.3 107.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.413 HE22 HG13 ' D' ' 55' ' ' VAL . 49.2 mt-30 -100.3 -46.36 5.29 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.1 -0.375 . . . . 75.22 110.224 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -169.92 121.99 0.69 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.484 0.49 . . . . 72.42 110.606 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.63 131.76 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 107.469 -1.308 . . . . 63.31 107.469 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HE2' ' HG2' ' D' ' 19' ' ' LYS . 44.3 p90 -162.52 178.47 8.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.52 0.676 . . . . 64.42 111.794 -173.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.2 p -104.91 123.75 48.29 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.671 0.788 . . . . 44.51 109.654 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' HE2' ' D' ' 17' ' ' TYR . 32.3 mtpt -91.27 -22.96 20.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.965 -0.383 . . . . 61.23 109.965 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.9 t70 -155.11 141.73 18.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.521 0.728 . . . . 73.05 109.76 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.482 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.2 mt -140.84 147.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.01 1.324 . . . . 71.14 108.085 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.74 145.99 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.843 0.857 . . . . 61.35 109.34 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.3 t80 -148.97 124.93 10.63 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.649 -1.611 . . . . 61.21 106.649 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.6 mt-10 -124.31 142.16 51.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.581 0.753 . . . . 73.24 109.487 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.685 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -147.68 76.31 10.8 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.763 0.825 . . . . 64.13 109.081 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.54 -47.71 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.43 2.087 . . . . 72.01 111.622 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' D' ' 72' ' ' THR . 26.1 m-20 -97.12 36.13 1.48 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.953 0.901 . . . . 74.44 108.955 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.685 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.47 -54.66 52.68 Favored Pre-proline 0 CA--C 1.559 1.289 0 N-CA-C 114.294 1.22 . . . . 33.11 114.294 -172.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.04 -7.3 14.23 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 121.237 1.477 . . . . 71.33 112.605 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.523 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 19.4 t-160 -83.83 -38.81 20.74 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.214 1.406 . . . . 73.53 110.099 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -82.96 -20.83 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 73.44 110.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.23 -28.91 69.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.856 0.862 . . . . 73.23 110.688 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 63.3 mt-30 -67.04 -20.39 65.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.749 1.219 . . . . 75.31 111.557 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -100.86 111.59 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.271 1.029 . . . . 74.44 110.059 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -85.86 63.26 7.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.354 1.061 . . . . 73.13 111.108 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.523 ' HB3' HD11 ' D' ' 68' ' ' LEU . 48.2 t-105 -144.69 167.98 21.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.71 116.64 66.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.586 0.754 . . . . 73.34 110.031 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -50.61 133.93 39.17 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.642 2.894 . . . . 42.45 113.764 170.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.39 130.6 43.89 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.782 -0.451 . . . . 71.01 109.782 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.43 134.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.382 0.673 . . . . 53.53 110.786 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.1 tmtt? -130.6 121.38 25.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.428 -1.693 . . . . 72.11 106.428 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 146.9 26.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.102 0.561 . . . . 61.34 110.978 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.8 m-20 -137.14 122.95 20.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.215 1.406 . . . . 73.11 107.609 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -117.2 144.24 44.99 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.986 0.514 . . . . 71.42 110.943 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 2.6 t70 -146.82 154.02 40.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.511 1.124 . . . . 74.11 109.3 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -142.76 148.42 37.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.469 0.708 . . . . 71.13 109.775 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 168.0 25.01 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.651 1.18 . . . . 70.5 108.14 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -160.5 153.83 21.96 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.054 0.454 . . . . 74.41 111.244 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -154.36 119.6 5.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.717 1.207 . . . . 63.44 108.98 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.58 126.28 29.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.167 0.587 . . . . 73.53 109.543 175.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.66 -40.69 13.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.942 0.497 . . . . 75.33 109.701 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.14 -174.97 4.99 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.078 -0.964 . . . . 70.22 110.243 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -63.08 123.35 18.36 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.631 -0.713 . . . . 63.42 110.301 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.44 -2.24 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.873 1.269 . . . . 73.43 112.909 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.413 HG13 HE22 ' D' ' 14' ' ' GLN . 89.7 t -108.68 118.68 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.842 0.857 . . . . 63.44 108.868 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -128.97 128.53 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.877 -1.157 . . . . 75.51 107.877 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -97.13 141.33 30.4 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.824 -1.547 . . . . 64.15 106.824 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.26 130.55 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.052 -0.722 . . . . 73.42 109.052 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.82 138.84 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 123.916 0.887 . . . . 74.2 109.684 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.17 120.77 27.95 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.528 -1.286 . . . . 54.22 107.528 171.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -107.25 121.62 44.91 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.231 1.012 . . . . 75.54 109.32 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.59 122.49 67.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.613 -1.255 . . . . 73.11 107.613 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.6 m -121.2 131.81 54.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.743 0.817 . . . . 63.31 109.462 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.503 HG23 HD13 ' D' ' 114' ' ' ILE . 80.7 t -119.55 109.13 25.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.082 1.353 . . . . 70.14 109.261 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 23.6 m -94.89 117.68 30.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.144 -1.058 . . . . 74.55 108.144 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.92 133.07 51.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.464 -0.569 . . . . 62.24 109.464 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 51.2 p -145.83 134.82 22.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.069 0.548 . . . . 70.22 109.797 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' D' ' 36' ' ' TRP . 19.0 tp -117.87 118.94 33.37 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.105 -0.702 . . . . 63.13 109.105 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.09 -115.18 4.01 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.15 -0.78 . . . . 43.54 111.15 -170.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.19 9.06 10.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.032 0.933 . . . . 61.43 110.268 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.88 156.56 39.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.014 0.926 . . . . 64.3 110.298 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 99.1 m -68.83 123.99 22.47 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.654 0.782 . . . . 70.23 110.576 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.52 -57.28 3.21 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.707 0.803 . . . . 61.44 109.322 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.94 149.75 16.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.801 -1.091 . . . . 74.04 109.683 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -113.65 153.64 28.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.418 1.087 . . . . 62.3 108.209 172.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.594 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.8 t -156.09 142.41 18.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.106 0.562 . . . . 75.21 109.592 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.22 121.4 4.3 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.838 0.455 . . . . 64.41 110.075 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.448 HG22 HG23 ' D' ' 21' ' ' ILE . 60.3 t -126.31 115.26 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.316 0.647 . . . . 74.33 109.973 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.2 mt-30 -89.16 87.76 7.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.737 -0.838 . . . . 60.14 108.737 169.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.89 104.04 10.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.516 -1.22 . . . . 74.34 108.664 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.59 143.68 15.7 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.901 -0.479 . . . . 61.22 111.901 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.453 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.99 131.41 4.57 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.789 -0.524 . . . . 73.52 111.789 -171.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.402 HG22 ' NE2' ' D' ' 14' ' ' GLN . 53.4 mt -88.8 123.03 40.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 C-N-CA 123.926 0.89 . . . . 64.44 108.761 175.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -128.64 163.05 25.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.925 0.89 . . . . 71.25 109.98 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.8 m -107.3 112.88 25.94 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.529 -0.915 . . . . 71.21 108.529 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.77 115.63 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 107.877 -1.157 . . . . 73.43 107.877 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -145.91 157.6 43.89 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.318 1.047 . . . . 54.21 109.785 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.44 -14.28 12.96 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.086 -0.506 . . . . 44.44 113.567 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.9 138.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.956 1.303 . . . . 74.11 109.312 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -152.4 -177.35 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.2 0.6 . . . . 73.34 110.718 174.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.64 -120.15 6.81 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.037 -0.529 . . . . 64.01 112.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.9 p -64.33 -39.3 93.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.805 0.842 . . . . 75.44 111.301 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.91 -37.63 72.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.738 0.415 . . . . 73.4 111.094 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.659 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 58.3 ttp -72.58 -36.1 68.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.596 0.359 . . . . 74.32 110.567 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.71 86.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.169 0.588 . . . . 61.42 110.392 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -68.3 -37.72 80.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.814 0.846 . . . . 73.44 110.809 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' D' ' 102' ' ' CYS . 33.3 t -68.68 -51.25 43.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.673 0.389 . . . . 61.43 110.158 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.41 -18.78 59.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.347 0.659 . . . . 65.41 111.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.61 -8.98 44.87 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.409 -0.662 . . . . 74.12 114.14 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.94 -63.19 0.35 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.878 0.839 . . . . 70.52 112.25 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.13 -56.52 11.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.397 0.888 . . . . 72.53 113.397 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' D' ' 97' ' ' CYS . 65.4 m -61.91 -43.27 86.51 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-O 118.594 -0.717 . . . . 75.32 111.606 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -51.6 -39.6 65.38 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.463 2.109 . . . . 61.02 114.121 164.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -69.98 -25.29 63.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.599 0.76 . . . . 74.5 111.063 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 48.2 mm -70.27 -40.61 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.349 0.66 . . . . 53.22 110.112 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.453 HD21 ' HA3' ' D' ' 82' ' ' GLY . 61.7 mt -77.06 -26.51 53.62 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.194 -0.912 . . . . 50.0 111.667 -174.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.505 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 85.4 t80 -53.97 -47.91 95.52 Favored Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 125.039 1.336 . . . . 73.43 114.469 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 80.7 Cg_exo -51.0 -41.07 57.97 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.431 2.087 . . . . 63.54 113.712 172.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -75.87 -34.98 60.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.892 0.877 . . . . 75.44 111.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.84 73.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.141 0.577 . . . . 71.24 109.894 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -56.45 -48.34 77.25 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.581 1.176 . . . . 70.23 110.234 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.45 -44.69 95.81 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.081 0.863 . . . . 74.51 111.121 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.6 t -61.38 -43.71 98.41 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.594 0.559 . . . . 73.21 110.856 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.594 HG12 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -57.11 -57.91 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.877 0.871 . . . . 63.51 110.23 173.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.587 HG23 ' HG3' ' D' ' 125' ' ' GLN . 87.9 m -53.79 -46.69 71.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.362 1.465 . . . . 73.02 112.02 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -62.55 -41.11 98.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.91 -1.041 . . . . 71.14 110.036 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.05 -33.8 72.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.144 0.578 . . . . 73.15 111.667 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -64.39 -43.3 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.594 0.758 . . . . 75.05 110.406 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.79 -33.51 66.32 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 116.105 -0.498 . . . . 73.54 110.704 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -68.06 -32.68 73.2 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.997 0.919 . . . . 75.0 110.42 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.04 81.86 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.719 -0.673 . . . . 52.45 112.849 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 56.18 45.15 23.85 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.446 1.498 . . . . 72.23 112.258 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -117.85 155.37 50.98 Favored Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.799 -1.092 . . . . 75.11 110.23 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.48 112.07 0.61 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.25 2.633 . . . . 53.22 112.321 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.587 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.9 tt0 -61.28 128.74 37.83 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.148 0.905 . . . . 75.2 112.025 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.25 120.29 41.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.878 -1.156 . . . . 64.34 107.878 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -112.72 95.13 5.25 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.864 -1.162 . . . . 62.03 107.864 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.505 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.2 OUTLIER -70.34 125.93 28.19 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.062 0.545 . . . . 72.12 109.642 -174.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 142.14 96.66 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.896 0.878 . . . . 73.41 111.508 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.4 124.9 6.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.948 2.432 . . . . 74.32 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -127.27 123.72 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.947 0.899 . . . . 54.52 109.481 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -76.82 94.83 3.93 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.894 -0.78 . . . . 75.33 108.894 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 19.7 p90 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 118.815 -0.612 . . . . 74.24 111.256 175.405 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.232 0.183 0 N-CA-C 108.051 -1.092 . . . . 70.54 108.051 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -131.56 152.91 50.39 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.282 0.633 . . . . 74.4 110.316 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -155.84 123.24 5.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.565 0.746 . . . . 64.41 109.522 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -81.04 125.91 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.641 -1.615 . . . . 60.32 106.641 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HB3' HH11 ' A' ' 15' ' ' ARG . 88.3 mt-30 -109.83 -42.05 4.35 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 122.092 -0.38 . . . . 73.12 111.134 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.482 HH11 ' HB3' ' A' ' 14' ' ' GLN . 2.3 mpt_? -152.34 141.46 21.32 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.219 -1.03 . . . . 70.41 108.219 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.701 HG23 HD23 ' A' ' 106' ' ' LEU . 55.5 mt -141.13 101.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.025 -1.842 . . . . 74.12 106.025 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 73.0 m-85 -155.36 177.97 10.75 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.634 0.774 . . . . 75.0 110.287 -162.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.3 p -98.24 113.56 25.53 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.679 -0.691 . . . . 63.24 109.846 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -78.17 -32.61 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.802 -0.444 . . . . 73.43 109.802 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.0 t70 -149.02 147.63 28.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.999 -0.546 . . . . 73.42 109.735 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.8 mt -140.72 144.13 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.198 1.399 . . . . 73.41 107.803 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -157.4 120.9 4.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.77 0.319 . . . . 70.42 110.915 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.8 t80 -118.41 134.3 55.17 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.126 -1.435 . . . . 71.5 107.126 171.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -129.55 140.8 51.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.216 -1.031 . . . . 70.04 108.216 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -139.16 84.29 16.91 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.55 -0.907 . . . . 55.34 108.55 173.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.23 -49.64 1.85 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.986 2.457 . . . . 64.42 112.199 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 44.4 m-80 -103.28 43.92 1.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.605 0.762 . . . . 70.42 109.445 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -59.42 -51.95 77.71 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.125 0.97 . . . . 73.44 113.205 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -22.66 14.73 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.867 1.711 . . . . 73.43 111.939 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 7.5 t60 -83.04 -25.35 32.21 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.948 1.299 . . . . 53.23 111.992 -168.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.99 -26.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.915 0.886 . . . . 41.02 112.553 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.412 ' HD2' ' HZ2' ' A' ' 36' ' ' TRP . 70.2 m-85 -70.3 -34.73 73.09 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.621 0.768 . . . . 75.14 112.169 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -63.36 -36.32 83.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.199 0.999 . . . . 70.11 110.177 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.84 154.79 23.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.549 -1.205 . . . . 72.02 110.756 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.0 118.49 16.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.008 -0.738 . . . . 65.13 109.008 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.412 ' HZ2' ' HD2' ' A' ' 32' ' ' PHE . 5.5 m0 -60.47 86.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 71.31 112.298 -174.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -128.26 75.04 79.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.074 0.95 . . . . 71.42 108.579 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.16 139.88 7.36 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.589 2.193 . . . . 64.34 112.279 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -95.82 106.77 18.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.708 -1.59 . . . . 74.42 106.708 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -85.15 92.07 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 123.651 0.594 . . . . 51.4 109.537 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.462 ' NZ ' ' HB2' ' A' ' 67' ' ' SER . 10.7 mptt -75.82 133.03 40.74 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.944 -0.761 . . . . 73.51 108.944 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -121.56 115.79 23.45 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.466 -1.309 . . . . 74.13 107.466 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.5 m-20 -122.14 135.76 54.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.02 0.928 . . . . 73.41 108.707 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.0 mt -121.72 134.06 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.692 0.797 . . . . 64.22 109.11 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 33.8 t70 -142.17 144.66 33.53 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.896 0.478 . . . . 53.23 110.039 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -139.11 130.59 27.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.77 0.828 . . . . 50.52 110.73 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.45 149.27 42.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.958 0.903 . . . . 71.14 109.754 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.6 p -106.28 164.17 12.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.577 0.751 . . . . 63.52 109.628 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -153.97 131.16 11.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.056 0.942 . . . . 72.11 108.476 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -88.73 122.35 32.05 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.023 0.529 . . . . 74.13 110.563 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.2 mt -91.5 -44.71 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.164 -0.925 . . . . 53.52 109.106 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.18 176.82 10.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.626 -1.17 . . . . 73.12 109.532 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.84 114.62 10.12 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.919 -1.141 . . . . 71.22 107.919 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 75.23 3.52 4.06 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.314 1.446 . . . . 75.35 112.908 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 29.1 t -112.79 111.97 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 108.649 -0.871 . . . . 50.11 108.649 173.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -125.21 156.01 39.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.433 0.693 . . . . 75.34 110.054 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HB2' HD11 ' A' ' 51' ' ' LEU . 42.2 tt0 -131.5 117.78 19.26 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.155 0.982 . . . . 74.42 108.743 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.98 128.63 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.167 -1.049 . . . . 62.43 108.167 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -109.03 134.23 51.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.636 0.775 . . . . 73.44 109.197 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.15 118.75 37.57 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.447 -1.316 . . . . 74.54 107.447 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.55 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.26 101.75 13.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.166 -1.05 . . . . 73.12 108.166 171.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.4 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.3 t -95.32 132.77 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.78 -1.193 . . . . 72.1 107.78 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.0 m -118.24 133.12 56.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.844 -0.799 . . . . 61.32 108.844 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -132.52 105.07 8.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.798 -1.556 . . . . 62.31 106.798 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.8 m -113.21 129.45 56.51 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.929 -0.767 . . . . 64.13 108.929 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.89 105.42 11.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.742 -1.207 . . . . 73.2 107.742 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 23.9 m -121.66 127.82 51.22 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.674 -0.491 . . . . 61.31 109.674 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt -89.17 81.98 6.65 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.917 -1.512 . . . . 72.31 106.917 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -119.17 5.14 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.419 -0.81 . . . . 31.15 112.245 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.81 -14.66 41.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.776 0.83 . . . . 73.25 111.3 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.3 132.56 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.661 1.184 . . . . 72.13 109.336 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -83.83 131.37 34.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.856 0.36 . . . . 60.5 110.717 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.91 -54.11 5.34 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.883 0.873 . . . . 74.42 109.008 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -159.79 174.13 14.95 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.539 -0.755 . . . . 72.34 111.533 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 tp -141.18 148.4 39.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.571 1.548 . . . . 72.01 108.058 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 60.2 m -136.86 133.44 35.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.432 -0.951 . . . . 65.42 108.432 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.96 124.8 11.91 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.14 -0.689 . . . . 74.32 109.14 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.93 117.12 25.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 123.581 0.753 . . . . 72.31 109.45 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -84.79 85.1 7.49 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.309 -0.997 . . . . 72.55 108.309 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.21 92.44 6.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.774 -1.195 . . . . 61.33 107.774 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -103.66 143.67 15.78 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.762 -0.935 . . . . 63.31 110.762 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.51 141.82 11.44 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.308 -0.717 . . . . 74.12 111.308 -174.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.4 mt -88.37 120.76 37.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.981 -0.748 . . . . 74.41 108.981 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.88 118.1 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.45 1.1 . . . . 73.31 108.086 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -83.74 115.32 22.15 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.262 -1.014 . . . . 34.43 108.262 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.454 HG21 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -133.71 135.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.22 0.608 . . . . 44.13 109.38 -173.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 172.33 15.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.796 1.239 . . . . 71.52 109.669 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.34 -36.84 3.8 Favored Glycine 0 N--CA 1.465 0.613 0 CA-C-N 115.575 -0.738 . . . . 64.24 112.673 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -126.8 147.42 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.367 0.667 . . . . 70.42 110.374 -175.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.7 tt0 -135.98 -176.33 4.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.133 0.973 . . . . 74.44 108.951 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.504 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.49 -137.15 28.74 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.94 -0.367 . . . . 74.12 112.88 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -65.6 -20.79 66.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.917 0.887 . . . . 62.23 111.723 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.69 -53.33 22.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.012 0.925 . . . . 61.13 110.626 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -29.19 62.23 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 116.347 -0.388 . . . . 71.01 110.343 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.72 96.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.359 0.664 . . . . 62.51 109.862 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.3 t-80 -62.48 -39.01 92.08 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.328 -1.305 . . . . 74.11 110.741 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.671 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 7.1 m -78.35 -61.96 1.84 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.047 0.758 . . . . 50.4 113.047 -175.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 86' ' ' ILE . 95.0 mt -67.74 -22.7 65.22 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 75.03 112.471 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.06 -10.84 44.59 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.407 -0.663 . . . . 55.21 114.364 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -149.01 -52.6 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.979 1.474 . . . . 75.23 114.979 -169.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.4 t80 -55.24 -59.74 4.36 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.077 0.951 . . . . 72.32 110.25 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -67.88 -45.65 43.14 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 114.334 -1.303 . . . . 72.01 112.747 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.44 -42.2 41.97 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.661 2.241 . . . . 74.04 114.54 168.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -71.73 -30.75 65.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.794 0.438 . . . . 73.43 110.493 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.8 mm -70.54 -34.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 70.32 110.278 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.701 HD23 HG23 ' A' ' 16' ' ' ILE . 84.0 mt -73.29 -28.77 62.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.907 0.883 . . . . 74.15 111.305 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.81 -44.87 87.14 Favored Pre-proline 0 CA--C 1.568 1.647 0 N-CA-C 115.144 1.535 . . . . 72.5 115.144 -167.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.51 -31.31 80.36 Favored 'Trans proline' 0 C--N 1.387 2.589 0 CA-C-N 122.028 1.76 . . . . 72.0 113.257 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.82 -34.29 39.63 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.245 0.618 . . . . 72.52 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.82 77.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.55 -0.537 . . . . 71.11 109.55 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.54 HH12 HD12 ' C' ' 105' ' ' ILE . 38.4 ttm180 -52.6 -49.84 64.23 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.922 1.389 . . . . 64.14 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.36 -48.02 81.61 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.046 0.841 . . . . 75.3 111.196 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.5 t -60.39 -36.02 77.1 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.797 0.686 . . . . 62.21 111.491 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.463 HG21 HG21 ' A' ' 64' ' ' VAL . 87.4 mt -67.08 -58.68 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.678 0.791 . . . . 74.11 109.945 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 125' ' ' GLN . 69.0 m -56.09 -31.76 63.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.736 1.214 . . . . 71.03 111.438 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.2 -47.42 67.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.111 -0.95 . . . . 54.41 110.163 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.51 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -62.36 -38.24 88.79 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 122.696 0.399 . . . . 72.31 111.221 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.0 t -60.2 -49.56 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 O-C-N 123.968 0.792 . . . . 71.54 109.787 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -26.93 62.36 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.733 -0.667 . . . . 73.33 111.478 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.21 -31.09 65.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.385 0.674 . . . . 63.32 109.559 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 5.52 80.37 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.852 -0.613 . . . . 54.12 112.888 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 4.3 t 58.26 21.82 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.253 2.221 . . . . 73.22 113.902 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.2 148.11 44.11 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.982 -0.748 . . . . 74.15 108.982 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.45 128.17 26.81 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.026 2.484 . . . . 62.14 112.084 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -58.16 146.05 34.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.475 0.71 . . . . 71.32 111.532 -168.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.19 97.97 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.226 0.61 . . . . 73.12 109.376 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.19 108.05 20.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 55.12 108.532 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.444 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.6 mm? -74.4 148.58 41.07 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.745 0.818 . . . . 72.5 110.954 -173.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -69.68 129.91 90.87 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.141 0.576 . . . . 45.43 110.427 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 11.9 Cg_exo -67.89 108.72 1.75 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.027 . . . . 70.21 111.549 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.7 t -99.7 111.11 28.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.092 . . . . 42.01 108.053 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -82.17 86.25 6.66 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.995 0.902 . . . . 52.32 109.379 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -59.95 -32.36 70.74 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.511 -1.222 . . . . 64.12 110.656 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.446 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.4 p-10 . . . . . 0 N--CA 1.475 0.783 0 C-N-CA 124.189 0.996 . . . . 72.13 111.577 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.486 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 6.7 ptt? . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 113.299 0.851 . . . . 64.31 113.299 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.2 t -156.11 131.78 9.65 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 107.849 -1.167 . . . . 61.02 107.849 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' B' ' 85' ' ' SER . 69.3 t80 -131.71 146.36 52.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.926 0.891 . . . . 61.03 109.494 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -159.37 142.85 14.63 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.638 0.375 . . . . 73.44 110.756 170.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.448 HD11 HD13 ' B' ' 105' ' ' ILE . 54.3 mt -89.53 123.3 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.284 -1.006 . . . . 73.51 108.284 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.1 -35.7 16.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.748 0.419 . . . . 73.11 109.935 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 62.1 ttt180 -163.77 146.65 9.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.49 0.316 . . . . 70.21 110.589 -171.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.47 139.77 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.807 -1.553 . . . . 70.43 106.807 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.453 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 15.0 p90 -173.03 168.34 4.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.038 0.923 . . . . 74.21 112.642 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 66.9 m -90.38 129.27 36.6 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.32 -1.309 . . . . 73.43 108.89 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 48.6 mtpt -98.17 -40.1 8.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.399 0.68 . . . . 73.22 110.573 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.2 t70 -146.8 135.11 21.78 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.589 -0.732 . . . . 52.05 109.896 -163.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.7 mm -136.3 140.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.713 1.205 . . . . 74.35 109.382 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -140.29 131.41 26.38 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.138 -1.43 . . . . 42.3 107.138 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.435 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -147.03 119.03 8.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.172 -1.418 . . . . 74.12 107.172 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.99 129.94 55.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.495 -0.928 . . . . 63.52 108.495 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -125.84 81.2 66.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 174.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.93 -27.73 20.51 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.649 2.233 . . . . 72.41 111.764 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.91 29.47 7.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.136 0.974 . . . . 74.41 109.839 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.57 -50.61 65.16 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.595 1.158 . . . . 74.21 113.179 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.69 -12.67 6.25 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 122.055 1.837 . . . . 71.33 113.277 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.429 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.7 m-70 -93.7 3.82 54.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.883 0.873 . . . . 73.52 110.116 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.21 -14.37 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 123.751 0.82 . . . . 63.24 111.442 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -64.65 -30.9 71.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.494 0.718 . . . . 73.11 112.503 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.585 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.5 pt20 -85.19 -33.29 22.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.597 0.359 . . . . 74.32 110.104 171.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.598 ' HD3' ' HB3' ' B' ' 68' ' ' LEU . 95.8 mttt -109.48 66.49 0.63 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 74.43 111.984 -175.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.52 85.57 4.96 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 108.62 -0.881 . . . . 72.14 108.62 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -156.47 169.91 23.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.04 -0.726 . . . . 75.02 109.04 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.1 113.98 23.59 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.644 0.778 . . . . 75.35 110.609 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.629 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 2.8 Cg_exo -73.46 144.19 35.9 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.339 2.026 . . . . 74.22 111.9 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.01 103.2 1.78 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.466 -0.788 . . . . 74.53 109.204 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.41 135.75 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.241 -0.891 . . . . 71.22 110.782 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.625 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 97.1 mttt -132.12 101.21 5.31 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.357 1.063 . . . . 74.53 108.376 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.62 144.96 28.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.279 0.632 . . . . 75.13 109.828 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -148.25 139.21 23.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.757 -0.831 . . . . 75.44 108.757 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.31 133.17 53.83 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.965 0.906 . . . . 73.23 108.697 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.7 t70 -127.91 135.74 50.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 55.21 108.952 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -109.97 114.08 27.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.683 0.793 . . . . 75.14 110.324 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.2 151.68 36.39 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.118 0.967 . . . . 75.33 109.336 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -145.08 168.82 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.797 0.439 . . . . 74.41 111.157 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.0 p -153.75 154.49 34.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 74.43 108.92 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.96 103.27 13.37 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.179 -0.674 . . . . 63.45 109.179 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' B' ' 57' ' ' GLU . 67.4 mt -77.88 -34.16 51.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.19 -0.913 . . . . 74.11 110.631 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.94 -170.64 2.01 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.805 0.842 . . . . 65.14 110.256 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.58 108.79 2.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.746 -1.116 . . . . 63.14 109.39 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 72.31 2.58 4.38 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.376 1.47 . . . . 62.45 112.863 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.87 93.4 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.651 -1.24 . . . . 61.44 107.651 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -107.26 138.38 43.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.993 -1.003 . . . . 74.22 109.392 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' B' ' 51' ' ' LEU . 23.2 tt0 -98.87 127.43 44.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.537 -1.282 . . . . 71.42 107.537 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.27 122.05 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 108.06 -1.089 . . . . 61.24 108.06 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 45.5 t -102.91 114.07 41.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.256 -1.016 . . . . 35.34 108.256 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -91.24 127.12 36.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.75 -1.574 . . . . 72.22 106.75 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.3 ttt180 -119.0 120.77 38.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.613 -0.884 . . . . 63.32 108.613 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.576 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.2 t -112.85 112.94 42.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.966 -1.124 . . . . 53.43 107.966 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 43.0 m -93.96 135.88 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.273 -1.01 . . . . 71.23 108.273 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 114' ' ' ILE . 82.6 t -130.31 130.95 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.027 0.931 . . . . 73.11 109.15 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.8 m -125.1 148.23 48.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.006 -1.109 . . . . 65.01 108.006 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.09 132.74 17.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.053 -1.091 . . . . 72.23 108.053 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 14.0 m -139.87 137.11 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.372 0.269 . . . . 71.03 110.579 -172.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HB3' ' HD3' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -117.39 113.16 21.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.871 -1.159 . . . . 65.34 107.871 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.14 -129.59 18.04 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.624 0.578 . . . . 54.2 112.89 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -92.86 19.46 7.64 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 74.13 111.267 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.422 ' HB3' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 tp10 -147.96 159.3 44.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.588 0.355 . . . . 72.45 111.12 -171.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.7 m -71.23 137.48 48.69 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.477 0.711 . . . . 75.41 109.752 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.42 -56.63 3.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.078 -1.082 . . . . 64.1 108.078 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.49 171.32 17.25 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.731 -1.122 . . . . 74.14 110.674 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -141.1 146.17 36.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.609 1.564 . . . . 73.32 107.308 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.41 154.73 35.02 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.395 -0.595 . . . . 70.54 109.395 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.09 133.53 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.231 -0.655 . . . . 71.42 109.231 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.1 t -126.77 144.98 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.624 0.769 . . . . 72.2 109.138 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.0 mt-30 -123.15 94.8 4.37 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.816 -0.809 . . . . 74.32 108.816 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.81 98.82 9.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.926 -1.034 . . . . 72.05 109.106 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 143.85 17.6 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.83 -0.908 . . . . 61.32 110.83 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.64 130.66 3.86 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.259 -0.736 . . . . 74.04 111.259 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.57 126.24 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.88 -0.785 . . . . 74.52 108.88 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.65 162.08 33.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.471 1.109 . . . . 71.11 109.125 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.8 m -131.51 112.97 13.12 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.493 0.717 . . . . 64.24 109.735 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.447 HD12 ' N ' ' B' ' 86' ' ' ILE . 1.1 mp -125.29 114.9 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.119 -1.067 . . . . 63.13 108.119 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.22 147.15 45.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.281 0.632 . . . . 52.03 110.793 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.23 -40.15 2.53 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.818 0.699 . . . . 65.11 113.133 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' B' ' 93' ' ' GLN . 5.7 tp -91.01 148.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.049 0.54 . . . . 72.52 111.037 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.504 ' H ' HD12 ' B' ' 89' ' ' ILE . 10.2 pt-20 -156.47 164.14 38.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.616 0.766 . . . . 71.41 111.319 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.97 -137.57 18.79 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 114.908 -1.042 . . . . 52.14 113.435 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 43.4 m -65.63 -40.35 92.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.089 0.956 . . . . 61.31 111.921 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.702 ' HB2' HD11 ' B' ' 89' ' ' ILE . 2.3 mp0 -66.0 -36.85 84.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 74.31 111.054 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.413 ' HB2' HG13 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -75.34 -25.21 57.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.206 0.602 . . . . 65.31 110.66 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.41 -21.93 64.54 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.47 0.708 . . . . 61.12 111.907 173.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -86.47 -20.31 28.29 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.232 0.613 . . . . 74.14 111.231 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.84 -62.6 1.33 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.431 0.292 . . . . 73.11 110.4 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.68 -16.43 41.86 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.093 -0.379 . . . . 70.42 111.532 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.32 -37.4 17.99 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 123.471 0.482 . . . . 61.21 112.669 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.42 -50.54 1.76 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.704 0.631 . . . . 63.12 112.704 -170.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -69.44 -54.57 13.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.259 0.624 . . . . 53.05 111.602 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.413 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.4 m -63.33 -46.83 85.13 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.54 -0.743 . . . . 73.04 112.015 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.6 Cg_exo -54.95 -38.25 93.12 Favored 'Trans proline' 0 C--N 1.391 2.782 0 C-N-CA 121.94 1.76 . . . . 64.44 113.901 170.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.73 -32.87 74.5 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.015 0.435 . . . . 75.32 111.083 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.448 HD13 HD11 ' B' ' 13' ' ' ILE . 94.8 mt -67.84 -44.25 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.262 1.025 . . . . 75.12 110.684 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.34 -26.1 46.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.022 0.929 . . . . 51.42 112.199 -172.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.413 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 49.3 t80 -59.43 -45.13 98.93 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.707 1.203 . . . . 74.53 113.986 -169.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 18.7 Cg_endo -58.23 -37.24 96.2 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.328 2.018 . . . . 73.31 113.984 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -70.36 -45.3 66.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.91 0.484 . . . . 72.23 110.368 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.467 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.84 -42.51 89.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.33 -0.85 . . . . 62.34 110.367 175.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 21.6 mtp-105 -52.21 -63.42 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.302 1.041 . . . . 74.31 111.391 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.44 -29.69 67.96 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.197 0.936 . . . . 64.31 110.639 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.8 t -70.81 -48.6 53.22 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.104 0.561 . . . . 71.45 111.086 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.601 HG21 HG21 ' B' ' 64' ' ' VAL . 48.2 mt -62.07 -51.86 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 123.417 0.687 . . . . 74.21 110.059 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -34.52 72.48 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.585 -1.189 . . . . 74.13 110.875 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -67.39 -50.2 60.65 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.534 -0.757 . . . . 43.01 110.392 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -63.48 -38.04 89.63 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.884 0.473 . . . . 72.11 111.421 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.99 -43.16 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.014 0.925 . . . . 63.44 110.767 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -62.68 -36.77 83.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.925 0.89 . . . . 61.0 111.055 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 93.6 mtt-85 -68.74 -20.62 64.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.138 -0.937 . . . . 75.4 111.472 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.07 16.63 59.87 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 119.482 -0.621 . . . . 72.23 114.209 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p 72.65 13.0 5.34 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 126.528 1.931 . . . . 71.2 112.836 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -97.94 152.83 38.27 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 122.641 0.376 . . . . 71.34 110.922 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.34 144.14 98.29 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.227 2.618 . . . . 71.33 112.001 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.766 ' HB3' HE21 ' C' ' 125' ' ' GLN . 4.9 pp0? -61.41 129.24 40.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.527 0.731 . . . . 74.51 111.715 -172.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.19 86.86 2.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.694 -0.854 . . . . 75.1 108.694 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -90.64 118.4 30.06 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.672 -1.233 . . . . 70.31 107.672 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.55 ' HB2' ' HG2' ' B' ' 111' ' ' ARG . 2.4 mm? -77.47 128.34 34.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.277 -0.638 . . . . 75.53 109.277 -173.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.37 136.51 93.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.37 0.668 . . . . 60.12 110.626 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.544 ' HG2' HG21 ' D' ' 13' ' ' ILE . 19.0 Cg_endo -60.5 89.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.135 2.557 . . . . 73.31 112.796 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.55 118.95 39.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.721 -0.844 . . . . 74.33 108.721 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.67 114.59 7.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.564 0.745 . . . . 73.43 110.419 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 53.3 m-85 -64.75 -29.18 70.15 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.826 0.85 . . . . 62.41 110.268 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -66.64 -40.92 88.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.946 0.898 . . . . 72.41 110.807 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.07 68.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.453 0.701 . . . . 52.12 110.948 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.482 1.14 0 C-N-CA 124.032 0.933 . . . . 75.34 109.314 173.889 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.683 ' HG2' ' HB ' ' C' ' 89' ' ' ILE . 69.0 mtp . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 121.131 0.491 . . . . 63.01 111.518 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.694 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 49.4 m -84.43 85.91 7.34 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.447 -1.316 . . . . 61.2 107.447 173.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.45 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 80.9 t80 -106.16 126.25 51.98 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.435 -1.257 . . . . 72.32 109.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -145.8 139.78 26.65 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.018 -0.734 . . . . 62.31 109.018 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.39 106.45 3.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.209 -1.034 . . . . 64.12 108.209 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.8 mm-40 -77.29 -48.83 16.42 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 123.254 0.346 . . . . 72.33 110.343 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -166.87 149.29 6.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.526 -0.761 . . . . 74.45 109.438 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.2 mt -133.89 132.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 107.633 -1.247 . . . . 73.53 107.633 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.413 ' OH ' HD11 ' C' ' 83' ' ' ILE . 31.7 p90 -171.11 165.28 7.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.033 0.921 . . . . 62.23 112.849 -173.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -88.04 104.01 16.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.296 -1.32 . . . . 75.14 109.072 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 7.0 mtmt -71.1 -23.71 62.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.884 0.374 . . . . 64.03 110.201 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.5 t70 -158.25 140.7 14.38 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.603 -0.726 . . . . 72.12 109.319 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.1 mt -134.69 144.16 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.212 -1.403 . . . . 74.1 107.212 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -149.57 150.12 31.74 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.345 0.658 . . . . 54.11 109.276 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -155.69 118.75 4.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.256 -1.016 . . . . 75.32 108.256 175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.95 121.39 40.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.398 -0.964 . . . . 65.05 108.398 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.89 85.76 29.27 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.043 -1.095 . . . . 75.43 108.043 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.94 -37.81 10.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.59 2.193 . . . . 74.32 111.857 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.645 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 1.9 m-20 -107.69 39.8 1.85 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.91 -0.774 . . . . 72.22 108.91 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.575 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -51.65 -49.54 82.41 Favored Pre-proline 0 CA--C 1.563 1.448 0 N-CA-C 114.271 1.212 . . . . 72.42 114.271 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.666 ' HD3' ' HZ1' ' D' ' 19' ' ' LYS . 37.2 Cg_endo -86.99 -22.2 1.87 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 121.523 1.482 . . . . 62.42 112.831 173.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.645 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 25.1 t-80 -69.51 -23.49 63.62 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.119 0.968 . . . . 75.45 111.547 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 7.1 p -60.55 -23.4 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.85 0.86 . . . . 73.13 112.25 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.446 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 82.2 t80 -59.14 -41.18 87.68 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.147 0.979 . . . . 72.32 111.847 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -86.96 6.0 34.34 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.62 0.6 . . . . 73.51 112.62 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.532 ' HZ3' ' HA ' ' C' ' 31' ' ' VAL . 16.1 pttm -123.42 178.28 5.23 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.255 0.55 . . . . 73.44 110.736 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.62 133.97 33.72 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.484 -1.235 . . . . 70.33 110.003 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.467 ' HB3' ' HG3' ' C' ' 124' ' ' PRO . 20.4 m-90 -85.38 64.72 8.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.752 0.821 . . . . 74.12 111.041 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -144.37 62.98 10.59 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.466 1.107 . . . . 74.34 108.737 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.53 174.99 9.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.226 1.951 . . . . 45.31 110.847 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -85.36 115.83 23.33 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.901 -0.778 . . . . 71.51 108.901 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.13 101.18 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.564 -0.902 . . . . 74.21 108.564 173.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.81 98.47 11.62 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.552 -1.647 . . . . 62.13 106.552 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -89.38 162.36 15.83 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.42 0.288 . . . . 74.11 110.506 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -159.62 108.47 1.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.272 0.629 . . . . 65.43 109.575 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -107.57 141.15 39.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.104 0.961 . . . . 63.24 108.804 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.28 153.73 35.4 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.921 0.888 . . . . 64.12 108.69 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -131.76 133.84 45.21 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.405 -0.591 . . . . 71.43 109.405 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -113.24 172.25 7.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.536 1.135 . . . . 61.22 109.261 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.1 p -151.24 146.62 26.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.323 0.649 . . . . 75.22 109.971 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.538 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 10.1 m -144.14 149.07 35.91 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.577 -1.268 . . . . 64.1 107.577 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.13 114.55 28.75 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.649 -1.241 . . . . 72.02 107.649 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' C' ' 57' ' ' GLU . 24.9 mt -93.03 -36.89 12.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.394 0.678 . . . . 74.24 109.846 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.09 -175.64 5.53 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.922 -1.035 . . . . 55.23 110.039 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.24 108.5 1.09 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.399 -1.273 . . . . 72.54 110.016 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 70.6 -2.38 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.694 1.597 . . . . 72.23 113.106 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.0 t -98.61 102.81 13.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.412 -0.959 . . . . 74.12 108.412 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -110.19 160.21 16.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.539 0.736 . . . . 70.22 109.352 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.617 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.3 tt0 -120.51 127.27 52.04 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.142 0.977 . . . . 64.25 108.72 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.87 127.39 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.491 -1.3 . . . . 75.32 107.491 170.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 27.0 t -112.79 101.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.287 -1.005 . . . . 53.44 108.287 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.64 95.07 9.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.829 -1.174 . . . . 75.32 107.829 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -88.29 112.5 22.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.509 -1.223 . . . . 73.01 108.827 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.7 t -107.44 139.89 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.586 -0.894 . . . . 71.44 108.586 174.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -131.44 133.94 45.7 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.626 -0.879 . . . . 70.41 108.626 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.34 111.5 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.692 1.197 . . . . 74.11 108.6 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.537 HG23 HD23 ' C' ' 75' ' ' LEU . 2.4 m -99.06 146.57 25.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.835 -1.172 . . . . 72.04 107.835 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.86 107.99 7.22 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.945 -1.502 . . . . 54.2 106.945 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.441 ' HB3' HG23 ' C' ' 72' ' ' THR . 11.8 p -162.43 144.13 10.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.475 0.484 . . . . 65.1 110.577 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.9 tp -118.72 85.82 2.43 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.809 -1.182 . . . . 75.15 107.809 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -107.88 2.35 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 114.698 -1.137 . . . . 42.1 111.525 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.55 -32.89 17.94 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.708 -0.478 . . . . 71.22 109.708 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -75.12 84.17 2.34 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.605 0.762 . . . . 73.23 110.089 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.441 HG23 ' HB3' ' C' ' 67' ' ' SER . 61.4 m -81.89 126.29 31.72 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.053 -0.976 . . . . 64.22 110.145 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.94 -61.04 2.11 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.649 -0.871 . . . . 43.12 108.649 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -158.33 178.02 10.62 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.876 0.846 . . . . 71.01 112.259 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.537 HD23 HG23 ' C' ' 65' ' ' THR . 3.0 tm? -141.62 146.2 35.93 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.575 -2.009 . . . . 74.12 105.575 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -150.55 148.2 28.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.258 -1.016 . . . . 54.02 108.258 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.16 134.54 10.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.781 -0.452 . . . . 72.53 109.781 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -133.17 116.63 26.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 123.815 0.846 . . . . 70.24 108.921 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.6 mt-30 -87.8 86.17 7.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.342 -1.355 . . . . 74.41 107.342 169.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -79.48 96.1 5.99 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.936 -1.029 . . . . 73.51 108.832 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -88.48 144.35 18.35 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.244 -0.742 . . . . 63.23 111.244 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.18 119.93 1.3 Allowed Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 110.259 -1.136 . . . . 65.54 110.259 -175.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.562 HD12 HD11 ' C' ' 51' ' ' LEU . 7.4 mm -82.58 123.76 38.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.206 -1.035 . . . . 70.23 108.206 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.49 120.94 24.91 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.887 0.875 . . . . 71.44 108.829 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 22.0 p -77.93 109.81 12.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.987 -1.116 . . . . 75.14 107.987 170.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 27.2 pt -118.51 113.22 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.4 0.619 . . . . 74.23 109.352 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.694 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -123.83 156.23 36.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.823 0.849 . . . . 72.33 109.762 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.34 -35.8 3.52 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.572 0.545 . . . . 74.52 113.382 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.683 ' HB ' ' HG2' ' C' ' 9' ' ' MET . 19.3 tt -88.4 145.97 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.075 0.55 . . . . 70.33 110.667 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.78 -177.56 5.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.003 0.921 . . . . 73.52 110.403 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 60.67 -147.07 46.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.649 -0.705 . . . . 73.43 114.626 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -69.86 -19.18 63.45 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 61.52 111.863 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.12 -42.36 69.35 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.746 0.819 . . . . 75.2 110.566 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 25.9 ptt? -69.87 -28.57 65.76 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 110.223 -0.288 . . . . 60.25 110.223 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.29 90.26 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.75 0.656 . . . . 61.12 110.365 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -60.54 -39.38 87.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 74.05 110.783 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -63.21 -58.29 7.69 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.839 0.455 . . . . 74.13 110.952 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -77.12 -12.47 59.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.586 0.587 . . . . 73.44 112.586 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.9 9.79 21.13 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.341 -0.699 . . . . 43.31 114.739 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -53.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 117.764 0.782 . . . . 72.34 111.284 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.61 -59.84 2.55 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.368 0.667 . . . . 74.43 111.584 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 70.2 m -60.78 -44.89 96.47 Favored Pre-proline 0 CA--C 1.566 1.565 0 C-N-CA 124.465 1.106 . . . . 71.2 113.461 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.35 -20.86 48.16 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.005 1.803 . . . . 64.24 113.476 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -71.53 -30.63 66.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.994 0.517 . . . . 54.3 110.467 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.54 HD12 HH12 ' A' ' 111' ' ' ARG . 44.2 mm -68.2 -28.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 73.14 110.261 173.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.564 HD21 ' HA3' ' C' ' 82' ' ' GLY . 85.7 mt -86.47 -22.85 26.23 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.819 0.848 . . . . 73.53 112.182 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -53.77 -50.6 82.74 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.996 -1.002 . . . . 73.14 113.374 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.01 -36.5 96.57 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 122.022 1.815 . . . . 44.25 113.482 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.36 -44.44 62.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.139 0.576 . . . . 73.45 111.089 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -41.92 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.465 0.478 . . . . 54.25 109.887 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -60.28 -51.29 70.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.14 1.376 . . . . 73.42 111.142 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.2 tm-20 -70.81 -30.36 66.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.498 0.499 . . . . 64.42 110.291 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.0 t -69.86 -30.82 68.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.832 0.453 . . . . 74.34 111.178 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.461 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -77.3 -50.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.528 0.731 . . . . 70.3 109.949 175.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -62.98 -29.08 70.54 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.625 0.77 . . . . 74.14 111.228 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -64.91 -52.31 57.15 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.837 -0.801 . . . . 60.42 108.837 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.47 -38.71 78.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.435 1.094 . . . . 44.53 112.754 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.404 HG23 ' O ' ' C' ' 114' ' ' ILE . 87.5 t -61.86 -50.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.274 0.629 . . . . 60.21 109.864 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.1 t -71.14 -22.23 62.09 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.179 -0.919 . . . . 54.31 111.392 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -71.9 -37.11 70.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.067 -0.716 . . . . 72.15 109.067 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.28 3.76 79.95 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.905 0.753 . . . . 72.32 113.131 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.496 HG23 ' HB3' ' D' ' 17' ' ' TYR . 71.4 p 57.5 40.74 26.86 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.8 1.64 . . . . 51.01 112.153 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -99.29 165.04 15.55 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.758 1.223 . . . . 75.45 110.838 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' C' ' 36' ' ' TRP . 22.5 Cg_endo -57.48 147.36 78.85 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.572 2.848 . . . . 22.11 113.927 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.766 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.6 mm-40 -58.51 111.94 1.42 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.555 1.142 . . . . 75.11 111.522 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.6 tp -122.15 97.28 5.4 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.408 0.683 . . . . 73.53 109.319 -174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -101.35 115.9 31.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 74.22 108.709 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.13 134.56 50.74 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.956 -0.757 . . . . 72.15 108.956 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -64.35 132.35 95.32 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.077 0.551 . . . . 74.34 111.171 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 129' ' ' ALA . 13.2 Cg_exo -71.37 90.19 0.69 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.974 2.449 . . . . 75.14 112.783 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 67.0 t -100.12 112.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.737 0.815 . . . . 72.1 109.792 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -97.75 95.38 7.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.352 0.661 . . . . 72.42 109.384 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -65.86 -30.43 71.04 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.516 0.726 . . . . 72.44 111.348 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 121.279 0.562 . . . . 72.01 110.208 177.816 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.527 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.6 tpt . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 113.595 0.961 . . . . 70.42 113.595 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.1 m -143.36 140.54 30.55 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.747 0.819 . . . . 55.32 110.166 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 44.5 t80 -143.01 115.61 8.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.937 -1.505 . . . . 72.44 106.937 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 44.2 mt-30 -128.13 147.36 50.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.276 -0.639 . . . . 72.32 109.276 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.544 HG21 ' HG2' ' B' ' 130' ' ' PRO . 3.8 mp -103.6 121.0 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.992 -1.114 . . . . 60.3 107.992 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.45 -42.22 6.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.893 0.477 . . . . 73.31 111.891 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.518 ' HD3' HD12 ' D' ' 83' ' ' ILE . 47.4 ttt180 -163.7 123.83 2.16 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.701 -0.19 . . . . 73.41 110.616 -168.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.6 136.62 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.156 -1.424 . . . . 55.5 107.156 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.575 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 39.7 p90 -166.0 177.72 6.88 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.947 0.779 . . . . 70.12 111.32 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -101.89 117.47 34.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.206 -0.907 . . . . 65.34 109.073 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.666 ' HZ1' ' HD3' ' C' ' 29' ' ' PRO . 26.9 mtpp -80.53 -27.91 37.5 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.569 -0.287 . . . . 74.51 110.356 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.69 148.88 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.529 0.731 . . . . 70.14 109.13 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.551 HG21 ' HE2' ' C' ' 117' ' ' MET . 83.3 mt -143.44 147.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.97 1.308 . . . . 50.24 108.506 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -148.03 144.44 27.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.491 1.116 . . . . 71.44 109.275 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.433 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.61 126.29 8.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.154 -1.795 . . . . 64.03 106.154 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -128.65 141.13 51.44 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.206 0.602 . . . . 72.23 109.46 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.75 77.13 9.54 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.211 1.004 . . . . 53.02 108.349 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.54 -38.71 13.8 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.611 2.207 . . . . 71.4 111.421 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.505 HD21 ' HB ' ' D' ' 72' ' ' THR . 13.2 p30 -102.24 31.06 4.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.814 1.646 . . . . 63.12 109.746 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.515 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.07 -48.48 94.39 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 114.53 1.307 . . . . 74.32 114.53 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.29 -4.71 11.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 CA-C-N 121.299 1.5 . . . . 73.21 112.685 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.6 t-160 -81.39 -54.74 5.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 74.22 109.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' D' ' 73' ' ' ALA . 52.8 t -67.9 -16.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.918 0.887 . . . . 71.24 111.186 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -63.56 -18.28 63.7 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.323 1.049 . . . . 71.33 112.415 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.89 -16.09 57.49 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.163 0.585 . . . . 74.3 111.1 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.473 ' HZ3' ' HB3' ' D' ' 71' ' ' GLU . 49.8 mtmt -113.81 104.41 12.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.965 0.906 . . . . 71.24 110.187 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.47 95.34 8.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.006 0.522 . . . . 62.52 109.981 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.504 ' HB3' HD11 ' D' ' 68' ' ' LEU . 56.3 t-105 -161.69 158.53 26.11 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.73 110.11 8.98 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.121 0.969 . . . . 72.41 109.614 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.18 131.13 31.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.771 2.98 . . . . 72.5 113.312 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.06 119.55 13.53 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.56 -0.533 . . . . 63.31 109.56 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' D' ' 66' ' ' ALA . 9.3 m -98.83 120.77 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.42 0.688 . . . . 74.04 111.436 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -87.66 115.85 25.38 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.018 -1.104 . . . . 74.05 108.018 166.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -96.51 142.11 28.99 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.833 -0.803 . . . . 63.51 108.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.657 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -127.8 112.33 14.64 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.89 -1.152 . . . . 72.32 107.89 173.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -96.57 134.48 39.74 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.952 -0.759 . . . . 61.02 108.952 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.1 t70 -152.22 147.95 27.01 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.943 -1.132 . . . . 61.34 107.943 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -139.59 163.92 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.078 0.466 . . . . 75.34 110.28 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.06 163.05 39.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.148 0.979 . . . . 75.31 109.761 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -142.41 153.33 43.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.658 -0.867 . . . . 73.21 108.658 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -155.76 152.46 28.52 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.359 1.064 . . . . 72.34 108.352 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -99.42 134.09 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.502 -0.555 . . . . 41.42 109.502 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' D' ' 57' ' ' GLU . 46.4 mt -103.14 -41.37 6.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.709 0.804 . . . . 74.32 109.265 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.18 -171.83 3.52 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.205 -0.907 . . . . 74.5 109.95 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.28 122.84 18.04 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.559 -0.746 . . . . 73.44 109.233 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 63.78 9.17 4.23 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.527 1.131 . . . . 63.54 112.831 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -119.26 120.56 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.058 0.943 . . . . 72.34 108.486 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.423 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 73.0 m-85 -136.34 135.98 39.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.852 0.461 . . . . 74.14 110.246 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD21 ' D' ' 51' ' ' LEU . 6.2 tp10 -91.08 113.75 26.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.094 0.958 . . . . 63.31 109.378 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.44 127.82 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.659 -1.237 . . . . 61.41 107.659 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.2 t -113.36 146.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.433 0.693 . . . . 73.41 109.341 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -127.47 108.76 11.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.006 -1.109 . . . . 61.12 108.006 176.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.7 ttm-85 -85.13 107.05 17.02 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.201 -0.666 . . . . 71.31 109.201 170.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.0 t -105.29 103.95 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.013 -1.106 . . . . 75.5 108.013 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.657 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 45.3 m -96.61 135.84 37.96 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.888 -0.782 . . . . 73.03 108.888 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.462 HG23 HD13 ' D' ' 114' ' ' ILE . 64.1 t -122.35 127.41 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.194 -1.039 . . . . 72.23 108.194 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -129.03 93.55 3.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.706 -1.22 . . . . 71.13 107.706 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.601 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -95.95 148.97 22.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.181 0.592 . . . . 65.4 110.039 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -151.05 136.91 18.12 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.988 0.805 . . . . 71.41 109.525 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' D' ' 36' ' ' TRP . 24.9 tp -120.53 128.34 53.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.813 -0.81 . . . . 74.41 108.813 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.88 -119.39 8.12 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.193 0.308 . . . . 62.24 112.349 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.36 7.01 17.52 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.073 0.949 . . . . 71.2 109.783 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.473 ' HB3' ' HZ3' ' D' ' 34' ' ' LYS . 11.0 tp10 -116.46 145.88 42.96 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.497 1.119 . . . . 55.35 109.304 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.505 ' HB ' HD21 ' D' ' 27' ' ' ASN . 54.2 m -59.23 145.67 42.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.556 0.743 . . . . 72.31 109.038 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -106.57 -57.36 2.07 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.955 -0.387 . . . . 62.04 109.955 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.44 147.22 18.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.765 -0.652 . . . . 63.23 110.148 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 48.3 mt -110.69 149.15 30.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.538 1.135 . . . . 65.01 108.701 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -160.06 149.66 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.195 0.598 . . . . 62.21 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -156.61 141.0 16.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.506 -0.924 . . . . 61.31 108.506 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -136.37 118.66 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.301 -0.629 . . . . 75.01 109.301 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.5 85.75 6.59 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.534 -0.913 . . . . 74.33 108.534 170.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.58 102.15 8.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.517 -1.219 . . . . 63.54 108.7 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.8 142.96 15.86 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.315 -0.714 . . . . 65.23 111.315 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.88 132.19 5.63 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.415 -1.074 . . . . 52.2 110.415 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.518 HD12 ' HD3' ' D' ' 15' ' ' ARG . 89.7 mt -88.09 114.26 26.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.441 -0.948 . . . . 64.24 108.441 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.63 136.44 54.39 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.053 0.941 . . . . 74.34 109.461 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 6.5 m -79.31 105.98 11.01 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.923 -0.769 . . . . 63.52 108.923 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 37.3 mm -106.18 102.57 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.253 -1.018 . . . . 60.12 108.253 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.21 152.99 51.35 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.954 0.901 . . . . 63.23 109.535 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.89 -1.93 66.44 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 114.632 0.613 . . . . 62.14 114.632 174.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.86 125.76 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.011 -0.737 . . . . 74.11 109.011 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.94 -173.92 3.94 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.467 0.707 . . . . 70.12 111.075 -171.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 -134.58 25.14 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.782 -0.644 . . . . 52.42 113.05 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.803 0.841 . . . . 75.43 111.215 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -68.18 -38.47 82.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.645 0.778 . . . . 62.23 110.871 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.29 66.78 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.534 -0.303 . . . . 23.02 110.399 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.2 71.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.347 0.659 . . . . 63.22 111.113 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -67.66 -40.28 84.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 73.34 110.847 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -68.64 -52.3 32.75 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.061 -0.518 . . . . 60.11 110.624 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.56 -16.96 61.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.597 0.759 . . . . 75.03 111.637 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.04 -24.68 24.25 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.769 -0.462 . . . . 75.03 114.052 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.1 -57.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.679 0.74 . . . . 63.4 111.805 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -67.07 -50.75 60.71 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.798 0.839 . . . . 74.33 112.633 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.59 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 19.3 m -69.67 -44.79 24.65 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.307 0.643 . . . . 72.21 111.679 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.8 Cg_exo -58.72 -31.84 95.74 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.147 1.898 . . . . 70.31 113.416 169.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.95 -37.49 87.59 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.073 0.549 . . . . 72.33 110.721 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.57 -41.81 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.539 0.736 . . . . 72.02 109.976 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.8 -17.69 60.58 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.17 -0.923 . . . . 72.0 112.143 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -68.36 -42.7 29.85 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 113.607 0.966 . . . . 73.4 113.607 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.8 -37.14 84.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 122.072 1.848 . . . . 74.44 113.618 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 94.7 m-85 -81.37 -33.58 32.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.995 0.918 . . . . 72.34 111.431 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.63 66.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.383 0.673 . . . . 60.32 109.382 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.0 ttp180 -53.25 -53.42 51.08 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.964 -1.471 . . . . 73.3 110.458 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.9 -46.65 84.63 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.281 0.988 . . . . 63.41 111.838 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.43 -42.0 90.84 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.986 0.804 . . . . 70.4 111.175 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.462 HD13 HG23 ' D' ' 64' ' ' VAL . 75.9 mt -65.22 -53.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.666 0.604 . . . . 71.13 110.277 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.421 HG23 ' HG3' ' D' ' 125' ' ' GLN . 48.4 m -55.19 -40.54 70.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.701 1.2 . . . . 73.21 111.513 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.8 t -66.75 -43.21 84.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.59 -1.186 . . . . 64.41 110.436 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.4 mtm -67.77 -32.83 73.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.007 0.523 . . . . 73.32 112.163 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 83.4 t -67.41 -42.01 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.372 0.669 . . . . 70.31 109.764 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -76.08 -28.39 57.57 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.097 -0.502 . . . . 74.51 111.131 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -71.61 -32.48 68.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.644 0.778 . . . . 73.24 109.567 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 6.13 73.52 Favored Glycine 0 C--N 1.355 1.623 0 O-C-N 123.754 0.659 . . . . 33.34 112.544 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' C' ' 17' ' ' TYR . 63.3 p 57.58 21.46 7.16 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.83 2.052 . . . . 75.31 114.291 176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.39 157.6 58.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.928 0.891 . . . . 62.15 109.301 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.51 121.82 10.71 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.718 2.278 . . . . 62.34 111.477 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.421 ' HG3' HG23 ' D' ' 115' ' ' THR . 24.1 tt0 -48.29 132.23 16.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.009 1.324 . . . . 63.32 112.47 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -107.14 106.1 16.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -97.61 89.71 4.76 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.702 -1.222 . . . . 61.01 107.702 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.478 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 5.6 mp -62.9 112.51 2.6 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.786 0.679 . . . . 54.34 109.594 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.79 139.57 73.86 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.255 -0.646 . . . . 64.24 109.255 -178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.51 165.28 27.79 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.245 1.963 . . . . 62.33 112.727 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.81 138.7 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.368 -0.605 . . . . 73.53 109.368 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -74.81 95.26 2.88 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 108.955 -0.757 . . . . 74.51 108.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.474 0.757 0 CA-C-N 115.039 -0.982 . . . . 75.2 111.045 -179.83 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.0 m . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.62 -0.511 . . . . 70.41 109.62 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -139.85 115.33 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.326 -0.99 . . . . 74.42 108.326 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 55.2 mt-30 -134.25 122.65 23.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.154 0.582 . . . . 74.23 110.104 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.43 107.99 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.539 -0.911 . . . . 75.1 108.539 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -86.33 -40.33 15.57 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.443 0.297 . . . . 75.21 110.434 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.793 ' HD2' HG21 ' B' ' 122' ' ' THR . 10.1 tpp180 -167.68 134.4 2.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.471 -0.566 . . . . 65.12 109.471 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 91.6 mt -138.4 100.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.962 -0.755 . . . . 73.31 108.962 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.9 m-85 -164.09 176.16 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 74.32 109.693 -165.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -85.33 114.05 22.11 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.146 -0.479 . . . . 72.33 110.093 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -88.92 -34.47 16.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.727 0.298 . . . . 73.44 110.371 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.792 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 9.1 m-20 -137.38 147.0 45.14 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.482 0.658 . . . . 65.25 109.736 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.561 HD13 ' SD ' ' B' ' 117' ' ' MET . 66.9 mt -144.99 143.88 22.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 126.381 1.872 . . . . 72.24 106.508 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -158.79 121.36 3.64 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.607 -0.516 . . . . 72.21 109.607 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.633 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.9 t80 -119.8 136.62 54.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.428 -1.323 . . . . 65.45 107.428 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.38 148.8 51.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.578 0.751 . . . . 64.54 109.017 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.12 80.72 7.79 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.869 -1.16 . . . . 61.32 107.869 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -31.2 24.86 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.528 2.152 . . . . 62.45 111.667 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -112.53 34.29 4.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.544 1.138 . . . . 74.44 109.334 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.45 -47.1 99.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.444 1.097 . . . . 71.42 113.581 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.1 -20.9 32.64 Favored 'Trans proline' 0 C--N 1.392 2.828 0 CA-C-N 121.124 1.437 . . . . 75.51 112.421 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -79.87 -24.97 40.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.58 0.752 . . . . 64.51 111.656 -172.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.16 -22.32 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 112.461 0.541 . . . . 75.01 112.461 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -80.04 -35.02 37.78 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.297 1.039 . . . . 72.13 110.699 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -88.36 -18.04 29.28 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.178 0.591 . . . . 73.11 111.108 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 68' ' ' LEU . 96.4 mttt -75.59 167.15 22.43 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.864 0.69 . . . . 64.25 112.864 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.27 118.28 23.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.69 -1.141 . . . . 52.23 108.05 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.483 ' HA ' HD12 ' A' ' 68' ' ' LEU . 20.5 m-90 -73.33 85.72 1.46 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.759 0.79 . . . . 72.12 110.939 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -130.78 76.98 76.35 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.063 1.345 . . . . 74.23 108.195 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.46 111.86 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.717 2.278 . . . . 75.34 111.843 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -96.14 85.09 3.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.94 -1.504 . . . . 75.54 106.94 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.1 m -88.25 122.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.453 -1.248 . . . . 65.52 111.889 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -108.17 116.61 32.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.652 1.181 . . . . 72.04 109.111 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.04 108.24 19.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.181 0.593 . . . . 63.35 109.691 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.4 t70 -103.41 130.38 50.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.728 0.811 . . . . 61.43 109.601 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 131' ' ' VAL . 4.6 mp -110.43 119.75 40.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.509 -0.922 . . . . 70.01 108.509 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.485 ' O ' HD23 ' A' ' 60' ' ' LEU . 25.3 t70 -122.68 138.08 54.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.493 0.717 . . . . 72.35 109.532 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.7 m -133.35 143.69 49.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.938 0.495 . . . . 64.0 110.146 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.71 152.69 40.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.406 1.082 . . . . 74.01 109.395 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -130.96 155.97 45.89 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.515 -0.92 . . . . 64.25 108.515 172.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -163.26 116.43 1.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 117.882 0.31 . . . . 74.45 110.314 -173.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.588 HE21 ' H ' ' A' ' 54' ' ' ASP . 51.8 tt0 -70.22 105.62 3.02 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.992 0.917 . . . . 65.43 110.353 -177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 57' ' ' GLU . 44.9 mt -77.94 -39.9 41.25 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.309 1.044 . . . . 74.53 111.008 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.08 -171.81 3.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.822 -1.081 . . . . 43.32 109.447 -172.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.76 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.114 0.566 . . . . 74.23 110.5 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.588 ' H ' HE21 ' A' ' 50' ' ' GLN . 9.4 m-20 54.6 31.4 15.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.117 1.367 . . . . 73.23 112.932 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 54.6 t -107.55 122.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.9 -1.519 . . . . 51.2 106.9 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 138.02 49.65 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.953 -0.758 . . . . 73.43 108.953 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' A' ' 51' ' ' LEU . 37.0 tt0 -86.92 121.87 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.987 -1.116 . . . . 73.3 107.987 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -99.29 118.58 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.446 -1.316 . . . . 72.25 107.446 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 90.9 t -98.18 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 123.28 0.632 . . . . 74.32 109.545 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -120.93 110.47 16.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.291 -1.744 . . . . 73.43 106.291 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.592 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 23.4 ttp180 -104.84 103.61 13.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.661 -0.866 . . . . 74.42 108.661 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.39 129.08 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.535 -1.211 . . . . 73.02 108.662 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 41.5 m -109.17 131.76 54.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.739 -0.837 . . . . 54.14 108.739 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 t -123.93 107.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.21 -1.404 . . . . 42.41 107.21 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -107.45 135.66 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.117 -1.068 . . . . 62.21 108.117 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.32 136.78 49.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.501 -1.296 . . . . 72.54 107.501 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.2 m -147.22 135.65 21.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.81 0.844 . . . . 75.24 109.651 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 2.3 mm? -87.23 86.52 7.28 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.868 -1.16 . . . . 73.13 107.868 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.57 -85.15 1.25 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.017 -0.992 . . . . 51.22 111.483 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -26.0 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.322 0.649 . . . . 64.24 111.312 -175.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -101.06 133.04 46.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.064 0.546 . . . . 64.23 109.965 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 m -65.44 146.35 54.99 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.154 0.982 . . . . 72.22 112.729 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -90.12 -65.56 1.0 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.833 1.253 . . . . 63.43 108.436 168.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -150.33 159.8 44.19 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.242 -1.345 . . . . 73.24 110.375 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.6 tp -134.72 116.84 15.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.231 1.012 . . . . 71.52 109.565 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.2 m -106.47 142.51 36.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 75.23 110.311 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -148.07 118.78 7.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.371 1.068 . . . . 72.53 108.838 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.32 116.73 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.136 0.425 . . . . 65.41 109.917 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.792 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 15.6 mp0 -85.57 86.51 7.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.434 -1.321 . . . . 70.13 107.434 169.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -77.01 96.01 4.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.085 -0.962 . . . . 63.31 108.607 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.84 146.0 18.1 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.274 -0.73 . . . . 75.42 111.274 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.18 123.89 2.53 Favored Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.265 -1.134 . . . . 71.4 110.265 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' B' ' 29' ' ' PRO . 56.4 mt -81.02 125.22 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.351 -0.611 . . . . 64.4 109.351 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -134.4 119.85 19.09 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.722 -0.844 . . . . 75.45 108.722 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 33.3 t -81.43 92.7 6.49 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.654 -0.869 . . . . 74.55 108.654 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' THR . 11.0 pt -125.89 127.21 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.558 0.743 . . . . 72.33 110.801 -170.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -160.89 171.11 19.32 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.981 0.913 . . . . 75.53 110.759 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.56 -24.07 32.35 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.391 -0.822 . . . . 72.22 113.135 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -109.5 146.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.94 0.496 . . . . 73.2 109.791 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -147.46 175.81 10.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.243 -0.889 . . . . 61.14 111.282 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.97 -132.46 33.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 114.683 -1.144 . . . . 73.04 112.642 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -69.48 -20.68 63.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.575 0.75 . . . . 75.24 111.882 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.08 -44.64 46.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.505 0.722 . . . . 74.15 110.736 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.7 tpt -80.73 -25.07 38.32 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.239 -0.437 . . . . 73.43 110.195 177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -38.49 88.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.218 0.607 . . . . 73.23 109.837 171.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.87 -43.35 83.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.742 -1.117 . . . . 72.3 110.491 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.714 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.4 m -73.05 -34.34 66.22 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.595 0.961 . . . . 51.22 113.595 -171.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -91.42 -9.24 45.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.486 0.314 . . . . 75.51 111.556 176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.65 5.88 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 113.665 0.226 . . . . 50.44 113.665 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.6 -65.7 0.71 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.806 0.842 . . . . 72.12 111.034 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.4 t80 -43.62 -61.51 1.37 Allowed 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 125.125 1.37 . . . . 72.43 113.193 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 83.6 m -72.63 -50.82 7.44 Favored Pre-proline 0 CA--C 1.556 1.194 0 CA-C-O 118.255 -0.878 . . . . 71.33 112.822 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.05 -17.94 61.7 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.718 1.612 . . . . 62.1 113.815 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.29 -48.25 68.23 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 72.3 108.592 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.0 mm -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.58 -1.191 . . . . 72.22 110.782 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.441 HD23 HG23 ' A' ' 16' ' ' ILE . 95.3 mt -71.47 -28.64 64.08 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.738 -0.665 . . . . 73.21 111.953 -173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -65.23 -43.54 65.67 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.373 1.249 . . . . 74.22 114.373 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -34.92 96.53 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.194 1.93 . . . . 71.22 113.381 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -80.96 -33.92 33.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 73.3 111.494 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.13 63.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 110.046 -0.353 . . . . 62.3 110.046 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.483 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.1 ttm180 -51.75 -45.06 63.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.678 1.191 . . . . 75.01 110.348 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.61 -50.32 71.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.026 0.93 . . . . 54.12 111.487 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.47 -39.96 95.12 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.178 0.924 . . . . 55.34 111.098 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.594 HG21 HG21 ' A' ' 64' ' ' VAL . 12.8 mt -64.33 -58.11 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.561 0.745 . . . . 73.13 110.374 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -53.02 -38.95 62.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.159 0.912 . . . . 73.3 111.289 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -66.34 -42.43 88.13 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.384 -0.826 . . . . 72.31 110.472 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.6 mtm -63.49 -37.73 88.42 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.982 0.513 . . . . 64.33 111.168 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.9 t -63.12 -45.41 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.281 1.032 . . . . 71.33 110.545 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.0 p -75.17 -29.63 60.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.02 -0.537 . . . . 61.44 111.327 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -72.05 -28.07 63.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 74.12 109.81 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.13 1.25 89.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.552 -0.749 . . . . 64.53 113.014 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 m 68.68 18.33 8.77 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.762 1.225 . . . . 60.44 111.578 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -90.37 154.37 46.56 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.702 0.801 . . . . 62.33 110.805 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -59.79 134.11 55.2 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.94 2.426 . . . . 74.31 112.253 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -62.7 132.34 51.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.605 0.762 . . . . 73.22 111.883 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.3 mt -113.0 114.4 26.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.018 -1.104 . . . . 75.32 108.018 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -97.4 100.86 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.993 -1.114 . . . . 45.12 107.993 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.63 135.78 57.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.235 0.614 . . . . 74.34 110.619 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.06 145.86 88.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.995 0.518 . . . . 74.4 110.99 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.5 119.92 7.03 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.941 1.761 . . . . 72.52 109.174 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 44' ' ' LEU . 97.5 t -95.64 111.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.251 -1.388 . . . . 74.4 107.251 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -82.12 66.17 7.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.937 -1.029 . . . . 74.42 109.318 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -68.8 -34.83 76.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.624 -0.716 . . . . 54.11 109.85 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 CA--C 1.544 0.74 0 O-C-N 123.958 0.786 . . . . 73.33 109.743 172.749 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.59 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.7 ptm . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 114.941 1.46 . . . . 61.34 114.941 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -143.39 122.36 12.8 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.184 -1.043 . . . . 63.13 108.184 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -110.51 134.86 51.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.027 0.931 . . . . 64.43 108.677 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -145.61 141.37 28.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.774 -0.824 . . . . 73.32 108.774 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.624 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -91.66 134.49 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.79 -0.818 . . . . 72.14 108.79 173.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -92.4 -50.3 5.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.129 0.572 . . . . 73.45 109.585 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -164.54 139.26 5.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.436 -0.802 . . . . 72.15 109.409 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -114.84 144.7 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 106.218 -1.771 . . . . 73.15 106.218 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.3 149.44 2.24 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.133 0.424 . . . . 72.22 110.908 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.486 HG21 HD11 ' B' ' 21' ' ' ILE . 26.8 m -80.14 121.66 25.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.353 -0.61 . . . . 73.11 109.353 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -87.7 -33.8 18.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.014 0.526 . . . . 72.34 110.203 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.4 t70 -146.99 127.97 14.54 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.13 -0.486 . . . . 65.4 110.75 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 34.3 mm -113.47 147.08 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.395 -1.335 . . . . 71.2 107.395 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -150.72 140.51 21.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.294 -0.632 . . . . 61.32 109.294 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 93.3 t80 -155.22 114.91 3.7 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 107.663 -1.236 . . . . 73.33 107.663 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.65 113.88 17.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.731 -1.211 . . . . 72.34 107.731 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.687 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -106.0 89.32 3.61 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.544 -0.91 . . . . 61.52 108.544 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.17 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.837 2.358 . . . . 63.42 112.602 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -127.26 29.58 5.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.013 0.925 . . . . 72.52 110.773 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.687 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -48.1 -55.8 16.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 C-N-CA 123.983 0.913 . . . . 64.41 112.419 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HA ' HD11 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -70.5 -16.66 34.45 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.845 1.697 . . . . 73.22 112.622 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -101.5 4.81 41.51 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.5 0.926 . . . . 71.44 113.5 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.68 -31.36 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 118.22 0.464 . . . . 71.3 111.775 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -73.35 -17.82 61.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.464 0.705 . . . . 72.44 110.958 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -79.43 -35.79 39.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.251 1.02 . . . . 62.43 110.813 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -108.02 110.28 21.95 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.39 0.676 . . . . 72.43 110.607 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -98.45 78.03 2.38 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.227 0.611 . . . . 75.31 110.374 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -151.35 161.6 42.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.374 -1.343 . . . . 71.43 107.374 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -85.3 133.5 42.43 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 122.722 0.409 . . . . 73.11 110.221 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.52 136.51 26.18 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.421 2.081 . . . . 73.42 112.799 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -66.63 104.16 1.23 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.8 0.84 . . . . 73.54 109.067 168.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.465 HG11 HD21 ' B' ' 126' ' ' LEU . 11.0 m -98.43 150.44 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.979 0.511 . . . . 72.55 110.423 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' B' ' 65' ' ' THR . 1.1 tmmt? -150.69 121.63 7.64 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.566 -0.901 . . . . 74.43 108.566 -175.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.487 HD11 HD12 ' B' ' 126' ' ' LEU . 2.2 mm? -96.49 134.69 39.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.795 0.838 . . . . 73.23 109.602 -173.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.607 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.6 m-20 -123.62 113.45 18.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.342 -0.984 . . . . 74.34 108.342 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -101.67 148.0 25.78 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.384 -0.599 . . . . 72.14 109.384 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -161.31 152.33 18.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.62 -1.252 . . . . 53.41 107.62 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -153.43 143.87 22.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.988 0.423 . . . . 55.01 110.73 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.66 161.16 35.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.991 1.316 . . . . 74.2 108.331 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.3 m -130.44 165.18 23.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.335 0.588 . . . . 71.02 110.729 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -151.54 146.29 25.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.067 1.347 . . . . 71.31 107.554 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.65 112.13 24.92 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.292 -0.632 . . . . 53.05 109.292 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.39 -34.49 25.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.015 0.436 . . . . 75.02 110.086 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -159.94 178.6 9.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.8 0.84 . . . . 44.01 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.46 117.29 5.51 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.649 -1.159 . . . . 72.42 109.524 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 71.53 -4.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.438 1.495 . . . . 73.22 112.542 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 78.7 t -104.93 95.23 3.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.399 -0.963 . . . . 71.34 108.399 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -107.58 136.4 47.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.629 -0.714 . . . . 74.01 110.435 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -101.48 100.75 11.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.539 -1.282 . . . . 73.14 107.539 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.18 127.32 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.243 1.017 . . . . 72.31 109.669 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.2 t -103.63 123.63 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.825 0.85 . . . . 52.15 110.036 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.94 134.38 35.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.926 -1.509 . . . . 75.23 106.926 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -120.51 121.74 39.09 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.08 0.952 . . . . 75.21 108.701 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -115.53 104.29 16.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.093 -1.447 . . . . 74.5 107.093 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 21.7 m -96.92 130.22 44.26 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.542 -0.91 . . . . 74.12 108.542 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.49 HG23 HD13 ' B' ' 114' ' ' ILE . 69.8 t -112.85 130.7 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.394 0.678 . . . . 72.13 109.401 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HE3' ' B' ' 41' ' ' LYS . 22.0 m -119.67 123.64 44.31 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.514 -0.921 . . . . 62.32 108.514 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 140.18 49.05 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 122.734 0.413 . . . . 73.41 109.984 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.552 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 22.5 p -138.2 126.71 23.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 62.34 110.152 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 2.6 tt -93.46 100.55 12.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.914 -1.513 . . . . 42.44 106.914 -176.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.39 -137.47 19.75 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 111.767 -0.533 . . . . 70.31 111.767 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.53 33.93 1.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.676 0.79 . . . . 60.11 110.387 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.28 146.7 24.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.058 0.943 . . . . 74.31 108.794 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -74.99 138.3 42.14 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.074 0.464 . . . . 72.34 111.388 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.552 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.07 -61.92 1.58 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.292 -1.003 . . . . 42.32 108.292 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.37 157.62 32.7 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.782 -1.099 . . . . 75.31 110.078 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.79 111.82 12.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.394 -1.335 . . . . 71.33 107.394 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.32 152.8 35.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.412 0.685 . . . . 53.41 109.538 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -155.61 134.64 12.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.514 -0.921 . . . . 75.51 108.514 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -129.07 141.36 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.366 -0.605 . . . . 62.24 109.366 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 51.4 mt-30 -118.88 100.88 7.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.378 1.071 . . . . 75.45 109.007 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -87.41 101.17 13.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.715 -0.675 . . . . 74.33 109.362 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 150.64 21.57 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.316 -0.714 . . . . 74.13 111.316 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.26 125.86 2.04 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 111.65 -0.58 . . . . 75.01 111.65 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.66 126.53 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.061 -1.088 . . . . 75.21 108.061 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -130.85 160.38 34.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.651 1.18 . . . . 72.24 108.855 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -130.79 108.06 9.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.934 0.893 . . . . 52.41 108.777 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.714 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -123.69 115.38 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.823 1.249 . . . . 62.25 109.428 -174.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 51.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.702 0.801 . . . . 65.32 110.275 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.01 -46.01 1.23 Allowed Glycine 0 C--N 1.345 1.031 0 O-C-N 123.548 0.53 . . . . 63.01 112.112 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -90.75 154.23 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.1 0.96 . . . . 71.4 111.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -159.46 156.81 28.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.694 0.398 . . . . 65.34 110.522 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.27 -116.45 7.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.245 -0.434 . . . . 53.21 112.749 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -67.75 -33.48 74.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.769 0.828 . . . . 64.21 111.044 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -65.14 -50.31 66.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.735 -0.666 . . . . 72.44 110.529 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 28.2 ttt -71.73 -28.19 63.5 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.287 -0.87 . . . . 74.43 110.944 -178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -38.14 85.81 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.805 -0.634 . . . . 54.12 110.688 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -70.47 -34.79 72.79 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.505 -0.771 . . . . 74.42 110.299 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.31 -48.39 56.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.171 0.588 . . . . 73.44 111.034 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.25 -16.85 44.76 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.524 0.73 . . . . 73.42 111.812 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.75 2.84 58.73 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.88 -0.4 . . . . 63.42 113.307 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.84 -55.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.276 0.538 . . . . 75.33 112.132 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -81.52 -50.98 8.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.942 0.497 . . . . 74.15 111.768 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.7 m -56.89 -49.6 92.94 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.712 -0.661 . . . . 74.42 112.518 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.45 -26.86 47.3 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.989 1.793 . . . . 73.45 112.842 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.99 -33.56 76.34 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.942 0.401 . . . . 72.12 110.995 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.21 -47.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.672 0.789 . . . . 72.31 110.189 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.22 -22.36 61.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.226 -0.897 . . . . 74.11 112.268 -172.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -63.66 -47.87 81.39 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 114.211 1.189 . . . . 75.3 114.211 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.42 -36.14 93.39 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.09 1.86 . . . . 72.15 113.352 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.41 ' HE2' HG21 ' D' ' 115' ' ' THR . 69.4 m-85 -70.93 -46.84 61.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.194 0.597 . . . . 73.11 110.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.09 94.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.467 0.707 . . . . 55.53 110.651 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -59.38 -56.0 27.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.885 0.874 . . . . 75.45 110.624 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -37.8 84.35 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.791 0.682 . . . . 75.35 110.057 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.5 m -57.08 -53.44 58.03 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 73.54 111.917 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.49 HD13 HG23 ' B' ' 64' ' ' VAL . 80.9 mt -60.73 -58.12 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.595 0.758 . . . . 75.45 111.065 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.3 m -63.56 -30.3 71.43 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.252 0.97 . . . . 70.44 111.206 -168.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 43.7 t -59.79 -56.59 19.91 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.684 -0.689 . . . . 50.23 109.397 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.642 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 19.1 mmt -61.57 -32.96 73.07 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.748 0.819 . . . . 73.53 112.158 -175.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.12 -50.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.027 0.931 . . . . 72.13 110.66 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 84.8 p -74.54 -20.1 60.09 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.292 0.637 . . . . 74.3 111.339 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.642 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.43 -33.48 75.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.786 0.834 . . . . 62.51 110.06 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.73 8.66 78.25 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.39 0.431 . . . . 73.31 112.622 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.793 HG21 ' HD2' ' A' ' 15' ' ' ARG . 4.8 p 69.09 15.05 8.77 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.64 1.976 . . . . 73.31 113.148 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.05 155.3 67.42 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.776 0.83 . . . . 74.41 111.104 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.56 128.79 30.85 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.518 2.812 . . . . 70.23 113.396 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.43 ' HG3' ' OE1' ' C' ' 125' ' ' GLN . 72.7 mt-30 -55.66 133.33 50.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.171 1.388 . . . . 74.34 112.516 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.487 HD12 HD11 ' B' ' 42' ' ' LEU . 3.7 mm? -109.51 82.36 1.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.929 -0.767 . . . . 74.31 108.929 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -91.84 96.23 10.29 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.933 -1.136 . . . . 71.14 107.933 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.19 128.63 35.92 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.179 -0.674 . . . . 75.32 109.179 -177.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.95 148.5 94.57 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.033 0.933 . . . . 60.1 111.376 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.29 93.62 0.57 Allowed 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.177 1.918 . . . . 74.03 111.401 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.6 140.75 15.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.083 -0.962 . . . . 60.11 108.648 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -68.23 99.89 0.97 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.568 0.747 . . . . 65.0 110.339 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -56.34 -30.76 63.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.074 -0.966 . . . . 74.31 110.096 170.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.4 -56.91 13.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.063 1.345 . . . . 54.21 111.46 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.9 94.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.886 0.741 . . . . 62.54 111.74 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 tt . . . . . 0 N--CA 1.482 1.147 0 C-N-CA 123.69 0.796 . . . . 64.44 109.567 178.308 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.661 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 13.0 tmm? . . . . . 0 CA--C 1.559 1.297 0 N-CA-C 113.288 0.847 . . . . 60.52 113.288 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -94.22 105.79 17.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 53.55 110.023 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.661 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 80.3 t80 -122.61 143.18 49.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 71.21 109.232 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.76 140.47 17.04 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.177 0.591 . . . . 72.43 109.687 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.0 mt -79.11 117.88 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.251 -1.018 . . . . 74.24 108.251 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -88.9 -45.4 9.73 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.772 0.67 . . . . 74.44 110.064 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.8 144.45 6.02 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.887 0.475 . . . . 61.11 110.277 177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.84 139.85 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.173 -1.047 . . . . 74.34 108.173 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.519 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 32.6 p90 -173.78 158.18 3.21 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.312 0.577 . . . . 75.32 111.136 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -82.47 116.92 22.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.502 -0.772 . . . . 63.24 109.513 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -78.09 -41.0 36.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.696 0.76 . . . . 73.41 109.074 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -140.41 140.02 35.39 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.55 -1.205 . . . . 62.21 109.741 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.9 mt -136.36 141.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.482 1.513 . . . . 54.22 107.093 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -158.61 148.8 19.78 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.189 0.519 . . . . 74.34 110.222 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -148.27 149.41 31.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -143.45 146.42 33.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.046 1.338 . . . . 72.34 107.714 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' D' ' 19' ' ' LYS . . . -149.77 82.79 6.53 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.83 -1.174 . . . . 54.52 107.83 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.25 -31.9 43.17 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.497 2.131 . . . . 62.1 111.996 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 79.0 m-20 -112.15 38.82 2.58 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 70.42 109.599 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -57.86 -48.79 96.53 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.512 1.125 . . . . 72.01 113.348 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.89 -21.14 8.47 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.729 1.619 . . . . 71.13 112.613 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.8 t-160 -67.56 -20.31 65.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.893 0.877 . . . . 75.33 111.686 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.518 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 11.7 p -46.03 -28.99 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 124.792 1.237 . . . . 42.34 114.212 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -66.92 -43.07 84.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.906 0.482 . . . . 72.32 111.824 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -127.66 39.15 3.92 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.536 0.684 . . . . 71.04 110.806 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -94.03 169.56 10.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 167.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.99 120.89 25.83 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.51 -0.922 . . . . 62.52 108.51 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t90 -78.44 81.61 4.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.481 0.657 . . . . 71.45 109.674 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -153.86 74.95 6.28 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.478 -1.237 . . . . 50.25 107.745 168.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.26 106.64 1.76 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.745 2.296 . . . . 74.53 110.611 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.67 94.89 8.74 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.323 -1.732 . . . . 64.22 106.323 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 96.4 t -86.07 102.33 11.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.549 -1.205 . . . . 52.22 110.198 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -90.29 101.83 14.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.255 -1.338 . . . . 63.24 108.007 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.56 ' H ' HD23 ' C' ' 42' ' ' LEU . 0.7 OUTLIER -89.11 147.49 24.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.978 -0.749 . . . . 72.21 108.978 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.3 t70 -142.69 136.19 28.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.631 0.772 . . . . 60.44 109.156 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 135.44 41.87 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.89 0.876 . . . . 72.1 109.085 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.34 152.06 30.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.445 1.098 . . . . 72.31 108.204 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -131.02 135.78 47.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.421 0.629 . . . . 62.12 110.896 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.52 170.64 8.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.975 -1.011 . . . . 52.32 108.747 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 59.5 p -150.86 151.22 31.93 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.654 0.382 . . . . 60.54 110.534 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.7 p -147.3 128.07 14.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.201 1.001 . . . . 70.21 109.189 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -72.2 118.15 14.72 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.629 -0.508 . . . . 71.45 109.629 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' C' ' 57' ' ' GLU . 54.9 mt -87.28 -43.83 11.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.214 -0.661 . . . . 71.44 109.214 176.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.97 -178.35 6.43 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.705 -1.134 . . . . 43.43 109.895 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.74 120.32 11.0 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.573 -0.74 . . . . 73.44 110.157 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 66.92 3.45 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.755 1.222 . . . . 70.23 112.872 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.99 113.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.907 0.883 . . . . 71.1 108.985 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.13 125.46 43.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.355 1.062 . . . . 63.12 108.717 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.569 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.7 tt0 -83.74 110.99 18.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.094 -0.706 . . . . 65.21 109.094 172.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -95.55 124.01 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.573 -1.269 . . . . 62.34 107.573 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.83 107.57 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.351 0.66 . . . . 74.45 109.245 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.52 104.89 16.9 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.556 -0.905 . . . . 71.53 108.556 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -90.78 121.29 32.52 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.066 1.346 . . . . 75.23 110.219 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.22 121.65 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.82 0.848 . . . . 73.42 109.302 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.0 m -103.34 141.58 35.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.901 -0.778 . . . . 72.13 108.901 166.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.576 HG21 HG21 ' C' ' 114' ' ' ILE . 87.3 t -129.45 112.32 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.094 -1.076 . . . . 75.51 108.094 173.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -108.16 106.95 17.38 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.684 -0.858 . . . . 62.34 108.684 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.94 100.61 10.1 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.851 -0.796 . . . . 63.51 108.851 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -156.81 146.5 20.73 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.111 -0.7 . . . . 54.45 109.111 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 tp -71.2 -44.97 64.36 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.501 -0.926 . . . . 62.52 108.501 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.75 -76.92 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.359 -1.096 . . . . 70.03 110.359 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.31 -33.29 16.16 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 74.14 109.376 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.4 93.72 0.9 Allowed 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.196 -1.038 . . . . 73.41 108.196 171.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -89.53 118.18 28.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.877 -0.601 . . . . 75.32 109.624 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.93 -57.73 4.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.308 -1.368 . . . . 75.23 107.308 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.42 158.69 27.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.123 -0.944 . . . . 65.02 110.725 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -126.21 143.97 50.94 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.254 -1.758 . . . . 41.31 106.254 170.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 34.9 t -150.89 147.52 27.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.634 -0.506 . . . . 72.44 109.634 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -156.53 129.76 8.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.831 -0.433 . . . . 70.31 109.831 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 36.9 t -127.49 114.73 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.177 0.991 . . . . 72.21 108.827 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.5 mt-30 -91.27 95.26 9.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.515 -0.921 . . . . 65.13 108.515 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.607 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.0 tp-100 -83.22 108.62 16.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.594 -0.73 . . . . 74.12 109.817 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.53 150.47 25.67 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 111.809 -0.516 . . . . 70.24 111.809 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.97 118.06 0.88 Allowed Glycine 0 CA--C 1.501 -0.828 0 N-CA-C 110.556 -1.018 . . . . 50.43 110.556 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.475 HD12 HD11 ' C' ' 51' ' ' LEU . 15.4 mm -79.61 127.91 38.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.48 -1.304 . . . . 73.35 107.48 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -135.21 150.63 50.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 75.12 110.172 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -108.42 113.93 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.238 -0.892 . . . . 73.34 108.991 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 51.5 mt -116.01 110.19 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.984 0.914 . . . . 73.12 108.834 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.41 159.16 42.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 64.25 109.817 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -26.24 8.16 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.361 -0.381 . . . . 61.23 113.374 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' C' ' 93' ' ' GLN . 10.4 tt -123.43 159.19 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.643 0.777 . . . . 63.42 110.33 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -157.93 -177.35 6.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.437 0.695 . . . . 34.35 110.34 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -153.25 40.19 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.189 -0.459 . . . . 40.51 113.563 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 76.0 p -66.0 -21.16 66.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.55 0.74 . . . . 71.13 111.259 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.464 ' HB3' HD11 ' C' ' 89' ' ' ILE . 23.2 mt-30 -59.32 -51.68 68.92 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.012 0.925 . . . . 75.34 110.88 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.407 ' HB3' HG23 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -76.26 -23.76 54.47 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.329 -0.396 . . . . 73.44 110.916 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.78 97.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.235 0.614 . . . . 71.42 111.536 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.82 -26.87 64.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.615 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -69.95 -60.78 2.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 110.357 -0.238 . . . . 75.55 110.357 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 pp -72.89 -13.98 61.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.088 0.403 . . . . 65.21 112.088 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.99 -21.14 28.82 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.779 -0.456 . . . . 61.14 113.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.8 -59.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.392 0.596 . . . . 70.3 111.432 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -51.71 66.85 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.54 0.736 . . . . 75.54 112.365 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 m -68.13 -46.68 40.74 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.731 0.812 . . . . 61.13 112.506 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.57 -24.05 49.04 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.013 1.809 . . . . 64.42 113.793 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -69.88 -20.18 63.4 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 122.751 0.42 . . . . 71.43 112.006 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 ' NH1' ' A' ' 111' ' ' ARG . 36.4 mm -70.34 -41.4 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.365 0.602 . . . . 73.14 109.722 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.511 HD21 ' HA3' ' C' ' 82' ' ' GLY . 78.9 mt -81.67 -27.81 33.86 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.849 -1.069 . . . . 65.12 111.931 -171.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.524 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 49.1 t80 -56.26 -47.44 98.86 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 117.692 -1.147 . . . . 74.33 113.607 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.12 -42.1 67.23 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.345 2.03 . . . . 63.21 113.036 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.4 -47.52 76.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.976 0.91 . . . . 72.34 111.388 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.7 -37.47 86.53 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.796 -0.638 . . . . 61.33 110.894 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -62.16 -46.1 90.48 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.387 1.055 . . . . 64.54 110.134 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.11 -37.11 75.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.713 0.633 . . . . 74.14 110.705 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.5 t -64.7 -31.81 73.2 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.522 0.513 . . . . 60.41 110.793 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.576 HG21 HG21 ' C' ' 64' ' ' VAL . 96.1 mt -73.99 -49.16 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.911 -0.586 . . . . 71.51 110.756 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.0 m -57.8 -33.63 68.77 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.44 0.638 . . . . 52.04 110.703 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -65.84 -51.57 57.76 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.702 -1.135 . . . . 71.21 109.574 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.543 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.25 -37.09 74.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.769 1.228 . . . . 74.23 112.79 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.0 t -69.28 -43.51 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.809 0.844 . . . . 75.31 109.821 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.6 t -69.63 -25.39 63.91 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.12 -0.945 . . . . 73.34 110.988 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -71.54 -38.76 71.02 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 108.793 -0.818 . . . . 72.44 108.793 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.31 84.63 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 123.789 0.681 . . . . 71.42 113.043 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.6 p 62.88 29.81 16.56 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.437 1.895 . . . . 73.31 112.852 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -92.4 163.97 24.6 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 124.43 1.092 . . . . 70.51 111.246 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.62 177.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.065 3.177 . . . . 71.3 115.935 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.43 ' OE1' ' HG3' ' B' ' 125' ' ' GLN . 19.5 mm100 -60.42 112.12 1.84 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.708 1.203 . . . . 74.44 112.026 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -111.33 90.49 3.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.785 -1.561 . . . . 50.1 106.785 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -122.81 105.02 9.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.761 -1.2 . . . . 64.31 107.761 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.524 HD22 ' HZ ' ' C' ' 107' ' ' PHE . 2.8 tt -80.87 116.47 20.87 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.629 -0.878 . . . . 73.24 108.629 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 142.77 98.72 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.087 0.955 . . . . 41.52 111.739 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.446 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 18.3 Cg_endo -58.03 109.66 0.52 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.974 2.449 . . . . 70.41 112.847 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 p -97.89 110.39 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.943 -1.132 . . . . 75.45 107.943 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -102.44 78.39 1.72 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.684 -0.689 . . . . 72.21 111.1 -164.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -69.44 -29.16 66.81 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.18 -0.918 . . . . 75.13 110.508 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 CA--C 1.545 0.758 0 CA-C-N 115.724 -0.671 . . . . 73.34 109.923 178.337 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 CA--C 1.561 1.368 0 N-CA-C 114.716 1.376 . . . . 74.21 114.716 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.7 m -144.86 142.73 30.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 72.12 108.936 166.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.78 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 29.4 t80 -152.79 121.45 6.43 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.051 -1.092 . . . . 75.11 108.051 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -137.67 144.39 41.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.989 0.516 . . . . 75.32 109.765 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.3 mm -84.13 116.91 28.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.95 0.9 . . . . 72.23 108.657 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -101.46 -48.68 4.27 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.929 0.331 . . . . 70.42 111.753 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.425 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 35.3 ttt180 -173.96 128.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 111.923 0.342 . . . . 74.11 111.923 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.13 132.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 124.177 0.991 . . . . 64.42 108.373 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 18.2 p90 -163.13 176.02 10.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.692 0.797 . . . . 75.53 112.043 -172.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.452 HG21 HD11 ' D' ' 21' ' ' ILE . 76.8 p -111.05 126.59 54.97 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 64.01 109.636 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.524 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 35.3 mtpt -97.39 -14.41 21.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.78 0.432 . . . . 60.33 110.302 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -161.33 138.29 8.68 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.385 1.074 . . . . 73.51 109.136 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.543 HG21 ' HE2' ' C' ' 117' ' ' MET . 51.8 mt -140.68 144.49 27.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.787 -1.56 . . . . 64.41 106.787 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 20.3 t -150.23 143.5 25.01 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.024 -0.732 . . . . 61.4 109.024 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.54 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -152.39 125.7 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.67 -1.604 . . . . 63.41 106.67 173.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.0 mt-10 -126.59 142.02 51.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.995 0.918 . . . . 73.34 108.528 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 85.4 60.4 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.021 -1.103 . . . . 73.32 108.021 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.04 -45.08 8.45 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.448 2.765 . . . . 74.43 113.803 -167.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -114.53 44.56 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.154 0.982 . . . . 72.33 108.432 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.519 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -50.91 -57.86 12.23 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 115.808 1.781 . . . . 72.52 115.808 -167.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -85.25 -5.76 9.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 122.345 1.873 . . . . 74.1 112.636 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.441 ' HA ' HE21 ' D' ' 33' ' ' GLN . 7.1 t-160 -84.07 -39.79 19.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.27 1.428 . . . . 64.12 109.947 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.03 -16.59 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.517 0.727 . . . . 64.13 109.828 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -55.46 -32.44 62.78 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.438 1.095 . . . . 74.13 111.789 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.441 HE21 ' HA ' ' D' ' 30' ' ' HIS . 47.1 mt-30 -67.72 -8.21 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.457 0.703 . . . . 74.41 112.531 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -125.47 106.19 9.61 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.295 1.038 . . . . 61.13 109.485 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -89.23 81.93 6.63 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.28 1.038 . . . . 74.51 110.478 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.577 ' HB3' HD11 ' D' ' 68' ' ' LEU . 33.5 t-105 -146.04 157.25 43.86 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.925 -1.139 . . . . 62.23 107.925 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -61.41 105.21 0.55 Allowed Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 125.161 1.384 . . . . 75.14 110.912 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -61.35 111.38 1.11 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.272 2.648 . . . . 72.32 111.883 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 113.27 2.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.378 0.671 . . . . 71.13 110.542 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.7 m -100.76 150.27 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 54.05 110.579 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -121.63 118.92 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.621 -1.992 . . . . 73.34 105.621 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.65 ' HG ' HD21 ' D' ' 128' ' ' LEU . 0.0 OUTLIER -96.38 151.45 19.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.726 -0.842 . . . . 44.33 108.726 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -149.79 144.15 25.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.421 0.688 . . . . 64.43 109.754 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -119.73 131.82 55.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.706 0.802 . . . . 72.41 110.01 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.7 t70 -134.04 117.71 16.96 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.539 -1.282 . . . . 72.52 107.539 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -103.5 156.91 17.41 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.218 0.533 . . . . 61.31 110.359 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 171.38 18.09 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.16 0.984 . . . . 71.34 109.076 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 48.5 p -150.45 163.32 38.69 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.458 0.703 . . . . 73.43 109.582 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -158.14 118.13 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.769 -1.197 . . . . 64.32 107.769 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -85.43 122.63 29.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.454 -0.572 . . . . 74.11 109.454 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.9 -40.55 12.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.51 0.724 . . . . 71.12 109.44 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.59 5.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.698 -1.137 . . . . 74.52 109.491 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.55 130.65 43.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.41 -0.589 . . . . 73.44 109.41 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.57 5.49 5.41 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.769 1.227 . . . . 72.13 111.635 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 99.9 t -126.95 115.29 40.85 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 124.658 1.183 . . . . 74.32 108.906 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 24.7 m-85 -134.27 127.26 31.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.076 -0.713 . . . . 60.41 109.076 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.67 114.43 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.84 1.256 . . . . 52.35 108.678 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.53 137.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.446 -0.946 . . . . 73.02 108.446 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 67.9 t -115.7 138.56 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.981 0.913 . . . . 72.34 108.921 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.593 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -126.48 119.6 27.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.386 -1.338 . . . . 72.41 107.386 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -102.85 98.69 8.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.518 -0.919 . . . . 73.52 108.518 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.15 130.92 40.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.962 -0.755 . . . . 70.52 108.962 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -123.4 143.32 50.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.894 -0.594 . . . . 61.41 110.062 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.418 HG23 HD13 ' D' ' 114' ' ' ILE . 70.8 t -130.1 125.41 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.486 1.114 . . . . 70.4 108.859 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 84.3 m -115.55 110.62 19.5 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.095 -1.076 . . . . 44.21 108.095 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.506 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -98.53 157.49 16.2 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.84 0.456 . . . . 62.25 109.8 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.5 p -158.34 137.28 11.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.656 -0.498 . . . . 53.53 109.656 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' D' ' 36' ' ' TRP . 18.1 tp -136.03 110.34 8.43 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.054 -1.091 . . . . 72.41 108.054 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.95 -127.35 7.97 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.596 0.56 . . . . 54.24 113.382 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -94.4 9.44 38.32 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.182 0.593 . . . . 74.52 111.838 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.45 163.93 31.51 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.249 0.547 . . . . 75.31 111.349 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -74.18 134.51 42.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.823 -1.08 . . . . 72.11 109.516 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.29 -53.03 5.26 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.49 0.716 . . . . 75.41 109.865 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.92 172.47 18.4 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.76 -1.109 . . . . 73.41 109.7 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 98.5 mt -138.68 149.57 45.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.241 1.417 . . . . 73.4 108.087 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.783 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -159.76 142.37 13.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.676 0.39 . . . . 53.44 110.671 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -155.94 126.85 6.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.941 0.496 . . . . 72.14 109.883 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.33 119.07 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.667 0.787 . . . . 64.44 110.074 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.745 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 25.3 mt-30 -89.22 88.09 7.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.715 0.769 . . . . 71.41 109.037 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.86 107.99 13.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.197 -1.365 . . . . 75.41 108.676 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.47 164.04 18.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 112.347 -0.301 . . . . 63.41 112.347 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.53 3.74 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.903 -0.479 . . . . 65.32 111.903 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -88.85 126.94 41.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.639 -0.875 . . . . 63.21 108.639 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -130.54 143.48 50.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.352 1.061 . . . . 73.52 109.101 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 12.9 m -80.66 101.18 9.08 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.816 -0.809 . . . . 70.11 108.816 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 43.1 mm -107.01 106.04 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.093 -1.076 . . . . 61.33 108.093 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.11 162.13 39.46 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.387 0.675 . . . . 65.34 110.849 -173.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 -0.2 55.33 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.926 0.73 . . . . 63.32 114.926 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.404 HD11 HG23 ' D' ' 86' ' ' ILE . 17.1 pt -134.03 141.21 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.879 0.872 . . . . 70.35 109.806 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.41 166.03 25.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.578 0.751 . . . . 74.54 110.873 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.75 -112.6 3.23 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.794 0.684 . . . . 74.13 114.018 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -72.57 -30.51 64.46 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.311 1.044 . . . . 74.21 111.353 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -67.05 -52.47 41.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 64.41 110.577 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.417 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 27.5 ptm -70.26 -29.91 66.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.818 -0.628 . . . . 64.14 110.545 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.48 77.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.895 0.478 . . . . 74.31 111.09 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -64.41 -43.01 95.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.329 0.652 . . . . 73.14 110.031 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.96 -49.36 77.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.884 0.473 . . . . 54.51 111.033 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' D' ' 94' ' ' MET . 88.2 mt -70.76 -22.32 62.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.637 0.775 . . . . 75.45 111.78 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.44 9.1 24.34 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.247 -0.752 . . . . 72.32 114.607 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.11 -75.77 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.021 0.91 . . . . 50.1 111.279 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -68.69 -50.91 47.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.276 0.843 . . . . 73.4 113.276 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.78 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 25.5 m -62.9 -46.32 87.5 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.743 -0.646 . . . . 64.22 111.849 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.593 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.2 Cg_exo -57.95 -33.93 97.74 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.47 2.113 . . . . 74.33 113.347 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.53 -29.68 69.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.462 0.705 . . . . 73.52 111.147 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.73 -38.6 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.492 0.663 . . . . 70.45 110.228 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 52.2 mt -81.55 -13.65 57.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.991 -1.004 . . . . 73.35 111.624 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.614 ' HZ ' HD22 ' D' ' 128' ' ' LEU . 56.9 t80 -69.04 -46.28 30.38 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.217 -0.897 . . . . 65.21 113.371 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 -32.42 90.88 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.085 1.857 . . . . 64.23 112.912 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.89 -35.39 38.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.767 0.827 . . . . 53.31 111.948 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.64 -51.91 63.12 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.111 0.564 . . . . 71.2 109.817 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -67.69 -34.24 76.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.15 -0.932 . . . . 73.41 111.552 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.94 -43.93 81.93 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.18 0.925 . . . . 75.0 110.159 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.7 t -57.53 -43.13 84.09 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 123.626 0.579 . . . . 25.04 109.929 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.783 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.2 mt -63.74 -46.1 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.188 -0.914 . . . . 71.42 110.749 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.41 HG21 ' HE2' ' B' ' 109' ' ' TYR . 94.0 m -55.76 -49.73 72.35 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.291 1.037 . . . . 53.51 110.527 -176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -65.3 -44.12 88.93 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 113.581 -1.645 . . . . 73.24 110.387 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.415 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 76.3 mtm -64.63 -35.92 82.57 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.894 0.478 . . . . 74.55 112.217 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.1 t -67.56 -44.77 86.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.441 0.696 . . . . 71.34 110.492 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.83 -25.73 62.1 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 122.478 0.311 . . . . 61.42 111.192 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -74.69 -34.81 62.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.641 0.777 . . . . 74.24 109.162 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 0.4 76.37 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 115.393 -0.821 . . . . 72.11 112.362 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.26 27.86 16.67 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 126.85 2.06 . . . . 72.12 112.907 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.557 ' HB2' HG13 ' D' ' 118' ' ' VAL . 37.3 m-85 -94.92 160.63 30.64 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.45 -1.25 . . . . 62.2 108.706 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -53.44 136.07 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 124.066 3.177 . . . . 53.3 113.571 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.0 128.06 31.84 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 124.303 1.002 . . . . 74.34 111.804 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.403 HD21 HG11 ' D' ' 64' ' ' VAL . 47.7 tp -117.15 95.63 5.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 74.01 110.805 -175.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -99.91 113.34 25.83 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.801 -1.185 . . . . 72.12 107.801 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.65 HD21 ' HG ' ' D' ' 42' ' ' LEU . 1.1 tt -74.57 124.66 27.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.768 -0.456 . . . . 71.12 109.768 -174.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -61.79 131.32 92.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.663 0.785 . . . . 74.25 110.99 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -77.78 127.4 8.68 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.65 2.233 . . . . 71.34 112.53 -170.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.37 112.5 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.451 0.643 . . . . 75.21 109.389 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -89.03 72.97 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.919 0.866 . . . . 55.14 109.413 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 t80 . . . . . 0 CA--C 1.546 0.818 0 CA-C-N 114.789 -1.096 . . . . 73.22 110.866 178.233 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 108.103 -1.073 . . . . 63.14 108.103 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -139.79 119.44 13.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.359 0.663 . . . . 64.34 109.45 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -138.54 115.64 10.97 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.044 0.538 . . . . 72.0 110.103 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.475 HG13 ' HD2' ' A' ' 84' ' ' PHE . 2.9 mp -78.28 115.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.35 -1.352 . . . . 41.43 107.35 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -94.13 -44.41 8.02 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.601 0.36 . . . . 72.43 111.061 -171.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.566 ' HD3' HG21 ' B' ' 122' ' ' THR . 86.0 mtt180 -159.02 157.05 30.47 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.141 0.976 . . . . 75.44 110.228 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -144.63 101.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HD1' ' HB3' ' A' ' 15' ' ' ARG . 89.4 m-85 -159.87 177.66 10.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.943 1.297 . . . . 65.42 109.476 -165.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.411 HG21 ' SG ' ' A' ' 113' ' ' CYS . 73.2 p -90.84 135.58 33.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 122.241 -0.287 . . . . 64.2 110.735 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 42.4 mtpt -96.47 -48.64 5.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.178 -0.675 . . . . 75.21 109.178 168.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 27.8 t70 -133.26 137.23 45.96 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.271 -1.331 . . . . 74.12 109.28 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 79.4 mt -139.19 139.48 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 106.876 -1.527 . . . . 73.45 106.876 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -147.53 129.38 15.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.582 0.753 . . . . 51.32 109.458 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.575 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 81.7 t80 -142.1 125.06 16.16 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.076 -1.453 . . . . 74.21 107.076 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.78 116.45 14.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.029 -0.73 . . . . 70.42 109.029 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.64 82.99 48.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 108.878 -0.786 . . . . 74.34 108.878 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 -32.76 13.98 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.574 2.183 . . . . 62.14 111.294 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 72' ' ' THR . 80.5 m-20 -104.72 31.39 4.77 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.05 0.94 . . . . 74.25 109.859 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.93 98.26 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.991 0.916 . . . . 74.15 112.22 171.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -70.18 -14.97 35.36 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.962 1.775 . . . . 70.0 113.609 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 14.2 m170 -68.96 -46.59 67.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.758 -0.46 . . . . 71.33 109.758 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.8 -20.19 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.415 1.086 . . . . 73.43 112.153 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.22 -42.05 94.34 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.171 0.988 . . . . 65.04 111.107 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.95 -20.28 14.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.749 0.82 . . . . 72.12 111.652 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HD3' ' H ' ' A' ' 35' ' ' ASP . 3.9 tmtp? -83.79 163.37 20.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.261 1.024 . . . . 74.34 110.582 -171.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.634 ' H ' ' HD3' ' A' ' 34' ' ' LYS . 10.6 m-20 -63.69 143.53 57.76 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.207 1.003 . . . . 73.5 111.431 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -96.34 65.08 2.31 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.1 . . . . 73.23 110.609 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.44 77.38 9.72 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 109.558 -0.534 . . . . 70.34 109.558 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 7.6 Cg_endo -82.14 148.48 15.06 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.032 1.821 . . . . 64.13 111.037 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.23 99.87 12.04 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.768 -1.197 . . . . 64.04 107.768 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.458 HG22 HD13 ' A' ' 126' ' ' LEU . 26.8 t -76.69 95.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.138 -0.937 . . . . 73.33 109.946 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -79.87 131.9 35.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.148 0.979 . . . . 64.55 109.796 174.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.437 HD12 HG22 ' A' ' 64' ' ' VAL . 2.1 mm? -115.3 149.47 37.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.115 0.483 . . . . 72.24 110.789 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.6 m-20 -136.34 125.92 25.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.076 1.35 . . . . 70.42 107.611 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.4 mt -116.64 119.1 34.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.622 -0.881 . . . . 75.02 108.622 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -132.51 147.74 52.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.98 0.912 . . . . 71.31 109.979 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.4 m -142.84 128.67 19.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.428 0.691 . . . . 62.13 110.161 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.78 152.3 49.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.648 0.779 . . . . 44.31 109.395 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.5 m -127.2 167.34 16.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 42.41 109.597 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -168.25 122.06 0.9 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 122.978 0.174 . . . . 72.32 110.548 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -69.78 114.45 7.99 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.793 0.837 . . . . 64.21 110.905 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 57' ' ' GLU . 58.7 mt -83.54 -41.93 17.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.324 1.05 . . . . 51.24 110.955 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.12 178.78 7.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.549 1.14 . . . . 70.12 108.309 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.14 99.01 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.922 0.392 . . . . 42.01 110.151 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 1.4 m-20 69.53 29.89 4.19 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 113.803 -1.544 . . . . 74.4 111.696 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -114.8 121.73 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.132 -1.803 . . . . 63.41 106.132 164.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.488 ' CE2' ' HA ' ' A' ' 54' ' ' ASP . 4.0 m-85 -132.49 137.33 47.16 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.309 0.576 . . . . 72.11 109.616 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 51' ' ' LEU . 10.3 tt0 -87.09 114.14 23.44 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.283 -1.326 . . . . 75.2 108.645 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.39 110.16 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.05 -1.093 . . . . 54.15 108.05 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 97.4 t -98.45 137.79 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.523 0.729 . . . . 64.01 110.572 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.66 110.78 21.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.257 -1.386 . . . . 70.34 107.257 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -108.83 111.33 23.01 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.927 0.891 . . . . 75.21 109.386 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.1 t -110.71 128.79 66.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 123.578 0.751 . . . . 71.31 109.304 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.7 m -108.83 143.78 37.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.235 -0.654 . . . . 73.22 109.235 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.659 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.7 t -137.21 109.28 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.655 1.582 . . . . 73.2 107.759 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.4 m -114.81 119.49 36.81 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.651 -0.5 . . . . 74.24 109.651 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -103.28 107.33 18.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.738 -1.208 . . . . 25.24 107.738 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.0 m -129.79 128.63 42.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.917 0.487 . . . . 73.43 109.769 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.549 HD22 ' HE2' ' A' ' 34' ' ' LYS . 4.7 tt -101.44 85.49 2.79 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.162 -1.421 . . . . 55.31 107.162 172.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.86 2.19 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.204 -0.907 . . . . 73.41 111.756 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -88.16 -28.05 21.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.55 0.74 . . . . 64.42 110.779 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.46 125.5 35.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 71.55 110.212 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 23.1 m -88.02 114.92 25.11 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.95 -0.759 . . . . 73.14 108.95 169.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.89 -51.47 58.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.645 0.778 . . . . 72.04 109.347 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.483 ' HZ ' HD12 ' A' ' 126' ' ' LEU . 52.5 p90 -164.36 173.59 12.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.385 -1.28 . . . . 70.32 111.931 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.27 146.65 52.14 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.729 1.611 . . . . 72.02 107.921 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.659 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.5 m -141.92 138.99 32.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.165 0.986 . . . . 70.45 108.751 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -150.92 133.0 15.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.962 -0.755 . . . . 54.52 108.962 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 113' ' ' CYS . 47.0 t -131.53 115.62 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.458 0.703 . . . . 74.3 109.121 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 62.5 mt-30 -84.6 84.83 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.057 -1.09 . . . . 64.14 108.057 170.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.91 95.82 4.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.742 -1.117 . . . . 71.24 108.555 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.84 142.96 19.55 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.819 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -137.83 122.47 2.47 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.211 -1.556 . . . . 64.23 109.211 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -89.3 122.38 40.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HD2' HG13 ' A' ' 13' ' ' ILE . 29.3 m-85 -125.45 118.46 25.88 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.435 -2.061 . . . . 74.13 105.435 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -93.79 94.61 8.63 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.907 -1.146 . . . . 64.23 107.907 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -117.85 148.48 20.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 123.666 0.786 . . . . 73.25 110.136 -174.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -170.93 148.22 2.79 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.949 1.3 . . . . 75.34 109.351 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.44 6.64 62.53 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.167 0.292 . . . . 71.24 113.305 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.555 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.6 mp -127.33 136.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.116 -1.438 . . . . 72.24 107.116 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 175.58 11.19 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.312 0.505 . . . . 71.43 110.596 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 -152.14 48.15 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.262 -0.881 . . . . 70.53 112.767 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -65.48 -24.99 67.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.077 0.951 . . . . 43.14 112.429 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -59.65 -49.74 76.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.287 0.635 . . . . 73.14 109.969 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.555 ' SD ' ' HB ' ' A' ' 89' ' ' ILE . 2.5 tpt -80.86 -30.81 35.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.133 -0.939 . . . . 74.15 110.94 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -29.56 69.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.212 0.605 . . . . 52.53 110.842 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 36.6 t-80 -73.55 -36.96 65.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.988 -0.551 . . . . 75.25 110.522 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 53.3 t -76.78 -65.11 0.98 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.912 -0.131 . . . . 74.13 111.11 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.92 -29.27 70.46 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.954 0.502 . . . . 62.44 112.327 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.44 -22.77 36.17 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 114.333 0.493 . . . . 73.23 114.333 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -133.09 -49.85 0.87 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.534 0.667 . . . . 65.05 112.424 -170.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -71.84 -47.55 52.33 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.856 0.862 . . . . 74.21 111.742 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 73.9 m -67.32 -47.62 48.71 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.425 1.09 . . . . 74.11 112.675 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.26 -26.88 56.28 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.891 1.727 . . . . 72.12 112.825 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.72 -29.29 62.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.622 0.369 . . . . 74.42 110.436 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 49.7 mt -61.44 -47.04 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.752 0.821 . . . . 73.22 109.429 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -73.71 -20.4 60.54 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.698 -1.137 . . . . 61.41 112.053 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -64.65 -46.11 76.41 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 114.627 1.343 . . . . 64.11 114.627 -166.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.63 -35.13 98.91 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.932 1.754 . . . . 64.14 112.706 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -73.72 -36.46 65.22 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.369 -0.832 . . . . 73.33 111.609 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.17 -42.81 68.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.262 0.225 . . . . 74.1 110.453 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.435 HH22 ' HA ' ' A' ' 130' ' ' PRO . 38.2 ttm105 -52.13 -48.6 64.76 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.114 0.884 . . . . 61.11 110.289 175.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.36 -52.53 61.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.851 -1.068 . . . . 71.32 111.429 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.418 ' HB3' HG11 ' A' ' 78' ' ' VAL . 46.8 t -61.42 -29.21 69.8 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.908 0.755 . . . . 71.32 112.013 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.658 HG21 HG21 ' A' ' 64' ' ' VAL . 79.1 mt -71.68 -60.37 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.69 -0.686 . . . . 64.5 109.694 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -55.03 -30.31 59.29 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.548 1.139 . . . . 64.2 112.333 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 -44.49 72.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.69 -0.686 . . . . 70.13 109.992 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.9 mtm -61.11 -41.11 96.09 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.881 0.473 . . . . 52.23 110.58 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -58.23 -47.76 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.532 -1.213 . . . . 72.42 110.667 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -75.21 -26.95 59.35 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.894 -0.594 . . . . 75.23 111.411 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -71.71 -27.88 63.31 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.708 0.803 . . . . 74.12 109.852 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.65 3.78 77.2 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.494 -0.775 . . . . 45.34 112.642 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.3 m 68.06 14.6 9.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.943 1.297 . . . . 70.2 111.216 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -85.81 149.91 51.98 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.853 -0.795 . . . . 72.51 108.853 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.82 143.3 91.34 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.574 2.182 . . . . 71.11 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -61.48 132.69 54.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.685 0.394 . . . . 74.32 110.734 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.483 HD12 ' HZ ' ' A' ' 74' ' ' PHE . 63.8 mt -133.42 96.36 3.7 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.306 -0.998 . . . . 63.43 108.306 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -98.85 123.23 42.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.101 -0.5 . . . . 64.23 109.759 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.4 pt? -73.13 152.72 41.05 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.919 0.762 . . . . 74.03 110.576 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.62 147.85 68.82 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.37 1.068 . . . . 64.34 112.074 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' C' ' 13' ' ' ILE . 15.7 Cg_exo -68.59 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.404 2.07 . . . . 62.43 110.964 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.91 111.79 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.305 -0.998 . . . . 74.45 108.305 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.61 96.65 6.86 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.494 -0.928 . . . . 73.42 108.494 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -59.55 -23.41 62.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.472 -0.786 . . . . 75.01 110.258 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 19.0 t70 . . . . . 0 C--N 1.348 0.53 0 C-N-CA 123.997 0.919 . . . . 73.31 111.16 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.9 ptm . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 114.419 1.266 . . . . 72.54 114.419 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -140.34 122.22 15.51 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.248 -1.019 . . . . 71.44 108.248 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -123.95 141.0 52.43 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.321 -0.622 . . . . 75.44 109.321 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 59.8 tt0 -153.97 141.69 19.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.827 0.851 . . . . 71.45 109.161 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.674 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -94.41 117.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.39 -0.967 . . . . 71.34 108.39 175.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -87.04 -48.87 7.74 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.285 -0.416 . . . . 63.31 110.119 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -164.34 140.84 6.33 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.683 -0.488 . . . . 75.34 109.683 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -114.64 141.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.937 -1.505 . . . . 61.11 106.937 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -168.25 148.35 4.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.202 0.455 . . . . 73.14 111.825 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.2 m -74.24 126.82 31.46 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.071 -0.714 . . . . 73.12 109.071 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.2 mtpp -94.51 -41.0 9.58 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.385 -0.598 . . . . 64.01 109.385 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -139.62 141.46 37.09 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.771 -0.65 . . . . 74.14 110.533 -171.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.439 HD13 HG13 ' B' ' 78' ' ' VAL . 41.0 mm -135.81 143.09 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.161 1.384 . . . . 54.34 107.512 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 57.4 p -148.0 138.7 23.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.697 -0.853 . . . . 71.44 108.697 168.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 83.5 t80 -141.21 116.44 10.0 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 106.244 -1.761 . . . . 75.13 106.244 168.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.81 110.86 14.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.688 -1.597 . . . . 73.13 106.688 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -111.91 88.18 9.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.707 -0.849 . . . . 52.14 108.707 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.95 -26.59 51.28 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.007 2.472 . . . . 71.04 112.447 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -120.81 28.31 8.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.774 0.829 . . . . 72.22 110.054 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.531 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.94 -46.34 81.23 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 124.786 1.234 . . . . 54.24 113.669 171.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 84.1 Cg_endo -79.06 -15.15 13.14 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.717 1.611 . . . . 63.04 113.088 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.468 ' HB3' HE21 ' B' ' 33' ' ' GLN . 58.7 m80 -100.43 1.55 41.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.894 0.878 . . . . 72.13 112.899 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.46 -20.91 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.452 0.701 . . . . 62.0 111.786 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.06 -28.15 69.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 63.13 111.851 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.468 HE21 ' HB3' ' B' ' 30' ' ' HIS . 42.9 mt-30 -67.37 -46.64 72.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.663 -0.698 . . . . 74.45 109.587 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' B' ' 68' ' ' LEU . 79.2 mttt -111.86 74.83 0.88 Allowed 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.828 -1.078 . . . . 62.4 111.355 -171.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.94 82.75 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.162 -1.051 . . . . 61.24 108.162 167.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -153.78 165.61 35.49 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.37 -0.832 . . . . 63.55 109.041 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -77.99 120.67 82.15 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.804 -0.813 . . . . 64.21 108.804 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.401 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 98.7 Cg_endo -77.36 154.59 32.03 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.324 2.016 . . . . 64.32 112.068 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 22.1 mm-40 -64.75 115.4 5.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.02 -0.733 . . . . 74.33 109.02 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 p -83.8 122.32 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.607 -0.886 . . . . 72.44 108.607 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.568 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 93.4 mttt -126.44 100.38 6.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.604 -1.258 . . . . 62.02 107.604 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.425 ' H ' ' HG ' ' B' ' 42' ' ' LEU . 1.5 pp -88.91 140.04 29.84 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.078 -0.965 . . . . 63.21 110.78 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.806 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.0 m-20 -136.8 145.47 44.56 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.473 -1.677 . . . . 62.01 106.473 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -140.39 161.54 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.903 -1.147 . . . . 74.14 107.903 176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.8 t70 -159.16 143.22 15.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.192 -0.67 . . . . 73.14 109.192 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -107.34 109.67 21.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.931 -1.137 . . . . 70.32 107.931 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -113.91 154.52 27.4 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.121 -1.066 . . . . 50.14 108.121 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -143.78 162.7 35.36 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.356 0.598 . . . . 72.34 112.108 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -162.87 151.49 14.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.368 1.467 . . . . 52.33 108.4 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -123.14 127.3 48.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.13 -37.65 12.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.946 0.498 . . . . 73.34 110.047 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.93 -175.53 3.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.903 0.881 . . . . 71.45 110.758 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -72.98 124.47 25.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.963 -1.017 . . . . 74.54 108.631 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 68.69 11.95 8.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.072 1.349 . . . . 75.22 111.932 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.65 88.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.45 1.1 . . . . 52.11 108.171 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.498 ' HB2' HD11 ' B' ' 86' ' ' ILE . 3.5 t80 -97.85 166.21 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.101 -0.703 . . . . 62.24 109.101 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -140.3 100.1 3.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.097 -1.446 . . . . 72.51 107.097 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -95.8 137.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.985 0.514 . . . . 72.24 109.657 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 21.9 t -117.17 152.45 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.414 1.086 . . . . 71.35 109.131 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -127.89 119.65 26.05 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.158 -1.423 . . . . 75.54 107.158 176.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.5 ttt180 -105.45 106.37 16.84 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.042 -0.725 . . . . 73.14 109.042 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.42 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.2 t -106.33 111.91 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.329 -0.989 . . . . 71.25 108.329 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.806 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.0 m -106.05 125.94 51.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.357 -0.608 . . . . 54.42 109.357 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.404 HG23 HD13 ' B' ' 114' ' ' ILE . 82.7 t -120.32 99.46 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.209 1.003 . . . . 73.45 109.345 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 86.4 m -86.84 147.84 25.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.991 -1.004 . . . . 74.23 109.312 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.64 152.49 37.96 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.986 0.514 . . . . 51.11 110.287 175.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 41.1 p -147.01 128.83 15.31 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.301 0.376 . . . . 74.44 111.726 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 60.9 mt -91.42 100.65 13.39 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.222 -1.029 . . . . 72.34 108.222 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.51 -120.62 8.37 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.211 -0.904 . . . . 52.32 111.885 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.61 22.73 13.1 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.668 0.747 . . . . 73.22 110.145 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -137.1 144.49 43.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 74.45 109.298 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -68.87 136.86 53.3 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.751 0.31 . . . . 70.03 110.917 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.13 -65.29 1.03 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.411 -0.959 . . . . 51.32 108.411 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.27 166.78 29.86 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 114.658 -1.155 . . . . 72.53 110.018 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.2 mt -135.92 109.73 8.13 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.79 -1.559 . . . . 73.23 106.79 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -118.89 141.46 48.63 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.509 -0.923 . . . . 73.13 108.509 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -149.45 129.05 13.13 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.534 -0.913 . . . . 71.43 108.534 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.439 HG13 HD13 ' B' ' 21' ' ' ILE . 79.1 t -125.03 148.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 73.34 109.211 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -127.63 99.58 5.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 174.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -89.09 109.22 20.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.136 -0.938 . . . . 71.55 109.325 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.15 169.65 26.74 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 111.987 -0.445 . . . . 42.4 111.987 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.03 130.92 2.12 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.271 -0.731 . . . . 51.52 111.271 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.77 127.67 40.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -134.78 135.59 41.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.234 1.014 . . . . 63.32 109.282 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 6.6 m -88.57 121.51 31.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.115 0.966 . . . . 74.41 108.702 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pp -134.55 130.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.09 0.556 . . . . 63.43 110.545 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.99 153.09 33.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.672 0.789 . . . . 72.23 109.939 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.03 -53.84 4.51 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.641 0.588 . . . . 62.52 113.27 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.53 133.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.048 1.339 . . . . 72.3 111.526 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -150.58 176.0 11.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.58 0.752 . . . . 72.24 111.411 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.13 -136.76 35.21 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.066 -1.425 . . . . 64.44 113.199 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.5 m -65.59 -37.54 86.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.885 0.874 . . . . 71.1 111.079 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -65.26 -27.79 68.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.115 -1.402 . . . . 71.32 111.006 -172.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 -33.39 69.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.215 0.606 . . . . 62.4 110.604 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.35 70.49 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.189 0.596 . . . . 61.04 111.379 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -76.74 -23.02 53.01 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.332 0.653 . . . . 75.34 111.344 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.72 -64.97 1.0 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.736 0.414 . . . . 64.13 110.545 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 mt -80.05 -28.56 39.23 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.889 0.476 . . . . 73.24 111.766 -172.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.5 66.74 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-O 119.559 -0.578 . . . . 52.42 113.846 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 -57.05 0.34 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.87 0.835 . . . . 72.01 112.351 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.33 -47.56 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.268 0.627 . . . . 75.44 112.126 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -65.88 -46.38 65.15 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.641 -0.695 . . . . 71.22 111.377 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.457 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 94.6 Cg_exo -50.84 -38.67 57.92 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.491 2.127 . . . . 62.42 113.791 166.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.545 HD21 ' HA ' ' B' ' 132' ' ' ASN . 1.7 m120 -64.4 -29.73 70.79 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.243 0.46 . . . . 64.23 112.243 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.73 -42.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.724 -0.473 . . . . 63.22 109.724 172.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.19 -17.41 54.95 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.124 -0.944 . . . . 75.33 111.756 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.403 ' HZ ' ' HB3' ' B' ' 128' ' ' LEU . 65.1 t80 -61.97 -49.78 83.87 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.88 -1.057 . . . . 72.12 113.592 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.04 -39.38 70.06 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.44 2.093 . . . . 52.01 113.873 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.19 -46.57 49.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.642 -0.708 . . . . 74.31 111.114 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.44 78.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.616 0.766 . . . . 64.25 110.387 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -64.66 -50.8 65.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 75.03 110.549 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -34.68 78.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.162 0.585 . . . . 73.24 109.931 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.1 m -59.74 -52.83 63.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.751 0.82 . . . . 35.13 111.405 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 62' ' ' VAL . 69.2 mt -58.25 -56.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.661 0.785 . . . . 73.1 110.805 178.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -64.77 -31.94 73.39 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 124.154 0.909 . . . . 74.1 111.582 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.6 t -61.79 -50.4 72.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.01 0.524 . . . . 74.4 110.039 174.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.9 mmt -68.85 -34.09 74.89 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.4 0.68 . . . . 73.41 111.232 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.08 -43.16 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.843 0.857 . . . . 64.34 110.309 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 73.1 m -67.93 -30.34 69.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.367 -0.833 . . . . 71.13 111.995 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.524 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -68.38 -28.09 66.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.409 0.684 . . . . 74.51 110.927 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.78 17.09 59.88 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 114.334 0.494 . . . . 63.41 114.334 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.566 HG21 ' HD3' ' A' ' 15' ' ' ARG . 4.1 p 69.67 12.31 8.06 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.049 1.74 . . . . 73.03 113.233 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.84 144.56 30.42 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 109.162 -0.681 . . . . 72.25 109.162 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.58 146.29 54.34 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.944 2.43 . . . . 60.11 111.676 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.428 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 18.7 mp0 -64.48 114.43 4.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.514 0.509 . . . . 74.21 110.978 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.26 85.06 2.07 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.575 -1.269 . . . . 63.25 107.575 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -101.47 121.59 42.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.14 -1.391 . . . . 71.44 108.148 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.403 ' HB3' ' HZ ' ' B' ' 107' ' ' PHE . 0.2 OUTLIER -76.96 139.66 40.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.281 0.632 . . . . 61.12 109.548 -172.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 154.12 84.05 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 124.02 0.928 . . . . 51.33 111.047 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.13 92.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.252 2.635 . . . . 70.32 112.567 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.51 111.92 25.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.492 -0.776 . . . . 74.14 109.499 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . 0.545 ' HA ' HD21 ' B' ' 104' ' ' ASN . 2.1 m-20 -82.06 107.23 14.6 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.421 -0.955 . . . . 53.32 108.421 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -58.83 -37.19 75.88 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.363 1.04 . . . . 72.1 110.581 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.61 -52.74 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.872 -1.058 . . . . 73.43 110.724 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.02 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.87 0.731 . . . . 75.21 112.013 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 N--CA 1.471 0.624 0 O-C-N 124.193 0.933 . . . . 72.33 110.446 176.448 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.2 ttp . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 121.038 0.447 . . . . 71.11 111.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.5 m -118.6 102.06 8.59 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.098 -1.445 . . . . 51.41 107.098 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -118.6 122.79 43.45 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.687 0.795 . . . . 71.14 109.242 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -137.28 136.19 37.81 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.513 -0.551 . . . . 71.44 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.605 HD11 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -68.55 123.45 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.04 -0.726 . . . . 52.41 109.04 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -103.25 -47.96 4.16 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.723 -0.671 . . . . 72.21 109.76 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -173.24 151.98 2.16 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.651 0.595 . . . . 73.14 110.407 -176.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.605 HG13 HD11 ' C' ' 13' ' ' ILE . 89.6 mt -138.26 140.42 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.539 1.136 . . . . 62.32 108.354 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -172.02 158.53 4.72 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.762 0.791 . . . . 74.51 111.364 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.426 HG22 HE22 ' C' ' 80' ' ' GLN . 76.1 p -78.76 106.13 10.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.444 -1.253 . . . . 70.21 109.05 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 5.3 mmmm -66.85 -42.76 85.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.751 0.786 . . . . 61.0 109.638 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -144.53 141.47 29.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.502 -1.227 . . . . 72.31 109.341 -175.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.2 mt -135.82 146.2 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.182 -1.414 . . . . 43.44 107.182 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -154.82 149.27 26.25 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.229 0.538 . . . . 65.11 109.886 171.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -146.61 144.29 29.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.805 -1.089 . . . . 71.41 108.064 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -137.79 139.56 40.09 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.623 1.169 . . . . 74.13 107.89 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 79.29 66.25 Favored Pre-proline 0 C--O 1.241 0.652 0 N-CA-C 107.811 -1.181 . . . . 73.03 107.811 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.64 -22.04 64.89 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.641 2.227 . . . . 61.31 111.844 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 93.5 m-20 -125.91 47.24 2.27 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.448 1.099 . . . . 62.14 109.972 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -58.15 -54.96 50.29 Favored Pre-proline 0 CA--C 1.571 1.754 0 C-N-CA 124.279 1.031 . . . . 64.13 112.157 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 21.0 Cg_exo -66.85 -26.44 44.66 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 121.976 1.784 . . . . 43.23 112.74 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.648 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 21.2 m170 -66.39 -16.35 64.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.26 1.024 . . . . 71.44 113.304 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.627 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 7.9 p -48.59 -33.66 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 112.757 0.651 . . . . 73.54 112.757 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.413 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 92.6 m-85 -76.13 -30.53 58.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.473 0.709 . . . . 70.53 111.939 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -112.88 3.51 16.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.995 0.918 . . . . 74.35 112.866 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -89.97 172.73 8.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.425 0.557 . . . . 60.44 111.061 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.421 ' HB3' HD22 ' C' ' 68' ' ' LEU . 20.6 t70 -83.9 133.36 34.72 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.197 0.999 . . . . 75.1 110.451 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -75.31 78.26 2.4 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.705 0.802 . . . . 73.24 109.995 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.438 ' HB3' HD13 ' C' ' 68' ' ' LEU . 49.6 tt0 -164.48 78.49 1.44 Allowed Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.28 -1.378 . . . . 73.34 107.28 169.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -85.22 106.62 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.285 1.99 . . . . 70.25 111.885 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -84.29 92.14 7.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.372 -1.344 . . . . 61.52 107.372 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 89.3 t -84.71 110.54 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.904 -1.498 . . . . 74.31 109.385 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -93.05 115.68 28.34 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.323 -0.621 . . . . 74.33 109.323 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.39 126.7 34.56 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.06 -1.459 . . . . 74.43 107.06 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -120.32 132.93 55.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.414 -0.958 . . . . 73.23 108.414 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tt -134.35 117.83 16.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.392 -1.336 . . . . 71.32 107.392 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.61 149.9 52.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.962 1.305 . . . . 64.23 108.381 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -142.08 153.42 44.16 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.058 0.456 . . . . 75.32 110.032 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.96 178.35 10.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.654 1.182 . . . . 53.21 108.635 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -145.73 159.63 42.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.036 0.535 . . . . 74.44 110.333 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -145.65 126.91 14.82 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.912 0.885 . . . . 62.33 108.662 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.38 117.64 24.43 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.124 -0.695 . . . . 74.25 109.124 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' C' ' 57' ' ' GLU . 25.7 mt -100.93 -26.89 13.58 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.967 0.907 . . . . 73.45 110.48 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.03 -170.54 1.96 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.14 0.976 . . . . 41.32 109.918 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -69.7 101.7 1.73 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.564 -0.743 . . . . 73.23 109.606 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 74.82 6.92 4.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.538 1.535 . . . . 75.23 112.532 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.62 113.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.442 -0.947 . . . . 72.21 108.442 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.36 125.31 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.108 0.963 . . . . 74.0 109.307 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.72 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.2 tt0 -86.08 116.67 24.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.565 -0.902 . . . . 63.42 108.565 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.22 125.51 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.636 -1.246 . . . . 63.32 107.636 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.37 106.31 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.946 -1.131 . . . . 45.42 107.946 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.66 98.33 8.04 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.425 -0.954 . . . . 62.34 108.425 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -83.14 124.19 30.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.076 -0.966 . . . . 55.43 109.627 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.76 124.83 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.768 -1.197 . . . . 64.15 107.768 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -127.64 125.0 39.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 70.35 109.655 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.619 HG23 HD13 ' C' ' 114' ' ' ILE . 90.1 t -107.28 119.96 57.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.743 -0.836 . . . . 75.31 108.743 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.433 HG23 HD23 ' C' ' 75' ' ' LEU . 3.5 m -99.7 139.52 35.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.229 -1.397 . . . . 64.45 107.229 167.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.46 107.22 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.046 -1.464 . . . . 72.54 107.046 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 58.3 p -159.85 150.96 19.43 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.425 0.453 . . . . 73.4 111.29 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' C' ' 37' ' ' GLN . 66.0 tp -83.76 -48.17 10.39 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.701 -0.851 . . . . 63.53 108.701 165.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.56 -82.05 0.05 OUTLIER Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.553 -1.019 . . . . 52.24 110.553 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.95 -31.94 17.91 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.954 -0.758 . . . . 74.42 108.954 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.93 87.49 4.11 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.415 -0.957 . . . . 54.45 108.415 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.6 m -88.75 121.1 30.77 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.836 -0.62 . . . . 62.45 109.813 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.87 -61.73 1.9 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.923 -0.769 . . . . 74.42 108.923 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . 0.464 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 41.7 p90 -158.89 171.87 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.72 0.772 . . . . 63.1 112.112 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.433 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -137.28 135.45 37.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.235 -1.765 . . . . 72.43 106.235 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.9 t -137.98 136.76 37.26 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.279 -1.008 . . . . 54.15 108.279 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.2 120.96 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.868 0.467 . . . . 64.34 110.053 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.26 125.73 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.312 1.045 . . . . 52.43 109.585 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 1.7 mp0 -100.15 91.83 4.94 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.569 -1.271 . . . . 72.23 107.569 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.426 HE22 HG22 ' C' ' 18' ' ' THR . 8.4 tp-100 -82.12 100.13 9.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.015 -0.539 . . . . 73.41 109.59 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 145.54 22.99 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.918 -0.873 . . . . 60.14 110.918 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.521 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.63 121.49 1.39 Allowed Glycine 0 CA--C 1.5 -0.902 0 N-CA-C 111.281 -0.727 . . . . 52.43 111.281 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 18.3 mm -80.31 128.09 38.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 108.067 -1.086 . . . . 41.42 108.067 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.65 139.43 38.49 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.272 0.629 . . . . 63.42 109.483 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.7 p -91.73 104.7 17.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.188 -1.041 . . . . 73.15 108.188 170.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.45 100.18 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.15 -1.056 . . . . 73.01 108.15 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.22 161.47 31.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.999 0.92 . . . . 63.4 110.364 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.47 -18.39 33.79 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.365 0.506 . . . . 54.1 114.365 168.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.78 144.82 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.282 1.033 . . . . 74.11 110.218 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -146.12 149.74 34.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.929 0.491 . . . . 64.4 111.689 -167.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.03 24.72 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.383 -0.826 . . . . 34.04 113.486 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -64.22 -23.94 67.49 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.165 0.986 . . . . 53.31 111.46 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -58.26 -57.38 13.14 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.648 0.779 . . . . 70.0 110.23 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.441 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.8 ptt? -73.12 -25.91 61.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.451 -0.795 . . . . 63.04 110.956 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.43 78.59 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.595 0.56 . . . . 70.22 110.485 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -67.36 -30.94 70.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.528 -0.76 . . . . 74.12 111.064 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.07 -64.43 1.01 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 64.14 110.307 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.5 pp -73.79 -16.32 61.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.558 0.577 . . . . 70.13 112.558 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.44 -9.92 37.27 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 119.449 -0.64 . . . . 62.13 114.018 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.01 -52.56 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.967 0.884 . . . . 64.04 112.571 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -73.18 -51.55 17.41 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.906 0.482 . . . . 70.13 112.2 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.509 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.6 m -61.89 -47.12 92.24 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 123.413 0.685 . . . . 62.13 110.842 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.0 Cg_exo -53.1 -36.62 77.38 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.603 2.202 . . . . 72.32 114.513 168.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.454 HD21 ' ND2' ' C' ' 132' ' ' ASN . 27.5 t-20 -63.3 -38.54 91.57 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.523 0.729 . . . . 73.44 110.974 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -39.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.443 0.697 . . . . 63.1 110.417 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.521 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.1 mt -80.67 -28.94 36.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.491 -0.777 . . . . 71.34 112.415 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -54.14 -47.12 98.23 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-O 118.012 -0.994 . . . . 54.04 113.603 -173.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.58 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.546 2.164 . . . . 73.15 114.155 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.56 -45.52 79.08 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.36 0.664 . . . . 74.03 110.504 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.04 82.67 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.224 -0.898 . . . . 75.31 110.826 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.55 -46.99 80.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.455 1.502 . . . . 75.55 110.355 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.78 -34.4 64.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.96 0.504 . . . . 64.03 110.118 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.8 t -66.42 -27.01 67.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.84 0.456 . . . . 63.22 111.017 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.619 HD13 HG23 ' C' ' 64' ' ' VAL . 77.0 mt -75.27 -54.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.922 -0.581 . . . . 42.43 109.916 171.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.8 m -62.35 -29.49 70.5 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.256 0.622 . . . . 74.41 111.696 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -67.01 -49.41 65.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.101 -0.703 . . . . 54.42 109.101 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.537 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.58 -35.18 77.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.13 0.972 . . . . 60.24 112.308 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.52 -47.5 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.42 0.688 . . . . 60.44 109.683 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.428 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 37.9 t -69.13 -27.04 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.155 -0.93 . . . . 73.41 111.211 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -71.34 -34.23 70.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 73.02 109.602 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.14 1.99 88.45 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.537 0.523 . . . . 72.21 112.494 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.8 p 60.15 35.79 21.11 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.591 1.956 . . . . 63.32 113.354 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.16 154.91 43.19 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.595 0.758 . . . . 72.5 109.817 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.91 169.75 8.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.345 2.696 . . . . 74.25 114.376 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.559 ' NE2' HD21 ' C' ' 127' ' ' ASN . 47.5 tp60 -60.22 113.81 2.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.476 -1.238 . . . . 71.4 111.389 -173.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.464 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 33.3 tp -134.88 115.12 13.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.791 0.836 . . . . 74.45 108.925 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.559 HD21 ' NE2' ' C' ' 125' ' ' GLN . 5.0 m120 -129.95 130.43 45.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.255 1.022 . . . . 70.42 108.404 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.2 140.45 40.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.731 0.412 . . . . 73.21 110.801 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.19 137.8 78.76 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.658 0.783 . . . . 51.1 110.675 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.67 107.86 1.54 Allowed 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.847 2.364 . . . . 71.23 112.211 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.43 110.93 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.326 -0.99 . . . . 65.1 108.326 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.454 ' ND2' HD21 ' C' ' 104' ' ' ASN . 15.5 m120 -103.24 89.2 3.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.524 0.73 . . . . 52.23 110.823 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -72.76 -31.85 65.21 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.771 0.796 . . . . 75.41 109.095 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 . . . . . 0 CA--C 1.541 0.612 0 CA-C-N 113.997 -1.456 . . . . 62.45 111.132 172.635 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.4 ttp . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 113.996 1.109 . . . . 71.41 113.996 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.3 m -138.46 122.08 17.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.06 0.944 . . . . 70.1 108.622 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -141.98 101.18 3.89 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.181 -1.044 . . . . 71.44 108.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -122.04 127.38 50.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.067 0.547 . . . . 63.12 110.086 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.37 112.21 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.983 -1.117 . . . . 75.03 107.983 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.97 -47.81 7.36 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 119.528 -0.273 . . . . 74.55 111.716 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.413 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 42.6 ttt85 -173.12 132.92 0.51 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.563 0.209 . . . . 63.03 111.563 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.3 134.45 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.513 -1.292 . . . . 74.5 107.513 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -162.83 177.83 8.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.893 0.854 . . . . 62.35 111.641 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.1 p -109.72 118.96 37.92 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.617 -1.174 . . . . 74.1 108.351 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 30.0 mtpt -85.46 -21.51 28.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.651 -0.5 . . . . 73.14 109.651 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.1 t70 -155.65 140.57 17.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.284 1.034 . . . . 72.32 108.657 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.537 HD12 ' HG3' ' C' ' 117' ' ' MET . 48.8 mt -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.521 -1.289 . . . . 75.41 107.521 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -153.24 140.38 19.4 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 123.748 0.655 . . . . 45.34 110.329 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.5 t80 -142.85 135.98 28.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.714 -1.587 . . . . 75.1 106.714 170.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.661 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -134.33 150.75 50.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.151 0.98 . . . . 41.23 108.538 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.63 77.69 10.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.82 -32.91 17.4 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.777 2.318 . . . . 75.24 113.545 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -114.75 41.7 2.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.935 0.894 . . . . 65.44 108.61 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.46 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -57.12 -56.28 35.32 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.64 1.348 . . . . 74.51 114.64 -169.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.45 -3.75 12.1 Favored 'Trans proline' 0 C--N 1.39 2.725 0 CA-C-N 122.11 1.789 . . . . 71.53 112.708 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.438 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 23.1 t-160 -84.65 -42.73 15.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.382 1.073 . . . . 64.51 110.393 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.04 -10.17 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-O 121.18 0.514 . . . . 64.54 110.546 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.65 -36.88 77.29 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.918 -0.583 . . . . 74.13 110.262 166.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 56.4 mt-30 -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.51 110.594 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -98.93 70.59 1.84 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.011 -1.107 . . . . 72.53 108.011 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.71 88.8 0.99 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.33 1.062 . . . . 60.23 109.666 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.542 ' HB3' HD21 ' D' ' 68' ' ' LEU . 67.8 t-105 -160.46 170.63 20.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.398 -1.273 . . . . 71.13 108.468 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -71.75 110.09 6.96 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.937 1.295 . . . . 74.52 109.613 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.547 ' HA ' HD13 ' D' ' 68' ' ' LEU . 27.4 Cg_exo -65.66 141.9 68.35 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.227 2.618 . . . . 74.42 112.72 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.72 113.64 3.91 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.102 -0.703 . . . . 71.25 109.102 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.77 115.11 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.205 1.002 . . . . 61.43 110.593 -171.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -87.61 111.07 20.87 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 165.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.683 ' H ' HD23 ' D' ' 42' ' ' LEU . 2.0 pt? -96.76 148.2 23.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.451 -0.944 . . . . 64.54 108.451 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.4 t70 -151.38 151.94 32.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.775 0.43 . . . . 75.23 110.729 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.08 154.18 49.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.891 0.876 . . . . 73.51 109.97 170.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.3 t70 -152.36 137.58 17.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.426 1.091 . . . . 70.02 108.433 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -104.46 144.82 31.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 109.02 -0.733 . . . . 62.43 109.02 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.67 162.86 40.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.102 -1.073 . . . . 62.43 108.102 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.4 p -168.82 158.95 9.29 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.072 0.463 . . . . 73.42 111.916 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.7 p -152.11 119.58 6.01 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.685 1.194 . . . . 71.34 108.616 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.64 124.33 23.33 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.998 -0.742 . . . . 74.3 108.998 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 69.2 mt -87.96 -36.91 16.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.455 0.472 . . . . 72.21 109.925 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.99 -175.24 4.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.625 0.77 . . . . 61.22 111.061 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.97 124.51 20.98 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.938 -1.028 . . . . 70.12 109.141 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 19.0 m-20 66.54 -0.09 1.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.411 1.084 . . . . 74.14 113.112 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -116.05 118.06 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.051 0.94 . . . . 63.33 108.62 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.98 129.69 40.49 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.508 -0.923 . . . . 70.32 108.508 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.76 136.04 33.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.022 -1.103 . . . . 71.22 108.022 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' D' ' 102' ' ' CYS . 7.4 p -123.8 132.22 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.465 -0.939 . . . . 72.31 108.465 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 62.0 t -108.62 128.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 123.383 0.673 . . . . 70.31 109.199 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.58 114.89 27.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.945 -1.131 . . . . 74.41 107.945 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -97.14 133.09 42.25 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.645 -1.161 . . . . 73.02 108.623 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.73 120.2 44.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.523 -1.288 . . . . 62.21 107.523 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.6 m -116.95 137.41 52.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.563 0.745 . . . . 72.52 110.245 -172.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 75.3 t -125.41 117.73 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.621 1.168 . . . . 50.32 109.33 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 63.9 m -110.44 92.51 4.07 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.792 -1.188 . . . . 64.52 107.792 170.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.02 132.5 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.347 -0.612 . . . . 62.0 109.347 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.3 m -148.48 135.02 19.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.155 -1.054 . . . . 71.12 108.155 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' D' ' 38' ' ' PRO . 20.0 tp -113.83 124.9 53.35 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 117.789 0.268 . . . . 75.03 110.489 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.13 -110.66 3.17 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.722 -0.551 . . . . 62.14 111.722 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 4.31 9.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.589 0.756 . . . . 73.33 110.149 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.36 154.91 27.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.663 0.785 . . . . 45.31 109.435 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.0 m -74.62 141.28 44.68 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 110.045 -0.354 . . . . 64.42 110.045 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.416 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -97.7 -62.5 1.24 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.049 0.94 . . . . 74.33 109.421 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -158.17 138.23 12.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.373 -0.83 . . . . 75.44 109.235 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.661 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 92.3 mt -102.76 153.91 19.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.607 -0.886 . . . . 71.41 108.607 172.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.494 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 53.8 t -159.11 145.78 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.522 -0.547 . . . . 63.31 109.522 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -156.56 131.24 8.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.288 -1.005 . . . . 72.32 108.288 168.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -124.34 140.32 48.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.469 -0.937 . . . . 71.2 108.469 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -118.89 86.21 2.5 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.989 -1.115 . . . . 61.52 107.989 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.441 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.5 tp-100 -80.26 97.5 7.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.673 -1.603 . . . . 71.43 108.925 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.79 141.65 15.73 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.856 -0.498 . . . . 62.24 111.856 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 138.01 7.24 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.726 -0.55 . . . . 71.02 111.726 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.47 130.12 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.564 0.746 . . . . 60.35 109.064 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -132.67 142.48 49.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.564 0.746 . . . . 74.44 109.585 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -78.58 108.26 11.84 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.167 -1.049 . . . . 62.24 108.167 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 35.8 mm -106.7 100.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.093 -1.447 . . . . 72.53 107.093 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.706 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -144.88 158.24 43.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.136 -0.938 . . . . 74.1 109.709 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.52 -0.04 51.47 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.48 0.487 . . . . 63.3 113.75 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.22 128.67 68.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.918 1.287 . . . . 74.35 107.806 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 179.83 6.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.668 0.787 . . . . 52.54 111.245 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.1 -141.96 29.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.474 -0.785 . . . . 75.31 113.218 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 35.3 m -78.33 -18.94 54.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.599 0.76 . . . . 70.01 110.429 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -46.4 85.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.347 0.659 . . . . 72.52 110.745 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -69.59 -26.7 64.59 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.405 0.441 . . . . 50.34 110.758 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.92 71.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.376 0.671 . . . . 74.33 110.947 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.79 -38.15 64.72 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.975 0.51 . . . . 70.13 110.737 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.91 -42.35 97.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.029 0.532 . . . . 53.11 110.953 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tt -78.49 -33.31 48.3 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.294 0.638 . . . . 62.11 109.613 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.43 58.97 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.138 -0.483 . . . . 74.22 114.281 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -52.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.493 0.647 . . . . 60.11 112.024 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -68.7 -43.7 75.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.658 0.614 . . . . 71.45 112.658 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.468 ' HB3' HG11 ' D' ' 58' ' ' VAL . 69.5 m -69.17 -43.05 23.7 Favored Pre-proline 0 CA--C 1.567 1.599 0 C-N-CA 122.943 0.497 . . . . 71.02 111.524 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.41 -34.48 89.28 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.765 2.31 . . . . 63.1 113.878 165.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -66.44 -26.52 67.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.708 0.803 . . . . 72.21 111.01 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.4 -41.23 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.62 0.724 . . . . 75.43 109.739 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.441 HD13 ' O ' ' D' ' 80' ' ' GLN . 94.4 mt -78.92 -14.41 59.24 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.688 -1.142 . . . . 63.13 111.836 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.414 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 55.7 t80 -61.98 -47.99 89.74 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.769 1.228 . . . . 73.54 113.745 -173.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 37.6 Cg_exo -59.98 -33.7 95.42 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 121.852 1.701 . . . . 71.44 112.682 175.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -76.18 -31.64 58.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 74.22 111.73 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.39 -56.26 19.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.076 0.55 . . . . 72.44 110.098 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -67.81 -32.42 72.95 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.508 -1.224 . . . . 74.22 110.787 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.29 -50.99 71.86 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.219 0.949 . . . . 73.44 110.155 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.5 t -58.61 -42.59 88.49 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.862 0.726 . . . . 74.25 110.867 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.421 HG12 ' SG ' ' D' ' 76' ' ' CYS . 73.8 mt -61.44 -52.53 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.342 0.657 . . . . 72.13 110.34 175.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.51 HG23 ' HG3' ' D' ' 125' ' ' GLN . 99.1 m -53.6 -47.33 70.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.553 1.141 . . . . 75.0 110.999 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.2 t -63.82 -42.05 97.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.5 -1.227 . . . . 73.32 110.322 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.8 mtm -69.61 -30.64 68.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.089 0.556 . . . . 64.23 111.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.3 t -74.02 -37.86 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.304 0.641 . . . . 61.13 110.514 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -74.05 -30.26 62.31 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 120.843 0.354 . . . . 73.33 110.497 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -72.25 -30.41 64.84 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.742 0.817 . . . . 74.4 109.606 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.93 4.21 81.04 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.481 -0.781 . . . . 52.13 112.599 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 81.4 p 60.6 34.19 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.238 1.815 . . . . 72.42 113.72 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.34 163.88 27.61 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 123.815 0.846 . . . . 75.1 112.13 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.47 125.3 5.92 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 124.375 3.383 . . . . 53.02 114.273 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.1 tt0 -55.04 130.36 41.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.656 1.182 . . . . 75.42 111.51 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.57 92.76 3.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.271 0.628 . . . . 50.2 109.596 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -100.86 113.49 26.48 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 14.7 tp -76.07 127.74 33.57 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.409 0.443 . . . . 74.45 109.831 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.77 138.96 82.46 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.555 0.742 . . . . 74.53 111.805 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.8 Cg_endo -75.43 96.29 1.03 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.298 1.999 . . . . 62.24 110.555 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.69 134.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.512 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -88.71 104.84 17.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.12 -1.067 . . . . 71.45 108.12 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 74.4 t80 . . . . . 0 N--CA 1.478 0.974 0 C-N-CA 123.203 0.601 . . . . 72.21 110.984 -178.155 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 109.625 -0.509 . . . . 50.4 109.625 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -139.68 112.92 8.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.78 -1.193 . . . . 72.51 107.78 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -133.84 116.97 16.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.177 0.591 . . . . 72.12 109.77 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 16' ' ' ILE . 3.9 mp -77.66 115.32 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.264 -1.013 . . . . 74.43 108.264 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.06 -44.86 10.05 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.81 -0.441 . . . . 71.24 109.81 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -174.52 144.69 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.795 0.438 . . . . 72.21 110.616 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 13' ' ' ILE . 3.7 mp -117.87 123.7 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 64.32 107.725 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -152.51 148.22 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.597 0.713 . . . . 73.32 111.126 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -79.96 112.58 17.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.638 -1.165 . . . . 73.51 109.904 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -82.1 -21.65 36.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.589 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -153.04 141.44 20.68 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.312 -0.858 . . . . 72.24 109.947 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 71.4 mt -144.78 143.11 22.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.812 1.645 . . . . 74.31 106.779 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.6 t -158.4 124.58 4.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.423 0.452 . . . . 63.33 110.208 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 91.8 t80 -116.49 147.54 41.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.027 -1.471 . . . . 74.41 107.027 169.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -142.5 140.49 31.86 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.871 0.868 . . . . 62.02 109.543 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -152.14 68.14 7.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 106.685 -1.598 . . . . 54.11 106.685 170.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.02 -20.46 21.86 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.234 1.956 . . . . 75.01 110.948 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -105.86 16.12 25.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.37 1.068 . . . . 74.11 109.729 -179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.684 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -54.19 -45.49 99.14 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.166 1.173 . . . . 75.13 114.166 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -64.68 -26.93 60.71 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.93 1.753 . . . . 71.21 113.006 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -75.33 -33.5 61.14 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.781 0.832 . . . . 70.2 111.747 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG21 ' HE1' ' A' ' 123' ' ' PHE . 3.9 m -72.07 -23.62 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 122.923 0.489 . . . . 71.2 111.285 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -70.88 -31.37 68.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.794 -1.094 . . . . 52.43 110.232 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -76.53 -47.41 22.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.897 0.879 . . . . 73.24 110.381 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -82.65 167.1 18.58 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.5 -0.773 . . . . 65.5 111.928 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 116.21 6.34 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.778 -0.823 . . . . 63.34 108.778 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.0 p90 -84.88 63.98 8.37 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 122.583 1.182 . . . . 73.51 110.53 -171.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -120.51 86.42 39.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 107.252 -1.388 . . . . 63.23 107.252 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.56 173.17 7.6 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.522 2.148 . . . . 73.43 113.154 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -96.6 124.36 40.56 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.5 90.17 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.499 -0.926 . . . . 74.11 108.499 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -96.39 127.91 42.83 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.016 -1.105 . . . . 74.02 108.016 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -134.21 145.97 49.69 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.064 -0.717 . . . . 75.31 109.064 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.74 148.5 39.1 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.023 -1.103 . . . . 75.5 108.023 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.8 147.58 40.98 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.197 -0.668 . . . . 72.14 109.197 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 11.6 t70 -154.11 137.28 15.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.966 0.906 . . . . 72.12 109.083 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -107.53 130.44 54.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.559 0.744 . . . . 62.1 109.634 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.74 150.6 52.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.184 0.994 . . . . 73.15 109.118 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -134.37 161.35 35.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.283 0.633 . . . . 73.45 110.816 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -152.29 152.75 32.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 63.42 108.753 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.38 123.43 48.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.146 -0.687 . . . . 63.33 109.146 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 57' ' ' GLU . 51.5 mt -101.81 -33.27 9.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.863 0.865 . . . . 64.11 110.725 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -165.57 -167.67 1.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.664 0.786 . . . . 74.44 110.64 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.16 99.37 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.215 1.006 . . . . 73.33 110.803 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 66.49 13.03 9.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.008 1.323 . . . . 72.44 112.303 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 56.5 t -99.54 111.04 28.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.541 -1.652 . . . . 71.32 106.541 167.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -119.79 168.84 10.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.526 -0.761 . . . . 72.44 109.167 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HB2' HD11 ' A' ' 51' ' ' LEU . 37.6 tt0 -132.51 134.53 45.12 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 125.065 1.346 . . . . 63.02 107.389 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.401 HG11 ' HD3' ' A' ' 103' ' ' PRO . 97.9 t -121.18 124.17 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 171.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.8 t -109.78 135.42 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.126 0.97 . . . . 43.03 109.338 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 121.28 44.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.681 -0.859 . . . . 75.22 108.681 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.23 105.09 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.472 0.709 . . . . 65.1 109.565 172.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.45 128.23 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.283 -1.006 . . . . 75.43 108.283 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -119.26 120.58 37.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.158 0.504 . . . . 73.5 109.832 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 114' ' ' ILE . 71.0 t -112.25 105.84 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.346 1.058 . . . . 71.11 108.549 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.9 m -110.83 138.23 47.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.063 -0.717 . . . . 63.51 109.063 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.13 127.75 40.4 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.024 -1.102 . . . . 72.24 108.024 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -141.36 125.62 17.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.891 0.477 . . . . 64.25 110.632 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.1 pt? -93.39 84.27 4.71 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.159 0.984 . . . . 72.44 108.369 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.41 -102.44 1.49 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.339 -1.301 . . . . 54.32 112.093 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -95.96 -24.26 16.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.56 0.744 . . . . 71.13 109.664 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -92.06 135.55 33.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.895 1.278 . . . . 52.3 109.482 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 80.9 m -77.93 133.01 38.14 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.72 -0.474 . . . . 65.14 109.72 170.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.8 -59.92 2.57 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.003 -0.74 . . . . 71.41 109.003 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -165.88 166.79 17.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.125 -1.398 . . . . 75.31 110.189 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.22 127.57 32.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.226 1.01 . . . . 60.3 108.697 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.543 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 57.1 m -119.27 137.72 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.993 0.917 . . . . 64.2 108.657 172.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.16 122.48 9.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.407 -0.96 . . . . 71.44 108.407 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.28 132.21 69.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.302 0.641 . . . . 73.04 109.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.733 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.1 mt-30 -96.98 90.57 5.24 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.427 -0.806 . . . . 74.14 109.428 166.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.8 95.49 6.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.725 -1.125 . . . . 52.31 108.34 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.37 161.33 26.29 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.188 -0.46 . . . . 71.24 112.092 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.44 140.67 7.37 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.835 -0.906 . . . . 41.21 110.835 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.7 mt -86.26 127.19 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 N-CA-C 108.635 -0.876 . . . . 62.15 108.635 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -133.19 118.13 18.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.374 -0.973 . . . . 72.53 108.374 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -88.0 100.56 13.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.777 -0.823 . . . . 75.53 108.777 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.5 pt -119.52 147.75 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.262 0.553 . . . . 71.15 111.428 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -171.53 164.69 6.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.978 1.711 . . . . 62.33 108.852 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.45 9.01 87.37 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.752 -0.471 . . . . 54.33 114.11 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -120.26 146.67 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.452 0.701 . . . . 71.42 109.94 176.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.16 170.78 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.318 0.647 . . . . 71.53 109.469 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.76 -125.55 37.25 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.776 0.672 . . . . 71.15 114.758 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -72.4 -37.94 68.56 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.884 0.874 . . . . 61.32 111.705 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.51 -35.06 78.2 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.114 0.566 . . . . 75.41 111.003 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 55.8 ttp -68.93 -45.73 70.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.952 0.901 . . . . 71.12 111.054 175.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.84 -34.04 73.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.627 0.771 . . . . 74.44 111.478 177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -66.05 -48.43 71.05 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.915 -1.039 . . . . 75.53 110.551 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 0.8 OUTLIER -68.81 -55.68 10.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.304 0.853 . . . . 74.32 113.304 -168.11 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 pp -76.3 -25.67 55.06 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 122.113 -0.367 . . . . 73.25 111.382 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.07 -18.67 45.76 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 114.292 0.477 . . . . 70.04 114.292 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -135.98 -58.01 0.76 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.169 0.588 . . . . 71.41 111.638 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.672 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 1.4 t80 -54.88 -53.6 53.31 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.179 0.992 . . . . 74.32 113.065 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m -68.56 -49.58 29.53 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.616 -0.707 . . . . 72.03 112.684 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' HG11 ' A' ' 58' ' ' VAL . 38.3 Cg_endo -65.56 -15.41 49.4 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 121.637 1.558 . . . . 74.23 113.56 172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 35.3 t-20 -72.79 -35.74 67.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.469 -0.567 . . . . 73.54 109.469 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mm -65.75 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.471 0.709 . . . . 73.03 110.135 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.8 -24.26 60.89 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.102 -0.954 . . . . 64.33 111.557 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.14 -45.02 39.93 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 114.451 1.278 . . . . 73.42 114.451 -168.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.63 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 29.4 Cg_endo -62.83 -29.86 77.01 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 121.553 1.59 . . . . 71.14 112.511 174.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.518 ' HE2' ' HB3' ' C' ' 130' ' ' PRO . 11.6 m-85 -81.94 -26.23 34.19 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.882 0.473 . . . . 71.52 111.861 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.29 49.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.684 -0.858 . . . . 41.13 108.684 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.513 HH12 HD12 ' C' ' 105' ' ' ILE . 39.2 ttm180 -51.6 -48.15 63.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.026 -1.443 . . . . 73.23 110.913 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.48 -47.93 77.13 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.428 -0.806 . . . . 74.22 111.149 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.23 -32.95 73.68 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.401 0.681 . . . . 70.41 111.402 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.429 HG21 HG21 ' A' ' 64' ' ' VAL . 74.9 mt -71.71 -58.51 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.706 0.802 . . . . 71.23 110.139 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.403 HG23 ' HG3' ' A' ' 125' ' ' GLN . 88.0 m -56.23 -33.74 65.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.69 1.196 . . . . 74.04 111.955 -173.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -67.34 -44.0 80.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.341 -0.845 . . . . 52.41 110.583 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.0 mtm -65.17 -35.0 79.71 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.593 0.357 . . . . 72.14 111.253 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.65 -46.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.8 0.84 . . . . 71.51 110.286 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.4 p -74.25 -28.95 61.46 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.783 -0.644 . . . . 72.51 111.458 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -71.79 -29.79 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.453 0.701 . . . . 70.23 109.828 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.27 -0.18 85.78 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.627 -0.715 . . . . 71.5 112.685 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m 68.04 29.75 6.23 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.89 1.276 . . . . 54.24 110.8 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.611 ' HE1' HG21 ' A' ' 31' ' ' VAL . 83.2 m-85 -99.11 152.1 37.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 115.287 -0.87 . . . . 73.23 110.329 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.05 141.7 77.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.386 2.057 . . . . 72.5 111.353 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.3 tt0 -62.28 144.73 55.26 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.562 0.745 . . . . 72.24 112.312 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -146.48 103.01 3.64 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.336 -1.357 . . . . 55.34 107.336 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.17 119.11 37.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.419 0.688 . . . . 52.33 109.212 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.49 136.51 44.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.325 0.65 . . . . 71.41 110.404 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.21 138.36 86.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 45.32 111.36 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HB3' HH22 ' A' ' 111' ' ' ARG . 46.9 Cg_endo -77.84 112.24 3.25 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.981 1.788 . . . . 72.24 111.035 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.58 136.05 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.65 -0.87 . . . . 63.54 108.65 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -72.96 78.48 1.17 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.277 0.631 . . . . 74.33 110.771 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -77.02 -26.6 53.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.862 -1.063 . . . . 72.42 108.758 173.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 . . . . . 0 CA--C 1.546 0.806 0 CA-C-N 113.891 -1.504 . . . . 72.23 110.504 175.473 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ptm . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 113.672 0.989 . . . . 52.41 113.672 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -160.49 143.08 13.07 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.499 -0.773 . . . . 73.22 109.877 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -132.43 113.36 13.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.832 -0.803 . . . . 75.02 108.832 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.78 140.11 52.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.256 1.022 . . . . 71.31 108.539 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.586 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.67 137.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.819 -0.808 . . . . 73.53 108.819 167.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -101.47 -51.58 3.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.726 0.41 . . . . 71.43 110.431 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -161.13 139.4 9.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.035 -0.357 . . . . 71.12 110.035 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.34 140.58 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 107.271 -1.381 . . . . 75.1 107.271 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -167.84 147.96 5.03 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.279 0.561 . . . . 72.15 112.151 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -74.34 119.36 18.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.923 -1.035 . . . . 64.42 108.724 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -93.92 -29.47 15.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.565 0.746 . . . . 72.23 111.807 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 29.4 t70 -160.2 142.72 13.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.625 0.25 . . . . 73.23 110.803 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.5 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 31.6 mm -143.83 145.57 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.837 1.255 . . . . 74.11 109.055 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -146.38 141.95 27.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.302 -1.369 . . . . 72.03 107.302 163.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.516 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -150.03 111.83 4.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.244 -1.761 . . . . 60.54 106.244 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -115.98 156.9 25.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.597 -0.89 . . . . 73.32 108.597 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -144.67 76.39 14.19 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 105.817 -1.92 . . . . 64.51 105.817 174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.02 -28.79 80.82 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.229 2.62 . . . . 74.54 113.212 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -124.48 29.31 6.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.855 . . . . 44.35 109.589 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -46.44 -53.39 24.19 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 115.162 1.541 . . . . 63.45 115.162 -172.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.83 -8.85 18.13 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.151 1.9 . . . . 74.31 113.433 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -97.75 -42.48 7.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.608 0.763 . . . . 71.25 110.65 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' B' ' 73' ' ' ALA . 61.8 t -73.69 -13.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.224 1.01 . . . . 63.53 110.181 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.73 -36.63 57.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.419 1.088 . . . . 73.51 111.342 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -70.6 -23.28 62.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.698 0.799 . . . . 72.4 112.488 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.98 111.24 20.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.688 0.795 . . . . 74.42 111.543 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.68 87.85 3.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.914 0.486 . . . . 54.53 109.904 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.684 ' HB3' HD21 ' B' ' 68' ' ' LEU . 29.9 t90 -154.36 157.31 38.39 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.016 -1.105 . . . . 75.04 108.016 174.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -67.1 116.87 40.47 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.368 0.667 . . . . 72.35 110.4 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.418 ' HG2' HD11 ' B' ' 126' ' ' LEU . 53.8 Cg_endo -67.87 127.53 16.31 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.057 1.838 . . . . 74.03 111.463 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.03 104.61 0.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.576 1.15 . . . . 73.24 109.848 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -91.65 136.01 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.314 0.578 . . . . 62.02 111.363 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -136.75 104.95 5.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.297 1.039 . . . . 63.15 108.572 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.498 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -86.49 167.85 14.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.193 0.597 . . . . 62.53 110.828 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 29.4 t70 -153.01 115.17 4.38 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.287 -0.869 . . . . 62.43 108.763 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.65 134.64 43.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.611 -0.885 . . . . 73.43 108.611 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.5 t70 -142.92 142.17 31.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.768 0.827 . . . . 64.4 109.612 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 42.7 p -118.55 116.19 26.14 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.411 -0.813 . . . . 71.23 109.76 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -114.81 152.31 32.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.135 -1.432 . . . . 71.3 107.135 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 62.3 m -143.53 169.96 16.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.019 0.438 . . . . 61.12 110.78 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -155.13 169.07 24.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.406 1.082 . . . . 22.31 108.679 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -125.1 128.03 47.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.713 0.805 . . . . 64.12 108.929 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -100.16 -22.65 15.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.429 0.691 . . . . 71.44 110.911 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.99 176.54 4.67 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.792 0.837 . . . . 74.35 110.207 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.69 122.26 13.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.702 -0.481 . . . . 63.44 109.702 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 72.37 -5.85 1.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.821 1.648 . . . . 64.21 112.705 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.4 t -103.78 100.84 11.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 N-CA-C 108.462 -0.94 . . . . 71.35 108.462 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.55 137.82 50.23 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.282 0.633 . . . . 73.33 109.699 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -110.29 97.39 6.87 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.349 -1.352 . . . . 74.42 107.349 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 57.8 t -95.97 123.55 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.363 0.665 . . . . 54.1 110.079 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 45.8 t -100.61 119.04 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.033 0.933 . . . . 74.31 110.108 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.16 114.19 26.27 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.219 -1.03 . . . . 73.43 108.219 177.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 29.3 ttm180 -99.51 117.62 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.932 0.396 . . . . 64.45 110.249 171.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -112.94 102.64 14.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.967 -1.123 . . . . 64.03 107.967 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 7.0 m -98.1 134.94 40.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.44 HG21 HG21 ' B' ' 114' ' ' ILE . 93.2 t -123.32 137.27 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.54 0.736 . . . . 70.11 109.941 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -121.33 146.44 46.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.213 1.005 . . . . 72.12 108.844 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -144.17 129.16 18.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.633 -0.877 . . . . 72.0 108.633 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -130.22 139.57 50.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.994 -0.743 . . . . 65.44 108.994 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' B' ' 36' ' ' TRP . 1.8 tt -124.99 105.98 9.61 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.964 -1.124 . . . . 72.24 107.964 -177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.28 -115.06 4.15 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.651 -0.704 . . . . 74.44 112.016 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -108.75 4.52 23.78 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.822 0.811 . . . . 73.24 111.509 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.86 169.5 17.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.934 0.494 . . . . 52.14 111.158 -173.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -73.62 133.11 43.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.51 -0.768 . . . . 70.14 110.26 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -85.44 -58.22 2.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.146 0.978 . . . . 74.22 108.378 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . 0.521 ' HZ ' HD12 ' B' ' 126' ' ' LEU . 45.4 p90 -164.3 161.51 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.548 -1.205 . . . . 73.13 110.246 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.73 152.12 47.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.08 1.352 . . . . 74.35 108.941 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.9 t -151.51 157.92 42.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.427 0.691 . . . . 41.04 109.408 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -165.77 128.48 2.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.76 -0.83 . . . . 73.44 108.76 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.4 ' HA ' HD13 ' B' ' 21' ' ' ILE . 65.7 t -126.17 143.6 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.044 -0.724 . . . . 64.24 109.044 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -124.75 102.36 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.531 -0.915 . . . . 54.13 108.531 172.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -94.04 100.66 12.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.132 -1.062 . . . . 71.0 108.132 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.66 144.18 16.93 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.452 -0.659 . . . . 55.33 111.452 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.48 127.47 3.64 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.694 -0.562 . . . . 74.54 111.694 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.16 125.99 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.33 -0.989 . . . . 71.32 108.33 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -131.43 161.44 32.46 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.363 1.065 . . . . 74.14 109.319 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -131.29 93.54 3.39 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.874 0.87 . . . . 73.43 108.725 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.526 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -117.33 139.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.999 0.92 . . . . 63.32 110.098 -176.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.91 168.82 26.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 60.45 109.792 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.55 -28.77 5.16 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 123.539 0.525 . . . . 32.42 113.513 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 pt -90.84 137.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.709 1.204 . . . . 65.32 110.552 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -149.31 149.8 31.48 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.022 0.929 . . . . 62.41 109.243 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.23 -118.78 9.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.704 -0.68 . . . . 74.3 113.367 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.3 m -65.22 -40.43 94.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.794 0.838 . . . . 70.25 110.339 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -63.06 -34.19 77.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.672 -1.149 . . . . 63.15 110.853 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.527 ' SD ' HD11 ' B' ' 98' ' ' LEU . 13.2 tmm? -79.94 -43.07 22.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.909 -1.041 . . . . 60.45 111.089 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.13 91.96 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.564 -0.744 . . . . 51.23 112.46 -168.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 3.0 p80 -82.82 -12.46 57.45 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.602 -0.272 . . . . 74.45 110.996 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -85.35 -68.68 0.71 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.614 -0.266 . . . . 73.11 110.355 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.527 HD11 ' SD ' ' B' ' 94' ' ' MET . 2.4 pp -85.07 -14.8 46.11 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.198 0.444 . . . . 52.13 112.198 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.2 -2.98 59.0 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.75 -0.472 . . . . 43.24 113.303 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -147.29 -60.86 0.28 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.274 0.537 . . . . 73.4 112.036 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.67 -43.52 89.06 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.914 0.485 . . . . 74.0 112.136 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.1 m -69.35 -44.72 26.95 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.198 0.599 . . . . 71.03 111.403 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.522 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 80.2 Cg_exo -53.3 -37.34 80.87 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.152 1.901 . . . . 73.53 113.731 164.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.35 -27.32 66.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.48 0.312 . . . . 72.23 111.798 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.53 -42.69 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.663 0.785 . . . . 44.31 110.009 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 mt -81.54 -15.63 54.25 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.791 -1.095 . . . . 71.43 111.243 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -60.17 -49.6 90.03 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 117.533 -1.223 . . . . 70.22 113.9 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.52 -32.21 96.01 Favored 'Trans proline' 0 C--N 1.38 2.202 0 CA-C-N 121.748 1.66 . . . . 61.13 112.913 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.38 -47.51 48.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.22 0.608 . . . . 75.24 110.413 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.46 86.72 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.635 -0.711 . . . . 73.1 110.294 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -58.97 -52.01 67.59 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.633 1.573 . . . . 63.25 111.313 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.32 -37.09 86.05 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.928 0.767 . . . . 74.31 110.313 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.8 t -65.79 -41.43 91.98 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 123.612 0.57 . . . . 74.13 111.49 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.44 HG21 HG21 ' B' ' 64' ' ' VAL . 72.6 mt -60.95 -53.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.449 0.7 . . . . 72.32 110.343 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -69.14 -24.1 64.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.762 -0.654 . . . . 73.11 111.403 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.8 t -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.09 0.556 . . . . 73.44 110.054 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -70.44 -32.04 69.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.485 0.314 . . . . 73.05 110.452 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.07 -35.76 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.836 0.854 . . . . 74.33 110.695 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 m -61.39 -46.51 89.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.267 0.627 . . . . 62.4 110.082 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -63.81 -36.5 84.09 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.738 -1.119 . . . . 74.02 111.189 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.9 -1.25 87.11 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.389 -0.673 . . . . 33.1 113.434 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 60.4 p 55.81 30.76 16.35 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.098 1.759 . . . . 65.23 112.598 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.38 162.87 38.51 Favored Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 124.565 1.146 . . . . 61.13 110.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.11 164.02 15.46 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 123.229 2.619 . . . . 74.34 113.649 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.6 OUTLIER -65.14 111.11 2.78 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.295 -0.866 . . . . 74.4 110.585 -172.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.521 HD12 ' HZ ' ' B' ' 74' ' ' PHE . 96.1 mt -135.05 83.58 2.03 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.779 -1.193 . . . . 74.44 107.779 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -101.07 122.61 43.87 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.362 -1.348 . . . . 71.42 107.362 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 33.6 tp -66.4 133.53 50.66 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.652 0.595 . . . . 72.45 111.034 -170.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.07 143.74 94.7 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.245 1.018 . . . . 71.1 111.67 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 87.24 0.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.911 2.407 . . . . 71.52 112.423 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 63.1 t -94.89 133.89 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.45 0.7 . . . . 72.22 110.526 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.96 113.74 26.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.33 1.052 . . . . 74.34 109.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.79 -29.4 67.76 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 63.34 111.916 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.6 -34.23 67.24 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.608 0.763 . . . . 63.35 110.763 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.78 -38.23 88.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.89 -0.595 . . . . 74.2 109.717 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.4 tm? . . . . . 0 N--CA 1.48 1.034 0 C-N-CA 124.015 0.926 . . . . 74.41 109.69 176.269 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.0 ttp . . . . . 0 N--CA 1.48 1.042 0 CA-C-O 121.255 0.55 . . . . 61.05 112.105 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -86.8 86.41 7.32 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.837 -0.801 . . . . 73.02 108.837 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.441 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 67.5 t80 -89.6 128.12 35.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.396 -0.594 . . . . 70.12 109.396 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.14 132.84 22.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.302 -0.629 . . . . 75.55 109.302 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.1 134.57 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.9 -0.778 . . . . 74.41 108.9 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -105.42 -51.44 3.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.523 0.329 . . . . 63.41 110.346 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -171.09 145.85 2.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.695 0.398 . . . . 73.42 109.934 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -124.05 138.45 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.116 -1.068 . . . . 44.11 108.116 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.681 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -170.94 146.18 2.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.547 0.339 . . . . 60.41 110.103 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -69.17 128.98 38.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.87 0.468 . . . . 73.44 110.448 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -84.48 -46.26 11.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.054 0.931 . . . . 72.21 108.869 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 8.0 t70 -134.79 136.95 42.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.175 -1.375 . . . . 74.31 109.325 -173.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -134.56 139.65 47.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.289 -1.374 . . . . 71.22 107.289 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.61 143.67 25.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.56 -0.745 . . . . 75.11 109.43 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -153.37 109.25 3.29 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.074 -1.084 . . . . 75.54 108.074 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.4 136.07 53.43 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.939 0.896 . . . . 74.33 109.106 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.78 91.7 10.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.46 -0.941 . . . . 62.41 108.46 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.95 -41.83 12.77 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 75.41 112.367 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 33.0 m-20 -99.09 35.53 1.88 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.171 0.588 . . . . 74.13 109.687 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -59.55 -51.54 80.41 Favored Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 118.254 -0.879 . . . . 55.03 112.941 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 37.9 Cg_exo -64.79 -33.52 53.26 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 121.783 1.656 . . . . 75.51 112.351 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.522 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -66.58 -19.5 65.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.52 1.128 . . . . 64.43 112.41 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 3.2 p -58.5 -14.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 113.043 0.757 . . . . 64.34 113.043 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -55.41 -40.66 71.72 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.06 0.944 . . . . 75.11 111.341 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -114.74 40.25 2.64 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.432 1.093 . . . . 74.11 109.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.587 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 0.0 OUTLIER -83.61 144.13 29.65 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.975 0.91 . . . . 72.41 110.721 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -88.1 113.57 23.87 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.625 -1.25 . . . . 74.15 107.625 163.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -83.47 64.02 7.64 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.839 0.828 . . . . 71.42 110.161 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -142.44 52.58 2.47 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.977 1.311 . . . . 75.23 108.573 174.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.41 144.81 9.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.023 1.816 . . . . 54.25 111.697 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.25 95.92 8.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.54 -0.911 . . . . 72.44 108.54 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' C' ' 65' ' ' THR . 16.7 m -71.76 102.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.293 -0.867 . . . . 73.13 110.565 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.1 mttt -91.97 100.2 12.9 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.159 -1.052 . . . . 65.22 108.159 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.3 163.53 16.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.347 -0.612 . . . . 42.31 109.347 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.6 t70 -156.33 146.29 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.53 -0.915 . . . . 75.13 108.53 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -133.8 117.35 16.78 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 74.22 107.757 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.78 137.57 46.85 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.02 1.328 . . . . 75.43 107.861 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.8 t -113.11 149.82 32.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.428 0.633 . . . . 64.43 110.28 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.53 162.17 28.8 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.568 -1.196 . . . . 72.53 107.995 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -135.63 151.15 49.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.282 0.633 . . . . 53.54 109.7 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.4 t -149.91 125.99 10.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.098 -1.075 . . . . 71.34 108.098 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -83.63 120.52 26.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.184 -0.673 . . . . 74.21 109.184 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -92.79 -40.81 10.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.42 0.688 . . . . 63.01 109.842 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 175.3 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.832 -1.076 . . . . 64.32 109.339 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.67 123.74 18.34 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.542 0.526 . . . . 71.13 109.76 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 68.16 2.14 3.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.055 1.342 . . . . 73.12 113.554 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.76 112.35 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.46 -0.941 . . . . 54.42 108.46 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -125.05 122.51 37.44 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.513 0.673 . . . . 74.1 109.295 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.4 tt0 -85.46 138.36 32.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.161 -1.382 . . . . 75.13 108.303 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.552 HG23 HD11 ' C' ' 106' ' ' LEU . 17.5 m -130.25 143.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.975 -0.75 . . . . 75.32 108.975 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.67 105.12 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.312 -0.995 . . . . 73.02 108.312 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.8 tm? -92.54 104.39 16.7 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.168 -1.049 . . . . 74.22 108.168 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -79.07 124.07 27.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.386 1.074 . . . . 75.41 109.385 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' C' ' 114' ' ' ILE . 22.0 t -112.84 110.22 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.596 -1.261 . . . . 73.33 107.596 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.8 m -99.21 136.57 38.97 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.904 -1.147 . . . . 71.24 107.904 176.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 114' ' ' ILE . 64.9 t -135.94 113.16 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.135 0.974 . . . . 73.13 108.74 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 21.3 m -104.06 144.35 31.67 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.658 -0.867 . . . . 71.24 108.658 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.28 104.24 5.14 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.204 -1.036 . . . . 60.34 108.204 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.464 ' HB3' HG23 ' C' ' 72' ' ' THR . 56.5 p -159.91 169.16 24.1 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.113 0.565 . . . . 74.02 109.923 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -120.73 -40.82 2.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.954 -0.758 . . . . 72.3 108.954 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.36 -97.8 0.12 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 110.799 -0.92 . . . . 51.11 110.799 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -88.08 -27.86 21.69 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.645 -0.872 . . . . 61.54 108.645 170.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.33 87.92 1.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.356 -0.838 . . . . 75.13 109.334 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 67' ' ' SER . 64.6 m -88.03 136.68 32.86 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.44 -0.8 . . . . 74.21 109.476 171.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.39 -63.95 1.28 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.633 -0.877 . . . . 60.24 108.633 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.42 177.36 9.59 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.299 1.047 . . . . 75.12 111.96 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.3 tm? -135.31 143.75 46.35 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 105.009 -2.219 . . . . 63.52 105.009 168.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.9 t -149.49 144.15 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.106 -1.072 . . . . 61.52 108.106 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -158.85 131.24 6.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.557 -0.535 . . . . 74.52 109.557 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -126.98 120.75 56.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.975 -1.011 . . . . 74.42 108.725 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -99.15 90.39 4.57 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.807 -1.183 . . . . 74.13 107.807 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.96 108.86 13.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.261 -1.336 . . . . 63.21 109.511 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 158.69 29.71 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.977 -0.556 . . . . 34.55 112.266 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.22 126.23 1.56 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.365 -0.294 . . . . 42.42 112.365 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.527 HD12 HD11 ' C' ' 51' ' ' LEU . 12.2 mm -88.4 124.62 41.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.553 -0.906 . . . . 75.14 108.553 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.76 122.5 18.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.549 0.74 . . . . 63.42 109.674 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -90.36 110.44 21.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.965 0.506 . . . . 64.3 110.093 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.76 118.68 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 108.491 -0.929 . . . . 72.22 108.491 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.75 160.44 30.81 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.472 0.709 . . . . 70.04 111.531 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.87 -61.15 3.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.48 -0.782 . . . . 73.55 112.389 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.9 mm -91.02 145.71 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.007 0.923 . . . . 71.22 110.204 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 13.1 pt-20 -147.02 -171.31 3.74 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.3 1.04 . . . . 74.34 110.258 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 73.21 -143.34 32.95 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.171 -0.468 . . . . 72.4 113.316 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.9 p -66.84 -23.18 66.0 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.93 0.892 . . . . 73.33 111.914 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.06 -44.09 66.48 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.605 0.762 . . . . 63.12 110.994 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.495 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 21.6 ptt? -71.91 -32.96 67.89 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.447 -0.575 . . . . 65.24 109.447 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.15 -27.21 67.85 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.26 0.624 . . . . 44.15 110.989 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -73.42 -38.66 65.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.529 0.732 . . . . 75.0 110.411 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -67.97 -61.51 1.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.405 0.282 . . . . 73.51 111.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -76.3 -16.55 59.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.125 0.57 . . . . 74.22 112.142 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.96 -24.02 23.81 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.768 -0.462 . . . . 70.41 113.352 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.43 -59.05 1.1 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.393 0.596 . . . . 64.45 111.819 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -60.42 -57.27 13.46 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.74 0.816 . . . . 72.24 111.967 -172.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 47.4 m -62.05 -47.7 90.14 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 115.312 -0.858 . . . . 74.44 112.17 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.594 ' HB3' HD23 ' C' ' 60' ' ' LEU . 89.8 Cg_exo -54.03 -35.67 81.91 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.85 2.366 . . . . 75.55 114.594 169.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -21.16 60.1 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.09 0.556 . . . . 75.22 111.368 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.513 HD12 HH12 ' A' ' 111' ' ' ARG . 21.8 mm -77.48 -35.05 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.464 0.706 . . . . 75.23 109.945 171.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.552 HD11 HG23 ' C' ' 58' ' ' VAL . 98.8 mt -76.45 -38.77 54.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.222 0.609 . . . . 74.55 111.992 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.14 -41.35 74.15 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 124.359 1.063 . . . . 72.55 113.333 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.63 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 39.7 Cg_exo -43.9 -55.21 3.21 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.643 2.229 . . . . 75.14 115.883 168.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.19 -30.63 71.13 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.328 0.585 . . . . 72.24 110.343 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.6 73.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.093 -0.958 . . . . 71.13 111.274 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.481 ' HD3' ' CZ ' ' A' ' 109' ' ' TYR . 22.3 ttt180 -56.43 -51.76 67.18 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.492 0.717 . . . . 75.25 110.982 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.75 -31.32 69.23 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.451 0.47 . . . . 74.41 110.667 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.427 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 7.1 t -69.25 -28.11 66.03 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.664 0.386 . . . . 63.31 111.245 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.491 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.2 mt -79.17 -50.1 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.402 0.681 . . . . 74.02 110.141 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -65.55 -29.33 69.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.866 0.467 . . . . 61.53 111.353 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -63.98 -52.25 60.51 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.287 -0.634 . . . . 71.55 109.287 172.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.473 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.66 -40.69 75.93 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.629 1.172 . . . . 75.3 112.468 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 114' ' ' ILE . 78.6 t -65.75 -43.4 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.555 0.742 . . . . 74.14 110.383 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.418 ' HB2' HE22 ' C' ' 125' ' ' GLN . 37.9 t -69.6 -25.0 63.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.786 -0.643 . . . . 64.44 111.451 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.2 mtt-85 -72.03 -34.37 68.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.3 0.64 . . . . 74.24 109.994 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.67 6.34 74.15 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.618 0.574 . . . . 74.2 113.146 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.584 HG23 ' HB3' ' D' ' 17' ' ' TYR . 44.4 p 65.28 22.23 12.08 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.722 2.009 . . . . 73.45 113.268 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -84.52 162.12 51.77 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.84 0.856 . . . . 71.22 110.415 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.423 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 36.7 Cg_endo -64.06 151.05 86.98 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.657 2.238 . . . . 61.42 113.074 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.418 HE22 ' HB2' ' C' ' 119' ' ' SER . 24.4 mm-40 -60.26 112.36 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.965 0.906 . . . . 62.33 112.036 -172.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.61 90.35 3.28 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.346 0.658 . . . . 75.02 110.089 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.47 118.49 31.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.491 0.716 . . . . 74.34 109.937 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.458 ' O ' ' HD2' ' C' ' 111' ' ' ARG . 3.0 mm? -87.19 135.07 33.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.985 0.914 . . . . 73.01 109.233 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 141.86 87.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.451 0.7 . . . . 75.11 111.153 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HB3' ' HE2' ' A' ' 109' ' ' TYR . 38.5 Cg_endo -65.65 125.72 14.84 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.4 2.067 . . . . 63.0 111.302 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.43 114.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.526 -0.916 . . . . 71.13 108.526 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.411 HD22 ' N ' ' C' ' 132' ' ' ASN . 0.8 OUTLIER -77.61 75.22 4.16 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.005 0.922 . . . . 72.22 109.958 -177.39 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.55 -43.61 18.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.733 0.413 . . . . 72.21 110.188 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 . . . . . 0 N--CA 1.475 0.821 0 CA-C-N 115.958 -0.565 . . . . 74.03 110.015 177.327 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.486 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm . . . . . 0 N--CA 1.478 0.958 0 N-CA-C 112.664 0.616 . . . . 44.21 112.664 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 32.7 m -115.36 143.08 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.782 0.433 . . . . 74.14 109.868 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.8 t80 -157.14 94.67 1.43 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.636 -1.246 . . . . 65.2 107.636 171.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -112.95 121.47 44.75 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.641 -0.709 . . . . 72.1 109.351 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.88 99.65 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 106.974 -1.491 . . . . 51.44 106.974 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -79.17 -46.92 16.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.682 -0.236 . . . . 73.1 110.915 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.496 ' HD3' HD12 ' D' ' 83' ' ' ILE . 43.4 ttt180 -169.04 131.66 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.213 -0.449 . . . . 61.04 111.964 -161.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.7 138.5 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.772 -1.195 . . . . 63.3 107.772 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' C' ' 122' ' ' THR . 10.1 p90 -164.76 177.3 8.07 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 121.872 0.844 . . . . 71.45 111.212 -176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -109.69 118.46 36.6 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.351 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.7 mtpt -88.57 -23.96 22.99 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.624 -0.51 . . . . 73.43 109.624 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.8 t70 -156.84 130.43 8.14 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.95 -1.023 . . . . 73.03 109.228 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.6 mt -128.09 135.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.261 1.024 . . . . 74.04 108.292 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -134.83 137.48 43.35 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.082 0.953 . . . . 70.13 108.473 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -149.5 120.55 7.72 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.318 -1.364 . . . . 72.43 107.318 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 1.8 mp0 -120.41 137.65 54.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.993 -0.743 . . . . 75.02 108.993 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.41 81.07 37.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.32 -0.993 . . . . 62.13 108.32 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.3 -44.1 0.33 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.753 2.302 . . . . 71.11 112.764 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' D' ' 72' ' ' THR . 81.4 m-20 -100.87 44.36 1.02 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.217 1.007 . . . . 64.34 108.637 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.681 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.74 -53.57 63.05 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 114.118 -1.401 . . . . 75.33 114.471 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.72 6.65 5.46 Favored 'Trans proline' 0 C--N 1.392 2.868 0 CA-C-N 121.972 1.74 . . . . 65.4 112.662 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.533 ' HA ' HE21 ' D' ' 33' ' ' GLN . 4.9 t-160 -85.06 -46.23 11.35 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.32 1.048 . . . . 65.24 109.323 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.88 -16.98 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.169 0.509 . . . . 72.11 110.699 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -56.54 -30.23 62.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.734 1.214 . . . . 75.14 111.854 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' D' ' 30' ' ' HIS . 35.9 mt-30 -82.7 -16.4 48.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.71 0.804 . . . . 72.03 111.056 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.612 ' HB3' HD23 ' D' ' 68' ' ' LEU . 85.7 mttt -109.53 112.41 24.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.005 0.922 . . . . 73.04 111.537 -173.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -99.91 71.65 1.67 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.812 0.845 . . . . 62.41 110.873 -178.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -164.57 158.85 18.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.083 -0.71 . . . . 74.51 109.083 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -62.02 114.09 10.46 Favored Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.075 0.55 . . . . 54.24 111.436 -176.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.614 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 43.6 Cg_exo -60.06 114.82 2.26 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 121.972 1.781 . . . . 64.42 109.647 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.31 121.66 10.69 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.207 0.942 . . . . 71.51 109.897 -174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -96.67 112.32 28.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.375 -0.829 . . . . 55.3 110.292 -168.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.599 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 63.0 tttt -87.07 142.02 28.23 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.922 -1.14 . . . . 72.03 107.922 167.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.39 139.88 49.12 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 9.2 t70 -141.9 149.1 39.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.725 -1.213 . . . . 74.42 107.725 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.29 166.32 24.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.053 0.541 . . . . 65.25 110.971 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.5 t70 -170.18 156.11 5.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.766 1.227 . . . . 70.33 108.033 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.1 t -135.08 161.18 36.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.061 0.545 . . . . 64.22 109.828 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.93 163.47 38.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.831 0.852 . . . . 62.31 109.076 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -148.93 153.48 38.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.138 0.575 . . . . 53.13 110.092 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -159.77 121.64 3.3 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.464 0.706 . . . . 52.45 109.366 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.5 124.88 26.11 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.134 -0.691 . . . . 71.43 109.134 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.6 mt -94.08 -33.69 13.28 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.799 0.44 . . . . 73.32 110.423 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.46 -172.02 2.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.002 -0.999 . . . . 73.12 110.595 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.1 116.42 6.48 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.804 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 10.1 m-20 63.32 19.29 11.6 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 73.24 112.068 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -119.53 120.5 63.71 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -130.4 129.38 42.99 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.881 -0.785 . . . . 65.22 108.881 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' D' ' 51' ' ' LEU . 10.3 tm-20 -100.8 137.45 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.801 -1.185 . . . . 74.35 107.801 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.525 HG11 ' HB3' ' D' ' 102' ' ' CYS . 4.2 p -127.17 134.17 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.673 -0.862 . . . . 75.53 108.673 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 80.3 t -106.08 131.08 56.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.153 0.581 . . . . 44.12 109.756 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -107.38 120.97 43.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.808 -1.553 . . . . 65.21 106.808 174.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.6 ttm-85 -105.39 107.36 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.711 -0.848 . . . . 73.22 108.711 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.4 t -107.44 124.29 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.052 0.941 . . . . 64.32 108.662 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 8.8 m -125.04 130.66 52.76 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.235 0.614 . . . . 72.34 110.124 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.64 107.45 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.382 1.073 . . . . 74.03 109.104 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.0 m -103.19 96.92 7.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.262 0.625 . . . . 73.44 109.583 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.18 124.73 41.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.972 -0.751 . . . . 72.43 108.972 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 69.5 m -147.31 130.48 16.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.673 0.789 . . . . 53.23 109.419 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' D' ' 34' ' ' LYS . 35.7 tp -116.81 121.8 42.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.355 -0.609 . . . . 43.22 109.355 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 -113.66 4.24 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.576 -0.609 . . . . 64.34 111.576 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.29 2.42 8.48 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.318 0.647 . . . . 63.45 110.944 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -115.46 150.96 35.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.045 0.538 . . . . 71.1 110.618 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 94.3 m -69.45 120.68 15.61 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 114.586 -1.188 . . . . 71.44 110.205 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.4 -59.64 2.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 122.941 0.496 . . . . 74.34 109.664 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.31 152.61 26.22 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.394 -0.821 . . . . 72.45 110.454 172.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -124.29 153.34 41.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.562 1.145 . . . . 75.31 109.823 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -158.31 146.17 18.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.64 -0.709 . . . . 72.0 110.356 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.88 132.11 11.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.8 -0.815 . . . . 72.41 108.8 172.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.59 124.24 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 122.744 0.418 . . . . 74.05 109.994 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.593 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 40.5 mt-30 -88.97 85.09 6.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.767 -0.827 . . . . 73.33 108.767 166.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.83 96.79 6.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.203 -1.362 . . . . 74.41 108.593 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.06 155.95 24.0 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.302 -0.408 . . . . 52.2 112.179 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.567 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -153.21 133.77 4.15 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.645 0.223 . . . . 71.21 112.683 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.496 HD12 ' HD3' ' D' ' 15' ' ' ARG . 68.5 mt -89.24 126.0 42.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 C-N-CA 124.067 0.947 . . . . 70.45 109.502 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.96 138.44 46.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.411 0.685 . . . . 75.02 109.835 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.9 m -91.66 100.15 12.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.472 0.709 . . . . 75.13 109.502 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.1 116.69 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.638 0.775 . . . . 55.03 110.384 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -147.67 162.5 39.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.228 1.011 . . . . 52.11 110.801 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.49 -20.19 6.36 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 114.879 0.712 . . . . 71.33 114.879 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -114.51 157.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.054 0.942 . . . . 72.23 110.493 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.24 -174.55 4.99 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.692 0.797 . . . . 63.44 110.84 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.67 -133.85 51.48 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.717 0.636 . . . . 74.03 113.711 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -73.9 -22.54 59.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.307 0.643 . . . . 73.53 110.722 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.34 -41.06 73.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.806 0.842 . . . . 72.4 111.041 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -75.12 -30.43 60.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.995 -0.372 . . . . 60.31 109.995 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.4 63.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.241 0.616 . . . . 64.53 110.949 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -79.45 -44.13 21.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.898 0.879 . . . . 73.22 110.693 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.8 t -66.5 -48.91 68.29 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.173 -0.467 . . . . 54.24 110.92 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.01 -39.5 25.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.693 0.797 . . . . 64.33 109.812 -176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -27.58 35.66 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.69 -0.505 . . . . 74.42 114.251 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.88 -53.2 2.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.852 0.826 . . . . 61.2 111.391 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -74.09 -44.97 52.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.546 0.573 . . . . 64.53 112.546 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.525 ' HB3' HG11 ' D' ' 58' ' ' VAL . 72.4 m -63.48 -46.48 84.02 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.417 -0.801 . . . . 63.34 112.499 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 31.9 Cg_exo -64.23 -30.07 64.36 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 122.12 1.88 . . . . 70.32 112.862 171.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.84 -31.36 71.92 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.334 0.654 . . . . 74.0 110.363 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -69.95 -42.83 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.501 0.721 . . . . 75.21 109.974 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.567 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -74.42 -18.47 60.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.87 -0.605 . . . . 71.44 111.72 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -68.26 -42.76 31.14 Favored Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 114.314 1.227 . . . . 73.23 114.314 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.66 -32.1 96.12 Favored 'Trans proline' 0 C--N 1.383 2.358 0 CA-C-N 121.627 1.617 . . . . 71.44 112.871 171.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -81.45 -30.06 33.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.386 0.674 . . . . 73.0 110.995 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.49 -53.98 43.62 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.641 -0.874 . . . . 72.3 108.641 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.12 -50.09 65.19 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 113.91 -1.495 . . . . 73.42 110.981 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.92 -44.17 93.72 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.924 0.765 . . . . 53.11 111.661 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 -41.47 86.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.567 0.542 . . . . 54.05 110.761 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.511 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.0 mt -66.26 -53.81 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.093 -0.958 . . . . 63.3 110.21 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.515 HG23 ' HG3' ' D' ' 125' ' ' GLN . 37.5 m -54.46 -38.35 66.29 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.771 1.228 . . . . 53.11 111.765 -176.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -70.19 -46.23 65.03 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.356 -0.838 . . . . 53.42 110.805 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.4 mtm -63.42 -33.07 74.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.782 0.433 . . . . 75.42 111.74 176.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' D' ' 123' ' ' PHE . 39.6 t -68.2 -40.66 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.922 -1.035 . . . . 60.13 110.225 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -76.08 -22.91 55.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.263 0.225 . . . . 65.04 111.335 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.427 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 85.1 mtt-85 -76.85 -33.08 57.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.503 0.721 . . . . 74.33 109.487 173.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 0.84 88.49 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 115.43 -0.804 . . . . 65.14 112.079 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 61.54 17.86 8.91 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.921 2.088 . . . . 71.31 113.417 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.52 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 30.1 m-85 -82.94 168.97 19.37 Favored Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.615 1.566 . . . . 75.4 110.634 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 52.5 Cg_endo -64.17 135.7 48.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.007 2.471 . . . . 60.22 113.135 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.515 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.2 tt0 -55.21 131.5 45.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.895 0.878 . . . . 64.32 111.778 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.88 97.62 7.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.92 0.888 . . . . 64.24 108.722 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -97.44 86.9 3.98 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.336 -0.987 . . . . 74.51 108.336 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.58 123.3 18.45 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.806 -1.088 . . . . 74.21 109.489 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.73 131.66 86.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 O-C-N 123.727 0.642 . . . . 75.23 110.768 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.37 115.36 3.3 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 121.966 1.777 . . . . 61.23 111.329 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.45 108.93 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.31 -0.626 . . . . 70.24 109.31 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -84.99 103.74 14.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.297 -0.865 . . . . 61.12 109.046 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 N--CA 1.477 0.909 0 CA-C-N 115.393 -0.821 . . . . 75.02 111.173 -179.43 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.9 m . . . . . 0 N--CA 1.468 0.442 0 N-CA-C 109.24 -0.652 . . . . 72.42 109.24 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' HG22 ' A' ' 86' ' ' ILE . 49.0 m-85 -136.35 112.14 9.48 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.291 -1.374 . . . . 75.04 107.291 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -132.77 134.44 44.72 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.042 0.537 . . . . 65.22 110.702 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.25 97.09 5.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 106.448 -1.686 . . . . 73.31 106.448 167.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -72.83 -40.2 65.97 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.216 0.606 . . . . 71.32 109.912 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -165.31 140.93 5.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.745 -0.835 . . . . 73.42 108.745 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.13 137.96 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.646 -0.872 . . . . 65.13 108.646 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -171.69 170.97 5.44 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.808 0.693 . . . . 72.01 111.195 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -91.06 117.95 30.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.446 -0.797 . . . . 71.35 109.213 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 34.4 mtpt -80.54 -28.84 37.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 110.04 -0.356 . . . . 63.1 110.04 172.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.3 t70 -149.13 142.16 24.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.582 -0.735 . . . . 62.42 110.301 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG23 ' SD ' ' A' ' 117' ' ' MET . 59.0 mt -134.66 136.18 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.29 -1.374 . . . . 74.52 107.29 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -142.98 129.7 20.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.461 -0.94 . . . . 72.35 108.461 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 89.3 t80 -144.36 122.53 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.375 -1.343 . . . . 63.4 107.375 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.63 143.69 51.14 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.148 -0.686 . . . . 72.4 109.148 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.22 73.98 63.05 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.503 -1.295 . . . . 64.2 107.503 171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.42 -32.03 20.84 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.588 2.192 . . . . 74.15 111.204 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' VAL . 86.5 m-20 -103.92 30.6 5.03 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.699 -1.137 . . . . 75.13 109.768 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -55.71 -46.53 99.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.578 -0.725 . . . . 61.22 112.7 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 38.4 Cg_exo -61.46 -28.28 83.43 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 121.828 1.686 . . . . 71.25 112.98 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -74.21 -32.92 63.22 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 116.038 -0.528 . . . . 71.21 110.448 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 27' ' ' ASN . 55.1 t -63.51 -27.54 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.511 0.596 . . . . 55.34 111.659 -176.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -71.09 -39.66 72.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.417 0.687 . . . . 75.31 111.591 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.77 -38.29 14.79 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.383 0.673 . . . . 71.31 111.125 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HB3' HD11 ' A' ' 68' ' ' LEU . 13.6 mmmm -82.03 157.81 24.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 62.44 109.243 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.43 ' O ' HD13 ' A' ' 68' ' ' LEU . 22.6 m-20 -71.77 118.03 14.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.762 0.425 . . . . 75.5 110.572 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -75.66 76.96 2.65 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.484 1.135 . . . . 75.02 110.374 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -136.99 82.67 30.15 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.182 -1.414 . . . . 74.43 107.182 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -87.11 155.8 8.35 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.53 2.153 . . . . 65.04 113.049 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.3 124.04 41.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.716 -1.216 . . . . 72.21 107.716 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 92.52 2.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 109.129 -0.693 . . . . 73.44 109.129 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.3 tttt -87.29 139.43 30.57 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.66 -1.237 . . . . 74.11 107.66 169.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 pt? -139.1 151.23 46.54 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.056 0.542 . . . . 74.04 109.959 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -131.15 136.08 48.01 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.421 0.688 . . . . 70.34 109.767 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.0 tp -103.91 128.78 51.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.057 0.943 . . . . 65.43 109.495 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 14.7 t70 -146.23 139.32 25.74 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.878 -0.786 . . . . 75.31 108.878 170.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.1 m -144.89 134.18 22.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.301 1.041 . . . . 74.52 109.124 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.501 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -159.66 133.09 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.635 0.374 . . . . 64.54 110.238 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 58' ' ' VAL . 59.9 p -91.38 177.06 6.34 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.29 0.636 . . . . 73.54 110.828 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.4 t -166.61 116.76 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.195 -0.669 . . . . 62.22 109.195 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -69.62 104.91 2.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.407 0.442 . . . . 75.42 109.968 -173.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 57' ' ' GLU . 49.7 mt -78.69 -37.27 42.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.659 0.784 . . . . 43.14 111.086 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.86 -173.5 4.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.648 0.779 . . . . 72.53 109.532 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.71 97.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.325 0.65 . . . . 75.14 111.166 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 6.0 m-20 60.1 31.01 20.41 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.47 1.108 . . . . 61.05 112.173 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.26 120.63 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.009 -1.478 . . . . 74.43 107.009 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.83 130.49 41.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.503 -0.925 . . . . 72.53 108.503 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.3 tt0 -86.13 117.98 25.3 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.86 -0.793 . . . . 72.43 108.86 171.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 48' ' ' SER . 47.2 t -98.73 118.64 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 107.406 -1.331 . . . . 73.13 107.406 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.513 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 36.2 t -102.45 131.47 50.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.4 -0.593 . . . . 54.44 109.4 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.59 115.1 29.76 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.197 -1.408 . . . . 75.32 107.197 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.666 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -89.89 100.88 13.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.002 -1.481 . . . . 74.41 107.002 172.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.53 124.36 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.14 -1.059 . . . . 65.24 108.14 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 13.5 m -112.22 138.9 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.413 -0.958 . . . . 44.12 108.413 172.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.1 t -133.63 107.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.893 1.277 . . . . 75.13 107.673 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 43.4 m -103.66 136.89 42.51 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.961 -0.755 . . . . 65.21 108.961 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.79 23.67 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.406 0.682 . . . . 73.51 109.364 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.3 m -143.22 142.73 31.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.421 0.688 . . . . 71.02 110.36 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.07 78.73 2.11 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 169.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.43 -99.31 1.08 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.647 -0.706 . . . . 73.54 112.287 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.41 -28.24 21.04 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.644 0.778 . . . . 74.24 110.834 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.561 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 5.4 tp10 -94.73 132.18 39.76 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.273 -0.64 . . . . 72.15 109.273 -174.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -82.4 130.82 35.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.203 -0.665 . . . . 73.4 109.203 170.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.92 -59.93 2.54 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.447 -0.945 . . . . 60.44 108.447 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -168.51 174.92 6.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.675 -1.148 . . . . 72.25 110.779 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 tp -132.12 144.87 51.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.551 1.141 . . . . 54.12 109.277 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.588 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.2 m -137.99 140.14 40.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.385 1.074 . . . . 64.24 109.477 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -149.32 130.32 14.38 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.46 -0.57 . . . . 71.13 109.46 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.18 110.79 18.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.689 0.796 . . . . 72.33 108.922 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -86.75 85.17 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.085 -0.962 . . . . 72.32 108.887 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.8 tp-100 -79.08 96.52 5.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.478 -1.237 . . . . 74.13 108.728 -177.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.14 142.86 16.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.333 -0.707 . . . . 75.43 111.333 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.14 126.4 3.35 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 110.411 -1.076 . . . . 65.54 110.411 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.79 129.8 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -134.41 121.09 20.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.517 0.727 . . . . 74.11 109.928 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -91.06 95.99 10.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.481 -0.933 . . . . 75.24 108.481 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 11' ' ' PHE . 26.1 pt -130.04 131.88 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.793 0.837 . . . . 73.21 110.354 -171.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -168.99 176.9 5.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.39 0.676 . . . . 65.2 111.44 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.57 31.07 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.088 -0.96 . . . . 71.54 112.399 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.09 172.33 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 124.216 1.007 . . . . 74.13 110.159 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.3 tt0 -154.73 -169.14 3.12 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.69 -0.855 . . . . 64.51 108.69 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.552 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.2 -130.68 24.39 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 120.129 -0.262 . . . . 64.21 112.971 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -66.96 -32.85 74.37 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.857 0.863 . . . . 73.34 111.395 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.63 -39.66 80.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.776 0.83 . . . . 73.33 110.823 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.0 tpp -72.7 -41.78 64.91 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.354 0.409 . . . . 74.23 110.441 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.54 66.46 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 72.22 111.279 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -79.88 -37.71 34.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.51 0.724 . . . . 63.44 111.054 172.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HG ' ' HD2' ' A' ' 11' ' ' PHE . 53.9 t -63.03 -57.44 10.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.651 0.38 . . . . 74.32 111.955 -174.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' HA ' ' SG ' ' A' ' 102' ' ' CYS . 0.5 OUTLIER -95.18 -10.3 30.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.398 0.518 . . . . 64.21 112.398 -177.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.5 -21.26 15.12 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.156 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.43 -64.59 1.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.591 0.756 . . . . 73.32 110.257 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 97' ' ' CYS . 75.8 t80 -60.21 -53.12 61.53 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.166 0.986 . . . . 73.43 112.725 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 98' ' ' LEU . 84.4 m -60.21 -52.26 74.45 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.165 -0.921 . . . . 55.23 112.735 -176.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.86 -24.09 40.58 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.816 1.677 . . . . 71.05 113.233 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -73.61 -28.76 61.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.944 0.498 . . . . 72.15 110.605 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -68.84 -42.41 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.389 0.676 . . . . 74.13 109.418 168.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.461 HD21 ' HA3' ' A' ' 82' ' ' GLY . 88.7 mt -71.61 -25.96 62.38 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.962 -1.017 . . . . 71.32 111.768 -176.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -67.24 -44.61 48.66 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.81 -1.091 . . . . 72.51 113.823 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 20.6 Cg_endo -62.66 -33.27 77.82 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 121.875 1.717 . . . . 74.12 112.647 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -75.14 -34.36 61.62 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.181 0.592 . . . . 73.55 111.875 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.87 65.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.355 -0.609 . . . . 70.22 109.355 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.483 HH12 HD12 ' C' ' 105' ' ' ILE . 34.7 ttm180 -51.96 -51.68 55.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.121 1.368 . . . . 75.25 110.684 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.17 -48.48 81.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.253 0.971 . . . . 73.05 111.211 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.477 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.9 t -56.84 -45.76 82.17 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.297 0.998 . . . . 71.42 110.92 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.3 mt -63.59 -52.4 58.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 124.084 0.865 . . . . 72.3 110.551 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 125' ' ' GLN . 71.5 m -53.82 -43.77 69.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.816 0.847 . . . . 64.34 111.112 -176.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.38 -42.99 82.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.652 -1.158 . . . . 51.3 110.365 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.472 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mtp -56.5 -46.19 80.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.736 0.814 . . . . 55.15 111.25 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.1 t -60.99 -47.47 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.699 -1.137 . . . . 74.44 110.989 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -71.82 -26.57 62.45 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.995 -0.548 . . . . 71.41 111.246 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 40.0 mtt180 -72.88 -30.38 63.92 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.489 0.716 . . . . 73.11 110.017 172.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.04 0.48 78.87 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.564 -0.743 . . . . 22.13 112.543 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 66.89 37.85 3.87 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.804 1.242 . . . . 75.32 110.109 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -113.69 153.7 45.86 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.893 -1.048 . . . . 64.24 109.299 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.98 132.97 52.75 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.009 2.472 . . . . 74.42 112.189 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.52 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.7 pt20 -61.99 147.4 47.17 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.867 0.73 . . . . 64.2 111.262 -172.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -117.8 95.44 4.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.05 0.54 . . . . 75.55 109.555 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -100.76 97.24 7.9 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.699 -0.852 . . . . 71.4 108.699 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -73.39 136.99 44.4 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.659 -0.867 . . . . 72.2 108.659 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.68 148.48 91.07 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.039 0.535 . . . . 73.22 111.753 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -77.9 119.48 4.75 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.906 1.737 . . . . 74.41 111.458 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.81 111.52 31.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.519 -1.289 . . . . 71.41 107.519 170.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.99 93.0 9.23 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.253 0.621 . . . . 63.01 109.593 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -61.96 -27.92 69.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.42 -0.809 . . . . 61.41 108.859 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 . . . . . 0 C--N 1.352 0.686 0 CA-C-N 115.076 -0.965 . . . . 75.25 111.592 173.225 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.428 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 21.8 ptm . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 114.528 1.307 . . . . 72.21 114.528 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -152.78 125.64 8.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.763 1.225 . . . . 70.52 107.742 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -135.72 135.52 40.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.686 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 55.3 tt0 -150.42 142.33 23.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.809 0.844 . . . . 60.5 109.192 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.5 115.05 32.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.485 -1.302 . . . . 64.41 107.485 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.436 HE22 HG13 ' B' ' 55' ' ' VAL . 71.6 mt-30 -79.79 -48.31 13.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.933 -0.395 . . . . 72.11 109.933 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -167.74 136.32 2.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.743 -0.662 . . . . 73.01 109.747 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.1 mt -114.67 140.99 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.051 -1.463 . . . . 74.11 107.051 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -165.96 146.73 6.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.528 0.68 . . . . 74.2 111.077 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.615 HG21 HD11 ' B' ' 21' ' ' ILE . 40.6 m -77.44 117.07 18.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.108 -0.951 . . . . 71.44 109.078 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -86.92 -27.64 23.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.318 0.647 . . . . 72.52 110.82 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 21.1 t70 -150.9 139.68 20.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.272 -0.422 . . . . 73.51 111.097 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.615 HD11 HG21 ' B' ' 18' ' ' THR . 33.7 mm -128.66 143.5 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.126 1.37 . . . . 74.45 108.142 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.3 t -141.03 142.93 34.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.099 -1.075 . . . . 71.15 108.099 169.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -157.8 120.04 3.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.656 -1.609 . . . . 71.22 106.656 171.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.05 146.69 49.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.304 -0.628 . . . . 73.51 109.304 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -146.69 79.84 10.07 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.046 -1.094 . . . . 63.14 108.046 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.6 -25.46 20.87 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.067 2.511 . . . . 72.14 112.793 -172.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -116.66 19.39 14.57 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.872 0.869 . . . . 63.3 109.793 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.634 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -47.49 -52.69 35.14 Favored Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 115.313 1.597 . . . . 61.42 115.313 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.28 -11.42 19.21 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 121.839 1.693 . . . . 64.35 112.725 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -97.89 -26.24 14.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.657 0.783 . . . . 74.21 111.728 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.459 ' HB ' HD12 ' B' ' 68' ' ' LEU . 34.7 m -82.24 0.49 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.459 0.304 . . . . 73.11 111.176 175.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.99 -42.61 99.33 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.339 1.056 . . . . 72.32 110.892 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.25 -13.89 48.42 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.114 0.566 . . . . 74.53 111.479 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -83.95 78.69 9.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.386 0.674 . . . . 63.25 110.06 -170.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.91 102.59 5.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.791 -0.818 . . . . 53.12 108.791 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -159.56 162.6 35.42 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 73.45 108.059 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.49 109.19 29.88 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.546 -0.74 . . . . 73.34 109.032 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' B' ' 67' ' ' SER . 32.2 Cg_exo -56.15 131.03 43.42 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.648 2.232 . . . . 74.31 113.408 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.25 102.51 2.13 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 107.741 -1.207 . . . . 71.21 107.741 167.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' B' ' 65' ' ' THR . 23.7 m -97.6 146.35 7.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.2 -0.909 . . . . 52.04 110.765 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.84 118.87 19.49 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.514 -1.291 . . . . 71.43 107.514 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.422 ' HG ' HD12 ' B' ' 128' ' ' LEU . 2.4 tt -96.28 123.55 39.95 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.024 -1.843 . . . . 64.44 106.024 171.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.5 t70 -124.8 129.95 51.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.875 -0.787 . . . . 54.04 108.875 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.17 125.82 53.87 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.193 -1.04 . . . . 65.33 108.193 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.82 133.07 35.51 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -118.78 121.77 40.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.23 0.612 . . . . 63.12 111.21 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.38 160.93 19.83 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.799 1.24 . . . . 45.05 108.582 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 61.3 p -143.35 163.92 31.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 122.892 0.477 . . . . 71.13 110.3 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 159.32 43.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.485 1.114 . . . . 65.33 108.86 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -125.54 119.76 29.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.442 0.697 . . . . 73.05 109.133 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.2 -36.75 26.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.178 0.591 . . . . 73.22 110.566 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.33 -177.6 5.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.107 0.963 . . . . 52.34 109.915 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -66.1 118.58 10.05 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.597 -0.729 . . . . 74.02 110.105 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 71.67 3.17 4.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.524 1.53 . . . . 71.5 112.151 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.436 HG13 HE22 ' B' ' 14' ' ' GLN . 59.0 t -109.93 87.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.758 1.223 . . . . 73.52 108.329 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.445 ' CD1' HD11 ' B' ' 86' ' ' ILE . 12.2 m-85 -98.84 147.0 25.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.1 0.56 . . . . 75.54 109.587 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -131.79 100.31 5.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.016 -1.105 . . . . 72.35 108.016 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 29.8 m -94.22 138.1 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.858 -0.423 . . . . 53.3 109.858 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.08 114.11 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.631 0.773 . . . . 53.41 109.756 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.51 129.55 39.68 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.409 -1.33 . . . . 73.32 107.409 176.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -122.04 112.32 18.1 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.808 0.843 . . . . 75.15 109.157 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.05 125.77 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.619 -0.882 . . . . 70.22 108.619 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.2 m -117.91 146.85 43.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.215 0.531 . . . . 74.24 109.577 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.661 HG21 HG21 ' B' ' 114' ' ' ILE . 42.9 t -132.6 132.69 59.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.443 1.497 . . . . 54.22 108.723 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 100.0 m -126.13 143.74 51.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.924 -0.769 . . . . 70.41 108.924 169.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' B' ' 38' ' ' PRO . . . -135.54 140.25 44.57 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.743 -1.206 . . . . 73.11 107.743 171.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' B' ' 38' ' ' PRO . 17.1 m -129.51 128.83 43.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.795 0.438 . . . . 54.02 110.048 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.459 HD12 ' HB ' ' B' ' 31' ' ' VAL . 31.3 mt -114.69 102.25 9.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.499 -0.926 . . . . 73.34 108.499 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.99 -131.61 10.52 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.586 -0.734 . . . . 51.11 111.896 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -95.33 8.3 43.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.206 0.602 . . . . 73.3 110.632 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -135.81 166.52 23.09 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.645 0.778 . . . . 74.4 111.288 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -71.33 125.68 27.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.283 -0.871 . . . . 54.13 110.911 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' B' ' 31' ' ' VAL . . . -73.55 -62.86 1.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.527 0.731 . . . . 63.01 109.095 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -160.84 165.56 30.01 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 74.24 110.726 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.21 154.92 46.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.732 1.613 . . . . 55.42 108.366 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.0 t -160.76 132.09 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.199 -0.667 . . . . 52.43 109.199 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.436 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.4 tt0 -141.82 123.65 15.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.351 -0.981 . . . . 73.13 108.351 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -122.57 143.76 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.508 -0.553 . . . . 72.22 109.508 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.7 mt-30 -121.97 103.18 8.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.306 -0.861 . . . . 75.42 109.175 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.06 103.53 16.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.562 -0.745 . . . . 52.45 109.129 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.9 143.56 16.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.141 -0.784 . . . . 64.11 111.141 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.23 126.53 3.23 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 112.002 -0.439 . . . . 61.12 112.002 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 12.8 mt -85.85 131.83 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.557 -0.905 . . . . 74.44 108.557 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -138.06 137.16 37.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.977 0.911 . . . . 72.23 109.574 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.686 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 23.4 m -88.89 113.28 24.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.567 -0.901 . . . . 52.11 108.567 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.563 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -121.66 138.33 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.127 0.571 . . . . 71.41 110.411 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.02 163.36 37.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.011 0.924 . . . . 50.43 109.277 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.48 -48.25 3.93 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 122.663 0.173 . . . . 62.23 112.905 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -61.06 153.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.256 1.023 . . . . 53.23 111.857 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.423 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 0.3 OUTLIER -167.1 165.29 15.69 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.882 0.873 . . . . 53.44 110.149 176.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -119.68 19.3 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.44 0.462 . . . . 54.45 113.491 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.6 m -69.38 -31.67 70.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.93 0.892 . . . . 70.14 111.124 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.521 ' HB3' HG22 ' B' ' 89' ' ' ILE . 93.7 mt-30 -62.89 -52.57 62.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.446 0.699 . . . . 70.22 110.382 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.511 ' SD ' HD13 ' B' ' 89' ' ' ILE . 3.4 tpt -62.99 -45.14 93.8 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.456 -0.793 . . . . 65.11 110.628 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.47 78.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.372 0.669 . . . . 65.21 111.693 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -76.77 -33.13 58.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.324 0.649 . . . . 72.03 110.387 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -65.23 -52.4 54.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.136 0.575 . . . . 73.44 110.881 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.84 -20.36 31.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.877 0.471 . . . . 75.24 111.804 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -31.77 16.48 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.347 0.404 . . . . 52.2 113.258 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.05 1.82 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.916 0.487 . . . . 64.24 111.484 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -76.28 -41.93 47.19 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.187 0.81 . . . . 64.15 113.187 -168.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.407 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.3 m -63.76 -45.94 82.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 118.688 -0.672 . . . . 64.11 110.913 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 70.3 Cg_exo -56.57 -37.14 98.07 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.974 1.782 . . . . 64.35 113.514 166.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.36 -35.43 79.11 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.971 0.508 . . . . 73.33 111.416 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -66.13 -49.51 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.757 0.823 . . . . 64.33 110.162 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.34 -16.33 52.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.112 -0.949 . . . . 62.51 112.409 -168.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.56 -46.96 68.8 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 117.48 -1.248 . . . . 75.33 113.075 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.7 Cg_endo -58.6 -36.78 96.83 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.153 1.902 . . . . 53.31 112.688 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' B' ' 113' ' ' CYS . 74.7 m-85 -65.68 -49.42 68.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.399 0.68 . . . . 73.44 110.732 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -35.37 80.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.672 0.789 . . . . 64.31 110.96 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.735 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.0 ttp180 -59.78 -65.13 0.73 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.348 1.059 . . . . 74.22 110.479 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.15 -20.93 64.93 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.96 -1.018 . . . . 75.32 110.619 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.9 t -67.12 -49.62 64.26 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.709 -0.478 . . . . 72.43 109.709 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.661 HG21 HG21 ' B' ' 64' ' ' VAL . 91.4 mt -58.96 -54.44 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 123.731 0.645 . . . . 73.12 110.267 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.469 HG22 ' NE2' ' B' ' 125' ' ' GLN . 8.5 m -61.31 -29.17 69.71 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.105 0.962 . . . . 75.02 111.523 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -77.01 -35.36 57.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.447 0.699 . . . . 42.11 111.118 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.1 mmt -68.01 -30.86 70.21 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.893 0.378 . . . . 72.43 110.26 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.77 -39.23 83.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.97 0.908 . . . . 64.32 109.952 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.2 m -64.26 -32.46 74.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.523 0.729 . . . . 75.0 111.617 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.477 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.3 mtt-85 -71.32 -35.21 71.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.415 -0.811 . . . . 62.55 110.112 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.0 3.05 82.05 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.903 0.752 . . . . 55.01 112.951 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p 56.84 24.03 8.76 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.082 1.753 . . . . 71.35 112.649 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.05 156.09 42.5 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 65.42 110.137 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.2 140.58 93.22 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.052 2.501 . . . . 71.15 111.807 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.469 ' NE2' HG22 ' B' ' 115' ' ' THR . 14.7 mm100 -63.95 122.65 17.0 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.778 0.831 . . . . 75.44 112.493 -170.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -110.16 97.22 6.75 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.065 -1.457 . . . . 70.33 107.065 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -91.36 135.67 33.65 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.479 -0.782 . . . . 72.43 108.975 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.735 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -82.31 115.18 21.25 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.746 -0.835 . . . . 75.05 108.746 -173.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 137.92 88.47 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 124.404 1.065 . . . . 33.02 110.9 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.509 ' HG3' HD11 ' D' ' 16' ' ' ILE . 60.1 Cg_endo -66.6 99.05 0.42 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.739 2.293 . . . . 74.32 111.026 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.0 120.45 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.077 -1.083 . . . . 73.01 108.077 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.31 88.63 0.46 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.901 0.88 . . . . 74.44 110.515 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -52.92 -36.71 59.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.285 1.034 . . . . 75.23 112.221 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.22 -42.61 99.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.587 1.155 . . . . 73.03 111.892 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.92 -35.24 59.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.295 0.638 . . . . 71.14 110.597 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 N--CA 1.485 1.296 0 C-N-CA 123.614 0.766 . . . . 75.53 110.412 173.725 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.7 ttm . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.286 0.565 . . . . 74.25 112.246 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 21.7 m -84.84 92.78 8.35 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.321 -0.992 . . . . 71.32 108.321 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -116.41 125.85 52.61 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -151.76 134.24 15.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.207 0.603 . . . . 72.53 109.41 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.408 HG12 ' HE2' ' C' ' 84' ' ' PHE . 41.1 mt -74.81 109.0 7.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.555 -0.906 . . . . 70.22 108.555 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -85.88 -41.24 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.266 0.626 . . . . 72.13 111.175 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -170.77 142.95 2.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.957 -0.757 . . . . 63.22 108.957 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.0 mt -131.76 133.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.829 -0.804 . . . . 70.43 108.829 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.505 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 19.4 p90 -173.06 153.03 2.44 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.41 0.624 . . . . 64.31 111.509 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -74.76 125.09 28.0 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.954 -1.021 . . . . 73.43 109.782 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -77.64 -47.68 18.66 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.565 -1.272 . . . . 73.45 107.565 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -132.34 143.48 49.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.125 -1.398 . . . . 53.32 110.231 -171.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.2 mt -142.35 142.68 27.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.659 1.583 . . . . 73.45 106.767 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.48 148.71 21.66 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.163 0.506 . . . . 64.25 109.904 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -150.28 115.08 5.29 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.245 -1.391 . . . . 64.34 107.245 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -116.42 111.1 19.54 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.605 -0.517 . . . . 64.32 109.605 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.53 78.86 54.94 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 60.13 108.641 167.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.28 -28.61 39.76 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.045 1.83 . . . . 70.51 109.341 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 30' ' ' HIS . 2.2 m-20 -92.99 27.25 2.48 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.115 -1.402 . . . . 71.41 110.443 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.48 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.73 -50.17 89.44 Favored Pre-proline 0 CA--C 1.574 1.881 0 C-N-CA 123.746 0.818 . . . . 64.01 111.584 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 22.1 Cg_exo -66.1 -21.14 56.3 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.473 2.115 . . . . 75.41 113.247 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' C' ' 27' ' ' ASN . 12.6 m170 -60.59 -34.16 73.8 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 118.14 -0.933 . . . . 61.15 111.047 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.422 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.3 p -51.05 -31.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.196 0.813 . . . . 70.22 113.196 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -73.58 -29.18 62.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.811 0.844 . . . . 64.52 111.664 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.48 11.78 12.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.778 0.831 . . . . 73.53 112.217 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 18.5 ttpp -110.37 159.38 17.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 71.1 110.206 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.96 118.24 20.78 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.475 -0.784 . . . . 65.4 109.192 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -86.22 63.63 8.12 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.969 0.89 . . . . 73.32 110.862 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -145.2 72.95 14.56 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.177 -1.416 . . . . 75.54 107.177 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.56 151.61 4.3 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.787 2.325 . . . . 73.21 112.027 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.84 112.79 21.44 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.208 -1.034 . . . . 73.23 108.208 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.72 99.08 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 108.672 -0.862 . . . . 64.5 108.672 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 24.7 tptt -92.94 100.98 13.33 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.429 -1.322 . . . . 74.51 107.429 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -92.27 135.28 34.14 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.338 -0.986 . . . . 62.35 108.338 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.84 103.73 4.89 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.258 -1.016 . . . . 51.25 108.258 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -95.42 148.75 22.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.446 -0.576 . . . . 74.02 109.446 176.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -148.85 162.51 39.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.74 1.216 . . . . 71.53 107.976 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' C' ' 60' ' ' LEU . 10.2 t -145.65 137.14 25.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.344 0.657 . . . . 72.11 109.563 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.85 162.02 22.97 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.095 0.958 . . . . 61.42 108.985 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -139.31 143.78 38.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.894 0.477 . . . . 74.51 110.581 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -148.86 126.51 11.73 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.745 0.818 . . . . 74.43 109.518 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -88.29 120.22 29.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.539 -0.911 . . . . 71.24 108.539 173.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -91.2 -39.1 12.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.514 0.726 . . . . 63.21 110.699 -174.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.3 -175.54 5.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.477 -0.783 . . . . 61.21 110.305 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.6 105.39 1.51 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.028 0.931 . . . . 74.04 110.937 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 68.85 10.91 8.16 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.26 1.424 . . . . 73.41 112.979 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 76.2 t -105.34 113.71 42.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 64.32 108.341 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -117.5 160.47 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.056 0.942 . . . . 71.31 109.129 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.6 tt0 -127.58 146.69 50.45 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.055 1.342 . . . . 62.51 107.741 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.42 HG21 ' HG3' ' C' ' 103' ' ' PRO . 3.2 p -137.21 124.77 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.642 -0.873 . . . . 73.44 108.642 171.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.92 104.97 15.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.607 -0.886 . . . . 72.03 108.607 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.688 ' H ' HD23 ' C' ' 60' ' ' LEU . 0.8 OUTLIER -91.38 118.22 30.35 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.938 -0.393 . . . . 74.41 109.938 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -83.88 105.17 14.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.635 -0.876 . . . . 70.24 108.635 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.4 t -100.2 125.88 53.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.899 -1.149 . . . . 61.01 107.899 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 31.2 m -118.77 133.47 55.82 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.553 -0.906 . . . . 73.45 108.553 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.448 HG21 HG21 ' C' ' 114' ' ' ILE . 94.7 t -128.23 109.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.443 -0.947 . . . . 74.43 108.443 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 8.9 m -99.22 144.07 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.387 -0.968 . . . . 74.11 108.387 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.92 95.44 3.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.307 -1.738 . . . . 54.21 106.307 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -153.01 138.69 17.85 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.675 -0.491 . . . . 70.12 109.675 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.64 92.25 6.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.61 -79.31 1.26 Allowed Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.401 -0.818 . . . . 65.32 112.281 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -30.66 2.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.952 0.901 . . . . 74.14 110.617 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.62 102.59 0.93 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.754 0.821 . . . . 72.33 109.852 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -81.37 136.27 35.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.447 -0.797 . . . . 74.24 110.789 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.0 -55.45 3.68 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 55.2 107.485 163.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.67 175.07 9.15 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.844 0.831 . . . . 44.23 112.072 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.403 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -135.55 146.1 47.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.642 -1.984 . . . . 70.14 105.642 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.408 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.0 t -152.53 113.4 4.16 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.401 -0.592 . . . . 72.41 109.401 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -126.55 118.9 25.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.034 0.534 . . . . 63.42 109.852 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.84 134.05 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.825 0.85 . . . . 72.43 109.66 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.681 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -110.45 97.5 6.94 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.888 -1.153 . . . . 64.52 107.888 174.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -83.48 115.62 22.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.877 -0.602 . . . . 72.03 109.869 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.04 153.34 21.82 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.606 0.566 . . . . 61.43 111.775 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 119.99 0.97 Allowed Glycine 0 C--O 1.238 0.374 0 N-CA-C 111.195 -0.762 . . . . 74.3 111.195 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.7 mm -84.28 125.81 40.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.435 -0.95 . . . . 62.14 108.435 176.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.408 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.5 m-85 -137.62 135.08 36.26 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.967 0.907 . . . . 72.31 109.298 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -75.85 118.4 18.61 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.236 -1.024 . . . . 72.45 108.236 166.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 mm -122.29 110.0 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.802 -0.814 . . . . 55.21 108.802 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.77 165.18 31.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.658 0.783 . . . . 73.34 109.206 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.9 -50.54 3.96 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.404 -0.362 . . . . 72.33 112.22 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.73 141.89 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.705 0.802 . . . . 72.43 109.203 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -148.74 155.53 41.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.897 0.479 . . . . 74.31 110.862 -170.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.14 -145.41 28.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.865 0.728 . . . . 52.31 113.059 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.8 p -62.62 -28.33 69.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.996 . . . . 55.21 111.559 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -59.24 -49.0 79.53 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.535 0.734 . . . . 73.24 110.676 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -40.17 70.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 74.11 110.358 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.39 78.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.611 0.764 . . . . 73.41 110.904 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -70.97 -41.27 71.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.306 -0.861 . . . . 52.32 110.777 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.11 -51.71 65.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.664 0.386 . . . . 71.31 110.818 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.0 tp -75.87 -16.14 60.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.671 0.788 . . . . 73.21 111.087 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.89 3.32 31.89 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 119.511 -0.605 . . . . 53.44 114.113 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.37 -60.77 0.41 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.731 0.766 . . . . 51.43 110.851 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -68.44 -57.28 6.1 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.706 0.629 . . . . 73.0 111.835 -171.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.43 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 56.9 m -58.46 -45.95 99.65 Favored Pre-proline 0 CA--C 1.564 1.513 0 CA-C-O 118.415 -0.802 . . . . 74.52 111.901 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 44.3 Cg_exo -57.57 -37.12 98.1 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.278 1.985 . . . . 73.41 113.737 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -73.02 -26.55 61.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.767 0.427 . . . . 72.31 111.311 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 HH12 ' A' ' 111' ' ' ARG . 26.2 mm -65.56 -42.19 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.26 0.552 . . . . 75.45 109.587 169.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.3 mt -79.77 -19.26 49.06 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.651 -1.159 . . . . 74.13 111.882 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.5 -45.35 99.68 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.645 -1.169 . . . . 72.4 113.124 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 75.0 Cg_exo -52.91 -39.69 77.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.465 2.11 . . . . 74.21 113.262 172.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -68.98 -44.76 72.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.627 0.771 . . . . 74.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.02 99.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.216 0.606 . . . . 74.05 110.248 175.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -61.66 -49.41 76.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.84 1.256 . . . . 65.33 110.768 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.96 -33.83 74.34 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.684 0.615 . . . . 72.41 110.295 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -67.54 -37.33 82.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 75.43 110.975 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.448 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -71.54 -47.47 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.707 0.803 . . . . 74.52 110.631 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 41.6 m -67.07 -28.85 68.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.77 0.828 . . . . 72.01 111.076 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.1 t -68.61 -45.09 72.83 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.373 0.669 . . . . 71.41 109.442 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.58 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.91 -39.8 93.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.027 0.931 . . . . 63.14 111.941 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.31 -45.32 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.634 0.774 . . . . 72.15 109.917 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.1 t -64.92 -33.09 75.19 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.061 -0.972 . . . . 65.01 111.369 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -73.69 -33.59 64.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.596 0.758 . . . . 64.4 110.291 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.57 -3.98 90.14 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.55 0.531 . . . . 74.23 112.46 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 65.29 45.43 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.581 1.952 . . . . 71.22 112.182 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.4 m-85 -106.89 164.22 15.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-N 114.077 -1.42 . . . . 73.11 109.1 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 95.3 Cg_endo -72.33 179.65 4.84 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.752 2.301 . . . . 75.33 112.977 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -60.11 111.99 1.73 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.7 -0.682 . . . . 73.42 111.592 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.27 96.58 5.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 106.362 -1.718 . . . . 43.41 106.362 169.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.12 122.47 47.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.647 0.779 . . . . 74.43 109.511 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 57.0 mt -83.0 133.57 35.09 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.227 0.611 . . . . 55.15 109.402 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.74 143.19 78.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 123.509 0.506 . . . . 74.04 110.607 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -62.97 133.37 41.07 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.395 2.064 . . . . 64.14 111.726 175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 p -102.0 111.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.458 -0.941 . . . . 62.14 108.458 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -83.75 57.68 4.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.446 0.698 . . . . 73.41 110.389 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -76.88 -21.53 54.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.817 0.818 . . . . 72.03 109.232 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 . . . . . 0 C--O 1.242 0.707 0 C-N-CA 124.534 1.134 . . . . 72.32 110.951 172.424 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.504 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.9 tpt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 113.848 1.055 . . . . 74.34 113.848 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -148.18 142.3 26.03 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.449 1.1 . . . . 75.23 109.12 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -164.2 103.5 0.86 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.67 -1.233 . . . . 73.34 107.67 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.536 ' HG3' ' HB2' ' D' ' 85' ' ' SER . 5.2 pt20 -149.51 127.08 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.528 0.731 . . . . 62.01 109.569 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.502 HD12 ' O ' ' D' ' 83' ' ' ILE . 3.3 tp -84.26 110.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 73.11 109.353 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -73.36 -40.99 63.95 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.332 1.053 . . . . 72.43 112.036 -175.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.411 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 43.6 ttt180 -159.77 124.51 3.94 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.404 -0.221 . . . . 73.41 110.404 -166.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.509 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.2 mp -103.26 132.61 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 107.069 -1.456 . . . . 64.13 107.069 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 28.9 p90 -158.83 167.62 28.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.084 0.945 . . . . 71.4 111.724 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.425 HG21 HD11 ' D' ' 21' ' ' ILE . 73.6 p -102.52 120.21 40.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.038 -1.437 . . . . 74.12 109.426 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -87.63 -24.37 23.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 71.25 110.754 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.8 t70 -158.11 139.65 13.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.336 -0.847 . . . . 72.53 109.354 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.58 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.4 mt -139.82 144.88 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.828 -1.175 . . . . 54.32 107.828 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -149.77 144.82 26.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.141 0.976 . . . . 60.15 109.031 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.7 t80 -151.92 111.55 3.98 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.047 -1.834 . . . . 74.21 106.047 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.6 mt-10 -122.44 113.78 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.745 0.418 . . . . 53.14 110.527 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.61 81.22 54.48 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.983 0.913 . . . . 73.01 109.227 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . 0.447 ' HG2' ' ND2' ' D' ' 27' ' ' ASN . 58.8 Cg_endo -71.5 -37.56 5.41 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.619 2.213 . . . . 41.41 111.945 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' D' ' 26' ' ' PRO . 2.0 m-80 -103.72 38.53 1.79 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.983 0.913 . . . . 75.13 108.699 -175.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.7 -50.66 84.26 Favored Pre-proline 0 CA--C 1.575 1.904 0 N-CA-C 114.561 1.319 . . . . 63.01 114.561 -168.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.96 -12.72 4.89 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 121.757 1.638 . . . . 74.42 112.853 171.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -69.74 -40.07 76.41 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.625 1.17 . . . . 75.24 109.837 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.36 -18.13 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.139 0.576 . . . . 64.41 110.429 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -57.45 -35.53 70.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.362 0.665 . . . . 74.33 111.362 171.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -59.66 -25.28 64.6 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.91 0.756 . . . . 72.31 111.343 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -110.84 91.42 3.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.323 -1.362 . . . . 73.34 107.323 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.49 67.14 5.16 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 122.465 1.126 . . . . 45.33 110.929 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -128.3 158.23 38.75 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.791 -1.188 . . . . 61.03 107.791 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 20.9 mm-40 -84.73 118.23 70.54 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 122.849 0.459 . . . . 73.43 110.049 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.492 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 34.1 Cg_exo -64.59 158.76 48.19 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.845 3.03 . . . . 74.13 113.844 -172.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.2 tt0 -71.82 124.63 25.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.987 -0.745 . . . . 74.45 108.987 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.504 HG23 HG13 ' D' ' 64' ' ' VAL . 3.2 p -96.8 114.25 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.68 0.752 . . . . 73.05 110.088 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.575 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 8.9 tppt? -95.57 107.62 19.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.787 -1.19 . . . . 75.13 107.787 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -101.04 116.9 33.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.906 -0.405 . . . . 72.3 109.906 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.456 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.7 m-20 -116.66 124.85 50.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.739 0.816 . . . . 62.34 109.52 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.18 137.61 48.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.488 0.715 . . . . 74.53 110.108 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -146.33 146.71 30.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.899 1.28 . . . . 62.31 108.061 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -123.55 165.51 17.01 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.907 -0.405 . . . . 44.23 109.907 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -157.38 164.52 37.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.4 0.68 . . . . 70.24 109.789 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.0 p -156.22 153.4 29.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.01 0.524 . . . . 62.21 110.897 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 98.0 p -154.47 155.0 34.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 60.2 108.655 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -97.26 116.96 30.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.208 -0.664 . . . . 75.55 109.208 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' D' ' 57' ' ' GLU . 25.3 mt -92.5 -28.89 16.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.028 0.531 . . . . 72.11 110.123 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -164.19 -178.98 5.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.23 1.014 . . . . 70.34 110.623 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.36 117.12 8.16 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.548 -1.66 . . . . 61.43 110.513 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 63.18 21.25 12.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.26 1.424 . . . . 74.11 111.442 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 88.8 t -131.5 115.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 124.141 0.976 . . . . 74.01 109.137 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -132.74 130.27 39.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.511 -0.922 . . . . 63.51 108.511 -172.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.496 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.7 tt0 -86.54 138.08 32.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.62 0.768 . . . . 74.32 109.146 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.482 HG11 ' HD3' ' D' ' 103' ' ' PRO . 97.6 t -122.07 128.89 75.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.434 -1.321 . . . . 74.24 107.434 170.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 29.3 t -110.42 132.74 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.293 -0.632 . . . . 74.2 109.293 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.61 119.0 38.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.063 -1.088 . . . . 74.23 108.063 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.47 103.52 13.9 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.411 -0.959 . . . . 72.31 108.411 175.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.76 133.02 46.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.195 -1.039 . . . . 75.42 108.195 170.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 7.9 m -126.95 128.15 45.97 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.504 HG13 HG23 ' D' ' 40' ' ' VAL . 61.1 t -119.38 102.12 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.12 0.968 . . . . 70.0 108.658 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 96.0 m -106.19 100.89 10.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.613 0.765 . . . . 51.3 109.354 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -98.66 134.96 40.85 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.75 0.42 . . . . 71.12 110.11 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 40.8 p -146.32 140.15 26.22 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.613 -0.884 . . . . 73.24 108.613 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.62 119.13 25.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.529 -0.545 . . . . 62.35 109.529 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.1 -117.9 5.78 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.821 0.701 . . . . 73.01 113.238 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 5.33 46.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.88 . . . . 74.15 110.993 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.41 155.06 43.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.006 0.431 . . . . 73.53 111.434 -161.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.402 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 98.2 m -66.77 136.91 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.432 1.093 . . . . 62.12 110.726 174.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.35 -66.72 0.89 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.579 0.752 . . . . 64.25 109.526 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 151.22 26.23 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.629 0.772 . . . . 63.21 109.396 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.9 mt -118.95 154.25 33.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.889 0.876 . . . . 61.13 109.173 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 54.1 t -158.66 146.22 17.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.02 0.528 . . . . 73.14 110.894 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -156.52 137.77 13.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.65 -0.871 . . . . 53.23 108.65 167.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -135.31 116.21 19.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.41 0.684 . . . . 74.11 109.27 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 53.0 mt-30 -92.29 85.28 5.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.504 0.722 . . . . 74.31 109.059 171.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.84 100.83 8.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.805 1.242 . . . . 73.44 109.721 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 143.28 16.51 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.144 -0.382 . . . . 60.13 112.144 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.15 134.21 6.6 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.945 -0.462 . . . . 72.34 111.945 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.502 ' O ' HD12 ' D' ' 13' ' ' ILE . 60.1 mt -90.51 125.82 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.708 0.803 . . . . 71.11 109.142 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.23 129.26 49.7 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.446 0.699 . . . . 70.32 110.218 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' D' ' 12' ' ' GLN . 33.0 m -79.12 104.97 10.11 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 167.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.6 117.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.586 0.754 . . . . 63.45 110.09 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.97 43.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.612 0.765 . . . . 71.02 109.948 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 86.72 -20.79 22.03 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.086 -0.506 . . . . 23.13 114.292 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.26 144.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.738 0.815 . . . . 71.04 109.89 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -176.51 5.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.816 0.846 . . . . 60.12 110.256 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.59 -140.16 44.22 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.641 0.588 . . . . 40.34 114.188 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -63.03 -34.02 76.67 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.106 0.963 . . . . 60.45 111.397 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.48 -51.35 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.13 0.572 . . . . 73.32 109.743 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.82 -42.98 97.55 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.822 0.701 . . . . 75.11 111.256 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.63 97.07 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.827 0.704 . . . . 73.14 110.88 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -71.41 -34.27 70.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.811 . . . . 72.13 111.055 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.57 -48.05 76.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.746 0.418 . . . . 62.31 109.982 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -71.92 -18.19 62.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 122.797 0.439 . . . . 71.24 111.824 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.57 10.5 32.87 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.222 -0.765 . . . . 44.53 114.25 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.1 -64.22 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.948 0.874 . . . . 52.54 111.842 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -69.2 -40.1 78.23 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.409 0.683 . . . . 54.12 112.592 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.9 m -73.26 -44.84 7.88 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.478 0.711 . . . . 74.3 110.976 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.482 ' HD3' HG11 ' D' ' 58' ' ' VAL . 72.2 Cg_exo -54.85 -33.16 80.58 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.514 2.142 . . . . 55.52 113.694 166.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.16 -39.02 93.46 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.826 0.85 . . . . 73.12 109.948 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.15 -41.75 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.029 0.932 . . . . 74.53 110.868 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' D' ' 82' ' ' GLY . 93.5 mt -76.08 -20.16 57.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.406 -0.815 . . . . 74.22 112.27 -173.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -65.1 -41.96 57.46 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.789 1.033 . . . . 71.23 113.789 -170.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.29 -41.25 67.33 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.22 1.947 . . . . 60.41 113.317 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.9 m-85 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.766 0.826 . . . . 75.34 111.842 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -51.02 64.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 52.43 109.855 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -57.29 -44.52 84.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.557 -1.201 . . . . 70.34 111.332 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.48 -47.46 85.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.696 0.798 . . . . 71.33 111.528 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.15 -39.52 79.02 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.914 0.759 . . . . 53.45 110.972 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.7 -49.7 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.76 0.824 . . . . 73.5 110.842 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.433 HG23 ' HG3' ' D' ' 125' ' ' GLN . 30.2 m -57.06 -39.14 74.32 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.109 0.964 . . . . 73.23 111.578 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 36.4 t -65.89 -43.01 89.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.38 -0.827 . . . . 70.42 111.067 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.88 -35.16 74.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.813 0.445 . . . . 51.31 111.717 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.21 -40.92 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.27 -0.877 . . . . 64.34 110.315 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -71.19 -29.96 65.8 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.334 0.253 . . . . 53.11 110.886 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 93.8 mtt-85 -69.26 -32.82 72.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.044 0.538 . . . . 73.23 110.322 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.22 7.52 80.35 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.694 0.621 . . . . 74.22 113.0 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.4 p 53.71 36.08 22.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.787 1.635 . . . . 74.0 112.466 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -104.69 155.07 38.01 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.464 1.105 . . . . 75.34 109.815 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.55 141.15 97.13 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.416 2.744 . . . . 74.1 113.125 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.4 tt0 -54.46 133.71 45.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.398 1.079 . . . . 70.41 112.231 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.18 97.37 6.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.029 -1.1 . . . . 73.34 108.029 -173.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -108.58 108.94 20.04 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.578 0.751 . . . . 62.3 109.435 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.24 139.88 44.63 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.729 0.812 . . . . 75.35 111.3 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -68.95 145.59 96.78 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.937 0.895 . . . . 62.14 111.957 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 18.6 Cg_exo -69.07 104.38 1.2 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.23 2.62 . . . . 74.42 112.137 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.02 110.35 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.219 -0.66 . . . . 41.0 109.219 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -88.04 92.67 9.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.532 -0.914 . . . . 75.25 108.532 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 122.828 0.451 . . . . 75.25 110.561 178.515 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.0 m . . . . . 0 N--CA 1.475 0.821 0 N-CA-C 109.465 -0.568 . . . . 73.51 109.465 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HZ ' ' HG ' ' A' ' 102' ' ' CYS . 47.5 t80 -137.21 125.06 22.57 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.32 -0.993 . . . . 73.12 108.32 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -135.69 112.56 10.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.347 0.659 . . . . 75.12 109.721 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.8 mp -79.12 119.68 28.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.813 -1.18 . . . . 61.12 107.813 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 82.0 mm-40 -81.55 -41.51 21.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.651 0.594 . . . . 74.01 109.92 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.745 HH11 HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -173.47 163.96 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.319 1.048 . . . . 62.31 110.281 173.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' C' ' 130' ' ' PRO . 1.6 pp -144.03 101.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 64.7 m-85 -155.64 173.45 16.69 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.018 0.927 . . . . 72.35 109.886 -166.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.96 115.47 26.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.264 -0.425 . . . . 55.41 111.076 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -73.79 -44.74 55.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.967 -0.753 . . . . 64.13 108.967 171.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.8 t70 -135.78 148.35 48.73 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.757 -1.11 . . . . 75.11 110.368 -174.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.4 mt -145.13 142.75 22.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 126.021 1.728 . . . . 75.1 106.94 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -155.47 133.02 11.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.761 0.424 . . . . 72.32 110.403 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 77.1 t80 -127.28 131.11 50.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.241 -1.392 . . . . 74.14 107.241 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -129.24 126.51 39.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.235 0.614 . . . . 62.23 109.708 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 79.33 32.07 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.402 -0.962 . . . . 73.43 108.402 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.72 -11.87 20.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.771 2.314 . . . . 62.13 112.328 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -119.16 30.99 6.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.311 1.044 . . . . 73.14 109.112 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.27 99.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 N-CA-C 113.688 0.996 . . . . 62.41 113.688 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.17 -18.12 35.27 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 121.572 1.515 . . . . 60.41 113.277 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -80.12 -12.75 59.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.705 0.802 . . . . 75.14 112.765 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.12 -33.62 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 124.093 0.957 . . . . 73.43 112.806 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.27 -32.79 74.64 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.31 0.644 . . . . 74.34 111.637 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -90.72 -36.44 14.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 74.53 111.078 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.17 155.52 23.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.116 0.966 . . . . 75.34 111.517 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' HD11 ' A' ' 68' ' ' LEU . 7.6 m-20 -70.43 137.11 50.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.758 0.823 . . . . 60.12 110.007 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -88.36 61.66 6.28 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.87 -0.789 . . . . 61.11 108.87 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -142.45 58.56 7.6 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.972 0.909 . . . . 61.04 109.94 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.55 152.43 7.67 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.875 1.717 . . . . 71.45 112.208 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -93.28 117.51 30.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.583 -1.265 . . . . 73.5 107.583 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.68 136.25 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.971 0.508 . . . . 65.34 110.826 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -119.04 131.45 55.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.316 1.447 . . . . 65.13 108.913 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -97.53 152.2 19.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.986 -1.116 . . . . 72.12 107.986 170.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 62' ' ' VAL . 26.3 t70 -144.2 143.35 31.02 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.087 -1.079 . . . . 75.5 108.087 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -140.61 125.31 18.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.494 0.717 . . . . 64.13 109.837 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 12.8 t70 -132.54 142.91 49.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.047 0.939 . . . . 74.35 109.517 -177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.9 m -124.46 124.4 42.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.527 0.731 . . . . 75.45 110.404 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.56 8.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.362 0.665 . . . . 73.11 110.41 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.8 m -90.8 158.09 17.02 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.584 0.753 . . . . 60.34 109.585 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.5 t -162.13 118.35 2.01 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.085 0.402 . . . . 42.21 111.048 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.53 103.39 2.47 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.492 0.717 . . . . 72.03 110.74 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.766 HD11 ' HB2' ' A' ' 57' ' ' GLU . 48.2 mt -83.36 -34.54 25.59 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 71.41 110.862 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.36 -174.6 4.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.44 1.096 . . . . 43.43 108.908 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.84 96.32 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.433 0.458 . . . . 72.45 110.979 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.47 27.71 15.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.915 1.286 . . . . 73.32 112.278 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.18 113.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.784 -1.561 . . . . 74.31 106.784 168.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 49' ' ' SER . 22.7 m-85 -119.1 129.06 54.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.868 -0.79 . . . . 73.41 108.868 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.766 ' HB2' HD11 ' A' ' 51' ' ' LEU . 39.5 tt0 -83.32 114.99 21.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.906 -1.146 . . . . 65.14 107.906 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.85 111.26 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.314 -1.365 . . . . 73.05 107.314 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 80.7 t -97.16 136.11 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.353 1.061 . . . . 53.22 109.352 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -108.16 116.14 31.42 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.062 -0.718 . . . . 72.51 109.062 175.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -92.9 106.49 18.45 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.777 -0.823 . . . . 63.22 108.777 173.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 49.5 t -107.74 133.17 53.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.323 0.649 . . . . 72.21 109.666 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.1 m -121.95 138.96 54.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.574 -0.528 . . . . 72.25 109.574 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 114' ' ' ILE . 53.6 t -126.12 105.63 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.877 -1.527 . . . . 72.43 106.877 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.0 m -108.13 144.0 36.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.417 -0.957 . . . . 74.45 108.417 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.37 124.87 27.96 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.991 -1.115 . . . . 54.22 107.991 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -126.05 125.95 43.46 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.654 0.596 . . . . 72.44 109.829 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 35' ' ' ASP . 49.0 tp -91.86 73.3 5.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.035 0.934 . . . . 61.14 108.922 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.61 -92.12 0.78 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.715 -0.675 . . . . 74.52 112.847 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -98.84 -26.81 14.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.822 0.849 . . . . 72.32 111.23 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.37 138.01 44.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.575 0.75 . . . . 73.2 111.001 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -60.65 129.72 42.96 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.446 0.466 . . . . 71.41 110.202 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.86 -56.05 4.22 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.585 -0.524 . . . . 74.25 109.585 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.517 ' HE1' ' HG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -164.75 166.89 19.51 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.326 0.65 . . . . 61.02 109.77 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 76' ' ' CYS . 27.8 tp -143.79 146.4 33.07 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.201 0.6 . . . . 75.12 111.283 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.517 ' HG ' ' HE1' ' A' ' 74' ' ' PHE . 51.7 m -143.54 142.29 31.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.2 1.4 . . . . 73.14 109.88 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -148.45 123.53 10.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 70.11 109.602 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.18 130.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.609 0.764 . . . . 74.42 110.183 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 72.3 mt-30 -95.67 96.95 9.36 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.472 0.709 . . . . 64.31 109.57 168.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -83.21 93.94 7.78 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.026 -0.731 . . . . 74.22 109.026 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.2 144.4 19.24 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.823 -0.511 . . . . 63.54 111.823 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.37 122.25 2.03 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.445 -1.062 . . . . 65.41 110.445 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.745 HD12 HH11 ' A' ' 15' ' ' ARG . 33.8 mt -82.79 123.87 38.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.572 -0.899 . . . . 75.31 108.572 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -129.28 138.31 51.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.158 -0.682 . . . . 71.24 109.158 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.6 m -108.63 119.09 38.51 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.918 -1.141 . . . . 62.13 107.918 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.36 131.16 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 120.975 0.417 . . . . 65.22 110.829 -172.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.7 165.53 28.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.202 1.001 . . . . 61.41 110.88 -173.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.4 -33.19 6.38 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 116.063 -0.517 . . . . 72.01 112.86 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.85 178.26 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.085 0.954 . . . . 64.13 108.827 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 14.6 tt0 -161.64 -179.44 7.28 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 110.238 -0.282 . . . . 61.44 110.238 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.97 -147.96 40.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.561 0.585 . . . . 64.1 114.561 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -63.37 -26.76 68.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.371 1.068 . . . . 72.44 113.013 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.12 -41.05 82.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.194 0.598 . . . . 71.55 111.915 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.469 ' SD ' ' HA ' ' A' ' 90' ' ' GLU . 3.4 ptp -84.02 -33.86 24.42 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.717 -0.219 . . . . 62.3 111.39 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -24.15 67.77 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.227 0.537 . . . . 54.03 110.718 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -64.86 -54.49 30.17 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 70.41 109.984 164.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.6 m -65.73 -63.37 1.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.268 0.84 . . . . 71.21 113.268 -170.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.08 -8.07 34.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.862 0.756 . . . . 62.34 112.206 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.49 -4.0 40.47 Favored Glycine 0 C--N 1.36 1.911 0 N-CA-C 115.263 0.865 . . . . 61.31 115.263 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.02 -59.23 0.25 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.767 0.784 . . . . 51.44 111.025 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.0 t80 -53.46 -54.74 32.65 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 124.571 1.148 . . . . 71.44 112.949 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.576 ' HG ' ' HZ ' ' A' ' 11' ' ' PHE . 19.7 m -71.69 -42.02 10.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.384 0.674 . . . . 72.22 111.739 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.78 -39.02 78.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.463 2.109 . . . . 71.41 113.973 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -72.62 -24.45 61.07 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.367 0.667 . . . . 72.14 111.442 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.7 mm -69.13 -45.59 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.411 0.684 . . . . 71.34 109.407 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.31 -33.56 71.68 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.283 -0.871 . . . . 73.44 112.01 -173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.64 -44.7 92.34 Favored Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 114.56 1.318 . . . . 72.41 114.56 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.48 -32.25 96.02 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.111 1.874 . . . . 74.03 113.617 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.72 -32.46 31.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.423 0.689 . . . . 53.2 111.358 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.22 75.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.711 -0.477 . . . . 71.13 109.711 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -54.54 -49.05 71.21 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.67 1.231 . . . . 72.02 110.19 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.67 -51.46 69.68 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.162 0.914 . . . . 74.41 110.912 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.15 -45.56 79.59 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.192 0.933 . . . . 62.24 111.155 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 118' ' ' VAL . 5.7 mt -60.43 -58.49 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 74.43 110.189 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 125' ' ' GLN . 65.7 m -52.67 -40.5 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.988 0.915 . . . . 72.44 112.087 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.6 t -66.9 -43.24 83.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.212 -0.904 . . . . 74.23 109.981 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.452 ' SD ' HG23 ' A' ' 21' ' ' ILE . 10.9 mtp -58.36 -44.03 88.64 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.509 0.724 . . . . 60.32 110.954 174.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 114' ' ' ILE . 39.3 t -61.2 -46.0 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.626 0.77 . . . . 65.33 110.6 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.3 p -73.36 -30.66 63.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.34 -0.846 . . . . 74.23 111.111 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -69.75 -25.21 63.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.568 0.747 . . . . 73.03 109.782 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.95 0.02 84.08 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.649 -0.705 . . . . 54.41 112.682 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.0 m 69.98 12.19 7.79 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.823 1.249 . . . . 72.31 111.137 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -94.47 152.99 40.44 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 123.268 0.627 . . . . 74.55 110.37 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -54.11 120.45 7.97 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.776 2.317 . . . . 73.22 111.4 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.665 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.4 pt20 -60.08 160.22 8.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.961 0.904 . . . . 63.53 112.63 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.4 115.27 17.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.614 -0.884 . . . . 60.33 108.614 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.54 120.98 43.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.71 0.804 . . . . 74.21 109.194 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 64' ' ' VAL . 57.3 mt -73.36 135.38 44.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.753 0.821 . . . . 75.13 110.437 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.91 136.61 96.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.372 0.42 . . . . 65.41 110.569 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 29.7 Cg_endo -91.1 103.09 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.999 2.466 . . . . 61.32 112.311 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.3 t -121.1 116.04 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.028 -1.101 . . . . 64.24 108.028 176.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -69.83 106.48 3.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.474 -0.565 . . . . 72.24 109.474 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.59 -17.27 62.3 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.286 -0.87 . . . . 70.33 111.71 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.042 0.537 . . . . 71.03 111.479 174.857 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 11.7 ptm . . . . . 0 N--CA 1.494 1.746 0 N-CA-C 114.758 1.392 . . . . 75.12 114.758 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -155.85 136.2 13.12 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.813 1.245 . . . . 75.42 108.003 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.566 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 8.5 t80 -134.84 112.16 10.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.509 -0.552 . . . . 74.41 109.509 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -127.03 115.94 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.786 -0.82 . . . . 74.14 108.786 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.5 135.76 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 116.455 -0.339 . . . . 73.13 110.218 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -98.47 -50.14 4.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.61 -0.885 . . . . 75.14 108.61 169.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -163.1 142.31 8.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.068 -0.515 . . . . 71.22 110.696 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.426 ' HB ' HE22 ' D' ' 125' ' ' GLN . 81.2 mt -116.89 142.26 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 106.403 -1.703 . . . . 70.42 106.403 165.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -167.74 142.12 3.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.136 0.425 . . . . 73.23 111.374 -173.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -72.19 121.48 19.41 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.189 -0.914 . . . . 73.32 108.808 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.456 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.8 mtpt -97.07 -24.87 15.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.472 0.709 . . . . 73.21 110.729 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -156.66 138.13 13.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.863 -0.608 . . . . 72.31 110.28 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.5 mm -132.63 148.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.752 1.221 . . . . 63.52 107.963 173.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -150.22 142.33 24.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.294 -0.867 . . . . 75.12 109.162 165.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.1 t80 -146.57 114.2 6.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.076 -1.824 . . . . 72.23 106.076 168.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.92 114.35 20.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.806 -0.813 . . . . 73.31 108.806 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.597 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.45 85.59 1.81 Allowed Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.418 -0.956 . . . . 53.12 108.418 171.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.76 -20.81 29.64 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.827 2.351 . . . . 54.35 111.289 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.496 ' O ' HG23 ' B' ' 31' ' ' VAL . 80.7 m-20 -125.98 20.2 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.532 1.133 . . . . 73.11 110.577 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.597 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -37.81 -55.0 2.24 Favored Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 125.671 1.589 . . . . 73.14 114.415 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 8.5 Cg_exo -69.56 -20.11 36.21 Favored 'Trans proline' 0 C--N 1.392 2.847 0 C-N-CA 123.057 2.505 . . . . 63.13 112.903 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -96.59 -27.45 14.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.026 0.93 . . . . 54.24 112.442 -171.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 27' ' ' ASN . 64.2 t -67.22 -22.78 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.119 0.568 . . . . 73.42 110.916 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -57.33 -38.3 73.86 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.214 0.606 . . . . 74.32 111.499 171.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -73.6 -15.59 61.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.915 0.886 . . . . 74.22 111.731 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -104.17 108.86 20.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.529 0.732 . . . . 63.52 111.16 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -100.03 86.02 3.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.489 0.716 . . . . 73.24 109.949 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.638 ' HB3' HD21 ' B' ' 68' ' ' LEU . 22.3 t90 -165.75 157.98 14.81 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.893 0.877 . . . . 74.23 109.107 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.7 121.35 84.92 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.4 109.536 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 146.69 52.37 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.48 2.12 . . . . 55.24 112.811 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.39 103.52 2.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.2 0.6 . . . . 73.54 109.503 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.769 HG11 HD21 ' B' ' 126' ' ' LEU . 23.0 t -106.46 144.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.316 0.646 . . . . 64.12 109.838 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -145.17 131.07 19.15 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.159 -1.052 . . . . 70.52 108.159 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.476 HD21 ' HG ' ' B' ' 128' ' ' LEU . 7.1 mp -88.49 165.98 14.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.455 -0.572 . . . . 74.24 109.455 173.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -160.76 142.85 12.5 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.348 -1.352 . . . . 64.01 107.348 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.63 170.01 10.46 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.243 0.544 . . . . 70.21 110.72 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.4 t70 -142.14 126.37 17.52 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.683 -1.144 . . . . 51.43 108.281 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 p -107.93 103.94 13.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.602 0.761 . . . . 73.43 109.202 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.56 133.2 34.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.646 0.778 . . . . 63.11 109.699 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 8.6 m -140.13 164.97 28.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.548 0.739 . . . . 72.13 109.113 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -151.63 139.73 20.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.838 0.455 . . . . 61.22 110.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -81.84 112.53 19.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.938 -0.764 . . . . 72.14 108.938 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.19 -51.93 12.19 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.424 0.631 . . . . 75.42 110.016 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.9 -172.35 3.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.47 1.108 . . . . 54.22 109.527 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 124.33 23.99 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.992 -0.744 . . . . 73.14 108.992 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 63.38 22.08 13.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.318 1.047 . . . . 72.25 112.152 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -138.75 123.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.097 -1.075 . . . . 71.34 108.097 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.487 ' HE1' ' HB2' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -130.88 -179.51 5.36 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.662 -0.496 . . . . 73.04 109.662 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -142.39 109.65 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.04 -1.096 . . . . 71.05 108.04 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.58 124.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.755 0.822 . . . . 73.31 109.397 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.1 t -106.69 122.31 60.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 N-CA-C 109.487 -0.561 . . . . 75.04 109.487 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.36 112.17 23.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.131 -1.433 . . . . 72.31 107.131 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 52.6 ttt180 -102.02 126.19 48.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.743 -0.465 . . . . 64.33 109.743 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.81 111.1 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.309 1.044 . . . . 62.44 108.882 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -94.79 138.59 32.4 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.761 -0.829 . . . . 65.54 108.761 170.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.5 t -131.52 130.03 62.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.107 0.963 . . . . 71.01 108.414 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.9 m -125.54 138.41 53.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.325 -0.621 . . . . 74.43 109.325 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 137.45 32.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.556 0.743 . . . . 74.31 109.289 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.3 p -144.03 124.82 14.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.284 0.634 . . . . 61.32 109.957 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.638 HD21 ' HB3' ' B' ' 36' ' ' TRP . 3.0 tt -95.63 112.8 24.44 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.78 -1.192 . . . . 71.22 107.78 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.13 -111.51 3.28 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.914 -0.874 . . . . 74.54 110.914 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.98 15.69 9.99 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.067 0.947 . . . . 72.42 110.612 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.63 141.12 48.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.5 1.12 . . . . 74.12 108.665 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 71.5 m -61.4 134.49 56.97 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.325 0.511 . . . . 63.1 110.517 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.4 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.86 -58.11 2.59 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.376 -0.972 . . . . 63.15 108.376 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.44 159.1 30.53 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.778 -1.101 . . . . 75.12 109.765 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.02 145.78 51.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.364 -1.347 . . . . 54.13 107.364 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.2 146.1 22.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.307 -0.627 . . . . 65.14 109.307 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -158.7 125.25 4.68 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.714 -0.476 . . . . 73.55 109.714 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.57 150.22 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 72.41 109.36 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -127.05 102.47 6.99 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.03 -0.73 . . . . 72.42 109.03 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -89.82 104.02 16.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.889 -0.596 . . . . 74.33 109.586 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.0 170.38 37.72 Favored Glycine 0 C--O 1.245 0.809 0 O-C-N 123.551 0.532 . . . . 71.52 112.133 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.56 125.84 1.36 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.913 -0.475 . . . . 52.33 111.913 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.7 mt -86.36 119.36 34.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.639 -0.874 . . . . 73.03 108.639 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.487 ' HB2' ' HE1' ' B' ' 56' ' ' TYR . 47.0 m-85 -121.83 135.05 54.9 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -100.61 120.87 40.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.203 1.001 . . . . 73.32 108.669 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.09 109.55 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.629 0.771 . . . . 73.13 111.528 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.74 140.12 50.11 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.704 0.801 . . . . 64.13 110.382 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.01 -26.91 14.51 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 111.993 -0.443 . . . . 60.05 111.993 -170.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' B' ' 94' ' ' MET . 2.1 mp -63.95 131.97 29.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 125.339 1.455 . . . . 62.11 110.897 -176.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -159.79 143.58 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.214 0.946 . . . . 73.14 109.716 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.35 -117.86 11.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.831 0.707 . . . . 64.13 113.997 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . 0.579 ' HA ' ' HB3' ' B' ' 95' ' ' ALA . 39.3 m -65.88 -29.8 70.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.363 1.065 . . . . 73.4 111.898 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -49.9 -46.66 52.02 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 124.111 0.882 . . . . 73.52 111.064 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.52 ' HA ' ' HB3' ' B' ' 97' ' ' CYS . 9.1 ptm -94.18 -29.07 15.31 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.423 0.897 . . . . 74.14 113.423 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' B' ' 92' ' ' THR . . . -57.54 -28.86 63.89 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.912 0.778 . . . . 74.32 111.362 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.07 -32.72 17.41 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.257 1.023 . . . . 73.43 110.952 172.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.566 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 42.6 t -70.17 -66.82 0.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.923 0.489 . . . . 74.22 111.556 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.463 HD23 ' HE2' ' B' ' 56' ' ' TYR . 0.8 OUTLIER -63.77 -18.71 64.34 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 118.07 0.396 . . . . 71.35 111.773 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.44 -20.25 58.92 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 116.126 -0.488 . . . . 32.42 113.858 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.61 -58.7 0.16 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.398 0.599 . . . . 72.24 112.543 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.37 -51.7 61.97 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.943 0.72 . . . . 74.01 112.943 -167.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 75.2 m -60.71 -48.52 92.9 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.545 -0.74 . . . . 72.31 111.263 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 96.5 Cg_exo -50.14 -35.52 42.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.373 2.049 . . . . 74.12 114.797 167.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -35.67 78.99 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.355 0.525 . . . . 62.32 111.433 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.881 0.872 . . . . 70.54 110.1 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 74.6 mt -84.26 -20.49 32.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.793 -1.094 . . . . 71.03 112.401 -170.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -58.39 -48.94 96.05 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.047 -0.978 . . . . 73.25 113.311 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 76.9 Cg_exo -55.22 -39.76 89.29 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.571 2.181 . . . . 54.43 114.15 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.5 m-85 -65.89 -49.6 67.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.698 . . . . 74.41 111.257 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.86 96.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.678 0.791 . . . . 42.02 110.863 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.57 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.0 ttt-85 -63.11 -56.23 18.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.134 1.374 . . . . 72.34 111.457 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.89 -40.87 73.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.377 1.071 . . . . 72.23 110.83 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.543 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -65.93 -44.4 85.21 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.577 -0.283 . . . . 63.23 111.082 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.404 HD12 HD21 ' B' ' 128' ' ' LEU . 72.7 mt -60.52 -54.8 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 123.524 0.729 . . . . 74.21 110.992 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -58.36 -29.79 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.448 0.699 . . . . 72.44 111.501 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -70.16 -54.37 13.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.436 0.694 . . . . 73.31 110.131 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.3 mmt -63.2 -34.86 78.55 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.248 0.619 . . . . 74.12 111.866 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.8 -46.66 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.901 0.881 . . . . 62.22 110.902 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.44 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 80.4 p -73.58 -24.79 60.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.773 0.429 . . . . 73.11 111.714 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -63.42 -28.58 70.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.708 0.803 . . . . 74.41 110.637 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.99 17.28 59.55 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.249 -0.75 . . . . 53.11 113.631 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.2 p 70.19 13.35 7.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 126.231 1.813 . . . . 64.32 113.418 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -90.61 150.5 42.62 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 122.618 0.367 . . . . 72.51 110.373 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.8 159.13 18.31 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.363 2.709 . . . . 70.45 113.368 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.31 135.6 57.7 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.882 0.739 . . . . 71.41 110.112 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.769 HD21 HG11 ' B' ' 40' ' ' VAL . 1.3 tm? -108.61 110.91 22.48 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.796 -1.557 . . . . 72.24 106.796 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -91.62 94.25 9.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.798 -0.816 . . . . 64.41 108.798 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.57 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 5.4 mp -69.93 108.14 3.88 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.589 -1.263 . . . . 71.01 107.589 171.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.31 139.26 87.0 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.563 0.539 . . . . 72.45 110.081 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.49 82.72 0.68 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 122.194 1.929 . . . . 72.51 111.14 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 66.1 t -91.32 132.59 35.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 114.722 -1.126 . . . . 65.23 108.424 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -70.73 113.2 7.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.526 0.73 . . . . 53.13 110.299 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.12 -40.17 92.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.329 1.051 . . . . 71.23 110.788 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -61.42 -34.17 74.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.154 -0.93 . . . . 75.11 111.046 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.52 90.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.938 0.495 . . . . 64.53 111.163 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.559 1.316 0 N-CA-C 109.208 -0.664 . . . . 72.24 109.208 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 54.2 ttp . . . . . 0 CA--C 1.55 0.968 0 CA-C-O 121.885 0.85 . . . . 71.54 112.093 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -128.27 101.58 6.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.434 -1.321 . . . . 62.24 107.434 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.488 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -114.78 143.47 45.02 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.376 0.67 . . . . 65.33 110.181 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -147.84 144.62 28.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.274 0.629 . . . . 74.5 110.02 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -92.2 120.24 41.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.815 -0.809 . . . . 55.54 108.815 171.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -91.39 -38.32 12.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.53 0.332 . . . . 72.41 110.42 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.56 148.54 3.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.073 -0.343 . . . . 72.4 110.073 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -136.04 132.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.137 -1.06 . . . . 72.45 108.137 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.0 p90 -170.72 162.56 7.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.643 0.735 . . . . 54.44 112.09 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -87.39 117.35 26.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.826 -1.079 . . . . 54.02 110.203 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.508 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 6.8 mtmt -92.83 -7.52 46.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.411 0.284 . . . . 74.22 110.697 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.8 t70 -160.27 135.19 7.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.391 -0.966 . . . . 70.04 108.391 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.9 mt -149.05 139.11 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.014 -1.847 . . . . 72.44 106.014 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -158.92 151.04 21.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.063 0.459 . . . . 74.52 109.869 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.9 128.98 15.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.519 -1.289 . . . . 71.23 107.519 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.7 142.43 51.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.72 -0.844 . . . . 64.21 108.72 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -154.43 77.94 5.26 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.753 -0.832 . . . . 72.24 108.753 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 -30.5 22.87 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.48 2.12 . . . . 71.23 111.574 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' C' ' 72' ' ' THR . 37.4 m-20 -112.14 33.51 4.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.007 0.923 . . . . 75.43 109.371 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.556 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -54.29 -45.89 99.1 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.496 1.118 . . . . 71.01 113.583 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -75.57 -25.55 10.89 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.401 2.067 . . . . 74.2 113.4 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.13 -51.28 70.28 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.741 0.651 . . . . 73.01 111.256 -172.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.528 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 14.5 p -55.39 -25.53 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.423 1.089 . . . . 60.05 113.342 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -66.88 -42.82 84.93 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.84 0.456 . . . . 72.35 111.515 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -103.4 13.85 32.73 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.26 0.624 . . . . 73.52 110.29 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 24.3 ttpp -124.46 174.2 7.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.368 1.067 . . . . 72.4 109.434 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.415 ' N ' ' HG2' ' C' ' 34' ' ' LYS . 21.5 t70 -54.57 113.8 1.43 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.337 1.055 . . . . 43.22 110.958 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -86.85 64.97 8.77 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.879 0.847 . . . . 72.33 111.24 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -158.95 78.79 2.98 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.617 -0.883 . . . . 74.32 108.617 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -88.35 174.22 4.39 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.697 2.265 . . . . 74.51 111.574 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' C' ' 67' ' ' SER . 11.0 tp10 -85.8 107.63 17.73 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.052 -0.722 . . . . 65.33 109.052 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 57.4 t -74.96 99.98 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.274 -0.875 . . . . 71.44 108.988 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.8 tmtt? -107.41 103.22 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.292 -1.003 . . . . 70.24 108.292 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.643 HD13 ' H ' ' C' ' 42' ' ' LEU . 0.0 OUTLIER -87.25 155.37 20.1 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.141 -0.689 . . . . 72.11 109.141 173.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.1 t70 -150.95 143.82 24.55 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.998 -0.741 . . . . 63.15 108.998 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.98 145.72 48.39 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.467 -0.568 . . . . 73.15 109.467 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -156.99 149.98 23.78 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.78 0.832 . . . . 73.24 108.794 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -130.8 154.3 48.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.187 0.518 . . . . 74.2 110.214 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -140.8 171.13 14.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.022 . . . . 75.41 108.607 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 25.8 p -159.02 143.55 15.63 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.9 0.48 . . . . 65.05 110.35 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -149.84 128.02 12.03 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.859 0.863 . . . . 74.12 109.021 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.74 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.54 0.336 . . . . 71.43 110.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' C' ' 57' ' ' GLU . 31.7 mt -103.49 -30.12 10.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.835 0.854 . . . . 63.53 110.204 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.58 -178.43 6.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.88 0.872 . . . . 63.32 110.489 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -62.16 117.31 5.86 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.299 -0.864 . . . . 73.51 109.925 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.91 0.27 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.528 1.131 . . . . 75.04 113.171 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.2 t -103.8 114.81 44.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.215 0.531 . . . . 75.54 109.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -124.22 123.56 40.53 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.732 -1.21 . . . . 74.02 107.732 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.6 111.08 18.25 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.74 -0.837 . . . . 71.13 108.74 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.28 126.66 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.287 -1.005 . . . . 73.43 108.287 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 42.0 t -110.96 102.3 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.112 -1.07 . . . . 75.21 108.112 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.2 tm? -91.95 102.83 15.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.781 -0.822 . . . . 72.04 108.781 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -85.08 125.47 32.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.904 1.281 . . . . 63.21 110.866 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.2 t -119.27 141.73 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.313 1.045 . . . . 73.32 108.954 170.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.0 m -131.94 133.46 44.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.888 0.875 . . . . 70.44 109.256 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.737 HG23 HD13 ' C' ' 114' ' ' ILE . 93.2 t -116.74 117.18 54.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.345 -0.983 . . . . 74.0 108.345 167.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.43 HG23 HD23 ' C' ' 75' ' ' LEU . 13.9 m -105.15 141.92 35.84 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.597 -0.89 . . . . 53.12 108.597 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.02 93.04 2.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.176 -1.416 . . . . 75.42 107.176 176.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' C' ' 39' ' ' GLU . 59.6 p -161.85 131.84 4.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.874 0.47 . . . . 75.03 109.896 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.78 39.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.793 0.806 . . . . 74.35 109.911 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.89 -84.33 0.72 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.093 -0.803 . . . . 33.54 111.093 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.12 -31.34 17.14 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.712 0.805 . . . . 55.54 111.232 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -101.23 98.73 9.09 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.087 0.955 . . . . 73.02 110.252 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 32.2 m -88.88 118.31 28.5 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.96 0.504 . . . . 74.14 111.997 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -51.74 29.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.681 0.792 . . . . 62.13 109.071 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -162.52 174.72 12.29 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.98 -1.464 . . . . 73.24 110.621 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.4 tm? -145.56 146.39 31.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 73.22 105.773 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.451 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -151.4 132.64 14.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.715 -0.846 . . . . 63.14 108.715 175.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -141.38 134.47 29.22 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.431 -0.581 . . . . 73.24 109.431 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.19 140.4 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.032 . . . . 72.21 108.603 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.0 mt-30 -115.04 102.19 9.71 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.594 -0.891 . . . . 74.33 108.594 170.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.1 tp-100 -82.45 99.6 9.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.919 0.888 . . . . 73.31 109.552 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.65 144.85 22.43 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.317 -0.713 . . . . 53.42 111.317 174.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.27 118.94 1.35 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.211 -0.755 . . . . 73.1 111.211 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -80.97 122.17 35.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.984 -1.117 . . . . 60.53 107.984 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -135.54 154.57 51.33 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.014 0.525 . . . . 74.31 110.608 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -105.19 118.83 37.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.34 -0.985 . . . . 71.13 108.34 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.432 HG21 ' HG3' ' C' ' 94' ' ' MET . 3.8 mp -113.86 107.01 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.158 -1.423 . . . . 70.32 107.158 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.61 16.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.997 0.919 . . . . 64.23 110.341 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.92 -55.23 4.06 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.945 -0.57 . . . . 44.21 112.686 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.6 pp -110.02 175.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.731 0.812 . . . . 54.21 111.139 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.2 pt-20 -163.78 -176.21 4.5 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.795 -0.638 . . . . 73.3 110.78 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.23 -124.8 28.49 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.333 -0.394 . . . . 61.22 113.768 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -60.58 -36.76 79.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.122 0.969 . . . . 51.12 111.175 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -66.93 -42.18 85.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.621 -1.172 . . . . 71.53 110.991 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.507 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 58.8 ttm -71.84 -36.53 70.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.951 0.501 . . . . 74.14 110.385 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.27 94.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.282 0.633 . . . . 55.45 111.075 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.73 -27.62 66.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.603 0.761 . . . . 65.11 111.134 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 36.6 t -72.81 -62.46 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 110.047 -0.353 . . . . 74.24 110.047 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.23 -17.83 62.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.829 0.452 . . . . 70.4 112.126 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.61 -10.83 46.09 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.433 -0.649 . . . . 71.25 114.181 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.83 -56.18 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 117.874 0.837 . . . . 40.31 112.343 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -70.68 -49.43 47.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.14 0.576 . . . . 73.43 112.128 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.522 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.9 m -63.4 -46.36 84.51 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.358 0.663 . . . . 61.52 111.247 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.1 Cg_exo -55.54 -36.67 94.87 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.686 2.257 . . . . 74.53 114.73 169.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.508 HD21 ' ND2' ' C' ' 132' ' ' ASN . 28.2 t-20 -58.4 -38.7 77.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.356 0.662 . . . . 65.42 111.265 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.01 -41.94 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.116 -0.947 . . . . 75.21 110.403 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.65 -20.0 28.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.589 -1.187 . . . . 64.3 112.428 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.46 -50.55 87.43 Favored Pre-proline 0 CA--C 1.554 1.103 0 CA-C-O 117.772 -1.108 . . . . 74.05 113.147 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 -37.9 94.43 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.238 1.959 . . . . 62.22 113.365 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -67.92 -51.32 49.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.788 0.835 . . . . 75.32 111.605 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -59.64 -35.83 75.16 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.038 0.935 . . . . 74.5 110.891 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -65.39 -47.92 74.67 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.707 -1.588 . . . . 74.03 110.527 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.518 0.511 . . . . 74.05 110.234 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.3 t -69.0 -29.23 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.82 0.448 . . . . 72.41 110.817 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.737 HD13 HG23 ' C' ' 64' ' ' VAL . 80.1 mt -75.89 -49.02 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.701 -0.681 . . . . 72.44 109.945 169.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.525 HG23 ' HG3' ' C' ' 125' ' ' GLN . 54.1 m -52.83 -41.92 64.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 73.32 111.491 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.5 t -63.0 -49.02 76.3 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.303 -1.317 . . . . 74.34 109.377 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.516 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.76 -42.11 88.13 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.564 1.145 . . . . 73.4 112.959 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.34 -43.69 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 109.519 -0.549 . . . . 62.43 109.519 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.7 t -71.79 -25.88 62.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.001 0.92 . . . . 61.23 111.7 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.4 mtt-85 -71.44 -33.86 69.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.393 0.677 . . . . 73.01 109.577 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.4 11.2 56.64 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 124.041 0.838 . . . . 71.21 112.703 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.538 HG23 ' HB3' ' D' ' 17' ' ' TYR . 68.1 p 57.02 26.4 11.88 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.256 1.822 . . . . 71.4 112.918 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.417 ' HE1' HG11 ' C' ' 31' ' ' VAL . 69.0 m-85 -94.83 146.78 31.99 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.68 -0.859 . . . . 64.4 108.68 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -60.91 146.55 97.47 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.94 2.427 . . . . 72.02 112.647 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.525 ' HG3' HG23 ' C' ' 115' ' ' THR . 19.8 mp0 -59.1 125.37 23.31 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.837 0.855 . . . . 53.42 112.467 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -109.7 90.46 3.31 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.048 -1.834 . . . . 65.32 106.048 168.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -91.07 109.34 20.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.57 132.22 48.18 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.074 0.859 . . . . 72.33 109.713 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.89 132.58 89.43 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 123.558 0.536 . . . . 71.23 111.056 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.568 ' HG3' HD11 ' A' ' 16' ' ' ILE . 61.3 Cg_endo -69.75 102.81 1.07 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.905 2.403 . . . . 73.35 112.491 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 6.8 p -105.33 122.63 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.072 0.549 . . . . 72.01 109.853 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.508 ' ND2' HD21 ' C' ' 104' ' ' ASN . 15.6 m120 -109.12 81.54 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.567 0.747 . . . . 62.11 110.386 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -72.89 -31.8 64.94 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.806 -0.813 . . . . 75.02 108.806 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.539 0.549 0 CA-C-N 114.401 -1.272 . . . . 74.53 111.269 170.232 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.452 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 12.1 tpt . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 112.797 0.666 . . . . 70.22 112.797 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 92.5 m -143.05 141.59 31.33 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.096 0.958 . . . . 61.3 110.282 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -160.91 90.21 0.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.263 -1.755 . . . . 73.14 106.263 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -114.03 150.23 34.24 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.854 -0.612 . . . . 72.13 110.377 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.4 120.86 43.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.767 0.827 . . . . 73.03 109.057 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -100.27 -49.54 4.23 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.014 0.196 . . . . 74.24 110.575 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -167.81 118.72 0.83 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.559 -0.163 . . . . 73.15 110.559 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.04 134.26 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.065 -1.458 . . . . 74.12 107.065 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.538 ' HB3' HG23 ' C' ' 122' ' ' THR . 37.2 p90 -164.96 177.35 7.89 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.528 0.68 . . . . 64.1 111.705 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -97.43 124.16 41.52 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.181 -0.918 . . . . 63.04 109.053 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.3 mtpt -88.61 -27.54 21.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.61 -0.515 . . . . 65.35 109.61 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.3 t70 -150.06 145.09 26.17 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.426 -0.806 . . . . 72.43 109.784 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.516 HG21 ' HE2' ' C' ' 117' ' ' MET . 64.0 mt -144.99 149.08 17.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.411 1.484 . . . . 72.42 107.667 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -151.87 144.88 24.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.553 0.741 . . . . 64.45 109.528 171.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.4 t80 -154.1 123.81 6.69 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.089 -1.448 . . . . 61.31 107.089 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 49.1 mt-10 -131.36 142.5 50.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.252 0.548 . . . . 75.41 110.089 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.68 74.49 10.36 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.404 1.082 . . . . 74.21 108.144 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.4 -43.39 4.32 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 121.906 1.738 . . . . 73.23 110.937 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.448 ' O ' HG23 ' D' ' 31' ' ' VAL . 18.7 m-20 -92.17 25.49 2.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.601 1.16 . . . . 65.22 109.769 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HD2' ' C' ' 19' ' ' LYS . . . -54.64 -56.73 23.99 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.326 1.232 . . . . 71.23 114.326 -168.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.89 -19.09 18.47 Favored 'Trans proline' 0 C--N 1.386 2.553 0 CA-C-N 121.437 1.549 . . . . 72.23 112.089 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 21.3 t-160 -70.87 -36.76 72.95 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.018 1.327 . . . . 71.15 110.342 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' D' ' 73' ' ' ALA . 84.5 t -79.0 -33.98 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.38 0.672 . . . . 74.13 110.68 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -60.82 -20.83 62.39 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.737 0.643 . . . . 64.21 112.737 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.8 -32.96 74.89 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 64.42 110.621 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -91.52 105.91 18.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.25 1.02 . . . . 63.2 108.813 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.08 89.81 5.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.287 0.635 . . . . 71.31 109.595 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.595 ' HB3' HD11 ' D' ' 68' ' ' LEU . 41.5 t-105 -163.75 158.45 20.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.479 0.712 . . . . 73.41 109.854 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -87.66 115.13 61.93 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.917 0.887 . . . . 75.23 110.148 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -51.64 166.71 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 125.029 3.819 . . . . 64.33 116.667 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -98.22 113.24 25.1 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.439 -1.255 . . . . 72.44 108.316 177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.591 HG13 HG13 ' D' ' 64' ' ' VAL . 45.0 t -98.43 111.37 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.661 0.784 . . . . 53.34 110.767 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -86.85 117.36 25.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.796 -1.557 . . . . 71.45 106.796 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 tp -96.33 141.74 29.3 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.251 -0.648 . . . . 74.24 109.251 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.6 t70 -129.87 146.77 51.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.826 -1.175 . . . . 74.5 107.826 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . 0.485 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.9 pt? -125.94 141.69 51.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.347 0.659 . . . . 74.44 110.049 -171.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.3 t70 -157.74 150.84 23.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.835 0.854 . . . . 65.12 109.212 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -130.77 158.07 41.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 60.2 108.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.14 173.7 14.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.99 -0.55 . . . . 63.11 109.929 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.574 ' HB3' HD21 ' D' ' 98' ' ' LEU . 66.0 p -157.65 158.82 36.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.056 0.543 . . . . 43.42 110.745 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.31 118.27 2.25 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.215 1.006 . . . . 50.15 108.434 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -77.9 117.19 19.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.796 -0.816 . . . . 73.22 108.796 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.61 -35.07 14.45 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.861 -0.609 . . . . 55.54 110.406 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.17 -179.09 7.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.562 -0.745 . . . . 62.44 110.433 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.23 116.26 9.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.133 -0.939 . . . . 75.3 109.65 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.7 9.29 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.784 1.234 . . . . 63.24 112.502 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.26 114.29 46.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.629 -0.878 . . . . 71.34 108.629 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -125.04 129.42 50.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.15 0.98 . . . . 73.01 108.741 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.1 117.47 34.42 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 124.222 1.009 . . . . 73.51 108.664 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.495 HG11 ' HD3' ' D' ' 103' ' ' PRO . 43.6 t -100.52 135.82 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.243 -1.021 . . . . 71.14 108.243 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 84.5 t -113.72 146.56 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.74 0.816 . . . . 65.1 109.072 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.47 124.92 42.44 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.079 -1.452 . . . . 73.43 107.079 176.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.9 ttm-85 -104.68 105.13 15.09 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.71 -0.848 . . . . 74.02 108.71 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.17 103.08 14.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.844 -1.169 . . . . 71.34 107.844 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 37.8 m -102.08 129.14 48.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.249 0.619 . . . . 73.23 109.805 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.591 HG13 HG13 ' D' ' 40' ' ' VAL . 74.2 t -129.1 102.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.435 1.094 . . . . 54.23 109.15 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 61.8 m -102.07 108.09 19.41 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.433 -0.951 . . . . 50.05 108.433 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.37 141.85 41.14 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.081 -0.711 . . . . 54.12 109.081 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.1 p -147.56 126.4 12.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.394 -0.821 . . . . 63.22 109.58 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' D' ' 36' ' ' TRP . 30.8 tp -99.87 110.44 22.8 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.521 -0.918 . . . . 72.51 108.521 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.46 -124.09 6.39 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.402 -0.679 . . . . 73.33 111.402 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 5.67 46.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.287 0.635 . . . . 74.25 110.966 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.18 144.85 47.48 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.382 0.673 . . . . 71.1 111.319 -170.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -63.64 125.23 23.6 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.57 0.748 . . . . 71.31 110.551 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.41 -73.83 0.5 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.286 1.034 . . . . 65.22 109.648 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -144.17 138.02 27.84 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-O 121.246 0.546 . . . . 51.12 110.127 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.6 mt -103.08 148.14 26.09 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.257 1.023 . . . . 70.23 108.413 175.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.0 t -160.22 146.41 15.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.082 0.553 . . . . 72.12 110.381 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -157.18 127.6 6.47 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.063 -0.717 . . . . 65.44 109.063 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.429 HG22 HG23 ' D' ' 21' ' ' ILE . 67.7 t -126.73 115.89 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.857 0.463 . . . . 71.33 109.9 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.639 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.3 mt-30 -91.79 87.16 6.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.5 0.72 . . . . 71.01 109.181 170.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.43 108.44 12.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.566 -1.197 . . . . 75.34 108.81 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.43 141.69 15.4 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.693 -0.563 . . . . 33.31 111.693 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.408 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.41 130.49 5.13 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.045 -0.822 . . . . 53.21 111.045 -175.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.1 mt -88.97 116.45 30.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.701 1.2 . . . . 71.23 108.995 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -120.7 143.87 48.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.747 0.819 . . . . 73.32 109.237 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -98.29 96.84 8.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.905 -0.776 . . . . 75.51 108.905 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.65 109.16 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.401 -0.963 . . . . 54.55 108.401 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -140.66 168.65 19.29 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.14 0.976 . . . . 45.45 109.527 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.18 -15.09 30.01 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 114.189 0.435 . . . . 74.42 114.189 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -139.4 153.54 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.579 0.752 . . . . 64.31 110.144 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . 0.504 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -149.81 -170.24 3.59 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.778 0.831 . . . . 75.21 110.662 177.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.36 -142.33 26.98 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.002 -0.544 . . . . 61.24 113.843 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -73.94 -21.0 60.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.483 0.713 . . . . 70.34 111.762 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.35 -47.98 66.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.191 0.597 . . . . 72.34 110.273 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 23.5 ptt? -71.94 -27.27 62.68 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.349 0.406 . . . . 70.53 110.608 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.41 67.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.45 0.7 . . . . 55.3 111.25 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.6 t-80 -71.93 -29.32 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.593 0.757 . . . . 54.2 110.663 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.14 -43.45 78.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 110.327 -0.249 . . . . 63.2 110.327 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' D' ' 48' ' ' SER . 9.2 tt -75.36 -45.23 40.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.524 0.73 . . . . 61.12 110.712 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.73 6.97 79.87 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.769 -0.462 . . . . 52.04 114.063 -172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -147.09 -63.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.489 0.645 . . . . 63.11 111.8 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.6 -40.26 84.77 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.632 0.604 . . . . 61.43 112.632 -169.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.12 -44.66 14.09 Favored Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.413 0.685 . . . . 73.4 111.575 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.584 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.7 Cg_exo -54.66 -32.62 76.21 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 122.815 2.343 . . . . 72.53 113.448 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' D' ' 133' ' ' PHE . 4.1 t-20 -64.8 -36.62 84.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.178 0.591 . . . . 64.15 110.915 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.9 -42.82 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.577 0.751 . . . . 73.42 110.07 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.408 HD21 ' HA3' ' D' ' 82' ' ' GLY . 84.1 mt -76.8 -20.63 56.18 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.943 -1.026 . . . . 74.13 112.053 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -64.09 -45.73 79.81 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 114.55 1.315 . . . . 75.23 114.55 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 22.1 Cg_endo -59.16 -35.2 98.21 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.656 1.571 . . . . 73.53 112.683 174.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.9 -36.21 64.73 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.822 0.849 . . . . 72.53 111.601 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.35 -50.59 69.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.835 0.854 . . . . 73.41 109.947 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -55.76 -48.68 74.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.996 -1.456 . . . . 63.35 111.225 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -62.99 -45.88 90.33 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.637 0.775 . . . . 74.23 111.278 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.9 t -55.45 -39.28 70.11 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.942 0.776 . . . . 73.11 111.002 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.544 HG21 HD12 ' D' ' 126' ' ' LEU . 52.8 mt -66.62 -50.92 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.373 -0.83 . . . . 74.4 110.779 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.6 m -58.79 -38.5 78.7 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.898 0.749 . . . . 55.23 111.54 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 38.5 t -63.69 -44.87 92.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.268 -0.878 . . . . 73.23 110.538 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -67.47 -35.15 78.62 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.95 0.5 . . . . 71.1 111.538 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.22 -40.37 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.972 0.909 . . . . 72.5 110.672 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.52 -32.83 66.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 120.959 0.409 . . . . 74.02 110.718 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' D' ' 116' ' ' SER . 94.5 mtt-85 -67.39 -31.83 72.32 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.698 0.799 . . . . 74.15 110.204 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -87.93 6.07 84.0 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.896 0.747 . . . . 75.4 112.983 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' C' ' 17' ' ' TYR . 48.8 p 54.74 27.61 9.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 126.199 1.8 . . . . 73.35 113.408 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -92.25 159.9 36.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.43 1.092 . . . . 63.22 110.686 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.17 138.29 85.6 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.405 2.736 . . . . 62.35 112.259 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.426 HE22 ' HB ' ' B' ' 16' ' ' ILE . 51.6 tt0 -50.99 129.97 24.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.726 1.266 . . . . 65.3 112.758 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.544 HD12 HG21 ' D' ' 114' ' ' ILE . 2.7 tm? -115.9 95.74 5.26 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.32 107.714 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -133.83 114.58 13.5 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.872 -1.158 . . . . 52.23 107.872 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.6 148.96 40.3 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.652 -0.704 . . . . 64.52 110.417 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.79 162.93 64.58 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.997 -1.001 . . . . 71.21 109.966 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.34 154.94 49.43 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.255 1.97 . . . . 70.52 112.868 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.63 139.43 23.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 115.683 -0.69 . . . . 53.34 109.378 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -68.44 117.54 10.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.949 -0.759 . . . . 62.33 108.949 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' D' ' 104' ' ' ASN . 33.3 p90 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 123.982 0.913 . . . . 74.02 113.388 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m . . . . . 0 N--CA 1.467 0.383 0 N-CA-C 108.553 -0.906 . . . . 72.21 108.553 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.419 ' HZ ' ' SG ' ' A' ' 102' ' ' CYS . 1.2 t80 -139.76 114.84 9.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.625 -0.88 . . . . 75.05 108.625 167.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -155.63 137.29 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.24 0.616 . . . . 71.43 109.668 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.646 ' H ' HD12 ' A' ' 13' ' ' ILE . 2.5 mp -75.96 131.72 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.474 -0.935 . . . . 74.52 108.474 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 -35.79 12.52 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.808 0.276 . . . . 65.41 111.052 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 137.58 12.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 121.999 0.12 . . . . 75.15 110.821 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.438 HG13 HG21 ' A' ' 13' ' ' ILE . 2.3 mp -122.88 118.84 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.058 -1.46 . . . . 74.1 107.058 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 43.7 p90 -166.55 177.57 6.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.218 1.008 . . . . 74.13 113.031 -171.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -102.68 124.02 47.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.253 -1.34 . . . . 73.33 108.875 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.9 mtpt -91.58 -24.05 19.7 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.03 0.443 . . . . 73.41 110.071 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -153.21 138.26 17.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.937 -1.029 . . . . 71.14 109.308 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 74.5 mt -141.93 143.64 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.088 1.355 . . . . 63.23 107.593 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -155.8 139.16 15.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.343 0.592 . . . . 71.33 110.136 170.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -131.14 134.88 46.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.32 -1.733 . . . . 74.35 106.32 171.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.08 118.74 12.34 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.132 -0.692 . . . . 70.13 109.132 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.51 82.11 59.14 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 107.205 -1.405 . . . . 73.34 107.205 173.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.39 -29.8 20.31 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.171 1.914 . . . . 64.21 110.344 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.624 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.4 m-20 -110.14 31.69 5.7 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.904 -1.044 . . . . 72.11 109.598 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.547 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.58 -44.58 99.23 Favored Pre-proline 0 CA--C 1.565 1.525 0 C-N-CA 123.736 0.815 . . . . 75.53 112.276 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.64 -20.07 20.72 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 121.735 1.623 . . . . 75.13 112.786 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.4 m-70 -85.25 -20.01 30.74 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.851 0.461 . . . . 64.32 111.945 -171.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG11 ' HE2' ' A' ' 123' ' ' PHE . 9.8 p -71.61 -19.19 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 120.968 0.414 . . . . 71.13 111.297 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -78.73 -41.68 30.18 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.572 0.749 . . . . 75.03 110.745 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -75.95 -29.0 58.14 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.904 0.482 . . . . 64.03 110.63 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 33.8 mmtp -83.2 169.45 15.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.273 0.629 . . . . 75.32 110.543 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.14 128.96 37.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.557 -0.905 . . . . 75.23 108.557 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HH2' ' NH2' ' B' ' 15' ' ' ARG . 2.8 t90 -84.78 68.31 10.4 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.148 0.975 . . . . 71.22 108.6 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.36 76.38 10.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 114.226 -1.352 . . . . 75.34 107.638 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -85.52 166.83 10.43 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.298 1.999 . . . . 45.35 111.389 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.19 128.53 42.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.35 -1.352 . . . . 70.15 107.35 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.519 0.676 . . . . 73.15 110.358 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 1.7 ttpp -116.65 115.62 26.02 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.916 -1.142 . . . . 72.21 107.916 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.15 106.48 15.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.342 -0.984 . . . . 64.14 108.342 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.591 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -109.02 111.67 23.44 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.816 -0.809 . . . . 73.21 108.816 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.43 122.6 46.94 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.564 -0.532 . . . . 65.03 109.564 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -139.03 135.25 34.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.171 0.989 . . . . 61.13 109.399 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.8 m -107.52 138.57 43.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.278 0.631 . . . . 64.31 109.607 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.29 150.22 52.24 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.659 1.183 . . . . 63.53 108.012 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.2 m -124.38 161.18 26.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.144 0.497 . . . . 74.44 111.208 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 t -150.21 147.41 27.66 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.995 1.318 . . . . 64.34 108.768 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -112.85 124.52 52.78 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.947 -0.76 . . . . 62.32 108.947 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.72 -36.38 9.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.983 0.513 . . . . 71.04 110.471 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.69 -174.23 4.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.584 0.754 . . . . 62.43 110.2 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.39 117.57 8.81 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 24.8 m-20 67.89 5.26 4.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.531 1.133 . . . . 64.23 112.583 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -108.78 104.52 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.52 -1.289 . . . . 74.3 107.52 173.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -122.58 146.47 47.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.499 0.666 . . . . 72.33 110.714 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 112.58 15.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.185 -1.413 . . . . 72.53 107.185 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 98' ' ' LEU . 30.8 m -102.91 126.62 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.077 -1.082 . . . . 41.42 108.077 174.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.536 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.4 t -102.97 129.39 54.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.721 0.808 . . . . 72.12 109.342 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.401 HD11 ' HD1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -98.84 112.13 24.32 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.59 -1.263 . . . . 73.2 107.59 -177.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -103.17 106.89 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.638 0.775 . . . . 74.13 109.883 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.32 133.3 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.836 -1.074 . . . . 65.42 109.15 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.4 m -116.34 143.13 45.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.604 -0.888 . . . . 71.04 108.604 171.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 37.1 t -133.94 130.73 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.138 -1.43 . . . . 60.15 107.138 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -132.46 139.08 47.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.007 -0.368 . . . . 71.45 110.007 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.84 105.32 12.57 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.131 -1.063 . . . . 61.42 108.131 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -133.24 126.21 31.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.906 0.483 . . . . 53.23 110.525 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.12 86.33 4.56 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.14 -1.429 . . . . 74.32 107.14 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.99 -85.06 1.0 Allowed Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.448 -0.661 . . . . 73.15 111.448 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -118.1 -27.32 6.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 73.53 110.015 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.508 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -77.8 91.77 4.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.042 0.537 . . . . 75.41 109.853 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 85.1 m -73.79 105.97 5.31 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 122.894 0.477 . . . . 61.05 110.205 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.53 72.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.493 1.117 . . . . 43.53 110.061 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -161.35 173.07 15.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.078 -1.419 . . . . 70.41 111.548 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 76' ' ' CYS . 25.4 tp -142.06 147.97 37.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.67 1.588 . . . . 72.42 107.904 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.2 m -144.91 140.27 28.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.449 1.1 . . . . 70.42 109.266 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -149.55 120.32 7.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.32 -0.622 . . . . 71.33 109.32 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 113' ' ' CYS . 58.7 t -128.75 113.29 28.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.622 0.769 . . . . 74.15 109.684 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.8 mt-30 -89.88 90.89 8.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.552 0.741 . . . . 74.5 109.581 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.97 98.97 8.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.224 1.01 . . . . 75.23 109.007 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -98.55 144.58 17.31 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 112.152 -0.379 . . . . 55.11 112.152 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.86 132.44 6.03 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 110.994 -0.842 . . . . 70.23 110.994 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.0 mt -83.86 129.77 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.695 -0.854 . . . . 64.24 108.695 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -129.79 120.11 24.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.122 0.569 . . . . 70.13 109.703 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -82.8 110.85 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.88 -0.785 . . . . 75.11 108.88 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 22.3 pt -120.9 157.3 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.369 0.668 . . . . 75.23 109.973 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.93 146.64 1.56 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.471 0.708 . . . . 62.43 110.47 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.74 -25.39 23.6 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 114.963 0.745 . . . . 72.31 114.963 169.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.2 pt -109.9 134.85 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.674 0.737 . . . . 62.43 109.857 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.29 172.11 12.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.587 . . . . 70.02 109.965 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -132.95 44.51 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.213 0.321 . . . . 62.2 113.578 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 27.1 p -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.987 0.915 . . . . 65.3 112.228 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -63.98 -54.53 33.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.405 0.682 . . . . 73.23 110.38 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -24.82 39.98 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.542 -0.754 . . . . 75.34 110.785 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -70.9 -28.1 64.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.744 0.418 . . . . 72.42 111.011 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.31 -51.06 26.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.357 0.663 . . . . 73.12 109.784 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 6.1 m -73.84 -35.63 64.83 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.706 1.002 . . . . 74.23 113.706 -167.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB3' HG11 ' A' ' 58' ' ' VAL . 88.8 mt -87.4 -23.61 24.48 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.011 0.369 . . . . 75.25 111.003 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.15 -20.53 35.59 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 114.434 0.534 . . . . 61.42 114.434 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -138.05 -60.16 0.63 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.202 0.601 . . . . 54.24 111.59 -170.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 9.7 t80 -52.68 -56.28 16.59 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.411 1.084 . . . . 71.43 112.26 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.419 ' SG ' ' HZ ' ' A' ' 11' ' ' PHE . 82.2 m -74.49 -44.3 5.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.454 -1.26 . . . . 62.2 114.314 -171.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.38 -27.51 85.18 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.914 1.719 . . . . 61.34 112.439 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -73.86 -32.19 63.53 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 122.811 0.444 . . . . 70.23 110.663 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.6 mm -65.89 -42.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.706 0.802 . . . . 64.32 109.935 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.03 -18.39 60.34 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.128 -0.942 . . . . 60.22 111.292 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.401 ' HD1' HD11 ' A' ' 60' ' ' LEU . 24.6 t80 -70.92 -43.38 13.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.543 -1.218 . . . . 73.33 114.158 -170.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.526 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 32.1 Cg_endo -63.12 -27.51 73.35 Favored 'Trans proline' 0 C--N 1.383 2.38 0 CA-C-N 122.087 1.781 . . . . 71.13 112.363 172.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.44 -41.01 48.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.442 0.697 . . . . 74.51 111.7 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.88 75.7 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.994 -0.373 . . . . 54.12 109.994 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.441 ' NH1' HD12 ' C' ' 105' ' ' ILE . 39.0 ttm180 -55.29 -49.73 71.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.547 1.155 . . . . 73.55 109.873 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.03 -47.82 84.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.188 0.93 . . . . 64.11 111.176 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB3' HG11 ' A' ' 78' ' ' VAL . 34.4 t -65.1 -37.01 86.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.95 0.781 . . . . 72.2 111.637 -174.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.574 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 92.3 mt -67.21 -60.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.179 -0.674 . . . . 62.35 109.179 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.528 HG23 ' HG3' ' A' ' 125' ' ' GLN . 66.4 m -50.73 -37.35 41.21 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.84 1.338 . . . . 71.15 112.309 -176.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.9 t -69.38 -43.83 72.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.71 -0.677 . . . . 43.2 110.065 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 44.0 mtm -62.9 -38.64 91.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.798 0.439 . . . . 72.14 111.063 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 114' ' ' ILE . 87.0 t -57.66 -50.24 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.34 1.025 . . . . 65.41 110.005 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -73.7 -28.53 61.78 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.644 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -70.47 -27.73 64.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.495 0.718 . . . . 72.3 109.96 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 5.99 69.82 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.748 0.655 . . . . 61.22 113.331 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.522 HG22 HH21 ' B' ' 15' ' ' ARG . 6.5 m 64.87 27.98 12.78 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.833 1.253 . . . . 70.33 110.753 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG11 ' A' ' 31' ' ' VAL . 90.1 m-85 -97.45 153.85 38.21 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.455 1.102 . . . . 62.14 109.337 172.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -65.96 143.31 72.17 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.104 1.87 . . . . 60.22 111.37 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.528 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -59.07 137.67 57.85 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 124.191 0.932 . . . . 74.24 112.565 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.15 102.0 5.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.399 -0.963 . . . . 73.11 108.399 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.984 -0.747 . . . . 63.23 108.984 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.53 139.33 56.96 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 71.01 109.837 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.12 128.54 92.45 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 122.983 0.513 . . . . 73.33 111.226 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 2.7 Cg_exo -76.43 89.36 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.964 2.443 . . . . 60.02 112.456 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.61 115.02 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.808 0.843 . . . . 73.53 109.434 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.95 106.03 5.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.446 0.698 . . . . 75.32 110.314 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.97 -6.26 58.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.732 0.813 . . . . 73.02 111.978 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.49 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 2.0 m-20 . . . . . 0 N--CA 1.481 1.089 0 O-C-N 123.438 0.461 . . . . 75.32 110.519 169.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.51 ' HB3' HG23 ' B' ' 89' ' ' ILE . 22.5 ptm . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 116.216 1.932 . . . . 61.23 116.216 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.8 m -143.25 118.96 10.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.494 -1.685 . . . . 71.1 107.763 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -120.22 134.93 55.15 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.092 -0.707 . . . . 74.52 109.092 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -151.19 127.79 10.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.051 -0.722 . . . . 73.44 109.051 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.482 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -86.05 143.39 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.234 -0.654 . . . . 54.12 109.234 173.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -109.3 -48.46 3.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.032 0.533 . . . . 64.55 109.58 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.522 HH21 HG22 ' A' ' 122' ' ' THR . 16.0 ttt180 -158.17 149.91 21.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.463 -0.335 . . . . 63.13 110.948 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -127.96 144.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.594 -1.632 . . . . 73.33 106.594 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -171.66 147.12 2.25 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.493 0.317 . . . . 73.13 111.342 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -73.79 119.36 17.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.605 -0.887 . . . . 61.55 108.605 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -92.26 -33.69 14.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.966 0.506 . . . . 74.4 110.362 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.2 t70 -151.78 143.2 23.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.836 -168.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.1 mm -140.96 147.12 22.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.715 1.606 . . . . 72.11 107.59 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -150.33 140.27 21.93 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.888 -0.782 . . . . 52.22 108.888 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -145.65 125.2 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.506 -1.294 . . . . 74.32 107.506 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -128.54 122.46 31.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.685 0.794 . . . . 64.05 109.338 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.14 84.8 9.48 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.121 -1.437 . . . . 53.3 107.121 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.22 -31.53 35.58 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.646 2.231 . . . . 72.21 111.951 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -124.31 27.41 7.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.07 0.948 . . . . 50.34 110.138 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.751 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.14 -53.13 17.81 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 125.395 1.478 . . . . 74.32 114.741 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.21 -9.24 14.0 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.904 1.736 . . . . 74.03 112.891 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -95.68 -33.39 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.687 0.795 . . . . 63.22 110.54 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' B' ' 34' ' ' LYS . 8.7 p -81.36 -8.38 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.854 0.862 . . . . 60.32 110.379 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -59.29 -37.43 77.68 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.784 0.833 . . . . 74.33 110.232 171.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -69.83 -26.94 64.47 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.513 0.725 . . . . 71.32 111.168 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' HG23 ' B' ' 31' ' ' VAL . 84.7 mttt -87.02 97.45 10.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.205 0.602 . . . . 72.35 110.391 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.09 77.88 9.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.091 0.472 . . . . 53.33 110.352 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.479 ' HB2' HD11 ' B' ' 68' ' ' LEU . 17.1 m-90 -151.84 168.88 23.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.414 1.086 . . . . 75.45 108.283 176.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -86.41 115.73 63.24 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.795 -1.187 . . . . 74.33 107.795 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 30.8 Cg_endo -62.44 139.67 77.89 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.248 1.966 . . . . 51.41 111.195 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.1 104.06 0.68 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.036 -0.728 . . . . 53.31 109.036 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.435 HG11 HD23 ' B' ' 126' ' ' LEU . 27.2 m -92.05 158.52 2.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.109 -0.951 . . . . 74.34 111.56 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -149.04 118.84 7.05 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.286 -1.325 . . . . 61.31 108.551 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.95 148.87 25.15 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.027 -0.731 . . . . 74.12 109.027 163.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.87 110.27 2.86 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.57 -1.271 . . . . 64.14 107.57 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.436 HD22 HG11 ' B' ' 131' ' ' VAL . 5.6 mp -101.71 152.09 21.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.932 0.893 . . . . 73.25 109.85 -174.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.439 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 13.7 t70 -145.82 144.66 30.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.198 1.399 . . . . 62.31 108.42 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -114.05 141.14 47.83 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.342 -0.614 . . . . 75.52 109.342 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.69 154.92 49.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.014 0.926 . . . . 63.32 109.026 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -145.05 163.22 34.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.328 0.651 . . . . 74.54 110.781 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -152.47 139.26 18.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.476 1.11 . . . . 70.13 108.17 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -96.27 118.02 31.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.427 -0.583 . . . . 65.4 109.427 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -90.41 -39.81 12.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.691 -0.485 . . . . 74.34 109.691 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.92 -171.64 3.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.309 -0.86 . . . . 60.24 110.332 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.84 119.76 8.84 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 114.946 -1.024 . . . . 72.43 109.927 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.7 -1.73 1.56 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.575 1.15 . . . . 71.12 112.777 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.6 t -104.33 106.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.617 -0.882 . . . . 54.34 108.617 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.08 134.82 54.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.196 0.522 . . . . 74.53 110.224 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -100.32 97.43 8.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.482 -1.673 . . . . 65.11 106.482 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.29 124.5 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.853 0.861 . . . . 74.13 109.121 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.703 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 38.4 t -100.68 142.97 14.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.122 -0.696 . . . . 60.53 109.122 177.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -116.29 121.01 40.75 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.576 -1.268 . . . . 63.23 107.576 173.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.439 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 58.0 ttt180 -106.76 116.77 32.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.249 1.02 . . . . 64.51 109.545 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -114.79 120.23 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.963 -1.125 . . . . 75.21 107.963 171.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -116.03 133.36 56.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.227 0.611 . . . . 73.25 109.403 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.642 HG21 HG21 ' B' ' 114' ' ' ILE . 38.7 t -114.28 136.35 51.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.406 1.083 . . . . 74.3 110.586 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -125.1 145.18 50.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.672 1.189 . . . . 62.22 108.303 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.08 141.61 25.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.006 -0.738 . . . . 71.32 109.006 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.3 p -146.37 134.96 22.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.716 0.635 . . . . 73.04 109.829 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' B' ' 36' ' ' TRP . 14.4 tp -132.24 122.23 24.87 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.805 -0.813 . . . . 74.11 108.805 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.93 -128.21 8.32 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.868 0.73 . . . . 71.12 112.215 -174.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.67 19.62 20.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.519 0.728 . . . . 74.42 110.927 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -156.54 167.05 31.63 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.808 0.443 . . . . 60.54 111.83 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -70.56 136.39 49.24 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.406 -0.815 . . . . 74.23 110.275 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -89.71 -54.81 3.89 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.117 0.967 . . . . 61.11 109.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.73 167.58 29.12 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.267 -0.879 . . . . 75.25 110.971 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.57 145.12 34.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.868 1.667 . . . . 73.53 107.553 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -151.14 159.43 44.46 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.175 -0.676 . . . . 51.33 109.175 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.78 136.62 3.7 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.989 -0.745 . . . . 70.31 108.989 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.8 t -130.0 144.87 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.967 -0.753 . . . . 71.42 108.967 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.8 mt-30 -128.18 97.66 4.84 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.237 -0.653 . . . . 71.43 109.237 173.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -88.15 103.13 15.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.028 -0.987 . . . . 72.33 108.881 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.01 147.46 19.28 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.602 -0.599 . . . . 70.12 111.602 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.15 126.54 2.74 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.535 -0.626 . . . . 54.05 111.535 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -85.57 117.95 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.412 -0.958 . . . . 72.22 108.412 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -124.49 167.07 14.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 74.44 109.816 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -132.47 114.59 14.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.13 0.972 . . . . 75.04 109.157 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.2 pp -118.96 135.84 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.15 0.98 . . . . 62.32 110.429 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 166.66 32.4 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.732 0.813 . . . . 55.24 109.42 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.84 -61.79 4.71 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.267 0.355 . . . . 54.31 112.398 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.684 HD13 ' SD ' ' B' ' 94' ' ' MET . 1.1 pp -56.97 150.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.877 0.871 . . . . 61.44 112.802 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.53 164.01 36.52 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.69 0.796 . . . . 74.22 110.659 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -120.72 23.69 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.803 0.689 . . . . 71.44 113.312 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.2 m -67.95 -35.23 78.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.282 0.633 . . . . 64.02 111.588 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -68.91 -43.33 75.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.103 0.561 . . . . 71.44 110.726 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.684 ' SD ' HD13 ' B' ' 89' ' ' ILE . 5.3 tpt -67.85 -43.45 79.45 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.952 -0.567 . . . . 74.24 110.327 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.57 75.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.206 0.603 . . . . 63.31 111.899 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.44 -32.0 58.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.665 0.786 . . . . 74.5 110.776 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.81 -52.87 17.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.889 0.476 . . . . 64.43 111.225 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' B' ' 94' ' ' MET . 4.5 pp -69.71 -26.36 64.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.058 0.543 . . . . 71.3 110.786 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 3.15 63.24 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-O 119.246 -0.752 . . . . 53.03 114.839 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -154.11 -53.52 0.1 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.853 0.826 . . . . 70.03 112.138 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.6 -56.03 16.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.556 0.742 . . . . 54.51 111.206 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.9 m -61.51 -50.22 83.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.253 -0.879 . . . . 64.05 112.191 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.6 Cg_exo -55.06 -36.43 92.8 Favored 'Trans proline' 0 C--N 1.399 3.194 0 C-N-CA 122.287 1.991 . . . . 63.42 113.975 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.22 -33.82 76.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.65 0.38 . . . . 60.05 111.323 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.18 -44.61 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 60.11 110.446 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HB2' HD12 ' B' ' 60' ' ' LEU . 77.3 mt -83.29 -19.4 36.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.913 -1.04 . . . . 71.34 112.637 -169.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.41 -45.84 94.58 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 117.677 -1.154 . . . . 70.11 113.689 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.61 -43.25 46.51 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.656 2.238 . . . . 63.21 113.977 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 73.7 m-85 -65.94 -44.92 83.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.873 0.733 . . . . 71.13 110.506 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.55 87.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.656 -0.702 . . . . 74.14 111.06 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.69 -53.57 54.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.044 1.338 . . . . 74.11 110.953 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -40.68 95.21 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.722 0.639 . . . . 75.45 110.223 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.468 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -66.66 -33.26 75.26 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 123.814 0.696 . . . . 73.13 111.853 -174.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.642 HG21 HG21 ' B' ' 64' ' ' VAL . 71.3 mt -68.24 -52.63 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.398 -0.593 . . . . 73.51 109.398 172.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.5 m -59.12 -28.65 66.74 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 124.176 0.922 . . . . 74.23 111.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -66.99 -53.17 34.03 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 115.297 -0.865 . . . . 70.04 109.658 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.49 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 20.6 mmt -64.3 -34.72 78.78 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 123.455 0.472 . . . . 60.15 111.95 -176.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.78 -48.39 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.906 0.882 . . . . 74.42 110.665 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -72.41 -24.22 61.2 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.872 -0.604 . . . . 64.31 111.448 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -67.5 -32.68 73.67 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.359 0.664 . . . . 72.54 109.907 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.23 8.69 75.81 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.96 0.788 . . . . 64.0 113.282 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 17' ' ' TYR . 69.9 p 57.7 34.07 24.01 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.976 1.71 . . . . 73.03 113.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.22 156.27 39.07 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.808 0.843 . . . . 73.44 110.18 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 179.57 0.55 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.124 2.549 . . . . 74.11 113.542 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -56.68 113.88 1.82 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.501 -0.772 . . . . 75.42 111.254 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.435 HD23 HG11 ' B' ' 40' ' ' VAL . 3.2 tm? -129.22 100.91 5.78 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.486 -1.672 . . . . 73.04 106.486 172.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -131.44 134.11 45.87 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.691 -0.855 . . . . 74.1 108.691 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.3 132.93 35.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.553 0.741 . . . . 73.04 110.419 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.69 154.0 81.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.047 0.939 . . . . 73.53 110.151 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.401 ' HD3' HD13 ' D' ' 16' ' ' ILE . 35.8 Cg_endo -59.98 114.18 1.97 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.931 2.421 . . . . 51.4 111.845 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.436 HG11 HD22 ' B' ' 44' ' ' LEU . 90.7 t -90.0 118.15 34.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.644 -0.707 . . . . 55.3 109.998 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.91 93.47 3.78 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.292 -0.632 . . . . 74.42 109.292 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 91.6 m-85 -62.65 -35.76 80.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.673 -1.149 . . . . 71.04 110.858 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -63.69 -39.53 94.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.516 -1.22 . . . . 63.45 110.961 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.61 -27.48 58.49 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.705 0.628 . . . . 62.12 111.807 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.479 1.001 0 N-CA-C 109.121 -0.696 . . . . 71.32 109.121 178.555 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 57.1 ttp . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.747 0.308 . . . . 64.23 111.305 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -85.92 93.43 8.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.218 -0.66 . . . . 74.21 109.218 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.458 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.9 t80 -118.97 123.56 44.87 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.983 -1.008 . . . . 72.4 108.392 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -137.84 140.96 40.76 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.707 0.403 . . . . 72.44 110.068 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.608 HD11 HG13 ' C' ' 16' ' ' ILE . 5.6 tp -85.27 136.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.128 0.571 . . . . 74.23 109.854 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.7 mm-40 -109.55 -50.64 2.96 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.615 -0.721 . . . . 74.14 109.74 174.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -169.02 138.65 2.18 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.655 -0.702 . . . . 73.51 109.41 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.608 HG13 HD11 ' C' ' 13' ' ' ILE . 88.4 mt -122.39 144.57 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.6 -1.259 . . . . 73.44 107.6 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.5 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -174.24 165.26 4.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.364 0.602 . . . . 75.21 110.612 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.411 HG22 HE22 ' C' ' 80' ' ' GLN . 81.4 p -85.04 107.35 17.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.997 -1.001 . . . . 72.24 109.802 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.423 ' HZ3' ' HD3' ' D' ' 29' ' ' PRO . 23.6 mmmt -65.86 -35.03 79.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.761 -0.654 . . . . 74.44 109.877 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -150.53 144.4 25.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.98 -1.009 . . . . 74.24 109.549 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.3 mt -139.28 140.45 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.64 -1.615 . . . . 74.25 106.64 172.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.43 147.6 17.56 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.799 -0.445 . . . . 74.31 109.799 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -147.32 116.67 6.98 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.192 -1.04 . . . . 72.54 108.192 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.94 120.44 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.77 0.828 . . . . 74.53 108.99 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -124.2 85.58 54.96 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 73.15 108.583 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.12 -32.58 33.82 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.725 2.284 . . . . 75.32 111.595 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 73.6 m-20 -114.56 38.4 3.11 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.023 0.929 . . . . 70.25 109.422 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.83 -50.98 85.09 Favored Pre-proline 0 CA--C 1.569 1.682 0 N-CA-C 114.333 1.234 . . . . 64.21 114.333 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.2 Cg_exo -73.6 -28.59 11.7 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 121.871 1.714 . . . . 74.1 111.554 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.407 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 80.5 t60 -68.0 -20.67 65.04 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.33 1.052 . . . . 64.31 112.583 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -62.07 -16.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 118.117 0.417 . . . . 74.14 111.827 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.43 -43.53 76.93 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.492 -0.558 . . . . 71.33 109.492 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -92.07 51.24 1.77 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.62 1.168 . . . . 75.12 109.379 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.01 148.11 47.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.099 0.56 . . . . 71.23 110.997 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.47 129.28 37.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.19 -1.041 . . . . 72.45 108.19 164.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -83.93 69.5 10.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.799 0.809 . . . . 74.44 110.738 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.63 73.19 13.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.103 1.361 . . . . 71.54 107.46 165.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.59 118.87 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.215 1.943 . . . . 64.24 111.419 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.52 116.11 22.95 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.388 -0.968 . . . . 71.15 108.388 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.44 101.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 114.743 -1.117 . . . . 51.03 108.827 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.45 103.9 16.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 74.31 108.258 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.26 133.15 33.71 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.187 -0.671 . . . . 64.41 109.187 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.5 t70 -119.63 143.64 47.57 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.763 1.225 . . . . 73.51 108.148 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.22 148.94 49.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.668 0.787 . . . . 74.21 109.173 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -156.18 150.79 25.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.657 0.783 . . . . 62.33 109.034 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -133.88 146.59 50.71 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.849 0.46 . . . . 70.04 110.236 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.99 144.8 30.34 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.5 -0.926 . . . . 74.13 108.5 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.3 p -126.99 147.04 50.13 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.156 0.583 . . . . 40.31 110.172 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -147.14 127.81 14.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.068 0.947 . . . . 54.43 108.941 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -81.41 117.62 22.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.232 -0.655 . . . . 74.11 109.232 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 23.8 mt -87.94 -40.63 13.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.566 0.747 . . . . 74.15 109.974 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -150.37 -177.42 5.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.806 -1.088 . . . . 74.24 110.282 -177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.83 109.43 1.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.512 -1.222 . . . . 71.24 110.11 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 70.22 7.67 6.32 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.165 1.386 . . . . 70.24 112.895 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 70.4 t -110.32 105.74 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.352 0.661 . . . . 73.35 109.593 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.99 129.06 56.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.195 0.998 . . . . 72.12 109.989 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.9 tt0 -85.61 143.78 28.25 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.157 -0.683 . . . . 72.45 109.157 165.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.437 HG13 HD11 ' C' ' 106' ' ' LEU . 5.0 p -132.07 134.95 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.094 -1.076 . . . . 72.43 108.094 169.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.74 105.92 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.352 -0.981 . . . . 73.04 108.352 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.97 108.01 19.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.756 -1.201 . . . . 61.02 107.756 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -79.05 123.48 27.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.21 1.004 . . . . 64.14 109.136 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.88 122.33 68.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.843 -1.169 . . . . 55.22 107.843 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 19.7 m -125.62 123.87 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.62 HG23 HD13 ' C' ' 114' ' ' ILE . 97.4 t -105.0 123.6 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.516 0.726 . . . . 54.42 109.107 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -113.96 115.0 26.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.701 -0.852 . . . . 73.33 108.701 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.785 -1.561 . . . . 70.32 106.785 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -154.71 -178.11 6.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.498 0.555 . . . . 74.23 112.498 -166.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -134.3 29.99 3.6 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.198 1.399 . . . . 61.41 107.784 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.35 -108.14 1.31 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.02 -0.991 . . . . 52.24 110.972 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.34 -31.39 18.94 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.598 -0.89 . . . . 72.41 108.598 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.95 91.79 0.21 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.743 1.217 . . . . 71.3 109.839 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.3 m -89.71 128.19 36.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.417 -0.811 . . . . 53.4 111.063 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 -58.45 3.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.058 -1.09 . . . . 71.31 108.058 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.33 144.59 22.07 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.051 -0.977 . . . . 73.54 110.747 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.458 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -105.04 145.75 30.03 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.662 -1.607 . . . . 72.15 106.662 163.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.458 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -150.42 143.23 24.66 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.182 -0.673 . . . . 72.11 109.182 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.09 131.9 17.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 71.45 109.95 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.86 123.52 62.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.684 -0.858 . . . . 75.44 108.684 168.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -97.84 104.33 16.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.037 -1.097 . . . . 75.42 108.037 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -91.98 114.47 27.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.17 0.588 . . . . 73.24 109.64 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.72 146.69 17.23 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.918 -0.473 . . . . 62.53 111.918 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.562 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.45 123.36 2.15 Favored Glycine 0 CA--C 1.505 -0.554 0 N-CA-C 111.302 -0.719 . . . . 72.04 111.302 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.539 HD12 HD11 ' C' ' 51' ' ' LEU . 7.1 mm -83.49 122.92 38.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.424 -0.954 . . . . 73.23 108.424 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -134.75 125.22 26.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.799 0.839 . . . . 71.5 109.633 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -80.48 109.47 15.02 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.35 -0.611 . . . . 52.4 109.35 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 60.3 mt -114.99 120.63 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.838 0.855 . . . . 71.44 109.567 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.66 163.17 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.367 1.067 . . . . 75.14 109.847 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.27 -36.41 3.42 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.283 -0.417 . . . . 50.32 112.385 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -112.75 141.23 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.647 1.179 . . . . 62.03 109.631 -173.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.95 156.39 42.2 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.615 0.766 . . . . 64.34 110.33 -175.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 -141.63 20.43 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.167 -0.47 . . . . 62.3 113.379 172.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -64.77 -28.66 69.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.805 0.842 . . . . 74.31 111.503 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.93 -46.39 89.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.871 0.868 . . . . 73.21 109.997 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.53 -35.24 75.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.985 -1.007 . . . . 63.04 110.259 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.16 -27.33 67.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.536 0.734 . . . . 72.3 111.654 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.29 -57.58 8.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.198 0.599 . . . . 73.33 110.439 171.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.0 -41.57 98.21 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.822 0.701 . . . . 75.01 111.195 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp -76.79 -27.18 55.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.413 1.085 . . . . 52.3 110.997 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.19 -5.32 46.7 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-O 119.378 -0.679 . . . . 63.15 114.325 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -135.32 -56.68 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.706 0.753 . . . . 64.34 111.59 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -68.98 -54.13 16.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.973 0.36 . . . . 71.14 111.973 -173.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 21.7 m -59.83 -46.29 98.33 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.673 -0.68 . . . . 62.01 111.317 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 56.6 Cg_exo -50.21 -39.53 52.12 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.106 2.538 . . . . 72.02 114.714 167.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.49 -23.9 61.89 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.296 0.638 . . . . 71.42 112.183 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.441 HD12 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -75.4 -33.17 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 109.596 -0.52 . . . . 74.22 109.596 172.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.562 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.7 mt -82.61 -28.36 30.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.152 0.981 . . . . 74.54 112.56 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.04 -46.16 99.89 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.535 -1.222 . . . . 73.24 113.586 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 73.9 Cg_exo -54.36 -41.63 74.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.236 1.957 . . . . 70.24 113.609 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.98 -46.31 68.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.523 0.729 . . . . 70.2 110.571 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -61.13 -40.64 94.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.512 -0.767 . . . . 72.12 111.17 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -62.26 -51.97 65.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.2 -1.364 . . . . 75.24 110.728 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.62 -31.29 70.35 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 123.607 0.567 . . . . 74.12 110.175 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.422 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.5 t -71.29 -29.88 65.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.886 0.474 . . . . 51.23 110.963 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.62 HD13 HG23 ' C' ' 64' ' ' VAL . 88.0 mt -74.32 -50.54 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.464 -0.569 . . . . 72.31 109.464 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -56.69 -33.69 66.69 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.17 0.988 . . . . 50.24 111.112 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -51.43 55.58 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.648 -1.16 . . . . 74.02 109.674 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.22 -33.87 71.51 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.631 0.772 . . . . 72.12 112.493 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.7 t -67.22 -48.26 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 73.43 109.717 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 70.0 p -70.61 -26.83 63.68 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.343 -0.844 . . . . 73.14 110.654 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -70.78 -34.57 71.92 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.048 -0.978 . . . . 73.34 109.766 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.01 86.89 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.216 -0.769 . . . . 42.45 113.083 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.484 HG23 ' HB3' ' D' ' 17' ' ' TYR . 73.2 p 58.04 35.13 24.94 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.88 1.672 . . . . 73.33 111.91 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -97.73 164.46 17.45 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.096 1.358 . . . . 74.1 110.451 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -53.7 142.02 62.83 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 123.528 2.818 . . . . 64.13 113.568 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.7 115.58 3.75 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.427 1.091 . . . . 63.13 110.325 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 63.0 tp -111.57 124.03 51.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.494 1.118 . . . . 74.21 110.446 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -133.88 120.86 20.93 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.835 0.854 . . . . 71.41 109.924 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.65 140.69 29.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.328 0.651 . . . . 70.15 110.845 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 148.88 50.0 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 123.86 0.864 . . . . 63.23 110.092 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.52 145.57 37.89 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.305 2.003 . . . . 74.33 112.194 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.77 110.62 25.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.835 -1.172 . . . . 52.02 107.835 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -90.85 58.23 3.77 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.724 0.773 . . . . 71.31 109.861 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -80.97 -46.36 15.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.827 -1.079 . . . . 75.44 108.609 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 17.2 t70 . . . . . 0 C--N 1.354 0.765 0 CA-C-N 115.393 -0.821 . . . . 72.51 109.796 175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 114.513 1.301 . . . . 42.32 114.513 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.4 m -119.97 142.05 49.11 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.794 0.837 . . . . 72.24 108.919 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' D' ' 85' ' ' SER . 83.2 t80 -150.35 108.8 3.79 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.558 -0.904 . . . . 73.21 108.558 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.41 131.52 51.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.781 0.833 . . . . 75.14 109.995 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.74 104.79 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.843 -1.169 . . . . 72.4 107.843 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -79.39 -47.65 15.38 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.98 0.733 . . . . 71.21 112.98 -170.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -159.2 121.16 3.43 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.369 -0.234 . . . . 71.54 110.369 -165.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.406 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.9 mp -105.47 129.34 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.459 -1.312 . . . . 64.32 107.459 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.484 ' HB3' HG23 ' C' ' 122' ' ' THR . 38.7 p90 -165.87 178.09 6.73 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-O 121.876 0.846 . . . . 70.44 112.153 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.472 HG21 HD11 ' D' ' 21' ' ' ILE . 70.8 p -107.82 125.58 51.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.536 -1.211 . . . . 71.15 109.488 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 28.5 mtpt -97.87 -22.3 16.43 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.608 -0.516 . . . . 65.51 109.608 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -152.03 131.63 13.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.78 -1.1 . . . . 75.24 108.835 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.574 HD13 ' HE3' ' C' ' 117' ' ' MET . 84.2 mt -134.89 142.69 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.53 -1.285 . . . . 74.12 107.53 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 24.2 t -146.77 139.27 24.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.102 0.961 . . . . 62.54 108.45 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.43 116.89 5.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.187 -1.783 . . . . 62.51 106.187 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.3 mt-10 -121.26 140.28 52.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.065 0.546 . . . . 75.22 109.602 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -146.97 78.89 10.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.377 -0.972 . . . . 73.24 108.377 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.67 -32.31 6.04 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.37 2.047 . . . . 64.45 111.546 175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.477 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 17.6 m-20 -100.71 31.15 3.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.525 1.13 . . . . 62.24 108.839 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -59.6 -47.63 97.27 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 115.023 1.49 . . . . 64.05 115.023 -169.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HZ3' ' C' ' 19' ' ' LYS . 33.8 Cg_endo -88.87 -3.99 6.24 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.637 1.558 . . . . 75.12 112.591 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.534 ' HA ' HE21 ' D' ' 33' ' ' GLN . 21.0 t-160 -77.2 -40.95 43.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.326 1.05 . . . . 71.33 109.491 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' D' ' 73' ' ' ALA . 61.7 t -79.29 -15.89 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.677 0.791 . . . . 72.03 110.201 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -65.68 -25.99 67.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.596 0.758 . . . . 70.12 110.888 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.534 HE21 ' HA ' ' D' ' 30' ' ' HIS . 45.5 mt-30 -73.62 -17.96 61.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.396 0.678 . . . . 62.4 111.334 174.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -105.73 106.41 16.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.704 0.802 . . . . 64.41 109.452 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.96 51.37 2.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.792 0.837 . . . . 65.11 110.317 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -131.64 162.55 30.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.444 0.697 . . . . 75.14 109.622 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.33 110.51 29.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.302 1.041 . . . . 74.1 109.33 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' D' ' 68' ' ' LEU . 90.5 Cg_exo -49.21 150.98 6.78 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 124.132 3.221 . . . . 73.25 115.117 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -75.55 132.75 40.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.977 -0.749 . . . . 74.32 108.977 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.4 124.99 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.275 0.559 . . . . 73.52 110.633 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -110.49 110.71 21.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.019 -1.845 . . . . 73.35 106.019 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.9 tp -96.14 137.4 35.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.112 0.482 . . . . 74.22 110.448 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.595 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.4 m-20 -129.63 141.25 50.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.746 1.218 . . . . 75.31 108.1 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.67 147.55 44.97 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.095 -0.705 . . . . 71.44 109.095 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.5 t70 -154.1 145.97 23.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.351 -0.981 . . . . 43.23 108.351 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.9 t -114.28 164.87 13.32 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.092 0.557 . . . . 73.21 109.56 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.37 147.98 22.72 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.509 0.724 . . . . 54.33 109.424 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.7 p -135.12 151.98 51.21 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.056 -0.72 . . . . 71.23 109.056 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -157.1 117.1 3.48 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.18 -1.044 . . . . 62.05 108.18 -175.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -72.61 124.96 26.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.364 -0.606 . . . . 72.23 109.364 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.83 -40.69 12.28 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.69 -0.485 . . . . 70.25 109.69 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.64 4.32 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.183 -0.917 . . . . 51.41 110.327 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.34 116.97 4.66 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.21 -0.905 . . . . 72.14 110.177 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.0 2.96 4.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.391 1.476 . . . . 72.31 113.089 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.67 116.84 52.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.42 -0.956 . . . . 75.34 108.42 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.488 ' HB2' HD13 ' D' ' 86' ' ' ILE . 50.5 m-85 -129.08 127.47 41.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.628 -1.249 . . . . 75.21 107.628 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -96.13 137.23 35.5 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.035 0.934 . . . . 72.02 108.655 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.62 126.23 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.687 -1.227 . . . . 73.21 107.687 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.1 t -102.48 135.42 39.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.007 -0.738 . . . . 70.41 109.007 173.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -112.47 121.45 44.87 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.786 -0.82 . . . . 74.44 108.786 175.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.8 ttm-85 -97.72 115.8 28.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.901 -0.777 . . . . 72.21 108.901 174.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.87 123.06 70.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.013 -1.106 . . . . 74.21 108.013 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -126.65 133.37 50.99 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.384 0.611 . . . . 61.02 110.088 -172.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 76.7 t -126.44 103.7 11.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.973 1.309 . . . . 61.31 109.118 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -97.53 93.17 6.29 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.069 -1.085 . . . . 55.43 108.069 172.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.86 133.99 41.61 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.198 -0.667 . . . . 55.34 109.198 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 59.2 p -140.78 131.7 26.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.802 0.841 . . . . 61.33 109.254 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' D' ' 38' ' ' PRO . 9.5 tp -107.12 107.63 18.7 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 73.03 108.474 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.72 -121.99 5.67 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.479 -0.782 . . . . 60.34 112.805 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.59 4.99 50.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.041 0.936 . . . . 60.44 110.981 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.36 147.21 35.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.697 0.399 . . . . 64.3 110.347 -163.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.477 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 99.7 m -58.48 141.53 51.47 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.785 0.834 . . . . 70.22 111.56 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -100.47 -68.14 0.82 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.602 1.161 . . . . 73.32 109.519 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.84 139.0 19.22 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.843 -0.617 . . . . 75.11 109.491 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.606 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.1 mt -101.06 152.81 20.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.95 -0.759 . . . . 75.13 108.95 173.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.654 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.5 t -159.26 143.4 15.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.826 0.45 . . . . 71.04 110.279 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -155.94 121.88 5.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.007 0.523 . . . . 61.41 109.667 171.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.03 114.86 43.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.326 0.651 . . . . 74.22 109.898 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.686 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -90.24 89.63 7.72 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.026 -0.731 . . . . 75.01 109.026 167.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.17 95.83 5.71 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.531 -1.213 . . . . 75.15 108.46 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 140.95 18.02 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.684 -0.566 . . . . 74.55 111.684 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.03 129.45 4.77 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.241 -1.144 . . . . 72.11 110.241 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.92 128.42 41.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.438 -0.949 . . . . 74.35 108.438 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.19 161.57 28.99 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.074 0.55 . . . . 74.44 110.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 32.8 m -116.42 108.89 16.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.984 0.914 . . . . 75.31 109.35 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.51 HG12 HD11 ' D' ' 98' ' ' LEU . 3.3 mp -109.57 119.4 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.399 0.68 . . . . 70.42 109.415 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.97 155.64 44.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.409 1.083 . . . . 45.22 109.226 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 -13.07 5.73 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 114.323 0.489 . . . . 64.54 114.323 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.501 HG23 HG23 ' D' ' 86' ' ' ILE . 5.5 tt -134.9 137.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.313 1.445 . . . . 71.21 107.822 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -161.56 175.15 12.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.794 0.837 . . . . 62.11 110.012 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.6 -133.38 13.04 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.255 0.347 . . . . 62.2 113.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -71.41 -38.07 71.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.149 0.979 . . . . 74.02 112.137 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.45 -32.74 70.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.149 0.579 . . . . 72.41 110.029 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.489 ' HG3' HG21 ' D' ' 86' ' ' ILE . 59.2 ttp -69.21 -37.72 78.22 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.689 -0.687 . . . . 73.24 110.363 174.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.79 70.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.095 0.558 . . . . 70.1 111.25 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -71.56 -37.67 71.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.338 0.655 . . . . 63.01 110.744 173.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.56 -50.19 47.18 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.927 0.491 . . . . 74.14 111.203 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.51 HD11 HG12 ' D' ' 86' ' ' ILE . 9.9 mp -75.8 -25.11 56.07 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.802 0.841 . . . . 65.15 111.573 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.38 66.43 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 119.592 -0.56 . . . . 71.13 113.511 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.14 -66.43 0.52 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.474 0.546 . . . . 62.2 112.474 -174.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -62.19 -46.08 90.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.335 0.654 . . . . 73.43 112.425 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -67.11 -44.27 48.84 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-O 118.672 -0.68 . . . . 72.54 112.316 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.52 ' HB2' ' HZ ' ' D' ' 133' ' ' PHE . 77.0 Cg_exo -54.4 -32.29 71.99 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.418 2.079 . . . . 71.31 114.482 166.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -64.51 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.28 0.491 . . . . 63.21 111.741 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -67.8 -42.91 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 121.436 0.636 . . . . 71.43 110.019 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.467 HD21 ' HA3' ' D' ' 82' ' ' GLY . 97.2 mt -77.01 -27.64 54.72 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.834 -1.076 . . . . 73.11 112.725 -171.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.74 -45.89 88.14 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.891 1.071 . . . . 65.12 113.891 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -34.76 98.3 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.714 1.609 . . . . 73.41 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.88 -34.47 51.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 75.13 111.485 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.25 -46.82 69.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.279 0.632 . . . . 70.33 110.841 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -69.86 -33.47 72.3 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.215 -0.902 . . . . 54.41 110.669 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -66.32 -42.4 88.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.305 1.003 . . . . 75.24 111.005 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -59.69 -40.04 86.56 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.739 0.65 . . . . 61.31 110.139 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.654 HG12 ' SG ' ' D' ' 76' ' ' CYS . 53.7 mt -63.29 -50.39 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.051 0.845 . . . . 63.15 110.548 173.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 50.0 m -56.43 -44.62 80.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.129 0.972 . . . . 74.43 111.464 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.8 t -65.16 -44.95 86.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 114.68 -1.145 . . . . 71.25 110.429 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.17 -31.2 72.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.737 0.415 . . . . 71.34 112.074 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.416 HG23 ' O ' ' D' ' 114' ' ' ILE . 55.8 t -70.49 -41.91 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.818 0.698 . . . . 72.41 110.483 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -73.38 -24.45 60.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.669 0.271 . . . . 72.33 110.97 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 92.2 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.602 0.761 . . . . 72.31 109.582 172.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.3 -3.66 88.65 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.766 0.666 . . . . 75.24 112.399 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.4 p 58.32 30.92 20.24 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.426 1.89 . . . . 61.44 112.208 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -95.03 169.38 9.51 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.714 1.606 . . . . 73.1 110.099 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.75 130.99 43.36 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.115 2.543 . . . . 62.51 112.625 175.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.27 147.49 16.65 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.251 1.02 . . . . 61.53 112.255 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -135.4 95.81 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.083 0.468 . . . . 53.23 110.499 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -100.97 114.41 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.914 -1.143 . . . . 70.43 107.914 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 98.7 mt -75.94 134.71 40.14 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.773 0.321 . . . . 71.03 110.514 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.59 142.03 91.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 65.14 111.078 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.3 131.24 27.66 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.41 2.073 . . . . 53.1 111.077 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.15 127.02 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.803 0.841 . . . . 72.32 110.219 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.55 77.97 9.75 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.919 . . . . 52.25 109.18 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.52 ' HZ ' ' HB2' ' D' ' 103' ' ' PRO . 45.2 p90 . . . . . 0 CA--C 1.541 0.63 0 CA-C-N 114.81 -1.086 . . . . 72.45 111.05 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.8 m . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 108.875 -0.787 . . . . 62.35 108.875 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -135.83 120.43 18.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.877 -1.157 . . . . 75.14 107.877 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 78.8 mt-30 -132.16 108.6 9.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.415 0.686 . . . . 62.43 109.347 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 pt -83.73 86.96 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.322 -0.992 . . . . 72.35 108.322 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -72.88 -39.53 66.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.946 -0.57 . . . . 61.34 111.496 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -172.07 146.78 2.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.317 -0.623 . . . . 73.14 109.317 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.474 HD12 ' HG2' ' C' ' 130' ' ' PRO . 94.7 mt -137.1 100.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.174 0.59 . . . . 74.42 109.433 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 26.6 m-85 -159.67 160.66 34.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.483 1.113 . . . . 74.23 110.701 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.48 HG21 ' SG ' ' A' ' 113' ' ' CYS . 30.5 p -71.64 129.18 38.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.445 -1.252 . . . . 74.14 111.117 -167.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -84.43 -38.67 19.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.416 0.627 . . . . 63.31 109.583 169.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.6 t70 -139.9 137.66 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.968 -1.014 . . . . 71.4 109.442 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -132.65 146.1 33.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.077 1.351 . . . . 63.24 107.515 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.65 140.24 17.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.961 -0.755 . . . . 54.33 108.961 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 88.9 t80 -142.71 123.47 14.23 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 106.01 -1.848 . . . . 75.2 106.01 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -118.29 152.05 36.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.407 -0.96 . . . . 72.12 108.407 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -145.3 74.33 14.11 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.881 -1.526 . . . . 64.22 106.881 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.98 -20.71 25.22 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.556 2.171 . . . . 73.23 111.842 -172.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 31' ' ' VAL . 89.1 m-20 -118.46 29.93 7.49 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.425 1.09 . . . . 51.11 109.661 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.17 -49.47 92.09 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 113.182 0.808 . . . . 64.31 113.182 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 31.9 Cg_exo -61.99 -27.05 79.16 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.007 1.805 . . . . 71.31 113.373 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -73.41 -38.32 65.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.943 0.497 . . . . 60.25 110.502 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 27' ' ' ASN . 60.1 t -66.78 -34.44 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.524 0.73 . . . . 74.11 110.416 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -56.47 -31.09 63.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.39 1.076 . . . . 53.1 111.361 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -91.22 -45.56 8.57 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.456 1.102 . . . . 62.02 110.714 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.58 165.61 20.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.354 0.662 . . . . 53.04 112.193 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.15 126.19 28.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.845 -1.071 . . . . 54.44 110.894 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.17 82.28 7.13 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.576 -0.738 . . . . 64.4 110.21 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -142.88 79.12 14.99 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.039 -1.097 . . . . 61.13 108.039 171.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -86.65 144.07 7.49 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.616 2.211 . . . . 63.14 112.736 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -98.03 126.0 43.26 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.384 1.074 . . . . 62.21 108.151 175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.58 130.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.226 0.536 . . . . 64.1 110.749 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 63.1 tttm -119.62 112.32 19.16 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.079 -1.452 . . . . 73.4 107.079 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 mt -115.48 107.74 15.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.638 -0.875 . . . . 64.23 108.638 -167.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.8 m-20 -106.13 109.18 21.03 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 55.53 109.331 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.25 132.58 49.4 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.358 -0.608 . . . . 74.11 109.358 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 60' ' ' LEU . 16.3 t70 -142.55 141.65 32.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.13 0.972 . . . . 73.43 109.04 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.9 m -137.73 140.51 40.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.292 0.637 . . . . 73.42 110.428 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.93 134.73 14.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.599 0.76 . . . . 53.12 110.391 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 58' ' ' VAL . 68.0 p -111.31 167.72 10.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.117 0.567 . . . . 73.34 110.297 173.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -168.58 119.13 0.76 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.583 -0.525 . . . . 65.44 109.583 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -69.09 108.07 3.43 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.252 0.621 . . . . 73.32 109.936 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.66 HD11 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -77.83 -41.59 36.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.584 0.754 . . . . 74.32 110.488 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -172.87 4.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.915 . . . . 73.12 109.779 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.28 105.18 0.31 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.976 0.51 . . . . 63.12 110.124 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 58.15 22.04 8.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.105 1.362 . . . . 74.04 112.984 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.2 t -108.33 120.82 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.089 -1.449 . . . . 71.14 107.089 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 136.09 41.2 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.813 -1.18 . . . . 74.42 107.813 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 51' ' ' LEU . 30.4 tt0 -89.13 115.74 26.87 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.94 0.896 . . . . 72.33 108.789 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 48' ' ' SER . 26.9 t -99.25 110.98 27.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 107.017 -1.475 . . . . 64.42 107.017 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -99.41 119.66 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.061 0.544 . . . . 73.31 109.671 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.66 112.47 24.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.038 -1.097 . . . . 72.43 108.038 175.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -101.29 106.67 17.88 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.901 0.881 . . . . 73.44 109.443 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.99 114.37 46.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.524 1.13 . . . . 64.34 109.137 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.1 m -102.83 146.51 28.17 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 50.1 t -142.01 107.16 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.716 1.206 . . . . 70.04 108.073 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.6 m -103.14 135.83 44.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.312 -0.625 . . . . 72.24 109.312 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.59 118.37 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.552 -1.277 . . . . 73.25 107.552 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -124.32 126.2 45.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.281 -0.637 . . . . 63.01 109.281 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.47 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.61 62.91 6.05 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.82 0.819 . . . . 71.52 109.134 -179.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.77 -106.85 1.42 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.877 -1.289 . . . . 14.0 109.877 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -115.82 -26.22 7.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.799 0.84 . . . . 74.21 110.336 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.26 132.05 37.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.911 0.484 . . . . 75.22 109.832 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -71.81 110.89 6.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.931 0.892 . . . . 62.54 110.212 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.47 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -59.1 -57.23 13.97 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.064 0.945 . . . . 65.25 109.598 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -161.72 173.23 14.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.013 -1.449 . . . . 72.0 109.631 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 76' ' ' CYS . 47.3 tp -137.62 149.36 46.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.228 1.011 . . . . 70.11 109.752 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.536 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.5 m -136.82 139.95 42.11 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 124.652 1.181 . . . . 72.2 108.694 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -150.18 129.3 12.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.483 -0.562 . . . . 72.05 109.483 172.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.86 112.51 13.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.774 0.829 . . . . 74.2 109.393 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.3 mt-30 -85.75 82.5 8.17 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.741 -0.837 . . . . 65.05 108.741 171.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.65 93.58 3.65 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.235 -1.348 . . . . 72.35 109.545 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.17 146.1 20.92 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.195 -0.457 . . . . 61.14 112.056 -177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.47 122.97 2.51 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.156 -1.178 . . . . 50.11 110.156 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.9 mt -86.08 121.74 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.731 -0.84 . . . . 34.11 108.731 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -128.68 118.97 23.79 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.967 -1.123 . . . . 72.34 107.967 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 26.7 t -94.92 86.34 4.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.067 -1.086 . . . . 42.14 108.067 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -114.72 143.39 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.232 0.613 . . . . 72.13 110.756 -175.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.65 167.47 23.11 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.172 0.989 . . . . 61.23 110.885 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.01 -6.18 79.0 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.256 -0.884 . . . . 72.21 113.66 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.26 146.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.566 0.746 . . . . 62.42 109.779 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 172.2 14.82 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.949 0.499 . . . . 72.43 110.375 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.18 -127.55 40.48 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.264 0.353 . . . . 74.41 113.391 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -74.4 -20.44 60.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.341 0.656 . . . . 64.14 112.015 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.27 -49.69 68.62 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.459 0.704 . . . . 71.32 109.962 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.9 tmm? -75.67 -37.25 59.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.478 -1.237 . . . . 75.44 110.755 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.99 85.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.378 0.609 . . . . 70.41 110.758 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -65.7 -41.8 91.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.075 -0.966 . . . . 72.52 110.419 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.5 m -74.71 -26.91 60.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.467 0.914 . . . . 71.02 113.467 -173.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.68 -23.36 24.23 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.64 0.376 . . . . 73.14 111.149 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.47 -16.08 21.27 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.526 0.57 . . . . 43.51 114.526 -176.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.9 -64.22 0.58 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.597 0.698 . . . . 63.1 111.636 -172.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 12.5 t80 -48.89 -65.92 0.49 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.577 1.151 . . . . 73.42 113.084 -174.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.31 -44.78 13.61 Favored Pre-proline 0 CA--C 1.559 1.317 0 CA-C-O 118.207 -0.902 . . . . 63.51 113.067 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.56 -31.82 87.43 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.839 1.693 . . . . 62.54 113.849 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -67.92 -34.13 76.03 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.131 0.423 . . . . 63.41 110.45 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.39 -41.23 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.691 0.796 . . . . 60.33 110.238 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.9 mt -70.53 -25.51 63.15 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.49 -0.777 . . . . 41.22 112.003 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -67.0 -43.23 46.19 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.675 1.361 . . . . 65.54 114.675 -167.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.4 -36.79 88.58 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.284 1.989 . . . . 72.21 113.596 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -76.07 -39.0 56.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.19 0.596 . . . . 70.22 111.523 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.38 92.4 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.58 0.352 . . . . 62.24 110.25 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HD12 ' C' ' 105' ' ' ILE . 40.6 ttm180 -53.85 -51.81 62.41 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.813 1.32 . . . . 73.31 110.358 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.61 -42.67 99.21 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.086 -0.961 . . . . 75.33 112.022 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.48 ' SG ' HG21 ' A' ' 18' ' ' THR . 45.0 t -68.23 -39.02 82.43 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.654 0.596 . . . . 61.42 111.523 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.529 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 85.0 mt -64.51 -55.2 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.48 0.712 . . . . 45.03 109.626 176.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 125' ' ' GLN . 64.8 m -58.43 -34.16 70.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.351 1.061 . . . . 73.42 111.792 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -65.28 -44.27 88.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.806 -0.634 . . . . 62.22 110.578 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.529 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 52.2 mtm -63.41 -40.75 98.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.712 0.405 . . . . 74.11 110.869 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.1 t -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 O-C-N 124.191 0.932 . . . . 44.11 110.622 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -74.47 -31.35 62.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.943 -0.571 . . . . 71.24 111.16 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -69.44 -29.95 67.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.657 0.783 . . . . 65.31 110.042 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -3.66 82.98 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.569 -0.741 . . . . 71.44 112.985 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m 67.47 17.7 10.06 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.507 1.123 . . . . 72.1 110.783 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.54 157.12 37.7 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.911 0.884 . . . . 72.23 110.884 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.64 122.77 11.48 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.999 2.466 . . . . 74.53 112.478 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.553 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -53.17 136.52 36.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.951 1.3 . . . . 72.4 112.563 -176.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.7 mt -120.67 99.25 6.43 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.728 -0.841 . . . . 73.01 108.728 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -98.89 125.22 44.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.543 0.737 . . . . 60.4 109.391 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.21 138.26 45.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.806 0.843 . . . . 54.5 110.202 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.82 126.1 92.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.659 -0.497 . . . . 73.51 109.659 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -65.95 103.63 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.406 2.071 . . . . 73.24 112.388 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.1 143.16 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.744 0.818 . . . . 52.33 110.008 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -89.27 85.45 6.61 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.235 1.014 . . . . 71.3 110.606 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -36.5 72.5 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.65 1.18 . . . . 64.43 113.042 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 . . . . . 0 N--CA 1.479 0.984 0 C-N-CA 123.536 0.734 . . . . 61.41 111.334 -175.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.594 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.3 ptm . . . . . 0 N--CA 1.493 1.678 0 N-CA-C 115.003 1.482 . . . . 62.35 115.003 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 95.9 m -154.65 136.61 14.6 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.131 1.373 . . . . 42.44 107.616 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -143.06 138.2 29.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.564 -0.532 . . . . 73.52 109.564 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.608 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 58.2 tt0 -155.16 140.82 17.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.822 0.849 . . . . 61.31 109.664 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.31 117.41 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 108.978 -0.749 . . . . 74.14 108.978 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.86 -50.3 9.35 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.803 0.274 . . . . 72.41 110.499 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -166.31 142.32 4.8 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.85 0.46 . . . . 75.21 109.822 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.5 mt -115.01 148.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.313 -1.366 . . . . 53.23 107.313 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' B' ' 83' ' ' ILE . 27.0 p90 -170.63 143.89 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.198 0.454 . . . . 73.23 110.973 -177.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.0 m -73.61 118.31 16.42 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.414 -0.812 . . . . 61.44 108.848 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -91.31 -29.24 17.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.567 0.747 . . . . 74.34 111.182 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.9 t70 -160.58 146.38 14.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.336 0.397 . . . . 72.15 111.19 -172.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.7 mm -143.03 143.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 C-N-CA 125.975 1.71 . . . . 74.14 108.172 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.9 t -143.07 140.35 30.89 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.163 1.385 . . . . 54.11 107.285 171.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.3 t80 -151.64 126.78 9.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.316 -1.365 . . . . 73.35 107.316 171.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 138.46 53.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.901 0.88 . . . . 43.04 108.995 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -129.37 81.41 70.19 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 107.044 -1.465 . . . . 63.32 107.044 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.49 -26.0 55.16 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.805 2.337 . . . . 71.12 111.979 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -126.48 32.92 5.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.361 1.064 . . . . 75.24 109.514 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.54 -50.09 51.93 Favored Pre-proline 0 CA--C 1.565 1.538 0 C-N-CA 124.504 1.122 . . . . 72.13 113.347 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.61 -12.06 26.6 Favored 'Trans proline' 0 C--N 1.391 2.763 0 C-N-CA 121.769 1.646 . . . . 74.02 113.774 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -97.07 -22.27 16.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.622 0.769 . . . . 73.13 112.515 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 28' ' ' ALA . 8.3 p -68.63 -23.88 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.808 0.443 . . . . 74.22 112.1 -174.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.91 -29.91 71.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.396 0.678 . . . . 73.4 111.53 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.47 -30.77 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.285 0.634 . . . . 72.5 110.419 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.39 94.55 7.12 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 74.24 111.548 -172.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -94.19 81.1 4.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.361 0.665 . . . . 54.34 109.269 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -151.12 162.03 41.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.688 1.195 . . . . 74.24 108.517 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -75.05 113.84 28.97 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.222 1.009 . . . . 61.41 109.354 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.684 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 69.7 Cg_endo -71.92 147.47 49.65 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.348 2.032 . . . . 74.41 111.017 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 37.6 tt0 -51.7 106.43 0.14 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.588 0.755 . . . . 71.55 110.449 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.52 122.34 37.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.517 -1.29 . . . . 64.12 107.517 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -149.09 104.23 3.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.897 -0.592 . . . . 71.11 109.497 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.8 147.25 23.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.366 -0.833 . . . . 73.04 109.225 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -136.71 145.8 45.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.404 1.082 . . . . 61.11 108.096 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.61 163.04 22.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.146 -0.687 . . . . 71.51 109.146 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.0 t70 -164.04 139.21 6.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.832 -1.076 . . . . 71.31 108.946 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -122.43 115.63 22.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.546 0.738 . . . . 72.0 110.211 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -120.51 160.01 24.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 73.3 109.466 174.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 169.04 18.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.279 1.032 . . . . 63.23 109.354 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 1.5 m -149.42 135.11 18.64 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.395 -0.965 . . . . 72.34 108.395 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.85 100.44 12.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.285 -1.006 . . . . 75.15 108.285 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.9 mt -78.85 -31.28 45.62 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.603 -0.726 . . . . 62.3 110.315 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.72 -171.49 1.63 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.072 0.949 . . . . 73.41 110.648 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.96 124.86 24.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.798 -1.092 . . . . 64.12 109.533 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.37 -4.91 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.89 1.276 . . . . 60.54 112.31 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.73 97.16 5.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.602 0.761 . . . . 55.4 109.118 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -102.51 170.82 7.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.542 0.737 . . . . 73.02 110.131 172.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 8.8 tm-20 -145.76 103.01 3.74 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.018 -1.105 . . . . 70.34 108.018 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.07 125.9 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.178 0.591 . . . . 54.24 110.389 -175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 32.3 t -103.98 111.82 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.933 0.893 . . . . 75.45 109.147 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.72 110.23 22.1 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.041 -1.096 . . . . 72.22 108.041 176.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 66.8 ttt180 -97.23 116.23 29.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.344 0.658 . . . . 62.0 109.921 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -114.03 120.92 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.217 -1.031 . . . . 75.32 108.217 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.0 m -114.61 136.97 52.46 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.703 0.801 . . . . 33.54 109.191 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.687 HG21 HG21 ' B' ' 114' ' ' ILE . 52.8 t -115.99 132.9 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.588 1.155 . . . . 74.31 109.646 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -127.21 144.38 51.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.465 0.706 . . . . 65.4 109.667 170.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -143.76 150.85 39.2 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.362 -0.835 . . . . 73.14 110.333 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 m -134.78 136.8 42.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.21 0.604 . . . . 75.35 110.951 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 31.4 mt -129.95 99.59 5.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.282 1.033 . . . . 73.12 108.924 172.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -132.79 16.46 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.38 -0.827 . . . . 71.12 113.091 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -93.18 21.46 5.9 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.824 0.85 . . . . 72.41 111.364 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.74 161.07 41.38 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 123.834 0.853 . . . . 73.45 109.179 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -76.98 134.81 38.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.971 -0.559 . . . . 62.03 110.005 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.27 -65.59 0.94 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.488 -0.93 . . . . 75.13 108.488 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -155.38 160.37 40.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.757 . . . . 75.42 111.053 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -133.07 135.21 45.19 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.47 1.508 . . . . 74.12 107.093 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.3 t -139.15 158.06 44.85 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.362 -0.977 . . . . 53.04 108.362 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -165.28 128.04 2.18 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.146 -0.687 . . . . 73.13 109.146 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.1 t -126.01 146.55 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.832 0.853 . . . . 71.03 108.961 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -123.85 96.41 4.94 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.231 -1.026 . . . . 73.33 108.231 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -85.55 100.4 11.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.377 -0.971 . . . . 74.14 108.377 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.55 169.41 35.72 Favored Glycine 0 C--O 1.244 0.775 0 N-CA-C 111.163 -0.775 . . . . 64.02 111.163 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.8 128.63 1.65 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.44 -0.664 . . . . 33.44 111.44 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.4 HG13 ' HE1' ' B' ' 17' ' ' TYR . 38.3 mt -84.73 126.81 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.677 -0.861 . . . . 65.15 108.677 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -132.1 133.17 44.02 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.318 1.047 . . . . 74.3 108.658 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 26.6 m -93.3 97.59 10.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.802 -0.814 . . . . 72.44 108.802 173.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.61 HG12 HD13 ' B' ' 98' ' ' LEU . 2.6 pp -115.6 140.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.282 1.033 . . . . 64.3 110.463 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.37 172.35 18.5 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.901 0.88 . . . . 62.24 109.495 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.62 -58.65 5.02 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.249 -0.195 . . . . 44.44 112.642 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.473 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.0 OUTLIER -55.01 127.49 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.519 0.728 . . . . 71.2 110.97 174.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.67 161.74 39.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 32.0 109.698 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.68 -131.32 10.96 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.908 -0.587 . . . . 65.45 112.225 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -76.39 -35.69 58.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.69 0.796 . . . . 73.3 110.944 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -64.71 -28.63 69.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.166 -0.925 . . . . 71.45 112.043 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.486 ' HE1' HD22 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.453 0.701 . . . . 73.13 110.106 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.6 78.63 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.384 -0.825 . . . . 64.23 111.461 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 27.7 t-80 -79.07 -23.7 44.01 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.607 0.763 . . . . 74.12 111.246 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.27 -66.32 0.91 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.582 0.353 . . . . 70.3 110.501 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.61 HD13 HG12 ' B' ' 86' ' ' ILE . 14.0 tp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.845 0.458 . . . . 61.42 111.451 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.28 -21.64 58.31 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.806 -0.634 . . . . 75.51 113.728 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -113.14 -56.0 2.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.306 0.553 . . . . 72.11 111.768 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -68.52 -43.69 76.23 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.564 0.54 . . . . 74.52 112.359 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.542 ' SG ' HD12 ' B' ' 98' ' ' LEU . 75.3 m -63.73 -49.36 76.86 Favored Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 118.298 -0.858 . . . . 40.35 111.533 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.488 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 88.0 Cg_exo -56.73 -33.02 93.02 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.115 1.876 . . . . 71.42 114.143 168.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.38 -31.8 72.27 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.088 0.555 . . . . 73.35 110.859 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.91 -48.43 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.831 0.853 . . . . 72.35 109.615 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 65.4 mt -82.27 -12.64 57.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.326 -0.852 . . . . 75.31 111.919 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.59 -47.91 55.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 117.78 -1.105 . . . . 74.23 113.049 -174.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.43 -36.09 98.81 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 121.909 1.739 . . . . 73.43 113.313 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.507 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 43.3 m-85 -70.51 -45.58 65.31 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.649 0.78 . . . . 75.35 110.474 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.05 99.49 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.7 0.8 . . . . 61.03 110.264 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -56.86 -54.96 40.47 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.83 1.652 . . . . 70.14 111.589 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.3 -31.94 73.34 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.733 0.646 . . . . 71.25 110.032 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.5 t -68.09 -41.97 81.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.536 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.687 HG21 HG21 ' B' ' 64' ' ' VAL . 62.8 mt -63.79 -51.88 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.133 0.573 . . . . 73.41 110.085 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.6 m -58.27 -34.24 70.28 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.139 0.976 . . . . 74.33 111.072 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.9 t -64.41 -54.65 29.4 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.129 -0.941 . . . . 72.21 109.414 173.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.9 mmt -61.88 -33.86 74.97 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.133 0.573 . . . . 63.31 112.13 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.9 -46.82 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.709 0.804 . . . . 72.31 110.934 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 74.7 p -70.01 -25.29 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.584 0.353 . . . . 64.1 110.999 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.518 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 85.1 mtt-85 -69.85 -20.23 63.42 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 118.783 -0.627 . . . . 62.52 111.172 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.2 12.18 61.95 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.12 -0.822 . . . . 70.35 114.365 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.7 p 72.54 14.54 5.2 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.936 1.694 . . . . 72.12 112.169 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -91.14 154.18 44.86 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 122.725 0.41 . . . . 73.1 111.125 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -55.16 149.5 44.14 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 123.321 2.681 . . . . 65.33 113.06 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -59.02 123.25 15.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.39 1.076 . . . . 71.31 111.592 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.07 100.99 7.69 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.121 -1.066 . . . . 54.55 108.121 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -99.8 117.67 34.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 74.42 109.189 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.79 134.93 37.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.171 0.588 . . . . 61.42 110.16 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.05 139.81 36.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.801 0.84 . . . . 74.12 110.398 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.6 99.53 0.45 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.907 2.405 . . . . 74.54 111.972 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -90.81 126.07 43.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.753 -0.832 . . . . 75.13 108.753 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.23 113.23 11.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.531 -0.914 . . . . 70.0 108.531 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -63.88 -20.89 66.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.662 0.785 . . . . 74.03 110.859 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.079 1.352 . . . . 73.1 109.735 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.64 -31.31 63.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.481 -1.236 . . . . 54.13 110.682 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp . . . . . 0 N--CA 1.486 1.331 0 C-N-CA 123.141 0.576 . . . . 75.14 110.075 176.823 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.475 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 54.0 ttp . . . . . 0 CA--C 1.553 1.094 0 CA-C-O 121.291 0.567 . . . . 73.11 111.812 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.8 m -99.79 87.39 3.52 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.501 -1.296 . . . . 74.15 107.501 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.448 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 20.5 t80 -89.09 133.12 34.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.367 -0.833 . . . . 74.43 109.233 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 7.9 tt0 -151.81 144.95 24.6 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.937 -0.764 . . . . 63.44 108.937 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.5 HD11 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -92.52 136.88 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.386 -0.598 . . . . 72.23 109.386 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -105.24 -50.06 3.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.642 0.777 . . . . 74.04 110.281 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -163.18 142.64 8.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.049 0.54 . . . . 74.41 109.549 -173.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.5 HG13 HD11 ' C' ' 13' ' ' ILE . 79.8 mt -128.24 134.84 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.417 -1.327 . . . . 71.31 107.417 174.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.561 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 5.7 p90 -171.16 153.79 3.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 71.41 111.336 -173.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -79.11 120.74 24.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.168 -0.923 . . . . 74.12 109.471 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -74.26 -49.01 25.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.321 -0.992 . . . . 75.14 108.321 170.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -134.39 138.33 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.747 -1.569 . . . . 60.24 109.135 -167.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -142.73 139.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.711 -1.588 . . . . 64.11 106.711 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.88 149.52 18.15 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.83 -0.433 . . . . 53.23 109.83 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -154.34 108.8 3.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.124 -1.065 . . . . 74.25 108.124 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.79 122.13 42.61 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.076 -0.713 . . . . 53.21 109.076 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.81 93.42 20.51 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 108.423 -0.955 . . . . 75.22 108.423 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.68 -49.45 8.65 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.108 2.538 . . . . 63.24 111.697 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' C' ' 72' ' ' THR . 68.4 m-20 -103.79 53.19 0.75 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.429 -0.805 . . . . 74.11 109.036 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.11 -52.99 70.78 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.982 1.104 . . . . 73.15 113.982 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 39.4 Cg_exo -63.81 -21.72 69.28 Favored 'Trans proline' 0 C--N 1.398 3.139 0 C-N-CA 122.185 1.924 . . . . 72.05 112.909 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.44 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 13.6 m-70 -64.64 -18.95 65.41 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.291 1.036 . . . . 74.23 113.133 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.46 -37.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.087 0.955 . . . . 73.02 113.494 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -81.14 -36.4 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.054 0.941 . . . . 54.41 111.091 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -85.17 4.64 33.53 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 125.293 1.437 . . . . 53.24 111.08 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.627 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.2 ttmp? -107.81 153.18 23.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.376 1.07 . . . . 71.33 111.024 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.25 114.23 19.0 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.06 -1.459 . . . . 73.34 107.06 166.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -85.32 61.47 6.88 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.141 0.972 . . . . 74.41 112.504 -168.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -150.23 58.74 3.26 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.011 1.325 . . . . 71.31 107.598 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.47 160.8 31.85 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.011 1.807 . . . . 71.25 111.364 -176.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.45 103.94 13.2 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.896 -1.15 . . . . 70.32 107.896 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.82 97.41 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 114.963 -1.017 . . . . 65.11 108.642 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 50.7 mtpt -95.77 105.64 17.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.996 -0.742 . . . . 74.25 108.996 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -87.04 149.1 24.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.901 0.881 . . . . 73.31 109.609 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.492 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.3 t70 -149.17 127.41 12.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.314 -0.995 . . . . 72.35 108.314 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.78 149.68 50.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.228 0.467 . . . . 73.23 110.769 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 17.5 m-20 -140.81 161.1 38.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 64.35 109.826 176.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -130.48 136.06 48.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.054 0.941 . . . . 64.43 108.473 171.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -131.51 172.51 12.13 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.124 0.97 . . . . 61.33 108.507 176.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.7 p -164.61 160.14 19.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.927 0.491 . . . . 23.01 111.112 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -167.34 138.21 3.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.061 0.944 . . . . 74.04 109.452 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -77.87 117.5 19.29 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.88 -0.785 . . . . 74.2 108.88 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.5 mt -87.27 -37.97 16.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.734 0.413 . . . . 54.52 110.608 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -159.23 -172.05 3.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.262 -0.881 . . . . 50.22 110.682 -174.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.67 111.56 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.01 -0.995 . . . . 64.21 109.681 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 64.09 15.9 9.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.831 1.252 . . . . 63.11 112.314 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 89.1 t -118.0 103.79 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.298 -1.001 . . . . 71.43 108.298 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.443 ' CD1' ' HB ' ' C' ' 86' ' ' ILE . 14.9 m-85 -117.95 139.17 51.54 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.907 0.883 . . . . 72.42 108.959 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.612 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.2 tt0 -100.3 146.14 27.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.843 0.857 . . . . 65.21 109.355 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.38 144.33 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.747 -0.835 . . . . 75.44 108.747 165.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 58.2 t -119.63 107.14 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.886 0.875 . . . . 64.1 109.127 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.25 99.91 12.84 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.074 -1.084 . . . . 64.3 108.074 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 75.6 ttt-85 -84.53 134.82 34.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.858 0.863 . . . . 73.12 109.385 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.412 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -129.05 148.13 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.794 -1.187 . . . . 71.33 107.794 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 57.5 m -138.9 135.35 34.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 75.31 107.5 171.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.542 HG23 HD13 ' C' ' 114' ' ' ILE . 47.1 t -118.36 113.33 41.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 107.659 -1.237 . . . . 75.31 107.659 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.1 m -98.33 134.35 41.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.749 -1.204 . . . . 74.5 107.749 171.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 94.82 3.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.231 -1.396 . . . . 74.12 107.231 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 14.1 m -144.76 143.48 30.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.279 0.632 . . . . 62.24 109.692 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.03 10.17 39.8 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.493 0.717 . . . . 70.55 109.578 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.27 -95.63 0.4 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.395 -1.082 . . . . 35.53 110.395 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.48 -32.98 16.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 72.22 109.261 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.627 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 8.7 tp10 -83.67 91.28 7.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.874 0.87 . . . . 61.32 109.484 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 28.3 m -86.75 135.88 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.284 -0.871 . . . . 72.32 110.232 -178.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.59 -65.03 1.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.669 -0.863 . . . . 71.52 108.669 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.36 175.5 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.907 0.86 . . . . 74.13 112.332 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.463 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -137.34 135.6 37.2 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 105.219 -2.141 . . . . 53.52 105.219 169.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.2 t -144.73 117.84 8.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.841 0.456 . . . . 70.21 109.983 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -121.06 131.35 54.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.03 135.41 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.194 0.998 . . . . 75.51 108.488 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.6 mt-30 -115.04 103.2 10.66 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.567 -0.901 . . . . 74.4 108.567 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.34 110.02 18.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.587 0.755 . . . . 64.34 109.618 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.02 146.65 22.14 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.178 -0.769 . . . . 63.42 111.178 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.545 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.52 118.66 0.99 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.913 -0.475 . . . . 41.35 111.913 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.493 HD12 ' CD1' ' C' ' 51' ' ' LEU . 8.7 mm -87.72 119.36 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.917 -0.771 . . . . 65.53 108.917 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.434 ' CE2' HD13 ' C' ' 13' ' ' ILE . 98.9 m-85 -129.36 128.7 43.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.9 0.88 . . . . 74.34 109.237 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 24.5 m -70.82 108.74 4.62 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.305 -0.628 . . . . 73.4 109.305 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' C' ' 56' ' ' TYR . 43.5 mm -114.36 101.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.21 -1.034 . . . . 74.31 108.21 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -133.53 150.05 51.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.97 0.908 . . . . 64.02 109.754 -177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.37 28.76 Favored Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.349 0.5 . . . . 70.14 114.349 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' C' ' 9' ' ' MET . 17.8 tt -108.57 151.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.331 1.052 . . . . 74.53 110.134 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -164.13 154.68 15.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.185 0.594 . . . . 74.42 110.756 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.83 -148.61 19.31 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.369 0.509 . . . . 74.32 112.243 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.9 p -65.89 -21.18 66.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.946 0.898 . . . . 75.51 111.115 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -61.53 -51.1 70.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.173 0.989 . . . . 74.0 109.95 170.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 53.3 ttm -66.47 -35.82 81.22 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.901 -0.59 . . . . 75.13 110.376 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.2 95.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.497 0.719 . . . . 73.41 111.487 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 56.5 t-80 -68.5 -23.74 64.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.251 -0.886 . . . . 74.12 111.415 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 99.6 m -82.7 -51.33 7.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.221 0.608 . . . . 60.14 110.896 173.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.74 -42.67 66.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.735 1.214 . . . . 70.11 111.314 -163.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.61 11.53 46.45 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.02 -0.537 . . . . 73.24 113.438 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' C' ' 134' ' ' ASP . . . -146.12 -73.44 0.23 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.505 0.652 . . . . 73.22 111.963 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.58 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 92.0 t80 -65.22 -53.55 42.81 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.308 0.855 . . . . 74.11 113.308 -168.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.448 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 31.9 m -61.04 -44.55 94.75 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 123.126 0.57 . . . . 70.03 111.835 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 87.9 Cg_exo -55.23 -33.59 85.12 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.654 2.236 . . . . 63.3 114.536 166.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.19 -25.15 65.09 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 123.048 0.539 . . . . 73.03 111.762 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.46 HD12 ' NH1' ' A' ' 111' ' ' ARG . 38.4 mm -69.0 -39.67 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.476 -0.564 . . . . 74.31 109.476 171.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.545 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.5 mt -76.93 -26.89 54.58 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.843 -1.071 . . . . 72.23 111.811 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -56.03 -47.09 99.52 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.405 1.082 . . . . 62.11 113.807 -173.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.78 -40.16 86.22 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.031 1.821 . . . . 61.45 113.542 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.38 -45.76 71.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.224 0.61 . . . . 74.34 110.712 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.4 82.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.713 0.805 . . . . 44.2 110.665 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -65.83 -49.45 68.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.411 -1.268 . . . . 55.32 110.658 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.09 -29.74 66.79 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.416 0.686 . . . . 62.14 110.673 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.8 t -65.61 -40.43 92.61 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.408 0.683 . . . . 45.1 110.12 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.542 HD13 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -67.9 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.867 -0.606 . . . . 74.44 110.133 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 62.3 m -58.24 -29.56 65.85 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.823 0.849 . . . . 73.35 111.011 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.9 -51.51 18.31 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.37 -0.832 . . . . 71.45 109.715 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.585 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.17 -39.51 60.16 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.806 0.842 . . . . 52.3 112.369 177.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.6 t -68.85 -44.92 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.389 0.676 . . . . 72.31 110.259 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.07 -28.61 66.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.281 0.562 . . . . 63.52 110.926 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -67.21 -37.19 83.21 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 114.71 -1.132 . . . . 73.12 110.05 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.62 83.74 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 119.352 -0.693 . . . . 73.32 112.952 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' D' ' 17' ' ' TYR . 64.0 p 58.96 25.36 13.69 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.237 1.815 . . . . 25.31 112.833 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.441 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 84.3 m-85 -93.21 160.43 33.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.298 1.039 . . . . 74.31 108.923 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -64.06 117.46 4.47 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.716 2.277 . . . . 70.24 112.418 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.12 134.72 44.17 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.467 1.107 . . . . 64.31 112.414 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.59 107.35 18.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.948 -1.13 . . . . 73.0 107.948 -174.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.67 100.64 13.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.266 -1.013 . . . . 73.02 108.266 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 134.36 48.63 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.339 0.655 . . . . 73.22 110.079 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.66 99.06 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.773 0.829 . . . . 75.31 110.974 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.474 ' HG2' HD12 ' A' ' 16' ' ' ILE . 24.0 Cg_exo -64.18 87.19 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.84 2.36 . . . . 72.01 112.702 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.33 111.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.682 -0.859 . . . . 75.52 108.682 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -109.44 103.12 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.962 -0.755 . . . . 63.13 108.962 -177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.19 -29.24 69.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.21 1.004 . . . . 75.33 111.561 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.469 ' HB3' ' HB1' ' C' ' 100' ' ' ALA . 4.8 p-10 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 123.584 0.753 . . . . 74.53 110.584 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.439 ' HG3' HG13 ' D' ' 89' ' ' ILE . 6.0 ttp . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 114.004 1.112 . . . . 72.21 114.004 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -139.32 136.8 35.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.778 0.831 . . . . 74.2 109.037 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -152.97 93.78 1.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 74.33 107.518 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.3 mt-30 -114.51 153.61 29.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.562 -0.744 . . . . 73.21 109.587 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.57 131.07 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.95 0.9 . . . . 74.21 109.16 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -109.42 -49.57 3.1 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.363 0.528 . . . . 63.3 111.909 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.31 121.08 0.73 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.509 0.559 . . . . 70.05 112.509 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.43 HD12 ' N ' ' D' ' 16' ' ' ILE . 1.7 mp -108.6 133.52 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.653 -1.239 . . . . 73.25 107.653 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' C' ' 122' ' ' THR . 36.1 p90 -161.89 176.05 11.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.911 0.862 . . . . 72.34 112.021 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -107.07 117.87 35.21 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.778 -1.101 . . . . 74.12 109.265 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.447 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.6 mtpt -85.47 -25.24 27.02 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.287 -0.634 . . . . 74.5 109.287 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.712 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.1 t70 -148.32 141.03 24.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.328 1.051 . . . . 55.0 109.869 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.585 HD13 ' HE3' ' C' ' 117' ' ' MET . 46.1 mt -138.41 142.96 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.445 1.498 . . . . 73.55 107.713 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -148.01 137.09 22.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.233 1.013 . . . . 65.01 108.852 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.4 t80 -153.86 119.54 5.25 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.117 -1.438 . . . . 75.25 107.117 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.0 118.54 19.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.394 0.677 . . . . 73.23 109.57 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.75 90.2 12.49 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.703 -0.851 . . . . 73.21 108.703 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.61 -46.44 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.964 2.443 . . . . 51.1 112.829 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.4 m-20 -103.31 43.51 1.08 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.279 1.032 . . . . 50.32 108.26 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.02 -53.46 64.95 Favored Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 114.795 1.406 . . . . 63.35 114.795 -168.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.67 -3.86 12.0 Favored 'Trans proline' 0 C--N 1.393 2.88 0 CA-C-N 121.806 1.681 . . . . 74.22 113.865 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.448 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -84.6 -40.17 17.84 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.896 0.878 . . . . 65.14 110.454 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -82.26 -14.05 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.755 0.822 . . . . 74.01 109.923 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.21 -28.76 70.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.377 1.071 . . . . 74.15 110.96 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 61.0 mt-30 -72.64 -7.66 51.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.39 1.076 . . . . 61.44 111.293 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -111.78 111.81 23.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.423 1.089 . . . . 75.52 109.877 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.63 63.4 7.54 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.705 0.802 . . . . 61.22 110.052 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.506 ' HB3' HD21 ' D' ' 68' ' ' LEU . 65.7 t-105 -150.58 166.87 28.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.826 -0.805 . . . . 74.21 108.826 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.74 108.69 27.1 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.118 0.967 . . . . 63.32 110.471 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -43.24 144.94 1.55 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 124.506 3.471 . . . . 74.21 115.612 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.73 118.37 15.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.569 -0.741 . . . . 71.23 110.379 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.441 HG13 HG13 ' D' ' 64' ' ' VAL . 99.1 t -109.23 125.33 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.877 0.871 . . . . 64.1 111.02 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -111.54 120.95 43.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.68 -1.23 . . . . 62.44 107.68 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 155.66 16.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.403 -0.962 . . . . 74.1 108.403 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.6 t70 -143.59 140.89 30.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.887 0.875 . . . . 73.32 108.963 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.9 153.44 31.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.275 0.63 . . . . 63.3 110.544 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.9 t0 -165.75 152.7 10.04 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.579 1.152 . . . . 62.51 108.781 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -125.08 164.52 20.03 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.31 0.576 . . . . 51.1 110.279 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.86 167.53 30.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.529 1.131 . . . . 61.54 108.465 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.4 p -161.6 154.34 20.42 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.971 0.508 . . . . 61.03 110.97 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -154.95 149.62 26.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.513 1.125 . . . . 74.4 108.832 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -91.34 118.53 30.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.548 -0.908 . . . . 74.33 108.548 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.54 -38.49 12.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.099 0.56 . . . . 52.34 109.995 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.72 -177.11 6.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.662 0.744 . . . . 62.11 111.013 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.66 125.64 29.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.74 -1.118 . . . . 73.1 110.083 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 63.8 10.58 5.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.304 1.442 . . . . 70.24 112.308 -172.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.1 t -123.76 120.07 58.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.787 0.835 . . . . 71.13 109.025 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.501 ' HD1' ' HB ' ' D' ' 86' ' ' ILE . 64.3 m-85 -132.88 130.03 39.18 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.778 -0.823 . . . . 74.35 108.778 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.9 138.82 31.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.199 1.0 . . . . 64.24 108.888 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.66 123.92 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.228 -1.397 . . . . 73.34 107.228 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.1 t -102.25 130.73 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 74.54 108.808 175.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.48 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -105.5 117.93 35.28 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.575 -1.268 . . . . 71.3 107.575 176.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -96.58 107.2 19.58 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.727 -1.212 . . . . 74.54 107.727 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.15 129.91 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.448 -0.945 . . . . 73.25 108.448 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -116.71 147.55 41.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.919 0.888 . . . . 72.33 109.65 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 23.7 t -134.11 128.72 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 73.11 108.442 174.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -124.83 119.64 29.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.08 139.3 53.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.311 0.644 . . . . 62.42 109.634 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 41.7 p -155.49 129.13 8.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.62 0.768 . . . . 52.31 109.415 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' D' ' 36' ' ' TRP . 15.5 tp -113.54 111.61 22.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.504 -0.925 . . . . 64.3 108.504 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.97 -144.98 26.73 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.876 0.735 . . . . 63.34 111.88 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.37 2.88 34.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.611 0.764 . . . . 64.25 112.021 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.448 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.1 pt-20 -123.81 152.16 42.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.777 0.831 . . . . 74.31 110.423 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 80.9 m -74.07 136.04 43.03 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.61 0.569 . . . . 73.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.58 -54.8 3.74 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.918 0.887 . . . . 73.24 109.436 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -161.52 164.04 29.85 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.78 -1.1 . . . . 65.13 109.312 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.79 152.53 50.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.102 1.361 . . . . 74.22 107.803 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.639 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.4 t -159.63 142.94 14.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.732 0.413 . . . . 52.43 110.784 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.45 127.54 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.169 0.588 . . . . 73.05 109.562 168.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.2 115.82 42.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 123.617 0.767 . . . . 64.0 109.549 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.712 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.3 mt-30 -89.86 87.13 6.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.867 0.841 . . . . 72.14 108.874 170.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.35 95.75 6.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 113.612 -1.631 . . . . 73.15 109.429 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 142.76 18.35 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.173 -0.371 . . . . 53.12 112.173 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.05 131.95 4.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.545 -0.622 . . . . 42.01 111.545 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.45 123.28 44.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 124.488 1.115 . . . . 65.52 108.78 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -126.16 131.77 51.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.935 0.894 . . . . 72.54 109.635 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 9.8 m -80.59 94.51 6.31 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.641 -0.874 . . . . 24.34 108.641 173.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.501 ' HB ' ' HD1' ' D' ' 56' ' ' TYR . 69.9 mt -108.5 111.02 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 63.22 109.205 -175.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.64 128.81 15.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.634 0.774 . . . . 43.21 109.822 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.76 50.13 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-O 119.756 -0.469 . . . . 62.33 113.705 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.483 HD13 HG23 ' D' ' 86' ' ' ILE . 2.9 mp -95.8 126.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.706 -1.591 . . . . 71.23 106.706 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.26 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.751 0.82 . . . . 75.21 111.35 -169.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.31 -141.84 39.89 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.039 -0.982 . . . . 72.12 112.719 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -90.38 -16.33 29.32 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.649 0.78 . . . . 74.42 110.02 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.46 -33.37 72.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.583 1.153 . . . . 53.43 111.123 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -64.1 -33.16 75.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.996 0.519 . . . . 74.32 111.694 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.58 80.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.201 0.6 . . . . 73.23 110.427 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -72.78 -36.19 67.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.907 -0.588 . . . . 60.42 110.925 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -64.33 -43.29 95.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.794 0.437 . . . . 34.13 110.053 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.6 tp -72.73 -35.98 67.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.175 0.99 . . . . 71.25 111.336 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.14 53.98 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.446 -0.641 . . . . 51.54 114.434 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.448 ' HB1' ' HD1' ' D' ' 133' ' ' PHE . . . -132.92 -60.27 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.741 0.77 . . . . 61.43 111.873 -175.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.22 -46.13 85.19 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.364 0.666 . . . . 73.51 112.145 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 33.4 m -71.62 -45.3 12.78 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-O 118.558 -0.734 . . . . 72.03 112.03 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.48 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.8 Cg_exo -57.82 -29.06 84.75 Favored 'Trans proline' 0 C--N 1.399 3.226 0 C-N-CA 122.446 2.097 . . . . 75.45 113.915 169.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.86 -32.29 73.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.262 0.625 . . . . 53.31 110.702 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.23 -34.56 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 123.661 0.785 . . . . 74.41 110.186 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.6 mt -82.5 -17.76 43.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.23 1.012 . . . . 65.02 112.39 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -65.78 -44.66 64.14 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.656 0.984 . . . . 72.31 113.656 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.86 -32.07 90.96 Favored 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 121.952 1.768 . . . . 64.52 112.873 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -80.16 -33.97 37.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 71.34 112.398 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.17 58.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.263 -0.643 . . . . 52.42 109.263 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -68.35 -31.7 71.27 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 114.883 -1.053 . . . . 72.45 111.213 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.13 -50.38 72.1 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 124.223 0.952 . . . . 72.41 110.692 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.3 t -59.02 -42.04 89.18 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.689 0.618 . . . . 65.32 110.52 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.639 HG12 ' SG ' ' D' ' 76' ' ' CYS . 99.5 mt -59.3 -52.84 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.314 1.045 . . . . 74.22 110.708 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.523 HG23 ' HG3' ' D' ' 125' ' ' GLN . 74.1 m -58.64 -41.82 86.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.882 0.873 . . . . 74.45 110.808 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.56 -43.97 88.19 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 114.65 -1.159 . . . . 70.12 110.448 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.41 -30.58 69.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.711 0.404 . . . . 63.31 111.459 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' D' ' 123' ' ' PHE . 55.0 t -66.92 -45.42 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.451 0.701 . . . . 72.4 110.029 173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -74.26 -25.63 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.748 0.419 . . . . 73.04 110.967 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -75.63 -35.23 60.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.593 0.757 . . . . 65.13 109.255 172.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.38 -3.89 88.84 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.854 0.721 . . . . 62.11 112.039 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.5 p 58.05 34.69 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.71 2.004 . . . . 72.33 112.894 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.472 ' HB2' HG13 ' D' ' 118' ' ' VAL . 51.1 m-85 -93.28 166.74 15.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.738 1.215 . . . . 73.23 108.989 171.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.56 132.26 44.89 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.097 1.864 . . . . 73.32 111.514 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.523 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.6 tt0 -52.49 139.6 24.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.544 1.137 . . . . 74.21 112.406 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.425 HD21 HG11 ' D' ' 40' ' ' VAL . 46.7 tp -126.04 99.89 6.11 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.947 0.403 . . . . 72.22 110.862 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -100.15 117.81 35.18 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.179 -1.415 . . . . 75.14 107.179 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -73.17 123.16 23.1 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.624 -0.509 . . . . 61.13 109.624 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.66 147.07 84.73 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 124.635 1.209 . . . . 64.2 112.311 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.93 123.06 12.21 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.262 2.641 . . . . 73.12 113.555 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.75 145.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.828 0.851 . . . . 72.2 109.92 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -68.25 118.48 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.328 -0.99 . . . . 54.41 108.328 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.448 ' HD1' ' HB1' ' D' ' 100' ' ' ALA . 23.2 p90 . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 124.772 1.229 . . . . 74.2 113.969 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 108.809 -0.811 . . . . 75.13 108.809 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.01 114.0 9.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.401 -1.703 . . . . 74.31 106.401 159.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -138.78 121.07 15.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.335 -0.617 . . . . 70.43 109.335 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.448 HD12 ' HG2' ' C' ' 130' ' ' PRO . 25.0 pt -73.98 111.77 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 64.55 109.036 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -96.39 -43.32 7.71 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.764 -0.458 . . . . 64.21 109.764 -174.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -155.95 140.43 16.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.139 0.976 . . . . 64.31 108.865 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.555 HG23 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -128.72 112.53 26.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 106.122 -1.807 . . . . 63.33 106.122 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 28.8 p90 -157.64 169.14 25.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.252 0.548 . . . . 72.15 111.817 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -89.4 121.77 31.97 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.797 -0.816 . . . . 74.33 108.797 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.7 mtpt -87.51 -36.0 17.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.217 0.532 . . . . 71.33 109.751 175.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -146.83 140.44 25.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.108 -0.951 . . . . 55.22 108.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.5 mt -132.62 146.58 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.314 1.046 . . . . 73.43 108.671 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.2 m -146.1 124.96 12.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.182 0.993 . . . . 73.11 109.229 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 83.3 t80 -123.91 126.89 47.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.192 -1.781 . . . . 75.01 106.192 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -134.73 108.36 7.95 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.994 -0.743 . . . . 70.23 108.994 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.72 82.42 59.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.975 0.91 . . . . 53.34 108.796 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.2 -22.22 22.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.591 2.194 . . . . 72.14 111.576 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 89.3 m-20 -114.34 33.72 5.13 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.112 0.965 . . . . 75.43 109.953 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.48 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.37 -46.57 98.99 Favored Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 123.827 0.851 . . . . 74.45 112.491 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD2' ' HD2' ' A' ' 30' ' ' HIS . 7.7 Cg_exo -74.81 -28.91 9.12 Favored 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 121.937 1.758 . . . . 64.11 112.747 172.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.2 m-70 -68.93 -28.22 66.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.543 0.737 . . . . 55.0 111.34 -172.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.53 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.4 p -63.96 -27.0 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.478 0.711 . . . . 63.23 111.587 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -68.12 -30.67 69.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.746 0.818 . . . . 72.33 110.583 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -75.89 -46.08 32.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.519 -0.764 . . . . 73.13 109.965 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HB3' HD11 ' A' ' 68' ' ' LEU . 41.3 mtpt -81.73 157.37 24.58 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.676 -1.147 . . . . 62.43 110.66 -173.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -64.44 135.36 56.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.552 0.341 . . . . 60.12 111.008 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -84.29 64.88 8.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.111 0.958 . . . . 73.21 109.529 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -132.0 66.59 77.94 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.065 1.346 . . . . 63.13 108.01 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -87.54 156.04 7.78 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.053 1.835 . . . . 71.23 112.389 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -96.34 124.22 40.26 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.509 -0.923 . . . . 54.24 108.509 177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 9.1 t -90.59 99.59 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.825 0.85 . . . . 51.35 109.656 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 90.2 mttt -95.55 142.28 28.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.544 0.737 . . . . 71.45 110.424 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.06 112.28 12.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.458 -0.792 . . . . 70.44 109.795 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -115.32 113.55 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.231 1.012 . . . . 75.13 108.698 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.07 155.8 25.3 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.446 0.641 . . . . 41.4 111.449 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 15.8 t70 -149.16 154.95 39.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 54.34 109.059 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -133.41 132.82 41.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.809 0.844 . . . . 63.22 109.201 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.06 130.31 41.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.676 0.79 . . . . 62.51 109.681 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -88.65 155.27 19.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.299 0.64 . . . . 74.35 110.464 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.3 t -149.53 119.06 6.92 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 -176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.87 107.88 19.53 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.785 -0.82 . . . . 64.45 108.785 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.32 -27.98 20.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.863 -0.608 . . . . 74.01 110.659 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.94 -174.03 1.96 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.868 -1.06 . . . . 42.42 110.205 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.5 128.43 35.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.339 -0.846 . . . . 54.14 109.68 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 62.04 18.18 9.72 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.582 1.176 . . . . 72.11 111.813 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.0 107.31 17.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 124.482 1.113 . . . . 64.13 108.057 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -125.97 124.48 40.84 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.786 0.834 . . . . 75.24 108.996 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.95 124.43 49.5 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.4 1.48 . . . . 62.12 108.666 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.38 134.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.187 -1.042 . . . . 73.0 108.187 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.6 t -106.6 125.33 62.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.048 -0.978 . . . . 61.44 108.387 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.39 107.53 19.92 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.45 -1.685 . . . . 73.35 106.45 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 5.3 ttp180 -94.46 97.08 9.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.11 -1.441 . . . . 60.13 107.11 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.8 132.57 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -126.29 126.7 44.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.381 -0.97 . . . . 73.34 108.381 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.479 HG23 HD13 ' A' ' 114' ' ' ILE . 89.8 t -120.78 129.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.3 -1.371 . . . . 71.34 107.3 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 34.5 m -125.51 137.61 53.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.036 -0.727 . . . . 71.14 109.036 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.18 105.8 10.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.948 -1.501 . . . . 63.25 106.948 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -130.71 125.9 35.09 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.621 -0.881 . . . . 63.24 108.621 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.3 pt? -91.07 84.25 5.69 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.992 -1.114 . . . . 64.21 107.992 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.85 -124.25 7.04 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.724 -1.125 . . . . 62.12 110.639 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.86 -26.9 21.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.801 0.841 . . . . 61.54 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -96.25 133.16 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 74.02 110.63 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -80.33 126.92 31.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.976 0.91 . . . . 70.35 110.844 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.75 -51.46 12.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.001 0.92 . . . . 65.31 109.189 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -161.95 168.3 23.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.148 0.979 . . . . 71.25 110.061 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 76' ' ' CYS . 40.6 tp -138.11 149.11 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.66 1.184 . . . . 72.22 109.221 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.435 ' H ' HD12 ' A' ' 75' ' ' LEU . 63.7 m -139.66 140.34 36.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.068 1.347 . . . . 74.3 108.947 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.37 132.63 18.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.71 0.804 . . . . 74.01 108.839 170.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.76 112.86 13.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.805 -0.813 . . . . 64.12 108.805 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.23 80.58 9.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.765 -1.107 . . . . 75.33 108.399 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.76 92.71 3.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.808 -1.087 . . . . 65.21 109.129 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -93.33 144.74 17.24 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.664 -0.574 . . . . 71.41 111.664 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.55 127.55 3.81 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.752 -0.539 . . . . 74.45 111.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.39 126.18 39.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.975 -1.12 . . . . 72.32 107.975 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.15 121.48 20.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.221 -0.659 . . . . 75.54 109.221 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -81.09 110.77 16.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.932 -0.766 . . . . 74.01 108.932 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.36 144.21 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.142 0.577 . . . . 72.31 110.684 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.4 162.75 22.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.998 . . . . 64.12 109.779 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.17 -6.83 48.47 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 115.99 -0.55 . . . . 74.24 114.47 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.93 155.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.461 1.104 . . . . 71.13 109.288 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -164.28 174.61 10.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.355 -0.609 . . . . 72.53 109.355 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.14 -125.17 29.37 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 116.112 -0.494 . . . . 63.43 112.75 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -73.16 -18.78 61.23 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.804 0.842 . . . . 71.32 111.945 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -70.71 -50.75 32.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.607 0.763 . . . . 72.32 109.59 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -75.23 -29.85 60.38 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.423 -0.808 . . . . 74.14 110.441 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.97 -44.08 97.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.143 0.577 . . . . 71.53 110.042 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.08 -49.52 77.34 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 115.518 -0.765 . . . . 73.55 110.688 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.3 m -69.17 -59.78 2.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 74.54 112.973 -171.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.75 -14.95 60.78 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.142 0.423 . . . . 63.3 112.142 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.42 -18.42 30.84 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.862 -0.41 . . . . 43.42 113.817 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.59 -69.17 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.492 0.646 . . . . 74.01 111.998 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 8.6 t80 -44.12 -57.89 3.15 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.1 1.36 . . . . 72.41 112.788 -174.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.7 -47.99 5.1 Favored Pre-proline 0 CA--C 1.559 1.325 0 CA-C-O 117.856 -1.069 . . . . 75.11 113.077 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HA ' HD12 ' A' ' 106' ' ' LEU . 22.0 Cg_endo -62.63 -21.45 72.93 Favored 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.739 1.657 . . . . 42.55 113.398 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.06 -26.89 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.085 0.554 . . . . 65.2 110.213 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 33.4 mm -67.74 -41.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.356 0.598 . . . . 64.13 109.526 167.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 16' ' ' ILE . 68.8 mt -71.46 -25.68 62.4 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.015 -0.993 . . . . 72.22 111.315 -175.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.05 -43.4 67.11 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 117.709 -1.139 . . . . 72.53 114.005 -170.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.9 Cg_exo -55.47 -39.89 88.56 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.336 2.024 . . . . 71.43 113.633 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -77.08 -32.7 56.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.477 0.711 . . . . 72.52 111.871 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -46.68 70.03 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.343 -0.614 . . . . 44.22 109.343 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.499 ' NH1' HD12 ' C' ' 105' ' ' ILE . 35.4 ttm180 -53.5 -49.72 66.93 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.881 1.363 . . . . 75.0 110.443 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.61 -49.65 75.74 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.434 1.084 . . . . 75.1 110.849 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.2 -40.42 93.89 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 124.139 0.899 . . . . 71.54 111.584 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 64' ' ' VAL . 80.1 mt -65.31 -59.22 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 123.832 0.707 . . . . 74.32 110.061 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.0 m -55.54 -33.29 63.69 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.516 1.135 . . . . 74.43 111.533 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -71.67 -43.63 65.68 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.42 -0.809 . . . . 72.03 110.545 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 49.9 mtm -59.29 -41.71 89.61 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.146 0.43 . . . . 75.12 110.756 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.5 t -57.16 -50.31 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.526 -1.216 . . . . 61.13 110.422 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.48 -23.31 58.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.971 0.508 . . . . 70.23 111.692 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.46 -28.36 61.0 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.438 0.695 . . . . 74.25 109.609 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 8.07 71.85 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 115.537 -0.756 . . . . 53.41 112.497 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.626 HG22 ' HB3' ' B' ' 17' ' ' TYR . 7.1 t 48.13 43.74 18.69 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.693 1.997 . . . . 51.53 112.771 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.53 ' HE1' HG11 ' A' ' 31' ' ' VAL . 83.0 m-85 -99.1 158.54 32.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.749 -1.114 . . . . 61.31 108.657 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.62 149.86 64.81 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.602 2.201 . . . . 74.14 111.884 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -69.67 134.46 48.72 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.361 0.664 . . . . 63.32 111.704 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.11 112.19 23.4 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.544 -0.91 . . . . 71.23 108.544 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' C' ' 15' ' ' ARG . 80.5 m-20 -98.47 100.55 11.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.421 0.688 . . . . 74.34 109.531 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.6 mp -56.06 120.98 8.35 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.144 0.978 . . . . 70.24 110.05 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.58 85.88 Favored Pre-proline 0 C--O 1.242 0.695 0 O-C-N 123.56 0.537 . . . . 43.51 109.662 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.47 104.78 1.63 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.866 1.711 . . . . 75.35 111.692 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -99.93 110.76 27.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.618 -1.253 . . . . 72.51 107.618 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 11.4 t30 -79.86 90.93 5.31 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.613 -1.255 . . . . 71.52 107.613 176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.938 -1.028 . . . . 75.31 111.166 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.404 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . 4.7 m-20 . . . . . 0 C--O 1.217 -0.616 0 C-N-CA 125.121 1.368 . . . . 71.11 112.232 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.442 ' SD ' HD12 ' B' ' 89' ' ' ILE . 17.1 ptm . . . . . 0 N--CA 1.494 1.749 0 N-CA-C 114.262 1.208 . . . . 54.34 114.262 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.2 m -138.75 103.62 4.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.633 -1.247 . . . . 61.24 107.633 174.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -110.72 146.58 36.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.441 0.696 . . . . 74.44 109.462 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 49.4 tt0 -164.54 141.4 6.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.285 0.634 . . . . 55.13 110.333 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.27 131.28 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 108.759 -0.83 . . . . 74.23 108.759 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -101.15 -50.83 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.15 -0.315 . . . . 63.42 110.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -157.43 140.93 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.514 -0.312 . . . . 70.2 110.183 -171.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.6 mt -123.16 134.68 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.867 -1.531 . . . . 75.43 106.867 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.626 ' HB3' HG22 ' A' ' 122' ' ' THR . 9.2 p90 -166.97 147.12 5.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.428 0.899 . . . . 43.23 113.428 -172.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.2 m -73.68 122.04 21.69 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.059 -1.428 . . . . 63.05 108.837 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.9 mtpt -97.46 -29.05 13.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.669 0.788 . . . . 75.34 110.674 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 24.4 t70 -157.13 141.6 16.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.389 -0.369 . . . . 71.23 110.787 -169.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.429 HD12 HG22 ' B' ' 78' ' ' VAL . 47.0 mm -138.48 144.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.719 1.208 . . . . 72.42 109.366 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.562 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -136.98 138.44 40.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.948 1.299 . . . . 63.33 108.422 167.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -142.85 131.46 22.5 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.064 -1.828 . . . . 72.41 106.064 164.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.5 mt-10 -131.48 136.42 47.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.739 -0.837 . . . . 74.31 108.739 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -131.4 80.37 67.71 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 107.223 -1.399 . . . . 61.21 107.223 170.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.21 -33.48 60.1 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.527 2.151 . . . . 52.33 110.779 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.448 ' O ' HG23 ' B' ' 31' ' ' VAL . 83.4 m-20 -118.77 24.29 10.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.581 1.152 . . . . 74.1 110.0 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -38.14 -56.18 2.11 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 115.053 1.501 . . . . 55.01 115.053 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.8 Cg_endo -82.21 -6.63 12.04 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.338 2.026 . . . . 40.24 113.332 -176.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.443 ' HA ' HE22 ' B' ' 33' ' ' GLN . 72.2 m80 -96.82 -24.22 16.0 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.696 0.798 . . . . 72.43 111.572 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' B' ' 73' ' ' ALA . 59.8 t -82.3 -6.66 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.584 0.754 . . . . 70.15 110.085 173.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.66 -43.27 72.26 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.277 1.031 . . . . 73.41 111.155 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.443 HE22 ' HA ' ' B' ' 30' ' ' HIS . 0.8 OUTLIER -72.81 -32.83 65.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.543 0.737 . . . . 74.14 110.151 -178.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.18 85.16 4.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.1 -0.955 . . . . 55.45 110.426 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.54 77.41 9.31 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.746 0.784 . . . . 71.33 108.967 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.474 ' HB2' HD21 ' B' ' 68' ' ' LEU . 5.9 m-90 -151.88 158.0 42.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.387 1.475 . . . . 73.12 108.294 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.94 113.74 45.33 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.151 -1.055 . . . . 64.32 108.151 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 56.7 Cg_endo -68.43 160.74 47.86 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.402 2.068 . . . . 73.4 112.572 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.0 tt0 -60.27 103.73 0.26 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.072 0.858 . . . . 71.35 110.046 175.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.13 135.41 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.064 -0.717 . . . . 62.11 109.064 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -142.41 134.99 28.08 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.871 -0.788 . . . . 72.11 108.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.23 123.49 48.37 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.751 -1.203 . . . . 74.11 107.751 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.628 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 8.8 m-20 -122.9 111.49 16.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.671 -1.233 . . . . 71.51 107.671 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.603 HD21 HG11 ' B' ' 131' ' ' VAL . 7.5 mp -100.31 143.3 30.66 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.365 0.666 . . . . 60.43 110.178 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.9 t70 -147.59 147.12 29.73 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.524 1.13 . . . . 65.43 108.129 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -132.53 124.56 28.72 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.311 0.644 . . . . 72.14 109.815 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.64 154.87 30.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.175 0.99 . . . . 40.33 108.49 173.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.1 p -145.46 161.18 40.33 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.236 0.614 . . . . 72.23 110.085 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.4 p -169.08 159.96 9.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.03 0.932 . . . . 74.2 109.482 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -118.08 134.98 54.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.06 0.544 . . . . 61.01 109.806 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.31 -49.18 5.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.86 0.864 . . . . 74.21 110.695 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 -172.8 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.331 -0.85 . . . . 54.0 110.376 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.55 107.62 1.77 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.36 1.037 . . . . 73.11 110.789 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' B' ' 85' ' ' SER . 21.3 m-20 77.82 1.07 2.85 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 126.516 1.926 . . . . 62.2 111.3 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.57 88.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.341 -1.355 . . . . 74.52 107.341 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -95.75 165.69 12.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.604 -0.888 . . . . 71.33 108.604 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.81 113.74 7.98 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.754 -1.202 . . . . 73.33 107.754 -174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.09 127.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.39 0.676 . . . . 64.24 109.745 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 27.9 t -103.27 131.99 50.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.926 0.89 . . . . 71.32 109.308 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -116.21 112.04 21.05 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.401 -1.333 . . . . 73.52 107.401 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 28.7 ttm180 -100.02 121.95 42.16 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.853 -0.425 . . . . 75.4 109.853 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' B' ' 114' ' ' ILE . 17.4 t -117.22 133.64 63.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.477 -1.305 . . . . 71.41 107.477 168.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.4 m -119.09 134.35 55.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.063 -0.717 . . . . 63.43 109.063 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.569 HG23 HD13 ' B' ' 114' ' ' ILE . 63.7 t -117.15 104.8 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.91 0.884 . . . . 73.0 108.839 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.0 m -97.48 140.85 31.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.121 -1.399 . . . . 75.0 108.871 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -141.5 134.22 28.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.327 0.392 . . . . 43.13 110.359 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -140.36 135.83 32.54 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.31 0.644 . . . . 72.14 109.312 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 17.1 tp -136.55 124.0 22.11 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.227 0.611 . . . . 74.23 109.486 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.1 -116.85 4.47 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.656 -0.702 . . . . 64.42 111.505 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.81 19.75 13.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.352 1.061 . . . . 73.32 109.693 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -156.23 176.63 12.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.895 0.478 . . . . 74.12 111.038 -170.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -72.58 141.93 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.618 0.767 . . . . 73.34 110.563 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -94.32 -59.24 2.0 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.038 -0.727 . . . . 42.12 109.038 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -157.89 168.76 26.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.871 -1.059 . . . . 73.52 109.886 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 78.8 mt -141.04 140.69 34.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.37 1.468 . . . . 63.21 107.251 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.8 t -148.99 155.47 40.85 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.877 -0.786 . . . . 75.31 108.877 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.6 tt0 -164.49 138.47 5.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.899 -0.778 . . . . 74.21 108.899 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.429 HG22 HD12 ' B' ' 21' ' ' ILE . 92.4 t -134.54 145.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.93 0.892 . . . . 65.22 109.098 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.5 mt-30 -122.08 94.15 4.21 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.289 -1.004 . . . . 73.33 108.289 170.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.417 ' O ' HD13 ' B' ' 106' ' ' LEU . 7.8 tp-100 -84.54 101.15 11.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.731 -0.84 . . . . 73.33 108.731 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.53 165.83 31.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.27 -0.732 . . . . 60.44 111.27 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.66 133.73 3.54 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 112.325 -0.31 . . . . 71.33 112.325 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.479 HG13 ' HE1' ' B' ' 17' ' ' TYR . 63.6 mt -86.32 123.39 39.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.875 -0.787 . . . . 71.42 108.875 171.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.28 135.24 46.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.627 1.171 . . . . 75.12 109.077 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.568 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 53.5 m -101.81 106.35 17.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.81 0.844 . . . . 71.22 109.009 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.57 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -126.03 131.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.881 0.873 . . . . 74.35 109.417 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 160.6 40.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.136 0.974 . . . . 73.31 109.022 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 -29.09 3.98 Favored Glycine 0 N--CA 1.473 1.118 0 N-CA-C 114.281 0.472 . . . . 65.4 114.281 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.442 HD12 ' SD ' ' B' ' 9' ' ' MET . 16.0 tt -83.03 152.35 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.975 0.91 . . . . 51.41 110.352 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 166.07 32.7 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.172 0.511 . . . . 72.3 112.008 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.82 30.53 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 114.761 -1.109 . . . . 40.41 113.848 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 47.4 m -65.04 -33.81 76.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.97 0.908 . . . . 72.24 110.611 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.54 -51.98 66.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.109 -0.951 . . . . 72.31 110.381 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -62.6 -41.06 98.74 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.805 0.842 . . . . 54.32 111.388 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.8 81.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.007 0.817 . . . . 73.45 112.09 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -95.99 -12.32 25.17 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.539 0.336 . . . . 64.44 111.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -80.38 -65.02 1.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.659 -0.497 . . . . 74.21 109.659 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 20.6 tp -75.89 -28.31 58.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.085 -0.507 . . . . 63.34 110.468 -177.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.2 -34.06 18.6 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.754 -0.657 . . . . 50.03 114.294 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.86 -41.3 2.12 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.05 0.925 . . . . 65.21 113.075 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -76.94 -39.93 48.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.803 0.441 . . . . 74.42 111.29 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -66.34 -45.51 59.9 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.698 -0.668 . . . . 74.21 110.782 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.432 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 85.6 Cg_exo -55.73 -35.74 93.85 Favored 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 122.49 2.127 . . . . 63.55 113.896 163.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.673 0.389 . . . . 55.52 111.425 -178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.96 -44.51 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.078 0.951 . . . . 72.44 110.001 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.417 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.7 mt -75.43 -23.52 56.98 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.853 -1.067 . . . . 75.4 112.37 -173.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.87 -48.07 95.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 113.936 1.087 . . . . 75.35 113.936 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.33 -34.47 94.13 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.153 1.902 . . . . 72.32 113.383 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.63 -43.82 62.75 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.228 0.611 . . . . 64.25 110.316 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.51 -39.57 80.45 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 123.49 0.716 . . . . 72.25 110.135 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 61.0 ttt180 -56.46 -63.98 1.02 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.749 1.22 . . . . 73.11 111.128 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.01 -28.69 69.67 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.112 0.882 . . . . 73.31 110.785 -171.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -69.27 -42.77 75.11 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.846 0.458 . . . . 40.52 110.843 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.569 HD13 HG23 ' B' ' 64' ' ' VAL . 93.5 mt -62.97 -53.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.204 0.602 . . . . 73.24 110.045 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -59.26 -33.11 70.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.508 -1.223 . . . . 70.54 110.796 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.3 t -62.87 -53.66 50.68 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.123 -0.944 . . . . 62.32 109.942 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.54 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 14.4 mmt -60.29 -34.99 74.54 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.195 0.598 . . . . 52.41 111.965 -175.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.77 -48.64 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.833 0.853 . . . . 65.13 111.005 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 61.0 p -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.915 0.486 . . . . 72.33 111.615 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.54 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 86.5 mtt-85 -68.18 -37.63 81.16 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.392 0.677 . . . . 73.14 109.324 171.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 11.88 54.29 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.133 0.895 . . . . 72.24 113.41 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.8 p 53.14 39.68 30.01 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.662 1.585 . . . . 64.43 112.341 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.596 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 65.5 m-85 -108.44 159.74 29.67 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 124.759 1.224 . . . . 73.4 110.336 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 106.66 0.2 Allowed 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 123.037 2.491 . . . . 51.41 112.483 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' C' ' 125' ' ' GLN . 12.9 pt20 -50.03 125.26 11.72 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.284 1.434 . . . . 65.44 111.598 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.29 112.97 25.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.276 -1.009 . . . . 73.3 108.276 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -90.38 129.73 36.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.688 0.795 . . . . 63.41 109.091 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.453 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -77.5 107.38 9.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.015 0.926 . . . . 63.13 109.214 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.26 152.55 96.45 Favored Pre-proline 0 CA--C 1.554 1.107 0 CA-C-N 115.704 -0.68 . . . . 63.21 109.695 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.4 111.21 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.427 2.752 . . . . 73.24 113.034 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . 0.603 HG11 HD21 ' B' ' 44' ' ' LEU . 48.5 t -88.65 110.09 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.743 -1.577 . . . . 53.15 106.743 168.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.64 91.61 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -56.09 -42.76 77.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.091 0.956 . . . . 72.44 111.25 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.07 -54.59 45.31 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.49 -1.232 . . . . 72.32 110.908 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.1 63.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.449 -0.796 . . . . 72.11 112.164 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt . . . . . 0 N--CA 1.488 1.464 0 C-N-CA 124.196 0.998 . . . . 71.21 109.595 -176.723 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.2 ttm . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 121.397 0.618 . . . . 52.31 111.798 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -85.78 85.93 7.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.879 -0.786 . . . . 72.41 108.879 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.405 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -105.17 121.49 43.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.389 -1.278 . . . . 73.31 108.093 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.23 137.2 38.83 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.367 -0.605 . . . . 64.3 109.367 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 49.5 mt -81.29 121.51 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.105 -0.952 . . . . 74.0 109.241 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -89.47 -49.6 6.59 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.194 0.598 . . . . 72.43 109.965 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.487 ' HA ' HD21 ' A' ' 127' ' ' ASN . 53.2 ttt180 -164.01 122.69 1.91 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.61 0.364 . . . . 72.24 110.538 -176.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.62 136.33 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.468 -0.938 . . . . 71.44 108.468 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 36.0 p90 -169.07 165.65 11.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.108 0.956 . . . . 74.43 112.855 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -87.01 111.73 21.15 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.732 -1.576 . . . . 65.43 108.838 173.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 57.9 mmtt -65.29 -48.46 73.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.389 1.09 . . . . 74.13 108.49 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -134.62 140.4 46.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.133 -1.848 . . . . 70.34 109.207 -170.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.6 mt -137.13 143.45 34.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.074 -1.454 . . . . 64.41 107.074 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -160.63 151.04 18.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.389 0.614 . . . . 45.12 109.86 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -152.72 115.22 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.282 -1.377 . . . . 72.21 107.282 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -116.08 109.14 17.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.304 -0.628 . . . . 74.44 109.304 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.15 85.28 15.12 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.382 1.073 . . . . 64.31 108.113 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -35.23 20.29 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 121.927 1.751 . . . . 35.33 110.382 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 77.7 m-20 -98.55 30.58 3.19 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.712 1.205 . . . . 75.43 110.29 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.15 99.96 Favored Pre-proline 0 CA--C 1.57 1.727 0 C-N-CA 124.558 1.143 . . . . 62.52 112.591 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.35 -18.37 4.07 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.169 1.913 . . . . 73.32 113.189 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.434 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -69.75 -41.33 75.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.447 0.699 . . . . 73.44 110.529 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.695 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.1 p -66.63 -16.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.553 1.141 . . . . 75.31 112.311 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -62.36 -37.19 84.74 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.087 1.355 . . . . 72.24 112.059 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -118.77 24.93 10.57 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.826 0.822 . . . . 72.54 109.398 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 20.1 ttpp -123.53 176.12 6.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.05 0.54 . . . . 51.42 110.675 -170.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' C' ' 37' ' ' GLN . 5.0 p-10 -55.24 120.74 7.5 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.379 1.072 . . . . 71.33 111.203 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -90.02 63.31 5.88 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.899 -0.592 . . . . 74.43 109.525 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' C' ' 35' ' ' ASP . 15.4 pt20 -146.16 64.57 9.99 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-O 121.19 0.519 . . . . 65.14 111.147 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.04 134.12 8.05 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 121.724 1.616 . . . . 64.21 110.648 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -84.52 93.67 8.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.37 -1.344 . . . . 75.23 107.37 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 65.8 t -67.39 133.19 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.445 -1.252 . . . . 70.54 110.413 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -130.04 130.22 44.66 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.554 -1.276 . . . . 64.3 107.554 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.596 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.4 pt? -95.49 133.3 39.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.367 -0.975 . . . . 71.03 108.367 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -118.88 141.03 49.02 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.955 -1.498 . . . . 74.2 106.955 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -134.06 143.03 47.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.047 0.451 . . . . 64.45 110.205 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -147.5 149.7 33.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.261 1.024 . . . . 64.01 108.655 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 14.5 t -130.99 144.1 51.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.809 0.444 . . . . 74.02 110.437 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.01 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.282 1.033 . . . . 75.4 108.433 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -130.83 142.37 50.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.834 0.453 . . . . 52.02 110.344 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -160.6 133.41 6.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.815 0.846 . . . . 72.42 109.814 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.21 133.44 40.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.11 0.564 . . . . 53.22 110.168 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' C' ' 57' ' ' GLU . 49.0 mt -102.7 -38.56 7.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.226 0.61 . . . . 72.42 110.253 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.19 178.77 9.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.835 0.854 . . . . 62.31 110.097 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.93 116.87 5.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.184 -0.916 . . . . 63.5 109.112 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.98 0.11 2.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.332 1.453 . . . . 75.43 113.11 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 53.4 t -109.69 108.43 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.301 -0.629 . . . . 75.43 109.301 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -113.59 161.65 17.17 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.923 0.889 . . . . 70.21 109.036 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.53 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.0 tt0 -124.25 141.45 52.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.985 0.914 . . . . 72.24 108.808 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.41 HG23 HD11 ' C' ' 106' ' ' LEU . 24.6 m -129.37 134.53 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 122.916 0.486 . . . . 70.24 109.933 168.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' C' ' 46' ' ' THR . 58.0 t -103.41 128.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.681 -1.229 . . . . 73.24 107.681 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.5 96.43 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.133 -1.062 . . . . 73.35 108.133 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -86.47 114.81 23.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.175 -1.375 . . . . 62.13 110.49 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.35 109.94 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.736 -0.838 . . . . 65.03 108.736 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -103.55 113.48 27.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.194 0.521 . . . . 71.23 109.603 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.513 HG23 HD13 ' C' ' 114' ' ' ILE . 71.1 t -100.8 109.75 26.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 123.571 0.748 . . . . 55.03 109.206 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 15.2 m -102.0 127.31 48.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.155 -0.683 . . . . 64.1 109.155 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.72 100.2 6.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.651 -1.24 . . . . 55.2 107.651 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -151.15 147.08 26.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.702 -0.681 . . . . 74.42 109.961 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.77 -14.56 56.27 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.254 -0.43 . . . . 73.41 109.919 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.47 -102.18 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 110.977 -0.849 . . . . 71.41 110.977 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.39 -23.38 26.14 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.685 -0.857 . . . . 64.54 108.685 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -79.67 100.87 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.269 1.028 . . . . 64.0 109.02 174.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.0 m -88.97 128.56 35.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.549 -0.75 . . . . 74.21 110.429 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.29 -56.71 4.45 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 44.15 107.914 170.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -154.87 155.92 35.22 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.002 -0.999 . . . . 63.41 110.816 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.406 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -121.7 143.63 49.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.358 -2.09 . . . . 73.4 105.358 170.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.6 t -147.08 145.66 29.71 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.258 -1.015 . . . . 63.01 108.258 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.0 128.33 6.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.86 0.362 . . . . 72.41 110.42 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -131.13 139.15 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.69 1.196 . . . . 63.24 108.495 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -113.66 94.69 4.96 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.515 -0.921 . . . . 75.31 108.515 171.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.462 ' O ' HD13 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.77 98.13 7.63 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.319 -0.855 . . . . 74.4 109.114 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.89 144.6 17.24 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.286 -0.726 . . . . 73.22 111.286 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -140.77 128.36 3.74 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 112.369 -0.292 . . . . 71.02 112.369 -172.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -91.43 122.96 43.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.898 -1.149 . . . . 64.22 107.898 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -137.84 121.77 17.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.613 0.765 . . . . 72.41 109.61 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 p -84.22 113.4 21.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 64.4 109.127 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 44.2 pt -115.18 127.47 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.577 0.703 . . . . 60.43 109.687 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.62 154.25 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.475 1.11 . . . . 62.31 108.485 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -18.82 38.97 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 120.426 -0.097 . . . . 75.25 112.866 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' C' ' 93' ' ' GLN . 10.7 tp -123.3 151.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.89 0.876 . . . . 71.13 109.488 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.497 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 14.3 pt-20 -159.82 -179.58 7.96 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.041 0.537 . . . . 63.04 111.183 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.35 -149.35 50.85 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.456 -0.793 . . . . 64.54 114.3 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.7 p -60.79 -24.33 65.72 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.506 1.122 . . . . 74.21 112.002 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.421 ' HB3' HD11 ' C' ' 89' ' ' ILE . 16.0 mt-30 -67.72 -51.1 53.31 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.7 1.2 . . . . 64.32 111.189 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.497 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 21.2 ptt? -70.88 -24.4 62.48 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.917 -0.401 . . . . 61.25 109.917 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.09 84.53 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.715 0.634 . . . . 73.41 110.7 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -63.87 -37.7 88.35 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.504 0.502 . . . . 62.23 110.667 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -65.54 -55.47 17.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.751 -0.463 . . . . 72.44 109.751 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.25 -16.26 63.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.792 0.837 . . . . 71.51 112.238 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.11 3.77 26.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.478 -0.624 . . . . 62.34 114.114 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.13 -64.73 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.558 0.679 . . . . 71.54 110.483 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.63 -55.36 31.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.958 0.503 . . . . 55.03 112.211 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 18.2 m -60.97 -47.09 96.52 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.574 -0.726 . . . . 64.12 111.883 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 70.6 Cg_exo -50.23 -38.9 52.39 Favored 'Trans proline' 0 C--N 1.396 3.045 0 C-N-CA 122.767 2.311 . . . . 71.11 114.478 165.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.46 -25.52 63.22 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.516 0.726 . . . . 75.13 111.765 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.499 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.54 -41.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.169 0.588 . . . . 74.03 109.665 171.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.462 HD13 ' O ' ' C' ' 80' ' ' GLN . 95.9 mt -75.3 -26.36 58.63 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.074 -0.966 . . . . 63.13 111.848 -175.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.4 -44.01 94.67 Favored Pre-proline 0 CA--C 1.565 1.534 0 CA-C-O 117.637 -1.173 . . . . 73.24 113.764 -172.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.76 -46.22 33.36 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.604 2.203 . . . . 74.21 113.752 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.28 -43.39 77.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.75 0.82 . . . . 72.51 110.908 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.47 98.81 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.637 -0.71 . . . . 63.22 110.317 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -57.48 -50.0 74.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.579 1.152 . . . . 73.21 111.053 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.63 -31.78 71.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.244 0.618 . . . . 70.44 110.212 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.7 t -71.37 -29.7 65.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.217 0.607 . . . . 74.33 111.221 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.513 HD13 HG23 ' C' ' 64' ' ' VAL . 80.8 mt -80.03 -48.65 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 73.13 110.248 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 43.4 m -60.57 -32.11 71.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.664 0.786 . . . . 72.54 110.818 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -61.63 -51.64 67.66 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.248 -0.887 . . . . 72.24 109.34 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.545 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.53 -38.96 92.03 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.71 1.204 . . . . 72.13 113.078 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.0 t -60.2 -45.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.199 1.0 . . . . 72.12 109.253 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -70.41 -31.11 68.17 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.159 -1.382 . . . . 73.43 111.544 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -70.63 -35.67 73.04 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.63 0.772 . . . . 73.43 109.891 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.2 -0.91 90.43 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.32 -0.711 . . . . 44.55 113.173 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p 59.14 62.6 1.8 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.704 1.602 . . . . 73.13 111.693 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 63.1 m-85 -123.57 161.98 42.92 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 114.39 -1.277 . . . . 73.12 110.096 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 30.7 Cg_endo -61.57 158.3 37.45 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.236 2.624 . . . . 73.34 114.317 -173.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -59.61 119.69 8.05 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.022 0.929 . . . . 64.24 110.403 -175.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 54.3 tp -131.01 114.44 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.298 -0.865 . . . . 45.13 108.905 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -123.79 129.71 51.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.425 -0.954 . . . . 74.04 108.425 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 90.9 mt -86.79 121.76 29.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.174 0.59 . . . . 64.21 110.41 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.39 88.33 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 123.414 0.686 . . . . 61.12 110.19 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.448 ' HG2' HD12 ' A' ' 13' ' ' ILE . 42.4 Cg_endo -68.19 143.06 57.71 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.076 1.851 . . . . 65.35 112.136 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.6 108.78 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.773 -1.195 . . . . 65.35 107.773 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -98.48 90.7 4.86 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.463 0.649 . . . . 72.03 111.348 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -75.23 -29.61 60.31 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.925 -1.034 . . . . 75.11 109.425 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 . . . . . 0 CA--C 1.544 0.744 0 CA-C-N 114.476 -1.238 . . . . 65.04 111.312 177.021 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' D' ' 87' ' ' ALA . 7.9 ttp . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 113.189 0.811 . . . . 64.53 113.189 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.8 m -122.57 142.74 50.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.631 -0.877 . . . . 72.21 108.631 173.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' D' ' 85' ' ' SER . 57.3 t80 -154.09 101.36 2.4 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.125 -1.065 . . . . 61.44 108.125 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -132.08 147.0 52.42 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.837 0.855 . . . . 74.32 109.336 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -102.49 105.8 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.672 -0.862 . . . . 72.52 108.672 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -74.84 -45.23 44.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.4 1.08 . . . . 74.12 112.098 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.421 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 54.7 ttt180 -155.3 129.55 8.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.181 0.193 . . . . 72.45 110.512 -170.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.509 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.5 mp -114.43 126.71 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.606 1.162 . . . . 74.14 107.877 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.421 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 38.0 p90 -162.87 177.32 9.37 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.946 0.879 . . . . 73.03 112.884 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -112.95 129.61 56.42 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.472 -1.24 . . . . 62.25 109.059 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -98.46 -25.05 14.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.758 0.423 . . . . 74.12 110.782 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.6 t70 -149.81 132.59 15.98 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.733 -0.839 . . . . 73.02 108.733 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.545 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.1 mt -131.83 146.62 33.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.805 -1.183 . . . . 71.23 107.805 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -148.35 142.46 26.0 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.315 1.046 . . . . 70.24 108.913 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.8 t80 -151.62 124.3 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.219 -1.771 . . . . 71.42 106.219 170.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -131.28 122.65 26.82 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.881 0.872 . . . . 75.33 109.18 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.65 85.0 13.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.573 -0.899 . . . . 60.01 108.573 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.83 -31.58 10.09 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.44 2.094 . . . . 71.33 113.056 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.9 m-20 -114.37 41.65 2.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.429 1.092 . . . . 53.33 108.639 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -55.05 -52.75 68.45 Favored Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 115.306 1.595 . . . . 63.14 115.306 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' NZ ' ' C' ' 19' ' ' LYS . 19.3 Cg_endo -91.06 2.69 4.6 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.8 1.667 . . . . 65.42 112.474 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 17.3 t-160 -84.39 -42.09 16.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.648 1.179 . . . . 61.52 108.954 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.2 t -78.16 -11.62 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 C-N-CA 123.595 0.758 . . . . 74.01 110.402 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -55.32 -36.41 66.21 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.954 0.902 . . . . 74.33 111.853 167.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -83.18 -1.72 53.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.653 0.781 . . . . 71.0 112.606 -172.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.422 ' HD3' ' HG ' ' D' ' 68' ' ' LEU . 14.3 ptpt -127.56 107.81 10.25 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.387 0.675 . . . . 73.45 111.155 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.19 92.6 8.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.165 0.986 . . . . 60.03 109.72 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.593 ' HB3' HD11 ' D' ' 68' ' ' LEU . 25.1 t-105 -161.6 166.85 26.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.593 -0.892 . . . . 71.54 108.593 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.8 111.64 39.14 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.284 1.034 . . . . 75.33 109.109 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.61 142.6 49.25 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.968 2.445 . . . . 71.33 113.263 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -75.8 122.55 24.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.144 -0.687 . . . . 63.44 109.144 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.421 HG13 HG13 ' D' ' 64' ' ' VAL . 61.6 t -99.24 135.34 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.836 0.854 . . . . 72.34 110.988 -173.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -110.56 138.01 47.5 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.221 -1.029 . . . . 72.04 108.221 164.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.698 HD22 HD11 ' D' ' 128' ' ' LEU . 48.5 tp -101.76 142.41 33.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.024 -1.102 . . . . 61.51 108.024 171.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.587 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.4 t70 -140.73 128.2 21.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.283 -1.006 . . . . 74.4 108.283 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.6 mt -118.48 150.4 39.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.032 0.533 . . . . 70.11 110.786 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.6 t70 -152.62 132.34 13.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.095 1.358 . . . . 74.52 107.699 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -109.21 153.21 24.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.195 0.522 . . . . 54.25 109.987 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.71 165.65 35.32 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.279 1.032 . . . . 71.43 108.692 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -166.56 161.52 16.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.273 0.629 . . . . 64.33 111.334 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -151.27 152.8 33.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.483 1.113 . . . . 71.42 108.843 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -92.04 119.06 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.031 -0.359 . . . . 72.21 110.031 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' D' ' 57' ' ' GLU . 30.9 mt -92.58 -35.79 13.37 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.071 0.548 . . . . 75.32 110.312 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.07 -176.41 5.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.808 0.843 . . . . 65.51 110.24 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.72 107.64 0.63 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.709 0.804 . . . . 63.44 110.525 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 5.9 m-20 62.21 15.91 7.93 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.191 0.996 . . . . 71.32 112.473 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 20.4 t -107.51 125.38 63.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.028 -1.101 . . . . 71.14 108.028 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.23 133.52 45.55 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.759 -0.655 . . . . 74.31 110.849 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.6 tt0 -87.29 111.8 21.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.557 -1.275 . . . . 73.33 107.557 168.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.71 120.04 47.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 N-CA-C 107.458 -1.312 . . . . 53.14 107.458 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 92.1 t -99.69 140.27 19.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 123.603 0.761 . . . . 64.34 109.488 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.72 122.58 38.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.487 -0.931 . . . . 71.23 108.487 179.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 43.3 ttm-85 -102.42 105.94 16.6 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.12 0.968 . . . . 65.35 108.496 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.3 t -105.97 120.65 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.208 -1.034 . . . . 62.34 108.208 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.8 m -123.96 130.71 53.04 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.413 0.685 . . . . 63.05 109.876 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.521 HG23 HD13 ' D' ' 114' ' ' ILE . 90.7 t -116.21 117.86 56.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.878 1.271 . . . . 60.54 109.35 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -111.88 93.73 4.6 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.886 -1.153 . . . . 61.52 107.886 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.57 137.18 42.79 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.304 0.641 . . . . 71.31 109.764 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.7 p -142.39 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.357 0.663 . . . . 75.11 109.52 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' D' ' 36' ' ' TRP . 15.2 tp -120.26 115.98 24.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.195 0.598 . . . . 53.22 109.422 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 -123.68 6.28 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.067 -0.813 . . . . 42.31 111.067 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.25 4.36 20.83 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.45 0.7 . . . . 73.11 110.663 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.03 162.98 16.26 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.711 0.805 . . . . 52.03 109.74 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.2 m -76.23 136.79 39.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.548 -0.538 . . . . 71.14 109.548 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -93.07 -55.28 3.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.25 -0.886 . . . . 71.31 109.434 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -163.14 154.61 17.39 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.137 -0.938 . . . . 72.5 109.745 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.84 148.42 48.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.723 1.209 . . . . 51.33 108.184 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' D' ' 114' ' ' ILE . 46.4 t -157.53 147.36 20.4 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.818 0.447 . . . . 64.22 110.244 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -156.45 133.23 10.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 74.14 109.482 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -133.22 117.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.163 0.585 . . . . 64.41 109.846 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -91.31 88.49 6.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.661 0.785 . . . . 70.41 110.053 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.57 102.61 9.89 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.881 1.272 . . . . 70.23 109.355 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.74 141.43 15.63 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.626 -0.589 . . . . 43.12 111.626 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.66 132.04 5.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.138 -0.785 . . . . 70.21 111.138 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -89.06 108.22 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.34 -0.615 . . . . 73.11 109.34 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.03 126.16 51.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.761 0.824 . . . . 73.43 110.09 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 42.7 m -78.2 114.36 17.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.823 0.849 . . . . 71.13 108.945 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 73.3 mt -108.14 144.11 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.131 -1.433 . . . . 65.34 107.131 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' D' ' 9' ' ' MET . . . -162.05 151.44 15.97 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.262 -0.644 . . . . 75.05 109.262 173.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 1.76 53.83 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 123.815 0.697 . . . . 74.52 114.782 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.52 139.36 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.443 0.697 . . . . 53.13 110.574 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 -171.0 3.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.046 0.939 . . . . 75.22 110.386 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.8 -133.79 14.12 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.52 0.512 . . . . 71.33 113.221 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -63.81 -37.54 87.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.688 0.795 . . . . 64.01 111.386 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -71.24 -36.45 71.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.96 0.504 . . . . 55.42 112.147 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -70.13 -34.7 73.39 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.443 0.565 . . . . 64.14 109.926 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.9 -31.38 69.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.643 0.777 . . . . 63.24 110.677 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -75.32 -30.41 60.32 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.65 1.18 . . . . 74.34 110.527 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.485 ' HB3' ' SG ' ' D' ' 102' ' ' CYS . 73.5 m -68.36 -51.32 45.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.557 -0.534 . . . . 72.43 109.557 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.22 -24.32 64.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.024 0.53 . . . . 51.33 111.441 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.46 -0.4 37.47 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.799 -1.0 . . . . 71.42 114.719 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.87 -62.58 0.11 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.47 1.135 . . . . 55.21 112.408 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.97 -49.34 29.74 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.775 0.657 . . . . 70.15 112.775 -164.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' D' ' 97' ' ' CYS . 58.7 m -63.9 -45.89 81.14 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.541 -0.742 . . . . 53.41 111.691 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.448 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 89.3 Cg_exo -54.06 -35.31 81.07 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.723 2.282 . . . . 74.45 113.83 166.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.244 0.618 . . . . 63.12 111.258 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -67.46 -43.33 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.561 0.744 . . . . 64.3 110.314 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.3 mt -75.52 -23.42 56.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.982 -1.008 . . . . 74.44 112.35 -173.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -64.98 -42.42 61.97 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 117.917 -1.039 . . . . 62.23 113.694 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.05 -42.87 63.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.113 1.876 . . . . 70.3 113.4 170.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -72.83 -36.69 67.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.817 0.847 . . . . 73.23 111.619 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.57 -43.12 77.25 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.451 0.7 . . . . 73.1 110.462 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -59.58 -48.18 82.66 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.2 1.0 . . . . 54.1 110.291 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.53 -46.17 91.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.26 0.975 . . . . 72.12 111.372 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -57.84 -41.15 81.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.186 0.929 . . . . 72.44 110.575 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.521 HD13 HG23 ' D' ' 64' ' ' VAL . 84.3 mt -60.0 -58.64 6.32 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 O-C-N 123.924 0.765 . . . . 70.13 110.145 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 5.6 m -54.02 -41.74 68.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.645 1.178 . . . . 61.02 111.492 -170.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -65.06 -44.87 87.57 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.575 -1.193 . . . . 71.1 110.552 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.2 mtm -68.91 -31.25 70.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.041 0.537 . . . . 73.41 112.232 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.7 t -70.56 -38.94 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.442 0.697 . . . . 74.3 110.058 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.95 -28.6 57.98 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.626 0.37 . . . . 63.35 110.803 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -70.37 -31.41 68.65 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.553 0.741 . . . . 75.22 109.34 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.55 8.52 64.89 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.324 -0.853 . . . . 60.03 112.58 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.417 ' HG1' ' HE ' ' C' ' 15' ' ' ARG . 36.8 p 55.71 26.25 9.18 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.401 1.881 . . . . 75.34 113.809 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 43.8 m-85 -96.9 164.88 17.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 73.45 108.858 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.69 143.58 94.83 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.254 1.969 . . . . 75.3 110.027 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -65.0 150.95 47.17 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.368 0.531 . . . . 55.32 110.839 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.48 100.21 9.79 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.59 92.38 5.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.276 -1.009 . . . . 62.11 108.276 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.698 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -70.8 115.07 9.52 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.104 -1.073 . . . . 75.42 108.104 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -71.65 132.75 85.09 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.489 0.716 . . . . 53.35 111.445 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.5 Cg_exo -65.15 127.34 18.16 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.242 2.628 . . . . 64.52 112.458 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.61 152.07 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.864 0.866 . . . . 54.12 110.49 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -74.69 109.46 8.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.354 0.661 . . . . 75.14 110.607 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 . . . . . 0 N--CA 1.482 1.162 0 C-N-CA 124.118 0.967 . . . . 73.01 111.702 -178.975 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.4 m . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 108.342 -0.985 . . . . 64.15 108.342 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -139.91 114.27 9.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.362 -0.977 . . . . 72.22 108.362 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -150.46 136.73 18.69 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.733 0.301 . . . . 74.3 111.262 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.415 1.086 . . . . 72.15 110.67 169.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.14 -44.56 5.41 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 74.23 109.247 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD2' ' HZ ' ' B' ' 32' ' ' PHE . 78.3 mtt180 -158.79 153.32 24.36 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.328 1.051 . . . . 73.42 110.86 172.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.658 HG23 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -123.2 119.62 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.116 -1.809 . . . . 65.41 106.116 173.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 34.9 p90 -160.03 167.77 27.13 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 120.947 0.403 . . . . 74.54 111.674 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -91.31 118.29 30.37 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.861 -0.422 . . . . 73.34 109.861 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.04 -26.39 29.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.733 0.413 . . . . 74.55 111.052 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.43 148.3 21.39 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.221 -0.659 . . . . 73.44 109.221 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.6 mt -145.38 142.6 22.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.233 1.413 . . . . 64.22 107.522 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -148.0 136.73 21.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.401 0.681 . . . . 74.3 109.325 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.443 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 79.1 t80 -136.21 143.04 44.15 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.209 -1.404 . . . . 54.22 107.209 171.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.38 147.58 39.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.884 0.873 . . . . 74.14 109.159 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 72.09 11.72 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.613 -1.625 . . . . 52.33 106.613 167.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 -24.44 36.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.228 1.952 . . . . 54.11 111.188 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 58.9 m-20 -113.61 33.51 5.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.519 1.128 . . . . 62.54 109.09 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.98 99.34 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 123.834 0.854 . . . . 72.54 113.04 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.73 -29.31 35.95 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 121.637 1.558 . . . . 74.14 113.006 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.2 m-70 -74.46 -35.77 63.31 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.702 0.401 . . . . 75.43 111.653 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.29 -21.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 121.09 0.471 . . . . 64.53 110.712 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -74.77 -39.66 61.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.498 0.719 . . . . 63.43 110.399 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.22 -26.78 32.97 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.516 0.726 . . . . 64.04 110.771 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.45 173.38 10.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.43 0.692 . . . . 64.41 111.373 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -72.94 138.06 45.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.875 0.87 . . . . 60.14 110.722 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -84.88 69.62 10.78 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.801 0.81 . . . . 74.22 109.57 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -129.23 73.47 81.66 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.039 -0.982 . . . . 70.02 108.711 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.43 158.76 10.96 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.549 2.166 . . . . 44.11 112.173 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.43 127.89 44.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.769 -0.826 . . . . 71.33 108.769 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.03 94.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 123.75 0.656 . . . . 55.44 109.28 176.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -102.86 115.03 29.8 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.702 -1.221 . . . . 73.44 107.702 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.91 148.57 43.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.378 0.671 . . . . 75.34 109.702 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 27.7 m-20 -141.35 149.07 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.979 1.311 . . . . 74.52 108.847 170.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.92 160.93 22.46 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.064 -0.717 . . . . 52.23 109.064 169.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -159.28 144.64 15.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.492 0.717 . . . . 75.1 109.368 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 m -127.33 135.52 50.65 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.086 0.954 . . . . 74.44 108.829 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.83 133.02 45.57 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.157 0.983 . . . . 61.42 109.308 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -92.95 153.28 18.85 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.599 0.759 . . . . 62.02 110.59 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.7 t -160.45 138.91 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 72.54 108.622 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.9 122.17 42.6 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.92 -34.04 13.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.69 0.796 . . . . 61.21 111.976 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -155.87 -177.56 6.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 65.44 109.618 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.64 117.09 7.59 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.722 -0.844 . . . . 74.52 108.722 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 68.05 8.98 6.88 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.433 1.093 . . . . 71.51 112.776 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 38.5 t -112.09 106.38 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.777 -1.194 . . . . 62.43 107.777 174.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -107.78 162.51 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.594 0.711 . . . . 74.21 109.518 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -133.16 125.23 29.02 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.699 1.2 . . . . 73.25 108.35 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -107.49 121.01 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.212 -1.403 . . . . 72.11 107.212 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.4 t -99.53 136.73 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.538 -0.912 . . . . 54.02 108.538 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.08 114.1 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -104.7 128.6 52.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.871 0.868 . . . . 74.55 108.841 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -116.09 129.93 71.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.558 -0.904 . . . . 73.11 108.558 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 14.4 m -110.52 134.7 52.13 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.801 -0.815 . . . . 72.3 108.801 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 114' ' ' ILE . 53.0 t -135.18 106.57 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.437 1.095 . . . . 53.22 108.48 -174.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 45.6 m -104.25 138.31 40.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.413 -0.588 . . . . 75.23 109.413 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.31 112.17 17.8 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.167 -1.42 . . . . 52.34 107.167 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.7 m -130.95 129.37 42.08 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.195 0.598 . . . . 73.53 109.576 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -87.76 85.16 7.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.459 1.123 . . . . 72.1 108.479 177.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -86.65 1.28 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 114.23 -1.35 . . . . 64.32 111.237 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -121.74 -26.1 4.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.485 0.714 . . . . 50.01 110.878 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.78 127.51 32.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.956 0.502 . . . . 62.31 109.791 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.2 m -75.0 122.64 23.81 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.715 -0.476 . . . . 63.02 109.715 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.97 -51.66 11.92 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.59 -0.893 . . . . 64.32 108.59 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -166.73 169.58 13.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.479 -1.237 . . . . 63.04 110.239 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 76' ' ' CYS . 31.7 tp -137.13 143.34 42.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.252 1.021 . . . . 74.42 109.079 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.408 ' H ' HD12 ' A' ' 75' ' ' LEU . 21.2 m -135.5 136.69 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.334 1.054 . . . . 74.34 108.605 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.88 125.13 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.303 -0.628 . . . . 63.14 109.303 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.54 130.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 123.825 0.85 . . . . 71.51 109.653 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -103.41 90.92 3.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.375 1.07 . . . . 74.42 108.815 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.46 92.34 5.24 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.052 -1.092 . . . . 71.42 108.052 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.87 144.96 17.99 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.305 -0.718 . . . . 62.31 111.305 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.88 132.73 5.7 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.253 -0.739 . . . . 51.41 111.253 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.1 mt -85.12 128.71 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.435 -0.95 . . . . 75.41 108.435 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -134.98 118.26 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.636 -0.876 . . . . 74.14 108.636 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.4 t -85.29 99.09 10.9 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.621 -0.881 . . . . 75.24 108.621 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.87 141.8 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.818 0.847 . . . . 75.22 109.553 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.03 152.51 0.91 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.877 0.871 . . . . 72.11 110.965 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.33 64.69 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.463 0.477 . . . . 73.41 113.934 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.456 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.2 mp -110.98 147.59 14.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.512 -1.292 . . . . 70.02 107.512 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -142.19 176.07 9.26 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.906 0.882 . . . . 74.44 108.63 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.97 -152.72 52.51 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.238 -0.437 . . . . 70.44 113.172 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 26.0 p -70.74 -15.33 62.68 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.197 0.999 . . . . 74.42 112.617 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -73.55 -42.23 61.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.045 0.538 . . . . 74.3 110.448 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.456 ' SD ' ' HB ' ' A' ' 89' ' ' ILE . 1.3 tpt -76.69 -31.38 57.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.724 -0.473 . . . . 60.04 109.724 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -64.79 -32.59 74.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.697 0.799 . . . . 42.55 111.167 174.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 5.6 t-80 -61.9 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.64 -0.709 . . . . 75.53 110.019 170.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.3 m -73.44 -47.55 40.76 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.592 0.59 . . . . 62.4 112.592 -173.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.4 mp -86.62 -23.69 25.61 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 111.75 0.278 . . . . 74.33 111.75 -174.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.85 5.22 34.48 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.25 -0.75 . . . . 63.51 113.949 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.786 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.52 -60.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.169 0.985 . . . . 64.23 112.21 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -53.03 -60.17 3.62 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.544 1.138 . . . . 73.43 111.052 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 69.7 m -61.4 -51.8 74.96 Favored Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 114.167 1.173 . . . . 71.31 114.167 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.62 -26.64 75.79 Favored 'Trans proline' 0 C--N 1.394 2.954 0 CA-C-N 121.914 1.719 . . . . 70.3 113.609 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.72 -26.2 44.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.957 0.503 . . . . 72.42 110.833 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 101' ' ' TYR . 25.6 mm -67.02 -42.35 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 121.661 0.743 . . . . 62.11 109.681 171.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.658 HD23 HG23 ' A' ' 16' ' ' ILE . 50.3 mt -79.86 -29.36 40.03 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.562 -1.199 . . . . 75.12 112.484 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.3 -42.63 81.72 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.514 1.302 . . . . 60.51 114.514 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.21 -35.48 95.48 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.296 1.997 . . . . 65.34 113.429 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -85.23 -29.57 24.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.607 0.763 . . . . 63.31 111.222 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.87 76.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.999 0.52 . . . . 73.45 109.779 173.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -58.41 -48.51 80.44 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.546 1.154 . . . . 74.43 109.968 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.73 -44.85 96.11 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.014 0.821 . . . . 72.14 111.062 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.48 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.0 t -62.87 -41.21 99.3 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.909 0.756 . . . . 74.42 111.491 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 79.2 mt -66.28 -57.24 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.453 0.701 . . . . 62.33 110.534 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.472 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.4 m -53.45 -39.57 64.54 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.904 1.282 . . . . 72.24 111.778 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.24 -42.38 79.79 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.181 -0.918 . . . . 63.04 110.444 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 63.8 mtm -61.06 -37.73 83.68 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.731 0.412 . . . . 55.35 111.307 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 80.9 t -59.66 -49.21 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.05 0.94 . . . . 72.03 110.458 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 83.5 p -71.59 -29.48 64.75 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.597 -0.728 . . . . 61.12 111.482 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -71.81 -29.89 64.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.588 0.755 . . . . 75.13 110.061 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.68 55.69 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.53 -0.759 . . . . 64.52 112.855 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.408 HG23 ' HB2' ' D' ' 125' ' ' GLN . 30.4 m 69.24 35.5 2.65 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-O 123.058 1.409 . . . . 62.31 109.63 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -115.33 149.94 43.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 114.818 -1.083 . . . . 73.42 109.34 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.85 151.96 73.61 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.561 2.174 . . . . 74.1 111.055 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.472 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.3 tt0 -58.78 133.73 56.22 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.639 0.607 . . . . 73.41 112.639 -175.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.05 95.2 4.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.101 -1.074 . . . . 61.35 108.101 168.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -98.94 126.66 44.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.339 -0.985 . . . . 73.4 108.339 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.7 mm? -74.0 150.26 40.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.625 -0.716 . . . . 74.41 110.736 -175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.57 143.62 98.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.308 0.643 . . . . 63.24 110.881 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.96 109.58 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.475 2.117 . . . . 72.25 111.371 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.53 111.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.308 -1.738 . . . . 63.23 106.308 174.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.03 70.55 10.5 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.317 -1.364 . . . . 72.33 107.317 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -69.05 -28.76 66.83 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.699 -1.591 . . . . 63.21 111.374 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.786 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.4 p-10 . . . . . 0 N--CA 1.467 0.407 0 CA-C-N 114.858 -1.065 . . . . 72.24 111.264 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.514 ' SD ' HD12 ' B' ' 89' ' ' ILE . 18.8 ptm . . . . . 0 N--CA 1.498 1.951 0 N-CA-C 113.29 0.848 . . . . 72.04 113.29 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 98.0 m -140.13 127.72 21.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.706 0.802 . . . . 75.12 109.576 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.03 130.28 37.31 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -150.97 138.94 19.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.334 0.654 . . . . 72.11 109.237 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.596 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -90.17 128.68 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.451 -0.944 . . . . 74.32 108.451 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.468 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 10.4 mm100 -94.09 -49.87 5.56 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.314 -0.624 . . . . 74.24 109.314 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -164.05 146.07 9.04 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.678 -0.692 . . . . 75.02 109.17 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.15 145.78 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.047 -1.464 . . . . 61.22 107.047 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -169.71 146.28 3.23 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.452 0.569 . . . . 72.42 112.362 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -73.54 116.12 13.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.036 -0.984 . . . . 61.33 108.374 168.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -86.81 -34.16 19.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.672 -0.695 . . . . 63.44 110.691 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.48 142.09 18.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.645 -0.252 . . . . 61.33 110.56 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -132.49 144.35 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.752 1.221 . . . . 61.43 109.081 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.0 t -141.88 131.91 24.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 75.21 107.591 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.631 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -144.64 122.31 11.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.158 -1.423 . . . . 70.52 107.158 169.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 48.2 mt-10 -124.64 134.72 52.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.556 0.743 . . . . 73.44 109.174 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.939 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -132.2 80.75 63.15 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.497 -0.927 . . . . 52.04 108.497 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.69 -31.88 19.97 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.983 2.455 . . . . 70.13 111.71 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.458 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 40.8 m-80 -117.99 28.53 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.133 0.973 . . . . 71.41 109.887 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.939 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -49.46 -50.41 65.73 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.013 1.325 . . . . 62.22 113.82 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.6 Cg_exo -79.05 -12.31 14.56 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.123 1.882 . . . . 54.31 112.83 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.458 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 68.2 m-70 -98.49 -6.83 29.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.075 0.95 . . . . 74.23 111.681 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.405 HG11 ' HE1' ' B' ' 123' ' ' PHE . 6.9 p -68.59 -15.7 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.191 0.596 . . . . 74.02 111.26 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . 0.463 ' HZ ' ' HD2' ' A' ' 15' ' ' ARG . 75.8 m-85 -76.18 -7.78 55.58 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.724 0.81 . . . . 61.51 111.781 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -82.33 -32.3 29.45 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.689 0.757 . . . . 42.14 109.095 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -106.73 90.83 3.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.527 -1.215 . . . . 75.53 110.556 -162.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.56 84.97 2.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.943 0.402 . . . . 73.23 110.427 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -153.45 -179.45 7.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.477 1.511 . . . . 70.12 108.052 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -78.82 118.63 73.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.142 -1.058 . . . . 73.33 108.142 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.72 149.92 67.78 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.477 2.118 . . . . 65.32 110.994 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.42 104.21 3.71 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.587 -0.894 . . . . 71.04 108.587 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.449 HG11 HD21 ' B' ' 126' ' ' LEU . 39.4 t -95.72 137.06 24.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.485 -0.78 . . . . 72.02 110.189 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -130.04 119.29 22.89 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.266 1.026 . . . . 73.4 108.405 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.73 HD12 HG22 ' B' ' 64' ' ' VAL . 1.6 mm? -104.44 134.96 46.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.942 -0.762 . . . . 51.32 108.942 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -137.45 153.32 50.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.074 0.95 . . . . 54.42 109.573 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.15 150.07 42.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.987 0.915 . . . . 74.32 109.727 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.1 t70 -136.7 141.75 43.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.103 0.961 . . . . 71.14 108.624 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.2 p -113.41 104.34 12.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.44 0.696 . . . . 72.44 109.445 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.66 156.63 33.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.038 0.935 . . . . 71.24 109.014 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -145.11 173.78 11.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 75.05 110.462 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -156.61 133.96 10.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.985 0.914 . . . . 73.3 109.016 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -81.38 120.75 25.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.964 0.506 . . . . 44.15 110.835 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -88.08 -37.87 15.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.425 0.69 . . . . 73.25 110.114 174.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.5 -176.11 5.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.873 0.869 . . . . 74.12 110.618 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.73 116.19 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.696 -1.138 . . . . 61.54 109.527 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' B' ' 85' ' ' SER . 20.3 m-20 72.18 -5.1 1.83 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.493 1.517 . . . . 51.21 112.872 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -105.19 96.41 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.523 -0.917 . . . . 75.02 108.523 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -112.34 138.44 49.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.815 -0.629 . . . . 74.51 109.313 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.401 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.5 tm-20 -101.95 97.57 7.9 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 125.192 1.397 . . . . 72.03 107.518 -178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -90.9 121.02 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.91 0.884 . . . . 74.23 110.198 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -102.97 120.82 53.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.544 0.738 . . . . 72.41 110.315 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.2 121.54 34.68 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.908 -1.516 . . . . 63.4 106.908 170.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 61.6 ttt180 -110.5 108.93 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.275 -0.639 . . . . 71.24 109.275 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.63 121.14 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.304 -0.999 . . . . 70.24 108.304 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.1 m -116.29 130.64 56.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.097 0.475 . . . . 75.35 109.896 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.767 HG21 HG21 ' B' ' 114' ' ' ILE . 51.8 t -111.37 135.46 50.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.912 1.285 . . . . 72.12 110.132 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 30.9 m -124.76 144.58 50.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.604 -0.887 . . . . 55.21 108.604 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 125.31 11.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.387 -0.968 . . . . 51.44 108.387 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.4 m -138.62 134.5 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.084 -0.71 . . . . 63.35 109.084 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 22.4 tp -133.57 122.94 24.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.779 -0.823 . . . . 71.23 108.779 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.99 -131.39 13.82 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.594 0.559 . . . . 71.32 112.573 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -93.78 1.41 56.49 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 75.15 111.147 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.73 155.83 48.15 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.101 0.56 . . . . 61.35 110.984 -167.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 130.53 39.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.685 -0.689 . . . . 73.24 109.665 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.02 -56.19 4.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.576 0.751 . . . . 65.3 109.208 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.68 161.47 23.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.772 -1.104 . . . . 55.12 109.739 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 95.4 mt -132.53 146.96 52.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.886 1.275 . . . . 53.12 108.22 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.0 t -150.15 157.15 42.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.195 -0.668 . . . . 70.24 109.195 175.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.4 tt0 -165.43 131.48 2.67 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.408 -0.96 . . . . 73.41 108.408 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.1 t -125.02 144.0 36.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.897 0.879 . . . . 63.55 108.693 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.504 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 19.7 mt-30 -122.84 89.87 3.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.711 -0.848 . . . . 73.14 108.711 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -81.68 100.01 9.23 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.14 -0.937 . . . . 61.13 108.502 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.61 169.97 37.93 Favored Glycine 0 C--O 1.244 0.78 0 N-CA-C 111.062 -0.815 . . . . 74.14 111.062 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.11 127.36 1.43 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.086 -0.806 . . . . 64.23 111.086 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 21.3 mt -84.98 129.52 37.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.623 -1.251 . . . . 71.35 107.623 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -132.25 162.51 30.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.474 1.11 . . . . 64.53 108.572 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 73.7 m -129.11 108.17 10.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.616 0.767 . . . . 54.13 109.042 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.481 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -119.02 127.28 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.175 1.39 . . . . 71.44 108.782 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -140.6 145.53 36.81 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.628 0.771 . . . . 54.34 110.118 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -29.81 3.86 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.66 0.6 . . . . 52.13 114.237 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.514 HD12 ' SD ' ' B' ' 9' ' ' MET . 19.4 tt -78.4 139.51 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.683 0.793 . . . . 51.35 110.718 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.31 165.87 35.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.753 0.821 . . . . 74.33 111.608 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.29 -131.61 24.88 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.285 -0.871 . . . . 54.14 114.104 173.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -66.08 -36.66 83.78 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.385 1.074 . . . . 65.52 110.731 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.46 -34.64 72.65 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.45 -1.25 . . . . 73.11 110.096 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 56.9 ttp -52.95 -53.05 55.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.646 1.178 . . . . 65.22 110.732 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.34 72.51 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.279 -0.873 . . . . 52.24 111.924 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 20.4 t60 -71.03 -25.15 62.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.963 0.905 . . . . 61.21 110.969 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.13 -69.08 0.71 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.467 0.307 . . . . 22.42 111.464 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.8 pp -73.45 -22.86 60.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.542 0.571 . . . . 61.24 112.542 -170.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.87 -25.58 24.52 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.462 0.476 . . . . 64.23 112.508 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -122.91 -54.95 1.81 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.383 0.512 . . . . 63.21 112.383 -170.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -72.61 -48.66 37.82 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.554 0.576 . . . . 74.32 112.554 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.48 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.9 m -59.69 -48.09 96.07 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 118.608 -0.71 . . . . 74.3 111.482 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 75.2 Cg_exo -57.11 -34.87 98.55 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.426 2.084 . . . . 63.32 114.117 169.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -63.14 -34.17 77.05 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 122.95 0.5 . . . . 74.23 111.054 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.37 -47.44 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.889 0.876 . . . . 73.12 110.401 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.408 ' HB2' HD12 ' B' ' 60' ' ' LEU . 83.3 mt -80.75 -19.6 44.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.954 -1.021 . . . . 74.52 112.742 -169.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -63.23 -46.85 85.75 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.41 -1.281 . . . . 62.54 113.63 -171.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.31 -37.0 97.63 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.055 1.837 . . . . 42.5 113.688 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -67.78 -48.92 64.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.101 0.56 . . . . 74.31 110.38 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.88 86.75 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.25 -0.886 . . . . 74.34 111.04 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.621 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.8 ttt180 -57.75 -57.83 11.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.679 1.591 . . . . 61.44 110.679 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.15 -31.09 71.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.07 -0.968 . . . . 72.1 110.538 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.42 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.2 t -70.9 -38.6 73.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.989 0.516 . . . . 63.51 111.361 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.767 HG21 HG21 ' B' ' 64' ' ' VAL . 77.3 mt -64.4 -50.13 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.267 0.627 . . . . 72.22 109.907 175.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.447 HG21 ' OG ' ' C' ' 119' ' ' SER . 20.6 m -58.16 -36.44 73.01 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.489 -1.232 . . . . 72.21 110.956 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.2 t -64.84 -45.37 86.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.357 -1.292 . . . . 64.44 110.719 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 38.0 mmt -59.44 -45.22 92.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.106 0.562 . . . . 64.55 111.711 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.642 0.777 . . . . 73.22 111.54 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.3 p -70.34 -28.4 65.11 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.725 -0.67 . . . . 65.25 112.086 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 86.6 mtt-85 -67.07 -30.44 70.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.352 0.661 . . . . 72.41 111.232 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 13.26 39.64 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-O 119.613 -0.549 . . . . 73.52 112.94 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.6 p 54.81 23.65 5.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.441 1.896 . . . . 63.13 113.009 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.405 ' HE1' HG11 ' B' ' 31' ' ' VAL . 37.9 m-85 -89.97 156.92 46.53 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.76 0.824 . . . . 75.11 109.337 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.8 121.47 10.08 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 74.03 110.712 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.548 ' H ' ' HB2' ' C' ' 125' ' ' GLN . 4.9 pp0? -58.94 152.38 19.71 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.912 0.757 . . . . 65.21 112.284 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.449 HD21 HG11 ' B' ' 40' ' ' VAL . 1.4 tm? -111.32 105.5 14.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.766 -1.198 . . . . 74.51 107.766 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -90.85 112.59 24.49 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.963 -1.125 . . . . 73.33 107.963 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.621 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.13 117.98 10.68 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.676 -0.861 . . . . 74.25 108.676 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.65 87.64 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.636 0.585 . . . . 72.01 110.654 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.422 ' HG2' HD13 ' D' ' 13' ' ' ILE . 37.4 Cg_endo -63.29 86.36 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.682 2.255 . . . . 73.34 112.571 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 80.7 t -91.13 110.79 22.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.585 -0.895 . . . . 74.13 108.585 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -88.61 109.79 20.39 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.86 -33.46 75.75 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.505 1.122 . . . . 73.42 109.826 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . 0.446 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -59.93 -44.5 94.29 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.031 -1.441 . . . . 72.13 110.918 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.16 67.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.587 0.755 . . . . 64.11 111.557 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.481 1.083 0 C-N-CA 122.807 0.443 . . . . 75.3 110.393 177.121 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 113.58 0.956 . . . . 62.41 113.58 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -87.43 103.9 15.95 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 169.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -124.88 141.09 52.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.944 0.897 . . . . 64.32 109.162 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -160.76 123.34 3.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.179 0.592 . . . . 74.23 109.729 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -76.14 140.62 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.755 -0.832 . . . . 65.52 108.755 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.661 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -111.45 -49.71 2.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.679 0.792 . . . . 75.32 110.219 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -164.01 123.35 1.99 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.791 0.436 . . . . 74.21 110.04 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.9 mt -106.46 148.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.056 -1.09 . . . . 64.34 108.056 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.596 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 38.0 p90 -173.98 168.64 4.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.365 0.666 . . . . 73.35 110.325 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.0 p -86.62 117.7 25.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.156 0.582 . . . . 74.51 109.635 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.596 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 24.4 mmmt -66.86 -46.79 73.94 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.819 -0.808 . . . . 71.33 108.819 172.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.23 150.99 34.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.275 -1.329 . . . . 71.42 109.388 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.6 mt -142.46 142.47 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.791 1.636 . . . . 54.11 106.892 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -154.19 149.55 27.16 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.798 0.839 . . . . 62.02 109.183 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 80.4 t80 -152.16 128.38 10.51 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.467 -1.309 . . . . 75.21 107.467 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.59 130.75 36.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 63.24 108.45 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 82.67 15.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.841 -0.8 . . . . 64.35 108.841 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -67.37 -30.95 35.9 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.134 2.556 . . . . 71.55 112.366 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.79 34.01 3.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.831 0.852 . . . . 74.02 110.172 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -59.65 -56.81 31.98 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.058 -0.972 . . . . 75.25 112.534 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 14.9 Cg_exo -68.45 -27.5 33.49 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.838 1.692 . . . . 73.0 111.827 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.93 -23.33 65.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.755 1.222 . . . . 74.44 112.539 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.723 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 5.5 p -59.07 -20.99 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.481 0.712 . . . . 64.44 112.39 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.26 -41.44 99.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.349 1.06 . . . . 73.22 111.341 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -109.82 44.97 1.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.069 0.937 . . . . 64.52 109.511 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 22.3 ttpt -125.17 140.98 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.655 0.782 . . . . 75.34 110.794 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.44 132.85 39.89 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.105 0.962 . . . . 74.42 109.592 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -84.78 71.5 10.84 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.946 0.899 . . . . 73.51 111.317 -172.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -143.32 69.67 17.77 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.961 -1.018 . . . . 74.45 108.411 168.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.98 140.08 2.72 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.402 2.068 . . . . 64.23 111.121 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.92 111.39 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 107.495 -1.298 . . . . 74.43 107.495 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -75.85 98.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.272 -1.011 . . . . 64.31 108.272 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 59.9 tttm -98.22 105.26 17.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.47 1.108 . . . . 74.33 108.959 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.509 HD12 HG22 ' C' ' 64' ' ' VAL . 2.2 mm? -87.73 156.8 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.989 0.515 . . . . 72.23 110.021 -177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -144.8 105.82 4.18 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.476 0.711 . . . . 60.12 109.728 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.31 126.47 50.48 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.857 -0.794 . . . . 60.13 108.857 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.1 t70 -135.09 151.65 50.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.869 0.867 . . . . 73.45 109.019 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 3.1 m -133.48 127.48 33.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.127 0.571 . . . . 65.45 111.112 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.14 164.2 19.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.893 1.277 . . . . 62.44 108.483 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -154.43 145.44 22.68 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.959 0.345 . . . . 74.33 110.982 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -145.76 129.54 17.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.642 1.177 . . . . 73.31 109.378 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.66 119.95 21.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.253 -0.647 . . . . 75.54 109.253 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.476 HD11 HD12 ' C' ' 83' ' ' ILE . 84.2 mt -87.69 -38.38 15.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.348 0.659 . . . . 74.3 111.097 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -159.06 -172.93 3.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.437 -0.802 . . . . 72.01 110.518 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.2 105.13 0.84 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.796 1.239 . . . . 73.3 110.08 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 69.0 6.73 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.352 1.461 . . . . 70.34 113.019 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 91.9 t -103.07 118.16 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.947 -0.76 . . . . 71.11 108.947 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.1 158.42 32.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.871 0.868 . . . . 71.13 109.353 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -126.16 137.79 53.61 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.622 -1.621 . . . . 75.22 106.622 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.31 133.08 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 109.908 -0.405 . . . . 74.23 109.908 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 46' ' ' THR . 46.3 t -110.93 107.23 22.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.498 1.119 . . . . 73.04 108.918 -174.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.23 101.35 13.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.546 -1.279 . . . . 72.24 107.546 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.6 ttt180 -79.38 129.57 34.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.489 1.116 . . . . 64.51 109.121 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.39 105.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.857 -1.164 . . . . 74.33 107.857 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.5 m -103.08 113.85 27.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.534 -0.913 . . . . 72.33 108.534 170.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.509 HG22 HD12 ' C' ' 42' ' ' LEU . 79.6 t -101.34 108.42 23.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.175 -1.046 . . . . 75.34 108.175 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.506 HG23 HD23 ' C' ' 75' ' ' LEU . 4.0 m -99.06 140.35 33.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.323 -0.991 . . . . 72.15 108.323 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.41 95.34 4.23 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.712 -1.588 . . . . 52.41 106.712 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -147.02 132.46 18.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.533 0.333 . . . . 74.1 111.145 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 65.8 tp -67.79 -30.61 70.08 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.629 0.772 . . . . 72.4 109.952 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.67 -87.55 0.09 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.266 -1.134 . . . . 52.3 110.266 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -89.11 -25.01 22.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.636 0.774 . . . . 71.44 109.091 171.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -90.5 96.02 10.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.253 1.021 . . . . 60.04 109.266 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -89.31 133.36 34.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 70.01 110.784 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.449 ' HA ' ' NZ ' ' C' ' 34' ' ' LYS . . . -75.03 -59.51 2.7 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.145 0.978 . . . . 63.33 109.845 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.03 170.75 21.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.774 -1.103 . . . . 73.54 111.01 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.506 HD23 HG23 ' C' ' 65' ' ' THR . 2.9 tm? -136.03 140.88 44.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.127 -1.805 . . . . 75.51 106.127 173.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.22 150.85 34.47 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.522 -0.918 . . . . 63.32 108.522 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.58 131.2 9.76 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.687 -0.486 . . . . 71.42 109.687 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.76 115.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.27 -1.011 . . . . 45.3 108.27 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 75.7 mt-30 -88.15 91.27 8.71 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.506 -1.294 . . . . 71.23 107.506 174.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -82.39 115.14 21.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.672 -0.694 . . . . 73.32 109.41 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.66 179.57 23.51 Favored Glycine 0 C--O 1.244 0.723 0 O-C-N 123.452 0.47 . . . . 44.33 112.836 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.91 154.65 16.54 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.245 -0.477 . . . . 51.22 112.022 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.8 mm -102.4 123.5 55.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.684 -1.228 . . . . 74.32 107.684 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -136.37 120.23 17.45 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.979 -0.748 . . . . 64.41 108.979 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.4 p -78.32 118.3 20.39 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.819 -0.808 . . . . 65.3 108.819 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.24 107.04 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 107.284 -1.376 . . . . 73.35 107.284 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.64 169.75 17.4 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.165 0.507 . . . . 70.35 111.735 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.21 -58.42 2.75 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 115.145 -0.934 . . . . 75.51 112.576 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.18 -177.55 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.685 0.794 . . . . 62.43 112.211 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.12 -173.89 4.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.708 0.803 . . . . 75.13 110.884 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.11 -141.51 39.66 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 116.086 -0.506 . . . . 73.15 113.748 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 34.8 p -68.08 -18.47 64.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.013 0.925 . . . . 71.34 111.637 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -68.9 -40.63 79.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.484 0.714 . . . . 74.23 110.522 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.74 -34.0 24.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.329 0.251 . . . . 43.14 110.755 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -70.45 -25.74 63.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.871 0.868 . . . . 52.22 111.764 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -57.54 -51.62 68.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.785 0.834 . . . . 73.02 110.324 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.48 -52.75 12.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.995 -0.548 . . . . 72.15 110.533 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.78 -25.91 67.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.438 0.695 . . . . 54.55 112.064 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.46 -29.06 8.55 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.055 -0.52 . . . . 43.0 113.847 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -117.07 -60.03 1.89 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.682 0.741 . . . . 60.4 111.202 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.01 -56.06 15.31 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.09 0.556 . . . . 64.22 112.235 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 59.5 m -56.9 -50.68 86.7 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.188 -0.911 . . . . 62.14 112.727 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 45.4 Cg_exo -61.16 -31.09 89.85 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.194 1.929 . . . . 73.54 113.286 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -72.82 -28.93 62.85 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.772 0.829 . . . . 72.4 110.374 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.85 -39.97 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.399 1.08 . . . . 75.4 109.85 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' C' ' 102' ' ' CYS . 68.9 mt -82.59 -16.31 48.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.336 -0.847 . . . . 72.21 111.397 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.64 -55.29 44.6 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.059 -0.972 . . . . 74.11 113.141 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.43 -37.85 46.41 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.085 1.857 . . . . 41.4 113.207 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -63.33 -45.86 89.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.322 0.649 . . . . 64.12 111.25 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.45 96.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.62 -0.718 . . . . 54.5 110.831 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 6.2 ttp-105 -60.51 -43.13 97.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 75.33 110.583 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.77 -34.89 67.27 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.922 0.764 . . . . 63.44 110.387 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.456 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 34.0 t -68.53 -30.33 69.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.787 0.435 . . . . 75.53 111.339 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 118' ' ' VAL . 92.5 mt -77.81 -43.97 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.833 -0.622 . . . . 54.44 110.094 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 54.3 m -55.93 -36.83 68.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.603 0.761 . . . . 72.13 110.427 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.7 t -61.06 -53.75 53.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.228 -1.351 . . . . 63.32 109.535 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -38.02 80.65 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.847 1.259 . . . . 53.42 113.28 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.4 t -63.98 -49.27 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.705 0.802 . . . . 72.33 109.349 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.447 ' OG ' HG21 ' B' ' 115' ' ' THR . 33.7 t -68.74 -26.49 65.27 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.167 -0.924 . . . . 74.41 111.747 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.6 mtt-85 -68.83 -39.25 80.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.279 0.632 . . . . 73.12 109.482 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 10.35 60.51 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.626 0.579 . . . . 73.11 112.747 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p 56.38 40.68 29.65 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.055 1.742 . . . . 74.41 112.503 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.16 156.82 34.84 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.583 -1.189 . . . . 74.15 108.281 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -65.28 171.47 9.11 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.084 2.523 . . . . 72.43 113.858 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.548 ' HB2' ' H ' ' B' ' 125' ' ' GLN . 51.3 tp60 -60.23 132.07 52.76 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.318 -0.856 . . . . 64.23 113.083 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.92 85.9 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.477 -1.305 . . . . 71.02 107.477 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -95.71 105.89 17.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.851 -1.166 . . . . 71.43 107.851 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' C' ' 128' ' ' LEU . 1.1 tm? -74.2 137.0 42.8 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 106.775 -1.565 . . . . 61.33 106.775 170.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -53.65 131.87 55.56 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 124.342 1.026 . . . . 72.13 111.506 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.428 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.4 Cg_exo -68.09 89.22 0.38 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.512 2.141 . . . . 71.4 111.168 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 94.0 t -97.92 109.67 24.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.464 -0.789 . . . . 62.35 109.31 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -104.77 83.0 1.95 Allowed 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.261 -1.015 . . . . 74.34 108.261 176.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.78 -44.58 69.84 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.107 -0.951 . . . . 75.41 111.267 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.482 1.127 0 C-N-CA 123.268 0.627 . . . . 73.14 110.946 177.296 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.495 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.5 ptm . . . . . 0 CA--C 1.562 1.414 0 N-CA-C 114.648 1.351 . . . . 74.41 114.648 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.2 m -144.0 140.25 29.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.279 1.032 . . . . 55.32 108.265 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' D' ' 85' ' ' SER . 78.5 t80 -155.57 113.64 3.4 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -134.81 131.05 37.0 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.421 0.688 . . . . 74.24 109.643 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' B' ' 130' ' ' PRO . 2.7 pp -78.94 141.18 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.481 -0.933 . . . . 71.02 108.481 172.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -111.5 -46.03 3.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.682 0.393 . . . . 62.13 110.673 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.22 122.84 1.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.148 -0.315 . . . . 72.4 110.148 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.6 126.69 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 106.523 -1.658 . . . . 55.53 106.523 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -168.1 178.03 5.26 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.811 0.695 . . . . 73.01 111.538 -165.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.6 p -108.21 133.48 52.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.005 -0.998 . . . . 65.03 109.59 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.43 -32.92 9.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.428 -0.582 . . . . 73.11 109.428 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -144.21 138.61 28.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.867 -1.061 . . . . 64.34 108.898 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.15 149.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 44.23 108.199 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -152.74 145.39 24.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.249 0.62 . . . . 64.43 110.35 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.564 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.3 t80 -147.58 124.8 11.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.689 -1.597 . . . . 74.44 106.689 168.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.0 mp0 -120.16 142.04 49.32 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.692 -0.855 . . . . 63.23 108.692 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.28 73.75 10.88 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.355 -0.979 . . . . 71.01 108.355 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.38 -18.57 17.82 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.446 2.097 . . . . 73.14 111.553 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.505 ' O ' HG23 ' D' ' 31' ' ' VAL . 57.5 m-20 -114.23 23.88 12.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.136 0.974 . . . . 73.14 109.617 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -48.0 -53.8 29.61 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.885 1.439 . . . . 74.32 114.885 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.533 ' HB3' HD11 ' C' ' 83' ' ' ILE . 28.6 Cg_endo -84.48 -4.32 10.09 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.482 1.454 . . . . 42.15 112.892 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.492 ' HA ' HE21 ' D' ' 33' ' ' GLN . 21.5 t-160 -80.62 -36.95 31.95 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.848 1.259 . . . . 73.54 109.522 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 27' ' ' ASN . 59.3 t -72.77 -25.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.332 0.653 . . . . 74.11 110.663 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.29 -28.99 57.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.07 0.948 . . . . 73.13 112.083 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.492 HE21 ' HA ' ' D' ' 30' ' ' HIS . 42.3 mt-30 -76.41 -15.32 59.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.324 0.65 . . . . 71.34 112.408 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -125.61 111.92 15.56 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.439 0.696 . . . . 65.04 110.641 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.25 87.33 7.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.975 0.91 . . . . 72.53 109.855 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.689 ' HB3' HD11 ' D' ' 68' ' ' LEU . 42.6 t-105 -160.01 158.08 29.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.724 -0.843 . . . . 75.22 108.724 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -74.44 116.82 56.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.077 0.551 . . . . 70.44 109.918 174.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.07 141.87 86.5 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.134 2.556 . . . . 61.5 113.593 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.61 113.38 4.18 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.55 -0.907 . . . . 72.52 108.55 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.428 HG13 HG13 ' D' ' 64' ' ' VAL . 61.8 t -99.09 106.57 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.65 -0.5 . . . . 74.42 109.65 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -87.41 109.39 19.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.194 -1.41 . . . . 62.02 107.194 167.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.77 156.29 16.39 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.52 -0.918 . . . . 60.55 108.52 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.7 t70 -151.2 155.74 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.157 0.583 . . . . 74.01 109.966 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -133.35 152.12 51.9 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.348 0.659 . . . . 52.32 110.824 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.5 t70 -153.36 151.51 30.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.006 1.322 . . . . 64.32 108.175 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -128.9 152.37 48.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.299 -0.63 . . . . 52.4 109.299 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.79 169.6 20.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.557 -0.905 . . . . 65.53 108.557 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -149.04 159.45 44.21 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.84 0.456 . . . . 53.43 110.737 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -155.7 119.26 4.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.115 0.966 . . . . 74.0 109.184 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.23 121.62 23.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.83 -0.433 . . . . 64.51 109.83 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.63 -26.5 14.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.416 0.686 . . . . 73.33 110.889 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.17 -177.01 3.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.026 0.93 . . . . 64.52 110.036 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.46 120.57 22.64 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.23 -1.026 . . . . 54.44 108.23 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 72.15 3.87 4.82 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.067 1.347 . . . . 65.5 112.742 -172.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.15 117.51 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.423 -0.584 . . . . 61.13 109.423 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -133.04 130.5 39.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.362 0.665 . . . . 73.21 109.468 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -87.16 140.1 29.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 64.1 108.372 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.34 132.87 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.76 -1.2 . . . . 53.31 107.76 169.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.72 130.94 57.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.564 1.145 . . . . 44.15 108.783 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 121.8 45.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.675 -0.861 . . . . 73.21 108.675 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.5 ttm-85 -106.88 99.17 8.76 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.891 -0.781 . . . . 73.1 108.891 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.59 104.13 15.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.199 -1.037 . . . . 71.41 108.199 172.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.2 m -99.3 148.12 24.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.152 -0.931 . . . . 74.52 110.022 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 25.3 t -138.43 132.98 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.629 1.572 . . . . 62.44 107.927 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -133.94 93.44 3.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.721 -1.215 . . . . 74.41 107.721 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.36 141.76 29.3 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.719 -0.673 . . . . 54.01 109.288 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -149.51 126.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.123 0.969 . . . . 71.31 108.975 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' D' ' 36' ' ' TRP . 19.7 tp -99.13 114.06 26.61 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.58 -0.896 . . . . 70.54 108.58 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.95 -113.33 4.13 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.7 0.625 . . . . 72.52 113.051 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 5.88 41.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.728 0.811 . . . . 72.33 111.205 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.446 ' HG2' ' CE1' ' D' ' 30' ' ' HIS . 9.7 tp10 -149.22 151.52 34.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.471 0.308 . . . . 54.32 111.336 -165.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.451 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 71.8 m -55.21 141.46 35.11 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.983 1.313 . . . . 62.51 111.711 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -106.99 -71.85 0.74 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.037 0.935 . . . . 65.11 109.522 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -147.54 137.63 22.99 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.367 0.603 . . . . 64.3 109.778 173.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 51.3 mt -105.03 154.02 20.69 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.397 1.079 . . . . 75.52 108.491 175.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.68 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.5 t -160.64 146.28 14.78 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.935 0.494 . . . . 75.12 110.043 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.05 126.48 6.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.379 -0.6 . . . . 63.22 109.379 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.71 116.88 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.787 0.435 . . . . 62.22 110.638 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.7 mt-30 -92.45 88.03 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.29 1.036 . . . . 70.41 110.084 170.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.2 98.73 7.48 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.679 -1.146 . . . . 70.43 108.857 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.38 141.89 17.01 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.627 -0.589 . . . . 71.04 111.627 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.72 132.16 5.47 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.291 -0.723 . . . . 62.15 111.291 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.52 123.6 42.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 C-N-CA 123.93 0.892 . . . . 75.43 109.007 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -133.04 141.32 48.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.124 0.57 . . . . 71.44 109.684 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 33.2 m -100.17 105.23 16.81 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.726 0.81 . . . . 72.53 108.972 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mt -108.04 102.03 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.596 -0.89 . . . . 75.21 108.596 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.18 169.1 16.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.004 1.321 . . . . 74.53 109.879 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.42 -4.66 33.06 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 114.49 0.556 . . . . 73.33 114.49 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.44 151.41 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.96 0.904 . . . . 60.22 109.863 -170.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.15 177.02 8.07 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.014 0.926 . . . . 64.12 111.974 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -132.64 48.25 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 116.287 1.275 . . . . 74.45 116.287 165.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 8.5 t -62.94 -35.89 81.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 72.5 112.45 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -73.79 -39.42 64.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.774 0.43 . . . . 71.24 111.626 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.9 ptm -73.63 -31.95 63.78 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 110.022 -0.362 . . . . 75.2 110.022 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.75 70.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.438 0.695 . . . . 62.02 110.628 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -71.86 -33.36 68.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.159 0.984 . . . . 74.4 110.321 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.9 -52.1 53.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.157 -0.474 . . . . 72.21 110.548 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.59 -18.02 46.26 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.82 0.448 . . . . 73.14 112.114 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.65 -26.63 16.82 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-O 119.795 -0.447 . . . . 71.0 113.72 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.88 -59.36 1.27 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.932 0.493 . . . . 63.1 111.641 -174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -67.29 -47.23 71.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.377 0.423 . . . . 71.34 111.972 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.4 m -67.61 -45.46 46.15 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 118.328 -0.844 . . . . 71.11 111.936 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.92 -35.23 98.47 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.359 2.039 . . . . 74.41 113.498 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.17 -32.96 74.71 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.415 0.686 . . . . 72.01 110.784 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.54 -45.06 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.416 0.687 . . . . 71.53 109.815 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.478 HD21 ' HA3' ' D' ' 82' ' ' GLY . 90.1 mt -73.68 -21.4 60.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.162 -0.926 . . . . 74.1 112.1 -174.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.422 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 42.8 t80 -66.12 -46.81 62.89 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 113.934 1.087 . . . . 64.4 113.934 -168.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.67 -34.16 97.74 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.072 1.848 . . . . 74.43 112.768 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -76.03 -37.68 58.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.023 0.929 . . . . 64.13 111.026 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -49.94 67.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.565 0.746 . . . . 72.34 110.792 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -71.54 -31.88 67.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.862 -1.063 . . . . 73.13 111.186 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.02 -42.94 89.0 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.029 0.831 . . . . 74.2 110.707 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 -39.5 80.24 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.821 0.7 . . . . 75.24 110.259 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.68 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.0 mt -61.56 -54.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.69 0.796 . . . . 62.11 110.35 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.446 HG23 ' HG3' ' D' ' 125' ' ' GLN . 28.8 m -57.71 -39.06 76.35 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.463 1.105 . . . . 72.31 111.593 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -67.06 -43.61 82.23 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 114.855 -1.066 . . . . 75.4 110.141 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.65 -27.18 63.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.775 0.43 . . . . 74.23 111.738 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.1 t -67.96 -43.09 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.564 0.746 . . . . 72.44 109.651 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 94.1 p -74.27 -25.98 59.93 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.895 0.478 . . . . 71.12 111.225 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.6 mtt-85 -75.38 -32.17 60.72 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.456 0.703 . . . . 75.12 109.758 173.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.56 -0.37 89.92 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.62 -0.718 . . . . 64.44 111.991 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.7 p 63.39 27.27 15.23 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.68 1.992 . . . . 62.42 113.257 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.472 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 56.5 m-85 -94.07 162.3 27.11 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 124.707 1.203 . . . . 65.33 110.535 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.1 140.91 97.22 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 123.483 2.789 . . . . 63.2 112.402 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.446 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.1 tt0 -54.68 135.01 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.119 0.968 . . . . 75.34 112.722 -174.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 60.6 tp -126.02 102.5 7.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.892 0.877 . . . . 73.34 109.913 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -102.58 121.44 42.39 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.71 -0.848 . . . . 74.41 108.71 175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.422 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.1 OUTLIER -74.76 114.54 13.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.345 -0.983 . . . . 53.55 108.345 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.12 143.36 97.7 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 122.63 0.372 . . . . 73.14 110.898 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.81 132.22 22.81 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 62.55 112.887 -169.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.18 128.97 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.136 0.574 . . . . 73.35 109.771 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.73 93.3 7.9 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.88 -0.785 . . . . 72.15 108.88 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 t80 . . . . . 0 N--CA 1.476 0.862 0 C-N-CA 123.242 0.617 . . . . 72.34 111.101 -178.976 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 90.1 m . . . . . 0 CA--C 1.534 0.33 0 N-CA-C 107.554 -1.276 . . . . 45.21 107.554 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -138.82 121.85 16.75 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.026 -0.731 . . . . 74.12 109.026 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 29.6 tt0 -134.12 111.7 10.54 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.585 0.754 . . . . 60.34 109.159 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.62 109.21 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 108.174 -1.047 . . . . 72.13 108.174 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -91.99 -40.53 11.06 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.407 -0.59 . . . . 74.53 109.407 -174.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -170.73 140.96 1.75 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.321 0.648 . . . . 61.04 110.083 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.602 HG23 HD23 ' A' ' 106' ' ' LEU . 3.9 mp -128.59 100.54 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.033 -1.469 . . . . 74.5 107.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -160.82 175.8 12.17 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.234 1.014 . . . . 73.44 110.157 -166.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -81.44 127.01 32.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.649 0.261 . . . . 71.1 110.692 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.4 mtpt -83.27 -47.45 11.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.755 0.788 . . . . 72.22 109.045 165.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 12.0 t70 -136.86 139.36 41.61 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.529 -1.214 . . . . 64.21 109.595 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.521 HG23 ' SD ' ' A' ' 117' ' ' MET . 78.5 mt -128.21 136.06 61.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.876 -1.527 . . . . 74.41 106.876 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -146.16 108.24 4.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.162 -0.681 . . . . 65.0 109.162 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 89.8 t80 -112.56 119.26 37.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.959 -1.497 . . . . 61.01 106.959 173.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -127.99 111.93 14.09 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.038 -0.727 . . . . 73.21 109.038 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -111.19 84.68 4.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.613 -1.255 . . . . 70.45 107.613 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.38 -31.29 18.03 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.285 1.99 . . . . 64.52 111.428 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.7 m-20 -109.29 34.38 3.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.501 1.12 . . . . 64.41 108.767 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -59.24 -47.33 98.5 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.658 0.783 . . . . 53.15 113.059 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.8 Cg_exo -67.64 -24.59 41.31 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.229 1.953 . . . . 73.21 113.275 171.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 25.4 m80 -64.89 -38.11 89.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.613 0.365 . . . . 73.34 110.611 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.81 -25.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.79 0.436 . . . . 64.11 111.626 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.26 -38.44 90.33 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.108 0.563 . . . . 72.32 111.283 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -90.32 -21.19 22.16 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.902 0.481 . . . . 71.23 111.12 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 6.1 tmtt? -82.0 148.79 28.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.036 0.934 . . . . 55.14 111.479 -172.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.42 139.34 57.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.638 0.775 . . . . 74.25 110.736 170.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -84.61 74.04 10.48 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.927 0.87 . . . . 74.41 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -139.38 74.12 35.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.779 -0.823 . . . . 54.34 108.779 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.46 141.51 4.01 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.433 2.088 . . . . 64.14 112.665 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.94 121.97 40.5 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.874 -1.158 . . . . 74.21 107.874 171.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.67 115.49 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.184 0.594 . . . . 73.31 110.542 -167.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -93.77 121.09 34.85 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.298 1.039 . . . . 71.52 109.15 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.0 129.36 55.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.463 0.705 . . . . 72.1 110.328 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -114.39 113.46 24.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.806 0.843 . . . . 74.5 108.8 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.24 118.27 36.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.487 -1.301 . . . . 63.45 107.487 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' O ' HD23 ' A' ' 60' ' ' LEU . 21.6 t70 -129.23 144.93 51.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.77 0.828 . . . . 73.33 109.782 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.4 m -142.13 135.72 29.33 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.273 0.629 . . . . 54.55 110.342 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.48 119.65 9.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.439 0.695 . . . . 72.02 110.928 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 t -91.73 154.21 19.12 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.374 -0.602 . . . . 63.15 109.374 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.3 t -161.86 115.94 1.9 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 117.932 0.333 . . . . 70.42 110.308 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.518 HE21 ' H ' ' A' ' 54' ' ' ASP . 63.7 tt0 -73.44 105.87 5.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.784 0.834 . . . . 72.03 111.651 -172.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 57' ' ' GLU . 70.1 mt -77.93 -40.48 39.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.85 0.86 . . . . 64.35 111.253 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.99 -172.0 3.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.122 0.969 . . . . 61.03 109.542 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.07 100.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.323 0.649 . . . . 62.41 111.159 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.518 ' H ' HE21 ' A' ' 50' ' ' GLN . 1.5 m-20 52.86 32.79 13.02 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.797 1.239 . . . . 65.0 113.083 -174.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 49.1 t -108.51 121.64 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 106.715 -1.587 . . . . 71.44 106.715 167.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -132.48 131.04 41.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.254 -0.647 . . . . 65.32 109.254 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.1 tt0 -86.37 120.22 27.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.629 -0.878 . . . . 63.42 108.629 168.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.33 116.25 42.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.715 -1.217 . . . . 54.3 107.715 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.2 t -98.07 134.88 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.129 -0.693 . . . . 74.35 109.129 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -109.39 109.86 20.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.141 -1.429 . . . . 75.21 107.141 171.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -96.99 102.0 13.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.913 -1.143 . . . . 74.0 107.913 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.86 140.6 16.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.511 -1.292 . . . . 73.24 107.511 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -129.48 124.4 33.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.338 -0.616 . . . . 74.12 109.338 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 114' ' ' ILE . 70.8 t -115.76 105.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.935 -1.135 . . . . 50.45 107.935 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.3 m -112.33 122.86 48.93 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.561 -0.903 . . . . 71.23 108.561 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.25 110.81 21.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.613 -1.625 . . . . 72.35 106.613 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -148.38 147.47 29.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 70.23 109.827 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.451 HD23 ' NZ ' ' A' ' 34' ' ' LYS . 28.1 tp -113.32 86.85 2.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.032 -1.099 . . . . 60.2 108.032 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.11 -93.12 1.5 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.15 -0.932 . . . . 74.31 111.472 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -116.04 -26.9 7.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.72 0.808 . . . . 73.14 111.014 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.0 tp10 -77.67 107.08 9.9 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.184 -1.043 . . . . 72.25 108.184 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -76.01 142.53 41.85 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.479 -0.563 . . . . 63.41 109.479 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.46 -58.68 2.47 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.377 -0.971 . . . . 74.44 108.377 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -168.89 176.76 5.3 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.558 0.743 . . . . 75.15 110.727 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.3 tp -139.42 141.82 37.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.186 1.395 . . . . 72.42 108.342 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 35.3 m -147.69 97.79 2.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.943 0.497 . . . . 75.03 110.144 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.43 122.32 46.04 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.575 0.75 . . . . 71.42 109.622 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.11 115.0 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.535 0.734 . . . . 71.14 109.864 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -85.91 82.19 8.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.401 1.081 . . . . 74.22 108.207 172.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.49 93.57 3.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.899 -1.046 . . . . 72.33 108.97 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.47 145.91 18.66 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.138 -0.483 . . . . 52.53 111.9 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.56 122.76 2.22 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 110.205 -1.158 . . . . 75.31 110.205 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.617 HD11 ' HA ' ' B' ' 29' ' ' PRO . 54.9 mt -82.21 126.83 40.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.8 -0.815 . . . . 70.34 108.8 175.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -132.71 117.05 17.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.426 -0.953 . . . . 61.33 108.426 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.682 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 40.7 t -84.56 97.64 9.7 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.397 -0.964 . . . . 73.34 108.397 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 10' ' ' THR . 34.1 pt -120.21 125.67 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.696 0.76 . . . . 51.04 111.59 -172.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.73 158.82 43.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.0 1.32 . . . . 54.33 108.932 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.17 8.74 86.07 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.796 -0.447 . . . . 52.22 114.213 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -117.69 134.1 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.823 -0.806 . . . . 74.23 108.823 173.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.33 169.1 17.72 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.99 0.516 . . . . 63.35 111.198 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.95 -111.76 0.79 Allowed Glycine 0 C--N 1.358 1.773 0 O-C-N 124.774 1.296 . . . . 43.41 115.209 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.0 p -70.12 -35.84 74.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.176 0.99 . . . . 70.32 111.772 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.89 -47.56 82.77 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.268 0.627 . . . . 72.31 111.197 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -72.13 -35.75 69.21 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.019 0.528 . . . . 74.02 111.333 -177.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.09 81.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.546 0.738 . . . . 62.32 110.595 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -46.88 86.73 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.625 -1.171 . . . . 73.01 109.985 172.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.0 m -70.84 -37.66 73.16 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.048 0.758 . . . . 74.23 113.048 -172.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 86' ' ' ILE . 77.8 mt -84.84 -18.86 33.56 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.926 0.343 . . . . 65.14 111.926 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.71 -10.85 54.97 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 119.831 -0.427 . . . . 61.24 113.268 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -73.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.734 -0.651 . . . . 61.25 112.642 -172.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.5 t80 -41.41 -54.92 2.94 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 124.882 1.273 . . . . 73.11 113.158 -175.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -78.6 -52.54 1.34 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-O 118.256 -0.878 . . . . 72.1 112.975 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' HD12 ' A' ' 106' ' ' LEU . 38.6 Cg_endo -64.67 -25.27 61.69 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.791 1.661 . . . . 72.1 114.448 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -71.62 -33.98 69.43 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.933 0.493 . . . . 75.15 110.454 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.0 mm -62.16 -42.37 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.273 0.629 . . . . 55.43 109.879 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.602 HD23 HG23 ' A' ' 16' ' ' ILE . 60.2 mt -72.89 -25.42 61.06 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.586 -0.734 . . . . 74.33 111.678 -174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.58 -43.32 70.35 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 115.088 1.514 . . . . 71.43 115.088 -168.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.23 -34.52 98.66 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.114 1.876 . . . . 61.3 113.232 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -80.0 -35.55 37.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.733 0.813 . . . . 73.44 111.158 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.1 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.135 0.574 . . . . 62.1 109.574 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -53.79 -45.64 70.77 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.764 1.29 . . . . 75.41 110.466 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.08 -50.23 64.82 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.633 0.773 . . . . 61.45 111.352 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.2 t -56.09 -46.6 78.99 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.214 0.946 . . . . 34.21 110.659 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 64' ' ' VAL . 11.6 mt -57.77 -54.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.104 0.878 . . . . 74.22 110.657 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 125' ' ' GLN . 65.8 m -56.44 -39.54 73.3 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.73 0.644 . . . . 53.34 111.594 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.35 -39.27 81.93 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.474 -0.785 . . . . 62.33 109.814 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.521 ' SD ' HG23 ' A' ' 21' ' ' ILE . 17.6 mtp -61.17 -40.85 95.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.524 0.73 . . . . 63.53 110.92 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 114' ' ' ILE . 92.1 t -62.89 -46.5 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.268 1.027 . . . . 75.15 110.698 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.7 p -75.25 -37.05 61.18 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.575 -0.739 . . . . 74.34 111.211 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -66.31 -28.33 68.6 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.308 0.643 . . . . 73.44 109.909 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.01 -3.07 89.36 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.558 -0.747 . . . . 33.34 113.43 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 65.83 38.32 5.18 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.028 1.394 . . . . 70.31 110.541 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.05 150.53 43.72 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 115.025 -0.989 . . . . 75.32 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.7 130.53 40.43 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.935 2.423 . . . . 75.05 112.271 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HG2' HD22 ' A' ' 127' ' ' ASN . 32.7 tt0 -58.46 127.31 31.49 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.064 0.853 . . . . 74.35 112.128 -175.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.9 mt -117.32 95.58 5.04 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.994 -1.113 . . . . 72.32 107.994 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.427 HD22 ' HG2' ' A' ' 125' ' ' GLN . 4.3 p30 -98.4 126.74 44.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.746 -0.835 . . . . 74.24 108.746 176.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.28 149.0 40.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.772 -0.649 . . . . 65.21 111.958 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.03 142.02 87.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.326 0.651 . . . . 65.52 110.142 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -78.24 96.94 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.171 1.914 . . . . 50.1 110.785 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.9 m -99.66 114.04 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.752 0.787 . . . . 73.34 109.04 -179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -93.23 93.28 8.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.964 -1.016 . . . . 73.43 109.663 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -64.55 -26.59 68.48 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.306 -0.861 . . . . 62.31 111.316 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 t70 . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 123.625 0.77 . . . . 72.24 110.214 -175.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 114.205 1.187 . . . . 74.01 114.205 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.3 m -148.2 131.34 16.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.73 0.812 . . . . 74.44 109.059 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' B' ' 85' ' ' SER . 66.9 t80 -136.58 142.74 43.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.756 0.422 . . . . 74.31 110.397 172.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -155.92 140.49 16.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.317 1.047 . . . . 74.1 109.306 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.07 106.35 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.478 -1.304 . . . . 63.51 107.478 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -78.24 -46.42 20.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.68 0.392 . . . . 74.13 110.19 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -163.58 140.87 7.3 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.063 -0.517 . . . . 71.02 110.166 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.1 mt -117.96 144.84 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.342 -1.355 . . . . 73.41 107.342 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.432 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.7 p90 -170.12 147.0 3.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.592 0.633 . . . . 73.13 111.913 -177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -72.92 119.22 16.87 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.666 -1.152 . . . . 73.52 108.069 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -90.95 -30.25 16.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.326 0.65 . . . . 75.35 110.851 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -158.02 138.94 13.15 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.583 0.552 . . . . 72.03 111.112 -171.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.467 HD12 HG22 ' B' ' 78' ' ' VAL . 47.8 mm -132.33 138.22 52.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 C-N-CA 124.635 1.174 . . . . 63.34 109.007 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -131.25 136.08 47.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.332 -1.359 . . . . 51.23 107.332 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.6 t80 -151.84 122.1 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.363 -1.347 . . . . 64.5 107.363 171.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 42.1 mt-10 -124.1 133.68 53.55 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.29 -1.004 . . . . 71.42 108.29 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -128.78 87.47 54.67 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.162 -0.681 . . . . 53.05 109.162 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.7 -22.99 36.62 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.158 1.905 . . . . 62.11 111.004 172.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -115.04 24.96 11.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.135 0.974 . . . . 71.25 111.148 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.81 -53.64 40.21 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 123.704 0.801 . . . . 70.33 111.133 164.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.617 ' HA ' HD11 ' A' ' 83' ' ' ILE . 69.2 Cg_endo -77.0 -22.78 11.16 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.907 1.738 . . . . 71.32 113.374 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -94.46 2.94 55.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.54 0.736 . . . . 73.45 111.662 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.83 -31.73 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.222 1.009 . . . . 74.43 112.813 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -74.12 -34.83 64.05 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.354 . . . . 62.33 110.772 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -68.93 -23.78 64.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.648 1.179 . . . . 44.42 110.962 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' B' ' 34' ' ' LYS . 10.6 mmpt? -75.9 100.27 4.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.253 0.621 . . . . 64.1 111.422 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -113.42 78.84 1.17 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.339 1.056 . . . . 75.25 111.149 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -176.89 178.22 1.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.626 1.97 . . . . 75.44 107.143 171.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.56 131.93 36.63 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.501 -0.926 . . . . 54.24 108.501 164.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 47.6 Cg_endo -67.7 133.6 30.12 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.165 1.91 . . . . 72.43 112.961 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 25.5 tt0 -51.21 117.18 2.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.811 1.244 . . . . 61.4 109.631 164.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 134.2 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.736 0.414 . . . . 60.32 110.604 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -142.85 101.83 3.92 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.343 1.057 . . . . 64.03 108.611 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -94.8 153.07 17.92 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.177 -0.675 . . . . 70.45 109.177 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -138.35 130.27 28.26 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.403 -0.962 . . . . 72.13 108.403 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.96 128.47 53.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.606 -1.257 . . . . 63.34 107.606 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.3 t70 -142.85 155.66 44.81 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.428 1.091 . . . . 61.12 108.777 -174.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.1 p -141.89 119.59 11.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.369 0.668 . . . . 43.44 110.358 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.99 119.07 25.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.372 -0.973 . . . . 72.2 108.372 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -117.0 164.54 14.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.637 0.375 . . . . 70.43 110.979 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -152.41 136.89 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.2 1.0 . . . . 73.31 109.03 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -80.8 121.62 26.16 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.227 -0.657 . . . . 75.3 109.227 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 45.6 mt -80.53 -39.87 27.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.564 -0.532 . . . . 70.54 109.564 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.25 -179.1 4.88 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.758 -1.11 . . . . 51.53 109.966 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.78 129.59 41.15 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.409 -0.814 . . . . 73.45 108.95 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' B' ' 85' ' ' SER . 2.5 m-20 71.07 1.49 3.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.479 1.112 . . . . 74.44 112.283 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 t -125.75 88.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.475 -0.935 . . . . 73.43 108.475 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -108.86 137.85 46.13 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.823 -0.806 . . . . 72.43 108.823 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -119.76 108.3 14.25 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.405 -0.961 . . . . 61.24 108.405 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -99.94 124.11 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.857 0.863 . . . . 51.23 109.188 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 24.9 t -103.33 124.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 109.575 -0.528 . . . . 62.2 109.575 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.3 116.48 29.04 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.001 -1.481 . . . . 73.21 107.001 171.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.502 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 43.1 ttt180 -105.17 107.82 19.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.144 0.577 . . . . 63.41 109.887 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -107.9 121.39 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.963 -0.754 . . . . 61.13 108.963 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -109.46 141.96 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.365 0.666 . . . . 72.33 109.532 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.591 HG21 HG21 ' B' ' 114' ' ' ILE . 43.0 t -124.88 127.0 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.997 0.919 . . . . 74.2 108.658 171.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -125.62 147.24 49.38 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.776 -0.824 . . . . 62.34 108.776 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.11 148.72 30.93 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.605 0.565 . . . . 64.44 111.418 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.1 m -133.99 126.71 30.84 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 115.327 -0.852 . . . . 54.4 108.743 174.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 1.7 tt -118.92 115.82 25.19 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.948 -1.501 . . . . 61.41 106.948 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -143.95 29.94 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.343 -0.703 . . . . 72.51 111.343 -170.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -92.3 19.74 6.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 62.13 112.197 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.44 178.93 8.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.321 0.648 . . . . 63.55 110.45 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.5 m -69.2 139.49 54.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.241 0.616 . . . . 65.35 110.551 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -87.41 -65.2 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.108 0.956 . . . . 63.32 108.762 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -156.02 161.44 40.45 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 113.311 -1.768 . . . . 55.11 108.848 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 81.6 mt -132.17 143.17 49.78 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.079 -1.452 . . . . 74.25 107.079 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -155.87 152.22 28.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.882 -0.784 . . . . 53.23 108.882 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.1 tt0 -165.85 135.9 3.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.696 -0.853 . . . . 74.41 108.696 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' B' ' 113' ' ' CYS . 93.1 t -125.1 143.6 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.56 0.744 . . . . 52.33 109.022 174.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 23.3 mt-30 -123.69 91.05 3.39 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.549 -0.908 . . . . 63.03 108.549 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -83.8 101.06 11.34 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.366 -0.834 . . . . 55.44 109.622 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.1 164.9 32.58 Favored Glycine 0 C--O 1.243 0.661 0 O-C-N 123.419 0.449 . . . . 73.4 112.074 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.88 125.34 1.46 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.676 -0.57 . . . . 51.34 111.676 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.432 HG13 ' HE1' ' B' ' 17' ' ' TYR . 45.7 mt -85.23 119.64 34.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 108.17 -1.048 . . . . 72.21 108.17 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.94 151.3 43.74 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.851 0.86 . . . . 60.31 109.864 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 13.4 m -96.3 100.57 12.18 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.051 -1.092 . . . . 65.02 108.051 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.554 HG21 ' SD ' ' B' ' 94' ' ' MET . 12.3 mm -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.496 -0.557 . . . . 63.24 109.496 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -142.42 153.01 43.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.988 0.515 . . . . 64.42 111.077 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.01 -67.15 3.8 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.914 0.759 . . . . 52.33 112.212 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 tt -49.24 135.29 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.281 1.832 . . . . 73.22 112.325 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -151.74 177.14 10.69 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.658 0.383 . . . . 74.14 111.241 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.08 -133.57 34.0 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.39 -0.823 . . . . 71.12 113.636 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.1 m -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.279 1.032 . . . . 60.13 110.858 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -66.67 -47.62 71.9 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.869 -1.514 . . . . 70.04 109.719 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.554 ' SD ' HG21 ' B' ' 86' ' ' ILE . 11.4 tpt -70.57 -33.97 71.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.611 0.764 . . . . 54.13 111.301 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.813 0.445 . . . . 74.14 111.072 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 27.2 t-80 -67.49 -37.49 82.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.81 0.844 . . . . 74.11 111.189 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -69.93 -45.25 67.9 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.5 0.667 . . . . 62.24 110.961 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.27 -38.17 66.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.526 1.13 . . . . 54.42 111.228 -172.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.24 4.81 60.67 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.508 -0.769 . . . . 74.41 114.38 -173.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -150.48 -61.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.865 0.833 . . . . 72.04 112.758 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -64.63 -52.97 54.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.636 0.774 . . . . 73.54 112.148 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.476 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 77.8 m -62.06 -51.15 76.88 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.274 -0.87 . . . . 72.31 112.33 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 32.3 Cg_exo -61.38 -29.51 85.71 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 121.935 1.757 . . . . 74.03 113.764 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.46 -35.99 81.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.941 0.497 . . . . 71.25 111.221 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.75 -40.26 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 124.043 0.937 . . . . 72.22 110.166 172.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.85 -18.84 31.72 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.871 -1.059 . . . . 63.52 112.763 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -59.4 -45.95 98.96 Favored Pre-proline 0 N--CA 1.485 1.282 0 N-CA-C 114.301 1.223 . . . . 74.24 114.301 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.89 -43.27 48.06 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.347 2.032 . . . . 74.4 113.734 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -70.0 -44.02 70.22 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.247 -0.888 . . . . 72.43 110.561 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.31 96.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.451 0.7 . . . . 71.44 110.917 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.588 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.7 ttt180 -56.88 -58.55 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.491 1.517 . . . . 75.32 110.92 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.09 -38.83 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.729 1.212 . . . . 70.15 111.085 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.05 -46.95 75.97 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.286 -0.415 . . . . 75.04 110.935 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.591 HG21 HG21 ' B' ' 64' ' ' VAL . 50.7 mt -60.37 -53.4 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.743 0.417 . . . . 62.34 110.589 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -26.76 68.76 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.271 -0.877 . . . . 72.35 111.406 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 48.1 t -72.26 -50.07 30.13 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.138 0.575 . . . . 51.43 110.526 172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.1 mmt -65.65 -35.06 79.68 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.441 0.696 . . . . 64.3 112.273 -173.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.65 -34.19 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.773 0.429 . . . . 63.43 110.751 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 33.2 t -67.63 -30.4 69.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.762 0.825 . . . . 73.1 110.565 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.422 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 92.6 mtt-85 -65.79 -26.77 67.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.702 0.801 . . . . 73.04 111.552 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 10.4 65.7 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-O 119.681 -0.51 . . . . 62.03 114.261 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 5.1 p 67.85 12.09 8.67 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.18 1.792 . . . . 62.52 113.129 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -85.88 159.1 55.36 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.877 -0.582 . . . . 74.25 110.311 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -41.81 124.94 2.85 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.512 2.808 . . . . 71.3 113.271 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.414 ' HB2' HE21 ' C' ' 125' ' ' GLN . 53.3 tt0 -65.47 111.78 3.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.552 -0.749 . . . . 72.45 109.517 178.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.9 94.79 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.154 -1.054 . . . . 73.22 108.154 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -91.66 121.73 33.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.847 -1.168 . . . . 75.44 107.847 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.588 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -73.8 144.83 45.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 74.14 110.92 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.37 144.88 54.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.274 -0.876 . . . . 64.25 109.686 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.69 ' HG3' HD13 ' D' ' 16' ' ' ILE . 37.0 Cg_endo -63.07 99.41 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.626 2.217 . . . . 50.43 112.327 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.38 132.03 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.307 0.575 . . . . 65.01 110.249 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.46 113.12 24.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.84 0.856 . . . . 50.2 108.983 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -72.81 -18.71 61.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.698 0.799 . . . . 62.02 111.841 -174.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.86 -41.6 95.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.199 0.6 . . . . 62.12 109.742 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.02 88.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.284 -0.871 . . . . 55.45 110.057 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt . . . . . 0 CA--C 1.548 0.894 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.442 178.149 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 29.3 ttm . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 121.305 0.574 . . . . 73.52 111.435 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -101.36 75.16 1.6 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.535 -1.283 . . . . 72.21 107.535 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' C' ' 85' ' ' SER . 56.6 t80 -84.8 118.06 24.24 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 108.221 -1.029 . . . . 54.33 108.221 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -147.49 131.97 17.68 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.725 -0.842 . . . . 41.35 108.725 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -75.95 125.65 35.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.75 -0.834 . . . . 74.4 108.75 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.3 mm-40 -95.11 -45.49 7.19 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 72.12 110.115 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -166.76 126.31 1.5 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.958 0.503 . . . . 74.21 109.888 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.01 144.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.974 -1.121 . . . . 73.2 107.974 174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -177.97 161.22 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.454 0.645 . . . . 73.02 111.017 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -86.28 110.69 19.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.38 -0.827 . . . . 72.23 108.977 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.473 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 7.3 mmmt -72.23 -44.71 62.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.397 -0.964 . . . . 72.32 108.397 172.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.9 t70 -134.51 143.86 47.69 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.661 -1.154 . . . . 70.34 110.234 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.93 147.77 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.267 1.827 . . . . 74.13 106.444 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -157.55 151.64 24.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.066 0.546 . . . . 71.13 110.153 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -148.74 146.28 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.871 -1.159 . . . . 75.02 107.871 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 47.6 mt-10 -141.79 150.11 41.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.259 -1.385 . . . . 71.32 107.259 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -154.85 88.97 3.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.47 -45.58 17.65 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.832 2.355 . . . . 75.05 111.759 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 67.1 m-80 -98.79 40.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.733 -0.667 . . . . 62.11 110.594 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.19 -42.19 91.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.335 1.054 . . . . 61.42 113.32 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.95 -34.7 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 121.611 1.541 . . . . 64.53 112.833 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 38.1 t-80 -68.11 -19.49 64.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.064 1.346 . . . . 73.21 111.874 -172.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.562 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.1 p -48.58 -35.27 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 124.618 1.167 . . . . 73.15 113.55 175.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -59.18 -40.4 85.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.797 0.839 . . . . 71.24 111.35 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -115.6 18.31 15.9 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.364 -0.835 . . . . 72.41 111.331 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.562 ' HE2' HG23 ' C' ' 31' ' ' VAL . 0.0 OUTLIER -82.63 165.51 19.97 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.236 -0.653 . . . . 75.12 109.236 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.39 130.75 35.09 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.721 -0.844 . . . . 71.24 108.721 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -75.34 85.85 2.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.632 0.73 . . . . 74.03 110.075 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -154.27 68.8 6.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.562 -1.199 . . . . 64.31 107.773 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -91.95 112.34 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.334 2.023 . . . . 60.02 111.287 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.56 95.04 9.61 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 108.104 -1.073 . . . . 53.01 108.104 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.95 107.58 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.126 -0.943 . . . . 44.45 110.134 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.5 mttp -91.05 102.83 15.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 72.13 107.669 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.503 HD23 HG22 ' C' ' 64' ' ' VAL . 3.1 tm? -87.07 145.23 26.54 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.131 -1.063 . . . . 74.25 108.131 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -139.91 137.82 35.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.874 0.87 . . . . 71.04 108.691 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.34 146.49 51.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.894 0.878 . . . . 60.42 109.149 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.04 154.71 28.06 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.045 0.938 . . . . 54.23 109.218 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -155.87 148.54 24.01 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.929 0.395 . . . . 64.21 110.384 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.78 163.35 33.59 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.04 0.936 . . . . 73.12 109.036 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.1 p -130.72 147.16 52.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.994 0.517 . . . . 53.2 110.048 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.0 p -143.97 129.06 18.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.73 0.812 . . . . 72.24 109.305 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -78.46 116.49 18.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.915 0.486 . . . . 73.03 110.295 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' C' ' 57' ' ' GLU . 47.2 mt -87.96 -45.77 9.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.799 0.84 . . . . 73.05 109.317 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.71 -179.49 6.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.39 -1.277 . . . . 60.44 109.343 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.38 109.57 0.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.929 0.768 . . . . 65.41 110.216 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.67 22.44 7.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.603 1.161 . . . . 64.22 112.018 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.1 105.61 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.511 1.124 . . . . 62.54 108.027 173.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -114.64 128.81 56.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.675 0.79 . . . . 74.53 110.07 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.98 115.29 22.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.595 0.758 . . . . 74.35 109.195 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.9 t -96.81 121.17 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.14 -1.059 . . . . 44.12 108.14 173.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.7 105.31 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.5 -0.926 . . . . 50.31 108.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.3 tm? -91.29 105.0 17.47 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.277 -1.008 . . . . 70.01 108.277 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -95.9 121.93 38.16 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.951 0.9 . . . . 70.24 110.194 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.8 t -107.35 146.67 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 107.909 -1.145 . . . . 74.54 107.909 169.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 23.4 m -139.46 120.69 14.82 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.495 0.664 . . . . 62.31 109.501 170.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.503 HG22 HD23 ' C' ' 42' ' ' LEU . 85.7 t -101.85 108.86 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.73 -1.123 . . . . 75.32 108.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.8 m -97.92 135.55 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.178 -1.415 . . . . 73.34 107.178 169.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.28 102.97 5.15 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.028 -1.471 . . . . 63.35 107.028 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.438 ' HB3' HG23 ' C' ' 72' ' ' THR . 26.2 p -168.51 154.48 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.695 0.622 . . . . 51.44 110.838 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -95.5 -42.81 8.27 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.187 -0.672 . . . . 52.42 109.187 171.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.42 -80.85 0.05 OUTLIER Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.781 -0.928 . . . . 55.41 110.781 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -89.4 -31.65 17.65 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.779 -0.823 . . . . 73.11 108.779 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.91 85.25 2.23 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.626 -0.715 . . . . 74.55 109.48 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.438 HG23 ' HB3' ' C' ' 67' ' ' SER . 27.5 m -89.31 116.86 27.84 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.233 -0.44 . . . . 75.45 110.197 172.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.51 -64.78 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.511 -1.292 . . . . 55.14 107.511 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.81 171.61 16.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.545 0.688 . . . . 54.13 111.645 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.7 tm? -132.08 145.35 51.35 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.563 -2.014 . . . . 73.21 105.563 171.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -151.72 142.99 23.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.382 -0.97 . . . . 62.34 108.382 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -150.1 134.25 17.11 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.404 -0.591 . . . . 73.43 109.404 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' C' ' 110' ' ' ALA . 50.3 t -134.27 113.69 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.89 0.876 . . . . 65.34 108.661 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 54.3 mt-30 -91.05 90.13 7.71 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.525 -0.917 . . . . 73.25 108.525 171.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.7 tp-100 -78.81 103.77 8.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.84 -1.073 . . . . 74.1 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.74 144.74 22.28 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.458 -0.657 . . . . 72.13 111.458 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.05 117.1 0.9 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.557 -1.017 . . . . 74.5 110.557 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.525 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -80.0 126.73 39.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.854 -1.165 . . . . 60.21 107.854 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.6 143.33 47.27 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.892 0.477 . . . . 73.44 109.812 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 15.6 m -82.1 107.14 14.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.656 -1.238 . . . . 75.15 107.656 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.4 99.72 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.095 -1.076 . . . . 73.42 108.095 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -128.75 159.31 36.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.362 1.065 . . . . 62.43 110.152 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -53.45 4.37 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.53 0.519 . . . . 72.13 113.435 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' C' ' 94' ' ' MET . 30.0 pt -80.92 150.82 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.872 0.869 . . . . 65.12 112.117 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -147.23 153.75 40.18 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.77 1.228 . . . . 72.44 108.85 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.64 -111.32 2.07 Favored Glycine 0 C--N 1.355 1.612 0 O-C-N 123.548 0.53 . . . . 74.04 114.136 170.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 24.9 p -50.6 -55.42 16.37 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.293 1.437 . . . . 74.24 112.868 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.38 -46.32 80.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.054 0.542 . . . . 73.55 111.502 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.405 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.0 ptt? -68.83 -31.48 70.5 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.356 0.41 . . . . 75.42 111.484 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.61 75.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.166 0.587 . . . . 73.11 111.528 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -69.58 -29.46 67.01 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.837 -0.62 . . . . 71.43 110.846 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.34 -58.93 3.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.908 0.483 . . . . 42.45 110.486 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -73.36 -15.62 61.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.94 0.496 . . . . 74.21 111.652 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.32 7.73 58.46 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 119.588 -0.562 . . . . 64.13 113.822 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB2' ' HD2' ' C' ' 133' ' ' PHE . . . -159.43 -60.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.689 0.745 . . . . 71.14 112.152 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -73.41 -44.8 57.65 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.453 0.701 . . . . 74.21 112.788 -167.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 38.0 m -68.65 -47.2 34.44 Favored Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.14 0.576 . . . . 53.41 111.415 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 38.2 Cg_exo -64.48 -26.15 62.66 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.177 1.918 . . . . 74.45 114.192 173.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.541 ' ND2' HD22 ' C' ' 132' ' ' ASN . 29.2 t-20 -55.06 -49.05 72.6 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.894 0.877 . . . . 70.14 110.277 176.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -56.96 -41.98 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 124.163 0.915 . . . . 71.11 110.897 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.1 mt -83.41 -23.0 32.55 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.126 -0.943 . . . . 63.43 112.566 -171.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.74 -50.34 87.25 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.57 -1.205 . . . . 64.32 113.494 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.41 -34.17 93.82 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.071 1.847 . . . . 72.34 112.918 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -68.0 -50.72 53.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.787 0.835 . . . . 73.11 111.448 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -65.31 -35.03 79.74 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 116.018 -0.537 . . . . 50.21 111.117 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.473 HH12 ' HG3' ' C' ' 130' ' ' PRO . 59.6 ttt180 -60.66 -48.51 81.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.797 1.639 . . . . 60.14 110.647 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.422 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 3.1 tm-20 -72.82 -33.62 66.31 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.873 0.469 . . . . 74.41 109.993 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.423 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 8.6 t -65.55 -28.73 69.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.979 0.512 . . . . 74.04 111.135 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.468 HD13 HG23 ' C' ' 64' ' ' VAL . 87.9 mt -78.77 -51.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.659 -0.7 . . . . 54.32 110.033 173.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 33.6 m -58.97 -28.56 66.44 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.251 0.548 . . . . 71.45 111.173 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 44.6 t -63.38 -55.27 25.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.266 1.026 . . . . 74.33 109.053 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.473 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -34.69 71.19 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.739 1.216 . . . . 73.22 112.774 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.9 t -66.2 -48.09 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.855 -0.794 . . . . 73.45 108.855 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -31.97 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.022 -0.99 . . . . 70.33 111.214 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.5 mtt-85 -66.94 -40.85 87.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.524 0.73 . . . . 72.11 109.437 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.73 3.93 62.52 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.826 0.704 . . . . 71.14 112.988 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 59.69 31.33 20.81 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.436 1.894 . . . . 65.21 112.994 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.98 153.47 43.42 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.078 0.951 . . . . 72.13 108.929 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 -169.89 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.91 2.406 . . . . 73.55 113.536 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' B' ' 125' ' ' GLN . 50.9 mm-40 -52.28 117.96 3.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.367 1.067 . . . . 71.52 113.138 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.55 104.39 4.93 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.033 -1.469 . . . . 72.33 107.033 170.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.12 131.1 38.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.672 1.189 . . . . 64.31 108.227 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -86.11 142.54 28.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.925 -0.398 . . . . 74.13 109.925 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 139.03 97.55 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.32 1.048 . . . . 53.41 111.922 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.473 ' HG3' HH12 ' C' ' 111' ' ' ARG . 27.0 Cg_exo -63.44 98.28 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.758 2.305 . . . . 74.33 112.837 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.86 109.17 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.05 -0.722 . . . . 71.51 109.05 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.541 HD22 ' ND2' ' C' ' 104' ' ' ASN . 19.2 m120 -115.36 102.99 10.35 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.79 0.836 . . . . 64.11 109.95 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' C' ' 100' ' ' ALA . 67.2 t80 -80.37 -24.18 39.97 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.58 0.705 . . . . 75.15 110.212 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 N--CA 1.472 0.637 0 C-N-CA 124.406 1.083 . . . . 71.24 111.123 176.087 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 114.851 1.426 . . . . 64.41 114.851 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 45.5 m -145.69 143.65 29.91 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.452 1.101 . . . . 72.43 109.202 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' D' ' 85' ' ' SER . 44.8 t80 -154.08 109.92 3.23 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.053 -1.091 . . . . 71.53 108.053 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.8 116.42 27.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.313 0.645 . . . . 64.01 110.259 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 30.9 pt -78.39 99.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.483 -0.932 . . . . 75.21 108.483 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -83.44 -45.31 13.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.944 -0.472 . . . . 74.23 111.669 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.422 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 20.5 ttt180 -164.71 126.6 2.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.597 -0.149 . . . . 75.3 110.597 -167.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.69 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -113.15 133.68 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.639 -1.245 . . . . 62.44 107.639 174.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.9 p90 -159.03 178.42 10.08 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.429 0.692 . . . . 71.42 111.782 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 58.2 p -107.36 132.19 53.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.619 -0.882 . . . . 73.34 108.619 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.0 mtpt -96.21 -31.48 12.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.195 -0.298 . . . . 62.54 110.195 175.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.0 t70 -150.24 141.27 22.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.929 0.892 . . . . 74.11 108.916 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.1 mt -143.75 148.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.7 1.2 . . . . 50.05 107.921 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.6 t -151.64 145.46 25.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.331 1.053 . . . . 72.21 109.176 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -150.59 125.27 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.725 -1.954 . . . . 73.44 105.725 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -131.79 131.94 43.35 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.139 0.427 . . . . 71.1 110.104 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.55 79.69 11.22 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.779 -0.823 . . . . 75.13 108.779 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.77 -39.72 14.42 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.584 2.189 . . . . 73.32 111.303 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -98.79 24.73 7.27 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.811 . . . . 52.33 109.97 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.513 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -51.97 -49.13 85.77 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 115.132 1.53 . . . . 43.45 115.132 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.83 -7.37 9.47 Favored 'Trans proline' 0 C--N 1.39 2.745 0 CA-C-N 121.791 1.675 . . . . 62.33 112.996 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -83.82 -40.15 19.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 74.11 109.813 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.42 -12.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.549 0.739 . . . . 62.51 110.712 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -56.82 -29.77 63.08 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.667 1.187 . . . . 74.53 111.815 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.89 -14.24 62.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.228 1.011 . . . . 64.32 112.124 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.42 108.76 13.06 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.805 0.842 . . . . 64.11 109.771 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.69 82.16 3.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.654 0.74 . . . . 64.14 110.383 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -148.63 165.46 31.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.193 0.997 . . . . 74.05 108.666 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.5 mp0 -69.52 110.67 6.8 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.281 1.433 . . . . 74.44 111.222 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 16.6 Cg_exo -71.12 124.07 10.2 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.058 2.505 . . . . 70.45 112.392 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -60.99 118.91 7.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.378 0.424 . . . . 72.04 110.807 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.484 HG23 HG13 ' D' ' 64' ' ' VAL . 2.3 p -98.91 128.0 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.797 0.839 . . . . 43.15 109.498 -176.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 9.3 tmtt? -99.29 117.0 32.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.046 -1.835 . . . . 74.41 106.046 170.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.467 HD22 HD22 ' D' ' 128' ' ' LEU . 53.2 tp -95.1 134.79 37.42 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.984 -1.117 . . . . 65.14 107.984 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.5 t70 -135.43 149.92 49.72 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.263 -1.384 . . . . 75.14 107.263 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -135.43 164.69 27.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.482 0.313 . . . . 63.41 111.195 -174.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.9 t70 -171.23 156.18 4.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.514 1.125 . . . . 63.12 109.351 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -134.63 160.54 37.79 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.476 0.711 . . . . 73.42 110.003 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.1 162.83 39.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.056 0.942 . . . . 43.21 109.344 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -140.63 157.94 44.72 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.163 0.585 . . . . 71.23 110.803 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -161.15 130.2 4.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.571 1.148 . . . . 34.11 108.567 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -89.89 123.55 33.93 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.09 -0.707 . . . . 73.42 109.09 172.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' D' ' 57' ' ' GLU . 56.6 mt -97.94 -35.62 10.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.791 0.836 . . . . 62.11 110.056 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -160.32 -175.62 5.14 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.954 -1.021 . . . . 44.02 110.564 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.97 109.39 1.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.787 -1.097 . . . . 62.23 109.674 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.81 10.01 6.5 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.985 1.314 . . . . 75.12 112.925 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 89.1 t -109.02 118.33 56.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.233 -1.025 . . . . 62.52 108.233 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.63 129.83 44.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.066 -0.97 . . . . 73.43 109.74 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.615 ' HB2' HD11 ' D' ' 51' ' ' LEU . 35.3 tt0 -87.24 130.75 34.45 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.316 1.046 . . . . 73.13 108.683 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.0 145.0 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.142 -1.059 . . . . 72.05 108.142 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 85.6 t -117.46 142.46 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.017 0.927 . . . . 74.13 108.73 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 116.56 24.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.435 -1.321 . . . . 63.1 107.435 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -101.44 103.92 14.84 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.126 -1.064 . . . . 53.32 108.126 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.73 117.77 49.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.244 -1.021 . . . . 72.03 108.244 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 10.4 m -118.02 127.92 54.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.245 0.618 . . . . 74.5 110.385 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 73.4 t -114.63 123.78 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.322 1.449 . . . . 63.42 108.962 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 32.3 m -123.6 91.61 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.908 -1.145 . . . . 73.13 107.908 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 138.74 34.3 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.254 -0.647 . . . . 52.34 109.254 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -154.62 125.86 7.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.437 -0.801 . . . . 72.54 109.692 -173.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' D' ' 71' ' ' GLU . 46.4 tp -113.38 99.19 7.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.067 -0.716 . . . . 74.03 109.067 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.83 -128.74 9.08 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 112.157 -0.377 . . . . 61.35 112.157 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -90.33 14.54 12.52 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.307 1.043 . . . . 71.43 110.839 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' D' ' 68' ' ' LEU . 3.3 tp10 -115.31 134.31 55.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.179 0.992 . . . . 73.2 111.431 -158.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.3 m -69.59 110.47 4.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.594 -0.891 . . . . 75.24 108.594 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 -66.83 0.84 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.66 -0.496 . . . . 61.31 109.66 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -154.35 136.6 14.85 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.399 0.619 . . . . 71.13 110.265 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.3 mt -105.12 152.49 22.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.649 1.18 . . . . 52.42 108.0 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 41.0 t -160.37 148.77 16.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.119 0.568 . . . . 33.33 109.963 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.7 125.75 6.59 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.818 -0.808 . . . . 75.21 108.818 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.413 0.685 . . . . 74.34 109.607 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -93.89 87.11 5.27 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.719 -0.845 . . . . 73.25 108.719 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.04 110.01 13.87 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.434 -1.257 . . . . 64.12 108.45 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.45 143.93 15.75 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.239 -0.344 . . . . 72.55 112.239 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.48 139.84 9.45 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.833 0.317 . . . . 71.33 112.347 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.35 123.17 40.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.806 0.842 . . . . 71.31 108.984 173.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.08 141.51 48.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.106 0.963 . . . . 71.33 108.729 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 17.4 m -102.37 112.69 25.5 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.315 -0.624 . . . . 70.51 109.315 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.99 103.56 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.245 -1.02 . . . . 73.14 108.245 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.55 153.48 49.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.442 1.097 . . . . 74.42 109.711 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 2.78 61.29 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.102 0.252 . . . . 71.21 113.367 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 44.9 mm -131.41 129.83 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.861 1.264 . . . . 74.04 108.317 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.65 179.1 7.02 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.191 0.997 . . . . 74.04 110.814 -174.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.0 -135.46 24.39 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.886 -0.597 . . . . 63.11 114.083 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -80.1 -21.85 42.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.936 0.894 . . . . 75.51 111.927 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.57 -40.4 73.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.959 0.504 . . . . 75.34 111.164 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -28.64 64.75 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 110.311 -0.255 . . . . 72.24 110.311 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.55 -32.76 66.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.475 0.71 . . . . 64.25 110.555 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -65.93 -43.43 88.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.257 0.623 . . . . 73.35 110.198 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.54 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 89.8 m -61.67 -42.33 98.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.437 0.295 . . . . 65.41 110.884 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.01 -40.02 65.54 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.065 0.546 . . . . 63.31 111.629 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.97 3.68 38.59 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-O 119.414 -0.659 . . . . 71.55 114.662 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.43 -63.24 0.37 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.979 0.889 . . . . 74.21 112.203 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 82.7 t80 -64.95 -58.19 6.79 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.372 0.508 . . . . 72.51 112.372 -170.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 66.1 m -59.94 -44.23 96.36 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 118.513 -0.756 . . . . 72.02 112.737 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.43 -37.5 94.76 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.419 2.079 . . . . 63.22 113.919 167.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.96 -28.54 66.73 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.446 0.698 . . . . 54.34 110.858 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.5 -40.63 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.398 0.618 . . . . 63.23 109.773 170.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.422 HD21 ' HA3' ' D' ' 82' ' ' GLY . 82.7 mt -76.53 -18.97 58.42 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.23 -0.896 . . . . 61.24 112.008 -176.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -64.11 -43.4 74.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.293 1.22 . . . . 73.44 114.293 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.45 -39.94 63.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.051 1.834 . . . . 61.52 113.292 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -78.93 -30.18 44.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.746 0.818 . . . . 75.32 111.621 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.67 65.62 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.212 0.605 . . . . 63.4 109.641 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.44 -49.42 74.62 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.2 -1.364 . . . . 75.32 110.607 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.73 -45.9 92.48 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.041 0.838 . . . . 75.45 111.697 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -59.13 -40.97 87.1 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.715 0.635 . . . . 71.42 110.745 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.52 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.6 mt -61.79 -56.89 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 123.791 0.682 . . . . 70.42 109.873 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' D' ' 125' ' ' GLN . 41.0 m -54.11 -38.69 65.68 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.649 1.18 . . . . 75.14 111.787 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -66.8 -44.01 82.36 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.791 -1.095 . . . . 73.31 110.399 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.5 -29.77 65.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.116 0.566 . . . . 73.24 111.907 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.9 t -68.16 -42.26 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 123.785 0.678 . . . . 73.43 109.336 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -75.63 -28.0 58.65 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.257 -0.429 . . . . 64.02 111.174 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.423 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 94.2 mtt-85 -69.97 -35.74 74.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.509 0.724 . . . . 74.01 109.614 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.53 0.16 77.03 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.794 0.683 . . . . 34.45 112.33 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.62 28.13 16.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.51 1.924 . . . . 72.44 112.677 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.406 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 37.4 m-85 -91.03 162.25 33.18 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.19 1.396 . . . . 73.52 110.683 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.9 133.22 52.25 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.766 2.31 . . . . 75.02 111.853 177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.7 tt0 -56.62 137.84 53.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.874 0.869 . . . . 75.33 112.446 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.39 108.95 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.894 -1.151 . . . . 73.22 107.894 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -113.27 110.96 21.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.805 -0.813 . . . . 72.34 108.805 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.467 HD22 HD22 ' D' ' 42' ' ' LEU . 90.5 mt -69.2 135.58 50.8 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.133 0.573 . . . . 62.41 110.279 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.51 146.95 98.81 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.024 0.929 . . . . 64.42 111.42 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -66.7 121.37 8.59 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.638 2.226 . . . . 74.43 111.269 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.74 118.8 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.338 0.655 . . . . 75.52 110.323 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -86.55 78.35 9.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.153 -1.054 . . . . 73.21 108.153 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 74.11 111.333 178.214 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 N--CA 1.466 0.361 0 N-CA-C 108.267 -1.012 . . . . 71.53 108.267 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' HG12 ' A' ' 86' ' ' ILE . 19.0 p90 -134.87 117.38 15.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.924 0.89 . . . . 72.0 108.868 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -155.32 138.42 15.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.963 0.505 . . . . 52.52 110.386 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 13' ' ' ILE . 4.1 mp -68.15 116.38 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 72.1 109.319 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.97 -41.67 17.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.013 -0.736 . . . . 61.44 109.013 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.537 HH11 ' HD2' ' B' ' 32' ' ' PHE . 72.0 ttt180 -168.56 140.63 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.502 0.721 . . . . 62.32 109.072 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.24 137.78 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.592 -0.892 . . . . 72.11 108.592 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -173.68 167.71 4.47 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.399 0.619 . . . . 64.34 112.251 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -86.15 123.97 32.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.835 -0.802 . . . . 64.43 108.835 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -86.36 -32.14 21.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.438 0.637 . . . . 62.33 109.523 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.735 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.9 t70 -141.63 140.91 33.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.955 -1.021 . . . . 63.13 110.45 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.4 mt -141.59 145.38 24.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.949 1.7 . . . . 71.42 106.795 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -159.24 130.32 6.09 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.722 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 84.4 t80 -132.11 119.51 21.05 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.353 -1.351 . . . . 64.33 107.353 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -118.59 140.87 49.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.822 -0.807 . . . . 74.32 108.822 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.68 78.66 15.77 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 107.444 -1.317 . . . . 74.4 107.444 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 -29.98 61.88 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.519 2.146 . . . . 73.33 111.726 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 31.6 m-80 -117.01 40.71 2.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.879 0.872 . . . . 71.11 109.23 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.16 99.47 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.089 0.956 . . . . 64.13 113.2 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.25 -25.8 18.34 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.573 1.515 . . . . 71.41 112.462 171.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.6 m-70 -77.79 -33.37 52.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.793 -0.639 . . . . 63.1 112.223 -173.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' A' ' 123' ' ' PHE . 11.1 p -64.45 -22.17 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 120.958 0.409 . . . . 73.2 111.501 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -72.94 -29.54 63.18 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 63.42 110.681 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -82.7 -51.43 7.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.33 1.052 . . . . 63.14 110.574 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HE3' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -82.22 133.89 35.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.829 0.852 . . . . 74.33 109.8 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 68' ' ' LEU . 18.7 t70 -56.64 134.57 54.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.048 1.339 . . . . 73.45 113.221 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -71.1 83.06 0.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.546 0.738 . . . . 74.44 112.419 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -137.01 78.87 39.78 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.272 1.029 . . . . 74.24 109.011 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -84.03 133.3 5.68 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.955 2.436 . . . . 64.12 112.389 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.4 116.25 29.26 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.905 -1.146 . . . . 75.23 107.905 171.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.53 119.73 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.309 0.643 . . . . 65.44 110.761 -173.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -110.18 138.44 46.55 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.958 -1.127 . . . . 75.35 107.958 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.06 146.16 52.27 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.31 0.644 . . . . 71.14 111.388 -169.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.85 144.62 50.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.418 1.087 . . . . 43.41 109.382 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -138.27 136.69 36.75 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 62.25 109.182 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 17.4 t70 -158.13 149.29 21.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.786 0.434 . . . . 73.52 110.84 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 m -135.19 126.58 28.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.199 1.0 . . . . 54.34 110.176 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.49 110.26 10.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.073 0.549 . . . . 73.01 110.11 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -88.39 153.25 21.33 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.78 -0.822 . . . . 63.14 108.78 175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -164.88 117.04 1.21 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.213 0.46 . . . . 52.14 110.197 -171.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.84 105.39 3.78 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.828 0.851 . . . . 75.21 110.629 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 57' ' ' GLU . 97.6 mt -77.45 -37.72 50.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.804 0.842 . . . . 62.14 111.635 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -145.63 -174.11 4.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.255 1.022 . . . . 72.42 108.592 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.42 97.42 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.108 0.563 . . . . 62.51 110.519 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 58.71 27.72 16.29 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.722 1.209 . . . . 74.1 112.661 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 86.1 t -103.91 121.09 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.884 -1.524 . . . . 64.22 106.884 165.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.84 130.04 50.59 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.277 -0.638 . . . . 71.4 109.277 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 51' ' ' LEU . 42.2 tt0 -85.86 118.81 25.58 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.008 0.923 . . . . 71.52 108.63 168.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.42 111.8 29.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.396 -1.335 . . . . 65.11 107.396 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.4 t -99.26 130.96 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.501 -0.555 . . . . 51.44 109.501 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -106.79 113.56 27.12 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.579 -0.897 . . . . 75.31 108.579 -174.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -87.45 102.69 14.79 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.973 -0.751 . . . . 73.31 108.973 174.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.04 130.34 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.341 -0.985 . . . . 71.34 108.341 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 m -121.18 133.21 55.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.352 -0.981 . . . . 72.35 108.352 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.15 104.61 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.976 -1.12 . . . . 73.1 107.976 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -105.77 146.26 30.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.818 -0.808 . . . . 74.21 108.818 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.53 115.72 13.38 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.645 -1.243 . . . . 72.15 107.645 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -109.26 126.0 52.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.52 -0.548 . . . . 53.13 109.52 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.09 82.7 6.06 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 105.777 -1.935 . . . . 71.21 105.777 176.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.7 -127.18 7.83 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.435 -0.802 . . . . 64.12 111.665 -170.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.25 -14.72 30.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.972 0.509 . . . . 74.02 111.093 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -95.03 135.02 37.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.879 0.871 . . . . 75.32 109.511 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -65.34 129.25 39.06 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.01 0.524 . . . . 64.13 111.227 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -77.81 -58.05 3.47 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.093 -1.077 . . . . 64.44 108.093 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -166.91 165.74 15.87 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.641 -1.163 . . . . 73.54 110.437 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -134.73 145.14 48.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.535 1.134 . . . . 65.34 108.792 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.722 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 20.0 m -141.58 98.92 3.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.611 0.764 . . . . 73.23 109.44 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -109.28 129.21 55.52 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.625 -0.509 . . . . 71.43 109.625 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -130.51 132.82 64.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 123.753 0.821 . . . . 72.34 109.325 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.735 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.2 mt-30 -105.74 102.91 12.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.592 -0.731 . . . . 61.14 109.52 169.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.77 98.89 12.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.842 -1.072 . . . . 71.23 109.366 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.4 142.14 15.97 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.374 -0.69 . . . . 62.44 111.374 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.52 122.58 2.42 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.929 -0.868 . . . . 72.41 110.929 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -80.91 125.37 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.636 -0.876 . . . . 63.42 108.636 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.8 121.58 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.203 0.601 . . . . 75.04 109.508 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -84.13 103.37 13.29 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.278 -1.008 . . . . 53.14 108.278 171.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.585 HD11 HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.47 124.69 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.48 0.657 . . . . 72.32 109.811 -171.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.29 175.77 13.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.126 0.97 . . . . 63.4 111.045 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.23 -24.97 29.02 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.758 -0.656 . . . . 24.14 113.043 177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.585 HD11 HD11 ' A' ' 86' ' ' ILE . 13.6 pt -110.46 168.88 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.23 110.615 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.545 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 24.3 tt0 -150.85 -172.37 4.18 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.576 -1.193 . . . . 63.42 108.507 -171.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.545 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.46 -142.62 46.84 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.03 0.772 . . . . 62.32 115.03 171.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -77.29 -14.39 59.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.086 0.954 . . . . 62.13 111.561 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -47.96 69.9 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.763 0.825 . . . . 73.31 110.015 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 20.1 ttt -80.64 -35.83 33.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 51.23 111.074 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.88 -32.44 67.7 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.403 0.621 . . . . 61.13 111.447 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.28 -49.67 70.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.633 -1.167 . . . . 64.23 110.272 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.598 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 5.3 m -68.24 -63.22 1.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.701 1.0 . . . . 42.42 113.701 -170.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -12.35 60.04 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 118.88 0.764 . . . . 72.2 112.415 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.69 -6.07 44.16 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.178 -0.79 . . . . 74.34 114.5 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.19 -57.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 117.873 0.836 . . . . 62.15 111.786 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -55.69 -58.35 8.17 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.576 1.15 . . . . 71.23 112.045 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.96 -41.8 6.97 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 113.314 0.857 . . . . 53.22 113.314 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.9 Cg_endo -66.28 -24.86 50.2 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 121.624 1.55 . . . . 73.42 113.873 169.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.442 HD21 ' ND2' ' A' ' 132' ' ' ASN . 66.9 t30 -76.47 -22.35 54.66 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.941 0.791 . . . . 53.1 110.21 176.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mm -67.45 -43.02 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.267 0.627 . . . . 75.24 109.493 166.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.3 mt -71.25 -31.44 67.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.042 -0.981 . . . . 74.51 111.99 -175.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.51 -43.33 84.01 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.819 1.044 . . . . 73.43 113.819 -168.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.82 -31.79 82.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.276 1.984 . . . . 62.43 113.835 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -83.38 -28.78 28.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.186 0.594 . . . . 65.02 111.863 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.99 77.49 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.296 -0.631 . . . . 45.25 109.296 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.462 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.2 ttm180 -65.84 -38.35 88.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.524 -1.216 . . . . 73.44 110.327 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -53.51 -54.21 40.47 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.215 1.006 . . . . 75.22 110.247 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -61.85 -50.96 70.15 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.936 -1.484 . . . . 71.22 111.24 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 118' ' ' VAL . 17.7 mt -62.41 -58.9 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.703 0.801 . . . . 60.11 111.371 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -54.49 -38.58 66.61 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.871 0.732 . . . . 43.31 111.088 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.5 t -65.88 -45.89 80.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.496 -0.775 . . . . 42.05 110.285 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.5 mtp -57.15 -41.83 79.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.595 0.758 . . . . 42.42 111.31 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.2 t -60.45 -47.67 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.901 0.881 . . . . 64.31 110.233 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.663 -0.699 . . . . 64.25 111.585 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -74.62 -30.53 61.69 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.738 0.815 . . . . 73.54 109.747 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.48 2.37 67.48 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.519 -0.764 . . . . 65.5 112.569 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 68.27 22.31 8.14 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.874 1.27 . . . . 63.41 110.552 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.411 ' HE1' HG11 ' A' ' 31' ' ' VAL . 24.6 m-85 -96.5 153.27 38.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.823 0.849 . . . . 74.42 110.288 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 123.73 14.54 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.652 2.235 . . . . 61.53 111.075 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.75 147.44 27.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 124.036 0.835 . . . . 62.12 111.747 -171.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.0 mt -111.95 105.77 14.28 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.717 -0.846 . . . . 62.34 108.717 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.13 93.05 6.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.535 -0.913 . . . . 63.05 108.535 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.07 127.7 33.57 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.443 -175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 137.56 94.75 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.544 0.738 . . . . 75.03 111.58 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.434 ' HB3' HH22 ' A' ' 111' ' ' ARG . 34.1 Cg_endo -83.83 145.92 11.56 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.594 2.196 . . . . 61.21 113.02 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 114.21 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.636 -0.876 . . . . 60.44 108.636 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.442 ' ND2' HD21 ' A' ' 104' ' ' ASN . 15.5 m120 -85.4 75.21 10.25 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.691 0.758 . . . . 64.41 110.008 176.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -68.89 -28.31 66.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.591 -1.186 . . . . 74.23 109.895 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 115.205 -0.907 . . . . 75.44 110.402 175.584 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.3 ptm . . . . . 0 N--CA 1.497 1.883 0 N-CA-C 114.17 1.174 . . . . 74.4 114.17 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.0 m -152.42 125.58 8.62 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.136 0.974 . . . . 52.02 108.604 171.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -136.24 127.87 28.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.37 -0.604 . . . . 61.33 109.37 163.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -158.02 141.53 15.38 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.998 -1.112 . . . . 74.11 107.998 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.28 123.14 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 170.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -83.29 -50.6 8.22 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.083 -0.34 . . . . 74.43 110.083 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.31 130.48 1.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.113 -0.494 . . . . 72.42 109.817 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' B' ' 109' ' ' TYR . 92.3 mt -114.22 146.04 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.651 -0.87 . . . . 70.01 108.651 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -163.49 155.41 17.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.413 0.625 . . . . 74.44 111.494 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.6 m -78.26 126.17 30.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.007 -0.997 . . . . 75.12 108.625 170.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.506 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.3 mtpt -98.18 -32.6 11.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.57 0.748 . . . . 74.14 111.175 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.3 t70 -155.8 139.9 16.46 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.07 -0.514 . . . . 70.12 111.523 -167.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.8 mm -147.14 145.69 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.658 1.583 . . . . 64.3 108.355 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.92 151.98 32.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.718 -0.845 . . . . 73.31 108.718 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -147.58 115.48 6.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.853 -1.536 . . . . 74.22 106.853 173.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.6 121.97 42.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.7 -0.852 . . . . 54.12 108.7 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.866 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -125.47 80.61 65.49 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.853 -1.166 . . . . 54.25 107.853 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.09 -45.63 0.64 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.55 2.167 . . . . 60.53 111.693 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -98.8 18.65 16.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.699 0.8 . . . . 73.21 110.743 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.866 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.11 -50.53 54.65 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 125.213 1.405 . . . . 60.43 114.239 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -20.77 25.9 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.879 1.72 . . . . 74.33 112.593 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -91.0 -28.37 18.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.769 0.828 . . . . 71.01 110.868 -173.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.01 -8.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.424 0.689 . . . . 55.41 110.256 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . 0.537 ' HD2' HH11 ' A' ' 15' ' ' ARG . 75.9 t80 -56.72 -33.94 66.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.929 1.292 . . . . 64.33 110.81 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -71.8 -29.52 64.54 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.037 -0.983 . . . . 64.53 111.27 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.447 ' HD3' HD22 ' B' ' 68' ' ' LEU . 95.6 mttt -94.89 110.21 22.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.448 0.699 . . . . 73.11 111.086 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.22 81.72 1.86 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.455 -0.942 . . . . 71.51 108.455 171.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.792 ' HB2' HD21 ' B' ' 68' ' ' LEU . 51.0 m95 -149.94 178.07 9.27 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.461 1.104 . . . . 71.0 108.457 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -78.04 127.36 81.84 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.43 0.692 . . . . 74.23 110.026 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' B' ' 68' ' ' LEU . 72.6 Cg_endo -77.86 146.83 23.77 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.946 1.764 . . . . 65.33 112.212 168.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.75 103.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.061 0.945 . . . . 73.42 108.932 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -86.62 129.98 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.541 0.736 . . . . 73.42 109.493 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.607 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.1 tttm -136.14 128.48 30.17 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.419 -0.956 . . . . 70.41 108.419 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.02 153.87 26.2 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.646 -0.872 . . . . 75.12 108.646 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.607 -0.886 . . . . 75.35 108.607 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.72 138.2 40.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.891 0.876 . . . . 74.34 109.014 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.2 t70 -144.79 152.7 40.74 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.02 1.328 . . . . 73.51 108.308 -174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.9 t -151.33 140.46 21.2 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.312 0.645 . . . . 71.15 109.381 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.68 124.47 17.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.8 -1.185 . . . . 53.42 107.8 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -97.29 160.99 14.01 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.686 -0.487 . . . . 75.31 109.686 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 57' ' ' GLU . 32.7 t -149.41 155.37 40.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.006 -1.109 . . . . 62.11 108.006 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -124.78 129.17 49.94 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.364 0.665 . . . . 75.14 109.692 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.87 -45.06 10.02 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.324 0.649 . . . . 65.12 109.641 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.12 -176.09 5.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.295 -0.866 . . . . 71.41 110.093 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -61.9 125.96 25.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.0 -1.0 . . . . 62.01 109.055 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.36 2.85 3.47 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.134 1.374 . . . . 64.51 112.762 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 t -120.32 96.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.607 -0.886 . . . . 73.31 108.607 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.22 165.16 11.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.995 0.518 . . . . 44.35 110.159 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' B' ' 49' ' ' SER . 6.3 tm-20 -142.97 95.44 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.288 -1.745 . . . . 74.22 106.288 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.9 131.23 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.303 -0.628 . . . . 44.55 109.303 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.7 t -106.13 151.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.942 0.897 . . . . 75.32 109.952 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.18 119.49 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.087 -1.449 . . . . 72.21 107.087 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.607 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 38.3 ttp180 -105.96 120.98 43.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.872 0.368 . . . . 74.23 110.846 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' B' ' 114' ' ' ILE . 23.5 t -108.06 128.15 63.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.927 -1.138 . . . . 73.0 107.927 168.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -120.78 130.28 53.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.378 -0.601 . . . . 73.04 109.378 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.495 HG23 HD13 ' B' ' 114' ' ' ILE . 98.7 t -118.22 134.14 62.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.276 -0.875 . . . . 74.41 109.055 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 98.6 m -125.58 137.65 53.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.901 -1.045 . . . . 64.45 108.489 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.73 125.36 19.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.508 -1.293 . . . . 74.21 107.508 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 p -136.46 123.44 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.286 -1.005 . . . . 74.11 108.286 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' B' ' 36' ' ' TRP . 3.2 tt -95.61 116.18 28.48 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.48 -0.933 . . . . 73.32 108.48 -172.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -114.06 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 124.11 0.881 . . . . 43.52 111.517 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.48 4.73 15.34 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.182 0.993 . . . . 71.51 111.637 -175.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 12.2 pt-20 -129.62 163.89 25.07 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.317 0.647 . . . . 74.31 110.023 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 12.6 m -67.21 148.59 51.57 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.446 0.466 . . . . 61.14 110.66 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.93 -56.83 2.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.578 0.751 . . . . 64.12 109.024 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -165.36 153.67 11.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.139 -0.937 . . . . 74.12 110.235 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -131.43 144.56 51.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 75.14 108.13 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 40.2 t -151.57 152.27 32.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.559 -0.534 . . . . 73.44 109.559 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -158.36 129.6 6.48 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.21 0.604 . . . . 74.32 109.416 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.454 HG22 ' CD1' ' B' ' 21' ' ' ILE . 82.7 t -124.56 148.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.812 0.845 . . . . 72.41 109.985 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.607 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 41.7 mt-30 -125.69 98.45 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.23 -1.026 . . . . 63.11 108.23 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.9 tp-100 -85.89 104.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.839 -0.619 . . . . 74.23 109.429 174.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.74 168.47 25.01 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 111.544 -0.622 . . . . 71.13 111.544 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.47 130.76 2.2 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.466 -0.397 . . . . 71.42 112.97 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -84.14 128.92 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.147 0.979 . . . . 71.21 109.018 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.61 140.85 44.91 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.34 1.056 . . . . 63.3 109.759 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -87.49 107.6 18.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.211 1.004 . . . . 73.42 109.032 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.412 HG13 HD21 ' B' ' 98' ' ' LEU . 17.6 mm -122.77 121.8 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.673 0.789 . . . . 64.43 110.478 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.36 167.68 29.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.074 0.55 . . . . 54.24 110.987 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 85.62 -45.19 3.45 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.97 -0.559 . . . . 65.21 113.398 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.411 HG21 ' HB2' ' B' ' 97' ' ' CYS . 41.2 mm -74.36 138.49 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.663 0.785 . . . . 61.15 109.763 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.03 -172.43 4.03 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.809 0.843 . . . . 75.04 111.149 -176.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.28 -113.52 5.98 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.742 0.651 . . . . 53.42 113.981 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -88.29 -35.6 17.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.723 0.809 . . . . 61.33 110.59 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -71.2 -18.98 62.45 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.096 -0.956 . . . . 74.41 111.599 -168.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 19.7 ptp -56.12 -28.78 59.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.992 0.917 . . . . 73.32 112.097 173.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.25 87.61 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.101 0.96 . . . . 65.4 112.358 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -88.99 -27.53 20.82 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.367 -0.833 . . . . 71.21 111.218 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . 0.411 ' HB2' HG21 ' B' ' 89' ' ' ILE . 48.6 t -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.624 0.369 . . . . 64.14 111.821 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.412 HD21 HG13 ' B' ' 86' ' ' ILE . 77.4 mt -102.49 -35.08 8.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.749 0.42 . . . . 72.21 111.976 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.8 -23.25 53.53 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 120.029 -0.317 . . . . 72.15 113.842 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.35 -46.75 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.145 0.473 . . . . 51.04 112.047 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -77.1 -48.57 17.4 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.372 0.669 . . . . 74.45 110.796 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.2 m -60.72 -49.98 87.25 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.682 -0.675 . . . . 64.33 111.6 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.9 Cg_exo -56.77 -30.77 85.96 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.6 2.2 . . . . 71.04 114.496 171.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -63.36 -32.64 74.12 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.08 0.467 . . . . 64.43 110.965 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.2 mt -74.17 -44.54 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.864 0.866 . . . . 33.21 110.582 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' B' ' 80' ' ' GLN . 96.3 mt -72.36 -29.99 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.726 -1.125 . . . . 64.02 112.397 -172.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 80.5 t80 -59.93 -46.1 98.18 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 113.901 1.074 . . . . 71.2 113.901 -168.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.62 -41.75 72.51 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.233 1.955 . . . . 73.14 113.113 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.452 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.0 m-30 -64.26 -39.42 93.9 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.907 -1.042 . . . . 75.05 109.991 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.53 82.93 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.881 0.872 . . . . 74.4 110.961 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -57.23 -58.96 5.95 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.411 1.084 . . . . 73.22 111.752 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 -25.39 63.66 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.199 0.312 . . . . 64.31 110.267 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.435 ' O ' ' HG2' ' B' ' 117' ' ' MET . 13.4 t -70.2 -30.32 67.39 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.929 0.492 . . . . 51.21 111.626 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.495 HD13 HG23 ' B' ' 64' ' ' VAL . 88.6 mt -72.26 -55.92 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.082 0.553 . . . . 70.25 109.662 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.5 m -60.84 -27.98 68.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.54 -1.209 . . . . 73.54 111.411 -172.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.43 -46.02 84.99 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.915 0.886 . . . . 73.21 110.375 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.0 mmt -68.32 -31.3 70.63 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.095 0.558 . . . . 75.11 110.702 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.05 -38.96 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.956 0.902 . . . . 75.34 110.279 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.0 m -66.31 -37.74 86.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.726 0.81 . . . . 61.13 110.99 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -65.02 -38.8 92.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.275 -0.875 . . . . 75.23 109.351 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.35 -0.51 72.12 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 124.057 0.848 . . . . 64.25 113.877 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 55.39 36.26 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.596 1.558 . . . . 72.05 112.309 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -104.86 157.12 34.89 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.609 1.163 . . . . 62.43 110.282 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 129.39 33.87 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.119 2.546 . . . . 60.32 112.508 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -60.4 130.58 47.31 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.913 0.885 . . . . 62.53 112.514 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 90.2 mt -118.97 99.89 7.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.396 -0.965 . . . . 74.21 108.396 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.429 HD22 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -95.19 131.07 41.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.398 0.679 . . . . 73.23 109.469 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.456 ' HB3' ' CZ ' ' B' ' 107' ' ' PHE . 2.1 mm? -76.16 139.06 41.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.351 0.661 . . . . 71.01 110.922 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.38 141.44 45.8 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.027 0.931 . . . . 54.11 111.41 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.71 100.12 0.41 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.896 2.397 . . . . 70.34 112.46 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.87 133.36 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.759 0.824 . . . . 74.4 109.366 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.52 108.55 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.565 0.746 . . . . 64.43 111.219 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -59.95 -35.86 75.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.298 1.039 . . . . 72.04 110.167 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -56.69 14.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.228 -1.351 . . . . 75.04 111.954 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.74 68.84 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.625 0.77 . . . . 74.51 111.51 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 47.2 tp . . . . . 0 CA--C 1.55 0.96 0 C-N-CA 124.268 1.027 . . . . 64.11 110.613 176.347 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 121.336 0.589 . . . . 73.53 112.229 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 25.9 m -85.76 95.45 9.41 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.441 -0.948 . . . . 50.33 108.441 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -119.66 131.86 55.54 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.393 -1.276 . . . . 70.42 108.702 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -151.68 141.72 22.15 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.245 -0.65 . . . . 71.44 109.245 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.9 mt -76.49 116.34 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.525 -0.917 . . . . 71.55 108.525 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -88.33 -49.64 6.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.987 0.515 . . . . 64.0 110.217 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -159.13 138.8 11.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.96 -0.564 . . . . 62.04 109.48 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.84 135.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.1 -1.074 . . . . 54.31 108.1 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -171.57 158.22 5.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.514 0.674 . . . . 63.53 112.152 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.426 HG22 HE22 ' C' ' 80' ' ' GLN . 64.9 p -83.99 111.2 19.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.894 -1.048 . . . . 72.03 108.934 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -79.26 -46.68 17.3 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.717 0.77 . . . . 71.22 109.255 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.8 t70 -133.66 137.38 45.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.687 -1.142 . . . . 74.33 108.728 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -142.27 141.64 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.245 1.418 . . . . 64.23 107.379 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -155.24 143.14 19.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.811 -0.44 . . . . 72.52 109.811 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -142.64 141.95 31.99 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 107.54 -1.281 . . . . 72.43 107.54 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -140.08 142.6 36.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.563 -1.273 . . . . 71.02 107.563 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' D' ' 19' ' ' LYS . . . -142.15 84.28 11.72 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 108.86 -0.793 . . . . 73.25 108.86 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.59 -39.46 15.96 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.909 2.406 . . . . 60.4 112.212 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 88.4 m-20 -111.87 44.75 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.77 0.828 . . . . 63.33 109.658 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -56.41 -57.9 20.22 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.435 1.094 . . . . 54.14 113.709 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.3 Cg_exo -72.52 -26.54 16.63 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 122.013 1.809 . . . . 63.43 112.009 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.569 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.5 t60 -67.11 -21.73 65.84 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.298 1.439 . . . . 64.54 111.463 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.433 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.6 p -54.53 -24.1 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.15 0.58 . . . . 62.3 112.538 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -63.5 -40.75 97.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.296 1.038 . . . . 74.02 111.527 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.0 pt20 -90.14 5.29 47.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.646 0.379 . . . . 74.15 111.043 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 73' ' ' ALA . 4.7 ttpm? -100.74 146.76 26.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.097 0.959 . . . . 73.12 109.918 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -85.54 134.55 34.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.661 0.784 . . . . 74.33 109.185 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -69.22 71.29 0.26 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.406 1.083 . . . . 64.3 112.382 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -137.65 74.84 45.12 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 108.04 -1.096 . . . . 71.51 108.04 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.42 113.59 3.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.154 1.903 . . . . 63.44 109.591 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.56 83.79 7.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 105.021 -2.214 . . . . 63.34 105.021 174.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.607 HG11 HD11 ' C' ' 126' ' ' LEU . 31.9 m -71.7 128.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-N 115.215 -0.902 . . . . 72.22 111.824 -166.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -92.98 103.65 15.95 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.586 -1.635 . . . . 74.42 106.586 172.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -93.12 151.68 19.71 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.515 -0.766 . . . . 75.23 109.602 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 45.2 t0 -158.15 147.38 19.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.276 -0.875 . . . . 72.21 108.979 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 148.87 49.35 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 53.4 109.381 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.428 ' O ' HD23 ' C' ' 60' ' ' LEU . 12.0 m-20 -150.34 161.37 42.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.484 1.114 . . . . 74.41 108.904 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -138.71 154.23 48.56 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.125 -0.695 . . . . 73.5 109.125 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.65 151.43 43.06 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.576 -0.527 . . . . 53.04 109.576 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -123.58 143.52 50.16 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.365 0.666 . . . . 62.33 110.171 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -153.13 126.41 8.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.878 0.871 . . . . 72.23 108.701 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -82.61 127.0 32.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.239 -0.652 . . . . 62.42 109.239 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.659 HD11 HD12 ' C' ' 83' ' ' ILE . 59.9 mt -89.59 -42.05 11.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.209 0.604 . . . . 64.12 110.123 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.8 -174.37 4.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.471 0.708 . . . . 71.24 110.621 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.26 114.32 2.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.884 -1.053 . . . . 75.05 109.761 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 69.43 -4.59 1.31 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.196 1.399 . . . . 74.42 112.956 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.46 114.11 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.846 -0.798 . . . . 73.34 108.846 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -126.52 158.83 35.1 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.529 0.732 . . . . 73.21 109.962 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.78 138.36 53.84 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.308 1.043 . . . . 73.43 108.818 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.35 137.81 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.071 -1.085 . . . . 60.52 108.071 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.35 109.35 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.902 -0.777 . . . . 65.23 108.902 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.428 HD23 ' O ' ' C' ' 45' ' ' ASP . 0.7 OUTLIER -87.47 102.92 15.03 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.182 -1.044 . . . . 61.05 108.182 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.601 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 18.7 ttp85 -82.79 106.58 14.74 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.936 -0.764 . . . . 70.22 108.936 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.5 t -99.68 132.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.682 -0.858 . . . . 75.25 108.682 173.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 55.2 m -115.18 130.51 56.94 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.827 0.851 . . . . 72.4 109.156 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.498 HG11 ' HG ' ' C' ' 126' ' ' LEU . 78.1 t -122.13 134.24 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.186 -1.37 . . . . 71.41 107.918 172.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -123.86 143.15 50.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.342 -1.355 . . . . 54.51 107.342 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.0 106.86 8.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.689 -1.226 . . . . 62.41 107.689 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -154.75 158.26 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.69 . . . . 74.13 110.079 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 tp -123.84 78.87 1.66 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.726 -1.953 . . . . 71.41 105.726 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.42 -119.78 4.96 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 115.71 -0.677 . . . . 55.42 112.231 -173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.28 -20.84 26.28 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.625 0.77 . . . . 62.42 109.669 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.488 ' HG3' ' HD3' ' C' ' 34' ' ' LYS . 16.0 tp10 -71.42 86.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.512 1.125 . . . . 71.24 109.446 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 36.0 m -84.75 121.77 28.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.253 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.512 ' HB2' ' HE3' ' C' ' 34' ' ' LYS . . . -71.86 -55.51 7.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.165 -1.05 . . . . 61.31 108.165 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -162.86 173.27 13.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.808 -1.087 . . . . 72.3 111.423 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.92 143.52 45.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.759 -1.571 . . . . 74.22 106.759 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -149.45 130.43 14.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.693 0.397 . . . . 73.44 110.338 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -131.71 133.28 44.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.671 -0.863 . . . . 72.22 108.671 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -129.52 138.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.687 0.795 . . . . 71.44 108.914 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.601 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.1 mt-30 -113.23 98.59 7.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.585 -0.894 . . . . 74.24 108.585 173.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.426 HE22 HG22 ' C' ' 18' ' ' THR . 8.3 tp-100 -84.87 103.84 14.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.361 -0.836 . . . . 70.2 109.688 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.13 148.78 21.65 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.887 -0.485 . . . . 74.15 111.887 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.34 121.32 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.688 -0.565 . . . . 61.23 111.688 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.659 HD12 HD11 ' C' ' 51' ' ' LEU . 8.5 mm -85.66 126.89 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.647 -0.872 . . . . 63.32 108.647 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -135.35 134.72 40.1 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.814 0.846 . . . . 73.43 109.473 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.6 p -81.18 116.57 21.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.414 -0.588 . . . . 74.03 109.414 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.44 111.4 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 54.41 108.511 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.51 169.61 19.2 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 50.02 110.339 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.07 -58.36 3.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.447 -0.661 . . . . 71.32 111.447 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.14 166.33 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 61.22 108.668 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.99 156.18 44.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.543 0.737 . . . . 73.22 110.537 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.39 -148.0 44.88 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.47 0.481 . . . . 14.44 114.155 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . 0.593 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 32.4 p -69.38 -18.26 63.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.679 0.792 . . . . 73.35 112.098 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -63.7 -42.47 97.98 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.205 0.602 . . . . 71.03 110.285 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -82.92 -26.33 31.56 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.569 0.348 . . . . 74.22 110.884 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -68.16 -22.05 64.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.666 0.786 . . . . 74.41 111.577 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -53.41 -48.75 68.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.934 0.494 . . . . 73.34 110.763 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -65.17 -47.63 76.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.714 -0.676 . . . . 62.41 110.162 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.32 -32.84 74.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.599 0.76 . . . . 74.0 110.925 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.8 -5.32 61.31 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-O 119.572 -0.571 . . . . 63.04 114.251 -171.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.53 -63.17 0.51 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.658 0.729 . . . . 72.22 111.243 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -62.93 -47.64 82.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.035 0.534 . . . . 72.1 112.419 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.69 -42.76 36.88 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.642 -0.695 . . . . 71.45 112.281 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.43 -38.91 89.59 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.266 1.977 . . . . 54.11 113.248 166.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.29 -29.16 70.53 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.973 0.509 . . . . 74.24 111.62 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.462 HD12 ' NH1' ' A' ' 111' ' ' ARG . 38.0 mm -69.9 -41.47 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.139 0.575 . . . . 60.02 110.052 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.542 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -75.8 -25.3 56.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.208 -0.905 . . . . 71.3 111.924 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -56.88 -46.25 99.88 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.596 1.158 . . . . 73.54 113.852 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.63 -40.24 85.09 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.359 2.04 . . . . 73.2 114.074 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.437 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 57.1 m-85 -71.24 -39.99 71.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.811 0.445 . . . . 74.41 110.34 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.2 94.66 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.489 -0.778 . . . . 74.31 110.546 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -59.27 -54.33 48.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.248 1.019 . . . . 64.45 109.91 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -62.33 -35.01 77.74 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.043 0.839 . . . . 60.12 111.1 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 26.1 t -71.24 -36.84 71.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.307 0.643 . . . . 71.42 110.973 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.469 ' O ' HG23 ' C' ' 118' ' ' VAL . 77.8 mt -72.19 -50.1 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.4 -0.593 . . . . 70.35 109.4 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 78.6 m -57.19 -33.59 67.63 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.338 1.055 . . . . 73.21 110.793 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -64.52 -54.41 32.77 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 115.352 -0.84 . . . . 74.13 108.74 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.32 -40.16 70.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.808 1.243 . . . . 71.54 112.76 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.1 t -64.62 -48.44 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.803 0.841 . . . . 71.24 109.411 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.464 ' HB2' HE21 ' C' ' 125' ' ' GLN . 36.4 t -66.98 -28.06 67.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.606 -1.179 . . . . 71.41 111.335 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.4 HH12 ' CD ' ' D' ' 112' ' ' GLU . 77.1 mtt-85 -70.67 -37.38 73.66 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 123.738 0.815 . . . . 62.52 109.271 176.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.34 3.28 73.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.912 0.757 . . . . 74.21 113.363 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.449 HG23 ' HB3' ' D' ' 17' ' ' TYR . 66.0 p 60.28 28.45 18.06 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.036 1.734 . . . . 73.04 112.731 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -97.46 161.76 24.86 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.545 1.138 . . . . 74.25 111.07 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.37 119.3 6.47 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.342 2.695 . . . . 70.41 112.384 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' C' ' 119' ' ' SER . 90.1 mt-30 -62.13 146.88 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.556 1.142 . . . . 54.42 113.416 -172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.607 HD11 HG11 ' C' ' 40' ' ' VAL . 4.4 mm? -106.85 95.12 5.5 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.069 0.948 . . . . 65.5 108.958 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -90.35 90.83 8.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.73 126.18 29.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.909 -1.041 . . . . 75.11 110.807 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.67 156.12 86.86 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.091 0.956 . . . . 65.53 111.292 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.86 124.74 11.77 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.177 1.918 . . . . 72.32 111.851 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.96 138.01 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.041 0.537 . . . . 70.25 109.556 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 23.8 p30 -88.1 61.5 6.33 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.904 0.859 . . . . 65.33 110.234 178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.98 -32.22 70.31 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.851 -1.068 . . . . 74.32 111.149 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 122.71 0.404 . . . . 72.3 110.054 175.292 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 9' ' ' MET . . . . . 0.559 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.6 ptm . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 113.28 0.844 . . . . 73.42 113.28 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 40.0 m -128.64 146.63 50.81 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.926 -0.768 . . . . 74.25 108.926 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.476 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 49.9 t80 -155.93 102.44 2.17 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.483 -1.303 . . . . 73.23 107.483 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.23 139.99 53.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.062 0.545 . . . . 64.32 110.027 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.58 110.2 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.194 0.998 . . . . 62.41 108.97 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -89.26 -47.43 8.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.04 0.136 . . . . 74.12 111.357 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.23 119.74 0.7 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 119.423 -0.323 . . . . 71.13 110.341 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.22 136.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.215 -1.031 . . . . 73.2 108.215 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.449 ' HB3' HG23 ' C' ' 122' ' ' THR . 40.0 p90 -165.99 174.32 9.57 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.637 0.732 . . . . 65.11 111.769 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -101.73 128.12 48.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.388 -0.823 . . . . 73.1 109.088 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.3 mtpt -98.46 -16.49 19.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.873 0.469 . . . . 63.01 110.244 176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -161.2 141.88 11.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.277 1.031 . . . . 71.42 109.496 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.9 mt -144.49 145.22 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.426 . . . . 71.34 107.676 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -148.25 144.05 27.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.872 0.869 . . . . 74.0 109.631 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -152.7 127.1 9.28 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.774 -1.565 . . . . 74.11 106.774 172.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.4 mt-10 -133.61 120.81 21.18 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.434 0.693 . . . . 63.33 109.481 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -130.14 83.88 61.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.368 -0.975 . . . . 73.23 108.368 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.62 -50.47 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.083 2.522 . . . . 62.11 111.725 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.511 ' O ' HG23 ' D' ' 31' ' ' VAL . 56.2 m-20 -89.34 31.8 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.183 0.993 . . . . 70.24 109.765 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -58.41 -48.73 96.43 Favored Pre-proline 0 CA--C 1.561 1.4 0 N-CA-C 114.736 1.384 . . . . 75.51 114.736 -170.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.19 -7.09 12.06 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.595 1.53 . . . . 71.22 112.558 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.513 ' HA ' HE21 ' D' ' 33' ' ' GLN . 19.3 t-160 -83.78 -36.31 23.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.878 1.271 . . . . 74.05 110.123 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' D' ' 73' ' ' ALA . 92.0 t -69.43 -25.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.544 0.738 . . . . 53.41 110.207 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.23 -24.53 64.93 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.21 1.004 . . . . 51.54 111.974 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' D' ' 30' ' ' HIS . 38.8 mt-30 -81.54 -14.16 57.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.753 0.821 . . . . 74.0 112.209 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -121.33 110.72 16.45 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.999 0.919 . . . . 62.21 109.818 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 91.85 8.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.879 0.871 . . . . 72.4 110.621 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.656 ' HB3' HD11 ' D' ' 68' ' ' LEU . 38.6 t-105 -168.23 163.98 13.17 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.593 HE21 ' HG3' ' D' ' 124' ' ' PRO . 1.2 mp0 -90.87 116.15 65.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.302 0.641 . . . . 42.2 110.455 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.417 ' HG3' ' HB2' ' D' ' 68' ' ' LEU . 85.7 Cg_exo -47.35 149.03 4.46 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 124.855 3.703 . . . . 60.12 116.078 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 60.8 mm-40 -64.89 112.09 3.13 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.734 -0.839 . . . . 53.33 108.734 169.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.413 HG22 ' HB2' ' D' ' 66' ' ' ALA . 76.6 t -109.37 117.15 53.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.457 0.646 . . . . 61.53 110.801 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.74 147.65 23.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.497 -1.229 . . . . 61.25 108.074 164.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.42 HD13 ' H ' ' D' ' 42' ' ' LEU . 0.0 OUTLIER -128.42 154.96 45.49 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.079 -1.082 . . . . 63.43 108.079 176.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.2 t70 -150.43 155.84 40.31 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.38 0.672 . . . . 74.13 109.395 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -134.9 139.69 45.19 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.053 -0.721 . . . . 75.5 109.053 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.49 132.12 25.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 55.43 106.968 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -104.25 163.46 12.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.455 0.57 . . . . 75.2 110.754 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -160.92 172.42 16.97 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.068 0.947 . . . . 62.12 109.422 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.6 p -166.97 178.29 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.027 0.531 . . . . 65.44 111.138 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -169.89 118.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.979 1.312 . . . . 55.41 108.114 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -79.53 122.22 26.2 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.785 -0.45 . . . . 71.13 109.785 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.11 -36.62 14.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.215 0.606 . . . . 73.42 109.88 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.45 -176.54 4.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.968 0.907 . . . . 73.31 110.721 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.39 122.49 16.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.956 -1.02 . . . . 75.22 109.165 175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 65.89 1.24 1.78 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.027 1.331 . . . . 71.53 113.044 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.13 116.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.88 -0.785 . . . . 55.34 108.88 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.93 162.58 24.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.218 -1.03 . . . . 74.45 108.218 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -131.18 131.93 44.38 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 105.736 -1.95 . . . . 74.45 105.736 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.61 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.625 -0.88 . . . . 75.44 108.625 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 58.5 t -116.95 138.58 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.521 0.728 . . . . 73.1 109.688 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -118.35 118.12 30.91 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.638 -1.245 . . . . 43.23 107.638 177.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.0 ttm-85 -99.24 103.22 15.06 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.287 1.035 . . . . 65.14 108.323 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.09 124.95 50.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.511 -0.922 . . . . 72.32 108.511 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.9 m -108.96 145.39 35.55 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.65 0.594 . . . . 72.54 110.066 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.27 133.39 52.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.843 1.257 . . . . 73.02 108.544 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 46.3 m -127.69 115.63 19.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.152 -1.055 . . . . 74.43 108.152 172.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -124.81 130.57 52.65 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.032 0.533 . . . . 54.54 109.935 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.2 m -142.08 130.08 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.756 0.822 . . . . 72.24 108.95 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' D' ' 36' ' ' TRP . 23.6 tp -105.35 108.21 19.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.879 -0.786 . . . . 65.32 108.879 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.44 -110.41 3.35 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.879 -0.888 . . . . 61.23 110.879 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.89 7.49 9.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 63.11 110.191 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.68 147.86 42.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.191 0.596 . . . . 73.34 111.162 -175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 100.0 m -65.54 115.12 5.42 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.78 0.675 . . . . 61.5 109.978 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.665 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.89 -63.98 1.26 Allowed 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.604 0.565 . . . . 74.23 110.35 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -156.13 139.03 15.31 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.567 -0.742 . . . . 70.32 109.794 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 66.9 mt -109.0 149.7 28.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.448 -1.316 . . . . 74.31 107.448 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.6 t -158.39 139.33 13.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.654 -0.212 . . . . 65.42 110.578 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -154.84 123.21 5.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.733 0.413 . . . . 60.43 109.954 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -123.8 117.6 51.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.443 0.697 . . . . 63.33 109.833 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.728 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.3 mt-30 -93.94 88.17 5.63 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.581 0.705 . . . . 71.25 109.266 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.451 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.69 108.26 13.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.245 -1.343 . . . . 72.43 109.209 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.23 172.83 32.32 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.154 0.308 . . . . 63.23 112.394 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.25 138.32 4.57 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 111.822 -0.511 . . . . 64.23 111.822 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.7 mt -90.56 120.74 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.066 -0.716 . . . . 65.3 109.066 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -125.47 125.65 43.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.608 1.163 . . . . 71.14 109.226 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.9 m -82.42 95.38 7.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.99 -0.744 . . . . 71.41 108.99 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.56 115.74 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.921 -0.77 . . . . 45.31 108.921 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.49 168.35 19.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.823 0.849 . . . . 65.05 110.698 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.5 -2.13 48.2 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.845 0.716 . . . . 61.23 114.676 173.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -135.51 157.31 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.327 1.051 . . . . 64.21 109.141 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.42 173.11 12.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.628 0.771 . . . . 64.03 111.098 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.49 -121.78 21.76 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.984 0.754 . . . . 50.02 114.984 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -68.85 -18.78 64.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.717 0.807 . . . . 75.21 112.654 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -75.27 -48.53 22.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.22 0.608 . . . . 74.24 110.287 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -75.04 -25.78 58.96 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 116.678 -0.237 . . . . 63.42 110.379 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.42 75.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.38 0.672 . . . . 62.41 110.495 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.63 -36.35 82.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.881 0.872 . . . . 74.32 110.552 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 91.0 m -67.56 -54.08 22.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.254 0.346 . . . . 74.4 111.04 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.62 -19.69 60.79 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 122.327 -0.233 . . . . 54.15 111.597 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.48 -27.2 10.06 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.298 -0.723 . . . . 74.11 114.175 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 -51.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.959 0.88 . . . . 72.52 112.891 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . 0.543 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 49.2 t80 -73.33 -55.19 6.73 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.752 0.649 . . . . 72.35 112.752 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.476 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 58.3 m -60.46 -44.64 96.3 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 118.517 -0.754 . . . . 62.43 111.676 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.56 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.0 Cg_exo -53.02 -35.69 72.95 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.492 2.128 . . . . 61.23 114.046 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -66.15 -39.67 89.98 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.572 0.749 . . . . 71.52 109.721 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -63.7 -41.03 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.497 0.719 . . . . 73.3 110.079 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.451 HD13 ' O ' ' D' ' 80' ' ' GLN . 91.8 mt -75.43 -24.43 57.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.076 -0.965 . . . . 64.24 112.14 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -62.84 -42.49 78.34 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 117.881 -1.056 . . . . 35.51 113.697 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.29 -38.82 73.17 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 121.923 1.748 . . . . 75.2 113.59 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.55 -32.14 28.75 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.637 0.775 . . . . 71.23 111.831 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.75 74.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.236 0.614 . . . . 64.31 109.807 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 35.0 ttp180 -61.07 -45.9 92.87 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 124.338 1.024 . . . . 72.24 110.282 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.7 tm-20 -55.26 -50.25 69.99 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.539 1.149 . . . . 75.24 111.694 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' D' ' 21' ' ' ILE . 42.0 t -60.97 -40.98 95.45 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.249 0.968 . . . . 33.41 111.217 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.626 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -60.19 -55.9 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.369 0.668 . . . . 61.23 110.204 173.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.2 m -53.51 -40.66 65.61 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.117 1.367 . . . . 73.11 110.65 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.3 t -69.51 -47.87 62.42 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.412 -1.267 . . . . 62.21 110.954 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.0 mtm -67.08 -30.95 71.13 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.078 0.399 . . . . 75.45 112.078 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -67.39 -46.06 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 123.557 0.535 . . . . 61.24 109.868 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -71.18 -25.28 62.46 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.477 -0.329 . . . . 54.2 110.757 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -75.69 -33.71 60.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.966 0.906 . . . . 74.52 109.511 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.56 1.05 67.88 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.552 -0.749 . . . . 61.15 112.537 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.5 p 56.04 40.44 30.31 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.265 1.826 . . . . 71.22 112.106 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 58.4 m-85 -103.68 169.68 7.06 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 125.075 1.35 . . . . 73.11 108.172 171.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.593 ' HG3' HE21 ' D' ' 37' ' ' GLN . 34.6 Cg_endo -62.92 138.92 71.08 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.899 1.732 . . . . 75.54 109.864 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -63.36 156.01 27.13 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.425 0.557 . . . . 75.2 111.176 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tt -116.85 115.11 24.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.128 -1.064 . . . . 64.22 108.128 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -107.78 92.96 4.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.474 0.71 . . . . 74.42 109.642 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.448 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 68.9 mt -67.17 117.24 8.93 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.848 -0.614 . . . . 74.22 109.543 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 133.13 94.31 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 122.359 0.263 . . . . 74.23 110.494 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.18 109.29 2.79 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.222 1.948 . . . . 61.44 110.465 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 93.7 t -107.46 111.08 34.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.906 0.882 . . . . 72.01 109.046 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -83.1 73.2 10.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.024 0.916 . . . . 71.42 109.626 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 t80 . . . . . 0 N--CA 1.477 0.909 0 CA-C-N 114.904 -1.043 . . . . 72.34 109.764 176.326 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 ttm . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 109.385 -0.598 . . . . 61.43 109.385 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.7 p -176.94 -62.92 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.351 1.06 . . . . 64.3 109.716 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.79 81.14 5.11 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 123.663 0.785 . . . . 64.41 109.865 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -143.48 33.99 1.3 Allowed 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 122.742 1.258 . . . . 65.33 107.618 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -72.88 84.27 1.23 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 113.86 -1.518 . . . . 52.0 108.646 176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -101.65 157.67 16.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 107.75 -1.204 . . . . 61.24 107.75 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 t -80.01 62.16 4.12 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.465 1.126 . . . . 73.21 110.637 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -92.53 -48.53 6.57 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.473 -0.785 . . . . 73.15 109.426 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.457 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 0.0 OUTLIER -65.06 149.43 49.89 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.48 0.657 . . . . 73.34 112.49 -173.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.457 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 62.6 m -147.85 116.52 6.69 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.286 -1.376 . . . . 60.44 107.286 174.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -136.98 132.1 33.86 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.425 0.69 . . . . 61.1 109.27 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -137.77 134.95 35.87 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.746 0.418 . . . . 61.4 110.1 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.418 HG13 ' H ' ' A' ' 13' ' ' ILE . 1.5 pp -81.58 88.2 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.078 0 N-CA-C 109.201 -0.666 . . . . 75.21 109.201 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -74.91 -41.71 59.19 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.297 0.639 . . . . 72.22 110.601 -170.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.404 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 12.9 tpp85 -165.56 133.47 3.03 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.971 -0.559 . . . . 74.22 110.3 -177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.604 HD13 ' HG3' ' C' ' 130' ' ' PRO . 3.8 mp -131.04 120.26 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.386 -1.338 . . . . 63.12 107.386 176.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.404 ' CD1' ' HG3' ' A' ' 15' ' ' ARG . 4.7 p90 -164.06 176.21 9.53 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.696 0.799 . . . . 55.15 110.411 -169.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.44 HG21 ' SG ' ' A' ' 113' ' ' CYS . 78.7 p -92.69 117.9 30.48 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.201 -0.666 . . . . 64.43 109.201 174.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.9 mtpt -75.69 -30.52 59.36 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 109.909 -0.404 . . . . 63.22 109.909 170.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -155.59 143.13 19.55 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.543 -0.753 . . . . 64.34 109.63 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.554 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 68.4 mt -139.3 144.34 29.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 107.618 -1.252 . . . . 74.2 107.618 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -150.03 136.19 18.79 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.375 -0.602 . . . . 71.42 109.375 176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.4 t80 -140.82 109.75 6.09 Favored 'General case' 0 C--O 1.221 -0.439 0 N-CA-C 106.714 -1.587 . . . . 73.23 106.714 171.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -118.81 119.52 34.62 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.48 -0.563 . . . . 74.43 109.48 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.08 83.16 37.89 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 108.021 -1.103 . . . . 72.21 108.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.29 -18.48 34.49 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 122.728 2.285 . . . . 32.32 111.937 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -117.35 37.39 3.9 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.361 1.064 . . . . 71.41 109.749 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.13 93.18 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 114.379 1.252 . . . . 73.44 114.379 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -77.19 -25.13 8.87 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.698 1.599 . . . . 74.32 111.649 170.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -78.97 -14.23 59.33 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 125.935 1.694 . . . . 74.35 111.418 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.44 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 7.1 p -69.76 -22.31 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 123.692 0.797 . . . . 62.25 111.879 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.82 -25.59 66.52 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.808 0.843 . . . . 53.11 111.358 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -86.85 -34.06 19.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.239 1.016 . . . . 72.42 111.48 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.675 ' HD3' HD21 ' A' ' 68' ' ' LEU . 12.5 ptpt -80.57 171.76 14.63 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.224 0.535 . . . . 75.24 111.36 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -83.17 144.96 29.46 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 115.247 -0.888 . . . . 73.0 109.336 171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.8 m-90 -89.61 63.73 6.35 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.703 0.763 . . . . 74.31 110.956 -176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -149.08 82.37 7.11 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 114.941 -1.027 . . . . 63.1 108.352 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -85.39 170.01 9.46 Favored 'Trans proline' 0 C--N 1.368 1.565 0 C-N-CA 122.675 2.25 . . . . 73.24 111.265 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -96.98 114.72 26.35 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 108.621 -0.881 . . . . 65.51 108.621 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' ' HG3' ' F' ' 128' ' ' LYS . 59.5 t -75.61 96.98 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 123.829 0.852 . . . . 63.42 109.532 -177.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 54.6 tttm -102.45 116.44 32.63 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.538 1.135 . . . . 64.1 109.204 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.04 128.83 53.5 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 108.203 -1.036 . . . . 72.13 108.203 -178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.621 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 16.3 m-20 -115.06 131.04 57.05 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.084 0.954 . . . . 70.32 108.668 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.5 138.65 53.72 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.919 0.888 . . . . 73.13 109.657 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 26.5 t70 -155.43 146.81 22.83 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.67 0.788 . . . . 73.04 109.913 174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.7 m -140.09 139.02 35.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.42 0.688 . . . . 62.43 110.617 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -139.86 154.34 47.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.236 1.014 . . . . 63.22 110.183 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.6 m -129.08 157.77 40.81 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.667 0.787 . . . . 73.15 108.947 173.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.3 t -161.45 115.47 1.97 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.256 -0.275 . . . . 61.43 110.256 -172.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -72.06 104.79 3.69 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 71.33 109.817 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 57' ' ' GLU . 65.1 mt -77.79 -41.35 37.67 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.194 0.998 . . . . 65.21 110.891 176.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.28 -175.62 4.7 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.644 -1.162 . . . . 52.23 108.379 -174.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -58.63 98.41 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.865 0.466 . . . . 64.43 110.671 -178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 59.15 33.55 22.83 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.859 1.264 . . . . 62.24 112.483 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 61.5 t -112.95 118.3 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 106.717 -1.586 . . . . 75.01 106.717 167.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.436 ' HA ' ' O ' ' A' ' 49' ' ' SER . 0.4 OUTLIER -129.6 131.69 46.56 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.766 -0.828 . . . . 75.33 108.766 -177.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.604 ' HB2' HD11 ' A' ' 51' ' ' LEU . 43.6 tt0 -89.25 121.07 31.18 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.697 0.799 . . . . 73.23 109.054 173.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 99.0 t -100.25 121.85 51.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 123.807 0.843 . . . . 75.32 108.775 178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.441 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.5 t -108.5 133.66 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 109.666 -0.494 . . . . 64.14 109.666 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.94 116.0 31.19 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 107.067 -1.457 . . . . 73.03 107.067 176.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.591 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.3 OUTLIER -91.78 102.3 14.9 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.635 -1.246 . . . . 63.44 107.635 170.318 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' A' ' 114' ' ' ILE . 2.9 t -101.18 130.33 50.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 107.036 -1.468 . . . . 73.53 107.036 168.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -132.04 125.99 32.8 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-O 121.221 0.534 . . . . 71.41 109.726 176.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 47.3 t -111.28 110.05 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 124.156 0.982 . . . . 73.4 109.167 -179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.471 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 26.3 m -101.12 135.94 41.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.667 -0.864 . . . . 73.43 108.667 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.52 103.85 7.57 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 107.751 -1.204 . . . . 54.21 107.751 174.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.5 m -143.67 128.06 17.87 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.203 0.601 . . . . 71.11 109.535 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.675 HD21 ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -94.28 84.93 4.49 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.502 -1.295 . . . . 73.13 107.502 172.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.27 -116.89 4.66 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 114.539 -1.209 . . . . 40.14 111.277 -172.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -89.01 -25.44 21.99 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.783 0.833 . . . . 70.14 111.059 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.574 ' HG3' ' NZ ' ' A' ' 34' ' ' LYS . 8.3 tp10 -81.25 96.05 7.14 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 109.556 -0.535 . . . . 73.34 109.556 -173.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.4 m -75.31 129.0 36.68 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.313 0.645 . . . . 52.52 110.811 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.95 -57.11 4.03 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.015 0.926 . . . . 75.32 108.917 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -164.94 173.99 11.02 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 114.586 -1.188 . . . . 71.51 110.62 178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.9 tp -140.92 137.75 33.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.575 1.15 . . . . 60.22 108.449 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 70.0 m -127.54 141.96 51.51 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.802 1.241 . . . . 55.12 108.751 178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -148.14 134.91 19.98 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.207 -0.664 . . . . 74.31 109.207 170.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 48.0 t -137.76 111.57 8.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 123.776 0.831 . . . . 73.54 108.991 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -85.52 84.53 7.59 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.437 -0.949 . . . . 50.33 108.437 171.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -80.17 96.36 6.53 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.697 -1.223 . . . . 72.23 107.697 178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -102.99 146.33 16.55 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 111.665 -0.574 . . . . 75.33 111.665 -178.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.98 133.9 5.72 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.027 -0.829 . . . . 73.01 111.027 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -85.79 127.49 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 N-CA-C 109.075 -0.713 . . . . 71.13 109.075 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.6 118.95 18.82 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.155 -1.054 . . . . 74.1 108.155 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 54.0 p -89.52 94.04 9.72 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.837 -0.801 . . . . 33.53 108.837 176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.75 HG12 HD11 ' A' ' 98' ' ' LEU . 2.8 pp -119.21 144.01 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 122.747 0.419 . . . . 72.54 111.259 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.31 177.52 3.08 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.273 1.429 . . . . 65.41 108.835 175.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 83.53 3.34 89.82 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 114.898 0.719 . . . . 73.34 114.898 173.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -136.1 150.15 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.069 -1.085 . . . . 75.42 108.069 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -128.55 173.63 10.09 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.484 -0.561 . . . . 74.13 109.484 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 50.83 -112.33 1.61 Allowed Glycine 0 C--N 1.352 1.434 0 O-C-N 124.832 1.333 . . . . 73.51 116.176 164.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 58.0 p -61.89 -50.81 70.7 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.08 0.952 . . . . 70.11 111.5 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.43 -33.99 69.89 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.382 0.673 . . . . 70.51 112.118 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 49.1 tpp -63.85 -51.57 64.05 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.304 0.378 . . . . 60.11 110.381 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.56 -35.78 76.88 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.153 0.581 . . . . 62.21 111.067 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.423 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 59.7 t-80 -75.74 -22.22 56.73 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.118 0.967 . . . . 71.43 111.103 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HB3' HD22 ' A' ' 98' ' ' LEU . 43.3 t -70.61 -60.55 2.19 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 109.638 -0.505 . . . . 75.54 109.638 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.75 HD11 HG12 ' A' ' 86' ' ' ILE . 1.7 mm? -81.92 -23.14 36.39 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.837 -0.619 . . . . 72.22 111.822 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.32 -28.03 9.48 Favored Glycine 0 C--N 1.343 0.923 0 O-C-N 123.534 0.521 . . . . 74.4 113.857 -175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -112.97 -63.59 1.42 Allowed 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 117.478 0.639 . . . . 72.11 111.004 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -63.3 -50.23 70.88 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.778 0.831 . . . . 73.35 112.55 -173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.0 m -65.12 -49.09 68.36 Favored Pre-proline 0 CA--C 1.556 1.197 0 CA-C-O 118.077 -0.963 . . . . 73.42 112.65 -172.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.57 -24.29 56.13 Favored 'Trans proline' 0 C--N 1.393 2.915 0 C-N-CA 121.848 1.698 . . . . 73.25 112.703 173.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -74.03 -27.74 61.09 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.271 0.628 . . . . 53.45 110.44 175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.23 -39.67 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 C-N-CA 123.57 0.748 . . . . 73.23 109.718 170.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.9 mt -76.72 -24.86 53.07 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 115.339 -0.846 . . . . 71.52 111.692 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.05 -41.86 47.48 Favored Pre-proline 0 CA--C 1.563 1.463 0 N-CA-C 114.535 1.309 . . . . 75.23 114.535 -169.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -59.94 -38.73 76.84 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 122.034 1.823 . . . . 75.23 113.007 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -77.95 -31.87 51.18 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.684 -0.689 . . . . 74.45 111.245 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.19 -45.69 72.7 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.357 0.663 . . . . 65.14 109.506 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HD12 ' C' ' 105' ' ' ILE . 36.0 ttm180 -51.3 -52.85 41.4 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 124.988 1.43 . . . . 73.23 110.382 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -63.37 -47.81 80.51 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.724 -1.126 . . . . 72.22 111.86 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.521 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.4 t -59.88 -29.85 68.61 Favored 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.949 0.781 . . . . 42.44 111.77 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 118' ' ' VAL . 94.8 mt -73.29 -58.67 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.534 -0.543 . . . . 70.51 109.534 172.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -51.24 -39.85 57.55 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 125.093 1.357 . . . . 70.51 112.641 -172.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.7 t -70.23 -40.66 74.36 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 115.082 -0.963 . . . . 74.22 111.283 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.545 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -62.17 -43.24 99.27 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 120.864 0.364 . . . . 64.45 110.585 176.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.8 t -57.17 -45.8 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 CA-C-N 114.663 -1.153 . . . . 63.33 110.92 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -70.57 -30.9 67.72 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.529 -0.76 . . . . 74.13 111.663 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 49.8 mtt-85 -68.96 -31.28 70.04 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.501 0.72 . . . . 73.13 110.86 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.13 3.52 65.65 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-O 119.447 -0.64 . . . . 62.41 113.418 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.8 m 67.25 35.17 4.54 Favored 'General case' 0 CA--C 1.556 1.182 0 CA-C-O 122.419 1.104 . . . . 62.11 109.781 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -111.24 149.79 41.06 Favored Pre-proline 0 N--CA 1.478 0.926 0 CA-C-N 114.865 -1.061 . . . . 71.11 110.044 177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.35 143.14 94.67 Favored 'Trans proline' 0 C--N 1.382 2.305 0 C-N-CA 122.872 2.381 . . . . 72.24 112.808 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -53.72 138.62 34.81 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.856 0.862 . . . . 73.22 112.459 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.421 ' HG ' HG11 ' A' ' 64' ' ' VAL . 1.4 tm? -120.93 109.28 14.91 Favored 'General case' 0 C--N 1.346 0.42 0 N-CA-C 107.579 -1.267 . . . . 70.54 107.579 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -98.97 127.17 44.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.764 0.825 . . . . 63.44 108.859 176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.38 132.59 43.2 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.412 0.685 . . . . 73.5 109.817 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.58 130.04 86.23 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-O 118.68 -0.676 . . . . 54.13 109.848 178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.61 115.65 2.82 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.341 2.027 . . . . 64.23 111.887 178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.7 t -99.86 114.2 37.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 107.316 -1.364 . . . . 73.23 107.316 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 21.6 p-10 -76.9 74.68 3.5 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.4 0.68 . . . . 53.31 109.97 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -55.6 -44.05 76.62 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 63.0 110.994 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.46 -52.48 38.88 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.768 -1.105 . . . . 73.13 111.972 -178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.427 ' HB3' ' HB2' ' A' ' 132' ' ' ASN . . . -71.16 -43.44 67.5 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 123.739 0.649 . . . . 53.41 111.611 -172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.7 tp -67.36 -35.09 78.66 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.729 0.812 . . . . 63.14 111.569 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -64.34 -46.83 81.79 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 110.072 -0.344 . . . . 73.32 110.072 177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.498 ' HB3' ' NE2' ' A' ' 143' ' ' GLN . 77.1 mmm -73.57 -29.21 62.28 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 115.88 -0.6 . . . . 75.4 111.367 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -58.59 -60.32 3.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.858 1.263 . . . . 73.44 109.098 173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -64.13 -31.62 72.88 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 114.809 -1.087 . . . . 75.22 111.98 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 6.7 tt -55.86 -48.31 75.75 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.83 0.852 . . . . 70.43 110.737 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -172.9 -13.8 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.845 0.716 . . . . 74.33 111.886 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.498 ' NE2' ' HB3' ' A' ' 138' ' ' MET . 43.0 mt-30 -88.83 46.35 1.38 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.423 0.63 . . . . 73.5 111.161 -172.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.501 ' HB3' ' HA ' ' C' ' 1' ' ' MET . 48.7 mt-30 -72.81 -12.22 60.9 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.256 -0.884 . . . . 75.22 111.977 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.71 22.21 3.61 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.229 1.012 . . . . 73.2 109.687 175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.2 158.04 15.69 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.768 -0.651 . . . . 53.02 113.177 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.706 ' HG3' ' HB ' ' C' ' 7' ' ' THR . 29.6 tt0 -143.32 124.93 14.88 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.345 0.658 . . . . 72.35 109.872 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.01 92.61 0.35 Allowed Glycine 0 C--N 1.348 1.235 0 N-CA-C 111.826 -0.509 . . . . 75.21 111.826 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -77.76 161.99 27.28 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.231 0.612 . . . . 74.31 110.113 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.26 133.82 54.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.639 0.776 . . . . 70.1 110.383 -176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.59 123.46 21.39 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 109.15 -0.685 . . . . 70.02 109.15 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.584 ' HA ' ' HE2' ' C' ' 137' ' ' PHE . 44.9 m80 -80.45 88.51 5.61 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.595 -0.73 . . . . 65.32 109.436 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.2 tp60 -93.13 139.81 30.18 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.678 -1.147 . . . . 74.35 110.181 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.77 -69.47 0.29 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.006 0.923 . . . . 73.22 110.585 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 124.382 1.073 . . . . 71.12 108.345 179.765 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 109.222 -0.659 . . . . 61.45 109.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -147.42 -70.32 0.23 Allowed 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.014 -1.106 . . . . 73.12 108.014 173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 56.79 23.61 8.21 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.499 1.119 . . . . 64.4 112.514 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -87.84 93.21 9.39 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.687 -0.857 . . . . 75.42 108.687 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -63.45 108.6 1.38 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.764 0.826 . . . . 75.22 110.617 -175.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -70.53 132.65 45.83 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.297 0.998 . . . . 74.05 110.152 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.8 t -138.85 161.6 36.88 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 124.398 1.079 . . . . 70.2 108.912 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.2 -38.79 91.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.254 0.622 . . . . 72.1 110.147 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.505 ' HE3' HD12 ' B' ' 89' ' ' ILE . 19.4 ptm 47.49 -173.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 126.17 1.788 . . . . 73.45 114.194 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 32.8 m -152.79 127.51 9.49 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 107.188 -1.412 . . . . 70.21 107.188 173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -124.3 154.46 40.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.963 -0.755 . . . . 71.53 108.963 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.657 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 50.2 tt0 -153.49 139.42 18.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.959 0.904 . . . . 72.14 109.829 176.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.689 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -97.55 113.15 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 N-CA-C 107.092 -1.447 . . . . 72.22 107.092 166.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -77.76 -49.4 14.46 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 122.034 -0.416 . . . . 53.44 110.042 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.2 ttt180 -161.94 133.05 5.17 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.478 -0.328 . . . . 71.24 110.194 -172.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -114.13 137.42 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 107.046 -1.465 . . . . 75.43 107.046 172.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -165.89 145.52 6.31 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.365 0.602 . . . . 74.14 111.744 -174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 65.6 m -75.81 115.15 15.21 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 114.907 -1.042 . . . . 44.25 108.698 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.449 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 43.1 mtpt -85.75 -31.39 22.43 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.088 0.555 . . . . 74.22 110.568 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.3 t70 -157.78 143.84 17.46 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.729 -0.668 . . . . 70.21 111.303 -168.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.501 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 37.6 mm -139.97 141.03 34.8 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 125.304 1.442 . . . . 65.21 108.646 178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -141.26 132.39 26.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.601 -1.259 . . . . 75.12 107.601 173.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.554 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 84.5 t80 -144.27 109.71 5.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.244 -1.761 . . . . 75.4 106.244 170.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -119.18 117.3 28.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.013 -0.736 . . . . 74.34 109.013 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.36 86.1 7.76 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.708 -1.219 . . . . 75.51 107.708 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.57 -28.02 32.1 Favored 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.447 2.098 . . . . 73.53 110.811 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -107.0 27.77 8.67 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.745 1.218 . . . . 71.21 109.244 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.455 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -47.62 -57.39 9.98 Favored Pre-proline 0 CA--C 1.57 1.734 0 C-N-CA 124.67 1.188 . . . . 74.32 112.954 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 78.0 Cg_endo -82.48 -1.28 10.56 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 121.77 1.647 . . . . 74.14 112.843 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.421 ' HA ' HE21 ' B' ' 33' ' ' GLN . 2.8 m-70 -99.57 -16.43 18.27 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.644 0.778 . . . . 73.04 111.885 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.18 -21.96 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.534 0.733 . . . . 72.34 112.784 -167.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 p90 -73.65 -16.72 61.21 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 111.517 0.192 . . . . 63.43 111.517 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.421 HE21 ' HA ' ' B' ' 30' ' ' HIS . 41.0 mt-30 -81.69 -4.87 57.36 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.664 0.786 . . . . 72.33 111.082 176.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' B' ' 68' ' ' LEU . 72.7 mmtt -106.51 102.17 11.58 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.573 1.149 . . . . 73.31 109.898 -177.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -115.9 85.99 2.39 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.487 0.715 . . . . 55.4 111.954 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.503 ' HB2' HD23 ' B' ' 68' ' ' LEU . 6.2 m0 -159.27 -170.5 3.0 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 126.678 1.991 . . . . 63.05 106.657 169.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -83.51 125.4 73.94 Favored Pre-proline 0 N--CA 1.478 0.925 0 N-CA-C 107.628 -1.249 . . . . 72.31 107.628 162.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.443 ' HA ' ' HG ' ' B' ' 68' ' ' LEU . 30.3 Cg_endo -62.68 132.64 38.52 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.08 1.853 . . . . 61.35 112.143 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -68.93 103.27 1.77 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 114.657 -1.156 . . . . 74.11 108.443 171.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 97.7 t -105.17 128.68 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.742 0.817 . . . . 63.14 110.079 -174.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -121.75 109.74 15.08 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.642 1.177 . . . . 74.51 108.048 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.492 HD21 HD12 ' E' ' 129' ' ' LEU . 1.6 pp -92.15 153.57 19.24 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.608 0.763 . . . . 51.25 110.64 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.615 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 10.0 m-20 -136.04 137.17 40.88 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 107.948 -1.13 . . . . 75.51 107.948 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.501 HD21 HG21 ' B' ' 131' ' ' VAL . 7.1 mp -115.78 132.64 56.58 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 109.083 -0.71 . . . . 52.04 109.083 178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 17.9 t70 -139.05 155.94 47.56 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.846 1.258 . . . . 73.11 108.637 -173.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -138.32 140.11 39.38 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 123.759 0.824 . . . . 73.33 109.042 171.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.61 116.88 17.23 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 107.485 -1.302 . . . . 32.21 107.485 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 20.5 m -106.38 161.5 14.52 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.109 0.564 . . . . 64.04 110.733 -175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 68.9 p -160.48 136.04 8.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 108.688 -0.856 . . . . 72.03 108.688 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.455 HE22 ' HE3' ' E' ' 114' ' ' LYS . 62.9 tt0 -88.4 120.27 29.61 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.649 -0.871 . . . . 64.4 108.649 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 30.3 mt -81.28 -39.33 25.41 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-O 121.259 0.552 . . . . 75.53 110.375 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -157.32 -177.86 6.92 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 114.789 -1.096 . . . . 62.54 110.016 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -69.87 130.66 42.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.068 -1.086 . . . . 74.33 108.068 174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.49 -4.81 1.27 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 124.604 1.162 . . . . 75.24 112.761 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 60.0 t -123.08 116.96 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.628 0.771 . . . . 74.02 109.61 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.418 ' HD2' HG13 ' B' ' 58' ' ' VAL . 30.0 p90 -126.19 171.58 10.77 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.188 0.595 . . . . 74.33 109.418 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -144.71 108.15 4.61 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.625 -1.25 . . . . 74.51 107.625 -178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' B' ' 56' ' ' TYR . 29.5 m -104.47 137.47 33.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 109.148 -0.686 . . . . 72.31 109.148 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 40.6 t -109.38 119.59 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 N-CA-C 109.149 -0.686 . . . . 63.03 109.149 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tt -93.02 114.32 26.84 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.54 -1.281 . . . . 74.43 107.54 175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.5 ttt180 -106.24 122.29 45.93 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.78 0.832 . . . . 73.12 109.985 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -113.27 118.63 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.806 -0.813 . . . . 75.05 108.806 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 20.1 m -99.92 145.37 27.89 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 124.418 1.087 . . . . 61.42 108.513 176.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 52.3 t -136.57 130.17 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 123.702 0.801 . . . . 71.34 109.268 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 60.1 m -120.96 145.58 47.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.134 -1.062 . . . . 73.32 108.134 171.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.56 151.33 37.15 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 120.711 0.291 . . . . 62.15 110.36 175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 44.3 p -162.25 143.24 10.41 Favored 'General case' 0 C--N 1.333 -0.146 0 O-C-N 124.672 1.232 . . . . 63.2 109.657 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.623 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.0 mp -112.38 137.08 51.06 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.249 -1.019 . . . . 72.04 108.249 168.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.13 -118.33 6.79 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.112 -0.795 . . . . 75.23 111.112 -176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.59 29.48 6.57 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.481 0.712 . . . . 71.1 110.506 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -145.4 142.92 29.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.113 0.565 . . . . 64.01 110.355 -171.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 9.1 m -59.52 151.83 23.35 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.338 1.055 . . . . 72.04 112.137 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.623 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -112.27 -61.78 1.67 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.446 1.098 . . . . 62.22 108.926 176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.8 156.88 28.28 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 113.79 -1.55 . . . . 74.42 108.94 -177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 52.8 mt -132.37 141.93 49.11 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 107.335 -1.358 . . . . 70.55 107.335 177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 44.1 t -154.21 152.48 30.39 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.454 -0.573 . . . . 72.04 109.454 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -165.15 140.71 5.34 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.264 -0.643 . . . . 72.35 109.264 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.425 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.3 t -133.66 146.79 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.079 0.952 . . . . 71.31 108.748 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.485 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 26.7 mt-30 -126.34 101.05 6.54 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.233 0.613 . . . . 74.21 109.443 174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -90.8 105.34 17.75 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.531 -0.759 . . . . 74.45 109.801 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.449 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -92.36 156.19 23.23 Favored Glycine 0 C--O 1.244 0.727 0 N-CA-C 111.532 -0.627 . . . . 61.24 111.532 174.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 126.56 1.96 Allowed Glycine 0 C--N 1.333 0.383 0 N-CA-C 111.862 -0.495 . . . . 61.03 111.862 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.3 mt -86.0 126.18 40.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.575 -0.898 . . . . 72.24 108.575 171.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -131.51 155.95 46.53 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.223 1.009 . . . . 70.12 109.093 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.657 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 44.1 m -131.92 134.32 45.54 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.293 1.037 . . . . 65.24 109.627 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.72 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.7 pp -131.59 147.7 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.152 0.981 . . . . 71.52 111.006 -173.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.584 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.5 149.7 27.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.436 1.094 . . . . 63.21 108.763 174.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.04 -47.25 2.01 Favored Glycine 0 CA--C 1.537 1.423 0 C-N-CA 123.12 0.39 . . . . 34.22 113.905 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.72 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -83.94 165.0 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 123.531 0.732 . . . . 74.25 112.073 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -167.9 163.51 13.87 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.729 0.811 . . . . 53.21 110.361 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -113.22 5.0 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.992 0.808 . . . . 61.54 113.143 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.7 m -74.08 -34.28 63.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.871 0.868 . . . . 64.45 111.052 -179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -32.9 74.15 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.039 0.535 . . . . 54.33 109.913 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 13.2 tpt -76.98 -43.98 32.87 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.476 0.71 . . . . 62.02 110.811 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.14 75.84 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.828 0.851 . . . . 54.13 111.321 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -70.81 -30.41 66.84 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.285 1.034 . . . . 62.31 111.084 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -69.47 -59.45 2.98 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.092 0.557 . . . . 74.22 110.384 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 2.5 pp -72.45 -19.07 61.63 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 111.88 0.326 . . . . 65.04 111.88 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.97 -22.07 43.66 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 114.493 0.557 . . . . 74.42 114.493 -175.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.18 -55.26 0.44 Allowed 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 117.189 0.494 . . . . 74.14 111.572 -172.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -62.07 -45.53 93.13 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.742 0.817 . . . . 73.53 112.082 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.408 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 85.8 m -71.13 -47.15 14.33 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.546 -0.74 . . . . 71.31 112.222 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.2 Cg_exo -52.86 -31.5 52.37 Favored 'Trans proline' 0 C--N 1.397 3.126 0 C-N-CA 122.249 1.966 . . . . 65.43 114.221 168.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -36.64 83.02 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 122.941 0.496 . . . . 74.33 111.558 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.03 -45.21 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 123.592 0.757 . . . . 72.34 110.4 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.6 mt -80.08 -25.24 40.13 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.043 -0.981 . . . . 63.3 113.058 -169.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -60.76 -47.85 94.69 Favored Pre-proline 0 N--CA 1.483 1.186 0 CA-C-O 117.399 -1.286 . . . . 71.22 113.975 -170.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -50.18 -41.12 50.73 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 122.333 2.022 . . . . 73.3 113.655 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -68.1 -51.73 43.04 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.609 -0.723 . . . . 72.41 110.99 -178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.97 91.71 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.564 0.745 . . . . 61.44 111.294 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.58 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 23.6 ttp180 -61.88 -58.93 6.05 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.256 1.422 . . . . 71.44 110.992 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -69.79 -26.42 64.26 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.728 -1.124 . . . . 75.3 111.098 -173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.451 ' O ' ' HG2' ' B' ' 117' ' ' MET . 14.3 t -68.63 -37.18 79.51 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.824 0.45 . . . . 24.11 111.062 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.6 mt -60.61 -49.24 85.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.126 0.57 . . . . 62.34 109.768 173.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 1.4 m -69.68 -23.44 63.45 Favored 'General case' 0 CA--C 1.555 1.15 0 CA-C-N 115.472 -0.785 . . . . 73.44 111.606 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 31.0 t -75.89 -29.1 58.35 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.697 0.799 . . . . 63.04 110.958 175.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 21.5 mmt -78.94 -26.68 43.63 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.766 0.426 . . . . 73.4 110.187 174.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' B' ' 125' ' ' GLN . 49.6 t -58.85 -41.82 83.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.96 0.904 . . . . 54.33 111.113 170.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 36.5 t -53.1 -38.72 62.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.401 1.081 . . . . 23.11 111.634 173.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 76.0 mtt-85 -76.67 -26.52 54.89 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.113 -0.949 . . . . 74.42 111.377 -174.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.2 0.54 81.6 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-O 119.472 -0.626 . . . . 63.11 113.743 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 59.6 p 63.12 18.91 11.31 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 126.112 1.765 . . . . 73.42 114.484 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' B' ' 118' ' ' VAL . 55.1 p90 -110.42 166.76 10.16 Favored Pre-proline 0 N--CA 1.492 1.642 0 CA-C-O 118.73 -0.652 . . . . 74.21 110.683 -176.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.31 147.19 22.15 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.34 2.694 . . . . 74.12 114.539 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.556 ' HA ' HG11 ' B' ' 118' ' ' VAL . 5.0 pm0 -54.1 145.0 18.01 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.05 1.34 . . . . 73.33 113.729 -175.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' B' ' 126' ' ' LEU . 1.9 tm? -133.23 85.4 2.21 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 107.537 -1.283 . . . . 73.53 107.537 171.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -104.93 133.76 49.19 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 107.909 -1.145 . . . . 73.22 107.909 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.58 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.0 mm? -86.7 138.47 31.62 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.369 0.668 . . . . 53.4 109.544 -169.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.477 ' HB2' ' HA ' ' E' ' 131' ' ' ALA . . . -67.96 148.71 98.39 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 123.078 0.551 . . . . 73.21 110.603 177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.31 112.93 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.804 2.336 . . . . 54.32 111.634 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.501 HG21 HD21 ' B' ' 44' ' ' LEU . 90.9 t -89.77 127.32 42.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 122.869 0.468 . . . . 62.52 109.829 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -80.41 83.18 6.28 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.739 0.816 . . . . 75.44 109.784 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -63.01 -29.09 70.55 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.615 0.766 . . . . 73.04 111.279 176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -69.9 -53.53 17.54 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.727 0.811 . . . . 62.03 110.257 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.63 77.38 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.272 0.629 . . . . 44.14 110.682 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.462 HD21 ' N ' ' E' ' 124' ' ' ARG . 7.3 tt -67.75 -38.34 83.35 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.249 1.02 . . . . 60.13 110.549 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -63.0 -37.75 88.46 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.442 0.697 . . . . 62.55 109.959 176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 62.9 mtt -68.39 -38.86 81.74 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.895 -0.593 . . . . 75.13 109.993 174.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.55 -15.12 60.86 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.282 0.633 . . . . 75.3 111.611 -178.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -72.66 -40.2 66.53 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.171 0.588 . . . . 74.21 110.105 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.465 HD11 ' NE2' ' B' ' 144' ' ' GLN . 1.5 pp -121.51 26.96 8.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.419 0.687 . . . . 64.44 111.73 -177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 64.39 -78.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.481 1.512 . . . . 74.45 112.944 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 28.5 mp0 -129.21 144.98 51.41 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.256 0.622 . . . . 75.33 109.998 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.465 ' NE2' HD11 ' B' ' 141' ' ' LEU . 32.5 mm-40 -65.2 117.69 8.15 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.83 0.707 . . . . 73.53 109.438 173.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.75 91.78 1.41 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 107.782 -1.192 . . . . 41.11 107.782 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -124.91 -71.99 0.21 Allowed Glycine 0 C--N 1.343 0.949 0 CA-C-N 116.122 -0.49 . . . . 64.22 113.929 -168.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 69.15 148.76 0.07 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.762 1.225 . . . . 63.43 111.506 -175.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.83 -154.92 24.4 Favored Glycine 0 C--N 1.34 0.803 0 CA-C-O 119.456 -0.636 . . . . 50.11 111.737 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 68.7 m 56.81 73.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.892 0.877 . . . . 74.25 110.291 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -92.98 142.78 26.91 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 114.803 -1.089 . . . . 70.04 110.749 -174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -81.41 94.69 6.85 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.367 -0.605 . . . . 62.23 109.367 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.0 p80 -89.68 49.64 1.77 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.126 0.571 . . . . 75.42 109.862 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -66.49 91.5 0.18 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.527 0.731 . . . . 71.41 110.9 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -110.15 160.77 16.19 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.118 0.967 . . . . 64.41 108.872 173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 N-CA-C 108.819 -0.808 . . . . 74.41 108.819 -178.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.501 ' HA ' ' HB3' ' A' ' 144' ' ' GLN . 83.0 mtp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 109.908 -0.404 . . . . 75.21 109.908 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -93.43 90.7 6.83 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.229 -1.026 . . . . 64.34 108.229 177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -80.41 67.82 6.38 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.925 0.869 . . . . 63.44 110.346 -174.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -105.95 -0.85 24.69 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.615 1.166 . . . . 71.1 110.548 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.647 HD22 HG22 ' C' ' 7' ' ' THR . 1.0 OUTLIER -122.63 141.22 51.96 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.736 1.214 . . . . 73.41 110.206 -172.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -87.7 10.27 18.77 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 113.457 0.91 . . . . 61.31 113.457 -169.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.706 ' HB ' ' HG3' ' A' ' 147' ' ' GLU . 14.4 t -61.7 -26.27 67.93 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.097 0.559 . . . . 73.32 112.037 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -72.32 -37.97 68.79 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.102 0.561 . . . . 62.41 111.052 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.9 ttp 63.97 126.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.93 1.292 . . . . 65.13 111.838 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 35.6 m -83.83 85.47 7.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.399 -0.963 . . . . 73.35 108.399 178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' C' ' 85' ' ' SER . 50.0 t80 -106.44 140.97 38.51 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 114.413 -1.267 . . . . 74.22 109.443 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 6.0 tp60 -145.68 137.39 25.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.831 0.452 . . . . 73.54 110.477 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.445 ' HB ' HD22 ' F' ' 129' ' ' LEU . 25.5 mm -86.31 110.31 19.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 N-CA-C 107.94 -1.133 . . . . 53.33 107.94 172.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.425 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 86.8 mm-40 -83.99 -49.22 9.15 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.867 -0.419 . . . . 70.2 109.867 176.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 52.0 ttt85 -169.1 136.8 1.89 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.693 -0.685 . . . . 73.31 109.627 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -117.06 138.93 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 N-CA-C 107.744 -1.206 . . . . 71.35 107.744 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.515 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 20.7 p90 -176.46 144.02 0.51 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 122.6 0.36 . . . . 74.43 110.822 -175.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.435 HG22 ' NE2' ' C' ' 80' ' ' GLN . 81.9 p -70.48 124.55 24.47 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.408 0.683 . . . . 54.12 110.124 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -77.07 -49.45 15.29 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 107.873 -1.158 . . . . 73.51 107.873 171.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -135.01 142.14 46.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.185 -1.371 . . . . 75.45 110.309 -174.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.2 mt -136.18 143.01 37.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 106.055 -1.832 . . . . 74.53 106.055 173.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.2 t -156.07 150.31 25.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.311 0.577 . . . . 72.41 109.954 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -148.76 138.79 22.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.627 -1.169 . . . . 71.31 108.034 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.1 132.12 35.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 107.768 -1.197 . . . . 74.13 107.768 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.12 80.93 16.4 Favored Pre-proline 0 C--N 1.321 -0.668 0 N-CA-C 107.254 -1.387 . . . . 64.23 107.254 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.83 -38.19 40.61 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.514 2.143 . . . . 73.34 110.996 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 1.1 m-20 -100.1 32.89 2.79 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.382 1.073 . . . . 73.33 109.914 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.408 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.75 -43.84 96.0 Favored Pre-proline 0 CA--C 1.566 1.576 0 N-CA-C 114.131 1.16 . . . . 72.11 114.131 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -74.88 -23.68 13.83 Favored 'Trans proline' 0 C--N 1.383 2.36 0 CA-C-N 121.435 1.548 . . . . 42.31 112.834 171.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 51.1 m80 -65.19 -20.38 66.42 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.532 0.733 . . . . 73.22 112.852 179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' C' ' 34' ' ' LYS . 52.6 t -49.46 -32.07 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 C-N-CA 124.284 1.034 . . . . 54.24 113.104 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -62.96 -39.88 96.0 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.893 0.477 . . . . 72.0 111.695 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -106.86 15.2 25.74 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.079 0.952 . . . . 75.35 111.261 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.686 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 3.4 ttpm? -108.68 137.02 47.3 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.873 0.869 . . . . 61.41 109.023 174.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.13 131.83 35.24 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 108.176 -1.046 . . . . 73.1 108.176 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -79.67 72.26 6.35 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.079 0.552 . . . . 74.2 109.813 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -143.28 48.15 0.92 Allowed Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 123.79 0.836 . . . . 74.21 110.165 169.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -79.11 143.81 18.12 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 121.358 1.372 . . . . 75.23 110.841 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -87.11 115.21 24.35 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.789 -0.819 . . . . 54.21 108.789 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 6.1 p -69.99 107.5 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.391 -0.822 . . . . 61.55 110.24 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.454 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 7.3 tmtt? -92.45 104.56 16.87 Favored 'General case' 0 CA--C 1.529 0.155 0 N-CA-C 106.375 -1.713 . . . . 74.02 106.375 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.403 HD13 ' HG ' ' C' ' 128' ' ' LEU . 13.5 tp -84.0 146.95 27.7 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.73 -1.211 . . . . 75.42 107.73 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -143.48 143.3 31.51 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.257 -1.386 . . . . 63.55 107.257 173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.06 153.97 51.86 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 121.233 0.54 . . . . 60.33 111.379 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.8 t70 -151.38 153.26 34.4 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.784 1.234 . . . . 73.05 108.626 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -139.33 141.53 37.67 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.077 -0.712 . . . . 55.44 109.077 170.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -128.66 170.09 13.68 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.101 0.96 . . . . 74.52 109.106 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -147.14 144.66 29.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.457 0.703 . . . . 50.23 109.995 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 66.2 p -144.88 126.29 14.91 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.265 -1.013 . . . . 73.11 108.265 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -79.88 115.86 19.71 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' C' ' 57' ' ' GLU . 51.7 mt -89.36 -35.72 15.92 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.154 0.582 . . . . 75.3 109.635 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.59 -173.84 4.59 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.493 1.117 . . . . 73.42 110.016 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -66.65 117.29 8.6 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.378 -0.828 . . . . 70.02 109.775 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 68.58 0.28 2.55 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.603 1.561 . . . . 74.24 112.364 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.9 t -101.72 108.99 24.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.744 -0.836 . . . . 75.23 108.744 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.26 123.53 41.66 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.529 1.132 . . . . 73.42 108.756 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.569 ' HB2' HD11 ' C' ' 51' ' ' LEU . 32.7 tt0 -83.34 139.05 33.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.253 -1.017 . . . . 75.55 108.253 169.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 95.6 t -118.93 131.86 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 108.357 -0.979 . . . . 62.22 108.357 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 60.5 t -110.1 102.5 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.745 -0.835 . . . . 73.21 108.745 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -90.56 109.19 20.34 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 108.109 -1.071 . . . . 65.3 108.109 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.703 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 65.2 mtt85 -95.75 132.7 40.69 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.814 0.845 . . . . 53.03 109.526 177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.402 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.0 t -126.62 131.02 71.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 108.164 -1.05 . . . . 74.02 108.164 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -125.92 120.45 30.43 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 108.912 -0.773 . . . . 71.03 108.912 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.431 HG21 HG21 ' C' ' 114' ' ' ILE . 94.4 t -110.27 114.36 46.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 C-N-CA 124.145 0.978 . . . . 65.31 108.82 -179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 16.3 m -98.81 139.16 34.9 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.868 -1.16 . . . . 52.4 107.868 168.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.98 110.65 7.1 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.024 -1.843 . . . . 44.31 106.024 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.499 ' HB3' HG23 ' C' ' 72' ' ' THR . 12.5 p -158.16 139.99 13.89 Favored 'General case' 0 C--O 1.24 0.574 0 O-C-N 123.641 0.588 . . . . 74.4 110.689 -173.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 30.0 tp -80.7 -23.85 39.24 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 115.473 -0.785 . . . . 71.44 109.276 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 174.04 -97.2 0.11 Allowed Glycine 0 C--N 1.347 1.14 0 N-CA-C 110.056 -1.217 . . . . 71.3 110.056 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -90.46 -31.93 16.6 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.651 -0.87 . . . . 74.1 108.651 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -69.93 84.04 0.49 Allowed 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.018 -1.105 . . . . 63.53 108.018 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.499 HG23 ' HB3' ' C' ' 67' ' ' SER . 78.7 m -87.89 136.72 32.84 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.248 -1.342 . . . . 74.35 109.889 -173.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.686 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -72.32 -73.56 0.19 Allowed 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.92 -1.141 . . . . 55.13 107.92 170.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -154.0 167.59 29.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.736 0.779 . . . . 75.13 112.333 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -125.59 138.71 53.95 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 105.726 -1.953 . . . . 72.35 105.726 166.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.2 t -151.77 113.27 4.36 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 110.011 -0.366 . . . . 44.42 110.011 -175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -117.06 136.11 53.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 122.518 0.327 . . . . 74.42 110.129 176.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' C' ' 110' ' ' ALA . 25.4 t -125.25 114.16 38.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.12 0.968 . . . . 55.24 108.673 171.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -90.26 92.7 9.04 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.472 -0.936 . . . . 65.4 108.472 171.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.435 ' NE2' HG22 ' C' ' 18' ' ' THR . 7.5 tp-100 -78.16 136.54 37.85 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.687 -0.688 . . . . 74.24 109.345 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -116.42 153.04 17.67 Favored Glycine 0 N--CA 1.464 0.549 0 N-CA-C 111.3 -0.72 . . . . 55.11 111.3 175.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.446 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 121.19 1.08 Allowed Glycine 0 CA--C 1.503 -0.704 0 N-CA-C 111.477 -0.649 . . . . 71.54 111.477 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.461 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.3 mm -81.71 120.78 33.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 107.685 -1.228 . . . . 71.32 107.685 174.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -131.83 138.01 48.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.512 0.725 . . . . 62.11 109.962 -174.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.51 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 58.9 m -89.89 113.93 25.62 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.552 -0.906 . . . . 64.43 108.552 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.6 100.55 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.96 -1.126 . . . . 71.42 107.96 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -130.74 152.68 49.82 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.914 0.886 . . . . 64.3 110.352 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.16 -39.3 2.8 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.02 -0.536 . . . . 73.44 112.209 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.57 160.01 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.256 0.622 . . . . 65.51 109.968 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -151.03 152.86 34.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.169 0.588 . . . . 75.22 110.551 -177.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.45 -111.91 4.17 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 123.769 0.668 . . . . 24.43 113.198 169.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 44.3 p -73.73 -34.37 64.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.051 0.94 . . . . 54.44 111.693 -175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.26 -36.55 74.52 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.694 -0.484 . . . . 72.21 109.694 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.462 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 59.5 ttm -68.23 -36.46 79.53 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.913 -0.585 . . . . 63.3 110.174 176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.9 -33.09 74.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.638 0.775 . . . . 71.55 111.024 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -68.34 -35.57 77.96 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.14 0.576 . . . . 73.53 110.845 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 24.9 t -71.87 -62.65 1.34 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.638 0.375 . . . . 72.03 110.633 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.1 pp -75.71 -14.13 60.33 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 112.309 0.485 . . . . 70.31 112.309 -176.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.31 -18.99 37.04 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.602 -0.555 . . . . 74.12 113.259 178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.81 -56.48 0.62 Allowed 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 117.786 0.793 . . . . 73.53 112.642 -174.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -66.53 -61.15 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.61 0.364 . . . . 64.52 111.862 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 40.6 m -57.05 -45.45 99.95 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 124.08 0.952 . . . . 73.12 113.457 -176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.79 -25.2 46.12 Favored 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 121.798 1.666 . . . . 71.03 113.493 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -70.55 -29.16 65.55 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 122.754 0.422 . . . . 64.51 110.175 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.484 HD12 ' NH1' ' A' ' 111' ' ' ARG . 47.4 mm -68.4 -40.07 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.569 0.748 . . . . 61.4 109.939 171.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.446 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.6 mt -78.31 -26.28 46.88 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 114.99 -1.005 . . . . 74.22 112.307 -174.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.0 -42.08 79.9 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.507 -1.235 . . . . 71.11 114.062 -173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -53.17 -43.63 55.56 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.158 1.905 . . . . 63.4 112.904 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -66.35 -41.31 89.73 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.66 0.784 . . . . 64.54 110.785 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.452 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -68.84 -44.8 72.67 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.665 -0.698 . . . . 43.4 110.868 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.5 ttt180 -50.95 -55.69 16.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.419 1.488 . . . . 62.4 110.995 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -65.31 -36.82 85.25 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.035 0.834 . . . . 71.22 109.931 -175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.531 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 12.0 t -66.47 -36.54 83.0 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.444 0.698 . . . . 74.01 111.566 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.466 ' O ' HG23 ' C' ' 118' ' ' VAL . 95.1 mt -70.06 -49.51 55.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.379 0.672 . . . . 74.32 109.917 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.409 HG21 HD21 ' C' ' 127' ' ' ASN . 19.6 m -66.37 -30.23 70.57 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.109 0.564 . . . . 63.24 111.187 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -65.45 -45.87 82.1 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.113 -0.699 . . . . 65.41 109.113 171.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.563 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.73 -34.9 75.09 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.157 0.983 . . . . 54.05 112.404 177.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.466 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.1 t -62.49 -46.32 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.387 0.675 . . . . 72.35 109.542 174.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.4 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 29.7 t -67.48 -31.89 72.34 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.149 -0.932 . . . . 53.52 111.669 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 77.5 mtt-85 -68.87 -42.0 77.61 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.376 0.67 . . . . 74.11 109.664 177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.35 -4.37 86.86 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.804 0.69 . . . . 73.22 112.811 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 22.9 p 65.57 32.83 9.02 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.716 2.006 . . . . 63.51 113.085 172.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -89.09 166.49 21.58 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.587 1.155 . . . . 74.1 110.554 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.506 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 31.3 Cg_endo -63.77 112.93 1.95 Allowed 'Trans proline' 0 C--N 1.38 2.227 0 C-N-CA 122.074 1.849 . . . . 74.0 111.89 173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.4 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 84.4 mt-30 -60.99 136.37 58.07 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.91 0.484 . . . . 74.45 111.023 175.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.729 HD21 ' HB ' ' E' ' 142' ' ' ILE . 38.9 tp -144.6 123.33 12.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.195 -1.039 . . . . 73.33 108.195 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.409 HD21 HG21 ' C' ' 115' ' ' THR . 26.8 m120 -103.32 123.73 47.34 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.824 0.45 . . . . 74.34 109.789 -176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.403 ' HG ' HD13 ' C' ' 42' ' ' LEU . 1.4 tm? -74.24 128.51 35.73 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.16 0.984 . . . . 74.32 109.546 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.5 146.43 98.65 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.797 0.839 . . . . 70.22 111.374 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.604 ' HG3' HD13 ' A' ' 16' ' ' ILE . 35.5 Cg_endo -61.41 136.09 61.59 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.896 2.397 . . . . 73.23 113.31 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.9 p -127.58 109.83 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 108.077 -1.082 . . . . 74.44 108.077 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.417 ' H ' HD13 ' E' ' 148' ' ' LEU . 15.9 m120 -112.51 93.83 4.62 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.748 0.819 . . . . 42.2 110.666 -174.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -71.79 -33.09 68.3 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 109.019 -0.734 . . . . 72.31 109.019 170.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -57.39 -55.05 39.77 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.77 1.228 . . . . 73.13 111.615 174.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.71 -19.68 58.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.567 0.747 . . . . 73.22 111.837 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.0 tp -55.62 -29.81 59.81 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.675 0.79 . . . . 73.4 112.117 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.584 ' HE2' ' HA ' ' A' ' 152' ' ' HIS . 92.7 m-85 -73.48 -32.39 64.28 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.334 0.654 . . . . 74.54 111.501 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.1 mtp -74.85 -33.65 62.17 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.85 0.86 . . . . 72.41 110.127 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -67.72 -39.92 84.27 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.565 1.146 . . . . 55.42 110.097 176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.48 -80.08 0.05 OUTLIER 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.699 1.199 . . . . 73.14 110.051 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.1 tp -52.63 101.9 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.501 1.12 . . . . 75.12 111.763 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.47 ' HA ' HE21 ' C' ' 142' ' ' GLN . 0.0 OUTLIER -81.79 144.96 30.7 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 114.778 -1.101 . . . . 71.54 108.157 171.129 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -73.67 -83.94 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.194 0.309 . . . . 64.11 111.27 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 179.38 -59.99 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.715 0.806 . . . . 75.54 108.862 -173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.57 159.88 28.89 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.416 1.086 . . . . 73.41 111.972 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.16 -44.05 0.02 OUTLIER Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.802 -0.519 . . . . 45.44 111.802 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -75.49 114.94 14.62 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.41 0.684 . . . . 73.41 110.68 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -100.36 -101.68 2.44 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 110.751 -0.94 . . . . 74.24 110.751 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 10.1 m 66.62 165.21 0.2 Allowed 'General case' 0 CA--C 1.567 1.603 0 C-N-CA 124.573 1.149 . . . . 71.24 110.62 -177.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 75.11 104.44 0.07 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.993 1.317 . . . . 72.11 111.582 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.97 -90.01 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.655 1.182 . . . . 74.3 109.328 -177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 60.66 -89.88 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.533 1.533 . . . . 74.21 113.402 169.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -171.23 151.13 3.08 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.193 0.597 . . . . 62.42 110.068 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -97.68 -37.4 9.91 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.763 0.825 . . . . 71.21 110.604 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.056 0 C-N-CA 123.925 0.89 . . . . 54.14 110.589 -176.63 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptm . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.962 -0.385 . . . . 72.42 109.962 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 55.7 p -155.4 145.05 21.27 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.5 1.12 . . . . 70.14 108.939 -178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -67.76 -55.09 14.4 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.827 0.704 . . . . 63.23 110.067 -177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 60.56 102.24 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.139 1.376 . . . . 74.42 112.85 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -127.67 90.39 3.1 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.107 -1.072 . . . . 61.41 108.107 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 -159.08 138.13 11.23 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.091 -0.707 . . . . 74.13 109.091 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.2 t -99.48 -4.33 31.59 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.862 0.865 . . . . 74.12 111.593 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -69.4 -19.49 63.81 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.178 0.591 . . . . 74.44 112.035 178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.454 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 20.3 ptm -33.62 151.82 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.452 0 C-N-CA 125.115 1.366 . . . . 31.32 114.622 165.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 37.8 m -107.88 143.87 35.89 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 123.445 0.698 . . . . 70.51 109.318 170.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' D' ' 85' ' ' SER . 63.2 t80 -155.55 106.91 2.56 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.39 -0.967 . . . . 75.23 108.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -129.3 146.34 51.21 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.234 0.614 . . . . 74.23 109.614 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -92.78 109.82 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 107.568 -1.271 . . . . 61.4 107.568 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -82.69 -47.66 11.77 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 123.034 0.208 . . . . 74.24 111.46 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -170.11 129.25 0.91 Allowed 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 116.58 -0.282 . . . . 74.43 111.175 -167.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.41 133.2 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 N-CA-C 107.272 -1.381 . . . . 54.21 107.272 173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -155.47 144.52 20.77 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.214 0.531 . . . . 63.14 111.551 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.9 p -79.31 115.03 18.71 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.441 -0.8 . . . . 61.35 109.193 173.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.2 mtpt -81.1 -24.5 37.67 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.957 -0.386 . . . . 73.11 109.957 175.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.737 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.9 t70 -153.99 141.59 19.88 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.027 -0.988 . . . . 61.11 109.724 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.563 HG21 ' HE2' ' C' ' 117' ' ' MET . 86.3 mt -139.65 149.55 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.216 1.406 . . . . 73.41 107.689 173.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -153.04 144.91 23.62 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.584 1.154 . . . . 74.43 108.404 174.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 85.4 t80 -152.29 115.3 4.65 Favored 'General case' 0 C--O 1.216 -0.668 0 N-CA-C 105.928 -1.879 . . . . 72.25 105.928 173.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 40.1 mt-10 -127.23 111.41 13.92 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.7 0.4 . . . . 60.02 110.008 -176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.19 90.52 4.72 Favored Pre-proline 0 CA--C 1.545 0.782 0 N-CA-C 107.809 -1.182 . . . . 71.41 107.809 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.32 -40.56 1.57 Allowed 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.663 2.242 . . . . 72.0 113.082 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.482 ' HB2' ' HB3' ' D' ' 30' ' ' HIS . 5.0 p30 -113.56 43.96 1.68 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.321 1.048 . . . . 74.54 108.927 178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.515 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.36 -49.23 86.43 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 115.786 1.773 . . . . 75.14 115.786 -169.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.67 -15.99 13.34 Favored 'Trans proline' 0 C--N 1.388 2.654 0 CA-C-N 122.102 1.786 . . . . 53.44 113.381 173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.482 ' HB3' ' HB2' ' D' ' 27' ' ' ASN . 7.1 t-160 -77.08 -46.53 23.31 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.136 0.974 . . . . 73.01 111.199 -178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.411 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.2 p -70.59 -22.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-O 120.968 0.413 . . . . 74.15 110.989 176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -62.17 -33.24 74.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.688 0.795 . . . . 72.45 111.051 170.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -72.78 -15.37 61.65 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.703 0.801 . . . . 65.04 111.156 175.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.5 ' HZ2' ' HB3' ' D' ' 71' ' ' GLU . 89.7 mttt -93.0 106.82 18.72 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.227 -0.657 . . . . 73.43 109.227 175.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -83.41 89.63 7.07 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 109.285 -0.635 . . . . 71.2 109.285 175.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.516 ' HB3' HD21 ' D' ' 68' ' ' LEU . 6.3 t-105 -169.99 158.87 7.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 108.487 -0.931 . . . . 74.31 108.487 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.438 ' HG3' ' HB2' ' F' ' 140' ' ' SER . 29.9 mm-40 -86.94 114.48 58.48 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.037 0.535 . . . . 64.22 110.458 175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -61.79 140.58 86.5 Favored 'Trans proline' 0 C--N 1.367 1.538 0 C-N-CA 123.407 2.738 . . . . 74.15 114.217 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.02 126.16 28.95 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.953 0.901 . . . . 55.05 109.863 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.49 HG13 HG13 ' D' ' 64' ' ' VAL . 47.9 t -99.58 112.09 30.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.516 0.726 . . . . 72.13 110.258 -176.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 1.4 tmtp? -88.09 122.14 31.31 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.028 -1.471 . . . . 70.22 107.028 168.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 6.3 tt -97.08 115.4 27.43 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.773 -1.195 . . . . 50.11 107.773 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.643 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.7 m-20 -108.27 136.81 47.3 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 107.97 -1.122 . . . . 75.52 107.97 172.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -135.93 133.33 37.52 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.083 0.553 . . . . 52.33 109.922 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.8 t70 -142.06 157.25 45.13 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 73.43 108.198 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -132.29 158.13 42.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.833 0.853 . . . . 71.45 109.5 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.539 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.68 170.04 21.23 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.957 -0.757 . . . . 64.1 108.957 174.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.468 ' HB2' ' HB3' ' D' ' 152' ' ' HIS . 39.6 m -150.68 159.56 44.43 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.973 0.509 . . . . 75.14 109.965 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . 0.433 ' HB3' ' HB3' ' D' ' 57' ' ' GLU . 40.3 t -152.06 127.07 9.71 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.479 -0.934 . . . . 55.24 108.479 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -85.53 117.8 24.65 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 108.44 -0.948 . . . . 63.14 108.44 172.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.509 HD11 ' HB2' ' D' ' 57' ' ' GLU . 35.2 mt -98.09 -29.73 13.08 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.171 0.588 . . . . 72.24 110.165 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.501 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -161.02 -179.03 7.19 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 124.033 0.933 . . . . 72.42 109.972 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -68.15 118.66 11.58 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.006 -0.997 . . . . 75.42 108.819 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 67.53 16.91 9.99 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.131 0.972 . . . . 74.33 112.032 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.501 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 76.8 t -127.33 117.12 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.449 -0.945 . . . . 74.3 108.449 174.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -135.2 129.31 33.53 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.785 -0.643 . . . . 74.31 109.787 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' D' ' 51' ' ' LEU . 13.3 tt0 -87.15 148.16 25.32 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 124.604 1.162 . . . . 73.14 108.394 167.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.498 HG13 HD11 ' D' ' 106' ' ' LEU . 4.1 p -134.5 138.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.734 -1.21 . . . . 75.22 107.734 171.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 94.7 t -108.84 136.85 43.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.072 -0.714 . . . . 64.23 109.072 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -115.56 116.99 29.09 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 107.024 -1.473 . . . . 72.31 107.024 174.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -97.46 98.21 9.75 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.36 -0.978 . . . . 54.41 108.36 177.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.1 116.64 39.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.282 -1.007 . . . . 71.24 108.282 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 33.3 m -125.46 132.51 52.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.04 -0.982 . . . . 73.44 109.04 -171.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.596 HG11 HD11 ' D' ' 126' ' ' LEU . 56.6 t -122.59 102.82 12.31 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 C-N-CA 124.085 0.954 . . . . 55.31 109.059 -176.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 25.3 m -95.81 91.95 6.3 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.98 -1.119 . . . . 74.42 107.98 173.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.51 139.61 31.53 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.598 -0.89 . . . . 75.11 108.598 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.8 p -151.99 135.43 16.05 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 123.625 0.578 . . . . 71.1 110.34 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.516 HD21 ' HB3' ' D' ' 36' ' ' TRP . 12.6 tp -112.78 106.09 14.37 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.714 -0.676 . . . . 74.03 109.318 177.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.94 -133.12 11.79 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.755 -0.657 . . . . 75.01 112.201 -177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.27 3.78 41.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.584 0.753 . . . . 72.03 111.617 -177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.5 ' HB3' ' HZ2' ' D' ' 34' ' ' LYS . 9.5 tp10 -138.46 149.22 45.22 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.729 0.812 . . . . 65.33 109.17 -165.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 30.7 m -56.77 152.85 11.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.405 1.082 . . . . 75.43 111.206 176.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.411 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -107.26 -62.29 1.44 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.463 -0.94 . . . . 65.23 108.463 171.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -156.1 149.37 24.52 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 115.075 -0.966 . . . . 74.43 109.151 172.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.8 mt -112.03 151.19 29.62 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.982 -1.118 . . . . 72.04 107.982 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.509 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.7 t -158.42 146.77 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 123.401 0.438 . . . . 72.11 109.987 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -155.65 132.28 10.43 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 123.587 0.755 . . . . 74.01 109.062 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 93.8 t -131.5 113.2 22.6 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.425 -0.954 . . . . 72.14 108.425 176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.737 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.7 mt-30 -89.45 81.79 6.53 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.038 -1.097 . . . . 63.3 108.038 171.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.427 ' O ' HD13 ' D' ' 106' ' ' LEU . 6.9 tp-100 -79.7 99.75 7.56 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 112.914 -1.948 . . . . 75.51 109.216 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.24 161.66 31.64 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.91 -0.476 . . . . 35.21 111.91 177.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -164.86 136.23 4.11 Favored Glycine 0 C--N 1.335 0.518 0 N-CA-C 111.626 -0.59 . . . . 63.11 111.626 176.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 36.5 mt -91.96 137.08 22.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 C-N-CA 123.591 0.756 . . . . 72.42 110.074 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -134.95 132.69 38.71 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.848 0.859 . . . . 54.42 109.533 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 5.7 m -75.52 95.89 3.4 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.352 -0.981 . . . . 74.5 108.352 172.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 53.4 mt -105.94 99.36 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 108.451 -0.944 . . . . 64.14 108.451 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.469 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -126.88 153.19 46.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.677 1.191 . . . . 74.04 108.778 -176.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.06 -7.9 62.05 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.753 -0.471 . . . . 70.13 113.454 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.559 HD12 ' HG2' ' D' ' 93' ' ' GLN . 5.5 mm -137.97 129.27 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.938 0.895 . . . . 72.45 110.671 -174.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.607 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 3.0 pp20? -148.36 -173.83 4.43 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.655 0.782 . . . . 73.13 110.232 172.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.42 -140.52 25.46 Favored Glycine 0 C--N 1.351 1.363 0 CA-C-O 120.014 -0.326 . . . . 52.13 113.137 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 11.2 t -69.99 -25.11 63.45 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.202 0.601 . . . . 51.22 110.851 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.559 ' HG2' HD12 ' D' ' 89' ' ' ILE . 6.2 tp-100 -72.74 -32.07 65.4 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.278 0.631 . . . . 51.11 110.355 178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.607 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 21.1 ttt -71.34 -42.41 68.56 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.826 -0.435 . . . . 73.22 109.826 171.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.54 -27.62 69.29 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.863 0.465 . . . . 65.44 111.036 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.78 -52.76 8.96 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.676 0.79 . . . . 64.1 110.733 173.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -64.29 -51.64 62.51 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 120.944 0.402 . . . . 63.03 110.963 -172.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 22.5 tp -75.81 -19.3 59.06 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.634 1.174 . . . . 73.05 110.929 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.41 -5.51 36.93 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.516 -0.602 . . . . 54.32 114.287 -176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.31 -61.9 0.72 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 117.941 0.871 . . . . 51.43 111.408 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.83 -47.32 54.0 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.444 0.465 . . . . 74.33 112.027 -171.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HG ' ' HZ ' ' D' ' 11' ' ' PHE . 59.8 m -64.75 -44.78 74.38 Favored Pre-proline 0 CA--C 1.566 1.558 0 C-N-CA 123.491 0.716 . . . . 63.34 111.722 -178.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.499 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.9 Cg_exo -57.16 -34.89 98.6 Favored 'Trans proline' 0 C--N 1.397 3.114 0 C-N-CA 122.513 2.142 . . . . 65.55 113.871 166.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.75 -34.43 78.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.082 0.553 . . . . 60.05 110.73 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.37 -33.43 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 123.691 0.796 . . . . 63.2 110.561 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.498 HD11 HG13 ' D' ' 58' ' ' VAL . 91.3 mt -79.38 -20.66 47.16 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.819 0.848 . . . . 63.24 112.603 -178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -65.05 -42.84 64.36 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 113.968 1.099 . . . . 73.1 113.968 -172.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -54.81 -39.83 87.91 Favored 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 122.054 1.836 . . . . 70.34 113.281 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -73.67 -36.39 65.32 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.596 0.758 . . . . 72.34 111.38 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.58 -51.07 70.07 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.297 0.639 . . . . 45.32 110.121 176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.0 -48.09 79.28 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.777 1.298 . . . . 75.21 110.589 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -61.0 -43.16 99.29 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 124.364 1.04 . . . . 73.44 111.736 -177.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -61.55 -41.62 97.64 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 123.553 0.533 . . . . 75.41 110.767 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.509 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.3 mt -67.7 -43.47 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 115.556 -0.747 . . . . 73.22 110.716 175.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 60.4 m -55.63 -46.37 77.41 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.996 0.918 . . . . 70.13 110.66 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.5 t -64.82 -46.93 79.87 Favored 'General case' 0 C--O 1.219 -0.525 0 CA-C-N 114.026 -1.443 . . . . 44.54 110.578 -176.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -64.49 -36.5 84.38 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.007 0.523 . . . . 65.21 112.089 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.445 HG13 ' HB2' ' D' ' 123' ' ' PHE . 45.3 t -67.18 -40.95 86.23 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.215 -0.902 . . . . 51.15 110.661 177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.4 p -75.17 -23.53 57.74 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 122.416 0.287 . . . . 73.45 111.408 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.531 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 89.2 mtt-85 -74.56 -38.17 62.78 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.499 0.72 . . . . 73.34 109.723 174.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.42 1.55 76.11 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.541 -0.754 . . . . 33.45 112.391 173.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.2 p 60.13 23.51 12.78 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.852 2.061 . . . . 71.24 113.146 175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.445 ' HB2' HG13 ' D' ' 118' ' ' VAL . 78.7 m-85 -80.6 161.16 65.22 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 124.862 1.265 . . . . 51.04 109.114 169.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.21 135.42 43.25 Favored 'Trans proline' 0 C--N 1.373 1.86 0 C-N-CA 122.355 2.037 . . . . 73.24 112.234 -177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -48.45 130.92 17.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.048 1.339 . . . . 74.33 112.562 -174.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.596 HD11 HG11 ' D' ' 64' ' ' VAL . 9.6 tt -108.71 112.49 24.83 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.618 0.767 . . . . 50.3 109.553 -171.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -124.74 92.71 3.71 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.388 0.675 . . . . 75.21 109.683 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 69.4 mt -68.53 132.68 47.37 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.124 0.569 . . . . 72.55 110.238 174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.47 139.89 94.61 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.41 0.684 . . . . 64.55 111.234 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.94 127.66 20.99 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.828 2.352 . . . . 73.31 112.529 -176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 39.6 t -114.61 111.43 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.015 0.926 . . . . 71.03 109.849 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -84.73 101.81 12.51 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.656 -0.498 . . . . 71.13 109.656 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -70.95 -22.26 62.23 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.43 0.692 . . . . 72.23 111.256 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.81 -50.46 70.88 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.552 1.141 . . . . 73.34 111.716 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.4 -35.35 80.13 Favored 'General case' 0 N--CA 1.481 1.112 0 O-C-N 123.616 0.573 . . . . 71.31 111.708 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -66.06 -39.99 90.56 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.247 -0.888 . . . . 72.1 109.875 176.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -66.48 -32.16 73.35 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.794 0.838 . . . . 74.44 111.079 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 16.4 mmt -59.48 -46.51 88.59 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.314 0.578 . . . . 63.55 110.075 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -71.18 -31.39 67.59 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 114.677 -1.147 . . . . 64.53 111.365 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -57.12 -36.84 71.14 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.715 0.806 . . . . 74.42 112.436 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.13 -44.13 87.62 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 64.51 111.752 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -87.67 3.36 48.12 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 122.823 0.449 . . . . 72.33 111.55 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -120.67 71.18 0.92 Allowed 'General case' 0 C--O 1.24 0.601 0 CA-C-O 121.738 0.78 . . . . 75.0 109.627 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -143.8 102.04 3.85 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.234 -1.348 . . . . 71.11 107.995 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.29 -27.87 60.92 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-O 121.531 0.681 . . . . 72.12 109.939 170.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 170.2 -166.37 39.6 Favored Glycine 0 C--O 1.242 0.595 0 CA-C-N 114.472 -1.24 . . . . 75.35 110.194 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 61.41 -172.56 0.14 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.972 0.909 . . . . 73.11 112.341 175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.32 92.91 0.14 Allowed Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.738 -0.545 . . . . 71.14 111.738 177.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 14.2 t -134.36 146.74 50.2 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.218 0.607 . . . . 73.03 110.248 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.13 175.92 10.64 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.632 1.173 . . . . 74.32 109.788 178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -149.55 122.66 8.87 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.009 0.524 . . . . 64.42 109.881 178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . 0.468 ' HB3' ' HB2' ' D' ' 48' ' ' SER . 72.4 m80 -140.62 100.2 3.81 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.906 0.882 . . . . 73.45 108.854 176.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -161.38 116.03 2.03 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.308 0.643 . . . . 61.12 109.481 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -142.57 153.87 43.93 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 108.302 -0.999 . . . . 74.22 108.302 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.751 -0.642 . . . . 74.14 109.968 -176.925 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 110.158 -0.312 . . . . 70.3 110.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -71.76 91.96 1.17 Allowed 'General case' 0 C--O 1.24 0.578 0 O-C-N 123.632 0.582 . . . . 75.01 110.019 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.09 84.72 7.37 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 108.298 -1.001 . . . . 62.24 108.298 172.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -74.64 79.77 2.01 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 121.625 0.726 . . . . 71.14 109.445 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -168.87 -39.75 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.146 1.378 . . . . 73.42 108.999 -177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -63.76 -54.48 34.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.539 0.736 . . . . 74.34 110.62 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.598 ' HG2' ' H ' ' E' ' 115' ' ' LEU . 30.0 ttpt 67.46 -163.18 0.22 Allowed 'General case' 0 CA--C 1.564 1.491 0 C-N-CA 124.269 1.028 . . . . 73.54 110.316 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.598 ' H ' ' HG2' ' E' ' 114' ' ' LYS . 78.7 mt -92.57 36.44 1.01 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.559 0.744 . . . . 71.42 111.456 -176.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.67 71.32 15.43 Favored Pre-proline 0 CA--C 1.551 0.992 0 N-CA-C 109.178 -0.675 . . . . 70.04 109.178 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -93.64 4.15 3.06 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 123.084 2.523 . . . . 65.14 113.043 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -157.35 142.3 16.87 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 108.637 -0.875 . . . . 64.24 108.637 -174.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 98.2 m -100.32 -48.59 4.53 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.831 0.853 . . . . 64.35 110.846 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 73.9 t-105 65.42 88.89 0.1 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.805 1.242 . . . . 73.11 109.883 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -134.12 76.37 1.65 Allowed 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.571 -1.27 . . . . 72.51 107.571 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -167.38 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.696 -0.684 . . . . 55.32 111.267 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 31.2 t 55.55 80.21 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.021 0.928 . . . . 74.13 108.925 -159.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . 0.462 ' N ' HD21 ' B' ' 136' ' ' LEU . 48.1 ttt85 -74.22 75.24 1.81 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.88 0.872 . . . . 75.43 110.164 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -97.0 95.47 7.83 Favored 'General case' 0 C--O 1.223 -0.31 0 N-CA-C 108.355 -0.98 . . . . 72.44 108.355 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -94.77 6.73 48.1 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.572 0.749 . . . . 72.44 111.476 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -114.84 59.21 0.42 Allowed Glycine 0 C--N 1.348 1.216 0 N-CA-C 112.211 -0.355 . . . . 73.42 112.211 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -58.24 130.26 45.84 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 123.636 0.774 . . . . 64.11 111.334 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . 0.492 HD12 HD21 ' B' ' 42' ' ' LEU . 1.2 pp -139.51 -166.24 2.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.383 1.073 . . . . 74.42 109.596 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 12.2 tt -123.27 -45.66 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.353 0.661 . . . . 61.4 109.371 175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . 0.477 ' HA ' ' HB2' ' B' ' 129' ' ' ALA . . . -167.69 -169.06 1.1 Allowed 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.408 1.083 . . . . 74.21 109.103 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -65.75 134.88 95.36 Favored Pre-proline 0 CA--C 1.557 1.241 0 CA-C-O 117.928 -1.034 . . . . 73.14 108.837 169.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.68 87.04 0.04 OUTLIER 'Trans proline' 0 C--N 1.387 2.557 0 C-N-CA 123.389 2.726 . . . . 74.41 113.445 -176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 19.2 tt -174.89 124.19 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.263 1.425 . . . . 72.35 107.991 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.84 103.61 14.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.087 0.555 . . . . 64.13 110.544 -174.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 41.2 t -91.8 -9.4 10.13 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 C-N-CA 124.004 0.921 . . . . 71.15 109.877 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -78.08 76.09 4.6 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.936 1.294 . . . . 74.42 110.466 -175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.55 109.41 0.73 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.9 0.88 . . . . 62.23 109.632 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . 0.487 HD23 ' HB2' ' C' ' 126' ' ' LEU . 24.0 tp -165.89 133.71 2.92 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.522 0.729 . . . . 74.21 109.955 176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -139.73 -151.81 0.39 Allowed 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 -178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 76.6 mt 67.6 17.24 9.93 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.273 1.029 . . . . 63.33 112.154 175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . 0.729 ' HB ' HD21 ' C' ' 126' ' ' LEU . 6.7 tt -84.43 126.94 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.321 1.048 . . . . 75.22 109.129 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 54.9 89.56 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.895 0.878 . . . . 63.15 111.356 -176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -65.97 -22.8 66.49 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.456 -0.793 . . . . 74.25 110.052 173.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -97.66 -176.55 3.51 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.386 1.074 . . . . 74.31 111.094 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -83.37 -166.37 1.35 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.555 1.142 . . . . 73.34 110.871 176.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.49 169.64 17.89 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.215 1.006 . . . . 74.4 110.448 176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.417 HD13 ' H ' ' C' ' 132' ' ' ASN . 9.9 tt -85.01 112.45 43.32 Favored Pre-proline 0 CA--C 1.552 1.051 0 N-CA-C 109.15 -0.685 . . . . 74.12 109.15 176.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo . . . . . 0 C--N 1.38 2.235 0 C-N-CA 123.568 2.845 . . . . 63.25 112.247 174.566 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 109.725 -0.472 . . . . 74.21 109.725 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -133.29 8.12 3.96 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.006 0.922 . . . . 72.15 110.927 177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -165.01 101.95 0.76 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.244 0.617 . . . . 74.21 111.037 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 47.2 t80 66.19 121.73 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.248 1.819 . . . . 72.45 113.579 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -162.84 -79.41 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 106.7 -1.592 . . . . 74.51 106.7 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 54.24 90.37 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.254 1.422 . . . . 73.13 112.205 169.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 42.8 mttp -67.1 154.43 41.24 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.652 -0.704 . . . . 74.03 111.351 -174.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.83 -37.64 85.22 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.11 -0.7 . . . . 71.2 109.11 169.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -117.73 87.31 26.38 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 123.591 0.757 . . . . 74.52 109.633 176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -86.04 -70.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.85 2.367 . . . . 73.23 110.499 169.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 24.2 t80 58.75 92.04 0.04 OUTLIER 'General case' 0 C--N 1.363 1.184 0 C-N-CA 125.32 1.448 . . . . 71.44 111.779 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 2.0 m -64.25 -55.57 20.56 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.592 -0.731 . . . . 75.22 110.662 -175.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 50.91 43.53 28.6 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.909 1.284 . . . . 74.35 111.484 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -87.47 37.69 0.79 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.071 -1.422 . . . . 65.11 110.082 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.02 29.86 1.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.549 1.14 . . . . 25.13 110.214 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 17.4 m -60.58 118.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.418 0.687 . . . . 43.23 111.28 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -155.96 126.28 6.67 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.184 -0.462 . . . . 71.43 110.274 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -155.27 154.55 32.31 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.368 1.467 . . . . 74.35 108.042 177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -64.92 -69.32 0.3 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.77 0.428 . . . . 44.2 111.268 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 130.65 -98.81 0.41 Allowed Glycine 0 C--N 1.341 0.814 0 N-CA-C 110.948 -0.861 . . . . 72.13 110.948 -176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . 0.712 ' HG3' ' HB ' ' A' ' 40' ' ' VAL . 2.9 mppt? -81.89 157.45 24.35 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 109.924 -0.398 . . . . 70.11 109.924 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.445 HD22 ' HB ' ' C' ' 13' ' ' ILE . 1.0 OUTLIER -140.06 -8.62 1.18 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.873 0.869 . . . . 65.14 111.42 175.382 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 27.9 pt -68.91 137.13 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.101 0.56 . . . . 72.32 110.326 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.76 -55.37 0.73 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.088 0.555 . . . . 64.41 110.841 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -85.15 108.12 14.43 Favored Pre-proline 0 CA--C 1.551 1.017 0 N-CA-C 109.176 -0.676 . . . . 73.35 109.176 177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.33 73.55 0.26 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 123.392 2.728 . . . . 73.12 111.758 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.431 HG12 HG13 ' F' ' 136' ' ' VAL . 16.0 tt -62.89 125.84 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-N 116.141 -0.481 . . . . 75.22 110.403 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.19 96.2 2.73 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.302 0.641 . . . . 75.41 109.498 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.632 HG23 ' H ' ' F' ' 137' ' ' GLU . 2.8 m -127.56 -85.27 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.813 0.845 . . . . 72.1 110.544 -176.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . 0.632 ' H ' HG23 ' F' ' 136' ' ' VAL . 44.8 tt0 55.07 -80.76 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.5 1.52 . . . . 74.33 112.391 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -128.08 126.17 40.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.091 . . . . 71.33 108.972 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.58 119.17 9.32 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.244 1.018 . . . . 63.12 111.589 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . 0.438 ' HB2' ' HG3' ' D' ' 37' ' ' GLN . 18.8 m -93.25 170.23 9.79 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.991 0.916 . . . . 73.14 108.866 172.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 61.7 mt 67.56 11.26 8.28 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.6 1.16 . . . . 75.13 111.775 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 13.1 tt -87.05 125.22 40.92 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 C-N-CA 123.498 0.719 . . . . 44.54 109.22 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 13.6 t80 63.63 -176.05 0.16 Allowed 'General case' 0 CA--C 1.564 1.512 0 C-N-CA 124.205 1.002 . . . . 75.32 110.381 177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -103.02 -171.0 1.87 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.808 0.843 . . . . 75.11 109.53 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -98.76 32.88 2.45 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.683 -1.229 . . . . 64.51 107.683 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -76.55 -79.34 0.11 Allowed 'General case' 0 C--N 1.348 0.523 0 N-CA-C 108.954 -0.758 . . . . 71.14 108.954 177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 4.8 tt 50.54 75.52 0.18 Allowed 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.792 1.237 . . . . 71.34 109.825 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 pp -71.74 131.98 85.55 Favored Pre-proline 0 CA--C 1.551 0.99 0 CA-C-N 116.159 -0.473 . . . . 64.44 110.66 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo . . . . . 0 C--N 1.377 2.04 0 C-N-CA 122.756 2.304 . . . . 70.5 112.074 175.02 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtm . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.63 -0.507 . . . . 75.33 109.63 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -162.66 -70.71 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.033 0.933 . . . . 60.34 108.933 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -121.07 122.84 40.94 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.759 0.824 . . . . 73.31 108.838 178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 66.7 84.11 0.16 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.481 1.112 . . . . 71.2 110.925 178.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -107.25 92.22 3.98 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.226 -1.027 . . . . 64.13 108.226 170.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -136.72 -10.72 1.82 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.029 0.932 . . . . 71.05 110.671 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -95.56 -57.81 2.29 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 122.826 0.45 . . . . 70.14 110.534 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.24 -46.24 51.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.721 0.808 . . . . 73.11 111.783 -173.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.8 mtt -139.26 144.46 38.41 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.686 0.794 . . . . 74.22 109.255 174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.5 m -146.94 129.84 16.26 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.007 0.923 . . . . 61.12 109.47 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 20.8 p90 -139.09 114.47 9.7 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.298 -1.001 . . . . 74.42 108.298 168.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 85' ' ' SER . 96.5 mt-30 -133.66 122.35 23.31 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 109.216 -0.661 . . . . 72.34 109.216 -178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -82.27 88.93 1.98 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 N-CA-C 108.722 -0.844 . . . . 72.24 108.722 173.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -77.28 -41.22 41.72 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 116.119 -0.491 . . . . 74.22 111.882 -165.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -153.94 137.27 15.77 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.209 1.003 . . . . 73.55 108.293 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.657 HD13 ' HG3' ' C' ' 130' ' ' PRO . 4.4 mp -130.6 119.19 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 106.927 -1.509 . . . . 73.04 106.927 174.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -152.93 174.68 13.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.456 0.702 . . . . 74.31 111.521 -172.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.7 p -97.73 117.15 31.39 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.757 -0.831 . . . . 53.22 108.757 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 39.7 mtpt -80.73 -22.67 40.04 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.582 -0.281 . . . . 63.45 110.315 174.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 16.3 t70 -157.82 147.02 19.67 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 124.031 0.832 . . . . 74.02 109.637 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 94.7 mt -143.99 138.9 24.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 125.536 1.534 . . . . 43.15 106.944 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.2 t -153.64 108.39 3.12 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 122.955 0.502 . . . . 73.45 109.888 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.602 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 57.2 t80 -109.11 131.51 55.0 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 106.343 -1.725 . . . . 74.45 106.343 170.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -124.97 141.45 52.12 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.307 -0.627 . . . . 75.23 109.307 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.71 72.72 9.71 Favored Pre-proline 0 CA--C 1.544 0.744 0 N-CA-C 107.834 -1.173 . . . . 43.53 107.834 170.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.05 -25.46 19.37 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.433 2.089 . . . . 61.21 111.063 176.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.445 ' HA ' ' CD2' ' A' ' 30' ' ' HIS . 92.1 m-20 -104.61 26.15 9.41 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.895 0.878 . . . . 50.02 110.602 177.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.652 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.73 -49.0 93.93 Favored Pre-proline 0 CA--C 1.567 1.634 0 C-N-CA 123.359 0.664 . . . . 61.14 112.788 178.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.3 Cg_exo -70.02 -23.09 30.02 Favored 'Trans proline' 0 C--N 1.397 3.085 0 C-N-CA 121.779 1.653 . . . . 75.15 112.236 174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.445 ' CD2' ' HA ' ' A' ' 27' ' ' ASN . 9.4 m-70 -74.33 -21.07 59.88 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.617 -0.719 . . . . 75.31 111.271 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HE2' ' A' ' 123' ' ' PHE . 84.2 t -53.62 -25.8 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 112.625 0.602 . . . . 63.43 112.625 -174.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -67.67 -40.85 84.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.313 0.645 . . . . 65.32 111.487 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -89.99 -14.01 34.89 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.415 0.686 . . . . 71.24 111.305 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.6 mmpt? -75.27 146.09 41.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.808 0.443 . . . . 73.42 111.484 -178.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -73.25 118.46 16.23 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.296 -1.001 . . . . 72.12 108.296 174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -79.18 86.06 5.01 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.918 0.487 . . . . 72.32 111.039 -175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 35.1 tt0 -139.95 71.12 35.55 Favored Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 108.127 -1.064 . . . . 61.02 108.127 170.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -80.68 117.49 3.35 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.717 2.278 . . . . 44.42 112.073 -172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.72 110.72 22.81 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.166 -1.05 . . . . 71.42 108.166 171.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 65' ' ' THR . 15.7 m -82.69 92.7 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 CA-C-O 122.498 1.142 . . . . 73.43 109.528 175.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -94.49 130.52 40.85 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 114.293 -1.322 . . . . 74.11 108.567 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.479 HD11 ' HD2' ' F' ' 125' ' ' TYR . 2.7 pt? -124.64 151.3 45.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 122.798 0.439 . . . . 60.44 111.378 -170.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.3 m-20 -128.97 127.87 42.55 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.775 1.23 . . . . 71.33 108.483 178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' F' ' 123' ' ' VAL . 79.9 mt -118.22 133.86 55.52 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.106 0.562 . . . . 64.41 109.821 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.601 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 15.7 t70 -146.64 150.16 34.91 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.712 0.805 . . . . 75.25 109.666 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.0 m -142.02 127.22 18.59 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.887 0.875 . . . . 73.44 109.843 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.58 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -142.78 146.17 33.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.525 0.73 . . . . 63.32 109.767 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.8 m -105.7 169.98 8.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.618 0.767 . . . . 75.21 111.239 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.9 t -154.94 120.46 5.05 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.989 0.916 . . . . 35.51 108.829 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -77.81 114.57 16.8 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.964 -0.384 . . . . 62.04 109.964 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.6 mt -85.65 -40.71 15.89 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.605 0.762 . . . . 62.42 109.986 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.56 -174.62 4.87 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.333 -0.849 . . . . 75.4 110.144 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.3 117.26 6.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 109.31 -0.626 . . . . 74.11 109.31 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 71.96 2.53 4.34 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.934 1.293 . . . . 73.12 112.34 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.5 t -107.7 112.6 40.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.236 -1.024 . . . . 71.4 108.236 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -130.94 123.36 28.69 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.223 -0.658 . . . . 44.43 109.223 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' HB2' HD11 ' A' ' 51' ' ' LEU . 32.4 tt0 -88.28 140.9 29.0 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.856 0.862 . . . . 60.14 108.921 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 90.4 t -127.38 123.39 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.844 -1.169 . . . . 45.51 107.844 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.567 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 33.5 t -103.57 148.8 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.784 0.834 . . . . 54.12 109.82 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.68 117.6 26.14 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.407 -0.961 . . . . 73.3 108.407 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 1.7 mpp_? -88.93 106.87 18.69 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.38 -0.97 . . . . 71.12 108.38 171.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG21 ' HB1' ' A' ' 110' ' ' ALA . 7.7 t -111.17 114.11 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.144 -1.058 . . . . 65.42 108.144 169.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 27.5 m -110.41 130.55 55.53 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.095 -1.076 . . . . 71.02 108.095 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.1 t -129.16 108.18 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.105 -1.072 . . . . 63.04 108.105 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 16.1 m -110.67 133.86 52.95 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 109.908 -0.405 . . . . 73.43 109.908 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.47 105.31 15.16 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.097 -1.075 . . . . 52.44 108.097 171.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.8 m -118.06 127.16 53.53 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.155 0.582 . . . . 72.0 110.277 177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 0.8 OUTLIER -88.99 85.71 6.77 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.862 0.839 . . . . 73.51 109.05 177.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.34 -88.97 1.3 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.301 -0.863 . . . . 70.41 111.049 -176.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.21 -28.75 4.65 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.431 0.692 . . . . 75.52 110.804 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -79.04 134.15 36.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.71 0.804 . . . . 72.22 109.657 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.3 m -85.88 121.37 28.43 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.099 0.408 . . . . 71.44 110.591 178.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.65 -58.16 7.07 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.52 0.728 . . . . 42.23 109.645 172.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -164.27 162.18 22.34 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.434 -1.257 . . . . 73.42 110.564 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.2 tp -117.54 147.72 42.54 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.452 1.101 . . . . 72.13 109.776 176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.51 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 61.9 m -140.85 100.15 3.77 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 124.206 1.002 . . . . 72.34 109.482 173.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -125.99 126.56 44.51 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.132 0.973 . . . . 74.41 109.176 -173.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -136.69 138.78 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.389 0.676 . . . . 51.42 109.764 -178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -105.52 96.84 6.79 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.577 172.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -84.56 98.94 10.43 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 109.109 -0.701 . . . . 71.11 109.109 177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -112.39 144.96 17.96 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 111.606 -0.598 . . . . 71.04 111.606 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.87 146.79 17.9 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 112.374 -0.29 . . . . 64.02 112.374 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 64.3 mt -82.69 128.06 39.08 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 108.692 -0.855 . . . . 45.24 108.692 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -128.92 118.16 22.2 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.323 -0.621 . . . . 73.05 109.323 176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 20.5 m -83.54 87.04 7.01 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.471 -0.937 . . . . 74.21 108.471 176.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -115.96 138.49 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.849 0.859 . . . . 74.2 110.023 -176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.07 161.28 12.53 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.931 0.893 . . . . 64.31 110.881 -174.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.84 4.24 85.24 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 115.738 -0.665 . . . . 54.52 114.665 172.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.572 ' HB ' ' HE2' ' A' ' 94' ' ' MET . 46.2 mt -119.52 136.48 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 N-CA-C 108.019 -1.104 . . . . 63.34 108.019 -176.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.97 174.69 10.44 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.175 0.59 . . . . 74.23 109.812 -175.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.86 -144.75 49.24 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-N 115.239 -0.891 . . . . 73.43 113.579 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.623 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 41.2 p -71.21 -15.07 62.44 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.322 1.049 . . . . 73.45 112.318 -176.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -63.56 -50.9 67.67 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.286 0.634 . . . . 71.42 110.424 175.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.572 ' HE2' ' HB ' ' A' ' 89' ' ' ILE . 56.1 tpp -83.14 -29.03 28.97 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.887 0.475 . . . . 70.32 111.054 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -62.21 -28.1 69.45 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.324 0.583 . . . . 63.1 110.83 172.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -68.81 -54.68 14.47 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 114.862 -1.063 . . . . 72.15 109.78 166.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 4.2 m -64.46 -56.87 11.34 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.593 1.331 . . . . 73.5 114.593 -166.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.558 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 77.9 mt -69.71 -15.86 63.23 Favored 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.635 0.652 . . . . 71.4 112.3 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.55 -0.27 43.15 Favored Glycine 0 C--N 1.35 1.345 0 CA-C-O 119.703 -0.498 . . . . 31.5 113.903 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.529 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -147.59 -65.91 0.26 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.049 0.54 . . . . 43.12 111.358 -177.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.7 t80 -51.65 -52.95 43.86 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 124.779 1.232 . . . . 70.23 112.818 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 65.3 m -73.24 -48.48 7.41 Favored Pre-proline 0 CA--C 1.555 1.153 0 CA-C-O 118.309 -0.853 . . . . 72.12 112.644 -174.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -62.54 -20.21 69.99 Favored 'Trans proline' 0 C--N 1.383 2.351 0 CA-C-N 121.153 1.448 . . . . 70.31 113.337 170.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.24 -41.84 80.58 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 123.452 0.701 . . . . 74.31 110.407 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -61.91 -37.35 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.432 0.693 . . . . 53.21 110.452 174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.2 mt -81.69 -26.36 34.73 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 115.357 -0.838 . . . . 72.11 112.133 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -62.56 -44.34 86.79 Favored Pre-proline 0 CA--C 1.566 1.568 0 N-CA-C 114.896 1.443 . . . . 74.2 114.896 -169.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.64 -39.48 43.55 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 121.884 1.723 . . . . 73.34 112.306 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -73.69 -31.32 63.36 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.416 0.687 . . . . 75.0 111.369 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.403 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -64.51 -51.77 61.23 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.327 0.651 . . . . 33.42 109.342 174.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.483 HH12 HD12 ' C' ' 105' ' ' ILE . 39.2 ttm180 -52.43 -51.5 58.88 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.477 -1.238 . . . . 72.42 110.966 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.19 -46.84 85.22 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.589 -0.732 . . . . 74.2 111.62 -175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.468 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.8 t -57.95 -38.92 76.86 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.599 0.562 . . . . 72.53 111.335 -179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.494 HG23 ' HB3' ' A' ' 76' ' ' CYS . 95.9 mt -67.65 -52.65 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.231 1.012 . . . . 64.54 110.796 175.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.474 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -60.89 -34.0 73.97 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.495 1.118 . . . . 52.54 111.673 -175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.3 t -69.48 -39.97 77.37 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.585 -0.734 . . . . 73.25 109.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.602 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.8 mtm -63.51 -38.66 91.99 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 122.627 0.371 . . . . 74.24 110.781 176.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG22 ' SG ' ' A' ' 76' ' ' CYS . 81.3 t -59.66 -49.65 82.93 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 123.829 0.851 . . . . 63.32 110.622 177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.0 p -71.07 -34.09 70.84 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 116.022 -0.535 . . . . 73.21 111.638 -176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -68.8 -30.73 69.36 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.508 0.723 . . . . 64.14 109.873 174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.66 -1.12 90.06 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.595 -0.729 . . . . 62.23 112.777 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.0 m 65.33 46.45 2.6 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 122.831 1.3 . . . . 64.3 110.194 177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG21 ' A' ' 31' ' ' VAL . 59.6 m-85 -121.16 149.67 52.06 Favored Pre-proline 0 C--O 1.241 0.641 0 CA-C-N 114.29 -1.323 . . . . 74.3 109.095 173.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.99 140.1 91.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.395 2.063 . . . . 62.52 111.41 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.474 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -51.14 134.97 26.41 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.669 1.188 . . . . 70.13 113.315 -174.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.412 HD22 HG11 ' A' ' 40' ' ' VAL . 86.8 mt -121.11 100.98 7.37 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.081 0.952 . . . . 73.02 108.762 176.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -117.29 105.02 11.74 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 55.24 109.542 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.26 150.72 44.96 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 64.32 109.509 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.24 142.82 93.23 Favored Pre-proline 0 N--CA 1.473 0.719 0 C-N-CA 123.62 0.768 . . . . 53.41 111.608 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -65.23 115.47 3.34 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.075 1.85 . . . . 64.34 110.74 170.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 40.6 t -98.64 113.07 32.33 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 107.806 -1.183 . . . . 64.31 107.806 -175.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -82.71 72.89 9.78 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 122.5 1.143 . . . . 72.2 108.221 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -70.59 -20.91 62.73 Favored 'General case' 0 C--O 1.242 0.67 0 CA-C-N 113.522 -1.672 . . . . 74.22 109.647 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.529 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.4 t70 -59.01 -47.3 85.68 Favored 'General case' 0 C--N 1.347 0.464 0 C-N-CA 124.184 0.994 . . . . 71.24 109.922 176.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.33 -30.83 69.77 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.275 0.985 . . . . 75.31 112.347 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 54.6 tp -58.5 -49.27 77.99 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.722 0.409 . . . . 63.35 111.206 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -85.79 -28.33 24.6 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.169 -0.469 . . . . 72.14 110.678 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.573 ' SD ' HD23 ' A' ' 141' ' ' LEU . 13.0 tpt -66.9 -30.08 70.13 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.638 0.375 . . . . 71.54 111.23 -177.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 91.4 m-20 -61.5 -35.31 77.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.174 0.589 . . . . 70.2 110.915 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -79.04 -36.83 40.41 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.913 -0.585 . . . . 72.35 110.393 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.573 HD23 ' SD ' ' A' ' 138' ' ' MET . 47.6 tp -67.97 -49.86 59.19 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 124.162 0.985 . . . . 61.25 112.124 -172.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -159.9 15.35 0.14 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.113 0.565 . . . . 73.03 110.256 -173.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.0 OUTLIER 57.98 -90.07 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.367 1.067 . . . . 74.11 111.363 -173.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -156.04 113.21 3.21 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 108.737 -0.838 . . . . 73.0 108.737 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.07 165.0 2.86 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.612 1.165 . . . . 70.41 110.005 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' C' ' 140' ' ' TYR . . . 91.99 121.64 2.8 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-O 119.783 -0.454 . . . . 63.22 112.196 176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -105.05 100.54 10.13 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 117.665 0.733 . . . . 73.21 109.621 -179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.65 76.94 1.81 Allowed Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.462 -1.055 . . . . 61.14 110.462 172.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.8 m -118.36 107.54 13.98 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.678 0.791 . . . . 70.22 110.471 -173.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -160.27 84.77 0.72 Allowed 'General case' 0 C--O 1.241 0.608 0 N-CA-C 108.057 -1.09 . . . . 60.25 108.057 176.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.432 ' HG2' ' HE1' ' C' ' 133' ' ' PHE . 36.2 mt-10 -76.93 91.94 3.63 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 115.31 -0.859 . . . . 74.1 109.226 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -89.28 145.03 25.65 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.361 1.064 . . . . 74.4 109.973 -172.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -78.02 91.22 4.23 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.983 -0.747 . . . . 74.3 108.983 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -101.26 132.51 46.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.21 1.004 . . . . 74.14 110.031 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.562 ' H ' ' HD3' ' E' ' 145' ' ' LYS . . . . . . . . 0 N--CA 1.486 1.358 0 C-N-CA 124.113 0.965 . . . . 73.24 110.327 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtm . . . . . 0 N--CA 1.482 1.152 0 N-CA-C 109.938 -0.393 . . . . 73.55 109.938 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -146.12 132.55 19.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.616 -0.883 . . . . 53.22 108.616 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -93.55 159.49 15.21 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.322 0.649 . . . . 74.43 111.226 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -123.16 87.25 2.72 Favored 'General case' 0 C--O 1.241 0.633 0 N-CA-C 108.108 -1.071 . . . . 75.45 108.108 172.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -110.41 167.29 10.31 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.521 0.729 . . . . 40.42 110.316 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -76.31 135.8 39.58 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 108.114 -1.069 . . . . 54.33 108.114 166.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -67.0 -28.86 68.59 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 122.706 0.403 . . . . 71.24 111.024 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 67.73 -70.86 0.11 Allowed 'General case' 0 C--N 1.362 1.136 0 C-N-CA 125.535 1.534 . . . . 71.21 110.496 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.535 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 12.0 ptm 58.58 -178.22 0.08 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 126.158 1.783 . . . . 75.44 113.036 177.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 8.5 t -165.22 142.84 6.0 Favored 'General case' 0 C--O 1.248 0.991 0 N-CA-C 108.068 -1.086 . . . . 70.03 108.068 174.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -139.51 134.41 32.2 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.808 -0.812 . . . . 74.32 108.808 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -149.37 143.78 25.99 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.126 0.57 . . . . 60.25 110.195 177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.87 122.98 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 107.623 -1.251 . . . . 72.23 107.623 170.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -85.82 -42.84 13.8 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.514 -0.55 . . . . 74.22 109.514 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -166.25 134.35 2.87 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 116.159 -0.473 . . . . 75.23 109.894 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 86.3 mt -114.9 134.53 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 N-CA-C 107.149 -1.426 . . . . 71.4 107.149 171.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -162.4 154.48 18.85 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.659 0.742 . . . . 73.4 112.093 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.5 m -80.51 127.3 32.27 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.421 -1.263 . . . . 61.32 108.676 169.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -97.31 -32.36 11.93 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.999 0.919 . . . . 33.21 110.884 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -160.07 143.47 13.96 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 123.176 0.297 . . . . 54.3 110.562 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.484 HD12 HG22 ' B' ' 78' ' ' VAL . 48.3 mm -136.68 138.0 46.83 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 C-N-CA 125.038 1.335 . . . . 75.45 108.616 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.0 t -134.7 139.5 45.27 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.103 -1.443 . . . . 74.43 107.103 173.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.1 t80 -153.33 112.57 3.79 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 106.322 -1.733 . . . . 72.54 106.322 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -124.41 112.8 17.35 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.146 -0.687 . . . . 61.2 109.146 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -108.51 83.17 1.88 Allowed Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 108.293 -1.003 . . . . 52.2 108.293 174.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.67 -12.19 15.19 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.698 2.265 . . . . 71.05 112.079 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.424 ' O ' HG23 ' B' ' 31' ' ' VAL . 75.2 m-20 -125.57 24.19 7.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.973 0.909 . . . . 75.55 109.436 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.466 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.33 -52.55 35.09 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.351 1.241 . . . . 73.04 114.351 -174.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.74 -10.77 20.12 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.089 1.86 . . . . 71.54 113.625 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -94.16 -25.56 17.06 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.731 0.813 . . . . 73.15 111.075 -177.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 27' ' ' ASN . 88.7 t -75.31 -19.16 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 C-N-CA 123.838 0.855 . . . . 55.42 110.43 174.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -51.91 -42.25 62.61 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.632 1.173 . . . . 74.04 112.423 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -81.84 -12.71 58.37 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.265 0.626 . . . . 74.44 112.016 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -98.02 100.48 11.81 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.74 0.816 . . . . 63.22 110.843 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -89.05 78.1 7.5 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.658 0.783 . . . . 74.54 110.621 -176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.698 ' HB2' HD21 ' B' ' 68' ' ' LEU . 14.8 m-90 -150.41 161.55 42.29 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.236 1.015 . . . . 75.03 108.635 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -77.75 112.15 22.7 Favored Pre-proline 0 CA--C 1.547 0.861 0 N-CA-C 108.293 -1.002 . . . . 73.44 108.293 171.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 31.3 Cg_endo -62.36 117.99 4.87 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.637 2.225 . . . . 73.01 111.313 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -61.0 115.48 3.77 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 123.853 0.721 . . . . 73.43 110.816 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.529 HG21 HD21 ' B' ' 126' ' ' LEU . 27.5 m -97.49 136.75 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.849 0.833 . . . . 73.14 112.236 -177.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -114.09 114.06 25.57 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.999 1.32 . . . . 64.44 108.036 167.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.419 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -115.66 140.5 49.13 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.469 -0.567 . . . . 53.33 109.469 179.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -131.87 147.14 52.46 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.684 0.794 . . . . 64.43 110.175 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.1 mp -99.24 131.73 45.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.825 -1.079 . . . . 64.41 108.32 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.51 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 16.1 t70 -126.13 140.83 52.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 107.993 -1.114 . . . . 73.21 107.993 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -121.36 143.74 49.04 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.244 0.545 . . . . 75.01 110.422 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.81 157.9 43.65 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.502 1.121 . . . . 71.44 108.084 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 67.3 m -142.4 168.04 20.67 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.584 0.707 . . . . 42.22 109.676 174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' B' ' 57' ' ' GLU . 41.4 t -150.94 157.36 42.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.207 -1.36 . . . . 74.0 107.352 177.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -121.0 115.86 23.98 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.34 -0.615 . . . . 75.52 109.34 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 68.8 mt -90.02 -35.46 15.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.402 0.681 . . . . 75.11 109.494 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.63 177.29 11.64 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 72.44 110.212 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -63.46 125.19 23.38 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.949 -0.76 . . . . 74.21 108.949 171.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 70.85 0.03 3.19 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 124.904 1.282 . . . . 71.33 112.826 -176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.7 t -112.62 96.11 4.41 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 C-N-CA 123.716 0.806 . . . . 72.33 108.951 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.41 ' CD1' HD11 ' B' ' 86' ' ' ILE . 18.5 m-85 -111.24 139.57 46.53 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-O 121.505 0.669 . . . . 73.4 110.359 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' B' ' 49' ' ' SER . 7.1 tm-20 -103.59 97.09 7.18 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 107.165 -1.42 . . . . 72.43 107.165 177.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.5 t -95.52 121.69 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.604 0.761 . . . . 75.54 109.419 -175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 13.9 t -102.44 135.74 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.438 0.695 . . . . 64.25 109.916 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.69 117.83 31.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 106.35 -1.722 . . . . 71.12 106.35 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.51 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.6 ttp180 -112.43 113.54 25.78 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.871 0.367 . . . . 73.34 110.057 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 57.3 t -104.23 106.32 20.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.533 -1.284 . . . . 60.23 107.533 172.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.6 m -99.22 123.94 43.9 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 109.552 -0.536 . . . . 73.1 109.552 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.663 HG21 HG21 ' B' ' 114' ' ' ILE . 63.4 t -114.15 129.54 69.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 114.945 -1.025 . . . . 73.13 109.222 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 92.5 m -119.28 143.33 47.4 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.468 -1.308 . . . . 74.24 107.468 172.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -133.62 140.02 46.86 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 109.46 -0.571 . . . . 63.32 109.46 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 44.4 p -135.95 128.82 31.18 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.857 . . . . 73.41 108.899 177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.698 HD21 ' HB2' ' B' ' 36' ' ' TRP . 2.4 tt -117.54 120.72 38.94 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 107.455 -1.313 . . . . 74.35 107.455 178.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.26 -110.8 3.11 Favored Glycine 0 C--N 1.341 0.811 0 O-C-N 123.896 0.747 . . . . 64.5 111.958 -178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -116.39 3.13 13.27 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.141 0.976 . . . . 73.15 111.411 -174.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -137.12 168.54 19.41 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.268 0.627 . . . . 74.2 111.441 -173.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.0 m -67.06 120.87 14.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.062 -0.972 . . . . 74.12 110.481 173.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -75.49 -53.38 8.75 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 123.307 0.643 . . . . 74.14 109.508 176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -163.98 170.84 16.08 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.369 -1.287 . . . . 73.34 109.735 175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.88 154.25 45.71 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.889 1.275 . . . . 75.53 107.724 177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -157.59 154.2 28.09 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.336 -0.616 . . . . 74.4 109.336 178.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.5 tt0 -164.56 130.59 2.89 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.573 -0.899 . . . . 72.12 108.573 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.484 HG22 HD12 ' B' ' 21' ' ' ILE . 94.5 t -125.62 142.34 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 N-CA-C 109.136 -0.69 . . . . 71.22 109.136 173.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 48.9 mt-30 -117.39 99.67 7.16 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 107.609 -1.256 . . . . 75.35 107.609 169.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.2 tp-100 -91.44 100.2 13.02 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.169 -1.049 . . . . 74.12 108.169 173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -97.38 143.41 16.71 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 110.86 -0.896 . . . . 75.44 110.86 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.92 127.26 3.35 Favored Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 110.969 -0.852 . . . . 71.1 110.969 -175.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.16 131.22 35.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.96 -1.126 . . . . 74.42 107.96 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -135.19 142.62 46.11 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.664 0.785 . . . . 64.44 110.703 -173.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 19.3 m -90.68 105.77 18.05 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.349 -0.982 . . . . 63.13 108.349 169.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.41 HD11 ' CD1' ' B' ' 56' ' ' TYR . 1.6 pp -117.58 108.65 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 123.547 0.739 . . . . 41.32 110.19 -177.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -140.48 157.94 44.75 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.581 0.752 . . . . 50.32 110.6 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.535 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 103.2 -71.3 0.29 Allowed Glycine 0 C--N 1.348 1.203 0 CA-C-N 115.835 -0.62 . . . . 74.32 112.3 174.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -73.6 158.35 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 122.691 0.396 . . . . 62.44 110.444 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -152.22 -176.32 5.63 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.478 0.711 . . . . 73.23 110.131 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.2 -131.52 50.0 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.584 0.552 . . . . 64.15 113.019 176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 11.8 m -67.55 -24.27 65.51 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 123.593 0.757 . . . . 54.44 111.456 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -73.71 -37.15 65.25 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.312 0.645 . . . . 74.31 110.957 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 56.3 tpp -73.93 -31.5 63.08 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 109.77 -0.456 . . . . 71.32 109.77 174.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.539 ' HA ' ' HD1' ' E' ' 116' ' ' TYR . . . -65.63 -36.22 83.08 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.748 -0.66 . . . . 63.21 111.049 174.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.8 t60 -75.46 -36.45 60.67 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.5 0.72 . . . . 73.32 110.35 177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -63.82 -59.01 5.09 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.203 0.601 . . . . 72.54 111.021 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' E' ' 116' ' ' TYR . 7.0 mp -75.88 -18.72 59.31 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 73.24 110.949 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.05 1.2 67.46 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-O 119.672 -0.516 . . . . 54.34 114.184 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.417 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -153.69 -60.05 0.13 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 117.775 0.787 . . . . 60.11 112.518 -176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -65.91 -45.56 81.51 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.92 0.888 . . . . 73.42 111.335 -171.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 64.4 m -68.45 -49.88 29.47 Favored Pre-proline 0 CA--C 1.566 1.571 0 CA-C-N 115.442 -0.799 . . . . 53.5 112.187 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.39 -22.41 52.47 Favored 'Trans proline' 0 C--N 1.389 2.675 0 C-N-CA 121.634 1.556 . . . . 54.3 113.799 173.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -62.38 -37.64 86.52 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.259 0.552 . . . . 70.04 110.859 176.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.93 -40.71 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.342 1.057 . . . . 71.2 110.871 174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 55.6 mt -80.98 -18.65 46.21 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.289 -0.869 . . . . 71.22 111.915 -173.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -59.55 -48.03 96.48 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.571 1.323 . . . . 65.52 114.571 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -62.49 -31.66 80.41 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 121.596 1.531 . . . . 70.43 112.985 177.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.9 m-85 -68.26 -46.93 69.11 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.483 0.713 . . . . 65.43 110.817 176.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -57.64 -43.66 85.02 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.42 -0.809 . . . . 74.32 110.071 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 20.7 mtp-105 -51.26 -64.32 0.85 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.224 1.01 . . . . 72.55 111.434 175.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -61.54 -28.99 69.71 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.625 0.77 . . . . 64.21 110.842 -172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -71.48 -44.91 63.86 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.829 0.451 . . . . 45.13 110.574 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.663 HG21 HG21 ' B' ' 64' ' ' VAL . 57.0 mt -62.94 -51.26 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 123.61 0.764 . . . . 64.51 109.979 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.0 m -59.52 -37.7 79.02 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 114.944 -1.026 . . . . 72.41 111.041 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 36.7 t -60.65 -52.23 66.03 Favored 'General case' 0 C--N 1.349 0.552 0 CA-C-N 115.581 -0.736 . . . . 65.1 110.063 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.0 mmt -63.75 -38.84 92.61 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.174 0.589 . . . . 71.43 111.151 -175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 114' ' ' ILE . 83.2 t -60.6 -45.44 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.537 0.735 . . . . 72.32 110.739 175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 42.6 t -69.5 -27.81 65.51 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.265 -0.88 . . . . 74.12 112.019 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.468 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 90.7 mtt-85 -68.9 -34.41 75.35 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.488 0.715 . . . . 70.3 110.222 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.2 7.72 55.28 Favored Glycine 0 C--N 1.353 1.483 0 O-C-N 123.823 0.702 . . . . 72.35 112.842 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.7 p 55.78 32.01 18.68 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.111 1.764 . . . . 51.2 112.078 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -93.57 157.55 38.24 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.978 0.911 . . . . 71.15 109.985 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -47.73 147.4 7.08 Favored 'Trans proline' 0 C--N 1.388 2.619 0 C-N-CA 123.82 3.013 . . . . 64.43 114.287 177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.628 HE22 ' HB2' ' B' ' 127' ' ' ASN . 21.7 tm0? -62.26 129.75 42.17 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.583 0.753 . . . . 73.43 109.721 -177.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.529 HD21 HG21 ' B' ' 40' ' ' VAL . 2.2 tm? -126.09 111.18 14.37 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.407 -0.59 . . . . 65.13 109.407 -178.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.628 ' HB2' HE22 ' B' ' 125' ' ' GLN . 41.0 t30 -111.02 134.81 52.33 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.267 1.027 . . . . 64.22 109.374 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.599 HD11 HD12 ' B' ' 114' ' ' ILE . 36.9 mt -87.46 134.77 33.55 Favored 'General case' 0 C--O 1.245 0.852 0 N-CA-C 109.296 -0.631 . . . . 73.25 109.296 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.41 148.52 85.95 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 123.17 0.588 . . . . 72.05 110.087 174.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.34 99.82 0.12 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.914 2.41 . . . . 62.11 112.518 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -90.38 110.46 22.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.883 -1.154 . . . . 74.32 107.883 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -69.6 101.79 1.71 Allowed 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.067 -0.716 . . . . 65.53 109.067 174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.417 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 48.6 m-85 -56.65 -33.93 66.81 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.503 1.121 . . . . 72.4 110.112 176.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -64.64 -63.76 1.04 Allowed 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.017 -1.447 . . . . 74.42 111.247 176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -26.42 68.59 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.446 0.699 . . . . 52.32 111.708 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.5 tt -57.86 -52.36 65.81 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.912 0.885 . . . . 72.34 109.759 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.461 ' HE1' ' HB3' ' E' ' 122' ' ' ALA . 27.9 t80 -91.35 -29.87 16.86 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.35 -0.841 . . . . 73.44 112.199 -170.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 33.4 mmt -75.49 -29.65 59.62 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.798 0.439 . . . . 72.3 111.176 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -76.35 -28.57 56.89 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.909 -0.404 . . . . 73.34 109.909 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -70.01 -25.57 63.65 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 116.041 -0.527 . . . . 73.23 110.217 174.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 61.4 mt -117.96 35.46 4.71 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.22 1.008 . . . . 64.34 110.236 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -57.08 109.79 0.71 Allowed 'General case' 0 CA--C 1.549 0.905 0 CA-C-O 120.856 0.36 . . . . 74.02 110.379 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -158.84 -0.03 0.09 Allowed 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.84 0.856 . . . . 70.12 109.764 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.77 112.58 6.61 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 108.069 -1.086 . . . . 73.3 108.069 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.01 150.21 34.23 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.975 0.91 . . . . 72.35 109.174 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.04 91.8 0.28 Allowed Glycine 0 C--N 1.342 0.908 0 O-C-N 123.137 0.273 . . . . 54.31 112.456 -176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -80.64 128.54 33.73 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.224 0.609 . . . . 64.3 110.119 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.45 -144.11 16.31 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-O 119.919 -0.378 . . . . 73.01 112.299 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 35.4 m 63.49 90.93 0.08 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.8 1.24 . . . . 71.25 111.475 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.54 48.13 2.28 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.759 0.824 . . . . 72.31 109.754 177.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' D' ' 2' ' ' SER . 37.4 tt0 -47.31 120.29 3.11 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.928 1.291 . . . . 73.33 112.528 -177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -142.11 78.74 1.64 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.463 -0.94 . . . . 75.11 108.463 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -114.67 112.73 23.32 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.108 0.963 . . . . 73.33 108.918 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -141.34 139.48 33.59 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.811 0.845 . . . . 73.22 109.718 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.242 0 C-N-CA 123.348 0.659 . . . . 74.45 109.512 -176.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 1.007 0 N-CA-C 109.982 -0.377 . . . . 72.14 109.982 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m -78.47 80.1 4.87 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.952 -0.759 . . . . 73.42 108.952 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -72.07 96.35 1.74 Allowed 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.195 -0.911 . . . . 70.21 110.358 -174.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 67.07 100.56 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.78 1.232 . . . . 71.14 111.546 176.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -136.97 162.21 33.91 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.493 0.717 . . . . 75.13 109.241 178.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -126.41 118.24 24.59 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.639 0.776 . . . . 62.23 109.095 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' C' ' 143' ' ' GLN . 23.2 p -117.88 106.21 12.74 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.901 0.88 . . . . 52.32 109.742 178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.5 ' HG3' ' H ' ' C' ' 9' ' ' MET . 7.4 pt-20 -60.69 -68.01 0.34 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 122.976 0.51 . . . . 61.44 111.365 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.5 ' H ' ' HG3' ' C' ' 8' ' ' GLU . 27.9 ttt 52.65 111.93 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.75 1.62 . . . . 74.05 113.509 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -99.0 111.5 23.89 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.903 0.881 . . . . 73.13 108.832 171.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.641 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 58.3 t80 -119.03 130.72 55.8 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.395 -0.965 . . . . 71.41 108.395 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -144.79 133.54 22.31 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.619 0.367 . . . . 73.13 110.218 178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.436 HD13 ' CE2' ' C' ' 84' ' ' PHE . 5.7 tp -83.96 134.38 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 123.389 0.676 . . . . 62.33 109.309 171.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.446 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 25.0 mm-40 -101.99 -47.28 4.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.654 0.782 . . . . 74.01 109.556 176.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 36.5 ttt85 -168.95 138.85 2.25 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.959 0.503 . . . . 72.32 110.899 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 60.9 mt -111.01 148.03 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.55 1.14 . . . . 71.5 108.131 170.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -177.23 164.23 2.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.289 0.636 . . . . 74.13 110.692 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.2 p -84.57 119.08 24.79 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.649 -0.871 . . . . 62.42 108.649 174.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.537 ' HE2' ' HD3' ' D' ' 29' ' ' PRO . 25.1 mmtp -73.0 -48.2 38.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.446 -0.946 . . . . 64.11 108.446 168.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.641 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.0 t70 -136.92 144.08 43.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.22 -1.355 . . . . 73.0 110.093 -172.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 83.4 mt -139.53 142.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.023 -1.473 . . . . 71.11 107.023 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -156.01 149.52 24.81 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 121.046 0.45 . . . . 65.2 110.453 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.88 108.51 3.48 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 107.815 -1.18 . . . . 75.44 107.815 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -117.41 110.82 18.5 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.234 -0.654 . . . . 64.15 109.234 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' C' ' 28' ' ' ALA . . . -112.91 93.85 26.62 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 108.664 -0.865 . . . . 54.23 108.664 175.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -64.67 -35.13 48.42 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.879 2.386 . . . . 73.15 112.118 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 50.2 m-20 -108.41 36.91 2.65 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 115.361 -0.836 . . . . 75.45 109.379 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' C' ' 25' ' ' ALA . . . -58.85 -45.98 99.57 Favored Pre-proline 0 CA--C 1.563 1.479 0 N-CA-C 114.305 1.224 . . . . 70.32 114.305 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.51 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 24.1 Cg_exo -68.79 -37.3 12.07 Favored 'Trans proline' 0 C--N 1.389 2.699 0 CA-C-N 121.305 1.502 . . . . 75.12 112.678 171.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -66.84 -18.31 65.32 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.071 0.948 . . . . 72.52 112.771 -174.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.593 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 12.1 p -41.72 -38.18 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 115.397 1.628 . . . . 70.45 115.397 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -65.4 -31.0 71.88 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-O 121.226 0.536 . . . . 74.22 111.625 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -110.31 15.4 22.31 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.086 0.954 . . . . 75.21 111.953 -174.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 0.1 OUTLIER -89.96 174.96 7.38 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 118.326 0.512 . . . . 72.15 110.06 178.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.425 ' HB3' HD22 ' C' ' 68' ' ' LEU . 24.6 t0 -87.98 108.93 19.45 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 109.005 -0.739 . . . . 72.52 109.005 174.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.5 p90 -84.37 68.2 10.14 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 122.242 1.02 . . . . 74.13 112.034 -174.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -161.84 44.2 0.13 Allowed Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 114.898 -1.046 . . . . 64.12 109.656 171.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.08 170.21 20.12 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 121.434 1.423 . . . . 64.11 112.2 -168.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -84.73 93.0 8.35 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.928 -1.138 . . . . 72.43 107.928 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.474 HG11 HD21 ' C' ' 126' ' ' LEU . 46.3 t -77.4 95.72 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 107.552 -1.277 . . . . 74.01 107.552 174.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.6 109.43 21.5 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.839 -1.073 . . . . 75.44 108.304 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.67 164.5 16.75 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.962 -0.563 . . . . 64.4 110.432 178.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.464 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 25.7 t70 -147.49 138.33 23.48 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 108.074 -1.084 . . . . 74.54 108.074 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.51 141.31 46.68 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -152.69 141.81 21.36 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.124 -0.695 . . . . 73.31 109.124 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.403 HG21 ' HA2' ' C' ' 99' ' ' GLY . 12.7 t -114.69 136.28 53.23 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.939 -0.763 . . . . 54.45 108.939 173.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.58 160.43 21.79 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.94 0.896 . . . . 45.3 108.633 172.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -141.91 147.22 36.73 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 122.748 0.419 . . . . 64.01 110.272 -178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.9 t -153.95 132.29 11.98 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.491 0.716 . . . . 75.44 109.682 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -78.29 117.65 19.75 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 109.001 -0.74 . . . . 72.12 109.001 174.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.638 HD11 ' HB2' ' C' ' 57' ' ' GLU . 74.1 mt -87.24 -45.48 10.59 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.463 0.705 . . . . 71.22 109.259 176.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.51 -170.99 3.76 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.536 -0.757 . . . . 71.42 110.781 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -61.39 107.09 0.72 Allowed 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.248 -0.887 . . . . 60.04 109.987 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 73.46 -0.82 3.25 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.452 1.501 . . . . 71.52 112.562 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.05 115.5 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 N-CA-C 108.741 -0.837 . . . . 73.03 108.741 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -129.73 125.52 36.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.875 0.87 . . . . 63.24 109.267 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.638 ' HB2' HD11 ' C' ' 51' ' ' LEU . 39.9 tt0 -83.9 143.13 30.07 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.768 0.427 . . . . 62.33 110.671 173.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.8 t -117.49 122.95 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 107.507 -1.294 . . . . 60.13 107.507 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -106.12 106.38 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 108.429 -0.952 . . . . 75.11 108.429 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -97.27 105.92 18.15 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.415 0.686 . . . . 71.21 109.487 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -81.71 131.67 35.27 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.472 -0.785 . . . . 72.03 110.283 172.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 28.1 t -124.09 122.87 65.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 107.089 -1.449 . . . . 65.34 107.089 163.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.464 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.9 m -119.49 145.13 46.58 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.202 -1.036 . . . . 74.45 108.202 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.05 108.42 13.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.564 -1.272 . . . . 72.34 107.564 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.5 m -104.12 111.5 24.11 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.676 -0.861 . . . . 72.23 108.676 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.45 106.22 16.62 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 106.337 -1.727 . . . . 65.05 106.337 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.4 m -151.18 133.06 15.05 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.692 0.397 . . . . 64.23 109.968 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.425 HD22 ' HB3' ' C' ' 35' ' ' ASP . 30.9 tp -67.82 -48.15 67.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.176 0.59 . . . . 63.35 110.464 176.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.16 -73.76 0.04 OUTLIER Glycine 0 C--N 1.345 1.073 0 N-CA-C 110.144 -1.183 . . . . 54.43 110.144 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -101.03 -31.49 11.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.398 0.679 . . . . 75.44 109.28 170.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -73.4 101.13 3.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.693 0.797 . . . . 72.15 109.741 173.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -83.39 130.02 35.02 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.632 -0.507 . . . . 63.12 109.632 173.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.681 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -73.15 -66.56 0.66 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.11 -1.071 . . . . 73.42 108.11 167.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -161.62 174.75 12.88 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.572 0.701 . . . . 72.05 111.668 177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.402 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -129.08 141.88 51.07 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 105.667 -1.975 . . . . 75.14 105.667 169.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.402 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.3 112.23 4.28 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.383 -0.599 . . . . 75.31 109.383 174.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -122.88 129.29 51.46 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.835 0.454 . . . . 74.54 110.018 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.27 134.85 65.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 108.448 -0.945 . . . . 73.34 108.448 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.641 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.1 mt-30 -115.16 90.59 3.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.487 -1.301 . . . . 70.12 107.487 177.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -79.11 108.65 12.76 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.549 -1.205 . . . . 32.1 109.891 -175.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.11 146.05 20.15 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 111.958 -0.457 . . . . 61.02 111.958 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.48 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.68 120.84 1.24 Allowed Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 111.603 -0.599 . . . . 73.25 111.603 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.557 HD12 HD11 ' C' ' 51' ' ' LEU . 10.4 mm -87.07 110.77 20.83 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 109.114 -0.699 . . . . 75.23 109.114 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.436 ' CE2' HD13 ' C' ' 13' ' ' ILE . 77.2 m-85 -121.76 119.9 33.07 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.555 0.342 . . . . 75.0 110.207 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 61.1 m -84.16 114.34 21.71 Favored 'General case' 0 C--O 1.244 0.786 0 N-CA-C 109.409 -0.589 . . . . 71.41 109.409 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -116.53 131.23 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.275 0.63 . . . . 73.12 109.657 177.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.91 168.78 24.65 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.851 1.26 . . . . 65.53 108.582 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.35 -27.47 5.66 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 120.916 0.176 . . . . 73.21 112.934 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -122.8 158.87 27.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 C-N-CA 124.725 1.21 . . . . 63.03 109.146 -176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.81 -175.56 5.5 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.665 0.386 . . . . 73.04 111.323 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.67 -146.33 40.08 Favored Glycine 0 C--N 1.352 1.425 0 CA-C-N 115.606 -0.724 . . . . 73.43 113.729 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.7 p -68.32 -19.53 64.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.863 0.865 . . . . 34.31 111.588 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -65.97 -49.21 68.66 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.803 0.841 . . . . 73.13 110.722 176.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.71 -25.68 56.86 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 116.476 -0.329 . . . . 43.52 110.746 178.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.44 -42.82 74.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.038 0.535 . . . . 64.32 110.979 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.409 ' CE1' ' HA ' ' C' ' 134' ' ' ASP . 53.4 t-80 -70.9 -28.13 64.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.179 0.592 . . . . 74.14 110.488 174.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -65.66 -60.41 2.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.738 0.415 . . . . 53.11 109.985 175.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.418 HD23 ' SG ' ' C' ' 102' ' ' CYS . 87.8 mt -70.7 -14.86 62.61 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 123.475 0.71 . . . . 72.12 111.768 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.403 ' HA2' HG21 ' C' ' 46' ' ' THR . . . -110.36 3.92 29.69 Favored Glycine 0 C--N 1.356 1.645 0 N-CA-C 114.848 0.699 . . . . 75.52 114.848 -175.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.99 -51.53 0.1 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 117.936 0.868 . . . . 75.3 111.374 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -70.32 -58.97 3.16 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.561 0.744 . . . . 74.45 111.578 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.641 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 32.7 m -58.02 -48.66 96.69 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.49 1.116 . . . . 64.43 112.986 178.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -64.75 -24.27 62.09 Favored 'Trans proline' 0 C--N 1.389 2.71 0 C-N-CA 121.729 1.62 . . . . 44.52 114.052 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -73.88 -28.09 61.39 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 118.314 0.506 . . . . 71.31 110.393 175.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 HH12 ' A' ' 111' ' ' ARG . 45.0 mm -64.33 -31.99 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.145 0.498 . . . . 72.03 109.943 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.48 HD21 ' HA3' ' C' ' 82' ' ' GLY . 84.0 mt -86.86 -24.6 24.86 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.044 0.938 . . . . 74.42 112.247 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -56.43 -46.22 99.84 Favored Pre-proline 0 CA--C 1.564 1.49 0 N-CA-C 114.249 1.203 . . . . 72.33 114.249 -174.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -59.91 -38.61 77.99 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.086 1.857 . . . . 61.35 113.247 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -66.56 -45.31 79.77 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.414 0.686 . . . . 70.24 110.487 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.61 90.76 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.568 -0.742 . . . . 63.22 110.88 176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -64.53 -50.94 65.38 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.904 1.282 . . . . 65.15 110.62 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.36 -31.96 71.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.245 0.618 . . . . 75.5 109.695 -178.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.7 t -69.66 -35.38 75.11 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 122.99 0.516 . . . . 72.42 111.204 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.412 ' O ' HG23 ' C' ' 118' ' ' VAL . 40.5 mt -70.71 -51.0 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 122.899 0.48 . . . . 61.41 110.137 173.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 20.2 m -62.99 -28.88 70.4 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.286 0.634 . . . . 65.22 111.183 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 35.3 t -64.05 -52.19 60.53 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 108.826 -0.805 . . . . 73.33 108.826 171.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.525 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.52 -39.33 83.55 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 124.5 1.12 . . . . 75.3 112.755 -179.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 98.8 t -61.69 -47.92 91.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.54 0.736 . . . . 73.11 109.583 175.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 40.6 t -68.28 -25.9 65.39 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 114.94 -1.027 . . . . 75.23 111.616 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -73.38 -40.12 64.59 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.429 0.692 . . . . 74.12 109.326 177.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.24 -1.08 79.81 Favored Glycine 0 C--N 1.357 1.707 0 O-C-N 123.673 0.608 . . . . 73.51 112.341 172.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.2 p 62.48 35.77 14.49 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.632 1.973 . . . . 64.02 112.816 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.464 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 95.2 m-85 -86.27 165.29 34.47 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 114.738 -1.119 . . . . 71.31 108.852 169.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 74.3 Cg_endo -69.01 -175.0 0.84 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.205 1.936 . . . . 70.11 112.933 -176.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -58.77 114.19 2.4 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-N 115.361 -0.836 . . . . 74.15 110.618 177.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.474 HD21 HG11 ' C' ' 40' ' ' VAL . 0.9 OUTLIER -138.65 92.64 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.129 -1.434 . . . . 71.33 107.129 178.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -123.4 131.8 53.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.334 1.054 . . . . 74.15 108.851 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.69 140.08 43.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.286 0.635 . . . . 74.33 110.892 -170.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.21 146.56 74.9 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.132 0.973 . . . . 72.03 112.061 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.657 ' HG3' HD13 ' A' ' 16' ' ' ILE . 58.5 Cg_endo -71.26 105.43 1.72 Allowed 'Trans proline' 0 C--N 1.374 1.889 0 C-N-CA 123.211 2.607 . . . . 71.25 112.877 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.19 111.15 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.778 -1.193 . . . . 71.14 107.778 172.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 16.2 m120 -111.33 92.14 3.93 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.503 0.721 . . . . 72.55 110.853 -173.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.432 ' HE1' ' HG2' ' A' ' 151' ' ' GLU . 57.9 t80 -78.71 -25.38 44.68 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.893 0.854 . . . . 65.52 109.341 169.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.409 ' HA ' ' CE1' ' C' ' 96' ' ' HIS . 1.4 p-10 -70.73 -60.71 2.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.471 1.508 . . . . 70.15 111.827 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -58.71 -31.19 68.03 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.311 1.044 . . . . 44.51 112.568 -170.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.408 ' O ' ' HD1' ' C' ' 140' ' ' TYR . 55.8 tp -57.89 -56.62 19.66 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 124.195 0.934 . . . . 62.52 110.195 177.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -76.99 -22.01 53.83 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.814 0.446 . . . . 72.11 111.662 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -63.05 -51.15 67.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.387 0.675 . . . . 71.45 111.858 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -71.14 -37.25 72.28 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 123.623 0.577 . . . . 74.01 110.967 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 146' ' ' GLY . 49.0 m-85 -71.5 -84.07 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.115 0.966 . . . . 73.32 112.257 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 tp -137.06 106.91 6.23 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.669 0.787 . . . . 72.52 109.6 -175.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -160.02 -75.66 0.07 Allowed 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.907 -0.405 . . . . 63.53 109.907 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.43 ' HA ' ' OG1' ' C' ' 7' ' ' THR . 22.0 tm0? -141.32 106.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 107.574 -1.269 . . . . 72.34 107.574 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -132.1 91.21 2.92 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.952 -0.759 . . . . 72.43 108.952 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.62 126.13 4.45 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.725 -1.125 . . . . 74.21 108.953 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.62 179.28 38.61 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.375 0.422 . . . . 71.12 112.349 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -164.62 170.68 15.42 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.049 0.94 . . . . 61.25 109.487 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -64.18 146.5 50.39 Favored Glycine 0 C--N 1.352 1.427 0 C-N-CA 122.796 0.236 . . . . 50.34 112.964 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 42.8 p -97.92 -175.77 3.25 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.948 0.899 . . . . 75.5 111.017 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -133.96 135.35 43.45 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.784 -1.562 . . . . 75.33 106.784 175.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -130.75 22.85 5.01 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 122.836 0.454 . . . . 72.4 111.598 -170.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 77.3 m80 65.79 36.61 6.09 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.484 1.114 . . . . 54.05 110.079 -170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -76.74 144.22 39.4 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.748 -0.66 . . . . 71.13 111.69 -173.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.9 t70 51.37 68.18 0.83 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.975 1.31 . . . . 75.11 111.97 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.334 0 CA-C-N 114.952 -1.022 . . . . 60.31 108.838 178.19 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 108.944 -0.762 . . . . 71.33 108.944 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . 0.529 ' HA ' ' HG3' ' B' ' 151' ' ' GLU . 37.6 t -130.16 128.47 41.83 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.321 0.648 . . . . 65.23 109.326 -175.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.69 173.49 10.86 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.157 0.983 . . . . 65.42 110.142 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -154.97 144.75 21.54 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.62 -0.882 . . . . 73.35 108.62 175.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -69.4 82.47 0.38 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-O 121.468 0.652 . . . . 72.12 110.194 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -98.85 35.27 1.9 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.221 1.008 . . . . 71.13 109.383 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.5 m -69.25 -12.04 61.33 Favored 'General case' 0 CA--C 1.563 1.455 0 C-N-CA 124.123 0.969 . . . . 74.04 111.669 -177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.78 -16.78 62.77 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.074 0.949 . . . . 75.14 111.589 173.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.487 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 8.0 ptm -33.05 149.39 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.342 1.608 . . . . 70.41 115.342 171.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 14.8 m -121.11 144.42 48.57 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 115.163 -0.926 . . . . 64.31 108.878 171.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.559 ' HA ' ' O ' ' D' ' 85' ' ' SER . 33.4 t80 -154.0 102.55 2.5 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 108.253 -1.017 . . . . 74.32 108.253 175.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -121.06 118.3 29.42 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.882 -0.784 . . . . 74.02 108.882 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mp -73.2 102.47 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 107.914 -1.143 . . . . 74.31 107.914 178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -77.63 -44.69 27.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.877 0.471 . . . . 72.53 111.302 -174.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -161.76 132.21 4.97 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 119.838 -0.125 . . . . 74.21 111.137 -170.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.463 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -107.61 132.79 54.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.946 -1.502 . . . . 74.12 106.946 173.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.1 p90 -169.94 162.85 9.4 Favored 'General case' 0 C--N 1.345 0.372 0 CA-C-O 121.839 0.828 . . . . 62.52 111.945 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.438 HG21 HD11 ' D' ' 21' ' ' ILE . 67.7 p -95.37 126.91 40.99 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 114.711 -1.131 . . . . 74.24 109.833 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.51 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 47.5 mtpt -95.51 -29.04 14.59 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.009 0.524 . . . . 73.22 110.048 177.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.636 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.8 t70 -150.74 137.11 18.64 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 124.124 0.89 . . . . 63.51 109.271 177.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.525 HG21 ' HE2' ' C' ' 117' ' ' MET . 60.1 mt -137.58 147.73 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.489 1.116 . . . . 73.13 108.056 175.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.5 t -150.86 143.92 24.69 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.153 0.981 . . . . 72.22 109.494 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.577 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 74.0 t80 -149.53 130.0 13.89 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 105.767 -1.938 . . . . 73.24 105.767 169.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.7 mt-10 -134.46 136.63 43.34 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.126 0.57 . . . . 64.54 109.829 -177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -125.03 84.6 58.93 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 123.594 0.758 . . . . 73.45 109.068 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.53 -46.93 6.32 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.186 2.591 . . . . 55.15 113.082 -175.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -114.18 37.94 3.18 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.454 0.702 . . . . 74.54 109.617 -176.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.824 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.48 -56.53 25.76 Favored Pre-proline 0 CA--C 1.566 1.591 0 N-CA-C 115.332 1.604 . . . . 65.1 115.332 -168.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.537 ' HD3' ' HE2' ' C' ' 19' ' ' LYS . 21.6 Cg_endo -87.62 -3.59 7.45 Favored 'Trans proline' 0 C--N 1.38 2.195 0 CA-C-N 121.496 1.57 . . . . 74.03 112.49 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.9 t-160 -82.76 -41.99 18.52 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 125.267 1.427 . . . . 64.44 109.173 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 6.3 p -81.72 -21.84 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 115.121 -0.945 . . . . 53.54 110.145 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -60.53 -26.4 66.85 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.271 1.429 . . . . 64.43 112.571 175.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -67.07 -33.17 74.94 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.241 0.617 . . . . 75.21 110.6 175.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -95.34 98.35 10.52 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.571 -0.9 . . . . 73.2 108.571 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' F' ' 135' ' ' ALA . 17.3 p-10 -80.25 95.29 6.27 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.213 0.53 . . . . 64.0 110.223 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.62 ' HB3' HD11 ' D' ' 68' ' ' LEU . 68.4 t-105 -160.88 165.96 29.27 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.677 0.791 . . . . 75.21 109.685 175.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.43 HE22 ' HB1' ' F' ' 135' ' ' ALA . 1.9 mp0 -81.15 117.38 67.9 Favored Pre-proline 0 CA--C 1.556 1.202 0 C-N-CA 124.413 1.085 . . . . 74.1 110.631 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.27 144.0 94.81 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 C-N-CA 123.499 2.799 . . . . 74.43 114.278 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.51 128.17 35.58 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.33 -0.619 . . . . 73.53 109.33 170.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.512 HG11 HG23 ' F' ' 142' ' ' ILE . 15.0 p -98.61 149.81 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.2 0.6 . . . . 62.52 110.434 -173.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 27.5 tptp -131.98 114.98 15.26 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.592 -1.262 . . . . 75.01 107.592 171.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.87 145.87 25.47 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 123.121 0.568 . . . . 73.1 110.045 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.531 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 33.2 t70 -145.46 138.94 26.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 114.587 -1.188 . . . . 55.04 108.442 175.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.15 134.8 35.02 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.368 -0.975 . . . . 74.44 108.368 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -144.31 146.2 32.45 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.668 1.187 . . . . 64.41 108.354 178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.7 t -117.46 154.51 31.29 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.525 -0.546 . . . . 74.22 109.525 175.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.59 167.47 27.98 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.049 0.94 . . . . 31.44 109.446 -175.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 34.2 p -158.43 166.12 32.99 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 121.121 0.486 . . . . 74.53 111.41 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 42.6 t -159.44 116.82 2.69 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.779 1.232 . . . . 74.23 107.911 -178.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -79.54 123.34 27.49 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.095 -0.706 . . . . 64.43 109.095 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.3 mt -90.59 -41.04 11.58 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.015 0.526 . . . . 74.44 109.947 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.61 -177.47 6.5 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.282 -0.872 . . . . 74.22 110.611 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -64.78 120.16 11.97 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.398 -0.819 . . . . 72.51 109.241 177.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 65.34 17.31 10.94 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.164 0.986 . . . . 74.32 111.767 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -120.75 120.45 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.31 -0.996 . . . . 74.12 108.31 170.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.443 ' HB2' HD12 ' D' ' 86' ' ' ILE . 64.1 m-85 -128.91 126.47 39.77 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.57 -0.9 . . . . 74.51 108.57 176.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -89.97 132.95 35.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.557 -1.646 . . . . 74.51 106.557 169.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.43 133.58 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 108.177 -1.045 . . . . 61.24 108.177 -172.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 96.4 t -111.75 133.15 58.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 123.435 0.694 . . . . 75.53 109.395 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.428 HD11 ' HD1' ' D' ' 107' ' ' PHE . 0.9 OUTLIER -110.87 115.42 29.48 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.122 -1.066 . . . . 64.15 108.122 170.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 3.2 tmm_? -100.74 107.95 19.67 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.214 -1.032 . . . . 74.34 108.214 -176.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -102.71 133.35 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 108.771 -0.826 . . . . 61.15 108.771 169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.531 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 59.1 m -121.95 135.21 54.85 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.363 0.601 . . . . 71.22 109.646 170.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 46.6 t -125.52 131.53 72.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 C-N-CA 124.846 1.258 . . . . 64.44 108.455 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 94.0 m -131.14 112.74 13.12 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.196 0.998 . . . . 65.1 108.86 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.33 140.83 48.31 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 123.744 0.818 . . . . 71.33 109.165 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.473 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 15.2 m -146.2 127.59 14.95 Favored 'General case' 0 C--O 1.234 0.281 0 O-C-N 123.665 0.603 . . . . 64.2 109.67 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' D' ' 36' ' ' TRP . 47.5 tp -111.86 122.8 48.77 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 108.686 -0.857 . . . . 62.41 108.686 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 -115.68 5.95 Favored Glycine 0 C--N 1.342 0.914 0 O-C-N 123.599 0.562 . . . . 72.14 112.836 -177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -110.86 8.51 22.29 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.274 0.629 . . . . 72.11 111.825 -175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.08 164.27 30.22 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.226 0.611 . . . . 75.11 110.97 -172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 61.7 m -74.55 127.94 34.31 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 116.055 -0.52 . . . . 65.01 110.523 178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.58 -61.29 1.87 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.259 1.023 . . . . 45.15 109.677 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.06 157.9 42.28 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 121.257 0.551 . . . . 72.31 111.321 171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 79.0 mt -121.97 147.82 45.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.231 1.412 . . . . 60.23 107.586 174.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.561 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.8 t -158.57 141.65 14.76 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.457 0.303 . . . . 64.44 110.216 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.08 135.98 13.71 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.33 0.652 . . . . 74.42 109.788 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.1 t -134.94 119.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.097 0.559 . . . . 71.42 109.633 177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.636 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.6 mt-30 -89.48 86.11 6.69 Favored 'General case' 0 C--O 1.243 0.755 0 N-CA-C 108.489 -0.93 . . . . 75.52 108.489 167.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -79.83 101.72 8.69 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 114.434 -1.257 . . . . 73.25 108.448 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.17 174.41 40.33 Favored Glycine 0 C--O 1.243 0.7 0 O-C-N 123.456 0.472 . . . . 64.52 112.143 177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.95 135.5 2.84 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 111.654 -0.578 . . . . 64.14 111.654 177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 54.3 mt -87.8 129.96 38.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.513 -0.921 . . . . 74.43 108.513 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -132.28 135.78 46.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.491 0.717 . . . . 71.03 109.586 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.7 m -75.33 116.14 15.74 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 107.944 -1.132 . . . . 71.43 107.944 168.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' D' ' 56' ' ' TYR . 57.2 mt -121.23 101.72 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 109.634 -0.506 . . . . 73.34 109.634 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.63 152.6 48.17 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.406 1.082 . . . . 74.44 109.072 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 75.2 1.33 63.6 Favored Glycine 0 C--N 1.348 1.214 0 O-C-N 123.434 0.459 . . . . 63.31 113.587 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.519 HG23 ' HG2' ' D' ' 93' ' ' GLN . 53.7 mt -117.11 126.77 74.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 107.814 -1.18 . . . . 65.22 107.814 -174.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' D' ' 93' ' ' GLN . 7.5 pt-20 -145.84 148.86 33.33 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.973 0.731 . . . . 71.24 112.973 -163.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.09 -127.01 32.27 Favored Glycine 0 C--N 1.353 1.508 0 C-N-CA 123.353 0.501 . . . . 62.14 114.197 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 46.9 p -70.34 -20.61 62.97 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.356 0.662 . . . . 65.04 111.32 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.519 ' HG2' HG23 ' D' ' 89' ' ' ILE . 55.9 tt0 -70.47 -41.47 72.7 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.737 0.815 . . . . 74.32 110.134 176.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 5.1 ppp? -78.63 -29.42 45.85 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.288 0.235 . . . . 73.32 110.541 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.66 -35.77 80.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.067 0.547 . . . . 53.12 110.272 171.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.01 -35.87 69.55 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.335 -0.848 . . . . 74.12 110.537 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.5 t -66.29 -43.08 87.36 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.941 0.496 . . . . 62.11 110.584 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 59.4 mt -80.09 -21.91 42.78 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.331 0.652 . . . . 75.05 111.082 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.97 -19.79 38.65 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.932 -0.371 . . . . 63.41 113.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.79 -69.04 0.69 Allowed 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 112.39 0.515 . . . . 72.43 112.39 -172.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -65.07 -60.92 2.5 Favored 'General case' 0 CA--C 1.555 1.135 0 N-CA-C 112.283 0.475 . . . . 73.41 112.283 -167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -58.07 -46.97 99.64 Favored Pre-proline 0 CA--C 1.565 1.537 0 C-N-CA 123.78 0.832 . . . . 74.14 113.122 -176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.61 -30.72 51.16 Favored 'Trans proline' 0 C--N 1.392 2.845 0 C-N-CA 121.921 1.747 . . . . 52.21 113.266 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -65.82 -35.97 82.18 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.035 0.534 . . . . 63.24 110.646 177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 41.4 mm -62.16 -42.71 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 123.712 0.805 . . . . 73.21 110.35 173.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -78.67 -19.01 53.5 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.27 -0.877 . . . . 54.52 112.181 -174.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.428 ' HD1' HD11 ' D' ' 60' ' ' LEU . 70.8 t80 -62.21 -45.72 90.67 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 113.759 1.022 . . . . 64.45 113.759 -174.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.83 -36.91 75.9 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.113 1.875 . . . . 63.02 113.724 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -79.07 -33.84 44.23 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.893 0.877 . . . . 75.14 111.693 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.75 -48.47 71.79 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.874 0.47 . . . . 61.44 109.829 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -54.95 -50.82 67.94 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.368 -1.287 . . . . 73.53 111.013 177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -57.98 -46.76 84.66 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.113 0.883 . . . . 75.33 110.8 -176.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -60.11 -45.13 94.0 Favored 'General case' 0 CA--C 1.543 0.703 0 O-C-N 123.939 0.774 . . . . 50.1 110.947 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.561 HG23 ' SG ' ' D' ' 76' ' ' CYS . 79.3 mt -59.49 -56.5 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.746 0.818 . . . . 63.25 110.897 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 89.6 m -53.03 -46.36 68.42 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.667 1.187 . . . . 64.25 111.796 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 34.5 t -62.84 -44.09 97.07 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.032 -0.985 . . . . 53.12 110.2 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.43 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 74.8 mtm -68.07 -32.93 73.61 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.103 0.561 . . . . 50.11 111.852 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 64.9 t -70.62 -39.18 75.64 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 C-N-CA 123.269 0.628 . . . . 72.53 110.438 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.5 p -74.89 -26.26 59.52 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 122.547 0.339 . . . . 74.14 110.881 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -75.47 -32.27 60.55 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.664 0.786 . . . . 71.24 109.635 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.95 -1.13 90.19 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-N 115.534 -0.757 . . . . 70.03 111.922 172.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 21.3 p 59.81 22.79 11.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 126.591 1.957 . . . . 62.44 112.805 173.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -86.31 159.89 52.5 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.334 1.054 . . . . 74.44 109.514 173.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.622 ' HA ' ' H ' ' F' ' 137' ' ' GLU . 52.8 Cg_exo -53.7 118.08 4.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.529 2.153 . . . . 75.24 112.701 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -48.88 133.19 18.03 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.062 0.945 . . . . 71.44 112.393 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tt -124.6 107.86 11.46 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.953 -1.129 . . . . 71.52 107.953 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -102.57 107.76 18.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.481 0.712 . . . . 51.44 109.466 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -67.95 145.02 54.94 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.73 0.812 . . . . 73.14 111.166 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.62 148.06 36.5 Favored Pre-proline 0 N--CA 1.471 0.597 0 C-N-CA 122.917 0.487 . . . . 72.45 110.264 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -62.37 130.82 31.53 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.545 2.163 . . . . 73.0 111.984 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 3.2 p -108.13 109.61 28.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.486 0.714 . . . . 51.23 110.041 -172.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -86.72 106.78 17.89 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.802 0.841 . . . . 74.34 108.744 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -78.09 -33.71 50.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.039 0.536 . . . . 75.3 110.624 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -59.04 -45.08 91.64 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.777 1.231 . . . . 70.22 111.583 -173.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.3 -37.96 79.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.41 0.684 . . . . 51.14 112.15 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.65 -25.75 45.04 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.469 0.707 . . . . 74.32 110.648 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -69.72 -32.51 71.12 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.778 0.831 . . . . 75.44 110.28 176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.5 mmt -61.18 -36.55 80.15 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-O 121.31 0.576 . . . . 74.2 109.52 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -66.7 -34.42 77.81 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.857 -1.065 . . . . 65.15 111.122 178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -69.85 -30.91 68.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.63 0.372 . . . . 74.43 111.68 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.9 mp -71.23 -36.13 71.72 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.978 -0.451 . . . . 73.52 111.344 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -91.06 -0.76 57.8 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.059 0.544 . . . . 75.11 111.687 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -142.66 89.2 2.12 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.202 -1.407 . . . . 72.35 107.202 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -140.12 122.88 16.42 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.751 -0.463 . . . . 52.13 109.751 -169.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.43 166.79 22.66 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 124.371 1.068 . . . . 74.34 109.184 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.28 115.05 7.41 Favored Glycine 0 C--N 1.346 1.106 0 O-C-N 123.515 0.51 . . . . 61.02 111.832 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -104.64 134.63 47.48 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.345 0.658 . . . . 75.41 110.257 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.48 89.36 0.36 Allowed Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.353 -0.699 . . . . 74.21 111.353 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 56.1 p -67.97 83.2 0.21 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.236 1.014 . . . . 54.13 111.345 -175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -110.38 -153.93 0.53 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 124.483 1.113 . . . . 54.02 109.878 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 63.54 54.95 1.82 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.533 1.133 . . . . 62.21 109.694 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -141.78 172.1 13.15 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 114.018 -1.446 . . . . 73.35 108.859 172.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 62.88 79.74 0.25 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.067 0.947 . . . . 74.44 109.277 -173.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 66.89 172.62 0.25 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.966 1.306 . . . . 74.44 111.524 -170.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.482 0 C-N-CA 123.375 0.67 . . . . 37.71 109.598 -177.81 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.484 1.246 0 N-CA-C 108.953 -0.758 . . . . 75.31 108.953 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -123.18 103.18 8.38 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.31 0.644 . . . . 74.15 110.4 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.32 129.25 35.08 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 123.805 0.842 . . . . 73.14 109.345 173.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -77.76 94.78 4.53 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 109.484 -0.561 . . . . 74.12 109.484 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' E' ' 117' ' ' PRO . 11.5 pt20 -150.62 126.76 10.55 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.912 0.885 . . . . 75.33 109.085 177.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -142.58 -43.46 0.32 Allowed 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.719 0.408 . . . . 52.42 111.428 -173.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -74.85 161.91 29.13 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.059 0.544 . . . . 61.41 110.852 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 59.0 mt -50.05 140.25 12.79 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.78 1.232 . . . . 70.52 113.124 179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . 0.539 ' HD1' ' HA ' ' B' ' 95' ' ' ALA . 10.6 t80 59.78 58.49 4.73 Favored Pre-proline 0 CA--C 1.55 0.967 0 O-C-N 124.79 1.306 . . . . 71.4 109.618 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.63 ' HB2' ' HB2' ' E' ' 112' ' ' GLN . 90.4 Cg_endo -77.92 -1.83 11.98 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 122.881 2.388 . . . . 71.54 113.308 -169.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -145.48 116.72 7.92 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.765 -0.828 . . . . 43.45 108.765 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 60.5 p -85.13 133.12 34.22 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 124.05 0.94 . . . . 70.53 108.82 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 3.8 p-90 -76.78 89.84 3.43 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-O 122.113 0.959 . . . . 74.54 109.818 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -70.7 -45.25 65.32 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.097 -0.956 . . . . 75.44 111.235 -173.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . 0.461 ' HB3' ' HE1' ' B' ' 137' ' ' PHE . . . -71.28 85.67 0.79 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 121.451 0.643 . . . . 60.34 111.194 -176.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 23.6 m -99.51 131.54 46.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 124.551 1.14 . . . . 65.22 108.774 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -165.48 132.47 2.85 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.776 0.431 . . . . 73.34 110.828 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -140.56 92.62 2.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.295 0.569 . . . . 74.31 109.972 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -105.12 67.52 0.79 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.959 0.903 . . . . 74.12 108.968 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -134.02 87.31 0.26 Allowed Glycine 0 C--N 1.341 0.856 0 CA-C-N 115.17 -0.923 . . . . 61.42 111.205 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -63.9 141.03 58.92 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.021 0.528 . . . . 63.13 110.745 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 pp -153.12 161.19 42.75 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.246 0.618 . . . . 61.41 110.303 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 10.0 tp -156.42 168.7 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 N-CA-C 108.625 -0.88 . . . . 73.52 108.625 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.39 147.82 47.28 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.394 0.678 . . . . 54.1 110.669 174.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -61.67 153.37 71.32 Favored Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 123.866 0.867 . . . . 71.41 112.573 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -58.98 94.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.996 2.464 . . . . 61.35 112.154 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 7.2 tt -161.05 -46.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 124.683 1.193 . . . . 70.41 108.662 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 52.46 65.13 1.6 Allowed 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.546 1.139 . . . . 72.04 109.822 -170.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 14.2 p -65.9 -13.89 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-N 114.935 -1.029 . . . . 75.2 111.214 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -62.27 82.65 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.543 1.137 . . . . 73.44 112.029 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -164.3 25.95 0.07 Allowed 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 114.476 -1.238 . . . . 74.41 109.899 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 11.0 mp -91.96 27.17 2.2 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.247 1.019 . . . . 72.11 110.543 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.6 p -73.58 -13.53 61.04 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.338 1.055 . . . . 55.23 111.419 175.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 5.0 tt -73.39 83.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.848 0.859 . . . . 74.55 108.925 176.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . 0.47 HG12 ' HB ' ' C' ' 40' ' ' VAL . 23.9 mt -123.94 -57.47 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 124.66 1.184 . . . . 74.01 108.13 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -138.89 164.44 29.66 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.09 1.356 . . . . 71.22 108.672 178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . 0.517 ' H ' HD22 ' E' ' 144' ' ' ASN . 0.1 OUTLIER -130.39 -17.3 3.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 112.333 0.494 . . . . 73.21 112.333 -176.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . 0.562 ' HD3' ' H ' ' A' ' 155' ' ' ALA . 27.1 mtpp -76.45 -177.55 4.2 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.88 0.472 . . . . 65.34 110.343 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.43 -87.58 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.072 0.549 . . . . 74.55 110.278 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 68.9 mt -156.49 -66.17 0.11 Allowed 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.183 -1.043 . . . . 71.12 108.183 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 5.9 mp -100.24 -51.96 0.18 Allowed Pre-proline 0 CA--C 1.565 1.544 0 CA-C-N 115.272 -0.876 . . . . 73.1 109.806 173.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo . . . . . 0 C--N 1.394 2.947 0 C-N-CA 121.832 1.688 . . . . 73.34 113.59 175.625 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.6 t70 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.593 -0.892 . . . . 74.53 108.593 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 68.53 85.05 0.14 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.022 0.929 . . . . 70.24 109.604 -176.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 71.83 -70.03 0.17 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.283 1.433 . . . . 60.01 111.212 -175.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -70.45 97.32 1.27 Allowed 'General case' 0 C--O 1.246 0.897 0 C-N-CA 123.86 0.864 . . . . 72.43 110.124 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 127.94 34.63 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.49 -0.929 . . . . 51.22 108.49 175.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -72.91 84.83 1.25 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.351 0.596 . . . . 74.21 110.476 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -99.28 59.46 1.13 Allowed 'General case' 0 C--O 1.238 0.49 0 N-CA-C 108.731 -0.84 . . . . 72.34 108.731 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.536 ' H ' HD23 ' F' ' 115' ' ' LEU . 2.2 pt? -65.96 83.84 0.08 Allowed 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.744 -1.116 . . . . 74.34 109.394 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -148.16 157.35 42.89 Favored Pre-proline 0 N--CA 1.482 1.143 0 C-N-CA 124.188 0.995 . . . . 72.32 110.759 -170.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 98' ' ' LEU . 65.3 Cg_endo -84.07 154.07 12.84 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.263 2.642 . . . . 74.32 113.097 -179.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -70.19 137.24 50.77 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.008 -0.542 . . . . 60.32 109.888 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 48.7 p -80.73 80.55 7.17 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.653 0.781 . . . . 71.42 110.508 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -100.89 157.57 16.63 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.13 0.972 . . . . 75.33 111.183 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.41 11.38 35.05 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.828 0.851 . . . . 74.41 109.95 174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.45 -22.02 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.414 0.685 . . . . 74.31 111.641 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 22.9 m -68.23 -24.76 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.87 0.868 . . . . 75.21 112.193 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 40.8 ttp180 -50.63 -55.9 14.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.357 1.063 . . . . 75.12 112.033 -171.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . 0.479 ' HD2' HD11 ' A' ' 42' ' ' LEU . 63.9 t80 66.88 167.38 0.23 Allowed 'General case' 0 CA--C 1.563 1.457 0 C-N-CA 124.621 1.168 . . . . 72.45 112.729 170.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -158.28 144.28 17.09 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.402 1.081 . . . . 72.24 109.198 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 169.15 105.86 0.19 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.154 -0.778 . . . . 73.13 111.154 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -87.09 105.61 17.3 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.953 0.501 . . . . 73.02 110.041 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.51 106.49 17.6 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.828 -0.434 . . . . 64.02 109.828 174.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 10.8 tp -84.9 -19.12 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.217 0 C-N-CA 124.122 0.969 . . . . 53.43 110.501 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 69.23 -76.81 0.06 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.516 1.526 . . . . 54.5 110.966 -174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -171.84 132.67 0.78 Allowed Pre-proline 0 C--O 1.244 0.767 0 C-N-CA 124.255 1.022 . . . . 74.34 108.454 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.09 78.2 1.48 Allowed 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 122.821 2.347 . . . . 72.1 111.92 173.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.431 HG13 HG13 ' F' ' 136' ' ' VAL . 6.8 tp -86.09 137.96 19.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 CA-C-N 114.744 -1.116 . . . . 62.34 108.538 175.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.466 ' H ' ' HB2' ' D' ' 35' ' ' ASP . . . -75.67 86.05 2.71 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-O 121.167 0.508 . . . . 74.52 109.899 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.431 HG13 HG13 ' F' ' 134' ' ' ILE . 10.6 m -122.79 170.16 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.579 1.152 . . . . 61.22 110.632 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . 0.622 ' H ' ' HA ' ' D' ' 124' ' ' PRO . 0.5 OUTLIER 53.26 33.23 15.01 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.927 1.291 . . . . 62.03 112.875 177.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -141.51 18.7 2.2 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.185 0.994 . . . . 72.5 110.507 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.637 ' HG ' HD11 ' F' ' 142' ' ' ILE . 16.1 tp -76.39 82.65 3.13 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 121.907 0.861 . . . . 64.5 110.532 -175.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 61.3 p -111.39 13.01 21.55 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.276 -1.329 . . . . 61.25 111.067 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 69.0 mt -81.07 15.26 1.93 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.245 0.618 . . . . 73.04 111.343 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.637 HD11 ' HG ' ' F' ' 139' ' ' LEU . 2.8 mm -86.27 154.77 3.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 108.143 -1.058 . . . . 63.23 108.143 177.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 67.07 -74.7 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 125.463 1.505 . . . . 75.42 110.815 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 68.69 -80.74 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.363 1.465 . . . . 72.24 110.632 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -90.16 123.32 33.88 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.119 0.568 . . . . 75.04 109.649 176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 44.66 92.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.529 1.532 . . . . 63.3 113.61 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 7.2 tt -65.79 -72.7 0.15 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.549 -0.908 . . . . 72.34 108.549 175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 tt -168.78 73.04 0.78 Allowed Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 106.316 -1.735 . . . . 53.15 106.316 174.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 C--N 1.377 2.044 0 C-N-CA 123.354 2.702 . . . . 65.13 111.421 178.566 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.333 -0.247 . . . . 72.21 110.333 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.3 m -91.83 93.99 9.11 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.926 -0.768 . . . . 73.31 108.926 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -82.02 -70.76 0.52 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.342 -0.984 . . . . 72.42 108.342 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -88.27 91.32 8.74 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.933 -0.765 . . . . 53.3 108.933 172.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -66.2 -40.56 90.47 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 114.921 -1.036 . . . . 70.43 109.419 173.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -93.34 98.13 11.04 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.311 -0.859 . . . . 74.05 109.437 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -99.99 101.41 12.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.425 0.69 . . . . 74.43 110.121 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -130.96 86.91 2.42 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.109 0.964 . . . . 75.22 109.653 175.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.9 OUTLIER -93.58 149.33 21.31 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.006 0.922 . . . . 74.42 109.752 177.267 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m -144.93 100.95 3.57 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.548 -0.908 . . . . 75.04 108.548 169.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -134.41 134.79 42.04 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.3 0.64 . . . . 73.45 109.351 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.437 ' HB2' ' OG ' ' A' ' 85' ' ' SER . 92.4 mt-30 -132.82 123.85 26.89 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.592 -0.892 . . . . 73.25 108.592 -178.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.3 mp -79.69 103.95 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.897 -1.149 . . . . 74.53 107.897 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -86.61 -39.78 15.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 115.941 -0.572 . . . . 72.24 110.947 -177.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.634 ' HD3' HG21 ' B' ' 122' ' ' THR . 0.1 OUTLIER -158.6 143.99 16.47 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 119.144 -0.455 . . . . 74.04 109.962 -175.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 84.6 mt -145.85 100.01 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 107.505 -1.295 . . . . 72.13 107.505 171.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.594 ' HD1' ' HG3' ' A' ' 15' ' ' ARG . 71.6 m-85 -157.61 169.96 23.47 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.298 0.639 . . . . 73.32 109.779 -170.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.8 p -81.91 111.66 18.31 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 116.079 -0.51 . . . . 71.33 110.337 -173.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 35.4 mtpt -79.5 -32.52 42.44 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.141 -0.481 . . . . 73.54 110.768 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -148.97 145.1 27.2 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.702 0.627 . . . . 54.45 109.616 176.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 81.2 mt -134.59 144.2 35.63 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 C-N-CA 125.065 1.346 . . . . 65.23 107.567 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 25.9 t -148.69 130.67 15.29 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 123.753 0.821 . . . . 74.3 108.857 178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.566 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 90.3 t80 -147.6 119.28 8.03 Favored 'General case' 0 C--O 1.213 -0.82 0 N-CA-C 106.962 -1.496 . . . . 73.01 106.962 174.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -134.55 139.63 45.54 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.831 0.452 . . . . 74.45 109.84 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.616 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -129.23 80.32 72.65 Favored Pre-proline 0 CA--C 1.544 0.739 0 C-N-CA 124.221 1.008 . . . . 74.32 108.515 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.51 -43.46 21.98 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 123.299 2.666 . . . . 64.31 112.627 -171.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 32.1 m-80 -113.09 37.47 3.13 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.187 -0.915 . . . . 74.4 109.656 -176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.616 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.37 -46.03 99.84 Favored Pre-proline 0 CA--C 1.567 1.602 0 C-N-CA 124.121 0.968 . . . . 70.01 113.087 177.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.06 -22.97 29.96 Favored 'Trans proline' 0 C--N 1.394 2.941 0 C-N-CA 121.976 1.784 . . . . 72.11 112.631 174.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.534 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.3 m-70 -78.11 -18.62 55.46 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.561 0.744 . . . . 73.42 111.656 -177.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG21 ' HE1' ' A' ' 123' ' ' PHE . 79.1 t -52.53 -28.41 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.876 0.87 . . . . 74.04 112.447 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -65.53 -42.65 91.73 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.11 0.781 . . . . 72.32 113.11 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.455 HE21 ' HB3' ' A' ' 30' ' ' HIS . 3.6 pp0? -78.37 -26.05 46.51 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.577 0.171 . . . . 72.11 110.665 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 41.5 mmtm -76.73 152.08 35.81 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.101 0.56 . . . . 73.4 110.498 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -80.47 147.71 30.79 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.442 -0.947 . . . . 71.44 108.442 167.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.4 m-90 -79.05 75.33 5.56 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.911 0.884 . . . . 65.41 110.634 -172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -123.23 82.9 51.84 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.495 1.118 . . . . 54.3 108.639 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.85 123.41 5.21 Favored 'Trans proline' 0 C--N 1.371 1.757 0 C-N-CA 122.927 2.418 . . . . 62.22 111.964 -178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -95.07 86.02 4.49 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 107.143 -1.428 . . . . 63.33 107.143 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 65' ' ' THR . 61.1 t -87.26 103.68 13.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 CA-C-N 114.333 -1.303 . . . . 61.32 110.505 -170.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.533 ' HA ' ' HA3' ' F' ' 127' ' ' GLY . 56.2 tttm -96.5 140.02 31.74 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 122.726 0.41 . . . . 65.13 110.392 176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 36.1 mt -106.45 139.33 41.1 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.187 -1.042 . . . . 70.23 108.187 173.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.799 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.3 m-20 -129.6 108.23 10.06 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.567 -1.271 . . . . 73.35 107.567 174.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.412 ' N ' HD12 ' A' ' 44' ' ' LEU . 3.2 mp -103.72 130.59 51.24 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.367 -0.975 . . . . 75.22 108.367 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 60' ' ' LEU . 19.2 t70 -144.05 151.68 39.98 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.857 0.863 . . . . 72.24 110.205 -176.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 24.0 m -139.24 138.63 36.99 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.597 0.759 . . . . 64.34 110.094 175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.2 149.05 52.05 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.631 1.172 . . . . 63.25 109.716 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -96.15 170.35 9.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.293 0.637 . . . . 71.13 111.101 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 31.0 t -165.7 147.82 7.39 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.879 1.272 . . . . 73.2 108.526 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -111.98 133.52 54.11 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.488 -0.931 . . . . 74.11 108.488 168.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 62.6 mt -104.69 -44.62 4.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.579 -0.526 . . . . 63.14 109.579 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.62 -174.35 4.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.583 -0.735 . . . . 73.11 110.38 -177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -62.27 117.84 6.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.345 1.058 . . . . 74.3 110.748 176.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 69.31 -8.2 0.74 Allowed 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 125.533 1.533 . . . . 74.44 113.08 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -101.3 109.58 26.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.492 -0.929 . . . . 64.24 108.492 -175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -124.15 157.01 35.69 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.891 0.876 . . . . 72.22 108.763 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 44.9 tt0 -132.46 118.91 19.91 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 123.53 0.732 . . . . 74.21 109.986 -174.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.2 t -104.56 112.6 38.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 N-CA-C 107.717 -1.216 . . . . 54.41 107.717 172.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.576 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.5 t -100.0 131.63 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 122.919 0.488 . . . . 70.01 109.924 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.4 OUTLIER -100.63 114.23 27.74 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 107.092 -1.447 . . . . 72.02 107.092 175.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 29.1 ttp180 -99.22 104.1 16.02 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.722 -0.844 . . . . 73.05 108.722 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.7 t -95.49 141.96 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 N-CA-C 108.382 -0.97 . . . . 74.42 108.382 172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.799 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 85.6 m -125.78 141.13 52.15 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 171.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 76.9 t -135.24 110.86 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 C-N-CA 124.616 1.166 . . . . 64.32 108.37 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 28.1 m -101.95 142.15 33.68 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.711 -0.848 . . . . 71.24 108.711 177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.46 121.78 20.41 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 107.873 -1.158 . . . . 70.23 107.873 173.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.1 m -130.95 130.14 43.05 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.127 0.571 . . . . 65.43 110.135 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.529 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 78.4 mt -87.61 78.71 8.46 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 107.801 -1.185 . . . . 74.25 107.801 174.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.59 -106.73 2.17 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-N 114.392 -1.276 . . . . 61.51 112.219 -176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -89.12 -26.99 21.04 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.531 0.732 . . . . 72.31 109.984 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.24 131.3 44.69 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.186 0.994 . . . . 73.43 109.627 -174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 64.1 m -76.19 128.73 35.52 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.066 0.46 . . . . 31.23 110.524 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -76.83 -56.4 4.63 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.235 1.014 . . . . 71.11 108.971 178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -167.57 174.86 7.47 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.163 -0.926 . . . . 63.33 111.207 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 tp -143.05 150.48 39.61 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.845 1.258 . . . . 71.53 109.133 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.696 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 61.6 m -141.59 141.34 33.49 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.441 0.696 . . . . 74.03 110.681 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 56.4 mp0 -141.47 133.41 27.52 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.285 1.034 . . . . 73.33 108.321 170.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.7 t -137.42 108.4 5.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.265 -1.013 . . . . 71.3 108.265 175.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -86.81 80.39 8.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.207 -1.361 . . . . 71.11 107.645 176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -76.12 92.5 3.23 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 114.046 -1.434 . . . . 74.32 107.886 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.24 145.62 21.42 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.374 -0.83 . . . . 54.35 111.3 -177.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -135.52 120.25 2.26 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.772 -0.931 . . . . 51.22 110.772 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.5 mt -85.2 124.99 40.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.728 0 N-CA-C 108.082 -1.081 . . . . 73.44 108.082 173.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -136.46 138.49 41.5 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.391 -0.966 . . . . 73.34 108.391 176.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.437 ' OG ' ' HB2' ' A' ' 12' ' ' GLN . 13.7 p -96.42 105.25 17.3 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.368 -0.604 . . . . 52.42 109.368 172.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.6 mp -96.86 132.47 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.215 0.606 . . . . 62.54 110.072 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.04 162.88 26.08 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.658 1.183 . . . . 72.43 109.666 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.83 -25.11 12.34 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 114.61 0.604 . . . . 32.34 114.61 171.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -112.42 152.26 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 117.303 0.552 . . . . 71.32 110.918 -175.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 8.5 tt0 -155.89 -172.71 4.22 Favored 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 109.329 -0.619 . . . . 62.44 109.329 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.487 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.63 -153.25 48.79 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 116.637 -0.256 . . . . 71.13 113.244 176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.451 ' HB ' HD21 ' A' ' 141' ' ' LEU . 32.6 p -65.35 -26.36 67.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.604 0.762 . . . . 75.52 111.318 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.33 -42.69 99.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.536 0.734 . . . . 74.12 110.641 174.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 47.0 ttp -64.13 -53.14 54.17 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.139 0.975 . . . . 74.22 110.926 178.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.08 -47.69 68.32 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.935 0.894 . . . . 44.24 110.958 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.443 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -56.94 -47.71 80.02 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.617 -1.629 . . . . 72.23 111.192 173.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.656 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.1 m -71.37 -29.41 64.92 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.585 0.957 . . . . 72.04 113.585 -171.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.9 mt -83.78 -38.8 20.84 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.049 0.54 . . . . 64.31 111.1 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.56 5.26 56.93 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.958 -0.565 . . . . 73.45 113.827 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -144.29 -66.67 0.34 Allowed 'General case' 0 N--CA 1.481 1.075 0 CA-C-N 117.784 0.792 . . . . 74.31 112.384 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.656 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.2 t80 -48.96 -56.58 8.45 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 124.194 0.998 . . . . 73.12 112.434 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 59.3 m -71.52 -44.56 12.76 Favored Pre-proline 0 CA--C 1.561 1.372 0 CA-C-O 118.389 -0.815 . . . . 53.21 112.471 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -53.28 -37.27 80.65 Favored 'Trans proline' 0 C--N 1.387 2.587 0 C-N-CA 122.152 1.901 . . . . 72.53 113.732 168.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 61.8 m-20 -60.44 -40.61 91.7 Favored 'General case' 0 N--CA 1.501 2.117 0 C-N-CA 124.108 0.963 . . . . 72.51 110.788 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.3 mm -64.7 -41.46 92.28 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-N 115.084 -0.962 . . . . 73.24 110.569 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.543 HD21 ' HA3' ' A' ' 82' ' ' GLY . 68.7 mt -75.24 -27.19 59.39 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 115.634 -0.712 . . . . 73.1 111.751 -173.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -63.15 -42.74 78.08 Favored Pre-proline 0 CA--C 1.564 1.503 0 N-CA-C 114.741 1.386 . . . . 74.11 114.741 -168.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -56.84 -35.57 98.3 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 122.307 2.005 . . . . 41.3 113.603 174.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -78.8 -37.92 39.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.333 0.653 . . . . 73.33 111.399 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.32 -41.46 98.56 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.669 -0.493 . . . . 33.22 109.669 173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.524 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.5 ttm180 -57.23 -53.44 58.07 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.354 1.062 . . . . 74.1 110.908 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.95 -47.88 84.4 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.119 0.887 . . . . 63.22 111.008 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.15 -46.69 82.51 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 124.08 0.862 . . . . 61.43 111.126 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.599 HG21 HG21 ' A' ' 64' ' ' VAL . 98.9 mt -62.66 -52.47 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 123.709 0.63 . . . . 73.34 110.474 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 125' ' ' GLN . 87.7 m -56.13 -39.41 72.21 Favored 'General case' 0 CA--C 1.551 0.999 0 O-C-N 123.82 0.7 . . . . 74.43 111.596 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -66.47 -48.18 70.71 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.345 -0.843 . . . . 61.1 110.185 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.566 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 11.1 mtp -54.36 -45.13 72.68 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 123.864 0.866 . . . . 74.03 111.486 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' ILE . 71.0 t -61.86 -47.41 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.943 -1.026 . . . . 75.41 110.852 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.2 p -71.38 -24.3 62.05 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.985 -0.552 . . . . 75.44 111.553 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -71.77 -27.06 62.7 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.302 0.641 . . . . 51.1 110.313 175.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.75 10.09 63.45 Favored Glycine 0 C--N 1.353 1.489 0 O-C-N 123.469 0.481 . . . . 72.12 113.045 169.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.567 HG22 ' HB3' ' B' ' 17' ' ' TYR . 5.9 t 51.97 24.62 2.69 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 127.03 2.132 . . . . 62.22 113.279 -175.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE1' HG21 ' A' ' 31' ' ' VAL . 75.6 m-85 -86.55 151.84 53.72 Favored Pre-proline 0 C--O 1.244 0.809 0 CA-C-N 115.628 -0.715 . . . . 60.54 109.177 173.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -55.24 129.0 32.89 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.717 2.278 . . . . 72.13 110.56 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.463 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.5 pt20 -55.81 142.52 34.56 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.156 0.91 . . . . 75.0 111.345 -169.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.403 ' HG ' HG11 ' A' ' 118' ' ' VAL . 51.2 mt -119.46 97.66 5.76 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.525 0.678 . . . . 71.02 109.231 -178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -98.57 123.06 42.52 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 114.308 -1.315 . . . . 53.52 108.067 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.471 HD11 HD12 ' A' ' 114' ' ' ILE . 69.3 mt -66.12 122.61 17.81 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.481 0.712 . . . . 74.43 110.565 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 131' ' ' VAL . . . -53.29 136.65 50.23 Favored Pre-proline 0 CA--C 1.551 0.986 0 CA-C-O 119.012 -0.518 . . . . 73.02 110.293 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -59.43 99.99 0.12 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.628 2.218 . . . . 71.5 112.102 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 129' ' ' ALA . 53.9 t -100.25 112.86 34.12 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 N-CA-C 108.17 -1.048 . . . . 74.34 108.17 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -85.42 92.12 8.4 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 108.243 -1.021 . . . . 73.05 108.243 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -64.41 -28.54 69.76 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.8 -0.636 . . . . 73.53 110.418 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.488 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 3.6 t70 -68.53 -52.09 35.85 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.082 0.953 . . . . 73.31 110.658 -171.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.66 -39.18 88.08 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.024 -0.989 . . . . 65.25 110.688 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.406 ' HA ' HD21 ' A' ' 139' ' ' ASN . 7.2 tt -60.05 -46.2 90.34 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 124.188 0.93 . . . . 71.04 109.887 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -65.93 -40.15 91.15 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.057 -0.974 . . . . 73.12 109.973 -176.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 mmt -63.54 -56.32 16.89 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.783 0.677 . . . . 74.22 111.507 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.406 HD21 ' HA ' ' A' ' 136' ' ' LEU . 12.3 p30 -65.14 -31.99 73.46 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.172 0.295 . . . . 74.14 111.483 -174.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -66.79 -52.31 45.46 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 123.379 0.424 . . . . 72.33 110.068 176.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.451 HD21 ' HB ' ' A' ' 92' ' ' THR . 55.4 tp -56.18 -51.26 68.65 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 114.782 -1.099 . . . . 54.32 111.49 -171.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 170.78 -17.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 125.002 1.439 . . . . 74.52 110.811 175.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -82.24 91.23 6.71 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.624 0.726 . . . . 72.12 110.408 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 3.7 pm0 -58.3 -30.41 66.62 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.263 1.425 . . . . 72.21 112.57 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -97.57 -75.53 0.54 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.273 0.629 . . . . 35.42 110.846 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 129.24 96.08 0.8 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.648 -0.581 . . . . 52.32 111.648 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' C' ' 145' ' ' ALA . 7.5 pt-20 -115.32 125.03 52.76 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.443 0.697 . . . . 63.31 110.185 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.86 87.79 0.08 OUTLIER Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.362 -1.095 . . . . 52.05 110.362 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -157.82 38.85 0.27 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 121.969 0.89 . . . . 52.42 109.537 -172.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 77.27 1.09 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 122.187 0.994 . . . . 73.13 109.622 -178.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -105.96 133.38 50.76 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 107.443 -1.318 . . . . 72.53 107.443 176.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -123.93 -70.0 0.78 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.67 0.388 . . . . 74.52 110.428 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -169.93 111.4 0.44 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.784 0.434 . . . . 71.35 110.394 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -112.04 108.79 18.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.768 0.827 . . . . 71.31 110.306 177.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.959 0 N-CA-C 107.808 -1.182 . . . . 73.41 107.808 177.229 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.457 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 110.321 -0.251 . . . . 74.05 110.321 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -169.67 154.25 5.38 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.406 0.682 . . . . 63.23 110.931 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 57.7 83.06 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.791 1.236 . . . . 72.41 111.665 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -174.46 -169.95 0.48 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.856 0.862 . . . . 75.3 110.253 -173.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.63 -171.85 2.35 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 123.897 0.879 . . . . 74.52 109.913 175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -68.88 87.3 0.36 Allowed 'General case' 0 N--CA 1.483 1.218 0 CA-C-O 121.745 0.783 . . . . 63.21 109.994 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 4.4 m -142.96 170.93 14.77 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.45 -1.25 . . . . 73.04 108.937 -173.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 71.7 111.76 0.06 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.653 1.581 . . . . 73.31 112.104 172.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 15.7 ptm 53.49 175.96 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.652 1.981 . . . . 55.2 114.695 175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.8 p -141.46 127.5 19.51 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.616 1.166 . . . . 74.11 108.096 171.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -122.46 128.09 50.42 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.667 -0.864 . . . . 72.22 108.667 178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -142.84 140.82 31.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.427 0.691 . . . . 63.41 109.176 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.669 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.82 141.52 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.601 -0.888 . . . . 74.53 108.601 172.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.602 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 20.2 mm-40 -106.68 -50.66 3.08 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 122.963 0.505 . . . . 70.24 109.884 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -168.49 149.03 4.69 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.976 0.91 . . . . 72.33 108.567 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' B' ' 109' ' ' TYR . 75.6 mt -128.3 149.31 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 107.708 -1.219 . . . . 65.23 107.708 171.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.567 ' HB3' HG22 ' A' ' 122' ' ' THR . 24.1 p90 -170.87 150.44 3.18 Favored 'General case' 0 C--N 1.344 0.346 0 CA-C-O 121.255 0.55 . . . . 63.21 112.436 -174.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 51.7 m -72.98 122.3 21.48 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.012 -0.995 . . . . 65.14 108.535 167.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 36.7 mtpt -94.33 -33.74 13.08 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.799 0.839 . . . . 73.41 110.563 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 22.9 t70 -152.14 140.52 20.54 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 123.47 0.481 . . . . 72.1 111.103 -166.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.9 mm -140.96 137.54 34.52 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 C-N-CA 124.713 1.205 . . . . 74.42 108.315 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -139.81 108.3 5.87 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.333 -1.358 . . . . 70.1 107.333 174.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.5 t80 -126.11 108.25 11.17 Favored 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 107.451 -1.314 . . . . 63.34 107.451 169.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -118.96 111.42 18.32 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.327 -0.99 . . . . 61.42 108.327 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -107.59 86.97 3.12 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.53 -1.285 . . . . 45.13 107.53 170.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.31 -32.49 41.4 Favored 'Trans proline' 0 C--N 1.378 2.122 0 C-N-CA 122.493 2.129 . . . . 63.32 110.951 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.47 ' HB3' ' HB2' ' B' ' 30' ' ' HIS . 87.0 m-20 -111.87 30.43 7.02 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 114.501 -1.227 . . . . 73.45 109.97 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.3 -46.98 46.41 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.298 1.039 . . . . 51.32 111.964 167.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.486 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 73.6 Cg_endo -76.83 -16.75 16.12 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 122.086 1.858 . . . . 72.53 114.549 174.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' B' ' 27' ' ' ASN . 65.3 m80 -95.97 -16.19 21.86 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 112.872 0.693 . . . . 53.35 112.872 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 35.1 m -79.91 -11.79 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 122.742 0.417 . . . . 64.32 110.041 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -59.74 -43.93 94.01 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 123.584 0.754 . . . . 65.14 109.886 174.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' B' ' 30' ' ' HIS . 16.0 mp0 -81.03 -32.02 34.3 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 116.074 -0.512 . . . . 63.51 110.201 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.57 92.73 7.21 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.475 0.71 . . . . 71.15 111.093 -176.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -89.31 105.98 18.15 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 109.579 -0.526 . . . . 74.53 109.579 176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -172.98 169.23 4.75 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.926 0.89 . . . . 74.33 109.453 175.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.36 114.67 49.18 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 123.877 0.871 . . . . 64.31 108.741 173.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -66.92 150.67 82.99 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.381 2.054 . . . . 74.22 112.392 -177.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 104.94 1.18 Allowed 'General case' 0 C--O 1.242 0.68 0 N-CA-C 108.773 -0.825 . . . . 73.22 108.773 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.2 m -97.57 154.35 3.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 121.885 0.85 . . . . 72.02 111.765 -173.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.652 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 70.2 tttt -147.24 115.17 6.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 113.794 -1.548 . . . . 71.1 107.104 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 mp -86.02 159.39 19.61 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 108.19 -1.041 . . . . 54.41 108.19 171.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.478 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 27.4 t70 -164.94 110.53 0.94 Allowed 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.352 -0.61 . . . . 65.34 109.352 176.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.661 ' HB2' HG11 ' E' ' 123' ' ' VAL . 6.3 mp -102.98 144.48 31.2 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.931 0.396 . . . . 72.54 109.985 -178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -133.68 141.97 47.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.558 1.143 . . . . 72.21 108.683 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.5 t -121.65 139.0 54.1 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.633 -0.506 . . . . 72.22 109.633 177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.61 161.02 41.79 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.224 1.01 . . . . 24.22 109.227 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 33.7 t -144.01 170.23 16.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.071 0.548 . . . . 72.42 109.981 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 21.4 p -155.31 136.2 13.66 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.991 0.916 . . . . 73.14 108.624 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.91 120.58 29.39 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.073 0.549 . . . . 74.42 111.068 -172.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.1 mt -87.3 -37.54 17.07 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.328 -0.619 . . . . 64.51 109.328 172.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.96 -179.48 7.19 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.032 0.933 . . . . 71.32 110.676 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -70.54 125.27 26.33 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.925 -1.034 . . . . 71.13 109.537 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 65.42 10.44 6.56 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.473 1.109 . . . . 61.2 112.385 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -127.33 95.61 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 N-CA-C 108.207 -1.035 . . . . 62.44 108.207 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.427 ' HE1' HD12 ' E' ' 115' ' ' LEU . 75.8 m-85 -117.35 138.11 52.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.875 0.47 . . . . 73.51 109.883 -176.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -102.02 103.47 14.08 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.761 -1.2 . . . . 73.15 107.761 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' B' ' 98' ' ' LEU . 48.7 t -95.3 129.26 45.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 123.721 0.808 . . . . 62.3 109.48 -175.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.486 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.9 t -109.55 129.65 64.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 123.928 0.891 . . . . 70.0 109.844 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -106.75 134.04 50.5 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 107.316 -1.364 . . . . 62.33 107.316 173.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.51 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 27.6 ttm180 -119.19 130.95 55.77 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.857 -0.794 . . . . 61.54 108.857 173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.523 ' HB ' HD11 ' B' ' 114' ' ' ILE . 16.9 t -124.67 123.12 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.38 -0.97 . . . . 64.43 108.38 174.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 33.3 m -108.75 144.85 36.02 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 124.305 1.042 . . . . 73.21 109.512 -177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.462 HG21 HG21 ' B' ' 114' ' ' ILE . 91.0 t -135.94 98.52 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 124.636 1.174 . . . . 41.12 108.21 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 27.4 m -83.07 139.3 33.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.939 -0.763 . . . . 42.33 108.939 169.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.69 140.06 21.37 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 122.839 0.456 . . . . 75.55 110.06 175.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.527 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.3 m -142.1 131.91 24.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.401 0.68 . . . . 72.51 109.835 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.19 108.3 20.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.157 -1.424 . . . . 73.54 107.157 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.01 -118.83 5.75 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.803 -0.919 . . . . 71.02 110.803 -171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -111.93 4.59 18.31 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.276 0.63 . . . . 73.32 111.986 -177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.77 147.28 43.14 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.487 0.715 . . . . 72.45 110.013 178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.3 m -66.05 127.13 30.9 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.021 0.528 . . . . 64.11 111.686 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.527 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -86.99 -54.5 4.3 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.267 -1.012 . . . . 53.5 108.267 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -161.88 157.52 24.04 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 114.739 -1.119 . . . . 72.4 110.062 175.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 84.5 mt -130.82 110.82 11.6 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 106.554 -1.647 . . . . 75.12 106.554 174.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -117.15 136.15 53.24 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.603 -0.888 . . . . 75.15 108.603 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.415 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.6 tt0 -157.61 135.09 10.45 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 109.094 -0.706 . . . . 71.44 109.094 -170.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.28 149.97 34.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.376 -0.829 . . . . 75.33 109.045 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 43.0 mt-30 -123.26 106.04 10.38 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 108.102 -1.073 . . . . 75.1 108.102 167.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.427 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -94.88 101.05 12.83 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.58 -0.896 . . . . 62.44 108.58 175.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.17 171.56 32.65 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.546 -0.622 . . . . 53.54 111.546 175.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.11 141.91 5.99 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.483 -0.647 . . . . 50.42 111.483 -178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 22.1 mt -92.72 128.05 44.5 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 108.811 -0.811 . . . . 72.44 108.811 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -130.06 134.82 47.64 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.048 0.939 . . . . 73.15 108.545 -176.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 52.7 m -107.24 104.27 13.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.568 0.747 . . . . 44.32 109.002 175.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.509 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.14 121.15 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 124.691 1.196 . . . . 73.11 109.365 -176.003 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.5 159.08 40.44 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.908 0.883 . . . . 64.02 109.6 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.52 -43.63 2.77 Favored Glycine 0 C--N 1.346 1.1 0 O-C-N 123.622 0.577 . . . . 73.21 112.805 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.405 ' H ' HG13 ' B' ' 89' ' ' ILE . 1.7 pp -62.49 138.97 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 123.572 0.749 . . . . 72.33 111.105 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -150.3 172.06 15.98 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.128 0.971 . . . . 75.24 110.416 -174.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.76 -128.98 43.86 Favored Glycine 0 C--N 1.351 1.363 0 O-C-N 124.173 0.921 . . . . 65.33 113.496 176.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.2 m -67.81 -30.3 69.68 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.78 0.832 . . . . 74.21 110.814 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -74.72 -33.64 62.42 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.796 -0.638 . . . . 75.43 111.543 -168.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.422 ' SD ' ' HA ' ' E' ' 115' ' ' LEU . 0.0 OUTLIER -72.39 -36.46 68.7 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.162 0.506 . . . . 75.53 110.299 174.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.14 -26.96 66.04 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 114.793 -1.094 . . . . 64.24 111.247 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -86.56 -34.6 19.87 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.384 1.074 . . . . 74.3 110.164 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.02 -63.36 1.32 Allowed 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.258 0.623 . . . . 50.4 111.573 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.461 ' HB2' HG21 ' B' ' 58' ' ' VAL . 1.4 pp -93.75 -3.26 52.49 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 111.958 0.355 . . . . 65.03 111.958 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.11 -16.34 51.01 Favored Glycine 0 C--N 1.348 1.231 0 O-C-N 123.242 0.339 . . . . 61.41 112.674 174.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.37 -52.82 0.72 Allowed 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.219 0.452 . . . . 55.32 112.219 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -70.94 -43.83 67.38 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 111.998 0.37 . . . . 73.13 111.998 -174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.427 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 90.7 m -61.86 -49.97 83.43 Favored Pre-proline 0 CA--C 1.56 1.338 0 CA-C-O 118.5 -0.762 . . . . 63.14 110.917 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 80.0 Cg_exo -54.72 -33.63 80.97 Favored 'Trans proline' 0 C--N 1.391 2.8 0 C-N-CA 122.062 1.841 . . . . 70.35 113.805 168.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.81 -32.49 74.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 122.881 0.472 . . . . 75.24 111.186 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.86 -42.99 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.288 0.635 . . . . 60.01 110.169 173.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 87.4 mt -75.85 -26.61 57.3 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.677 -1.147 . . . . 73.21 111.827 -172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.26 -49.86 82.39 Favored Pre-proline 0 CA--C 1.552 1.042 0 N-CA-C 113.726 1.01 . . . . 72.01 113.726 -170.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.43 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 35.3 Cg_endo -61.38 -31.32 88.47 Favored 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 121.704 1.603 . . . . 73.14 112.58 178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.452 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.8 m-30 -69.06 -45.57 70.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.821 0.848 . . . . 71.2 110.25 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.83 -37.98 89.38 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.335 -0.848 . . . . 62.15 110.798 175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.409 ' HA ' HD23 ' B' ' 128' ' ' LEU . 33.9 ttt180 -59.31 -54.6 44.98 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.652 1.581 . . . . 74.44 111.35 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.57 -33.91 77.02 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.719 0.637 . . . . 52.13 109.854 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.515 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.9 t -68.35 -38.37 81.39 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.163 -0.471 . . . . 74.25 111.075 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.523 HD11 ' HB ' ' B' ' 62' ' ' VAL . 52.6 mt -64.04 -58.74 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 109.685 -0.487 . . . . 53.54 109.685 175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 12.8 m -59.01 -31.3 68.69 Favored 'General case' 0 CA--C 1.55 0.949 0 O-C-N 124.18 0.925 . . . . 65.32 111.368 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 39.2 t -62.01 -54.38 42.4 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.387 0.675 . . . . 73.51 110.48 174.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -62.31 -36.63 82.77 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.19 0.596 . . . . 73.22 110.931 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.2 t -63.0 -42.65 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.074 0.949 . . . . 74.34 110.908 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 27.3 m -68.18 -31.86 71.7 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.328 0.651 . . . . 75.0 111.035 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.412 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 94.6 mtt-85 -68.65 -21.53 64.45 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.552 0.741 . . . . 73.55 110.921 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.11 15.12 61.93 Favored Glycine 0 C--N 1.356 1.685 0 CA-C-O 119.258 -0.746 . . . . 72.31 114.125 175.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.634 HG21 ' HD3' ' A' ' 15' ' ' ARG . 1.9 p 73.59 12.84 4.53 Favored 'General case' 0 N--CA 1.507 2.397 0 C-N-CA 126.377 1.871 . . . . 71.53 113.247 178.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -89.24 149.82 43.66 Favored Pre-proline 0 N--CA 1.476 0.826 0 O-C-N 122.183 -0.323 . . . . 70.35 111.163 -174.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -63.21 163.11 24.11 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.243 2.629 . . . . 31.3 113.667 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.446 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 0.6 OUTLIER -63.57 115.35 4.61 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.232 1.013 . . . . 73.52 111.063 -176.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 4.7 tt -130.11 97.47 4.46 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.074 -1.454 . . . . 72.35 107.074 175.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -92.75 136.07 33.55 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.527 -0.916 . . . . 70.11 108.527 177.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 111' ' ' ARG . 2.6 mm? -75.11 125.13 28.28 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 109.086 -0.709 . . . . 71.04 109.086 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' E' ' 129' ' ' LEU . . . -71.85 153.9 92.92 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 123.267 0.627 . . . . 41.41 111.056 -177.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.39 99.06 0.35 Allowed 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.089 2.526 . . . . 61.15 112.419 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 5.2 p -90.84 113.27 26.37 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 CA-C-O 121.487 0.661 . . . . 60.53 109.336 174.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -76.55 101.9 5.86 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.967 -0.753 . . . . 61.5 108.967 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -59.74 -28.68 67.57 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.102 -0.954 . . . . 72.03 109.898 172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -53.51 -52.72 58.68 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.589 1.556 . . . . 62.33 110.684 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.65 -47.35 79.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 124.458 1.099 . . . . 60.2 111.173 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.652 ' HG ' ' HA ' ' E' ' 123' ' ' VAL . 2.9 tm? -58.84 -54.59 45.42 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 123.81 0.694 . . . . 73.24 110.799 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -63.89 -38.71 92.08 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 123.749 0.656 . . . . 65.22 111.065 -173.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.0 mmm -71.32 -36.24 71.51 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.901 0.48 . . . . 65.43 111.004 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.44 -25.96 54.97 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.197 0.599 . . . . 73.24 111.21 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -61.16 -37.19 81.99 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.591 0.756 . . . . 73.12 111.247 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 pp -120.25 23.04 11.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.21 1.004 . . . . 72.15 111.196 -176.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -79.69 96.5 6.24 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.014 0.525 . . . . 63.54 109.665 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -163.18 -35.76 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.569 0.748 . . . . 74.42 110.583 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 61.57 88.94 0.08 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.804 1.242 . . . . 70.0 108.821 -171.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.31 -43.15 91.96 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.822 0.849 . . . . 64.22 111.713 -174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.68 -163.14 54.36 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.897 -0.592 . . . . 71.54 113.895 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -154.56 -175.76 5.57 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.728 0.811 . . . . 62.24 110.167 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -165.35 125.86 1.41 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.696 -0.562 . . . . 73.42 111.696 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 51.4 p -105.55 135.42 46.99 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.468 0.707 . . . . 54.53 110.134 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -136.97 100.95 4.43 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.714 0.805 . . . . 73.43 109.098 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.99 143.8 26.19 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.87 0.868 . . . . 72.51 110.53 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -129.75 163.63 25.76 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.915 0.886 . . . . 71.11 109.556 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -158.28 128.85 6.21 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.682 -0.858 . . . . 73.05 108.682 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -136.13 95.03 3.12 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.057 0.543 . . . . 71.25 109.813 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.115 0 C-N-CA 123.372 0.669 . . . . 62.23 110.253 178.208 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.989 -0.745 . . . . 73.51 108.989 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.7 p -99.44 39.6 1.29 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.697 0.799 . . . . 62.13 111.655 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.66 82.7 4.06 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-O 122.934 1.35 . . . . 65.32 109.224 175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' F' ' 123' ' ' VAL . 23.3 mm-40 -86.11 84.29 7.54 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 114.876 -1.056 . . . . 73.12 108.647 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 m-20 -73.7 91.04 1.86 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.655 -1.157 . . . . 65.55 110.703 -172.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -153.13 100.04 2.44 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.089 -1.078 . . . . 64.23 108.089 174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 34.9 p -113.75 -4.69 13.36 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.393 0.677 . . . . 75.53 111.807 -176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -85.43 140.36 30.78 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 109.986 -0.375 . . . . 74.52 109.986 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.5 ttm 63.97 115.33 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.469 1.508 . . . . 72.22 111.235 -174.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 11.9 m -87.92 77.54 8.47 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 108.65 -0.87 . . . . 74.23 108.65 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -114.66 137.31 52.05 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.527 -0.76 . . . . 71.5 109.534 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -152.06 134.53 15.3 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.297 0.639 . . . . 73.14 109.483 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 21.4 pt -76.27 136.45 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-N 115.717 -0.674 . . . . 72.44 109.319 173.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -104.68 -49.04 3.62 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.887 0.475 . . . . 64.53 110.005 -178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -166.11 141.46 4.72 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.58 -0.736 . . . . 74.11 109.475 -174.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -129.4 136.02 60.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.827 -1.175 . . . . 65.5 107.827 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.623 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 7.7 p90 -173.11 154.38 2.74 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.306 0.574 . . . . 53.54 111.697 -172.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -77.0 116.64 17.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.342 -0.845 . . . . 55.22 109.052 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.402 ' HD3' ' CE2' ' C' ' 17' ' ' TYR . 26.5 mmtp -70.91 -48.59 52.82 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 107.972 -1.122 . . . . 74.02 107.972 169.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 6.0 t70 -137.02 141.14 42.5 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 113.479 -1.692 . . . . 63.44 109.548 -171.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.9 mt -136.57 141.51 40.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 107.321 -1.363 . . . . 71.53 107.321 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -150.23 141.84 23.55 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.395 -0.594 . . . . 62.4 109.395 176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -142.85 141.71 31.64 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.529 -1.285 . . . . 75.34 107.529 172.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.79 144.0 31.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.569 -1.271 . . . . 73.31 107.569 -178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.478 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -150.47 83.18 6.0 Favored Pre-proline 0 C--O 1.239 0.534 0 N-CA-C 108.386 -0.968 . . . . 44.3 108.386 176.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.07 -15.17 39.43 Favored 'Trans proline' 0 C--N 1.375 1.94 0 C-N-CA 123.026 2.484 . . . . 75.01 112.69 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -126.1 37.89 4.25 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.171 0.988 . . . . 51.34 109.517 176.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.478 ' HB2' ' CB ' ' C' ' 25' ' ' ALA . . . -58.74 -51.74 79.69 Favored Pre-proline 0 CA--C 1.562 1.42 0 N-CA-C 113.809 1.04 . . . . 64.23 113.809 -178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.69 -24.53 7.27 Favored 'Trans proline' 0 C--N 1.391 2.764 0 C-N-CA 121.64 1.56 . . . . 62.43 112.43 173.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.7 t60 -67.75 -22.54 65.21 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.661 1.184 . . . . 73.15 111.802 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.661 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 11.2 p -50.1 -32.29 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.353 1.061 . . . . 62.24 113.8 -174.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -67.4 -31.01 70.92 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.341 0.656 . . . . 73.14 112.001 -178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -118.01 48.84 1.32 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.699 0.8 . . . . 72.41 110.355 -177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 14.6 ptpt -124.41 173.12 8.63 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 109.881 -0.414 . . . . 62.2 109.881 170.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -83.59 113.41 20.8 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.026 -1.101 . . . . 63.52 108.026 169.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.6 p90 -83.76 79.6 9.41 Favored 'General case' 0 CA--C 1.55 0.946 0 CA-C-O 122.268 1.032 . . . . 71.45 110.81 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.719 ' HB3' HD13 ' C' ' 68' ' ' LEU . 48.4 tt0 -123.53 79.63 54.66 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.342 -1.355 . . . . 74.34 107.342 168.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.486 ' HG2' ' HG ' ' E' ' 139' ' ' LEU . 2.8 Cg_exo -77.13 91.08 1.2 Allowed 'Trans proline' 0 C--N 1.373 1.82 0 C-N-CA 123.053 2.502 . . . . 72.04 111.973 -173.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -85.61 91.96 8.42 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 105.9 -1.889 . . . . 63.51 105.9 169.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.0 m -83.5 141.03 15.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.367 -0.833 . . . . 72.44 109.354 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB2' ' NZ ' ' C' ' 41' ' ' LYS . 4.3 ttmp? -127.13 103.75 7.6 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 109.031 -0.729 . . . . 72.25 109.031 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.698 ' H ' HD23 ' C' ' 42' ' ' LEU . 1.6 pt? -89.9 160.71 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.322 -0.853 . . . . 73.22 109.848 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -145.93 117.51 8.06 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.536 0.735 . . . . 41.1 109.216 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.43 120.21 39.64 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.86 -0.793 . . . . 62.1 108.86 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -134.2 140.93 46.84 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.715 1.206 . . . . 70.32 108.786 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 8.1 t -142.57 138.4 30.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.317 0.58 . . . . 65.12 110.455 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.26 177.32 5.41 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.143 0.977 . . . . 55.24 108.934 174.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -151.83 160.33 43.59 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.859 0.361 . . . . 64.2 111.129 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -155.84 140.07 16.58 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.334 1.053 . . . . 75.41 108.614 177.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.46 115.35 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.497 -0.927 . . . . 64.14 108.497 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.585 HD11 HD12 ' C' ' 83' ' ' ILE . 47.5 mt -85.52 -42.62 14.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.005 -0.739 . . . . 63.12 109.005 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.56 179.78 8.08 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.515 -1.22 . . . . 63.53 109.103 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.06 128.01 34.39 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.001 -0.741 . . . . 75.43 109.001 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 70.55 -3.66 1.85 Allowed 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.803 1.241 . . . . 64.31 112.487 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.29 111.22 35.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 108.771 -0.826 . . . . 73.35 108.771 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -126.34 125.47 42.32 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.601 0.761 . . . . 63.43 109.124 -173.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.542 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.9 tt0 -84.5 137.75 33.16 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.696 0.798 . . . . 52.12 109.166 171.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.43 HG23 HD11 ' C' ' 106' ' ' LEU . 29.3 m -124.25 140.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 108.344 -0.984 . . . . 40.12 108.344 165.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' C' ' 46' ' ' THR . 47.5 t -117.51 103.6 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 108.397 -0.964 . . . . 65.24 108.397 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -88.64 96.8 10.79 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.258 -1.016 . . . . 72.21 108.258 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -85.67 126.78 34.2 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 114.817 -1.083 . . . . 73.44 109.663 175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.9 t -115.18 134.18 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 108.276 -1.009 . . . . 43.33 108.276 171.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 4.4 m -118.98 141.71 48.43 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.468 -0.938 . . . . 74.54 108.468 172.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.581 HG21 HG21 ' C' ' 114' ' ' ILE . 86.3 t -128.64 117.24 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 C-N-CA 124.668 1.187 . . . . 65.33 108.356 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 19.8 m -99.87 144.37 29.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.438 -1.319 . . . . 71.45 107.438 165.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.84 106.7 6.24 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.354 -1.721 . . . . 51.4 106.354 174.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.2 m -152.45 160.96 43.21 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.557 0.535 . . . . 72.41 110.815 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.719 HD13 ' HB3' ' C' ' 37' ' ' GLN . 20.0 tp -79.27 -50.26 11.19 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.172 -1.047 . . . . 70.15 108.172 162.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -168.4 -77.31 0.04 OUTLIER Glycine 0 C--N 1.343 0.946 0 N-CA-C 110.068 -1.213 . . . . 63.31 110.068 175.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -89.99 -31.3 17.28 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.229 -0.656 . . . . 75.21 109.229 170.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -78.05 93.38 4.49 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.277 1.031 . . . . 63.15 109.933 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.0 m -87.91 130.57 34.88 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.932 0.493 . . . . 42.33 111.65 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.25 -65.07 0.82 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.167 0.987 . . . . 61.33 108.943 169.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -156.54 164.0 38.72 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 123.797 0.686 . . . . 52.43 111.622 176.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.445 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.5 tm? -121.66 144.65 48.64 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 106.655 -1.609 . . . . 55.43 106.655 168.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.445 ' N ' HD13 ' C' ' 75' ' ' LEU . 41.9 t -148.14 150.95 34.75 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 108.777 -0.823 . . . . 60.34 108.777 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -159.69 131.59 6.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 122.724 0.409 . . . . 62.11 110.078 177.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 72.6 t -129.95 114.64 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 123.867 0.867 . . . . 72.22 108.757 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.5 mt-30 -90.24 88.6 7.29 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.036 -1.098 . . . . 75.31 108.036 172.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.62 107.22 12.23 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.892 -1.049 . . . . 74.02 109.512 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.95 154.95 27.13 Favored Glycine 0 C--N 1.34 0.773 0 N-CA-C 112.147 -0.381 . . . . 71.01 112.147 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.05 122.87 1.24 Allowed Glycine 0 C--N 1.332 0.322 0 N-CA-C 111.382 -0.687 . . . . 71.34 111.382 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.585 HD12 HD11 ' C' ' 51' ' ' LEU . 10.0 mm -87.9 123.47 40.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.397 -0.964 . . . . 70.22 108.397 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.32 123.33 22.75 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.555 0.742 . . . . 73.32 110.053 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 70.3 m -76.93 112.15 13.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 122.822 0.449 . . . . 55.43 109.821 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 47.5 mt -116.42 112.12 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 108.308 -0.997 . . . . 74.12 108.308 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -148.01 165.66 30.08 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.741 0.817 . . . . 71.05 110.255 -177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.66 -24.42 8.71 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.156 -0.474 . . . . 63.21 113.765 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.561 HD11 ' HB3' ' C' ' 93' ' ' GLN . 19.8 tt -123.48 151.66 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.403 1.081 . . . . 62.03 109.558 -174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -149.75 161.0 43.09 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 123.205 0.602 . . . . 63.14 110.606 -173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.1 -153.61 22.4 Favored Glycine 0 C--N 1.351 1.403 0 C-N-CA 122.986 0.327 . . . . 72.12 112.856 175.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.5 m -59.53 -26.55 65.44 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.997 0.919 . . . . 73.41 110.454 174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.561 ' HB3' HD11 ' C' ' 89' ' ' ILE . 36.8 mt-30 -61.1 -49.84 75.67 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 113.904 -1.498 . . . . 64.44 110.799 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.32 -21.33 46.09 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 116.273 -0.422 . . . . 73.23 110.694 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.08 -36.08 83.17 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.034 0.533 . . . . 64.24 110.57 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -66.09 -31.13 71.81 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.539 -0.755 . . . . 72.32 110.508 172.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.3 t -72.98 -59.27 2.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.67 0.388 . . . . 75.31 110.737 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.1 tt -74.14 -51.05 16.79 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.434 0.694 . . . . 74.33 111.108 -173.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.27 6.53 81.03 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.383 -0.676 . . . . 44.1 114.599 -169.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.15 -57.22 0.37 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 117.906 0.853 . . . . 75.53 111.829 -177.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -68.49 -54.05 19.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.289 0.636 . . . . 74.22 111.233 -173.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 76.7 m -59.3 -46.96 99.07 Favored Pre-proline 0 CA--C 1.565 1.539 0 C-N-CA 123.863 0.865 . . . . 74.42 112.597 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -64.3 -33.55 58.85 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 121.954 1.769 . . . . 63.11 113.378 171.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.36 -21.6 63.8 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 122.918 0.487 . . . . 55.41 111.78 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.524 HD12 ' NH1' ' A' ' 111' ' ' ARG . 32.4 mm -73.75 -39.35 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.216 0.606 . . . . 73.13 109.492 170.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.543 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.5 mt -75.44 -26.85 58.64 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.077 -0.965 . . . . 63.14 111.735 -176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -54.98 -49.87 89.63 Favored Pre-proline 0 CA--C 1.558 1.255 0 CA-C-O 117.993 -1.003 . . . . 71.53 113.12 -175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.58 -39.96 73.97 Favored 'Trans proline' 0 C--N 1.387 2.578 0 C-N-CA 122.227 1.951 . . . . 63.11 113.879 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -69.98 -45.27 67.71 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.132 0.573 . . . . 75.03 110.882 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.21 81.06 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.248 0.619 . . . . 70.23 110.09 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 46.5 ttt180 -63.73 -50.12 70.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.108 1.363 . . . . 72.14 111.244 -174.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.46 -28.53 66.17 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.704 0.402 . . . . 72.01 110.109 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.6 t -69.33 -35.98 76.48 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 122.778 0.431 . . . . 74.32 110.71 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.581 HG21 HG21 ' C' ' 64' ' ' VAL . 93.4 mt -71.25 -53.23 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 N-CA-C 109.49 -0.559 . . . . 72.25 109.49 174.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.6 m -61.32 -28.91 69.54 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 123.794 0.838 . . . . 71.01 111.336 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 38.9 t -65.94 -50.34 64.72 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.084 -0.71 . . . . 50.44 109.084 170.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.519 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.85 -31.89 71.31 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.954 0.901 . . . . 73.13 112.436 179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.493 HG23 ' O ' ' C' ' 114' ' ' ILE . 43.9 t -71.66 -38.9 68.43 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 109.199 -0.667 . . . . 64.02 109.199 176.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.3 t -66.47 -29.9 70.13 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.853 0.861 . . . . 63.13 111.377 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -74.16 -42.74 59.46 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 123.43 0.692 . . . . 71.23 109.893 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -72.52 -7.33 68.46 Favored Glycine 0 C--N 1.352 1.424 0 O-C-N 123.418 0.449 . . . . 75.04 112.417 170.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 63.14 30.25 16.06 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.937 2.095 . . . . 73.1 112.561 175.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -82.77 162.32 55.68 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 114.639 -1.164 . . . . 74.11 108.409 166.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.71 140.27 92.72 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.41 2.074 . . . . 74.13 111.639 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.446 ' HG2' ' HB2' ' B' ' 125' ' ' GLN . 13.1 mm100 -57.59 112.55 1.47 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.891 0.877 . . . . 71.15 111.897 -173.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 37.0 tp -107.43 93.21 4.42 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.45 -0.945 . . . . 74.02 108.45 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -102.27 127.75 49.11 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.665 -1.152 . . . . 75.24 108.554 175.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.532 HD11 HG22 ' C' ' 64' ' ' VAL . 86.8 mt -81.39 144.69 31.26 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.039 0.535 . . . . 70.32 111.114 -174.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.23 143.26 95.64 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.323 0.649 . . . . 70.51 110.421 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -62.52 139.49 76.45 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.634 2.223 . . . . 64.31 112.33 177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.25 118.2 45.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 N-CA-C 108.888 -0.782 . . . . 73.41 108.888 176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.556 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 4.2 m-20 -83.87 60.24 5.68 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.864 0.84 . . . . 71.41 109.99 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -78.91 -43.43 24.85 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.844 -1.071 . . . . 74.2 110.034 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -70.99 -37.09 72.71 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.792 -0.64 . . . . 64.42 109.694 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -62.27 -29.82 70.69 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 124.267 1.027 . . . . 63.31 111.757 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.623 HD12 HD21 ' E' ' 148' ' ' LEU . 9.5 tt -52.93 -51.11 62.48 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.85 0.86 . . . . 61.43 110.246 171.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -74.47 -27.14 60.44 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.624 -0.716 . . . . 74.15 111.279 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 95.8 mmm -69.41 -31.05 69.16 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.288 0.635 . . . . 55.2 111.462 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -63.81 -39.35 94.04 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.779 0.675 . . . . 52.13 110.171 175.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 59.7 t80 -71.52 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.524 -0.762 . . . . 73.45 110.779 177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.0 mm? 58.42 167.74 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.246 1.018 . . . . 60.11 112.545 -168.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -161.56 92.82 0.9 Allowed 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.524 -0.762 . . . . 73.22 109.14 173.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -160.69 135.42 7.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.189 -0.914 . . . . 64.3 109.077 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -86.59 149.1 25.17 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.548 0.739 . . . . 65.32 110.086 -176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.545 ' HB3' ' HB3' ' A' ' 147' ' ' GLU . . . -144.68 -168.35 2.89 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.113 0.965 . . . . 71.44 109.061 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 163.18 99.64 0.14 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.773 -0.931 . . . . 72.3 110.773 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.36 171.74 0.74 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.749 0.82 . . . . 73.41 112.034 174.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 100.42 -47.28 1.27 Allowed Glycine 0 C--N 1.338 0.666 0 CA-C-N 115.699 -0.682 . . . . 44.03 111.903 175.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -69.78 123.5 21.58 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.705 -0.85 . . . . 63.21 108.705 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -75.03 -8.18 55.79 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.363 0.665 . . . . 64.43 112.634 -172.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -150.76 174.87 12.55 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.386 0.674 . . . . 63.33 110.768 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -82.46 90.59 6.75 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-O 121.788 0.804 . . . . 75.45 109.976 -178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -145.91 173.47 12.11 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.687 0.795 . . . . 71.43 109.589 178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -74.03 160.42 31.32 Favored 'General case' 0 C--O 1.247 0.942 0 CA-C-N 116.198 -0.456 . . . . 63.32 109.918 172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 N-CA-C 108.743 -0.836 . . . . 52.51 108.743 -179.217 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mpp? . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.287 -0.634 . . . . 62.32 109.287 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 45.4 t -124.86 13.55 8.54 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.421 1.089 . . . . 63.33 110.599 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 60.97 91.33 0.06 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.807 1.243 . . . . 73.44 109.249 -167.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -64.95 93.25 0.11 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 114.971 -1.013 . . . . 54.02 110.247 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -91.64 102.21 14.84 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.921 0.888 . . . . 72.42 109.26 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -61.78 -30.09 70.58 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.477 1.111 . . . . 70.31 111.836 -177.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 m -67.38 -45.74 75.35 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.315 0.646 . . . . 75.42 111.433 -175.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -87.67 -14.28 40.34 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 118.886 -0.578 . . . . 74.23 111.65 -174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.5 ttp -30.24 125.31 0.16 Allowed 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.906 1.283 . . . . 75.22 113.289 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -122.95 142.41 50.85 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 123.588 0.755 . . . . 71.42 109.301 177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -155.04 98.9 2.06 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.658 -1.238 . . . . 70.41 107.658 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -127.7 132.62 49.62 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.269 0.628 . . . . 65.24 109.82 -176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 tp -89.61 128.21 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 C-N-CA 123.15 0.58 . . . . 61.23 109.548 177.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -99.62 -40.5 7.76 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.835 0.854 . . . . 74.24 111.037 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 45.7 ttt180 -163.04 123.44 2.31 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.772 -0.649 . . . . 72.1 110.471 -162.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.93 132.1 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 107.294 -1.373 . . . . 62.5 107.294 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.544 ' HE1' HG13 ' D' ' 83' ' ' ILE . 12.4 p90 -160.04 143.52 14.03 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.957 0.786 . . . . 74.54 111.476 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -76.1 117.48 17.85 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 114.943 -1.026 . . . . 73.21 108.917 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -82.59 -26.14 32.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.91 0.386 . . . . 64.21 109.99 175.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.7 t70 -154.11 141.69 19.85 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 114.848 -1.069 . . . . 63.21 109.437 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.519 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.1 mt -141.63 145.98 23.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 C-N-CA 125.221 1.408 . . . . 73.21 107.544 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 15.2 t -147.34 141.72 26.35 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.986 0.914 . . . . 73.02 108.69 176.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 79.9 t80 -153.77 124.89 7.38 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.285 -1.746 . . . . 55.32 106.285 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -141.43 112.66 7.43 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 118.596 0.634 . . . . 71.11 110.27 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.9 91.37 12.6 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.38 0.672 . . . . 42.02 109.353 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.5 -43.87 0.45 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.759 2.306 . . . . 55.13 112.919 -175.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 44.6 m-80 -99.63 43.42 1.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.754 0.822 . . . . 70.34 109.056 178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.623 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.78 -52.36 73.04 Favored Pre-proline 0 CA--C 1.57 1.737 0 N-CA-C 114.742 1.386 . . . . 75.42 114.742 -169.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.5 -6.0 8.09 Favored 'Trans proline' 0 C--N 1.388 2.656 0 CA-C-N 121.524 1.58 . . . . 63.14 112.578 172.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.51 ' HA ' HE21 ' D' ' 33' ' ' GLN . 21.8 t-160 -81.09 -42.15 21.43 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.08 0.952 . . . . 74.35 110.048 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.11 -18.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.27 0.628 . . . . 74.24 110.052 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -62.98 -29.62 70.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.949 0.9 . . . . 75.41 110.876 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.51 HE21 ' HA ' ' D' ' 30' ' ' HIS . 43.5 mt-30 -68.55 -17.71 64.2 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.675 0.79 . . . . 70.44 111.841 177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -109.07 109.97 21.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.768 0.827 . . . . 72.02 110.168 -178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' F' ' 135' ' ' ALA . 4.8 m-20 -79.73 81.99 5.91 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.99 0.916 . . . . 74.13 110.882 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -159.42 161.35 35.56 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.654 -0.499 . . . . 73.24 109.654 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.433 ' HG3' ' HA ' ' F' ' 139' ' ' LEU . 1.5 mp0 -82.9 109.07 14.62 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.876 0.87 . . . . 74.54 109.792 173.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -50.19 140.37 33.42 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.44 2.76 . . . . 74.54 113.569 175.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.446 ' HG3' HD22 ' F' ' 141' ' ' LEU . 36.2 tt0 -57.73 127.29 31.31 Favored 'General case' 0 C--O 1.241 0.632 0 O-C-N 124.051 0.845 . . . . 63.24 110.116 175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.573 ' HB ' ' HA ' ' F' ' 142' ' ' ILE . 88.7 t -96.33 105.84 17.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.734 -0.839 . . . . 63.3 108.734 -176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -102.78 108.85 20.23 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.217 -1.401 . . . . 74.12 107.217 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.647 HD13 HD21 ' D' ' 128' ' ' LEU . 1.5 pt? -116.3 149.85 38.59 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.065 0.46 . . . . 72.51 110.498 -174.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -140.69 130.27 24.09 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.395 1.078 . . . . 51.25 108.289 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.21 131.13 54.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.222 0.609 . . . . 62.45 109.503 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.1 t70 -133.55 128.95 36.36 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 107.853 -1.166 . . . . 74.41 107.853 177.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.7 t -106.23 150.03 26.29 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.522 0.329 . . . . 74.55 110.211 179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.13 169.02 22.27 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.8 0.84 . . . . 71.21 110.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.4 m -147.87 158.73 44.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.874 0.869 . . . . 65.21 110.019 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.9 t -155.35 118.42 4.35 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.17 -1.048 . . . . 64.33 108.17 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -74.62 123.14 24.3 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.147 -0.686 . . . . 64.44 109.147 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' D' ' 57' ' ' GLU . 51.2 mt -96.21 -31.54 12.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.547 . . . . 71.41 110.366 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 179.64 8.18 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.857 0.863 . . . . 75.31 110.088 177.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -71.06 121.34 18.06 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.906 -1.043 . . . . 71.43 109.274 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 68.24 17.01 9.36 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.994 1.318 . . . . 71.21 112.069 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 77.9 t -130.36 116.68 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.786 -0.82 . . . . 64.21 108.786 174.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.628 ' HB2' HD13 ' D' ' 86' ' ' ILE . 82.6 m-85 -129.15 129.83 45.64 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.736 -0.839 . . . . 71.11 108.736 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.456 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.5 tt0 -87.79 135.37 33.41 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.845 -1.071 . . . . 73.14 108.64 171.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.1 t -116.02 139.2 43.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.853 -1.166 . . . . 71.5 107.853 173.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 46.2 t -122.69 131.84 72.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 108.39 -0.967 . . . . 71.44 108.39 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -114.58 117.14 30.06 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 107.267 -1.383 . . . . 73.22 107.267 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 44.6 ttm-85 -95.78 98.72 10.66 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.59 -1.263 . . . . 61.42 107.59 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.567 HG21 ' HB1' ' D' ' 110' ' ' ALA . 47.6 t -99.21 113.81 35.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 108.031 -1.1 . . . . 71.12 108.031 174.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 11.2 m -117.3 132.23 56.65 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.662 -0.699 . . . . 72.31 109.232 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 58.4 t -133.28 107.1 10.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.964 0.906 . . . . 72.45 109.286 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.8 m -92.57 119.77 32.35 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.687 -0.857 . . . . 74.3 108.687 167.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.73 137.11 46.33 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 108.699 -0.852 . . . . 44.05 108.699 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.426 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 57.3 p -149.15 140.38 23.12 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 122.846 0.459 . . . . 55.3 109.951 -176.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 28.6 tp -131.86 130.18 41.36 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.386 -1.338 . . . . 73.44 107.386 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.23 -121.14 12.91 Favored Glycine 0 CA--C 1.531 1.034 0 N-CA-C 111.706 -0.557 . . . . 74.42 111.706 -172.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -115.15 6.95 15.23 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.247 1.019 . . . . 74.1 111.402 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -113.95 150.19 34.13 Favored 'General case' 0 C--O 1.247 0.934 0 C-N-CA 123.118 0.567 . . . . 71.43 109.751 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.6 m -79.8 116.72 20.13 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 109.814 -0.439 . . . . 73.02 109.814 175.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.11 -56.08 10.14 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.824 0.849 . . . . 72.23 110.102 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.54 169.19 23.47 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.021 -0.991 . . . . 75.33 110.211 170.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.4 mt -124.41 153.26 42.17 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.759 1.224 . . . . 73.14 108.012 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.517 ' SG ' HG12 ' D' ' 114' ' ' ILE . 47.2 t -158.43 139.66 13.27 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.137 0.575 . . . . 64.04 109.638 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.27 130.66 8.79 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 108.896 -0.779 . . . . 70.43 108.896 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 85.5 t -129.74 115.29 33.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 109.076 -0.713 . . . . 72.33 109.076 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.2 mt-30 -89.36 83.4 6.41 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 122.302 1.048 . . . . 62.44 108.478 170.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -79.79 102.97 9.37 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 113.174 -1.83 . . . . 52.02 109.509 -177.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.2 162.71 23.87 Favored Glycine 0 C--N 1.338 0.663 0 CA-C-N 116.319 -0.401 . . . . 33.33 112.393 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.0 136.77 5.08 Favored Glycine 0 C--N 1.336 0.57 0 N-CA-C 110.951 -0.86 . . . . 72.23 110.951 176.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.544 HG13 ' HE1' ' D' ' 17' ' ' TYR . 69.2 mt -89.48 120.83 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 108.814 -0.81 . . . . 73.13 108.814 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -121.4 147.12 46.14 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.565 -0.531 . . . . 64.41 109.565 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 66.1 m -94.58 106.94 18.94 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 108.794 -0.817 . . . . 74.01 108.794 170.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.653 HG21 ' HG2' ' D' ' 94' ' ' MET . 3.5 mp -107.26 107.69 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.33 -0.989 . . . . 63.55 108.33 178.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.46 148.81 50.3 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.121 0.568 . . . . 62.43 109.977 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.43 -22.71 11.93 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.073 -0.512 . . . . 64.44 114.273 171.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.566 HG22 ' HB2' ' D' ' 94' ' ' MET . 32.5 mm -136.41 139.89 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 107.247 -1.39 . . . . 72.34 107.247 176.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.01 179.7 7.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.182 0.593 . . . . 72.01 109.996 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.64 -99.83 0.7 Allowed Glycine 0 C--N 1.337 0.603 0 CA-C-N 116.297 -0.41 . . . . 73.45 113.762 174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.7 p -83.45 -56.1 3.93 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.077 0.551 . . . . 42.4 111.977 -168.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.03 -37.63 78.73 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 120.796 0.332 . . . . 62.31 110.85 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.653 ' HG2' HG21 ' D' ' 86' ' ' ILE . 44.5 tpp -77.31 -19.93 55.7 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.956 -0.565 . . . . 73.12 111.751 -177.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.63 -32.49 70.48 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 120.996 0.427 . . . . 62.13 111.124 172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -62.65 -40.57 97.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.244 -0.889 . . . . 74.25 110.988 174.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.409 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 38.5 t -72.26 -51.26 21.71 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.786 0.434 . . . . 73.04 110.27 -178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.5 HD13 ' HG3' ' D' ' 94' ' ' MET . 10.7 mp -67.37 -18.86 65.31 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.466 0.706 . . . . 73.3 111.796 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.04 -2.94 56.96 Favored Glycine 0 C--N 1.348 1.229 0 CA-C-O 119.372 -0.682 . . . . 61.21 114.056 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.69 -62.79 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 117.95 0.875 . . . . 53.03 111.999 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -71.06 -50.08 37.8 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 112.826 0.676 . . . . 72.12 112.826 -170.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.431 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 18.6 m -62.67 -45.23 88.3 Favored Pre-proline 0 CA--C 1.561 1.387 0 C-N-CA 123.373 0.669 . . . . 62.14 111.877 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.547 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 75.9 Cg_exo -55.99 -37.63 95.85 Favored 'Trans proline' 0 C--N 1.391 2.809 0 C-N-CA 121.985 1.79 . . . . 61.23 113.057 168.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -64.82 -32.47 74.17 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.537 0.735 . . . . 65.24 111.143 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.14 -41.97 90.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 123.283 0.633 . . . . 75.33 110.136 173.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 70.9 mt -77.42 -17.96 57.67 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.172 -0.922 . . . . 60.31 111.541 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -61.98 -44.19 89.09 Favored Pre-proline 0 CA--C 1.563 1.459 0 N-CA-C 114.181 1.178 . . . . 71.45 114.181 -173.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -51.23 -41.9 56.28 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.156 1.904 . . . . 64.35 112.808 171.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -77.98 -32.62 51.38 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.153 -0.93 . . . . 73.13 111.597 -178.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.567 ' HB1' HG21 ' D' ' 62' ' ' VAL . . . -62.86 -55.61 24.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.593 0.757 . . . . 63.41 109.441 177.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.0 ttp180 -57.07 -40.45 76.89 Favored 'General case' 0 C--O 1.218 -0.601 0 CA-C-N 114.025 -1.443 . . . . 73.12 110.337 176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 3.4 tm-20 -57.42 -53.55 56.84 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.73 0.812 . . . . 75.23 111.742 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.404 ' O ' ' HG3' ' D' ' 117' ' ' MET . 42.6 t -57.74 -42.22 83.45 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.018 0.824 . . . . 71.41 110.935 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.517 HG12 ' SG ' ' D' ' 76' ' ' CYS . 60.6 mt -63.35 -54.15 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-N 115.348 -0.842 . . . . 72.51 110.642 174.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.516 HG23 ' HG3' ' D' ' 125' ' ' GLN . 48.0 m -54.02 -38.03 64.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.413 1.485 . . . . 71.24 111.389 -175.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -73.02 -44.49 60.83 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.062 -0.972 . . . . 73.2 110.462 178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' D' ' 113' ' ' CYS . 73.4 mtm -65.2 -31.02 71.98 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 122.785 0.434 . . . . 52.24 111.803 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' D' ' 123' ' ' PHE . 79.4 t -66.36 -47.55 83.74 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 124.008 0.817 . . . . 74.02 109.771 176.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.8 p -70.49 -27.91 64.57 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 123.356 0.41 . . . . 73.12 111.06 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -73.5 -34.79 65.45 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.794 0.838 . . . . 73.05 110.044 173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.45 -1.56 88.73 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 115.663 -0.698 . . . . 71.31 112.008 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.4 p 58.94 34.69 23.76 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.753 2.021 . . . . 72.42 112.784 174.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.448 ' HB2' HG13 ' D' ' 118' ' ' VAL . 68.7 m-85 -96.45 163.58 20.25 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-N 114.489 -1.232 . . . . 70.1 108.287 170.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.28 139.62 72.77 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.02 1.814 . . . . 74.1 111.025 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.516 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.3 tt0 -55.21 135.23 49.78 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.716 0.807 . . . . 73.31 112.189 -173.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.403 HD23 HG21 ' D' ' 114' ' ' ILE . 58.7 tp -103.02 104.84 15.06 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.491 -0.929 . . . . 73.12 108.491 -175.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -98.42 84.5 3.21 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.205 -1.406 . . . . 75.42 107.205 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.647 HD21 HD13 ' D' ' 42' ' ' LEU . 0.5 OUTLIER -63.78 115.41 4.77 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.07 -1.085 . . . . 74.43 108.07 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.11 135.35 90.67 Favored Pre-proline 0 CA--C 1.544 0.717 0 O-C-N 124.153 0.908 . . . . 44.14 111.554 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.18 107.25 0.27 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.663 2.242 . . . . 71.54 111.567 173.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.6 m -107.33 144.38 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.69 0.796 . . . . 63.33 109.455 -176.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.461 ' H ' HD21 ' F' ' 148' ' ' LEU . 50.5 t-20 -82.15 101.45 10.44 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.138 -0.69 . . . . 74.3 109.138 -178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -62.17 -31.9 72.46 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.733 0.813 . . . . 74.5 111.374 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.71 -40.23 80.08 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 123.93 0.769 . . . . 72.3 110.33 -177.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.38 -34.17 77.13 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.111 0.564 . . . . 54.51 111.276 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -76.71 -32.51 57.88 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.622 -0.717 . . . . 74.12 109.566 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -64.28 -31.99 73.41 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.875 0.87 . . . . 63.42 110.412 178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 14.2 mmt -57.52 -46.9 83.28 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 121.553 0.692 . . . . 73.41 109.187 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -65.12 -36.62 84.85 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 114.467 -1.242 . . . . 71.14 111.2 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -59.23 -41.93 89.86 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.625 0.77 . . . . 73.13 111.237 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -65.44 -30.67 71.49 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.324 0.649 . . . . 74.13 111.066 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.66 3.35 29.33 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.63 0.772 . . . . 70.52 111.666 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -120.91 92.46 3.77 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.148 0.979 . . . . 74.1 109.331 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -143.7 133.71 24.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.495 0.718 . . . . 71.23 109.687 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.5 168.81 17.94 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.924 0.89 . . . . 51.31 110.209 -177.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -133.08 142.25 13.74 Favored Glycine 0 C--N 1.339 0.724 0 N-CA-C 111.076 -0.81 . . . . 73.41 111.076 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -137.52 123.24 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.121 -1.066 . . . . 60.35 108.121 -178.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -153.63 142.58 9.3 Favored Glycine 0 C--N 1.342 0.915 0 N-CA-C 111.339 -0.705 . . . . 64.34 111.339 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.3 m -132.46 124.69 29.06 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.147 0.579 . . . . 72.31 110.065 -176.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -73.84 159.86 32.27 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.338 0.655 . . . . 63.12 110.013 173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -80.45 149.62 30.04 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.066 0.546 . . . . 72.02 110.245 -176.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -73.57 -34.95 65.38 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.447 -0.575 . . . . 72.02 109.447 172.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -163.6 104.61 0.94 Allowed 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 107.065 -1.457 . . . . 63.3 107.065 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -80.84 103.62 10.8 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 109.103 -0.703 . . . . 35.14 109.103 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.943 0 C-N-CA 123.21 0.604 . . . . 72.23 110.185 179.327 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 . . . . . 0 N--CA 1.483 1.219 0 CA-C-O 119.848 -0.12 . . . . 71.21 110.75 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 66.58 28.87 9.18 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 124.55 1.14 . . . . 65.11 112.671 173.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -136.06 -16.93 1.64 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.01 0.524 . . . . 71.24 111.944 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -102.76 142.72 33.43 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.495 0.718 . . . . 75.23 109.46 173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -65.68 127.5 32.16 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 123.928 0.768 . . . . 74.15 110.887 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -77.67 -77.21 0.16 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.068 -1.086 . . . . 73.04 108.068 169.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt 174.58 -46.69 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.103 1.361 . . . . 73.42 107.569 -175.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.427 HD12 ' HE1' ' B' ' 56' ' ' TYR . 27.1 mt 50.38 75.14 0.19 Allowed 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.96 1.413 . . . . 74.13 110.698 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . 0.425 ' HA ' HD11 ' B' ' 98' ' ' LEU . 72.6 t80 -166.65 136.33 2.47 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 115.493 -0.776 . . . . 75.15 109.211 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -54.05 133.85 57.12 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.919 2.413 . . . . 74.13 112.988 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -48.41 -40.29 25.41 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 125.054 1.342 . . . . 73.41 112.369 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 22.6 p -143.46 -55.16 0.39 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.331 1.052 . . . . 74.1 108.627 174.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 5.7 t90 80.43 -19.86 0.41 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 126.315 1.846 . . . . 71.1 110.48 -172.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 30.3 t70 70.87 -87.96 0.03 OUTLIER 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.774 1.63 . . . . 52.54 111.183 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.86 143.05 0.31 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.959 0.904 . . . . 74.4 109.13 -173.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . 0.661 HG11 ' HB2' ' B' ' 44' ' ' LEU . 8.1 p -74.47 94.19 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.008 0 CA-C-O 122.292 1.044 . . . . 55.2 110.525 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -89.02 91.49 8.85 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.636 -0.875 . . . . 61.25 108.636 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -105.28 -171.2 1.87 Allowed 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.919 -1.037 . . . . 61.15 108.951 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -74.43 4.15 6.4 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.106 0.78 . . . . 74.21 113.106 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 75.99 -85.75 0.89 Allowed Glycine 0 C--N 1.351 1.406 0 N-CA-C 111.915 -0.474 . . . . 72.21 111.915 176.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -79.85 107.74 12.87 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.449 -0.574 . . . . 74.31 109.449 175.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . 0.44 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . 0.0 OUTLIER -62.36 -20.67 64.64 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.192 0.997 . . . . 73.25 112.343 179.069 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.435 HG13 HD13 ' E' ' 129' ' ' LEU . 52.2 mt -66.24 95.31 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 124.347 1.059 . . . . 61.11 109.967 -179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.55 -43.84 46.51 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.991 0.516 . . . . 74.21 110.293 176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 19.8 p90 -148.22 116.79 4.07 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.846 0.858 . . . . 62.12 109.153 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.52 164.78 10.8 Favored 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.481 2.121 . . . . 73.11 112.359 173.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.98 -45.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.152 0.581 . . . . 73.13 110.026 176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 74.97 -34.72 0.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.712 1.605 . . . . 74.22 112.86 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 21.8 t 68.56 12.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 125.366 1.466 . . . . 70.21 110.282 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 62.38 171.17 0.13 Allowed 'General case' 0 C--N 1.364 1.225 0 C-N-CA 125.584 1.554 . . . . 75.41 113.064 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.54 115.52 5.84 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.885 -0.598 . . . . 72.5 109.665 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . 0.486 ' HG ' ' HG2' ' C' ' 38' ' ' PRO . 9.8 mp -65.55 89.33 0.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.875 0.734 . . . . 61.14 109.428 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 18.6 m -88.88 176.36 7.07 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 114.336 -1.302 . . . . 55.12 109.826 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 56.5 mt 68.39 5.04 4.53 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.624 1.17 . . . . 73.55 112.126 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 30.6 pt -78.1 -41.74 27.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 C-N-CA 123.305 0.642 . . . . 75.33 109.554 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -160.41 119.09 2.64 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 126.141 1.776 . . . . 72.44 107.27 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -74.01 -73.4 0.23 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.943 -0.762 . . . . 72.43 108.943 177.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -144.96 -165.25 2.12 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.327 1.051 . . . . 64.23 109.112 175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 70.28 -172.36 0.17 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 124.75 1.22 . . . . 73.31 111.303 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -152.73 -76.69 0.12 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 107.436 -1.32 . . . . 60.12 107.436 172.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.623 HD21 HD12 ' C' ' 136' ' ' LEU . 9.6 tt -161.68 96.28 1.28 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 107.523 -1.288 . . . . 64.31 107.523 -177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.561 1.866 0 C-N-CA 123.235 2.623 . . . . 74.13 111.258 174.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 109.704 -0.48 . . . . 74.32 109.704 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.48 103.89 5.4 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.584 0.753 . . . . 74.21 109.054 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.82 161.06 22.09 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.722 -0.473 . . . . 52.03 109.722 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -127.1 -170.09 2.15 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.246 1.018 . . . . 61.44 109.214 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 73.99 165.95 0.29 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.557 1.143 . . . . 72.24 111.798 178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -93.89 149.04 21.58 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.135 -0.939 . . . . 72.13 110.22 -176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' F' ' 114' ' ' LYS . 0.4 OUTLIER -92.08 83.51 5.14 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.064 -1.087 . . . . 74.31 108.064 175.159 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.7 103.37 0.42 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.48 -0.782 . . . . 75.32 110.175 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -170.21 79.33 0.61 Allowed Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 124.113 0.883 . . . . 73.44 109.507 173.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.6 -52.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.429 2.086 . . . . 72.44 112.174 176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -89.3 -171.76 3.37 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.193 0.997 . . . . 75.31 109.108 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 76.1 m -134.63 -74.51 0.47 Allowed 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.086 0.554 . . . . 74.22 110.327 178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -171.96 132.21 0.68 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.643 -1.243 . . . . 73.42 107.643 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -85.47 -161.11 0.57 Allowed 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 122.974 0.51 . . . . 73.12 110.582 -174.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -83.05 44.6 0.95 Allowed 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.234 1.014 . . . . 51.2 112.189 -175.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.403 ' HA ' ' OE1' ' C' ' 4' ' ' GLN . 16.1 t -84.54 71.42 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.652 0 N-CA-C 108.24 -1.022 . . . . 72.13 108.24 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -92.77 -52.61 4.54 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.539 -1.21 . . . . 73.04 109.156 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 68.48 136.07 0.03 OUTLIER 'General case' 0 C--N 1.356 0.873 0 O-C-N 125.192 1.558 . . . . 73.53 112.817 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -83.1 -172.01 3.89 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.172 -0.922 . . . . 65.43 109.111 171.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 41' ' ' LYS . . . -158.33 83.93 0.13 Allowed Glycine 0 C--N 1.345 1.055 0 C-N-CA 120.533 -0.841 . . . . 64.52 115.117 -175.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -131.83 20.61 4.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.249 1.02 . . . . 74.24 108.562 167.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 3.9 pp -85.85 138.27 32.16 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 115.844 -0.616 . . . . 75.24 111.229 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 8.2 tp -161.56 134.58 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 124.817 1.247 . . . . 62.15 107.782 174.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.13 -62.49 1.41 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 109.618 -0.512 . . . . 73.34 109.618 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -167.07 119.71 0.77 Allowed Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 115.307 -0.861 . . . . 73.01 109.07 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -82.35 79.03 3.2 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.836 2.357 . . . . 63.54 111.072 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.427 HG23 HG22 ' F' ' 136' ' ' VAL . 7.8 tt -62.33 141.75 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 115.729 -0.669 . . . . 64.42 110.146 175.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.431 ' HB3' ' HB3' ' D' ' 35' ' ' ASP . . . -69.17 79.91 0.34 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.375 0.67 . . . . 60.1 111.046 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.427 HG22 HG23 ' F' ' 134' ' ' ILE . 34.7 m -139.8 147.6 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.865 1.266 . . . . 73.0 108.781 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -165.37 -74.96 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 107.499 -1.297 . . . . 73.51 107.499 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.28 113.69 20.76 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.995 0.918 . . . . 31.3 109.003 177.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.433 ' HA ' ' HG3' ' D' ' 37' ' ' GLN . 28.5 tp -64.46 100.56 0.37 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.236 1.014 . . . . 74.51 110.755 177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 25.6 m -94.72 -160.83 0.81 Allowed 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 114.362 -1.29 . . . . 75.14 109.353 175.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . 0.446 HD22 ' HG3' ' D' ' 39' ' ' GLU . 0.5 OUTLIER 70.77 34.43 2.01 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 124.29 1.036 . . . . 72.24 109.164 -177.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.573 ' HA ' ' HB ' ' D' ' 40' ' ' VAL . 14.8 mm -69.48 122.3 20.72 Favored 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-N 114.964 -1.016 . . . . 75.22 108.636 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 70.2 121.66 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.47 1.108 . . . . 75.05 110.571 -172.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -68.99 -45.29 70.96 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 109.317 -0.623 . . . . 64.25 109.317 168.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 8.7 mtpm? -74.86 -82.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.22 -0.9 . . . . 71.04 110.472 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -169.98 148.59 3.48 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.366 0.666 . . . . 64.24 110.241 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . 0.431 HD23 HD13 ' F' ' 148' ' ' LEU . 6.4 tt -88.76 93.46 9.58 Favored 'General case' 0 C--O 1.241 0.641 0 N-CA-C 108.154 -1.054 . . . . 72.32 108.154 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . 0.461 HD21 ' H ' ' D' ' 132' ' ' ASN . 9.9 mp 68.42 147.82 0.12 Allowed Pre-proline 0 N--CA 1.488 1.465 0 C-N-CA 124.516 1.127 . . . . 34.35 111.373 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo . . . . . 0 C--N 1.376 1.989 0 C-N-CA 122.339 2.026 . . . . 75.32 111.234 -178.584 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tpt . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.131 -0.322 . . . . 72.01 110.131 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 t -84.06 107.38 16.37 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.624 0.77 . . . . 75.24 109.109 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.15 38.57 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.817 0.847 . . . . 74.5 110.311 -170.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.22 133.6 54.71 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.515 0.726 . . . . 73.31 109.547 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -156.08 144.72 20.19 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.519 0.728 . . . . 73.41 109.27 -176.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -141.07 134.65 30.06 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.103 -0.703 . . . . 72.03 109.103 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.5 m -145.47 -43.0 0.22 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.547 0.739 . . . . 62.23 109.417 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 63.3 98.26 0.04 OUTLIER 'General case' 0 C--N 1.354 0.794 0 C-N-CA 125.366 1.466 . . . . 71.5 109.8 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.633 ' HB3' HG23 ' A' ' 89' ' ' ILE . 1.9 ppp? -160.36 162.3 33.37 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.589 0.756 . . . . 43.41 110.962 -174.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.487 HG23 ' H ' ' A' ' 154' ' ' ASP . 20.4 m -153.37 123.99 7.22 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.837 1.255 . . . . 35.31 109.064 173.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -121.58 130.44 53.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.621 -1.251 . . . . 74.13 107.621 167.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.621 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 30.9 tt0 -133.57 106.65 7.53 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 109.205 -0.665 . . . . 70.14 109.205 -179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -75.87 102.92 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 107.402 -1.333 . . . . 63.52 107.402 171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.452 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 7.2 tp-100 -74.75 -43.16 56.38 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.796 -0.638 . . . . 72.35 110.8 -178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 178.36 156.67 0.43 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.281 1.032 . . . . 71.11 110.243 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 74.1 mt -137.56 106.42 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 124.228 1.011 . . . . 72.13 108.555 -172.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' CD1' HG22 ' B' ' 122' ' ' THR . 77.0 m-85 -148.39 157.66 43.61 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.388 0.675 . . . . 75.15 110.604 -172.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -73.72 120.69 19.66 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.033 0.933 . . . . 73.44 110.526 -175.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.8 mtpt -88.81 -22.58 23.16 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.983 -0.553 . . . . 70.51 110.743 174.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -154.86 141.86 19.24 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.937 0.773 . . . . 62.35 110.278 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 79.8 mt -143.19 141.62 26.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 125.539 1.536 . . . . 60.04 107.534 178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -149.97 135.17 18.03 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.285 -1.006 . . . . 75.43 108.285 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.625 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 74.0 t80 -138.08 111.59 8.11 Favored 'General case' 0 C--O 1.211 -0.928 0 N-CA-C 106.099 -1.815 . . . . 74.4 106.099 176.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -118.87 118.81 32.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 122.801 0.44 . . . . 65.1 110.183 -172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.69 75.07 32.05 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.694 0.797 . . . . 70.4 109.726 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -69.12 -27.56 29.37 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.47 2.113 . . . . 72.44 110.656 169.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 31' ' ' VAL . 57.7 m-20 -96.69 24.96 5.53 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.08 -1.418 . . . . 72.45 109.777 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.58 -46.14 99.86 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.985 0.914 . . . . 72.4 112.829 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.07 -16.35 40.38 Favored 'Trans proline' 0 C--N 1.396 3.048 0 C-N-CA 121.714 1.609 . . . . 65.11 112.638 172.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -85.81 -20.5 29.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.662 0.785 . . . . 74.24 110.461 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 27' ' ' ASN . 46.3 t -68.97 -23.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.201 0.524 . . . . 72.34 110.459 174.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -67.98 -30.25 69.47 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 115.592 -0.731 . . . . 75.25 110.517 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -72.6 -30.39 64.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.964 0.906 . . . . 52.13 110.177 175.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -75.42 161.28 29.37 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.676 -0.693 . . . . 73.25 111.243 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -77.41 159.72 29.25 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.818 -1.083 . . . . 74.43 108.755 164.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.0 m-90 -82.82 57.25 3.74 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.322 0.582 . . . . 65.5 110.283 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -154.9 79.67 4.62 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 123.554 0.741 . . . . 63.41 109.406 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -79.98 155.89 23.29 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.202 1.935 . . . . 62.13 110.83 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -94.17 115.97 28.31 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 108.007 -1.109 . . . . 62.53 108.007 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 65' ' ' THR . 21.9 m -98.96 98.8 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.703 0.764 . . . . 74.33 110.921 -173.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.4 ttpt -79.73 115.44 19.33 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 108.364 -0.976 . . . . 70.45 108.364 172.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.606 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 pt? -98.71 145.05 27.3 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 109.379 -0.6 . . . . 72.35 109.379 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.576 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 13.1 t70 -137.67 122.52 18.85 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 108.03 -1.1 . . . . 65.12 108.03 -178.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.466 HD21 HG11 ' A' ' 131' ' ' VAL . 4.1 mp -102.62 118.12 36.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.837 -0.801 . . . . 71.12 108.837 -176.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -132.12 137.27 47.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.484 0.714 . . . . 72.33 109.734 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.7 m -131.1 139.11 49.8 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.868 0.867 . . . . 55.24 109.631 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -148.76 115.32 5.93 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.668 0.787 . . . . 73.04 109.946 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 53.2 m -90.17 155.37 19.07 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.569 0.748 . . . . 74.54 110.51 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -149.57 161.15 42.72 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.534 1.134 . . . . 65.4 108.786 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -114.85 115.93 27.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.275 0.63 . . . . 71.51 109.719 179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -90.04 -31.22 17.27 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.402 0.681 . . . . 72.54 111.471 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.25 -172.48 3.43 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.744 0.652 . . . . 71.21 110.365 -178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -64.74 105.65 1.03 Allowed 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.209 1.003 . . . . 73.13 111.055 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 67.93 12.44 8.81 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.083 1.353 . . . . 73.35 112.733 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.9 t -98.33 106.86 19.36 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 107.48 -1.304 . . . . 73.11 107.48 174.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -113.16 123.96 51.44 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.967 -1.015 . . . . 72.43 109.146 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -99.7 119.86 38.79 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.147 -1.388 . . . . 75.0 108.548 176.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.4 t -100.24 123.61 53.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.676 -1.601 . . . . 75.12 106.676 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 99.4 t -104.19 130.0 55.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.635 -0.876 . . . . 44.14 108.635 173.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.19 113.14 26.49 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.574 -1.639 . . . . 75.21 106.574 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 64.8 ttp85 -100.22 101.99 13.15 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.969 -1.123 . . . . 64.45 107.969 176.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.3 t -95.11 126.79 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 108.278 -1.008 . . . . 52.34 108.278 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 23.2 m -110.55 133.95 52.84 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.3 t -133.24 105.85 8.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 107.166 -1.42 . . . . 62.43 107.166 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.0 m -103.78 130.35 51.3 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 108.732 -0.84 . . . . 54.02 108.732 176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.36 109.69 18.27 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.147 -1.057 . . . . 73.22 108.147 177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 38.3 m -136.61 128.5 29.26 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 109.035 -0.728 . . . . 54.24 109.035 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 tt -94.65 87.66 5.15 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 106.611 -1.625 . . . . 63.14 106.611 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.76 -121.3 5.4 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.528 -0.629 . . . . 64.32 111.528 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -90.8 -25.84 19.74 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.195 0.598 . . . . 72.12 111.602 -176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -88.61 125.79 34.98 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.774 -0.454 . . . . 63.25 109.774 177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.3 m -74.36 134.37 42.48 Favored 'General case' 0 C--N 1.344 0.342 0 CA-C-N 115.776 -0.647 . . . . 62.41 109.658 172.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.63 -55.62 4.34 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 175.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -167.3 168.99 12.84 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.039 -0.982 . . . . 75.53 110.476 176.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 38.5 tp -132.52 143.68 49.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.644 1.178 . . . . 55.11 108.673 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.625 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 13.8 m -138.02 124.93 21.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.635 0.774 . . . . 64.14 109.432 176.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -137.41 125.77 23.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.106 -0.701 . . . . 52.25 109.106 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.2 t -131.89 114.69 25.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.556 0 C-N-CA 123.979 0.912 . . . . 74.23 109.512 -175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 74.1 mt-30 -85.53 86.6 7.36 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.154 -0.93 . . . . 72.11 108.876 172.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.67 99.1 5.68 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.078 -0.965 . . . . 73.53 109.071 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.66 152.41 21.08 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 111.593 -0.603 . . . . 73.14 111.593 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.07 134.24 5.67 Favored Glycine 0 CA--C 1.502 -0.746 0 N-CA-C 110.273 -1.131 . . . . 71.21 110.273 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 43.4 mt -87.85 125.71 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.255 -1.017 . . . . 72.24 108.255 176.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -131.82 120.23 22.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.726 -0.842 . . . . 75.53 108.726 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 48.3 t -92.2 100.83 13.37 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.177 -1.045 . . . . 65.31 108.177 173.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.425 HD13 HD21 ' A' ' 98' ' ' LEU . 50.5 pt -116.16 141.01 35.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 C-N-CA 123.246 0.618 . . . . 74.13 110.515 -174.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -169.39 174.32 6.08 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.115 0.966 . . . . 51.42 110.119 173.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 91.61 -32.1 5.47 Favored Glycine 0 C--N 1.349 1.264 0 CA-C-N 116.129 -0.487 . . . . 71.32 112.791 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 9' ' ' MET . 2.1 pp -112.47 156.42 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 123.872 0.869 . . . . 61.55 109.883 -176.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.9 175.04 12.96 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.042 -0.725 . . . . 41.23 109.042 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.46 -144.52 37.41 Favored Glycine 0 C--N 1.344 1.022 0 N-CA-C 111.871 -0.492 . . . . 54.33 111.871 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 11.2 t -65.41 -16.3 63.48 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 123.147 0.579 . . . . 73.23 112.151 -178.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -64.19 -54.55 31.82 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.832 0.853 . . . . 72.2 110.204 172.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.579 ' SD ' ' HB3' ' F' ' 115' ' ' LEU . 56.3 ttm -72.22 -34.62 68.48 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.451 -0.795 . . . . 71.5 110.761 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.48 ' HB1' ' HB3' ' F' ' 118' ' ' PHE . . . -65.12 -41.29 95.0 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.537 0.735 . . . . 74.32 111.63 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -59.76 -40.28 87.62 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.678 -0.692 . . . . 55.33 110.159 170.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.768 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 8.6 m -76.08 -37.34 58.31 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.598 0.962 . . . . 74.52 113.598 -172.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.425 HD21 HD13 ' A' ' 86' ' ' ILE . 89.1 mt -85.41 -15.45 43.04 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 117.93 0.332 . . . . 71.33 110.578 177.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.59 -28.65 9.4 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-O 119.399 -0.667 . . . . 73.34 113.56 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.06 -55.71 0.71 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 118.255 1.027 . . . . 73.24 113.153 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.768 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 5.4 t80 -50.64 -65.04 0.63 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 123.722 0.809 . . . . 74.33 111.699 -177.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 75.4 m -64.46 -45.67 77.42 Favored Pre-proline 0 CA--C 1.558 1.286 0 CA-C-O 118.209 -0.9 . . . . 63.32 112.848 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -50.68 -41.34 54.28 Favored 'Trans proline' 0 C--N 1.392 2.85 0 C-N-CA 122.181 1.921 . . . . 73.31 113.69 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.444 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 21.4 t-20 -71.78 -32.24 67.43 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.371 0.669 . . . . 75.21 110.52 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.511 HG12 ' O ' ' A' ' 101' ' ' TYR . 24.3 mm -65.37 -35.27 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.781 0.832 . . . . 54.13 110.487 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -80.69 -20.42 42.97 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.168 0.987 . . . . 72.45 111.471 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.519 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 25.8 t80 -67.63 -43.39 40.18 Favored Pre-proline 0 CA--C 1.559 1.318 0 N-CA-C 114.263 1.209 . . . . 75.1 114.263 -168.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 104' ' ' ASN . 36.3 Cg_exo -62.13 -34.89 78.12 Favored 'Trans proline' 0 C--N 1.389 2.664 0 C-N-CA 121.78 1.653 . . . . 75.22 112.425 175.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -74.25 -40.99 62.01 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.445 0.698 . . . . 73.13 111.593 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.29 -44.75 82.62 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.789 0.436 . . . . 72.13 109.923 176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD12 ' C' ' 105' ' ' ILE . 32.5 ttm180 -53.88 -51.68 62.89 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.509 1.131 . . . . 74.43 110.164 176.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -61.72 -46.15 90.91 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 124.181 0.925 . . . . 72.11 110.881 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -57.75 -48.75 78.75 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.898 0.749 . . . . 32.54 110.773 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -61.93 -50.62 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 124.063 0.945 . . . . 73.15 110.499 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.575 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.2 m -57.24 -41.42 79.56 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.722 0.809 . . . . 51.14 111.33 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -68.14 -40.71 82.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 115.284 -0.871 . . . . 72.41 109.691 -177.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 16.4 mtp -59.14 -42.06 89.78 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.805 0.842 . . . . 73.15 110.951 174.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -63.65 -45.83 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 C-N-CA 124.006 0.922 . . . . 70.02 110.952 178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 71.4 p -73.88 -28.86 61.77 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.923 0.489 . . . . 65.31 111.429 -177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.407 HH12 ' HG3' ' B' ' 112' ' ' GLU . 83.0 mtt-85 -72.38 -28.42 62.99 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.504 0.721 . . . . 74.42 109.264 172.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.18 0.17 89.05 Favored Glycine 0 C--N 1.352 1.444 0 CA-C-N 115.456 -0.793 . . . . 75.33 112.831 174.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.5 m 68.67 17.14 8.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.651 1.181 . . . . 52.31 111.515 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -92.03 161.01 34.49 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 123.642 0.777 . . . . 74.22 110.739 -177.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.62 123.88 14.77 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.469 2.113 . . . . 40.41 111.176 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.575 ' HG3' HG23 ' A' ' 115' ' ' THR . 30.2 tt0 -54.45 141.3 31.27 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.869 1.268 . . . . 61.3 112.96 -175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.417 HD22 HG11 ' A' ' 40' ' ' VAL . 82.3 mt -125.63 96.11 4.67 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.593 0.757 . . . . 61.12 109.563 -177.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -98.2 105.45 17.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.713 -0.847 . . . . 73.45 108.713 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.531 HD11 HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -62.73 130.14 43.63 Favored 'General case' 0 CA--C 1.554 1.13 0 O-C-N 123.651 0.594 . . . . 71.41 110.0 -174.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.41 ' HB3' ' HE1' ' F' ' 125' ' ' TYR . . . -69.67 144.92 94.42 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 122.908 0.483 . . . . 63.43 111.2 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.587 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 73.7 Cg_exo -54.62 144.52 63.66 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 124.152 3.235 . . . . 73.44 115.153 -175.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.466 HG11 HD21 ' A' ' 44' ' ' LEU . 31.5 m -115.98 115.06 48.03 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.062 0 C-N-CA 123.81 0.844 . . . . 63.35 109.873 177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 9.5 m120 -89.41 65.72 7.21 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.625 0.77 . . . . 73.31 109.0 174.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -79.61 -33.11 41.82 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.384 -0.826 . . . . 73.21 109.857 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.48 ' O ' ' HG2' ' A' ' 138' ' ' MET . 5.6 m-20 -58.62 -46.51 86.88 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 122.947 0.499 . . . . 73.23 110.037 171.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.44 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -60.69 -41.07 94.41 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.407 0.683 . . . . 72.3 111.649 175.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.432 ' HA ' HD21 ' A' ' 139' ' ' ASN . 35.2 tp -59.59 -36.42 76.21 Favored 'General case' 0 N--CA 1.483 1.208 0 O-C-N 123.948 0.78 . . . . 73.53 110.83 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -68.32 -49.47 60.16 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.792 -0.64 . . . . 62.33 110.421 170.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 33.8 mmt -57.09 -44.95 83.66 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.573 0.749 . . . . 64.44 112.92 -170.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 10.8 p30 -68.04 -34.89 77.32 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 120.763 0.316 . . . . 75.13 111.702 -176.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.01 -45.13 59.52 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 115.583 -0.735 . . . . 74.01 109.807 177.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.16 -47.87 66.87 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.293 1.437 . . . . 64.32 112.108 -172.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -149.78 -13.03 0.28 Allowed 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 112.255 0.465 . . . . 73.13 112.255 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 59.5 tt0 63.47 -78.27 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.174 1.39 . . . . 64.12 110.629 -168.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -87.57 80.32 8.06 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.431 -0.951 . . . . 72.5 108.431 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -71.85 109.16 5.52 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.738 -0.665 . . . . 64.11 110.308 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -64.63 140.49 42.71 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.738 0.649 . . . . 65.11 113.023 -178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -65.9 141.19 58.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.39 0.676 . . . . 74.24 111.26 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.11 122.01 2.01 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-N 116.044 -0.526 . . . . 25.3 111.896 -177.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.7 p -98.12 164.08 12.48 Favored 'General case' 0 C--O 1.245 0.825 0 C-N-CA 123.541 0.736 . . . . 64.24 110.239 173.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.81 172.78 9.86 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.777 0.831 . . . . 70.23 111.154 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -97.13 -56.26 2.6 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.721 -1.214 . . . . 64.32 107.721 168.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 8.5 m80 -158.86 -175.5 5.33 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.369 1.067 . . . . 75.53 110.207 171.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -134.32 175.22 9.7 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.309 1.443 . . . . 63.3 108.608 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.487 ' H ' HG23 ' A' ' 10' ' ' THR . 5.5 m-20 58.55 20.79 7.93 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.142 0.977 . . . . 61.21 111.192 -174.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.395 1.078 . . . . 64.41 108.882 -174.15 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.264 -0.643 . . . . 73.14 109.264 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 55.4 p -108.78 113.88 27.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.373 0.669 . . . . 53.43 109.625 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.67 97.08 1.29 Allowed 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.902 -0.777 . . . . 72.42 108.902 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -131.53 11.63 4.88 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.043 0.937 . . . . 75.32 109.491 173.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -133.26 -86.43 0.44 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.723 0.809 . . . . 75.33 109.131 -164.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -176.54 80.3 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.099 1.36 . . . . 62.33 108.651 168.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 12.8 t -150.47 -172.2 4.12 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.926 -0.579 . . . . 71.35 109.895 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 68.82 137.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 124.903 1.281 . . . . 72.23 111.217 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.6 ptm 51.67 -178.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 126.16 1.784 . . . . 73.12 115.036 175.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 18.0 p -134.68 127.03 30.27 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 107.363 -1.347 . . . . 74.13 107.363 169.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -121.98 146.86 46.75 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.635 -0.876 . . . . 73.4 108.635 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.53 ' HA ' ' HG ' ' F' ' 147' ' ' LEU . 23.9 tt0 -166.81 142.54 4.39 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.932 0.77 . . . . 75.42 110.145 169.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 39.8 mt -95.07 120.41 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.393 -0.966 . . . . 75.01 108.393 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -79.88 -47.31 15.3 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 109.948 -0.39 . . . . 75.31 109.948 171.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -164.47 145.34 8.06 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 115.92 -0.582 . . . . 72.35 109.83 -173.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 61.5 mt -118.05 150.19 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 106.851 -1.537 . . . . 75.34 106.851 169.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -168.75 145.61 3.72 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.832 0.453 . . . . 73.21 111.172 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 55.3 m -73.04 117.24 14.53 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.037 -1.097 . . . . 74.52 108.037 167.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -83.94 -42.98 15.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.829 -0.623 . . . . 73.23 110.2 175.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 25.9 t70 -144.81 142.03 29.64 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.028 -0.533 . . . . 63.21 111.578 -168.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.3 mm -137.15 142.96 35.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 125.091 1.357 . . . . 73.54 108.053 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.499 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -141.35 137.97 32.73 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.924 -1.51 . . . . 73.33 106.924 172.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.421 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -152.01 110.04 3.69 Favored 'General case' 0 C--O 1.22 -0.486 0 N-CA-C 107.778 -1.193 . . . . 73.52 107.778 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -118.72 111.89 19.07 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.869 -0.789 . . . . 74.04 108.869 177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -108.8 85.92 3.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 109.116 -0.698 . . . . 75.12 109.116 170.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.8 -22.85 36.19 Favored 'Trans proline' 0 C--N 1.386 2.52 0 C-N-CA 123.024 2.483 . . . . 72.3 110.8 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -125.03 29.89 6.01 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.88 1.272 . . . . 73.24 109.617 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.27 -48.11 45.06 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 125.191 1.397 . . . . 45.31 113.365 168.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.511 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.5 Cg_endo -84.65 -15.06 6.24 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.364 2.043 . . . . 74.12 112.771 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -96.92 -0.32 47.79 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.232 0.613 . . . . 63.43 111.6 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.475 HG23 HD12 ' B' ' 68' ' ' LEU . 11.2 p -69.46 -31.13 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.225 0.61 . . . . 75.5 110.919 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -71.66 -40.6 69.54 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.551 0.74 . . . . 61.44 110.96 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -81.1 -8.32 59.74 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.372 -0.831 . . . . 55.25 111.264 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' HD22 ' B' ' 68' ' ' LEU . 5.8 mmtp -100.13 109.1 21.38 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.057 0.943 . . . . 72.12 109.98 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -96.0 75.89 3.09 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.59 0.756 . . . . 75.13 111.903 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.441 ' HB2' HD23 ' B' ' 68' ' ' LEU . 4.8 m-90 -153.76 172.28 17.56 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.47 1.508 . . . . 74.01 107.159 163.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 22.0 mp0 -90.24 119.49 69.22 Favored Pre-proline 0 CA--C 1.546 0.804 0 N-CA-C 108.655 -0.869 . . . . 64.42 108.655 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.19 102.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 123.117 2.544 . . . . 75.01 112.214 172.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -67.83 102.55 1.26 Allowed 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.042 -0.526 . . . . 72.41 109.826 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.403 HG13 HG13 ' B' ' 64' ' ' VAL . 59.7 t -89.57 121.38 39.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 123.607 0.763 . . . . 72.24 110.121 -175.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -118.86 123.68 45.31 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 124.856 1.262 . . . . 65.23 108.52 173.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.479 HD21 HD22 ' B' ' 128' ' ' LEU . 6.4 mp -92.72 158.88 15.69 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.3 0.64 . . . . 74.31 110.279 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -152.59 110.76 3.68 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.948 -1.13 . . . . 63.22 107.948 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.0 mp -104.99 150.19 25.13 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 121.37 0.605 . . . . 71.24 110.063 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.545 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.4 t70 -138.16 128.12 25.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.447 -1.252 . . . . 74.32 108.643 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 36.9 p -110.35 108.15 18.12 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.505 0.722 . . . . 42.12 109.335 178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.54 153.94 33.39 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.242 1.017 . . . . 71.41 109.492 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 50.8 m -143.57 162.98 34.47 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.32 0.648 . . . . 54.44 109.508 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.7 p -150.6 150.4 31.13 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.161 0.584 . . . . 73.13 109.658 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 33.3 tp60 -84.56 112.6 20.57 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.847 -0.797 . . . . 75.14 108.847 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.453 HD12 HG23 ' B' ' 83' ' ' ILE . 82.8 mt -88.93 -54.2 4.24 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.724 -0.473 . . . . 65.34 109.724 172.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -170.24 3.59 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.784 0.834 . . . . 61.22 110.004 -178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.84 117.38 7.46 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.19 -0.914 . . . . 74.41 110.19 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 71.41 -2.27 2.48 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.456 1.503 . . . . 55.31 112.092 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 72.7 t -106.51 103.15 14.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.784 0.833 . . . . 74.03 109.448 -172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -108.65 141.39 40.67 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.85 0.86 . . . . 64.13 109.641 175.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' B' ' 51' ' ' LEU . 15.5 tt0 -99.64 102.52 14.04 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.393 -0.965 . . . . 74.23 108.393 172.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 46.4 t -88.05 118.56 33.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 108.565 -0.902 . . . . 73.01 108.565 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 46.5 t -104.82 119.57 53.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 123.721 0.808 . . . . 74.15 109.164 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.3 OUTLIER -93.24 129.45 39.29 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 106.674 -1.602 . . . . 74.31 106.674 171.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.545 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 24.7 ttp180 -121.31 108.25 13.49 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 108.723 -0.843 . . . . 73.44 108.723 176.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.519 ' HB ' HD11 ' B' ' 114' ' ' ILE . 19.9 t -105.17 120.04 55.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.865 -1.161 . . . . 62.44 107.865 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.7 m -113.54 126.96 55.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.962 -0.755 . . . . 73.32 108.962 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.632 HG21 HG21 ' B' ' 114' ' ' ILE . 42.0 t -113.65 119.26 60.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.432 1.093 . . . . 72.22 109.153 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -118.31 140.33 49.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.327 -0.99 . . . . 63.24 108.327 170.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.87 143.41 50.14 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.053 -1.091 . . . . 64.35 108.053 173.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 29.4 p -130.71 130.35 43.72 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 109.771 -0.455 . . . . 73.51 109.771 178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.479 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 0.8 OUTLIER -110.31 112.66 24.76 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 108.146 -1.057 . . . . 64.3 108.146 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.69 -113.3 3.77 Favored Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.331 -1.107 . . . . 75.33 110.331 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -120.62 5.5 10.57 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 123.811 0.844 . . . . 74.43 111.164 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -114.43 166.84 11.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.523 0.729 . . . . 74.31 109.245 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 33.5 m -69.59 135.63 50.24 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.035 0.534 . . . . 72.42 110.707 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -87.31 -58.66 2.5 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.5 -1.296 . . . . 73.22 107.5 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -156.95 163.69 38.85 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.617 -1.174 . . . . 65.13 109.956 168.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 73.6 mt -124.74 143.27 50.87 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.822 -1.547 . . . . 74.53 106.822 175.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.3 t -154.3 151.89 29.64 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.507 -0.923 . . . . 60.32 108.507 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.499 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 43.1 tt0 -165.16 130.99 2.68 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.049 -0.723 . . . . 73.44 109.049 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.2 t -125.17 144.94 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 109.369 -0.604 . . . . 55.4 109.369 173.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.473 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 25.7 mt-30 -121.14 94.62 4.4 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.62 -1.252 . . . . 72.25 107.62 169.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -85.39 100.44 11.85 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.57 -0.9 . . . . 63.31 108.57 174.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.86 162.92 31.71 Favored Glycine 0 C--N 1.336 0.575 0 N-CA-C 111.149 -0.78 . . . . 63.4 111.149 177.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.37 127.5 1.75 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.619 -0.592 . . . . 60.44 111.619 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.453 HG23 HD12 ' B' ' 51' ' ' LEU . 40.6 mt -85.08 126.0 40.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 123.691 0.796 . . . . 71.34 109.162 174.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -133.29 134.04 43.36 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.026 0.931 . . . . 71.41 108.748 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 45.3 m -100.98 100.56 11.19 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.029 0.932 . . . . 63.52 108.727 175.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.524 HG13 HD11 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -121.61 143.04 35.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.092 0.957 . . . . 71.52 110.813 -177.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.57 159.17 43.28 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 43.33 109.709 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.54 -44.42 2.26 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.359 0.412 . . . . 75.01 112.692 178.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.532 HG22 ' HB3' ' B' ' 93' ' ' GLN . 13.1 pt -65.64 140.27 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 74.04 111.828 177.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -151.65 152.01 32.24 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 124.351 1.06 . . . . 52.44 108.36 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.623 ' HA2' ' HD2' ' E' ' 117' ' ' PRO . . . 58.92 -113.87 5.49 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 124.027 0.829 . . . . 34.24 113.284 176.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 68.4 m -65.79 -40.55 92.06 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.49 1.116 . . . . 72.22 111.609 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.532 ' HB3' HG22 ' B' ' 89' ' ' ILE . 90.0 mt-30 -65.81 -43.69 87.89 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 122.835 0.454 . . . . 54.23 111.172 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.549 ' HE2' HD12 ' E' ' 115' ' ' LEU . 14.2 tpt -69.37 -35.5 75.9 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.562 -0.745 . . . . 74.25 110.676 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.4 -24.96 59.19 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.289 -0.869 . . . . 63.34 110.99 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.442 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 25.8 t-80 -81.97 -29.54 32.1 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.274 0.63 . . . . 74.23 110.59 176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.0 t -78.91 -68.09 0.69 Allowed 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 109.458 -0.571 . . . . 73.45 109.458 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.524 HD11 HG13 ' B' ' 86' ' ' ILE . 8.4 mp -73.5 -25.99 60.69 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.924 0.489 . . . . 62.44 112.289 -173.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.2 -30.13 23.39 Favored Glycine 0 C--N 1.334 0.457 0 O-C-N 123.368 0.417 . . . . 71.04 113.018 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -123.44 -56.58 1.7 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 112.734 0.642 . . . . 44.22 112.734 -170.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -72.94 -49.18 30.91 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 112.295 0.48 . . . . 75.11 112.295 -169.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 73.3 m -60.39 -47.81 95.47 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 124.263 1.025 . . . . 71.03 111.828 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.532 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 72.7 Cg_exo -56.5 -37.77 96.66 Favored 'Trans proline' 0 C--N 1.395 3.011 0 C-N-CA 121.985 1.79 . . . . 65.22 113.102 169.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -66.4 -29.94 70.21 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 122.826 0.45 . . . . 75.02 110.892 -178.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.9 mt -64.39 -49.23 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.654 0.781 . . . . 64.13 109.774 169.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 67.7 mt -79.83 -12.61 59.75 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.155 0.982 . . . . 73.25 111.942 -171.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -66.05 -48.0 61.37 Favored Pre-proline 0 CA--C 1.55 0.942 0 CA-C-O 118.141 -0.933 . . . . 74.22 112.944 -172.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -59.46 -33.43 97.29 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.023 1.816 . . . . 74.52 113.488 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HE2' HG21 ' D' ' 115' ' ' THR . 53.8 m-85 -71.08 -44.47 65.66 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 123.426 0.69 . . . . 75.33 110.556 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.404 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -63.2 -38.77 92.5 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.883 0.873 . . . . 74.21 110.193 175.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.513 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 57.4 ttt-85 -60.3 -57.02 14.59 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.487 1.515 . . . . 71.41 111.087 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.407 ' HG3' HH12 ' A' ' 120' ' ' ARG . 14.5 tp10 -58.38 -33.49 69.65 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.923 0.889 . . . . 64.5 110.89 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.512 ' HB3' HG21 ' B' ' 78' ' ' VAL . 1.3 m -63.31 -54.94 29.25 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.312 0.645 . . . . 65.14 111.38 173.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.632 HG21 HG21 ' B' ' 64' ' ' VAL . 57.6 mt -58.86 -54.53 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.233 0.613 . . . . 60.33 110.05 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.3 m -55.9 -39.26 71.35 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.762 1.225 . . . . 71.25 111.663 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -62.04 -50.67 71.06 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-N 115.788 -0.642 . . . . 74.32 110.094 176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.482 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 17.0 mmt -65.74 -33.71 76.49 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.441 0.696 . . . . 75.13 111.522 -175.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 114' ' ' ILE . 76.9 t -63.26 -46.57 95.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.886 0.874 . . . . 73.52 110.192 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.427 ' OG ' ' HG3' ' B' ' 125' ' ' GLN . 23.3 m -68.35 -28.92 67.55 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.653 -0.703 . . . . 73.2 111.481 177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 96.1 mtt-85 -72.3 -16.08 61.9 Favored 'General case' 0 C--O 1.208 -1.127 0 CA-C-N 115.621 -0.718 . . . . 64.2 110.708 175.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.15 15.89 59.9 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 118.657 -1.079 . . . . 63.15 115.476 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.491 HG22 ' CD1' ' A' ' 17' ' ' TYR . 15.5 p 79.56 13.17 1.1 Allowed 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 126.576 1.95 . . . . 71.13 112.507 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 119' ' ' SER . 96.6 m-85 -103.63 153.7 38.45 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 122.811 0.444 . . . . 72.32 110.597 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.08 153.26 59.53 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.856 2.371 . . . . 75.12 112.296 172.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 1.1 mp0 -64.86 115.11 5.0 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.445 0.465 . . . . 73.42 110.227 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 91.2 mt -108.12 85.65 2.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 107.983 -1.117 . . . . 65.22 107.983 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -92.37 132.63 36.59 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.045 -0.979 . . . . 71.52 109.07 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.513 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 30.5 mt -81.0 147.85 30.02 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.42 -0.809 . . . . 71.24 111.439 -169.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.58 147.94 50.67 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.519 0.728 . . . . 65.23 109.639 176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -66.85 97.9 0.41 Allowed 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.912 2.408 . . . . 53.45 111.474 -178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.87 111.94 23.88 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 107.92 -1.141 . . . . 62.32 107.92 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.18 100.62 1.31 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 115.4 -0.818 . . . . 73.4 110.159 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -59.45 -33.2 70.99 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.115 -0.948 . . . . 74.35 109.649 172.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -65.13 -39.01 92.44 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.611 1.564 . . . . 75.21 112.175 177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.46 -34.12 73.91 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.791 0.436 . . . . 72.42 110.434 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -72.91 -36.95 67.37 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.061 -0.972 . . . . 74.32 109.615 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -65.93 -43.46 87.97 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.253 1.021 . . . . 73.23 109.758 176.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -60.01 -36.79 77.99 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.257 1.023 . . . . 72.24 110.343 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -74.46 -21.52 59.55 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.339 -1.3 . . . . 71.23 111.086 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -65.06 -47.27 77.92 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.488 0.715 . . . . 60.0 110.34 177.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.97 20.19 6.96 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.494 0.718 . . . . 71.15 110.555 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 64.5 -166.96 0.22 Allowed 'General case' 0 C--N 1.361 1.071 0 C-N-CA 124.799 1.24 . . . . 70.4 112.106 171.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -108.85 165.54 11.49 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.578 0.751 . . . . 63.42 110.125 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -121.71 -78.91 0.6 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.325 0.65 . . . . 71.22 110.422 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.35 170.89 0.16 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.44 1.096 . . . . 74.32 112.132 -171.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -157.63 -150.91 5.86 Favored Glycine 0 C--O 1.238 0.396 0 CA-C-N 115.316 -0.857 . . . . 35.23 111.67 178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.13 -177.94 6.99 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.364 0.666 . . . . 71.13 110.59 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.65 165.26 29.16 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.417 -0.673 . . . . 72.22 111.417 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.5 p -113.91 158.62 20.85 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.454 0.701 . . . . 54.44 111.099 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -112.49 143.04 44.31 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 106.901 -1.518 . . . . 73.24 106.901 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.11 152.49 30.77 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.904 0.482 . . . . 63.13 111.76 -171.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 6.6 m80 -151.95 81.51 1.27 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.415 1.086 . . . . 74.04 108.724 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 134.59 51.4 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.332 -0.988 . . . . 65.22 108.332 173.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -72.56 135.98 45.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.576 0.351 . . . . 74.35 110.656 -178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.761 0.824 . . . . 72.25 109.985 177.66 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ptm . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.833 -0.062 . . . . 43.42 110.833 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 9.5 t -152.44 -49.3 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.512 -0.28 . . . . 72.1 111.558 -172.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 58.03 81.26 0.15 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.967 0.907 . . . . 73.34 109.554 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.63 ' HB2' ' H ' ' C' ' 149' ' ' THR . 22.4 mp0 -70.26 126.47 29.76 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.845 -0.616 . . . . 64.34 109.986 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -64.71 111.64 2.85 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 124.169 0.918 . . . . 60.42 111.242 -174.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -68.45 145.06 54.43 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.711 1.204 . . . . 63.05 111.114 177.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 13.7 t -155.91 154.98 32.05 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 123.479 0.712 . . . . 54.5 109.685 177.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 57.58 88.06 0.06 Allowed 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.925 1.29 . . . . 71.21 111.823 -176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.476 ' HG3' HG12 ' C' ' 89' ' ' ILE . 28.0 ttt 64.71 116.46 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.09 1.356 . . . . 71.34 112.784 176.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 44.0 m -115.62 88.42 2.88 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.638 -0.71 . . . . 74.01 109.217 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.587 ' HD2' ' HG2' ' A' ' 130' ' ' PRO . 73.5 t80 -97.63 129.96 44.69 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.62 -0.882 . . . . 74.21 108.62 175.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -139.89 125.73 19.53 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.277 0.631 . . . . 53.13 109.367 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 64.3 mt -77.67 119.99 27.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.635 0 N-CA-C 108.702 -0.851 . . . . 74.23 108.702 174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 32.5 mm-40 -83.95 -49.32 9.09 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.641 0.377 . . . . 74.42 110.038 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.631 HH22 HG21 ' F' ' 134' ' ' ILE . 50.7 ttt180 -170.09 145.36 2.83 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.682 0.614 . . . . 63.43 109.741 -171.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -133.11 133.95 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 107.748 -1.204 . . . . 75.31 107.748 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' D' ' 122' ' ' THR . 34.2 p90 -167.47 162.68 14.64 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.901 0.858 . . . . 75.3 111.676 -175.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -83.38 120.52 25.98 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.064 -0.971 . . . . 71.45 109.462 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -73.35 -49.33 27.86 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 108.527 -0.916 . . . . 74.32 108.527 168.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.1 t70 -134.3 139.26 45.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.681 -1.145 . . . . 53.31 109.412 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -137.2 138.24 45.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.097 -1.446 . . . . 71.41 107.097 175.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 38.9 t -152.11 149.87 29.28 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.479 0.712 . . . . 51.13 109.118 -172.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -155.67 138.47 15.25 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.08 -1.081 . . . . 72.34 108.08 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.608 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 56.4 mt-10 -135.1 148.25 49.75 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.284 1.034 . . . . 74.43 108.452 172.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -154.98 85.5 3.55 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 106.963 -1.495 . . . . 74.15 106.963 172.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.05 -50.12 4.15 Favored 'Trans proline' 0 C--N 1.379 2.15 0 C-N-CA 122.328 2.018 . . . . 65.45 111.144 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -93.48 35.68 1.1 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.025 0.93 . . . . 63.24 110.517 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.507 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.3 -50.37 88.46 Favored Pre-proline 0 CA--C 1.565 1.519 0 C-N-CA 124.441 1.096 . . . . 63.13 113.81 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.81 -25.08 20.6 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 121.642 1.561 . . . . 64.54 112.126 176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -67.93 -19.57 64.99 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.96 1.304 . . . . 74.33 112.809 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.5 p -54.17 -25.44 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 113.621 0.971 . . . . 65.25 113.621 -175.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -65.79 -40.42 91.93 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.212 0.529 . . . . 71.0 110.667 175.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -98.75 13.59 31.73 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.258 1.023 . . . . 74.4 110.413 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.95 136.7 38.03 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 109.325 -0.62 . . . . 74.05 109.325 -176.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -85.05 92.58 8.39 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.327 -1.731 . . . . 44.22 106.327 168.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.6 p90 -75.34 89.28 2.6 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.763 0.792 . . . . 74.52 112.028 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -150.27 67.74 8.36 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 108.018 -1.104 . . . . 43.24 108.018 163.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -91.85 154.46 3.38 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.651 2.234 . . . . 72.44 111.747 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -86.82 118.35 26.16 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.85 -0.796 . . . . 64.04 108.85 175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 61.8 t -70.78 97.54 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 108.177 -1.046 . . . . 74.31 108.177 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.511 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 53.0 mtpt -95.2 101.28 13.01 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.342 -0.984 . . . . 73.34 108.342 178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.654 HD23 HG22 ' C' ' 64' ' ' VAL . 2.9 tm? -102.13 129.77 48.57 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.116 -1.068 . . . . 54.31 108.116 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.31 131.92 45.64 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.048 0.939 . . . . 55.23 108.83 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 99.3 mt -123.78 148.47 46.63 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.825 0.85 . . . . 75.11 109.384 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -153.21 125.43 8.02 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.74 -0.837 . . . . 74.13 108.74 168.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 15.0 t -113.4 147.72 37.2 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 109.569 -0.53 . . . . 52.03 109.569 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.99 156.06 42.74 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.209 1.004 . . . . 71.01 108.435 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -137.8 145.96 42.97 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.722 0.409 . . . . 74.21 110.259 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.1 p -145.0 129.81 18.21 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.625 0.77 . . . . 72.11 109.691 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -74.36 118.18 17.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.026 0.53 . . . . 70.23 109.881 -178.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.47 HD11 HD12 ' C' ' 83' ' ' ILE . 74.2 mt -84.67 -40.61 17.19 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.145 0.578 . . . . 73.55 109.774 176.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.09 -178.94 7.67 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.429 1.092 . . . . 73.3 109.399 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -62.75 124.87 22.16 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.967 -0.56 . . . . 53.01 109.993 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 73.03 -5.98 1.81 Allowed 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.288 1.435 . . . . 60.5 111.944 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 79.1 t -106.28 114.78 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.061 0.944 . . . . 72.53 109.697 -176.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -129.93 125.5 35.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.18 0.992 . . . . 70.14 108.869 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.412 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.7 tt0 -95.39 121.19 36.8 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.997 0.919 . . . . 71.33 109.935 178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -102.73 132.41 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 108.596 -0.89 . . . . 73.24 108.596 174.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.9 t -126.28 112.53 30.2 Favored 'Isoleucine or valine' 0 C--O 1.242 0.697 0 C-N-CA 124.164 0.985 . . . . 64.3 108.777 177.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.95 111.72 23.64 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.319 -0.993 . . . . 73.42 108.319 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -79.82 107.33 12.51 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.114 -0.699 . . . . 75.22 109.114 169.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 23.1 t -100.76 127.2 54.12 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.583 0 CA-C-N 114.956 -1.02 . . . . 71.22 108.408 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 48.4 m -131.43 130.23 42.26 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.405 -0.591 . . . . 74.24 109.405 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.654 HG22 HD23 ' C' ' 42' ' ' LEU . 86.0 t -120.11 120.85 64.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 123.92 0.888 . . . . 72.11 109.302 176.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.9 m -114.45 130.0 56.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.544 -0.909 . . . . 70.12 108.544 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.33 93.62 4.49 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.904 -1.517 . . . . 75.12 106.904 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 78.7 p -158.56 140.42 13.75 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.282 0.633 . . . . 72.23 109.565 -177.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 48.1 tp -77.99 -32.97 51.5 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 109.291 -0.633 . . . . 74.11 109.291 172.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -178.82 -82.67 0.06 OUTLIER Glycine 0 C--N 1.345 1.059 0 N-CA-C 110.4 -1.08 . . . . 62.1 110.4 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.88 -31.79 16.29 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.185 0.594 . . . . 60.43 109.841 177.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.46 96.08 7.28 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.22 0.608 . . . . 73.44 109.789 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 25.8 m -90.69 133.63 35.0 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.274 -0.876 . . . . 74.01 110.929 178.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.2 -56.91 3.76 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.406 -0.961 . . . . 53.21 108.406 166.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -160.74 175.34 12.72 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.745 -1.116 . . . . 75.23 111.952 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.5 tm? -141.29 146.65 37.05 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.387 1.875 . . . . 60.31 105.95 177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.424 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.5 t -152.78 153.55 33.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.274 0.629 . . . . 50.12 109.315 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 40.7 tt0 -159.64 136.47 9.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.707 0.403 . . . . 65.14 111.128 177.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' C' ' 110' ' ' ALA . 45.8 t -140.78 113.49 4.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.518 1.127 . . . . 72.41 108.881 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 66.1 mt-30 -91.97 97.76 11.16 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 108.252 -1.018 . . . . 73.43 108.252 173.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.562 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 6.8 tp-100 -86.56 114.16 23.06 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.514 0.726 . . . . 64.43 109.755 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.27 145.07 15.86 Favored Glycine 0 C--N 1.343 0.917 0 N-CA-C 112.201 -0.359 . . . . 74.32 112.201 177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.539 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.72 132.81 4.55 Favored Glycine 0 CA--C 1.504 -0.601 0 N-CA-C 111.839 -0.504 . . . . 75.13 111.839 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.47 HD12 HD11 ' C' ' 51' ' ' LEU . 7.8 mm -87.29 121.59 38.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.695 0 N-CA-C 108.226 -1.027 . . . . 43.3 108.226 177.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.34 123.8 26.06 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.607 0.763 . . . . 73.12 109.569 -175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 36.5 p -97.75 125.46 42.58 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.84 0.456 . . . . 50.11 110.167 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pp -115.77 132.74 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 108.381 -0.97 . . . . 75.14 108.381 173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -137.01 147.79 46.45 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.581 0.752 . . . . 63.33 109.755 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.1 -53.02 3.89 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.936 -0.574 . . . . 60.11 111.726 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.476 HG12 ' HG3' ' C' ' 9' ' ' MET . 2.9 pp -96.78 164.82 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.858 0.863 . . . . 71.42 111.487 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -168.41 -170.62 1.29 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 124.891 1.276 . . . . 74.44 109.264 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.09 -121.98 26.13 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-O 119.77 -0.461 . . . . 64.23 113.427 175.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 18.2 p -65.22 -33.21 75.47 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.943 0.897 . . . . 63.12 112.281 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.57 -42.49 67.73 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.908 0.483 . . . . 61.21 110.908 -178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptm -76.1 -24.93 55.03 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 123.005 0.19 . . . . 74.31 110.644 176.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.88 -43.7 78.74 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.165 0.507 . . . . 74.44 110.269 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -67.79 -34.36 76.63 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.268 -0.878 . . . . 60.34 110.805 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.7 t -69.88 -54.8 11.83 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.767 0.427 . . . . 55.35 110.478 -178.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.486 HD23 ' SG ' ' C' ' 102' ' ' CYS . 63.8 mt -76.45 -14.53 60.05 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.648 0.779 . . . . 65.42 111.569 -177.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.48 -29.88 8.52 Favored Glycine 0 C--N 1.35 1.351 0 O-C-N 123.388 0.43 . . . . 73.11 113.483 -178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.3 -59.39 1.98 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.094 0.558 . . . . 71.22 110.93 -176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.411 ' O ' HG12 ' C' ' 105' ' ' ILE . 62.0 t80 -72.66 -55.43 6.83 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.206 0.941 . . . . 73.32 111.721 -164.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.486 ' SG ' HD23 ' C' ' 98' ' ' LEU . 61.0 m -58.45 -48.06 97.64 Favored Pre-proline 0 CA--C 1.564 1.498 0 C-N-CA 124.073 0.949 . . . . 72.25 112.804 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.467 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 49.5 Cg_exo -59.38 -34.25 97.55 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.296 1.998 . . . . 71.32 113.082 173.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.581 HD21 ' HB ' ' C' ' 131' ' ' VAL . 38.5 t-20 -70.79 -33.85 71.16 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.64 0.776 . . . . 73.15 110.308 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.505 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.7 mm -66.85 -42.17 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 122.851 0.46 . . . . 72.21 109.842 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.539 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.9 mt -68.88 -32.19 71.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.053 -0.976 . . . . 74.55 111.408 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.66 -53.52 59.39 Favored Pre-proline 0 CA--C 1.563 1.462 0 N-CA-C 114.315 1.228 . . . . 73.1 114.315 -169.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.58 -34.41 95.3 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.325 2.016 . . . . 73.45 113.541 -177.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.409 ' HE2' HG21 ' A' ' 115' ' ' THR . 47.9 m-85 -67.96 -45.72 73.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.541 0.737 . . . . 72.31 110.469 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.562 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.59 -35.71 80.87 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.421 -0.809 . . . . 74.24 110.946 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -65.32 -46.77 78.99 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.96 1.304 . . . . 64.05 110.363 -178.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.6 tm-20 -68.39 -35.59 77.91 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.06 0.544 . . . . 64.13 109.779 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.404 ' HB3' HG21 ' C' ' 78' ' ' VAL . 10.6 t -68.65 -31.39 70.49 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 122.884 0.473 . . . . 65.41 111.351 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.43 HD13 HG23 ' C' ' 64' ' ' VAL . 63.3 mt -74.32 -47.92 38.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.259 0.624 . . . . 74.15 110.162 175.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.4 m -63.48 -28.92 70.29 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 123.063 0.545 . . . . 52.21 110.746 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 43.3 t -69.2 -46.75 66.68 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 123.861 0.865 . . . . 53.53 109.559 174.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.569 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -60.58 -39.9 89.77 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.214 1.005 . . . . 71.51 112.256 178.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.46 HG13 ' HB2' ' C' ' 123' ' ' PHE . 79.6 t -67.71 -38.78 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 123.95 0.9 . . . . 72.11 110.254 176.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.583 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 40.4 t -65.22 -37.66 87.99 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.564 -0.744 . . . . 74.43 111.069 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.5 mtt-85 -68.64 -35.89 77.87 Favored 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.247 -0.888 . . . . 70.21 109.469 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.55 1.91 80.46 Favored Glycine 0 C--N 1.354 1.54 0 O-C-N 123.801 0.688 . . . . 74.44 113.339 176.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' D' ' 17' ' ' TYR . 69.7 p 55.53 60.99 3.04 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.746 1.618 . . . . 33.51 111.853 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.46 ' HB2' HG13 ' C' ' 118' ' ' VAL . 86.7 m-85 -124.04 163.76 33.64 Favored Pre-proline 0 CA--C 1.558 1.251 0 C-N-CA 124.89 1.276 . . . . 74.02 108.822 175.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.662 ' HG3' ' HB ' ' E' ' 136' ' ' VAL . 97.2 Cg_endo -74.33 -169.26 0.57 Allowed 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.948 2.432 . . . . 72.22 113.484 -174.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.413 ' HB3' ' OD1' ' C' ' 127' ' ' ASN . 21.0 mm-40 -54.41 112.02 0.91 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.059 -0.973 . . . . 71.34 111.591 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.462 HD11 HG11 ' C' ' 64' ' ' VAL . 3.1 tm? -108.07 87.01 2.4 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 105.426 -2.064 . . . . 72.05 105.426 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.413 ' OD1' ' HB3' ' C' ' 125' ' ' GLN . 12.1 m120 -95.31 97.53 9.92 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.311 -0.996 . . . . 54.23 108.311 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.516 HD23 ' H ' ' C' ' 129' ' ' ALA . 1.2 tt -63.6 149.21 46.93 Favored 'General case' 0 CA--C 1.554 1.115 0 CA-C-N 115.205 -0.907 . . . . 73.42 108.99 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.516 ' H ' HD23 ' C' ' 128' ' ' LEU . . . -49.54 153.09 2.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 124.68 1.192 . . . . 74.53 112.76 -178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.11 -158.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.503 2.042 0 C-N-CA 123.417 2.745 . . . . 62.21 114.959 176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.581 ' HB ' HD21 ' C' ' 104' ' ' ASN . 20.5 m -93.94 155.19 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 CA-C-O 121.838 0.828 . . . . 71.12 112.493 -168.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -69.83 110.62 5.07 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 113.776 -1.556 . . . . 64.43 110.936 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -44.54 -34.49 2.14 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 125.371 1.468 . . . . 70.41 114.305 176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.443 ' HA ' ' HD2' ' C' ' 137' ' ' PHE . 17.6 t0 -65.38 -19.23 65.86 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 112.197 0.443 . . . . 73.52 112.197 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.55 -29.21 59.32 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.783 0.833 . . . . 63.13 112.141 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.667 HD12 HD22 ' C' ' 139' ' ' ASN . 26.8 tp -64.8 -29.56 70.53 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.236 0.614 . . . . 75.23 110.617 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.443 ' HD2' ' HA ' ' C' ' 134' ' ' ASP . 97.2 m-85 -66.94 -20.29 65.87 Favored 'General case' 0 N--CA 1.487 1.375 0 CA-C-N 115.691 -0.686 . . . . 74.51 112.622 177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 7.9 tmm? -69.25 -41.67 76.62 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.324 -0.621 . . . . 75.53 109.324 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.667 HD22 HD12 ' C' ' 136' ' ' LEU . 47.8 m-20 -60.79 -36.97 80.35 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.674 -1.148 . . . . 63.24 110.742 -176.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.468 ' HD1' ' HG3' ' A' ' 138' ' ' MET . 16.9 t80 -59.71 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.964 0 O-C-N 124.416 1.073 . . . . 72.41 109.553 164.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 49.3 tp 70.64 -88.36 0.03 OUTLIER 'General case' 0 C--N 1.357 0.932 0 C-N-CA 124.63 1.172 . . . . 74.24 108.741 -173.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -149.69 -75.48 0.16 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.45 0.7 . . . . 72.43 109.781 171.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -144.71 21.92 1.63 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.326 0.651 . . . . 71.43 111.529 -171.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 16.9 tm0? -55.94 123.52 14.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.96 0.904 . . . . 61.44 111.445 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.507 ' HB2' ' ND2' ' A' ' 139' ' ' ASN . . . -148.58 77.69 1.39 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.033 0.933 . . . . 53.24 108.705 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -132.3 69.12 0.54 Allowed Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.573 -0.74 . . . . 53.12 112.459 -176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.72 111.62 15.0 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.657 -1.238 . . . . 73.54 107.657 172.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 167.3 -124.37 1.21 Allowed Glycine 0 C--N 1.34 0.774 0 CA-C-O 119.47 -0.628 . . . . 51.53 112.644 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.63 ' H ' ' HB2' ' C' ' 4' ' ' GLN . 8.1 m 63.46 26.61 14.92 Favored 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.574 1.15 . . . . 74.14 109.932 -176.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -87.46 121.73 30.28 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.932 -1.031 . . . . 71.1 111.287 -169.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -152.69 125.82 8.57 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.896 1.278 . . . . 70.22 110.107 173.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -98.61 114.65 27.19 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.435 0.694 . . . . 75.03 109.469 170.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -78.92 107.78 11.91 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.03 -0.73 . . . . 74.13 109.03 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.24 125.89 30.43 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.032 -0.729 . . . . 71.12 109.032 173.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.206 0 C-N-CA 123.777 0.831 . . . . 64.55 109.758 -178.382 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 107.986 -1.116 . . . . 72.31 107.986 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 24.5 t 69.64 57.38 0.33 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.848 1.343 . . . . 62.1 110.558 -175.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.69 80.38 1.54 Allowed 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.764 -1.107 . . . . 70.25 109.705 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -131.19 -62.68 0.88 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.525 -0.762 . . . . 72.03 109.925 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 59.54 32.6 21.74 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.994 0.918 . . . . 51.1 110.933 -175.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -59.18 140.53 55.82 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.533 -1.212 . . . . 71.12 109.986 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -71.93 73.16 0.86 Allowed 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.783 0.833 . . . . 65.05 110.179 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 174.3 111.73 0.02 OUTLIER 'General case' 0 C--O 1.243 0.714 0 C-N-CA 126.222 1.809 . . . . 72.35 106.306 -176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.458 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 7.1 ttp -33.17 128.92 0.27 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 124.79 1.236 . . . . 63.01 113.602 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 60.0 m -131.02 130.53 43.43 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.298 1.039 . . . . 44.22 108.827 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.1 t80 -149.11 104.31 3.41 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.278 -1.008 . . . . 73.4 108.278 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -119.23 127.5 53.33 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.456 0.702 . . . . 65.2 109.732 -177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mp -78.25 117.52 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 108.529 -0.915 . . . . 73.1 108.529 178.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -95.4 -46.99 6.47 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.137 0.575 . . . . 71.32 112.429 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -164.6 134.29 3.81 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 117.741 0.246 . . . . 73.01 111.165 -168.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.438 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.8 mp -118.64 130.54 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.673 -1.232 . . . . 73.33 107.673 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.413 ' HB3' HG23 ' C' ' 122' ' ' THR . 39.7 p90 -168.34 150.24 5.16 Favored 'General case' 0 C--N 1.341 0.222 0 CA-C-O 121.883 0.849 . . . . 54.14 112.115 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.0 p -81.9 123.07 28.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.837 -1.074 . . . . 72.44 109.388 177.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.4 mtpt -92.47 -20.34 21.08 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 110.199 -0.297 . . . . 54.02 110.199 174.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.707 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.7 t70 -155.41 134.62 12.31 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.412 -0.813 . . . . 65.02 108.841 -177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.569 HG21 ' HE2' ' C' ' 117' ' ' MET . 79.8 mt -139.79 148.56 22.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.613 0 C-N-CA 124.807 1.243 . . . . 75.02 107.865 177.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -150.26 141.5 23.19 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 123.934 0.893 . . . . 72.24 109.284 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.2 t80 -153.29 132.76 12.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.811 -1.922 . . . . 74.41 105.811 171.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.1 mt-10 -135.23 145.25 47.45 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.69 0.796 . . . . 60.23 109.136 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -146.81 71.45 12.48 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.252 -1.018 . . . . 72.14 108.252 175.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.8 -26.08 19.49 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.683 2.255 . . . . 74.43 112.609 -173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.51 ' O ' HG23 ' D' ' 31' ' ' VAL . 28.8 m-20 -115.11 23.11 12.77 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.927 0.891 . . . . 35.42 109.629 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -48.04 -54.93 20.46 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 115.783 1.772 . . . . 71.45 115.783 -168.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.488 ' HA ' ' CD1' ' D' ' 32' ' ' PHE . 51.9 Cg_endo -76.1 -16.97 17.57 Favored 'Trans proline' 0 C--N 1.384 2.417 0 CA-C-N 121.162 1.451 . . . . 70.3 112.469 -177.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.7 t-160 -77.18 -30.49 54.88 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.514 1.525 . . . . 71.51 109.782 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.558 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.7 t -77.26 -27.81 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.2 0.6 . . . . 64.52 110.384 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.488 ' CD1' ' HA ' ' D' ' 29' ' ' PRO . 18.4 m-30 -66.05 -21.08 66.36 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.74 0.416 . . . . 74.43 111.381 175.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.4 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 75.7 mt-30 -64.71 -33.46 76.02 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.495 0.718 . . . . 64.14 110.439 174.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -94.18 100.35 12.45 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 108.144 -1.058 . . . . 71.51 108.144 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -78.4 63.26 3.22 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.985 0.914 . . . . 40.44 111.532 -175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -143.62 160.11 41.24 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.444 -0.576 . . . . 71.41 109.444 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.521 ' HB3' ' H ' ' F' ' 140' ' ' SER . 1.5 mp0 -81.52 107.08 7.09 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.784 1.234 . . . . 71.34 108.736 178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.465 ' HA ' HD13 ' D' ' 68' ' ' LEU . 35.8 Cg_exo -44.28 151.41 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 124.204 3.269 . . . . 72.1 116.392 -177.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.564 ' HG2' HD22 ' F' ' 141' ' ' LEU . 7.6 tm-20 -61.44 138.32 58.26 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.222 -1.354 . . . . 71.23 110.226 174.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 21.9 t -116.58 106.24 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 122.603 0.361 . . . . 74.12 110.329 -177.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -98.99 142.5 30.39 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 167.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.682 HD11 HD21 ' D' ' 128' ' ' LEU . 2.7 mm? -120.08 122.17 40.47 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.157 0.583 . . . . 63.34 109.438 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.785 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 7.0 m-20 -107.23 130.9 54.67 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.219 -1.4 . . . . 73.01 107.219 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.38 147.97 39.88 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.152 0.581 . . . . 72.43 110.638 -175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 28.5 t70 -164.98 154.32 12.87 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.265 1.026 . . . . 71.01 108.773 177.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -142.11 162.4 35.58 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.456 0.702 . . . . 71.51 109.432 176.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.43 163.34 40.12 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.776 0.83 . . . . 44.02 109.114 176.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -154.17 153.7 32.26 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 122.859 0.463 . . . . 73.34 109.918 174.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 85.4 p -150.28 146.67 26.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.987 0.915 . . . . 72.15 109.248 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -90.67 119.05 30.59 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.669 -0.863 . . . . 72.2 108.669 174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -92.0 -31.47 15.59 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.073 0.549 . . . . 62.22 109.772 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.21 -170.21 1.07 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.063 0.945 . . . . 74.13 110.63 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.45 116.27 7.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.449 0.7 . . . . 63.04 110.374 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 62.91 17.21 9.82 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.475 1.11 . . . . 53.33 112.237 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 76.7 t -116.0 118.64 59.43 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 N-CA-C 107.479 -1.304 . . . . 74.23 107.479 172.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.693 ' HB2' HD13 ' D' ' 86' ' ' ILE . 87.5 m-85 -136.45 130.1 32.12 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 108.55 -0.907 . . . . 61.13 108.55 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' D' ' 51' ' ' LEU . 29.0 tt0 -91.15 125.86 36.06 Favored 'General case' 0 C--O 1.221 -0.4 0 C-N-CA 124.586 1.154 . . . . 62.41 109.629 175.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 70.1 t -110.74 125.59 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 N-CA-C 109.085 -0.709 . . . . 71.43 109.085 172.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 60.9 t -104.96 133.85 48.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.617 0.767 . . . . 74.15 109.428 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -110.78 125.43 53.54 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 107.584 -1.265 . . . . 53.23 107.584 174.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 14.0 ttm180 -104.95 102.49 12.0 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.009 -0.737 . . . . 73.24 109.009 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 62.3 t -98.19 118.01 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 107.821 -1.177 . . . . 72.44 107.821 168.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.0 m -116.96 136.32 53.03 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 122.992 0.517 . . . . 65.34 109.634 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.434 HG23 HD13 ' D' ' 114' ' ' ILE . 54.8 t -115.64 115.96 50.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 C-N-CA 124.193 0.997 . . . . 74.33 109.141 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.0 m -103.19 115.95 31.54 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 107.846 -1.168 . . . . 73.34 107.846 168.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.44 134.62 54.64 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 64.44 110.065 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.446 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 74.1 p -139.27 146.34 40.27 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.654 0.782 . . . . 75.42 109.006 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.465 HD13 ' HA ' ' D' ' 38' ' ' PRO . 16.7 tp -134.76 106.05 6.74 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.535 -0.913 . . . . 52.33 108.535 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.16 -114.99 4.59 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.577 -0.738 . . . . 13.21 111.691 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.36 4.56 14.4 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.654 0.781 . . . . 73.42 110.2 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -123.53 162.55 22.7 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.492 0.717 . . . . 65.14 110.583 -172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -72.07 129.03 37.54 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.67 0.606 . . . . 75.43 109.888 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.558 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.3 -58.9 2.56 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.436 0.694 . . . . 64.14 109.452 178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -161.33 166.14 27.97 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.64 -1.164 . . . . 75.12 109.21 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 95.4 mt -126.8 153.09 46.07 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.402 1.081 . . . . 71.35 108.271 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.503 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.9 t -158.41 144.99 17.39 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 123.063 0.545 . . . . 55.3 109.719 177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.21 135.61 11.28 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.888 0.875 . . . . 73.43 109.151 174.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.72 114.48 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 109.515 -0.55 . . . . 65.33 109.515 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.707 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.5 mt-30 -90.48 87.02 6.6 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 122.041 0.924 . . . . 73.54 109.397 169.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -79.77 96.71 6.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 113.558 -1.655 . . . . 75.42 109.146 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -84.83 144.1 20.96 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 111.37 -0.692 . . . . 35.51 111.37 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.24 4.57 Favored Glycine 0 CA--C 1.502 -0.743 0 N-CA-C 110.603 -0.999 . . . . 71.45 110.603 177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.7 mt -87.69 123.83 40.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 107.214 -1.402 . . . . 74.14 107.214 173.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -127.12 164.26 22.0 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.062 0.945 . . . . 73.42 108.475 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 6.1 t -113.18 106.43 14.64 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.904 -1.147 . . . . 73.34 107.904 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.693 HD13 ' HB2' ' D' ' 56' ' ' TYR . 3.6 mp -108.86 107.48 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 108.512 -0.922 . . . . 73.31 108.512 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.628 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -134.08 146.4 50.26 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.237 1.015 . . . . 70.15 109.583 178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.13 -21.56 8.04 Favored Glycine 0 CA--C 1.532 1.144 0 N-CA-C 114.526 0.57 . . . . 44.13 114.526 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.481 HD11 ' HG3' ' D' ' 93' ' ' GLN . 12.1 tt -109.2 130.44 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.614 0.765 . . . . 74.22 108.99 -176.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.64 -177.45 5.3 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.431 0.692 . . . . 75.1 111.673 -168.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.53 -140.33 36.82 Favored Glycine 0 C--N 1.349 1.251 0 O-C-N 123.978 0.799 . . . . 72.13 113.408 177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -81.43 -20.85 39.5 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.453 0.701 . . . . 74.31 111.437 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.481 ' HG3' HD11 ' D' ' 89' ' ' ILE . 7.2 tp60 -69.65 -40.24 76.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.189 0.596 . . . . 73.55 111.051 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.43 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 5.2 ppp? -69.34 -33.78 73.62 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.796 -0.446 . . . . 70.51 109.796 174.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.97 99.89 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.361 0.664 . . . . 75.25 110.812 177.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -72.32 -34.32 68.0 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.5 -0.773 . . . . 72.25 110.183 178.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.8 t -64.94 -36.73 85.32 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.342 0.657 . . . . 63.03 111.124 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.624 HD21 HG12 ' D' ' 86' ' ' ILE . 31.5 mt -80.17 -23.2 41.21 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.976 0.51 . . . . 62.4 111.013 178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.75 -2.35 55.23 Favored Glycine 0 C--N 1.347 1.164 0 CA-C-O 119.697 -0.502 . . . . 63.13 113.736 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.13 -60.43 0.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 CA-C-N 117.617 0.709 . . . . 73.13 111.412 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -72.61 -40.99 66.05 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.942 0.497 . . . . 63.41 111.797 -171.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.472 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 68.8 m -69.26 -49.04 25.14 Favored Pre-proline 0 CA--C 1.559 1.313 0 CA-C-O 118.956 -0.545 . . . . 73.22 110.975 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.483 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 77.4 Cg_exo -52.13 -31.13 43.93 Favored 'Trans proline' 0 C--N 1.393 2.917 0 C-N-CA 122.542 2.161 . . . . 43.22 114.566 168.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.66 -35.64 81.37 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.993 0.517 . . . . 74.11 110.755 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 42.3 mm -71.19 -44.11 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.242 0.617 . . . . 62.4 110.251 173.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 77.8 mt -75.8 -20.24 58.35 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.341 -0.845 . . . . 43.02 112.027 -172.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 74.8 t80 -65.48 -48.03 67.26 Favored Pre-proline 0 N--CA 1.485 1.29 0 N-CA-C 113.459 0.911 . . . . 74.33 113.459 -171.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.48 -34.01 88.06 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.884 1.722 . . . . 53.24 112.821 174.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.27 -35.68 47.77 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.863 0.865 . . . . 73.13 111.816 178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.79 -44.69 76.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.286 0.634 . . . . 72.05 109.963 -178.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.4 HH12 ' HG3' ' D' ' 130' ' ' PRO . 14.4 ptt180 -75.11 -31.63 61.19 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 114.958 -1.019 . . . . 64.52 110.784 -178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.98 -49.71 75.01 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 124.007 0.817 . . . . 63.32 110.305 177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.81 -40.47 84.22 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.853 0.72 . . . . 75.13 110.517 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.503 HG12 ' SG ' ' D' ' 76' ' ' CYS . 64.9 mt -57.58 -53.18 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 123.794 0.684 . . . . 44.45 110.236 171.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.465 HG23 ' HG3' ' D' ' 125' ' ' GLN . 86.0 m -57.62 -45.79 84.95 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 124.26 1.024 . . . . 74.14 111.17 -172.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -64.31 -41.04 97.02 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.636 -1.166 . . . . 65.21 110.138 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.0 mtm -69.02 -33.53 73.79 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.111 0.565 . . . . 72.13 111.587 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.41 HG23 ' O ' ' D' ' 114' ' ' ILE . 53.3 t -64.11 -46.76 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 O-C-N 123.823 0.702 . . . . 55.24 110.203 175.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 93.7 p -71.16 -29.46 65.22 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.617 0.367 . . . . 62.41 110.858 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.7 mtt-85 -70.55 -30.29 66.97 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.653 0.781 . . . . 71.35 110.1 172.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.63 7.16 81.98 Favored Glycine 0 C--N 1.357 1.712 0 O-C-N 123.724 0.64 . . . . 74.11 112.834 175.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' C' ' 17' ' ' TYR . 43.5 p 56.76 28.69 14.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 126.395 1.878 . . . . 71.43 113.262 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -95.74 158.59 34.11 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 123.883 0.873 . . . . 73.5 110.137 175.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.76 127.33 25.71 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 123.008 2.472 . . . . 65.21 112.932 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.465 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.0 tt0 -51.26 130.61 27.07 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.611 1.195 . . . . 71.01 112.201 -175.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 46.1 tp -115.19 100.89 8.47 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.63 0.372 . . . . 64.33 110.292 -176.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-20 -99.61 112.51 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.351 -1.352 . . . . 73.45 107.351 174.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.682 HD21 HD11 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -74.37 135.85 42.45 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 123.42 0.45 . . . . 75.35 110.592 -171.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.17 123.05 58.26 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 124.467 1.104 . . . . 60.51 110.933 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.588 ' HD2' HD12 ' F' ' 147' ' ' LEU . 43.0 Cg_exo -57.4 129.87 36.22 Favored 'Trans proline' 0 C--N 1.38 2.206 0 C-N-CA 122.321 2.014 . . . . 74.24 111.238 177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' F' ' 148' ' ' LEU . 51.6 t -123.73 110.55 26.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 109.194 -0.669 . . . . 65.13 109.194 177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -77.28 95.57 4.38 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 107.794 -1.188 . . . . 73.03 107.794 167.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.21 -30.92 71.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.641 -0.709 . . . . 73.12 111.159 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -65.45 -51.6 59.02 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.354 0.662 . . . . 74.5 109.549 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.55 -38.5 91.36 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.811 0.844 . . . . 65.24 111.519 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -58.56 -47.3 84.72 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.243 0.964 . . . . 70.22 109.992 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -77.23 -30.94 54.78 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.995 0.518 . . . . 73.15 111.292 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 61.2 mtm -62.49 -23.03 66.71 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-O 119.251 -0.404 . . . . 73.33 111.944 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -51.12 -44.05 61.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.497 0.719 . . . . 75.14 111.342 169.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.99 -40.58 91.28 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.807 0.843 . . . . 74.33 111.648 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.9 mp -62.31 -30.47 71.17 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.233 0.613 . . . . 41.12 111.003 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -79.7 2.58 22.17 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.123 0.969 . . . . 70.22 111.976 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -130.16 89.83 2.86 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.266 1.026 . . . . 51.14 109.363 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -166.39 173.09 10.3 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.315 1.046 . . . . 73.55 109.91 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.65 -32.32 28.27 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.14 0.576 . . . . 72.03 110.751 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 102.61 -95.83 1.32 Allowed Glycine 0 C--N 1.346 1.135 0 CA-C-N 116.195 -0.457 . . . . 52.2 112.705 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -94.47 109.79 21.64 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.707 0.803 . . . . 74.44 111.19 -175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.08 -134.9 2.88 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 116.251 -0.431 . . . . 50.53 112.81 177.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 21.0 m -68.2 -16.95 64.18 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 124.248 1.019 . . . . 74.41 112.019 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -60.91 -27.78 68.43 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.524 1.13 . . . . 65.2 112.358 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -40.72 73.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.78 0.832 . . . . 61.12 110.174 171.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 -84.34 104.59 14.49 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.15 -0.932 . . . . 71.33 108.955 178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -75.52 82.24 2.56 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.318 0.647 . . . . 72.34 109.367 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -84.08 142.96 30.04 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.066 -0.97 . . . . 75.42 109.995 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 CA-C-O 118.764 -0.636 . . . . 43.24 110.627 -178.06 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.356 -0.609 . . . . 64.15 109.356 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -76.36 -23.87 54.16 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.059 0.544 . . . . 73.4 110.886 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.51 81.44 8.73 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.653 0.781 . . . . 62.3 109.473 176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -81.88 -37.69 26.51 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.651 -0.704 . . . . 65.3 110.562 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -105.69 161.53 14.32 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.141 0.976 . . . . 73.52 111.076 -171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -161.4 145.63 13.16 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.57 0.748 . . . . 63.12 110.294 175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.52 ' H ' ' HD3' ' E' ' 114' ' ' LYS . 0.0 OUTLIER -134.52 142.27 46.96 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.696 1.198 . . . . 50.14 108.254 178.128 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.549 HD12 ' HE2' ' B' ' 94' ' ' MET . 82.7 mt -89.38 -32.95 17.05 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.522 0.329 . . . . 61.3 110.709 177.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -103.76 100.26 19.13 Favored Pre-proline 0 C--N 1.357 0.93 0 N-CA-C 109.689 -0.486 . . . . 74.11 109.689 171.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.623 ' HD2' ' HA2' ' B' ' 91' ' ' GLY . 26.4 Cg_endo -92.72 5.35 3.3 Favored 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 122.947 2.431 . . . . 71.02 111.303 163.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -76.09 141.84 41.88 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 123.686 0.794 . . . . 65.4 109.771 -177.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 55.7 m -77.07 87.51 3.57 Favored 'General case' 0 C--O 1.243 0.762 0 C-N-CA 123.469 0.708 . . . . 65.24 110.408 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 56.2 t-105 -97.74 85.58 3.59 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 107.979 -1.119 . . . . 72.42 107.979 171.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -129.26 22.6 5.62 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.784 -1.098 . . . . 64.35 109.839 175.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.15 -89.29 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 118.951 -0.547 . . . . 70.03 110.518 -175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 40.3 t 37.83 67.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 125.014 1.326 . . . . 74.35 111.164 -173.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -78.97 -51.66 9.32 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.999 -0.546 . . . . 74.13 110.12 -169.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 2.3 t80 64.36 -174.87 0.17 Allowed 'General case' 0 CA--C 1.561 1.402 0 C-N-CA 124.591 1.156 . . . . 75.25 111.396 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -157.33 153.87 28.07 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.455 0.702 . . . . 75.11 110.019 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -96.62 25.92 24.18 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 115.896 -0.593 . . . . 73.02 113.133 -178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' E' ' 131' ' ' ALA . 2.8 tmtp? -112.34 114.92 27.91 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.357 -1.349 . . . . 64.22 107.357 178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' B' ' 128' ' ' LEU . 6.2 tt -145.26 -54.02 0.29 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.161 -1.052 . . . . 75.23 108.161 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.469 HD12 ' HB3' ' E' ' 129' ' ' LEU . 3.4 mp -79.44 84.87 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 108.682 -0.858 . . . . 74.42 108.682 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . 0.426 ' HB2' ' HE2' ' E' ' 128' ' ' LYS . . . -85.27 -36.0 21.17 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.965 -1.016 . . . . 73.52 109.522 174.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.69 103.03 53.78 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.132 -1.062 . . . . 73.1 108.132 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -83.76 46.94 2.16 Favored 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.898 2.398 . . . . 62.41 111.593 177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 7.3 tp -71.56 84.49 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.232 0 CA-C-O 122.472 1.129 . . . . 25.3 109.579 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.51 -21.82 57.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.36 -1.291 . . . . 72.4 111.183 -177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.662 ' HB ' ' HG3' ' C' ' 124' ' ' PRO . 73.7 t 62.05 -86.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 124.599 1.16 . . . . 53.24 109.958 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 59.48 -165.27 0.2 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.211 1.004 . . . . 71.51 111.897 -178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 66.01 14.53 9.65 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.198 0.999 . . . . 71.54 111.753 -176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 1.5 pp -120.3 31.27 6.55 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.714 1.206 . . . . 72.44 109.821 176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 48.2 m -93.88 9.25 38.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 115.713 -0.676 . . . . 61.42 111.005 176.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . 0.638 ' H ' HD23 ' E' ' 141' ' ' LEU . 1.4 pt? -78.23 83.31 4.49 Favored 'General case' 0 C--N 1.361 1.066 0 CA-C-O 122.325 1.06 . . . . 75.14 109.19 174.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . 0.573 HG12 ' H ' ' E' ' 143' ' ' TYR . 13.3 tt -128.74 -177.62 2.03 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 CA-C-N 114.414 -1.266 . . . . 74.04 107.97 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . 0.573 ' H ' HG12 ' E' ' 142' ' ' ILE . 83.6 m-85 -54.49 103.12 0.08 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.028 0.931 . . . . 74.43 112.293 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -120.72 96.04 4.96 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.311 -0.996 . . . . 62.03 108.311 174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' E' ' 146' ' ' ASP . 58.8 tttm -171.15 178.32 3.37 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.381 1.072 . . . . 73.44 108.468 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . 0.423 ' H ' ' HG2' ' E' ' 145' ' ' LYS . 5.9 p-10 -69.48 79.96 0.4 Allowed 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 122.127 0.965 . . . . 54.04 111.221 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 pp -88.93 -10.02 49.36 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.476 -0.784 . . . . 70.32 110.609 174.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.568 HD11 HD22 ' C' ' 136' ' ' LEU . 3.9 tp -177.83 87.5 0.24 Allowed Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.154 1.381 . . . . 70.21 108.944 175.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo . . . . . 0 CA--C 1.561 1.849 0 C-N-CA 123.215 2.61 . . . . 74.0 111.839 172.674 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.484 1.256 0 N-CA-C 110.027 -0.36 . . . . 75.33 110.027 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -74.5 130.33 39.4 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.698 0.799 . . . . 70.11 110.4 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.86 114.69 8.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.912 0.885 . . . . 71.03 110.58 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -127.16 -63.04 1.07 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.965 0.906 . . . . 74.44 109.152 176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 39.95 73.0 0.13 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.126 1.771 . . . . 72.22 114.004 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -107.38 92.69 4.18 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 108.114 -1.069 . . . . 71.55 108.114 172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -119.93 141.55 49.53 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.544 0.737 . . . . 63.44 109.894 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.579 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 89.6 mt -70.7 100.06 1.8 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.9 0.88 . . . . 62.42 110.662 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -159.71 84.11 2.23 Favored Pre-proline 0 CA--C 1.551 0.995 0 N-CA-C 108.44 -0.948 . . . . 75.25 108.44 176.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -95.03 -173.27 0.28 Allowed 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 123.352 2.701 . . . . 71.24 113.998 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . 0.48 ' HB3' ' HB1' ' A' ' 95' ' ' ALA . 47.0 t80 62.11 84.46 0.14 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.75 1.62 . . . . 73.2 110.81 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 3.3 t -69.44 86.63 0.44 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-N 115.075 -0.966 . . . . 54.11 110.845 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 87.8 t90 -158.22 144.37 17.23 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.744 -1.117 . . . . 75.34 109.067 178.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -165.62 97.89 0.67 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.914 0.886 . . . . 72.22 109.003 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.92 94.08 2.43 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.965 -0.754 . . . . 72.34 108.965 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 6.8 p -142.5 121.35 8.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.559 0.744 . . . . 75.22 109.988 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 25.6 mtt180 -125.61 176.17 7.06 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 106.744 -1.576 . . . . 74.41 106.744 167.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . 0.41 ' HE1' ' HB3' ' A' ' 129' ' ' ALA . 49.4 t80 -159.37 117.64 2.82 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.988 -1.486 . . . . 74.01 106.988 167.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . 0.484 HD22 ' N ' ' F' ' 126' ' ' ASN . 0.8 OUTLIER -96.42 -55.94 2.77 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.454 -0.943 . . . . 75.22 108.454 177.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 60.43 -144.3 47.55 Favored Glycine 0 C--N 1.353 1.508 0 O-C-N 123.988 0.805 . . . . 32.54 113.37 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -165.34 119.17 1.23 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.019 -1.104 . . . . 73.55 108.019 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.442 HD23 HG21 ' A' ' 40' ' ' VAL . 22.6 tp -128.14 167.18 17.17 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.013 0.525 . . . . 74.31 110.365 -173.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 59.5 mt 69.62 86.14 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 125.494 1.518 . . . . 60.33 109.068 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -86.98 -52.88 5.19 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.22 -0.9 . . . . 63.03 110.682 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -139.98 106.9 6.84 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.309 0.644 . . . . 75.42 109.657 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.32 179.25 6.34 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.989 2.459 . . . . 74.43 112.39 175.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.631 HG21 HH22 ' C' ' 15' ' ' ARG . 13.5 tt -166.76 146.31 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 C-N-CA 123.547 0.739 . . . . 62.24 109.357 -177.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.72 119.57 16.08 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.165 0.586 . . . . 72.32 109.888 173.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 8.9 m -137.69 30.88 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 C-N-CA 124.025 0.93 . . . . 75.13 111.293 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -63.92 -63.56 1.13 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.143 0.977 . . . . 72.34 109.988 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -154.6 151.28 28.65 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 114.216 -1.356 . . . . 64.13 108.187 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' D' ' 37' ' ' GLN . 15.5 tp -82.02 139.88 34.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.074 0.55 . . . . 71.25 109.653 -175.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . 0.521 ' H ' ' HB3' ' D' ' 37' ' ' GLN . 22.0 t -78.48 179.16 7.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.561 0.744 . . . . 62.14 110.875 -171.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . 0.564 HD22 ' HG2' ' D' ' 39' ' ' GLU . 6.4 mp 61.21 21.79 12.2 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.308 1.043 . . . . 74.22 112.188 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 9.3 tp -72.2 144.02 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 108.851 -0.796 . . . . 75.44 108.851 172.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . 0.729 ' HB3' ' HB2' ' F' ' 146' ' ' ASP . 90.2 m-85 -69.21 95.88 0.79 Allowed 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.265 0.626 . . . . 72.25 110.777 -174.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 47.8 t-20 -66.84 114.91 6.06 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 115.332 -0.849 . . . . 61.32 109.662 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . 0.411 ' HB2' ' NZ ' ' F' ' 145' ' ' LYS . 3.3 ttmp? 74.52 -5.47 2.1 Favored 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 125.307 1.443 . . . . 54.34 112.564 175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' F' ' 143' ' ' TYR . 32.3 m-20 -93.89 47.09 1.2 Allowed 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 121.584 0.707 . . . . 74.32 109.589 177.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . 0.588 HD12 ' HD2' ' D' ' 130' ' ' PRO . 2.1 mm? -99.36 105.24 17.19 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.361 -1.348 . . . . 73.03 107.361 178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . 0.425 ' HB2' ' HA ' ' D' ' 131' ' ' VAL . 5.4 mp -92.8 101.19 4.83 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 123.639 0.776 . . . . 74.11 108.99 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo . . . . . 0 C--N 1.377 2.045 0 C-N-CA 122.682 2.255 . . . . 44.01 111.966 -178.564 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.823 -0.436 . . . . 52.33 109.823 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.7 p -170.04 -42.12 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.034 0.934 . . . . 74.03 108.784 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 62.28 23.48 13.9 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.491 1.116 . . . . 71.51 112.107 174.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -137.45 -5.39 1.8 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.503 0.721 . . . . 73.41 111.527 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -66.55 155.58 37.35 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.663 0.785 . . . . 75.32 111.371 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -95.91 23.62 6.19 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.104 0.962 . . . . 64.35 110.27 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.2 m -83.03 2.39 35.21 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.741 0.817 . . . . 70.33 111.07 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -84.78 155.14 21.96 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.975 0.91 . . . . 72.12 109.472 171.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -65.86 131.22 45.74 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.927 -0.768 . . . . 55.05 108.927 171.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 47.3 m -151.91 131.1 12.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.154 0.582 . . . . 65.42 110.387 -177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -139.93 137.26 34.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.478 1.111 . . . . 74.12 108.394 170.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -160.69 136.76 8.4 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.269 0.227 . . . . 55.31 110.838 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.8 mp -69.18 114.48 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.077 -1.083 . . . . 73.24 108.077 173.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -95.29 -30.07 14.15 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.138 0.575 . . . . 71.54 111.176 -178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.8 tpt180 -166.03 148.41 7.17 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.682 -0.488 . . . . 73.35 109.682 -175.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.45 HG12 ' HG3' ' C' ' 130' ' ' PRO . 2.5 pp -141.03 139.05 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 107.726 -1.213 . . . . 74.13 107.726 171.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.584 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 42.1 p90 -176.97 176.16 1.47 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.566 0.698 . . . . 74.24 110.949 -175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.6 p -99.73 111.07 23.43 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 124.042 0.937 . . . . 64.41 109.241 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.3 mtpt -76.01 -28.92 57.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.957 -0.386 . . . . 63.1 109.957 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 19.0 t70 -150.61 147.77 27.82 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.955 -0.566 . . . . 73.43 110.126 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 82.4 mt -138.72 145.39 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 125.477 1.511 . . . . 73.21 107.398 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.5 t -154.22 117.58 4.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 122.662 0.385 . . . . 64.33 110.457 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.699 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.1 t80 -124.44 116.32 22.34 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.353 -1.351 . . . . 74.41 107.353 172.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -119.67 128.17 53.58 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.433 -0.58 . . . . 74.34 109.433 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.56 76.61 48.15 Favored Pre-proline 0 C--O 1.24 0.553 0 N-CA-C 108.546 -0.909 . . . . 61.43 108.546 175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.71 -18.23 22.4 Favored 'Trans proline' 0 C--N 1.373 1.837 0 C-N-CA 122.68 2.253 . . . . 72.21 112.024 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 64.6 m-20 -115.76 30.72 7.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.934 0.893 . . . . 75.35 108.962 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.438 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -58.12 -46.33 99.68 Favored Pre-proline 0 CA--C 1.566 1.561 0 C-N-CA 123.864 0.866 . . . . 63.31 112.584 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 31.6 Cg_exo -62.92 -28.16 75.13 Favored 'Trans proline' 0 C--N 1.397 3.094 0 C-N-CA 122.025 1.817 . . . . 62.4 113.21 169.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.1 m80 -73.13 -24.39 60.6 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.77 0.428 . . . . 75.04 111.327 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.41 -27.41 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 120.967 0.413 . . . . 61.2 110.819 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.593 ' HD2' HH11 ' B' ' 15' ' ' ARG . 81.9 t80 -74.86 -41.69 59.35 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.381 0.672 . . . . 72.01 110.239 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.453 ' HG2' ' HA ' ' A' ' 30' ' ' HIS . 13.1 pt20 -80.3 -30.47 38.22 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 122.584 0.354 . . . . 50.44 111.556 -178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 3.8 mmmp? -82.36 156.85 24.0 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.883 0.873 . . . . 65.24 112.107 -176.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -58.59 140.4 54.41 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.473 -1.24 . . . . 74.13 110.757 169.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -88.24 63.92 7.4 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 121.634 0.731 . . . . 72.43 109.378 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -124.63 78.34 63.36 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.376 1.07 . . . . 73.42 108.819 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -77.87 167.2 24.14 Favored 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.985 2.457 . . . . 62.33 113.606 -173.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -123.77 95.37 4.55 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 106.829 -1.545 . . . . 65.2 106.829 174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -82.25 125.62 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 121.311 0.577 . . . . 75.54 110.391 -175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 35.5 mttp -120.85 114.77 22.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.391 1.077 . . . . 42.44 108.612 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.515 HD12 ' HA3' ' F' ' 127' ' ' GLY . 72.6 mt -111.1 107.26 16.57 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.734 -1.121 . . . . 73.44 108.778 -171.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -114.46 145.23 42.13 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.606 1.162 . . . . 61.42 110.128 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.6 mt -129.48 153.23 48.18 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.0 0.92 . . . . 72.13 110.605 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.468 ' O ' HD23 ' A' ' 60' ' ' LEU . 20.7 t70 -157.86 143.47 17.1 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.383 1.073 . . . . 55.43 109.014 177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.1 m -126.62 135.08 50.74 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.672 0.789 . . . . 71.13 109.584 174.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -133.55 132.48 40.96 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.075 0.95 . . . . 43.0 109.842 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -91.35 153.26 20.02 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.104 0.478 . . . . 64.23 110.445 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.3 t -150.82 138.28 19.57 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.079 1.352 . . . . 71.24 108.262 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -113.75 124.34 52.03 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 109.44 -0.578 . . . . 61.35 109.44 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -97.15 -44.07 7.11 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.566 0.746 . . . . 72.53 110.393 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 -173.45 4.35 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.461 -0.791 . . . . 73.03 109.982 -176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -63.02 112.66 2.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.302 0.641 . . . . 55.4 109.773 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 65.02 8.9 5.03 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.858 1.263 . . . . 62.51 113.038 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.01 109.93 25.97 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 108.004 -1.109 . . . . 71.14 108.004 172.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -119.94 123.82 44.48 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.491 0.716 . . . . 75.15 109.579 -176.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -97.5 131.54 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.609 -1.178 . . . . 70.0 108.641 174.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.7 t -110.53 129.63 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.938 -1.134 . . . . 64.24 107.938 172.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.443 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.8 t -104.49 132.57 50.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 108.534 -0.913 . . . . 73.05 108.534 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -108.85 110.18 21.48 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.715 -1.587 . . . . 73.35 106.715 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.6 ttp180 -103.29 102.67 12.63 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.808 0.843 . . . . 73.33 108.792 -175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.41 134.48 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 114.686 -1.143 . . . . 74.54 109.295 -176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 31.7 m -120.39 141.37 50.17 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 109.092 -0.707 . . . . 62.23 109.092 174.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -138.54 107.83 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.926 1.29 . . . . 72.41 108.321 -177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 19.2 m -102.22 146.05 28.54 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.316 -0.624 . . . . 74.41 109.316 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.17 120.28 15.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.492 0.717 . . . . 70.2 109.146 176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 49.1 m -128.56 125.15 37.69 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.998 0.519 . . . . 75.44 110.008 175.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.438 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.71 85.16 6.37 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 121.75 0.786 . . . . 71.02 109.054 178.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.3 -118.65 5.14 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 114.283 -1.326 . . . . 63.4 111.359 -176.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -87.89 -31.98 19.2 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.39 0.676 . . . . 71.0 109.347 174.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -81.15 133.77 35.52 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.67 0.788 . . . . 74.45 109.469 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 66.6 m -78.94 136.68 37.32 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 110.094 -0.335 . . . . 73.45 110.094 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -82.57 -60.55 2.15 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.496 0.718 . . . . 53.13 109.112 175.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -165.83 176.13 8.15 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.628 -1.169 . . . . 75.31 111.098 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 53.5 tp -138.62 145.82 40.98 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.34 1.456 . . . . 72.13 108.139 177.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.1 m -135.89 140.37 44.05 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.928 0.891 . . . . 74.04 109.838 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -150.33 130.7 13.75 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.179 0.592 . . . . 72.45 109.652 175.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.8 t -134.82 119.86 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.171 0.589 . . . . 73.3 110.362 177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -89.26 83.12 6.45 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 124.445 1.098 . . . . 74.54 108.523 173.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.415 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.7 tp-100 -76.49 94.39 3.68 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.279 -0.873 . . . . 72.14 109.443 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -88.93 144.16 17.93 Favored Glycine 0 C--N 1.344 0.99 0 N-CA-C 111.772 -0.531 . . . . 73.42 111.772 178.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.541 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.86 124.18 2.77 Favored Glycine 0 CA--C 1.504 -0.648 0 N-CA-C 110.811 -0.916 . . . . 62.23 110.811 -176.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.4 mt -81.61 128.49 38.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 N-CA-C 108.671 -0.863 . . . . 71.13 108.671 175.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -135.18 140.0 45.01 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.666 -0.864 . . . . 75.23 108.666 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.1 p -101.92 106.88 17.89 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 109.015 -0.735 . . . . 72.23 109.015 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.2 pt -125.19 131.55 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.335 0.654 . . . . 74.41 110.769 -177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.85 157.42 26.63 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.114 0.965 . . . . 73.5 110.207 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.97 -12.16 64.86 Favored Glycine 0 C--N 1.342 0.876 0 CA-C-N 116.067 -0.515 . . . . 61.04 114.383 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.534 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -111.63 145.48 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 117.643 0.721 . . . . 73.0 109.368 -177.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 9.9 tt0 -142.68 179.32 7.06 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.021 0.528 . . . . 74.53 109.956 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 55.73 -123.81 31.73 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 124.239 0.924 . . . . 72.01 114.738 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.729 ' HB ' HD11 ' A' ' 141' ' ' LEU . 66.6 p -74.86 -26.56 59.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 74.24 111.365 -172.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -65.72 -48.66 71.2 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.744 0.817 . . . . 64.5 110.063 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.435 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 39.8 ttp -79.71 -33.29 41.08 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.202 -1.363 . . . . 44.35 110.6 -176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.97 -45.58 92.22 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 121.27 0.557 . . . . 72.52 109.956 173.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -55.13 -47.54 74.92 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 114.547 -1.206 . . . . 74.44 111.092 171.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.691 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 35.3 m -71.33 -33.22 69.45 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.741 1.015 . . . . 74.32 113.741 -172.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.446 HD12 ' HD2' ' F' ' 117' ' ' PRO . 86.3 mt -80.09 -30.09 39.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.809 0.443 . . . . 60.02 111.342 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.98 -17.61 31.92 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.633 -0.537 . . . . 31.42 114.292 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.52 -63.91 0.73 Allowed 'General case' 0 N--CA 1.485 1.312 0 CA-C-N 117.708 0.754 . . . . 62.0 112.614 -171.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.83 -56.39 12.42 Favored 'General case' 0 N--CA 1.509 2.492 0 C-N-CA 124.085 0.954 . . . . 62.34 112.758 -173.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -71.56 -48.62 12.05 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.315 -0.85 . . . . 72.42 113.113 -171.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.3 -20.27 62.04 Favored 'Trans proline' 0 C--N 1.388 2.636 0 CA-C-N 121.111 1.432 . . . . 75.42 113.718 172.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -65.29 -42.8 92.72 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.017 0.527 . . . . 60.22 110.711 175.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -59.65 -41.85 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.97 0.89 . . . . 64.11 110.201 176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.541 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.9 mt -74.99 -29.1 60.8 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 113.874 -1.512 . . . . 61.23 112.579 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.49 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 20.6 t80 -64.26 -45.17 78.46 Favored Pre-proline 0 CA--C 1.558 1.28 0 N-CA-C 114.866 1.432 . . . . 74.34 114.866 -167.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_exo -57.88 -32.51 95.23 Favored 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 121.616 1.544 . . . . 70.34 113.046 175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -79.73 -37.72 34.93 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.453 0.701 . . . . 74.11 112.349 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.08 -48.19 71.78 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 110.01 -0.367 . . . . 53.22 110.01 176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -53.51 -48.8 68.66 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.371 1.068 . . . . 44.35 110.102 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.26 -47.25 86.88 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.982 0.913 . . . . 62.2 111.613 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.546 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.3 t -60.37 -44.19 95.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.548 0.739 . . . . 72.33 111.002 -176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 64' ' ' VAL . 15.3 mt -63.08 -51.79 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.31 1.044 . . . . 72.35 110.905 176.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.548 HG23 ' HG3' ' A' ' 125' ' ' GLN . 87.8 m -59.1 -36.4 75.08 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.258 1.023 . . . . 71.35 112.023 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.65 -39.72 80.55 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.515 -0.766 . . . . 75.43 110.115 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.699 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 46.5 mtm -63.08 -39.63 95.28 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.637 0.375 . . . . 74.51 110.533 176.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -61.88 -47.05 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 124.146 0.978 . . . . 74.02 111.207 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -72.61 -33.37 66.63 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 116.096 -0.502 . . . . 43.15 111.184 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.451 HH12 ' HG3' ' B' ' 112' ' ' GLU . 82.7 mtt-85 -69.39 -26.61 64.73 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.333 0.653 . . . . 71.41 110.138 173.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.61 1.07 88.7 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 115.683 -0.69 . . . . 75.52 112.861 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.4 m 69.56 18.14 7.78 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 124.392 1.077 . . . . 73.24 111.277 175.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -94.44 152.38 40.02 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 123.508 0.723 . . . . 73.12 110.892 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.76 125.35 18.8 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.74 2.293 . . . . 63.21 112.0 173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.548 ' HG3' HG23 ' A' ' 115' ' ' THR . 25.3 tt0 -50.34 136.66 19.84 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.859 1.264 . . . . 64.11 112.957 -175.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.2 mt -125.61 104.62 8.49 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.837 0.855 . . . . 64.3 108.81 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -101.9 123.18 45.39 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.678 0.791 . . . . 50.25 109.103 174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.49 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 2.4 tt -73.4 120.44 19.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.909 -1.145 . . . . 75.51 107.909 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.09 129.07 85.92 Favored Pre-proline 0 N--CA 1.475 0.787 0 O-C-N 123.864 0.727 . . . . 53.3 110.631 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.63 107.4 0.51 Allowed 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 122.045 1.83 . . . . 75.25 111.741 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.5 m -98.96 110.84 27.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.51 -1.292 . . . . 64.11 107.51 172.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.12 82.04 8.54 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 115.437 -0.801 . . . . 55.24 109.823 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -60.22 -32.78 71.44 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 114.246 -1.343 . . . . 74.03 109.803 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -56.5 -49.67 74.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.359 1.064 . . . . 62.4 111.606 173.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.67 -42.88 99.86 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 122.944 0.498 . . . . 71.5 111.72 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.38 -44.11 84.04 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.418 0.687 . . . . 72.2 110.497 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -66.59 -35.94 81.41 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.644 -0.707 . . . . 75.41 109.795 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.592 ' HB3' ' HA ' ' A' ' 144' ' ' GLN . 92.0 mmm -71.05 -41.77 70.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 122.783 0.433 . . . . 74.04 110.804 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -56.45 -38.65 71.93 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.232 0.613 . . . . 72.23 110.746 174.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -73.27 -40.58 64.48 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 114.95 -1.023 . . . . 64.13 110.993 176.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.729 HD11 ' HB ' ' A' ' 92' ' ' THR . 18.7 tp -66.66 -50.39 63.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.295 1.038 . . . . 74.5 111.368 -170.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -168.94 28.76 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.125 -0.943 . . . . 70.02 110.092 -170.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.453 ' HB3' ' HG3' ' C' ' 144' ' ' GLN . 79.5 mt-30 62.27 34.21 16.07 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.883 0.873 . . . . 73.33 111.484 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 138' ' ' MET . 79.7 mt-30 69.3 141.1 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.067 1.747 . . . . 75.44 110.776 -172.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.85 155.98 24.39 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 123.54 0.736 . . . . 61.34 109.431 -176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -135.09 162.49 24.77 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.366 0.416 . . . . 74.24 113.433 -174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -152.14 117.46 5.28 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 123.323 0.649 . . . . 75.54 109.978 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -76.48 102.62 1.63 Allowed Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.591 -1.004 . . . . 72.43 110.591 169.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.0 m -59.16 -51.46 69.9 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.495 0.664 . . . . 71.24 109.852 177.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -174.88 171.57 3.09 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 113.97 -1.468 . . . . 73.45 108.983 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -134.15 68.8 1.47 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.277 -1.008 . . . . 64.33 108.277 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -132.24 167.78 19.21 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.878 0.871 . . . . 74.21 110.802 -175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -159.97 88.82 0.84 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 107.906 -1.146 . . . . 74.23 107.906 170.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -85.99 83.43 7.79 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 108.286 -1.005 . . . . 74.33 108.286 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.155 0 C-N-CA 124.761 1.224 . . . . 55.32 110.883 -173.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 109.491 -0.559 . . . . 65.13 109.491 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.0 m -144.57 98.28 3.17 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.23 1.012 . . . . 73.44 108.884 175.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -82.64 134.51 35.16 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.569 0.748 . . . . 74.01 110.308 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -63.4 147.88 50.0 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.475 1.11 . . . . 73.52 112.016 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 28.9 p-10 -82.63 170.72 14.83 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.992 0.517 . . . . 74.52 110.863 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -93.77 -29.3 15.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.57 0.348 . . . . 54.23 111.764 -178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.588 HG21 ' HA ' ' B' ' 150' ' ' GLU . 28.1 m -92.27 99.76 12.47 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-O 121.023 0.44 . . . . 65.24 111.839 -174.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -172.59 -59.13 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.466 1.106 . . . . 72.34 108.319 165.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.8 ptm 48.02 -172.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.0 1.72 . . . . 65.24 112.494 -169.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.415 HG22 ' HB3' ' B' ' 87' ' ' ALA . 15.2 t -155.61 143.54 19.85 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.082 -0.71 . . . . 65.12 109.082 170.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -139.45 113.28 8.61 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.158 -1.052 . . . . 74.2 108.158 170.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.486 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 22.8 tt0 -133.11 139.76 47.29 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.487 0.715 . . . . 73.4 109.469 174.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.6 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -89.83 116.04 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 108.183 -1.043 . . . . 45.44 108.183 170.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 72.5 mt-30 -77.63 -40.83 40.58 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 109.753 -0.462 . . . . 64.23 109.753 177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.593 HH11 ' HD2' ' A' ' 32' ' ' PHE . 18.6 ttt180 -166.42 137.89 3.57 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.846 -0.798 . . . . 65.2 108.846 -177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 57.8 mt -114.39 139.23 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 106.986 -1.487 . . . . 73.14 106.986 170.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -168.19 146.57 4.39 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.762 0.71 . . . . 71.42 112.298 -174.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -73.35 120.83 19.51 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.655 -1.157 . . . . 64.2 108.711 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -96.44 -26.59 15.26 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.443 0.697 . . . . 74.53 111.242 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -161.26 141.74 11.04 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.055 0.222 . . . . 62.42 110.924 -170.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.512 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -138.3 141.69 37.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.506 0 C-N-CA 125.024 1.33 . . . . 53.25 109.035 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 35.0 t -140.12 124.22 17.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.166 -1.42 . . . . 63.44 107.166 174.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.0 t80 -138.61 111.41 7.72 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 107.396 -1.335 . . . . 75.32 107.396 168.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -117.98 117.51 29.43 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.671 -0.863 . . . . 74.04 108.671 -177.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 84.68 6.89 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 107.492 -1.299 . . . . 72.33 107.492 168.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.63 -26.92 11.25 Favored 'Trans proline' 0 C--N 1.377 2.049 0 C-N-CA 122.829 2.353 . . . . 54.53 112.649 -174.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 1.8 m-20 -110.96 20.24 17.69 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.242 1.017 . . . . 64.41 109.438 -177.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.584 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.01 -60.52 1.65 Allowed Pre-proline 0 CA--C 1.574 1.89 0 C-N-CA 126.368 1.867 . . . . 25.12 114.931 -169.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 51.1 Cg_endo -85.0 -1.86 9.49 Favored 'Trans proline' 0 C--N 1.385 2.496 0 C-N-CA 122.26 1.973 . . . . 61.41 113.57 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -96.74 -38.21 9.99 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 73.14 110.505 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' B' ' 73' ' ' ALA . 10.5 p -79.33 -14.16 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 115.478 -0.783 . . . . 52.34 110.114 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -52.06 -34.56 44.03 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.676 1.19 . . . . 73.2 111.798 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -73.15 -15.94 61.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.068 0.947 . . . . 75.13 112.028 -176.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.593 ' HD3' HD12 ' B' ' 68' ' ' LEU . 89.6 mttt -105.52 109.37 21.31 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.148 0.979 . . . . 65.34 110.481 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -92.27 83.63 5.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.367 0.667 . . . . 62.25 110.407 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.572 ' HE3' HD11 ' B' ' 68' ' ' LEU . 3.6 m-90 -153.43 161.75 41.97 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.492 1.117 . . . . 74.21 109.378 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -84.31 119.94 73.81 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.207 -1.034 . . . . 73.3 108.207 168.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.14 167.72 26.04 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.787 2.325 . . . . 54.4 113.684 -174.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -73.66 103.39 4.23 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 107.955 -1.128 . . . . 61.55 107.955 175.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.425 HG21 HD21 ' B' ' 126' ' ' LEU . 27.4 m -100.88 127.78 53.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.206 0.602 . . . . 74.2 110.261 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -106.63 124.6 49.85 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.608 -0.886 . . . . 64.41 108.608 174.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 67.4 mt -92.25 124.79 36.58 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.037 -1.098 . . . . 72.4 108.037 173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.514 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 11.0 t70 -136.23 151.89 50.16 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 107.996 -1.113 . . . . 75.31 107.996 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.1 pp -142.57 169.41 17.62 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.184 0.516 . . . . 54.04 111.674 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.9 t70 -159.39 142.72 14.49 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.755 1.222 . . . . 73.23 108.432 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.454 HG21 ' CD1' ' E' ' 120' ' ' TRP . 6.5 t -109.29 118.7 37.38 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.765 -0.828 . . . . 61.24 108.765 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.533 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.73 151.3 37.55 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.349 1.06 . . . . 42.12 108.553 172.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.3 p -145.43 163.75 33.67 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 122.927 0.491 . . . . 63.42 110.511 174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 73.0 p -157.83 136.54 11.34 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.679 1.191 . . . . 72.25 108.148 176.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -93.79 127.02 39.3 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.926 0.49 . . . . 74.42 110.032 -178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 81.6 mt -87.66 -40.32 14.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.215 -0.661 . . . . 33.15 109.215 174.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.49 -178.83 5.13 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.779 1.232 . . . . 74.33 108.851 175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -72.45 134.51 45.39 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.876 -0.787 . . . . 73.43 108.876 173.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.424 ' O ' ' HA ' ' B' ' 85' ' ' SER . 6.3 m-20 73.64 -3.87 2.38 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.404 1.481 . . . . 63.21 111.808 -174.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 43.9 t -126.38 84.62 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 107.993 -1.114 . . . . 63.34 107.993 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -110.39 138.95 46.1 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.949 -0.759 . . . . 71.3 108.949 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -115.04 110.0 18.92 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.829 -1.174 . . . . 71.22 107.829 -172.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.655 HG21 ' HB3' ' B' ' 98' ' ' LEU . 67.0 t -104.55 128.83 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 122.988 0.515 . . . . 71.11 110.187 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 39.6 t -102.37 119.91 51.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 124.538 1.135 . . . . 71.4 109.466 178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.442 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.4 OUTLIER -92.89 111.67 23.37 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 107.166 -1.42 . . . . 72.14 107.166 172.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.6 ttt180 -100.18 125.38 46.31 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.009 -0.737 . . . . 73.33 109.009 175.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.697 HG11 HD11 ' B' ' 128' ' ' LEU . 15.4 t -119.58 127.5 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 N-CA-C 108.856 -0.794 . . . . 72.01 108.856 173.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 86.1 m -104.04 141.05 36.87 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 123.57 0.544 . . . . 54.32 110.11 173.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.71 HG21 HG21 ' B' ' 114' ' ' ILE . 53.0 t -133.3 122.18 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 124.491 1.116 . . . . 74.14 108.549 177.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.7 m -117.36 146.17 43.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.744 . . . . 63.23 108.993 173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.41 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -145.0 133.41 21.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.755 -0.832 . . . . 71.52 108.755 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 63.6 p -138.52 136.34 36.0 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 122.877 0.471 . . . . 70.42 110.207 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.593 HD12 ' HD3' ' B' ' 34' ' ' LYS . 0.3 OUTLIER -110.44 107.86 17.67 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 107.891 -1.152 . . . . 52.24 107.891 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.33 -111.37 3.24 Favored Glycine 0 C--N 1.342 0.89 0 O-C-N 123.662 0.601 . . . . 34.15 112.755 174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.87 2.46 23.47 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.216 0.606 . . . . 65.34 111.042 -176.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 11.9 pt-20 -135.71 170.46 15.94 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 122.989 0.516 . . . . 73.44 110.441 -174.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.1 m -71.84 143.57 49.4 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.271 0.629 . . . . 73.25 110.334 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -98.4 -58.77 1.89 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.919 0.888 . . . . 74.21 109.07 173.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -161.04 164.34 30.94 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.313 -0.858 . . . . 74.34 110.353 173.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -135.26 141.59 45.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.911 1.284 . . . . 75.14 107.646 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.1 t -149.74 154.59 38.76 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.076 0.55 . . . . 62.43 109.87 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.2 tt0 -164.96 133.88 3.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.7 -0.852 . . . . 75.03 108.7 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.409 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.8 t -127.25 145.41 34.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 N-CA-C 108.68 -0.859 . . . . 55.25 108.68 177.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -122.98 93.09 3.85 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.744 -0.835 . . . . 74.24 108.744 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.6 tp-100 -84.69 100.43 11.47 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.601 -0.889 . . . . 71.13 108.601 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 173.5 40.1 Favored Glycine 0 C--O 1.245 0.788 0 N-CA-C 111.775 -0.53 . . . . 72.32 111.775 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.5 133.2 2.71 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.697 -0.561 . . . . 44.43 111.697 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.404 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 36.7 mt -85.85 131.12 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 N-CA-C 108.373 -0.973 . . . . 74.15 108.373 172.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -129.54 152.85 48.62 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.068 0.947 . . . . 72.42 109.626 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 14.8 m -123.59 105.05 9.42 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.052 0.941 . . . . 73.21 108.894 -172.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.62 HG21 HD11 ' B' ' 98' ' ' LEU . 0.2 OUTLIER -134.46 141.89 42.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.101 0.56 . . . . 63.23 112.053 -169.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.415 ' HB3' HG22 ' B' ' 10' ' ' THR . . . -149.05 167.69 25.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.399 1.08 . . . . 74.42 109.734 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.75 -62.45 4.38 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.609 0.568 . . . . 61.01 112.328 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.579 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.5 pp -68.62 145.58 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.057 0 C-N-CA 123.922 0.889 . . . . 75.12 111.992 179.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 0.0 OUTLIER -155.33 175.52 13.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.247 1.019 . . . . 71.55 110.45 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.62 -122.26 29.23 Favored Glycine 0 C--N 1.348 1.203 0 O-C-N 123.883 0.74 . . . . 65.53 113.536 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -70.8 -33.59 70.88 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.889 0.875 . . . . 74.43 110.878 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -74.23 -29.86 61.91 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.274 -0.876 . . . . 73.33 110.779 -172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.662 ' HG3' ' HB3' ' E' ' 115' ' ' LEU . 0.3 OUTLIER -71.07 -43.9 66.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.552 0.741 . . . . 41.21 109.199 173.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.76 -23.52 66.09 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 115.041 -0.981 . . . . 61.25 111.769 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -73.43 -38.56 65.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.979 0.512 . . . . 73.33 110.212 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.57 -59.14 2.87 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.368 -0.833 . . . . 75.53 110.83 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.655 ' HB3' HG21 ' B' ' 58' ' ' VAL . 6.1 mp -87.37 -14.05 41.76 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.756 0.651 . . . . 63.0 112.756 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.09 -37.15 8.5 Favored Glycine 0 C--N 1.341 0.813 0 CA-C-O 120.151 -0.25 . . . . 13.01 112.668 177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -111.15 -48.09 3.14 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 117.495 0.648 . . . . 63.14 111.841 -173.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -79.38 -42.36 25.72 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.119 0.415 . . . . 75.33 112.119 -171.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.644 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 96.6 m -61.19 -47.74 93.73 Favored Pre-proline 0 CA--C 1.557 1.244 0 CA-C-O 118.43 -0.795 . . . . 74.22 111.746 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -53.44 -35.2 74.87 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 122.03 1.82 . . . . 72.24 114.601 168.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -64.76 -33.2 75.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 118.173 0.442 . . . . 62.25 110.95 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 70.8 mt -68.03 -47.11 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.071 0.948 . . . . 73.33 110.554 173.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.442 ' HB2' HD12 ' B' ' 60' ' ' LEU . 78.4 mt -78.82 -19.31 52.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.135 -0.938 . . . . 51.43 112.196 -172.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.523 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 66.6 t80 -62.92 -45.73 87.22 Favored Pre-proline 0 CA--C 1.552 1.024 0 N-CA-C 113.886 1.069 . . . . 71.12 113.886 -171.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -55.25 -38.78 93.47 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 121.96 1.773 . . . . 75.43 113.352 174.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.442 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 77.2 m-85 -68.05 -45.55 73.58 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.091 0.556 . . . . 75.4 110.671 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -43.74 97.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.376 -0.829 . . . . 73.1 110.545 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -56.71 -54.79 42.17 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.31 1.444 . . . . 75.23 110.929 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.451 ' HG3' HH12 ' A' ' 120' ' ' ARG . 9.9 tp10 -59.26 -41.02 87.84 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.492 1.117 . . . . 63.41 111.018 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.8 t -68.78 -39.36 80.22 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 116.655 -0.248 . . . . 74.41 111.262 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.71 HG21 HG21 ' B' ' 64' ' ' VAL . 89.4 mt -62.58 -54.69 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 123.054 0.542 . . . . 61.53 109.79 175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 39.2 m -61.78 -30.1 70.58 Favored 'General case' 0 CA--C 1.554 1.112 0 O-C-N 124.108 0.88 . . . . 65.51 111.526 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 42.6 t -67.06 -45.76 76.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.401 0.681 . . . . 74.35 110.483 174.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.4 mmt -67.98 -37.01 81.0 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.492 0.317 . . . . 64.41 110.739 -178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.18 -41.09 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.941 0.896 . . . . 63.31 110.195 173.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.444 ' OG ' HG21 ' C' ' 115' ' ' THR . 36.9 t -65.16 -34.99 79.7 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.807 -1.088 . . . . 60.3 111.248 176.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.546 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 85.5 mtt-85 -68.59 -28.43 66.93 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.207 0.603 . . . . 72.04 111.11 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.43 9.58 61.23 Favored Glycine 0 C--N 1.351 1.395 0 O-C-N 123.703 0.627 . . . . 75.54 112.623 172.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 77.0 p 52.53 55.07 9.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.99 1.716 . . . . 55.31 112.531 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -107.52 161.22 23.85 Favored Pre-proline 0 N--CA 1.486 1.331 0 CA-C-N 115.63 -0.714 . . . . 63.15 110.257 176.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.26 -167.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.394 2.953 0 C-N-CA 123.312 2.675 . . . . 45.22 114.046 178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.737 ' HB3' ' HA ' ' C' ' 124' ' ' PRO . 29.0 pt20 -62.76 122.65 16.43 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 116.244 -0.435 . . . . 72.14 111.217 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.425 HD21 HG21 ' B' ' 40' ' ' VAL . 1.1 tm? -151.28 81.77 1.31 Allowed 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.758 -0.83 . . . . 71.11 108.758 176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -95.13 135.96 36.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.742 0.817 . . . . 73.14 108.887 172.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.697 HD11 HG11 ' B' ' 62' ' ' VAL . 0.9 OUTLIER -64.55 131.33 46.73 Favored 'General case' 0 CA--C 1.554 1.122 0 O-C-N 123.969 0.793 . . . . 73.21 109.005 177.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.91 146.09 87.28 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.506 0.722 . . . . 75.21 110.858 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.22 108.74 0.38 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 123.016 2.477 . . . . 75.42 113.218 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 74.4 t -91.72 123.19 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 123.621 0.768 . . . . 74.21 110.171 177.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -87.22 92.54 9.1 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.384 0.674 . . . . 73.02 110.005 172.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -62.47 -41.48 98.81 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 115.306 -0.861 . . . . 61.5 109.754 173.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.6 -35.16 73.77 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 113.415 -1.72 . . . . 60.15 112.015 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.37 -49.78 45.65 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.433 0.693 . . . . 52.15 111.867 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.79 -43.8 97.64 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 109.173 -0.677 . . . . 73.23 109.173 179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -68.31 -33.62 74.66 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-N 115.009 -0.996 . . . . 74.21 110.857 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -71.35 -34.2 70.29 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.619 0.768 . . . . 65.53 109.97 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.34 -13.93 60.45 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.08 0.552 . . . . 52.23 110.92 177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -83.93 -34.1 24.55 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.838 -0.801 . . . . 72.51 108.838 168.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 55.2 mt -102.14 29.25 5.21 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.574 0.75 . . . . 64.24 111.167 -178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -65.35 -23.14 66.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.693 0.797 . . . . 73.54 112.941 -175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.6 81.96 2.61 Favored 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 123.74 0.816 . . . . 65.44 109.762 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 59.6 124.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 125.856 1.663 . . . . 74.3 113.516 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.95 83.33 2.12 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.474 0.71 . . . . 43.2 109.674 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.47 -161.45 29.59 Favored Glycine 0 C--N 1.347 1.188 0 CA-C-N 115.468 -0.787 . . . . 53.2 113.224 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -132.42 -167.69 1.93 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.482 1.113 . . . . 61.34 109.218 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.41 -87.16 0.39 Allowed Glycine 0 C--N 1.348 1.195 0 N-CA-C 111.787 -0.525 . . . . 64.54 111.787 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -159.39 159.51 33.84 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.84 0.856 . . . . 71.12 109.935 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.588 ' HA ' HG21 ' B' ' 7' ' ' THR . 47.9 mt-10 -133.7 119.59 19.53 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.643 0.777 . . . . 63.43 109.425 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.555 ' H ' HG21 ' B' ' 7' ' ' THR . 9.2 pt-20 -149.13 173.3 13.57 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 124.282 1.033 . . . . 73.23 110.362 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 67.1 m80 -136.97 121.87 18.82 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.874 0.87 . . . . 75.45 108.988 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -87.48 146.42 25.83 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.884 . . . . 72.44 110.285 -176.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.48 110.49 1.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.759 0.823 . . . . 70.34 110.276 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.224 0 C-N-CA 124.074 0.95 . . . . 53.21 110.477 -177.373 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.486 1.363 0 N-CA-C 109.872 -0.418 . . . . 63.2 109.872 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -162.92 173.95 13.0 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.197 1.399 . . . . 74.54 109.385 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -132.41 89.36 2.64 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.156 -1.053 . . . . 63.5 108.156 165.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 55.03 61.85 2.77 Favored 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 124.322 1.049 . . . . 74.43 110.45 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -127.03 -62.23 1.12 Allowed 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 107.37 -1.344 . . . . 74.21 107.37 -179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 63.6 17.23 10.26 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.672 1.189 . . . . 64.25 112.519 171.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -99.1 146.72 25.8 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.329 1.052 . . . . 71.13 110.259 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.23 151.92 44.97 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.666 0.786 . . . . 75.33 111.395 174.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 25.8 ttt 64.74 116.0 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.074 1.349 . . . . 73.52 112.588 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 55.0 m -85.1 98.06 10.22 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.151 -1.055 . . . . 73.33 108.151 169.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -108.67 129.0 55.34 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.345 -0.983 . . . . 72.23 108.345 175.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.414 HE21 ' NE2' ' C' ' 14' ' ' GLN . 29.9 tt0 -142.32 125.3 16.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.846 -0.428 . . . . 75.34 109.846 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.648 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -75.92 133.64 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 N-CA-C 108.533 -0.914 . . . . 70.21 108.533 175.166 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.414 ' NE2' HE21 ' C' ' 12' ' ' GLN . 29.9 mm-40 -107.74 -48.73 3.35 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.231 0.612 . . . . 74.2 110.689 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -162.06 136.15 6.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.673 0.389 . . . . 64.12 110.16 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.648 HG13 HD11 ' C' ' 13' ' ' ILE . 88.3 mt -119.87 140.54 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.037 -1.097 . . . . 74.23 108.037 173.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.522 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 25.8 p90 -173.77 161.33 3.83 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.229 0.538 . . . . 74.3 110.968 -177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.4 p -82.66 112.92 19.97 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.161 -0.927 . . . . 71.34 109.387 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.8 mmmt -74.28 -33.27 63.2 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 109.195 -0.669 . . . . 60.14 109.195 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -146.52 147.17 30.88 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 115.367 -0.833 . . . . 74.13 110.233 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.8 mt -146.3 145.87 19.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.993 1.717 . . . . 65.22 106.842 174.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -162.96 151.97 14.82 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 122.87 0.468 . . . . 43.13 110.117 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -152.14 108.35 3.41 Favored 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 108.492 -0.929 . . . . 61.23 108.492 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.18 118.73 33.11 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.794 0.837 . . . . 71.41 109.218 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.58 83.81 48.12 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 124.55 1.14 . . . . 64.22 108.411 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.88 -19.06 31.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.732 2.288 . . . . 74.22 111.775 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' C' ' 72' ' ' THR . 77.9 m-20 -117.69 38.61 3.57 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.169 0.987 . . . . 73.43 109.51 177.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.501 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.07 -47.24 98.93 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 123.586 0.754 . . . . 73.22 112.705 176.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -68.97 -14.64 38.98 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.788 1.659 . . . . 74.44 113.852 173.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -67.61 -23.91 65.42 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 119.186 -0.435 . . . . 74.41 111.984 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.6 p -53.59 -29.54 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 123.727 0.811 . . . . 52.14 112.523 -176.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.468 ' HA ' HD12 ' E' ' 134' ' ' ILE . 38.2 m-85 -68.75 -41.44 78.89 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.229 0.612 . . . . 70.21 111.315 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -97.26 5.78 49.45 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.047 -0.979 . . . . 63.12 110.527 -177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.42 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.6 ttmp? -93.47 145.85 24.2 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.66 0.784 . . . . 74.24 110.403 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -88.44 132.07 34.62 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.861 -1.162 . . . . 64.31 107.861 172.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 36.0 p90 -74.99 78.48 2.19 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-O 122.312 1.053 . . . . 72.31 111.575 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.436 ' O ' HD13 ' C' ' 68' ' ' LEU . 38.0 tt0 -157.56 65.13 3.33 Favored Pre-proline 0 CA--C 1.554 1.117 0 CA-C-N 113.924 -1.489 . . . . 53.2 108.327 168.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -90.08 150.81 4.75 Favored 'Trans proline' 0 C--N 1.375 1.942 0 C-N-CA 121.653 1.569 . . . . 72.34 111.254 169.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.411 ' HG3' HD22 ' E' ' 141' ' ' LEU . 37.8 tt0 -86.32 96.06 9.85 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.522 -1.288 . . . . 72.31 107.522 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.53 98.35 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-O 122.474 1.131 . . . . 44.3 108.86 175.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -91.18 116.84 29.14 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 113.805 -1.543 . . . . 73.02 108.331 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.589 HD13 HD11 ' C' ' 128' ' ' LEU . 30.1 tp -84.24 144.12 29.13 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.374 -0.973 . . . . 74.14 108.374 172.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.9 t70 -137.47 128.56 27.61 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.496 -1.298 . . . . 73.43 107.496 177.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 25.2 tp -134.83 132.07 38.18 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.049 -0.723 . . . . 75.1 109.049 -170.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -137.65 155.84 48.7 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.805 0.842 . . . . 72.54 109.009 174.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.5 t -138.32 149.52 45.71 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.923 0.489 . . . . 62.22 109.921 176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.74 167.59 21.76 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.768 0.827 . . . . 52.55 109.179 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.3 p -148.3 144.64 27.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.649 0.379 . . . . 72.23 111.062 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 75.9 p -147.66 145.77 29.05 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.062 0.945 . . . . 74.1 110.242 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -87.14 130.56 34.47 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.007 -0.738 . . . . 74.31 109.007 171.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.635 HD11 ' HB2' ' C' ' 57' ' ' GLU . 59.5 mt -106.37 -41.84 5.2 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.627 0.771 . . . . 61.34 109.944 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.18 -169.32 3.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.507 0.723 . . . . 45.32 110.736 -174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.83 108.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 115.132 -0.94 . . . . 55.22 109.396 177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.411 ' HB3' ' O ' ' C' ' 86' ' ' ILE . 52.1 m-20 69.97 -0.84 2.58 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.639 1.175 . . . . 61.34 113.269 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 87.7 t -96.68 113.95 32.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 C-N-CA 123.533 0.733 . . . . 75.42 109.166 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -123.97 130.16 52.12 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.361 1.064 . . . . 74.32 108.71 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.635 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.6 tt0 -87.98 143.9 26.84 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.362 -0.835 . . . . 72.34 108.817 171.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.454 HG13 HD11 ' C' ' 106' ' ' LEU . 2.6 p -125.46 124.6 67.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.557 -0.905 . . . . 74.25 108.557 169.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.7 t -102.85 104.69 16.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 107.578 -1.267 . . . . 74.1 107.578 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -101.49 100.85 11.34 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.974 0.91 . . . . 73.34 108.759 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -81.65 124.15 29.32 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.573 0.749 . . . . 73.4 110.237 178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 17.6 t -114.26 126.56 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 N-CA-C 107.531 -1.285 . . . . 72.41 107.531 170.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.502 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.5 m -128.59 128.79 44.9 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.899 -0.778 . . . . 74.33 108.899 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.666 HG23 HD13 ' C' ' 114' ' ' ILE . 88.5 t -110.71 110.16 31.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 108.664 -0.865 . . . . 53.42 108.664 174.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.403 HG23 HD23 ' C' ' 75' ' ' LEU . 8.8 m -99.34 110.29 22.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.85 -0.796 . . . . 73.14 108.85 173.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.22 99.97 9.18 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.488 -1.301 . . . . 73.44 107.488 -177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 42.3 p -146.65 156.45 43.21 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.647 0.592 . . . . 50.53 109.865 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.436 HD13 ' O ' ' C' ' 37' ' ' GLN . 53.7 tp -111.8 80.18 1.29 Allowed 'General case' 0 C--O 1.243 0.711 0 N-CA-C 106.767 -1.568 . . . . 73.3 106.767 170.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 63.91 -96.2 0.18 Allowed Glycine 0 C--N 1.345 1.07 0 CA-C-N 114.903 -1.044 . . . . 72.11 112.339 -174.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -91.13 -31.94 16.03 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.847 0.859 . . . . 74.32 111.221 -176.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.42 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 13.2 tp10 -87.22 93.13 9.29 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.652 0.781 . . . . 53.32 110.281 -176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 60.8 m -84.72 130.44 34.7 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.826 -0.624 . . . . 75.34 111.038 -176.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.36 -55.76 4.67 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.028 0.931 . . . . 63.4 109.863 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -157.37 170.73 21.8 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.408 0.623 . . . . 74.12 111.721 178.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.403 HD23 HG23 ' C' ' 65' ' ' THR . 3.1 tm? -143.51 111.5 6.12 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 106.723 -1.584 . . . . 64.42 106.723 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 44.8 t -111.02 143.98 40.86 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.981 -0.748 . . . . 74.32 108.981 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -147.55 117.8 7.35 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.203 0.601 . . . . 75.33 109.621 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -125.87 114.99 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.787 1.235 . . . . 74.32 109.234 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -94.16 102.62 14.67 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.141 -0.689 . . . . 70.24 109.141 172.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.622 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.1 tp-100 -87.56 109.4 19.6 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.471 0.708 . . . . 70.2 109.34 178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.62 146.88 20.26 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.617 -0.593 . . . . 70.33 111.617 175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.46 117.36 1.27 Allowed Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 111.569 -0.613 . . . . 71.54 111.569 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' C' ' 51' ' ' LEU . 12.8 mm -83.01 126.09 40.07 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.614 -0.884 . . . . 63.42 108.614 174.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -140.62 138.33 34.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.649 0.38 . . . . 71.42 110.114 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.9 m -94.54 117.75 30.61 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.552 -0.907 . . . . 70.43 108.552 169.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' C' ' 54' ' ' ASP . 2.8 pp -116.12 142.06 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 122.72 0.408 . . . . 52.21 110.113 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -155.86 155.82 33.59 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.219 0.608 . . . . 75.41 110.443 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.26 -45.81 3.32 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 116.195 -0.457 . . . . 70.4 112.556 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -88.7 151.03 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 123.8 0.84 . . . . 63.22 109.09 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -152.9 -179.45 7.66 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.858 0.463 . . . . 72.33 109.811 -177.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 58.23 -137.33 50.1 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 115.268 0.867 . . . . 73.24 115.268 175.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 27.1 p -72.2 -20.09 61.63 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.98 0.912 . . . . 73.45 112.39 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.401 HE21 ' HB2' ' C' ' 93' ' ' GLN . 0.1 OUTLIER -80.12 -38.77 30.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.23 0.212 . . . . 65.44 110.863 178.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 16.9 ptt? -70.21 -31.81 69.41 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 109.443 -0.577 . . . . 72.04 109.443 176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.07 71.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.474 -0.785 . . . . 64.01 110.433 177.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -61.67 -49.17 77.59 Favored 'General case' 0 N--CA 1.474 0.747 0 O-C-N 123.459 0.474 . . . . 75.13 110.173 173.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -61.96 -48.86 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.51 0.506 . . . . 73.45 110.478 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.69 -16.35 63.33 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.613 0.765 . . . . 63.23 111.38 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -115.0 10.8 20.62 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-O 119.622 -0.544 . . . . 73.31 114.279 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.15 -61.11 0.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 117.703 0.751 . . . . 64.35 111.02 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -69.4 -56.68 6.77 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 122.707 0.403 . . . . 61.13 111.673 -175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 60.7 m -56.81 -46.95 99.8 Favored Pre-proline 0 CA--C 1.559 1.323 0 C-N-CA 123.59 0.756 . . . . 63.3 111.951 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 92.1 Cg_exo -53.32 -38.35 82.06 Favored 'Trans proline' 0 C--N 1.39 2.738 0 C-N-CA 122.512 2.141 . . . . 64.43 114.923 166.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -63.4 -36.44 83.75 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 123.81 0.844 . . . . 65.31 110.506 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 48.2 mm -59.68 -40.21 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.586 0.755 . . . . 73.51 110.414 175.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.454 HD11 HG13 ' C' ' 58' ' ' VAL . 64.2 mt -85.72 -26.12 26.07 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.565 -1.198 . . . . 40.14 112.096 -171.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -55.52 -47.58 98.32 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 113.809 1.04 . . . . 73.24 113.809 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -57.32 -40.43 82.02 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.277 1.984 . . . . 54.51 113.612 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -65.7 -43.37 89.37 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.165 0.586 . . . . 73.44 110.374 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.622 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -69.5 -33.74 73.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.414 -0.812 . . . . 73.51 111.241 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 9.1 ttp-105 -64.98 -47.36 77.85 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.398 1.079 . . . . 74.14 110.001 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -71.92 -33.0 67.92 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.695 -0.684 . . . . 73.02 109.552 -178.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 47.9 t -69.12 -31.15 69.64 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.234 0.614 . . . . 72.1 111.089 177.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.666 HD13 HG23 ' C' ' 64' ' ' VAL . 63.3 mt -72.62 -51.52 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.04 0.536 . . . . 71.22 109.762 171.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.444 HG21 ' OG ' ' B' ' 119' ' ' SER . 39.9 m -61.73 -31.08 71.22 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 122.815 0.446 . . . . 73.33 111.143 -174.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.1 t -60.18 -54.31 47.41 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 124.181 0.992 . . . . 62.21 108.995 171.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.423 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.82 -42.32 79.37 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.031 1.333 . . . . 65.24 112.475 179.349 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 85.5 t -66.02 -40.85 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 52.21 109.924 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 34.2 t -73.75 -24.04 59.82 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 114.935 -1.03 . . . . 73.14 111.645 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.3 mtt-85 -74.1 -40.06 62.98 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.254 -0.647 . . . . 64.11 109.254 175.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.58 -1.24 65.31 Favored Glycine 0 C--N 1.355 1.637 0 O-C-N 123.824 0.703 . . . . 64.14 112.229 170.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 37.5 p 63.73 25.8 14.28 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.869 2.067 . . . . 53.53 112.83 173.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -83.12 158.77 63.8 Favored Pre-proline 0 CA--C 1.557 1.233 0 C-N-CA 124.049 0.94 . . . . 71.12 108.538 167.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.737 ' HA ' ' HB3' ' B' ' 125' ' ' GLN . 36.3 Cg_endo -61.25 151.32 79.89 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.799 2.333 . . . . 74.31 114.206 -176.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -56.55 112.05 1.17 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.084 1.354 . . . . 60.12 111.761 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -108.06 90.15 3.21 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 107.524 -1.287 . . . . 62.01 107.524 175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -91.31 110.38 21.68 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.527 -0.916 . . . . 62.54 108.527 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.589 HD11 HD13 ' C' ' 42' ' ' LEU . 0.9 OUTLIER -77.19 134.17 38.72 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 124.095 0.958 . . . . 74.34 110.316 -171.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.79 144.96 83.61 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 124.252 1.021 . . . . 75.02 111.846 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.45 ' HG3' HG12 ' A' ' 16' ' ' ILE . 93.1 Cg_endo -78.54 104.13 1.77 Allowed 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.816 2.344 . . . . 70.15 112.895 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 47.9 t -101.62 107.73 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 107.111 -1.441 . . . . 63.21 107.111 171.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 m-20 -105.64 98.02 7.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.081 0.552 . . . . 70.35 109.803 -173.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -67.1 -36.95 83.03 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.432 0.693 . . . . 64.04 110.1 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -56.94 -48.96 77.08 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.449 -1.25 . . . . 74.52 111.702 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -38.27 63.24 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.04 0.936 . . . . 22.33 112.844 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.717 HD11 HD21 ' E' ' 148' ' ' LEU . 8.3 mp -69.79 -47.61 62.23 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.267 0.627 . . . . 62.04 110.507 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -72.97 -27.05 61.59 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 123.391 0.676 . . . . 73.41 111.617 -174.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 94.3 mmm -71.47 -39.7 70.75 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.145 0.578 . . . . 73.22 111.417 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -71.59 -38.79 70.84 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 110.123 -0.325 . . . . 72.14 110.123 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -55.19 -82.12 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.695 0.798 . . . . 74.22 110.916 174.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.3 87.39 3.71 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.447 0.642 . . . . 73.24 109.381 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -69.96 158.32 35.83 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.436 -1.256 . . . . 64.2 110.946 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -114.56 -71.06 0.76 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 122.527 0.331 . . . . 62.22 110.33 -178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.453 ' HG3' ' HB3' ' A' ' 143' ' ' GLN . 0.5 OUTLIER 57.03 86.91 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.684 1.194 . . . . 64.11 110.323 -171.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.33 -172.11 3.74 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.039 -0.982 . . . . 35.22 108.595 176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.17 83.67 0.04 OUTLIER Glycine 0 C--N 1.336 0.569 0 N-CA-C 112.005 -0.438 . . . . 75.21 112.005 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.71 89.47 0.55 Allowed 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 107.32 -1.363 . . . . 73.04 107.32 172.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -123.25 60.39 0.59 Allowed Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.19 -0.913 . . . . 72.41 112.456 -172.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 17.4 p -64.14 178.13 0.72 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.002 0.521 . . . . 64.42 111.371 170.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -64.73 139.82 58.8 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.051 0.54 . . . . 70.21 111.538 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -64.18 101.47 0.41 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.015 0.926 . . . . 72.11 108.836 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -78.79 102.98 8.43 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.566 0.747 . . . . 73.45 110.818 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -147.85 102.77 3.44 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.536 -0.913 . . . . 71.42 108.536 168.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -113.05 169.13 9.15 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.555 1.142 . . . . 62.13 110.086 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.359 0 C-N-CA 123.637 0.775 . . . . 37.61 110.544 -175.586 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 111.14 0.052 . . . . 73.24 111.14 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -140.38 150.99 44.61 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.989 0.516 . . . . 63.51 110.326 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -171.55 -52.03 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.195 0.998 . . . . 74.45 109.346 175.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 66.45 -80.81 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.201 0 C-N-CA 124.794 1.238 . . . . 60.34 108.654 -170.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.538 ' HB3' ' HG2' ' D' ' 8' ' ' GLU . 17.5 t-20 177.21 145.4 0.1 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 125.067 1.347 . . . . 55.42 108.084 167.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p-10 -63.81 -32.98 74.67 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.288 0.635 . . . . 64.3 112.239 -177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.486 HG22 ' OD1' ' D' ' 5' ' ' ASN . 4.3 t -82.78 -19.47 37.7 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 117.659 0.209 . . . . 74.04 111.196 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' D' ' 5' ' ' ASN . 27.1 mm-40 -70.11 -16.02 63.06 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-O 119.114 -0.47 . . . . 65.51 111.773 176.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 19.3 ttt -32.16 133.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 124.528 1.131 . . . . 75.32 113.518 172.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 90.3 m -142.55 139.96 31.59 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.409 1.084 . . . . 72.34 108.326 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.452 ' CE2' ' SG ' ' D' ' 102' ' ' CYS . 79.5 t80 -155.01 101.09 2.24 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.529 -1.285 . . . . 72.01 107.529 178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -124.23 122.7 38.48 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.88 0.472 . . . . 73.12 109.825 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.13 119.75 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 N-CA-C 109.138 -0.69 . . . . 61.34 109.138 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.442 HE22 HG22 ' D' ' 55' ' ' VAL . 40.9 mt-30 -98.67 -46.46 5.69 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 122.574 0.35 . . . . 64.2 110.586 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.617 HH12 HG21 ' E' ' 134' ' ' ILE . 34.5 ttt180 -165.07 120.08 1.33 Allowed 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 110.505 -0.183 . . . . 72.21 110.505 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 mp -103.06 136.91 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 N-CA-C 107.77 -1.196 . . . . 50.53 107.77 174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -164.37 177.59 8.12 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 123.826 0.85 . . . . 74.04 110.763 -177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.8 p -107.5 127.56 53.72 Favored 'General case' 0 C--O 1.241 0.605 0 CA-C-N 115.738 -0.665 . . . . 62.42 110.013 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 27.4 mtpt -95.54 -30.99 13.54 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 109.529 -0.545 . . . . 62.12 109.529 175.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.782 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 15.9 t70 -144.61 134.9 24.3 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 108.834 -0.802 . . . . 74.22 108.834 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.524 HG23 HG22 ' D' ' 78' ' ' VAL . 27.1 mt -139.04 147.7 24.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.144 -1.428 . . . . 74.43 107.144 174.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -155.13 147.47 23.92 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.986 0.422 . . . . 73.12 110.351 171.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.623 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 67.8 t80 -150.06 127.89 11.76 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.16 1.384 . . . . 71.31 107.351 173.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -126.61 148.06 49.83 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.039 0.936 . . . . 74.32 108.974 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.25 84.03 61.14 Favored Pre-proline 0 CA--C 1.548 0.885 0 N-CA-C 108.816 -0.809 . . . . 55.15 108.816 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -64.24 -48.06 5.3 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.789 2.993 . . . . 65.42 114.195 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 53.3 m-80 -111.87 45.57 1.23 Allowed 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.885 -0.783 . . . . 74.22 108.885 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.522 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -52.79 -59.34 9.06 Favored Pre-proline 0 CA--C 1.575 1.928 0 N-CA-C 115.703 1.742 . . . . 62.41 115.703 -166.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -83.66 -4.45 10.73 Favored 'Trans proline' 0 C--N 1.394 2.969 0 CA-C-N 122.545 1.945 . . . . 72.11 112.99 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -84.15 -35.62 23.47 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.332 1.053 . . . . 72.12 110.476 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.6 p -84.31 -13.29 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 121.394 0.616 . . . . 71.43 110.411 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -30.7 69.71 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 115.862 -0.608 . . . . 74.4 109.939 166.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -72.38 -6.28 42.31 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.444 1.098 . . . . 31.12 111.943 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.408 ' HZ1' ' HG2' ' D' ' 70' ' ' GLU . 93.9 mttt -125.41 87.13 2.65 Favored 'General case' 0 C--O 1.245 0.842 0 C-N-CA 124.379 1.072 . . . . 51.41 109.225 178.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.504 ' HB2' ' HA ' ' F' ' 134' ' ' ILE . 7.2 p-10 -80.23 93.86 5.95 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-O 122.172 0.987 . . . . 63.52 110.425 -177.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -159.38 170.98 20.61 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.314 1.046 . . . . 73.42 109.815 175.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.441 HE21 ' HB3' ' D' ' 124' ' ' PRO . 1.8 mp0 -80.59 107.37 7.12 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.191 -1.04 . . . . 62.22 108.191 166.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -66.63 153.92 76.25 Favored 'Trans proline' 0 C--N 1.373 1.834 0 C-N-CA 122.945 2.43 . . . . 71.51 113.001 -178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -72.01 123.81 23.59 Favored 'General case' 0 C--N 1.349 0.544 0 N-CA-C 108.444 -0.947 . . . . 73.33 108.444 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.531 HG11 HD13 ' D' ' 126' ' ' LEU . 7.7 p -117.71 142.35 32.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 C-N-CA 123.079 0.552 . . . . 74.52 110.283 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.515 ' HE2' ' HA ' ' D' ' 41' ' ' LYS . 11.4 mmpt? -109.77 123.83 50.22 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 124.344 1.058 . . . . 63.4 108.711 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.62 126.87 55.84 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.464 0.706 . . . . 75.23 110.566 -171.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -130.67 120.2 23.56 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.945 0.898 . . . . 62.25 109.168 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.629 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.8 pt? -108.48 132.56 53.69 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 109.219 -0.66 . . . . 42.32 109.219 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.449 ' O ' HD23 ' D' ' 60' ' ' LEU . 26.7 t70 -135.48 145.26 46.96 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.862 0.865 . . . . 64.11 108.967 -173.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 10.5 t -123.59 155.58 37.39 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.852 0.834 . . . . 74.4 111.62 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.515 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.19 166.86 27.59 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 113.801 -1.545 . . . . 62.32 108.073 175.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 50.4 p -151.91 156.38 39.98 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.133 0.573 . . . . 70.23 109.568 177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.4 t -158.51 119.03 3.3 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.774 0.83 . . . . 73.31 109.022 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -69.71 117.79 11.76 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 108.987 -0.746 . . . . 71.04 108.987 175.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.55 -36.38 17.61 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 109.306 -0.627 . . . . 74.1 109.306 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.84 -171.38 2.88 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.754 -0.657 . . . . 71.11 111.322 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -54.8 104.68 0.12 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.607 1.563 . . . . 55.45 111.371 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 58.33 20.65 7.48 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.19 0.996 . . . . 71.42 112.432 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.442 HG22 HE22 ' D' ' 14' ' ' GLN . 75.3 t -109.46 122.22 63.73 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 107.523 -1.288 . . . . 60.32 107.523 170.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -130.89 128.41 40.5 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.836 -0.801 . . . . 73.22 108.836 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -88.66 135.88 33.28 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.528 1.131 . . . . 72.4 108.464 172.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 81.3 t -117.87 139.83 43.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.34 -0.985 . . . . 71.23 108.34 172.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.6 t -115.78 141.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.237 -1.023 . . . . 41.15 108.237 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -127.36 118.61 24.47 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 107.287 -1.375 . . . . 73.04 107.287 176.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 4.3 tmm_? -107.28 97.86 7.57 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.963 -0.754 . . . . 53.31 108.963 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.1 t -92.02 125.74 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.876 -0.787 . . . . 74.04 108.876 174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 21.5 m -113.1 144.43 42.65 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.691 0.796 . . . . 53.5 109.798 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.618 HG21 HG21 ' D' ' 114' ' ' ILE . 25.6 t -135.8 104.82 4.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 C-N-CA 125.243 1.417 . . . . 62.14 108.367 -173.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 10.0 m -112.14 90.99 3.49 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 107.563 -1.273 . . . . 54.33 107.563 177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' D' ' 40' ' ' VAL . . . -97.53 125.32 42.17 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.44 -0.578 . . . . 72.04 109.44 -177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 24.9 p -158.69 124.92 4.58 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.167 0.987 . . . . 71.55 109.539 177.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -130.85 130.07 43.14 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 107.556 -1.276 . . . . 74.32 107.556 169.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.48 -146.41 18.2 Favored Glycine 0 C--N 1.34 0.797 0 CA-C-N 116.012 -0.54 . . . . 23.45 113.323 -177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . 0.408 ' HG2' ' HZ1' ' D' ' 34' ' ' LYS . 10.5 pt-20 -88.03 11.11 16.85 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.207 1.003 . . . . 65.12 112.239 -177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -147.76 161.9 40.31 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 120.819 0.342 . . . . 63.43 111.428 -167.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 85.0 m -83.33 124.79 30.96 Favored 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.644 -0.707 . . . . 71.34 110.063 171.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.466 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -73.4 -63.84 1.11 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.125 0.97 . . . . 71.42 110.161 -178.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -157.87 157.56 33.44 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.142 0.496 . . . . 64.13 111.065 171.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 91.9 mt -122.96 146.62 47.45 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.408 1.083 . . . . 63.25 109.075 179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.563 ' SG ' HG12 ' D' ' 114' ' ' ILE . 53.7 t -160.0 141.42 12.61 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.191 0.596 . . . . 65.14 110.334 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -154.41 122.34 5.92 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.374 -0.602 . . . . 71.52 109.374 175.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.524 HG22 HG23 ' D' ' 21' ' ' ILE . 47.8 t -124.48 123.95 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 123.446 0.698 . . . . 71.13 110.581 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.782 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -89.5 93.61 9.57 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.386 0.612 . . . . 74.33 109.396 164.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.69 109.88 14.5 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.979 -1.009 . . . . 74.44 108.371 173.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.69 149.37 19.1 Favored Glycine 0 N--CA 1.468 0.81 0 N-CA-C 111.735 -0.546 . . . . 64.4 111.735 177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.479 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -144.22 130.52 4.02 Favored Glycine 0 CA--C 1.509 -0.335 0 N-CA-C 110.885 -0.886 . . . . 62.53 110.885 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 72.4 mt -88.77 126.34 41.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 108.022 -1.103 . . . . 74.24 108.022 175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' D' ' 86' ' ' ILE . 49.3 m-85 -129.98 162.75 27.97 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 109.297 -0.631 . . . . 71.41 109.297 177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 3.9 t -116.35 101.62 8.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.556 0.742 . . . . 71.24 109.354 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' D' ' 84' ' ' PHE . 3.8 mp -109.77 110.63 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.083 0.953 . . . . 64.32 110.097 -174.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.56 160.53 38.2 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.012 0.925 . . . . 74.53 109.829 175.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.76 -20.0 6.84 Favored Glycine 0 N--CA 1.477 1.432 0 N-CA-C 114.646 0.619 . . . . 63.01 114.646 174.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.452 HD11 ' HG3' ' D' ' 93' ' ' GLN . 4.4 tt -121.16 137.26 55.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.781 0 C-N-CA 124.237 1.015 . . . . 54.22 109.478 -174.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -150.69 -170.99 3.81 Favored 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 123.72 0.808 . . . . 71.13 110.822 -177.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.5 -140.81 26.76 Favored Glycine 0 C--N 1.351 1.37 0 O-C-N 123.32 0.387 . . . . 73.05 113.606 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.3 m -80.0 -24.44 40.84 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.52 0.728 . . . . 45.14 110.833 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.452 ' HG3' HD11 ' D' ' 89' ' ' ILE . 6.5 tp-100 -70.26 -36.95 74.78 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.135 0.574 . . . . 53.52 110.632 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' D' ' 90' ' ' GLU . 0.0 OUTLIER -74.55 -33.6 62.76 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 109.668 -0.493 . . . . 65.43 109.668 174.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.18 -37.76 81.2 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.361 0.601 . . . . 74.42 110.425 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.508 ' HB2' HD11 ' D' ' 141' ' ' LEU . 8.2 t-80 -67.71 -44.81 76.79 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 114.972 -1.013 . . . . 73.11 111.231 172.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -60.96 -50.5 73.13 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.051 0.54 . . . . 65.03 110.699 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -76.34 -22.85 54.39 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 123.869 0.868 . . . . 73.53 111.316 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.2 -7.56 46.24 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 115.215 0.846 . . . . 75.14 115.215 -172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.28 -51.86 0.35 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.793 0.796 . . . . 71.34 110.965 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -71.8 -39.44 69.86 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.764 0.426 . . . . 74.11 112.057 -172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.452 ' SG ' ' CE2' ' D' ' 11' ' ' PHE . 57.7 m -73.37 -44.59 7.59 Favored Pre-proline 0 CA--C 1.556 1.179 0 CA-C-O 118.693 -0.67 . . . . 74.24 111.347 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.528 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 64.6 Cg_exo -56.64 -32.75 91.58 Favored 'Trans proline' 0 C--N 1.392 2.82 0 C-N-CA 121.983 1.789 . . . . 71.33 113.244 168.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -63.82 -35.75 81.64 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.205 0.602 . . . . 64.33 110.669 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -65.75 -42.11 91.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 C-N-CA 123.437 0.695 . . . . 63.31 110.111 172.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.479 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.0 mt -75.9 -19.26 58.97 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.075 -0.966 . . . . 65.4 112.318 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -66.23 -43.84 56.41 Favored Pre-proline 0 CA--C 1.557 1.248 0 N-CA-C 113.851 1.056 . . . . 74.14 113.851 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -54.99 -41.4 79.2 Favored 'Trans proline' 0 C--N 1.388 2.629 0 C-N-CA 121.937 1.758 . . . . 75.03 113.512 171.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -72.43 -38.36 68.37 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.516 0.726 . . . . 74.22 111.525 -178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.65 79.35 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.486 0.714 . . . . 52.53 110.398 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -55.35 -52.37 63.72 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.507 1.129 . . . . 73.21 110.6 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.18 -43.95 93.52 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 123.894 0.746 . . . . 73.43 111.779 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 51.6 t -55.35 -40.3 71.07 Favored 'General case' 0 N--CA 1.478 0.958 0 O-C-N 123.764 0.665 . . . . 74.5 110.833 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.618 HG21 HG21 ' D' ' 64' ' ' VAL . 97.3 mt -65.83 -53.38 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 115.071 -0.968 . . . . 73.21 110.483 174.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.433 HG23 ' HG3' ' D' ' 125' ' ' GLN . 22.5 m -57.31 -35.99 70.53 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.252 1.021 . . . . 52.43 111.818 -173.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.1 t -66.99 -45.69 76.86 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 115.204 -0.907 . . . . 74.45 110.139 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.425 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 79.1 mtm -65.6 -31.45 72.5 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.24 0.616 . . . . 72.02 111.7 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.417 HG23 ' O ' ' D' ' 114' ' ' ILE . 71.2 t -66.25 -46.21 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-N 115.388 -0.824 . . . . 64.14 110.038 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.9 p -73.03 -25.44 60.95 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-N 116.333 -0.394 . . . . 74.32 111.428 -179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 91.2 mtt-85 -74.39 -35.42 63.47 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.588 0.755 . . . . 61.02 109.676 174.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.67 -1.37 83.11 Favored Glycine 0 C--N 1.355 1.622 0 CA-C-N 115.692 -0.685 . . . . 72.32 112.111 172.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p 57.19 36.29 27.27 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 126.2 1.8 . . . . 73.54 111.825 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -99.62 158.31 32.38 Favored Pre-proline 0 C--O 1.241 0.623 0 CA-C-N 113.908 -1.496 . . . . 72.03 109.815 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.503 ' HB2' HD11 ' F' ' 139' ' ' LEU . 73.1 Cg_exo -54.13 128.24 29.07 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.526 2.151 . . . . 65.24 113.07 174.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' D' ' 115' ' ' THR . 27.1 tt0 -52.39 140.97 20.79 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.052 1.341 . . . . 73.41 112.702 -175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.531 HD13 HG11 ' D' ' 40' ' ' VAL . 28.2 tp -112.99 126.77 55.86 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.11 -0.7 . . . . 73.54 109.11 174.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.467 ' HB3' HG13 ' B' ' 13' ' ' ILE . 94.3 m-20 -121.28 103.78 9.23 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.074 0.95 . . . . 70.0 109.025 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -66.76 119.75 12.36 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.641 0.776 . . . . 73.12 110.12 174.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.96 147.18 88.32 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.089 0.556 . . . . 73.52 110.602 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.91 110.7 1.36 Allowed 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 122.464 2.109 . . . . 75.25 111.827 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 92.1 t -106.65 110.83 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 108.08 -1.082 . . . . 70.54 108.08 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 59.3 t30 -82.31 75.29 9.23 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.157 0.979 . . . . 73.53 109.375 -176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.505 ' HA ' HD22 ' F' ' 148' ' ' LEU . 28.4 t80 -78.51 -24.05 46.0 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 114.304 -1.316 . . . . 75.3 109.767 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -52.66 -34.96 54.02 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 125.585 1.554 . . . . 71.45 111.287 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.459 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -63.32 -31.96 73.25 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.04 0.936 . . . . 71.13 112.992 178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 46.8 tp -66.22 -37.34 85.33 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.254 0.549 . . . . 74.25 110.379 177.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.4 ' O ' HD13 ' D' ' 141' ' ' LEU . 62.7 m-85 -66.15 -28.54 68.86 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.168 -0.924 . . . . 54.4 112.872 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 15.3 mmt -52.35 -50.07 63.08 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.041 0.448 . . . . 72.42 110.041 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -66.32 -49.19 67.86 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 114.946 -1.025 . . . . 62.01 110.389 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -52.64 -42.71 64.91 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.58 1.552 . . . . 73.32 112.285 -174.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' D' ' 96' ' ' HIS . 8.0 mp -67.16 -51.14 57.48 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.304 1.042 . . . . 70.31 110.958 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -77.2 -4.04 42.66 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 116.069 -0.514 . . . . 65.41 112.144 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -122.41 41.85 3.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 108.459 -0.941 . . . . 74.41 108.459 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -162.96 -71.77 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.808 1.643 . . . . 75.52 107.637 177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 53.23 89.55 0.03 OUTLIER 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.225 1.41 . . . . 43.34 111.022 -173.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.92 -168.66 12.7 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 116.234 -0.439 . . . . 52.3 112.389 -178.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -134.47 121.78 21.54 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.828 -0.804 . . . . 74.43 108.828 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.41 65.0 0.6 Allowed Glycine 0 C--N 1.341 0.835 0 N-CA-C 111.455 -0.658 . . . . 75.3 111.455 -178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.9 t -156.92 175.52 13.97 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.878 -0.786 . . . . 64.2 108.878 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.73 -53.63 0.71 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.012 0.525 . . . . 74.52 110.131 -178.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 175.61 132.98 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.209 0 C-N-CA 124.211 1.004 . . . . 74.42 108.318 -172.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -119.97 118.02 29.58 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 107.619 -1.252 . . . . 74.45 107.619 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -65.23 101.34 0.54 Allowed 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.366 0.603 . . . . 73.01 110.666 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -78.75 122.89 26.59 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 114.087 -1.415 . . . . 65.2 108.424 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.397 0 C-N-CA 124.135 0.974 . . . . 65.44 108.726 -178.369 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 108.851 -0.796 . . . . 61.04 108.851 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 98.4 mttt 57.58 36.01 26.35 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.421 1.088 . . . . 64.21 112.204 174.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.8 63.89 6.25 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.438 0.695 . . . . 74.53 109.507 175.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -78.17 143.87 36.86 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.526 -0.761 . . . . 73.14 109.88 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -77.76 84.05 4.1 Favored 'General case' 0 C--O 1.244 0.784 0 CA-C-N 115.985 -0.552 . . . . 72.24 110.352 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -76.23 166.65 23.15 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.019 -0.991 . . . . 75.31 109.271 171.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.45 -73.85 0.09 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.165 0.586 . . . . 52.1 109.683 176.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.662 ' HB3' ' HG3' ' B' ' 94' ' ' MET . 6.7 mp -141.01 -33.14 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.478 0.711 . . . . 71.23 111.699 178.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -125.85 83.64 62.34 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 123.11 0.564 . . . . 75.3 111.065 -166.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -90.54 -17.44 1.42 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.014 2.476 . . . . 70.33 113.394 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -109.31 118.8 37.64 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.472 0.709 . . . . 71.32 109.873 -164.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 44.6 p -116.86 60.53 0.74 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.958 0.903 . . . . 75.33 110.222 -176.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.454 ' CD1' HG21 ' B' ' 46' ' ' THR . 15.1 m95 64.14 -82.19 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.978 1.311 . . . . 55.11 113.165 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 27.7 t70 67.79 153.06 0.09 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.959 1.304 . . . . 64.0 110.952 -166.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 59.34 34.9 23.04 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.159 0.984 . . . . 71.43 111.716 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 38.3 t -71.6 87.99 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 CA-C-N 115.099 -0.955 . . . . 72.02 109.72 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -142.61 92.22 2.39 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 107.763 -1.199 . . . . 74.21 107.763 176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -84.91 67.97 10.35 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.158 -1.053 . . . . 73.35 108.158 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -82.8 80.57 8.84 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.447 -0.946 . . . . 61.12 108.447 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -126.2 110.09 1.23 Allowed Glycine 0 C--N 1.337 0.637 0 CA-C-N 114.286 -1.324 . . . . 52.3 109.997 177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -65.89 102.64 0.8 Allowed 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.723 -0.473 . . . . 71.44 109.723 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 pp -161.14 148.41 15.17 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.086 0.954 . . . . 72.13 110.023 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 7.3 tp -157.94 89.2 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 123.61 0.764 . . . . 73.43 109.354 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 56.85 -150.65 0.43 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.262 1.025 . . . . 60.12 111.081 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -98.48 124.3 47.08 Favored Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 107.658 -1.238 . . . . 73.33 107.658 167.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -59.09 106.99 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.9 2.4 . . . . 74.21 113.696 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . 0.617 HG21 HH12 ' D' ' 15' ' ' ARG . 7.7 tt -167.84 120.32 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.167 0.987 . . . . 73.13 109.532 176.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -89.98 89.66 7.81 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.398 0.679 . . . . 32.11 110.324 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 t -86.22 -22.7 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 122.878 0.471 . . . . 62.31 109.91 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 66.25 -170.97 0.19 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.594 1.158 . . . . 72.33 113.139 172.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -82.59 119.88 24.82 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.28 0.632 . . . . 64.41 110.311 177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 7.1 mp -92.39 126.45 37.48 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.234 1.014 . . . . 74.3 109.864 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 26.9 t -150.58 110.89 4.18 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.48 0.712 . . . . 54.15 109.869 179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . 0.411 HD22 ' HG3' ' C' ' 39' ' ' GLU . 3.6 tt -159.82 78.82 0.7 Allowed 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 107.359 -1.349 . . . . 72.13 107.359 177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 15.7 pt -137.79 -50.49 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.56 0.744 . . . . 71.22 110.505 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -143.76 -59.89 0.4 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 107.054 -1.461 . . . . 64.02 107.054 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 73.89 -4.25 2.31 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.365 1.466 . . . . 62.31 113.297 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -133.93 -76.67 0.47 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.579 0.752 . . . . 71.3 109.852 172.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.82 96.66 10.55 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.169 0.987 . . . . 64.3 110.041 -175.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -73.52 -56.89 4.44 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.761 -1.2 . . . . 62.23 107.761 172.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.717 HD21 HD11 ' C' ' 136' ' ' LEU . 5.9 tt -170.55 96.39 0.45 Allowed Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 107.392 -1.336 . . . . 72.25 107.392 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 CA--C 1.57 2.281 0 C-N-CA 123.316 2.678 . . . . 74.23 111.928 174.498 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 36.5 t70 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 110.002 -0.37 . . . . 71.43 110.002 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -133.57 158.03 44.21 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.255 1.022 . . . . 73.44 109.468 178.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -150.68 119.1 6.42 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.961 0.905 . . . . 73.22 108.765 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -117.44 95.13 4.82 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 108.546 -0.909 . . . . 70.35 108.546 178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.35 22.62 10.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.763 0.825 . . . . 73.31 110.695 -178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -59.19 113.1 1.97 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.348 1.059 . . . . 75.15 110.148 175.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -166.44 152.18 8.46 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.023 -0.732 . . . . 73.51 109.023 -171.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.414 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 11.6 tp -78.51 72.59 5.04 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 109.09 -0.707 . . . . 63.43 109.09 179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -154.86 87.72 3.32 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.147 0.979 . . . . 74.11 108.675 -178.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . 0.446 ' HD2' HD12 ' A' ' 98' ' ' LEU . 44.3 Cg_endo -91.89 9.04 2.87 Favored 'Trans proline' 0 C--N 1.372 1.804 0 C-N-CA 123.185 2.59 . . . . 53.03 113.834 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -78.63 94.58 5.06 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 109.339 -0.615 . . . . 72.24 109.339 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 32.6 m -133.71 87.72 2.41 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.161 -1.051 . . . . 63.53 108.161 176.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . 0.453 ' CZ2' ' HB3' ' F' ' 122' ' ' ALA . 59.3 t90 -159.13 148.06 18.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.911 0.885 . . . . 75.13 109.349 -176.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -146.68 98.16 3.02 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.4 0.68 . . . . 55.41 110.372 -172.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . 0.453 ' HB3' ' CZ2' ' F' ' 120' ' ' TRP . . . -167.9 83.76 0.2 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.798 0.839 . . . . 64.24 109.677 169.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 6.1 p -151.09 136.05 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.363 0.665 . . . . 60.03 110.512 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.8 146.56 50.79 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.991 0.916 . . . . 74.14 108.836 172.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . 0.422 ' HE2' ' HA ' ' A' ' 43' ' ' ASP . 32.5 p90 -151.6 147.51 26.86 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.859 0.864 . . . . 72.33 109.32 178.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 31.4 p30 -145.7 -173.89 4.26 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.407 0.683 . . . . 75.42 110.201 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . 0.515 ' HA3' HD12 ' A' ' 42' ' ' LEU . . . -157.9 87.76 0.12 Allowed Glycine 0 C--N 1.342 0.888 0 CA-C-N 116.251 -0.431 . . . . 62.33 112.231 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -76.47 -75.37 0.2 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.147 -1.057 . . . . 75.34 108.147 171.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.443 ' HB3' ' H ' ' F' ' 130' ' ' ILE . 9.2 mp 47.58 -146.94 0.22 Allowed 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 124.734 1.213 . . . . 73.14 111.751 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.443 ' H ' ' HB3' ' F' ' 129' ' ' LEU . 37.4 mm 58.21 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.708 1.203 . . . . 60.05 110.91 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -95.07 111.17 23.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.1 -0.955 . . . . 74.14 109.135 177.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 40.6 t80 69.14 112.87 0.03 OUTLIER Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.94 1.296 . . . . 72.15 110.785 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -80.42 150.02 19.36 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.712 2.275 . . . . 73.13 112.264 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.504 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 14.8 tt -142.03 118.02 6.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 109.23 -0.656 . . . . 72.34 109.23 175.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.23 95.66 5.04 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 109.033 -0.729 . . . . 65.51 109.033 175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 13.6 m -82.49 79.07 1.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 CA-C-O 122.238 1.018 . . . . 75.24 110.354 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -115.13 -176.68 2.96 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.108 -0.951 . . . . 75.42 110.79 -173.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.26 134.22 44.18 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.485 0.714 . . . . 14.34 112.834 -169.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' D' ' 124' ' ' PRO . 10.3 mp -83.47 43.17 0.87 Allowed 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.612 1.165 . . . . 51.14 110.465 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 31.9 m -75.4 -13.74 60.42 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.345 0.658 . . . . 74.03 111.333 177.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.41 -27.34 65.94 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.151 0.98 . . . . 74.52 112.965 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.52 HG21 ' H ' ' D' ' 40' ' ' VAL . 2.9 pp -78.22 2.27 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 123.524 0.73 . . . . 75.33 112.81 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -103.01 156.82 17.41 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.686 0.794 . . . . 72.31 111.153 177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -145.65 45.84 1.29 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.991 0.916 . . . . 71.43 108.532 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt 73.08 -18.35 0.37 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.466 1.506 . . . . 70.11 112.886 175.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -74.83 92.32 2.51 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 124.049 0.94 . . . . 60.51 110.493 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 87.2 mt -119.16 35.13 4.94 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.3 1.04 . . . . 73.42 108.388 177.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' D' ' 133' ' ' PHE . 8.5 mp 59.43 67.2 1.94 Allowed Pre-proline 0 CA--C 1.555 1.161 0 CA-C-N 114.059 -1.428 . . . . 71.1 109.589 -163.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo . . . . . 0 C--N 1.389 2.689 0 C-N-CA 123.762 2.975 . . . . 71.14 111.6 -178.656 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ttt . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.765 0.317 . . . . 64.35 110.184 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 m -74.94 92.69 2.6 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.134 0.574 . . . . 73.34 109.477 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -94.93 33.61 1.47 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.654 -0.703 . . . . 53.3 111.094 -176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -78.79 91.62 4.74 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.139 -1.06 . . . . 62.11 108.139 170.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.414 HD22 ' N ' ' A' ' 5' ' ' ASN . 0.8 OUTLIER -77.21 -68.75 0.58 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.439 0.696 . . . . 71.31 110.475 -173.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -149.66 128.7 12.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.188 -0.671 . . . . 73.32 109.188 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 m -78.91 83.93 4.99 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 109.144 -0.687 . . . . 73.44 109.144 176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -84.64 -165.66 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.053 -0.976 . . . . 72.41 110.295 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.46 ' SD ' HG13 ' A' ' 89' ' ' ILE . 58.3 mtt 74.93 177.52 0.22 Allowed 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.385 1.074 . . . . 51.24 111.96 170.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.6 m -140.93 130.67 24.23 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.624 0.769 . . . . 62.35 109.498 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -133.17 112.38 11.68 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.744 -1.206 . . . . 74.33 107.744 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -140.06 110.5 6.67 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 109.27 -0.641 . . . . 75.3 109.27 177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' E' ' 147' ' ' LEU . 1.5 mp -81.11 119.41 30.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.525 0 N-CA-C 107.559 -1.274 . . . . 64.43 107.559 174.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.43 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.0 OUTLIER -84.17 -41.49 16.97 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 109.014 -0.736 . . . . 72.14 109.014 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -168.07 137.47 2.51 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 119.328 -0.367 . . . . 74.33 110.561 -166.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.642 HG23 HD23 ' A' ' 106' ' ' LEU . 92.0 mt -139.88 98.86 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 107.988 -1.115 . . . . 72.15 107.988 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.418 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.3 m-85 -163.45 166.02 23.19 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.102 0.961 . . . . 75.32 109.409 -167.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.9 p -74.18 126.33 30.34 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 110.075 -0.342 . . . . 73.4 110.075 -176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 41.2 mtpt -85.05 -44.41 13.06 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.392 0.615 . . . . 63.03 109.456 171.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.5 t70 -135.36 142.1 45.68 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.71 -1.132 . . . . 73.44 109.885 -176.052 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 86.5 mt -138.19 140.01 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.453 1.501 . . . . 73.11 107.684 179.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -151.74 128.65 10.99 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.333 -0.618 . . . . 73.22 109.333 174.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.0 t80 -134.1 125.07 27.23 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 107.389 -1.338 . . . . 71.1 107.389 174.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -125.75 148.07 49.19 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 109.039 -0.726 . . . . 65.45 109.039 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.0 77.78 25.48 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 106.628 -1.619 . . . . 74.24 106.628 174.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.93 -31.86 36.98 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.749 2.299 . . . . 72.13 111.873 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 40.3 m-20 -109.28 32.14 5.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.704 0.802 . . . . 73.41 109.524 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.31 -46.8 99.07 Favored Pre-proline 0 CA--C 1.563 1.461 0 C-N-CA 124.262 1.025 . . . . 52.51 113.282 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.61 -12.99 29.73 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.688 1.592 . . . . 72.04 113.167 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -90.14 -11.82 40.06 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.762 0.825 . . . . 74.33 111.698 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 29.9 m -60.24 -15.09 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 113.617 0.969 . . . . 64.34 113.617 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -72.64 -41.19 65.75 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.509 0.724 . . . . 72.35 110.844 176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -89.84 -15.61 31.88 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.375 -0.83 . . . . 74.1 110.567 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 3.7 mmpt? -73.21 129.21 37.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.231 0.612 . . . . 73.32 111.096 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -71.64 116.73 12.34 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.153 -1.055 . . . . 75.23 108.153 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 82.6 m95 -71.52 83.49 0.83 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.816 0.817 . . . . 75.21 111.283 -173.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -141.0 80.19 17.39 Favored Pre-proline 0 CA--C 1.545 0.752 0 N-CA-C 106.203 -1.777 . . . . 74.23 106.203 171.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.74 135.36 6.76 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.904 2.403 . . . . 70.31 111.597 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -94.2 100.77 12.78 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 105.862 -1.903 . . . . 55.12 105.862 174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.4 t -73.01 90.94 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.571 0 CA-C-O 121.751 0.786 . . . . 60.44 109.068 -175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 56.7 tttp -86.39 127.67 34.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 114.36 -1.291 . . . . 70.44 108.837 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 tp -123.16 144.31 49.43 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.707 -0.849 . . . . 74.03 108.707 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -146.32 144.74 30.0 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.752 -0.833 . . . . 75.14 108.752 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.96 124.06 17.72 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.15 0.58 . . . . 74.32 110.272 -175.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.606 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 20.7 t70 -123.5 148.04 46.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 124.994 1.317 . . . . 62.41 109.513 -176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 99.6 m -139.54 136.77 34.83 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.039 0.536 . . . . 73.12 110.579 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' VAL . . . -146.29 127.64 14.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.28 0.632 . . . . 54.01 110.527 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -89.07 161.13 16.71 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.579 0.752 . . . . 74.31 109.87 176.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 47.2 t -167.33 116.67 0.83 Allowed 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.991 -0.374 . . . . 74.34 109.991 -174.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.63 HE21 ' H ' ' A' ' 54' ' ' ASP . 62.8 tt0 -71.25 104.17 3.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.452 0.701 . . . . 75.43 110.011 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' HB2' ' A' ' 57' ' ' GLU . 86.6 mt -77.95 -38.8 44.5 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.861 0.865 . . . . 72.45 111.044 176.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.92 -172.35 4.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.889 0.875 . . . . 71.33 109.776 -176.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -57.21 97.08 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.188 0.595 . . . . 73.53 111.183 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.63 ' H ' HE21 ' A' ' 50' ' ' GLN . 10.4 m-20 58.39 32.95 22.68 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.201 1.4 . . . . 70.44 112.299 -176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 59.9 t -107.72 120.57 59.3 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 106.651 -1.611 . . . . 73.52 106.651 168.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 49' ' ' SER . 2.0 m-85 -130.89 128.5 40.69 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 108.952 -0.759 . . . . 75.32 108.952 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.468 ' HB2' HD11 ' A' ' 51' ' ' LEU . 40.2 tt0 -91.81 123.16 34.99 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 108.901 -0.777 . . . . 72.3 108.901 172.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' ALA . 33.2 m -99.75 122.09 51.19 Favored 'Isoleucine or valine' 0 C--N 1.34 0.195 0 N-CA-C 107.543 -1.28 . . . . 70.43 107.543 170.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.497 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 58.9 t -100.49 130.13 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 109.14 -0.689 . . . . 75.55 109.14 177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -105.7 112.97 26.26 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.425 -1.324 . . . . 73.31 107.425 179.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.606 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttm-85 -93.14 106.94 18.83 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.715 -1.217 . . . . 74.22 107.715 175.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -103.65 124.36 57.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.517 -0.92 . . . . 63.54 108.517 174.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.6 m -123.64 129.75 51.61 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.781 0.432 . . . . 62.45 109.952 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 53.0 t -123.63 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.541 1.136 . . . . 73.34 109.883 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 m -103.46 141.16 36.47 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.963 -0.384 . . . . 64.22 109.963 174.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.66 103.0 8.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.39 -1.337 . . . . 52.0 107.39 168.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.561 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 34.3 m -112.0 125.3 53.92 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.476 0.655 . . . . 73.41 109.401 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 73' ' ' ALA . 5.9 mp -102.32 86.67 2.87 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.753 -1.943 . . . . 73.43 105.753 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.96 -122.91 5.96 Favored Glycine 0 C--N 1.347 1.154 0 N-CA-C 110.931 -0.868 . . . . 71.45 110.931 -173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -87.64 -23.78 24.14 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.235 0.614 . . . . 70.52 110.104 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -86.91 108.93 19.0 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.336 0.654 . . . . 65.13 111.17 -175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 80.4 m -74.39 117.35 16.11 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 123.373 0.669 . . . . 71.02 109.517 173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.417 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -59.57 -54.86 41.67 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.553 0.741 . . . . 54.12 109.529 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -156.56 153.67 29.04 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-N 114.36 -1.291 . . . . 71.43 111.526 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -125.49 135.85 52.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.906 1.282 . . . . 73.22 108.732 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 77.0 m -120.35 140.61 51.04 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.665 1.186 . . . . 71.01 109.247 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -147.43 125.59 12.18 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 108.784 -0.821 . . . . 71.33 108.784 166.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.9 t -132.34 109.64 15.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 C-N-CA 124.211 1.005 . . . . 53.32 108.511 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.583 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 79.2 mt-30 -86.8 84.86 7.28 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.332 -0.849 . . . . 64.25 109.098 175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.36 96.6 4.04 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.088 -1.414 . . . . 53.43 109.548 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.74 145.68 18.04 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.81 -0.516 . . . . 74.11 111.81 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.536 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.97 122.65 2.38 Favored Glycine 0 CA--C 1.506 -0.518 0 N-CA-C 110.719 -0.952 . . . . 72.13 110.719 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 14' ' ' GLN . 48.0 mt -82.3 125.02 39.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 N-CA-C 109.268 -0.642 . . . . 74.32 109.268 174.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD2' HG13 ' A' ' 13' ' ' ILE . 55.4 m-85 -130.93 120.35 23.44 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.698 -0.853 . . . . 71.43 108.698 177.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' VAL . 36.1 t -96.35 107.02 19.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.788 0.835 . . . . 24.04 109.111 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.612 ' HB ' HD13 ' A' ' 89' ' ' ILE . 42.9 pt -130.45 127.79 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 123.148 0.579 . . . . 73.2 110.767 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.85 134.18 27.95 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.627 0.771 . . . . 60.24 109.926 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.15 7.8 62.02 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 123.549 0.531 . . . . 60.34 113.237 -176.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.612 HD13 ' HB ' ' A' ' 86' ' ' ILE . 4.5 mp -109.32 136.03 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 108.238 -1.023 . . . . 73.41 108.238 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 13.4 tt0 -159.62 -178.14 6.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.13 0.572 . . . . 72.54 109.52 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.515 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.39 -143.23 36.94 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 116.659 -0.246 . . . . 65.05 112.821 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.1 p -68.93 -17.79 64.0 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.063 0.945 . . . . 63.42 112.116 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -67.92 -57.7 5.77 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.599 0.76 . . . . 74.21 109.312 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 12.7 ttp -65.27 -40.42 93.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.93 1.292 . . . . 62.55 111.236 177.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -55.25 -50.12 70.3 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.002 0.814 . . . . 75.31 110.044 177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -64.27 -48.49 75.53 Favored 'General case' 0 C--O 1.21 -0.974 0 CA-C-N 114.401 -1.272 . . . . 75.3 111.309 174.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 36.3 m -71.01 -45.23 64.31 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.969 1.1 . . . . 75.4 113.969 -165.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -83.26 -15.19 51.25 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.044 0.387 . . . . 74.41 112.044 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -116.56 -3.94 18.04 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 114.727 0.651 . . . . 73.34 114.727 -176.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.97 -60.58 0.46 Allowed 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 117.591 0.696 . . . . 70.1 110.941 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.507 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.2 t80 -57.55 -62.54 1.71 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.163 0.985 . . . . 74.52 112.394 -169.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -77.01 -39.0 2.09 Favored Pre-proline 0 CA--C 1.557 1.222 0 CA-C-N 114.182 -1.372 . . . . 73.43 112.924 -168.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HA ' HD12 ' A' ' 106' ' ' LEU . 10.4 Cg_endo -57.29 -37.86 96.53 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.703 1.602 . . . . 64.43 113.399 165.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -65.96 -37.71 86.7 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 118.079 0.4 . . . . 71.03 110.531 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 14.4 mm -58.26 -40.57 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 123.999 0.92 . . . . 51.33 110.946 171.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.642 HD23 HG23 ' A' ' 16' ' ' ILE . 94.6 mt -70.74 -31.54 68.41 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 115.672 -0.695 . . . . 64.23 111.84 -176.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -58.08 -43.73 98.68 Favored Pre-proline 0 CA--C 1.573 1.844 0 C-N-CA 124.845 1.258 . . . . 64.14 114.251 -167.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_exo -61.32 -35.48 83.99 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.415 2.077 . . . . 70.43 114.219 173.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -79.02 -22.37 45.56 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 122.606 0.362 . . . . 75.22 111.485 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.4 65.03 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.531 -0.544 . . . . 71.11 109.531 168.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.414 HH22 ' HB3' ' A' ' 130' ' ' PRO . 42.1 ttm180 -56.75 -42.31 79.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.648 1.179 . . . . 75.01 110.975 178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.405 ' HG2' HH12 ' B' ' 120' ' ' ARG . 21.9 tt0 -48.71 -56.55 8.23 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.211 1.404 . . . . 63.42 111.372 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 50.3 t -66.72 -48.69 68.44 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 113.82 -1.537 . . . . 74.53 111.363 -173.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 118' ' ' VAL . 93.8 mt -57.35 -54.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 O-C-N 124.14 0.9 . . . . 71.1 110.565 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.3 m -61.54 -34.48 75.63 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.83 0.706 . . . . 71.54 111.801 -173.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -67.84 -44.92 76.06 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.248 -0.433 . . . . 61.44 110.347 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 10.8 mtp -55.62 -45.16 77.57 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.802 0.841 . . . . 62.43 110.978 175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 114' ' ' ILE . 76.1 t -61.89 -46.96 95.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 124.603 1.161 . . . . 72.4 111.135 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 88.3 p -73.06 -24.68 60.71 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 116.077 -0.511 . . . . 63.21 111.84 -176.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.482 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 92.8 mtt-85 -74.96 -24.07 58.39 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.244 0.618 . . . . 64.14 110.627 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.31 16.23 24.67 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 123.537 0.523 . . . . 74.11 112.421 168.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 t 52.38 28.89 6.21 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 127.224 2.21 . . . . 71.14 112.848 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -94.06 140.11 22.79 Favored Pre-proline 0 CA--C 1.544 0.749 0 N-CA-C 108.133 -1.062 . . . . 74.12 108.133 172.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -60.99 144.25 99.53 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.53 2.154 . . . . 73.2 111.07 176.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -54.79 132.62 46.45 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 123.724 0.64 . . . . 64.33 112.338 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 96.2 mt -132.08 98.85 4.54 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 106.607 -1.627 . . . . 73.34 106.607 173.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.438 HD21 ' HA ' ' C' ' 15' ' ' ARG . 8.0 p30 -98.21 126.15 43.56 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.481 0.658 . . . . 61.41 109.927 -175.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 128' ' ' LEU . 1.8 pp -68.91 141.47 55.02 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.598 -1.183 . . . . 73.04 111.382 -178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.18 142.54 84.95 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 123.402 0.681 . . . . 73.52 110.113 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.414 ' HB3' HH22 ' A' ' 111' ' ' ARG . 60.6 Cg_endo -74.57 136.68 21.7 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 122.408 2.072 . . . . 75.31 111.349 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 22.2 t -100.05 111.41 29.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 107.234 -1.395 . . . . 62.24 107.234 177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -85.82 75.86 9.98 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.694 0.759 . . . . 75.21 110.621 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.16 -40.58 90.42 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 114.291 -1.322 . . . . 71.11 110.559 172.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.74 -50.69 73.0 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.258 -0.883 . . . . 75.0 111.67 175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.12 90.73 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 123.691 0.619 . . . . 64.24 110.805 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.01 -46.94 84.46 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.115 0.566 . . . . 73.24 110.802 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.25 -49.83 25.61 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 115.826 -0.625 . . . . 71.42 110.408 -178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.557 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 59.0 mtp -80.41 -23.29 40.47 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.228 0.825 . . . . 73.2 113.228 -166.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -61.28 -39.25 89.71 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.345 0.593 . . . . 74.55 109.419 171.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -80.3 -34.64 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.835 -1.075 . . . . 74.44 110.819 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.557 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 64.6 tp -67.32 -53.74 26.99 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.072 0.549 . . . . 72.34 111.504 -173.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -158.49 -0.75 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 123.559 0.744 . . . . 72.42 112.422 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 66.12 163.11 0.16 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 124.778 1.231 . . . . 71.33 112.005 -174.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -69.5 100.11 1.36 Allowed 'General case' 0 N--CA 1.48 1.038 0 O-C-N 121.892 -0.505 . . . . 75.13 109.852 172.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.48 16.28 5.98 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.1 0.96 . . . . 71.42 109.995 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -92.33 145.04 17.45 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.729 -0.669 . . . . 75.13 113.121 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -113.01 135.71 53.48 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.153 0.981 . . . . 72.31 109.197 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.27 77.98 2.03 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.569 -0.613 . . . . 73.24 111.569 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.8 m -71.46 117.29 12.82 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.355 0.662 . . . . 75.13 110.764 -176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -69.06 93.16 0.56 Allowed 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.321 0.648 . . . . 64.21 110.979 177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -79.8 -42.15 25.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 107.076 -1.453 . . . . 70.25 107.076 163.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 62.58 100.66 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.899 1.679 . . . . 74.42 112.936 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -74.07 110.62 8.51 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.07 -1.085 . . . . 61.35 108.07 172.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -84.11 -68.98 0.67 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.318 0.647 . . . . 73.0 110.729 -171.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.655 ' HA ' ' HB2' ' E' ' 143' ' ' TYR . . . . . . . . 0 C--O 1.245 0.856 0 CA-C-N 115.262 -0.881 . . . . 64.44 110.144 -169.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 108.674 -0.861 . . . . 72.41 108.674 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.6 m -69.93 94.73 0.87 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.597 -0.52 . . . . 64.32 109.597 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -64.64 99.42 0.32 Allowed 'General case' 0 C--N 1.348 0.54 0 CA-C-N 115.391 -0.822 . . . . 52.32 109.286 177.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -170.06 174.94 5.25 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.504 1.122 . . . . 73.31 108.558 -176.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 76.28 164.62 0.25 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.011 1.324 . . . . 72.51 111.786 173.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -142.55 -54.51 0.42 Allowed 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.139 0.975 . . . . 73.02 108.676 -172.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.532 HG22 ' H ' ' B' ' 9' ' ' MET . 21.5 m 71.17 150.1 0.09 Allowed 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.096 1.358 . . . . 71.41 111.807 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.97 -39.16 72.69 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.838 -0.43 . . . . 64.44 109.838 173.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.532 ' H ' HG22 ' B' ' 7' ' ' THR . 15.9 ptm 50.65 -177.04 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.788 2.035 . . . . 50.53 114.243 176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 3.9 p -145.75 133.22 20.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.832 0.853 . . . . 72.41 108.805 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.442 ' HD1' HG22 ' B' ' 86' ' ' ILE . 91.4 t80 -129.71 139.17 51.41 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.648 0.779 . . . . 72.33 109.857 -177.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.55 ' HB2' ' HA ' ' F' ' 145' ' ' LYS . 8.2 tp-100 -160.37 143.04 13.24 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 123.278 0.361 . . . . 71.54 111.494 173.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.61 HG21 HG13 ' B' ' 16' ' ' ILE . 3.7 mp -86.02 123.11 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.493 -0.928 . . . . 75.41 108.493 173.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.25 -40.03 24.4 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.739 0.416 . . . . 73.55 110.395 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.3 ttt85 -161.36 136.62 7.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.274 -0.421 . . . . 74.31 110.43 -173.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.61 HG13 HG21 ' B' ' 13' ' ' ILE . 67.0 mt -115.91 139.7 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 107.101 -1.444 . . . . 72.31 107.101 168.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -167.52 164.78 14.86 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.982 0.896 . . . . 74.33 112.461 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.5 m -96.87 125.61 41.43 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.066 -1.425 . . . . 74.44 108.821 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.445 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 33.1 mtpt -97.64 -32.85 11.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.654 0.782 . . . . 74.12 110.372 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -152.18 138.58 18.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.966 -0.561 . . . . 51.23 110.641 -168.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.481 HD11 ' SG ' ' B' ' 113' ' ' CYS . 45.7 mm -141.01 142.17 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.381 1.473 . . . . 74.22 108.86 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 87.1 p -138.84 145.61 40.22 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 108.562 -0.903 . . . . 63.33 108.562 170.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 89.0 t80 -152.19 109.79 3.61 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 107.006 -1.479 . . . . 63.21 107.006 166.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -118.21 114.39 22.95 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.494 0.718 . . . . 72.22 109.213 -178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -109.54 87.27 5.13 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.904 0.882 . . . . 72.53 109.214 175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.12 -24.98 16.49 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.781 2.321 . . . . 71.52 112.59 -175.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -117.42 18.5 14.33 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.784 0.834 . . . . 74.13 110.447 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.807 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.37 -49.11 55.11 Favored Pre-proline 0 N--CA 1.493 1.707 0 C-N-CA 125.446 1.499 . . . . 50.41 114.249 174.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 18.1 Cg_exo -65.49 -29.19 53.35 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.103 1.868 . . . . 72.22 112.118 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -99.55 -8.97 23.84 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.011 0.925 . . . . 71.41 112.836 -172.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -74.55 -14.07 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 112.597 0.592 . . . . 72.33 112.597 -167.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -66.82 -21.69 66.02 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 122.955 0.502 . . . . 73.02 111.583 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -76.57 -13.41 60.08 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.948 0.899 . . . . 63.02 111.37 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.661 ' HB3' HD22 ' B' ' 68' ' ' LEU . 35.5 mmtp -102.43 101.7 11.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.703 0.801 . . . . 71.22 110.85 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -96.13 84.47 3.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.36 -0.978 . . . . 72.53 108.36 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -164.69 166.38 20.06 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.43 1.092 . . . . 65.11 108.207 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -89.46 127.36 55.08 Favored Pre-proline 0 N--CA 1.477 0.88 0 CA-C-O 119.203 -0.427 . . . . 72.23 110.127 178.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.74 133.57 25.93 Favored 'Trans proline' 0 C--N 1.374 1.872 0 C-N-CA 122.015 1.81 . . . . 74.31 112.086 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.92 107.34 5.25 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 108.441 -0.948 . . . . 75.33 108.441 172.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.4 m -93.08 133.99 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.965 0.412 . . . . 73.44 109.962 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -114.78 104.06 11.58 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 108.625 -0.88 . . . . 74.23 108.625 166.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' B' ' 42' ' ' LEU . 2.1 pp -94.92 141.52 28.55 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 114.876 -1.056 . . . . 71.1 108.823 175.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -162.9 147.16 11.4 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.913 -0.773 . . . . 71.14 108.913 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mp -108.96 152.5 24.86 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.502 0.721 . . . . 74.11 109.933 -174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -141.33 150.47 42.54 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 125.047 1.339 . . . . 64.15 108.109 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.486 HG21 ' NE1' ' E' ' 120' ' ' TRP . 39.4 p -119.56 137.43 53.84 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.179 0.514 . . . . 74.23 111.148 -175.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -130.83 150.1 52.16 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.651 1.181 . . . . 60.33 108.133 173.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.7 p -142.67 162.21 36.06 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.689 0.395 . . . . 70.04 110.234 -176.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -165.84 148.21 7.34 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.102 0.961 . . . . 70.51 109.206 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -119.29 125.33 48.83 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.075 -0.713 . . . . 62.31 109.075 173.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 40.5 mt -89.71 -46.65 8.46 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.528 0.731 . . . . 73.21 110.053 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -148.7 178.1 8.93 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.076 -0.966 . . . . 44.45 110.133 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -56.42 114.06 1.85 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.04 0.936 . . . . 64.34 110.201 172.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 69.98 3.16 4.21 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.685 1.194 . . . . 53.11 112.913 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.406 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 61.7 t -108.66 95.76 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.673 -1.232 . . . . 73.3 107.673 176.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -112.83 135.98 52.98 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.52 -0.919 . . . . 72.52 108.52 -174.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -111.59 107.3 16.41 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.882 0.873 . . . . 74.3 108.686 -176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 48.5 t -95.54 133.68 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.498 0.719 . . . . 74.45 109.828 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 35.4 t -112.33 120.8 63.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 123.533 0.733 . . . . 70.04 109.686 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.95 121.37 35.35 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 107.497 -1.297 . . . . 73.23 107.497 174.118 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -111.05 119.48 39.16 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.378 -0.601 . . . . 71.04 109.378 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -111.83 111.99 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.544 -0.91 . . . . 64.32 108.544 175.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 49.6 m -97.35 135.99 38.45 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.236 -0.653 . . . . 75.31 109.236 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.596 HG11 HD13 ' B' ' 126' ' ' LEU . 79.5 t -132.69 134.1 58.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 123.485 0.714 . . . . 63.22 109.247 177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 94.8 m -124.71 148.24 48.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 124.368 1.067 . . . . 74.23 108.167 173.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.45 148.49 32.32 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 122.803 0.441 . . . . 70.2 109.967 174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 m -138.23 124.01 19.9 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 123.837 0.711 . . . . 74.42 109.934 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' B' ' 34' ' ' LYS . 0.7 OUTLIER -104.45 119.36 38.79 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.127 -1.064 . . . . 73.44 108.127 -177.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.76 -112.08 3.41 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.024 -0.83 . . . . 72.02 111.024 -173.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -119.64 13.8 12.54 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.875 0.87 . . . . 51.11 110.949 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.36 167.41 22.98 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.667 0.787 . . . . 63.43 110.271 -170.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 10.3 m -62.09 134.46 56.62 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.663 0.602 . . . . 74.13 110.846 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -90.18 -57.68 2.76 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.911 -1.144 . . . . 73.11 107.911 174.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.437 ' CE1' HD11 ' B' ' 126' ' ' LEU . 52.5 p90 -160.92 169.08 23.33 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 113.697 -1.592 . . . . 73.23 109.779 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.2 mt -135.32 140.95 45.51 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 106.616 -1.624 . . . . 75.23 106.616 174.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -155.19 142.53 19.5 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.545 -0.539 . . . . 62.32 109.545 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -158.81 133.24 7.95 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 109.158 -0.682 . . . . 73.24 109.158 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.402 HG23 HG12 ' B' ' 114' ' ' ILE . 93.2 t -124.41 148.1 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.674 0.79 . . . . 51.13 109.342 -178.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -123.16 100.52 6.91 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.439 -0.949 . . . . 75.04 108.439 169.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -86.91 99.05 11.58 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.269 -1.011 . . . . 73.24 108.269 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.445 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.65 157.92 26.92 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.147 -0.781 . . . . 74.21 111.147 177.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.75 134.03 3.65 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 111.958 -0.457 . . . . 45.35 111.958 -177.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 43.6 mt -89.9 121.22 39.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 108.739 -0.837 . . . . 72.42 108.739 175.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -123.82 136.45 54.39 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.632 0.773 . . . . 74.3 110.091 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.0 m -99.26 108.37 20.91 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.606 1.162 . . . . 74.04 108.021 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.6 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -125.7 137.94 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.847 0.859 . . . . 71.23 108.825 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 132.26 10.17 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.16 -1.052 . . . . 60.22 108.16 176.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.6 11.36 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 119.385 -0.675 . . . . 54.03 113.744 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.605 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 27.2 pt -50.16 146.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 123.779 0.832 . . . . 73.01 111.989 -179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -150.71 156.27 40.98 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.043 0.757 . . . . 74.31 113.043 -167.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.66 -126.28 41.55 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.763 -1.562 . . . . 34.11 113.481 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.43 -38.09 42.19 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.57 0.748 . . . . 52.14 109.981 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -67.41 -21.95 65.55 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 114.634 -1.166 . . . . 73.35 110.839 -171.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.605 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 49.3 ttm -54.37 -49.23 70.32 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.275 1.03 . . . . 72.23 110.762 169.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.78 -34.39 69.4 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.445 -1.252 . . . . 74.33 111.761 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.447 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 69.2 m-70 -74.76 -18.85 60.42 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.522 0.329 . . . . 65.02 111.875 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -69.59 -56.15 8.1 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.404 0.621 . . . . 65.44 110.324 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.404 HD23 ' SG ' ' B' ' 102' ' ' CYS . 87.3 mt -86.97 -22.34 25.64 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.215 -0.902 . . . . 64.41 112.026 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.74 -15.7 41.94 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 113.897 0.319 . . . . 23.12 113.897 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -129.51 -55.83 1.15 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 117.101 0.45 . . . . 72.33 111.955 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -70.22 -49.29 51.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.006 0.522 . . . . 74.42 111.547 -175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.5 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 87.7 m -60.18 -50.79 84.43 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 118.568 -0.729 . . . . 75.21 112.505 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 51.5 Cg_exo -58.53 -31.55 94.64 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.25 1.967 . . . . 72.12 113.577 173.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -71.43 -27.41 63.27 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.621 0.369 . . . . 60.52 111.231 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.405 HG23 ' NH2' ' D' ' 111' ' ' ARG . 97.5 mt -70.25 -43.36 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 123.591 0.756 . . . . 74.14 109.714 170.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 82.4 mt -73.62 -17.71 61.13 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 115.047 -0.979 . . . . 71.44 111.529 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -60.35 -51.3 81.12 Favored Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.791 1.236 . . . . 71.05 113.886 -170.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.495 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 28.6 Cg_endo -60.29 -33.06 94.87 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.957 1.772 . . . . 75.45 113.047 178.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -69.13 -43.97 73.33 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.095 0.558 . . . . 75.22 111.038 178.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.69 98.38 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.268 0.627 . . . . 44.32 110.501 176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.495 ' HD3' ' HA ' ' B' ' 108' ' ' PRO . 29.7 mtp-105 -54.21 -57.73 10.07 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 124.503 1.121 . . . . 73.21 111.427 176.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -69.59 -26.56 64.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.414 -0.812 . . . . 75.44 110.287 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.1 t -68.76 -46.32 69.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.446 0.299 . . . . 65.13 110.44 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.402 HG12 HG23 ' B' ' 78' ' ' VAL . 69.3 mt -60.97 -48.03 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 C-N-CA 123.058 0.543 . . . . 73.41 109.585 176.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 25.1 m -55.15 -43.65 74.41 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.438 -1.256 . . . . 61.23 111.429 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.4 t -65.68 -45.02 84.45 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.648 -0.706 . . . . 51.35 110.838 -176.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -71.91 -35.96 69.86 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.038 0.535 . . . . 74.42 111.392 -175.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.618 HG22 ' HB2' ' B' ' 123' ' ' PHE . 9.1 p -75.35 -28.55 20.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 116.073 -0.512 . . . . 73.02 110.959 -177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.448 ' HA ' HE22 ' C' ' 125' ' ' GLN . 69.9 m -63.14 -35.64 80.95 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.437 0.695 . . . . 61.22 110.855 173.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.441 ' HG3' ' O ' ' B' ' 116' ' ' SER . 68.1 mtt-85 -69.57 -19.14 63.68 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 114.721 -1.127 . . . . 74.53 111.385 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.52 13.63 61.13 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-O 119.179 -0.789 . . . . 74.42 114.74 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 18.5 p 70.06 13.44 7.82 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 126.034 1.733 . . . . 71.12 113.038 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.618 ' HB2' HG22 ' B' ' 118' ' ' VAL . 73.2 m-85 -104.18 145.56 30.89 Favored Pre-proline 0 N--CA 1.475 0.812 0 CA-C-O 119.246 -0.407 . . . . 72.11 110.259 -177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -57.31 165.28 5.78 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.619 2.879 . . . . 53.12 113.825 -176.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -61.06 155.66 19.8 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.297 -0.865 . . . . 73.33 111.915 -176.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.596 HD13 HG11 ' B' ' 64' ' ' VAL . 87.6 mt -131.44 84.0 2.14 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.915 -0.772 . . . . 52.32 108.915 176.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.411 ' HB3' HH21 ' B' ' 111' ' ' ARG . 35.6 m-80 -106.65 100.36 9.88 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.788 -1.096 . . . . 74.11 108.376 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.58 133.88 53.21 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 115.169 -0.923 . . . . 63.03 109.312 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.54 150.13 94.19 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.074 0.55 . . . . 63.53 110.808 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -57.48 96.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.043 2.496 . . . . 73.0 112.565 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.8 m -89.43 117.56 33.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.567 -0.901 . . . . 43.22 108.567 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -78.15 97.63 5.54 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 107.024 -1.472 . . . . 73.12 107.024 170.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 19.2 m-85 -55.82 -30.2 61.01 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.135 0.974 . . . . 71.34 110.664 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -62.11 -36.45 81.79 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 114.614 -1.175 . . . . 72.34 111.076 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.14 -51.87 64.75 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.579 0.752 . . . . 71.13 111.127 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.91 -32.74 74.59 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.731 0.644 . . . . 65.35 110.118 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 0.2 OUTLIER -62.91 -45.02 94.48 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.532 0.733 . . . . 74.32 109.18 175.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.0 mmt -66.91 -28.59 68.43 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.759 0.823 . . . . 73.24 111.079 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -72.54 -38.58 67.98 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.194 0.598 . . . . 72.34 110.54 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -66.65 -25.43 66.57 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 115.351 -0.84 . . . . 74.24 110.655 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 49.2 mt -105.77 18.61 21.89 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.375 0.67 . . . . 64.32 111.54 -176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.13 74.74 0.68 Allowed 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.982 0.896 . . . . 73.51 110.265 178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -151.63 145.22 24.93 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.295 1.438 . . . . 75.32 108.291 -177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -156.73 140.24 15.85 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.55 0.74 . . . . 73.51 109.335 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.31 -48.52 0.06 Allowed 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.43 0.692 . . . . 45.11 110.264 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 73.54 -167.49 54.33 Favored Glycine 0 C--N 1.346 1.12 0 CA-C-N 115.421 -0.809 . . . . 75.43 112.668 -175.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.37 162.09 24.8 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.743 0.817 . . . . 70.23 109.415 174.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 114.93 14.09 8.81 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.005 -0.543 . . . . 44.55 111.785 -177.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 28.1 m -65.07 116.49 6.53 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.844 0.858 . . . . 75.03 110.191 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -151.58 133.28 14.84 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.965 0.906 . . . . 62.51 109.273 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -156.58 167.75 29.48 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.718 -0.845 . . . . 64.2 108.718 -177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 72.2 t60 75.68 136.26 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 124.954 1.302 . . . . 75.1 111.967 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -121.28 140.16 52.44 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.249 1.019 . . . . 74.4 109.182 172.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.72 174.34 8.9 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.89 0.476 . . . . 72.12 109.867 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 N-CA-C 109.103 -0.703 . . . . 65.52 109.103 178.394 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtm . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.106 -0.701 . . . . 75.42 109.106 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.401 ' HB3' ' HB1' ' F' ' 122' ' ' ALA . 21.6 p -105.23 104.03 13.68 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.819 0.847 . . . . 65.15 110.451 -178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -101.31 13.92 33.57 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.516 0.726 . . . . 62.53 111.193 177.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -79.19 73.55 5.77 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.842 -0.799 . . . . 74.42 108.842 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -100.43 103.16 14.51 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.909 0.883 . . . . 75.32 109.356 -175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -141.13 -30.28 0.63 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.764 0.826 . . . . 75.34 110.316 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m 71.04 -74.27 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.364 1.466 . . . . 72.01 110.999 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 64.79 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 125.263 1.425 . . . . 74.25 111.154 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.3 ttm 66.01 123.93 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.793 1.237 . . . . 73.01 111.441 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -85.56 87.34 7.38 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.146 -1.057 . . . . 34.24 108.146 173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -105.58 136.41 45.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 114.874 -1.057 . . . . 72.53 109.19 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -152.92 132.83 13.28 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.246 0.618 . . . . 74.23 109.705 173.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.55 105.72 11.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 108.157 -1.053 . . . . 65.3 108.157 173.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.7 mm-40 -78.92 -41.58 29.18 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.893 -0.594 . . . . 64.1 110.11 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.438 ' HA ' HD21 ' A' ' 127' ' ' ASN . 23.2 ttt85 -170.79 157.17 5.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.668 0.605 . . . . 74.23 110.996 175.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 70.8 mt -128.51 145.92 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 107.194 -1.41 . . . . 70.44 107.194 172.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -173.86 162.25 3.92 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.648 0.737 . . . . 73.14 109.866 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 67.0 p -80.14 111.76 16.81 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.868 -1.06 . . . . 63.43 108.249 173.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -65.86 -45.75 81.0 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 108.098 -1.075 . . . . 74.33 108.098 170.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.2 t70 -140.37 140.99 35.65 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 113.57 -1.65 . . . . 72.15 109.697 -175.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 97.3 mt -131.46 145.58 34.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 106.907 -1.516 . . . . 72.54 106.907 170.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.6 t -153.82 146.63 24.34 Favored 'General case' 0 C--O 1.242 0.678 0 CA-C-O 121.338 0.59 . . . . 71.21 109.602 173.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -146.25 144.02 29.59 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.555 -1.276 . . . . 71.12 107.555 170.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -138.48 144.95 40.27 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.674 1.189 . . . . 73.23 107.835 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.508 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -150.6 80.04 7.02 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 106.683 -1.599 . . . . 63.34 106.683 175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -67.73 -37.11 16.96 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 122.578 2.185 . . . . 63.11 111.349 -177.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.53 ' ND2' ' HG3' ' C' ' 71' ' ' GLU . 1.7 m-20 -107.93 27.65 9.02 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.472 1.109 . . . . 72.22 109.439 -174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.508 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -50.17 -51.88 58.7 Favored Pre-proline 0 CA--C 1.561 1.386 0 C-N-CA 124.888 1.275 . . . . 53.01 113.889 -174.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 66.3 Cg_endo -86.57 -19.21 2.91 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 121.67 1.58 . . . . 64.25 113.321 175.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 47.1 m170 -68.18 -21.64 64.88 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.983 0.913 . . . . 71.41 112.553 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 6.9 p -74.61 -5.49 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.902 0 C-N-CA 123.343 0.657 . . . . 74.25 112.506 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.573 ' HZ ' ' HD2' ' D' ' 15' ' ' ARG . 19.8 m-85 -67.42 -27.7 67.28 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 123.349 0.66 . . . . 65.23 112.451 177.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.69 29.0 7.34 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.485 0.714 . . . . 62.05 109.368 176.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.8 155.33 41.25 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.299 0.64 . . . . 72.4 111.253 -175.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -72.71 129.99 39.48 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.385 -1.279 . . . . 73.33 110.572 173.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.456 ' CD1' ' HB3' ' E' ' 137' ' ' GLU . 32.0 p90 -84.53 65.65 9.09 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 122.19 0.995 . . . . 74.22 111.933 -176.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -151.54 60.42 3.75 Favored Pre-proline 0 CA--C 1.551 1.005 0 CA-C-N 115.564 -0.744 . . . . 73.44 110.673 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HG ' ' E' ' 139' ' ' LEU . 14.8 Cg_exo -67.38 153.92 75.43 Favored 'Trans proline' 0 C--N 1.384 2.429 0 C-N-CA 122.21 1.94 . . . . 72.23 110.498 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.72 109.15 17.83 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 106.828 -1.545 . . . . 71.01 106.828 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.424 HG13 HD11 ' C' ' 126' ' ' LEU . 77.8 t -75.25 106.36 4.95 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.891 -1.05 . . . . 70.11 110.646 -174.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.727 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 6.4 mtpm? -103.35 143.88 32.09 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.272 1.029 . . . . 61.33 108.323 176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.5 pp -128.87 164.05 23.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 122.79 0.436 . . . . 73.4 110.896 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.41 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 24.0 t70 -154.29 125.91 7.56 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.428 -0.805 . . . . 71.52 108.991 175.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -115.4 112.07 21.77 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 107.646 -1.242 . . . . 75.33 107.646 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -126.68 119.98 28.33 Favored 'General case' 0 C--O 1.219 -0.521 0 N-CA-C 107.609 -1.256 . . . . 71.2 107.609 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.3 t -118.42 150.42 39.59 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.389 -0.597 . . . . 71.11 109.389 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.09 171.96 13.35 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.017 0.927 . . . . 71.23 109.13 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 64.1 p -146.83 143.39 28.56 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.843 -0.799 . . . . 61.55 108.843 176.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.7 t -145.0 126.39 14.9 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.307 -0.997 . . . . 42.33 108.307 -175.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -80.1 117.33 20.81 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.525 -0.546 . . . . 73.52 109.525 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' C' ' 57' ' ' GLU . 69.9 mt -86.73 -45.5 10.89 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.684 0.793 . . . . 55.05 110.087 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.79 -165.15 2.19 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.66 -0.7 . . . . 62.42 111.132 -173.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -61.13 102.03 0.19 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 124.1 0.875 . . . . 60.22 110.966 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 63.72 18.5 11.17 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.154 0.982 . . . . 73.54 111.884 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -106.96 114.22 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 108.27 -1.011 . . . . 73.24 108.27 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -122.0 124.82 44.89 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.151 0.98 . . . . 54.4 108.891 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.616 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.8 tt0 -89.59 114.99 26.66 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.177 0.991 . . . . 75.32 109.245 173.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.3 t -95.86 129.47 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 108.089 -1.078 . . . . 73.52 108.089 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.2 t -120.64 106.53 18.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.667 -0.864 . . . . 65.12 108.667 -175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.9 102.41 14.99 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.473 -0.936 . . . . 64.53 108.473 176.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.407 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 33.3 ttm105 -79.51 107.3 12.18 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.587 -0.894 . . . . 74.13 108.587 168.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 9.6 t -99.96 124.28 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 107.137 -1.431 . . . . 60.44 107.137 169.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 18.9 m -123.74 119.59 30.2 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.785 -0.821 . . . . 73.33 108.785 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 77.7 t -111.01 129.41 66.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.739 -1.119 . . . . 64.54 108.626 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.727 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 8.5 m -122.69 138.17 54.69 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.722 0.809 . . . . 71.42 109.164 -173.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.62 100.88 6.41 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.281 -1.377 . . . . 72.02 107.281 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 18.5 p -140.63 118.21 11.57 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.827 -0.805 . . . . 63.32 108.827 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 59.0 tp -59.26 -40.18 85.22 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.32 0.648 . . . . 75.44 110.238 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.12 -79.19 0.05 OUTLIER Glycine 0 C--N 1.34 0.771 0 N-CA-C 110.482 -1.047 . . . . 75.52 110.482 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -90.0 -32.01 16.95 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.727 0.811 . . . . 60.21 109.434 175.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.53 ' HG3' ' ND2' ' C' ' 27' ' ' ASN . 40.8 tt0 -88.69 121.32 30.94 Favored 'General case' 0 C--O 1.242 0.676 0 C-N-CA 124.194 0.997 . . . . 73.1 111.096 -178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 89.6 m -84.23 126.71 33.41 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 122.999 0.52 . . . . 72.15 110.107 169.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.93 -55.21 5.83 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.817 0.847 . . . . 72.32 109.105 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -158.57 165.44 34.49 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.581 -1.19 . . . . 74.13 110.84 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.474 HD23 HG23 ' C' ' 65' ' ' THR . 3.0 tm? -135.05 144.92 47.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.271 -1.381 . . . . 54.13 107.271 174.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.409 ' N ' HD13 ' C' ' 75' ' ' LEU . 43.6 t -144.8 143.96 30.91 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 109.158 -0.682 . . . . 72.1 109.158 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -153.17 134.18 14.02 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.143 0.577 . . . . 73.24 109.507 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.413 HG11 ' HA ' ' C' ' 110' ' ' ALA . 39.8 t -133.09 113.55 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.236 1.014 . . . . 72.43 108.444 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -92.73 90.6 7.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.914 0.885 . . . . 55.21 108.73 174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.3 tp-100 -82.97 105.97 14.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.081 -0.963 . . . . 72.52 109.897 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.11 147.54 18.63 Favored Glycine 0 C--N 1.335 0.478 0 N-CA-C 111.79 -0.524 . . . . 64.21 111.79 176.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.555 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.63 123.46 2.16 Favored Glycine 0 CA--C 1.501 -0.804 0 N-CA-C 110.759 -0.937 . . . . 70.42 110.759 -179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.419 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.2 mm -80.65 118.51 28.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.931 -1.137 . . . . 72.24 107.931 177.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -132.75 130.8 40.43 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.468 0.707 . . . . 73.4 109.534 -176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 41.2 m -81.49 115.55 20.86 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 109.053 -0.721 . . . . 50.11 109.053 171.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.657 HG13 HD21 ' C' ' 98' ' ' LEU . 27.3 mm -116.73 100.89 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.404 -0.961 . . . . 71.23 108.404 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.92 168.45 19.55 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.323 0.649 . . . . 54.15 110.179 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.29 -56.27 4.25 Favored Glycine 0 C--N 1.346 1.106 0 CA-C-N 116.028 -0.533 . . . . 70.43 112.354 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 9.0 tp -104.01 163.08 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 123.826 0.85 . . . . 62.14 109.472 -178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -147.8 -177.12 5.55 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.729 0.412 . . . . 71.01 111.543 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.42 -144.76 48.9 Favored Glycine 0 C--N 1.35 1.361 0 CA-C-N 115.485 -0.78 . . . . 53.43 114.818 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 43.7 p -68.67 -19.89 64.42 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.65 0.78 . . . . 73.31 111.863 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -67.02 -41.66 86.25 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.231 1.012 . . . . 74.3 110.305 176.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 20.0 ptt? -83.14 -23.21 33.08 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 116.247 -0.433 . . . . 75.13 110.366 175.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -71.45 -25.8 62.46 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.096 0.559 . . . . 52.21 111.256 178.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.469 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 29.5 t-80 -63.58 -30.59 71.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.796 0.438 . . . . 64.44 110.221 170.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.559 ' HG ' ' HG ' ' C' ' 102' ' ' CYS . 17.6 t -76.61 -60.36 2.38 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 109.202 -0.666 . . . . 62.35 109.202 175.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.657 HD21 HG13 ' C' ' 86' ' ' ILE . 98.6 mt -60.72 -26.83 67.45 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.062 0.945 . . . . 43.05 113.065 -174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.19 10.86 33.85 Favored Glycine 0 C--N 1.346 1.097 0 CA-C-O 119.545 -0.586 . . . . 64.32 113.902 -176.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -155.05 -60.64 0.11 Allowed 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.584 0.692 . . . . 73.44 111.698 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' C' ' 104' ' ' ASN . 65.1 t80 -75.13 -42.47 56.21 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.877 0.695 . . . . 74.33 112.877 -170.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.559 ' HG ' ' HG ' ' C' ' 97' ' ' CYS . 63.3 m -66.44 -49.39 52.83 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.207 0.603 . . . . 55.24 111.708 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.46 -18.25 43.68 Favored 'Trans proline' 0 C--N 1.391 2.784 0 C-N-CA 121.594 1.529 . . . . 73.24 113.265 173.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' C' ' 101' ' ' TYR . 27.1 t-20 -57.13 -41.75 79.65 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.549 0.69 . . . . 72.32 109.92 171.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 32.4 mm -69.45 -38.58 77.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.858 0 CA-C-N 114.141 -1.391 . . . . 64.14 110.875 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.555 HD21 ' HA3' ' C' ' 82' ' ' GLY . 90.5 mt -81.29 -34.25 32.09 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.193 -0.912 . . . . 72.13 112.369 -170.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -54.66 -45.73 99.48 Favored Pre-proline 0 CA--C 1.562 1.413 0 C-N-CA 124.299 1.04 . . . . 74.0 113.527 -174.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -45.71 -52.03 7.4 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 122.795 2.33 . . . . 72.11 113.686 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -63.91 -48.71 75.54 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.357 -0.838 . . . . 74.13 111.732 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.52 -41.23 96.51 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.085 0.554 . . . . 72.51 111.735 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -64.16 -44.53 91.82 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 124.2 0.937 . . . . 62.42 110.592 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -70.65 -31.87 68.95 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.522 -0.763 . . . . 63.52 110.188 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.7 t -66.8 -34.2 77.29 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.093 0.557 . . . . 65.3 110.436 176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.09 -42.21 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.369 0.668 . . . . 73.52 110.379 174.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 81.6 m -62.2 -30.93 71.42 Favored 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 123.004 0.522 . . . . 64.03 110.284 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.4 t -70.86 -54.18 12.48 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.634 0.773 . . . . 73.22 109.912 174.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.553 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.48 -45.93 66.35 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 124.482 1.113 . . . . 73.02 112.385 179.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.01 -42.33 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.907 0.883 . . . . 70.32 110.834 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -64.21 -32.53 74.14 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.933 -0.576 . . . . 74.2 111.02 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 79.3 mtt-85 -70.49 -35.46 73.25 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 115.387 -0.824 . . . . 63.52 109.696 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.98 2.76 67.83 Favored Glycine 0 C--N 1.352 1.461 0 O-C-N 123.683 0.614 . . . . 72.53 113.188 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 69.7 p 54.38 48.12 21.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.088 1.755 . . . . 75.44 112.184 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.416 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 90.9 m-85 -115.02 149.29 42.27 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 114.083 -1.417 . . . . 72.24 108.091 169.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -55.5 154.98 22.52 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 123.654 2.902 . . . . 60.51 113.844 177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.448 HE22 ' HA ' ' B' ' 119' ' ' SER . 87.8 mt-30 -58.11 150.44 21.18 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.893 0.877 . . . . 74.11 112.753 -173.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.424 HD11 HG13 ' C' ' 40' ' ' VAL . 1.9 tt -145.47 85.97 1.73 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.298 -1.371 . . . . 64.02 107.298 174.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -91.05 108.29 19.77 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.834 -1.076 . . . . 62.05 108.349 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.65 130.41 46.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 124.294 1.038 . . . . 74.22 109.964 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.32 137.17 97.04 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 123.677 0.791 . . . . 72.52 111.685 -175.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.433 ' HG2' HD21 ' E' ' 147' ' ' LEU . 35.9 Cg_endo -65.68 122.64 10.32 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 122.747 2.298 . . . . 75.53 112.04 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -98.86 109.86 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.137 -1.06 . . . . 44.24 108.137 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.678 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 4.0 m-20 -87.2 63.62 7.92 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.978 0.911 . . . . 75.25 109.579 -177.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -77.13 -43.95 32.21 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 116.021 -0.536 . . . . 72.23 110.582 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -61.41 -39.32 90.3 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.829 0.851 . . . . 51.4 110.457 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.678 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -69.62 -31.22 69.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.533 -1.212 . . . . 64.43 111.455 178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 47.7 tp -59.67 -31.04 69.19 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.541 1.136 . . . . 54.42 112.282 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -68.44 -43.16 77.67 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.845 0.458 . . . . 74.33 110.464 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 68.5 mtm -77.73 -41.71 36.79 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 123.622 0.769 . . . . 72.1 112.014 -174.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -71.83 -36.13 70.1 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.571 0.748 . . . . 75.45 111.657 -175.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -68.35 -88.91 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 118.154 -0.927 . . . . 75.43 109.217 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tt 25.34 -97.36 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 126.941 2.096 . . . . 74.3 111.973 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 164.82 124.37 0.01 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.126 2.57 . . . . 75.31 105.9 171.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -132.19 126.16 32.91 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.338 -1.356 . . . . 64.33 107.338 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -167.74 106.29 0.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.303 0.641 . . . . 72.14 109.583 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -166.35 160.95 16.22 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.961 0.904 . . . . 72.43 109.364 176.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.75 174.64 20.97 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.711 -0.556 . . . . 75.15 111.711 179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -151.48 -39.86 0.12 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.566 0.746 . . . . 64.32 109.423 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 119.99 -150.13 17.65 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 114.915 -1.039 . . . . 65.33 110.892 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 96.2 m -149.03 129.78 14.15 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.816 0.846 . . . . 71.0 109.134 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -69.03 104.01 2.0 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.888 -1.153 . . . . 71.02 107.888 169.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.86 126.15 26.69 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.157 0.983 . . . . 74.44 111.703 -172.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -132.61 60.56 1.69 Allowed 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.217 1.007 . . . . 62.44 108.594 174.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -120.6 101.53 7.81 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.992 -1.004 . . . . 71.33 109.752 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -77.4 135.91 38.36 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.34 -0.615 . . . . 54.43 109.34 173.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 C-N-CA 123.688 0.795 . . . . 72.05 109.217 179.494 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.8 mmt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.764 -0.458 . . . . 70.44 109.764 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 74.0 m -76.54 81.82 3.22 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.783 0.802 . . . . 70.23 109.75 173.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -96.52 51.27 1.17 Allowed 'General case' 0 C--O 1.242 0.684 0 CA-C-N 114.369 -1.287 . . . . 73.32 108.533 177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -60.03 105.64 0.42 Allowed 'General case' 0 C--N 1.348 0.535 0 CA-C-N 114.269 -1.332 . . . . 72.32 110.462 -174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -62.21 145.86 52.39 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.393 -0.821 . . . . 75.15 109.246 175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.9 t-20 -60.42 -63.33 1.34 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.519 -0.919 . . . . 75.33 108.519 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 2.5 m 64.99 178.4 0.19 Allowed 'General case' 0 CA--C 1.564 1.514 0 C-N-CA 124.121 0.968 . . . . 71.42 110.372 177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -75.13 143.85 43.11 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 121.108 -0.995 . . . . 75.23 109.725 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.552 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm -31.88 128.26 0.2 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 125.497 1.519 . . . . 73.22 113.33 177.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 27.4 m -132.88 139.56 47.47 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.152 -1.055 . . . . 62.34 108.152 177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.419 ' HA ' ' O ' ' D' ' 85' ' ' SER . 45.3 t80 -159.07 98.06 1.43 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 124.01 0.819 . . . . 72.31 108.792 -176.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.21 115.39 24.11 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.61 0.764 . . . . 71.52 109.618 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' D' ' 84' ' ' PHE . 3.9 tp -77.61 104.38 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 N-CA-C 108.408 -0.96 . . . . 70.32 108.408 171.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -84.62 -39.13 19.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.11 -0.95 . . . . 64.11 111.833 -170.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.573 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 65.2 ttt180 -165.41 127.5 2.07 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.587 -0.279 . . . . 71.41 110.354 -166.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.508 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.4 mp -112.65 129.1 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.323 -1.362 . . . . 73.22 107.323 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -165.49 176.91 7.81 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-O 122.176 0.989 . . . . 74.14 113.117 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.8 p -108.32 119.36 39.26 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 114.02 -1.446 . . . . 65.13 108.36 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.41 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 39.7 mtpt -86.94 -17.94 31.94 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.32 -0.622 . . . . 73.44 109.32 173.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.769 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 22.5 t70 -155.7 140.24 16.89 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.009 0.924 . . . . 75.24 109.817 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.553 HD13 ' HE3' ' C' ' 117' ' ' MET . 58.5 mt -139.92 140.02 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.548 1.539 . . . . 75.33 107.786 177.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 28.3 t -143.84 136.84 27.49 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.457 0.703 . . . . 63.43 109.473 175.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.591 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.8 t80 -142.8 116.9 9.46 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 105.98 -1.859 . . . . 71.44 105.98 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.429 ' O ' ' HD3' ' D' ' 26' ' ' PRO . 44.7 mt-10 -127.32 116.27 20.27 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.108 -0.701 . . . . 72.22 109.108 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.748 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -107.47 88.79 4.37 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 123.313 0.645 . . . . 75.34 109.559 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' D' ' 24' ' ' GLU . 16.6 Cg_exo -71.01 -38.7 4.78 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 123.222 2.615 . . . . 64.11 112.49 -173.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.454 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 85.3 m-20 -118.24 40.86 3.08 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.221 1.008 . . . . 51.1 110.035 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.748 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -54.84 -57.8 17.56 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 114.976 1.473 . . . . 73.4 114.976 -169.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -83.53 -3.83 10.76 Favored 'Trans proline' 0 C--N 1.385 2.458 0 CA-C-N 121.619 1.614 . . . . 65.44 112.266 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -83.98 -45.03 13.57 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.06 1.344 . . . . 74.31 109.804 -179.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 12.7 p -80.97 -19.74 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.734 0.814 . . . . 73.41 110.312 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -60.5 -23.86 64.85 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.309 1.043 . . . . 75.24 111.791 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -79.61 -3.24 46.2 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.503 0.721 . . . . 73.12 111.769 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -121.59 110.02 15.49 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 123.635 0.774 . . . . 65.4 110.082 -176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.61 93.52 4.86 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.851 0.861 . . . . 73.41 109.744 175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 49.7 t-105 -169.05 158.37 8.48 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.45 1.1 . . . . 75.23 108.49 171.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' F' ' 139' ' ' LEU . 1.8 mp0 -76.49 111.93 18.56 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 123.825 0.85 . . . . 70.01 110.033 174.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.438 ' HD2' HD13 ' F' ' 139' ' ' LEU . 84.5 Cg_exo -52.64 128.1 26.93 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.048 2.498 . . . . 63.45 112.599 173.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -67.43 118.74 11.17 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 109.165 -0.679 . . . . 75.14 109.165 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.516 HG11 HD11 ' D' ' 126' ' ' LEU . 98.8 t -99.36 133.46 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 115.223 -0.899 . . . . 65.3 110.819 -172.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -101.8 142.79 32.57 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.422 -0.955 . . . . 71.42 108.422 166.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -114.31 126.03 54.55 Favored 'General case' 0 C--O 1.241 0.611 0 N-CA-C 108.721 -0.844 . . . . 72.42 108.721 178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 22.7 t70 -121.94 149.22 43.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.449 1.1 . . . . 74.11 108.142 176.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.4 pp -128.16 151.39 49.28 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.863 0.465 . . . . 64.52 110.855 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.636 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 16.1 t70 -155.83 155.6 33.25 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.178 0.991 . . . . 73.3 108.82 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -133.45 160.03 38.62 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.278 0.631 . . . . 72.23 109.67 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 164.51 37.31 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.682 -0.858 . . . . 62.32 108.682 174.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 63.8 m -148.36 159.84 43.61 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 120.964 0.411 . . . . 62.31 111.136 -177.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.5 t -160.86 126.71 3.88 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.33 1.052 . . . . 72.03 109.785 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -87.51 120.34 28.71 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.859 -0.793 . . . . 73.2 108.859 171.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.416 HD11 ' HB2' ' D' ' 57' ' ' GLU . 41.9 mt -91.95 -40.96 10.84 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.766 -0.652 . . . . 72.54 110.182 -177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.59 -168.74 1.9 Allowed 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.508 -0.769 . . . . 73.4 110.433 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.44 115.81 3.84 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 114.97 -1.013 . . . . 72.13 110.275 175.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 65.74 5.24 3.25 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.622 1.169 . . . . 64.24 112.318 175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.5 t -108.93 120.23 59.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.976 0 N-CA-C 107.531 -1.285 . . . . 74.02 107.531 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -131.47 161.79 31.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.333 -0.849 . . . . 64.22 108.96 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.416 ' HB2' HD11 ' D' ' 51' ' ' LEU . 6.6 tm-20 -132.43 136.92 47.08 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 107.085 -1.45 . . . . 63.54 107.085 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.35 134.8 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.748 -0.834 . . . . 73.52 108.748 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.5 t -107.48 128.18 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 123.752 0.821 . . . . 53.1 109.575 -176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -102.08 121.99 43.25 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.394 -1.336 . . . . 63.52 107.394 169.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.636 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 9.9 ttm180 -104.36 108.42 19.82 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 108.33 -0.989 . . . . 63.4 108.33 171.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.9 t -95.2 127.73 46.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 107.715 -1.217 . . . . 43.03 107.715 166.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.5 m -118.27 127.13 53.43 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.773 0.797 . . . . 53.54 109.846 177.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 53.7 t -115.01 114.29 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 125.879 1.671 . . . . 60.44 108.245 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 15.8 m -112.19 97.8 6.89 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.525 -0.917 . . . . 51.24 108.525 178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.19 129.91 43.38 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 109.046 -0.724 . . . . 70.01 109.046 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.472 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 34.9 p -145.49 128.79 16.8 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 109.125 -0.695 . . . . 72.33 109.125 -175.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 27.2 tp -123.23 123.91 41.83 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.476 -0.935 . . . . 54.14 108.476 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.5 -116.0 4.57 Favored Glycine 0 C--N 1.34 0.785 0 O-C-N 123.516 0.51 . . . . 72.13 112.494 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -123.44 26.5 7.84 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.023 0.529 . . . . 64.33 110.464 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.454 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.0 pt-20 -137.69 155.19 49.39 Favored 'General case' 0 C--O 1.246 0.92 0 C-N-CA 123.64 0.776 . . . . 74.25 110.053 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 89.3 m -78.7 117.12 19.54 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 109.696 -0.483 . . . . 72.55 109.696 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -68.39 -61.55 1.79 Allowed 'General case' 0 C--O 1.239 0.534 0 C-N-CA 123.589 0.755 . . . . 61.42 110.025 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -162.1 170.01 19.93 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.658 -1.156 . . . . 61.52 109.819 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 80.0 mt -126.74 145.54 50.56 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.385 1.074 . . . . 74.4 108.721 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.51 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 1.8 m -143.07 136.06 27.95 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.689 -1.226 . . . . 70.03 107.689 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -156.74 121.01 4.4 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.531 -0.914 . . . . 74.24 108.531 174.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.1 t -130.76 117.82 39.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 C-N-CA 122.988 0.515 . . . . 52.55 109.635 -176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.769 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.8 mt-30 -89.74 87.46 7.0 Favored 'General case' 0 C--O 1.239 0.544 0 O-C-N 124.057 0.848 . . . . 73.13 109.079 170.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -79.5 98.57 6.88 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.393 -1.276 . . . . 70.43 109.171 177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.25 144.3 17.06 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 116.437 -0.347 . . . . 63.4 112.292 178.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -146.91 135.76 5.86 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.999 -0.441 . . . . 43.1 111.999 -174.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 55.9 mt -92.18 128.48 43.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 123.717 0.807 . . . . 71.01 109.877 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.489 ' CE2' HD13 ' D' ' 13' ' ' ILE . 63.4 m-85 -130.23 137.05 49.84 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.7 0.8 . . . . 74.0 109.811 175.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.419 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 18.6 m -77.73 103.68 7.81 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.144 -1.058 . . . . 72.23 108.144 168.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 62.6 mt -107.43 106.65 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 N-CA-C 108.72 -0.844 . . . . 74.04 108.72 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -148.65 167.83 24.45 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.289 1.036 . . . . 72.5 109.628 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.14 6.08 67.72 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 116.49 -0.323 . . . . 71.32 113.799 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 tp -141.08 143.73 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.83 0.852 . . . . 54.21 109.444 -177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.81 -172.05 4.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.107 0.563 . . . . 73.23 110.818 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.67 -138.82 22.85 Favored Glycine 0 C--N 1.348 1.196 0 O-C-N 123.52 0.513 . . . . 64.21 113.382 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -83.86 -24.2 30.99 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.509 0.724 . . . . 70.41 111.001 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -70.69 -32.97 70.39 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.11 0.564 . . . . 72.51 111.846 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.3 -30.35 67.31 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 110.161 -0.311 . . . . 75.14 110.161 175.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.61 -36.88 68.2 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.535 0.734 . . . . 74.34 110.405 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -65.2 -36.74 85.13 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.353 -0.84 . . . . 72.53 110.613 173.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 47.9 t -69.1 -47.29 65.57 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.995 -0.548 . . . . 63.34 110.022 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -73.15 -27.48 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.621 0.768 . . . . 74.45 111.452 -175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.34 5.06 33.38 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-O 119.361 -0.688 . . . . 70.12 114.526 -172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -147.46 -58.29 0.26 Allowed 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 117.88 0.84 . . . . 62.15 111.534 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -70.92 -54.41 11.5 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.141 0.576 . . . . 71.33 112.17 -170.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.445 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 66.2 m -62.11 -46.13 91.26 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 123.852 0.861 . . . . 73.14 112.072 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.529 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 69.6 Cg_exo -57.24 -36.05 98.97 Favored 'Trans proline' 0 C--N 1.396 3.058 0 C-N-CA 122.409 2.073 . . . . 64.23 113.436 169.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -62.66 -34.74 77.71 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 122.95 0.5 . . . . 75.41 111.187 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 71.0 mt -66.75 -40.22 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.007 0.923 . . . . 74.13 110.616 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' D' ' 82' ' ' GLY . 87.3 mt -74.51 -21.49 59.52 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.702 -0.681 . . . . 71.44 111.548 -176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -62.68 -46.0 88.5 Favored Pre-proline 0 CA--C 1.561 1.403 0 N-CA-C 114.143 1.164 . . . . 73.21 114.143 -171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -51.95 -38.22 68.61 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 122.056 1.837 . . . . 70.24 113.227 173.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -79.31 -34.71 42.07 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.099 0.96 . . . . 74.04 111.618 -178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -48.63 73.28 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.359 0.664 . . . . 71.11 109.862 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.405 ' NH2' HG23 ' B' ' 105' ' ' ILE . 41.5 ttp180 -57.54 -45.44 85.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 114.365 -1.289 . . . . 74.23 110.749 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -61.45 -46.5 89.8 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 124.097 0.873 . . . . 72.42 111.109 -177.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.33 -41.7 85.19 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.719 0.637 . . . . 44.11 111.353 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.416 HG21 HG21 ' D' ' 64' ' ' VAL . 90.4 mt -63.14 -56.12 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 115.214 -0.903 . . . . 63.1 110.372 175.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 42.4 m -53.43 -39.03 64.06 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.582 1.153 . . . . 72.52 112.046 -175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -71.78 -41.05 68.81 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.422 -0.808 . . . . 65.21 110.813 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.29 -31.59 72.8 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 122.71 0.404 . . . . 74.33 111.408 176.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.416 HG23 ' O ' ' D' ' 114' ' ' ILE . 78.2 t -68.23 -42.35 84.58 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.79 0.836 . . . . 62.54 110.252 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.481 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 72.8 p -74.18 -26.4 60.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.36 0.264 . . . . 62.11 111.25 178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -75.63 -29.69 59.25 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.548 0.739 . . . . 74.41 110.049 173.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.34 2.96 87.5 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.645 -0.707 . . . . 74.53 112.051 171.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 14.7 p 63.84 18.01 10.89 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.094 2.158 . . . . 63.11 114.267 172.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.468 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 59.6 m-85 -87.65 166.2 26.21 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 124.847 1.259 . . . . 73.13 109.948 174.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 56.5 Cg_endo -68.13 134.17 30.88 Favored 'Trans proline' 0 C--N 1.383 2.364 0 C-N-CA 122.142 1.895 . . . . 75.24 111.143 -178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.37 143.47 34.31 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.201 0.6 . . . . 63.13 110.534 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.516 HD11 HG11 ' D' ' 40' ' ' VAL . 4.4 tt -110.5 111.62 22.99 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.282 -1.007 . . . . 74.31 108.282 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -98.96 87.11 3.63 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 107.658 -1.238 . . . . 73.32 107.658 175.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tt -66.16 117.1 7.98 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.109 -0.95 . . . . 71.21 108.647 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -53.84 136.57 55.62 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.89 0.876 . . . . 61.43 111.568 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 13.6 Cg_exo -68.91 122.59 9.5 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.222 1.948 . . . . 71.31 110.446 176.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.82 144.82 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.171 0.588 . . . . 73.3 109.415 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -74.3 94.68 2.54 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.467 -0.938 . . . . 62.44 108.467 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -61.84 -30.23 70.7 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.343 -0.844 . . . . 73.0 111.649 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -64.77 -50.52 66.49 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.777 0.831 . . . . 74.23 110.417 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.23 76.62 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.402 0.681 . . . . 61.3 111.93 -179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -74.42 -37.12 63.43 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 115.393 -0.822 . . . . 72.41 109.588 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -69.26 -30.44 68.57 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.756 0.822 . . . . 70.33 110.967 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 43.0 mtt -63.42 -32.73 74.25 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.501 0.72 . . . . 71.54 110.776 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.459 ' HA ' HE21 ' D' ' 142' ' ' GLN . 5.9 t30 -67.88 -38.32 82.9 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.158 0.583 . . . . 74.41 110.329 174.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -60.94 -39.61 90.15 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.152 0.981 . . . . 75.42 111.558 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.98 -29.64 70.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.393 0.677 . . . . 70.52 111.617 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.459 HE21 ' HA ' ' D' ' 139' ' ' ASN . 47.6 mt-30 -83.2 6.92 17.74 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.804 0.842 . . . . 73.04 111.87 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -120.6 90.9 3.41 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.964 0.905 . . . . 73.32 109.268 -177.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -142.53 153.89 43.99 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.959 1.304 . . . . 65.51 108.587 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.57 146.49 25.25 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.702 0.401 . . . . 72.03 110.859 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.22 113.15 4.17 Favored Glycine 0 C--N 1.347 1.145 0 N-CA-C 111.221 -0.752 . . . . 42.13 111.221 174.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -121.73 108.21 13.25 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.448 0.699 . . . . 72.53 110.685 -174.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.92 139.46 25.22 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 111.013 -0.835 . . . . 70.14 111.013 169.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 43.2 p -99.85 -58.46 1.91 Allowed 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 117.65 0.725 . . . . 55.51 109.967 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 58.63 97.83 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.761 1.224 . . . . 75.1 110.373 -173.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -127.32 161.79 27.78 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.509 0.724 . . . . 75.14 110.784 -169.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -92.47 157.3 16.64 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.487 1.115 . . . . 72.33 109.397 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -101.54 -101.12 0.26 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 109.284 -0.636 . . . . 72.11 109.284 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -158.07 13.84 0.21 Allowed 'General case' 0 N--CA 1.497 1.919 0 C-N-CA 123.915 0.886 . . . . 71.54 111.319 -173.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.155 0 C-N-CA 124.553 1.141 . . . . 73.33 110.845 -172.174 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 22.0 t70 . . . . . 0 CA--C 1.544 0.713 0 N-CA-C 109.444 -0.576 . . . . 74.24 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -154.79 -144.94 0.15 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.0 1.32 . . . . 65.21 107.598 -171.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.39 91.46 0.08 Allowed 'General case' 0 C--N 1.356 0.865 0 N-CA-C 109.627 -0.509 . . . . 63.51 109.627 170.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -82.89 161.03 22.01 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 124.11 0.964 . . . . 74.21 110.911 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -71.51 178.86 3.26 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.154 0.982 . . . . 72.23 111.891 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -73.84 158.86 33.75 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.923 0.489 . . . . 64.45 110.507 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 61.1 mttp 68.68 129.81 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.993 1.317 . . . . 72.55 111.457 -176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.522 HD22 HG12 ' B' ' 86' ' ' ILE . 5.6 mp -86.96 48.84 1.71 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.535 0.734 . . . . 74.21 109.964 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -168.85 90.9 0.6 Allowed Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 108.977 -0.749 . . . . 75.02 108.977 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.587 ' HD3' ' SD ' ' B' ' 94' ' ' MET . 93.6 Cg_endo -86.23 -2.12 8.61 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.874 2.382 . . . . 74.0 113.78 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -98.21 163.61 12.66 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.625 0.77 . . . . 70.23 110.206 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 25.4 p -90.23 -48.74 6.96 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.639 0.776 . . . . 52.14 109.752 175.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.486 ' NE1' HG21 ' B' ' 46' ' ' THR . 3.8 t-105 60.09 35.08 21.3 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.266 1.026 . . . . 71.24 110.777 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -77.45 -28.83 52.55 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.798 0.839 . . . . 34.54 110.746 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.05 81.88 5.28 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.728 0.811 . . . . 73.43 110.539 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 41.4 t -126.96 113.99 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.003 0.921 . . . . 71.24 109.064 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -137.03 142.42 42.47 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.996 0.918 . . . . 70.43 109.991 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -146.81 56.92 1.15 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.261 1.029 . . . . 74.45 109.47 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -77.09 80.81 3.61 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 114.664 -1.153 . . . . 72.35 109.408 175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -120.69 -48.68 0.3 Allowed Glycine 0 C--N 1.342 0.903 0 CA-C-N 115.942 -0.572 . . . . 64.35 112.197 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt 65.77 85.8 0.14 Allowed 'General case' 0 C--N 1.359 0.998 0 C-N-CA 124.654 1.181 . . . . 75.12 109.944 -171.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.02 140.95 14.9 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.945 -0.761 . . . . 71.23 108.945 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 5.5 tt -162.62 -53.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.157 0.583 . . . . 72.43 110.676 -175.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.94 131.69 52.94 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.323 0.649 . . . . 73.23 110.483 -175.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . 0.722 ' HB3' ' HB2' ' E' ' 135' ' ' ALA . 61.6 t80 -70.04 140.59 88.53 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 107.955 -1.128 . . . . 74.43 107.955 168.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -47.74 -40.32 31.33 Favored 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 123.549 2.833 . . . . 64.51 114.656 -172.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . 0.457 HG23 ' HD1' ' C' ' 32' ' ' PHE . 0.3 OUTLIER -118.97 38.07 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.634 0 CA-C-O 122.695 1.236 . . . . 71.43 109.409 -176.495 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' E' ' 132' ' ' TYR . . . -87.0 34.26 0.67 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.072 -1.018 . . . . 71.13 111.087 174.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 24.7 t 65.29 112.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 C-N-CA 125.458 1.503 . . . . 74.54 110.421 -172.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' C' ' 36' ' ' TRP . 37.5 tt0 -79.75 162.84 24.92 Favored 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 108.428 -0.952 . . . . 73.32 108.428 172.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -46.16 128.39 9.47 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.813 1.245 . . . . 41.23 112.473 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . 0.473 ' HG ' ' HD2' ' C' ' 38' ' ' PRO . 10.1 mp -61.13 93.24 0.03 OUTLIER 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.289 0.993 . . . . 55.34 110.01 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.1 m -78.08 -7.91 57.56 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 114.671 -1.149 . . . . 75.32 111.397 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 5.8 tt -91.22 105.41 17.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.07 -1.085 . . . . 72.45 108.07 175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 14.9 tt -168.38 153.57 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.677 0.791 . . . . 74.11 109.209 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . 0.655 ' HB2' ' HA ' ' A' ' 155' ' ' ALA . 26.5 p90 -67.89 159.54 30.28 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.44 0.696 . . . . 55.42 110.582 176.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -157.22 90.05 1.1 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.389 -0.597 . . . . 74.22 109.389 178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . 0.541 ' HA ' ' HE3' ' E' ' 145' ' ' LYS . 0.7 OUTLIER -132.8 82.86 2.02 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.488 -0.56 . . . . 73.34 109.488 178.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 54.43 -156.01 0.23 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.399 1.08 . . . . 74.5 111.77 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 13' ' ' ILE . 3.7 tt -151.83 142.74 23.02 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.002 -1.481 . . . . 61.55 107.002 172.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.407 ' N ' HD23 ' E' ' 147' ' ' LEU . 7.1 mp -56.55 137.25 76.94 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 123.544 0.738 . . . . 75.21 110.746 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--N 1.377 2.065 0 C-N-CA 122.754 2.303 . . . . 65.21 111.869 173.823 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 25.0 t70 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 110.013 -0.366 . . . . 52.22 110.013 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 61.7 mttp 63.97 39.48 7.98 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.954 1.301 . . . . 71.54 111.98 -178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -135.35 -76.04 0.45 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.071 0.548 . . . . 40.14 110.433 176.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 66.6 t80 71.85 -22.82 0.2 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.38 1.472 . . . . 75.5 113.655 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -60.87 -30.83 70.38 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.202 1.001 . . . . 75.23 111.56 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 31.2 t70 55.89 -94.38 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.98 1.312 . . . . 72.31 111.409 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -161.91 122.65 2.64 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.408 0.683 . . . . 75.13 109.296 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 89' ' ' ILE . 16.1 tp -94.57 59.28 2.46 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.161 0.584 . . . . 54.41 109.875 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 29.0 t80 -168.61 63.16 0.54 Allowed Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.626 0.771 . . . . 65.42 109.734 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -91.27 10.82 2.65 Favored 'Trans proline' 0 C--N 1.38 2.186 0 C-N-CA 123.109 2.539 . . . . 70.45 113.562 178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -110.45 132.29 54.31 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.177 0.591 . . . . 72.33 109.862 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 66.9 p -106.28 124.29 49.36 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.03 0.932 . . . . 63.21 109.276 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.64 77.96 6.22 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 123.45 0.7 . . . . 75.22 110.482 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.91 98.23 9.66 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.785 -1.561 . . . . 65.5 106.785 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' C' ' 2' ' ' SER . . . -151.9 -87.53 0.06 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.376 0.67 . . . . 64.33 109.819 -174.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 14.2 p -176.41 150.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.398 1.079 . . . . 73.12 108.942 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -76.49 -59.92 2.57 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 108.246 -1.02 . . . . 73.25 108.246 173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -167.4 -178.19 3.92 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.283 -0.872 . . . . 73.15 109.932 175.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -154.68 124.63 6.68 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.214 -0.661 . . . . 54.0 109.214 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.51 162.25 10.29 Favored Glycine 0 C--N 1.346 1.107 0 O-C-N 123.348 0.405 . . . . 64.32 113.176 173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . 0.547 ' HA ' ' HE3' ' F' ' 128' ' ' LYS . 0.0 OUTLIER -129.39 141.04 51.15 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.949 1.3 . . . . 54.12 108.717 175.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -151.25 146.89 26.38 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.12 0.568 . . . . 63.45 109.769 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 10.8 tp -132.21 1.89 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.246 0 C-N-CA 124.562 1.145 . . . . 71.41 108.637 173.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 63.61 -80.17 0.03 OUTLIER 'General case' 0 C--N 1.364 1.216 0 C-N-CA 125.328 1.451 . . . . 53.15 110.37 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -163.78 118.32 1.08 Allowed Pre-proline 0 C--O 1.245 0.828 0 N-CA-C 107.482 -1.303 . . . . 42.53 107.482 171.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.05 84.66 1.29 Allowed 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 122.293 1.995 . . . . 73.41 111.037 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.406 HG12 HG13 ' F' ' 136' ' ' VAL . 9.4 tt -68.1 -31.8 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 CA-C-N 115.423 -0.808 . . . . 64.42 110.206 174.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 73.67 -9.74 1.17 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.767 1.227 . . . . 61.33 114.209 169.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.406 HG13 HG12 ' F' ' 134' ' ' ILE . 20.0 m -53.97 134.73 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.216 0.606 . . . . 52.35 111.137 176.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -156.39 142.54 18.19 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.19 0.596 . . . . 75.51 110.231 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 55.14 79.74 0.14 Allowed 'General case' 0 C--N 1.355 0.814 0 O-C-N 124.575 1.172 . . . . 42.31 111.866 176.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.438 HD13 ' HD2' ' D' ' 38' ' ' PRO . 20.3 tp -65.7 100.62 0.55 Allowed 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.601 -0.727 . . . . 72.11 109.954 177.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 37.5 m -116.45 -125.19 0.28 Allowed 'General case' 0 CA--C 1.556 1.2 0 CA-C-N 114.526 -1.216 . . . . 63.55 109.33 -174.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 79.6 mt 64.84 19.63 11.9 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 124.684 1.194 . . . . 75.42 112.072 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 42.9 pt -116.65 172.71 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.157 0.983 . . . . 54.32 109.824 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -59.0 137.52 57.9 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.223 0.609 . . . . 61.01 110.163 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . 0.405 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 28.7 p30 -152.52 161.26 42.83 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.498 0.319 . . . . 64.34 111.59 -172.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . 0.55 ' HA ' ' HB2' ' B' ' 12' ' ' GLN . 49.3 tttm 78.36 -42.27 0.33 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.991 2.116 . . . . 74.43 111.866 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -74.48 146.23 42.93 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.641 0.776 . . . . 71.22 110.397 173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 19.0 tp -129.41 5.87 5.23 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.038 0.935 . . . . 75.12 109.788 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 5.1 mp 54.88 73.03 0.95 Allowed Pre-proline 0 CA--C 1.556 1.2 0 C-N-CA 125.342 1.457 . . . . 72.21 111.006 -172.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--N 1.374 1.906 0 C-N-CA 122.599 2.2 . . . . 54.22 112.67 -178.757 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 111.556 0.206 . . . . 72.52 111.556 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 p -84.37 124.7 31.58 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 122.944 0.498 . . . . 64.14 110.601 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -153.76 139.81 18.32 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.372 1.069 . . . . 75.34 109.402 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -121.79 -170.01 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.983 0.913 . . . . 53.43 109.945 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -60.83 112.13 1.92 Allowed 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.954 -1.128 . . . . 70.44 107.954 172.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -72.45 -77.4 0.1 Allowed 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.975 0.91 . . . . 71.21 110.849 -168.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 p -143.48 107.08 4.61 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.923 0.889 . . . . 70.13 108.946 -176.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -72.02 89.44 1.12 Allowed 'General case' 0 C--N 1.35 0.614 0 N-CA-C 107.93 -1.137 . . . . 70.11 107.93 171.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.539 ' SD ' HG22 ' A' ' 89' ' ' ILE . 65.4 mtt -143.8 175.89 9.66 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.273 1.029 . . . . 73.0 109.902 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -141.9 99.42 3.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.85 0.86 . . . . 71.42 108.694 175.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -137.9 113.51 9.61 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.709 -0.848 . . . . 73.52 108.709 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -142.0 137.88 31.47 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.51 0.724 . . . . 75.5 109.769 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.37 133.44 29.92 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 123.999 0.92 . . . . 71.42 109.929 173.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.92 -42.31 11.28 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.65 -0.5 . . . . 72.35 109.65 173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.541 ' HD2' HD12 ' A' ' 83' ' ' ILE . 11.9 ptp180 -175.56 146.07 0.76 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.067 -0.969 . . . . 72.3 109.39 -172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.505 ' HB ' ' HG2' ' C' ' 130' ' ' PRO . 77.2 mt -137.03 125.98 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 108.123 -1.065 . . . . 72.4 108.123 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.531 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 22.2 p90 -164.75 161.65 20.69 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 123.805 0.842 . . . . 74.32 110.635 -170.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.1 p -75.83 123.25 25.34 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.092 -0.504 . . . . 72.21 109.825 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 43.1 mtpt -86.99 -32.05 20.27 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.695 0.398 . . . . 70.41 109.999 172.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -147.28 144.94 29.2 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.524 -0.762 . . . . 64.3 109.907 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.51 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 85.2 mt -134.99 146.4 30.59 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 C-N-CA 125.451 1.5 . . . . 63.32 107.674 174.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.3 t -149.33 138.78 21.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.306 0.642 . . . . 72.41 109.812 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -147.19 126.95 13.43 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.12 -1.437 . . . . 74.55 107.12 175.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -135.86 127.54 29.03 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.564 -0.902 . . . . 64.4 108.564 175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -119.18 86.61 32.91 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 109.007 -0.738 . . . . 63.14 109.007 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -67.33 -34.47 27.03 Favored 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.165 2.577 . . . . 73.11 113.081 -174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 2.4 m-80 -109.84 33.94 4.12 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.549 0.74 . . . . 70.3 109.926 177.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.454 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -52.88 -48.51 91.17 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 113.727 1.01 . . . . 73.21 113.727 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.5 Cg_exo -68.62 -30.94 27.53 Favored 'Trans proline' 0 C--N 1.392 2.822 0 C-N-CA 121.674 1.582 . . . . 74.4 112.214 172.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.2 OUTLIER -75.8 -21.89 56.9 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.697 0.799 . . . . 74.14 111.825 -170.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 27' ' ' ASN . 57.9 t -53.61 -27.24 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 123.773 0.829 . . . . 75.5 111.848 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -78.82 -39.03 36.67 Favored 'General case' 0 CA--C 1.558 1.261 0 C-N-CA 123.746 0.818 . . . . 74.51 111.047 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -88.29 -26.64 22.17 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.302 0.641 . . . . 70.33 112.383 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HB2' HD12 ' A' ' 68' ' ' LEU . 55.8 mtpt -80.5 163.49 23.71 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.15 0.58 . . . . 62.31 111.234 -176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -75.06 115.84 15.13 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.457 0.703 . . . . 71.05 109.331 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.592 ' HZ3' ' HB2' ' F' ' 133' ' ' PRO . 23.1 p-90 -73.24 86.01 1.42 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.987 0.915 . . . . 75.4 111.445 -172.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -125.53 80.63 65.69 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 124.031 0.932 . . . . 74.55 108.899 171.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.45 121.71 8.47 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.876 2.384 . . . . 74.45 111.872 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.86 105.96 18.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 108.378 -0.971 . . . . 72.24 108.378 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.1 t -85.09 92.47 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.705 -0.85 . . . . 64.2 108.705 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 61.2 tttm -100.33 115.29 29.62 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.92 0.888 . . . . 72.31 109.139 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.422 HD11 ' HG ' ' F' ' 129' ' ' LEU . 4.2 mp -100.84 141.91 33.05 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.028 0.531 . . . . 74.13 109.808 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.698 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.5 m-20 -128.19 111.68 13.69 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.265 -1.383 . . . . 74.52 107.265 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 131' ' ' VAL . 75.2 mt -109.74 119.89 40.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.753 -0.462 . . . . 72.51 109.753 -174.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -130.31 137.46 49.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.051 0.94 . . . . 74.11 109.463 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.6 m -117.07 132.97 56.56 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.572 0.749 . . . . 75.33 109.902 176.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.78 146.03 51.92 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.641 1.176 . . . . 74.4 109.036 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.7 p -132.54 158.94 40.86 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.594 0.758 . . . . 75.41 110.43 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.6 t -157.17 157.34 34.24 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.458 1.103 . . . . 75.05 110.009 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -113.95 136.97 52.31 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.776 0.83 . . . . 54.4 109.572 174.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.5 mt -120.03 -33.91 3.83 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.134 0.573 . . . . 73.51 111.209 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.46 -174.04 4.08 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.232 0.613 . . . . 62.22 110.199 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -68.1 117.01 9.37 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.457 0.703 . . . . 72.13 109.487 176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 67.62 14.65 9.59 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.481 1.112 . . . . 72.14 111.816 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.1 t -118.93 104.93 16.67 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.478 -0.934 . . . . 64.21 108.478 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -125.53 126.65 45.18 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.67 0.788 . . . . 75.24 109.116 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -92.48 130.04 38.25 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.747 1.219 . . . . 74.4 109.432 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.402 HG11 ' HD3' ' A' ' 103' ' ' PRO . 65.4 t -114.28 123.22 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 107.956 -1.127 . . . . 65.13 107.956 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 50.5 t -106.52 134.96 46.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 123.617 0.767 . . . . 61.52 109.277 176.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.413 HD22 HG22 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -104.9 113.93 27.83 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.296 -1.372 . . . . 64.31 107.296 177.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 27.2 ttp180 -96.6 100.72 12.27 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.988 -1.115 . . . . 75.35 107.988 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG22 HD22 ' A' ' 60' ' ' LEU . 11.1 t -101.84 131.61 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 108.525 -0.917 . . . . 73.1 108.525 177.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.698 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.1 m -116.6 137.15 52.4 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.784 -1.191 . . . . 63.32 107.784 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 114' ' ' ILE . 86.3 t -128.72 128.05 67.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 105.567 -2.012 . . . . 74.24 105.567 175.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.52 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 27.6 m -124.67 139.24 54.04 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 106.934 -1.506 . . . . 62.45 106.934 -176.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.95 119.75 20.54 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.403 -0.962 . . . . 62.44 108.403 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.585 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 68.5 m -107.07 131.37 54.17 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.369 -0.604 . . . . 73.4 109.369 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.534 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.2 OUTLIER -88.94 76.22 7.91 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 107.559 -1.275 . . . . 71.24 107.559 -175.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.36 -102.2 2.26 Favored Glycine 0 C--N 1.338 0.657 0 N-CA-C 109.324 -1.51 . . . . 71.41 109.324 -167.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -121.56 -27.82 4.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.373 0.669 . . . . 74.35 110.096 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -86.44 131.44 34.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.936 0.894 . . . . 73.24 108.59 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 24.5 m -62.01 130.17 44.32 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.331 1.052 . . . . 61.35 113.205 -164.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -76.89 -59.3 2.84 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.433 1.093 . . . . 51.22 109.307 173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -161.83 174.48 13.11 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.631 -1.168 . . . . 72.21 111.112 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 61.0 tp -137.69 145.26 42.38 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.03 1.332 . . . . 71.24 108.329 -175.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.566 ' HB3' HG23 ' A' ' 114' ' ' ILE . 70.2 m -146.99 104.44 3.69 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.914 0.885 . . . . 71.4 110.165 -176.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -129.21 126.35 38.95 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.895 0.478 . . . . 72.11 109.774 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.1 t -134.89 112.49 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.871 0.868 . . . . 60.44 109.663 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.488 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 2.6 mp0 -85.09 83.39 8.05 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.402 -0.962 . . . . 63.03 108.402 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -77.14 98.53 5.1 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.222 -0.899 . . . . 64.21 109.448 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.47 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.01 144.49 19.41 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 111.83 -0.508 . . . . 64.34 111.83 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.557 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.21 122.46 2.43 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.114 -1.194 . . . . 64.54 110.114 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.541 HD12 ' HD2' ' A' ' 15' ' ' ARG . 49.5 mt -88.5 129.13 40.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.275 -1.009 . . . . 72.32 108.275 174.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -129.1 126.02 38.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.652 0.381 . . . . 74.54 110.313 -178.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 28.0 p -83.24 100.13 10.4 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 108.887 -0.782 . . . . 73.22 108.887 172.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.5 pt -112.8 137.1 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 123.798 0.839 . . . . 73.33 111.437 -175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.18 155.77 11.84 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.882 1.273 . . . . 33.32 108.964 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.1 9.89 86.54 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-O 120.154 -0.248 . . . . 64.01 113.63 176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 HG22 ' SD ' ' A' ' 9' ' ' MET . 44.7 pt -110.47 140.9 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.994 0.918 . . . . 74.11 109.259 -173.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 22.5 tt0 -155.47 177.74 11.02 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 122.864 0.466 . . . . 62.52 110.292 -174.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.485 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 64.1 -157.18 43.57 Favored Glycine 0 C--N 1.345 1.07 0 C-N-CA 123.936 0.779 . . . . 72.51 114.127 178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.8 p -71.83 -13.84 61.79 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.797 0.839 . . . . 52.22 111.026 173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -62.12 -46.66 88.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.317 1.047 . . . . 61.35 111.022 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.01 -36.4 61.96 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 110.094 -0.335 . . . . 74.33 110.094 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.53 -35.29 75.64 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.338 0.655 . . . . 63.42 110.704 175.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.411 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 6.3 t-80 -65.04 -48.12 74.94 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.764 1.226 . . . . 51.23 110.07 172.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 13.4 m -73.84 -26.02 60.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 113.955 1.094 . . . . 53.22 113.955 -171.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.2 mt -97.31 -30.61 12.85 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.854 0.462 . . . . 74.42 111.332 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -20.34 49.7 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 116.098 -0.501 . . . . 73.14 113.217 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.7 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -132.77 -70.7 0.54 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.23 0.455 . . . . 71.3 112.23 -170.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.672 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.1 t80 -45.0 -58.6 3.07 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 124.899 1.279 . . . . 73.01 113.9 -172.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 70.5 m -72.08 -41.61 8.8 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.323 -0.846 . . . . 65.4 113.166 -172.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.402 ' HD3' HG11 ' A' ' 58' ' ' VAL . 9.3 Cg_endo -60.72 -23.91 77.44 Favored 'Trans proline' 0 C--N 1.388 2.63 0 CA-C-N 121.281 1.493 . . . . 64.42 113.851 165.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.558 HD21 ' HB2' ' A' ' 133' ' ' PHE . 32.9 m-80 -73.19 -35.52 66.4 Favored 'General case' 0 N--CA 1.502 2.171 0 CA-C-N 118.71 0.686 . . . . 44.43 110.484 172.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.6 mm -60.29 -41.87 88.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.236 0.615 . . . . 73.02 109.576 172.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.557 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.2 mt -71.47 -24.89 62.08 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.219 -0.901 . . . . 72.21 112.354 -176.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -64.97 -44.05 70.23 Favored Pre-proline 0 CA--C 1.564 1.503 0 CA-C-O 117.825 -1.084 . . . . 74.51 113.859 -167.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -60.89 -32.64 92.82 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.247 1.965 . . . . 71.4 113.577 172.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -75.94 -38.58 57.48 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.247 0.619 . . . . 74.22 110.959 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.53 -46.24 76.82 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.106 0.562 . . . . 63.11 109.629 174.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -50.67 -54.28 24.34 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 124.865 1.353 . . . . 75.52 110.478 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -58.1 -49.47 76.85 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.437 1.085 . . . . 64.03 111.748 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.448 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 46.1 t -58.99 -43.57 91.47 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.062 0.851 . . . . 64.42 110.934 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.566 HG23 ' HB3' ' A' ' 76' ' ' CYS . 84.7 mt -60.55 -55.1 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 123.997 0.811 . . . . 71.22 110.265 174.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 92.8 m -59.71 -34.57 73.08 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.768 1.227 . . . . 73.12 111.837 -172.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.1 t -73.46 -42.13 62.33 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.648 -0.705 . . . . 74.32 110.137 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 7.5 mtp -57.47 -42.2 82.14 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.552 0.741 . . . . 74.42 111.128 174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 114' ' ' ILE . 81.0 t -61.14 -46.76 96.0 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 C-N-CA 124.619 1.167 . . . . 60.03 111.016 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 87.2 p -75.76 -26.54 57.48 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 122.864 0.466 . . . . 74.43 111.506 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -71.96 -29.22 64.04 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.566 0.747 . . . . 75.01 109.762 172.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 1.51 79.52 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.154 -0.93 . . . . 73.43 112.652 173.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.3 m 68.59 11.69 8.43 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 124.865 1.266 . . . . 63.22 111.558 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -87.09 150.25 49.32 Favored Pre-proline 0 C--O 1.243 0.75 0 CA-C-N 115.608 -0.724 . . . . 74.32 109.093 179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -45.84 112.63 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.144 2.563 . . . . 73.22 112.698 175.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -53.05 122.8 10.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.854 1.262 . . . . 64.43 111.656 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -107.28 96.08 6.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.186 -1.042 . . . . 64.44 108.186 -167.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -99.83 83.57 2.76 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.379 -0.971 . . . . 72.33 108.379 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.661 ' H ' HD23 ' A' ' 128' ' ' LEU . 1.2 pt? -59.63 136.88 58.13 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 115.003 -0.998 . . . . 74.52 111.941 -177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.91 148.82 82.74 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 124.413 1.085 . . . . 65.15 112.018 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -56.8 129.74 36.21 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.015 2.477 . . . . 75.43 113.72 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.447 HG21 HD11 ' A' ' 44' ' ' LEU . 87.9 t -103.08 122.03 55.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 N-CA-C 108.632 -0.877 . . . . 65.24 108.632 174.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 25.0 p-10 -88.57 71.25 8.89 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.919 0.888 . . . . 54.41 111.006 -173.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.558 ' HB2' HD21 ' A' ' 104' ' ' ASN . 39.6 m-85 -61.43 -38.76 88.32 Favored 'General case' 0 N--CA 1.483 1.212 0 CA-C-O 121.726 0.774 . . . . 52.42 109.263 176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.7 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 10.9 t70 -71.38 -40.78 70.36 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.427 -1.26 . . . . 60.04 111.318 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.666 ' HB3' ' HB2' ' A' ' 132' ' ' ASN . . . -78.75 -29.54 45.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 CA-C-N 114.558 -1.201 . . . . 54.12 112.08 -171.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tt -60.94 -47.33 86.93 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 108.996 -0.742 . . . . 64.15 108.996 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -69.46 -37.44 77.32 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.593 -0.73 . . . . 75.33 110.415 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.416 ' HB3' ' HA ' ' A' ' 135' ' ' ALA . 0.0 OUTLIER -62.67 -35.77 80.75 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.885 0.874 . . . . 64.12 111.209 -178.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -57.39 -55.77 30.52 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.342 0.657 . . . . 70.45 109.832 174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -69.16 -33.01 72.73 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 114.997 -1.001 . . . . 74.32 112.105 -175.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 64.2 tp -63.91 -53.34 51.89 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 123.707 0.629 . . . . 61.42 111.277 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.407 ' H ' ' H ' ' A' ' 143' ' ' GLN . 87.1 mt-30 -160.13 -13.06 0.05 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.093 0.957 . . . . 74.24 111.058 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.512 ' HB2' HE22 ' C' ' 4' ' ' GLN . 51.3 tt0 56.47 81.95 0.12 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.256 1.022 . . . . 61.0 109.72 -164.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -93.8 129.25 40.25 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.961 -0.563 . . . . 75.53 110.169 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.01 -49.3 3.66 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.535 0.734 . . . . 72.25 109.183 168.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 104.98 174.43 24.5 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.974 -0.557 . . . . 75.15 112.608 174.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.9 149.22 17.85 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.056 -0.72 . . . . 71.14 109.056 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 166.51 -163.32 36.87 Favored Glycine 0 C--N 1.341 0.85 0 CA-C-N 116.181 -0.463 . . . . 54.42 112.654 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 25.0 m -129.16 -38.98 1.57 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.609 1.164 . . . . 73.42 109.769 -175.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 75.47 149.28 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.788 1.305 . . . . 73.0 111.649 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 66.7 84.85 0.15 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.681 1.192 . . . . 64.15 111.146 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -128.72 -21.5 3.4 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.276 0.63 . . . . 75.32 111.473 -177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -162.93 150.16 13.14 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.553 0.341 . . . . 65.42 110.923 -171.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.4 t70 68.47 93.81 0.07 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.423 1.489 . . . . 62.14 111.655 175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.336 0 C-N-CA 124.431 1.093 . . . . 54.04 108.193 176.006 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.481 1.094 0 N-CA-C 109.04 -0.726 . . . . 51.45 109.04 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.7 m -87.04 167.94 13.75 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.864 0.865 . . . . 70.55 111.456 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.15 126.06 30.3 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.46 -0.791 . . . . 71.1 109.912 178.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -81.94 72.57 8.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.484 0.714 . . . . 73.2 110.112 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.7 m120 59.87 -84.8 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.073 1.349 . . . . 62.24 111.254 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.425 HD21 ' ND2' ' D' ' 132' ' ' ASN . 24.2 p30 -167.31 12.44 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.483 1.113 . . . . 61.41 110.765 -178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 13.5 t -76.85 162.72 27.41 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.892 0.477 . . . . 75.23 110.69 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 66.88 -173.85 0.19 Allowed 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.87 1.268 . . . . 71.23 111.513 -171.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.715 ' HB3' HG23 ' B' ' 89' ' ' ILE . 21.8 ptm 56.4 173.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 126.457 1.903 . . . . 74.42 115.279 178.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -137.05 136.92 38.82 Favored 'General case' 0 C--O 1.243 0.747 0 CA-C-N 114.335 -1.302 . . . . 72.02 107.785 166.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.04 124.46 40.71 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 108.32 -0.993 . . . . 74.24 108.32 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.438 ' NE2' HD11 ' F' ' 147' ' ' LEU . 0.1 OUTLIER -137.43 110.34 7.68 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.151 0.58 . . . . 54.3 109.596 -177.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.492 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -70.19 115.86 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 N-CA-C 109.313 -0.625 . . . . 71.01 109.313 172.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -85.84 -51.62 6.28 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 121.263 0.554 . . . . 75.33 109.653 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -169.71 133.89 1.32 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.098 -0.956 . . . . 51.34 108.535 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.447 HG21 ' CD1' ' B' ' 109' ' ' TYR . 73.3 mt -114.75 146.13 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.539 -1.282 . . . . 73.03 107.539 174.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -168.02 149.67 5.32 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.598 0.592 . . . . 63.44 112.598 -176.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -73.59 124.92 26.85 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.199 -0.91 . . . . 74.32 108.7 168.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 38.9 mtpt -98.31 -37.37 9.67 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.347 0.659 . . . . 55.34 110.858 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 26.8 m-20 -148.09 133.51 18.61 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.064 -0.517 . . . . 60.44 109.91 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.1 mm -130.01 142.58 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 74.12 109.74 174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.629 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 29.4 m -133.68 135.34 44.02 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.311 1.444 . . . . 75.04 108.867 174.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.51 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.5 t80 -149.63 127.0 11.45 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.808 -1.182 . . . . 74.23 107.808 166.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -137.16 126.68 25.13 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.72 0.808 . . . . 74.55 109.297 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.585 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.19 88.0 53.15 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.136 -0.69 . . . . 72.42 109.136 177.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.37 -27.47 28.31 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 123.028 2.485 . . . . 53.11 112.034 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -117.61 28.98 8.11 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.146 0.979 . . . . 73.12 109.019 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.585 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -44.49 -54.19 12.91 Favored Pre-proline 0 C--N 1.366 1.312 0 C-N-CA 124.684 1.194 . . . . 74.44 112.331 167.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 12.0 Cg_exo -69.32 -19.79 37.77 Favored 'Trans proline' 0 C--N 1.395 3.023 0 C-N-CA 122.339 2.026 . . . . 51.21 112.498 -175.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.442 ' O ' ' HG2' ' B' ' 34' ' ' LYS . 11.5 m-70 -96.67 2.98 52.69 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.238 1.015 . . . . 64.34 111.936 -175.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -56.47 -32.69 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 112.861 0.689 . . . . 35.02 112.861 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -74.21 -26.69 60.4 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-O 121.17 0.509 . . . . 74.44 110.563 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -73.87 -16.66 61.12 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 124.807 1.243 . . . . 73.43 110.523 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 mmmt -101.91 95.46 6.39 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.979 0.912 . . . . 61.11 111.707 -170.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -100.75 87.14 3.25 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.519 0.728 . . . . 64.13 111.062 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 179.98 -176.96 0.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.698 1.599 . . . . 75.41 108.136 171.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -87.98 133.83 36.49 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 123.254 0.622 . . . . 73.42 109.727 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -65.5 134.78 39.75 Favored 'Trans proline' 0 C--N 1.379 2.18 0 C-N-CA 122.005 1.803 . . . . 73.14 111.874 170.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.455 ' HG3' ' HE2' ' B' ' 41' ' ' LYS . 16.0 tp10 -63.95 103.93 0.65 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.253 0.621 . . . . 70.13 109.39 169.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.1 m -93.27 147.94 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.79 0.836 . . . . 72.05 111.42 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.455 ' HE2' ' HG3' ' B' ' 39' ' ' GLU . 73.4 mmtt -136.48 143.92 44.08 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.74 1.216 . . . . 74.41 109.423 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -127.48 132.72 49.95 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.684 0.794 . . . . 74.34 109.269 169.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 11.6 m-20 -132.14 115.42 15.71 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 108.281 -1.007 . . . . 74.04 108.281 -177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.29 135.27 40.15 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.862 -0.792 . . . . 73.4 108.862 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 31.9 t70 -146.07 149.12 33.47 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 123.935 0.894 . . . . 75.22 108.953 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.43 HG21 ' HE1' ' E' ' 120' ' ' TRP . 40.9 p -128.97 123.81 33.44 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.48 0.712 . . . . 72.13 109.602 -177.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.595 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -114.48 159.43 20.36 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.495 -1.298 . . . . 54.01 107.495 174.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.9 p -145.26 164.23 32.03 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 121.25 0.548 . . . . 75.53 111.028 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 79.2 p -153.58 143.03 21.67 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 114.591 -1.186 . . . . 74.45 107.983 169.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -106.06 104.9 14.71 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.927 -0.768 . . . . 74.04 108.927 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -73.51 -45.21 55.19 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 121.032 0.444 . . . . 72.22 109.808 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.02 -178.07 6.27 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.012 -0.994 . . . . 72.22 110.005 175.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.35 128.67 35.9 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.957 -1.02 . . . . 61.23 109.186 177.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 67.42 10.73 7.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.635 1.174 . . . . 51.21 112.061 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 88.4 t -129.23 99.17 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.31 1.044 . . . . 73.51 108.781 178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -99.55 167.54 10.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.925 0.869 . . . . 73.41 111.266 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 tm-20 -138.98 95.02 2.88 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 104.473 -2.418 . . . . 70.54 104.473 171.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 19.7 m -99.18 130.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 121.241 0.543 . . . . 75.12 109.612 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.595 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 32.9 t -102.03 143.46 14.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-N 114.953 -1.022 . . . . 52.23 109.172 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.7 OUTLIER -119.59 111.08 17.63 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 107.588 -1.264 . . . . 74.43 107.588 176.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.0 ttt180 -96.69 108.84 21.54 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.072 0.549 . . . . 64.34 110.23 176.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.507 ' HB ' HD11 ' B' ' 114' ' ' ILE . 14.1 t -105.88 118.83 54.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 108.445 -0.946 . . . . 70.21 108.445 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 38.0 m -103.92 141.34 36.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.565 0.746 . . . . 63.53 109.028 178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.672 HG21 HG21 ' B' ' 114' ' ' ILE . 47.5 t -129.25 130.82 67.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 124.367 1.067 . . . . 73.41 108.901 176.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.3 m -125.42 140.07 53.1 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.896 -0.779 . . . . 73.12 108.896 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.17 131.37 26.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.608 -0.886 . . . . 64.13 108.608 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.486 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 33.0 p -133.29 126.26 31.06 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.808 -0.441 . . . . 64.11 109.808 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.553 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 0.9 OUTLIER -110.86 130.07 55.69 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 106.67 -1.604 . . . . 71.32 106.67 -176.232 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.47 -119.09 5.7 Favored Glycine 0 C--N 1.341 0.818 0 N-CA-C 110.585 -1.006 . . . . 34.21 110.585 -173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -120.35 3.81 10.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.654 0.782 . . . . 63.54 110.711 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -115.48 165.5 12.93 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.818 0.847 . . . . 61.22 110.145 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 42.6 m -70.23 131.6 44.46 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.105 -0.498 . . . . 71.24 109.711 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -86.16 -57.99 2.81 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.024 -1.102 . . . . 74.35 108.024 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -160.27 166.44 29.54 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.327 -1.306 . . . . 73.54 110.679 174.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.7 mt -133.91 136.16 44.09 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.496 1.518 . . . . 72.34 107.033 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 50.0 t -143.23 147.49 34.92 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.443 -0.947 . . . . 61.45 108.443 177.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.629 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.3 tt0 -162.94 139.1 7.19 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 109.167 -0.679 . . . . 71.53 109.167 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' B' ' 113' ' ' CYS . 98.7 t -130.95 144.31 38.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 123.644 0.778 . . . . 64.45 109.021 178.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 26.4 mt-30 -122.82 92.91 3.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.624 -0.88 . . . . 73.55 108.624 173.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -85.43 102.73 13.7 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 114.823 -1.08 . . . . 52.2 109.296 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.31 168.71 29.87 Favored Glycine 0 C--O 1.24 0.504 0 N-CA-C 111.617 -0.593 . . . . 71.31 111.617 174.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.25 128.56 1.75 Allowed Glycine 0 N--CA 1.446 -0.671 0 N-CA-C 112.084 -0.407 . . . . 51.02 112.084 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.7 mt -83.58 121.18 35.95 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.075 -1.083 . . . . 74.02 108.075 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -130.13 132.9 46.29 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.022 -0.733 . . . . 54.43 109.022 177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.6 m -95.82 115.07 26.88 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.788 -0.819 . . . . 74.13 108.788 171.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.581 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -129.11 137.37 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.754 1.222 . . . . 64.42 109.212 -175.299 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.8 173.05 16.4 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.296 0.638 . . . . 60.14 109.896 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 94.59 -66.7 1.4 Allowed Glycine 0 C--N 1.345 1.029 0 N-CA-C 111.922 -0.471 . . . . 63.23 111.922 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.715 HG23 ' HB3' ' B' ' 9' ' ' MET . 8.3 pt -60.74 145.11 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.708 0.803 . . . . 71.12 111.887 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.54 146.26 24.27 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.061 -0.972 . . . . 63.31 109.411 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.99 -126.08 7.64 Favored Glycine 0 C--N 1.346 1.109 0 O-C-N 123.416 0.448 . . . . 75.45 112.76 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 33.8 m -70.04 -50.14 44.28 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.656 0.783 . . . . 74.53 111.124 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -61.46 -24.94 66.91 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.925 0.89 . . . . 73.4 111.696 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' E' ' 115' ' ' LEU . 52.6 ttp -67.24 -40.21 86.26 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.503 1.121 . . . . 73.0 110.823 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.22 -29.14 69.34 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.856 0.862 . . . . 23.33 111.991 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -65.45 -29.65 70.35 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.231 0.612 . . . . 75.41 111.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.2 -68.53 0.65 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.227 0.211 . . . . 73.44 111.437 -176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.497 HD23 ' SG ' ' B' ' 102' ' ' CYS . 94.1 mt -75.65 -22.89 56.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 112.256 0.465 . . . . 74.42 112.256 -172.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.75 -39.52 24.64 Favored Glycine 0 C--N 1.337 0.63 0 O-C-N 123.575 0.547 . . . . 61.12 112.327 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.15 -53.6 1.5 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.783 0.66 . . . . 73.53 112.783 -164.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -66.31 -45.38 80.53 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.311 0.644 . . . . 53.53 112.015 -171.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.497 ' SG ' HD23 ' B' ' 98' ' ' LEU . 71.4 m -63.99 -50.06 71.51 Favored Pre-proline 0 CA--C 1.556 1.191 0 CA-C-O 118.373 -0.823 . . . . 70.33 110.61 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.456 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.2 Cg_exo -51.18 -33.03 42.61 Favored 'Trans proline' 0 C--N 1.399 3.199 0 C-N-CA 122.624 2.216 . . . . 35.15 114.865 165.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -68.75 -25.27 64.65 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 118.355 0.525 . . . . 73.22 112.067 177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.5 mt -78.77 -42.18 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.377 0.671 . . . . 75.31 109.77 171.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.425 ' HB2' HD12 ' B' ' 60' ' ' LEU . 95.8 mt -72.99 -24.73 60.8 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.025 -0.989 . . . . 63.12 110.926 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -63.17 -50.69 74.34 Favored Pre-proline 0 CA--C 1.551 1.009 0 CA-C-O 117.756 -1.116 . . . . 65.3 113.169 -169.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' D' ' 112' ' ' GLU . 37.6 Cg_endo -63.17 -32.42 74.29 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 121.638 1.558 . . . . 62.31 112.094 177.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.447 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.7 m-30 -66.42 -43.3 86.09 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 124.018 0.927 . . . . 70.44 110.454 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.42 -42.31 87.96 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.962 0.905 . . . . 61.12 110.204 175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -61.68 -52.99 62.06 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.649 1.58 . . . . 74.35 111.476 -173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -62.84 -33.61 75.59 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.079 0.862 . . . . 74.23 109.756 -178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.7 t -71.94 -34.99 69.47 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 115.854 -0.612 . . . . 70.15 111.059 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.672 HG21 HG21 ' B' ' 64' ' ' VAL . 53.1 mt -65.22 -54.03 33.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 109.122 -0.696 . . . . 74.34 109.122 174.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -58.97 -31.33 68.64 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 114.799 -1.092 . . . . 64.32 110.846 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.441 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.5 t -64.61 -55.5 19.92 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 123.652 0.781 . . . . 70.31 110.159 174.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.529 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 14.3 mmt -63.23 -36.75 84.69 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 122.702 0.401 . . . . 72.02 111.619 -174.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.16 -51.63 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 C-N-CA 124.056 0.942 . . . . 74.41 110.687 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 88.1 p -73.35 -20.24 60.82 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.067 0.547 . . . . 74.13 111.991 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.448 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 84.4 mtt-85 -68.89 -31.36 70.22 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.308 0.643 . . . . 75.55 110.28 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.5 14.59 57.64 Favored Glycine 0 CA--C 1.535 1.342 0 O-C-N 123.854 0.721 . . . . 73.31 112.666 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.516 HG23 ' HB3' ' A' ' 17' ' ' TYR . 74.7 p 55.45 30.7 15.52 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 125.83 1.652 . . . . 73.22 112.492 -178.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -94.46 155.45 39.65 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 123.928 0.891 . . . . 64.22 109.999 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.07 143.09 99.58 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.029 2.486 . . . . 72.34 113.034 -176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -59.08 123.11 15.54 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.76 1.224 . . . . 73.01 111.566 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 86.7 mt -113.15 89.73 3.16 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.476 0.71 . . . . 71.05 109.849 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.37 100.14 12.52 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.224 -0.898 . . . . 64.12 110.377 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -63.49 151.02 42.43 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.203 1.001 . . . . 63.54 112.6 -176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' E' ' 130' ' ' ILE . . . -75.35 150.43 84.99 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.641 -0.709 . . . . 72.33 110.682 174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -69.26 110.84 2.55 Favored 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.434 2.089 . . . . 64.22 110.044 176.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.7 t -87.49 110.81 21.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 106.981 -1.488 . . . . 71.55 106.981 175.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.4 t-20 -76.26 91.55 3.22 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 106.875 -1.528 . . . . 74.33 106.875 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -53.48 -40.24 65.16 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.89 -1.05 . . . . 61.21 110.399 -177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -66.74 -53.99 27.61 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.512 1.125 . . . . 72.3 111.688 -173.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.41 -22.38 64.62 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.613 0.765 . . . . 75.05 111.674 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 tt -60.33 -51.71 68.38 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.785 0.834 . . . . 54.34 109.793 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.5 ' HB2' ' HZ3' ' E' ' 120' ' ' TRP . 26.8 t80 -76.88 -28.74 55.49 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.835 -0.621 . . . . 74.44 110.541 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 59.6 ttp -65.39 -31.14 72.09 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.027 0.531 . . . . 75.02 110.71 175.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.61 -30.85 59.69 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 74.11 110.376 175.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -65.09 -35.59 81.62 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 120.98 0.419 . . . . 74.11 109.981 171.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 39.8 mt -93.96 36.02 1.13 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.035 0.934 . . . . 34.34 109.906 178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -57.6 98.49 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.07 0.948 . . . . 73.25 111.562 -175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -136.56 -170.56 2.7 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.722 1.209 . . . . 71.23 108.672 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.38 136.91 53.47 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.661 0.784 . . . . 71.24 110.074 -178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -164.51 137.54 4.93 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.118 1.367 . . . . 72.31 108.361 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.98 156.44 19.54 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 121.801 -0.238 . . . . 72.11 113.139 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -112.92 71.19 0.73 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.596 0.712 . . . . 71.42 111.127 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.06 87.66 1.57 Allowed Glycine 0 C--N 1.34 0.783 0 CA-C-N 114.852 -1.067 . . . . 41.52 110.675 171.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.0 p -123.68 -91.2 0.55 Allowed 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 109.067 -0.716 . . . . 71.53 109.067 -177.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 62.05 134.11 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.656 1.582 . . . . 75.25 113.744 171.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -151.42 119.74 6.38 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.685 -0.857 . . . . 75.44 108.685 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -123.95 111.8 16.45 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.886 0.874 . . . . 71.51 108.916 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -73.83 119.74 18.46 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.144 0.978 . . . . 55.04 110.452 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -113.99 65.31 0.66 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.173 0.989 . . . . 73.12 108.713 172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 N-CA-C 108.494 -0.928 . . . . 64.22 108.494 179.687 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 37.2 tpp . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.463 -0.569 . . . . 74.45 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 65.0 p -80.82 152.17 28.36 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.823 -0.626 . . . . 74.21 109.901 173.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -67.57 115.5 7.23 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.701 -0.851 . . . . 73.23 108.701 174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.512 HE22 ' HB2' ' A' ' 143' ' ' GLN . 26.9 mt-30 -91.18 56.44 3.14 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.713 0.805 . . . . 74.31 110.871 -170.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -75.66 118.21 18.25 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.129 -0.941 . . . . 74.51 110.362 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -152.41 -87.31 0.06 Allowed 'General case' 0 CA--C 1.547 0.86 0 N-CA-C 108.466 -0.938 . . . . 64.11 108.466 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 175.73 144.37 0.07 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 126.896 2.078 . . . . 73.43 107.253 -177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -142.7 67.81 1.31 Allowed 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.035 0.934 . . . . 75.1 108.671 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.425 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 52.7 ttp 65.1 116.34 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.495 -1.229 . . . . 71.4 110.545 -168.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.528 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 40.2 m -84.04 78.79 9.69 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.128 -1.064 . . . . 72.1 108.128 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.515 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 42.2 t80 -100.18 127.94 46.35 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 113.809 -1.541 . . . . 72.34 108.571 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -138.03 142.73 40.35 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 109.336 -0.616 . . . . 74.12 109.336 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 61.5 mt -76.33 110.21 11.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 115.319 -0.855 . . . . 64.52 108.738 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.5 mm-40 -77.67 -39.93 43.26 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.93 -0.577 . . . . 74.12 109.938 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.489 HH11 ' HD1' ' D' ' 32' ' ' PHE . 24.2 ttt180 179.27 124.4 0.06 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.393 0.677 . . . . 75.33 109.953 -173.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 87.9 mt -110.08 138.62 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 107.818 -1.178 . . . . 63.33 107.818 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.64 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.9 p90 -174.17 154.1 2.16 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 123.752 0.657 . . . . 73.53 110.729 -175.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.3 p -75.58 122.93 24.66 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.28 -0.873 . . . . 72.55 109.733 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.3 mmtp -78.34 -50.58 11.51 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 108.218 -1.03 . . . . 53.4 108.218 172.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.464 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 26.5 t70 -133.53 139.19 46.47 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 114.551 -1.204 . . . . 74.3 109.939 -172.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.523 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.8 mt -139.37 140.06 38.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 106.794 -1.558 . . . . 60.25 106.794 176.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.8 t -160.7 150.75 17.74 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.119 0.485 . . . . 63.15 109.708 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 78.4 t80 -152.16 115.79 4.82 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 107.854 -1.165 . . . . 75.43 107.854 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -117.98 110.57 17.86 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.156 0.582 . . . . 72.15 110.432 177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.6 86.24 34.29 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.405 1.082 . . . . 71.4 108.573 167.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -67.81 -32.31 29.87 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.414 2.076 . . . . 64.42 110.56 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -89.23 22.69 2.75 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.132 -1.394 . . . . 73.03 111.415 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.512 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -55.49 -43.59 99.22 Favored Pre-proline 0 CA--C 1.574 1.866 0 C-N-CA 124.226 1.011 . . . . 72.31 113.52 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -89.41 -17.96 1.75 Allowed 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 121.958 1.772 . . . . 63.31 113.17 169.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -70.59 -31.69 68.78 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.535 1.134 . . . . 62.35 110.593 -176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -78.87 -2.45 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 C-N-CA 124.473 1.109 . . . . 74.02 112.344 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.654 ' HA ' HD12 ' E' ' 134' ' ' ILE . 74.4 t80 -49.99 -41.72 47.61 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 125.389 1.476 . . . . 65.54 113.11 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -125.12 49.63 1.86 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.245 1.018 . . . . 73.44 108.499 -172.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.79 149.29 47.53 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.82 -0.55 . . . . 61.14 111.22 -172.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -65.2 132.91 50.33 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.285 -0.871 . . . . 75.43 110.406 178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.807 ' HB3' ' HA ' ' E' ' 136' ' ' VAL . 29.1 p90 -83.52 65.86 8.63 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.026 0.917 . . . . 74.21 110.509 177.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -152.61 58.18 2.39 Favored Pre-proline 0 CA--C 1.558 1.281 0 CA-C-N 115.12 -0.946 . . . . 71.14 110.553 171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.0 149.54 9.52 Favored 'Trans proline' 0 C--N 1.389 2.709 0 C-N-CA 122.1 1.866 . . . . 70.42 110.8 165.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -88.24 113.63 24.04 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.284 0.634 . . . . 75.23 109.902 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 37.7 t -77.51 111.8 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 123.141 0.576 . . . . 72.1 109.747 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.635 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 26.6 mmmt -92.79 104.57 16.82 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 107.853 -1.165 . . . . 75.02 107.853 177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.54 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.4 pt? -87.25 145.65 26.29 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.524 0.33 . . . . 70.41 110.194 -177.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.558 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 30.2 t70 -140.88 109.02 5.75 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 109.11 -0.7 . . . . 73.22 109.11 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mp -117.22 125.68 51.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.951 -0.759 . . . . 72.01 108.951 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -143.92 160.53 40.66 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.446 1.098 . . . . 71.24 109.869 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.4 t -129.76 153.72 47.92 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 123.282 0.633 . . . . 75.5 109.651 173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.57 164.58 26.32 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.067 0.947 . . . . 54.21 109.079 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.471 ' HB3' HD21 ' C' ' 98' ' ' LEU . 33.1 p -142.31 145.36 33.88 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 123.037 0.535 . . . . 64.14 110.5 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.8 t -145.99 126.38 14.02 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.379 1.072 . . . . 64.04 108.431 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -84.68 116.05 23.0 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.462 -0.94 . . . . 74.45 108.462 175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.678 HD11 HD12 ' C' ' 83' ' ' ILE . 67.0 mt -85.41 -43.02 13.99 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.47 0.708 . . . . 75.42 110.17 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.96 -171.98 3.61 Favored 'General case' 0 C--O 1.243 0.714 0 CA-C-N 114.847 -1.069 . . . . 71.51 109.964 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.25 108.91 0.99 Allowed 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.129 -0.941 . . . . 75.24 110.025 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 71.04 -3.08 2.13 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.972 1.309 . . . . 74.3 112.955 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.4 t -95.53 97.28 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 107.842 -1.169 . . . . 70.13 107.842 174.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -106.97 159.07 16.55 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.541 0.736 . . . . 75.23 110.119 -178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -124.99 120.26 31.07 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 124.426 1.09 . . . . 74.52 108.265 178.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 72.7 t -108.41 133.79 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 107.854 -1.165 . . . . 62.04 107.854 172.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.2 t -124.21 105.65 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 109.184 -0.673 . . . . 60.51 109.184 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.526 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.05 99.44 12.45 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 107.905 -1.146 . . . . 52.14 107.905 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.548 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 9.6 tmm_? -92.28 120.94 33.3 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.288 0.635 . . . . 74.54 110.151 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' C' ' 114' ' ' ILE . 37.2 t -112.09 125.33 69.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 108.569 -0.9 . . . . 65.32 108.569 172.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.558 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 21.3 m -118.53 123.66 45.64 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.486 -0.931 . . . . 71.33 108.486 173.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.45 HG23 HD13 ' C' ' 114' ' ' ILE . 76.3 t -106.61 112.68 40.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.989 -1.005 . . . . 63.13 108.725 174.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 5.7 m -98.46 136.54 38.44 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.579 -1.637 . . . . 75.31 106.579 169.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.22 106.65 6.83 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.985 -1.857 . . . . 74.23 105.985 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 12.5 p -164.46 158.12 18.01 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 123.622 0.576 . . . . 63.22 110.688 -172.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 14.9 tp -113.71 20.24 16.06 Favored 'General case' 0 CA--C 1.553 1.089 0 CA-C-O 121.645 0.735 . . . . 41.14 110.181 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.86 -83.47 0.35 Allowed Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.437 -0.801 . . . . 75.14 111.166 -175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -100.12 -32.03 11.12 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.29 0.636 . . . . 54.22 110.423 177.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 21.4 tp10 -82.35 91.36 6.79 Favored 'General case' 0 C--N 1.348 0.5 0 N-CA-C 108.896 -0.779 . . . . 71.3 108.896 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -81.87 128.22 33.81 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.004 -0.543 . . . . 73.32 109.563 177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.26 -64.11 1.01 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 107.614 -1.254 . . . . 63.14 107.614 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -159.76 172.37 17.83 Favored 'General case' 0 C--N 1.352 0.713 0 CA-C-O 121.971 0.891 . . . . 73.23 111.524 176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -129.25 140.67 51.37 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 105.627 -1.99 . . . . 63.4 105.627 168.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 41.3 t -146.39 144.32 29.66 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.402 -0.962 . . . . 61.3 108.402 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.97 128.71 7.88 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.602 -0.518 . . . . 54.45 109.602 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.0 t -129.13 123.22 58.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.01 -0.995 . . . . 61.14 108.567 174.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.548 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 74.1 mt-30 -98.25 91.28 5.16 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 107.224 -1.398 . . . . 72.1 107.224 175.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -78.34 102.53 7.76 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.868 -0.606 . . . . 72.51 109.572 -175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.19 145.44 23.22 Favored Glycine 0 C--N 1.339 0.712 0 CA-C-N 115.417 -0.811 . . . . 64.45 111.186 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.533 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -149.6 116.06 0.76 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.343 -1.103 . . . . 41.32 110.343 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.678 HD12 HD11 ' C' ' 51' ' ' LEU . 12.7 mm -81.44 127.82 39.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 107.932 -1.136 . . . . 74.44 107.932 174.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -134.88 123.5 23.56 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 123.358 0.663 . . . . 63.54 109.553 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 20.5 p -77.04 106.54 8.8 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 107.729 -1.211 . . . . 73.31 107.729 168.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 48.3 mt -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.127 -1.064 . . . . 62.1 108.127 -177.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.528 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -127.84 158.63 37.23 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 123.767 0.827 . . . . 50.44 110.25 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.12 -51.76 3.78 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 115.828 -0.623 . . . . 71.51 113.029 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 14.7 tt -81.28 145.47 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 123.539 0.735 . . . . 74.25 109.978 -174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.12 -179.36 8.07 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.99 0.516 . . . . 62.22 110.759 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.26 -148.64 47.72 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.61 -0.723 . . . . 20.0 112.789 -178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 77.0 p -69.67 -18.05 63.53 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.22 1.008 . . . . 72.13 111.453 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -64.9 -46.19 82.76 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 73.54 110.108 174.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 57.5 ttp -68.07 -32.2 72.37 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.451 -0.795 . . . . 74.55 110.181 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.74 85.09 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.333 0.653 . . . . 53.32 110.981 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.452 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 46.7 t-80 -65.78 -32.75 74.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.719 0.808 . . . . 75.23 111.308 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.531 ' HG ' ' HG ' ' C' ' 102' ' ' CYS . 43.8 t -76.33 -55.34 5.64 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.89 0.376 . . . . 54.44 110.294 177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' C' ' 48' ' ' SER . 9.6 tt -65.64 -31.82 73.05 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.298 1.039 . . . . 65.2 111.225 -172.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.85 10.06 55.54 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.44 -0.644 . . . . 63.3 114.024 -175.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -151.75 -59.03 0.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 CA-C-N 117.776 0.788 . . . . 73.11 111.657 -178.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -69.88 -55.54 9.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.449 0.7 . . . . 62.43 111.967 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.531 ' HG ' ' HG ' ' C' ' 97' ' ' CYS . 9.8 m -61.56 -45.82 93.85 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 123.635 0.774 . . . . 64.1 112.039 -177.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.526 ' HB3' HD23 ' C' ' 60' ' ' LEU . 39.1 Cg_exo -61.05 -32.18 91.67 Favored 'Trans proline' 0 C--N 1.397 3.089 0 C-N-CA 122.349 2.032 . . . . 73.24 113.501 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.95 -35.63 79.03 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 123.457 0.703 . . . . 72.32 110.882 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 46.2 mm -62.42 -44.69 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 123.586 0.755 . . . . 73.15 110.254 175.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.533 HD21 ' HA3' ' C' ' 82' ' ' GLY . 62.7 mt -82.28 -23.96 34.97 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.869 -1.06 . . . . 72.43 112.506 -171.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.406 ' HE2' ' HA ' ' C' ' 130' ' ' PRO . 39.8 t80 -54.8 -48.22 96.15 Favored Pre-proline 0 CA--C 1.564 1.485 0 C-N-CA 124.84 1.256 . . . . 75.45 113.59 -172.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.5 ' HA ' ' HD3' ' C' ' 111' ' ' ARG . 23.3 Cg_exo -63.7 -34.44 62.48 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 121.932 1.755 . . . . 73.04 113.019 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -64.75 -44.75 89.1 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.105 0.562 . . . . 74.12 110.46 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.79 -42.62 99.24 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.445 -0.798 . . . . 41.43 110.667 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.5 ' HD3' ' HA ' ' C' ' 108' ' ' PRO . 39.4 mtp180 -56.38 -53.39 57.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.966 0.906 . . . . 74.52 111.402 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -69.46 -32.76 71.89 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 123.711 0.632 . . . . 74.34 110.794 -173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 8.6 t -70.6 -29.96 66.5 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 122.565 0.346 . . . . 65.32 110.811 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.45 HD13 HG23 ' C' ' 64' ' ' VAL . 65.3 mt -73.65 -49.09 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 122.996 0.518 . . . . 74.34 109.724 171.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 92.3 m -59.47 -35.42 74.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.026 0.93 . . . . 73.03 111.454 -175.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.1 t -63.31 -51.27 66.73 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.241 -0.891 . . . . 54.5 109.114 173.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.6 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -60.87 -32.72 72.14 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.754 0.822 . . . . 73.3 112.704 179.255 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.5 t -73.72 -37.6 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 123.458 0.703 . . . . 53.44 110.141 178.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 63.6 p -75.54 -25.36 57.09 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.923 0.489 . . . . 71.23 110.745 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.6 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.0 mtt-85 -70.49 -44.0 68.57 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.703 0.801 . . . . 71.21 109.567 172.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.33 -5.5 85.58 Favored Glycine 0 C--N 1.351 1.403 0 O-C-N 123.528 0.517 . . . . 44.14 112.618 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p 67.31 25.97 8.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.534 1.933 . . . . 64.11 113.336 170.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.43 ' HB2' HG13 ' C' ' 118' ' ' VAL . 98.6 m-85 -85.45 163.77 43.32 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 123.682 0.793 . . . . 64.23 109.794 173.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -54.38 151.36 30.11 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.128 2.552 . . . . 52.44 113.984 177.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.488 HE22 HD22 ' C' ' 127' ' ' ASN . 0.6 OUTLIER -58.92 112.33 1.62 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.861 1.264 . . . . 60.41 110.069 -173.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 4.9 tt -126.4 107.75 10.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 108.846 -0.798 . . . . 73.32 108.846 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.488 HD22 HE22 ' C' ' 125' ' ' GLN . 6.0 p30 -126.62 133.6 50.97 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 107.196 -1.409 . . . . 41.14 107.196 173.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.8 113.89 4.66 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 107.75 -1.204 . . . . 72.24 107.75 -179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -57.67 134.1 82.61 Favored Pre-proline 0 CA--C 1.547 0.852 0 O-C-N 123.883 0.74 . . . . 63.31 110.846 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.505 ' HG2' ' HB ' ' A' ' 16' ' ' ILE . 52.7 Cg_exo -56.13 90.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 123.485 2.79 . . . . 41.02 113.248 -175.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -104.67 110.37 30.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 108.537 -0.912 . . . . 75.02 108.537 174.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -85.7 89.32 7.71 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.62 -0.718 . . . . 74.44 110.509 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.64 -40.81 93.36 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 114.568 -1.196 . . . . 71.14 109.13 171.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -53.47 -38.47 63.65 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 113.68 -1.6 . . . . 72.21 112.969 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.64 -34.49 77.95 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.611 0.765 . . . . 43.14 112.846 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.0 -47.77 79.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 109.689 -0.486 . . . . 72.15 109.689 177.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.486 ' HA ' ' HD1' ' C' ' 140' ' ' TYR . 80.3 m-85 -82.41 -14.44 55.16 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.767 0.827 . . . . 74.32 112.63 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 26.1 ttt -68.24 -44.51 75.53 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.488 0.715 . . . . 61.43 109.844 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -64.18 -35.16 79.9 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.768 0.668 . . . . 74.21 111.431 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' C' ' 137' ' ' PHE . 65.6 m-85 -53.95 -83.9 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.13 0.972 . . . . 75.5 110.759 170.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.623 ' H ' HD23 ' C' ' 141' ' ' LEU . 1.3 pt? -102.66 100.65 10.72 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.645 0.736 . . . . 53.51 109.135 177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -89.12 47.55 1.51 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.184 0.994 . . . . 74.12 109.554 178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -81.33 75.84 8.28 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.613 0.72 . . . . 75.54 111.513 -170.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 15.0 mm100 -141.79 88.98 2.16 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 106.871 -1.529 . . . . 75.15 106.871 172.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.62 96.48 0.94 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.178 0.514 . . . . 75.04 110.382 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.3 83.0 0.05 OUTLIER Glycine 0 C--N 1.335 0.484 0 N-CA-C 109.522 -1.431 . . . . 62.3 109.522 176.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -49.52 144.3 5.92 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 124.444 1.098 . . . . 74.34 113.06 -171.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -111.34 47.43 1.04 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 111.024 -0.83 . . . . 42.2 111.024 176.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 53.1 p -62.67 97.39 0.1 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.08 0.552 . . . . 60.43 109.869 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -83.28 -173.07 4.5 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.081 -0.963 . . . . 62.24 110.748 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.01 106.76 5.91 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 106.987 -1.486 . . . . 63.44 106.987 165.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 -53.06 103.64 0.08 Allowed 'General case' 0 N--CA 1.477 0.901 0 O-C-N 124.46 1.1 . . . . 74.24 111.055 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.1 158.11 23.63 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.835 -1.075 . . . . 71.25 111.405 -177.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -147.0 113.45 5.95 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 109.131 -0.692 . . . . 72.22 109.131 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.909 0 N-CA-C 108.962 -0.755 . . . . 51.14 108.962 -176.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 121.195 0.521 . . . . 42.43 110.267 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 43.8 t -146.21 156.77 43.63 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.952 -1.129 . . . . 53.12 107.952 177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -166.98 108.99 0.67 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.596 0.358 . . . . 73.23 110.368 -178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.639 ' HB2' ' H ' ' D' ' 90' ' ' GLU . 83.9 mm-40 -120.9 122.9 41.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.644 -0.873 . . . . 73.33 108.644 173.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -133.16 70.82 1.46 Allowed 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.011 -1.477 . . . . 72.2 107.011 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -111.46 155.88 22.52 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.191 -1.368 . . . . 73.24 109.892 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.1 m -79.35 11.52 2.9 Favored 'General case' 0 CA--C 1.562 1.428 0 C-N-CA 124.051 0.941 . . . . 74.42 111.883 -170.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -77.07 -24.91 51.89 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.708 -0.62 . . . . 74.11 111.388 173.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp -31.89 128.46 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.855 1.347 . . . . 72.24 114.363 -176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.6 m -138.69 139.93 38.6 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 106.979 -1.489 . . . . 74.31 106.979 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -144.79 114.44 7.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.268 -1.012 . . . . 75.24 108.268 -177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -129.87 142.54 50.65 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.98 -0.748 . . . . 71.52 108.98 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -91.1 101.59 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.041 -1.466 . . . . 55.34 107.041 176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -74.43 -46.67 38.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.491 0.717 . . . . 61.23 111.221 -169.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 40.6 ttt85 -166.9 133.77 2.4 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.957 -0.565 . . . . 74.14 110.072 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.509 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.7 mp -108.91 135.87 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 107.366 -1.346 . . . . 73.11 107.366 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -161.96 170.95 18.43 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-O 122.13 0.967 . . . . 73.3 112.423 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 46.6 p -104.55 119.17 38.37 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 114.679 -1.146 . . . . 71.01 109.088 172.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.512 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 36.7 mtpt -86.45 -30.79 21.78 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 110.056 -0.35 . . . . 61.25 110.056 175.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.644 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.9 t70 -145.9 137.59 25.05 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.857 -0.61 . . . . 64.33 109.984 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.555 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.3 mt -134.41 148.62 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 73.43 108.242 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 34.2 t -148.26 140.97 24.57 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.294 1.037 . . . . 74.52 109.07 171.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.523 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.4 t80 -148.36 111.39 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 105.708 -1.96 . . . . 62.44 105.708 169.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -123.03 110.48 15.4 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.457 0.703 . . . . 71.21 109.348 -175.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -106.2 88.14 2.97 Favored Pre-proline 0 CA--C 1.542 0.673 0 N-CA-C 108.063 -1.088 . . . . 62.52 108.063 177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -75.12 -45.52 0.27 Allowed 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.455 2.103 . . . . 74.34 112.405 -171.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.486 ' O ' HG23 ' D' ' 31' ' ' VAL . 36.3 m-80 -102.9 42.33 1.16 Allowed 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.048 0.939 . . . . 74.01 108.475 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.64 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -57.33 -51.96 77.8 Favored Pre-proline 0 CA--C 1.571 1.78 0 N-CA-C 114.225 1.194 . . . . 63.03 114.225 -169.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -85.59 -0.6 8.82 Favored 'Trans proline' 0 C--N 1.387 2.577 0 CA-C-N 121.591 1.604 . . . . 72.42 112.968 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.485 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 13.6 t-160 -83.05 -26.7 30.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.67 1.188 . . . . 71.32 109.011 173.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.486 HG23 ' O ' ' D' ' 27' ' ' ASN . 93.2 t -82.31 -24.29 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 C-N-CA 123.211 0.604 . . . . 71.34 110.114 174.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.489 ' HD1' HH11 ' C' ' 15' ' ' ARG . 60.5 t80 -53.98 -39.84 66.36 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 124.105 0.962 . . . . 72.13 112.542 176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -79.37 -13.73 59.42 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 112.246 0.461 . . . . 73.42 112.246 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -111.5 100.68 9.2 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 109.069 -0.715 . . . . 75.52 109.069 173.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -79.39 89.24 4.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.011 0.524 . . . . 71.03 109.8 177.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.562 ' HB3' HD11 ' D' ' 68' ' ' LEU . 17.0 t-105 -159.21 158.24 32.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 108.027 -1.101 . . . . 74.33 108.027 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -81.66 112.52 35.05 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.474 0.709 . . . . 53.01 110.508 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -48.88 139.15 25.71 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 123.771 2.981 . . . . 71.52 114.058 175.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.12 121.69 16.69 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 109.529 -0.545 . . . . 73.53 109.529 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' F' ' 142' ' ' ILE . 17.8 t -100.13 115.69 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.085 0.469 . . . . 60.33 110.572 -174.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -87.26 146.28 26.02 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.491 1.116 . . . . 74.22 108.901 170.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -110.18 131.03 55.42 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.179 -0.675 . . . . 44.15 109.179 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.54 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.5 m-20 -133.37 142.72 48.53 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.652 1.181 . . . . 55.5 108.195 171.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pp -138.49 164.75 28.59 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.788 0.435 . . . . 72.3 110.707 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 29.3 t70 -168.43 155.36 7.55 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.498 1.119 . . . . 64.41 108.721 174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -132.48 158.06 43.05 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.987 -0.745 . . . . 73.12 108.987 177.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.7 167.7 29.3 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.511 0.725 . . . . 63.34 109.632 177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.508 ' HA ' ' HA ' ' D' ' 58' ' ' VAL . 56.5 p -159.6 153.6 23.3 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.791 0.836 . . . . 63.23 110.196 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.5 p -151.52 142.59 23.13 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.933 0.893 . . . . 73.22 108.627 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -90.69 117.51 29.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.058 0.543 . . . . 73.44 109.591 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 44.7 mt -89.62 -31.66 17.45 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.511 -0.552 . . . . 72.34 109.511 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.75 -177.84 4.97 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.121 -0.945 . . . . 60.43 109.852 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -63.58 119.67 10.27 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.565 -1.198 . . . . 51.03 108.946 172.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 71.58 2.78 4.41 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.263 1.425 . . . . 71.15 112.741 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.1 t -113.77 123.91 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.539 0.736 . . . . 71.42 109.391 176.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -135.26 130.42 35.13 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.775 0.43 . . . . 73.13 110.516 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.3 tt0 -92.86 112.05 23.88 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.35 -0.982 . . . . 63.0 108.35 167.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' D' ' 48' ' ' SER . 12.7 m -102.3 137.87 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 108.203 -1.036 . . . . 75.13 108.203 170.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -110.39 140.27 30.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 109.182 -0.673 . . . . 75.12 109.182 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -112.56 123.81 51.14 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.175 -1.046 . . . . 63.4 108.175 177.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.3 ttm-85 -105.44 101.94 11.44 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 109.207 -0.664 . . . . 72.13 109.207 175.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -98.42 119.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.868 -1.16 . . . . 73.35 107.868 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 18.0 m -125.35 142.71 51.35 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.622 0.725 . . . . 64.25 109.675 -172.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -137.35 123.62 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 C-N-CA 124.881 1.273 . . . . 54.51 108.875 -170.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.9 m -115.72 108.48 16.41 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 108.788 -0.819 . . . . 62.21 108.788 172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.3 133.1 53.88 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.322 -0.622 . . . . 75.44 109.322 -175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.463 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 41.7 p -142.0 125.79 17.04 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 123.174 0.59 . . . . 74.42 109.661 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' D' ' 36' ' ' TRP . 28.0 tp -99.72 116.64 32.29 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.575 -0.898 . . . . 71.15 108.575 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.2 -133.16 23.98 Favored Glycine 0 C--N 1.347 1.176 0 O-C-N 123.72 0.637 . . . . 73.11 112.432 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -92.1 21.6 4.95 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.43 0.692 . . . . 65.01 110.847 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -141.14 146.41 36.98 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.249 0.619 . . . . 63.5 111.157 -170.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 75.1 m -68.67 130.8 43.88 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 123.249 0.619 . . . . 64.43 109.968 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.484 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -92.12 -64.12 1.15 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.574 0.75 . . . . 65.53 109.323 -178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -156.47 161.64 40.03 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.31 -0.859 . . . . 72.31 110.321 173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 71.8 mt -121.38 151.23 40.4 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.282 1.433 . . . . 72.14 107.163 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.7 t -156.98 141.53 16.72 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 110.153 -0.314 . . . . 71.15 110.153 -179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.92 137.67 14.3 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.654 0.782 . . . . 63.53 109.139 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' D' ' 113' ' ' CYS . 66.7 t -135.15 114.24 16.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 N-CA-C 109.44 -0.578 . . . . 75.04 109.44 176.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.644 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.5 mt-30 -91.93 85.16 5.48 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.221 -0.9 . . . . 74.25 108.89 171.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -80.15 101.89 9.07 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.913 -1.494 . . . . 73.4 109.705 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.27 142.36 15.99 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 111.759 -0.537 . . . . 70.03 111.759 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.3 133.65 5.55 Favored Glycine 0 C--O 1.236 0.279 0 N-CA-C 111.77 -0.532 . . . . 73.24 111.77 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 44.6 mt -87.87 128.85 39.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 107.602 -1.258 . . . . 70.21 107.602 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -128.59 144.6 51.18 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.788 0.835 . . . . 74.53 108.817 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 21.3 m -97.52 102.43 14.19 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.983 -0.747 . . . . 64.25 108.983 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.511 HG21 ' HG3' ' D' ' 94' ' ' MET . 3.4 mp -107.62 99.7 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 107.564 -1.273 . . . . 73.14 107.564 177.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -127.41 123.21 35.58 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.49 -0.559 . . . . 74.25 109.49 -178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 114.12 -10.8 22.5 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-O 118.571 -1.127 . . . . 64.55 114.872 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 mt -140.41 140.31 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-N 118.57 1.185 . . . . 72.41 110.424 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.639 ' H ' ' HB2' ' D' ' 4' ' ' GLN . 42.7 mt-10 -136.94 175.84 9.25 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.875 1.27 . . . . 72.11 109.856 -174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.36 -140.97 26.17 Favored Glycine 0 C--N 1.34 0.778 0 N-CA-C 114.537 0.575 . . . . 71.35 114.537 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 43.1 p -66.31 -32.45 73.86 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.057 0.943 . . . . 62.43 111.618 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -70.53 -40.96 73.14 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.436 0.694 . . . . 73.02 110.155 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.511 ' HG3' HG21 ' D' ' 86' ' ' ILE . 49.7 ttp -70.89 -32.68 69.72 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.533 -0.758 . . . . 72.01 110.564 174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.39 -44.24 83.61 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.226 0.61 . . . . 71.32 110.29 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -62.0 -34.0 75.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.698 0.799 . . . . 70.41 110.53 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.5 t -68.55 -51.43 42.9 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.919 -0.582 . . . . 73.24 110.387 176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 88.7 mt -73.4 -28.4 61.98 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.81 0.844 . . . . 54.21 112.597 -173.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.28 -4.44 25.45 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-O 119.216 -0.769 . . . . 70.34 114.393 -169.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -54.6 0.89 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 117.984 0.892 . . . . 73.34 110.629 178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -73.15 -43.49 61.46 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 122.718 0.407 . . . . 74.04 111.931 -173.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.426 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 63.4 m -70.35 -45.56 19.91 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 118.694 -0.67 . . . . 72.55 111.381 -177.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.516 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.2 Cg_exo -53.89 -36.37 83.04 Favored 'Trans proline' 0 C--N 1.393 2.883 0 C-N-CA 122.438 2.092 . . . . 74.35 113.229 165.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -64.97 -33.05 75.11 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.493 0.717 . . . . 54.11 110.928 178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.8 mm -68.4 -43.33 84.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 123.044 0.538 . . . . 70.05 110.059 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.0 mt -75.88 -19.63 58.71 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.318 -0.855 . . . . 73.44 111.738 -175.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.435 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 60.6 t80 -66.71 -42.26 43.65 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.946 -1.026 . . . . 74.24 113.413 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.43 -38.34 73.85 Favored 'Trans proline' 0 C--N 1.388 2.641 0 C-N-CA 121.902 1.735 . . . . 75.34 112.993 168.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -78.57 -35.32 46.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.106 0.962 . . . . 64.43 112.115 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.74 -42.07 74.43 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.253 0.621 . . . . 75.51 109.553 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.498 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.2 ttp180 -62.42 -46.84 86.76 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-N 114.331 -1.304 . . . . 72.4 109.922 173.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' B' ' 108' ' ' PRO . 2.6 tm-20 -56.35 -48.97 75.7 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 124.292 0.995 . . . . 70.44 111.553 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.437 ' HB3' HG21 ' D' ' 78' ' ' VAL . 49.4 t -61.24 -41.22 96.53 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.04 0.837 . . . . 65.42 110.903 -177.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.491 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.6 mt -63.29 -50.72 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.146 0.578 . . . . 74.3 110.105 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 85.8 m -54.03 -43.26 69.99 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.969 1.308 . . . . 75.14 111.134 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.8 t -69.16 -44.96 71.22 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.756 -1.111 . . . . 51.03 110.605 -177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.9 mtm -67.81 -33.2 74.33 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.671 0.388 . . . . 65.0 111.827 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.6 t -67.53 -42.52 87.0 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.944 0.897 . . . . 74.11 110.248 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 97.7 p -72.72 -29.45 63.37 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 122.668 0.387 . . . . 62.43 110.897 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 74.9 mtt-85 -74.62 -26.98 60.25 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.859 0.864 . . . . 74.33 110.303 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.85 12.42 67.42 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.531 -0.758 . . . . 35.34 112.731 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.517 HG23 ' HB3' ' C' ' 17' ' ' TYR . 60.6 p 56.57 21.94 6.19 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 125.874 1.67 . . . . 65.21 113.243 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -95.41 154.85 39.26 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.751 0.82 . . . . 73.53 109.955 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.88 137.94 83.77 Favored 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 123.418 2.745 . . . . 74.22 112.671 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -57.8 124.91 20.81 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 123.774 0.672 . . . . 74.2 112.233 -171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.478 HD12 HD23 ' F' ' 139' ' ' LEU . 5.1 tt -108.51 99.05 8.48 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.727 -0.842 . . . . 53.14 108.727 -177.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -100.61 103.07 14.36 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.553 -0.906 . . . . 60.52 108.553 173.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.498 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 0.2 OUTLIER -64.06 116.47 5.94 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.375 0.67 . . . . 53.1 109.636 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.0 145.33 99.12 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 123.305 0.642 . . . . 60.52 111.927 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -58.73 106.0 0.26 Allowed 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.569 2.179 . . . . 72.23 111.508 172.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 30.9 m -108.04 147.82 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 123.205 0.602 . . . . 54.45 110.351 -177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.526 HD21 ' HB2' ' D' ' 134' ' ' ASP . 5.3 t-20 -79.33 91.1 5.01 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.051 -0.522 . . . . 74.31 109.77 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -76.14 -22.24 55.68 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.849 -0.614 . . . . 71.41 110.624 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.526 ' HB2' HD21 ' D' ' 132' ' ' ASN . 4.9 m-20 -53.53 -41.09 66.02 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.318 1.047 . . . . 74.22 112.062 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.49 -54.22 43.2 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 123.959 0.787 . . . . 54.54 110.797 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.67 -42.11 96.42 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.543 0.737 . . . . 52.51 111.584 -178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -65.18 -42.32 93.73 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.166 0.986 . . . . 73.32 110.627 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 7.4 ttp -62.07 -46.31 89.67 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.284 1.033 . . . . 63.24 110.824 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -60.64 -41.71 95.46 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.081 0.553 . . . . 72.32 110.676 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -62.8 -41.98 99.51 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 124.283 1.033 . . . . 74.12 111.913 -176.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 mp -64.52 -30.14 71.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.333 0.653 . . . . 63.0 111.737 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -82.24 1.24 37.53 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.295 0.638 . . . . 72.31 111.326 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -127.11 44.5 2.9 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.524 0.73 . . . . 73.32 109.611 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -164.24 143.25 7.46 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.044 0.538 . . . . 63.31 111.431 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.04 99.71 0.21 Allowed 'General case' 0 C--O 1.24 0.58 0 C-N-CA 125.326 1.45 . . . . 45.24 107.272 172.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -177.59 81.65 0.07 OUTLIER Glycine 0 C--N 1.342 0.875 0 N-CA-C 111.615 -0.594 . . . . 63.44 111.615 -177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -89.28 113.34 24.59 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.701 0.8 . . . . 71.04 109.524 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.61 -118.9 0.88 Allowed Glycine 0 C--N 1.34 0.769 0 N-CA-C 111.112 -0.795 . . . . 74.31 111.112 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 25.8 m 67.29 111.97 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.836 1.254 . . . . 71.13 111.863 177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -140.15 90.44 2.37 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.173 -1.047 . . . . 74.33 108.173 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -76.86 74.04 3.48 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.727 -0.669 . . . . 73.03 109.22 175.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 34.7 t-80 -89.32 70.71 8.19 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.584 -0.895 . . . . 60.23 108.584 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -78.76 92.2 4.78 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 108.047 -1.094 . . . . 73.05 108.047 173.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -97.76 -21.94 16.69 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.773 -0.648 . . . . 74.24 110.263 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.09 0 N-CA-C 108.934 -0.765 . . . . 50.5 108.934 170.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 31.2 t0 . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 109.282 -0.636 . . . . 73.1 109.282 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 60.69 49.6 6.21 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.794 0.838 . . . . 65.23 109.505 -168.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -86.19 106.28 17.18 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.233 -0.894 . . . . 74.34 110.246 -176.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -108.04 129.76 55.12 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.757 0.823 . . . . 75.2 109.141 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.09 79.85 2.92 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.519 0.676 . . . . 71.23 109.353 173.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.41 167.77 20.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 114.727 -1.124 . . . . 72.24 109.327 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.77 160.38 4.55 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.697 0.399 . . . . 62.51 111.472 178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.565 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.6 mp -62.75 -15.23 52.34 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.605 0.965 . . . . 75.22 113.605 -165.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -114.73 90.81 23.31 Favored Pre-proline 0 CA--C 1.549 0.917 0 N-CA-C 108.564 -0.902 . . . . 73.3 108.564 166.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -88.98 -171.5 0.57 Allowed 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.28 2.653 . . . . 72.33 112.392 173.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 62.71 -176.42 0.14 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.669 1.187 . . . . 72.33 111.957 -177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 11.7 t -133.35 27.36 4.11 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.24 -1.022 . . . . 74.2 108.24 172.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.5 ' HZ3' ' HB2' ' B' ' 137' ' ' PHE . 8.9 m95 62.61 -88.02 0.02 OUTLIER 'General case' 0 C--N 1.359 0.987 0 CA-C-N 114.516 -1.22 . . . . 70.12 110.36 -166.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 35.5 t70 67.64 143.04 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.025 1.33 . . . . 62.41 112.598 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.5 11.32 8.31 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.912 1.285 . . . . 65.44 112.261 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 86.4 t -89.22 100.76 11.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 124.565 1.146 . . . . 74.44 109.797 -178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -144.97 98.42 3.17 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.057 -1.09 . . . . 72.12 108.057 175.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -73.39 89.61 1.63 Allowed 'General case' 0 CA--C 1.543 0.673 0 CA-C-N 115.621 -0.718 . . . . 72.23 109.478 -177.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -130.0 94.14 3.65 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.281 -1.377 . . . . 74.12 107.281 175.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 156.37 130.07 1.23 Allowed Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.443 -1.063 . . . . 63.21 110.443 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 74.02 -59.22 0.56 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.512 1.525 . . . . 73.43 112.298 -177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 56.88 -142.16 0.77 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.525 0.73 . . . . 60.21 109.537 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.454 ' HA ' ' HB2' ' B' ' 129' ' ' ALA . 24.2 pt -65.75 -10.76 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-N 118.994 0.816 . . . . 73.35 112.679 -177.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 70.4 -74.04 0.09 Allowed 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 125.373 1.469 . . . . 73.43 112.677 169.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -119.21 94.57 48.46 Favored Pre-proline 0 N--CA 1.478 0.971 0 C-N-CA 123.986 0.914 . . . . 63.24 110.174 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.9 -20.65 25.54 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.587 2.191 . . . . 63.1 112.337 166.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' C' ' 32' ' ' PHE . 7.3 pt 55.6 -171.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 126.653 1.981 . . . . 53.31 113.093 176.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.481 ' O ' HG13 ' E' ' 134' ' ' ILE . . . -76.26 165.78 24.39 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.263 0.625 . . . . 61.32 110.45 172.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.807 ' HA ' ' HB3' ' C' ' 36' ' ' TRP . 19.1 t 67.71 68.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-O 122.657 1.218 . . . . 74.54 110.171 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -98.12 -28.86 13.55 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.911 -1.495 . . . . 71.2 110.047 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -130.0 140.29 50.91 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.526 1.131 . . . . 64.4 109.233 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 25.8 tp -134.46 118.91 17.89 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.683 0.793 . . . . 75.2 109.649 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 35.0 p -152.29 80.49 1.24 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.799 0.84 . . . . 54.43 109.206 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 2.1 tt -151.96 89.85 1.49 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 106.841 -1.54 . . . . 72.22 106.841 175.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' C' ' 42' ' ' LEU . 11.3 tt -163.83 -143.9 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.347 0 N-CA-C 106.538 -1.653 . . . . 74.43 106.538 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . 0.512 ' H ' HG12 ' E' ' 142' ' ' ILE . 21.6 p90 -75.56 67.55 2.08 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-N 119.784 1.174 . . . . 75.01 110.339 172.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -70.03 113.12 6.92 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.445 -0.798 . . . . 51.51 110.399 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt 63.49 26.56 14.85 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.702 1.201 . . . . 70.44 112.261 178.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.53 -70.73 0.23 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.514 0.725 . . . . 74.25 111.574 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? 63.47 -168.27 0.2 Allowed 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.294 1.038 . . . . 75.22 112.596 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 5.8 mp -84.46 156.21 62.46 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.917 0.887 . . . . 73.02 109.55 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo . . . . . 0 CA--C 1.564 2.021 0 C-N-CA 122.203 1.935 . . . . 70.54 111.227 170.345 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 109.872 -0.418 . . . . 73.13 109.872 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -138.94 151.22 46.73 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.066 0.546 . . . . 61.23 110.478 177.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -100.17 8.81 43.59 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.515 -0.766 . . . . 74.4 110.51 172.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 60.51 89.73 0.07 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.808 1.243 . . . . 72.1 110.305 -175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 69.64 -179.7 0.23 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 125.504 1.522 . . . . 64.0 111.611 -175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -157.41 147.43 20.65 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 107.794 -1.187 . . . . 70.25 107.794 171.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -80.83 78.47 7.61 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 109.289 -0.634 . . . . 74.22 109.289 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 80.1 mt -64.57 104.4 0.8 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.999 -1.0 . . . . 74.22 110.107 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -144.55 149.7 44.8 Favored Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 124.269 1.028 . . . . 73.11 109.614 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.76 137.21 34.94 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.893 2.395 . . . . 73.14 112.121 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -58.76 -47.59 84.14 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.767 0.827 . . . . 75.23 111.528 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 95.6 m -157.61 126.25 5.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.018 0.927 . . . . 75.23 109.717 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 73.8 t-105 -151.9 88.54 1.4 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.69 -1.226 . . . . 70.31 107.69 169.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -130.51 -3.21 4.28 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.943 0.897 . . . . 61.02 111.276 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -111.35 97.62 6.9 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.653 0.781 . . . . 71.55 109.637 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.85 99.38 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.568 0.747 . . . . 71.33 109.195 177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -82.89 77.88 9.56 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.704 0.801 . . . . 74.34 109.536 173.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -80.82 125.82 30.56 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.938 -0.764 . . . . 72.03 108.938 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -147.8 -171.03 3.72 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.057 0.943 . . . . 62.35 109.444 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.92 176.09 45.33 Favored Glycine 0 C--N 1.343 0.931 0 CA-C-N 116.001 -0.545 . . . . 72.33 111.748 -177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -91.0 106.23 18.37 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.232 0.613 . . . . 64.12 109.678 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 42' ' ' LEU . 2.7 mm? -62.99 -44.23 96.59 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.178 0.591 . . . . 60.53 111.025 -175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 1.8 pp -141.52 168.14 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.578 1.151 . . . . 74.24 108.96 172.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -156.03 19.0 0.37 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.212 0.605 . . . . 73.41 110.722 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -141.64 103.49 5.89 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 123.137 0.575 . . . . 61.11 109.591 -177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . 0.592 ' HB2' ' HZ3' ' A' ' 36' ' ' TRP . 41.1 Cg_endo -89.05 45.84 0.9 Allowed 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 123.014 2.476 . . . . 65.0 112.753 179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 14.8 tt -62.67 116.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.034 0 CA-C-O 121.198 0.523 . . . . 64.33 111.002 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.7 86.61 4.65 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 115.407 -0.815 . . . . 63.24 109.208 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.615 HG23 ' H ' ' F' ' 137' ' ' GLU . 2.5 m -80.98 -69.82 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.074 -0.966 . . . . 71.53 109.923 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . 0.615 ' H ' HG23 ' F' ' 136' ' ' VAL . 3.8 mm-40 52.7 -82.9 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.397 0 C-N-CA 125.65 1.58 . . . . 73.24 113.287 176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.65 148.12 35.33 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.367 0.667 . . . . 72.35 109.68 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.478 HD23 HD12 ' D' ' 126' ' ' LEU . 10.4 tp -94.34 112.26 24.04 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.288 0.635 . . . . 73.24 110.863 -169.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 52.0 p -100.75 -160.34 0.79 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.358 1.063 . . . . 64.25 110.394 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 8.0 mp 64.25 26.5 13.76 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.953 1.301 . . . . 74.44 110.856 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.608 ' HB ' ' HB ' ' D' ' 40' ' ' VAL . 10.3 tt -144.39 155.55 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 C-N-CA 125.491 1.516 . . . . 55.23 107.961 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 65.02 25.86 12.63 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.805 1.242 . . . . 71.13 109.98 -174.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -60.72 115.44 3.65 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.357 -1.292 . . . . 63.31 109.071 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? 79.59 -48.69 0.38 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 125.728 1.611 . . . . 73.44 111.934 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -146.1 155.22 42.61 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.002 0.521 . . . . 73.21 110.753 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . 0.438 HD11 ' NE2' ' B' ' 12' ' ' GLN . 3.8 mm? -64.76 -42.1 95.38 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 124.741 1.216 . . . . 64.43 111.62 -176.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 62.0 tp -123.92 85.88 53.84 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.704 -1.221 . . . . 74.31 107.704 178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo . . . . . 0 C--N 1.376 2.005 0 C-N-CA 123.319 2.679 . . . . 51.34 112.718 -178.727 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.478 0.952 0 N-CA-C 110.362 -0.236 . . . . 72.33 110.362 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.3 m -81.22 159.08 24.65 Favored 'General case' 0 C--O 1.247 0.959 0 C-N-CA 123.476 0.71 . . . . 51.54 109.094 167.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -66.39 110.87 3.26 Favored 'General case' 0 C--O 1.238 0.478 0 O-C-N 123.494 0.496 . . . . 75.23 110.465 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.6 mm-40 -66.18 -42.02 89.45 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 107.209 -1.404 . . . . 74.32 107.209 169.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 64.49 -69.91 0.08 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.946 2.098 . . . . 75.11 113.57 163.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -60.12 92.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.451 1.1 . . . . 64.42 111.325 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 t -117.1 106.11 13.0 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.024 -1.473 . . . . 74.12 107.024 167.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -62.26 -70.55 0.19 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.637 0.775 . . . . 65.04 111.265 -172.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 67.8 mtt -142.11 138.06 31.39 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.127 0.971 . . . . 71.42 108.833 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -142.92 134.73 26.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.618 0.767 . . . . 41.34 110.233 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -139.3 115.73 10.55 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 107.089 -1.449 . . . . 75.42 107.089 168.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -149.79 134.47 17.64 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.545 0.338 . . . . 73.42 111.068 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 16' ' ' ILE . 2.7 pp -80.93 132.1 32.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 108.312 -0.996 . . . . 75.12 108.312 169.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -113.8 -38.37 4.27 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.962 0.505 . . . . 64.41 110.792 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.4 ttt85 -165.15 123.18 1.62 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 109.911 -0.403 . . . . 73.21 109.911 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.569 HD11 ' HB ' ' A' ' 13' ' ' ILE . 4.5 mp -121.71 123.39 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.083 -1.08 . . . . 74.42 108.083 178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.669 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 9.5 p90 -172.23 176.58 3.37 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.511 0.724 . . . . 75.12 110.929 -169.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 64.9 p -102.01 120.84 41.07 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.76 0.824 . . . . 71.34 108.832 177.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HD3' HG22 ' A' ' 59' ' ' VAL . 18.5 ptmt -98.44 -27.62 13.99 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.196 0.198 . . . . 65.22 111.155 178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.751 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 13.7 m-20 -137.77 129.52 28.46 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.759 -0.83 . . . . 64.0 108.759 175.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.582 HG23 HG22 ' A' ' 78' ' ' VAL . 54.6 mt -132.34 137.46 54.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 108.144 -1.058 . . . . 53.32 108.144 171.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.9 t -145.19 127.23 15.56 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.8 0.84 . . . . 73.1 109.405 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.677 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 88.6 t80 -131.12 133.01 45.2 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 106.692 -1.595 . . . . 74.02 106.692 171.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -141.0 119.34 12.17 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.394 0.677 . . . . 75.42 109.522 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -125.12 82.1 62.29 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 107.831 -1.174 . . . . 61.25 107.831 176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.31 -35.89 29.96 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.753 2.302 . . . . 72.43 111.369 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 72' ' ' THR . 78.5 m-20 -111.49 35.63 3.55 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.66 -1.155 . . . . 42.21 109.458 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.594 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -57.68 -47.14 99.46 Favored Pre-proline 0 CA--C 1.568 1.656 0 C-N-CA 123.988 0.915 . . . . 60.43 111.803 171.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -73.38 -13.86 25.3 Favored 'Trans proline' 0 C--N 1.403 3.42 0 C-N-CA 122.419 2.079 . . . . 54.24 113.428 176.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -69.82 -32.59 71.11 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.423 0.289 . . . . 74.0 110.46 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.565 ' HA ' ' HB2' ' A' ' 34' ' ' LYS . 17.5 t -64.98 -19.21 25.21 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.224 0 C-N-CA 122.84 0.456 . . . . 74.51 110.793 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.64 -41.09 80.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.564 0.746 . . . . 75.13 111.3 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.6 pp0? -99.89 -23.53 14.92 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.143 0.577 . . . . 63.32 111.55 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 31' ' ' VAL . 30.2 mmtp -77.27 144.97 37.77 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.283 0.563 . . . . 64.52 111.767 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -79.82 158.1 26.87 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.91 -1.041 . . . . 73.33 110.067 176.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -90.22 80.17 6.28 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.054 0.931 . . . . 73.45 110.649 -174.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -135.73 74.56 58.29 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.157 -1.383 . . . . 61.42 107.434 168.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -91.99 144.39 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.764 2.309 . . . . 62.31 112.567 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -97.1 115.6 27.8 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 107.848 -1.167 . . . . 74.43 107.848 174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 65' ' ' THR . 85.0 t -95.26 135.94 27.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 123.545 0.738 . . . . 55.23 110.133 -175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.527 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 53.3 mtpt -120.62 143.4 48.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.439 0.695 . . . . 72.42 109.492 173.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 92.8 mt -133.22 108.2 8.63 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 114.66 -1.154 . . . . 72.11 109.21 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -123.48 117.66 25.64 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.604 1.162 . . . . 64.2 108.662 -177.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' N ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -118.4 159.91 22.61 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.075 0.95 . . . . 63.15 110.847 -172.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.476 ' O ' HD23 ' A' ' 60' ' ' LEU . 24.1 t70 -157.83 148.66 21.02 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.38 0.672 . . . . 71.11 110.369 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.494 HG21 ' O ' ' A' ' 98' ' ' LEU . 78.4 m -131.72 134.49 45.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.509 0.724 . . . . 61.53 110.092 175.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.78 135.69 29.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.748 0.819 . . . . 72.14 109.825 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.8 m -113.96 157.88 21.86 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.131 0.572 . . . . 64.5 109.507 174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.7 t -160.79 116.07 2.2 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.392 -0.595 . . . . 74.13 109.392 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.654 HE21 ' H ' ' A' ' 54' ' ' ASP . 62.6 tt0 -70.98 108.66 4.67 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 123.355 0.662 . . . . 61.43 110.18 -173.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' A' ' 57' ' ' GLU . 71.6 mt -79.04 -40.24 31.87 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.859 0.864 . . . . 72.35 110.89 175.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.28 -176.12 5.1 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.198 0.999 . . . . 71.54 109.004 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -56.79 102.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.347 0.659 . . . . 74.43 111.518 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.654 ' H ' HE21 ' A' ' 50' ' ' GLN . 3.6 m-20 58.41 29.67 18.56 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.201 1.4 . . . . 75.32 112.631 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.3 t -112.13 122.22 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 106.5 -1.667 . . . . 71.54 106.5 168.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -135.64 133.43 38.2 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.492 -0.929 . . . . 73.34 108.492 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 83' ' ' ILE . 35.0 tt0 -85.8 121.72 28.85 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 108.644 -0.873 . . . . 72.44 108.644 169.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.2 t -101.57 115.12 42.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.999 0.919 . . . . 73.13 108.715 175.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.416 HG22 ' HD3' ' A' ' 19' ' ' LYS . 97.6 t -97.29 135.09 32.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 115.228 -0.896 . . . . 65.54 109.257 176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.476 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.2 OUTLIER -110.73 115.09 28.95 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.098 -1.445 . . . . 74.41 107.098 170.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 63.2 ttp85 -102.64 106.02 16.61 Favored 'General case' 0 N--CA 1.462 0.155 0 N-CA-C 109.014 -0.735 . . . . 64.21 109.014 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -103.32 133.02 48.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 N-CA-C 108.47 -0.937 . . . . 71.01 108.47 175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -123.54 125.23 44.5 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.849 -0.797 . . . . 62.31 108.849 177.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 114' ' ' ILE . 61.4 t -118.42 130.83 72.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 N-CA-C 107.624 -1.25 . . . . 73.52 107.624 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 17.2 m -127.7 149.45 50.21 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.497 -0.927 . . . . 63.41 108.497 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.24 121.26 13.69 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.256 -1.387 . . . . 61.23 107.256 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.6 m -144.47 129.24 18.27 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.102 0.561 . . . . 74.05 110.481 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.41 HD13 ' HD2' ' A' ' 34' ' ' LYS . 2.4 tt -88.04 80.92 7.57 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 106.452 -1.685 . . . . 71.41 106.452 175.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.77 -110.17 2.98 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-N 114.67 -1.15 . . . . 72.34 111.649 -175.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -91.74 -26.31 18.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.081 0.952 . . . . 73.05 111.291 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -83.34 116.44 22.46 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.84 -0.8 . . . . 74.54 108.84 178.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 32.9 m -77.43 126.56 31.11 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 110.056 -0.35 . . . . 72.32 110.056 178.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.55 -52.39 9.12 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.382 -0.97 . . . . 61.32 108.382 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -161.95 170.33 19.54 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.06 -0.973 . . . . 73.31 111.204 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.5 tp -141.12 148.77 40.62 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.34 1.456 . . . . 73.45 107.936 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 62.4 m -142.82 139.74 31.04 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.488 1.115 . . . . 74.41 108.488 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -149.41 118.96 6.93 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.965 -0.754 . . . . 65.2 108.965 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.582 HG22 HG23 ' A' ' 21' ' ' ILE . 54.8 t -122.82 118.89 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 121.124 0.488 . . . . 74.54 109.715 175.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 48.5 mt-30 -89.92 91.46 8.6 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 114.971 -1.013 . . . . 75.55 108.97 170.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -76.73 97.65 4.54 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 114.593 -1.185 . . . . 75.44 108.6 175.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.8 140.38 17.09 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.789 -0.924 . . . . 40.51 110.789 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.72 120.64 1.52 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 109.858 -1.297 . . . . 75.34 109.858 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 57' ' ' GLU . 38.6 mt -81.75 129.26 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 108.703 -0.851 . . . . 63.33 108.703 177.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -135.73 122.15 20.61 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 107.857 -1.164 . . . . 62.43 107.857 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 23.8 t -90.96 105.97 18.2 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.044 -0.724 . . . . 33.1 109.044 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 45.2 pt -122.01 135.03 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.349 0.66 . . . . 72.34 110.537 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.73 157.81 42.54 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 124.613 1.165 . . . . 71.12 109.476 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.21 -18.68 9.56 Favored Glycine 0 N--CA 1.471 1.004 0 N-CA-C 114.601 0.601 . . . . 52.43 114.601 174.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.7 pp -112.98 133.3 59.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 108.319 -0.993 . . . . 71.55 108.319 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -147.39 174.32 11.79 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.875 0.87 . . . . 73.14 109.664 -169.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.6 -115.42 7.12 Favored Glycine 0 C--N 1.346 1.101 0 CA-C-O 119.623 -0.543 . . . . 44.01 113.182 177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.3 p -71.26 -22.57 61.95 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.297 0.639 . . . . 63.23 111.418 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.42 -50.53 44.9 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.243 1.017 . . . . 73.42 110.789 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.34 -27.65 52.8 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 116.012 -0.54 . . . . 74.3 110.14 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.54 -39.94 94.68 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.334 0.654 . . . . 54.52 110.348 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.407 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 25.7 t-80 -65.58 -54.28 30.09 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 114.532 -1.213 . . . . 63.53 110.219 170.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.703 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 62.7 m -68.2 -59.34 3.29 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.047 0.758 . . . . 71.35 113.047 -168.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 46' ' ' THR . 92.6 mt -67.71 -25.72 65.8 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.234 0.457 . . . . 73.13 112.234 -177.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.24 -13.77 56.91 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-O 119.448 -0.64 . . . . 42.03 114.084 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.678 ' HB2' ' HD2' ' A' ' 133' ' ' PHE . . . -140.76 -67.27 0.42 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 117.775 0.788 . . . . 63.34 112.638 -173.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.703 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -50.34 -57.71 7.31 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 124.611 1.164 . . . . 54.22 113.423 -175.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 52.6 m -71.69 -45.37 12.56 Favored Pre-proline 0 CA--C 1.559 1.312 0 CA-C-O 118.562 -0.732 . . . . 71.45 112.93 -172.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.92 -25.25 74.19 Favored 'Trans proline' 0 C--N 1.387 2.577 0 C-N-CA 121.548 1.499 . . . . 74.32 113.516 168.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 37.1 t-20 -69.25 -37.47 77.97 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.45 -0.574 . . . . 72.25 109.45 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 24.0 mm -63.03 -44.78 99.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.758 0.823 . . . . 64.11 110.489 171.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 90.7 mt -74.85 -24.02 58.52 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-N 115.568 -0.742 . . . . 73.33 112.249 -173.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -67.08 -44.57 50.22 Favored Pre-proline 0 N--CA 1.487 1.414 0 N-CA-C 114.109 1.151 . . . . 74.44 114.109 -169.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.63 -34.65 96.12 Favored 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 122.12 1.88 . . . . 75.1 112.862 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -76.92 -43.13 36.69 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.659 0.784 . . . . 75.43 111.631 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.76 -45.01 79.88 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 122.588 0.355 . . . . 51.34 110.439 177.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.51 HH12 HD12 ' C' ' 105' ' ' ILE . 29.3 ttm180 -48.53 -58.26 4.95 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 124.726 1.266 . . . . 63.24 109.545 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -59.98 -42.92 95.23 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 124.403 1.064 . . . . 73.45 111.909 -175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.91 -34.55 78.22 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 123.631 0.582 . . . . 75.34 111.572 -177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' A' ' 64' ' ' VAL . 4.4 mt -70.12 -53.11 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.097 0.559 . . . . 72.42 109.669 171.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.405 ' CG2' ' HG2' ' A' ' 125' ' ' GLN . 62.2 m -58.8 -30.64 67.77 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.965 1.306 . . . . 72.52 111.759 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -71.74 -43.16 66.31 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.045 -0.979 . . . . 72.22 109.86 177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.677 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 57.0 mtm -61.4 -36.85 81.42 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.747 0.419 . . . . 54.01 110.96 176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' ILE . 48.7 t -65.93 -46.5 88.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 O-C-N 123.854 0.721 . . . . 64.35 110.595 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.427 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 84.9 p -71.68 -34.85 70.02 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.17 -0.468 . . . . 73.15 110.997 -177.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -67.16 -32.09 72.96 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.703 0.801 . . . . 74.51 109.586 171.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.47 -1.42 65.35 Favored Glycine 0 C--N 1.353 1.528 0 CA-C-N 115.196 -0.911 . . . . 74.23 112.837 174.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.8 m 73.26 10.5 5.11 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.071 1.348 . . . . 73.22 111.627 171.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -88.04 157.62 50.99 Favored Pre-proline 0 C--O 1.245 0.864 0 N-CA-C 108.961 -0.755 . . . . 64.21 108.961 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.74 113.62 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.418 2.078 . . . . 64.52 111.058 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 119' ' ' SER . 17.6 tt0 -57.06 119.67 6.72 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.515 1.126 . . . . 75.23 110.717 -172.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.8 mt -104.93 101.44 11.01 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.321 0.648 . . . . 72.15 109.598 -168.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.407 ' OD1' ' HB ' ' C' ' 16' ' ' ILE . 10.1 m-80 -100.07 105.76 17.44 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.523 -1.288 . . . . 75.41 107.523 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.449 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.5 mm? -74.62 157.79 34.79 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.988 0.915 . . . . 73.33 112.513 -167.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.471 ' HB2' HD21 ' F' ' 129' ' ' LEU . . . -71.35 142.81 87.23 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.86 0.864 . . . . 61.2 111.794 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.429 ' HB3' HH22 ' A' ' 111' ' ' ARG . 72.8 Cg_endo -86.37 116.31 1.42 Allowed 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.498 2.132 . . . . 70.13 112.827 170.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 72.4 t -102.29 114.03 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 108.254 -1.017 . . . . 62.13 108.254 169.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -82.89 99.35 9.7 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.684 -0.858 . . . . 71.52 108.684 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.678 ' HD2' ' HB2' ' A' ' 100' ' ' ALA . 61.8 t80 -69.63 -26.76 64.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.308 0.243 . . . . 64.14 110.516 179.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -55.22 -38.62 68.68 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.326 0.65 . . . . 72.41 110.369 174.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.03 -48.56 81.15 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.452 0.701 . . . . 63.53 110.81 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 59.4 tp -71.56 -37.16 71.11 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.223 1.009 . . . . 54.01 112.047 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -69.47 -50.8 42.0 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.732 -0.47 . . . . 72.34 109.732 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.432 ' HB3' ' HB2' ' A' ' 145' ' ' ALA . 97.1 mmm -66.37 -25.39 66.77 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.221 0.609 . . . . 75.41 110.875 -179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.689 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 43.3 t30 -64.16 -42.67 96.64 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.28 1.032 . . . . 64.41 111.053 173.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -77.35 -33.07 55.44 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.362 -0.836 . . . . 74.02 110.572 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 22.6 tp -67.48 -49.86 61.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.431 0.692 . . . . 74.41 110.987 -174.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -155.7 -3.17 0.13 Allowed 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 116.106 -0.497 . . . . 75.03 111.281 -177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.689 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.6 tt0 70.79 -73.1 0.1 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 125.305 1.442 . . . . 72.13 111.205 -174.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -74.74 99.64 3.78 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.853 0.861 . . . . 63.4 109.075 177.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 138' ' ' MET . . . -91.09 96.14 10.45 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.578 -0.527 . . . . 74.25 109.578 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 80.16 -74.15 2.37 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 115.607 -0.724 . . . . 72.21 113.382 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 65.23 119.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.542 1.537 . . . . 75.13 110.549 -168.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 85.58 174.88 50.14 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.426 -0.67 . . . . 62.15 111.426 -172.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.6 t -165.74 175.24 8.95 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.258 0.623 . . . . 74.4 110.732 -176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.75 29.28 1.72 Allowed 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 107.79 -1.189 . . . . 61.24 107.79 169.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 58.35 -90.57 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.453 1.501 . . . . 64.35 109.962 -176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 19.1 t-160 173.7 -52.03 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.902 1.281 . . . . 64.0 109.746 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 67.54 86.69 0.13 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.21 1.404 . . . . 61.23 109.51 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.26 112.95 24.53 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.409 0.684 . . . . 50.33 110.256 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 C-N-CA 123.407 0.683 . . . . 73.45 109.678 177.697 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 109.943 -0.391 . . . . 64.0 109.943 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.9 t -95.39 176.9 6.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.375 0.67 . . . . 55.22 109.595 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.484 ' HG3' ' HB2' ' B' ' 93' ' ' GLN . 0.3 OUTLIER -151.99 -74.28 0.14 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.012 -1.477 . . . . 43.31 107.012 175.346 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -169.92 -23.75 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.446 1.099 . . . . 74.45 109.144 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 67.3 35.75 4.25 Favored 'General case' 0 C--N 1.368 1.396 0 C-N-CA 124.595 1.158 . . . . 71.33 111.381 173.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 61.34 -165.2 0.23 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.561 1.144 . . . . 73.31 111.036 -177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.532 HG23 ' HB3' ' B' ' 151' ' ' GLU . 25.0 m 64.4 14.36 8.75 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 122.886 1.327 . . . . 62.23 110.351 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -138.49 -144.01 0.17 Allowed 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 105.751 -1.944 . . . . 74.33 105.751 -178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptm 50.85 -174.58 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 125.092 1.357 . . . . 74.32 114.124 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' B' ' 87' ' ' ALA . 1.1 p -150.57 123.2 8.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.261 1.024 . . . . 72.02 108.412 173.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -119.74 126.08 50.21 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.547 -0.908 . . . . 70.12 108.547 173.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.663 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 8.3 tt0 -139.48 132.32 29.2 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.828 0.851 . . . . 64.02 109.145 -178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.97 114.82 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.369 -0.975 . . . . 75.42 108.369 174.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -82.83 -46.24 13.29 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.783 0.433 . . . . 75.14 110.257 174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -164.55 142.24 6.62 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 116.573 -0.285 . . . . 73.25 111.176 -173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -116.54 141.46 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 N-CA-C 107.231 -1.396 . . . . 71.54 107.231 168.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.471 ' HE1' HG13 ' B' ' 83' ' ' ILE . 14.5 p90 -170.53 151.09 3.55 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.816 0.673 . . . . 64.41 112.816 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.3 m -80.2 123.15 27.67 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.983 0.913 . . . . 73.3 108.93 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -97.02 -28.84 13.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.329 0.652 . . . . 73.21 110.974 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.683 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 11.2 t70 -154.09 140.03 18.23 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.207 -0.452 . . . . 75.02 109.984 -170.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 31.5 mm -133.95 143.57 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.412 1.085 . . . . 72.14 109.098 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 45.5 m -139.64 135.24 33.07 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.257 1.023 . . . . 73.1 108.81 168.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -139.61 107.9 5.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 106.172 -1.788 . . . . 74.23 106.172 166.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 22.1 mt-10 -119.07 112.98 20.22 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.495 -0.928 . . . . 54.54 108.495 -172.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -117.21 86.48 21.18 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.974 -1.121 . . . . 73.14 107.974 178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.97 -22.81 41.45 Favored 'Trans proline' 0 C--N 1.382 2.317 0 C-N-CA 122.843 2.362 . . . . 72.12 112.99 -173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -115.94 22.53 12.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.83 0.852 . . . . 73.34 110.267 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.669 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -49.8 -53.08 45.85 Favored Pre-proline 0 CA--C 1.561 1.367 0 N-CA-C 114.54 1.311 . . . . 64.23 114.54 -176.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.29 -21.39 41.53 Favored 'Trans proline' 0 C--N 1.392 2.82 0 CA-C-N 121.075 1.42 . . . . 75.32 112.646 179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -99.99 1.96 43.03 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.346 1.058 . . . . 70.43 112.623 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.426 HG21 ' CE1' ' B' ' 123' ' ' PHE . 11.5 p -62.1 -25.83 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 113.785 1.031 . . . . 70.2 113.785 -167.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -75.84 -0.61 21.81 Favored 'General case' 0 CA--C 1.555 1.143 0 N-CA-C 112.399 0.518 . . . . 61.44 112.399 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -80.77 -32.93 35.34 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.875 0.87 . . . . 73.11 110.027 165.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.653 ' HD2' ' HB3' ' B' ' 68' ' ' LEU . 75.7 mmtt -85.44 84.89 7.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.377 1.071 . . . . 71.33 110.454 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -116.4 83.0 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 123.546 0.738 . . . . 65.22 111.114 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -166.86 -171.76 1.91 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 125.276 1.43 . . . . 75.33 108.934 173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -86.93 115.67 63.34 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.318 0.647 . . . . 72.23 109.593 173.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -78.07 153.37 28.55 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.525 2.15 . . . . 64.34 112.74 178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -69.52 103.78 2.15 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.547 -0.909 . . . . 70.41 108.547 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.6 p -100.53 126.07 54.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 123.43 0.692 . . . . 64.33 110.472 -176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -110.5 127.89 55.37 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.952 1.301 . . . . 54.33 108.866 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -98.89 123.61 43.27 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 105.427 -2.064 . . . . 61.55 105.427 161.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.576 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 9.6 t70 -124.07 129.51 51.0 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.266 -1.383 . . . . 74.11 107.266 -177.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.513 HD21 HG11 ' B' ' 131' ' ' VAL . 3.9 mp -106.19 136.65 45.52 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 107.753 -1.202 . . . . 60.05 107.753 -176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.437 ' HA ' ' NE1' ' E' ' 120' ' ' TRP . 37.9 t70 -154.71 156.37 36.26 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.691 -0.855 . . . . 71.3 108.691 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -146.27 137.04 24.24 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.488 0.661 . . . . 64.4 110.167 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.01 158.21 31.01 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.491 -1.67 . . . . 72.25 106.491 168.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 51.9 p -145.03 171.31 14.64 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 118.501 0.592 . . . . 51.34 111.425 -177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 77.8 p -151.61 135.82 16.71 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.382 -1.34 . . . . 75.12 107.382 173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -100.83 110.17 22.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.88 0.764 . . . . 74.21 109.487 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.3 mt -72.34 -30.24 64.56 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.69 0.796 . . . . 73.41 112.002 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.07 179.18 8.16 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.861 0.864 . . . . 35.32 109.456 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -63.49 121.09 12.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.222 -0.899 . . . . 74.43 108.603 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 19.5 m-20 76.24 -5.72 2.13 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 125.992 1.717 . . . . 74.13 112.726 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 57.5 t -107.31 88.79 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.006 -1.109 . . . . 50.25 108.006 178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.94 138.33 38.14 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 108.522 -0.918 . . . . 72.32 108.522 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -110.75 100.98 9.64 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.023 -1.473 . . . . 42.45 107.023 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.3 t -95.45 124.21 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.398 0.679 . . . . 73.04 109.762 -174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.599 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.2 t -106.03 116.34 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.778 0.831 . . . . 41.4 110.043 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.28 113.92 26.3 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.076 -1.083 . . . . 70.43 108.076 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -99.62 109.62 22.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.986 0.915 . . . . 74.12 109.829 175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.8 t -106.24 119.24 55.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.912 -0.773 . . . . 71.22 108.912 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.1 m -106.08 146.94 29.52 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.292 1.037 . . . . 51.54 109.616 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.491 HG23 HD13 ' B' ' 114' ' ' ILE . 55.8 t -132.68 131.77 59.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 124.405 1.082 . . . . 74.32 108.572 173.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 93.0 m -124.44 136.5 54.09 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.521 -0.918 . . . . 60.35 108.521 172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.8 131.06 30.61 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.745 -1.206 . . . . 52.15 107.745 176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 66.4 p -137.57 134.24 35.39 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.071 0.548 . . . . 72.04 109.884 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.653 ' HB3' ' HD2' ' B' ' 34' ' ' LYS . 0.9 OUTLIER -113.6 117.78 32.56 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 107.336 -1.357 . . . . 75.24 107.336 -179.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.64 -130.25 10.14 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.793 -0.523 . . . . 55.23 111.793 -175.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -107.27 31.67 5.21 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.893 0.877 . . . . 74.21 109.655 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -147.83 145.28 28.66 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.477 0.711 . . . . 61.45 110.082 -171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -68.12 132.14 46.68 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 122.863 0.465 . . . . 72.04 110.392 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.443 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -87.87 -55.39 3.79 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.399 1.079 . . . . 73.03 108.721 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -163.58 164.7 24.08 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.152 -0.931 . . . . 73.32 110.842 172.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.52 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 52.3 mt -133.42 145.34 50.19 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 125.203 1.401 . . . . 74.03 107.739 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.7 t -153.63 143.14 21.69 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 108.409 -0.96 . . . . 72.24 108.409 176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -158.99 133.14 7.7 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 108.809 -0.812 . . . . 75.05 108.809 -174.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' B' ' 113' ' ' CYS . 90.1 t -125.22 145.45 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 123.844 0.858 . . . . 70.21 108.916 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.683 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 39.7 mt-30 -119.97 93.59 4.11 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.332 -0.988 . . . . 75.42 108.332 171.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.439 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -84.01 100.23 10.93 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.52 -0.763 . . . . 63.24 109.263 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -87.41 166.47 36.42 Favored Glycine 0 C--O 1.239 0.433 0 N-CA-C 111.71 -0.556 . . . . 73.11 111.71 177.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.47 126.66 1.51 Allowed Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.462 -0.655 . . . . 53.25 111.462 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.471 HG13 ' HE1' ' B' ' 17' ' ' TYR . 33.5 mt -85.97 116.1 28.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 53.01 108.581 174.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -120.51 163.79 17.41 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 108.687 -0.857 . . . . 72.31 108.687 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.663 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 24.9 m -129.68 93.22 3.48 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 107.783 -1.191 . . . . 63.55 107.783 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.448 HG21 ' SG ' ' B' ' 97' ' ' CYS . 0.1 OUTLIER -112.31 111.68 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 N-CA-C 107.969 -1.123 . . . . 73.15 107.969 -175.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.508 ' HB2' ' HB3' ' B' ' 54' ' ' ASP . . . -130.55 159.37 37.35 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.914 0.885 . . . . 53.2 110.499 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.48 -42.97 2.04 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.605 0.566 . . . . 64.02 114.096 171.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.455 HG12 ' HB3' ' B' ' 94' ' ' MET . 0.2 OUTLIER -74.58 165.4 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.942 0.897 . . . . 71.22 112.527 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.546 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 8.4 pt-20 -161.41 -178.2 6.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 114.917 -1.038 . . . . 74.32 110.547 166.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.62 -118.9 15.96 Favored Glycine 0 C--N 1.35 1.359 0 CA-C-N 115.348 -0.842 . . . . 74.01 114.488 172.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 15.8 m -71.72 -35.64 70.24 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.685 0.794 . . . . 75.34 111.143 -177.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.484 ' HB2' ' HG3' ' B' ' 3' ' ' GLU . 1.6 tt0 -73.54 -35.41 65.53 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.801 0.441 . . . . 73.55 110.878 -171.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.546 ' SD ' ' HA ' ' B' ' 90' ' ' GLU . 24.2 ptt? -74.72 -25.65 59.27 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 122.45 0.3 . . . . 73.44 110.964 176.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.16 82.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.249 0.62 . . . . 64.1 111.266 175.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 16.8 m-70 -85.34 -21.34 28.95 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.202 0.601 . . . . 73.24 111.453 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' B' ' 86' ' ' ILE . 35.8 t -84.37 -62.74 1.48 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 120.926 0.394 . . . . 73.33 110.403 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.0 mp -73.0 -27.0 61.53 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.819 0.448 . . . . 73.54 111.456 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.58 -1.31 60.45 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-O 119.422 -0.655 . . . . 51.34 114.381 -175.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -150.16 -50.83 0.14 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.995 0.897 . . . . 72.23 112.674 -174.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -65.23 -49.34 70.05 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.455 0.702 . . . . 61.14 110.744 -176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.487 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 71.9 m -64.0 -51.73 61.36 Favored Pre-proline 0 CA--C 1.569 1.69 0 CA-C-O 118.538 -0.744 . . . . 72.41 111.575 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 86.4 Cg_exo -53.37 -34.56 71.53 Favored 'Trans proline' 0 C--N 1.403 3.405 0 C-N-CA 122.627 2.218 . . . . 73.32 114.726 171.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -64.73 -37.9 89.18 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.069 0.548 . . . . 62.12 111.163 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 86.5 mt -64.59 -43.33 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 123.709 0.804 . . . . 52.24 110.038 174.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 84.0 mt -78.28 -20.91 50.6 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.147 -0.933 . . . . 71.42 112.504 -172.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -59.69 -51.59 79.87 Favored Pre-proline 0 N--CA 1.483 1.183 0 CA-C-O 117.844 -1.074 . . . . 73.22 113.769 -171.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.06 -34.43 92.57 Favored 'Trans proline' 0 C--N 1.39 2.72 0 C-N-CA 122.088 1.859 . . . . 44.13 113.285 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 89.1 m-85 -68.63 -49.74 56.85 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.695 0.798 . . . . 75.41 110.824 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.01 -38.98 84.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.544 0.738 . . . . 70.41 110.808 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.46 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 31.8 ttt180 -62.67 -52.56 62.84 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 63.54 110.956 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -63.97 -38.33 90.69 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.135 -0.938 . . . . 62.4 110.167 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.433 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -69.31 -34.31 74.49 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.93 -0.577 . . . . 74.2 111.929 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.491 HD13 HG23 ' B' ' 64' ' ' VAL . 66.0 mt -64.66 -57.74 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 123.023 0.529 . . . . 71.24 109.584 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 19.3 m -60.4 -31.16 70.1 Favored 'General case' 0 CA--C 1.55 0.946 0 O-C-N 123.942 0.776 . . . . 64.52 111.5 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.2 t -62.84 -48.29 79.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.85 0.86 . . . . 63.21 110.917 175.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.2 mmt -67.83 -34.41 76.68 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.91 0.484 . . . . 61.04 110.867 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.519 HG11 HD13 ' B' ' 126' ' ' LEU . 74.1 t -63.21 -37.66 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.184 0 C-N-CA 124.17 0.988 . . . . 72.23 110.86 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 19.2 m -63.83 -40.64 97.08 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.533 0.733 . . . . 53.45 110.866 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -64.39 -32.05 73.5 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.735 -1.12 . . . . 61.11 111.947 -177.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.76 17.5 56.27 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.672 0.608 . . . . 54.01 113.697 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.403 HG23 ' HB3' ' A' ' 17' ' ' TYR . 73.0 p 60.53 26.74 16.39 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 125.616 1.566 . . . . 72.04 112.912 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.426 ' CE1' HG21 ' B' ' 31' ' ' VAL . 81.3 m-85 -91.84 156.79 42.31 Favored Pre-proline 0 N--CA 1.485 1.29 0 C-N-CA 123.395 0.678 . . . . 74.52 110.663 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.41 177.42 3.27 Favored 'Trans proline' 0 C--N 1.39 2.754 0 C-N-CA 123.238 2.625 . . . . 75.3 114.241 -175.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -67.26 124.32 22.78 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.825 -1.079 . . . . 65.2 111.62 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.519 HD13 HG11 ' B' ' 118' ' ' VAL . 11.0 mp -117.27 96.41 5.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.96 0.904 . . . . 71.35 109.36 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.694 HD21 HG23 ' E' ' 130' ' ' ILE . 0.2 OUTLIER -91.75 92.63 8.5 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-O 121.08 0.467 . . . . 74.43 110.29 173.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.46 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 73.1 mt -67.27 141.9 57.06 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.175 0.59 . . . . 63.13 110.606 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.95 143.27 39.81 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.224 0.61 . . . . 55.34 110.558 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.7 123.34 12.48 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.129 2.552 . . . . 74.33 111.598 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.513 HG11 HD21 ' B' ' 44' ' ' LEU . 12.8 t -100.0 127.63 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 109.753 -0.462 . . . . 62.21 109.753 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -87.61 96.43 10.41 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 107.957 -1.127 . . . . 62.33 107.957 171.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.463 ' HD1' ' HH2' ' E' ' 120' ' ' TRP . 58.8 m-85 -59.17 -34.52 72.2 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.11 0.964 . . . . 65.44 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -64.72 -39.09 93.05 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 114.384 -1.28 . . . . 73.31 111.198 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.69 -36.19 78.17 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.322 0.649 . . . . 74.02 111.585 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.63 -49.63 74.41 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.849 0.718 . . . . 62.53 110.274 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -75.07 -20.42 59.52 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 115.687 -0.688 . . . . 74.12 112.588 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.714 ' SD ' ' HB2' ' B' ' 145' ' ' ALA . 71.8 mtm -74.8 -38.28 62.15 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 109.938 -0.393 . . . . 54.41 109.938 173.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -74.53 -19.55 60.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.994 0.518 . . . . 74.43 110.96 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 51.8 t80 -69.23 -28.6 66.49 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.167 0.508 . . . . 63.21 110.389 170.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.6 mt -100.76 13.46 34.86 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.87 0.868 . . . . 73.2 111.497 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 63.37 51.81 2.54 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.221 1.008 . . . . 72.14 110.082 -177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 56.32 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.456 1.503 . . . . 73.41 110.839 -177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -132.61 109.06 9.48 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.367 0.667 . . . . 61.31 109.797 175.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.714 ' HB2' ' SD ' ' B' ' 138' ' ' MET . . . -145.4 154.03 41.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.098 0.959 . . . . 64.34 110.27 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -156.22 121.71 1.12 Allowed Glycine 0 C--N 1.345 1.058 0 N-CA-C 111.483 -0.647 . . . . 73.24 111.483 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -78.97 111.94 15.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.971 -0.751 . . . . 74.32 108.971 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.07 61.05 0.23 Allowed Glycine 0 C--N 1.343 0.966 0 N-CA-C 112.27 -0.332 . . . . 73.44 112.27 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 83.3 m -122.78 83.46 2.12 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.953 0.901 . . . . 63.21 108.724 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.616 ' HA ' HD23 ' F' ' 148' ' ' LEU . 43.3 mt-10 -135.54 152.43 51.29 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.696 1.198 . . . . 74.42 109.23 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.532 ' HB3' HG23 ' B' ' 7' ' ' THR . 9.7 tp10 69.74 143.64 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 125.462 1.505 . . . . 74.43 111.408 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -84.82 143.72 28.9 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.893 -0.78 . . . . 54.01 108.893 174.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -92.83 84.69 5.0 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 106.738 -1.578 . . . . 74.4 106.738 166.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -93.25 108.99 20.51 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.134 -0.939 . . . . 75.23 109.173 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.315 0.646 . . . . 70.43 109.356 178.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.557 ' SD ' ' HB2' ' F' ' 122' ' ' ALA . 64.9 mtt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.426 -0.583 . . . . 74.43 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -149.44 145.59 27.0 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.787 0.835 . . . . 63.3 109.378 175.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.63 178.9 7.01 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.958 0.903 . . . . 64.14 109.648 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 66.38 141.23 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.296 1.438 . . . . 74.32 111.73 -170.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.419 ' ND2' ' HB2' ' C' ' 150' ' ' GLU . 6.0 p30 -161.16 136.15 7.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.229 0.612 . . . . 71.02 110.726 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -128.61 93.63 3.67 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.422 -1.325 . . . . 72.22 107.422 170.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 32.9 p -67.4 99.0 0.69 Allowed 'General case' 0 C--O 1.244 0.798 0 CA-C-N 115.348 -0.842 . . . . 64.02 110.981 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -65.34 131.31 46.14 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 108.79 -0.818 . . . . 72.11 108.79 171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 44.6 ttp 63.88 112.68 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 O-C-N 124.706 1.254 . . . . 74.1 110.401 -166.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.66 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 12.4 m -86.79 76.29 9.49 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.604 -1.258 . . . . 51.33 107.604 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -92.0 129.19 38.02 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.211 -0.904 . . . . 73.02 108.591 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -149.88 139.53 21.66 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.266 -0.642 . . . . 74.13 109.266 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.696 HD11 HG13 ' C' ' 16' ' ' ILE . 0.0 OUTLIER -82.56 133.76 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 107.542 -1.281 . . . . 72.24 107.542 174.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.447 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 28.9 mm-40 -107.62 -46.91 3.72 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.355 0.662 . . . . 65.21 110.006 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -166.79 141.15 4.02 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.59 -0.732 . . . . 71.22 109.654 -172.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.696 HG13 HD11 ' C' ' 13' ' ' ILE . 86.3 mt -129.39 142.01 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 N-CA-C 106.926 -1.509 . . . . 70.24 106.926 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -174.03 160.46 3.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.624 0.77 . . . . 54.43 110.248 -170.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 72.5 p -85.47 107.37 17.39 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.706 -0.679 . . . . 63.2 109.544 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.6 mmmt -65.97 -41.84 90.64 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 109.281 -0.637 . . . . 52.14 109.281 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 10.6 t70 -147.8 147.12 29.5 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.768 -0.651 . . . . 75.15 109.815 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.526 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.2 mt -143.79 145.57 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 C-N-CA 125.484 1.513 . . . . 64.42 106.965 177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -157.96 150.07 22.09 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 123.081 0.553 . . . . 61.24 109.55 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -146.15 123.27 11.47 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.655 -1.239 . . . . 63.1 107.655 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 36.0 mt-10 -123.59 112.43 17.43 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.46 0.704 . . . . 60.43 109.558 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -118.22 85.92 25.82 Favored Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 108.69 -0.856 . . . . 71.23 108.69 172.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.84 -36.33 10.79 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 122.586 2.19 . . . . 75.55 111.429 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.523 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 66.8 m-80 -106.45 36.05 2.75 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.151 -0.931 . . . . 73.11 110.156 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.422 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -56.11 -47.18 99.34 Favored Pre-proline 0 CA--C 1.568 1.671 0 C-N-CA 124.504 1.122 . . . . 65.32 112.536 177.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 16.4 Cg_endo -94.39 -10.04 1.48 Allowed 'Trans proline' 0 C--N 1.397 3.111 0 C-N-CA 122.257 1.971 . . . . 63.02 113.641 173.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.523 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-160 -71.96 -30.95 65.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.332 0.653 . . . . 73.25 111.282 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.576 HG11 ' HE1' ' C' ' 123' ' ' PHE . 7.6 p -76.76 -13.73 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.303 0 C-N-CA 123.839 0.855 . . . . 75.44 111.832 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -51.51 -37.34 48.76 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.407 1.483 . . . . 73.43 113.259 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -126.54 26.49 6.3 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.399 0.68 . . . . 71.52 110.134 -177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -125.4 153.0 44.08 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 121.252 -0.905 . . . . 73.41 111.922 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.85 133.14 47.65 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.536 1.534 . . . . 61.15 112.586 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.521 ' HB3' ' HB1' ' E' ' 135' ' ' ALA . 24.2 p90 -86.1 104.76 15.99 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.691 0.796 . . . . 74.55 110.598 175.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -161.47 68.5 2.36 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.441 -0.948 . . . . 63.22 108.441 169.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -86.92 138.47 5.04 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.063 1.842 . . . . 71.21 110.959 171.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.46 97.62 9.08 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 105.771 -1.937 . . . . 71.13 105.771 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -79.37 99.45 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 CA-C-N 114.812 -1.085 . . . . 63.41 110.837 -172.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -93.51 117.1 29.66 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.278 -0.874 . . . . 63.41 110.185 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 pp -92.02 148.29 22.31 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.686 -0.857 . . . . 53.15 108.686 169.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 22.9 t70 -146.77 112.45 5.65 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.16 -1.052 . . . . 73.24 108.16 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -103.37 111.56 24.04 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.043 -1.095 . . . . 73.24 108.043 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -123.61 158.55 31.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.686 1.195 . . . . 70.02 108.657 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.5 t -145.64 151.36 37.93 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.281 0.562 . . . . 64.22 109.742 178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.2 173.8 11.2 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.541 1.136 . . . . 74.35 108.338 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.7 p -152.3 148.09 27.12 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 122.866 0.467 . . . . 61.14 110.016 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 42.3 t -145.38 125.47 13.68 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 107.675 -1.231 . . . . 75.15 107.675 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -84.44 115.16 22.4 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.369 -0.974 . . . . 74.12 108.369 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.594 HD11 HD12 ' C' ' 83' ' ' ILE . 58.9 mt -84.92 -39.33 18.32 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.458 0.703 . . . . 65.45 110.272 -174.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.71 -173.33 4.06 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.021 -0.99 . . . . 43.35 110.384 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -59.28 111.73 1.47 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.34 -1.3 . . . . 74.1 110.322 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 64.8 17.52 11.03 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.611 1.164 . . . . 75.43 112.443 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.4 103.82 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 108.343 -0.984 . . . . 75.54 108.343 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -118.12 125.84 51.05 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.82 0.848 . . . . 71.0 109.933 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.518 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.5 tt0 -84.03 112.09 19.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.05 0.94 . . . . 65.31 109.306 171.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -96.72 129.34 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 107.745 -1.206 . . . . 74.32 107.745 170.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 43.3 t -117.42 105.23 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 -176.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -87.68 100.38 12.78 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.192 -1.04 . . . . 63.33 108.192 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -93.43 111.33 22.97 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.097 1.359 . . . . 64.0 109.486 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.526 ' HB ' HD11 ' C' ' 114' ' ' ILE . 2.9 t -103.11 137.23 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 109.02 -0.733 . . . . 72.23 109.02 175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 54.1 m -119.17 133.76 55.59 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.541 -0.911 . . . . 70.32 108.541 169.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.54 HG21 HG21 ' C' ' 114' ' ' ILE . 93.9 t -124.76 117.31 49.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 124.979 1.312 . . . . 61.33 107.49 174.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.2 m -117.02 134.4 54.79 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.937 -0.764 . . . . 71.21 108.937 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.0 95.52 4.85 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.889 -1.523 . . . . 63.52 106.889 172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 52.3 p -149.07 123.16 9.46 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 122.367 0.267 . . . . 60.5 111.317 -174.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 36.6 tp -85.86 77.29 9.75 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.045 -1.095 . . . . 54.14 108.045 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.44 -93.23 0.24 Allowed Glycine 0 C--N 1.344 0.998 0 CA-C-N 115.169 -0.923 . . . . 74.23 112.643 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -96.4 -15.48 21.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.998 0.919 . . . . 65.31 111.522 -175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.5 tp10 -98.1 95.42 7.43 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.088 0.555 . . . . 63.05 110.231 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 34.8 m -89.46 118.39 29.08 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.012 0.434 . . . . 65.12 111.242 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.83 -53.44 11.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.127 0.971 . . . . 63.43 108.846 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -157.15 168.48 27.3 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.454 -1.248 . . . . 63.11 111.844 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.4 tm? -140.65 146.31 37.73 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 105.39 -2.078 . . . . 72.5 105.39 176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.8 t -153.33 130.81 11.38 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.179 -0.675 . . . . 64.3 109.179 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -136.36 129.55 31.48 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.757 -0.46 . . . . 50.51 109.757 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 40.6 t -128.71 114.67 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 123.844 0.857 . . . . 55.54 109.062 176.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.408 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.99 95.44 10.12 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.146 0.978 . . . . 64.43 108.701 173.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.617 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -83.67 105.76 14.85 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.851 -0.613 . . . . 72.51 109.685 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.24 144.37 21.63 Favored Glycine 0 C--N 1.338 0.677 0 N-CA-C 111.565 -0.614 . . . . 61.43 111.565 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.418 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -146.43 117.16 0.93 Allowed Glycine 0 CA--C 1.502 -0.749 0 N-CA-C 110.155 -1.178 . . . . 71.32 110.155 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.594 HD12 HD11 ' C' ' 51' ' ' LEU . 11.2 mm -81.52 122.33 36.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.093 -1.077 . . . . 73.2 108.093 176.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -131.2 128.75 40.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.731 0.812 . . . . 74.3 109.028 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 42.3 m -71.36 114.19 9.17 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.128 -0.693 . . . . 71.1 109.128 169.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 33.9 mm -116.85 101.24 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.957 0.903 . . . . 74.31 108.64 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.66 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -133.94 150.58 51.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.444 0.698 . . . . 52.41 109.76 178.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -47.12 3.58 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 121.247 0.36 . . . . 24.42 113.074 174.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.2 tt -83.75 149.44 4.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 124.84 1.256 . . . . 65.44 110.527 -176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -160.6 155.93 24.87 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.935 0.494 . . . . 74.14 111.032 -174.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.09 -142.76 28.89 Favored Glycine 0 C--N 1.35 1.343 0 C-N-CA 123.166 0.412 . . . . 51.02 113.687 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 12.0 p -61.42 -24.72 66.72 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.161 0.984 . . . . 74.44 111.821 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -58.95 -57.39 13.29 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.82 0.848 . . . . 75.23 110.097 172.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.428 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 26.6 ptm -74.41 -23.35 58.94 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.775 -0.648 . . . . 62.43 111.056 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.86 -36.63 84.54 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.296 0.638 . . . . 65.14 111.064 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -68.51 -29.99 68.71 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.255 0.622 . . . . 75.51 110.955 174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.37 -62.34 1.51 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 122.536 0.334 . . . . 73.35 110.296 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.8 pp -76.08 -12.92 60.2 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.172 0.589 . . . . 74.4 112.521 -175.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.38 33.16 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.587 -0.563 . . . . 53.25 113.962 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' C' ' 133' ' ' PHE . . . -148.28 -56.94 0.22 Allowed 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 117.626 0.713 . . . . 65.03 111.588 -179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -70.78 -61.46 1.76 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 122.684 0.394 . . . . 74.32 111.798 -172.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 69.3 m -54.86 -45.5 99.7 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 123.97 0.908 . . . . 40.32 112.291 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -47.97 -48.57 15.94 Favored 'Trans proline' 0 C--N 1.4 3.258 0 C-N-CA 122.757 2.304 . . . . 63.51 113.72 167.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.541 HD21 ' HA ' ' C' ' 132' ' ' ASN . 4.8 m-20 -74.63 -15.42 60.82 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.687 0.795 . . . . 71.34 113.114 -177.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.51 HD12 HH12 ' A' ' 111' ' ' ARG . 36.3 mm -75.5 -40.89 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 109.279 -0.637 . . . . 75.42 109.279 169.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.418 HD21 ' HA3' ' C' ' 82' ' ' GLY . 67.8 mt -86.31 -17.92 33.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.178 0.991 . . . . 74.21 111.915 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.43 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 50.2 t80 -65.12 -46.63 73.17 Favored Pre-proline 0 CA--C 1.55 0.981 0 CA-C-O 117.535 -1.221 . . . . 63.2 113.031 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -56.89 -37.75 97.49 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 121.942 1.761 . . . . 63.13 112.634 176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -65.28 -52.68 52.7 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 74.42 110.873 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.617 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.16 -35.17 79.77 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.151 0.58 . . . . 74.1 111.351 -178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 54.0 ttt180 -59.24 -53.11 61.95 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.573 1.149 . . . . 73.13 110.217 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.1 tm-20 -67.35 -34.94 78.36 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.837 0.711 . . . . 71.24 110.107 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 27.6 t -67.39 -32.92 74.16 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.071 0.548 . . . . 73.34 111.393 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.54 HG21 HG21 ' C' ' 64' ' ' VAL . 88.7 mt -73.11 -51.03 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.362 0.665 . . . . 74.1 110.223 172.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 34.8 m -63.03 -29.0 70.48 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 123.281 0.632 . . . . 51.23 110.929 -174.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 45.4 t -65.44 -52.4 53.46 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 115.306 -0.861 . . . . 73.13 109.033 170.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.487 ' HA ' ' HD2' ' C' ' 120' ' ' ARG . 0.0 OUTLIER -56.53 -40.44 75.07 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.889 1.276 . . . . 73.44 113.016 179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.0 t -65.89 -45.2 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.667 0.787 . . . . 52.4 109.761 178.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.44 ' HB2' HE22 ' C' ' 125' ' ' GLN . 35.9 t -70.64 -24.01 62.63 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.153 -0.931 . . . . 53.34 111.26 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.487 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 87.4 mtt-85 -69.94 -36.41 75.27 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.472 0.709 . . . . 72.21 109.272 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.34 10.06 62.43 Favored Glycine 0 C--N 1.355 1.589 0 O-C-N 124.002 0.814 . . . . 51.44 112.79 172.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.44 HG23 ' HB3' ' D' ' 17' ' ' TYR . 81.9 p 57.61 37.21 27.41 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.046 1.738 . . . . 44.02 113.425 176.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.576 ' HE1' HG11 ' C' ' 31' ' ' VAL . 61.1 m-85 -105.73 162.23 20.36 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 124.363 1.065 . . . . 73.12 110.216 177.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.422 ' HB3' ' HA ' ' E' ' 136' ' ' VAL . 25.5 Cg_endo -59.99 146.0 97.02 Favored 'Trans proline' 0 C--N 1.391 2.783 0 C-N-CA 123.107 2.538 . . . . 55.24 113.384 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.44 HE22 ' HB2' ' C' ' 119' ' ' SER . 1.8 mp0 -58.49 108.92 0.69 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.003 0.921 . . . . 74.2 109.632 173.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.2 tp -110.21 91.64 3.73 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 107.839 -1.171 . . . . 72.23 107.839 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -91.17 115.47 28.05 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.564 -0.902 . . . . 72.33 108.564 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.43 ' HB3' ' HZ ' ' C' ' 107' ' ' PHE . 2.3 tt -64.97 132.86 50.42 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.94 139.42 70.72 Favored Pre-proline 0 CA--C 1.549 0.921 0 O-C-N 124.11 0.882 . . . . 62.35 110.968 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.48 104.61 0.37 Allowed 'Trans proline' 0 C--N 1.376 2.015 0 C-N-CA 122.303 2.002 . . . . 72.14 111.296 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.5 t -97.0 107.66 20.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 108.402 -0.962 . . . . 74.42 108.402 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.541 ' HA ' HD21 ' C' ' 104' ' ' ASN . 15.3 m120 -113.23 89.52 3.1 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.498 0.719 . . . . 73.43 110.149 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.438 ' HD2' ' HB2' ' C' ' 100' ' ' ALA . 67.7 t80 -70.78 -30.32 66.76 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.049 -0.978 . . . . 72.13 109.428 172.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -59.08 -39.5 82.33 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.245 1.018 . . . . 73.52 111.364 173.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.13 70.28 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 123.719 0.808 . . . . 55.42 111.885 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 83.5 mt -63.9 -39.38 94.04 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.637 0.775 . . . . 74.35 110.776 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -74.04 -41.05 62.38 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 114.656 -1.156 . . . . 62.33 110.509 174.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.668 ' HA ' ' HB2' ' C' ' 142' ' ' GLN . 25.8 ttt -65.67 -45.23 83.7 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.165 0.986 . . . . 61.5 112.37 -170.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -65.28 -38.19 89.52 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 123.339 0.399 . . . . 72.55 110.174 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -71.88 -88.04 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 O-C-N 124.321 1.013 . . . . 73.12 111.479 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 93.6 mt -142.21 82.92 1.81 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.954 0.902 . . . . 52.14 108.604 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.668 ' HB2' ' HA ' ' C' ' 138' ' ' MET . 27.8 tt0 -94.5 99.08 11.3 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 109.054 -0.721 . . . . 75.32 109.054 173.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.1 pt20 -65.06 125.54 25.24 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.018 -0.992 . . . . 62.0 110.231 175.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -162.08 170.17 19.67 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.48 0.657 . . . . 55.41 111.674 -178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.7 -177.2 6.1 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 125.138 1.375 . . . . 54.21 108.22 173.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -131.03 -37.21 0.32 Allowed Glycine 0 N--CA 1.471 1.018 0 N-CA-C 111.529 -0.628 . . . . 72.32 111.529 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 61.42 84.86 0.13 Allowed 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.887 1.275 . . . . 73.42 111.59 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.58 -127.31 44.65 Favored Glycine 0 C--N 1.354 1.545 0 O-C-N 124.036 0.835 . . . . 63.23 112.666 -178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -176.27 178.17 1.41 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.484 1.113 . . . . 72.43 109.072 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.419 ' HB2' ' ND2' ' C' ' 5' ' ' ASN . 41.1 tt0 -134.27 139.82 45.99 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.552 0.741 . . . . 72.0 109.361 176.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -147.6 150.08 33.76 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 108.232 -1.025 . . . . 64.11 108.232 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 63.95 83.69 0.16 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.51 1.124 . . . . 62.31 110.677 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -72.73 -35.38 67.53 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.237 -0.892 . . . . 74.45 111.514 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -149.85 163.29 38.43 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.293 0.637 . . . . 72.54 111.266 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.039 0 C-N-CA 123.867 0.867 . . . . 72.34 111.045 -177.647 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ttt . . . . . 0 N--CA 1.482 1.157 0 N-CA-C 109.152 -0.684 . . . . 74.21 109.152 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 17.1 m -59.81 95.12 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 123.767 0.827 . . . . 71.45 110.323 170.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -74.59 114.06 12.57 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.899 0.88 . . . . 73.23 109.479 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -155.37 -170.29 3.41 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 122.834 0.454 . . . . 73.1 110.186 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -68.42 79.94 0.26 Allowed 'General case' 0 CA--C 1.558 1.274 0 CA-C-O 122.299 1.047 . . . . 73.31 110.128 173.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 50.5 t-20 -141.3 152.11 44.19 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.405 1.082 . . . . 73.12 108.618 -172.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.5 m 64.18 31.86 12.94 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.772 1.229 . . . . 72.11 109.143 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.25 76.68 4.76 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.255 -1.339 . . . . 71.31 107.898 175.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.6 ttp -34.27 125.99 0.47 Allowed 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.469 1.508 . . . . 75.14 113.13 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.604 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.0 m -115.26 135.15 54.46 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 108.173 -1.047 . . . . 73.13 108.173 166.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' D' ' 85' ' ' SER . 72.0 t80 -154.22 119.31 5.03 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.443 -0.947 . . . . 64.41 108.443 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -132.37 147.21 52.38 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.565 0.746 . . . . 64.42 110.371 -174.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.91 122.0 39.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.916 -1.142 . . . . 72.3 107.916 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.413 HE22 HG13 ' D' ' 55' ' ' VAL . 49.2 mt-30 -100.3 -46.36 5.29 Favored 'General case' 0 N--CA 1.476 0.851 0 O-C-N 122.1 -0.375 . . . . 75.22 110.224 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -169.92 121.99 0.69 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.484 0.49 . . . . 72.42 110.606 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 mp -109.63 131.76 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 107.469 -1.308 . . . . 63.31 107.469 178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.448 ' HE2' ' HG2' ' D' ' 19' ' ' LYS . 44.3 p90 -162.52 178.47 8.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.52 0.676 . . . . 64.42 111.794 -173.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 65.2 p -104.91 123.75 48.29 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.671 0.788 . . . . 44.51 109.654 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.448 ' HG2' ' HE2' ' D' ' 17' ' ' TYR . 32.3 mtpt -91.27 -22.96 20.31 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.965 -0.383 . . . . 61.23 109.965 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.9 t70 -155.11 141.73 18.87 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.521 0.728 . . . . 73.05 109.76 175.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.482 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.2 mt -140.84 147.88 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.01 1.324 . . . . 71.14 108.085 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -150.74 145.99 26.13 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.843 0.857 . . . . 61.35 109.34 171.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.526 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.3 t80 -148.97 124.93 10.63 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 106.649 -1.611 . . . . 61.21 106.649 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.6 mt-10 -124.31 142.16 51.49 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.581 0.753 . . . . 73.24 109.487 -174.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.685 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -147.68 76.31 10.8 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.763 0.825 . . . . 64.13 109.081 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.54 -47.71 0.66 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.43 2.087 . . . . 72.01 111.622 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' D' ' 72' ' ' THR . 26.1 m-20 -97.12 36.13 1.48 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.953 0.901 . . . . 74.44 108.955 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.685 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.47 -54.66 52.68 Favored Pre-proline 0 CA--C 1.559 1.289 0 N-CA-C 114.294 1.22 . . . . 33.11 114.294 -172.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.04 -7.3 14.23 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 121.237 1.477 . . . . 71.33 112.605 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.523 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 19.4 t-160 -83.83 -38.81 20.74 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.214 1.406 . . . . 73.53 110.099 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.0 p -82.96 -20.83 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.437 0.695 . . . . 73.44 110.966 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -61.23 -28.91 69.5 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.856 0.862 . . . . 73.23 110.688 174.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.523 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 63.3 mt-30 -67.04 -20.39 65.84 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.749 1.219 . . . . 75.31 111.557 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -100.86 111.59 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.271 1.029 . . . . 74.44 110.059 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -85.86 63.26 7.94 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.354 1.061 . . . . 73.13 111.108 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.523 ' HB3' HD11 ' D' ' 68' ' ' LEU . 48.2 t-105 -144.69 167.98 21.28 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.824 -0.806 . . . . 75.31 108.824 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.71 116.64 66.48 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.586 0.754 . . . . 73.34 110.031 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.436 ' O ' HD11 ' F' ' 139' ' ' LEU . 95.2 Cg_exo -50.61 133.93 39.17 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.642 2.894 . . . . 42.45 113.764 170.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -65.39 130.6 43.89 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.782 -0.451 . . . . 71.01 109.782 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.43 134.61 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 123.382 0.673 . . . . 53.53 110.786 -177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 10.1 tmtt? -130.6 121.38 25.54 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 106.428 -1.693 . . . . 72.11 106.428 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -100.0 146.9 26.19 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.102 0.561 . . . . 61.34 110.978 -176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.8 m-20 -137.14 122.95 20.0 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.215 1.406 . . . . 73.11 107.609 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 96.2 mt -117.2 144.24 44.99 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.986 0.514 . . . . 71.42 110.943 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 2.6 t70 -146.82 154.02 40.86 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.511 1.124 . . . . 74.11 109.3 -179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t -142.76 148.42 37.19 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.469 0.708 . . . . 71.13 109.775 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.87 168.0 25.01 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.651 1.18 . . . . 70.5 108.14 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 31.4 p -160.5 153.83 21.96 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.054 0.454 . . . . 74.41 111.244 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -154.36 119.6 5.06 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.717 1.207 . . . . 63.44 108.98 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -72.58 126.28 29.49 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.167 0.587 . . . . 73.53 109.543 175.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.66 -40.69 13.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.942 0.497 . . . . 75.33 109.701 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.14 -174.97 4.99 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.078 -0.964 . . . . 70.22 110.243 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -63.08 123.35 18.36 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 115.631 -0.713 . . . . 63.42 110.301 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 69.44 -2.24 1.96 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.873 1.269 . . . . 73.43 112.909 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.413 HG13 HE22 ' D' ' 14' ' ' GLN . 89.7 t -108.68 118.68 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 123.842 0.857 . . . . 63.44 108.868 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -128.97 128.53 43.9 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.877 -1.157 . . . . 75.51 107.877 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -97.13 141.33 30.4 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 106.824 -1.547 . . . . 64.15 106.824 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 3.3 p -139.26 130.55 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.052 -0.722 . . . . 73.42 109.052 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 61.1 t -98.82 138.84 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.519 0 C-N-CA 123.916 0.887 . . . . 74.2 109.684 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.17 120.77 27.95 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.528 -1.286 . . . . 54.22 107.528 171.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -107.25 121.62 44.91 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 124.231 1.012 . . . . 75.54 109.32 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -113.59 122.49 67.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.613 -1.255 . . . . 73.11 107.613 171.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.6 m -121.2 131.81 54.46 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.743 0.817 . . . . 63.31 109.462 -175.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.503 HG23 HD13 ' D' ' 114' ' ' ILE . 80.7 t -119.55 109.13 25.37 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 125.082 1.353 . . . . 70.14 109.261 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 23.6 m -94.89 117.68 30.53 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 108.144 -1.058 . . . . 74.55 108.144 168.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.92 133.07 51.98 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 109.464 -0.569 . . . . 62.24 109.464 -179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 51.2 p -145.83 134.82 22.6 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.069 0.548 . . . . 70.22 109.797 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.523 HD11 ' HB3' ' D' ' 36' ' ' TRP . 19.0 tp -117.87 118.94 33.37 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.105 -0.702 . . . . 63.13 109.105 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.09 -115.18 4.01 Favored Glycine 0 C--N 1.342 0.888 0 N-CA-C 111.15 -0.78 . . . . 43.54 111.15 -170.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.19 9.06 10.38 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.032 0.933 . . . . 61.43 110.268 -177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.88 156.56 39.46 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.014 0.926 . . . . 64.3 110.298 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 99.1 m -68.83 123.99 22.47 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.654 0.782 . . . . 70.23 110.576 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -84.52 -57.28 3.21 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.707 0.803 . . . . 61.44 109.322 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.94 149.75 16.49 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.801 -1.091 . . . . 74.04 109.683 171.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.621 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 87.0 mt -113.65 153.64 28.56 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.418 1.087 . . . . 62.3 108.209 172.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.594 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.8 t -156.09 142.41 18.4 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.106 0.562 . . . . 75.21 109.592 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.22 121.4 4.3 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 122.838 0.455 . . . . 64.41 110.075 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.448 HG22 HG23 ' D' ' 21' ' ' ILE . 60.3 t -126.31 115.26 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.316 0.647 . . . . 74.33 109.973 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 45.2 mt-30 -89.16 87.76 7.29 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.737 -0.838 . . . . 60.14 108.737 169.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.89 104.04 10.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.516 -1.22 . . . . 74.34 108.664 178.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.59 143.68 15.7 Favored Glycine 0 C--N 1.34 0.772 0 N-CA-C 111.901 -0.479 . . . . 61.22 111.901 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.453 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.99 131.41 4.57 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.789 -0.524 . . . . 73.52 111.789 -171.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.402 HG22 ' NE2' ' D' ' 14' ' ' GLN . 53.4 mt -88.8 123.03 40.88 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 C-N-CA 123.926 0.89 . . . . 64.44 108.761 175.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -128.64 163.05 25.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.925 0.89 . . . . 71.25 109.98 176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.8 m -107.3 112.88 25.94 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.529 -0.915 . . . . 71.21 108.529 173.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.77 115.63 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 N-CA-C 107.877 -1.157 . . . . 73.43 107.877 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -145.91 157.6 43.89 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.318 1.047 . . . . 54.21 109.785 -177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.44 -14.28 12.96 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 116.086 -0.506 . . . . 44.44 113.567 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 27.3 pt -138.9 138.68 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 124.956 1.303 . . . . 74.11 109.312 -176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' D' ' 94' ' ' MET . 0.0 OUTLIER -152.4 -177.35 6.15 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.2 0.6 . . . . 73.34 110.718 174.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.64 -120.15 6.81 Favored Glycine 0 C--N 1.349 1.267 0 CA-C-N 116.037 -0.529 . . . . 64.01 112.602 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . 0.504 ' HB ' HD23 ' D' ' 141' ' ' LEU . 23.9 p -64.33 -39.3 93.62 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.805 0.842 . . . . 75.44 111.301 -178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -70.91 -37.63 72.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.738 0.415 . . . . 73.4 111.094 -178.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.659 ' HB2' ' HA ' ' D' ' 90' ' ' GLU . 58.3 ttp -72.58 -36.1 68.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.596 0.359 . . . . 74.32 110.567 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.71 86.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.169 0.588 . . . . 61.42 110.392 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -68.3 -37.72 80.91 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.814 0.846 . . . . 73.44 110.809 174.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' D' ' 102' ' ' CYS . 33.3 t -68.68 -51.25 43.86 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 122.673 0.389 . . . . 61.43 110.158 -177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 93.2 mt -75.41 -18.78 59.83 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.347 0.659 . . . . 65.41 111.63 -178.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.61 -8.98 44.87 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-O 119.409 -0.662 . . . . 74.12 114.14 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.94 -63.19 0.35 Allowed 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 117.878 0.839 . . . . 70.52 112.25 -175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -66.13 -56.52 11.05 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.397 0.888 . . . . 72.53 113.397 -169.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.519 ' SG ' ' SG ' ' D' ' 97' ' ' CYS . 65.4 m -61.91 -43.27 86.51 Favored Pre-proline 0 CA--C 1.564 1.515 0 CA-C-O 118.594 -0.717 . . . . 75.32 111.606 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -51.6 -39.6 65.38 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.463 2.109 . . . . 61.02 114.121 164.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -69.98 -25.29 63.55 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.599 0.76 . . . . 74.5 111.063 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.417 ' O ' ' HD2' ' D' ' 108' ' ' PRO . 48.2 mm -70.27 -40.61 78.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.349 0.66 . . . . 53.22 110.112 171.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.453 HD21 ' HA3' ' D' ' 82' ' ' GLY . 61.7 mt -77.06 -26.51 53.62 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.194 -0.912 . . . . 50.0 111.667 -174.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.505 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 85.4 t80 -53.97 -47.91 95.52 Favored Pre-proline 0 CA--C 1.568 1.642 0 C-N-CA 125.039 1.336 . . . . 73.43 114.469 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' D' ' 105' ' ' ILE . 80.7 Cg_exo -51.0 -41.07 57.97 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.431 2.087 . . . . 63.54 113.712 172.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -75.87 -34.98 60.03 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.892 0.877 . . . . 75.44 111.888 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.92 -45.84 73.23 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.141 0.577 . . . . 71.24 109.894 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -56.45 -48.34 77.25 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 124.581 1.176 . . . . 70.23 110.234 174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.45 -44.69 95.81 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 124.081 0.863 . . . . 74.51 111.121 -176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.6 t -61.38 -43.71 98.41 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 123.594 0.559 . . . . 73.21 110.856 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.594 HG12 ' SG ' ' D' ' 76' ' ' CYS . 66.5 mt -57.11 -57.91 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.877 0.871 . . . . 63.51 110.23 173.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.587 HG23 ' HG3' ' D' ' 125' ' ' GLN . 87.9 m -53.79 -46.69 71.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.362 1.465 . . . . 73.02 112.02 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.1 t -62.55 -41.11 98.69 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 114.91 -1.041 . . . . 71.14 110.036 -176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.4 mtm -70.05 -33.8 72.41 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.144 0.578 . . . . 73.15 111.667 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.7 t -64.39 -43.3 97.03 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.84 0 C-N-CA 123.594 0.758 . . . . 75.05 110.406 176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 87.0 p -72.79 -33.51 66.32 Favored 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 116.105 -0.498 . . . . 73.54 110.704 -178.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 78.9 mtt-85 -68.06 -32.68 73.2 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.997 0.919 . . . . 75.0 110.42 173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.91 7.04 81.86 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.719 -0.673 . . . . 52.45 112.849 178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 71.9 p 56.18 45.15 23.85 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.446 1.498 . . . . 72.23 112.258 175.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -117.85 155.37 50.98 Favored Pre-proline 0 N--CA 1.475 0.814 0 CA-C-N 114.799 -1.092 . . . . 75.11 110.23 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -49.48 112.07 0.61 Allowed 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.25 2.633 . . . . 53.22 112.321 175.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.587 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.9 tt0 -61.28 128.74 37.83 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 124.148 0.905 . . . . 75.2 112.025 -175.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.25 120.29 41.19 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 107.878 -1.156 . . . . 64.34 107.878 -174.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -112.72 95.13 5.25 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 107.864 -1.162 . . . . 62.03 107.864 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.505 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.2 OUTLIER -70.34 125.93 28.19 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.062 0.545 . . . . 72.12 109.642 -174.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.22 142.14 96.66 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 123.896 0.878 . . . . 73.41 111.508 -178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -79.4 124.9 6.05 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.948 2.432 . . . . 74.32 111.109 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 5.4 p -127.27 123.72 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.947 0.899 . . . . 54.52 109.481 -175.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -76.82 94.83 3.93 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.894 -0.78 . . . . 75.33 108.894 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.47 ' HA ' HD23 ' D' ' 136' ' ' LEU . 19.7 p90 -85.31 -16.83 38.72 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 118.815 -0.612 . . . . 74.24 111.256 175.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' D' ' 138' ' ' MET . 2.2 m-20 -48.61 -50.75 31.3 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 124.077 0.951 . . . . 64.12 111.482 174.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.469 ' HB1' ' HG2' ' B' ' 150' ' ' GLU . . . -51.14 -38.08 49.94 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 124.298 0.999 . . . . 54.12 113.112 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' D' ' 133' ' ' PHE . 2.9 mm? -78.67 -35.6 44.93 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.231 0.613 . . . . 65.43 110.777 -178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -63.67 -28.96 70.26 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.316 0.646 . . . . 63.33 111.948 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 59.4 mtt -56.1 -31.18 63.01 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.522 0.729 . . . . 72.32 111.877 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -74.41 -38.85 62.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.321 0.649 . . . . 75.24 110.523 175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -56.0 -36.2 67.65 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.646 0.778 . . . . 70.32 111.836 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.504 HD23 ' HB ' ' D' ' 92' ' ' THR . 10.7 mp -62.19 -34.61 76.77 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.22 0.608 . . . . 71.13 111.011 176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -89.01 0.01 57.04 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.779 0.831 . . . . 73.43 111.088 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -126.47 48.07 2.2 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.577 1.151 . . . . 55.42 108.735 -177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -146.12 107.87 4.31 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 115.299 -0.864 . . . . 74.5 109.462 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.36 169.07 18.4 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.169 0.988 . . . . 62.12 110.122 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.86 148.96 13.6 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-N 115.987 -0.551 . . . . 74.23 112.528 -178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -166.98 173.44 9.3 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.629 0.771 . . . . 75.24 110.542 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 164.82 141.19 3.06 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.614 -0.548 . . . . 63.02 112.492 175.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 29.1 m -75.2 96.04 3.23 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.466 0.706 . . . . 64.4 109.855 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -73.34 164.88 26.04 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.364 0.666 . . . . 73.32 111.793 -175.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 58.1 -87.21 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.961 1.304 . . . . 63.31 110.397 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 36.5 t60 43.88 35.53 1.13 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.623 1.569 . . . . 73.12 112.596 176.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -69.21 126.26 29.23 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.1 0.56 . . . . 71.13 111.024 -171.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.22 167.14 21.84 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.606 0.762 . . . . 74.11 110.756 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.228 0 C-N-CA 123.683 0.793 . . . . 73.21 109.527 -178.644 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 110.117 -0.327 . . . . 63.22 110.117 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp 70.25 89.63 0.1 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 125.097 1.359 . . . . 63.14 110.208 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.69 142.98 57.84 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.345 1.058 . . . . 71.32 112.888 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -74.5 155.56 37.83 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.036 0.934 . . . . 70.33 110.796 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -120.43 158.83 26.36 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.203 1.001 . . . . 74.31 109.901 -178.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.27 -44.16 92.46 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.191 0.997 . . . . 54.43 111.097 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -76.8 148.98 36.28 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.233 -0.894 . . . . 75.12 110.217 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.57 ' H ' HD23 ' E' ' 115' ' ' LEU . 2.2 pt? -76.48 18.29 0.33 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 114.514 1.302 . . . . 61.35 114.514 -164.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -124.99 87.19 55.74 Favored Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 107.899 -1.149 . . . . 71.31 107.899 164.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -84.21 -30.16 0.74 Allowed 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.943 2.429 . . . . 62.4 113.799 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -70.2 132.6 46.01 Favored 'General case' 0 C--N 1.35 0.587 0 C-N-CA 123.284 0.634 . . . . 54.21 110.135 -177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 11.2 t -86.06 30.27 0.69 Allowed 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.976 0.91 . . . . 61.23 110.558 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.463 ' HH2' ' HD1' ' B' ' 133' ' ' PHE . 73.8 t-105 59.05 88.98 0.06 Allowed 'General case' 0 C--N 1.359 1.022 0 C-N-CA 124.508 1.123 . . . . 64.02 110.21 -172.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -94.39 -68.75 0.78 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.283 -0.871 . . . . 64.14 111.073 -168.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.39 113.18 16.16 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.281 0.633 . . . . 71.24 111.846 -169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 1.1 m -128.2 -111.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.356 0 C-N-CA 124.879 1.272 . . . . 51.3 109.835 174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.23 22.57 11.95 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.494 1.117 . . . . 74.15 112.349 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -79.2 126.65 31.03 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 109.788 -0.449 . . . . 73.22 109.788 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -168.91 -166.86 0.68 Allowed 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 107.246 -1.39 . . . . 62.43 107.246 170.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 89.51 -43.92 3.03 Favored Glycine 0 N--CA 1.473 1.1 0 CA-C-N 118.017 0.371 . . . . 71.4 113.554 173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -73.06 -81.24 0.06 Allowed 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.631 -0.507 . . . . 52.21 109.631 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 54.97 -90.65 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 124.386 1.074 . . . . 72.05 111.17 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.694 HG23 HD21 ' B' ' 127' ' ' ASN . 72.2 mt -129.01 80.84 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 106.833 -1.543 . . . . 73.41 106.833 176.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.21 -40.57 71.06 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.49 -0.777 . . . . 74.31 110.141 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -118.83 96.08 49.75 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 123.818 0.847 . . . . 60.43 110.596 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -82.37 78.46 3.4 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.105 1.87 . . . . 54.11 110.353 164.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 40.4 mm -68.49 90.83 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.383 0.673 . . . . 54.44 110.339 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . 0.521 ' HB1' ' HB3' ' C' ' 36' ' ' TRP . . . 61.88 24.76 14.79 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 114.955 -1.02 . . . . 72.55 112.728 170.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.422 ' HA ' ' HB3' ' C' ' 124' ' ' PRO . 33.8 m -83.51 72.94 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 CA-C-O 123.049 1.404 . . . . 70.33 111.211 -174.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -102.75 -179.81 4.07 Favored 'General case' 0 CA--C 1.557 1.219 0 CA-C-N 114.463 -1.244 . . . . 61.13 109.279 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -56.5 -31.37 64.0 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.595 1.158 . . . . 63.3 112.077 177.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 18.5 tp 61.88 31.95 18.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.557 1.143 . . . . 74.51 110.836 173.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 19.8 m -91.02 55.5 2.92 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.687 -1.142 . . . . 74.33 111.16 -173.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 88.2 mt -79.78 -32.12 40.9 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.439 -0.8 . . . . 62.34 110.48 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 25.6 pt -85.91 159.14 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 115.47 -0.786 . . . . 62.42 110.715 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 71.07 154.01 0.13 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.465 1.506 . . . . 71.32 112.124 -176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -148.55 -73.72 0.19 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.967 -0.56 . . . . 71.24 109.934 -174.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -92.17 -43.41 9.36 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.549 0.74 . . . . 75.2 110.365 -178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -111.59 159.13 18.44 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.123 0.569 . . . . 54.05 110.314 177.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 2.5 pp -104.81 -10.19 17.55 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.034 0.934 . . . . 73.43 110.874 174.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 49.2 tp -103.32 114.98 64.59 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 123.978 0.911 . . . . 74.24 109.031 -177.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo . . . . . 0 C--N 1.382 2.304 0 C-N-CA 122.893 2.395 . . . . 62.25 112.219 179.514 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.995 0.426 . . . . 75.03 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -132.57 -42.08 0.94 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.594 1.158 . . . . 71.13 108.232 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -141.17 82.41 1.83 Allowed 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.29 -1.323 . . . . 62.4 107.878 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -86.91 87.04 7.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.437 0.695 . . . . 71.42 110.329 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 57.82 86.98 0.07 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.469 1.107 . . . . 61.52 111.994 172.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -131.0 -174.29 3.34 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.726 -0.842 . . . . 71.31 108.726 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -72.06 95.64 1.64 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.945 0.898 . . . . 63.4 110.755 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -108.44 20.65 18.33 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 124.583 1.153 . . . . 62.34 110.879 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . 0.416 ' H ' ' HD2' ' F' ' 117' ' ' PRO . 58.1 t80 -176.66 -54.52 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.412 0 C-N-CA 124.835 1.254 . . . . 72.11 111.391 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . 0.416 ' HD2' ' H ' ' F' ' 116' ' ' TYR . 73.0 Cg_endo -70.38 106.98 1.87 Allowed 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 121.818 1.678 . . . . 74.33 113.025 -170.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -120.71 147.55 45.14 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.686 0.794 . . . . 71.23 109.733 172.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 11.3 t -90.82 113.43 25.58 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.373 0.669 . . . . 61.35 110.113 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 65.2 t-105 -162.62 160.34 25.66 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.69 0.796 . . . . 65.33 109.67 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -150.34 -47.26 0.13 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.51 0.724 . . . . 71.25 110.592 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . 0.557 ' HB2' ' SD ' ' C' ' 1' ' ' MET . . . -68.42 83.13 0.26 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.014 0.526 . . . . 55.42 111.72 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 85.0 t -98.65 -66.46 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.782 0.833 . . . . 63.21 108.843 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 69.99 143.37 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.391 1.476 . . . . 63.42 111.82 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -149.4 138.16 21.06 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.691 -0.855 . . . . 75.33 108.691 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -148.26 161.69 41.0 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.064 0.945 . . . . 62.42 109.367 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 112.2 104.32 2.72 Favored Glycine 0 C--N 1.342 0.899 0 N-CA-C 111.696 -0.562 . . . . 75.35 111.696 -177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.69 -12.15 24.19 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.518 0.727 . . . . 74.32 110.62 173.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.471 HD21 ' HB2' ' A' ' 129' ' ' ALA . 3.4 mm? 62.96 21.32 12.81 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 124.698 1.199 . . . . 74.43 112.651 176.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 38.1 mm -79.94 85.04 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.659 -0.867 . . . . 72.52 108.659 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.73 -54.37 3.91 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 114.995 -1.002 . . . . 74.23 110.357 -178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -150.25 115.98 3.42 Favored Pre-proline 0 CA--C 1.548 0.886 0 CA-C-N 115.952 -0.567 . . . . 71.35 110.174 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -80.22 75.52 5.01 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.073 2.515 . . . . 61.44 112.725 177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 9.6 tt -72.96 148.95 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 N-CA-C 108.086 -1.079 . . . . 71.25 108.086 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.47 -77.23 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.684 0.794 . . . . 52.24 112.176 -173.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 31.1 t 64.96 -3.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.58 2.111 0 C-N-CA 125.001 1.32 . . . . 50.23 113.069 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -67.01 -70.34 0.26 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.951 0.9 . . . . 73.2 110.678 -176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.62 47.91 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-O 121.092 0.472 . . . . 73.23 110.393 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.436 HD11 ' O ' ' D' ' 38' ' ' PRO . 9.8 tp -100.5 84.41 2.77 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 107.149 -1.426 . . . . 71.44 107.149 176.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.1 m -68.28 -16.63 64.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.131 -1.395 . . . . 74.35 112.98 -169.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.73 92.71 2.5 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.015 0.436 . . . . 75.14 109.993 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 13.0 tt -157.06 146.31 11.05 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 C-N-CA 123.787 0.835 . . . . 74.24 109.308 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -66.17 139.06 58.1 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.299 0.639 . . . . 64.15 111.229 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -122.39 -10.12 8.48 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 74.52 109.859 173.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -66.97 -34.22 77.27 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.751 1.22 . . . . 53.41 110.429 -175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -109.15 97.56 7.15 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.979 -1.01 . . . . 75.03 109.89 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 6.7 tt -158.48 115.81 2.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.178 -1.416 . . . . 71.13 107.178 172.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . 0.616 HD23 ' HA ' ' B' ' 150' ' ' GLU . 5.9 mp -86.94 116.12 64.95 Favored Pre-proline 0 N--CA 1.477 0.879 0 N-CA-C 109.121 -0.696 . . . . 71.34 109.121 176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 C--N 1.376 2.007 0 C-N-CA 123.853 3.036 . . . . 73.41 112.422 176.418 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.4 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 109.821 -0.437 . . . . 63.31 109.821 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 p -133.81 88.42 2.47 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.807 0.843 . . . . 73.32 109.853 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -89.21 114.07 25.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.055 0.942 . . . . 65.25 109.407 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -78.24 -66.26 0.87 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.201 -1.037 . . . . 74.23 108.201 173.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -170.71 138.69 1.44 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.568 1.147 . . . . 74.03 108.431 175.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -74.61 -93.38 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.328 0.651 . . . . 74.42 109.341 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -163.58 -60.31 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.35 1.06 . . . . 75.43 108.379 -174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 60.75 87.75 0.09 Allowed 'General case' 0 C--O 1.243 0.73 0 CA-C-N 114.468 -1.242 . . . . 44.1 110.93 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -60.36 134.16 56.8 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.914 -0.585 . . . . 74.04 110.374 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 m -141.01 101.98 4.16 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.051 -1.092 . . . . 70.54 108.051 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -131.56 152.91 50.39 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.282 0.633 . . . . 74.4 110.316 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -155.84 123.24 5.49 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 123.565 0.746 . . . . 64.41 109.522 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -81.04 125.91 39.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 106.641 -1.615 . . . . 60.32 106.641 168.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.482 ' HB3' HH11 ' A' ' 15' ' ' ARG . 88.3 mt-30 -109.83 -42.05 4.35 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 122.092 -0.38 . . . . 73.12 111.134 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.482 HH11 ' HB3' ' A' ' 14' ' ' GLN . 2.3 mpt_? -152.34 141.46 21.32 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 108.219 -1.03 . . . . 70.41 108.219 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.701 HG23 HD23 ' A' ' 106' ' ' LEU . 55.5 mt -141.13 101.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 N-CA-C 106.025 -1.842 . . . . 74.12 106.025 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 73.0 m-85 -155.36 177.97 10.75 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.634 0.774 . . . . 75.0 110.287 -162.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.3 p -98.24 113.56 25.53 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.679 -0.691 . . . . 63.24 109.846 -175.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -78.17 -32.61 50.27 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 109.802 -0.444 . . . . 73.43 109.802 172.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.0 t70 -149.02 147.63 28.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.999 -0.546 . . . . 73.42 109.735 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.435 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.8 mt -140.72 144.13 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.198 1.399 . . . . 73.41 107.803 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.0 t -157.4 120.9 4.1 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.77 0.319 . . . . 70.42 110.915 175.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.51 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 93.8 t80 -118.41 134.3 55.17 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.126 -1.435 . . . . 71.5 107.126 171.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -129.55 140.8 51.12 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 108.216 -1.031 . . . . 70.04 108.216 176.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -139.16 84.29 16.91 Favored Pre-proline 0 CA--C 1.545 0.78 0 N-CA-C 108.55 -0.907 . . . . 55.34 108.55 173.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.23 -49.64 1.85 Allowed 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 122.986 2.457 . . . . 64.42 112.199 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 44.4 m-80 -103.28 43.92 1.05 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.605 0.762 . . . . 70.42 109.445 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -59.42 -51.95 77.71 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 124.125 0.97 . . . . 73.44 113.205 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -22.66 14.73 Favored 'Trans proline' 0 C--N 1.39 2.737 0 C-N-CA 121.867 1.711 . . . . 73.43 111.939 175.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 7.5 t60 -83.04 -25.35 32.21 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.948 1.299 . . . . 53.23 111.992 -168.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.4 p -61.99 -26.41 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.915 0.886 . . . . 41.02 112.553 -174.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.412 ' HD2' ' HZ2' ' A' ' 36' ' ' TRP . 70.2 m-85 -70.3 -34.73 73.09 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.621 0.768 . . . . 75.14 112.169 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -63.36 -36.32 83.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.199 0.999 . . . . 70.11 110.177 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.84 154.79 23.29 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 114.549 -1.205 . . . . 72.02 110.756 175.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -73.0 118.49 16.01 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.008 -0.738 . . . . 65.13 109.008 173.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.412 ' HZ2' ' HD2' ' A' ' 32' ' ' PHE . 5.5 m0 -60.47 86.62 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.736 0.814 . . . . 71.31 112.298 -174.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -128.26 75.04 79.31 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.074 0.95 . . . . 71.42 108.579 173.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -85.16 139.88 7.36 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.589 2.193 . . . . 64.34 112.279 -177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -95.82 106.77 18.94 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.708 -1.59 . . . . 74.42 106.708 175.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' F' ' 128' ' ' LYS . 47.4 t -85.15 92.07 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 O-C-N 123.651 0.594 . . . . 51.4 109.537 -177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.462 ' NZ ' ' HB2' ' A' ' 67' ' ' SER . 10.7 mptt -75.82 133.03 40.74 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.944 -0.761 . . . . 73.51 108.944 175.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD12 ' HD2' ' F' ' 125' ' ' TYR . 2.2 tm? -121.56 115.79 23.45 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.466 -1.309 . . . . 74.13 107.466 179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.649 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.5 m-20 -122.14 135.76 54.83 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.02 0.928 . . . . 73.41 108.707 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 92.0 mt -121.72 134.06 54.94 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.692 0.797 . . . . 64.22 109.11 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 33.8 t70 -142.17 144.66 33.53 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.896 0.478 . . . . 53.23 110.039 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.1 m -139.11 130.59 27.12 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.77 0.828 . . . . 50.52 110.73 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.45 149.27 42.35 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.958 0.903 . . . . 71.14 109.754 171.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 51.6 p -106.28 164.17 12.24 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.577 0.751 . . . . 63.52 109.628 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -153.97 131.16 11.12 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.056 0.942 . . . . 72.11 108.476 178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -88.73 122.35 32.05 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.023 0.529 . . . . 74.13 110.563 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.402 HD11 ' HB2' ' A' ' 57' ' ' GLU . 59.2 mt -91.5 -44.71 8.94 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.164 -0.925 . . . . 53.52 109.106 176.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.18 176.82 10.82 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.626 -1.17 . . . . 73.12 109.532 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.673 ' H ' ' HB1' ' F' ' 110' ' ' ALA . 9.6 t70 -71.84 114.62 10.12 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 107.919 -1.141 . . . . 71.22 107.919 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 75.23 3.52 4.06 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.314 1.446 . . . . 75.35 112.908 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 29.1 t -112.79 111.97 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 108.649 -0.871 . . . . 50.11 108.649 173.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -125.21 156.01 39.15 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.433 0.693 . . . . 75.34 110.054 -173.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.402 ' HB2' HD11 ' A' ' 51' ' ' LEU . 42.2 tt0 -131.5 117.78 19.26 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.155 0.982 . . . . 74.42 108.743 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.7 t -101.98 128.63 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 108.167 -1.049 . . . . 62.43 108.167 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.0 t -109.03 134.23 51.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.636 0.775 . . . . 73.44 109.197 177.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.15 118.75 37.57 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.447 -1.316 . . . . 74.54 107.447 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.55 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.26 101.75 13.51 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.166 -1.05 . . . . 73.12 108.166 171.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.4 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.3 t -95.32 132.77 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.78 -1.193 . . . . 72.1 107.78 171.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.649 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 33.0 m -118.24 133.12 56.17 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.844 -0.799 . . . . 61.32 108.844 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -132.52 105.07 8.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 106.798 -1.556 . . . . 62.31 106.798 -178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.8 m -113.21 129.45 56.51 Favored 'General case' 0 C--O 1.21 -0.997 0 N-CA-C 108.929 -0.767 . . . . 64.13 108.929 -174.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -117.89 105.42 11.91 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.742 -1.207 . . . . 73.2 107.742 176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.462 ' HB2' ' NZ ' ' A' ' 41' ' ' LYS . 23.9 m -121.66 127.82 51.22 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.674 -0.491 . . . . 61.31 109.674 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.0 tt -89.17 81.98 6.65 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 106.917 -1.512 . . . . 72.31 106.917 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.06 -119.17 5.14 Favored Glycine 0 C--N 1.347 1.152 0 CA-C-N 115.419 -0.81 . . . . 31.15 112.245 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.81 -14.66 41.57 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.776 0.83 . . . . 73.25 111.3 -178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -105.3 132.56 51.35 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.661 1.184 . . . . 72.13 109.336 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -83.83 131.37 34.89 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.856 0.36 . . . . 60.5 110.717 177.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.91 -54.11 5.34 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 123.883 0.873 . . . . 74.42 109.008 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -159.79 174.13 14.95 Favored 'General case' 0 CA--C 1.551 1.007 0 CA-C-N 115.539 -0.755 . . . . 72.34 111.533 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 69.4 tp -141.18 148.4 39.92 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.571 1.548 . . . . 72.01 108.058 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 60.2 m -136.86 133.44 35.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.432 -0.951 . . . . 65.42 108.432 175.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.96 124.8 11.91 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 109.14 -0.689 . . . . 74.32 109.14 -178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.5 t -133.93 117.12 25.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 123.581 0.753 . . . . 72.31 109.45 -176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -84.79 85.1 7.49 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.309 -0.997 . . . . 72.55 108.309 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -81.21 92.44 6.32 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.774 -1.195 . . . . 61.33 107.774 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -103.66 143.67 15.78 Favored Glycine 0 C--N 1.338 0.685 0 N-CA-C 110.762 -0.935 . . . . 63.31 110.762 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.51 141.82 11.44 Favored Glycine 0 CA--C 1.505 -0.579 0 N-CA-C 111.308 -0.717 . . . . 74.12 111.308 -174.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 49.4 mt -88.37 120.76 37.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.981 -0.748 . . . . 74.41 108.981 176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -129.88 118.1 21.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.45 1.1 . . . . 73.31 108.086 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -83.74 115.32 22.15 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 108.262 -1.014 . . . . 34.43 108.262 174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.454 HG21 HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -133.71 135.42 55.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 C-N-CA 123.22 0.608 . . . . 44.13 109.38 -173.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.13 172.33 15.03 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.796 1.239 . . . . 71.52 109.669 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.34 -36.84 3.8 Favored Glycine 0 N--CA 1.465 0.613 0 CA-C-N 115.575 -0.738 . . . . 64.24 112.673 175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.416 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -126.8 147.42 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.367 0.667 . . . . 70.42 110.374 -175.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.541 ' HG3' HD12 ' F' ' 115' ' ' LEU . 21.7 tt0 -135.98 -176.33 4.27 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.133 0.973 . . . . 74.44 108.951 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.504 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.49 -137.15 28.74 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-O 119.94 -0.367 . . . . 74.12 112.88 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.2 p -65.6 -20.79 66.46 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.917 0.887 . . . . 62.23 111.723 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -68.69 -53.33 22.83 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.012 0.925 . . . . 61.13 110.626 179.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.61 -29.19 62.23 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 116.347 -0.388 . . . . 71.01 110.343 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.9 -40.72 96.42 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.359 0.664 . . . . 62.51 109.862 176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.518 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 8.3 t-80 -62.48 -39.01 92.08 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.328 -1.305 . . . . 74.11 110.741 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.671 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 7.1 m -78.35 -61.96 1.84 Allowed 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.047 0.758 . . . . 50.4 113.047 -175.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.454 HD21 HG21 ' A' ' 86' ' ' ILE . 95.0 mt -67.74 -22.7 65.22 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.138 0.575 . . . . 75.03 112.471 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.06 -10.84 44.59 Favored Glycine 0 C--N 1.345 1.047 0 CA-C-O 119.407 -0.663 . . . . 55.21 114.364 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -149.01 -52.6 0.16 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 114.979 1.474 . . . . 75.23 114.979 -169.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.4 t80 -55.24 -59.74 4.36 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 124.077 0.951 . . . . 72.32 110.25 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.5 m -67.88 -45.65 43.14 Favored Pre-proline 0 CA--C 1.552 1.024 0 CA-C-N 114.334 -1.303 . . . . 72.01 112.747 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -49.44 -42.2 41.97 Favored 'Trans proline' 0 C--N 1.391 2.792 0 C-N-CA 122.661 2.241 . . . . 74.04 114.54 168.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -71.73 -30.75 65.97 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.794 0.438 . . . . 73.43 110.493 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.8 mm -70.54 -34.2 56.46 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.504 0.722 . . . . 70.32 110.278 172.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.701 HD23 HG23 ' A' ' 16' ' ' ILE . 84.0 mt -73.29 -28.77 62.29 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.907 0.883 . . . . 74.15 111.305 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -62.81 -44.87 87.14 Favored Pre-proline 0 CA--C 1.568 1.647 0 N-CA-C 115.144 1.535 . . . . 72.5 115.144 -167.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -62.51 -31.31 80.36 Favored 'Trans proline' 0 C--N 1.387 2.589 0 CA-C-N 122.028 1.76 . . . . 72.0 113.257 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -79.82 -34.29 39.63 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.245 0.618 . . . . 72.52 110.817 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.51 -47.82 77.43 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.55 -0.537 . . . . 71.11 109.55 172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.54 HH12 HD12 ' C' ' 105' ' ' ILE . 38.4 ttm180 -52.6 -49.84 64.23 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.922 1.389 . . . . 64.14 110.606 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -62.36 -48.02 81.61 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.046 0.841 . . . . 75.3 111.196 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.5 t -60.39 -36.02 77.1 Favored 'General case' 0 N--CA 1.48 1.049 0 O-C-N 123.797 0.686 . . . . 62.21 111.491 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.463 HG21 HG21 ' A' ' 64' ' ' VAL . 87.4 mt -67.08 -58.68 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 123.678 0.791 . . . . 74.11 109.945 174.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 125' ' ' GLN . 69.0 m -56.09 -31.76 63.53 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.736 1.214 . . . . 71.03 111.438 -174.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.2 -47.42 67.96 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.111 -0.95 . . . . 54.41 110.163 176.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.51 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 38.2 mtm -62.36 -38.24 88.79 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 122.696 0.399 . . . . 72.31 111.221 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ILE . 61.0 t -60.2 -49.56 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 O-C-N 123.968 0.792 . . . . 71.54 109.787 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -26.93 62.36 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.733 -0.667 . . . . 73.33 111.478 -176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.5 mtt-85 -72.21 -31.09 65.55 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.385 0.674 . . . . 63.32 109.559 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.36 5.52 80.37 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.852 -0.613 . . . . 54.12 112.888 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.477 ' CG2' ' HE ' ' B' ' 15' ' ' ARG . 4.3 t 58.26 21.82 8.6 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 127.253 2.221 . . . . 73.22 113.902 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -87.2 148.11 44.11 Favored Pre-proline 0 CA--C 1.55 0.964 0 N-CA-C 108.982 -0.748 . . . . 74.15 108.982 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.45 128.17 26.81 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.026 2.484 . . . . 62.14 112.084 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 115' ' ' THR . 1.2 pt20 -58.16 146.05 34.89 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.475 0.71 . . . . 71.32 111.532 -168.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.8 mt -121.19 97.97 5.76 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.226 0.61 . . . . 73.12 109.376 -179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -98.19 108.05 20.66 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.132 -0.94 . . . . 55.12 108.532 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.444 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.6 mm? -74.4 148.58 41.07 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.745 0.818 . . . . 72.5 110.954 -173.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -69.68 129.91 90.87 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 123.141 0.576 . . . . 45.43 110.427 -177.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.45 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 11.9 Cg_exo -67.89 108.72 1.75 Allowed 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.341 2.027 . . . . 70.21 111.549 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 62.7 t -99.7 111.11 28.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.053 -1.092 . . . . 42.01 108.053 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -82.17 86.25 6.66 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.995 0.902 . . . . 52.32 109.379 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -59.95 -32.36 70.74 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 114.511 -1.222 . . . . 64.12 110.656 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.446 ' HB2' ' NE2' ' A' ' 96' ' ' HIS . 8.4 p-10 -65.7 -30.69 71.41 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.189 0.996 . . . . 72.13 111.577 -176.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.51 -36.8 73.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.933 -0.576 . . . . 64.35 110.647 172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.4 tp -59.92 -42.16 93.32 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.028 0.931 . . . . 73.53 112.391 -174.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 100' ' ' ALA . 25.7 m-85 -59.87 -47.16 86.87 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 122.663 0.385 . . . . 63.31 110.834 176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.519 ' HB3' ' HG3' ' A' ' 144' ' ' GLN . 85.0 mmm -73.58 -28.46 61.84 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.324 0.65 . . . . 51.01 111.165 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -69.61 -35.29 75.15 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.213 1.405 . . . . 62.42 110.459 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -85.32 -31.31 23.09 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.649 -0.705 . . . . 61.44 110.441 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.2 tp -67.34 -48.69 66.78 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.663 0.785 . . . . 72.1 111.495 -175.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -159.01 17.56 0.18 Allowed 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 116.497 -0.32 . . . . 65.44 110.793 -174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 55.12 70.17 0.66 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.98 0.912 . . . . 62.34 111.22 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.519 ' HG3' ' HB3' ' A' ' 138' ' ' MET . 4.5 pt20 -154.35 178.85 9.57 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 115.484 -0.78 . . . . 73.44 110.491 -173.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -142.66 163.84 31.72 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.799 0.84 . . . . 71.44 109.529 177.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -84.4 51.38 4.55 Favored Glycine 0 C--N 1.348 1.215 0 N-CA-C 112.618 -0.193 . . . . 75.44 112.618 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -105.73 127.7 53.24 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.005 -1.109 . . . . 52.33 108.005 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.76 155.17 7.07 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.439 -0.645 . . . . 42.21 111.586 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m 59.88 109.44 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.105 1.362 . . . . 73.32 113.292 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -90.75 169.09 11.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.184 0.594 . . . . 73.35 109.76 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.436 ' H ' ' HD1' ' C' ' 137' ' ' PHE . 42.5 mt-10 65.03 -172.3 0.18 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.925 1.29 . . . . 54.31 112.575 176.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -158.02 119.14 3.5 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.746 -0.835 . . . . 53.42 108.746 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 133.02 54.33 Favored 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 108.983 -0.747 . . . . 73.11 108.983 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -53.87 107.7 0.28 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.092 0.957 . . . . 72.12 111.36 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.251 0 C-N-CA 124.278 1.031 . . . . 72.34 108.804 -178.781 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.64 0.257 . . . . 61.12 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.9 m -139.02 155.33 48.05 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 123.432 0.693 . . . . 73.52 109.637 174.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.31 16.04 2.2 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.866 0.866 . . . . 72.03 111.252 176.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -72.68 -18.14 61.58 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.589 1.156 . . . . 75.14 110.506 170.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 14.3 m120 71.54 -76.95 0.06 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.374 1.47 . . . . 74.1 111.629 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -68.07 137.41 54.98 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.91 0.884 . . . . 74.35 110.808 -175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.715 ' HB ' HD13 ' B' ' 89' ' ' ILE . 89.3 m -146.41 129.74 16.72 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.922 -1.14 . . . . 73.34 107.922 178.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -68.88 -35.51 76.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.3 1.04 . . . . 64.01 110.764 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.486 ' HB3' ' HB ' ' B' ' 89' ' ' ILE . 6.7 ptt? 51.91 -163.21 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 125.591 1.556 . . . . 64.31 113.299 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 2.2 t -156.11 131.78 9.65 Favored 'General case' 0 CA--C 1.553 1.064 0 N-CA-C 107.849 -1.167 . . . . 61.02 107.849 173.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' B' ' 85' ' ' SER . 69.3 t80 -131.71 146.36 52.13 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.926 0.891 . . . . 61.03 109.494 -176.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.743 ' HB2' ' HA ' ' F' ' 146' ' ' ASP . 20.1 tt0 -159.37 142.85 14.63 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 122.638 0.375 . . . . 73.44 110.756 170.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.448 HD11 HD13 ' B' ' 105' ' ' ILE . 54.3 mt -89.53 123.3 41.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 N-CA-C 108.284 -1.006 . . . . 73.51 108.284 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -89.1 -35.7 16.15 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 122.748 0.419 . . . . 73.11 109.935 172.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.477 ' HE ' ' CG2' ' A' ' 122' ' ' THR . 62.1 ttt180 -163.77 146.65 9.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.49 0.316 . . . . 70.21 110.589 -171.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 71.1 mt -132.47 139.77 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.807 -1.553 . . . . 70.43 106.807 170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.453 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 15.0 p90 -173.03 168.34 4.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.038 0.923 . . . . 74.21 112.642 -176.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 66.9 m -90.38 129.27 36.6 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.32 -1.309 . . . . 73.43 108.89 172.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.453 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 48.6 mtpt -98.17 -40.1 8.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.399 0.68 . . . . 73.22 110.573 175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.2 t70 -146.8 135.11 21.78 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.589 -0.732 . . . . 52.05 109.896 -163.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 45.7 mm -136.3 140.37 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 124.713 1.205 . . . . 74.35 109.382 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 22.6 t -140.29 131.41 26.38 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.138 -1.43 . . . . 42.3 107.138 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.435 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -147.03 119.03 8.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.172 -1.418 . . . . 74.12 107.172 169.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -117.99 129.94 55.89 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 108.495 -0.928 . . . . 63.52 108.495 175.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -125.84 81.2 66.05 Favored Pre-proline 0 CA--C 1.538 0.487 0 N-CA-C 107.547 -1.279 . . . . 74.52 107.547 174.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.93 -27.73 20.51 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 122.649 2.233 . . . . 72.41 111.764 -174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -113.91 29.47 7.98 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.136 0.974 . . . . 74.41 109.839 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.57 -50.61 65.16 Favored Pre-proline 0 CA--C 1.568 1.65 0 C-N-CA 124.595 1.158 . . . . 74.21 113.179 174.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.69 -12.67 6.25 Favored 'Trans proline' 0 C--N 1.39 2.746 0 C-N-CA 122.055 1.837 . . . . 71.33 113.277 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.429 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.7 m-70 -93.7 3.82 54.88 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.883 0.873 . . . . 73.52 110.116 -175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.7 p -71.21 -14.37 17.8 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.24 0 C-N-CA 123.751 0.82 . . . . 63.24 111.442 175.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -64.65 -30.9 71.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.494 0.718 . . . . 73.11 112.503 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.585 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.5 pt20 -85.19 -33.29 22.3 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 122.597 0.359 . . . . 74.32 110.104 171.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.598 ' HD3' ' HB3' ' B' ' 68' ' ' LEU . 95.8 mttt -109.48 66.49 0.63 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.487 0.715 . . . . 74.43 111.984 -175.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -93.52 85.57 4.96 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 108.62 -0.881 . . . . 72.14 108.62 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 19.7 t90 -156.47 169.91 23.53 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.04 -0.726 . . . . 75.02 109.04 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -71.1 113.98 23.59 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 123.644 0.778 . . . . 75.35 110.609 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.629 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 2.8 Cg_exo -73.46 144.19 35.9 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.339 2.026 . . . . 74.22 111.9 178.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.01 103.2 1.78 Allowed 'General case' 0 C--O 1.241 0.657 0 CA-C-N 115.466 -0.788 . . . . 74.53 109.204 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.8 m -87.41 135.75 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.241 -0.891 . . . . 71.22 110.782 -173.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.625 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 97.1 mttt -132.12 101.21 5.31 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.357 1.063 . . . . 74.53 108.376 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 pp -99.62 144.96 28.11 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.279 0.632 . . . . 75.13 109.828 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -148.25 139.21 23.15 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.757 -0.831 . . . . 75.44 108.757 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.31 133.17 53.83 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.965 0.906 . . . . 73.23 108.697 -173.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.7 t70 -127.91 135.74 50.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.556 1.142 . . . . 55.21 108.952 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -109.97 114.08 27.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 123.683 0.793 . . . . 75.14 110.324 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.543 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.2 151.68 36.39 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.118 0.967 . . . . 75.33 109.336 177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 88.8 p -145.08 168.82 19.4 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 122.797 0.439 . . . . 74.41 111.157 174.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.0 p -153.75 154.49 34.14 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.209 1.004 . . . . 74.43 108.92 170.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -102.96 103.27 13.37 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.179 -0.674 . . . . 63.45 109.179 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.449 HD11 ' HB2' ' B' ' 57' ' ' GLU . 67.4 mt -77.88 -34.16 51.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.19 -0.913 . . . . 74.11 110.631 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.94 -170.64 2.01 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.805 0.842 . . . . 65.14 110.256 179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -66.58 108.79 2.56 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.746 -1.116 . . . . 63.14 109.39 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 72.31 2.58 4.38 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 125.376 1.47 . . . . 62.45 112.863 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 54.3 t -102.87 93.4 2.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 107.651 -1.24 . . . . 61.44 107.651 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -107.26 138.38 43.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 114.993 -1.003 . . . . 74.22 109.392 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.449 ' HB2' HD11 ' B' ' 51' ' ' LEU . 23.2 tt0 -98.87 127.43 44.79 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.537 -1.282 . . . . 71.42 107.537 172.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.8 t -105.27 122.05 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 108.06 -1.089 . . . . 61.24 108.06 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 45.5 t -102.91 114.07 41.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.256 -1.016 . . . . 35.34 108.256 173.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tt -91.24 127.12 36.55 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 106.75 -1.574 . . . . 72.22 106.75 175.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 48.3 ttt180 -119.0 120.77 38.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.613 -0.884 . . . . 63.32 108.613 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.576 ' HB ' HD11 ' B' ' 114' ' ' ILE . 38.2 t -112.85 112.94 42.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 107.966 -1.124 . . . . 53.43 107.966 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 43.0 m -93.96 135.88 34.83 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 108.273 -1.01 . . . . 71.23 108.273 174.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 114' ' ' ILE . 82.6 t -130.31 130.95 65.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 124.027 0.931 . . . . 73.11 109.15 -178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 97.8 m -125.1 148.23 48.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.006 -1.109 . . . . 65.01 108.006 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.629 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.09 132.74 17.83 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.053 -1.091 . . . . 72.23 108.053 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.461 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 14.0 m -139.87 137.11 34.62 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.372 0.269 . . . . 71.03 110.579 -172.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.598 ' HB3' ' HD3' ' B' ' 34' ' ' LYS . 0.2 OUTLIER -117.39 113.16 21.68 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.871 -1.159 . . . . 65.34 107.871 -179.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.14 -129.59 18.04 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.624 0.578 . . . . 54.2 112.89 178.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -92.86 19.46 7.64 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.555 0.742 . . . . 74.13 111.267 -178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.422 ' HB3' ' NZ ' ' B' ' 34' ' ' LYS . 9.8 tp10 -147.96 159.3 44.02 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 122.588 0.355 . . . . 72.45 111.12 -171.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 87.7 m -71.23 137.48 48.69 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.477 0.711 . . . . 75.41 109.752 175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -91.42 -56.63 3.06 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.078 -1.082 . . . . 64.1 108.078 177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.49 171.32 17.25 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 114.731 -1.122 . . . . 74.14 110.674 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -141.1 146.17 36.74 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.609 1.564 . . . . 73.32 107.308 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.4 t -153.41 154.73 35.02 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 109.395 -0.595 . . . . 70.54 109.395 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -166.09 133.53 2.78 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.231 -0.655 . . . . 71.42 109.231 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.459 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.1 t -126.77 144.98 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 123.624 0.769 . . . . 72.2 109.138 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.0 mt-30 -123.15 94.8 4.37 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 108.816 -0.809 . . . . 74.32 108.816 173.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -82.81 98.82 9.33 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 114.926 -1.034 . . . . 72.05 109.106 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 143.85 17.6 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 110.83 -0.908 . . . . 61.32 110.83 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.64 130.66 3.86 Favored Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.259 -0.736 . . . . 74.04 111.259 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -86.57 126.24 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 108.88 -0.785 . . . . 74.52 108.88 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -134.65 162.08 33.31 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.471 1.109 . . . . 71.11 109.125 -175.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 49.8 m -131.51 112.97 13.12 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.493 0.717 . . . . 64.24 109.735 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.447 HD12 ' N ' ' B' ' 86' ' ' ILE . 1.1 mp -125.29 114.9 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 108.119 -1.067 . . . . 63.13 108.119 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.22 147.15 45.61 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.281 0.632 . . . . 52.03 110.793 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.23 -40.15 2.53 Favored Glycine 0 C--N 1.344 1.022 0 O-C-N 123.818 0.699 . . . . 65.11 113.133 175.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.715 HD13 ' HB ' ' B' ' 7' ' ' THR . 5.7 tp -91.01 148.34 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 C-N-CA 123.049 0.54 . . . . 72.52 111.037 -179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.504 ' H ' HD12 ' B' ' 89' ' ' ILE . 10.2 pt-20 -156.47 164.14 38.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.616 0.766 . . . . 71.41 111.319 177.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.97 -137.57 18.79 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 114.908 -1.042 . . . . 52.14 113.435 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 43.4 m -65.63 -40.35 92.46 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.089 0.956 . . . . 61.31 111.921 -170.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.702 ' HB2' HD11 ' B' ' 89' ' ' ILE . 2.3 mp0 -66.0 -36.85 84.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.647 0.779 . . . . 74.31 111.054 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.413 ' HB2' HG13 ' B' ' 89' ' ' ILE . 0.3 OUTLIER -75.34 -25.21 57.6 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.206 0.602 . . . . 65.31 110.66 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.434 ' HB2' ' HG2' ' E' ' 117' ' ' PRO . . . -61.41 -21.93 64.54 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.47 0.708 . . . . 61.12 111.907 173.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -86.47 -20.31 28.29 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.232 0.613 . . . . 74.14 111.231 175.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -70.84 -62.6 1.33 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.431 0.292 . . . . 73.11 110.4 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 19.0 mt -84.68 -16.43 41.86 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 122.093 -0.379 . . . . 70.42 111.532 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.32 -37.4 17.99 Favored Glycine 0 C--N 1.344 0.98 0 O-C-N 123.471 0.482 . . . . 61.21 112.669 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -124.42 -50.54 1.76 Allowed 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.704 0.631 . . . . 63.12 112.704 -170.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -69.44 -54.57 13.66 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.259 0.624 . . . . 53.05 111.602 -168.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.413 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 81.4 m -63.33 -46.83 85.13 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.54 -0.743 . . . . 73.04 112.015 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 78.6 Cg_exo -54.95 -38.25 93.12 Favored 'Trans proline' 0 C--N 1.391 2.782 0 C-N-CA 121.94 1.76 . . . . 64.44 113.901 170.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -63.73 -32.87 74.5 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.015 0.435 . . . . 75.32 111.083 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.448 HD13 HD11 ' B' ' 13' ' ' ILE . 94.8 mt -67.84 -44.25 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.262 1.025 . . . . 75.12 110.684 174.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.5 mt -78.34 -26.1 46.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.022 0.929 . . . . 51.42 112.199 -172.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.413 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 49.3 t80 -59.43 -45.13 98.93 Favored Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.707 1.203 . . . . 74.53 113.986 -169.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.536 ' HA ' ' HD3' ' B' ' 111' ' ' ARG . 18.7 Cg_endo -58.23 -37.24 96.2 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.328 2.018 . . . . 73.31 113.984 175.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -70.36 -45.3 66.37 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.91 0.484 . . . . 72.23 110.368 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.467 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.84 -42.51 89.45 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 115.33 -0.85 . . . . 62.34 110.367 175.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' B' ' 128' ' ' LEU . 21.6 mtp-105 -52.21 -63.42 1.15 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.302 1.041 . . . . 74.31 111.391 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -59.44 -29.69 67.96 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 124.197 0.936 . . . . 64.31 110.639 -173.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.8 t -70.81 -48.6 53.22 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.104 0.561 . . . . 71.45 111.086 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.601 HG21 HG21 ' B' ' 64' ' ' VAL . 48.2 mt -62.07 -51.86 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 123.417 0.687 . . . . 74.21 110.059 178.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 8.4 m -59.35 -34.52 72.48 Favored 'General case' 0 CA--C 1.555 1.145 0 CA-C-N 114.585 -1.189 . . . . 74.13 110.875 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -67.39 -50.2 60.65 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.534 -0.757 . . . . 43.01 110.392 175.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.8 mmt -63.48 -38.04 89.63 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 122.884 0.473 . . . . 72.11 111.421 -175.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.5 t -64.99 -43.16 96.2 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.011 0 C-N-CA 124.014 0.925 . . . . 63.44 110.767 176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.4 t -62.68 -36.77 83.97 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.925 0.89 . . . . 61.0 111.055 175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 93.6 mtt-85 -68.74 -20.62 64.39 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.138 -0.937 . . . . 75.4 111.472 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.07 16.63 59.87 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-O 119.482 -0.621 . . . . 72.23 114.209 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.5 p 72.65 13.0 5.34 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 126.528 1.931 . . . . 71.2 112.836 -179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -97.94 152.83 38.27 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 122.641 0.376 . . . . 71.34 110.922 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.34 144.14 98.29 Favored 'Trans proline' 0 C--N 1.387 2.562 0 C-N-CA 123.227 2.618 . . . . 71.33 112.001 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.766 ' HB3' HE21 ' C' ' 125' ' ' GLN . 4.9 pp0? -61.41 129.24 40.24 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.527 0.731 . . . . 74.51 111.715 -172.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.19 86.86 2.41 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.694 -0.854 . . . . 75.1 108.694 177.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -90.64 118.4 30.06 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.672 -1.233 . . . . 70.31 107.672 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.55 ' HB2' ' HG2' ' B' ' 111' ' ' ARG . 2.4 mm? -77.47 128.34 34.04 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 109.277 -0.638 . . . . 75.53 109.277 -173.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.37 136.51 93.44 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 123.37 0.668 . . . . 60.12 110.626 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.544 ' HG2' HG21 ' D' ' 13' ' ' ILE . 19.0 Cg_endo -60.5 89.48 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.135 2.557 . . . . 73.31 112.796 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -92.55 118.95 39.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.721 -0.844 . . . . 74.33 108.721 174.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.67 114.59 7.17 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.564 0.745 . . . . 73.43 110.419 178.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 53.3 m-85 -64.75 -29.18 70.15 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.826 0.85 . . . . 62.41 110.268 178.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -66.64 -40.92 88.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.946 0.898 . . . . 72.41 110.807 174.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.67 -30.07 68.67 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.453 0.701 . . . . 52.12 110.948 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 4.0 tt -60.05 -43.82 95.11 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.032 0.933 . . . . 75.34 109.314 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -63.84 -39.03 93.26 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.535 0.734 . . . . 73.41 111.233 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 24.5 mmt -65.91 -35.9 81.89 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.75 0.42 . . . . 73.12 110.181 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.67 -23.93 49.51 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.253 1.021 . . . . 73.51 110.805 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -71.65 -30.32 65.61 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.194 0.998 . . . . 73.15 109.618 177.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.53 21.32 5.48 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.148 0.979 . . . . 72.51 110.423 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 68.65 -74.25 0.08 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.215 1.406 . . . . 74.41 109.815 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -166.18 147.06 6.53 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.084 0.953 . . . . 74.31 108.786 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -146.8 136.78 23.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.186 0.594 . . . . 73.23 109.92 178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -87.07 126.24 34.63 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.372 -0.974 . . . . 64.15 108.372 170.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -87.86 86.69 1.51 Allowed Glycine 0 C--N 1.341 0.826 0 N-CA-C 111.768 -0.533 . . . . 63.45 111.768 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -66.44 132.65 48.75 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.041 0.536 . . . . 74.13 110.901 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.52 -179.44 32.31 Favored Glycine 0 C--N 1.344 1.006 0 CA-C-N 116.414 -0.357 . . . . 64.33 112.694 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.7 t -139.3 -171.45 3.12 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.497 1.119 . . . . 75.41 108.258 175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -125.31 142.61 51.4 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 118.533 0.606 . . . . 74.41 111.326 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.34 -50.11 6.15 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.885 -1.154 . . . . 73.33 107.885 164.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 3.4 t60 61.71 35.69 16.79 Favored 'General case' 0 CA--C 1.555 1.144 0 C-N-CA 124.94 1.296 . . . . 75.01 110.577 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.83 115.37 4.3 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.762 0.825 . . . . 72.23 109.878 177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -75.86 164.24 26.41 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.218 0.607 . . . . 40.54 111.451 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 CA-C-N 115.476 -0.783 . . . . 63.33 110.259 178.63 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptp . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 119.594 -0.241 . . . . 64.5 111.005 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 60.14 46.72 10.24 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-O 121.624 0.726 . . . . 75.21 110.2 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -83.5 130.33 35.01 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.774 -1.103 . . . . 64.12 110.047 -178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 65.22 94.46 0.06 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 125.67 1.588 . . . . 63.32 111.837 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -157.57 74.83 0.77 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 106.644 -1.613 . . . . 75.51 106.644 164.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.454 HD22 ' N ' ' C' ' 6' ' ' ASN . 0.0 OUTLIER -167.64 18.87 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 114.631 -1.168 . . . . 72.21 111.052 -173.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p -92.02 100.44 13.09 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.876 -0.416 . . . . 61.42 109.876 177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -73.31 173.33 9.68 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.476 0.711 . . . . 72.21 109.632 170.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.683 ' HG2' ' HB ' ' C' ' 89' ' ' ILE . 69.0 mtp 65.38 119.77 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.553 1.141 . . . . 63.01 111.518 -174.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.694 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 49.4 m -84.43 85.91 7.34 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.447 -1.316 . . . . 61.2 107.447 173.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.45 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 80.9 t80 -106.16 126.25 51.98 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 114.435 -1.257 . . . . 72.32 109.895 -177.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -145.8 139.78 26.65 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 109.018 -0.734 . . . . 62.31 109.018 172.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 15.6 mm -73.39 106.45 3.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 108.209 -1.034 . . . . 64.12 108.209 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.546 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.8 mm-40 -77.29 -48.83 16.42 Favored 'General case' 0 C--O 1.242 0.672 0 O-C-N 123.254 0.346 . . . . 72.33 110.343 -178.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.8 ttt85 -166.87 149.29 6.35 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.526 -0.761 . . . . 74.45 109.438 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.2 mt -133.89 132.63 56.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 N-CA-C 107.633 -1.247 . . . . 73.53 107.633 175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.413 ' OH ' HD11 ' C' ' 83' ' ' ILE . 31.7 p90 -171.11 165.28 7.42 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.033 0.921 . . . . 62.23 112.849 -173.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 78.1 p -88.04 104.01 16.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 114.296 -1.32 . . . . 75.14 109.072 176.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.461 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 7.0 mtmt -71.1 -23.71 62.16 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.884 0.374 . . . . 64.03 110.201 174.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.599 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 13.5 t70 -158.25 140.7 14.38 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.603 -0.726 . . . . 72.12 109.319 -178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 89.1 mt -134.69 144.16 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.212 -1.403 . . . . 74.1 107.212 173.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -149.57 150.12 31.74 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.345 0.658 . . . . 54.11 109.276 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -155.69 118.75 4.3 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 108.256 -1.016 . . . . 75.32 108.256 175.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -117.95 121.39 40.54 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.398 -0.964 . . . . 65.05 108.398 177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -118.89 85.76 29.27 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 108.043 -1.095 . . . . 75.43 108.043 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.94 -37.81 10.64 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.59 2.193 . . . . 74.32 111.857 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.645 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 1.9 m-20 -107.69 39.8 1.85 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.91 -0.774 . . . . 72.22 108.91 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.575 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -51.65 -49.54 82.41 Favored Pre-proline 0 CA--C 1.563 1.448 0 N-CA-C 114.271 1.212 . . . . 72.42 114.271 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.666 ' HD3' ' HZ1' ' D' ' 19' ' ' LYS . 37.2 Cg_endo -86.99 -22.2 1.87 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 C-N-CA 121.523 1.482 . . . . 62.42 112.831 173.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.645 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 25.1 t-80 -69.51 -23.49 63.62 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.119 0.968 . . . . 75.45 111.547 -176.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.532 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 7.1 p -60.55 -23.4 28.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.094 0 C-N-CA 123.85 0.86 . . . . 73.13 112.25 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.446 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 82.2 t80 -59.14 -41.18 87.68 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.147 0.979 . . . . 72.32 111.847 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -86.96 6.0 34.34 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 112.62 0.6 . . . . 73.51 112.62 -172.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.532 ' HZ3' ' HA ' ' C' ' 31' ' ' VAL . 16.1 pttm -123.42 178.28 5.23 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.255 0.55 . . . . 73.44 110.736 173.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -87.62 133.97 33.72 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 114.484 -1.235 . . . . 70.33 110.003 176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.467 ' HB3' ' HG3' ' C' ' 124' ' ' PRO . 20.4 m-90 -85.38 64.72 8.81 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.752 0.821 . . . . 74.12 111.041 -177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -144.37 62.98 10.59 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.466 1.107 . . . . 74.34 108.737 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -82.53 174.99 9.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.226 1.951 . . . . 45.31 110.847 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.445 ' HA ' HD11 ' E' ' 141' ' ' LEU . 43.1 tt0 -85.36 115.83 23.33 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 108.901 -0.778 . . . . 71.51 108.901 -178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.436 ' H ' HD21 ' E' ' 141' ' ' LEU . 88.6 t -75.13 101.18 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.564 -0.902 . . . . 74.21 108.564 173.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 20.5 tptt -91.81 98.47 11.62 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.552 -1.647 . . . . 62.13 106.552 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 pp -89.38 162.36 15.83 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.42 0.288 . . . . 74.11 110.506 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -159.62 108.47 1.8 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.272 0.629 . . . . 65.43 109.575 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -107.57 141.15 39.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.104 0.961 . . . . 63.24 108.804 -175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -151.28 153.73 35.4 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.921 0.888 . . . . 64.12 108.69 177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.3 t -131.76 133.84 45.21 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.405 -0.591 . . . . 71.43 109.405 175.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -113.24 172.25 7.07 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.536 1.135 . . . . 61.22 109.261 177.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.1 p -151.24 146.62 26.19 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.323 0.649 . . . . 75.22 109.971 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.538 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 10.1 m -144.14 149.07 35.91 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 107.577 -1.268 . . . . 64.1 107.577 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -106.13 114.55 28.75 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.649 -1.241 . . . . 72.02 107.649 166.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' C' ' 57' ' ' GLU . 24.9 mt -93.03 -36.89 12.47 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.394 0.678 . . . . 74.24 109.846 -176.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.496 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.09 -175.64 5.53 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.922 -1.035 . . . . 55.23 110.039 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -62.24 108.5 1.09 Allowed 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.399 -1.273 . . . . 72.54 110.016 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.7 m-20 70.6 -2.38 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 125.694 1.597 . . . . 72.23 113.106 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 97.0 t -98.61 102.81 13.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.412 -0.959 . . . . 74.12 108.412 178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -110.19 160.21 16.7 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.539 0.736 . . . . 70.22 109.352 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.617 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.3 tt0 -120.51 127.27 52.04 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 124.142 0.977 . . . . 64.25 108.72 174.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 62.9 t -106.87 127.39 62.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 107.491 -1.3 . . . . 75.32 107.491 170.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 27.0 t -112.79 101.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 108.287 -1.005 . . . . 53.44 108.287 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -87.64 95.07 9.92 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.829 -1.174 . . . . 75.32 107.829 -179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -88.29 112.5 22.89 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.509 -1.223 . . . . 73.01 108.827 -176.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.7 t -107.44 139.89 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 N-CA-C 108.586 -0.894 . . . . 71.44 108.586 174.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 25.6 m -131.44 133.94 45.7 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 108.626 -0.879 . . . . 70.41 108.626 169.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 72.9 t -125.34 111.5 27.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.692 1.197 . . . . 74.11 108.6 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.537 HG23 HD23 ' C' ' 75' ' ' LEU . 2.4 m -99.06 146.57 25.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.835 -1.172 . . . . 72.04 107.835 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.86 107.99 7.22 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.945 -1.502 . . . . 54.2 106.945 175.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.441 ' HB3' HG23 ' C' ' 72' ' ' THR . 11.8 p -162.43 144.13 10.62 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.475 0.484 . . . . 65.1 110.577 -170.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.9 tp -118.72 85.82 2.43 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.809 -1.182 . . . . 75.15 107.809 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.42 -107.88 2.35 Favored Glycine 0 C--N 1.345 1.064 0 CA-C-N 114.698 -1.137 . . . . 42.1 111.525 -176.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -88.55 -32.89 17.94 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.708 -0.478 . . . . 71.22 109.708 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -75.12 84.17 2.34 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.605 0.762 . . . . 73.23 110.089 -174.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.441 HG23 ' HB3' ' C' ' 67' ' ' SER . 61.4 m -81.89 126.29 31.72 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 115.053 -0.976 . . . . 64.22 110.145 -177.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.94 -61.04 2.11 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.649 -0.871 . . . . 43.12 108.649 175.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -158.33 178.02 10.62 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 121.876 0.846 . . . . 71.01 112.259 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.537 HD23 HG23 ' C' ' 65' ' ' THR . 3.0 tm? -141.62 146.2 35.93 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 105.575 -2.009 . . . . 74.12 105.575 173.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.4 t -150.55 148.2 28.38 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.258 -1.016 . . . . 54.02 108.258 176.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -157.16 134.54 10.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.781 -0.452 . . . . 72.53 109.781 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.8 t -133.17 116.63 26.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 C-N-CA 123.815 0.846 . . . . 70.24 108.921 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.599 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.6 mt-30 -87.8 86.17 7.13 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.342 -1.355 . . . . 74.41 107.342 169.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -79.48 96.1 5.99 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.936 -1.029 . . . . 73.51 108.832 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -88.48 144.35 18.35 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 111.244 -0.742 . . . . 63.23 111.244 177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.564 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -145.18 119.93 1.3 Allowed Glycine 0 CA--C 1.497 -1.043 0 N-CA-C 110.259 -1.136 . . . . 65.54 110.259 -175.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.562 HD12 HD11 ' C' ' 51' ' ' LEU . 7.4 mm -82.58 123.76 38.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.206 -1.035 . . . . 70.23 108.206 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -130.49 120.94 24.91 Favored 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.887 0.875 . . . . 71.44 108.829 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 22.0 p -77.93 109.81 12.3 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.987 -1.116 . . . . 75.14 107.987 170.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 27.2 pt -118.51 113.22 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 121.4 0.619 . . . . 74.23 109.352 173.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.694 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -123.83 156.23 36.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.823 0.849 . . . . 72.33 109.762 178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.34 -35.8 3.52 Favored Glycine 0 C--N 1.342 0.906 0 O-C-N 123.572 0.545 . . . . 74.52 113.382 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.683 ' HB ' ' HG2' ' C' ' 9' ' ' MET . 19.3 tt -88.4 145.97 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 123.075 0.55 . . . . 70.33 110.667 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.78 -177.56 5.79 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.003 0.921 . . . . 73.52 110.403 -176.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 60.67 -147.07 46.46 Favored Glycine 0 C--N 1.35 1.315 0 CA-C-N 115.649 -0.705 . . . . 73.43 114.626 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 40.8 p -69.86 -19.18 63.45 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.128 0.971 . . . . 61.52 111.863 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -71.12 -42.36 69.35 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.746 0.819 . . . . 75.2 110.566 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' C' ' 91' ' ' GLY . 25.9 ptt? -69.87 -28.57 65.76 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 110.223 -0.288 . . . . 60.25 110.223 177.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.93 -42.29 90.26 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 123.75 0.656 . . . . 61.12 110.365 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -60.54 -39.38 87.68 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.486 0.714 . . . . 74.05 110.783 173.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -63.21 -58.29 7.69 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.839 0.455 . . . . 74.13 110.952 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -77.12 -12.47 59.95 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.586 0.587 . . . . 73.44 112.586 -176.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -114.9 9.79 21.13 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-O 119.341 -0.699 . . . . 43.31 114.739 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.83 -53.33 0.13 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 117.764 0.782 . . . . 72.34 111.284 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -74.61 -59.84 2.55 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.368 0.667 . . . . 74.43 111.584 -174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 70.2 m -60.78 -44.89 96.47 Favored Pre-proline 0 CA--C 1.566 1.565 0 C-N-CA 124.465 1.106 . . . . 71.2 113.461 -177.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.35 -20.86 48.16 Favored 'Trans proline' 0 C--N 1.393 2.886 0 C-N-CA 122.005 1.803 . . . . 64.24 113.476 175.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -71.53 -30.63 66.13 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.994 0.517 . . . . 54.3 110.467 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.54 HD12 HH12 ' A' ' 111' ' ' ARG . 44.2 mm -68.2 -28.9 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.288 0.635 . . . . 73.14 110.261 173.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.564 HD21 ' HA3' ' C' ' 82' ' ' GLY . 85.7 mt -86.47 -22.85 26.23 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.819 0.848 . . . . 73.53 112.182 -178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -53.77 -50.6 82.74 Favored Pre-proline 0 CA--C 1.562 1.426 0 CA-C-O 117.996 -1.002 . . . . 73.14 113.374 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.01 -36.5 96.57 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 122.022 1.815 . . . . 44.25 113.482 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -72.36 -44.44 62.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.139 0.576 . . . . 73.45 111.089 -177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -41.92 86.26 Favored 'General case' 0 N--CA 1.482 1.17 0 O-C-N 123.465 0.478 . . . . 54.25 109.887 173.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -60.28 -51.29 70.17 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.14 1.376 . . . . 73.42 111.142 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.404 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.2 tm-20 -70.81 -30.36 66.79 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 123.498 0.499 . . . . 64.42 110.291 -178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 10.0 t -69.86 -30.82 68.38 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.832 0.453 . . . . 74.34 111.178 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.461 HD11 ' HB ' ' C' ' 62' ' ' VAL . 98.0 mt -77.3 -50.31 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.528 0.731 . . . . 70.3 109.949 175.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -62.98 -29.08 70.54 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.625 0.77 . . . . 74.14 111.228 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -64.91 -52.31 57.15 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.837 -0.801 . . . . 60.42 108.837 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.47 -38.71 78.15 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.435 1.094 . . . . 44.53 112.754 179.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.404 HG23 ' O ' ' C' ' 114' ' ' ILE . 87.5 t -61.86 -50.01 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.274 0.629 . . . . 60.21 109.864 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.1 t -71.14 -22.23 62.09 Favored 'General case' 0 CA--C 1.552 1.057 0 CA-C-N 115.179 -0.919 . . . . 54.31 111.392 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -71.9 -37.11 70.17 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.067 -0.716 . . . . 72.15 109.067 174.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.28 3.76 79.95 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.905 0.753 . . . . 72.32 113.131 174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.496 HG23 ' HB3' ' D' ' 17' ' ' TYR . 71.4 p 57.5 40.74 26.86 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.8 1.64 . . . . 51.01 112.153 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -99.29 165.04 15.55 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 124.758 1.223 . . . . 75.45 110.838 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' C' ' 36' ' ' TRP . 22.5 Cg_endo -57.48 147.36 78.85 Favored 'Trans proline' 0 C--N 1.394 2.925 0 C-N-CA 123.572 2.848 . . . . 22.11 113.927 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.766 HE21 ' HB3' ' B' ' 125' ' ' GLN . 7.6 mm-40 -58.51 111.94 1.42 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.555 1.142 . . . . 75.11 111.522 -177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 40.6 tp -122.15 97.28 5.4 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.408 0.683 . . . . 73.53 109.319 -174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -101.35 115.9 31.56 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.101 0.96 . . . . 74.22 108.709 177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.13 134.56 50.74 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 108.956 -0.757 . . . . 72.15 108.956 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -64.35 132.35 95.32 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 123.077 0.551 . . . . 74.34 111.171 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' C' ' 129' ' ' ALA . 13.2 Cg_exo -71.37 90.19 0.69 Allowed 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 122.974 2.449 . . . . 75.14 112.783 -178.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.4 HG22 ' HB3' ' E' ' 147' ' ' LEU . 67.0 t -100.12 112.36 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.737 0.815 . . . . 72.1 109.792 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -97.75 95.38 7.52 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.352 0.661 . . . . 72.42 109.384 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -65.86 -30.43 71.04 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.516 0.726 . . . . 72.44 111.348 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -67.86 -47.24 69.5 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.279 0.562 . . . . 72.01 110.208 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.89 63.14 Favored 'General case' 0 C--O 1.213 -0.861 0 CA-C-N 114.763 -1.108 . . . . 40.42 111.911 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.565 HD11 ' HD2' ' E' ' 149' ' ' PRO . 10.4 tt -50.04 -39.51 42.07 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 125.243 1.417 . . . . 65.2 112.67 -176.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.436 ' HD1' ' H ' ' A' ' 151' ' ' GLU . 81.9 m-85 -72.19 -46.88 54.43 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.963 0.905 . . . . 64.41 111.226 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 73.7 mtm -71.84 -26.33 62.33 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.427 1.091 . . . . 34.31 112.284 -176.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.557 HD22 HD21 ' E' ' 148' ' ' LEU . 93.5 m-20 -67.63 -34.59 77.28 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.995 0.918 . . . . 70.31 110.535 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -68.84 -96.36 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.271 0 O-C-N 123.637 0.585 . . . . 74.51 110.949 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mp 55.42 177.29 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 124.179 0.992 . . . . 73.33 112.702 -170.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 59.72 121.03 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 125.863 1.665 . . . . 74.44 113.377 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -70.2 93.13 0.8 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.321 0.648 . . . . 74.52 109.484 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 64.16 108.34 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.025 1.33 . . . . 71.43 112.476 173.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.77 169.37 14.28 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.842 0.857 . . . . 63.32 111.794 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -107.58 -130.35 6.33 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-N 115.869 -0.605 . . . . 74.51 111.631 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -159.93 141.14 12.51 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.565 0.746 . . . . 73.04 110.43 176.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -129.56 62.13 0.65 Allowed Glycine 0 C--N 1.35 1.321 0 N-CA-C 111.033 -0.827 . . . . 51.03 111.033 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 71.2 p -68.07 97.24 0.68 Allowed 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 124.247 1.019 . . . . 71.14 111.068 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -89.06 112.46 23.42 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.033 0.533 . . . . 74.32 109.944 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -75.91 138.8 41.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.723 0.809 . . . . 73.44 110.58 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -98.97 143.43 29.26 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.702 -0.851 . . . . 75.32 108.702 171.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -71.3 127.22 31.85 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.192 -1.04 . . . . 61.24 108.192 172.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -78.81 -21.63 47.43 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.475 0.31 . . . . 61.35 110.837 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 124.771 1.228 . . . . 62.3 110.402 -173.96 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.134 -0.321 . . . . 73.42 110.134 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -164.44 179.27 6.84 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.14 0.976 . . . . 74.54 108.843 -177.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -82.55 135.74 35.02 Favored 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 108.615 -0.883 . . . . 74.22 108.615 168.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -82.54 -61.78 1.79 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.028 0.931 . . . . 54.53 110.289 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.97 106.69 1.06 Allowed 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.12 -0.946 . . . . 73.05 110.226 -173.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -76.04 84.96 2.92 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.52 -0.918 . . . . 75.01 108.52 173.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -71.44 168.93 16.44 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.092 -1.413 . . . . 71.24 108.695 173.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -60.74 106.26 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 108.686 -0.857 . . . . 74.31 108.686 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.527 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.6 tpt -28.87 124.95 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 126.107 1.763 . . . . 70.42 113.595 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.1 m -143.36 140.54 30.55 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.747 0.819 . . . . 55.32 110.166 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.59 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 44.5 t80 -143.01 115.61 8.62 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.937 -1.505 . . . . 72.44 106.937 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 44.2 mt-30 -128.13 147.36 50.54 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.276 -0.639 . . . . 72.32 109.276 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.544 HG21 ' HG2' ' B' ' 130' ' ' PRO . 3.8 mp -103.6 121.0 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 107.992 -1.114 . . . . 60.3 107.992 176.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -101.45 -42.22 6.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.893 0.477 . . . . 73.31 111.891 -177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.518 ' HD3' HD12 ' D' ' 83' ' ' ILE . 47.4 ttt180 -163.7 123.83 2.16 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 119.701 -0.19 . . . . 73.41 110.616 -168.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.6 136.62 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.156 -1.424 . . . . 55.5 107.156 171.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.575 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 39.7 p90 -166.0 177.72 6.88 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 123.947 0.779 . . . . 70.12 111.32 177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -101.89 117.47 34.9 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.206 -0.907 . . . . 65.34 109.073 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.666 ' HZ1' ' HD3' ' C' ' 29' ' ' PRO . 26.9 mtpp -80.53 -27.91 37.5 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 116.569 -0.287 . . . . 74.51 110.356 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -156.69 148.88 23.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.529 0.731 . . . . 70.14 109.13 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.551 HG21 ' HE2' ' C' ' 117' ' ' MET . 83.3 mt -143.44 147.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.97 1.308 . . . . 50.24 108.506 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 43.0 t -148.03 144.44 27.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.491 1.116 . . . . 71.44 109.275 172.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.433 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.61 126.29 8.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.154 -1.795 . . . . 64.03 106.154 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.477 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 48.0 mt-10 -128.65 141.13 51.44 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.206 0.602 . . . . 72.23 109.46 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.75 77.13 9.54 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 124.211 1.004 . . . . 53.02 108.349 177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.54 -38.71 13.8 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.611 2.207 . . . . 71.4 111.421 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.505 HD21 ' HB ' ' D' ' 72' ' ' THR . 13.2 p30 -102.24 31.06 4.16 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.814 1.646 . . . . 63.12 109.746 -175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.515 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -60.07 -48.48 94.39 Favored Pre-proline 0 CA--C 1.563 1.469 0 N-CA-C 114.53 1.307 . . . . 74.32 114.53 -173.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.29 -4.71 11.05 Favored 'Trans proline' 0 C--N 1.387 2.603 0 CA-C-N 121.299 1.5 . . . . 73.21 112.685 175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.6 t-160 -81.39 -54.74 5.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.881 1.272 . . . . 74.22 109.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.542 HG21 ' HA ' ' D' ' 73' ' ' ALA . 52.8 t -67.9 -16.32 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 C-N-CA 123.918 0.887 . . . . 71.24 111.186 177.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -63.56 -18.28 63.7 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.323 1.049 . . . . 71.33 112.415 173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.89 -16.09 57.49 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.163 0.585 . . . . 74.3 111.1 174.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.473 ' HZ3' ' HB3' ' D' ' 71' ' ' GLU . 49.8 mtmt -113.81 104.41 12.16 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.965 0.906 . . . . 71.24 110.187 -178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -84.47 95.34 8.77 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.006 0.522 . . . . 62.52 109.981 173.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.504 ' HB3' HD11 ' D' ' 68' ' ' LEU . 56.3 t-105 -161.69 158.53 26.11 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.773 -0.825 . . . . 74.53 108.773 170.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -74.73 110.11 8.98 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.121 0.969 . . . . 72.41 109.614 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.519 ' HD2' HD22 ' F' ' 139' ' ' LEU . 31.3 Cg_exo -63.18 131.13 31.09 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.771 2.98 . . . . 72.5 113.312 -178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -69.06 119.55 13.53 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.56 -0.533 . . . . 63.31 109.56 176.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.601 HG12 ' HB2' ' D' ' 66' ' ' ALA . 9.3 m -98.83 120.77 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.42 0.688 . . . . 74.04 111.436 -174.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -87.66 115.85 25.38 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 108.018 -1.104 . . . . 74.05 108.018 166.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.5 pp -96.51 142.11 28.99 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 108.833 -0.803 . . . . 63.51 108.833 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.657 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -127.8 112.33 14.64 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 107.89 -1.152 . . . . 72.32 107.89 173.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.4 mt -96.57 134.48 39.74 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.952 -0.759 . . . . 61.02 108.952 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.1 t70 -152.22 147.95 27.01 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 107.943 -1.132 . . . . 61.34 107.943 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.8 t -139.59 163.92 31.27 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.078 0.466 . . . . 75.34 110.28 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.06 163.05 39.17 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.148 0.979 . . . . 75.31 109.761 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 59.6 p -142.41 153.33 43.65 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.658 -0.867 . . . . 73.21 108.658 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 39.6 t -155.76 152.46 28.52 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.359 1.064 . . . . 72.34 108.352 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -99.42 134.09 42.79 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.502 -0.555 . . . . 41.42 109.502 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' D' ' 57' ' ' GLU . 46.4 mt -103.14 -41.37 6.1 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.709 0.804 . . . . 74.32 109.265 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.18 -171.83 3.52 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.205 -0.907 . . . . 74.5 109.95 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -65.28 122.84 18.04 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.559 -0.746 . . . . 73.44 109.233 176.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 63.78 9.17 4.23 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.527 1.131 . . . . 63.54 112.831 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 95.4 t -119.26 120.56 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 124.058 0.943 . . . . 72.34 108.486 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.423 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 73.0 m-85 -136.34 135.98 39.31 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 122.852 0.461 . . . . 74.14 110.246 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.454 ' HB2' HD21 ' D' ' 51' ' ' LEU . 6.2 tp10 -91.08 113.75 26.09 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.094 0.958 . . . . 63.31 109.378 175.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 58.1 t -101.44 127.82 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 107.659 -1.237 . . . . 61.41 107.659 172.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 59.2 t -113.36 146.48 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 123.433 0.693 . . . . 73.41 109.341 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.494 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -127.47 108.76 11.09 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.006 -1.109 . . . . 61.12 108.006 176.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.7 ttm-85 -85.13 107.05 17.02 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 109.201 -0.666 . . . . 71.31 109.201 170.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.0 t -105.29 103.95 16.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 108.013 -1.106 . . . . 75.5 108.013 168.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.657 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 45.3 m -96.61 135.84 37.96 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.888 -0.782 . . . . 73.03 108.888 176.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.462 HG23 HD13 ' D' ' 114' ' ' ILE . 64.1 t -122.35 127.41 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.194 -1.039 . . . . 72.23 108.194 174.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 33.1 m -129.03 93.55 3.62 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.706 -1.22 . . . . 71.13 107.706 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.601 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -95.95 148.97 22.08 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.181 0.592 . . . . 65.4 110.039 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 34.8 p -151.05 136.91 18.12 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 123.988 0.805 . . . . 71.41 109.525 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.504 HD11 ' HB3' ' D' ' 36' ' ' TRP . 24.9 tp -120.53 128.34 53.01 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.813 -0.81 . . . . 74.41 108.813 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.88 -119.39 8.12 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.193 0.308 . . . . 62.24 112.349 -175.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.36 7.01 17.52 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.073 0.949 . . . . 71.2 109.783 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.473 ' HB3' ' HZ3' ' D' ' 34' ' ' LYS . 11.0 tp10 -116.46 145.88 42.96 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.497 1.119 . . . . 55.35 109.304 -175.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.505 ' HB ' HD21 ' D' ' 27' ' ' ASN . 54.2 m -59.23 145.67 42.01 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.556 0.743 . . . . 72.31 109.038 169.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.542 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -106.57 -57.36 2.07 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 109.955 -0.387 . . . . 62.04 109.955 -178.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.44 147.22 18.88 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.765 -0.652 . . . . 63.23 110.148 172.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 48.3 mt -110.69 149.15 30.88 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.538 1.135 . . . . 65.01 108.701 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -160.06 149.66 17.95 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.195 0.598 . . . . 62.21 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -156.61 141.0 16.67 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.506 -0.924 . . . . 61.31 108.506 168.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.3 t -136.37 118.66 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 109.301 -0.629 . . . . 75.01 109.301 175.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -89.5 85.75 6.59 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.534 -0.913 . . . . 74.33 108.534 170.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.58 102.15 8.71 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.517 -1.219 . . . . 63.54 108.7 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.8 142.96 15.86 Favored Glycine 0 C--N 1.337 0.618 0 N-CA-C 111.315 -0.714 . . . . 65.23 111.315 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.88 132.19 5.63 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.415 -1.074 . . . . 52.2 110.415 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.518 HD12 ' HD3' ' D' ' 15' ' ' ARG . 89.7 mt -88.09 114.26 26.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.441 -0.948 . . . . 64.24 108.441 177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -119.63 136.44 54.39 Favored 'General case' 0 C--O 1.24 0.605 0 C-N-CA 124.053 0.941 . . . . 74.34 109.461 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.463 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 6.5 m -79.31 105.98 11.01 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.923 -0.769 . . . . 63.52 108.923 172.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.423 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 37.3 mm -106.18 102.57 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 108.253 -1.018 . . . . 60.12 108.253 -178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.21 152.99 51.35 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.954 0.901 . . . . 63.23 109.535 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 77.89 -1.93 66.44 Favored Glycine 0 C--N 1.346 1.125 0 N-CA-C 114.632 0.613 . . . . 62.14 114.632 174.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 12.1 tt -136.86 125.76 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 109.011 -0.737 . . . . 74.11 109.011 -177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -141.94 -173.92 3.94 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.467 0.707 . . . . 70.12 111.075 -171.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.16 -134.58 25.14 Favored Glycine 0 C--N 1.357 1.698 0 CA-C-N 115.782 -0.644 . . . . 52.42 113.05 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -89.07 -16.86 30.53 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.803 0.841 . . . . 75.43 111.215 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -68.18 -38.47 82.07 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.645 0.778 . . . . 62.23 110.871 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -29.29 66.78 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 116.534 -0.303 . . . . 23.02 110.399 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.51 -31.2 71.78 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.347 0.659 . . . . 63.22 111.113 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -67.66 -40.28 84.49 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 73.34 110.847 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -68.64 -52.3 32.75 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.061 -0.518 . . . . 60.11 110.624 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 9.3 mp -73.56 -16.96 61.25 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.597 0.759 . . . . 75.03 111.637 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.04 -24.68 24.25 Favored Glycine 0 C--N 1.349 1.303 0 CA-C-O 119.769 -0.462 . . . . 75.03 114.052 178.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.1 -57.67 1.09 Allowed 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 117.679 0.74 . . . . 63.4 111.805 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -67.07 -50.75 60.71 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.798 0.839 . . . . 74.33 112.633 -169.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.59 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 19.3 m -69.67 -44.79 24.65 Favored Pre-proline 0 CA--C 1.561 1.396 0 C-N-CA 123.307 0.643 . . . . 72.21 111.679 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.494 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 51.8 Cg_exo -58.72 -31.84 95.74 Favored 'Trans proline' 0 C--N 1.395 2.987 0 C-N-CA 122.147 1.898 . . . . 70.31 113.416 169.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -63.95 -37.49 87.59 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.073 0.549 . . . . 72.33 110.721 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 68.3 mt -63.57 -41.81 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 123.539 0.736 . . . . 72.02 109.976 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.8 -17.69 60.58 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.17 -0.923 . . . . 72.0 112.143 -176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -68.36 -42.7 29.85 Favored Pre-proline 0 N--CA 1.483 1.22 0 N-CA-C 113.607 0.966 . . . . 73.4 113.607 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -53.8 -37.14 84.56 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 122.072 1.848 . . . . 74.44 113.618 169.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.442 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 94.7 m-85 -81.37 -33.58 32.26 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.995 0.918 . . . . 72.34 111.431 -174.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.63 66.88 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.383 0.673 . . . . 60.32 109.382 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.478 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 26.0 ttp180 -53.25 -53.42 51.08 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.964 -1.471 . . . . 73.3 110.458 175.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -57.9 -46.65 84.63 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 124.281 0.988 . . . . 63.41 111.838 -175.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.4 t -59.43 -42.0 90.84 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.986 0.804 . . . . 70.4 111.175 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.462 HD13 HG23 ' D' ' 64' ' ' VAL . 75.9 mt -65.22 -53.88 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 O-C-N 123.666 0.604 . . . . 71.13 110.277 176.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.421 HG23 ' HG3' ' D' ' 125' ' ' GLN . 48.4 m -55.19 -40.54 70.84 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.701 1.2 . . . . 73.21 111.513 -172.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 30.8 t -66.75 -43.21 84.74 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.59 -1.186 . . . . 64.41 110.436 178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 79.4 mtm -67.77 -32.83 73.68 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.007 0.523 . . . . 73.32 112.163 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.436 HG23 ' O ' ' D' ' 114' ' ' ILE . 83.4 t -67.41 -42.01 86.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 C-N-CA 123.372 0.669 . . . . 70.31 109.764 177.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.8 p -76.08 -28.39 57.57 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-N 116.097 -0.502 . . . . 74.51 111.131 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -71.61 -32.48 68.05 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.644 0.778 . . . . 73.24 109.567 173.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 6.13 73.52 Favored Glycine 0 C--N 1.355 1.623 0 O-C-N 123.754 0.659 . . . . 33.34 112.544 173.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' C' ' 17' ' ' TYR . 63.3 p 57.58 21.46 7.16 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.83 2.052 . . . . 75.31 114.291 176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.7 m-85 -85.39 157.6 58.61 Favored Pre-proline 0 CA--C 1.545 0.764 0 C-N-CA 123.928 0.891 . . . . 62.15 109.301 170.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.51 121.82 10.71 Favored 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.718 2.278 . . . . 62.34 111.477 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.421 ' HG3' HG23 ' D' ' 115' ' ' THR . 24.1 tt0 -48.29 132.23 16.35 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.009 1.324 . . . . 63.32 112.47 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' F' ' 142' ' ' ILE . 61.4 tp -107.14 106.1 16.43 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.373 -0.973 . . . . 74.35 108.373 -176.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -97.61 89.71 4.76 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.702 -1.222 . . . . 61.01 107.702 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.52 ' HA ' HG12 ' F' ' 142' ' ' ILE . 5.6 mp -62.9 112.51 2.6 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 123.786 0.679 . . . . 54.34 109.594 -176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' F' ' 147' ' ' LEU . . . -74.79 139.57 73.86 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 109.255 -0.646 . . . . 64.24 109.255 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.51 165.28 27.79 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.245 1.963 . . . . 62.33 112.727 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.81 138.7 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 109.368 -0.605 . . . . 73.53 109.368 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 -74.81 95.26 2.88 Favored 'General case' 0 C--O 1.245 0.863 0 N-CA-C 108.955 -0.757 . . . . 74.51 108.955 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -59.68 -39.61 85.07 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.039 -0.982 . . . . 75.2 111.045 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -62.32 -54.87 34.25 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.458 1.103 . . . . 60.34 111.846 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 -32.84 74.74 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.074 0.549 . . . . 73.35 112.332 -173.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -69.86 -41.24 75.12 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.314 0.646 . . . . 75.44 109.524 175.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.447 ' O ' HD13 ' D' ' 141' ' ' LEU . 58.8 t80 -64.13 -31.61 72.87 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.373 1.069 . . . . 73.31 111.185 -178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.7 mmt -53.72 -51.55 62.95 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.361 0.664 . . . . 62.12 111.097 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -72.69 -30.61 64.38 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.766 -1.107 . . . . 54.33 111.145 -176.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -58.01 -35.91 71.92 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.708 0.803 . . . . 71.13 111.62 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.447 HD13 ' O ' ' D' ' 137' ' ' PHE . 8.4 mp -61.17 -45.53 94.24 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.229 0.612 . . . . 74.52 111.687 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -82.35 3.93 25.9 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.071 0.397 . . . . 73.4 112.071 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -121.26 87.68 2.8 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.65 0.78 . . . . 64.02 109.766 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.1 84.93 1.78 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.856 -1.165 . . . . 55.11 107.856 177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.73 -3.93 1.44 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.655 0.782 . . . . 70.04 110.985 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -72.39 127.48 12.31 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 111.634 -0.586 . . . . 43.14 111.634 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.35 -26.38 68.0 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.313 0.645 . . . . 74.52 111.668 -178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 64.78 -149.09 51.56 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.569 0.543 . . . . 55.54 112.519 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 72.5 p -125.79 137.44 53.79 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 15.01 108.816 174.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -70.79 91.84 0.85 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 109.132 -0.692 . . . . 73.02 109.132 173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -94.04 113.53 25.52 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.301 -0.863 . . . . 70.24 110.038 -174.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -154.28 169.83 22.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.286 1.034 . . . . 73.21 109.33 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.09 151.35 44.59 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.928 0.491 . . . . 72.54 110.712 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -94.84 -42.04 8.9 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.401 0.68 . . . . 70.14 109.532 173.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.84 0 CA-C-N 115.655 -0.702 . . . . 64.41 109.629 175.76 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 30.2 t70 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.865 -0.42 . . . . 73.53 109.865 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -139.16 55.5 1.7 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 107.062 -1.459 . . . . 61.22 107.062 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 73.16 178.74 0.23 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.645 1.578 . . . . 74.4 111.439 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -143.62 -173.11 3.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.391 0.677 . . . . 65.53 110.576 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.91 171.29 15.45 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.116 0.966 . . . . 73.25 110.907 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -80.06 177.95 8.58 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.419 0.687 . . . . 75.1 111.466 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm 64.75 85.21 0.14 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.649 1.179 . . . . 73.13 109.507 -167.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' B' ' 90' ' ' GLU . 26.3 tp -80.59 80.75 6.99 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.868 -1.06 . . . . 61.04 109.336 -176.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -164.95 77.97 1.36 Allowed Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 124.395 1.078 . . . . 75.35 109.368 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.434 ' HG2' ' HB2' ' B' ' 95' ' ' ALA . 96.5 Cg_endo -90.12 -178.98 1.66 Allowed 'Trans proline' 0 C--N 1.368 1.597 0 C-N-CA 122.567 2.178 . . . . 72.44 113.542 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 62.45 -93.52 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.432 1.493 . . . . 70.34 111.931 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 24.2 m 57.23 89.35 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.742 0.817 . . . . 64.33 110.792 -171.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 28.1 p90 -66.39 114.61 5.55 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 121.264 0.554 . . . . 74.43 109.802 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -87.29 34.83 0.69 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 122.484 1.135 . . . . 42.12 110.229 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.73 85.29 0.7 Allowed 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.197 -1.038 . . . . 71.24 108.197 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 34.1 m -74.05 -35.0 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.234 176.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? 65.56 -72.27 0.07 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.731 1.613 . . . . 72.53 111.603 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . 0.412 ' HB3' ' H ' ' E' ' 126' ' ' ASN . 7.1 m-85 64.33 -137.4 0.28 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.195 0.998 . . . . 75.2 110.658 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . 0.412 ' H ' ' HB3' ' E' ' 125' ' ' TYR . 59.3 t30 -147.77 151.48 36.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.84 -0.8 . . . . 72.51 108.84 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -57.07 -49.66 70.18 Favored Glycine 0 C--N 1.354 1.561 0 O-C-N 124.222 0.951 . . . . 42.25 114.182 -171.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -96.2 -40.97 8.92 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.712 -0.477 . . . . 63.04 109.712 174.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 42.5 tp 69.4 -63.13 0.39 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.857 1.663 . . . . 74.51 112.434 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 24.7 pt -62.48 89.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 CA-C-O 122.383 1.087 . . . . 74.42 112.654 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.56 85.52 3.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.921 -1.036 . . . . 62.32 109.613 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -133.31 132.72 22.22 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 107.763 -1.199 . . . . 54.1 107.763 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -52.93 -30.0 46.27 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 123.348 2.699 . . . . 75.42 115.145 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 2.9 pp -127.28 165.99 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 122.956 0.502 . . . . 73.43 111.112 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -140.45 113.07 8.05 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.937 -1.134 . . . . 41.21 107.937 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.83 138.12 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 123.559 0.744 . . . . 63.14 111.437 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -85.64 -163.54 0.87 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.827 0.851 . . . . 60.14 111.606 -175.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -96.83 104.47 16.48 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.472 0.709 . . . . 74.52 109.585 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 41.6 tp -76.74 124.64 27.99 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.297 0.639 . . . . 43.14 111.002 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 34.7 t -173.0 129.89 0.48 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.68 1.192 . . . . 64.14 108.479 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' C' ' 39' ' ' GLU . 2.3 pt? -155.83 19.15 0.38 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.866 0.866 . . . . 72.41 110.039 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 31.7 pt -93.35 158.29 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.262 1.025 . . . . 72.04 111.288 -175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 60.17 76.57 0.36 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.658 1.183 . . . . 73.23 112.211 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -91.41 70.44 5.99 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 108.916 -0.772 . . . . 63.25 108.916 172.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 47.4 tttm 178.78 -71.51 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.292 1.437 . . . . 71.43 108.529 178.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -178.58 169.32 1.73 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.969 1.308 . . . . 53.14 108.613 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . 0.4 ' HB3' HG22 ' C' ' 131' ' ' VAL . 71.6 mt -75.72 -27.87 58.33 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.093 0.557 . . . . 74.42 111.094 176.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.557 HD21 HD22 ' C' ' 139' ' ' ASN . 6.1 mp -104.43 125.85 33.05 Favored Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 124.28 1.032 . . . . 74.15 109.118 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . 0.565 ' HD2' HD11 ' C' ' 136' ' ' LEU . 43.2 Cg_endo . . . . . 0 CA--C 1.566 2.082 0 C-N-CA 122.46 2.106 . . . . 65.11 111.569 168.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.926 -0.398 . . . . 73.32 109.926 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -121.28 112.57 18.77 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.918 0.887 . . . . 62.44 109.459 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . 0.673 ' HB1' ' H ' ' A' ' 53' ' ' ASP . . . 69.05 3.39 4.03 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 114.055 1.131 . . . . 44.14 114.055 165.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -90.15 -35.53 15.34 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.414 0.552 . . . . 75.32 111.043 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -61.81 140.46 58.25 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.762 0.825 . . . . 61.21 110.955 -174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -56.36 123.1 13.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.438 1.095 . . . . 75.14 112.522 -173.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.428 ' HG2' ' N ' ' F' ' 115' ' ' LEU . 67.0 tttt -138.39 155.59 48.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.042 1.737 . . . . 74.1 106.897 -177.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.541 HD12 ' HG3' ' A' ' 90' ' ' GLU . 26.4 tp 77.33 -29.24 0.17 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.073 1.349 . . . . 65.04 112.735 167.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -124.12 76.48 59.64 Favored Pre-proline 0 CA--C 1.558 1.267 0 C-N-CA 124.292 1.037 . . . . 70.54 110.12 -173.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -90.59 -2.28 5.13 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.406 2.07 . . . . 73.14 112.376 165.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -80.22 113.44 18.39 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 123.941 0.896 . . . . 72.04 109.361 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 70.6 p -79.19 87.45 4.92 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.535 0.734 . . . . 71.24 110.261 177.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 34.9 t-105 -73.09 114.24 11.04 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.211 0.605 . . . . 74.42 110.376 177.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -152.52 87.83 1.33 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.287 0.635 . . . . 52.11 109.944 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.59 24.91 0.46 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.822 0.849 . . . . 74.35 109.175 171.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 3.6 m -89.34 97.49 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 CA-C-N 115.141 -0.936 . . . . 64.4 110.657 -174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -160.33 140.05 11.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.301 1.04 . . . . 73.21 108.754 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . 0.439 ' HD2' HD12 ' A' ' 42' ' ' LEU . 43.1 t80 -154.34 66.71 0.71 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.277 -1.009 . . . . 65.22 108.277 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -77.61 -178.22 5.19 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.047 -0.979 . . . . 62.54 112.442 -171.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 106.54 -130.09 10.03 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.616 -0.993 . . . . 70.14 110.616 -175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 40' ' ' VAL . 23.7 pttm -161.5 163.17 30.45 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.25 0.62 . . . . 74.5 110.885 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 61.3 tp -139.35 136.81 35.17 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.179 0.591 . . . . 65.2 109.641 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 8.8 tp -157.98 138.98 4.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 124.023 0.929 . . . . 72.12 108.745 173.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -94.29 -72.4 0.62 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.232 -0.655 . . . . 51.34 109.232 174.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -137.08 105.56 8.74 Favored Pre-proline 0 C--O 1.244 0.777 0 N-CA-C 108.483 -0.932 . . . . 63.42 108.483 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.21 78.78 3.12 Favored 'Trans proline' 0 C--N 1.372 1.783 0 C-N-CA 122.749 2.299 . . . . 71.21 111.335 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 14.8 tt -63.91 -40.27 88.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.775 -0.648 . . . . 70.21 109.421 174.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 60.19 46.49 10.39 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.73 1.212 . . . . 51.34 111.867 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 5.4 m -60.26 119.81 5.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 CA-C-N 115.226 -0.897 . . . . 75.33 111.373 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -78.82 146.47 33.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.082 0.953 . . . . 73.2 109.527 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -51.5 117.36 2.6 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.45 1.1 . . . . 74.44 111.583 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.519 HD22 ' HD2' ' D' ' 38' ' ' PRO . 28.4 tp -66.06 99.46 0.51 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.684 1.194 . . . . 63.55 110.714 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.6 m -110.49 14.52 22.49 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.04 -0.982 . . . . 65.35 111.245 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 65.9 mt -77.15 7.02 5.52 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.388 0.675 . . . . 54.23 112.535 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' D' ' 126' ' ' LEU . 9.8 tp -62.54 -39.79 85.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 C-N-CA 124.018 0.927 . . . . 74.12 111.372 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -146.3 168.16 21.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.738 1.215 . . . . 73.32 109.088 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -153.22 156.87 39.32 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 120.757 0.313 . . . . 72.21 111.463 -173.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' F' ' 145' ' ' LYS . 0.6 OUTLIER 64.65 49.96 2.2 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.896 1.678 . . . . 71.34 111.822 175.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . 0.743 ' HA ' ' HB2' ' B' ' 12' ' ' GLN . 13.5 m-20 53.29 30.39 10.02 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 124.87 1.268 . . . . 74.25 113.469 171.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . 0.548 HD11 ' HB1' ' D' ' 129' ' ' ALA . 86.2 mt 60.78 -172.48 0.13 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.217 1.007 . . . . 70.45 113.418 173.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.0 mp -98.96 161.89 23.35 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-N 114.575 -1.193 . . . . 74.42 108.643 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 CA--C 1.57 2.288 0 C-N-CA 122.08 1.853 . . . . 55.1 112.42 169.457 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 110.415 -0.217 . . . . 72.25 110.415 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.7 m -130.14 107.53 9.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.917 0.887 . . . . 73.42 110.014 -171.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -158.96 63.63 0.41 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 121.985 0.898 . . . . 74.42 110.492 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -127.46 109.91 12.22 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.509 -1.293 . . . . 72.01 107.509 172.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -69.93 146.26 51.31 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.705 0.802 . . . . 71.52 111.11 -172.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.81 163.96 23.0 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.498 0.719 . . . . 64.41 110.989 176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -69.72 157.1 37.93 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 115.103 -0.953 . . . . 73.14 110.069 173.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -65.98 161.54 21.23 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 122.75 0.42 . . . . 73.23 110.059 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.4 mpt? 73.17 160.61 0.23 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.777 1.231 . . . . 73.32 111.214 -172.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.0 m -145.96 134.16 21.67 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.657 0.783 . . . . 70.41 109.62 178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.4 p90 -139.85 115.33 9.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.326 -0.99 . . . . 74.42 108.326 170.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 55.2 mt-30 -134.25 122.65 23.04 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.154 0.582 . . . . 74.23 110.104 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mp -85.43 107.99 16.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.539 -0.911 . . . . 75.1 108.539 176.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -86.33 -40.33 15.57 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.443 0.297 . . . . 75.21 110.434 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.793 ' HD2' HG21 ' B' ' 122' ' ' THR . 10.1 tpp180 -167.68 134.4 2.18 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.471 -0.566 . . . . 65.12 109.471 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.446 ' HB ' ' HG3' ' C' ' 130' ' ' PRO . 91.6 mt -138.4 100.38 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.962 -0.755 . . . . 73.31 108.962 177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 38.9 m-85 -164.09 176.16 9.56 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.653 1.181 . . . . 74.32 109.693 -165.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.9 p -85.33 114.05 22.11 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.146 -0.479 . . . . 72.33 110.093 -169.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -88.92 -34.47 16.91 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.727 0.298 . . . . 73.44 110.371 177.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.792 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 9.1 m-20 -137.38 147.0 45.14 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.482 0.658 . . . . 65.25 109.736 173.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.561 HD13 ' SD ' ' B' ' 117' ' ' MET . 66.9 mt -144.99 143.88 22.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 C-N-CA 126.381 1.872 . . . . 72.24 106.508 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.4 t -158.79 121.36 3.64 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 109.607 -0.516 . . . . 72.21 109.607 173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.633 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 85.9 t80 -119.8 136.62 54.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.428 -1.323 . . . . 65.45 107.428 171.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -133.38 148.8 51.84 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.578 0.751 . . . . 64.54 109.017 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.12 80.72 7.79 Favored Pre-proline 0 CA--C 1.54 0.588 0 N-CA-C 107.869 -1.16 . . . . 61.32 107.869 172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -68.93 -31.2 24.86 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.528 2.152 . . . . 62.45 111.667 -178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -112.53 34.29 4.43 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.544 1.138 . . . . 74.44 109.334 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.45 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.45 -47.1 99.39 Favored Pre-proline 0 CA--C 1.561 1.378 0 C-N-CA 124.444 1.097 . . . . 71.42 113.581 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.1 -20.9 32.64 Favored 'Trans proline' 0 C--N 1.392 2.828 0 CA-C-N 121.124 1.437 . . . . 75.51 112.421 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -79.87 -24.97 40.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.58 0.752 . . . . 64.51 111.656 -172.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -62.16 -22.32 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 112.461 0.541 . . . . 75.01 112.461 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -80.04 -35.02 37.78 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.297 1.039 . . . . 72.13 110.699 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -88.36 -18.04 29.28 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.178 0.591 . . . . 73.11 111.108 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 68' ' ' LEU . 96.4 mttt -75.59 167.15 22.43 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 112.864 0.69 . . . . 64.25 112.864 -177.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -82.27 118.28 23.01 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.69 -1.141 . . . . 52.23 108.05 171.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.483 ' HA ' HD12 ' A' ' 68' ' ' LEU . 20.5 m-90 -73.33 85.72 1.46 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.759 0.79 . . . . 72.12 110.939 -174.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -130.78 76.98 76.35 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.063 1.345 . . . . 74.23 108.195 175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.46 111.86 2.86 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 122.717 2.278 . . . . 75.34 111.843 -176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -96.14 85.09 3.92 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.94 -1.504 . . . . 75.54 106.94 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 65' ' ' THR . 31.1 m -88.25 122.72 40.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 114.453 -1.248 . . . . 65.52 111.889 -169.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -108.17 116.61 32.27 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.652 1.181 . . . . 72.04 109.111 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 80.4 mt -104.04 108.24 19.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.181 0.593 . . . . 63.35 109.691 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.566 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 26.4 t70 -103.41 130.38 50.72 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.728 0.811 . . . . 61.43 109.601 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 131' ' ' VAL . 4.6 mp -110.43 119.75 40.2 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.509 -0.922 . . . . 70.01 108.509 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.485 ' O ' HD23 ' A' ' 60' ' ' LEU . 25.3 t70 -122.68 138.08 54.71 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.493 0.717 . . . . 72.35 109.532 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.7 m -133.35 143.69 49.13 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.938 0.495 . . . . 64.0 110.146 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.71 152.69 40.0 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.406 1.082 . . . . 74.01 109.395 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 t -130.96 155.97 45.89 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 108.515 -0.92 . . . . 64.25 108.515 172.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -163.26 116.43 1.56 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 117.882 0.31 . . . . 74.45 110.314 -173.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.588 HE21 ' H ' ' A' ' 54' ' ' ASP . 51.8 tt0 -70.22 105.62 3.02 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.992 0.917 . . . . 65.43 110.353 -177.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 57' ' ' GLU . 44.9 mt -77.94 -39.9 41.25 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.309 1.044 . . . . 74.53 111.008 176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.08 -171.81 3.86 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.822 -1.081 . . . . 43.32 109.447 -172.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -58.76 96.75 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.114 0.566 . . . . 74.23 110.5 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.588 ' H ' HE21 ' A' ' 50' ' ' GLN . 9.4 m-20 54.6 31.4 15.0 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.117 1.367 . . . . 73.23 112.932 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 54.6 t -107.55 122.67 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 N-CA-C 106.9 -1.519 . . . . 51.2 106.9 167.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -130.85 138.02 49.65 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 108.953 -0.758 . . . . 73.43 108.953 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.552 ' HB2' HD11 ' A' ' 51' ' ' LEU . 37.0 tt0 -86.92 121.87 30.0 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 107.987 -1.116 . . . . 73.3 107.987 166.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.1 t -99.29 118.58 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 107.446 -1.316 . . . . 72.25 107.446 174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.44 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 90.9 t -98.18 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 123.28 0.632 . . . . 74.32 109.545 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -120.93 110.47 16.34 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.291 -1.744 . . . . 73.43 106.291 169.93 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.592 ' HB2' ' HG3' ' A' ' 79' ' ' GLN . 23.4 ttp180 -104.84 103.61 13.24 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.661 -0.866 . . . . 74.42 108.661 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.39 129.08 46.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 CA-C-N 114.535 -1.211 . . . . 73.02 108.662 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.566 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 41.5 m -109.17 131.76 54.76 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.739 -0.837 . . . . 54.14 108.739 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.4 t -123.93 107.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 107.21 -1.404 . . . . 42.41 107.21 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.2 m -107.45 135.66 48.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.117 -1.068 . . . . 62.21 108.117 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.32 136.78 49.49 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 107.501 -1.296 . . . . 72.54 107.501 175.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.2 m -147.22 135.65 21.78 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.81 0.844 . . . . 75.24 109.651 -176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 34' ' ' LYS . 2.3 mm? -87.23 86.52 7.28 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 107.868 -1.16 . . . . 73.13 107.868 176.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.57 -85.15 1.25 Allowed Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.017 -0.992 . . . . 51.22 111.483 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.56 -26.0 2.31 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.322 0.649 . . . . 64.24 111.312 -175.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -101.06 133.04 46.17 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.064 0.546 . . . . 64.23 109.965 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.6 m -65.44 146.35 54.99 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.154 0.982 . . . . 72.22 112.729 -167.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB2' HD22 ' A' ' 68' ' ' LEU . . . -90.12 -65.56 1.0 Allowed 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.833 1.253 . . . . 63.43 108.436 168.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -150.33 159.8 44.19 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.242 -1.345 . . . . 73.24 110.375 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 55.6 tp -134.72 116.84 15.36 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.231 1.012 . . . . 71.52 109.565 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.2 m -106.47 142.51 36.02 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.62 1.168 . . . . 75.23 110.311 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -148.07 118.78 7.52 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.371 1.068 . . . . 72.53 108.838 175.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -127.32 116.73 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-N 118.136 0.425 . . . . 65.41 109.917 176.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.792 ' HB2' ' HB2' ' A' ' 20' ' ' ASP . 15.6 mp0 -85.57 86.51 7.36 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.434 -1.321 . . . . 70.13 107.434 169.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -77.01 96.01 4.3 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.085 -0.962 . . . . 63.31 108.607 173.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.84 146.0 18.1 Favored Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.274 -0.73 . . . . 75.42 111.274 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.18 123.89 2.53 Favored Glycine 0 CA--C 1.507 -0.413 0 N-CA-C 110.265 -1.134 . . . . 71.4 110.265 -177.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.523 HD11 ' HA ' ' B' ' 29' ' ' PRO . 56.4 mt -81.02 125.22 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.351 -0.611 . . . . 64.4 109.351 176.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -134.4 119.85 19.09 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 108.722 -0.844 . . . . 75.45 108.722 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.519 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 33.3 t -81.43 92.7 6.49 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 108.654 -0.869 . . . . 74.55 108.654 169.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' THR . 11.0 pt -125.89 127.21 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.558 0.743 . . . . 72.33 110.801 -170.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -160.89 171.11 19.32 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.981 0.913 . . . . 75.53 110.759 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.56 -24.07 32.35 Favored Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.391 -0.822 . . . . 72.22 113.135 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -109.5 146.71 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 122.94 0.496 . . . . 73.2 109.791 -177.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -147.46 175.81 10.53 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.243 -0.889 . . . . 61.14 111.282 -176.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.97 -132.46 33.97 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 114.683 -1.144 . . . . 73.04 112.642 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 t -69.48 -20.68 63.73 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.575 0.75 . . . . 75.24 111.882 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -75.08 -44.64 46.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.505 0.722 . . . . 74.15 110.736 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.571 ' HG2' HD22 ' F' ' 115' ' ' LEU . 9.7 tpt -80.73 -25.07 38.32 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 116.239 -0.437 . . . . 73.43 110.195 177.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' F' ' 117' ' ' PRO . . . -66.22 -38.49 88.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.218 0.607 . . . . 73.23 109.837 171.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -66.87 -43.35 83.78 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.742 -1.117 . . . . 72.3 110.491 171.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.714 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.4 m -73.05 -34.34 66.22 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.595 0.961 . . . . 51.22 113.595 -171.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.435 HD12 ' H ' ' F' ' 116' ' ' TYR . 84.3 mt -91.42 -9.24 45.4 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.486 0.314 . . . . 75.51 111.556 176.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -104.94 -27.65 5.88 Favored Glycine 0 N--CA 1.476 1.333 0 N-CA-C 113.665 0.226 . . . . 50.44 113.665 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.6 -65.7 0.71 Allowed 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.806 0.842 . . . . 72.12 111.034 -168.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 11.4 t80 -43.62 -61.51 1.37 Allowed 'General case' 0 N--CA 1.505 2.283 0 C-N-CA 125.125 1.37 . . . . 72.43 113.193 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 83.6 m -72.63 -50.82 7.44 Favored Pre-proline 0 CA--C 1.556 1.194 0 CA-C-O 118.255 -0.878 . . . . 71.33 112.822 -173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.05 -17.94 61.7 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.718 1.612 . . . . 62.1 113.815 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -67.29 -48.25 68.23 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.592 -0.892 . . . . 72.3 108.592 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 30.0 mm -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 114.58 -1.191 . . . . 72.22 110.782 174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.441 HD23 HG23 ' A' ' 16' ' ' ILE . 95.3 mt -71.47 -28.64 64.08 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.738 -0.665 . . . . 73.21 111.953 -173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -65.23 -43.54 65.67 Favored Pre-proline 0 CA--C 1.561 1.392 0 N-CA-C 114.373 1.249 . . . . 74.22 114.373 -168.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -56.59 -34.92 96.53 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 122.194 1.93 . . . . 71.22 113.381 173.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -80.96 -33.92 33.54 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.594 0.758 . . . . 73.3 111.494 -176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.15 -47.13 63.0 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 110.046 -0.353 . . . . 62.3 110.046 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.483 ' NH1' HD12 ' C' ' 105' ' ' ILE . 33.1 ttm180 -51.75 -45.06 63.54 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.678 1.191 . . . . 75.01 110.348 173.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.61 -50.32 71.73 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.026 0.93 . . . . 54.12 111.487 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.47 -39.96 95.12 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 124.178 0.924 . . . . 55.34 111.098 -176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.594 HG21 HG21 ' A' ' 64' ' ' VAL . 12.8 mt -64.33 -58.11 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 123.561 0.745 . . . . 73.13 110.374 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 96.7 m -53.02 -38.95 62.81 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.159 0.912 . . . . 73.3 111.289 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -66.34 -42.43 88.13 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.384 -0.826 . . . . 72.31 110.472 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.633 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.6 mtm -63.49 -37.73 88.42 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.982 0.513 . . . . 64.33 111.168 175.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 114' ' ' ILE . 74.9 t -63.12 -45.41 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 124.281 1.032 . . . . 71.33 110.545 178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.0 p -75.17 -29.63 60.48 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.02 -0.537 . . . . 61.44 111.327 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.2 mtt-85 -72.05 -28.07 63.1 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.446 0.698 . . . . 74.12 109.81 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.13 1.25 89.0 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 115.552 -0.749 . . . . 64.53 113.014 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 m 68.68 18.33 8.77 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 124.762 1.225 . . . . 60.44 111.578 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -90.37 154.37 46.56 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.702 0.801 . . . . 62.33 110.805 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -59.79 134.11 55.2 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.94 2.426 . . . . 74.31 112.253 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -62.7 132.34 51.98 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.605 0.762 . . . . 73.22 111.883 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 75.3 mt -113.0 114.4 26.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.018 -1.104 . . . . 75.32 108.018 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -97.4 100.86 12.3 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 107.993 -1.114 . . . . 45.12 107.993 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.63 135.78 57.78 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.235 0.614 . . . . 74.34 110.619 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.592 ' HB2' ' HG ' ' F' ' 129' ' ' LEU . . . -61.06 145.86 88.84 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 122.995 0.518 . . . . 74.4 110.99 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.5 119.92 7.03 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.941 1.761 . . . . 72.52 109.174 169.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 44' ' ' LEU . 97.5 t -95.64 111.28 25.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 107.251 -1.388 . . . . 74.4 107.251 -176.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.401 HD22 ' HB3' ' A' ' 135' ' ' ALA . 3.8 p-10 -82.12 66.17 7.58 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.937 -1.029 . . . . 74.42 109.318 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -68.8 -34.83 76.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.624 -0.716 . . . . 54.11 109.85 -175.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 138' ' ' MET . 2.1 m-20 -56.58 -53.01 62.58 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 123.958 0.786 . . . . 73.33 109.743 172.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -70.65 -28.64 64.96 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.577 0.751 . . . . 74.32 111.434 -177.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' F' ' 123' ' ' VAL . 56.4 tp -65.25 -48.23 74.0 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.449 1.099 . . . . 73.44 110.201 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -70.04 -28.18 65.26 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.976 -1.011 . . . . 74.31 110.236 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 14.3 mmt -65.54 -34.01 77.25 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 119.077 -0.487 . . . . 75.23 112.079 178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -56.71 -32.15 65.2 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.259 0.552 . . . . 60.13 110.699 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -81.73 -39.7 23.82 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 114.932 -1.031 . . . . 74.12 110.865 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.4 tp -71.66 -52.41 18.04 Favored 'General case' 0 CA--C 1.56 1.344 0 N-CA-C 113.411 0.893 . . . . 75.12 113.411 -172.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -169.35 20.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.048 0.539 . . . . 73.53 110.438 -169.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 65.79 -159.64 0.27 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.983 -1.118 . . . . 72.15 107.983 -166.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.625 ' HG2' ' HB3' ' C' ' 6' ' ' ASN . 0.2 OUTLIER -73.82 74.47 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.026 1.284 . . . . 61.55 111.92 -173.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.658 ' HB1' ' HB3' ' C' ' 145' ' ' ALA . . . -179.68 128.38 0.09 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.73 1.612 . . . . 70.23 107.973 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.52 -39.84 0.24 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 117.845 0.293 . . . . 72.42 112.898 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -83.95 171.36 13.08 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.585 0.707 . . . . 73.04 112.359 177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 67.4 -137.7 33.26 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 113.811 -1.54 . . . . 74.32 112.883 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 5.8 m 61.79 80.05 0.23 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.082 0.953 . . . . 70.11 111.123 171.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -145.03 166.35 25.59 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 121.084 0.469 . . . . 75.31 111.89 -176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -155.55 -47.95 0.08 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 114.807 -1.088 . . . . 74.32 110.581 -177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 55.9 m-70 -71.9 90.56 1.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.547 0.689 . . . . 74.42 111.975 -172.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -84.89 -17.48 37.75 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 114.757 -1.111 . . . . 61.44 109.267 169.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -72.06 143.45 49.09 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.661 0.784 . . . . 73.41 110.528 173.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.364 0 N-CA-C 109.0 -0.741 . . . . 61.04 109.0 177.98 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.524 ' HA ' ' HB3' ' B' ' 141' ' ' LEU . 61.1 mtt . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 110.003 -0.369 . . . . 53.1 110.003 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.3 m 63.61 80.84 0.22 Allowed 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.6 1.188 . . . . 71.1 110.857 176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -118.28 145.76 44.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 114.966 -1.015 . . . . 74.24 109.604 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -165.41 11.34 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.601 0.593 . . . . 75.23 112.601 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.507 HD21 ' HG2' ' B' ' 93' ' ' GLN . 0.8 OUTLIER -74.17 161.37 30.04 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.284 0.493 . . . . 75.24 111.63 -177.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -134.86 -177.89 4.83 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.887 0.875 . . . . 73.0 108.954 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 31.5 p -70.53 78.33 0.57 Allowed 'General case' 0 CA--C 1.555 1.153 0 CA-C-O 122.117 0.96 . . . . 62.22 108.912 165.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -124.94 -156.72 0.74 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.992 1.317 . . . . 72.13 109.217 -173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.59 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.7 ptm 56.18 -177.35 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 126.049 1.74 . . . . 61.34 114.941 170.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -143.39 122.36 12.8 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 108.184 -1.043 . . . . 63.13 108.184 170.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -110.51 134.86 51.98 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.027 0.931 . . . . 64.43 108.677 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -145.61 141.37 28.11 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.774 -0.824 . . . . 73.32 108.774 173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.624 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -91.66 134.49 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 108.79 -0.818 . . . . 72.14 108.79 173.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -92.4 -50.3 5.71 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.129 0.572 . . . . 73.45 109.585 174.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 39.5 ttt180 -164.54 139.26 5.49 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.436 -0.802 . . . . 72.15 109.409 -175.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.4 mt -114.84 144.7 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 106.218 -1.771 . . . . 73.15 106.218 169.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -172.3 149.44 2.24 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.133 0.424 . . . . 72.22 110.908 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.486 HG21 HD11 ' B' ' 21' ' ' ILE . 26.8 m -80.14 121.66 25.85 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 109.353 -0.61 . . . . 73.11 109.353 173.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -87.7 -33.8 18.61 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.014 0.526 . . . . 72.34 110.203 177.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.404 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.4 t70 -146.99 127.97 14.54 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 116.13 -0.486 . . . . 65.4 110.75 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.506 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 34.3 mm -113.47 147.08 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 107.395 -1.335 . . . . 71.2 107.395 165.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 12.5 t -150.72 140.51 21.8 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.294 -0.632 . . . . 61.32 109.294 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.549 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 93.3 t80 -155.22 114.91 3.7 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 107.663 -1.236 . . . . 73.33 107.663 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -126.65 113.88 17.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.731 -1.211 . . . . 72.34 107.731 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.687 ' HB3' ' HB2' ' B' ' 28' ' ' ALA . . . -106.0 89.32 3.61 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 108.544 -0.91 . . . . 61.52 108.544 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.17 -16.76 56.48 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.837 2.358 . . . . 63.42 112.602 -174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -127.26 29.58 5.54 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.013 0.925 . . . . 72.52 110.773 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.687 ' HB2' ' HB3' ' B' ' 25' ' ' ALA . . . -48.1 -55.8 16.65 Favored Pre-proline 0 N--CA 1.493 1.692 0 C-N-CA 123.983 0.913 . . . . 64.41 112.419 172.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.523 ' HA ' HD11 ' A' ' 83' ' ' ILE . 47.9 Cg_endo -70.5 -16.66 34.45 Favored 'Trans proline' 0 C--N 1.39 2.756 0 C-N-CA 121.845 1.697 . . . . 73.22 112.622 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -101.5 4.81 41.51 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.5 0.926 . . . . 71.44 113.5 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.68 -31.36 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-N 118.22 0.464 . . . . 71.3 111.775 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 9.6 p90 -73.35 -17.82 61.24 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.464 0.705 . . . . 72.44 110.958 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -79.43 -35.79 39.94 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.251 1.02 . . . . 62.43 110.813 -173.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -108.02 110.28 21.95 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.39 0.676 . . . . 72.43 110.607 -177.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -98.45 78.03 2.38 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.227 0.611 . . . . 75.31 110.374 178.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 14.7 m-90 -151.35 161.6 42.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.374 -1.343 . . . . 71.43 107.374 175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -85.3 133.5 42.43 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 122.722 0.409 . . . . 73.11 110.221 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.52 136.51 26.18 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.421 2.081 . . . . 73.42 112.799 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -66.63 104.16 1.23 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.8 0.84 . . . . 73.54 109.067 168.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.465 HG11 HD21 ' B' ' 126' ' ' LEU . 11.0 m -98.43 150.44 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 122.979 0.511 . . . . 72.55 110.423 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.421 ' HE3' ' HB ' ' B' ' 65' ' ' THR . 1.1 tmmt? -150.69 121.63 7.64 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 108.566 -0.901 . . . . 74.43 108.566 -175.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.487 HD11 HD12 ' B' ' 126' ' ' LEU . 2.2 mm? -96.49 134.69 39.37 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.795 0.838 . . . . 73.23 109.602 -173.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.607 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 16.6 m-20 -123.62 113.45 18.69 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.342 -0.984 . . . . 74.34 108.342 -178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.2 mp -101.67 148.0 25.78 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.384 -0.599 . . . . 72.14 109.384 176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -161.31 152.33 18.44 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.62 -1.252 . . . . 53.41 107.62 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.0 t -153.43 143.87 22.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.988 0.423 . . . . 55.01 110.73 174.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.66 161.16 35.91 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.991 1.316 . . . . 74.2 108.331 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.3 m -130.44 165.18 23.15 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-O 121.335 0.588 . . . . 71.02 110.729 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 39.1 t -151.54 146.29 25.77 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.067 1.347 . . . . 71.31 107.554 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -103.65 112.13 24.92 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.292 -0.632 . . . . 53.05 109.292 174.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 41.9 mt -83.39 -34.49 25.54 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.015 0.436 . . . . 75.02 110.086 176.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -159.94 178.6 9.57 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.8 0.84 . . . . 44.01 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -61.46 117.29 5.51 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 114.649 -1.159 . . . . 72.42 109.524 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 71.53 -4.99 1.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 125.438 1.495 . . . . 73.22 112.542 -177.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 78.7 t -104.93 95.23 3.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 108.399 -0.963 . . . . 71.34 108.399 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -107.58 136.4 47.41 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.629 -0.714 . . . . 74.01 110.435 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -101.48 100.75 11.23 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.539 -1.282 . . . . 73.14 107.539 175.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 39.6 t -101.18 127.32 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.243 1.017 . . . . 72.31 109.669 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 28.2 t -103.63 123.63 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 123.825 0.85 . . . . 52.15 110.036 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -92.94 134.38 35.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 106.926 -1.509 . . . . 75.23 106.926 169.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -120.51 121.74 39.09 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 124.08 0.952 . . . . 75.21 108.701 175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -115.53 104.29 16.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.093 -1.447 . . . . 74.5 107.093 169.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 21.7 m -96.92 130.22 44.26 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 108.542 -0.91 . . . . 74.12 108.542 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.49 HG23 HD13 ' B' ' 114' ' ' ILE . 69.8 t -112.85 130.7 66.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.394 0.678 . . . . 72.13 109.401 177.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HE3' ' B' ' 41' ' ' LYS . 22.0 m -119.67 123.64 44.31 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.514 -0.921 . . . . 62.32 108.514 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 140.18 49.05 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 122.734 0.413 . . . . 73.41 109.984 176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.552 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 22.5 p -138.2 126.71 23.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.799 -0.637 . . . . 62.34 110.152 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.4 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 2.6 tt -93.46 100.55 12.83 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.914 -1.513 . . . . 42.44 106.914 -176.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.39 -137.47 19.75 Favored Glycine 0 C--N 1.346 1.103 0 N-CA-C 111.767 -0.533 . . . . 70.31 111.767 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -92.53 33.93 1.09 Allowed 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.676 0.79 . . . . 60.11 110.387 175.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -153.28 146.7 24.9 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.058 0.943 . . . . 74.31 108.794 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -74.99 138.3 42.14 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 121.074 0.464 . . . . 72.34 111.388 -176.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.552 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.07 -61.92 1.58 Allowed 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.292 -1.003 . . . . 42.32 108.292 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -158.37 157.62 32.7 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.782 -1.099 . . . . 75.31 110.078 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 81.0 mt -129.79 111.82 12.99 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 107.394 -1.335 . . . . 71.33 107.394 178.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.5 t -118.32 152.8 35.1 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.412 0.685 . . . . 53.41 109.538 -177.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -155.61 134.64 12.13 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 108.514 -0.921 . . . . 75.51 108.514 173.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -129.07 141.36 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 109.366 -0.605 . . . . 62.24 109.366 171.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 51.4 mt-30 -118.88 100.88 7.66 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.378 1.071 . . . . 75.45 109.007 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -87.41 101.17 13.32 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.715 -0.675 . . . . 74.33 109.362 174.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.07 150.64 21.57 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.316 -0.714 . . . . 74.13 111.316 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -150.26 125.86 2.04 Favored Glycine 0 CA--C 1.509 -0.305 0 N-CA-C 111.65 -0.58 . . . . 75.01 111.65 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 21.0 mt -85.66 126.53 40.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 108.061 -1.088 . . . . 75.21 108.061 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -130.85 160.38 34.61 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.651 1.18 . . . . 72.24 108.855 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 69.1 m -130.79 108.06 9.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.934 0.893 . . . . 52.41 108.777 177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.714 ' HB ' HD11 ' B' ' 89' ' ' ILE . 0.2 OUTLIER -123.69 115.38 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 C-N-CA 124.823 1.249 . . . . 62.25 109.428 -174.13 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -129.61 146.81 51.38 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.702 0.801 . . . . 65.32 110.275 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.01 -46.01 1.23 Allowed Glycine 0 C--N 1.345 1.031 0 O-C-N 123.548 0.53 . . . . 63.01 112.112 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.714 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -90.75 154.23 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.1 0.96 . . . . 71.4 111.231 178.315 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.407 ' HG3' ' HA ' ' E' ' 115' ' ' LEU . 35.0 tt0 -159.46 156.81 28.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.694 0.398 . . . . 65.34 110.522 175.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.27 -116.45 7.58 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-N 116.245 -0.434 . . . . 53.21 112.749 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -67.75 -33.48 74.93 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.769 0.828 . . . . 64.21 111.044 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.507 ' HG2' HD21 ' B' ' 5' ' ' ASN . 44.1 mt-30 -65.14 -50.31 66.5 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.735 -0.666 . . . . 72.44 110.529 179.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.593 ' SD ' ' HB3' ' E' ' 115' ' ' LEU . 28.2 ttt -71.73 -28.19 63.5 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.287 -0.87 . . . . 74.43 110.944 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.33 -38.14 85.81 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.805 -0.634 . . . . 54.12 110.688 173.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -70.47 -34.79 72.79 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.505 -0.771 . . . . 74.42 110.299 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -70.31 -48.39 56.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.171 0.588 . . . . 73.44 111.034 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.25 -16.85 44.76 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.524 0.73 . . . . 73.42 111.812 -176.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.75 2.84 58.73 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 119.88 -0.4 . . . . 63.42 113.307 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.84 -55.94 0.33 Allowed 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 117.276 0.538 . . . . 75.33 112.132 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -81.52 -50.98 8.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.942 0.497 . . . . 74.15 111.768 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 72.7 m -56.89 -49.6 92.94 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-O 118.712 -0.661 . . . . 74.42 112.518 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.45 -26.86 47.3 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.989 1.793 . . . . 73.45 112.842 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -64.99 -33.56 76.34 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 120.942 0.401 . . . . 72.12 110.995 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.21 -47.94 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.672 0.789 . . . . 72.31 110.189 175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.0 mt -72.22 -22.36 61.27 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.226 -0.897 . . . . 74.11 112.268 -172.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -63.66 -47.87 81.39 Favored Pre-proline 0 CA--C 1.56 1.365 0 N-CA-C 114.211 1.189 . . . . 75.3 114.211 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -55.42 -36.14 93.39 Favored 'Trans proline' 0 C--N 1.386 2.545 0 C-N-CA 122.09 1.86 . . . . 72.15 113.352 176.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.41 ' HE2' HG21 ' D' ' 115' ' ' THR . 69.4 m-85 -70.93 -46.84 61.76 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.194 0.597 . . . . 73.11 110.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.71 -41.09 94.54 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.467 0.707 . . . . 55.53 110.651 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -59.38 -56.0 27.62 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.885 0.874 . . . . 75.45 110.624 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.23 -37.8 84.35 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.791 0.682 . . . . 75.35 110.057 -175.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 16.5 m -57.08 -53.44 58.03 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.84 0.856 . . . . 73.54 111.917 174.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.49 HD13 HG23 ' B' ' 64' ' ' VAL . 80.9 mt -60.73 -58.12 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.595 0.758 . . . . 75.45 111.065 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 2.3 m -63.56 -30.3 71.43 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 124.252 0.97 . . . . 70.44 111.206 -168.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 43.7 t -59.79 -56.59 19.91 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 115.684 -0.689 . . . . 50.23 109.397 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.642 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 19.1 mmt -61.57 -32.96 73.07 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.748 0.819 . . . . 73.53 112.158 -175.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 85.4 t -66.12 -50.98 64.97 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.027 0.931 . . . . 72.13 110.66 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 84.8 p -74.54 -20.1 60.09 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.292 0.637 . . . . 74.3 111.339 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.642 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 93.1 mtt-85 -67.43 -33.48 75.25 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.786 0.834 . . . . 62.51 110.06 171.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.73 8.66 78.25 Favored Glycine 0 C--N 1.351 1.391 0 O-C-N 123.39 0.431 . . . . 73.31 112.622 174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.793 HG21 ' HD2' ' A' ' 15' ' ' ARG . 4.8 p 69.09 15.05 8.77 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.64 1.976 . . . . 73.31 113.148 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -83.05 155.3 67.42 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 123.776 0.83 . . . . 74.41 111.104 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.56 128.79 30.85 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 123.518 2.812 . . . . 70.23 113.396 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.43 ' HG3' ' OE1' ' C' ' 125' ' ' GLN . 72.7 mt-30 -55.66 133.33 50.57 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.171 1.388 . . . . 74.34 112.516 -175.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.487 HD12 HD11 ' B' ' 42' ' ' LEU . 3.7 mm? -109.51 82.36 1.58 Allowed 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.929 -0.767 . . . . 74.31 108.929 174.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -91.84 96.23 10.29 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.933 -1.136 . . . . 71.14 107.933 175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.445 HD21 ' HE2' ' E' ' 125' ' ' TYR . 0.8 OUTLIER -75.19 128.63 35.92 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 109.179 -0.674 . . . . 75.32 109.179 -177.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.95 148.5 94.57 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.033 0.933 . . . . 60.1 111.376 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -70.29 93.62 0.57 Allowed 'Trans proline' 0 C--N 1.382 2.293 0 C-N-CA 122.177 1.918 . . . . 74.03 111.401 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.6 140.75 15.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 CA-C-N 115.083 -0.962 . . . . 60.11 108.648 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -68.23 99.89 0.97 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 123.568 0.747 . . . . 65.0 110.339 -175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -56.34 -30.76 63.03 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.074 -0.966 . . . . 74.31 110.096 170.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -54.4 -56.91 13.87 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.063 1.345 . . . . 54.21 111.46 172.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.9 94.83 Favored 'General case' 0 N--CA 1.477 0.885 0 O-C-N 123.886 0.741 . . . . 62.54 111.74 -176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' E' ' 123' ' ' VAL . 4.0 tt -59.87 -45.93 90.89 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.69 0.796 . . . . 64.44 109.567 178.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.404 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 88.3 t80 -64.85 -40.88 95.88 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 114.874 -1.057 . . . . 64.35 111.456 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 98.2 mmm -68.1 -30.14 69.24 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.799 0.44 . . . . 74.24 111.201 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -76.35 -17.83 59.2 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.226 0.611 . . . . 71.44 111.287 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -76.43 -30.8 57.56 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 109.932 -0.396 . . . . 73.31 109.932 171.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' B' ' 1' ' ' MET . 72.0 mt -81.1 39.13 0.49 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.2 1.0 . . . . 65.24 112.745 -173.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -81.73 79.55 8.26 Favored 'General case' 0 CA--C 1.551 1.013 0 O-C-N 120.976 -1.078 . . . . 73.32 110.634 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -139.25 161.71 36.77 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 124.248 1.019 . . . . 74.51 108.45 170.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.8 -60.67 2.15 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.801 0.44 . . . . 73.24 110.11 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.23 108.85 4.68 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.289 0.635 . . . . 73.21 110.405 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.68 60.87 0.64 Allowed Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.491 -1.044 . . . . 71.1 110.491 172.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -69.94 101.49 1.78 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.831 0.852 . . . . 75.41 110.653 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -75.89 78.84 1.18 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 110.68 -0.968 . . . . 31.33 110.68 174.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 66.1 p -79.12 162.93 25.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.768 0.827 . . . . 74.31 112.447 -171.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -84.8 153.1 23.2 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.817 0.847 . . . . 72.1 111.383 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -143.74 80.94 1.68 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.117 0.961 . . . . 73.15 110.207 177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -99.15 133.6 43.19 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.559 -0.746 . . . . 74.01 110.182 -177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -107.7 140.36 40.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.918 0.887 . . . . 64.52 110.533 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.96 -60.73 2.26 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.603 0.761 . . . . 74.3 109.333 172.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.449 0 C-N-CA 123.999 0.92 . . . . 71.45 108.972 -179.695 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.485 1.297 0 N-CA-C 109.252 -0.647 . . . . 74.21 109.252 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.3 m -72.98 -70.34 0.36 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.182 0.593 . . . . 75.3 110.31 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.599 ' HB3' ' HB2' ' C' ' 145' ' ' ALA . 39.4 tt0 -121.7 144.88 48.53 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.38 0.61 . . . . 70.02 110.46 -175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -138.47 169.54 17.61 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.636 1.574 . . . . 74.24 107.502 -179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 17.2 m120 74.03 115.06 0.06 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 124.353 1.061 . . . . 74.43 112.403 172.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.625 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 41.8 t30 -161.68 161.66 29.54 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.643 1.177 . . . . 73.11 108.822 178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 26.4 m -58.81 118.39 5.67 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.023 0.929 . . . . 64.1 111.028 177.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.53 -40.86 66.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.099 0.96 . . . . 72.31 110.534 -178.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.661 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 13.0 tmm? 65.73 125.31 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 125.077 1.351 . . . . 60.52 113.288 177.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 19.2 m -94.22 105.79 17.77 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 53.55 110.023 175.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.661 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 80.3 t80 -122.61 143.18 49.92 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.508 0.723 . . . . 71.21 109.232 175.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -155.76 140.47 17.04 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.177 0.591 . . . . 72.43 109.687 177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 70.0 mt -79.11 117.88 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.251 -1.018 . . . . 74.24 108.251 170.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -88.9 -45.4 9.73 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 123.772 0.67 . . . . 74.44 110.064 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.617 HH11 ' HB3' ' F' ' 132' ' ' TYR . 51.3 ttt85 -165.8 144.45 6.02 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 122.887 0.475 . . . . 61.11 110.277 177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.2 mt -121.84 139.85 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 N-CA-C 108.173 -1.047 . . . . 74.34 108.173 174.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.519 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 32.6 p90 -173.78 158.18 3.21 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.312 0.577 . . . . 75.32 111.136 -179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.7 p -82.47 116.92 22.13 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.502 -0.772 . . . . 63.24 109.513 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -78.09 -41.0 36.62 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.696 0.76 . . . . 73.41 109.074 174.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 17.4 t70 -140.41 140.02 35.39 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 114.55 -1.205 . . . . 62.21 109.741 -178.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 88.9 mt -136.36 141.36 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 C-N-CA 125.482 1.513 . . . . 54.22 107.093 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.8 t -158.61 148.8 19.78 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.189 0.519 . . . . 74.34 110.222 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -148.27 149.41 31.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 107.801 -1.185 . . . . 72.21 107.801 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -143.45 146.42 33.42 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.046 1.338 . . . . 72.34 107.714 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.524 ' HB3' ' HA ' ' D' ' 19' ' ' LYS . . . -149.77 82.79 6.53 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 107.83 -1.174 . . . . 54.52 107.83 177.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.25 -31.9 43.17 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 122.497 2.131 . . . . 62.1 111.996 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.458 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 79.0 m-20 -112.15 38.82 2.58 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.627 0.771 . . . . 70.42 109.599 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.471 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -57.86 -48.79 96.53 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.512 1.125 . . . . 72.01 113.348 177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -79.89 -21.14 8.47 Favored 'Trans proline' 0 C--N 1.387 2.595 0 C-N-CA 121.729 1.619 . . . . 71.13 112.613 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.8 t-160 -67.56 -20.31 65.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.893 0.877 . . . . 75.33 111.686 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.518 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 11.7 p -46.03 -28.99 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.563 1.475 0 C-N-CA 124.792 1.237 . . . . 42.34 114.212 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -66.92 -43.07 84.24 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.906 0.482 . . . . 72.32 111.824 177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -127.66 39.15 3.92 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-O 121.536 0.684 . . . . 71.04 110.806 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -94.03 169.56 10.18 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.351 -0.981 . . . . 72.44 108.351 167.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -81.99 120.89 25.83 Favored 'General case' 0 C--O 1.244 0.782 0 N-CA-C 108.51 -0.922 . . . . 62.52 108.51 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.1 t90 -78.44 81.61 4.77 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 121.481 0.657 . . . . 71.45 109.674 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -153.86 74.95 6.28 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 114.478 -1.237 . . . . 50.25 107.745 168.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.26 106.64 1.76 Allowed 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.745 2.296 . . . . 74.53 110.611 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -84.67 94.89 8.74 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 106.323 -1.732 . . . . 64.22 106.323 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.539 HG21 HD21 ' E' ' 139' ' ' LEU . 96.4 t -86.07 102.33 11.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 CA-C-N 114.549 -1.205 . . . . 52.22 110.198 -175.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -90.29 101.83 14.55 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.255 -1.338 . . . . 63.24 108.007 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.56 ' H ' HD23 ' C' ' 42' ' ' LEU . 0.7 OUTLIER -89.11 147.49 24.19 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 108.978 -0.749 . . . . 72.21 108.978 -179.26 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.612 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.3 t70 -142.69 136.19 28.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.631 0.772 . . . . 60.44 109.156 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 135.44 41.87 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.89 0.876 . . . . 72.1 109.085 175.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -153.34 152.06 30.68 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.445 1.098 . . . . 72.31 108.204 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 12.3 t -131.02 135.78 47.9 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.421 0.629 . . . . 62.12 110.896 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -112.52 170.64 8.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.975 -1.011 . . . . 52.32 108.747 171.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 59.5 p -150.86 151.22 31.93 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 122.654 0.382 . . . . 60.54 110.534 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 23.7 p -147.3 128.07 14.33 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.201 1.001 . . . . 70.21 109.189 176.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -72.2 118.15 14.72 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.629 -0.508 . . . . 71.45 109.629 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.569 HD11 ' HB2' ' C' ' 57' ' ' GLU . 54.9 mt -87.28 -43.83 11.88 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.214 -0.661 . . . . 71.44 109.214 176.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.97 -178.35 6.43 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.705 -1.134 . . . . 43.43 109.895 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.74 120.32 11.0 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.573 -0.74 . . . . 73.44 110.157 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 66.92 3.45 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.755 1.222 . . . . 70.23 112.872 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 85.7 t -110.99 113.01 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.907 0.883 . . . . 71.1 108.985 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -125.13 125.46 43.76 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.355 1.062 . . . . 63.12 108.717 -175.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.569 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.7 tt0 -83.74 110.99 18.76 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.094 -0.706 . . . . 65.21 109.094 172.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 96.7 t -95.55 124.01 47.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.573 -1.269 . . . . 62.34 107.573 174.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.83 107.57 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 123.351 0.66 . . . . 74.45 109.245 178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -87.52 104.89 16.9 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.556 -0.905 . . . . 71.53 108.556 175.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -90.78 121.29 32.52 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.066 1.346 . . . . 75.23 110.219 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.1 t -111.22 121.65 64.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 123.82 0.848 . . . . 73.42 109.302 174.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 42.0 m -103.34 141.58 35.69 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.901 -0.778 . . . . 72.13 108.901 166.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.576 HG21 HG21 ' C' ' 114' ' ' ILE . 87.3 t -129.45 112.32 24.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 108.094 -1.076 . . . . 75.51 108.094 173.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 7.1 m -108.16 106.95 17.38 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 108.684 -0.858 . . . . 62.34 108.684 177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.94 100.61 10.1 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.851 -0.796 . . . . 63.51 108.851 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 17.0 p -156.81 146.5 20.73 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 109.111 -0.7 . . . . 54.45 109.111 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 44.1 tp -71.2 -44.97 64.36 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.501 -0.926 . . . . 62.52 108.501 167.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -172.75 -76.92 0.05 OUTLIER Glycine 0 C--N 1.342 0.863 0 N-CA-C 110.359 -1.096 . . . . 70.03 110.359 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.31 -33.29 16.16 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.25 0.62 . . . . 74.14 109.376 173.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -70.4 93.72 0.9 Allowed 'General case' 0 C--N 1.35 0.625 0 N-CA-C 108.196 -1.038 . . . . 73.41 108.196 171.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -89.53 118.18 28.98 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.877 -0.601 . . . . 75.32 109.624 174.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.93 -57.73 4.69 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.308 -1.368 . . . . 75.23 107.308 173.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -161.42 158.69 27.14 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.123 -0.944 . . . . 65.02 110.725 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -126.21 143.97 50.94 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.254 -1.758 . . . . 41.31 106.254 170.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 34.9 t -150.89 147.52 27.31 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.634 -0.506 . . . . 72.44 109.634 -178.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -156.53 129.76 8.03 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.831 -0.433 . . . . 70.31 109.831 175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 36.9 t -127.49 114.73 37.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 124.177 0.991 . . . . 72.21 108.827 175.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.412 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 25.5 mt-30 -91.27 95.26 9.93 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.515 -0.921 . . . . 65.13 108.515 173.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.607 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.0 tp-100 -83.22 108.62 16.58 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.594 -0.73 . . . . 74.12 109.817 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.53 150.47 25.67 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 111.809 -0.516 . . . . 70.24 111.809 175.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.511 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.97 118.06 0.88 Allowed Glycine 0 CA--C 1.501 -0.828 0 N-CA-C 110.556 -1.018 . . . . 50.43 110.556 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.475 HD12 HD11 ' C' ' 51' ' ' LEU . 15.4 mm -79.61 127.91 38.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 107.48 -1.304 . . . . 73.35 107.48 175.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -135.21 150.63 50.14 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.123 0.487 . . . . 75.12 110.172 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.5 p -108.42 113.93 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.238 -0.892 . . . . 73.34 108.991 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 51.5 mt -116.01 110.19 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 123.984 0.914 . . . . 73.12 108.834 177.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -137.41 159.16 42.74 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.374 1.07 . . . . 64.25 109.817 -177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -26.24 8.16 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-N 116.361 -0.381 . . . . 61.23 113.374 176.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' C' ' 93' ' ' GLN . 10.4 tt -123.43 159.19 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.643 0.777 . . . . 63.42 110.33 -176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -157.93 -177.35 6.51 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.437 0.695 . . . . 34.35 110.34 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.7 -153.25 40.19 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 116.189 -0.459 . . . . 40.51 113.563 175.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 76.0 p -66.0 -21.16 66.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.55 0.74 . . . . 71.13 111.259 177.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.464 ' HB3' HD11 ' C' ' 89' ' ' ILE . 23.2 mt-30 -59.32 -51.68 68.92 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.012 0.925 . . . . 75.34 110.88 173.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.407 ' HB3' HG23 ' C' ' 89' ' ' ILE . 0.0 OUTLIER -76.26 -23.76 54.47 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 116.329 -0.396 . . . . 73.44 110.916 -179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.99 -42.78 97.1 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.235 0.614 . . . . 71.42 111.536 -177.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -69.82 -26.87 64.45 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 116.167 -0.469 . . . . 75.33 110.615 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 34.3 t -69.95 -60.78 2.09 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 110.357 -0.238 . . . . 75.55 110.357 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 pp -72.89 -13.98 61.39 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.088 0.403 . . . . 65.21 112.088 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.99 -21.14 28.82 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.779 -0.456 . . . . 61.14 113.929 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.8 -59.53 0.89 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 117.392 0.596 . . . . 70.3 111.432 -176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -62.06 -51.71 66.85 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.54 0.736 . . . . 75.54 112.365 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 27.6 m -68.13 -46.68 40.74 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.731 0.812 . . . . 61.13 112.506 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.57 -24.05 49.04 Favored 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 122.013 1.809 . . . . 64.42 113.793 174.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -69.88 -20.18 63.4 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 122.751 0.42 . . . . 71.43 112.006 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 ' NH1' ' A' ' 111' ' ' ARG . 36.4 mm -70.34 -41.4 78.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.365 0.602 . . . . 73.14 109.722 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.511 HD21 ' HA3' ' C' ' 82' ' ' GLY . 78.9 mt -81.67 -27.81 33.86 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 114.849 -1.069 . . . . 65.12 111.931 -171.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.524 ' HZ ' HD22 ' C' ' 128' ' ' LEU . 49.1 t80 -56.26 -47.44 98.86 Favored Pre-proline 0 CA--C 1.56 1.329 0 CA-C-O 117.692 -1.147 . . . . 74.33 113.607 -174.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.12 -42.1 67.23 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 122.345 2.03 . . . . 63.21 113.036 176.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.4 -47.52 76.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.976 0.91 . . . . 72.34 111.388 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.607 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -65.7 -37.47 86.53 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.796 -0.638 . . . . 61.33 110.894 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 4.1 ttp-105 -62.16 -46.1 90.48 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.387 1.055 . . . . 64.54 110.134 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -70.11 -37.11 75.28 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 123.713 0.633 . . . . 74.14 110.705 -179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 14.5 t -64.7 -31.81 73.2 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.522 0.513 . . . . 60.41 110.793 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.576 HG21 HG21 ' C' ' 64' ' ' VAL . 96.1 mt -73.99 -49.16 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 115.911 -0.586 . . . . 71.51 110.756 171.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.0 m -57.8 -33.63 68.77 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-O 121.44 0.638 . . . . 52.04 110.703 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -65.84 -51.57 57.76 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 114.702 -1.135 . . . . 71.21 109.574 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.543 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.25 -37.09 74.24 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.769 1.228 . . . . 74.23 112.79 -179.455 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.435 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.0 t -69.28 -43.51 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.809 0.844 . . . . 75.31 109.821 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.6 t -69.63 -25.39 63.91 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.12 -0.945 . . . . 73.34 110.988 178.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 85.2 mtt-85 -71.54 -38.76 71.02 Favored 'General case' 0 C--O 1.213 -0.84 0 N-CA-C 108.793 -0.818 . . . . 72.44 108.793 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.05 -3.31 84.63 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 123.789 0.681 . . . . 71.42 113.043 173.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.6 p 62.88 29.81 16.56 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.437 1.895 . . . . 73.31 112.852 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -92.4 163.97 24.6 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 124.43 1.092 . . . . 70.51 111.246 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' E' ' 136' ' ' VAL . 19.5 Cg_endo -55.62 177.75 0.12 Allowed 'Trans proline' 0 C--N 1.394 2.951 0 C-N-CA 124.065 3.177 . . . . 71.3 115.935 -178.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.43 ' OE1' ' HG3' ' B' ' 125' ' ' GLN . 19.5 mm100 -60.42 112.12 1.84 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.708 1.203 . . . . 74.44 112.026 -175.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -111.33 90.49 3.35 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.785 -1.561 . . . . 50.1 106.785 172.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -122.81 105.02 9.67 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.761 -1.2 . . . . 64.31 107.761 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.524 HD22 ' HZ ' ' C' ' 107' ' ' PHE . 2.8 tt -80.87 116.47 20.87 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.629 -0.878 . . . . 73.24 108.629 -174.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.92 142.77 98.72 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 124.087 0.955 . . . . 41.52 111.739 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.446 ' HG3' ' HB ' ' A' ' 16' ' ' ILE . 18.3 Cg_endo -58.03 109.66 0.52 Allowed 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.974 2.449 . . . . 70.41 112.847 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.9 p -97.89 110.39 25.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 N-CA-C 107.943 -1.132 . . . . 75.45 107.943 173.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -102.44 78.39 1.72 Allowed 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 115.684 -0.689 . . . . 72.21 111.1 -164.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -69.44 -29.16 66.81 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.18 -0.918 . . . . 75.13 110.508 177.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -69.92 -50.12 45.31 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.724 -0.671 . . . . 73.34 109.923 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.418 ' HA ' ' HB2' ' C' ' 138' ' ' MET . . . -68.55 -23.21 64.48 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.453 1.101 . . . . 74.45 111.903 -174.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.1 tt -54.56 -52.1 63.16 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.66 0.784 . . . . 60.24 109.007 172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -77.71 -32.79 53.16 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 115.447 -0.797 . . . . 70.13 111.661 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.418 ' HB2' ' HA ' ' C' ' 135' ' ' ALA . 96.3 mmm -68.68 -30.73 69.47 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 111.913 0.338 . . . . 51.12 111.913 -176.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -71.21 -41.13 70.64 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.869 0.468 . . . . 64.21 110.266 173.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -70.76 -83.75 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.583 0.753 . . . . 71.41 111.847 176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 97.6 mt 66.94 1.61 2.37 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 125.085 1.354 . . . . 60.01 112.149 -172.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' C' ' 143' ' ' GLN . 52.6 tt0 54.31 -82.39 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.697 1.599 . . . . 23.33 111.278 -170.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.527 ' HG2' ' HG2' ' C' ' 142' ' ' GLN . 12.9 mm-40 -132.71 138.14 47.14 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.776 0.831 . . . . 64.5 109.674 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -153.14 -85.59 0.07 Allowed 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 107.295 -1.372 . . . . 74.5 107.295 174.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.658 ' HB3' ' HB1' ' A' ' 145' ' ' ALA . . . -174.88 177.24 2.04 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.889 0.875 . . . . 75.3 110.981 177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -160.47 146.19 12.19 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.665 -0.974 . . . . 33.53 110.665 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.54 161.37 29.86 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.115 0.566 . . . . 72.42 110.501 -174.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 90.68 162.04 37.9 Favored Glycine 0 C--N 1.343 0.958 0 CA-C-N 115.696 -0.684 . . . . 51.23 113.561 173.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 70.4 m -140.36 -54.84 0.52 Allowed 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 107.914 -1.143 . . . . 24.52 107.914 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -172.81 -40.59 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.006 0.922 . . . . 72.42 110.714 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 62.46 -89.46 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.588 1.155 . . . . 51.0 109.07 -162.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 50.21 41.36 23.92 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.047 1.339 . . . . 73.42 112.8 170.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.89 153.49 20.86 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.406 1.082 . . . . 51.45 112.987 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 65.37 -86.17 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.45 1.5 . . . . 72.2 110.864 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 N-CA-C 108.44 -0.948 . . . . 63.25 108.44 177.575 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptp . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 111.537 0.199 . . . . 52.42 111.537 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -98.47 121.97 41.08 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.605 -0.517 . . . . 74.32 109.605 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -74.71 82.7 2.09 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.674 0.79 . . . . 74.24 109.683 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -147.37 161.31 41.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.495 -0.775 . . . . 61.24 110.439 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -154.11 47.46 0.61 Allowed 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 106.7 -1.593 . . . . 72.22 106.7 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -84.17 5.76 25.1 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.993 -1.003 . . . . 75.31 111.842 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -67.23 98.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.156 0.982 . . . . 75.3 109.763 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -81.62 66.0 6.99 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.36 1.064 . . . . 70.04 110.778 -177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 3.8 ttt -34.09 141.27 0.05 Allowed 'General case' 0 CA--C 1.561 1.368 0 N-CA-C 114.716 1.376 . . . . 74.21 114.716 174.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 42.7 m -144.86 142.73 30.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.928 0.891 . . . . 72.12 108.936 166.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.78 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 29.4 t80 -152.79 121.45 6.43 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.051 -1.092 . . . . 75.11 108.051 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -137.67 144.39 41.8 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.989 0.516 . . . . 75.32 109.765 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.3 mm -84.13 116.91 28.75 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 C-N-CA 123.95 0.9 . . . . 72.23 108.657 176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -101.46 -48.68 4.27 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 117.929 0.331 . . . . 70.42 111.753 -179.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.425 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 35.3 ttt180 -173.96 128.59 0.39 Allowed 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 111.923 0.342 . . . . 74.11 111.923 -173.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.13 132.34 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 124.177 0.991 . . . . 64.42 108.373 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.425 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 18.2 p90 -163.13 176.02 10.45 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.692 0.797 . . . . 75.53 112.043 -172.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.452 HG21 HD11 ' D' ' 21' ' ' ILE . 76.8 p -111.05 126.59 54.97 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 64.01 109.636 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.524 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . 35.3 mtpt -97.39 -14.41 21.24 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.78 0.432 . . . . 60.33 110.302 174.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 11.4 t70 -161.33 138.29 8.68 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.385 1.074 . . . . 73.51 109.136 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.543 HG21 ' HE2' ' C' ' 117' ' ' MET . 51.8 mt -140.68 144.49 27.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 106.787 -1.56 . . . . 64.41 106.787 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 20.3 t -150.23 143.5 25.01 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.024 -0.732 . . . . 61.4 109.024 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.54 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.7 t80 -152.39 125.7 8.71 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.67 -1.604 . . . . 63.41 106.67 173.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 43.0 mt-10 -126.59 142.02 51.67 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.995 0.918 . . . . 73.34 108.528 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.52 85.4 60.4 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.021 -1.103 . . . . 73.32 108.021 177.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.04 -45.08 8.45 Favored 'Trans proline' 0 C--N 1.381 2.278 0 C-N-CA 123.448 2.765 . . . . 74.43 113.803 -167.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -114.53 44.56 1.71 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.154 0.982 . . . . 72.33 108.432 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.519 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -50.91 -57.86 12.23 Favored Pre-proline 0 CA--C 1.575 1.939 0 N-CA-C 115.808 1.781 . . . . 72.52 115.808 -167.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -85.25 -5.76 9.35 Favored 'Trans proline' 0 C--N 1.385 2.452 0 CA-C-N 122.345 1.873 . . . . 74.1 112.636 176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.441 ' HA ' HE21 ' D' ' 33' ' ' GLN . 7.1 t-160 -84.07 -39.79 19.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.27 1.428 . . . . 64.12 109.947 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.2 p -81.03 -16.59 12.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 123.517 0.727 . . . . 64.13 109.828 -177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -55.46 -32.44 62.78 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.438 1.095 . . . . 74.13 111.789 170.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.441 HE21 ' HA ' ' D' ' 30' ' ' HIS . 47.1 mt-30 -67.72 -8.21 33.49 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.457 0.703 . . . . 74.41 112.531 -177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -125.47 106.19 9.61 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.295 1.038 . . . . 61.13 109.485 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 p-10 -89.23 81.93 6.63 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 122.28 1.038 . . . . 74.51 110.478 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.577 ' HB3' HD11 ' D' ' 68' ' ' LEU . 33.5 t-105 -146.04 157.25 43.86 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 107.925 -1.139 . . . . 62.23 107.925 175.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.585 ' NE2' HG23 ' F' ' 136' ' ' VAL . 1.7 mp0 -61.41 105.21 0.55 Allowed Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 125.161 1.384 . . . . 75.14 110.912 176.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.543 ' HD2' HD22 ' F' ' 139' ' ' LEU . 45.1 Cg_exo -61.35 111.38 1.11 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.272 2.648 . . . . 72.32 111.883 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.16 113.27 2.05 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.378 0.671 . . . . 71.13 110.542 178.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' D' ' 66' ' ' ALA . 27.7 m -100.76 150.27 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.539 -0.755 . . . . 54.05 110.579 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -121.63 118.92 30.4 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 105.621 -1.992 . . . . 73.34 105.621 173.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.65 ' HG ' HD21 ' D' ' 128' ' ' LEU . 0.0 OUTLIER -96.38 151.45 19.53 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.726 -0.842 . . . . 44.33 108.726 179.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -149.79 144.15 25.84 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.421 0.688 . . . . 64.43 109.754 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 78.7 mt -119.73 131.82 55.48 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.706 0.802 . . . . 72.41 110.01 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.7 t70 -134.04 117.71 16.96 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.539 -1.282 . . . . 72.52 107.539 172.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -103.5 156.91 17.41 Favored 'General case' 0 C--O 1.243 0.75 0 CA-C-O 121.218 0.533 . . . . 61.31 110.359 -176.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.33 171.38 18.09 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 124.16 0.984 . . . . 71.34 109.076 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 48.5 p -150.45 163.32 38.69 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.458 0.703 . . . . 73.43 109.582 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 35.7 t -158.14 118.13 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.769 -1.197 . . . . 64.32 107.769 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -85.43 122.63 29.85 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.454 -0.572 . . . . 74.11 109.454 176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 54.3 mt -89.9 -40.55 12.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.51 0.724 . . . . 71.12 109.44 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.19 -177.59 5.82 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.698 -1.137 . . . . 74.52 109.491 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -67.55 130.65 43.71 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.41 -0.589 . . . . 73.44 109.41 176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 70.57 5.49 5.41 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 124.769 1.227 . . . . 72.13 111.635 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 99.9 t -126.95 115.29 40.85 Favored 'Isoleucine or valine' 0 C--N 1.359 1.014 0 C-N-CA 124.658 1.183 . . . . 74.32 108.906 177.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.483 ' CD1' ' HB ' ' D' ' 86' ' ' ILE . 24.7 m-85 -134.27 127.26 31.47 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.076 -0.713 . . . . 60.41 109.076 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -87.67 114.43 24.27 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.84 1.256 . . . . 52.35 108.678 171.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -100.53 137.92 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 108.446 -0.946 . . . . 73.02 108.446 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 67.9 t -115.7 138.56 45.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 123.981 0.913 . . . . 72.34 108.921 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.593 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -126.48 119.6 27.61 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.386 -1.338 . . . . 72.41 107.386 175.108 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 19.5 ttm-85 -102.85 98.69 8.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.518 -0.919 . . . . 73.52 108.518 176.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -92.15 130.92 40.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.962 -0.755 . . . . 70.52 108.962 171.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 26.2 m -123.4 143.32 50.2 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.894 -0.594 . . . . 61.41 110.062 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.418 HG23 HD13 ' D' ' 114' ' ' ILE . 70.8 t -130.1 125.41 60.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 C-N-CA 124.486 1.114 . . . . 70.4 108.859 175.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 84.3 m -115.55 110.62 19.5 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.095 -1.076 . . . . 44.21 108.095 170.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.506 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -98.53 157.49 16.2 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.84 0.456 . . . . 62.25 109.8 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 28.5 p -158.34 137.28 11.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.656 -0.498 . . . . 53.53 109.656 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.577 HD11 ' HB3' ' D' ' 36' ' ' TRP . 18.1 tp -136.03 110.34 8.43 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.054 -1.091 . . . . 72.41 108.054 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.95 -127.35 7.97 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.596 0.56 . . . . 54.24 113.382 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -94.4 9.44 38.32 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.182 0.593 . . . . 74.52 111.838 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -142.45 163.93 31.51 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.249 0.547 . . . . 75.31 111.349 -172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 32.9 m -74.18 134.51 42.78 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.823 -1.08 . . . . 72.11 109.516 173.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.29 -53.03 5.26 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.49 0.716 . . . . 75.41 109.865 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -157.92 172.47 18.4 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.76 -1.109 . . . . 73.41 109.7 173.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.622 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 98.5 mt -138.68 149.57 45.28 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.241 1.417 . . . . 73.4 108.087 -177.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.783 ' SG ' HG12 ' D' ' 114' ' ' ILE . 41.8 t -159.76 142.37 13.66 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.676 0.39 . . . . 53.44 110.671 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -155.94 126.85 6.94 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.941 0.496 . . . . 72.14 109.883 173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -132.33 119.07 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 123.667 0.787 . . . . 64.44 110.074 -174.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.745 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 25.3 mt-30 -89.22 88.09 7.39 Favored 'General case' 0 C--O 1.24 0.593 0 CA-C-O 121.715 0.769 . . . . 71.41 109.037 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -79.86 107.99 13.07 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 114.197 -1.365 . . . . 75.41 108.676 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.47 164.04 18.93 Favored Glycine 0 C--N 1.338 0.691 0 N-CA-C 112.347 -0.301 . . . . 63.41 112.347 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.01 135.53 3.74 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 111.903 -0.479 . . . . 65.32 111.903 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -88.85 126.94 41.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 N-CA-C 108.639 -0.875 . . . . 63.21 108.639 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -130.54 143.48 50.78 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.352 1.061 . . . . 73.52 109.101 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 12.9 m -80.66 101.18 9.08 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 108.816 -0.809 . . . . 70.11 108.816 173.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.483 ' HB ' ' CD1' ' D' ' 56' ' ' TYR . 43.1 mm -107.01 106.04 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.093 -1.076 . . . . 61.33 108.093 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -147.11 162.13 39.46 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 123.387 0.675 . . . . 65.34 110.849 -173.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.35 -0.2 55.33 Favored Glycine 0 C--N 1.348 1.246 0 N-CA-C 114.926 0.73 . . . . 63.32 114.926 176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.404 HD11 HG23 ' D' ' 86' ' ' ILE . 17.1 pt -134.03 141.21 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 123.879 0.872 . . . . 70.35 109.806 -173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.41 166.03 25.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.578 0.751 . . . . 74.54 110.873 -176.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.75 -112.6 3.23 Favored Glycine 0 C--N 1.352 1.442 0 O-C-N 123.794 0.684 . . . . 74.13 114.018 174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 7.0 m -72.57 -30.51 64.46 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.311 1.044 . . . . 74.21 111.353 -175.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -67.05 -52.47 41.86 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.748 0.819 . . . . 64.41 110.577 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.417 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 27.5 ptm -70.26 -29.91 66.82 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.818 -0.628 . . . . 64.14 110.545 178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.34 -34.48 77.42 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.895 0.478 . . . . 74.31 111.09 177.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -64.41 -43.01 95.71 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.329 0.652 . . . . 73.14 110.031 173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.96 -49.36 77.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 122.884 0.473 . . . . 54.51 111.033 176.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' D' ' 94' ' ' MET . 88.2 mt -70.76 -22.32 62.41 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.637 0.775 . . . . 75.45 111.78 -177.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -113.44 9.1 24.34 Favored Glycine 0 C--N 1.349 1.265 0 CA-C-O 119.247 -0.752 . . . . 72.32 114.607 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.11 -75.77 0.12 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 118.021 0.91 . . . . 50.1 111.279 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -68.69 -50.91 47.22 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 113.276 0.843 . . . . 73.4 113.276 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.78 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 25.5 m -62.9 -46.32 87.5 Favored Pre-proline 0 CA--C 1.566 1.592 0 CA-C-O 118.743 -0.646 . . . . 64.22 111.849 -177.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.593 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 54.2 Cg_exo -57.95 -33.93 97.74 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.47 2.113 . . . . 74.33 113.347 169.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -66.53 -29.68 69.82 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.462 0.705 . . . . 73.52 111.147 -178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.8 mm -67.73 -38.6 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 CA-C-O 121.492 0.663 . . . . 70.45 110.228 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 52.2 mt -81.55 -13.65 57.81 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 114.991 -1.004 . . . . 73.35 111.624 -175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.614 ' HZ ' HD22 ' D' ' 128' ' ' LEU . 56.9 t80 -69.04 -46.28 30.38 Favored Pre-proline 0 CA--C 1.561 1.402 0 CA-C-O 118.217 -0.897 . . . . 65.21 113.371 -174.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -56.7 -32.42 90.88 Favored 'Trans proline' 0 C--N 1.389 2.672 0 C-N-CA 122.085 1.857 . . . . 64.23 112.912 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -79.89 -35.39 38.09 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.767 0.827 . . . . 53.31 111.948 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.64 -51.91 63.12 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.111 0.564 . . . . 71.2 109.817 177.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -67.69 -34.24 76.49 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 115.15 -0.932 . . . . 73.41 111.552 -176.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -66.94 -43.93 81.93 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 124.18 0.925 . . . . 75.0 110.159 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.7 t -57.53 -43.13 84.09 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 123.626 0.579 . . . . 25.04 109.929 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.783 HG12 ' SG ' ' D' ' 76' ' ' CYS . 74.2 mt -63.74 -46.1 95.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.188 -0.914 . . . . 71.42 110.749 175.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.41 HG21 ' HE2' ' B' ' 109' ' ' TYR . 94.0 m -55.76 -49.73 72.35 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.291 1.037 . . . . 53.51 110.527 -176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.3 t -65.3 -44.12 88.93 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 113.581 -1.645 . . . . 73.24 110.387 -175.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.415 ' HE3' ' SG ' ' D' ' 76' ' ' CYS . 76.3 mtm -64.63 -35.92 82.57 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.894 0.478 . . . . 74.55 112.217 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' D' ' 123' ' ' PHE . 54.1 t -67.56 -44.77 86.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 123.441 0.696 . . . . 71.34 110.492 176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.83 -25.73 62.1 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 122.478 0.311 . . . . 61.42 111.192 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -74.69 -34.81 62.71 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.641 0.777 . . . . 74.24 109.162 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.56 0.4 76.37 Favored Glycine 0 C--N 1.358 1.764 0 CA-C-N 115.393 -0.821 . . . . 72.11 112.362 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.26 27.86 16.67 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 126.85 2.06 . . . . 72.12 112.907 173.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.557 ' HB2' HG13 ' D' ' 118' ' ' VAL . 37.3 m-85 -94.92 160.63 30.64 Favored Pre-proline 0 CA--C 1.557 1.217 0 CA-C-N 114.45 -1.25 . . . . 62.2 108.706 172.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.403 ' HB3' HG22 ' F' ' 136' ' ' VAL . 16.3 Cg_endo -53.44 136.07 62.53 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 124.066 3.177 . . . . 53.3 113.571 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.0 128.06 31.84 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 124.303 1.002 . . . . 74.34 111.804 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.708 HD13 ' HG ' ' F' ' 139' ' ' LEU . 47.7 tp -117.15 95.63 5.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.546 0.738 . . . . 74.01 110.805 -175.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 -99.91 113.34 25.83 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.801 -1.185 . . . . 72.12 107.801 174.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.65 HD21 ' HG ' ' D' ' 42' ' ' LEU . 1.1 tt -74.57 124.66 27.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 109.768 -0.456 . . . . 71.12 109.768 -174.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -61.79 131.32 92.94 Favored Pre-proline 0 CA--C 1.556 1.182 0 C-N-CA 123.663 0.785 . . . . 74.25 110.99 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.2 Cg_endo -77.78 127.4 8.68 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.65 2.233 . . . . 71.34 112.53 -170.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.5 p -106.37 112.5 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 121.451 0.643 . . . . 75.21 109.389 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -89.03 72.97 8.33 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.919 0.866 . . . . 55.14 109.413 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -71.71 -24.23 61.77 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.789 -1.096 . . . . 73.22 110.866 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -60.64 -42.53 97.14 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.926 0.89 . . . . 72.33 110.846 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' D' ' 138' ' ' MET . . . -68.62 -22.93 64.4 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.728 -0.669 . . . . 73.35 112.796 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.96 -49.2 75.69 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.423 0.689 . . . . 75.34 110.813 -179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' D' ' 140' ' ' TYR . 64.2 t80 -81.19 -30.08 34.43 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.863 -0.608 . . . . 72.51 110.533 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.459 ' HB3' ' HA ' ' D' ' 135' ' ' ALA . 30.2 ttm -57.51 -37.58 73.23 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.351 0.66 . . . . 73.12 111.109 176.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.465 ' HA ' HE21 ' D' ' 142' ' ' GLN . 62.6 t30 -68.08 -30.15 69.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.468 -0.787 . . . . 70.44 110.818 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' D' ' 137' ' ' PHE . 87.0 t80 -58.27 -35.35 71.64 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.549 0.739 . . . . 64.0 111.399 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.28 -32.44 73.44 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.172 0.589 . . . . 74.41 110.676 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.465 HE21 ' HA ' ' D' ' 139' ' ' ASN . 35.9 mt-30 -87.42 -0.37 56.69 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.485 0.714 . . . . 74.4 111.014 178.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -121.65 47.23 1.91 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.748 -1.204 . . . . 75.13 107.748 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -171.52 -61.42 0.02 OUTLIER 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.556 -1.202 . . . . 71.32 108.135 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . 57.67 29.75 17.78 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.569 1.147 . . . . 74.13 111.774 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.51 -122.11 0.59 Allowed Glycine 0 C--N 1.351 1.365 0 CA-C-N 115.758 -0.655 . . . . 72.31 113.486 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -97.51 -178.99 4.32 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.877 0.871 . . . . 72.43 110.549 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.78 -54.53 3.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 110.781 -0.928 . . . . 65.12 110.781 174.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.9 t -173.92 159.49 3.38 Favored 'General case' 0 C--O 1.245 0.816 0 C-N-CA 123.879 0.872 . . . . 73.01 110.679 179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -106.96 99.13 8.72 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 107.565 -1.272 . . . . 75.31 107.565 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -80.33 95.53 6.39 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.727 0.411 . . . . 74.12 111.367 -176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -84.94 73.24 10.7 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.613 -1.625 . . . . 65.43 106.613 163.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -147.63 152.71 38.34 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.538 -1.21 . . . . 65.44 109.113 -167.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -76.7 72.59 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.908 0.861 . . . . 73.25 109.82 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.186 0 CA-C-N 114.746 -1.115 . . . . 72.11 108.373 -174.557 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 110.16 -0.311 . . . . 75.52 110.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.54 156.49 21.65 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.568 0.747 . . . . 72.33 109.14 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.53 -15.83 60.34 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.441 0.696 . . . . 75.43 111.225 175.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 78.5 t80 70.71 154.59 0.13 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.323 1.449 . . . . 55.34 111.028 -177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.38 70.83 4.8 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.342 0.591 . . . . 72.31 109.554 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -87.38 -59.01 2.37 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 108.6 -0.889 . . . . 45.1 108.6 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -133.75 178.62 6.79 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.198 0.999 . . . . 74.53 110.061 175.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.593 ' HB3' ' SD ' ' B' ' 94' ' ' MET . 6.9 mp -66.42 -32.81 74.42 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 109.136 -0.691 . . . . 71.12 109.136 169.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -117.93 86.11 24.58 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.104 0.962 . . . . 75.54 109.06 172.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -98.72 24.57 0.21 Allowed 'Trans proline' 0 C--N 1.375 1.931 0 C-N-CA 123.508 2.805 . . . . 73.45 112.166 173.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -96.52 149.69 21.47 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.51 0.724 . . . . 54.14 109.998 -174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 9.5 t -103.3 138.19 40.41 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.698 0.799 . . . . 52.54 111.762 -173.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -121.24 108.73 14.1 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.095 -1.076 . . . . 71.33 108.095 174.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -142.43 -7.31 0.89 Allowed 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.662 0.785 . . . . 75.44 111.382 -175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.7 122.21 38.21 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.294 0.638 . . . . 73.11 109.957 -178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . 0.486 ' HA ' HD21 ' B' ' 136' ' ' LEU . 65.1 t -127.46 131.79 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.585 1.154 . . . . 74.13 108.773 178.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -127.87 138.58 52.73 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.054 0.942 . . . . 70.14 109.497 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . 0.445 ' HE2' HD21 ' B' ' 128' ' ' LEU . 0.1 OUTLIER -135.49 -75.54 0.45 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 73.05 109.658 178.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.86 32.69 22.48 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 124.109 0.964 . . . . 71.12 110.673 -176.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -77.24 139.75 23.7 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 115.046 -0.979 . . . . 72.04 113.496 -174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -105.88 88.49 2.83 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 124.127 0.971 . . . . 62.4 110.451 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mp -90.73 -63.91 1.2 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.386 -0.825 . . . . 73.01 110.499 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 19.2 mt -79.2 -2.11 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.64 0.776 . . . . 70.21 110.783 -177.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.75 -24.4 67.75 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.36 0.664 . . . . 74.53 112.002 174.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -80.41 128.88 71.22 Favored Pre-proline 0 CA--C 1.556 1.201 0 N-CA-C 108.665 -0.865 . . . . 62.25 108.665 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.67 9.78 2.15 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.201 2.601 . . . . 72.01 114.972 -168.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 14.3 tt -75.7 137.31 23.08 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 122.895 0.478 . . . . 54.42 109.883 175.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -109.11 -81.3 0.57 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.311 -0.626 . . . . 61.41 109.311 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.403 ' O ' ' HB3' ' C' ' 124' ' ' PRO . 23.8 t 53.03 30.24 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 122.313 1.054 . . . . 74.24 109.986 -175.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -81.05 161.38 24.21 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.423 -0.808 . . . . 73.23 111.17 -171.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 68.12 -96.88 0.04 OUTLIER 'General case' 0 C--N 1.351 0.642 0 C-N-CA 125.309 1.444 . . . . 54.53 109.651 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . 0.539 HD21 HG21 ' C' ' 40' ' ' VAL . 18.3 tp 169.36 -25.91 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.151 0.98 . . . . 71.3 109.451 -177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 15.1 t 77.49 -71.58 0.11 Allowed 'General case' 0 C--N 1.359 0.99 0 C-N-CA 125.49 1.516 . . . . 42.31 110.957 177.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 6.1 tt -108.47 112.98 25.66 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.466 -0.568 . . . . 54.11 109.466 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . 0.455 ' HB ' HD23 ' E' ' 139' ' ' LEU . 10.3 tt -160.38 142.55 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.159 0.984 . . . . 71.14 109.416 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 9.2 t80 67.57 177.74 0.24 Allowed 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.568 1.147 . . . . 75.12 111.101 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -100.55 169.19 9.23 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.486 0.714 . . . . 70.34 111.034 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.9 -48.92 76.87 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.512 -0.767 . . . . 74.23 109.904 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -92.01 159.66 15.61 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 115.62 -0.718 . . . . 72.3 110.563 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 87.7 mt -69.48 -50.56 44.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.953 0.901 . . . . 75.22 111.298 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -112.9 95.68 34.85 Favored Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 123.583 0.753 . . . . 73.52 109.018 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.379 2.159 0 C-N-CA 123.037 2.492 . . . . 72.12 112.157 178.469 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 110.116 -0.327 . . . . 74.12 110.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -155.51 140.38 17.21 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.341 0.656 . . . . 73.25 110.315 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.66 161.97 38.63 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.728 1.211 . . . . 63.41 109.217 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -75.37 81.09 2.44 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 108.144 -1.058 . . . . 73.31 108.144 170.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -68.57 -30.53 69.32 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.837 -1.074 . . . . 74.14 111.452 -175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.18 132.65 52.48 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.121 0.568 . . . . 64.31 110.051 175.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -77.15 -69.26 0.54 Allowed 'General case' 0 C--O 1.241 0.653 0 N-CA-C 109.567 -0.531 . . . . 73.32 109.567 176.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.571 HD22 ' HG2' ' A' ' 94' ' ' MET . 19.3 mt 58.67 -179.86 0.07 Allowed 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 125.177 1.391 . . . . 74.12 112.088 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . 0.435 ' H ' HD12 ' A' ' 98' ' ' LEU . 12.6 t80 71.98 150.61 0.13 Allowed Pre-proline 0 N--CA 1.496 1.86 0 C-N-CA 124.599 1.16 . . . . 75.24 112.211 166.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . 0.433 ' HA ' ' HB1' ' A' ' 95' ' ' ALA . 10.2 Cg_endo -54.1 141.99 67.41 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.911 2.407 . . . . 71.22 114.467 171.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -94.42 -168.58 1.87 Allowed 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.851 1.26 . . . . 75.35 110.126 175.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 97.7 m -85.16 122.9 30.02 Favored 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 123.845 0.858 . . . . 71.23 111.781 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -152.57 -39.42 0.11 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.205 -1.035 . . . . 74.33 108.205 170.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 64.0 14.22 8.29 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 125.311 1.445 . . . . 74.23 114.748 168.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -79.27 84.43 5.21 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.562 -0.903 . . . . 54.05 108.562 174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.509 ' HA ' HD21 ' A' ' 136' ' ' LEU . 69.7 t -107.35 123.08 62.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.241 1.016 . . . . 63.4 109.609 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.42 137.24 5.83 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.183 0.993 . . . . 73.1 108.572 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -147.34 -47.55 0.17 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.363 0.665 . . . . 71.21 110.46 -177.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -169.8 -74.24 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.603 0.761 . . . . 72.14 110.116 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 149.81 -102.22 0.23 Allowed Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.75 -0.94 . . . . 41.43 110.75 -174.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -85.2 -61.6 1.73 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.199 0.6 . . . . 75.14 109.625 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.592 ' HG ' ' HB2' ' A' ' 129' ' ' ALA . 1.6 tm? 65.46 105.83 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.749 1.62 . . . . 71.51 110.64 -171.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 9.1 tt -153.23 124.29 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 123.965 0.906 . . . . 73.03 108.556 171.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.23 157.15 42.23 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.472 0.709 . . . . 70.33 110.245 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . 0.617 ' HB3' HH11 ' C' ' 15' ' ' ARG . 2.2 m-85 59.01 54.09 4.85 Favored Pre-proline 0 CA--C 1.56 1.359 0 C-N-CA 124.934 1.293 . . . . 61.12 111.966 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' F' ' 132' ' ' TYR . 49.3 Cg_endo -95.47 52.88 0.19 Allowed 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 123.396 2.73 . . . . 63.0 111.626 -176.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.457 HG12 HG12 ' F' ' 136' ' ' VAL . 8.1 tt -55.8 115.37 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.091 0 CA-C-N 115.039 -0.982 . . . . 73.41 110.847 -177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.04 83.03 2.26 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.465 -0.789 . . . . 70.45 110.849 -175.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.585 HG23 ' NE2' ' D' ' 37' ' ' GLN . 13.9 p -165.11 81.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-O 122.597 1.189 . . . . 70.2 108.266 176.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -97.6 -22.97 16.2 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 114.907 -1.042 . . . . 71.42 111.477 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.37 133.99 55.44 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.943 0.897 . . . . 51.43 109.488 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.708 ' HG ' HD13 ' D' ' 126' ' ' LEU . 0.9 OUTLIER -70.15 -50.55 39.28 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 108.901 -0.777 . . . . 61.3 108.901 178.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.0 m 72.57 -49.74 0.7 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 125.169 1.388 . . . . 65.5 113.913 173.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 69.5 mt -83.62 56.93 3.82 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.528 1.131 . . . . 65.02 110.828 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.631 HD11 ' HG ' ' D' ' 128' ' ' LEU . 4.8 tp -117.28 126.05 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.529 0.732 . . . . 65.11 110.154 -177.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . 0.507 ' CE1' ' HB3' ' F' ' 145' ' ' LYS . 44.9 t80 66.85 -74.68 0.06 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.699 1.6 . . . . 75.32 110.694 176.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 59.8 t30 56.44 76.83 0.28 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.591 1.157 . . . . 73.11 111.501 174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . 0.507 ' HB3' ' CE1' ' F' ' 143' ' ' TYR . 0.1 OUTLIER -171.01 171.28 5.91 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-N 114.527 -1.215 . . . . 72.33 108.225 -176.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.11 -2.57 4.3 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.938 1.088 . . . . 74.5 113.938 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 76.3 mt 70.39 10.89 7.35 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 124.332 1.053 . . . . 75.42 111.696 177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 66.8 tp -154.9 106.57 2.31 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 107.936 -1.135 . . . . 73.43 107.936 -177.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 CA--C 1.564 2.014 0 C-N-CA 122.432 2.088 . . . . 71.22 112.527 -178.773 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 109.978 -0.379 . . . . 74.03 109.978 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 70.0 m -156.36 108.5 2.54 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.595 1.158 . . . . 71.04 108.811 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -81.59 87.46 6.26 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.637 -0.875 . . . . 70.15 108.637 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -123.43 -59.19 1.57 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.67 0.388 . . . . 74.33 111.348 -171.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 76.22 -28.83 0.18 Allowed 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 125.449 1.499 . . . . 73.32 112.438 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 77.32 -70.34 0.13 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 125.643 1.577 . . . . 74.43 111.855 171.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.4 p -108.91 -80.57 0.58 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.432 0.693 . . . . 73.33 110.141 -176.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -169.19 -54.02 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.592 1.157 . . . . 74.24 108.046 -175.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.58 136.64 33.7 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.103 -0.953 . . . . 71.14 110.446 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.6 m -141.56 127.26 19.11 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.463 1.105 . . . . 63.14 108.103 172.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -139.79 119.44 13.21 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.359 0.663 . . . . 64.34 109.45 175.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -138.54 115.64 10.97 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.044 0.538 . . . . 72.0 110.103 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.475 HG13 ' HD2' ' A' ' 84' ' ' PHE . 2.9 mp -78.28 115.44 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 107.35 -1.352 . . . . 41.43 107.35 172.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -94.13 -44.41 8.02 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 122.601 0.36 . . . . 72.43 111.061 -171.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.566 ' HD3' HG21 ' B' ' 122' ' ' THR . 86.0 mtt180 -159.02 157.05 30.47 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 124.141 0.976 . . . . 75.44 110.228 176.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -144.63 101.64 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.539 -1.282 . . . . 74.44 107.539 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' HD1' ' HB3' ' A' ' 15' ' ' ARG . 89.4 m-85 -159.87 177.66 10.57 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 124.943 1.297 . . . . 65.42 109.476 -165.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.411 HG21 ' SG ' ' A' ' 113' ' ' CYS . 73.2 p -90.84 135.58 33.64 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 122.241 -0.287 . . . . 64.2 110.735 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HB3' ' HE2' ' A' ' 19' ' ' LYS . 42.4 mtpt -96.47 -48.64 5.48 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.178 -0.675 . . . . 75.21 109.178 168.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 27.8 t70 -133.26 137.23 45.96 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 114.271 -1.331 . . . . 74.12 109.28 -171.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.421 ' CG2' ' SD ' ' A' ' 117' ' ' MET . 79.4 mt -139.19 139.48 39.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 106.876 -1.527 . . . . 73.45 106.876 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 42.8 t -147.53 129.38 15.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.582 0.753 . . . . 51.32 109.458 -176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.575 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 81.7 t80 -142.1 125.06 16.16 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 107.076 -1.453 . . . . 74.21 107.076 175.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -134.78 116.45 14.87 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 109.029 -0.73 . . . . 70.42 109.029 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.64 82.99 48.21 Favored Pre-proline 0 CA--C 1.541 0.627 0 N-CA-C 108.878 -0.786 . . . . 74.34 108.878 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.74 -32.76 13.98 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.574 2.183 . . . . 62.14 111.294 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 72' ' ' THR . 80.5 m-20 -104.72 31.39 4.77 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.05 0.94 . . . . 74.25 109.859 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.09 -47.93 98.26 Favored Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 123.991 0.916 . . . . 74.15 112.22 171.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -70.18 -14.97 35.36 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.962 1.775 . . . . 70.0 113.609 177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 34' ' ' LYS . 14.2 m170 -68.96 -46.59 67.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 109.758 -0.46 . . . . 71.33 109.758 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.8 -20.19 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 124.415 1.086 . . . . 73.43 112.153 -175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -60.22 -42.05 94.34 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 124.171 0.988 . . . . 65.04 111.107 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -102.95 -20.28 14.29 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.749 0.82 . . . . 72.12 111.652 178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.634 ' HD3' ' H ' ' A' ' 35' ' ' ASP . 3.9 tmtp? -83.79 163.37 20.19 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.261 1.024 . . . . 74.34 110.582 -171.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.634 ' H ' ' HD3' ' A' ' 34' ' ' LYS . 10.6 m-20 -63.69 143.53 57.76 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.207 1.003 . . . . 73.5 111.431 177.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -96.34 65.08 2.31 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.451 1.1 . . . . 73.23 110.609 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -148.44 77.38 9.72 Favored Pre-proline 0 N--CA 1.476 0.869 0 N-CA-C 109.558 -0.534 . . . . 70.34 109.558 173.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 7.6 Cg_endo -82.14 148.48 15.06 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 122.032 1.821 . . . . 64.13 111.037 177.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.23 99.87 12.04 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.768 -1.197 . . . . 64.04 107.768 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG22 HD13 ' A' ' 126' ' ' LEU . 26.8 t -76.69 95.14 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 115.138 -0.937 . . . . 73.33 109.946 -172.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.519 ' HA ' ' HG2' ' F' ' 128' ' ' LYS . 35.2 tttm -79.87 131.9 35.97 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.148 0.979 . . . . 64.55 109.796 174.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.437 HD12 HG22 ' A' ' 64' ' ' VAL . 2.1 mm? -115.3 149.47 37.8 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.115 0.483 . . . . 72.24 110.789 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 9.6 m-20 -136.34 125.92 25.31 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.076 1.35 . . . . 70.42 107.611 174.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 70.4 mt -116.64 119.1 34.46 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.622 -0.881 . . . . 75.02 108.622 -178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -132.51 147.74 52.37 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.98 0.912 . . . . 71.31 109.979 -174.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.4 m -142.84 128.67 19.41 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.428 0.691 . . . . 62.13 110.161 179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.78 152.3 49.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 123.648 0.779 . . . . 44.31 109.395 175.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.5 m -127.2 167.34 16.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.253 0.621 . . . . 42.41 109.597 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.7 t -168.25 122.06 0.9 Allowed 'General case' 0 C--N 1.354 0.796 0 O-C-N 122.978 0.174 . . . . 72.32 110.548 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.551 HE22 ' HE3' ' F' ' 114' ' ' LYS . 47.8 tt0 -69.78 114.45 7.99 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.793 0.837 . . . . 64.21 110.905 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' A' ' 57' ' ' GLU . 58.7 mt -83.54 -41.93 17.38 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.324 1.05 . . . . 51.24 110.955 174.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.12 178.78 7.96 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.549 1.14 . . . . 70.12 108.309 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.14 99.01 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 120.922 0.392 . . . . 42.01 110.151 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 1.4 m-20 69.53 29.89 4.19 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 113.803 -1.544 . . . . 74.4 111.696 175.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 49.9 t -114.8 121.73 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 106.132 -1.803 . . . . 63.41 106.132 164.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.488 ' CE2' ' HA ' ' A' ' 54' ' ' ASP . 4.0 m-85 -132.49 137.33 47.16 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.309 0.576 . . . . 72.11 109.616 -178.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' A' ' 51' ' ' LEU . 10.3 tt0 -87.09 114.14 23.44 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 114.283 -1.326 . . . . 75.2 108.645 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.39 110.16 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 108.05 -1.093 . . . . 54.15 108.05 175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 97.4 t -98.45 137.79 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 123.523 0.729 . . . . 64.01 110.572 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.66 110.78 21.93 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.257 -1.386 . . . . 70.34 107.257 172.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 51.7 ttp85 -108.83 111.33 23.01 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.927 0.891 . . . . 75.21 109.386 -175.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.1 t -110.71 128.79 66.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 123.578 0.751 . . . . 71.31 109.304 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.7 m -108.83 143.78 37.56 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.235 -0.654 . . . . 73.22 109.235 174.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.659 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 54.7 t -137.21 109.28 6.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 C-N-CA 125.655 1.582 . . . . 73.2 107.759 -175.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 17.4 m -114.81 119.49 36.81 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.651 -0.5 . . . . 74.24 109.651 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 38' ' ' PRO . . . -103.28 107.33 18.11 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 107.738 -1.208 . . . . 25.24 107.738 -178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.0 m -129.79 128.63 42.76 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.917 0.487 . . . . 73.43 109.769 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.549 HD22 ' HE2' ' A' ' 34' ' ' LYS . 4.7 tt -101.44 85.49 2.79 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.162 -1.421 . . . . 55.31 107.162 172.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.56 -106.86 2.19 Favored Glycine 0 C--N 1.348 1.21 0 CA-C-N 115.204 -0.907 . . . . 73.41 111.756 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -88.16 -28.05 21.47 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.55 0.74 . . . . 64.42 110.779 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -89.46 125.5 35.2 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.188 0.595 . . . . 71.55 110.212 -174.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.4 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 23.1 m -88.02 114.92 25.11 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.95 -0.759 . . . . 73.14 108.95 169.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.89 -51.47 58.45 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.645 0.778 . . . . 72.04 109.347 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.483 ' HZ ' HD12 ' A' ' 126' ' ' LEU . 52.5 p90 -164.36 173.59 12.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.385 -1.28 . . . . 70.32 111.931 177.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 tp -132.27 146.65 52.14 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.729 1.611 . . . . 72.02 107.921 176.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.659 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 64.5 m -141.92 138.99 32.41 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.165 0.986 . . . . 70.45 108.751 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -150.92 133.0 15.26 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.962 -0.755 . . . . 54.52 108.962 169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.418 HG11 ' HB3' ' A' ' 113' ' ' CYS . 47.0 t -131.53 115.62 29.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.458 0.703 . . . . 74.3 109.121 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 62.5 mt-30 -84.6 84.83 7.53 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.057 -1.09 . . . . 64.14 108.057 170.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -76.91 95.82 4.2 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.742 -1.117 . . . . 71.24 108.555 178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.84 142.96 19.55 Favored Glycine 0 C--N 1.34 0.79 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.819 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.535 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -137.83 122.47 2.47 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.211 -1.556 . . . . 64.23 109.211 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.0 mt -89.3 122.38 40.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.875 -0.787 . . . . 75.42 108.875 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HD2' HG13 ' A' ' 13' ' ' ILE . 29.3 m-85 -125.45 118.46 25.88 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 105.435 -2.061 . . . . 74.13 105.435 178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 35.9 t -93.79 94.61 8.63 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.907 -1.146 . . . . 64.23 107.907 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -117.85 148.48 20.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 123.666 0.786 . . . . 73.25 110.136 -174.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -170.93 148.22 2.79 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.949 1.3 . . . . 75.34 109.351 178.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.44 6.64 62.53 Favored Glycine 0 C--N 1.342 0.886 0 O-C-N 123.167 0.292 . . . . 71.24 113.305 175.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.555 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.6 mp -127.33 136.97 59.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 107.116 -1.438 . . . . 72.24 107.116 175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -149.04 175.58 11.19 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 118.312 0.505 . . . . 71.43 110.596 -176.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.07 -152.14 48.15 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.262 -0.881 . . . . 70.53 112.767 179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 40.9 p -65.48 -24.99 67.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.077 0.951 . . . . 43.14 112.429 -178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -59.65 -49.74 76.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.287 0.635 . . . . 73.14 109.969 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.778 ' SD ' HD12 ' F' ' 115' ' ' LEU . 2.5 tpt -80.86 -30.81 35.55 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.133 -0.939 . . . . 74.15 110.94 -177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.68 -29.56 69.6 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.212 0.605 . . . . 52.53 110.842 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.461 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 36.6 t-80 -73.55 -36.96 65.71 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.988 -0.551 . . . . 75.25 110.522 173.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 94' ' ' MET . 53.3 t -76.78 -65.11 0.98 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.912 -0.131 . . . . 74.13 111.11 -176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.92 -29.27 70.46 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 122.954 0.502 . . . . 62.44 112.327 -177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.44 -22.77 36.17 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 114.333 0.493 . . . . 73.23 114.333 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -133.09 -49.85 0.87 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.534 0.667 . . . . 65.05 112.424 -170.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -71.84 -47.55 52.33 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.856 0.862 . . . . 74.21 111.742 -175.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 105' ' ' ILE . 73.9 m -67.32 -47.62 48.71 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.425 1.09 . . . . 74.11 112.675 -175.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.26 -26.88 56.28 Favored 'Trans proline' 0 C--N 1.393 2.874 0 C-N-CA 121.891 1.727 . . . . 72.12 112.825 172.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.72 -29.29 62.17 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 122.622 0.369 . . . . 74.42 110.436 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 102' ' ' CYS . 49.7 mt -61.44 -47.04 95.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.752 0.821 . . . . 73.22 109.429 167.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.535 HD21 ' HA3' ' A' ' 82' ' ' GLY . 84.1 mt -73.71 -20.4 60.54 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-N 114.698 -1.137 . . . . 61.41 112.053 -174.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -64.65 -46.11 76.41 Favored Pre-proline 0 CA--C 1.558 1.253 0 N-CA-C 114.627 1.343 . . . . 64.11 114.627 -166.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.63 -35.13 98.91 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.932 1.754 . . . . 64.14 112.706 174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -73.72 -36.46 65.22 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 115.369 -0.832 . . . . 73.33 111.609 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.17 -42.81 68.61 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 122.262 0.225 . . . . 74.1 110.453 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.435 HH22 ' HA ' ' A' ' 130' ' ' PRO . 38.2 ttm105 -52.13 -48.6 64.76 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 124.114 0.884 . . . . 61.11 110.289 175.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -63.36 -52.53 61.38 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.851 -1.068 . . . . 71.32 111.429 -177.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.418 ' HB3' HG11 ' A' ' 78' ' ' VAL . 46.8 t -61.42 -29.21 69.8 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.908 0.755 . . . . 71.32 112.013 -175.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.658 HG21 HG21 ' A' ' 64' ' ' VAL . 79.1 mt -71.68 -60.37 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 115.69 -0.686 . . . . 64.5 109.694 172.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 99.0 m -55.03 -30.31 59.29 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 124.548 1.139 . . . . 64.2 112.333 -175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.3 t -69.03 -44.49 72.59 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.69 -0.686 . . . . 70.13 109.992 178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.523 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.9 mtm -61.11 -41.11 96.09 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 122.881 0.473 . . . . 52.23 110.58 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 84.5 t -58.23 -47.76 86.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 114.532 -1.213 . . . . 72.42 110.667 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.3 p -75.21 -26.95 59.35 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.894 -0.594 . . . . 75.23 111.411 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -71.71 -27.88 63.31 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.708 0.803 . . . . 74.12 109.852 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.65 3.78 77.2 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 115.494 -0.775 . . . . 45.34 112.642 174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.3 m 68.06 14.6 9.35 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.943 1.297 . . . . 70.2 111.216 176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -85.81 149.91 51.98 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 108.853 -0.795 . . . . 72.51 108.853 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -56.82 143.3 91.34 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.574 2.182 . . . . 71.11 111.282 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -61.48 132.69 54.24 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.685 0.394 . . . . 74.32 110.734 177.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.483 HD12 ' HZ ' ' A' ' 74' ' ' PHE . 63.8 mt -133.42 96.36 3.7 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.306 -0.998 . . . . 63.43 108.306 -175.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -98.85 123.23 42.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.101 -0.5 . . . . 64.23 109.759 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.488 ' H ' HD23 ' A' ' 128' ' ' LEU . 2.4 pt? -73.13 152.72 41.05 Favored 'General case' 0 C--O 1.244 0.792 0 O-C-N 123.919 0.762 . . . . 74.03 110.576 174.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.62 147.85 68.82 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.37 1.068 . . . . 64.34 112.074 -177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.461 ' HD3' HG22 ' C' ' 13' ' ' ILE . 15.7 Cg_exo -68.59 97.56 0.54 Allowed 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.404 2.07 . . . . 62.43 110.964 173.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.7 t -99.91 111.79 30.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 N-CA-C 108.305 -0.998 . . . . 74.45 108.305 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -103.61 96.65 6.86 Favored 'General case' 0 C--O 1.244 0.801 0 N-CA-C 108.494 -0.928 . . . . 73.42 108.494 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -59.55 -23.41 62.85 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.472 -0.786 . . . . 75.01 110.258 168.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.544 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 19.0 t70 -62.23 -51.31 68.26 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 123.997 0.919 . . . . 73.31 111.16 175.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.24 -30.67 69.77 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 123.622 0.576 . . . . 71.1 111.83 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.8 tp -75.84 -36.63 59.56 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.212 0.605 . . . . 61.44 110.894 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 140' ' ' TYR . 41.8 t80 -87.49 -23.05 24.55 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 122.749 0.42 . . . . 71.13 111.487 -177.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 9.8 tpt -77.47 -33.88 54.51 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 108.707 -0.849 . . . . 72.12 108.707 175.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -62.06 -54.01 47.4 Favored 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 114.301 -1.318 . . . . 74.11 109.722 166.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.457 ' HB3' ' HA ' ' A' ' 137' ' ' PHE . 90.8 t80 -63.5 -29.1 70.43 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.102 0.961 . . . . 75.42 111.91 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.5 tp -50.26 -47.29 55.33 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.577 1.151 . . . . 71.14 111.477 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -168.54 -16.13 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.65 0.594 . . . . 64.43 111.971 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -71.55 -53.9 12.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.591 0.356 . . . . 74.13 111.947 -167.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 70.77 -64.51 0.37 Allowed 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 124.86 1.264 . . . . 74.01 111.551 -177.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.91 131.67 21.37 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.777 0.831 . . . . 64.24 109.357 172.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.76 173.9 43.36 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 111.53 -0.628 . . . . 62.53 111.53 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -108.45 149.25 29.03 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.254 0.622 . . . . 73.23 109.8 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -70.51 97.72 0.63 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 111.202 -0.759 . . . . 53.02 111.202 174.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 40.4 p -67.43 98.94 0.69 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.439 0.696 . . . . 62.1 110.931 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -79.75 93.99 5.67 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.777 -0.823 . . . . 73.44 108.777 177.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -108.38 134.13 51.6 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 108.236 -1.024 . . . . 75.11 108.236 170.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -73.97 93.34 2.21 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.952 0.901 . . . . 70.02 109.253 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -70.04 101.0 1.71 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.308 -0.86 . . . . 73.4 110.199 -177.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -67.01 140.49 57.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.099 -0.955 . . . . 64.43 110.598 -177.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.055 0 O-C-N 124.271 0.982 . . . . 72.43 110.728 -177.581 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.442 ' O ' ' HG3' ' E' ' 112' ' ' GLN . 10.6 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 108.998 -0.742 . . . . 74.51 108.998 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 51.8 m -149.04 95.41 2.39 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.929 0.891 . . . . 73.1 109.412 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -124.77 84.39 2.27 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.191 0.996 . . . . 74.15 108.348 170.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -82.82 100.34 10.26 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 114.722 -1.126 . . . . 73.52 110.404 -172.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -168.32 163.02 12.88 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.354 1.062 . . . . 74.23 109.194 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -72.71 87.12 1.25 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.141 -1.059 . . . . 64.22 108.141 168.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 24.6 p -87.02 133.45 33.58 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.046 -0.979 . . . . 75.13 108.37 175.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -58.01 -21.15 43.58 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 124.343 1.057 . . . . 71.54 112.33 -174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 16.9 ptm 58.96 -179.76 0.08 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 126.571 1.949 . . . . 72.54 114.419 171.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 57.0 m -140.34 122.22 15.51 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.248 -1.019 . . . . 71.44 108.248 178.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -123.95 141.0 52.43 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.321 -0.622 . . . . 75.44 109.321 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.473 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 59.8 tt0 -153.97 141.69 19.98 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.827 0.851 . . . . 71.45 109.161 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.674 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -94.41 117.62 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 108.39 -0.967 . . . . 71.34 108.39 175.562 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -87.04 -48.87 7.74 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.285 -0.416 . . . . 63.31 110.119 178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 -164.34 140.84 6.33 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.683 -0.488 . . . . 75.34 109.683 -179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 82.0 mt -114.64 141.41 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 106.937 -1.505 . . . . 61.11 106.937 170.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 37.8 p90 -168.25 148.35 4.76 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 118.202 0.455 . . . . 73.14 111.825 -177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.2 m -74.24 126.82 31.46 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 109.071 -0.714 . . . . 73.12 109.071 170.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 19.2 mtpp -94.51 -41.0 9.58 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.385 -0.598 . . . . 64.01 109.385 175.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 19.3 t70 -139.62 141.46 37.09 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.771 -0.65 . . . . 74.14 110.533 -171.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.439 HD13 HG13 ' B' ' 78' ' ' VAL . 41.0 mm -135.81 143.09 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.161 1.384 . . . . 54.34 107.512 172.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 57.4 p -148.0 138.7 23.09 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.697 -0.853 . . . . 71.44 108.697 168.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 83.5 t80 -141.21 116.44 10.0 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 106.244 -1.761 . . . . 75.13 106.244 168.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -124.81 110.86 14.83 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 106.688 -1.597 . . . . 73.13 106.688 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -111.91 88.18 9.6 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 108.707 -0.849 . . . . 52.14 108.707 -178.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -65.95 -26.59 51.28 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 123.007 2.472 . . . . 71.04 112.447 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -120.81 28.31 8.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.774 0.829 . . . . 72.22 110.054 -178.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.531 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.94 -46.34 81.23 Favored Pre-proline 0 N--CA 1.489 1.504 0 C-N-CA 124.786 1.234 . . . . 54.24 113.669 171.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.421 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 84.1 Cg_endo -79.06 -15.15 13.14 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 121.717 1.611 . . . . 63.04 113.088 176.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.468 ' HB3' HE21 ' B' ' 33' ' ' GLN . 58.7 m80 -100.43 1.55 41.39 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.894 0.878 . . . . 72.13 112.899 -178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.46 -20.91 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 123.452 0.701 . . . . 62.0 111.786 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.06 -28.15 69.89 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.042 0.937 . . . . 63.13 111.851 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.468 HE21 ' HB3' ' B' ' 30' ' ' HIS . 42.9 mt-30 -67.37 -46.64 72.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.663 -0.698 . . . . 74.45 109.587 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.462 ' HB2' HD13 ' B' ' 68' ' ' LEU . 79.2 mttt -111.86 74.83 0.88 Allowed 'General case' 0 C--O 1.244 0.769 0 CA-C-N 114.828 -1.078 . . . . 62.4 111.355 -171.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.94 82.75 3.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.162 -1.051 . . . . 61.24 108.162 167.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 24.6 t90 -153.78 165.61 35.49 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.37 -0.832 . . . . 63.55 109.041 -171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -77.99 120.67 82.15 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.804 -0.813 . . . . 64.21 108.804 176.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.401 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 98.7 Cg_endo -77.36 154.59 32.03 Favored 'Trans proline' 0 C--N 1.371 1.758 0 C-N-CA 122.324 2.016 . . . . 64.32 112.068 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 22.1 mm-40 -64.75 115.4 5.23 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.02 -0.733 . . . . 74.33 109.02 173.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 5.8 p -83.8 122.32 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.607 -0.886 . . . . 72.44 108.607 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.568 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 93.4 mttt -126.44 100.38 6.24 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.604 -1.258 . . . . 62.02 107.604 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.462 HD22 ' HE1' ' E' ' 125' ' ' TYR . 1.5 pp -88.91 140.04 29.84 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.078 -0.965 . . . . 63.21 110.78 -173.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.806 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 9.0 m-20 -136.8 145.47 44.56 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.473 -1.677 . . . . 62.01 106.473 174.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.66 ' HG ' HG12 ' E' ' 123' ' ' VAL . 1.3 pt? -140.39 161.54 37.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.903 -1.147 . . . . 74.14 107.903 176.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.746 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 26.8 t70 -159.16 143.22 15.2 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.192 -0.67 . . . . 73.14 109.192 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -107.34 109.67 21.48 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.931 -1.137 . . . . 70.32 107.931 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.571 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -113.91 154.52 27.4 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.121 -1.066 . . . . 50.14 108.121 -174.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 25.5 p -143.78 162.7 35.36 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.356 0.598 . . . . 72.34 112.108 -169.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 24.0 t -162.87 151.49 14.46 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.368 1.467 . . . . 52.33 108.4 177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -123.14 127.3 48.49 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.13 -37.65 12.01 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 122.946 0.498 . . . . 73.34 110.047 177.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.93 -175.53 3.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.903 0.881 . . . . 71.45 110.758 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -72.98 124.47 25.54 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 114.963 -1.017 . . . . 74.54 108.631 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 68.69 11.95 8.51 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 125.072 1.349 . . . . 75.22 111.932 -176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.0 t -128.65 88.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.45 1.1 . . . . 52.11 108.171 176.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.498 ' HB2' HD11 ' B' ' 86' ' ' ILE . 3.5 t80 -97.85 166.21 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.101 -0.703 . . . . 62.24 109.101 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -140.3 100.1 3.81 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.097 -1.446 . . . . 72.51 107.097 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 41.4 t -95.8 137.47 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 122.985 0.514 . . . . 72.24 109.657 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.571 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 21.9 t -117.17 152.45 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.414 1.086 . . . . 71.35 109.131 177.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.457 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.2 OUTLIER -127.89 119.65 26.05 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.158 -1.423 . . . . 75.54 107.158 176.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.746 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 57.5 ttt180 -105.45 106.37 16.84 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.042 -0.725 . . . . 73.14 109.042 178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.42 ' HB ' HD11 ' B' ' 114' ' ' ILE . 39.2 t -106.33 111.91 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 108.329 -0.989 . . . . 71.25 108.329 176.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.806 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 7.0 m -106.05 125.94 51.6 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.357 -0.608 . . . . 54.42 109.357 178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.404 HG23 HD13 ' B' ' 114' ' ' ILE . 82.7 t -120.32 99.46 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 124.209 1.003 . . . . 73.45 109.345 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 86.4 m -86.84 147.84 25.64 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 114.991 -1.004 . . . . 74.23 109.312 173.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -147.64 152.49 37.96 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.986 0.514 . . . . 51.11 110.287 175.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.427 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 41.1 p -147.01 128.83 15.31 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 123.301 0.376 . . . . 74.44 111.726 -178.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.496 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 60.9 mt -91.42 100.65 13.39 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.222 -1.029 . . . . 72.34 108.222 175.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.51 -120.62 8.37 Favored Glycine 0 C--N 1.345 1.054 0 CA-C-N 115.211 -0.904 . . . . 52.32 111.885 -176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -102.61 22.73 13.1 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 121.668 0.747 . . . . 73.22 110.145 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -137.1 144.49 43.1 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.761 0.824 . . . . 74.45 109.298 -177.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -68.87 136.86 53.3 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.751 0.31 . . . . 70.03 110.917 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.13 -65.29 1.03 Allowed 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.411 -0.959 . . . . 51.32 108.411 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -151.27 166.78 29.86 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 114.658 -1.155 . . . . 72.53 110.018 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 90.2 mt -135.92 109.73 8.13 Favored 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 106.79 -1.559 . . . . 73.23 106.79 178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.5 t -118.89 141.46 48.63 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 108.509 -0.923 . . . . 73.13 108.509 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -149.45 129.05 13.13 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.534 -0.913 . . . . 71.43 108.534 176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.439 HG13 HD13 ' B' ' 21' ' ' ILE . 79.1 t -125.03 148.57 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 123.642 0.777 . . . . 73.34 109.211 178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.4 mt-30 -127.63 99.58 5.64 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 174.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -89.09 109.22 20.1 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.136 -0.938 . . . . 71.55 109.325 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.15 169.65 26.74 Favored Glycine 0 C--O 1.24 0.53 0 N-CA-C 111.987 -0.445 . . . . 42.4 111.987 176.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.03 130.92 2.12 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.271 -0.731 . . . . 51.52 111.271 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 39.1 mt -86.77 127.67 40.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -134.78 135.59 41.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.234 1.014 . . . . 63.32 109.282 -175.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 6.6 m -88.57 121.51 31.02 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.115 0.966 . . . . 74.41 108.702 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.498 HD11 ' HB2' ' B' ' 56' ' ' TYR . 1.8 pp -134.55 130.4 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 123.09 0.556 . . . . 63.43 110.545 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.99 153.09 33.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.672 0.789 . . . . 72.23 109.939 -177.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.03 -53.84 4.51 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 123.641 0.588 . . . . 62.52 113.27 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.53 133.18 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 125.048 1.339 . . . . 72.3 111.526 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -150.58 176.0 11.39 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.58 0.752 . . . . 72.24 111.411 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.13 -136.76 35.21 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 114.066 -1.425 . . . . 64.44 113.199 178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.5 m -65.59 -37.54 86.94 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.885 0.874 . . . . 71.1 111.079 -175.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -65.26 -27.79 68.89 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.115 -1.402 . . . . 71.32 111.006 -172.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.4 -33.39 69.44 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.215 0.606 . . . . 62.4 110.604 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.09 -29.35 70.49 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.189 0.596 . . . . 61.04 111.379 176.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -76.74 -23.02 53.01 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.332 0.653 . . . . 75.34 111.344 178.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.72 -64.97 1.0 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.736 0.414 . . . . 64.13 110.545 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 57.7 mt -80.05 -28.56 39.23 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.889 0.476 . . . . 73.24 111.766 -172.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.1 -4.5 66.74 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-O 119.559 -0.578 . . . . 52.42 113.846 -175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 -57.05 0.34 Allowed 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 117.87 0.835 . . . . 72.01 112.351 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -68.33 -47.56 67.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.268 0.627 . . . . 75.44 112.126 -172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.4 m -65.88 -46.38 65.15 Favored Pre-proline 0 CA--C 1.561 1.382 0 CA-C-O 118.641 -0.695 . . . . 71.22 111.377 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.457 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 94.6 Cg_exo -50.84 -38.67 57.92 Favored 'Trans proline' 0 C--N 1.394 2.94 0 C-N-CA 122.491 2.127 . . . . 62.42 113.791 166.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.545 HD21 ' HA ' ' B' ' 132' ' ' ASN . 1.7 m120 -64.4 -29.73 70.79 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 112.243 0.46 . . . . 64.23 112.243 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -71.73 -42.21 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 N-CA-C 109.724 -0.473 . . . . 63.22 109.724 172.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.19 -17.41 54.95 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.124 -0.944 . . . . 75.33 111.756 -171.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.403 ' HZ ' ' HB3' ' B' ' 128' ' ' LEU . 65.1 t80 -61.97 -49.78 83.87 Favored Pre-proline 0 CA--C 1.556 1.209 0 CA-C-O 117.88 -1.057 . . . . 72.12 113.592 -172.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -52.04 -39.38 70.06 Favored 'Trans proline' 0 C--N 1.389 2.66 0 C-N-CA 122.44 2.093 . . . . 52.01 113.873 176.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -73.19 -46.57 49.85 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.642 -0.708 . . . . 74.31 111.114 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.44 78.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 123.616 0.766 . . . . 64.25 110.387 176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -64.66 -50.8 65.65 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.08 1.352 . . . . 75.03 110.549 -178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.63 -34.68 78.41 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.162 0.585 . . . . 73.24 109.931 -178.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 28.1 m -59.74 -52.83 63.79 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.751 0.82 . . . . 35.13 111.405 174.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.42 HD11 ' HB ' ' B' ' 62' ' ' VAL . 69.2 mt -58.25 -56.06 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 123.661 0.785 . . . . 73.1 110.805 178.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 24.1 m -64.77 -31.94 73.39 Favored 'General case' 0 CA--C 1.546 0.799 0 O-C-N 124.154 0.909 . . . . 74.1 111.582 -169.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.419 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 45.6 t -61.79 -50.4 72.49 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.01 0.524 . . . . 74.4 110.039 174.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 19.9 mmt -68.85 -34.09 74.89 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.4 0.68 . . . . 73.41 111.232 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.08 -43.16 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.843 0.857 . . . . 64.34 110.309 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 73.1 m -67.93 -30.34 69.63 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.367 -0.833 . . . . 71.13 111.995 176.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.524 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 92.5 mtt-85 -68.38 -28.09 66.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.409 0.684 . . . . 74.51 110.927 176.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.78 17.09 59.88 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 114.334 0.494 . . . . 63.41 114.334 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.566 HG21 ' HD3' ' A' ' 15' ' ' ARG . 4.1 p 69.67 12.31 8.06 Favored 'General case' 0 N--CA 1.495 1.822 0 C-N-CA 126.049 1.74 . . . . 73.03 113.233 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.84 144.56 30.42 Favored Pre-proline 0 C--O 1.241 0.627 0 N-CA-C 109.162 -0.681 . . . . 72.25 109.162 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.58 146.29 54.34 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.944 2.43 . . . . 60.11 111.676 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.428 ' HG2' ' HB2' ' C' ' 119' ' ' SER . 18.7 mp0 -64.48 114.43 4.33 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.514 0.509 . . . . 74.21 110.978 -175.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -107.26 85.06 2.07 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 107.575 -1.269 . . . . 63.25 107.575 174.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -101.47 121.59 42.23 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 114.14 -1.391 . . . . 71.44 108.148 176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.403 ' HB3' ' HZ ' ' B' ' 107' ' ' PHE . 0.2 OUTLIER -76.96 139.66 40.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.281 0.632 . . . . 61.12 109.548 -172.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.28 154.12 84.05 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 124.02 0.928 . . . . 51.33 111.047 179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -55.13 92.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.252 2.635 . . . . 70.32 112.567 178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.4 m -93.51 111.92 25.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.492 -0.776 . . . . 74.14 109.499 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.545 ' HA ' HD21 ' B' ' 104' ' ' ASN . 2.1 m-20 -82.06 107.23 14.6 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.421 -0.955 . . . . 53.32 108.421 177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -58.83 -37.19 75.88 Favored 'General case' 0 CA--C 1.547 0.864 0 O-C-N 124.363 1.04 . . . . 72.1 110.581 -177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -62.61 -52.74 62.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.872 -1.058 . . . . 73.43 110.724 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.39 -37.88 85.02 Favored 'General case' 0 N--CA 1.479 0.985 0 O-C-N 123.87 0.731 . . . . 75.21 112.013 -174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.593 HD22 ' HD2' ' E' ' 125' ' ' TYR . 56.3 tp -59.31 -49.01 79.48 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 124.193 0.933 . . . . 72.33 110.446 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -77.5 -16.71 58.56 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.721 -0.672 . . . . 74.15 111.378 -174.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 57.2 mtm -66.85 -15.44 63.62 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 122.749 0.42 . . . . 65.24 111.993 174.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -77.85 -28.28 50.05 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.676 0.79 . . . . 64.02 110.436 173.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -70.08 -30.67 67.96 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.175 0.59 . . . . 74.4 109.598 169.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 49.6 mt -90.35 20.28 4.58 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.271 1.029 . . . . 74.44 111.276 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -70.26 97.69 1.26 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 107.666 -1.235 . . . . 73.4 107.666 175.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -133.36 114.27 13.53 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.221 1.008 . . . . 71.34 109.044 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 56.26 82.34 0.11 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.646 1.179 . . . . 60.01 110.123 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -85.38 93.0 8.63 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.227 -0.657 . . . . 74.34 109.227 175.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.08 86.92 0.13 Allowed Glycine 0 C--N 1.346 1.125 0 N-CA-C 111.147 -0.781 . . . . 70.42 111.147 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.72 128.61 14.42 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.991 -1.115 . . . . 72.52 107.991 -178.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.78 162.65 32.23 Favored Glycine 0 C--N 1.347 1.139 0 O-C-N 123.006 0.191 . . . . 61.32 113.103 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.9 t -157.95 147.29 19.69 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.647 1.179 . . . . 62.53 108.987 177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -137.57 134.16 35.28 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.47 0.708 . . . . 74.21 109.477 176.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -163.69 166.06 22.61 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.127 0.971 . . . . 65.22 109.041 177.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 m80 72.44 75.36 0.15 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.881 1.272 . . . . 75.23 109.932 177.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -68.46 151.54 46.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 114.793 -1.094 . . . . 74.25 111.469 -176.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -162.21 95.34 0.94 Allowed 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.582 -0.896 . . . . 74.32 108.582 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.131 0 N-CA-C 108.523 -0.917 . . . . 74.31 108.523 179.692 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.1 mtt . . . . . 0 N--CA 1.475 0.809 0 CA-C-O 121.679 0.752 . . . . 73.44 109.283 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.8 t -103.75 -29.17 11.21 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.015 -0.993 . . . . 73.14 108.848 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.08 157.24 33.13 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 123.705 0.802 . . . . 73.02 109.482 170.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -150.35 153.62 36.36 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.445 0.698 . . . . 65.45 109.793 -175.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.49 ' HA ' ' OE1' ' C' ' 144' ' ' GLN . 19.0 m120 -122.57 28.04 7.54 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.396 0.678 . . . . 70.31 111.496 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -76.12 86.18 2.98 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.624 0.77 . . . . 74.41 109.571 173.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.546 ' HB ' ' HA ' ' C' ' 145' ' ' ALA . 4.1 m -144.99 174.53 10.94 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 108.83 -0.804 . . . . 72.42 108.83 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.477 ' H ' HG22 ' C' ' 7' ' ' THR . 7.7 mp0 -61.39 175.36 0.59 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 124.431 1.092 . . . . 72.33 112.31 -177.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 51.2 ttp 65.4 119.61 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.905 1.282 . . . . 71.11 111.462 -168.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 29.5 m -118.6 102.06 8.59 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.098 -1.445 . . . . 51.41 107.098 169.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -118.6 122.79 43.45 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.687 0.795 . . . . 71.14 109.242 -175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -137.28 136.19 37.81 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 109.513 -0.551 . . . . 71.44 109.513 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.605 HD11 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -68.55 123.45 21.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 109.04 -0.726 . . . . 52.41 109.04 172.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -103.25 -47.96 4.16 Favored 'General case' 0 C--O 1.242 0.698 0 CA-C-N 115.723 -0.671 . . . . 72.21 109.76 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.506 HH22 ' CG1' ' F' ' 134' ' ' ILE . 20.4 ttt180 -173.24 151.98 2.16 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 123.651 0.595 . . . . 73.14 110.407 -176.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.605 HG13 HD11 ' C' ' 13' ' ' ILE . 89.6 mt -138.26 140.42 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 124.539 1.136 . . . . 62.32 108.354 176.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -172.02 158.53 4.72 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.762 0.791 . . . . 74.51 111.364 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.426 HG22 HE22 ' C' ' 80' ' ' GLN . 76.1 p -78.76 106.13 10.54 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.444 -1.253 . . . . 70.21 109.05 177.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.46 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 5.3 mmmm -66.85 -42.76 85.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.751 0.786 . . . . 61.0 109.638 172.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -144.53 141.47 29.53 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.502 -1.227 . . . . 72.31 109.341 -175.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 91.2 mt -135.82 146.2 29.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 107.182 -1.414 . . . . 43.44 107.182 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -154.82 149.27 26.25 Favored 'General case' 0 C--O 1.242 0.688 0 CA-C-O 121.229 0.538 . . . . 65.11 109.886 171.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -146.61 144.29 29.42 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.805 -1.089 . . . . 71.41 108.064 172.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -137.79 139.56 40.09 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.623 1.169 . . . . 74.13 107.89 177.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.31 79.29 66.25 Favored Pre-proline 0 C--O 1.241 0.652 0 N-CA-C 107.811 -1.181 . . . . 73.03 107.811 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.64 -22.04 64.89 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.641 2.227 . . . . 61.31 111.844 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.648 ' HB3' ' HB2' ' C' ' 30' ' ' HIS . 93.5 m-20 -125.91 47.24 2.27 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 124.448 1.099 . . . . 62.14 109.972 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -58.15 -54.96 50.29 Favored Pre-proline 0 CA--C 1.571 1.754 0 C-N-CA 124.279 1.031 . . . . 64.13 112.157 176.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 21.0 Cg_exo -66.85 -26.44 44.66 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 121.976 1.784 . . . . 43.23 112.74 175.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.648 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 21.2 m170 -66.39 -16.35 64.01 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.26 1.024 . . . . 71.44 113.304 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.627 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 7.9 p -48.59 -33.66 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 112.757 0.651 . . . . 73.54 112.757 178.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.66 ' HE2' ' HB3' ' E' ' 132' ' ' TYR . 92.6 m-85 -76.13 -30.53 58.24 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.473 0.709 . . . . 70.53 111.939 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -112.88 3.51 16.38 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.995 0.918 . . . . 74.35 112.866 -163.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.627 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -89.97 172.73 8.65 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.425 0.557 . . . . 60.44 111.061 -172.841 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.421 ' HB3' HD22 ' C' ' 68' ' ' LEU . 20.6 t70 -83.9 133.36 34.72 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 124.197 0.999 . . . . 75.1 110.451 -177.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 38.3 t90 -75.31 78.26 2.4 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.705 0.802 . . . . 73.24 109.995 175.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.438 ' HB3' HD13 ' C' ' 68' ' ' LEU . 49.6 tt0 -164.48 78.49 1.44 Allowed Pre-proline 0 C--O 1.243 0.719 0 N-CA-C 107.28 -1.378 . . . . 73.34 107.28 169.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.418 ' HG2' ' HA ' ' E' ' 139' ' ' LEU . 73.7 Cg_endo -85.22 106.62 0.98 Allowed 'Trans proline' 0 C--N 1.362 1.286 0 C-N-CA 122.285 1.99 . . . . 70.25 111.885 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -84.29 92.14 7.92 Favored 'General case' 0 C--O 1.244 0.792 0 N-CA-C 107.372 -1.344 . . . . 61.52 107.372 173.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.414 ' O ' HG12 ' E' ' 142' ' ' ILE . 89.3 t -84.71 110.54 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 113.904 -1.498 . . . . 74.31 109.385 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -93.05 115.68 28.34 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.323 -0.621 . . . . 74.33 109.323 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.39 126.7 34.56 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 107.06 -1.459 . . . . 74.43 107.06 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 16.1 t70 -120.32 132.93 55.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.414 -0.958 . . . . 73.23 108.414 174.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.5 tt -134.35 117.83 16.8 Favored 'General case' 0 C--O 1.238 0.455 0 N-CA-C 107.392 -1.336 . . . . 71.32 107.392 176.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.61 149.9 52.34 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.962 1.305 . . . . 64.23 108.381 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.8 t -142.08 153.42 44.16 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.058 0.456 . . . . 75.32 110.032 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.96 178.35 10.03 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.654 1.182 . . . . 53.21 108.635 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.6 p -145.73 159.63 42.89 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.036 0.535 . . . . 74.44 110.333 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 36.0 t -145.65 126.91 14.82 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.912 0.885 . . . . 62.33 108.662 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -85.38 117.64 24.43 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.124 -0.695 . . . . 74.25 109.124 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' C' ' 57' ' ' GLU . 25.7 mt -100.93 -26.89 13.58 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.967 0.907 . . . . 73.45 110.48 -177.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.03 -170.54 1.96 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.14 0.976 . . . . 41.32 109.918 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -69.7 101.7 1.73 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 115.564 -0.743 . . . . 73.23 109.606 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 74.82 6.92 4.38 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.538 1.535 . . . . 75.23 112.532 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.2 t -96.62 113.68 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 108.442 -0.947 . . . . 72.21 108.442 173.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -124.36 125.31 44.1 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.108 0.963 . . . . 74.0 109.307 -177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.72 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.2 tt0 -86.08 116.67 24.44 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.565 -0.902 . . . . 63.42 108.565 167.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.22 125.51 46.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.636 -1.246 . . . . 63.32 107.636 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.37 106.31 20.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.946 -1.131 . . . . 45.42 107.946 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -105.66 98.33 8.04 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.425 -0.954 . . . . 62.34 108.425 -176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -83.14 124.19 30.26 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.076 -0.966 . . . . 55.43 109.627 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 22.5 t -119.76 124.83 73.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.768 -1.197 . . . . 64.15 107.768 169.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 22.0 m -127.64 125.0 39.33 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 122.987 0.515 . . . . 70.35 109.655 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.619 HG23 HD13 ' C' ' 114' ' ' ILE . 90.1 t -107.28 119.96 57.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.743 -0.836 . . . . 75.31 108.743 173.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.433 HG23 HD23 ' C' ' 75' ' ' LEU . 3.5 m -99.7 139.52 35.24 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.229 -1.397 . . . . 64.45 107.229 167.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.46 107.22 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 107.046 -1.464 . . . . 72.54 107.046 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 58.3 p -159.85 150.96 19.43 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.425 0.453 . . . . 73.4 111.29 -172.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' C' ' 37' ' ' GLN . 66.0 tp -83.76 -48.17 10.39 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 108.701 -0.851 . . . . 63.53 108.701 165.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -173.56 -82.05 0.05 OUTLIER Glycine 0 C--N 1.346 1.114 0 N-CA-C 110.553 -1.019 . . . . 52.24 110.553 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -88.95 -31.94 17.91 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 108.954 -0.758 . . . . 74.42 108.954 173.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.93 87.49 4.11 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 108.415 -0.957 . . . . 54.45 108.415 170.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 78.6 m -88.75 121.1 30.77 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 115.836 -0.62 . . . . 62.45 109.813 174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.87 -61.73 1.9 Allowed 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.923 -0.769 . . . . 74.42 108.923 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.464 ' HZ ' HD23 ' C' ' 126' ' ' LEU . 41.7 p90 -158.89 171.87 19.26 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.72 0.772 . . . . 63.1 112.112 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.433 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -137.28 135.45 37.15 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 106.235 -1.765 . . . . 72.43 106.235 171.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.501 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.9 t -137.98 136.76 37.26 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.279 -1.008 . . . . 54.15 108.279 177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -149.2 120.96 8.09 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 122.868 0.467 . . . . 64.34 110.053 -175.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.26 125.73 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.312 1.045 . . . . 52.43 109.585 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 1.7 mp0 -100.15 91.83 4.94 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 107.569 -1.271 . . . . 72.23 107.569 175.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.426 HE22 HG22 ' C' ' 18' ' ' THR . 8.4 tp-100 -82.12 100.13 9.62 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.015 -0.539 . . . . 73.41 109.59 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.51 145.54 22.99 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 110.918 -0.873 . . . . 60.14 110.918 176.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.521 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.63 121.49 1.39 Allowed Glycine 0 CA--C 1.5 -0.902 0 N-CA-C 111.281 -0.727 . . . . 52.43 111.281 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 18.3 mm -80.31 128.09 38.9 Favored 'Isoleucine or valine' 0 C--O 1.246 0.907 0 N-CA-C 108.067 -1.086 . . . . 41.42 108.067 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -138.65 139.43 38.49 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.272 0.629 . . . . 63.42 109.483 178.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.7 p -91.73 104.7 17.13 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.188 -1.041 . . . . 73.15 108.188 170.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 56.6 mt -114.45 100.18 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.15 -1.056 . . . . 73.01 108.15 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.22 161.47 31.09 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.999 0.92 . . . . 63.4 110.364 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.47 -18.39 33.79 Favored Glycine 0 C--N 1.349 1.296 0 N-CA-C 114.365 0.506 . . . . 54.1 114.365 168.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.5 tt -117.78 144.82 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 124.282 1.033 . . . . 74.11 110.218 -171.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -146.12 149.74 34.6 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.929 0.491 . . . . 64.4 111.689 -167.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -143.03 24.72 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.383 -0.826 . . . . 34.04 113.486 172.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.3 p -64.22 -23.94 67.49 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.165 0.986 . . . . 53.31 111.46 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -58.26 -57.38 13.14 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.648 0.779 . . . . 70.0 110.23 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.441 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.8 ptt? -73.12 -25.91 61.03 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.451 -0.795 . . . . 63.04 110.956 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.62 -36.43 78.59 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.595 0.56 . . . . 70.22 110.485 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -67.36 -30.94 70.87 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.528 -0.76 . . . . 74.12 111.064 176.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -74.07 -64.43 1.01 Allowed 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.159 -0.473 . . . . 64.14 110.307 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.5 pp -73.79 -16.32 61.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 112.558 0.577 . . . . 70.13 112.558 -173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.44 -9.92 37.27 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-O 119.449 -0.64 . . . . 62.13 114.018 -177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.01 -52.56 0.28 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.967 0.884 . . . . 64.04 112.571 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -73.18 -51.55 17.41 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 122.906 0.482 . . . . 70.13 112.2 -172.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.509 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.6 m -61.89 -47.12 92.24 Favored Pre-proline 0 CA--C 1.563 1.457 0 C-N-CA 123.413 0.685 . . . . 62.13 110.842 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 82.0 Cg_exo -53.1 -36.62 77.38 Favored 'Trans proline' 0 C--N 1.395 2.979 0 C-N-CA 122.603 2.202 . . . . 72.32 114.513 168.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.454 HD21 ' ND2' ' C' ' 132' ' ' ASN . 27.5 t-20 -63.3 -38.54 91.57 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.523 0.729 . . . . 73.44 110.974 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -63.07 -39.18 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 123.443 0.697 . . . . 63.1 110.417 175.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.521 HD21 ' HA3' ' C' ' 82' ' ' GLY . 86.1 mt -80.67 -28.94 36.66 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.491 -0.777 . . . . 71.34 112.415 -173.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -54.14 -47.12 98.23 Favored Pre-proline 0 CA--C 1.558 1.276 0 CA-C-O 118.012 -0.994 . . . . 54.04 113.603 -173.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_exo -53.58 -41.32 74.62 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.546 2.164 . . . . 73.15 114.155 177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -66.56 -45.52 79.08 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.36 0.664 . . . . 74.03 110.504 -179.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -36.04 82.67 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 115.224 -0.898 . . . . 75.31 110.826 176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.0 ttt180 -64.55 -46.99 80.46 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.455 1.502 . . . . 75.55 110.355 -177.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -73.78 -34.4 64.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.96 0.504 . . . . 64.03 110.118 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.8 t -66.42 -27.01 67.5 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.84 0.456 . . . . 63.22 111.017 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.619 HD13 HG23 ' C' ' 64' ' ' VAL . 77.0 mt -75.27 -54.08 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.922 -0.581 . . . . 42.43 109.916 171.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.8 m -62.35 -29.49 70.5 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.256 0.622 . . . . 74.41 111.696 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 45.0 t -67.01 -49.41 65.38 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 109.101 -0.703 . . . . 54.42 109.101 174.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.537 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.58 -35.18 77.1 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.13 0.972 . . . . 60.24 112.308 178.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 76.4 t -62.52 -47.5 92.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.42 0.688 . . . . 60.44 109.683 174.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.428 ' HB2' ' HG2' ' B' ' 125' ' ' GLN . 37.9 t -69.13 -27.04 65.21 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.155 -0.93 . . . . 73.41 111.211 179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 89.2 mtt-85 -71.34 -34.23 70.33 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.468 0.707 . . . . 73.02 109.602 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.14 1.99 88.45 Favored Glycine 0 C--N 1.352 1.468 0 O-C-N 123.537 0.523 . . . . 72.21 112.494 172.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 67.8 p 60.15 35.79 21.11 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 126.591 1.956 . . . . 63.32 113.354 176.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -92.16 154.91 43.19 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.595 0.758 . . . . 72.5 109.817 173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.91 169.75 8.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 123.345 2.696 . . . . 74.25 114.376 -177.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.559 ' NE2' HD21 ' C' ' 127' ' ' ASN . 47.5 tp60 -60.22 113.81 2.56 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.476 -1.238 . . . . 71.4 111.389 -173.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.464 HD23 ' HZ ' ' C' ' 74' ' ' PHE . 33.3 tp -134.88 115.12 13.27 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.791 0.836 . . . . 74.45 108.925 178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.559 HD21 ' NE2' ' C' ' 125' ' ' GLN . 5.0 m120 -129.95 130.43 45.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.255 1.022 . . . . 70.42 108.404 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 88.9 mt -77.2 140.45 40.14 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.731 0.412 . . . . 73.21 110.801 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.19 137.8 78.76 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 123.658 0.783 . . . . 51.1 110.675 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -67.67 107.86 1.54 Allowed 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 122.847 2.364 . . . . 71.23 112.211 177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.43 110.93 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 108.326 -0.99 . . . . 65.1 108.326 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.454 ' ND2' HD21 ' C' ' 104' ' ' ASN . 15.5 m120 -103.24 89.2 3.33 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.524 0.73 . . . . 52.23 110.823 -175.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -72.76 -31.85 65.21 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.771 0.796 . . . . 75.41 109.095 172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -56.84 -53.0 62.85 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 113.997 -1.456 . . . . 62.45 111.132 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.53 ' HA ' ' HB3' ' C' ' 138' ' ' MET . . . -64.26 -28.27 69.61 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.521 0.728 . . . . 64.2 112.354 -174.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.591 ' HB2' HD21 ' E' ' 148' ' ' LEU . 45.6 tp -56.09 -58.39 8.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.876 0.871 . . . . 72.22 110.691 177.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.8 -14.59 57.94 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.204 -0.907 . . . . 73.14 111.616 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.53 ' HB3' ' HA ' ' C' ' 135' ' ' ALA . 24.4 ttt -71.71 -31.21 66.49 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.792 0.437 . . . . 60.34 110.607 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -57.71 -38.7 75.7 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.236 -0.283 . . . . 74.12 110.236 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -72.59 -85.88 0.03 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 123.657 0.783 . . . . 73.25 111.232 171.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 11.7 tp -102.35 -177.33 3.37 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.287 1.035 . . . . 74.04 110.596 -169.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.421 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 28.3 tt0 95.21 -15.61 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 126.483 1.913 . . . . 72.41 111.895 174.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -83.09 159.01 22.2 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 122.891 0.477 . . . . 63.2 110.17 173.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.49 ' OE1' ' HA ' ' C' ' 5' ' ' ASN . 6.1 tp-100 58.36 75.38 0.39 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 124.597 1.186 . . . . 71.34 110.215 -176.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.546 ' HA ' ' HB ' ' C' ' 7' ' ' THR . . . -175.55 -176.55 0.9 Allowed 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.51 -1.223 . . . . 54.11 108.968 -175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 101.63 -143.6 16.12 Favored Glycine 0 N--CA 1.467 0.749 0 O-C-N 123.152 0.282 . . . . 61.34 112.931 172.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -144.23 172.68 12.57 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.96 0.904 . . . . 73.34 110.634 -174.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.55 108.86 0.22 Allowed Glycine 0 C--N 1.35 1.345 0 CA-C-N 116.197 -0.456 . . . . 55.33 112.133 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -147.77 152.51 37.83 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.782 0.833 . . . . 74.5 109.463 176.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -100.46 133.26 45.14 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.331 0.652 . . . . 73.13 109.716 176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.57 135.92 35.49 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 106.855 -1.535 . . . . 72.53 106.855 172.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -128.77 136.46 50.57 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 122.877 0.471 . . . . 63.33 110.101 -178.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -108.13 127.74 54.08 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.904 0.882 . . . . 74.41 109.143 172.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 10.7 40.88 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.714 0.806 . . . . 64.41 110.177 174.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 124.087 0.955 . . . . 43.41 110.771 178.535 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ttt . . . . . 0 N--CA 1.487 1.384 0 N-CA-C 109.236 -0.653 . . . . 70.02 109.236 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 37.8 t 72.4 154.86 0.15 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.975 1.31 . . . . 72.2 112.423 177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -78.81 91.51 4.74 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.951 -1.022 . . . . 74.12 109.726 -174.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 86.9 mm-40 -71.95 93.47 1.36 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.555 0.742 . . . . 71.22 110.662 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -76.49 124.1 27.05 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.15 -0.932 . . . . 72.41 108.921 177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.553 HD22 ' HB1' ' D' ' 87' ' ' ALA . 52.1 t30 -151.7 144.12 24.13 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.914 -0.772 . . . . 74.41 108.914 -177.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.0 t -107.42 173.66 6.23 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.909 . . . . 64.01 109.881 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 64.91 86.32 0.13 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.659 1.184 . . . . 73.1 109.144 178.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.4 ttp -32.24 127.24 0.25 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 125.109 1.364 . . . . 71.41 113.996 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 90.3 m -138.46 122.08 17.42 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.06 0.944 . . . . 70.1 108.622 175.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -141.98 101.18 3.89 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 108.181 -1.044 . . . . 71.44 108.181 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -122.04 127.38 50.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.067 0.547 . . . . 63.12 110.086 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 mp -75.37 112.21 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 107.983 -1.117 . . . . 75.03 107.983 174.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -90.97 -47.81 7.36 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-O 119.528 -0.273 . . . . 74.55 111.716 -177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.413 ' HD2' ' HZ ' ' C' ' 32' ' ' PHE . 42.6 ttt85 -173.12 132.92 0.51 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.563 0.209 . . . . 63.03 111.563 -173.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.3 134.45 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 107.513 -1.292 . . . . 74.5 107.513 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -162.83 177.83 8.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.893 0.854 . . . . 62.35 111.641 -177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 72.1 p -109.72 118.96 37.92 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-N 114.617 -1.174 . . . . 74.1 108.351 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 30.0 mtpt -85.46 -21.51 28.67 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 109.651 -0.5 . . . . 73.14 109.651 175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 25.1 t70 -155.65 140.57 17.25 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.284 1.034 . . . . 72.32 108.657 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.537 HD12 ' HG3' ' C' ' 117' ' ' MET . 48.8 mt -138.11 146.97 26.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.521 -1.289 . . . . 75.41 107.521 173.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.6 t -153.24 140.38 19.4 Favored 'General case' 0 C--O 1.239 0.516 0 O-C-N 123.748 0.655 . . . . 45.34 110.329 172.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.495 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 91.5 t80 -142.85 135.98 28.27 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 106.714 -1.587 . . . . 75.1 106.714 170.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.661 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 42.4 mt-10 -134.33 150.75 50.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.151 0.98 . . . . 41.23 108.538 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.63 77.69 10.29 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.745 -1.206 . . . . 73.1 107.745 175.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.82 -32.91 17.4 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 122.777 2.318 . . . . 75.24 113.545 -171.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -114.75 41.7 2.31 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.935 0.894 . . . . 65.44 108.61 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.46 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -57.12 -56.28 35.32 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.64 1.348 . . . . 74.51 114.64 -169.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.45 -3.75 12.1 Favored 'Trans proline' 0 C--N 1.39 2.725 0 CA-C-N 122.11 1.789 . . . . 71.53 112.708 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.438 ' HA ' ' NE2' ' D' ' 33' ' ' GLN . 23.1 t-160 -84.65 -42.73 15.06 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.382 1.073 . . . . 64.51 110.393 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.8 p -82.04 -10.17 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 CA-C-O 121.18 0.514 . . . . 64.54 110.546 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.429 ' HZ ' ' HB2' ' F' ' 132' ' ' TYR . 31.0 t80 -59.65 -36.88 77.29 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.918 -0.583 . . . . 74.13 110.262 166.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.438 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 56.4 mt-30 -62.58 -32.81 73.86 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.51 110.594 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -98.93 70.59 1.84 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.011 -1.107 . . . . 72.53 108.011 172.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -71.71 88.8 0.99 Allowed 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 122.33 1.062 . . . . 60.23 109.666 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.542 ' HB3' HD21 ' D' ' 68' ' ' LEU . 67.8 t-105 -160.46 170.63 20.57 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.398 -1.273 . . . . 71.13 108.468 -174.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -71.75 110.09 6.96 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.937 1.295 . . . . 74.52 109.613 178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.547 ' HA ' HD13 ' D' ' 68' ' ' LEU . 27.4 Cg_exo -65.66 141.9 68.35 Favored 'Trans proline' 0 C--N 1.367 1.544 0 C-N-CA 123.227 2.618 . . . . 74.42 112.72 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -64.72 113.64 3.91 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 109.102 -0.703 . . . . 71.25 109.102 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -103.77 115.11 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.205 1.002 . . . . 61.43 110.593 -171.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -87.61 111.07 20.87 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 106.205 -1.776 . . . . 74.14 106.205 165.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.683 ' H ' HD23 ' D' ' 42' ' ' LEU . 2.0 pt? -96.76 148.2 23.14 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.451 -0.944 . . . . 64.54 108.451 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 26.4 t70 -151.38 151.94 32.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.775 0.43 . . . . 75.23 110.729 -178.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.08 154.18 49.27 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.891 0.876 . . . . 73.51 109.97 170.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.3 t70 -152.36 137.58 17.46 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.426 1.091 . . . . 70.02 108.433 -177.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 9.1 t -104.46 144.82 31.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 109.02 -0.733 . . . . 62.43 109.02 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.67 162.86 40.3 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.102 -1.073 . . . . 62.43 108.102 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.4 p -168.82 158.95 9.29 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.072 0.463 . . . . 73.42 111.916 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 25.7 p -152.11 119.58 6.01 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.685 1.194 . . . . 71.34 108.616 173.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -68.64 124.33 23.33 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.998 -0.742 . . . . 74.3 108.998 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 69.2 mt -87.96 -36.91 16.81 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.455 0.472 . . . . 72.21 109.925 -177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.99 -175.24 4.53 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.625 0.77 . . . . 61.22 111.061 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -61.97 124.51 20.98 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.938 -1.028 . . . . 70.12 109.141 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 19.0 m-20 66.54 -0.09 1.65 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.411 1.084 . . . . 74.14 113.112 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -116.05 118.06 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.051 0.94 . . . . 63.33 108.62 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -131.98 129.69 40.49 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.508 -0.923 . . . . 70.32 108.508 -178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -92.76 136.04 33.58 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.022 -1.103 . . . . 71.22 108.022 170.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' D' ' 102' ' ' CYS . 7.4 p -123.8 132.22 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.465 -0.939 . . . . 72.31 108.465 175.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.479 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 62.0 t -108.62 128.01 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 C-N-CA 123.383 0.673 . . . . 70.31 109.199 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -112.58 114.89 27.75 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.945 -1.131 . . . . 74.41 107.945 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 21.7 ttm-85 -97.14 133.09 42.25 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.645 -1.161 . . . . 73.02 108.623 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 57.9 t -131.73 120.2 44.2 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 N-CA-C 107.523 -1.288 . . . . 62.21 107.523 174.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 17.6 m -116.95 137.41 52.24 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.563 0.745 . . . . 72.52 110.245 -172.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.494 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 75.3 t -125.41 117.73 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.621 1.168 . . . . 50.32 109.33 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 63.9 m -110.44 92.51 4.07 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 107.792 -1.188 . . . . 64.52 107.792 170.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.02 132.5 43.52 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 109.347 -0.612 . . . . 62.0 109.347 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 50.3 m -148.48 135.02 19.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 108.155 -1.054 . . . . 71.12 108.155 177.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' D' ' 38' ' ' PRO . 20.0 tp -113.83 124.9 53.35 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 117.789 0.268 . . . . 75.03 110.489 178.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.13 -110.66 3.17 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 111.722 -0.551 . . . . 62.14 111.722 -177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.05 4.31 9.31 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.589 0.756 . . . . 73.33 110.149 175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.36 154.91 27.24 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.663 0.785 . . . . 45.31 109.435 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 83.0 m -74.62 141.28 44.68 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 110.045 -0.354 . . . . 64.42 110.045 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.416 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -97.7 -62.5 1.24 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.049 0.94 . . . . 74.33 109.421 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -158.17 138.23 12.36 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-N 115.373 -0.83 . . . . 75.44 109.235 175.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.661 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 92.3 mt -102.76 153.91 19.69 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.607 -0.886 . . . . 71.41 108.607 172.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.494 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 53.8 t -159.11 145.78 16.93 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.522 -0.547 . . . . 63.31 109.522 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -156.56 131.24 8.87 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.288 -1.005 . . . . 72.32 108.288 168.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 92.7 t -124.34 140.32 48.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 108.469 -0.937 . . . . 71.2 108.469 178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.53 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.9 mt-30 -118.89 86.21 2.5 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.989 -1.115 . . . . 61.52 107.989 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.441 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.5 tp-100 -80.26 97.5 7.0 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 113.673 -1.603 . . . . 71.43 108.925 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -96.79 141.65 15.73 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.856 -0.498 . . . . 62.24 111.856 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.06 138.01 7.24 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 111.726 -0.55 . . . . 71.02 111.726 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.47 130.12 39.32 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 C-N-CA 123.564 0.746 . . . . 60.35 109.064 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -132.67 142.48 49.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.564 0.746 . . . . 74.44 109.585 175.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -78.58 108.26 11.84 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.167 -1.049 . . . . 62.24 108.167 169.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 35.8 mm -106.7 100.4 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 107.093 -1.447 . . . . 72.53 107.093 176.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.706 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -144.88 158.24 43.87 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.136 -0.938 . . . . 74.1 109.709 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.52 -0.04 51.47 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.48 0.487 . . . . 63.3 113.75 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.22 128.67 68.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.918 1.287 . . . . 74.35 107.806 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 179.83 6.23 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.668 0.787 . . . . 52.54 111.245 -177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.1 -141.96 29.88 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-N 115.474 -0.785 . . . . 75.31 113.218 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 35.3 m -78.33 -18.94 54.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.599 0.76 . . . . 70.01 110.429 177.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.83 -46.4 85.27 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.347 0.659 . . . . 72.52 110.745 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.4 ppp? -69.59 -26.7 64.59 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 123.405 0.441 . . . . 50.34 110.758 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.58 -46.92 71.25 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.376 0.671 . . . . 74.33 110.947 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -73.79 -38.15 64.72 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 122.975 0.51 . . . . 70.13 110.737 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -63.91 -42.35 97.43 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.029 0.532 . . . . 53.11 110.953 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tt -78.49 -33.31 48.3 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.294 0.638 . . . . 62.11 109.613 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.23 -22.43 58.97 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 116.138 -0.483 . . . . 74.22 114.281 -173.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.51 -52.89 0.88 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.493 0.647 . . . . 60.11 112.024 -172.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -68.7 -43.7 75.5 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.658 0.614 . . . . 71.45 112.658 -173.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.468 ' HB3' HG11 ' D' ' 58' ' ' VAL . 69.5 m -69.17 -43.05 23.7 Favored Pre-proline 0 CA--C 1.567 1.599 0 C-N-CA 122.943 0.497 . . . . 71.02 111.524 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -55.41 -34.48 89.28 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.765 2.31 . . . . 63.1 113.878 165.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -66.44 -26.52 67.25 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.708 0.803 . . . . 72.21 111.01 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 39.4 mm -69.4 -41.23 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 CA-C-O 121.62 0.724 . . . . 75.43 109.739 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.441 HD13 ' O ' ' D' ' 80' ' ' GLN . 94.4 mt -78.92 -14.41 59.24 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.688 -1.142 . . . . 63.13 111.836 -175.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.414 ' HB3' ' HD3' ' D' ' 108' ' ' PRO . 55.7 t80 -61.98 -47.99 89.74 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.769 1.228 . . . . 73.54 113.745 -173.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' D' ' 107' ' ' PHE . 37.6 Cg_exo -59.98 -33.7 95.42 Favored 'Trans proline' 0 C--N 1.39 2.713 0 C-N-CA 121.852 1.701 . . . . 71.44 112.682 175.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -76.18 -31.64 58.61 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.557 0.743 . . . . 74.22 111.73 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.39 -56.26 19.98 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.076 0.55 . . . . 72.44 110.098 175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -67.81 -32.42 72.95 Favored 'General case' 0 C--N 1.353 0.754 0 CA-C-N 114.508 -1.224 . . . . 74.22 110.787 -174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -59.29 -50.99 71.86 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.219 0.949 . . . . 73.44 110.155 174.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.5 t -58.61 -42.59 88.49 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 123.862 0.726 . . . . 74.25 110.867 -178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.421 HG12 ' SG ' ' D' ' 76' ' ' CYS . 73.8 mt -61.44 -52.53 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 123.342 0.657 . . . . 72.13 110.34 175.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.51 HG23 ' HG3' ' D' ' 125' ' ' GLN . 99.1 m -53.6 -47.33 70.29 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.553 1.141 . . . . 75.0 110.999 -176.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 32.2 t -63.82 -42.05 97.74 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.5 -1.227 . . . . 73.32 110.322 -175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 73.8 mtm -69.61 -30.64 68.43 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.089 0.556 . . . . 64.23 111.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.402 HG23 ' O ' ' D' ' 114' ' ' ILE . 72.3 t -74.02 -37.86 48.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.304 0.641 . . . . 61.13 110.514 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -74.05 -30.26 62.31 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-O 120.843 0.354 . . . . 73.33 110.497 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 60.9 mtt-85 -72.25 -30.41 64.84 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.742 0.817 . . . . 74.4 109.606 171.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.93 4.21 81.04 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-N 115.481 -0.781 . . . . 52.13 112.599 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 81.4 p 60.6 34.19 20.24 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 126.238 1.815 . . . . 72.42 113.72 173.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -121.34 163.88 27.61 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 123.815 0.846 . . . . 75.1 112.13 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.47 125.3 5.92 Favored 'Trans proline' 0 C--N 1.4 3.278 0 C-N-CA 124.375 3.383 . . . . 53.02 114.273 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.51 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.1 tt0 -55.04 130.36 41.5 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.656 1.182 . . . . 75.42 111.51 -179.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 57.6 tp -116.57 92.76 3.97 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.271 0.628 . . . . 50.2 109.596 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -100.86 113.49 26.48 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 108.048 -1.093 . . . . 73.43 108.048 175.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 14.7 tp -76.07 127.74 33.57 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 123.409 0.443 . . . . 74.45 109.831 -177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.406 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -57.77 138.96 82.46 Favored Pre-proline 0 N--CA 1.48 1.059 0 C-N-CA 123.555 0.742 . . . . 74.53 111.805 -173.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 1.8 Cg_endo -75.43 96.29 1.03 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.298 1.999 . . . . 62.24 110.555 -176.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.69 134.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.512 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -88.71 104.84 17.26 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.12 -1.067 . . . . 71.45 108.12 178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -67.56 -33.43 75.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.203 0.601 . . . . 72.21 110.984 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.47 -42.43 96.2 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.629 0.771 . . . . 43.14 110.313 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.48 93.63 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.281 0.632 . . . . 74.24 110.922 177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.469 HD13 HD21 ' F' ' 148' ' ' LEU . 55.8 tp -66.78 -33.64 76.08 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.325 0.65 . . . . 70.53 111.03 178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -65.05 -47.52 77.07 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.674 0.79 . . . . 74.44 109.77 176.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 68.7 mtm -73.65 -19.19 60.91 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.481 0.712 . . . . 73.1 111.273 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.18 -35.03 78.8 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.928 -0.767 . . . . 55.02 108.928 173.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -69.37 -26.89 64.89 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-O 120.691 0.282 . . . . 75.42 110.965 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -71.21 -32.34 68.71 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 121.54 -0.725 . . . . 53.12 111.152 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -91.78 -1.21 57.47 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 122.693 0.397 . . . . 73.02 111.575 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -147.02 91.25 1.98 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.562 1.145 . . . . 72.12 109.116 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -139.59 18.47 2.53 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.839 0.856 . . . . 72.43 110.595 -174.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.51 -50.75 10.28 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.531 0.732 . . . . 74.54 110.459 -179.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 164.38 50.54 0.02 OUTLIER Glycine 0 C--N 1.344 1.027 0 N-CA-C 111.881 -0.488 . . . . 72.4 111.881 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -124.5 126.5 45.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.728 1.211 . . . . 75.3 109.074 -177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -177.53 132.55 2.01 Favored Glycine 0 C--N 1.341 0.859 0 N-CA-C 111.647 -0.581 . . . . 43.32 111.647 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 45.0 p -89.23 141.31 28.64 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.567 0.747 . . . . 75.33 110.104 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -106.53 -93.13 0.39 Allowed 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.505 -1.294 . . . . 65.21 107.505 170.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 57.67 164.33 0.03 OUTLIER 'General case' 0 C--N 1.363 1.18 0 C-N-CA 125.447 1.499 . . . . 71.24 112.989 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -162.87 177.74 9.0 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 115.555 -0.748 . . . . 64.04 110.137 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -64.96 117.47 7.67 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.487 -1.233 . . . . 74.42 108.603 175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -68.6 -60.9 2.09 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.141 0.576 . . . . 64.14 110.346 -176.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.255 0 C-N-CA 124.092 0.957 . . . . 42.22 108.552 177.009 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 24.1 t70 . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 110.573 -0.158 . . . . 73.43 110.573 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -126.45 27.6 6.13 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.445 1.098 . . . . 74.31 109.83 176.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.73 83.49 4.09 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 110.017 -0.364 . . . . 72.43 110.017 -178.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -65.85 -52.98 45.75 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.717 0.807 . . . . 74.22 110.414 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' B' ' 1' ' ' MET . 49.8 tp60 63.02 12.66 6.09 Favored 'General case' 0 CA--C 1.566 1.59 0 C-N-CA 124.497 1.119 . . . . 64.35 111.842 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -61.97 -35.72 79.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.178 0.991 . . . . 63.13 110.087 177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -116.56 163.31 16.28 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.17 -1.377 . . . . 74.13 108.251 168.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 9.0 mp -77.97 77.77 4.47 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 109.06 -0.718 . . . . 72.14 109.06 173.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -177.31 71.44 0.23 Allowed Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 125.772 1.629 . . . . 75.25 107.767 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -93.22 162.23 2.52 Favored 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 123.169 2.579 . . . . 72.0 112.874 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 14.7 t80 62.81 -175.54 0.15 Allowed 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.085 0.954 . . . . 74.52 110.845 172.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 15.3 t -160.03 173.69 15.47 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.97 0.508 . . . . 75.11 110.132 174.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -75.79 132.89 40.71 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.852 0.861 . . . . 70.5 110.808 177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.66 -19.57 23.49 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.599 0.76 . . . . 61.32 111.186 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -154.43 99.8 2.22 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.288 0.635 . . . . 61.32 110.19 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . 0.66 HG12 ' HG ' ' B' ' 44' ' ' LEU . 5.4 t -87.51 69.08 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 N-CA-C 108.797 -0.816 . . . . 74.12 108.797 176.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -161.01 147.15 14.7 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.137 0.575 . . . . 73.35 110.916 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . 0.593 ' HD2' HD22 ' B' ' 136' ' ' LEU . 1.3 p90 -134.75 133.43 39.9 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.146 0.978 . . . . 72.44 109.036 169.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -128.98 173.79 10.11 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.253 1.021 . . . . 73.4 109.843 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 141.18 -145.74 16.51 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-N 115.915 -0.584 . . . . 74.15 111.663 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -108.01 85.01 2.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.665 0.786 . . . . 73.12 109.812 -176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 5.9 mp -94.75 149.75 20.92 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.842 -0.617 . . . . 74.41 110.745 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 56.3 mt 61.31 78.58 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 C-N-CA 125.084 1.354 . . . . 73.31 110.57 -176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -120.05 21.83 11.68 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 115.379 -0.828 . . . . 73.42 109.682 174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . 0.66 ' HB3' ' HE2' ' C' ' 32' ' ' PHE . 98.4 m-85 -116.54 91.38 33.77 Favored Pre-proline 0 N--CA 1.475 0.782 0 C-N-CA 123.855 0.862 . . . . 75.32 110.239 -173.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -80.22 127.58 6.81 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.913 2.408 . . . . 60.23 112.516 -178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . 0.551 HG23 HG22 ' C' ' 31' ' ' VAL . 48.3 mm -94.74 128.73 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.656 0.783 . . . . 74.23 109.043 176.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.57 15.5 3.73 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.255 0.622 . . . . 73.35 112.319 -175.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.507 ' H ' HG22 ' E' ' 134' ' ' ILE . 12.5 p -146.78 140.04 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 123.767 0.827 . . . . 73.11 109.491 176.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -164.85 -177.86 4.93 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.564 1.146 . . . . 72.13 109.283 170.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 53.37 56.81 6.88 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 124.166 0.916 . . . . 74.3 110.387 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . 0.418 ' HA ' ' HG2' ' C' ' 38' ' ' PRO . 7.4 mp -68.5 92.36 0.44 Allowed 'General case' 0 C--N 1.352 0.676 0 CA-C-N 115.067 -0.969 . . . . 54.42 109.8 -176.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 30.9 p -151.29 110.32 3.9 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.086 -0.961 . . . . 74.24 108.725 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 1.9 tt -160.02 44.98 0.22 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.803 -1.554 . . . . 72.31 106.803 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . 0.414 HG12 ' O ' ' C' ' 40' ' ' VAL . 5.4 mt -118.74 -70.02 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-N 115.551 -0.749 . . . . 73.34 109.851 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -115.9 138.38 51.22 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.557 0.743 . . . . 72.13 109.672 -175.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -81.6 -36.06 29.39 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.21 0.604 . . . . 74.13 110.149 176.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -166.72 -68.38 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.279 -1.378 . . . . 70.45 107.279 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' E' ' 149' ' ' PRO . 6.0 m-20 61.36 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.105 1.362 . . . . 71.51 113.057 167.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . 0.456 HD11 ' H ' ' A' ' 13' ' ' ILE . 2.4 tt 59.69 75.62 0.39 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.646 1.178 . . . . 65.32 109.114 -175.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.591 HD21 ' HB2' ' C' ' 136' ' ' LEU . 57.1 tp 61.68 80.39 0.25 Allowed Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.268 1.027 . . . . 72.42 110.668 -179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . 0.575 ' HG3' ' HB3' ' E' ' 146' ' ' ASP . 8.1 Cg_endo . . . . . 0 CA--C 1.56 1.811 0 C-N-CA 123.024 2.483 . . . . 74.42 111.599 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 27.8 t70 . . . . . 0 N--CA 1.472 0.662 0 N-CA-C 109.136 -0.691 . . . . 75.02 109.136 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -90.22 -59.31 2.22 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 108.555 -0.906 . . . . 73.43 108.555 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -132.91 88.92 2.56 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.267 1.027 . . . . 55.33 108.353 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -135.12 -53.06 0.79 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.122 0.969 . . . . 72.23 108.544 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 60.15 114.22 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.097 1.359 . . . . 63.23 110.221 -172.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . 0.412 ' O ' HD22 ' F' ' 115' ' ' LEU . 28.7 t70 -69.88 86.95 0.52 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.435 0.694 . . . . 73.45 110.327 -173.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.551 ' HE3' HE22 ' A' ' 50' ' ' GLN . 53.0 mttp -84.56 130.77 34.7 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.905 0.882 . . . . 61.2 110.707 -176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.778 HD12 ' SD ' ' A' ' 94' ' ' MET . 0.4 OUTLIER -149.51 143.14 25.44 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.766 -1.106 . . . . 42.33 110.61 -156.702 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -149.27 163.12 26.56 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 124.397 1.079 . . . . 64.31 110.962 -172.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.86 -169.47 0.76 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.875 2.383 . . . . 75.04 111.897 165.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -153.22 158.4 41.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.739 0.816 . . . . 65.53 108.999 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 13.9 t -81.31 139.22 35.52 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 109.14 -0.689 . . . . 75.12 109.14 174.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 28.0 p-90 -145.67 -73.84 0.23 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 119.196 -0.43 . . . . 74.01 111.138 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 23.7 t70 59.04 153.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 124.955 1.302 . . . . 74.4 112.403 -170.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -149.85 13.44 0.8 Allowed 'General case' 0 N--CA 1.483 1.187 0 O-C-N 121.907 -0.495 . . . . 74.4 111.639 178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -135.19 -27.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.936 0.495 . . . . 65.23 111.75 -172.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? 63.63 60.53 1.08 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.644 1.178 . . . . 74.21 108.372 -173.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -66.18 103.15 0.93 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.927 -1.033 . . . . 74.11 111.706 -168.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -140.92 24.05 2.2 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 124.764 1.226 . . . . 71.31 107.835 174.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -73.36 126.69 10.24 Favored Glycine 0 C--N 1.356 1.675 0 CA-C-N 115.042 -0.981 . . . . 51.05 112.214 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . 0.519 ' HG2' ' HA ' ' A' ' 41' ' ' LYS . 52.2 mtmt -106.37 140.52 39.16 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.559 0.743 . . . . 75.2 110.983 -175.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 128' ' ' LEU . 2.3 pt? -142.13 -172.15 3.53 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.832 0.853 . . . . 62.43 109.869 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 11.0 tt -156.04 -30.63 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.824 0.85 . . . . 74.14 110.508 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 64.38 -154.14 0.3 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.745 1.218 . . . . 71.02 110.093 -174.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . 0.429 ' HB2' ' HZ ' ' D' ' 32' ' ' PHE . 13.7 p90 -119.28 88.21 37.17 Favored Pre-proline 0 CA--C 1.555 1.142 0 CA-C-O 121.385 0.612 . . . . 74.21 111.102 176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -93.72 -176.21 0.52 Allowed 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 123.376 2.717 . . . . 74.31 112.98 175.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.506 ' CG1' HH22 ' C' ' 15' ' ' ARG . 10.6 mm -94.85 122.38 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.355 -0.98 . . . . 74.13 108.355 172.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -76.62 -75.44 0.2 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.457 0.703 . . . . 54.31 110.393 -175.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 19.4 m 42.86 -165.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 126.577 1.951 . . . . 74.12 114.856 174.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -136.39 -68.3 0.5 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.841 1.256 . . . . 73.32 108.164 173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.27 -169.62 3.42 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 113.528 -1.669 . . . . 74.43 107.497 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.43 HD11 ' O ' ' D' ' 38' ' ' PRO . 0.0 OUTLIER -83.57 -57.2 3.33 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 109.279 -0.637 . . . . 74.12 109.279 178.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 19.4 m 69.1 -12.54 0.4 Allowed 'General case' 0 CA--C 1.566 1.563 0 N-CA-C 115.063 1.505 . . . . 70.41 115.063 169.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.93 -24.5 55.54 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.58 0.627 . . . . 72.13 111.523 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.455 HG22 HD22 ' D' ' 42' ' ' LEU . 18.7 pt -67.25 121.6 16.7 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.198 -0.668 . . . . 44.03 109.198 169.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 74.06 -60.66 0.52 Allowed 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 125.429 1.492 . . . . 73.24 111.61 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 40.0 t30 63.89 95.13 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 124.942 1.297 . . . . 74.24 110.809 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm 65.67 -72.33 0.08 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 74.54 111.516 -177.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -62.24 94.45 0.06 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.365 1.066 . . . . 64.13 110.684 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.86 102.08 1.19 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 107.347 -1.353 . . . . 72.12 107.347 173.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . 0.469 HD21 HD13 ' D' ' 136' ' ' LEU . 55.0 tp 65.5 85.45 0.16 Allowed Pre-proline 0 CA--C 1.556 1.206 0 C-N-CA 124.569 1.148 . . . . 70.21 109.321 -170.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--N 1.377 2.028 0 C-N-CA 123.13 2.553 . . . . 72.03 111.349 176.601 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ppp? . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 120.413 0.149 . . . . 72.42 111.023 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 p -163.4 142.91 8.49 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.807 0.843 . . . . 64.02 109.733 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.47 146.85 36.22 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.562 -0.533 . . . . 75.42 109.562 170.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.14 140.9 29.78 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.333 0.587 . . . . 73.15 110.441 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -126.99 -177.11 3.92 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.29 1.036 . . . . 62.15 109.456 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -78.6 79.16 5.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.981 0.896 . . . . 55.15 110.858 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.0 t -164.57 135.32 4.15 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 114.675 -1.148 . . . . 75.42 108.788 -178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 55.32 -159.36 0.2 Allowed 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 123.987 0.915 . . . . 73.4 111.989 -173.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 75.0 mtm 66.57 135.06 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.743 1.217 . . . . 70.1 110.701 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 51.0 m -139.75 112.08 7.69 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.121 0.568 . . . . 50.4 109.625 -175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 14.0 p90 -139.68 112.92 8.25 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 107.78 -1.193 . . . . 72.51 107.78 167.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.5 tp60 -133.84 116.97 16.3 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.177 0.591 . . . . 72.12 109.77 -174.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.413 HG21 HD11 ' A' ' 16' ' ' ILE . 3.9 mp -77.66 115.32 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 N-CA-C 108.264 -1.013 . . . . 74.43 108.264 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.06 -44.86 10.05 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.81 -0.441 . . . . 71.24 109.81 -176.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -174.52 144.69 0.89 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.795 0.438 . . . . 72.21 110.616 -173.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 13' ' ' ILE . 3.7 mp -117.87 123.7 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 107.725 -1.213 . . . . 64.32 107.725 178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -152.51 148.22 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.597 0.713 . . . . 73.32 111.126 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.7 p -79.96 112.58 17.39 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.638 -1.165 . . . . 73.51 109.904 -178.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -82.1 -21.65 36.65 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.219 -0.446 . . . . 72.42 110.589 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.6 t70 -153.04 141.44 20.68 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 115.312 -0.858 . . . . 72.24 109.947 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 71.4 mt -144.78 143.11 22.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.812 1.645 . . . . 74.31 106.779 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.6 t -158.4 124.58 4.64 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 123.423 0.452 . . . . 63.33 110.208 171.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 91.8 t80 -116.49 147.54 41.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.027 -1.471 . . . . 74.41 107.027 169.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -142.5 140.49 31.86 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.871 0.868 . . . . 62.02 109.543 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -152.14 68.14 7.2 Favored Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 106.685 -1.598 . . . . 54.11 106.685 170.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.02 -20.46 21.86 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 122.234 1.956 . . . . 75.01 110.948 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 72' ' ' THR . 0.8 OUTLIER -105.86 16.12 25.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.37 1.068 . . . . 74.11 109.729 -179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.684 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -54.19 -45.49 99.14 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.166 1.173 . . . . 75.13 114.166 -174.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -64.68 -26.93 60.71 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.93 1.753 . . . . 71.21 113.006 175.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -75.33 -33.5 61.14 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.781 0.832 . . . . 70.2 111.747 -173.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG21 ' HE1' ' A' ' 123' ' ' PHE . 3.9 m -72.07 -23.62 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 122.923 0.489 . . . . 71.2 111.285 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -70.88 -31.37 68.01 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.794 -1.094 . . . . 52.43 110.232 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -76.53 -47.41 22.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.897 0.879 . . . . 73.24 110.381 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 50.7 mtpt -82.65 167.1 18.58 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.5 -0.773 . . . . 65.5 111.928 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -65.21 116.21 6.34 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.778 -0.823 . . . . 63.34 108.778 171.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.712 ' HE1' ' HB1' ' F' ' 135' ' ' ALA . 38.0 p90 -84.88 63.98 8.37 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 122.583 1.182 . . . . 73.51 110.53 -171.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -120.51 86.42 39.5 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 107.252 -1.388 . . . . 63.23 107.252 177.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.56 173.17 7.6 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 122.522 2.148 . . . . 73.43 113.154 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -96.6 124.36 40.56 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.699 -0.852 . . . . 75.14 108.699 175.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.2 t -79.5 90.17 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 108.499 -0.926 . . . . 74.11 108.499 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -96.39 127.91 42.83 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.016 -1.105 . . . . 74.02 108.016 173.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD21 ' HA3' ' F' ' 127' ' ' GLY . 4.0 pp -134.21 145.97 49.69 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 109.064 -0.717 . . . . 75.31 109.064 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -141.74 148.5 39.1 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.023 -1.103 . . . . 75.5 108.023 176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -139.8 147.58 40.98 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.197 -0.668 . . . . 72.14 109.197 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 11.6 t70 -154.11 137.28 15.63 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.966 0.906 . . . . 72.12 109.083 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 88.1 m -107.53 130.44 54.86 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.559 0.744 . . . . 62.1 109.634 174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.74 150.6 52.1 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.184 0.994 . . . . 73.15 109.118 176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.8 m -134.37 161.35 35.22 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.283 0.633 . . . . 73.45 110.816 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.1 t -152.29 152.75 32.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.73 1.212 . . . . 63.42 108.753 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.38 123.43 48.35 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.146 -0.687 . . . . 63.33 109.146 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.488 HD11 ' HB2' ' A' ' 57' ' ' GLU . 51.5 mt -101.81 -33.27 9.88 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.863 0.865 . . . . 64.11 110.725 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -165.57 -167.67 1.18 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.664 0.786 . . . . 74.44 110.64 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -64.16 99.37 0.27 Allowed 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.215 1.006 . . . . 73.33 110.803 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 66.49 13.03 9.08 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 125.008 1.323 . . . . 72.44 112.303 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 56.5 t -99.54 111.04 28.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 106.541 -1.652 . . . . 71.32 106.541 167.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -119.79 168.84 10.69 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.526 -0.761 . . . . 72.44 109.167 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HB2' HD11 ' A' ' 51' ' ' LEU . 37.6 tt0 -132.51 134.53 45.12 Favored 'General case' 0 C--N 1.314 -0.969 0 C-N-CA 125.065 1.346 . . . . 63.02 107.389 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.401 HG11 ' HD3' ' A' ' 103' ' ' PRO . 97.9 t -121.18 124.17 71.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 N-CA-C 107.721 -1.215 . . . . 73.31 107.721 171.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 67.8 t -109.78 135.42 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.126 0.97 . . . . 43.03 109.338 178.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 121.28 44.8 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.681 -0.859 . . . . 75.22 108.681 -177.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.23 105.09 17.18 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.472 0.709 . . . . 65.1 109.565 172.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 19.7 t -107.45 128.23 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 108.283 -1.006 . . . . 75.43 108.283 168.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.6 m -119.26 120.58 37.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.158 0.504 . . . . 73.5 109.832 176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.429 HG21 HG21 ' A' ' 114' ' ' ILE . 71.0 t -112.25 105.84 19.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 124.346 1.058 . . . . 71.11 108.549 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.9 m -110.83 138.23 47.49 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.063 -0.717 . . . . 63.51 109.063 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.13 127.75 40.4 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.024 -1.102 . . . . 72.24 108.024 179.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.5 m -141.36 125.62 17.48 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.891 0.477 . . . . 64.25 110.632 177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.746 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.1 pt? -93.39 84.27 4.71 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.159 0.984 . . . . 72.44 108.369 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.41 -102.44 1.49 Allowed Glycine 0 C--N 1.346 1.093 0 CA-C-N 114.339 -1.301 . . . . 54.32 112.093 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -95.96 -24.26 16.47 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.56 0.744 . . . . 71.13 109.664 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -92.06 135.55 33.87 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.895 1.278 . . . . 52.3 109.482 -174.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 80.9 m -77.93 133.01 38.14 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.72 -0.474 . . . . 65.14 109.72 170.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.61 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -76.8 -59.92 2.57 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.003 -0.74 . . . . 71.41 109.003 172.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -165.88 166.79 17.31 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 114.125 -1.398 . . . . 75.31 110.189 178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 42.1 tp -134.22 127.57 32.19 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.226 1.01 . . . . 60.3 108.697 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.543 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 57.1 m -119.27 137.72 53.48 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.993 0.917 . . . . 64.2 108.657 172.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -148.16 122.48 9.63 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 108.407 -0.96 . . . . 71.44 108.407 172.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.28 132.21 69.78 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 123.302 0.641 . . . . 73.04 109.664 -178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.733 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 47.1 mt-30 -96.98 90.57 5.24 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 115.427 -0.806 . . . . 74.14 109.428 166.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.8 95.49 6.68 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.725 -1.125 . . . . 52.31 108.34 177.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.37 161.33 26.29 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.188 -0.46 . . . . 71.24 112.092 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.44 140.67 7.37 Favored Glycine 0 N--CA 1.451 -0.311 0 N-CA-C 110.835 -0.906 . . . . 41.21 110.835 175.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 60.7 mt -86.26 127.19 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.635 0 N-CA-C 108.635 -0.876 . . . . 62.15 108.635 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -133.19 118.13 18.27 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.374 -0.973 . . . . 72.53 108.374 -178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -88.0 100.56 13.01 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.777 -0.823 . . . . 75.53 108.777 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 38.5 pt -119.52 147.75 22.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.262 0.553 . . . . 71.15 111.428 -175.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HA ' HD21 ' F' ' 115' ' ' LEU . . . -171.53 164.69 6.87 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.978 1.711 . . . . 62.33 108.852 -178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.45 9.01 87.37 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.752 -0.471 . . . . 54.33 114.11 177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.465 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -120.26 146.67 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 C-N-CA 123.452 0.701 . . . . 71.42 109.94 176.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -152.16 170.78 19.12 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.318 0.647 . . . . 71.53 109.469 -175.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.76 -125.55 37.25 Favored Glycine 0 C--N 1.353 1.506 0 O-C-N 123.776 0.672 . . . . 71.15 114.758 175.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.7 p -72.4 -37.94 68.56 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.884 0.874 . . . . 61.32 111.705 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -62.51 -35.06 78.2 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.114 0.566 . . . . 75.41 111.003 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' F' ' 115' ' ' LEU . 55.8 ttp -68.93 -45.73 70.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.952 0.901 . . . . 71.12 111.054 175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' HA ' ' HG3' ' F' ' 117' ' ' PRO . . . -60.84 -34.04 73.97 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.627 0.771 . . . . 74.44 111.478 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -66.05 -48.43 71.05 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 114.915 -1.039 . . . . 75.53 110.551 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.672 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 0.8 OUTLIER -68.81 -55.68 10.42 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.304 0.853 . . . . 74.32 113.304 -168.11 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.507 HD21 ' HD3' ' F' ' 117' ' ' PRO . 4.1 pp -76.3 -25.67 55.06 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 122.113 -0.367 . . . . 73.25 111.382 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.07 -18.67 45.76 Favored Glycine 0 C--N 1.351 1.406 0 N-CA-C 114.292 0.477 . . . . 70.04 114.292 -174.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -135.98 -58.01 0.76 Allowed 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.169 0.588 . . . . 71.41 111.638 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.672 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 1.4 t80 -54.88 -53.6 53.31 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 124.179 0.992 . . . . 74.32 113.065 -176.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 73.6 m -68.56 -49.58 29.53 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-O 118.616 -0.707 . . . . 72.03 112.684 -176.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' HD3' HG11 ' A' ' 58' ' ' VAL . 38.3 Cg_endo -65.56 -15.41 49.4 Favored 'Trans proline' 0 C--N 1.387 2.58 0 C-N-CA 121.637 1.558 . . . . 74.23 113.56 172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 35.3 t-20 -72.79 -35.74 67.45 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.469 -0.567 . . . . 73.54 109.469 175.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.7 mm -65.75 -43.24 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.471 0.709 . . . . 73.03 110.135 170.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 78.9 mt -72.8 -24.26 60.89 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.102 -0.954 . . . . 64.33 111.557 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -68.14 -45.02 39.93 Favored Pre-proline 0 N--CA 1.486 1.347 0 N-CA-C 114.451 1.278 . . . . 73.42 114.451 -168.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.63 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 29.4 Cg_endo -62.83 -29.86 77.01 Favored 'Trans proline' 0 C--N 1.379 2.148 0 CA-C-N 121.553 1.59 . . . . 71.14 112.511 174.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.518 ' HE2' ' HB3' ' C' ' 130' ' ' PRO . 11.6 m-85 -81.94 -26.23 34.19 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.882 0.473 . . . . 71.52 111.861 176.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.29 49.49 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.684 -0.858 . . . . 41.13 108.684 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.513 HH12 HD12 ' C' ' 105' ' ' ILE . 39.2 ttm180 -51.6 -48.15 63.32 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 114.026 -1.443 . . . . 73.23 110.913 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.48 -47.93 77.13 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.428 -0.806 . . . . 74.22 111.149 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 117' ' ' MET . 47.2 t -62.23 -32.95 73.68 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.401 0.681 . . . . 70.41 111.402 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.429 HG21 HG21 ' A' ' 64' ' ' VAL . 74.9 mt -71.71 -58.51 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.706 0.802 . . . . 71.23 110.139 175.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.403 HG23 ' HG3' ' A' ' 125' ' ' GLN . 88.0 m -56.23 -33.74 65.66 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.69 1.196 . . . . 74.04 111.955 -173.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.6 t -67.34 -44.0 80.18 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.341 -0.845 . . . . 52.41 110.583 177.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.465 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 40.0 mtm -65.17 -35.0 79.71 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 122.593 0.357 . . . . 72.14 111.253 176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 74.3 t -62.65 -46.95 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 123.8 0.84 . . . . 71.51 110.286 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.4 p -74.25 -28.95 61.46 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 115.783 -0.644 . . . . 72.51 111.458 -178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 85.8 mtt-85 -71.79 -29.79 64.85 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.453 0.701 . . . . 70.23 109.828 173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.27 -0.18 85.78 Favored Glycine 0 C--N 1.352 1.446 0 CA-C-N 115.627 -0.715 . . . . 71.5 112.685 173.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.9 m 68.04 29.75 6.23 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.89 1.276 . . . . 54.24 110.8 175.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.611 ' HE1' HG21 ' A' ' 31' ' ' VAL . 83.2 m-85 -99.11 152.1 37.65 Favored Pre-proline 0 N--CA 1.477 0.896 0 CA-C-N 115.287 -0.87 . . . . 73.23 110.329 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -64.05 141.7 77.95 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.386 2.057 . . . . 72.5 111.353 176.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 115' ' ' THR . 34.3 tt0 -62.28 144.73 55.26 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.562 0.745 . . . . 72.24 112.312 -175.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -146.48 103.01 3.64 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 107.336 -1.357 . . . . 55.34 107.336 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.17 119.11 37.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.419 0.688 . . . . 52.33 109.212 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.49 136.51 44.15 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.325 0.65 . . . . 71.41 110.404 -178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.21 138.36 86.96 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 123.414 0.686 . . . . 45.32 111.36 -172.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HB3' HH22 ' A' ' 111' ' ' ARG . 46.9 Cg_endo -77.84 112.24 3.25 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 121.981 1.788 . . . . 72.24 111.035 177.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.58 136.05 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.65 -0.87 . . . . 63.54 108.65 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.479 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 4.1 m-20 -72.96 78.48 1.17 Allowed 'General case' 0 C--N 1.353 0.742 0 C-N-CA 123.277 0.631 . . . . 74.33 110.771 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -77.02 -26.6 53.97 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.862 -1.063 . . . . 72.42 108.758 173.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -64.54 -48.42 75.14 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 113.891 -1.504 . . . . 72.23 110.504 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -79.57 -19.31 49.71 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.597 -0.729 . . . . 71.44 111.806 177.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.564 HD12 HD22 ' A' ' 139' ' ' ASN . 49.8 tp -66.7 -33.19 75.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.942 0.497 . . . . 72.45 110.374 174.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -67.41 -27.6 67.21 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.063 -0.517 . . . . 75.12 110.892 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.451 ' HA ' ' HB3' ' A' ' 141' ' ' LEU . 66.0 mtp -68.12 -22.17 64.9 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 122.525 0.33 . . . . 71.2 111.506 178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.564 HD22 HD12 ' A' ' 136' ' ' LEU . 81.7 m-20 -66.78 -27.55 67.68 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.367 0.667 . . . . 74.53 111.144 172.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -85.98 -35.6 20.31 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.783 0.833 . . . . 74.42 110.475 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' A' ' 138' ' ' MET . 63.4 tp -63.17 -50.0 72.09 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.955 0.902 . . . . 75.34 111.971 -174.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.36 25.33 0.09 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.355 -0.609 . . . . 72.05 109.355 -178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.5 tt0 62.35 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.341 1.457 . . . . 44.31 111.333 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -153.94 110.76 3.37 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 108.82 -0.808 . . . . 73.44 108.82 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.12 151.6 33.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.648 0.779 . . . . 45.31 110.038 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -142.51 -169.04 12.04 Favored Glycine 0 N--CA 1.469 0.896 0 N-CA-C 111.57 -0.612 . . . . 45.41 111.57 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.44 156.73 37.32 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.803 0.441 . . . . 63.12 110.747 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -117.29 41.57 2.05 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.465 -0.788 . . . . 43.34 112.486 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 8.5 p -69.98 84.92 0.51 Allowed 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.603 0.716 . . . . 51.42 109.715 172.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.88 149.83 32.34 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.235 -0.893 . . . . 63.24 110.774 -176.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 49.36 50.35 18.24 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.069 1.348 . . . . 74.55 112.999 166.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -74.04 90.54 2.0 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.353 0.597 . . . . 73.33 109.57 178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -102.12 120.45 40.46 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.981 -1.008 . . . . 75.42 110.713 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -137.04 82.34 1.93 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.209 1.004 . . . . 73.23 108.376 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.94 0 N-CA-C 109.088 -0.708 . . . . 42.54 109.088 -179.583 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttt . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.917 -0.772 . . . . 62.33 108.917 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 t 65.43 26.11 11.91 Favored 'General case' 0 N--CA 1.505 2.309 0 C-N-CA 124.343 1.057 . . . . 65.14 109.606 -163.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -164.31 160.57 21.09 Favored 'General case' 0 C--O 1.247 0.921 0 C-N-CA 125.063 1.345 . . . . 75.34 108.179 -170.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -166.7 132.79 2.32 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 122.842 0.457 . . . . 72.23 110.184 177.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.62 ' HB3' ' HB2' ' B' ' 90' ' ' GLU . 42.5 t30 -148.72 136.93 21.02 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.581 -0.896 . . . . 61.23 108.581 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -135.12 135.91 41.52 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.646 0.779 . . . . 70.14 109.281 177.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.634 HG22 ' H ' ' B' ' 8' ' ' GLU . 5.2 m -118.75 -159.94 0.78 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 107.386 -1.339 . . . . 71.31 107.386 174.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.634 ' H ' HG22 ' B' ' 7' ' ' THR . 19.6 mm-40 -62.56 -27.38 69.14 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 120.076 1.307 . . . . 61.0 110.767 175.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 10.7 ptm 57.91 -179.22 0.06 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 126.779 2.032 . . . . 52.41 113.672 175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 13.4 t -160.49 143.08 13.07 Favored 'General case' 0 C--O 1.244 0.779 0 CA-C-N 115.499 -0.773 . . . . 73.22 109.877 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -132.43 113.36 13.05 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.832 -0.803 . . . . 75.02 108.832 173.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.78 140.11 52.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.256 1.022 . . . . 71.31 108.539 174.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.586 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -95.67 137.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 N-CA-C 108.819 -0.808 . . . . 73.53 108.819 167.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -101.47 -51.58 3.44 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.726 0.41 . . . . 71.43 110.431 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.2 ttt180 -161.13 139.4 9.64 Favored 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 110.035 -0.357 . . . . 71.12 110.035 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 62.7 mt -115.34 140.58 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 107.271 -1.381 . . . . 75.1 107.271 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -167.84 147.96 5.03 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.279 0.561 . . . . 72.15 112.151 -177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.1 m -74.34 119.36 18.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.923 -1.035 . . . . 64.42 108.724 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -93.92 -29.47 15.27 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.565 0.746 . . . . 72.23 111.807 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.418 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 29.4 t70 -160.2 142.72 13.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.625 0.25 . . . . 73.23 110.803 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.5 ' HB ' ' H ' ' A' ' 23' ' ' PHE . 31.6 mm -143.83 145.57 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 124.837 1.255 . . . . 74.11 109.055 -175.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 32.2 t -146.38 141.95 27.71 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.302 -1.369 . . . . 72.03 107.302 163.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.516 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -150.03 111.83 4.55 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.244 -1.761 . . . . 60.54 106.244 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -115.98 156.9 25.44 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.597 -0.89 . . . . 73.32 108.597 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -144.67 76.39 14.19 Favored Pre-proline 0 C--N 1.318 -0.781 0 N-CA-C 105.817 -1.92 . . . . 64.51 105.817 174.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.02 -28.79 80.82 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 123.229 2.62 . . . . 74.54 113.212 -166.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -124.48 29.31 6.34 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.836 0.855 . . . . 44.35 109.589 -177.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -46.44 -53.39 24.19 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 115.162 1.541 . . . . 63.45 115.162 -172.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -76.83 -8.85 18.13 Favored 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.151 1.9 . . . . 74.31 113.433 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 -97.75 -42.48 7.58 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.608 0.763 . . . . 71.25 110.65 -174.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.41 HG11 ' HA ' ' B' ' 73' ' ' ALA . 61.8 t -73.69 -13.75 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 124.224 1.01 . . . . 63.53 110.181 173.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -52.73 -36.63 57.95 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.419 1.088 . . . . 73.51 111.342 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -70.6 -23.28 62.54 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.698 0.799 . . . . 72.4 112.488 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -86.98 111.24 20.65 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.688 0.795 . . . . 74.42 111.543 -174.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -99.68 87.85 3.67 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.914 0.486 . . . . 54.53 109.904 172.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.684 ' HB3' HD21 ' B' ' 68' ' ' LEU . 29.9 t90 -154.36 157.31 38.39 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 108.016 -1.105 . . . . 75.04 108.016 174.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.9 mm-40 -67.1 116.87 40.47 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 123.368 0.667 . . . . 72.35 110.4 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.418 ' HG2' HD11 ' B' ' 126' ' ' LEU . 53.8 Cg_endo -67.87 127.53 16.31 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.057 1.838 . . . . 74.03 111.463 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -60.03 104.61 0.32 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.576 1.15 . . . . 73.24 109.848 175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 28.3 m -91.65 136.01 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.314 0.578 . . . . 62.02 111.363 -175.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -136.75 104.95 5.67 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.297 1.039 . . . . 63.15 108.572 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.498 HD13 ' H ' ' B' ' 42' ' ' LEU . 0.0 OUTLIER -86.49 167.85 14.27 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.193 0.597 . . . . 62.53 110.828 179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 29.4 t70 -153.01 115.17 4.38 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.287 -0.869 . . . . 62.43 108.763 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.65 134.64 43.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.611 -0.885 . . . . 73.43 108.611 176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.5 t70 -142.92 142.17 31.65 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.768 0.827 . . . . 64.4 109.612 -176.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 42.7 p -118.55 116.19 26.14 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.411 -0.813 . . . . 71.23 109.76 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -114.81 152.31 32.37 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.135 -1.432 . . . . 71.3 107.135 168.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 62.3 m -143.53 169.96 16.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.019 0.438 . . . . 61.12 110.78 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.6 t -155.13 169.07 24.99 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.406 1.082 . . . . 22.31 108.679 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -125.1 128.03 47.81 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.713 0.805 . . . . 64.12 108.929 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 79.2 mt -100.16 -22.65 15.09 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.429 0.691 . . . . 71.44 110.911 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.99 176.54 4.67 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.792 0.837 . . . . 74.35 110.207 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.69 122.26 13.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.702 -0.481 . . . . 63.44 109.702 173.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 72.37 -5.85 1.7 Allowed 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 125.821 1.648 . . . . 64.21 112.705 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.4 t -103.78 100.84 11.29 Favored 'Isoleucine or valine' 0 C--N 1.347 0.494 0 N-CA-C 108.462 -0.94 . . . . 71.35 108.462 -177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -112.55 137.82 50.23 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.282 0.633 . . . . 73.33 109.699 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -110.29 97.39 6.87 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.349 -1.352 . . . . 74.42 107.349 -177.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 57.8 t -95.97 123.55 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 123.363 0.665 . . . . 54.1 110.079 -174.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.456 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 45.8 t -100.61 119.04 48.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.033 0.933 . . . . 74.31 110.108 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.16 114.19 26.27 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 108.219 -1.03 . . . . 73.43 108.219 177.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 29.3 ttm180 -99.51 117.62 34.31 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.932 0.396 . . . . 64.45 110.249 171.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.8 t -112.94 102.64 14.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.967 -1.123 . . . . 64.03 107.967 168.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 7.0 m -98.1 134.94 40.48 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 108.806 -0.813 . . . . 71.32 108.806 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.44 HG21 HG21 ' B' ' 114' ' ' ILE . 93.2 t -123.32 137.27 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.54 0.736 . . . . 70.11 109.941 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 85.3 m -121.33 146.44 46.85 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.213 1.005 . . . . 72.12 108.844 175.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -144.17 129.16 18.53 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 108.633 -0.877 . . . . 72.0 108.633 173.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -130.22 139.57 50.79 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.994 -0.743 . . . . 65.44 108.994 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' B' ' 36' ' ' TRP . 1.8 tt -124.99 105.98 9.61 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.964 -1.124 . . . . 72.24 107.964 -177.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.28 -115.06 4.15 Favored Glycine 0 C--N 1.345 1.059 0 CA-C-N 115.651 -0.704 . . . . 74.44 112.016 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -108.75 4.52 23.78 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 117.822 0.811 . . . . 73.24 111.509 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -137.86 169.5 17.69 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 122.934 0.494 . . . . 52.14 111.158 -173.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -73.62 133.11 43.41 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.51 -0.768 . . . . 70.14 110.26 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.519 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -85.44 -58.22 2.76 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.146 0.978 . . . . 74.22 108.378 176.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.521 ' HZ ' HD12 ' B' ' 126' ' ' LEU . 45.4 p90 -164.3 161.51 21.89 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.548 -1.205 . . . . 73.13 110.246 174.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -126.73 152.12 47.25 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.08 1.352 . . . . 74.35 108.941 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.9 t -151.51 157.92 42.93 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.427 0.691 . . . . 41.04 109.408 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -165.77 128.48 2.06 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 108.76 -0.83 . . . . 73.44 108.76 178.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.4 ' HA ' HD13 ' B' ' 21' ' ' ILE . 65.7 t -126.17 143.6 39.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 109.044 -0.724 . . . . 64.24 109.044 174.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.418 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 28.0 mt-30 -124.75 102.36 7.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.531 -0.915 . . . . 54.13 108.531 172.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -94.04 100.66 12.75 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.132 -1.062 . . . . 71.0 108.132 176.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -92.66 144.18 16.93 Favored Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.452 -0.659 . . . . 55.33 111.452 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.48 127.47 3.64 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.694 -0.562 . . . . 74.54 111.694 -175.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 40.7 mt -85.16 125.99 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 108.33 -0.989 . . . . 71.32 108.33 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -131.43 161.44 32.46 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.363 1.065 . . . . 74.14 109.319 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.5 m -131.29 93.54 3.39 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 123.874 0.87 . . . . 73.43 108.725 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.526 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -117.33 139.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.999 0.92 . . . . 63.32 110.098 -176.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.91 168.82 26.33 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.147 0.979 . . . . 60.45 109.792 176.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.55 -28.77 5.16 Favored Glycine 0 C--N 1.357 1.739 0 O-C-N 123.539 0.525 . . . . 32.42 113.513 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 19.2 pt -90.84 137.64 21.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 124.709 1.204 . . . . 65.32 110.552 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' B' ' 5' ' ' ASN . 42.4 mt-10 -149.31 149.8 31.48 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.022 0.929 . . . . 62.41 109.243 -178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.23 -118.78 9.73 Favored Glycine 0 C--N 1.349 1.255 0 CA-C-N 115.704 -0.68 . . . . 74.3 113.367 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.3 m -65.22 -40.43 94.11 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.794 0.838 . . . . 70.25 110.339 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -63.06 -34.19 77.05 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.672 -1.149 . . . . 63.15 110.853 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.527 ' SD ' HD11 ' B' ' 98' ' ' LEU . 13.2 tmm? -79.94 -43.07 22.77 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 114.909 -1.041 . . . . 60.45 111.089 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.35 -39.13 91.96 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.564 -0.744 . . . . 51.23 112.46 -168.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 3.0 p80 -82.82 -12.46 57.45 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 116.602 -0.272 . . . . 74.45 110.996 179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.1 t -85.35 -68.68 0.71 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.614 -0.266 . . . . 73.11 110.355 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.527 HD11 ' SD ' ' B' ' 94' ' ' MET . 2.4 pp -85.07 -14.8 46.11 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 112.198 0.444 . . . . 52.13 112.198 -175.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.2 -2.98 59.0 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-O 119.75 -0.472 . . . . 43.24 113.303 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -147.29 -60.86 0.28 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 117.274 0.537 . . . . 73.4 112.036 -175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -65.67 -43.52 89.06 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 122.914 0.485 . . . . 74.0 112.136 -174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 67.1 m -69.35 -44.72 26.95 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 123.198 0.599 . . . . 71.03 111.403 -177.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.522 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 80.2 Cg_exo -53.3 -37.34 80.87 Favored 'Trans proline' 0 C--N 1.39 2.758 0 C-N-CA 122.152 1.901 . . . . 73.53 113.731 164.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -68.35 -27.32 66.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 122.48 0.312 . . . . 72.23 111.798 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 59.0 mt -63.53 -42.69 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 123.663 0.785 . . . . 44.31 110.009 170.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 42.4 mt -81.54 -15.63 54.25 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 114.791 -1.095 . . . . 71.43 111.243 -174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -60.17 -49.6 90.03 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-O 117.533 -1.223 . . . . 70.22 113.9 -174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.52 -32.21 96.01 Favored 'Trans proline' 0 C--N 1.38 2.202 0 CA-C-N 121.748 1.66 . . . . 61.13 112.913 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -72.38 -47.51 48.79 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.22 0.608 . . . . 75.24 110.413 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.02 -43.46 86.72 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-N 115.635 -0.711 . . . . 73.1 110.294 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -58.97 -52.01 67.59 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.633 1.573 . . . . 63.25 111.313 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -65.32 -37.09 86.05 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 123.928 0.767 . . . . 74.31 110.313 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.524 ' O ' ' HG2' ' B' ' 117' ' ' MET . 9.8 t -65.79 -41.43 91.98 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 123.612 0.57 . . . . 74.13 111.49 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.44 HG21 HG21 ' B' ' 64' ' ' VAL . 72.6 mt -60.95 -53.94 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 123.449 0.7 . . . . 72.32 110.343 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -69.14 -24.1 64.05 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-N 115.762 -0.654 . . . . 73.11 111.403 -176.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 46.8 t -68.9 -39.65 79.59 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.09 0.556 . . . . 73.44 110.054 173.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.524 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.6 mmt -70.44 -32.04 69.45 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.485 0.314 . . . . 73.05 110.452 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.8 t -68.07 -35.76 72.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.836 0.854 . . . . 74.33 110.695 172.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 41.2 m -61.39 -46.51 89.87 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.267 0.627 . . . . 62.4 110.082 173.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' B' ' 116' ' ' SER . 81.5 mtt-85 -63.81 -36.5 84.09 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.738 -1.119 . . . . 74.02 111.189 -179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.9 -1.25 87.11 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-O 119.389 -0.673 . . . . 33.1 113.434 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 60.4 p 55.81 30.76 16.35 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 126.098 1.759 . . . . 65.23 112.598 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -88.38 162.87 38.51 Favored Pre-proline 0 CA--C 1.563 1.443 0 C-N-CA 124.565 1.146 . . . . 61.13 110.715 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -61.11 164.02 15.46 Favored 'Trans proline' 0 C--N 1.39 2.727 0 C-N-CA 123.229 2.619 . . . . 74.34 113.649 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.423 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.6 OUTLIER -65.14 111.11 2.78 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-N 115.295 -0.866 . . . . 74.4 110.585 -172.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.521 HD12 ' HZ ' ' B' ' 74' ' ' PHE . 96.1 mt -135.05 83.58 2.03 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 107.779 -1.193 . . . . 74.44 107.779 173.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -101.07 122.61 43.87 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.362 -1.348 . . . . 71.42 107.362 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 33.6 tp -66.4 133.53 50.66 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.652 0.595 . . . . 72.45 111.034 -170.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.07 143.74 94.7 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.245 1.018 . . . . 71.1 111.67 -175.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -68.55 87.24 0.42 Allowed 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.911 2.407 . . . . 71.52 112.423 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 63.1 t -94.89 133.89 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.45 0.7 . . . . 72.22 110.526 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.96 113.74 26.09 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.33 1.052 . . . . 74.34 109.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -68.79 -29.4 67.76 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.747 0.819 . . . . 63.34 111.916 -174.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.6 -34.23 67.24 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.608 0.763 . . . . 63.35 110.763 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.78 -38.23 88.47 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.89 -0.595 . . . . 74.2 109.717 172.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.53 HD11 HG12 ' E' ' 123' ' ' VAL . 2.4 tm? -64.8 -40.38 95.12 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.015 0.926 . . . . 74.41 109.69 176.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -57.12 -47.52 80.9 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.69 0.796 . . . . 72.41 110.759 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 64.4 mtt -70.45 -38.35 74.49 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.578 -0.737 . . . . 73.11 110.432 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -18.56 59.27 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.331 0.652 . . . . 75.42 111.594 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.405 ' CE1' ' HB3' ' E' ' 122' ' ' ALA . 25.2 t80 -53.85 -46.37 71.22 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.602 1.161 . . . . 63.52 110.15 177.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 3.1 pp -118.96 22.23 12.02 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.179 -1.373 . . . . 62.02 110.596 -174.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 61.57 127.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 124.966 1.307 . . . . 72.21 111.426 -170.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 -69.31 81.69 0.37 Allowed 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 121.946 0.879 . . . . 74.21 111.239 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -171.31 95.06 0.18 Allowed 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 106.53 -1.656 . . . . 51.22 106.53 174.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.09 157.58 36.29 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.101 0.96 . . . . 71.43 108.801 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -176.87 63.43 0.09 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 111.06 -0.816 . . . . 43.42 111.06 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.0 48.75 1.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.319 1.047 . . . . 65.32 110.984 -177.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -72.64 78.52 0.73 Allowed Glycine 0 C--N 1.35 1.331 0 N-CA-C 111.296 -0.722 . . . . 63.14 111.296 172.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.0 t -149.31 162.13 40.66 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 123.531 0.732 . . . . 71.52 109.911 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -143.07 -174.6 4.24 Favored 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.272 1.029 . . . . 72.43 108.805 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.98 143.41 18.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.433 -0.58 . . . . 53.11 109.433 173.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -91.84 102.23 14.82 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.577 -0.897 . . . . 73.24 108.577 172.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -141.32 109.37 5.78 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.025 0.93 . . . . 71.42 109.023 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -155.33 142.97 19.73 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.998 0.519 . . . . 74.14 109.712 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.561 1.39 0 O-C-N 124.606 1.191 . . . . 37.61 111.216 -178.359 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.927 -0.397 . . . . 63.41 109.927 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -155.32 26.55 0.41 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 125.597 1.559 . . . . 71.4 108.253 173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -91.28 -25.35 19.5 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.543 1.137 . . . . 62.14 112.796 -164.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.584 ' HB3' ' HG2' ' C' ' 150' ' ' GLU . 0.5 OUTLIER -69.83 166.34 19.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 120.867 0.365 . . . . 71.34 111.194 174.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -128.93 -64.85 0.9 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.844 0.458 . . . . 63.31 109.954 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.7 t30 58.99 79.87 0.21 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.17 0.988 . . . . 55.25 111.088 -177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.1 p -134.65 18.9 3.57 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.559 0.743 . . . . 62.23 110.529 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -104.64 78.87 1.49 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.909 0.883 . . . . 74.12 109.842 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 63.0 ttp 65.61 112.31 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 126.005 1.722 . . . . 61.05 112.105 178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -86.8 86.41 7.32 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.837 -0.801 . . . . 73.02 108.837 172.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.441 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 67.5 t80 -89.6 128.12 35.99 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.396 -0.594 . . . . 70.12 109.396 175.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -144.14 132.84 22.39 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.302 -0.629 . . . . 75.55 109.302 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 tt -86.1 134.57 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.9 -0.778 . . . . 74.41 108.9 176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -105.42 -51.44 3.01 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 122.523 0.329 . . . . 63.41 110.346 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -171.09 145.85 2.33 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.695 0.398 . . . . 73.42 109.934 -175.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 79.1 mt -124.05 138.45 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.116 -1.068 . . . . 44.11 108.116 174.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.681 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -170.94 146.18 2.46 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.547 0.339 . . . . 60.41 110.103 -177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -69.17 128.98 38.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 122.87 0.468 . . . . 73.44 110.448 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 12.0 mmtp -84.48 -46.26 11.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 122.054 0.931 . . . . 72.21 108.869 172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 8.0 t70 -134.79 136.95 42.94 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 114.175 -1.375 . . . . 74.31 109.325 -173.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 95.1 mt -134.56 139.65 47.35 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 N-CA-C 107.289 -1.374 . . . . 71.22 107.289 170.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.61 143.67 25.7 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-N 115.56 -0.745 . . . . 75.11 109.43 176.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -153.37 109.25 3.29 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.074 -1.084 . . . . 75.54 108.074 174.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -117.4 136.07 53.43 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.939 0.896 . . . . 74.33 109.106 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.78 91.7 10.38 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 108.46 -0.941 . . . . 62.41 108.46 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -65.95 -41.83 12.77 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 123.023 2.482 . . . . 75.41 112.367 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.522 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 33.0 m-20 -99.09 35.53 1.88 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.171 0.588 . . . . 74.13 109.687 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.481 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -59.55 -51.54 80.41 Favored Pre-proline 0 CA--C 1.556 1.211 0 CA-C-O 118.254 -0.879 . . . . 55.03 112.941 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 37.9 Cg_exo -64.79 -33.52 53.26 Favored 'Trans proline' 0 C--N 1.385 2.447 0 C-N-CA 121.783 1.656 . . . . 75.51 112.351 172.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.522 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -66.58 -19.5 65.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.52 1.128 . . . . 64.43 112.41 -178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.587 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 3.2 p -58.5 -14.36 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 113.043 0.757 . . . . 64.34 113.043 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -55.41 -40.66 71.72 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.06 0.944 . . . . 75.11 111.341 171.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -114.74 40.25 2.64 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.432 1.093 . . . . 74.11 109.84 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.587 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 0.0 OUTLIER -83.61 144.13 29.65 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.975 0.91 . . . . 72.41 110.721 178.334 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -88.1 113.57 23.87 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.625 -1.25 . . . . 74.15 107.625 163.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.3 m-90 -83.47 64.02 7.64 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.839 0.828 . . . . 71.42 110.161 -175.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.495 ' HG2' ' HB3' ' E' ' 140' ' ' SER . 74.1 mt-30 -142.44 52.58 2.47 Favored Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.977 1.311 . . . . 75.23 108.573 174.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.41 144.81 9.24 Favored 'Trans proline' 0 C--N 1.385 2.476 0 C-N-CA 122.023 1.816 . . . . 54.25 111.697 -175.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.585 ' HA ' HD22 ' E' ' 141' ' ' LEU . 38.5 tt0 -84.25 95.92 8.83 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.54 -0.911 . . . . 72.44 108.54 179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' C' ' 65' ' ' THR . 16.7 m -71.76 102.74 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.293 -0.867 . . . . 73.13 110.565 -178.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 94.1 mttt -91.97 100.2 12.9 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.159 -1.052 . . . . 65.22 108.159 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 pp -88.3 163.53 16.02 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.347 -0.612 . . . . 42.31 109.347 177.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 23.6 t70 -156.33 146.29 21.19 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.53 -0.915 . . . . 75.13 108.53 177.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -133.8 117.35 16.78 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.757 -1.201 . . . . 74.22 107.757 171.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -132.78 137.57 46.85 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.02 1.328 . . . . 75.43 107.861 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.8 t -113.11 149.82 32.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.428 0.633 . . . . 64.43 110.28 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.53 162.17 28.8 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.568 -1.196 . . . . 72.53 107.995 170.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.7 p -135.63 151.15 49.96 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.282 0.633 . . . . 53.54 109.7 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 39.4 t -149.91 125.99 10.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.098 -1.075 . . . . 71.34 108.098 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -83.63 120.52 26.08 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.184 -0.673 . . . . 74.21 109.184 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -92.79 -40.81 10.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.42 0.688 . . . . 63.01 109.842 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.62 175.3 11.3 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.832 -1.076 . . . . 64.32 109.339 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.67 123.74 18.34 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.542 0.526 . . . . 71.13 109.76 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 68.16 2.14 3.1 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 125.055 1.342 . . . . 73.12 113.554 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.76 112.35 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 108.46 -0.941 . . . . 54.42 108.46 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -125.05 122.51 37.44 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.513 0.673 . . . . 74.1 109.295 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.538 ' HB2' HD11 ' C' ' 51' ' ' LEU . 33.4 tt0 -85.46 138.36 32.28 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.161 -1.382 . . . . 75.13 108.303 170.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.552 HG23 HD11 ' C' ' 106' ' ' LEU . 17.5 m -130.25 143.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 N-CA-C 108.975 -0.75 . . . . 75.32 108.975 171.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 53.8 t -126.67 105.12 13.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.312 -0.995 . . . . 73.02 108.312 -174.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.8 tm? -92.54 104.39 16.7 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.168 -1.049 . . . . 74.22 108.168 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -79.07 124.07 27.94 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.386 1.074 . . . . 75.41 109.385 174.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.491 ' HB ' HD11 ' C' ' 114' ' ' ILE . 22.0 t -112.84 110.22 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.596 -1.261 . . . . 73.33 107.596 169.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 27.8 m -99.21 136.57 38.97 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.904 -1.147 . . . . 71.24 107.904 176.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 114' ' ' ILE . 64.9 t -135.94 113.16 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.135 0.974 . . . . 73.13 108.74 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' C' ' 40' ' ' VAL . 21.3 m -104.06 144.35 31.67 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.658 -0.867 . . . . 71.24 108.658 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.28 104.24 5.14 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 108.204 -1.036 . . . . 60.34 108.204 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.464 ' HB3' HG23 ' C' ' 72' ' ' THR . 56.5 p -159.91 169.16 24.1 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.113 0.565 . . . . 74.02 109.923 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 tt -120.73 -40.82 2.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 108.954 -0.758 . . . . 72.3 108.954 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -162.36 -97.8 0.12 Allowed Glycine 0 C--N 1.349 1.281 0 N-CA-C 110.799 -0.92 . . . . 51.11 110.799 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -88.08 -27.86 21.69 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.645 -0.872 . . . . 61.54 108.645 170.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -73.33 87.92 1.53 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.356 -0.838 . . . . 75.13 109.334 170.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 67' ' ' SER . 64.6 m -88.03 136.68 32.86 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.44 -0.8 . . . . 74.21 109.476 171.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.39 -63.95 1.28 Allowed 'General case' 0 C--O 1.236 0.362 0 N-CA-C 108.633 -0.877 . . . . 60.24 108.633 169.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -162.42 177.36 9.59 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.299 1.047 . . . . 75.12 111.96 -175.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.407 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.3 tm? -135.31 143.75 46.35 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 105.009 -2.219 . . . . 63.52 105.009 168.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.407 ' N ' HD13 ' C' ' 75' ' ' LEU . 44.9 t -149.49 144.15 26.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.106 -1.072 . . . . 61.52 108.106 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -158.85 131.24 6.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.557 -0.535 . . . . 74.52 109.557 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 87.6 t -126.98 120.75 56.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.975 -1.011 . . . . 74.42 108.725 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -99.15 90.39 4.57 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.807 -1.183 . . . . 74.13 107.807 176.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -79.96 108.86 13.87 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 114.261 -1.336 . . . . 63.21 109.511 -174.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 158.69 29.71 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.977 -0.556 . . . . 34.55 112.266 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -161.22 126.23 1.56 Allowed Glycine 0 C--N 1.338 0.67 0 N-CA-C 112.365 -0.294 . . . . 42.42 112.365 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.527 HD12 HD11 ' C' ' 51' ' ' LEU . 12.2 mm -88.4 124.62 41.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 N-CA-C 108.553 -0.906 . . . . 75.14 108.553 175.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -137.76 122.5 18.72 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.549 0.74 . . . . 63.42 109.674 -178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 49.7 m -90.36 110.44 21.52 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 122.965 0.506 . . . . 64.3 110.093 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.76 118.68 58.63 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 108.491 -0.929 . . . . 72.22 108.491 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.75 160.44 30.81 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.472 0.709 . . . . 70.04 111.531 -175.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.87 -61.15 3.79 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 115.48 -0.782 . . . . 73.55 112.389 173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 16.9 mm -91.02 145.71 7.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.007 0.923 . . . . 71.22 110.204 -179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 13.1 pt-20 -147.02 -171.31 3.74 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 124.3 1.04 . . . . 74.34 110.258 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 73.21 -143.34 32.95 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-N 116.171 -0.468 . . . . 72.4 113.316 177.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 35.9 p -66.84 -23.18 66.0 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.93 0.892 . . . . 73.33 111.914 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -71.06 -44.09 66.48 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.605 0.762 . . . . 63.12 110.994 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.495 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 21.6 ptt? -71.91 -32.96 67.89 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 109.447 -0.575 . . . . 65.24 109.447 175.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.15 -27.21 67.85 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.26 0.624 . . . . 44.15 110.989 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -73.42 -38.66 65.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.529 0.732 . . . . 75.0 110.411 170.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -67.97 -61.51 1.83 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.405 0.282 . . . . 73.51 111.297 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' C' ' 94' ' ' MET . 3.7 pp -76.3 -16.55 59.75 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.125 0.57 . . . . 74.22 112.142 -178.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.96 -24.02 23.81 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-O 119.768 -0.462 . . . . 70.41 113.352 -178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -129.43 -59.05 1.1 Allowed 'General case' 0 N--CA 1.483 1.2 0 CA-C-N 117.393 0.596 . . . . 64.45 111.819 -174.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -60.42 -57.27 13.46 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.74 0.816 . . . . 72.24 111.967 -172.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.492 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 47.4 m -62.05 -47.7 90.14 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 115.312 -0.858 . . . . 74.44 112.17 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.594 ' HB3' HD23 ' C' ' 60' ' ' LEU . 89.8 Cg_exo -54.03 -35.67 81.91 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.85 2.366 . . . . 75.55 114.594 169.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.99 -21.16 60.1 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.09 0.556 . . . . 75.22 111.368 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.513 HD12 HH12 ' A' ' 111' ' ' ARG . 21.8 mm -77.48 -35.05 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 123.464 0.706 . . . . 75.23 109.945 171.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.552 HD11 HG23 ' C' ' 58' ' ' VAL . 98.8 mt -76.45 -38.77 54.93 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.222 0.609 . . . . 74.55 111.992 -175.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -51.14 -41.35 74.15 Favored Pre-proline 0 N--CA 1.489 1.475 0 C-N-CA 124.359 1.063 . . . . 72.55 113.333 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.63 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 39.7 Cg_exo -43.9 -55.21 3.21 Favored 'Trans proline' 0 C--N 1.38 2.213 0 C-N-CA 122.643 2.229 . . . . 75.14 115.883 168.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.19 -30.63 71.13 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 121.328 0.585 . . . . 72.24 110.343 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.66 -39.6 73.5 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.093 -0.958 . . . . 71.13 111.274 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.481 ' HD3' ' CZ ' ' A' ' 109' ' ' TYR . 22.3 ttt180 -56.43 -51.76 67.18 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.492 0.717 . . . . 75.25 110.982 179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.75 -31.32 69.23 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 123.451 0.47 . . . . 74.41 110.667 -177.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.427 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 7.1 t -69.25 -28.11 66.03 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.664 0.386 . . . . 63.31 111.245 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.491 HD11 ' HB ' ' C' ' 62' ' ' VAL . 89.2 mt -79.17 -50.1 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 123.402 0.681 . . . . 74.02 110.141 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.9 m -65.55 -29.33 69.94 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 122.866 0.467 . . . . 61.53 111.353 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -63.98 -52.25 60.51 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.287 -0.634 . . . . 71.55 109.287 172.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.473 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.66 -40.69 75.93 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.629 1.172 . . . . 75.3 112.468 179.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.411 HG23 ' O ' ' C' ' 114' ' ' ILE . 78.6 t -65.75 -43.4 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 123.555 0.742 . . . . 74.14 110.383 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.418 ' HB2' HE22 ' C' ' 125' ' ' GLN . 37.9 t -69.6 -25.0 63.75 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.786 -0.643 . . . . 64.44 111.451 176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.419 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 81.2 mtt-85 -72.03 -34.37 68.75 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.3 0.64 . . . . 74.24 109.994 176.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.67 6.34 74.15 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.618 0.574 . . . . 74.2 113.146 172.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.584 HG23 ' HB3' ' D' ' 17' ' ' TYR . 44.4 p 65.28 22.23 12.08 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.722 2.009 . . . . 73.45 113.268 178.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -84.52 162.12 51.77 Favored Pre-proline 0 N--CA 1.487 1.405 0 C-N-CA 123.84 0.856 . . . . 71.22 110.415 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.479 ' HD3' HG13 ' E' ' 136' ' ' VAL . 36.7 Cg_endo -64.06 151.05 86.98 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.657 2.238 . . . . 61.42 113.074 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.418 HE22 ' HB2' ' C' ' 119' ' ' SER . 24.4 mm-40 -60.26 112.36 1.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.965 0.906 . . . . 62.33 112.036 -172.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.61 90.35 3.28 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.346 0.658 . . . . 75.02 110.089 -175.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -92.47 118.49 31.01 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.491 0.716 . . . . 74.34 109.937 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.458 ' O ' ' HD2' ' C' ' 111' ' ' ARG . 3.0 mm? -87.19 135.07 33.44 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.985 0.914 . . . . 73.01 109.233 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.75 141.86 87.8 Favored Pre-proline 0 CA--C 1.552 1.039 0 C-N-CA 123.451 0.7 . . . . 75.11 111.153 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.518 ' HB3' ' HE2' ' A' ' 109' ' ' TYR . 38.5 Cg_endo -65.65 125.72 14.84 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.4 2.067 . . . . 63.0 111.302 174.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 65.9 t -96.43 114.24 32.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.526 -0.916 . . . . 71.13 108.526 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.642 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 0.8 OUTLIER -77.61 75.22 4.16 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.005 0.922 . . . . 72.22 109.958 -177.39 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -81.55 -43.61 18.48 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.733 0.413 . . . . 72.21 110.188 -176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.95 -45.66 60.26 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.958 -0.565 . . . . 74.03 110.015 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -63.74 -20.7 65.95 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.83 -1.077 . . . . 75.24 111.984 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 28.8 tp -64.22 -37.51 87.73 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.62 0.768 . . . . 75.13 110.765 174.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -79.92 -31.3 40.12 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.059 0.544 . . . . 64.22 110.728 175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.528 ' HA ' ' HB3' ' C' ' 142' ' ' GLN . 85.4 mtp -64.21 -44.03 93.2 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.083 0.553 . . . . 55.04 111.739 -178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -68.39 -34.65 76.42 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 123.085 0.241 . . . . 73.3 110.436 178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -63.99 -84.42 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.903 0.881 . . . . 73.01 110.954 177.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 57.3 tp -142.17 95.19 2.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.017 0.527 . . . . 73.33 109.677 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.528 ' HB3' ' HA ' ' C' ' 138' ' ' MET . 53.9 tt0 -170.32 112.55 0.44 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.956 0.903 . . . . 52.31 109.129 175.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.92 7.3 3.45 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.754 0.821 . . . . 44.31 111.005 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -83.05 175.81 9.72 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.893 0.877 . . . . 73.53 111.127 176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.74 82.98 0.17 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.375 1.07 . . . . 74.13 110.423 -178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -162.7 -34.7 0.02 OUTLIER Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.366 -0.834 . . . . 73.32 111.749 -174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -83.43 112.72 20.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 108.16 -1.052 . . . . 70.1 108.16 173.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -132.37 -162.53 10.37 Favored Glycine 0 C--N 1.337 0.614 0 CA-C-N 115.585 -0.734 . . . . 44.01 111.758 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 2.5 t -72.81 82.84 1.18 Allowed 'General case' 0 CA--C 1.552 1.041 0 CA-C-O 121.697 0.76 . . . . 65.04 109.896 174.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.584 ' HG2' ' HB3' ' C' ' 4' ' ' GLN . 11.7 pt-20 -70.46 -31.56 68.77 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.12 -0.946 . . . . 71.25 110.93 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.446 ' HG3' ' HG3' ' C' ' 150' ' ' GLU . 1.8 pp20? -135.69 144.28 45.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.854 0.862 . . . . 72.3 109.72 174.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 177.5 116.29 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.93 1.692 . . . . 72.35 108.048 176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -78.31 145.39 35.36 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.918 -0.771 . . . . 50.3 108.918 168.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -61.96 95.81 0.06 Allowed 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.312 1.045 . . . . 75.23 111.482 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.885 0 C-N-CA 124.054 0.941 . . . . 53.12 109.779 -175.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 63.1 mtt . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.324 -0.621 . . . . 74.3 109.324 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m -149.88 90.97 1.74 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.066 0.947 . . . . 63.32 108.907 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -104.9 118.42 36.49 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.24 -1.393 . . . . 52.15 107.24 173.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -68.17 119.23 12.42 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.146 0.498 . . . . 74.24 110.717 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -76.43 104.88 7.17 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 107.075 -1.454 . . . . 71.42 107.075 164.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -66.32 87.76 0.12 Allowed 'General case' 0 C--N 1.352 0.715 0 CA-C-O 121.617 0.722 . . . . 74.42 109.493 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -128.71 170.11 13.68 Favored 'General case' 0 C--O 1.246 0.883 0 C-N-CA 125.21 1.404 . . . . 71.14 108.124 177.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -71.48 83.37 0.82 Allowed 'General case' 0 C--O 1.239 0.544 0 N-CA-C 109.342 -0.614 . . . . 63.32 109.342 172.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.486 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.5 ptm -32.18 129.99 0.17 Allowed 'General case' 0 C--N 1.363 1.194 0 C-N-CA 125.316 1.446 . . . . 44.21 112.664 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 32.7 m -115.36 143.08 45.81 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 122.782 0.433 . . . . 74.14 109.868 -177.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' D' ' 85' ' ' SER . 80.8 t80 -157.14 94.67 1.43 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 107.636 -1.246 . . . . 65.2 107.636 171.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -112.95 121.47 44.75 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.641 -0.709 . . . . 72.1 109.351 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -73.88 99.65 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 106.974 -1.491 . . . . 51.44 106.974 174.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -79.17 -46.92 16.98 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.682 -0.236 . . . . 73.1 110.915 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.496 ' HD3' HD12 ' D' ' 83' ' ' ILE . 43.4 ttt180 -169.04 131.66 1.27 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.213 -0.449 . . . . 61.04 111.964 -161.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.7 138.5 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 N-CA-C 107.772 -1.195 . . . . 63.3 107.772 169.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' C' ' 122' ' ' THR . 10.1 p90 -164.76 177.3 8.07 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-O 121.872 0.844 . . . . 71.45 111.212 -176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.8 p -109.69 118.46 36.6 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.869 -1.06 . . . . 71.43 109.351 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.42 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 37.7 mtpt -88.57 -23.96 22.99 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 109.624 -0.51 . . . . 73.43 109.624 176.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.8 t70 -156.84 130.43 8.14 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 114.95 -1.023 . . . . 73.03 109.228 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' C' ' 117' ' ' MET . 68.6 mt -128.09 135.87 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.261 1.024 . . . . 74.04 108.292 175.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 22.8 t -134.83 137.48 43.35 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 124.082 0.953 . . . . 70.13 108.473 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 84.9 t80 -149.5 120.55 7.72 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.318 -1.364 . . . . 72.43 107.318 172.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 1.8 mp0 -120.41 137.65 54.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.993 -0.743 . . . . 75.02 108.993 -178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.41 81.07 37.7 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 108.32 -0.993 . . . . 62.13 108.32 172.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.3 -44.1 0.33 Allowed 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.753 2.302 . . . . 71.11 112.764 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' D' ' 72' ' ' THR . 81.4 m-20 -100.87 44.36 1.02 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.217 1.007 . . . . 64.34 108.637 177.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.681 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.74 -53.57 63.05 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-N 114.118 -1.401 . . . . 75.33 114.471 -173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.72 6.65 5.46 Favored 'Trans proline' 0 C--N 1.392 2.868 0 CA-C-N 121.972 1.74 . . . . 65.4 112.662 173.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.533 ' HA ' HE21 ' D' ' 33' ' ' GLN . 4.9 t-160 -85.06 -46.23 11.35 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.32 1.048 . . . . 65.24 109.323 177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -72.88 -16.98 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 CA-C-O 121.169 0.509 . . . . 72.11 110.699 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -56.54 -30.23 62.84 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.734 1.214 . . . . 75.14 111.854 168.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' D' ' 30' ' ' HIS . 35.9 mt-30 -82.7 -16.4 48.25 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.71 0.804 . . . . 72.03 111.056 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.612 ' HB3' HD23 ' D' ' 68' ' ' LEU . 85.7 mttt -109.53 112.41 24.49 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.005 0.922 . . . . 73.04 111.537 -173.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.416 ' HA ' HD11 ' F' ' 139' ' ' LEU . 3.8 m-20 -99.91 71.65 1.67 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.812 0.845 . . . . 62.41 110.873 -178.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -164.57 158.85 18.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 109.083 -0.71 . . . . 74.51 109.083 177.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.505 ' HB3' HD12 ' F' ' 141' ' ' LEU . 26.9 tp60 -62.02 114.09 10.46 Favored Pre-proline 0 N--CA 1.484 1.267 0 C-N-CA 123.075 0.55 . . . . 54.24 111.436 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.614 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 43.6 Cg_exo -60.06 114.82 2.26 Favored 'Trans proline' 0 C--N 1.368 1.603 0 C-N-CA 121.972 1.781 . . . . 64.42 109.647 168.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.31 121.66 10.69 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 124.207 0.942 . . . . 71.51 109.897 -174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -96.67 112.32 28.53 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 CA-C-N 115.375 -0.829 . . . . 55.3 110.292 -168.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.599 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 63.0 tttt -87.07 142.02 28.23 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.922 -1.14 . . . . 72.03 107.922 167.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -114.39 139.88 49.12 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.663 -0.866 . . . . 72.12 108.663 178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 9.2 t70 -141.9 149.1 39.76 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 107.725 -1.213 . . . . 74.42 107.725 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 pp -137.29 166.32 24.07 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.053 0.541 . . . . 65.25 110.971 -175.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.5 t70 -170.18 156.11 5.71 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.766 1.227 . . . . 70.33 108.033 178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.1 t -135.08 161.18 36.04 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.061 0.545 . . . . 64.22 109.828 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.93 163.47 38.63 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.831 0.852 . . . . 62.31 109.076 177.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 22.9 m -148.93 153.48 38.04 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.138 0.575 . . . . 53.13 110.092 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.4 p -159.77 121.64 3.3 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.464 0.706 . . . . 52.45 109.366 -179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -72.5 124.88 26.11 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 109.134 -0.691 . . . . 71.43 109.134 174.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.451 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.6 mt -94.08 -33.69 13.28 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.799 0.44 . . . . 73.32 110.423 179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.46 -172.02 2.07 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 115.002 -0.999 . . . . 73.12 110.595 -172.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.1 116.42 6.48 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.804 176.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 10.1 m-20 63.32 19.29 11.6 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 73.24 112.068 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -119.53 120.5 63.71 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 N-CA-C 108.819 -0.808 . . . . 74.23 108.819 173.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -130.4 129.38 42.99 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.881 -0.785 . . . . 65.22 108.881 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.451 ' HB2' HD11 ' D' ' 51' ' ' LEU . 10.3 tm-20 -100.8 137.45 39.16 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.801 -1.185 . . . . 74.35 107.801 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.525 HG11 ' HB3' ' D' ' 102' ' ' CYS . 4.2 p -127.17 134.17 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.673 -0.862 . . . . 75.53 108.673 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 80.3 t -106.08 131.08 56.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 123.153 0.581 . . . . 44.12 109.756 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -107.38 120.97 43.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 106.808 -1.553 . . . . 65.21 106.808 174.224 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.6 ttm-85 -105.39 107.36 18.3 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 108.711 -0.848 . . . . 73.22 108.711 178.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 77.4 t -107.44 124.29 63.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 124.052 0.941 . . . . 64.32 108.662 178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 8.8 m -125.04 130.66 52.76 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.235 0.614 . . . . 72.34 110.124 -172.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 64.3 t -125.64 107.45 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.382 1.073 . . . . 74.03 109.104 -173.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.0 m -103.19 96.92 7.1 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.262 0.625 . . . . 73.44 109.583 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.614 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -97.18 124.73 41.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.972 -0.751 . . . . 72.43 108.972 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.423 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 69.5 m -147.31 130.48 16.46 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.673 0.789 . . . . 53.23 109.419 -177.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.612 HD23 ' HB3' ' D' ' 34' ' ' LYS . 35.7 tp -116.81 121.8 42.57 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.355 -0.609 . . . . 43.22 109.355 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.99 -113.66 4.24 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.576 -0.609 . . . . 64.34 111.576 -175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.29 2.42 8.48 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.318 0.647 . . . . 63.45 110.944 175.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -115.46 150.96 35.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.045 0.538 . . . . 71.1 110.618 -174.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' D' ' 27' ' ' ASN . 94.3 m -69.45 120.68 15.61 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-N 114.586 -1.188 . . . . 71.44 110.205 176.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -83.4 -59.64 2.39 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 122.941 0.496 . . . . 74.34 109.664 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -157.31 152.61 26.22 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.394 -0.821 . . . . 72.45 110.454 172.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.48 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 85.8 mt -124.29 153.34 41.88 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.562 1.145 . . . . 75.31 109.823 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.511 ' SG ' HG23 ' D' ' 114' ' ' ILE . 44.3 t -158.31 146.17 18.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.64 -0.709 . . . . 72.0 110.356 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.88 132.11 11.04 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.8 -0.815 . . . . 72.41 108.8 172.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.8 t -129.59 124.24 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 122.744 0.418 . . . . 74.05 109.994 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.593 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 40.5 mt-30 -88.97 85.09 6.64 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.767 -0.827 . . . . 73.33 108.767 166.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -79.83 96.79 6.42 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.203 -1.362 . . . . 74.41 108.593 178.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.06 155.95 24.0 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-N 116.302 -0.408 . . . . 52.2 112.179 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.567 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -153.21 133.77 4.15 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.645 0.223 . . . . 71.21 112.683 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.496 HD12 ' HD3' ' D' ' 15' ' ' ARG . 68.5 mt -89.24 126.0 42.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.801 0 C-N-CA 124.067 0.947 . . . . 70.45 109.502 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -132.96 138.44 46.9 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.411 0.685 . . . . 75.02 109.835 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 24.9 m -91.66 100.15 12.93 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.472 0.709 . . . . 75.13 109.502 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.8 mt -108.1 116.69 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.638 0.775 . . . . 55.03 110.384 -172.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -147.67 162.5 39.02 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.228 1.011 . . . . 52.11 110.801 -177.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.49 -20.19 6.36 Favored Glycine 0 C--N 1.352 1.438 0 N-CA-C 114.879 0.712 . . . . 71.33 114.879 174.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 33.2 pt -114.51 157.81 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.054 0.942 . . . . 72.23 110.493 -174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.24 -174.55 4.99 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.692 0.797 . . . . 63.44 110.84 -175.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.67 -133.85 51.48 Favored Glycine 0 C--N 1.354 1.531 0 O-C-N 123.717 0.636 . . . . 74.03 113.711 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -73.9 -22.54 59.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.307 0.643 . . . . 73.53 110.722 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -70.34 -41.06 73.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.806 0.842 . . . . 72.4 111.041 -177.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 4.2 ppp? -75.12 -30.43 60.85 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 109.995 -0.372 . . . . 60.31 109.995 176.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.59 -26.4 63.5 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.241 0.616 . . . . 64.53 110.949 175.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -79.45 -44.13 21.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.898 0.879 . . . . 73.22 110.693 174.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 50.8 t -66.5 -48.91 68.29 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 116.173 -0.467 . . . . 54.24 110.92 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 tt -81.01 -39.5 25.76 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.693 0.797 . . . . 64.33 109.812 -176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.42 -27.58 35.66 Favored Glycine 0 C--N 1.348 1.24 0 CA-C-O 119.69 -0.505 . . . . 74.42 114.251 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -115.88 -53.2 2.58 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.852 0.826 . . . . 61.2 111.391 -172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -74.09 -44.97 52.06 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.546 0.573 . . . . 64.53 112.546 -174.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.525 ' HB3' HG11 ' D' ' 58' ' ' VAL . 72.4 m -63.48 -46.48 84.02 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.417 -0.801 . . . . 63.34 112.499 -176.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.601 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 31.9 Cg_exo -64.23 -30.07 64.36 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 122.12 1.88 . . . . 70.32 112.862 171.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -66.84 -31.36 71.92 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.334 0.654 . . . . 74.0 110.363 176.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -69.95 -42.83 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 123.501 0.721 . . . . 75.21 109.974 171.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.567 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.2 mt -74.42 -18.47 60.64 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.87 -0.605 . . . . 71.44 111.72 -175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -68.26 -42.76 31.14 Favored Pre-proline 0 CA--C 1.557 1.247 0 N-CA-C 114.314 1.227 . . . . 73.23 114.314 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -58.66 -32.1 96.12 Favored 'Trans proline' 0 C--N 1.383 2.358 0 CA-C-N 121.627 1.617 . . . . 71.44 112.871 171.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -81.45 -30.06 33.58 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.386 0.674 . . . . 73.0 110.995 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.49 -53.98 43.62 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.641 -0.874 . . . . 72.3 108.641 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -53.12 -50.09 65.19 Favored 'General case' 0 C--N 1.353 0.746 0 CA-C-N 113.91 -1.495 . . . . 73.42 110.981 177.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.92 -44.17 93.72 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.924 0.765 . . . . 53.11 111.661 -175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.9 t -58.71 -41.47 86.42 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 123.567 0.542 . . . . 54.05 110.761 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.511 HG23 ' SG ' ' D' ' 76' ' ' CYS . 74.0 mt -66.26 -53.81 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 CA-C-N 115.093 -0.958 . . . . 63.3 110.21 176.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.515 HG23 ' HG3' ' D' ' 125' ' ' GLN . 37.5 m -54.46 -38.35 66.29 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.771 1.228 . . . . 53.11 111.765 -176.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -70.19 -46.23 65.03 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.356 -0.838 . . . . 53.42 110.805 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.4 mtm -63.42 -33.07 74.76 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.782 0.433 . . . . 75.42 111.74 176.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' D' ' 123' ' ' PHE . 39.6 t -68.2 -40.66 83.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-N 114.922 -1.035 . . . . 60.13 110.225 177.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -76.08 -22.91 55.08 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.263 0.225 . . . . 65.04 111.335 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.427 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 85.1 mtt-85 -76.85 -33.08 57.91 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.503 0.721 . . . . 74.33 109.487 173.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.47 0.84 88.49 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-N 115.43 -0.804 . . . . 65.14 112.079 171.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 26.0 p 61.54 17.86 8.91 Favored 'General case' 0 CA--C 1.562 1.407 0 C-N-CA 126.921 2.088 . . . . 71.31 113.417 174.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.52 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 30.1 m-85 -82.94 168.97 19.37 Favored Pre-proline 0 CA--C 1.566 1.57 0 C-N-CA 125.615 1.566 . . . . 75.4 110.634 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 52.5 Cg_endo -64.17 135.7 48.31 Favored 'Trans proline' 0 C--N 1.389 2.667 0 C-N-CA 123.007 2.471 . . . . 60.22 113.135 -177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.515 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.2 tt0 -55.21 131.5 45.5 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.895 0.878 . . . . 64.32 111.778 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.88 97.62 7.42 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.92 0.888 . . . . 64.24 108.722 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -97.44 86.9 3.98 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.336 -0.987 . . . . 74.51 108.336 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.58 123.3 18.45 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 114.806 -1.088 . . . . 74.21 109.489 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.73 131.66 86.01 Favored Pre-proline 0 CA--C 1.545 0.755 0 O-C-N 123.727 0.642 . . . . 75.23 110.768 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.37 115.36 3.3 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 121.966 1.777 . . . . 61.23 111.329 -177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 64.7 t -106.45 108.93 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.31 -0.626 . . . . 70.24 109.31 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.515 HD21 ' HB2' ' D' ' 134' ' ' ASP . 18.6 t-20 -84.99 103.74 14.3 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.297 -0.865 . . . . 61.12 109.046 176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -73.24 -22.36 60.43 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.393 -0.821 . . . . 75.02 111.173 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.515 ' HB2' HD21 ' D' ' 132' ' ' ASN . 20.9 m-20 -58.01 -54.48 46.5 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.69 1.196 . . . . 63.35 112.477 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.79 84.73 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 123.967 0.792 . . . . 72.41 111.865 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 40.5 tp -73.57 -43.52 59.63 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.791 0.837 . . . . 70.53 110.976 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.52 -29.38 64.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.488 0.715 . . . . 74.35 110.715 178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 34.7 ttm -60.18 -27.15 66.89 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 124.567 1.147 . . . . 52.03 111.89 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.552 ' HA ' HE21 ' D' ' 142' ' ' GLN . 8.3 t30 -72.63 -30.49 64.37 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.727 0.811 . . . . 73.41 111.535 178.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -62.39 -31.63 72.33 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.004 0.922 . . . . 70.32 111.383 176.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.36 -27.36 68.46 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.647 0.779 . . . . 71.14 111.195 177.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.552 HE21 ' HA ' ' D' ' 139' ' ' ASN . 31.9 mt-30 -89.39 0.62 56.7 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.432 0.693 . . . . 54.4 111.625 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -134.02 51.08 2.15 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.953 0.901 . . . . 73.3 110.0 -177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -141.99 124.53 15.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.358 0.599 . . . . 71.32 109.967 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -163.96 148.8 10.4 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.556 1.142 . . . . 63.02 108.547 -179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 117.75 120.63 3.07 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 112.025 -0.43 . . . . 22.12 112.025 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -102.56 74.94 1.4 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 107.987 -1.116 . . . . 43.52 107.987 172.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.43 140.36 21.89 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 115.34 -0.845 . . . . 30.44 112.307 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -134.3 174.33 10.63 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.505 0.722 . . . . 52.23 110.288 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.1 153.89 37.18 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 123.691 0.796 . . . . 65.51 109.832 178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.04 134.25 34.22 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.582 0.753 . . . . 74.15 109.471 178.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -115.41 114.22 24.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.276 -1.009 . . . . 55.42 108.276 175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -81.11 64.64 5.93 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.659 0.743 . . . . 71.21 110.183 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.57 116.32 22.53 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.387 -0.824 . . . . 71.14 110.023 -177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.086 0 C-N-CA 124.077 0.951 . . . . 73.42 109.203 -175.309 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.614 0.245 . . . . 74.22 110.415 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -82.05 123.0 28.53 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.062 -0.517 . . . . 71.21 110.571 -177.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -149.27 104.9 3.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.236 1.014 . . . . 44.14 108.601 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -126.76 128.67 46.99 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.127 0.571 . . . . 75.32 110.566 -172.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -71.27 133.79 46.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 108.958 -0.756 . . . . 75.21 108.958 172.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -158.57 -83.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.137 -0.32 . . . . 74.32 110.137 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -149.31 -177.13 5.67 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.132 0.973 . . . . 70.02 110.334 -175.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.47 ' HG ' ' HG3' ' B' ' 94' ' ' MET . 6.7 mp -83.69 71.81 10.37 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.776 0.83 . . . . 73.21 109.916 174.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -146.97 156.35 47.37 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 124.414 1.085 . . . . 71.45 109.705 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.29 133.34 40.02 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 121.995 1.796 . . . . 75.12 111.102 173.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -68.38 -150.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 124.393 1.077 . . . . 74.42 111.308 177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 39.8 m -45.38 -56.9 4.47 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 124.513 1.125 . . . . 75.11 113.092 -175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 73.55 -27.59 0.19 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 124.934 1.294 . . . . 65.03 112.97 176.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -73.1 81.6 1.26 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.087 0.955 . . . . 62.21 110.072 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . 0.405 ' HB3' ' CE1' ' B' ' 140' ' ' TYR . . . -168.4 17.01 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.113 1.365 . . . . 75.34 109.814 174.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . 0.53 HG12 HD11 ' B' ' 136' ' ' LEU . 11.7 m -70.87 76.13 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.908 0.883 . . . . 54.43 110.715 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 38.2 ptt85 -63.15 -38.17 90.13 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 115.159 -0.928 . . . . 73.44 111.461 -176.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.67 -148.63 0.48 Allowed 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.408 1.068 . . . . 72.45 110.467 -178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 67.48 170.09 0.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.886 0.874 . . . . 75.1 111.452 172.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 113.05 -114.78 3.5 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 111.439 -0.664 . . . . 41.22 111.439 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -103.28 66.7 0.9 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-O 121.822 0.82 . . . . 51.11 109.961 -175.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -98.16 -54.55 3.04 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.09 0.956 . . . . 70.43 109.277 176.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 41.6 mm -80.87 73.99 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 107.59 -1.263 . . . . 72.14 107.59 171.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.93 82.6 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.427 -1.26 . . . . 55.2 111.743 -174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -133.17 142.43 44.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.853 . . . . 64.25 109.993 -175.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -89.07 25.67 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 123.241 2.627 . . . . 65.54 113.104 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 19.2 pt -64.18 127.5 24.9 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.798 0.839 . . . . 61.51 110.636 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.28 59.03 4.78 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.055 0.942 . . . . 75.52 111.681 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.479 HG13 ' HD3' ' C' ' 124' ' ' PRO . 14.3 t -91.51 58.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 N-CA-C 108.043 -1.095 . . . . 72.15 108.043 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -115.74 -44.59 2.93 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 115.225 -0.898 . . . . 74.44 111.324 -170.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -150.98 154.06 36.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.476 0.711 . . . . 75.21 110.463 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 4.3 mp -86.41 117.23 25.07 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.297 -1.001 . . . . 74.22 108.297 176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . 0.495 ' HB3' ' HG2' ' C' ' 37' ' ' GLN . 45.4 t -63.82 -36.69 84.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.929 0.492 . . . . 71.11 111.094 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . 0.585 HD22 ' HA ' ' C' ' 39' ' ' GLU . 3.7 tt -104.18 110.59 22.85 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.079 -1.082 . . . . 61.52 108.079 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 7.5 tt -167.46 117.89 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 123.891 0.876 . . . . 74.03 110.155 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 61.41 160.36 0.06 Allowed 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 124.736 1.215 . . . . 74.2 114.075 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -159.26 64.79 0.39 Allowed 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.617 -1.174 . . . . 61.42 108.364 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt 69.55 -2.31 1.97 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 125.045 1.338 . . . . 70.51 112.705 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -86.78 25.65 1.25 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.562 0.745 . . . . 63.23 111.83 -173.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . 0.448 HD12 ' N ' ' E' ' 148' ' ' LEU . 3.4 pp -62.19 -31.62 72.16 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.986 0.514 . . . . 75.04 110.877 169.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.448 ' N ' HD12 ' E' ' 147' ' ' LEU . 39.8 tp -169.69 87.82 0.57 Allowed Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 125.093 1.357 . . . . 75.41 107.523 174.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 CA--C 1.563 1.954 0 C-N-CA 122.681 2.254 . . . . 51.35 112.34 178.318 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.118 -0.697 . . . . 74.51 109.118 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -69.22 -54.6 13.92 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.551 0.532 . . . . 74.03 111.095 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 53.82 57.29 6.18 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-O 122.014 0.911 . . . . 73.43 111.24 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -91.61 12.11 22.11 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.966 -1.015 . . . . 74.3 112.939 -173.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -57.94 -59.59 5.02 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.369 0.667 . . . . 75.15 110.976 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -169.1 112.46 0.53 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.914 0.886 . . . . 73.14 109.311 174.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 24.8 pttm -160.81 176.3 11.63 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.706 0.802 . . . . 74.4 109.728 172.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.817 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 8.8 mp 61.0 45.55 9.23 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.425 1.09 . . . . 62.34 112.116 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -140.19 114.7 7.64 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 107.946 -1.131 . . . . 74.4 107.946 167.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . 0.507 ' HD3' HD21 ' A' ' 98' ' ' LEU . 16.8 Cg_endo -99.91 -162.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.368 1.586 0 C-N-CA 123.769 2.979 . . . . 71.51 114.369 -169.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -62.61 155.89 24.85 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 114.6 -1.182 . . . . 73.41 110.589 167.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 10.0 t -77.48 -19.97 55.11 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 122.574 0.35 . . . . 73.14 111.308 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 25.9 t90 69.43 -68.75 0.18 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.132 1.373 . . . . 74.53 111.388 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.1 t70 69.48 87.48 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.131 . . . . 72.24 110.894 176.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.61 103.36 0.1 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 24.14 109.178 174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 58.7 t -122.6 107.77 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 123.442 0.697 . . . . 72.24 110.099 -177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . 0.419 ' HA ' ' HE ' ' F' ' 124' ' ' ARG . 4.0 tpm_? -106.03 85.72 2.25 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 107.762 -1.199 . . . . 73.35 107.762 172.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -115.75 143.3 45.57 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.763 0.825 . . . . 74.12 109.452 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -128.78 144.61 51.21 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.56 0.744 . . . . 71.44 109.635 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . 0.433 ' HA3' HD21 ' A' ' 42' ' ' LEU . . . -148.12 21.39 1.41 Allowed Glycine 0 C--N 1.347 1.156 0 O-C-N 123.235 0.334 . . . . 71.44 113.222 -178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.28 65.96 8.23 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.976 0.894 . . . . 75.31 108.776 176.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' F' ' 129' ' ' LEU . 3.7 pp -102.18 -14.96 16.82 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.304 -1.316 . . . . 73.43 110.782 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 13.9 tt -66.03 88.72 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-O 122.863 1.316 . . . . 73.11 109.693 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -137.08 -41.34 0.58 Allowed 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 113.931 -1.486 . . . . 73.35 109.425 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -62.79 108.93 1.94 Allowed Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 123.65 0.78 . . . . 71.52 111.087 -178.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.04 111.75 2.74 Favored 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 122.697 2.264 . . . . 74.15 111.109 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 6.0 tp -167.63 77.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.851 0 CA-C-O 122.364 1.078 . . . . 64.32 108.853 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.712 ' HB1' ' HE1' ' A' ' 36' ' ' TRP . . . -78.99 112.38 16.13 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 108.059 -1.089 . . . . 73.32 108.059 172.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.507 ' HA ' HD13 ' F' ' 139' ' ' LEU . 16.2 t -72.83 -8.15 11.0 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.334 0 C-N-CA 124.355 1.062 . . . . 71.21 110.641 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -69.61 -32.92 71.92 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.444 1.497 . . . . 73.41 111.074 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.86 -27.38 66.63 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.265 0.626 . . . . 53.12 110.274 174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' F' ' 136' ' ' VAL . 7.0 mp -80.16 2.08 25.63 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.483 -0.78 . . . . 71.31 111.836 177.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 20.4 m -110.3 105.68 14.8 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.206 0.603 . . . . 62.34 110.365 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . 0.505 HD12 ' HB3' ' D' ' 37' ' ' GLN . 80.0 mt -130.78 -49.7 1.04 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.248 1.019 . . . . 64.24 108.894 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 37.6 mm 67.48 127.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 C-N-CA 125.396 1.478 . . . . 71.22 112.526 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -55.05 145.06 21.63 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 124.746 1.218 . . . . 75.33 112.074 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -157.06 127.18 6.36 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 122.96 0.504 . . . . 75.45 110.36 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . 0.484 ' HA ' ' HE2' ' F' ' 145' ' ' LYS . 6.0 mmpt? -144.19 -46.83 0.26 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.197 0.999 . . . . 73.03 109.715 176.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -138.05 -59.57 0.64 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.189 -1.041 . . . . 73.13 108.189 175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 62.4 mt 65.05 22.6 12.39 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.997 1.319 . . . . 54.41 111.434 -175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 8.1 mp 55.17 74.68 0.69 Allowed Pre-proline 0 CA--C 1.556 1.207 0 C-N-CA 124.864 1.266 . . . . 74.01 111.114 -174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.379 2.155 0 C-N-CA 122.771 2.314 . . . . 62.13 112.858 -178.686 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.461 -0.57 . . . . 63.2 109.461 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.453 ' HB3' HE22 ' A' ' 4' ' ' GLN . 38.7 m -150.02 91.25 1.76 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.128 0.571 . . . . 53.31 110.104 178.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -120.52 92.24 3.72 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.725 0.81 . . . . 75.33 109.101 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.453 HE22 ' HB3' ' A' ' 2' ' ' SER . 0.1 OUTLIER -136.83 144.03 43.42 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.055 0.942 . . . . 64.34 109.017 177.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -83.13 72.08 10.14 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.675 0.75 . . . . 75.3 110.199 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.3 p-10 -93.88 -166.69 1.55 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.014 -0.994 . . . . 54.34 110.059 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.431 HG23 ' SD ' ' A' ' 9' ' ' MET . 8.8 t -62.64 154.95 27.59 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 123.364 0.666 . . . . 71.33 111.495 176.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -91.46 130.19 37.33 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.541 -0.754 . . . . 72.1 108.998 171.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.431 ' SD ' HG23 ' A' ' 7' ' ' THR . 3.6 mpp? -98.62 137.86 36.65 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.072 -0.714 . . . . 72.45 109.072 175.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 93.9 m -140.24 130.06 24.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.545 0.738 . . . . 72.42 109.24 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' HA ' HG22 ' A' ' 86' ' ' ILE . 49.0 m-85 -136.35 112.14 9.48 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 107.291 -1.374 . . . . 75.04 107.291 176.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -132.77 134.44 44.72 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.042 0.537 . . . . 65.22 110.702 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.699 ' HB ' HD13 ' E' ' 147' ' ' LEU . 3.3 mp -86.25 97.09 5.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 106.448 -1.686 . . . . 73.31 106.448 167.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -72.83 -40.2 65.97 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.216 0.606 . . . . 71.32 109.912 -174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 27.5 ttt180 -165.31 140.93 5.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.745 -0.835 . . . . 73.42 108.745 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.4 pp -131.13 137.96 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.646 -0.872 . . . . 65.13 108.646 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -171.69 170.97 5.44 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.808 0.693 . . . . 72.01 111.195 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -91.06 117.95 30.0 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.446 -0.797 . . . . 71.35 109.213 174.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.634 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 34.4 mtpt -80.54 -28.84 37.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 110.04 -0.356 . . . . 63.1 110.04 172.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 15.3 t70 -149.13 142.16 24.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.582 -0.735 . . . . 62.42 110.301 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG23 ' SD ' ' A' ' 117' ' ' MET . 59.0 mt -134.66 136.18 52.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.29 -1.374 . . . . 74.52 107.29 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 48.4 t -142.98 129.7 20.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.461 -0.94 . . . . 72.35 108.461 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.505 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 89.3 t80 -144.36 122.53 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.375 -1.343 . . . . 63.4 107.375 177.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.63 143.69 51.14 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 109.148 -0.686 . . . . 72.4 109.148 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -135.22 73.98 63.05 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 107.503 -1.295 . . . . 64.2 107.503 171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.42 -32.03 20.84 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.588 2.192 . . . . 74.15 111.204 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.413 ' O ' HG23 ' A' ' 31' ' ' VAL . 86.5 m-20 -103.92 30.6 5.03 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 114.699 -1.137 . . . . 75.13 109.768 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.42 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -55.71 -46.53 99.72 Favored Pre-proline 0 CA--C 1.563 1.447 0 CA-C-O 118.578 -0.725 . . . . 61.22 112.7 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 38.4 Cg_exo -61.46 -28.28 83.43 Favored 'Trans proline' 0 C--N 1.396 3.047 0 C-N-CA 121.828 1.686 . . . . 71.25 112.98 171.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -74.21 -32.92 63.22 Favored 'General case' 0 C--O 1.205 -1.274 0 CA-C-N 116.038 -0.528 . . . . 71.21 110.448 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 27' ' ' ASN . 55.1 t -63.51 -27.54 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.511 0.596 . . . . 55.34 111.659 -176.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -71.09 -39.66 72.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.417 0.687 . . . . 75.31 111.591 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -88.77 -38.29 14.79 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 123.383 0.673 . . . . 71.31 111.125 -177.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HB3' HD11 ' A' ' 68' ' ' LEU . 13.6 mmmm -82.03 157.81 24.04 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.318 1.047 . . . . 62.44 109.243 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.43 ' O ' HD13 ' A' ' 68' ' ' LEU . 22.6 m-20 -71.77 118.03 14.1 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.762 0.425 . . . . 75.5 110.572 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.2 p-90 -75.66 76.96 2.65 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 122.484 1.135 . . . . 75.02 110.374 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -136.99 82.67 30.15 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.182 -1.414 . . . . 74.43 107.182 176.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -87.11 155.8 8.35 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 122.53 2.153 . . . . 65.04 113.049 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -97.3 124.04 41.3 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.716 -1.216 . . . . 72.21 107.716 173.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 92.52 2.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 109.129 -0.693 . . . . 73.44 109.129 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 80.3 tttt -87.29 139.43 30.57 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.66 -1.237 . . . . 74.11 107.66 169.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 63' ' ' THR . 1.5 pt? -139.1 151.23 46.54 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 123.056 0.542 . . . . 74.04 109.959 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -131.15 136.08 48.01 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.421 0.688 . . . . 70.34 109.767 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.0 tp -103.91 128.78 51.41 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.057 0.943 . . . . 65.43 109.495 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 14.7 t70 -146.23 139.32 25.74 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.878 -0.786 . . . . 75.31 108.878 170.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.1 m -144.89 134.18 22.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.301 1.041 . . . . 74.52 109.124 -175.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.501 ' HB3' HH22 ' A' ' 61' ' ' ARG . . . -159.66 133.09 7.07 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.635 0.374 . . . . 64.54 110.238 176.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.601 ' HB3' HG22 ' A' ' 58' ' ' VAL . 59.9 p -91.38 177.06 6.34 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.29 0.636 . . . . 73.54 110.828 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.559 ' HA ' ' HD2' ' F' ' 114' ' ' LYS . 34.4 t -166.61 116.76 0.93 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.195 -0.669 . . . . 62.22 109.195 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -69.62 104.91 2.51 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 123.407 0.442 . . . . 75.42 109.968 -173.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.64 HD11 ' HB2' ' A' ' 57' ' ' GLU . 49.7 mt -78.69 -37.27 42.07 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.659 0.784 . . . . 43.14 111.086 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.86 -173.5 4.31 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.648 0.779 . . . . 72.53 109.532 -175.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -58.71 97.95 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.325 0.65 . . . . 75.14 111.166 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 6.0 m-20 60.1 31.01 20.41 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.47 1.108 . . . . 61.05 112.173 -176.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.9 t -112.26 120.63 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 107.009 -1.478 . . . . 74.43 107.009 167.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.83 130.49 41.8 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 108.503 -0.925 . . . . 72.53 108.503 -179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.3 tt0 -86.13 117.98 25.3 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.86 -0.793 . . . . 72.43 108.86 171.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 48' ' ' SER . 47.2 t -98.73 118.64 45.59 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.086 0 N-CA-C 107.406 -1.331 . . . . 73.13 107.406 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.513 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 36.2 t -102.45 131.47 50.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 109.4 -0.593 . . . . 54.44 109.4 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.59 115.1 29.76 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.197 -1.408 . . . . 75.32 107.197 177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.666 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.5 OUTLIER -89.89 100.88 13.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 107.002 -1.481 . . . . 74.41 107.002 172.295 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.2 t -98.53 124.36 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.14 -1.059 . . . . 65.24 108.14 172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 13.5 m -112.22 138.9 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.413 -0.958 . . . . 44.12 108.413 172.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.588 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 71.1 t -133.63 107.16 10.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 124.893 1.277 . . . . 75.13 107.673 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 43.4 m -103.66 136.89 42.51 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.961 -0.755 . . . . 65.21 108.961 174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.41 117.79 23.67 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.406 0.682 . . . . 73.51 109.364 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.3 m -143.22 142.73 31.49 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.421 0.688 . . . . 71.02 110.36 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' A' ' 71' ' ' GLU . 0.4 OUTLIER -100.07 78.73 2.11 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 108.448 -0.945 . . . . 74.45 108.448 169.076 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.43 -99.31 1.08 Allowed Glycine 0 C--N 1.346 1.132 0 CA-C-N 115.647 -0.706 . . . . 73.54 112.287 177.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.41 -28.24 21.04 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.644 0.778 . . . . 74.24 110.834 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.561 ' HB3' ' HG ' ' A' ' 68' ' ' LEU . 5.4 tp10 -94.73 132.18 39.76 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 109.273 -0.64 . . . . 72.15 109.273 -174.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 26.4 m -82.4 130.82 35.19 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.203 -0.665 . . . . 73.4 109.203 170.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.92 -59.93 2.54 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.447 -0.945 . . . . 60.44 108.447 170.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -168.51 174.92 6.53 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.675 -1.148 . . . . 72.25 110.779 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 41.9 tp -132.12 144.87 51.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.551 1.141 . . . . 54.12 109.277 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.588 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 68.2 m -137.99 140.14 40.03 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.385 1.074 . . . . 64.24 109.477 177.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -149.32 130.32 14.38 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 109.46 -0.57 . . . . 71.13 109.46 169.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.18 110.79 18.42 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 123.689 0.796 . . . . 72.33 108.922 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -86.75 85.17 7.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.085 -0.962 . . . . 72.32 108.887 175.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG3' HD22 ' A' ' 106' ' ' LEU . 7.8 tp-100 -79.08 96.52 5.84 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.478 -1.237 . . . . 74.13 108.728 -177.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -92.14 142.86 16.22 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.333 -0.707 . . . . 75.43 111.333 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.461 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -139.14 126.4 3.35 Favored Glycine 0 CA--C 1.504 -0.619 0 N-CA-C 110.411 -1.076 . . . . 65.54 110.411 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 55.1 mt -81.79 129.8 36.89 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 173.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -134.41 121.09 20.64 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.517 0.727 . . . . 74.11 109.928 -174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -91.06 95.99 10.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.481 -0.933 . . . . 75.24 108.481 173.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG22 ' HA ' ' A' ' 11' ' ' PHE . 26.1 pt -130.04 131.88 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.793 0.837 . . . . 73.21 110.354 -171.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -168.99 176.9 5.16 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.39 0.676 . . . . 65.2 111.44 -174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 104.56 -23.57 31.07 Favored Glycine 0 C--N 1.346 1.134 0 CA-C-N 115.088 -0.96 . . . . 71.54 112.399 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.09 172.33 14.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 C-N-CA 124.216 1.007 . . . . 74.13 110.159 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.552 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 21.3 tt0 -154.73 -169.14 3.12 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 108.69 -0.855 . . . . 64.51 108.69 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.552 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 69.2 -130.68 24.39 Favored Glycine 0 C--N 1.348 1.228 0 CA-C-O 120.129 -0.262 . . . . 64.21 112.971 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -66.96 -32.85 74.37 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.857 0.863 . . . . 73.34 111.395 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -68.63 -39.66 80.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.776 0.83 . . . . 73.33 110.823 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . 48.0 tpp -72.7 -41.78 64.91 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 123.354 0.409 . . . . 74.23 110.441 174.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.54 66.46 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.382 0.673 . . . . 72.22 111.279 177.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -79.88 -37.71 34.22 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.51 0.724 . . . . 63.44 111.054 172.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.426 ' HG ' ' HD2' ' A' ' 11' ' ' PHE . 53.9 t -63.03 -57.44 10.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.651 0.38 . . . . 74.32 111.955 -174.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.607 HD11 ' HB3' ' F' ' 116' ' ' TYR . 0.5 OUTLIER -95.18 -10.3 30.88 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 112.398 0.518 . . . . 64.21 112.398 -177.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.5 -21.26 15.12 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.156 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.43 -64.59 1.21 Allowed 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.591 0.756 . . . . 73.32 110.257 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.401 ' HB3' ' O ' ' A' ' 97' ' ' CYS . 75.8 t80 -60.21 -53.12 61.53 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.166 0.986 . . . . 73.43 112.725 -172.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.479 ' SG ' ' HA ' ' A' ' 98' ' ' LEU . 84.4 m -60.21 -52.26 74.45 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.165 -0.921 . . . . 55.23 112.735 -176.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.86 -24.09 40.58 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 121.816 1.677 . . . . 71.05 113.233 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -73.61 -28.76 61.98 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.944 0.498 . . . . 72.15 110.605 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 26.7 mm -68.84 -42.41 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.389 0.676 . . . . 74.13 109.418 168.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.461 HD21 ' HA3' ' A' ' 82' ' ' GLY . 88.7 mt -71.61 -25.96 62.38 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.962 -1.017 . . . . 71.32 111.768 -176.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -67.24 -44.61 48.66 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.81 -1.091 . . . . 72.51 113.823 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.448 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 20.6 Cg_endo -62.66 -33.27 77.82 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 121.875 1.717 . . . . 74.12 112.647 173.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -75.14 -34.36 61.62 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.181 0.592 . . . . 73.55 111.875 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.58 -46.87 65.35 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 109.355 -0.609 . . . . 70.22 109.355 175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.483 HH12 HD12 ' C' ' 105' ' ' ILE . 34.7 ttm180 -51.96 -51.68 55.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.121 1.368 . . . . 75.25 110.684 176.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -61.17 -48.48 81.39 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.253 0.971 . . . . 73.05 111.211 -177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.477 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.9 t -56.84 -45.76 82.17 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 124.297 0.998 . . . . 71.42 110.92 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.3 mt -63.59 -52.4 58.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 O-C-N 124.084 0.865 . . . . 72.3 110.551 178.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 125' ' ' GLN . 71.5 m -53.82 -43.77 69.69 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.816 0.847 . . . . 64.34 111.112 -176.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.38 -42.99 82.47 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.652 -1.158 . . . . 51.3 110.365 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.472 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 11.5 mtp -56.5 -46.19 80.64 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 123.736 0.814 . . . . 55.15 111.25 175.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.1 t -60.99 -47.47 93.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 CA-C-N 114.699 -1.137 . . . . 74.44 110.989 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 89.3 p -71.82 -26.57 62.45 Favored 'General case' 0 CA--C 1.553 1.07 0 CA-C-N 115.995 -0.548 . . . . 71.41 111.246 -176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' HA ' ' B' ' 113' ' ' CYS . 40.0 mtt180 -72.88 -30.38 63.92 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.489 0.716 . . . . 73.11 110.017 172.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.04 0.48 78.87 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.564 -0.743 . . . . 22.13 112.543 172.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.4 m 66.89 37.85 3.87 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 124.804 1.242 . . . . 75.32 110.109 174.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -113.69 153.7 45.86 Favored Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 114.893 -1.048 . . . . 64.24 109.299 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -53.98 132.97 52.75 Favored 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.009 2.472 . . . . 74.42 112.189 173.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.52 ' HB2' HG23 ' A' ' 115' ' ' THR . 2.7 pt20 -61.99 147.4 47.17 Favored 'General case' 0 CA--C 1.547 0.851 0 O-C-N 123.867 0.73 . . . . 64.2 111.262 -172.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -117.8 95.44 4.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.05 0.54 . . . . 75.55 109.555 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -100.76 97.24 7.9 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.699 -0.852 . . . . 71.4 108.699 175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -73.39 136.99 44.4 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 108.659 -0.867 . . . . 72.2 108.659 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.68 148.48 91.07 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.039 0.535 . . . . 73.22 111.753 -178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -77.9 119.48 4.75 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 121.906 1.737 . . . . 74.41 111.458 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.3 t -101.81 111.52 31.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 107.519 -1.289 . . . . 71.41 107.519 170.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -86.99 93.0 9.23 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 123.253 0.621 . . . . 63.01 109.593 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -61.96 -27.92 69.18 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 115.42 -0.809 . . . . 61.41 108.859 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.25 -55.46 28.19 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 115.076 -0.965 . . . . 75.25 111.592 173.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.77 -47.59 82.08 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.168 0.918 . . . . 60.25 112.081 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 pp -68.58 -34.25 75.47 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 123.931 0.769 . . . . 72.24 112.094 -175.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -88.87 -23.22 22.82 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.511 0.724 . . . . 72.4 111.301 -178.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 14.7 mmt -75.98 -53.6 8.14 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.857 -0.592 . . . . 75.11 109.599 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' C' ' 145' ' ' ALA . 3.8 p30 -60.85 -33.63 73.35 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.62 0.575 . . . . 71.31 109.552 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.485 ' HA ' ' HB3' ' C' ' 145' ' ' ALA . 2.7 t80 -53.0 -59.62 4.31 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.889 1.276 . . . . 74.34 111.256 171.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.1 tp -64.89 -53.64 43.45 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 123.827 0.704 . . . . 74.31 111.045 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.484 ' HG2' ' HG2' ' C' ' 144' ' ' GLN . 0.0 OUTLIER 174.32 -21.83 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 124.989 1.316 . . . . 53.13 110.597 174.14 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 57.21 101.08 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.406 1.483 . . . . 62.25 112.636 -173.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -172.19 135.37 0.77 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.625 1.17 . . . . 75.05 109.061 172.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -162.37 123.44 2.58 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.612 0.765 . . . . 72.34 109.419 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.8 76.1 0.22 Allowed Glycine 0 C--N 1.343 0.93 0 N-CA-C 111.503 -0.639 . . . . 54.04 111.503 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -139.72 137.09 34.84 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 108.76 -0.83 . . . . 74.24 108.76 176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -98.89 164.45 20.67 Favored Glycine 0 C--N 1.344 0.988 0 O-C-N 123.666 0.604 . . . . 43.2 112.589 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.3 m -98.9 120.04 38.67 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.621 0.768 . . . . 74.4 109.672 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 150' ' ' GLU . 6.8 pt-20 -77.69 91.77 4.08 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 108.636 -0.875 . . . . 74.41 108.636 171.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.675 ' HG3' ' HB2' ' E' ' 146' ' ' ASP . 1.9 tm-20 -67.72 96.54 0.56 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.366 1.067 . . . . 72.41 110.753 -171.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 176.01 149.86 0.12 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.661 1.584 . . . . 71.21 107.523 171.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -167.67 -76.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.748 0.419 . . . . 53.31 110.454 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.434 ' H ' ' H ' ' A' ' 155' ' ' ALA . 32.1 t70 -154.56 -15.1 0.12 Allowed 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 124.268 1.027 . . . . 52.04 110.118 -171.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.434 ' H ' ' H ' ' A' ' 154' ' ' ASP . . . . . . . . 0 C--O 1.245 0.842 0 C-N-CA 124.292 1.037 . . . . 70.51 110.494 -177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 108.966 -0.753 . . . . 72.14 108.966 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -141.34 156.85 45.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.696 0.798 . . . . 54.12 110.258 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -138.09 153.45 49.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.389 0.676 . . . . 62.01 109.566 176.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.433 ' HB2' HE22 ' D' ' 143' ' ' GLN . 13.3 pt20 -84.37 33.89 0.51 Allowed 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 124.552 1.141 . . . . 74.2 111.933 -178.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -132.13 152.3 51.32 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.534 1.134 . . . . 74.04 108.872 -176.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -64.73 89.34 0.07 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.487 0.715 . . . . 53.14 109.272 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -141.17 -2.27 1.29 Allowed 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.816 1.247 . . . . 62.11 109.238 175.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.63 126.24 39.8 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 107.726 -1.213 . . . . 71.34 107.726 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.428 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 21.8 ptm 50.76 177.63 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 126.497 1.919 . . . . 72.21 114.528 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -152.78 125.64 8.42 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.763 1.225 . . . . 70.52 107.742 177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -135.72 135.52 40.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.542 -0.91 . . . . 64.41 108.542 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.686 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 55.3 tt0 -150.42 142.33 23.86 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.809 0.844 . . . . 60.5 109.192 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.5 115.05 32.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.616 0 N-CA-C 107.485 -1.302 . . . . 64.41 107.485 174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.436 HE22 HG13 ' B' ' 55' ' ' VAL . 71.6 mt-30 -79.79 -48.31 13.78 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.933 -0.395 . . . . 72.11 109.933 175.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -167.74 136.32 2.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.743 -0.662 . . . . 73.01 109.747 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 54.1 mt -114.67 140.99 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 107.051 -1.463 . . . . 74.11 107.051 171.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -165.96 146.73 6.67 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.528 0.68 . . . . 74.2 111.077 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.615 HG21 HD11 ' B' ' 21' ' ' ILE . 40.6 m -77.44 117.07 18.55 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.108 -0.951 . . . . 71.44 109.078 173.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -86.92 -27.64 23.23 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.318 0.647 . . . . 72.52 110.82 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 21.1 t70 -150.9 139.68 20.79 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.272 -0.422 . . . . 73.51 111.097 -173.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.615 HD11 HG21 ' B' ' 18' ' ' THR . 33.7 mm -128.66 143.5 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.126 1.37 . . . . 74.45 108.142 170.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.436 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.3 t -141.03 142.93 34.17 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.099 -1.075 . . . . 71.15 108.099 169.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 86.4 t80 -157.8 120.04 3.76 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.656 -1.609 . . . . 71.22 106.656 171.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.05 146.69 49.32 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.304 -0.628 . . . . 73.51 109.304 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.632 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -146.69 79.84 10.07 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 108.046 -1.094 . . . . 63.14 108.046 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.6 -25.46 20.87 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 123.067 2.511 . . . . 72.14 112.793 -172.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -116.66 19.39 14.57 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.872 0.869 . . . . 63.3 109.793 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.634 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -47.49 -52.69 35.14 Favored Pre-proline 0 CA--C 1.568 1.65 0 N-CA-C 115.313 1.597 . . . . 61.42 115.313 -173.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.28 -11.42 19.21 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 121.839 1.693 . . . . 64.35 112.725 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -97.89 -26.24 14.74 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.657 0.783 . . . . 74.21 111.728 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.459 ' HB ' HD12 ' B' ' 68' ' ' LEU . 34.7 m -82.24 0.49 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 122.459 0.304 . . . . 73.11 111.176 175.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.99 -42.61 99.33 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.339 1.056 . . . . 72.32 110.892 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -85.25 -13.89 48.42 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.114 0.566 . . . . 74.53 111.479 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -83.95 78.69 9.69 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.386 0.674 . . . . 63.25 110.06 -170.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -75.91 102.59 5.62 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.791 -0.818 . . . . 53.12 108.791 175.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -159.56 162.6 35.42 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.059 -1.089 . . . . 73.45 108.059 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -89.49 109.19 29.88 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.546 -0.74 . . . . 73.34 109.032 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' B' ' 67' ' ' SER . 32.2 Cg_exo -56.15 131.03 43.42 Favored 'Trans proline' 0 C--N 1.381 2.277 0 C-N-CA 122.648 2.232 . . . . 74.31 113.408 -175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.25 102.51 2.13 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 107.741 -1.207 . . . . 71.21 107.741 167.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' B' ' 65' ' ' THR . 23.7 m -97.6 146.35 7.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 CA-C-N 115.2 -0.909 . . . . 52.04 110.765 -173.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.84 118.87 19.49 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 107.514 -1.291 . . . . 71.43 107.514 -178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.668 ' H ' HD22 ' E' ' 129' ' ' LEU . 2.4 tt -96.28 123.55 39.95 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 106.024 -1.843 . . . . 64.44 106.024 171.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 14.5 t70 -124.8 129.95 51.44 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.875 -0.787 . . . . 54.04 108.875 -174.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -115.17 125.82 53.87 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.193 -1.04 . . . . 65.33 108.193 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -136.82 133.07 35.51 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.987 -1.116 . . . . 73.23 107.987 175.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.424 HG21 ' HE1' ' E' ' 120' ' ' TRP . 36.9 p -118.78 121.77 40.84 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.23 0.612 . . . . 63.12 111.21 -174.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -116.38 160.93 19.83 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 124.799 1.24 . . . . 45.05 108.582 171.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' B' ' 58' ' ' VAL . 61.3 p -143.35 163.92 31.71 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 122.892 0.477 . . . . 71.13 110.3 178.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 38.2 t -152.38 159.32 43.44 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.485 1.114 . . . . 65.33 108.86 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -125.54 119.76 29.03 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.442 0.697 . . . . 73.05 109.133 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.0 mt -82.2 -36.75 26.97 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.178 0.591 . . . . 73.22 110.566 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.33 -177.6 5.78 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.107 0.963 . . . . 52.34 109.915 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -66.1 118.58 10.05 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.597 -0.729 . . . . 74.02 110.105 -177.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 71.67 3.17 4.57 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.524 1.53 . . . . 71.5 112.151 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.436 HG13 HE22 ' B' ' 14' ' ' GLN . 59.0 t -109.93 87.87 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.758 1.223 . . . . 73.52 108.329 177.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.445 ' CD1' HD11 ' B' ' 86' ' ' ILE . 12.2 m-85 -98.84 147.0 25.37 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.1 0.56 . . . . 75.54 109.587 178.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -131.79 100.31 5.05 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.016 -1.105 . . . . 72.35 108.016 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' B' ' 48' ' ' SER . 29.8 m -94.22 138.1 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 109.858 -0.423 . . . . 53.3 109.858 -177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 43.9 t -108.08 114.11 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 123.631 0.773 . . . . 53.41 109.756 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.51 129.55 39.68 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.409 -1.33 . . . . 73.32 107.409 176.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 45.9 ttt180 -122.04 112.32 18.1 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.808 0.843 . . . . 75.15 109.157 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.3 t -111.05 125.77 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 108.619 -0.882 . . . . 70.22 108.619 176.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 11.2 m -117.91 146.85 43.65 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.215 0.531 . . . . 74.24 109.577 -178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.661 HG21 HG21 ' B' ' 114' ' ' ILE . 42.9 t -132.6 132.69 59.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 C-N-CA 125.443 1.497 . . . . 54.22 108.723 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 100.0 m -126.13 143.74 51.01 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.924 -0.769 . . . . 70.41 108.924 169.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' B' ' 38' ' ' PRO . . . -135.54 140.25 44.57 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 107.743 -1.206 . . . . 73.11 107.743 171.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' B' ' 38' ' ' PRO . 17.1 m -129.51 128.83 43.63 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.795 0.438 . . . . 54.02 110.048 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.459 HD12 ' HB ' ' B' ' 31' ' ' VAL . 31.3 mt -114.69 102.25 9.85 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.499 -0.926 . . . . 73.34 108.499 176.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.99 -131.61 10.52 Favored Glycine 0 C--N 1.34 0.804 0 CA-C-N 115.586 -0.734 . . . . 51.11 111.896 -176.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -95.33 8.3 43.57 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.206 0.602 . . . . 73.3 110.632 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -135.81 166.52 23.09 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.645 0.778 . . . . 74.4 111.288 -170.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 84.8 m -71.33 125.68 27.61 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.283 -0.871 . . . . 54.13 110.911 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.443 ' HA ' HG11 ' B' ' 31' ' ' VAL . . . -73.55 -62.86 1.34 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.527 0.731 . . . . 63.01 109.095 171.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -160.84 165.56 30.01 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 114.932 -1.031 . . . . 74.24 110.726 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -129.21 154.92 46.31 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.732 1.613 . . . . 55.42 108.366 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.0 t -160.76 132.09 5.64 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.199 -0.667 . . . . 52.43 109.199 173.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.436 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.4 tt0 -141.82 123.65 15.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.351 -0.981 . . . . 73.13 108.351 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.3 t -122.57 143.76 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 109.508 -0.553 . . . . 72.22 109.508 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.7 mt-30 -121.97 103.18 8.64 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.306 -0.861 . . . . 75.42 109.175 174.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -91.06 103.53 16.22 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.562 -0.745 . . . . 52.45 109.129 175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.9 143.56 16.77 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.141 -0.784 . . . . 64.11 111.141 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.23 126.53 3.23 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 112.002 -0.439 . . . . 61.12 112.002 -175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 12.8 mt -85.85 131.83 33.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 108.557 -0.905 . . . . 74.44 108.557 173.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -138.06 137.16 37.53 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.977 0.911 . . . . 72.23 109.574 -176.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.686 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 23.4 m -88.89 113.28 24.26 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.567 -0.901 . . . . 52.11 108.567 170.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.563 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -121.66 138.33 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 123.127 0.571 . . . . 71.41 110.411 179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.02 163.36 37.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.011 0.924 . . . . 50.43 109.277 177.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.48 -48.25 3.93 Favored Glycine 0 N--CA 1.476 1.333 0 C-N-CA 122.663 0.173 . . . . 62.23 112.905 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.563 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -61.06 153.33 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.256 1.023 . . . . 53.23 111.857 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.423 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 0.3 OUTLIER -167.1 165.29 15.69 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.882 0.873 . . . . 53.44 110.149 176.352 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.5 -119.68 19.3 Favored Glycine 0 C--N 1.348 1.217 0 O-C-N 123.44 0.462 . . . . 54.45 113.491 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.6 m -69.38 -31.67 70.2 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.93 0.892 . . . . 70.14 111.124 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.521 ' HB3' HG22 ' B' ' 89' ' ' ILE . 93.7 mt-30 -62.89 -52.57 62.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.446 0.699 . . . . 70.22 110.382 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.511 ' SD ' HD13 ' B' ' 89' ' ' ILE . 3.4 tpt -62.99 -45.14 93.8 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.456 -0.793 . . . . 65.11 110.628 178.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.47 78.65 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.372 0.669 . . . . 65.21 111.693 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 19.5 t60 -76.77 -33.13 58.07 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.324 0.649 . . . . 72.03 110.387 178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -65.23 -52.4 54.85 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.136 0.575 . . . . 73.44 110.881 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -84.84 -20.36 31.0 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.877 0.471 . . . . 75.24 111.804 -179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.0 -31.77 16.48 Favored Glycine 0 C--N 1.347 1.16 0 O-C-N 123.347 0.404 . . . . 52.2 113.258 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.88 -57.05 1.82 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.916 0.487 . . . . 64.24 111.484 -172.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -76.28 -41.93 47.19 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.187 0.81 . . . . 64.15 113.187 -168.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.407 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.3 m -63.76 -45.94 82.02 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-O 118.688 -0.672 . . . . 64.11 110.913 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 70.3 Cg_exo -56.57 -37.14 98.07 Favored 'Trans proline' 0 C--N 1.392 2.846 0 C-N-CA 121.974 1.782 . . . . 64.35 113.514 166.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -62.36 -35.43 79.11 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 122.971 0.508 . . . . 73.33 111.416 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 62.4 mt -66.13 -49.51 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.757 0.823 . . . . 64.33 110.162 174.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.34 -16.33 52.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.112 -0.949 . . . . 62.51 112.409 -168.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -65.56 -46.96 68.8 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-O 117.48 -1.248 . . . . 75.33 113.075 -173.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.414 ' HB3' ' CD2' ' D' ' 109' ' ' TYR . 18.7 Cg_endo -58.6 -36.78 96.83 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 122.153 1.902 . . . . 53.31 112.688 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' B' ' 113' ' ' CYS . 74.7 m-85 -65.68 -49.42 68.64 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.399 0.68 . . . . 73.44 110.732 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.38 -35.37 80.76 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.672 0.789 . . . . 64.31 110.96 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.735 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 37.0 ttp180 -59.78 -65.13 0.73 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.348 1.059 . . . . 74.22 110.479 -178.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -68.15 -20.93 64.93 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.96 -1.018 . . . . 75.32 110.619 -174.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.9 t -67.12 -49.62 64.26 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.709 -0.478 . . . . 72.43 109.709 175.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.661 HG21 HG21 ' B' ' 64' ' ' VAL . 91.4 mt -58.96 -54.44 34.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 123.731 0.645 . . . . 73.12 110.267 174.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.469 HG22 ' NE2' ' B' ' 125' ' ' GLN . 8.5 m -61.31 -29.17 69.71 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.105 0.962 . . . . 75.02 111.523 -172.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.7 t -77.01 -35.36 57.11 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.447 0.699 . . . . 42.11 111.118 174.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.1 mmt -68.01 -30.86 70.21 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 120.893 0.378 . . . . 72.43 110.26 176.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.9 t -66.77 -39.23 83.19 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.97 0.908 . . . . 64.32 109.952 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 26.2 m -64.26 -32.46 74.06 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.523 0.729 . . . . 75.0 111.617 174.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.477 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.3 mtt-85 -71.32 -35.21 71.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.415 -0.811 . . . . 62.55 110.112 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.0 3.05 82.05 Favored Glycine 0 C--N 1.353 1.5 0 O-C-N 123.903 0.752 . . . . 55.01 112.951 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.2 p 56.84 24.03 8.76 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 126.082 1.753 . . . . 71.35 112.649 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -92.05 156.09 42.5 Favored Pre-proline 0 N--CA 1.476 0.865 0 C-N-CA 123.952 0.901 . . . . 65.42 110.137 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.2 140.58 93.22 Favored 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 123.052 2.501 . . . . 71.15 111.807 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.469 ' NE2' HG22 ' B' ' 115' ' ' THR . 14.7 mm100 -63.95 122.65 17.0 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.778 0.831 . . . . 75.44 112.493 -170.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -110.16 97.22 6.75 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 107.065 -1.457 . . . . 70.33 107.065 174.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -91.36 135.67 33.65 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.479 -0.782 . . . . 72.43 108.975 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.735 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.5 mm? -82.31 115.18 21.25 Favored 'General case' 0 C--O 1.246 0.885 0 N-CA-C 108.746 -0.835 . . . . 75.05 108.746 -173.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.24 137.92 88.47 Favored Pre-proline 0 CA--C 1.543 0.675 0 O-C-N 124.404 1.065 . . . . 33.02 110.9 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.509 ' HG3' HD11 ' D' ' 16' ' ' ILE . 60.1 Cg_endo -66.6 99.05 0.42 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 122.739 2.293 . . . . 74.32 111.026 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 22.3 t -89.0 120.45 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 108.077 -1.083 . . . . 73.01 108.077 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -69.31 88.63 0.46 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.901 0.88 . . . . 74.44 110.515 -173.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -52.92 -36.71 59.98 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.285 1.034 . . . . 75.23 112.221 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.22 -42.61 99.46 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.587 1.155 . . . . 73.03 111.892 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.92 -35.24 59.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.295 0.638 . . . . 71.14 110.597 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 mp -60.22 -43.5 95.95 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.614 0.766 . . . . 75.53 110.412 173.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -67.33 -40.26 85.92 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 114.635 -1.166 . . . . 71.15 110.41 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.9 ttt -66.87 -37.17 83.93 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.28 1.032 . . . . 74.24 111.352 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.437 ' HA ' ' HB2' ' B' ' 142' ' ' GLN . 42.4 m-80 -86.15 -18.74 31.47 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.884 0.474 . . . . 73.33 110.927 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -70.83 -27.18 63.67 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 109.429 -0.582 . . . . 73.21 109.429 171.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 65.1 mt -114.79 30.98 6.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.382 1.073 . . . . 64.12 110.188 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.437 ' HB2' ' HA ' ' B' ' 139' ' ' ASN . 23.8 tp60 -65.75 102.74 0.79 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 122.849 0.46 . . . . 63.34 111.831 -170.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -166.36 145.0 5.61 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.396 1.078 . . . . 62.32 108.684 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -65.62 -65.15 0.71 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.424 0.69 . . . . 73.41 112.476 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 63.88 -167.41 0.21 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 124.415 1.072 . . . . 63.33 110.257 -167.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 167.7 72.77 0.03 OUTLIER Glycine 0 C--N 1.348 1.239 0 C-N-CA 120.662 -0.78 . . . . 64.43 114.102 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.77 142.42 24.54 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 108.789 -0.819 . . . . 62.45 108.789 168.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 179.22 -19.21 0.03 OUTLIER Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.991 -0.55 . . . . 53.43 112.962 -171.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 74.2 p -77.59 161.29 27.96 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.886 0.474 . . . . 70.53 109.936 174.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -76.5 -33.06 58.65 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.197 -0.456 . . . . 65.41 111.422 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 73.85 -56.64 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.446 1.498 . . . . 74.51 107.928 -160.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 85.07 132.0 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.59 1.556 . . . . 63.13 111.862 165.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -81.73 168.12 18.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.57 0.748 . . . . 70.41 110.462 176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -143.41 -60.92 0.41 Allowed 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 109.317 -0.623 . . . . 70.21 109.317 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.557 1.236 0 C-N-CA 125.076 1.351 . . . . 63.11 111.965 175.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.482 1.134 0 N-CA-C 109.724 -0.473 . . . . 75.31 109.724 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -116.97 90.96 3.45 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.083 -1.451 . . . . 72.5 107.083 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -84.21 136.53 33.92 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.752 -0.658 . . . . 74.51 111.886 -166.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -135.83 162.98 31.29 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.86 1.264 . . . . 63.21 109.375 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -165.94 132.14 2.57 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.519 -0.548 . . . . 63.41 109.519 177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -72.91 90.89 1.49 Allowed 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.918 -0.771 . . . . 70.34 108.918 173.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.2 p -79.76 118.58 21.69 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.288 -0.869 . . . . 72.41 109.764 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -97.01 179.23 5.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.366 0.666 . . . . 74.34 109.762 174.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 32.7 ttm 65.49 115.97 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.536 1.135 . . . . 74.25 112.246 177.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.567 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 21.7 m -84.84 92.78 8.35 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.321 -0.992 . . . . 71.32 108.321 172.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -116.41 125.85 52.61 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.15 -1.056 . . . . 73.31 108.15 171.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -151.76 134.24 15.37 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.207 0.603 . . . . 72.53 109.41 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.408 HG12 ' HE2' ' C' ' 84' ' ' PHE . 41.1 mt -74.81 109.0 7.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 N-CA-C 108.555 -0.906 . . . . 70.22 108.555 172.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -85.88 -41.24 15.14 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.266 0.626 . . . . 72.13 111.175 -177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -170.77 142.95 2.03 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.957 -0.757 . . . . 63.22 108.957 -177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 66.0 mt -131.76 133.41 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.829 -0.804 . . . . 70.43 108.829 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.505 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 19.4 p90 -173.06 153.03 2.44 Favored 'General case' 0 C--N 1.35 0.598 0 CA-C-O 121.41 0.624 . . . . 64.31 111.509 -175.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -74.76 125.09 28.0 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 114.954 -1.021 . . . . 73.43 109.782 175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -77.64 -47.68 18.66 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.565 -1.272 . . . . 73.45 107.565 168.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.681 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -132.34 143.48 49.88 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 114.125 -1.398 . . . . 53.32 110.231 -171.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.536 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 76.2 mt -142.35 142.68 27.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 125.659 1.583 . . . . 73.45 106.767 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.48 148.71 21.66 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.163 0.506 . . . . 64.25 109.904 173.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -150.28 115.08 5.29 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.245 -1.391 . . . . 64.34 107.245 173.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -116.42 111.1 19.54 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 109.605 -0.517 . . . . 64.32 109.605 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.53 78.86 54.94 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 123.978 0.911 . . . . 60.13 108.641 167.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.28 -28.61 39.76 Favored 'Trans proline' 0 C--N 1.376 2.001 0 C-N-CA 122.045 1.83 . . . . 70.51 109.341 169.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' C' ' 30' ' ' HIS . 2.2 m-20 -92.99 27.25 2.48 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.115 -1.402 . . . . 71.41 110.443 177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.48 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.73 -50.17 89.44 Favored Pre-proline 0 CA--C 1.574 1.881 0 C-N-CA 123.746 0.818 . . . . 64.01 111.584 171.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 22.1 Cg_exo -66.1 -21.14 56.3 Favored 'Trans proline' 0 C--N 1.399 3.209 0 C-N-CA 122.473 2.115 . . . . 75.41 113.247 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.402 ' HB2' ' O ' ' C' ' 27' ' ' ASN . 12.6 m170 -60.59 -34.16 73.8 Favored 'General case' 0 C--O 1.205 -1.249 0 CA-C-O 118.14 -0.933 . . . . 61.15 111.047 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.422 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.3 p -51.05 -31.39 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 N-CA-C 113.196 0.813 . . . . 70.22 113.196 -170.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -73.58 -29.18 62.25 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.811 0.844 . . . . 64.52 111.664 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -119.48 11.78 12.22 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.778 0.831 . . . . 73.53 112.217 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.422 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 18.5 ttpp -110.37 159.38 17.51 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.892 0.877 . . . . 71.1 110.206 -174.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -78.96 118.24 20.78 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 115.475 -0.784 . . . . 65.4 109.192 171.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -86.22 63.63 8.12 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.969 0.89 . . . . 73.32 110.862 177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -145.2 72.95 14.56 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.177 -1.416 . . . . 75.54 107.177 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -90.56 151.61 4.3 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.787 2.325 . . . . 73.21 112.027 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.84 112.79 21.44 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.208 -1.034 . . . . 73.23 108.208 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.72 99.08 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 108.672 -0.862 . . . . 64.5 108.672 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.448 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 24.7 tptt -92.94 100.98 13.33 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.429 -1.322 . . . . 74.51 107.429 179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -92.27 135.28 34.14 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 108.338 -0.986 . . . . 62.35 108.338 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -138.84 103.73 4.89 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.258 -1.016 . . . . 51.25 108.258 173.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -95.42 148.75 22.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.446 -0.576 . . . . 74.02 109.446 176.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -148.85 162.51 39.68 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.74 1.216 . . . . 71.53 107.976 -177.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' C' ' 60' ' ' LEU . 10.2 t -145.65 137.14 25.06 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.344 0.657 . . . . 72.11 109.563 173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.85 162.02 22.97 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.095 0.958 . . . . 61.42 108.985 176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 46.4 p -139.31 143.78 38.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.894 0.477 . . . . 74.51 110.581 -176.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -148.86 126.51 11.73 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.745 0.818 . . . . 74.43 109.518 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -88.29 120.22 29.44 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 108.539 -0.911 . . . . 71.24 108.539 173.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' C' ' 57' ' ' GLU . 29.8 mt -91.2 -39.1 12.3 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.514 0.726 . . . . 63.21 110.699 -174.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.3 -175.54 5.31 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 115.477 -0.783 . . . . 61.21 110.305 -179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -66.6 105.39 1.51 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.028 0.931 . . . . 74.04 110.937 -176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 68.85 10.91 8.16 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.26 1.424 . . . . 73.41 112.979 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 76.2 t -105.34 113.71 42.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 108.341 -0.985 . . . . 64.32 108.341 169.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -117.5 160.47 21.16 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.056 0.942 . . . . 71.31 109.129 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.6 tt0 -127.58 146.69 50.45 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 125.055 1.342 . . . . 62.51 107.741 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.42 HG21 ' HG3' ' C' ' 103' ' ' PRO . 3.2 p -137.21 124.77 31.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 108.642 -0.873 . . . . 73.44 108.642 171.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 61.9 t -121.92 104.97 15.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 108.607 -0.886 . . . . 72.03 108.607 -178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.688 ' H ' HD23 ' C' ' 60' ' ' LEU . 0.8 OUTLIER -91.38 118.22 30.35 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.938 -0.393 . . . . 74.41 109.938 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 65.3 ttp85 -83.88 105.17 14.56 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.635 -0.876 . . . . 70.24 108.635 175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.4 t -100.2 125.88 53.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.899 -1.149 . . . . 61.01 107.899 174.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 31.2 m -118.77 133.47 55.82 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 108.553 -0.906 . . . . 73.45 108.553 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.448 HG21 HG21 ' C' ' 114' ' ' ILE . 94.7 t -128.23 109.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 N-CA-C 108.443 -0.947 . . . . 74.43 108.443 178.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 8.9 m -99.22 144.07 28.77 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.387 -0.968 . . . . 74.11 108.387 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.92 95.44 3.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.307 -1.738 . . . . 54.21 106.307 172.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.4 p -153.01 138.69 17.85 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 109.675 -0.491 . . . . 70.12 109.675 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.64 92.25 6.52 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 108.322 -0.992 . . . . 72.24 108.322 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.61 -79.31 1.26 Allowed Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.401 -0.818 . . . . 65.32 112.281 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -30.66 2.78 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.952 0.901 . . . . 74.14 110.617 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.62 102.59 0.93 Allowed 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.754 0.821 . . . . 72.33 109.852 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 9.3 m -81.37 136.27 35.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.447 -0.797 . . . . 74.24 110.789 -174.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.0 -55.45 3.68 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.485 -1.302 . . . . 55.2 107.485 163.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -165.67 175.07 9.15 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.844 0.831 . . . . 44.23 112.072 177.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.403 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -135.55 146.1 47.68 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 105.642 -1.984 . . . . 70.14 105.642 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.408 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.0 t -152.53 113.4 4.16 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 109.401 -0.592 . . . . 72.41 109.401 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -126.55 118.9 25.81 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.034 0.534 . . . . 63.42 109.852 -177.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 69.1 t -120.84 134.05 65.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.825 0.85 . . . . 72.43 109.66 176.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.681 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 26.9 mt-30 -110.45 97.5 6.94 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.888 -1.153 . . . . 64.52 107.888 174.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -83.48 115.62 22.16 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.877 -0.602 . . . . 72.03 109.869 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.04 153.34 21.82 Favored Glycine 0 C--N 1.339 0.738 0 O-C-N 123.606 0.566 . . . . 61.43 111.775 174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.94 119.99 0.97 Allowed Glycine 0 C--O 1.238 0.374 0 N-CA-C 111.195 -0.762 . . . . 74.3 111.195 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.442 HD12 ' CD1' ' C' ' 51' ' ' LEU . 11.7 mm -84.28 125.81 40.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.435 -0.95 . . . . 62.14 108.435 176.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.408 ' HE2' HG12 ' C' ' 13' ' ' ILE . 94.5 m-85 -137.62 135.08 36.26 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.967 0.907 . . . . 72.31 109.298 -179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 68.6 m -75.85 118.4 18.61 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 108.236 -1.024 . . . . 72.45 108.236 166.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 16.2 mm -122.29 110.0 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.802 -0.814 . . . . 55.21 108.802 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.77 165.18 31.33 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.658 0.783 . . . . 73.34 109.206 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.9 -50.54 3.96 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 116.404 -0.362 . . . . 72.33 112.22 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 17.1 tt -80.73 141.89 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.705 0.802 . . . . 72.43 109.203 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -148.74 155.53 41.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.897 0.479 . . . . 74.31 110.862 -170.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.14 -145.41 28.25 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.865 0.728 . . . . 52.31 113.059 172.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 46.8 p -62.62 -28.33 69.82 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.189 0.996 . . . . 55.21 111.559 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -59.24 -49.0 79.53 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.535 0.734 . . . . 73.24 110.676 172.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -40.17 70.78 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.275 0.63 . . . . 74.11 110.358 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.72 -36.39 78.73 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.611 0.764 . . . . 73.41 110.904 177.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -70.97 -41.27 71.24 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.306 -0.861 . . . . 52.32 110.777 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.11 -51.71 65.47 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.664 0.386 . . . . 71.31 110.818 -177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 24.0 tp -75.87 -16.14 60.1 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.671 0.788 . . . . 73.21 111.087 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.89 3.32 31.89 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 119.511 -0.605 . . . . 53.44 114.113 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.37 -60.77 0.41 Allowed 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 117.731 0.766 . . . . 51.43 110.851 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -68.44 -57.28 6.1 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.706 0.629 . . . . 73.0 111.835 -171.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.43 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 56.9 m -58.46 -45.95 99.65 Favored Pre-proline 0 CA--C 1.564 1.513 0 CA-C-O 118.415 -0.802 . . . . 74.52 111.901 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 44.3 Cg_exo -57.57 -37.12 98.1 Favored 'Trans proline' 0 C--N 1.397 3.092 0 C-N-CA 122.278 1.985 . . . . 73.41 113.737 170.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -73.02 -26.55 61.35 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.767 0.427 . . . . 72.31 111.311 -176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.483 HD12 HH12 ' A' ' 111' ' ' ARG . 26.2 mm -65.56 -42.19 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 121.26 0.552 . . . . 75.45 109.587 169.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.3 mt -79.77 -19.26 49.06 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.651 -1.159 . . . . 74.13 111.882 -176.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -58.5 -45.35 99.68 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.645 -1.169 . . . . 72.4 113.124 -174.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.448 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 75.0 Cg_exo -52.91 -39.69 77.8 Favored 'Trans proline' 0 C--N 1.385 2.491 0 C-N-CA 122.465 2.11 . . . . 74.21 113.262 172.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -68.98 -44.76 72.23 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.627 0.771 . . . . 74.0 111.259 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.02 99.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.216 0.606 . . . . 74.05 110.248 175.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -61.66 -49.41 76.63 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.84 1.256 . . . . 65.33 110.768 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -68.96 -33.83 74.34 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.684 0.615 . . . . 72.41 110.295 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 36.0 t -67.54 -37.33 82.56 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.039 0.536 . . . . 75.43 110.975 178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.448 HG21 HG21 ' C' ' 64' ' ' VAL . 96.3 mt -71.54 -47.47 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 123.707 0.803 . . . . 74.52 110.631 174.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 41.6 m -67.07 -28.85 68.53 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.77 0.828 . . . . 72.01 111.076 -175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 43.1 t -68.61 -45.09 72.83 Favored 'General case' 0 C--N 1.354 0.776 0 C-N-CA 123.373 0.669 . . . . 71.41 109.442 173.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.58 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -61.91 -39.8 93.27 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.027 0.931 . . . . 63.14 111.941 178.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -61.31 -45.32 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 123.634 0.774 . . . . 72.15 109.917 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 48.1 t -64.92 -33.09 75.19 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 115.061 -0.972 . . . . 65.01 111.369 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 mtt-85 -73.69 -33.59 64.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.596 0.758 . . . . 64.4 110.291 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.57 -3.98 90.14 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.55 0.531 . . . . 74.23 112.46 172.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 65.29 45.43 2.92 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.581 1.952 . . . . 71.22 112.182 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.448 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 98.4 m-85 -106.89 164.22 15.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-N 114.077 -1.42 . . . . 73.11 109.1 173.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' E' ' 136' ' ' VAL . 95.3 Cg_endo -72.33 179.65 4.84 Favored 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 122.752 2.301 . . . . 75.33 112.977 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -60.11 111.99 1.73 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.7 -0.682 . . . . 73.42 111.592 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 7.9 tt -113.27 96.58 5.99 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 106.362 -1.718 . . . . 43.41 106.362 169.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -109.12 122.47 47.35 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.647 0.779 . . . . 74.43 109.511 -177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 57.0 mt -83.0 133.57 35.09 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 123.227 0.611 . . . . 55.15 109.402 177.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.74 143.19 78.08 Favored Pre-proline 0 CA--C 1.548 0.869 0 O-C-N 123.509 0.506 . . . . 74.04 110.607 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.513 ' HG2' HD11 ' E' ' 147' ' ' LEU . 28.0 Cg_endo -62.97 133.37 41.07 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.395 2.064 . . . . 64.14 111.726 175.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.6 p -102.0 111.38 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 N-CA-C 108.458 -0.941 . . . . 62.14 108.458 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.785 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 7.2 m-20 -83.75 57.68 4.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.446 0.698 . . . . 73.41 110.389 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -76.88 -21.53 54.81 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.817 0.818 . . . . 72.03 109.232 -178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 20.5 p-10 -79.78 -47.41 15.27 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 124.534 1.134 . . . . 72.32 110.951 172.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.785 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -64.88 -47.66 77.03 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 124.417 1.073 . . . . 61.31 112.186 -170.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.473 HD13 ' HD2' ' E' ' 149' ' ' PRO . 56.7 tp -54.02 -43.88 70.49 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.859 0.724 . . . . 73.12 112.405 -175.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -79.83 -32.73 40.64 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 112.416 0.524 . . . . 75.43 112.416 -175.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.0 ptm -78.19 -30.04 48.78 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 117.741 0.246 . . . . 72.52 111.194 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -72.13 -37.94 69.34 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.882 0.873 . . . . 65.11 109.956 173.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -70.7 -151.32 0.02 OUTLIER 'General case' 0 CA--C 1.576 1.959 0 C-N-CA 123.748 0.819 . . . . 60.23 109.285 168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.511 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 14.3 tp 65.12 -172.01 0.18 Allowed 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.271 1.028 . . . . 73.21 109.627 -176.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.511 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 0.0 OUTLIER -147.52 91.86 2.02 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 122.091 0.948 . . . . 74.31 110.087 175.44 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 139' ' ' ASN . 51.7 mt-30 -116.2 114.0 23.83 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.744 -1.206 . . . . 72.12 107.744 174.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.484 ' HG2' ' HG2' ' A' ' 142' ' ' GLN . 77.5 mt-30 -108.64 138.54 44.79 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.338 0.655 . . . . 72.1 110.569 -175.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 140' ' ' TYR . . . -96.72 159.52 14.88 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 124.101 0.96 . . . . 40.34 109.218 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -149.63 166.19 29.69 Favored Glycine 0 C--O 1.24 0.517 0 CA-C-N 115.738 -0.665 . . . . 70.43 111.691 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -163.08 141.9 8.44 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 106.848 -1.538 . . . . 70.4 106.848 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -158.51 124.42 1.38 Allowed Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.081 -0.807 . . . . 75.55 111.081 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -119.48 151.03 39.25 Favored 'General case' 0 C--O 1.24 0.594 0 C-N-CA 122.883 0.473 . . . . 73.13 110.727 -176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -164.56 113.75 1.14 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.609 1.164 . . . . 73.24 108.517 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.07 172.67 17.74 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 125.198 1.399 . . . . 73.23 108.783 174.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -167.31 122.04 1.03 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.673 0.789 . . . . 72.33 109.199 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -60.96 -38.11 84.75 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.77 0.828 . . . . 73.13 111.295 178.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -72.79 105.13 4.22 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.561 1.145 . . . . 62.34 110.328 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 C-N-CA 123.52 0.728 . . . . 74.34 110.68 -178.525 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mmt . . . . . 0 N--CA 1.483 1.178 0 N-CA-C 109.618 -0.512 . . . . 65.43 109.618 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -144.54 -170.91 3.49 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.632 0.773 . . . . 52.24 109.076 177.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -144.44 88.84 1.96 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.287 0.635 . . . . 74.23 109.52 174.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -90.12 154.62 19.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.13 -0.693 . . . . 61.31 109.13 174.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -74.79 128.1 34.76 Favored 'General case' 0 C--O 1.245 0.82 0 N-CA-C 108.189 -1.041 . . . . 74.24 108.189 170.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -61.61 127.64 32.42 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 123.855 0.722 . . . . 65.13 110.276 -176.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 74.2 p -85.39 175.3 8.95 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.387 0.675 . . . . 51.21 109.504 175.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.23 -178.58 1.35 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.849 0.459 . . . . 73.31 109.964 171.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.504 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 9.9 tpt -30.81 123.07 0.21 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.221 1.408 . . . . 74.34 113.848 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -148.18 142.3 26.03 Favored 'General case' 0 C--O 1.242 0.68 0 C-N-CA 124.449 1.1 . . . . 75.23 109.12 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -164.2 103.5 0.86 Allowed 'General case' 0 C--O 1.237 0.414 0 N-CA-C 107.67 -1.233 . . . . 73.34 107.67 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.536 ' HG3' ' HB2' ' D' ' 85' ' ' SER . 5.2 pt20 -149.51 127.08 11.61 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.528 0.731 . . . . 62.01 109.569 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.502 HD12 ' O ' ' D' ' 83' ' ' ILE . 3.3 tp -84.26 110.91 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 124.287 1.035 . . . . 73.11 109.353 -178.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.431 ' O ' ' HB1' ' E' ' 131' ' ' ALA . 74.9 mt-30 -73.36 -40.99 63.95 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.332 1.053 . . . . 72.43 112.036 -175.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.466 HH12 HG12 ' E' ' 134' ' ' ILE . 43.6 ttt180 -159.77 124.51 3.94 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 110.404 -0.221 . . . . 73.41 110.404 -166.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.509 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.2 mp -103.26 132.61 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 107.069 -1.456 . . . . 64.13 107.069 175.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.411 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 28.9 p90 -158.83 167.62 28.97 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 122.084 0.945 . . . . 71.4 111.724 176.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.425 HG21 HD11 ' D' ' 21' ' ' ILE . 73.6 p -102.52 120.21 40.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.038 -1.437 . . . . 74.12 109.426 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.482 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 37.4 mtpt -87.63 -24.37 23.97 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.153 0.581 . . . . 71.25 110.754 177.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.494 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.8 t70 -158.11 139.65 13.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.336 -0.847 . . . . 72.53 109.354 178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.58 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.4 mt -139.82 144.88 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 107.828 -1.175 . . . . 54.32 107.828 176.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 46.2 t -149.77 144.82 26.28 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.141 0.976 . . . . 60.15 109.031 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.7 t80 -151.92 111.55 3.98 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 106.047 -1.834 . . . . 74.21 106.047 171.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 46.6 mt-10 -122.44 113.78 19.82 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 122.745 0.418 . . . . 53.14 110.527 -174.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.61 81.22 54.48 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 123.983 0.913 . . . . 73.01 109.227 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . 0.447 ' HG2' ' ND2' ' D' ' 27' ' ' ASN . 58.8 Cg_endo -71.5 -37.56 5.41 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.619 2.213 . . . . 41.41 111.945 178.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.447 ' ND2' ' HG2' ' D' ' 26' ' ' PRO . 2.0 m-80 -103.72 38.53 1.79 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.983 0.913 . . . . 75.13 108.699 -175.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.505 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.7 -50.66 84.26 Favored Pre-proline 0 CA--C 1.575 1.904 0 N-CA-C 114.561 1.319 . . . . 63.01 114.561 -168.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.96 -12.72 4.89 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 121.757 1.638 . . . . 74.42 112.853 171.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -69.74 -40.07 76.41 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.625 1.17 . . . . 75.24 109.837 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 8.1 p -82.36 -18.13 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 C-N-CA 123.139 0.576 . . . . 64.41 110.429 -177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -57.45 -35.53 70.25 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.362 0.665 . . . . 74.33 111.362 171.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -59.66 -25.28 64.6 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.91 0.756 . . . . 72.31 111.343 -178.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -110.84 91.42 3.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.323 -1.362 . . . . 73.34 107.323 169.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -79.49 67.14 5.16 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 122.465 1.126 . . . . 45.33 110.929 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -128.3 158.23 38.75 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.791 -1.188 . . . . 61.03 107.791 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 20.9 mm-40 -84.73 118.23 70.54 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 122.849 0.459 . . . . 73.43 110.049 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.492 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 34.1 Cg_exo -64.59 158.76 48.19 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 123.845 3.03 . . . . 74.13 113.844 -172.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 42.2 tt0 -71.82 124.63 25.23 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.987 -0.745 . . . . 74.45 108.987 172.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.504 HG23 HG13 ' D' ' 64' ' ' VAL . 3.2 p -96.8 114.25 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-O 121.68 0.752 . . . . 73.05 110.088 -177.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.575 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 8.9 tppt? -95.57 107.62 19.82 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 107.787 -1.19 . . . . 75.13 107.787 176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 41.4 tp -101.04 116.9 33.93 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 109.906 -0.405 . . . . 72.3 109.906 -179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.456 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.7 m-20 -116.66 124.85 50.74 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.739 0.816 . . . . 62.34 109.52 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -111.18 137.61 48.67 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.488 0.715 . . . . 74.53 110.108 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.0 t70 -146.33 146.71 30.78 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.899 1.28 . . . . 62.31 108.061 176.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -123.55 165.51 17.01 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.907 -0.405 . . . . 44.23 109.907 177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -157.38 164.52 37.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.4 0.68 . . . . 70.24 109.789 177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 25.0 p -156.22 153.4 29.13 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.01 0.524 . . . . 62.21 110.897 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 98.0 p -154.47 155.0 34.11 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.353 1.061 . . . . 60.2 108.655 178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -97.26 116.96 30.44 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.208 -0.664 . . . . 75.55 109.208 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' D' ' 57' ' ' GLU . 25.3 mt -92.5 -28.89 16.52 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.028 0.531 . . . . 72.11 110.123 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -164.19 -178.98 5.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.23 1.014 . . . . 70.34 110.623 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -66.36 117.12 8.16 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 113.548 -1.66 . . . . 61.43 110.513 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 63.18 21.25 12.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.26 1.424 . . . . 74.11 111.442 -175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 88.8 t -131.5 115.06 27.18 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 C-N-CA 124.141 0.976 . . . . 74.01 109.137 177.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -132.74 130.27 39.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.511 -0.922 . . . . 63.51 108.511 -172.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.496 ' HB2' HD11 ' D' ' 51' ' ' LEU . 31.7 tt0 -86.54 138.08 32.0 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 123.62 0.768 . . . . 74.32 109.146 173.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.482 HG11 ' HD3' ' D' ' 103' ' ' PRO . 97.6 t -122.07 128.89 75.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.434 -1.321 . . . . 74.24 107.434 170.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 29.3 t -110.42 132.74 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.293 -0.632 . . . . 74.2 109.293 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -109.61 119.0 38.05 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 108.063 -1.088 . . . . 74.23 108.063 178.469 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 33.3 ttm-85 -102.47 103.52 13.9 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.411 -0.959 . . . . 72.31 108.411 175.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -101.76 133.02 46.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 108.195 -1.039 . . . . 75.42 108.195 170.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 7.9 m -126.95 128.15 45.97 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 110.133 -0.321 . . . . 72.52 110.133 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.504 HG13 HG23 ' D' ' 40' ' ' VAL . 61.1 t -119.38 102.12 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.12 0.968 . . . . 70.0 108.658 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 96.0 m -106.19 100.89 10.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.613 0.765 . . . . 51.3 109.354 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -98.66 134.96 40.85 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 122.75 0.42 . . . . 71.12 110.11 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 40.8 p -146.32 140.15 26.22 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.613 -0.884 . . . . 73.24 108.613 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 41.8 tp -127.62 119.13 25.24 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.529 -0.545 . . . . 62.35 109.529 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.1 -117.9 5.78 Favored Glycine 0 C--N 1.345 1.058 0 O-C-N 123.821 0.701 . . . . 73.01 113.238 178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.53 5.33 46.11 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.901 0.88 . . . . 74.15 110.993 -177.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -144.41 155.06 43.59 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.006 0.431 . . . . 73.53 111.434 -161.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.402 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 98.2 m -66.77 136.91 56.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.432 1.093 . . . . 62.12 110.726 174.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.35 -66.72 0.89 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.579 0.752 . . . . 64.25 109.526 176.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -156.27 151.22 26.23 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.629 0.772 . . . . 63.21 109.396 173.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 77.9 mt -118.95 154.25 33.31 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.889 0.876 . . . . 61.13 109.173 -177.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.45 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 54.1 t -158.66 146.22 17.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.02 0.528 . . . . 73.14 110.894 178.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -156.52 137.77 13.78 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.65 -0.871 . . . . 53.23 108.65 167.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.4 t -135.31 116.21 19.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 123.41 0.684 . . . . 74.11 109.27 177.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.494 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 53.0 mt-30 -92.29 85.28 5.36 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.504 0.722 . . . . 74.31 109.059 171.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.84 100.83 8.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.805 1.242 . . . . 73.44 109.721 -177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.32 143.28 16.51 Favored Glycine 0 C--N 1.343 0.967 0 N-CA-C 112.144 -0.382 . . . . 60.13 112.144 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.416 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.15 134.21 6.6 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 111.945 -0.462 . . . . 72.34 111.945 -177.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.502 ' O ' HD12 ' D' ' 13' ' ' ILE . 60.1 mt -90.51 125.82 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.708 0.803 . . . . 71.11 109.142 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -125.23 129.26 49.7 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.446 0.699 . . . . 70.32 110.218 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' D' ' 12' ' ' GLN . 33.0 m -79.12 104.97 10.11 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 167.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 47.3 mm -109.6 117.97 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 123.586 0.754 . . . . 63.45 110.09 -176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.8 159.97 43.94 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.612 0.765 . . . . 71.02 109.948 175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 86.72 -20.79 22.03 Favored Glycine 0 C--N 1.346 1.137 0 CA-C-N 116.086 -0.506 . . . . 23.13 114.292 175.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 35.2 pt -116.26 144.52 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.738 0.815 . . . . 71.04 109.89 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.07 -176.51 5.38 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.816 0.846 . . . . 60.12 110.256 -179.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.59 -140.16 44.22 Favored Glycine 0 C--N 1.349 1.274 0 O-C-N 123.641 0.588 . . . . 40.34 114.188 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 23.3 m -63.03 -34.02 76.67 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 124.106 0.963 . . . . 60.45 111.397 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.48 -51.35 63.47 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.13 0.572 . . . . 73.32 109.743 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 53.2 ttp -63.82 -42.98 97.55 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 123.822 0.701 . . . . 75.11 111.256 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.14 -41.63 97.07 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.827 0.704 . . . . 73.14 110.88 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -71.41 -34.27 70.2 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.811 . . . . 72.13 111.055 176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.57 -48.05 76.44 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.746 0.418 . . . . 62.31 109.982 -175.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 pp -71.92 -18.19 62.04 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 122.797 0.439 . . . . 71.24 111.824 178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -109.57 10.5 32.87 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-O 119.222 -0.765 . . . . 44.53 114.25 -178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.1 -64.22 0.12 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 117.948 0.874 . . . . 52.54 111.842 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -69.2 -40.1 78.23 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.409 0.683 . . . . 54.12 112.592 -171.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 60.9 m -73.26 -44.84 7.88 Favored Pre-proline 0 CA--C 1.561 1.4 0 C-N-CA 123.478 0.711 . . . . 74.3 110.976 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.482 ' HD3' HG11 ' D' ' 58' ' ' VAL . 72.2 Cg_exo -54.85 -33.16 80.58 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.514 2.142 . . . . 55.52 113.694 166.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.16 -39.02 93.46 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.826 0.85 . . . . 73.12 109.948 178.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.15 -41.75 93.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.029 0.932 . . . . 74.53 110.868 173.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.416 HD21 ' HA3' ' D' ' 82' ' ' GLY . 93.5 mt -76.08 -20.16 57.95 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.406 -0.815 . . . . 74.22 112.27 -173.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -65.1 -41.96 57.46 Favored Pre-proline 0 CA--C 1.562 1.409 0 N-CA-C 113.789 1.033 . . . . 71.23 113.789 -170.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -52.29 -41.25 67.33 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 122.22 1.947 . . . . 60.41 113.317 169.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' B' ' 108' ' ' PRO . 97.9 m-85 -74.75 -35.26 62.61 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.766 0.826 . . . . 75.34 111.842 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.81 -51.02 64.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.161 0.584 . . . . 52.43 109.855 176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.4 ttp180 -57.29 -44.52 84.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.557 -1.201 . . . . 70.34 111.332 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -61.48 -47.46 85.56 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.696 0.798 . . . . 71.33 111.528 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -58.15 -39.52 79.02 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 123.914 0.759 . . . . 53.45 110.972 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . . . . . . . . . 77.5 mt -66.7 -49.7 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 123.76 0.824 . . . . 73.5 110.842 176.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.433 HG23 ' HG3' ' D' ' 125' ' ' GLN . 30.2 m -57.06 -39.14 74.32 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.109 0.964 . . . . 73.23 111.578 -176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 36.4 t -65.89 -43.01 89.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.38 -0.827 . . . . 70.42 111.067 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.88 -35.16 74.43 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.813 0.445 . . . . 51.31 111.717 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.21 -40.92 88.23 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-N 115.27 -0.877 . . . . 64.34 110.315 176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 82.6 p -71.19 -29.96 65.8 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 122.334 0.253 . . . . 53.11 110.886 177.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' D' ' 116' ' ' SER . 93.8 mtt-85 -69.26 -32.82 72.27 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.044 0.538 . . . . 73.23 110.322 173.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.22 7.52 80.35 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.694 0.621 . . . . 74.22 113.0 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.464 HG23 ' HB3' ' C' ' 17' ' ' TYR . 82.4 p 53.71 36.08 22.87 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.787 1.635 . . . . 74.0 112.466 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -104.69 155.07 38.01 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.464 1.105 . . . . 75.34 109.815 175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -58.55 141.15 97.13 Favored 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 123.416 2.744 . . . . 74.1 113.125 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG23 ' D' ' 115' ' ' THR . 33.4 tt0 -54.46 133.71 45.85 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.398 1.079 . . . . 70.41 112.231 -173.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.468 HD23 ' HG ' ' F' ' 139' ' ' LEU . 3.2 tm? -112.18 97.37 6.6 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.029 -1.1 . . . . 73.34 108.029 -173.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -108.58 108.94 20.04 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.578 0.751 . . . . 62.3 109.435 178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 82.3 mt -74.24 139.88 44.63 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.729 0.812 . . . . 75.35 111.3 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -68.95 145.59 96.78 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 123.937 0.895 . . . . 62.14 111.957 -178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 18.6 Cg_exo -69.07 104.38 1.2 Allowed 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 123.23 2.62 . . . . 74.42 112.137 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.3 t -108.02 110.35 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 N-CA-C 109.219 -0.66 . . . . 41.0 109.219 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -88.04 92.67 9.23 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.532 -0.914 . . . . 75.25 108.532 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -65.66 -33.49 76.02 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.828 0.451 . . . . 75.25 110.561 178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -56.0 -42.86 77.05 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.89 0.876 . . . . 73.41 110.813 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.39 -60.04 4.1 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 124.26 0.975 . . . . 73.23 111.007 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.641 HD21 ' HD2' ' F' ' 149' ' ' PRO . 8.6 mp -61.16 -34.62 75.32 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.202 0.601 . . . . 71.15 112.103 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 59.1 t80 -62.34 -62.33 1.84 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.758 0.823 . . . . 74.33 110.002 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.6 ptp -65.32 -28.35 69.24 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.524 -0.762 . . . . 61.34 111.223 -172.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.409 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 95.1 m-20 -70.35 -42.95 71.16 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 123.818 0.699 . . . . 64.42 110.829 177.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -62.02 -43.17 99.4 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 123.25 0.344 . . . . 74.24 110.455 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 11.2 mp -65.74 -46.13 80.05 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.281 0.632 . . . . 73.42 111.472 178.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.5 pt20 -76.27 2.21 13.91 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 122.731 0.412 . . . . 73.42 111.986 -176.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.433 HE22 ' HB2' ' B' ' 4' ' ' GLN . 96.7 mt-30 -121.2 44.61 2.48 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.811 0.844 . . . . 63.34 109.319 174.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -145.73 123.7 12.05 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.743 1.217 . . . . 61.22 107.817 175.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -113.44 143.2 44.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 44.21 110.582 -175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 172.83 -154.02 19.9 Favored Glycine 0 C--N 1.342 0.907 0 O-C-N 123.772 0.67 . . . . 44.01 111.459 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -128.6 148.12 50.77 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.624 0.77 . . . . 64.25 110.534 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -144.52 -176.25 18.36 Favored Glycine 0 C--N 1.342 0.895 0 CA-C-N 115.773 -0.649 . . . . 74.53 111.652 176.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 42.9 p -74.97 88.45 2.36 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 123.373 0.669 . . . . 73.13 112.154 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.8 73.73 8.4 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 122.591 1.186 . . . . 65.15 109.462 175.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -72.75 121.23 19.53 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.502 -1.226 . . . . 72.22 110.984 -172.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -122.27 123.74 42.15 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.681 0.792 . . . . 75.41 109.322 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -118.26 -179.5 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.908 0.883 . . . . 73.42 110.372 -179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -81.74 115.5 21.01 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.834 -0.802 . . . . 71.21 108.834 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 123.206 0.602 . . . . 63.43 110.925 -179.262 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.861 -0.422 . . . . 60.41 109.861 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -115.39 54.23 0.81 Allowed 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 121.364 0.602 . . . . 72.14 111.138 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -84.22 -42.59 15.76 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.808 -0.812 . . . . 53.52 108.808 169.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 21.0 t80 76.84 -57.05 0.54 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.284 1.834 . . . . 62.41 112.274 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 61.24 75.74 0.4 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.507 1.123 . . . . 75.42 110.847 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -177.57 -59.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 114.787 -1.097 . . . . 53.34 109.13 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -58.58 -32.2 68.73 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.329 1.052 . . . . 72.44 112.491 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.462 ' O ' ' HD3' ' E' ' 117' ' ' PRO . 37.1 tp 78.34 -52.48 0.49 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 125.526 1.53 . . . . 71.15 111.663 177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -86.68 94.26 0.36 Allowed Pre-proline 0 N--CA 1.483 1.194 0 C-N-CA 124.648 1.179 . . . . 74.32 108.669 173.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' E' ' 115' ' ' LEU . 50.0 Cg_endo -102.17 5.89 0.49 Allowed 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 123.158 2.572 . . . . 64.14 113.509 -172.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -152.97 120.73 6.05 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 123.107 0.563 . . . . 62.23 109.754 -168.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 70.7 p -82.6 107.35 15.18 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 123.977 0.798 . . . . 75.01 109.238 174.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.424 ' HE1' HG21 ' B' ' 46' ' ' THR . 18.1 t-105 -75.26 105.76 6.45 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 121.794 0.807 . . . . 71.31 111.158 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -97.93 115.47 28.2 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 114.484 -1.234 . . . . 65.41 108.805 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -69.92 159.53 33.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.385 0.674 . . . . 54.22 111.44 -178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 18.3 m -83.69 2.08 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.258 0.836 . . . . 73.1 113.258 -168.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 74.25 -69.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.666 1.186 . . . . 72.15 110.374 -177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 65.0 t80 74.68 133.8 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 125.484 1.514 . . . . 64.51 112.841 172.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -170.91 144.51 2.2 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.628 1.171 . . . . 70.15 109.232 170.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 145.11 -137.82 7.35 Favored Glycine 0 N--CA 1.473 1.16 0 N-CA-C 111.172 -0.771 . . . . 61.34 111.172 -176.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.64 87.82 2.18 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.865 0.841 . . . . 75.52 109.804 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . 0.668 HD22 ' H ' ' B' ' 42' ' ' LEU . 2.2 pp -97.69 2.99 50.33 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 114.366 -1.288 . . . . 73.25 110.785 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 8.5 tp -85.51 145.43 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 108.98 -0.748 . . . . 71.5 108.98 176.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' D' ' 14' ' ' GLN . . . -61.03 -71.56 0.14 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.746 0.818 . . . . 72.41 110.592 175.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -162.82 147.68 9.45 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.009 0.924 . . . . 75.01 108.6 173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -64.19 101.4 0.34 Allowed 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.947 2.431 . . . . 75.43 112.964 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . 0.466 HG12 HH12 ' D' ' 15' ' ' ARG . 6.1 tp -129.93 120.92 50.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 107.965 -1.124 . . . . 73.22 107.965 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.89 139.06 39.21 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.104 -0.702 . . . . 45.21 109.104 176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.545 ' HB ' ' HD3' ' C' ' 124' ' ' PRO . 16.5 m -126.64 -19.85 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.73 0.812 . . . . 73.03 111.069 -178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 67.46 127.69 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 125.56 1.544 . . . . 52.21 110.586 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.38 74.82 1.38 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.349 0.659 . . . . 64.51 110.129 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 3.6 pp -65.33 138.04 57.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 123.6 0.76 . . . . 70.14 111.869 -172.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 22.8 p -150.16 27.26 0.77 Allowed 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.0 0.92 . . . . 64.31 110.438 -171.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . 0.68 ' H ' HD23 ' E' ' 141' ' ' LEU . 2.0 pt? -89.51 42.46 1.09 Allowed 'General case' 0 N--CA 1.483 1.189 0 CA-C-O 122.177 0.989 . . . . 72.12 109.703 177.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 11.6 mt -106.78 -67.1 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.407 1.083 . . . . 73.22 108.631 -175.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -144.94 100.86 3.56 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.52 1.128 . . . . 71.23 109.322 177.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -90.73 94.98 9.91 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.328 -0.99 . . . . 72.41 108.328 172.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . 0.524 ' HG2' ' H ' ' E' ' 146' ' ' ASP . 2.3 ttmp? 68.59 -163.25 0.19 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 124.268 1.027 . . . . 74.33 110.19 173.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . 0.675 ' HB2' ' HG3' ' A' ' 151' ' ' GLU . 34.3 t70 65.01 101.15 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.006 1.323 . . . . 73.23 110.993 177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . 0.699 HD13 ' HB ' ' A' ' 13' ' ' ILE . 1.2 tt -145.88 143.5 29.63 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.698 -0.853 . . . . 63.45 108.698 -177.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.62 ' HB2' ' HB2' ' C' ' 132' ' ' ASN . 4.8 mp -70.69 135.16 85.92 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 123.579 0.752 . . . . 74.25 109.671 -175.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . 0.473 ' HD2' HD13 ' C' ' 136' ' ' LEU . 8.1 Cg_exo . . . . . 0 CA--C 1.562 1.884 0 C-N-CA 122.365 2.044 . . . . 63.13 110.657 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 121.398 0.618 . . . . 63.25 109.664 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -83.2 90.11 7.05 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.088 0.955 . . . . 61.12 109.457 -179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -140.45 88.93 2.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.932 0.893 . . . . 74.24 109.405 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -76.79 86.88 3.39 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 109.08 -0.711 . . . . 70.05 109.08 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -77.13 146.67 37.0 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.662 -1.154 . . . . 71.4 110.396 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -61.91 120.21 10.32 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.047 -1.094 . . . . 75.25 108.047 167.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.559 ' HD2' ' HA ' ' A' ' 49' ' ' SER . 11.0 tppt? -57.45 -48.75 78.33 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.257 0.973 . . . . 75.21 110.233 -173.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 35.7 tp -170.66 -35.36 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 114.364 -1.289 . . . . 75.25 107.855 171.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 98' ' ' LEU . 35.1 p90 -75.22 123.23 88.66 Favored Pre-proline 0 CA--C 1.545 0.771 0 CA-C-N 114.802 -1.09 . . . . 73.01 111.495 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -95.77 -166.13 0.11 Allowed 'Trans proline' 0 CA--C 1.555 1.538 0 C-N-CA 123.161 2.574 . . . . 53.42 110.369 158.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 52.4 t80 57.26 87.28 0.06 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.294 1.037 . . . . 60.4 112.17 175.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 57.3 m -110.39 105.17 14.08 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.61 0.764 . . . . 75.34 109.175 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 6.9 p-90 -109.56 156.7 19.84 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.831 0.852 . . . . 71.3 110.817 -175.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -125.35 131.97 52.9 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.648 0.779 . . . . 74.41 110.155 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -168.63 -34.05 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.907 0.883 . . . . 74.4 111.104 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 35.1 m -68.37 155.12 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.053 0.541 . . . . 71.02 111.727 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -144.56 121.94 11.64 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.572 -0.74 . . . . 71.1 109.447 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -105.16 150.17 25.28 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.996 0.918 . . . . 65.35 109.569 177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -161.2 151.06 17.12 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.257 -1.016 . . . . 73.41 108.257 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -72.47 -93.23 0.09 OUTLIER Glycine 0 C--N 1.347 1.156 0 O-C-N 123.606 0.566 . . . . 44.52 111.824 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 67.6 mttm 60.65 -75.7 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.109 1.364 . . . . 75.31 111.892 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.461 ' HG ' ' H ' ' F' ' 129' ' ' LEU . 1.2 pp -68.61 132.5 47.01 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.751 0.82 . . . . 64.45 111.924 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 56.5 mt -134.51 148.63 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.697 1.199 . . . . 72.01 108.316 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.22 123.81 23.07 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 109.656 -0.498 . . . . 62.23 109.656 174.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -71.0 125.42 92.01 Favored Pre-proline 0 CA--C 1.555 1.15 0 O-C-N 123.301 0.375 . . . . 74.13 110.332 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -94.9 164.2 1.71 Allowed 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 122.857 2.372 . . . . 70.4 112.753 171.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.5 HG12 ' H ' ' F' ' 135' ' ' ALA . 14.4 tt -89.86 -177.8 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 N-CA-C 107.33 -1.359 . . . . 73.1 107.33 166.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.5 ' H ' HG12 ' F' ' 134' ' ' ILE . . . -62.07 88.31 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.577 0.626 . . . . 55.25 110.331 174.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 15.8 m -107.52 96.82 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.787 0.835 . . . . 70.35 110.461 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -145.14 -70.87 0.27 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.006 0.922 . . . . 62.24 109.116 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -152.34 128.77 10.64 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.736 0.814 . . . . 63.52 109.085 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.468 ' HG ' HD23 ' D' ' 126' ' ' LEU . 0.6 OUTLIER -66.01 96.74 0.33 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.071 0.948 . . . . 73.22 109.366 -176.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 19.7 m -80.06 172.58 13.58 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.865 0.866 . . . . 65.33 110.163 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 57.5 mt 65.03 30.45 11.71 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.433 1.093 . . . . 63.31 109.482 -163.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.48 HD12 HG11 ' D' ' 40' ' ' VAL . 10.2 tp -70.9 148.15 10.82 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 CA-C-N 114.299 -1.319 . . . . 73.23 109.41 177.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -58.09 139.2 55.18 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 123.69 0.796 . . . . 72.23 111.373 178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -106.4 -41.37 5.32 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 122.969 0.508 . . . . 75.13 110.302 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -82.26 70.84 9.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-O 121.307 0.575 . . . . 74.13 109.967 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . 0.585 ' HA ' ' HG3' ' F' ' 149' ' ' PRO . 28.8 t0 -164.66 173.65 11.66 Favored 'General case' 0 C--O 1.242 0.685 0 CA-C-N 114.838 -1.074 . . . . 73.43 108.305 176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 tt 64.18 71.42 0.48 Allowed 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 106.757 -1.571 . . . . 73.32 106.757 -168.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 7.9 mp 60.08 73.77 0.62 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 114.593 -1.185 . . . . 72.02 110.34 -171.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . 0.641 ' HD2' HD21 ' D' ' 136' ' ' LEU . 27.5 Cg_exo . . . . . 0 C--N 1.384 2.399 0 C-N-CA 122.701 2.267 . . . . 54.45 111.537 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.485 1.304 0 N-CA-C 110.126 -0.324 . . . . 62.05 110.126 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -65.21 105.26 1.06 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.729 0.812 . . . . 63.02 110.703 -177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -79.66 86.23 5.3 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.337 0.655 . . . . 74.35 109.891 -176.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -153.12 154.7 35.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.96 0.904 . . . . 73.3 110.235 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -118.12 -45.41 2.65 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.537 0.735 . . . . 73.43 109.788 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 60.65 63.05 1.39 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.691 1.196 . . . . 72.12 111.129 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.6 p -131.32 154.76 48.21 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.402 0.681 . . . . 63.24 110.839 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 61.48 71.88 0.53 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.573 1.149 . . . . 73.32 111.583 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -99.14 152.8 19.47 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 114.774 -1.103 . . . . 71.2 109.782 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.0 m -143.11 113.69 7.46 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.496 0.718 . . . . 73.51 109.465 176.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HZ ' ' HG ' ' A' ' 102' ' ' CYS . 47.5 t80 -137.21 125.06 22.57 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 108.32 -0.993 . . . . 73.12 108.32 175.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 tp60 -135.69 112.56 10.24 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.347 0.659 . . . . 75.12 109.721 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 13' ' ' ILE . 3.8 mp -79.12 119.68 28.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 107.813 -1.18 . . . . 61.12 107.813 175.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.442 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . 82.0 mm-40 -81.55 -41.51 21.51 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.651 0.594 . . . . 74.01 109.92 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.745 HH11 HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -173.47 163.96 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.319 1.048 . . . . 62.31 110.281 173.473 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.568 HD11 ' HG3' ' C' ' 130' ' ' PRO . 1.6 pp -144.03 101.7 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 64.7 m-85 -155.64 173.45 16.69 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.018 0.927 . . . . 72.35 109.886 -166.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.1 p -88.96 115.47 26.54 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.264 -0.425 . . . . 55.41 111.076 -170.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -73.79 -44.74 55.03 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.967 -0.753 . . . . 64.13 108.967 171.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 16.8 t70 -135.78 148.35 48.73 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.757 -1.11 . . . . 75.11 110.368 -174.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.455 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 92.4 mt -145.13 142.75 22.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 C-N-CA 126.021 1.728 . . . . 75.1 106.94 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.0 t -155.47 133.02 11.11 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 122.761 0.424 . . . . 72.32 110.403 173.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 77.1 t80 -127.28 131.11 50.59 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 107.241 -1.392 . . . . 74.14 107.241 175.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -129.24 126.51 39.27 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.235 0.614 . . . . 62.23 109.708 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.15 79.33 32.07 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.402 -0.962 . . . . 73.43 108.402 172.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.72 -11.87 20.17 Favored 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.771 2.314 . . . . 62.13 112.328 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -119.16 30.99 6.84 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.311 1.044 . . . . 73.14 109.112 177.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.38 -46.27 99.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 N-CA-C 113.688 0.996 . . . . 62.41 113.688 -178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -70.17 -18.12 35.27 Favored 'Trans proline' 0 C--N 1.393 2.912 0 C-N-CA 121.572 1.515 . . . . 60.41 113.277 175.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -80.12 -12.75 59.64 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.705 0.802 . . . . 75.14 112.765 -172.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.1 p -53.12 -33.62 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 C-N-CA 124.093 0.957 . . . . 73.43 112.806 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -65.27 -32.79 74.64 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.31 0.644 . . . . 74.34 111.637 178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -90.72 -36.44 14.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.125 0.97 . . . . 74.53 111.078 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -83.17 155.52 23.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.116 0.966 . . . . 75.34 111.517 -174.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' HD11 ' A' ' 68' ' ' LEU . 7.6 m-20 -70.43 137.11 50.11 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.758 0.823 . . . . 60.12 110.007 176.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 16.6 m0 -88.36 61.66 6.28 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 108.87 -0.789 . . . . 61.11 108.87 174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -142.45 58.56 7.6 Favored Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 123.972 0.909 . . . . 61.04 109.94 177.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -87.55 152.43 7.67 Favored 'Trans proline' 0 C--N 1.38 2.228 0 C-N-CA 121.875 1.717 . . . . 71.45 112.208 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -93.28 117.51 30.17 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 107.583 -1.265 . . . . 73.5 107.583 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.68 136.25 29.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 C-N-CA 122.971 0.508 . . . . 65.34 110.826 -174.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -119.04 131.45 55.97 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.316 1.447 . . . . 65.13 108.913 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.436 HD23 HD21 ' F' ' 129' ' ' LEU . 4.6 pp -97.53 152.2 19.25 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.986 -1.116 . . . . 72.12 107.986 170.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 62' ' ' VAL . 26.3 t70 -144.2 143.35 31.02 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 108.087 -1.079 . . . . 75.5 108.087 172.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -140.61 125.31 18.04 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.494 0.717 . . . . 64.13 109.837 -175.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 12.8 t70 -132.54 142.91 49.39 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.047 0.939 . . . . 74.35 109.517 -177.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.9 m -124.46 124.4 42.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.527 0.731 . . . . 75.45 110.404 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.82 109.56 8.62 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.362 0.665 . . . . 73.11 110.41 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.8 m -90.8 158.09 17.02 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.584 0.753 . . . . 60.34 109.585 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' TYR . 42.5 t -162.13 118.35 2.01 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 118.085 0.402 . . . . 42.21 111.048 -171.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -70.53 103.39 2.47 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.492 0.717 . . . . 72.03 110.74 -175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.766 HD11 ' HB2' ' A' ' 57' ' ' GLU . 48.2 mt -83.36 -34.54 25.59 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 71.41 110.862 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.36 -174.6 4.43 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.44 1.096 . . . . 43.43 108.908 -176.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.84 96.32 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.299 0 O-C-N 123.433 0.458 . . . . 72.45 110.979 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 58.47 27.71 15.92 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.915 1.286 . . . . 73.32 112.278 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -104.18 113.44 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 106.784 -1.561 . . . . 74.31 106.784 168.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 49' ' ' SER . 22.7 m-85 -119.1 129.06 54.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.868 -0.79 . . . . 73.41 108.868 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.766 ' HB2' HD11 ' A' ' 51' ' ' LEU . 39.5 tt0 -83.32 114.99 21.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.906 -1.146 . . . . 65.14 107.906 168.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.9 t -98.85 111.26 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 107.314 -1.365 . . . . 73.05 107.314 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.562 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 80.7 t -97.16 136.11 29.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.353 1.061 . . . . 53.22 109.352 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -108.16 116.14 31.42 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.062 -0.718 . . . . 72.51 109.062 175.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' A' ' 79' ' ' GLN . 0.0 OUTLIER -92.9 106.49 18.45 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.777 -0.823 . . . . 63.22 108.777 173.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 43' ' ' ASP . 49.5 t -107.74 133.17 53.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 123.323 0.649 . . . . 72.21 109.666 176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.1 m -121.95 138.96 54.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 109.574 -0.528 . . . . 72.25 109.574 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' A' ' 114' ' ' ILE . 53.6 t -126.12 105.63 14.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 106.877 -1.527 . . . . 72.43 106.877 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.0 m -108.13 144.0 36.13 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.417 -0.957 . . . . 74.45 108.417 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.37 124.87 27.96 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 107.991 -1.115 . . . . 54.22 107.991 171.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.0 m -126.05 125.95 43.46 Favored 'General case' 0 C--O 1.237 0.405 0 O-C-N 123.654 0.596 . . . . 72.44 109.829 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 35' ' ' ASP . 49.0 tp -91.86 73.3 5.7 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.035 0.934 . . . . 61.14 108.922 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.61 -92.12 0.78 Allowed Glycine 0 CA--C 1.533 1.163 0 CA-C-N 115.715 -0.675 . . . . 74.52 112.847 177.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -98.84 -26.81 14.18 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.822 0.849 . . . . 72.32 111.23 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -107.37 138.01 44.36 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.575 0.75 . . . . 73.2 111.001 -175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.6 m -60.65 129.72 42.96 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 123.446 0.466 . . . . 71.41 110.202 170.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.86 -56.05 4.22 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 109.585 -0.524 . . . . 74.25 109.585 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.517 ' HE1' ' HG ' ' A' ' 76' ' ' CYS . 0.0 OUTLIER -164.75 166.89 19.51 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.326 0.65 . . . . 61.02 109.77 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.413 HD12 ' H ' ' A' ' 76' ' ' CYS . 27.8 tp -143.79 146.4 33.07 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.201 0.6 . . . . 75.12 111.283 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.517 ' HG ' ' HE1' ' A' ' 74' ' ' PHE . 51.7 m -143.54 142.29 31.05 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.2 1.4 . . . . 73.14 109.88 172.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -148.45 123.53 10.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.314 0.645 . . . . 70.11 109.602 173.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.18 130.09 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 123.609 0.764 . . . . 74.42 110.183 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HG3' ' A' ' 61' ' ' ARG . 72.3 mt-30 -95.67 96.95 9.36 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.472 0.709 . . . . 64.31 109.57 168.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -83.21 93.94 7.78 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.026 -0.731 . . . . 74.22 109.026 173.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.562 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.2 144.4 19.24 Favored Glycine 0 C--N 1.342 0.87 0 N-CA-C 111.823 -0.511 . . . . 63.54 111.823 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.37 122.25 2.03 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 110.445 -1.062 . . . . 65.41 110.445 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.745 HD12 HH11 ' A' ' 15' ' ' ARG . 33.8 mt -82.79 123.87 38.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 108.572 -0.899 . . . . 75.31 108.572 176.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -129.28 138.31 51.56 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.158 -0.682 . . . . 71.24 109.158 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 18.6 m -108.63 119.09 38.51 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 107.918 -1.141 . . . . 62.13 107.918 176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 20.4 tt -130.36 131.16 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 CA-C-O 120.975 0.417 . . . . 65.22 110.829 -172.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.7 165.53 28.01 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.202 1.001 . . . . 61.41 110.88 -173.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 99.4 -33.19 6.38 Favored Glycine 0 N--CA 1.471 1.021 0 CA-C-N 116.063 -0.517 . . . . 72.01 112.86 174.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -121.85 178.26 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.085 0.954 . . . . 64.13 108.827 179.014 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 14.6 tt0 -161.64 -179.44 7.28 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 110.238 -0.282 . . . . 61.44 110.238 175.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.453 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 72.97 -147.96 40.56 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 114.561 0.585 . . . . 64.1 114.561 176.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.2 t -63.37 -26.76 68.9 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.371 1.068 . . . . 72.44 113.013 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -68.12 -41.05 82.33 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.194 0.598 . . . . 71.55 111.915 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.707 ' SD ' ' HG ' ' F' ' 115' ' ' LEU . 3.4 ptp -84.02 -33.86 24.42 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 116.717 -0.219 . . . . 62.3 111.39 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.06 -24.15 67.77 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.227 0.537 . . . . 54.03 110.718 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -64.86 -54.49 30.17 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.145 0.978 . . . . 70.41 109.984 164.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.574 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 2.6 m -65.73 -63.37 1.11 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.268 0.84 . . . . 71.21 113.268 -170.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.08 -8.07 34.9 Favored 'General case' 0 CA--C 1.563 1.45 0 CA-C-N 118.862 0.756 . . . . 62.34 112.206 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.49 -4.0 40.47 Favored Glycine 0 C--N 1.36 1.911 0 N-CA-C 115.263 0.865 . . . . 61.31 115.263 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.02 -59.23 0.25 Allowed 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 117.767 0.784 . . . . 51.44 111.025 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.574 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 4.0 t80 -53.46 -54.74 32.65 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 124.571 1.148 . . . . 71.44 112.949 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.576 ' HG ' ' HZ ' ' A' ' 11' ' ' PHE . 19.7 m -71.69 -42.02 10.12 Favored Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 123.384 0.674 . . . . 72.22 111.739 -176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -52.78 -39.02 78.4 Favored 'Trans proline' 0 C--N 1.385 2.451 0 C-N-CA 122.463 2.109 . . . . 71.41 113.973 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -72.62 -24.45 61.07 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 123.367 0.667 . . . . 72.14 111.442 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.7 mm -69.13 -45.59 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 123.411 0.684 . . . . 71.34 109.407 168.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 85.1 mt -70.31 -33.56 71.68 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.283 -0.871 . . . . 73.44 112.01 -173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.64 -44.7 92.34 Favored Pre-proline 0 CA--C 1.561 1.398 0 N-CA-C 114.56 1.318 . . . . 72.41 114.56 -167.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.48 -32.25 96.02 Favored 'Trans proline' 0 C--N 1.383 2.365 0 C-N-CA 122.111 1.874 . . . . 74.03 113.617 175.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -81.72 -32.46 31.58 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.423 0.689 . . . . 53.2 111.358 -178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.41 -44.22 75.53 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.711 -0.477 . . . . 71.13 109.711 171.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -54.54 -49.05 71.21 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 124.67 1.231 . . . . 72.02 110.19 176.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.67 -51.46 69.68 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 124.162 0.914 . . . . 74.41 110.912 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 47.6 t -56.15 -45.56 79.59 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.192 0.933 . . . . 62.24 111.155 -177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.574 ' O ' HG23 ' A' ' 118' ' ' VAL . 5.7 mt -60.43 -58.49 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.52 0.728 . . . . 74.43 110.189 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.665 HG23 ' HB2' ' A' ' 125' ' ' GLN . 65.7 m -52.67 -40.5 62.93 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.988 0.915 . . . . 72.44 112.087 -176.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.6 t -66.9 -43.24 83.92 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.212 -0.904 . . . . 74.23 109.981 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.452 ' SD ' HG23 ' A' ' 21' ' ' ILE . 10.9 mtp -58.36 -44.03 88.64 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.509 0.724 . . . . 60.32 110.954 174.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 114' ' ' ILE . 39.3 t -61.2 -46.0 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.626 0.77 . . . . 65.33 110.6 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 83.3 p -73.36 -30.66 63.46 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.34 -0.846 . . . . 74.23 111.111 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -69.75 -25.21 63.72 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.568 0.747 . . . . 73.03 109.782 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.95 0.02 84.08 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.649 -0.705 . . . . 54.41 112.682 172.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.0 m 69.98 12.19 7.79 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.823 1.249 . . . . 72.31 111.137 177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -94.47 152.99 40.44 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 123.268 0.627 . . . . 74.55 110.37 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -54.11 120.45 7.97 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 122.776 2.317 . . . . 73.22 111.4 172.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.665 ' HB2' HG23 ' A' ' 115' ' ' THR . 3.4 pt20 -60.08 160.22 8.41 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.961 0.904 . . . . 63.53 112.63 -173.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.4 115.27 17.96 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.614 -0.884 . . . . 60.33 108.614 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -106.54 120.98 43.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.71 0.804 . . . . 74.21 109.194 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.441 HD21 HG22 ' A' ' 64' ' ' VAL . 57.3 mt -73.36 135.38 44.29 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.753 0.821 . . . . 75.13 110.437 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.91 136.61 96.81 Favored Pre-proline 0 CA--C 1.551 0.982 0 O-C-N 123.372 0.42 . . . . 65.41 110.569 179.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 29.7 Cg_endo -91.1 103.09 0.26 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.999 2.466 . . . . 61.32 112.311 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.43 HG21 ' H ' ' F' ' 126' ' ' ASN . 45.3 t -121.1 116.04 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.028 -1.101 . . . . 64.24 108.028 176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -69.83 106.48 3.15 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 109.474 -0.565 . . . . 72.24 109.474 176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 39.3 t80 -71.59 -17.27 62.3 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 115.286 -0.87 . . . . 70.33 111.71 -176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -60.09 -39.22 85.37 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.042 0.537 . . . . 71.03 111.479 174.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.95 -31.83 70.23 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.157 0.91 . . . . 70.53 111.534 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 tt -68.77 -39.84 80.03 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.742 0.817 . . . . 63.1 110.955 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.411 ' HE2' HD13 ' A' ' 141' ' ' LEU . 46.8 t80 -89.24 -20.91 23.55 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 116.407 -0.36 . . . . 73.3 111.951 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.8 tpt -61.23 -43.36 99.0 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.395 0.678 . . . . 64.45 110.837 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 8.8 p30 -65.49 -21.11 66.6 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.045 -0.98 . . . . 65.55 111.701 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -92.15 -34.83 14.18 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.507 0.723 . . . . 75.5 110.692 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.411 HD13 ' HE2' ' A' ' 137' ' ' PHE . 62.4 tp -68.14 -51.75 42.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.771 0.828 . . . . 75.43 112.438 -170.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -147.83 -15.11 0.37 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.144 0.978 . . . . 74.14 109.378 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.528 HE22 ' HA2' ' C' ' 146' ' ' GLY . 24.2 tm0? 62.92 -77.03 0.03 OUTLIER 'General case' 0 C--N 1.361 1.075 0 C-N-CA 125.374 1.469 . . . . 63.51 111.228 -179.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 tp60 -65.01 -53.04 52.37 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.934 0.894 . . . . 73.25 110.659 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.75 -171.06 0.16 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.317 1.047 . . . . 75.03 110.979 -174.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 152.13 92.67 0.09 OUTLIER Glycine 0 C--N 1.344 1.011 0 N-CA-C 112.09 -0.404 . . . . 54.25 112.09 176.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -81.21 136.43 35.84 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 122.958 0.503 . . . . 75.1 110.128 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.43 -8.37 85.12 Favored Glycine 0 C--N 1.344 1.026 0 O-C-N 123.776 0.672 . . . . 71.15 112.687 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 155' ' ' ALA . 75.0 p -70.23 128.73 37.26 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.045 0.938 . . . . 73.54 110.348 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -153.55 -40.25 0.1 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.919 0.487 . . . . 72.04 111.846 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.414 ' HB3' ' OD2' ' A' ' 154' ' ' ASP . 2.9 tt0 -93.72 -88.33 0.23 Allowed 'General case' 0 CA--C 1.554 1.128 0 CA-C-O 118.806 -0.616 . . . . 72.0 110.41 -173.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -174.01 -43.76 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 112.696 0.628 . . . . 74.34 112.696 176.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -66.56 -17.04 64.6 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.248 0.547 . . . . 64.1 111.227 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 151' ' ' GLU . 14.0 p-10 -102.56 100.5 10.59 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.248 1.419 . . . . 72.51 109.674 177.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' A' ' 149' ' ' THR . . . . . . . . 0 C--O 1.252 1.221 0 CA-C-O 117.86 -1.067 . . . . 71.05 109.533 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.478 0.933 0 N-CA-C 109.949 -0.389 . . . . 62.33 109.949 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.2 p -149.52 152.14 35.06 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.88 0.872 . . . . 50.42 109.418 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.35 78.93 1.35 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 107.97 -1.122 . . . . 75.42 107.97 -178.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -135.77 134.34 38.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.914 0.486 . . . . 62.05 109.995 -174.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -80.01 107.33 12.71 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 108.812 -0.81 . . . . 72.52 108.812 171.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -166.71 -164.59 0.66 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.447 -0.945 . . . . 70.22 108.447 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 43.7 p -79.63 68.28 5.64 Favored 'General case' 0 CA--C 1.55 0.974 0 CA-C-O 121.99 0.9 . . . . 72.53 110.063 172.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' B' ' 9' ' ' MET . 21.9 tt0 -121.7 -162.89 1.01 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 106.889 -1.523 . . . . 72.44 106.889 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.491 ' H ' ' HG2' ' B' ' 8' ' ' GLU . 11.7 ptm 59.32 169.78 0.07 Allowed 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 126.096 1.758 . . . . 75.12 114.758 170.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 37.7 p -155.85 136.2 13.12 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.813 1.245 . . . . 75.42 108.003 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.566 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 8.5 t80 -134.84 112.16 10.47 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 109.509 -0.552 . . . . 74.41 109.509 -176.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -127.03 115.94 19.97 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.786 -0.82 . . . . 74.14 108.786 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -68.5 135.76 27.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 116.455 -0.339 . . . . 73.13 110.218 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -98.47 -50.14 4.4 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.61 -0.885 . . . . 75.14 108.61 169.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -163.1 142.31 8.62 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.068 -0.515 . . . . 71.22 110.696 -173.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.426 ' HB ' HE22 ' D' ' 125' ' ' GLN . 81.2 mt -116.89 142.26 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 N-CA-C 106.403 -1.703 . . . . 70.42 106.403 165.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -167.74 142.12 3.61 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 118.136 0.425 . . . . 73.23 111.374 -173.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.1 m -72.19 121.48 19.41 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.189 -0.914 . . . . 73.32 108.808 170.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.456 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 45.8 mtpt -97.07 -24.87 15.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.472 0.709 . . . . 73.21 110.729 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -156.66 138.13 13.97 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.863 -0.608 . . . . 72.31 110.28 -172.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.5 mm -132.63 148.72 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.752 1.221 . . . . 63.52 107.963 173.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.6 t -150.22 142.33 24.04 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.294 -0.867 . . . . 75.12 109.162 165.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 86.1 t80 -146.57 114.2 6.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 106.076 -1.824 . . . . 72.23 106.076 168.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -122.92 114.35 20.33 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.806 -0.813 . . . . 73.31 108.806 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.597 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -106.45 85.59 1.81 Allowed Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 108.418 -0.956 . . . . 53.12 108.418 171.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.76 -20.81 29.64 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 122.827 2.351 . . . . 54.35 111.289 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.496 ' O ' HG23 ' B' ' 31' ' ' VAL . 80.7 m-20 -125.98 20.2 7.66 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.532 1.133 . . . . 73.11 110.577 -177.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.597 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -37.81 -55.0 2.24 Favored Pre-proline 0 N--CA 1.499 2.02 0 C-N-CA 125.671 1.589 . . . . 73.14 114.415 176.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 8.5 Cg_exo -69.56 -20.11 36.21 Favored 'Trans proline' 0 C--N 1.392 2.847 0 C-N-CA 123.057 2.505 . . . . 63.13 112.903 -175.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -96.59 -27.45 14.82 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.026 0.93 . . . . 54.24 112.442 -171.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.496 HG23 ' O ' ' B' ' 27' ' ' ASN . 64.2 t -67.22 -22.78 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.119 0.568 . . . . 73.42 110.916 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -57.33 -38.3 73.86 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.214 0.606 . . . . 74.32 111.499 171.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -73.6 -15.59 61.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.915 0.886 . . . . 74.22 111.731 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -104.17 108.86 20.43 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.529 0.732 . . . . 63.52 111.16 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -100.03 86.02 3.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.489 0.716 . . . . 73.24 109.949 176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.638 ' HB3' HD21 ' B' ' 68' ' ' LEU . 22.3 t90 -165.75 157.98 14.81 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.893 0.877 . . . . 74.23 109.107 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -75.7 121.35 84.92 Favored Pre-proline 0 N--CA 1.477 0.901 0 N-CA-C 109.536 -0.542 . . . . 71.4 109.536 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -71.14 146.69 52.37 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.48 2.12 . . . . 55.24 112.811 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -70.39 103.52 2.45 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.2 0.6 . . . . 73.54 109.503 172.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.769 HG11 HD21 ' B' ' 126' ' ' LEU . 23.0 t -106.46 144.33 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 123.316 0.646 . . . . 64.12 109.838 -177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -145.17 131.07 19.15 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.159 -1.052 . . . . 70.52 108.159 172.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.476 HD21 ' HG ' ' B' ' 128' ' ' LEU . 7.1 mp -88.49 165.98 14.51 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 109.455 -0.572 . . . . 74.24 109.455 173.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -160.76 142.85 12.5 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 107.348 -1.352 . . . . 64.01 107.348 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 37.7 mt -122.63 170.01 10.46 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.243 0.544 . . . . 70.21 110.72 -178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.673 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 19.4 t70 -142.14 126.37 17.52 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 114.683 -1.144 . . . . 51.43 108.281 174.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 11.9 p -107.93 103.94 13.3 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 123.602 0.761 . . . . 73.43 109.202 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.56 133.2 34.2 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.646 0.778 . . . . 63.11 109.699 -176.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.442 ' HB2' ' CE1' ' E' ' 116' ' ' TYR . 8.6 m -140.13 164.97 28.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.548 0.739 . . . . 72.13 109.113 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 56.1 p -151.63 139.73 20.18 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 122.838 0.455 . . . . 61.22 110.238 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 42.7 tp60 -81.84 112.53 19.06 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.938 -0.764 . . . . 72.14 108.938 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 60.9 mt -75.19 -51.93 12.19 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.424 0.631 . . . . 75.42 110.016 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.9 -172.35 3.54 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.47 1.108 . . . . 54.22 109.527 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -70.62 124.33 23.99 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.992 -0.744 . . . . 73.14 108.992 173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 63.38 22.08 13.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.318 1.047 . . . . 72.25 112.152 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -138.75 123.14 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 108.097 -1.075 . . . . 71.34 108.097 174.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.487 ' HE1' ' HB2' ' B' ' 84' ' ' PHE . 0.0 OUTLIER -130.88 -179.51 5.36 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.662 -0.496 . . . . 73.04 109.662 173.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -142.39 109.65 5.61 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.04 -1.096 . . . . 71.05 108.04 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.58 124.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.755 0.822 . . . . 73.31 109.397 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.431 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.1 t -106.69 122.31 60.5 Favored 'Isoleucine or valine' 0 C--O 1.245 0.824 0 N-CA-C 109.487 -0.561 . . . . 75.04 109.487 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.36 112.17 23.94 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.131 -1.433 . . . . 72.31 107.131 171.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.673 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 52.6 ttt180 -102.02 126.19 48.89 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.743 -0.465 . . . . 64.33 109.743 174.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.81 111.1 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 124.309 1.044 . . . . 62.44 108.882 176.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.4 m -94.79 138.59 32.4 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.761 -0.829 . . . . 65.54 108.761 170.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.5 t -131.52 130.03 62.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.107 0.963 . . . . 71.01 108.414 178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.9 m -125.54 138.41 53.96 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.325 -0.621 . . . . 74.43 109.325 175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 137.45 32.18 Favored 'General case' 0 C--O 1.24 0.589 0 C-N-CA 123.556 0.743 . . . . 74.31 109.289 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 29.3 p -144.03 124.82 14.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.284 0.634 . . . . 61.32 109.957 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.638 HD21 ' HB3' ' B' ' 36' ' ' TRP . 3.0 tt -95.63 112.8 24.44 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.78 -1.192 . . . . 71.22 107.78 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.13 -111.51 3.28 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 110.914 -0.874 . . . . 74.54 110.914 -173.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.98 15.69 9.99 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.067 0.947 . . . . 72.42 110.612 173.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -118.63 141.12 48.9 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.5 1.12 . . . . 74.12 108.665 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 71.5 m -61.4 134.49 56.97 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 118.325 0.511 . . . . 63.1 110.517 176.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.4 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -90.86 -58.11 2.59 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.376 -0.972 . . . . 63.15 108.376 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -160.44 159.1 30.53 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 114.778 -1.101 . . . . 75.12 109.765 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.2 mt -129.02 145.78 51.16 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.364 -1.347 . . . . 54.13 107.364 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.6 t -155.2 146.1 22.48 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.307 -0.627 . . . . 65.14 109.307 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -158.7 125.25 4.68 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.714 -0.476 . . . . 73.55 109.714 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 77.0 t -122.57 150.22 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 123.724 0.81 . . . . 72.41 109.36 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -127.05 102.47 6.99 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.03 -0.73 . . . . 72.42 109.03 175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.478 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.5 tp-100 -89.82 104.02 16.62 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.889 -0.596 . . . . 74.33 109.586 175.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.456 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -89.0 170.38 37.72 Favored Glycine 0 C--O 1.245 0.809 0 O-C-N 123.551 0.532 . . . . 71.52 112.133 175.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.56 125.84 1.36 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.913 -0.475 . . . . 52.33 111.913 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 61.7 mt -86.36 119.36 34.34 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.639 -0.874 . . . . 73.03 108.639 172.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.487 ' HB2' ' HE1' ' B' ' 56' ' ' TYR . 47.0 m-85 -121.83 135.05 54.9 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 109.101 -0.703 . . . . 74.34 109.101 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 16.1 m -100.61 120.87 40.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.203 1.001 . . . . 73.32 108.669 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.09 109.55 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.245 0 C-N-CA 123.629 0.771 . . . . 73.13 111.528 -171.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -117.74 140.12 50.11 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 123.704 0.801 . . . . 64.13 110.382 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.01 -26.91 14.51 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 111.993 -0.443 . . . . 60.05 111.993 -170.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.411 ' CG2' ' HB3' ' B' ' 94' ' ' MET . 2.1 mp -63.95 131.97 29.7 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 C-N-CA 125.339 1.455 . . . . 62.11 110.897 -176.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -159.79 143.58 14.46 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 124.214 0.946 . . . . 73.14 109.716 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.35 -117.86 11.8 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.831 0.707 . . . . 64.13 113.997 173.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.579 ' HA ' ' HB3' ' B' ' 95' ' ' ALA . 39.3 m -65.88 -29.8 70.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.363 1.065 . . . . 73.4 111.898 -176.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -49.9 -46.66 52.02 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 124.111 0.882 . . . . 73.52 111.064 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.52 ' HA ' ' HB3' ' B' ' 97' ' ' CYS . 9.1 ptm -94.18 -29.07 15.31 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.423 0.897 . . . . 74.14 113.423 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' B' ' 92' ' ' THR . . . -57.54 -28.86 63.89 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 118.912 0.778 . . . . 74.32 111.362 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.07 -32.72 17.41 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 124.257 1.023 . . . . 73.43 110.952 172.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.566 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 42.6 t -70.17 -66.82 0.55 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.923 0.489 . . . . 74.22 111.556 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.539 HD21 ' HD2' ' E' ' 117' ' ' PRO . 0.8 OUTLIER -63.77 -18.71 64.34 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 118.07 0.396 . . . . 71.35 111.773 175.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.44 -20.25 58.92 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 116.126 -0.488 . . . . 32.42 113.858 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -151.61 -58.7 0.16 Allowed 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 117.398 0.599 . . . . 72.24 112.543 -173.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -64.37 -51.7 61.97 Favored 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 112.943 0.72 . . . . 74.01 112.943 -167.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.537 ' SG ' ' SG ' ' B' ' 97' ' ' CYS . 75.2 m -60.71 -48.52 92.9 Favored Pre-proline 0 CA--C 1.558 1.288 0 CA-C-O 118.545 -0.74 . . . . 72.31 111.263 176.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 96.5 Cg_exo -50.14 -35.52 42.72 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.373 2.049 . . . . 74.12 114.797 167.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.84 -35.67 78.99 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.355 0.525 . . . . 62.32 111.433 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 C-N-CA 123.881 0.872 . . . . 70.54 110.1 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 74.6 mt -84.26 -20.49 32.12 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 114.793 -1.094 . . . . 71.03 112.401 -170.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -58.39 -48.94 96.05 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.047 -0.978 . . . . 73.25 113.311 -173.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' D' ' 108' ' ' PRO . 76.9 Cg_exo -55.22 -39.76 89.29 Favored 'Trans proline' 0 C--N 1.381 2.258 0 C-N-CA 122.571 2.181 . . . . 54.43 114.15 176.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.478 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 97.5 m-85 -65.89 -49.6 67.48 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.446 0.698 . . . . 74.41 111.257 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.59 -40.86 96.31 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.678 0.791 . . . . 42.02 110.863 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.57 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 49.0 ttt-85 -63.11 -56.23 18.59 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.134 1.374 . . . . 72.34 111.457 -178.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.89 -40.87 73.6 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.377 1.071 . . . . 72.23 110.83 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.543 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.4 t -65.93 -44.4 85.21 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 116.577 -0.283 . . . . 63.23 111.082 -176.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.404 HD12 HD21 ' B' ' 128' ' ' LEU . 72.7 mt -60.52 -54.8 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 123.524 0.729 . . . . 74.21 110.992 174.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 22.6 m -58.36 -29.79 66.26 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.448 0.699 . . . . 72.44 111.501 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 47.7 t -70.16 -54.37 13.19 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.436 0.694 . . . . 73.31 110.131 174.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.543 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 18.3 mmt -63.2 -34.86 78.55 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.248 0.619 . . . . 74.12 111.866 -174.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.8 -46.66 88.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 123.901 0.881 . . . . 62.22 110.902 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.44 ' HB2' ' HG2' ' C' ' 125' ' ' GLN . 80.4 p -73.58 -24.79 60.12 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 122.773 0.429 . . . . 73.11 111.714 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.476 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -63.42 -28.58 70.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.708 0.803 . . . . 74.41 110.637 172.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -96.99 17.28 59.55 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.249 -0.75 . . . . 53.11 113.631 177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 6.2 p 70.19 13.35 7.71 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 126.231 1.813 . . . . 64.32 113.418 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -90.61 150.5 42.62 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 122.618 0.367 . . . . 72.51 110.373 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.8 159.13 18.31 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.363 2.709 . . . . 70.45 113.368 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -59.31 135.6 57.7 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.882 0.739 . . . . 71.41 110.112 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.769 HD21 HG11 ' B' ' 40' ' ' VAL . 1.3 tm? -108.61 110.91 22.48 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 106.796 -1.557 . . . . 72.24 106.796 177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 -91.62 94.25 9.32 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.798 -0.816 . . . . 64.41 108.798 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.57 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 5.4 mp -69.93 108.14 3.88 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 107.589 -1.263 . . . . 71.01 107.589 171.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.31 139.26 87.0 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 123.563 0.539 . . . . 72.45 110.081 -178.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.49 82.72 0.68 Allowed 'Trans proline' 0 C--N 1.375 1.974 0 C-N-CA 122.194 1.929 . . . . 72.51 111.14 175.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' E' ' 125' ' ' TYR . 66.1 t -91.32 132.59 35.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-N 114.722 -1.126 . . . . 65.23 108.424 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -70.73 113.2 7.57 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.526 0.73 . . . . 53.13 110.299 -177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 35.9 m-85 -61.12 -40.17 92.78 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.329 1.051 . . . . 71.23 110.788 177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' B' ' 138' ' ' MET . 4.2 p30 -61.42 -34.17 74.94 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.154 -0.93 . . . . 75.11 111.046 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.35 -45.52 90.8 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.938 0.495 . . . . 64.53 111.163 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.421 ' HB3' ' CH2' ' E' ' 120' ' ' TRP . 0.2 OUTLIER -67.2 -34.43 77.5 Favored 'General case' 0 CA--C 1.559 1.316 0 N-CA-C 109.208 -0.664 . . . . 72.24 109.208 179.277 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -61.55 -41.32 97.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.064 0.945 . . . . 65.23 111.127 172.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.502 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 19.6 mmt -63.34 -37.81 88.71 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 120.974 0.416 . . . . 74.04 110.218 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.458 ' HA ' ' HG3' ' B' ' 142' ' ' GLN . 36.0 m-80 -76.43 -22.04 55.17 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.544 -0.753 . . . . 64.15 112.322 -178.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -68.24 -32.98 73.56 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.667 0.387 . . . . 73.13 110.741 173.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 21.9 mt -91.86 4.62 52.49 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.734 0.414 . . . . 65.33 111.818 -173.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.458 ' HG3' ' HA ' ' B' ' 139' ' ' ASN . 5.4 pp0? -132.82 174.91 9.83 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.484 0.713 . . . . 70.15 109.708 177.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -150.64 157.42 42.96 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.079 -0.711 . . . . 75.21 109.079 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.41 86.31 0.43 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 108.028 -1.101 . . . . 71.22 108.028 168.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.75 120.51 26.11 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.888 -1.051 . . . . 75.31 111.087 -170.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.25 -30.39 58.84 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.401 -0.68 . . . . 72.33 111.401 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 61.94 25.93 15.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.815 1.246 . . . . 74.32 112.067 174.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -115.92 -9.89 11.74 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.927 -0.579 . . . . 32.14 112.598 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.503 HG21 ' HB3' ' B' ' 154' ' ' ASP . 21.0 m -70.57 131.26 43.7 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 123.241 0.616 . . . . 73.02 111.874 -174.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -63.98 -36.97 85.71 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.379 0.671 . . . . 72.45 110.822 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -72.22 119.18 16.06 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.683 -0.69 . . . . 55.23 109.153 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -79.62 -8.38 59.15 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.597 0.759 . . . . 74.51 111.937 -176.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -68.73 -30.71 69.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.798 0.839 . . . . 71.01 109.89 170.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.503 ' HB3' HG21 ' B' ' 149' ' ' THR . 25.2 t70 -111.17 144.67 39.96 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.674 0.79 . . . . 62.04 109.786 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 C-N-CA 122.984 0.514 . . . . 61.03 110.285 -178.944 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 49.2 ttm . . . . . 0 N--CA 1.477 0.91 0 N-CA-C 109.795 -0.446 . . . . 73.32 109.795 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 74.3 m -148.15 89.63 1.75 Allowed 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.045 0.938 . . . . 75.02 108.776 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -77.56 79.47 4.06 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-O 122.067 0.937 . . . . 72.23 110.275 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -77.81 78.82 4.31 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 122.314 1.054 . . . . 73.02 108.916 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -74.61 112.5 10.87 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.76 -1.563 . . . . 73.4 111.081 -174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -154.53 132.05 11.3 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 109.524 -0.547 . . . . 73.24 109.524 172.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -119.81 -17.0 8.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.291 1.037 . . . . 72.24 109.773 174.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -89.5 106.73 18.65 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.721 0.809 . . . . 74.24 109.61 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.5 ' H ' HG23 ' C' ' 89' ' ' ILE . 54.2 ttp 65.68 115.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.421 1.488 . . . . 71.54 112.093 -178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.9 m -128.27 101.58 6.3 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 107.434 -1.321 . . . . 62.24 107.434 178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.488 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -114.78 143.47 45.02 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.376 0.67 . . . . 65.33 110.181 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -147.84 144.62 28.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.274 0.629 . . . . 74.5 110.02 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 62.2 mt -92.2 120.24 41.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.815 -0.809 . . . . 55.54 108.815 171.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -91.39 -38.32 12.67 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.53 0.332 . . . . 72.41 110.42 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.56 148.54 3.75 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 110.073 -0.343 . . . . 72.4 110.073 -177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 76.9 mt -136.04 132.94 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.137 -1.06 . . . . 72.45 108.137 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.465 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.0 p90 -170.72 162.56 7.78 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.643 0.735 . . . . 54.44 112.09 -176.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.8 p -87.39 117.35 26.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.826 -1.079 . . . . 54.02 110.203 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.508 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 6.8 mtmt -92.83 -7.52 46.12 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.411 0.284 . . . . 74.22 110.697 175.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.634 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 7.8 t70 -160.27 135.19 7.77 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.391 -0.966 . . . . 70.04 108.391 -176.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 77.9 mt -149.05 139.11 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 106.014 -1.847 . . . . 72.44 106.014 177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.7 t -158.92 151.04 21.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.063 0.459 . . . . 74.52 109.869 175.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -146.9 128.98 15.56 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.519 -1.289 . . . . 71.23 107.519 176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -124.7 142.43 51.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.72 -0.844 . . . . 64.21 108.72 177.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -154.43 77.94 5.26 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 108.753 -0.832 . . . . 72.24 108.753 175.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.61 -30.5 22.87 Favored 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.48 2.12 . . . . 71.23 111.574 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' C' ' 72' ' ' THR . 37.4 m-20 -112.14 33.51 4.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.007 0.923 . . . . 75.43 109.371 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.556 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -54.29 -45.89 99.1 Favored Pre-proline 0 CA--C 1.564 1.508 0 C-N-CA 124.496 1.118 . . . . 71.01 113.583 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -75.57 -25.55 10.89 Favored 'Trans proline' 0 C--N 1.391 2.791 0 C-N-CA 122.401 2.067 . . . . 74.2 113.4 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -60.13 -51.28 70.28 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 123.741 0.651 . . . . 73.01 111.256 -172.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.528 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 14.5 p -55.39 -25.53 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 124.423 1.089 . . . . 60.05 113.342 -172.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -66.88 -42.82 84.93 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 122.84 0.456 . . . . 72.35 111.515 178.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -103.4 13.85 32.73 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.26 0.624 . . . . 73.52 110.29 -176.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 24.3 ttpp -124.46 174.2 7.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.368 1.067 . . . . 72.4 109.434 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.415 ' N ' ' HG2' ' C' ' 34' ' ' LYS . 21.5 t70 -54.57 113.8 1.43 Allowed 'General case' 0 C--O 1.243 0.746 0 C-N-CA 124.337 1.055 . . . . 43.22 110.958 169.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 11.4 p90 -86.85 64.97 8.77 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.879 0.847 . . . . 72.33 111.24 175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -158.95 78.79 2.98 Favored Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 108.617 -0.883 . . . . 74.32 108.617 173.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -88.35 174.22 4.39 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.697 2.265 . . . . 74.51 111.574 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' C' ' 67' ' ' SER . 11.0 tp10 -85.8 107.63 17.73 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.052 -0.722 . . . . 65.33 109.052 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.657 ' H ' HD12 ' E' ' 141' ' ' LEU . 57.4 t -74.96 99.98 1.63 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-N 115.274 -0.875 . . . . 71.44 108.988 176.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 10.8 tmtt? -107.41 103.22 12.51 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 108.292 -1.003 . . . . 70.24 108.292 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.643 HD13 ' H ' ' C' ' 42' ' ' LEU . 0.0 OUTLIER -87.25 155.37 20.1 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.141 -0.689 . . . . 72.11 109.141 173.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 21.1 t70 -150.95 143.82 24.55 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 108.998 -0.741 . . . . 63.15 108.998 -177.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.98 145.72 48.39 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.467 -0.568 . . . . 73.15 109.467 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -156.99 149.98 23.78 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.78 0.832 . . . . 73.24 108.794 -175.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.0 t -130.8 154.3 48.16 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.187 0.518 . . . . 74.2 110.214 176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.488 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -140.8 171.13 14.52 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.022 . . . . 75.41 108.607 175.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' C' ' 57' ' ' GLU . 25.8 p -159.02 143.55 15.63 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 122.9 0.48 . . . . 65.05 110.35 177.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -149.84 128.02 12.03 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.859 0.863 . . . . 74.12 109.021 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.74 127.68 33.74 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.54 0.336 . . . . 71.43 110.557 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' C' ' 57' ' ' GLU . 31.7 mt -103.49 -30.12 10.73 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.835 0.854 . . . . 63.53 110.204 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.58 -178.43 6.88 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.88 0.872 . . . . 63.32 110.489 -177.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -62.16 117.31 5.86 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.299 -0.864 . . . . 73.51 109.925 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 67.91 0.27 2.29 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.528 1.131 . . . . 75.04 113.171 -177.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.2 t -103.8 114.81 44.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 CA-C-O 121.215 0.531 . . . . 75.54 109.702 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -124.22 123.56 40.53 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 107.732 -1.21 . . . . 74.02 107.732 -178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.9 tt0 -82.6 111.08 18.25 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 108.74 -0.837 . . . . 71.13 108.74 173.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 88.0 t -95.28 126.66 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.287 -1.005 . . . . 73.43 108.287 176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 42.0 t -110.96 102.3 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 N-CA-C 108.112 -1.07 . . . . 75.21 108.112 -176.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.2 tm? -91.95 102.83 15.4 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 108.781 -0.822 . . . . 72.04 108.781 -179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -85.08 125.47 32.79 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.904 1.281 . . . . 63.21 110.866 177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 44.2 t -119.27 141.73 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.313 1.045 . . . . 73.32 108.954 170.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.0 m -131.94 133.46 44.56 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.888 0.875 . . . . 70.44 109.256 174.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.737 HG23 HD13 ' C' ' 114' ' ' ILE . 93.2 t -116.74 117.18 54.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 108.345 -0.983 . . . . 74.0 108.345 167.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.43 HG23 HD23 ' C' ' 75' ' ' LEU . 13.9 m -105.15 141.92 35.84 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.597 -0.89 . . . . 53.12 108.597 175.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.02 93.04 2.87 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.176 -1.416 . . . . 75.42 107.176 176.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.473 ' O ' ' HB3' ' C' ' 39' ' ' GLU . 59.6 p -161.85 131.84 4.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 122.874 0.47 . . . . 75.03 109.896 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.78 39.1 0.83 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-O 121.793 0.806 . . . . 74.35 109.911 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.89 -84.33 0.72 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.093 -0.803 . . . . 33.54 111.093 -174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -90.12 -31.34 17.14 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.712 0.805 . . . . 55.54 111.232 -174.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -101.23 98.73 9.09 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.087 0.955 . . . . 73.02 110.252 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.545 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 32.2 m -88.88 118.31 28.5 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.96 0.504 . . . . 74.14 111.997 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -51.74 29.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.681 0.792 . . . . 62.13 109.071 174.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -162.52 174.72 12.29 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 113.98 -1.464 . . . . 73.24 110.621 174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.451 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.4 tm? -145.56 146.39 31.38 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 105.773 -1.936 . . . . 73.22 105.773 175.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.451 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.1 t -151.4 132.64 14.49 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.715 -0.846 . . . . 63.14 108.715 175.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -141.38 134.47 29.22 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.431 -0.581 . . . . 73.24 109.431 174.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.6 t -131.19 140.4 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.279 1.032 . . . . 72.21 108.603 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 77.0 mt-30 -115.04 102.19 9.71 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 108.594 -0.891 . . . . 74.33 108.594 170.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.1 tp-100 -82.45 99.6 9.54 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.919 0.888 . . . . 73.31 109.552 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -83.65 144.85 22.43 Favored Glycine 0 C--N 1.341 0.817 0 N-CA-C 111.317 -0.713 . . . . 53.42 111.317 174.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.27 118.94 1.35 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 111.211 -0.755 . . . . 73.1 111.211 -174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -80.97 122.17 35.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 107.984 -1.117 . . . . 60.53 107.984 176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -135.54 154.57 51.33 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.014 0.525 . . . . 74.31 110.608 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 40.3 m -105.19 118.83 37.53 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 108.34 -0.985 . . . . 71.13 108.34 169.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.432 HG21 ' HG3' ' C' ' 94' ' ' MET . 3.8 mp -113.86 107.01 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.158 -1.423 . . . . 70.32 107.158 178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -133.33 169.61 16.66 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.997 0.919 . . . . 64.23 110.341 -174.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.92 -55.23 4.06 Favored Glycine 0 C--N 1.344 0.991 0 CA-C-N 115.945 -0.57 . . . . 44.21 112.686 174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.5 HG23 ' H ' ' C' ' 9' ' ' MET . 2.6 pp -110.02 175.91 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.731 0.812 . . . . 54.21 111.139 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 13.2 pt-20 -163.78 -176.21 4.5 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 115.795 -0.638 . . . . 73.3 110.78 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.23 -124.8 28.49 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 116.333 -0.394 . . . . 61.22 113.768 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 66.6 p -60.58 -36.76 79.31 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.122 0.969 . . . . 51.12 111.175 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -66.93 -42.18 85.78 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.621 -1.172 . . . . 71.53 110.991 -178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.507 ' HB2' ' HA ' ' C' ' 90' ' ' GLU . 58.8 ttm -71.84 -36.53 70.2 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 122.951 0.501 . . . . 74.14 110.385 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.27 94.76 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.282 0.633 . . . . 55.45 111.075 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -67.73 -27.62 66.95 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.603 0.761 . . . . 65.11 111.134 177.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 36.6 t -72.81 -62.46 1.44 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 110.047 -0.353 . . . . 74.24 110.047 179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 pp -71.23 -17.83 62.48 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.829 0.452 . . . . 70.4 112.126 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.61 -10.83 46.09 Favored Glycine 0 C--N 1.349 1.301 0 CA-C-O 119.433 -0.649 . . . . 71.25 114.181 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.83 -56.18 0.38 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 117.874 0.837 . . . . 40.31 112.343 -174.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -70.68 -49.43 47.3 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.14 0.576 . . . . 73.43 112.128 -172.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.522 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 11.9 m -63.4 -46.36 84.51 Favored Pre-proline 0 CA--C 1.563 1.462 0 C-N-CA 123.358 0.663 . . . . 61.52 111.247 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 73.1 Cg_exo -55.54 -36.67 94.87 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 122.686 2.257 . . . . 74.53 114.73 169.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.508 HD21 ' ND2' ' C' ' 132' ' ' ASN . 28.2 t-20 -58.4 -38.7 77.88 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 123.356 0.662 . . . . 65.42 111.265 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 34.4 mm -59.01 -41.94 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 115.116 -0.947 . . . . 75.21 110.403 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.65 -20.0 28.45 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.589 -1.187 . . . . 64.3 112.428 -170.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -58.46 -50.55 87.43 Favored Pre-proline 0 CA--C 1.554 1.103 0 CA-C-O 117.772 -1.108 . . . . 74.05 113.147 -176.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 -37.9 94.43 Favored 'Trans proline' 0 C--N 1.386 2.505 0 C-N-CA 122.238 1.959 . . . . 62.22 113.365 178.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -67.92 -51.32 49.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.788 0.835 . . . . 75.32 111.605 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -59.64 -35.83 75.16 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.038 0.935 . . . . 74.5 110.891 177.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 32.7 ttt180 -65.39 -47.92 74.67 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.707 -1.588 . . . . 74.03 110.527 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -72.85 -30.17 63.79 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 123.518 0.511 . . . . 74.05 110.234 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.3 t -69.0 -29.23 67.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 122.82 0.448 . . . . 72.41 110.817 178.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.737 HD13 HG23 ' C' ' 64' ' ' VAL . 80.1 mt -75.89 -49.02 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.701 -0.681 . . . . 72.44 109.945 169.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.525 HG23 ' HG3' ' C' ' 125' ' ' GLN . 54.1 m -52.83 -41.92 64.66 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.268 1.027 . . . . 73.32 111.491 -176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 48.5 t -63.0 -49.02 76.3 Favored 'General case' 0 C--O 1.217 -0.608 0 CA-C-N 114.303 -1.317 . . . . 74.34 109.377 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.516 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.76 -42.11 88.13 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.564 1.145 . . . . 73.4 112.959 179.236 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 70.5 t -62.34 -43.69 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 109.519 -0.549 . . . . 62.43 109.519 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 16.7 t -71.79 -25.88 62.19 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.001 0.92 . . . . 61.23 111.7 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 78.4 mtt-85 -71.44 -33.86 69.76 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.393 0.677 . . . . 73.01 109.577 175.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.4 11.2 56.64 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 124.041 0.838 . . . . 71.21 112.703 172.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.538 HG23 ' HB3' ' D' ' 17' ' ' TYR . 68.1 p 57.02 26.4 11.88 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 126.256 1.822 . . . . 71.4 112.918 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.417 ' HE1' HG11 ' C' ' 31' ' ' VAL . 69.0 m-85 -94.83 146.78 31.99 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.68 -0.859 . . . . 64.4 108.68 174.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -60.91 146.55 97.47 Favored 'Trans proline' 0 C--N 1.367 1.545 0 C-N-CA 122.94 2.427 . . . . 72.02 112.647 175.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.525 ' HG3' HG23 ' C' ' 115' ' ' THR . 19.8 mp0 -59.1 125.37 23.31 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.837 0.855 . . . . 53.42 112.467 -174.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -109.7 90.46 3.31 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 106.048 -1.834 . . . . 65.32 106.048 168.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -91.07 109.34 20.59 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.279 -1.008 . . . . 71.24 108.279 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tt -55.57 132.22 48.18 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 124.074 0.859 . . . . 72.33 109.713 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.89 132.58 89.43 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 123.558 0.536 . . . . 71.23 111.056 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.568 ' HG3' HD11 ' A' ' 16' ' ' ILE . 61.3 Cg_endo -69.75 102.81 1.07 Allowed 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.905 2.403 . . . . 73.35 112.491 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 6.8 p -105.33 122.63 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.072 0.549 . . . . 72.01 109.853 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.508 ' ND2' HD21 ' C' ' 104' ' ' ASN . 15.6 m120 -109.12 81.54 1.46 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.567 0.747 . . . . 62.11 110.386 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -72.89 -31.8 64.94 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.806 -0.813 . . . . 75.02 108.806 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -51.75 -57.59 8.83 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.401 -1.272 . . . . 74.53 111.269 170.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' C' ' 138' ' ' MET . . . -71.6 -24.21 61.85 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 123.845 0.858 . . . . 55.25 111.457 -176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.471 HD22 HD11 ' E' ' 148' ' ' LEU . 63.2 tp -60.55 -53.74 53.81 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 123.984 0.803 . . . . 72.03 110.42 175.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -77.19 -23.05 51.52 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.138 -0.483 . . . . 74.34 110.61 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.569 ' HA ' HD23 ' C' ' 141' ' ' LEU . 27.6 ttt -71.03 -38.62 72.58 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.338 0.655 . . . . 70.24 111.696 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 12.2 p30 -67.99 -33.43 74.61 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 110.205 -0.294 . . . . 72.34 110.205 175.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -66.27 -88.69 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.995 0 CA-C-O 118.977 -0.535 . . . . 72.42 110.541 172.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' C' ' 138' ' ' MET . 1.3 mm? 48.51 84.68 0.03 OUTLIER 'General case' 0 C--N 1.368 1.371 0 C-N-CA 124.003 0.921 . . . . 75.05 110.574 -173.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -69.29 86.81 0.41 Allowed 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.287 0.565 . . . . 72.34 110.172 -174.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -158.75 179.5 9.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.415 1.086 . . . . 72.21 109.402 -177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -133.69 137.53 45.35 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.269 0.627 . . . . 75.13 110.07 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.45 133.96 55.34 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.948 0.899 . . . . 72.15 110.204 -177.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.528 ' HA2' HE22 ' A' ' 143' ' ' GLN . . . -153.18 159.2 28.4 Favored Glycine 0 C--N 1.341 0.826 0 O-C-N 123.783 0.677 . . . . 64.33 111.437 178.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.42 138.15 35.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.2 0.6 . . . . 75.51 110.218 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.62 -131.75 5.63 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 111.067 -0.813 . . . . 73.13 111.067 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 7.8 t -130.83 83.36 2.11 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-O 122.144 0.973 . . . . 64.34 109.156 175.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -120.01 123.66 44.01 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.437 -0.801 . . . . 73.21 109.514 174.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -77.82 109.79 12.13 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-O 121.651 0.739 . . . . 73.25 111.037 -175.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -80.87 84.3 6.41 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.475 -0.784 . . . . 75.13 109.629 178.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -130.75 129.41 42.44 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 124.778 1.231 . . . . 61.03 107.733 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -76.11 136.71 39.84 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.063 0.545 . . . . 70.12 110.676 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.958 0 C-N-CA 123.891 0.876 . . . . 73.21 111.137 -174.676 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 110.11 -0.329 . . . . 72.51 110.11 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 18.5 m 65.95 -79.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.601 1.16 . . . . 63.2 111.527 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -78.68 110.48 13.86 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.776 0.83 . . . . 73.25 110.054 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -75.02 81.17 2.21 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 109.198 -0.668 . . . . 75.12 109.198 174.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -117.6 -29.55 5.73 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.975 0.91 . . . . 72.11 110.533 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 61.86 84.33 0.14 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.676 1.191 . . . . 72.05 110.446 -176.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.0 m -147.48 -34.98 0.24 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.936 1.294 . . . . 74.53 107.859 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -63.57 115.39 4.65 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 114.359 -1.291 . . . . 64.35 110.233 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.452 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 12.1 tpt -33.03 128.56 0.26 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.805 1.242 . . . . 70.22 112.797 168.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 92.5 m -143.05 141.59 31.33 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.096 0.958 . . . . 61.3 110.282 -175.043 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -160.91 90.21 0.83 Allowed 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 106.263 -1.755 . . . . 73.14 106.263 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -114.03 150.23 34.24 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.854 -0.612 . . . . 72.13 110.377 -174.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.1 mm -93.4 120.86 43.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 123.767 0.827 . . . . 73.03 109.057 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -100.27 -49.54 4.23 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.014 0.196 . . . . 74.24 110.575 174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 49.4 ttt180 -167.81 118.72 0.83 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 110.559 -0.163 . . . . 73.15 110.559 -167.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -109.04 134.26 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.065 -1.458 . . . . 74.12 107.065 172.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.538 ' HB3' HG23 ' C' ' 122' ' ' THR . 37.2 p90 -164.96 177.35 7.89 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.528 0.68 . . . . 64.1 111.705 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.7 p -97.43 124.16 41.52 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-N 115.181 -0.918 . . . . 63.04 109.053 173.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.3 mtpt -88.61 -27.54 21.27 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 109.61 -0.515 . . . . 65.35 109.61 172.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.639 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 19.3 t70 -150.06 145.09 26.17 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.426 -0.806 . . . . 72.43 109.784 179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.516 HG21 ' HE2' ' C' ' 117' ' ' MET . 64.0 mt -144.99 149.08 17.19 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 C-N-CA 125.411 1.484 . . . . 72.42 107.667 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 36.1 t -151.87 144.88 24.51 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.553 0.741 . . . . 64.45 109.528 171.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.4 t80 -154.1 123.81 6.69 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 107.089 -1.448 . . . . 61.31 107.089 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 49.1 mt-10 -131.36 142.5 50.07 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.252 0.548 . . . . 75.41 110.089 -178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.68 74.49 10.36 Favored Pre-proline 0 CA--C 1.541 0.599 0 C-N-CA 124.404 1.082 . . . . 74.21 108.144 177.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.4 -43.39 4.32 Favored 'Trans proline' 0 C--N 1.372 1.809 0 C-N-CA 121.906 1.738 . . . . 73.23 110.937 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.448 ' O ' HG23 ' D' ' 31' ' ' VAL . 18.7 m-20 -92.17 25.49 2.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.601 1.16 . . . . 65.22 109.769 -175.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HD2' ' C' ' 19' ' ' LYS . . . -54.64 -56.73 23.99 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.326 1.232 . . . . 71.23 114.326 -168.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.89 -19.09 18.47 Favored 'Trans proline' 0 C--N 1.386 2.553 0 CA-C-N 121.437 1.549 . . . . 72.23 112.089 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 21.3 t-160 -70.87 -36.76 72.95 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.018 1.327 . . . . 71.15 110.342 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' D' ' 73' ' ' ALA . 84.5 t -79.0 -33.98 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.38 0.672 . . . . 74.13 110.68 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -60.82 -20.83 62.39 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 112.737 0.643 . . . . 64.21 112.737 178.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -64.8 -32.96 74.89 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.432 0.693 . . . . 64.42 110.621 175.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -91.52 105.91 18.1 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.25 1.02 . . . . 63.2 108.813 172.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -81.08 89.81 5.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.287 0.635 . . . . 71.31 109.595 178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.595 ' HB3' HD11 ' D' ' 68' ' ' LEU . 41.5 t-105 -163.75 158.45 20.25 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.479 0.712 . . . . 73.41 109.854 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.413 ' NE2' ' HA ' ' F' ' 136' ' ' VAL . 1.7 mp0 -87.66 115.13 61.93 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 123.917 0.887 . . . . 75.23 110.148 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -51.64 166.71 0.5 Allowed 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 125.029 3.819 . . . . 64.33 116.667 -173.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.562 ' HA ' ' HB2' ' F' ' 141' ' ' LEU . 20.8 mt-10 -98.22 113.24 25.1 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.439 -1.255 . . . . 72.44 108.316 177.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.591 HG13 HG13 ' D' ' 64' ' ' VAL . 45.0 t -98.43 111.37 27.94 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 123.661 0.784 . . . . 53.34 110.767 -173.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -86.85 117.36 25.54 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 106.796 -1.557 . . . . 71.45 106.796 170.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.3 tp -96.33 141.74 29.3 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.251 -0.648 . . . . 74.24 109.251 177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 21.6 t70 -129.87 146.77 51.59 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.826 -1.175 . . . . 74.5 107.826 171.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.485 HD23 ' H ' ' D' ' 44' ' ' LEU . 1.9 pt? -125.94 141.69 51.86 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.347 0.659 . . . . 74.44 110.049 -171.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.3 t70 -157.74 150.84 23.22 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.835 0.854 . . . . 65.12 109.212 174.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.7 t -130.77 158.07 41.11 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 108.367 -0.975 . . . . 60.2 108.367 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.596 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.14 173.7 14.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.99 -0.55 . . . . 63.11 109.929 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.574 ' HB3' HD21 ' D' ' 98' ' ' LEU . 66.0 p -157.65 158.82 36.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.056 0.543 . . . . 43.42 110.745 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 40.7 t -161.31 118.27 2.25 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.215 1.006 . . . . 50.15 108.434 178.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -77.9 117.19 19.01 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 108.796 -0.816 . . . . 73.22 108.796 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 72.5 mt -91.61 -35.07 14.45 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.861 -0.609 . . . . 55.54 110.406 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.17 -179.09 7.21 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.562 -0.745 . . . . 62.44 110.433 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -69.23 116.26 9.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.133 -0.939 . . . . 75.3 109.65 -177.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 67.7 9.29 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 124.784 1.234 . . . . 63.24 112.502 -175.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.26 114.29 46.59 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.629 -0.878 . . . . 71.34 108.629 175.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -125.04 129.42 50.26 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.15 0.98 . . . . 73.01 108.741 -172.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.1 117.47 34.42 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 124.222 1.009 . . . . 73.51 108.664 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.495 HG11 ' HD3' ' D' ' 103' ' ' PRO . 43.6 t -100.52 135.82 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 N-CA-C 108.243 -1.021 . . . . 71.14 108.243 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 84.5 t -113.72 146.56 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 123.74 0.816 . . . . 65.1 109.072 178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -125.47 124.92 42.44 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.079 -1.452 . . . . 73.43 107.079 176.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.9 ttm-85 -104.68 105.13 15.09 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 108.71 -0.848 . . . . 74.02 108.71 174.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 93.2 t -97.17 103.08 14.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 107.844 -1.169 . . . . 71.34 107.844 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 37.8 m -102.08 129.14 48.34 Favored 'General case' 0 C--N 1.34 0.175 0 C-N-CA 123.249 0.619 . . . . 73.23 109.805 -179.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.591 HG13 HG13 ' D' ' 40' ' ' VAL . 74.2 t -129.1 102.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.435 1.094 . . . . 54.23 109.15 -175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 61.8 m -102.07 108.09 19.41 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.433 -0.951 . . . . 50.05 108.433 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -109.37 141.85 41.14 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.081 -0.711 . . . . 54.12 109.081 -176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.45 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 42.1 p -147.56 126.4 12.69 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.394 -0.821 . . . . 63.22 109.58 -178.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.595 HD11 ' HB3' ' D' ' 36' ' ' TRP . 30.8 tp -99.87 110.44 22.8 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.521 -0.918 . . . . 72.51 108.521 177.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.46 -124.09 6.39 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.402 -0.679 . . . . 73.33 111.402 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.13 5.67 46.79 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.287 0.635 . . . . 74.25 110.966 175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -120.18 144.85 47.48 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.382 0.673 . . . . 71.1 111.319 -170.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 22.1 m -63.64 125.23 23.6 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 123.57 0.748 . . . . 71.31 110.551 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.456 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -89.41 -73.83 0.5 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.286 1.034 . . . . 65.22 109.648 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -144.17 138.02 27.84 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-O 121.246 0.546 . . . . 51.12 110.127 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 75.6 mt -103.08 148.14 26.09 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.257 1.023 . . . . 70.23 108.413 175.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.536 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.0 t -160.22 146.41 15.54 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.082 0.553 . . . . 72.12 110.381 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -157.18 127.6 6.47 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.063 -0.717 . . . . 65.44 109.063 170.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.429 HG22 HG23 ' D' ' 21' ' ' ILE . 67.7 t -126.73 115.89 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 122.857 0.463 . . . . 71.33 109.9 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.639 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.3 mt-30 -91.79 87.16 6.16 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.5 0.72 . . . . 71.01 109.181 170.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.43 108.44 12.96 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.566 -1.197 . . . . 75.34 108.81 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.43 141.69 15.4 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 111.693 -0.563 . . . . 33.31 111.693 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.408 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.41 130.49 5.13 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 111.045 -0.822 . . . . 53.21 111.045 -175.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 48.1 mt -88.97 116.45 30.54 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 C-N-CA 124.701 1.2 . . . . 71.23 108.995 179.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -120.7 143.87 48.52 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.747 0.819 . . . . 73.32 109.237 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.0 m -98.29 96.84 8.34 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.905 -0.776 . . . . 75.51 108.905 175.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 58.0 mt -106.65 109.16 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 108.401 -0.963 . . . . 54.55 108.401 -175.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -140.66 168.65 19.29 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.14 0.976 . . . . 45.45 109.527 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.18 -15.09 30.01 Favored Glycine 0 CA--C 1.533 1.165 0 N-CA-C 114.189 0.435 . . . . 74.42 114.189 175.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.5 tp -139.4 153.54 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.579 0.752 . . . . 64.31 110.144 -174.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.504 ' HA ' ' SD ' ' D' ' 94' ' ' MET . 0.3 OUTLIER -149.81 -170.24 3.59 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.778 0.831 . . . . 75.21 110.662 177.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.36 -142.33 26.98 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.002 -0.544 . . . . 61.24 113.843 174.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 37.8 p -73.94 -21.0 60.19 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.483 0.713 . . . . 70.34 111.762 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 58.1 tp60 -68.35 -47.98 66.02 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.191 0.597 . . . . 72.34 110.273 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.504 ' SD ' ' HA ' ' D' ' 90' ' ' GLU . 23.5 ptt? -71.94 -27.27 62.68 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.349 0.406 . . . . 70.53 110.608 177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.18 -49.41 67.45 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.45 0.7 . . . . 55.3 111.25 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.414 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 14.6 t-80 -71.93 -29.32 64.17 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.593 0.757 . . . . 54.2 110.663 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.2 t -68.14 -43.45 78.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 110.327 -0.249 . . . . 63.2 110.327 175.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.574 HD21 ' HB3' ' D' ' 48' ' ' SER . 9.2 tt -75.36 -45.23 40.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.524 0.73 . . . . 61.12 110.712 -175.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.73 6.97 79.87 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.769 -0.462 . . . . 52.04 114.063 -172.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.762 ' HB2' ' HB2' ' D' ' 137' ' ' PHE . . . -147.09 -63.62 0.28 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.489 0.645 . . . . 63.11 111.8 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -67.6 -40.26 84.77 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 112.632 0.604 . . . . 61.43 112.632 -169.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 86.0 m -71.12 -44.66 14.09 Favored Pre-proline 0 CA--C 1.563 1.442 0 C-N-CA 123.413 0.685 . . . . 73.4 111.575 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.584 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 86.7 Cg_exo -54.66 -32.62 76.21 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 122.815 2.343 . . . . 72.53 113.448 165.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . 0.549 ' HB2' ' HB3' ' D' ' 133' ' ' PHE . 4.1 t-20 -64.8 -36.62 84.9 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.178 0.591 . . . . 64.15 110.915 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -64.9 -42.82 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 123.577 0.751 . . . . 73.42 110.07 173.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.408 HD21 ' HA3' ' D' ' 82' ' ' GLY . 84.1 mt -76.8 -20.63 56.18 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.943 -1.026 . . . . 74.13 112.053 -174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -64.09 -45.73 79.81 Favored Pre-proline 0 CA--C 1.555 1.167 0 N-CA-C 114.55 1.315 . . . . 75.23 114.55 -171.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . 0.545 ' HB2' ' HG2' ' B' ' 108' ' ' PRO . 22.1 Cg_endo -59.16 -35.2 98.21 Favored 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 121.656 1.571 . . . . 73.53 112.683 174.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -73.9 -36.21 64.73 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.822 0.849 . . . . 72.53 111.601 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.35 -50.59 69.36 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.835 0.854 . . . . 73.41 109.947 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -55.76 -48.68 74.86 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.996 -1.456 . . . . 63.35 111.225 177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -62.99 -45.88 90.33 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.637 0.775 . . . . 74.23 111.278 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.9 t -55.45 -39.28 70.11 Favored 'General case' 0 N--CA 1.479 0.981 0 O-C-N 123.942 0.776 . . . . 73.11 111.002 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.544 HG21 HD12 ' D' ' 126' ' ' LEU . 52.8 mt -66.62 -50.92 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 115.373 -0.83 . . . . 74.4 110.779 174.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 10.6 m -58.79 -38.5 78.7 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.898 0.749 . . . . 55.23 111.54 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 38.5 t -63.69 -44.87 92.42 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.268 -0.878 . . . . 73.23 110.538 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.1 mtm -67.47 -35.15 78.62 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.95 0.5 . . . . 71.1 111.538 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.22 -40.37 82.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 C-N-CA 123.972 0.909 . . . . 72.5 110.672 178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 95.2 p -72.52 -32.83 66.44 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 120.959 0.409 . . . . 74.02 110.718 178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' D' ' 116' ' ' SER . 94.5 mtt-85 -67.39 -31.83 72.32 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.698 0.799 . . . . 74.15 110.204 172.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -87.93 6.07 84.0 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 123.896 0.747 . . . . 75.4 112.983 177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.465 HG23 ' HB3' ' C' ' 17' ' ' TYR . 48.8 p 54.74 27.61 9.03 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 126.199 1.8 . . . . 73.35 113.408 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -92.25 159.9 36.34 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.43 1.092 . . . . 63.22 110.686 174.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -57.17 138.29 85.6 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 123.405 2.736 . . . . 62.35 112.259 173.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.426 HE22 ' HB ' ' B' ' 16' ' ' ILE . 51.6 tt0 -50.99 129.97 24.71 Favored 'General case' 0 CA--C 1.546 0.809 0 O-C-N 124.726 1.266 . . . . 65.3 112.758 -173.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.544 HD12 HG21 ' D' ' 114' ' ' ILE . 2.7 tm? -115.9 95.74 5.26 Favored 'General case' 0 C--N 1.348 0.539 0 N-CA-C 107.714 -1.217 . . . . 72.32 107.714 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -133.83 114.58 13.5 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 107.872 -1.158 . . . . 52.23 107.872 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 5.1 mp -74.6 148.96 40.3 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.652 -0.704 . . . . 64.52 110.417 -174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.79 162.93 64.58 Favored Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 114.997 -1.001 . . . . 71.21 109.966 173.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.34 154.94 49.43 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.255 1.97 . . . . 70.52 112.868 174.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.63 139.43 23.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 CA-C-N 115.683 -0.69 . . . . 53.34 109.378 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -68.44 117.54 10.33 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.949 -0.759 . . . . 62.33 108.949 171.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.549 ' HB3' ' HB2' ' D' ' 104' ' ' ASN . 33.3 p90 -53.94 -28.47 37.33 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.982 0.913 . . . . 74.02 113.388 -177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.29 -39.51 69.94 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.175 0.99 . . . . 71.52 111.753 174.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.72 88.94 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.324 0.649 . . . . 52.21 111.424 178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.76 -44.3 93.88 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.359 0.664 . . . . 63.45 109.385 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.762 ' HB2' ' HB2' ' D' ' 100' ' ' ALA . 75.8 t80 -64.58 -49.36 71.45 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.984 -1.007 . . . . 74.45 111.617 -177.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.3 ptp -72.83 -30.59 64.16 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.748 0.419 . . . . 75.13 111.071 -175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.57 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 4.9 m-20 -68.31 -37.67 80.84 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 119.208 -0.425 . . . . 62.13 110.855 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 63.3 t80 -47.43 -38.41 13.39 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.249 1.019 . . . . 74.13 112.504 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.54 -46.6 75.58 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.551 -0.749 . . . . 54.22 110.871 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -91.22 38.75 0.97 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.015 0.926 . . . . 75.15 112.582 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 18.7 mm100 -117.4 79.02 1.28 Allowed 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.092 0.949 . . . . 74.15 110.3 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -144.39 73.25 1.37 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.612 -1.625 . . . . 71.33 106.612 169.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -158.19 120.01 3.6 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 114.223 -1.353 . . . . 72.1 109.185 -178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -153.99 40.2 0.67 Allowed Glycine 0 C--O 1.235 0.213 0 N-CA-C 110.033 -1.227 . . . . 75.33 110.033 176.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -48.55 81.29 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.064 0.946 . . . . 75.02 111.617 -174.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 61.85 103.48 0.01 OUTLIER Glycine 0 C--N 1.346 1.102 0 O-C-N 123.451 0.469 . . . . 24.42 112.899 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 55.6 p -61.43 -32.89 72.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.216 0.606 . . . . 73.44 110.49 178.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 61.53 33.54 18.38 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 124.889 1.276 . . . . 63.02 110.789 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -73.6 139.93 45.86 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.434 -0.803 . . . . 73.33 111.675 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -148.63 81.0 1.45 Allowed 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.789 0.836 . . . . 74.4 109.006 -176.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -90.36 106.93 18.83 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.807 -0.812 . . . . 74.24 108.807 174.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -98.43 58.22 1.25 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.542 1.137 . . . . 62.31 108.828 176.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 CA-C-N 114.357 -1.292 . . . . 70.21 109.005 -175.326 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.482 1.13 0 N-CA-C 110.337 -0.246 . . . . 73.41 110.337 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -136.05 64.07 1.57 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.572 -1.27 . . . . 74.52 107.572 172.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 62.19 -155.87 0.34 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.364 1.066 . . . . 74.44 110.479 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -150.19 -82.02 0.11 Allowed 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.501 -0.555 . . . . 73.11 109.501 173.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -110.49 -37.24 5.54 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 108.967 -0.753 . . . . 73.45 108.967 173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . 0.47 ' CB ' ' HB3' ' E' ' 116' ' ' TYR . 5.2 m-20 -63.04 148.88 46.48 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 114.901 -1.045 . . . . 74.24 109.968 175.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -73.1 -63.79 1.11 Allowed 'General case' 0 CA--C 1.545 0.752 0 O-C-N 123.717 0.635 . . . . 65.34 111.699 -170.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.435 ' HB3' ' SD ' ' B' ' 94' ' ' MET . 7.1 mp -93.89 -38.81 11.03 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.242 0.217 . . . . 64.42 111.009 -179.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . 0.47 ' HB3' ' CB ' ' E' ' 113' ' ' ASP . 63.9 t80 -48.19 109.8 1.24 Allowed Pre-proline 0 CA--C 1.559 1.32 0 C-N-CA 124.84 1.256 . . . . 74.25 111.867 -176.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.539 ' HD2' HD21 ' B' ' 98' ' ' LEU . 95.4 Cg_endo -78.4 -51.65 0.07 OUTLIER 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.04 2.493 . . . . 70.13 113.224 -170.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -166.17 -50.14 0.03 OUTLIER 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.5 0.72 . . . . 75.13 110.361 -177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 59.5 m 63.09 112.09 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.84 1.256 . . . . 73.35 110.351 -168.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.421 ' CH2' ' HB3' ' B' ' 136' ' ' LEU . 5.1 p-90 -55.2 124.48 17.1 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.354 1.062 . . . . 70.05 112.332 -175.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -104.93 84.22 2.11 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.036 -0.727 . . . . 72.44 109.036 177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.5 34.64 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.367 1.067 . . . . 64.44 110.02 179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 8.1 p -84.99 66.75 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 CA-C-O 122.85 1.31 . . . . 73.24 110.875 -175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -66.29 -35.24 79.88 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.68 -1.146 . . . . 73.34 110.285 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . 0.449 ' CE1' ' HB ' ' B' ' 131' ' ' VAL . 21.2 t80 64.04 28.68 14.32 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.176 0.99 . . . . 65.14 111.045 172.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -72.14 143.71 48.86 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 114.789 -1.096 . . . . 70.32 110.751 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.35 -172.96 39.43 Favored Glycine 0 C--O 1.242 0.654 0 CA-C-N 115.519 -0.764 . . . . 53.05 111.685 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -89.57 82.07 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.007 0.523 . . . . 72.24 109.856 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 7.2 mp -103.69 111.47 23.97 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.105 -0.702 . . . . 75.15 109.105 176.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 8.7 tp -166.23 -42.97 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 124.174 0.99 . . . . 72.45 109.08 178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 64.1 -170.2 0.19 Allowed 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.75 1.22 . . . . 61.21 110.902 -174.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -108.1 102.85 47.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 N-CA-C 109.335 -0.617 . . . . 71.24 109.335 173.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -74.55 119.64 5.83 Favored 'Trans proline' 0 C--N 1.374 1.873 0 C-N-CA 122.07 1.847 . . . . 52.43 111.206 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 6.8 tp -67.03 105.37 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.109 0 CA-C-O 121.462 0.649 . . . . 55.15 109.737 175.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.17 84.93 1.36 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.159 -0.928 . . . . 65.14 109.558 178.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 27.8 m -77.78 -26.58 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 CA-C-N 114.961 -1.018 . . . . 74.51 112.148 -175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 49.82 -81.08 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.659 1.583 . . . . 71.04 113.346 176.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.68 -2.49 36.32 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.499 1.12 . . . . 74.32 113.311 -173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 60.6 tp -74.44 83.28 1.96 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.527 0.68 . . . . 65.31 109.995 173.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 63.0 m -153.94 -71.17 0.14 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.278 -1.008 . . . . 72.0 108.278 175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . 0.657 HD12 ' H ' ' C' ' 40' ' ' VAL . 89.6 mt 61.57 14.37 5.91 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.726 1.211 . . . . 74.31 112.854 178.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 59.3 mt -83.94 143.52 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.514 0.726 . . . . 63.24 110.211 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -68.9 103.07 1.71 Allowed 'General case' 0 CA--C 1.559 1.325 0 CA-C-O 121.56 0.695 . . . . 74.12 109.984 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -96.28 32.62 1.93 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.15 0.98 . . . . 71.33 111.281 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -153.68 -69.83 0.14 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.281 0.632 . . . . 70.34 110.2 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -83.19 75.82 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.556 0.742 . . . . 65.41 110.096 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 10.5 tt -62.89 -45.02 94.5 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.175 -0.92 . . . . 73.13 110.001 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.471 HD11 HD22 ' C' ' 136' ' ' LEU . 56.8 tp -160.42 91.18 1.68 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 107.979 -1.119 . . . . 74.44 107.979 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 C--N 1.375 1.928 0 C-N-CA 123.121 2.547 . . . . 74.04 111.729 179.094 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.573 0.225 . . . . 73.44 110.704 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -79.83 125.26 29.47 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.355 0.662 . . . . 74.21 110.317 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -161.91 140.57 9.38 Favored 'General case' 0 C--O 1.241 0.631 0 C-N-CA 123.568 0.747 . . . . 61.13 110.095 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -107.55 113.77 27.32 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.605 0.762 . . . . 72.14 110.043 175.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -88.74 158.52 18.15 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.41 0.684 . . . . 62.21 109.642 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . 0.422 ' HA ' ' CD2' ' F' ' 116' ' ' TYR . 21.0 t70 82.21 87.66 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.421 1.488 . . . . 73.13 111.699 167.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 32.7 mtmt -136.49 132.14 34.92 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.924 0.89 . . . . 75.02 109.015 167.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.707 ' HG ' ' SD ' ' A' ' 94' ' ' MET . 8.5 mp 67.99 0.71 2.47 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 124.916 1.286 . . . . 74.03 113.525 167.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . 0.422 ' CD2' ' HA ' ' F' ' 113' ' ' ASP . 18.5 m-85 -69.47 153.63 95.6 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 123.475 0.71 . . . . 72.32 112.465 -169.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.17 -168.78 0.63 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 122.779 2.319 . . . . 44.0 113.966 -171.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -84.55 160.32 20.5 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 115.139 -0.937 . . . . 73.45 109.797 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 17.9 m -65.97 -28.55 68.98 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 123.619 0.575 . . . . 70.54 110.785 176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 70.7 m95 67.77 174.9 0.27 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 125.083 1.353 . . . . 73.41 110.892 -174.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -160.25 -77.66 0.06 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.721 -0.474 . . . . 60.35 109.721 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -80.63 81.06 6.98 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.295 0.638 . . . . 75.14 110.414 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.91 83.31 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 106.958 -1.497 . . . . 45.55 106.958 172.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -87.05 62.36 7.31 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.159 -0.928 . . . . 73.33 108.981 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -86.88 124.44 33.1 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.12 -1.4 . . . . 65.22 107.727 -175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . 0.43 ' H ' HG21 ' A' ' 131' ' ' VAL . 1.4 m-20 -66.67 92.01 0.2 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.413 0.685 . . . . 75.43 109.916 -176.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.52 135.13 11.98 Favored Glycine 0 C--N 1.343 0.946 0 CA-C-N 115.798 -0.637 . . . . 73.45 111.778 -177.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -147.94 -58.62 0.25 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.155 -1.054 . . . . 61.52 108.155 175.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.436 HD21 HD23 ' A' ' 42' ' ' LEU . 80.2 mt 76.83 -25.01 0.21 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 125.297 1.439 . . . . 44.41 114.459 163.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 6.7 tp -71.14 88.52 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.066 0 CA-C-O 122.358 1.075 . . . . 64.0 109.328 179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.32 164.4 25.58 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.194 -1.366 . . . . 50.23 109.355 178.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -70.09 108.17 3.13 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 123.285 0.634 . . . . 75.53 109.895 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -96.98 -157.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 123.347 2.698 . . . . 42.14 111.736 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 13.5 tt -162.97 130.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 107.976 -1.12 . . . . 71.4 107.976 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.87 93.42 2.65 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.614 0.765 . . . . 60.14 109.209 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.413 ' HA ' ' NE2' ' D' ' 37' ' ' GLN . 15.3 m -111.73 117.5 55.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-N 115.541 -0.754 . . . . 73.11 111.189 -174.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.64 -65.26 0.7 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.912 0.885 . . . . 73.21 109.919 177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -166.26 -74.02 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.207 -1.405 . . . . 74.42 107.207 172.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.468 ' HG ' HD23 ' D' ' 126' ' ' LEU . 0.3 OUTLIER -171.79 120.83 0.47 Allowed 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 106.761 -1.57 . . . . 71.02 106.761 172.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' D' ' 37' ' ' GLN . 28.7 t -78.14 -73.86 0.29 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.168 0.587 . . . . 71.45 110.887 -172.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . 0.562 ' HB2' ' HA ' ' D' ' 39' ' ' GLU . 4.3 mp -87.89 109.86 20.1 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.698 -0.853 . . . . 62.42 108.698 -177.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.53 ' HA ' ' HB ' ' D' ' 40' ' ' VAL . 14.2 tt -132.32 150.55 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.642 0.777 . . . . 62.44 109.215 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 76.95 138.82 0.07 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.366 1.467 . . . . 74.4 110.872 -176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -84.54 71.67 10.73 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.776 -0.824 . . . . 50.23 108.776 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -175.79 -73.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 106.889 -1.523 . . . . 60.45 106.889 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -161.78 -79.29 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.307 1.043 . . . . 75.03 108.527 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 tt 174.32 145.51 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 125.868 1.667 . . . . 73.2 106.599 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 55.8 tp -111.78 92.96 18.7 Favored Pre-proline 0 N--CA 1.48 1.049 0 N-CA-C 108.924 -0.769 . . . . 74.25 108.924 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo . . . . . 0 CA--C 1.562 1.882 0 C-N-CA 123.508 2.805 . . . . 52.11 112.275 177.537 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.367 -0.605 . . . . 74.41 109.367 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.7 m -152.32 123.0 7.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.398 1.079 . . . . 70.22 108.71 -179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -71.14 -62.43 1.4 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.052 -0.722 . . . . 74.32 109.052 174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 65.25 144.49 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 126.252 1.821 . . . . 72.3 113.122 176.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -74.63 -27.72 60.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.366 1.066 . . . . 61.43 111.183 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -61.41 86.87 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 124.192 0.997 . . . . 73.11 111.884 -172.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.0 p -65.42 -49.69 68.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.023 -0.99 . . . . 71.01 108.707 172.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -174.72 93.62 0.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 113.554 -1.657 . . . . 75.41 107.925 167.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 87.9 mtp -140.49 132.93 28.49 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.975 -0.75 . . . . 62.03 108.975 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 58.7 m -149.21 118.7 6.92 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.553 -0.906 . . . . 72.21 108.553 174.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' HZ ' ' SG ' ' A' ' 102' ' ' CYS . 1.2 t80 -139.76 114.84 9.66 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.625 -0.88 . . . . 75.05 108.625 167.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 -155.63 137.29 14.24 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.24 0.616 . . . . 71.43 109.668 174.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.646 ' H ' HD12 ' A' ' 13' ' ' ILE . 2.5 mp -75.96 131.72 34.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 108.474 -0.935 . . . . 74.52 108.474 -177.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -93.89 -35.79 12.52 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.808 0.276 . . . . 65.41 111.052 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.51 137.58 12.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 121.999 0.12 . . . . 75.15 110.821 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.438 HG13 HG21 ' A' ' 13' ' ' ILE . 2.3 mp -122.88 118.84 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 107.058 -1.46 . . . . 74.1 107.058 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' HB2' ' HA2' ' B' ' 121' ' ' GLY . 43.7 p90 -166.55 177.57 6.57 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 122.218 1.008 . . . . 74.13 113.031 -171.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.9 p -102.68 124.02 47.45 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.253 -1.34 . . . . 73.33 108.875 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.9 mtpt -91.58 -24.05 19.7 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.03 0.443 . . . . 73.41 110.071 176.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.9 t70 -153.21 138.26 17.29 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.937 -1.029 . . . . 71.14 109.308 -178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 74.5 mt -141.93 143.64 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.088 1.355 . . . . 63.23 107.593 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -155.8 139.16 15.75 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 121.343 0.592 . . . . 71.33 110.136 170.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.3 t80 -131.14 134.88 46.98 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.32 -1.733 . . . . 74.35 106.32 171.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -140.08 118.74 12.34 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.132 -0.692 . . . . 70.13 109.132 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.51 82.11 59.14 Favored Pre-proline 0 C--O 1.241 0.642 0 N-CA-C 107.205 -1.405 . . . . 73.34 107.205 173.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.39 -29.8 20.31 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.171 1.914 . . . . 64.21 110.344 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.624 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 33.4 m-20 -110.14 31.69 5.7 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.904 -1.044 . . . . 72.11 109.598 -177.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.547 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -58.58 -44.58 99.23 Favored Pre-proline 0 CA--C 1.565 1.525 0 C-N-CA 123.736 0.815 . . . . 75.53 112.276 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.64 -20.07 20.72 Favored 'Trans proline' 0 C--N 1.394 2.955 0 C-N-CA 121.735 1.623 . . . . 75.13 112.786 170.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.624 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 10.4 m-70 -85.25 -20.01 30.74 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 122.851 0.461 . . . . 64.32 111.945 -171.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG11 ' HE2' ' A' ' 123' ' ' PHE . 9.8 p -71.61 -19.19 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 120.968 0.414 . . . . 71.13 111.297 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -78.73 -41.68 30.18 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.572 0.749 . . . . 75.03 110.745 -178.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -75.95 -29.0 58.14 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.904 0.482 . . . . 64.03 110.63 179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.508 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 33.8 mmtp -83.2 169.45 15.76 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.273 0.629 . . . . 75.32 110.543 171.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -65.14 128.96 37.96 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.557 -0.905 . . . . 75.23 108.557 168.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HH2' ' NH2' ' B' ' 15' ' ' ARG . 2.8 t90 -84.78 68.31 10.4 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.148 0.975 . . . . 71.22 108.6 178.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -148.36 76.38 10.14 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 114.226 -1.352 . . . . 75.34 107.638 175.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -85.52 166.83 10.43 Favored 'Trans proline' 0 C--N 1.37 1.661 0 C-N-CA 122.298 1.999 . . . . 45.35 111.389 175.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.19 128.53 42.1 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 107.35 -1.352 . . . . 70.15 107.35 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 8.2 p -89.1 130.15 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-O 121.519 0.676 . . . . 73.15 110.358 -174.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 64' ' ' VAL . 1.7 ttpp -116.65 115.62 26.02 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 107.916 -1.142 . . . . 72.21 107.916 -173.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -110.15 106.48 15.95 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 108.342 -0.984 . . . . 64.14 108.342 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.591 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.1 m-20 -109.02 111.67 23.44 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.816 -0.809 . . . . 73.21 108.816 -177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -107.43 122.6 46.94 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.564 -0.532 . . . . 65.03 109.564 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -139.03 135.25 34.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.171 0.989 . . . . 61.13 109.399 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.8 m -107.52 138.57 43.49 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.278 0.631 . . . . 64.31 109.607 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.29 150.22 52.24 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.659 1.183 . . . . 63.53 108.012 175.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.2 m -124.38 161.18 26.5 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.144 0.497 . . . . 74.44 111.208 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.0 t -150.21 147.41 27.66 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.995 1.318 . . . . 64.34 108.768 -176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -112.85 124.52 52.78 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.947 -0.76 . . . . 62.32 108.947 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.9 mt -98.72 -36.38 9.86 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.983 0.513 . . . . 71.04 110.471 177.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.444 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -159.69 -174.23 4.52 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.584 0.754 . . . . 62.43 110.2 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.39 117.57 8.81 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 109.013 -0.736 . . . . 74.22 109.013 171.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 24.8 m-20 67.89 5.26 4.41 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.531 1.133 . . . . 64.23 112.583 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 49.1 t -108.78 104.52 17.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.52 -1.289 . . . . 74.3 107.52 173.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -122.58 146.47 47.4 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.499 0.666 . . . . 72.33 110.714 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -126.62 112.58 15.66 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.185 -1.413 . . . . 72.53 107.185 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 98' ' ' LEU . 30.8 m -102.91 126.62 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 108.077 -1.082 . . . . 41.42 108.077 174.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.536 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 39.4 t -102.97 129.39 54.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.721 0.808 . . . . 72.12 109.342 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.401 HD11 ' HD1' ' A' ' 107' ' ' PHE . 0.0 OUTLIER -98.84 112.13 24.32 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 107.59 -1.263 . . . . 73.2 107.59 -177.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 22.0 ttp180 -103.17 106.89 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 123.638 0.775 . . . . 74.13 109.883 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.32 133.3 58.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-N 114.836 -1.074 . . . . 65.42 109.15 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.4 m -116.34 143.13 45.94 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.604 -0.888 . . . . 71.04 108.604 171.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 41' ' ' LYS . 37.1 t -133.94 130.73 55.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.138 -1.43 . . . . 60.15 107.138 177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.7 m -132.46 139.08 47.84 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.007 -0.368 . . . . 71.45 110.007 175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.84 105.32 12.57 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 108.131 -1.063 . . . . 61.42 108.131 173.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.6 m -133.24 126.21 31.02 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.906 0.483 . . . . 53.23 110.525 -177.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tt -95.12 86.33 4.56 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 107.14 -1.429 . . . . 74.32 107.14 170.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.99 -85.06 1.0 Allowed Glycine 0 C--N 1.347 1.158 0 N-CA-C 111.448 -0.661 . . . . 73.15 111.448 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -118.1 -27.32 6.13 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.082 0.953 . . . . 73.53 110.015 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.508 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.7 tp10 -77.8 91.77 4.14 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.042 0.537 . . . . 75.41 109.853 -174.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 27' ' ' ASN . 85.1 m -73.79 105.97 5.31 Favored 'General case' 0 C--N 1.346 0.447 0 C-N-CA 122.894 0.477 . . . . 61.05 110.205 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.69 -50.53 72.87 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.493 1.117 . . . . 43.53 110.061 178.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -161.35 173.07 15.49 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.078 -1.419 . . . . 70.41 111.548 173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' H ' ' A' ' 76' ' ' CYS . 25.4 tp -142.06 147.97 37.67 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.67 1.588 . . . . 72.42 107.904 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 75.2 m -144.91 140.27 28.17 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.449 1.1 . . . . 70.42 109.266 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -149.55 120.32 7.57 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.32 -0.622 . . . . 71.33 109.32 168.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 113' ' ' CYS . 58.7 t -128.75 113.29 28.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 C-N-CA 123.622 0.769 . . . . 74.15 109.684 -176.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 50.8 mt-30 -89.88 90.89 8.37 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.552 0.741 . . . . 74.5 109.581 172.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -80.97 98.97 8.16 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.224 1.01 . . . . 75.23 109.007 177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -98.55 144.58 17.31 Favored Glycine 0 C--N 1.34 0.768 0 N-CA-C 112.152 -0.379 . . . . 55.11 112.152 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.86 132.44 6.03 Favored Glycine 0 C--N 1.328 0.129 0 N-CA-C 110.994 -0.842 . . . . 70.23 110.994 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.0 mt -83.86 129.77 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 108.695 -0.854 . . . . 64.24 108.695 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -129.79 120.11 24.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.122 0.569 . . . . 70.13 109.703 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 47.2 t -82.8 110.85 18.18 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.88 -0.785 . . . . 75.11 108.88 174.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.413 ' O ' ' HB3' ' A' ' 54' ' ' ASP . 22.3 pt -120.9 157.3 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 123.369 0.668 . . . . 75.23 109.973 -178.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.93 146.64 1.56 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.471 0.708 . . . . 62.43 110.47 176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.74 -25.39 23.6 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 114.963 0.745 . . . . 72.31 114.963 169.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 37.2 pt -109.9 134.85 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 CA-C-N 117.674 0.737 . . . . 62.43 109.857 -172.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.29 172.11 12.86 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.169 0.587 . . . . 70.02 109.965 -169.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -132.95 44.51 Favored Glycine 0 C--N 1.351 1.394 0 O-C-N 123.213 0.321 . . . . 62.2 113.578 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.495 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 27.1 p -67.59 -19.02 65.2 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.987 0.915 . . . . 65.3 112.228 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -63.98 -54.53 33.08 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.405 0.682 . . . . 73.23 110.38 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -24.82 39.98 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.542 -0.754 . . . . 75.34 110.785 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -70.9 -28.1 64.28 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.744 0.418 . . . . 72.42 111.011 175.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.31 -51.06 26.45 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.357 0.663 . . . . 73.12 109.784 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.67 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 6.1 m -73.84 -35.63 64.83 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.706 1.002 . . . . 74.23 113.706 -167.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB3' HG11 ' A' ' 58' ' ' VAL . 88.8 mt -87.4 -23.61 24.48 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 118.011 0.369 . . . . 75.25 111.003 174.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.15 -20.53 35.59 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 114.434 0.534 . . . . 61.42 114.434 -175.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -138.05 -60.16 0.63 Allowed 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.202 0.601 . . . . 54.24 111.59 -170.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 9.7 t80 -52.68 -56.28 16.59 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 124.411 1.084 . . . . 71.43 112.26 -177.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.419 ' SG ' ' HZ ' ' A' ' 11' ' ' PHE . 82.2 m -74.49 -44.3 5.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-O 117.454 -1.26 . . . . 62.2 114.314 -171.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.38 -27.51 85.18 Favored 'Trans proline' 0 C--N 1.386 2.547 0 CA-C-N 121.914 1.719 . . . . 61.34 112.439 168.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -73.86 -32.19 63.53 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 122.811 0.444 . . . . 70.23 110.663 175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 17.6 mm -65.89 -42.04 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.706 0.802 . . . . 64.32 109.935 170.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.6 mt -75.03 -18.39 60.34 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 115.128 -0.942 . . . . 60.22 111.292 -176.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.401 ' HD1' HD11 ' A' ' 60' ' ' LEU . 24.6 t80 -70.92 -43.38 13.84 Favored Pre-proline 0 CA--C 1.556 1.189 0 CA-C-O 117.543 -1.218 . . . . 73.33 114.158 -170.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.526 ' HB2' ' HG2' ' C' ' 108' ' ' PRO . 32.1 Cg_endo -63.12 -27.51 73.35 Favored 'Trans proline' 0 C--N 1.383 2.38 0 CA-C-N 122.087 1.781 . . . . 71.13 112.363 172.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -76.44 -41.01 48.98 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.442 0.697 . . . . 74.51 111.7 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -70.12 -38.88 75.7 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.994 -0.373 . . . . 54.12 109.994 175.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.441 ' NH1' HD12 ' C' ' 105' ' ' ILE . 39.0 ttm180 -55.29 -49.73 71.37 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.547 1.155 . . . . 73.55 109.873 174.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -61.03 -47.82 84.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.188 0.93 . . . . 64.11 111.176 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB3' HG11 ' A' ' 78' ' ' VAL . 34.4 t -65.1 -37.01 86.09 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 123.95 0.781 . . . . 72.2 111.637 -174.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.574 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 92.3 mt -67.21 -60.48 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 109.179 -0.674 . . . . 62.35 109.179 174.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.528 HG23 ' HG3' ' A' ' 125' ' ' GLN . 66.4 m -50.73 -37.35 41.21 Favored 'General case' 0 CA--C 1.547 0.835 0 O-C-N 124.84 1.338 . . . . 71.15 112.309 -176.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.9 t -69.38 -43.83 72.74 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.71 -0.677 . . . . 43.2 110.065 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.574 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 44.0 mtm -62.9 -38.64 91.74 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.798 0.439 . . . . 72.14 111.063 176.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 114' ' ' ILE . 87.0 t -57.66 -50.24 78.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 O-C-N 124.34 1.025 . . . . 65.41 110.005 177.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 81.6 p -73.7 -28.53 61.78 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.592 -0.731 . . . . 71.45 111.644 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -70.47 -27.73 64.45 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.495 0.718 . . . . 72.3 109.96 175.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.23 5.99 69.82 Favored Glycine 0 C--N 1.352 1.462 0 O-C-N 123.748 0.655 . . . . 61.22 113.331 174.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.522 HG22 HH21 ' B' ' 15' ' ' ARG . 6.5 m 64.87 27.98 12.78 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 124.833 1.253 . . . . 70.33 110.753 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.458 ' HE2' HG11 ' A' ' 31' ' ' VAL . 90.1 m-85 -97.45 153.85 38.21 Favored Pre-proline 0 N--CA 1.479 0.998 0 C-N-CA 124.455 1.102 . . . . 62.14 109.337 172.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -65.96 143.31 72.17 Favored 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.104 1.87 . . . . 60.22 111.37 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.528 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -59.07 137.67 57.85 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 124.191 0.932 . . . . 74.24 112.565 -176.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 93.9 mt -131.15 102.0 5.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.399 -0.963 . . . . 73.11 108.399 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.403 ' H ' HD11 ' F' ' 130' ' ' ILE . 87.8 m-20 -97.04 124.13 40.95 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 108.984 -0.747 . . . . 63.23 108.984 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -67.53 139.33 56.96 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.002 0.521 . . . . 71.01 109.837 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.12 128.54 92.45 Favored Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 122.983 0.513 . . . . 73.33 111.226 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 2.7 Cg_exo -76.43 89.36 1.28 Allowed 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 122.964 2.443 . . . . 60.02 112.456 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.6 t -109.61 115.02 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.808 0.843 . . . . 73.53 109.434 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.95 106.03 5.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.446 0.698 . . . . 75.32 110.314 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -86.97 -6.26 58.82 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.732 0.813 . . . . 73.02 111.978 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.49 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 2.0 m-20 -52.9 -51.91 59.49 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 123.438 0.461 . . . . 75.32 110.519 169.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.76 -31.06 66.12 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.207 0.942 . . . . 75.03 112.249 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.6 tt -64.14 -52.13 60.56 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.713 0.805 . . . . 72.21 109.503 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -68.68 -31.36 70.41 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.945 -0.571 . . . . 71.14 110.901 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 93.1 mmm -66.5 -38.55 87.48 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 119.191 -0.433 . . . . 75.4 111.103 -177.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -56.3 -30.38 62.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 123.549 0.531 . . . . 72.04 111.074 176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -80.42 -39.0 29.11 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.696 0.799 . . . . 53.42 111.114 174.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.4 tt -66.72 -57.76 6.47 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.042 0.537 . . . . 72.13 110.829 -173.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.419 ' H ' ' H ' ' A' ' 143' ' ' GLN . 11.6 mm100 -173.34 -16.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 125.606 1.562 . . . . 73.33 109.896 178.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.419 ' H ' ' H ' ' A' ' 142' ' ' GLN . 34.4 tt0 79.81 -48.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 126.264 1.825 . . . . 74.13 110.272 178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -83.56 137.3 33.9 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.291 1.037 . . . . 63.45 109.922 168.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -141.41 152.66 44.5 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.884 0.874 . . . . 63.41 109.175 171.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.02 112.62 0.53 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-N 116.24 -0.436 . . . . 73.14 112.643 -174.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -131.37 174.99 9.51 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.347 0.659 . . . . 74.12 109.905 172.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -171.65 68.76 0.12 Allowed Glycine 0 C--N 1.342 0.877 0 N-CA-C 110.479 -1.048 . . . . 34.22 110.479 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 26.0 m -70.51 90.13 0.73 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.459 0.704 . . . . 51.12 110.866 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -88.87 172.2 9.36 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 115.288 -0.869 . . . . 61.11 110.424 177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -156.04 157.92 36.93 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.29 -0.868 . . . . 63.1 109.361 171.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -151.51 66.34 0.88 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.634 0.774 . . . . 71.32 109.377 177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -80.36 134.05 35.99 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 115.912 -0.585 . . . . 55.43 110.573 177.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -90.28 107.73 19.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.279 0.632 . . . . 62.13 109.373 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.155 0 C-N-CA 123.533 0.733 . . . . 73.43 110.001 179.908 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.512 0.196 . . . . 62.13 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -81.37 -0.26 40.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.703 0.801 . . . . 54.4 112.138 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 65.19 -175.64 0.18 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.527 1.131 . . . . 54.21 113.048 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -93.91 150.73 20.11 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.327 1.051 . . . . 72.42 110.8 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.44 166.01 0.27 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 124.542 1.151 . . . . 75.13 112.22 172.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.487 ' HB2' ' HA3' ' B' ' 148' ' ' GLY . 1.8 m-20 -70.45 82.8 0.57 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.353 0.661 . . . . 74.45 110.388 174.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -77.91 99.29 5.94 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 108.549 -0.908 . . . . 55.44 108.549 170.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.516 ' HG2' ' H ' ' B' ' 9' ' ' MET . 5.8 tt0 -154.99 -153.71 0.46 Allowed 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.426 -1.324 . . . . 74.55 107.426 -176.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.516 ' H ' ' HG2' ' B' ' 8' ' ' GLU . 22.5 ptm 52.85 176.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.216 1.932 . . . . 61.23 116.216 169.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 85.8 m -143.25 118.96 10.46 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 113.494 -1.685 . . . . 71.1 107.763 175.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -120.22 134.93 55.15 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.092 -0.707 . . . . 74.52 109.092 173.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -151.19 127.79 10.8 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.051 -0.722 . . . . 73.44 109.051 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.482 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -86.05 143.39 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 109.234 -0.654 . . . . 54.12 109.234 173.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -109.3 -48.46 3.25 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.032 0.533 . . . . 64.55 109.58 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.522 HH21 HG22 ' A' ' 122' ' ' THR . 16.0 ttt180 -158.17 149.91 21.54 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.463 -0.335 . . . . 63.13 110.948 -175.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 64.6 mt -127.96 144.07 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.225 0 N-CA-C 106.594 -1.632 . . . . 73.33 106.594 168.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -171.66 147.12 2.25 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 122.493 0.317 . . . . 73.13 111.342 -176.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.9 m -73.79 119.36 17.9 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.605 -0.887 . . . . 61.55 108.605 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.1 mtpt -92.26 -33.69 14.55 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.966 0.506 . . . . 74.4 110.362 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 18.2 t70 -151.78 143.2 23.45 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.151 -0.477 . . . . 75.21 110.836 -168.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.412 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 38.1 mm -140.96 147.12 22.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.538 0 C-N-CA 125.715 1.606 . . . . 72.11 107.59 176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.7 t -150.33 140.27 21.93 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 108.888 -0.782 . . . . 52.22 108.888 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.0 t80 -145.65 125.2 13.21 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 107.506 -1.294 . . . . 74.32 107.506 174.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -128.54 122.46 31.11 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.685 0.794 . . . . 64.05 109.338 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.14 84.8 9.48 Favored Pre-proline 0 CA--C 1.545 0.755 0 N-CA-C 107.121 -1.437 . . . . 53.3 107.121 169.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.22 -31.53 35.58 Favored 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 122.646 2.231 . . . . 72.21 111.951 -173.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -124.31 27.41 7.05 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.07 0.948 . . . . 50.34 110.138 -174.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.751 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.14 -53.13 17.81 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 125.395 1.478 . . . . 74.32 114.741 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.21 -9.24 14.0 Favored 'Trans proline' 0 C--N 1.388 2.616 0 C-N-CA 121.904 1.736 . . . . 74.03 112.891 -178.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -95.68 -33.39 12.35 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.687 0.795 . . . . 63.22 110.54 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.424 HG23 ' HD2' ' B' ' 34' ' ' LYS . 8.7 p -81.36 -8.38 11.32 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 C-N-CA 123.854 0.862 . . . . 60.32 110.379 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -59.29 -37.43 77.68 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.784 0.833 . . . . 74.33 110.232 171.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -69.83 -26.94 64.47 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.513 0.725 . . . . 71.32 111.168 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.424 ' HD2' HG23 ' B' ' 31' ' ' VAL . 84.7 mttt -87.02 97.45 10.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.205 0.602 . . . . 72.35 110.391 -176.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -86.09 77.88 9.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.091 0.472 . . . . 53.33 110.352 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.479 ' HB2' HD11 ' B' ' 68' ' ' LEU . 17.1 m-90 -151.84 168.88 23.71 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.414 1.086 . . . . 75.45 108.283 176.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -86.41 115.73 63.24 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 107.795 -1.187 . . . . 74.33 107.795 174.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 30.8 Cg_endo -62.44 139.67 77.89 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.248 1.966 . . . . 51.41 111.195 177.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.1 104.06 0.68 Allowed 'General case' 0 C--O 1.24 0.571 0 N-CA-C 109.036 -0.728 . . . . 53.31 109.036 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.435 HG11 HD23 ' B' ' 126' ' ' LEU . 27.2 m -92.05 158.52 2.87 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 CA-C-N 115.109 -0.951 . . . . 74.34 111.56 -174.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -149.04 118.84 7.05 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 114.286 -1.325 . . . . 61.31 108.551 -178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.95 148.87 25.15 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 109.027 -0.731 . . . . 74.12 109.027 163.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.87 110.27 2.86 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 107.57 -1.271 . . . . 64.14 107.57 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.529 HD13 ' HB3' ' E' ' 125' ' ' TYR . 5.6 mp -101.71 152.09 21.26 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.932 0.893 . . . . 73.25 109.85 -174.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.439 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 13.7 t70 -145.82 144.66 30.4 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.198 1.399 . . . . 62.31 108.42 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.509 ' H ' HG11 ' E' ' 123' ' ' VAL . 11.9 t -114.05 141.14 47.83 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.342 -0.614 . . . . 75.52 109.342 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -137.69 154.92 49.6 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.014 0.926 . . . . 63.32 109.026 178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.4 p -145.05 163.22 34.91 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.328 0.651 . . . . 74.54 110.781 178.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 35.0 t -152.47 139.26 18.91 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.476 1.11 . . . . 70.13 108.17 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -96.27 118.02 31.97 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.427 -0.583 . . . . 65.4 109.427 172.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -90.41 -39.81 12.43 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.691 -0.485 . . . . 74.34 109.691 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.92 -171.64 3.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.309 -0.86 . . . . 60.24 110.332 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -60.84 119.76 8.84 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 114.946 -1.024 . . . . 72.43 109.927 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 67.7 -1.73 1.56 Allowed 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.575 1.15 . . . . 71.12 112.777 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 82.6 t -104.33 106.72 20.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.832 0 N-CA-C 108.617 -0.882 . . . . 54.34 108.617 -176.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -118.08 134.82 54.64 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.196 0.522 . . . . 74.53 110.224 178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -100.32 97.43 8.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 106.482 -1.673 . . . . 65.11 106.482 175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 64.6 t -92.29 124.5 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 123.853 0.861 . . . . 74.13 109.121 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.703 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 38.4 t -100.68 142.97 14.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 109.122 -0.696 . . . . 60.53 109.122 177.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.42 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.2 OUTLIER -116.29 121.01 40.75 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.576 -1.268 . . . . 63.23 107.576 173.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.439 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 58.0 ttt180 -106.76 116.77 32.49 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.249 1.02 . . . . 64.51 109.545 176.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.4 t -114.79 120.23 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 107.963 -1.125 . . . . 75.21 107.963 171.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 17.0 m -116.03 133.36 56.11 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.227 0.611 . . . . 73.25 109.403 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.642 HG21 HG21 ' B' ' 114' ' ' ILE . 38.7 t -114.28 136.35 51.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 124.406 1.083 . . . . 74.3 110.586 178.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -125.1 145.18 50.05 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.672 1.189 . . . . 62.22 108.303 173.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -148.08 141.61 25.42 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.006 -0.738 . . . . 71.32 109.006 174.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.403 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 37.3 p -146.37 134.96 22.13 Favored 'General case' 0 N--CA 1.463 0.216 0 O-C-N 123.716 0.635 . . . . 73.04 109.829 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.479 HD11 ' HB2' ' B' ' 36' ' ' TRP . 14.4 tp -132.24 122.23 24.87 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.805 -0.813 . . . . 74.11 108.805 -177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.93 -128.21 8.32 Favored Glycine 0 C--N 1.343 0.922 0 O-C-N 123.868 0.73 . . . . 71.12 112.215 -174.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -105.67 19.62 20.26 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.519 0.728 . . . . 74.42 110.927 -174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -156.54 167.05 31.63 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.808 0.443 . . . . 60.54 111.83 -174.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 93.1 m -70.56 136.39 49.24 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.406 -0.815 . . . . 74.23 110.275 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.403 ' H ' ' HA ' ' B' ' 67' ' ' SER . . . -89.71 -54.81 3.89 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.117 0.967 . . . . 61.11 109.22 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -158.73 167.58 29.12 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.267 -0.879 . . . . 75.25 110.971 173.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -141.57 145.12 34.7 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.868 1.667 . . . . 73.53 107.553 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.3 t -151.14 159.43 44.46 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.175 -0.676 . . . . 51.33 109.175 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -165.78 136.62 3.7 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.989 -0.745 . . . . 70.31 108.989 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' B' ' 113' ' ' CYS . 95.8 t -130.0 144.87 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 108.967 -0.753 . . . . 71.42 108.967 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.667 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 20.8 mt-30 -128.18 97.66 4.84 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.237 -0.653 . . . . 71.43 109.237 173.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.3 tp-100 -88.15 103.13 15.46 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.028 -0.987 . . . . 72.33 108.881 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.01 147.46 19.28 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.602 -0.599 . . . . 70.12 111.602 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.15 126.54 2.74 Favored Glycine 0 C--N 1.33 0.237 0 N-CA-C 111.535 -0.626 . . . . 54.05 111.535 -177.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.5 mt -85.57 117.95 31.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 108.412 -0.958 . . . . 72.22 108.412 174.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -124.49 167.07 14.94 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.06 0.944 . . . . 74.44 109.816 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 64.3 m -132.47 114.59 14.48 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.13 0.972 . . . . 75.04 109.157 174.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.2 pp -118.96 135.84 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.15 0.98 . . . . 62.32 110.429 -178.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.15 166.66 32.4 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.732 0.813 . . . . 55.24 109.42 177.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.84 -61.79 4.71 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.267 0.355 . . . . 54.31 112.398 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.684 HD13 ' SD ' ' B' ' 94' ' ' MET . 1.1 pp -56.97 150.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.877 0.871 . . . . 61.44 112.802 177.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -158.53 164.01 36.52 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.69 0.796 . . . . 74.22 110.659 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.71 -120.72 23.69 Favored Glycine 0 C--N 1.356 1.688 0 O-C-N 123.803 0.689 . . . . 71.44 113.312 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 34.2 m -67.95 -35.23 78.04 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.282 0.633 . . . . 64.02 111.588 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -68.91 -43.33 75.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.103 0.561 . . . . 71.44 110.726 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.684 ' SD ' HD13 ' B' ' 89' ' ' ILE . 5.3 tpt -67.85 -43.45 79.45 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 115.952 -0.567 . . . . 74.24 110.327 175.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.3 -34.57 75.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.206 0.603 . . . . 63.31 111.899 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -76.44 -32.0 58.18 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.665 0.786 . . . . 74.5 110.776 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.7 t -70.81 -52.87 17.76 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.889 0.476 . . . . 64.43 111.225 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.42 HD23 ' HG3' ' B' ' 94' ' ' MET . 4.5 pp -69.71 -26.36 64.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.058 0.543 . . . . 71.3 110.786 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.51 3.15 63.24 Favored Glycine 0 C--N 1.353 1.51 0 CA-C-O 119.246 -0.752 . . . . 53.03 114.839 -174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.434 ' HA ' ' HB2' ' B' ' 133' ' ' PHE . . . -154.11 -53.52 0.1 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 117.853 0.826 . . . . 70.03 112.138 -178.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -64.6 -56.03 16.52 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.556 0.742 . . . . 54.51 111.206 -169.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.438 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 70.9 m -61.51 -50.22 83.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 CA-C-O 118.253 -0.879 . . . . 64.05 112.191 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 76.6 Cg_exo -55.06 -36.43 92.8 Favored 'Trans proline' 0 C--N 1.399 3.194 0 C-N-CA 122.287 1.991 . . . . 63.42 113.975 172.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -66.22 -33.82 76.63 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.65 0.38 . . . . 60.05 111.323 -176.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.18 -44.61 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.901 0.88 . . . . 60.11 110.446 174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.42 ' HB2' HD12 ' B' ' 60' ' ' LEU . 77.3 mt -83.29 -19.4 36.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 114.913 -1.04 . . . . 71.34 112.637 -169.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.41 -45.84 94.58 Favored Pre-proline 0 CA--C 1.557 1.245 0 CA-C-O 117.677 -1.154 . . . . 70.11 113.689 -172.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.61 -43.25 46.51 Favored 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 122.656 2.238 . . . . 63.21 113.977 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 73.7 m-85 -65.94 -44.92 83.65 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.873 0.733 . . . . 71.13 110.506 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.43 -37.55 87.26 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 115.656 -0.702 . . . . 74.14 111.06 178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -61.69 -53.57 54.29 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.044 1.338 . . . . 74.11 110.953 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.02 -40.68 95.21 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.722 0.639 . . . . 75.45 110.223 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.468 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.5 t -66.66 -33.26 75.26 Favored 'General case' 0 CA--C 1.551 0.983 0 O-C-N 123.814 0.696 . . . . 73.13 111.853 -174.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.642 HG21 HG21 ' B' ' 64' ' ' VAL . 71.3 mt -68.24 -52.63 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 109.398 -0.593 . . . . 73.51 109.398 172.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 20.5 m -59.12 -28.65 66.74 Favored 'General case' 0 CA--C 1.555 1.151 0 O-C-N 124.176 0.922 . . . . 74.23 111.016 -176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 45.5 t -66.99 -53.17 34.03 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 115.297 -0.865 . . . . 70.04 109.658 174.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.49 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 20.6 mmt -64.3 -34.72 78.78 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 123.455 0.472 . . . . 60.15 111.95 -176.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 79.6 t -63.78 -48.39 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 123.906 0.882 . . . . 74.42 110.665 175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 89.7 p -72.41 -24.22 61.2 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.872 -0.604 . . . . 64.31 111.448 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.49 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.6 mtt-85 -67.5 -32.68 73.67 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 123.359 0.664 . . . . 72.54 109.907 172.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.416 ' HA2' ' HB2' ' A' ' 17' ' ' TYR . . . -87.23 8.69 75.81 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.96 0.788 . . . . 64.0 113.282 176.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 17' ' ' TYR . 69.9 p 57.7 34.07 24.01 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 125.976 1.71 . . . . 73.03 113.205 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -94.22 156.27 39.07 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 123.808 0.843 . . . . 73.44 110.18 175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.99 179.57 0.55 Allowed 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 123.124 2.549 . . . . 74.11 113.542 -176.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -56.68 113.88 1.82 Allowed 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.501 -0.772 . . . . 75.42 111.254 -177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.435 HD23 HG11 ' B' ' 40' ' ' VAL . 3.2 tm? -129.22 100.91 5.78 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.486 -1.672 . . . . 73.04 106.486 172.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -131.44 134.11 45.87 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.691 -0.855 . . . . 74.1 108.691 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.3 132.93 35.22 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.553 0.741 . . . . 73.04 110.419 -172.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -77.69 154.0 81.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.047 0.939 . . . . 73.53 110.151 176.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.401 ' HD3' HD13 ' D' ' 16' ' ' ILE . 35.8 Cg_endo -59.98 114.18 1.97 Allowed 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 122.931 2.421 . . . . 51.4 111.845 -177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.436 HG11 HD22 ' B' ' 44' ' ' LEU . 90.7 t -90.0 118.15 34.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 115.644 -0.707 . . . . 55.3 109.998 -178.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -76.91 93.47 3.78 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.292 -0.632 . . . . 74.42 109.292 168.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.434 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 91.6 m-85 -62.65 -35.76 80.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 114.673 -1.149 . . . . 71.04 110.858 179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -63.69 -39.53 94.54 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 114.516 -1.22 . . . . 63.45 110.961 177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -75.61 -27.48 58.49 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 123.705 0.628 . . . . 62.12 111.807 -176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.401 HD12 ' HZ3' ' E' ' 120' ' ' TRP . 1.6 tm? -77.5 -42.63 34.97 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.121 -0.696 . . . . 71.32 109.121 178.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -66.46 -29.19 69.26 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.572 0.749 . . . . 74.4 110.321 174.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 57.6 ttp -57.64 -33.29 68.13 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.054 0.942 . . . . 73.44 112.13 177.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -74.25 -25.76 59.82 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.886 0.475 . . . . 74.24 111.478 -178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -62.38 -48.88 77.82 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.636 0.775 . . . . 71.51 111.237 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' B' ' 144' ' ' GLN . 0.5 OUTLIER -106.03 8.24 32.26 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.735 -0.666 . . . . 62.41 111.584 -176.217 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 56.57 91.94 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.718 1.207 . . . . 73.41 111.025 -177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 70.61 143.05 0.05 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.254 1.422 . . . . 74.43 111.462 -176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . 0.459 ' HB3' HD11 ' B' ' 141' ' ' LEU . 9.9 pt20 -152.81 170.8 19.42 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.308 0.643 . . . . 75.2 110.708 172.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -135.86 139.32 43.3 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.105 -0.952 . . . . 72.12 109.085 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -161.87 32.85 0.34 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.166 0.291 . . . . 75.43 112.787 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -80.2 89.85 5.48 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.579 0.752 . . . . 60.15 109.172 176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' B' ' 6' ' ' ASN . . . 161.51 95.44 0.11 Allowed Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.513 -0.767 . . . . 32.32 111.582 -177.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.1 t -142.45 3.21 1.49 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.368 0.667 . . . . 74.41 110.528 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -66.93 143.78 56.62 Favored 'General case' 0 C--N 1.363 1.158 0 C-N-CA 122.736 0.414 . . . . 74.24 110.629 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.89 151.27 45.87 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.45 1.1 . . . . 73.01 112.514 -176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -164.01 1.95 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.689 -1.141 . . . . 75.42 109.86 167.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.429 HE21 ' N ' ' B' ' 9' ' ' MET . 47.3 mt-30 -133.98 165.8 24.19 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.015 0.926 . . . . 74.51 109.617 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -124.03 8.41 8.65 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.718 0.807 . . . . 64.51 109.364 171.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 C-N-CA 125.021 1.328 . . . . 71.43 108.05 173.919 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.48 ' SD ' ' NE2' ' C' ' 153' ' ' GLN . 17.5 tpt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 109.759 -0.46 . . . . 64.14 109.759 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t 67.14 166.68 0.23 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.153 1.381 . . . . 64.04 110.867 -169.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 63.51 77.12 0.34 Allowed 'General case' 0 CA--C 1.556 1.178 0 C-N-CA 124.155 0.982 . . . . 64.25 108.503 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -101.26 174.93 5.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.618 0.767 . . . . 54.13 111.083 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -69.69 -9.04 52.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 124.46 1.104 . . . . 73.42 112.545 174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -49.09 146.4 3.52 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.088 1.355 . . . . 72.14 110.789 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 36.7 p -47.39 120.55 3.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.765 1.226 . . . . 51.13 112.98 -171.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -74.52 -71.78 0.32 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 114.723 -1.126 . . . . 75.32 111.196 -173.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 57.1 ttp 62.75 114.67 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.717 1.207 . . . . 64.23 111.305 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -85.92 93.43 8.94 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.218 -0.66 . . . . 74.21 109.218 177.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.458 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 53.9 t80 -118.97 123.56 44.87 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.983 -1.008 . . . . 72.4 108.392 178.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -137.84 140.96 40.76 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.707 0.403 . . . . 72.44 110.068 -177.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.608 HD11 HG13 ' C' ' 16' ' ' ILE . 5.6 tp -85.27 136.49 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 C-N-CA 123.128 0.571 . . . . 74.23 109.854 175.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.7 mm-40 -109.55 -50.64 2.96 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.615 -0.721 . . . . 74.14 109.74 174.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -169.02 138.65 2.18 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.655 -0.702 . . . . 73.51 109.41 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.608 HG13 HD11 ' C' ' 13' ' ' ILE . 88.4 mt -122.39 144.57 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.6 -1.259 . . . . 73.44 107.6 171.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.5 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 38.4 p90 -174.24 165.26 4.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.364 0.602 . . . . 75.21 110.612 -177.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.411 HG22 HE22 ' C' ' 80' ' ' GLN . 81.4 p -85.04 107.35 17.11 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.997 -1.001 . . . . 72.24 109.802 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.423 ' HZ3' ' HD3' ' D' ' 29' ' ' PRO . 23.6 mmmt -65.86 -35.03 79.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.761 -0.654 . . . . 74.44 109.877 173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -150.53 144.4 25.3 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 114.98 -1.009 . . . . 74.24 109.549 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.3 mt -139.28 140.45 37.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 106.64 -1.615 . . . . 74.25 106.64 172.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.43 147.6 17.56 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.799 -0.445 . . . . 74.31 109.799 175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -147.32 116.67 6.98 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 108.192 -1.04 . . . . 72.54 108.192 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.94 120.44 37.87 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 123.77 0.828 . . . . 74.53 108.99 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -124.2 85.58 54.96 Favored Pre-proline 0 CA--C 1.544 0.736 0 N-CA-C 108.583 -0.895 . . . . 73.15 108.583 176.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -67.12 -32.58 33.82 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.725 2.284 . . . . 75.32 111.595 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 73.6 m-20 -114.56 38.4 3.11 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.023 0.929 . . . . 70.25 109.422 -176.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.506 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -58.83 -50.98 85.09 Favored Pre-proline 0 CA--C 1.569 1.682 0 N-CA-C 114.333 1.234 . . . . 64.21 114.333 -178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.2 Cg_exo -73.6 -28.59 11.7 Favored 'Trans proline' 0 C--N 1.392 2.838 0 C-N-CA 121.871 1.714 . . . . 74.1 111.554 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.407 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 80.5 t60 -68.0 -20.67 65.04 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.33 1.052 . . . . 64.31 112.583 -176.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -62.07 -16.19 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 118.117 0.417 . . . . 74.14 111.827 175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -68.43 -43.53 76.93 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 109.492 -0.558 . . . . 71.33 109.492 170.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -92.07 51.24 1.77 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.62 1.168 . . . . 75.12 109.379 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.01 148.11 47.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.099 0.56 . . . . 71.23 110.997 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.47 129.28 37.02 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.19 -1.041 . . . . 72.45 108.19 164.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 23.1 t90 -83.93 69.5 10.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.799 0.809 . . . . 74.44 110.738 -177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.63 73.19 13.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.103 1.361 . . . . 71.54 107.46 165.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -87.59 118.87 1.31 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.215 1.943 . . . . 64.24 111.419 177.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.52 116.11 22.95 Favored 'General case' 0 C--O 1.246 0.869 0 N-CA-C 108.388 -0.968 . . . . 71.15 108.388 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.44 101.08 12.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 114.743 -1.117 . . . . 51.03 108.827 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -90.45 103.9 16.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.309 1.044 . . . . 74.31 108.258 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.26 133.15 33.71 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.187 -0.671 . . . . 64.41 109.187 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.526 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.5 t70 -119.63 143.64 47.57 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.763 1.225 . . . . 73.51 108.148 174.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.22 148.94 49.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.668 0.787 . . . . 74.21 109.173 177.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -156.18 150.79 25.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.657 0.783 . . . . 62.33 109.034 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 14.6 t -133.88 146.59 50.71 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.849 0.46 . . . . 70.04 110.236 176.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.99 144.8 30.34 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 108.5 -0.926 . . . . 74.13 108.5 172.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 60.3 p -126.99 147.04 50.13 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.156 0.583 . . . . 40.31 110.172 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -147.14 127.81 14.24 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.068 0.947 . . . . 54.43 108.941 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -81.41 117.62 22.01 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.232 -0.655 . . . . 74.11 109.232 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' C' ' 57' ' ' GLU . 23.8 mt -87.94 -40.63 13.76 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.566 0.747 . . . . 74.15 109.974 -178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -150.37 -177.42 5.94 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.806 -1.088 . . . . 74.24 110.282 -177.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -63.83 109.43 1.74 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.512 -1.222 . . . . 71.24 110.11 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 70.22 7.67 6.32 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.165 1.386 . . . . 70.24 112.895 -177.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 70.4 t -110.32 105.74 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.352 0.661 . . . . 73.35 109.593 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -112.99 129.06 56.63 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.195 0.998 . . . . 72.12 109.989 -176.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.9 tt0 -85.61 143.78 28.25 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.157 -0.683 . . . . 72.45 109.157 165.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.437 HG13 HD11 ' C' ' 106' ' ' LEU . 5.0 p -132.07 134.95 59.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 108.094 -1.076 . . . . 72.43 108.094 169.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 45.4 t -120.74 105.92 17.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.352 -0.981 . . . . 73.04 108.352 -174.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -93.97 108.01 19.86 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 107.756 -1.201 . . . . 61.02 107.756 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -79.05 123.48 27.37 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.21 1.004 . . . . 64.14 109.136 173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 32.2 t -114.88 122.33 68.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.843 -1.169 . . . . 55.22 107.843 171.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 19.7 m -125.62 123.87 39.95 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.099 -0.704 . . . . 74.55 109.099 -177.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.62 HG23 HD13 ' C' ' 114' ' ' ILE . 97.4 t -105.0 123.6 59.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 123.516 0.726 . . . . 54.42 109.107 175.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.2 m -113.96 115.0 26.96 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.701 -0.852 . . . . 73.33 108.701 169.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.785 -1.561 . . . . 70.32 106.785 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 62.1 p -154.71 -178.11 6.96 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.498 0.555 . . . . 74.23 112.498 -166.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.2 tp -134.3 29.99 3.6 Favored 'General case' 0 CA--C 1.562 1.411 0 C-N-CA 125.198 1.399 . . . . 61.41 107.784 176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.35 -108.14 1.31 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 115.02 -0.991 . . . . 52.24 110.972 -174.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.34 -31.39 18.94 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.598 -0.89 . . . . 72.41 108.598 172.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.95 91.79 0.21 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.743 1.217 . . . . 71.3 109.839 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 21.3 m -89.71 128.19 36.06 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.417 -0.811 . . . . 53.4 111.063 -177.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.59 -58.45 3.67 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 108.058 -1.09 . . . . 71.31 108.058 169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -154.33 144.59 22.07 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 115.051 -0.977 . . . . 73.54 110.747 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.458 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.2 tm? -105.04 145.75 30.03 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 106.662 -1.607 . . . . 72.15 106.662 163.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.458 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.2 t -150.42 143.23 24.66 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.182 -0.673 . . . . 72.11 109.182 175.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -148.09 131.9 17.02 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 122.918 0.487 . . . . 71.45 109.95 175.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.86 123.52 62.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.684 -0.858 . . . . 75.44 108.684 168.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -97.84 104.33 16.35 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.037 -1.097 . . . . 75.42 108.037 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.9 tp-100 -91.98 114.47 27.02 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.17 0.588 . . . . 73.24 109.64 -176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -101.72 146.69 17.23 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.918 -0.473 . . . . 62.53 111.918 176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.562 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.45 123.36 2.15 Favored Glycine 0 CA--C 1.505 -0.554 0 N-CA-C 111.302 -0.719 . . . . 72.04 111.302 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.539 HD12 HD11 ' C' ' 51' ' ' LEU . 7.1 mm -83.49 122.92 38.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 108.424 -0.954 . . . . 73.23 108.424 175.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -134.75 125.22 26.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.799 0.839 . . . . 71.5 109.633 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 57.9 m -80.48 109.47 15.02 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 109.35 -0.611 . . . . 52.4 109.35 172.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 60.3 mt -114.99 120.63 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.838 0.855 . . . . 71.44 109.567 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.66 163.17 33.99 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.367 1.067 . . . . 75.14 109.847 177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.27 -36.41 3.42 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 116.283 -0.417 . . . . 50.32 112.385 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 47.3 mm -112.75 141.23 29.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 124.647 1.179 . . . . 62.03 109.631 -173.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -148.95 156.39 42.2 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.615 0.766 . . . . 64.34 110.33 -175.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.68 -141.63 20.43 Favored Glycine 0 C--N 1.348 1.241 0 CA-C-N 116.167 -0.47 . . . . 62.3 113.379 172.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.5 p -64.77 -28.66 69.73 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.805 0.842 . . . . 74.31 111.503 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -61.93 -46.39 89.53 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.871 0.868 . . . . 73.21 109.997 174.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 58.1 ttp -69.53 -35.24 75.28 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.985 -1.007 . . . . 63.04 110.259 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.16 -27.33 67.2 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.536 0.734 . . . . 72.3 111.654 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -65.29 -57.58 8.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.198 0.599 . . . . 73.33 110.439 171.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.0 -41.57 98.21 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 123.822 0.701 . . . . 75.01 111.195 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 35.7 tp -76.79 -27.18 55.14 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.413 1.085 . . . . 52.3 110.997 -175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.19 -5.32 46.7 Favored Glycine 0 C--N 1.353 1.474 0 CA-C-O 119.378 -0.679 . . . . 63.15 114.325 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -135.32 -56.68 0.8 Allowed 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 117.706 0.753 . . . . 64.34 111.59 -177.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -68.98 -54.13 16.95 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 111.973 0.36 . . . . 71.14 111.973 -173.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.475 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 21.7 m -59.83 -46.29 98.33 Favored Pre-proline 0 CA--C 1.562 1.438 0 CA-C-O 118.673 -0.68 . . . . 62.01 111.317 -177.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 56.6 Cg_exo -50.21 -39.53 52.12 Favored 'Trans proline' 0 C--N 1.391 2.794 0 C-N-CA 123.106 2.538 . . . . 72.02 114.714 167.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -71.49 -23.9 61.89 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.296 0.638 . . . . 71.42 112.183 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.441 HD12 ' NH1' ' A' ' 111' ' ' ARG . 48.2 mm -75.4 -33.17 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 N-CA-C 109.596 -0.52 . . . . 74.22 109.596 172.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.562 HD21 ' HA3' ' C' ' 82' ' ' GLY . 91.7 mt -82.61 -28.36 30.85 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.152 0.981 . . . . 74.54 112.56 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -57.04 -46.16 99.89 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 117.535 -1.222 . . . . 73.24 113.586 -172.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 108' ' ' PRO . 73.9 Cg_exo -54.36 -41.63 74.8 Favored 'Trans proline' 0 C--N 1.386 2.538 0 C-N-CA 122.236 1.957 . . . . 70.24 113.609 176.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -68.98 -46.31 68.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.523 0.729 . . . . 70.2 110.571 -177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.501 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -61.13 -40.64 94.57 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 115.512 -0.767 . . . . 72.12 111.17 177.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -62.26 -51.97 65.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.2 -1.364 . . . . 75.24 110.728 -179.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -68.62 -31.29 70.35 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 123.607 0.567 . . . . 74.12 110.175 -178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.422 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.5 t -71.29 -29.88 65.58 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.886 0.474 . . . . 51.23 110.963 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.62 HD13 HG23 ' C' ' 64' ' ' VAL . 88.0 mt -74.32 -50.54 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 109.464 -0.569 . . . . 72.31 109.464 170.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 70.0 m -56.69 -33.69 66.69 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.17 0.988 . . . . 50.24 111.112 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 38.3 t -66.84 -51.43 55.58 Favored 'General case' 0 C--O 1.215 -0.76 0 CA-C-N 114.648 -1.16 . . . . 74.02 109.674 173.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.22 -33.87 71.51 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.631 0.772 . . . . 72.12 112.493 178.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 114' ' ' ILE . 84.7 t -67.22 -48.26 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.519 0.728 . . . . 73.43 109.717 176.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 70.0 p -70.61 -26.83 63.68 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.343 -0.844 . . . . 73.14 110.654 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -70.78 -34.57 71.92 Favored 'General case' 0 C--O 1.217 -0.631 0 CA-C-N 115.048 -0.978 . . . . 73.34 109.766 174.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.36 1.01 86.89 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-O 119.216 -0.769 . . . . 42.45 113.083 173.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.484 HG23 ' HB3' ' D' ' 17' ' ' TYR . 73.2 p 58.04 35.13 24.94 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.88 1.672 . . . . 73.33 111.91 -178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -97.73 164.46 17.45 Favored Pre-proline 0 CA--C 1.556 1.183 0 C-N-CA 125.096 1.358 . . . . 74.1 110.451 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -53.7 142.02 62.83 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 123.528 2.818 . . . . 64.13 113.568 -174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -60.7 115.58 3.75 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.427 1.091 . . . . 63.13 110.325 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 63.0 tp -111.57 124.03 51.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.494 1.118 . . . . 74.21 110.446 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -133.88 120.86 20.93 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.835 0.854 . . . . 71.41 109.924 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -88.65 140.69 29.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.328 0.651 . . . . 70.15 110.845 176.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.67 148.88 50.0 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 123.86 0.864 . . . . 63.23 110.092 172.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.52 145.57 37.89 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.305 2.003 . . . . 74.33 112.194 177.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.77 110.62 25.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 107.835 -1.172 . . . . 52.02 107.835 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.521 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 66.5 m-20 -90.85 58.23 3.77 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.724 0.773 . . . . 71.31 109.861 -174.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -80.97 -46.36 15.23 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 114.827 -1.079 . . . . 75.44 108.609 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.529 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 17.2 t70 -71.23 -42.63 68.64 Favored 'General case' 0 C--N 1.354 0.765 0 CA-C-N 115.393 -0.821 . . . . 72.51 109.796 175.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -63.88 -24.68 67.83 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-N 115.01 -0.996 . . . . 54.33 111.99 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 -33.13 66.87 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.185 0.594 . . . . 75.21 110.346 173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -72.35 -34.39 67.97 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.869 0.468 . . . . 73.33 111.252 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 47.9 mtt -79.29 -30.08 42.79 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.875 0.47 . . . . 75.12 111.661 175.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -64.28 -44.32 92.06 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.04 0.936 . . . . 65.44 109.835 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -64.65 -80.61 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 113.952 -1.476 . . . . 72.31 109.221 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 32.2 tp 73.74 -71.75 0.13 Allowed 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.506 1.523 . . . . 71.33 110.499 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 57.03 89.13 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.788 1.235 . . . . 62.04 111.28 178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -162.38 142.5 9.8 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 123.671 0.788 . . . . 72.44 109.174 170.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.79 95.27 3.02 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 106.901 -1.518 . . . . 64.03 106.901 176.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.61 -42.81 11.8 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.396 0.678 . . . . 72.15 110.05 176.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 155.03 179.07 29.93 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.451 -0.795 . . . . 62.23 112.458 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.52 -62.95 1.17 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.48 1.112 . . . . 70.34 111.355 -175.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 68.69 67.58 1.91 Allowed Glycine 0 C--N 1.351 1.382 0 O-C-N 123.433 0.458 . . . . 71.45 113.75 176.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 14.5 t -146.06 155.94 43.13 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.932 0.493 . . . . 73.32 110.834 176.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -106.67 108.17 19.55 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.949 0.9 . . . . 60.52 109.342 174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -64.45 -38.52 91.3 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.338 1.055 . . . . 74.42 111.114 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.1 t-80 -59.37 -30.89 68.74 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.375 -0.83 . . . . 74.03 111.172 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.48 ' NE2' ' SD ' ' C' ' 1' ' ' MET . 7.6 tt0 -73.66 102.78 4.03 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.997 -0.547 . . . . 72.23 109.707 173.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -82.49 -13.83 56.03 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.084 0.954 . . . . 60.34 110.725 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.556 1.198 0 C-N-CA 123.775 0.83 . . . . 51.4 110.829 -178.78 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 108.992 -0.744 . . . . 74.15 108.992 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t 55.67 78.28 0.2 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.106 0.963 . . . . 65.12 110.221 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -153.76 -25.24 0.14 Allowed 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.753 -0.658 . . . . 63.11 111.005 -173.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.542 ' HG2' ' HA ' ' D' ' 89' ' ' ILE . 0.0 OUTLIER -63.44 88.41 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.706 0.802 . . . . 64.42 110.291 -176.172 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -160.38 3.9 0.07 Allowed 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.375 1.07 . . . . 71.2 109.448 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -125.96 161.04 28.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.974 0.91 . . . . 75.01 111.123 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 14.6 t -96.77 8.77 43.54 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.547 0.739 . . . . 73.12 110.333 174.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -73.59 -6.97 49.94 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 123.978 0.911 . . . . 65.22 111.211 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp -28.25 125.3 0.1 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 126.221 1.808 . . . . 42.32 114.513 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.4 m -119.97 142.05 49.11 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 123.794 0.837 . . . . 72.24 108.919 172.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.49 ' HA ' ' O ' ' D' ' 85' ' ' SER . 83.2 t80 -150.35 108.8 3.79 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 108.558 -0.904 . . . . 73.21 108.558 177.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -126.41 131.52 51.71 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.781 0.833 . . . . 75.14 109.995 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 mp -89.74 104.79 15.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 107.843 -1.169 . . . . 72.4 107.843 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -79.39 -47.65 15.38 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.98 0.733 . . . . 71.21 112.98 -170.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -159.2 121.16 3.43 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 110.369 -0.234 . . . . 71.54 110.369 -165.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.406 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.9 mp -105.47 129.34 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 107.459 -1.312 . . . . 64.32 107.459 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.484 ' HB3' HG23 ' C' ' 122' ' ' THR . 38.7 p90 -165.87 178.09 6.73 Favored 'General case' 0 N--CA 1.458 -0.068 0 CA-C-O 121.876 0.846 . . . . 70.44 112.153 -179.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.472 HG21 HD11 ' D' ' 21' ' ' ILE . 70.8 p -107.82 125.58 51.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.536 -1.211 . . . . 71.15 109.488 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 28.5 mtpt -97.87 -22.3 16.43 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.608 -0.516 . . . . 65.51 109.608 177.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.4 t70 -152.03 131.63 13.08 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 114.78 -1.1 . . . . 75.24 108.835 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.574 HD13 ' HE3' ' C' ' 117' ' ' MET . 84.2 mt -134.89 142.69 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.53 -1.285 . . . . 74.12 107.53 175.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 24.2 t -146.77 139.27 24.98 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.102 0.961 . . . . 62.54 108.45 175.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -152.43 116.89 5.0 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 106.187 -1.783 . . . . 62.51 106.187 171.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.606 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.3 mt-10 -121.26 140.28 52.27 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.065 0.546 . . . . 75.22 109.602 -175.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -146.97 78.89 10.29 Favored Pre-proline 0 CA--C 1.542 0.654 0 N-CA-C 108.377 -0.972 . . . . 73.24 108.377 176.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.67 -32.31 6.04 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 122.37 2.047 . . . . 64.45 111.546 175.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.477 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 17.6 m-20 -100.71 31.15 3.63 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.525 1.13 . . . . 62.24 108.839 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.5 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -59.6 -47.63 97.27 Favored Pre-proline 0 CA--C 1.57 1.724 0 N-CA-C 115.023 1.49 . . . . 64.05 115.023 -169.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HZ3' ' C' ' 19' ' ' LYS . 33.8 Cg_endo -88.87 -3.99 6.24 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 121.637 1.558 . . . . 75.12 112.591 173.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.534 ' HA ' HE21 ' D' ' 33' ' ' GLN . 21.0 t-160 -77.2 -40.95 43.27 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.326 1.05 . . . . 71.33 109.491 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.735 HG21 ' HA ' ' D' ' 73' ' ' ALA . 61.7 t -79.29 -15.89 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.677 0.791 . . . . 72.03 110.201 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -65.68 -25.99 67.58 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.596 0.758 . . . . 70.12 110.888 172.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.534 HE21 ' HA ' ' D' ' 30' ' ' HIS . 45.5 mt-30 -73.62 -17.96 61.1 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.396 0.678 . . . . 62.4 111.334 174.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -105.73 106.41 16.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.704 0.802 . . . . 64.41 109.452 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -86.96 51.37 2.23 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.792 0.837 . . . . 65.11 110.317 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -131.64 162.55 30.13 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.444 0.697 . . . . 75.14 109.622 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.33 110.51 29.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.302 1.041 . . . . 74.1 109.33 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.47 ' HA ' HD13 ' D' ' 68' ' ' LEU . 90.5 Cg_exo -49.21 150.98 6.78 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 124.132 3.221 . . . . 73.25 115.117 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -75.55 132.75 40.91 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.977 -0.749 . . . . 74.32 108.977 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.4 124.99 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 CA-C-O 121.275 0.559 . . . . 73.52 110.633 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 12.3 tmtt? -110.49 110.71 21.55 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.019 -1.845 . . . . 73.35 106.019 173.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 47.9 tp -96.14 137.4 35.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.112 0.482 . . . . 74.22 110.448 -172.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.595 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 6.4 m-20 -129.63 141.25 50.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.746 1.218 . . . . 75.31 108.1 170.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 pp -137.67 147.55 44.97 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 109.095 -0.705 . . . . 71.44 109.095 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.5 t70 -154.1 145.97 23.49 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.351 -0.981 . . . . 43.23 108.351 -178.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.9 t -114.28 164.87 13.32 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.092 0.557 . . . . 73.21 109.56 177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.46 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.37 147.98 22.72 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.509 0.724 . . . . 54.33 109.424 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 79.7 p -135.12 151.98 51.21 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 109.056 -0.72 . . . . 71.23 109.056 171.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 43.0 t -157.1 117.1 3.48 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.18 -1.044 . . . . 62.05 108.18 -175.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -72.61 124.96 26.33 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.364 -0.606 . . . . 72.23 109.364 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 59.9 mt -89.83 -40.69 12.28 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.69 -0.485 . . . . 70.25 109.69 178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.66 -174.64 4.32 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.183 -0.917 . . . . 51.41 110.327 -177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -60.34 116.97 4.66 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 115.21 -0.905 . . . . 72.14 110.177 177.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 70.0 2.96 4.13 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.391 1.476 . . . . 72.31 113.089 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.67 116.84 52.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 108.42 -0.956 . . . . 75.34 108.42 176.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.488 ' HB2' HD13 ' D' ' 86' ' ' ILE . 50.5 m-85 -129.08 127.47 41.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.628 -1.249 . . . . 75.21 107.628 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -96.13 137.23 35.5 Favored 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.035 0.934 . . . . 72.02 108.655 174.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 85.8 t -115.62 126.23 73.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 107.687 -1.227 . . . . 73.21 107.687 170.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 98.1 t -102.48 135.42 39.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 109.007 -0.738 . . . . 70.41 109.007 173.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.409 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.1 OUTLIER -112.47 121.45 44.87 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.786 -0.82 . . . . 74.44 108.786 175.512 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 29.8 ttm-85 -97.72 115.8 28.69 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.901 -0.777 . . . . 72.21 108.901 174.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 92.4 t -114.87 123.06 70.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.013 -1.106 . . . . 74.21 108.013 170.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 8.5 m -126.65 133.37 50.99 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.384 0.611 . . . . 61.02 110.088 -172.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 76.7 t -126.44 103.7 11.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 124.973 1.309 . . . . 61.31 109.118 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 16.1 m -97.53 93.17 6.29 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.069 -1.085 . . . . 55.43 108.069 172.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.86 133.99 41.61 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.198 -0.667 . . . . 55.34 109.198 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 59.2 p -140.78 131.7 26.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.802 0.841 . . . . 61.33 109.254 177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' D' ' 38' ' ' PRO . 9.5 tp -107.12 107.63 18.7 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.474 -0.935 . . . . 73.03 108.474 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.72 -121.99 5.67 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 115.479 -0.782 . . . . 60.34 112.805 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.59 4.99 50.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.041 0.936 . . . . 60.44 110.981 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.36 147.21 35.91 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 122.697 0.399 . . . . 64.3 110.347 -163.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.477 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 99.7 m -58.48 141.53 51.47 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.785 0.834 . . . . 70.22 111.56 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.735 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -100.47 -68.14 0.82 Allowed 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.602 1.161 . . . . 73.32 109.519 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -151.84 139.0 19.22 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 115.843 -0.617 . . . . 75.11 109.491 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.606 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 76.1 mt -101.06 152.81 20.16 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.95 -0.759 . . . . 75.13 108.95 173.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.654 ' SG ' HG12 ' D' ' 114' ' ' ILE . 42.5 t -159.26 143.4 15.16 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 122.826 0.45 . . . . 71.04 110.279 176.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -155.94 121.88 5.02 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.007 0.523 . . . . 61.41 109.667 171.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.2 t -124.03 114.86 43.05 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 123.326 0.651 . . . . 74.22 109.898 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.686 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 43.2 mt-30 -90.24 89.63 7.72 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 109.026 -0.731 . . . . 75.01 109.026 167.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.17 95.83 5.71 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 114.531 -1.213 . . . . 75.15 108.46 178.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 140.95 18.02 Favored Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.684 -0.566 . . . . 74.55 111.684 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.467 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -137.03 129.45 4.77 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 110.241 -1.144 . . . . 72.11 110.241 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 62.1 mt -89.92 128.42 41.9 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 108.438 -0.949 . . . . 74.35 108.438 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -128.19 161.57 28.99 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.074 0.55 . . . . 74.44 110.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.49 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 32.8 m -116.42 108.89 16.59 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.984 0.914 . . . . 75.31 109.35 177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.51 HG12 HD11 ' D' ' 98' ' ' LEU . 3.3 mp -109.57 119.4 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.399 0.68 . . . . 70.42 109.415 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.97 155.64 44.72 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.409 1.083 . . . . 45.22 109.226 178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.93 -13.07 5.73 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 114.323 0.489 . . . . 64.54 114.323 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.542 ' HA ' ' HG2' ' D' ' 4' ' ' GLN . 5.5 tt -134.9 137.69 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 125.313 1.445 . . . . 71.21 107.822 -178.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -161.56 175.15 12.41 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.794 0.837 . . . . 62.11 110.012 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.6 -133.38 13.04 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 123.255 0.347 . . . . 62.2 113.4 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 32.1 m -71.41 -38.07 71.46 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.149 0.979 . . . . 74.02 112.137 -171.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -70.45 -32.74 70.43 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.149 0.579 . . . . 72.41 110.029 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.489 ' HG3' HG21 ' D' ' 86' ' ' ILE . 59.2 ttp -69.21 -37.72 78.22 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.689 -0.687 . . . . 73.24 110.363 174.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.79 70.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.095 0.558 . . . . 70.1 111.25 176.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.584 ' HA ' ' HE1' ' D' ' 137' ' ' PHE . 42.2 t-80 -71.56 -37.67 71.05 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.338 0.655 . . . . 63.01 110.744 173.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -69.56 -50.19 47.18 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.927 0.491 . . . . 74.14 111.203 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.51 HD11 HG12 ' D' ' 86' ' ' ILE . 9.9 mp -75.8 -25.11 56.07 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.802 0.841 . . . . 65.15 111.573 -176.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.84 -12.38 66.43 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-O 119.592 -0.56 . . . . 71.13 113.511 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.14 -66.43 0.52 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 112.474 0.546 . . . . 62.2 112.474 -174.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -62.19 -46.08 90.53 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.335 0.654 . . . . 73.43 112.425 -170.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 57.7 m -67.11 -44.27 48.84 Favored Pre-proline 0 CA--C 1.563 1.45 0 CA-C-O 118.672 -0.68 . . . . 72.54 112.316 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.52 ' HB2' ' HZ ' ' D' ' 133' ' ' PHE . 77.0 Cg_exo -54.4 -32.29 71.99 Favored 'Trans proline' 0 C--N 1.387 2.585 0 C-N-CA 122.418 2.079 . . . . 71.31 114.482 166.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -64.51 -31.08 72.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.28 0.491 . . . . 63.21 111.741 176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -67.8 -42.91 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 121.436 0.636 . . . . 71.43 110.019 173.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.467 HD21 ' HA3' ' D' ' 82' ' ' GLY . 97.2 mt -77.01 -27.64 54.72 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.834 -1.076 . . . . 73.11 112.725 -171.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -62.74 -45.89 88.14 Favored Pre-proline 0 CA--C 1.557 1.226 0 N-CA-C 113.891 1.071 . . . . 65.12 113.891 -169.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.05 -34.76 98.3 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 121.714 1.609 . . . . 73.41 112.602 175.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -77.88 -34.47 51.55 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.598 0.759 . . . . 75.13 111.485 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.25 -46.82 69.42 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.279 0.632 . . . . 70.33 110.841 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -69.86 -33.47 72.3 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.215 -0.902 . . . . 54.41 110.669 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -66.32 -42.4 88.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.305 1.003 . . . . 75.24 111.005 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.1 t -59.69 -40.04 86.56 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 123.739 0.65 . . . . 61.31 110.139 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.654 HG12 ' SG ' ' D' ' 76' ' ' CYS . 53.7 mt -63.29 -50.39 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 O-C-N 124.051 0.845 . . . . 63.15 110.548 173.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 50.0 m -56.43 -44.62 80.57 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.129 0.972 . . . . 74.43 111.464 -175.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 42.8 t -65.16 -44.95 86.9 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 114.68 -1.145 . . . . 71.25 110.429 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.5 mtm -65.17 -31.2 72.27 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.737 0.415 . . . . 71.34 112.074 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.416 HG23 ' O ' ' D' ' 114' ' ' ILE . 55.8 t -70.49 -41.91 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 O-C-N 123.818 0.698 . . . . 72.41 110.483 176.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.6 p -73.38 -24.45 60.31 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 120.669 0.271 . . . . 72.33 110.97 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 92.2 mtt-85 -75.65 -34.71 60.52 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.602 0.761 . . . . 72.31 109.582 172.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.3 -3.66 88.65 Favored Glycine 0 C--N 1.354 1.579 0 O-C-N 123.766 0.666 . . . . 75.24 112.399 171.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 19.4 p 58.32 30.92 20.24 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 126.426 1.89 . . . . 61.44 112.208 175.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -95.03 169.38 9.51 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.714 1.606 . . . . 73.1 110.099 175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.417 ' HD3' HG11 ' F' ' 136' ' ' VAL . 16.1 Cg_endo -55.75 130.99 43.36 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 123.115 2.543 . . . . 62.51 112.625 175.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.27 147.49 16.65 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.251 1.02 . . . . 61.53 112.255 -178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 54.0 tp -135.4 95.81 3.35 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.083 0.468 . . . . 53.23 110.499 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -100.97 114.41 28.3 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.914 -1.143 . . . . 70.43 107.914 172.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 98.7 mt -75.94 134.71 40.14 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 120.773 0.321 . . . . 71.03 110.514 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.59 142.03 91.17 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.68 0.792 . . . . 65.14 111.078 -177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -65.3 131.24 27.66 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.41 2.073 . . . . 53.1 111.077 178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.4 p -134.15 127.02 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.803 0.841 . . . . 72.32 110.219 -176.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -83.55 77.97 9.75 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 122.029 0.919 . . . . 52.25 109.18 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.52 ' HZ ' ' HB2' ' D' ' 103' ' ' PRO . 45.2 p90 -67.45 -18.22 65.0 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.81 -1.086 . . . . 72.45 111.05 175.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.491 ' O ' ' HG3' ' D' ' 138' ' ' MET . 24.0 t0 -59.74 -39.38 84.56 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.705 0.802 . . . . 71.45 111.763 176.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.97 -31.83 67.27 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 120.835 0.35 . . . . 73.03 111.804 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.96 -37.25 24.35 Favored 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 124.111 0.964 . . . . 74.32 109.201 176.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.584 ' HE1' ' HA ' ' D' ' 96' ' ' HIS . 76.6 t80 -62.9 -32.55 73.84 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.517 1.127 . . . . 64.21 111.266 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.491 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 45.8 mtt -59.34 -44.66 92.62 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.293 0.637 . . . . 71.04 110.205 176.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -60.78 -38.73 86.28 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.024 0.93 . . . . 54.44 111.115 -178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.82 -39.92 93.46 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.407 -0.815 . . . . 64.01 110.663 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.0 mp -71.41 -28.88 64.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.789 0.836 . . . . 73.52 111.712 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -80.88 -0.15 37.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.005 0.522 . . . . 64.11 111.819 178.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -129.85 45.28 2.83 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.323 0.649 . . . . 73.11 109.585 -178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -163.97 156.29 17.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.734 0.814 . . . . 62.44 110.263 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.82 8.18 0.07 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.259 0.624 . . . . 70.01 111.887 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -118.9 120.63 4.73 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-O 120.091 -0.283 . . . . 64.12 112.523 -177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.98 132.85 42.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.954 -1.128 . . . . 64.24 107.954 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -93.02 81.54 1.08 Allowed Glycine 0 C--N 1.347 1.166 0 N-CA-C 111.908 -0.477 . . . . 63.33 111.908 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 47.5 p -68.24 85.28 0.26 Allowed 'General case' 0 CA--C 1.549 0.941 0 CA-C-O 121.379 0.609 . . . . 55.1 110.33 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -99.16 123.99 43.86 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.815 -0.63 . . . . 62.33 109.857 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -86.29 164.45 17.11 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.49 0.662 . . . . 61.25 110.328 174.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -125.73 152.38 45.4 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 107.522 -1.288 . . . . 75.51 107.522 171.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -67.69 95.0 0.47 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.226 -0.657 . . . . 74.32 109.226 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.85 -28.26 68.2 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.989 0.916 . . . . 72.21 110.523 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.306 0 O-C-N 124.687 1.242 . . . . 73.24 112.541 168.132 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 109.479 -0.563 . . . . 72.33 109.479 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -85.69 68.45 10.39 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 108.953 -0.758 . . . . 75.0 108.953 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -81.55 86.15 6.4 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.469 -0.937 . . . . 74.31 108.469 177.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -138.21 144.65 40.74 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.666 -1.152 . . . . 62.24 108.742 -175.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . 0.474 ' HG2' ' H ' ' E' ' 113' ' ' ASP . 10.7 tt0 -144.58 -159.56 1.01 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 107.423 -1.325 . . . . 62.22 107.423 -178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . 0.474 ' H ' ' HG2' ' E' ' 112' ' ' GLN . 1.3 p30 -55.58 -31.3 62.07 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.202 0.601 . . . . 72.22 110.02 163.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . 0.551 ' HG2' ' H ' ' E' ' 116' ' ' TYR . 39.8 ttmt -97.78 137.72 36.22 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.636 1.174 . . . . 64.4 109.469 170.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.587 HD13 ' H ' ' E' ' 115' ' ' LEU . 0.0 OUTLIER -87.19 0.2 55.7 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.612 0.597 . . . . 74.03 112.612 -177.084 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . 0.551 ' H ' ' HG2' ' E' ' 114' ' ' LYS . 14.2 t80 -77.24 110.53 12.57 Favored Pre-proline 0 CA--C 1.559 1.318 0 C-N-CA 123.645 0.778 . . . . 64.41 109.505 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' E' ' 116' ' ' TYR . 3.9 Cg_endo -88.39 -66.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.953 0 C-N-CA 123.849 3.033 . . . . 75.14 113.501 -169.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -157.82 138.33 12.85 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.826 0.85 . . . . 70.33 109.541 -172.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 17.1 m -105.23 130.47 53.37 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.78 -0.822 . . . . 75.13 108.78 172.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.444 ' CD1' HG21 ' B' ' 46' ' ' THR . 1.2 p-90 -70.26 88.04 0.62 Allowed 'General case' 0 CA--C 1.556 1.184 0 CA-C-O 121.442 0.639 . . . . 71.24 112.394 -175.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -72.46 -18.38 61.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.088 0.955 . . . . 73.03 111.086 176.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.8 5.67 3.88 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.973 0.909 . . . . 61.54 112.628 174.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . 0.509 HG11 ' H ' ' B' ' 46' ' ' THR . 7.3 p -54.23 131.44 16.79 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 C-N-CA 124.398 1.079 . . . . 74.32 111.476 172.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -153.97 -64.8 0.14 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.62 0.768 . . . . 72.02 108.982 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . 0.529 ' HB3' HD13 ' B' ' 44' ' ' LEU . 60.9 t80 54.85 92.59 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.58 1.152 . . . . 71.31 110.728 -172.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -93.0 151.41 19.91 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.016 0.526 . . . . 72.54 110.408 177.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 155.79 168.1 18.26 Favored Glycine 0 C--O 1.244 0.744 0 CA-C-N 115.228 -0.896 . . . . 44.33 111.16 -176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -121.34 145.5 47.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.359 0.664 . . . . 60.45 110.422 -178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -87.28 178.4 6.87 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 115.598 -0.728 . . . . 63.2 109.613 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 3.5 mp 62.59 81.7 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 C-N-CA 124.429 1.092 . . . . 74.34 109.01 -175.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.78 -32.36 52.43 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 115.328 -0.851 . . . . 51.12 111.13 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -143.2 98.25 5.57 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 123.356 0.662 . . . . 74.31 110.632 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.46 43.94 0.82 Allowed 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 123.233 2.622 . . . . 72.24 111.852 172.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . 0.406 ' H ' HG13 ' E' ' 134' ' ' ILE . 2.7 pp -69.71 -25.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 CA-C-N 115.333 -0.848 . . . . 62.3 112.427 -174.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.78 -143.07 0.07 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 107.975 -1.121 . . . . 75.01 107.975 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.593 HG23 ' H ' ' E' ' 137' ' ' GLU 0.308 30.8 m 52.56 -100.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 C-N-CA 125.486 1.515 . . . . 74.12 113.088 175.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . 0.593 ' H ' HG23 ' E' ' 136' ' ' VAL . 46.7 mt-10 56.5 -79.58 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.252 0 CA-C-N 119.912 1.233 . . . . 65.53 113.413 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.67 34.18 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.176 0.99 . . . . 71.53 110.111 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -87.97 113.17 23.35 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.445 0.698 . . . . 75.31 109.627 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 22.5 m -83.98 -52.49 6.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.108 0.563 . . . . 71.3 110.853 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 79.9 mt -79.95 87.47 5.37 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.419 -0.585 . . . . 73.14 109.419 178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 10.5 tt -150.53 140.67 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.612 0.765 . . . . 74.12 108.944 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 65.49 179.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.173 0.989 . . . . 70.44 111.202 -171.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -78.93 -68.56 0.64 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.782 -0.821 . . . . 75.33 108.782 174.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -163.74 -60.84 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 107.152 -1.425 . . . . 71.42 107.152 178.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' E' ' 149' ' ' PRO . 22.6 m-20 -84.41 164.75 18.69 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.514 -0.767 . . . . 64.42 110.365 172.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 72.4 mt -95.21 -60.62 1.64 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.854 0.861 . . . . 72.13 110.181 -175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' C' ' 132' ' ' ASN . 37.7 tp -93.32 -50.21 0.27 Allowed Pre-proline 0 CA--C 1.562 1.43 0 CA-C-O 117.838 -1.077 . . . . 63.43 111.718 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' E' ' 146' ' ' ASP . 31.3 Cg_exo . . . . . 0 C--N 1.399 3.196 0 C-N-CA 122.218 1.945 . . . . 51.33 112.307 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 110.656 -0.127 . . . . 74.13 110.656 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm 78.57 -34.86 0.17 Allowed 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 125.855 1.662 . . . . 75.04 114.264 167.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -77.72 78.84 4.22 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.525 0.679 . . . . 61.35 109.255 174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -91.78 -53.94 4.08 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.307 -0.861 . . . . 64.44 109.815 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . 0.516 HE22 ' HG3' ' F' ' 114' ' ' LYS . 0.0 OUTLIER -82.37 -64.89 1.09 Allowed 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.168 -0.924 . . . . 73.22 109.938 -170.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 30.8 t70 63.56 82.68 0.18 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.642 1.177 . . . . 71.24 112.264 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.516 ' HG3' HE22 ' F' ' 112' ' ' GLN . 49.3 mtmt -148.29 143.33 26.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.502 1.121 . . . . 62.33 109.321 168.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.412 HD12 HG13 ' A' ' 86' ' ' ILE . 18.1 mt -84.79 77.84 10.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.788 -0.819 . . . . 65.1 108.788 172.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -133.69 126.12 18.81 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 115.616 -0.72 . . . . 74.31 109.71 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 95' ' ' ALA . 97.1 Cg_endo -73.33 147.98 42.69 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.685 2.256 . . . . 63.44 111.879 -177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -77.78 150.81 34.27 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.739 -0.467 . . . . 64.24 109.739 171.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 6.7 p -64.8 109.37 2.04 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.845 0.858 . . . . 65.14 110.811 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -128.18 150.09 50.16 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 107.994 -1.113 . . . . 74.45 107.994 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -147.87 -77.75 0.16 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.032 -0.729 . . . . 53.52 109.032 -178.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . 58.18 -78.58 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 124.593 1.157 . . . . 62.54 111.605 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 89.8 t 63.78 117.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 125.37 1.468 . . . . 72.51 111.93 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -111.15 -72.95 0.7 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.559 0.744 . . . . 75.14 109.009 176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 56.6 -133.63 1.38 Allowed 'General case' 0 CA--C 1.554 1.117 0 O-C-N 124.228 0.955 . . . . 65.41 111.135 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 63.2 t30 72.47 142.09 0.06 Allowed 'General case' 0 C--N 1.367 1.358 0 C-N-CA 124.668 1.187 . . . . 62.04 112.192 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 142.58 -162.68 27.32 Favored Glycine 0 C--N 1.343 0.966 0 N-CA-C 111.223 -0.751 . . . . 34.5 111.223 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -82.99 130.09 35.1 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 122.704 0.402 . . . . 73.51 110.762 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 mp -97.96 -118.55 0.13 Allowed 'General case' 0 CA--C 1.557 1.237 0 C-N-CA 124.076 0.95 . . . . 75.24 108.801 174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.432 ' H ' HD12 ' F' ' 130' ' ' ILE . 3.7 mp -82.1 91.38 2.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.12 0 N-CA-C 107.195 -1.409 . . . . 70.24 107.195 172.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -71.86 -16.09 62.14 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.255 0.622 . . . . 70.22 111.764 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -142.47 97.44 6.11 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 123.469 0.707 . . . . 73.41 109.61 176.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -86.78 174.57 5.56 Favored 'Trans proline' 0 C--N 1.372 1.814 0 C-N-CA 122.533 2.155 . . . . 71.53 112.29 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 18.2 tt -87.27 -32.5 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 C-N-CA 123.179 0.592 . . . . 64.32 109.981 176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . 56.38 24.84 8.84 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 125.006 1.322 . . . . 71.32 113.868 170.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.417 HG11 ' HD3' ' D' ' 124' ' ' PRO . 7.5 p -96.99 158.31 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.193 0 C-N-CA 123.391 0.676 . . . . 73.44 111.383 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -102.34 -75.88 0.59 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.252 0.621 . . . . 74.31 110.821 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -153.82 168.97 24.53 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.708 0.803 . . . . 63.31 111.003 -170.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -68.91 101.36 1.35 Allowed 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.183 0.593 . . . . 73.1 110.07 173.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 18.0 m -67.99 -32.6 73.11 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.484 -0.78 . . . . 61.22 109.851 170.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 64.5 mt -78.73 120.19 23.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.892 -0.595 . . . . 60.1 109.49 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.436 HG13 ' H ' ' F' ' 143' ' ' TYR . 9.5 tp -147.92 177.38 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 N-CA-C 108.257 -1.016 . . . . 62.45 108.257 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . 0.436 ' H ' HG13 ' F' ' 142' ' ' ILE . 9.8 p90 -67.48 77.84 0.17 Allowed 'General case' 0 CA--C 1.562 1.425 0 CA-C-O 121.898 0.856 . . . . 60.1 111.406 175.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -100.72 98.07 8.65 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.017 0.927 . . . . 71.44 109.158 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . 0.435 ' HB3' ' NZ ' ' F' ' 145' ' ' LYS . 0.4 OUTLIER -179.96 -41.85 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.321 1.448 . . . . 60.23 109.038 178.655 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -159.66 110.8 1.99 Allowed 'General case' 0 C--O 1.241 0.627 0 C-N-CA 124.605 1.162 . . . . 74.34 108.618 176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . 0.498 ' HB3' ' HD3' ' F' ' 149' ' ' PRO . 3.1 tt -90.33 -49.44 6.53 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 108.291 -1.003 . . . . 74.13 108.291 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 tt 58.17 64.3 3.83 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 124.469 1.108 . . . . 74.45 110.501 -172.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . 0.498 ' HD3' ' HB3' ' F' ' 147' ' ' LEU . 51.0 Cg_exo . . . . . 0 C--N 1.384 2.44 0 C-N-CA 122.203 1.935 . . . . 60.22 112.581 171.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 109.708 -0.478 . . . . 70.33 109.708 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 m -83.72 -173.53 4.77 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.217 1.007 . . . . 74.23 110.319 172.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 79.66 -43.84 0.29 Allowed 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 125.474 1.509 . . . . 71.22 111.946 174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -62.09 93.92 0.05 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.835 0.854 . . . . 74.31 111.084 174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -89.53 2.7 54.26 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.693 0.797 . . . . 63.21 111.49 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.27 150.89 19.74 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.633 0.773 . . . . 71.25 109.093 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -67.39 111.19 3.92 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.069 0.548 . . . . 72.43 111.018 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -62.54 159.03 16.6 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.422 -0.808 . . . . 74.44 110.535 170.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.438 ' HG2' ' HA3' ' A' ' 88' ' ' GLY . 56.1 mtm -71.67 150.52 44.5 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 109.254 -0.647 . . . . 74.54 109.254 174.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.8 m -141.23 132.38 26.37 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.875 -0.787 . . . . 62.35 108.875 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -135.83 120.43 18.26 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.877 -1.157 . . . . 75.14 107.877 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 78.8 mt-30 -132.16 108.6 9.38 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.415 0.686 . . . . 62.43 109.347 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 pt -83.73 86.96 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.322 -0.992 . . . . 72.35 108.322 169.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -72.88 -39.53 66.34 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 115.946 -0.57 . . . . 61.34 111.496 -170.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -172.07 146.78 2.0 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.317 -0.623 . . . . 73.14 109.317 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.474 HD12 ' HG2' ' C' ' 130' ' ' PRO . 94.7 mt -137.1 100.8 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 123.174 0.59 . . . . 74.42 109.433 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' B' ' 120' ' ' ARG . 26.6 m-85 -159.67 160.66 34.46 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.483 1.113 . . . . 74.23 110.701 -173.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.48 HG21 ' SG ' ' A' ' 113' ' ' CYS . 30.5 p -71.64 129.18 38.07 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 114.445 -1.252 . . . . 74.14 111.117 -167.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.9 mtpt -84.43 -38.67 19.91 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.416 0.627 . . . . 63.31 109.583 169.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.6 t70 -139.9 137.66 35.02 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.968 -1.014 . . . . 71.4 109.442 -175.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 70.1 mt -132.65 146.1 33.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 125.077 1.351 . . . . 63.24 107.515 175.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.65 140.24 17.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.961 -0.755 . . . . 54.33 108.961 171.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 88.9 t80 -142.71 123.47 14.23 Favored 'General case' 0 C--O 1.214 -0.803 0 N-CA-C 106.01 -1.848 . . . . 75.2 106.01 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -118.29 152.05 36.5 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.407 -0.96 . . . . 72.12 108.407 177.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -145.3 74.33 14.11 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 106.881 -1.526 . . . . 64.22 106.881 168.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -71.98 -20.71 25.22 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.556 2.171 . . . . 73.23 111.842 -172.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' HG23 ' A' ' 31' ' ' VAL . 89.1 m-20 -118.46 29.93 7.49 Favored 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.425 1.09 . . . . 51.11 109.661 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -55.17 -49.47 92.09 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 113.182 0.808 . . . . 64.31 113.182 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 31.9 Cg_exo -61.99 -27.05 79.16 Favored 'Trans proline' 0 C--N 1.396 3.067 0 C-N-CA 122.007 1.805 . . . . 71.31 113.373 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.6 m-70 -73.41 -38.32 65.63 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.943 0.497 . . . . 60.25 110.502 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 27' ' ' ASN . 60.1 t -66.78 -34.44 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 123.524 0.73 . . . . 74.11 110.416 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -56.47 -31.09 63.68 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.39 1.076 . . . . 53.1 111.361 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -91.22 -45.56 8.57 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.456 1.102 . . . . 62.02 110.714 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -81.58 165.61 20.96 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.354 0.662 . . . . 53.04 112.193 -169.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -67.15 126.19 28.4 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 114.845 -1.071 . . . . 54.44 110.894 -178.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -81.17 82.28 7.13 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.576 -0.738 . . . . 64.4 110.21 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -142.88 79.12 14.99 Favored Pre-proline 0 CA--C 1.547 0.837 0 N-CA-C 108.039 -1.097 . . . . 61.13 108.039 171.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -86.65 144.07 7.49 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.616 2.211 . . . . 63.14 112.736 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -98.03 126.0 43.26 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.384 1.074 . . . . 62.21 108.151 175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 30.4 m -82.58 130.82 35.1 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 121.226 0.536 . . . . 64.1 110.749 -176.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.545 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 63.1 tttm -119.62 112.32 19.16 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.079 -1.452 . . . . 73.4 107.079 177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.0 mt -115.48 107.74 15.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.638 -0.875 . . . . 64.23 108.638 -167.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 11.8 m-20 -106.13 109.18 21.03 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.355 1.062 . . . . 55.53 109.331 -175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -103.25 132.58 49.4 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 109.358 -0.608 . . . . 74.11 109.358 -176.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 60' ' ' LEU . 16.3 t70 -142.55 141.65 32.07 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.13 0.972 . . . . 73.43 109.04 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 95.9 m -137.73 140.51 40.73 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.292 0.637 . . . . 73.42 110.428 -177.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.93 134.73 14.63 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.599 0.76 . . . . 53.12 110.391 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 58' ' ' VAL . 68.0 p -111.31 167.72 10.08 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.117 0.567 . . . . 73.34 110.297 173.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -168.58 119.13 0.76 Allowed 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.583 -0.525 . . . . 65.44 109.583 -171.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -69.09 108.07 3.43 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 123.252 0.621 . . . . 73.32 109.936 -174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.66 HD11 ' HB2' ' A' ' 57' ' ' GLU . 53.6 mt -77.83 -41.59 36.54 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.584 0.754 . . . . 74.32 110.488 175.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.38 -172.87 4.12 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.986 0.915 . . . . 73.12 109.779 -175.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -59.28 105.18 0.31 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.976 0.51 . . . . 63.12 110.124 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 58.15 22.04 8.66 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 125.105 1.362 . . . . 74.04 112.984 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 48.2 t -108.33 120.82 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 107.089 -1.449 . . . . 71.14 107.089 170.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -135.37 136.09 41.2 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.813 -1.18 . . . . 74.42 107.813 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HB2' HD11 ' A' ' 51' ' ' LEU . 30.4 tt0 -89.13 115.74 26.87 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.94 0.896 . . . . 72.33 108.789 174.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 48' ' ' SER . 26.9 t -99.25 110.98 27.66 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 107.017 -1.475 . . . . 64.42 107.017 174.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 43.8 t -99.41 119.66 47.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.061 0.544 . . . . 73.31 109.671 177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -95.66 112.47 24.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.038 -1.097 . . . . 72.43 108.038 175.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -101.29 106.67 17.88 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 123.901 0.881 . . . . 73.44 109.443 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.7 t -110.99 114.37 46.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.524 1.13 . . . . 64.34 109.137 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.1 m -102.83 146.51 28.17 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.662 -0.866 . . . . 74.11 108.662 174.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.536 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 50.1 t -142.01 107.16 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 124.716 1.206 . . . . 70.04 108.073 -175.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 25.6 m -103.14 135.83 44.06 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.312 -0.625 . . . . 72.24 109.312 176.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.59 118.37 34.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.552 -1.277 . . . . 73.25 107.552 171.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.0 m -124.32 126.2 45.62 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.281 -0.637 . . . . 63.01 109.281 175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.47 ' HG ' ' HB2' ' A' ' 73' ' ' ALA . 0.3 OUTLIER -89.61 62.91 6.05 Favored 'General case' 0 N--CA 1.486 1.329 0 CA-C-O 121.82 0.819 . . . . 71.52 109.134 -179.277 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.77 -106.85 1.42 Allowed Glycine 0 C--N 1.346 1.126 0 N-CA-C 109.877 -1.289 . . . . 14.0 109.877 -168.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -115.82 -26.22 7.46 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.799 0.84 . . . . 74.21 110.336 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -78.26 132.05 37.35 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.911 0.484 . . . . 75.22 109.832 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.3 m -71.81 110.89 6.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.931 0.892 . . . . 62.54 110.212 -179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.47 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . . . -59.1 -57.23 13.97 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.064 0.945 . . . . 65.25 109.598 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -161.72 173.23 14.95 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 114.013 -1.449 . . . . 72.0 109.631 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 76' ' ' CYS . 47.3 tp -137.62 149.36 46.57 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.228 1.011 . . . . 70.11 109.752 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.536 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 56.5 m -136.82 139.95 42.11 Favored 'General case' 0 C--O 1.219 -0.545 0 C-N-CA 124.652 1.181 . . . . 72.2 108.694 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -150.18 129.3 12.71 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 109.483 -0.562 . . . . 72.05 109.483 172.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.5 t -135.86 112.51 13.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.774 0.829 . . . . 74.2 109.393 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.444 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 43.3 mt-30 -85.75 82.5 8.17 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 108.741 -0.837 . . . . 65.05 108.741 171.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -76.65 93.58 3.65 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.235 -1.348 . . . . 72.35 109.545 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -86.17 146.1 20.92 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.195 -0.457 . . . . 61.14 112.056 -177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.568 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.47 122.97 2.51 Favored Glycine 0 CA--C 1.506 -0.5 0 N-CA-C 110.156 -1.178 . . . . 50.11 110.156 178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.9 mt -86.08 121.74 37.76 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 108.731 -0.84 . . . . 34.11 108.731 174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -128.68 118.97 23.79 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 107.967 -1.123 . . . . 72.34 107.967 -177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.642 ' HB3' ' HB2' ' A' ' 12' ' ' GLN . 26.7 t -94.92 86.34 4.64 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 108.067 -1.086 . . . . 42.14 108.067 172.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 10' ' ' THR . 0.3 OUTLIER -114.72 143.39 24.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.232 0.613 . . . . 72.13 110.756 -175.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.65 167.47 23.11 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.172 0.989 . . . . 61.23 110.885 -176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.438 ' HA3' ' HG2' ' A' ' 9' ' ' MET . . . 92.01 -6.18 79.0 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.256 -0.884 . . . . 72.21 113.66 176.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.554 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.26 146.19 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.566 0.746 . . . . 62.42 109.779 178.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.42 172.2 14.82 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.949 0.499 . . . . 72.43 110.375 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.18 -127.55 40.48 Favored Glycine 0 C--N 1.349 1.303 0 O-C-N 123.264 0.353 . . . . 74.41 113.391 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 36.5 p -74.4 -20.44 60.06 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.341 0.656 . . . . 64.14 112.015 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -65.27 -49.69 68.62 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.459 0.704 . . . . 71.32 109.962 176.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 9.9 tmm? -75.67 -37.25 59.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.478 -1.237 . . . . 75.44 110.755 -177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.99 85.32 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-O 121.378 0.609 . . . . 70.41 110.758 174.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -65.7 -41.8 91.94 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.075 -0.966 . . . . 72.52 110.419 172.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.689 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.5 m -74.71 -26.91 60.14 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.467 0.914 . . . . 71.02 113.467 -173.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.68 -23.36 24.23 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.64 0.376 . . . . 73.14 111.149 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' F' ' 120' ' ' TRP . . . -103.47 -16.08 21.27 Favored Glycine 0 C--N 1.35 1.316 0 N-CA-C 114.526 0.57 . . . . 43.51 114.526 -176.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.9 -64.22 0.58 Allowed 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 117.597 0.698 . . . . 63.1 111.636 -172.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 12.5 t80 -48.89 -65.92 0.49 Allowed 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 124.577 1.151 . . . . 73.42 113.084 -174.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 61.4 m -71.31 -44.78 13.61 Favored Pre-proline 0 CA--C 1.559 1.317 0 CA-C-O 118.207 -0.902 . . . . 63.51 113.067 -171.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -61.56 -31.82 87.43 Favored 'Trans proline' 0 C--N 1.39 2.761 0 C-N-CA 121.839 1.693 . . . . 62.54 113.849 172.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -67.92 -34.13 76.03 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 118.131 0.423 . . . . 63.41 110.45 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -65.39 -41.23 90.7 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.691 0.796 . . . . 60.33 110.238 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.568 HD21 ' HA3' ' A' ' 82' ' ' GLY . 96.9 mt -70.53 -25.51 63.15 Favored 'General case' 0 CA--C 1.55 0.966 0 CA-C-N 115.49 -0.777 . . . . 41.22 112.003 -176.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -67.0 -43.23 46.19 Favored Pre-proline 0 CA--C 1.563 1.461 0 N-CA-C 114.675 1.361 . . . . 65.54 114.675 -167.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -54.4 -36.79 88.58 Favored 'Trans proline' 0 C--N 1.388 2.636 0 C-N-CA 122.284 1.989 . . . . 72.21 113.596 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -76.07 -39.0 56.37 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.19 0.596 . . . . 70.22 111.523 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.07 -43.38 92.4 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 122.58 0.352 . . . . 62.24 110.25 177.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.46 ' NH1' HD12 ' C' ' 105' ' ' ILE . 40.6 ttm180 -53.85 -51.81 62.41 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 124.813 1.32 . . . . 73.31 110.358 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.61 -42.67 99.21 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.086 -0.961 . . . . 75.33 112.022 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.48 ' SG ' HG21 ' A' ' 18' ' ' THR . 45.0 t -68.23 -39.02 82.43 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 123.654 0.596 . . . . 61.42 111.523 -178.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.529 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 85.0 mt -64.51 -55.2 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 123.48 0.712 . . . . 45.03 109.626 176.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 125' ' ' GLN . 64.8 m -58.43 -34.16 70.5 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.351 1.061 . . . . 73.42 111.792 -175.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.8 t -65.28 -44.27 88.51 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.806 -0.634 . . . . 62.22 110.578 177.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.529 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 52.2 mtm -63.41 -40.75 98.03 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.712 0.405 . . . . 74.11 110.869 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.1 t -60.29 -44.51 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 O-C-N 124.191 0.932 . . . . 44.11 110.622 179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 90.3 p -74.47 -31.35 62.19 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.943 -0.571 . . . . 71.24 111.16 -178.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -69.44 -29.95 67.77 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.657 0.783 . . . . 65.31 110.042 173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.42 -3.66 82.98 Favored Glycine 0 C--N 1.352 1.453 0 CA-C-N 115.569 -0.741 . . . . 71.44 112.985 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.5 m 67.47 17.7 10.06 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.507 1.123 . . . . 72.1 110.783 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -94.54 157.12 37.7 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 123.911 0.884 . . . . 72.23 110.884 -178.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -52.64 122.77 11.48 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.999 2.466 . . . . 74.53 112.478 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.553 ' HG3' HG23 ' A' ' 115' ' ' THR . 27.5 tt0 -53.17 136.52 36.0 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.951 1.3 . . . . 72.4 112.563 -176.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 67.7 mt -120.67 99.25 6.43 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 108.728 -0.841 . . . . 73.01 108.728 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -98.89 125.22 44.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.543 0.737 . . . . 60.4 109.391 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 46.3 mt -73.21 138.26 45.5 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.806 0.843 . . . . 54.5 110.202 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.82 126.1 92.33 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 109.659 -0.497 . . . . 73.51 109.659 178.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -65.95 103.63 0.63 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.406 2.071 . . . . 73.24 112.388 176.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.3 m -102.1 143.16 15.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.744 0.818 . . . . 52.33 110.008 178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -89.27 85.45 6.61 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.235 1.014 . . . . 71.3 110.606 -177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -57.89 -36.5 72.5 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 124.65 1.18 . . . . 64.43 113.042 -176.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.91 -41.68 70.92 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.536 0.734 . . . . 61.41 111.334 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.93 -32.14 61.69 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 122.922 0.489 . . . . 63.53 110.1 177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.406 HD13 HD22 ' A' ' 139' ' ' ASN . 1.8 mm? -65.62 -35.85 82.0 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.751 0.82 . . . . 74.35 110.086 174.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -65.53 -46.14 80.75 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.818 0.447 . . . . 73.41 109.796 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 17.2 mmt -60.38 -39.76 88.43 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.523 0.729 . . . . 72.22 110.768 177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.406 HD22 HD13 ' A' ' 136' ' ' LEU . 19.7 t30 -60.53 -52.45 65.13 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.08 1.352 . . . . 54.44 111.163 177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -74.61 -30.14 61.56 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 122.298 0.239 . . . . 74.52 111.514 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.6 -49.15 78.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.38 0.672 . . . . 61.23 110.802 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -167.82 6.18 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.01 0.524 . . . . 70.22 111.181 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 60.47 26.75 16.36 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.959 0.904 . . . . 75.33 110.049 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -100.07 150.87 22.03 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.503 1.121 . . . . 72.45 109.859 -175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 65.44 -82.7 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 125.104 1.361 . . . . 63.25 111.008 -177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 78.29 -65.37 3.36 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-O 121.048 0.249 . . . . 62.31 112.902 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -123.38 162.67 22.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.249 1.42 . . . . 74.44 109.028 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 101.95 61.9 0.75 Allowed Glycine 0 C--N 1.348 1.218 0 N-CA-C 111.659 -0.576 . . . . 71.45 111.659 178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.9 p -69.87 132.37 45.91 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.769 0.827 . . . . 73.33 110.871 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -149.99 79.0 1.36 Allowed 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 108.673 -0.862 . . . . 75.23 108.673 -173.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.29 76.67 1.28 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 122.712 1.244 . . . . 74.31 108.897 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -165.95 149.29 7.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 113.698 -1.592 . . . . 51.33 108.228 -174.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 69.86 4.33 4.72 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 124.699 1.2 . . . . 51.11 112.779 -178.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -83.24 -49.62 9.24 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.409 1.084 . . . . 72.33 110.192 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.325 0 C-N-CA 124.485 1.114 . . . . 60.22 111.657 176.258 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 15.0 tpt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.495 -0.557 . . . . 65.43 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.0 p -176.12 62.79 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.381 1.073 . . . . 71.11 108.144 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -76.66 178.52 6.67 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.055 -0.975 . . . . 72.05 112.397 -169.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -69.23 109.17 3.96 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.263 -1.335 . . . . 70.03 109.875 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -82.97 175.15 10.27 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 123.37 0.668 . . . . 51.13 110.251 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 55.9 t30 58.82 74.38 0.44 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.14 1.376 . . . . 72.32 110.262 -170.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 37.9 p -117.73 156.71 27.79 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.783 0.833 . . . . 70.21 110.522 -179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.92 -30.12 68.53 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.962 0.905 . . . . 71.34 111.301 -176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.594 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 11.3 ptm 59.23 174.4 0.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 126.745 2.018 . . . . 62.35 115.003 177.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 95.9 m -154.65 136.61 14.6 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 125.131 1.373 . . . . 42.44 107.616 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -143.06 138.2 29.76 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.564 -0.532 . . . . 73.52 109.564 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.608 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 58.2 tt0 -155.16 140.82 17.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.822 0.849 . . . . 61.31 109.664 175.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 56.7 mt -97.31 117.41 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 108.978 -0.749 . . . . 74.14 108.978 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -81.86 -50.3 9.35 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.803 0.274 . . . . 72.41 110.499 173.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -166.31 142.32 4.8 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.85 0.46 . . . . 75.21 109.822 -174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 73.5 mt -115.01 148.67 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 N-CA-C 107.313 -1.366 . . . . 53.23 107.313 171.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.4 ' HE1' HG13 ' B' ' 83' ' ' ILE . 27.0 p90 -170.63 143.89 2.26 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.198 0.454 . . . . 73.23 110.973 -177.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 52.0 m -73.61 118.31 16.42 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.414 -0.812 . . . . 61.44 108.848 172.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 34.6 mtpt -91.31 -29.24 17.25 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.567 0.747 . . . . 74.34 111.182 -178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 24.9 t70 -160.58 146.38 14.94 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 123.336 0.397 . . . . 72.15 111.19 -172.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.7 mm -143.03 143.1 25.42 Favored 'Isoleucine or valine' 0 C--N 1.346 0.434 0 C-N-CA 125.975 1.71 . . . . 74.14 108.172 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.564 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.9 t -143.07 140.35 30.89 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.163 1.385 . . . . 54.11 107.285 171.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.3 t80 -151.64 126.78 9.83 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.316 -1.365 . . . . 73.35 107.316 171.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -127.32 138.46 53.05 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 123.901 0.88 . . . . 43.04 108.995 176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -129.37 81.41 70.19 Favored Pre-proline 0 C--O 1.24 0.564 0 N-CA-C 107.044 -1.465 . . . . 63.32 107.044 176.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -65.49 -26.0 55.16 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 122.805 2.337 . . . . 71.12 111.979 -173.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -126.48 32.92 5.09 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.361 1.064 . . . . 75.24 109.514 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.484 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.54 -50.09 51.93 Favored Pre-proline 0 CA--C 1.565 1.538 0 C-N-CA 124.504 1.122 . . . . 72.13 113.347 175.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.61 -12.06 26.6 Favored 'Trans proline' 0 C--N 1.391 2.763 0 C-N-CA 121.769 1.646 . . . . 74.02 113.774 176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 29.3 m80 -97.07 -22.27 16.88 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.622 0.769 . . . . 73.13 112.515 -175.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 28' ' ' ALA . 8.3 p -68.63 -23.88 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.808 0.443 . . . . 74.22 112.1 -174.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -62.91 -29.91 71.14 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.396 0.678 . . . . 73.4 111.53 178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -75.47 -30.77 60.03 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.285 0.634 . . . . 72.5 110.419 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -97.39 94.55 7.12 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.301 0.64 . . . . 74.24 111.548 -172.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -94.19 81.1 4.03 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.361 0.665 . . . . 54.34 109.269 173.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -151.12 162.03 41.63 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.688 1.195 . . . . 74.24 108.517 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -75.05 113.84 28.97 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 124.222 1.009 . . . . 61.41 109.354 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.684 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 69.7 Cg_endo -71.92 147.47 49.65 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.348 2.032 . . . . 74.41 111.017 176.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 37.6 tt0 -51.7 106.43 0.14 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.588 0.755 . . . . 71.55 110.449 176.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 p -83.52 122.34 37.49 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 107.517 -1.29 . . . . 64.12 107.517 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -149.09 104.23 3.4 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.897 -0.592 . . . . 71.11 109.497 -173.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -93.8 147.25 23.24 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.366 -0.833 . . . . 73.04 109.225 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.496 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 19.5 t70 -136.71 145.8 45.11 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.404 1.082 . . . . 61.11 108.096 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.586 HD21 ' CD1' ' E' ' 125' ' ' TYR . 1.9 mm? -124.61 163.04 22.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 109.146 -0.687 . . . . 71.51 109.146 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 23.0 t70 -164.04 139.21 6.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.832 -1.076 . . . . 71.31 108.946 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.1 p -122.43 115.63 22.58 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.546 0.738 . . . . 72.0 110.211 -173.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -120.51 160.01 24.02 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.027 0.931 . . . . 73.3 109.466 174.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 169.04 18.36 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.279 1.032 . . . . 63.23 109.354 173.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.453 ' HB2' ' HB3' ' B' ' 57' ' ' GLU . 1.5 m -149.42 135.11 18.64 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.395 -0.965 . . . . 72.34 108.395 178.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -95.85 100.44 12.14 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.285 -1.006 . . . . 75.15 108.285 174.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.9 mt -78.85 -31.28 45.62 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.603 -0.726 . . . . 62.3 110.315 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.72 -171.49 1.63 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.072 0.949 . . . . 73.41 110.648 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -67.96 124.86 24.55 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.798 -1.092 . . . . 64.12 109.533 175.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 69.37 -4.91 1.22 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 124.89 1.276 . . . . 60.54 112.31 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 66.5 t -110.73 97.16 5.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 123.602 0.761 . . . . 55.4 109.118 -173.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -102.51 170.82 7.81 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.542 0.737 . . . . 73.02 110.131 172.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' B' ' 49' ' ' SER . 8.8 tm-20 -145.76 103.01 3.74 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 108.018 -1.105 . . . . 70.34 108.018 -175.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 54.2 t -91.07 125.9 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.178 0.591 . . . . 54.24 110.389 -175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 32.3 t -103.98 111.82 35.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 123.933 0.893 . . . . 75.45 109.147 175.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.0 OUTLIER -94.72 110.23 22.1 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.041 -1.096 . . . . 72.22 108.041 176.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.591 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 66.8 ttt180 -97.23 116.23 29.05 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.344 0.658 . . . . 62.0 109.921 173.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 23.5 t -114.03 120.92 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.217 -1.031 . . . . 75.32 108.217 171.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.0 m -114.61 136.97 52.46 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.703 0.801 . . . . 33.54 109.191 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.687 HG21 HG21 ' B' ' 114' ' ' ILE . 52.8 t -115.99 132.9 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 124.588 1.155 . . . . 74.31 109.646 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 83.4 m -127.21 144.38 51.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.465 0.706 . . . . 65.4 109.667 170.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.684 ' HB1' ' HB2' ' B' ' 38' ' ' PRO . . . -143.76 150.85 39.2 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.362 -0.835 . . . . 73.14 110.333 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.2 m -134.78 136.8 42.85 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.21 0.604 . . . . 75.35 110.951 -174.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 31.4 mt -129.95 99.59 5.15 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.282 1.033 . . . . 73.12 108.924 172.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.65 -132.79 16.46 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 115.38 -0.827 . . . . 71.12 113.091 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -93.18 21.46 5.9 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.824 0.85 . . . . 72.41 111.364 -174.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -146.74 161.07 41.38 Favored 'General case' 0 C--O 1.248 0.981 0 C-N-CA 123.834 0.853 . . . . 73.45 109.179 -177.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 63.0 m -76.98 134.81 38.75 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.971 -0.559 . . . . 62.03 110.005 177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.27 -65.59 0.94 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.488 -0.93 . . . . 75.13 108.488 178.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -155.38 160.37 40.63 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.536 -0.757 . . . . 75.42 111.053 176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 75.4 mt -133.07 135.21 45.19 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.47 1.508 . . . . 74.12 107.093 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.48 ' HB3' ' HB ' ' B' ' 64' ' ' VAL . 42.3 t -139.15 158.06 44.85 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.362 -0.977 . . . . 53.04 108.362 177.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 35.3 tt0 -165.28 128.04 2.18 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.146 -0.687 . . . . 73.13 109.146 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.1 t -126.01 146.55 31.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 123.832 0.853 . . . . 71.03 108.961 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -123.85 96.41 4.94 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 108.231 -1.026 . . . . 73.33 108.231 169.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -85.55 100.4 11.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.377 -0.971 . . . . 74.14 108.377 174.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.55 169.41 35.72 Favored Glycine 0 C--O 1.244 0.775 0 N-CA-C 111.163 -0.775 . . . . 64.02 111.163 175.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -170.8 128.63 1.65 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 111.44 -0.664 . . . . 33.44 111.44 -176.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.4 HG13 ' HE1' ' B' ' 17' ' ' TYR . 38.3 mt -84.73 126.81 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.677 -0.861 . . . . 65.15 108.677 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -132.1 133.17 44.02 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.318 1.047 . . . . 74.3 108.658 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 26.6 m -93.3 97.59 10.7 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.802 -0.814 . . . . 72.44 108.802 173.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.61 HG12 HD13 ' B' ' 98' ' ' LEU . 2.6 pp -115.6 140.74 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.282 1.033 . . . . 64.3 110.463 -176.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.37 172.35 18.5 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.901 0.88 . . . . 62.24 109.495 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.594 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.62 -58.65 5.02 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-O 120.249 -0.195 . . . . 44.44 112.642 176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.473 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.0 OUTLIER -55.01 127.49 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 123.519 0.728 . . . . 71.2 110.97 174.657 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.67 161.74 39.85 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.978 0.911 . . . . 32.0 109.698 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.68 -131.32 10.96 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.908 -0.587 . . . . 65.45 112.225 -175.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -76.39 -35.69 58.49 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.69 0.796 . . . . 73.3 110.944 -177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -64.71 -28.63 69.73 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.166 -0.925 . . . . 71.45 112.043 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.454 ' HE1' HD22 ' B' ' 98' ' ' LEU . 0.0 OUTLIER -65.15 -42.38 93.84 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.453 0.701 . . . . 73.13 110.106 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.56 -34.6 78.63 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.384 -0.825 . . . . 64.23 111.461 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 27.7 t-80 -79.07 -23.7 44.01 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.607 0.763 . . . . 74.12 111.246 179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -85.27 -66.32 0.91 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.582 0.353 . . . . 70.3 110.501 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.61 HD13 HG12 ' B' ' 86' ' ' ILE . 14.0 tp -73.76 -33.45 64.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.845 0.458 . . . . 61.42 111.451 -174.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.28 -21.64 58.31 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.806 -0.634 . . . . 75.51 113.728 -174.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -113.14 -56.0 2.46 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 117.306 0.553 . . . . 72.11 111.768 -176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -68.52 -43.69 76.23 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.564 0.54 . . . . 74.52 112.359 -174.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.542 ' SG ' HD12 ' B' ' 98' ' ' LEU . 75.3 m -63.73 -49.36 76.86 Favored Pre-proline 0 CA--C 1.564 1.507 0 CA-C-O 118.298 -0.858 . . . . 40.35 111.533 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.488 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 88.0 Cg_exo -56.73 -33.02 93.02 Favored 'Trans proline' 0 C--N 1.394 2.935 0 C-N-CA 122.115 1.876 . . . . 71.42 114.143 168.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -67.38 -31.8 72.27 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 123.088 0.555 . . . . 73.35 110.859 178.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -66.91 -48.43 79.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.831 0.853 . . . . 72.35 109.615 172.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' B' ' 102' ' ' CYS . 65.4 mt -82.27 -12.64 57.91 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 115.326 -0.852 . . . . 75.31 111.919 -169.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -66.59 -47.91 55.88 Favored Pre-proline 0 N--CA 1.478 0.933 0 CA-C-O 117.78 -1.105 . . . . 74.23 113.049 -174.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.43 -36.09 98.81 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 121.909 1.739 . . . . 73.43 113.313 174.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.507 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 43.3 m-85 -70.51 -45.58 65.31 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.649 0.78 . . . . 75.35 110.474 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -43.05 99.49 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.7 0.8 . . . . 61.03 110.264 175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 36.1 ttt-85 -56.86 -54.96 40.47 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 125.83 1.652 . . . . 70.14 111.589 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.3 -31.94 73.34 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.733 0.646 . . . . 71.25 110.032 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.533 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.5 t -68.09 -41.97 81.05 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.98 -0.555 . . . . 71.44 110.536 177.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.687 HG21 HG21 ' B' ' 64' ' ' VAL . 62.8 mt -63.79 -51.88 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.133 0.573 . . . . 73.41 110.085 176.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 30.6 m -58.27 -34.24 70.28 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 124.139 0.976 . . . . 74.33 111.072 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 26.9 t -64.41 -54.65 29.4 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.129 -0.941 . . . . 72.21 109.414 173.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.533 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.9 mmt -61.88 -33.86 74.97 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.133 0.573 . . . . 63.31 112.13 -174.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.9 t -66.9 -46.82 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.709 0.804 . . . . 72.31 110.934 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 74.7 p -70.01 -25.29 63.52 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 122.584 0.353 . . . . 64.1 110.999 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.518 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 85.1 mtt-85 -69.85 -20.23 63.42 Favored 'General case' 0 C--O 1.205 -1.286 0 CA-C-O 118.783 -0.627 . . . . 62.52 111.172 174.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -99.2 12.18 61.95 Favored Glycine 0 C--N 1.343 0.971 0 CA-C-O 119.12 -0.822 . . . . 70.35 114.365 177.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 2.7 p 72.54 14.54 5.2 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 125.936 1.694 . . . . 72.12 112.169 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -91.14 154.18 44.86 Favored Pre-proline 0 N--CA 1.48 1.069 0 C-N-CA 122.725 0.41 . . . . 73.1 111.125 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -55.16 149.5 44.14 Favored 'Trans proline' 0 C--N 1.388 2.613 0 C-N-CA 123.321 2.681 . . . . 65.33 113.06 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -59.02 123.25 15.95 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.39 1.076 . . . . 71.31 111.592 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -119.07 100.99 7.69 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.121 -1.066 . . . . 54.55 108.121 -177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -99.8 117.67 34.62 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.727 0.811 . . . . 74.42 109.189 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 5.8 mp -77.79 134.93 37.93 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.171 0.588 . . . . 61.42 110.16 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.05 139.81 36.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.801 0.84 . . . . 74.12 110.398 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.6 99.53 0.45 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.907 2.405 . . . . 74.54 111.972 179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 28.0 m -90.81 126.07 43.57 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 108.753 -0.832 . . . . 75.13 108.753 172.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -74.23 113.23 11.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.531 -0.914 . . . . 70.0 108.531 173.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -63.88 -20.89 66.17 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.662 0.785 . . . . 74.03 110.859 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.15 -49.13 78.86 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.079 1.352 . . . . 73.1 109.735 170.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.64 -31.31 63.44 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-N 114.481 -1.236 . . . . 54.13 110.682 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 46.7 tp -63.3 -43.62 97.35 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.141 0.576 . . . . 75.14 110.075 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.447 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 60.2 t80 -70.82 -38.71 73.27 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.954 -1.021 . . . . 73.05 110.283 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 23.8 ttt -64.39 -36.15 83.22 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.607 0.763 . . . . 71.42 110.499 178.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.567 ' HB3' ' HD2' ' E' ' 124' ' ' ARG . 0.9 OUTLIER -75.5 -26.69 58.35 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 115.315 -0.857 . . . . 71.31 110.187 178.695 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -68.31 -31.28 70.6 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.029 0.531 . . . . 73.01 109.676 171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 16.2 mt -85.31 3.25 40.54 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.186 0.594 . . . . 73.11 110.812 177.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 66.37 27.68 9.94 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.489 1.116 . . . . 75.42 110.898 174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 63.69 20.7 12.36 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.994 1.317 . . . . 55.41 112.27 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -68.11 123.37 20.47 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.867 0.867 . . . . 71.14 111.707 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.97 -57.96 2.16 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.781 0.833 . . . . 53.21 109.649 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.32 74.67 0.61 Allowed Glycine 0 C--N 1.352 1.46 0 CA-C-N 115.685 -0.688 . . . . 74.42 113.973 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.95 148.84 36.11 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.002 0.921 . . . . 54.34 110.624 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.49 64.25 0.5 Allowed Glycine 0 C--N 1.349 1.272 0 N-CA-C 112.349 -0.301 . . . . 54.44 112.349 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 40.8 p -84.24 153.64 23.47 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.22 0.608 . . . . 64.11 110.229 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -132.56 137.55 47.15 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.743 0.817 . . . . 62.21 110.25 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -125.65 134.75 51.75 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.963 0.905 . . . . 54.41 110.556 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.7 m80 -138.41 101.96 4.5 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.999 0.92 . . . . 75.23 109.32 172.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -163.72 128.91 2.95 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.176 1.39 . . . . 64.0 108.058 175.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -151.03 142.93 23.88 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.134 0.574 . . . . 61.5 109.62 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.038 0 N-CA-C 108.68 -0.859 . . . . 54.35 108.68 177.79 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 108.418 -0.956 . . . . 54.04 108.418 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 51.1 m -149.33 27.42 0.83 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.978 0.911 . . . . 72.32 110.199 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -62.78 100.75 0.21 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.186 0.995 . . . . 64.44 111.082 -173.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -91.48 135.59 33.74 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.299 -1.0 . . . . 74.51 108.299 172.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -74.06 110.76 8.61 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.273 -0.64 . . . . 70.33 109.273 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -71.71 86.58 0.93 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.258 0.623 . . . . 52.3 111.156 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 53.2 p -77.88 163.32 26.14 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.495 0.718 . . . . 74.02 109.8 171.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.89 81.82 0.15 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.022 0.929 . . . . 53.31 109.621 -174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.475 ' HB2' ' HB ' ' C' ' 89' ' ' ILE . 54.0 ttp 65.42 113.9 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.366 1.467 . . . . 73.11 111.812 -170.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.8 m -99.79 87.39 3.52 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.501 -1.296 . . . . 74.15 107.501 168.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.448 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 20.5 t80 -89.09 133.12 34.49 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.367 -0.833 . . . . 74.43 109.233 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.469 ' HB3' ' HB2' ' C' ' 85' ' ' SER . 7.9 tt0 -151.81 144.95 24.6 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.937 -0.764 . . . . 63.44 108.937 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.5 HD11 HG13 ' C' ' 16' ' ' ILE . 5.8 tp -92.52 136.88 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 N-CA-C 109.386 -0.598 . . . . 72.23 109.386 172.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 27.5 mm-40 -105.24 -50.06 3.32 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.642 0.777 . . . . 74.04 110.281 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 59.2 ttt180 -163.18 142.64 8.67 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.049 0.54 . . . . 74.41 109.549 -173.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.5 HG13 HD11 ' C' ' 13' ' ' ILE . 79.8 mt -128.24 134.84 64.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.417 -1.327 . . . . 71.31 107.417 174.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.561 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 5.7 p90 -171.16 153.79 3.82 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.237 0.541 . . . . 71.41 111.336 -173.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -79.11 120.74 24.08 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.168 -0.923 . . . . 74.12 109.471 176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -74.26 -49.01 25.02 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 108.321 -0.992 . . . . 75.14 108.321 170.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -134.39 138.33 44.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 113.747 -1.569 . . . . 60.24 109.135 -167.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.6 mt -142.73 139.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.711 -1.588 . . . . 64.11 106.711 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -159.88 149.52 18.15 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.83 -0.433 . . . . 53.23 109.83 176.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -154.34 108.8 3.02 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.124 -1.065 . . . . 74.25 108.124 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -117.79 122.13 42.61 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.076 -0.713 . . . . 53.21 109.076 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.81 93.42 20.51 Favored Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 108.423 -0.955 . . . . 75.22 108.423 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.68 -49.45 8.65 Favored 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 123.108 2.538 . . . . 63.24 111.697 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' C' ' 72' ' ' THR . 68.4 m-20 -103.79 53.19 0.75 Allowed 'General case' 0 CA--C 1.55 0.981 0 CA-C-N 115.429 -0.805 . . . . 74.11 109.036 176.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.447 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.11 -52.99 70.78 Favored Pre-proline 0 CA--C 1.566 1.594 0 N-CA-C 113.982 1.104 . . . . 73.15 113.982 177.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 39.4 Cg_exo -63.81 -21.72 69.28 Favored 'Trans proline' 0 C--N 1.398 3.139 0 C-N-CA 122.185 1.924 . . . . 72.05 112.909 177.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.44 ' HB2' ' HB3' ' C' ' 27' ' ' ASN . 13.6 m-70 -64.64 -18.95 65.41 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 124.291 1.036 . . . . 74.23 113.133 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 8.9 p -41.46 -37.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.087 0.955 . . . . 73.02 113.494 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -81.14 -36.4 30.31 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.054 0.941 . . . . 54.41 111.091 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -85.17 4.64 33.53 Favored 'General case' 0 CA--C 1.564 1.502 0 C-N-CA 125.293 1.437 . . . . 53.24 111.08 -175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.627 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 4.2 ttmp? -107.81 153.18 23.37 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.376 1.07 . . . . 71.33 111.024 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -80.25 114.23 19.0 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 107.06 -1.459 . . . . 73.34 107.06 166.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -85.32 61.47 6.88 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 122.141 0.972 . . . . 74.41 112.504 -168.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -150.23 58.74 3.26 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 125.011 1.325 . . . . 71.31 107.598 173.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' E' ' 139' ' ' LEU . 92.5 Cg_endo -77.47 160.8 31.85 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.011 1.807 . . . . 71.25 111.364 -176.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -83.45 103.94 13.2 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.896 -1.15 . . . . 70.32 107.896 -176.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -73.82 97.41 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-N 114.963 -1.017 . . . . 65.11 108.642 -177.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 50.7 mtpt -95.77 105.64 17.67 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.996 -0.742 . . . . 74.25 108.996 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 73.5 mt -87.04 149.1 24.97 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.901 0.881 . . . . 73.31 109.609 -177.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.492 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.3 t70 -149.17 127.41 12.11 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 108.314 -0.995 . . . . 72.35 108.314 177.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -134.78 149.68 50.44 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 118.228 0.467 . . . . 73.23 110.769 -176.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 17.5 m-20 -140.81 161.1 38.6 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.115 0.966 . . . . 64.35 109.826 176.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -130.48 136.06 48.6 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.054 0.941 . . . . 64.43 108.473 171.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -131.51 172.51 12.13 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.124 0.97 . . . . 61.33 108.507 176.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.7 p -164.61 160.14 19.79 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 122.927 0.491 . . . . 23.01 111.112 -177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 69.4 p -167.34 138.21 3.03 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.061 0.944 . . . . 74.04 109.452 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -77.87 117.5 19.29 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.88 -0.785 . . . . 74.2 108.88 175.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.612 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.5 mt -87.27 -37.97 16.72 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.734 0.413 . . . . 54.52 110.608 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -159.23 -172.05 3.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.262 -0.881 . . . . 50.22 110.682 -174.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -67.67 111.56 4.29 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.01 -0.995 . . . . 64.21 109.681 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 64.09 15.9 9.6 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.831 1.252 . . . . 63.11 112.314 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 89.1 t -118.0 103.79 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.298 -1.001 . . . . 71.43 108.298 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.443 ' CD1' ' HB ' ' C' ' 86' ' ' ILE . 14.9 m-85 -117.95 139.17 51.54 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.907 0.883 . . . . 72.42 108.959 -178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.612 ' HB2' HD11 ' C' ' 51' ' ' LEU . 35.2 tt0 -100.3 146.14 27.28 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.843 0.857 . . . . 65.21 109.355 174.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 26.8 m -126.38 144.33 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.747 -0.835 . . . . 75.44 108.747 165.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 58.2 t -119.63 107.14 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.886 0.875 . . . . 64.1 109.127 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.9 tm? -90.25 99.91 12.84 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.074 -1.084 . . . . 64.3 108.074 177.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 75.6 ttt-85 -84.53 134.82 34.41 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.858 0.863 . . . . 73.12 109.385 177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.412 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -129.05 148.13 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 107.794 -1.187 . . . . 71.33 107.794 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.492 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 57.5 m -138.9 135.35 34.36 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 107.5 -1.296 . . . . 75.31 107.5 171.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.542 HG23 HD13 ' C' ' 114' ' ' ILE . 47.1 t -118.36 113.33 41.63 Favored 'Isoleucine or valine' 0 C--O 1.244 0.799 0 N-CA-C 107.659 -1.237 . . . . 75.31 107.659 173.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 4.1 m -98.33 134.35 41.47 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.749 -1.204 . . . . 74.5 107.749 171.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.58 94.82 3.84 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.231 -1.396 . . . . 74.12 107.231 -176.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 14.1 m -144.76 143.48 30.69 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.279 0.632 . . . . 62.24 109.692 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 16.6 tp -102.03 10.17 39.8 Favored 'General case' 0 CA--C 1.556 1.193 0 C-N-CA 123.493 0.717 . . . . 70.55 109.578 174.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 128.27 -95.63 0.4 Allowed Glycine 0 C--N 1.352 1.43 0 N-CA-C 110.395 -1.082 . . . . 35.53 110.395 -176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -89.48 -32.98 16.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.909 0.884 . . . . 72.22 109.261 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.627 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 8.7 tp10 -83.67 91.28 7.43 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.874 0.87 . . . . 61.32 109.484 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.506 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 28.3 m -86.75 135.88 33.21 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.284 -0.871 . . . . 72.32 110.232 -178.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.59 -65.03 1.05 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.669 -0.863 . . . . 71.52 108.669 167.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -160.36 175.5 12.74 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.907 0.86 . . . . 74.13 112.332 -175.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.463 HD23 HG23 ' C' ' 65' ' ' THR . 2.5 tm? -137.34 135.6 37.2 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 105.219 -2.141 . . . . 53.52 105.219 169.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 47.2 t -144.73 117.84 8.9 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.841 0.456 . . . . 70.21 109.983 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -121.06 131.35 54.22 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.576 -0.527 . . . . 73.35 109.576 176.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 76.0 t -129.03 135.41 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.194 0.998 . . . . 75.51 108.488 170.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.499 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.6 mt-30 -115.04 103.2 10.66 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.567 -0.901 . . . . 74.4 108.567 172.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -85.34 110.02 18.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.587 0.755 . . . . 64.34 109.618 -178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.02 146.65 22.14 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.178 -0.769 . . . . 63.42 111.178 173.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.545 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.52 118.66 0.99 Allowed Glycine 0 C--N 1.335 0.494 0 N-CA-C 111.913 -0.475 . . . . 41.35 111.913 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.493 HD12 ' CD1' ' C' ' 51' ' ' LEU . 8.7 mm -87.72 119.36 35.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.917 -0.771 . . . . 65.53 108.917 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.434 ' CE2' HD13 ' C' ' 13' ' ' ILE . 98.9 m-85 -129.36 128.7 43.61 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.9 0.88 . . . . 74.34 109.237 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' C' ' 12' ' ' GLN . 24.5 m -70.82 108.74 4.62 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 109.305 -0.628 . . . . 73.4 109.305 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.443 ' HB ' ' CD1' ' C' ' 56' ' ' TYR . 43.5 mm -114.36 101.03 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.21 -1.034 . . . . 74.31 108.21 -178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -133.53 150.05 51.68 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.97 0.908 . . . . 64.02 109.754 -177.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.56 -19.37 28.76 Favored Glycine 0 N--CA 1.476 1.357 0 N-CA-C 114.349 0.5 . . . . 70.14 114.349 169.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.475 ' HB ' ' HB2' ' C' ' 9' ' ' MET . 17.8 tt -108.57 151.88 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 124.331 1.052 . . . . 74.53 110.134 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -164.13 154.68 15.17 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.185 0.594 . . . . 74.42 110.756 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.83 -148.61 19.31 Favored Glycine 0 C--N 1.349 1.275 0 C-N-CA 123.369 0.509 . . . . 74.32 112.243 174.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.9 p -65.89 -21.18 66.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.946 0.898 . . . . 75.51 111.115 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -61.53 -51.1 70.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.173 0.989 . . . . 74.0 109.95 170.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 53.3 ttm -66.47 -35.82 81.22 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 115.901 -0.59 . . . . 75.13 110.376 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.2 95.83 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.497 0.719 . . . . 73.41 111.487 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 56.5 t-80 -68.5 -23.74 64.59 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 115.251 -0.886 . . . . 74.12 111.415 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 99.6 m -82.7 -51.33 7.81 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.221 0.608 . . . . 60.14 110.896 173.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 19.3 tp -71.74 -42.67 66.99 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.735 1.214 . . . . 70.11 111.314 -163.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.61 11.53 46.45 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-N 116.02 -0.537 . . . . 73.24 113.438 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.469 ' HB1' ' HB3' ' C' ' 134' ' ' ASP . . . -146.12 -73.44 0.23 Allowed 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 117.505 0.652 . . . . 73.22 111.963 -175.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.58 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 92.0 t80 -65.22 -53.55 42.81 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.308 0.855 . . . . 74.11 113.308 -168.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.448 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 31.9 m -61.04 -44.55 94.75 Favored Pre-proline 0 CA--C 1.572 1.815 0 C-N-CA 123.126 0.57 . . . . 70.03 111.835 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 87.9 Cg_exo -55.23 -33.59 85.12 Favored 'Trans proline' 0 C--N 1.39 2.762 0 C-N-CA 122.654 2.236 . . . . 63.3 114.536 166.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -68.19 -25.15 65.09 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 123.048 0.539 . . . . 73.03 111.762 179.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.46 HD12 ' NH1' ' A' ' 111' ' ' ARG . 38.4 mm -69.0 -39.67 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 N-CA-C 109.476 -0.564 . . . . 74.31 109.476 171.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.545 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.5 mt -76.93 -26.89 54.58 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 114.843 -1.071 . . . . 72.23 111.811 -176.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -56.03 -47.09 99.52 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.405 1.082 . . . . 62.11 113.807 -173.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.78 -40.16 86.22 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.031 1.821 . . . . 61.45 113.542 174.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -68.38 -45.76 71.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.224 0.61 . . . . 74.34 110.712 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.4 82.7 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.713 0.805 . . . . 44.2 110.665 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 13.7 ttp-105 -65.83 -49.45 68.16 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.411 -1.268 . . . . 55.32 110.658 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -70.09 -29.74 66.79 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.416 0.686 . . . . 62.14 110.673 -177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 21.8 t -65.61 -40.43 92.61 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.408 0.683 . . . . 45.1 110.12 176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.542 HD13 HG23 ' C' ' 64' ' ' VAL . 96.1 mt -67.9 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 115.867 -0.606 . . . . 74.44 110.133 172.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 62.3 m -58.24 -29.56 65.85 Favored 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 123.823 0.849 . . . . 73.35 111.011 -176.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.8 t -72.9 -51.51 18.31 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.37 -0.832 . . . . 71.45 109.715 172.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.585 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -52.17 -39.51 60.16 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 123.806 0.842 . . . . 52.3 112.369 177.66 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' C' ' 114' ' ' ILE . 60.6 t -68.85 -44.92 81.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 C-N-CA 123.389 0.676 . . . . 72.31 110.259 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 95.1 p -69.07 -28.61 66.68 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.281 0.562 . . . . 63.52 110.926 -178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -67.21 -37.19 83.21 Favored 'General case' 0 C--O 1.208 -1.115 0 CA-C-N 114.71 -1.132 . . . . 73.12 110.05 174.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.95 1.62 83.74 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-O 119.352 -0.693 . . . . 73.32 112.952 174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.511 HG23 ' HB3' ' D' ' 17' ' ' TYR . 64.0 p 58.96 25.36 13.69 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.237 1.815 . . . . 25.31 112.833 -178.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.441 ' HZ ' ' HA ' ' C' ' 28' ' ' ALA . 84.3 m-85 -93.21 160.43 33.43 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 124.298 1.039 . . . . 74.31 108.923 175.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.573 ' HG2' HD21 ' E' ' 139' ' ' LEU . 35.5 Cg_endo -64.06 117.46 4.47 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.716 2.277 . . . . 70.24 112.418 -179.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -54.12 134.72 44.17 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 124.467 1.107 . . . . 64.31 112.414 179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.59 107.35 18.14 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.948 -1.13 . . . . 73.0 107.948 -174.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -92.67 100.64 13.11 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 108.266 -1.013 . . . . 73.02 108.266 175.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.64 134.36 48.63 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.339 0.655 . . . . 73.22 110.079 -176.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.14 145.66 99.06 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 123.773 0.829 . . . . 75.31 110.974 176.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.474 ' HG2' HD12 ' A' ' 16' ' ' ILE . 24.0 Cg_exo -64.18 87.19 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.84 2.36 . . . . 72.01 112.702 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.0 p -99.33 111.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.682 -0.859 . . . . 75.52 108.682 176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -109.44 103.12 11.97 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.962 -0.755 . . . . 63.13 108.962 -177.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -61.19 -29.24 69.69 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.21 1.004 . . . . 75.33 111.561 -178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.469 ' HB3' ' HB1' ' C' ' 100' ' ' ALA . 4.8 p-10 -76.21 -32.23 58.84 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.584 0.753 . . . . 74.53 110.584 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.89 -20.46 60.4 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.89 0.876 . . . . 51.34 111.626 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.84 -28.12 67.28 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.952 0.501 . . . . 74.12 110.696 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.407 ' HA ' ' HD1' ' C' ' 140' ' ' TYR . 78.7 t80 -69.36 -18.47 63.79 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.575 0.75 . . . . 72.2 111.733 174.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 11.4 tmm? -69.03 -30.9 69.37 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 122.805 0.442 . . . . 64.23 110.111 175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.1 -38.34 90.73 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.311 0.644 . . . . 64.54 109.851 174.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . 0.407 ' HD1' ' HA ' ' C' ' 137' ' ' PHE . 91.4 m-85 -71.42 -88.12 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.479 -0.782 . . . . 74.31 109.159 170.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 52.09 38.28 23.73 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.186 1.394 . . . . 74.02 111.034 172.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.541 ' HA ' HE21 ' C' ' 142' ' ' GLN . 0.0 OUTLIER -83.29 70.81 10.21 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 121.771 0.795 . . . . 74.4 110.301 -177.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -122.76 2.46 9.47 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.749 -1.114 . . . . 71.52 109.079 171.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -135.86 111.2 9.09 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 106.829 -1.545 . . . . 72.13 106.829 -178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -103.06 94.98 5.83 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.639 0.776 . . . . 71.12 109.887 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -93.67 128.46 9.47 Favored Glycine 0 C--N 1.347 1.164 0 O-C-N 123.447 0.467 . . . . 74.01 112.374 179.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -85.46 59.27 5.53 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 122.118 0.961 . . . . 73.32 108.857 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 137.13 67.93 0.05 OUTLIER Glycine 0 C--N 1.34 0.788 0 CA-C-N 114.898 -1.046 . . . . 73.21 110.829 -172.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 20.7 m -71.65 -19.76 62.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.736 0.814 . . . . 52.12 110.706 174.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -81.48 40.58 0.58 Allowed 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.867 1.267 . . . . 63.04 112.711 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -75.96 83.73 2.86 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.343 0.592 . . . . 73.15 110.524 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -86.37 72.85 10.26 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 107.566 -1.272 . . . . 73.01 107.566 174.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -76.75 74.62 3.4 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.693 0.758 . . . . 73.05 109.209 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -178.11 132.9 0.15 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 113.967 -1.469 . . . . 71.15 108.288 -174.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.204 0 N-CA-C 108.565 -0.902 . . . . 62.33 108.565 179.247 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptp . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.972 -0.381 . . . . 73.02 109.972 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t -119.61 107.61 13.47 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.97 -1.122 . . . . 63.52 107.97 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -61.82 -56.7 16.7 Favored 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.774 0.671 . . . . 54.4 110.661 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 69.03 174.03 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.848 1.259 . . . . 73.22 112.065 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.489 HD21 ' HA ' ' D' ' 87' ' ' ALA . 13.2 t-20 -160.57 86.25 0.73 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.129 -1.063 . . . . 72.55 108.129 -178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -147.58 106.52 3.84 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.498 0.719 . . . . 63.31 109.951 -172.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -171.82 -176.34 1.72 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 125.226 1.411 . . . . 71.24 108.427 177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 136.96 45.39 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.924 -0.769 . . . . 63.02 108.924 168.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.439 ' HG3' HG13 ' D' ' 89' ' ' ILE . 6.0 ttp -30.87 126.55 0.17 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 126.008 1.723 . . . . 72.21 114.004 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 25.8 m -139.32 136.8 35.22 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 123.778 0.831 . . . . 74.2 109.037 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -152.97 93.78 1.78 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.518 -1.29 . . . . 74.33 107.518 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.485 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 48.3 mt-30 -114.51 153.61 29.71 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.562 -0.744 . . . . 73.21 109.587 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.4 mm -92.57 131.07 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 123.95 0.9 . . . . 74.21 109.16 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -109.42 -49.57 3.1 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-N 118.363 0.528 . . . . 63.3 111.909 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -169.31 121.08 0.73 Allowed 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 112.509 0.559 . . . . 70.05 112.509 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.43 HD12 ' N ' ' D' ' 16' ' ' ILE . 1.7 mp -108.6 133.52 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 N-CA-C 107.653 -1.239 . . . . 73.25 107.653 178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.511 ' HB3' HG23 ' C' ' 122' ' ' THR . 36.1 p90 -161.89 176.05 11.24 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.911 0.862 . . . . 72.34 112.021 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -107.07 117.87 35.21 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 114.778 -1.101 . . . . 74.12 109.265 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.447 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.6 mtpt -85.47 -25.24 27.02 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 109.287 -0.634 . . . . 74.5 109.287 175.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.712 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 9.1 t70 -148.32 141.03 24.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.328 1.051 . . . . 55.0 109.869 176.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.585 HD13 ' HE3' ' C' ' 117' ' ' MET . 46.1 mt -138.41 142.96 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 125.445 1.498 . . . . 73.55 107.713 172.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 32.8 t -148.01 137.09 22.05 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.233 1.013 . . . . 65.01 108.852 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.567 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.4 t80 -153.86 119.54 5.25 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.117 -1.438 . . . . 75.25 107.117 173.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -132.0 118.54 19.86 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.394 0.677 . . . . 73.23 109.57 -177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.75 90.2 12.49 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 108.703 -0.851 . . . . 73.21 108.703 176.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.61 -46.44 0.34 Allowed 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 122.964 2.443 . . . . 51.1 112.829 -173.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.448 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.4 m-20 -103.31 43.51 1.08 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.279 1.032 . . . . 50.32 108.26 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.561 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -60.02 -53.46 64.95 Favored Pre-proline 0 CA--C 1.571 1.784 0 N-CA-C 114.795 1.406 . . . . 63.35 114.795 -168.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.67 -3.86 12.0 Favored 'Trans proline' 0 C--N 1.393 2.88 0 CA-C-N 121.806 1.681 . . . . 74.22 113.865 170.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.448 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 18.6 t-160 -84.6 -40.17 17.84 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 123.896 0.878 . . . . 65.14 110.454 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 p -82.26 -14.05 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 123.755 0.822 . . . . 74.01 109.923 177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.21 -28.76 70.26 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.377 1.071 . . . . 74.15 110.96 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' D' ' 30' ' ' HIS . 61.0 mt-30 -72.64 -7.66 51.43 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.39 1.076 . . . . 61.44 111.293 178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -111.78 111.81 23.04 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.423 1.089 . . . . 75.52 109.877 -177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -87.63 63.4 7.54 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.705 0.802 . . . . 61.22 110.052 -177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.506 ' HB3' HD21 ' D' ' 68' ' ' LEU . 65.7 t-105 -150.58 166.87 28.95 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.826 -0.805 . . . . 74.21 108.826 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.74 108.69 27.1 Favored Pre-proline 0 CA--C 1.554 1.122 0 C-N-CA 124.118 0.967 . . . . 63.32 110.471 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -43.24 144.94 1.55 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 124.506 3.471 . . . . 74.21 115.612 173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -72.73 118.37 15.58 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 115.569 -0.741 . . . . 71.23 110.379 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.512 HG21 HD13 ' F' ' 139' ' ' LEU . 99.1 t -109.23 125.33 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.877 0.871 . . . . 64.1 111.02 -175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -111.54 120.95 43.85 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.68 -1.23 . . . . 62.44 107.68 167.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 155.66 16.66 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.403 -0.962 . . . . 74.1 108.403 175.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.583 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 13.6 t70 -143.59 140.89 30.4 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.887 0.875 . . . . 73.32 108.963 -176.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 92.8 mt -115.9 153.44 31.55 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.275 0.63 . . . . 63.3 110.544 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.59 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.9 t0 -165.75 152.7 10.04 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.579 1.152 . . . . 62.51 108.781 173.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 14.1 t -125.08 164.52 20.03 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 121.31 0.576 . . . . 51.1 110.279 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.86 167.53 30.2 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.529 1.131 . . . . 61.54 108.465 175.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.4 p -161.6 154.34 20.42 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.971 0.508 . . . . 61.03 110.97 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 83.4 p -154.95 149.62 26.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.513 1.125 . . . . 74.4 108.832 177.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -91.34 118.53 30.59 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.548 -0.908 . . . . 74.33 108.548 171.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 61.0 mt -91.54 -38.49 12.48 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.099 0.56 . . . . 52.34 109.995 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.72 -177.11 6.05 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.662 0.744 . . . . 62.11 111.013 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -74.66 125.64 29.13 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.74 -1.118 . . . . 73.1 110.083 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 63.8 10.58 5.26 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 125.304 1.442 . . . . 70.24 112.308 -172.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 84.1 t -123.76 120.07 58.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 C-N-CA 123.787 0.835 . . . . 71.13 109.025 -178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.501 ' HD1' ' HB ' ' D' ' 86' ' ' ILE . 64.3 m-85 -132.88 130.03 39.18 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.778 -0.823 . . . . 74.35 108.778 -177.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -87.9 138.82 31.12 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.199 1.0 . . . . 64.24 108.888 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 54.9 t -122.66 123.92 69.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 107.228 -1.397 . . . . 73.34 107.228 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 48.1 t -102.25 130.73 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 N-CA-C 108.808 -0.812 . . . . 74.54 108.808 175.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.534 HD21 HD11 ' D' ' 136' ' ' LEU . 0.0 OUTLIER -105.5 117.93 35.28 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 107.575 -1.268 . . . . 71.3 107.575 176.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.59 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 30.2 ttm-85 -96.58 107.2 19.58 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.727 -1.212 . . . . 74.54 107.727 173.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 72.2 t -109.15 129.91 63.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.448 -0.945 . . . . 73.25 108.448 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.4 m -116.71 147.55 41.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.919 0.888 . . . . 72.33 109.65 178.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 23.7 t -134.11 128.72 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 124.968 1.307 . . . . 73.11 108.442 174.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 98.7 m -124.83 119.64 29.43 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.08 139.3 53.51 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.311 0.644 . . . . 62.42 109.634 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 41.7 p -155.49 129.13 8.48 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.62 0.768 . . . . 52.31 109.415 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.506 HD21 ' HB3' ' D' ' 36' ' ' TRP . 15.5 tp -113.54 111.61 22.19 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 108.504 -0.925 . . . . 64.3 108.504 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.97 -144.98 26.73 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.876 0.735 . . . . 63.34 111.88 -172.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.37 2.88 34.22 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.611 0.764 . . . . 64.25 112.021 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.448 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 13.1 pt-20 -123.81 152.16 42.55 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.777 0.831 . . . . 74.31 110.423 -170.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 80.9 m -74.07 136.04 43.03 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 123.61 0.569 . . . . 73.43 110.147 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -91.58 -54.8 3.74 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.918 0.887 . . . . 73.24 109.436 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -161.52 164.04 29.85 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.78 -1.1 . . . . 65.13 109.312 173.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.79 152.53 50.89 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.102 1.361 . . . . 74.22 107.803 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.639 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.4 t -159.63 142.94 14.29 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 122.732 0.413 . . . . 52.43 110.784 -178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.45 127.54 6.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.169 0.588 . . . . 73.05 109.562 168.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.2 115.82 42.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 C-N-CA 123.617 0.767 . . . . 64.0 109.549 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.712 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 51.3 mt-30 -89.86 87.13 6.83 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-O 121.867 0.841 . . . . 72.14 108.874 170.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -80.35 95.75 6.47 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 113.612 -1.631 . . . . 73.15 109.429 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 142.76 18.35 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 112.173 -0.371 . . . . 53.12 112.173 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.05 131.95 4.98 Favored Glycine 0 C--N 1.336 0.553 0 N-CA-C 111.545 -0.622 . . . . 42.01 111.545 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.6 mt -92.45 123.28 44.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 C-N-CA 124.488 1.115 . . . . 65.52 108.78 -179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -126.16 131.77 51.96 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.935 0.894 . . . . 72.54 109.635 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 9.8 m -80.59 94.51 6.31 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 108.641 -0.874 . . . . 24.34 108.641 173.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.501 ' HB ' ' HD1' ' D' ' 56' ' ' TYR . 69.9 mt -108.5 111.02 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.843 0.857 . . . . 63.22 109.205 -175.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.489 ' HA ' HD21 ' D' ' 5' ' ' ASN . . . -146.64 128.81 15.66 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.634 0.774 . . . . 43.21 109.822 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 103.72 -7.76 50.13 Favored Glycine 0 N--CA 1.471 1.016 0 CA-C-O 119.756 -0.469 . . . . 62.33 113.705 177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.483 HD13 HG23 ' D' ' 86' ' ' ILE . 2.9 mp -95.8 126.16 48.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 106.706 -1.591 . . . . 71.23 106.706 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.26 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.751 0.82 . . . . 75.21 111.35 -169.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.31 -141.84 39.89 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 115.039 -0.982 . . . . 72.12 112.719 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -90.38 -16.33 29.32 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.649 0.78 . . . . 74.42 110.02 173.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -60.46 -33.37 72.48 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.583 1.153 . . . . 53.43 111.123 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -64.1 -33.16 75.14 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.996 0.519 . . . . 74.32 111.694 178.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.28 -41.58 80.81 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.201 0.6 . . . . 73.23 110.427 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 42.5 t-80 -72.78 -36.19 67.58 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.907 -0.588 . . . . 60.42 110.925 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -64.33 -43.29 95.11 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.794 0.437 . . . . 34.13 110.053 177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 24.6 tp -72.73 -35.98 67.67 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.175 0.99 . . . . 71.25 111.336 -177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.38 -9.14 53.98 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.446 -0.641 . . . . 51.54 114.434 -172.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.768 ' HB2' ' HB2' ' D' ' 137' ' ' PHE . . . -132.92 -60.27 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 117.741 0.77 . . . . 61.43 111.873 -175.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -64.22 -46.13 85.19 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.364 0.666 . . . . 73.51 112.145 -172.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 33.4 m -71.62 -45.3 12.78 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-O 118.558 -0.734 . . . . 72.03 112.03 -177.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.48 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 52.8 Cg_exo -57.82 -29.06 84.75 Favored 'Trans proline' 0 C--N 1.399 3.226 0 C-N-CA 122.446 2.097 . . . . 75.45 113.915 169.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -65.86 -32.29 73.73 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.262 0.625 . . . . 53.31 110.702 179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.6 mm -67.23 -34.56 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 123.661 0.785 . . . . 74.41 110.186 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.6 mt -82.5 -17.76 43.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.23 1.012 . . . . 65.02 112.39 -176.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -65.78 -44.66 64.14 Favored Pre-proline 0 CA--C 1.557 1.242 0 N-CA-C 113.656 0.984 . . . . 72.31 113.656 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.86 -32.07 90.96 Favored 'Trans proline' 0 C--N 1.389 2.668 0 C-N-CA 121.952 1.768 . . . . 64.52 112.873 171.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -80.16 -33.97 37.98 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.69 0.796 . . . . 71.34 112.398 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.17 58.95 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.263 -0.643 . . . . 52.42 109.263 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -68.35 -31.7 71.27 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 114.883 -1.053 . . . . 72.45 111.213 -176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.13 -50.38 72.1 Favored 'General case' 0 N--CA 1.484 1.24 0 O-C-N 124.223 0.952 . . . . 72.41 110.692 175.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.3 t -59.02 -42.04 89.18 Favored 'General case' 0 N--CA 1.479 0.987 0 O-C-N 123.689 0.618 . . . . 65.32 110.52 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.639 HG12 ' SG ' ' D' ' 76' ' ' CYS . 99.5 mt -59.3 -52.84 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.314 1.045 . . . . 74.22 110.708 173.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.523 HG23 ' HG3' ' D' ' 125' ' ' GLN . 74.1 m -58.64 -41.82 86.91 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.882 0.873 . . . . 74.45 110.808 -174.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.6 t -65.56 -43.97 88.19 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 114.65 -1.159 . . . . 70.12 110.448 -178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.6 mtm -68.41 -30.58 69.51 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 122.711 0.404 . . . . 63.31 111.459 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' D' ' 123' ' ' PHE . 55.0 t -66.92 -45.42 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 123.451 0.701 . . . . 72.4 110.029 173.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 78.5 p -74.26 -25.63 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.748 0.419 . . . . 73.04 110.967 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -75.63 -35.23 60.52 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.593 0.757 . . . . 65.13 109.255 172.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.38 -3.89 88.84 Favored Glycine 0 C--N 1.356 1.67 0 O-C-N 123.854 0.721 . . . . 62.11 112.039 171.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 24.5 p 58.05 34.69 24.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.71 2.004 . . . . 72.33 112.894 173.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.472 ' HB2' HG13 ' D' ' 118' ' ' VAL . 51.1 m-85 -93.28 166.74 15.53 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.738 1.215 . . . . 73.23 108.989 171.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.56 132.26 44.89 Favored 'Trans proline' 0 C--N 1.387 2.592 0 C-N-CA 122.097 1.864 . . . . 73.32 111.514 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.523 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.6 tt0 -52.49 139.6 24.79 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.544 1.137 . . . . 74.21 112.406 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.758 ' HB2' HD12 ' F' ' 139' ' ' LEU . 46.7 tp -126.04 99.89 6.11 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.947 0.403 . . . . 72.22 110.862 -178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 -100.15 117.81 35.18 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.179 -1.415 . . . . 75.14 107.179 173.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 90.7 mt -73.17 123.16 23.1 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.624 -0.509 . . . . 61.13 109.624 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.66 147.07 84.73 Favored Pre-proline 0 CA--C 1.552 1.025 0 O-C-N 124.635 1.209 . . . . 64.2 112.311 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -52.93 123.06 12.21 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.262 2.641 . . . . 73.12 113.555 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 9.8 p -118.75 145.0 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.828 0.851 . . . . 72.2 109.92 178.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.553 HD22 ' HB2' ' D' ' 134' ' ' ASP . 5.7 p-10 -68.25 118.48 11.41 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 108.328 -0.99 . . . . 54.41 108.328 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.448 ' HD1' ' HB1' ' D' ' 100' ' ' ALA . 23.2 p90 -50.08 -23.0 1.85 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.772 1.229 . . . . 74.2 113.969 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.553 ' HB2' HD22 ' D' ' 132' ' ' ASN . 4.9 m-20 -63.47 -38.79 92.48 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.88 0.872 . . . . 71.21 111.191 176.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.72 -24.17 66.92 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.084 0.554 . . . . 51.53 111.398 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.534 HD11 HD21 ' D' ' 60' ' ' LEU . 5.0 tt -83.28 -31.53 26.88 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.938 0.895 . . . . 74.25 109.265 175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.768 ' HB2' ' HB2' ' D' ' 100' ' ' ALA . 47.1 t80 -62.2 -30.88 71.39 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.483 0.713 . . . . 64.45 110.993 175.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 16.4 mmt -58.25 -32.82 68.72 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.684 0.393 . . . . 61.12 110.696 178.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.519 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 20.3 m120 -65.99 -30.95 71.59 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.821 0.848 . . . . 61.33 112.116 178.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.43 -35.81 80.43 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.062 0.945 . . . . 74.15 111.326 177.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.33 -35.56 30.79 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.471 0.709 . . . . 74.45 111.735 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.519 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 10.8 pt20 -91.06 23.37 3.26 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 112.383 0.512 . . . . 74.12 112.383 -173.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -121.3 90.41 3.31 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.444 0.64 . . . . 64.31 111.862 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -165.91 85.31 0.34 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 105.668 -1.975 . . . . 63.51 105.668 167.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -149.47 160.04 43.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.982 0.913 . . . . 63.0 110.182 -177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.42 155.67 8.11 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 111.109 -0.796 . . . . 72.44 111.109 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -155.32 127.67 7.79 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.474 0.71 . . . . 74.13 109.793 -176.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -131.32 137.34 9.38 Favored Glycine 0 C--N 1.344 0.989 0 N-CA-C 111.816 -0.514 . . . . 42.45 111.816 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 8.5 t -152.08 138.17 18.24 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.823 0.849 . . . . 62.24 109.244 176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -140.38 86.73 2.09 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.205 0.602 . . . . 53.51 109.701 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -77.83 98.25 5.52 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 108.326 -0.991 . . . . 75.32 108.326 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 54.1 m80 -63.13 115.89 4.89 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.035 0.934 . . . . 62.24 111.612 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -65.95 145.53 55.79 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.998 -0.741 . . . . 63.43 108.998 167.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -160.34 147.07 15.74 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.215 -0.661 . . . . 63.02 109.215 -177.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 C-N-CA 123.721 0.808 . . . . 71.41 109.515 -177.115 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 109.686 -0.487 . . . . 55.44 109.686 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -130.87 -169.54 2.18 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.271 1.028 . . . . 75.12 109.575 179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -157.92 72.36 0.64 Allowed 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 109.242 -0.651 . . . . 63.23 109.242 173.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -121.93 108.41 13.4 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.652 0.781 . . . . 75.12 109.065 177.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -65.31 -52.44 54.0 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.373 0.669 . . . . 75.55 110.707 -177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 24.1 t70 53.68 -89.52 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.606 1.163 . . . . 73.24 109.432 -172.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -143.58 132.62 22.92 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.756 1.222 . . . . 53.14 107.92 165.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 7.3 mp -72.56 120.97 18.92 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.087 0.955 . . . . 70.31 109.812 -175.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 81.7 t80 66.37 77.49 0.27 Allowed Pre-proline 0 CA--C 1.557 1.214 0 C-N-CA 125.34 1.456 . . . . 74.31 110.349 -170.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -94.3 24.84 0.38 Allowed 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 123.213 2.609 . . . . 73.0 112.984 174.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -80.44 -71.98 0.43 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.101 0.561 . . . . 73.41 111.892 -174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 67.6 m 55.65 88.94 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.792 0.837 . . . . 64.34 110.733 -170.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 3.8 p90 -99.84 178.31 4.86 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 121.431 0.634 . . . . 72.23 110.403 174.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -110.0 -147.1 0.41 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.832 -1.076 . . . . 73.34 108.82 -171.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.99 -27.44 68.87 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.618 0.767 . . . . 71.41 111.348 168.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 48.5 t 61.48 -82.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 125.688 1.595 . . . . 74.25 110.43 -178.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . 0.567 ' HD2' ' HB3' ' B' ' 139' ' ' ASN . 0.1 OUTLIER -163.88 81.82 0.43 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.67 1.188 . . . . 74.52 108.407 176.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . 0.586 ' CD1' HD21 ' B' ' 44' ' ' LEU . 56.9 t80 -75.71 112.76 12.42 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.323 -0.853 . . . . 72.33 109.683 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -101.53 87.12 3.1 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.534 0.734 . . . . 73.34 109.301 171.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -100.26 108.41 3.5 Favored Glycine 0 C--N 1.337 0.584 0 N-CA-C 110.781 -0.928 . . . . 61.01 110.781 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.41 27.41 3.36 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.28 0.632 . . . . 73.41 110.606 177.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . 0.46 ' HG ' HG13 ' E' ' 130' ' ' ILE . 2.5 pt? -50.85 -36.36 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.05 1.34 . . . . 62.25 112.296 -177.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . 0.46 HG13 ' HG ' ' E' ' 129' ' ' LEU . 50.5 mt -94.94 81.01 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 N-CA-C 108.001 -1.111 . . . . 75.13 108.001 170.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.06 62.78 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.301 -0.863 . . . . 73.44 110.64 175.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -151.81 168.08 11.9 Favored Pre-proline 0 CA--C 1.556 1.21 0 C-N-CA 124.732 1.213 . . . . 74.02 108.436 176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.87 98.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 122.574 2.183 . . . . 74.44 111.747 173.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 11.1 tp -89.55 32.95 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 CA-C-O 122.215 1.007 . . . . 74.31 110.274 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.4 72.57 6.03 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.639 0.776 . . . . 74.42 109.343 172.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 24.8 t -90.41 -16.16 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 114.685 -1.143 . . . . 74.53 109.267 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . 0.405 ' H ' ' HG2' ' E' ' 137' ' ' GLU . 7.0 pt-20 -73.25 88.75 1.52 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.79 -1.096 . . . . 65.13 111.033 175.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -143.29 25.09 1.74 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.506 -1.224 . . . . 74.42 109.308 173.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . 0.573 HD21 ' HG2' ' C' ' 124' ' ' PRO . 0.3 OUTLIER -100.6 83.29 2.57 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.559 0.744 . . . . 62.21 111.429 -177.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 46.8 t -82.44 -64.94 1.08 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.049 -1.093 . . . . 62.41 108.049 170.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 45.91 -78.94 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 126.182 1.793 . . . . 75.04 113.522 177.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 26.2 pt -66.28 -32.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.299 1.44 . . . . 53.51 112.715 -174.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -80.88 -83.45 0.11 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 119.116 -0.469 . . . . 75.04 110.499 -175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 47.5 72.33 0.26 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.888 0.875 . . . . 63.45 111.77 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 75.39 -61.69 0.47 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.388 1.475 . . . . 75.34 111.276 -175.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -71.71 91.56 1.13 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.025 0.93 . . . . 74.21 110.867 -178.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 65.6 mt -76.48 -31.9 58.03 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 115.026 -0.988 . . . . 64.31 109.929 174.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 40.3 tp -149.93 92.97 4.01 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 108.114 -1.069 . . . . 73.25 108.114 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--N 1.376 1.988 0 C-N-CA 122.961 2.44 . . . . 64.52 111.81 177.898 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 120.904 0.383 . . . . 65.33 110.743 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.15 31.23 4.15 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.599 1.16 . . . . 72.24 109.407 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.97 134.85 54.8 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.531 -0.759 . . . . 74.32 110.232 178.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 76.9 t80 65.93 103.35 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.554 1.159 . . . . 75.24 110.815 -173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -122.21 -47.83 2.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.743 0.817 . . . . 71.12 109.085 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -90.03 167.43 12.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.678 -1.147 . . . . 65.45 111.031 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -116.65 117.85 30.97 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.85 1.26 . . . . 71.33 109.817 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.16 35.01 0.65 Allowed 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 107.962 -1.125 . . . . 74.15 107.962 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -159.87 92.46 1.74 Allowed Pre-proline 0 CA--C 1.547 0.827 0 CA-C-N 114.318 -1.31 . . . . 74.23 107.951 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.58 -59.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.79 2.327 . . . . 73.31 111.729 -178.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -159.6 177.56 10.77 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.391 1.077 . . . . 63.54 109.39 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 20.3 p -125.27 -171.04 2.28 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.354 1.061 . . . . 72.32 109.492 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . 0.516 ' NE1' ' HA ' ' F' ' 123' ' ' VAL . 21.3 t-105 -59.03 127.91 34.59 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 123.377 0.671 . . . . 73.12 111.896 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -120.01 160.91 21.86 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.025 0.93 . . . . 62.45 109.511 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . 76.9 -60.55 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 125.571 1.549 . . . . 34.12 111.353 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.516 ' HA ' ' NE1' ' F' ' 120' ' ' TRP . 40.1 t 72.48 -76.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.419 1.487 . . . . 71.1 111.343 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? 58.39 63.38 1.73 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.929 0.891 . . . . 73.1 109.985 -176.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.37 78.11 8.18 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.256 -1.338 . . . . 70.44 109.344 -175.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -76.76 117.49 18.43 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.413 -0.812 . . . . 61.53 109.501 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 163.92 110.01 0.23 Allowed Glycine 0 C--N 1.337 0.63 0 N-CA-C 110.843 -0.903 . . . . 70.41 110.843 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -75.41 -34.35 61.03 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.329 0.652 . . . . 75.42 109.5 175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 61.05 -175.76 0.12 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.651 1.18 . . . . 72.45 110.815 -170.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 55.7 mt 60.3 73.78 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 C-N-CA 124.313 1.045 . . . . 64.1 110.369 174.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.3 -62.1 1.79 Allowed 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 115.242 -0.89 . . . . 71.14 110.112 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -141.08 102.45 6.22 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.424 -1.324 . . . . 75.42 107.424 170.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -87.33 172.27 6.07 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.536 2.157 . . . . 73.21 111.973 175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 18.0 tt -110.95 128.36 67.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.65 0 N-CA-C 106.7 -1.593 . . . . 74.13 106.7 163.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.7 72.87 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.631 0.772 . . . . 70.34 111.995 -171.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 14.3 m 49.17 171.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 C-N-CA 126.523 1.929 . . . . 71.03 114.553 -177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -179.57 -76.9 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.715 1.206 . . . . 74.34 108.693 174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -160.02 133.56 7.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.918 0.887 . . . . 73.31 109.343 -175.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.758 HD12 ' HB2' ' D' ' 126' ' ' LEU . 48.4 mt -66.86 101.34 0.82 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.95 0.9 . . . . 34.44 110.69 -178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 57.9 p -66.15 -32.56 74.07 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.165 0.986 . . . . 64.54 111.126 178.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 81.9 mt -81.96 116.46 21.6 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.076 -0.966 . . . . 74.02 109.924 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -172.62 -43.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.561 1.544 . . . . 74.35 108.074 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' F' ' 146' ' ' ASP . 64.4 m-85 -136.9 -58.17 0.72 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.653 1.581 . . . . 65.45 107.165 174.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 67.14 -66.49 0.19 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 126.07 1.748 . . . . 71.51 112.24 177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . 0.419 ' HA ' ' HE2' ' F' ' 145' ' ' LYS . 0.5 OUTLIER -73.36 78.49 1.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.711 0.804 . . . . 41.44 109.23 173.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' F' ' 143' ' ' TYR . 18.6 m-20 66.28 156.76 0.1 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.196 1.398 . . . . 51.13 112.357 -173.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . 0.464 HD11 ' HG3' ' B' ' 12' ' ' GLN . 68.0 mt -90.06 -26.32 20.34 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.714 -0.675 . . . . 70.31 110.908 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . 0.622 ' H ' ' HD2' ' F' ' 149' ' ' PRO . 1.8 tt -157.94 -51.91 0.01 OUTLIER Pre-proline 0 CA--C 1.576 1.962 0 CA-C-O 117.865 -1.064 . . . . 73.33 110.851 -175.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . 0.622 ' HD2' ' H ' ' F' ' 148' ' ' LEU . 19.8 Cg_endo . . . . . 0 C--N 1.407 3.623 0 C-N-CA 122.901 2.401 . . . . 74.34 113.441 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 108.424 -0.954 . . . . 64.33 108.424 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.9 m -85.71 71.47 10.69 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.623 0.769 . . . . 45.01 109.948 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -107.24 -69.36 0.84 Allowed 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.297 0.639 . . . . 50.31 110.943 -173.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.32 78.06 3.84 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-O 122.571 1.177 . . . . 71.35 110.028 179.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -166.47 156.9 12.25 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 113.897 -1.502 . . . . 75.25 107.889 -174.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 7.2 t30 70.41 -75.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 124.619 1.168 . . . . 71.42 111.201 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 m -71.19 91.92 0.97 Allowed 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.13 -0.692 . . . . 73.54 109.13 178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -168.69 -67.38 0.02 OUTLIER 'General case' 0 C--O 1.243 0.717 0 CA-C-N 115.086 -0.961 . . . . 74.11 108.66 -170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.423 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.5 OUTLIER 60.66 177.09 0.1 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.506 1.122 . . . . 74.43 111.572 -174.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 29.1 m -153.39 124.18 7.3 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 108.809 -0.811 . . . . 75.13 108.809 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.01 114.0 9.36 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.401 -1.703 . . . . 74.31 106.401 159.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -138.78 121.07 15.9 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 109.335 -0.617 . . . . 70.43 109.335 -174.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.448 HD12 ' HG2' ' C' ' 130' ' ' PRO . 25.0 pt -73.98 111.77 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 123.754 0.822 . . . . 64.55 109.036 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -96.39 -43.32 7.71 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 109.764 -0.458 . . . . 64.21 109.764 -174.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 mtt180 -155.95 140.43 16.81 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.139 0.976 . . . . 64.31 108.865 175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.555 HG23 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -128.72 112.53 26.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.856 0 N-CA-C 106.122 -1.807 . . . . 63.33 106.122 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.42 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 28.8 p90 -157.64 169.14 25.33 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.252 0.548 . . . . 72.15 111.817 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.3 p -89.4 121.77 31.97 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.797 -0.816 . . . . 74.33 108.797 175.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 31.7 mtpt -87.51 -36.0 17.87 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.217 0.532 . . . . 71.33 109.751 175.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -146.83 140.44 25.77 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.108 -0.951 . . . . 55.22 108.639 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.5 mt -132.62 146.58 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 124.314 1.046 . . . . 73.43 108.671 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 72.2 m -146.1 124.96 12.66 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 124.182 0.993 . . . . 73.11 109.229 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 83.3 t80 -123.91 126.89 47.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 106.192 -1.781 . . . . 75.01 106.192 165.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -134.73 108.36 7.95 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.994 -0.743 . . . . 70.23 108.994 -174.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -124.72 82.42 59.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 123.975 0.91 . . . . 53.34 108.796 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -72.2 -22.22 22.57 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.591 2.194 . . . . 72.14 111.576 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 89.3 m-20 -114.34 33.72 5.13 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 124.112 0.965 . . . . 75.43 109.953 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.48 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -59.37 -46.57 98.99 Favored Pre-proline 0 CA--C 1.566 1.563 0 C-N-CA 123.827 0.851 . . . . 74.45 112.491 178.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD2' ' HD2' ' A' ' 30' ' ' HIS . 7.7 Cg_exo -74.81 -28.91 9.12 Favored 'Trans proline' 0 C--N 1.393 2.899 0 C-N-CA 121.937 1.758 . . . . 64.11 112.747 172.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 8.2 m-70 -68.93 -28.22 66.46 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.543 0.737 . . . . 55.0 111.34 -172.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.53 HG11 ' HE1' ' A' ' 123' ' ' PHE . 9.4 p -63.96 -27.0 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 123.478 0.711 . . . . 63.23 111.587 -176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -68.12 -30.67 69.87 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.746 0.818 . . . . 72.33 110.583 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -75.89 -46.08 32.0 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.519 -0.764 . . . . 73.13 109.965 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HB3' HD11 ' A' ' 68' ' ' LEU . 41.3 mtpt -81.73 157.37 24.58 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.676 -1.147 . . . . 62.43 110.66 -173.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -64.44 135.36 56.01 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 122.552 0.341 . . . . 60.12 111.008 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -84.29 64.88 8.56 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 122.111 0.958 . . . . 73.21 109.529 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -132.0 66.59 77.94 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.065 1.346 . . . . 63.13 108.01 173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -87.54 156.04 7.78 Favored 'Trans proline' 0 C--N 1.381 2.26 0 C-N-CA 122.053 1.835 . . . . 71.23 112.389 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.581 ' HG3' ' HE2' ' F' ' 128' ' ' LYS . 34.4 tt0 -96.34 124.22 40.26 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.509 -0.923 . . . . 54.24 108.509 177.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.555 HG11 HD11 ' F' ' 129' ' ' LEU . 9.1 t -90.59 99.59 9.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 123.825 0.85 . . . . 51.35 109.656 -174.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 90.2 mttt -95.55 142.28 28.07 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.544 0.737 . . . . 71.45 110.424 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.06 112.28 12.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 115.458 -0.792 . . . . 70.44 109.795 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -115.32 113.55 23.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.231 1.012 . . . . 75.13 108.698 175.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -114.07 155.8 25.3 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 121.446 0.641 . . . . 41.4 111.449 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 15.8 t70 -149.16 154.95 39.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.839 1.256 . . . . 54.34 109.059 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 45.2 m -133.41 132.82 41.61 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.809 0.844 . . . . 63.22 109.201 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.06 130.31 41.14 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.676 0.79 . . . . 62.51 109.681 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 p -88.65 155.27 19.71 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.299 0.64 . . . . 74.35 110.464 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.3 t -149.53 119.06 6.92 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.272 -1.01 . . . . 75.31 108.272 -176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -91.87 107.88 19.53 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.785 -0.82 . . . . 64.45 108.785 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 59.5 mt -89.32 -27.98 20.16 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.863 -0.608 . . . . 74.01 110.659 -178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -168.94 -174.03 1.96 Allowed 'General case' 0 C--O 1.242 0.669 0 CA-C-N 114.868 -1.06 . . . . 42.42 110.205 -176.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -72.5 128.43 35.57 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.339 -0.846 . . . . 54.14 109.68 170.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 62.04 18.18 9.72 Favored 'General case' 0 N--CA 1.48 1.029 0 O-C-N 124.582 1.176 . . . . 72.11 111.813 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.0 t -126.0 107.31 17.35 Favored 'Isoleucine or valine' 0 C--O 1.245 0.848 0 C-N-CA 124.482 1.113 . . . . 64.13 108.057 176.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -125.97 124.48 40.84 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.786 0.834 . . . . 75.24 108.996 -178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -104.95 124.43 49.5 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 125.4 1.48 . . . . 62.12 108.666 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 m -107.38 134.97 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 N-CA-C 108.187 -1.042 . . . . 73.0 108.187 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.584 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 42.6 t -106.6 125.33 62.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 CA-C-N 115.048 -0.978 . . . . 61.44 108.387 178.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.39 107.53 19.92 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 106.45 -1.685 . . . . 73.35 106.45 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 5.3 ttp180 -94.46 97.08 9.92 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.11 -1.441 . . . . 60.13 107.11 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 t -100.8 132.57 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.9 m -126.29 126.7 44.4 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.381 -0.97 . . . . 73.34 108.381 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.479 HG23 HD13 ' A' ' 114' ' ' ILE . 89.8 t -120.78 129.69 75.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 N-CA-C 107.3 -1.371 . . . . 71.34 107.3 -177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 34.5 m -125.51 137.61 53.95 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.036 -0.727 . . . . 71.14 109.036 -172.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.18 105.8 10.92 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 106.948 -1.501 . . . . 63.25 106.948 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.1 m -130.71 125.9 35.09 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 108.621 -0.881 . . . . 63.24 108.621 176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 68' ' ' LEU . 1.3 pt? -91.07 84.25 5.69 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.992 -1.114 . . . . 64.21 107.992 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.85 -124.25 7.04 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 114.724 -1.125 . . . . 62.12 110.639 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -88.86 -26.9 21.39 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.801 0.841 . . . . 61.54 111.819 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -96.25 133.16 40.93 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.58 0.352 . . . . 74.02 110.63 -176.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.7 m -80.33 126.92 31.76 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.976 0.91 . . . . 70.35 110.844 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.75 -51.46 12.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.001 0.92 . . . . 65.31 109.189 175.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -161.95 168.3 23.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.148 0.979 . . . . 71.25 110.061 173.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.435 HD12 ' H ' ' A' ' 76' ' ' CYS . 40.6 tp -138.11 149.11 45.63 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.66 1.184 . . . . 72.22 109.221 -175.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.435 ' H ' HD12 ' A' ' 75' ' ' LEU . 63.7 m -139.66 140.34 36.88 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.068 1.347 . . . . 74.3 108.947 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -147.37 132.63 18.45 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.71 0.804 . . . . 74.01 108.839 170.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 28.2 t -135.76 112.86 13.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 108.805 -0.813 . . . . 64.12 108.805 178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -85.23 80.58 9.14 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.765 -1.107 . . . . 75.33 108.399 174.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -76.76 92.71 3.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.808 -1.087 . . . . 65.21 109.129 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -93.33 144.74 17.24 Favored Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.664 -0.574 . . . . 71.41 111.664 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.55 127.55 3.81 Favored Glycine 0 CA--C 1.503 -0.684 0 N-CA-C 111.752 -0.539 . . . . 74.45 111.752 -176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 57.7 mt -80.39 126.18 39.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 107.975 -1.12 . . . . 72.32 107.975 174.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -135.15 121.48 20.34 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 109.221 -0.659 . . . . 75.54 109.221 178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.3 t -81.09 110.77 16.92 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 108.932 -0.766 . . . . 74.01 108.932 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 46.2 pt -123.36 144.21 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.142 0.577 . . . . 72.31 110.684 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.4 162.75 22.31 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.196 0.998 . . . . 64.12 109.779 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 78.17 -6.83 48.47 Favored Glycine 0 N--CA 1.475 1.265 0 CA-C-N 115.99 -0.55 . . . . 74.24 114.47 173.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.93 155.86 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 124.461 1.104 . . . . 71.13 109.288 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -164.28 174.61 10.94 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.355 -0.609 . . . . 72.53 109.355 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.14 -125.17 29.37 Favored Glycine 0 C--N 1.338 0.659 0 CA-C-N 116.112 -0.494 . . . . 63.43 112.75 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 39.5 p -73.16 -18.78 61.23 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.804 0.842 . . . . 71.32 111.945 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -70.71 -50.75 32.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.607 0.763 . . . . 72.32 109.59 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -75.23 -29.85 60.38 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.423 -0.808 . . . . 74.14 110.441 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.97 -44.08 97.5 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.143 0.577 . . . . 71.53 110.042 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.08 -49.52 77.34 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-N 115.518 -0.765 . . . . 73.55 110.688 173.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.625 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 34.3 m -69.17 -59.78 2.79 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.973 0.731 . . . . 74.54 112.973 -171.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 53.9 mt -74.75 -14.95 60.78 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 112.142 0.423 . . . . 63.3 112.142 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.42 -18.42 30.84 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.862 -0.41 . . . . 43.42 113.817 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.59 -69.17 0.44 Allowed 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 117.492 0.646 . . . . 74.01 111.998 -175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.625 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 8.6 t80 -44.12 -57.89 3.15 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 125.1 1.36 . . . . 72.41 112.788 -174.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.3 m -74.7 -47.99 5.1 Favored Pre-proline 0 CA--C 1.559 1.325 0 CA-C-O 117.856 -1.069 . . . . 75.11 113.077 -171.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HA ' HD12 ' A' ' 106' ' ' LEU . 22.0 Cg_endo -62.63 -21.45 72.93 Favored 'Trans proline' 0 C--N 1.397 3.112 0 CA-C-N 121.739 1.657 . . . . 42.55 113.398 170.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -80.06 -26.89 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.085 0.554 . . . . 65.2 110.213 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.4 ' O ' ' HD2' ' A' ' 108' ' ' PRO . 33.4 mm -67.74 -41.46 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.356 0.598 . . . . 64.13 109.526 167.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.555 HD23 HG23 ' A' ' 16' ' ' ILE . 68.8 mt -71.46 -25.68 62.4 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.015 -0.993 . . . . 72.22 111.315 -175.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -65.05 -43.4 67.11 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 117.709 -1.139 . . . . 72.53 114.005 -170.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 105' ' ' ILE . 77.9 Cg_exo -55.47 -39.89 88.56 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.336 2.024 . . . . 71.43 113.633 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -77.08 -32.7 56.9 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.477 0.711 . . . . 72.52 111.871 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.18 -46.68 70.03 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.343 -0.614 . . . . 44.22 109.343 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.499 ' NH1' HD12 ' C' ' 105' ' ' ILE . 35.4 ttm180 -53.5 -49.72 66.93 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.881 1.363 . . . . 75.0 110.443 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.61 -49.65 75.74 Favored 'General case' 0 C--N 1.345 0.396 0 O-C-N 124.434 1.084 . . . . 75.1 110.849 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 117' ' ' MET . 42.2 t -61.2 -40.42 93.89 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 124.139 0.899 . . . . 71.54 111.584 -177.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.479 HD13 HG23 ' A' ' 64' ' ' VAL . 80.1 mt -65.31 -59.22 4.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 123.832 0.707 . . . . 74.32 110.061 176.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.0 m -55.54 -33.29 63.69 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.516 1.135 . . . . 74.43 111.533 -175.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.9 t -71.67 -43.63 65.68 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.42 -0.809 . . . . 72.03 110.545 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.462 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 49.9 mtm -59.29 -41.71 89.61 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 118.146 0.43 . . . . 75.12 110.756 175.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.5 t -57.16 -50.31 76.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.943 0 CA-C-N 114.526 -1.216 . . . . 61.13 110.422 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 78.3 p -74.48 -23.31 58.85 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 122.971 0.508 . . . . 70.23 111.692 -176.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 86.8 mtt-85 -74.46 -28.36 61.0 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.438 0.695 . . . . 74.25 109.609 173.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.97 8.07 71.85 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 115.537 -0.756 . . . . 53.41 112.497 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.626 HG22 ' HB3' ' B' ' 17' ' ' TYR . 7.1 t 48.13 43.74 18.69 Favored 'General case' 0 CA--C 1.56 1.328 0 C-N-CA 126.693 1.997 . . . . 51.53 112.771 179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.53 ' HE1' HG11 ' A' ' 31' ' ' VAL . 83.0 m-85 -99.1 158.54 32.11 Favored Pre-proline 0 CA--C 1.552 1.038 0 CA-C-N 114.749 -1.114 . . . . 61.31 108.657 171.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.62 149.86 64.81 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.602 2.201 . . . . 74.14 111.884 175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -69.67 134.46 48.72 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.361 0.664 . . . . 63.32 111.704 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.11 112.19 23.4 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.544 -0.91 . . . . 71.23 108.544 172.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.487 HD21 ' HA ' ' C' ' 15' ' ' ARG . 80.5 m-20 -98.47 100.55 11.82 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.421 0.688 . . . . 74.34 109.531 -177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.506 ' HA ' HD22 ' F' ' 129' ' ' LEU . 7.6 mp -56.06 120.98 8.35 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.144 0.978 . . . . 70.24 110.05 -178.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.24 125.58 85.88 Favored Pre-proline 0 C--O 1.242 0.695 0 O-C-N 123.56 0.537 . . . . 43.51 109.662 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -71.47 104.78 1.63 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 121.866 1.711 . . . . 75.35 111.692 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 89.9 t -99.93 110.76 27.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.618 -1.253 . . . . 72.51 107.618 174.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.404 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 11.4 t30 -79.86 90.93 5.31 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.613 -1.255 . . . . 71.52 107.613 176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -57.06 -31.35 65.12 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.938 -1.028 . . . . 75.31 111.166 -178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.404 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . 4.7 m-20 -52.11 -38.69 58.22 Favored 'General case' 0 C--O 1.217 -0.616 0 C-N-CA 125.121 1.368 . . . . 71.11 112.232 177.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.73 78.52 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 123.923 0.764 . . . . 72.42 111.888 -177.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 18.8 tp -75.02 -39.4 61.12 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 109.576 -0.527 . . . . 55.2 109.576 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -67.12 -29.06 68.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.542 0.737 . . . . 70.33 111.688 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.7 mmt -62.41 -51.72 66.41 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 109.246 -0.65 . . . . 73.45 109.246 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -53.68 -30.08 41.74 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.246 0.966 . . . . 71.42 111.688 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -82.17 -46.77 13.34 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.907 0.883 . . . . 71.45 111.155 176.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 44.3 tp -69.7 -52.93 21.22 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 113.231 0.826 . . . . 74.41 113.231 -167.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -170.14 29.38 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.369 0.604 . . . . 75.44 109.686 -171.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.52 ' HG3' ' H ' ' A' ' 144' ' ' GLN . 5.6 tp60 61.38 -151.49 0.39 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.357 1.063 . . . . 72.53 108.41 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.52 ' H ' ' HG3' ' A' ' 143' ' ' GLN . 41.1 mt-30 -74.86 73.02 2.1 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 119.991 1.268 . . . . 74.42 110.565 -178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . 172.66 162.75 0.12 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.382 1.873 . . . . 33.31 107.7 -173.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 149.03 -43.44 0.78 Allowed Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.914 -0.13 . . . . 13.04 113.118 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -82.62 170.72 14.84 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.25 0.62 . . . . 45.21 111.767 -174.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.9 67.13 0.03 OUTLIER Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.92 -0.872 . . . . 72.04 110.92 -178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.9 p -130.61 19.91 5.15 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.239 1.016 . . . . 74.12 110.923 -175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.21 62.19 5.81 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-O 122.401 1.096 . . . . 70.55 110.906 -177.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -151.74 106.14 3.2 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.41 -0.959 . . . . 74.4 108.41 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -133.16 155.38 49.41 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.583 0.753 . . . . 74.14 111.069 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.36 148.3 27.96 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.831 1.253 . . . . 60.53 108.453 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 66.19 92.08 0.08 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.767 1.227 . . . . 43.44 110.907 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 C-N-CA 123.945 0.898 . . . . 52.44 108.85 179.436 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.788 0.327 . . . . 64.42 110.354 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -161.25 95.68 1.05 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.168 -1.049 . . . . 72.31 108.168 175.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -77.23 77.7 3.76 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.451 0.701 . . . . 74.15 110.638 -173.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -158.76 15.96 0.19 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.957 0.903 . . . . 74.44 111.322 -176.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -108.53 -177.27 3.27 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.857 0.863 . . . . 64.1 109.659 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.706 ' HA ' HE22 ' B' ' 93' ' ' GLN . 3.7 p-10 -102.13 166.28 10.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.094 0.558 . . . . 60.33 111.212 -177.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.656 HG21 ' HA ' ' B' ' 89' ' ' ILE . 8.6 t -164.58 152.4 11.98 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.289 1.036 . . . . 54.12 109.947 177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -88.85 -13.33 39.52 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.877 0.871 . . . . 72.14 110.305 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.442 ' SD ' HD12 ' B' ' 89' ' ' ILE . 17.1 ptm 53.55 -171.89 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 126.664 1.986 . . . . 54.34 114.262 175.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.2 m -138.75 103.62 4.88 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 107.633 -1.247 . . . . 61.24 107.633 174.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -110.72 146.58 36.05 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.441 0.696 . . . . 74.44 109.462 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 49.4 tt0 -164.54 141.4 6.29 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.285 0.634 . . . . 55.13 110.333 177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -95.27 131.28 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 108.759 -0.83 . . . . 74.23 108.759 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -101.15 -50.83 3.68 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 110.15 -0.315 . . . . 63.42 110.15 171.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -157.43 140.93 15.65 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 116.514 -0.312 . . . . 70.2 110.183 -171.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 88.6 mt -123.16 134.68 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 N-CA-C 106.867 -1.531 . . . . 75.43 106.867 173.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.626 ' HB3' HG22 ' A' ' 122' ' ' THR . 9.2 p90 -166.97 147.12 5.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.428 0.899 . . . . 43.23 113.428 -172.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 58.2 m -73.68 122.04 21.69 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.059 -1.428 . . . . 63.05 108.837 169.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.412 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 44.9 mtpt -97.46 -29.05 13.71 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.669 0.788 . . . . 75.34 110.674 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 24.4 t70 -157.13 141.6 16.58 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.389 -0.369 . . . . 71.23 110.787 -169.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.429 HD12 HG22 ' B' ' 78' ' ' VAL . 47.0 mm -138.48 144.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.719 1.208 . . . . 72.42 109.366 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.562 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -136.98 138.44 40.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.948 1.299 . . . . 63.33 108.422 167.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -142.85 131.46 22.5 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 106.064 -1.828 . . . . 72.41 106.064 164.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.5 mt-10 -131.48 136.42 47.91 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 108.739 -0.837 . . . . 74.31 108.739 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -131.4 80.37 67.71 Favored Pre-proline 0 C--O 1.239 0.52 0 N-CA-C 107.223 -1.399 . . . . 61.21 107.223 170.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.21 -33.48 60.1 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 122.527 2.151 . . . . 52.33 110.779 -176.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.448 ' O ' HG23 ' B' ' 31' ' ' VAL . 83.4 m-20 -118.77 24.29 10.95 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.581 1.152 . . . . 74.1 110.0 -176.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -38.14 -56.18 2.11 Favored Pre-proline 0 CA--C 1.567 1.604 0 N-CA-C 115.053 1.501 . . . . 55.01 115.053 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 2.8 Cg_endo -82.21 -6.63 12.04 Favored 'Trans proline' 0 C--N 1.386 2.552 0 C-N-CA 122.338 2.026 . . . . 40.24 113.332 -176.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.443 ' HA ' HE22 ' B' ' 33' ' ' GLN . 72.2 m80 -96.82 -24.22 16.0 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.696 0.798 . . . . 72.43 111.572 179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' B' ' 73' ' ' ALA . 59.8 t -82.3 -6.66 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 C-N-CA 123.584 0.754 . . . . 70.15 110.085 173.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -54.66 -43.27 72.26 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.277 1.031 . . . . 73.41 111.155 172.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.443 HE22 ' HA ' ' B' ' 30' ' ' HIS . 0.8 OUTLIER -72.81 -32.83 65.8 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.543 0.737 . . . . 74.14 110.151 -178.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -78.18 85.16 4.37 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.1 -0.955 . . . . 55.45 110.426 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -82.54 77.41 9.31 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 121.746 0.784 . . . . 71.33 108.967 175.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.474 ' HB2' HD21 ' B' ' 68' ' ' LEU . 5.9 m-90 -151.88 158.0 42.62 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.387 1.475 . . . . 73.12 108.294 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.94 113.74 45.33 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 108.151 -1.055 . . . . 64.32 108.151 172.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.585 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 56.7 Cg_endo -68.43 160.74 47.86 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.402 2.068 . . . . 73.4 112.572 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 24.0 tt0 -60.27 103.73 0.26 Allowed 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.072 0.858 . . . . 71.35 110.046 175.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 33.6 m -87.13 135.41 25.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 N-CA-C 109.064 -0.717 . . . . 62.11 109.064 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -142.41 134.99 28.08 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.871 -0.788 . . . . 72.11 108.871 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -107.23 123.49 48.37 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.751 -1.203 . . . . 74.11 107.751 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.628 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 8.8 m-20 -122.9 111.49 16.71 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 107.671 -1.233 . . . . 71.51 107.671 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.603 HD21 HG11 ' B' ' 131' ' ' VAL . 7.5 mp -100.31 143.3 30.66 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.365 0.666 . . . . 60.43 110.178 -172.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.9 t70 -147.59 147.12 29.73 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.524 1.13 . . . . 65.43 108.129 177.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 50.7 p -132.53 124.56 28.72 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 123.311 0.644 . . . . 72.14 109.815 -177.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -117.64 154.87 30.87 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.175 0.99 . . . . 40.33 108.49 173.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 47.1 p -145.46 161.18 40.33 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 123.236 0.614 . . . . 72.23 110.085 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 55.4 p -169.08 159.96 9.52 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.03 0.932 . . . . 74.2 109.482 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -118.08 134.98 54.48 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.06 0.544 . . . . 61.01 109.806 177.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 62.8 mt -96.31 -49.18 5.3 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.86 0.864 . . . . 74.21 110.695 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.63 -172.8 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.331 -0.85 . . . . 54.0 110.376 -173.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.55 107.62 1.77 Allowed 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.36 1.037 . . . . 73.11 110.789 -177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' B' ' 85' ' ' SER . 21.3 m-20 77.82 1.07 2.85 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 126.516 1.926 . . . . 62.2 111.3 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.57 88.5 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.37 0 N-CA-C 107.341 -1.355 . . . . 74.52 107.341 -176.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -95.75 165.69 12.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 108.604 -0.888 . . . . 71.33 108.604 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -141.81 113.74 7.98 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.754 -1.202 . . . . 73.33 107.754 -174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 57.9 t -109.09 127.02 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.39 0.676 . . . . 64.24 109.745 -178.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 27.9 t -103.27 131.99 50.51 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.926 0.89 . . . . 71.32 109.308 176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -116.21 112.04 21.05 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 107.401 -1.333 . . . . 73.52 107.401 178.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 28.7 ttm180 -100.02 121.95 42.16 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 109.853 -0.425 . . . . 75.4 109.853 173.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' B' ' 114' ' ' ILE . 17.4 t -117.22 133.64 63.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.477 -1.305 . . . . 71.41 107.477 168.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.628 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 6.4 m -119.09 134.35 55.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.063 -0.717 . . . . 63.43 109.063 177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.569 HG23 HD13 ' B' ' 114' ' ' ILE . 63.7 t -117.15 104.8 17.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 123.91 0.884 . . . . 73.0 108.839 175.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 91.0 m -97.48 140.85 31.3 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.121 -1.399 . . . . 75.0 108.871 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -141.5 134.22 28.65 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.327 0.392 . . . . 43.13 110.359 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 68.7 p -140.36 135.83 32.54 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.31 0.644 . . . . 72.14 109.312 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' B' ' 38' ' ' PRO . 17.1 tp -136.55 124.0 22.11 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 123.227 0.611 . . . . 74.23 109.486 -175.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.1 -116.85 4.47 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 115.656 -0.702 . . . . 64.42 111.505 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -118.81 19.75 13.03 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.352 1.061 . . . . 73.32 109.693 -177.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -156.23 176.63 12.43 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.895 0.478 . . . . 74.12 111.038 -170.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 29.0 m -72.58 141.93 48.4 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.618 0.767 . . . . 73.34 110.563 175.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.67 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -94.32 -59.24 2.0 Allowed 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.038 -0.727 . . . . 42.12 109.038 174.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -157.89 168.76 26.25 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.871 -1.059 . . . . 73.52 109.886 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.506 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 78.8 mt -141.04 140.69 34.3 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.37 1.468 . . . . 63.21 107.251 -178.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 45.8 t -148.99 155.47 40.85 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.877 -0.786 . . . . 75.31 108.877 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.6 tt0 -164.49 138.47 5.27 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.899 -0.778 . . . . 74.21 108.899 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.429 HG22 HD12 ' B' ' 21' ' ' ILE . 92.4 t -134.54 145.99 31.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.93 0.892 . . . . 65.22 109.098 177.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.497 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 22.5 mt-30 -122.08 94.15 4.21 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.289 -1.004 . . . . 73.33 108.289 170.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.417 ' O ' HD13 ' B' ' 106' ' ' LEU . 7.8 tp-100 -84.54 101.15 11.86 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.731 -0.84 . . . . 73.33 108.731 175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.53 165.83 31.33 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 111.27 -0.732 . . . . 60.44 111.27 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.66 133.73 3.54 Favored Glycine 0 CA--C 1.518 0.221 0 N-CA-C 112.325 -0.31 . . . . 71.33 112.325 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.479 HG13 ' HE1' ' B' ' 17' ' ' TYR . 63.6 mt -86.32 123.39 39.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.875 -0.787 . . . . 71.42 108.875 171.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -132.28 135.24 46.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.627 1.171 . . . . 75.12 109.077 -174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.568 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 53.5 m -101.81 106.35 17.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.81 0.844 . . . . 71.22 109.009 173.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.613 HG12 HD21 ' E' ' 115' ' ' LEU . 0.2 OUTLIER -126.03 131.94 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.881 0.873 . . . . 74.35 109.417 -179.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.91 160.6 40.28 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.136 0.974 . . . . 73.31 109.022 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.18 -29.09 3.98 Favored Glycine 0 N--CA 1.473 1.118 0 N-CA-C 114.281 0.472 . . . . 65.4 114.281 176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.656 ' HA ' HG21 ' B' ' 7' ' ' THR . 16.0 tt -83.03 152.35 3.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 C-N-CA 123.975 0.91 . . . . 51.41 110.352 -176.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -158.89 166.07 32.7 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 121.172 0.511 . . . . 72.3 112.008 -174.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.63 -134.82 30.53 Favored Glycine 0 C--N 1.35 1.327 0 CA-C-N 114.761 -1.109 . . . . 40.41 113.848 174.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 47.4 m -65.04 -33.81 76.92 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.97 0.908 . . . . 72.24 110.611 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.706 HE22 ' HA ' ' B' ' 6' ' ' ASN . 78.3 mt-30 -61.54 -51.98 66.35 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.109 -0.951 . . . . 72.31 110.381 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 10.4 tmm? -62.6 -41.06 98.74 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.805 0.842 . . . . 54.32 111.388 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.8 81.4 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 124.007 0.817 . . . . 73.45 112.09 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 14.4 p-80 -95.99 -12.32 25.17 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 122.539 0.336 . . . . 64.44 111.339 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.7 t -80.38 -65.02 1.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 109.659 -0.497 . . . . 74.21 109.659 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.423 HD23 ' HB2' ' E' ' 116' ' ' TYR . 20.6 tp -75.89 -28.31 58.04 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.085 -0.507 . . . . 63.34 110.468 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.2 -34.06 18.6 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.754 -0.657 . . . . 50.03 114.294 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.86 -41.3 2.12 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 118.05 0.925 . . . . 65.21 113.075 -171.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -76.94 -39.93 48.96 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 122.803 0.441 . . . . 74.42 111.29 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -66.34 -45.51 59.9 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.698 -0.668 . . . . 74.21 110.782 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.432 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 85.6 Cg_exo -55.73 -35.74 93.85 Favored 'Trans proline' 0 C--N 1.396 3.071 0 C-N-CA 122.49 2.127 . . . . 63.55 113.896 163.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -65.3 -31.3 72.36 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 122.673 0.389 . . . . 55.52 111.425 -178.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 84.7 mt -64.96 -44.51 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 124.078 0.951 . . . . 72.44 110.001 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.417 HD13 ' O ' ' B' ' 80' ' ' GLN . 78.7 mt -75.43 -23.52 56.98 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.853 -1.067 . . . . 75.4 112.37 -173.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -59.87 -48.07 95.76 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 113.936 1.087 . . . . 75.35 113.936 -170.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -56.33 -34.47 94.13 Favored 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 122.153 1.902 . . . . 72.32 113.383 176.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -72.63 -43.82 62.75 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.228 0.611 . . . . 64.25 110.316 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.51 -39.57 80.45 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 123.49 0.716 . . . . 72.25 110.135 174.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.453 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 61.0 ttt180 -56.46 -63.98 1.02 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.749 1.22 . . . . 73.11 111.128 178.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.01 -28.69 69.67 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.112 0.882 . . . . 73.31 110.785 -171.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.511 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.8 t -69.27 -42.77 75.11 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 122.846 0.458 . . . . 40.52 110.843 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.569 HD13 HG23 ' B' ' 64' ' ' VAL . 93.5 mt -62.97 -53.89 40.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 123.204 0.602 . . . . 73.24 110.045 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 6.8 m -59.26 -33.11 70.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 114.508 -1.223 . . . . 70.54 110.796 -173.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.3 t -62.87 -53.66 50.68 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 115.123 -0.944 . . . . 62.32 109.942 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.54 ' HA ' ' HD2' ' B' ' 120' ' ' ARG . 14.4 mmt -60.29 -34.99 74.54 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 123.195 0.598 . . . . 52.41 111.965 -175.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.77 -48.64 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.833 0.853 . . . . 65.13 111.005 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 61.0 p -73.02 -20.25 61.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.915 0.486 . . . . 72.33 111.615 178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.54 ' HD2' ' HA ' ' B' ' 117' ' ' MET . 86.5 mtt-85 -68.18 -37.63 81.16 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 123.392 0.677 . . . . 73.14 109.324 171.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.59 11.88 54.29 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.133 0.895 . . . . 72.24 113.41 177.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 74.8 p 53.14 39.68 30.01 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 125.662 1.585 . . . . 64.43 112.341 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.596 ' HZ ' ' HA ' ' B' ' 28' ' ' ALA . 65.5 m-85 -108.44 159.74 29.67 Favored Pre-proline 0 N--CA 1.484 1.23 0 C-N-CA 124.759 1.224 . . . . 73.4 110.336 176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.44 106.66 0.2 Allowed 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 123.037 2.491 . . . . 51.41 112.483 174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' C' ' 125' ' ' GLN . 12.9 pt20 -50.03 125.26 11.72 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.284 1.434 . . . . 65.44 111.598 178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -111.29 112.97 25.11 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.276 -1.009 . . . . 73.3 108.276 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -90.38 129.73 36.55 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.688 0.795 . . . . 63.41 109.091 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.453 ' H ' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -77.5 107.38 9.91 Favored 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.015 0.926 . . . . 63.13 109.214 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' E' ' 129' ' ' LEU . . . -68.26 152.55 96.45 Favored Pre-proline 0 CA--C 1.554 1.107 0 CA-C-N 115.704 -0.68 . . . . 63.21 109.695 174.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.4 111.21 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.427 2.752 . . . . 73.24 113.034 -174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.603 HG11 HD21 ' B' ' 44' ' ' LEU . 48.5 t -88.65 110.09 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 106.743 -1.577 . . . . 53.15 106.743 168.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -75.64 91.61 2.88 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.022 -1.103 . . . . 73.2 108.022 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.42 ' HB3' ' HZ2' ' E' ' 120' ' ' TRP . 97.7 m-85 -56.09 -42.76 77.25 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.091 0.956 . . . . 72.44 111.25 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -59.07 -54.59 45.31 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.49 -1.232 . . . . 72.32 110.908 178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.2 -28.1 63.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.449 -0.796 . . . . 72.11 112.164 -176.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' E' ' 125' ' ' TYR . 5.6 tt -57.14 -55.21 37.64 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 124.196 0.998 . . . . 71.21 109.595 -176.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -75.24 -28.77 60.01 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 114.686 -1.143 . . . . 72.13 110.587 -176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 51.3 ttm -61.3 -37.52 83.5 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.767 0.827 . . . . 72.34 111.035 175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -75.08 -29.03 60.55 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 115.004 -0.998 . . . . 72.03 110.356 -179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -67.75 -33.08 74.14 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.185 0.594 . . . . 70.02 110.138 174.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 65.7 mt -90.3 35.69 0.87 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 123.802 0.841 . . . . 70.2 111.566 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -67.11 103.39 1.19 Allowed 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 120.985 0.421 . . . . 62.11 110.34 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -148.51 -55.4 0.2 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.526 -0.916 . . . . 71.52 108.526 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -81.13 107.99 14.41 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.65 -0.5 . . . . 74.31 109.65 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -59.63 -29.9 68.34 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.113 0.965 . . . . 23.14 111.077 177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.03 -151.99 24.14 Favored Glycine 0 C--N 1.346 1.119 0 CA-C-N 115.306 -0.861 . . . . 61.2 111.359 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -163.05 159.02 22.79 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 124.006 0.923 . . . . 54.32 109.294 176.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 178.48 125.31 0.92 Allowed Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.584 -0.341 . . . . 42.24 112.356 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 6.6 t -140.45 119.89 13.12 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.448 -0.945 . . . . 74.24 108.448 171.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.09 142.9 32.86 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.414 0.685 . . . . 54.42 110.126 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -72.71 173.17 9.42 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.865 0.866 . . . . 73.34 111.435 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -131.87 144.71 51.07 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.259 -0.645 . . . . 75.02 109.259 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -95.37 174.99 6.75 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.169 0.588 . . . . 60.12 109.855 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -72.62 113.73 9.97 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 108.854 -0.795 . . . . 63.53 108.854 171.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.238 0 C-N-CA 123.679 0.792 . . . . 74.45 111.084 -171.551 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.476 0.857 0 N-CA-C 108.884 -0.784 . . . . 74.54 108.884 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p -160.5 84.98 0.71 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.176 0.991 . . . . 73.23 109.166 -177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.23 126.47 6.59 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 108.504 -0.925 . . . . 62.23 108.504 -177.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -173.28 -56.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 107.657 -1.238 . . . . 73.43 107.657 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -95.83 177.76 5.67 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 114.838 -1.073 . . . . 63.04 110.428 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -78.73 107.72 11.64 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 115.314 -0.857 . . . . 74.45 108.924 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -66.94 -25.78 66.52 Favored 'General case' 0 CA--C 1.553 1.08 0 O-C-N 123.956 0.785 . . . . 74.44 110.214 173.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.41 ' HA ' ' HA3' ' C' ' 146' ' ' GLY . 36.8 tt0 61.86 117.86 0.02 OUTLIER 'General case' 0 C--N 1.361 1.071 0 C-N-CA 126.43 1.892 . . . . 75.14 112.976 175.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 38.2 ttm 64.32 114.24 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.502 1.121 . . . . 52.31 111.798 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 55.5 m -85.78 85.93 7.38 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.879 -0.786 . . . . 72.41 108.879 173.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.405 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 49.2 t80 -105.17 121.49 43.93 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 114.389 -1.278 . . . . 73.31 108.093 177.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.23 137.2 38.83 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.367 -0.605 . . . . 64.3 109.367 172.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 49.5 mt -81.29 121.51 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-N 115.105 -0.952 . . . . 74.0 109.241 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -89.47 -49.6 6.59 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.194 0.598 . . . . 72.43 109.965 -179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.487 ' HA ' HD21 ' A' ' 127' ' ' ASN . 53.2 ttt180 -164.01 122.69 1.91 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.61 0.364 . . . . 72.24 110.538 -176.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 85.3 mt -108.62 136.33 44.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.468 -0.938 . . . . 71.44 108.468 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 36.0 p90 -169.07 165.65 11.17 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 122.108 0.956 . . . . 74.43 112.855 -177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -87.01 111.73 21.15 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.732 -1.576 . . . . 65.43 108.838 173.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.436 ' HD3' ' HE2' ' C' ' 17' ' ' TYR . 57.9 mmtt -65.29 -48.46 73.09 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.389 1.09 . . . . 74.13 108.49 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 20.6 t70 -134.62 140.4 46.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 113.133 -1.848 . . . . 70.34 109.207 -170.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.6 mt -137.13 143.45 34.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.074 -1.454 . . . . 64.41 107.074 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -160.63 151.04 18.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.389 0.614 . . . . 45.12 109.86 176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -152.72 115.22 4.49 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.282 -1.377 . . . . 72.21 107.282 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -116.08 109.14 17.09 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.304 -0.628 . . . . 74.44 109.304 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.15 85.28 15.12 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 124.382 1.073 . . . . 64.31 108.113 168.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -68.11 -35.23 20.29 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 121.927 1.751 . . . . 35.33 110.382 173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 77.7 m-20 -98.55 30.58 3.19 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.712 1.205 . . . . 75.43 110.29 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.16 -45.15 99.96 Favored Pre-proline 0 CA--C 1.57 1.727 0 C-N-CA 124.558 1.143 . . . . 62.52 112.591 176.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -85.35 -18.37 4.07 Favored 'Trans proline' 0 C--N 1.393 2.889 0 C-N-CA 122.169 1.913 . . . . 73.32 113.189 173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.434 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 9.7 t-80 -69.75 -41.33 75.36 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.447 0.699 . . . . 73.44 110.529 -176.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.695 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . 8.1 p -66.63 -16.25 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.553 1.141 . . . . 75.31 112.311 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.403 ' HA ' HG12 ' E' ' 134' ' ' ILE . 57.5 t80 -62.36 -37.19 84.74 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 125.087 1.355 . . . . 72.24 112.059 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -118.77 24.93 10.57 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-O 121.826 0.822 . . . . 72.54 109.398 179.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.695 ' HE3' ' HA ' ' C' ' 31' ' ' VAL . 20.1 ttpp -123.53 176.12 6.38 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.05 0.54 . . . . 51.42 110.675 -170.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' C' ' 37' ' ' GLN . 5.0 p-10 -55.24 120.74 7.5 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.379 1.072 . . . . 71.33 111.203 174.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.0 p90 -90.02 63.31 5.88 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 115.899 -0.592 . . . . 74.43 109.525 169.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' C' ' 35' ' ' ASP . 15.4 pt20 -146.16 64.57 9.99 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-O 121.19 0.519 . . . . 65.14 111.147 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.04 134.12 8.05 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 121.724 1.616 . . . . 64.21 110.648 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -84.52 93.67 8.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.37 -1.344 . . . . 75.23 107.37 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 65.8 t -67.39 133.19 31.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 114.445 -1.252 . . . . 70.54 110.413 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -130.04 130.22 44.66 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 107.554 -1.276 . . . . 64.3 107.554 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.596 ' H ' HD23 ' C' ' 42' ' ' LEU . 2.4 pt? -95.49 133.3 39.63 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.367 -0.975 . . . . 71.03 108.367 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -118.88 141.03 49.02 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.955 -1.498 . . . . 74.2 106.955 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -134.06 143.03 47.79 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.047 0.451 . . . . 64.45 110.205 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -147.5 149.7 33.15 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.261 1.024 . . . . 64.01 108.655 177.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 14.5 t -130.99 144.1 51.22 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 122.809 0.444 . . . . 74.02 110.437 176.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.53 145.01 51.78 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.282 1.033 . . . . 75.4 108.433 173.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -130.83 142.37 50.38 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.834 0.453 . . . . 52.02 110.344 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 52.5 p -160.6 133.41 6.41 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.815 0.846 . . . . 72.42 109.814 -177.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.21 133.44 40.14 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.11 0.564 . . . . 53.22 110.168 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.53 HD11 ' HB2' ' C' ' 57' ' ' GLU . 49.0 mt -102.7 -38.56 7.42 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.226 0.61 . . . . 72.42 110.253 177.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -152.19 178.77 9.13 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.835 0.854 . . . . 62.31 110.097 -178.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -62.93 116.87 5.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.184 -0.916 . . . . 63.5 109.112 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 68.98 0.11 2.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 125.332 1.453 . . . . 75.43 113.11 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 53.4 t -109.69 108.43 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 N-CA-C 109.301 -0.629 . . . . 75.43 109.301 178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -113.59 161.65 17.17 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 123.923 0.889 . . . . 70.21 109.036 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.53 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.0 tt0 -124.25 141.45 52.05 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 123.985 0.914 . . . . 72.24 108.808 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.41 HG23 HD11 ' C' ' 106' ' ' LEU . 24.6 m -129.37 134.53 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 122.916 0.486 . . . . 70.24 109.933 168.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' C' ' 46' ' ' THR . 58.0 t -103.41 128.98 56.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.681 -1.229 . . . . 73.24 107.681 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -120.5 96.43 5.13 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.133 -1.062 . . . . 73.35 108.133 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -86.47 114.81 23.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.175 -1.375 . . . . 62.13 110.49 -177.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 46.1 t -109.35 109.94 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.736 -0.838 . . . . 65.03 108.736 172.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 16.3 m -103.55 113.48 27.02 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.194 0.521 . . . . 71.23 109.603 174.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.513 HG23 HD13 ' C' ' 114' ' ' ILE . 71.1 t -100.8 109.75 26.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 123.571 0.748 . . . . 55.03 109.206 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 15.2 m -102.0 127.31 48.92 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.155 -0.683 . . . . 64.1 109.155 175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.72 100.2 6.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.651 -1.24 . . . . 55.2 107.651 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 63.8 p -151.15 147.08 26.6 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.702 -0.681 . . . . 74.42 109.961 -177.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 32.4 tp -81.77 -14.56 56.27 Favored 'General case' 0 CA--C 1.553 1.077 0 CA-C-N 116.254 -0.43 . . . . 73.41 109.919 172.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.47 -102.18 0.17 Allowed Glycine 0 C--N 1.352 1.419 0 N-CA-C 110.977 -0.849 . . . . 71.41 110.977 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.39 -23.38 26.14 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.685 -0.857 . . . . 64.54 108.685 173.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -79.67 100.87 8.07 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 124.269 1.028 . . . . 64.0 109.02 174.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.0 m -88.97 128.56 35.7 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.549 -0.75 . . . . 74.21 110.429 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.29 -56.71 4.45 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 44.15 107.914 170.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -154.87 155.92 35.22 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 115.002 -0.999 . . . . 63.41 110.816 177.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.406 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.7 tm? -121.7 143.63 49.24 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.358 -2.09 . . . . 73.4 105.358 170.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.486 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.6 t -147.08 145.66 29.71 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.258 -1.015 . . . . 63.01 108.258 177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -158.0 128.33 6.22 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.86 0.362 . . . . 72.41 110.42 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 95.2 t -131.13 139.15 51.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.69 1.196 . . . . 63.24 108.495 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -113.66 94.69 4.96 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.515 -0.921 . . . . 75.31 108.515 171.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.462 ' O ' HD13 ' C' ' 106' ' ' LEU . 7.9 tp-100 -80.77 98.13 7.63 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.319 -0.855 . . . . 74.4 109.114 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.89 144.6 17.24 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.286 -0.726 . . . . 73.22 111.286 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.431 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -140.77 128.36 3.74 Favored Glycine 0 C--N 1.336 0.571 0 N-CA-C 112.369 -0.292 . . . . 71.02 112.369 -172.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' C' ' 51' ' ' LEU . 10.7 mm -91.43 122.96 43.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.898 -1.149 . . . . 64.22 107.898 177.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -137.84 121.77 17.73 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.613 0.765 . . . . 72.41 109.61 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.0 p -84.22 113.4 21.07 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 109.127 -0.694 . . . . 64.4 109.127 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 44.2 pt -115.18 127.47 72.74 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-O 121.577 0.703 . . . . 60.43 109.687 176.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -142.62 154.25 44.22 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.475 1.11 . . . . 62.31 108.485 177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.28 -18.82 38.97 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 120.426 -0.097 . . . . 75.25 112.866 -179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.421 HD11 ' HB3' ' C' ' 93' ' ' GLN . 10.7 tp -123.3 151.36 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 123.89 0.876 . . . . 71.13 109.488 -177.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.497 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 14.3 pt-20 -159.82 -179.58 7.96 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.041 0.537 . . . . 63.04 111.183 177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.35 -149.35 50.85 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.456 -0.793 . . . . 64.54 114.3 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 64.7 p -60.79 -24.33 65.72 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 124.506 1.122 . . . . 74.21 112.002 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.421 ' HB3' HD11 ' C' ' 89' ' ' ILE . 16.0 mt-30 -67.72 -51.1 53.31 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.7 1.2 . . . . 64.32 111.189 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.497 ' SD ' ' HA ' ' C' ' 90' ' ' GLU . 21.2 ptt? -70.88 -24.4 62.48 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 109.917 -0.401 . . . . 61.25 109.917 178.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.36 -37.09 84.53 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 123.715 0.634 . . . . 73.41 110.7 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -63.87 -37.7 88.35 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.504 0.502 . . . . 62.23 110.667 174.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.0 t -65.54 -55.47 17.57 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.751 -0.463 . . . . 72.44 109.751 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.25 -16.26 63.02 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.792 0.837 . . . . 71.51 112.238 -176.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.11 3.77 26.98 Favored Glycine 0 C--N 1.349 1.299 0 CA-C-O 119.478 -0.624 . . . . 62.34 114.114 -177.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.13 -64.73 0.25 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.558 0.679 . . . . 71.54 110.483 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.63 -55.36 31.52 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 122.958 0.503 . . . . 55.03 112.211 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.452 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 18.2 m -60.97 -47.09 96.52 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.574 -0.726 . . . . 64.12 111.883 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 70.6 Cg_exo -50.23 -38.9 52.39 Favored 'Trans proline' 0 C--N 1.396 3.045 0 C-N-CA 122.767 2.311 . . . . 71.11 114.478 165.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -70.46 -25.52 63.22 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 123.516 0.726 . . . . 75.13 111.765 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.499 HD12 ' NH1' ' A' ' 111' ' ' ARG . 35.1 mm -72.54 -41.34 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.169 0.588 . . . . 74.03 109.665 171.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.462 HD13 ' O ' ' C' ' 80' ' ' GLN . 95.9 mt -75.3 -26.36 58.63 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.074 -0.966 . . . . 63.13 111.848 -175.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -60.4 -44.01 94.67 Favored Pre-proline 0 CA--C 1.565 1.534 0 CA-C-O 117.637 -1.173 . . . . 73.24 113.764 -172.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -51.76 -46.22 33.36 Favored 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 122.604 2.203 . . . . 74.21 113.752 172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -68.28 -43.39 77.86 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.75 0.82 . . . . 72.51 110.908 -177.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.47 98.81 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 115.637 -0.71 . . . . 63.22 110.317 177.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -57.48 -50.0 74.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.579 1.152 . . . . 73.21 111.053 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.63 -31.78 71.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.244 0.618 . . . . 70.44 110.212 -175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 9.7 t -71.37 -29.7 65.28 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.217 0.607 . . . . 74.33 111.221 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.513 HD13 HG23 ' C' ' 64' ' ' VAL . 80.8 mt -80.03 -48.65 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.228 0.611 . . . . 73.13 110.248 175.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 43.4 m -60.57 -32.11 71.21 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.664 0.786 . . . . 72.54 110.818 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.8 t -61.63 -51.64 67.66 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 115.248 -0.887 . . . . 72.24 109.34 171.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.545 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.53 -38.96 92.03 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.71 1.204 . . . . 72.13 113.078 -178.567 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.0 t -60.2 -45.64 95.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.199 1.0 . . . . 72.12 109.253 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -70.41 -31.11 68.17 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 114.159 -1.382 . . . . 73.43 111.544 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -70.63 -35.67 73.04 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.63 0.772 . . . . 73.43 109.891 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.2 -0.91 90.43 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 119.32 -0.711 . . . . 44.55 113.173 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 70.9 p 59.14 62.6 1.8 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.704 1.602 . . . . 73.13 111.693 -178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.405 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 63.1 m-85 -123.57 161.98 42.92 Favored Pre-proline 0 CA--C 1.561 1.37 0 CA-C-N 114.39 -1.277 . . . . 73.12 110.096 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 30.7 Cg_endo -61.57 158.3 37.45 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 123.236 2.624 . . . . 73.34 114.317 -173.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.485 ' HG2' ' HG2' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -59.61 119.69 8.05 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.022 0.929 . . . . 64.24 110.403 -175.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 54.3 tp -131.01 114.44 15.2 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 115.298 -0.865 . . . . 45.13 108.905 178.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -123.79 129.71 51.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 108.425 -0.954 . . . . 74.04 108.425 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 90.9 mt -86.79 121.76 29.73 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.174 0.59 . . . . 64.21 110.41 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -72.65 146.39 88.33 Favored Pre-proline 0 CA--C 1.548 0.904 0 C-N-CA 123.414 0.686 . . . . 61.12 110.19 175.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.448 ' HG2' HD12 ' A' ' 13' ' ' ILE . 42.4 Cg_endo -68.19 143.06 57.71 Favored 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 122.076 1.851 . . . . 65.35 112.136 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.0 p -124.6 108.78 20.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.773 -1.195 . . . . 65.35 107.773 170.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -98.48 90.7 4.86 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.463 0.649 . . . . 72.03 111.348 -171.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -75.23 -29.61 60.31 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.925 -1.034 . . . . 75.11 109.425 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -63.28 -42.69 99.11 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.476 -1.238 . . . . 65.04 111.312 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.19 -34.65 73.22 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.684 0.794 . . . . 51.44 111.916 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tt -57.85 -47.2 83.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.608 0.763 . . . . 72.55 109.744 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -71.73 -40.56 69.33 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.636 0.774 . . . . 75.21 110.972 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -55.06 -34.11 63.3 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.432 1.093 . . . . 74.24 112.636 -176.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -50.11 -33.34 18.42 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.88 1.272 . . . . 71.34 113.74 -178.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.72 -160.02 0.02 OUTLIER 'General case' 0 CA--C 1.573 1.827 0 N-CA-C 113.028 0.751 . . . . 75.03 113.028 -169.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.426 ' HB3' HE22 ' C' ' 143' ' ' GLN . 5.9 mp -95.41 135.0 37.6 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.805 -1.183 . . . . 72.31 107.805 176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -125.46 122.77 37.62 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.888 0.475 . . . . 74.53 109.819 -174.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.426 HE22 ' HB3' ' C' ' 141' ' ' LEU . 26.2 mp0 -125.39 29.31 6.07 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.312 0.645 . . . . 74.42 110.121 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -83.84 138.23 33.31 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 109.652 -0.499 . . . . 74.4 109.652 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -84.13 174.28 10.38 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 124.062 0.945 . . . . 53.13 111.211 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' C' ' 8' ' ' GLU . . . 153.36 57.68 0.01 OUTLIER Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.472 -0.786 . . . . 62.4 111.702 178.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -61.62 144.81 53.85 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.192 0.597 . . . . 62.02 110.074 173.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.1 147.79 21.11 Favored Glycine 0 C--N 1.344 0.993 0 O-C-N 123.121 0.263 . . . . 62.42 112.644 -173.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 24.8 m -146.54 133.92 20.74 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.095 -1.446 . . . . 55.23 107.095 166.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.41 -53.36 29.85 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.339 -0.615 . . . . 73.33 109.339 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 47.1 78.19 0.08 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.885 1.674 . . . . 75.14 112.002 174.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -173.52 17.45 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.772 0.829 . . . . 70.12 109.825 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.3 75.42 3.09 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 108.138 -1.06 . . . . 75.44 108.138 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -178.02 117.84 0.09 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.256 1.023 . . . . 73.4 108.242 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.238 0 C-N-CA 123.138 0.575 . . . . 74.5 110.008 179.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 13.8 tpt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 109.074 -0.713 . . . . 64.23 109.074 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 64.2 m 66.88 116.3 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.197 1.399 . . . . 73.44 111.117 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -80.2 -168.55 1.71 Allowed 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.152 0.981 . . . . 75.23 111.097 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -73.79 -14.51 61.12 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 123.444 0.698 . . . . 54.5 110.896 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 50.2 t30 71.75 141.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 124.736 1.215 . . . . 75.22 111.916 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -104.62 174.67 5.78 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.359 -0.978 . . . . 63.23 108.359 -178.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -71.86 76.01 0.88 Allowed 'General case' 0 CA--C 1.552 1.045 0 CA-C-O 122.236 1.017 . . . . 70.14 110.248 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -104.39 -25.46 12.82 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.545 1.138 . . . . 72.01 108.573 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' D' ' 87' ' ' ALA . 7.9 ttp -32.54 125.82 0.31 Allowed 'General case' 0 C--N 1.363 1.177 0 C-N-CA 125.412 1.485 . . . . 64.53 113.189 172.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.8 m -122.57 142.74 50.29 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 108.631 -0.877 . . . . 72.21 108.631 173.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.429 ' HA ' ' O ' ' D' ' 85' ' ' SER . 57.3 t80 -154.09 101.36 2.4 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.125 -1.065 . . . . 61.44 108.125 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -132.08 147.0 52.42 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.837 0.855 . . . . 74.32 109.336 -178.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 6.4 tp -102.49 105.8 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.992 0 N-CA-C 108.672 -0.862 . . . . 72.52 108.672 174.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -74.84 -45.23 44.63 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.4 1.08 . . . . 74.12 112.098 -174.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.421 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 54.7 ttt180 -155.3 129.55 8.92 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.181 0.193 . . . . 72.45 110.512 -170.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.509 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.5 mp -114.43 126.71 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 124.606 1.162 . . . . 74.14 107.877 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.421 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 38.0 p90 -162.87 177.32 9.37 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.946 0.879 . . . . 73.03 112.884 -176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.7 p -112.95 129.61 56.42 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 114.472 -1.24 . . . . 62.25 109.059 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -98.46 -25.05 14.91 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.758 0.423 . . . . 74.12 110.782 176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.555 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 29.6 t70 -149.81 132.59 15.98 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 108.733 -0.839 . . . . 73.02 108.733 178.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.545 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.1 mt -131.83 146.62 33.09 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.805 -1.183 . . . . 71.23 107.805 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.1 t -148.35 142.46 26.0 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 124.315 1.046 . . . . 70.24 108.913 176.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.8 t80 -151.62 124.3 8.47 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 106.219 -1.771 . . . . 71.42 106.219 170.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -131.28 122.65 26.82 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.881 0.872 . . . . 75.33 109.18 -178.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.65 85.0 13.23 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 108.573 -0.899 . . . . 60.01 108.573 178.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.83 -31.58 10.09 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.44 2.094 . . . . 71.33 113.056 -169.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' D' ' 30' ' ' HIS . 77.9 m-20 -114.37 41.65 2.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.429 1.092 . . . . 53.33 108.639 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.439 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -55.05 -52.75 68.45 Favored Pre-proline 0 CA--C 1.572 1.801 0 N-CA-C 115.306 1.595 . . . . 63.14 115.306 -168.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.406 ' HD3' ' NZ ' ' C' ' 19' ' ' LYS . 19.3 Cg_endo -91.06 2.69 4.6 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.8 1.667 . . . . 65.42 112.474 176.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' D' ' 27' ' ' ASN . 17.3 t-160 -84.39 -42.09 16.04 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.648 1.179 . . . . 61.52 108.954 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' D' ' 73' ' ' ALA . 57.2 t -78.16 -11.62 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.249 0 C-N-CA 123.595 0.758 . . . . 74.01 110.402 178.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -55.32 -36.41 66.21 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.954 0.902 . . . . 74.33 111.853 167.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -83.18 -1.72 53.7 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.653 0.781 . . . . 71.0 112.606 -172.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.422 ' HD3' ' HG ' ' D' ' 68' ' ' LEU . 14.3 ptpt -127.56 107.81 10.25 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.387 0.675 . . . . 73.45 111.155 -178.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.19 92.6 8.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.165 0.986 . . . . 60.03 109.72 176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.593 ' HB3' HD11 ' D' ' 68' ' ' LEU . 25.1 t-105 -161.6 166.85 26.28 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.593 -0.892 . . . . 71.54 108.593 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -85.8 111.64 39.14 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.284 1.034 . . . . 75.33 109.109 175.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -52.61 142.6 49.25 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.968 2.445 . . . . 71.33 113.263 169.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -75.8 122.55 24.23 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.144 -0.687 . . . . 63.44 109.144 172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.421 HG13 HG13 ' D' ' 64' ' ' VAL . 61.6 t -99.24 135.34 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.836 0.854 . . . . 72.34 110.988 -173.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -110.56 138.01 47.5 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.221 -1.029 . . . . 72.04 108.221 164.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.698 HD22 HD11 ' D' ' 128' ' ' LEU . 48.5 tp -101.76 142.41 33.13 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.024 -1.102 . . . . 61.51 108.024 171.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.587 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.4 t70 -140.73 128.2 21.32 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 108.283 -1.006 . . . . 74.4 108.283 174.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 93.6 mt -118.48 150.4 39.66 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.032 0.533 . . . . 70.11 110.786 -177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 13.6 t70 -152.62 132.34 13.17 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.095 1.358 . . . . 74.52 107.699 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 8.9 t -109.21 153.21 24.12 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.195 0.522 . . . . 54.25 109.987 176.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.71 165.65 35.32 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.279 1.032 . . . . 71.43 108.692 176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 11.3 p -166.56 161.52 16.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.273 0.629 . . . . 64.33 111.334 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 99.3 p -151.27 152.8 33.74 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.483 1.113 . . . . 71.42 108.843 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -92.04 119.06 31.39 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 110.031 -0.359 . . . . 72.21 110.031 175.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' D' ' 57' ' ' GLU . 30.9 mt -92.58 -35.79 13.37 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.071 0.548 . . . . 75.32 110.312 177.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.07 -176.41 5.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.808 0.843 . . . . 65.51 110.24 -175.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -59.72 107.64 0.63 Allowed 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.709 0.804 . . . . 63.44 110.525 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.408 ' HB3' ' O ' ' D' ' 86' ' ' ILE . 5.9 m-20 62.21 15.91 7.93 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.191 0.996 . . . . 71.32 112.473 -178.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 20.4 t -107.51 125.38 63.85 Favored 'Isoleucine or valine' 0 C--O 1.242 0.684 0 N-CA-C 108.028 -1.101 . . . . 71.14 108.028 176.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -131.23 133.52 45.55 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 115.759 -0.655 . . . . 74.31 110.849 -175.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.554 ' HB2' HD11 ' D' ' 51' ' ' LEU . 24.6 tt0 -87.29 111.8 21.42 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.557 -1.275 . . . . 73.33 107.557 168.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.71 120.04 47.51 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.26 0 N-CA-C 107.458 -1.312 . . . . 53.14 107.458 177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.434 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 92.1 t -99.69 140.27 19.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 C-N-CA 123.603 0.761 . . . . 64.34 109.488 177.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.448 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -123.72 122.58 38.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.487 -0.931 . . . . 71.23 108.487 179.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.544 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 43.3 ttm-85 -102.42 105.94 16.6 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.12 0.968 . . . . 65.35 108.496 177.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 63.3 t -105.97 120.65 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.208 -1.034 . . . . 62.34 108.208 174.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 9.8 m -123.96 130.71 53.04 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 123.413 0.685 . . . . 63.05 109.876 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.521 HG23 HD13 ' D' ' 114' ' ' ILE . 90.7 t -116.21 117.86 56.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 124.878 1.271 . . . . 60.54 109.35 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 17.2 m -111.88 93.73 4.6 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.886 -1.153 . . . . 61.52 107.886 174.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.57 137.18 42.79 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.304 0.641 . . . . 71.31 109.764 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.41 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 61.7 p -142.39 137.37 30.4 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 123.357 0.663 . . . . 75.11 109.52 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.593 HD11 ' HB3' ' D' ' 36' ' ' TRP . 15.2 tp -120.26 115.98 24.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.195 0.598 . . . . 53.22 109.422 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.76 -123.68 6.28 Favored Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.067 -0.813 . . . . 42.31 111.067 -172.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -110.25 4.36 20.83 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.45 0.7 . . . . 73.11 110.663 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -115.03 162.98 16.26 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.711 0.805 . . . . 52.03 109.74 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 92.2 m -76.23 136.79 39.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.548 -0.538 . . . . 71.14 109.548 174.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.712 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -93.07 -55.28 3.39 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.25 -0.886 . . . . 71.31 109.434 -178.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -163.14 154.61 17.39 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 115.137 -0.938 . . . . 72.5 109.745 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 94.9 mt -124.84 148.42 48.23 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.723 1.209 . . . . 51.33 108.184 177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.498 ' SG ' HG23 ' D' ' 114' ' ' ILE . 46.4 t -157.53 147.36 20.4 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.818 0.447 . . . . 64.22 110.244 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -156.45 133.23 10.29 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.466 0.706 . . . . 74.14 109.482 175.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.0 t -133.22 117.8 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.163 0.585 . . . . 64.41 109.846 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.555 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.6 mt-30 -91.31 88.49 6.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.661 0.785 . . . . 70.41 110.053 168.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.57 102.61 9.89 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.881 1.272 . . . . 70.23 109.355 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.74 141.43 15.63 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 111.626 -0.589 . . . . 43.12 111.626 177.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.66 132.04 5.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 111.138 -0.785 . . . . 70.21 111.138 -177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.1 mt -89.06 108.22 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 109.34 -0.615 . . . . 73.11 109.34 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -106.03 126.16 51.87 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.761 0.824 . . . . 73.43 110.09 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 42.7 m -78.2 114.36 17.02 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.823 0.849 . . . . 71.13 108.945 168.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.408 ' O ' ' HB3' ' D' ' 54' ' ' ASP . 73.3 mt -108.14 144.11 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 107.131 -1.433 . . . . 65.34 107.131 173.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' D' ' 9' ' ' MET . . . -162.05 151.44 15.97 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.262 -0.644 . . . . 75.05 109.262 173.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.59 1.76 53.83 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 123.815 0.697 . . . . 74.52 114.782 170.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 9.6 tp -140.52 139.36 35.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 123.443 0.697 . . . . 53.13 110.574 -172.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -152.95 -171.0 3.79 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.046 0.939 . . . . 75.22 110.386 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.8 -133.79 14.12 Favored Glycine 0 C--N 1.346 1.085 0 O-C-N 123.52 0.512 . . . . 71.33 113.221 174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 25.4 m -63.81 -37.54 87.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.688 0.795 . . . . 64.01 111.386 -178.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -71.24 -36.45 71.81 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 122.96 0.504 . . . . 55.42 112.147 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 23.9 ptm -70.13 -34.7 73.39 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-N 118.443 0.565 . . . . 64.14 109.926 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.9 -31.38 69.13 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.643 0.777 . . . . 63.24 110.677 175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -75.32 -30.41 60.32 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.65 1.18 . . . . 74.34 110.527 176.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.485 ' HB3' ' SG ' ' D' ' 102' ' ' CYS . 73.5 m -68.36 -51.32 45.69 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.557 -0.534 . . . . 72.43 109.557 173.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.22 -24.32 64.0 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.024 0.53 . . . . 51.33 111.441 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.46 -0.4 37.47 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.799 -1.0 . . . . 71.42 114.719 -174.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -155.87 -62.58 0.11 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.47 1.135 . . . . 55.21 112.408 -178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -72.97 -49.34 29.74 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.775 0.657 . . . . 70.15 112.775 -164.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' D' ' 97' ' ' CYS . 58.7 m -63.9 -45.89 81.14 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.541 -0.742 . . . . 53.41 111.691 177.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.448 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 89.3 Cg_exo -54.06 -35.31 81.07 Favored 'Trans proline' 0 C--N 1.399 3.193 0 C-N-CA 122.723 2.282 . . . . 74.45 113.83 166.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -64.02 -33.23 75.27 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.244 0.618 . . . . 63.12 111.258 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -67.46 -43.33 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.561 0.744 . . . . 64.3 110.314 173.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' D' ' 82' ' ' GLY . 94.3 mt -75.52 -23.42 56.67 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 114.982 -1.008 . . . . 74.44 112.35 -173.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 31.6 t80 -64.98 -42.42 61.97 Favored Pre-proline 0 CA--C 1.562 1.418 0 CA-C-O 117.917 -1.039 . . . . 62.23 113.694 -169.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -54.05 -42.87 63.34 Favored 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 122.113 1.876 . . . . 70.3 113.4 170.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -72.83 -36.69 67.53 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.817 0.847 . . . . 73.23 111.619 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.57 -43.12 77.25 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.451 0.7 . . . . 73.1 110.462 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 28.7 ttp180 -59.58 -48.18 82.66 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 124.2 1.0 . . . . 54.1 110.291 175.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.53 -46.17 91.16 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 124.26 0.975 . . . . 72.12 111.372 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -57.84 -41.15 81.72 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 124.186 0.929 . . . . 72.44 110.575 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.521 HD13 HG23 ' D' ' 64' ' ' VAL . 84.3 mt -60.0 -58.64 6.32 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 O-C-N 123.924 0.765 . . . . 70.13 110.145 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 5.6 m -54.02 -41.74 68.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.645 1.178 . . . . 61.02 111.492 -170.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.9 t -65.06 -44.87 87.57 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 114.575 -1.193 . . . . 71.1 110.552 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 71.2 mtm -68.91 -31.25 70.02 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.041 0.537 . . . . 73.41 112.232 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.7 t -70.56 -38.94 75.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 123.442 0.697 . . . . 74.3 110.058 178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.8 p -75.95 -28.6 57.98 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 122.626 0.37 . . . . 63.35 110.803 178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.0 mtt-85 -70.37 -31.41 68.65 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.553 0.741 . . . . 75.22 109.34 171.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.55 8.52 64.89 Favored Glycine 0 C--N 1.353 1.516 0 CA-C-N 115.324 -0.853 . . . . 60.03 112.58 173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.417 ' HG1' ' HE ' ' C' ' 15' ' ' ARG . 36.8 p 55.71 26.25 9.18 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 126.401 1.881 . . . . 75.34 113.809 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.427 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 43.8 m-85 -96.9 164.88 17.0 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.433 1.093 . . . . 73.45 108.858 172.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -57.69 143.58 94.83 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.254 1.969 . . . . 75.3 110.027 175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -65.0 150.95 47.17 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 118.368 0.531 . . . . 55.32 110.839 -174.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -105.48 100.21 9.79 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.02 -1.104 . . . . 74.42 108.02 -176.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -98.59 92.38 5.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 108.276 -1.009 . . . . 62.11 108.276 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.698 HD11 HD22 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -70.8 115.07 9.52 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 108.104 -1.073 . . . . 75.42 108.104 178.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -71.65 132.75 85.09 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 123.489 0.716 . . . . 53.35 111.445 -175.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 23.5 Cg_exo -65.15 127.34 18.16 Favored 'Trans proline' 0 C--N 1.383 2.358 0 C-N-CA 123.242 2.628 . . . . 64.52 112.458 -176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.61 152.07 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.864 0.866 . . . . 54.12 110.49 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -74.69 109.46 8.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.354 0.661 . . . . 75.14 110.607 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -71.52 -24.63 61.99 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.118 0.967 . . . . 73.01 111.702 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -63.54 -44.51 93.99 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.642 0.777 . . . . 72.04 110.748 177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.62 71.77 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.516 0.727 . . . . 51.2 111.735 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -72.42 -45.29 60.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.303 1.041 . . . . 73.45 109.668 176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -61.79 -30.38 70.77 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.508 1.123 . . . . 73.41 111.67 -174.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 18.3 mmt -55.2 -48.8 73.33 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 121.15 0.5 . . . . 75.24 110.585 175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -63.45 -34.91 78.79 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.038 -0.983 . . . . 62.21 111.495 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -57.54 -46.57 83.71 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.886 0.874 . . . . 71.13 111.488 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.57 -30.08 68.4 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.684 0.794 . . . . 72.05 111.931 -178.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -84.57 8.98 14.86 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.781 0.833 . . . . 74.43 112.088 -177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -122.23 86.43 2.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.77 0.828 . . . . 70.41 109.692 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.91 97.99 2.98 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.502 0.668 . . . . 74.03 110.015 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.54 17.29 0.1 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.407 0.683 . . . . 50.41 111.411 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.19 83.99 1.37 Allowed Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.611 -0.596 . . . . 53.12 111.611 177.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -118.34 143.95 46.24 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.84 0.856 . . . . 72.33 109.705 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.02 88.29 1.35 Allowed Glycine 0 C--N 1.344 0.99 0 O-C-N 123.429 0.455 . . . . 73.02 112.361 177.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -73.12 161.61 30.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.848 0.859 . . . . 62.23 110.638 176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -139.1 131.38 28.31 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.083 0.468 . . . . 74.12 109.88 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -151.37 136.56 17.53 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.207 1.003 . . . . 74.05 108.615 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -135.85 149.08 48.92 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.505 1.122 . . . . 73.01 108.387 -175.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 64.01 -174.75 0.16 Allowed 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.292 1.037 . . . . 64.33 111.663 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.66 176.49 9.18 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.708 0.803 . . . . 64.2 109.853 176.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.961 0 N-CA-C 108.569 -0.9 . . . . 72.34 108.569 175.284 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 110.004 -0.369 . . . . 74.33 110.004 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -122.66 155.79 35.68 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.983 0.913 . . . . 72.0 109.913 -179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -131.87 170.04 15.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.718 0.807 . . . . 63.14 110.904 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -130.16 172.57 11.64 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.591 -1.186 . . . . 74.34 108.16 173.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 67.28 -169.52 0.2 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.035 0.934 . . . . 64.45 111.665 176.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -77.22 -2.12 33.0 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.304 1.442 . . . . 64.34 112.075 175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -92.92 62.8 3.71 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.786 -0.82 . . . . 63.15 108.786 176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.629 ' H ' HD23 ' E' ' 115' ' ' LEU . 1.9 pt? -86.43 73.51 10.12 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.571 -1.195 . . . . 74.44 109.891 -175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . 0.423 ' HB2' HD23 ' B' ' 98' ' ' LEU . 50.1 t80 -155.91 69.64 5.13 Favored Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 114.842 -1.072 . . . . 71.41 109.088 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.11 -30.58 2.63 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 122.572 2.181 . . . . 53.04 111.331 173.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -83.76 141.39 31.45 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 124.488 1.115 . . . . 73.12 109.061 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 23.7 m -141.0 156.6 46.01 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.815 -1.18 . . . . 71.1 107.815 173.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.451 ' HZ3' HD22 ' B' ' 136' ' ' LEU . 53.6 m95 -53.39 105.5 0.13 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.833 0.853 . . . . 72.02 111.933 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -65.3 -63.29 1.14 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.122 -0.944 . . . . 71.53 109.869 176.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.12 -67.66 0.52 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.01 -0.541 . . . . 73.42 110.903 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . 0.261 1.9 p 65.05 -34.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.471 0 C-N-CA 127.577 2.351 . . . . 72.43 114.736 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -74.8 98.63 3.54 Favored 'General case' 0 C--N 1.351 0.655 0 C-N-CA 123.321 0.649 . . . . 72.21 110.155 178.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . 0.466 ' HB2' HD11 ' B' ' 136' ' ' LEU . 93.7 t80 -73.82 123.78 24.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 115.505 -0.77 . . . . 73.54 109.721 173.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -97.75 160.57 14.23 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.353 0.661 . . . . 51.03 109.827 172.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 101.07 -152.87 19.04 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 111.806 -0.518 . . . . 45.42 111.806 -175.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 159.59 43.43 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.731 0.812 . . . . 72.43 110.802 -173.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' B' ' 129' ' ' ALA . 4.9 mp -129.52 83.41 2.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.65 -0.87 . . . . 75.21 108.65 171.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 46.0 mm -103.22 -39.34 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 124.073 0.949 . . . . 73.01 109.664 177.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . 62.06 -86.41 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.382 1.473 . . . . 73.2 111.024 -174.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -167.77 106.09 0.58 Allowed Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 107.743 -1.206 . . . . 74.25 107.743 174.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . 0.485 ' O ' HG22 ' E' ' 136' ' ' VAL . 50.4 Cg_endo -87.0 7.26 4.93 Favored 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.829 2.352 . . . . 72.45 113.664 -177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' C' ' 32' ' ' PHE . 3.8 mp 57.74 -81.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 C-N-CA 124.768 1.227 . . . . 60.12 109.756 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -175.95 36.01 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.701 1.6 . . . . 65.31 107.997 172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.485 HG22 ' O ' ' E' ' 133' ' ' PRO . 22.0 m -90.29 45.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 123.114 1.435 . . . . 71.21 110.292 -175.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -97.59 66.14 1.95 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 114.2 -1.364 . . . . 71.55 109.35 -172.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . 70.48 159.06 0.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 125.14 1.376 . . . . 71.5 111.983 -176.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -155.02 162.47 41.07 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 122.473 0.309 . . . . 74.41 111.039 177.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 31.0 t -162.32 158.05 23.61 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.055 0.942 . . . . 63.13 109.257 173.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 7.2 tt -164.98 -49.6 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.121 -0.696 . . . . 65.22 109.121 -176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 19.9 pt -79.54 -19.86 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 73.31 113.743 -172.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -117.38 106.96 13.78 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 108.476 -0.935 . . . . 73.5 108.476 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -108.52 -55.17 2.42 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.477 0.711 . . . . 65.24 109.337 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 11.8 ptpt -147.74 11.59 0.97 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.136 0.975 . . . . 53.41 110.105 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -124.47 142.95 50.92 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.143 0.977 . . . . 75.43 109.673 -170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 35.1 tp -170.56 -58.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.773 0.829 . . . . 74.3 109.098 -177.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 50.0 tp -144.35 79.81 12.48 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 109.09 -0.707 . . . . 25.01 109.09 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 C--N 1.382 2.295 0 C-N-CA 122.853 2.368 . . . . 73.05 111.275 174.875 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 109.501 -0.555 . . . . 44.33 109.501 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.68 -72.27 0.7 Allowed 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 108.076 -1.083 . . . . 64.42 108.076 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.5 109.2 17.18 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.036 0.935 . . . . 62.13 110.922 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -76.35 -60.08 2.49 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.382 0.673 . . . . 75.04 109.629 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -136.34 144.47 44.66 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.295 1.038 . . . . 75.42 110.148 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -116.51 142.38 46.95 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.666 0.786 . . . . 64.31 110.628 175.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 91.4 mttt 56.35 72.42 0.5 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.609 1.564 . . . . 61.52 112.591 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.2 -15.01 56.94 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.233 -0.894 . . . . 72.24 110.578 172.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -71.21 109.69 5.85 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.18 0.992 . . . . 73.44 109.999 177.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.04 -52.68 0.02 OUTLIER 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 122.575 2.184 . . . . 73.24 114.431 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -108.32 122.89 47.91 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.244 1.018 . . . . 72.13 110.256 -168.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 34.6 p -87.42 137.73 32.08 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.969 0.908 . . . . 61.41 109.62 174.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -93.37 131.04 38.91 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.768 0.427 . . . . 74.23 110.813 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -154.98 86.66 1.12 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.336 0.655 . . . . 72.33 109.285 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.27 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.837 0.855 . . . . 72.43 110.599 172.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 29.1 m -128.64 131.11 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.769 -0.826 . . . . 73.54 108.769 171.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -113.88 -58.99 2.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.087 0.555 . . . . 74.43 111.061 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 63.48 96.75 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.052 0.941 . . . . 63.41 109.521 -171.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -54.13 -44.64 71.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.661 1.184 . . . . 65.1 112.72 -168.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -160.02 -141.72 3.21 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.289 -0.414 . . . . 64.2 112.898 -178.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . 0.581 ' HE2' ' HG3' ' A' ' 39' ' ' GLU . 0.4 OUTLIER -84.18 174.32 10.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.989 0.915 . . . . 73.54 110.976 -173.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.555 HD11 HG11 ' A' ' 40' ' ' VAL . 1.2 pp -134.43 6.18 3.52 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.359 1.063 . . . . 65.51 111.912 -172.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . 0.414 HG23 HD12 ' F' ' 129' ' ' LEU . 15.9 pt -120.16 119.28 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.53 0.732 . . . . 72.03 109.519 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.24 -56.48 3.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.547 0.739 . . . . 41.13 110.107 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 48.5 t80 -93.59 112.58 57.32 Favored Pre-proline 0 CA--C 1.548 0.896 0 N-CA-C 108.653 -0.869 . . . . 71.4 108.653 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.27 75.68 4.84 Favored 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.604 2.203 . . . . 73.55 111.882 -178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 13.3 tt -72.42 92.15 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.183 0 CA-C-O 122.311 1.053 . . . . 63.52 110.382 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -100.68 112.44 24.84 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-N 114.689 -1.141 . . . . 71.23 108.657 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 11.3 p -144.58 133.23 18.06 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.413 -0.588 . . . . 75.1 109.413 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.68 -83.21 0.13 Allowed 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.184 0.594 . . . . 75.13 111.413 -167.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -167.63 161.42 13.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.34 1.056 . . . . 35.0 108.755 -173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -72.95 92.82 1.67 Allowed 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.422 0.63 . . . . 64.51 110.69 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 15.6 m -90.57 -15.41 30.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.53 -1.214 . . . . 73.05 110.52 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.57 69.86 10.69 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 121.693 0.759 . . . . 63.23 110.055 177.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 5.4 tt -138.72 117.4 13.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 106.999 -1.482 . . . . 73.32 106.999 174.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 59.95 -156.23 0.35 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.89 0.876 . . . . 62.55 109.165 -165.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -156.65 -66.22 0.1 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.235 0.471 . . . . 72.31 109.833 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 10.8 tmtt? -88.4 85.02 6.8 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 108.42 -0.955 . . . . 72.33 108.42 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 60.78 -167.53 0.19 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 124.711 1.204 . . . . 75.32 111.991 177.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 34.7 mt -100.16 -176.64 3.29 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.287 0.635 . . . . 72.3 109.526 172.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.3 mp -97.23 101.49 9.99 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.449 0.7 . . . . 72.24 109.13 -177.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo . . . . . 0 C--N 1.383 2.356 0 C-N-CA 123.357 2.704 . . . . 75.23 110.835 -179.848 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.577 0.227 . . . . 63.02 110.433 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m -151.0 -149.54 0.31 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.693 1.197 . . . . 72.23 108.722 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 73.47 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.658 1.583 . . . . 64.44 112.166 177.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -148.57 121.73 8.92 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 107.829 -1.175 . . . . 65.54 107.829 174.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -68.26 142.59 55.55 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.751 0.821 . . . . 64.43 110.331 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -72.02 136.4 46.68 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.74 0.416 . . . . 72.12 110.156 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.0 t -95.25 128.08 41.81 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.519 0.728 . . . . 74.1 109.703 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -75.12 137.45 41.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.969 0.907 . . . . 73.33 110.353 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.6 mtt -95.54 132.73 40.34 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 122.75 0.42 . . . . 61.43 110.789 -177.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.4 m -157.01 129.57 7.53 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.258 1.423 . . . . 64.15 108.342 175.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -139.91 114.27 9.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.362 -0.977 . . . . 72.22 108.362 170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -150.46 136.73 18.69 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.733 0.301 . . . . 74.3 111.262 -174.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.13 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 C-N-CA 124.415 1.086 . . . . 72.15 110.67 169.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.14 -44.56 5.41 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.247 -0.649 . . . . 74.23 109.247 173.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HD2' ' HZ ' ' B' ' 32' ' ' PHE . 78.3 mtt180 -158.79 153.32 24.36 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.328 1.051 . . . . 73.42 110.86 172.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.658 HG23 HD23 ' A' ' 106' ' ' LEU . 4.0 mp -123.2 119.62 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 106.116 -1.809 . . . . 65.41 106.116 173.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 34.9 p90 -160.03 167.77 27.13 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-O 120.947 0.403 . . . . 74.54 111.674 -170.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 74.0 p -91.31 118.29 30.37 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 109.861 -0.422 . . . . 73.34 109.861 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -84.04 -26.39 29.12 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.733 0.413 . . . . 74.55 111.052 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -157.43 148.3 21.39 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.221 -0.659 . . . . 73.44 109.221 -179.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.6 mt -145.38 142.6 22.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 125.233 1.413 . . . . 64.22 107.522 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 43.8 t -148.0 136.73 21.78 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.401 0.681 . . . . 74.3 109.325 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.443 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 79.1 t80 -136.21 143.04 44.15 Favored 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 107.209 -1.404 . . . . 54.22 107.209 171.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -140.38 147.58 39.99 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 123.884 0.873 . . . . 74.14 109.159 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.54 72.09 11.72 Favored Pre-proline 0 C--O 1.238 0.486 0 N-CA-C 106.613 -1.625 . . . . 52.33 106.613 167.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -68.49 -24.44 36.29 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.228 1.952 . . . . 54.11 111.188 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.443 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 58.9 m-20 -113.61 33.51 5.11 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.519 1.128 . . . . 62.54 109.09 -179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.41 -43.98 99.34 Favored Pre-proline 0 CA--C 1.565 1.535 0 C-N-CA 123.834 0.854 . . . . 72.54 113.04 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.73 -29.31 35.95 Favored 'Trans proline' 0 C--N 1.392 2.833 0 C-N-CA 121.637 1.558 . . . . 74.14 113.006 170.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.2 m-70 -74.46 -35.77 63.31 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 122.702 0.401 . . . . 75.43 111.653 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -76.29 -21.13 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 CA-C-O 121.09 0.471 . . . . 64.53 110.712 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -74.77 -39.66 61.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.498 0.719 . . . . 63.43 110.399 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.22 -26.78 32.97 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.516 0.726 . . . . 64.04 110.771 178.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.45 173.38 10.29 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.43 0.692 . . . . 64.41 111.373 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -72.94 138.06 45.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.875 0.87 . . . . 60.14 110.722 178.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -84.88 69.62 10.78 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.801 0.81 . . . . 74.22 109.57 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -129.23 73.47 81.66 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.039 -0.982 . . . . 70.02 108.711 178.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -85.43 158.76 10.96 Favored 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.549 2.166 . . . . 44.11 112.173 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -98.43 127.89 44.56 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.769 -0.826 . . . . 71.33 108.769 174.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.419 HG11 ' HB3' ' F' ' 129' ' ' LEU . 46.0 t -72.03 94.37 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 O-C-N 123.75 0.656 . . . . 55.44 109.28 176.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.48 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 87.3 tttt -102.86 115.03 29.8 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 107.702 -1.221 . . . . 73.44 107.702 176.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 40.0 tp -119.91 148.57 43.35 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.378 0.671 . . . . 75.34 109.702 -173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.588 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 27.7 m-20 -141.35 149.07 40.66 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.979 1.311 . . . . 74.52 108.847 170.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.92 160.93 22.46 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 109.064 -0.717 . . . . 52.23 109.064 169.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -159.28 144.64 15.94 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.492 0.717 . . . . 75.1 109.368 -179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 43.3 m -127.33 135.52 50.65 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 124.086 0.954 . . . . 74.44 108.829 176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.83 133.02 45.57 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.157 0.983 . . . . 61.42 109.308 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.7 m -92.95 153.28 18.85 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 123.599 0.759 . . . . 62.02 110.59 -177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.7 t -160.45 138.91 10.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.277 1.031 . . . . 72.54 108.622 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -117.9 122.17 42.6 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.489 -0.56 . . . . 73.32 109.489 168.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.92 -34.04 13.95 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.69 0.796 . . . . 61.21 111.976 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' CG2' ' A' ' 55' ' ' VAL . . . -155.87 -177.56 6.66 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.457 0.703 . . . . 65.44 109.618 -179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -65.64 117.09 7.59 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.722 -0.844 . . . . 74.52 108.722 172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 68.05 8.98 6.88 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.433 1.093 . . . . 71.51 112.776 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 52' ' ' ALA . 38.5 t -112.09 106.38 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.777 -1.194 . . . . 62.43 107.777 174.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -107.78 162.51 13.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.594 0.711 . . . . 74.21 109.518 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -133.16 125.23 29.02 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 124.699 1.2 . . . . 73.25 108.35 172.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.3 t -107.49 121.01 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 107.212 -1.403 . . . . 72.11 107.212 171.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.4 t -99.53 136.73 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.538 -0.912 . . . . 54.02 108.538 174.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -118.08 114.1 22.6 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.22 -1.4 . . . . 72.1 107.22 175.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -104.7 128.6 52.83 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.871 0.868 . . . . 74.55 108.841 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.4 t -116.09 129.93 71.67 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 108.558 -0.904 . . . . 73.11 108.558 174.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.588 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 14.4 m -110.52 134.7 52.13 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 108.801 -0.815 . . . . 72.3 108.801 175.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.462 HG21 HG21 ' A' ' 114' ' ' ILE . 53.0 t -135.18 106.57 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.437 1.095 . . . . 53.22 108.48 -174.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 45.6 m -104.25 138.31 40.9 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.413 -0.588 . . . . 75.23 109.413 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.31 112.17 17.8 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 107.167 -1.42 . . . . 52.34 107.167 169.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.7 m -130.95 129.37 42.08 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.195 0.598 . . . . 73.53 109.576 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.518 ' H ' HD23 ' A' ' 68' ' ' LEU . 0.8 OUTLIER -87.76 85.16 7.01 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-O 122.459 1.123 . . . . 72.1 108.479 177.254 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.07 -86.65 1.28 Allowed Glycine 0 C--N 1.342 0.904 0 CA-C-N 114.23 -1.35 . . . . 64.32 111.237 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -121.74 -26.1 4.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.485 0.714 . . . . 50.01 110.878 -177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -78.78 127.51 32.15 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 122.956 0.502 . . . . 62.31 109.791 176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 50.2 m -75.0 122.64 23.81 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.715 -0.476 . . . . 63.02 109.715 173.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.97 -51.66 11.92 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.59 -0.893 . . . . 64.32 108.59 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -166.73 169.58 13.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.479 -1.237 . . . . 63.04 110.239 176.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 76' ' ' CYS . 31.7 tp -137.13 143.34 42.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.252 1.021 . . . . 74.42 109.079 176.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.408 ' H ' HD12 ' A' ' 75' ' ' LEU . 21.2 m -135.5 136.69 41.45 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.334 1.054 . . . . 74.34 108.605 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -147.88 125.13 11.51 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.303 -0.628 . . . . 63.14 109.303 172.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.1 t -129.54 130.13 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 C-N-CA 123.825 0.85 . . . . 71.51 109.653 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 18.6 mp0 -103.41 90.92 3.84 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 124.375 1.07 . . . . 74.42 108.815 175.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -79.46 92.34 5.24 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.052 -1.092 . . . . 71.42 108.052 176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.87 144.96 17.99 Favored Glycine 0 C--N 1.338 0.65 0 N-CA-C 111.305 -0.718 . . . . 62.31 111.305 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.88 132.73 5.7 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 111.253 -0.739 . . . . 51.41 111.253 -177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 54.1 mt -85.12 128.71 38.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 108.435 -0.95 . . . . 75.41 108.435 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -134.98 118.26 16.65 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.636 -0.876 . . . . 74.14 108.636 177.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.4 t -85.29 99.09 10.9 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.621 -0.881 . . . . 75.24 108.621 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.87 141.8 38.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 123.818 0.847 . . . . 75.22 109.553 -175.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -177.03 152.51 0.91 Allowed 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.877 0.871 . . . . 72.11 110.965 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 96.1 -14.33 64.69 Favored Glycine 0 C--N 1.345 1.042 0 O-C-N 123.463 0.477 . . . . 73.41 113.934 175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.456 ' HB ' ' SD ' ' A' ' 94' ' ' MET . 3.2 mp -110.98 147.59 14.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.512 -1.292 . . . . 70.02 107.512 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -142.19 176.07 9.26 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.906 0.882 . . . . 74.44 108.63 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.97 -152.72 52.51 Favored Glycine 0 CA--C 1.526 0.773 0 CA-C-N 116.238 -0.437 . . . . 70.44 113.172 176.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 26.0 p -70.74 -15.33 62.68 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.197 0.999 . . . . 74.42 112.617 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -73.55 -42.23 61.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.045 0.538 . . . . 74.3 110.448 176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.503 ' HG2' ' HB3' ' F' ' 115' ' ' LEU . 1.3 tpt -76.69 -31.38 57.19 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.724 -0.473 . . . . 60.04 109.724 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -64.79 -32.59 74.35 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.697 0.799 . . . . 42.55 111.167 174.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 5.6 t-80 -61.9 -43.41 98.91 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.64 -0.709 . . . . 75.53 110.019 170.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.647 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 1.3 m -73.44 -47.55 40.76 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.592 0.59 . . . . 62.4 112.592 -173.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD22 ' O ' ' F' ' 115' ' ' LEU . 8.4 mp -86.62 -23.69 25.61 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 111.75 0.278 . . . . 74.33 111.75 -174.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.85 5.22 34.48 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-O 119.25 -0.75 . . . . 63.51 113.949 -176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.786 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.52 -60.34 0.24 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 118.169 0.985 . . . . 64.23 112.21 -179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.647 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 0.9 OUTLIER -53.03 -60.17 3.62 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 124.544 1.138 . . . . 73.43 111.052 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 69.7 m -61.4 -51.8 74.96 Favored Pre-proline 0 CA--C 1.565 1.546 0 N-CA-C 114.167 1.173 . . . . 71.31 114.167 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.62 -26.64 75.79 Favored 'Trans proline' 0 C--N 1.394 2.954 0 CA-C-N 121.914 1.719 . . . . 70.3 113.609 175.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -78.72 -26.2 44.76 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.957 0.503 . . . . 72.42 110.833 178.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.41 HG12 ' O ' ' A' ' 101' ' ' TYR . 25.6 mm -67.02 -42.35 88.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 121.661 0.743 . . . . 62.11 109.681 171.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.658 HD23 HG23 ' A' ' 16' ' ' ILE . 50.3 mt -79.86 -29.36 40.03 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 114.562 -1.199 . . . . 75.12 112.484 -171.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -62.3 -42.63 81.72 Favored Pre-proline 0 CA--C 1.565 1.552 0 N-CA-C 114.514 1.302 . . . . 60.51 114.514 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -56.21 -35.48 95.48 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 122.296 1.997 . . . . 65.34 113.429 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -85.23 -29.57 24.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.607 0.763 . . . . 63.31 111.222 -175.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.21 -41.87 76.5 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.999 0.52 . . . . 73.45 109.779 173.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttm180 -58.41 -48.51 80.44 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.546 1.154 . . . . 74.43 109.968 175.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.73 -44.85 96.11 Favored 'General case' 0 N--CA 1.479 1.002 0 O-C-N 124.014 0.821 . . . . 72.14 111.062 -176.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.48 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 42.0 t -62.87 -41.21 99.3 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.909 0.756 . . . . 74.42 111.491 -178.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.462 HG21 HG21 ' A' ' 64' ' ' VAL . 79.2 mt -66.28 -57.24 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 123.453 0.701 . . . . 62.33 110.534 176.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.472 HG23 ' HG3' ' A' ' 125' ' ' GLN . 94.4 m -53.45 -39.57 64.54 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.904 1.282 . . . . 72.24 111.778 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.7 t -68.24 -42.38 79.79 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.181 -0.918 . . . . 63.04 110.444 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 63.8 mtm -61.06 -37.73 83.68 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 122.731 0.412 . . . . 55.35 111.307 175.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 114' ' ' ILE . 80.9 t -59.66 -49.21 84.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 C-N-CA 124.05 0.94 . . . . 72.03 110.458 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 83.5 p -71.59 -29.48 64.75 Favored 'General case' 0 CA--C 1.553 1.071 0 CA-C-N 115.597 -0.728 . . . . 61.12 111.482 -178.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 90.9 mtt-85 -71.81 -29.89 64.91 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.588 0.755 . . . . 75.13 110.061 175.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -75.36 1.68 55.69 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-N 115.53 -0.759 . . . . 64.52 112.855 174.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.408 HG23 ' HB2' ' D' ' 125' ' ' GLN . 30.4 m 69.24 35.5 2.65 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-O 123.058 1.409 . . . . 62.31 109.63 178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -115.33 149.94 43.63 Favored Pre-proline 0 C--O 1.244 0.783 0 CA-C-N 114.818 -1.083 . . . . 73.42 109.34 175.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -60.85 151.96 73.61 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.561 2.174 . . . . 74.1 111.055 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.472 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.3 tt0 -58.78 133.73 56.22 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.639 0.607 . . . . 73.41 112.639 -175.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.05 95.2 4.71 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 108.101 -1.074 . . . . 61.35 108.101 168.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -98.94 126.66 44.68 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 108.339 -0.985 . . . . 73.4 108.339 173.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.415 ' H ' HD22 ' A' ' 128' ' ' LEU . 1.7 mm? -74.0 150.26 40.8 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.625 -0.716 . . . . 74.41 110.736 -175.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.57 143.62 98.62 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.308 0.643 . . . . 63.24 110.881 -178.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.96 109.58 0.51 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.475 2.117 . . . . 72.25 111.371 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.4 t -98.53 111.36 28.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 106.308 -1.738 . . . . 63.23 106.308 174.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -84.03 70.55 10.5 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.317 -1.364 . . . . 72.33 107.317 -176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -69.05 -28.76 66.83 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.699 -1.591 . . . . 63.21 111.374 -165.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.786 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.4 p-10 -59.95 -47.69 84.76 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.858 -1.065 . . . . 72.24 111.264 172.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.68 -28.33 65.76 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 122.943 0.497 . . . . 75.33 111.714 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.6 -38.16 83.77 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.204 0.602 . . . . 73.04 111.65 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -87.87 -43.54 11.74 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.294 0.638 . . . . 73.4 111.14 176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.12 -33.22 73.13 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.558 0.743 . . . . 41.44 111.995 -168.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -65.11 -31.93 73.38 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-O 121.233 0.54 . . . . 75.11 110.208 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -75.84 -35.34 59.99 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.33 -0.85 . . . . 73.42 110.56 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 43.0 tp -67.38 -51.6 50.07 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 112.483 0.549 . . . . 74.12 112.483 -175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -153.28 7.59 0.39 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 111.531 0.197 . . . . 74.33 111.531 -176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 61.45 -154.43 0.36 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.362 0.665 . . . . 71.53 111.656 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -75.31 79.4 2.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.798 0.839 . . . . 74.52 109.528 177.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -155.8 22.09 0.39 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.008 0.523 . . . . 30.44 111.651 -172.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -68.67 142.55 38.7 Favored Glycine 0 C--N 1.353 1.509 0 N-CA-C 111.946 -0.461 . . . . 53.14 111.946 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -123.31 -73.19 0.65 Allowed 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 117.456 0.628 . . . . 65.04 110.922 -171.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.58 ' HA2' ' HB2' ' C' ' 142' ' ' GLN . . . 100.71 169.93 28.83 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-N 116.645 -0.252 . . . . 71.4 112.754 -175.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.9 t -156.87 144.04 18.77 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.554 1.142 . . . . 74.32 109.969 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -137.4 93.48 2.81 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 121.939 0.876 . . . . 75.34 108.835 167.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -79.04 -12.35 60.02 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.803 -1.544 . . . . 62.43 109.866 169.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.6 t60 80.93 -27.62 0.14 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 125.926 1.69 . . . . 71.54 112.487 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -59.24 144.52 45.93 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.634 0.773 . . . . 65.02 110.732 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -74.0 -37.37 64.44 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.741 0.416 . . . . 75.34 110.635 -176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.948 0 C-N-CA 124.03 0.932 . . . . 74.12 109.063 -179.819 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 121.143 0.497 . . . . 71.41 110.245 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 12.6 p -169.5 157.18 7.1 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.561 1.144 . . . . 54.13 109.614 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -147.26 129.86 15.96 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.711 0.404 . . . . 71.51 111.499 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -169.48 139.46 2.1 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.882 1.273 . . . . 75.21 109.343 170.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 32.2 p30 -134.47 -18.48 1.95 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.7 0.8 . . . . 71.55 111.15 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -76.86 78.46 3.45 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.968 0.907 . . . . 74.54 109.805 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 25.7 p 70.86 -51.65 0.68 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 127.544 2.337 . . . . 63.32 114.743 170.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -66.85 -13.67 61.86 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.569 1.148 . . . . 74.11 113.068 -175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.514 ' SD ' HD12 ' B' ' 89' ' ' ILE . 18.8 ptm 53.21 -172.23 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 126.057 1.743 . . . . 72.04 113.29 178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 98.0 m -140.13 127.72 21.62 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.706 0.802 . . . . 75.12 109.576 178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -134.03 130.28 37.31 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.326 -0.99 . . . . 72.34 108.326 169.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -150.97 138.94 19.98 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.334 0.654 . . . . 72.11 109.237 174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.596 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -90.17 128.68 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.451 -0.944 . . . . 74.32 108.451 177.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.468 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 10.4 mm100 -94.09 -49.87 5.56 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 109.314 -0.624 . . . . 74.24 109.314 -177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -164.05 146.07 9.04 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.678 -0.692 . . . . 75.02 109.17 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 66.3 mt -117.15 145.78 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 N-CA-C 107.047 -1.464 . . . . 61.22 107.047 170.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -169.71 146.28 3.23 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.452 0.569 . . . . 72.42 112.362 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 53.7 m -73.54 116.12 13.75 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.036 -0.984 . . . . 61.33 108.374 168.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.2 mtpt -86.81 -34.16 19.63 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.672 -0.695 . . . . 63.44 110.691 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -155.48 142.09 18.78 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.645 -0.252 . . . . 61.33 110.56 -170.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 47.0 mm -132.49 144.35 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 124.752 1.221 . . . . 61.43 109.081 175.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.465 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 39.0 t -141.88 131.91 24.61 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.875 1.27 . . . . 75.21 107.591 174.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.631 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -144.64 122.31 11.84 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.158 -1.423 . . . . 70.52 107.158 169.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 48.2 mt-10 -124.64 134.72 52.81 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.556 0.743 . . . . 73.44 109.174 -176.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.939 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -132.2 80.75 63.15 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 108.497 -0.927 . . . . 52.04 108.497 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -69.69 -31.88 19.97 Favored 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 122.983 2.455 . . . . 70.13 111.71 -177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.458 ' HA ' ' HD2' ' B' ' 30' ' ' HIS . 40.8 m-80 -117.99 28.53 8.34 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.133 0.973 . . . . 71.41 109.887 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.939 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -49.46 -50.41 65.73 Favored Pre-proline 0 CA--C 1.56 1.336 0 C-N-CA 125.013 1.325 . . . . 62.22 113.82 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 3.6 Cg_exo -79.05 -12.31 14.56 Favored 'Trans proline' 0 C--N 1.387 2.565 0 C-N-CA 122.123 1.882 . . . . 54.31 112.83 178.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.458 ' HD2' ' HA ' ' B' ' 27' ' ' ASN . 68.2 m-70 -98.49 -6.83 29.53 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.075 0.95 . . . . 74.23 111.681 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.405 HG11 ' HE1' ' B' ' 123' ' ' PHE . 6.9 p -68.59 -15.7 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.191 0.596 . . . . 74.02 111.26 -177.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.463 ' HZ ' ' HD2' ' A' ' 15' ' ' ARG . 75.8 m-85 -76.18 -7.78 55.58 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.724 0.81 . . . . 61.51 111.781 -178.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -82.33 -32.3 29.45 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.689 0.757 . . . . 42.14 109.095 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -106.73 90.83 3.44 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.527 -1.215 . . . . 75.53 110.556 -162.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -109.56 84.97 2.01 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.943 0.402 . . . . 73.23 110.427 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -153.45 -179.45 7.77 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.477 1.511 . . . . 70.12 108.052 170.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -78.82 118.63 73.55 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 108.142 -1.058 . . . . 73.33 108.142 170.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.72 149.92 67.78 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.477 2.118 . . . . 65.32 110.994 178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -72.42 104.21 3.71 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.587 -0.894 . . . . 71.04 108.587 177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.449 HG11 HD21 ' B' ' 126' ' ' LEU . 39.4 t -95.72 137.06 24.76 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 CA-C-N 115.485 -0.78 . . . . 72.02 110.189 -175.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -130.04 119.29 22.89 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 124.266 1.026 . . . . 73.4 108.405 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.73 HD12 HG22 ' B' ' 64' ' ' VAL . 1.6 mm? -104.44 134.96 46.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.942 -0.762 . . . . 51.32 108.942 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -137.45 153.32 50.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.074 0.95 . . . . 54.42 109.573 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 pp -141.15 150.07 42.31 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.987 0.915 . . . . 74.32 109.727 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.1 t70 -136.7 141.75 43.11 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.103 0.961 . . . . 71.14 108.624 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.2 p -113.41 104.34 12.19 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.44 0.696 . . . . 72.44 109.445 176.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -122.66 156.63 33.96 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.038 0.935 . . . . 71.24 109.014 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 79.8 p -145.11 173.78 11.63 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.109 0.564 . . . . 75.05 110.462 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 44.6 p -156.61 133.96 10.66 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.985 0.914 . . . . 73.3 109.016 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -81.38 120.75 25.36 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 122.964 0.506 . . . . 44.15 110.835 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -88.08 -37.87 15.9 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.425 0.69 . . . . 73.25 110.114 174.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.5 -176.11 5.16 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.873 0.869 . . . . 74.12 110.618 178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.73 116.19 4.6 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.696 -1.138 . . . . 61.54 109.527 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' B' ' 85' ' ' SER . 20.3 m-20 72.18 -5.1 1.83 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 125.493 1.517 . . . . 51.21 112.872 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -105.19 96.41 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.523 -0.917 . . . . 75.02 108.523 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -112.34 138.44 49.06 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.815 -0.629 . . . . 74.51 109.313 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.401 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.5 tm-20 -101.95 97.57 7.9 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 125.192 1.397 . . . . 72.03 107.518 -178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -90.9 121.02 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.91 0.884 . . . . 74.23 110.198 -176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 16.3 t -102.97 120.82 53.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.544 0.738 . . . . 72.41 110.315 175.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.408 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.2 121.54 34.68 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 106.908 -1.516 . . . . 63.4 106.908 170.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.504 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 61.6 ttt180 -110.5 108.93 19.08 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 109.275 -0.639 . . . . 71.24 109.275 177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.63 121.14 56.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 108.304 -0.999 . . . . 70.24 108.304 174.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 21.1 m -116.29 130.64 56.88 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.097 0.475 . . . . 75.35 109.896 -178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.767 HG21 HG21 ' B' ' 114' ' ' ILE . 51.8 t -111.37 135.46 50.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.912 1.285 . . . . 72.12 110.132 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 30.9 m -124.76 144.58 50.18 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.604 -0.887 . . . . 55.21 108.604 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.94 125.31 11.6 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.387 -0.968 . . . . 51.44 108.387 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 3.4 m -138.62 134.5 33.82 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 109.084 -0.71 . . . . 63.35 109.084 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . . . . . . . . . 22.4 tp -133.57 122.94 24.27 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 108.779 -0.823 . . . . 71.23 108.779 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.99 -131.39 13.82 Favored Glycine 0 C--N 1.346 1.11 0 O-C-N 123.594 0.559 . . . . 71.32 112.573 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -93.78 1.41 56.49 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.907 0.883 . . . . 75.15 111.147 -178.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.73 155.83 48.15 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.101 0.56 . . . . 61.35 110.984 -167.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.9 m -75.48 130.53 39.05 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.685 -0.689 . . . . 73.24 109.665 175.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.02 -56.19 4.42 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.576 0.751 . . . . 65.3 109.208 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -163.68 161.47 23.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.772 -1.104 . . . . 55.12 109.739 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 95.4 mt -132.53 146.96 52.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.886 1.275 . . . . 53.12 108.22 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' B' ' 114' ' ' ILE . 42.0 t -150.15 157.15 42.8 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.195 -0.668 . . . . 70.24 109.195 175.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.465 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.4 tt0 -165.43 131.48 2.67 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.408 -0.96 . . . . 73.41 108.408 179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 98.1 t -125.02 144.0 36.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.897 0.879 . . . . 63.55 108.693 175.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.504 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 19.7 mt-30 -122.84 89.87 3.19 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.711 -0.848 . . . . 73.14 108.711 174.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -81.68 100.01 9.23 Favored 'General case' 0 C--N 1.342 0.266 0 CA-C-N 115.14 -0.937 . . . . 61.13 108.502 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.61 169.97 37.93 Favored Glycine 0 C--O 1.244 0.78 0 N-CA-C 111.062 -0.815 . . . . 74.14 111.062 174.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.11 127.36 1.43 Allowed Glycine 0 N--CA 1.441 -0.989 0 N-CA-C 111.086 -0.806 . . . . 64.23 111.086 -177.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 21.3 mt -84.98 129.52 37.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 N-CA-C 107.623 -1.251 . . . . 71.35 107.623 174.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -132.25 162.51 30.78 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.474 1.11 . . . . 64.53 108.572 -178.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 73.7 m -129.11 108.17 10.16 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 123.616 0.767 . . . . 54.13 109.042 175.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.481 ' H ' HD13 ' B' ' 86' ' ' ILE . 0.2 OUTLIER -119.02 127.28 75.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.175 1.39 . . . . 71.44 108.782 -178.347 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -140.6 145.53 36.81 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.628 0.771 . . . . 54.34 110.118 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -29.81 3.86 Favored Glycine 0 C--N 1.348 1.238 0 O-C-N 123.66 0.6 . . . . 52.13 114.237 177.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.514 HD12 ' SD ' ' B' ' 9' ' ' MET . 19.4 tt -78.4 139.51 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.968 0 C-N-CA 123.683 0.793 . . . . 51.35 110.718 -174.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -156.31 165.87 35.1 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.753 0.821 . . . . 74.33 111.608 -168.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.44 ' HA2' ' HB3' ' E' ' 112' ' ' GLN . . . 69.29 -131.61 24.88 Favored Glycine 0 C--N 1.352 1.454 0 CA-C-N 115.285 -0.871 . . . . 54.14 114.104 173.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.3 m -66.08 -36.66 83.78 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 124.385 1.074 . . . . 65.52 110.731 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -70.46 -34.64 72.65 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 114.45 -1.25 . . . . 73.11 110.096 -174.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.465 ' HG3' HD23 ' E' ' 115' ' ' LEU . 56.9 ttp -52.95 -53.05 55.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.646 1.178 . . . . 65.22 110.732 172.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.34 72.51 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.279 -0.873 . . . . 52.24 111.924 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 20.4 t60 -71.03 -25.15 62.54 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.963 0.905 . . . . 61.21 110.969 178.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.13 -69.08 0.71 Allowed 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 122.467 0.307 . . . . 22.42 111.464 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.8 pp -73.45 -22.86 60.08 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 112.542 0.571 . . . . 61.24 112.542 -170.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.87 -25.58 24.52 Favored Glycine 0 C--N 1.345 1.048 0 O-C-N 123.462 0.476 . . . . 64.23 112.508 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -122.91 -54.95 1.81 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.383 0.512 . . . . 63.21 112.383 -170.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -72.61 -48.66 37.82 Favored 'General case' 0 CA--C 1.553 1.062 0 N-CA-C 112.554 0.576 . . . . 74.32 112.554 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.48 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.9 m -59.69 -48.09 96.07 Favored Pre-proline 0 CA--C 1.56 1.361 0 CA-C-O 118.608 -0.71 . . . . 74.3 111.482 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 75.2 Cg_exo -57.11 -34.87 98.55 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.426 2.084 . . . . 63.32 114.117 169.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -63.14 -34.17 77.05 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 122.95 0.5 . . . . 74.23 111.054 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 68.4 mt -65.37 -47.44 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.889 0.876 . . . . 73.12 110.401 173.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.408 ' HB2' HD12 ' B' ' 60' ' ' LEU . 83.3 mt -80.75 -19.6 44.56 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.954 -1.021 . . . . 74.52 112.742 -169.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -63.23 -46.85 85.75 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-O 117.41 -1.281 . . . . 62.54 113.63 -171.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.31 -37.0 97.63 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 122.055 1.837 . . . . 42.5 113.688 176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -67.78 -48.92 64.99 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.101 0.56 . . . . 74.31 110.38 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.88 86.75 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 115.25 -0.886 . . . . 74.34 111.04 177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.621 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 45.8 ttt180 -57.75 -57.83 11.01 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.679 1.591 . . . . 61.44 110.679 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -67.15 -31.09 71.28 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.07 -0.968 . . . . 72.1 110.538 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.42 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.2 t -70.9 -38.6 73.02 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.989 0.516 . . . . 63.51 111.361 -177.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.767 HG21 HG21 ' B' ' 64' ' ' VAL . 77.3 mt -64.4 -50.13 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.267 0.627 . . . . 72.22 109.907 175.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.447 HG21 ' OG ' ' C' ' 119' ' ' SER . 20.6 m -58.16 -36.44 73.01 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 114.489 -1.232 . . . . 72.21 110.956 -176.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 28.2 t -64.84 -45.37 86.43 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.357 -1.292 . . . . 64.44 110.719 176.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 38.0 mmt -59.44 -45.22 92.2 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.106 0.562 . . . . 64.55 111.711 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 65.1 t -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.642 0.777 . . . . 73.22 111.54 -176.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 70.3 p -70.34 -28.4 65.11 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.725 -0.67 . . . . 65.25 112.086 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 86.6 mtt-85 -67.07 -30.44 70.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.352 0.661 . . . . 72.41 111.232 176.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.13 13.26 39.64 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-O 119.613 -0.549 . . . . 73.52 112.94 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 81.6 p 54.81 23.65 5.07 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.441 1.896 . . . . 63.13 113.009 -176.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.405 ' HE1' HG11 ' B' ' 31' ' ' VAL . 37.9 m-85 -89.97 156.92 46.53 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 123.76 0.824 . . . . 75.11 109.337 176.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -57.8 121.47 10.08 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.48 2.12 . . . . 74.03 110.712 169.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.548 ' H ' ' HB2' ' C' ' 125' ' ' GLN . 4.9 pp0? -58.94 152.38 19.71 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.912 0.757 . . . . 65.21 112.284 -173.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.449 HD21 HG11 ' B' ' 40' ' ' VAL . 1.4 tm? -111.32 105.5 14.17 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 107.766 -1.198 . . . . 74.51 107.766 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -90.85 112.59 24.49 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.963 -1.125 . . . . 73.33 107.963 177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.621 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 2.7 mm? -68.13 117.98 10.68 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.676 -0.861 . . . . 74.25 108.676 178.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.07 146.65 87.64 Favored Pre-proline 0 CA--C 1.55 0.966 0 O-C-N 123.636 0.585 . . . . 72.01 110.654 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.422 ' HG2' HD13 ' D' ' 13' ' ' ILE . 37.4 Cg_endo -63.29 86.36 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.682 2.255 . . . . 73.34 112.571 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 80.7 t -91.13 110.79 22.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 N-CA-C 108.585 -0.895 . . . . 74.13 108.585 175.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -88.61 109.79 20.39 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.165 -0.68 . . . . 72.5 109.165 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -63.86 -33.46 75.75 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.505 1.122 . . . . 73.42 109.826 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.446 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 20.6 t70 -59.93 -44.5 94.29 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.031 -1.441 . . . . 72.13 110.918 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.16 67.18 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.587 0.755 . . . . 64.11 111.557 179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 93.5 mt -64.35 -49.98 69.55 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.807 0.443 . . . . 75.3 110.393 177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -69.95 -31.64 69.48 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.026 -0.534 . . . . 75.11 111.197 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 48.3 ttm -62.46 -37.16 84.86 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.732 0.813 . . . . 71.33 110.61 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -77.97 -21.02 51.59 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 114.741 -1.118 . . . . 71.42 110.747 -175.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -76.1 -24.14 54.97 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.392 0.677 . . . . 71.44 110.535 174.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.37 16.51 6.29 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.656 0.783 . . . . 72.31 110.022 172.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.592 ' HG2' ' HG2' ' B' ' 143' ' ' GLN . 29.6 tt0 67.54 -84.69 0.03 OUTLIER 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.647 1.579 . . . . 65.21 110.219 -177.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.592 ' HG2' ' HG2' ' B' ' 142' ' ' GLN . 28.8 pt20 -171.81 15.65 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.32 1.048 . . . . 73.34 110.376 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -75.53 129.07 36.64 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.429 0.692 . . . . 71.23 110.064 -176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.44 99.58 11.75 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.241 0.616 . . . . 74.41 110.391 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.26 38.0 Favored Glycine 0 C--N 1.346 1.12 0 O-C-N 123.364 0.415 . . . . 42.24 113.331 -177.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -79.0 155.33 28.92 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.933 0.893 . . . . 74.42 111.113 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -114.16 150.53 18.6 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-N 115.827 -0.624 . . . . 62.42 111.553 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.8 m -79.39 136.37 36.95 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 108.777 -0.823 . . . . 73.25 108.777 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.15 137.73 40.26 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 122.845 0.458 . . . . 75.43 110.195 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.405 ' OE2' ' HG3' ' B' ' 153' ' ' GLN . 1.0 OUTLIER -62.19 125.07 22.61 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.7 0.8 . . . . 64.22 109.311 177.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -143.97 100.83 3.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 122.918 0.487 . . . . 54.35 109.737 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.405 ' HG3' ' OE2' ' B' ' 151' ' ' GLU . 21.0 mt-30 -64.14 150.91 44.63 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.222 0.609 . . . . 73.2 110.54 173.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -103.97 126.18 50.9 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.062 -0.718 . . . . 73.35 109.062 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.543 0.737 . . . . 44.33 110.309 179.356 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 50.1 ttm . . . . . 0 N--CA 1.478 0.942 0 CA-C-O 120.827 0.346 . . . . 73.03 110.378 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -134.53 -59.06 0.82 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.421 0.688 . . . . 74.44 109.804 -176.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.58 66.94 1.09 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.19 0.996 . . . . 75.23 111.005 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -68.7 -24.74 64.53 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 114.122 -1.399 . . . . 62.42 110.686 175.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -90.45 172.97 8.35 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.095 0.958 . . . . 72.3 109.699 173.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -79.6 98.74 7.02 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.855 -0.612 . . . . 54.11 109.717 175.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.8 t -78.5 86.95 4.5 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 122.185 0.993 . . . . 73.34 109.465 175.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -110.92 -80.97 0.58 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.516 -0.766 . . . . 75.22 109.457 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 26.1 ttt 64.17 133.89 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.326 1.45 . . . . 62.41 113.58 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 58.9 m -87.43 103.9 15.95 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.89 -0.781 . . . . 63.21 108.89 169.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -124.88 141.09 52.35 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.944 0.897 . . . . 64.32 109.162 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -160.76 123.34 3.22 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.179 0.592 . . . . 74.23 109.729 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 30.4 mt -76.14 140.62 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 108.755 -0.832 . . . . 65.52 108.755 174.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.661 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 24.5 mm-40 -111.45 -49.71 2.98 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.679 0.792 . . . . 75.32 110.219 -178.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -164.01 123.35 1.99 Allowed 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.791 0.436 . . . . 74.21 110.04 -177.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 95.9 mt -106.46 148.57 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.056 -1.09 . . . . 64.34 108.056 175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.596 ' HE2' ' HD2' ' C' ' 19' ' ' LYS . 38.0 p90 -173.98 168.64 4.16 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.365 0.666 . . . . 73.35 110.325 -175.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.0 p -86.62 117.7 25.56 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.156 0.582 . . . . 74.51 109.635 173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.596 ' HD2' ' HE2' ' C' ' 17' ' ' TYR . 24.4 mmmt -66.86 -46.79 73.94 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.819 -0.808 . . . . 71.33 108.819 172.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -148.23 150.99 34.71 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 114.275 -1.329 . . . . 71.42 109.388 -175.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.564 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 82.6 mt -142.46 142.47 27.01 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 C-N-CA 125.791 1.636 . . . . 54.11 106.892 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 42.1 t -154.19 149.55 27.16 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.798 0.839 . . . . 62.02 109.183 -178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 80.4 t80 -152.16 128.38 10.51 Favored 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 107.467 -1.309 . . . . 75.21 107.467 172.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -134.59 130.75 36.96 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 63.24 108.45 178.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.72 82.67 15.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 108.841 -0.8 . . . . 64.35 108.841 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -67.37 -30.95 35.9 Favored 'Trans proline' 0 C--N 1.383 2.361 0 C-N-CA 123.134 2.556 . . . . 71.55 112.366 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -105.79 34.01 3.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.831 0.852 . . . . 74.02 110.172 178.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.525 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -59.65 -56.81 31.98 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.058 -0.972 . . . . 75.25 112.534 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 14.9 Cg_exo -68.45 -27.5 33.49 Favored 'Trans proline' 0 C--N 1.39 2.753 0 CA-C-N 121.838 1.692 . . . . 73.0 111.827 175.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -67.93 -23.33 65.06 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.755 1.222 . . . . 74.44 112.539 -176.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.723 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 5.5 p -59.07 -20.99 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.481 0.712 . . . . 64.44 112.39 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.26 -41.44 99.03 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.349 1.06 . . . . 73.22 111.341 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -109.82 44.97 1.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.069 0.937 . . . . 64.52 109.511 177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' C' ' 31' ' ' VAL . 22.3 ttpt -125.17 140.98 52.38 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.655 0.782 . . . . 75.34 110.794 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -76.44 132.85 39.89 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.105 0.962 . . . . 74.42 109.592 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 17.2 m-90 -84.78 71.5 10.84 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.946 0.899 . . . . 73.51 111.317 -172.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -143.32 69.67 17.77 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 114.961 -1.018 . . . . 74.45 108.411 168.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -90.98 140.08 2.72 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.402 2.068 . . . . 64.23 111.121 172.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -83.92 111.39 19.2 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 107.495 -1.298 . . . . 74.43 107.495 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -75.85 98.3 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 108.272 -1.011 . . . . 64.31 108.272 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 59.9 tttm -98.22 105.26 17.38 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.47 1.108 . . . . 74.33 108.959 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.509 HD12 HG22 ' C' ' 64' ' ' VAL . 2.2 mm? -87.73 156.8 19.27 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.989 0.515 . . . . 72.23 110.021 -177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.532 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.6 t70 -144.8 105.82 4.18 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.476 0.711 . . . . 60.12 109.728 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -103.31 126.47 50.48 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.857 -0.794 . . . . 60.13 108.857 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 22.1 t70 -135.09 151.65 50.93 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.869 0.867 . . . . 73.45 109.019 -178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' C' ' 59' ' ' VAL . 3.1 m -133.48 127.48 33.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.127 0.571 . . . . 65.45 111.112 178.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -123.14 164.2 19.11 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.893 1.277 . . . . 62.44 108.483 171.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -154.43 145.44 22.68 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 117.959 0.345 . . . . 74.33 110.982 -176.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 44.0 t -145.76 129.54 17.2 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.642 1.177 . . . . 73.31 109.378 -176.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.66 119.95 21.17 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.253 -0.647 . . . . 75.54 109.253 176.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.476 HD11 HD12 ' C' ' 83' ' ' ILE . 84.2 mt -87.69 -38.38 15.89 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.348 0.659 . . . . 74.3 111.097 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -159.06 -172.93 3.98 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.437 -0.802 . . . . 72.01 110.518 -175.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.2 105.13 0.84 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.796 1.239 . . . . 73.3 110.08 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 69.0 6.73 5.81 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 125.352 1.461 . . . . 70.34 113.019 -175.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 91.9 t -103.07 118.16 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 108.947 -0.76 . . . . 71.11 108.947 175.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -124.1 158.42 32.29 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.871 0.868 . . . . 71.13 109.353 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -126.16 137.79 53.61 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.622 -1.621 . . . . 75.22 106.622 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 8.0 p -134.31 133.08 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 109.908 -0.405 . . . . 74.23 109.908 -177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' C' ' 46' ' ' THR . 46.3 t -110.93 107.23 22.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 124.498 1.119 . . . . 73.04 108.918 -174.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -92.23 101.35 13.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 107.546 -1.279 . . . . 72.24 107.546 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 20.6 ttt180 -79.38 129.57 34.59 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.489 1.116 . . . . 64.51 109.121 176.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.39 105.99 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.857 -1.164 . . . . 74.33 107.857 173.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.532 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.5 m -103.08 113.85 27.67 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.534 -0.913 . . . . 72.33 108.534 170.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.509 HG22 HD12 ' C' ' 42' ' ' LEU . 79.6 t -101.34 108.42 23.44 Favored 'Isoleucine or valine' 0 C--O 1.244 0.79 0 N-CA-C 108.175 -1.046 . . . . 75.34 108.175 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.506 HG23 HD23 ' C' ' 75' ' ' LEU . 4.0 m -99.06 140.35 33.34 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.323 -0.991 . . . . 72.15 108.323 176.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.41 95.34 4.23 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 106.712 -1.588 . . . . 52.41 106.712 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 27.6 p -147.02 132.46 18.61 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 122.533 0.333 . . . . 74.1 111.145 -172.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 65.8 tp -67.79 -30.61 70.08 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.629 0.772 . . . . 72.4 109.952 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 169.67 -87.55 0.09 OUTLIER Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.266 -1.134 . . . . 52.3 110.266 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -89.11 -25.01 22.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.636 0.774 . . . . 71.44 109.091 171.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -90.5 96.02 10.45 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.253 1.021 . . . . 60.04 109.266 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -89.31 133.36 34.51 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.803 0.841 . . . . 70.01 110.784 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.449 ' HA ' ' NZ ' ' C' ' 34' ' ' LYS . . . -75.03 -59.51 2.7 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.145 0.978 . . . . 63.33 109.845 171.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -155.03 170.75 21.06 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.774 -1.103 . . . . 73.54 111.01 175.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.506 HD23 HG23 ' C' ' 65' ' ' THR . 2.9 tm? -136.03 140.88 44.18 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 106.127 -1.805 . . . . 75.51 106.127 173.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.22 150.85 34.47 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.522 -0.918 . . . . 63.32 108.522 176.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -155.58 131.2 9.76 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.687 -0.486 . . . . 71.42 109.687 178.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.76 115.07 26.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.27 -1.011 . . . . 45.3 108.27 173.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 75.7 mt-30 -88.15 91.27 8.71 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 107.506 -1.294 . . . . 71.23 107.506 174.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -82.39 115.14 21.29 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.672 -0.694 . . . . 73.32 109.41 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -105.66 179.57 23.51 Favored Glycine 0 C--O 1.244 0.723 0 O-C-N 123.452 0.47 . . . . 44.33 112.836 176.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.91 154.65 16.54 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.245 -0.477 . . . . 51.22 112.022 179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.8 mm -102.4 123.5 55.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.684 -1.228 . . . . 74.32 107.684 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -136.37 120.23 17.45 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.979 -0.748 . . . . 64.41 108.979 -176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.4 p -78.32 118.3 20.39 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 108.819 -0.808 . . . . 65.3 108.819 173.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 39.8 mm -113.24 107.04 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 107.284 -1.376 . . . . 73.35 107.284 -177.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.64 169.75 17.4 Favored 'General case' 0 C--O 1.247 0.934 0 CA-C-O 121.165 0.507 . . . . 70.35 111.735 -170.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.21 -58.42 2.75 Favored Glycine 0 C--N 1.346 1.125 0 CA-C-N 115.145 -0.934 . . . . 75.51 112.576 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.2 pp -123.18 -177.55 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.685 0.794 . . . . 62.43 112.211 -172.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -147.12 -173.89 4.36 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.708 0.803 . . . . 75.13 110.884 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.11 -141.51 39.66 Favored Glycine 0 C--N 1.352 1.47 0 CA-C-N 116.086 -0.506 . . . . 73.15 113.748 174.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 34.8 p -68.08 -18.47 64.68 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.013 0.925 . . . . 71.34 111.637 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -68.9 -40.63 79.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.484 0.714 . . . . 74.23 110.522 179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -83.74 -34.0 24.94 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.329 0.251 . . . . 43.14 110.755 175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -70.45 -25.74 63.33 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.871 0.868 . . . . 52.22 111.764 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -57.54 -51.62 68.73 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.785 0.834 . . . . 73.02 110.324 174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 47.2 t -73.48 -52.75 12.56 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.995 -0.548 . . . . 72.15 110.533 -178.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 38.9 tp -61.78 -25.91 67.76 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.438 0.695 . . . . 54.55 112.064 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.46 -29.06 8.55 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-N 116.055 -0.52 . . . . 43.0 113.847 -178.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' C' ' 104' ' ' ASN . . . -117.07 -60.03 1.89 Allowed 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 117.682 0.741 . . . . 60.4 111.202 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -65.01 -56.06 15.31 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.09 0.556 . . . . 64.22 112.235 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.501 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 59.5 m -56.9 -50.68 86.7 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.188 -0.911 . . . . 62.14 112.727 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 45.4 Cg_exo -61.16 -31.09 89.85 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 122.194 1.929 . . . . 73.54 113.286 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' C' ' 100' ' ' ALA . 0.2 OUTLIER -72.82 -28.93 62.85 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.772 0.829 . . . . 72.4 110.374 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 17.7 mm -66.85 -39.97 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.399 1.08 . . . . 75.4 109.85 172.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' C' ' 102' ' ' CYS . 68.9 mt -82.59 -16.31 48.94 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.336 -0.847 . . . . 72.21 111.397 -174.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -56.64 -55.29 44.6 Favored Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 118.059 -0.972 . . . . 74.11 113.141 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.43 -37.85 46.41 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 122.085 1.857 . . . . 41.4 113.207 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -63.33 -45.86 89.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.322 0.649 . . . . 64.12 111.25 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.29 -42.45 96.38 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 115.62 -0.718 . . . . 54.5 110.831 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 6.2 ttp-105 -60.51 -43.13 97.39 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.476 1.11 . . . . 75.33 110.583 -176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.77 -34.89 67.27 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.922 0.764 . . . . 63.44 110.387 -178.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.456 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 34.0 t -68.53 -30.33 69.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.787 0.435 . . . . 75.53 111.339 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' C' ' 118' ' ' VAL . 92.5 mt -77.81 -43.97 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 115.833 -0.622 . . . . 54.44 110.094 174.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 54.3 m -55.93 -36.83 68.17 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.603 0.761 . . . . 72.13 110.427 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 27.7 t -61.06 -53.75 53.32 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.228 -1.351 . . . . 63.32 109.535 173.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.76 -38.02 80.65 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.847 1.259 . . . . 53.42 113.28 -178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.4 t -63.98 -49.27 82.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.705 0.802 . . . . 72.33 109.349 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.447 ' OG ' HG21 ' B' ' 115' ' ' THR . 33.7 t -68.74 -26.49 65.27 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.167 -0.924 . . . . 74.41 111.747 179.128 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 74.6 mtt-85 -68.83 -39.25 80.08 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.279 0.632 . . . . 73.12 109.482 177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.92 10.35 60.51 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 123.626 0.579 . . . . 73.11 112.747 172.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 68.9 p 56.38 40.68 29.65 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 126.055 1.742 . . . . 74.41 112.503 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -100.16 156.82 34.84 Favored Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 114.583 -1.189 . . . . 74.15 108.281 172.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.584 ' HD3' HG22 ' E' ' 136' ' ' VAL . 38.5 Cg_endo -65.28 171.47 9.11 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 123.084 2.523 . . . . 72.43 113.858 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.548 ' HB2' ' H ' ' B' ' 125' ' ' GLN . 51.3 tp60 -60.23 132.07 52.76 Favored 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 115.318 -0.856 . . . . 64.23 113.083 -170.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -119.92 85.9 2.46 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.477 -1.305 . . . . 71.02 107.477 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -95.71 105.89 17.94 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.851 -1.166 . . . . 71.43 107.851 168.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' C' ' 128' ' ' LEU . 1.1 tm? -74.2 137.0 42.8 Favored 'General case' 0 C--O 1.246 0.908 0 N-CA-C 106.775 -1.565 . . . . 61.33 106.775 170.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' C' ' 130' ' ' PRO . . . -53.65 131.87 55.56 Favored Pre-proline 0 CA--C 1.549 0.924 0 O-C-N 124.342 1.026 . . . . 72.13 111.506 -175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.428 ' HB2' HD13 ' A' ' 16' ' ' ILE . 17.4 Cg_exo -68.09 89.22 0.38 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.512 2.141 . . . . 71.4 111.168 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.646 ' HA ' HD11 ' E' ' 148' ' ' LEU . 94.0 t -97.92 109.67 24.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.464 -0.789 . . . . 62.35 109.31 -178.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.499 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 1.8 m-20 -104.77 83.0 1.95 Allowed 'General case' 0 C--O 1.24 0.584 0 N-CA-C 108.261 -1.015 . . . . 74.34 108.261 176.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -69.78 -44.58 69.84 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.107 -0.951 . . . . 75.41 111.267 -173.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.47 -38.26 90.41 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.268 0.627 . . . . 73.14 110.946 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -73.51 -20.69 60.6 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.243 -0.889 . . . . 51.15 111.605 178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 9.3 tt -70.29 -36.91 74.67 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.49 0.716 . . . . 73.43 109.466 172.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -62.35 -39.89 94.6 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.773 0.829 . . . . 73.12 110.121 175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 64.2 mtt -76.5 -28.98 56.63 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 124.034 0.933 . . . . 72.25 111.649 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -61.48 -43.46 98.83 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 124.794 1.237 . . . . 62.52 111.749 -177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -63.8 -88.03 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.136 0.897 . . . . 64.34 109.478 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 25.8 tp 31.94 68.17 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 125.875 1.67 . . . . 75.43 113.007 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.58 ' HB2' ' HA2' ' A' ' 148' ' ' GLY . 30.2 mm-40 -70.52 99.67 1.66 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 115.527 -0.76 . . . . 64.2 109.908 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 14.2 tp60 -98.93 135.82 39.81 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 114.43 -1.259 . . . . 75.02 108.693 -178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -91.32 -171.84 3.08 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.217 0.607 . . . . 65.11 110.445 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . 69.01 -176.82 0.21 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.469 1.108 . . . . 74.32 111.668 -178.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.56 54.01 5.22 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.105 -0.498 . . . . 74.32 111.958 -177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -73.95 83.01 1.71 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.842 0.857 . . . . 62.34 109.021 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 87.3 -162.98 33.92 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.839 -0.619 . . . . 73.42 111.989 -173.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.2 t -164.29 18.71 0.06 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.553 0.741 . . . . 72.42 110.783 -177.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.65 133.74 55.97 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.668 0.787 . . . . 72.42 111.46 -173.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -105.6 163.36 12.73 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.549 1.139 . . . . 64.44 109.258 -175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -75.73 91.34 2.91 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.554 -0.906 . . . . 65.3 108.554 172.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -85.66 85.07 7.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.675 0.75 . . . . 63.12 109.02 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -86.04 146.61 26.57 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.804 -1.089 . . . . 63.33 109.597 177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.423 0.689 . . . . 73.25 110.709 -178.066 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptp . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 110.387 -0.227 . . . . 54.51 110.387 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.1 t -108.12 164.84 11.95 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.595 0.758 . . . . 52.34 110.333 -178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.2 159.89 28.29 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 116.38 -0.373 . . . . 45.24 110.589 170.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.33 163.88 31.75 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.797 0.839 . . . . 71.02 110.593 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -172.16 156.27 3.9 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.98 0.912 . . . . 73.2 109.735 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -153.86 152.26 30.45 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.815 0.846 . . . . 50.53 108.955 173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.509 HG23 ' HG2' ' D' ' 8' ' ' GLU . 5.7 t -62.47 -33.03 74.04 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.363 0.665 . . . . 75.04 111.248 177.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.509 ' HG2' HG23 ' D' ' 7' ' ' THR . 34.7 mm-40 -105.37 166.26 10.55 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.008 0.923 . . . . 74.12 110.026 178.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.495 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.5 ptm -33.85 157.42 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.414 0 C-N-CA 125.641 1.576 . . . . 74.41 114.648 165.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.587 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.2 m -144.0 140.25 29.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.279 1.032 . . . . 55.32 108.265 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' D' ' 85' ' ' SER . 78.5 t80 -155.57 113.64 3.4 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.346 -0.983 . . . . 73.35 108.346 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -134.81 131.05 37.0 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.421 0.688 . . . . 74.24 109.643 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.422 HD13 ' HG2' ' B' ' 130' ' ' PRO . 2.7 pp -78.94 141.18 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 108.481 -0.933 . . . . 71.02 108.481 172.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -111.5 -46.03 3.32 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 122.682 0.393 . . . . 62.13 110.673 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.22 122.84 1.86 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.148 -0.315 . . . . 72.4 110.148 -170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 mp -116.6 126.69 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 N-CA-C 106.523 -1.658 . . . . 55.53 106.523 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -168.1 178.03 5.26 Favored 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.811 0.695 . . . . 73.01 111.538 -165.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 71.6 p -108.21 133.48 52.4 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.005 -0.998 . . . . 65.03 109.59 178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 33.7 mtpt -102.43 -32.92 9.74 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.428 -0.582 . . . . 73.11 109.428 176.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 16.6 t70 -144.21 138.61 28.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 114.867 -1.061 . . . . 64.34 108.898 178.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.15 149.34 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.795 1.238 . . . . 44.23 108.199 176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -152.74 145.39 24.25 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.249 0.62 . . . . 64.43 110.35 173.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.564 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 89.3 t80 -147.58 124.8 11.49 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 106.689 -1.597 . . . . 74.44 106.689 168.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 2.0 mp0 -120.16 142.04 49.32 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.692 -0.855 . . . . 63.23 108.692 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -148.28 73.75 10.88 Favored Pre-proline 0 C--O 1.24 0.566 0 N-CA-C 108.355 -0.979 . . . . 71.01 108.355 175.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.38 -18.57 17.82 Favored 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.446 2.097 . . . . 73.14 111.553 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.505 ' O ' HG23 ' D' ' 31' ' ' VAL . 57.5 m-20 -114.23 23.88 12.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.136 0.974 . . . . 73.14 109.617 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -48.0 -53.8 29.61 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 114.885 1.439 . . . . 74.32 114.885 -178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.533 ' HB3' HD11 ' C' ' 83' ' ' ILE . 28.6 Cg_endo -84.48 -4.32 10.09 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 121.482 1.454 . . . . 42.15 112.892 179.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.492 ' HA ' HE21 ' D' ' 33' ' ' GLN . 21.5 t-160 -80.62 -36.95 31.95 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.848 1.259 . . . . 73.54 109.522 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 27' ' ' ASN . 59.3 t -72.77 -25.69 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.332 0.653 . . . . 74.11 110.663 178.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -55.29 -28.99 57.3 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 124.07 0.948 . . . . 73.13 112.083 171.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.492 HE21 ' HA ' ' D' ' 30' ' ' HIS . 42.3 mt-30 -76.41 -15.32 59.96 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.324 0.65 . . . . 71.34 112.408 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -125.61 111.92 15.56 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.439 0.696 . . . . 65.04 110.641 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.25 87.33 7.18 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.975 0.91 . . . . 72.53 109.855 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.689 ' HB3' HD11 ' D' ' 68' ' ' LEU . 42.6 t-105 -160.01 158.08 29.93 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.724 -0.843 . . . . 75.22 108.724 176.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.451 ' HG2' ' H ' ' F' ' 140' ' ' SER . 1.7 mp0 -74.44 116.82 56.75 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 123.077 0.551 . . . . 70.44 109.918 174.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -56.07 141.87 86.5 Favored 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.134 2.556 . . . . 61.5 113.593 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -65.61 113.38 4.18 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.55 -0.907 . . . . 72.52 108.55 170.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.428 HG13 HG13 ' D' ' 64' ' ' VAL . 61.8 t -99.09 106.57 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.65 -0.5 . . . . 74.42 109.65 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -87.41 109.39 19.54 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.194 -1.41 . . . . 62.02 107.194 167.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 pp -95.77 156.29 16.39 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 108.52 -0.918 . . . . 60.55 108.52 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 36.7 t70 -151.2 155.74 39.47 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.157 0.583 . . . . 74.01 109.966 -177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 pp -133.35 152.12 51.9 Favored 'General case' 0 C--O 1.242 0.658 0 C-N-CA 123.348 0.659 . . . . 52.32 110.824 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.598 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 15.5 t70 -153.36 151.51 30.03 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.006 1.322 . . . . 64.32 108.175 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -128.9 152.37 48.61 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 109.299 -0.63 . . . . 52.4 109.299 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.79 169.6 20.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.557 -0.905 . . . . 65.53 108.557 177.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 56.3 p -149.04 159.45 44.21 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 122.84 0.456 . . . . 53.43 110.737 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -155.7 119.26 4.41 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.115 0.966 . . . . 74.0 109.184 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -76.23 121.62 23.18 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.83 -0.433 . . . . 64.51 109.83 177.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 90.5 mt -99.63 -26.5 14.06 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.416 0.686 . . . . 73.33 110.889 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.17 -177.01 3.94 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.026 0.93 . . . . 64.52 110.036 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -77.46 120.57 22.64 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.23 -1.026 . . . . 54.44 108.23 177.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 72.15 3.87 4.82 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.067 1.347 . . . . 65.5 112.742 -172.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -117.15 117.51 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 109.423 -0.584 . . . . 61.13 109.423 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -133.04 130.5 39.48 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.362 0.665 . . . . 73.21 109.468 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -87.16 140.1 29.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.372 -0.973 . . . . 64.1 108.372 169.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.34 132.87 69.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 107.76 -1.2 . . . . 53.31 107.76 169.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -106.72 130.94 57.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.564 1.145 . . . . 44.15 108.783 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.73 121.8 45.45 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.675 -0.861 . . . . 73.21 108.675 178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 32.5 ttm-85 -106.88 99.17 8.76 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.891 -0.781 . . . . 73.1 108.891 177.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -96.59 104.13 15.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 108.199 -1.037 . . . . 71.41 108.199 172.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 14.2 m -99.3 148.12 24.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.152 -0.931 . . . . 74.52 110.022 -178.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 25.3 t -138.43 132.98 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 125.629 1.572 . . . . 62.44 107.927 -179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 62.5 m -133.94 93.44 3.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.721 -1.215 . . . . 74.41 107.721 176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.36 141.76 29.3 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 115.719 -0.673 . . . . 54.01 109.288 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.9 p -149.51 126.79 11.41 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.123 0.969 . . . . 71.31 108.975 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' D' ' 36' ' ' TRP . 19.7 tp -99.13 114.06 26.61 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 108.58 -0.896 . . . . 70.54 108.58 -179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.95 -113.33 4.13 Favored Glycine 0 C--N 1.348 1.242 0 O-C-N 123.7 0.625 . . . . 72.52 113.051 176.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 5.88 41.86 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.728 0.811 . . . . 72.33 111.205 -175.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.446 ' HG2' ' CE1' ' D' ' 30' ' ' HIS . 9.7 tp10 -149.22 151.52 34.41 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.471 0.308 . . . . 54.32 111.336 -165.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.451 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 71.8 m -55.21 141.46 35.11 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.983 1.313 . . . . 62.51 111.711 177.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.491 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -106.99 -71.85 0.74 Allowed 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.037 0.935 . . . . 65.11 109.522 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -147.54 137.63 22.99 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-O 121.367 0.603 . . . . 64.3 109.778 173.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 51.3 mt -105.03 154.02 20.69 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.397 1.079 . . . . 75.52 108.491 175.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.68 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.5 t -160.64 146.28 14.78 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.935 0.494 . . . . 75.12 110.043 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.05 126.48 6.7 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.379 -0.6 . . . . 63.22 109.379 172.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -127.71 116.88 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.787 0.435 . . . . 62.22 110.638 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.623 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 42.7 mt-30 -92.45 88.03 6.22 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.29 1.036 . . . . 70.41 110.084 170.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.2 98.73 7.48 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 114.679 -1.146 . . . . 70.43 108.857 175.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.38 141.89 17.01 Favored Glycine 0 C--N 1.343 0.942 0 N-CA-C 111.627 -0.589 . . . . 71.04 111.627 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.478 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -139.72 132.16 5.47 Favored Glycine 0 C--N 1.334 0.448 0 N-CA-C 111.291 -0.723 . . . . 62.15 111.291 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.0 mt -90.52 123.6 42.77 Favored 'Isoleucine or valine' 0 C--O 1.245 0.818 0 C-N-CA 123.93 0.892 . . . . 75.43 109.007 177.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -133.04 141.32 48.18 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.124 0.57 . . . . 71.44 109.684 178.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 33.2 m -100.17 105.23 16.81 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.726 0.81 . . . . 72.53 108.972 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mt -108.04 102.03 13.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.596 -0.89 . . . . 75.21 108.596 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.587 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.18 169.1 16.38 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.004 1.321 . . . . 74.53 109.879 -176.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.42 -4.66 33.06 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 114.49 0.556 . . . . 73.33 114.49 174.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 10.7 tp -139.44 151.41 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 123.96 0.904 . . . . 60.22 109.863 -170.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.15 177.02 8.07 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.014 0.926 . . . . 64.12 111.974 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.89 -132.64 48.25 Favored Glycine 0 C--N 1.353 1.481 0 N-CA-C 116.287 1.275 . . . . 74.45 116.287 165.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 8.5 t -62.94 -35.89 81.6 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 72.5 112.45 -172.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -73.79 -39.42 64.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.774 0.43 . . . . 71.24 111.626 -176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.9 ptm -73.63 -31.95 63.78 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 110.022 -0.362 . . . . 75.2 110.022 178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.75 70.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.438 0.695 . . . . 62.02 110.628 175.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 19.9 t-80 -71.86 -33.36 68.34 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.159 0.984 . . . . 74.4 110.321 174.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.9 -52.1 53.01 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.157 -0.474 . . . . 72.21 110.548 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.0 pp -81.59 -18.02 46.26 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 122.82 0.448 . . . . 73.14 112.114 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.65 -26.63 16.82 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-O 119.795 -0.447 . . . . 71.0 113.72 -176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.88 -59.36 1.27 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.932 0.493 . . . . 63.1 111.641 -174.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -67.29 -47.23 71.23 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 123.377 0.423 . . . . 71.34 111.972 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 81.4 m -67.61 -45.46 46.15 Favored Pre-proline 0 CA--C 1.56 1.364 0 CA-C-O 118.328 -0.844 . . . . 71.11 111.936 -176.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.92 -35.23 98.47 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 122.359 2.039 . . . . 74.41 113.498 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -66.17 -32.96 74.71 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 123.415 0.686 . . . . 72.01 110.784 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.54 -45.06 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 C-N-CA 123.416 0.687 . . . . 71.53 109.815 171.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.478 HD21 ' HA3' ' D' ' 82' ' ' GLY . 90.1 mt -73.68 -21.4 60.27 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.162 -0.926 . . . . 74.1 112.1 -174.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.422 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 42.8 t80 -66.12 -46.81 62.89 Favored Pre-proline 0 CA--C 1.559 1.291 0 N-CA-C 113.934 1.087 . . . . 64.4 113.934 -168.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.67 -34.16 97.74 Favored 'Trans proline' 0 C--N 1.39 2.736 0 C-N-CA 122.072 1.848 . . . . 74.43 112.768 174.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -76.03 -37.68 58.11 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.023 0.929 . . . . 64.13 111.026 -178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -49.94 67.67 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.565 0.746 . . . . 72.34 110.792 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -71.54 -31.88 67.52 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 114.862 -1.063 . . . . 73.13 111.186 -175.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -66.02 -42.94 89.0 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 124.029 0.831 . . . . 74.2 110.707 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 43.0 t -58.5 -39.5 80.24 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 123.821 0.7 . . . . 75.24 110.259 177.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.68 HG12 ' SG ' ' D' ' 76' ' ' CYS . 65.0 mt -61.56 -54.27 37.16 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.69 0.796 . . . . 62.11 110.35 172.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.446 HG23 ' HG3' ' D' ' 125' ' ' GLN . 28.8 m -57.71 -39.06 76.35 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.463 1.105 . . . . 72.31 111.593 -174.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 40.5 t -67.06 -43.61 82.23 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-N 114.855 -1.066 . . . . 75.4 110.141 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 70.9 mtm -70.65 -27.18 63.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 122.775 0.43 . . . . 74.23 111.738 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' D' ' 114' ' ' ILE . 65.1 t -67.96 -43.09 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 C-N-CA 123.564 0.746 . . . . 72.44 109.651 174.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 94.1 p -74.27 -25.98 59.93 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 122.895 0.478 . . . . 71.12 111.225 179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.456 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 86.6 mtt-85 -75.38 -32.17 60.72 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.456 0.703 . . . . 75.12 109.758 173.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.56 -0.37 89.92 Favored Glycine 0 C--N 1.353 1.483 0 CA-C-N 115.62 -0.718 . . . . 64.44 111.991 171.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.7 p 63.39 27.27 15.23 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 126.68 1.992 . . . . 62.42 113.257 172.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.472 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 56.5 m-85 -94.07 162.3 27.11 Favored Pre-proline 0 CA--C 1.56 1.329 0 C-N-CA 124.707 1.203 . . . . 65.33 110.535 175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.1 140.91 97.22 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 123.483 2.789 . . . . 63.2 112.402 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.446 ' HG3' HG23 ' D' ' 115' ' ' THR . 34.1 tt0 -54.68 135.01 47.38 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.119 0.968 . . . . 75.34 112.722 -174.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.46 HD13 ' HG ' ' F' ' 139' ' ' LEU . 60.6 tp -126.02 102.5 7.28 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.892 0.877 . . . . 73.34 109.913 179.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -102.58 121.44 42.39 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.71 -0.848 . . . . 74.41 108.71 175.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.422 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.1 OUTLIER -74.76 114.54 13.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 108.345 -0.983 . . . . 53.55 108.345 179.673 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.41 ' HB3' ' CD2' ' F' ' 143' ' ' TYR . . . -67.12 143.36 97.7 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 122.63 0.372 . . . . 73.14 110.898 -176.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -69.81 132.22 22.81 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.567 2.178 . . . . 62.55 112.887 -169.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 7.6 p -108.18 128.97 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.136 0.574 . . . . 73.35 109.771 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -83.73 93.3 7.9 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 108.88 -0.785 . . . . 72.15 108.88 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -62.04 -32.22 72.71 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.242 0.617 . . . . 72.34 111.101 -178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.66 -42.1 61.86 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.834 1.254 . . . . 72.15 111.911 179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.35 -43.89 92.75 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 124.056 0.847 . . . . 73.13 111.613 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 74.4 mt -76.47 -29.25 56.83 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.38 0.672 . . . . 55.4 111.124 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -69.51 -29.17 66.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.558 1.143 . . . . 62.24 110.986 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.6 mmt -52.45 -41.25 63.14 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 123.353 0.661 . . . . 72.05 110.717 176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -69.14 -35.4 76.33 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.081 0.952 . . . . 75.14 112.124 -178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -54.08 -43.09 70.01 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.075 0.95 . . . . 70.24 111.514 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.05 -32.62 73.94 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.859 0.864 . . . . 60.34 111.018 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -89.33 1.44 55.77 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.687 0.795 . . . . 73.33 111.763 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -121.55 73.4 1.06 Allowed 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 121.686 0.755 . . . . 75.23 110.597 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -148.01 91.39 1.92 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.866 -1.061 . . . . 74.41 109.441 176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -176.2 17.08 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.692 1.197 . . . . 74.22 111.157 177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -166.5 44.93 0.26 Allowed Glycine 0 C--N 1.353 1.479 0 C-N-CA 121.784 -0.246 . . . . 45.14 113.496 -175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -80.12 120.15 23.87 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.492 -0.929 . . . . 74.41 108.492 171.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.76 -69.01 0.01 OUTLIER Glycine 0 C--N 1.345 1.067 0 CA-C-N 117.846 0.293 . . . . 25.3 112.968 -176.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 40.2 m -58.88 95.03 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.059 0.943 . . . . 52.32 112.059 -176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -106.26 80.21 1.47 Allowed 'General case' 0 C--O 1.242 0.694 0 N-CA-C 106.22 -1.77 . . . . 73.14 106.22 169.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -83.63 132.61 34.88 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.059 -0.973 . . . . 70.33 108.814 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -135.79 80.05 1.81 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.638 1.175 . . . . 74.31 109.31 -178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -64.54 -54.48 31.54 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.81 0.844 . . . . 70.33 109.831 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -84.09 85.92 7.28 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.731 -1.211 . . . . 72.51 107.731 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 123.889 0.876 . . . . 71.54 109.27 -178.967 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 109.672 -0.492 . . . . 70.23 109.672 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -113.06 66.3 0.65 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.058 0.943 . . . . 65.12 109.078 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -76.03 150.16 37.41 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.812 0.845 . . . . 72.34 110.973 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -110.78 174.27 5.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.036 0.534 . . . . 74.31 110.857 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . 0.44 ' HB3' ' HA2' ' B' ' 91' ' ' GLY . 20.2 pt20 -146.1 138.25 25.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.277 1.031 . . . . 70.53 109.067 177.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -166.48 153.31 9.18 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.72 0.808 . . . . 72.51 108.915 -176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm 48.04 -97.48 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.316 1.446 . . . . 73.43 110.816 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.465 HD23 ' HG3' ' B' ' 94' ' ' MET . 0.9 OUTLIER 176.9 56.88 0.0 OUTLIER 'General case' 0 C--N 1.353 0.759 0 N-CA-C 105.607 -1.997 . . . . 63.22 105.607 175.075 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -176.58 -58.38 0.0 OUTLIER Pre-proline 0 CA--C 1.565 1.534 0 CA-C-N 114.841 -1.072 . . . . 71.31 112.466 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -52.51 112.55 0.91 Allowed 'Trans proline' 0 C--N 1.4 3.289 0 C-N-CA 123.403 2.736 . . . . 63.42 113.92 -169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -169.41 -48.51 0.02 OUTLIER 'General case' 0 C--O 1.241 0.607 0 C-N-CA 125.508 1.523 . . . . 62.14 108.177 175.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 38.0 m 62.34 98.76 0.03 OUTLIER 'General case' 0 C--N 1.366 1.31 0 C-N-CA 124.916 1.286 . . . . 64.13 109.674 -170.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 12.3 p-90 -66.25 93.83 0.23 Allowed 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.683 0.754 . . . . 71.04 109.848 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.82 75.78 1.14 Allowed 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.327 -0.851 . . . . 62.02 109.162 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.72 29.26 0.1 Allowed 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.068 -0.969 . . . . 75.4 110.104 -171.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 23.9 m -92.64 31.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.208 0.603 . . . . 65.21 111.107 -177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -82.52 114.72 21.12 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 109.11 -0.7 . . . . 73.31 109.11 174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -151.44 159.51 44.17 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.746 1.218 . . . . 64.42 108.427 174.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -67.03 140.94 57.7 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 109.176 -0.676 . . . . 75.11 109.176 176.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -92.46 7.49 77.74 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-O 119.787 -0.452 . . . . 72.43 114.075 -174.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -118.64 -29.78 5.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.48 0.712 . . . . 75.24 109.35 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . 0.433 HD13 ' HB2' ' B' ' 42' ' ' LEU . 11.0 mp 69.82 -81.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.607 1.163 . . . . 71.44 112.131 174.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.24 158.0 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.544 0.738 . . . . 75.42 112.511 -170.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.6 -69.36 0.2 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.376 0.67 . . . . 73.52 109.808 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 61.44 106.5 0.03 OUTLIER Pre-proline 0 CA--C 1.557 1.237 0 C-N-CA 124.86 1.264 . . . . 71.33 110.814 -172.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -52.31 -37.86 71.81 Favored 'Trans proline' 0 C--N 1.384 2.437 0 C-N-CA 123.438 2.758 . . . . 65.41 113.516 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 2.7 pp -86.18 -19.95 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 CA-C-N 115.304 -0.862 . . . . 60.14 111.966 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 58.22 78.57 0.24 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.937 1.295 . . . . 72.23 111.889 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . 0.584 HG22 ' HD3' ' C' ' 124' ' ' PRO . 7.4 p -81.76 92.53 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.273 0 CA-C-O 121.741 0.781 . . . . 71.52 109.193 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . 0.521 ' HA ' ' HB3' ' C' ' 124' ' ' PRO . 3.1 tm-20 -140.39 -45.61 0.41 Allowed 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.292 0.637 . . . . 50.33 111.19 -170.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.65 85.73 1.62 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.203 0.525 . . . . 53.23 111.304 -177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . 0.511 ' HB2' ' HG2' ' C' ' 124' ' ' PRO . 5.1 tt -103.32 120.53 40.95 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 107.086 -1.45 . . . . 75.42 107.086 173.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 57.0 m -145.97 -160.92 1.21 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.843 0.857 . . . . 75.02 109.509 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 71.96 48.7 0.27 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.38 1.072 . . . . 72.13 109.045 176.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 24.1 mt -111.54 -66.05 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.505 -1.225 . . . . 73.12 107.948 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -143.31 157.53 44.4 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 124.462 1.105 . . . . 62.3 110.046 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -91.9 -59.13 2.19 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.312 1.045 . . . . 52.14 110.701 -174.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -138.56 -53.56 0.6 Allowed 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.213 0.605 . . . . 64.43 110.223 -176.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -75.22 142.61 43.4 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-O 121.005 0.431 . . . . 61.32 110.784 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 80.5 mt -124.76 -59.46 1.43 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.019 -1.104 . . . . 75.41 108.019 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.646 HD11 ' HA ' ' C' ' 131' ' ' VAL . 6.2 mp -112.16 146.78 35.57 Favored Pre-proline 0 N--CA 1.479 0.977 0 N-CA-C 107.462 -1.31 . . . . 75.41 107.462 167.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo . . . . . 0 C--N 1.381 2.287 0 C-N-CA 123.513 2.809 . . . . 74.33 113.304 175.903 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 25.5 t70 . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.084 -0.339 . . . . 60.23 110.084 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -95.94 -168.99 1.85 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.317 0.647 . . . . 73.33 111.245 179.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . 68.76 16.85 8.91 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.69 1.196 . . . . 73.05 112.907 175.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -55.35 103.95 0.11 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 109.124 -0.695 . . . . 72.23 109.124 171.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -63.52 82.77 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 O-C-N 124.204 0.94 . . . . 73.42 110.966 -172.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -72.11 -31.61 66.2 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.997 -1.001 . . . . 72.41 109.302 179.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 63.8 mttm 63.87 79.72 0.25 Allowed 'General case' 0 C--N 1.357 0.926 0 C-N-CA 124.867 1.267 . . . . 71.23 110.505 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 94' ' ' MET . 81.9 mt -79.75 54.36 1.81 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.633 0.73 . . . . 61.22 109.933 172.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -124.67 62.94 35.7 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.756 1.223 . . . . 74.32 108.735 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -86.48 76.85 2.43 Favored 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 122.969 2.446 . . . . 70.52 111.99 -172.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -155.51 138.42 15.38 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.45 -0.796 . . . . 74.24 110.861 175.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 32.0 p -111.36 84.53 1.96 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.862 1.265 . . . . 75.15 107.835 171.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -136.58 -61.83 0.67 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.477 0.711 . . . . 73.04 109.825 -172.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 24.9 t70 68.07 151.7 0.08 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.791 1.236 . . . . 73.45 111.686 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.51 118.72 8.55 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.164 0.586 . . . . 65.15 112.115 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 33.9 m -75.99 -172.53 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.169 0 C-N-CA 124.006 0.922 . . . . 71.13 110.818 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 7.0 ppt_? -76.44 173.29 11.66 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.134 0.493 . . . . 71.23 110.501 177.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -139.78 -67.33 0.44 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.365 0.666 . . . . 63.31 111.716 -169.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -155.8 143.17 19.35 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.293 0.637 . . . . 75.34 109.964 -169.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -140.76 128.95 3.94 Favored Glycine 0 C--N 1.344 1.004 0 N-CA-C 111.134 -0.787 . . . . 44.3 111.134 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt 65.44 88.54 0.1 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.819 1.247 . . . . 64.25 110.14 -172.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.419 ' HB3' HG11 ' A' ' 40' ' ' VAL . 44.8 tp -107.58 168.23 9.4 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 115.081 -0.963 . . . . 73.53 109.429 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 46.4 mm 80.61 -57.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 126.269 1.828 . . . . 72.43 110.13 177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . 76.57 -47.11 0.53 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 125.794 1.638 . . . . 70.35 112.471 176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -115.64 93.69 37.9 Favored Pre-proline 0 C--O 1.245 0.828 0 C-N-CA 123.741 0.816 . . . . 63.3 109.403 175.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.88 89.62 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.409 2.072 . . . . 63.12 109.636 175.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -60.77 99.7 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-N 115.513 -0.767 . . . . 65.54 110.404 -178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.95 84.14 5.75 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 115.248 -0.887 . . . . 52.14 109.315 -177.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . . . . . . . . . 12.6 p -136.4 112.86 12.88 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 N-CA-C 108.13 -1.063 . . . . 75.22 108.13 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.04 147.23 24.72 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.764 -0.458 . . . . 74.32 109.764 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 66.73 99.7 0.05 OUTLIER 'General case' 0 C--N 1.354 0.798 0 C-N-CA 125.375 1.47 . . . . 74.2 111.404 176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.46 ' HG ' HD13 ' D' ' 126' ' ' LEU . 0.0 OUTLIER -67.69 88.68 0.24 Allowed 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 108.034 -1.098 . . . . 74.44 108.034 176.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . 0.451 ' H ' ' HG2' ' D' ' 37' ' ' GLN . 22.4 t -87.6 1.01 54.8 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.655 0.782 . . . . 60.1 111.88 -171.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 44.7 mt -97.99 -8.61 27.61 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.426 0.528 . . . . 61.21 112.426 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.436 HD12 HD11 ' D' ' 126' ' ' LEU . 7.0 tt -77.87 113.22 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 N-CA-C 109.306 -0.627 . . . . 72.43 109.306 176.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' F' ' 146' ' ' ASP . 58.5 m-85 76.35 -49.75 0.58 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.696 1.599 . . . . 72.32 113.029 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 50.5 t30 72.36 -79.21 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.438 1.495 . . . . 75.04 111.029 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -128.46 -27.39 2.65 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.615 0.766 . . . . 75.35 110.191 -177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' F' ' 143' ' ' TYR . 24.6 t70 -80.68 159.23 25.36 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.875 0.87 . . . . 75.05 110.667 175.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 55.8 tp -157.57 -74.95 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 107.699 -1.222 . . . . 74.52 107.699 173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 40.1 tp -171.94 66.12 0.4 Allowed Pre-proline 0 CA--C 1.549 0.926 0 N-CA-C 106.96 -1.496 . . . . 65.12 106.96 168.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 C--N 1.383 2.364 0 C-N-CA 122.729 2.286 . . . . 55.41 110.973 179.601 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.9 ttp . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 109.8 -0.445 . . . . 60.22 109.8 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -122.23 84.26 2.23 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.934 0.894 . . . . 74.12 108.918 169.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 81.89 8.5 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.233 -1.395 . . . . 70.03 107.233 174.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -129.8 131.21 46.11 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.04 0.936 . . . . 63.43 110.014 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -130.6 121.22 25.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.722 0.809 . . . . 73.01 109.707 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -72.56 155.11 40.4 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.872 -0.788 . . . . 55.22 108.872 169.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.6 p -67.49 80.59 0.16 Allowed 'General case' 0 CA--C 1.554 1.122 0 CA-C-O 121.953 0.883 . . . . 53.35 111.733 -175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -138.12 -158.82 0.89 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.727 1.211 . . . . 73.23 109.303 -173.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.11 140.13 58.77 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.182 0.593 . . . . 63.22 109.749 175.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.489 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 90.1 m -140.15 120.36 13.84 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.554 -1.276 . . . . 45.21 107.554 -178.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -138.82 121.85 16.75 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.026 -0.731 . . . . 74.12 109.026 176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.682 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 29.6 tt0 -134.12 111.7 10.54 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.585 0.754 . . . . 60.34 109.159 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 pp -79.62 109.21 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 N-CA-C 108.174 -1.047 . . . . 72.13 108.174 170.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.489 ' HB3' ' HB ' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -91.99 -40.53 11.06 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 109.407 -0.59 . . . . 74.53 109.407 -174.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -170.73 140.96 1.75 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.321 0.648 . . . . 61.04 110.083 173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.602 HG23 HD23 ' A' ' 106' ' ' LEU . 3.9 mp -128.59 100.54 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.033 -1.469 . . . . 74.5 107.033 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -160.82 175.8 12.17 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.234 1.014 . . . . 73.44 110.157 -166.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -81.44 127.01 32.34 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.649 0.261 . . . . 71.1 110.692 -175.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 40.4 mtpt -83.27 -47.45 11.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 121.755 0.788 . . . . 72.22 109.045 165.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 12.0 t70 -136.86 139.36 41.61 Favored 'General case' 0 C--O 1.241 0.608 0 CA-C-N 114.529 -1.214 . . . . 64.21 109.595 -174.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.521 HG23 ' SD ' ' A' ' 117' ' ' MET . 78.5 mt -128.21 136.06 61.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.876 -1.527 . . . . 74.41 106.876 173.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -146.16 108.24 4.38 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.162 -0.681 . . . . 65.0 109.162 177.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 89.8 t80 -112.56 119.26 37.54 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 106.959 -1.497 . . . . 61.01 106.959 173.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -127.99 111.93 14.09 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.038 -0.727 . . . . 73.21 109.038 177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 28' ' ' ALA . . . -111.19 84.68 4.79 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 107.613 -1.255 . . . . 70.45 107.613 171.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.38 -31.29 18.03 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.285 1.99 . . . . 64.52 111.428 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.7 m-20 -109.29 34.38 3.79 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.501 1.12 . . . . 64.41 108.767 -178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.447 ' HB2' ' CB ' ' A' ' 25' ' ' ALA . . . -59.24 -47.33 98.5 Favored Pre-proline 0 CA--C 1.57 1.717 0 C-N-CA 123.658 0.783 . . . . 53.15 113.059 -177.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.8 Cg_exo -67.64 -24.59 41.31 Favored 'Trans proline' 0 C--N 1.394 2.927 0 C-N-CA 122.229 1.953 . . . . 73.21 113.275 171.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 25.4 m80 -64.89 -38.11 89.89 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 122.613 0.365 . . . . 73.34 110.611 177.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.81 -25.24 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 122.79 0.436 . . . . 64.11 111.626 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -65.26 -38.44 90.33 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.108 0.563 . . . . 72.32 111.283 176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -90.32 -21.19 22.16 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 122.902 0.481 . . . . 71.23 111.12 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 6.1 tmtt? -82.0 148.79 28.47 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.036 0.934 . . . . 55.14 111.479 -172.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.42 139.34 57.1 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.638 0.775 . . . . 74.25 110.736 170.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 9.1 p90 -84.61 74.04 10.48 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.927 0.87 . . . . 74.41 110.9 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -139.38 74.12 35.42 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.779 -0.823 . . . . 54.34 108.779 171.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.46 141.51 4.01 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.433 2.088 . . . . 64.14 112.665 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -97.94 121.97 40.5 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 107.874 -1.158 . . . . 74.21 107.874 171.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.67 115.49 43.54 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 123.184 0.594 . . . . 73.31 110.542 -167.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -93.77 121.09 34.85 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.298 1.039 . . . . 71.52 109.15 173.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -110.0 129.36 55.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.463 0.705 . . . . 72.1 110.328 -178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -114.39 113.46 24.55 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.806 0.843 . . . . 74.5 108.8 173.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -102.24 118.27 36.53 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 107.487 -1.301 . . . . 63.45 107.487 176.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' O ' HD23 ' A' ' 60' ' ' LEU . 21.6 t70 -129.23 144.93 51.4 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.77 0.828 . . . . 73.33 109.782 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.4 m -142.13 135.72 29.33 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 123.273 0.629 . . . . 54.55 110.342 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.48 119.65 9.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.439 0.695 . . . . 72.02 110.928 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 t -91.73 154.21 19.12 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 109.374 -0.602 . . . . 63.15 109.374 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.3 t -161.86 115.94 1.9 Allowed 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 117.932 0.333 . . . . 70.42 110.308 -171.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.518 HE21 ' H ' ' A' ' 54' ' ' ASP . 63.7 tt0 -73.44 105.87 5.0 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.784 0.834 . . . . 72.03 111.651 -172.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.579 HD11 ' HB2' ' A' ' 57' ' ' GLU . 70.1 mt -77.93 -40.48 39.45 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.85 0.86 . . . . 64.35 111.253 176.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.99 -172.0 3.95 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.122 0.969 . . . . 61.03 109.542 -175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -56.07 100.28 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.323 0.649 . . . . 62.41 111.159 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.518 ' H ' HE21 ' A' ' 50' ' ' GLN . 1.5 m-20 52.86 32.79 13.02 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 124.797 1.239 . . . . 65.0 113.083 -174.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.614 ' HA ' ' HA ' ' A' ' 85' ' ' SER . 49.1 t -108.51 121.64 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 106.715 -1.587 . . . . 71.44 106.715 167.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.426 ' CE1' ' HB3' ' F' ' 114' ' ' LYS . 2.1 m-85 -132.48 131.04 41.25 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.254 -0.647 . . . . 65.32 109.254 -178.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.579 ' HB2' HD11 ' A' ' 51' ' ' LEU . 41.1 tt0 -86.37 120.22 27.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.629 -0.878 . . . . 63.42 108.629 168.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.33 116.25 42.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 N-CA-C 107.715 -1.217 . . . . 54.3 107.715 174.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.529 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 71.2 t -98.07 134.88 34.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 109.129 -0.693 . . . . 74.35 109.129 177.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.1 OUTLIER -109.39 109.86 20.84 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.141 -1.429 . . . . 75.21 107.141 171.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -96.99 102.0 13.69 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.913 -1.143 . . . . 74.0 107.913 175.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.0 t -93.86 140.6 16.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 107.511 -1.292 . . . . 73.24 107.511 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 7.3 m -129.48 124.4 33.92 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.338 -0.616 . . . . 74.12 109.338 173.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.521 HG21 HG21 ' A' ' 114' ' ' ILE . 70.8 t -115.76 105.61 18.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.935 -1.135 . . . . 50.45 107.935 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 22.3 m -112.33 122.86 48.93 Favored 'General case' 0 N--CA 1.461 0.099 0 N-CA-C 108.561 -0.903 . . . . 71.23 108.561 178.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.25 110.81 21.78 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 106.613 -1.625 . . . . 72.35 106.613 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.0 m -148.38 147.47 29.26 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.07 0.548 . . . . 70.23 109.827 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.451 HD23 ' NZ ' ' A' ' 34' ' ' LYS . 28.1 tp -113.32 86.85 2.47 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 108.032 -1.099 . . . . 60.2 108.032 171.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.11 -93.12 1.5 Allowed Glycine 0 C--N 1.341 0.847 0 CA-C-N 115.15 -0.932 . . . . 74.31 111.472 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -116.04 -26.9 7.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.72 0.808 . . . . 73.14 111.014 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.0 tp10 -77.67 107.08 9.9 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.184 -1.043 . . . . 72.25 108.184 177.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.7 m -76.01 142.53 41.85 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.479 -0.563 . . . . 63.41 109.479 177.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.46 -58.68 2.47 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.377 -0.971 . . . . 74.44 108.377 169.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -168.89 176.76 5.3 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.558 0.743 . . . . 75.15 110.727 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 37.3 tp -139.42 141.82 37.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.186 1.395 . . . . 72.42 108.342 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.476 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 35.3 m -147.69 97.79 2.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.943 0.497 . . . . 75.03 110.144 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -106.43 122.32 46.04 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.575 0.75 . . . . 71.42 109.622 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.1 t -126.11 115.0 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.535 0.734 . . . . 71.14 109.864 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 15.7 mp0 -85.91 82.19 8.24 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.401 1.081 . . . . 74.22 108.207 172.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -76.49 93.57 3.56 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.899 -1.046 . . . . 72.33 108.97 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -89.47 145.91 18.66 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.138 -0.483 . . . . 52.53 111.9 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -140.56 122.76 2.22 Favored Glycine 0 CA--C 1.504 -0.653 0 N-CA-C 110.205 -1.158 . . . . 75.31 110.205 -179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.617 HD11 ' HA ' ' B' ' 29' ' ' PRO . 54.9 mt -82.21 126.83 40.0 Favored 'Isoleucine or valine' 0 C--O 1.242 0.675 0 N-CA-C 108.8 -0.815 . . . . 70.34 108.8 175.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -132.71 117.05 17.36 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.426 -0.953 . . . . 61.33 108.426 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.682 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 40.7 t -84.56 97.64 9.7 Favored 'General case' 0 C--O 1.24 0.586 0 N-CA-C 108.397 -0.964 . . . . 73.34 108.397 174.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.489 ' HA ' ' O ' ' A' ' 10' ' ' THR . 34.1 pt -120.21 125.67 74.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.696 0.76 . . . . 51.04 111.59 -172.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.73 158.82 43.41 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.0 1.32 . . . . 54.33 108.932 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.17 8.74 86.07 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.796 -0.447 . . . . 52.22 114.213 177.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.536 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -117.69 134.1 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 108.823 -0.806 . . . . 74.23 108.823 173.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -134.33 169.1 17.72 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 122.99 0.516 . . . . 63.35 111.198 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.95 -111.76 0.79 Allowed Glycine 0 C--N 1.358 1.773 0 O-C-N 124.774 1.296 . . . . 43.41 115.209 171.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 34.0 p -70.12 -35.84 74.39 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.176 0.99 . . . . 70.32 111.772 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.89 -47.56 82.77 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.268 0.627 . . . . 72.31 111.197 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' F' ' 115' ' ' LEU . 26.3 ptt? -72.13 -35.75 69.21 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.019 0.528 . . . . 74.02 111.333 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -39.09 81.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.546 0.738 . . . . 62.32 110.595 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.32 -46.88 86.73 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 114.625 -1.171 . . . . 73.01 109.985 172.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.586 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 12.0 m -70.84 -37.66 73.16 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.048 0.758 . . . . 74.23 113.048 -172.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.462 HD21 HD11 ' A' ' 86' ' ' ILE . 77.8 mt -84.84 -18.86 33.56 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 111.926 0.343 . . . . 65.14 111.926 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.71 -10.85 54.97 Favored Glycine 0 C--N 1.342 0.887 0 CA-C-O 119.831 -0.427 . . . . 61.24 113.268 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.93 -73.24 0.29 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 118.734 -0.651 . . . . 61.25 112.642 -172.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.586 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 7.5 t80 -41.41 -54.92 2.94 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 124.882 1.273 . . . . 73.11 113.158 -175.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 60.2 m -78.6 -52.54 1.34 Allowed Pre-proline 0 CA--C 1.562 1.442 0 CA-C-O 118.256 -0.878 . . . . 72.1 112.975 -173.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.416 ' HA ' HD12 ' A' ' 106' ' ' LEU . 38.6 Cg_endo -64.67 -25.27 61.69 Favored 'Trans proline' 0 C--N 1.389 2.666 0 C-N-CA 121.791 1.661 . . . . 72.1 114.448 177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -71.62 -33.98 69.43 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.933 0.493 . . . . 75.15 110.454 178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 18.0 mm -62.16 -42.37 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.273 0.629 . . . . 55.43 109.879 170.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.602 HD23 HG23 ' A' ' 16' ' ' ILE . 60.2 mt -72.89 -25.42 61.06 Favored 'General case' 0 CA--C 1.556 1.188 0 CA-C-N 115.586 -0.734 . . . . 74.33 111.678 -174.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -64.58 -43.32 70.35 Favored Pre-proline 0 N--CA 1.49 1.556 0 N-CA-C 115.088 1.514 . . . . 71.43 115.088 -168.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.23 -34.52 98.66 Favored 'Trans proline' 0 C--N 1.386 2.521 0 C-N-CA 122.114 1.876 . . . . 61.3 113.232 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -80.0 -35.55 37.23 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.733 0.813 . . . . 73.44 111.158 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.84 -49.1 71.91 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.135 0.574 . . . . 62.1 109.574 173.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -53.79 -45.64 70.77 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.764 1.29 . . . . 75.41 110.466 177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.08 -50.23 64.82 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.633 0.773 . . . . 61.45 111.352 -177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 51.2 t -56.09 -46.6 78.99 Favored 'General case' 0 N--CA 1.476 0.836 0 O-C-N 124.214 0.946 . . . . 34.21 110.659 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.521 HG21 HG21 ' A' ' 64' ' ' VAL . 11.6 mt -57.77 -54.72 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 O-C-N 124.104 0.878 . . . . 74.22 110.657 174.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 125' ' ' GLN . 65.8 m -56.44 -39.54 73.3 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.73 0.644 . . . . 53.34 111.594 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.35 -39.27 81.93 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.474 -0.785 . . . . 62.33 109.814 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.521 ' SD ' HG23 ' A' ' 21' ' ' ILE . 17.6 mtp -61.17 -40.85 95.44 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.524 0.73 . . . . 63.53 110.92 172.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 114' ' ' ILE . 92.1 t -62.89 -46.5 96.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.268 1.027 . . . . 75.15 110.698 179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 80.7 p -75.25 -37.05 61.18 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.575 -0.739 . . . . 74.34 111.211 -173.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.0 mtt-85 -66.31 -28.33 68.6 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.308 0.643 . . . . 73.44 109.909 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.01 -3.07 89.36 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 115.558 -0.747 . . . . 33.34 113.43 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.5 m 65.83 38.32 5.18 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.028 1.394 . . . . 70.31 110.541 176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -114.05 150.53 43.72 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-N 115.025 -0.989 . . . . 75.32 110.611 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.7 130.53 40.43 Favored 'Trans proline' 0 C--N 1.384 2.43 0 C-N-CA 122.935 2.423 . . . . 75.05 112.271 175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HG2' HD22 ' A' ' 127' ' ' ASN . 32.7 tt0 -58.46 127.31 31.49 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 124.064 0.853 . . . . 74.35 112.128 -175.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 87.9 mt -117.32 95.58 5.04 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.994 -1.113 . . . . 72.32 107.994 171.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.427 HD22 ' HG2' ' A' ' 125' ' ' GLN . 4.3 p30 -98.4 126.74 44.04 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.746 -0.835 . . . . 74.24 108.746 176.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 20.3 mt -74.28 149.0 40.94 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.772 -0.649 . . . . 65.21 111.958 -173.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.03 142.02 87.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 123.326 0.651 . . . . 65.52 110.142 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -78.24 96.94 1.11 Allowed 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 122.171 1.914 . . . . 50.1 110.785 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.677 HG11 ' HA ' ' F' ' 125' ' ' TYR . 16.9 m -99.66 114.04 36.71 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.752 0.787 . . . . 73.34 109.04 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -93.23 93.28 8.15 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.964 -1.016 . . . . 73.43 109.663 -173.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -64.55 -26.59 68.48 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 115.306 -0.861 . . . . 62.31 111.316 177.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -67.3 -40.07 86.0 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.625 0.77 . . . . 72.24 110.214 -175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.33 -43.63 77.11 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.985 -1.007 . . . . 72.34 110.776 173.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.7 tt -57.18 -50.14 73.76 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.141 0.977 . . . . 75.41 110.176 -178.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -68.03 -31.35 70.96 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.18 0.592 . . . . 53.33 111.501 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.542 ' SD ' HD23 ' A' ' 141' ' ' LEU . 11.5 tpt -71.17 -38.05 72.17 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.452 0.47 . . . . 61.44 111.157 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 41.3 m-80 -63.94 -19.49 65.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.058 0.543 . . . . 71.34 111.627 176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -90.58 -42.91 10.53 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.439 0.696 . . . . 73.23 110.305 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.542 HD23 ' SD ' ' A' ' 138' ' ' MET . 56.2 tp -65.79 -50.84 63.25 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.824 1.249 . . . . 73.53 112.497 -167.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -154.66 -1.11 0.17 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.109 0.564 . . . . 42.24 110.728 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 27.9 mp0 59.08 -165.04 0.2 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.73 1.212 . . . . 75.0 111.202 -172.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 62.74 90.99 0.07 Allowed 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.672 1.189 . . . . 64.21 109.942 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.78 4.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.954 0.501 . . . . 74.51 110.388 -177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.465 ' HA3' ' HG2' ' C' ' 144' ' ' GLN . . . 152.54 -89.26 0.13 Allowed Glycine 0 C--N 1.349 1.26 0 O-C-N 123.511 0.507 . . . . 34.44 112.563 177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -119.38 158.21 26.61 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 107.587 -1.264 . . . . 73.34 107.587 175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.46 -29.07 0.24 Allowed Glycine 0 N--CA 1.464 0.51 0 N-CA-C 110.346 -1.102 . . . . 63.33 110.346 -177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -145.51 159.62 42.83 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 124.132 0.973 . . . . 64.53 109.557 175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -152.1 104.26 2.96 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 106.041 -1.837 . . . . 75.34 106.041 172.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.81 129.36 41.48 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.196 0.999 . . . . 74.05 112.324 -171.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -67.98 154.6 41.28 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.126 0.971 . . . . 75.2 110.754 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -52.72 133.07 36.97 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.39 1.076 . . . . 73.51 112.512 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -162.1 -62.96 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.931 0.892 . . . . 53.13 109.272 -177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.559 1.308 0 C-N-CA 124.653 1.181 . . . . 72.24 111.058 -179.546 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 58.5 mtt . . . . . 0 N--CA 1.484 1.253 0 N-CA-C 110.228 -0.286 . . . . 70.11 110.228 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.9 m -125.17 141.38 52.14 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.716 0.806 . . . . 73.44 109.594 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -145.66 108.18 4.45 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.134 0.492 . . . . 71.31 110.172 177.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.74 -176.39 5.4 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.538 1.135 . . . . 75.4 108.122 164.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -91.83 168.51 11.39 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.687 -0.486 . . . . 72.15 109.687 176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -144.17 148.15 34.61 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 109.346 -0.613 . . . . 72.52 109.346 176.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.6 m -96.2 158.27 15.52 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 124.298 1.039 . . . . 74.33 110.237 -176.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 77.53 -64.91 0.29 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 126.008 1.723 . . . . 63.02 112.476 176.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 18.7 ptm 50.66 -174.99 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 126.144 1.778 . . . . 74.01 114.205 -177.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.3 m -148.2 131.34 16.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.73 0.812 . . . . 74.44 109.059 178.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.552 ' HD2' HD11 ' F' ' 147' ' ' LEU . 66.9 t80 -136.58 142.74 43.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.756 0.422 . . . . 74.31 110.397 172.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -155.92 140.49 16.91 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.317 1.047 . . . . 74.1 109.306 170.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 61.2 mt -87.07 106.35 15.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 107.478 -1.304 . . . . 63.51 107.478 169.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -78.24 -46.42 20.41 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.68 0.392 . . . . 74.13 110.19 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 ttt180 -163.58 140.87 7.3 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.063 -0.517 . . . . 71.02 110.166 -176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 63.1 mt -117.96 144.84 24.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 107.342 -1.355 . . . . 73.41 107.342 170.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.432 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.7 p90 -170.12 147.0 3.11 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.592 0.633 . . . . 73.13 111.913 -177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 54.4 m -72.92 119.22 16.87 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.666 -1.152 . . . . 73.52 108.069 169.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -90.95 -30.25 16.97 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.326 0.65 . . . . 75.35 110.851 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -158.02 138.94 13.15 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 123.583 0.552 . . . . 72.03 111.112 -171.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.467 HD12 HG22 ' B' ' 78' ' ' VAL . 47.8 mm -132.33 138.22 52.75 Favored 'Isoleucine or valine' 0 C--N 1.347 0.473 0 C-N-CA 124.635 1.174 . . . . 63.34 109.007 173.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.468 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 33.3 t -131.25 136.08 47.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.332 -1.359 . . . . 51.23 107.332 175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.499 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.6 t80 -151.84 122.1 7.24 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.363 -1.347 . . . . 64.5 107.363 171.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 42.1 mt-10 -124.1 133.68 53.55 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.29 -1.004 . . . . 71.42 108.29 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.507 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -128.78 87.47 54.67 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 109.162 -0.681 . . . . 53.05 109.162 175.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.7 -22.99 36.62 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.158 1.905 . . . . 62.11 111.004 172.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -115.04 24.96 11.26 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.135 0.974 . . . . 71.25 111.148 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.507 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -49.81 -53.64 40.21 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 123.704 0.801 . . . . 70.33 111.133 164.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.617 ' HA ' HD11 ' A' ' 83' ' ' ILE . 69.2 Cg_endo -77.0 -22.78 11.16 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 121.907 1.738 . . . . 71.32 113.374 177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 46.0 m-70 -94.46 2.94 55.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.54 0.736 . . . . 73.45 111.662 -173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -53.83 -31.73 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 124.222 1.009 . . . . 74.43 112.813 -176.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -74.12 -34.83 64.05 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.586 0.354 . . . . 62.33 110.772 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -68.93 -23.78 64.21 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.648 1.179 . . . . 44.42 110.962 176.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' B' ' 34' ' ' LYS . 10.6 mmpt? -75.9 100.27 4.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.253 0.621 . . . . 64.1 111.422 -176.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -113.42 78.84 1.17 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.339 1.056 . . . . 75.25 111.149 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -176.89 178.22 1.21 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 126.626 1.97 . . . . 75.44 107.143 171.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -90.56 131.93 36.63 Favored Pre-proline 0 N--CA 1.475 0.815 0 N-CA-C 108.501 -0.926 . . . . 54.24 108.501 164.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HB2' ' HB1' ' B' ' 66' ' ' ALA . 47.6 Cg_endo -67.7 133.6 30.12 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.165 1.91 . . . . 72.43 112.961 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' B' ' 66' ' ' ALA . 25.5 tt0 -51.21 117.18 2.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.811 1.244 . . . . 61.4 109.631 164.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 96.8 t -103.08 134.2 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 122.736 0.414 . . . . 60.32 110.604 -178.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -142.85 101.83 3.92 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.343 1.057 . . . . 64.03 108.611 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 pp -94.8 153.07 17.92 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 109.177 -0.675 . . . . 70.45 109.177 174.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -138.35 130.27 28.26 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.403 -0.962 . . . . 72.13 108.403 -178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 79.3 mt -105.96 128.47 53.82 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.606 -1.257 . . . . 63.34 107.606 174.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 27.3 t70 -142.85 155.66 44.81 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.428 1.091 . . . . 61.12 108.777 -174.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.1 p -141.89 119.59 11.8 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.369 0.668 . . . . 43.44 110.358 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.99 119.07 25.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.372 -0.973 . . . . 72.2 108.372 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 28.7 p -117.0 164.54 14.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.637 0.375 . . . . 70.43 110.979 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.9 p -152.41 136.89 16.78 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.2 1.0 . . . . 73.31 109.03 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -80.8 121.62 26.16 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.227 -0.657 . . . . 75.3 109.227 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 45.6 mt -80.53 -39.87 27.02 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.564 -0.532 . . . . 70.54 109.564 176.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.25 -179.1 4.88 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.758 -1.11 . . . . 51.53 109.966 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.78 129.59 41.15 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.409 -0.814 . . . . 73.45 108.95 173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' B' ' 85' ' ' SER . 2.5 m-20 71.07 1.49 3.83 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.479 1.112 . . . . 74.44 112.283 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 29.8 t -125.75 88.78 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 N-CA-C 108.475 -0.935 . . . . 73.43 108.475 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -108.86 137.85 46.13 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.823 -0.806 . . . . 72.43 108.823 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 tm-20 -119.76 108.3 14.25 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.405 -0.961 . . . . 61.24 108.405 -173.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 t -99.94 124.11 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.857 0.863 . . . . 51.23 109.188 -175.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 24.9 t -103.33 124.79 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 N-CA-C 109.575 -0.528 . . . . 62.2 109.575 176.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.1 OUTLIER -93.3 116.48 29.04 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.001 -1.481 . . . . 73.21 107.001 171.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.502 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 43.1 ttt180 -105.17 107.82 19.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.144 0.577 . . . . 63.41 109.887 177.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 15.9 t -107.9 121.39 60.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 N-CA-C 108.963 -0.754 . . . . 61.13 108.963 172.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 12.2 m -109.46 141.96 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 123.365 0.666 . . . . 72.33 109.532 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.591 HG21 HG21 ' B' ' 114' ' ' ILE . 43.0 t -124.88 127.0 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 123.997 0.919 . . . . 74.2 108.658 171.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.8 m -125.62 147.24 49.38 Favored 'General case' 0 C--O 1.244 0.764 0 N-CA-C 108.776 -0.824 . . . . 62.34 108.776 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 39' ' ' GLU . . . -148.11 148.72 30.93 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 123.605 0.565 . . . . 64.44 111.418 178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.1 m -133.99 126.71 30.84 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 115.327 -0.852 . . . . 54.4 108.743 174.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.584 ' HB2' ' HB2' ' B' ' 73' ' ' ALA . 1.7 tt -118.92 115.82 25.19 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.948 -1.501 . . . . 61.41 106.948 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.47 -143.95 29.94 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.343 -0.703 . . . . 72.51 111.343 -170.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -92.3 19.74 6.76 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.073 0.949 . . . . 62.13 112.197 -175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -150.44 178.93 8.58 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.321 0.648 . . . . 63.55 110.45 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 56.5 m -69.2 139.49 54.54 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.241 0.616 . . . . 65.35 110.551 -178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.584 ' HB2' ' HB2' ' B' ' 68' ' ' LEU . . . -87.41 -65.2 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 122.108 0.956 . . . . 63.32 108.762 176.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -156.02 161.44 40.45 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-N 113.311 -1.768 . . . . 55.11 108.848 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.617 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 81.6 mt -132.17 143.17 49.78 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.079 -1.452 . . . . 74.25 107.079 177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.0 t -155.87 152.22 28.07 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 108.882 -0.784 . . . . 53.23 108.882 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.468 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 39.1 tt0 -165.85 135.9 3.47 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 108.696 -0.853 . . . . 74.41 108.696 -178.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.474 HG21 ' HB3' ' B' ' 113' ' ' CYS . 93.1 t -125.1 143.6 38.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 123.56 0.744 . . . . 52.33 109.022 174.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.502 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 23.3 mt-30 -123.69 91.05 3.39 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.549 -0.908 . . . . 63.03 108.549 173.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -83.8 101.06 11.34 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 115.366 -0.834 . . . . 55.44 109.622 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.1 164.9 32.58 Favored Glycine 0 C--O 1.243 0.661 0 O-C-N 123.419 0.449 . . . . 73.4 112.074 177.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.88 125.34 1.46 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 111.676 -0.57 . . . . 51.34 111.676 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.432 HG13 ' HE1' ' B' ' 17' ' ' TYR . 45.7 mt -85.23 119.64 34.23 Favored 'Isoleucine or valine' 0 C--O 1.243 0.737 0 N-CA-C 108.17 -1.048 . . . . 72.21 108.17 174.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.94 151.3 43.74 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.851 0.86 . . . . 60.31 109.864 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' B' ' 11' ' ' PHE . 13.4 m -96.3 100.57 12.18 Favored 'General case' 0 C--O 1.226 -0.146 0 N-CA-C 108.051 -1.092 . . . . 65.02 108.051 -179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.554 HG21 ' SD ' ' B' ' 94' ' ' MET . 12.3 mm -114.68 109.42 28.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 109.496 -0.557 . . . . 63.24 109.496 -174.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -142.42 153.01 43.37 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.988 0.515 . . . . 64.42 111.077 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.01 -67.15 3.8 Favored Glycine 0 C--N 1.353 1.502 0 O-C-N 123.914 0.759 . . . . 52.33 112.212 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 tt -49.24 135.29 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.289 0 C-N-CA 126.281 1.832 . . . . 73.22 112.325 178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -151.74 177.14 10.69 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 122.658 0.383 . . . . 74.14 111.241 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.08 -133.57 34.0 Favored Glycine 0 C--N 1.351 1.387 0 CA-C-N 115.39 -0.823 . . . . 71.12 113.636 174.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 10.1 m -63.72 -31.94 73.27 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.279 1.032 . . . . 60.13 110.858 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -66.67 -47.62 71.9 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.869 -1.514 . . . . 70.04 109.719 -175.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.554 ' SD ' HG21 ' B' ' 86' ' ' ILE . 11.4 tpt -70.57 -33.97 71.69 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.611 0.764 . . . . 54.13 111.301 176.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.56 85.67 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.813 0.445 . . . . 74.14 111.072 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.433 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 27.2 t-80 -67.49 -37.49 82.92 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.81 0.844 . . . . 74.11 111.189 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.1 t -69.93 -45.25 67.9 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-O 121.5 0.667 . . . . 62.24 110.961 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 46.3 tp -73.27 -38.17 66.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.526 1.13 . . . . 54.42 111.228 -172.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.24 4.81 60.67 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.508 -0.769 . . . . 74.41 114.38 -173.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -150.48 -61.57 0.2 Allowed 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 117.865 0.833 . . . . 72.04 112.758 -175.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -64.63 -52.97 54.62 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.636 0.774 . . . . 73.54 112.148 -170.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.476 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 77.8 m -62.06 -51.15 76.88 Favored Pre-proline 0 CA--C 1.565 1.54 0 CA-C-O 118.274 -0.87 . . . . 72.31 112.33 -178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 32.3 Cg_exo -61.38 -29.51 85.71 Favored 'Trans proline' 0 C--N 1.393 2.872 0 C-N-CA 121.935 1.757 . . . . 74.03 113.764 176.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -66.46 -35.99 81.65 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.941 0.497 . . . . 71.25 111.221 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 82.6 mt -60.75 -40.26 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 C-N-CA 124.043 0.937 . . . . 72.22 110.166 172.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.85 -18.84 31.72 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.871 -1.059 . . . . 63.52 112.763 -169.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -59.4 -45.95 98.96 Favored Pre-proline 0 N--CA 1.485 1.282 0 N-CA-C 114.301 1.223 . . . . 74.24 114.301 -174.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -50.89 -43.27 48.06 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 122.347 2.032 . . . . 74.4 113.734 176.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -70.0 -44.02 70.22 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.247 -0.888 . . . . 72.43 110.561 -177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.28 -44.31 96.83 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.451 0.7 . . . . 71.44 110.917 178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.588 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.7 ttt180 -56.88 -58.55 7.63 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.491 1.517 . . . . 75.32 110.92 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -57.09 -38.83 73.91 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.729 1.212 . . . . 70.15 111.085 178.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.9 t -66.05 -46.95 75.97 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 116.286 -0.415 . . . . 75.04 110.935 -176.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.591 HG21 HG21 ' B' ' 64' ' ' VAL . 50.7 mt -60.37 -53.4 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 122.743 0.417 . . . . 62.34 110.589 179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -62.58 -26.76 68.76 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-N 115.271 -0.877 . . . . 72.35 111.406 -173.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 48.1 t -72.26 -50.07 30.13 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.138 0.575 . . . . 51.43 110.526 172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 23.1 mmt -65.65 -35.06 79.68 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 123.441 0.696 . . . . 64.3 112.273 -173.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 10.9 p -73.65 -34.19 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 122.773 0.429 . . . . 63.43 110.751 177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 33.2 t -67.63 -30.4 69.97 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.762 0.825 . . . . 73.1 110.565 175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.422 ' NH2' ' HG3' ' C' ' 112' ' ' GLU . 92.6 mtt-85 -65.79 -26.77 67.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.702 0.801 . . . . 73.04 111.552 176.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.1 10.4 65.7 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-O 119.681 -0.51 . . . . 62.03 114.261 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 5.1 p 67.85 12.09 8.67 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.18 1.792 . . . . 62.52 113.129 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -85.88 159.1 55.36 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.877 -0.582 . . . . 74.25 110.311 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -41.81 124.94 2.85 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.512 2.808 . . . . 71.3 113.271 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.414 ' HB2' HE21 ' C' ' 125' ' ' GLN . 53.3 tt0 -65.47 111.78 3.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.552 -0.749 . . . . 72.45 109.517 178.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.9 94.79 5.2 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.154 -1.054 . . . . 73.22 108.154 -177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -91.66 121.73 33.58 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 107.847 -1.168 . . . . 75.44 107.847 179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.588 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 6.6 mp -73.8 144.83 45.4 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.493 0.717 . . . . 74.14 110.92 -172.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.37 144.88 54.37 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 115.274 -0.876 . . . . 64.25 109.686 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.69 ' HG3' HD13 ' D' ' 16' ' ' ILE . 37.0 Cg_endo -63.07 99.41 0.22 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.626 2.217 . . . . 50.43 112.327 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 m -91.38 132.03 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-O 121.307 0.575 . . . . 65.01 110.249 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -95.46 113.12 24.74 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.84 0.856 . . . . 50.2 108.983 176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -72.81 -18.71 61.44 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.698 0.799 . . . . 62.02 111.841 -174.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.86 -41.6 95.54 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.199 0.6 . . . . 62.12 109.742 173.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.02 88.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.284 -0.871 . . . . 55.45 110.057 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.26 -33.33 73.35 Favored 'General case' 0 CA--C 1.548 0.894 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.442 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -74.9 -46.59 34.93 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.101 0.96 . . . . 73.44 111.321 -177.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 65.7 mtt -79.21 -36.38 40.21 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.228 0.611 . . . . 71.22 111.598 -173.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -77.54 -13.7 59.85 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.272 0.629 . . . . 71.14 111.09 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -64.75 -34.14 77.63 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 121.612 0.72 . . . . 70.03 109.972 171.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 57.0 mt -90.36 9.74 27.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.607 -1.178 . . . . 52.4 110.511 176.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.604 ' HG3' ' HG2' ' B' ' 143' ' ' GLN . 6.7 tp60 60.68 -92.38 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.365 1.466 . . . . 71.45 109.996 -168.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.604 ' HG2' ' HG3' ' B' ' 142' ' ' GLN . 13.5 pt20 -169.52 156.03 6.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.179 0.992 . . . . 72.2 109.037 -178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.71 128.3 10.77 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 109.66 -0.496 . . . . 70.11 109.66 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.03 -54.3 0.92 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.888 0.875 . . . . 74.34 109.089 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.7 -78.15 0.49 Allowed Glycine 0 C--N 1.35 1.352 0 CA-C-N 115.265 -0.88 . . . . 44.44 111.285 -174.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -96.95 103.37 15.3 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.173 0.989 . . . . 72.01 108.864 174.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.79 92.48 0.09 OUTLIER Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.467 -0.653 . . . . 74.54 111.467 178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 22.4 p -73.21 102.68 3.7 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.584 0.754 . . . . 72.14 112.078 -174.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -80.6 106.78 12.87 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.302 1.041 . . . . 74.5 110.024 177.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -92.69 144.47 25.28 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.035 0.934 . . . . 64.11 110.108 178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -120.2 99.14 6.41 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.516 0.726 . . . . 55.44 110.278 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -81.8 77.91 8.58 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.312 0.645 . . . . 75.2 109.933 176.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.82 84.75 3.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.68 -0.691 . . . . 52.52 109.638 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 108.399 -0.964 . . . . 61.34 108.399 -178.502 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.483 1.215 0 N-CA-C 110.108 -0.33 . . . . 72.1 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.7 p -91.04 -92.29 0.14 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.153 0.581 . . . . 71.3 109.591 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.438 ' HB2' ' HD3' ' F' ' 124' ' ' ARG . 3.5 tm-20 -127.82 98.46 5.17 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.424 -0.954 . . . . 74.42 108.424 -176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -135.6 22.47 3.38 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.437 1.095 . . . . 74.34 108.874 170.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.523 ' H ' HD22 ' C' ' 5' ' ' ASN . 0.1 OUTLIER -89.09 100.49 13.25 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 122.115 0.959 . . . . 71.24 111.239 -171.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.568 ' HA ' ' HA2' ' C' ' 146' ' ' GLY . 2.6 p30 -146.65 79.78 1.53 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.453 1.101 . . . . 73.32 108.862 178.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -96.04 -67.13 0.87 Allowed 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.117 -0.947 . . . . 74.52 109.477 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -169.42 168.44 9.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.369 1.067 . . . . 72.51 108.88 175.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 29.3 ttm 66.85 112.36 0.04 OUTLIER 'General case' 0 C--N 1.348 0.503 0 C-N-CA 125.934 1.694 . . . . 73.52 111.435 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 12.8 m -101.36 75.16 1.6 Allowed 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.535 -1.283 . . . . 72.21 107.535 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' C' ' 85' ' ' SER . 56.6 t80 -84.8 118.06 24.24 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 108.221 -1.029 . . . . 54.33 108.221 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -147.49 131.97 17.68 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 108.725 -0.842 . . . . 41.35 108.725 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.2 mt -75.95 125.65 35.84 Favored 'Isoleucine or valine' 0 C--O 1.239 0.517 0 N-CA-C 108.75 -0.834 . . . . 74.4 108.75 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 26.3 mm-40 -95.11 -45.49 7.19 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 72.12 110.115 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.6 HH22 HD12 ' F' ' 134' ' ' ILE . 76.9 ttt180 -166.76 126.31 1.5 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 122.958 0.503 . . . . 74.21 109.888 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.9 mt -108.01 144.3 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 107.974 -1.121 . . . . 73.2 107.974 174.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -177.97 161.22 1.53 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.454 0.645 . . . . 73.02 111.017 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 82.3 p -86.28 110.69 19.82 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.38 -0.827 . . . . 72.23 108.977 174.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.473 ' HD2' ' HB3' ' D' ' 28' ' ' ALA . 7.3 mmmt -72.23 -44.71 62.49 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.397 -0.964 . . . . 72.32 108.397 172.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.9 t70 -134.51 143.86 47.69 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 114.661 -1.154 . . . . 70.34 110.234 -176.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.471 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 96.6 mt -141.93 147.77 21.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 126.267 1.827 . . . . 74.13 106.444 177.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -157.55 151.64 24.55 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.066 0.546 . . . . 71.13 110.153 174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -148.74 146.28 28.01 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 107.871 -1.159 . . . . 75.02 107.871 173.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.426 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 47.6 mt-10 -141.79 150.11 41.28 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 107.259 -1.385 . . . . 71.32 107.259 174.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.458 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -154.85 88.97 3.19 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 108.687 -0.857 . . . . 74.13 108.687 175.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -61.47 -45.58 17.65 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 122.832 2.355 . . . . 75.05 111.759 175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 67.1 m-80 -98.79 40.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.733 -0.667 . . . . 62.11 110.594 177.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.57 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -59.19 -42.19 91.88 Favored Pre-proline 0 N--CA 1.491 1.584 0 C-N-CA 124.335 1.054 . . . . 61.42 113.32 173.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.95 -34.7 0.26 Allowed 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 121.611 1.541 . . . . 64.53 112.833 169.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 38.1 t-80 -68.11 -19.49 64.84 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.064 1.346 . . . . 73.21 111.874 -172.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.562 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.1 p -48.58 -35.27 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 C-N-CA 124.618 1.167 . . . . 73.15 113.55 175.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -59.18 -40.4 85.56 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.797 0.839 . . . . 71.24 111.35 176.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -115.6 18.31 15.9 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.364 -0.835 . . . . 72.41 111.331 -173.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.562 ' HE2' HG23 ' C' ' 31' ' ' VAL . 0.0 OUTLIER -82.63 165.51 19.97 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 109.236 -0.653 . . . . 75.12 109.236 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -88.39 130.75 35.09 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.721 -0.844 . . . . 71.24 108.721 171.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -75.34 85.85 2.51 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.632 0.73 . . . . 74.03 110.075 178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -154.27 68.8 6.0 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-N 114.562 -1.199 . . . . 64.31 107.773 166.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -91.95 112.34 0.31 Allowed 'Trans proline' 0 C--N 1.377 2.073 0 C-N-CA 122.334 2.023 . . . . 60.02 111.287 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -86.56 95.04 9.61 Favored 'General case' 0 C--O 1.246 0.919 0 N-CA-C 108.104 -1.073 . . . . 53.01 108.104 175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.4 p -73.95 107.58 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 115.126 -0.943 . . . . 44.45 110.134 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.416 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 62.5 mttp -91.05 102.83 15.59 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.669 -1.234 . . . . 72.13 107.669 172.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.503 HD23 HG22 ' C' ' 64' ' ' VAL . 3.1 tm? -87.07 145.23 26.54 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.131 -1.063 . . . . 74.25 108.131 178.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 31.2 t70 -139.91 137.82 35.14 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.874 0.87 . . . . 71.04 108.691 -176.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 86.9 mt -130.34 146.49 51.93 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.894 0.878 . . . . 60.42 109.149 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.04 154.71 28.06 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.045 0.938 . . . . 54.23 109.218 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 9.9 t -155.87 148.54 24.01 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 120.929 0.395 . . . . 64.21 110.384 172.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.78 163.35 33.59 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.04 0.936 . . . . 73.12 109.036 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 50.1 p -130.72 147.16 52.35 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.994 0.517 . . . . 53.2 110.048 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 35.0 p -143.97 129.06 18.64 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.73 0.812 . . . . 72.24 109.305 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -78.46 116.49 18.89 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.915 0.486 . . . . 73.03 110.295 -175.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' C' ' 57' ' ' GLU . 47.2 mt -87.96 -45.77 9.95 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.799 0.84 . . . . 73.05 109.317 177.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.71 -179.49 6.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.39 -1.277 . . . . 60.44 109.343 177.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.38 109.57 0.91 Allowed 'General case' 0 N--CA 1.479 0.979 0 O-C-N 123.929 0.768 . . . . 65.41 110.216 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 68.67 22.44 7.5 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.603 1.161 . . . . 64.22 112.018 176.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 89.3 t -120.1 105.61 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 124.511 1.124 . . . . 62.54 108.027 173.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -114.64 128.81 56.52 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.675 0.79 . . . . 74.53 110.07 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.578 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.98 115.29 22.25 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.595 0.758 . . . . 74.35 109.195 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 99.9 t -96.81 121.17 47.05 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 108.14 -1.059 . . . . 44.12 108.14 173.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.7 105.31 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 108.5 -0.926 . . . . 50.31 108.5 177.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' C' ' 103' ' ' PRO . 2.3 tm? -91.29 105.0 17.47 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.277 -1.008 . . . . 70.01 108.277 176.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -95.9 121.93 38.16 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.951 0.9 . . . . 70.24 110.194 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.413 ' HB ' HD11 ' C' ' 114' ' ' ILE . 10.8 t -107.35 146.67 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 107.909 -1.145 . . . . 74.54 107.909 169.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 23.4 m -139.46 120.69 14.82 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.495 0.664 . . . . 62.31 109.501 170.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.503 HG22 HD23 ' C' ' 42' ' ' LEU . 85.7 t -101.85 108.86 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.73 -1.123 . . . . 75.32 108.472 174.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.416 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 6.8 m -97.92 135.55 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.178 -1.415 . . . . 73.34 107.178 169.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.28 102.97 5.15 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.028 -1.471 . . . . 63.35 107.028 -177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.438 ' HB3' HG23 ' C' ' 72' ' ' THR . 26.2 p -168.51 154.48 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.695 0.622 . . . . 51.44 110.838 -172.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 26.0 tp -95.5 -42.81 8.27 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 109.187 -0.672 . . . . 52.42 109.187 171.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . -174.42 -80.85 0.05 OUTLIER Glycine 0 C--N 1.347 1.179 0 N-CA-C 110.781 -0.928 . . . . 55.41 110.781 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -89.4 -31.65 17.65 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 108.779 -0.823 . . . . 73.11 108.779 171.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.91 85.25 2.23 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 115.626 -0.715 . . . . 74.55 109.48 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.438 HG23 ' HB3' ' C' ' 67' ' ' SER . 27.5 m -89.31 116.86 27.84 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 116.233 -0.44 . . . . 75.45 110.197 172.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.51 -64.78 0.81 Allowed 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 107.511 -1.292 . . . . 55.14 107.511 172.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -162.81 171.61 16.47 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.545 0.688 . . . . 54.13 111.645 178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.7 tm? -132.08 145.35 51.35 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 105.563 -2.014 . . . . 73.21 105.563 171.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.5 t -151.72 142.99 23.35 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.382 -0.97 . . . . 62.34 108.382 175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -150.1 134.25 17.11 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 109.404 -0.591 . . . . 73.43 109.404 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' C' ' 110' ' ' ALA . 50.3 t -134.27 113.69 17.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 123.89 0.876 . . . . 65.34 108.661 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.751 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 54.3 mt-30 -91.05 90.13 7.71 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.525 -0.917 . . . . 73.25 108.525 171.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.454 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 7.7 tp-100 -78.81 103.77 8.99 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.84 -1.073 . . . . 74.1 109.48 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.74 144.74 22.28 Favored Glycine 0 C--N 1.34 0.781 0 N-CA-C 111.458 -0.657 . . . . 72.13 111.458 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.531 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.05 117.1 0.9 Allowed Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.557 -1.017 . . . . 74.5 110.557 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.525 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -80.0 126.73 39.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 N-CA-C 107.854 -1.165 . . . . 60.21 107.854 177.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -134.6 143.33 47.27 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 122.892 0.477 . . . . 73.44 109.812 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' C' ' 11' ' ' PHE . 15.6 m -82.1 107.14 14.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.656 -1.238 . . . . 75.15 107.656 167.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -116.4 99.72 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 108.095 -1.076 . . . . 73.42 108.095 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' C' ' 9' ' ' MET . . . -128.75 159.31 36.09 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.362 1.065 . . . . 62.43 110.152 -176.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.44 -53.45 4.37 Favored Glycine 0 C--N 1.344 0.974 0 O-C-N 123.53 0.519 . . . . 72.13 113.435 171.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' C' ' 94' ' ' MET . 30.0 pt -80.92 150.82 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.872 0.869 . . . . 65.12 112.117 -171.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -147.23 153.75 40.18 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.77 1.228 . . . . 72.44 108.85 -173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.64 -111.32 2.07 Favored Glycine 0 C--N 1.355 1.612 0 O-C-N 123.548 0.53 . . . . 74.04 114.136 170.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 24.9 p -50.6 -55.42 16.37 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.293 1.437 . . . . 74.24 112.868 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -65.38 -46.32 80.57 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.054 0.542 . . . . 73.55 111.502 -175.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.405 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.0 ptt? -68.83 -31.48 70.5 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 123.356 0.41 . . . . 75.42 111.484 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.58 -47.61 75.18 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.166 0.587 . . . . 73.11 111.528 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -69.58 -29.46 67.01 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.837 -0.62 . . . . 71.43 110.846 177.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.34 -58.93 3.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 122.908 0.483 . . . . 42.45 110.486 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 pp -73.36 -15.62 61.37 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.94 0.496 . . . . 74.21 111.652 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.32 7.73 58.46 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-O 119.588 -0.562 . . . . 64.13 113.822 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB2' ' HD2' ' C' ' 133' ' ' PHE . . . -159.43 -60.32 0.07 Allowed 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 117.689 0.745 . . . . 71.14 112.152 -178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -73.41 -44.8 57.65 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 123.453 0.701 . . . . 74.21 112.788 -167.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 38.0 m -68.65 -47.2 34.44 Favored Pre-proline 0 CA--C 1.566 1.591 0 C-N-CA 123.14 0.576 . . . . 53.41 111.415 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 38.2 Cg_exo -64.48 -26.15 62.66 Favored 'Trans proline' 0 C--N 1.391 2.788 0 C-N-CA 122.177 1.918 . . . . 74.45 114.192 173.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.541 ' ND2' HD22 ' C' ' 132' ' ' ASN . 29.2 t-20 -55.06 -49.05 72.6 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 123.894 0.877 . . . . 70.14 110.277 176.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.6 mm -56.96 -41.98 78.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 O-C-N 124.163 0.915 . . . . 71.11 110.897 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.531 HD21 ' HA3' ' C' ' 82' ' ' GLY . 70.1 mt -83.41 -23.0 32.55 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-N 115.126 -0.943 . . . . 63.43 112.566 -171.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -59.74 -50.34 87.25 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.57 -1.205 . . . . 64.32 113.494 -174.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.41 -34.17 93.82 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.071 1.847 . . . . 72.34 112.918 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -68.0 -50.72 53.87 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.787 0.835 . . . . 73.11 111.448 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -65.31 -35.03 79.74 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 116.018 -0.537 . . . . 50.21 111.117 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.473 HH12 ' HG3' ' C' ' 130' ' ' PRO . 59.6 ttt180 -60.66 -48.51 81.47 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.797 1.639 . . . . 60.14 110.647 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.422 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 3.1 tm-20 -72.82 -33.62 66.31 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.873 0.469 . . . . 74.41 109.993 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.423 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 8.6 t -65.55 -28.73 69.38 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.979 0.512 . . . . 74.04 111.135 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.468 HD13 HG23 ' C' ' 64' ' ' VAL . 87.9 mt -78.77 -51.98 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 CA-C-N 115.659 -0.7 . . . . 54.32 110.033 173.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 33.6 m -58.97 -28.56 66.44 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.251 0.548 . . . . 71.45 111.173 -176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 44.6 t -63.38 -55.27 25.77 Favored 'General case' 0 C--N 1.348 0.51 0 C-N-CA 124.266 1.026 . . . . 74.33 109.053 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.473 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.49 -34.69 71.19 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 124.739 1.216 . . . . 73.22 112.774 179.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.453 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.9 t -66.2 -48.09 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 108.855 -0.794 . . . . 73.45 108.855 177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 46.7 t -66.46 -31.97 73.05 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.022 -0.99 . . . . 70.33 111.214 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.407 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 78.5 mtt-85 -66.94 -40.85 87.68 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.524 0.73 . . . . 72.11 109.437 176.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.73 3.93 62.52 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.826 0.704 . . . . 71.14 112.988 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 59.69 31.33 20.81 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.436 1.894 . . . . 65.21 112.994 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.98 153.47 43.42 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.078 0.951 . . . . 72.13 108.929 171.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -76.2 -169.89 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.91 2.406 . . . . 73.55 113.536 -175.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' B' ' 125' ' ' GLN . 50.9 mm-40 -52.28 117.96 3.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.367 1.067 . . . . 71.52 113.138 -175.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' E' ' 139' ' ' LEU . 2.8 tm? -139.55 104.39 4.93 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 107.033 -1.469 . . . . 72.33 107.033 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -134.12 131.1 38.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.672 1.189 . . . . 64.31 108.227 175.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -86.11 142.54 28.6 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.925 -0.398 . . . . 74.13 109.925 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.77 139.03 97.55 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 124.32 1.048 . . . . 53.41 111.922 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.473 ' HG3' HH12 ' C' ' 111' ' ' ARG . 27.0 Cg_exo -63.44 98.28 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.758 2.305 . . . . 74.33 112.837 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 2.7 p -98.86 109.17 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 109.05 -0.722 . . . . 71.51 109.05 175.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.541 HD22 ' ND2' ' C' ' 104' ' ' ASN . 19.2 m120 -115.36 102.99 10.35 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.79 0.836 . . . . 64.11 109.95 -178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' C' ' 100' ' ' ALA . 67.2 t80 -80.37 -24.18 39.97 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-O 121.58 0.705 . . . . 75.15 110.212 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -75.33 -39.0 59.89 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.406 1.083 . . . . 71.24 111.123 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.479 ' HA ' ' HG3' ' C' ' 138' ' ' MET . . . -59.96 -39.12 84.52 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.884 0.74 . . . . 60.41 111.395 -178.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 46.9 tp -54.02 -45.01 71.44 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.276 1.03 . . . . 73.25 111.212 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -80.71 -36.56 32.01 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.245 -0.888 . . . . 73.32 111.772 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.479 ' HG3' ' HA ' ' C' ' 135' ' ' ALA . 0.0 OUTLIER -70.24 -29.01 65.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 112.029 0.381 . . . . 75.21 112.029 -170.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -59.07 -44.12 91.82 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 120.884 0.373 . . . . 74.33 110.646 172.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -71.62 -84.88 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.514 -0.766 . . . . 70.42 109.303 171.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 53.9 tp -105.03 118.9 37.7 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.747 0.819 . . . . 62.0 109.926 -177.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -73.83 177.45 5.53 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.819 0.848 . . . . 61.45 111.156 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -103.09 154.6 19.11 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.26 1.024 . . . . 72.14 110.879 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.465 ' HG2' ' HA3' ' A' ' 146' ' ' GLY . 35.1 mt-30 -75.4 157.84 33.59 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.231 0.612 . . . . 72.01 111.274 178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -140.25 112.45 7.73 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.088 0.955 . . . . 52.42 109.163 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.568 ' HA2' ' HA ' ' C' ' 6' ' ' ASN . . . -118.95 67.37 0.37 Allowed Glycine 0 C--N 1.339 0.709 0 N-CA-C 111.46 -0.656 . . . . 72.34 111.46 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -122.08 179.38 4.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.459 0.704 . . . . 60.12 110.494 175.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -166.06 142.91 7.98 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.278 -0.874 . . . . 74.45 111.038 177.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -74.0 -68.96 0.47 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.05 -0.722 . . . . 72.45 109.05 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 44.22 80.3 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.964 1.305 . . . . 74.42 111.61 177.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -59.65 -39.92 85.97 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.214 -0.903 . . . . 73.5 110.725 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -175.61 -81.95 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 O-C-N 124.638 1.211 . . . . 71.14 109.281 165.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -144.48 151.32 39.01 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 124.828 1.251 . . . . 72.12 108.605 -177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t70 65.57 107.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 124.216 1.006 . . . . 63.2 111.027 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.312 0 N-CA-C 109.245 -0.65 . . . . 72.23 109.245 179.426 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.485 1.288 0 N-CA-C 109.686 -0.487 . . . . 74.45 109.686 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t 179.67 69.85 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 106.771 -1.566 . . . . 75.4 106.771 -177.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -78.27 75.27 4.8 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.077 -0.965 . . . . 75.13 110.182 -172.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -134.41 100.09 4.56 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.223 -1.029 . . . . 61.4 108.223 -177.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -77.81 100.17 6.21 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.126 0.97 . . . . 74.52 109.089 -178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -57.47 131.81 51.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.376 0.67 . . . . 74.14 111.779 -176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.6 t -70.4 -40.21 74.02 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.406 0.683 . . . . 64.33 111.522 -175.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -82.66 132.18 35.19 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.027 0.531 . . . . 73.43 109.72 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -30.4 135.86 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 125.367 1.667 . . . . 64.41 114.851 178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 45.5 m -145.69 143.65 29.91 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.452 1.101 . . . . 72.43 109.202 174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' D' ' 85' ' ' SER . 44.8 t80 -154.08 109.92 3.23 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.053 -1.091 . . . . 71.53 108.053 174.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -115.8 116.42 27.99 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.313 0.645 . . . . 64.01 110.259 -174.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 30.9 pt -78.39 99.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 N-CA-C 108.483 -0.932 . . . . 75.21 108.483 171.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -83.44 -45.31 13.8 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 121.944 -0.472 . . . . 74.23 111.669 -173.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.422 ' HG2' ' HD1' ' D' ' 17' ' ' TYR . 20.5 ttt180 -164.71 126.6 2.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 110.597 -0.149 . . . . 75.3 110.597 -167.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.69 HD13 ' HG3' ' B' ' 130' ' ' PRO . 1.7 mp -113.15 133.68 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.639 -1.245 . . . . 62.44 107.639 174.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HD1' ' HG2' ' D' ' 15' ' ' ARG . 22.9 p90 -159.03 178.42 10.08 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 123.429 0.692 . . . . 71.42 111.782 -176.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 58.2 p -107.36 132.19 53.42 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.619 -0.882 . . . . 73.34 108.619 171.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.57 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 32.0 mtpt -96.21 -31.48 12.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 110.195 -0.298 . . . . 62.54 110.195 175.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 12.0 t70 -150.24 141.27 22.98 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.929 0.892 . . . . 74.11 108.916 -177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.473 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.1 mt -143.75 148.51 18.81 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 124.7 1.2 . . . . 50.05 107.921 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.6 t -151.64 145.46 25.09 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.331 1.053 . . . . 72.21 109.176 174.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' C' ' 20' ' ' ASP . 84.6 t80 -150.59 125.27 9.69 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 105.725 -1.954 . . . . 73.44 105.725 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -131.79 131.94 43.35 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 118.139 0.427 . . . . 71.1 110.104 -178.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.513 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.55 79.69 11.22 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.779 -0.823 . . . . 75.13 108.779 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.77 -39.72 14.42 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.584 2.189 . . . . 73.32 111.303 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -98.79 24.73 7.27 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.726 0.811 . . . . 52.33 109.97 -175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.513 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -51.97 -49.13 85.77 Favored Pre-proline 0 CA--C 1.573 1.851 0 N-CA-C 115.132 1.53 . . . . 43.45 115.132 179.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.83 -7.37 9.47 Favored 'Trans proline' 0 C--N 1.39 2.745 0 CA-C-N 121.791 1.675 . . . . 62.33 112.996 175.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -83.82 -40.15 19.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 74.11 109.813 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 11.5 p -81.42 -12.05 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.549 0.739 . . . . 62.51 110.712 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -56.82 -29.77 63.08 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 124.667 1.187 . . . . 74.53 111.815 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -70.89 -14.24 62.32 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.228 1.011 . . . . 64.32 112.124 178.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -123.42 108.76 13.06 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.805 0.842 . . . . 64.11 109.771 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -97.69 82.16 3.02 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 121.654 0.74 . . . . 64.14 110.383 -178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 -148.63 165.46 31.25 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.193 0.997 . . . . 74.05 108.666 175.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.481 ' HB3' ' HG ' ' F' ' 141' ' ' LEU . 15.5 mp0 -69.52 110.67 6.8 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.281 1.433 . . . . 74.44 111.222 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 16.6 Cg_exo -71.12 124.07 10.2 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 123.058 2.505 . . . . 70.45 112.392 -178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -60.99 118.91 7.33 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.378 0.424 . . . . 72.04 110.807 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.484 HG23 HG13 ' D' ' 64' ' ' VAL . 2.3 p -98.91 128.0 50.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.797 0.839 . . . . 43.15 109.498 -176.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.495 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 9.3 tmtt? -99.29 117.0 32.78 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 106.046 -1.835 . . . . 74.41 106.046 170.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.467 HD22 HD22 ' D' ' 128' ' ' LEU . 53.2 tp -95.1 134.79 37.42 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.984 -1.117 . . . . 65.14 107.984 176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 8.5 t70 -135.43 149.92 49.72 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.263 -1.384 . . . . 75.14 107.263 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 pp -135.43 164.69 27.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.482 0.313 . . . . 63.41 111.195 -174.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 24.9 t70 -171.23 156.18 4.59 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.514 1.125 . . . . 63.12 109.351 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 11.9 t -134.63 160.54 37.79 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.476 0.711 . . . . 73.42 110.003 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.1 162.83 39.17 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.056 0.942 . . . . 43.21 109.344 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.2 p -140.63 157.94 44.72 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.163 0.585 . . . . 71.23 110.803 -177.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 30.8 t -161.15 130.2 4.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.571 1.148 . . . . 34.11 108.567 -177.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -89.89 123.55 33.93 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 109.09 -0.707 . . . . 73.42 109.09 172.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' D' ' 57' ' ' GLU . 56.6 mt -97.94 -35.62 10.41 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.791 0.836 . . . . 62.11 110.056 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -160.32 -175.62 5.14 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.954 -1.021 . . . . 44.02 110.564 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -60.97 109.39 1.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 114.787 -1.097 . . . . 62.23 109.674 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 65.81 10.01 6.5 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.985 1.314 . . . . 75.12 112.925 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 89.1 t -109.02 118.33 56.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.233 -1.025 . . . . 62.52 108.233 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -129.63 129.83 44.83 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.066 -0.97 . . . . 73.43 109.74 -171.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.615 ' HB2' HD11 ' D' ' 51' ' ' LEU . 35.3 tt0 -87.24 130.75 34.45 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.316 1.046 . . . . 73.13 108.683 168.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 11.8 p -121.0 145.0 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 108.142 -1.059 . . . . 72.05 108.142 172.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 85.6 t -117.46 142.46 31.48 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 C-N-CA 124.017 0.927 . . . . 74.13 108.73 -178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.0 116.56 24.53 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 107.435 -1.321 . . . . 63.1 107.435 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 34.2 ttm-85 -101.44 103.92 14.84 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.126 -1.064 . . . . 53.32 108.126 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 97.5 t -103.73 117.77 49.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 108.244 -1.021 . . . . 72.03 108.244 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 10.4 m -118.02 127.92 54.27 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.245 0.618 . . . . 74.5 110.385 -171.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 73.4 t -114.63 123.78 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 125.322 1.449 . . . . 63.42 108.962 -178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 32.3 m -123.6 91.61 3.51 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 107.908 -1.145 . . . . 73.13 107.908 175.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.28 138.74 34.3 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 109.254 -0.647 . . . . 52.34 109.254 -176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 30.2 p -154.62 125.86 7.31 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.437 -0.801 . . . . 72.54 109.692 -173.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.406 ' O ' ' HB3' ' D' ' 71' ' ' GLU . 46.4 tp -113.38 99.19 7.59 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.067 -0.716 . . . . 74.03 109.067 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.83 -128.74 9.08 Favored Glycine 0 C--N 1.341 0.821 0 N-CA-C 112.157 -0.377 . . . . 61.35 112.157 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -90.33 14.54 12.52 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 124.307 1.043 . . . . 71.43 110.839 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' D' ' 68' ' ' LEU . 3.3 tp10 -115.31 134.31 55.23 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.179 0.992 . . . . 73.2 111.431 -158.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 65.3 m -69.59 110.47 4.83 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.594 -0.891 . . . . 75.24 108.594 161.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.79 -66.83 0.84 Allowed 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.66 -0.496 . . . . 61.31 109.66 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -154.35 136.6 14.85 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 121.399 0.619 . . . . 71.13 110.265 169.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 57.3 mt -105.12 152.49 22.73 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.649 1.18 . . . . 52.42 108.0 175.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' D' ' 64' ' ' VAL . 41.0 t -160.37 148.77 16.7 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.119 0.568 . . . . 33.33 109.963 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -155.7 125.75 6.59 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.818 -0.808 . . . . 75.21 108.818 169.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -125.34 115.41 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.413 0.685 . . . . 74.34 109.607 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.604 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 21.1 mt-30 -93.89 87.11 5.27 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.719 -0.845 . . . . 73.25 108.719 171.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -79.04 110.01 13.87 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 114.434 -1.257 . . . . 64.12 108.45 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.45 143.93 15.75 Favored Glycine 0 N--CA 1.472 1.055 0 N-CA-C 112.239 -0.344 . . . . 72.55 112.239 -178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.48 139.84 9.45 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 116.833 0.317 . . . . 71.33 112.347 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 58.1 mt -88.35 123.17 40.63 Favored 'Isoleucine or valine' 0 C--O 1.245 0.837 0 C-N-CA 123.806 0.842 . . . . 71.31 108.984 173.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -133.08 141.51 48.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.106 0.963 . . . . 71.33 108.729 175.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 17.4 m -102.37 112.69 25.5 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.315 -0.624 . . . . 70.51 109.315 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 3.8 mp -106.99 103.56 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.245 -1.02 . . . . 73.14 108.245 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -131.55 153.48 49.81 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.442 1.097 . . . . 74.42 109.711 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.64 2.78 61.29 Favored Glycine 0 C--N 1.349 1.294 0 O-C-N 123.102 0.252 . . . . 71.21 113.367 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 44.9 mm -131.41 129.83 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.861 1.264 . . . . 74.04 108.317 -176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.65 179.1 7.02 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.191 0.997 . . . . 74.04 110.814 -174.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.0 -135.46 24.39 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-N 115.886 -0.597 . . . . 63.11 114.083 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.7 p -80.1 -21.85 42.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.936 0.894 . . . . 75.51 111.927 -178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -70.57 -40.4 73.35 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.959 0.504 . . . . 75.34 111.164 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.84 -28.64 64.75 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 110.311 -0.255 . . . . 72.24 110.311 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.55 -32.76 66.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.475 0.71 . . . . 64.25 110.555 176.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -65.93 -43.43 88.12 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.257 0.623 . . . . 73.35 110.198 170.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.54 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 89.8 m -61.67 -42.33 98.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 122.437 0.295 . . . . 65.41 110.884 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -73.01 -40.02 65.54 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.065 0.546 . . . . 63.31 111.629 -175.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.97 3.68 38.59 Favored Glycine 0 N--CA 1.474 1.191 0 CA-C-O 119.414 -0.659 . . . . 71.55 114.662 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.466 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -144.43 -63.24 0.37 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.979 0.889 . . . . 74.21 112.203 -178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.54 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 82.7 t80 -64.95 -58.19 6.79 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.372 0.508 . . . . 72.51 112.372 -170.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 66.1 m -59.94 -44.23 96.36 Favored Pre-proline 0 CA--C 1.569 1.678 0 CA-C-O 118.513 -0.756 . . . . 72.02 112.737 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -55.43 -37.5 94.76 Favored 'Trans proline' 0 C--N 1.39 2.76 0 C-N-CA 122.419 2.079 . . . . 63.22 113.919 167.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -68.96 -28.54 66.73 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.446 0.698 . . . . 54.34 110.858 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 48.6 mm -66.5 -40.63 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 121.398 0.618 . . . . 63.23 109.773 170.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.422 HD21 ' HA3' ' D' ' 82' ' ' GLY . 82.7 mt -76.53 -18.97 58.42 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.23 -0.896 . . . . 61.24 112.008 -176.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -64.11 -43.4 74.01 Favored Pre-proline 0 N--CA 1.491 1.576 0 N-CA-C 114.293 1.22 . . . . 73.44 114.293 -172.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -51.45 -39.94 63.51 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.051 1.834 . . . . 61.52 113.292 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -78.93 -30.18 44.52 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.746 0.818 . . . . 75.32 111.621 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.67 65.62 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.212 0.605 . . . . 63.4 109.641 175.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -56.44 -49.42 74.62 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-N 114.2 -1.364 . . . . 75.32 110.607 177.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.73 -45.9 92.48 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.041 0.838 . . . . 75.45 111.697 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -59.13 -40.97 87.1 Favored 'General case' 0 N--CA 1.478 0.949 0 O-C-N 123.715 0.635 . . . . 71.42 110.745 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.52 HG12 ' SG ' ' D' ' 76' ' ' CYS . 78.6 mt -61.79 -56.89 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 O-C-N 123.791 0.682 . . . . 70.42 109.873 173.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' D' ' 125' ' ' GLN . 41.0 m -54.11 -38.69 65.68 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.649 1.18 . . . . 75.14 111.787 -173.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 38.0 t -66.8 -44.01 82.36 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 114.791 -1.095 . . . . 73.31 110.399 179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.9 mtm -71.5 -29.77 65.19 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.116 0.566 . . . . 73.24 111.907 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' D' ' 114' ' ' ILE . 75.9 t -68.16 -42.26 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 O-C-N 123.785 0.678 . . . . 73.43 109.336 175.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.8 p -75.63 -28.0 58.65 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 116.257 -0.429 . . . . 64.02 111.174 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.423 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 94.2 mtt-85 -69.97 -35.74 74.68 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.509 0.724 . . . . 74.01 109.614 171.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.53 0.16 77.03 Favored Glycine 0 C--N 1.354 1.547 0 O-C-N 123.794 0.683 . . . . 34.45 112.33 172.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 33.6 p 58.62 28.13 16.71 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 126.51 1.924 . . . . 72.44 112.677 175.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.406 ' HZ ' ' HA ' ' D' ' 28' ' ' ALA . 37.4 m-85 -91.03 162.25 33.18 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.19 1.396 . . . . 73.52 110.683 174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.435 ' HD3' HG11 ' F' ' 136' ' ' VAL . 18.6 Cg_endo -58.9 133.22 52.25 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.766 2.31 . . . . 75.02 111.853 177.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' D' ' 115' ' ' THR . 31.7 tt0 -56.62 137.84 53.25 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.874 0.869 . . . . 75.33 112.446 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 6.8 tt -124.39 108.95 12.71 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.894 -1.151 . . . . 73.22 107.894 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -113.27 110.96 21.22 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.805 -0.813 . . . . 72.34 108.805 175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.467 HD22 HD22 ' D' ' 42' ' ' LEU . 90.5 mt -69.2 135.58 50.8 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.133 0.573 . . . . 62.41 110.279 174.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.51 146.95 98.81 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.024 0.929 . . . . 64.42 111.42 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -66.7 121.37 8.59 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.638 2.226 . . . . 74.43 111.269 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.74 118.8 59.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 C-N-CA 123.338 0.655 . . . . 75.52 110.323 -177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -86.55 78.35 9.21 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.153 -1.054 . . . . 73.21 108.153 172.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.565 ' HA ' HD23 ' D' ' 136' ' ' LEU . 34.1 p90 -78.85 -10.32 59.76 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.333 -0.849 . . . . 74.11 111.333 178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.466 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 4.6 m-20 -47.23 -51.21 19.34 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.8 1.24 . . . . 74.33 112.332 173.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.82 -36.18 74.1 Favored 'General case' 0 N--CA 1.481 1.118 0 O-C-N 123.97 0.794 . . . . 71.1 111.695 -177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' D' ' 133' ' ' PHE . 3.3 mm? -71.07 -41.95 70.05 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 115.24 -0.891 . . . . 54.14 110.389 -178.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.445 ' O ' HD13 ' D' ' 141' ' ' LEU . 49.4 m-85 -70.69 -32.08 69.19 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.329 0.651 . . . . 74.35 111.879 178.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.4 ' HE3' ' HB3' ' D' ' 134' ' ' ASP . 57.5 mtt -59.25 -41.72 89.42 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 122.943 0.497 . . . . 72.34 110.154 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.452 HD22 ' N ' ' D' ' 139' ' ' ASN . 0.8 OUTLIER -77.05 -42.33 38.81 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.968 -1.014 . . . . 61.41 110.713 178.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -63.74 -36.49 84.05 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.823 0.849 . . . . 74.34 111.874 -174.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.445 HD13 ' O ' ' D' ' 137' ' ' PHE . 5.6 mp -66.38 -29.32 69.46 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.411 0.684 . . . . 72.02 110.893 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -88.53 0.67 56.07 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.437 0.695 . . . . 75.21 111.282 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -137.51 49.69 1.99 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.001 0.921 . . . . 71.22 109.354 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -146.49 166.27 26.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.277 0.631 . . . . 61.25 110.519 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.25 170.6 7.98 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.962 0.905 . . . . 61.15 110.618 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -129.04 31.46 3.48 Favored Glycine 0 N--CA 1.472 1.077 0 N-CA-C 111.494 -0.643 . . . . 62.14 111.494 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -78.99 155.01 29.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.919 0.887 . . . . 62.42 111.517 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 148.31 44.98 0.03 OUTLIER Glycine 0 C--N 1.344 1.016 0 CA-C-N 116.225 -0.443 . . . . 60.24 112.135 175.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 11.2 t -63.1 127.65 32.24 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.61 0.364 . . . . 65.4 110.063 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -163.77 -172.38 2.84 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.096 0.559 . . . . 64.42 110.004 -171.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.95 -75.23 0.17 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.583 -0.525 . . . . 74.15 109.583 178.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 52.35 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.463 1.105 . . . . 73.04 112.095 177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -59.32 128.9 39.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.777 0.431 . . . . 72.42 110.506 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -89.93 126.66 35.81 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.817 0.447 . . . . 71.42 110.238 -177.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.323 0 C-N-CA 123.405 0.682 . . . . 71.3 109.844 175.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 N--CA 1.485 1.314 0 N-CA-C 110.172 -0.307 . . . . 64.32 110.172 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 95.8 mttt 68.8 6.8 5.76 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 125.624 1.569 . . . . 65.25 112.653 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . -87.98 116.21 25.98 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.567 -0.901 . . . . 51.42 108.567 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -87.58 155.54 19.92 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.056 0.542 . . . . 72.12 110.795 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -133.36 147.03 51.79 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.834 0.854 . . . . 64.31 110.361 177.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -87.87 -22.57 24.35 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.573 -0.739 . . . . 73.54 110.392 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -126.92 129.13 47.58 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.804 0.841 . . . . 73.24 109.966 -178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.67 95.84 6.09 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.106 0.962 . . . . 75.51 109.007 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . 0.477 ' N ' ' HD3' ' E' ' 117' ' ' PRO . 0.1 OUTLIER -145.72 57.76 4.36 Favored Pre-proline 0 CA--C 1.558 1.265 0 CA-C-N 115.286 -0.87 . . . . 72.12 112.149 178.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' E' ' 116' ' ' TYR . 4.4 Cg_exo -85.63 125.89 2.93 Favored 'Trans proline' 0 C--N 1.374 1.914 0 C-N-CA 122.615 2.21 . . . . 72.32 110.249 166.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -141.32 85.97 1.99 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.128 0.49 . . . . 64.31 109.791 -177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 24.3 m -100.54 78.47 2.01 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.569 -0.741 . . . . 72.01 109.152 177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -164.79 -71.25 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.479 -0.782 . . . . 74.4 109.667 -179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 58.05 36.5 26.07 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.892 0.877 . . . . 73.3 110.954 -177.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . . . . . . . . . . . 64.47 176.99 0.18 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 125.103 1.361 . . . . 70.02 112.905 -178.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 10.8 p -139.62 4.94 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.072 0 CA-C-N 115.632 -0.713 . . . . 74.2 109.891 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 69.2 mtt85 67.63 -68.95 0.15 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.484 1.514 . . . . 73.34 112.28 -172.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 43.0 t80 69.1 150.27 0.08 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.777 0.831 . . . . 62.41 109.618 -173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -150.88 148.92 29.04 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.932 0.493 . . . . 74.52 109.696 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . -159.82 138.8 5.77 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.403 -0.817 . . . . 74.24 111.405 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -73.33 100.34 3.14 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.616 0.767 . . . . 72.14 110.053 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.45 -38.16 55.84 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.597 0.759 . . . . 74.1 110.636 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 42.7 mt -84.99 79.86 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 N-CA-C 109.009 -0.737 . . . . 72.3 109.009 175.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -162.81 82.62 0.51 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 114.597 -1.183 . . . . 73.13 108.553 175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -156.87 90.41 2.54 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 108.391 -0.966 . . . . 63.14 108.391 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.13 37.61 0.5 Allowed 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.485 2.79 . . . . 73.02 114.383 -170.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 39.7 pt -72.88 -1.81 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 112.53 0.567 . . . . 72.5 112.53 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.25 9.86 7.28 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 124.877 1.271 . . . . 62.2 113.32 173.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 83.6 t -80.24 -65.1 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 C-N-CA 122.966 0.506 . . . . 75.15 109.718 -179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 72.5 -54.85 0.68 Allowed 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 125.109 1.364 . . . . 72.33 112.815 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . . . . . . . . . . . -156.72 166.97 31.87 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.014 1.325 . . . . 32.33 108.926 173.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . 0.446 ' HB2' HD23 ' C' ' 126' ' ' LEU . 7.4 mp -76.0 140.89 42.21 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 120.753 0.311 . . . . 73.21 110.802 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 37.7 m -90.97 169.02 11.24 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.05 0.94 . . . . 74.35 110.665 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . . . . . . . . . 77.9 mt 62.38 28.7 17.0 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.75 1.22 . . . . 72.32 111.873 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -72.14 -49.62 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 115.553 -0.749 . . . . 70.23 109.38 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -169.33 131.91 1.23 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.64 1.976 . . . . 72.01 107.237 171.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -80.26 -57.01 3.81 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 109.004 -0.739 . . . . 54.4 109.004 174.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -165.07 80.85 0.35 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 107.676 -1.231 . . . . 64.23 107.676 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -140.46 137.48 33.94 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.313 0.645 . . . . 74.44 110.58 -176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.28 -78.93 0.44 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.126 -1.064 . . . . 65.11 108.126 179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . 0.447 ' HB2' ' HD3' ' E' ' 149' ' ' PRO . 6.5 mp -116.39 -53.38 0.04 OUTLIER Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.515 -0.755 . . . . 74.44 110.581 178.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' E' ' 148' ' ' LEU . 4.2 Cg_exo . . . . . 0 C--N 1.398 3.174 0 C-N-CA 122.244 1.963 . . . . 54.44 111.914 176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 37.9 t70 . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.962 -0.385 . . . . 62.21 109.962 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.64 108.81 4.26 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.092 0.557 . . . . 73.3 110.394 177.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -92.17 146.38 23.77 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 115.587 -0.733 . . . . 53.4 109.062 168.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -90.84 26.21 2.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.447 0.699 . . . . 64.11 109.841 176.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 69.99 -54.34 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 126.492 1.917 . . . . 73.25 111.298 -172.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 64.8 21.24 12.33 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.758 1.223 . . . . 71.24 110.841 177.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . 0.426 ' HB3' ' CE1' ' A' ' 56' ' ' TYR . 13.9 mptt -67.29 104.88 1.59 Allowed 'General case' 0 C--O 1.24 0.574 0 C-N-CA 125.442 1.497 . . . . 74.21 109.24 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.474 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 7.9 mp 67.66 6.24 4.9 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.809 1.243 . . . . 62.22 111.836 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -126.38 78.83 71.32 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.368 -0.975 . . . . 62.42 108.368 -174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -99.52 2.72 0.95 Allowed 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.733 2.289 . . . . 65.45 112.572 171.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.3 115.92 28.49 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.647 0.779 . . . . 70.03 110.539 -167.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 43.5 p -94.81 97.05 9.75 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.89 0.876 . . . . 70.41 109.595 175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . 0.409 ' NE1' ' HA ' ' F' ' 123' ' ' VAL . 5.1 t-105 -83.13 144.96 29.5 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 109.696 -0.483 . . . . 75.14 109.696 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -142.65 -49.24 0.35 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.651 0.781 . . . . 72.44 111.341 -167.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.84 -31.53 72.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.5 0.556 . . . . 72.02 112.5 -173.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . 0.409 ' HA ' ' NE1' ' F' ' 120' ' ' TRP 0.298 4.1 p 47.42 -70.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 C-N-CA 126.93 2.092 . . . . 72.23 113.917 -173.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . 0.438 ' HD3' ' HB2' ' C' ' 3' ' ' GLU . 2.1 mmp_? 66.39 45.39 2.18 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.58 1.152 . . . . 74.32 110.989 177.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . 0.677 ' HA ' HG11 ' A' ' 131' ' ' VAL . 82.9 t80 -69.8 90.63 0.6 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 107.111 -1.44 . . . . 72.13 107.111 164.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.23 -92.13 0.05 OUTLIER 'General case' 0 C--N 1.35 0.624 0 CA-C-N 116.015 -0.539 . . . . 62.21 109.677 -176.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . 66.65 -79.31 0.13 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 111.794 -0.522 . . . . 44.31 111.794 -170.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 85.5 tttt 65.03 89.23 0.1 Allowed 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.837 1.255 . . . . 72.21 109.171 -175.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . . . . . . . . . 1.8 pp -155.44 141.64 18.43 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.95 -1.023 . . . . 74.43 110.128 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 7.0 tp -162.94 27.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.269 0 C-N-CA 124.628 1.171 . . . . 70.34 108.382 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.43 148.34 50.79 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-N 115.426 -0.806 . . . . 51.04 109.317 172.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' F' ' 135' ' ' ALA . 28.7 p90 -61.95 126.06 86.48 Favored Pre-proline 0 CA--C 1.559 1.304 0 N-CA-C 109.5 -0.555 . . . . 63.33 109.5 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -65.05 -29.59 56.78 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 122.858 2.372 . . . . 73.25 112.149 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . 0.6 HD12 HH22 ' C' ' 15' ' ' ARG . 15.6 tt -177.3 -30.58 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.129 0 C-N-CA 125.332 1.453 . . . . 74.2 108.866 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' F' ' 132' ' ' TYR . . . 65.47 73.94 0.39 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 125.592 1.557 . . . . 71.11 111.666 176.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.487 HG12 HG23 ' F' ' 134' ' ' ILE . 13.0 p -169.66 156.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.08 0.952 . . . . 72.21 108.498 -177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.89 -50.8 3.0 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.741 0.416 . . . . 65.3 111.62 -176.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . -169.74 165.77 9.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.847 0.859 . . . . 72.13 110.678 -176.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -65.69 93.74 0.18 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.336 0.654 . . . . 61.41 109.375 169.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 32.3 t -86.78 35.69 0.69 Allowed 'General case' 0 CA--C 1.559 1.323 0 C-N-CA 124.399 1.079 . . . . 65.32 110.461 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . 0.481 ' HG ' ' HB3' ' D' ' 37' ' ' GLN . 64.3 mt -109.93 -160.91 0.73 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.86 1.264 . . . . 74.03 108.746 175.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . . . . . . . . . 80.4 mt 74.12 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 124.316 1.046 . . . . 64.21 110.263 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -55.29 96.07 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.974 0.892 . . . . 63.03 110.849 174.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.02 123.37 28.3 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 115.276 -0.874 . . . . 70.5 109.559 -179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 65.97 179.16 0.2 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.78 1.232 . . . . 54.5 110.643 -168.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 56.06 31.5 18.22 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.69 0.796 . . . . 53.1 112.422 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . 0.552 HD11 ' HD2' ' B' ' 11' ' ' PHE . 3.0 pp -85.88 45.19 1.19 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.008 0.923 . . . . 62.3 112.384 -172.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 6.0 mp 56.22 57.97 9.31 Favored Pre-proline 0 CA--C 1.571 1.78 0 C-N-CA 123.72 0.808 . . . . 60.14 110.069 -167.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo . . . . . 0 C--N 1.391 2.809 0 C-N-CA 123.382 2.721 . . . . 62.42 111.015 178.814 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.482 1.171 0 N-CA-C 110.133 -0.321 . . . . 55.33 110.133 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 81.0 p -165.76 173.15 10.98 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.719 1.208 . . . . 75.04 109.373 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -152.79 2.19 0.31 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.114 0.566 . . . . 65.31 111.437 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.26 -166.4 1.6 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.856 0.862 . . . . 72.54 109.427 -173.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -62.92 135.97 57.6 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.807 0.843 . . . . 71.03 111.108 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -59.97 -41.09 91.22 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.615 0.766 . . . . 73.31 110.422 177.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m 61.21 70.68 0.59 Allowed 'General case' 0 CA--C 1.547 0.861 0 O-C-N 124.738 1.274 . . . . 65.41 110.256 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -86.37 38.02 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.867 -1.06 . . . . 63.35 112.168 -172.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.465 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 1.4 mpt? 70.43 141.09 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.107 1.363 . . . . 65.2 111.678 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.4 m -141.51 111.94 6.98 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.267 -1.012 . . . . 71.53 108.267 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.452 ' HB3' HG12 ' A' ' 86' ' ' ILE . 19.0 p90 -134.87 117.38 15.82 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.924 0.89 . . . . 72.0 108.868 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -155.32 138.42 15.56 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.963 0.505 . . . . 52.52 110.386 -177.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.571 ' H ' HD12 ' A' ' 13' ' ' ILE . 4.1 mp -68.15 116.38 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 123.817 0.847 . . . . 72.1 109.319 177.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -83.97 -41.67 17.06 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 109.013 -0.736 . . . . 61.44 109.013 178.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.537 HH11 ' HD2' ' B' ' 32' ' ' PHE . 72.0 ttt180 -168.56 140.63 2.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.502 0.721 . . . . 62.32 109.072 -173.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.24 137.78 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.592 -0.892 . . . . 72.11 108.592 175.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -173.68 167.71 4.47 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.399 0.619 . . . . 64.34 112.251 -172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.2 p -86.15 123.97 32.03 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.835 -0.802 . . . . 64.43 108.835 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -86.36 -32.14 21.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.438 0.637 . . . . 62.33 109.523 170.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.735 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.9 t70 -141.63 140.91 33.4 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 114.955 -1.021 . . . . 63.13 110.45 -176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.4 mt -141.59 145.38 24.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 125.949 1.7 . . . . 71.42 106.795 175.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -159.24 130.32 6.09 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.549 -0.537 . . . . 72.31 109.549 170.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.722 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 84.4 t80 -132.11 119.51 21.05 Favored 'General case' 0 C--O 1.223 -0.304 0 N-CA-C 107.353 -1.351 . . . . 64.33 107.353 177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -118.59 140.87 49.21 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.822 -0.807 . . . . 74.32 108.822 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.68 78.66 15.77 Favored Pre-proline 0 C--O 1.239 0.525 0 N-CA-C 107.444 -1.317 . . . . 74.4 107.444 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.49 -29.98 61.88 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.519 2.146 . . . . 73.33 111.726 -176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.659 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 31.6 m-80 -117.01 40.71 2.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.879 0.872 . . . . 71.11 109.23 -177.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.16 99.47 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.089 0.956 . . . . 64.13 113.2 177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -72.25 -25.8 18.34 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.573 1.515 . . . . 71.41 112.462 171.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.659 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.6 m-70 -77.79 -33.37 52.65 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.793 -0.639 . . . . 63.1 112.223 -173.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG11 ' HE1' ' A' ' 123' ' ' PHE . 11.1 p -64.45 -22.17 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-O 120.958 0.409 . . . . 73.2 111.501 -174.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -72.94 -29.54 63.18 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 123.488 0.715 . . . . 63.42 110.681 175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -82.7 -51.43 7.72 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.33 1.052 . . . . 63.14 110.574 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.58 ' HE3' ' HB3' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -82.22 133.89 35.27 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.829 0.852 . . . . 74.33 109.8 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.462 ' O ' HD11 ' A' ' 68' ' ' LEU . 18.7 t70 -56.64 134.57 54.66 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 125.048 1.339 . . . . 73.45 113.221 -168.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -71.1 83.06 0.7 Allowed 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.546 0.738 . . . . 74.44 112.419 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -137.01 78.87 39.78 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 124.272 1.029 . . . . 74.24 109.011 174.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -84.03 133.3 5.68 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 122.955 2.436 . . . . 64.12 112.389 176.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -97.4 116.25 29.26 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.905 -1.146 . . . . 75.23 107.905 171.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.6 t -89.53 119.73 37.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 123.309 0.643 . . . . 65.44 110.761 -173.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -110.18 138.44 46.55 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 107.958 -1.127 . . . . 75.35 107.958 175.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.468 HD11 ' HA ' ' F' ' 126' ' ' ASN . 0.6 OUTLIER -131.06 146.16 52.27 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.31 0.644 . . . . 71.14 111.388 -169.339 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -132.85 144.62 50.32 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.418 1.087 . . . . 43.41 109.382 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 22.0 tp -138.27 136.69 36.75 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.664 0.786 . . . . 62.25 109.182 -174.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' A' ' 61' ' ' ARG . 17.4 t70 -158.13 149.29 21.04 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 122.786 0.434 . . . . 73.52 110.84 -177.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.8 m -135.19 126.58 28.48 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.199 1.0 . . . . 54.34 110.176 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.49 110.26 10.37 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.073 0.549 . . . . 73.01 110.11 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.7 m -88.39 153.25 21.33 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 108.78 -0.822 . . . . 63.14 108.78 175.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.6 t -164.88 117.04 1.21 Allowed 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 118.213 0.46 . . . . 52.14 110.197 -171.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -71.84 105.39 3.78 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 123.828 0.851 . . . . 75.21 110.629 -173.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 57' ' ' GLU . 97.6 mt -77.45 -37.72 50.94 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.804 0.842 . . . . 62.14 111.635 175.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -145.63 -174.11 4.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.255 1.022 . . . . 72.42 108.592 -174.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -58.42 97.42 0.03 OUTLIER 'General case' 0 CA--C 1.556 1.185 0 C-N-CA 123.108 0.563 . . . . 62.51 110.519 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 58.71 27.72 16.29 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.722 1.209 . . . . 74.1 112.661 -177.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.412 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 86.1 t -103.91 121.09 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 106.884 -1.524 . . . . 64.22 106.884 165.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -125.84 130.04 50.59 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.277 -0.638 . . . . 71.4 109.277 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.558 ' HB2' HD11 ' A' ' 51' ' ' LEU . 42.2 tt0 -85.86 118.81 25.58 Favored 'General case' 0 C--O 1.24 0.604 0 C-N-CA 124.008 0.923 . . . . 71.52 108.63 168.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.1 t -99.42 111.8 29.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 N-CA-C 107.396 -1.335 . . . . 65.11 107.396 175.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 38.4 t -99.26 130.96 47.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 109.501 -0.555 . . . . 51.44 109.501 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.5 HD23 ' O ' ' A' ' 45' ' ' ASP . 0.6 OUTLIER -106.79 113.56 27.12 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 108.579 -0.897 . . . . 75.31 108.579 -174.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.728 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -87.45 102.69 14.79 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 108.973 -0.751 . . . . 73.31 108.973 174.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.7 t -105.04 130.34 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 108.341 -0.985 . . . . 71.34 108.341 168.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.7 m -121.18 133.21 55.18 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.352 -0.981 . . . . 72.35 108.352 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 75.8 t -131.15 104.61 9.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.976 -1.12 . . . . 73.1 107.976 -176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 12.5 m -105.77 146.26 30.07 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.818 -0.808 . . . . 74.21 108.818 -177.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.53 115.72 13.38 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.645 -1.243 . . . . 72.15 107.645 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -109.26 126.0 52.86 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 109.52 -0.548 . . . . 53.13 109.52 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 0.4 OUTLIER -90.09 82.7 6.06 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 105.777 -1.935 . . . . 71.21 105.777 176.176 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.7 -127.18 7.83 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-N 115.435 -0.802 . . . . 64.12 111.665 -170.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -91.25 -14.72 30.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.972 0.509 . . . . 74.02 111.093 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -95.03 135.02 37.07 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.879 0.871 . . . . 75.32 109.511 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.1 m -65.34 129.25 39.06 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.01 0.524 . . . . 64.13 111.227 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HB2' ' A' ' 68' ' ' LEU . . . -77.81 -58.05 3.47 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.093 -1.077 . . . . 64.44 108.093 171.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -166.91 165.74 15.87 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 114.641 -1.163 . . . . 73.54 110.437 177.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -134.73 145.14 48.19 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.535 1.134 . . . . 65.34 108.792 177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.722 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 20.0 m -141.58 98.92 3.44 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.611 0.764 . . . . 73.23 109.44 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -109.28 129.21 55.52 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 109.625 -0.509 . . . . 71.43 109.625 174.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -130.51 132.82 64.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 123.753 0.821 . . . . 72.34 109.325 176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.735 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 78.2 mt-30 -105.74 102.91 12.32 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.592 -0.731 . . . . 61.14 109.52 169.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -89.77 98.89 12.03 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.842 -1.072 . . . . 71.23 109.366 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -91.4 142.14 15.97 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.374 -0.69 . . . . 62.44 111.374 177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.556 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -138.52 122.58 2.42 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.929 -0.868 . . . . 72.41 110.929 -179.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -80.91 125.37 39.41 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 108.636 -0.876 . . . . 63.42 108.636 175.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -133.8 121.58 22.04 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.203 0.601 . . . . 75.04 109.508 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.8 p -84.13 103.37 13.29 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 108.278 -1.008 . . . . 53.14 108.278 171.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.585 HD11 HD11 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -138.47 124.69 25.17 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.101 0 CA-C-O 121.48 0.657 . . . . 72.32 109.811 -171.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.29 175.77 13.31 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.126 0.97 . . . . 63.4 111.045 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 97.23 -24.97 29.02 Favored Glycine 0 C--N 1.349 1.27 0 CA-C-N 115.758 -0.656 . . . . 24.14 113.043 177.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.585 HD11 HD11 ' A' ' 86' ' ' ILE . 13.6 pt -110.46 168.88 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.23 110.615 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' HA ' HD22 ' F' ' 115' ' ' LEU . 24.3 tt0 -150.85 -172.37 4.18 Favored 'General case' 0 CA--C 1.554 1.119 0 CA-C-N 114.576 -1.193 . . . . 63.42 108.507 -171.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.545 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 59.46 -142.62 46.84 Favored Glycine 0 C--N 1.351 1.383 0 N-CA-C 115.03 0.772 . . . . 62.32 115.03 171.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -77.29 -14.39 59.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.086 0.954 . . . . 62.13 111.561 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.407 ' HG3' HD11 ' A' ' 141' ' ' LEU . 0.6 OUTLIER -67.0 -47.96 69.9 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.763 0.825 . . . . 73.31 110.015 -177.143 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.467 ' SD ' HD13 ' F' ' 115' ' ' LEU . 20.1 ttt -80.64 -35.83 33.39 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 51.23 111.074 177.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.51 ' HB2' ' HD2' ' F' ' 117' ' ' PRO . . . -57.88 -32.44 67.7 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.403 0.621 . . . . 61.13 111.447 176.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -64.28 -49.67 70.93 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.633 -1.167 . . . . 64.23 110.272 168.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.598 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 5.3 m -68.24 -63.22 1.1 Allowed 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 113.701 1.0 . . . . 42.42 113.701 -170.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.43 -12.35 60.04 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 118.88 0.764 . . . . 72.2 112.415 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.69 -6.07 44.16 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-O 119.178 -0.79 . . . . 74.34 114.5 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.19 -57.83 0.23 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 117.873 0.836 . . . . 62.15 111.786 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.598 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 6.6 t80 -55.69 -58.35 8.17 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 124.576 1.15 . . . . 71.23 112.045 -177.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.96 -41.8 6.97 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 113.314 0.857 . . . . 53.22 113.314 -173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HA ' HD12 ' A' ' 106' ' ' LEU . 37.9 Cg_endo -66.28 -24.86 50.2 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 121.624 1.55 . . . . 73.42 113.873 169.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.442 HD21 ' ND2' ' A' ' 132' ' ' ASN . 66.9 t30 -76.47 -22.35 54.66 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 118.941 0.791 . . . . 53.1 110.21 176.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 21.8 mm -67.45 -43.02 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.267 0.627 . . . . 75.24 109.493 166.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.556 HD21 ' HA3' ' A' ' 82' ' ' GLY . 90.3 mt -71.25 -31.44 67.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.042 -0.981 . . . . 74.51 111.99 -175.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -62.51 -43.33 84.01 Favored Pre-proline 0 CA--C 1.559 1.294 0 N-CA-C 113.819 1.044 . . . . 73.43 113.819 -168.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -55.82 -31.79 82.26 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 122.276 1.984 . . . . 62.43 113.835 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -83.38 -28.78 28.69 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.186 0.594 . . . . 65.02 111.863 -179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.26 -40.99 77.49 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.296 -0.631 . . . . 45.25 109.296 170.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.462 ' NH1' HD12 ' C' ' 105' ' ' ILE . 37.2 ttm180 -65.84 -38.35 88.65 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.524 -1.216 . . . . 73.44 110.327 177.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -53.51 -54.21 40.47 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.215 1.006 . . . . 75.22 110.247 173.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.5 t -61.85 -50.96 70.15 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 113.936 -1.484 . . . . 71.22 111.24 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.458 ' O ' HG23 ' A' ' 118' ' ' VAL . 17.7 mt -62.41 -58.9 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.703 0.801 . . . . 60.11 111.371 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.5 m -54.49 -38.58 66.61 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.871 0.732 . . . . 43.31 111.088 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.5 t -65.88 -45.89 80.38 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 115.496 -0.775 . . . . 42.05 110.285 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.5 mtp -57.15 -41.83 79.86 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.595 0.758 . . . . 42.42 111.31 176.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.2 t -60.45 -47.67 91.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 C-N-CA 123.901 0.881 . . . . 64.31 110.233 178.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 96.4 p -75.76 -22.95 55.98 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.663 -0.699 . . . . 64.25 111.585 -176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -74.62 -30.53 61.69 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.738 0.815 . . . . 73.54 109.747 173.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.48 2.37 67.48 Favored Glycine 0 C--N 1.352 1.435 0 CA-C-N 115.519 -0.764 . . . . 65.5 112.569 172.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 14.7 m 68.27 22.31 8.14 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.874 1.27 . . . . 63.41 110.552 175.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.411 ' HE1' HG11 ' A' ' 31' ' ' VAL . 24.6 m-85 -96.5 153.27 38.9 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 123.823 0.849 . . . . 74.42 110.288 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 123.73 14.54 Favored 'Trans proline' 0 C--N 1.383 2.385 0 C-N-CA 122.652 2.235 . . . . 61.53 111.075 171.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -57.75 147.44 27.99 Favored 'General case' 0 CA--C 1.549 0.916 0 O-C-N 124.036 0.835 . . . . 62.12 111.747 -171.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 81.0 mt -111.95 105.77 14.28 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.717 -0.846 . . . . 62.34 108.717 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.13 93.05 6.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 108.535 -0.913 . . . . 63.05 108.535 -177.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' F' ' 125' ' ' TYR . 0.2 OUTLIER -67.07 127.7 33.57 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.028 -0.987 . . . . 73.34 109.443 -175.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.95 137.56 94.75 Favored Pre-proline 0 CA--C 1.561 1.37 0 C-N-CA 123.544 0.738 . . . . 75.03 111.58 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.434 ' HB3' HH22 ' A' ' 111' ' ' ARG . 34.1 Cg_endo -83.83 145.92 11.56 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.594 2.196 . . . . 61.21 113.02 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 114.21 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.636 -0.876 . . . . 60.44 108.636 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' ND2' HD21 ' A' ' 104' ' ' ASN . 15.5 m120 -85.4 75.21 10.25 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.691 0.758 . . . . 64.41 110.008 176.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -68.89 -28.31 66.57 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 114.591 -1.186 . . . . 74.23 109.895 175.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -64.44 -51.85 61.0 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.205 -0.907 . . . . 75.44 110.402 175.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.62 -34.53 78.04 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.772 0.829 . . . . 63.42 111.212 -176.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 61.3 tp -54.17 -50.22 67.53 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.31 1.044 . . . . 74.44 111.405 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -86.1 -26.42 25.26 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.929 -0.578 . . . . 73.42 111.028 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.602 ' SD ' HD23 ' A' ' 141' ' ' LEU . 13.9 tpt -71.3 -29.36 64.95 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.099 0.56 . . . . 75.11 111.278 -172.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -55.4 -52.33 63.92 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.44 0.696 . . . . 73.0 109.58 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.51 ' HA ' ' HG2' ' A' ' 143' ' ' GLN . 68.3 t80 -65.85 -39.2 90.55 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.214 -0.903 . . . . 63.12 111.034 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.602 HD23 ' SD ' ' A' ' 138' ' ' MET . 23.7 tp -67.75 -8.54 36.42 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.115 0.966 . . . . 74.31 112.038 -173.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -149.11 31.81 0.76 Allowed 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 122.601 0.361 . . . . 62.21 111.227 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 140' ' ' TYR . 20.8 mm-40 -56.12 -43.97 78.67 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 122.623 0.369 . . . . 74.41 111.039 172.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -78.34 99.08 6.19 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.395 -0.594 . . . . 63.11 109.395 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.85 164.71 36.69 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.365 1.066 . . . . 72.01 109.097 178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.88 110.82 0.99 Allowed Glycine 0 C--N 1.343 0.936 0 N-CA-C 112.103 -0.399 . . . . 64.11 112.103 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -156.63 148.37 22.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.487 0.715 . . . . 70.41 110.078 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -155.46 68.49 0.29 Allowed Glycine 0 C--N 1.348 1.225 0 N-CA-C 111.521 -0.632 . . . . 61.43 111.521 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 71.5 p -71.96 107.53 4.74 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.117 0.567 . . . . 73.11 110.189 176.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 63.6 tt0 -100.44 115.31 29.76 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.477 0.711 . . . . 73.22 109.438 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -115.94 105.21 12.4 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.828 -0.805 . . . . 73.51 108.828 178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -135.55 101.43 4.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.214 1.006 . . . . 73.24 108.848 177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -101.52 127.1 48.37 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.096 -0.705 . . . . 72.13 109.096 175.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -139.41 127.83 22.86 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.855 -0.794 . . . . 74.23 108.855 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.275 0 N-CA-C 109.041 -0.726 . . . . 74.53 109.041 -178.202 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 109.755 -0.461 . . . . 71.22 109.755 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 15.2 p -71.54 152.23 43.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.538 0.735 . . . . 62.52 111.406 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -79.76 118.05 21.21 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.522 0.729 . . . . 45.23 109.817 -178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -72.68 88.21 1.28 Allowed 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 122.219 1.009 . . . . 63.21 111.033 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -80.12 110.43 15.52 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.799 -1.091 . . . . 73.4 108.224 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -140.07 127.95 22.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.295 0.638 . . . . 71.13 110.1 -177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 35.6 p -143.01 70.61 1.32 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.398 1.079 . . . . 65.33 110.118 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -141.42 157.09 45.62 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.708 0.803 . . . . 72.52 109.768 175.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.42 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 24.3 ptm 40.8 -162.99 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 126.591 1.956 . . . . 74.4 114.17 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.0 m -152.42 125.58 8.62 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.136 0.974 . . . . 52.02 108.604 171.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -136.24 127.87 28.88 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.37 -0.604 . . . . 61.33 109.37 163.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -158.02 141.53 15.38 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.998 -1.112 . . . . 74.11 107.998 176.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -87.28 123.14 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.555 -0.906 . . . . 74.22 108.555 170.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -83.29 -50.6 8.22 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.083 -0.34 . . . . 74.43 110.083 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 22.2 ttt180 -168.31 130.48 1.41 Allowed 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 116.113 -0.494 . . . . 72.42 109.817 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' B' ' 109' ' ' TYR . 92.3 mt -114.22 146.04 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.651 -0.87 . . . . 70.01 108.651 174.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -163.49 155.41 17.45 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 121.413 0.625 . . . . 74.44 111.494 -176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 82.6 m -78.26 126.17 30.4 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.007 -0.997 . . . . 75.12 108.625 170.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.506 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 40.3 mtpt -98.18 -32.6 11.5 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.57 0.748 . . . . 74.14 111.175 -178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 35.3 t70 -155.8 139.9 16.46 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 116.07 -0.514 . . . . 70.12 111.523 -167.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.8 mm -147.14 145.69 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.658 1.583 . . . . 64.3 108.355 -177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -150.92 151.98 32.95 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.718 -0.845 . . . . 73.31 108.718 163.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.0 t80 -147.58 115.48 6.46 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.853 -1.536 . . . . 74.22 106.853 173.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -117.6 121.97 42.36 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.7 -0.852 . . . . 54.12 108.7 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.866 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -125.47 80.61 65.49 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.853 -1.166 . . . . 54.25 107.853 176.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -72.09 -45.63 0.64 Allowed 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.55 2.167 . . . . 60.53 111.693 -176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -98.8 18.65 16.49 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.699 0.8 . . . . 73.21 110.743 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.866 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.11 -50.53 54.65 Favored Pre-proline 0 CA--C 1.569 1.703 0 C-N-CA 125.213 1.405 . . . . 60.43 114.239 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.76 -20.77 25.9 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 121.879 1.72 . . . . 74.33 112.593 177.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -91.0 -28.37 18.04 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.769 0.828 . . . . 71.01 110.868 -173.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -81.01 -8.83 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.424 0.689 . . . . 55.41 110.256 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.537 ' HD2' HH11 ' A' ' 15' ' ' ARG . 75.9 t80 -56.72 -33.94 66.99 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.929 1.292 . . . . 64.33 110.81 168.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -71.8 -29.52 64.54 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.037 -0.983 . . . . 64.53 111.27 -178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.447 ' HD3' HD22 ' B' ' 68' ' ' LEU . 95.6 mttt -94.89 110.21 22.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.448 0.699 . . . . 73.11 111.086 -174.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -104.22 81.72 1.86 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.455 -0.942 . . . . 71.51 108.455 171.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.792 ' HB2' HD21 ' B' ' 68' ' ' LEU . 51.0 m95 -149.94 178.07 9.27 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.461 1.104 . . . . 71.0 108.457 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -78.04 127.36 81.84 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.43 0.692 . . . . 74.23 110.026 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' B' ' 68' ' ' LEU . 72.6 Cg_endo -77.86 146.83 23.77 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 121.946 1.764 . . . . 65.33 112.212 168.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.75 103.84 0.38 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.061 0.945 . . . . 73.42 108.932 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -86.62 129.98 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.541 0.736 . . . . 73.42 109.493 -177.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.607 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.1 tttm -136.14 128.48 30.17 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.419 -0.956 . . . . 70.41 108.419 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 pp -112.02 153.87 26.2 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.646 -0.872 . . . . 75.12 108.646 174.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -153.79 111.92 3.58 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.607 -0.886 . . . . 75.35 108.607 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -103.72 138.2 40.68 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.891 0.876 . . . . 74.34 109.014 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.4 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.2 t70 -144.79 152.7 40.74 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.02 1.328 . . . . 73.51 108.308 -174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.9 t -151.33 140.46 21.2 Favored 'General case' 0 C--O 1.242 0.697 0 C-N-CA 123.312 0.645 . . . . 71.15 109.381 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.68 124.47 17.13 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.8 -1.185 . . . . 53.42 107.8 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 78.5 p -97.29 160.99 14.01 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 109.686 -0.487 . . . . 75.31 109.686 -177.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' B' ' 57' ' ' GLU . 32.7 t -149.41 155.37 40.33 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.006 -1.109 . . . . 62.11 108.006 -177.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -124.78 129.17 49.94 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 123.364 0.665 . . . . 75.14 109.692 174.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -88.87 -45.06 10.02 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.324 0.649 . . . . 65.12 109.641 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.12 -176.09 5.64 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.295 -0.866 . . . . 71.41 110.093 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -61.9 125.96 25.67 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.0 -1.0 . . . . 62.01 109.055 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.36 2.85 3.47 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 125.134 1.374 . . . . 64.51 112.762 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 28.2 t -120.32 96.34 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 N-CA-C 108.607 -0.886 . . . . 73.31 108.607 -177.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -103.22 165.16 11.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 122.995 0.518 . . . . 44.35 110.159 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' B' ' 49' ' ' SER . 6.3 tm-20 -142.97 95.44 2.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.288 -1.745 . . . . 74.22 106.288 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 65.0 t -98.9 131.23 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 N-CA-C 109.303 -0.628 . . . . 44.55 109.303 -176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.549 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.7 t -106.13 151.53 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 123.942 0.897 . . . . 75.32 109.952 -179.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.18 119.49 18.88 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.087 -1.449 . . . . 72.21 107.087 178.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.607 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 38.3 ttp180 -105.96 120.98 43.15 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.872 0.368 . . . . 74.23 110.846 173.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.443 ' HB ' HD11 ' B' ' 114' ' ' ILE . 23.5 t -108.06 128.15 63.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 107.927 -1.138 . . . . 73.0 107.927 168.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.5 m -120.78 130.28 53.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.378 -0.601 . . . . 73.04 109.378 178.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.495 HG23 HD13 ' B' ' 114' ' ' ILE . 98.7 t -118.22 134.14 62.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.276 -0.875 . . . . 74.41 109.055 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.607 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 98.6 m -125.58 137.65 53.92 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 114.901 -1.045 . . . . 64.45 108.489 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.73 125.36 19.32 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.508 -1.293 . . . . 74.21 107.508 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 19.0 p -136.46 123.44 21.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.286 -1.005 . . . . 74.11 108.286 177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.792 HD21 ' HB2' ' B' ' 36' ' ' TRP . 3.2 tt -95.61 116.18 28.48 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.48 -0.933 . . . . 73.32 108.48 -172.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.38 -114.06 4.02 Favored Glycine 0 C--N 1.345 1.033 0 O-C-N 124.11 0.881 . . . . 43.52 111.517 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.48 4.73 15.34 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.182 0.993 . . . . 71.51 111.637 -175.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 12.2 pt-20 -129.62 163.89 25.07 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.317 0.647 . . . . 74.31 110.023 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 12.6 m -67.21 148.59 51.57 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 123.446 0.466 . . . . 61.14 110.66 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.93 -56.83 2.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.578 0.751 . . . . 64.12 109.024 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -165.36 153.67 11.57 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.139 -0.937 . . . . 74.12 110.235 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 77.6 mt -131.43 144.56 51.28 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.864 1.266 . . . . 75.14 108.13 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 40.2 t -151.57 152.27 32.69 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.559 -0.534 . . . . 73.44 109.559 176.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -158.36 129.6 6.48 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.21 0.604 . . . . 74.32 109.416 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.454 HG22 ' CD1' ' B' ' 21' ' ' ILE . 82.7 t -124.56 148.62 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.812 0.845 . . . . 72.41 109.985 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.607 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 41.7 mt-30 -125.69 98.45 5.57 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 108.23 -1.026 . . . . 63.11 108.23 167.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.9 tp-100 -85.89 104.01 15.15 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.839 -0.619 . . . . 74.23 109.429 174.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -96.74 168.47 25.01 Favored Glycine 0 C--O 1.243 0.687 0 N-CA-C 111.544 -0.622 . . . . 71.13 111.544 174.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.47 130.76 2.2 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 121.466 -0.397 . . . . 71.42 112.97 -178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 33.7 mt -84.14 128.92 38.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 C-N-CA 124.147 0.979 . . . . 71.21 109.018 171.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.61 140.85 44.91 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.34 1.056 . . . . 63.3 109.759 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 20.0 m -87.49 107.6 18.64 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.211 1.004 . . . . 73.42 109.032 173.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.412 HG13 HD21 ' B' ' 98' ' ' LEU . 17.6 mm -122.77 121.8 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.673 0.789 . . . . 64.43 110.478 -171.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -154.36 167.68 29.17 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.074 0.55 . . . . 54.24 110.987 176.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 85.62 -45.19 3.45 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 115.97 -0.559 . . . . 65.21 113.398 175.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.47 ' HB ' HD21 ' E' ' 115' ' ' LEU . 41.2 mm -74.36 138.49 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 123.663 0.785 . . . . 61.15 109.763 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.03 -172.43 4.03 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.809 0.843 . . . . 75.04 111.149 -176.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.28 -113.52 5.98 Favored Glycine 0 C--N 1.357 1.746 0 O-C-N 123.742 0.651 . . . . 53.42 113.981 172.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.6 m -88.29 -35.6 17.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.723 0.809 . . . . 61.33 110.59 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -71.2 -18.98 62.45 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.096 -0.956 . . . . 74.41 111.599 -168.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' E' ' 115' ' ' LEU . 19.7 ptp -56.12 -28.78 59.21 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.992 0.917 . . . . 73.32 112.097 173.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.64 -39.25 87.61 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.101 0.96 . . . . 65.4 112.358 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -88.99 -27.53 20.82 Favored 'General case' 0 C--O 1.221 -0.424 0 CA-C-N 115.367 -0.833 . . . . 71.21 111.218 -178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . 0.411 ' HB2' HG21 ' B' ' 89' ' ' ILE . 48.6 t -66.81 -44.01 82.3 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.624 0.369 . . . . 64.14 111.821 -176.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.412 HD21 HG13 ' B' ' 86' ' ' ILE . 77.4 mt -102.49 -35.08 8.89 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.749 0.42 . . . . 72.21 111.976 -178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -83.8 -23.25 53.53 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 120.029 -0.317 . . . . 72.15 113.842 -173.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.35 -46.75 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 117.145 0.473 . . . . 51.04 112.047 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -77.1 -48.57 17.4 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.372 0.669 . . . . 74.45 110.796 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.481 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 74.2 m -60.72 -49.98 87.25 Favored Pre-proline 0 CA--C 1.565 1.544 0 CA-C-O 118.682 -0.675 . . . . 64.33 111.6 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 72.9 Cg_exo -56.77 -30.77 85.96 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.6 2.2 . . . . 71.04 114.496 171.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -63.36 -32.64 74.12 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.08 0.467 . . . . 64.43 110.965 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 77.2 mt -74.17 -44.54 49.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 123.864 0.866 . . . . 33.21 110.582 175.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.414 HD13 ' O ' ' B' ' 80' ' ' GLN . 96.3 mt -72.36 -29.99 64.3 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.726 -1.125 . . . . 64.02 112.397 -172.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' B' ' 128' ' ' LEU . 80.5 t80 -59.93 -46.1 98.18 Favored Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 113.901 1.074 . . . . 71.2 113.901 -168.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.62 -41.75 72.51 Favored 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 122.233 1.955 . . . . 73.14 113.113 173.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.452 ' CD1' HG21 ' B' ' 16' ' ' ILE . 3.0 m-30 -64.26 -39.42 93.9 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.907 -1.042 . . . . 75.05 109.991 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.07 -39.53 82.93 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.881 0.872 . . . . 74.4 110.961 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -57.23 -58.96 5.95 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.411 1.084 . . . . 73.22 111.752 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.9 -25.39 63.66 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.199 0.312 . . . . 64.31 110.267 -175.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.435 ' O ' ' HG2' ' B' ' 117' ' ' MET . 13.4 t -70.2 -30.32 67.39 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.929 0.492 . . . . 51.21 111.626 179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.495 HD13 HG23 ' B' ' 64' ' ' VAL . 88.6 mt -72.26 -55.92 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 123.082 0.553 . . . . 70.25 109.662 171.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.5 m -60.84 -27.98 68.48 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.54 -1.209 . . . . 73.54 111.411 -172.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.43 -46.02 84.99 Favored 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.915 0.886 . . . . 73.21 110.375 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 16.0 mmt -68.32 -31.3 70.63 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.095 0.558 . . . . 75.11 110.702 -178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.05 -38.96 79.03 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.999 0 C-N-CA 123.956 0.902 . . . . 75.34 110.279 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 35.0 m -66.31 -37.74 86.09 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.726 0.81 . . . . 61.13 110.99 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' B' ' 116' ' ' SER . 71.3 mtt-85 -65.02 -38.8 92.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.275 -0.875 . . . . 75.23 109.351 176.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.35 -0.51 72.12 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 124.057 0.848 . . . . 64.25 113.877 176.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 55.39 36.26 26.73 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 125.596 1.558 . . . . 72.05 112.309 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -104.86 157.12 34.89 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.609 1.163 . . . . 62.43 110.282 177.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -57.28 129.39 33.87 Favored 'Trans proline' 0 C--N 1.385 2.462 0 C-N-CA 123.119 2.546 . . . . 60.32 112.508 175.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 22.3 pt20 -60.4 130.58 47.31 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 123.913 0.885 . . . . 62.53 112.514 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 90.2 mt -118.97 99.89 7.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 108.396 -0.965 . . . . 74.21 108.396 173.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.429 HD22 ' N ' ' B' ' 127' ' ' ASN . 0.8 OUTLIER -95.19 131.07 41.63 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.398 0.679 . . . . 73.23 109.469 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.456 ' HB3' ' CZ ' ' B' ' 107' ' ' PHE . 2.1 mm? -76.16 139.06 41.09 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.351 0.661 . . . . 71.01 110.922 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -82.38 141.44 45.8 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 124.027 0.931 . . . . 54.11 111.41 -176.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.71 100.12 0.41 Allowed 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 122.896 2.397 . . . . 70.34 112.46 176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 89.7 t -108.87 133.36 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.759 0.824 . . . . 74.4 109.366 175.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -72.52 108.55 5.64 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.565 0.746 . . . . 64.43 111.219 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -59.95 -35.86 75.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.298 1.039 . . . . 72.04 110.167 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -63.5 -56.69 14.05 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 114.228 -1.351 . . . . 75.04 111.954 178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.28 -27.74 68.84 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.625 0.77 . . . . 74.51 111.51 -176.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.92 -42.26 85.67 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.268 1.027 . . . . 64.11 110.613 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -79.93 -16.85 54.45 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.308 0.643 . . . . 74.31 111.384 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 81.5 mmm -68.24 -29.21 67.97 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 122.378 0.271 . . . . 64.05 111.456 177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -75.49 -25.49 57.35 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 122.52 0.328 . . . . 75.44 110.654 176.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . 0.403 ' HB2' ' HB2' ' E' ' 122' ' ' ALA . 30.1 t80 -71.22 -31.48 67.64 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.435 0.694 . . . . 72.33 109.684 175.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 59.3 mt -105.06 35.22 2.88 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 123.944 0.897 . . . . 71.42 110.329 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.12 126.87 29.16 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 123.589 0.756 . . . . 73.15 111.23 -176.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.05 -16.89 55.19 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.605 1.162 . . . . 71.45 113.39 -169.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.62 -0.47 8.75 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.295 0.638 . . . . 62.35 112.583 179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -72.05 -25.55 61.83 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.57 0.748 . . . . 74.24 111.27 170.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 118.17 137.75 5.79 Favored Glycine 0 C--N 1.344 1.028 0 CA-C-N 116.078 -0.51 . . . . 54.33 112.159 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -150.2 145.37 26.21 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.957 0.903 . . . . 72.21 109.053 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 134.83 -145.62 17.71 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-O 119.391 -0.672 . . . . 50.21 111.579 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 23.8 m 67.34 99.12 0.05 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.731 1.213 . . . . 64.04 111.472 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -70.18 -74.22 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.637 0.775 . . . . 64.54 111.091 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 62.43 121.36 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.944 1.298 . . . . 54.21 111.69 -173.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -142.76 164.86 28.95 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 120.841 0.353 . . . . 52.41 111.22 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -74.09 92.01 2.13 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.276 -0.875 . . . . 74.05 109.351 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -95.48 105.3 17.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.822 -0.626 . . . . 75.21 109.457 -178.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.132 0 C-N-CA 123.306 0.642 . . . . 72.12 110.557 178.309 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.3 mtm . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.982 0.42 . . . . 64.41 110.129 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.0 p -168.25 109.18 0.55 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.619 0.768 . . . . 72.34 109.228 177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -147.15 102.43 3.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.118 0.567 . . . . 73.32 111.301 176.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -98.51 110.29 22.91 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 107.554 -1.276 . . . . 54.24 107.554 167.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -153.38 107.45 3.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.137 0.575 . . . . 64.32 109.678 -177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -152.69 98.13 2.31 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.449 0.7 . . . . 64.55 109.552 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -110.76 8.66 22.55 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.689 0.795 . . . . 63.45 109.968 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -91.86 95.15 9.68 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.491 0.717 . . . . 71.34 110.027 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 56.7 ttp 65.65 126.05 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 125.189 1.396 . . . . 73.53 112.229 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 25.9 m -85.76 95.45 9.41 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.441 -0.948 . . . . 50.33 108.441 173.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -119.66 131.86 55.54 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 114.393 -1.276 . . . . 70.42 108.702 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -151.68 141.72 22.15 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 109.245 -0.65 . . . . 71.44 109.245 173.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 38.9 mt -76.49 116.34 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.525 -0.917 . . . . 71.55 108.525 173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -88.33 -49.64 6.83 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.987 0.515 . . . . 64.0 110.217 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -159.13 138.8 11.68 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 115.96 -0.564 . . . . 62.04 109.48 -174.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 65.7 mt -128.84 135.63 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 108.1 -1.074 . . . . 54.31 108.1 175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 10.6 p90 -171.57 158.22 5.04 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.514 0.674 . . . . 63.53 112.152 -174.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.426 HG22 HE22 ' C' ' 80' ' ' GLN . 64.9 p -83.99 111.2 19.05 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.894 -1.048 . . . . 72.03 108.934 175.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 mtmt -79.26 -46.68 17.3 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.717 0.77 . . . . 71.22 109.255 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 15.8 t70 -133.66 137.38 45.33 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 114.687 -1.142 . . . . 74.33 108.728 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.45 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.3 mt -142.27 141.64 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.245 1.418 . . . . 64.23 107.379 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.0 t -155.24 143.14 19.96 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 109.811 -0.44 . . . . 72.52 109.811 174.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -142.64 141.95 31.99 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 107.54 -1.281 . . . . 72.43 107.54 174.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -140.08 142.6 36.1 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.563 -1.273 . . . . 71.02 107.563 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' D' ' 19' ' ' LYS . . . -142.15 84.28 11.72 Favored Pre-proline 0 N--CA 1.475 0.78 0 N-CA-C 108.86 -0.793 . . . . 73.25 108.86 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.59 -39.46 15.96 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.909 2.406 . . . . 60.4 112.212 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 88.4 m-20 -111.87 44.75 1.33 Allowed 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.77 0.828 . . . . 63.33 109.658 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -56.41 -57.9 20.22 Favored Pre-proline 0 CA--C 1.575 1.911 0 C-N-CA 124.435 1.094 . . . . 54.14 113.709 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 7.3 Cg_exo -72.52 -26.54 16.63 Favored 'Trans proline' 0 C--N 1.389 2.701 0 C-N-CA 122.013 1.809 . . . . 63.43 112.009 175.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.569 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.5 t60 -67.11 -21.73 65.84 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 125.298 1.439 . . . . 64.54 111.463 -177.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.433 HG23 ' HE2' ' C' ' 34' ' ' LYS . 7.6 p -54.53 -24.1 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 123.15 0.58 . . . . 62.3 112.538 177.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -63.5 -40.75 97.89 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.296 1.038 . . . . 74.02 111.527 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 21.0 pt20 -90.14 5.29 47.5 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.646 0.379 . . . . 74.15 111.043 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 73' ' ' ALA . 4.7 ttpm? -100.74 146.76 26.83 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.097 0.959 . . . . 73.12 109.918 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -85.54 134.55 34.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.661 0.784 . . . . 74.33 109.185 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -69.22 71.29 0.26 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.406 1.083 . . . . 64.3 112.382 -174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -137.65 74.84 45.12 Favored Pre-proline 0 C--O 1.24 0.565 0 N-CA-C 108.04 -1.096 . . . . 71.51 108.04 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.42 113.59 3.57 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.154 1.903 . . . . 63.44 109.591 173.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . 0.726 ' HG2' HD22 ' E' ' 141' ' ' LEU . 0.7 OUTLIER -84.56 83.79 7.89 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 105.021 -2.214 . . . . 63.34 105.021 174.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.607 HG11 HD11 ' C' ' 126' ' ' LEU . 31.9 m -71.7 128.13 34.41 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 CA-C-N 115.215 -0.902 . . . . 72.22 111.824 -166.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -92.98 103.65 15.95 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 106.586 -1.635 . . . . 74.42 106.586 172.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 84.6 mt -93.12 151.68 19.71 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-N 115.515 -0.766 . . . . 75.23 109.602 176.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.575 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 45.2 t0 -158.15 147.38 19.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.276 -0.875 . . . . 72.21 108.979 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.49 148.87 49.35 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.3 0.64 . . . . 53.4 109.381 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.428 ' O ' HD23 ' C' ' 60' ' ' LEU . 12.0 m-20 -150.34 161.37 42.61 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.484 1.114 . . . . 74.41 108.904 174.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 13.1 t -138.71 154.23 48.56 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 109.125 -0.695 . . . . 73.5 109.125 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -141.65 151.43 43.06 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.576 -0.527 . . . . 53.04 109.576 174.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -123.58 143.52 50.16 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.365 0.666 . . . . 62.33 110.171 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.2 t -153.13 126.41 8.6 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.878 0.871 . . . . 72.23 108.701 175.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -82.61 127.0 32.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.239 -0.652 . . . . 62.42 109.239 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.659 HD11 HD12 ' C' ' 83' ' ' ILE . 59.9 mt -89.59 -42.05 11.63 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.209 0.604 . . . . 64.12 110.123 177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.8 -174.37 4.57 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.471 0.708 . . . . 71.24 110.621 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -60.26 114.32 2.84 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.884 -1.053 . . . . 75.05 109.761 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 69.43 -4.59 1.31 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 125.196 1.399 . . . . 74.42 112.956 -177.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 49.4 t -100.46 114.11 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.846 -0.798 . . . . 73.34 108.846 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -126.52 158.83 35.1 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.529 0.732 . . . . 73.21 109.962 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -125.78 138.36 53.84 Favored 'General case' 0 C--O 1.241 0.629 0 C-N-CA 124.308 1.043 . . . . 73.43 108.818 174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.35 137.81 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 108.071 -1.085 . . . . 60.52 108.071 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.35 109.35 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 108.902 -0.777 . . . . 65.23 108.902 -173.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.428 HD23 ' O ' ' C' ' 45' ' ' ASP . 0.7 OUTLIER -87.47 102.92 15.03 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 108.182 -1.044 . . . . 61.05 108.182 177.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.601 ' HG3' ' HG2' ' C' ' 79' ' ' GLN . 18.7 ttp85 -82.79 106.58 14.74 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 108.936 -0.764 . . . . 70.22 108.936 173.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' C' ' 114' ' ' ILE . 16.5 t -99.68 132.52 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.682 -0.858 . . . . 75.25 108.682 173.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.575 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 55.2 m -115.18 130.51 56.94 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.827 0.851 . . . . 72.4 109.156 172.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.498 HG11 ' HG ' ' C' ' 126' ' ' LEU . 78.1 t -122.13 134.24 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.186 -1.37 . . . . 71.41 107.918 172.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 20.9 m -123.86 143.15 50.52 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.342 -1.355 . . . . 54.51 107.342 174.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.0 106.86 8.68 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.689 -1.226 . . . . 62.41 107.689 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -154.75 158.26 39.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.683 -0.69 . . . . 74.13 110.079 -177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 50.5 tp -123.84 78.87 1.66 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 105.726 -1.953 . . . . 71.41 105.726 171.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.42 -119.78 4.96 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-N 115.71 -0.677 . . . . 55.42 112.231 -173.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -87.28 -20.84 26.28 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.625 0.77 . . . . 62.42 109.669 177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.488 ' HG3' ' HD3' ' C' ' 34' ' ' LYS . 16.0 tp10 -71.42 86.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.512 1.125 . . . . 71.24 109.446 176.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.421 ' O ' ' HB2' ' C' ' 27' ' ' ASN . 36.0 m -84.75 121.77 28.16 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.15 -0.477 . . . . 74.21 110.253 -177.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.512 ' HB2' ' HE3' ' C' ' 34' ' ' LYS . . . -71.86 -55.51 7.41 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.165 -1.05 . . . . 61.31 108.165 172.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -162.86 173.27 13.95 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 114.808 -1.087 . . . . 72.3 111.423 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -135.92 143.52 45.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 106.759 -1.571 . . . . 74.22 106.759 169.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.41 ' SG ' HG23 ' C' ' 114' ' ' ILE . 41.8 t -149.45 130.43 14.35 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.693 0.397 . . . . 73.44 110.338 179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -131.71 133.28 44.66 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 108.671 -0.863 . . . . 72.22 108.671 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.6 t -129.52 138.21 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.687 0.795 . . . . 71.44 108.914 171.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.601 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 66.1 mt-30 -113.23 98.59 7.22 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.585 -0.894 . . . . 74.24 108.585 173.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.426 HE22 HG22 ' C' ' 18' ' ' THR . 8.3 tp-100 -84.87 103.84 14.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.361 -0.836 . . . . 70.2 109.688 -178.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.13 148.78 21.65 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 111.887 -0.485 . . . . 74.15 111.887 176.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.542 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -150.34 121.32 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.688 -0.565 . . . . 61.23 111.688 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.659 HD12 HD11 ' C' ' 51' ' ' LEU . 8.5 mm -85.66 126.89 40.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.647 -0.872 . . . . 63.32 108.647 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -135.35 134.72 40.1 Favored 'General case' 0 C--O 1.244 0.769 0 C-N-CA 123.814 0.846 . . . . 73.43 109.473 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 19.6 p -81.18 116.57 21.14 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.414 -0.588 . . . . 74.03 109.414 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 31.9 mm -115.44 111.4 35.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 124.102 0.961 . . . . 54.41 108.511 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -147.51 169.61 19.2 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 50.02 110.339 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.07 -58.36 3.2 Favored Glycine 0 C--N 1.345 1.075 0 N-CA-C 111.447 -0.661 . . . . 71.32 111.447 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 30.1 mm -95.14 166.33 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 61.22 108.668 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -143.99 156.18 44.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.543 0.737 . . . . 73.22 110.537 -168.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.39 -148.0 44.88 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.47 0.481 . . . . 14.44 114.155 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.593 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 32.4 p -69.38 -18.26 63.76 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.679 0.792 . . . . 73.35 112.098 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -63.7 -42.47 97.98 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.205 0.602 . . . . 71.03 110.285 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -82.92 -26.33 31.56 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 122.569 0.348 . . . . 74.22 110.884 176.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -68.16 -22.05 64.87 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.666 0.786 . . . . 74.41 111.577 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -53.41 -48.75 68.43 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 122.934 0.494 . . . . 73.34 110.763 168.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -65.17 -47.63 76.31 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.714 -0.676 . . . . 62.41 110.162 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 7.7 tt -66.32 -32.84 74.48 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.599 0.76 . . . . 74.0 110.925 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.8 -5.32 61.31 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-O 119.572 -0.571 . . . . 63.04 114.251 -171.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.53 -63.17 0.51 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 117.658 0.729 . . . . 72.22 111.243 -177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -62.93 -47.64 82.38 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.035 0.534 . . . . 72.1 112.419 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 61.0 m -67.69 -42.76 36.88 Favored Pre-proline 0 CA--C 1.564 1.485 0 CA-C-O 118.642 -0.695 . . . . 71.45 112.281 -173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -54.43 -38.91 89.59 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.266 1.977 . . . . 54.11 113.248 166.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -63.29 -29.16 70.53 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 122.973 0.509 . . . . 74.24 111.62 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.462 HD12 ' NH1' ' A' ' 111' ' ' ARG . 38.0 mm -69.9 -41.47 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.139 0.575 . . . . 60.02 110.052 172.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.542 HD21 ' HA3' ' C' ' 82' ' ' GLY . 95.4 mt -75.8 -25.3 56.26 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.208 -0.905 . . . . 71.3 111.924 -174.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -56.88 -46.25 99.88 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 124.596 1.158 . . . . 73.54 113.852 -172.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -54.63 -40.24 85.09 Favored 'Trans proline' 0 C--N 1.377 2.074 0 C-N-CA 122.359 2.04 . . . . 73.2 114.074 174.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.437 ' OH ' ' HG2' ' A' ' 111' ' ' ARG . 57.1 m-85 -71.24 -39.99 71.31 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.811 0.445 . . . . 74.41 110.34 -179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.92 -40.2 94.66 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-N 115.489 -0.778 . . . . 74.31 110.546 175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 34.6 ttt-85 -59.27 -54.33 48.06 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.248 1.019 . . . . 64.45 109.91 175.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -62.33 -35.01 77.74 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.043 0.839 . . . . 60.12 111.1 -175.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 26.1 t -71.24 -36.84 71.94 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.307 0.643 . . . . 71.42 110.973 -176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.469 ' O ' HG23 ' C' ' 118' ' ' VAL . 77.8 mt -72.19 -50.1 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 109.4 -0.593 . . . . 70.35 109.4 173.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 78.6 m -57.19 -33.59 67.63 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.338 1.055 . . . . 73.21 110.793 -177.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 29.3 t -64.52 -54.41 32.77 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 115.352 -0.84 . . . . 74.13 108.74 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.535 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -55.32 -40.16 70.83 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 124.808 1.243 . . . . 71.54 112.76 179.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.469 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.1 t -64.62 -48.44 84.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 C-N-CA 123.803 0.841 . . . . 71.24 109.411 177.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.464 ' HB2' HE21 ' C' ' 125' ' ' GLN . 36.4 t -66.98 -28.06 67.96 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.606 -1.179 . . . . 71.41 111.335 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.4 HH12 ' CD ' ' D' ' 112' ' ' GLU . 77.1 mtt-85 -70.67 -37.38 73.66 Favored 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 123.738 0.815 . . . . 62.52 109.271 176.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.34 3.28 73.41 Favored Glycine 0 C--N 1.354 1.562 0 O-C-N 123.912 0.757 . . . . 74.21 113.363 173.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.449 HG23 ' HB3' ' D' ' 17' ' ' TYR . 66.0 p 60.28 28.45 18.06 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.036 1.734 . . . . 73.04 112.731 179.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -97.46 161.76 24.86 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.545 1.138 . . . . 74.25 111.07 -178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.431 ' HB3' ' H ' ' E' ' 138' ' ' ALA . 20.1 Cg_endo -58.37 119.3 6.47 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.342 2.695 . . . . 70.41 112.384 175.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.464 HE21 ' HB2' ' C' ' 119' ' ' SER . 90.1 mt-30 -62.13 146.88 49.29 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.556 1.142 . . . . 54.42 113.416 -172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.607 HD11 HG11 ' C' ' 40' ' ' VAL . 4.4 mm? -106.85 95.12 5.5 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.069 0.948 . . . . 65.5 108.958 179.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -90.35 90.83 8.22 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.325 -0.991 . . . . 73.24 108.325 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 86.0 mt -72.73 126.18 29.29 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 114.909 -1.041 . . . . 75.11 110.807 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -74.67 156.12 86.86 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 124.091 0.956 . . . . 65.53 111.292 -177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -68.86 124.74 11.77 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 122.177 1.918 . . . . 72.32 111.851 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.4 p -98.96 138.01 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 123.041 0.537 . . . . 70.25 109.556 176.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.632 ' HB2' ' HB3' ' C' ' 135' ' ' ALA . 23.8 p30 -88.1 61.5 6.33 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-O 121.904 0.859 . . . . 65.33 110.234 178.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -69.98 -32.22 70.31 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.851 -1.068 . . . . 74.32 111.149 -174.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -73.66 -33.97 64.73 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.71 0.404 . . . . 72.3 110.054 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.632 ' HB3' ' HB2' ' C' ' 132' ' ' ASN . . . -73.61 -30.59 63.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.694 -0.684 . . . . 62.35 112.573 -175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 4.3 pp -65.32 -24.08 67.18 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 118.012 0.369 . . . . 64.2 110.914 177.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -74.45 -55.86 5.49 Favored 'General case' 0 C--N 1.351 0.634 0 N-CA-C 109.465 -0.569 . . . . 74.54 109.465 167.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 15.4 mmt -52.24 -28.15 17.59 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 114.394 1.257 . . . . 62.5 114.394 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -50.33 -29.41 9.78 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.034 1.334 . . . . 74.15 113.209 175.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -152.43 0.0 OUTLIER 'General case' 0 CA--C 1.575 1.926 0 C-N-CA 124.436 1.094 . . . . 75.22 112.486 176.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 24.8 tp 70.68 168.07 0.31 Allowed 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.481 1.112 . . . . 64.23 111.065 169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -143.56 -172.08 3.65 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 123.34 0.656 . . . . 74.31 109.353 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -59.33 124.88 21.46 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 123.805 0.691 . . . . 63.13 109.199 172.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -133.53 165.02 25.85 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.753 0.821 . . . . 71.43 110.211 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -151.57 175.38 12.4 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.292 -0.867 . . . . 70.21 110.005 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.8 83.42 0.7 Allowed Glycine 0 C--N 1.348 1.223 0 N-CA-C 111.989 -0.445 . . . . 62.22 111.989 176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -65.72 143.87 57.26 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.973 0.909 . . . . 52.11 111.213 -178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -57.08 -45.05 92.85 Favored Glycine 0 C--N 1.353 1.481 0 O-C-N 123.867 0.729 . . . . 62.43 113.607 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.9 t -99.16 159.95 14.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.876 -0.416 . . . . 54.54 109.876 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -136.22 157.66 46.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.439 0.696 . . . . 52.33 109.479 174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -161.89 172.59 15.8 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 123.029 0.532 . . . . 71.13 109.787 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -83.45 76.06 9.96 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.455 0.645 . . . . 73.31 109.774 177.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 25.0 tp60 -88.9 96.58 10.76 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.645 -0.872 . . . . 73.12 108.645 173.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -79.56 150.91 30.96 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 115.443 -0.798 . . . . 71.44 109.995 175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.208 0 C-N-CA 123.458 0.703 . . . . 72.41 110.101 -175.009 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.483 1.184 0 N-CA-C 110.186 -0.301 . . . . 64.21 110.186 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 60.4 m -146.24 120.92 9.82 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.507 0.723 . . . . 61.12 110.779 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.31 72.17 1.24 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 105.941 -1.874 . . . . 74.42 105.941 168.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -132.25 113.73 13.6 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.977 -1.011 . . . . 75.11 109.617 -172.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.4 HD22 HG23 ' D' ' 149' ' ' THR . 5.8 p30 -157.59 121.41 4.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.837 0.855 . . . . 70.41 109.722 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -133.06 -78.11 0.49 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 108.227 -1.027 . . . . 72.31 108.227 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 24.0 m -151.49 51.21 0.82 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.705 -1.22 . . . . 74.31 107.705 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.88 -6.2 58.89 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.074 -0.966 . . . . 72.01 111.497 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.559 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.6 ptm -33.4 134.32 0.14 Allowed 'General case' 0 C--N 1.365 1.277 0 C-N-CA 124.745 1.218 . . . . 73.42 113.28 166.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.6 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 40.0 m -128.64 146.63 50.81 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.926 -0.768 . . . . 74.25 108.926 175.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.476 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 49.9 t80 -155.93 102.44 2.17 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.483 -1.303 . . . . 73.23 107.483 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -124.23 139.99 53.39 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.062 0.545 . . . . 64.32 110.027 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 50.7 mm -85.58 110.2 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.194 0.998 . . . . 62.41 108.97 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -89.26 -47.43 8.06 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.04 0.136 . . . . 74.12 111.357 177.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 21.6 ttt180 -169.23 119.74 0.7 Allowed 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 119.423 -0.323 . . . . 71.13 110.341 -170.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.6 mp -107.22 136.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.215 -1.031 . . . . 73.2 108.215 175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.449 ' HB3' HG23 ' C' ' 122' ' ' THR . 40.0 p90 -165.99 174.32 9.57 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 121.637 0.732 . . . . 65.11 111.769 -174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -101.73 128.12 48.2 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.388 -0.823 . . . . 73.1 109.088 177.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.466 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.3 mtpt -98.46 -16.49 19.2 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.873 0.469 . . . . 63.01 110.244 176.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.728 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.6 t70 -161.2 141.88 11.21 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.277 1.031 . . . . 71.42 109.496 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' C' ' 117' ' ' MET . 61.9 mt -144.49 145.22 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 125.264 1.426 . . . . 71.34 107.676 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -148.25 144.05 27.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.872 0.869 . . . . 74.0 109.631 173.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.45 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.2 t80 -152.7 127.1 9.28 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.774 -1.565 . . . . 74.11 106.774 172.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 45.4 mt-10 -133.61 120.81 21.18 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.434 0.693 . . . . 63.33 109.481 -176.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -130.14 83.88 61.87 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 108.368 -0.975 . . . . 73.23 108.368 178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.62 -50.47 0.18 Allowed 'Trans proline' 0 C--N 1.382 2.291 0 C-N-CA 123.083 2.522 . . . . 62.11 111.725 -179.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.511 ' O ' HG23 ' D' ' 31' ' ' VAL . 56.2 m-20 -89.34 31.8 0.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.183 0.993 . . . . 70.24 109.765 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -58.41 -48.73 96.43 Favored Pre-proline 0 CA--C 1.561 1.4 0 N-CA-C 114.736 1.384 . . . . 75.51 114.736 -170.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.19 -7.09 12.06 Favored 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 121.595 1.53 . . . . 71.22 112.558 174.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.513 ' HA ' HE21 ' D' ' 33' ' ' GLN . 19.3 t-160 -83.78 -36.31 23.67 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.878 1.271 . . . . 74.05 110.123 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.665 HG21 ' HA ' ' D' ' 73' ' ' ALA . 92.0 t -69.43 -25.99 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 123.544 0.738 . . . . 53.41 110.207 176.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -60.23 -24.53 64.93 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 124.21 1.004 . . . . 51.54 111.974 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' D' ' 30' ' ' HIS . 38.8 mt-30 -81.54 -14.16 57.21 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.753 0.821 . . . . 74.0 112.209 -177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -121.33 110.72 16.45 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.999 0.919 . . . . 62.21 109.818 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.01 91.85 8.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.879 0.871 . . . . 72.4 110.621 -173.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.656 ' HB3' HD11 ' D' ' 68' ' ' LEU . 38.6 t-105 -168.23 163.98 13.17 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 176.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.593 HE21 ' HG3' ' D' ' 124' ' ' PRO . 1.2 mp0 -90.87 116.15 65.8 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 123.302 0.641 . . . . 42.2 110.455 176.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.417 ' HG3' ' HB2' ' D' ' 68' ' ' LEU . 85.7 Cg_exo -47.35 149.03 4.46 Favored 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 124.855 3.703 . . . . 60.12 116.078 -178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' D' ' 66' ' ' ALA . 60.8 mm-40 -64.89 112.09 3.13 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 108.734 -0.839 . . . . 53.33 108.734 169.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.574 HG21 ' HG ' ' F' ' 139' ' ' LEU . 76.6 t -109.37 117.15 53.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 CA-C-O 121.457 0.646 . . . . 61.53 110.801 -177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.74 147.65 23.11 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-N 114.497 -1.229 . . . . 61.25 108.074 164.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.42 HD13 ' H ' ' D' ' 42' ' ' LEU . 0.0 OUTLIER -128.42 154.96 45.49 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.079 -1.082 . . . . 63.43 108.079 176.245 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.571 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 32.2 t70 -150.43 155.84 40.31 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.38 0.672 . . . . 74.13 109.395 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -134.9 139.69 45.19 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.053 -0.721 . . . . 75.5 109.053 174.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -141.49 132.12 25.55 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 106.968 -1.493 . . . . 55.43 106.968 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 6.4 t -104.25 163.46 12.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.455 0.57 . . . . 75.2 110.754 -174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -160.92 172.42 16.97 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.068 0.947 . . . . 62.12 109.422 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 71.6 p -166.97 178.29 5.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.027 0.531 . . . . 65.44 111.138 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 47.8 t -169.89 118.0 0.59 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.979 1.312 . . . . 55.41 108.114 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -79.53 122.22 26.2 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.785 -0.45 . . . . 71.13 109.785 178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 44.8 mt -90.11 -36.62 14.74 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.215 0.606 . . . . 73.42 109.88 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.45 -176.54 4.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.968 0.907 . . . . 73.31 110.721 179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -64.39 122.49 16.84 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 114.956 -1.02 . . . . 75.22 109.165 175.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 65.89 1.24 1.78 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 125.027 1.331 . . . . 71.53 113.044 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.13 116.05 51.33 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 N-CA-C 108.88 -0.785 . . . . 55.34 108.88 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -124.93 162.58 24.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.218 -1.03 . . . . 74.45 108.218 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -131.18 131.93 44.38 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 105.736 -1.95 . . . . 74.45 105.736 173.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 92.1 t -125.61 136.23 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 108.625 -0.88 . . . . 75.44 108.625 -174.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 58.5 t -116.95 138.58 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 C-N-CA 123.521 0.728 . . . . 73.1 109.688 -177.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' D' ' 103' ' ' PRO . 0.0 OUTLIER -118.35 118.12 30.91 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 107.638 -1.245 . . . . 43.23 107.638 177.184 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 20.0 ttm-85 -99.24 103.22 15.06 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.287 1.035 . . . . 65.14 108.323 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.09 124.95 50.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 108.511 -0.922 . . . . 72.32 108.511 169.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.571 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 29.9 m -108.96 145.39 35.55 Favored 'General case' 0 CA--C 1.536 0.41 0 O-C-N 123.65 0.594 . . . . 72.54 110.066 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -135.27 133.39 52.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 C-N-CA 124.843 1.257 . . . . 73.02 108.544 176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 46.3 m -127.69 115.63 19.02 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.152 -1.055 . . . . 74.43 108.152 172.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' D' ' 39' ' ' GLU . . . -124.81 130.57 52.65 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.032 0.533 . . . . 54.54 109.935 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.2 m -142.08 130.08 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.756 0.822 . . . . 72.24 108.95 177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' D' ' 36' ' ' TRP . 23.6 tp -105.35 108.21 19.61 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.879 -0.786 . . . . 65.32 108.879 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.44 -110.41 3.35 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 110.879 -0.888 . . . . 61.23 110.879 -174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.89 7.49 9.32 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.799 0.84 . . . . 63.11 110.191 -178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -117.68 147.86 42.52 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.191 0.596 . . . . 73.34 111.162 -175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 100.0 m -65.54 115.12 5.42 Favored 'General case' 0 C--N 1.348 0.509 0 O-C-N 123.78 0.675 . . . . 61.5 109.978 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.665 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -82.89 -63.98 1.26 Allowed 'General case' 0 C--O 1.238 0.463 0 O-C-N 123.604 0.565 . . . . 74.23 110.35 -178.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -156.13 139.03 15.31 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.567 -0.742 . . . . 70.32 109.794 172.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 66.9 mt -109.0 149.7 28.86 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 107.448 -1.316 . . . . 74.31 107.448 174.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.6 t -158.39 139.33 13.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 119.654 -0.212 . . . . 65.42 110.578 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -154.84 123.21 5.99 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 122.733 0.413 . . . . 60.43 109.954 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 77.2 t -123.8 117.6 51.58 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 C-N-CA 123.443 0.697 . . . . 63.33 109.833 -178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.728 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.3 mt-30 -93.94 88.17 5.63 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.581 0.705 . . . . 71.25 109.266 171.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.451 ' O ' HD13 ' D' ' 106' ' ' LEU . 7.4 tp-100 -79.69 108.26 13.1 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 114.245 -1.343 . . . . 72.43 109.209 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.23 172.83 32.32 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 121.154 0.308 . . . . 63.23 112.394 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -173.25 138.32 4.57 Favored Glycine 0 C--O 1.225 -0.439 0 N-CA-C 111.822 -0.511 . . . . 64.23 111.822 178.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 50.7 mt -90.56 120.74 39.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 109.066 -0.716 . . . . 65.3 109.066 177.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -125.47 125.65 43.64 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.608 1.163 . . . . 71.14 109.226 -176.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.9 m -82.42 95.38 7.65 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.99 -0.744 . . . . 71.41 108.99 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 64.1 mt -106.56 115.74 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 N-CA-C 108.921 -0.77 . . . . 45.31 108.921 -172.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -142.49 168.35 19.93 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.823 0.849 . . . . 65.05 110.698 -174.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 74.5 -2.13 48.2 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.845 0.716 . . . . 61.23 114.676 173.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 30.5 pt -135.51 157.31 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.327 1.051 . . . . 64.21 109.141 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.42 173.11 12.95 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.628 0.771 . . . . 64.03 111.098 -172.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.49 -121.78 21.76 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 114.984 0.754 . . . . 50.02 114.984 171.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 40.4 p -68.85 -18.78 64.21 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.717 0.807 . . . . 75.21 112.654 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.428 ' HA ' HD21 ' D' ' 141' ' ' LEU . 11.6 mp0 -75.27 -48.53 22.84 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.22 0.608 . . . . 74.24 110.287 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -75.04 -25.78 58.96 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 116.678 -0.237 . . . . 63.42 110.379 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.98 -34.42 75.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.38 0.672 . . . . 62.41 110.495 173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -66.63 -36.35 82.35 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.881 0.872 . . . . 74.32 110.552 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' D' ' 101' ' ' TYR . 91.0 m -67.56 -54.08 22.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 123.254 0.346 . . . . 74.4 111.04 178.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.62 -19.69 60.79 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 122.327 -0.233 . . . . 54.15 111.597 -177.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.48 -27.2 10.06 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-O 119.298 -0.723 . . . . 74.11 114.175 -174.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 -51.53 0.43 Allowed 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 117.959 0.88 . . . . 72.52 112.891 -170.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . 0.543 ' HB3' ' HA ' ' D' ' 97' ' ' CYS . 49.2 t80 -73.33 -55.19 6.73 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 112.752 0.649 . . . . 72.35 112.752 -169.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.476 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 58.3 m -60.46 -44.64 96.3 Favored Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 118.517 -0.754 . . . . 62.43 111.676 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.56 ' HB3' ' HG ' ' D' ' 60' ' ' LEU . 81.0 Cg_exo -53.02 -35.69 72.95 Favored 'Trans proline' 0 C--N 1.396 3.053 0 C-N-CA 122.492 2.128 . . . . 61.23 114.046 166.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -66.15 -39.67 89.98 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 123.572 0.749 . . . . 71.52 109.721 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 51.6 mm -63.7 -41.03 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 123.497 0.719 . . . . 73.3 110.079 174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.451 HD13 ' O ' ' D' ' 80' ' ' GLN . 91.8 mt -75.43 -24.43 57.09 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 115.076 -0.965 . . . . 64.24 112.14 -175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -62.84 -42.49 78.34 Favored Pre-proline 0 N--CA 1.482 1.157 0 CA-C-O 117.881 -1.056 . . . . 35.51 113.697 -170.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -52.29 -38.82 73.17 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 121.923 1.748 . . . . 75.2 113.59 170.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -82.55 -32.14 28.75 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.637 0.775 . . . . 71.23 111.831 -177.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.97 -41.75 74.04 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.236 0.614 . . . . 64.31 109.807 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.448 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 35.0 ttp180 -61.07 -45.9 92.87 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 124.338 1.024 . . . . 72.24 110.282 172.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.4 ' CD ' HH12 ' C' ' 120' ' ' ARG . 1.7 tm-20 -55.26 -50.25 69.99 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 124.539 1.149 . . . . 75.24 111.694 -174.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' D' ' 21' ' ' ILE . 42.0 t -60.97 -40.98 95.45 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 124.249 0.968 . . . . 33.41 111.217 -178.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.626 HG12 ' SG ' ' D' ' 76' ' ' CYS . 71.8 mt -60.19 -55.9 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 123.369 0.668 . . . . 61.23 110.204 173.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 43.2 m -53.51 -40.66 65.61 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.117 1.367 . . . . 73.11 110.65 -176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.3 t -69.51 -47.87 62.42 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.412 -1.267 . . . . 62.21 110.954 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 69.0 mtm -67.08 -30.95 71.13 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.078 0.399 . . . . 75.45 112.078 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -67.39 -46.06 84.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 O-C-N 123.557 0.535 . . . . 61.24 109.868 174.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.5 p -71.18 -25.28 62.46 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.477 -0.329 . . . . 54.2 110.757 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -75.69 -33.71 60.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.966 0.906 . . . . 74.52 109.511 173.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.56 1.05 67.88 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 115.552 -0.749 . . . . 61.15 112.537 172.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.5 p 56.04 40.44 30.31 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.265 1.826 . . . . 71.22 112.106 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.444 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 58.4 m-85 -103.68 169.68 7.06 Favored Pre-proline 0 CA--C 1.554 1.114 0 C-N-CA 125.075 1.35 . . . . 73.11 108.172 171.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.593 ' HG3' HE21 ' D' ' 37' ' ' GLN . 34.6 Cg_endo -62.92 138.92 71.08 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 121.899 1.732 . . . . 75.54 109.864 173.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -63.36 156.01 27.13 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 118.425 0.557 . . . . 75.2 111.176 -174.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.401 HD21 HD12 ' F' ' 142' ' ' ILE . 2.8 tt -116.85 115.11 24.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.128 -1.064 . . . . 64.22 108.128 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -107.78 92.96 4.28 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.474 0.71 . . . . 74.42 109.642 -178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.448 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 68.9 mt -67.17 117.24 8.93 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.848 -0.614 . . . . 74.22 109.543 173.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.47 133.13 94.31 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 122.359 0.263 . . . . 74.23 110.494 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.18 109.29 2.79 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.222 1.948 . . . . 61.44 110.465 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 93.7 t -107.46 111.08 34.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.906 0.882 . . . . 72.01 109.046 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -83.1 73.2 10.08 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 122.024 0.916 . . . . 71.42 109.626 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -79.85 -14.57 58.56 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.904 -1.043 . . . . 72.34 109.764 176.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -50.87 -40.4 56.25 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.214 1.406 . . . . 73.53 111.495 168.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -56.41 -32.55 64.95 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 124.47 1.106 . . . . 71.2 112.865 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 60.5 tp -68.58 -45.04 73.09 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.416 0.686 . . . . 63.22 110.655 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -72.86 -34.86 67.02 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.787 -0.642 . . . . 64.43 110.661 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 16.2 ttp -67.91 -31.97 72.1 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.104 0.961 . . . . 71.31 110.443 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -54.46 -41.25 69.24 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.373 1.069 . . . . 45.33 111.206 173.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -66.79 -41.4 87.7 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.765 0.826 . . . . 74.12 111.304 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.668 ' HA ' HE21 ' D' ' 144' ' ' GLN . 10.9 mp -60.56 -34.12 73.7 Favored 'General case' 0 N--CA 1.48 1.074 0 O-C-N 123.744 0.652 . . . . 72.31 111.427 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' D' ' 138' ' ' MET . 45.5 mt-30 -81.05 2.35 27.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.244 0.617 . . . . 65.33 111.72 -178.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -129.26 45.4 2.81 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.27 0.628 . . . . 72.5 109.42 177.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . 0.668 HE21 ' HA ' ' D' ' 141' ' ' LEU . 28.7 pt20 -161.96 148.94 13.96 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.313 -0.858 . . . . 75.23 109.75 176.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.14 150.07 16.38 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.46 0.704 . . . . 71.05 109.723 177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.46 162.6 29.97 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 112.063 -0.415 . . . . 43.13 112.063 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.84 -177.4 4.54 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.383 1.073 . . . . 73.42 109.517 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.26 69.94 1.3 Allowed Glycine 0 C--N 1.341 0.844 0 N-CA-C 111.609 -0.596 . . . . 42.45 111.609 -174.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . 0.4 HG23 HD22 ' D' ' 5' ' ' ASN . 16.6 p -62.04 168.92 2.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.97 0.908 . . . . 74.43 112.628 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -82.18 38.41 0.54 Allowed 'General case' 0 CA--C 1.564 1.481 0 C-N-CA 123.876 0.87 . . . . 70.35 110.386 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 55.31 -164.32 0.13 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 125.4 1.48 . . . . 65.31 112.383 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -137.39 -39.02 0.59 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.417 0.687 . . . . 75.05 109.172 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -88.32 153.57 21.09 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.72 1.208 . . . . 75.14 109.268 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -70.65 -67.55 0.49 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.336 0.654 . . . . 61.44 110.752 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.793 0 C-N-CA 123.752 0.821 . . . . 64.01 109.081 177.359 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 108.96 -0.756 . . . . 74.33 108.96 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 63.84 -86.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.772 1.229 . . . . 72.42 111.167 -175.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 110' ' ' ALA . . . . . . . . . . . . . . . 66.51 157.14 0.11 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 125.057 1.343 . . . . 70.25 111.878 -172.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 111' ' ' PHE . . . . . . . . . . . . . 79.8 t80 74.92 -48.32 0.64 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 126.064 1.746 . . . . 74.51 111.808 -176.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 112' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -62.34 161.37 11.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.358 1.063 . . . . 73.24 112.509 -178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 113' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -81.62 -178.09 6.81 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.657 -1.156 . . . . 63.03 111.307 177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 67.87 113.87 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.107 1.363 . . . . 74.3 109.14 -174.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 115' ' ' LEU . . . . . 0.47 HD21 ' HB ' ' B' ' 89' ' ' ILE . 6.3 mp -80.77 -101.94 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 118.759 -0.638 . . . . 74.04 111.447 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 116' ' ' TYR . . . . . 0.411 ' H ' HD12 ' B' ' 98' ' ' LEU . 2.6 m-30 59.77 111.72 0.02 OUTLIER Pre-proline 0 CA--C 1.564 1.495 0 C-N-CA 124.285 1.034 . . . . 65.15 111.835 -168.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 117' ' ' PRO . . . . . 0.427 ' HB2' ' HB2' ' E' ' 120' ' ' TRP . 92.8 Cg_exo -47.21 121.81 5.72 Favored 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.727 2.951 . . . . 73.44 113.401 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 118' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -63.36 84.48 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.39 0 C-N-CA 123.943 0.897 . . . . 74.43 110.519 -175.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 119' ' ' THR . . . . . . . . . . . . . 30.3 m 56.95 86.26 0.07 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.287 1.035 . . . . 72.03 111.034 -168.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 120' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' E' ' 117' ' ' PRO . 73.2 t-105 -71.58 140.06 49.66 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 109.218 -0.66 . . . . 71.02 109.218 173.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 121' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -163.48 -153.57 0.24 Allowed 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.12 -1.437 . . . . 70.23 107.12 177.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 122' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' B' ' 140' ' ' TYR . . . 76.16 -14.36 0.81 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.936 1.294 . . . . 71.32 112.933 175.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 123' ' ' VAL . . . . . . . . . . . . . 6.9 p -70.37 85.29 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.942 1.353 . . . . 73.31 109.982 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 124' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -122.59 -52.62 1.91 Allowed 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.209 -1.36 . . . . 73.14 109.632 -169.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 125' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 69.19 -70.77 0.13 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.877 1.271 . . . . 72.32 110.767 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 126' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 68.07 103.49 0.05 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.742 1.217 . . . . 64.35 110.789 175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 127' ' ' GLY . . . . . . . . . . . . . . . 131.45 -176.1 19.3 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 116.171 -0.468 . . . . 73.34 112.396 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 128' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -122.32 143.36 49.67 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.936 0.895 . . . . 72.03 109.482 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 129' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.81 -17.02 61.61 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.493 0.717 . . . . 74.32 112.841 -176.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 130' ' ' ILE . . . . . . . . . . . . . 14.3 tt -69.07 103.49 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 CA-C-O 121.574 0.702 . . . . 71.34 110.615 -178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.22 -65.37 1.02 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.735 0.814 . . . . 63.42 110.221 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 132' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -108.52 150.49 40.74 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 123.812 0.845 . . . . 72.14 110.201 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 133' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.85 -21.78 18.27 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.594 2.196 . . . . 64.11 111.944 172.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 134' ' ' ILE . . . . . . . . . . . . . 6.2 tt -78.11 86.47 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.19 0 CA-C-O 122.57 1.176 . . . . 71.42 109.787 173.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 135' ' ' ALA . . . . . . . . . . . . . . . -90.56 -14.0 33.4 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.447 -1.252 . . . . 62.4 109.652 168.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 136' ' ' VAL . . . . . . . . . . . . . 16.1 t 70.75 -1.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 C-N-CA 126.177 1.791 . . . . 54.44 110.647 -173.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 137' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -73.0 84.11 1.26 Allowed 'General case' 0 C--N 1.363 1.184 0 C-N-CA 124.036 0.934 . . . . 73.13 111.287 -174.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 138' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' C' ' 124' ' ' PRO . . . -174.01 102.66 0.11 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 124.914 1.286 . . . . 40.45 107.918 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 139' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.5 116.72 26.93 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 109.294 -0.632 . . . . 74.21 109.294 -179.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 140' ' ' SER . . . . . . . . . . . . . 47.1 t -74.43 -68.68 0.51 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.387 0.675 . . . . 73.12 110.643 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 141' ' ' LEU . . . . . 0.726 HD22 ' HG2' ' C' ' 39' ' ' GLU . 5.0 mp -96.78 110.1 22.64 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 109.484 -0.562 . . . . 71.25 109.484 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 142' ' ' ILE . . . . . . . . . . . . . 10.5 tt -146.68 127.2 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 122.964 0.506 . . . . 63.12 110.968 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 143' ' ' TYR . . . . . . . . . . . . . 1.4 t80 63.96 9.6 4.7 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 125.979 1.712 . . . . 64.14 112.885 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 144' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -88.81 114.71 25.72 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 109.29 -0.633 . . . . 64.31 109.29 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 145' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -143.54 -59.4 0.41 Allowed 'General case' 0 C--O 1.238 0.495 0 N-CA-C 107.676 -1.231 . . . . 74.52 107.676 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 146' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -172.31 -55.63 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.076 0.95 . . . . 64.41 109.974 173.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 147' ' ' LEU . . . . . . . . . . . . . 90.6 mt 63.62 162.0 0.11 Allowed 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 125.442 1.497 . . . . 60.44 112.563 -174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 148' ' ' LEU . . . . . . . . . . . . . 7.0 mp -107.86 144.38 29.22 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 109.103 -0.702 . . . . 75.03 109.103 175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 149' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo . . . . . 0 CA--C 1.563 1.933 0 C-N-CA 122.632 2.221 . . . . 62.35 111.558 168.1 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 109.661 -0.496 . . . . 71.41 109.661 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -71.86 87.21 0.99 Allowed 'General case' 0 CA--C 1.555 1.148 0 CA-C-O 121.779 0.799 . . . . 75.54 111.129 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.43 120.31 16.83 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.075 0.95 . . . . 72.4 110.72 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 111' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -108.26 136.48 47.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.065 0.546 . . . . 73.5 110.377 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 112' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -115.06 111.8 21.65 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.949 0.9 . . . . 73.34 109.442 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -108.89 104.29 13.51 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.497 0.719 . . . . 73.2 110.037 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 114' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -177.9 30.23 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.073 1.349 . . . . 72.31 109.507 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 115' ' ' LEU . . . . . 0.615 HD22 ' HA ' ' A' ' 90' ' ' GLU . 93.2 mt 63.7 32.55 13.68 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.426 1.09 . . . . 71.34 110.659 -170.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 116' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.2 51.41 3.87 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 114.727 -1.124 . . . . 75.22 110.248 174.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 117' ' ' PRO . . . . . 0.51 ' HD2' ' HB2' ' A' ' 95' ' ' ALA . 56.2 Cg_endo -90.13 13.66 2.24 Favored 'Trans proline' 0 C--N 1.388 2.653 0 C-N-CA 122.316 2.011 . . . . 52.32 112.309 177.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 118' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -145.41 108.11 4.48 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.907 0.883 . . . . 74.1 108.665 -173.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 119' ' ' THR . . . . . . . . . . . . . 22.3 p -99.29 -42.61 6.93 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.37 1.068 . . . . 71.42 109.813 176.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 120' ' ' TRP . . . . . . . . . . . . . 20.5 t90 57.46 76.56 0.31 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.075 1.35 . . . . 71.21 111.211 -175.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 121' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -71.16 111.5 6.56 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.147 -0.933 . . . . 71.5 108.558 172.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 122' ' ' ALA . . . . . . . . . . . . . . . -148.58 -58.17 0.22 Allowed 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.911 0.884 . . . . 64.35 109.652 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 123' ' ' VAL . . . . . . . . . . . . . 32.4 m -72.17 155.46 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.606 -0.724 . . . . 70.04 111.799 -175.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 124' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -149.62 139.54 21.93 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.741 0.816 . . . . 71.32 109.398 178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 125' ' ' TYR . . . . . 0.433 ' CE2' HD11 ' A' ' 128' ' ' LEU . 1.8 p90 -116.42 16.05 15.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.249 1.02 . . . . 74.2 111.181 -171.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 126' ' ' ASN . . . . . 0.468 ' HA ' HD11 ' A' ' 42' ' ' LEU . 7.2 t30 -68.89 99.01 0.99 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.543 0.737 . . . . 75.31 110.155 -178.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 127' ' ' GLY . . . . . . . . . . . . . . . -144.57 153.41 25.13 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.557 -1.017 . . . . 21.13 110.557 177.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 128' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -76.14 99.98 4.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.536 0.684 . . . . 74.34 110.17 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 129' ' ' LEU . . . . . 0.538 ' H ' HD23 ' F' ' 129' ' ' LEU . 0.7 OUTLIER -88.58 50.98 2.06 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.148 0.975 . . . . 73.12 108.871 171.431 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' F' F ' 130' ' ' ILE . . . . . . . . . . . . . 7.1 tp -73.02 124.45 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 CA-C-N 114.696 -1.138 . . . . 75.23 109.141 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.91 144.23 41.22 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-N 115.878 -0.601 . . . . 54.44 110.049 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 132' ' ' TYR . . . . . 0.42 ' HA ' ' HD3' ' F' ' 133' ' ' PRO . 57.4 t80 -59.88 122.53 66.32 Favored Pre-proline 0 CA--C 1.544 0.743 0 N-CA-C 108.57 -0.9 . . . . 72.24 108.57 170.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 133' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' F' ' 132' ' ' TYR . 4.0 Cg_exo -74.49 70.39 4.89 Favored 'Trans proline' 0 C--N 1.379 2.162 0 C-N-CA 122.699 2.266 . . . . 60.21 111.328 -179.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 134' ' ' ILE . . . . . . . . . . . . . 11.9 tt -69.57 139.39 20.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 115.044 -0.98 . . . . 64.43 109.642 178.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.51 87.35 0.47 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.94 0.496 . . . . 54.34 109.97 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 136' ' ' VAL . . . . . 0.43 HG12 ' HD3' ' D' ' 124' ' ' PRO . 15.6 m -131.03 77.55 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.377 1.071 . . . . 62.31 110.464 -177.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 137' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -72.02 -70.31 0.34 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.489 -0.778 . . . . 65.54 109.833 177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 138' ' ' ALA . . . . . . . . . . . . . . . 170.13 151.02 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 126.369 1.868 . . . . 74.34 107.187 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 139' ' ' LEU . . . . . 0.574 ' HG ' HG21 ' D' ' 40' ' ' VAL . 3.2 mm? -70.67 83.98 0.63 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.447 -0.575 . . . . 75.45 109.447 174.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 140' ' ' SER . . . . . . . . . . . . . 16.7 m -97.73 -22.84 16.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.392 1.077 . . . . 30.42 110.506 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 141' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -69.32 -5.82 25.66 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.856 0.862 . . . . 73.21 112.807 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 142' ' ' ILE . . . . . 0.401 HD12 HD21 ' D' ' 126' ' ' LEU . 10.8 tt -64.39 154.23 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.462 0 C-N-CA 124.245 1.018 . . . . 73.13 110.842 174.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 143' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 67.2 85.29 0.14 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.963 1.305 . . . . 75.22 109.423 -173.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 144' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -64.61 -51.89 60.33 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.096 0.958 . . . . 62.1 111.721 -171.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 145' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -86.83 -75.35 0.4 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 110.066 -0.346 . . . . 75.42 110.066 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -151.22 -174.95 4.97 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.065 0.46 . . . . 64.42 110.667 -175.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 147' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -157.29 25.62 0.3 Allowed 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.553 1.141 . . . . 70.24 109.942 -171.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 148' ' ' LEU . . . . . . . . . . . . . 10.9 mp 72.27 157.48 0.16 Allowed Pre-proline 0 N--CA 1.496 1.831 0 C-N-CA 124.909 1.284 . . . . 53.41 111.068 -172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 149' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo . . . . . 0 C--N 1.395 2.979 0 C-N-CA 123.798 2.999 . . . . 74.32 114.575 -176.875 . . . . . . . . 0 0 . 1 stop_ save_